PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Cheng, WW; Wu, ZY; Liang, S; Fu, HL; Wu, SQ; Tang, YY; Ye, ZY; Wang, H				Cheng, Weiwei; Wu, Zhenyu; Liang, Sheng; Fu, Hongliang; Wu, Shuqi; Tang, Yiyun; Ye, Zhiyi; Wang, Hui			Comparison of F-18-AIF-NOTA-PRGD2 and F-18-FDG Uptake in Lymph Node Metastasis of Differentiated Thyroid Cancer	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; LUNG-CANCER; IN-VIVO; INTEGRIN; PET; TUMOR; EXPRESSION; CARCINOMA; ANGIOGENESIS; DIAGNOSIS	A widespread application of integrin alpha(v)beta(3) imaging has been emerging in both pre-clinical and clinical studies. But few studies reported its value as compared with F-18-FDG PET, especially for differentiated thyroid cancer (DTC). In this study, we compared the tracer uptake of F-18-AIF-NOTA-PRGD2 and F-18-FDG in lymph node metastasis of DTC to evaluate F-18-AIF-NOTA-PRGD2 as compared with F-18-FDG. Methods: 20 DTC patients with presumptive lymph node metastasis were examined with F-18-AIF-NOTA-PRGD2 and F-18-FDG PET/CT. 16 patients undergoing fine needle aspiration biopsy (FNAB) were evaluated by cytology results. For lesions without FNAB, the findings of clinical staging procedures served as the standard of reference (including neck ultrasound and serum thyroglobulin). Results: A total of 39 presumptive lymph node metastases were visualized on PET/CT images. 35 lesions were confirmed as malignant by FNAB and other clinical findings. The mean F-18-AIF-NOTA-PRGD2 in radioactive iodine-refractory (RAIR) lesions and benign lesions were 2.5 +/- 0.9 and 2.8 +/- 0.9 respectively. The mean SUV for F-18-FDG in all malignant lesions was 4.5 +/- 1.6 while in benign lesions it was 3.3 +/- 1.2. For all malignant lesions, the mean SUV for F-18-FDG was significantly higher than that for F-18-AIF-NOTA-PRGD2 (P<0.05). No significant correlation was found between the SUVs of F-18-AIF-NOTA-PRGD2 and F-18-FDG for 35 lesions (r = 0.114, P = 0.515). Moreover, 15 lesions of which the diameter larger than 1.5cm had higher F-18-AIFNOTA- PRGD2 uptake as compared with the lesions smaller than 1.5cm. Conclusion: Although most lymph node metastases of DTC showed abnormal uptake of F-18-AIF-NOTA-PRGD2, its diagnostic value was inferior to F-18-FDG. No correlation was found between the uptake of F-18-AIF-NOTA-PRGD2 and F-18-FDG, which may suggest the two tracers provide complementary information in DTC lesions.	[Cheng, Weiwei; Wu, Zhenyu; Liang, Sheng; Fu, Hongliang; Wu, Shuqi; Tang, Yiyun; Ye, Zhiyi; Wang, Hui] Shanghai Jiao Tong Univ, Sch Med, Xin Hua Hosp, Dept Nucl Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Wang, H (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xin Hua Hosp, Dept Nucl Med, Shanghai 200030, Peoples R China.	wanghuishanghai@hotmail.com			National Natural Science Fund [81271612]	National Natural Science Fund(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Fund (no. 81271612). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonov AS, 2011, J CELL PHYSIOL, V226, P469, DOI 10.1002/jcp.22356; Battle MR, 2011, J NUCL MED, V52, P424, DOI 10.2967/jnumed.110.077479; Beer AJ, 2008, J NUCL MED, V49, P22, DOI 10.2967/jnumed.107.045864; Beer AJ, 2011, THERANOSTICS, V1, P48, DOI 10.7150/thno/v01p0048; BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; Caires KC, 2009, REPRODUCTION, V138, P667, DOI 10.1530/REP-09-0020; Carr LL, 2010, CLIN CANCER RES, V16, P5260, DOI 10.1158/1078-0432.CCR-10-0994; Cheng CX, 2011, HELL J NUCL MED, V14, P15; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Danhier F, 2012, MOL PHARMACEUT, V9, P2961, DOI 10.1021/mp3002733; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Gao HK, 2012, EUR J NUCL MED MOL I, V39, P683, DOI 10.1007/s00259-011-2052-1; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Jin J, 2013, ADV HEALTHC IN PRESS, V2; Kenny LM, 2008, J NUCL MED, V49, P879, DOI 10.2967/jnumed.107.049452; Kruger S, 2006, J INTERN MED, V260, P545, DOI 10.1111/j.1365-2796.2006.01729.x; Liu S, 2009, BIOCONJUGATE CHEM, V20, P2199, DOI 10.1021/bc900167c; Martin MNC, 2007, REV ESP MED NUCL, V26, P263; Pacini F, 2012, ANN ONCOL, V23, P110, DOI 10.1093/annonc/mds230; Paik JY, 2005, NUCL MED BIOL, V32, P561, DOI 10.1016/j.nucmedbio.2005.04.016; Pedersen MWB, 2001, NEOPLASIA, V3, P80, DOI 10.1038/sj.neo.7900133; Powles T, 2007, EUR UROL, V51, P1511, DOI 10.1016/j.eururo.2007.01.061; Rivera M, 2008, CANCER-AM CANCER SOC, V113, P48, DOI 10.1002/cncr.23515; Soret M, 2007, J NUCL MED, V48, P932, DOI 10.2967/jnumed.106.035774; Strauss LG, 2004, J NUCL MED, V45, P1528; Wan WX, 2013, J NUCL MED, V54, P691, DOI 10.2967/jnumed.112.113563; Zhao D, 2012, J NUCL MED, V53, P1872, DOI 10.2967/jnumed.112.107821; Zhu ZH, 2012, J NUCL MED, V53, P716, DOI 10.2967/jnumed.111.098988; Zitzmann S, 2002, CANCER RES, V62, P5139	30	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100521	10.1371/journal.pone.0100521	http://dx.doi.org/10.1371/journal.pone.0100521			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956393	Green Published, gold, Green Submitted			2022-12-27	WOS:000338917900062
J	Machado, AMD; Sommer, MOA				Machado, Ana Manuel Dantas; Sommer, Morten O. A.			Human Intestinal Cells Modulate Conjugational Transfer of Multidrug Resistance Plasmids between Clinical Escherichia coli Isolates	PLOS ONE			English	Article							GENE-TRANSFER; GUT INFLAMMATION; MICROFLORA; MICROBIOTA; DIVERSITY; HEALTH	Bacterial conjugation in the human gut microbiota is believed to play a major role in the dissemination of antibiotic resistance genes and virulence plasmids. However, the modulation of bacterial conjugation by the human host remains poorly understood and there is a need for controlled systems to study this process. We established an in vitro co-culture system to study the interaction between human intestinal cells and bacteria. We show that the conjugation efficiency of a plasmid encoding an extended spectrum beta-lactamase is reduced when clinical isolates of Escherichia coli are co-cultured with human intestinal cells. We show that filtered media from co-cultures contain a factor that reduces conjugation efficiency. Protease treatment of the filtered media eliminates this inhibition of conjugation. This data suggests that a peptide or protein based factor is secreted on the apical side of the intestinal cells exposed to bacteria leading to a two-fold reduction in conjugation efficiency. These results show that human gut epithelial cells can modulate bacterial conjugation and may have relevance to gene exchange in the gut.	[Machado, Ana Manuel Dantas; Sommer, Morten O. A.] Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Sommer, Morten O. A.] Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, Horsholm, Denmark	Technical University of Denmark; Technical University of Denmark	Sommer, MOA (corresponding author), Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark.	msom@bio.dtu.dk		Sommer, Morten Otto Alexander/0000-0003-4005-5674	EU FP7-Health Program Evotar [282004]; Lundbeck Foundation; Novo Nordisk Foundation; Danish Free Research Councils; Lundbeck Foundation [R140-2013-13496, R77-2010-6772] Funding Source: researchfish; Novo Nordisk Fonden [NNF10CC1016517, NNF14OC0011335, NNF13SA0009311, NNF13SA0006019] Funding Source: researchfish	EU FP7-Health Program Evotar; Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Free Research Councils; Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation)	This research was funded by the EU FP7-Health Program Evotar (282004) and the Lundbeck Foundation. MOAS acknowledges additional funding from the Novo Nordisk Foundation and The Danish Free Research Councils. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baquero F, 2011, ANTIMICROB AGENTS CH, V55, P3649, DOI 10.1128/AAC.00013-11; Bates S, 1998, J BACTERIOL, V180, P6538, DOI 10.1128/JB.180.24.6538-6543.1998; Burrus V, 2002, MOL MICROBIOL, V46, P601, DOI 10.1046/j.1365-2958.2002.03191.x; Chiller K, 2001, J INVEST DERM SYMP P, V6, P170, DOI 10.1046/j.0022-202x.2001.00043.x; Daniels JB, 2007, APPL ENVIRON MICROB, V73, P8005, DOI 10.1128/AEM.01325-07; Dantas G, 2013, ANNU REV MICROBIOL, V67, P459, DOI 10.1146/annurev-micro-092412-155642; Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061; Eisenhofer G, 1997, J CLIN ENDOCR METAB, V82, P3864, DOI 10.1210/jc.82.11.3864; Faure S, 2010, ANTIMICROB AGENTS CH, V54, P164, DOI 10.1128/AAC.00310-09; FRANKE AE, 1981, J BACTERIOL, V145, P494, DOI 10.1128/JB.145.1.494-502.1981; Halary S, 2010, P NATL ACAD SCI USA, V107, P127, DOI 10.1073/pnas.0908978107; HEINEMANN JA, 1991, TRENDS GENET, V7, P181, DOI 10.1016/0168-9525(91)90122-7; Hull MW, 2007, INFECT DIS CLIN N AM, V21, P265, DOI 10.1016/j.idc.2007.03.015; Karra E, 2010, MOL CELL ENDOCRINOL, V316, P120, DOI 10.1016/j.mce.2009.06.010; KASUYA M, 1964, J BACTERIOL, V88, P322, DOI 10.1128/JB.88.2.322-328.1964; Khoruts A, 2010, J CLIN GASTROENTEROL, V44, P354, DOI 10.1097/MCG.0b013e3181c87e02; Kunz C, 2009, ADV EXP MED BIOL, V639, P67, DOI 10.1007/978-1-4020-8749-3_6; Lester CH, 2006, ANTIMICROB AGENTS CH, V50, P596, DOI 10.1128/AAC.50.2.596-599.2006; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Licht TR, 1999, MICROBIOL-SGM, V145, P2615, DOI 10.1099/00221287-145-9-2615; Licht TR, 1999, ENVIRON MICROBIOL, V1, P23, DOI 10.1046/j.1462-2920.1999.00001.x; Lupp C, 2007, CELL HOST MICROBE, V2, P119, DOI 10.1016/j.chom.2007.06.010; MCCONNELL M A, 1991, Microbial Ecology in Health and Disease, V4, P343; Morelli L, 2008, J NUTR, V138, p1791S, DOI 10.1093/jn/138.9.1791S; Moubareck C, 2003, ANTIMICROB AGENTS CH, V47, P2993, DOI 10.1128/AAC.47.9.2993-2996.2003; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Neish AS, 2009, GASTROENTEROLOGY, V136, P65, DOI 10.1053/j.gastro.2008.10.080; Pedron T, 2008, CELL HOST MICROBE, V3, P344, DOI 10.1016/j.chom.2008.05.010; POULSEN LK, 1995, J BACTERIOL, V177, P5840, DOI 10.1128/jb.177.20.5840-5845.1995; ROBERTS M, 1979, INFECT IMMUN, V24, P982, DOI 10.1128/IAI.24.3.982-984.1979; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Smet A, 2011, J APPL MICROBIOL, V110, P541, DOI 10.1111/j.1365-2672.2010.04907.x; Sommer MOA, 2011, CURR OPIN MICROBIOL, V14, P556, DOI 10.1016/j.mib.2011.07.005; Sommer MOA, 2009, SCIENCE, V325, P1128, DOI 10.1126/science.1176950; Stecher B, 2007, PLOS BIOL, V5, P2177, DOI 10.1371/journal.pbio.0050244; Stecher B, 2012, P NATL ACAD SCI USA, V109, P1269, DOI 10.1073/pnas.1113246109; TATUM EL, 1947, J BACTERIOL, V53, P673, DOI 10.1128/JB.53.6.673-684.1947; Trobos M, 2009, J ANTIMICROB CHEMOTH, V63, P80, DOI 10.1093/jac/dkn437; WADOLKOWSKI EA, 1988, INFECT IMMUN, V56, P1030, DOI 10.1128/IAI.56.5.1030-1035.1988; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Winter SE, 2010, NATURE, V467, P426, DOI 10.1038/nature09415	41	18	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100739	10.1371/journal.pone.0100739	http://dx.doi.org/10.1371/journal.pone.0100739			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955767	Green Submitted, Green Published, gold			2022-12-27	WOS:000338917900092
J	Lyonnet, BB; Diacovich, L; Cabruja, M; Bardou, F; Quemard, A; Gago, G; Gramajo, H				Bazet Lyonnet, Bernardo; Diacovich, Lautaro; Cabruja, Matias; Bardou, Fabienne; Quemard, Annaik; Gago, Gabriela; Gramajo, Hugo			Pleiotropic Effect of AccD5 and AccE5 Depletion in Acyl-Coenzyme A Carboxylase Activity and in Lipid Biosynthesis in Mycobacteria	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; MYCOLIC ACID BIOSYNTHESIS; COA CARBOXYLASE; A CARBOXYLASE; FATTY-ACID; STREPTOMYCES-COELICOLOR; CONDENSING ENZYMES; ESCHERICHIA-COLI; TUBERCULOSIS; TRANSFORMATION	Mycobacteria contain a large variety of fatty acids which are used for the biosynthesis of several complex cell wall lipids that have been implicated in the ability of the organism to resist host defenses. The building blocks for the biosynthesis of all these lipids are provided by a fairly complex set of acyl-CoA carboxylases (ACCases) whose subunit composition and roles within these organisms have not yet been clearly established. Previous biochemical and structural studies provided strong evidences that ACCase 5 from Mycobacterium tuberculosis is formed by the AccA3, AccD5 and AccE5 subunits and that this enzyme complex carboxylates acetyl-CoA and propionyl-CoA with a clear substrate preference for the latest. In this work we used a genetic approach to unambiguously demonstrate that the products of both accD5 and accE5 genes are essential for the viability of Mycobacterium smegmatis. By obtaining a conditional mutant on the accD5-accE5 operon, we also demonstrated that the main physiological role of this enzyme complex was to provide the substrates for fatty acid and mycolic acid biosynthesis. Furthermore, enzymatic and biochemical analysis of the conditional mutant provided strong evidences supporting the notion that AccD5 and/or AccE5 have an additional role in the carboxylation of long chain acyl-CoA prior to mycolic acid condensation. These studies represent a significant step towards a better understanding of the roles of ACCases in mycobacteria and confirm ACCase 5 as an interesting target for the development of new antimycobacterial drugs.	[Bazet Lyonnet, Bernardo; Diacovich, Lautaro; Cabruja, Matias; Gago, Gabriela; Gramajo, Hugo] Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Inst Biol Mol & Celular Rosario IBR CONICET, Lab Physiol & Genet Actinomycetes, RA-2000 Rosario, Argentina; [Bardou, Fabienne; Quemard, Annaik] CNRS, IPBS, Dept TB & Biol Infect, Toulouse, France; [Bardou, Fabienne; Quemard, Annaik] Univ Toulouse, UPS, IPBS, Toulouse, France	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Gago, G (corresponding author), Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Inst Biol Mol & Celular Rosario IBR CONICET, Lab Physiol & Genet Actinomycetes, RA-2000 Rosario, Argentina.	gago@ibr-conicet.gov.ar; gramajo@ibr-conicet.gov.ar		Diacovich, Lautaro/0000-0002-3339-0100; Cabruja, Matias/0000-0001-7691-6494; Gago, Gabriela/0000-0001-7668-0119; Quemard, Annaik/0000-0002-5545-3424	NIH [1R01AI095183-01]; Ministerio de Ciencia, Tecnologia e Innovacion Productiva de la Republica Argentina (MINCYT)/ECOS-Sud France [A11B04]; Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2008-1640, PICTO 2011-0047, PICT 2011-0245]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095183] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministerio de Ciencia, Tecnologia e Innovacion Productiva de la Republica Argentina (MINCYT)/ECOS-Sud France; Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH (1R01AI095183-01 to HG), Ministerio de Ciencia, Tecnologia e Innovacion Productiva de la Republica Argentina (MINCYT)/ECOS-Sud France (A11B04 to HG and AQ), Agencia Nacional de Promocion Cientifica y Tecnologica (PICT 2008-1640 and PICTO 2011-0047 to HG, PICT 2011-0245 to GG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arabolaza A, 2010, MOL MICROBIOL, V78, P47, DOI 10.1111/j.1365-2958.2010.07274.x; Bhatt A, 2007, MOL MICROBIOL, V64, P1442, DOI 10.1111/j.1365-2958.2007.05761.x; Bhatt A, 2007, P NATL ACAD SCI USA, V104, P5157, DOI 10.1073/pnas.0608654104; Boldrin F, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq235; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Cegielski JP, 2010, CLIN INFECT DIS, V50, pS195, DOI 10.1086/651491; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; CONNELL ND, 1994, METHOD CELL BIOL, V45, P107; Consaul SA, 2004, FEMS MICROBIOL LETT, V234, P297, DOI 10.1016/j.femsle.2004.03.041; Cronan JE, 2002, PROG LIPID RES, V41, P407, DOI 10.1016/S0163-7827(02)00007-3; Daffe M, 2008, MYCOBACTERIAL CELL ENVELOPE, P3; Daniel J, 2007, J BACTERIOL, V189, P911, DOI 10.1128/JB.01019-06; Diacovich L, 2002, J BIOL CHEM, V277, P31228, DOI 10.1074/jbc.M203263200; Dubnau E, 2000, MOL MICROBIOL, V36, P630, DOI 10.1046/j.1365-2958.2000.01882.x; Forti F, 2009, J BIOTECHNOL, V140, P270, DOI 10.1016/j.jbiotec.2009.02.001; Gago G, 2006, J BACTERIOL, V188, P477, DOI 10.1128/JB.188.2.477-486.2006; Gago G, 2011, FEMS MICROBIOL REV, V35, P475, DOI 10.1111/j.1574-6976.2010.00259.x; Gande R, 2007, J BACTERIOL, V189, P5257, DOI 10.1128/JB.00254-07; Glickman MS, 2000, MOL CELL, V5, P717, DOI 10.1016/S1097-2765(00)80250-6; Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Harrington M, 2010, CLIN INFECT DIS, V50, pS260, DOI 10.1086/651500; Kremer L, 2000, J BIOL CHEM, V275, P16857, DOI 10.1074/jbc.M000569200; Kurth DG, 2009, MICROBIOLOGY; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lin TW, 2006, P NATL ACAD SCI USA, V103, P3072, DOI 10.1073/pnas.0510580103; Marrakchi H, 2014, CHEM BIOL, V21, P67, DOI 10.1016/j.chembiol.2013.11.011; Oh TJ, 2006, J BIOL CHEM, V281, P3899, DOI 10.1074/jbc.M511761200; Pawelczyk J, 2011, J BACTERIOL, V193, P6960, DOI 10.1128/JB.05638-11; Pelicic V, 1997, P NATL ACAD SCI USA, V94, P10955, DOI 10.1073/pnas.94.20.10955; Portevin D, 2005, J BIOL CHEM, V280, P8862, DOI 10.1074/jbc.M408578200; Portevin D, 2004, P NATL ACAD SCI USA, V101, P314, DOI 10.1073/pnas.0305439101; Rao V, 2006, J CLIN INVEST, V116, P1660, DOI 10.1172/JCI27335; Sambrook J., 2002, MOL CLONING LAB MANU; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Sun D, 2006, ANAL BIOCHEM, V349, P87, DOI 10.1016/j.ab.2005.10.006; Tong L, 2005, CELL MOL LIFE SCI, V62, P1784, DOI 10.1007/s00018-005-5121-4; Veyron-Churlet R, 2005, J MOL BIOL, V353, P847, DOI 10.1016/j.jmb.2005.09.016; Veyron-Churlet R, 2004, MOL MICROBIOL, V54, P1161, DOI 10.1111/j.1365-2958.2004.04334.x; Zumla A, 2013, NEW ENGL J MED, V368, P745, DOI 10.1056/NEJMra1200894	41	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e99853	10.1371/journal.pone.0099853	http://dx.doi.org/10.1371/journal.pone.0099853			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950047	gold, Green Published, Green Submitted			2022-12-27	WOS:000338276300020
J	Dobson, NC; De Grave, S; Johnson, ML				Dobson, Nicola C.; De Grave, Sammy; Johnson, Magnus L.			Linking Eye Design with Host Symbiont Relationships in Pontoniine Shrimps (Crustacea, Decapoda, Palaemonidae)	PLOS ONE			English	Article							INDO-PACIFIC PONTONIINAE; DEEP-SEA CRUSTACEANS; HABITAT DEPTH; PHYLOGENETIC ANALYSIS; SPECTRAL SENSITIVITY; PERICLIMENES COSTA; OPTICAL-PARAMETERS; REFLECTS HABITAT; ACCESSORY EYE; MATING SYSTEM	Symbiosis is prevalent in the marine environment with many studies examining the effects of such interactions between host and symbiont. Pontoniine shrimps are a group whose ecology is characterised by symbiotic interactions. This investigation examines the gross morphology of Pontoniinae compound eyes and superficial optical parameters with reference to their symbiotic relationship or lifestyle category; free-living, ectosymbiont, endosymbiont (bivalves) or endosymbiont (non-bivalves). The eye morphologies of free-living and ectosymbiotic species are very similar, yet differ from both forms of endosymbiotic species. Endosymbionts have significantly smaller and simpler eyes with larger facets and bigger interommatidial angles and eye parameters for increased sensitivity levels. However bivalve endosymbionts form an intermediary group between non-bivalve endosymbionts and ectosymbionts as a result of their more active lifestyle. The accessory eye or "nebenauge", although of uncertain function, commonly occurs in free-living Pontoniinae species but rarely in endosymbionts apart from in more primitive species. The variation in morphology reflects tensions between functional requirements and ecological pressures that have strongly influenced eye design in Pontoniinae.	[Dobson, Nicola C.; Johnson, Magnus L.] Univ Hull, Fac Sci & Engn, Ctr Environm & Marine Sci, Scarborough, N Yorkshire, England; [De Grave, Sammy] Univ Oxford, Museum Nat Hist, Oxford, England	University of Hull; University of Oxford	Dobson, NC (corresponding author), Univ Hull, Fac Sci & Engn, Ctr Environm & Marine Sci, Scarborough Campus, Scarborough, N Yorkshire, England.	n.dobson@biosci.hull.ac.uk		Dobson, Nicola/0000-0002-7061-1646; De Grave, Sammy/0000-0002-2437-2445				Baeza JA, 2011, INVERTEBR BIOL, V130, P351, DOI 10.1111/j.1744-7410.2011.00244.x; Baeza JA, 2011, J EXP MAR BIOL ECOL, V407, P41, DOI 10.1016/j.jembe.2011.07.011; Baeza JA, 2013, J ZOOL, V289, P172, DOI 10.1111/j.1469-7998.2012.00974.x; Baeza JA, 2008, MAR BIOL, V153, P387, DOI 10.1007/s00227-007-0815-9; Baeza JA, 2007, REV BIOL MAR OCEANOG, V42, P7; Baker RH, 2001, EVOLUTION, V55, P1373; Baker RH, 2003, EVOLUTION, V57, P87; Bauer RT., 2004, REMARKABLE SHRIMPS A; Bauer T, 1998, J ZOOL, V245, P467, DOI 10.1111/j.1469-7998.1998.tb00121.x; BOWMAN TE, 1984, J CRUSTACEAN BIOL, V4, P7, DOI 10.2307/1547891; Brooke MD, 1999, P ROY SOC B-BIOL SCI, V266, P405, DOI 10.1098/rspb.1999.0652; BRUCE A J, 1972, Crustaceana (Leiden), V23, P243, DOI 10.1163/156854072X00147; Bruce A.J., 1994, Theses Zoologicae, V25, P1; BRUCE A J, 1976, Micronesica, V12, P83; Bruce A. J., 1977, Atoll Res Bull, VNo. 205, P1; BRUCE AJ, 1966, B MAR SCI, V16, P584; Bruce AJ, 2003, CAH BIOL MAR, V44, P299; Bruce AJ, 2002, CRUSTACEANA, V75, P277, DOI 10.1163/156854002760095390; BRUCE AJ, 1981, CRUSTACEANA, V40, P113, DOI 10.1163/156854081X00516; BRUCE AJ, 1981, ATOLL RES B, V245, P1; Bruce AJ, 2007, CAH BIOL MAR, V48, P403; Bruce AJ, 2011, CAH BIOL MAR, V52, P119; Chace F.A., 1993, SMITHSONIAN CONTRIBU, V543, P1, DOI [10.5479/si.00810282.543, DOI 10.5479/SI.00810282.543, DOI 10.1371/journal.pone.0021987]; CHACE F A JR, 1969, Crustaceana (Leiden), V16, P251, DOI 10.1163/156854069X00295; Chiussi R, 2002, J CHEM ECOL, V28, P1787, DOI 10.1023/A:1020561101616; Cronin Thomas W., 2008, Evolution Education and Outreach, V1, P463, DOI 10.1007/s12052-008-0085-0; De Grave S., 2011, Zoologische Mededelingen (Leiden), V85, P195; De Grave S, 2001, J BIOGEOGR, V28, P1239, DOI 10.1046/j.1365-2699.2001.00633.x; De Grave S., 2009, Annalen des Naturhistorischen Museums in Wien Serie B Botanik und Zoologie, V110, P139; De Grave S, 2009, CRUSTACEANA, V82, P829, DOI 10.1163/156854009X427379; Duris Z, 2010, ZOOTAXA, P106; Duris Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021987; Ellers J, 2012, ECOL LETT, V15, P1071, DOI 10.1111/j.1461-0248.2012.01830.x; Fautin DG, 1995, MAR ECOL PROG SER, V129, P77, DOI 10.3354/meps129077; Field A., 2012, DISCOVERING STAT USI; FORDYCE D, 1993, PALEOBIOLOGY, V19, P288, DOI 10.1017/S0094837300000282; Frank TM, 2012, J EXP BIOL, V215, P3344, DOI 10.1242/jeb.072033; Fransen CHJM, 2012, ZOOTAXA, P43; Fransen Charles H. J. M., 2007, V29, P103; Fransen CHJM, 1995, VITA MARINA, V42, P105; Fransen CHJM, 2002, ZOOLOGISCHE VERHANDE, V336, P1, DOI DOI 10.1163/156854008784513483; Frederiksen R, 2008, J EXP BIOL, V211, P844, DOI 10.1242/jeb.012179; Gaten E, 1998, CONTRIB ZOOL, V67, P223, DOI 10.1163/18759866-06704001; GATEN E, 1992, J MAR BIOL ASSOC UK, V72, P61, DOI 10.1017/S0025315400048785; Goffredi SK, 2010, ENV MICROBIOL REP, V2, P479, DOI 10.1111/j.1758-2229.2010.00136.x; Guo CC, 1996, J EXP MAR BIOL ECOL, V202, P165, DOI 10.1016/0022-0981(96)00020-2; Hemmi JM, 2003, J EXP BIOL, V206, P3951, DOI 10.1242/jeb.00636; HILLERADAMS P, 1984, J COMP PHYSIOL, V154, P307, DOI 10.1007/BF00605230; HILLERADAMS P, 1985, ZOOMORPHOLOGY, V105, P108, DOI 10.1007/BF00312145; HILLERADAMS P, 1988, VISION RES, V28, P667, DOI 10.1016/0042-6989(88)90047-8; Huang HD, 2005, J EXP MAR BIOL ECOL, V326, P56, DOI 10.1016/j.jembe.2005.05.008; ITAYA SK, 1976, TISSUE CELL, V8, P583, DOI 10.1016/0040-8166(76)90032-X; Johnson ML, 2002, J MAR BIOL ASSOC UK, V82, P835, DOI 10.1017/S0025315402006203; Johnson ML, 2000, MAR BIOL, V136, P243, DOI 10.1007/s002270050682; Johnson ML, 2000, BIOL BULL, V199, P6, DOI 10.2307/1542701; Kawada H, 2006, J INSECT PHYSIOL, V52, P67, DOI 10.1016/j.jinsphys.2005.09.004; Kou Q, 2013, MOL PHYLOGENET EVOL, V68, P14, DOI 10.1016/j.ympev.2013.03.010; Land MF, 2002, ANIMAL EYES; LANGDON JW, 1985, MAR BEHAV PHYSIOL, V11, P315, DOI 10.1080/10236248509387056; Laughlin SB, 1998, NAT NEUROSCI, V1, P36, DOI 10.1038/236; Li H, 2002, J CRUSTACEAN BIOL, V22, P449, DOI 10.1651/0278-0372(2002)022[0449:TEOALO]2.0.CO;2; Li XZ, 2004, RAFFLES B ZOOL, P67; Liu Y, 2012, J MORPHOL, V273, P883, DOI 10.1002/jmor.20028; Martinelli JE, 2008, VIE MILIEU, V58, P133; Mascaro M, 2012, J EXP MAR BIOL ECOL, V413, P87, DOI 10.1016/j.jembe.2011.11.026; McCammon A, 2010, CORAL REEFS, V29, P419, DOI 10.1007/s00338-009-0583-8; McCormick T, 1998, PALEOBIOLOGY, V24, P235; MILLAR RH, 1971, ADV MAR BIOL, V9, P1, DOI 10.1016/S0065-2881(08)60341-7; Niven JE, 2008, J EXP BIOL, V211, P1792, DOI 10.1242/jeb.017574; Okuno J, 2010, ZOOTAXA, P85; Pachelle Paulo P. G., 2012, Marine Biodiversity Records, V5, pe83, DOI 10.1017/S1755267212000486; Paracer S, 2000, SYMBIOSIS INTRO BIOL, V2nd; PATTON WK, 1994, B MAR SCI, V55, P193; RCore Team, 2020, R LANG ENV STAT COMP; Ross D.M., 1983, P163; Rutowski RL, 2009, ARTHROPOD STRUCT DEV, V38, P91, DOI 10.1016/j.asd.2008.08.003; Rutowski RL, 2000, J ZOOL, V252, P187, DOI 10.1111/j.1469-7998.2000.tb00614.x; SAFFO MB, 1992, AM ZOOL, V32, P557; SNYDER AW, 1979, VISION INVERTEBRATES, P225; Spotte S, 1998, HELGOLANDER MEERESUN, V52, P59, DOI 10.1007/BF02908736; SPOTTE S, 1994, B MAR SCI, V55, P212; Stavenga D.G., 1989, FACETS VISION; Stavenga DG, 2003, J COMP PHYSIOL A, V189, P189, DOI 10.1007/s00359-003-0390-6; Thiel M, 2001, SYMBIOSIS, V30, P163; UGOLINI A, 1993, CRUSTACEANA, V65, P112, DOI 10.1163/156854093X00441; Van Damme K, 2011, ZOOL J LINN SOC-LOND, V161, P31, DOI 10.1111/j.1096-3642.2010.00639.x; VandenSpiegel D, 1998, J EXP MAR BIOL ECOL, V225, P185, DOI 10.1016/S0022-0981(97)00222-0; Waloszek D, 2005, ARTHROPOD STRUCT DEV, V34, P189, DOI 10.1016/j.asd.2005.01.005; WARRANT EJ, 1993, PROG NEUROBIOL, V40, P413, DOI 10.1016/0301-0082(93)90017-M; Warrant EJ, 2004, BIOL REV, V79, P671, DOI 10.1017/S1464793103006420; Welsh JH, 1937, BIOL BULL-US, V72, P57, DOI 10.2307/1537540; Welsh JH, 1938, BIOL BULL-US, V74, P364, DOI 10.2307/1537810; Williamson JE, 2012, J EXP MAR BIOL ECOL, V414, P38, DOI 10.1016/j.jembe.2012.01.009; Yamamura N, 1996, RES POPUL ECOL, V38, P211, DOI 10.1007/BF02515729	94	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e99505	10.1371/journal.pone.0099505	http://dx.doi.org/10.1371/journal.pone.0099505			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950292	Green Published, gold			2022-12-27	WOS:000338276300015
J	Duval, C; de Tayrac, M; Sanschagrin, F; Michaud, K; Gould, PV; Saikali, S				Duval, Celine; de Tayrac, Marie; Sanschagrin, Francois; Michaud, Karine; Gould, Peter Vincent; Saikali, Stephan			ImmunoFISH Is a Reliable Technique for the Assessment of 1p and 19q Status in Oligodendrogliomas	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; COMPARATIVE GENOMIC HYBRIDIZATION; PROGNOSTIC VALUE; 1P/19Q LOSS; MOLECULAR DIAGNOSTICS; EUROPEAN ORGANIZATION; GENETIC SIGNATURE; INTERPHASE FISH; TUMOR LOCATION; CHROMOSOMES 1P	Objective: To develop a new ImmunoFISH technique for the study of oligodendrogliomas by combining a standard immunohistochemical stain using MIB-1 antibody with a standard FISH technique using commercial 1p36 and 19q13 chromosomal probes. Methods: Validation was performed by two observers on a series of 36 pre-selected oligodendrogliomas and compared to the results previously determined by FISH alone. Results: The ImFISH technique is easy to perform and to analyze and is no more time-consuming than the usual FISH technique. Our results show that the inter-observer reliability of ImFISH is high (kappa = 0.86 and 0.95 respectively for 1p and 19q). Compared to FISH, the ImFISH exhibits a very high sensitivity (similar to 100%) and specificity (similar to 90%) for 1p and/or 19q deleted cases. The sensitivity is high for normal cases (similar to 85%) and imbalanced cases (similar to 90%) with a specificity ranging between 50 and 85%. Finally, there were no significant differences between FISH and ImFISH results calculated on 60, 40 or 20 cells. Conclusion: Our study demonstrates the reliability of the ImFISH technique in oligodendrogliomas and emphasizes its advantage in poorly cellular tumoral specimen.	[Duval, Celine; Sanschagrin, Francois; Gould, Peter Vincent; Saikali, Stephan] Ctr Hosp Univ Quebec, Dept Pathol, Quebec City, PQ, Canada; [de Tayrac, Marie] Ctr Hosp Univ Rennes, Dept Genom & Mol Genet, Rennes, France; [Michaud, Karine] Ctr Hosp Univ Quebec, Dept Neurosurg, Quebec City, PQ, Canada	Laval University; CHU Rennes; Universite de Rennes; Laval University	Saikali, S (corresponding author), Ctr Hosp Univ Quebec, Dept Pathol, Quebec City, PQ, Canada.	stephan.saikali.cha@ssss.gouv.qc.ca	de Tayrac, Marie/AAG-7800-2020; Michaud, Karine/AAM-3026-2020		Fondation des hopitaux Enfant-Jesus-Saint Sacrement (Quebec city Quebec) [682/8317]	Fondation des hopitaux Enfant-Jesus-Saint Sacrement (Quebec city Quebec)	This study was supported by the Fondation des hopitaux Enfant-Jesus-Saint Sacrement (Quebec city Quebec): grant number 682/8317. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldape K, 2007, ARCH PATHOL LAB MED, V131, P242; Ambros PF, 2001, MED PEDIATR ONCOL, V37, P492, DOI 10.1002/mpo.1242; Belaud-Rotureau MA, 2006, ACTA NEUROPATHOL, V111, P255, DOI 10.1007/s00401-005-0001-4; Bigner S H, 1999, Neuro Oncol, V1, P52, DOI 10.1093/neuonc/1.1.52; Bigner SH, 1999, AM J PATHOL, V155, P375, DOI 10.1016/S0002-9440(10)65134-6; Bouvier C, 2004, J NEURO-ONCOL, V68, P141, DOI 10.1023/B:NEON.0000027758.10286.c1; Broholm H, 2008, CLIN NEUROPATHOL, V27, P378; Burger PC, 2001, MODERN PATHOL, V14, P842, DOI 10.1038/modpathol.3880400; Cairncross G, 2008, CANCER J, V14, P352, DOI 10.1097/PPO.0b013e31818d8178; Calattini S, 2010, BLOOD, V116, P4546, DOI 10.1182/blood-2010-05-285452; Campos M, 2013, HISTOL HISTOPATHOL, V28, P1439, DOI 10.14670/HH-28.1439; Coons SW, 1997, NEUROSURGERY, V41, P878, DOI 10.1097/00006123-199710000-00021; Ducray F, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-41; Fallon KB, 2004, J NEUROPATH EXP NEUR, V63, P314, DOI 10.1093/jnen/63.4.314; Franco-Hernandez C, 2009, CANCER GENET CYTOGEN, V190, P93, DOI 10.1016/j.cancergencyto.2008.09.017; Fuller CE, 2005, ADV ANAT PATHOL, V12, P180, DOI 10.1097/01.pap.0000175117.47918.f7; Fuller CE, 2002, BRAIN PATHOL, V12, P67; Gadji M, 2009, CANCER GENET CYTOGEN, V194, P12, DOI 10.1016/j.cancergencyto.2009.05.004; Gatta LB, 2012, APPL IMMUNOHISTO M M, V20, P413, DOI 10.1097/PAI.0b013e31823fb322; Gelpi E, 2003, MODERN PATHOL, V16, P708, DOI 10.1097/01.MP.0000076981.90281.BF; Giannini C, 2008, BRAIN PATHOL, V18, P360, DOI 10.1111/j.1750-3639.2008.00129.x; Gonzales M, 2006, J CLIN NEUROSCI, V13, P96, DOI 10.1016/j.jocn.2005.06.004; Hartmann C, 2005, J NEUROPATH EXP NEUR, V64, P10, DOI 10.1093/jnen/64.1.10; Hartmann C, 2011, CLIN CANCER RES, V17, P4588, DOI 10.1158/1078-0432.CCR-10-3194; Hirose T, 2010, NEUROPATHOLOGY, V30, P586, DOI 10.1111/j.1440-1789.2010.01116.x; Horbinski C, 2012, J NEUROPATH EXP NEUR, V71, P73, DOI 10.1097/NEN.0b013e318240fa65; Horbinski C, 2011, BRAIN PATHOL, V21, P57, DOI 10.1111/j.1750-3639.2010.00453.x; Horbinski C, 2010, ACTA NEUROPATHOL, V119, P641, DOI 10.1007/s00401-009-0634-9; Huang L, 2009, NEUROPATH APPL NEURO, V35, P367, DOI 10.1111/j.1365-2990.2008.01002.x; Jenkins RB, 2006, CANCER RES, V66, P9852, DOI 10.1158/0008-5472.CAN-06-1796; Jeon YK, 2007, NEUROPATHOLOGY, V27, P10, DOI 10.1111/j.1440-1789.2006.00735.x; Jha P, 2011, DIAGN MOL PATHOL, V20, P40, DOI 10.1097/PDM.0b013e3181e961e9; Kanamori M, 2009, J NEURO-ONCOL, V93, P219, DOI 10.1007/s11060-008-9762-7; Kanner AA, 2006, J NEUROSURG, V104, P542, DOI 10.3171/jns.2006.104.4.542; Kitange G, 2005, GENE CHROMOSOME CANC, V42, P68, DOI 10.1002/gcc.20108; Koschny R, 2006, PATHOL RES PRACT, V202, P23, DOI 10.1016/j.prp.2005.10.010; Koschny R, 2002, CANCER GENET CYTOGEN, V135, P147, DOI 10.1016/S0165-4608(01)00650-1; Kouwenhoven MCM, 2006, EUR J CANCER, V42, P2499, DOI 10.1016/j.ejca.2006.05.021; Kros JM, 2007, J NEUROPATH EXP NEUR, V66, P545, DOI 10.1097/01.jnen.0000263869.84188.72; Lass U, 2013, BRAIN PATHOL, V23, P311, DOI 10.1111/bpa.12003; Law ME, 2005, CANCER GENET CYTOGEN, V160, P1, DOI 10.1016/j.cancergencyto.2004.11.012; Mahajan D, 2009, AM J CLIN PATHOL, V132, P118, DOI 10.1309/AJCP5Y7BNXBWCCNX; Martinez-Ramirez A, 2004, LEUKEMIA, V18, P348, DOI 10.1038/sj.leu.2403230; McDonald JM, 2005, CANCER-AM CANCER SOC, V104, P1468, DOI 10.1002/cncr.21338; Mohapatra G, 2006, J MOL DIAGN, V8, P268, DOI 10.2353/jmoldx.2006.050109; Mueller W, 2002, AM J PATHOL, V161, P313, DOI 10.1016/S0002-9440(10)64183-1; Nigro JM, 2001, AM J PATHOL, V158, P1253, DOI 10.1016/S0002-9440(10)64076-X; Perry A, 2001, AM J PATHOL, V159, P57, DOI 10.1016/S0002-9440(10)61673-2; Preusser M, 2012, HISTOPATHOLOGY, V60, P885, DOI 10.1111/j.1365-2559.2011.04134.x; Ramirez C, 2010, NEURO-ONCOLOGY, V12, P490, DOI 10.1093/neuonc/nop071; Reddy KS, 2008, CANCER GENET CYTOGEN, V184, P77, DOI 10.1016/j.cancergencyto.2008.03.009; Reifenberger G, 2003, J NEUROPATH EXP NEUR, V62, P111, DOI 10.1093/jnen/62.2.111; Sasaki H, 2002, J NEUROPATH EXP NEUR, V61, P58, DOI 10.1093/jnen/61.1.58; Scheie D, 2006, AM J SURG PATHOL, V30, P828, DOI 10.1097/01.pas.0000213250.44822.2e; Scheie D, 2011, NEURO-ONCOLOGY, V13, P1225, DOI 10.1093/neuonc/nor114; Senetta R, 2013, J NEUROPATH EXP NEUR, V72, P432, DOI 10.1097/NEN.0b013e3182901f41; Shukla B, 2009, NEUROL INDIA, V57, P559, DOI 10.4103/0028-3886.57795; Smith J.D.H., 1999, PUR AP M-WI; Smith JS, 2000, J CLIN ONCOL, V18, P636, DOI 10.1200/JCO.2000.18.3.636; Snuderl M, 2009, CLIN CANCER RES, V15, P6430, DOI 10.1158/1078-0432.CCR-09-0867; The WHO, 2020, CLASSIFICATION TUMOU; Trost D, 2007, INT J CANCER, V120, P2368, DOI 10.1002/ijc.22574; Trudel D, 2013, J HISTOCHEM CYTOCHEM, V61, P500, DOI 10.1369/0022155413490946; van den Bent MJ, 2003, CANCER-AM CANCER SOC, V97, P1276, DOI 10.1002/cncr.11187; WEBERMATTHIESEN K, 1992, J HISTOCHEM CYTOCHEM, V40, P171, DOI 10.1177/40.2.1552161; Wiens AL, 2012, J NEUROPATH EXP NEUR, V71, P618, DOI 10.1097/NEN.0b013e31825b5f7a; Woehrer A, 2011, CLIN NEUROPATHOL, V30, P47, DOI 10.5414/NPP30047; Zlatescu MC, 2001, CANCER RES, V61, P6713	68	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100342	10.1371/journal.pone.0100342	http://dx.doi.org/10.1371/journal.pone.0100342			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949947	Green Submitted, gold, Green Published			2022-12-27	WOS:000338276300067
J	Katsanou, ES; Kyriakopoulou, K; Emmanouil, C; Fokialakis, N; Skaltsounis, AL; Machera, K				Katsanou, Efrosini S.; Kyriakopoulou, Katerina; Emmanouil, Christina; Fokialakis, Nikolas; Skaltsounis, Alexios-Leandros; Machera, Kyriaki			Modulation of CYP1A1 and CYP1A2 Hepatic Enzymes after Oral Administration of Chios Mastic Gum to Male Wistar Rats	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; PROSTATE-CANCER CELLS; IN-VITRO; HELICOBACTER-PYLORI; DRUG-METABOLISM; RISK-ASSESSMENT; OLEANOLIC ACID; VAR. CHIA; INDUCTION; EXPRESSION	Chios mastic gum (CMG), a resin derived from Pistacia lentiscus var. chia, is known since ancient times for its pharmacological activities. CYP1A1 and CYP1A2 enzymes are among the most involved in the biotransformation of chemicals and the metabolic activation of pro-carcinogens. Previous studies referring to the modulation of these enzymes by CMG have revealed findings of unclear biological and toxicological significance. For hi purpose, the modulation of CYP1A1 and CYP1A2 enzymes in the liver of male Wistar rats following oral administration of CMG extract (CMGE), at the levels of mRNA and CYP1A1 enzyme activity, was compared to respective enzyme modulation following oral administration known bioactive natural product, caffeine, as control compound known to involve hepatic enzymes in its metabolism mRNA levels of Cyp1a1 and Cyp1a2 were measured by reverse transcription real-time polymerase chain reaction and the relative quantification was calculated. CYP1A1 enzyme induction was measured through the activity of ethoxyresorufin-O-deethylase (EROD). The results indicated that administration of CMGE at the recommended pharmaceutical dose does not induce significant transcriptional modulation of Cyp1a1/2 and subsequent enzyme activity induction of CYP1A1 while effects of he same order of magnitude were observed in the same test system following the administration of caffeine at the mean daily consumed levels. The outcome of this study further confirms the lack of any toxicological or biological significance of the specific findings on liver following the administration of CMGE.	[Katsanou, Efrosini S.; Kyriakopoulou, Katerina; Emmanouil, Christina; Machera, Kyriaki] Benaki Phytopathol Inst, Dept Pesticides Control & Phytopharm, Lab Toxicol Control Pesticides, Athens, Greece; [Fokialakis, Nikolas; Skaltsounis, Alexios-Leandros] Univ Athens, Fac Pharm, Dept Pharmacognosy & Nat Prod Chem, Athens, Greece	National & Kapodistrian University of Athens	Machera, K (corresponding author), Benaki Phytopathol Inst, Dept Pesticides Control & Phytopharm, Lab Toxicol Control Pesticides, Athens, Greece.	k.machera@bpi.gr	Katsanou, Efrosini/AAU-1502-2020; Fokialakis, Nikolas/AAD-1498-2020; skaltsounis, alexios leandros/AAE-9617-2019	Katsanou, Efrosini/0000-0002-6381-1332; Fokialakis, Nikolas/0000-0001-7028-1870; Emmanouil, Christina/0000-0003-0101-9531	Benaki Phytopathological Institute; INSPIRE project of the European Commission [FP7-REGPOT-2011-1/284460]	Benaki Phytopathological Institute; INSPIRE project of the European Commission	This work was funded by Benaki Phytopathological Institute in the frames of the wider project "Reaseach on bioactive natural compounds". Part of this work has been financially supported by INSPIRE project (FP7-REGPOT-2011-1/284460) of the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALHABBAL MJ, 1984, CLIN EXP PHARMACOL P, V11, P541, DOI 10.1111/j.1440-1681.1984.tb00864.x; Andreadou I, 2008, REV CLIN PHARM PHARM, V22, P107; AUSTIN CA, 1988, BIOCHEM PHARMACOL, V37, P2223, DOI 10.1016/0006-2952(88)90585-0; Balan KV, 2007, PHYTOMEDICINE, V14, P263, DOI 10.1016/j.phymed.2006.03.009; BERTHOU F, 1995, LIFE SCI, V57, P541, DOI 10.1016/0024-3205(95)00304-O; BURKE MD, 1985, BIOCHEM PHARMACOL, V34, P3337, DOI 10.1016/0006-2952(85)90355-7; Cheung C, 2008, J PHARMACOL EXP THER, V327, P288, DOI 10.1124/jpet.108.141242; Corcos L, 1998, FEBS LETT, V425, P293, DOI 10.1016/S0014-5793(98)00246-4; Denison MS, 2003, ANNU REV PHARMACOL, V43, P309, DOI 10.1146/annurev.pharmtox.43.100901.135828; DeOliveira ACAX, 1997, TOXICOL LETT, V92, P39, DOI 10.1016/S0378-4274(97)00034-9; Doi K, 2009, TOXICOL APPL PHARM, V234, P135, DOI 10.1016/j.taap.2008.10.001; Giaginis C, 2011, NUTR CANCER, V63, P1174, DOI 10.1080/01635581.2011.607546; Goasduff T, 1996, BIOCHEM PHARMACOL, V52, P1915, DOI 10.1016/S0006-2952(96)00522-9; He ML, 2007, ACTA PHARMACOL SIN, V28, P567, DOI 10.1111/j.1745-7254.2007.00535.x; He ML, 2007, ACTA PHARMACOL SIN, V28, P446, DOI 10.1111/j.1745-7254.2007.00536.x; He ML, 2006, CANCER-AM CANCER SOC, V106, P2547, DOI 10.1002/cncr.21935; Huang XY, 2010, ACTA PHARMACOL SIN, V31, P741, DOI 10.1038/aps.2010.54; Kang JS, 2007, FOOD CHEM TOXICOL, V45, P494, DOI 10.1016/j.fct.2006.09.013; Kim KA, 2004, LIFE SCI, V74, P2769, DOI 10.1016/j.lfs.2003.10.020; Kottakis F, 2009, EUR J GASTROEN HEPAT, V21, P143, DOI 10.1097/MEG.0b013e32831c50c9; Kuriyama S, 2003, TOXICOLOGY, V186, P11, DOI 10.1016/S0300-483X(02)00602-9; LIU J, 1995, J PHARMACOL EXP THER, V275, P768; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loizou S, 2009, EXP BIOL MED, V234, P553, DOI 10.3181/0811-RM-338; Magkouta S, 2009, NUTR CANCER, V61, P640, DOI 10.1080/01635580902825647; Marone P, 2001, J CHEMOTHERAPY, V13, P611, DOI 10.1179/joc.2001.13.6.611; Martignoni M, 2006, EXPERT OPIN DRUG MET, V2, P875, DOI 10.1517/17425255.2.6.875; Moulos P, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-68; Paraschos S, 2007, ANTIMICROB AGENTS CH, V51, P551, DOI 10.1128/AAC.00642-06; QUATTROCHI LC, 1994, J BIOL CHEM, V269, P6949; REICKS MM, 1993, XENOBIOTICA, V23, P809, DOI 10.3109/00498259309166786; Sidorova YA, 2005, TOXICOL LETT, V155, P253, DOI 10.1016/j.toxlet.2004.10.001; SILVER G, 1988, J BIOL CHEM, V263, P11802; Sterer N, 2008, J DENT, V36, P535, DOI 10.1016/j.jdent.2008.04.001; Takahashi K, 2003, J PERIODONTOL, V74, P501, DOI 10.1902/jop.2003.74.4.501; Tassou CC, 1995, INT BIODETER BIODEGR, V36, P411, DOI 10.1016/0964-8305(95)00103-4; Whitlock JP, 1999, ANNU REV PHARMACOL, V39, P103, DOI 10.1146/annurev.pharmtox.39.1.103; Wu RQ, 2006, INT J MOL MED, V18, P339	38	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100190	10.1371/journal.pone.0100190	http://dx.doi.org/10.1371/journal.pone.0100190			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950217	Green Published, Green Submitted, gold			2022-12-27	WOS:000338276300046
J	Petzold, S; Averbeck, M; Simon, JC; Lehmann, I; Polte, T				Petzold, Susanne; Averbeck, Marco; Simon, Jan C.; Lehmann, Irina; Polte, Tobias			Lifetime-Dependent Effects of Bisphenol A on Asthma Development in an Experimental Mouse Model	PLOS ONE			English	Article							ALLERGIC-ASTHMA; FETAL EXPOSURE; T-CELLS; GLUCOCORTICOID-RECEPTOR; ENDOCRINE DISRUPTORS; CYTOKINE PRODUCTION; PRENATAL EXPOSURE; RHESUS-MONKEYS; IN-VITRO; MICE	Background: Environmental factors are thought to contribute significantly to the increase of asthma prevalence in the last two decades. Bisphenol A (BPA) is a xenoestrogen commonly used in consumer products and the plastic industry. There is evidence and an ongoing discussion that endocrine disruptors like BPA may affect human health and also exert alterations on in the immune system. The aim of this study was to investigate age-dependent effects of BPA on the asthma risk using a murine model to explain the controversial results reported till date. Methods: BALB/c mice were exposed to BPA via the drinking water for different time periods including pregnancy and breastfeeding. To induce an asthma phenotype, mice were sensitized to ovalbumin (OVA), followed by an intrapulmonary allergen challenge. Results: BPA exposure during pregnancy and breastfeeding had no significant effect on asthma development in the offspring. In contrast, lifelong exposure from birth until the last antigen challenge clearly increased eosinophilic inflammation in the lung, airway hyperreactivity and antigen-specific serum IgE levels in OVA-sensitized adult mice compared to mice without BPA exposure. Surprisingly, BPA intake during the sensitization period significantly reduced the development of allergic asthma. This effect was reversed in the presence of a glucocorticoid receptor antagonist. Conclusions: Our results demonstrate that the impact of BPA on asthma risk is strongly age-dependent and ranges from asthma-promoting to asthma-reducing effects. This could explain the diversity of results from previous studies regarding the observed health impact of BPA.	[Petzold, Susanne; Lehmann, Irina; Polte, Tobias] UFZ Helmholtz Ctr Environm Res Leipzig Halle, Dept Environm Immunol, Leipzig, Germany; [Petzold, Susanne; Averbeck, Marco; Simon, Jan C.; Polte, Tobias] Univ Leipzig, Med Ctr, Dept Dermatol Venerol & Allergol, D-04109 Leipzig, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Leipzig University	Polte, T (corresponding author), UFZ Helmholtz Ctr Environm Res Leipzig Halle, Dept Environm Immunol, Leipzig, Germany.	tobias.polte@ufz.de	Jahreis, Susanne/AAA-9826-2020	Lehmann, Irina/0000-0001-8875-5587	Helmholtz Association [VG-NG-337]	Helmholtz Association(Helmholtz Association)	This work was supported by the Helmholtz Association grant VG-NG-337. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh M, 2006, J MED INVESTIG, V53, P70, DOI 10.2152/jmi.53.70; Bachmanov AA, 2002, BEHAV GENET, V32, P435, DOI 10.1023/A:1020884312053; Bauer SM, 2012, TOXICOL SCI, V130, P82, DOI 10.1093/toxsci/kfs227; Bickert T, 2009, INT ARCH ALLERGY IMM, V149, P219, DOI 10.1159/000199717; Biedermann S, 2010, ANAL BIOANAL CHEM, V398, P571, DOI 10.1007/s00216-010-3936-9; Bonisch U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039817; Cai YP, 2012, INT ARCH ALLERGY IMM, V158, P252, DOI 10.1159/000331437; DeBie JJ, 1996, BRIT J PHARMACOL, V119, P1484; Doerge DR, 2011, TOXICOL LETT, V207, P298, DOI 10.1016/j.toxlet.2011.09.020; Donohue KM, 2013, J ALLERGY CLIN IMMUN, V131, P736, DOI 10.1016/j.jaci.2012.12.1573; Ege MJ, 2006, J ALLERGY CLIN IMMUN, V117, P817, DOI 10.1016/j.jaci.2005.12.1307; Epstein MM, 2004, INT ARCH ALLERGY IMM, V133, P84, DOI 10.1159/000076131; Fund TBC, 2010, SAF ALT BISPH A BPA, P1; Goto M, 2007, BIOSCI BIOTECH BIOCH, V71, P2136, DOI 10.1271/bbb.70004; Guo HC, 2010, CELL MOL IMMUNOL, V7, P227, DOI 10.1038/cmi.2010.14; Inadera H, 2000, ENDOCRINOLOGY, V141, P50, DOI 10.1210/en.141.1.50; Jeffery PK, 1998, AM J RESP CRIT CARE, V157, pS174, DOI 10.1164/ajrccm.157.5.rsaa-1; Lack G, 1996, J IMMUNOL, V157, P1432; Lee MH, 2003, IMMUNOLOGY, V109, P76, DOI 10.1046/j.1365-2567.2003.01631.x; Li XM, 1996, J IMMUNOL, V157, P3216; Midoro-Horiuti T, 2010, ENVIRON HEALTH PERSP, V118, P273, DOI 10.1289/ehp.0901259; Nagel SC, 1997, ENVIRON HEALTH PERSP, V105, P70, DOI 10.1289/ehp.9710570; Nakajima Y, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-8; O'Brien E, 2013, J IMMUNOTOXICOL; Pearce N, 2006, INT J TUBERC LUNG D, V10, P125; Polte T, 2006, J CLIN INVEST, V116, P1025, DOI 10.1172/JCI23792; Polte T, 2008, CLIN EXP ALLERGY, V38, P1950, DOI 10.1111/j.1365-2222.2008.03096.x; Polte T, 2007, CLIN EXP ALLERGY, V37, P1374, DOI 10.1111/j.1365-2222.2007.02785.x; Polte T, 2008, J ALLERGY CLIN IMMUN, V122, P1022, DOI 10.1016/j.jaci.2008.09.014; Polte T, 2006, J ALLERGY CLIN IMMUN, V118, P942, DOI 10.1016/j.jaci.2006.07.014; Polte T, 2009, EUR J IMMUNOL, V39, P1736, DOI 10.1002/eji.200839004; Pottenger LH, 2000, TOXICOL SCI, V54, P3, DOI 10.1093/toxsci/54.1.3; Prasanth GK, 2010, J APPL TOXICOL, V30, P769, DOI 10.1002/jat.1570; Regal JF, 2000, P SOC EXP BIOL MED, V223, P372, DOI 10.1046/j.1525-1373.2000.22353.x; Reiprich M, 2013, ALLERGY, V68, P481, DOI 10.1111/all.12121; Rochester JR, 2013, REPROD TOXICOL, V42, P132, DOI 10.1016/j.reprotox.2013.08.008; Sargis RM, 2010, OBESITY, V18, P1283, DOI 10.1038/oby.2009.419; Schonfelder G, 2002, ENVIRON HEALTH PERSP, V110, pA703, DOI 10.1289/ehp.021100703; Schutze N, 2010, AM J RESP CRIT CARE, V181, P1188, DOI 10.1164/rccm.200909-1350OC; Spanier AJ, 2012, ENVIRON HEALTH PERSP, V120, P916, DOI 10.1289/ehp.1104175; Taylor JA, 2011, ENVIRON HEALTH PERSP, V119, P422, DOI 10.1289/ehp.1002514; Tian XL, 2003, INT ARCH ALLERGY IMM, V132, P240, DOI 10.1159/000074305; Umetsu DT, 2002, NAT IMMUNOL, V3, P715, DOI 10.1038/ni0802-715; Vaidya SV, 2012, J ASTHMA, V49, P800, DOI 10.3109/02770903.2012.721041; Van Winkle LS, 2013, ENVIRON HEALTH PERSP, V121, P912, DOI 10.1289/ehp.1206064; Vandenberg LN, 2007, REPROD TOXICOL, V24, P139, DOI 10.1016/j.reprotox.2007.07.010; Vandenberg Laura N., 2013, Reviews on Environmental Health, V28, P37, DOI 10.1515/reveh-2012-0034; Welshons WV, 1999, TOXICOL IND HEALTH, V15, P12, DOI 10.1191/074823399678846745; Wetherill YB, 2007, REPROD TOXICOL, V24, P178, DOI 10.1016/j.reprotox.2007.05.010; Yan HM, 2008, ENVIRON HEALTH PERSP, V116, P514, DOI 10.1289/ehp.10829; Yoshino S, 2004, IMMUNOLOGY, V112, P489, DOI 10.1111/j.1365-2567.2004.01900.x	51	30	33	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100468	10.1371/journal.pone.0100468	http://dx.doi.org/10.1371/journal.pone.0100468			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950052	Green Submitted, Green Published, gold			2022-12-27	WOS:000338276300076
J	Pijnenburg, M; Caeyenberghs, K; Janssens, L; Goossens, N; Swinnen, SP; Sunaert, S; Brumagne, S				Pijnenburg, Madelon; Caeyenberghs, Karen; Janssens, Lotte; Goossens, Nina; Swinnen, Stephan P.; Sunaert, Stefan; Brumagne, Simon			Microstructural Integrity of the Superior Cerebellar Peduncle Is Associated with an Impaired Proprioceptive Weighting Capacity in Individuals with Non-Specific Low Back Pain	PLOS ONE			English	Article							POSTURAL CONTROL; DISABILITY INDEX; MOVEMENT; BALANCE; REORGANIZATION; ORIENTATION; VIBRATION; PEOPLE; CORTEX; STANCE	Introduction: Postural control is a complex sensorimotor task that requires an intact network of white matter connections. The ability to weight proprioceptive signals is crucial for postural control. However, research into central processing of proprioceptive signals for postural control is lacking. This is specifically of interest in individuals with non-specific low back pain (NSLBP), because impairments in postural control have been observed as possible underlying mechanisms of NSLBP. Therefore, the objective was to investigate potential differences in sensorimotor white matter microstructure between individuals with NSLBP and healthy controls, and to determine whether the alterations in individuals with NSLBP are associated with the capacity to weight proprioceptive signals for postural control. Methods: The contribution of proprioceptive signals from the ankle and back muscles to postural control was evaluated by local muscle vibration in 18 individuals with NSLBP and 18 healthy controls. Center of pressure displacement in response to muscle vibration was determined during upright standing on a stable and unstable support surface. Diffusion magnetic resonance imaging was applied to examine whether this proprioceptive contribution was associated with sensorimotor white matter microstructure. Results: Individuals with NSLBP showed a trend towards a reduced fractional anisotropy along the left superior cerebellar peduncle compared to healthy controls (p = 0.039). The impaired microstructural integrity of the superior cerebellar peduncle in individuals with NSLBP was significantly correlated with the response to ankle muscle vibration (p < 0.003). Conclusions: In individuals with NSLBP, a decreased integrity of the superior cerebellar peduncle was associated with an increased reliance on ankle muscle proprioception, even on unstable support surface, which implies an impaired proprioceptive weighting capacity. Our findings emphasize the importance of the superior cerebellar peduncle in proprioceptive weighting for postural control in individuals with NSLBP.	[Pijnenburg, Madelon; Janssens, Lotte; Goossens, Nina; Brumagne, Simon] Univ Leuven, KU Leuven Dept Rehabil Sci, Leuven, Belgium; [Caeyenberghs, Karen] Univ Ghent, Dept Phys Therapy & Motor Rehabil, B-9000 Ghent, Belgium; [Caeyenberghs, Karen] Univ Ghent, Dept Movement & Sports Sci, B-9000 Ghent, Belgium; [Swinnen, Stephan P.] Univ Leuven, KU Leuven Dept Kinesiol, Leuven, Belgium; [Sunaert, Stefan] Univ Leuven, KU Leuven Dept Imaging & Pathol, Leuven, Belgium	KU Leuven; Ghent University; Ghent University; KU Leuven; KU Leuven	Pijnenburg, M (corresponding author), Univ Leuven, KU Leuven Dept Rehabil Sci, Leuven, Belgium.	Madelon.Pijnenburg@faber.kuleuven.be	Goossens, Nina/AAH-9865-2021; Janssens, Lotte/T-1845-2017; Sunaert, Stefan/E-8031-2011	Janssens, Lotte/0000-0002-6133-4915; Caeyenberghs, Karen/0000-0001-7009-6843; Sunaert, Stefan/0000-0002-1177-4680; Goossens, Nina/0000-0002-9458-3125; Brumagne, Simon/0000-0002-0251-9338	Agency for Innovation by Science and Technology - Flanders (IWT); Research Foundation - Flanders (FWO)	Agency for Innovation by Science and Technology - Flanders (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Research Foundation - Flanders (FWO)(FWO)	This work was supported by the Agency for Innovation by Science and Technology - Flanders (IWT) (PhD fellowship Madelon Pijnenburg) (http://www.iwt.be/) and by The Research Foundation - Flanders (FWO) (PhD fellowship Lotte Janssens) (http://www.fwo.be/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airaksinen O, 2006, EUR SPINE J, V15, pS192, DOI 10.1007/s00586-006-1072-1; [Anonymous], 2005, AM HERITAGE STEDMANS; Balague F, 2012, LANCET, V379, P482, DOI 10.1016/S0140-6736(11)60610-7; Brumagne S, 2004, NEUROSCI LETT, V366, P63, DOI 10.1016/j.neulet.2004.05.013; Brumagne S, 2000, SPINE, V25, P989, DOI 10.1097/00007632-200004150-00015; Brumagne S, 2013, SPINAL CONTROL REHAB, P219; Brumagne S, 2008, EUR SPINE J, V17, P1177, DOI 10.1007/s00586-008-0709-7; Buckalew N, 2010, PAIN MED, V11, P1183, DOI 10.1111/j.1526-4637.2010.00899.x; Caeyenberghs K, 2010, HUM BRAIN MAPP, V31, P992, DOI 10.1002/hbm.20911; Carver S, 2006, BIOL CYBERN, V95, P123, DOI 10.1007/s00422-006-0069-5; Claeys K, 2013, THESIS; Claeys K, 2011, EUR J APPL PHYSIOL, V111, P115, DOI 10.1007/s00421-010-1637-x; Cordo PJ, 2005, EXP BRAIN RES, V167, P324, DOI 10.1007/s00221-005-0034-x; della Volpe R, 2006, GAIT POSTURE, V24, P349, DOI 10.1016/j.gaitpost.2005.10.009; Deprez S, 2013, BRAIN IMAGING BEHAV, V7, P409, DOI 10.1007/s11682-012-9220-1; Fairbank JCT, 2000, SPINE, V25, P2940, DOI 10.1097/00007632-200011150-00017; Flor H, 1997, NEUROSCI LETT, V224, P5, DOI 10.1016/S0304-3940(97)13441-3; GANDEVIA SC, 1992, TRENDS NEUROSCI, V15, P62, DOI 10.1016/0166-2236(92)90028-7; Gill KP, 1998, SPINE, V23, P371, DOI 10.1097/00007632-199802010-00017; Hanaie R, 2013, CEREBELLUM, V12, P645, DOI 10.1007/s12311-013-0475-x; Hancock MJ, 2011, EUR SPINE J, V20, P2105, DOI 10.1007/s00586-011-1886-3; HOAGLIN DC, 1987, J AM STAT ASSOC, V82, P1147, DOI 10.1080/01621459.1987.10478551; Horak FB, 2006, AGE AGEING, V35, P7, DOI 10.1093/ageing/afl077; HORAK FB, 1994, J NEUROPHYSIOL, V72, P479, DOI 10.1152/jn.1994.72.2.479; Janssens L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057949; Janssens L, 2010, SPINE, V35, P1088, DOI 10.1097/BRS.0b013e3181bee5c3; Kiers H, 2014, GAIT POSTURE, VS0966-6362; Kiers H, 2012, EUR J APPL PHYSIOL, V112, P1577, DOI 10.1007/s00421-011-2124-8; Kong J, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-43; Lackner JR, 2005, ANNU REV PSYCHOL, V56, P115, DOI 10.1146/annurev.psych.55.090902.142023; Leemans A., 2009, P INT SOC MAG RESON, P3537, DOI DOI 10.1093/OCCMED/KQR069; Mansour AR, 2013, PAIN, V154, P2160, DOI 10.1016/j.pain.2013.06.044; Manto M, 2012, CEREBELLUM, V11, P457, DOI 10.1007/s12311-011-0331-9; Costa LDM, 2013, SPINE, V38, P148, DOI 10.1097/BRS.0b013e318267a92f; Mok NW, 2011, SPINE, V36, pE45, DOI 10.1097/BRS.0b013e3181dfce83; Newcomer KL, 2000, SPINE, V25, P2488, DOI 10.1097/00007632-200010010-00011; Paus T, 2010, BRAIN COGNITION, V72, P26, DOI 10.1016/j.bandc.2009.06.002; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Prosperini L, 2013, RADIOLOGY, V268, P181, DOI 10.1148/radiol.13121695; ROLL JP, 1982, EXP BRAIN RES, V47, P177; Roussel NA, 2013, CLIN J PAIN, V29, P625, DOI 10.1097/AJP.0b013e31826f9a71; Ruhe A, 2011, EUR SPINE J, V20, P358, DOI 10.1007/s00586-010-1543-2; Tsao H, 2008, BRAIN, V131, P2161, DOI 10.1093/brain/awn154; VERNON H, 1991, J MANIP PHYSIOL THER, V14, P409	44	22	22	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100666	10.1371/journal.pone.0100666	http://dx.doi.org/10.1371/journal.pone.0100666			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949796	Green Published, Green Submitted, gold			2022-12-27	WOS:000338276300105
J	Sherwood, JM; Holmes, D; Kaliviotis, E; Balabani, S				Sherwood, Joseph M.; Holmes, David; Kaliviotis, Efstathios; Balabani, Stavroula			Spatial Distributions of Red Blood Cells Significantly Alter Local Haemodynamics	PLOS ONE			English	Article							FREE LAYER FORMATION; SKELETAL-MUSCLE VENULES; ERYTHROCYTE AGGREGATION; MICROVASCULAR BIFURCATIONS; IN-VIVO; APPARENT VISCOSITY; VELOCITY PROFILES; FLOWING BLOOD; SHEAR RATE; TUBE FLOW	Although bulk changes in red blood cell concentration between vessels have been well characterised, local distributions are generally overlooked. Red blood cells aggregate, deform and migrate within vessels, forming heterogeneous distributions which have considerable effect on local haemodynamics. The present study reports data on the local distribution of human red blood cells in a sequentially bifurcating microchannel, representing the branching geometry of the microvasculature. Imaging methodologies with simple extrapolations are used to infer three dimensional, time-averaged velocity and haematocrit distributions under a range of flow conditions. Strong correlation between the bluntness of the velocity and haematocrit profiles in the parent branch of the geometry is observed and red blood cell aggregation has a notable effect on the observed trends. The two branches of the first bifurcation show similar characteristics in terms of the shapes of the profiles and the extent of plasma skimming, despite the difference in geometric configuration. In the second bifurcation, considerable asymmetry between the branches in the plasma skimming relationship is observed, and elucidated by considering individual haematocrit profiles. The results of the study highlight the importance of considering local haematocrit distributions in the analysis of blood flow and could lead to more accurate computational models of blood flow in microvascular networks. The experimental approaches developed in this work provide a foundation for further examining the characteristics of microhaemodynamics.	[Sherwood, Joseph M.] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England; [Sherwood, Joseph M.; Kaliviotis, Efstathios; Balabani, Stavroula] UCL, Dept Mech Engn, London, England; [Holmes, David] UCL, London Ctr Nanotechnol, London, England; [Holmes, David] Sphere Fluid Ltd, Cambridge, England	Imperial College London; University of London; University College London; University of London; University College London	Balabani, S (corresponding author), UCL, Dept Mech Engn, London, England.	s.balabani@ucl.ac.uk	Sherwood, Joseph M. M/I-7984-2014; Kaliviotis, Efstathios/A-7721-2016; Sherwood, Joseph M/P-9619-2018	Sherwood, Joseph M. M/0000-0002-4402-9767; Kaliviotis, Efstathios/0000-0003-4149-4396; Sherwood, Joseph M/0000-0002-4402-9767; balabani, stavroula/0000-0002-6287-1106	King's College London; UCL EPSRC Strategic Enterprise Award [GR/T11364/01]	King's College London; UCL EPSRC Strategic Enterprise Award(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Joseph Sherwood was partly funded by a King's College London Studentship David Holmes was funded via UCL EPSRC Strategic Enterprise Award (GR/T11364/01) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARTS PAMM, 1988, ARTERIOSCLEROSIS, V8, P819, DOI 10.1161/01.ATV.8.6.819; ALONSO C, 1995, AM J PHYSIOL-HEART C, V268, pH25, DOI 10.1152/ajpheart.1995.268.1.H25; Baskurt OK, 1999, BIORHEOLOGY, V36, P447; Bishop JJ, 2001, AM J PHYSIOL-HEART C, V281, pH939, DOI 10.1152/ajpheart.2001.281.2.H939; Bishop JJ, 2001, AM J PHYSIOL-HEART C, V280, pH222, DOI 10.1152/ajpheart.2001.280.1.H222; Bishop JJ, 2003, AM J PHYSIOL-HEART C, V286, p113H; Bruus H., 2008, THEORETICAL MICROFLU, V18; Cabel M, 1997, AM J PHYSIOL-HEART C, V272, pH1020; CARR RT, 1990, MICROVASC RES, V40, P179, DOI 10.1016/0026-2862(90)90017-L; CARR RT, 1991, MICROVASC RES, V41, P184, DOI 10.1016/0026-2862(91)90020-C; Carr Russell T., 1995, Microcirculation (New York), V2, P345, DOI 10.3109/10739689509148278; Chesnutt JKW, 2009, MICROVASC RES, V78, P301, DOI 10.1016/j.mvr.2009.09.003; CHIEN S, 1985, AM J PHYSIOL, V248, pH568, DOI 10.1152/ajpheart.1985.248.4.H568; Cokelet G., 2011, HEMORHEOLOGY HEMODYN; Cokelet GR, 2005, BIORHEOLOGY, V42, P385; Cokelet GR, 1999, BIORHEOLOGY, V36, P343; DELLIMORE JW, 1983, AM J PHYSIOL, V244, pH635, DOI 10.1152/ajpheart.1983.244.5.H635; Fedosov DA, 2011, P NATL ACAD SCI USA, V108, P11772, DOI 10.1073/pnas.1101210108; FENTON BM, 1985, MICROVASC RES, V29, P103, DOI 10.1016/0026-2862(85)90010-X; Freund JB, 2014, ANNU REV FLUID MECH, V46, P67, DOI 10.1146/annurev-fluid-010313-141349; Freund JB, 2011, J FLUID MECH, V671, P466, DOI 10.1017/S0022112010005835; Fry BC, 2012, MICROCIRCULATION, V19, P530, DOI 10.1111/j.1549-8719.2012.00184.x; GAEHTGENS P, 1979, PFLUG ARCH EUR J PHY, V380, P115, DOI 10.1007/BF00582145; GOLDSMIT.HL, 1972, PROC R SOC SER B-BIO, V182, P351, DOI 10.1098/rspb.1972.0084; GOLDSMITH HL, 1968, J GEN PHYSIOL, V52, pS5; GUSTAFSSON L, 1981, AM J PHYSIOL, V241, pH513, DOI 10.1152/ajpheart.1981.241.4.H513; HOUSE SD, 1986, AM J PHYSIOL, V250, pH828, DOI 10.1152/ajpheart.1986.250.5.H828; Imai Y, 2010, J BIOMECH, V43, P1386, DOI 10.1016/j.jbiomech.2010.01.011; Kaliviotis E, 2008, BIORHEOLOGY, V45, P639, DOI 10.3233/BIR-2008-0514; Kim S, 2006, AM J PHYSIOL-HEART C, V290, pH941, DOI 10.1152/ajpheart.00645.2005; Kline SJ, 1953, MECH ENG, V75, P3, DOI DOI 10.1016/J.CHAOS.2005.11.046; Lee J, 2008, MICROCIRCULATION, V15, P699, DOI 10.1080/10739680802229589; LIPOWSKY HH, 1974, MICROVASC RES, V7, P73, DOI 10.1016/0026-2862(74)90038-7; Manjunatha M, 2002, CLIN HEMORHEOL MICRO, V27, P91; Meiselman HJ, 2009, BIORHEOLOGY, V46, P1, DOI 10.3233/BIR-2009-0522; Moger J, 2004, J BIOMED OPT, V9, P982, DOI 10.1117/1.1781163; Olsen MG, 2000, EXP FLUIDS, V29, pS166, DOI 10.1007/s003480070018; Ong PK, 2013, MICROCIRCULATION, V20, P440, DOI 10.1111/micc.12045; Ong PK, 2011, MICROCIRCULATION, V18, P541, DOI 10.1111/j.1549-8719.2011.00114.x; Ong PK, 2010, AM J PHYSIOL-HEART C, V298, pH1870, DOI 10.1152/ajpheart.01182.2009; Pan Q, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4025879; PERKKIO J, 1987, THROMB RES, V45, P517, DOI 10.1016/0049-3848(87)90314-8; Poelma C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045247; POPEL AS, 1994, J APPL PHYSIOL, V77, P1790, DOI 10.1152/jappl.1994.77.4.1790; PRIES AR, 1990, CIRC RES, V67, P826, DOI 10.1161/01.RES.67.4.826; PRIES AR, 1989, MICROVASC RES, V38, P81, DOI 10.1016/0026-2862(89)90018-6; PRIES AR, 1992, AM J PHYSIOL, V263, pH1770, DOI 10.1152/ajpheart.1992.263.6.H1770; PRIES AR, 1994, CIRC RES, V75, P904, DOI 10.1161/01.RES.75.5.904; REINKE W, 1987, AM J PHYSIOL, V253, pH540, DOI 10.1152/ajpheart.1987.253.3.H540; REINKE W, 1986, CIRC RES, V59, P124, DOI 10.1161/01.RES.59.2.124; Reneman RS, 2006, J VASC RES, V43, P251, DOI 10.1159/000091648; Rossi M, 2012, EXP FLUIDS, V52, P1063, DOI 10.1007/s00348-011-1194-z; Secomb T, 2008, MICROCIRCULATION, V15, P765, DOI 10.1080/10739680802350112; Sherwood JM, 2012, BIOMICROFLUIDICS, V6, DOI 10.1063/1.4717755; Sherwood JM, 2014, BIOMECH MODEL MECHAN, V13, P259, DOI 10.1007/s10237-012-0449-9; SOUTANI M, 1995, AM J PHYSIOL-HEART C, V268, pH1959, DOI 10.1152/ajpheart.1995.268.5.H1959; Westerweel J, 2005, EXP FLUIDS, V39, P1096, DOI 10.1007/s00348-005-0016-6; Yalcin O, 2011, BIORHEOLOGY, V48; Zhang JF, 2009, MICROVASC RES, V77, P265, DOI 10.1016/j.mvr.2009.01.010	59	50	50	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100473	10.1371/journal.pone.0100473	http://dx.doi.org/10.1371/journal.pone.0100473			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950214	gold, Green Published, Green Submitted			2022-12-27	WOS:000338276300078
J	Yoshizaki, K; Hu, LZ; Nguyen, T; Sakai, K; He, B; Fong, C; Yamada, Y; Bikle, DD; Oda, Y				Yoshizaki, Keigo; Hu, Lizhi; Thai Nguyen; Sakai, Kiyoshi; He, Bing; Fong, Chak; Yamada, Yoshihiko; Bikle, Daniel D.; Oda, Yuko			Ablation of Coactivator Med1 Switches the Cell Fate of Dental Epithelia to That Generating Hair	PLOS ONE			English	Article							FOLLICLE STEM-CELLS; AMELOBLAST-LINEAGE; GENE-EXPRESSION; MEDIATOR; DIFFERENTIATION; NOTCH; TRANSCRIPTION; PROTEIN; TOOTH; REGULATOR	Cell fates are determined by specific transcriptional programs. Here we provide evidence that the transcriptional coactivator, Mediator 1 (Med1), is essential for the cell fate determination of ectodermal epithelia. Conditional deletion of Med1 in vivo converted dental epithelia into epidermal epithelia, causing defects in enamel organ development while promoting hair formation in the incisors. We identified multiple processes by which hairs are generated in Med1 deficient incisors: 1) dental epithelial stem cells lacking Med 1 fail to commit to the dental lineage, 2) Sox2-expressing stem cells extend into the differentiation zone and remain multi-potent due to reduced Notch1 signaling, and 3) epidermal fate is induced by calcium as demonstrated in dental epithelial cell cultures. These results demonstrate that Med1 is a master regulator in adult stem cells to govern epithelial cell fate.	[Hu, Lizhi; Thai Nguyen; Fong, Chak; Bikle, Daniel D.; Oda, Yuko] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Hu, Lizhi; Thai Nguyen; Fong, Chak; Bikle, Daniel D.; Oda, Yuko] Univ Calif San Francisco, Dept Endocrinol, San Francisco, CA 94143 USA; [Hu, Lizhi; Thai Nguyen; Fong, Chak; Bikle, Daniel D.; Oda, Yuko] Vet Affairs Med Ctr San Francisco, San Francisco, CA USA; [Yoshizaki, Keigo; Sakai, Kiyoshi; He, Bing; Yamada, Yoshihiko] Natl Inst Dent & Craniofacial Res, Lab Cell & Dev Biol, NIH, Bethesda, MD USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Oda, Y (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	yuko.oda@ucsf.edu	He, Bing/V-5552-2019	Yoshizaki, Keigo/0000-0002-0598-5879	National Institutes of Health [R01 AR050023]; DOD [CA110338]; VA Merit Review; Intramural Research Program of the National Institutes of Dental and Craniofacial Research, NIH; Japanese Research Fellowship of Japan Society for the Promotion of Science; Chinese Research grant NSFC [81301360]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050023] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R21DE025357, ZIADE000720] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); VA Merit Review(US Department of Veterans Affairs); Intramural Research Program of the National Institutes of Dental and Craniofacial Research, NIH; Japanese Research Fellowship of Japan Society for the Promotion of Science; Chinese Research grant NSFC; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the National Institutes of Health grant R01 AR050023 (DDB), DOD grant CA110338 (DDB), a VA Merit Review (DDB), the Intramural Research Program of the National Institutes of Dental and Craniofacial Research, NIH (YY), and Chinese Research grant NSFC 81301360 (LH). KY was supported in part by the Japanese Research Fellowship of Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biehs B, 2013, NAT CELL BIOL, V15, P846, DOI 10.1038/ncb2766; Bikle D, 2007, J STEROID BIOCHEM, V103, P396, DOI 10.1016/j.jsbmb.2006.12.063; Bikle DD, 2012, EXPERT REV ENDOCRINO, V7, P461, DOI 10.1586/EEM.12.34; Blanpain C, 2006, ANNU REV CELL DEV BI, V22, P339, DOI 10.1146/annurev.cellbio.22.010305.104357; Castro B, 2005, DEVELOPMENT, V132, P3333, DOI 10.1242/dev.01920; Felszeghy S, 2010, DIFFERENTIATION, V80, P241, DOI 10.1016/j.diff.2010.06.004; Fryer CJ, 2004, MOL CELL, V16, P509, DOI 10.1016/j.molcel.2004.10.014; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Gebauer JM, 2009, MATRIX BIOL, V28, P456, DOI 10.1016/j.matbio.2009.07.006; Harada H, 2006, BIOCHEM BIOPH RES CO, V340, P611, DOI 10.1016/j.bbrc.2005.12.053; Jia YZ, 2005, J BIOL CHEM, V280, P10766, DOI 10.1074/jbc.M413331200; Jia YZ, 2004, J BIOL CHEM, V279, P24427, DOI 10.1074/jbc.M402391200; Jiang PP, 2010, P NATL ACAD SCI USA, V107, P6765, DOI 10.1073/pnas.1001814107; Josephsen K, 2010, AM J PHYSIOL-CELL PH, V299, pC1299, DOI 10.1152/ajpcell.00218.2010; Juuri E, 2013, DEVELOPMENT, V140, P1424, DOI 10.1242/dev.089599; Juuri E, 2012, DEV CELL, V23, P317, DOI 10.1016/j.devcel.2012.05.012; Kadaja M, 2014, GENE DEV, V28, P328, DOI 10.1101/gad.233247.113; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Katsube K, 2009, DEV GROWTH DIFFER, V51, P55, DOI 10.1111/j.1440-169X.2009.01077.x; Kaufman CK, 2003, GENE DEV, V17, P2108, DOI 10.1101/gad.1115203; Klein OD, 2008, DEVELOPMENT, V135, P377, DOI 10.1242/dev.015081; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Lien WH, 2011, CELL STEM CELL, V9, P219, DOI 10.1016/j.stem.2011.07.015; Malik S, 2005, TRENDS BIOCHEM SCI, V30, P256, DOI 10.1016/j.tibs.2005.03.009; Mammucari C, 2005, DEV CELL, V8, P665, DOI 10.1016/j.devcel.2005.02.016; Mitsiadis TA, 2010, DEVELOPMENT, V137, P3025, DOI 10.1242/dev.049528; Mitsiadis TA, 2009, BIRTH DEFECTS RES C, V87, P199, DOI 10.1002/bdrc.20160; Mosher DF, 2012, MATRIX BIOL, V31, P155, DOI 10.1016/j.matbio.2012.01.003; Nakajima T, 2013, J INVEST DERMATOL, V133, P354, DOI 10.1038/jid.2012.293; Oda Y, 2012, J INVEST DERMATOL, V132, P1075, DOI 10.1038/jid.2011.430; Oda Y, 2010, J INVEST DERMATOL, V130, P2377, DOI 10.1038/jid.2010.148; Perdigoto CN, 2013, BBA-GEN SUBJECTS, V1830, P2307, DOI 10.1016/j.bbagen.2012.08.009; Poche RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030357; Seidel K, 2010, DEVELOPMENT, V137, P3753, DOI 10.1242/dev.056358; Sharabi AB, 2009, CLONING STEM CELLS, V11, P523, DOI 10.1089/clo.2009.0020; Simmer JP, 2009, J BIOL CHEM, V284, P19110, DOI 10.1074/jbc.M109.013623; Stumpf M, 2010, P NATL ACAD SCI USA, V107, P21541, DOI 10.1073/pnas.1005794107; Taatjes DJ, 2010, TRENDS BIOCHEM SCI, V35, P315, DOI 10.1016/j.tibs.2010.02.004; Tanimura S, 2011, CELL STEM CELL, V8, P177, DOI 10.1016/j.stem.2010.11.029; Wang XP, 2007, PLOS BIOL, V5, P1324, DOI 10.1371/journal.pbio.0050159; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Yue XJ, 2011, P NATL ACAD SCI USA, V108, P17105, DOI 10.1073/pnas.1109095108; Zheng LW, 2013, INT J ORAL SCI, V5, P1, DOI 10.1038/ijos.2013.14; Zuo GW, 2010, HISTOL HISTOPATHOL, V25, P795, DOI 10.14670/HH-25.795	44	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e99991	10.1371/journal.pone.0099991	http://dx.doi.org/10.1371/journal.pone.0099991			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949995	Green Published, gold, Green Submitted			2022-12-27	WOS:000338276300027
J	Callejas, FD; Martinez-Anton, A; Alobid, I; Fuentes, M; Cortijo, J; Picado, C; Roca-Ferrer, J; Mullol, J				de Borja Callejas, Francisco; Martinez-Anton, Asuncion; Alobid, Isam; Fuentes, Mireya; Cortijo, Julio; Picado, Cesar; Roca-Ferrer, Jordi; Mullol, Joaquim			Reconstituted Human Upper Airway Epithelium as 3-D In Vitro Model for Nasal Polyposis	PLOS ONE			English	Article							MUCIN GENE-EXPRESSION; MUCOCILIARY DIFFERENTIATION; EOSINOPHIL SURVIVAL; STEM-CELLS; GLANDULAR SECRETION; CYTOKINE SECRETION; MESSENGER-RNA; BASAL-CELLS; GM-CSF; CULTURE	Background: Primary human airway epithelial cells cultured in an air-liquid interface (ALI) develop a well-differentiated epithelium. However, neither characterization of mucociliar differentiation overtime nor the inflammatory function of reconstituted nasal polyp (NP) epithelia have been described. Objectives: 1st) To develop and characterize the mucociliar differentiation overtime of human epithelial cells of chronic rhinosinusitis with nasal polyps (CRSwNP) in ALI culture system; 2nd) To corroborate that 3D in vitro model of NP reconstituted epithelium maintains, compared to control nasal mucosa (NM), an inflammatory function. Methods: Epithelial cells were obtained from 9 NP and 7 control NM, and differentiated in ALI culture for 28 days. Mucociliary differentiation was characterized at different times (0, 7, 14, 21, and 28 days) using ultrastructure analysis by electron microscopy; DNp63 (basal stem/progenitor cell), beta-tubulin IV (cilia), and MUC5AC (goblet cell) expression by immunocytochemistry; and mucous (MUC5AC, MUC5B) and serous (Lactoferrin) secretion by ELISA. Inflammatory function of ALI cultures (at days 0, 14, and 28) through cytokine (IL-8, IL-1 beta, IL-6, IL-10, TNF-alpha, and IL-12p70) and chemokine (RANTES, MIG, MCP-1, IP-10, eotaxin-1, and GM-CSF) production was analysed by CBA (Cytometric Bead Array). Results: In both NP and control NM ALI cultures, pseudostratified epithelium with ciliated, mucus-secreting, and basal cells were observed by electron microscopy at days 14 and 28. Displaying epithelial cell re-differentation, b-tubulin IV and MUC5AC positive cells increased, while Delta Np63 positive cells decreased overtime. No significant differences were found overtime in MUC5AC, MUC5B, and lactoferrin secretions between both ALI cultures. IL-8 and GM-CSF were significantly increased in NP compared to control NM regenerated epithelia. Conclusion: Reconstituted epithelia from human NP epithelial cells cultured in ALI system provides a 3D in vitro model that could be useful both for studying the role of epithelium in CRSwNP while developing new therapeutic strategies, including cell therapy, for CRSwNP.	[de Borja Callejas, Francisco; Martinez-Anton, Asuncion; Alobid, Isam; Fuentes, Mireya; Picado, Cesar; Roca-Ferrer, Jordi; Mullol, Joaquim] Inst Invest Biomed August Pi i Sunyer IDIBAPS, Barcelona, Spain; [de Borja Callejas, Francisco; Martinez-Anton, Asuncion; Fuentes, Mireya; Cortijo, Julio; Picado, Cesar; Roca-Ferrer, Jordi; Mullol, Joaquim] CIBER Resp Dis CIBERES, Barcelona, Spain; [Alobid, Isam; Mullol, Joaquim] Univ Barcelona, Hosp Clin Barcelona, ENT Dept, Rhinol Unit, Barcelona, Catalonia, Spain; [Alobid, Isam; Mullol, Joaquim] Univ Barcelona, Hosp Clin Barcelona, ENT Dept, Smell Clin, Barcelona, Catalonia, Spain; [Picado, Cesar] Univ Barcelona, Hosp Clin Barcelona, Pneumol & Resp Allergy Dept, Barcelona, Catalonia, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona	Mullol, J (corresponding author), Inst Invest Biomed August Pi i Sunyer IDIBAPS, Barcelona, Spain.	jmullol@clinic.ub.es	Roca-Ferrer, Jordi/AFQ-4652-2022; /AFX-9519-2022; Fuentes, Mireya/J-5901-2017; Martinez Anton, Asuncion/A-5806-2017; de Borja Callejas Díaz, Francisco/AAK-3221-2020; Callejas Díaz, Francisco de Borja/G-3252-2014; /AAL-7347-2021	Roca-Ferrer, Jordi/0000-0002-9527-2273; Fuentes, Mireya/0000-0002-1381-5589; Martinez Anton, Asuncion/0000-0001-9758-5911; Callejas Díaz, Francisco de Borja/0000-0001-5292-4334; 	Fondo de Investigaciones de la Seguridad Social [PI08-0188, PI12-01129]; Instituto de Salud Carlos III; MINECO (Ministerio de Economia y Competividad); FEDER, Spain	Fondo de Investigaciones de la Seguridad Social; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); MINECO (Ministerio de Economia y Competividad); FEDER, Spain(European Commission)	This work was funded by research grants (PI08-0188 and PI12-01129) from Fondo de Investigaciones de la Seguridad Social, Instituto de Salud Carlos III (http://www.isciii.es/), MINECO (Ministerio de Economia y Competividad, http://www.idi.mineco.gob.es/portal/site/MICINN/), and co-funded by FEDER (http://ec.europa.eu/regional_policy/thefunds/regional/index_en.cfm), Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MS, 2007, LARYNGOSCOPE, V117, P932, DOI 10.1097/MLG.0b013e3180383651; Almstahl A, 2001, ORAL MICROBIOL IMMUN, V16, P345, DOI 10.1034/j.1399-302X.2001.160605.x; Antunes MB, 2007, BIOTECHNIQUES, V43, P195, DOI 10.2144/000112531; Bachert C, 2001, J ALLERGY CLIN IMMUN, V107, P607, DOI 10.1067/mai.2001.112374; Bernacki SH, 1999, AM J RESP CELL MOL, V20, P595, DOI 10.1165/ajrcmb.20.4.3442; Bernstein JM, 1997, J ALLERGY CLIN IMMUN, V99, P165, DOI 10.1016/S0091-6749(97)70091-5; Bleier BS, 2012, J PHARM PHARMACOL, V64, P449, DOI 10.1111/j.2042-7158.2011.01409.x; Bobic S, 2010, RHINOLOGY, V48, P401, DOI 10.4193/Rhino10.033; Booth BW, 2001, AM J RESP CELL MOL, V25, P739, DOI 10.1165/ajrcmb.25.6.4659; Bucheler M, 2003, DNA CELL BIOL, V22, P549, DOI 10.1089/104454903322405446; Calderon MA, 1997, J ALLERGY CLIN IMMUN, V99, P65, DOI 10.1016/S0091-6749(97)70302-6; Crystal Ronald G, 2008, Proc Am Thorac Soc, V5, P772, DOI 10.1513/pats.200805-041HR; Daniely Y, 2004, AM J PHYSIOL-CELL PH, V287, pC171, DOI 10.1152/ajpcell.00226.2003; Callejas FD, 2013, AM J RHINOL ALLERGY, V27, pE69, DOI 10.2500/ajra.2013.27.3908; DEVALIA JL, 1990, RESP MED, V84, P303, DOI 10.1016/S0954-6111(08)80058-3; Dimova S, 2005, TOXICOL IN VITRO, V19, P107, DOI 10.1016/j.tiv.2004.07.003; Dvorak A, 2011, AM J RESP CELL MOL, V44, P465, DOI 10.1165/rcmb.2009-0453OC; Eloy P, 2011, CURR ALLERGY ASTHM R, V11, P146, DOI 10.1007/s11882-011-0180-0; Fernandez-Morata JC, 2000, CLIN EXP ALLERGY, V30, P1275; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Gras D, 2012, J ALLERGY CLIN IMMUN, V129, P1259, DOI 10.1016/j.jaci.2012.01.073; Gray TE, 1996, AM J RESP CELL MOL, V14, P104, DOI 10.1165/ajrcmb.14.1.8534481; Hackett TL, 2008, STEM CELLS, V26, P2576, DOI 10.1634/stemcells.2008-0171; Hajj R, 2007, STEM CELLS, V25, P139, DOI 10.1634/stemcells.2006-0288; Kesimer M, 2009, AM J PHYSIOL-LUNG C, V296, pL92, DOI 10.1152/ajplung.90388.2008; Kim CH, 2005, ACTA OTO-LARYNGOL, V125, P76, DOI 10.1080/00016480410015785; Kondo M, 2002, AM J RESP CELL MOL, V27, P536, DOI 10.1165/rcmb.4682; Kondo Mitsuko, 2006, Allergol Int, V55, P329, DOI 10.2332/allergolint.55.329; Kumar PA, 2011, CELL, V147, P525, DOI 10.1016/j.cell.2011.10.001; Laudien M, 2011, RHINOLOGY, V49, P107, DOI 10.4193/Rhino10.036; Lee JT, 2010, AM J RHINOL ALLERGY, V24, P99, DOI 10.2500/ajra.2010.24.3444; Lee MK, 2005, DRUG DELIV, V12, P305, DOI 10.1080/10717540500177009; Martinez-Anton A, 2013, AM J RESP CELL MOL, V49, P384, DOI 10.1165/rcmb.2012-0368OC; McDougall CM, 2008, AM J RESP CELL MOL, V39, P560, DOI 10.1165/rcmb.2007-0325OC; Milara J, 2012, BRIT J PHARMACOL, V166, P2243, DOI 10.1111/j.1476-5381.2012.01929.x; Mullol J, 2010, J BIOL REG HOMEOS AG, V24, P403; MULLOL J, 1995, THORAX, V50, P270, DOI 10.1136/thx.50.3.270; Mullol J, 2002, J ALLERGY CLIN IMMUN, V109, P824, DOI 10.1067/mai.2002.123534; Mullol J, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-23; Nelson WJ, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000513; Ocampo CJ, 2012, J ALLERGY CLIN IMMUN, V129, pAB43, DOI 10.1016/j.jaci.2011.12.825; Oyer SL, 2013, LARYNGOSCOPE, V123, pE72, DOI 10.1002/lary.24305; Payne SC, 2008, AM J RHINOL, V22, P568, DOI 10.2500/ajr.2008.22.3233; Proud D, 2011, IMMUNOL REV, V242, P186, DOI 10.1111/j.1600-065X.2011.01033.x; Psaltis AJ, 2008, LARYNGOSCOPE, V118, P895, DOI 10.1097/MLG.0b013e31816381d4; Psaltis AJ, 2007, LARYNGOSCOPE, V117, P2030, DOI 10.1097/MLG.0b013e31812e01ab; Reichl S, 2012, J PHARM PHARMACOL, V64, P1621, DOI 10.1111/j.2042-7158.2012.01540.x; Riechelmann H, 2005, CLIN EXP ALLERGY, V35, P1186, DOI 10.1111/j.1365-2222.2005.02316.x; Roca-Ferrer J, 2001, J ALLERGY CLIN IMMUN, V108, P87, DOI 10.1067/mai.2001.115485; Roca-Ferrer J, 2000, J ALLERGY CLIN IMMUN, V106, P1053, DOI 10.1067/mai.2000.110476; Rock JR, 2011, CELL STEM CELL, V8, P639, DOI 10.1016/j.stem.2011.04.003; Rock JR, 2010, DIS MODEL MECH, V3, P545, DOI 10.1242/dmm.006031; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Ross AJ, 2007, AM J RESP CELL MOL, V37, P169, DOI 10.1165/rcmb.2006-0466OC; Rowe RK, 2004, IN VITRO CELL DEV-AN, V40, P303; Schleimer RP, 2007, J ALLERGY CLIN IMMUN, V120, P1279, DOI 10.1016/j.jaci.2007.08.046; Shin K, 2006, ANNU REV CELL DEV BI, V22, P207, DOI 10.1146/annurev.cellbio.22.010305.104219; Shin SH, 2006, ACTA OTO-LARYNGOL, V126, P1286, DOI 10.1080/00016480500395179; Steed E, 2010, TRENDS CELL BIOL, V20, P142, DOI 10.1016/j.tcb.2009.12.002; Stripp Barry R, 2008, Proc Am Thorac Soc, V5, P328, DOI 10.1513/pats.200711-167DR; Thomason HA, 2010, BIOCHEM J, V429, P419, DOI 10.1042/BJ20100567; Thornton DJ, 2008, ANNU REV PHYSIOL, V70, P459, DOI 10.1146/annurev.physiol.70.113006.100702; Van Bruaene N, 2011, CURR OPIN ALLERGY CL, V11, P8, DOI 10.1097/ACI.0b013e32834233ef; Van Zele T, 2006, ALLERGY, V61, P1280, DOI 10.1111/j.1398-9995.2006.01225.x; Wengst A, 2010, EUR J PHARM BIOPHARM, V74, P290, DOI 10.1016/j.ejpb.2009.08.008; Wickstrom C, 2001, J BIOL CHEM, V276, P47116, DOI 10.1074/jbc.M106593200; XAUBET A, 1994, CLIN EXP ALLERGY, V24, P307, DOI 10.1111/j.1365-2222.1994.tb00240.x; Yan Y, 2013, CURR OPIN OTOLARYNGO, V21, P263, DOI 10.1097/MOO.0b013e32835f80a0; Yasuo M, 2006, RESPIRATION, V73, P347, DOI 10.1159/000091391; Yoon JH, 1997, AM J RESP CELL MOL, V16, P724, DOI 10.1165/ajrcmb.16.6.9191474; Yoon JH, 2002, DIFFERENTIATION, V70, P77, DOI 10.1046/j.1432-0436.2002.700202.x; Zhao XN, 2012, AM J RHINOL ALLERGY, V26, P345, DOI 10.2500/ajra.2012.26.3794; Zhen GH, 2007, AM J RESP CELL MOL, V36, P244, DOI 10.1165/rcmb.2006-0180OC	73	17	17	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100537	10.1371/journal.pone.0100537	http://dx.doi.org/10.1371/journal.pone.0100537			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945146	Green Published, gold, Green Submitted			2022-12-27	WOS:000340721500089
J	George, J; Matucci-Cerinic, M; Bar, I; Shimoni, S				George, Jacob; Matucci-Cerinic, Marco; Bar, Iris; Shimoni, Sara			Circulating Autoantibodies to Endothelial Progenitor Cells: Binding Characteristics and Association with Risk Factors for Atherosclerosis	PLOS ONE			English	Article							SYSTEMIC-SCLEROSIS; ANTIBODY-LEVELS; LIVER-DISEASES; HEART; HYPERTENSION; CORRELATE	Objective: Endothelial progenitor cells (EPC) are committed to transform into EC promoting vasculogenic ischemic repair. Anti-endothelial cells (AECA) have been described in various disorders with an associated vascular damage. Herein, we explored a novel circulating population of IgG reactive with EPC, in patients with differential risk profile for atherosclerotic vascular disease. Approach and Results: A novel cyto-ELISA system was established where the coated cells were late outgrowth EPC. Levels of anti-EPC antibodies were determined in 100 subjects and differential risk score for atherosclerosis, as well as to circulating EPC levels and the inflammatory markers IL-6 and C-reactive protein. To study endothelial cell (EC) activating properties, sera were tested for their ability to induce VCAM-1 expression in a cell ELISA system. Detectable levels of anti-EPC antibodies, that correlated with age, Framingham risk score and CRP concentrations but did not associate with levels of LDL, HDL, hypertension or diabetes, were detected. Anti-EPC antibodies were distinct from EC binding antibodies as shown by competitive inhibition studies, and have been positively correlated with the extent of EC activation manifested by in vitro VCAM-1 expression. Conclusion: This is the first study showing a newly defined subgroup of self-antibodies binding EPC and associating positively with the Framingham risk score. Further studies are required to characterize and test this interesting subset of EPC binding autoantibodies and their potential significance.	[George, Jacob; Bar, Iris; Shimoni, Sara] Hebrew Univ Jerusalem, Kaplan Med Ctr, Ctr Heart, Jerusalem, Israel; [Matucci-Cerinic, Marco] Univ Florence, Div Rheumatol AOUC, Dept Expt & Clin Med, Florence, Italy	Hebrew University of Jerusalem; Kaplan Medical Center; University of Florence	George, J (corresponding author), Hebrew Univ Jerusalem, Kaplan Med Ctr, Ctr Heart, Jerusalem, Israel.	jgeorge@bezeqint.net	CERINIC, marco MATUCCI/AAO-2769-2020					Alessandri C, 2006, ADV CLIN CHEM, V42, P297, DOI 10.1016/S0065-2423(06)42008-4; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Avouac J, 2008, ANN RHEUM DIS, V67, P1455, DOI 10.1136/ard.2007.082131; Belizna C, 2006, ANN RHEUM DIS, V65, P1545, DOI 10.1136/ard.2005.035295; Ben-Shoshan J, 2007, PHARMACOL THERAPEUT, V115, P25, DOI 10.1016/j.pharmthera.2007.03.012; Caforio ALP, 2010, HEART, V96, P779, DOI 10.1136/hrt.2009.187138; Del Papa N, 2010, J RHEUMATOL, V37, P2053, DOI 10.3899/jrheum.091346; Elsheikh E, 2010, SCAND CARDIOVASC J, V44, P255, DOI 10.3109/14017431003797168; Fadini GP, 2012, CIRC RES, V110, P624, DOI 10.1161/CIRCRESAHA.111.243386; Geft D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003238; George J, 1998, CIRCULATION, V97, P900, DOI 10.1161/01.CIR.97.9.900; George J, 2006, TISSUE ENG, V12, P331, DOI 10.1089/ten.2006.12.331; George J, 2000, IMMUNOL LETT, V73, P23, DOI 10.1016/S0165-2478(00)00192-9; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Kawamoto A, 2008, TRENDS CARDIOVAS MED, V18, P33, DOI 10.1016/j.tcm.2007.11.004; Negi VS, 1998, J RHEUMATOL, V25, P462; NICHOLSON GC, 1977, CLIN IMMUNOL IMMUNOP, V7, P349, DOI 10.1016/0090-1229(77)90069-1; OYA H, 1995, ADV EXP MED BIOL, V371, P1087; Papadopoulos DP, 2008, INT J CARDIOL, V130, P405, DOI 10.1016/j.ijcard.2007.08.122; Papadopoulos DP, 2006, CLIN EXP HYPERTENS, V28, P663, DOI 10.1080/10641960601013567; Schwartzenberg S, 2007, ARTERIOSCL THROM VAS, V27, pE27, DOI 10.1161/ATVBAHA.107.139626; TANNENBAUM SH, 1986, J IMMUNOL, V137, P1532; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Zamanou A, 2002, J CLIN LAB ANAL, V16, P194, DOI 10.1002/jcla.10040	25	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e97836	10.1371/journal.pone.0097836	http://dx.doi.org/10.1371/journal.pone.0097836			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945945	Green Published, gold			2022-12-27	WOS:000340721500004
J	Li, YL; Cheng, DS; Cheng, R; Zhu, XY; Wan, T; Liu, JM; Zhang, RY				Li, Yali; Cheng, Deshu; Cheng, Ran; Zhu, Xinyu; Wan, Tao; Liu, Jianmiao; Zhang, Rongying			Mechanisms of U87 Astrocytoma Cell Uptake and Trafficking of Monomeric versus Protofibril Alzheimer's Disease Amyloid-beta Proteins	PLOS ONE			English	Article							A-BETA; APOLIPOPROTEIN-E; IN-VITRO; CLEARANCE; NEURONS; PEPTIDE; DEGRADATION; OLIGOMERS; MICROGLIA; BRAIN	A significant hallmark of Alzheimer's disease is the formation of senile plaques in the brain due to the unbalanced levels of amyloid-beta (A beta). However, although how A beta is produced from amyloid precursor proteins is well understood, little is known regarding the clearance and metabolism of various A beta aggregates from the brain. Similarly, little is known regarding how astrocytes internalize and degrade A beta, although astrocytes are known to play an important role in plaque maintenance and A beta clearance. The objective of this study is to investigate the cellular mechanisms that mediate the internalization of soluble monomeric versus oligomeric A beta by astrocytes. We used a combination of laser confocal microscopy and genetic and pharmacological experiments to dissect the internalization of sA beta 42 and oA beta 42 and their postendocytic transport by U87 human brain astrocytoma cell line. Both A beta 42 species were internalized by U87 cells through fluid phase macropinocytosis, which required dynamin 2. Depleting LDL receptor-related protein 1 (LRP1) decreased sA beta 42 uptake more significantly than that of oA beta 42. We finally show that both A beta 42 species were rapidly transported to lysosomes through an endolytic pathway and subjected to proteolysis after internalization, which had no significant toxic effects to the U87 cells under relatively low concentrations. We propose that macropinocytic sA beta 42 and oA beta 42 uptake and their subsequent proteolytic degradation in astroglial cells is a significant mechanism underlying A beta clearance from the extracellular milieu. Understanding the molecular events involved in astrocytic A beta internalization may identify potential therapeutic targets for Alzheimer's disease.	[Li, Yali; Cheng, Deshu; Cheng, Ran; Zhu, Xinyu; Wan, Tao; Liu, Jianmiao; Zhang, Rongying] Huazhong Univ Sci & Technol, Sch Life Sci & Technol, Key Lab Mol Biophys, Minist Educ, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology	Zhang, RY (corresponding author), Huazhong Univ Sci & Technol, Sch Life Sci & Technol, Key Lab Mol Biophys, Minist Educ, Wuhan 430074, Hubei, Peoples R China.	ryzhang@mail.hust.edu.cn			Major State Basic Research Program of China [2011CB910402]; National Science Foundation of China [31071249]	Major State Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Grants from the Major State Basic Research Program of China (2011CB910402) and the National Science Foundation of China (31071249). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki M, 2008, NEUROREPORT, V19, P1085, DOI 10.1097/WNR.0b013e328302c858; Basak JM, 2012, J BIOL CHEM, V287, P13959, DOI 10.1074/jbc.M111.288746; Benseny-Cases Nuria, 2012, Subcell Biochem, V65, P53, DOI 10.1007/978-94-007-5416-4_3; Boucrot E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010597; Cha MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034929; Chung HY, 1999, J BIOL CHEM, V274, P32301, DOI 10.1074/jbc.274.45.32301; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Evans NA, 2008, J NEUROSCI METH, V175, P96, DOI 10.1016/j.jneumeth.2008.08.001; Foster JK, 2009, MOL PSYCHIATR, V14, P239, DOI 10.1038/mp.2008.115; Fuentealba RA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011884; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; Herz J, 2002, ANNU REV BIOCHEM, V71, P405, DOI 10.1146/annurev.biochem.71.110601.135342; Jiang M, 2009, J NEUROSCI, V29, P8063, DOI 10.1523/JNEUROSCI.6139-08.2009; Jin LW, 2004, AM J PATHOL, V164, P975, DOI 10.1016/S0002-9440(10)63185-9; Kanekiyo T, 2012, J NEUROSCI, V32, P16458, DOI 10.1523/JNEUROSCI.3987-12.2012; Kanekiyo T, 2009, J BIOL CHEM, V284, P33352, DOI 10.1074/jbc.M109.015032; Kittelberger KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029940; Koenigsknecht J, 2004, J NEUROSCI, V24, P9838, DOI 10.1523/JNEUROSCI.2557-04.2004; Kong Y, 2010, J NEUROSCI, V30, P11848, DOI 10.1523/JNEUROSCI.2985-10.2010; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Larson ME, 2012, J NEUROCHEM, V120, P125, DOI 10.1111/j.1471-4159.2011.07478.x; Lee CYD, 2012, J BIOL CHEM, V287, P2032, DOI 10.1074/jbc.M111.295451; Lee CYD, 2010, J NEURAL TRANSM, V117, P949, DOI 10.1007/s00702-010-0433-4; Li YH, 2003, FEBS LETT, V555, P346, DOI 10.1016/S0014-5793(03)01272-9; Liu YW, 2008, MOL BIOL CELL, V19, P5347, DOI 10.1091/mbc.E08-08-0890; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Maezawa I, 2008, J NEUROCHEM, V104, P457, DOI 10.1111/j.1471-4159.2007.04972.x; Mandrekar S, 2009, J NEUROSCI, V29, P4252, DOI 10.1523/JNEUROSCI.5572-08.2009; Mohamed Amany, 2011, Int J Alzheimers Dis, V2011, P127984, DOI 10.4061/2011/127984; Mulder SD, 2012, EXP NEUROL, V233, P373, DOI 10.1016/j.expneurol.2011.11.001; Nielsen HM, 2010, GLIA, V58, P1235, DOI 10.1002/glia.21004; Nielsen HM, 2009, GLIA, V57, P978, DOI 10.1002/glia.20822; Omtri RS, 2012, MOL PHARMACEUT, V9, P1887, DOI 10.1021/mp200530q; Pichler H, 2004, BBA-BIOMEMBRANES, V1666, P51, DOI 10.1016/j.bbamem.2004.05.011; Pigino G, 2009, P NATL ACAD SCI USA, V106, P5907, DOI 10.1073/pnas.0901229106; Rossello XS, 2012, BRAIN RES, V1444, P87, DOI 10.1016/j.brainres.2012.01.017; Saavedra L, 2007, J BIOL CHEM, V282, P35722, DOI 10.1074/jbc.M701823200; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Song MS, 2011, NEUROSCIENCE, V178, P181, DOI 10.1016/j.neuroscience.2010.12.055; Stine WB, 2011, METHODS MOL BIOL, V670, P13, DOI 10.1007/978-1-60761-744-0_2; Tabira T, 2002, FRONT BIOSCI-LANDMRK, V7, pA44, DOI 10.2741/tabira; Urrutia R, 1997, P NATL ACAD SCI USA, V94, P377, DOI 10.1073/pnas.94.2.377; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang HM, 2010, J ALZHEIMERS DIS, V21, P597, DOI 10.3233/JAD-2010-091207; Wang PW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010202; Wang YJ, 2006, DRUG DISCOV TODAY, V11, P931, DOI 10.1016/j.drudis.2006.08.004; Wyss-Coray T, 2003, NAT MED, V9, P453, DOI 10.1038/nm838; Wyss-Coray T, 2001, NAT MED, V7, P612, DOI 10.1038/87945; Yang F, 2006, J MOL BIOL, V362, P821, DOI 10.1016/j.jmb.2006.07.059; Yu CJ, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-19; Zhou XF, 2011, PRION, V5, P161, DOI 10.4161/pri.5.3.16896	52	23	25	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99939	10.1371/journal.pone.0099939	http://dx.doi.org/10.1371/journal.pone.0099939			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941200	Green Published, Green Submitted, gold			2022-12-27	WOS:000338508200056
J	Lorca-Oro, C; Lopez-Olvera, JR; Ruiz-Fons, F; Acevedo, P; Garcia-Bocanegra, I; Oleaga, A; Gortazar, C; Pujols, J				Lorca-Oro, Cristina; Ramon Lopez-Olvera, Jorge; Ruiz-Fons, Francisco; Acevedo, Pelayo; Garcia-Bocanegra, Ignacio; Oleaga, Alvaro; Gortazar, Christian; Pujols, Joan			Long-Term Dynamics of Bluetongue Virus in Wild Ruminants: Relationship with Outbreaks in Livestock in Spain, 2006-2011	PLOS ONE			English	Article							DEER CERVUS-ELAPHUS; RED DEER; SEROTYPES 1; EPIDEMIOLOGY; SURVEILLANCE; INFECTION; DISEASE; FRANCE; EUROPE	Wild and domestic ruminants are susceptible to Bluetongue virus (BTV) infection. Three BTV serotypes (BTV-4, BTV-1 and BTV-8) have been detected in Spain in the last decade. Even though control strategies have been applied to livestock, BTV circulation has been frequently detected in wild ruminant populations in Spain. The aim of the present study is to assess the role for wild ruminants in maintaining BTV after the vaccination programs in livestock in mainland Spain. A total of 931 out 1,914 (48.6%) serum samples, collected from eight different wild ruminant species between 2006 and 2011, were BTV positive by ELISA. In order to detect specific antibodies against BTV-1, BTV-4 and BTV-8, positive sera were also tested by serumneutralisation test (SNT). From the ELISA positive samples that could be tested by SNT (687 out of 931), 292 (42.5%) showed neutralising antibodies against one or two BTV serotypes. For each BTV seroptype, the number of outbreaks in livestock (11,857 outbreaks in total) was modelled with pure autoregressive models and the resulting smoothed values, representing the predicted number of BTV outbreaks in livestock at municipality level, were positively correlated with BTV persistence in wild species. The strength of this relationship significantly decreased as red deer (Cervus elaphus) population abundance increased. In addition, BTV RNA was detected by real time RT-PCR in 32 out of 311 (10.3%) spleen samples from seropositive animals. Although BT outbreaks in livestock have decreased substantially after vaccination campaigns, our results indicated that wild ruminants have been exposed to BTV in territories where outbreaks in domestic animals occurred. The detection of BTV RNA and spatial association between BT outbreaks in livestock and BTV rates in red deer are consistent with the hypothesis of virus circulation and BTV maintenance within Iberian wild ruminant populations.	[Lorca-Oro, Cristina; Pujols, Joan] UAB IRTA, Ctr Recerca Sanitat Anim CReSA, Bellaterra, Cerdanyola Del, Spain; [Ramon Lopez-Olvera, Jorge] UAB, Dept Med & Cirurgia Anim, Serv Ecopatol Fauna Salvatge SEFaS, Barcelona, Spain; [Ruiz-Fons, Francisco; Acevedo, Pelayo; Oleaga, Alvaro; Gortazar, Christian] Inst Invest Recursos Cineget CSIC UCLM JCCM, SaBio IREC, Ciudad Real, Spain; [Acevedo, Pelayo] Univ Porto, InBio Lab Associado, CIBIO, Ctr Invest Biodiversidade & Recursos Genet, Vairao, Portugal; [Garcia-Bocanegra, Ignacio] UCO, Fac Vet, Dept Sanidad Anim, Cordoba, Spain; [Oleaga, Alvaro] Sociedad Serv Principado Asturias SA, SERPA, Gijon, Asturias, Spain; [Pujols, Joan] IRTA, Barcelona, Spain	IRTA; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha; Universidade do Porto; Universidad de Cordoba; IRTA	Lorca-Oro, C (corresponding author), UAB IRTA, Ctr Recerca Sanitat Anim CReSA, Campus Univ Autonoma Barcelona, Bellaterra, Cerdanyola Del, Spain.	cristina.lorca.oro@gmail.com	Oleaga, Alvaro/S-3966-2018; Pujols, Joan/K-9693-2015; Olvera, Jorge R López/H-8382-2015; Lorca-Oró, Cristina/ABE-7268-2021; Acevedo, Pelayo/L-6737-2013; Pujols, Joan/S-1141-2018; Bocanegra, Ignacio Garcia/G-1443-2016; Pujols, Joan/AAV-6427-2020; Gortazar, Christian/E-7918-2012; Ruiz-Fons, Francisco/K-3161-2014; Oleaga, Alvaro/Q-8070-2019	Oleaga, Alvaro/0000-0002-4080-3057; Pujols, Joan/0000-0002-6940-1529; Olvera, Jorge R López/0000-0002-2999-3451; Lorca-Oró, Cristina/0000-0001-5351-4169; Acevedo, Pelayo/0000-0002-3509-7696; Bocanegra, Ignacio Garcia/0000-0003-3388-2604; Pujols, Joan/0000-0002-6940-1529; Gortazar, Christian/0000-0003-0012-4006; Ruiz-Fons, Francisco/0000-0002-0820-5292; Oleaga, Alvaro/0000-0002-4080-3057	INIA [FAU2008-00019-C03-01]; FI-DGR grant (Agencia de Gestio d'Ajuts Universitaris i de Recerca, AGAUR); Spanish Ministry for the Economy and Competitiveness through a Juan de la Cierva contract; Fundacao para a Ciencia e a Tecnologia (FCT); Programa Operacional Potencial Humano (POPH) - Quadro de Referencia Estrategico Nacional (QREN) from the European Social Fund; Portuguese Ministerio da Educacao e Ciencia [SFRH/BPD/90320/2012]	INIA(Instituto de Investigacion Agropecuaria (INIA)); FI-DGR grant (Agencia de Gestio d'Ajuts Universitaris i de Recerca, AGAUR); Spanish Ministry for the Economy and Competitiveness through a Juan de la Cierva contract; Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Programa Operacional Potencial Humano (POPH) - Quadro de Referencia Estrategico Nacional (QREN) from the European Social Fund; Portuguese Ministerio da Educacao e Ciencia(Portuguese Foundation for Science and Technology)	The following funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was partially supported by the FAU2008-00019-C03-01 INIA research project, "Epidemiologia, control y aspectos entomologicos de la lengua azul (BTV) en rumiantes silvestres en Espana". C Lorca-Oro was funded by a FI-DGR grant (Agencia de Gestio d'Ajuts Universitaris i de Recerca, AGAUR). JF Ruiz-Fons was funded by the Spanish Ministry for the Economy and Competitiveness through a Juan de la Cierva contract. P Acevedo currently holds a post-doctoral grant from Fundacao para a Ciencia e a Tecnologia (FCT) funded by Programa Operacional Potencial Humano (POPH) - Quadro de Referencia Estrategico Nacional (QREN) from the European Social Fund and by the Portuguese Ministerio da Educacao e Ciencia (SFRH/BPD/90320/2012).	Acevedo P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014236; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Allepuz A, 2010, PREV VET MED, V96, P263, DOI 10.1016/j.prevetmed.2010.06.005; Bailey T, 1995, INTERACTIVE SPATIAL; CARRANZA J, 1991, APPL ANIM BEHAV SCI, V30, P363, DOI 10.1016/0168-1591(91)90141-J; Casaubon J, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-166; Conraths FJ, 2009, EMERG INFECT DIS, V15, P433, DOI 10.3201/eid1503.081210; Corbiere F, 2012, J WILDLIFE DIS, V48, P1047, DOI 10.7589/2011-12-359; De Curtis M, 2007, SEROLOGICAL MONITORI; Diggle P., 2003, STAT ANAL SPATIAL PO; Durand B, 2010, EMERG INFECT DIS, V16, P1861, DOI 10.3201/eid1612.100412; Enserink M, 2008, SCIENCE, V319, P710, DOI 10.1126/science.319.5864.710; Eschbaumer M, 2009, VACCINE, V27, P4169, DOI 10.1016/j.vaccine.2009.04.056; Falconi C, 2012, VET MICROBIOL, V159, P40, DOI 10.1016/j.vetmic.2012.03.023; Falconi C, 2011, VET MICROBIOL, V151, P209, DOI 10.1016/j.vetmic.2011.02.011; Fernandez-Pacheco P, 2008, VET REC, V162, P659, DOI 10.1136/vr.162.20.659; Garcia I, 2009, EUR J WILDLIFE RES, V55, P173, DOI 10.1007/s10344-008-0231-6; Garcia-Bocanegra I, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-88; Gerdes GH, 2004, VETER ITAL SER, V40, P39; Haining R., 2003, SPATIAL DATA ANAL TH; HOSMER DW, 1989, APPL LOGISTIC REGRES; LeSage JP, 1997, INT REGIONAL SCI REV, V20, P113, DOI 10.1177/016001769702000107; Linden A, 2008, VET REC, V162, P459, DOI 10.1136/vr.162.14.459-a; Linden A, 2010, EMERG INFECT DIS, V16, P833, DOI 10.3201/eid1605.091217; Lorca-Oro C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036380; Lorca-Oro C, 2012, VET MICROBIOL, V154, P240, DOI 10.1016/j.vetmic.2011.07.008; Lorca-Oro C, 2011, VET MICROBIOL, V149, P230, DOI 10.1016/j.vetmic.2010.10.023; Munoz PM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-46; OIE, 2009, BLUET EP HAEM DIS; Oura CAL, 2009, VACCINE, V27, P7326, DOI 10.1016/j.vaccine.2009.09.070; Pfeiffer DU, 2008, Spatial Analysis in Epidemiology, P1, DOI 10.1093/acprof:oso/9780198509882.001.0001; Purse BV, 2008, REV SCI TECH OIE, V27, P427, DOI 10.20506/rst.27.2.1801; Purse BV, 2005, NAT REV MICROBIOL, V3, P171, DOI 10.1038/nrmicro1090; Lopez-Olvera JR, 2010, VET MICROBIOL, V145, P148, DOI 10.1016/j.vetmic.2010.03.012; Rangel TF, 2010, ECOGRAPHY, V33, P46, DOI 10.1111/j.1600-0587.2009.06299.x; Rodriguez-Sanchez B, 2008, TRANSBOUND EMERG DIS, V55, P205, DOI 10.1111/j.1865-1682.2008.01029.x; Rodriguez-Sanchez B, 2010, VET MICROBIOL, V141, P164, DOI 10.1016/j.vetmic.2009.08.003; Rodriguez-Sanchez B, 2010, EMERG INFECT DIS, V16, P518, DOI 10.3201/eid1603.090626; Rossi S, 2014, TRANSBOUND EMERG DIS, V61, pE12, DOI 10.1111/tbed.12061; Rossi S, 2009, P 29EM RENC GROUP ET; Ruiz-Fons F, 2008, EMERG INFECT DIS, V14, P951, DOI 10.3201/eid1406.071586; Saenz De Buruaga M, 1991, RECONOCIMIENTO SEXO; Spanish Wildlife Disease Surveillance Scheme, 2011, INT REP SPAN MIN AGR; Stallknecht DE, 2004, VETER ITAL SER, V40, P203; Toussaint JF, 2007, J VIROL METHODS, V140, P115, DOI 10.1016/j.jviromet.2006.11.007; Zanella G, 2014, TRANSBOUND EMERG DIS, V61, P473, DOI 10.1111/tbed.12048	46	28	29	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100027	10.1371/journal.pone.0100027	http://dx.doi.org/10.1371/journal.pone.0100027			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940879	Green Submitted, Green Published, gold			2022-12-27	WOS:000338508200067
J	Roy, D; Paul, A; Roy, A; Ghosh, R; Ganguly, P; Chaudhuri, S				Roy, Dipan; Paul, Amit; Roy, Adrita; Ghosh, Ritesh; Ganguly, Payel; Chaudhuri, Shubho			Differential Acetylation of Histone H3 at the Regulatory Region of OsDREB1b Promoter Facilitates Chromatin Remodelling and Transcription Activation during Cold Stress	PLOS ONE			English	Article							RESPONSIVE GENE-EXPRESSION; LOW-TEMPERATURE; INDUCIBLE GENES; HIGH-SALT; DNASE-I; DROUGHT; RICE; ELEMENTS; BINDING; DOMAIN	The rice ortholog of DREB1, OsDREB1b, is transcriptionally induced by cold stress and over-expression of OsDREB1b results in increase tolerance towards high salt and freezing stress. This spatio-temporal expression of OsDREB1b is preceded by the change in chromatin structure at the promoter and the upstream region for gene activation. The promoter and the upstream region of OsDREB1b genes appear to be arranged into a nucleosome array. Nucleosome mapping of similar to 700bp upstream region of OsDREB1b shows two positioned nucleosomes between -610 to -258 and a weakly positioned nucleosome at the core promoter and the TSS. Upon cold stress, there is a significant change in the nucleosome arrangement at the upstream region with increase in DNasel hypersensitivity or MNase digestion in the vicinity of cis elements and TATA box at the core promoter. ChIP assays shows hyper-acetylation of histone H3K9 throughout the locus whereas region specific increase was observed in H3K14ac and H3K27ac. Moreover, there is an enrichment of RNA PolII occupancy at the promoter region during transcription activation. There is no significant change in the H3 occupancy in OsDREB1b locus negating the possibility of nucleosome loss during cold stress. Interestingly, cold induced enhanced transcript level of OsDREB1b as well as histone H3 acetylation at the upstream region was found to diminish when stressed plants were returned to normal temperature. The result indicates absolute necessity of changes in chromatin conformation for the transcription up-regulation of OsDREB1b gene in response to cold stress. The combined results show the existence of closed chromatin conformation at the upstream and promoter region of OsDREB1b in the transcription "off'' state. During cold stress, changes in region specific histone modification marks promote the alteration of chromatin structure to facilitate the binding of transcription machinery for proper gene expression.	[Roy, Dipan; Paul, Amit; Roy, Adrita; Ganguly, Payel; Chaudhuri, Shubho] Bose Inst, Div Plant Biol, Kolkta 700054, W Bengal, India; [Ghosh, Ritesh] Yeungnam Univ, Sch Biotechnol, Gyongsan, South Korea	Department of Science & Technology (India); Bose Institute; Yeungnam University	Chaudhuri, S (corresponding author), Bose Inst, Div Plant Biol, Centenary Campus,P-1-12,CIT Scheme 7 M, Kolkta 700054, W Bengal, India.	shubho@jcbose.ac.in		ROY, DIPAN/0000-0002-6566-8103; Ghosh, Ritesh/0000-0002-2528-7277	Department of Biotechnology; Government of India [BT/AB/05/02/2007]; CSIR; Government of India [09/015(0412)/2010-EMR-I]; Bose Institute	Department of Biotechnology; Government of India(Department of Biotechnology (DBT) India); CSIR; Government of India(Council of Scientific & Industrial Research (CSIR) - India); Bose Institute(Department of Science & Technology (India))	This work was supported by Department of Biotechnology; Government of India; grant number (BT/AB/05/02/2007). Dipan Roy sincerely acknowledges CSIR; Government of India, for his fellowship [09/015(0412)/2010-EMR-I.]. The authors sincerely acknowledge Bose Institute for the institutional fund support. Contents of this manuscript are solely the responsibility of the authors and do not necessarily represent the official views of the funding agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER SS, 1994, PLANT MOL BIOL, V24, P701, DOI 10.1007/BF00029852; Brown CE, 2000, TRENDS BIOCHEM SCI, V25, P15, DOI 10.1016/S0968-0004(99)01516-9; Casati P, 2008, PLANT CELL, V20, P827, DOI 10.1105/tpc.107.056457; Chua YL, 2001, PLANT CELL, V13, P599, DOI 10.1105/tpc.13.3.599; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; CONCONI A, 1993, J BIOL CHEM, V268, P430; Dubouzet JG, 2003, PLANT J, V33, P751, DOI 10.1046/j.1365-313X.2003.01661.x; Fenouil R, 2012, GENOME RES, V22, P2399, DOI 10.1101/gr.138776.112; Grativol C, 2012, BBA-GENE REGUL MECH, V1819, P176, DOI 10.1016/j.bbagrm.2011.08.010; Gutha LR, 2008, PLANT MOL BIOL, V68, P533, DOI 10.1007/s11103-008-9391-8; Hu Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022132; Hughes Amanda, 2009, J Biol, V8, P96, DOI 10.1186/jbiol207; Ito Y, 2006, PLANT CELL PHYSIOL, V47, P141, DOI 10.1093/pcp/pci230; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Karmodiya K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-424; Kim JM, 2008, PLANT CELL PHYSIOL, V49, P1580, DOI 10.1093/pcp/pcn133; Kim JM, 2010, PLANT CELL ENVIRON, V33, P604, DOI 10.1111/j.1365-3040.2009.02076.x; Kornberg RD, 1999, CURR OPIN GENET DEV, V9, P148, DOI 10.1016/S0959-437X(99)80022-7; Kwon CS, 2009, PLANT J, V60, P112, DOI 10.1111/j.1365-313X.2009.03938.x; Lawrence RJ, 2004, MOL CELL, V13, P599, DOI 10.1016/S1097-2765(04)00064-4; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Lodha M, 2005, PLANT MOL BIOL, V59, P501, DOI 10.1007/s11103-005-0450-0; Maniatis T., 1982, MOL CLONING; Mao F, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-76; Pavangadkar K, 2010, PLANT MOL BIOL, V74, P183, DOI 10.1007/s11103-010-9665-9; Qiu Y, 2012, GENE DEV, V26, P1376, DOI 10.1101/gad.188359.112; RoyChoudhury A, 2008, PLANT CELL REP, V27, P779, DOI 10.1007/s00299-007-0498-1; Sokol A, 2007, PLANTA, V227, P245, DOI 10.1007/s00425-007-0612-1; Stockinger EJ, 1997, P NATL ACAD SCI USA, V94, P1035, DOI 10.1073/pnas.94.3.1035; Suganuma T, 2011, ANNU REV BIOCHEM, V80, P473, DOI 10.1146/annurev-biochem-061809-175347; SVAREN J, 1994, EMBO J, V13, P4856, DOI 10.1002/j.1460-2075.1994.tb06812.x; Tillo D, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-442; Tsuji H, 2006, PLANT CELL PHYSIOL, V47, P995, DOI 10.1093/pcp/pcj072; VEGAPALAS MA, 1995, PLANT CELL, V7, P1923, DOI 10.1105/tpc.7.11.1923; VENTER U, 1994, EMBO J, V13, P4848, DOI 10.1002/j.1460-2075.1994.tb06811.x; WU C, 1980, NATURE, V286, P854, DOI 10.1038/286854a0; Xiong L, 2002, PLANT CELL ENVIRON, V25, P131, DOI 10.1046/j.1365-3040.2002.00782.x; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; YAMAGUCHISHINOZAKI K, 1994, PLANT CELL, V6, P251, DOI 10.1105/tpc.6.2.251; Zhang WL, 2012, PLANT CELL, V24, P2719, DOI 10.1105/tpc.112.098061; Zhang WL, 2012, GENOME RES, V22, P151, DOI 10.1101/gr.131342.111	44	55	60	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100343	10.1371/journal.pone.0100343	http://dx.doi.org/10.1371/journal.pone.0100343			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940877	Green Published, gold, Green Submitted			2022-12-27	WOS:000338508200095
J	Ye, JF; Zhang, L; Chen, Y; Fang, F; Luo, ZC; Zhang, J				Ye, Jiangfeng; Zhang, Lin; Chen, Yan; Fang, Fang; Luo, ZhongCheng; Zhang, Jun			Searching for the Definition of Macrosomia through an Outcome-Based Approach	PLOS ONE			English	Article							PLANNED CESAREAN-SECTION; BIRTH-WEIGHT; PERINATAL-MORTALITY; UNITED-STATES; BREECH PRESENTATION; MATERNAL OUTCOMES; PRETERM DELIVERY; FETAL MACROSOMIA; VAGINAL BIRTH; RISK	Background: Macrosomia has been defined in various ways by obstetricians and researchers. The purpose of the present study was to search for a definition of macrosomia through an outcome-based approach. Methods: In a study of 30,831,694 singleton term live births and 38,053 stillbirths in the U. S. Linked Birth-Infant Death Cohort datasets (1995-2004), we compared the occurrence of stillbirth, neonatal death, and 5-min Apgar score less than four in subgroups of birthweight (4000-4099 g, 4100-4199 g, 4200-4299 g, 4300-4399 g, 4400-4499 g, 4500-4999 g vs. reference group 3500-4000 g) and birthweight percentile for gestational age (90th-94th percentile, 95th-96th, and >= 97th percentile, vs. reference group 75th-90th percentile). Results: There was no significant increase in adverse perinatal outcomes until birthweight exceeded the 97th percentile. Weight-specific odds ratios (ORs) elevated substantially to 2 when birthweight exceeded 4500 g in Whites. In Blacks and Hispanics, the aORs exceeded 2 for 5-min Apgar less than four when birthweight exceeded 4300 g. For vaginal deliveries, the aORs of perinatal morbidity and mortality were larger for most of the subgroups, but the patterns remained the same. Conclusions: A birthweight greater than 4500 g in Whites, or 4300 g in Blacks and Hispanics regardless of gestational age is the optimal threshold to define macrosomia. A birthweight greater than the 97th percentile for a given gestational age, irrespective of race is also reasonable to define macrosomia. The former may be more clinically useful and simpler to apply.	[Ye, Jiangfeng; Chen, Yan; Fang, Fang; Luo, ZhongCheng; Zhang, Jun] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, MOE Shanghai Key Lab Childrens Environm Hlth, Shanghai 200030, Peoples R China; [Zhang, Lin] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Obstet, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhang, J (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, MOE Shanghai Key Lab Childrens Environm Hlth, Shanghai 200030, Peoples R China.	junjimzhang@gmail.com	Luo, Zhong-Cheng/T-3882-2017	Luo, Zhong-Cheng/0000-0002-1794-1312	Shanghai Municipal Health Bureau, China [GWIII-26.2]	Shanghai Municipal Health Bureau, China	This study was supported by a grant from the Shanghai Municipal Health Bureau, China (No. GWIII-26.2). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, ACOG PRACTICE B, V22; Boney CM, 2005, PEDIATRICS, V115, pE290, DOI 10.1542/peds.2004-1808; Boulet SL, 2006, AM J OBSTET GYNECOL, V195, P1571, DOI 10.1016/j.ajog.2006.03.069; Boulet SL, 2003, AM J OBSTET GYNECOL, V188, P1372, DOI 10.1067/mob.2003.302; Chauhan SP, 2005, AM J OBSTET GYNECOL, V193, P332, DOI 10.1016/j.ajog.2004.12.020; Dennedy MC, 2013, LANCET, V381, P435, DOI 10.1016/S0140-6736(12)62090-X; Dietz PM, 2007, PAEDIATR PERINAT EP, V21, P62, DOI 10.1111/j.1365-3016.2007.00862.x; Graafmans WC, 2002, EPIDEMIOLOGY, V13, P569, DOI 10.1097/00001648-200209000-00013; Hannah ME, 2004, AM J OBSTET GYNECOL, V191, P917, DOI 10.1016/j.ajog.2004.08.004; Hannah ME, 2000, LANCET, V356, P1375, DOI 10.1016/S0140-6736(00)02840-3; Haram K, 2002, ACTA OBSTET GYN SCAN, V81, P185, DOI 10.1034/j.1600-0412.2002.810301.x; Harder T, 2009, AM J EPIDEMIOL, V169, P1428, DOI 10.1093/aje/kwp065; Henriksen T, 2008, ACTA OBSTET GYN SCAN, V87, P134, DOI 10.1080/00016340801899289; Khashan AS, 2008, PSYCHOSOM MED, V70, P688, DOI 10.1097/PSY.0b013e318177940d; Koyanagi A, 2013, LANCET, V381, P476, DOI 10.1016/S0140-6736(12)61605-5; Kristensen J, 2005, BJOG-INT J OBSTET GY, V112, P403, DOI 10.1111/j.1471-0528.2005.00437.x; Mathews T J, 2000, Natl Vital Stat Rep, V48, P1; Mikolajczyk RT, 2011, LANCET, V377, P1855, DOI 10.1016/S0140-6736(11)60364-4; Morris BH, 2008, NEW ENGL J MED, V359, P1885, DOI 10.1056/NEJMoa0803024; Pasupathy D, 2012, PAEDIATR PERINAT EP, V26, P543, DOI 10.1111/ppe.12002; Qin C, 2007, PAEDIATR PERINAT EP, V21, P41, DOI 10.1111/j.1365-3016.2007.00860.x; Rouse DJ, 1996, JAMA-J AM MED ASSOC, V276, P1480, DOI 10.1001/jama.276.18.1480; Schellong K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047776; Scifres CM, 2008, AM J OBSTET GYNECOL, V198, P603, DOI 10.1016/j.ajog.2008.03.043; Souza JP, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-71; Stotland NE, 2004, INT J GYNECOL OBSTET, V87, P220, DOI 10.1016/j.ijgo.2004.08.010; Vahratian A, 2006, MATERN CHILD HLTH J, V10, P27, DOI 10.1007/s10995-005-0032-4; Vangen S, 2002, INT J EPIDEMIOL, V31, P654, DOI 10.1093/ije/31.3.654; WILCOX A, 1995, JAMA-J AM MED ASSOC, V273, P709, DOI 10.1001/jama.273.9.709; WILCOX AJ, 1986, INT J EPIDEMIOL, V15, P188, DOI 10.1093/ije/15.2.188; WILCOX AJ, 1983, INT J EPIDEMIOL, V12, P319, DOI 10.1093/ije/12.3.319; Yu CKH, 2006, BJOG-INT J OBSTET GY, V113, P1117, DOI 10.1111/j.1471-0528.2006.00991.x; Zhang X, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.12.005	33	18	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100192	10.1371/journal.pone.0100192	http://dx.doi.org/10.1371/journal.pone.0100192			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941024	Green Published, gold			2022-12-27	WOS:000338508200082
J	Zilli, L; Beirao, J; Schiavone, R; Herraez, MP; Gnoni, A; Vilella, S				Zilli, Loredana; Beirao, Jose; Schiavone, Roberta; Paz Herraez, Maria; Gnoni, Antonio; Vilella, Sebastiano			Comparative Proteome Analysis of Cryopreserved Flagella and Head Plasma Membrane Proteins from Sea Bream Spermatozoa: Effect of Antifreeze Proteins	PLOS ONE			English	Article							SPERM MOTILITY; DNA-DAMAGE; HATCHING SUCCESS; SPARUS-AURATA; QUALITY; BOAR; GLYCOPROTEINS; DECREASE; AFP	Cryopreservation induces injuries to fish spermatozoa that in turn affect sperm quality in terms of fertilization ability, motility, DNA and protein integrity and larval survival. To reduce the loss of sperm quality due to freezing-thawing, it is necessary to improve these procedures. In the present study we investigated the ability of two antifreeze proteins (AFPI and AFPIII) to reduce the loss of quality of sea bream spermatozoa due to cryopreservation. To do so, we compared viability, motility, straight-line velocity and curvilinear velocity of fresh and (AFPs)-cryopreserved spermatozoa. AFPIII addition to cryopreservation medium improved viability, motility and straight-line velocity with respect to DMSO or DMSO plus AFPI. To clarify the molecular mechanism(s) underlying these findings, the protein profile of two different cryopreserved sperm domains, flagella and head plasma membranes, was analysed. The protein profiles differed between fresh and frozen-thawed semen and results of the image analysis demonstrated that, after cryopreservation, out of 270 proteins 12 were decreased and 7 were increased in isolated flagella, and out of 150 proteins 6 showed a significant decrease and 4 showed a significant increase in head membranes. Mass spectrometry analysis identified 6 proteins (4 from isolated flagella and 2 present both in flagella and head plasma membranes) within the protein spots affected by the freezing-thawing procedure. 3 out of 4 proteins from isolated flagella were involved in the sperm bioenergetic system. Our results indicate that the ability of AFPIII to protect sea bream sperm quality can be, at least in part, ascribed to reducing changes in the sperm protein profile occurring during the freezing-thawing procedure. Our results clearly demonstrated that AFPIII addition to cryopreservation medium improved the protection against freezing respect to DMSO or DMSO plus AFPI. In addition we propose specific proteins of spermatozoa as markers related to the procedures of fish sperm cryopreservation.	[Zilli, Loredana; Schiavone, Roberta; Vilella, Sebastiano] Univ Salento, Dept Biol & Environm Sci & Technol, Lecce, Italy; [Beirao, Jose; Paz Herraez, Maria] Univ Leon, Dept Mol Biol, E-24071 Leon, Spain; [Gnoni, Antonio] Univ Bari, Dept Basic Med Sci Neurosci & Sense Organs, Bari, Italy	University of Salento; Universidad de Leon; Universita degli Studi di Bari Aldo Moro	Zilli, L (corresponding author), Univ Salento, Dept Biol & Environm Sci & Technol, Lecce, Italy.	loredana.zilli@unisalento.it	Beirao, Jose/N-2383-2019; Gnoni, Antonio/C-8078-2014; Beirao, Jose/K-6522-2012; Herraez, Paz/C-6264-2013	Beirao, Jose/0000-0002-4444-7563; Gnoni, Antonio/0000-0001-5071-611X; Beirao, Jose/0000-0002-4444-7563; Herraez, Paz/0000-0002-0028-3616	Apulia Region (Italy)	Apulia Region (Italy)	This work was supported by Apulia Region (Italy) under the program between the Apulia Region and the University of Salento. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZ JG, 1982, BIOL REPROD, V27, P1102, DOI 10.1095/biolreprod27.5.1102; Barbato F., 1998, Cahiers Options Mediterraneennes, V34, P281; Beirao J, 2011, CRYOBIOLOGY, V62, P22, DOI 10.1016/j.cryobiol.2010.11.005; Beirao J, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.093401; Cabrita E, 2005, CRYOBIOLOGY, V50, P273, DOI 10.1016/j.cryobiol.2005.02.005; Cao WL, 2003, ASIAN J ANDROL, V5, P43; Das PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056535; DEVRIES AL, 1988, COMP BIOCHEM PHYS B, V90, P611, DOI 10.1016/0305-0491(88)90302-1; DEVRIES AL, 1970, J BIOL CHEM, V245, P2901; DUMAN JG, 1974, NATURE, V247, P237, DOI 10.1038/247237a0; Fabbrocini A, 2000, CRYOBIOLOGY, V40, P46, DOI 10.1006/cryo.1999.2220; Feiden S, 2008, REPROD FERT DEVELOP, V20, P713, DOI 10.1071/RD08004; GWO JC, 1992, J EXP ZOOL, V264, P444, DOI 10.1002/jez.1402640410; Hamatani T, 2012, FERTIL STERIL, V97, P275, DOI 10.1016/j.fertnstert.2011.12.035; HANSEN TN, 1993, TRANSPLANT P, V25, P3182; HEW CL, 1984, J COMP PHYSIOL B, V155, P81, DOI 10.1007/BF00688795; Howard EI, 2011, J MOL RECOGNIT, V24, P724, DOI 10.1002/jmr.1130; Huang SY, 1999, THERIOGENOLOGY, V51, P1007, DOI 10.1016/S0093-691X(99)00046-1; Inaba K, 2003, CELL MOTIL CYTOSKEL, V55, P174, DOI 10.1002/cm.10119; Inglis SR, 2006, CURR PROTEIN PEPT SC, V7, P509, DOI 10.2174/138920306779025576; Karanova MV, 1997, BIOFIZIKA+, V42, P725; KARANOVA MV, 1994, IZV AKAD NAUK BIOL+, P818; Kastury K, 1997, J CLIN ENDOCR METAB, V82, P3047, DOI 10.1210/jc.82.9.3047; KOHSAKA T, 1992, J REPROD FERTIL, V95, P201, DOI 10.1530/jrf.0.0950201; Labbe C, 2001, MOL REPROD DEV, V60, P397, DOI 10.1002/mrd.1102; Lessard C, 2000, J ANDROL, V21, P700; Linhart O, 2000, CRYOBIOLOGY, V41, P241, DOI 10.1006/cryo.2000.2284; Maldjian A, 2005, THERIOGENOLOGY, V63, P411, DOI 10.1016/j.theriogenology.2004.09.021; Miki K, 2004, P NATL ACAD SCI USA, V101, P16501, DOI 10.1073/pnas.0407708101; Muller K, 2008, BIOL REPROD, V78, P390, DOI 10.1095/biolreprod.107.064253; Ostermeier GC, 2005, J ANDROL, V26, P70; Peeker R, 1997, MOL HUM REPROD, V3, P1061, DOI 10.1093/molehr/3.12.1061; PERCHEC G, 1995, J CELL SCI, V108, P747; Perez-Cerezales S, 2010, THERIOGENOLOGY, V74, P282, DOI 10.1016/j.theriogenology.2010.02.012; Perez-Cerezales S, 2009, THERIOGENOLOGY, V71, P605, DOI 10.1016/j.theriogenology.2008.09.057; Pike LJ, 2004, BIOCHEM J, V378, P281, DOI 10.1042/BJ20031672; Prathalingam NS, 2006, THERIOGENOLOGY, V66, P1894, DOI 10.1016/j.theriogenology.2006.04.041; RAO B, 1989, GAMETE RES, V24, P127, DOI 10.1002/mrd.1120240202; Roberts RJ, 1995, BROODSTOCK MANAGEMEN, P53; Rodina M, 2007, THERIOGENOLOGY, V67, P931, DOI 10.1016/j.theriogenology.2006.11.007; RUBINSKY B, 1991, BIOCHEM BIOPH RES CO, V180, P566, DOI 10.1016/S0006-291X(05)81102-7; Suquet M, 1998, AQUAT LIVING RESOUR, V11, P45, DOI 10.1016/S0990-7440(99)80030-8; Suquet M, 2000, AQUAC RES, V31, P231, DOI 10.1046/j.1365-2109.2000.00445.x; Taurino F, 2012, J PROTEOMICS, V75, P2331, DOI 10.1016/j.jprot.2012.02.002; Tomczak MM, 2002, BIOPHYS J, V82, P874, DOI 10.1016/S0006-3495(02)75449-0; Venketesh S, 2008, CRIT REV BIOTECHNOL, V28, P57, DOI [10.1080/07388550801891152, 10.1080/07388550801891152 ]; Wang JH, 2000, CRYOBIOLOGY, V41, P1, DOI 10.1006/cryo.2000.2265; Younis AI, 1998, J ANDROL, V19, P207; Zilli L, 2008, CRYOBIOLOGY, V57, P150, DOI 10.1016/j.cryobiol.2008.07.006; Zilli L, 2005, BIOL REPROD, V72, P1262, DOI 10.1095/biolreprod.104.036202; Zilli L, 2003, CRYOBIOLOGY, V47, P227, DOI 10.1016/j.cryobiol.2003.10.002	51	50	51	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99992	10.1371/journal.pone.0099992	http://dx.doi.org/10.1371/journal.pone.0099992			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941006	Green Published, Green Submitted, gold			2022-12-27	WOS:000338508200061
J	Ghamrawi, S; Renier, G; Saulnier, P; Cuenot, S; Zykwinska, A; Dutilh, BE; Thornton, C; Faure, S; Bouchara, JP				Ghamrawi, Sarah; Renier, Gilles; Saulnier, Patrick; Cuenot, Stephane; Zykwinska, Agata; Dutilh, Bas E.; Thornton, Christopher; Faure, Sebastien; Bouchara, Jean-Philippe			Cell Wall Modifications during Conidial Maturation of the Human Pathogenic Fungus Pseudallescheria boydii	PLOS ONE			English	Article							CRYPTOCOCCUS-NEOFORMANS; FILAMENTOUS FUNGI; MELANIN SYNTHESIS; ADHERENCE; VIRULENCE; COMPLEX; DIFFERENTIATION; HYDROPHOBICITY; COLONIZATION; SCEDOSPORIUM	Progress in extending the life expectancy of cystic fibrosis (CF) patients remains jeopardized by the increasing incidence of fungal respiratory infections. Pseudallescheria boydii (P. boydii), an emerging pathogen of humans, is a filamentous fungus frequently isolated from the respiratory secretions of CF patients. It is commonly believed that infection by this fungus occurs through inhalation of airborne conidia, but the mechanisms allowing the adherence of Pseudallescheria to the host epithelial cells and its escape from the host immune defenses remain largely unknown. Given that the cell wall orchestrates all these processes, we were interested in studying its dynamic changes in conidia as function of the age of cultures. We found that the surface hydrophobicity and electronegative charge of conidia increased with the age of culture. Melanin that can influence the cell surface properties, was extracted from conidia and estimated using UV-visible spectrophotometry. Cells were also directly examined and compared using electron paramagnetic resonance (EPR) that determines the production of free radicals. Consistent with the increased amount of melanin, the EPR signal intensity decreased suggesting polymerization of melanin. These results were confirmed by flow cytometry after studying the effect of melanin polymerization on the surface accessibility of mannose-containing glycoconjugates to fluorescent concanavalin A. In the absence of melanin, conidia showed a marked increase in fluorescence intensity as the age of culture increased. Using atomic force microscopy, we were unable to find rodlet-forming hydrophobins, molecules that can also affect conidial surface properties. In conclusion, the changes in surface properties and biochemical composition of the conidial wall with the age of culture highlight the process of conidial maturation. Mannose-containing glycoconjugates that are involved in immune recognition, are progressively masked by polymerization of melanin, an antioxidant that is commonly thought to allow fungal escape from the host immune defenses.	[Ghamrawi, Sarah; Renier, Gilles; Bouchara, Jean-Philippe] Univ Angers, LUNAM Univ, Grp Etud Interact Hote Pathogene EA 3142, Angers, France; [Renier, Gilles; Bouchara, Jean-Philippe] CHU Angers, Lab Parasitol Mycol, Angers, France; [Saulnier, Patrick] Univ Angers, LUNAM Univ, INSERM, U646, Angers, France; [Cuenot, Stephane; Zykwinska, Agata] Univ Nantes, LUNAM Univ, Inst Mat Jean Rouxel, Nantes, France; [Dutilh, Bas E.] Radboud Univ Nijmegen, Med Ctr, Ctr Mol & Biomol Informat, NL-6525 ED Nijmegen, Netherlands; [Dutilh, Bas E.] Univ Fed Rio de Janeiro, Inst Biol, Dept Marine Biol, Rio De Janeiro, Brazil; [Thornton, Christopher] Univ Exeter, Dept Biosci, Exeter, Devon, England; [Faure, Sebastien] LUNAM Univ, INSERM, U1063, Angers, France	Universite d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Nantes Universite; Radboud University Nijmegen; Universidade Federal do Rio de Janeiro; University of Exeter; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers	Ghamrawi, S (corresponding author), Univ Angers, LUNAM Univ, Grp Etud Interact Hote Pathogene EA 3142, Angers, France.	sarah.ghamrawi@gmail.com	Dutilh, Bas E./B-9719-2011; SAULNIER, Patrick/K-4271-2015; Clere, Nicolas/K-4414-2015	Dutilh, Bas E./0000-0003-2329-7890; Saulnier, Patrick/0000-0002-6408-3533; Faure, Sebastien/0000-0001-7524-8295; Cuenot, Stephane/0000-0003-1883-3847	"Region Pays de la Loire" in the frame of "Myco-AFM" research program; Dutch Virgo Consortium [FES0908, NGI 050-060-452]; CAPES/BRASIL	"Region Pays de la Loire" in the frame of "Myco-AFM" research program(Region Pays de la Loire); Dutch Virgo Consortium; CAPES/BRASIL(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The study was funded by "Region Pays de la Loire" in the frame of "Myco-AFM" research program). BED was supported by the Dutch Virgo Consortium (FES0908, NGI 050-060-452) and CAPES/BRASIL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bittencourt VCB, 2006, J BIOL CHEM, V281, P22614, DOI 10.1074/jbc.M511417200; Carrion SD, 2013, J IMMUNOL, V191, P2581, DOI 10.4049/jimmunol.1300748; Cortez KJ, 2008, CLIN MICROBIOL REV, V21, P157, DOI 10.1128/CMR.00039-07; Cunha MML, 2005, MICROSC RES TECHNIQ, V68, P377, DOI 10.1002/jemt.20260; Dalle F, 2003, INFECT IMMUN, V71, P7061, DOI 10.1128/IAI.71.12.7061-7068.2003; Desai C, 2011, FEMS YEAST RES, V11, P595, DOI 10.1111/j.1567-1364.2011.00743.x; Dubey MK, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-18; ENOCHS WS, 1993, PIGM CELL RES, V6, P91, DOI 10.1111/j.1600-0749.1993.tb00587.x; Fang WG, 2006, MYCOL RES, V110, P1165, DOI 10.1016/j.mycres.2006.04.014; Figueiredo RT, 2010, J BIOL CHEM, V285, P40714, DOI 10.1074/jbc.M110.181255; Frases S, 2007, APPL ENVIRON MICROB, V73, P615, DOI 10.1128/AEM.01947-06; GADD GM, 1982, T BRIT MYCOL SOC, V78, P115, DOI 10.1016/S0007-1536(82)80083-1; Gilgado F, 2005, J CLIN MICROBIOL, V43, P4930, DOI 10.1128/JCM.43.10.4930-4942.2005; Gilgado F, 2008, J CLIN MICROBIOL, V46, P766, DOI 10.1128/JCM.01122-07; Gilgado F, 2006, ANTIMICROB AGENTS CH, V50, P4211, DOI 10.1128/AAC.00981-06; Gravelat FN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003575; Gravelat FN, 2010, CELL MICROBIOL, V12, P473, DOI 10.1111/j.1462-5822.2009.01408.x; Khajo A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025092; Kiffer-Moreira T, 2007, ARCH MICROBIOL, V188, P159, DOI 10.1007/s00203-007-0232-y; Kim S, 2005, MOL MICROBIOL, V57, P1224, DOI 10.1111/j.1365-2958.2005.04750.x; Kriznik A, 2005, CR BIOL, V328, P928, DOI 10.1016/j.crvi.2005.05.011; Linder MB, 2005, FEMS MICROBIOL REV, V29, P877, DOI 10.1016/j.femsre.2005.01.004; Masuoka J, 1997, MICROBIOL-UK, V143, P3015, DOI 10.1099/00221287-143-9-3015; Masuoka J, 1999, FEMS IMMUNOL MED MIC, V24, P421, DOI 10.1111/j.1574-695X.1999.tb01314.x; MOLLER EM, 1992, NUCLEIC ACIDS RES, V20, P6115, DOI 10.1093/nar/20.22.6115; Nosanchuk JD, 1997, INFECT IMMUN, V65, P1836, DOI 10.1128/IAI.65.5.1836-1841.1997; Nosanchuk JD, 2006, ANTIMICROB AGENTS CH, V50, P3519, DOI 10.1128/AAC.00545-06; O'Bryan Thomas A, 2005, Expert Rev Anti Infect Ther, V3, P765, DOI 10.1586/14787210.3.5.765; Pihet M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-177; Pinto MR, 2004, MICROBES INFECT, V6, P1259, DOI 10.1016/j.micinf.2004.07.006; Pinto MR, 2002, GLYCOBIOLOGY, V12, P251, DOI 10.1093/glycob/12.4.251; Pokorny R, 2005, J BASIC MICROB, V45, P219, DOI 10.1002/jobm.200410354; Raggam RB, 2011, MYCOSES, V54, pE394, DOI 10.1111/j.1439-0507.2010.01933.x; Santos ALS, 2009, MED MYCOL, V47, P375, DOI 10.1080/13693780802610305; Sarangarajan R, 2006, MELANOMA RES, V16, P3, DOI 10.1097/01.cmr.0000195699.35143.df; Stringer JR, 2007, J EUKARYOT MICROBIOL, V54, P8, DOI 10.1111/j.1550-7408.2006.00225.x; Tronchin G, 2008, MED MYCOL, V46, P749, DOI 10.1080/13693780802206435; Voelz K, 2010, EUKARYOT CELL, V9, P835, DOI 10.1128/EC.00039-10; Wakamatsu K, 2002, PIGM CELL RES, V15, P174, DOI 10.1034/j.1600-0749.2002.02017.x; Wang YL, 1996, INFECT IMMUN, V64, P2420, DOI 10.1128/IAI.64.7.2420-2424.1996; Wargenau A, 2011, RES MICROBIOL, V162, P1011, DOI 10.1016/j.resmic.2011.07.006; Zouhair R, 2013, MED MYCOL, V51, P603, DOI 10.3109/13693786.2013.770606	42	19	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100290	10.1371/journal.pone.0100290	http://dx.doi.org/10.1371/journal.pone.0100290			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950099	Green Published, gold			2022-12-27	WOS:000338276300060
J	Kuppusamy, H; Ogmundsdottir, HM; Baigorri, E; Warkentin, A; Steingrimsdottir, H; Haraldsdottir, V; Mant, MJ; Mackey, J; Johnston, JB; Adamia, S; Belch, AR; Pilarski, LM				Kuppusamy, Hemalatha; Ogmundsdottir, Helga M.; Baigorri, Eva; Warkentin, Amanda; Steingrimsdottir, Hlif; Haraldsdottir, Vilhelmina; Mant, Michael J.; Mackey, John; Johnston, James B.; Adamia, Sophia; Belch, Andrew R.; Pilarski, Linda M.			Inherited Polymorphisms in Hyaluronan Synthase 1 Predict Risk of Systemic B-Cell Malignancies but Not of Breast Cancer	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; GENOME-WIDE ASSOCIATION; MULTIPLE-MYELOMA; GENE; RECEPTOR; HAS1; MACROGLOBULINEMIA; EXPRESSION; VARIANTS; SNPS	Genetic variations in the hyaluronan synthase 1 gene (HAS1) influence HAS1 aberrant splicing. HAS1 is aberrantly spliced in malignant cells from multiple myeloma (MM) and Waldenstrom macroglobulinemia (WM), but not in their counterparts from healthy donors. The presence of aberrant HAS1 splice variants predicts for poor survival in multiple myeloma (MM). We evaluated the influence of inherited HAS1 single nucleotide polymorphisms (SNP) on the risk of having a systemic B cell malignancy in 1414 individuals compromising 832 patients and 582 healthy controls, including familial analysis of an Icelandic kindred. We sequenced HAS1 gene segments from 181 patients with MM, 98 with monoclonal gammopathy of undetermined significance (MGUS), 72 with Waldenstrom macroglobulinemia (WM), 169 with chronic lymphocytic leukemia (CLL), as well as 34 members of a monoclonal gammopathy-prone Icelandic family, 212 age-matched healthy donors and a case-control cohort of 295 breast cancer patients with 353 healthy controls. Three linked single nucleotide polymorphisms (SNP) in HAS1 intron3 are significantly associated with B-cell malignancies (range p = 0.007 to p = 10(-5)), but not MGUS or breast cancer, and predict risk in a 34 member Icelandic family (p = 0.005, Odds Ratio = 5.8 (OR)), a relatively homogeneous cohort. In contrast, exon3 SNPs were not significantly different among the study groups. Pooled analyses showed a strong association between the linked HAS1 intron3 SNPs and B-cell malignancies (OR = 1.78), but not for sporadic MGUS or for breast cancer (OR, 1.0). The minor allele genotypes of HAS1 SNPs are significantly more frequent in MM, WM, CLL and in affected members of a monoclonal gammopathy-prone family than they are in breast cancer, sporadic MGUS or healthy donors. These inherited changes may increase the risk for systemic B-cell malignancies but not for solid tumors.	[Kuppusamy, Hemalatha; Baigorri, Eva; Warkentin, Amanda; Mant, Michael J.; Mackey, John; Belch, Andrew R.; Pilarski, Linda M.] Univ Alberta, Edmonton, AB, Canada; [Kuppusamy, Hemalatha; Baigorri, Eva; Warkentin, Amanda; Mant, Michael J.; Mackey, John; Belch, Andrew R.; Pilarski, Linda M.] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada; [Ogmundsdottir, Helga M.] Univ Iceland, Reykjavik, Iceland; [Steingrimsdottir, Hlif; Haraldsdottir, Vilhelmina] Landspitali Univ Hosp, Reykjavik, Iceland; [Johnston, James B.] Canc Care Manitoba, Dept Hematol, Winnipeg, MB, Canada; [Johnston, James B.] Univ Manitoba, Winnipeg, MB, Canada; [Adamia, Sophia] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA	University of Alberta; University of Alberta; University of Iceland; Landspitali National University Hospital; University of Manitoba; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Pilarski, LM (corresponding author), Univ Alberta, Edmonton, AB, Canada.	lpilarsk@ualberta.ca	Adamia, Sophia/AAG-7502-2020; Ögmundsdóttir, Helga M/L-6970-2015		Myeloma Alberta; Alberta Cancer Foundation; Canadian Institutes of Health Research	Myeloma Alberta; Alberta Cancer Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was funded by grants to LMP and ARB from Myeloma Alberta, the Alberta Cancer Foundation and the Canadian Institutes of Health Research (www.cihr-irsc.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamia S, 2005, CLIN LYMPHOMA, V5, P253, DOI 10.3816/CLM.2005.n.010; Adamia S, 2005, BLOOD, V105, P4836, DOI 10.1182/blood-2004-10-3825; Adamia S, 2013, CURR CANCER DRUG TAR, V13, P347, DOI 10.2174/1568009611313040001; Adamia S, 2008, BLOOD, V112, P5111, DOI 10.1182/blood-2008-02-141770; Altieri A, 2006, EUR J CANCER, V42, P1661, DOI 10.1016/j.ejca.2005.11.033; Berndt SI, 2013, NAT GENET, V45, P868, DOI 10.1038/ng.2652; Berulava T, 2010, EUR J HUM GENET, V18, P1054, DOI 10.1038/ejhg.2010.71; Coombs CC, 2012, BLOOD, V120, P1687, DOI 10.1182/blood-2012-02-408799; Ghosh A, 2009, J BIOL CHEM, V284, P18840, DOI 10.1074/jbc.M109.013813; Goldin LR, 2009, HAEMATOL-HEMATOL J, V94, P647, DOI 10.3324/haematol.2008.003632; Hiratani H, 2005, J CLIN ENDOCR METAB, V90, P2898, DOI 10.1210/jc.2004-2148; Kang SH, 2008, ACTA HAEMATOL-BASEL, V119, P60, DOI 10.1159/000117572; Kriangkum J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053469; Lachance J, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-57; Landgren O, 2009, BLOOD, V114, P791, DOI 10.1182/blood-2008-12-191676; Liang XY, 2009, BRIT J HAEMATOL, V146, P418, DOI 10.1111/j.1365-2141.2009.07790.x; Maggini V, 2008, LEUKEMIA RES, V32, P988, DOI 10.1016/j.leukres.2007.10.008; MasellisSmith A, 1996, BLOOD, V87, P1891; Mauro FR, 2006, HAEMATOLOGICA, V91, P1117; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; Ogmundsdottir HM, 2005, HAEMATOLOGICA, V90, P66; OGSMUNDSDOTTIR HM, 1994, SCAND J IMMUNOL, V40, P195, DOI 10.1111/j.1365-3083.1994.tb03450.x; Owen RG, 2003, SEMIN ONCOL, V30, P110, DOI 10.1053/sonc.2003.50082; Royer RH, 2010, BLOOD, V115, P4464, DOI 10.1182/blood-2009-10-247973; Sava GP, 2014, LEUKEMIA LYMPHOMA, V55, P160, DOI 10.3109/10428194.2013.800197; Simpson MA, 2001, J BIOL CHEM, V276, P17949, DOI 10.1074/jbc.M010064200; Smith A, 2006, BRIT J HAEMATOL, V132, P410, DOI 10.1111/j.1365-2141.2005.05867.x; Speedy HE, 2013, ADV EXP MED BIOL, V792, P293, DOI 10.1007/978-1-4614-8051-8_13; Treon SP, 2012, NEW ENGL J MED, V367, P826, DOI 10.1056/NEJMoa1200710; Wilkins K, 2011, HUM MOL GENET, V20, P4831, DOI 10.1093/hmg/ddr422; Yabushita H, 2005, ONCOL REP, V13, P1101; Yabushita H, 2004, ONCOL REP, V12, P739; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P20552, DOI 10.1073/pnas.0707106104	34	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100691	10.1371/journal.pone.0100691	http://dx.doi.org/10.1371/journal.pone.0100691			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950197	gold, Green Published, Green Submitted			2022-12-27	WOS:000338276300109
J	Thorndike, AN; Mills, S; Sonnenberg, L; Palakshappa, D; Gao, T; Pau, CT; Regan, S				Thorndike, Anne N.; Mills, Sarah; Sonnenberg, Lillian; Palakshappa, Deepak; Gao, Tian; Pau, Cindy T.; Regan, Susan			Activity Monitor Intervention to Promote Physical Activity of Physicians-In-Training: Randomized Controlled Trial	PLOS ONE			English	Article							INTERNAL-MEDICINE RESIDENTS; COUNSELING PRACTICES; PATIENT-CARE; HEALTH BEHAVIORS; BURNOUT; WELLNESS; PROGRAM; QUALITY; RISK; LIFE	Background: Physicians are expected to serve as role models for healthy lifestyles, but long work hours reduce time for healthy behaviors. A hospital-based physical activity intervention could improve physician health and increase counseling about exercise. Methods: We conducted a two-phase intervention among 104 medical residents at a large hospital in Boston, Massachusetts. Phase 1 was a 6-week randomized controlled trial comparing daily steps of residents assigned to an activity monitor displaying feedback about steps and energy consumed (intervention) or to a blinded monitor (control). Phase 2 immediately followed and was a 6-week non-randomized team steps competition in which all participants wore monitors with feedback. Phase 1 outcomes were: 1) median steps/day and 2) proportion of days activity monitor worn. The Phase 2 outcome was mean steps/day on days monitor worn ($500 steps/day). Physiologic measurements were collected at baseline and study end. Median steps/day were compared using Wilcoxon rank-sum tests. Mean steps were compared using repeated measures regression analyses. Results: In Phase 1, intervention and control groups had similar activity (6369 vs. 6063 steps/day, p = 0.16) and compliance with wearing the monitor (77% vs. 77% of days, p = 0.73). In Phase 2 (team competition), residents recorded more steps/day than during Phase 1 (Control: 7,971 vs. 7,567, p = 0.002; Intervention: 7,832 vs. 7,739, p = 0.13). Mean compliance with wearing the activity monitor decreased for both groups during Phase 2 compared to Phase 1 (60% vs. 77%, p<0.001). Mean systolic blood pressure decreased (p = 0.004) and HDL cholesterol increased (p<0.001) among all participants at end of study compared to baseline. Conclusions: Although the activity monitor intervention did not have a major impact on activity or health, the high participation rates of busy residents and modest changes in steps, blood pressure, and HDL suggest that more intensive hospital-based wellness programs have potential for promoting healthier lifestyles among physicians.	[Thorndike, Anne N.; Mills, Sarah; Palakshappa, Deepak; Gao, Tian; Pau, Cindy T.; Regan, Susan] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Sonnenberg, Lillian] Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Thorndike, AN (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.	athorndike@partners.org	Thorndike, Anne/R-6291-2019	Thorndike, Anne/0000-0003-1096-9221; Palakshappa, Deepak/0000-0003-1467-4965; Regan, Susan/0000-0003-0940-2017	National Institutes of Health/National Heart Lung and Blood Institute [K23 HL93221]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL093221] Funding Source: NIH RePORTER	National Institutes of Health/National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr. Thorndike is supported by the grant K23 HL93221 from the National Institutes of Health/National Heart Lung and Blood Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson S, 2000, CLIN J SPORT MED, V10, P40, DOI 10.1097/00042752-200001000-00008; Ahola K, 2012, J OCCUP ENVIRON MED, V54, P17, DOI 10.1097/JOM.0b013e31823ea9d9; Arnetz BB, 2001, SOC SCI MED, V52, P203, DOI 10.1016/S0277-9536(00)00220-3; Arora R, 2004, MIL MED, V169, P522, DOI 10.7205/MILMED.169.7.522; Bazargan M, 2009, ACAD PSYCHIATR, V33, P289, DOI 10.1176/appi.ap.33.4.289; Bravata DM, 2007, JAMA-J AM MED ASSOC, V298, P2296, DOI 10.1001/jama.298.19.2296; Chan CB, 2004, PREV MED, V39, P1215, DOI 10.1016/j.ypmed.2004.04.053; Collins J, 2008, ACAD RADIOL, V15, P1046, DOI 10.1016/j.acra.2008.02.014; Eckleberry-Hunt J, 2009, ACAD MED, V84, P269, DOI 10.1097/ACM.0b013e3181938a45; Fahrenkopf AM, 2008, BRIT MED J, V336, P488, DOI 10.1136/bmj.39469.763218.BE; Firth-Cozens J, 2001, SOC SCI MED, V52, P215, DOI 10.1016/S0277-9536(00)00221-5; Fitzpatrick S., 2012, ALLIED HLTH CLIN PEE, P1; Frank E, 2000, ARCH FAM MED, V9, P287, DOI 10.1001/archfami.9.3.287; Freak-Poli R, 2011, PREV MED, V53, P162, DOI 10.1016/j.ypmed.2011.06.005; Gopal R, 2005, ARCH INTERN MED, V165, P2595, DOI 10.1001/archinte.165.22.2595; Gross CP, 2000, ARCH INTERN MED, V160, P3209, DOI 10.1001/archinte.160.21.3209; Hull SK, 2008, ACAD PSYCHIATR, V32, P31, DOI 10.1176/appi.ap.32.1.31; Institute of Medicine, 2012, ACC PROGR OB PREV SO; Jonsdottir IH, 2010, PREV MED, V51, P373, DOI 10.1016/j.ypmed.2010.07.019; Lemaire JB, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-208; Leventer-Roberts M, 2013, J GRADUATE MED ED, P405; LEWIS CE, 1991, ANN INTERN MED, V114, P54, DOI 10.7326/0003-4819-114-1-54; Lobelo F, 2009, BRIT J SPORT MED, V43, P89, DOI 10.1136/bjsm.2008.055426; Lucas M, 2011, AM J EPIDEMIOL, V174, P1017, DOI 10.1093/aje/kwr218; McNerney JP, 2007, J AM OSTEOPATH ASSOC, V107, P537; Meldrum H, 2010, HEALTH CARE MANAG, V29, P324, DOI 10.1097/HCM.0b013e3181fa037a; Millstine D, 2011, SGIM FORUM, V34, P14; Rogers LQ, 2005, TEACH LEARN MED, V17, P27, DOI 10.1207/s15328015tlm1701_6; Rosen IM, 2006, ACAD MED, V81, P82, DOI 10.1097/00001888-200601000-00020; Rye PL, 2012, CLIN INVEST MED, V35, pE40; Shanafelt TD, 2012, ARCH INTERN MED, V172, P1377, DOI 10.1001/archinternmed.2012.3199; Shanafelt TD, 2005, ONCOLOGY-BASEL, V68, P23, DOI 10.1159/000084519; Shanafelt TD, 2003, AM J MED, V114, P513, DOI 10.1016/S0002-9343(03)00117-7; Shanafelt TD, 2002, ANN INTERN MED, V136, P358, DOI 10.7326/0003-4819-136-5-200203050-00008; Takacs J, 2013, J SCI MED SPORT; Taub S, 2006, OCCUP MED-OXFORD, V56, P77, DOI 10.1093/occmed/kqj025; Thomas NK, 2004, JAMA-J AM MED ASSOC, V292, P2880, DOI 10.1001/jama.292.23.2880; Thorndike AN, 2012, AM J PREV MED, V43, P27, DOI 10.1016/j.amepre.2012.02.029; Thorndike AN, 2011, PREV MED, V52, P164, DOI 10.1016/j.ypmed.2010.11.023; Toker S, 2012, J APPL PSYCHOL, V97, P699, DOI 10.1037/a0026914; Tudor-Locke C, 2004, SPORTS MED, V34, P1, DOI 10.2165/00007256-200434010-00001; Wallace JE, 2009, LANCET, V374, P1714, DOI 10.1016/S0140-6736(09)61424-0; Wallace JE, 2009, PSYCHOL HEALTH MED, V14, P545, DOI 10.1080/13548500903012871; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; West CP, 2011, JAMA-J AM MED ASSOC, V306, P952, DOI 10.1001/jama.2011.1247; West CP, 2009, JAMA-J AM MED ASSOC, V302, P1294, DOI 10.1001/jama.2009.1389	46	39	39	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100251	10.1371/journal.pone.0100251	http://dx.doi.org/10.1371/journal.pone.0100251			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK2UZ	24950218	Green Submitted, Green Published, gold			2022-12-27	WOS:000338276300054
J	Zeng, JB; He, XY; Wu, DZ; Zhu, B; Cai, SG; Nadira, UA; Jabeen, Z; Zhang, GP				Zeng, Jianbin; He, Xiaoyan; Wu, Dezhi; Zhu, Bo; Cai, Shengguan; Nadira, Umme Aktari; Jabeen, Zahra; Zhang, Guoping			Comparative Transcriptome Profiling of Two Tibetan Wild Barley Genotypes in Responses to Low Potassium	PLOS ONE			English	Article							ZINC-FINGER PROTEIN; RNA-SEQ; EXPRESSION ANALYSIS; LOWLAND RICE; GENE; STRESS; TOLERANCE; TRANSPORT; PLANTS; IDENTIFICATION	Potassium (K) deficiency is one of the major factors affecting crop growth and productivity. Development of low-K tolerant crops is an effective approach to solve the nutritional deficiency in agricultural production. Tibetan annual wild barley is rich in genetic diversity and can grow normally under poor soils, including low-K supply. However, the molecular mechanism about low K tolerance is still poorly understood. In this study, Illumina RNA-Sequencing was performed using two Tibetan wild barley genotypes differing in low K tolerance (XZ153, tolerant and XZ141, sensitive), to determine the genotypic difference in transcriptome profiling. We identified a total of 692 differentially expressed genes (DEGs) in two genotypes at 6 h and 48 h after low-K treatment, including transcription factors, transporters and kinases, oxidative stress and hormone signaling related genes. Meanwhile, 294 low-K tolerant associated DEGs were assigned to transporter and antioxidant activities, stimulus response, and other gene ontology (GO), which were mainly involved in starch and sucrose metabolism, lipid metabolism and ethylene biosynthesis. Finally, a hypothetical model of low-K tolerance mechanism in XZ153 was presented. It may be concluded that wild barley accession XZ153 has a higher capability of K absorption and use efficiency than XZ141 under low K stress. A rapid response to low K stress in XZ153 is attributed to its more K uptake and accumulation in plants, resulting in higher low K tolerance. The ethylene response pathway may account for the genotypic difference in low-K tolerance.	[Zeng, Jianbin; He, Xiaoyan; Wu, Dezhi; Zhu, Bo; Cai, Shengguan; Nadira, Umme Aktari; Jabeen, Zahra; Zhang, Guoping] Zhejiang Univ, Dept Agron, Key Lab Crop Germplasm Resource Zhejiang Prov, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Zhang, GP (corresponding author), Zhejiang Univ, Dept Agron, Key Lab Crop Germplasm Resource Zhejiang Prov, Hangzhou 310003, Zhejiang, Peoples R China.	zhanggp@zju.edu.cn	Wu, Dezhi/AAO-9316-2020; Jabeen, Zahra/AAN-2584-2020	Wu, Dezhi/0000-0002-7900-0542	Natural Science Foundation of China [31330055, 31171544]; "948" Project of Ministry of Agriculture, China [2012-Z25]; China Agriculture Research System [CARS-05]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "948" Project of Ministry of Agriculture, China; China Agriculture Research System	The authors are grateful for financial support by Natural Science Foundation of China (31330055 and 31171544), "948" Project of Ministry of Agriculture, China (2012-Z25) and China Agriculture Research System (CARS-05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amtmann A., 2009, Current Opinion in Plant Biology, V12, P275, DOI 10.1016/j.pbi.2009.04.014; Amtmann A, 2008, PHYSIOL PLANTARUM, V133, P682, DOI 10.1111/j.1399-3054.2008.01075.x; Armengaud P, 2009, PLANT PHYSIOL, V150, P772, DOI 10.1104/pp.108.133629; Banuelos MA, 2002, PLANT PHYSIOL, V130, P784, DOI 10.1104/pp.007781; Britto DT, 2008, PHYSIOL PLANTARUM, V133, P637, DOI 10.1111/j.1399-3054.2008.01067.x; Broadley MR, 2004, J EXP BOT, V55, P321, DOI 10.1093/jxb/erh002; Cloonan N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-234; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dai F, 2012, P NATL ACAD SCI USA, V109, P16969, DOI 10.1073/pnas.1215265109; Dreyer I, 2011, FEBS J, V278, P4293, DOI 10.1111/j.1742-4658.2011.08371.x; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Ellis RP, 2000, J EXP BOT, V51, P9, DOI 10.1093/jexbot/51.342.9; Fageria NK, 2003, ADV AGRON, V80, P63, DOI 10.1016/S0065-2113(03)80003-2; Gierth M, 2005, PLANT PHYSIOL, V137, P1105, DOI 10.1104/pp.104.057216; Gierth M, 2007, FEBS LETT, V581, P2348, DOI 10.1016/j.febslet.2007.03.035; Hermans C, 2006, TRENDS PLANT SCI, V11, P610, DOI 10.1016/j.tplants.2006.10.007; Hong JP, 2013, PLANT CELL PHYSIOL, V54, P1478, DOI 10.1093/pcp/pct094; Jan A, 2013, PLANT PHYSIOL, V161, P1202, DOI 10.1104/pp.112.205385; Jung JY, 2009, PLANT CELL, V21, P607, DOI 10.1105/tpc.108.063099; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kim MJ, 2012, MOL PLANT, V5, P1042, DOI 10.1093/mp/sss003; Kumimoto RW, 2010, PLANT J, V63, P379, DOI 10.1111/j.1365-313X.2010.04247.x; Lee TI, 2000, ANNU REV GENET, V34, P77, DOI 10.1146/annurev.genet.34.1.77; Lin PC, 2011, PLANT J, V65, P253, DOI 10.1111/j.1365-313X.2010.04419.x; Ma TL, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-161; Maathuis FJM, 2009, CURR OPIN PLANT BIOL, V12, P250, DOI 10.1016/j.pbi.2009.04.003; Marguerat S, 2010, CELL MOL LIFE SCI, V67, P569, DOI 10.1007/s00018-009-0180-6; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Merchante C, 2013, CURR OPIN PLANT BIOL, V16, P554, DOI 10.1016/j.pbi.2013.08.001; Mochida K, 2011, PLANT CELL PHYSIOL, V52, P2017, DOI 10.1093/pcp/pcr153; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nelson DE, 2007, P NATL ACAD SCI USA, V104, P16450, DOI 10.1073/pnas.0707193104; O'Rourke JA, 2013, PLANT PHYSIOL, V161, P705, DOI 10.1104/pp.112.209254; Oshlack A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-220; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Postnikova OA, 2013, PLANT CELL PHYSIOL, V54, P1041, DOI 10.1093/pcp/pct056; Qiu L, 2011, THEOR APPL GENET, V122, P695, DOI 10.1007/s00122-010-1479-2; Rengel Z, 2008, PHYSIOL PLANTARUM, V133, P624, DOI 10.1111/j.1399-3054.2008.01079.x; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Romheld V, 2010, PLANT SOIL, V335, P155, DOI 10.1007/s11104-010-0520-1; Santa-Maria GE, 1997, PLANT CELL, V9, P2281, DOI 10.1105/tpc.9.12.2281; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shankar A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070321; Szczerba MW, 2009, J PLANT PHYSIOL, V166, P447, DOI 10.1016/j.jplph.2008.12.009; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wang C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039856; Wang L, 2012, J PLANT NUTR SOIL SC, V175, P303, DOI 10.1002/jpln.201100199; Wang Y, 2013, ANNU REV PLANT BIOL, V64, P451, DOI 10.1146/annurev-arplant-050312-120153; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wu DZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022938; Zenoni S, 2010, PLANT PHYSIOL, V152, P1787, DOI 10.1104/pp.109.149716; Zhang X, 2011, PLANT CELL PHYSIOL, V52, P138, DOI 10.1093/pcp/pcq180; Zhang Y, 2013, J PLANT NUTR SOIL SC, V176, P400, DOI 10.1002/jpln.201200206; Zhao J, 2010, EUPHYTICA, V172, P395, DOI 10.1007/s10681-009-0064-8; Zhu Bo, 2014, Journal of Zhejiang University (Agriculture and Life Sciences), V40, P165	55	46	46	2	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100567	10.1371/journal.pone.0100567	http://dx.doi.org/10.1371/journal.pone.0100567			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949953	gold, Green Published, Green Submitted			2022-12-27	WOS:000338276300091
J	Bekalu, MA; Eggermont, S; Ramanadhan, S; Viswanath, K				Bekalu, Mesfin Awoke; Eggermont, Steven; Ramanadhan, Shoba; Viswanath, Kasisomayajula			Effect of Media Use on HIV-Related Stigma in Sub-Saharan Africa: A Cross-Sectional Study	PLOS ONE			English	Article							AIDS-RELATED STIGMA; MASS-MEDIA; HIV/AIDS STIGMA; YOUNG-PEOPLE; CAPE-TOWN; PREVENTION; IMPACT; DISCRIMINATION; INTERVENTIONS; SUPPORT	It is known that HIV-related stigma hinders prevention efforts. Previous studies have documented that HIV-related stigma may be associated with socioeconomic and socioecological factors. Mass media use may moderate this association, but there is limited research addressing that possibility. In this study, based on cross-sectional data pooled from the 2006-2011 Demographic and Health Surveys of 11 sub-Saharan African countries (N = 204,343), we investigated the moderating effects of exposure to mass media on HIV-related stigma. Hierarchical regression analysis indicated that HIV-related stigma tends to be higher among rural residents and individuals with low levels of education and HIV knowledge, as well as those who do not know people living with HIV. Media use was generally associated with low levels of HIV-related stigma, and attenuated the gap between individuals with high and low educational levels. However, the effect of mass media was found to be stronger among urbanites rather than among rural residents, which could lead to a widening gap between the two groups in endorsement of HIV-related stigma. The implication of this study regarding the effect of media use on HIV-related stigma in sub-Saharan Africa is twofold: 1) mass media may have the potential to minimize the gap in HIV-related stigma between individuals with high and low educational levels, and hence future efforts of reducing HIV-related stigma in the region may benefit from utilizing media; 2) due perhaps to low media penetration to rural sub-Saharan Africa, mass media could have the unintended effect of widening the urban-rural gap further unless other more customized and rural-focused communication interventions are put in place.	[Bekalu, Mesfin Awoke; Ramanadhan, Shoba; Viswanath, Kasisomayajula] Dana Farber Canc Inst, Ctr Community Based Res, Boston, MA 02115 USA; [Bekalu, Mesfin Awoke; Viswanath, Kasisomayajula] Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA; [Bekalu, Mesfin Awoke; Eggermont, Steven] Univ Leuven, Sch Mass Commun Res, Leuven, Belgium; [Bekalu, Mesfin Awoke] Bahir Dar Univ, Dept Journalism & Commun, Bahir Dar, Ethiopia	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; KU Leuven; Bahir Dar University	Bekalu, MA (corresponding author), Dana Farber Canc Inst, Ctr Community Based Res, Boston, MA 02115 USA.	mesfinawoke.bekalu@soc.kuleuven.be	Bekalu, Mesfin Awoke/AAQ-9176-2020; Eggermont, Steven/G-5670-2010	Eggermont, Steven/0000-0003-0428-092X; Bekalu, Mesfin Awoke/0000-0003-1243-5813	Research Foundation Flanders (FWO)	Research Foundation Flanders (FWO)(FWO)	The study was made possible through a long term research stay grant from Research Foundation Flanders (FWO) to the first author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaynew Y, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-8; Adetunji JA, 2011, 6 AFR POP C OUAG BUR; Bekalu MA, 2014, HEALTH PROMOT INT, V29, P739, DOI 10.1093/heapro/dat030; Bertrand JT, 2006, WHO TECH REP SER, V938, P205; Brown L, 2003, AIDS EDUC PREV, V15, P49, DOI 10.1521/aeap.15.1.49.23844; Chen JJ, 2005, AIDS EDUC PREV, V17, P1, DOI 10.1521/aeap.17.1.1.58689; Collins CB, 2010, PUBLIC HEALTH REP, V125, P55, DOI 10.1177/00333549101250S108; Creel AH, 2011, HEALTH EDUC RES, V26, P456, DOI 10.1093/her/cyr012; Fakolade R, 2010, J BIOSOC SCI, V42, P395, DOI 10.1017/S0021932009990538; Fanta W, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-8; Genberg BL, 2008, AIDS BEHAV, V12, P772, DOI 10.1007/s10461-007-9340-6; GERBNER G, 1980, J COMMUN, V30, P10, DOI 10.1111/j.1460-2466.1980.tb01987.x; Goffman E. M., 1963, BEHAV PUBLIC PLACES; Hendriksen ES, 2009, AIDS BEHAV, V13, P1213, DOI 10.1007/s10461-009-9608-0; Herek GM, 1998, AIDS PUBLIC POLICY J, V13, P36; Herek GM, 2002, AM J PUBLIC HEALTH, V92, P371, DOI 10.2105/AJPH.92.3.371; Jung M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068359; Kalichman SC, 2005, AIDS BEHAV, V9, P135, DOI 10.1007/s10461-005-3895-x; Kalichman SC, 2003, SEX TRANSM INFECT, V79, P442, DOI 10.1136/sti.79.6.442; Kalichman SC, 2004, AIDS CARE, V16, P572, DOI 10.1080/09540120410001716360; Kalichman SC, 2009, AIDS CARE, V21, P87, DOI 10.1080/09540120802032627; Kleinman A, 2009, J EPIDEMIOL COMMUN H, V63, P418, DOI 10.1136/jech.2008.084277; Leta TH, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-438; Li L, 2009, J HEALTH COMMUN, V14, P424, DOI 10.1080/10810730903032994; Lifson AR, 2012, BMC INT HEALTH HUM R, V12, DOI 10.1186/1472-698X-12-6; Logie CH, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001124; Mahajan AP, 2008, AIDS, V22, pS67, DOI 10.1097/01.aids.0000327438.13291.62; Malcolm A., 1998, CRITICAL PUBLIC HLTH, V8, P347, DOI [10.1080/09581599808402920, DOI 10.1080/09581599808402920]; Martinez J, 2012, AIDS PATIENT CARE ST, V26, P108, DOI 10.1089/apc.2011.0178; Muturi NW, 2005, J HEALTH COMMUN, V10, P77, DOI 10.1080/10810730590904607; Nyamwaya D, 1998, INT J HEALTH PLAN M, V13, P27, DOI 10.1002/(SICI)1099-1751(199801/03)13:1&lt;27::AID-HPM498&gt;3.0.CO;2-B; Parker R, 2003, SOC SCI MED, V57, P13, DOI 10.1016/S0277-9536(02)00304-0; Parker R, 2002, HIV AIDS STIGMA DISC; Pitpitan EV, 2012, ANN BEHAV MED, V43, P362, DOI 10.1007/s12160-012-9346-9; Pulerwitz J, 2010, PUBLIC HEALTH REP, V125, P272, DOI 10.1177/003335491012500218; Schulz A.J., 2006, GENDER RACE CLASS HL; Smolak A, 2013, AIDS BEHAV, V17, P2742, DOI 10.1007/s10461-013-0571-4; Stangl AL, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18734; Stein Jo, 2003, Afr J AIDS Res, V2, P95, DOI 10.2989/16085906.2003.9626564; Stephenson R, 2009, AIDS CARE, V21, P403, DOI 10.1080/09540120802290365; Turan JM, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001295; UNAIDS, 2011, EP UPD HLTH SECT PRO; *UNAIDS, 2009, AIDS EP UPD; UNAIDS, 2012, REG FACT SHEET SUBS; UNAIDS, 2010, 26 M UNAIDS PROGR CO; UNAIDS, 2007, RED HIV STIGM DISCR; Vanable PA, 2006, AIDS BEHAV, V10, P473, DOI 10.1007/s10461-006-9099-1; Viswanath K, 2006, J COMMUN, V56, pS238, DOI 10.1111/j.1460-2466.2006.00292.x; VISWANATH K, 2007, MACROSOCIAL DETERMIN; Viswanath K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014550; Waite KR, 2008, J GEN INTERN MED, V23, P1367, DOI 10.1007/s11606-008-0662-5; Williams DR, 2012, HEALTH SERV RES, V47, P1255, DOI 10.1111/j.1475-6773.2012.01404.x; Yebei VN, 2008, AFR HEALTH SCI, V8, P97	53	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100467	10.1371/journal.pone.0100467	http://dx.doi.org/10.1371/journal.pone.0100467			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN6QP	24945251	Green Published, Green Submitted, gold			2022-12-27	WOS:000340721500078
J	Dighe, SA; Kozminski, KG				Dighe, Shubha A.; Kozminski, Keith G.			Secretory Vesicles Deliver Cdc42p to Sites of Polarized Growth in S. cerevisiae	PLOS ONE			English	Article							POST-GOLGI VESICLES; CELL POLARITY; SACCHAROMYCES-CEREVISIAE; ACTIN CYTOSKELETON; BINDING PROTEINS; GTPASE CDC42P; YEAST; LOCALIZATION; SINGULARITY; MECHANISMS	The activation and localization of the Rho-family GTPase Cdc42p at one pole of a cell is necessary for maintaining an axis of polarized growth in many animal and fungal cells. How the asymmetric distribution of this key regulator of polarized morphogenesis is maintained is not fully understood, though divergent models have emerged from a congruence of multiple studies, including one that posits a role for polarized secretion. Here we show with S. cerevisiae that Cdc42p associates with secretory vesicles in vivo.	[Dighe, Shubha A.; Kozminski, Keith G.] Univ Virginia, Dept Biol, Charlottesville, VA 22903 USA; [Kozminski, Keith G.] Univ Virginia, Dept Cell Biol, Charlottesville, VA USA	University of Virginia; University of Virginia	Kozminski, KG (corresponding author), Univ Virginia, Dept Biol, Charlottesville, VA 22903 USA.	kkoz@virginia.edu			NSF [0723342]; University of Virginia	NSF(National Science Foundation (NSF)); University of Virginia	Funds for this work were provided by the NSF (grant #0723342) and the University of Virginia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo JE, 2001, J CELL BIOL, V155, P581, DOI 10.1083/jcb.200106065; Alfaro G, 2011, TRAFFIC, V12, P1521, DOI 10.1111/j.1600-0854.2011.01265.x; AMIT AG, 1985, NATURE, V313, P156, DOI 10.1038/313156a0; Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; Ayscough KR, 1999, MOL BIOL CELL, V10, P1061, DOI 10.1091/mbc.10.4.1061; Bergersen LH, 2008, NAT PROTOC, V3, P144, DOI 10.1038/nprot.2007.525; Bi EF, 2012, GENETICS, V191, P347, DOI 10.1534/genetics.111.132886; Boyd C, 2004, J CELL BIOL, V167, P889, DOI 10.1083/jcb.200408124; Caviston JP, 2002, P NATL ACAD SCI USA, V99, P12185, DOI 10.1073/pnas.182370299; Dighe SA, 2008, MOL BIOL CELL, V19, P4454, DOI 10.1091/mbc.E08-03-0252; Ellenbroek SIJ, 2012, SEMIN CANCER BIOL, V22, P208, DOI 10.1016/j.semcancer.2012.02.012; Forsmark A, 2011, TRAFFIC, V12, P740, DOI 10.1111/j.1600-0854.2011.01186.x; Goehring NW, 2013, TRENDS CELL BIOL, V23, P72, DOI 10.1016/j.tcb.2012.10.009; Goryachev AB, 2008, FEBS LETT, V582, P1437, DOI 10.1016/j.febslet.2008.03.029; GOUD B, 1988, CELL, V53, P753, DOI 10.1016/0092-8674(88)90093-1; GOVINDAN B, 1995, J CELL BIOL, V128, P1055, DOI 10.1083/jcb.128.6.1055; HARSAY E, 1995, J CELL BIOL, V131, P297, DOI 10.1083/jcb.131.2.297; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Howell AS, 2012, CELL, V149, P322, DOI 10.1016/j.cell.2012.03.012; Howell AS, 2009, CELL, V139, P731, DOI 10.1016/j.cell.2009.10.024; Irazoqui JE, 2005, MOL BIOL CELL, V16, P1296, DOI 10.1091/mbc.E04-05-0430; Kaiser CA, 2002, METHOD ENZYMOL, V351, P325; Kozminski KG, 2006, TRAFFIC, V7, P1224, DOI 10.1111/j.1600-0854.2006.00467.x; Kozminski KG, 2000, MOL BIOL CELL, V11, P339, DOI 10.1091/mbc.11.1.339; Layton AT, 2011, CURR BIOL, V21, P184, DOI 10.1016/j.cub.2011.01.012; Macias-Sanchez K, 2011, ANTON LEEUW INT J G, V99, P671, DOI 10.1007/s10482-010-9543-0; MCCAFFREY M, 1991, J CELL BIOL, V115, P309, DOI 10.1083/jcb.115.2.309; Moreno-Jimenez R, 2008, MICROBIOL-SGM, V154, P842, DOI 10.1099/mic.0.2007/012179-0; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; Orlando K, 2011, MOL BIOL CELL, V22, P624, DOI 10.1091/mbc.E10-06-0484; Osmani N, 2010, J CELL BIOL, V191, P1261, DOI 10.1083/jcb.201003091; Sarry JE, 2007, FEBS J, V274, P4287, DOI 10.1111/j.1742-4658.2007.05959.x; Savage NS, 2012, MOL BIOL CELL, V23, P1998, DOI 10.1091/mbc.E11-10-0837; Thompson BJ, 2013, DEVELOPMENT, V140, P13, DOI 10.1242/dev.083634; WALWORTH NC, 1987, J CELL BIOL, V105, P163, DOI 10.1083/jcb.105.1.163; Wedlich-Soldner R, 2003, SCIENCE, V299, P1231, DOI 10.1126/science.1080944; Yamamoto T, 2010, MOL BIOL CELL, V21, P1237, DOI 10.1091/mbc.E09-05-0412; Zajac A, 2005, MOL BIOL CELL, V16, P1500, DOI 10.1091/mbc.E04-10-0896; ZIMAN M, 1993, MOL BIOL CELL, V4, P1307, DOI 10.1091/mbc.4.12.1307	39	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e99494	10.1371/journal.pone.0099494	http://dx.doi.org/10.1371/journal.pone.0099494			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945395	Green Submitted, Green Published, gold			2022-12-27	WOS:000340721500021
J	Feng, LZ; Li, ZJ; Zhao, SW; Nair, H; Lai, SJ; Xu, WB; Li, MF; Wu, JG; Ren, LL; Liu, W; Yuan, ZH; Chen, Y; Wang, XH; Zhao, Z; Zhang, HL; Li, F; Ye, XF; Li, S; Feikin, D; Yu, HJ; Yang, WZ				Feng, Luzhao; Li, Zhongjie; Zhao, Shiwen; Nair, Harish; Lai, Shengjie; Xu, Wenbo; Li, Mengfeng; Wu, Jianguo; Ren, Lili; Liu, Wei; Yuan, Zhenghong; Chen, Yu; Wang, Xinhua; Zhao, Zhuo; Zhang, Honglong; Li, Fu; Ye, Xianfei; Li, Sa; Feikin, Daniel; Yu, Hongjie; Yang, Weizhong			Viral Etiologies of Hospitalized Acute Lower Respiratory Infection Patients in China, 2009-2013	PLOS ONE			English	Article							SYNCYTIAL VIRUS; YOUNG-CHILDREN; HUMAN METAPNEUMOVIRUS; CHILDHOOD PNEUMONIA; SEASONAL INFLUENZA; GLOBAL BURDEN; MORTALITY; SURVEILLANCE	Background: Acute lower respiratory infections (ALRIs) are an important cause of acute illnesses and mortality worldwide and in China. However, a large-scale study on the prevalence of viral infections across multiple provinces and seasons has not been previously reported from China. Here, we aimed to identify the viral etiologies associated with ALRIs from 22 Chinese provinces. Methods and Findings: Active surveillance for hospitalized ALRI patients in 108 sentinel hospitals in 24 provinces of China was conducted from January 2009-September 2013. We enrolled hospitalized all-age patients with ALRI, and collected respiratory specimens, blood or serum collected for diagnostic testing for respiratory syncytial virus (RSV), human influenza virus, adenoviruses (ADV), human parainfluenza virus (PIV), human metapneumovirus (hMPV), human coronavirus (hCoV) and human bocavirus (hBoV). We included 28,369 ALRI patients from 81 (of the 108) sentinel hospitals in 22 (of the 24) provinces, and 10,387 (36.6%) were positive for at least one etiology. The most frequently detected virus was RSV (9.9%), followed by influenza (6.6%), PIV (4.8%), ADV (3.4%), hBoV (1.9), hMPV (1.5%) and hCoV (1.4%). Co-detections were found in 7.2% of patients. RSV was the most common etiology (17.0%) in young children aged <2 years. Influenza viruses were the main cause of the ALRIs in adults and elderly. PIV, hBoV, hMPV and ADV infections were more frequent in children, while hCoV infection was distributed evenly in all-age. There were clear seasonal peaks for RSV, influenza, PIV, hBoV and hMPV infections. Conclusions: Our findings could serve as robust evidence for public health authorities in drawing up further plans to prevent and control ALRIs associated with viral pathogens. RSV is common in young children and prevention measures could have large public health impact. Influenza was most common in adults and influenza vaccination should be implemented on a wider scale in China.	[Feng, Luzhao; Li, Zhongjie; Lai, Shengjie; Zhang, Honglong; Li, Sa; Yu, Hongjie; Yang, Weizhong] Chinese Ctr Dis Control & Prevent, Div Infect Dis, Key Lab Surveillance & Early Warning Infect Dis, Beijing, Peoples R China; [Zhao, Shiwen] Yunnan Prov Ctr Dis Control & Prevent, Kunming, Peoples R China; [Nair, Harish] Univ Edinburgh, Global Hlth Acad, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Nair, Harish] Publ Hlth Fdn India, New Delhi, India; [Xu, Wenbo] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Li, Mengfeng; Li, Fu] Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control, Guangzhou 510275, Guangdong, Peoples R China; [Wu, Jianguo] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China; [Ren, Lili] Chinese Acad Med Sci, Inst Pathogen Biol, Beijing 100730, Peoples R China; [Ren, Lili] Peking Union Med Coll, Beijing 100021, Peoples R China; [Liu, Wei] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Yuan, Zhenghong; Ye, Xianfei] Shanghai Publ Hlth Clin Ctr, Shanghai, Peoples R China; [Chen, Yu] Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Xinhua] Gansu Prov Ctr Dis Control & Prevent, Lanzhou, Peoples R China; [Zhao, Zhuo] Liaoning Prov Ctr Dis Control & Prevent, Shenyang, Peoples R China; [Feikin, Daniel] Ctr Dis Control & Prevent, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA	Chinese Center for Disease Control & Prevention; University of Edinburgh; Public Health Foundation of India; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Sun Yat Sen University; Wuhan University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Beijing Institute of Microbiology & Epidemiology; Zhejiang University; Centers for Disease Control & Prevention - USA	Yu, HJ (corresponding author), Chinese Ctr Dis Control & Prevent, Div Infect Dis, Key Lab Surveillance & Early Warning Infect Dis, Beijing, Peoples R China.	yuhj@chinacdc.cn; yangwz@chinacdc.cn	meng, li/GVT-2063-2022; Yu, Hongjie/GZK-5351-2022; Chen, Yu/Y-3292-2019; Nair, Harish/E-7431-2010; Yang, Wei/HIA-0360-2022; Chen, Yi/HIR-2608-2022; Wang, Xin/AAN-8435-2021	Nair, Harish/0000-0002-9432-9100; Wang, Xin/0000-0002-4457-7376; Wu, Jianguo/0000-0002-8326-2895; Lai, Shengjie/0000-0001-9781-8148	National Key Science and Technology Project on Infectious Disease Surveillance Technique Platform of China [2009ZX10004-201, 2009ZX10004-202, 2009ZX10004-204, 2009ZX10004-206, 2009ZX10004-207];  [2009ZX10004-208];  [2009ZX10004-209];  [2009ZX10004-210];  [2009ZX10004-211];  [2009ZX10004-212];  [2009ZX10004-213];  [2012ZX10004-201];  [2013ZX10004-202];  [2012ZX10004-206];  [2012ZX10004-207];  [2012ZX10004-208];  [2012ZX10004-209];  [2012ZX10004-210];  [2012ZX10004-211];  [2012ZX10004-212];  [2012ZX10004-213]	National Key Science and Technology Project on Infectious Disease Surveillance Technique Platform of China; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; 	This work was supported by grants from the National Key Science and Technology Project on Infectious Disease Surveillance Technique Platform of China (2009ZX10004-201, 2009ZX10004-202, 2009ZX10004-204, 2009ZX10004-206, 2009ZX10004-207, 2009ZX10004-208, 2009ZX10004-209, 2009ZX10004-210, 2009ZX10004-211, 2009ZX10004-212, 2009ZX10004-213, 2012ZX10004-201, 2013ZX10004-202, 2012ZX10004-206, 2012ZX10004-207, 2012ZX10004-208, 2012ZX10004-209, 2012ZX10004-210, 2012ZX10004-211, 2012ZX10004-212, 2012ZX10004-213). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berkley JA, 2010, JAMA-J AM MED ASSOC, V303, P2051, DOI 10.1001/jama.2010.675; de Mello WA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005095; Druce J, 2005, J MED VIROL, V75, P122, DOI 10.1002/jmv.20246; Feikin DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043656; Feng LZ, 2012, B WORLD HEALTH ORGAN, V90, P279, DOI 10.2471/BLT.11.096958; Feng LZ, 2010, VACCINE, V28, P6778, DOI 10.1016/j.vaccine.2010.07.064; Foulongne V, 2006, PEDIATR INFECT DIS J, V25, P354, DOI 10.1097/01.inf.0000207480.55201.f6; Haynes AK, 2013, J INFECT DIS, V208, pS246, DOI 10.1093/infdis/jit515; He J, 2011, J MICROBES INFECT, V6, P90; Huang GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064254; Huo X, 2012, J MED VIROL, V84, P1980, DOI 10.1002/jmv.23401; Lau SKP, 2006, J CLIN MICROBIOL, V44, P2063, DOI 10.1128/JCM.02614-05; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Luksic I, 2013, CROAT MED J, V54, P122, DOI 10.3325/cmj.2013.54.122; Management Office of National Science and Technology Major Project of China Chinese Center for Disease Control and Prevention, 2009, RESP INF SURV PROT 2; Mizgerd JP, 2006, PLOS MED, V3, P155, DOI 10.1371/journal.pmed.0030076; Nair H, 2013, LANCET, V381, P1380, DOI 10.1016/S0140-6736(12)61901-1; Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Ren L, 2009, CLIN MICROBIOL INFEC, V15, P1146, DOI 10.1111/j.1469-0691.2009.02746.x; Rudan I, 2013, J GLOB HEALTH, V3, DOI 10.7189/jogh.03.010401; Rudan I, 2010, LANCET, V375, P1083, DOI 10.1016/S0140-6736(10)60060-8; Shay DK, 1999, JAMA-J AM MED ASSOC, V282, P1440, DOI 10.1001/jama.282.15.1440; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; Weber MW, 1998, TROP MED INT HEALTH, V3, P268, DOI 10.1046/j.1365-3156.1998.00213.x; Wolf DG, 2006, PEDIATR INFECT DIS J, V25, P320, DOI 10.1097/01.inf.0000207395.80657.cf; Yang YW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045807; Yu HJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001552; Yu HJ, 2014, INFLUENZA OTHER RESP, V8, P53, DOI 10.1111/irv.12205; Yu HJ, 2013, INFLUENZA OTHER RESP, V7, P1350, DOI 10.1111/irv.12121; Zhang C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072606	32	80	119	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e99419	10.1371/journal.pone.0099419	http://dx.doi.org/10.1371/journal.pone.0099419			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945280	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000340721500019
J	Hernandez-Brito, D; Carrete, M; Popa-Lisseanu, AG; Ibanez, C; Tella, JL				Hernandez-Brito, Dailos; Carrete, Martina; Popa-Lisseanu, Ana G.; Ibanez, Carlos; Tella, Jose L.			Crowding in the City: Losing and Winning Competitors of an Invasive Bird	PLOS ONE			English	Article							PARAKEETS PSITTACULA-KRAMERI; SPARROW PASSER-DOMESTICUS; KESTREL FALCO-NAUMANNI; SPECIES INVASIONS; INTERSPECIFIC COMPETITION; BIOTIC HOMOGENIZATION; RISK-ASSESSMENT; NOCTULE BATS; HABITAT USE; IMPACT	Invasive species can take advantage of resources unexploited by natives (opportunism hypothesis) or they can exploit the same resources but more aggressively or efficiently (competition hypothesis), thus impacting native species. However, invasive species tend to exploit anthropogenic habitats that are inefficiently used by natives such as urban environments. Focusing on the ring-necked parakeet (Psittacula krameri), one of the most invasive birds worldwide, we combined observations of interspecific aggressions, species-specific cavity-nest preferences and the spatial distribution of the native cavity-nesting vertebrate community to determine the invasion process as well as its potential impacts on native species in a Mediterranean city. Our results support the competition hypothesis, suggesting that ring-necked parakeets are outcompeting native species sharing nest-site preferences. Parakeets initiated and won most interspecific aggressions, which were directed towards competitors but also towards predators. This behaviour could explain the spatial arrangement of natives, with most bird species breeding close to parakeets possibly to take advantage of their effective antipredatory behaviour. However, temporal and spatial patterns of segregation suggest that a threatened bat species is negatively affected by parakeets. This demonstrates that common species gain benefits and threatened ones (in this study, a bat and possibly a falcon) lose nest sites due to invaders. Therefore, the conservation status of the native species that pay the costs of competition with invaders should be considered. This scenario of winners and losers may, however, shift towards more losers if the ring-necked parakeet population continues to grow, thus requiring close monitoring and control/eradication programs to avoid further impacts.	[Hernandez-Brito, Dailos; Carrete, Martina; Tella, Jose L.] CSIC, Dept Conservat Biol, Estn Biol Donana, E-41080 Seville, Spain; [Carrete, Martina] Univ Pablo Olavide, Dept Phys Chem & Nat Syst, Seville, Spain; [Popa-Lisseanu, Ana G.] Leibniz Inst Zoo & Wildlife Res, Berlin, Germany; [Ibanez, Carlos] CSIC, Dept Evolutionary Ecol, Estn Biol Donana, E-41080 Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Universidad Pablo de Olavide; Leibniz Institut fur Zoo und Wildtierforschung; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Carrete, M (corresponding author), CSIC, Dept Conservat Biol, Estn Biol Donana, E-41080 Seville, Spain.	mcarrete@upo.es	Carrete, Martina/A-6376-2009; Carrete, Martina/D-2618-2017; Tella, José L/I-3707-2015; Hernández-Brito, Dailos/AAR-3234-2021; Ibanez, Carlos/H-7577-2015	Carrete, Martina/0000-0002-0491-2950; Tella, José L/0000-0002-3038-7424; Hernández-Brito, Dailos/0000-0002-5203-3512; Ibanez, Carlos/0000-0003-1181-7641; Chiaradia, Andre/0000-0002-6178-4211	Fundacion Repsol and Project of Excellence from the Junta de Andalucia [P08-RNM-4014]; COST (European Cooperation in Science and Technology) action ParrotNet; project EBD-Severo Ochoa [SEV-2012-0262];  [RYC-2009-04860]	Fundacion Repsol and Project of Excellence from the Junta de Andalucia; COST (European Cooperation in Science and Technology) action ParrotNet; project EBD-Severo Ochoa; 	MC (RYC-2009-04860) and JLT were supported by Fundacion Repsol and Project of Excellence from the Junta de Andalucia P08-RNM-4014. The authors would like to acknowledge the support provided by COST (European Cooperation in Science and Technology) action ParrotNet and the project EBD-Severo Ochoa (SEV-2012-0262) for the realization of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer HG, 2011, IBIS, V153, P204, DOI 10.1111/j.1474-919X.2010.01085.x; Blackburn TM, 2010, ANIM CONSERV, V13, P227, DOI 10.1111/j.1469-1795.2010.00372.x; Blackburn TM, 2009, OXFORD AVIAN BIOL, P1; Blanco G, 1997, ANIM BEHAV, V54, P335, DOI 10.1006/anbe.1996.0465; Bremner A, 2007, BIOL CONSERV, V139, P306, DOI 10.1016/j.biocon.2007.07.005; Brown CR, 2001, CURR ORNITHOL, V16, P1; Butler CJ, 2003, THESIS U OXFORD OXFO; Carrete M, 2010, ANIM CONSERV, V13, P390, DOI 10.1111/j.1469-1795.2010.00352.x; Carrete M, 2008, FRONT ECOL ENVIRON, V6, P466, DOI 10.1890/1540-9295-6.9.466.b; Carrete M, 2008, FRONT ECOL ENVIRON, V6, P207, DOI 10.1890/070075; Carrete M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018859; Catford JA, 2009, DIVERS DISTRIB, V15, P22, DOI 10.1111/j.1472-4642.2008.00521.x; Catry I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058320; Clavero M, 2009, BIOL CONSERV, V142, P2043, DOI 10.1016/j.biocon.2009.03.034; Clergeau P, 2009, PERRUCHE COLLIER PSI; Czajka Christina, 2011, Open Ornithology Journal, V4, P17, DOI 10.2174/1874453201104010017; Davis A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059332; Davis AY, 2014, BIOL INVASIONS, V16, P415, DOI 10.1007/s10530-013-0530-z; Diamond J.M., 1975, P342; Dunning J.B., 2007, CRC HDB AVIAN BODY M, V2nd ed., DOI [10.1201/9781420064452, DOI 10.1201/9781420064452]; Edelaar P, 2012, IBIS, V154, P635, DOI 10.1111/j.1474-919X.2012.01250.x; Fletcher M., 2007, REV STATUS ECOLOGY L; Forero MG, 1996, BIOL CONSERV, V78, P289, DOI 10.1016/S0006-3207(96)00011-0; Freed LA, 2009, CURR BIOL, V19, P1736, DOI 10.1016/j.cub.2009.08.044; Gebhardt H, 1996, WILDLIFE BIOL, V2, P205, DOI 10.2981/wlb.1996.020; Haarsma A-J, 2009, LEVENDE NATUUR, V114, P10; Halfwerk W, 2011, J APPL ECOL, V48, P210, DOI 10.1111/j.1365-2664.2010.01914.x; Hierro JL, 2005, J ECOL, V93, P5, DOI 10.1111/j.0022-0477.2004.00953.x; Ibanez C, 2001, P NATL ACAD SCI USA, V98, P9700, DOI 10.1073/pnas.171140598; Ibanez C., 2004, HDB SAUGETIERE EUROP, VII, P695, DOI DOI 10.1080/0964704X.2013.774246; Ibanez C, 2009, J MAMMAL, V90, P235, DOI 10.1644/08-MAMM-A-037.1; Japiot X., 2005, PSITTACIDES VILLES E; Krause J, 2002, LIVING GROUPS; Kumschick S, 2010, BIOL CONSERV, V143, P2757, DOI 10.1016/j.biocon.2010.07.023; Lever C., 2005, NATURALIZED BIRDS WO; MACARTHUR R, 1970, Theoretical Population Biology, V1, P1, DOI 10.1016/0040-5809(70)90039-0; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Martui R., 2003, ATLAS AVES REPRODUCT; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; McKinney ML, 1999, TRENDS ECOL EVOL, V14, P450, DOI 10.1016/S0169-5347(99)01679-1; Miller JR, 2002, CONSERV BIOL, V16, P330, DOI 10.1046/j.1523-1739.2002.00420.x; Moilanen A, 1998, ECOLOGY, V79, P2503, DOI 10.1890/0012-9658(1998)079[2503:MDEOHQ]2.0.CO;2; Mori E, 2013, HYSTRIX, V24, P195, DOI 10.4404/hystrix-24.2-8689; Munoz AR, 2006, DIVERS DISTRIB, V12, P656, DOI 10.1111/j.1472-4642.2006.00272.x; NEGRO JJ, 1993, BIRD STUDY, V40, P115, DOI 10.1080/00063659309477136; Newson SE, 2011, IBIS, V153, P509, DOI 10.1111/j.1474-919X.2011.01121.x; NEWTON I, 1994, BIOL CONSERV, V70, P265, DOI 10.1016/0006-3207(94)90172-4; Newton I., 1998, POPULATION LIMITATIO; Orchan Y, 2013, BIOL INVASIONS, V15, P429, DOI 10.1007/s10530-012-0298-6; Palomo LJ., 2007, ATLAS LIBRO ROJO MAM; Popa-Lisseanu AG, 2009, J ZOOL, V278, P126, DOI 10.1111/j.1469-7998.2009.00556.x; Popa-Lisseanu AG, 2008, ANIM BEHAV, V75, P471, DOI 10.1016/j.anbehav.2007.05.011; Robinson RA, 2005, IBIS, V147, P552, DOI 10.1111/j.1474-919x.2005.00427.x; Rosenzweig ML, 2001, EVOL ECOL RES, V3, P361; Sax DF, 2000, GLOBAL ECOL BIOGEOGR, V9, P363, DOI 10.1046/j.1365-2699.2000.00217.x; Sax DF, 2002, AM NAT, V160, P766, DOI 10.1086/343877; Sax DF, 2008, P NATL ACAD SCI USA, V105, P11490, DOI 10.1073/pnas.0802290105; Sebastian-Gonzalez E, 2010, P ROY SOC B-BIOL SCI, V277, P2983, DOI 10.1098/rspb.2010.0244; Serrano D, 2005, AM NAT, V166, pE22, DOI 10.1086/431255; Serrano D, 2004, ECOLOGY, V85, P3438, DOI 10.1890/04-0463; Shaw LM, 2008, J ORNITHOL, V149, P293, DOI 10.1007/s10336-008-0285-y; Simberloff D., 1981, P53; Simberloff D, 2013, TRENDS ECOL EVOL, V28, P58, DOI 10.1016/j.tree.2012.07.013; Slabbekoorn H, 2003, NATURE, V424, P267, DOI 10.1038/424267a; Sol D, 2012, OECOLOGIA, V169, P553, DOI 10.1007/s00442-011-2203-x; STAMPS JA, 1988, AM NAT, V131, P329, DOI 10.1086/284793; Start A. N., 1998, Western Australian Naturalist, V22, P123; Strayer DL, 2006, TRENDS ECOL EVOL, V21, P645, DOI 10.1016/j.tree.2006.07.007; Strubbe D, 2007, ECOGRAPHY, V30, P578, DOI 10.1111/j.0906-7590.2007.05096.x; Strubbe D, 2011, BIOL CONSERV, V144, P2112, DOI 10.1016/j.biocon.2011.05.001; Strubbe D, 2011, IBIS, V153, P180, DOI 10.1111/j.1474-919X.2010.01074.x; Strubbe D, 2010, J APPL ECOL, V47, P549, DOI 10.1111/j.1365-2664.2010.01808.x; Strubbe D, 2009, BIOL CONSERV, V142, P1588, DOI 10.1016/j.biocon.2009.02.026; Tablado Z, 2010, CONSERV BIOL, V24, P1230, DOI 10.1111/j.1523-1739.2010.01483.x; Tayleur J., 2010, BOU P IMP NONN SPEC; Tella J.L., 1996, P53, DOI 10.1016/B978-012100130-8/50009-2; Tella JL, 1998, CONSERV BIOL, V12, P593, DOI 10.1046/j.1523-1739.1998.96288.x; van Wilgenburg E, 2010, EVOL APPL, V3, P136, DOI 10.1111/j.1752-4571.2009.00114.x	78	66	71	3	112	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100593	10.1371/journal.pone.0100593	http://dx.doi.org/10.1371/journal.pone.0100593			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945439	Green Published, Green Submitted, gold			2022-12-27	WOS:000340721500095
J	Pang, XH; Chai, YC; Sun, LH; Chen, DY; Chen, Y; Zhang, ZH; Wu, H; Yang, T				Pang, Xiuhong; Chai, Yongchuan; Sun, Lianhua; Chen, Dongye; Chen, Ying; Zhang, Zhihua; Wu, Hao; Yang, Tao			Characterization of Spectrum, de novo Rate and Genotype-Phenotype Correlation of Dominant GJB2 Mutations in Chinese Hans	PLOS ONE			English	Article							SENSORINEURAL HEARING-LOSS; GENE; KERATODERMA; CONNEXIN26	Dominant mutations in GJB2 may lead to various degrees of sensorineural hearing impairment and/or hyperproliferative epidermal disorders. So far studies of dominant GJB2 mutations were mostly limited to case reports of individual patients and families. In this study, we identified 7 families, 11 subjects with dominant GJB2 mutations by sequencing of GJB2 in 2168 Chinese Han probands with sensorineural hearing impairment and characterized the associated spectrum, de novo rate and genotype-phenotype correlation. We identified p.R75Q, p.R75W and p.R184Q as the most frequent dominant GJB2 mutations among Chinese Hans, which had a very high de novo rate (71% of probands). A majority (10/11) of subjects carrying dominant GJB2 mutations exhibited palmoplantar keratoderma in addition to hearing impairment. In two families segregated with additional c.235delC or p.V37I mutations of GJB2, family members with the compound heterozygous mutations exhibited more severe phenotype than those with single dominant GJB2 mutation. Our study suggested that the high de novo mutation rate gives rise to a significant portion of dominant GJB2 mutations. The severity of the hearing and epidermal phenotypes associated with dominant GJB2 mutations may be modified by additional recessive mutations of GJB2.	[Pang, Xiuhong; Chai, Yongchuan; Sun, Lianhua; Chen, Dongye; Chen, Ying; Zhang, Zhihua; Wu, Hao; Yang, Tao] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Otorhinolaryngol Head & Neck Surg, Shanghai 200030, Peoples R China; [Pang, Xiuhong; Chai, Yongchuan; Sun, Lianhua; Chen, Dongye; Chen, Ying; Zhang, Zhihua; Wu, Hao; Yang, Tao] Shanghai Jiao Tong Univ, Ear Inst, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Wu, H (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Otorhinolaryngol Head & Neck Surg, Shanghai 200030, Peoples R China.	wuhao622@sina.cn; yangtfxl@sina.com	zhang, zh/GWV-4677-2022; Pang, Xiuhong/ABE-2751-2021	Yang, Tao/0000-0001-6011-987X	National Science Foundation of China [81222010, 30971596, 81170924]; National Basic Research Program of China [2011CB504501]; Shanghai Municipal Education Commission	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC))	This research was supported by grants from National Science Foundation of China (81222010 and 30971596 to TY, 81170924 to HW), grant from National Basic Research Program of China (2011CB504501 to HW), and the Oriental Scholar project from Shanghai Municipal Education Commission (to TY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; Dai P, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-26; Heathcote K, 2000, J MED GENET, V37, P50, DOI 10.1136/jmg.37.1.50; Hoischen A, 2010, NAT GENET, V42, P483, DOI 10.1038/ng.581; Iossa S, 2011, CURR GENOMICS, V12, P475, DOI 10.2174/138920211797904098; Iossa S, 2009, AM J MED GENET A, V149A, P685, DOI 10.1002/ajmg.a.32462; Kelsell DP, 2001, AM J HUM GENET, V68, P559, DOI 10.1086/318803; Lindhurst MJ, 2011, NEW ENGL J MED, V365, P611, DOI 10.1056/NEJMoa1104017; Maestrini E, 1999, HUM MOL GENET, V8, P1237, DOI 10.1093/hmg/8.7.1237; Morle L, 2000, J MED GENET, V37, P368, DOI 10.1136/jmg.37.5.368; Piazza V, 2005, CLIN GENET, V68, P161, DOI 10.1111/j.1399-0004.2005.00468.x; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Snoeckx RL, 2005, AM J HUM GENET, V77, P945, DOI 10.1086/497996; Welch KO, 2007, AM J MED GENET A, V143A, P1567, DOI 10.1002/ajmg.a.31701	14	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100483	10.1371/journal.pone.0100483	http://dx.doi.org/10.1371/journal.pone.0100483			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945352	Green Published, Green Submitted, gold			2022-12-27	WOS:000340721500080
J	Zhang, LD; Hu, P; Chen, X; Bie, P				Zhang, Leida; Hu, Peng; Chen, Xi; Bie, Ping			Transarterial Chemoembolization (TACE) plus Sorafenib Versus TACE for Intermediate or Advanced Stage Hepatocellular Carcinoma: A Meta-Analysis	PLOS ONE			English	Article							RANDOMIZED-TRIALS; NATIONWIDE SURVEY; CLINICAL-TRIALS; SURVIVAL; IMPROVES; ANGIOGENESIS; COMBINATION; JAPANESE; GROWTH; BIAS	Background: Sorafenib is used in patients with intermediate or advanced stage hepatocellular carcinoma (HCC) before or after of transarterial chemoembolization (TACE). However, the survival outcomes of TACE combined with sorafenib versus TACE alone remain controversial. Thus, we conducted a meta-analysis to evaluate the efficacy and safety of the combination therapy of TACE plus sorafenib in patients with intermediate or advanced stage of HCC. Methods: Pubmed and Embase databases were systematically reviewed for studies published up to November 2013, that compared TACE alone or in combination with sorafenib. Pooled hazard ratios (HRs) with 95% confidence intervals (95% CIs) were calculated for overall survival (OS), time to progression (TTP), objective response rate (ORR), and progression free survival (PFS) using random-effects or fixed-effects model, depending on the heterogeneity between the included studies. Results: Six studies published from 2011 to 2013, with a total of 1254 patients, were included in this meta-analysis. The pooled results showed that TACE combined with sorafenib significantly improved OS (HR = 0.65; 95% CI: 0.47-0.89, P = 0.007), TTP (HR = 0.68; 95% CI: 0.52-0.87, P = 0.003), ORR (HR = 1.06; 95% CI: 1.01-1.12, P = 0.021), but did not affect PFS (HR = 0.84; 95% CI: 0.62-1.14, P = 0.267). The incidence of grade III/IV adverse reaction was higher in the TACE plus sorafenib group than in the TACE group. Conclusions: The meta-analysis confirmed that the combination therapy of TACE plus sorafenib in patients with intermediate or advanced stage of HCC, can improve the OS, TTP, and ORR. This combination therapy was also associated with a significantly increased risk of adverse reactions.	[Zhang, Leida; Hu, Peng; Chen, Xi; Bie, Ping] Third Mil Med Univ, Southwest Hosp, Dept Hepatobiliary Surg, Chongqin, Peoples R China	Army Medical University	Bie, P (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Hepatobiliary Surg, Chongqin, Peoples R China.	pengboyfei@msn.com						Arii S, 2000, HEPATOLOGY, V32, P1224, DOI 10.1053/jhep.2000.20456; Bai W, 2013, J DIGEST DIS, V14, P181, DOI 10.1111/1751-2980.12038; Bayer, 2013, PHAS 2 RAND DOUBL BL; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bruix J, 2004, GASTROENTEROLOGY, V127, pS179, DOI 10.1053/j.gastro.2004.09.032; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Cabrera R, 2011, ALIMENT PHARM THER, V34, P205, DOI 10.1111/j.1365-2036.2011.04697.x; Chang YS, 2007, CANCER CHEMOTH PHARM, V59, P561, DOI 10.1007/s00280-006-0393-4; Chao Y, 2010, 2010 ASCO GASTR CANC; Choi GH, 2013, RADIOLOGY, V269, P602, DOI 10.1148/radiol.13130150; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Farrell GC, 2010, J GASTROEN HEPATOL, V25, P657, DOI 10.1111/j.1440-1746.2009.06167.x; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Ikai I, 2004, CANCER-AM CANCER SOC, V101, P796, DOI 10.1002/cncr.20426; Kudo M, 2011, EUR J CANCER, V47, P2117, DOI 10.1016/j.ejca.2011.05.007; Kunz R, 1998, BRIT MED J, V317, P1185, DOI 10.1136/bmj.317.7167.1185; Lencioni R, 2010, J CLIN ONCOL, V28; Llovet JM, 2003, HEPATOLOGY, V37, P429, DOI 10.1053/jhep.2003.50047; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mathonnet M, 2006, WORLD J GASTROENTERO, V12, P3782, DOI 10.3748/wjg.v12.i23.3782; Muhammad A, 2013, WORLD J HEPATOL, V5, P364, DOI 10.4254/wjh.v5.i7.364; Park J., 2010, P 4 ANN C INT LIV CA, P26; Qu XD, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-263; Sansonno D, 2012, ONCOLOGIST, V17, P359, DOI 10.1634/theoncologist.2011-0313; Sergio A, 2008, AM J GASTROENTEROL, V103, P914, DOI 10.1111/j.1572-0241.2007.01712.x; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Wells G SB, 2013, NEWCASTLE OTTAWA SCA; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Yuen MF, 2009, J GASTROEN HEPATOL, V24, P346, DOI 10.1111/j.1440-1746.2009.05784.x; Zhang T, 2010, ANTI-CANCER DRUG, V21, P326, DOI 10.1097/CAD.0b013e3283350e26; Zhang X, 2012, HEPATOB PANCREAT DIS, V11, P458, DOI 10.1016/S1499-3872(12)60209-4	34	80	84	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100305	10.1371/journal.pone.0100305	http://dx.doi.org/10.1371/journal.pone.0100305			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945380	Green Published, gold, Green Submitted			2022-12-27	WOS:000340721500058
J	Marques, DPD; Rosa, FM; Maciel, E; Negrao-Correa, D; Teles, HMS; Caldeira, RL; Jannotti-Passos, LK; Coelho, PMZ				de Almeida Marques, Daisymara Priscila; Rosa, Florence Mara; Maciel, Engels; Negrao-Correa, Deborah; Santana Teles, Horacio Manuel; Caldeira, Roberta Lima; Jannotti-Passos, Liana Konovaloff; Zech Coelho, Paulo Marcos			Reduced Susceptibility of a Biomphalaria tenagophila Population to Schistosoma mansoni after Introducing the Resistant Taim/RS Strain of B-tenagophila into Herivelton Martins Stream	PLOS ONE			English	Article							SAO-PAULO; DOMINANT CHARACTER; BANANAL STATE; INFECTION; BRAZIL; SNAILS; PLANORBIDAE; MORTALITY	Studies performed in the last 30 years demonstrated that a strain of B. tenagophila from the Taim Biological Reserve is completely resistant to Schistosoma mansoni infection. This resistance to parasite infection is a dominant characteristic during crossbreeding with susceptible B. tenagophila strains. These experiments also identified a 350 bp molecular marker that is exclusive to the Taim strain and does not occur in other geographic strains of this snail species. The Taim strain (Taim/RS) of Biomphalaria tenagophila was bred on a large scale, physically marked and introduced into a stream in which previous malacological analyses had revealed the presence of only parasite-susceptible B. tenagophila. Samples of offspring captured 4, 11 and 14 months after the introduction of the Taim strain were examined, and the susceptibility of the snails to S. mansoni infection dropped from 38.6-26.5% to 2.1% during the 14 months after the introduction of the Taim snail strain. A significant correlation was also observed between the absence of infection and the identification of the Taim molecular marker. These results demonstrate that the genetic marker from the Taim strain was successfully introduced into the wild snail population. In addition, a significant relationship exists between the marker and resistance to infection.	[de Almeida Marques, Daisymara Priscila; Zech Coelho, Paulo Marcos] Fiocruz MS, Res Ctr Rene Rachou, Lab Schistosomiasis, Belo Horizonte, MG, Brazil; [Rosa, Florence Mara] Univ Fed Juiz de Fora, Inst Biol Sci, Parasitol Lab, Sao Pedro, MG, Brazil; [Maciel, Engels] Chacara Santa Ines, Sao Paulo, Brazil; [Negrao-Correa, Deborah] Univ Fed Minas Gerais, Inst Biol Sci, Lab Schistosomiasis, Belo Horizonte, MG, Brazil; [Santana Teles, Horacio Manuel] SUCEN, Superintendencia Controle Endemias Estado Sao Pau, Sao Paulo, Brazil; [Caldeira, Roberta Lima] Fiocruz MS, Res Ctr Rene Rachou, Lab Helminthol & Med Malacol, Belo Horizonte, MG, Brazil; [Jannotti-Passos, Liana Konovaloff] Fiocruz MS, Res Ctr Rene Rachou, Mollusk Room Dr Lobato Paraense, Belo Horizonte, MG, Brazil	Fundacao Oswaldo Cruz; Universidade Federal de Minas Gerais; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Coelho, PMZ (corresponding author), Fiocruz MS, Res Ctr Rene Rachou, Lab Schistosomiasis, Belo Horizonte, MG, Brazil.	coelhopm@cpqrr.fiocruz.br	Coelho, Paulo Marcos Zech/ABE-6169-2021; Caldeira, Roberta/AAZ-3858-2020; Negrao, Carlos E/C-4281-2012	Coelho, Paulo Marcos Zech/0000-0002-2443-8897; Caldeira, Roberta/0000-0003-4706-0732; 	CNPq; FAPEMIG	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	Funding came from CNPq - www.cnpq.br and FAPEMIG - www.fapemig.br. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	de Mattos ACA, 2011, MEM I OSWALDO CRUZ, V106, P424, DOI 10.1590/S0074-02762011000400007; Barbosa L, 2006, PARASITE IMMUNOL, V28, P209, DOI 10.1111/j.1365-3024.2006.00827.x; BERNARDINI OJ, 1981, ARQ CATARIN MED, V10, P213; Bezerra F. S. D. M., 1997, Revista do Instituto de Medicina Tropical de Sao Paulo, V39, P197, DOI 10.1590/S0036-46651997000400003; Bezerra FSD, 2003, MEM I OSWALDO CRUZ, V98, P73, DOI 10.1590/S0074-02762003000100010; Blair L, 2007, J EVOLUTION BIOL, V20, P54, DOI 10.1111/j.1420-9101.2006.01230.x; Coelho JR, 2006, MEM I OSWALDO CRUZ, V101, P111, DOI 10.1590/S0074-02762006000100022; COELHO PMZ, 1986, REV I MED TROP, V28, P74, DOI 10.1590/S0036-46651986000200002; Coelho PMZ, 2004, MEM I OSWALDO CRUZ, V99, P109, DOI 10.1590/S0074-02762004000900020; CORREA MCR, 1979, REV INST MED TROP SP, V21, P72; de COELHO M V, 1962, Rev Inst Med Trop Sao Paulo, V4, P289; DEFREITAS JR, 1985, REV I MED TROP, V27, P6, DOI 10.1590/S0036-46651985000100002; KANE RA, 1994, MOL BIOCHEM PARASIT, V63, P153, DOI 10.1016/0166-6851(94)90018-3; LOOKER DL, 1979, J PARASITOL, V65, P880, DOI 10.2307/3280241; Martins-Souza RL, 2003, PARASITOL RES, V91, P500, DOI 10.1007/s00436-003-0985-4; Nacif-Pimenta R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045637; Negrao-Correa D, 2007, ISJ-INVERT SURVIV J, V4, P101; Negrao-Correa D, 2012, J Parasitol Res, V2012, P743920, DOI 10.1155/2012/743920; PARAENSE W. LOBATO, 1955, MEM INST OSWALDO CRUZ, V53, P277; PARAENSE WL, 1978, J PARASITOL, V64, P822, DOI 10.2307/3279509; PELLEGRINO J, 1955, J PARASITOL, V41, P329, DOI 10.2307/3274230; Pereira CAJ, 2008, PARASITE IMMUNOL, V30, P610, DOI 10.1111/j.1365-3024.2008.01062.x; Rosa FM, 2006, MEM I OSWALDO CRUZ, V101, P247, DOI 10.1590/S0074-02762006000900038; Rosa FM, 2013, REV INST MED TROP SP, V55, P39, DOI 10.1590/S0036-46652013000100007; Rosa FM, 2005, MEM I OSWALDO CRUZ, V100, P19, DOI 10.1590/S0074-02762005000100004; Rosa FM, 2004, MEM I OSWALDO CRUZ, V99, P85, DOI 10.1590/S0074-02762004000100015; Rosa FM, 2008, THESIS U FEDERAL MIN; SANTOS M. B. L., 1979, Revista do Instituto de Medicina Tropical de Sao Paulo, V21, P281; Teles HMS, 2005, REV SOC BRAS MED TRO, V38, P426, DOI 10.1590/S0037-86822005000500013; Teles HMS, 2002, MEM I OSWALDO CRUZ, V97, P181, DOI 10.1590/S0074-02762002000900035; Teles HMS, 2002, MEM I OSWALDO CRUZ, V97, P37, DOI 10.1590/S0074-02762002000900009; TELES HMS, 1991, REV SAUDE PUBL, V25, P350, DOI 10.1590/S0034-89101991000500004; Thiengo SC, 2001, MEM I OSWALDO CRUZ, V96, P177, DOI 10.1590/S0074-02762001000900028; Vidigal THDA, 2000, MEM I OSWALDO CRUZ, V95, P57, DOI 10.1590/S0074-02762000000100009; WOOLHOUSE MEJ, 1989, ANN TROP MED PARASIT, V83, P137, DOI 10.1080/00034983.1989.11812321; Coelho PMZ, 2008, ACTA TROP, V108, P245, DOI 10.1016/j.actatropica.2008.05.028	36	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99573	10.1371/journal.pone.0099573	http://dx.doi.org/10.1371/journal.pone.0099573			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941324	Green Published, Green Submitted, gold			2022-12-27	WOS:000338508200029
J	Losey, RJ; Jessup, E; Nomokonova, T; Sablin, M				Losey, Robert J.; Jessup, Erin; Nomokonova, Tatiana; Sablin, Mikhail			Craniomandibular Trauma and Tooth Loss in Northern Dogs and Wolves: Implications for the Archaeological Study of Dog Husbandry and Domestication	PLOS ONE			English	Article							CANINE-DISTEMPER VIRUS; SLED DOGS; LESIONS; LUPUS; CARNIVORES; ANOMALIES; BREAKAGE; TEETH; L.	Archaeological dog remains from many areas clearly show that these animals suffered tooth fractures, tooth loss, trauma, and dental defects during their lives. Relatively little research has explored the meanings of these patterns, particularly for ancient dog remains from small-scale societies of the North. One limiting issue is the lack of comparative data on dental health and experiences of trauma among northern wolves and dogs. This paper examines tooth loss, tooth fracture, enamel hypoplasia, and cranial trauma in a large sample of historic dog and wolf remains from North America and Northern Russia. The data indicate that the dogs more commonly experienced tooth loss and tooth fracture than the wolves, despite reportedly being fed mostly soft foods such as blubber and fish. The higher rates observed in the dogs likely is a result of food stress and self-provisioning through scavenging. The ability to self-provision was likely important for the long-term history of dog use in the north. Dogs also more commonly experienced cranial fractures than wolves, particularly depression fractures on their frontal bones, which were likely the result of blows from humans. Hypoplastic lesions are rare in both wolves and dogs, and probably result from multiple causes, including food stress, disease, and trauma.	[Losey, Robert J.; Jessup, Erin; Nomokonova, Tatiana] Univ Alberta, Dept Anthropol, Edmonton, AB, Canada; [Sablin, Mikhail] Russian Acad Sci, Inst Zool, St Petersburg 199034, Russia	University of Alberta; Russian Academy of Sciences; Zoological Institute of the Russian Academy of Sciences	Losey, RJ (corresponding author), Univ Alberta, Dept Anthropol, Edmonton, AB, Canada.	robert.losey@ualberta.ca	Mikhail, Sablin/K-7835-2013	Mikhail, Sablin/0000-0002-2773-7454	ERC [295458]; Russian Foundation for Basic Research [13-04-00203]	ERC(European Research Council (ERC)European Commission); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	Funding for this project was provided by an ERC Advanced Grant (#295458) to Dr. David Anderson, University of Aberdeen (http://erc.europa.eu). Financial support to Mikhail V. Sablin was provided by the Russian Foundation for Basic Research (Grant 13-04-00203; http://www.rfbr.ru/rffi/ru). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Kennel Club, 1975, COMPL DOG BOOK; Andersone Z, 2000, ACTA THERIOL, V45, P549; Arnall L., 1961, Journal of Small Animal Practice, V1, P169, DOI 10.1111/j.1748-5827.1960.tb06078.x; Baker J, 1980, ANIMAL DIARCHAEOLO, V1st; Bartelle BG, 2010, J ARCHAEOL SCI, V37, P2721, DOI 10.1016/j.jas.2010.06.008; BAUMGARTNER W, 1995, VET PATHOL, V32, P702, DOI 10.1177/030098589503200612; Bellars ARM, 1969, BRIT ANTARCTIC SURVE, V21, P1; Berten J, 1895, DTSCH MONATSSCHRIFT, V13, P483; Berten J, 1895, DTSCH MONATSSCHRIFT, V13, P533; Berten J, 1895, DTSCH MONATSSCHRIFT, V13, P587; Berten J, 1895, DTSCH MONATSSCHRIFT, V13, P425; Bibikov DI, 1985, VOLK PROISKHOZHDENIE, P609; Binois A, 2013, INT J PALEOPATHOL, V3, P39, DOI 10.1016/j.ijpp.2013.02.001; BJORGE RR, 1985, J RANGE MANAGE, V38, P483, DOI 10.2307/3899736; Boas F, 1974, CENTRAL ESKIMO; Bogoras W, 1909, MEMOIRS AM MUSEUM NA, V11; Bohm J, 1989, Arctic Med Res, V48, P195; BUCHALCZYK T, 1981, ACTA THERIOL, V26, P23, DOI 10.4098/AT.arch.81-2; Chikachev AG, 2004, EZDOVOE SOBAKOVODSTV; Coppinger R., 2001, DOGS NEW UNDERSTANDI; Croft A, 1937, POLAR REC, V2, P68; Crossley DA, 1995, BSAVA MANUAL SMALL A; Deem SL, 2000, J ZOO WILDLIFE MED, V31, P441, DOI 10.1638/1042-7260(2000)031[0441:CDITCA]2.0.CO;2; Degerbol M, 1976, ZOOLOGY 1 MAMMALS, V2; Dolgov V. A., 1964, Acta Theriologica, V8, P237, DOI 10.4098/AT.arch.64-16; DUBIELZIG RR, 1981, VET PATHOL, V18, P684, DOI 10.1177/030098588101800513; DUBIELZIG RR, 1979, VET PATHOL, V16, P268, DOI 10.1177/030098587901600216; Duffy DL, 2008, APPL ANIM BEHAV SCI, V114, P441, DOI 10.1016/j.applanim.2008.04.006; ELTON CHARLES, 1931, CANADIAN JOUR RES, V5, P673; Fiorello CV, 2006, CONSERV BIOL, V20, P762, DOI 10.1111/j.1523-1739.2006.00466.x; Freeman MMR, 1969, FOLK, V11-12, P155; Gerth N, 2009, J EXP BIOL, V212, P1131, DOI 10.1242/jeb.028324; Hammond KA, 1997, NATURE, V386, P457, DOI 10.1038/386457a0; HILLSON S, 1996, DENT ANTHR; Hillson S., 2005, TEETH; Hinchcliff KW, 1997, AM J VET RES, V58, P1457; Ikeya Kazunobu, 1994, AFRICAN STUDY MONOGR, V15, P119; Jensen B., 1961, FOLK, V3, P43; Jochelson W, 1968, HIST ETHNOLOGY ANTHR; Koster JM, 2008, CURR ANTHROPOL, V49, P935, DOI 10.1086/592021; Koster JM, 2012, P NATL ACAD SCI USA, V109, pE463, DOI 10.1073/pnas.1112515109; Krizan J, 2006, 11 DEP ENV WILDL RES; Labutin IuV, 1972, ZOOLOGICHESKIE PROBL, P413; Lawler DF, 2013, INT J PALEOPATHOL, V3, P282, DOI 10.1016/j.ijpp.2013.06.001; Leonard JA, 2007, CURR BIOL, V17, P1146, DOI 10.1016/j.cub.2007.05.072; Losey RJ, 2011, J ANTHROPOL ARCHAEOL, V30, P174, DOI 10.1016/j.jaa.2011.01.001; Lupo Karen D., 2011, ETHNOZOOARCHAEOLOGY, P4; MacKinnon M., 2006, DOGS PEOPLE SOCIAL W, P38; MacKinnon M, 2010, WORLD ARCHAEOL, V42, P290, DOI 10.1080/00438241003673011; MacNulty DR, 2009, J ANIM ECOL, V78, P532, DOI 10.1111/j.1365-2656.2008.01517.x; MacRury IK, 1991, THESIS U CAMBRIDGE; MALIK R, 1995, AUST VET PRACT, V25, P62; Maxie MG, 2007, PATHOLOGY DOMESTIC A; Mech LD, 1999, CAN J ZOOL, V77, P1196, DOI 10.1139/cjz-77-8-1196; Mellanby M., 1929, DIET TEETH EXPT STUD, P308; Miles AEW, 1990, COLYERS VARIATIONS D; Montcombroux G, 1997, CANADIAN INUIT DOG C; Morehouse AT, 2011, FRONT ECOL ENVIRON, V9, P440, DOI 10.1890/100172; Morey D.F., 2010, DOGS DOMESTICATION D, DOI 10.1017/CBO9780511778360; Morey DF, 2002, ARCTIC, V55, P44; Nielson CA, 1977, WOLF NECROPSY REPORT; O'Keefe FR, 2013, J MAMMAL, V94, P1223, DOI 10.1644/13-MAMM-A-069; PARK RW, 1987, ARCTIC, V40, P184; Pavlovc Dubravka, 2007, Veterinarski Arhiv, V77, P291; Peary RE, 1898, PLOS ONE, V2; Peary RE, 1898, PLOS ONE, V1; Peterson Rolf O., 2003, P104; Raikkonen J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067218; Riewe RR, 1977, TRUELOVE LOWLAND DEV, P623; Samar AP, 2010, TRADITSIONNOE SOBAKO; Stephenson RO, 1973, WOLF REPORT 1971 197; Van Valkenburgh B, 2009, BIOL J LINN SOC, V96, P68, DOI 10.1111/j.1095-8312.2008.01108.x; VANVALKENBURGH B, 1988, AM NAT, V131, P291, DOI 10.1086/284790; VANVALKENBURGH B, 1993, SCIENCE, V261, P456, DOI 10.1126/science.261.5120.456; Verstraete FJM, 1999, SELF ASSESSMENT COLO; VILA C, 1993, CAN J ZOOL, V71, P968, DOI 10.1139/z93-127; Warren DM, 2000, DOGS TIME ARCHAEOLOG, P105; Weyer EM, 1932, ESKIMOS THEIR ENV FO; WOBESER G, 1992, J WILDLIFE DIS, V28, P268, DOI 10.7589/0090-3558-28.2.268; Zinoviev AV, 2012, INT J OSTEOARCHAEOL, V22, P145, DOI 10.1002/oa.1191	80	29	30	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99746	10.1371/journal.pone.0099746	http://dx.doi.org/10.1371/journal.pone.0099746			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941003	Green Submitted, Green Published, gold			2022-12-27	WOS:000338508200040
J	Weir, SM; Talent, LG; Anderson, TA; Salice, CJ				Weir, Scott M.; Talent, Larry G.; Anderson, Todd A.; Salice, Christopher J.			Unraveling the Relative Importance of Oral and Dermal Contaminant Exposure in Reptiles: Insights from Studies Using the Western Fence Lizard (Sceloporus occidentalis)	PLOS ONE			English	Article							NONDIETARY ROUTES; PHTHALATE-ESTERS; ECOLOGICAL RISK; SHED SKINS; EXCRETION; TOXICITY; PESTICIDE; CHEMICALS; RATS; DOGS	Despite widespread recognition of significant data deficiencies, reptiles remain a relatively understudied taxon in ecotoxicology. To conduct ecological risk assessments on reptiles frequently requires using surrogate taxa such as birds, but recent research suggests that reptiles have significantly different exposure profiles and toxicant sensitivity. We exposed western fence lizards, Sceloporus occidentalis, to the same quantities of three model chemicals via oral (gavage) and dermal (ventral skin application) exposure for either 24 or 48 hours. Three phthalate esters (di-methyl phthalate [DMP], di-iso-butyl phthalate [DIBP], and di-n-octyl phthalate [DNOP]) were chosen as model chemicals because they represent a gradient of lipophilicity but are otherwise structurally similar. Overall, the more lipophilic phthalates (DIBP and DNOP) were found to have higher concentrations in tissues than the less lipophilic DMP. Significant differences in tissue concentrations between DIBP and DNOP were tissue-dependent, suggesting that delivery to a site of action following exposure is not only a simple function of lipophilicity. In dermal treatments, DMP usually had fewer detections (except in ventral skin samples), suggesting that lipophilicity (log K-ow>2) is a requirement for uptake across the skin. In general, tissue residues were greater in oral treatments than dermal treatments (significant in adipose and liver tissue), but differences were driven strongly by differences in DMP which did not appear to be absorbed well across skin. When differences in tissue residue concentrations between oral and dermal exposure did occur, the difference was not drastic. Taken together these results suggest that dermal exposure should be considered in risk assessments for reptilian receptors. Dermal exposure may be an especially important route for reptiles as their ectothermic physiology translates to lower energetic demands and dietary exposure compared to birds and mammals.	[Weir, Scott M.; Anderson, Todd A.; Salice, Christopher J.] Texas Tech Univ, Inst Environm & Human Hlth, Dept Environm Toxicol, Lubbock, TX 79409 USA; [Talent, Larry G.] Oklahoma State Univ, Dept Nat Resource Ecol & Management, Stillwater, OK 74078 USA	Texas Tech University System; Texas Tech University; Oklahoma State University System; Oklahoma State University - Stillwater	Weir, SM (corresponding author), Univ Georgia, Savannah River Ecol Lab, Aiken, SC 29802 USA.	smweir@uga.edu	Anderson, Todd A/A-2296-2012	Anderson, Todd A/0000-0001-8176-6339	Helen Jones Foundation; Office of the Provost of Texas Tech University; Permian Basin Petroleum Association	Helen Jones Foundation; Office of the Provost of Texas Tech University; Permian Basin Petroleum Association	SMW was provided funding by the Helen Jones Foundation and the Office of the Provost of Texas Tech University. SMW was partially funded by the Permian Basin Petroleum Association during the period this work took place. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard A, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3290; Alexander GJ, 2002, J ARID ENVIRON, V50, P121, DOI 10.1006/jare.2001.0848; Brooks JE, 1998, WILDLIFE RES, V25, P427, DOI 10.1071/WR97035; Brooks Joe E., 1998, Snake, V28, P33; Campbell KR, 2002, ENVIRON TOXICOL CHEM, V21, P894, DOI 10.1897/1551-5028(2002)021<0894:ALSPFD>2.0.CO;2; CONNELL DW, 1988, ECOTOX ENVIRON SAFE, V16, P242, DOI 10.1016/0147-6513(88)90054-1; Cousins I, 2000, CHEMOSPHERE, V41, P1389, DOI 10.1016/S0045-6535(00)00005-9; DRIVER CJ, 1991, ENVIRON TOXICOL CHEM, V10, P21, DOI 10.1002/etc.5620100104; DuRant SE, 2007, ENVIRON POLLUT, V149, P18, DOI 10.1016/j.envpol.2006.12.025; Gibbons JW, 2000, BIOSCIENCE, V50, P653, DOI 10.1641/0006-3568(2000)050[0653:TGDORD]2.0.CO;2; HENDERSON JD, 1994, B ENVIRON CONTAM TOX, V52, P633, DOI 10.1007/BF00195480; Hopkins WA, 2000, ENVIRON TOXICOL CHEM, V19, P2391, DOI 10.1002/etc.5620191001; IKEDA GJ, 1978, FOOD COSMET TOXICOL, V16, P409, DOI 10.1016/S0015-6264(78)80257-0; IKEDA GJ, 1980, FOOD COSMET TOXICOL, V18, P637, DOI 10.1016/S0015-6264(80)80012-5; Jones DE, 2006, ECOTOX ENVIRON SAFE, V64, P221, DOI 10.1016/j.ecoenv.2005.03.018; Jones DE, 2009, ECOTOX ENVIRON SAFE, V72, P2033, DOI 10.1016/j.ecoenv.2008.11.001; Jones DE, 2005, ECOTOX ENVIRON SAFE, V60, P282, DOI 10.1016/j.ecoenv.2004.06.005; McFarland CA, 2011, ENVIRON POLLUT, V159, P466, DOI 10.1016/j.envpol.2010.10.018; MCKIM J, 1985, TOXICOL APPL PHARM, V77, P1, DOI 10.1016/0041-008X(85)90262-5; Mineau Pierre, 2011, Integrated Environmental Assessment and Management, V7, P297, DOI 10.1002/ieam.174; R Development Core Team, 2012, R LANG ENV STAT COMP; Salice Christopher J., 2011, Integrated Environmental Assessment and Management, V7, P687, DOI 10.1002/ieam.266; Salice CJ, 2009, ENVIRON POLLUT, V157, P3457, DOI 10.1016/j.envpol.2009.06.013; Smith PN, 2007, ENVIRON POLLUT, V150, P41, DOI 10.1016/j.envpol.2007.06.009; Sparling DW, 2010, ECOTOXICOLOGY OF AMPHIBIANS AND REPTILES, SECOND EDITION, P1, DOI 10.1201/EBK1420064162-c1; Suski JG, 2008, ENVIRON TOXICOL CHEM, V27, P352, DOI 10.1897/07-149R.1; Talent LG, 2005, ENVIRON TOXICOL CHEM, V24, P3113, DOI 10.1897/05-053R.1; Talent LG, 2002, ENVIRON TOXICOL CHEM, V21, P899, DOI 10.1897/1551-5028(2002)021<0899:EOWFLS>2.0.CO;2; *USEPA, 2004, OV EC RISK ASS PROC; Vyas NB, 2007, ENVIRON MONIT ASSESS, V133, P209, DOI 10.1007/s10661-006-9573-2; Walker JD, 2003, ENVIRON TOXICOL CHEM, V22, P1870, DOI 10.1897/01-454; Weir SM, 2010, ENVIRON POLLUT, V158, P3596, DOI 10.1016/j.envpol.2010.08.011	32	21	23	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99666	10.1371/journal.pone.0099666	http://dx.doi.org/10.1371/journal.pone.0099666			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941063	Green Submitted, gold, Green Published			2022-12-27	WOS:000338508200034
J	Fuchs, MA; Sato, K; Niedzwiecki, D; Ye, X; Saltz, LB; Mayer, RJ; Mowat, RB; Whittom, R; Hantel, A; Benson, A; Atienza, D; Messino, M; Kindler, H; Venook, A; Ogino, S; Wu, KN; Willett, WC; Giovannucci, EL; Meyerhardt, JA				Fuchs, Michael A.; Sato, Kaori; Niedzwiecki, Donna; Ye, Xing; Saltz, Leonard B.; Mayer, Robert J.; Mowat, Rex B.; Whittom, Renaud; Hantel, Alexander; Benson, Al; Atienza, Daniel; Messino, Michael; Kindler, Hedy; Venook, Alan; Ogino, Shuji; Wu, Kana; Willett, Walter C.; Giovannucci, Edward L.; Meyerhardt, Jeffrey A.			Sugar-Sweetened Beverage Intake and Cancer Recurrence and Survival in CALGB 89803 (Alliance)	PLOS ONE			English	Article							III COLON-CANCER; FOOD FREQUENCY QUESTIONNAIRE; DIETARY GLYCEMIC LOAD; GROWTH-FACTOR-I; COLORECTAL-CANCER; BODY-WEIGHT; EPIDEMIOLOGIC EVIDENCE; PHYSICAL-ACTIVITY; CELL-LINE; C-PEPTIDE	Background: In colon cancer patients, obesity, sedentary lifestyle, and high dietary glycemic load have been associated with increased risk of cancer recurrence. High sugar-sweetened beverage intake has been associated with obesity, diabetes, and cardio-metabolic diseases, but the influence on colon cancer survival is unknown. Methods: We assessed the association between sugar-sweetened beverage consumption on cancer recurrence and mortality in 1,011 stage III colon cancer patients who completed food frequency questionnaires as part of a U.S. National Cancer Institute-sponsored adjuvant chemotherapy trial. Hazard ratios (HRs) and 95% confidence intervals (CIs) were calculated with Cox proportional hazard models. Results: Patients consuming >= 2 servings of sugar-sweetened beverages per day experienced an adjusted HR for disease recurrence or mortality of 1.67 (95% CI, 1.04-2.68), compared with those consuming <2 servings per month (P-trend = 0.02). The association of sugar-sweetened beverages on cancer recurrence or mortality appeared greater among patients who were both overweight (body mass index >= 25 kg/m(2)) and less physically active (metabolic equivalent task-hours per week < 18) (HR = 2.22; 95% CI, 1.29-3.81, P-trend = 0.0025). Conclusion: Higher sugar-sweetened beverage intake was associated with a significantly increased risk of cancer recurrence and mortality in stage III colon cancer patients.	[Fuchs, Michael A.] Brown Univ, Providence, RI 02912 USA; [Sato, Kaori; Mayer, Robert J.; Ogino, Shuji; Meyerhardt, Jeffrey A.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Niedzwiecki, Donna; Ye, Xing] Duke Univ, Med Ctr, Alliance Stat & Data Ctr, Durham, NC USA; [Saltz, Leonard B.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Mowat, Rex B.] Toledo Community Hosp, Oncol Program, Toledo, OH USA; [Whittom, Renaud] Hop Sacre Coeur, Montreal, PQ H4J 1C5, Canada; [Hantel, Alexander] Loyola Univ, Stritch Sch Med, Naperville, IL USA; [Benson, Al] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Atienza, Daniel] Virginia Oncol Associates, Norfolk, VA USA; [Messino, Michael] Mission Hosp Inc, Southeast Canc Control Consortium, Asheville, NC USA; [Kindler, Hedy] Univ Chicago, Chicago, IL 60637 USA; [Venook, Alan] Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94143 USA; [Ogino, Shuji] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Wu, Kana; Willett, Walter C.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Willett, Walter C.; Giovannucci, Edward L.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Giovannucci, Edward L.] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [Giovannucci, Edward L.] Harvard Univ, Sch Med, Boston, MA USA	Brown University; Harvard University; Dana-Farber Cancer Institute; Duke University; Memorial Sloan Kettering Cancer Center; Universite de Montreal; Loyola University Chicago; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; University of Chicago; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Meyerhardt, JA (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.	jmeyerhardt@partners.org		Niedzwiecki, Donna/0000-0002-3566-0450; Ogino, Shuji/0000-0002-3909-2323; Saltz, Leonard/0000-0001-8353-4670	National Cancer Institute [CA31946, R01 CA118553, R01 CA149222, R01 CA169141, P50 CA127003, CA33601]; Pfizer Oncology; NATIONAL CANCER INSTITUTE [R01CA118553, R01CA169141, U10CA180888, P50CA127003, U10CA031946, R01CA149222, U10CA033601] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Pfizer Oncology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	CALGB 89803 was supported, in part, by grants from the National Cancer Institute (CA31946) to the Alliance for Clinical Trials in Oncology (Monica Bertagnolli, M. D., Chairman) and to the Alliance Statistical Center (Daniel Sargent, PhD, CA33601 as well as support from Pharmacia & Upjohn Company, now Pfizer Oncology. Dr. Meyerhardt is supported in part by grants from the National Cancer Institute (R01 CA118553, R01 CA149222, R01 CA169141, and P50 CA127003). The sponsors did not participate in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Andreyeva T, 2011, PREV MED, V52, P413, DOI 10.1016/j.ypmed.2011.03.013; BJORK J, 1993, SCAND J GASTROENTERO, V28, P879, DOI 10.3109/00365529309103129; Chan AT, 2010, GASTROENTEROLOGY, V138, P2029, DOI 10.1053/j.gastro.2010.01.057; Choi Hyon K., 2010, JAMA (Journal of the American Medical Association), V304, P2270, DOI 10.1001/jama.2010.1638; COX DR, 1972, J R STAT SOC B, V34, P187; de Ruyter JC, 2012, CONTEMP CLIN TRIALS, V33, P247, DOI 10.1016/j.cct.2011.10.007; Demark-Wahnefried W, 2012, CANC EPIDEMIOL BIOMA, V21, P1244; DiMeglio DP, 2000, INT J OBESITY, V24, P794, DOI 10.1038/sj.ijo.0801229; Ebbeling CB, 2012, NEW ENGL J MED, V367, P1407, DOI 10.1056/NEJMoa1203388; Giovannucci E, 2003, J WOMEN HEALTH GEN-B, V12, P173, DOI 10.1089/154099903321576574; Giovannucci E, 2001, J NUTR, V131, p3109S, DOI 10.1093/jn/131.11.3109S; Hu FB, 2010, PHYSIOL BEHAV, V100, P47, DOI 10.1016/j.physbeh.2010.01.036; Kaaks R, 2000, JNCI-J NATL CANCER I, V92, P1592, DOI 10.1093/jnci/92.19.1592; KOENUMA M, 1989, JPN J CANCER RES, V80, P51, DOI 10.1111/j.1349-7006.1989.tb02244.x; Malik VS, 2006, AM J CLIN NUTR, V84, P274; Malik VS, 2011, AM J CLIN NUTR, V94, P1161, DOI 10.3945/ajcn.111.025676; Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079; Mattes Richard D., 1996, Physiology and Behavior, V59, P179, DOI 10.1016/0031-9384(95)02007-1; Meyerhardt JA, 2005, J CLIN ONCOL, V23, P8453, DOI 10.1200/JCO.2005.02.5460; Meyerhardt J, 2007, JAMA-J AM MED ASSOC, V298, P2263, DOI 10.1001/jama.298.19.2263-b; Meyerhardt JA, 2008, J CLIN ONCOL, V26, P4109, DOI 10.1200/JCO.2007.15.6687; Meyerhardt JA, 2007, JAMA-J AM MED ASSOC, V298, P754, DOI 10.1001/jama.298.7.754; Meyerhardt JA, 2006, J CLIN ONCOL, V24, P3535, DOI 10.1200/JCO.2006.06.0863; Meyerhardt JA, 2012, JNCI-J NATL CANCER I, V104, P1702, DOI 10.1093/jnci/djs399; Michaud DS, 2005, CANCER EPIDEM BIOMAR, V14, P138, DOI 10.1158/1055-9965.EPI-05-0428; Moghaddam AA, 2007, CANCER EPIDEM BIOMAR, V16, P2533, DOI 10.1158/1055-9965.EPI-07-0708; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; POLLAK MN, 1987, CANCER LETT, V38, P223, DOI 10.1016/0304-3835(87)90218-7; Qi QB, 2012, NEW ENGL J MED, V367, P1387, DOI 10.1056/NEJMoa1203039; Saltz LB, 2007, J CLIN ONCOL, V25, P3456, DOI 10.1200/JCO.2007.11.2144; SALVINI S, 1989, INT J EPIDEMIOL, V18, P858, DOI 10.1093/ije/18.4.858; Samad AKA, 2005, COLORECTAL DIS, V7, P204, DOI 10.1111/j.1463-1318.2005.00747.x; Schoen RE, 1999, JNCI-J NATL CANCER I, V91, P1147, DOI 10.1093/jnci/91.13.1147; Schulze MB, 2004, JAMA-J AM MED ASSOC, V292, P927, DOI 10.1001/jama.292.8.927; Singh GM, 2013, EPIDEMIOLOGY PREVENT, pMP22; Stanhope KL, 2009, J CLIN INVEST, V119, P1322, DOI 10.1172/JCI37385; Theodoratou E, 2013, EUR J CANC PREV; UDo Agriculture, 1989, AGR HDB, V8; Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782; WATKINS LF, 1990, INT J CANCER, V45, P372, DOI 10.1002/ijc.2910450227; Wei EK, 2005, CANCER EPIDEM BIOMAR, V14, P850, DOI 10.1158/1055-9965.EPI-04-0661; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366; WILLETT WC, 1987, J AM DIET ASSOC, V87, P43; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; Wolpin BM, 2009, J CLIN ONCOL, V27, P176, DOI 10.1200/JCO.2008.17.9945; Zhang XH, 2010, JNCI-J NATL CANCER I, V102, P771, DOI 10.1093/jnci/djq107; Zubrod C.G., 1960, J CHRON DIS, V11, P7	48	52	52	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99816	10.1371/journal.pone.0099816	http://dx.doi.org/10.1371/journal.pone.0099816			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937507	Green Published, gold, Green Submitted			2022-12-27	WOS:000338503400040
J	Guerrero-Bosagna, C; Weeks, S; Skinner, MK				Guerrero-Bosagna, Carlos; Weeks, Shelby; Skinner, Michael K.			Identification of Genomic Features in Environmentally Induced Epigenetic Transgenerational Inherited Sperm Epimutations	PLOS ONE			English	Article							CTCF-BINDING SITES; DNA METHYLATION; REGULATORY REGIONS; QUADRUPLEX MOTIFS; PATERNAL LINEAGE; MOUSE; VINCLOZOLIN; DISEASE; EXPOSURE; GENE	A variety of environmental toxicants have been shown to induce the epigenetic transgenerational inheritance of disease and phenotypic variation. The process involves exposure of a gestating female and the developing fetus to environmental factors that promote permanent alterations in the epigenetic programming of the germline. The molecular aspects of the phenomenon involve epigenetic modifications (epimutations) in the germline (e. g. sperm) that are transmitted to subsequent generations. The current study integrates previously described experimental epigenomic transgenerational data and web-based bioinformatic analyses to identify genomic features associated with these transgenerationally transmitted epimutations. A previously identified genomic feature associated with these epimutations is a low CpG density (<12/100bp). The current observations suggest the transgenerational differential DNA methylation regions (DMR) in sperm contain unique consensus DNA sequence motifs, zinc finger motifs and G-quadruplex sequences. Interaction of molecular factors with these sequences could alter chromatin structure and accessibility of proteins with DNA methyltransferases to alter de novo DNA methylation patterns. G-quadruplex regions can promote the opening of the chromatin that may influence the action of DNA methyltransferases, or factors interacting with them, for the establishment of epigenetic marks. Zinc finger binding factors can also promote this chromatin remodeling and influence the expression of non-coding RNA. The current study identified genomic features associated with sperm epimutations that may explain in part how these sites become susceptible for transgenerational programming.	[Guerrero-Bosagna, Carlos; Weeks, Shelby; Skinner, Michael K.] Washington State Univ, Sch Biol Sci, Ctr Reprod Biol, Pullman, WA 99164 USA; [Guerrero-Bosagna, Carlos] Linkoping Univ, Dept Phys Biol & Chem, Linkoping, Sweden	Washington State University; Linkoping University	Skinner, MK (corresponding author), Washington State Univ, Sch Biol Sci, Ctr Reprod Biol, Pullman, WA 99164 USA.	skinner@wsu.edu	Guerrero-Bosagna, Carlos/W-7319-2019	Guerrero-Bosagna, Carlos/0000-0003-1935-5875	NIH NIEHS; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012974] Funding Source: NIH RePORTER	NIH NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The study was supported by an NIH NIEHS grant to MKS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alabert C, 2012, NAT REV MOL CELL BIO, V13, P153, DOI 10.1038/nrm3288; Allegrucci C, 2005, REPRODUCTION, V129, P137, DOI 10.1530/rep.1.00360; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Arico JK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001391; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Brander SM, 2012, ENVIRON TOXICOL CHEM, V31, P2848, DOI 10.1002/etc.2019; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Cowin PA, 2010, ENDOCRINOLOGY, V151, P783, DOI 10.1210/en.2009-0982; Das MK, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S7-S21; Datta J, 2008, CANCER RES, V68, P5049, DOI 10.1158/0008-5472.CAN-07-6655; Dunn GA, 2011, ENDOCRINOLOGY, V152, P2228, DOI 10.1210/en.2010-1461; Durcova-Hills G, 2006, P NATL ACAD SCI USA, V103, P11184, DOI 10.1073/pnas.0602621103; Elnitski L, 2006, GENOME RES, V16, P1455, DOI 10.1101/gr.4140006; Feltus FA, 2006, GENOMICS, V87, P572, DOI 10.1016/j.ygeno.2005.12.016; Filippova GN, 2001, NAT GENET, V28, P335, DOI 10.1038/ng570; Frith MC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000071; Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Guerrero-Bosagna C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059922; Guerrero-Bosagna C, 2012, REPROD TOXICOL, V34, P694, DOI 10.1016/j.reprotox.2012.09.005; Guerrero-Bosagna C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013100; Hackett JA, 2012, TRENDS GENET, V28, P164, DOI 10.1016/j.tig.2012.01.005; Halder R, 2010, MOL BIOSYST, V6, P2439, DOI 10.1039/c0mb00009d; Ichiyanagi K, 2011, GENOME RES, V21, P2058, DOI 10.1101/gr.123679.111; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Klose RJ, 2005, MOL CELL, V19, P667, DOI 10.1016/j.molcel.2005.07.021; Kumar P, 2011, NUCLEIC ACIDS RES, V39, P8005, DOI 10.1093/nar/gkr536; Lees-Murdock DJ, 2008, EPIGENETICS-US, V3, P5, DOI 10.4161/epi.3.1.5553; Mahony S, 2007, NUCLEIC ACIDS RES, V35, pW253, DOI 10.1093/nar/gkm272; Manikkam M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055387; Manikkam M, 2012, REPROD TOXICOL, V34, P708, DOI 10.1016/j.reprotox.2012.08.010; Manikkam M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046249; Manikkam M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031901; Molaro A, 2011, CELL, V146, P1028, DOI 10.1016/j.cell.2011.08.016; Morgan CP, 2011, J NEUROSCI, V31, P11748, DOI 10.1523/JNEUROSCI.1887-11.2011; Nardone J, 2004, NAT IMMUNOL, V5, P768, DOI 10.1038/ni0804-768; Nilsson E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036129; Paeschke K, 2013, NATURE, V497, P458, DOI 10.1038/nature12149; Pitteloud N, 2008, J CLIN ENDOCR METAB, V93, P784, DOI 10.1210/jc.2007-2156; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Reutman SR, 2002, ENVIRON HEALTH PERSP, V110, P805, DOI 10.1289/ehp.02110805; ROBISON AK, 1985, J TOXICOL ENV HEALTH, V16, P493, DOI 10.1080/15287398509530758; Sarkies P, 2010, MOL CELL, V40, P703, DOI 10.1016/j.molcel.2010.11.009; Sasai N, 2010, NUCLEIC ACIDS RES, V38, P5015, DOI 10.1093/nar/gkq280; Saze H, 2012, GENES GENET SYST, V87, P145, DOI 10.1266/ggs.87.145; Singh S, 2012, GENE, V494, P85, DOI 10.1016/j.gene.2011.11.035; Skinner MK, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-228; Skinner MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066318; Skinner MK, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R91, 10.1186/gb-2012-13-10-r91]; Skinner MK, 2010, TRENDS ENDOCRIN MET, V21, P214, DOI 10.1016/j.tem.2009.12.007; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Stormo GD, 2000, BIOINFORMATICS, V16, P16, DOI 10.1093/bioinformatics/16.1.16; Tamaru H, 2003, MOL CELL BIOL, V23, P2379, DOI 10.1128/MCB.23.7.2379-2394.2003; Tanaka J, 2007, MOL CELL ENDOCRINOL, V272, P38, DOI 10.1016/j.mce.2007.04.008; Tracey R, 2013, REPROD TOXICOL, V36, P104, DOI 10.1016/j.reprotox.2012.11.011; Uzumcu M, 2004, REPROD TOXICOL, V18, P765, DOI 10.1016/j.reprotox.2004.05.008; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Webster KE, 2005, P NATL ACAD SCI USA, V102, P4068, DOI 10.1073/pnas.0500702102; Wen B, 2008, GENOME RES, V18, P1806, DOI 10.1101/gr.067587.108; Wienholz BL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001106; WONG CI, 1995, J BIOL CHEM, V270, P19998, DOI 10.1074/jbc.270.34.19998	64	36	36	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100194	10.1371/journal.pone.0100194	http://dx.doi.org/10.1371/journal.pone.0100194			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937757	Green Published, gold			2022-12-27	WOS:000338503400089
J	Luttikholt, S; Veldhuis, A; van den Brom, R; Moll, L; Lievaart-Peterson, K; Peperkamp, K; van Schaik, G; Vellema, P				Luttikholt, Saskia; Veldhuis, Anouk; van den Brom, Rene; Moll, Lammert; Lievaart-Peterson, Karianne; Peperkamp, Klaas; van Schaik, Gerdien; Vellema, Piet			Risk Factors for Malformations and Impact on Reproductive Performance and Mortality Rates of Schmallenberg Virus in Sheep Flocks in the Netherlands	PLOS ONE			English	Article							AKABANE VIRUS; CONGENITAL-ABNORMALITIES; BLUETONGUE VIRUS; NEWBORN LAMBS; INFECTION; SEROPREVALENCE; ANTIBODIES; CATTLE	In Northwestern Europe, an epizootic outbreak of congenital malformations in newborn lambs due to infection with Schmallenberg virus (SBV) started at the end of 2011. The objectives of this study were to describe clinical symptoms of SBV infection, the effect of infection on mortality rates, and reproductive performance in sheep, as well as to identify and quantify flock level risk factors for SBV infections resulting in malformations in newborn lambs. A case-control study design was used, with 93 case flocks that had notified malformed lambs and 84 control flocks with no such lambs. Overall animal seroprevalence in case flocks was estimated at 82.0% (95% CI: 74.3-87.8), and was not significantly different from the prevalence in control flocks being 76.4% (95% CI: 67.2-83.6). The percentages of stillborn lambs or lambs that died before weaning, repeat breeders, and lambs with abnormal suckling behaviour were significantly higher in case flocks compared to control flocks. However, effect of SBV infection on mortality rates and reproductive performance seemed to be limited. Multivariable analysis showed that sheep flocks with an early start of the mating season, i.e. before August 2011 (OR = 33.1; 95% CI: 10.0-109.8) and in August 2011 (OR = 8.2; 95% CI: 2.7-24.6) had increased odds of malformations in newborn lambs caused by SBV compared to sheep flocks with a start of the mating season in October 2011. Other flock-level risk factors for malformations in newborn lambs were purchase of silage (OR 5.0; 95% CI: 1.7-15.0) and flocks with one or more dogs (OR = 3.3; 95% CI: 1.3-8.3). Delaying mating until October could be a potential preventive measure for naive animals to reduce SBV induced losses. As duration of immunity after infection with SBV is expected to last for several years, future SBV induced congenital malformations are mainly expected in offspring of early mated seronegative animals.	[Luttikholt, Saskia; van den Brom, Rene; Moll, Lammert; Lievaart-Peterson, Karianne; Vellema, Piet] GD Anim Hlth, Dept Small Ruminant Hlth, Deventer, Netherlands; [Veldhuis, Anouk; van Schaik, Gerdien] GD Anim Hlth, Dept Epidemiol, Deventer, Netherlands; [Peperkamp, Klaas] GD Anim Hlth, Dept Pathol, Deventer, Netherlands		Luttikholt, S (corresponding author), GD Anim Hlth, Dept Small Ruminant Hlth, Deventer, Netherlands.	s.luttikholt@gddiergezondheid.nl	van Schaik, Gerdien/AAD-7771-2020; Lievaart-Peterson, Karianne/AAD-9383-2019	Lievaart-Peterson, Karianne/0000-0001-9517-6866; van Schaik, Gerdien/0000-0002-0460-2629	Dutch Ministry of Economic Affairs; European Commission (DG SANCO)	Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); European Commission (DG SANCO)(European CommissionEuropean Commission Joint Research Centre)	This study was financially supported by the Dutch Ministry of Economic Affairs and the European Commission (DG SANCO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER KA, 1994, AM J TROP MED HYG, V51, P568, DOI 10.4269/ajtmh.1994.51.568; De Regge N, 2013, VET MICROBIOL, V162, P595, DOI 10.1016/j.vetmic.2012.11.029; Dennis S. M., 1979, Veterinary Bulletin, V49, P233; Elbers ARW, 2013, EMERG INFECT DIS, V19, P106, DOI 10.3201/eid1901.121054; Gache K, 2013, VET REC, V173, P141, DOI 10.1136/vr.101377; HASHIGUCHI Y, 1979, NATL I ANIM HEALTH Q, V19, P1; Hoffmann B, 2012, EMERG INFECT DIS, V18, P469, DOI 10.3201/eid1803.111905; LUEDKE A J, 1985, P71; Martinelle L, 2012, FIELD VET SURVEY CLI; Meroc E, 2013, DISTRIBUTION SCHMALL; Muskens J, 2012, TIJDSCHR DIERGENEESK, V137, P112; NARITA M, 1979, J COMP PATHOL, V89, P229, DOI 10.1016/0021-9975(79)90062-8; OSBURN BI, 1994, COMP IMMUNOL MICROB, V17, P189, DOI 10.1016/0147-9571(94)90042-6; PARSONSON IM, 1977, INFECT IMMUN, V15, P254, DOI 10.1128/IAI.15.1.254-262.1977; ProMed-Mail, 2011, PRO AH EDR SCHM VIR; ROGAN WJ, 1978, AM J EPIDEMIOL, V107, P71, DOI 10.1093/oxfordjournals.aje.a112510; Saegerman C, 2013, PRELIMINARY SURVEY I; Sailleau C, 2013, EMERGING INFECT DIS, V19; SHUPE JL, 1983, VET HUM TOXICOL, V25, P415; van den Brom R, 2012, TIJDSCHR DIERGENEESK, V137, P106; van der Heijden HM, 2013, RES VET SCI; van Maanen C, 2012, VET REC, V171, P299, DOI 10.1136/vr.101061; Veldhuis AMB, 2013, PREV VET MED, V112, P35, DOI 10.1016/j.prevetmed.2013.06.010; Wensman JJ, 2013, J CLIN MICROBIOL, V51, P2802, DOI 10.1128/JCM.00877-13; Wernike K, 2013, VET MICROBIOL, V166, P461, DOI 10.1016/j.vetmic.2013.06.030; WinEpiscope2.0, 2000, STAT SOFTW COMP AID	26	18	20	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100135	10.1371/journal.pone.0100135	http://dx.doi.org/10.1371/journal.pone.0100135			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937443	Green Published, gold, Green Submitted			2022-12-27	WOS:000338503400080
J	Chiang, N; Hsiao, YT; Yang, HJ; Lin, YC; Lu, JC; Wang, CT				Chiang, Ning; Hsiao, Yu-Tien; Yang, Hui-Ju; Lin, Yu-Chun; Lu, Juu-Chin; Wang, Chih-Tien			Phosphomimetic Mutation of Cysteine String Protein-alpha Increases the Rate of Regulated Exocytosis by Modulating Fusion Pore Dynamics in PC12 Cells	PLOS ONE			English	Article							ADRENAL CHROMAFFIN CELLS; DENSE-CORE VESICLES; KISS-AND-RUN; CSP-ALPHA; CA2+-TRIGGERED EXOCYTOSIS; TRANSMITTER RELEASE; SYNAPTOTAGMIN-I; KINASE-A; SYNAPTIC VESICLES; SNARE-COMPLEX	Background: Cysteine string protein-alpha (CSP alpha) is a chaperone to ensure protein folding. Loss of CSP alpha function associates with many neurological diseases. However, its function in modulating regulated exocytosis remains elusive. Although csp alpha-knockouts exhibit impaired synaptic transmission, overexpression of CSP alpha in neuroendocrine cells inhibits secretion. These seemingly conflicting results lead to a hypothesis that CSP alpha may undergo a modification that switches its function in regulating neurotransmitter and hormone secretion. Previous studies implied that CSP alpha undergoes phosphorylation at Ser(10) that may influence exocytosis by altering fusion pore dynamics. However, direct evidence is missing up to date. Methodology/Principal Findings: Using amperometry, we investigated how phosphorylation at Ser(10) of CSP alpha (CSP alpha-Ser(10)) modulates regulated exocytosis and if this modulation involves regulating a specific kinetic step of fusion pore dynamics. The real-time exocytosis of single vesicles was detected in PC12 cells overexpressing control vector, wild-type CSP alpha (WT), the CSP alpha phosphodeficient mutant (S10A), or the CSP alpha phosphomimetic mutants (S10D and S10E). The shapes of amperometric signals were used to distinguish the full-fusion events (i.e., prespike feet followed by spikes) and the kiss-and-run events (i.e., square-shaped flickers). We found that the secretion rate was significantly increased in cells overexpressing S10D or S10E compared to WT or S10A. Further analysis showed that overexpression of S10D or S10E prolonged fusion pore lifetime compared to WT or S10A. The fraction of kiss-alpha nd-run events was significantly lower but the frequency of full-fusion events was higher in cells overexpressing S10D or S10E compared to WT or S10A. Advanced kinetic analysis suggests that overexpression of S10D or S10E may stabilize open fusion pores mainly by inhibiting them from closing. Conclusions/Significance: CSP alpha may modulate fusion pore dynamics in a phosphorylation-dependent manner. Therefore, through changing its phosphorylated state influenced by diverse cellular signalings, CSP alpha may have a great capacity to modulate the rate of regulated exocytosis.	[Chiang, Ning; Hsiao, Yu-Tien; Yang, Hui-Ju; Wang, Chih-Tien] Natl Taiwan Univ, Inst Mol & Cellular Biol, Taipei 10764, Taiwan; [Chiang, Ning; Wang, Chih-Tien] Natl Taiwan Univ, Dept Life Sci, Taipei 10764, Taiwan; [Chiang, Ning; Wang, Chih-Tien] Natl Taiwan Univ, Neurobiol & Cognit Sci Ctr, Taipei 10764, Taiwan; [Wang, Chih-Tien] Natl Taiwan Univ, Genome & Syst Biol Degree Program, Taipei 10764, Taiwan; [Lin, Yu-Chun; Lu, Juu-Chin] Chang Gung Univ, Dept Physiol & Pharmacol, Coll Med, Taoyuan, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; Chang Gung University	Lu, JC (corresponding author), Chang Gung Univ, Dept Physiol & Pharmacol, Coll Med, Taoyuan, Taiwan.	juuchin@mail.cgu.edu.tw; chihtienwang@ntu.edu.tw	Lu, Juu-Chin/ABB-3198-2020; Wang, Chih-Tien/GRE-8232-2022	Lu, Juu-Chin/0000-0001-8523-6992; Wang, Chih-Tien/0000-0001-7639-7508	Chang Gung Medical Research Project [CMRPD1C0591]; National Science Council [NSC-101-2320-B-182-007, NSC-102-2320-B-182-022-MY3, NSC-97-2311-B-002-001-MY2, NSC-100-2321-B-002-001, NSC-100-2311-B-002-010]; National Taiwan University; National Health Research Institutes [NHRI-EX100-9718NC]	Chang Gung Medical Research Project; National Science Council(Ministry of Science and Technology, Taiwan); National Taiwan University(National Taiwan University); National Health Research Institutes(National Health Research Institutes, Japan)	Funding was provided by Chang Gung Medical Research Project (CMRPD1C0591) and National Science Council (NSC-101-2320-B-182-007; NSC-102-2320-B-182-022-MY3) to JCL; National Taiwan University, National Science Council (NSC-97-2311-B-002-001-MY2; NSC-100-2321-B-002-001; NSC-100-2311-B-002-010) and National Health Research Institutes (NHRI-EX100-9718NC) to CTW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albillos A, 1997, NATURE, V389, P509, DOI 10.1038/39081; Ales E, 1999, NAT CELL BIOL, V1, P40, DOI 10.1038/9012; Alvarez de Toledo G, 1993, NATURE, V363, P554; Bai JH, 2004, NEURON, V41, P929, DOI 10.1016/S0896-6273(04)00117-5; Boal F, 2011, FASEB J, V25, P132, DOI 10.1096/fj.09-152033; Brown H, 1998, EMBO J, V17, P5048, DOI 10.1093/emboj/17.17.5048; BRUNS D, 1995, NATURE, V377, P62, DOI 10.1038/377062a0; Chamberlain LH, 1998, MOL BIOL CELL, V9, P2259, DOI 10.1091/mbc.9.8.2259; Chamberlain LH, 1996, J BIOL CHEM, V271, P19514, DOI 10.1074/jbc.271.32.19514; Chamberlain LH, 2000, J NEUROCHEM, V74, P1781, DOI 10.1046/j.1471-4159.2000.0741781.x; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Chapman ER, 2008, ANNU REV BIOCHEM, V77, P615, DOI 10.1146/annurev.biochem.77.062005.101135; Chiang CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047465; CHOW RH, 1992, NATURE, V356, P60, DOI 10.1038/356060a0; Chow Robert H., 1995, P245; Colliver TL, 2000, J NEUROCHEM, V74, P1086; COLQUHOUN D, 1982, PHILOS T ROY SOC B, V300, P1, DOI 10.1098/rstb.1982.0156; Colquhoun David, 1995, P397; Cormack B, 1994, CURRENT PROTOCOLS MO; Dernick G, 2003, NAT CELL BIOL, V5, P358, DOI 10.1038/ncb956; Dunn TA, 2008, DEV NEUROBIOL, V68, P835, DOI 10.1002/dneu.20619; Dunn TA, 2006, J NEUROSCI, V26, P12807, DOI 10.1523/JNEUROSCI.3238-06.2006; Evans GJO, 2005, EUR J NEUROSCI, V21, P2671, DOI 10.1111/j.1460-9568.2005.04118.x; Evans GJO, 2006, J BIOL CHEM, V281, P1564, DOI 10.1074/jbc.M503628200; Evans GJO, 2002, BIOCHEM J, V364, P343, DOI 10.1042/BJ20020123; Evans GJO, 2001, J BIOL CHEM, V276, P47877, DOI 10.1074/jbc.M108186200; Fernandez-Chacon R, 2004, NEURON, V42, P237, DOI 10.1016/S0896-6273(04)00190-4; Fulop T, 2007, J NEUROSCI METH, V166, P195, DOI 10.1016/j.jneumeth.2007.07.004; Graham ME, 2000, J NEUROSCI, V20, P1281; Haller M, 1998, BIOPHYSICAL J, V74; Han X, 2004, SCIENCE, V304, P289, DOI 10.1126/science.1095801; Han X, 2006, J CELL BIOL, V172, P281, DOI 10.1083/jcb.200510012; HAY JC, 1992, J CELL BIOL, V119, P139, DOI 10.1083/jcb.119.1.139; Hui EF, 2009, CELL, V138, P709, DOI 10.1016/j.cell.2009.05.049; JACKSON MB, 1992, METHOD ENZYMOL, V207, P729; Jackson MB, 2008, NAT STRUCT MOL BIOL, V15, P684, DOI 10.1038/nsmb.1449; Kochubey O, 2011, TRENDS NEUROSCI, V34, P237, DOI 10.1016/j.tins.2011.02.006; Kunkel MT, 2005, J BIOL CHEM, V280, P5581, DOI 10.1074/jbc.M411534200; Lynch KL, 2008, MOL BIOL CELL, V19, P5093, DOI 10.1091/mbc.E08-03-0235; MASTROGIACOMO A, 1994, SCIENCE, V263, P981, DOI 10.1126/science.7906056; Pang ZPP, 2010, CURR OPIN CELL BIOL, V22, P496, DOI 10.1016/j.ceb.2010.05.001; Prescott GR, 2008, BIOCHEM BIOPH RES CO, V377, P809, DOI 10.1016/j.bbrc.2008.10.069; Schmitz F, 2006, P NATL ACAD SCI USA, V103, P2926, DOI 10.1073/pnas.0510060103; Segovia M, 2010, P NATL ACAD SCI USA, V107, P19032, DOI 10.1073/pnas.1014070107; Sharma M, 2012, EMBO J, V31, P829, DOI 10.1038/emboj.2011.467; Sharma M, 2011, NAT CELL BIOL, V13, P30, DOI 10.1038/ncb2131; Sorensen JB, 2003, J GEN PHYSIOL, V122, P265, DOI 10.1085/jgp.200308855; UMBACH JA, 1994, NEURON, V13, P899, DOI 10.1016/0896-6273(94)90255-0; Wang CT, 2006, J PHYSIOL-LONDON, V570, P295, DOI 10.1113/jphysiol.2005.097378; Wang CT, 2003, NATURE, V424, P943, DOI 10.1038/nature01857; Wang CT, 2001, SCIENCE, V294, P1111, DOI 10.1126/science.1064002; Wang P, 2003, J BIOL CHEM, V278, P47030, DOI 10.1074/jbc.M306728200; WIGHTMAN RM, 1991, P NATL ACAD SCI USA, V88, P10754, DOI 10.1073/pnas.88.23.10754; Zhang H, 1998, FEBS LETT, V437, P267, DOI 10.1016/S0014-5793(98)01233-2; Zhang J, 2005, NATURE, V437, P569, DOI 10.1038/nature04140; Zhang YQ, 2012, NEURON, V74, P136, DOI 10.1016/j.neuron.2012.01.029; Zhang Z, 2008, J GEN PHYSIOL, V131, P117, DOI 10.1085/jgp.200709891; Zhang Z, 2011, MOL BIOL CELL, V22, P2324, DOI 10.1091/mbc.E11-02-0159; Zhang Z, 2010, MOL BIOL CELL, V21, P2821, DOI 10.1091/mbc.E10-04-0285; Zhang Z, 2009, MOL BIOL CELL, V20, P5086, DOI 10.1091/mbc.E09-08-0691; Zhou Z, 1996, BIOPHYS J, V70, P1543, DOI 10.1016/S0006-3495(96)79718-7; Zhu D, 2007, BIOCHEM BIOPH RES CO, V361, P922, DOI 10.1016/j.bbrc.2007.07.083; ZINSMAIER KE, 1994, SCIENCE, V263, P977, DOI 10.1126/science.8310297; ZINSMAIER KE, 1990, J NEUROGENET, V7, P15, DOI 10.3109/01677069009084150	64	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e99180	10.1371/journal.pone.0099180	http://dx.doi.org/10.1371/journal.pone.0099180			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956274	Green Published, Green Submitted, gold			2022-12-27	WOS:000338917900007
J	Forberg, H; Hauge, AG; Valheim, M; Garcon, F; Nunez, A; Gerner, W; Mair, KH; Graham, SP; Brookes, SM; Storset, AK				Forberg, Hilde; Hauge, Anna G.; Valheim, Mette; Garcon, Fanny; Nunez, Alejandro; Gerner, Wilhelm; Mair, Kerstin H.; Graham, Simon P.; Brookes, Sharon M.; Storset, Anne K.			Early Responses of Natural Killer Cells in Pigs Experimentally Infected with 2009 Pandemic H1N1 Influenza A Virus	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; NK CELLS; CYTOKINE RESPONSES; IMMUNE-RESPONSES; PORCINE NK; SWINE; ACTIVATION; NKP46; TRANSMISSION; PATHOGENESIS	Natural killer (NK) cells are important players in the innate immune response against influenza A virus and the activating receptor NKp46, which binds hemagglutinin on the surface of infected cells, has been assigned a role in this context. As pigs are natural hosts for influenza A viruses and pigs possess both NKp46 2 and NKp46(+) NK cells, they represent a good animal model for studying the role of the NKp46 receptor during influenza. We explored the role of NK cells in piglets experimentally infected with 2009 pandemic H1N1 influenza virus by flow cytometric analyses of cells isolated from blood and lung tissue and by immunostaining of lung tissue sections. The number of NKp46(+) NK cells was reduced while NKp46 2 NK cells remained unaltered in the blood 1-3 days after infection. In the lungs, the intensity of NKp46 expression on NK cells was increased during the first 3 days, and areas where influenza virus nucleoprotein was detected were associated with increased numbers of NKp46(+) NK cells when compared to uninfected areas. NKp46(+) NK cells in the lung were neither found to be infected with influenza virus nor to be undergoing apoptosis. The binding of porcine NKp46 to influenza virus infected cells was verified in an in vitro assay. These data support the involvement of porcine NKp46(+) NK cells in the local immune response against influenza virus.	[Forberg, Hilde; Hauge, Anna G.; Valheim, Mette] Norwegian Vet Inst, Dept Lab Serv, Oslo, Norway; [Garcon, Fanny; Graham, Simon P.; Brookes, Sharon M.] Anim Hlth & Vet Labs Agcy, Dept Virol, Addlestone, Surrey, England; [Nunez, Alejandro] Anim Hlth & Vet Labs Agcy, Dept Pathol, Addlestone, Surrey, England; [Gerner, Wilhelm; Mair, Kerstin H.] Univ Vet Med Vienna, Dept Pathobiol, Vienna, Austria; [Storset, Anne K.] Norwegian Univ Life Sci, Dept Food Safety & Infect Biol, Oslo, Norway	Norwegian Veterinary Institute; Veterinary Laboratories Agency; Veterinary Laboratories Agency; University of Veterinary Medicine Vienna; Norwegian University of Life Sciences	Forberg, H (corresponding author), Norwegian Vet Inst, Dept Lab Serv, Oslo, Norway.	hilde.forberg@vetinst.no	Gerner, Wilhelm/GOH-2654-2022; Castel, Alejandro Núñez/C-2560-2011; Brookes, Sharon M/C-8016-2011; Brookes, Sharon M/W-2128-2019; Mair, Kerstin/GVS-3351-2022; Graham, Simon P/C-8337-2011	Brookes, Sharon M/0000-0001-9207-6659; Brookes, Sharon M/0000-0001-9207-6659; Graham, Simon P/0000-0003-4852-405X; Nunez, Alejandro/0000-0001-5926-7541; Gerner, Wilhelm/0000-0002-2431-5889	European Commission [GA-258084]; Norwegian Research Council [207836]	European Commission(European CommissionEuropean Commission Joint Research Centre); Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was supported by the European Commission FP7 Flupig project GA-258084 and the Norwegian Research Council 207836. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achdout H, 2010, J VIROL, V84, P3993, DOI 10.1128/JVI.02289-09; Arnon TI, 2004, BLOOD, V103, P664, DOI 10.1182/blood-2003-05-1716; Barbe F, 2011, VET J, V187, P48, DOI 10.1016/j.tvjl.2009.12.012; Bean AGD, 2013, NAT REV IMMUNOL, V13, P851, DOI 10.1038/nri3551; Bouvier NM, 2010, VIRUSES-BASEL, V2, P1530, DOI 10.3390/v20801530; Brookes SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009068; Crisci E, 2013, MOL IMMUNOL, V55, P200, DOI 10.1016/j.molimm.2013.02.008; Denney L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010675; Draghi M, 2007, J IMMUNOL, V178, P2688, DOI 10.4049/jimmunol.178.5.2688; Du N, 2010, J VIROL, V84, P7822, DOI 10.1128/JVI.00069-10; Ferlazzo G, 2004, J IMMUNOL, V172, P1455, DOI 10.4049/jimmunol.172.3.1455; Fox A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031535; French AR, 2003, CURR OPIN IMMUNOL, V15, P45, DOI 10.1016/S095279150200002X; Gazit R, 2006, NAT IMMUNOL, V7, P517, DOI 10.1038/ni1322; Gerner W, 2009, DEV COMP IMMUNOL, V33, P310, DOI 10.1016/j.dci.2008.06.003; Gregoire C, 2007, IMMUNOL REV, V220, P169, DOI 10.1111/j.1600-065X.2007.00563.x; HALBUR PG, 1995, VET PATHOL, V32, P648, DOI 10.1177/030098589503200606; Hayden FG, 1998, J CLIN INVEST, V101, P643, DOI 10.1172/JCI1355; Heinen PP, 2001, J GEN VIROL, V82, P2697, DOI 10.1099/0022-1317-82-11-2697; Hofshagen M, 2009, EUROSURVEILLANCE, V14, P15; Jost S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025060; Jost S, 2011, IMMUNOLOGY, V132, P516, DOI 10.1111/j.1365-2567.2010.03394.x; Khatri M, 2010, J VIROL, V84, P11210, DOI 10.1128/JVI.01211-10; Kilander A, 2010, EUROSURVEILLANCE, V15, P1, DOI DOI 10.1128/JVI.01136-10; Kim B, 2009, J VET MED SCI, V71, P611, DOI 10.1292/jvms.71.611; Kuiken T, 2008, VACCINE, V26, pD59, DOI 10.1016/j.vaccine.2008.07.025; Liu Y, 2010, J VIROL, V84, P12069, DOI 10.1128/JVI.01639-10; Mair KH, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-13; Mair KH, 2012, EUR J IMMUNOL, V42, P1261, DOI 10.1002/eji.201141989; Mandelboim O, 2001, NATURE, V409, P1055, DOI 10.1038/35059110; Mao HW, 2009, J VIROL, V83, P9215, DOI 10.1128/JVI.00805-09; Meurens F, 2012, TRENDS MICROBIOL, V20, P50, DOI 10.1016/j.tim.2011.11.002; Nelson MI, 2012, J GEN VIROL, V93, P2195, DOI 10.1099/vir.0.044974-0; OIE (World Organisation for Animal Health), 2010, SWIN INFL MAN DIAGN; Owen RE, 2007, J VIROL, V81, P11170, DOI 10.1128/JVI.01217-07; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Punpanich W, 2012, INT J INFECT DIS, V16, pE714, DOI 10.1016/j.ijid.2012.05.1025; Seo SH, 2002, J VIROL, V76, P1071, DOI 10.1128/JVI.76.3.1071-1076.2002; Slomka MJ, 2010, INFLUENZA OTHER RESP, V4, P277, DOI 10.1111/j.1750-2659.2010.00149.x; Talker SC, 2013, DEV COMP IMMUNOL, V40, P51, DOI 10.1016/j.dci.2013.01.003; Valheim M, 2002, RES VET SCI, V73, P77, DOI 10.1016/S0034-5288(02)00071-1; van Helden MJG, 2012, J IMMUNOL, V189, P2333, DOI 10.4049/jimmunol.1200008; Van Reeth K, 1999, RES VET SCI, V67, P47, DOI 10.1053/rvsc.1998.0277; Weiss ID, 2010, J INTERF CYTOK RES, V30, P439, DOI 10.1089/jir.2009.0084; Welliver TP, 2007, J INFECT DIS, V195, P1126, DOI 10.1086/512615; WHO, 2009, CDC PROT REALT RT PC; Wurzer WJ, 2003, EMBO J, V22, P2717, DOI 10.1093/emboj/cdg279	48	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100619	10.1371/journal.pone.0100619	http://dx.doi.org/10.1371/journal.pone.0100619			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955764	gold, Green Published, Green Submitted			2022-12-27	WOS:000338917900074
J	Martin-Ramirez, J; Kok, MGM; Hofman, M; Bierings, R; Creemers, EE; Meijers, JCM; Voorberg, J; Pinto-Sietsma, SJ				Martin-Ramirez, Javier; Kok, Maayke G. M.; Hofman, Menno; Bierings, Ruben; Creemers, Esther E.; Meijers, Joost C. M.; Voorberg, Jan; Pinto-Sietsma, Sara-Joan			Individual with Subclinical Atherosclerosis Have Impaired Proliferation of Blood Outgrowth Endothelial Cells, Which Can Be Restored by Statin Therapy	PLOS ONE			English	Article							PROGENITOR CELLS; CORONARY-ARTERY; IDENTITY; INCREASE; NUMBER; MEN	Background: To study the regenerative capacity of the endothelium in patients with coronary artery disease (CAD), we cultured blood outgrowth endothelial cells (BOECs) of patients with premature CAD and their first degree relatives (FDR). Additionally we evaluated the influence of statin treatment on circulating BOEC precursors in subjects with subclinical atherosclerosis. Methods and Results: Patients with premature CAD (men <51 yr, women <56 yr) and their FDRs were included. Based on coronary calcification (CAC) scores FDRs were divided in a group of healthy subjects (CAC = 0) and subjects with subclinical atherosclerosis (CAC>0). We did not observe differences in the number of BOEC colonies and proliferation between premature CAD patients and FDRs. FDRs with subclinical atherosclerosis had lower colony numbers compared with healthy FDRs, however this was not statistically significant, and BOEC proliferation was significantly impaired (OR = 0.45, 95% CI 0.21-0.96). Unexpectedly, the number of BOEC colonies and BOEC proliferation were similar for premature CAD patients and healthy FDRs. Since a considerable number of premature CAD patients used statins, we studied the number of BOEC precursors as well as their proliferative capacity in ten individuals with subclinical atherosclerosis, before and after statin therapy. Interestingly, FDRs with subclinical atherosclerosis showed a significant increase in the number of BOEC colonies after statin therapy. Conclusion: BOEC proliferation of subjects with subclinical atherosclerosis is impaired compared with healthy controls. In these subjects, statin therapy significantly increased the number of circulating BOEC precursors as well as their proliferative capacity, revealing a beneficial effect of statins on endothelial regeneration.	[Martin-Ramirez, Javier; Hofman, Menno; Bierings, Ruben; Voorberg, Jan] Sanquin AMC Landsteiner Lab, Dept Plasma Prot, Amsterdam, Netherlands; [Kok, Maayke G. M.; Meijers, Joost C. M.; Pinto-Sietsma, Sara-Joan] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Creemers, Esther E.] Univ Amsterdam, Acad Med Ctr, Heart Failure Res Ctr, NL-1105 AZ Amsterdam, Netherlands; [Kok, Maayke G. M.; Meijers, Joost C. M.] Univ Amsterdam, Acad Med Ctr, Dept Expt Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Pinto-Sietsma, Sara-Joan] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Pinto-Sietsma, SJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	S.J.Pinto@amc.uva.nl	Meijers, J.C.M./S-5981-2019; SJ, Pinto-Sietsma/AAI-3207-2021; Bierings, Ruben/AAQ-8854-2020	Meijers, J.C.M./0000-0002-4198-6780; Bierings, Ruben/0000-0002-1205-9689; Voorberg, Jan/0000-0003-4585-2621; Creemers, Esther/0000-0002-9001-3854	CTMM, the Center for Translational Molecular Medicine, project INCOAG [01C-201]; Dutch Heart Foundation	CTMM, the Center for Translational Molecular Medicine, project INCOAG; Dutch Heart Foundation(Netherlands Heart Foundation)	This research was performed within the framework of CTMM, the Center for Translational Molecular Medicine (www.ctmm.nl), project INCOAG (grant 01C-201), and supported by the Dutch Heart Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bielak LF, 2009, CLIN MED INSIGHTS-CA, V3, P53; Campioni D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056377; Cheng S, 2010, CIRCULATION, V122, P1176, DOI 10.1161/CIRCULATIONAHA.109.931279; Fadini GP, 2012, CIRC RES, V110, P624, DOI 10.1161/CIRCRESAHA.111.243386; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hauser ER, 2003, AM HEART J, V145, P602, DOI 10.1067/mhj.2003.13; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Hirschi KK, 2008, ARTERIOSCL THROM VAS, V28, P1584, DOI 10.1161/ATVBAHA.107.155960; Hughes AD, 2007, EUR J CLIN INVEST, V37, P35, DOI 10.1111/j.1365-2362.2007.01743.x; Hur J, 2004, ARTERIOSCL THROM VAS, V24, P288, DOI 10.1161/01.ATV.0000114236.77009.06; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Landmesser U, 2004, CIRCULATION, V110, P1933, DOI 10.1161/01.CIR.0000143232.67642.7A; Laslett LJ, 2012, J AM COLL CARDIOL, V60, pS1, DOI 10.1016/j.jacc.2012.11.002; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Lin Y, 2000, J CLIN INVEST, V105, P71, DOI 10.1172/JCI8071; Martin-Ramirez J, 2012, NAT PROTOC, V7, P1709, DOI 10.1038/nprot.2012.093; Massa M, 2009, EXP HEMATOL, V37, P8, DOI 10.1016/j.exphem.2008.09.007; Medina RJ, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-18; Meneveau N, 2011, BASIC RES CARDIOL, V106, P1397, DOI 10.1007/s00395-011-0220-x; Schmidt-Lucke C, 2005, CIRCULATION, V111, P2981, DOI 10.1161/CIRCULATIONAHA.104.504340; Schmidt-Lucke C, 2010, ATHEROSCLEROSIS, V211, P249, DOI 10.1016/j.atherosclerosis.2010.02.007; Timmermans F, 2009, J CELL MOL MED, V13, P87, DOI 10.1111/j.1582-4934.2008.00598.x; van Agtmaal EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038399; Van Breevoort D, 2014, BLOOD, DOI 10.1182; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Vasa M, 2001, CIRCULATION, V103, P2885, DOI 10.1161/hc2401.092816; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Werner N, 2002, ARTERIOSCL THROM VAS, V22, P1567, DOI 10.1161/01.ATV.0000036417.43987.D8; Yoder MC, 2010, ARTERIOSCL THROM VAS, V30, P1094, DOI 10.1161/ATVBAHA.109.191635	29	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e99890	10.1371/journal.pone.0099890	http://dx.doi.org/10.1371/journal.pone.0099890			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955753	Green Submitted, gold, Green Published			2022-12-27	WOS:000338917900020
J	Sun, W; Li, ZR; Gao, FQ; Shi, ZC; Zhang, QD; Guo, WS				Sun, Wei; Li, Zirong; Gao, Fuqiang; Shi, Zhencai; Zhang, Qidong; Guo, Wanshou			Recombinant Human Bone Morphogenetic Protein-2 in Debridement and Impacted Bone Graft for the Treatment of Femoral Head Osteonecrosis	PLOS ONE			English	Article							CORE DECOMPRESSION; AVASCULAR NECROSIS; ROTATIONAL OSTEOTOMY; FOLLOW-UP; IMPLANTATION; PRESERVATION	The purpose of this study was to compare the clinical outcomes of impacted bone graft with or without recombinant human bone morphogenetic protein-2 (rhBMP-2) for osteonecrosis of the femoral head (ONFH). We examined the effect of bone-grafting through a window at the femoral head-neck junction, known as the "light bulb" approach, for the treatment of ONFH with a combination of artificial bone (Novobone) mixed with or without rhBMP-2. A total of 42 patients (72 hips) were followed-up from 5 to 7.67 years (average of 6.1 years). The patients with and without BMP were the first group (IBG+ rhBMP-2) and the second group (IBG), respectively. The clinical effectiveness was evaluated by Harris hip score (HHS). The radiographic follow-up was evaluated by pre- and postoperative X-ray and CT scan. Excellent, good, and fair functions were obtained in 36, 12, and 7 hips, respectively. The survival rate was 81.8% and 71.8% in the first and second group, respectively. However, the survival rate was 90.3% in ARCO stage IIb, c, and only 34.6% in ARCO stage IIIa(P<0.05). It was concluded that good and excellent mid-term follow-up could be achieved in selected patients with ONFH treated with impacted bone graft operation. The rhBMP-2 might improve the clinical efficacy and quality of bone repair.	[Sun, Wei; Li, Zirong; Gao, Fuqiang; Shi, Zhencai; Zhang, Qidong; Guo, Wanshou] China Japan Friendship Hosp, Ctr Osteonecrosis & Joint Preserving & Reconstruc, Beijing, Peoples R China	China-Japan Friendship Hospital	Sun, W (corresponding author), China Japan Friendship Hosp, Ctr Osteonecrosis & Joint Preserving & Reconstruc, Beijing, Peoples R China.	sun887@163.com; 13366656822@163.com			National Natural Science Foundation of China [81372013]; Research Fund of China-Japan Friendship Hospital [2013-MS-27]; China-Japan Friendship Hospital Youth Science and technology excellence project [2014-QNYC-A-06]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund of China-Japan Friendship Hospital; China-Japan Friendship Hospital Youth Science and technology excellence project	This study was supported by the National Natural Science Foundation of China (81372013) and the Research Fund of China-Japan Friendship Hospital (2013-MS-27). China-Japan Friendship Hospital Youth Science and technology excellence project (2014-QNYC-A-06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1992, ARCO NEWS; Carragee EJ, 2013, J BONE JOINT SURG AM, V95A, P1537, DOI 10.2106/JBJS.L.01483; Chen Ying, 2010, Zhonghua Yi Xue Za Zhi, V90, P2652; Gangji V, 2011, BONE, V49, P1005, DOI 10.1016/j.bone.2011.07.032; Hamanishi M, 2014, ARCH ORTHOP TRAUM SU, V134, P305, DOI 10.1007/s00402-013-1919-y; Hasegawa Y, 2003, J BONE JOINT SURG BR, V85B, P191, DOI 10.1302/0301-620X.85B2.13190; Hernigou P, 2005, J BONE JOINT SURG BR, V87B, P896, DOI 10.1302/0301-620X.87B7.16289; Hitt KD, 2004, SEMIN ARTHROPLAST, V15, P145; Hungerford DS, 2008, TECH ORTHOP, V23, P26, DOI 10.1097/BTO.0b013e3181690840; Israelite C, 2005, CLIN ORTHOP RELAT R, P285, DOI 10.1097/01.blo.0000192365.58958.84; Kim HKW, 2012, J BONE JOINT SURG AM, V94A, P659, DOI 10.2106/JBJS.J.01834; Leung PC, 1996, CLIN ORTHOP RELAT R, P139, DOI 10.1097/00003086-199602000-00019; [李子荣 Li Zirong], 2012, [中华骨科杂志, Chinese Journal of Orthopedics], V32, P515; Lieberman JR, 2012, CLIN ORTHOP RELAT R, V470, P525, DOI 10.1007/s11999-011-2050-4; Lieberman JR, 2004, CLIN ORTHOP RELAT R, P139, DOI 10.1097/01.blo.0000150312.53937.6f; Lieberman JR, 2004, CLIN ORTHOP RELAT R, P29; Marciniak D, 2005, J BONE JOINT SURG AM, V87A, P742, DOI 10.2106/JBJS.D.02004; Mesfin A, 2013, J BONE JOINT SURG AM, V95A, P1546, DOI 10.2106/JBJS.L.01730; Mont MA, 2003, CLIN ORTHOP RELAT R, P84, DOI 10.1097/01.blo.0000096826.67494.38; Mont MA, 2004, J BONE JOINT SURG AM, V86A, P41, DOI 10.2106/00004623-200412002-00008; Mont MA, 2001, J BONE JOINT SURG AM, V83A, P1013, DOI 10.2106/00004623-200107000-00006; Mont MA, 2010, J BONE JOINT SURG AM, V92A, P2165, DOI 10.2106/JBJS.I.00575; ROSENWASSER MP, 1994, CLIN ORTHOP RELAT R, P17; Sugioka Y, 2008, CLIN ORTHOP RELAT R, V466, P1104, DOI 10.1007/s11999-008-0192-9; Sun W, 2014, ORTHOPEDICS, V37, pE24, DOI 10.3928/01477447-20131219-12; Sun Wei, 2011, Orthop Surg, V3, P131, DOI 10.1111/j.1757-7861.2011.00127.x; Vandermeer JS, 2011, J BONE JOINT SURG AM, V93A, P905, DOI 10.2106/JBJS.J.00716; Wang BL, 2010, ARCH ORTHOP TRAUM SU, V130, P859, DOI 10.1007/s00402-009-0939-0; Wang BL, 2010, INT ORTHOP, V34, P635, DOI 10.1007/s00264-009-0822-1; Wang W, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-142; [杨强 Yang Qiang], 2011, [中华骨科杂志, Chinese Journal of Orthopedics], V31, P549; Zhao DW, 2012, BONE, V50, P325, DOI 10.1016/j.bone.2011.11.002	32	44	56	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100424	10.1371/journal.pone.0100424	http://dx.doi.org/10.1371/journal.pone.0100424			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956102	Green Published, Green Submitted, gold			2022-12-27	WOS:000338917900050
J	Annamanedi, M; Kalle, AM				Annamanedi, Madhavi; Kalle, Arunasree M.			Celecoxib Sensitizes Staphylococcus aureus to Antibiotics in Macrophages by Modulating SIRT1	PLOS ONE			English	Article							CHONDROCYTES IN-VITRO; RESVERATROL; INFLAMMATION; INHIBITION; APOPTOSIS; COX-2; PHAGOCYTOSIS; EXPRESSION; RESISTANCE; ACTIVATORS	We have previously shown that celecoxib in combination with an antibiotic, increase the bacterial sensitivity to antibiotics. However, the underlying molecular mechanism remained elusive. Efficacy of the combinatorial treatment of celecoxib and ampicillin in vitro was evaluated on macrophage-phagocytosed S aureus. To elucidate the mechanism, signaling pathway of infection and inflammation involving TLR2, JNK, SIRT1 and NF-kappa B was studied by FACS, Western blot, ELISA and activity assays. Combinatorial treatment of ampicillin and celecoxib reduced the bacterial load in the macrophages. Further studies clearly suggested the activation of the master regulator of oxidative stress and inflammation SIRT1,, by celecoxib when used alone and/or in combination with ampicillin. Also, the results indicated that celecoxib inhibited JNK phosphorylation thereby stabilizing and activating SIRT1 protein that inhibited the COX-2 gene transcription with a significant decrease in the levels of protein inflammatory cytokines like IL-6, MIP-1 alpha and IL-1 beta via inhibition of NF-kappa B. SIRT1 activation by celecoxib also resulted in increase of catalase and peroxidase activity with a decrease in Nitric oxide levels. In conclusion, we demonstrate a novel role of celecoxib in controlling inflammation as an enhancer of antibiotic activity against bacteria by modulating SIRT1.	[Annamanedi, Madhavi; Kalle, Arunasree M.] Univ Hyderabad, Sch Life Sci, Dept Anim Sci, Hyderabad 500134, Andhra Pradesh, India	University of Hyderabad	Kalle, AM (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Anim Sci, Hyderabad 500134, Andhra Pradesh, India.	arunasreemk@uohyd.ac.in	Kalle, Arunasree M./AAI-9819-2020	Kalle, Arunasree M./0000-0002-5948-2337; Annamanedi, Madhavi/0000-0001-5460-6532	Indian Council of Medical Research (ICMR), India [AMR-19-2011-ECD-I]; Department of Biotechnology-Innovative Young Biotechnologist Award (DBT-IYBA), India [BT/03/IYBA/2010]; National Institute of Animal Biotechnology (NIAB), India [NIAB/CP/108/2012]	Indian Council of Medical Research (ICMR), India(Indian Council of Medical Research (ICMR)); Department of Biotechnology-Innovative Young Biotechnologist Award (DBT-IYBA), India; National Institute of Animal Biotechnology (NIAB), India	This study was partially funded by Indian Council of Medical Research (ICMR), India (Grant# AMR-19-2011-ECD-I). Financial assistance from Department of Biotechnology-Innovative Young Biotechnologist Award (DBT-IYBA), India (Grant# BT/03/IYBA/2010) and National Institute of Animal Biotechnology (NIAB), India(Grant# NIAB/CP/108/2012) is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arunasree KM, 2008, LEUKEMIA RES, V32, P855, DOI 10.1016/j.leukres.2007.11.007; Caito S, 2010, FASEB J, V24, P3145, DOI 10.1096/fj.09-151308; Chen CJ, 2009, BIOCHEM BIOPH RES CO, V378, P389, DOI 10.1016/j.bbrc.2008.11.110; Csaki C, 2008, BIOCHEM PHARMACOL, V75, P677, DOI 10.1016/j.bcp.2007.09.014; Csaki C, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2850; Dolcet X, 2005, VIRCHOWS ARCH, V446, P475, DOI 10.1007/s00428-005-1264-9; Ejim L, 2010, NAT CHEM BIOL; Gajraj NM, 2007, CURR TOP MED CHEM, V7, P235, DOI 10.2174/156802607779941323; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Hojgard S., 2012, INFECT ECOL EPIDEMIO, V2, P18165; Howes Laurence Guy, 2007, Ther Clin Risk Manag, V3, P831; Iyori M, 2008, ANTIMICROB AGENTS CH, V52, P121, DOI 10.1128/AAC.00210-07; Kalle AM, 2011, ANTIMICROB AGENTS CH, V55, P439, DOI 10.1128/AAC.00735-10; Knutson MD, 2008, NUTR REV, V66, P591, DOI 10.1111/j.1753-4887.2008.00109.x; Koziel J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005210; Kume S, 2010, J CLIN INVEST, V120, P1043, DOI 10.1172/JCI41376; Lee JH, 2009, DIABETES, V58, P344, DOI 10.2337/db07-1795; Lefebre MD, 2001, MICROBIOL-SGM, V147, P97, DOI 10.1099/00221287-147-1-97; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Palladino MA, 2007, BIOL REPROD, V76, P958, DOI 10.1095/biolreprod.106.059410; Pietrocola G, 2011, INT J ARTIF ORGANS, V34, P799, DOI 10.5301/ijao.5000030; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Rahman I, 2012, PREV MED, V54, pS20, DOI 10.1016/j.ypmed.2011.11.014; Ruof J, 2000, Z RHEUMATOL, V59, P124, DOI 10.1007/s003930050217; Schug TT, 2010, MOL CELL BIOL, V30, P4712, DOI 10.1128/MCB.00657-10; Shakibaei M, 2009, MOL NUTR FOOD RES, V53, P115, DOI 10.1002/mnfr.200800148; Shakibaei M, 2008, BIOCHEM PHARMACOL, V76, P1426, DOI 10.1016/j.bcp.2008.05.029; Shakibaei M, 2007, ANN NY ACAD SCI, V1095, P554, DOI 10.1196/annals.1397.060; Shakibaei M, 2011, J BIOL CHEM, V286, P11492, DOI 10.1074/jbc.M110.198713; Stables MJ, 2010, BLOOD, V116, P2950, DOI 10.1182/blood-2010-05-284844; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Verdin E, 2007, MOL CELL, V28, P354, DOI 10.1016/j.molcel.2007.10.013; Wang GL, 2009, BIOCHEM BIOPH RES CO, V380, P644, DOI 10.1016/j.bbrc.2009.01.163; Wu JT, 2005, J SURG RES, V123, P158, DOI 10.1016/j.jss.2004.06.006; Yoshizaki T, 2010, AM J PHYSIOL-ENDOC M, V298, pE419, DOI 10.1152/ajpendo.00417.2009; Zhang R, 2010, J BIOL CHEM, V285, P7097, DOI 10.1074/jbc.M109.038604; Zhang ZY, 2010, J BIOL CHEM, V285, P41391, DOI 10.1074/jbc.M110.174482	37	17	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e99285	10.1371/journal.pone.0099285	http://dx.doi.org/10.1371/journal.pone.0099285			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950067	Green Submitted, Green Published, gold			2022-12-27	WOS:000338276300012
J	Farah, BL; Sinha, RA; Wu, YJ; Singh, BK; Zhou, J; Bay, BH; Yen, PM				Farah, Benjamin L.; Sinha, Rohit A.; Wu, Yajun; Singh, Brijesh K.; Zhou, Jin; Bay, Boon-Huat; Yen, Paul M.			beta-Adrenergic Agonist and Antagonist Regulation of Autophagy in HepG2 Cells, Primary Mouse Hepatocytes, and Mouse Liver	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; PROTEIN-KINASE-A; GLYCOGEN AUTOPHAGY; MICE; DEGRADATION; ACTIVATION; INHIBITION; GLUCOSE; MAINTENANCE; CLENBUTEROL	Autophagy recently has been shown to be involved in normal hepatic function and in pathological conditions such as nonalcoholic fatty liver disease. Adrenergic signalling also is an important regulator of hepatic metabolism and function. However, currently little is known about the potential role of adrenergic signaling on hepatic autophagy, and whether the beta-adrenergic receptor itself may be a key regulator of autophagy. To address these issues, we investigated the actions of the beta(2)-adrenergic receptor agonist, clenbuterol on hepatic autophagy. Surprisingly, we found that clenbuterol stimulated autophagy and autophagic flux in hepatoma cells, primary hepatocytes and in vivo. Similar effects also were observed with epinephrine treatment. Interestingly, propranolol caused a late block in autophagy in the absence and presence of clenbuterol, both in cell culture and in vivo. Thus, our results demonstrate that the beta(2)-adrenergic receptor is a key regulator of hepatic autophagy, and that the beta-blocker propranolol can independently induce a late block in autophagy.	[Farah, Benjamin L.; Sinha, Rohit A.; Singh, Brijesh K.; Zhou, Jin; Yen, Paul M.] Duke NUS Grad Med Sch Singapore, Cardiovasc & Metab Disorders Program, Singapore, Singapore; [Wu, Yajun; Bay, Boon-Huat] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Anat, Singapore 117595, Singapore; [Yen, Paul M.] Duke Univ, Med Ctr, Dept Med & Pharmacol, Sarah W Stedman Nutr & Metab Ctr, Durham, NC USA; [Yen, Paul M.] Duke Univ, Med Ctr, Dept Canc Biol, Sarah W Stedman Nutr & Metab Ctr, Durham, NC USA	National University of Singapore; National University of Singapore; Duke University; Duke University	Yen, PM (corresponding author), Duke NUS Grad Med Sch Singapore, Cardiovasc & Metab Disorders Program, Singapore, Singapore.	paul.yen@duke-nus.edu.sg	Sinha, Rohit/GXV-2427-2022; Yen, Paul M/V-9857-2019; Singh, Brijesh K/C-1093-2009	Singh, Brijesh K/0000-0003-4615-3988; Wu, Yajun/0000-0001-9598-4433; Yen, Paul/0000-0002-3790-8114	Singapore National Medical Research Council Grant [NMRC/CIRG/1340/2012]; Duke-NUS Graduate Medical School Faculty Funds; Singapore Ministry of Health; Singapore Ministry of Education; Singapore Ministry of Trade; A*STAR	Singapore National Medical Research Council Grant(National Medical Research Council, Singapore); Duke-NUS Graduate Medical School Faculty Funds; Singapore Ministry of Health(Ministry of Health-Singapore); Singapore Ministry of Education(Ministry of Education, Singapore); Singapore Ministry of Trade; A*STAR(Agency for Science Technology & Research (A*STAR))	This study was carried out with funds supplied by Singapore National Medical Research Council Grant [NMRC/CIRG/1340/2012] provided to Dr. Paul M. Yen, as well as by Duke-NUS Graduate Medical School Faculty Funds also to Dr. Paul M. Yen, sponsored by the Singapore Ministries of Health, Education, and Trade, as well as A*STAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alers S, 2012, MOL CELL BIOL, V32, P2, DOI 10.1128/MCB.06159-11; Aranguiz-Urroz P, 2011, BBA-MOL BASIS DIS, V1812, P23, DOI 10.1016/j.bbadis.2010.07.003; Ashoor R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082481; Baker JG, 2010, BRIT J PHARMACOL, V160, P1048, DOI 10.1111/j.1476-5381.2010.00754.x; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; BONER AL, 1988, PEDIATR PULM, V4, P197, DOI 10.1002/ppul.1950040402; BRODDE OE, 1990, AM HEART J, V120, P1565, DOI 10.1016/0002-8703(90)90060-B; Ding WX, 2010, GASTROENTEROLOGY, V139, P1740, DOI 10.1053/j.gastro.2010.07.041; Ezaki J, 2011, AUTOPHAGY, V7, P727, DOI 10.4161/auto.7.7.15371; Goncalves DAP, 2012, AM J PHYSIOL-ENDOC M, V302, pE123, DOI 10.1152/ajpendo.00188.2011; GORDON PB, 1991, BIOMED BIOCHIM ACTA, V50, P383; Hernandez-Gea V, 2013, J HEPATOL, V59, P98, DOI 10.1016/j.jhep.2013.02.016; Hernandez-Gea V, 2012, GASTROENTEROLOGY, V142, P938, DOI 10.1053/j.gastro.2011.12.044; Hidvegi T, 2010, SCIENCE, V329, P229, DOI 10.1126/science.1190354; HOLEN I, 1991, BIOMED BIOCHIM ACTA, V50, P389; Inoue H, 2013, EUR J PHARMACOL, V714, P170, DOI 10.1016/j.ejphar.2013.06.018; Ishizaki J, 2000, J PHARMACOL EXP THER, V294, P1088; JAVITT NB, 1990, FASEB J, V4, P161, DOI 10.1096/fasebj.4.2.2153592; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kamimoto T, 2006, J BIOL CHEM, V281, P4467, DOI 10.1074/jbc.M509409200; Kazmi F, 2013, DRUG METAB DISPOS, V41, P897, DOI 10.1124/dmd.112.050054; KLAUNIG JE, 1981, IN VITRO CELL DEV B, V17, P913; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Kondomerkos DJ, 2005, HISTOL HISTOPATHOL, V20, P689, DOI 10.14670/HH-20.689; Kotoulas OB, 2006, PATHOL RES PRACT, V202, P631, DOI 10.1016/j.prp.2006.04.001; Kotsafti A, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-118; Lampidonis AD, 2011, GENE, V477, P1, DOI 10.1016/j.gene.2011.01.007; Lin CW, 2013, J HEPATOL, V58, P993, DOI 10.1016/j.jhep.2013.01.011; Lizaso A, 2013, AUTOPHAGY, V9, P1228, DOI 10.4161/auto.24893; Loomba R, 2010, GASTROENTEROLOGY, V139, P836, DOI 10.1053/j.gastro.2010.06.009; McKee C, 2013, BIOCHEM BIOPH RES CO, V437, P597, DOI 10.1016/j.bbrc.2013.07.005; Meschini S, 2011, CURR CANCER DRUG TAR, V11, P357, DOI 10.2174/156800911794519707; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Omar B, 2009, CELL SIGNAL, V21, P760, DOI 10.1016/j.cellsig.2009.01.015; Pereira C, 2005, INT J BIOCHEM CELL B, V37, P1948, DOI 10.1016/j.biocel.2005.05.009; Pyo JO, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3300; Schmelzle T, 2004, MOL CELL BIOL, V24, P338, DOI 10.1128/MCB.24.1.338-351.2004; Serste T, 2010, HEPATOLOGY, V52, P1017, DOI 10.1002/hep.23775; Sharara-Chami RI, 2012, INT J BIOCHEM CELL B, V44, P905, DOI 10.1016/j.biocel.2012.02.016; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Sinha RA, 2013, HEPATOLOGY; Sinha RA, 2012, J CLIN INVEST, V122, P2428, DOI 10.1172/JCI60580; Stankov MV, 2012, AIDS, V26, P1995, DOI 10.1097/QAD.0b013e32835804f9; Takamura A, 2011, GENE DEV, V25, P795, DOI 10.1101/gad.2016211; Thoen LFR, 2011, J HEPATOL, V55, P1353, DOI 10.1016/j.jhep.2011.07.010; TRAGANOS F, 1994, METHOD CELL BIOL, V41, P185; Ugland H, 2011, AUTOPHAGY, V7, P1199, DOI 10.4161/auto.7.10.16649; Wachter SB, 2012, CARDIOLOGY, V122, P104, DOI 10.1159/000339271; Zhang C, 2008, NAT MED, V14, P959, DOI 10.1038/nm.1851	51	37	38	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e98155	10.1371/journal.pone.0098155	http://dx.doi.org/10.1371/journal.pone.0098155			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950230	gold, Green Published, Green Submitted			2022-12-27	WOS:000338276300006
J	Haimerl, M; Wachtler, M; Zeman, F; Verloh, N; Platzek, I; Schreyer, AG; Stroszczynski, C; Wiggermann, P				Haimerl, Michael; Waechtler, Max; Zeman, Florian; Verloh, Niklas; Platzek, Ivan; Schreyer, Andreas Georg; Stroszczynski, Christian; Wiggermann, Philipp			Quantitative Evaluation of Enhancement Patterns in Focal Solid Liver Lesions with Gd-EOB-DTPA-Enhanced MRI	PLOS ONE			English	Article							EARLY HEPATOCELLULAR-CARCINOMA; MULTICENTER PHASE-III; GADOXETIC-ACID; NODULAR HYPERPLASIA; HISTOPATHOLOGIC FINDINGS; CONTRAST AGENT; SPIRAL CT; GADOBENATE DIMEGLUMINE; INITIAL OBSERVATIONS; HEPATIC ADENOMA	Purpose: The objective was to investigate the dynamic enhancement patterns in focal solid liver lesions after the administration of gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid (Gd-EOB-DTPA) by means of dynamic magnetic resonance imaging (MRI) including hepatobiliary phase (HP) images 20 min after Gd-EOB-DTPA administration. Materials and Methods: Non-enhanced T1/T2-weighted as well as dynamic magnetic resonance (MR) images during the arterial phase (AP), the portal venous phase (PVP), the late phase (LP), and the HP (20 min) were obtained from 83 patients (54 male, 29 female, mean age 62.01 years) with focal solid liver lesions. MRI was conducted by means of a 1.5-T system for 63 patients with malignant liver lesions (HCCs: n = 34, metastases: n = 29) and for 20 patients with benign liver lesions (FNH lesions: n = 14, hemangiomas: n = 3, adenomas: n = 3). For quantitative analysis, signal-to-noise ratios (SNR), contrast enhancement ratios (CER), lesion-to-liver contrast ratios (LLC), and signal intensity (SI) ratios were measured. Results: The SNR of liver parenchyma significantly increased in each dynamic phase after Gd-EOB-DTPA administration compared to the SNR of non-enhanced images (p<0.001). The CER of HCCs and metastases significantly decreased between LP and HP images (p = 0.0011, p<0.0001). However, FNH lesions did not show any significant difference, whereas an increased CER was found in hemangiomas. The mean LLCs of FNH lesions were significantly higher than those of HCCs and metastases. The LLC values of hemangiomas remained negative during the entire time course, whereas the LLC of adenomas indicated hyperintensity from the AP to the LP. Furthermore, adenomas showed hypointensity in HP images. Conclusion: Gd-EOB-DTPA-enhanced MRI may help diagnose focal solid liver lesions by evaluating their enhancement patterns.	[Haimerl, Michael; Waechtler, Max; Verloh, Niklas; Schreyer, Andreas Georg; Stroszczynski, Christian; Wiggermann, Philipp] Univ Med Ctr Regensburg, Dept Radiol, Regensburg, Germany; [Zeman, Florian] Univ Med Ctr Regensburg, Ctr Clin Trials, Regensburg, Germany; [Platzek, Ivan] Univ Hosp Carl Gustav Carus Dresden, Dept Radiol, Dresden, Germany	University of Regensburg; University of Regensburg; Technische Universitat Dresden; Carl Gustav Carus University Hospital	Haimerl, M (corresponding author), Univ Med Ctr Regensburg, Dept Radiol, Regensburg, Germany.	michael.haimerl@ukr.de	Platzek, Ivan/AAZ-8124-2020; Wiggermann, Philipp/AAY-6759-2021; Verloh, Niklas/AAS-5386-2021; Schreye, Andreas/ABC-3197-2020; Zeman, Florian/GNH-3239-2022; WIGGERMANN, Philipp/AAX-6721-2021	Platzek, Ivan/0000-0002-5933-8108; Verloh, Niklas/0000-0002-8424-5827; Schreyer, Andreas/0000-0002-2539-059X				Bartolozzi C, 2007, EUR RADIOL, V17, P2519, DOI 10.1007/s00330-007-0602-5; Bluemke DA, 2005, RADIOLOGY, V237, P89, DOI 10.1148/radiol.2371031842; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Farges O, 2010, DIGEST SURG, V27, P32, DOI 10.1159/000268405; Frericks BB, 2009, AM J ROENTGENOL, V193, P1053, DOI 10.2214/AJR.08.1946; Giovanoli O, 2008, AM J ROENTGENOL, V190, pW290, DOI 10.2214/AJR.07.3198; Grazioli L, 2005, RADIOLOGY, V236, P166, DOI 10.1148/radiol.2361040338; Grazioli L, 2012, RADIOLOGY, V262, P520, DOI 10.1148/radiol.11101742; HAMM B, 1994, RADIOLOGY, V190, P417, DOI 10.1148/radiology.190.2.8284392; HAMM B, 1995, RADIOLOGY, V195, P785, DOI 10.1148/radiology.195.3.7754011; Hammerstingl R, 2008, EUR RADIOL, V18, P457, DOI 10.1007/s00330-007-0716-9; Huppertz A, 2005, RADIOLOGY, V234, P468, DOI 10.1148/radiol.2342040278; Ichikawa T, 2000, RADIOLOGY, V214, P861, DOI 10.1148/radiology.214.3.r00mr28861; Ichikawa T, 2010, INVEST RADIOL, V45, P133, DOI 10.1097/RLI.0b013e3181caea5b; Kim YK, 2006, RADIOLOGY, V238, P531, DOI 10.1148/radiol.2381042193; Kojiro M, 2009, HEPATOLOGY, V49, P658, DOI 10.1002/hep.22709; Lee SA, 2011, MAGN RESON IMAGING, V29, P83, DOI 10.1016/j.mri.2010.07.019; Mohajer K, 2012, J MAGN RESON IMAGING, V36, P686, DOI 10.1002/jmri.23701; Morana G, 2002, ACAD RADIOL, V9, pS476, DOI 10.1016/S1076-6332(03)80268-4; Morana G, 2011, INVEST RADIOL, V46, P225, DOI 10.1097/RLI.0b013e3181feee3a; Motosugi U, 2011, INVEST RADIOL, V46, P141, DOI 10.1097/RLI.0b013e3181f9c487; Motosugi U, 2010, RADIOLOGY, V256, P151, DOI 10.1148/radiol.10091885; Oudkerk M, 2002, RADIOLOGY, V223, P517, DOI 10.1148/radiol.2232010318; Petersein J, 2000, RADIOLOGY, V215, P727, DOI 10.1148/radiology.215.3.r00jn14727; PUECH A, 1964, Montp Med, V65, P114; Raman SS, 2010, J COMPUT ASSIST TOMO, V34, P163, DOI 10.1097/RCT.0b013e3181c89d87; Reimer P, 1997, EUR RADIOL, V7, P275, DOI 10.1007/s003300050150; Saito Kazuhiro, 2005, Magn Reson Med Sci, V4, P1, DOI 10.2463/mrms.4.1; Sano K, 2011, RADIOLOGY, V261, P834, DOI 10.1148/radiol.11101840; Semelka RC, 2001, J MAGN RESON IMAGING, V13, P397, DOI 10.1002/jmri.1057; Tanimoto A, 2009, EUR RADIOL, V19, pS975, DOI 10.1007/s00330-009-1624-y; Tsuda N, 2010, RADIOLOGY, V256, P767, DOI 10.1148/radiol.10092065; Vogl TJ, 1996, RADIOLOGY, V200, P59, DOI 10.1148/radiology.200.1.8657946; WANLESS IR, 1985, HEPATOLOGY, V5, P1194, DOI 10.1002/hep.1840050622; Weinmann HJ, 1996, ACAD RADIOL, V3, pS232, DOI 10.1016/S1076-6332(96)80544-7; Zech CJ, 2008, INVEST RADIOL, V43, P504, DOI 10.1097/RLI.0b013e3181705cd1	36	11	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100315	10.1371/journal.pone.0100315	http://dx.doi.org/10.1371/journal.pone.0100315			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950259	Green Published, gold, Green Submitted			2022-12-27	WOS:000338276300063
J	Wong, L; Hutson, PR; Bushman, W				Wong, Letitia; Hutson, Paul R.; Bushman, Wade			Prostatic Inflammation Induces Fibrosis in a Mouse Model of Chronic Bacterial Infection	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; URINARY-TRACT SYMPTOMS; FATTY LIVER-DISEASE; CIRCULATING FIBROCYTES; EXTRACELLULAR-MATRIX; MYOCARDIAL FIBROSIS; COLLAGEN-SYNTHESIS; TISSUE FIBROSIS; LUNG-DISEASE; PATHOGENESIS	Inflammation of the prostate is strongly correlated with development of lower urinary tract symptoms and several studies have implicated prostatic fibrosis in the pathogenesis of bladder outlet obstruction. It has been postulated that inflammation induces prostatic fibrosis but this relationship has never been tested. Here, we characterized the fibrotic response to inflammation in a mouse model of chronic bacterial-induced prostatic inflammation. Transurethral instillation of the uropathogenic E. coli into C3H/HeOuJ male mice induced persistent prostatic inflammation followed by a significant increase in collagen deposition and hydroxyproline content. This fibrotic response to inflammation was accompanied with an increase in collagen synthesis determined by the incorporation of H-3-hydroxyproline and mRNA expression of several collagen remodeling-associated genes, including Col1a1, Col1a2, Col3a1, Mmp2, Mmp9, and Lox. Correlation analysis revealed a positive correlation of inflammation severity with collagen deposition and immunohistochemical staining revealed that CD45+VIM+ fibrocytes were abundant in inflamed prostates at the time point coinciding with increased collagen synthesis. Furthermore, flow cytometric analysis demonstrated an increased percentage of these CD45+VIM+ fibrocytes among collagen type I expressing cells. These data show-for the first time-that chronic prostatic inflammation induces collagen deposition and implicates fibrocytes in the fibrotic process.	[Wong, Letitia; Bushman, Wade] Univ Wisconsin, Dept Urol, Madison, WI 53706 USA; [Wong, Letitia] Univ Wisconsin, Mol & Environm Toxicol Ctr, Madison, WI USA; [Hutson, Paul R.] Univ Wisconsin, Sch Pharm, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Bushman, W (corresponding author), Univ Wisconsin, Dept Urol, Madison, WI 53706 USA.	bushman@urology.wisc.edu			National Institutes of Health [R01DK0757]; National Institute of Environmental Health Sciences [T32 ES007015]; UW-Madison School of Medicine and Public Health; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007015] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); UW-Madison School of Medicine and Public Health; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by R01DK0757 (to WB) from the National Institutes of Health (http://www.nih.gov), T32 ES007015 (to LW) from the National Institute of Environmental Health Sciences (https://www.niehs.nih.gov), and Herman I. Shapiro Distinguished Graduate Fellowship (to LW) from UW-Madison School of Medicine and Public Health (http://www.med.wisc.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Andersson-Sjoland A, 2008, INT J BIOCHEM CELL B, V40, P2129, DOI 10.1016/j.biocel.2008.02.012; Armstrong L, 1999, AM J RESP CRIT CARE, V160, P1910, DOI 10.1164/ajrccm.160.6.9811084; Atamas SP, 2002, LIFE SCI, V72, P631, DOI 10.1016/S0024-3205(02)02299-3; Barron DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013751; Bercovich E, 1999, Arch Ital Urol Androl, V71, P287; Besnard AG, 2013, J LEUKOCYTE BIOL, V94, P1317, DOI 10.1189/jlb.0313140; Boehm BJ, 2012, PROSTATE, V72, P307, DOI 10.1002/pros.21433; Borthwick LA, 2013, BBA-MOL BASIS DIS, V1832, P1049, DOI 10.1016/j.bbadis.2012.09.014; Broughton G, 2006, PLAST RECONSTR SURG, V117, p12S, DOI 10.1097/01.prs.0000225430.42531.c2; BUCALA R, 1994, MOL MED, V1, P71, DOI 10.1007/bf03403533; Cantiello F, 2013, UROLOGY, V81, P1018, DOI 10.1016/j.urology.2013.01.053; CUNHA GR, 1983, DIFFERENTIATION, V24, P174, DOI 10.1111/j.1432-0436.1983.tb01317.x; De Marzo AM, 1999, AM J PATHOL, V155, P1985, DOI 10.1016/S0002-9440(10)65517-4; Degryse AL, 2011, AM J PHYSIOL-LUNG C, V300, pL887, DOI 10.1152/ajplung.00397.2010; Elkahwaji JE, 2007, PROSTATE, V67, P14, DOI 10.1002/pros.20445; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Fiocchi C, 1998, GASTROENTEROLOGY, V115, P182, DOI 10.1016/S0016-5085(98)70381-6; Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820; Galligan CL, 2012, ARTHRITIS RHEUM-US, V64, P3583, DOI 10.1002/art.34589; Galligan CL, 2010, RHEUMATOLOGY, V49, P640, DOI 10.1093/rheumatology/kep265; Garcia-Bolao I, 2008, EUR HEART J, V29, P898, DOI 10.1093/eurheartj/ehn098; Gharaee-Kermani M, 1998, J LEUKOCYTE BIOL, V64, P657, DOI 10.1002/jlb.64.5.657; Gharaee-Kermani M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049278; Gordon MK, 2010, CELL TISSUE RES, V339, P247, DOI 10.1007/s00441-009-0844-4; Hashimoto N, 2004, J CLIN INVEST, V113, P243, DOI 10.1172/JCI200418847; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Hutson PR, 2003, J CHROMATOGR B, V791, P427, DOI 10.1016/S1570-0232(03)00248-4; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; Kadler KE, 2007, J CELL SCI, V120, P1955, DOI 10.1242/jcs.03453; Kang HR, 2007, J BIOL CHEM, V282, P7723, DOI 10.1074/jbc.M610764200; Kramer G, 2007, EUR UROL, V51, P1202, DOI 10.1016/j.eururo.2006.12.011; Lagente V, 2005, BRAZ J MED BIOL RES, V38, P1521, DOI 10.1590/S0100-879X2005001000009; Lv XX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068631; Ma JJ, 2012, J UROLOGY, V188, P1375, DOI 10.1016/j.juro.2012.06.007; Marker PC, 2003, DEV BIOL, V253, P165, DOI 10.1016/S0012-1606(02)00031-3; McAnulty RJ, 2005, METH MOLEC MED, V117, P189; MCLENACHAN JM, 1990, AM J HYPERTENS, V3, P735, DOI 10.1093/ajh/3.10.735; Mehrad B, 2007, BIOCHEM BIOPH RES CO, V353, P104, DOI 10.1016/j.bbrc.2006.11.149; Morrison C, 2000, UROL RES, V28, P304, DOI 10.1007/s002400000123; Nickel JC, 2008, EUR UROL, V54, P1379, DOI 10.1016/j.eururo.2007.11.026; Pardo A, 2002, INT J BIOCHEM CELL B, V34, P1534, DOI 10.1016/S1357-2725(02)00091-2; Peng XY, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-12; Phillips RJ, 2004, J CLIN INVEST, V114, P438, DOI 10.1172/jci200420997; Pilling D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007475; Querejeta R, 2004, CIRCULATION, V110, P1263, DOI 10.1161/01.CIR.0000140973.60992.9A; Rieder F, 2009, NAT REV GASTRO HEPAT, V6, P228, DOI 10.1038/nrgastro.2009.31; Robert G, 2009, PROSTATE, V69, P1774, DOI 10.1002/pros.21027; Rodes J, 2007, TXB HEPATOLOGY BASIC; Roehrborn CG, 2006, BJU INT, V97, P7, DOI 10.1111/j.1464-410X.2006.06098.x; Rydell-Tormanen K, 2012, LAB INVEST, V92, P917, DOI 10.1038/labinvest.2012.57; Saito F, 2008, AM J RESP CELL MOL, V38, P566, DOI 10.1165/rcmb.2007-0299OC; Sakai N, 2006, P NATL ACAD SCI USA, V103, P14098, DOI 10.1073/pnas.0511200103; Sakai N, 2010, HUM PATHOL, V41, P672, DOI 10.1016/j.humpath.2009.10.008; Schmidt M, 2003, J IMMUNOL, V171, P380, DOI 10.4049/jimmunol.171.1.380; SELMAN M, 1986, THORAX, V41, P355, DOI 10.1136/thx.41.5.355; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Shappell SB, 2004, CANCER RES, V64, P2270, DOI 10.1158/0008-5472.CAN-03-0946; Shinohara DB, 2013, PROSTATE, V73, P1007, DOI 10.1002/pros.22648; Steiner GE, 2003, LAB INVEST, V83, P1131, DOI 10.1097/01.LAB.0000081388.40145.65; Thickett DR, 2001, SARCOIDOSIS VASC DIF, V18, P27; Ueha S, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00071; VATER CA, 1979, BIOCHEM J, V181, P639, DOI 10.1042/bj1810639; Wang CH, 2008, AM J RESP CRIT CARE, V178, P583, DOI 10.1164/rccm.200710-1557OC; Wight TN, 2011, AM J PHYSIOL-GASTR L, V301, pG950, DOI 10.1152/ajpgi.00132.2011; Wilson M, 2010, J PETROL, V51, P1, DOI 10.1093/petrology/egp099	66	34	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100770	10.1371/journal.pone.0100770	http://dx.doi.org/10.1371/journal.pone.0100770			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950301	Green Published, Green Submitted, gold			2022-12-27	WOS:000338276300111
J	Daniels, RW; Rossano, AJ; Macleod, GT; Ganetzky, B				Daniels, Richard W.; Rossano, Adam J.; Macleod, Gregory T.; Ganetzky, Barry			Expression of Multiple Transgenes from a Single Construct Using Viral 2A Peptides in Drosophila	PLOS ONE			English	Article							FLUORESCENT PROTEINS; CLEAVAGE; VECTORS	Expression of multiple reporter or effector transgenes in the same cell from a single construct is increasingly necessary in various experimental paradigms. The discovery of short, virus-derived peptide sequences that mediate a ribosome-skipping event enables generation of multiple separate peptide products from one mRNA. Here we describe methods and vectors to facilitate easy production of polycistronic-like sequences utilizing these 2A peptides tailored for expression in Drosophila both in vitro and in vivo. We tested the separation efficiency of different viral 2A peptides in cultured Drosophila cells and in vivo and found that the 2A peptides from porcine teschovirus-1 (P2A) and Thosea asigna virus (T2A) worked best. To demonstrate the utility of this approach, we used the P2A peptide to co-express the red fluorescent protein tdTomato and the genetically-encoded calcium indicator GCaMP5G in larval motorneurons. This technique enabled ratiometric calcium imaging with motion correction allowing us to record synaptic activity at the neuromuscular junction in an intact larval preparation through the cuticle. The tools presented here should greatly facilitate the generation of 2A peptide-mediated expression of multiple transgenes in Drosophila.	[Daniels, Richard W.; Ganetzky, Barry] Univ Wisconsin, Genet Lab, Madison, WI 53706 USA; [Rossano, Adam J.; Macleod, Gregory T.] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA	University of Wisconsin System; University of Wisconsin Madison; University of Texas System; University of Texas Health San Antonio	Daniels, RW (corresponding author), Univ Wisconsin, Genet Lab, Madison, WI 53706 USA.	rwdaniels@wisc.edu		Rossano, Adam/0000-0001-8959-106X; Macleod, Gregory/0000-0003-3782-6968	National Institutes of Health National Institute on Aging [T32 AG000213, R01 AG033620]; National Science Foundation EAGER [IOS-1147467]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS083031, R01NS061914] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG033620, T32AG000213] Funding Source: NIH RePORTER	National Institutes of Health National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Science Foundation EAGER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by a National Institutes of Health National Institute on Aging training grant T32 AG000213 (R.W.D), R01 AG033620 (BG), and supported in part by a grant from the National Science Foundation EAGER IOS-1147467 (GTM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Barolo S, 2004, BIOTECHNIQUES, V36, P436, DOI 10.2144/04363ST03; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Cattaert D, 2001, J NEUROBIOL, V48, P58, DOI 10.1002/neu.1042; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chouhan AK, 2010, J NEUROSCI, V30, P1869, DOI 10.1523/JNEUROSCI.4701-09.2010; Diao FQ, 2012, GENETICS, V190, P1139, DOI 10.1534/genetics.111.136291; Donnelly MLL, 2001, J GEN VIROL, V82, P1027, DOI 10.1099/0022-1317-82-5-1027; Gonzalez M, 2011, SCI REP-UK, V1, DOI 10.1038/srep00075; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Inagaki HK, 2012, CELL, V148, P583, DOI 10.1016/j.cell.2011.12.022; KAUFMAN RJ, 1991, NUCLEIC ACIDS RES, V19, P4485, DOI 10.1093/nar/19.16.4485; Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556; Le T, 2007, BIOTECHNIQUES, V42, P162, DOI 10.2144/000112386; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Masuyama K, 2012, J NEUROGENET, V26, P89, DOI 10.3109/01677063.2011.642910; Minskaia E, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/291730; Pfeiffer BD, 2010, GENETICS, V186, P735, DOI 10.1534/genetics.110.119917; Rossano AJ, 2013, J PHYSIOL-LONDON, V591, P1691, DOI 10.1113/jphysiol.2012.248377; RYAN MD, 1991, J GEN VIROL, V72, P2727, DOI 10.1099/0022-1317-72-11-2727; RYAN MD, 1994, EMBO J, V13, P928, DOI 10.1002/j.1460-2075.1994.tb06337.x; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Tang W, 2009, J NEUROSCI, V29, P8621, DOI 10.1523/JNEUROSCI.0359-09.2009; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	25	73	78	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100637	10.1371/journal.pone.0100637	http://dx.doi.org/10.1371/journal.pone.0100637			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945148	Green Published, Green Submitted, gold			2022-12-27	WOS:000340721500101
J	Fang, YW; Liu, LY; Zhang, HL; Jiang, DF; Chu, D				Fang, Yi-Wei; Liu, Ling-Yun; Zhang, Hua-Li; Jiang, De-Feng; Chu, Dong			Competitive Ability and Fitness Differences between Two Introduced Populations of the Invasive Whitefly Bemisia tabaci Q in China	PLOS ONE			English	Article							CYTOPLASMIC INCOMPATIBILITY; BACTERIAL SYMBIONT; PARASITOID WASP; BIOTYPE-Q; ENCARSIA-PERGANDIELLA; RAPID SPREAD; WOLBACHIA; CARDINIUM; HEMIPTERA; MITOCHONDRIAL	Background: Our long-term field survey revealed that the Cardinium infection rate in Bemisia tabaci Q (also known as biotype Q) population was low in Shandong, China over the past few years. We hypothesize that (1) the Cardinium-infected (C+) B. tabaci Q population cannot efficiently compete with the Cardinium-uninfected (C-) B. tabaci Q population; (2) no reproductive isolation may have occurred between C+ and C-; and (3) the C-population has higher fitness than the C+ population. Methodology and Results: To reveal the differences in competitive ability and fitness between the two introduced populations (C+ and C-), competition between C+ and C- was examined over several generations. Subsequently, the reproductive isolation between C+ and C- was studied by crossing C+ with C- individuals, and the fitnesses of C+ and C- populations were compared using a two-sex life table method. Our results demonstrate that the competitive ability of the C+ whiteflies was weaker than that of C-. There is that no reproductive isolation occurred between the two populations and the C- population had higher fitness than the C+ population. Conclusion: The competitive ability and fitness differences of two populations may explain why C- whitefly populations have been dominant during the past few years in Shandong, China. However, the potential role Cardinium plays in whitefly should be further explored.	[Fang, Yi-Wei; Liu, Ling-Yun; Zhang, Hua-Li; Jiang, De-Feng; Chu, Dong] Qingdao Agr Univ, Coll Agron & Plant Protect, Key Lab Integrated Crop Pest Management Shandong, Qingdao, Peoples R China	Qingdao Agricultural University	Chu, D (corresponding author), Qingdao Agr Univ, Coll Agron & Plant Protect, Key Lab Integrated Crop Pest Management Shandong, Qingdao, Peoples R China.	chinachudong@qau.edu.cn	CHU, DONG/AAI-1892-2020; Chu, Dong/AAS-3914-2020	Chu, Dong/0000-0001-5716-4979	High-Level Talents Fund of Qingdao Agricultural University [631212]; National Natural Science Foundation of China [31272105]; Science and Technology Development Planning Program of Qingdao [13-1-3-108-nsh]; Taishan Mountain Scholar Constructive Engineering Foundation of Shandong	High-Level Talents Fund of Qingdao Agricultural University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Development Planning Program of Qingdao; Taishan Mountain Scholar Constructive Engineering Foundation of Shandong	This research was supported by the High-Level Talents Fund of Qingdao Agricultural University (631212), the National Natural Science Foundation of China (31272105), the Science and Technology Development Planning Program of Qingdao (13-1-3-108-nsh), and the Taishan Mountain Scholar Constructive Engineering Foundation of Shandong to D. Chu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackman RL, 1998, B ENTOMOL RES, V88, P213, DOI 10.1017/S0007485300025785; Breeuwer J.A.J., 1992, Insect Molecular Biology, V1, P25, DOI 10.1111/j.1365-2583.1993.tb00074.x; Brownstin JS, 2003, J INVERTEBR PATHOL, V84, P24, DOI 10.1016/S0022-2011(03)00082-X; Bull J.J., 1983, EVOLUTION SEX DETERM; Chi H, 2006, ENVIRON ENTOMOL, V35, P10, DOI 10.1603/0046-225X-35.1.10; CHI H, 1988, ENVIRON ENTOMOL, V17, P26, DOI 10.1093/ee/17.1.26; Chi H, 2019, TWOSEX MSCHART COMPU; Chiel E, 2007, B ENTOMOL RES, V97, P407, DOI 10.1017/S0007485307005159; Chu D, 2011, B ENTOMOL RES, V101, P467, DOI 10.1017/S0007485311000022; Chu D, 2011, B ENTOMOL RES, V101, P477, DOI 10.1017/S0007485311000083; Chu D, 2006, FLA ENTOMOL, V89, P168, DOI 10.1653/0015-4040(2006)89[168:TIOTEQ]2.0.CO;2; Chu D, 2012, J ECON ENTOMOL, V105, P242, DOI 10.1603/EC11039; Chu D, 2010, ENVIRON ENTOMOL, V39, P1028, DOI 10.1603/EN09161; Czosnek H, 2011, WHITEFLY, BEMISIA TABACI (HOMOPTERA: ALEYRODIDAE) INTERACTION WITH GEMINIVIRUS-INFECTED HOST PLANTS: BEMISIA TABACI, HOST PLANTS AND GEMINIVIRUSES, P51, DOI 10.1007/978-94-007-1524-0_3; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Fisher RA, 1930, GENETICAL THEORY NAT; Giorgini M, 2009, HEREDITY, V102, P365, DOI 10.1038/hdy.2008.135; GOODMAN D, 1982, AM NAT, V119, P803, DOI 10.1086/283956; Gotoh T, 2007, HEREDITY, V98, P13, DOI 10.1038/sj.hdy.6800881; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hagimori T, 2006, CURR MICROBIOL, V52, P97, DOI 10.1007/s00284-005-0092-0; Haine ER, 2008, P ROY SOC B-BIOL SCI, V275, P353, DOI 10.1098/rspb.2007.1211; Harris LR, 2010, HEREDITY, V104, P239, DOI 10.1038/hdy.2009.130; Himler AG, 2011, SCIENCE, V332, P254, DOI 10.1126/science.1199410; Hunter MS, 2003, P ROY SOC B-BIOL SCI, V270, P2185, DOI 10.1098/rspb.2003.2475; Hurst GDD, 1999, P ROY SOC B-BIOL SCI, V266, P735, DOI 10.1098/rspb.1999.0698; Jaenike J, 2010, SCIENCE, V329, P212, DOI 10.1126/science.1188235; Kenyon SG, 2007, J EVOLUTION BIOL, V20, P707, DOI 10.1111/j.1420-9101.2006.01238.x; Khasdan V, 2005, B ENTOMOL RES, V95, P605, DOI 10.1079/BER2005390; Kurtti TJ, 1996, J INVERTEBR PATHOL, V67, P318, DOI 10.1006/jipa.1996.0050; Li XC, 2012, PEST MANAG SCI, V68, P83, DOI 10.1002/ps.2227; Luan JB, 2008, ENTOMOL EXP APPL, V129, P316, DOI 10.1111/j.1570-7458.2008.00777.x; Min KT, 1997, P NATL ACAD SCI USA, V94, P10792, DOI 10.1073/pnas.94.20.10792; Nakamura Y, 2009, APPL ENVIRON MICROB, V75, P6757, DOI 10.1128/AEM.01583-09; Nirgianaki A, 2003, CURR MICROBIOL, V47, P93, DOI 10.1007/s00284-002-3969-1; Oliveira MRV, 2001, CROP PROT, V20, P709, DOI 10.1016/S0261-2194(01)00108-9; Pan HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030760; Pan HP, 2011, J ECON ENTOMOL, V104, P978, DOI 10.1603/EC11009; Provencher LM, 2005, ANN ENTOMOL SOC AM, V98, P629, DOI 10.1603/0013-8746(2005)098[0629:PITANC]2.0.CO;2; Ros VID, 2009, HEREDITY, V102, P413, DOI 10.1038/hdy.2009.4; ROUSSET F, 1992, P ROY SOC B-BIOL SCI, V250, P91, DOI 10.1098/rspb.1992.0135; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Stefanini A, 2012, J EVOLUTION BIOL, V25, P1521, DOI 10.1111/j.1420-9101.2012.02535.x; STOUTHAMER R, 1993, NATURE, V361, P66, DOI 10.1038/361066a0; Stouthamer R, 1999, ANNU REV MICROBIOL, V53, P71, DOI 10.1146/annurev.micro.53.1.71; Teng X, 2010, FLA ENTOMOL, V93, P363, DOI 10.1653/024.093.0307; Vanthournout B, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-15; Wang HL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-401; Wang JJ, 2008, J ECON ENTOMOL, V101, P1711, DOI 10.1603/0022-0493(2008)101[1711:EOROCI]2.0.CO;2; Wang XW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-458; Weeks AR, 2001, SCIENCE, V292, P2479, DOI 10.1126/science.1060411; Weeks AR, 2004, P ROY SOC B-BIOL SCI, V271, pS193, DOI 10.1098/rsbl.2003.0137; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; White JA, 2011, HEREDITY, V106, P585, DOI 10.1038/hdy.2010.89; White JA, 2009, HEREDITY, V102, P483, DOI 10.1038/hdy.2009.5; Zchori-Fein E, 2004, INT J SYST EVOL MICR, V54, P961, DOI 10.1099/ijs.0.02957-0; Zchori-Fein E, 2001, P NATL ACAD SCI USA, V98, P12555, DOI 10.1073/pnas.221467498; Zchori-Fein E, 2002, ANN ENTOMOL SOC AM, V95, P711, DOI 10.1603/0013-8746(2002)095[0711:DOPAWB]2.0.CO;2; Zhang XF, 2012, ENVIRON ENTOMOL, V41, P833, DOI 10.1603/EN12078	61	29	34	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100423	10.1371/journal.pone.0100423	http://dx.doi.org/10.1371/journal.pone.0100423			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945699	Green Submitted, gold, Green Published			2022-12-27	WOS:000340721500073
J	Jemec, GBE; Kerihuel, JC; Ousey, K; Lauemoller, SL; Leaper, DJ				Jemec, Gregor B. E.; Kerihuel, Jean Charles; Ousey, Karen; Lauemoller, Sanne Lise; Leaper, David John			Cost-Effective Use of Silver Dressings for the Treatment of Hard-to-Heal Chronic Venous Leg Ulcers	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; CHRONIC WOUNDS; COMPRESSION; PREVALENCE; MANAGEMENT; ETIOLOGY; VULCAN	Aim: To estimate the cost-effectiveness of silver dressings using a health economic model based on time-to-wound-healing in hard-to-heal chronic venous leg ulcers (VLUs). Background: Chronic venous ulceration affects 1-3% of the adult population and typically has a protracted course of healing, resulting in considerable costs to the healthcare system. The pathogenesis of VLUs includes excessive and prolonged inflammation which is often related to critical colonisation and early infection. The use of silver dressings to control this bioburden and improve wound healing rates remains controversial. Methods: A decision tree was constructed to evaluate the cost-effectiveness of treatment with silver compared with non-silver dressings for four weeks in a primary care setting. The outcomes: 'Healed ulcer', 'Healing ulcer' or 'No improvement' were developed, reflecting the relative reduction in ulcer area from baseline to four weeks of treatment. A data set from a recent meta-analysis, based on four RCTs, was applied to the model. Results: Treatment with silver dressings for an initial four weeks was found to give a total cost saving (141.57) pound compared with treatment with non-silver dressings. In addition, patients treated with silver dressings had a faster wound closure compared with those who had been treated with non-silver dressings. Conclusion: The use of silver dressings improves healing time and can lead to overall cost savings. These results can be used to guide healthcare decision makers in evaluating the economic aspects of treatment with silver dressings in hard-to-heal chronic VLUs.	[Jemec, Gregor B. E.] Univ Copenhagen, Roskilde Hosp, Fac Hlth Sci, Dept Dermatol, Copenhagen, Denmark; [Kerihuel, Jean Charles] Vertical, Paris, France; [Ousey, Karen; Leaper, David John] Univ Huddersfield, Sch Human & Hlth Sci, Huddersfield HD1 3DH, W Yorkshire, England; [Lauemoller, Sanne Lise] Coloplast AS, Humlebaek, Denmark	University of Copenhagen; University of Huddersfield	Lauemoller, SL (corresponding author), Coloplast AS, Humlebaek, Denmark.	dkslm@coloplast.com	Jemec, Gregor/H-6702-2019; Ousey, Karen/W-1881-2018	Jemec, Gregor/0000-0002-0712-2540; Ousey, Karen/0000-0002-6993-9425	Coloplast A/S	Coloplast A/S	Coloplast A/S funded the work of this study. SLL, employed by Coloplast A/S, participated as an author in the preparation of the manuscript. The funders had no role in study design, data collection and analysis, and decision to publish.	Ashby RL, 2013, LANCET; BAKER SR, 1992, EUR J VASCULAR SURG, V6, P245, DOI 10.1016/S0950-821X(05)80313-5; Barwell JR, 2004, LANCET, V363, P1854, DOI 10.1016/S0140-6736(04)16353-8; Carter MJ, 2010, J AM ACAD DERMATOL, V63, P668, DOI 10.1016/j.jaad.2009.09.007; Chambers H, 2007, WOUND REPAIR REGEN, V15, P165, DOI 10.1111/j.1524-475X.2007.00201.x; CORNWALL JV, 1986, BRIT J SURG, V73, P693, DOI 10.1002/bjs.1800730905; Davies CE, 2007, WOUND REPAIR REGEN, V15, P17, DOI 10.1111/j.1524-475X.2006.00180.x; Gottrup F, 2013, J WOUND CARE, V22, P413, DOI 10.12968/jowc.2013.22.8.413; Gottrup F, 2010, J WOUND CARE, V19, P239; Green Julie, 2010, Br J Community Nurs, V15, pS4; Hermans Michel H, 2007, Adv Skin Wound Care, V20, P166, DOI 10.1097/01.ASW.0000262712.05035.61; International consensus, 2012, WOUNDS INT; Lansdown A B G, 2002, J Wound Care, V11, P125; Leaper D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067083; Leaper D, 2012, INT WOUND J, V9, P461, DOI 10.1111/j.1742-481X.2012.01091.x; Leaper D, 2011, INT WOUND J, V8, P1, DOI 10.1111/j.1742-481X.2010.00766.x; Leaper David J, 2006, Int Wound J, V3, P282, DOI 10.1111/j.1742-481X.2006.00265.x; Leaper DJ, 2012, INT WOUND J, V9, P1, DOI 10.1111/j.1742-481X.2012.01097.x; Lo SF, 2008, J CLIN NURS, V17, P1973, DOI 10.1111/j.1365-2702.2007.02264.x; Lo SF, 2009, J CLIN NURS, V18, P716, DOI 10.1111/j.1365-2702.2008.02534.x; Maddox Debbie, 2012, Nurs Stand, V26, P42; Margolis DJ, 2002, J AM ACAD DERMATOL, V46, P381, DOI 10.1067/mjd.2002.121739; Margolis DJ, 2000, AM J MED, V109, P15, DOI 10.1016/S0002-9343(00)00379-X; Michaels JA, 2009, BRIT J SURG, V96, P1147, DOI 10.1002/bjs.6786; Scanlon Elizabeth, 2005, Int Wound J, V2, P150, DOI 10.1111/j.1742-4801.2005.00083.x; Senet P, 2013, INT WOUND J; Storm-Versloot MN, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006478.pub2; Trengove NJ, 2000, WOUND REPAIR REGEN, V8, P13, DOI 10.1046/j.1524-475x.2000.00013.x; Vermeulen H, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005486.pub2; Vowden K, 2009, J Wound Care, V18, P93; White RJ, 2006, OSTOMY WOUND MANAG, V52, P50	31	13	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100582	10.1371/journal.pone.0100582	http://dx.doi.org/10.1371/journal.pone.0100582			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945381	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000340721500094
J	Casaleggio, A; Hines, ML; Migliore, M				Casaleggio, Aldo; Hines, Michael L.; Migliore, Michele			Computational Model of Erratic Arrhythmias in a Cardiac Cell Network: The Role of Gap Junctions	PLOS ONE			English	Article							REENTRANT VENTRICULAR-TACHYCARDIA; OPEN-CHEST DOGS; ATRIAL-FIBRILLATION; MYOCARDIAL-ISCHEMIA; ION CHANNELS; HUMAN HEART; ELECTROPHYSIOLOGY; CONNEXINS; MUSCLE; TISSUE	Cardiac morbidity and mortality increases with the population age. To investigate the underlying pathological mechanisms, and suggest new ways to reduce clinical risks, computational approaches complementing experimental and clinical investigations are becoming more and more important. Here we explore the possible processes leading to the occasional onset and termination of the (usually) non-fatal arrhythmias widely observed in the heart. Using a computational model of a two-dimensional network of cardiac cells, we tested the hypothesis that an ischemia alters the properties of the gap junctions inside the ischemic area. In particular, in agreement with experimental findings, we assumed that an ischemic episode can alter the gap junctions of the affected cells by reducing their average conductance. We extended these changes to include random fluctuations with time, and modifications in the gap junction rectifying conductive properties of cells along the edges of the ischemic area. The results demonstrate how these alterations can qualitatively give an account of all the main types of non-fatal arrhythmia observed experimentally, and suggest how premature beats can be eliminated in three different ways: a) with a relatively small surgical procedure, b) with a pharmacological reduction of the rectifying conductive properties of the gap-junctions, and c) by pharmacologically decreasing the gap junction conductance. In conclusion, our model strongly supports the hypothesis that non-fatal arrhythmias can develop from post-ischemic alteration of the electrical connectivity in a relatively small area of the cardiac cell network, and suggests experimentally testable predictions on their possible treatments.	[Casaleggio, Aldo] CNR, Inst Biophys, Genoa, Italy; [Hines, Michael L.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA; [Migliore, Michele] CNR, Inst Biophys, Palermo, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); Yale University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR)	Casaleggio, A (corresponding author), CNR, Inst Biophys, Genoa, Italy.	casaleggio@ge.ibf.cnr.it	Migliore, Michele/D-7448-2011	Migliore, Michele/0000-0002-7584-6292	Institute of Biophysics of the National Research Council (Italy); NINDS [R01-NS11613]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS011613] Funding Source: NIH RePORTER	Institute of Biophysics of the National Research Council (Italy); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work has been supported by the Institute of Biophysics of the National Research Council (Italy) and by NINDS grant R01-NS11613 to MLH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLESSIE MA, 1977, CIRC RES, V41, P9, DOI 10.1161/01.RES.41.1.9; [Anonymous], PROG BIOPHYS MOL BIO, V104, P22; ANUMONWO JMB, 1992, CIRC RES, V71, P229, DOI 10.1161/01.RES.71.2.229; Beardslee MA, 2000, CIRC RES, V87, P656, DOI 10.1161/01.RES.87.8.656; BEELER GW, 1977, J PHYSIOL-LONDON, V268, P177, DOI 10.1113/jphysiol.1977.sp011853; Bruzzone R, 1996, EUR J BIOCHEM, V238, P1, DOI 10.1111/j.1432-1033.1996.0001q.x; Casaleggio A, 2007, EUROPACE, V9, P385, DOI 10.1093/europace/eum050; Ch'en FFT, 1998, PROG BIOPHYS MOL BIO, V69, P515, DOI 10.1016/S0079-6107(98)00023-6; Chaldoupi SM, 2009, CARDIOVASC RES, V84, P15, DOI 10.1093/cvr/cvp203; Chen J, 2000, CARDIOVASC RES, V48, P220, DOI 10.1016/S0008-6363(00)00177-2; Cooper J, 2011, PROG BIOPHYS MOL BIO, V107, P74, DOI 10.1016/j.pbiomolbio.2011.06.002; de Boer TP, 2006, CARDIOVASC RES, V71, P704, DOI 10.1016/j.cardiores.2006.06.001; de Groot JR, 2004, CARDIOVASC RES, V62, P323, DOI 10.1016/j.cardiores.2004.01.033; Desplantez T, 2004, PFLUG ARCH EUR J PHY, V448, P363, DOI 10.1007/s00424-004-1250-0; Dupont E, 2001, CIRCULATION, V103, P842, DOI 10.1161/01.CIR.103.6.842; Eckardt Lars, 2002, Heart Fail Monit, V2, P110; Fontes MSC, 2012, BBA-BIOMEMBRANES, V1818, P2020, DOI 10.1016/j.bbamem.2011.07.039; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Gollob MH, 2006, CURR OPIN CARDIOL, V21, P155, DOI 10.1097/01.hco.0000221574.95383.6f; HAN J, 1964, CIRC RES, V14, P44, DOI 10.1161/01.RES.14.1.44; Hennan JK, 2006, J PHARMACOL EXP THER, V317, P236, DOI 10.1124/jpet.105.096933; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Holzem KM, 2012, EUROPACE, V14, pV50, DOI 10.1093/europace/eus275; Huang XD, 1999, J CARDIOVASC ELECTR, V10, P79, DOI 10.1111/j.1540-8167.1999.tb00645.x; Jalife J, 2000, ANNU REV PHYSIOL, V62, P25, DOI 10.1146/annurev.physiol.62.1.25; Jansen JA, 2010, J MOL CELL CARDIOL, V48, P76, DOI 10.1016/j.yjmcc.2009.08.018; Keldermann RH, 2009, AM J PHYSIOL-HEART C, V296, pH370, DOI 10.1152/ajpheart.00952.2008; Kjolbye AL, 2007, BASIC CLIN PHARMACOL, V101, P215, DOI 10.1111/j.1742-7843.2007.00123.x; KLEBER AG, 1987, CIRC RES, V61, P271, DOI 10.1161/01.RES.61.2.271; LUKE RA, 1991, J CLIN INVEST, V87, P1594, DOI 10.1172/JCI115173; Mines GR, 1914, T R SOC CAN, V8, P43; Mirams GR, 2012, BRIT J PHARMACOL, V167, P932, DOI 10.1111/j.1476-5381.2012.02020.x; Moody GA, 2001, IEEE ENG MED BIOL, V20, P45, DOI 10.1109/51.932724; Moreno AP, 2004, CARDIOVASC RES, V62, P276, DOI 10.1016/j.cardiores.2004.03.003; Nerbonne JM, 2005, PHYSIOL REV, V85, P1205, DOI 10.1152/physrev.00002.2005; Pandit SV, 2013, CIRC RES, V112, P849, DOI 10.1161/CIRCRESAHA.111.300158; Peters NS, 1997, CIRCULATION, V95, P988; Prasad SM, 2003, J THORAC CARDIOV SUR, V126, P1822, DOI 10.1016/S0022-5223(03)01287-X; Rackauskas M, 2007, BIOPHYS J, V92, P1952, DOI 10.1529/biophysj.106.099358; Rudy Y, 2006, Q REV BIOPHYS, V39, P57, DOI 10.1017/S0033583506004227; Schotten U, 2011, PHYSIOL REV, V91, P265, DOI 10.1152/physrev.00031.2009; Severs NJ, 2008, CARDIOVASC RES, V80, P9, DOI 10.1093/cvr/cvn133; Spitzer Kenneth W, 2006, J Cardiovasc Electrophysiol, V17 Suppl 1, pS8, DOI 10.1111/j.1540-8167.2006.00379.x; Stevenson WG, 1997, J AM COLL CARDIOL, V29, P1180, DOI 10.1016/S0735-1097(97)00065-X; Takemoto Y, 2012, AM J PHYSIOL-HEART C, V303, pH578, DOI 10.1152/ajpheart.00355.2012; Tchou GD, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-102; ten Tusscher KHWJ, 2006, AM J PHYSIOL-HEART C, V291, pH1088, DOI 10.1152/ajpheart.00109.2006; Vaquero M, 2008, HEART RHYTHM, V5, P872, DOI 10.1016/j.hrthm.2008.02.034; Volman V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020572; Wilhelms M, 2013, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00487; WINFREE AT, 1994, SCIENCE, V266, P1003, DOI 10.1126/science.7973648; Winslow RL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003528; Woie L, 2011, EUROPACE, V13, P864, DOI 10.1093/europace/euq466; Worley SJ, 1998, PACE, V21, P1636, DOI 10.1111/j.1540-8159.1998.tb00253.x; Xing DZ, 2003, J CARDIOVASC ELECTR, V14, P510, DOI 10.1046/j.1540-8167.2003.02329.x; Yang L, 2010, BIOPHYS J, V98, P1428, DOI [10.1016/j.bpj.2009.12.4300, 10.1016/j.bpj.09.12.4300]	56	12	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100288	10.1371/journal.pone.0100288	http://dx.doi.org/10.1371/journal.pone.0100288			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941068	Green Published, Green Submitted, gold			2022-12-27	WOS:000338508200090
J	Kawaguchi, M; Satoh, Y; Otsubo, Y; Kazama, T				Kawaguchi, Masanori; Satoh, Yasushi; Otsubo, Yukiko; Kazama, Tomiei			Molecular Hydrogen Attenuates Neuropathic Pain in Mice	PLOS ONE			English	Article							RAT MODEL; THERMAL HYPERALGESIA; NITRIC-OXIDE; WATER; CONSUMPTION; STRESS; ANTIOXIDANT; PREVENTS; GROWTH; GAS	Neuropathic pain remains intractable and the development of new therapeutic strategies are urgently required. Accumulating evidence indicates that overproduction of oxidative stress is a key event in the pathogenesis of neuropathic pain. However, repeated intra-peritoneal or intrathecal injections of antioxidants are unsuitable for continuous use in therapy. Here we show a novel therapeutic method against neuropathic pain: drinking water containing molecular hydrogen (H-2) as antioxidant. The effect of hydrogen on neuropathic pain was investigated using a partial sciatic nerve ligation model in mice. As indicators of neuropathic pain, temporal aspects of mechanical allodynia and thermal hyperalgesia were analysed for 3 weeks after ligation. Mechanical allodynia and thermal hyperalgesia were measured using the von Frey test and the plantar test, respectively. When mice were allowed to drink water containing hydrogen at a saturated level ad libitum after ligation, both allodynia and hyperalgesia were alleviated. These symptoms were also alleviated when hydrogen was administered only for the induction phase (from day 0 to 4 after ligation). When hydrogen was administered only for the maintenance phase (from day 4 to 21 after ligation), hyperalgesia but not allodynia was alleviated. Immunohistochemical staining for the oxidative stress marker, 4-hydroxy-2-nonenal and 8-hydroxydeoxyguanosine, showed that hydrogen administration suppressed oxidative stress induced by ligation in the spinal cord and the dorsal root ganglion. In conclusion, oral administration of hydrogen water may be useful for alleviating neuropathic pain in a clinical setting.	[Kawaguchi, Masanori; Satoh, Yasushi; Otsubo, Yukiko; Kazama, Tomiei] Natl Def Med Coll, Dept Anesthesiol, Tokorozawa, Saitama 359, Japan	National Defense Medical College - Japan	Satoh, Y (corresponding author), Natl Def Med Coll, Dept Anesthesiol, Tokorozawa, Saitama 359, Japan.	wndlt3@gmail.com			JSPS (Japan Society for the Promotion of Science, Tokyo, Japan) [25293331]	JSPS (Japan Society for the Promotion of Science, Tokyo, Japan)	This work was supported by JSPS (Japan Society for the Promotion of Science, Tokyo, Japan; Grant number 25293331). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen QB, 2013, CAN J NEUROL SCI, V40, P857, DOI 10.1017/S0317167100016024; Fu Y, 2009, NEUROSCI LETT, V453, P81, DOI 10.1016/j.neulet.2009.02.016; Fujita K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007247; Hayashida K, 2008, BIOCHEM BIOPH RES CO, V373, P30, DOI 10.1016/j.bbrc.2008.05.165; Ishibashi T, 2012, MED GAS RES, V2, DOI 10.1186/2045-9912-2-27; Janes K, 2012, BBA-MOL BASIS DIS, V1822, P815, DOI 10.1016/j.bbadis.2011.12.008; Khalil Z, 1999, PAIN, V79, P31, DOI 10.1016/S0304-3959(98)00143-2; Kikkawa YS, 2009, NEUROREPORT, V20, P689, DOI 10.1097/WNR.0b013e32832a5c68; Kim HK, 2006, PAIN, V122, P53, DOI 10.1016/j.pain.2006.01.013; Kim HK, 2004, PAIN, V111, P116, DOI 10.1016/j.pain.2004.06.008; Ko YK, 2012, KOREAN J ANESTHESIOL, V62, P558, DOI 10.4097/kjae.2012.62.6.558; Lee I, 2007, PAIN, V133, P9, DOI 10.1016/j.pain.2007.01.035; Liu HJ, 2005, CIRC RES, V97, P967, DOI 10.1161/01.RES.0000188210.72062.10; Meeus M, 2013, EXPERT OPIN THER TAR, V17, P1081, DOI 10.1517/14728222.2013.818657; Murad F, 2004, BIOSCIENCE REP, V24, P452, DOI 10.1007/s10540-005-2741-8; Nagata K, 2009, NEUROPSYCHOPHARMACOL, V34, P501, DOI 10.1038/npp.2008.95; Nakashima-Kamimura N, 2009, CANCER CHEMOTH PHARM, V64, P753, DOI 10.1007/s00280-008-0924-2; Narita M, 2005, J NEUROSCI, V25, P10000, DOI 10.1523/JNEUROSCI.2507-05.2005; Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577; Ohsawa I, 2008, BIOCHEM BIOPH RES CO, V377, P1195, DOI 10.1016/j.bbrc.2008.10.156; Otsubo Y, 2012, PAIN, V153, P2241, DOI 10.1016/j.pain.2012.07.020; Sauer H, 2001, CELL PHYSIOL BIOCHEM, V11, P173, DOI 10.1159/000047804; Tal M, 1996, NEUROREPORT, V7, P1382, DOI 10.1097/00001756-199605310-00010; Tao F, 2013, STEM CELLS, V31, P83, DOI 10.1002/stem.1258; Tedesco LS, 2002, PAIN, V95, P215, DOI 10.1016/S0304-3959(01)00402-X; Twining CM, 2004, PAIN, V110, P299, DOI 10.1016/j.pain.2004.04.008; Yanagihara T, 2005, BIOSCI BIOTECH BIOCH, V69, P1985, DOI 10.1271/bbb.69.1985; Yonamine R, 2013, ANESTHESIOLOGY, V118, P105, DOI 10.1097/ALN.0b013e318275146d; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	29	26	28	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100352	10.1371/journal.pone.0100352	http://dx.doi.org/10.1371/journal.pone.0100352			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941001	gold, Green Published, Green Submitted			2022-12-27	WOS:000338508200096
J	Low, VL; Adler, PH; Takaoka, H; Ya'cob, Z; Lim, PE; Tan, TK; Lim, YAL; Chen, CD; Norma-Rashid, Y; Sofian-Azirun, M				Low, Van Lun; Adler, Peter H.; Takaoka, Hiroyuki; Ya'cob, Zubaidah; Lim, Phaik Eem; Tiong Kai Tan; Lim, Yvonne A. L.; Chen, Chee Dhang; Norma-Rashid, Yusoff; Sofian-Azirun, Mohd			Mitochondrial DNA Markers Reveal High Genetic Diversity but Low Genetic Differentiation in the Black Fly Simulium tani Takaoka & Davies along an Elevational Gradient in Malaysia	PLOS ONE			English	Article							POPULATION-GENETICS; DIPTERA; NEUTRALITY; EVOLUTION; GROWTH; TESTS	The population genetic structure of Simulium tani was inferred from mitochondria-encoded sequences of cytochrome c oxidase subunits I (COI) and II (COII) along an elevational gradient in Cameron Highlands, Malaysia. A statistical parsimony network of 71 individuals revealed 71 haplotypes in the COI gene and 43 haplotypes in the COII gene; the concatenated sequences of the COI and COII genes revealed 71 haplotypes. High levels of genetic diversity but low levels of genetic differentiation were observed among populations of S. tani at five elevations. The degree of genetic diversity, however, was not in accordance with an altitudinal gradient, and a Mantel test indicated that elevation did not have a limiting effect on gene flow. No ancestral haplotype of S. tani was found among the populations. Pupae with unique structural characters at the highest elevation showed a tendency to form their own haplotype cluster, as revealed by the COII gene. Tajima's D, Fu's Fs, and mismatch distribution tests revealed population expansion of S. tani in Cameron Highlands. A strong correlation was found between nucleotide diversity and the levels of dissolved oxygen in the streams where S. tani was collected.	[Low, Van Lun; Takaoka, Hiroyuki; Ya'cob, Zubaidah; Lim, Phaik Eem; Chen, Chee Dhang; Norma-Rashid, Yusoff; Sofian-Azirun, Mohd] Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur, Malaysia; [Adler, Peter H.] Clemson Univ, Sch Agr Forest & Environm Sci, Clemson, SC USA; [Lim, Phaik Eem] Univ Malaya, Inst Ocean & Earth Sci, Kuala Lumpur, Malaysia; [Tiong Kai Tan; Lim, Yvonne A. L.] Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia	Universiti Malaya; Clemson University; Universiti Malaya; Universiti Malaya	Low, VL (corresponding author), Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur, Malaysia.	lucaslow24@gmail.com	Low, Van Lun/C-8045-2013; LIM, YVONNE AL/B-5276-2010; Ya'cob, Zubaidah/R-4012-2019; Tan, Tiong Kai/F-6565-2013; LIM, Phaik Eem/B-5331-2010; Chen, Chee Dhang/C-6482-2011; Ya'cob, Zubaidah/L-7021-2017; Norma-Rashid, Y/B-8028-2010; Takaoka, Hiroyuki/G-6120-2010; AZIRUN, MOHD SOFIAN/B-9127-2010; Chen, Chee Dhang/ABD-9353-2021	Low, Van Lun/0000-0002-4299-5339; LIM, YVONNE AL/0000-0003-4050-6332; Tan, Tiong Kai/0000-0003-0297-1727; LIM, Phaik Eem/0000-0001-9186-1487; Ya'cob, Zubaidah/0000-0002-7178-6122; Norma-Rashid, Y/0000-0002-1450-1995; 	University of Malaya [RP003C-13SUS, RP003A-13SUS, RG164/12SUS]	University of Malaya(Universiti Malaya)	This work was funded by University of Malaya grants (RP003C-13SUS, RP003A-13SUS and RG164/12SUS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler P.H., 2014, WORLD BLACKFLIES DIP; Adler PH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070765; Adler PH, 2010, INFECT GENET EVOL, V10, P846, DOI 10.1016/j.meegid.2010.07.003; Ahumada JA, 2004, J MED ENTOMOL, V41, P1157, DOI 10.1603/0022-2585-41.6.1157; Anbalagan S, 2012, BIOLOGIA, V67, P1195, DOI 10.2478/s11756-012-0104-z; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barrow CJ, 2009, J ENVIRON MANAGE, V10, P89; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; Conflitti IM, 2010, MOL PHYLOGENET EVOL, V57, P245, DOI 10.1016/j.ympev.2010.06.024; Finn DS, 2006, FRESHWATER BIOL, V51, P2240, DOI 10.1111/j.1365-2427.2006.01647.x; Finn DS, 2006, MOL ECOL, V15, P3553, DOI 10.1111/j.1365-294X.2006.03034.x; Fu YX, 1997, GENETICS, V147, P915; GOVINDARAJU DR, 1989, J EVOLUTION BIOL, V2, P173, DOI 10.1046/j.1420-9101.1989.2030173.x; Grunewald J., 1981, P227; Guo QF, 2013, SCI REP-UK, V3, DOI 10.1038/srep03007; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HARPENDING HC, 1994, HUM BIOL, V66, P591; Hodkinson ID, 2005, BIOL REV, V80, P489, DOI 10.1017/S1464793105006767; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; MANTEL N, 1967, CANCER RES, V27, P209; McCain C.M., 2010, ENCY LIFE SCI ELS, DOI 10.1002/9780470015902.a0022548; Millest AL, 1999, MED VET ENTOMOL, V13, P139, DOI 10.1046/j.1365-2915.1999.00158.x; Pramual P, 2005, MOL ECOL, V14, P3989, DOI 10.1111/j.1365-294X.2005.02639.x; Pramual P, 2013, ENTOMOL SCI, V16, P298, DOI 10.1111/ens.12008; Pramual P, 2011, ENTOMOL SCI, V14, P428, DOI 10.1111/j.1479-8298.2011.00465.x; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Saadati N, 2012, CHEM CENT J, V6, DOI 10.1186/1752-153X-6-130; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Spehn EM, 2010, DATA MINING FOR GLOBAL TRENDS IN MOUNTAIN BIODIVERSITY, P1; Swofford DL, 2002, PAUP PHYLOGENETIC AN; TAJIMA F, 1989, GENETICS, V123, P585; Takaoka H, 2012, MED VET ENTOMOL, V26, P372, DOI 10.1111/j.1365-2915.2012.01023.x; Takaoka H., 1995, BLACK FLIES DIPTERA; Tangkawanit U, 2009, ZOOL J LINN SOC-LOND, V155, P289, DOI 10.1111/j.1096-3642.2008.00433.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wei XZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066928; Wright S., 1978, EVOLUTION GENETIC PO	38	26	27	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100512	10.1371/journal.pone.0100512	http://dx.doi.org/10.1371/journal.pone.0100512			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941043	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000338508200104
J	Schokker, D; Zhang, J; Zhang, LL; Vastenhouw, SA; Heilig, HGHJ; Smidt, H; Rebel, JMJ; Smits, MA				Schokker, Dirkjan; Zhang, Jing; Zhang, Ling-li; Vastenhouw, Stephanie A.; Heilig, Hans G. H. J.; Smidt, Hauke; Rebel, Johanna M. J.; Smits, Mari A.			Early-Life Environmental Variation Affects Intestinal Microbiota and Immune Development in New-Born Piglets	PLOS ONE			English	Article							PHYLOGENETIC MICROARRAY; GUT MICROBIOTA; STAPHYLOCOCCUS-AUREUS; INNATE IMMUNITY; HOMEOSTASIS; DIVERSITY; CYTOSCAPE; RESPONSES; ESTABLISHMENT; COLONIZATION	Background: Early-life environmental variation affects gut microbial colonization and immune competence development; however, the timing and additional specifics of these processes are unknown. The impact of early-life environmental variations, as experienced under real life circumstances, on gut microbial colonization and immune development has not been studied extensively so far. We designed a study to investigate environmental variation, experienced early after birth, to gut microbial colonization and intestinal immune development. Methodology/Principal Findings: To investigate effects of early-life environmental changes, the piglets of 16 piglet litters were divided into 3 groups per litter and experimentally treated on day 4 after birth. During the course of the experiment, the piglets were kept with their mother sow. Group 1 was not treated, group 2 was treated with an antibiotic, and group 3 was treated with an antibiotic and simultaneously exposed to several routine, but stressful management procedures, including docking, clipping and weighing. Thereafter, treatment effects were measured at day 8 after birth in 16 piglets per treatment group by community-scale analysis of gut microbiota and genome-wide intestinal transcriptome profiling. We observed that the applied antibiotic treatment affected the composition and diversity of gut microbiota and reduced the expression of a large number of immune-related processes. The effect of management procedures on top of the use of an antibiotic was limited. Conclusions/Significance: We provide direct evidence that different early-life conditions, specifically focusing on antibiotic treatment and exposure to stress, affect gut microbial colonization and intestinal immune development. This reinforces the notion that the early phase of life is critical for intestinal immune development, also under regular production circumstances.	[Schokker, Dirkjan; Smits, Mari A.] Wageningen UR Livestock Res, Anim Breeding & Genom Ctr, Lelystad, Netherlands; [Zhang, Jing; Zhang, Ling-li; Heilig, Hans G. H. J.; Smidt, Hauke] Wageningen Univ, Microbiol Lab, NL-6700 AP Wageningen, Netherlands; [Vastenhouw, Stephanie A.; Rebel, Johanna M. J.; Smits, Mari A.] Cent Vet Inst, Lelystad, Netherlands	Wageningen University & Research; Wageningen University & Research; Wageningen University & Research	Schokker, D (corresponding author), Wageningen UR Livestock Res, Anim Breeding & Genom Ctr, Lelystad, Netherlands.	dirkjan.schokker@wur.nl	Smidt, Hauke/D-7054-2014; Schokker, Dirkjan/AAB-2668-2020; Schokker, Dirkjan/M-6385-2014; smits, mari/J-4892-2013	Smidt, Hauke/0000-0002-6138-5026; Schokker, Dirkjan/0000-0001-6082-7227; Schokker, Dirkjan/0000-0001-6082-7227; smits, mari/0000-0002-3493-291X; Rebel, Annemarie/0000-0003-4765-4215	Dutch Ministry of Economic Affairs; Central Veterinary Institute; Wageningen Livestock Research; China Scholarship Programme; European Union [227549]	Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); Central Veterinary Institute; Wageningen Livestock Research; China Scholarship Programme; European Union(European Commission)	D.S., S. A. V., J.M.J.R., and M. A. S. were supported by the funding of Dutch Ministry of Economic Affairs, Central Veterinary Institute and Wageningen Livestock Research. J.Z. was supported by a fellowship of the China Scholarship Programme, and J.Z., L.Z. and H. S. were partly supported by the European Union through the Interplay project, Grant agreement no. 227549). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlerberth I, 2009, ACTA PAEDIATR, V98, P229, DOI 10.1111/j.1651-2227.2008.01060.x; Barsky A, 2007, BIOINFORMATICS, V23, P1040, DOI 10.1093/bioinformatics/btm057; Bopp T, 2007, J EXP MED, V204, P1303, DOI 10.1084/jem.20062129; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; Chung HC, 2012, CELL, V149, P1578, DOI 10.1016/j.cell.2012.04.037; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; Derrien M, 2010, THESIS WAGENINGEN U, P40; Dominguez-Bello MG, 2011, GASTROENTEROLOGY, V140, P1713, DOI 10.1053/j.gastro.2011.02.011; El Aidy S, 2012, MUCOSAL IMMUNOL, V5, P567, DOI 10.1038/mi.2012.32; Geuking MB, 2011, GUT MICROBES, P2; Gittins R., 1986, ACTA BIOTHEOR, V35, P135; Haenen D, 2013, J NUTR, V143, P274, DOI 10.3945/jn.112.169672; Hansen CHF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034043; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hulst M, 2012, ARCH VIROLOGY; Inman CF, 2010, CLIN EXP IMMUNOL, V160, P431, DOI 10.1111/j.1365-2249.2010.04090.x; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Janczyk P, 2007, ISME J, V1, P180, DOI 10.1038/ismej.2007.29; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kelly D, 2007, MUTAT RES-FUND MOL M, V622, P58, DOI 10.1016/j.mrfmmm.2007.03.011; Konstantinov SR, 2006, ENVIRON MICROBIOL, V8, P1191, DOI 10.1111/j.1462-2920.2006.01009.x; Leps J, 2003, MULTIVARIATE ANAL EC; Lewis MC, 2012, PEDIAT ALLERGY IMMUN; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lindberg E, 2004, J CLIN MICROBIOL, V42, P530, DOI 10.1128/JCM.42.2.530-534.2004; Lindberg E, 2011, CLIN MICROBIOL INFEC, V17, P1209, DOI 10.1111/j.1469-0691.2010.03426.x; Lindberg E, 2000, PEDIATR RES, V48, P741, DOI 10.1203/00006450-200012000-00007; Lynn DJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.55; Mangin I, 2010, ANAEROBE, V16, P433, DOI 10.1016/j.anaerobe.2010.06.005; Mangin I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050257; Maslowski KM, 2011, NAT IMMUNOL, V12, P5, DOI 10.1038/ni0111-5; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mulder IE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028279; Mulder IE, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-79; O'Mahony SM, 2009, BIOL PSYCHIAT, V65, P263, DOI 10.1016/j.biopsych.2008.06.026; O'Sullivan O, 2013, J ANTIMICROB CHEMOTH, V68, P214, DOI 10.1093/jac/dks348; Ohnmacht C, 2011, CELL MICROBIOL, V13, P653, DOI 10.1111/j.1462-5822.2011.01577.x; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Penders J, 2007, ALLERGY, V62, P1223, DOI 10.1111/j.1398-9995.2007.01462.x; Penders J, 2007, GUT, V56, P661, DOI 10.1136/gut.2006.100164; Perez Gutierrez O., 2010, UNRAVELING PIGLET GU; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rajilic-Stojanovic M, 2010, MICROBIOL-SGM, V156, P3270, DOI 10.1099/mic.0.042044-0; Rajilic-Stojanovic M, 2009, ENVIRON MICROBIOL, V11, P1736, DOI 10.1111/j.1462-2920.2009.01900.x; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Salonen A, 2010, J MICROBIOL METH, V81, P127, DOI 10.1016/j.mimet.2010.02.007; Schmidt B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028284; Schreur PJW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022299; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; ter Braak C., 1990, UPDATE NOTES CANOCO; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; van Baarlen P, 2013, TRENDS IMMUNOL, V34, P208, DOI 10.1016/j.it.2013.01.005; van Baarlen P, 2011, P NATL ACAD SCI USA, V108, P4562, DOI 10.1073/pnas.1000079107; Van den Abbeele P, 2011, FEMS MICROBIOL REV, V35, P681, DOI 10.1111/j.1574-6976.2011.00270.x; van den Bogert B, 2011, APPL ENVIRON MICROB, V77, P2071, DOI 10.1128/AEM.02477-10; Wagner RD, 2008, ADV EXP MED BIOL, V635, P41, DOI 10.1007/978-0-387-09550-9_4; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04	63	108	119	5	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100040	10.1371/journal.pone.0100040	http://dx.doi.org/10.1371/journal.pone.0100040			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941112	Green Submitted, Green Published, gold			2022-12-27	WOS:000338508200069
J	Shahab, M; Verma, M; Pathak, M; Mitra, K; Misra-Bhattacharya, S				Shahab, Mohd; Verma, Meenakshi; Pathak, Manisha; Mitra, Kalyan; Misra-Bhattacharya, Shailja			Cloning, Expression and Characterization of UDP-N-Acetylglucosamine Enolpyruvyl Transferase (MurA) from Wolbachia Endosymbiont of Human Lymphatic Filarial Parasite Brugia malayi	PLOS ONE			English	Article							LIPID II BIOSYNTHESIS; CELL-WALL; PEPTIDOGLYCAN BIOSYNTHESIS; BACTERIAL ENDOSYMBIONTS; ANTIFILARIAL ACTIVITY; IDENTIFICATION; PROTEIN; TETRACYCLINE; TARGET; ENDOBACTERIA	Wolbachia, an endosymbiont of filarial nematode, is considered a promising target for treatment of lymphatic filariasis. Although functional characterization of the Wolbachia peptidoglycan assembly has not been fully explored, the Wolbachia genome provides evidence for coding all of the genes involved in lipid II biosynthesis, a part of peptidoglycan biosynthesis pathway. UDP-N-acetylglucosamine enolpyruvyl transferase (MurA) is one of the lipid II biosynthesis pathway enzymes and it has inevitably been recognized as an antibiotic target. In view of the vital role of MurA in bacterial viability and survival, MurA ortholog from Wolbachia endosymbiont of Brugia malayi (wBm-MurA) was cloned, expressed and purified for further molecular characterization. The enzyme kinetics and inhibition studies were undertaken using fosfomycin. wBm-MurA was found to be expressed in all the major life stages of B. malayi and was immunolocalized in Wolbachia within the microfilariae and female adults by the confocal microscopy. Sequence analysis suggests that the amino acids crucial for enzymatic activity are conserved. The purified wBm-MurA was shown to possess the EPSP synthase (3-phosphoshikimate 1-carboxyvinyltransferase) like activity at a broad pH range with optimal activity at pH 7.5 and 37 degrees C temperature. The apparent affinity constant (K-m) for the substrate UDP-N-acetylglucosamine was found to be 0.03149 mM and for phosphoenolpyruvate 0.009198 mM. The relative enzymatic activity was inhibited similar to 2 fold in presence of fosfomycin. Superimposition of the wBm-MurA homology model with the structural model of Haemophilus influenzae (Hi-MurA) suggests binding of fosfomycin at the same active site. The findings suggest wBm-MurA to be a putative antifilarial drug target for screening of novel compounds.	[Shahab, Mohd; Verma, Meenakshi; Mitra, Kalyan; Misra-Bhattacharya, Shailja] AcSIR, New Delhi, India; [Shahab, Mohd; Verma, Meenakshi; Pathak, Manisha; Misra-Bhattacharya, Shailja] CSIR Cent Drug Res Inst, Div Parasitol, Lucknow, Uttar Pradesh, India; [Mitra, Kalyan] CSIR Cent Drug Res Inst, Lucknow, Uttar Pradesh, India	Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Misra-Bhattacharya, S (corresponding author), AcSIR, New Delhi, India.	shailja_cdri@rediffmail.com			Indian Council of Medical Research (ICMR), New Delhi, India; CSIR Network Project SPLenDID	Indian Council of Medical Research (ICMR), New Delhi, India(Indian Council of Medical Research (ICMR)); CSIR Network Project SPLenDID	The financial supports in the form of research fellowships by Indian Council of Medical Research (ICMR), New Delhi, India to MS, MV and MP along with the financial assistance in the form of CSIR Network Project SPLenDID were gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, WKLY EPIDEMIOL REC, V37, P346; Bandi C, 1999, INT J PARASITOL, V29, P357, DOI 10.1016/S0020-7519(98)00200-8; Bandi C, 2001, VET PARASITOL, V98, P215, DOI 10.1016/S0304-4017(01)00432-0; Barreteau H, 2008, FEMS MICROBIOL REV, V32, P168, DOI 10.1111/j.1574-6976.2008.00104.x; Baum EZ, 2001, ANTIMICROB AGENTS CH, V45, P3182, DOI 10.1128/AAC.45.11.3182-3188.2001; Blake KL, 2009, MOL MICROBIOL, V72, P335, DOI 10.1111/j.1365-2958.2009.06648.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN ED, 1995, J BACTERIOL, V177, P4194, DOI 10.1128/jb.177.14.4194-4197.1995; BUGG TDH, 1992, NAT PROD REP, V9, P199, DOI 10.1039/np9920900199; De Smet KAL, 1999, MICROBIOL-UK, V145, P3177, DOI 10.1099/00221287-145-11-3177; Du WS, 2000, J BACTERIOL, V182, P4146, DOI 10.1128/JB.182.15.4146-4152.2000; Eschenburg S, 2000, PROTEINS, V40, P290, DOI 10.1002/(SICI)1097-0134(20000801)40:2<290::AID-PROT90>3.0.CO;2-0; Eschenburg S, 2005, J BIOL CHEM, V280, P3757, DOI 10.1074/jbc.M411325200; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Fenn K, 2004, TRENDS ECOL EVOL, V19, P163, DOI 10.1016/j.tree.2004.01.002; Foster J, 2005, PLOS BIOL, V3, P599, DOI 10.1371/journal.pbio.0030121; Gautam A, 2011, APPL MICROBIOL BIOT, V92, P211, DOI 10.1007/s00253-011-3512-z; Ghedin E, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000525; Haegeman A, 2009, INT J PARASITOL, V39, P1045, DOI 10.1016/j.ijpara.2009.01.006; Henrichfreise B, 2009, MOL MICROBIOL, V73, P913, DOI 10.1111/j.1365-2958.2009.06815.x; Hertig M, 1924, J MED RES, V44, P329; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; James CE, 2009, TRENDS PARASITOL, V25, P328, DOI 10.1016/j.pt.2009.04.004; Johnson KA, 2011, BIOCHEMISTRY-US, V50, P8264, DOI 10.1021/bi201284u; KAHAN FM, 1974, ANN NY ACAD SCI, V235, P364, DOI 10.1111/j.1749-6632.1974.tb43277.x; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Langworthy NG, 2000, P ROY SOC B-BIOL SCI, V267, P1063, DOI 10.1098/rspb.2000.1110; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laskowski RA, 2009, NUCLEIC ACIDS RES, V37, pD355, DOI 10.1093/nar/gkn860; Lentz CS, 2013, CHEM BIOL, V20, P177, DOI 10.1016/j.chembiol.2012.11.009; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Li HJ, 2012, J HARD TISSUE BIOL, V21, P17, DOI 10.2485/jhtb.21.17; Li ZR, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0035834, 10.1371/journal.pone.0051597]; MARQUARDT JL, 1994, BIOCHEMISTRY-US, V33, P10646, DOI 10.1021/bi00201a011; MCCALL JW, 1973, J PARASITOL, V59, P436, DOI 10.2307/3278767; McCoy AJ, 2003, J BACTERIOL, V185, P1218, DOI 10.1128/JB.185.4.1218-1228.2003; Mizyed S, 2005, BIOCHEMISTRY-US, V44, P4011, DOI 10.1021/bi047704w; PADAN E, 1981, BIOCHIM BIOPHYS ACTA, V650, P151, DOI 10.1016/0304-4157(81)90004-6; Pfarr K, 2005, PLOS MED, V2, P289, DOI 10.1371/journal.pmed.0020110; Punkosdy GA, 2001, J INFECT DIS, V184, P385, DOI 10.1086/322023; Rana AK, 2013, ANTIMICROB AGENTS CH, V57, P3843, DOI 10.1128/AAC.02264-12; Samland AK, 1999, BIOCHEMISTRY-US, V38, P13162, DOI 10.1021/bi991041e; SANGER I, 1981, ACTA TROP, V38, P277; Schiefer A, 2013, J ANTIMICROB CHEMOTH, V68, P1790, DOI 10.1093/jac/dkt105; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Shahab Mohd, 2012, Current Pharmacogenomics & Personalized Medicine, V10, P148; Shrivastava N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041113; Silver LL, 2006, BIOCHEM PHARMACOL, V71, P996, DOI 10.1016/j.bcp.2005.10.029; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Skarzynski T, 1996, STRUCTURE, V4, P1465, DOI 10.1016/S0969-2126(96)00153-0; SUZUKI T, 1979, JPN J EXP MED, V49, P117; Takahata S, 2010, INT J ANTIMICROB AG, V35, P333, DOI 10.1016/j.ijantimicag.2009.11.011; Taylor MJ, 2005, ADV PARASIT, V60, P245, DOI 10.1016/S0065-308X(05)60004-8; Taylor MJ, 1999, PARASITOL TODAY, V15, P437, DOI 10.1016/S0169-4758(99)01533-1; Vollmer J, 2013, INT J MED MICROBIOL, V303, P140, DOI 10.1016/j.ijmm.2013.01.002; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Voronin D, 2012, P NATL ACAD SCI USA, V109, pE1638, DOI 10.1073/pnas.1203519109; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; Wolstenholme AJ, 2004, TRENDS PARASITOL, V20, P469, DOI 10.1016/j.pt.2004.07.010; Xu D, 2011, BIOPHYS J, V101, P2525, DOI 10.1016/j.bpj.2011.10.024; Yoon HJ, 2008, PROTEINS, V71, P1032, DOI 10.1002/prot.21959	63	7	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99884	10.1371/journal.pone.0099884	http://dx.doi.org/10.1371/journal.pone.0099884			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941309	Green Published, Green Submitted, gold			2022-12-27	WOS:000338508200050
J	Xu, SF; Zhou, F; Tao, JS; Song, L; Ng, SC; Wang, XB; Chen, LP; Yi, FM; Ran, ZH; Zhou, R; Xia, B				Xu, Shufang; Zhou, Feng; Tao, Jinsheng; Song, Lu; Siew Chien Ng; Wang, Xiaobing; Chen, Liping; Yi, Fengming; Ran, Zhihua; Zhou, Rui; Xia, Bing			Exome Sequencing Identifies DLG1 as a Novel Gene for Potential Susceptibility to Crohn's Disease in a Chinese Family Study	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; HERITABILITY; GENERATION; MUTATIONS; SINGLE; RARE	Background: Genetic variants make some contributions to inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis (UC). More than 100 susceptibility loci were identified in Western IBD studies, but susceptibility gene has not been found in Chinese IBD patients till now. Sequencing of individuals with an IBD family history is a powerful approach toward our understanding of the genetics and pathogenesis of IBD. The aim of this study, which focuses on a Han Chinese CD family, is to identify high-risk variants and potentially novel loci using whole exome sequencing technique. Methods: Exome sequence data from 4 individuals belonging to a same family were analyzed using bioinformatics methods to narrow down the variants associated with CD. The potential risk genes were further analyzed by genotyping and Sanger sequencing in family members, additional 401 healthy controls (HC), 278 sporadic CD patients, 123 UC cases, a pair of monozygotic CD twins and another Chinese CD family. Results: From the CD family in which the father and daughter were affected, we identified a novel single nucleotide variant (SNV) c.374T>C (p.I125T) in exon 4 of discs large homolog 1 (DLG1), a gene has been reported to play mutiple roles in cell proliferation, T cell polarity and T cell receptor signaling. After genotyping among case and controls, a PLINK analysis showed the variant was of significance (P<0.05). 4 CD patients of the other Chinese family bore another non-synonymous variant c.833G>A (p.R278Q) in exon 9 of DLG1. Conclusions: We have discovered novel genetic variants in the coding regions of DLG1 gene, the results support that DLG1 is a novel potential susceptibility gene for CD in Chinese patients.	[Xu, Shufang; Zhou, Feng; Song, Lu; Wang, Xiaobing; Chen, Liping; Yi, Fengming; Xia, Bing] Wuhan Univ, Sch Med, Zhongnan Hosp, Dept Gastroenterol, Wuhan 430072, Peoples R China; [Zhou, Feng; Chen, Liping; Zhou, Rui; Xia, Bing] Hubei Clin Ctr, Wuhan, Peoples R China; [Zhou, Feng; Chen, Liping; Zhou, Rui; Xia, Bing] Key Lab Intestinal & Colorectal Dis, Wuhan, Peoples R China; [Zhou, Feng; Chen, Liping; Zhou, Rui; Xia, Bing] Hubei Key Lab Immune Related Dis, Wuhan, Peoples R China; [Tao, Jinsheng] BGI Shenzhen, Bei Shan Ind Zone, Shenzhen, Peoples R China; [Siew Chien Ng] Chinese Univ Hong Kong, Inst Digest Dis, Dept Med & Therapeut, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China; [Ran, Zhihua] Shanghai Jiao Tong Univ, Sch Med, Dept Gastroenterol, Renji Hosp,Shanghai Inst Digest Dis, Shanghai 200030, Peoples R China	Wuhan University; Beijing Genomics Institute (BGI); Chinese University of Hong Kong; Shanghai Jiao Tong University	Xia, B (corresponding author), Wuhan Univ, Sch Med, Zhongnan Hosp, Dept Gastroenterol, Wuhan 430072, Peoples R China.	bingxia@aliyun.com	Ng, Siew Chien/N-4733-2015	Ng, Siew Chien/0000-0002-6850-4454; Wang, Xiaobing/0000-0002-3134-0556	Hubei Clinical Center and Key Laboratory of Intestinal and Colorectal Diseases; Natural Science Foundation of China [81070280]; Ministry of Public Health of China [201002020]	Hubei Clinical Center and Key Laboratory of Intestinal and Colorectal Diseases; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Public Health of China	The study was supported by the Hubei Clinical Center and Key Laboratory of Intestinal and Colorectal Diseases, the Natural Science Foundation of China (No. 81070280) and a grant from the Ministry of Public Health of China (201002020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Brant SR, 2011, INFLAMM BOWEL DIS, V17, P1, DOI 10.1002/ibd.21385; Brunham LR, 2013, HUM GENET, V132, P603, DOI 10.1007/s00439-013-1286-3; Chatterjee S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034343; Cho JH, 2011, GASTROENTEROLOGY, V140, P1704, DOI 10.1053/j.gastro.2011.02.046; Christodoulou K, 2013, GUT, V62, P977, DOI 10.1136/gutjnl-2011-301833; Clarke AJ, 2010, EUR J HUM GENET, V18, P859, DOI 10.1038/ejhg.2010.35; Danese S, 2012, GUT, V61, P918, DOI 10.1136/gutjnl-2011-300904; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Freeman HJ, 2002, J CLIN GASTROENTEROL, V35, P9, DOI 10.1097/00004836-200207000-00004; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Gibson G, 2009, NAT REV GENET, V10, P134, DOI 10.1038/nrg2502; Gilissen C, 2012, EUR J HUM GENET, V20, P490, DOI 10.1038/ejhg.2011.258; Glocker EO, 2010, LANCET, V376, P1272, DOI 10.1016/S0140-6736(10)61008-2; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Gmyrek GB, 2013, EUR J IMMUNOL, V43, P1185, DOI 10.1002/eji.201142362; Humphries LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045276; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Liu XM, 2011, HUM MUTAT, V32, P894, DOI 10.1002/humu.21517; MacDonald TT, 2011, GASTROENTEROLOGY, V140, P1768, DOI 10.1053/j.gastro.2011.02.047; Majewski J, 2011, J MED GENET, V48, P580, DOI 10.1136/jmedgenet-2011-100223; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Mao H, 2012, GENES IMMUN, V13, P437, DOI 10.1038/gene.2012.8; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mitchell KJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-237; Mowat C, 2011, GUT, V60, P571, DOI 10.1136/gut.2010.224154; Nazarian A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044162; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ng SC, 2013, GASTROENTEROLOGY, V145, P158, DOI 10.1053/j.gastro.2013.04.007; O'Neill AK, 2011, J BIOL CHEM, V286, P43559, DOI 10.1074/jbc.M111.294603; Plevy SE, 2011, GASTROENTEROLOGY, V140, P1838, DOI 10.1053/j.gastro.2011.02.014; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Strober W, 2011, GASTROENTEROLOGY, V140, P1756, DOI 10.1053/j.gastro.2011.02.016; Surena AL, 2009, BBA-MOL CELL RES, V1793, P264, DOI 10.1016/j.bbamcr.2008.09.005; Teer JK, 2010, HUM MOL GENET, V19, pR145, DOI 10.1093/hmg/ddq333; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Van Assche G, 2010, J CROHNS COLITIS, V4, P7, DOI 10.1016/j.crohns.2009.12.003; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Worthey EA, 2011, GENET MED, V13, P255, DOI 10.1097/GIM.0b013e3182088158; Xavier R, 2004, J CELL BIOL, V166, P173, DOI 10.1083/jcb.200309044; Yi FM, 2012, EUR J GASTROEN HEPAT, V24, P1424, DOI 10.1097/MEG.0b013e3283583e5c; Zhao J, 2013, INFLAMM BOWEL DIS, V19, P1839, DOI 10.1097/MIB.0b013e31828a6551	45	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99807	10.1371/journal.pone.0099807	http://dx.doi.org/10.1371/journal.pone.0099807			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937328	Green Published, Green Submitted, gold			2022-12-27	WOS:000338503400039
J	Ao, Y; Mich-Basso, JD; Lin, B; Yang, L				Ao, Ying; Mich-Basso, Jocelyn Danielle; Lin, Bo; Yang, Lei			High Efficient Differentiation of Functional Hepatocytes from Porcine Induced Pluripotent Stem Cells	PLOS ONE			English	Article							HEPATIC DIFFERENTIATION; DEFINITIVE ENDODERM; EPITHELIAL-CELLS; GROWTH-FACTOR; LIVER; EXPRESSION; TRANSPLANTATION; COMBINATION; GENERATION; PATHWAYS	Hepatocyte transplantation is considered to be a promising therapy for patients with liver diseases. Induced pluripotent stem cells (iPSCs) provide an unlimited source for the generation of functional hepatocytes. In this study, we generated iPSCs from porcine ear fibroblasts (PEFs) by overexpressing Sox2, Klf4, Oct4, and c-Myc (SKOM), and developed a novel strategy for the efficient differentiation of hepatocyte-like cells from porcine iPSCs by following the processes of early liver development. The differentiated cells displayed the phenotypes of hepatocytes, exhibited classic hepatocyte-associated bio-functions, such as LDL uptake, glycogen storage and urea secretion, as well as possessed the metabolic activities of cytochrome P-450 (CYP) 3A and 2C. Furthermore, we compared the hepatocyte differentiation efficacy of our protocol with another published method, and the results demonstrated that our differentiation strategy could significantly improve the generation of morphological and functional hepatocyte-like cells from porcine iPSCs. In conclusion, this study establishes an efficient method for in vitro generation of functional hepatocytes from porcine iPSCs, which could represent a promising cell source for preclinical testing of cell-based therapeutics for liver failure and for pharmacological applications.	[Ao, Ying] Wuhan Univ, Dept Pharmacol, Basic Med Sch, Wuhan 430072, Hubei, Peoples R China; [Ao, Ying; Mich-Basso, Jocelyn Danielle; Lin, Bo; Yang, Lei] Univ Pittsburgh, Sch Med, Dept Dev Biol, Pittsburgh, PA 15260 USA	Wuhan University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Yang, L (corresponding author), Univ Pittsburgh, Sch Med, Dept Dev Biol, Pittsburgh, PA 15260 USA.	lyang@pitt.edu	Yang, Lei/D-7462-2015		National Institutes of Health Grants through the University of Pittsburgh Clinical and Translational Science Institute [UL1 RR024153, UL1TR000005]; National Natural Science Foundation of China [81001466]; State Scholarship Fund of China [201208420547]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER	National Institutes of Health Grants through the University of Pittsburgh Clinical and Translational Science Institute; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Scholarship Fund of China; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by the National Institutes of Health Grants UL1 RR024153 and UL1TR000005 through the University of Pittsburgh Clinical and Translational Science Institute to Stem Cell Core at of University of Pittsburgh under direction by L.Y., and by National Natural Science Foundation of China (No. 81001466) and State Scholarship Fund of China (No. 201208420547) to Y.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2008, STEM CELLS, V26, P1117, DOI 10.1634/stemcells.2007-1102; Aravalli RN, 2012, VET J, V194, P369, DOI 10.1016/j.tvjl.2012.05.013; Balasiddaiah A, 2013, J PHYSIOL BIOCHEM, V69, P835, DOI 10.1007/s13105-013-0260-9; Basma H, 2009, GASTROENTEROLOGY, V136, P990, DOI 10.1053/j.gastro.2008.10.047; BELANGER L, 1981, BIOCHEMISTRY-US, V20, P6665, DOI 10.1021/bi00526a022; Caperna TJ, 2011, IN VITRO CELL DEV-AN, V47, P218, DOI 10.1007/s11626-010-9382-3; Chen YF, 2012, HEPATOLOGY, V55, P1193, DOI 10.1002/hep.24790; Cheng X, 2012, CELL STEM CELL, V10, P371, DOI 10.1016/j.stem.2012.02.024; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; DEJUAN C, 1992, J CELL PHYSIOL, V152, P95, DOI 10.1002/jcp.1041520113; Fitzpatrick E, 2009, J INTERN MED, V266, P339, DOI 10.1111/j.1365-2796.2009.02152.x; Fondevila C, 2011, J SURG RES, V167, pE39, DOI 10.1016/j.jss.2011.01.012; Kubo A, 2004, DEVELOPMENT, V131, P1651, DOI 10.1242/dev.01044; Ma XC, 2013, STEM CELL TRANSL MED, V2, P409, DOI 10.5966/sctm.2012-0160; NAWA K, 1986, J BIOL CHEM, V261, P6883; Nieuwoudt M, 2006, BIOMATERIALS, V27, P3836, DOI 10.1016/j.biomaterials.2006.02.013; Qian LC, 2012, BIOTECHNOL J, V7, P440, DOI 10.1002/biot.201100184; Rossi JM, 2001, GENE DEV, V15, P1998, DOI 10.1101/gad.904601; Sanchez A, 2010, WORLD J GASTROENTERO, V16, P5148, DOI 10.3748/wjg.v16.i41.5148; Sancho-Bru P, 2011, J HEPATOL, V54, P98, DOI 10.1016/j.jhep.2010.06.014; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Snykers S, 2009, STEM CELLS, V27, P577, DOI 10.1634/stemcells.2008-0963; Sui L, 2013, INT J DEV BIOL, V57, P1, DOI [10.1387/ijdb.1201151s, 10.1387/ijdb.120115ls]; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tanimizu N, 2004, J CELL SCI, V117, P3165, DOI 10.1242/jcs.01169; Watt AJ, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-37; Wu Z, 2009, J MOL CELL BIOL, V1, P46, DOI 10.1093/jmcb/mjp003; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu Y, 2012, STEM CELL RES, V9, P196, DOI 10.1016/j.scr.2012.06.004; Zhang Q, 2011, CHINESE MED J-PEKING, V124, P3786, DOI 10.3760/cma.j.issn.0366-6999.2011.22.033; Zhang WX, 2010, ADV DRUG DELIVER REV, V62, P814, DOI 10.1016/j.addr.2010.02.005	31	16	17	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100417	10.1371/journal.pone.0100417	http://dx.doi.org/10.1371/journal.pone.0100417			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949734	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000338276300073
J	Hansell, AL; Rose, N; Cowie, CT; Belousova, EG; Bakolis, I; Ng, K; Toelle, BG; Marks, GB				Hansell, Anna L.; Rose, Nectarios; Cowie, Christine T.; Belousova, Elena G.; Bakolis, Ioannis; Ng, Kitty; Toelle, Brett G.; Marks, Guy B.		Childhood Asthma Prevention Study	Weighted Road Density and Allergic Disease in Children at High Risk of Developing Asthma	PLOS ONE			English	Article							AIR-POLLUTION EXPOSURE; RESPIRATORY SYMPTOMS; LUNG-FUNCTION; NITROGEN-DIOXIDE; BRONCHIAL HYPERRESPONSIVENESS; CHILDHOOD ASTHMA; SCHOOLCHILDREN; SENSITIZATION; PREVALENCE; ATOPY	Background: Evidence for an association between traffic-related air pollution and allergic disease is inconsistent, possibly because the adverse effects may be limited to susceptible subgroups and these have not been identified. This study examined children in the Childhood Asthma Prevention Study (CAPS), potentially susceptible to air pollution effects because of a family history of asthma. Methods: We examined cross-sectional associations at age eight years between road density within 75 m and 50 m of home address weighted by road type (traffic density), as a proxy for traffic-related air pollution, on the following allergic and respiratory outcomes: skin prick tests (SPTs), total and specific serum IgE, pre- and post-bronchodilator lung function, airway hyperresponsiveness, exhaled NO, and reported asthma and rhinitis. Results: Weighted road density was positively associated with allergic sensitisation and allergic rhinitis. Adjusted relative risk (RR) for house dust mite (HDM) positive SPT was 1.25 (95% CI: 1.06-1.48), for detectable house dust mite-specific IgE was 1.19 (95% CI: 1.01-1.41) and for allergic rhinitis was 1.30 (95% CI: 1.03-1.63) per 100 m local road or 33.3 m motorway within 50 m of home. Associations were also seen with small decrements of peak and mid-expiratory flows and increased risk of asthma, current wheeze and rhinitis in atopic children. Conclusion: Associations between road density and allergic disease were found in a potentially susceptible subgroup of children at high risk of developing atopy and asthma.	[Hansell, Anna L.; Bakolis, Ioannis] Univ London Imperial Coll Sci Technol & Med, MRC PHE Ctr Environm & Hlth, London, England; [Hansell, Anna L.] Imperial Coll Healthcare NHS Trust, Publ Hlth & Primary Care Directorate, London, England; [Rose, Nectarios; Cowie, Christine T.; Belousova, Elena G.; Ng, Kitty; Toelle, Brett G.; Marks, Guy B.] Univ Sydney, Woolcock Inst Med Res, Sydney, NSW 2006, Australia; [Rose, Nectarios] New South Wales Hlth Minist, Sydney, NSW, Australia; [Cowie, Christine T.; Marks, Guy B.] Univ New S Wales, South West Sydney Clin Sch, Liverpool, NSW, Australia; [Toelle, Brett G.] Sydney Local Hlth Dist, Sydney, NSW, Australia; [Marks, Guy B.] Liverpool Hosp, Dept Resp Med, Liverpool, NSW, Australia	Imperial College London; Imperial College London; University of Sydney; Woolcock Institute of Medical Research; University of New South Wales Sydney; Liverpool Hospital	Hansell, AL (corresponding author), Univ London Imperial Coll Sci Technol & Med, MRC PHE Ctr Environm & Hlth, London, England.	a.hansell@imperial.ac.uk	Toelle, Brett G/B-1531-2008; Cowie, Christine T/M-2864-2017; Cowie, Christine/X-5945-2019; Marks, Guy B./F-5058-2013	Toelle, Brett G/0000-0002-7375-0019; Cowie, Christine T/0000-0003-1177-4733; Cowie, Christine/0000-0003-1177-4733; Marks, Guy B./0000-0002-8976-8053; Bakolis, Ioannis/0000-0002-4800-1630; Garden, Frances/0000-0003-1653-3031; Hansell, Anna/0000-0001-9904-7447; Rose, Nectarios/0000-0002-7384-9967	National Health and Medical Research Council of Australia; Cooperative Research Centre for Asthma; New South Wales Department of Health; Children's Hospital Westmead; University of Sydney, Faculty of Medicine; Wellcome Trust [075833]; University of Sydney International Visiting Research Fellowship; New South Wales Department of Health Biostatistical Training Program; Medical Research Council [G0801056] Funding Source: researchfish; MRC [G0801056] Funding Source: UKRI	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cooperative Research Centre for Asthma(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); New South Wales Department of Health; Children's Hospital Westmead; University of Sydney, Faculty of Medicine(University of Sydney); Wellcome Trust(Wellcome TrustEuropean Commission); University of Sydney International Visiting Research Fellowship(University of Sydney); New South Wales Department of Health Biostatistical Training Program; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Sources of funding and support for this work include: National Health and Medical Research Council of Australia, Cooperative Research Centre for Asthma, New South Wales Department of Health, Children's Hospital Westmead, University of Sydney, Faculty of Medicine, University of Sydney, Faculty of Medicine, Strategic Research Grant 2008. Contributions of goods and services were made by Allergopharma Joachim Ganzer KG Germany, John Sands Australia, Hasbro, Toll refrigerated, AstraZeneca Australia, and Nu-Mega Ingredients Pty Ltd. Goods were provided at reduced cost by Auspharm, Allersearch and Goodman Fielder Foods. AH was funded by Wellcome Trust grant number 075833 and a University of Sydney International Visiting Research Fellowship. NR was supported by the New South Wales Department of Health Biostatistical Training Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Australian Institute of Health and Welfare website. Australian Centre for Asthma Monitoring (ACAM), 2011, AIHW ASTHM SER, V6; Baumann LM, 2011, J ALLERGY CLIN IMMUN, V127, P875, DOI 10.1016/j.jaci.2010.11.031; Bel EH, 2004, CURR OPIN PULM MED, V10, P44, DOI 10.1097/00063198-200401000-00008; Braback L, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-17; Brauer M, 2002, AM J RESP CRIT CARE, V166, P1092, DOI 10.1164/rccm.200108-007OC; Dales R, 2008, ENVIRON HEALTH PERSP, V116, P1423, DOI 10.1289/ehp.10943; Department of Environment CCaWN, 2010, CURR AIR QUAL NEW S; Diaz-Sanchez D, 1999, J ALLERGY CLIN IMMUN, V104, P1183, DOI 10.1016/S0091-6749(99)70011-4; Gauderman WJ, 2005, EPIDEMIOLOGY, V16, P737, DOI 10.1097/01.ede.0000181308.51440.75; Gehring U, 2013, ENVIRON HEALTH PERSP, V121, P1357, DOI 10.1289/ehp.1306770; Gehring U, 2010, AM J RESP CRIT CARE, V181, P596, DOI 10.1164/rccm.200906-0858OC; Gilbert NL, 2003, SCI TOTAL ENVIRON, V312, P43, DOI 10.1016/S0048-9697(03)00228-6; Gruzieva O, 2014, J ALLERGY CLIN IMMUN, V133, P767, DOI 10.1016/j.jaci.2013.07.048; Gruzieva O, 2012, J ALLERGY CLIN IMMUN, V129, P240, DOI 10.1016/j.jaci.2011.11.001; HEI publications website, 2010, TRAFFIC RELATED AIR; Hirsch T, 1999, EUR RESPIR J, V14, P669, DOI 10.1034/j.1399-3003.1999.14c29.x; Janssen NAH, 2003, ENVIRON HEALTH PERSP, V111, P1512, DOI 10.1289/ehp.6243; Karner AA, 2010, ENVIRON SCI TECHNOL, V44, P5334, DOI 10.1021/es100008x; Kim JJ, 2004, AM J RESP CRIT CARE, V170, P520, DOI 10.1164/rccm.200403-281OC; Lee YL, 2011, INT J HYG ENVIR HEAL, V214, P369, DOI 10.1016/j.ijheh.2011.05.004; Mihrshahi S, 2001, CONTROL CLIN TRIALS, V22, P333, DOI 10.1016/S0197-2456(01)00112-X; Morgenstern V, 2008, AM J RESP CRIT CARE, V177, P1331, DOI 10.1164/rccm.200701-036OC; Nicolai T, 2003, EUR RESPIR J, V21, P956, DOI 10.1183/09031936.03.00041103a; Nordling E, 2008, EPIDEMIOLOGY, V19, P401, DOI 10.1097/EDE.0b013e31816a1ce3; Osman Mustafa, 2007, Prim Care Respir J, V16, P28, DOI 10.3132/pcrj.2007.00006; Pearce N, 1999, THORAX, V54, P268, DOI 10.1136/thx.54.3.268; PEAT JK, 1990, J ALLERGY CLIN IMMUN, V85, P65, DOI 10.1016/0091-6749(90)90223-Q; Peters JM, 1999, AM J RESP CRIT CARE, V159, P760, DOI 10.1164/ajrccm.159.3.9804143; Pujades-Rodriguez M, 2009, OCCUP ENVIRON MED, V66, P679, DOI 10.1136/oem.2008.043885; Rose N, 2009, ATMOS ENVIRON, V43, P5009, DOI 10.1016/j.atmosenv.2009.06.049; Rosenlund M, 2009, THORAX, V64, P573, DOI 10.1136/thx.2007.094953; Schultz ES, 2012, AM J RESP CRIT CARE, V186, P1286, DOI 10.1164/rccm.201206-1045OC; Shima M, 2000, INT J EPIDEMIOL, V29, P862, DOI 10.1093/ije/29.5.862; Studnicka M, 1997, EUR RESPIR J, V10, P2275, DOI 10.1183/09031936.97.10102275; Toelle BG, 2004, BRIT MED J, V328, P386, DOI 10.1136/bmj.328.7436.386; Toelle BG, 2010, J ALLERGY CLIN IMMUN, V126, P388, DOI 10.1016/j.jaci.2010.04.031; vanVliet P, 1997, ENVIRON RES, V74, P122, DOI 10.1006/enrs.1997.3757; Venn A, 2000, OCCUP ENVIRON MED, V57, P152, DOI 10.1136/oem.57.3.152; WJST M, 1993, BRIT MED J, V307, P596, DOI 10.1136/bmj.307.6904.596; Zhou Y, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-89; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	41	16	16	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e98978	10.1371/journal.pone.0098978	http://dx.doi.org/10.1371/journal.pone.0098978			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949625	gold, Green Published, Green Submitted			2022-12-27	WOS:000338276300008
J	Luo, R; Jeong, SJ; Yang, AN; Wen, MY; Saslowsky, DE; Lencer, WI; Arac, D; Piao, XH				Luo, Rong; Jeong, Sung-Jin; Yang, Annie; Wen, Miaoyun; Saslowsky, David E.; Lencer, Wayne I.; Arac, Demet; Piao, Xianhua			Mechanism for Adhesion G Protein-Coupled Receptor GPR56-Mediated RhoA Activation Induced By Collagen III Stimulation	PLOS ONE			English	Article							LIPID RAFTS; CELL-ADHESION; FRONTOPARIETAL POLYMICROGYRIA; GPR56; GPCR; LAMINATION; EXPRESSION; SUBUNITS; DOMAIN; ROLES	GPR56 is a member of the adhesion G protein-coupled receptor (GPCR) family. Despite the importance of GPR56 in brain development, where mutations cause a devastating human brain malformation called bilateral frontoparietal polymicrogyria (BFPP), the signaling mechanism(s) remain largely unknown. Like many other adhesion GPCRs, GPR56 is cleaved via a GPCR autoproteolysis-inducing (GAIN) domain into N- and C-terminal fragments (GPR56(N) and GPR56(C)); however, the biological significance of this cleavage is elusive. Taking advantage of the recent identification of a GPR56 ligand and the presence of BFPP-associated mutations, we investigated the molecular mechanism of GPR56 signaling. We demonstrate that ligand binding releases GPR56(N) from the membrane-bound GPR56(C) and triggers the association of GPR56(C) with lipid rafts and RhoA activation. Furthermore, one of the BFPP-associated mutations, L640R, does not affect collagen III-induced lipid raft association of GPR56. Instead, it specifically abolishes collagen III-mediated RhoA activation. Together, these findings reveal a novel signaling mechanism that may apply to other members of the adhesion GPCR family.	[Luo, Rong; Jeong, Sung-Jin; Yang, Annie; Wen, Miaoyun; Piao, Xianhua] Boston Childrens Hosp, Div Newborn Med, Boston, MA 02115 USA; [Luo, Rong; Jeong, Sung-Jin; Yang, Annie; Wen, Miaoyun; Piao, Xianhua] Harvard Univ, Sch Med, Boston, MA USA; [Saslowsky, David E.; Lencer, Wayne I.] Boston Childrens Hosp, Div Gastroenterol, Boston, MA USA; [Arac, Demet] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; University of Chicago	Piao, XH (corresponding author), Boston Childrens Hosp, Div Newborn Med, Boston, MA 02115 USA.	xianhua.piao@childrens.harvard.edu		Lencer, Wayne/0000-0001-7346-2730; Piao, Xianhua/0000-0001-7540-6767	National Institute of Neurological Disorders and Stroke (NINDS) [R01 NS057536]; William Randolph Hearst Fund Award; Leonard and Isabelle Goldenson Research Fellowship; Cerebral Palsy International Research Foundation Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048106, R37DK048106] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057536] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); William Randolph Hearst Fund Award; Leonard and Isabelle Goldenson Research Fellowship; Cerebral Palsy International Research Foundation Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported in part by National Institute of Neurological Disorders and Stroke (NINDS) grant R01 NS057536 (X. P.); William Randolph Hearst Fund Award (S.J. & R. L); Leonard and Isabelle Goldenson Research Fellowship (R. L.); and Cerebral Palsy International Research Foundation Award (S.J.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arac D, 2012, EMBO J, V31, P1364, DOI 10.1038/emboj.2012.26; Bjarnadottir TK, 2004, GENOMICS, V84, P23, DOI 10.1016/j.ygeno.2003.12.004; Chiang NY, 2011, J BIOL CHEM, V286, P14215, DOI 10.1074/jbc.M110.183830; Guirland C, 2007, ADV EXP MED BIOL, V621, P144, DOI 10.1007/978-0-387-76715-4_11; Hollenstein K, 2013, NATURE, V499, P438, DOI 10.1038/nature12357; Huang YS, 2012, MOL CELL BIOL, V32, P1408, DOI 10.1128/MCB.06557-11; Jeong SJ, 2012, J COMP NEUROL, V520, P2930, DOI 10.1002/cne.23076; Jeong SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029767; Jin ZH, 2007, HUM MOL GENET, V16, P1972, DOI 10.1093/hmg/ddm144; Koirala S, 2009, J NEUROSCI, V29, P7439, DOI 10.1523/JNEUROSCI.1182-09.2009; Langenhan T, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003825; LENCER WI, 1995, P NATL ACAD SCI USA, V92, P10094, DOI 10.1073/pnas.92.22.10094; Li SH, 2008, J NEUROSCI, V28, P5817, DOI 10.1523/JNEUROSCI.0853-08.2008; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Luo R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029818; Luo R, 2011, P NATL ACAD SCI USA, V108, P12925, DOI 10.1073/pnas.1104821108; Luo R, 2011, PEDIATR NEUROL, V45, P49, DOI 10.1016/j.pediatrneurol.2011.02.004; Paavola KJ, 2011, J BIOL CHEM, V286, P28914, DOI 10.1074/jbc.M111.247973; Parrini E, 2008, EPILEPSIA; Piao XH, 2005, ANN NEUROL, V58, P680, DOI 10.1002/ana.20616; Piao XH, 2004, SCIENCE, V303, P2033, DOI 10.1126/science.1092780; Promel S, 2013, TRENDS PHARMACOL SCI, V34, P470, DOI 10.1016/j.tips.2013.06.002; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Shashidhar S, 2005, ONCOGENE, V24, P1673, DOI 10.1038/sj.onc.1208395; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; Staubach S, 2011, EXPERT REV PROTEOMIC, V8, P263, DOI [10.1586/EPR.11.2, 10.1586/epr.11.2]; Xu L, 2006, P NATL ACAD SCI USA, V103, P9023, DOI 10.1073/pnas.0602681103; Yang L, 2011, CANC RES; Yona S, 2008, TRENDS BIOCHEM SCI, V33, P491, DOI 10.1016/j.tibs.2008.07.005	32	47	49	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100043	10.1371/journal.pone.0100043	http://dx.doi.org/10.1371/journal.pone.0100043			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949629	Green Published, gold, Green Submitted			2022-12-27	WOS:000338276300032
J	Manresa, JAB; Fritsche, R; Vuilleumier, PH; Oehler, C; Morch, CD; Arendt-Nielsen, L; Andersen, OK; Curatolo, M				Manresa, Jose A. Biurrun; Fritsche, Raphael; Vuilleumier, Pascal H.; Oehler, Carmen; Morch, Carsten D.; Arendt-Nielsen, Lars; Andersen, Ole K.; Curatolo, Michele			Is the Conditioned Pain Modulation Paradigm Reliable? A Test-Retest Assessment Using the Nociceptive Withdrawal Reflex	PLOS ONE			English	Article							NOXIOUS INHIBITORY CONTROLS; TENSION-TYPE HEADACHE; TEMPORAL SUMMATION; RELIABILITY; STIMULI; FIBROMYALGIA; COEFFICIENT; ERROR	The aim of this study was to determine the reliability of the conditioned pain modulation (CPM) paradigm assessed by an objective electrophysiological method, the nociceptive withdrawal reflex (NWR), and psychophysical measures, using hypothetical sample sizes for future studies as analytical goals. Thirty-four healthy volunteers participated in two identical experimental sessions, separated by 1 to 3 weeks. In each session, the cold pressor test (CPT) was used to induce CPM, and the NWR thresholds, electrical pain detection thresholds and pain intensity ratings after suprathreshold electrical stimulation were assessed before and during CPT. CPM was consistently detected by all methods, and the electrophysiological measures did not introduce additional variation to the assessment. In particular, 99% of the trials resulted in higher NWR thresholds during CPT, with an average increase of 3.4 mA (p<0.001). Similarly, 96% of the trials resulted in higher electrical pain detection thresholds during CPT, with an average increase of 2.2 mA (p<0.001). Pain intensity ratings after suprathreshold electrical stimulation were reduced during CPT in 84% of the trials, displaying an average decrease of 1.5 points in a numeric rating scale (p<0.001). Under these experimental conditions, CPM reliability was acceptable for all assessment methods in terms of sample sizes for potential experiments. The presented results are encouraging with regards to the use of the CPM as an assessment tool in experimental and clinical pain.	[Manresa, Jose A. Biurrun; Morch, Carsten D.; Arendt-Nielsen, Lars; Andersen, Ole K.; Curatolo, Michele] Aalborg Univ, Dept Hlth Sci & Technol, Ctr Sensory Motor Interact, Aalborg, Denmark; [Fritsche, Raphael; Oehler, Carmen] Univ Bern, Inselspital, Univ Dept Anaesthesiol & Pain Therapy, CH-3010 Bern, Switzerland; [Vuilleumier, Pascal H.; Curatolo, Michele] Univ Washington, Dept Anaesthesiol & Pain Med, Seattle, WA 98195 USA	Aalborg University; University of Bern; University Hospital of Bern; University of Washington; University of Washington Seattle	Manresa, JAB (corresponding author), Aalborg Univ, Dept Hlth Sci & Technol, Ctr Sensory Motor Interact, Aalborg, Denmark.	jbiurrun@hst.aau.dk	Manresa, José A Biurrun/Q-4801-2017; Manresa, José A Biurrun/B-2190-2012; Arendt-Nielsen, Lars/T-4885-2018; Mørch, Carsten Dahl/J-5639-2019; Andersen, Ole Kæseler/J-7825-2013; Curatolo, Michele/A-5859-2011	Manresa, José A Biurrun/0000-0003-4060-9665; Mørch, Carsten Dahl/0000-0001-6693-2028; Andersen, Ole Kæseler/0000-0001-6307-8786; Curatolo, Michele/0000-0003-4130-6826; Vuilleumier, Pascal/0000-0002-9286-6797; Arendt-Nielsen, Lars/0000-0003-0892-1579	Swiss National Science Foundation (SPUM) [33CM30_124117]; Scientific Funds of the University Department of Anesthesiology, Inselspital Bern, Switzerland	Swiss National Science Foundation (SPUM)(Swiss National Science Foundation (SNSF)); Scientific Funds of the University Department of Anesthesiology, Inselspital Bern, Switzerland	This study is part of a project financed by the Swiss National Science Foundation (SPUM no. 33CM30_124117) and the Scientific Funds of the University Department of Anesthesiology, Inselspital Bern, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arendt-Nielsen L, 2012, CLIN J PAIN, V28, P623, DOI 10.1097/AJP.0b013e31823e15cb; Arendt-Nielsen L, 2010, PAIN, V149, P573, DOI 10.1016/j.pain.2010.04.003; Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; Atkinson G, 2000, SPORTS MED, V30, P375, DOI 10.2165/00007256-200030050-00005; Batterham AM, 2003, PHYS THER SPORT, V4, P122, DOI 10.1016/S1466-853X(03)00076-2; Biurrun Manresa JA, 2013, PAIN; Bland JM, 1996, BRIT MED J, V313, P744; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Bruton A, 2000, PHYSIOTHERAPY, V86, P94, DOI [10.1016/S0031-9406(05)61211-4, DOI 10.1016/S0031-9406(05)61211-4, 10.1016/s0031-9406(05)61211-4]; Buchgreitz L, 2008, BRAIN, V131, P3232, DOI 10.1093/brain/awn199; Cathcart S, 2009, PAIN RES MANAG, V14, P433, DOI 10.1155/2009/523098; Cathcart S, 2010, HEADACHE, V50, P403, DOI 10.1111/j.1526-4610.2009.01545.x; Curatolo M, 2011, SPINE, V36, pS200, DOI 10.1097/BRS.0b013e3182387f3d; Dransfield RD, 2012, GET TOP STAT DESIGN; Fitzpatrick R, 1998, HEALTH TECHNOL ASSES, V2; Gozariu M, 1997, J NEUROPHYSIOL, V78, P3165, DOI 10.1152/jn.1997.78.6.3165; Heymen S, 2010, CLIN J PAIN, V26, P104, DOI 10.1097/AJP.0b013e3181bff800; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Julien N, 2005, PAIN, V114, P295, DOI 10.1016/j.pain.2004.12.032; Julious SA, 2004, STAT MED, V23, P1921, DOI 10.1002/sim.1783; King CD, 2009, PAIN, V143, P172, DOI 10.1016/j.pain.2008.12.027; Lautenbacher S, 1997, CLIN J PAIN, V13, P189, DOI 10.1097/00002508-199709000-00003; LEBARS D, 1979, PAIN, V6, P283, DOI 10.1016/0304-3959(79)90049-6; Lewis GN, 2012, PAIN RES MANAG, V17, P98, DOI 10.1155/2012/610561; Manresa JAB, 2011, EUR J APPL PHYSIOL, V111, P83, DOI 10.1007/s00421-010-1634-0; Martel MO, 2013, PAIN MED; Micalos PS, 2009, EUR J APPL PHYSIOL, V105, P55, DOI 10.1007/s00421-008-0872-x; Moloney NA, 2012, J REHABIL RES DEV, V49, P191, DOI 10.1682/JRRD.2011.03.0044; Moloney NA, 2011, MUSCLE NERVE, V44, P547, DOI 10.1002/mus.22121; Morch Carsten Dahl, 2013, Int J Physiol Pathophysiol Pharmacol, V5, P203; MORROW JR, 1993, RES Q EXERCISE SPORT, V64, P352, DOI 10.1080/02701367.1993.10608821; Neziri AY, 2010, EUR J PAIN, V14, DOI 10.1016/j.ejpain.2009.04.010; Olds T, 2002, J SCI MED SPORT, V5, P336, DOI 10.1016/S1440-2440(02)80021-4; Olesen SS, 2012, REGION ANESTH PAIN M, V37, P530, DOI 10.1097/AAP.0b013e3182632c40; Olesen SS, 2010, CLIN GASTROENTEROL H, V8, P724, DOI 10.1016/j.cgh.2010.03.005; Oono Y, 2011, SCAND J PAIN, V2, P162, DOI 10.1016/j.sjpain.2011.05.006; Piche M, 2010, PAIN, V148, P49, DOI 10.1016/j.pain.2009.10.005; Pielsticker A, 2005, PAIN, V118, P215, DOI 10.1016/j.pain.2005.08.019; Potvin S, 2010, EUR J PAIN, V14, P742, DOI 10.1016/j.ejpain.2009.12.004; Potvin S, 2009, J PAIN, V10, P969, DOI 10.1016/j.jpain.2009.03.013; Pud D, 2009, PAIN, V144, P16, DOI 10.1016/j.pain.2009.02.015; Quan H, 1996, BIOMETRICS, V52, P1195, DOI 10.2307/2532835; Rhudy JL, 2010, PAIN, V149, P365, DOI 10.1016/j.pain.2010.02.041; ROBYBRAMI A, 1987, BRAIN, V110, P1497, DOI 10.1093/brain/110.6.1497; SANDRINI G, 1986, PAIN, V25, P403, DOI 10.1016/0304-3959(86)90245-9; Sandrini G, 2006, CEPHALALGIA, V26, P782, DOI 10.1111/j.1468-2982.2006.01130.x; Sandrini G, 2005, PROG NEUROBIOL, V77, P353, DOI 10.1016/j.pneurobio.2005.11.003; Serrao M, 2004, PAIN, V112, P353, DOI 10.1016/j.pain.2004.09.018; Song GH, 2006, PAIN, V126, P79, DOI 10.1016/j.pain.2006.06.017; Staud R, 2003, PAIN, V101, P167, DOI 10.1016/S0304-3959(02)00325-1; Terkelsen AJ, 2001, ACTA PHYSIOL SCAND, V172, P211, DOI 10.1046/j.1365-201x.2001.00856.x; Valencia C, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-182; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; WILLER JC, 1984, BRAIN, V107, P1095, DOI 10.1093/brain/107.4.1095; WILLER JC, 1989, J NEUROPHYSIOL, V62, P1028, DOI 10.1152/jn.1989.62.5.1028; Wilson H, 2013, PAIN, V154, P2633, DOI 10.1016/j.pain.2013.06.038; Yarnitsky D, 2012, PAIN, V153, P1193, DOI 10.1016/j.pain.2012.02.021; Yarnitsky D, 2010, CURR OPIN ANESTHESIO, V23, P611, DOI 10.1097/ACO.0b013e32833c348b; Yarnitsky D, 2010, EUR J PAIN, V14, P339, DOI 10.1016/j.ejpain.2010.02.004	59	44	45	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100241	10.1371/journal.pone.0100241	http://dx.doi.org/10.1371/journal.pone.0100241			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950186	gold, Green Published, Green Submitted			2022-12-27	WOS:000338276300053
J	Reynard, F; Vuadens, P; Deriaz, O; Terrier, P				Reynard, Fabienne; Vuadens, Philippe; Deriaz, Olivier; Terrier, Philippe			Could Local Dynamic Stability Serve as an Early Predictor of Falls in Patients with Moderate Neurological Gait Disorders? A Reliability and Comparison Study in Healthy Individuals and in Patients with Paresis of the Lower Extremities	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; OLDER-ADULTS; SPACE RECONSTRUCTION; LYAPUNOV EXPONENTS; WALKING SPEED; RISK-FACTORS; VARIABILITY; BALANCE; STROKE; MOTION	Falls while walking are frequent in patients with muscular dysfunction resulting from neurological disorders. Falls induce injuries that may lead to deconditioning and disabilities, which further increase the risk of falling. Therefore, an early gait stability index would be useful to evaluate patients in order to prevent the occurrence of future falls. Derived from chaos theory, local dynamic stability (LDS), defined by the maximal Lyapunov exponent, assesses the sensitivity of a dynamic system to small perturbations. LDS has already been used for fall risk prediction in elderly people. The aim of the present study was to provide information to facilitate future researches regarding gait stability in patients with neurological gait disorders. The main objectives were 1) to evaluate the intra-session repeatability of LDS in patients and 2) to assess the discriminative power of LDS to differentiate between healthy individuals and neurological patients. Eighty-three patients with mild to moderate neurological disorders associated with paresis of the lower extremities and 40 healthy controls participated in the study. The participants performed 2x30 s walking wearing a 3D accelerometer attached to the lower back, from which 2x35 steps were extracted. LDS was defined as the average exponential rate of divergence among trajectories in a reconstructed state-space that reflected the gait dynamics. LDS assessed along the medio-lateral axis offered the highest repeatability and discriminative power. Intra-session repeatability (intraclass correlation coefficient between the two repetitions) in the patients was 0.89 and the smallest detectable difference was 16%. LDS was substantially lower in the patients than in the controls (33% relative difference, standardized effect size 2.3). LDS measured in short over-ground walking tests seems sufficiently reliable. LDS exhibits good discriminative power to differentiate fall-prone individuals and opens up the possibility of future clinical applications for better prediction of fall risk in neurological patients.	[Reynard, Fabienne; Vuadens, Philippe; Deriaz, Olivier; Terrier, Philippe] SUVACare, Clin Romande Readaptat, Sion, Switzerland; [Deriaz, Olivier; Terrier, Philippe] Inst Res Rehabil, Sion, Switzerland		Terrier, P (corresponding author), SUVACare, Clin Romande Readaptat, Sion, Switzerland.	Philippe.Terrier@crr-suva.ch	Terrier, Philippe/H-3831-2012	Terrier, Philippe/0000-0002-3693-4505	Swiss accident insurance company SUVA; State of Valais; City of Sion; Clinique romande de readaptation	Swiss accident insurance company SUVA; State of Valais; City of Sion; Clinique romande de readaptation	This study was supported by the Swiss accident insurance company SUVA, which is an independent, non-profit company under public law and by Clinique romande de readaptation. The IRR is supported by the State of Valais and the City of Sion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauby CE, 2000, J BIOMECH, V33, P1433, DOI 10.1016/S0021-9290(00)00101-9; Benedetti MG, 1999, MULT SCLER J, V5, P363, DOI 10.1191/135245899678846393; Bohannon R W, 1991, Int J Rehabil Res, V14, P246, DOI 10.1097/00004356-199109000-00010; Brotherton SS, 2007, SPINAL CORD, V45, P37, DOI 10.1038/sj.sc.3101909; Bruijn SM, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0999; Bruijn SM, 2012, MED ENG PHYS, V34, P428, DOI 10.1016/j.medengphy.2011.07.024; Bruijn SM, 2010, ANN BIOMED ENG, V38, P2588, DOI 10.1007/s10439-010-0018-2; Bruijn SM, 2009, J BIOMECH, V42, P1506, DOI 10.1016/j.jbiomech.2009.03.047; Bruijn SM, 2009, J NEUROSCI METH, V178, P327, DOI 10.1016/j.jneumeth.2008.12.015; Buzzi UH, 2003, CLIN BIOMECH, V18, P435, DOI 10.1016/S0268-0033(03)00029-9; Chang JT, 2004, BRIT MED J, V328, P680, DOI 10.1136/bmj.328.7441.680; CHIOU IIL, 1985, PHYS THER, V65, P901, DOI 10.1093/ptj/65.6.901; England SA, 2007, GAIT POSTURE, V25, P172, DOI 10.1016/j.gaitpost.2006.03.003; Finlayson ML, 2006, ARCH PHYS MED REHAB, V87, P1274, DOI 10.1016/j.apmr.2006.06.002; FRASER AM, 1986, PHYS REV A, V33, P1134, DOI 10.1103/PhysRevA.33.1134; Gil-Agudo A, 2013, DISABIL REHABIL, V35, P1869, DOI 10.3109/09638288.2013.766268; Hauser SL, 2006, NEURON, V52, P61, DOI 10.1016/j.neuron.2006.09.011; Hilfiker Roger, 2013, BMC Res Notes, V6, P260, DOI 10.1186/1756-0500-6-260; Huisinga JM, 2013, ANN BIOMED ENG, V41, P1670, DOI 10.1007/s10439-012-0697-y; Kang HG, 2008, J BIOMECH, V41, P2899, DOI 10.1016/j.jbiomech.2008.08.002; Kang HG, 2008, GAIT POSTURE, V27, P572, DOI 10.1016/j.gaitpost.2007.07.009; Kang HG, 2006, GAIT POSTURE, V24, P386, DOI 10.1016/j.gaitpost.2005.11.004; Kelleher KJ, 2010, DISABIL REHABIL, V32, P1242, DOI 10.3109/09638280903464497; KENNEL MB, 1992, PHYS REV A, V45, P3403, DOI 10.1103/PhysRevA.45.3403; Kline R., 2004, SIGNIFICANCE TESTING; Lockhart T, 2008, ERGONOMICS, V51, P1860, DOI 10.1080/00140130802567079; Manor Brad, 2009, J Electromyogr Kinesiol, V19, pe320, DOI 10.1016/j.jelekin.2008.06.006; Martin CL, 2006, MULT SCLER J, V12, P620, DOI 10.1177/1352458506070658; McCulloch KL, 2010, J HEAD TRAUMA REHAB, V25, P155, DOI 10.1097/HTR.0b013e3181dc82e7; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.1.30; Moe-Nilssen R, 1998, CLIN BIOMECH, V13, P320, DOI 10.1016/S0268-0033(98)00089-8; NYBERG L, 1995, STROKE, V26, P838, DOI 10.1161/01.STR.26.5.838; OLNEY SJ, 1996, GAIT POSTURE, V4, P136, DOI 10.1016/0966-6362(96)01063-6; Patel S, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-21; Peterson EW, 2008, ARCH PHYS MED REHAB, V89, P1031, DOI 10.1016/j.apmr.2007.10.043; Reynard P, 2014, J BIOMECH, V47, P74, DOI 10.1016/j.jbiomech.2013.10.011; Ried-Larsen M, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-113; Roos PE, 2011, J BIOMECH, V44, P1514, DOI 10.1016/j.jbiomech.2011.03.003; ROSENSTEIN MT, 1993, PHYSICA D, V65, P117, DOI 10.1016/0167-2789(93)90009-P; Russell DM, 2014, J BIOMECH, V47, P102, DOI 10.1016/j.jbiomech.2013.10.012; Sinitksi EH, 2012, J BIOMECH, V45, P2084, DOI 10.1016/j.jbiomech.2012.05.039; Sloot LH, 2011, ANN BIOMED ENG, V39, P1563, DOI 10.1007/s10439-010-0240-y; Takens F, 1981, DYNAMICAL SYSTEMS TU, P366, DOI [10.1007/BFb0091924, DOI 10.1007/BFB0091924]; Terrier P, 2003, EUR J APPL PHYSIOL, V90, P554, DOI 10.1007/s00421-003-0906-3; Terrier P, 2013, J APPL BIOMECH; Terrier P, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00230; Terrier P, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-94; Terrier P, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-12; Toebes MJP, 2012, GAIT POSTURE, V36, P527, DOI 10.1016/j.gaitpost.2012.05.016; Tuunainen E, 2014, AURIS NASUS LARYNX, V41, P10, DOI 10.1016/j.anl.2013.05.002; van Schooten KS, 2014, GAIT POSTURE, V39, P695, DOI 10.1016/j.gaitpost.2013.09.020; van Schooten KS, 2013, J BIOMECH, V46, P137, DOI 10.1016/j.jbiomech.2012.10.032; van Schooten KS, 2011, GAIT POSTURE, V33, P656, DOI 10.1016/j.gaitpost.2011.02.017; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Williams G, 2010, J HEAD TRAUMA REHAB, V25, P366, DOI 10.1097/HTR.0b013e3181cd3600; Yang CC, 2010, SENSORS-BASEL, V10, P7772, DOI 10.3390/s100807772; Young PMM, 2012, GAIT POSTURE, V35, P472, DOI 10.1016/j.gaitpost.2011.11.010	57	38	38	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100550	10.1371/journal.pone.0100550	http://dx.doi.org/10.1371/journal.pone.0100550			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949737	Green Submitted, Green Published, gold			2022-12-27	WOS:000338276300089
J	Wang, WH; Zhang, XA; Xu, YJ; Weinstock, GM; Di Bisceglie, AM; Fan, XF				Wang, Weihua; Zhang, Xiaoan; Xu, Yanjuan; Weinstock, George M.; Di Bisceglie, Adrian M.; Fan, Xiaofeng			High-Resolution Quantification of Hepatitis C Virus Genome-Wide Mutation Load and Its Correlation with the Outcome of Peginterferon-Alpha2a and Ribavirin Combination Therapy	PLOS ONE			English	Article							RESISTANCE; AMPLIFICATION; INTERFERON; SEPARATION; DIVERSITY; DISCOVERY; DYNAMICS; CLONING	Hepatitis C virus (HCV) is a highly mutable RNA virus and circulates as a heterogeneous population in individual patients. The magnitude of such population heterogeneity has long been proposed to be linked with diverse clinical phenotypes, including antiviral therapy. Yet data accumulated thus far are fairly inconclusive. By the integration of long RT-PCR with 454 sequencing, we have built a pipeline optimized for the quantification of HCV genome-wide mutation load at 1% resolution of mutation frequency, followed by a retrospective study to examine the role of HCV mutation load in peginterferon-alpha2a and ribavirin combination antiviral therapy. Genome-wide HCV mutation load varied widely with a range from 92 to 1639 mutations and presented a Poisson distribution among 56 patients (Kolmogorov-Smirnov statistic = 0.078, p = 0.25). Patients achieving sustained virological response (n = 26) had significantly lower mutation loads than that in null responders (n = 30) (mean and standard derivation: 524 +/- 279 vs. 805 +/- 271, p = 0.00035). All 36,818 mutations detected in 56 patients displayed a power-law distribution in terms of mutation frequency in viral population. The low-frequency mutation load, but not the high-frequency load, was proportional firmly to the total mutation load. In-depth analyses revealed that intra-patient HCV population structure was shaped by multiple factors, including immune pressure, strain difference and genetic drift. These findings explain previous conflicting reports using low-resolution methods and highlight a dominant role of natural selection in response to therapeutic intervention. By attaining its signatures from complex interaction between host and virus, the high-resolution quantification of HCV mutation load predicts outcomes from interferon-based antiviral therapy and could also be a potential biomarker in other clinical settings.	[Wang, Weihua; Zhang, Xiaoan; Xu, Yanjuan; Di Bisceglie, Adrian M.; Fan, Xiaofeng] St Louis Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, St Louis, MO 63103 USA; [Di Bisceglie, Adrian M.; Fan, Xiaofeng] St Louis Univ, Sch Med, Ctr Liver, St Louis, MO USA; [Weinstock, George M.] Washington Univ, Sch Med, Genome Inst, St Louis, MO USA; [Wang, Weihua] Wuhan Ctr TB Control, Wuhan, Hubei, Peoples R China	Saint Louis University; Saint Louis University; Washington University (WUSTL)	Di Bisceglie, AM (corresponding author), St Louis Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, St Louis, MO 63103 USA.	dibiscam@slu.edu; fanx@slu.edu	Weinstock, George M/C-6314-2013	Weinstock, George M/0000-0002-2997-4592	US National Institutes of Health (NIH) [DK80711]; National Institute of Diabetes & Digestive & Kidney Diseases [N01-DK9-2326, N01-DK-9-2324, N01-DK-9-2319, N01-DK-9-2327, N01-DK-9-2320, N01-DK-9-2321, N01-DK-9-2325, N01-DK-9-2323, N01-DK-9-2322, N01-DK-9-2318, N01-DK-9-2328]; Hoffmann-La Roche, through a Cooperative Research and Development Agreement (CRADA); National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [N01DK092319, N01DK092321, N01DK092327, N01DK092318, N01DK092320, N01DK092326, N01DK092328, R01DK080711, N01DK092324, N01DK092325, N01DK092322, N01DK092323] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes & Digestive & Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Hoffmann-La Roche, through a Cooperative Research and Development Agreement (CRADA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the US National Institutes of Health (NIH) (grant DK80711 to XF). The HALT-C clinical trial was supported by National Institute of Diabetes & Digestive & Kidney Diseases contracts N01-DK9-2326, N01-DK-9-2324, Contract N01-DK-9-2319, N01-DK-9-2327, N01-DK-9-2320, N01-DK-9-2321, N01-DK-9-2325, N01-DK-9-2323, N01-DK-9-2322, N01-DK-9-2318, and N01-DK-9-2328. Additional financial support for the HALT-C clinical trial was provided by Hoffmann-La Roche, through a Cooperative Research and Development Agreement (CRADA) with the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias A, 2013, J GEN VIROL, V94, P817, DOI 10.1099/vir.0.049171-0; Balagopal A, 2010, GASTROENTEROLOGY, V139, P1865, DOI 10.1053/j.gastro.2010.10.004; Belshaw R, 2011, CURR OPIN VIROL, V1, P430, DOI 10.1016/j.coviro.2011.08.004; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Domingo E, 2012, MICROBIOL MOL BIOL R, V76, P159, DOI 10.1128/MMBR.05023-11; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Fan XF, 2006, BIOCHEM BIOPH RES CO, V346, P1163, DOI 10.1016/j.bbrc.2006.06.039; Fan XF, 2010, METHODS MOL BIOL, V630, P139, DOI 10.1007/978-1-60761-629-0_10; Fan XF, 2009, HEPATOLOGY, V50, P1765, DOI 10.1002/hep.23290; Gilles A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-245; Gillespie C. S., 2013, FITTING HEAVY TAILED; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Jabara CB, 2011, P NATL ACAD SCI USA, V108, P20166, DOI 10.1073/pnas.1110064108; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Kuiken C, 2005, BIOINFORMATICS, V21, P379, DOI 10.1093/bioinformatics/bth485; Lancaster KZ, 2012, CURR OPIN MICROBIOL, V15, P525, DOI 10.1016/j.mib.2012.05.007; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; LARDER BA, 1993, NATURE, V365, P671, DOI 10.1038/365671a0; Larsen BB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076502; Lee WM, 2004, CONTROL CLIN TRIALS, V25, P472, DOI 10.1016/j.cct.2004.08.003; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Parker J, 2008, INFECT GENET EVOL, V8, P239, DOI 10.1016/j.meegid.2007.08.001; Perales C, 2013, J VIROL, V87, P7593, DOI 10.1128/JVI.02824-12; Pickett BE, 2011, J VIRAL HEPATITIS, V18, P608, DOI 10.1111/j.1365-2893.2010.01342.x; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ray SC, 1999, J VIROL, V73, P2938, DOI 10.1128/JVI.73.4.2938-2946.1999; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Schmitt MW, 2012, P NATL ACAD SCI USA, V109, P14508, DOI 10.1073/pnas.1208715109; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Van Belleghem SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042605; Van Laethem K, 1999, J ACQ IMMUN DEF SYND, V22, P107; Wohnsland A, 2007, CLIN MICROBIOL REV, V20, P23, DOI 10.1128/CMR.00010-06; Wright CF, 2011, J VIROL, V85, P2266, DOI 10.1128/JVI.01396-10; Zagordi O, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-119; Zehender G, 2005, J VIROL, V79, P9145, DOI 10.1128/JVI.79.14.9145-9156.2005; Zhang XA, 2011, J CLIN VIROL, V52, P333, DOI 10.1016/j.jcv.2011.08.022; Zhou DH, 2007, J VIROL METHODS, V141, P220, DOI 10.1016/j.jviromet.2006.12.002	41	10	10	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100131	10.1371/journal.pone.0100131	http://dx.doi.org/10.1371/journal.pone.0100131			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950220	Green Published, Green Submitted, gold			2022-12-27	WOS:000338276300038
J	Zhou, MJ; Zhou, L; Zheng, L; Guo, LH; Wang, YH; Liu, HX; Ou, CS; Ding, ZH				Zhou, Meijuan; Zhou, Liang; Zheng, Li; Guo, Ling; Wang, Yinghui; Liu, Hongxia; Ou, Chengshan; Ding, Zhenhua			miR-365 Promotes Cutaneous Squamous Cell Carcinoma (CSCC) through Targeting Nuclear Factor I/B (NFIB)	PLOS ONE			English	Article							CANCER-CELLS; LUNG-CANCER; SKELETAL MYOGENESIS; MICRORNA TARGETS; TRANSCRIPTION; BREAST; PREDICTION; FAMILY; ROLES; BCL-2	Aberrant expression of microRNAs plays vital roles in tumor development and progression. As transcription factors (TFs) are the critical components of signaling cascades, specific targeting effects of microRNAs to specific TFs may determine the role of microRNAs in different cancers. In this study, we identified Nuclear Factor I/B (NFIB) as one of the targets of miR-365 which was previously verified as an onco-miR in cutaneous squamous cell carcinoma (CSCC). Down-regulation of NFIB was a general feature in both CSCC cell lines and tumors from patients which show drastically up-regulated miR-365 expression levels. The siRNA-based knockdown of NFIB mimic the carcinogenic transformation of normal cells by ectopically expression of miR-365 which indicates depletion of NFIB is necessary for miR-365 to exert its pro-carcinogenic function. NFIB may represent a functional barrier targeted by miR-365 to the development of CSCC. Further studies also discovered a conserved feedback regulatory circuitry formed by NFIB and miR-365 in CSCC development which may be potentially utilized as therapeutic target to improve the clinical CSCC treatment.	[Zhou, Meijuan; Zhou, Liang; Zheng, Li; Guo, Ling; Wang, Yinghui; Liu, Hongxia; Ou, Chengshan; Ding, Zhenhua] Southern Med Univ, Dept Radiat Med, Sch Publ Hlth & Trop Med, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China	Ding, ZH (corresponding author), Southern Med Univ, Dept Radiat Med, Sch Publ Hlth & Trop Med, Guangzhou, Guangdong, Peoples R China.	dingzh@smu.edu.cn	Zhou, Liang/P-4174-2015; wang, yinghui/GWV-7334-2022	Zhou, Liang/0000-0001-5973-7873; 	National Natural Science Foundation of China [81172634, 81202152]; School of Public Health and Tropical Medicine of southern Medical University, China [GW201314]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); School of Public Health and Tropical Medicine of southern Medical University, China	This work was supported by grants from the National Natural Science Foundation of China (81172634 and 81202152, http://www.nsfc.gov.cn/) and Grant from School of Public Health and Tropical Medicine of southern Medical University, China (GW201314, http://web2.fimmu.com/phatm/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cooper SJ, 2007, CURR CANCER DRUG TAR, V7, P325, DOI 10.2174/156800907780809714; Dooley AL, 2011, GENE DEV, V25, P1470, DOI 10.1101/gad.2046711; Enright AJ, 2004, GENOME BIOL, V5; Fujita S, 2008, J MOL BIOL, V378, P492, DOI 10.1016/j.jmb.2008.03.015; Giglia-Mari G, 2003, HUM MUTAT, V21, P217, DOI 10.1002/humu.10179; Gronostajski RM, 2000, GENE, V249, P31, DOI 10.1016/S0378-1119(00)00140-2; Guo L, 2009, PHOTOCHEM PHOTOBIOL, V85, P765, DOI 10.1111/j.1751-1097.2008.00482.x; Guo S-L, 2013, NATURE COMMUNICATION, V4, P2554; Hamada S, 2014, CELL SIGNAL, V26, P179, DOI 10.1016/j.cellsig.2013.11.003; Hsu YC, 2011, DEV BIOL, V354, P242, DOI 10.1016/j.ydbio.2011.04.002; Juin P, 2013, NAT REV CANCER, V13, P455, DOI 10.1038/nrc3538; Kang SM, 2013, CANCER LETT, V335, P487, DOI 10.1016/j.canlet.2013.03.006; Kollmann K, 2013, CANCER CELL, V24, P167, DOI 10.1016/j.ccr.2013.07.012; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Meek DW, 2009, NAT REV CANCER, V9, P714, DOI 10.1038/nrc2716; Moon HG, 2011, MOL ONCOL, V5, P538, DOI 10.1016/j.molonc.2011.08.002; Nie J, 2012, CARCINOGENESIS, V33, P220, DOI 10.1093/carcin/bgr245; Persson M, 2009, P NATL ACAD SCI USA, V106, P18740, DOI 10.1073/pnas.0909114106; Pjanic M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-181; Qi J, 2012, CELL CYCLE, V11, P177, DOI 10.4161/cc.11.1.18576; Sidransky D, 2002, NAT REV CANCER, V2, P210, DOI 10.1038/nrc755; Wang H, 2008, CANCER CELL, V14, P369, DOI 10.1016/j.ccr.2008.10.006; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Xia HP, 2005, INT J MOL MED, V16, P943; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808; Zhou L, 2012, J BIOL CHEM, V287, P25255, DOI 10.1074/jbc.M112.357053; Zhou L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033766; Zhou MJ, 2013, CARCINOGENESIS, V34, P1653, DOI 10.1093/carcin/bgt097; ZIEGLER A, 1994, NATURE, V372, P773, DOI 10.1038/372773a0	29	57	61	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100620	10.1371/journal.pone.0100620	http://dx.doi.org/10.1371/journal.pone.0100620			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949940	Green Published, gold, Green Submitted			2022-12-27	WOS:000338276300099
J	Dempsey, AF; Fuhrel-Forbis, A; Konrath, S				Dempsey, Amanda F.; Fuhrel-Forbis, Andrea; Konrath, Sara			Use of the Carolina HPV Immunization Attitudes and Beliefs Scale (CHIAS) in Young Adult Women	PLOS ONE			English	Article							NONINFLUENZA VACCINATION COVERAGE; AGED 13-17 YEARS; UNITED-STATES	Background: Validated measures that can accurate describe young adults' HPV vaccination attitudes and how these relate to vaccination intention and receipt are needed for developing interventions to improve low HPV vaccination levels. The Carolina HPV Immunization Attitudes Scale (CHIAS) is a validated measure of these outcomes that was originally designed for parents. Objective: To assess the performance of the CHIAS among young adult women using an exploratory factor analysis. Methods: A convenience sample of 139 young adult women (age 18-26 years) were given the CHIAS measure at baseline. Factor analysis was used to determine attitudinal factor groupings and the association of these factors with HPV vaccination intention. A 6-month follow up assessment examined the stability of the CHIAS over time and the association of baseline vaccine factors with vaccine receipt. Results: Five factors loaded on to the CHIAS in young adults - "Barriers,'' "Harms,'' "Effectiveness,'' "Risk Denial'' and "Uncertainty,'' - which was similar to the factor loadings of CHIAS for parents. "Harms'' was the factor most consistently associated with vaccination intention at all time points assessed. Only 5 women had received or made an appointment to receive the vaccine at the 6-month follow-up. Conclusions: In terms of categorizing HPV vaccination attitudes, the CHIAS appears to have similar performance among young adults as in parents. However, additional studies are needed to assess the utility of the CHIAS for predicting HPV vaccine receipt among the young adult population.	Univ Colorado Denver, Childrens Outcomes Res Program, Aurora, CO 80204 USA; [Fuhrel-Forbis, Andrea; Konrath, Sara] Univ Michigan, Inst Social Res, Ann Arbor, MI USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Michigan System; University of Michigan	Dempsey, AF (corresponding author), Univ Colorado Denver, Childrens Outcomes Res Program, Aurora, CO 80204 USA.	Amanda.dempsey@ucdenver.edu		Konrath, Sara/0000-0001-9182-0095	Office of the Vice President for Research at the University of Michigan	Office of the Vice President for Research at the University of Michigan(University of Michigan System)	This work was funded by the Office of the Vice President for Research at the University of Michigan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, MMWR MORB MORTAL WKL, V61, P671; [Anonymous], 2013, MMWR MORB MORTAL WKL, V62, P685; [Anonymous], 2013, MMWR MORB MORTAL WKL, V62, P66; Brewer NT, 2007, PREV MED, V45, P107, DOI 10.1016/j.ypmed.2007.05.013; Dempsey AF, 2006, PEDIATRICS, V117, P1486, DOI 10.1542/peds.2005-1381; Gowda C, 2012, HUM VACCIN IMMUNO, V9, P1; Gowda C, 2012, SYSTEMATIC EVALUATIO; Gowda C, 2012, SEX TRANSM DIS, V39, P475, DOI 10.1097/OLQ.0b013e318248a6d5; Jemal A, 2013, J NATL CANC I; Kessels SJM, 2012, VACCINE, V30, P3546, DOI 10.1016/j.vaccine.2012.03.063; McRee AL, 2010, SEX TRANSM DIS, V37, P234, DOI 10.1097/OLQ.0b013e3181c37e15; Ratanasiripong NT, 2012, J AM COLL HEALTH, V60, P461, DOI 10.1080/07448481.2012.684365; U.S. Department of Health and Human Services, 2010, HLTH PEOPL 2020; Williams WW, 2014, MMWR-MORBID MORTAL W, V63, P95	14	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100193	10.1371/journal.pone.0100193	http://dx.doi.org/10.1371/journal.pone.0100193			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945630	Green Published, gold, Green Submitted			2022-12-27	WOS:000340721500048
J	Faust, JE; Manisundaram, A; Ivanova, PT; Milne, SB; Summerville, JB; Brown, HA; Wangler, M; Stern, M; McNew, JA				Faust, Joseph E.; Manisundaram, Arvind; Ivanova, Pavlina T.; Milne, Stephen B.; Summerville, James B.; Brown, H. Alex; Wangler, Michael; Stern, Michael; McNew, James A.			Peroxisomes Are Required for Lipid Metabolism and Muscle Function in Drosophila melanogaster	PLOS ONE			English	Article							GENE DISRUPTION PROJECT; ZELLWEGER-SYNDROME; MEMBRANE-PROTEINS; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; TARGETING SIGNAL; MITOCHONDRIAL MYOPATHY; BIOGENESIS DISORDERS; OXIDATIVE STRESS; KNOCKOUT MOUSE	Peroxisomes are ubiquitous organelles that perform lipid and reactive oxygen species metabolism. Defects in peroxisome biogenesis cause peroxisome biogenesis disorders (PBDs). The most severe PBD, Zellweger syndrome, is characterized in part by neuronal dysfunction, craniofacial malformations, and low muscle tone (hypotonia). These devastating diseases lack effective therapies and the development of animal models may reveal new drug targets. We have generated Drosophila mutants with impaired peroxisome biogenesis by disrupting the early peroxin gene pex3, which participates in budding of pre-peroxisomes from the ER and peroxisomal membrane protein localization. pex3 deletion mutants lack detectible peroxisomes and die before or during pupariation. At earlier stages of development, larvae lacking Pex3 display reduced size and impaired lipid metabolism. Selective loss of peroxisomes in muscles impairs muscle function and results in flightless animals. Although, hypotonia in PBD patients is thought to be a secondary effect of neuronal dysfunction, our results suggest that peroxisome loss directly affects muscle physiology, possibly by disrupting energy metabolism. Understanding the role of peroxisomes in Drosophila physiology, specifically in muscle cells may reveal novel aspects of PBD etiology.	[Faust, Joseph E.; Manisundaram, Arvind; Summerville, James B.; Stern, Michael; McNew, James A.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA; [Ivanova, Pavlina T.; Milne, Stephen B.; Brown, H. Alex] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA; [Ivanova, Pavlina T.; Milne, Stephen B.; Brown, H. Alex] Vanderbilt Univ, Sch Med, Vanderbilt Inst Chem Biol, Nashville, TN 37212 USA; [Wangler, Michael] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Rice University; Vanderbilt University; Vanderbilt University; Baylor College of Medicine	McNew, JA (corresponding author), Rice Univ, Dept Biochem & Cell Biol, POB 1892, Houston, TX 77251 USA.	mcnew@rice.edu	McNew, James/ABD-8081-2020; McNew, James/AAV-4911-2020; Wangler, Michael/H-6368-2019	McNew, James/0000-0001-8459-3664; Wangler, Michael/0000-0001-5245-5910; Faust, Joseph/0000-0002-2183-8529	National Institutes of Health; Virginia; L.E. Simmons Family Foundation Collaborative Research Fund; Bixler-Johnson-Mayes Endowed Chair; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101377] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS076547] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Virginia; L.E. Simmons Family Foundation Collaborative Research Fund; Bixler-Johnson-Mayes Endowed Chair; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Work in the McNew lab is funded by the National Institutes of Health and The Virginia and L.E. Simmons Family Foundation Collaborative Research Fund. Partial support was also provided by the Bixler-Johnson-Mayes Endowed Chair (H.A.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; Acosta Ivan F, 2010, Arabidopsis Book, V8, pe0129, DOI 10.1199/tab.0129; Baes M, 2012, BBA-MOL BASIS DIS, V1822, P1489, DOI 10.1016/j.bbadis.2012.03.003; Baumgart E, 2001, AM J PATHOL, V159, P1477, DOI 10.1016/S0002-9440(10)62534-5; BEARD ME, 1987, P NATL ACAD SCI USA, V84, P7433, DOI 10.1073/pnas.84.21.7433; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Bellen HJ, 2011, GENETICS, V188, P731, DOI 10.1534/genetics.111.126995; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRAND AH, 1993, DEVELOPMENT, V118, P401; Carvalho M, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.29; Chen HY, 2010, HUM MOL GENET, V19, P494, DOI 10.1093/hmg/ddp518; Cook RK, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r21; Cutler RG, 2001, MECH AGEING DEV, V122, P895, DOI 10.1016/S0047-6374(01)00246-9; Dammai V, 2001, CELL, V105, P187, DOI 10.1016/S0092-8674(01)00310-5; Dirkx R, 2005, HEPATOLOGY, V41, P868, DOI 10.1002/hep.20628; Distel B, 1996, J CELL BIOL, V135, P1, DOI 10.1083/jcb.135.1.1; Fang Y, 2004, J CELL BIOL, V164, P863, DOI 10.1083/jcb.200311131; Faust JE, 2012, TRAFFIC, V13, P1378, DOI 10.1111/j.1600-0854.2012.01393.x; Faust PL, 1997, J CELL BIOL, V139, P1293, DOI 10.1083/jcb.139.5.1293; Feng YF, 2004, J NEUROGENET, V18, P377, DOI 10.1080/01677060490894522; Ferdinandusse S, 2009, MOL GENET METAB, V96, P121, DOI 10.1016/j.ymgme.2008.11.165; Ghosh A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003980; GOLDFISCHER S, 1973, SCIENCE, V182, P62, DOI 10.1126/science.182.4107.62; GOULD SJ, 1987, J CELL BIOL, V105, P2923, DOI 10.1083/jcb.105.6.2923; Gresham D, 2011, GENETICS, V187, P299, DOI 10.1534/genetics.110.120766; Gutierrez E, 2007, NATURE, V445, P275, DOI 10.1038/nature05382; Haghighi AP, 2003, NEURON, V39, P255, DOI 10.1016/S0896-6273(03)00427-6; Hanada K, 2009, BBA-MOL CELL BIOL L, V1791, P684, DOI 10.1016/j.bbalip.2009.01.006; Hettema EH, 2000, EMBO J, V19, P223, DOI 10.1093/emboj/19.2.223; Hoepfner D, 2005, CELL, V122, P85, DOI 10.1016/j.cell.2005.04.025; Jones JM, 2004, J CELL BIOL, V164, P57, DOI 10.1083/jcb.200304111; Komen JC, 2007, CELL MOL LIFE SCI, V64, P3271, DOI 10.1007/s00018-007-7357-7; Kovacs WJ, 2004, MOL CELL BIOL, V24, P1, DOI 10.1128/MCB.24.1.1-13.2004; Kragt A, 2005, J BIOL CHEM, V280, P34350, DOI 10.1074/jbc.M505432200; Ma CL, 2011, J CELL BIOL, V193, P7, DOI 10.1083/jcb.201010022; Mast FD, 2011, DIS MODEL MECH, V4, P659, DOI 10.1242/dmm.007419; Matsuzono Y, 2006, J BIOL CHEM, V281, P36, DOI 10.1074/jbc.M509819200; Maxwell M, 2003, MOL CELL BIOL, V23, P5947, DOI 10.1128/MCB.23.16.5947-5957.2003; Motley AM, 2007, J CELL BIOL, V178, P399, DOI 10.1083/jcb.200702167; Motley AM, 2012, EMBO J, V31, P2852, DOI 10.1038/emboj.2012.151; Motley AM, 2000, EMBO REP, V1, P40, DOI 10.1093/embo-reports/kvd010; Muller CC, 2011, DIS MODEL MECH, V4, P104, DOI 10.1242/dmm.004622; MULLERHOCKER J, 1984, VIRCHOWS ARCH B, V45, P125, DOI 10.1007/BF02889859; Munck JM, 2009, J CELL BIOL, V187, P463, DOI 10.1083/jcb.200906161; Nakayama M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022984; Ranganayakulu G, 1996, DEV BIOL, V176, P143, DOI 10.1006/dbio.1996.9987; Rietveld A, 1999, J BIOL CHEM, V274, P12049, DOI 10.1074/jbc.274.17.12049; SARNAT HB, 1983, CAN J NEUROL SCI, V10, P170, DOI 10.1017/S0317167100044863; Schrader M, 2006, BBA-MOL CELL RES, V1763, P1755, DOI 10.1016/j.bbamcr.2006.09.006; Sepp KJ, 1999, GENETICS, V151, P1093; Shibata H, 2004, J BIOL CHEM, V279, P38486, DOI 10.1074/jbc.M402204200; South ST, 2000, J CELL BIOL, V149, P1345, DOI 10.1083/jcb.149.7.1345; Southall TD, 2006, PHYSIOL GENOMICS, V26, P35, DOI 10.1152/physiolgenomics.00038.2006; Steinberg SJ, 2006, BBA-MOL CELL RES, V1763, P1733, DOI 10.1016/j.bbamcr.2006.09.010; STJULES R, 1990, EXP EYE RES, V51, P607; STJULES R, 1989, TISSUE CELL, V21, P661, DOI 10.1016/0040-8166(89)90077-3; Suster ML, 2003, J NEUROBIOL, V55, P233, DOI 10.1002/neu.10202; SWINKELS BW, 1991, EMBO J, V10, P3255, DOI 10.1002/j.1460-2075.1991.tb04889.x; Tam YYC, 2005, J BIOL CHEM, V280, P34933, DOI 10.1074/jbc.M506208200; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Vacaru AM, 2013, J BIOL CHEM, V288, P11520, DOI 10.1074/jbc.M113.460972; Vacaru AM, 2009, J CELL BIOL, V185, P1013, DOI 10.1083/jcb.200903152; van der Zand A, 2010, MOL BIOL CELL, V21, P2057, DOI 10.1091/mbc.E10-02-0082; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Venken KJT, 2009, NAT METHODS, V6, P431, DOI [10.1038/NMETH.1331, 10.1038/nmeth.1331]; Waddell S, 2000, CELL, V103, P805, DOI 10.1016/S0092-8674(00)00183-5; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; Wang SX, 2013, BIOCHEM BIOPH RES CO, V438, P452, DOI 10.1016/j.bbrc.2013.07.100; Wolff J, 1986, Pediatr Neurol, V2, P141, DOI 10.1016/0887-8994(86)90004-4; YEH E, 1995, P NATL ACAD SCI USA, V92, P7036, DOI 10.1073/pnas.92.15.7036; Zinke I, 2002, EMBO J, V21, P6162, DOI 10.1093/emboj/cdf600; Zolman BR, 2008, GENETICS, V180, P237, DOI 10.1534/genetics.108.090399	72	25	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100213	10.1371/journal.pone.0100213	http://dx.doi.org/10.1371/journal.pone.0100213			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945818	Green Published, gold, Green Submitted			2022-12-27	WOS:000340721500050
J	Kobayashi-Ishihara, M; Takahashi, H; Ohnishi, K; Nishimura, K; Terahara, K; Ato, M; Itamura, S; Kageyama, T; Tsunetsugu-Yokota, Y				Kobayashi-Ishihara, Mie; Takahashi, Hitoshi; Ohnishi, Kazuo; Nishimura, Kengo; Terahara, Kazutaka; Ato, Manabu; Itamura, Shigeyuki; Kageyama, Tsutomu; Tsunetsugu-Yokota, Yasuko			Broad Cross-Reactive Epitopes of the H5N1 Influenza Virus Identified by Murine Antibodies against the A/Vietnam/1194/2004 Hemagglutinin	PLOS ONE			English	Article							RECEPTOR-BINDING; MONOCLONAL-ANTIBODIES; HUMANS METAANALYSIS; ANTIGENIC DRIFT; INFECTIONS; SEROEVIDENCE; BIRDS	There is an urgent need for a rapid diagnostic system to detect the H5 subtype of the influenza A virus. We previously developed monoclonal antibodies (mAbs) against the H5 hemagglutinin (HA) for use in a rapid diagnostic kit. In this study, we determined the epitopes of the anti-H5 HA murine mAbs OM-b, AY-2C2, and YH-1A1. Binding assays of the mAbs to different strains of H5 HAs indicated that OM-b and AY-2C2 cross-reacted with HAs from clades 1, 2.1.3.2, 2.2, and 2.3.4, whereas YH-1A1 failed to bind to those of clades 2.1.3.2 and 2.3.4. HA chimeras revealed that the epitopes for each of the mAbs were in the HA1 region. Analysis of escape mutants revealed that OM-b and AY-2C2 mAbs interacted mainly with amino acid residues D43 and G46, and the YH-1A1 mAb interacted with G139 and K or R140 of H5 HA. Multiple alignments of H5 HA protein sequences showed that D43 and G46 were very conserved among H5N1 HAs, except those in clade 2.2.1 and clade 7 (88.7%). The epitope for YH-1A1 mAb was highly variable in the HAs of H5N1, although it was well conserved in those of H5N2-N9. The OM-b and AY-2C2 mAbs could bind to the HAs of clades 1.1 and 2.3.2.1 that are currently epidemic in Asia, and we conclude that these would be effective for the detection of H5N1 infections in this region.	[Kobayashi-Ishihara, Mie; Ohnishi, Kazuo; Terahara, Kazutaka; Ato, Manabu; Tsunetsugu-Yokota, Yasuko] Natl Inst Infect Dis, Dept Immunol, Shinjuku Ku, Tokyo 1628640, Japan; [Takahashi, Hitoshi; Itamura, Shigeyuki; Kageyama, Tsutomu] Natl Inst Infect Dis, Influenza Virus Res Ctr, Tokyo 1628640, Japan; [Nishimura, Kengo] Toyobo Co, Tsuruga Inst Biotechnol, Tsuruga, Fukui, Japan; [Tsunetsugu-Yokota, Yasuko] Tokyo Univ Technol, Sch Human Sci, Dept Med Technol, Ohta Ku, Tokyo, Japan	National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID); Toyobo Co., Ltd; Tokyo University of Technology	Tsunetsugu-Yokota, Y (corresponding author), Natl Inst Infect Dis, Dept Immunol, Shinjuku Ku, Tokyo 1628640, Japan.	yokotaysk@stf.teu.ac.jp	Ato, Manabu/K-6452-2019	Ato, Manabu/0000-0002-3178-2645; Terahara, Kazutaka/0000-0001-9876-4356	Human Science Foundation in the Ministry of Health, Labor and Welfare, Japan; Japanese government (Ministry of Health, Labor and Welfare); Grants-in-Aid for Scientific Research [26860311] Funding Source: KAKEN	Human Science Foundation in the Ministry of Health, Labor and Welfare, Japan; Japanese government (Ministry of Health, Labor and Welfare); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a grant from the Human Science Foundation in the Ministry of Health, Labor and Welfare, Japan, and carried out in collaboration with KN of Toyobo, Co., Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The work was completely funded by a grant from the Japanese government (Ministry of Health, Labor and Welfare), and all materials and results are owned by the institute, NIID (government research institute).	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Barik S, 1993, Methods Mol Biol, V15, P277, DOI 10.1385/0-89603-244-2:277; Cai ZP, 2012, J MOL BIOL, V422, P145, DOI 10.1016/j.jmb.2012.05.011; Chen YX, 2009, J INFECT DIS, V199, P49, DOI 10.1086/594374; Crusat M, 2013, VIROLOGY, V447, P326, DOI 10.1016/j.virol.2013.08.010; Das SR, 2013, CELL HOST MICROBE, V13, P314, DOI 10.1016/j.chom.2013.02.008; Dreyfus C, 2013, J VIROL, V87, P7149, DOI 10.1128/JVI.02975-12; Du A, 2009, BIOCHEM BIOPH RES CO, V378, P197, DOI 10.1016/j.bbrc.2008.11.022; Hensley SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015190; Hensley SE, 2009, SCIENCE, V326, P734, DOI 10.1126/science.1178258; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Kandun IN, 2008, LANCET, V372, P744, DOI 10.1016/S0140-6736(08)61125-3; Kaverin NV, 2007, J VIROL, V81, P12911, DOI 10.1128/JVI.01522-07; KOO GC, 1986, J IMMUNOL, V137, P3742; KOO GC, 1984, HYBRIDOMA, V3, P301, DOI 10.1089/hyb.1984.3.301; Li YB, 2011, EMERG INFECT DIS, V17, P265, DOI 10.3201/eid1702.100732; Mahy BWJ, 1996, VIROLOGY METHODS MAN; MAIOROV VN, 1994, J MOL BIOL, V235, P625, DOI 10.1006/jmbi.1994.1017; Miyagawa E, 2011, J VIROL METHODS, V173, P213, DOI 10.1016/j.jviromet.2011.02.007; Ohkura T, 2012, BIOCHEM BIOPH RES CO, V418, P38, DOI 10.1016/j.bbrc.2011.12.108; Ohnishi K, 2012, JPN J INFECT DIS, V65, P19; OKUNO Y, 1993, J VIROL, V67, P2552, DOI 10.1128/JVI.67.5.2552-2558.1993; Prabakaran M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004566; Reece PA, 2010, POSTGRAD MED, V122, P134, DOI 10.3810/pgm.2010.09.2210; Russell CA, 2012, SCIENCE, V336, P1541, DOI 10.1126/science.1222526; Sakoda Y, 2012, J GEN VIROL, V93, P541, DOI 10.1099/vir.0.037572-0; Sakurai A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076753; Tang DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043596; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; Van Kerkhove MD, 2012, SCIENCE, V336, DOI 10.1126/science.1221434; Velkov T, 2013, MOL IMMUNOL, V56, P705, DOI 10.1016/j.molimm.2013.07.010; Wang TT, 2012, SCIENCE, V335, P1463, DOI 10.1126/science.1218888; Watanabe Y, 2012, J GEN VIROL, V93, P2215, DOI 10.1099/vir.0.044032-0; Watanabe Y, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002068; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264; Yang ZY, 2007, SCIENCE, V317, P825, DOI 10.1126/science.1135165; Zhu XY, 2013, J VIROL, V87, P12619, DOI 10.1128/JVI.01577-13	38	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e99201	10.1371/journal.pone.0099201	http://dx.doi.org/10.1371/journal.pone.0099201			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945805	Green Submitted, gold, Green Published			2022-12-27	WOS:000340721500014
J	Kohn, KW; Zeeberg, BM; Reinhold, WC; Pommier, Y				Kohn, Kurt W.; Zeeberg, Barry M.; Reinhold, William C.; Pommier, Yves			Gene Expression Correlations in Human Cancer Cell Lines Define Molecular Interaction Networks for Epithelial Phenotype	PLOS ONE			English	Article							E3 UBIQUITIN LIGASE; TIGHT JUNCTION PROTEIN; COLORECTAL-CANCER; BREAST-CANCER; MESENCHYMAL TRANSITION; SODIUM-CHANNEL; INTERACTION MAPS; MATRIPTASE; GROWTH; DIFFERENTIATION	Using gene expression data to enhance our knowledge of control networks relevant to cancer biology and therapy is a challenging but urgent task. Based on the premise that genes that are expressed together in a variety of cell types are likely to functions together, we derived mutually correlated genes that function together in various processes in epithelial-like tumor cells. Expression-correlated genes were derived from data for the NCI-60 human tumor cell lines, as well as data from the Broad Institute's CCLE cell lines. NCI-60 cell lines that selectively expressed a mutually correlated subset of tight junction genes served as a signature for epithelial-like cancer cells. Those signature cell lines served as a seed to derive other correlated genes, many of which had various other epithelial-related functions. Literature survey yielded molecular interaction and function information about those genes, from which molecular interaction maps were assembled. Many of the genes had epithelial functions unrelated to tight junctions, demonstrating that new function categories were elicited. The most highly correlated genes were implicated in the following epithelial functions: interactions at tight junctions (CLDN7, CLDN4, CLDN3, MARVELD3, MARVELD2, TJP3, CGN, CRB3, LLGL2, EPCAM, LNX1); interactions at adherens junctions (CDH1, ADAP1, CAMSAP3); interactions at desmosomes (PPL, PKP3, JUP); transcription regulation of cell-cell junction complexes (GRHL1 and 2); epithelial RNA splicing regulators (ESRP1 and 2); epithelial vesicle traffic (RAB25, EPN3, GRHL2, EHF, ADAP1, MYO5B); epithelial Ca(+2) signaling (ATP2C2, S100A14, BSPRY); terminal differentiation of epithelial cells (OVOL1 and 2, ST14, PRSS8, SPINT1 and 2); maintenance of apico-basal polarity (RAB25, LLGL2, EPN3). The findings provide a foundation for future studies to elucidate the functions of regulatory networks specific to epithelial-like cancer cells and to probe for anti-cancer drug targets.	[Kohn, Kurt W.; Zeeberg, Barry M.; Reinhold, William C.; Pommier, Yves] NCI, Mol Pharmacol Lab, Ctr Canc Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Kohn, KW (corresponding author), NCI, Mol Pharmacol Lab, Ctr Canc Res, Bethesda, MD 20892 USA.	kohnk@dc37a.nci.nih.gov	Reinhold, William/J-6704-2017	Reinhold, William/0000-0001-5513-9323	budget of the Laboratory of Molecular Pharmacology allocated from the National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC006192] Funding Source: NIH RePORTER	budget of the Laboratory of Molecular Pharmacology allocated from the National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by the budget of the Laboratory of Molecular Pharmacology allocated from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038438; Ahn HJ, 2013, BIOCHEM BIOPH RES CO, V437, P557, DOI 10.1016/j.bbrc.2013.06.114; Ahn HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040293; Aigner K, 2007, FEBS LETT, V581, P1617, DOI 10.1016/j.febslet.2007.03.026; Akhmanova A, 2008, CELL, V135, P791, DOI 10.1016/j.cell.2008.11.002; Aktary Z, 2010, ONCOGENE, V29, P2118, DOI 10.1038/onc.2009.495; Albino D, 2012, CANCER RES, V72, P2889, DOI 10.1158/0008-5472.CAN-12-0212; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bartolome R. A., 2013, ONCOGENE; Bergum C, 2012, J CELL PHYSIOL, V227, P1604, DOI 10.1002/jcp.22877; Biggs LC, 2012, J INVEST DERMATOL, V132, P50, DOI 10.1038/jid.2011.272; Boczonadi V, 2012, FEBS LETT; Botti E, 2011, P NATL ACAD SCI USA, V108, P13710, DOI 10.1073/pnas.1110931108; Chaves-Perez A, 2012, ONCOGENE; Chen HY, 2012, J BIOL CHEM, V287, P17109, DOI 10.1074/jbc.M111.326975; Chen M, 2008, BBA-MOL CELL RES, V1783, P896, DOI 10.1016/j.bbamcr.2007.10.019; Chen MQ, 2010, MOL CELL BIOCHEM, V337, P259, DOI 10.1007/s11010-009-0307-y; Chen W, 2010, J BIOL CHEM, V285, P40852, DOI 10.1074/jbc.M110.103812; Chen YW, 2010, J BIOL CHEM, V285, P31755, DOI 10.1074/jbc.M110.150367; Chen YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064088; Cheng KW, 2012, EMBO MOL MED, V4, P125, DOI 10.1002/emmm.201100193; Cieply B, 2012, CANCER RES, V72, P2440, DOI 10.1158/0008-5472.CAN-11-4038; Citi S, 2012, ANN NY ACAD SCI, V1257, P125, DOI 10.1111/j.1749-6632.2012.06506.x; Coskun M, 2010, J CELL BIOCHEM, V109, P1118, DOI 10.1002/jcb.22490; D'Angelo R, 2007, MOL BIOL CELL, V18, P4780, DOI 10.1091/mbc.E06-12-1144; de la Garza G, 2013, J INVEST DERMATOL, V133, P68, DOI 10.1038/jid.2012.269; Dong WJ, 2012, DIGEST DIS SCI, V57, P1247, DOI 10.1007/s10620-011-1989-z; Dong WJ, 2009, BIOCHEM BIOPH RES CO, V387, P132, DOI 10.1016/j.bbrc.2009.06.140; Du D, 2010, DEV CELL, V18, P52, DOI 10.1016/j.devcel.2009.12.008; Fanning AS, 2012, MOL BIOL CELL, V23, P577, DOI 10.1091/mbc.E11-09-0791; Feng MY, 2010, CELL, V143, P84, DOI 10.1016/j.cell.2010.08.040; Fortier AM, 2013, J BIOL CHEM, V288, P11555, DOI 10.1074/jbc.M112.428920; Garrod DR, 2002, CURR OPIN CELL BIOL, V14, P537, DOI 10.1016/S0955-0674(02)00366-6; Garside VC, 2010, EXP CELL RES, V316, P2859, DOI 10.1016/j.yexcr.2010.06.014; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Griffiths EK, 2003, MOL CELL BIOL, V23, P7708, DOI 10.1128/MCB.23.21.7708-7718.2003; Guo ZG, 2012, J PROTEOME RES, V11, P4847, DOI 10.1021/pr300674c; Hall MP, 2013, RNA, V19, P627, DOI 10.1261/rna.038422.113; Herath NI, 2009, BRIT J CANCER, V100, P1095, DOI 10.1038/sj.bjc.6604970; Inouye K, 2010, J BIOL CHEM, V285, P33394, DOI 10.1074/jbc.M110.115816; Juneja M, 2013, MOL ONCOL; Kandouz M, 2012, CANCER METAST REV, V31, P353, DOI 10.1007/s10555-012-9352-1; Karashima T, 2002, J CELL SCI, V115, P5027, DOI 10.1242/jcs.00191; Karp CM, 2008, CANCER RES, V68, P4105, DOI 10.1158/0008-5472.CAN-07-6814; Kashyap A, 2013, ONCOGENE, V32, P1396, DOI 10.1038/onc.2012.162; Kim G, 2013, PATHOBIOLOGY, V80, P95, DOI 10.1159/000342394; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kohn KW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035716; Kohn KW, 2006, MOL BIOL CELL, V17, P1, DOI 10.1091/mbc.E05-09-0824; Kota P, 2012, BIOCHEMISTRY-US, V51, P3460, DOI 10.1021/bi2014773; Kroger C, 2013, J CELL BIOL; Lam L, 2012, ONCOGENESIS, V1, DOI 10.1038/oncsis.2012.4; Lawrence J, 2005, MOL PHARMACOL, V67, P1822, DOI 10.1124/mol.105.011338; Lefort CT, 2011, J BIOL CHEM, V286, P3149, DOI 10.1074/jbc.M110.115733; Lei Z, 2012, DEV BIOL; Lemmers C, 2004, MOL BIOL CELL, V15, P1324, DOI 10.1091/mbc.E03-04-0235; Lindsay AJ, 2009, CELL MOTIL CYTOSKEL, V66, P1057, DOI 10.1002/cm.20408; List K, 2007, J CELL PHYSIOL, V213, P237, DOI 10.1002/jcp.21115; Lo FY, 2011, CANCER-AM CANCER SOC, V117, P5344, DOI 10.1002/cncr.26153; Luna A, 2011, BIOINFORMATICS, V27, P2165, DOI 10.1093/bioinformatics/btr336; Marino N, 2012, CANCER METAST REV, V31, P593, DOI 10.1007/s10555-012-9374-8; Meng W, 2008, CELL, V135, P948, DOI 10.1016/j.cell.2008.09.040; Micaroni M, 2012, ADV EXP MED BIOL, V740, P439, DOI 10.1007/978-94-007-2888-2_18; Miller GS, 2012, CELL TISSUE RES; Moretti F, 2010, J CLIN INVEST, V120, P1570, DOI 10.1172/JCI40267; Musse AA, 2012, SEMIN CELL DEV BIOL, V23, P429, DOI 10.1016/j.semcdb.2012.01.011; Nair M, 2007, NUCLEIC ACIDS RES, V35, P1687, DOI 10.1093/nar/gkl1141; Nakatsukasa M, 2010, AM J PATHOL, V177, P1344, DOI 10.2353/ajpath.2010.100149; Nam KT, 2010, J CLIN INVEST, V120, P840, DOI 10.1172/JCI40728; Pai R, 2008, CANCER RES, V68, P5086, DOI 10.1158/0008-5472.CAN-07-2325; Paschoud S, 2011, MOL MEMBR BIOL, V28, P123, DOI 10.3109/09687688.2010.538937; Pellon-Cardenas O, 2013, MOL CELL BIOL, V33, P2963, DOI 10.1128/MCB.01698-12; Pestov NB, 2012, BIOCH BIOPHYS RES; Radomska KJ, 2013, HUM MOL GENET, V22, P1373, DOI 10.1093/hmg/dds553; Raleigh DR, 2010, MOL BIOL CELL, V21, P1200, DOI 10.1091/mbc.E09-08-0734; Ramirez-Carrozzi V, 2011, NAT IMMUNOL, V12, P1159, DOI 10.1038/ni.2156; Reinhold WC, 2012, CANCER RES, V72, P3499, DOI 10.1158/0008-5472.CAN-12-1370; Restivo G, 2011, EMBO J, V30, P4571, DOI 10.1038/emboj.2011.325; Rodgers LS, 2013, J CELL SCI, V126, P1565, DOI 10.1242/jcs.113399; Samson T, 2010, MOL BIOL CELL, V21, P1629, DOI 10.1091/mbc.E09-09-0809; Scheel C, 2012, SEMIN CANCER BIOL, V22, P396, DOI 10.1016/j.semcancer.2012.04.001; Schulzke JD, 2012, ANN NY ACAD SCI, V1257, P1, DOI 10.1111/j.1749-6632.2012.06485.x; Schweitzer JK, 2011, SEMIN CELL DEV BIOL, V22, P39, DOI 10.1016/j.semcdb.2010.09.002; Sen Arpita, 2012, Biomol Concepts, V3, P117; Senga K, 2012, MOL BIOL CELL, V23, P2845, DOI 10.1091/mbc.E12-02-0097; Shirakihara T, 2011, EMBO J, V30, P783, DOI 10.1038/emboj.2010.351; Shull GE, 2011, BIOFACTORS, V37, P150, DOI 10.1002/biof.141; Sonnenberg A, 2007, EXP CELL RES, V313, P2189, DOI 10.1016/j.yexcr.2007.03.039; Steed E, 2010, TRENDS CELL BIOL, V20, P142, DOI 10.1016/j.tcb.2009.12.002; Steed E, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-95; Stein U, 2013, EXPERT OPIN THER TAR, V17, P1039, DOI 10.1517/14728222.2013.815727; Stein U, 2010, J MOL MED, V88, P11, DOI 10.1007/s00109-009-0537-1; Stein U, 2009, CELL CYCLE, V8, P2467, DOI 10.4161/cc.8.15.9018; Stein U, 2009, NAT MED, V15, P59, DOI 10.1038/nm.1889; Sumigray KD, 2012, MOL BIOL CELL, V23, P792, DOI 10.1091/mbc.E11-11-0923; Takahashi S, 2009, J CELL SCI, V122, P985, DOI 10.1242/jcs.040055; Thomson S, 2011, CLIN EXP METASTAS, V28, P137, DOI 10.1007/s10585-010-9367-3; Tokonzaba E, 2013, J INVEST DERMATOL; Tomar A, 2009, J BIOL CHEM, V284, P35278, DOI 10.1074/jbc.C109.060830; van de Graaf SFJ, 2006, J AM SOC NEPHROL, V17, P26, DOI 10.1681/ASN.2005101025; Van Itallie CM, 2009, MOL BIOL CELL, V20, P3930, DOI 10.1091/mbc.E09-04-0320; Vuoriluoto K, 2010, ONCOGENE, V30, P1346; Wang HY, 2010, ONCOL REP, V23, P45, DOI 10.3892/or_00000604; Wang H, 2006, J BIOL CHEM, V281, P14129, DOI 10.1074/jbc.M512511200; Wang Q, 2007, KIDNEY INT, V72, P1448, DOI 10.1038/sj.ki.5002579; Warzecha CC, 2012, SEMIN CANC BIOL; Weixel KM, 2007, J BIOL CHEM, V282, P36534, DOI 10.1074/jbc.M703970200; Wells J, 2009, J BIOL CHEM, V284, P29125, DOI 10.1074/jbc.M109.008847; Werner S, 2013, J BIOL CHEM, V288, P22993, DOI 10.1074/jbc.M113.456293; Westphal JK, 2010, CELL MOL LIFE SCI, V67, P2057, DOI 10.1007/s00018-010-0313-y; Wolting CD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026248; Wu CJ, 2013, J BIOL CHEM; Wu D, 2010, J BIOL CHEM, V285, P28643, DOI 10.1074/jbc.M110.107649; Yamazaki T, 2009, J CELL SCI, V122, P243, DOI 10.1242/jcs.036467; Yokota T, 2006, ACTA NEUROPATHOL, V111, P29, DOI 10.1007/s00401-005-1085-6; Zhang P, 2012, MOL BIOL REP, V39, P1471, DOI 10.1007/s11033-011-0884-1; Zhang Y, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-23	117	59	59	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99269	10.1371/journal.pone.0099269	http://dx.doi.org/10.1371/journal.pone.0099269			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940735	Green Published, Green Submitted, gold			2022-12-27	WOS:000338508200017
J	Rice, MW; Smith, KL; Roberts, RC; Perez-Costas, E; Melendez-Ferro, M				Rice, Matthew W.; Smith, Kristen L.; Roberts, Rosalinda C.; Perez-Costas, Emma; Melendez-Ferro, Miguel			Assessment of Cytochrome C Oxidase Dysfunction in the Substantia Nigra/Ventral Tegmental Area in Schizophrenia	PLOS ONE			English	Article							MITOCHONDRIAL COMPLEX-I; OXIDATIVE-PHOSPHORYLATION; BASAL GANGLIA; BIPOLAR DISORDER; SUBUNIT-IV; MUTATION; PROTEIN; BRAIN; NEUROLEPTICS; INHIBITION	Perturbations in metabolism are a well-documented but complex facet of schizophrenia pathology. Optimal cellular performance requires the proper functioning of the electron transport chain, which is constituted by four enzymes located within the inner membrane of mitochondria. These enzymes create a proton gradient that is used to power the enzyme ATP synthase, producing ATP, which is crucial for the maintenance of cellular functioning. Anomalies in a single enzyme of the electron transport chain are sufficient to cause disruption of cellular metabolism. The last of these complexes is the cytochrome c oxidase (COX) enzyme, which is composed of thirteen different subunits. COX is a major site for oxidative phosphorylation, and anomalies in this enzyme are one of the most frequent causes of mitochondrial pathology. The objective of the present report was to assess if metabolic anomalies linked to COX dysfunction may contribute to substantia nigra/ventral tegmental area (SN/VTA) pathology in schizophrenia. We tested COX activity in postmortem SN/VTA from schizophrenia and non-psychiatric controls. We also tested the protein expression of key subunits for the assembly and activity of the enzyme, and the effect of antipsychotic medication on subunit expression. COX activity was not significantly different between schizophrenia and non-psychiatric controls. However, we found significant decreases in the expression of subunits II and IV-I of COX in schizophrenia. Interestingly, these decreases were observed in samples containing the entire rostro-caudal extent of the SN/VTA, while no significant differences were observed for samples containing only mid-caudal regions of the SN/VTA. Finally, rats chronically treated with antipsychotic drugs did not show significant changes in COX subunit expression. These findings suggest that COX subunit expression may be compromised in specific sub-regions of the SN/VTA (i.e. rostral regions), which may lead to a faulty assembly of the enzyme and a greater vulnerability to metabolic insult.	[Rice, Matthew W.; Smith, Kristen L.; Roberts, Rosalinda C.; Perez-Costas, Emma; Melendez-Ferro, Miguel] Univ Alabama Birmingham, Dept Psychiat & Behav Neurobiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Melendez-Ferro, M (corresponding author), Univ Alabama Birmingham, Dept Psychiat & Behav Neurobiol, Birmingham, AL 35294 USA.	lampreas@gmail.com		PEREZ-COSTAS, EMMA/0000-0002-9050-9593; Rice, Matthew/0000-0002-8160-3297	NIH R01 grant [MH066123]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066123] Funding Source: NIH RePORTER	NIH R01 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Work was supported by NIH R01 grant MH066123 to MMF, EPC and RCR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abril J, 2008, PROSTATE, V68, P1086, DOI 10.1002/pros.20771; Akil M, 1999, AM J PSYCHIAT, V156, P1580, DOI 10.1176/ajp.156.10.1580; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Arnold RS, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/239257; Augustine JR, 2008, HUMAN NEUROANATOMY, P49; Babcock DF, 1998, CURR OPIN NEUROBIOL, V8, P398, DOI 10.1016/S0959-4388(98)80067-6; Balijepalli S, 1999, NEUROPHARMACOLOGY, V38, P567, DOI 10.1016/S0028-3908(98)00215-9; Balijepalli S, 2001, NEUROCHEM INT, V38, P425, DOI 10.1016/S0197-0186(00)00108-X; Barksdale KA, 2010, FASEB J, V24, P3590, DOI 10.1096/fj.09-152108; Barrientos A, 2002, GENE, V286, P53, DOI 10.1016/S0378-1119(01)00803-4; Ben-Shachar D, 2009, J NEURAL TRANSM, V116, P1383, DOI 10.1007/s00702-009-0319-5; Ben-Shachar D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003676; Brodin L, 1999, PHILOS T R SOC B, V354, P365, DOI 10.1098/rstb.1999.0388; Bruno C, 1999, AM J HUM GENET, V65, P611, DOI 10.1086/302546; BURKHARDT C, 1993, ANN NEUROL, V33, P512, DOI 10.1002/ana.410330516; Campbell N.A., 2006, BIOL EXPLORING LIFE; CAVELIER L, 1995, GENOMICS, V29, P217, DOI 10.1006/geno.1995.1234; Clark KM, 1999, AM J HUM GENET, V64, P1330, DOI 10.1086/302361; Crosby EC, 1943, J COMP NEUROL, V78, P441, DOI 10.1002/cne.900780311; DIVAC I, 1995, J NEUROSCI METH, V56, P105, DOI 10.1016/0165-0270(94)00112-T; Fontanesi F, 2006, AM J PHYSIOL-CELL PH, V291, pC1129, DOI 10.1152/ajpcell.00233.2006; Francisconi S, 2006, J NEUROCHEM, V98, P223, DOI 10.1111/j.1471-4159.2006.03864.x; Fukui H, 2008, TRENDS NEUROSCI, V31, P251, DOI 10.1016/j.tins.2008.02.008; Gattermann N, 1997, BLOOD, V90, P4961, DOI 10.1182/blood.V90.12.4961.4961_4961_4972; Haber SN, 1997, CRIT REV NEUROBIOL, V11, P323, DOI 10.1615/CritRevNeurobiol.v11.i4.40; Hall CN, 2012, J NEUROSCI, V32, P8940, DOI 10.1523/JNEUROSCI.0026-12.2012; Huttemann M, 2001, GENE, V267, P111, DOI 10.1016/S0378-1119(01)00385-7; Ivanova MM, 2011, FASEB J, V25, P1402, DOI 10.1096/fj.10-169029; Joel D, 2000, NEUROSCIENCE, V96, P451, DOI 10.1016/S0306-4522(99)00575-8; Kadenbach B, 2000, FREE RADICAL BIO MED, V29, P211, DOI 10.1016/S0891-5849(00)00305-1; King L, 1999, SYNAPSE, V31, P67, DOI 10.1002/(SICI)1098-2396(199901)31:1<67::AID-SYN9>3.0.CO;2-#; Kolomeets NS, 1997, ZH NEVROPATOL PSIKH, V97, P39; Lee Y, 2013, NEUROSCI LETT, V535, P134, DOI 10.1016/j.neulet.2012.12.050; Li YF, 2006, J BIOENERG BIOMEMBR, V38, P283, DOI 10.1007/s10863-006-9052-z; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Manatt M, 2011, J MED GENET GENOMIC, V3, P84; Manji H, 2012, NAT REV NEUROSCI, V13, P293, DOI 10.1038/nrn3229; Marin O, 1998, TRENDS NEUROSCI, V21, P487, DOI 10.1016/S0166-2236(98)01297-1; Mattson MP, 2000, J NEUROCHEM, V74, P443, DOI 10.1046/j.1471-4159.2000.740443.x; Maurer I, 1997, MOL CELL BIOCHEM, V174, P255, DOI 10.1023/A:1006872911332; Maurer I, 2001, SCHIZOPHR RES, V48, P125, DOI 10.1016/S0920-9964(00)00075-X; Melendez-Ferro M, 2013, J NEUROSCI METH, V214, P156, DOI 10.1016/j.jneumeth.2013.01.010; Michel H, 1998, ANNU REV BIOPH BIOM, V27, P329, DOI 10.1146/annurev.biophys.27.1.329; Mitchell T, 2013, BIOCHEM SOC T, V41, P127, DOI 10.1042/BST20120231; Motulsky HJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-123; Motulsky HJ, 2010, INTUITIVE BIOSTATIST; Nijtmans LGJ, 1998, EUR J BIOCHEM, V254, P389, DOI 10.1046/j.1432-1327.1998.2540389.x; Orth M, 2001, AM J MED GENET, V106, P27, DOI 10.1002/ajmg.1425; Paxinos G., 1995, ATLAS HUMAN BRAINSTE; PEL HJ, 1994, MOL BIOL REP, V19, P183, DOI 10.1007/BF00986960; Perez J, 2010, BIOCHEM J, V428, P255, DOI 10.1042/BJ20100090; Perez-Costas E, 2008, J NEURAL TRANSM, V115, P745, DOI 10.1007/s00702-007-0004-5; Perez-Costas Emma, 2012, Front Psychiatry, V3, P31, DOI 10.3389/fpsyt.2012.00031; Perez-Costas E, 2010, J NEUROCHEM, V113, P287, DOI 10.1111/j.1471-4159.2010.06604.x; Poeggeler B, 1998, DEV NEUROSCI-BASEL, V20, P146, DOI 10.1159/000017309; Prince JA, 1999, NEUROPSYCHOPHARMACOL, V21, P372, DOI 10.1016/S0893-133X(99)00016-0; Prince JA, 1997, J PHARMACOL EXP THER, V280, P261; Rahman S, 1999, AM J HUM GENET, V65, P1030, DOI 10.1086/302590; Richman TR, 2014, NUCLEIC ACIDS RES, V42, P5483, DOI 10.1093/nar/gku179; Rollins B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004913; Rosenfeld M, 2011, BIOL PSYCHIAT, V69, P980, DOI 10.1016/j.biopsych.2011.01.010; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Saddar S, 2008, J BIOL CHEM, V283, P6677, DOI 10.1074/jbc.M708440200; Shoubridge EA, 2001, AM J MED GENET, V106, P46, DOI 10.1002/ajmg.1378; Somerville SM, 2012, SYNAPSE, V66, P29, DOI 10.1002/syn.20981; Somerville SM, 2011, SYNAPSE, V65, P215, DOI 10.1002/syn.20838; SPITZER RL, 1992, ARCH GEN PSYCHIAT, V49, P624; Streck EL, 2007, N-S ARCH PHARMACOL, V376, P127, DOI 10.1007/s00210-007-0178-2; Taanman JW, 1997, J BIOENERG BIOMEMBR, V29, P151, DOI 10.1023/A:1022638013825; TAKAHASHI Y, 1953, Folia Psychiatr Neurol Jpn, V6, P244; Tiranti V, 2000, HUM MOL GENET, V9, P2733, DOI 10.1093/hmg/9.18.2733; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; Uranova N, 2001, BRAIN RES BULL, V55, P597, DOI 10.1016/S0361-9230(01)00528-7; URANOVA NA, 1989, ZH NEVROPATOL PSIKH, V89, P56; VANDOMBURG PHMF, 1991, ADV ANAT EMBRYOL CEL, V121, P1; Verkhovsky MI, 1999, NATURE, V400, P480, DOI 10.1038/22813; Verstreken P, 2005, NEURON, V47, P365, DOI 10.1016/j.neuron.2005.06.018; Volz HP, 2000, BIOL PSYCHIAT, V47, P954, DOI 10.1016/S0006-3223(00)00235-3; Whatley SA, 1996, NEUROCHEM RES, V21, P995, DOI 10.1007/BF02532409; Whatley SA, 1998, MOL PSYCHIATR, V3, P227, DOI 10.1038/sj.mp.4000375; You KR, 2002, J BIOL CHEM, V277, P3870, DOI 10.1074/jbc.M109284200	81	20	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100054	10.1371/journal.pone.0100054	http://dx.doi.org/10.1371/journal.pone.0100054			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941246	gold, Green Submitted, Green Published			2022-12-27	WOS:000338508200070
J	Meinhardt-Injac, B; Persike, M; Meinhardt, G				Meinhardt-Injac, Bozana; Persike, Malte; Meinhardt, Guenter			Development of Visual Systems for Faces and Objects: Further Evidence for Prolonged Development of the Face System	PLOS ONE			English	Article							PRESCHOOL-AGED CHILDREN; EXTERNAL FEATURES; TIME-COURSE; RECOGNITION; FAMILIAR; CONTEXT; SENSITIVITY; CHILDHOOD; CORTEX; BRAIN	Background: The development of face and object processing has attracted much attention; however, studies that directly compare processing of both visual categories across age are rare. In the present study, we compared the developmental trajectories of face and object processing in younger children (8-10 years), older children (11-13 years), adolescents (14-16 years), and adults (20-37). Methodology/Principal Findings: We used a congruency paradigm in which subjects compared the internal features of two stimuli, while the (unattended) external features either agreed or disagreed independent of the identity of the internal features. We found a continuous increase in matching accuracy for faces and watches across childhood and adolescence, with different magnitudes for both visual categories. In watch perception, adult levels were reached at the age of 14-16, but not in face perception. The effect of context and inversion, as measures of holistic and configural processing, were clearly restricted to faces in all age groups. This finding suggests that different mechanisms are involved in face and object perception at any age tested. Moreover, the modulation of context and inversion effects by exposure duration was strongly age-dependent, with the strongest age-related differences found for brief timings below 140 ms. Conclusions/Significance: The results of the present study suggest prolonged development of face-specific processing up to young adulthood. The improvement in face processing is qualitatively different from the improvement of general perceptual and cognitive ability.	[Meinhardt-Injac, Bozana; Persike, Malte; Meinhardt, Guenter] Johannes Gutenberg Univ Mainz, Dept Psychol, D-55122 Mainz, Germany	Johannes Gutenberg University of Mainz	Meinhardt-Injac, B (corresponding author), Johannes Gutenberg Univ Mainz, Dept Psychol, D-55122 Mainz, Germany.	meinharb@uni-mainz.de	Meinhardt-Injac, Bozana/R-6743-2018	Meinhardt-Injac, Bozana/0000-0001-7023-8100	Johannes Gutenberg University Mainz	Johannes Gutenberg University Mainz	This study was supported by the research grant "Inneruniversitare Forschungsforderung'' of Johannes Gutenberg University Mainz given to BMI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews TJ, 2010, J NEUROSCI, V30, P3544, DOI 10.1523/JNEUROSCI.4863-09.2010; Anes MD, 2009, PERCEPTION, V38, P333, DOI 10.1068/p6092; Biederman I, 1997, PHILOS T ROY SOC B, V352, P1203, DOI 10.1098/rstb.1997.0103; CAMPBELL R, 1995, J EXP CHILD PSYCHOL, V59, P196, DOI 10.1006/jecp.1995.1009; Campbell R, 1999, VIS COGN, V6, P197, DOI 10.1080/713756807; Carey S., 1994, VIS COGN, V1, P253, DOI [DOI 10.1080/13506289408402302, 10.1080/13506289408402302]; Cassia VM, 2011, J EXP CHILD PSYCHOL, V109, P454, DOI 10.1016/j.jecp.2011.03.003; Cassia VM, 2009, DEVELOPMENTAL SCI, V12, P236, DOI 10.1111/j.1467-7687.2008.00765.x; Crookes K, 2009, COGNITION, V111, P219, DOI 10.1016/j.cognition.2009.02.004; de Heering A, 2007, J EXP CHILD PSYCHOL, V96, P57, DOI 10.1016/j.jecp.2006.07.001; DIAMOND R, 1986, J EXP PSYCHOL GEN, V115, P107, DOI 10.1037/0096-3445.115.2.107; Ding XP, 2014, NEUROIMAGE, V85, P335, DOI 10.1016/j.neuroimage.2013.07.051; ELLIS HD, 1979, PERCEPTION, V8, P431, DOI 10.1068/p080431; Germine LT, 2011, COGNITION, V118, P201, DOI 10.1016/j.cognition.2010.11.002; Golarai G, 2007, NAT NEUROSCI, V10, P512, DOI 10.1038/nn1865; Golarai Golijeh, 2010, Front Hum Neurosci, V3, P80, DOI 10.3389/neuro.09.080.2009; Haist F, 2013, NEUROPSYCHOLOGIA, V51, P2893, DOI 10.1016/j.neuropsychologia.2013.08.005; Haist F, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00181; Jacques C, 2009, J VISION, V9, DOI 10.1167/9.6.8; Joseph JE, 2012, NEUROIMAGE, V63, P1223, DOI 10.1016/j.neuroimage.2012.08.021; Juttner M, 2013, DEV PSYCHOL, V49, P161, DOI 10.1037/a0027707; Kadosh KC, 2007, TRENDS COGN SCI, V11, P367, DOI 10.1016/j.tics.2007.06.007; Kadosh KC, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2011.00400; Kadosh KC, 2011, CEREB CORTEX, V21, P1389, DOI 10.1093/cercor/bhq215; Knowles MM, 2014, ACTA PSYCHO IN PRESS; Leonard HC, 2010, J EXP CHILD PSYCHOL, V106, P193, DOI 10.1016/j.jecp.2010.03.005; Liu CH, 2002, COGNITION, V83, P31, DOI 10.1016/S0010-0277(01)00164-0; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; Meinhardt-Injac B, 2014, ACTA PSYCHO IN PRESS; Meinhardt-Injac B, 2013, ACTA PSYCHOL, V142, P265, DOI 10.1016/j.actpsy.2012.12.012; Meinhardt-Injac B, 2011, VISION RES, V51, P2121, DOI 10.1016/j.visres.2011.08.004; Meinhardt-Injac B, 2010, VISION RES, V50, P1598, DOI 10.1016/j.visres.2010.05.018; Mondloch CJ, 2002, PERCEPTION, V31, P553, DOI 10.1068/p3339; Nachson I, 1995, PSYCHOL RES, V58, P1; Picozzi M, 2009, J EXP CHILD PSYCHOL, V102, P487, DOI 10.1016/j.jecp.2008.11.001; Richler JJ, 2009, VISION RES, V49, P2856, DOI 10.1016/j.visres.2009.08.025; Robbins RA, 2011, J EXP CHILD PSYCHOL, V109, P371, DOI 10.1016/j.jecp.2011.02.004; Scherf KS, 2012, DEV COGN NEUROS-NETH, V2, P199, DOI 10.1016/j.dcn.2011.07.016; Schwarzer G, 2002, INFANT CHILD DEV, V11, P253, DOI 10.1002/icd.257; Schwarzer G, 2010, EUR J DEV PSYCHOL, V7, P511, DOI 10.1080/17405620903003697; Sinha P, 1996, NATURE, V384, P404, DOI 10.1038/384404a0; Tanaka JW, 1998, VIS COGN, V5, P479, DOI 10.1080/713756795; TANAKA JW, 1993, Q J EXP PSYCHOL-A, V46, P225, DOI 10.1080/14640749308401045; Veres-Injac B, 2009, PSIHOLOGIJA, V42, P47, DOI 10.2298/PSI0901047V; Veres-Injac B, 2009, PSYCHOL RES-PSYCH FO, V73, P43, DOI 10.1007/s00426-008-0147-5; Wakui E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061041; YOUNG AW, 1987, PERCEPTION, V16, P747, DOI 10.1068/p160747; Yue XM, 2006, VISION RES, V46, P3802, DOI 10.1016/j.visres.2006.06.017	48	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e99942	10.1371/journal.pone.0099942	http://dx.doi.org/10.1371/journal.pone.0099942			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL1WV	24955959	Green Published, gold, Green Submitted			2022-12-27	WOS:000338917900022
J	Peng, HS; Liao, MB; Zhang, MY; Xie, Y; Xu, L; Zhang, YJ; Zheng, XFS; Wang, HY; Chen, YF				Peng, Hai-Shan; Liao, Ming-Bin; Zhang, Mei-Yin; Xie, Yin; Xu, Li; Zhang, Yao-Jun; Zheng, X. F. Steven; Wang, Hui-Yun; Chen, Yi-Fei			Synergistic Inhibitory Effect of Hyperbaric Oxygen Combined with Sorafenib on Hepatoma Cells	PLOS ONE			English	Article							ADVANCED HEPATOCELLULAR-CARCINOMA; CANCER-CELLS; IN-VITRO; THERAPY; APOPTOSIS; PATHWAYS; SURVIVAL; HYPOXIA; CHEMOTHERAPY; MOBILIZATION	Objectives: Hypoxia is a common phenomenon in solid tumors, associated with chemotherapy and radiotherapy resistance, recurrence and metastasis. Hyperbaric oxygen (HBO) therapy can increase tissue oxygen pressure and content to prevent the resistance, recurrence and metastasis of cancer. Presently, Sorafenib is a first-line drug, targeted for hepatocellular carcinoma (HCC) but effective in only a small portion of patients and can induce hypoxia. The purpose of this study is to investigate the effect of HBO in combination with sorafenib on hepatoma cells. Methods: Hepatoma cell lines (BEL-7402 and SK-Hep1) were treated with HBO at 2 atmosphere absolute pressure for 80 min per day or combined with sorafenib or cisplatin. At different time points, cells were tested for cell growth, colony formation, apoptosis, cell cycle and migration. Finally, miRNA from the hepatoma cells was detected by microRNA array and validated by qRT-PCR. Results: Although HBO, sorafenib or cisplatin alone could inhibit growth of hepatoma cells, HBO combined with sorafenib or cisplatin resulted in much greater synergistic growth inhibition (cell proliferation and colony formation) in hepatoma cells. Similarly, the synergistic effect of HBO and sorafenib on induction of apoptosis was also observed in hepatoma cells. HBO induced G1 arrest in SK-Hep1 not in BEL-7402 cells, but enhanced cell cycle arrest induced by sorafenib in BEL-7402 treated cells. However, HBO had no obvious effect on the migration of hepatoma cells, and microRNA array analysis showed that hepatoma cells with HBO treatment had significantly different microRNA expression profiles from those with blank control. Conclusions: We show for the first time that HBO combined with sorafenib results in synergistic growth inhibition and apoptosis in hepatoma cells, suggesting a potential application of HBO combined with sorafenib in HCC patients. Additionally, we also show that HBO significantly altered microRNA expression in hepatoma cells.	[Peng, Hai-Shan; Zhang, Mei-Yin; Xie, Yin; Wang, Hui-Yun] State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [Peng, Hai-Shan; Zhang, Mei-Yin; Xie, Yin; Wang, Hui-Yun] Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, Guangzhou 510275, Guangdong, Peoples R China; [Liao, Ming-Bin; Chen, Yi-Fei] Guangzhou Med Univ, Guangzhou Peoples Hosp 1, Hyperbar Oxygen Therapy Ctr, Guangzhou, Guangdong, Peoples R China; [Xu, Li; Zhang, Yao-Jun] Sun Yat Sen Univ, Ctr Canc, Dept Hepatobiliary Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Zheng, X. F. Steven] Rutgers State Univ, Rutgers Canc Inst New Jersey, New Brunswick, NJ 08903 USA	State Key Lab Oncology South China; Sun Yat Sen University; Guangzhou Medical University; Sun Yat Sen University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Wang, HY (corresponding author), State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China.	wanghyun@mail.sysu.edu.cn; xwcyfmm2001@aliyun.com	YANG, YANG/U-3889-2017; Chen, Yi/HIR-2608-2022; Zhang, Yaojun/U-2965-2019	Zhang, Yaojun/0000-0002-9752-4729	Guangdong Natural Science Foundation [S2012010008627]; State Key Laboratory of Oncology in South China	Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); State Key Laboratory of Oncology in South China	The project is supported by Guangdong Natural Science Foundation (grant No: S2012010008627 for YFC) and partially supported by Research Fund of State Key Laboratory of Oncology in South China (to HYW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JF, 1963, BMJ-BRIT MED J, P314, DOI 10.1136/bmj.1.5326.314; Agnello F, 2013, WORLD J HEPATOL, V5, P417, DOI 10.4254/wjh.v5.i8.417; Chai H, 2010, INT J CLIN EXP PATHO, V3, P408; Chang AY, 2013, ANTI-CANCER DRUG, V24, P251, DOI 10.1097/CAD.0b013e32835ba289; Chen YC, 2007, LEUKEMIA RES, V31, P805, DOI 10.1016/j.leukres.2006.09.016; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Danesh-Sani SA, 2012, J CRANIOFAC SURG, V23, pE483, DOI 10.1097/SCS.0b013e3182668777; Daruwalla J, 2007, J DRUG TARGET, V15, P487, DOI 10.1080/10611860701499839; Di Costanzo GG, 2012, DIGEST LIVER DIS, V44, P788, DOI 10.1016/j.dld.2012.04.001; Di Marco V, 2013, ANN ONCOL, V24, pii30, DOI 10.1093/annonc/mdt055; Durmaz E, 1999, Br J Nurs, V8, P1067; Edwards ML, 2010, J VET EMERG CRIT CAR, V20, P289, DOI 10.1111/j.1476-4431.2010.00535_1.x; FELDMEIER JJ, 1994, UNDERSEA HYPERBAR M, V21, P467; Galmiche A, 2013, CANC LETT; Gedaly R, 2010, ANTICANCER RES, V30, P4951; Gill AL, 2004, QJM-INT J MED, V97, P385, DOI 10.1093/qjmed/hch074; Hsu CH, 2010, J HEPATOL, V53, P126, DOI 10.1016/j.jhep.2010.01.035; Hsu Chiun, 2009, Expert Rev Clin Pharmacol, V2, P129, DOI 10.1586/17512433.2.2.129; Huang SB, 2010, MOL CANCER THER, V9, P742, DOI 10.1158/1535-7163.MCT-09-1004; Kalns JE, 1999, IN VITRO CELL DEV-AN, V35, P98; Kane RC, 2009, ONCOLOGIST, V14, P95, DOI 10.1634/theoncologist.2008-0185; Lee CH, 2012, UNDERSEA HYPERBAR M, V39, P1089; Liang YJ, 2013, HEPATOLOGY, V57, P1847, DOI 10.1002/hep.26224; Liu LP, 2012, CLIN CANCER RES, V18, P5662, DOI 10.1158/1078-0432.CCR-12-0552; Liu WW, 2013, TARGET ONCOL, V8, P79, DOI 10.1007/s11523-013-0259-8; Moen I, 2012, TARGET ONCOL, V7, P233, DOI 10.1007/s11523-012-0233-x; Mori S, 2009, ONCOGENE, V28, P2796, DOI 10.1038/onc.2009.139; Nakada T, 2012, UROL INT, V89, P208, DOI 10.1159/000338910; Nakano M, 2013, ONCOLOGY-BASEL, V84, P108, DOI 10.1159/000342650; Ohguri T, 2009, INT J HYPERTHER, V25, P160, DOI 10.1080/02656730802610357; Ranieri G, 2012, CURR MED CHEM, V19, P938, DOI 10.2174/092986712799320736; Thom SR, 2006, AM J PHYSIOL-HEART C, V290, pH1378, DOI 10.1152/ajpheart.00888.2005; Thom SR, 2011, WOUND REPAIR REGEN, V19, P149, DOI 10.1111/j.1524-475X.2010.00660.x; Wei RR, 2013, CLIN CANCER RES, V19, P4780, DOI 10.1158/1078-0432.CCR-12-2728; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Xu Li, 2009, Zhonghua Zhongliu Zazhi, V31, P58, DOI 10.3760/cma.j.issn.0253-3766.2009.01.015; Yeh YT, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/290575; Yu CR, 2006, MOL CANCER THER, V5, P2378, DOI 10.1158/1535-7163.MCT-06-0235; Zavaglia C, 2013, EUR J GASTROEN HEPAT, V25, P180, DOI 10.1097/MEG.0b013e328359e550; Zhai B, 2013, WORLD J HEPATOL, V5, P345, DOI 10.4254/wjh.v5.i7.345; Zhang T, 2010, ANTI-CANCER DRUG, V21, P326, DOI 10.1097/CAD.0b013e3283350e26	41	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100814	10.1371/journal.pone.0100814	http://dx.doi.org/10.1371/journal.pone.0100814			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956259	Green Published, gold, Green Submitted			2022-12-27	WOS:000338917900097
J	Xue, XD; Huang, JH; Wang, HS				Xue, Xiaodong; Huang, Jianhua; Wang, Huishan			The Study of the Intercellular Trafficking of the Fusion Proteins of Herpes Simplex Virus Protein VP22	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; SKELETAL MYOBLAST TRANSPLANTATION; IMPROVES CARDIAC-FUNCTION; IMPROVED HEART FUNCTION; MARROW STROMAL CELLS; GENE-TRANSFER; MYOCARDIAL-INFARCTION; IN-VITRO; BONE; REGENERATION	Background: Genetic modifications can improve the therapeutic efficacy of mesenchymal stem cell (MSC) transplantation in myocardial infarction. However, so far, the efficiency of MSC modification is very low. Seeking for a more efficient way of MSC modification, we investigated the possibility of employing the intercellular trafficking capacity of the herpes simplex virus type-1 tegument protein VP22 on the enhancement of MSC modification. Methods: Plasmids pVP22-myc, pVP22-EGFP, pEGFP-VP22, pVP22-hBcl-xL and phBcl-xL-VP22 were constructed for the expressions of the myc-tagged VP22 and the fusion proteins VP22-EGFP, EGFP-VP22, VP22-hBcl-xL and hBcl-xL-VP22. MSCs were isolated from rat bone marrow and the surface markers were identified by Flowcytometry. COS-1 cells were transfected with the above plasmids and co-cultured with untransfected MSCs, the intercellular transportations of the constructed proteins were studied by immunofluorescence. The solubility of VP22-hBcl-xL and hBcl-xL-VP22 was analyzed by Western blot. Results: VP22-myc could be expressed in and spread between COS-1 cells, which indicates the validity of our VP22 expression construct. Flowcytometry analysis revealed that the isolated MSCs were CD29, CD44, and CD90 positive and were negative for the hematopoietic markers, CD34 and CD45. The co-culturing and immunofluorescence assay showed that VP22-myc, VP22-EGFP and EGFP-VP22 could traffic between COS-1 cells and MSCs, while the evidence of intercellular transportation of VP22-hBcl-xL and hBcl-xL-VP22 was not detected. Western blot analysis showed that VP22-hBcl-xL and hBcl-xL-VP22 were both insoluble in the cell lysate suggesting interactions of the fusion proteins with other cellular components. Conclusions: The intercellular trafficking of VP22-myc, VP22-EGFP and EGFP-VP22 between COS-1 cells and MSCs presents an intriguing prospect in the therapeutic application of VP22 as a delivery vehicle which enhances genetic modifications of MSCs. However, VP22-hBcl-xL and hBcl-xL-VP22 failed to spread between cells, which are due to the insolubility of the fusion protein incurred by interactions with other cellular components.	[Xue, Xiaodong; Wang, Huishan] Gen Hosp Shenyang Mil Area Command, Dept Cardiovasc Surg, Shenyang, Liaoning, Peoples R China; [Huang, Jianhua] Ningxia Peoples Hosp, Dept Cardiothorac Surg, Yinchuan, Ningxia, Peoples R China		Wang, HS (corresponding author), Gen Hosp Shenyang Mil Area Command, Dept Cardiovasc Surg, Shenyang, Liaoning, Peoples R China.	wanghuishanCA@126.com	Wang, Huishan/V-5258-2017	Wang, Huishan/0000-0001-6523-7488	National Natural Science Foundation of China [81071267]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by the National Natural Science Foundation of China (No. 81071267). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslan H, 2006, TISSUE ENG, V12, P877, DOI 10.1089/ten.2006.12.877; Boura JS, 2013, HUM GENE THER METHOD, V24, P38, DOI 10.1089/hgtb.2012.185; Chen JL, 2001, J NEUROL SCI, V189, P49, DOI 10.1016/S0022-510X(01)00557-3; Djouad F, 2003, BLOOD, V102, P3837, DOI 10.1182/blood-2003-04-1193; Edelstein ML, 2007, J GENE MED, V9, P833, DOI 10.1002/jgm.1100; Elliott G, 1997, CELL, V88, P223, DOI 10.1016/S0092-8674(00)81843-7; Fan L, 2009, EUR J HEART FAIL, V11, P1023, DOI 10.1093/eurjhf/hfp135; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Griffin M, 2010, DISCOV MED, V9, P219; Helledie T, 2008, STEM CELLS DEV, V17, P837, DOI 10.1089/scd.2007.0209; Huang JH, 2005, CIRCULATION, V112, P76, DOI 10.1161/CIRCULATIONAHA.105.535740; Huang JH, 2003, BIOCHEM BIOPH RES CO, V311, P64, DOI 10.1016/j.bbrc.2003.09.160; Jo JI, 2007, TISSUE ENG, V13, P313, DOI 10.1089/ten.2006.0133; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Kumar S, 2008, GENE THER, V15, P711, DOI 10.1038/gt.2008.35; Le Blanc K, 2003, EXP HEMATOL, V31, P890, DOI 10.1016/S0301-472X(03)00110-3; Lemken ML, 2007, MOL THER, V15, P310, DOI 10.1038/sj.mt.6300013; Lennon DP, 2006, EXP HEMATOL, V34, P1606, DOI 10.1016/j.exphem.2006.07.015; Leri A, 2005, PHYSIOL REV, V85, P1373, DOI 10.1152/physrev.00013.2005; Li RK, 1999, J MOL CELL CARDIOL, V31, P513, DOI 10.1006/jmcc.1998.0882; Li WZ, 2007, STEM CELLS, V25, P2118, DOI 10.1634/stemcells.2006-0771; Liang XP, 1997, VACCINE, V15, P1057, DOI 10.1016/S0264-410X(97)00008-X; Makino S, 1999, J CLIN INVEST, V103, P697, DOI 10.1172/JCI5298; Mangi AA, 2003, NAT MED, V9, P1195, DOI 10.1038/nm912; McMahon JM, 2006, STEM CELLS DEV, V15, P87, DOI 10.1089/scd.2006.15.87; Menasche P, 2003, J AM COLL CARDIOL, V41, P1078, DOI 10.1016/S0735-1097(03)00092-5; Min JY, 2003, J THORAC CARDIOV SUR, V125, P361, DOI 10.1067/mtc.2003.101; Murry CE, 1996, J CLIN INVEST, V98, P2512, DOI 10.1172/JCI119070; Nienhuis AW, 2006, MOL THER, V13, P1031, DOI 10.1016/j.ymthe.2006.03.001; Nishi K, 2007, J BIOL CHEM, V282, P27503, DOI 10.1074/jbc.M703810200; Nishikawa M, 2010, MOL THER, V18, P421, DOI 10.1038/mt.2009.203; PEREIRA RF, 1995, P NATL ACAD SCI USA, V92, P4857, DOI 10.1073/pnas.92.11.4857; Phelan A, 1998, NAT BIOTECHNOL, V16, P440, DOI 10.1038/nbt0598-440; Piao WH, 2010, ANGIOGENESIS, V13, P203, DOI 10.1007/s10456-010-9169-x; Pittenger MF, 2004, CIRC RES, V95, P9, DOI 10.1161/01.RES.0000135902.99383.6f; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Pontikoglou C, 2011, STEM CELL REV REP, V7, P569, DOI 10.1007/s12015-011-9228-8; Reed JC, 1998, ONCOGENE, V17, P3225, DOI 10.1038/sj.onc.1202591; Rutjes SA, 2003, J MOL MED, V81, P558, DOI 10.1007/s00109-003-0457-4; Sorrell JM, 2009, TISSUE ENG PT A, V15, P1751, DOI 10.1089/ten.tea.2008.0254; Stamm C, 2003, LANCET, V361, P45, DOI 10.1016/S0140-6736(03)12110-1; Tang T, 2007, CIRC RES, V100, P1540, DOI 10.1161/CIRCRESAHA.107.101102; Tang YL, 2005, J AM COLL CARDIOL, V46, P1339, DOI 10.1016/j.jacc.2005.05.079; Taylor DA, 1998, NAT MED, V4, P929, DOI 10.1038/nm0898-929; Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442; Tomita S, 1999, CIRCULATION, V100, P247, DOI 10.1161/01.cir.100.suppl_2.ii-247; Wollert KC, 2004, LANCET, V364, P141, DOI 10.1016/S0140-6736(04)16626-9; Yoo KJ, 2000, ANN THORAC SURG, V70, P859, DOI 10.1016/S0003-4975(00)01630-1; Zhang M, 2001, J MOL CELL CARDIOL, V33, P907, DOI 10.1006/jmcc.2001.1367	49	5	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100840	10.1371/journal.pone.0100840	http://dx.doi.org/10.1371/journal.pone.0100840			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955582	gold, Green Published, Green Submitted			2022-12-27	WOS:000338917900100
J	Gong, WP; Xiong, XL; Qi, Y; Jiao, J; Duan, CS; Wen, BH				Gong, Wenping; Xiong, Xiaolu; Qi, Yong; Jiao, Jun; Duan, Changsong; Wen, Bohai			Identification of Novel Surface-Exposed Proteins of Rickettsia rickettsii by Affinity Purification and Proteomics	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEINS; ACTIN-BASED MOTILITY; SPOTTED-FEVER; COXIELLA-BURNETII; DENDRITIC CELLS; AUTOTRANSPORTER; ADHERENCE; OMPA; EXPRESSION; PROTECTION	Rickettsia rickettsii, the causative agent of Rocky Mountain spotted fever, is the most pathogenic member among Rickettsia spp. Surface-exposed proteins (SEPs) of R. rickettsii may play important roles in its pathogenesis or immunity. In this study, R. rickettsii organisms were surface-labeled with sulfo-NHS-SS-biotin and the labeled proteins were affinity-purified with streptavidin. The isolated proteins were separated by two-dimensional electrophoresis, and 10 proteins were identified among 23 protein spots by electrospray ionization tandem mass spectrometry. Five (OmpA, OmpB, GroEL, GroES, and a DNA-binding protein) of the 10 proteins were previously characterized as surface proteins of R. rickettsii. Another 5 proteins (Adr1, Adr2, OmpW, Porin_4, and TolC) were first recognized as SEPs of R. rickettsii herein. The genes encoding the 5 novel SEPs were expressed in Escherichia coli cells, resulting in 5 recombinant SEPs (rSEPs), which were used to immunize mice. After challenge with viable R. rickettsii cells, the rickettsial load in the spleen, liver, or lung of mice immunized with rAdr2 and in the lungs of mice immunized with other rSEPs excluding rTolC was significantly lower than in mice that were mock-immunized with PBS. The in vitro neutralization test revealed that sera from mice immunized with rAdr1, rAdr2, or rOmpW reduced R. rickettsii adherence to and invasion of vascular endothelial cells. The immuno-electron microscopic assay clearly showed that the novel SEPs were located in the outer and/or inner membrane of R. rickettsii. Altogether, the 5 novel SEPs identified herein might be involved in the interaction of R. rickettsii with vascular endothelial cells, and all of them except TolC were protective antigens.	[Gong, Wenping; Xiong, Xiaolu; Qi, Yong; Jiao, Jun; Duan, Changsong; Wen, Bohai] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China	Beijing Institute of Microbiology & Epidemiology	Xiong, XL (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	xiongxiaolu624@sohu.com; wenbohai@yahoo.com	Gong, Wenping/B-8183-2018; Qi, Yong/AAK-8798-2021; Jiao, Jun/ABE-7519-2021	Gong, Wenping/0000-0002-0333-890X; Qi, Yong/0000-0001-6186-9023; 	National Basic Research Program of China [2010CB530200/2010CB530205]; National Natural Science Foundation of China [81371767, 31170161]; Natural Science and Technology Major Project of China [2013ZX10004803]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science and Technology Major Project of China	This work was supported by the National Basic Research Program of China [grant 2010CB530200/2010CB530205], the National Natural Science Foundation of China grants 81371767 and 31170161, and the Natural Science and Technology Major Project of China [grant 2013ZX10004803]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammerman Nicole C, 2008, Curr Protoc Microbiol, VChapter 3, DOI 10.1002/9780471729259.mc03a05s11; Balraj P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002582; Balraj P, 2009, ANN NY ACAD SCI, V1166, P94, DOI 10.1111/j.1749-6632.2009.04517.x; BENZ R, 1988, EUR J BIOCHEM, V176, P1, DOI 10.1111/j.1432-1033.1988.tb14245.x; Blanc G, 2005, MOL BIOL EVOL, V22, P2073, DOI 10.1093/molbev/msi199; Chan YGY, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00139; Clifton DR, 1998, P NATL ACAD SCI USA, V95, P4646, DOI 10.1073/pnas.95.8.4646; Croquet-Valdes PA, 2001, VACCINE, V20, P979; Diaz-Montero CM, 2001, AM J TROP MED HYG, V65, P371, DOI 10.4269/ajtmh.2001.65.371; Duan CS, 2011, AM J TROP MED HYG, V85, P504, DOI 10.4269/ajtmh.2011.10-0660; *EE M, 1899, MED SENTINEL, V7, P433; Ellison DW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005612; Feng HM, 2004, INFECT IMMUN, V72, P3524, DOI 10.1128/IAI.72.6.3524-3530.2004; HANSON BA, 1983, INFECT IMMUN, V42, P341, DOI 10.1128/IAI.42.1.341-349.1983; HARRELL GT, 1949, ARCH INTERN MED, V83, P331, DOI 10.1001/archinte.1949.00220320085007; Heinzen RA, 2003, ANN NY ACAD SCI, V990, P535, DOI 10.1111/j.1749-6632.2003.tb07424.x; Hong HD, 2006, J BIOL CHEM, V281, P7568, DOI 10.1074/jbc.M512365200; HORNEY LF, 1988, SOUTHERN MED J, V81, P915, DOI 10.1097/00007611-198807000-00028; Jacob-Dubuisson F, 2004, BBA-MOL CELL RES, V1694, P235, DOI 10.1016/j.bbamcr.2004.03.008; Jeng RL, 2004, CELL MICROBIOL, V6, P761, DOI 10.1111/j.1462-5822.2004.00402.x; Jiao YM, 2005, ANN NY ACAD SCI, V1063, P261, DOI 10.1196/annals.1355.042; Johnson JM, 1999, J MOL BIOL, V287, P695, DOI 10.1006/jmbi.1999.2630; Jordan JM, 2009, J INFECT DIS, V199, P236, DOI 10.1086/595833; Kaur SJ, 2012, J BACTERIOL, V194, P4920, DOI 10.1128/JB.00793-12; Kleba B, 2010, INFECT IMMUN, V78, P2240, DOI 10.1128/IAI.00100-10; Koronakis V, 1997, MOL MICROBIOL, V23, P617, DOI 10.1046/j.1365-2958.1997.d01-1880.x; Li H, 1998, MICROB PATHOGENESIS, V24, P289, DOI 10.1006/mpat.1997.0197; Lin J, 2002, MICROBES INFECT, V4, P325, DOI 10.1016/S1286-4579(02)01545-9; Mansueto P, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/967852; Marandi MV, 1997, INFECT IMMUN, V65, P4502, DOI 10.1128/IAI.65.11.4502-4508.1997; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Niu Dong-sheng, 2006, Zhonghua Liu Xing Bing Xue Za Zhi, V27, P526; Ogawa M, 2007, PROTEOMICS, V7, P1232, DOI 10.1002/pmic.200600721; PANTELIS G, 2004, NUCL ACIDS RES, V32; Park H, 2011, J BIOL CHEM, V286, P35096, DOI 10.1074/jbc.M111.263855; Pinne M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006071; POLICASTRO PF, 1994, MICROBIOL-SGM, V140, P2941, DOI 10.1099/13500872-140-11-2941; Pornwiroon W, 2009, INFECT IMMUN, V77, P5262, DOI 10.1128/IAI.00911-09; Qi Y, 2013, VACCINE, V31, P5643, DOI 10.1016/j.vaccine.2013.09.064; Qi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070440; Renesto P, 2005, FEMS MICROBIOL LETT, V245, P231, DOI 10.1016/j.femsle.2005.03.004; Renesto P, 2006, RES MICROBIOL, V157, P605, DOI 10.1016/j.resmic.2006.02.002; Riley SP, 2010, INFECT IMMUN, V78, P1895, DOI 10.1128/IAI.01165-09; Sears KT, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002856; SILVERMAN DJ, 1986, J INFECT DIS, V153, P694, DOI 10.1093/infdis/153.4.694; Uchiyama T, 2006, MICROBES INFECT, V8, P801, DOI 10.1016/j.micinf.2005.10.003; Vellaiswamy M, 2011, NEW MICROBIOL, V34, P209; Vellaiswamy M, 2011, MICROB PATHOGENESIS, V50, P233, DOI 10.1016/j.micpath.2011.01.009; WALKER DH, 1989, CLIN MICROBIOL REV, V2, P227, DOI 10.1128/CMR.2.3.227-240.1989; WALKER DH, 1980, HUM PATHOL, V11, P263, DOI 10.1016/S0046-8177(80)80008-6; Wei Y, 2011, J INFECT DIS, V203, P283, DOI 10.1093/infdis/jiq037; WEINBERG EH, 1969, J BACTERIOL, V98, P398, DOI 10.1128/JB.98.2.398-402.1969; XIONG X, 2012, VACCINE; Xiong XL, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-35	54	21	22	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100253	10.1371/journal.pone.0100253	http://dx.doi.org/10.1371/journal.pone.0100253			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950252	Green Submitted, Green Published, gold			2022-12-27	WOS:000338276300055
J	Zhao, G; Dai, CL; Zhao, MW				Zhao, Guang; Dai, Caili; Zhao, Mingwei			Investigation of the Profile Control Mechanisms of Dispersed Particle Gel	PLOS ONE			English	Article							WATER SHUTOFF; POLYMER	Dispersed particle gel (DPG) particles of nano-to micron-to mm-size have been prepared successfully and will be used for profile control treatment in mature oilfields. The profile control and enhanced oil recovery mechanisms of DPG particles have been investigated using core flow tests and visual simulation experiments. Core flow test results show that DPG particles can easily be injected into deep formations and can effectively plug the high permeability zones. The high profile improvement rate improves reservoir heterogeneity and diverts fluid into the low permeability zone. Both water and oil permeability were reduced when DPG particles were injected, but the disproportionate permeability reduction effect was significant. Water permeability decreases more than the oil permeability to ensure that oil flows in its own pathways and can easily be driven out. Visual simulation experiments demonstrate that DPG particles can pass directly or by deformation through porous media and enter deep formations. By retention, adsorption, trapping and bridging, DPG particles can effectively reduce the permeability of porous media in high permeability zones and divert fluid into a low permeability zone, thus improving formation profiles and enhancing oil recovery.	[Zhao, Guang; Dai, Caili; Zhao, Mingwei] China Univ Petr, State Key Lab Heavy Oil Proc, Qingdao, Shandong, Peoples R China	China University of Petroleum	Zhao, G (corresponding author), China Univ Petr, State Key Lab Heavy Oil Proc, Qingdao, Shandong, Peoples R China.	zhaoguang.sdau@163.com; daicl306@163.com		Dai, Cai li/0000-0002-7477-8865; Zhao, Guang/0000-0002-2254-3511	National Natural Science Foundation of China [51174221]; Science Funds for Distinguished Young Scholar of Shandong Province [JQ201013]; Program for New Century Excellent Talents in University [20110226]; Program for Changjiang Scholars and Innovative Reserch Team in University [IRT1294]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Funds for Distinguished Young Scholar of Shandong Province; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Program for Changjiang Scholars and Innovative Reserch Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was sponsored by Supported by National Natural Science Foundation of China (No. 51174221), Science Funds for Distinguished Young Scholar of Shandong Province (No. JQ201013), Program for New Century Excellent Talents in University (No. 20110226), Program for Changjiang Scholars and Innovative Reserch Team in University(IRT1294). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Muntasheri GA, 2007, J PETROL SCI ENG, V59, P73, DOI 10.1016/j.petrol.2007.02.010; Bai B., 2008, 2008 SPE DOE IMPR OI; Bai BJ, 2007, SPE RESERV EVAL ENG, V10, P415, DOI 10.2118/89389-PA; Beverte L, 2013, J APPL POLYM SCI, DOI [10.1002/app.39477, DOI 10.1002/APP.39477]; Bryant SL, 1996, SPE PROD FACIL, V11, P209, DOI 10.2118/35446-PA; Chauveteau G, 2001, 2001 SPE INT S OILF; Chauveteau G, 1999, INT S OILF CHEM C HO; Dai CL, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.39462; Dai CL, 2012, MOLECULES, V17, P14484, DOI 10.3390/molecules171214484; Liang TJ, 1995, SPE RESERV EVAL ENG, V10, P282; Liu Y, 2006, 2006 SPE DOE S IMPR; Liu Y.Z., 2013, SPE PROD OP S HELD O; Moradi-Araghi A, 2000, J PETROL SCI ENG, V26, P1, DOI 10.1016/S0920-4105(00)00015-2; Nimmo J. R., 2004, ENCY SOILS ENV, V3, P295, DOI DOI 10.1016/B978-0-12-409548-9.05265-9; Perez D, 2001, SPE DRILL COMPLETION, V16, P182, DOI 10.2118/73196-PA; Qin J.S., 2003, RESERVOIR PHYS, P265; Stavland A, 2001, ANN TECHN C EXH 30 S; You Q., 2013, J ENERGY RESOUR TECH, V135, P1; Zhao F.L., 2001, OILFIELD CHEM, P95; Zhao FL, 1999, J CHINA U PETROL, V23, P49; Zhao G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082651; Zhao G, 2013, J SOL-GEL SCI TECHN, V65, P392, DOI 10.1007/s10971-012-2951-z	22	19	21	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100471	10.1371/journal.pone.0100471	http://dx.doi.org/10.1371/journal.pone.0100471			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950174	Green Published, gold, Green Submitted			2022-12-27	WOS:000338276300077
J	Chung, HK; Cho, Y; Choi, S; Shin, MJ				Chung, Hye-Kyung; Cho, Yoonsu; Choi, Sumi; Shin, Min-Jeong			The Association between Serum 25-Hydroxyvitamin D Concentrations and Depressive Symptoms in Korean Adults: Findings from the Fifth Korea National Health and Nutrition Examination Survey 2010	PLOS ONE			English	Article							VITAMIN-D DEFICIENCY; PARATHYROID-HORMONE; MAJOR DEPRESSION; GLOBAL BURDEN; OLDER-ADULTS; DISEASE; POPULATION; SMOKING; LEVEL	The aims of this study were to examine the association between circulating vitamin D (25(OH) D) levels and depressive symptoms and to evaluate the associations between depressive symptoms and various sociodemographic factors. Data on serum 25(OH) D levels, sociodemographic factors, and information on depressive symptoms were obtained from the Korea National Health and Nutrition Examination Survey V-1 2010. A total of 3,570 Koreans aged >= 20 years were included in the statistical analysis. Subjects with depressive symptoms had lower serum levels of 25(OH) D (41.6 +/- 16.2 nmol/L) than those without (44.3 +/- 16.2 nmol/L; P-value<0.05; effect size = 0.17). In a logistic regression analysis, the 25(OH) D sufficiency group (>= 50 nmol/L) revealed fewer depressive symptoms (OR, 0.72; 95% CI, 0.53-0.97; P-value = 0.032) after adjusting for multiple factors. In addition, females (OR, 3.61; 95% CI, 2.55-5.11; P-value, 0.001), problematic alcohol users (OR, 2.33; 95% CI, 1.63-3.34; P-value, 0.001), current smokers (OR, 1.43; 95% CI, 1.02-1.99; P-value = 0.036), and subjects who experienced weight loss (OR, 1.78; 95% CI, 1.30-2.44; P-value, 0.001) were more likely to answer "yes" on question for depressive symptoms. In conclusion, low serum levels of 25(OH) D were associated with an increased risk for depression symptoms in Korean adults. In addition, several sociodemographic factors were related to the depressive symptoms. Our results provide insight into the relationships among vitamin D status, sociodemographic factors, and depression in the Korean population.	[Chung, Hye-Kyung] Yonsei Univ, Coll Med, Severance Inst Vasc & Metab Res, Seoul, South Korea; [Cho, Yoonsu; Shin, Min-Jeong] Korea Univ, Dept Food & Nutr, Seoul, South Korea; [Cho, Yoonsu; Shin, Min-Jeong] Korea Univ, Grad Sch, Dept Publ Hlth Sci, Seoul, South Korea; [Choi, Sumi] Pusan Natl Univ, Dept Child Dev & Family Studies, Pusan 609735, South Korea; [Shin, Min-Jeong] Korea Univ, Guro Hosp, Seoul, South Korea	Yonsei University; Yonsei University Health System; Korea University; Korea University; Pusan National University; Korea University; Korea University Medicine (KU Medicine)	Shin, MJ (corresponding author), Korea Univ, Dept Food & Nutr, Seoul, South Korea.	mjshin@korea.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-2013R1A1A2A10006101]; Creative Allied Project (CAP) grant - Korea Research Council of Fundamental Science and Technology (KRCF)	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology; Creative Allied Project (CAP) grant - Korea Research Council of Fundamental Science and Technology (KRCF)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (NRF-2013R1A1A2A10006101) and the Creative Allied Project (CAP) grant funded by the Korea Research Council of Fundamental Science and Technology (KRCF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvisa-Negrin J, 2009, ALCOHOL ALCOHOLISM, V44, P468, DOI 10.1093/alcalc/agp038; Bjelland I, 2008, SOC SCI MED, V66, P1334, DOI 10.1016/j.socscimed.2007.12.019; Brehm JM, 2012, AM J RESP CRIT CARE, V186, P140, DOI 10.1164/rccm.201203-0431OC; Chung HK, 2013, ANN NUTR METAB, V62, P129, DOI 10.1159/000345587; Cutillas-Marco E, 2012, PHOTODERMATOL PHOTO, V28, P159, DOI 10.1111/j.1600-0781.2012.00649.x; Daly RM, 2012, CLIN ENDOCRINOL, V77, P26, DOI 10.1111/j.1365-2265.2011.04320.x; Ernst CR, 2012, CRIT CARE NURS CLIN, V24, P509, DOI 10.1016/j.ccell.2012.07.006; Eskandari F, 2007, ARCH INTERN MED, V167, P2329, DOI 10.1001/archinte.167.21.2329; Fergusson DM, 2003, PSYCHOL MED, V33, P1357, DOI 10.1017/S0033291703008596; Foss YJ, 2009, MED HYPOTHESES, V72, P314, DOI 10.1016/j.mehy.2008.10.005; Gracious BL, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-38; Grant WB, 2005, ALTERN MED REV, V10, P94; Hendin Herbert., 2008, SUICIDE SUICIDE PREV; Herran A, 2000, PSYCHOSOM MED, V62, P779, DOI 10.1097/00006842-200011000-00006; Hoang MT, 2011, MAYO CLIN PROC, V86, P1050, DOI 10.4065/mcp.2011.0208; HOLICK MF, 1994, AM J CLIN NUTR, V60, P619, DOI 10.1093/ajcn/60.4.619; Holick MF, 2008, NUTR REV, V66, pS182, DOI 10.1111/j.1753-4887.2008.00104.x; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hoogendijk WJG, 2008, ARCH GEN PSYCHIAT, V65, P508, DOI 10.1001/archpsyc.65.5.508; Hurskainen AR, 2012, DIABETES-METAB RES, V28, P418, DOI 10.1002/dmrr.2286; Jang MS, 2005, KOR J DEV PSYCHOL, V18, P87; Jorde R, 2008, J INTERN MED, V264, P599, DOI 10.1111/j.1365-2796.2008.02008.x; Jorde R, 2006, J NEUROL, V253, P464, DOI 10.1007/s00415-005-0027-5; Kesby JP, 2011, MOL CELL ENDOCRINOL, V347, P121, DOI 10.1016/j.mce.2011.05.014; Korea Ministry of Health and Welfare, 2011, KOR HLTH STAT 2010 K; Langman CB, 2000, CURR OPIN PEDIATR, V12, P135, DOI 10.1097/00008480-200004000-00009; Le Strat Y, 2013, COMPR PSYCHIAT, V54, P831, DOI 10.1016/j.comppsych.2013.02.009; Lopez AD, 1998, NAT MED, V4, P1241, DOI 10.1038/3218; Molina MAL, 2014, PSYCHOL HEALTH MED, V19, P136, DOI 10.1080/13548506.2013.793369; Matud MP, 2004, PERS INDIV DIFFER, V37, P1401, DOI 10.1016/j.paid.2004.01.010; McGreevy C, 2011, ANN INTERN MED, V155, P820, DOI 10.7326/0003-4819-155-12-201112200-00004; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Oertel-Knochel V, 2014, EUR ARCH PSYCHIAT CL; *ORG EC COOP DEV, 2007, OECD HLTH DAT 2007; Palmer MT, 2013, INFLAMM BOWEL DIS, V19, P2245, DOI 10.1097/MIB.0b013e31828a3b6f; PARDRIDGE WM, 1985, J NEUROCHEM, V44, P1138, DOI 10.1111/j.1471-4159.1985.tb08735.x; Parker G, 2011, ACTA PSYCHIAT SCAND, V124, P243, DOI 10.1111/j.1600-0447.2011.01705.x; Pearce SHS, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5664; Picotto G, 2012, CANCER INVEST, V30, P604, DOI 10.3109/07357907.2012.721039; Rhee SY, 2012, DIABETIC MED, V29, P1003, DOI 10.1111/j.1464-5491.2012.03575.x; Saliba W, 2013, OSTEOPOROSIS INT, V24, P1447, DOI 10.1007/s00198-012-2129-0; Saraceno Benedetto, 2002, Epidemiol Psichiatr Soc, V11, P83; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schneider B, 2000, J NEURAL TRANSM, V107, P839, DOI 10.1007/s007020070063; Scragg R, 2007, AM J HYPERTENS, V20, P713, DOI 10.1016/j.amjhyper.2007.01.017; Stewart R, 2010, PSYCHOSOM MED, V72, P608, DOI 10.1097/PSY.0b013e3181e9bf15; Thuesen B, 2012, BONE, V50, P605, DOI 10.1016/j.bone.2011.12.016; Vieth R, 2011, BEST PRACT RES CL EN, V25, P681, DOI 10.1016/j.beem.2011.06.009; Wacker M, 2013, DERM-ENDOCRINOL, V5, DOI [10.4161/derm.24476, 10.4161/derm.24494]; Watkins C, 2001, BRIT MED J, V323, P1159, DOI 10.1136/bmj.323.7322.1159; WHO (World Health Organization), 2013, SCHIST PROGR REP 200; Wilkins CH, 2006, AM J GERIAT PSYCHIAT, V14, P1032, DOI 10.1097/01.JGP.0000240986.74642.7c	52	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e99185	10.1371/journal.pone.0099185	http://dx.doi.org/10.1371/journal.pone.0099185			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945632	Green Submitted, gold, Green Published			2022-12-27	WOS:000340721500012
J	Duarte, A; Castillo, AF; Podesta, EJ; Poderoso, C				Duarte, Alejandra; Fernanda Castillo, Ana; Podesta, Ernesto J.; Poderoso, Cecilia			Mitochondrial Fusion and ERK Activity Regulate Steroidogenic Acute Regulatory Protein Localization in Mitochondria	PLOS ONE			English	Article							SIDE-CHAIN CLEAVAGE; LEYDIG TUMOR-CELLS; ACYL-COA SYNTHETASE-4; ARACHIDONIC-ACID; STAR PROTEIN; CHOLESTEROL TRANSPORT; HORMONE STIMULATION; PHOSPHORYLATION; EXPRESSION; ACTIVATION	The rate-limiting step in the biosynthesis of steroid hormones, known as the transfer of cholesterol from the outer to the inner mitochondrial membrane, is facilitated by StAR, the Steroidogenic Acute Regulatory protein. We have described that mitochondrial ERK1/2 phosphorylates StAR and that mitochondrial fusion, through the up-regulation of a fusion protein Mitofusin 2, is essential during steroidogenesis. Here, we demonstrate that mitochondrial StAR together with mitochondrial active ERK and PKA are necessary for maximal steroid production. Phosphorylation of StAR by ERK is required for the maintenance of this protein in mitochondria, observed by means of over-expression of a StAR variant lacking the ERK phosphorylation residue. Mitochondrial fusion regulates StAR levels in mitochondria after hormone stimulation. In this study, Mitofusin 2 knockdown and mitochondrial fusion inhibition in MA-10 Leydig cells diminished StAR mRNA levels and concomitantly mitochondrial StAR protein. Together our results unveil the requirement of mitochondrial fusion in the regulation of the localization and mRNA abundance of StAR. We here establish the relevance of mitochondrial phosphorylation events in the correct localization of this key protein to exert its action in specialized cells. These discoveries highlight the importance of mitochondrial fusion and ERK phosphorylation in cholesterol transport by means of directing StAR to the outer mitochondrial membrane to achieve a large number of steroid molecules per unit of StAR.	[Duarte, Alejandra; Fernanda Castillo, Ana; Podesta, Ernesto J.; Poderoso, Cecilia] Univ Buenos Aires, Dept Biochem, Sch Med, Inst Biomed Invest,INBIOMED,UBA CONICET, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Poderoso, C (corresponding author), Univ Buenos Aires, Dept Biochem, Sch Med, Inst Biomed Invest,INBIOMED,UBA CONICET, Buenos Aires, DF, Argentina.	cepoderos@yahoo.com		Castillo, Ana Fernanda/0000-0002-1572-4728	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad de Buenos Aires (UBA)	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires (UBA)(University of Buenos Aires)	This investigation was supported by funding from the Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT), grants to E.J.P. and C.P.; from the Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) to E.J.P. and from the Universidad de Buenos Aires (UBA) to E.J.P., and C.P. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JA, 2006, ENDOCRINOLOGY, V147, P3924, DOI 10.1210/en.2005-1204; Alonso M, 2004, J NEUROCHEM, V89, P248, DOI 10.1111/j.1471-4159.2004.02323.x; Arciuch VGA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007523; Anuka E, 2013, MOL CELL ENDOCRINOL, V371, P47, DOI 10.1016/j.mce.2013.02.003; Arakane F, 1997, J BIOL CHEM, V272, P32656, DOI 10.1074/jbc.272.51.32656; Arakane F, 1996, P NATL ACAD SCI USA, V93, P13731, DOI 10.1073/pnas.93.24.13731; Artemenko IP, 2001, J BIOL CHEM, V276, P46583, DOI 10.1074/jbc.M107815200; ASCOLI M, 1981, ENDOCRINOLOGY, V108, P88, DOI 10.1210/endo-108-1-88; Baines CP, 2002, CIRC RES, V90, P390, DOI 10.1161/01.RES.0000012702.90501.8D; Bey P, 2003, ENDOCRINOLOGY, V144, P1399, DOI 10.1210/en.2002-220987; Bose HS, 2002, NATURE, V417, P87, DOI 10.1038/417087a; Bose M, 2008, J BIOL CHEM, V283, P8837, DOI 10.1074/jbc.M709221200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brion L, 2011, ENDOCRINOLOGY, V152, P2665, DOI 10.1210/en.2011-0021; Castillo AF, 2006, FEBS J, V273, P5011, DOI 10.1111/j.1742-4658.2006.05496.x; CLARK BJ, 1994, J BIOL CHEM, V269, P28314; COBB MH, 1991, CELL REGUL, V2, P965, DOI 10.1091/mbc.2.12.965; Duarte A, 2007, FEBS LETT, V581, P4023, DOI 10.1016/j.febslet.2007.07.040; Duarte A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045829; Castillo AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022822; Fleury A, 2004, J STEROID BIOCHEM, V91, P259, DOI 10.1016/j.jsbmb.2004.04.010; Granot Z, 2003, MOL ENDOCRINOL, V17, P2461, DOI 10.1210/me.2003-0074; Granot Z, 2007, MOL CELL ENDOCRINOL, V265, P51, DOI 10.1016/j.mce.2006.12.003; Granot Z, 2007, MOL ENDOCRINOL, V21, P2164, DOI 10.1210/me.2005-0458; Grozdanov PN, 2012, MOL ENDOCRINOL, V26, P2104, DOI 10.1210/me.2012-1123; Gyles SL, 2001, J BIOL CHEM, V276, P34888, DOI 10.1074/jbc.M102063200; Hauet T, 2005, MOL ENDOCRINOL, V19, P540, DOI 10.1210/me.2004-0307; Hirakawa T, 2003, MOL ENDOCRINOL, V17, P2189, DOI 10.1210/me.2003-0205; Ishihara N, 2003, BIOCHEM BIOPH RES CO, V301, P891, DOI 10.1016/S0006-291X(03)00050-0; Jefcoate C, 2002, J CLIN INVEST, V110, P881, DOI 10.1172/JCI200216771; Kallen CB, 1998, MOL CELL ENDOCRINOL, V145, P39, DOI 10.1016/S0303-7207(98)00167-1; KRUEGER RJ, 1983, J BIOL CHEM, V258, P159; Le T, 2001, ENDOCRINOLOGY, V142, P4282, DOI 10.1210/en.142.10.4282; Lewin TM, 2002, ARCH BIOCHEM BIOPHYS, V404, P263, DOI 10.1016/S0003-9861(02)00247-3; Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008; Maloberti P, 2005, FEBS J, V272, P1804, DOI 10.1111/j.1742-4658.2005.04616.x; Manna PR, 2003, STEROIDS, V68, P1125, DOI 10.1016/j.steroids.2003.07.009; Manna PR, 2013, J BIOL CHEM, V288, P8505, DOI 10.1074/jbc.M112.417873; Martinelle N, 2004, ENDOCRINOLOGY, V145, P4629, DOI 10.1210/en.2004-0496; Miller WL, 2007, MOL CELL ENDOCRINOL, V265, P46, DOI 10.1016/j.mce.2006.12.002; Miller WL, 2013, MOL CELL ENDOCRINOL; Otis M, 2007, MOL CELL ENDOCRINOL, V265, P126, DOI 10.1016/j.mce.2006.12.008; Papanicolaou KN, 2012, AM J PHYSIOL-HEART C, V302, pH167, DOI 10.1152/ajpheart.00833.2011; Poderoso C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001443; PRIVALLE CT, 1983, P NATL ACAD SCI-BIOL, V80, P702, DOI 10.1073/pnas.80.3.702; PRIVALLE CT, 1987, MOL CELL ENDOCRINOL, V53, P87, DOI 10.1016/0303-7207(87)90195-X; Reinhart AJ, 1999, MOL ENDOCRINOL, V13, P729, DOI 10.1210/me.13.5.729; Rone MB, 2012, MOL ENDOCRINOL, V26, P1868, DOI 10.1210/me.2012-1159; Seger R, 2001, J BIOL CHEM, V276, P13957, DOI 10.1074/jbc.M006852200; SIMPSON ER, 1972, EUR J BIOCHEM, V28, P442, DOI 10.1111/j.1432-1033.1972.tb01931.x; Stocco DM, 1996, ENDOCR REV, V17, P221, DOI 10.1210/er.17.3.221; STOCCO DM, 1991, J BIOL CHEM, V266, P19731; Tai P, 2011, MOL ENDOCRINOL, V25, P885, DOI 10.1210/me.2010-0489; van der Laan M, 2010, BBA-MOL CELL RES, V1803, P732, DOI 10.1016/j.bbamcr.2010.01.013; Wang XJ, 2000, J BIOL CHEM, V275, P20204, DOI 10.1074/jbc.M003113200; Xu FY, 2010, BBA-BIOMEMBRANES, V1798, P1577, DOI 10.1016/j.bbamem.2010.04.007; Zhao D, 2005, J STEROID BIOCHEM, V96, P155, DOI 10.1016/j.jsbmb.2005.02.011	57	51	52	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100387	10.1371/journal.pone.0100387	http://dx.doi.org/10.1371/journal.pone.0100387			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945345	gold, Green Published, Green Submitted			2022-12-27	WOS:000340721500068
J	Huang, YF; Mao, C; Yuan, JQ; Yang, ZY; Di, MY; Tam, WWS; Tang, JL				Huang, Yafang; Mao, Chen; Yuan, Jinqiu; Yang, Zuyao; Di, Mengyang; Tam, Wilson Wai-san; Tang, Jinling			Distribution and Epidemiological Characteristics of Published Individual Patient Data Meta-Analyses	PLOS ONE			English	Article							PARTICIPANT DATA; SYSTEMATIC-REVIEWS; BIAS	Background: Individual patient data meta-analyses (IPDMAs) prevail as the gold standard in clinical evaluations. We investigated the distribution and epidemiological characteristics of published IPDMA articles. Methodology/Principal Findings: IPDMA articles were identified through comprehensive literature searches from PubMed, Embase, and Cochrane library. Two investigators independently conducted article identification, data classification and extraction. Data related to the article characteristics were collected and analyzed descriptively. A total of 829 IPDMA articles indexed until 9 August 2012 were identified. An average of 3.7 IPDMA articles was published per year. Malignant neoplasms (267 [32.2%]) and circulatory diseases (179 [21.6%]) were the most frequently occurring topics. On average, each IPDMA article included a median of 8 studies (Interquartile range, IQR 5 to 15) involving 2,563 patients (IQR 927 to 8,349). Among 829 IPDMA articles, 229 (27.6%) did not perform a systematic search to identify related studies. In total, 207 (25.0%) sought and included individual patient data (IPD) from the "grey literature''. Only 496 (59.8%) successfully obtained IPD from all identified studies. Conclusions/Significance: The number of IPDMA articles exhibited an increasing trend over the past few years and mainly focused on cancer and circulatory diseases. Our data indicated that literature searches, including grey literature and data availability were inconsistent among different IPDMA articles. Possible biases may arise. Thus, decision makers should not uncritically accept all IPDMAs.	[Huang, Yafang; Mao, Chen; Yuan, Jinqiu; Yang, Zuyao; Di, Mengyang; Tam, Wilson Wai-san; Tang, Jinling] Chinese Univ Hong Kong, Jockey Club Sch Publ Hlth & Primary Care, Div Epidemiol, Hong Kong, Hong Kong, Peoples R China; [Mao, Chen; Yang, Zuyao; Tang, Jinling] Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen Municipal Key Lab Hlth Risk Anal, Shenzhen, Guangdong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong, Shenzhen	Tam, WWS (corresponding author), Chinese Univ Hong Kong, Jockey Club Sch Publ Hlth & Primary Care, Div Epidemiol, Hong Kong, Hong Kong, Peoples R China.	wilsontam@cuhk.edu.hk; jltang@cuhk.edu.hk	Yuan, Jinqiu/A-4867-2018; Mao, Chen/AAW-2742-2020; Tang, JL/G-1759-2013; Mao, Chen/G-9805-2013; Tam, Wilson/K-1664-2019; TAM, Wilson W.S./H-5890-2019; Di, Mengyang/U-4847-2018	Mao, Chen/0000-0002-6537-6215; Mao, Chen/0000-0001-7471-1516; TAM, Wilson W.S./0000-0003-0641-3060; Di, Mengyang/0000-0001-6165-2617				Abo-Zaid G, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-56; Ahmed I, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7762; Choy PY, 2007, COCHRANE DB SYST REV, V18; Cooper H, 2009, PSYCHOL METHODS, V14, P165, DOI 10.1037/a0015565; Davey J, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-160; Davidson J, 2005, CLIN THER, V27, pS75, DOI 10.1016/j.clinthera.2005.11.022; Davidson JA, 2009, CLIN THER, V31, P1641, DOI 10.1016/j.clinthera.2009.08.011; DiGiuro G, 2006, AM J SURG, V191, P773, DOI 10.1016/j.amjsurg.2006.01.030; HARVEY I, 1993, LANCET, V341, P964, DOI 10.1016/0140-6736(93)91258-N; Henmi M, 2010, STAT MED, V29, P2969, DOI 10.1002/sim.4029; Journal Citation Reports, 2011, J CITATION REPORTS; Kendrick D, 2009, INJURY PREV, V15, P197, DOI 10.1136/ip.2008.020677; Koopman L, 2007, J CLIN EPIDEMIOL, V60, P1002, DOI 10.1016/j.jclinepi.2007.01.018; Kovalchik SA, 2012, J CLIN EPIDEMIOL, V65, P1296, DOI 10.1016/j.jclinepi.2012.07.010; Lau J, 1998, LANCET, V351, P123, DOI 10.1016/S0140-6736(97)08468-7; Lyman Gary H, 2005, BMC Med Res Methodol, V5, P14, DOI 10.1186/1471-2288-5-14; Moher D, 2007, PLOS MED, V4, P447, DOI 10.1371/journal.pmed.0040078; Montori VM, 2005, BMJ-BRIT MED J, V330, P68, DOI 10.1136/bmj.38336.804167.47; PAULE RC, 1982, J RES NAT BUR STAND, V87, P377, DOI 10.6028/jres.087.022; Rathi V, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7570; Riley RD, 2008, STAT MED, V27, P1870, DOI 10.1002/sim.3165; Riley RD, 2007, J CLIN EPIDEMIOL, V60, P431, DOI 10.1016/j.jclinepi.2006.09.009; Riley RD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c221; Simmonds MC, 2005, CLIN TRIALS, V2, P209, DOI 10.1191/1740774505cn087oa; STEWART LA, 1993, LANCET, V341, P418, DOI 10.1016/0140-6736(93)93004-K; Tierney JF, 2005, INT J EPIDEMIOL, V34, P79, DOI 10.1093/ije/dyh300; VILLAR J, 1995, LANCET, V345, P772, DOI 10.1016/S0140-6736(95)90646-0; Vinjar B, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006687.pub2; WHO, 2011, INT STAT CLASS DIS R	29	11	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100151	10.1371/journal.pone.0100151	http://dx.doi.org/10.1371/journal.pone.0100151			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945406	gold, Green Published, Green Submitted			2022-12-27	WOS:000340721500046
J	Jamin, A; Thunuguntla, P; Wicklund, A; Jones, C; Wiebe, MS				Jamin, Augusta; Thunuguntla, Prasanth; Wicklund, April; Jones, Clinton; Wiebe, Matthew S.			Barrier to Autointegration Factor Becomes Dephosphorylated during HSV-1 Infection and Can Act as a Host Defense by Impairing Viral DNA Replication and Gene Expression	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; CELL-CYCLE PROGRESSION; TEMPERATURE-SENSITIVE MUTANTS; REGULATORY PROTEIN ICP27; VACCINIA-RELATED KINASES; FACTOR BAF; NUCLEAR-ENVELOPE; TYPE-1 ICP27; DELETION MUTANTS; STRUCTURAL BASIS	BAF (Barrier to Autointegration Factor) is a highly conserved DNA binding protein that senses poxviral DNA in the cytoplasm and tightly binds to the viral genome to interfere with DNA replication and transcription. To counteract BAF, a poxviral-encoded protein kinase phosphorylates BAF, which renders BAF unable to bind DNA and allows efficient viral replication to occur. Herein, we examined how BAF phosphorylation is affected by herpes simplex virus type 1 (HSV-1) infection and tested the ability of BAF to interfere with HSV-1 productive infection. Interestingly, we found that BAF phosphorylation decreases markedly following HSV-1 infection. To determine whether dephosphorylated BAF impacts HSV-1 productive infection, we employed cell lines stably expressing a constitutively unphosphorylated form of BAF (BAF-MAAAQ) and cells overexpressing wild type (wt) BAF for comparison. Although HSV-1 production in cells overexpressing wtBAF was similar to that in cells expressing no additional BAF, viral growth was reduced approximately 80% in the presence of BAF-MAAAQ. Experiments were also performed to determine the mechanism of the antiviral activity of BAF with the following results. BAF-MAAAQ was localized to the nucleus, whereas wtBAF was dispersed throughout cells prior to infection. Following infection, wtBAF becomes dephosphorylated and relocalized to the nucleus. Additionally, BAF was associated with the HSV-1 genome during infection, with BAF-MAAAQ associated to a greater extent than wtBAF. Importantly, unphosphorylated BAF inhibited both viral DNA replication and gene expression. For example, expression of two regulatory proteins, ICP0 and VP16, were substantially reduced in cells expressing BAF-MAAAQ. However, other viral genes were not dramatically affected suggesting that expression of certain viral genes can be differentially regulated by unphosphorylated BAF. Collectively, these results suggest that BAF can act in a phosphorylation-regulated manner to impair HSV-1 transcription and/or DNA replication, which is similar to the antiviral activity of BAF during vaccinia infection.	[Jamin, Augusta; Thunuguntla, Prasanth; Wicklund, April; Jones, Clinton; Wiebe, Matthew S.] Univ Nebraska, Sch Vet Med & Biomed Sci, Lincoln, NE 68588 USA; [Jamin, Augusta; Thunuguntla, Prasanth; Wicklund, April; Jones, Clinton; Wiebe, Matthew S.] Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Wiebe, MS (corresponding author), Univ Nebraska, Sch Vet Med & Biomed Sci, Lincoln, NE 68588 USA.	mwiebe2@unl.edu	Wiebe, Matthew/X-5007-2019; Wiebe, Matt/AAC-4642-2021	Wiebe, Matthew/0000-0001-6337-6556; 	National Institutes of Health [K22AI080941, R56AI099062, P30GM10359, T32 AI060547]; US Department of Agriculture [2013-01041]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI099062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103509] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Agriculture(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding came from K22AI080941-grant from the National Institutes of Health (www.nih.gov) to MW; R56AI099062 - grant from the National Institutes of Health (www.nih.gov) to MSW; P30GM10359-grant from the National Institutes of Health (www.nih.gov) supported MSW; T32 AI060547-grant from the National Institutes of Health (www.nih.gov) supported AJ; 2013-01041 - grant from the US Department of Agriculture (www.usda.gov) to CJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asencio C, 2012, CELL, V150, P122, DOI 10.1016/j.cell.2012.04.043; Bar DZ, 2014, MOL BIOL CELL, V25, P1127, DOI 10.1091/mbc.E13-08-0477; Bengtsson L, 2006, MOL BIOL CELL, V17, P1154, DOI 10.1091/mbc.E05-04-0356; Brachner A, 2012, J CELL SCI, V125, P1048, DOI 10.1242/jcs.098392; Bradley CM, 2005, NAT STRUCT MOL BIOL, V12, P935, DOI 10.1038/nsmb989; Cai M, 1998, NAT STRUCT BIOL, V5, P903, DOI 10.1038/2345; CAMPBELL MEM, 1984, J MOL BIOL, V180, P1, DOI 10.1016/0022-2836(84)90427-3; Cliffe AR, 2008, J VIROL, V82, P12030, DOI 10.1128/JVI.01575-08; de Oca RM, 2011, NUCLEUS-PHILA, V2, P580, DOI 10.4161/nucl.2.6.17960; de Oca RM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007050; de Oca ROM, 2005, J BIOL CHEM, V280, P42252, DOI 10.1074/jbc.M509917200; Dechat T, 2004, J CELL SCI, V117, P6117, DOI 10.1242/jcs.01529; DELUCA NA, 1985, J VIROL, V56, P558, DOI 10.1128/JVI.56.2.558-570.1985; DELUCA NA, 1985, MOL CELL BIOL, V5, P1997, DOI 10.1128/MCB.5.8.1997; Devireddy LR, 2000, J BIOL CHEM, V275, P77, DOI 10.1074/jbc.275.1.77; Dittrich CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0024555; DIXON RAF, 1980, J VIROL, V36, P189, DOI 10.1128/JVI.36.1.189-203.1980; EVERETT R, 1995, J VIROL, V69, P7339, DOI 10.1128/JVI.69.11.7339-7344.1995; Everett RD, 1999, J CELL SCI, V112, P4581; Everett RD, 1997, EMBO J, V16, P1519, DOI 10.1093/emboj/16.7.1519; FRAME MC, 1987, J GEN VIROL, V68, P2699, DOI 10.1099/0022-1317-68-10-2699; Furukawa K, 2003, J CELL SCI, V116, P3811, DOI 10.1242/jcs.00682; Gorjanacz M, 2007, EMBO J, V26, P132, DOI 10.1038/sj.emboj.7601470; GU BH, 1994, J VIROL, V68, P7953, DOI 10.1128/JVI.68.12.7953-7965.1994; GU BH, 1993, P NATL ACAD SCI USA, V90, P9528, DOI 10.1073/pnas.90.20.9528; Gu HD, 2005, P NATL ACAD SCI USA, V102, P7571, DOI 10.1073/pnas.0502658102; Haraguchi T, 2001, J CELL SCI, V114, P4575; Haraguchi T, 2008, J CELL SCI, V121, P2540, DOI 10.1242/jcs.033597; Haraguchi T, 2007, J CELL SCI, V120, P1967, DOI 10.1242/jcs.03461; HARDY WR, 1994, J VIROL, V68, P7790, DOI 10.1128/JVI.68.12.7790-7799.1994; Hobbs WE, 1999, J VIROL, V73, P8245, DOI 10.1128/JVI.73.10.8245-8255.1999; HOLLAND LE, 1980, VIROLOGY, V101, P10, DOI 10.1016/0042-6822(80)90479-1; HONESS RW, 1974, J VIROL, V14, P8, DOI 10.1128/JVI.14.1.8-19.1974; Ibrahim N, 2013, VIROLOGY, V444, P363, DOI 10.1016/j.virol.2013.07.002; Ibrahim N, 2011, J VIROL, V85, P11588, DOI 10.1128/JVI.00641-11; Jamin A, 2014, J VIROL, V88, P5342, DOI 10.1128/JVI.00427-14; Johnson KE, 2013, J VIROL, V87, P5005, DOI 10.1128/JVI.00082-13; Jordan Robert, 1997, Journal of Virology, V71, P6850; Kawaguchi Y, 1997, J VIROL, V71, P1019, DOI 10.1128/JVI.71.2.1019-1024.1997; Kawaguchi Y, 1997, J VIROL, V71, P7328, DOI 10.1128/JVI.71.10.7328-7336.1997; Kushnir AS, 2010, J VIROL, V84, P188, DOI 10.1128/JVI.01377-09; Lancaster OM, 2007, J CELL BIOL, V179, P817, DOI 10.1083/jcb.200706067; LIESEGANG TJ, 1989, ARCH OPHTHALMOL-CHIC, V107, P1155, DOI 10.1001/archopht.1989.01070020221029; Margalit A, 2007, J CELL BIOL, V178, P661, DOI 10.1083/jcb.200704049; Margalit Ayelet, 2005, V264, P231, DOI 10.1002/0470093765.ch16; MCCARTHY AM, 1989, J VIROL, V63, P18, DOI 10.1128/JVI.63.1.18-27.1989; MCMAHAN L, 1990, J VIROL, V64, P3471, DOI 10.1128/JVI.64.7.3471-3485.1990; Melroe GT, 2004, J VIROL, V78, P8411, DOI 10.1128/JVI.78.16.8411-8420.2004; MEREDITH M, 1995, VIROLOGY, V209, P174, DOI 10.1006/viro.1995.1241; MEREDITH M, 1994, VIROLOGY, V200, P457, DOI 10.1006/viro.1994.1209; MICHAEL N, 1993, P NATL ACAD SCI USA, V90, P2286, DOI 10.1073/pnas.90.6.2286; Molitor TP, 2014, MOL BIOL CELL; Nahmias A J, 1990, Scand J Infect Dis Suppl, V69, P19; NESBURN AB, 1983, REPORT CORNEAL DIS P; Nezu J, 1997, GENOMICS, V45, P327, DOI 10.1006/geno.1997.4938; Nichols RJ, 2006, MOL BIOL CELL, V17, P2451, DOI 10.1091/mbc.E05-12-1179; OHARE P, 1985, J VIROL, V56, P723, DOI 10.1128/JVI.56.3.723-733.1985; Orzalli MH, 2012, P NATL ACAD SCI USA, V109, pE3008, DOI 10.1073/pnas.1211302109; Poon APW, 2006, P NATL ACAD SCI USA, V103, P9993, DOI 10.1073/pnas.0604142103; Poon APW, 2003, J VIROL, V77, P12671, DOI 10.1128/JVI.77.23.12671-12678.2003; PURVES FC, 1987, J VIROL, V61, P2896, DOI 10.1128/JVI.61.9.2896-2901.1987; Remeijer L, 2004, OCUL IMMUNOL INFLAMM, V12, P255, DOI 10.1080/092739490500363; REMPEL RE, 1990, J VIROL, V64, P574, DOI 10.1128/JVI.64.2.574-583.1990; REMPEL RE, 1992, J VIROL, V66, P4413, DOI 10.1128/JVI.66.7.4413-4426.1992; ROBERTS MS, 1988, J VIROL, V62, P4307, DOI 10.1128/JVI.62.11.4307-4320.1988; ROIZMAN B, 2007, FIELDS VIROLOGY, P2502; SACKS WR, 1985, J VIROL, V55, P796, DOI 10.1128/JVI.55.3.796-805.1985; SANDRIGOLDIN RM, 1995, J VIROL, V69, P6063, DOI 10.1128/JVI.69.10.6063-6076.1995; Segura-Totten M, 2002, J CELL BIOL, V158, P475, DOI 10.1083/jcb.200202019; Shimi T, 2004, J STRUCT BIOL, V147, P31, DOI 10.1016/j.jsb.2003.11.013; Sinani D, 2013, J VIROL, V87, P13042, DOI 10.1128/JVI.02476-13; Skoko D, 2009, P NATL ACAD SCI USA, V106, P16610, DOI 10.1073/pnas.0909077106; SMITH CA, 1993, J VIROL, V67, P4676, DOI 10.1128/JVI.67.8.4676-4687.1993; SMITH RF, 1989, J VIROL, V63, P450, DOI 10.1128/JVI.63.1.450-455.1989; Suzuki Y, 2002, J VIROL, V76, P12376, DOI 10.1128/JVI.76.23.12376-12380.2002; Suzuki Y, 2010, J BIOL CHEM, V285, P24032, DOI 10.1074/jbc.M110.116640; Towbin BD, 2010, COLD SH Q B, V75, P555, DOI 10.1101/sqb.2010.75.041; Tyler Kenneth L, 2004, Herpes, V11 Suppl 2, p57A; Umland TC, 2000, BIOCHEMISTRY-US, V39, P9130, DOI 10.1021/bi000572w; Wang XJ, 2002, J BIOL CHEM, V277, P43288, DOI 10.1074/jbc.M207952200; Wang YM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004103; WASSLER M, 1987, BIOCHEM J, V247, P407, DOI 10.1042/bj2470407; WHITLEY RJ, 1991, DRUGS, V42, P406, DOI 10.2165/00003495-199142030-00005; Wiebe MS, 2007, CELL HOST MICROBE, V1, P187, DOI 10.1016/j.chom.2007.03.007; Xu FJ, 2002, J INFECT DIS, V185, P1019, DOI 10.1086/340041; Xu FJ, 2006, JAMA-J AM MED ASSOC, V296, P964, DOI 10.1001/jama.296.8.964; Zheng RL, 2000, P NATL ACAD SCI USA, V97, P8997, DOI 10.1073/pnas.150240197; Zhuang X, 2013, J BIOL CHEM	88	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100511	10.1371/journal.pone.0100511	http://dx.doi.org/10.1371/journal.pone.0100511			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945635	Green Published, gold			2022-12-27	WOS:000340721500083
J	Marcelli, F; Boisset, G; Schorderet, DF				Marcelli, Fabienne; Boisset, Gaelle; Schorderet, Daniel F.			A Dimerized HMX1 Inhibits EPHA6/epha4b in Mouse and Zebrafish Retinas	PLOS ONE			English	Article							OCULO-AURICULAR SYNDROME; HOMEOBOX GENE FAMILY; INNER-EAR; EXPRESSION; SYSTEM; IDENTIFICATION; PROJECTION; MUTATION; NEURONS; BINDING	HMX1 is a homeobox-containing transcription factor implicated in eye development and responsible for the oculo-auricular syndrome of Schorderet-Munier-Franceschetti. HMX1 is composed of two exons with three conserved domains in exon 2, a homeobox and two domains called SD1 and SD2. The function of the latter two domains remains unknown. During retinal development, HMX1 is expressed in a polarized manner and thus seems to play a role in the establishment of retinal polarity although its exact role and mode of action in eye development are unknown. Here, we demonstrated that HMX1 dimerized and that the SD1 and homeodomains are required for this function. In addition, we showed that proper nuclear localization requires the presence of the homeodomain. We also identified that EPHA6, a gene implicated in retinal axon guidance, is one of its targets in eye development and showed that a dimerized HMX1 is needed to inhibit EPHA6 expression.	[Marcelli, Fabienne; Boisset, Gaelle; Schorderet, Daniel F.] IRO Inst Res Ophthalmol, Sion, Switzerland; [Marcelli, Fabienne; Schorderet, Daniel F.] Ecole Polytech Fed Lausanne, Swiss Fed Inst Technol, Fac Life Sci, CH-1015 Lausanne, Switzerland; [Schorderet, Daniel F.] Univ Lausanne, Fac Biol & Med, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne	Schorderet, DF (corresponding author), IRO Inst Res Ophthalmol, Sion, Switzerland.	daniel.schorderet@irovision.ch			Swiss National Science Foundation [31003A_124990, 31003A_143474]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by grants from the Swiss National Science Foundation (No 31003A_124990 and 31003A_143474). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdus-Saboor I, 2012, DEV BIOL, V366, P298, DOI 10.1016/j.ydbio.2012.03.015; Adameyko I, 2009, CELL, V139, P366, DOI 10.1016/j.cell.2009.07.049; Adamska M, 2000, MECH DEVELOP, V97, P161, DOI 10.1016/S0925-4773(00)00414-7; Adamska M, 2001, DEV GENES EVOL, V211, P338, DOI 10.1007/s004270100162; Amendt BA, 1999, J BIOL CHEM, V274, P11635, DOI 10.1074/jbc.274.17.11635; Boisset G, 2012, EXP EYE RES, V105, P34, DOI 10.1016/j.exer.2012.10.002; Boulling A, 2013, MOL VIS, V19, P1779; Brown A, 2000, CELL, V102, P77, DOI 10.1016/S0092-8674(00)00012-X; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; Connor RJ, 1998, DEV BIOL, V193, P21, DOI 10.1006/dbio.1997.8786; Feldheim DA, 1998, NEURON, V21, P1303, DOI 10.1016/S0896-6273(00)80650-9; Furlan A, 2013, EMBO J, V32, P1613, DOI 10.1038/emboj.2013.85; Kasahara H, 2001, J BIOL CHEM, V276, P4570, DOI 10.1074/jbc.M004995200; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Meima L, 1997, MOL CELL NEUROSCI, V9, P314, DOI 10.1006/mcne.1997.0621; Munroe RJ, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-27; Quina LA, 2012, DEV BIOL, V365, P152, DOI 10.1016/j.ydbio.2012.02.022; Schorderet DF, 2008, AM J HUM GENET, V82, P1178, DOI 10.1016/j.ajhg.2008.03.007; Schulte D, 2000, DEVELOPMENT, V127, P5033; STADLER HS, 1992, P NATL ACAD SCI USA, V89, P11579, DOI 10.1073/pnas.89.23.11579; STADLER HS, 1995, MAMM GENOME, V6, P383, DOI 10.1007/BF00355637; STADLER HS, 1994, DEV BIOL, V161, P251, DOI 10.1006/dbio.1994.1025; Vaclavik V, 2011, OPHTHALMIC GENET, V32, P114, DOI 10.3109/13816810.2011.562955; Wang WD, 2000, MECH DEVELOP, V99, P123, DOI 10.1016/S0925-4773(00)00488-3; Wang WD, 1998, DEVELOPMENT, V125, P621; Yoshiura K, 1998, GENOMICS, V50, P61, DOI 10.1006/geno.1998.5284	26	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100096	10.1371/journal.pone.0100096	http://dx.doi.org/10.1371/journal.pone.0100096			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945320	Green Submitted, Green Published, gold			2022-12-27	WOS:000340721500044
J	Pulliero, A; Seydel, A; Camoirano, A; Sacca, SC; Sandri, M; Izzotti, A				Pulliero, Alessandra; Seydel, Anke; Camoirano, Anna; Sacca, Sergio Claudio; Sandri, Marco; Izzotti, Alberto			Oxidative Damage and Autophagy in the Human Trabecular Meshwork as Related with Ageing	PLOS ONE			English	Article							AQUEOUS-HUMOR DYNAMICS; OPEN-ANGLE GLAUCOMA; MOLECULAR-MECHANISMS; CELLS; P62; AGE; EYE	Autophagy is an intracellular lysosomal degradation process induced under stress conditions. Autophagy also plays a major role in ocular patho-physiology. Molecular aging does occur in the trabecular meshwork, the main regulator of aqueous humor outflow, and trabecular meshwork senescence is accompanied by increased oxidative stress. However, the role of autophagy in trabecular meshwork patho-physiology has not yet been examined in vivo in human ocular tissues. The purpose of the herein presented study is to evaluate autophagy occurrence in ex-vivo collected human trabecular meshwork specimens and to evaluate the relationship between autophagy, oxidative stress, and aging in this tissue. Fresh trabecular meshwork specimens were collected from 28 healthy corneal donors devoid of ocular pathologies and oxidative DNA damage, and LC3 and p62 protein expression analyzed. In a subset of 10 subjects, further to trabecular meshwork proteins, the amounts of cathepesin L and ubiquitin was analyzed by antibody microarray in aqueous humor. Obtained results demonstrate that autophagy activation, measured by LC3II/I ratio, is related with. oxidative damage occurrence during aging in human trabecular meshwork. The expression of autophagy marker p62 was lower in subjects older than 60 years as compared to younger subjects. These findings reflect the occurrence of an agedependent increase in the autophagy as occurring in the trabecular meshwork. Furthermore, we showed that aging promotes trabecular-meshwork senescence due to increased oxidative stress paralleled by autophagy increase. Indeed, both oxidative DNA damage and autophagy were more abundant in subjects older than 60 years. These findings shed new light on the role of oxidative damage and autophagy during trabecular-meshwork aging.	[Pulliero, Alessandra; Camoirano, Anna] Univ Genoa, Dept Hlth Sci, Genoa, Italy; [Seydel, Anke; Sandri, Marco] Venetian Inst Mol Med, Dulbecco Telethon Inst, Padua, Italy; [Sacca, Sergio Claudio] St Martino Hosp, Ophthalmol Unit, Dept Head Neck Pathol, Genoa, Italy; [Sacca, Sergio Claudio] Univ Padua, Dept Biomed Sci, Padua, Italy; [Izzotti, Alberto] IRCCS AOU San Martino IST, Genoa, Italy	University of Genoa; Fondazione Telethon; Dulbecco Telethon Institute (DTI); Veneto Institute Molecular Medicine; University of Padua; University of Genoa; IRCCS AOU San Martino IST	Izzotti, A (corresponding author), Univ Genoa, Dept Hlth Sci, Genoa, Italy.	izzotti@unige.it	Saccà, Sergio/AAG-3335-2019; Sacca, Sergio/D-5118-2018	Saccà, Sergio/0000-0001-6973-5978; Sacca, Sergio/0000-0001-6973-5978; izzotti, alberto/0000-0002-8588-0347	Department of Health Sciences University of Genoa; Fondazione Telethon Funding Source: Custom	Department of Health Sciences University of Genoa; Fondazione Telethon(Fondazione Telethon)	The source of funding is the Department of Health Sciences University of Genoa. The funders have contributed to the purchase of consumables with specific reference to reagent s and equipments used for Western blot, 8-oxo-dG, and antibody microarray analyses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVARADO J, 1984, OPHTHALMOLOGY, V91, P564; Bonaldo P, 2013, DIS MODEL MECH, V6, P25, DOI 10.1242/dmm.010389; Costello MJ, 2013, EXP EYE RES, V116, P141, DOI 10.1016/j.exer.2013.08.017; Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017; Duran A, 2008, CANCER CELL, V13, P343, DOI 10.1016/j.ccr.2008.02.001; Eiserich Jason P., 1998, Molecular Aspects of Medicine, V19, P221, DOI 10.1016/S0098-2997(99)00002-3; Ferreira SM, 2004, AM J OPHTHALMOL, V137, P62, DOI 10.1016/S0002-9394(03)00788-8; Gabelt BT, 2005, PROG RETIN EYE RES, V24, P612, DOI 10.1016/j.preteyeres.2004.10.003; Gelino S, 2012, J CLIN EXP PATHOL S4; Gibson SB, 2013, METHOD ENZYMOL, V528, P217, DOI 10.1016/B978-0-12-405881-1.00013-6; GRIERSON I, 1987, EYE, V1, P204, DOI 10.1038/eye.1987.38; Guimaraes CA, 2003, J BIOL CHEM, V278, P41938, DOI 10.1074/jbc.M306547200; HORSTMANN HJ, 1983, MECH AGEING DEV, V21, P121, DOI 10.1016/0047-6374(83)90069-6; Izzotti A, 2003, AM J MED, V114, P638, DOI 10.1016/S0002-9343(03)00114-1; Izzotti A, 2010, J PROTEOME RES, V9, P4831, DOI 10.1021/pr1005372; Izzotti A, 2012, EXPERT REV MOL DIAGN, V12, P629, DOI [10.1586/erm.12.57, 10.1586/ERM.12.57]; Izzotti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020110; Izzotti A, 2010, ARCH OPHTHALMOL-CHIC, V128, P724, DOI 10.1001/archophthalmol.2010.87; Izzotti A, 2009, INVEST OPHTH VIS SCI, V50, P5251, DOI 10.1167/iovs.09-3871; JEFFREY M, 1992, ACTA NEUROPATHOL, V84, P559, DOI 10.1007/BF00304476; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kaminskyy V, 2012, BBA-PROTEINS PROTEOM, V1824, P44, DOI 10.1016/j.bbapap.2011.05.013; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Korolchuk VI, 2009, AUTOPHAGY, V5, P862, DOI 10.4161/auto.8840; Lamark T, 2009, CELL CYCLE, V8, P1986, DOI 10.4161/cc.8.13.8892; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Liton PB, 2008, INVEST OPHTH VIS SCI, V49, P3961, DOI 10.1167/iovs.08-1915; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Petherick KJ, 2013, EMBO J, V32, P1903, DOI 10.1038/emboj.2013.123; Pinazo-Duran MD, 2013, CURR OPIN PHARMACOL, V13, P98, DOI 10.1016/j.coph.2012.10.007; Porter K, 2013, AUTOPHAGY, V9, P581, DOI 10.4161/auto.23568; Repnik U, 2012, BBA-PROTEINS PROTEOM, V1824, P22, DOI 10.1016/j.bbapap.2011.08.016; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Ryter SW, 2013, CURR PHARM DESIGN, V19, P2747; Sacca SC, 2005, ARCH OPHTHALMOL-CHIC, V123, P458, DOI 10.1001/archopht.123.4.458; Sandri M, 2013, INT J BIOCHEM CELL B, V45, P2121, DOI 10.1016/j.biocel.2013.04.023; SCHACHTSCHABEL DO, 1989, ARCH GERONTOL GERIAT, V9, P251, DOI 10.1016/0167-4943(89)90044-7; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SCHWARTZ LM, 1993, P NATL ACAD SCI USA, V90, P980, DOI 10.1073/pnas.90.3.980; Stewart M, 1996, CURR OPIN STRUC BIOL, V6, P162, DOI 10.1016/S0959-440X(96)80070-4; Tan GS, 2009, ARCH OPHTHALMOL-CHIC, V127, P1354, DOI 10.1001/archophthalmol.2009.268; Tasdemir E, 2008, AUTOPHAGY, V4, P810, DOI 10.4161/auto.6486; Toris CB, 1999, AM J OPHTHALMOL, V127, P407, DOI 10.1016/S0002-9394(98)00436-X; Viiri J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069563; Vittal Rao H, 2009, INVEST OPHTHALMOL VI, V50; Wang CH, 2013, EXP BIOL MED, V1; Wang QJ, 2006, J NEUROSCI, V26, P8057, DOI 10.1523/JNEUROSCI.2261-06.2006; Yang ZQ, 2013, OXID MED CELL LONGEV, V2013, DOI [10.1155/2013/146860, 10.1155/2013/329183]; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Yu BP, 1996, ANN NY ACAD SCI, V786, P1, DOI 10.1111/j.1749-6632.1996.tb39047.x	53	39	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e98106	10.1371/journal.pone.0098106	http://dx.doi.org/10.1371/journal.pone.0098106			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945152	Green Published, Green Submitted, gold			2022-12-27	WOS:000340721500005
J	Wang, YM; Tsai, IH; Chen, JM; Cheng, AC; Khoo, KH				Wang, Ying-Ming; Tsai, Inn-Ho; Chen, Jin-Mei; Cheng, An-Chun; Khoo, Kay-Hooi			Correlation between the Glycan Variations and Defibrinogenating Activities of Acutobin and Its Recombinant Glycoforms	PLOS ONE			English	Article							THROMBIN-LIKE ENZYME; DEINAGKISTRODON-ACUTUS VENOM; SNAKE-VENOM; SERINE-PROTEASE; FUNCTIONAL-CHARACTERIZATION; CARBOHYDRATE STRUCTURE; CRYSTAL-STRUCTURE; PICHIA-PASTORIS; PURIFICATION; GLYCOSYLATION	Acutobin isolated from Deinagkistrodon acutus venom has been used to prevent or treat stroke in patients. This defibrinogenating serine protease is a 39 kDa glycoprotein containing terminal disialyl-capped N-glycans. After sialidase treatment, the enzyme showed similar catalytic activities toward chromogenic substrate, and cleaved the A alpha chain of fibrinogen as efficiently as the native acutobin did. However, the level of fibrinogen degradation products in mice after i.p.-injection of desialylated-acutobin was significantly lower than the level after acutobin injection, suggesting that the disialyl moieties may improve or prolong the half-life of acutobin. Two recombinant enzymes with identical protein structures and similar amidolytic activities to those of native acutobin were expressed from HEK293T and SW1353 cells and designated as HKATB and SWATB, respectively. Mass spectrometric profiling showed that their glycans differed from those of acutobin. In contrast to acutobin, HKATB cleaved not only the A alpha chain but also the B beta and gamma chains of human fibrinogens, while SWATB showed a reduced alpha-fibrinogenase activity. Non-denaturing deglycosylation of these proteases by peptide N-glycosidase F significantly reduced their fibrinogenolytic activities and thermal stabilities. The in vivo defibrinogenating effect of HKATB was inferior to that of acutobin in mice. Taken together, our results suggest that the conjugated glycans of acutobin are involved in its interaction with fibrinogen, and that the selection of cells optimally expressing efficient glycoforms and further glycosylation engineering are desirable before a recombinant product can replace the native enzyme for clinical use.	[Wang, Ying-Ming; Tsai, Inn-Ho; Chen, Jin-Mei; Cheng, An-Chun; Khoo, Kay-Hooi] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Tsai, Inn-Ho; Khoo, Kay-Hooi] Natl Taiwan Univ, Inst Biochem Sci, Taipei, Taiwan	Academia Sinica - Taiwan; National Taiwan University	Tsai, IH (corresponding author), Acad Sinica, Inst Biol Chem, Taipei, Taiwan.	bc201@gate.sinica.edu.tw	wang, yan/GSE-6489-2022; wang, yingying/GRS-3058-2022; Khoo, Kay-Hooi/E-1989-2019	Khoo, Kay-Hooi/0000-0003-2906-406X	National Science Council of Taiwan [101-2319-B-001-003]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	NSC grant 101-2319-B-001-003 from National Science Council of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi M, 2013, BBA-MOL CELL RES, V1833, P2430, DOI 10.1016/j.bbamcr.2013.04.001; Castro HC, 2006, TOXIN REV, V25, P291, DOI 10.1080/15569540600567321; Chang HC, 2013, J PROTEOMICS, V89, P141, DOI 10.1016/j.jprot.2013.06.012; Costa FLS, 2009, TOXICON, V54, P725, DOI 10.1016/j.toxicon.2009.05.040; Gregoriadis G, 2005, INT J PHARM, V300, P125, DOI 10.1016/j.ijpharm.2005.06.007; Grewal PK, 2010, METHOD ENZYMOL, V479, P223, DOI 10.1016/S0076-6879(10)79013-3; Hodgson WC, 2009, CURR OPIN PHARMACOL, V9, P173, DOI 10.1016/j.coph.2008.11.007; Jiang XP, 2010, APPL MICROBIOL BIOT, V85, P635, DOI 10.1007/s00253-009-2141-2; LEE RT, 1992, ARCH BIOCHEM BIOPHYS, V299, P129, DOI 10.1016/0003-9861(92)90254-T; Leme AFP, 2008, J THROMB HAEMOST, V6, P1363, DOI 10.1111/j.1538-7836.2008.02995.x; Levy DE, 2009, STROKE, V40, P3796, DOI 10.1161/STROKEAHA.109.565119; Li QB, 2000, TOXICON, V38, P1355, DOI 10.1016/S0041-0101(99)00092-6; Lin CW, 2011, GLYCOBIOLOGY, V21, P530, DOI 10.1093/glycob/cwq195; Lin YX, 2009, PROTEIN EXPRES PURIF, V67, P48, DOI 10.1016/j.pep.2009.03.005; Lindhout T, 2011, P NATL ACAD SCI USA, V108, P7397, DOI 10.1073/pnas.1019266108; Liu S, 2011, STROKE, V42, P3277, DOI 10.1161/STROKEAHA.111.622753; LOCHNIT G, 1995, EUR J BIOCHEM, V228, P805, DOI 10.1111/j.1432-1033.1995.tb20326.x; Lovely RS, 2007, BRIT J HAEMATOL, V139, P494, DOI 10.1111/j.1365-2141.2007.06825.x; Mackessy S., 2011, TOXINS HEMOSTASIS BE, P519; Marsh N, 2005, TOXICON, V45, P1171, DOI 10.1016/j.toxicon.2005.02.016; Mukherjee AK, 2013, BBA-GEN SUBJECTS, V1830, P3476, DOI 10.1016/j.bbagen.2013.02.007; Nicoll G, 1999, J BIOL CHEM, V274, P34089, DOI 10.1074/jbc.274.48.34089; Nikai T, 1995, ARCH BIOCHEM BIOPHYS, V318, P9; Nikandrov NN, 2005, TOXICON, V46, P907, DOI 10.1016/j.toxicon.2005.08.016; NOSE T, 1994, TOXICON, V32, P1509, DOI 10.1016/0041-0101(94)90309-3; Otto VI, 2004, J BIOL CHEM, V279, P35201, DOI 10.1074/jbc.M404947200; OUYANG C, 1976, TOXICON, V14, P49, DOI 10.1016/0041-0101(76)90119-7; Oyama E, 2003, TOXICON, V41, P559, DOI 10.1016/S0041-0101(02)00363-X; PFEIFFER G, 1992, EUR J BIOCHEM, V205, P961, DOI 10.1111/j.1432-1033.1992.tb16863.x; Phillips Don J., 2010, P139; Serrano SMT, 2005, TOXICON, V45, P1115, DOI 10.1016/j.toxicon.2005.02.020; Silva-Junior FP, 2007, TOXICON, V50, P18, DOI 10.1016/j.toxicon.2007.02.018; Smith AA, 2003, THROMB RES, V112, P329, DOI 10.1016/j.thromres.2004.01.001; Ullah A, 2013, PROTEIN SCI, V22, P128, DOI 10.1002/pro.2189; Wang YM, 2001, BIOCHEM J, V354, P161, DOI 10.1042/0264-6021:3540161; Whitton CM, 2000, THROMB HAEMOSTASIS, V84, P258; You WK, 2004, FEBS LETT, V571, P67, DOI 10.1016/j.febslet.2004.06.060; Yu XL, 2007, PROTEIN EXPRES PURIF, V55, P257, DOI 10.1016/j.pep.2007.07.002; Yuen S, 2004, PROTEIN EXPRES PURIF, V38, P51; Zeng FX, 2013, ARCH TOXICOL, V87, P535, DOI 10.1007/s00204-012-0957-5; Zhao P, 2000, CHIN NEW DRUGS J, V9, P267; Zheng Y, 2013, TOXICON, V67, P1, DOI 10.1016/j.toxicon.2013.01.021; Zhu ZL, 2005, J BIOL CHEM, V280, P10524, DOI 10.1074/jbc.M412900200	43	4	4	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100354	10.1371/journal.pone.0100354	http://dx.doi.org/10.1371/journal.pone.0100354			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945257	Green Submitted, Green Published, gold			2022-12-27	WOS:000340721500066
J	Caldwell, CA; Eve, RM				Caldwell, Christine A.; Eve, Roland M.			Persistence of Contrasting Traditions in Cultural Evolution: Unpredictable Payoffs Generate Slower Rates of Cultural Change	PLOS ONE			English	Article							LABORATORY MICROCULTURE; PERSPECTIVE	We report an experimental test of the hypothesis that contrasting traditions will persist for longer, maintaining cultural differences between otherwise similar groups, under conditions of uncertainty about payoffs from individual learning. We studied the persistence of two alternative, experimentally-introduced, task solutions in chains of human participants. In some chains, participants were led to believe that final payoffs would be difficult to predict for an innovative solution, and in others, participants were aware that their final payoff would be directly linked to their immediate solution. Although the difference between the conditions was illusory (only participants' impressions were manipulated, not actual payoffs) clear differences were found between the conditions. Consistent with predictions, in the chains that were less certain about final payoffs, the distinctive variants endured over several replacement "generations" of participants. In contrast, in the other chains, the influence of the experimentally-introduced solutions was rapidly diluted by participants' exploration of alternative approaches. The finding provides support for the notion that rates of cultural change are likely to be slower for behaviors for which the relationship between performance and payoff may be hard to predict.	[Caldwell, Christine A.; Eve, Roland M.] Univ Stirling, Sch Nat Sci, Stirling FK9 4LA, Scotland	University of Stirling	Caldwell, CA (corresponding author), Univ Stirling, Sch Nat Sci, Stirling FK9 4LA, Scotland.	c.a.caldwell@stir.ac.uk	Caldwell, Christine/F-3134-2010	Caldwell, Christine/0000-0001-7362-2554	ESRC [RES-062-23-1634]; Economic and Social Research Council [ES/G021864/1] Funding Source: researchfish; ESRC [ES/G021864/1] Funding Source: UKRI	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This study was funded by the ESRC (www.esrc.ac.uk), grant number RES-062-23-1634). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baum WM, 2004, EVOL HUM BEHAV, V25, P305, DOI 10.1016/j.evolhumbehav.2004.05.003; Boyd R., 1988, P29; Caldwell CA, 2008, PHILOS T R SOC B, V363, P3529, DOI 10.1098/rstb.2008.0133; Caldwell CA, 2008, EVOL HUM BEHAV, V29, P165, DOI 10.1016/j.evolhumbehav.2007.12.001; Caldwell CA, 2012, J COMP PSYCHOL, V126, P161, DOI 10.1037/a0026828; Caldwell CA, 2010, EVOL HUM BEHAV, V31, P123, DOI 10.1016/j.evolhumbehav.2009.08.002; Caldwell CA, 2009, PSYCHOL SCI, V20, P1478, DOI 10.1111/j.1467-9280.2009.02469.x; Csibra G, 2006, ATTENTION PERFORM, P249; Gergely G., 2006, ROOTS HUMAN SOCIALIT, P229; JACOBS RC, 1961, J ABNORM SOC PSYCH, V62, P649, DOI 10.1037/h0044182; Kendal RL, 2005, ADV STUD BEHAV, V35, P333, DOI 10.1016/S0065-3454(05)35008-X; Laland KN, 2004, LEARN BEHAV, V32, P4; Mesoudi A, 2008, PHILOS T R SOC B, V363, P3489, DOI 10.1098/rstb.2008.0129; Richerson PJ., 2005, NOT GENES ALONE CULT; Sharon G, 2009, CURR ANTHROPOL, V50, P335, DOI 10.1086/598849; Tomasello Michael, 1999, CULTURAL ORIGINS HUM; WEICK KE, 1971, J PERS SOC PSYCHOL, V17, P179, DOI 10.1037/h0030461	17	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99708	10.1371/journal.pone.0099708	http://dx.doi.org/10.1371/journal.pone.0099708			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK6AC	24940597	Green Published, gold, Green Submitted			2022-12-27	WOS:000338508200037
J	Gao, LD; Hu, SX; Zhang, H; Luo, KW; Liu, YZ; Xu, QH; Huang, W; Deng, ZH; Zhou, SF; Liu, FQ; Zhang, F; Chen, Y				Gao, Li-Dong; Hu, Shi-Xiong; Zhang, Hong; Luo, Kai-Wei; Liu, Yun-Zhi; Xu, Qiao-Hua; Huang, Wei; Deng, Zhi-Hong; Zhou, Shuai-Feng; Liu, Fu-Qiang; Zhang, Fan; Chen, Yu			Correlation Analysis of EV71 Detection and Case Severity in Hand, Foot, and Mouth Disease in the Hunan Province of China	PLOS ONE			English	Article							INFECTION	An increase in the incidence of hand, foot and mouth disease (HFMD) cases has been observed in the Hunan province of mainland China since 2009 with a particularly higher level of severe cases in 2010-2012. Intestinal viruses of the picornaviridae family are responsible for the human syndrome associated with HFMD with enterovirus 71 (EV71) and Coxsackievirus A16 (Cox A16) being the most common causative strains. HFMD cases associated with EV71 are generally more severe with an increased association of morbidity and mortality. In this study, the etiology surveillance data of HFMD cases in Hunan province from March 2010 to October 2012 were analyzed to determine if there is a statistically relevant linear correlation exists between the detection rate of EV71 in mild cases and the proportion of severe cases among all HFMD patients. As the cases progressed from mild to severe to fatal, the likelihood of EV71 detection increased (25.78%, 52.20% and 84.18%, respectively). For all cases in the timeframe evaluated in this study, the presence of virus was detected in 63.21% of cases; among cases showing positivity for virus, EV71 infection accounted for 50.14%. These results provide evidence to support the observed higher morbidity and mortality associated with this outbreak and emphasizes the importance of early detection in order to implement necessary prevention measures to mitigate disease progression.	[Gao, Li-Dong; Hu, Shi-Xiong; Zhang, Hong; Luo, Kai-Wei; Liu, Yun-Zhi; Xu, Qiao-Hua; Huang, Wei; Deng, Zhi-Hong; Zhou, Shuai-Feng; Liu, Fu-Qiang; Zhang, Fan; Chen, Yu] Hunan Prov Ctr Dis Control & Prevent, Changsha, Hunan, Peoples R China		Luo, KW (corresponding author), Hunan Prov Ctr Dis Control & Prevent, Changsha, Hunan, Peoples R China.	hncdclbk@163.com			Chinese Preventive Medicine Association [20101801]	Chinese Preventive Medicine Association	This study was supported by the foundation from Chinese Preventive Medicine Association (Grant No: 20101801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang LW, 2009, ANN ACAD MED SINGAP, V38, P106; Chang Zhao-rui, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P676; China TMoHo, 2010, FOOT MOUTH DIS TREAT; China TMoHo, 2009, FOOT MOUTH DIS CONTR; Edmond M, 2011, PUBLIC HEALTH, V125, P777, DOI 10.1016/j.puhe.2011.09.002; Guo Ru-ning, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P530; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Hu Hai-Yun, 2012, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V26, P341; Huang WC, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-209; Ji H, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-248; Lin TY, 2002, J INFECT DIS, V186, P1161, DOI 10.1086/343809; Liu Zhong-Qiang, 2012, Zhongguo Dang Dai Er Ke Za Zhi, V14, P589; Mou J, 2013, EPIDEMIOL INFECT, P1; Pan Hao, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P763; Yan Xiu-feng, 2012, Zhonghua Er Ke Za Zhi, V50, P271; Yang TC, 2012, EUR J PEDIATR, V171, P1359, DOI 10.1007/s00431-012-1731-7	16	22	30	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100003	10.1371/journal.pone.0100003	http://dx.doi.org/10.1371/journal.pone.0100003			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941257	gold, Green Published, Green Submitted			2022-12-27	WOS:000338508200064
J	Qin, XY; Bochsler, TM; Aizpurua, A; Cheong, AMY; Koutstaal, W; Legge, GE				Qin, Xiaoyan; Bochsler, Tiana M.; Aizpurua, Alaitz; Cheong, Allen M. Y.; Koutstaal, Wilma; Legge, Gordon E.			Incidental Memory of Younger and Older Adults for Objects Encountered in a Real World Context	PLOS ONE			English	Article							AGE-RELATED DIFFERENCES; FALSE MEMORIES; LIFE-SPAN; KNOWLEDGE; PERCEPTION; SCENES; DISTRACTIBILITY; DETERMINANTS; RECOGNITION; CONSISTENCY	Effects of context on the perception of, and incidental memory for, real-world objects have predominantly been investigated in younger individuals, under conditions involving a single static viewpoint. We examined the effects of prior object context and object familiarity on both older and younger adults' incidental memory for real objects encountered while they traversed a conference room. Recognition memory for context-typical and context-atypical objects was compared with a third group of unfamiliar objects that were not readily named and that had no strongly associated context. Both older and younger adults demonstrated a typicality effect, showing significantly lower 2-alternative-forced-choice recognition of context-typical than context-atypical objects; for these objects, the recognition of older adults either significantly exceeded, or numerically surpassed, that of younger adults. Testing-awareness elevated recognition but did not interact with age or with object type. Older adults showed significantly higher recognition for context-atypical objects than for unfamiliar objects that had no prior strongly associated context. The observation of a typicality effect in both age groups is consistent with preserved semantic schemata processing in aging. The incidental recognition advantage of older over younger adults for the context-typical and context-atypical objects may reflect aging-related differences in goal-related processing, with older adults under comparatively more novel circumstances being more likely to direct their attention to the external environment, or age-related differences in top-down effortful distraction regulation, with older individuals' attention more readily captured by salient objects in the environment. Older adults' reduced recognition of unfamiliar objects compared to context-atypical objects may reflect possible age differences in contextually driven expectancy violations. The latter finding underscores the theoretical and methodological value of including a third type of objects-that are comparatively neutral with respect to their contextual associations-to help differentiate between contextual integration effects (for schema-consistent objects) and expectancy violations (for schema-inconsistent objects).	[Qin, Xiaoyan; Bochsler, Tiana M.; Koutstaal, Wilma; Legge, Gordon E.] Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA; [Aizpurua, Alaitz] Univ Basque Country, Fac Psychol, Donostia San Sebastian, Spain; [Cheong, Allen M. Y.] Hong Kong Polytech Univ, Sch Optometry, Hong Kong, Hong Kong, Peoples R China	University of Minnesota System; University of Minnesota Twin Cities; University of Basque Country; Hong Kong Polytechnic University	Qin, XY (corresponding author), Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA.	qinxx040@umn.edu	AIZPURUA, ALAITZ/AAB-7341-2020; Cheong, Allen Ming Yan/L-9008-2013	Legge, Gordon/0000-0002-3742-1680; Cheong, Allen Ming Yan/0000-0002-6746-3902; AIZPURUA, ALAITZ/0000-0003-1745-9451	Basque Government [AEGV11/02]; McKnight Presidential Fellowship; NIH [EY017835]; NATIONAL EYE INSTITUTE [P30EY011374, R01EY017835] Funding Source: NIH RePORTER	Basque Government(Basque Government); McKnight Presidential Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by AEGV11/02 grant from the Basque Government to AA, a McKnight Presidential Fellowship to WK, and by NIH grant EY017835 to GEL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARBUCKLE TY, 1994, PSYCHOL AGING, V9, P467, DOI 10.1037/0882-7974.9.3.467; ARBUCKLE TY, 1990, J EXP PSYCHOL LEARN, V16, P305, DOI 10.1037/0278-7393.16.2.305; Balota D. A., 2000, OXFORD HDB MEMORY, P395, DOI DOI 10.1037/A0015086; Bar M, 2004, NAT REV NEUROSCI, V5, P617, DOI 10.1038/nrn1476; Bartlett FC., 1995, REMEMBERING STUDY EX, V2nd edn; BIEDERMA.I, 1972, SCIENCE, V177, P77, DOI 10.1126/science.177.4043.77; BREWER WF, 1981, COGNITIVE PSYCHOL, V13, P207, DOI 10.1016/0010-0285(81)90008-6; Campbell KL, 2009, PSYCHOL AGING, V24, P163, DOI 10.1037/a0014106; CONNELLY SL, 1991, PSYCHOL AGING, V6, P533, DOI 10.1037/0882-7974.6.4.533; Davenport JL, 2004, PSYCHOL SCI, V15, P559, DOI 10.1111/j.0956-7976.2004.00719.x; DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017; Droll JA, 2009, VIS COGN, V17, P1159, DOI 10.1080/13506280902797125; Dywan J, 1996, PSYCHOL AGING, V11, P199, DOI 10.1037/0882-7974.11.2.199; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FRIEDMAN A, 1979, J EXP PSYCHOL GEN, V108, P316, DOI 10.1037/0096-3445.108.3.316; Garcia-Bajos E, 2003, EUR J COGN PSYCHOL, V15, P195, DOI 10.1080/09541440244000102; Garcia-Bajos E, 2012, APPL COGNITIVE PSYCH, V26, P737, DOI 10.1002/acp.2854; Gazzaley A, 2005, NAT NEUROSCI, V8, P1298, DOI 10.1038/nn1543; Gordon RD, 2006, MEM COGNITION, V34, P1484, DOI 10.3758/BF03195913; Healey MK, 2008, PROG BRAIN RES, V169, P353, DOI 10.1016/S0079-6123(07)00022-2; Hedden T, 2005, Q J EXP PSYCHOL-A, V58, P169, DOI 10.1080/02724980443000179; Hess TM, 2005, PSYCHOL BULL, V131, P383, DOI 10.1037/0033-2909.131.3.383; Hirt E. R., 1999, EXPECTANCIES SHAPE E, P93; Kim S, 2007, PSYCHON B REV, V14, P301, DOI 10.3758/BF03194068; Koutstaal W, 2006, PSYCHON B REV, V13, P84, DOI 10.3758/BF03193817; Koutstaal W, 2003, PSYCHOL SCI, V14, P189, DOI 10.1111/1467-9280.01441; Koutstaal W, 2003, J EXP PSYCHOL LEARN, V29, P499, DOI 10.1037/0278-7393.29.4.499; Lampinen JM, 2001, J EXP PSYCHOL LEARN, V27, P1211, DOI 10.1037/0278-7393.27.5.1211; LaPointe MRP, 2013, VIS COGN, V21, P99, DOI 10.1080/13506285.2013.787133; LIGHT LL, 1983, MEM COGNITION, V11, P435, DOI 10.3758/BF03196980; LIST JA, 1986, DEV PSYCHOL, V22, P50, DOI 10.1037/0012-1649.22.1.50; LOFTUS GR, 1978, J EXP PSYCHOL HUMAN, V4, P565, DOI 10.1037/0096-1523.4.4.565; Luo L, 2009, J MEM LANG, V60, P421, DOI 10.1016/j.jml.2009.01.005; Mack SC, 2011, J VISION, V11, DOI 10.1167/11.9.9; MANTYLA T, 1992, J EXP PSYCHOL LEARN, V18, P1298, DOI 10.1037/0278-7393.18.6.1298; May CP, 1999, PSYCHON B REV, V6, P142, DOI 10.3758/BF03210822; Migo E, 2009, Q J EXP PSYCHOL, V62, P1198, DOI 10.1080/17470210802391599; Miller MB, 1998, NEUROPSYCHOLOGIA, V36, P513, DOI 10.1016/S0028-3932(97)00148-6; Minsky M., 1975, PSYCHOL COMPUTER VIS, P211; Mourkoussis N, 2010, ACM T APPL PERCEPT, V8, DOI 10.1145/1857893.1857895; Ofen N, 2013, NEUROSCI BIOBEHAV R, V37, P2258, DOI 10.1016/j.neubiorev.2013.04.006; Pansky A, 2009, EUR J COGN PSYCHOL, V21, P303, DOI 10.1080/09541440802281183; PEZDEK K, 1989, J EXP PSYCHOL LEARN, V15, P587, DOI 10.1037/0278-7393.15.4.587; Plancher G, 2010, NEUROPSYCHOLOGY, V24, P379, DOI 10.1037/a0018680; Prull MW, 2013, APPL COGNITIVE PSYCH, V27, P384, DOI 10.1002/acp.2916; Sakamoto Y, 2004, J EXP PSYCHOL GEN, V133, P534, DOI 10.1037/0096-3445.133.4.534; Schmitz TW, 2010, J NEUROSCI, V30, P14750, DOI 10.1523/JNEUROSCI.2687-10.2010; Shih SI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033485; Spencer WD, 1995, PSYCHOL AGING, V10, P527, DOI 10.1037/0882-7974.10.4.527; Tatler BW, 2011, J VISION, V11, DOI 10.1167/11.5.5; Thomas RC, 2012, J EXP PSYCHOL LEARN, V38, P30, DOI 10.1037/a0024882; Triesch J, 2003, J VISION, V3, P86, DOI 10.1167/3.1.9; van Asselen M, 2006, PSYCHOL RES-PSYCH FO, V70, P151, DOI 10.1007/s00426-004-0199-0; Yang L, 2007, J GERONTOL B-PSYCHOL, V62, pP230, DOI 10.1093/geronb/62.4.P230	54	4	4	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99051	10.1371/journal.pone.0099051	http://dx.doi.org/10.1371/journal.pone.0099051			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK6AC	24941065	Green Published, gold, Green Submitted			2022-12-27	WOS:000338508200013
J	Vastfjall, D; Slovic, P; Mayorga, M; Peters, E				Vastfjall, Daniel; Slovic, Paul; Mayorga, Marcus; Peters, Ellen			Compassion Fade: Affect and Charity Are Greatest for a Single Child in Need	PLOS ONE			English	Article							AFFECTIVE PSYCHOLOGY; DECISION-MAKING; VICTIM; RISK; DONATIONS; IDENTIFIABILITY; INSENSITIVITY; PREFERENCES; ALTRUISM; JUDGMENT	Charitable giving in 2013 exceeded $300 billion, but why do we respond to some life-saving causes while ignoring others? In our first two studies, we demonstrated that valuation of lives is associated with affective feelings (self-reported and psychophysiological) and that a decline in compassion may begin with the second endangered life. In Study 3, this fading of compassion was reversed by describing multiple lives in a more unitary fashion. Study 4 extended our findings to loss-frame scenarios. Our capacity to feel sympathy for people in need appears limited, and this form of compassion fatigue can lead to apathy and inaction, consistent with what is seen repeatedly in response to many large-scale human and environmental catastrophes.	[Vastfjall, Daniel; Slovic, Paul; Mayorga, Marcus] Decis Res, Eugene, OR 97401 USA; [Vastfjall, Daniel] Linkoping Univ, Dept Behav Sci & Learning, Linkoping, Sweden; [Slovic, Paul; Mayorga, Marcus] Univ Oregon, Dept Psychol, Eugene, OR 97403 USA; [Peters, Ellen] Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA	Linkoping University; University of Oregon; University System of Ohio; Ohio State University	Vastfjall, D (corresponding author), Decis Res, Eugene, OR 97401 USA.	daniel.vastfjall@liu.se; pslovic@uoregon.edu	Västfjäll, Daniel/F-9629-2014	Vastfjall, Daniel/0000-0003-2873-4500; Mayorga, Marcus/0000-0001-5471-0655	Hewlett Foundation; National Science Foundation [SES-0649509, 1227729, 1024808]	Hewlett Foundation; National Science Foundation(National Science Foundation (NSF))	This material is based upon work supported by the Hewlett Foundation (http://www.hewlett.org/), and by the National Science Foundation (http://www.nsf.gov/) under Grants No. SES-0649509,1227729, and 1024808. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreassi J. L, 1995, PSYCHOPHYSIOLOGY HUM; ANDREONI J, 1990, ECON J, V100, P464, DOI 10.2307/2234133; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; BATSON CD, 1990, AM PSYCHOL, V45, P336, DOI 10.1037/0003-066X.45.3.336; Batson CD., 1991, ALTRUISM QUESTION SO; Bloom P, 2010, NATURE, V464, P490, DOI 10.1038/464490a; Blundell JE, 2009, HDB ASSESSMENT METHO, V2nd, P283; Bradley MM., 2000, SER AFFECTIVE SCI, P242; Burson K, 2013, MANAGE SCI, V59, P545, DOI 10.1287/mnsc.1120.1562; CABANAC M, 1992, J THEOR BIOL, V155, P173, DOI 10.1016/S0022-5193(05)80594-6; Cameron CD, 2011, J PERS SOC PSYCHOL, V100, P1, DOI 10.1037/a0021643; Condon P, 2013, EMOTION, V13, P817, DOI 10.1037/a0033747; Damasio A.R., 2005, DESCARTES ERROR EMOT; Dickert S, 2012, SYNTHESE, V189, P681, DOI 10.1007/s11229-012-0137-4; Dickert S, 2011, J BEHAV DECIS MAKING, V24, P361, DOI 10.1002/bdm.697; Dickert S, 2009, JUDGM DECIS MAK, V4, P297; Evans JSBT, 2008, ANNU REV PSYCHOL, V59, P255, DOI 10.1146/annurev.psych.59.103006.093629; Fetherstonhaugh D, 1997, J RISK UNCERTAINTY, V14, P283, DOI 10.1023/A:1007744326393; Genevsky A, 2013, J NEUROSCI, V 33, P17188, DOI 10.1523/JNEUROSCI.2348-13.2013; Goetz JL, 2010, PSYCHOL BULL, V136, P351, DOI 10.1037/a0018807; Greene Joshua., 2013, MORAL TRIBES EMOTION; Haidt J, 2001, PSYCHOL REV, V108, P814, DOI 10.1037//0033-295X.108.4.814; Hamilton DL, 1996, PSYCHOL REV, V103, P336, DOI 10.1037/0033-295X.103.2.336; Harbaugh WT, 2007, SCIENCE, V316, P1622, DOI 10.1126/science.1140738; Hsee CK, 2013, PSYCHOL SCI, V24, P1801, DOI 10.1177/0956797613482947; Hsee CK, 2004, J EXP PSYCHOL GEN, V133, P23, DOI 10.1037/0096-3445.133.1.23; Jenni KE, 1997, J RISK UNCERTAINTY, V14, P235, DOI 10.1023/A:1007740225484; Kahneman D, 2003, AM PSYCHOL, V58, P697, DOI 10.1037/0003-066X.58.9.697; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kahneman D., 2011, THINKING FAST SLOW; Kahneman D., 2011, THINKING FAST SLOW; Kogut T, 2005, J BEHAV DECIS MAKING, V18, P157, DOI 10.1002/bdm.492; Kruglanski AW, 2011, PSYCHOL REV, V118, P97, DOI 10.1037/a0020762; LeDoux J. E., 1996, EMOTIONAL BRAIN MYST; Loewenstein G, 2003, SER AFFECTIVE SCI, P619; Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267; Majdandzic J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047698; MANUCIA GK, 1984, J PERS SOC PSYCHOL, V46, P357, DOI 10.1037/0022-3514.46.2.357; Markowitz EM, 2013, JUDGM DECIS MAK, V8, P397; Moll J, 2006, P NATL ACAD SCI USA, V103, P15623, DOI 10.1073/pnas.0604475103; Penner LA, 2005, ANNU REV PSYCHOL, V56, P365, DOI 10.1146/annurev.psych.56.091103.070141; Peters E, 2006, J BEHAV DECIS MAKING, V19, P79, DOI 10.1002/bdm.528; Prinz, 2006, PHILOS EXPLOR, V9, P29, DOI [10.1080/13869790500492466, DOI 10.1080/13869790500492466, 10.1080/]; Rottenstreich Y, 2001, PSYCHOL SCI, V12, P185, DOI 10.1111/1467-9280.00334; Schelling TC, 1968, PROBLEMS PUBLIC EXPE, DOI DOI 10.1037/12069-015; Schley DR, 2014, PSYCHOL SCI, V25, P753, DOI 10.1177/0956797613515485; Singer Peter, 2009, LIFE YOU CAN SAVE AC; Singer T., 2014, SOC AFF SCI APRIL 26; Singer T, 2009, ANN NY ACAD SCI, V1156, P81, DOI 10.1111/j.1749-6632.2009.04418.x; Sloman SA, 1996, PSYCHOL BULL, V119, P3, DOI 10.1037/0033-2909.119.1.3; Slovic P, 2002, HEURISTICS BIASES PS, P397, DOI [DOI 10.1017/CBO9780511808098.025, 10.1017/CBO9780511808098.025]; Slovic P., 2010, IRRATIONAL ECONOMIST, P30; Slovic P, 2007, JUDGM DECIS MAK, V2, P79; Slovic P, 2010, PSYCHOL INQ, V21, P387, DOI 10.1080/1047840X.2010.521119; Slovic Paul, 2013, BEHAV FDN PUBLIC POL, p[126, 130]; Small DA, 2005, J BEHAV DECIS MAKING, V18, P311, DOI 10.1002/bdm.507; Small DA, 2003, J RISK UNCERTAINTY, V26, P5, DOI 10.1023/A:1022299422219; SMITH BD, 1983, PERS INDIV DIFFER, V4, P411, DOI 10.1016/0191-8869(83)90007-7; Smith RW, 2013, J CONSUM RES, V39, P961, DOI 10.1086/666470; Sunstein CR, 2005, BEHAV BRAIN SCI, V28, P531, DOI 10.1017/S0140525X05000099; Thompson DV, 2005, J MARKETING RES, V42, P431, DOI 10.1509/jmkr.2005.42.4.431; Ugazio G, 2012, EMOTION, V12, P579, DOI 10.1037/a0024611; ZAJONC RB, 1980, AM PSYCHOL, V35, P151, DOI 10.1037/0003-066X.35.2.151	63	114	114	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100115	10.1371/journal.pone.0100115	http://dx.doi.org/10.1371/journal.pone.0100115			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK6AC	24940738	Green Published, Green Submitted, gold			2022-12-27	WOS:000338508200073
J	Hancock, KJ; Lawrence, D; Zubrick, SR				Hancock, Kirsten J.; Lawrence, David; Zubrick, Stephen R.			Higher Maternal Protectiveness Is Associated with Higher Odds of Child Overweight and Obesity: A Longitudinal Australian Study	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; SOCIOECONOMIC-STATUS; WEIGHT STATUS; TRENDS; PARENTS; PERCEPTIONS; SAFETY; RISK; PLAY; FEAR	In recent years there has been an increasing interest in overprotective parenting and the potential role it plays in child development. While some have argued that a trend towards increased parental fear and reduced opportunity for independent mobility may be linked to increasing rates of child overweight and obesity, there is limited empirical information available to support this claim. Using data from the Longitudinal Study of Australian Children, this study aimed to examine the longitudinal relationships between maternal protectiveness and child overweight and obesity. A cohort of 4-5 year old children was followed up at 6-7, 8-9 and 10-11 years of age (n = 2596). Measures included a protective parenting scale administered when children were 6-7 and 8-9 years of age, child body mass index (BMI), family characteristics including household income, neighbourhood disadvantage, child's position amongst siblings, and maternal BMI, education, employment, mental health and age at first birth. International Obesity Taskforce age-and sex-specific BMI cut points were used to determine if children were in the normal, overweight or obese BMI range. There was no association between maternal protectiveness and the odds of children being overweight or obese at age 4-5, 6-7 or 8-9 years. However at age 10-11 years, a 1 standard deviation increase in maternal protectiveness was associated with a 13% increase in the odds of children being overweight or obese. The results provide evidence of a relationship between maternal protectiveness and child overweight and obesity, however further research is required to understand the mechanism(s) that links the two concepts.	[Hancock, Kirsten J.; Lawrence, David; Zubrick, Stephen R.] Univ Western Australia, Telethon Kids Inst, Perth, WA 6009, Australia	Telethon Kids Institute; University of Western Australia	Hancock, KJ (corresponding author), Univ Western Australia, Telethon Kids Inst, Perth, WA 6009, Australia.	kirsten.hancock@telethonkids.org.au	Lawrence, David/C-8292-2009; Zubrick, Stephen R/CAI-1970-2022; Hancock, Kirsten/T-1836-2019	Lawrence, David/0000-0003-4700-1425; Zubrick, Stephen R/0000-0002-6369-1713; Hancock, Kirsten/0000-0001-6213-2488	National Health and Medical Research Council program grant [572742]	National Health and Medical Research Council program grant(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by a National Health and Medical Research Council program grant (#572742) (http://www.nhmrc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIHW, 2012, PICT AUSTR CHILD 201; AIHW National Injury Surveillance Unit, 2012, INJ RES STAT SER, V75; Barton M, 2010, PEDIATRICS, V125, P361, DOI 10.1542/peds.2009-2037; Bayer JK, 2006, J APPL DEV PSYCHOL, V27, P542, DOI 10.1016/j.appdev.2006.08.002; Branche C., 2008, WORLD REPORT CHILD I; Brussoni M, 2013, QUAL HEALTH RES, V23, P1388, DOI 10.1177/1049732313505916; Carver A, 2008, HEALTH PLACE, V14, P217, DOI 10.1016/j.healthplace.2007.06.004; Carver A, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-57; Clements R., 2004, CONTEMP ISS EARLY CH, V5, P68; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Cooklin AR, 2014, J FAM ISSUES, V35, P1497, DOI 10.1177/0192513X13481776; Cooklin AR, 2013, J FAM PSYCHOL, V27, P618, DOI 10.1037/a0033332; Cooklin AR, 2012, AUST NZ J PUBL HEAL, V36, P249, DOI 10.1111/j.1753-6405.2012.00846.x; Craig L, 2014, BRIT J SOCIOL, V65, P555, DOI 10.1111/1468-4446.12035; Cunningham SA, 2014, NEW ENGL J MED, V370, P403, DOI [10.1056/NEJMoa1309753, 10.1056/NEJMc1402397]; Department of Social Services, 2014, ACC DSS LONG DAT; Ding D, 2012, AM J HEALTH PROMOT, V26, P189, DOI 10.4278/ajhp.100701-QUAN-224; Doukas G, 2010, ACCIDENT ANAL PREV, V42, P1705, DOI 10.1016/j.aap.2010.04.010; Eager D., 2011, P IPWEA INT PUBL WOR; Gabriel T., 2010, NY TIMES; Givertz M, 2014, COMMUN RES, V41, P1111, DOI 10.1177/0093650212456392; Gray P, 2011, AM J PLAY, V3, P443; Hafekost K, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-41; Hancock KJ, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-299; Harten N, 2004, AUST NZ J PUBL HEAL, V28, P167; Hedeker D., 2006, LONGITUDINAL DATA AN; Jones RA, 2010, INT J PEDIATR OBES, V5, P256, DOI 10.3109/17477160903271971; Karsten L., 2005, CHILDRENS GEOGRAPHIE, V3, P275, DOI 10.1080/14733280500352912; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Mitchell R, 2009, J PAEDIATR CHILD H, V45, P754, DOI 10.1111/j.1440-1754.2007.01157.x; Olds TS, 2010, INT J OBESITY, V34, P57, DOI 10.1038/ijo.2009.211; Page AS, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-2; Paton G, 2012, TELEGRAPH; Pleck J.H., 2010, ROLE FATHER CHILD DE, P58; Salmon J, 2005, AUST NZ J PUBL HEAL, V29, P337, DOI 10.1111/j.1467-842X.2005.tb00204.x; Schiffrin HH, 2014, J CHILD FAM STUD, V23, P548, DOI 10.1007/s10826-013-9716-3; SHUTT JE, 2004, CRIMINAL JUSTICE STU, V0017; Sipthorp M, 2009, 6 LSAC AUSTR I FAM S; Snyder Howard N., 2000, SEXUAL ASSAULT YOUNG; Soloff C., 2006, 3 LSAC AUSTR I FAM S; Thomasgard M, 1997, AM J ORTHOPSYCHIAT, V67, P330, DOI 10.1037/h0080237; Tomkinson Grant R, 2007, Med Sport Sci, V50, P168, DOI 10.1159/000101361; Tomkinson Grant R, 2007, Med Sport Sci, V50, P46, DOI 10.1159/000101075; Tulloch MI, 2004, J SOCIOL, V40, P362, DOI 10.1177/1440783304048380; Ungar M, 2009, AM J FAM THER, V37, P258, DOI 10.1080/01926180802534247; Valentine G., 2004, PUBLIC SPACE CULTURE, V1; Vaus D., 2002, ANAL SOCIAL SCI DATA; Veitch J, 2006, HEALTH PLACE, V12, P383, DOI 10.1016/j.healthplace.2005.02.009; Wilson DK, 2004, ANN BEHAV MED, V28, P20, DOI 10.1207/s15324796abm2801_4; Zubrick S., 2010, NOTHING FEAR ITSELF	50	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100686	10.1371/journal.pone.0100686	http://dx.doi.org/10.1371/journal.pone.0100686			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL1WV	24955586	gold, Green Published, Green Submitted			2022-12-27	WOS:000338917900082
J	Siggers, P; Carre, GA; Bogani, D; Warr, N; Wells, S; Hilton, H; Esapa, C; Hajihosseini, MK; Greenfield, A				Siggers, Pam; Carre, Gwenn-Ael; Bogani, Debora; Warr, Nick; Wells, Sara; Hilton, Helen; Esapa, Chris; Hajihosseini, Mohammad K.; Greenfield, Andy			A Novel Mouse Fgfr2 Mutant, Hobbyhorse (hob), Exhibits Complete XY Gonadal Sex Reversal	PLOS ONE			English	Article							FIBROBLAST GROWTH-FACTORS; SRY; EXPRESSION; SOX9; DIFFERENTIATION; PROLIFERATION; GENE	The secreted molecule fibroblast growth factor 9 (FGF9) plays a critical role in testis determination in the mouse. In embryonic gonadal somatic cells it is required for maintenance of SOX9 expression, a key determinant of Sertoli cell fate. Conditional gene targeting studies have identified FGFR2 as the main gonadal receptor for FGF9 during sex determination. However, such studies can be complicated by inefficient and variable deletion of floxed alleles, depending on the choice of Cre deleter strain. Here, we report a novel, constitutive allele of Fgfr2, hobbyhorse (hob), which was identified in an ENU-based forward genetic screen for novel testis-determining loci. Fgr2(hob) is caused by a C to T mutation in the invariant exon 7, resulting in a polypeptide with a mis-sense mutation at position 263 (Pro263Ser) in the third extracellular immunoglobulin-like domain of FGFR2. Mutant homozygous embryos show severe limb and lung defects and, when on the sensitised C57BL/6J (B6) genetic background, undergo complete XY gonadal sex reversal associated with failure to maintain expression of Sox9. Genetic crosses employing a null mutant of Fgfr2 suggest that Fgr2(hob) is a hypomorphic allele, affecting both the FGFR2b and FGFR2c splice isoforms of the receptor. We exploited the consistent phenotype of this constitutive mutant by analysing MAPK signalling at the sex-determining stage of gonad development, but no significant abnormalities in mutant embryos were detected.	[Siggers, Pam; Carre, Gwenn-Ael; Bogani, Debora; Warr, Nick; Hilton, Helen; Esapa, Chris; Greenfield, Andy] MRC, Mammalian Genet Unit, Harwell, Oxon, England; [Bogani, Debora; Wells, Sara] MRC, Mary Lyon Ctr, Harwell, Oxon, England; [Hajihosseini, Mohammad K.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England	University of East Anglia	Greenfield, A (corresponding author), MRC, Mammalian Genet Unit, Harwell, Oxon, England.	a.greenfield@har.mrc.ac.uk	Greenfield, Andy/F-5099-2017	Greenfield, Andy/0000-0002-1477-1776; Warr, Nick/0000-0003-0767-1360	UK Medical Research Council [MC_A390_5RX50]; Medical Research Council [MC_U142684167, MC_UP_1502/1] Funding Source: researchfish; MRC [MC_UP_1502/1, MC_U142684167] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the UK Medical Research Council through Core funding to AG at its Mammalian Genetics Unit, Harwell (MC_A390_5RX50). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagheri-Fam S, 2008, DEV BIOL, V314, P71, DOI 10.1016/j.ydbio.2007.11.010; Bogani D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000196; Bullejos M, 2001, DEV DYNAM, V221, P201, DOI 10.1002/dvdy.1134; Colvin JS, 2001, CELL, V104, P875, DOI 10.1016/S0092-8674(01)00284-7; Field S, 2011, DEVELOPMENT, V138, P1131, DOI 10.1242/dev.058149; Goetz R, 2013, NAT REV MOL CELL BIO, V14, P166, DOI 10.1038/nrm3528; Grimmond S, 2000, HUM MOL GENET, V9, P1553, DOI 10.1093/hmg/9.10.1553; Harada M, 2009, NAT GENET, V41, P289, DOI 10.1038/ng.316; Hiramatsu R, 2010, DEVELOPMENT, V137, P303, DOI 10.1242/dev.040519; Hiramatsu R, 2009, DEVELOPMENT, V136, P129, DOI 10.1242/dev.029587; Itoh N, 2011, J BIOCHEM, V149, P121, DOI 10.1093/jb/mvq121; Jameson SA, 2012, DEV BIOL, V370, P24, DOI 10.1016/j.ydbio.2012.06.009; Keren-Politansky A, 2009, DEV BIOL, V335, P374, DOI 10.1016/j.ydbio.2009.09.012; Kim Y, 2007, P NATL ACAD SCI USA, V104, P16558, DOI 10.1073/pnas.0702581104; Kim Y, 2006, PLOS BIOL, V4, P1000, DOI 10.1371/journal.pbio.0040187; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; Murakami S, 2000, P NATL ACAD SCI USA, V97, P1113, DOI 10.1073/pnas.97.3.1113; Patterson VL, 2009, HUM MOL GENET, V18, P1719, DOI 10.1093/hmg/ddp075; Schmahl J, 2004, DEVELOPMENT, V131, P3627, DOI 10.1242/dev.01239; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; Suzuki-Hirano A, 2010, DEV BIOL, V337, P284, DOI 10.1016/j.ydbio.2009.10.044; Warr N, 2014, HUM MOL GENET, V23, P3035, DOI 10.1093/hmg/ddu020; Warr N, 2012, DEV CELL, V23, P1020, DOI 10.1016/j.devcel.2012.09.016; Warr N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019572; Warr N, 2009, DEV BIOL, V326, P273, DOI 10.1016/j.ydbio.2008.11.023; Wilhelm D, 2009, MECH DEVELOP, V126, P324, DOI 10.1016/j.mod.2009.02.006; WRIGHT E, 1995, NAT GENET, V9, P15, DOI 10.1038/ng0195-15; Xu XL, 1998, DEVELOPMENT, V125, P753	29	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100447	10.1371/journal.pone.0100447	http://dx.doi.org/10.1371/journal.pone.0100447			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956260	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000338917900052
J	Rinde, E; Christie, H; Fagerli, CW; Bekkby, T; Gundersen, H; Norderhaug, KM; Hjermann, DO				Rinde, Eli; Christie, Hartvig; Fagerli, Camilla W.; Bekkby, Trine; Gundersen, Hege; Norderhaug, Kjell Magnus; Hjermann, Dag O.			The Influence of Physical Factors on Kelp and Sea Urchin Distribution in Previously and Still Grazed Areas in the NE Atlantic	PLOS ONE			English	Article							STRONGYLOCENTROTUS-DROEBACHIENSIS; LAMINARIA-HYPERBOREA; SPECIES DISTRIBUTION; MODEL SELECTION; FOREST RECOVERY; BARREN GROUNDS; ECOLOGY; GROWTH; STABILITY; COMMUNITY	The spatial distribution of kelp (Laminaria hyperborea) and sea urchins (Strongylocentrotus droebachiensis) in the NE Atlantic are highly related to physical factors and to temporal changes in temperature. On a large scale, we identified borders for kelp recovery and sea urchin persistence along the north-south gradient. Sea urchin persistence was also related to the coast-ocean gradient. The southern border corresponds to summer temperatures exceeding about 10 degrees C, a threshold value known to be critical for sea urchin recruitment and development. The outer border along the coast-ocean gradient is related to temperature, wave exposure and salinity. On a finer scale, kelp recovery occurs mainly at ridges in outer, wave exposed, saline and warm areas whereas sea urchins still dominate in inner, shallow and cold areas, particularly in areas with optimal current speed for sea urchin foraging. In contrast to other studies in Europe, we here show a positive influence of climate change to presence of a long-lived climax canopy-forming kelp. The extent of the coast-ocean gradient varies within the study area, and is especially wide in the southern part where the presence of islands and skerries increases the area of the shallow coastal zone. This creates a large area with intermediate physical conditions for the two species and a mosaic of kelp and sea urchin dominated patches. The statistical models (GAM and BRT) show high performance and indicate recovery of kelp in 45-60% of the study area. The study shows the value of combining a traditional (GAM) and a more complex (BRT) modeling approach to gain insight into complex spatial patterns of species or habitats. The results, methods and approaches are of general ecological relevance regardless of ecosystems and species, although they are particularly relevant for understanding and exploring the corresponding changes between algae and grazers in different coastal areas.	[Rinde, Eli; Christie, Hartvig; Fagerli, Camilla W.; Bekkby, Trine; Gundersen, Hege; Norderhaug, Kjell Magnus; Hjermann, Dag O.] Norwegian Inst Water Res, Sect Marine Biol, Oslo, Norway; [Fagerli, Camilla W.; Gundersen, Hege; Norderhaug, Kjell Magnus] Univ Oslo, Dept Biosci, Oslo, Norway; [Bekkby, Trine] Univ Oslo, Nat Hist Museum, Oslo, Norway	Norwegian Institute for Water Research (NIVA); University of Oslo; University of Oslo	Rinde, E (corresponding author), Norwegian Inst Water Res, Sect Marine Biol, Oslo, Norway.	eli.rinde@niva.no	Gundersen, Hege/F-1494-2013; Bekkby, Trine/GRY-2922-2022	Gundersen, Hege/0000-0001-9706-1325; Bekkby, Trine/0000-0001-8188-8264; Rinde, Eli/0000-0002-5960-3725; Fagerli, Camilla With/0000-0003-2855-7524	Directorate for Nature management and data from a national program on mapping of marine biodiversity; Ministry of the Environment and Ministry of Fisheries and Coastal Affairs; Research council of Norway [Vega2045]; Norwegian Institute for Water Research	Directorate for Nature management and data from a national program on mapping of marine biodiversity; Ministry of the Environment and Ministry of Fisheries and Coastal Affairs; Research council of Norway(Research Council of Norway); Norwegian Institute for Water Research	The study is based on field data sampled in projects financed by the Directorate for Nature management and data from a national program on mapping of marine biodiversity (financed by Ministry of the Environment and Ministry of Fisheries and Coastal Affairs). Part of the analysis is funded by the Research council of Norway trough the research project Vega2045. Time to write the paper is funded by Norwegian Institute for Water Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balch T, 2001, ECHINOD ST, V6, P1; Barton K., 2012, MUMIN MULTIMODEL INF; Bekkby T, 2009, ICES J MAR SCI, V66, P2106, DOI 10.1093/icesjms/fsp195; BOLTON JJ, 1982, MAR BIOL, V66, P89, DOI 10.1007/BF00397259; Brattegard T, 2011, 82011 NORW DIR NAT; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Cameron A, 2011, EUSEAMAP PREPARATORY; CHAPMAN ARO, 1981, MAR BIOL, V62, P307, DOI 10.1007/BF00397697; Christie H, 2003, J MAR BIOL ASSOC UK, V83, P687, DOI 10.1017/S0025315403007653h; Clemente S, 2013, MAR BIOL, V160, P579, DOI 10.1007/s00227-012-2114-3; DAYTON PK, 1985, ANNU REV ECOL SYST, V16, P215, DOI 10.1146/annurev.es.16.110185.001243; Downie AL, 2013, ESTUAR COAST SHELF S, V121, P8, DOI 10.1016/j.ecss.2012.12.020; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; ESTES JA, 1995, ECOL MONOGR, V65, P75, DOI 10.2307/2937159; Estes JA, 2013, B MAR SCI, V89, P11, DOI 10.5343/bms.2011.1122; Fagerli CW, 2014, MAR ECOL PROG SER, V502, P207, DOI 10.3354/meps10701; Fagerli CW, 2013, MAR ECOL PROG SER, V488, P119, DOI 10.3354/meps10413; Falk W, 2011, J VEG SCI, V22, P621, DOI 10.1111/j.1654-1103.2011.01294.x; Falk-Petersen I-B, 1983, SARSIA, V68, P7; Freeman EA, 2008, J STAT SOFTW, V23, P1; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Gorman D, 2013, MAR BIOL, V160, P309, DOI 10.1007/s00227-012-2089-0; Guisan A, 2007, ECOL MONOGR, V77, P615, DOI 10.1890/06-1060.1; HAGEN NT, 1987, SARSIA, V72, P213, DOI 10.1080/00364827.1987.10419719; HAGEN NT, 1983, SARSIA, V68, P177, DOI 10.1080/00364827.1983.10420570; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Hijmans R.J., 2011, DISMO SPECIES DISTRI; HIMMELMAN JH, 1983, OECOLOGIA, V59, P27, DOI 10.1007/BF00388068; JACKSON GA, 1977, J PHYCOL, V13, P32; KAIN J M, 1971, FAO (Food and Agriculture Organization of the United Nations) Fisheries Synopsis, V87, P1; KAIN JM, 1971, J MAR BIOL ASSOC UK, V51, P387, DOI 10.1017/S0025315400031866; Kawamata S, 1998, J EXP MAR BIOL ECOL, V224, P31, DOI 10.1016/S0022-0981(97)00165-2; KEATS DW, 1990, MAR ECOL PROG SER, V68, P181, DOI 10.3354/meps068181; Konar B, 2003, ECOLOGY, V84, P174, DOI 10.1890/0012-9658(2003)084[0174:TSOBRB]2.0.CO;2; Krumhansl KA, 2012, MAR ECOL PROG SER, V467, P281, DOI 10.3354/meps09940; LANGE R, 1964, COMP BIOCHEM PHYSIOL, V13, P205, DOI 10.1016/0010-406X(64)90117-3; Lauzon-Guay JS, 2010, MAR ECOL PROG SER, V403, P29, DOI 10.3354/meps08494; Lauzon-Guay JS, 2009, MAR ECOL PROG SER, V375, P25, DOI 10.3354/meps07758; Lee CT, 2008, NAT HAZARD EARTH SYS, V8, P941, DOI 10.5194/nhess-8-941-2008; Leinaas HP, 1996, OECOLOGIA, V105, P524, DOI 10.1007/BF00330016; Lindley JA, 2002, J MAR BIOL ASSOC UK, V82, P31, DOI 10.1017/S0025315402005155; Lobban C.S., 1994, SEAWEED ECOLOGY PHYS; LUNING K, 1986, BRIT PHYCOL J, V21, P269; Martinez-Rincon RO, 2012, ECOL MODEL, V233, P20, DOI 10.1016/j.ecolmodel.2012.03.006; Mass T, 2010, P NATL ACAD SCI USA, V107, P2527, DOI 10.1073/pnas.0912348107; Miller SM, 2011, J PHYCOL, V47, P505, DOI 10.1111/j.1529-8817.2011.00966.x; Nilsen JEO, 2006, PROG OCEANOGR, V70, P58, DOI 10.1016/j.pocean.2006.03.014; Norderhaug KM, 2011, ESTUAR COAST SHELF S, V95, P135, DOI 10.1016/j.ecss.2011.08.028; Norderhaug KM, 2009, MAR BIOL RES, V5, P515, DOI 10.1080/17451000902932985; Norderhaug KN, 2005, J MAR BIOL ASSOC UK, V85, P1279, DOI 10.1017/S0025315405012439; Ottersen G, 2010, ICES J MAR SCI, V67, P1525, DOI 10.1093/icesjms/fsq099; Pedersen MF, 2012, MAR ECOL PROG SER, V451, P45, DOI 10.3354/meps09594; R Core Team, 2021, R LANGUAGE ENV STAT; Raybaud V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066044; Rinde E, 2005, MAR BIOL, V146, P1051, DOI 10.1007/s00227-004-1513-5; Rinde E, 2007, THESIS U OSLO NORWAY; ROLLER RA, 1994, CAN J ZOOL, V72, P1931, DOI 10.1139/z94-262; SCHEIBLING R, 1986, OECOLOGIA, V68, P186, DOI 10.1007/BF00384786; SCHEIBLING RE, 1991, MAR BIOL, V110, P105, DOI 10.1007/BF01313097; Siikavuopio SI, 2006, AQUACULTURE, V255, P389, DOI 10.1016/j.aquaculture.2005.12.021; Siikavuopio SI, 2012, AQUACULTURE, V354, P27, DOI 10.1016/j.aquaculture.2012.04.036; Sivertsen K, 1997, CAN J FISH AQUAT SCI, V54, P2872, DOI 10.1139/cjfas-54-12-2872; Sivertsen K, 1982, 782 NORDL; Sjotun K, 2006, MAR BIOL RES, V2, P24, DOI 10.1080/17451000500537418; SJOTUN K, 1995, MAR ECOL PROG SER, V126, P213, DOI 10.3354/meps126213; SKADSHEIM A, 1995, MAR ECOL PROG SER, V119, P199, DOI 10.3354/meps119199; Smale DA, 2013, ECOL EVOL, V3, P4016, DOI 10.1002/ece3.774; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Steneck RS, 2004, ECOSYSTEMS, V7, P323, DOI 10.1007/s10021-004-0240-6; STEPHENS RE, 1972, BIOL BULL, V142, P132, DOI 10.2307/1540251; Stewart Nathan L., 2012, Journal of Marine Biology, P1; Tegner MJ, 1997, MAR ECOL PROG SER, V146, P117, DOI 10.3354/meps146117; Woll AK, 2006, ICES J MAR SCI, V63, P421, DOI 10.1016/j.icesjms.2005.10.004; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x	75	41	42	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100222	10.1371/journal.pone.0100222	http://dx.doi.org/10.1371/journal.pone.0100222			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949954	Green Published, gold			2022-12-27	WOS:000338276300051
J	Zhou, Y; Wang, DY; Gao, XF; Lew, K; Richards, AM; Wang, PP				Zhou, Yue; Wang, Daying; Gao, Xiufang; Lew, Karsheng; Richards, Arthur Mark; Wang, Peipei			mTORC2 Phosphorylation of Akt1: A Possible Mechanism for Hydrogen Sulfide-Induced Cardioprotection	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; PERMEABILITY TRANSITION PORE; HEART; KINASE; BAX; INHIBITOR; PROTECTS; SURVIVAL; GROWTH; MITOCHONDRIAL	Hydrogen sulfide (H2S) is known to have cardiac protective effects through Akt activation. Akt acts as a 'central sensor' for myocyte survival or death; its activity is regulated by multiple kinases including PI3K, mTORC2, PDK1 and phosphatases including PTEN, PP2A and PHLPPL. Based on the previous finding that PI3K inhibitor LY294002 abolishes H2S-induced Akt phosphorylation and cardioprotection, it is accepted that PI3K is the mediator of H2S-induced Akt phosphorylation. However, LY294002 inhibits both PI3K and mTOR, and PI3K only recruits Akt to the membrane where Akt is phosphorylated by Akt kinases. We undertook a series of experiments to further evaluate the role of mTORC2, PDK1, PTEN, PP2A and PHLPPL in H2S-induced Akt phosphorylation and cardioprotection, which, we believe, has not been investigated before. Hearts from adult Sprague-Dawley rats were isolated and subjected to (i) normoxia, (ii) global ischemia and (iii) ischemia/reperfusion in the presence or absence of 50 mu M of H2S donor NaHS. Cardiac mechanical function and lactate dehydrogenase (LDH) release were assessed. All hearts also were Western analyzed at the end of perfusion for Akt and a panel of appropriate Akt regulators and targets. Hearts pretreated with 50 mM NaHS had improved function at the end of reperfusion (Rate pressure product; 19 +/- 4x10(3) vs. 10 +/- 3x10(3) mmHg/min, p < 0.05) and reduced cell injury (LDH release 19 +/- 10 vs. 170 +/- 87 mU/ml p<0.05) compared to untreated hearts. NaHS significantly increased phospho-Akt, phospho-mTOR, phospho-Bim and Bcl-2 in reperfused hearts (P<0.05). Furthermore using H9c2 cells we demonstrate that NaHS pretreatment reduces apoptosis following hypoxia/re-oxygenation. Importantly, PP242, a specific mTOR inhibitor, abolished both cardioprotection and protein phosphorylation in isolated heart and reduced apoptotic effects in H9c2 cells. Treating hearts with NaHS only during reperfusion produced less cardioprotection through a similar mechanism. These data suggest mTORC2 phosphorylation of Akt is a key mediator of H2S-induced cardioprotection in I/R.	[Zhou, Yue; Lew, Karsheng; Richards, Arthur Mark; Wang, Peipei] Natl Univ Singapore, Cardiovasc Res Inst, Singapore 117548, Singapore; [Wang, Daying] Putuo Hosp, Dept Cardiol, Shanghai, Peoples R China; [Gao, Xiufang] Fudan Univ, Huashan Hosp, Dept Cardiol, Shanghai 200433, Peoples R China	National University of Singapore; Fudan University	Wang, PP (corresponding author), Natl Univ Singapore, Cardiovasc Res Inst, Singapore 117548, Singapore.	mdcwp@nus.edu.sg		Lew, Jason/0000-0002-6838-9900; Wang, Peipei/0000-0002-3768-7833; Zhou, Yue/0000-0002-7184-9920	Cardiovascular Research Institute Start-up Fund (National University of Singapore, Singapore); NMRC Centre Grant (National Medical Research Council, Ministry of Health, Singapore)	Cardiovascular Research Institute Start-up Fund (National University of Singapore, Singapore); NMRC Centre Grant (National Medical Research Council, Ministry of Health, Singapore)	The present work was supported by Cardiovascular Research Institute Start-up Fund (National University of Singapore, Singapore) and NMRC Centre Grant (National Medical Research Council, Ministry of Health, Singapore). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 1996, J NEUROSCI, V16, P1066; Aoyagi T, 2012, AM J PHYSIOL-HEART C, V303, pH75, DOI 10.1152/ajpheart.00241.2012; Ballou LM, 2007, J BIOL CHEM, V282, P24463, DOI 10.1074/jbc.M704741200; Bar N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010859; Bian JS, 2006, J PHARMACOL EXP THER, V316, P670, DOI 10.1124/jpet.105.092023; Bliksoen M, 2008, EUR J CARDIO-THORAC, V34, P344, DOI 10.1016/j.ejcts.2008.03.017; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Chen L, 2007, CHINESE MED J-PEKING, V120, P389, DOI 10.1097/00029330-200703010-00008; Chung EJ, 2010, INVEST OPHTH VIS SCI, V51, P6232, DOI 10.1167/iovs.10-5747; Das S, 2005, AM J PHYSIOL-HEART C, V288, pH328, DOI 10.1152/ajpheart.00453.2004; Degrande ST, 2012, J BIOL CHEM; Di Lisa F, 2001, J BIOL CHEM, V276, P2571, DOI 10.1074/jbc.M006825200; Eden M, 2013, CIRCULATION, V128; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Garofalo RS, 2003, J CLIN INVEST, V112, P197, DOI 10.1172/JCI200316885; Geng B, 2004, BIOCHEM BIOPH RES CO, V318, P756, DOI 10.1016/j.bbrc.2004.04.094; Gharbi SI, 2007, BIOCHEM J, V404, P15, DOI 10.1042/BJ20061489; Gurusamy N, 2010, CARDIOVASC RES, V86, P103, DOI 10.1093/cvr/cvp384; Harada H, 2004, P NATL ACAD SCI USA, V101, P15313, DOI 10.1073/pnas.0406837101; Hausenloy DJ, 2004, CARDIOVASC RES, V61, P448, DOI 10.1016/j.cardiores.2003.09.024; Hochhauser E, 2003, AM J PHYSIOL-HEART C, V284, pH2351, DOI 10.1152/ajpheart.00783.2002; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Hu Y, 2008, PFLUG ARCH EUR J PHY, V455, P607, DOI 10.1007/s00424-007-0321-4; Hwang SK, 2011, BMB REP, V44, P506, DOI 10.5483/BMBRep.2011.44.8.506; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Kelly PN, 2011, CELL DEATH DIFFER, V18, P1414, DOI 10.1038/cdd.2011.17; Matsui T, 1999, CIRCULATION, V100, P2373, DOI 10.1161/01.CIR.100.23.2373; Meller R, 2009, NEUROSCIENTIST, V15, P243, DOI 10.1177/1073858408327809; Narita M, 1998, P NATL ACAD SCI USA, V95, P14681, DOI 10.1073/pnas.95.25.14681; Osipov RM, 2009, J CARDIOVASC PHARM, V54, P287, DOI 10.1097/FJC.0b013e3181b2b72b; Pan LL, 2011, AMINO ACIDS, V41, P205, DOI 10.1007/s00726-011-0834-1; Persad S, 2001, J BIOL CHEM, V276, P27462, DOI 10.1074/jbc.M102940200; Salloum FN, 2009, CIRCULATION, V120, pS31, DOI 10.1161/CIRCULATIONAHA.108.843979; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sen U, 2008, PHARMACOLOGY, V82, P201, DOI 10.1159/000156486; Tsukamoto Y, 2010, CANCER RES, V70, P2339, DOI 10.1158/0008-5472.CAN-09-2777; Walsh K, 2006, CIRCULATION, V113, P2032, DOI 10.1161/CIRCULATIONAHA.106.615138; Wang PP, 2007, J PHARMACOL EXP THER, V321, P213, DOI 10.1124/jpet.106.115519; Wang PP, 2008, LIFE SCI, V83, P836, DOI 10.1016/j.lfs.2008.09.024; Wang PP, 2005, CIRCULATION, V111, P2066, DOI 10.1161/01.CIR.0000162466.06150.D4; Whiteman M, 2009, J CELL MOL MED, V13, P488, DOI 10.1111/j.1582-4934.2009.00645.x; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Yong QC, 2008, AM J PHYSIOL-HEART C, V295, pH1330, DOI 10.1152/ajpheart.00244.2008	46	90	96	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e99665	10.1371/journal.pone.0099665	http://dx.doi.org/10.1371/journal.pone.0099665			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949720	gold, Green Published, Green Submitted			2022-12-27	WOS:000338276300017
J	Blodorn, K; Hagglund, S; Fix, J; Dubuquoy, C; Makabi-Panzu, B; Thom, M; Karlsson, P; Roque, JL; Karlstam, E; Pringle, J; Eleouet, JF; Riffault, S; Taylor, G; Valarcher, JF				Blodorn, Krister; Hagglund, Sara; Fix, Jenna; Dubuquoy, Catherine; Makabi-Panzu, Boby; Thom, Michelle; Karlsson, Per; Roque, Jean-Louis; Karlstam, Erika; Pringle, John; Eleouet, Jean-Francois; Riffault, Sabine; Taylor, Geraldine; Valarcher, Jean Francois			Vaccine Safety and Efficacy Evaluation of a Recombinant Bovine Respiratory Syncytial Virus (BRSV) with Deletion of the SH Gene and Subunit Vaccines Based On Recombinant Human RSV Proteins: N-nanorings, P and M2-1, in Calves with Maternal Antibodies	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; FUSION GLYCOPROTEIN; GNOTOBIOTIC CALVES; PROTECTIVE IMMUNITY; CROSS-PRESENTATION; SEQUENCE-ANALYSIS; VIRAL-INFECTION; MESSENGER-RNA; COTTON RATS; DISEASE	The development of safe and effective vaccines against both bovine and human respiratory syncytial viruses (BRSV, HRSV) to be used in the presence of RSV-specific maternally-derived antibodies (MDA) remains a high priority in human and veterinary medicine. Herein, we present safety and efficacy results from a virulent BRSV challenge of calves with MDA, which were immunized with one of three vaccine candidates that allow serological differentiation of infected from vaccinated animals (DIVA): an SH gene-deleted recombinant BRSV (Delta SHrBRSV), and two subunit (SU) formulations based on HRSV-P, -M2- 1, and -N recombinant proteins displaying BRSV-F and -G epitopes, adjuvanted by either oil emulsion (Montanide ISA71(VG), SUMont) or immunostimulating complex matrices (AbISCO-300, SUAbis). Whereas all control animals developed severe respiratory disease and shed high levels of virus following BRSV challenge, Delta SHrBRSV-immunized calves demonstrated almost complete clinical and virological protection five weeks after a single intranasal vaccination. Although mucosal vaccination with DSHrBRSV failed to induce a detectable immunological response, there was a rapid and strong anamnestic mucosal BRSV-specific IgA, virus neutralizing antibody and local T cell response following challenge with virulent BRSV. Calves immunized twice intramuscularly, three weeks apart with SUMont were also well protected two weeks after boost. The protection was not as pronounced as that in Delta SHrBRSV-immunized animals, but superior to those immunized twice subcutaneously three weeks apart with SUAbis. Antibody responses induced by the subunit vaccines were non-neutralizing and not directed against BRSV F or G proteins. When formulated as SUMont but not as SUAbis, the HRSV N, P and M2-1 proteins induced strong systemic cross-protective cell-mediated immune responses detectable already after priming. Delta SHrBRSV and SUMont are two promising DIVA-compatible vaccines, apparently inducing protection by different immune responses that were influenced by vaccine-composition, immunization route and regimen.	[Blodorn, Krister; Hagglund, Sara; Pringle, John; Valarcher, Jean Francois] Swedish Univ Agr Sci, Host Pathogen Interact Grp, Dept Clin Sci, Uppsala, Sweden; [Fix, Jenna; Dubuquoy, Catherine; Eleouet, Jean-Francois; Riffault, Sabine] INRA, Unite Virol & Immunol Mol, Jouy en Josas, France; [Makabi-Panzu, Boby; Thom, Michelle; Taylor, Geraldine] Pirbright Inst, Pirbright, Surrey, England; [Karlsson, Per; Valarcher, Jean Francois] Natl Vet Inst, Dept Virol Immunol & Parasitol, S-75007 Uppsala, Sweden; [Roque, Jean-Louis] Clin Vet Mazets, Riom Es Montagnes, France; [Karlstam, Erika] Natl Vet Inst, Dept Pathol & Wildlife Dis, S-75007 Uppsala, Sweden	Swedish University of Agricultural Sciences; INRAE; UDICE-French Research Universities; Universite Paris Saclay; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; National Veterinary Institute SVA; National Veterinary Institute SVA	Hagglund, S (corresponding author), Swedish Univ Agr Sci, Host Pathogen Interact Grp, Dept Clin Sci, Uppsala, Sweden.	sara.hagglund@slu.se	Eléouët, Jean-François/AAD-1994-2019; Hägglund, Sara/AAE-4867-2020; Pringle, John/E-8332-2019; VALARCHER, JEAN FRANCOIS/AAE-4857-2020	Hägglund, Sara/0000-0002-6983-5722; Pringle, John/0000-0003-4013-0363; VALARCHER, JEAN FRANCOIS/0000-0002-8564-5603; Thom, Michelle/0000-0002-5678-8760; ELeouet, Jean-Francois/0000-0002-7361-4885	Swedish Research Council (Formas, Sweden); Biotechnology and Biological Sciences Research Council (BBSRC, UK); L'Agence Nationale de la Recherche (ANR, France), through EMIDA ERA NET [87]; BBSRC [BBS/E/I/00001325, BB/I017216/1, BBS/E/I/00001709] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001325, BBS/E/I/00001709, BB/I017216/1] Funding Source: researchfish	Swedish Research Council (Formas, Sweden); Biotechnology and Biological Sciences Research Council (BBSRC, UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); L'Agence Nationale de la Recherche (ANR, France), through EMIDA ERA NET(French National Research Agency (ANR)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Swedish Research Council (Formas, Sweden), the Biotechnology and Biological Sciences Research Council (BBSRC, UK), and L'Agence Nationale de la Recherche (ANR, France), through EMIDA ERA NET (Grant no FP#87). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. (http://www.formas.se/; http://www.bbsrc.ac.uk/; http://www.agence-nationale-recherche.fr/; http://emida-era.net/).	Antonis AFG, 2003, J VIROL, V77, P12067, DOI 10.1128/JVI.77.22.12067-12073.2003; ARBIZA J, 1992, J GEN VIROL, V73, P2225, DOI 10.1099/0022-1317-73-9-2225; Aucouturier J, 2001, VACCINE, V19, P2666, DOI 10.1016/S0264-410X(00)00498-9; Bastien N, 1997, VACCINE, V15, P1385, DOI 10.1016/S0264-410X(97)00033-9; Belyakov IM, 2009, J IMMUNOL, V183, P6883, DOI 10.4049/jimmunol.0901466; BRYSON DG, 1993, VET MED-US, V88, P894; Buchholz UJ, 2000, J VIROL, V74, P1187, DOI 10.1128/JVI.74.3.1187-1199.2000; Castagne N, 2004, J GEN VIROL, V85, P1643, DOI 10.1099/vir.0.79830-0; Chargelegue D, 1998, J VIROL, V72, P2040, DOI 10.1128/JVI.72.3.2040-2046.1998; Chase CCL, 2008, VET CLIN N AM-FOOD A, V24, P87, DOI 10.1016/j.cvfa.2007.11.001; Duewell P, 2011, J IMMUNOL; Ellis J, 2007, JAVMA-J AM VET MED A, V230, P233, DOI 10.2460/javma.230.2.233; Ellis JA, 2013, JAVMA-J AM VET MED A, V243, P1602, DOI 10.2460/javma.243.11.1602; Fogg MH, 2001, VACCINE, V19, P3226, DOI 10.1016/S0264-410X(01)00030-5; Fulton Robert W., 2009, Animal Health Research Reviews, V10, P131, DOI 10.1017/S146625230999017X; Furze JM, 1997, VIROLOGY, V231, P48, DOI 10.1006/viro.1997.8490; Gaddum RM, 2003, IMMUNOLOGY, V108, P220, DOI 10.1046/j.1365-2567.2003.01566.x; Hagglund S, 2004, VACCINE, V23, P646, DOI 10.1016/j.vaccine.2004.07.006; Hagglund S, 2014, CLIN VACCINE IMMUNOL, V21, P997, DOI 10.1128/CVI.00162-14; Hagglund S, 2011, VACCINE, V29, P8719, DOI 10.1016/j.vaccine.2011.07.146; Herve PL, 2014, J VIROL, V88, P325, DOI 10.1128/JVI.01141-13; Karger A, 2001, J GEN VIROL, V82, P631, DOI 10.1099/0022-1317-82-3-631; Karron RA, 2005, J INFECT DIS, V191, P1093, DOI 10.1086/427813; KENNEDY HE, 1988, J GEN VIROL, V69, P3023, DOI 10.1099/0022-1317-69-12-3023; KIM HW, 1969, AM J EPIDEMIOL, V89, P422, DOI 10.1093/oxfordjournals.aje.a120955; KIMMAN TG, 1989, VET QUART, V11, P250, DOI 10.1080/01652176.1989.9694231; KIMMAN TG, 1989, VET IMMUNOL IMMUNOP, V22, P145, DOI 10.1016/0165-2427(89)90057-3; KIMMAN TG, 1988, VET REC, V123, P104, DOI 10.1136/vr.123.4.104; KIMMAN TG, 1987, J CLIN MICROBIOL, V25, P1097, DOI 10.1128/JCM.25.6.1097-1106.1987; Larsen LE, 1998, VET MICROBIOL, V62, P265, DOI 10.1016/S0378-1135(98)00226-0; MALLIPEDDI SK, 1992, J GEN VIROL, V73, P2441, DOI 10.1099/0022-1317-73-9-2441; McLellan JS, 2013, SCIENCE, V342, P592, DOI 10.1126/science.1243283; McLellan JS, 2011, J VIROL, V85, P7788, DOI 10.1128/JVI.00555-11; Meyer G, 2008, COMP IMMUNOL MICROB, V31, P191, DOI 10.1016/j.cimid.2007.07.008; MOHANTY SB, 1975, AM J VET RES, V36, P417; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Paton DJ, 2006, VACCINE, V24, P6503, DOI 10.1016/j.vaccine.2006.06.032; PIAZZA FM, 1993, J VIROL, V67, P1503, DOI 10.1128/JVI.67.3.1503-1510.1993; Riffault S, 2010, VACCINE, V28, P3722, DOI 10.1016/j.vaccine.2010.03.008; Robson NC, 2008, EUR J IMMUNOL, V38, P1238, DOI 10.1002/eji.200737758; Roux X, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001766; Rudraraju R, 2013, VIRUSES-BASEL, V5, P577, DOI 10.3390/v5020577; SAMAL SK, 1991, VIROLOGY, V180, P453, DOI 10.1016/0042-6822(91)90057-I; Schnurr M, 2009, J IMMUNOL, V182, P1253, DOI 10.4049/jimmunol.182.3.1253; Schreiber P, 2000, J VET MED B, V47, P535, DOI 10.1046/j.1439-0450.2000.00380.x; Seiffert SN, 2013, DRUG RESIST UPDATE, V16, P22, DOI 10.1016/j.drup.2012.12.001; STOTT EJ, 1980, J HYG-CAMBRIDGE, V85, P257, DOI 10.1017/S0022172400063294; Tawar RG, 2009, SCIENCE, V326, P1279, DOI 10.1126/science.1177634; TAYLOR G, 1995, J VIROL, V69, P6658, DOI 10.1128/JVI.69.11.6658-6664.1995; Taylor G, 2005, VACCINE, V23, P1242, DOI 10.1016/j.vaccine.2004.09.005; Taylor G, 1997, J GEN VIROL, V78, P3195, DOI 10.1099/0022-1317-78-12-3195; Taylor G, 2014, J GEN VIROL, V95, P1244, DOI 10.1099/vir.0.064931-0; THOMAS LH, 1982, RES VET SCI, V33, P170, DOI 10.1016/S0034-5288(18)32331-2; THOMAS LH, 1984, ARCH VIROL, V79, P67, DOI 10.1007/BF01314304; Thomas LH, 1998, J INFECT DIS, V177, P874, DOI 10.1086/515234; Tran TL, 2007, J GEN VIROL, V88, P196, DOI 10.1099/vir.0.82282-0; Tran TL, 2009, J VIROL, V83, P6363, DOI 10.1128/JVI.00335-09; Uttenthal A, 2000, VET MICROBIOL, V76, P329, DOI 10.1016/S0378-1135(00)00261-3; Valarcher JF, 2007, VET RES, V38, P153, DOI 10.1051/vetres:2006053; Valarcher JF, 2000, J VIROL, V74, P10714, DOI 10.1128/JVI.74.22.10714-10728.2000; Valarcher JF, 2003, J VIROL, V77, P8426, DOI 10.1128/JVI.77.15.8426-8439.2003; Viuff B, 1996, VET PATHOL, V33, P383, DOI 10.1177/030098589603300403; WALSH EE, 1987, J INFECT DIS, V155, P1198, DOI 10.1093/infdis/155.6.1198; WESTENBRINK F, 1989, J GEN VIROL, V70, P591, DOI 10.1099/0022-1317-70-3-591; Wu SJ, 2007, J GEN VIROL, V88, P2719, DOI 10.1099/vir.0.82753-0; ZAMORA M, 1992, J GEN VIROL, V73, P737, DOI 10.1099/0022-1317-73-3-737	66	26	27	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100392	10.1371/journal.pone.0100392	http://dx.doi.org/10.1371/journal.pone.0100392			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945377	Green Published, Green Submitted, gold			2022-12-27	WOS:000340721500069
J	Erdelyi, M; Simon, J; Barnard, EA; Kaminski, CF				Erdelyi, Miklos; Simon, Joseph; Barnard, Eric A.; Kaminski, Clemens F.			Analyzing Receptor Assemblies in the Cell Membrane Using Fluorescence Anisotropy Imaging with TIRF Microscopy	PLOS ONE			English	Article							P2Y(1) RECEPTOR; QUANTITATIVE PROTOCOL; INTERNATIONAL UNION; SIGNALING COMPLEXES; HOMO-FRET; PROTEIN; PHARMACOLOGY; DIMERIZATION; ACTIVATION; CHANNEL	Signaling within and between animal cells is controlled by the many receptor proteins in their membrane. They variously operate as trans-membrane monomers and homo-or hetero-dimers, and may assemble with ion-channels: analyses thereof are needed in studies of receptor actions in tissue physiology and pathology. Interactions between membrane proteins are detectable when pre-labeled with fluorophores, but a much fuller analysis is achievable via advanced optical techniques on living cells. In this context, the measurement of polarization anisotropy in the emitted fluorescence has been the least exploited. Here we demonstrate its methodology and particular advantages in the study of receptor protein assembly. Through excitation in both TIRF and EPI fluorescence illumination modes we are able to quantify and suppress contributions to the signal from extraneous intra-cellular fluorescence, and we show that the loss of fluorescence-polarization measured in membrane proteins reports on receptor protein assembly in real time. Receptor monomers and homo-dimers in the cell membrane can be analyzed quantitatively and for homo-dimers only a single fluorescent marker is needed, thus suppressing ambiguities that arise in alternative assays, which require multiple label moieties and which are thus subject to stoichiometric uncertainty.	[Erdelyi, Miklos; Kaminski, Clemens F.] Univ Cambridge, Dept Chem Engn & Biotechnol, Cambridge, England; [Erdelyi, Miklos] Natl Phys Lab, Analyt Sci Div, Teddington TW11 0LW, Middx, England; [Simon, Joseph; Barnard, Eric A.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1QJ, England; [Erdelyi, Miklos] Univ Szeged, Dept Opt & Quantum Elect, Szeged, Hungary	University of Cambridge; National Physical Laboratory - UK; University of Cambridge; Szeged University	Kaminski, CF (corresponding author), Univ Cambridge, Dept Chem Engn & Biotechnol, Cambridge, England.	cfk23@cam.ac.uk	Kaminski, Clemens/G-7488-2016	Kaminski, Clemens/0000-0002-5194-0962	Wellcome Trust [089703/Z/09/Z]; Medical Research Council [MR/K015850/1, MR/K02292X/1]; Alzheimer Research UK Trust [ARUK-EG2012A-1]; Engineering and Physical Science Research Council [EP/H018301/1]; Marie-Curie [PCIG13-GA-2013-618273]; NMS (National Measurement Systems); Bolyai Janos fellowship; Alzheimers Research UK [ARUK-EG2012A-1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/H018301/1] Funding Source: researchfish; EPSRC [EP/H018301/1] Funding Source: UKRI; MRC [MR/K02292X/1, MR/K015850/1] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimer Research UK Trust(Alzheimer's Research UK (ARUK)); Engineering and Physical Science Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Marie-Curie(European Commission); NMS (National Measurement Systems); Bolyai Janos fellowship(Hungarian Academy of Sciences); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the Wellcome Trust (089703/Z/09/Z), the Medical Research Council (MR/K015850/1 and MR/K02292X/1), the Alzheimer Research UK Trust (ARUK-EG2012A-1), the Engineering and Physical Science Research Council (EP/H018301/1), Marie-Curie (PCIG13-GA-2013-618273), NMS (National Measurement Systems), and the Bolyai Janos fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbracchio MP, 2006, PHARMACOL REV, V58, P281, DOI 10.1124/pr.58.3.3; Ai HW, 2006, BIOCHEM J, V400, P531, DOI 10.1042/BJ20060874; Altier C, 2008, J RECEPT SIG TRANSD, V28, P71, DOI 10.1080/10799890801941947 ; AXELROD D, 1979, BIOPHYS J, V26, P557, DOI 10.1016/S0006-3495(79)85271-6; Axelrod D., 2007, SPRINGER SERIES OPTI, V87; Bockaert J, 2003, FEBS LETT, V546, P65, DOI 10.1016/S0014-5793(03)00453-8; Chan FTS, 2011, CHEMPHYSCHEM, V12, P500, DOI 10.1002/cphc.201000833; Choi RCY, 2008, J BIOL CHEM, V283, P11050, DOI 10.1074/jbc.M709266200; Chung I, 2010, NATURE, V464, P783, DOI 10.1038/nature08827; Dietz MS, 2013, BMC BIOPHYS, V6, DOI 10.1186/2046-1682-6-6; Digman MA, 2008, BIOPHYS J, V94, P2819, DOI 10.1529/biophysj.107.104984; Digman MA, 2008, BIOPHYS J, V94, P2320, DOI 10.1529/biophysj.107.114645; DIX JA, 1990, BIOPHYS J, V57, P231, DOI 10.1016/S0006-3495(90)82526-1; Doupnik CA, 2008, J RECEPT SIG TRANSD, V28, P83, DOI [10.1080/10799890801941970, 10.1080/10799890801941970 ]; Elder AD, 2009, J R SOC INTERFACE, V6, pS59, DOI 10.1098/rsif.2008.0381.focus; Elder A, 2008, J OPT SOC AM A, V25, P452, DOI 10.1364/JOSAA.25.000452; Esposito A, 2011, OPT EXPRESS, V19, P2546, DOI 10.1364/OE.19.002546; Filippov AK, 2000, BRIT J PHARMACOL, V129, P1063, DOI 10.1038/sj.bjp.0703185; Fujimoto Y., 2007, US patent, Patent No. [US 7,199,938 B2, 7199938]; Gautier I, 2001, BIOPHYS J, V80, P3000, DOI 10.1016/S0006-3495(01)76265-0; Hastie P, 2013, P NATL ACAD SCI USA, V110, P5163, DOI 10.1073/pnas.1218765110; Kaminski CF, 2014, METHODS MOL BIOL, V1076, P445, DOI 10.1007/978-1-62703-649-8_19; Kim HS, 2003, J MED CHEM, V46, P4974, DOI 10.1021/jm030127+; Lakowicz R. J., 2006, PRINCIPLES FLUORESCE, V3rd; Lidke DS, 2003, BIOCHEM SOC T, V31, P1020; Lin H, 2013, NAT METHODS, V10, P140, DOI [10.1038/NMETH.2324, 10.1038/nmeth.2324]; Lohse MJ, 2012, PHARMACOL REV, V64, P299, DOI 10.1124/pr.110.004309; Optics Reference, 2001, OSLO OPT SOFTW VERS; Padilla-Parra S, 2009, BIOPHYS J, V97, P2368, DOI 10.1016/j.bpj.2009.07.044; Pin JP, 2007, PHARMACOL REV, V59, P5, DOI 10.1124/pr.59.1.5; Sengupta P, 2011, NAT METHODS, V8, P969, DOI [10.1038/nmeth.1704, 10.1038/NMETH.1704]; Squire A, 2004, J STRUCT BIOL, V147, P62, DOI 10.1016/j.jsb.2003.10.013; Teramura Y, 2006, EMBO J, V25, P4215, DOI 10.1038/sj.emboj.7601308; van Ham TJ, 2010, J MOL BIOL, V395, P627, DOI 10.1016/j.jmb.2009.10.066; WEBB TE, 1993, FEBS LETT, V324, P219, DOI 10.1016/0014-5793(93)81397-I	35	11	11	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100526	10.1371/journal.pone.0100526	http://dx.doi.org/10.1371/journal.pone.0100526			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945870	Green Submitted, Green Published, gold			2022-12-27	WOS:000340721500086
J	Ghoshal, P; Rajendran, M; Odo, N; Ikuta, T				Ghoshal, Pushpankur; Rajendran, Mythilypriya; Odo, Nadine; Ikuta, Tohru			Glycosylation Inhibitors Efficiently Inhibit P-Selectin-Mediated Cell Adhesion to Endothelial Cells	PLOS ONE			English	Article							INHALED NITRIC-OXIDE; FETAL-HEMOGLOBIN PRODUCTION; GRANULE MEMBRANE-PROTEIN; ACUTE CHEST SYNDROME; RED-BLOOD-CELLS; SICKLE ERYTHROCYTES; IN-VIVO; HYPOXIA-REOXYGENATION; ADHERENT LEUKOCYTES; POTENTIAL ROLE	Adhesion molecules play a critical role in the adhesive interactions of multiple cell types in sickle cell disease (SCD). We previously showed that anti-P-selectin aptamer efficiently inhibits cell adhesion to endothelial cells (ECs) and permits SCD mice to survive hypoxic stress. In an effort to discover new mechanisms with which to inhibit P-selectin, we examined the role of glycosylation. P-selectin is a 90 kDa protein but was found to migrate as 90 and 140 kDa bands on gel electrophoresis. When P-selectin isolated from ECs was digested with peptide N-glycosidase F, but not O-glycosidase, the 140 kDa band was lost and the 90 kDa band was enhanced. Treatment of ECs with tunicamycin, an N-glycosylation inhibitor, suppressed CD62P (P-selectin) expression on the cell surface as well as the 140 kDa form in the cytoplasm. These results indicate that the 140 kDa band is N-glycosylated and glycosylation is critical for cell surface expression of P-selectin in ECs. Thrombin, which stimulates P-selectin expression on ECs, induced AKT phosphorylation, whereas tunicamycin inhibited AKT phosphorylation, suggesting that AKT signaling is involved in the tunicamycin-mediated inhibition of P-selectin expression. Importantly, the adhesion of sickle red blood cells (sRBCs) and leukocytes to ECs induced by thrombin or hypoxia was markedly inhibited by two structurally distinct glycosylation inhibitors; the levels of which were comparable to that of a P-selectin monoclonal antibody which most strongly inhibited cell adhesion in vivo. Knockdown studies of P-selectin using short-hairpin RNAs in ECs suppressed sRBC adhesion, indicating a legitimate role for P-selectin in sRBC adhesion. Together, these results demonstrate that P-selectin expression on ECs is regulated in part by glycosylation mechanisms and that glycosylation inhibitors efficiently reduce the adhesion of sRBCs and leukocytes to ECs. Glycosylation inhibitors may lead to a novel therapy which inhibits cell adhesion in SCD.	[Ghoshal, Pushpankur; Rajendran, Mythilypriya; Odo, Nadine; Ikuta, Tohru] Georgia Regents Univ, Med Coll Georgia, Dept Anesthesiol & Perioperat Med, Augusta, GA 30901 USA	University System of Georgia; Augusta University	Ghoshal, P (corresponding author), Georgia Regents Univ, Med Coll Georgia, Dept Anesthesiol & Perioperat Med, Augusta, GA 30901 USA.	pghoshal@gru.edu; tikuta@gru.edu	Odo, Nadine/AAV-5466-2021	Odo, Nadine/0000-0003-4103-1404	National Institute on Minority Health and Health Disparity [P20 MD003383]; National Institute on Minority Health and Health Disparities [P20MD003383] Funding Source: NIH RePORTER	National Institute on Minority Health and Health Disparity; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This study was supported by a grant from the National Institute on Minority Health and Health Disparity (P20 MD003383 to Tohru Ikuta). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinsheye I, 2011, BLOOD, V118, P19, DOI 10.1182/blood-2011-03-325258; Ataga KI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029786; Atz AM, 1997, ANESTHESIOLOGY, V87, P988, DOI 10.1097/00000542-199710000-00037; Ballas SK, 2005, HEMATOL ONCOL CLIN N, V19, P785, DOI 10.1016/j.hoc.2005.07.008; BIRCH KA, 1994, J CELL PHYSIOL, V160, P545, DOI 10.1002/jcp.1041600318; Brittain JE, 2001, J CLIN INVEST, V107, P1555, DOI 10.1172/JCI10817; Chames P, 2009, BRIT J PHARMACOL, V157, P220, DOI 10.1111/j.1476-5381.2009.00190.x; Chang JS, 2010, BLOOD, V116, P1779, DOI 10.1182/blood-2009-12-260513; Closse C, 1997, THROMB RES, V85, P159, DOI 10.1016/S0049-3848(96)00233-2; Closse C, 1996, HAEMOSTASIS, V26, P177; Dennis JW, 2009, CELL, V139, P1229, DOI 10.1016/j.cell.2009.12.008; Dwek RA, 2002, NAT REV DRUG DISCOV, V1, P65, DOI 10.1038/nrd708; Embury SH, 2004, BLOOD, V104, P3378, DOI 10.1182/blood-2004-02-0713; Embury SH, 2004, MICROCIRCULATION, V11, P101, DOI 10.1080/10739680490278277; Emoto T, 2012, AM J CARDIOL, V109, P42, DOI 10.1016/j.amjcard.2011.08.005; Ferrone FA, 2004, MICROCIRCULATION, V11, P115, DOI 10.1080/10739680490278312; Fuhler GM, 2003, BLOOD, V101, P1172, DOI 10.1182/blood.V101.3.1172; Ghoshal P, 2009, CANCER RES, V69, P4380, DOI 10.1158/0008-5472.CAN-08-3467; Gratton RJ, 2004, PLACENTA, V25, P62, DOI 10.1016/S0143-4004(03)00216-9; Gries A, 1998, CIRCULATION, V97, P1481; Gutsaeva DR, 2014, BLOOD, V123, P1917, DOI 10.1182/blood-2013-06-510180; Gutsaeva DR, 2011, BLOOD, V117, P727, DOI 10.1182/blood-2010-05-285718; Head CA, 2010, AM J HEMATOL, V85, P800, DOI 10.1002/ajh.21832; Hebbel RP, 1997, J CLIN INVEST, V99, P2561, DOI 10.1172/JCI119442; HEBBEL RP, 1980, NEW ENGL J MED, V302, P992, DOI 10.1056/NEJM198005013021803; HEIFETZ A, 1979, BIOCHEMISTRY-US, V18, P2186, DOI 10.1021/bi00578a008; Imai C, 2014, METABOLISM, V63, P746, DOI 10.1016/j.metabol.2013.12.014; JACOB GS, 1995, CURR OPIN STRUC BIOL, V5, P605, DOI 10.1016/0959-440X(95)80051-4; Jang WG, 2011, BMB REP, V44, P735, DOI 10.5483/BMBRep.2011.44.11.735; JOHNSTON GI, 1989, J BIOL CHEM, V264, P1816; Kasschau MR, 1996, BLOOD, V87, P771, DOI 10.1182/blood.V87.2.771.bloodjournal872771; Kaul DK, 2000, BLOOD, V95, P368, DOI 10.1182/blood.V95.2.368; Koutsioulis D, 2008, GLYCOBIOLOGY, V18, P799, DOI 10.1093/glycob/cwn069; KURANTSINMILLS J, 1992, BRIT J HAEMATOL, V81, P539, DOI 10.1111/j.1365-2141.1992.tb02989.x; Kutlar A, 2012, AM J HEMATOL, V87, P536, DOI 10.1002/ajh.23147; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Lee SP, 1998, BLOOD, V92, P2951, DOI 10.1182/blood.V92.8.2951.420k30_2951_2958; Levasseur DN, 2004, J BIOL CHEM, V279, P27518, DOI 10.1074/jbc.M402578200; Liao W, 2001, BIOCHEM J, V353, P493, DOI 10.1042/0264-6021:3530493; Matsui NM, 2002, BLOOD, V100, P3790, DOI 10.1182/blood-2002-02-0626; Matsui NM, 2001, BLOOD, V98, P1955, DOI 10.1182/blood.V98.6.1955; MCEVER RP, 1994, CURR OPIN IMMUNOL, V6, P75, DOI 10.1016/0952-7915(94)90037-X; MCEVER RP, 1989, J CLIN INVEST, V84, P92, DOI 10.1172/JCI114175; MILLER BA, 1986, BLOOD, V67, P1404; NELSON RM, 1993, BLOOD, V82, P3253; Oppert M, 2004, SWISS MED WKLY, V134, P165; Orbach H, 2004, SEMIN ARTHRITIS RHEU, V34, P593, DOI 10.1016/j.semarthrit.2004.06.003; PAHLSSON P, 1995, EUR J IMMUNOL, V25, P2452, DOI 10.1002/eji.1830250907; PAULING L, 1949, SCIENCE, V110, P543, DOI 10.1126/science.110.2865.543; PLATT OS, 1984, J CLIN INVEST, V74, P652, DOI 10.1172/JCI111464; Rodgers G P, 1989, Prog Clin Biol Res, V316B, P281; ROSSAINT R, 1993, NEW ENGL J MED, V328, P399, DOI 10.1056/NEJM199302113280605; Ryan TM, 1997, SCIENCE, V278, P873, DOI 10.1126/science.278.5339.873; SAUL R, 1985, P NATL ACAD SCI USA, V82, P93, DOI 10.1073/pnas.82.1.93; Setty BNY, 1996, BLOOD, V88, P2311, DOI 10.1182/blood.V88.6.2311.bloodjournal8862311; Stegelmeier BL, 2008, TOXICOL PATHOL, V36, P651, DOI 10.1177/0192623308317420; SUGAMA Y, 1992, J CELL BIOL, V119, P935, DOI 10.1083/jcb.119.4.935; SUGIHARA K, 1992, BLOOD, V80, P2634; Sullivan KJ, 1999, CRIT CARE MED, V27, P2563, DOI 10.1097/00003246-199911000-00039; Trottein F, 2009, GLYCOCONJUGATE J, V26, P1259, DOI 10.1007/s10719-009-9244-y; TSUCHIYA S, 1982, CANCER RES, V42, P1530; Turhan A, 2002, P NATL ACAD SCI USA, V99, P3047, DOI 10.1073/pnas.052522799; Turhan A, 2004, BLOOD, V103, P2397, DOI 10.1182/blood-2003-07-2209; van den Tweel XW, 2010, AM J HEMATOL, V85, P746, DOI 10.1002/ajh.21846; VANHOEK AN, 1995, BIOCHEMISTRY-US, V34, P2212, DOI 10.1021/bi00007a015; Varki A., 1999, ESSENTIALS GLYCOBIOL; Vichinsky E, 2002, LANCET, V360, P629, DOI 10.1016/S0140-6736(02)09776-3; Weiner DL, 2003, JAMA-J AM MED ASSOC, V289, P1136, DOI 10.1001/jama.289.9.1136; Wellen KE, 2012, NAT REV MOL CELL BIO, V13, P270, DOI 10.1038/nrm3305; Whitby K, 2005, J VIROL, V79, P8698, DOI 10.1128/JVI.79.14.8698-8706.2005; Wood KC, 2004, AM J PHYSIOL-HEART C, V286, pH1608, DOI 10.1152/ajpheart.01056.2003; YARBRO JW, 1965, P NATL ACAD SCI USA, V53, P1033, DOI 10.1073/pnas.53.5.1033	72	9	11	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e99363	10.1371/journal.pone.0099363	http://dx.doi.org/10.1371/journal.pone.0099363			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945938	Green Published, Green Submitted, gold			2022-12-27	WOS:000340721500016
J	Li, K; Li, WS; Dong, X				Li, Kai; Li, Wusheng; Dong, Xi			Association of 677 C > T (rs1801133) and 1298 A > C (rs1801131) Polymorphisms in the MTHFR Gene and Breast Cancer Susceptibility: A Meta-Analysis Based on 57 Individual Studies	PLOS ONE			English	Article							METHYLENETETRAHYDROFOLATE REDUCTASE MTHFR; ONE-CARBON METABOLISM; NESTED-CASE-CONTROL; DIETARY-FOLATE INTAKE; C677T POLYMORPHISM; POOLED METAANALYSIS; BRAZILIAN WOMEN; NO ASSOCIATION; CHINESE WOMEN; RISK	Objective: The 677 C>T and 1298 A>C polymorphisms of methylenetetrahydrofolate reductase (MTHFR) gene have been widely reported and considered to have a significant effect on breast cancer risk, but the results are inconsistent. A meta-analysis based on 57 eligible studies was carried out to clarify the role of MTHFR gene polymorphisms in breast cancer. Methods and Results: Eligible articles were identified by searching databases including PubMed, Web of Science, EMBASE, CNKI and CBM for the period up to August 2012. Finally, a total of 57 studies were included in this meta-analysis. Crude ORs with 95% CIs were used to assess the association between the MTHFR polymorphisms and breast cancer risk. The pooled ORs were performed with additive model, dominant model and recessive model, respectively. Subgroup analysis was also performed by ethnicity. The statistical heterogeneity across studies was examined with chi(2)-based Q-test. A meta-analysis was performed using the Stata 12.0 software. Overall, the 677 C allele was significantly associated with breast cancer risk (OR = 0.942, 95% CI = 0.898 to 0.988) when compared with the 677 T allele in the additive model, and the same results were also revealed under other genetic models. Simultaneously, the 1298 A allele was not associated with the breast cancer susceptibility when compared with the 1298 C allele (OR = 0.993, 95% CI = 0.978 to 1.009). Furthermore, analyses under the dominant, recessive and the allele contrast model yielded similar results. Conclusions: The results of this meta-analysis suggest that 677 C>T polymorphism in the MTHFR gene may contribute to breast cancer development. However, the 1298 A>C polymorphism is not significantly associated with increased risks of breast cancer.	[Li, Kai; Li, Wusheng; Dong, Xi] China Med Univ, Shengjing Hosp, Dept Oncol, Shenyang, Liaoning, Peoples R China	China Medical University	Li, K (corresponding author), China Med Univ, Shengjing Hosp, Dept Oncol, Shenyang, Liaoning, Peoples R China.	likaiwwtg@163.com						Akram M, 2012, ASIAN PAC J CANCER P, V13, P1599, DOI 10.7314/APJCP.2012.13.4.1599; Alshatwi AA, 2010, FOOD CHEM TOXICOL, V48, P1881, DOI 10.1016/j.fct.2010.04.028; Bailey LB, 1999, J NUTR, V129, P919, DOI 10.1093/jn/129.5.919; Batschauer AP, 2011, MOL CELL BIOCHEM, V357, P247, DOI 10.1007/s11010-011-0895-1; Cam R, 2009, BREAST CANCER RES TR, V115, P431, DOI 10.1007/s10549-008-0054-x; Campbell IG, 2002, BREAST CANCER RES, V4, DOI 10.1186/bcr457; Barbosa RDC, 2012, MOL BIOL REP, V39, P4899, DOI 10.1007/s11033-011-1285-1; Cerne JZ, 2011, MOL MED REP, V4, P175, DOI 10.3892/mmr.2010.406; Chen J, 2005, CANCER RES, V65, P1606, DOI 10.1158/0008-5472.CAN-04-2630; Cheng CW, 2008, BREAST CANCER RES TR, V111, P145, DOI 10.1007/s10549-007-9754-x; Choi SW, 2002, J NUTR, V132, p2413S, DOI 10.1093/jn/132.8.2413S; Chou YC, 2006, CARCINOGENESIS, V27, P2295, DOI 10.1093/carcin/bgl108; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; Deligezer U, 2005, IN VIVO, V19, P889; Devi ARR, 2004, CURR SCI INDIA, V86, P440; Dumitrescu RG, 2005, J CELL MOL MED, V9, P208, DOI 10.1111/j.1582-4934.2005.tb00350.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ergul E, 2003, TUMOR BIOL, V24, P286, DOI 10.1159/000076460; Ericson U, 2009, CANCER EPIDEM BIOMAR, V18, P1101, DOI 10.1158/1055-9965.EPI-08-0401; Forsti A, 2004, ONCOL REP, V11, P917; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Gao CM, 2009, J HUM GENET, V54, P414, DOI 10.1038/jhg.2009.57; Grieu F, 2004, ANTICANCER RES, V24, P3215; Hankinson SE, 2004, BREAST CANCER RES, V6, P213, DOI 10.1186/bcr921; Hekim N, 2007, CELL BIOCHEM FUNCT, V25, P115, DOI 10.1002/cbf.1274; Henriquez-Hernandez LA, 2009, ONCOL REP, V22, P1425, DOI 10.3892/or_00000584; Hosseini M, 2011, ARCH MED SCI, V7, P134, DOI 10.5114/aoms.2011.20618; Inoue M, 2008, CARCINOGENESIS, V29, P1967, DOI 10.1093/carcin/bgn177; Jakubowska A, 2012, BRIT J CANCER, V106, P2016, DOI 10.1038/bjc.2012.160; Justenhoven C, 2005, CANCER EPIDEM BIOMAR, V14, P3015, DOI 10.1158/1055-9965.EPI-05-0592; Kalemi TG, 2005, CANCER LETT, V222, P57, DOI 10.1016/j.canlet.2004.11.025; Kalyankumar CH, 2006, INT J CANC RES, V2, P143, DOI DOI 10.3923/ijcr.2006.143.151; [阚祥绪 KAN XiangXu], 2007, [肿瘤防治研究, Cancer Research on Prevention and Treatment], V34, P716; Kim YI, 1999, J NUTR BIOCHEM, V10, P66, DOI 10.1016/S0955-2863(98)00074-6; Kotsopoulos J, 2008, BREAST CANCER RES TR, V112, P585, DOI 10.1007/s10549-008-9895-6; Lajin B, 2012, TUMOR BIOL, V33, P1133, DOI 10.1007/s13277-012-0354-y; Langsenlehner T, 2008, BREAST CANCER RES TR, V107, P459, DOI 10.1007/s10549-007-9564-1; Langsenlehner U, 2003, BREAST CANCER RES TR, V81, P169, DOI 10.1023/A:1025752420309; Le Marchand L, 2004, CANCER EPIDEM BIOMAR, V13, P2071; Lee SA, 2004, EXP MOL MED, V36, P116, DOI 10.1038/emm.2004.17; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lin WY, 2004, ANTICANCER RES, V24, P3863; Lissowska J, 2007, INT J CANCER, V120, P2696, DOI 10.1002/ijc.22604; Ma E, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-122; Ma E, 2009, NUTR CANCER, V61, P447, DOI 10.1080/01635580802610123; Macis D, 2007, BREAST CANCER RES TR, V106, P263, DOI 10.1007/s10549-006-9491-6; Maruti SS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2462; Mason JB, 2000, ADV ENZYME REGUL, V40, P127, DOI 10.1016/S0065-2571(99)00037-0; Mohammad NS, 2011, MOL CELL BIOCHEM, V349, P159, DOI 10.1007/s11010-010-0670-8; Nass SJ, 2000, CANCER RES, V60, P4346; Naushad SM, 2011, MOL BIOL REP, V38, P4893, DOI 10.1007/s11033-010-0631-z; Papandreou CN, 2012, DNA CELL BIOL, V31, P193, DOI 10.1089/dna.2011.1292; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Platek ME, 2009, CANCER EPIDEM BIOMAR, V18, P2453, DOI 10.1158/1055-9965.EPI-09-0159; Prasad VVTS, 2011, ONKOLOGIE, V34, P422, DOI 10.1159/000331131; Qi Jun, 2004, Zhonghua Zhongliu Zazhi, V26, P287; Rejic A, 2007, CLIN BIOCHEM, V40, P981, DOI 10.1016/j.clinbiochem.2007.05.005; Rosenberg N, 2002, AM J HUM GENET, V70, P758, DOI 10.1086/338932; Sangrajrang S, 2010, BREAST CANCER RES TR, V123, P885, DOI 10.1007/s10549-010-0804-4; Schoenleber SJ, 2009, BRIT J CANCER, V100, P1385, DOI 10.1038/sj.bjc.6605017; Semenza JC, 2003, BREAST CANCER RES TR, V77, P217, DOI 10.1023/A:1021843019755; Sharp L, 2002, CANCER LETT, V181, P65, DOI 10.1016/S0304-3835(02)00030-7; Shrubsole MJ, 2004, CANCER EPIDEM BIOMAR, V13, P190, DOI 10.1158/1055-9965.EPI-03-0273; Soares J, 1999, CANCER, V85, P112, DOI 10.1002/(SICI)1097-0142(19990101)85:1<112::AID-CNCR16>3.3.CO;2-K; Stevens VL, 2007, CANCER EPIDEM BIOMAR, V16, P1140, DOI 10.1158/1055-9965.EPI-06-1037; Suzuki T, 2008, CARCINOGENESIS, V29, P356, DOI 10.1093/carcin/bgm295; The Cochrane Collaborative Review Group on HIV Infection and AIDS, 2009, ED POL INCL APPR EXP; Weisberg I, 1998, MOL GENET METAB, V64, P169, DOI 10.1006/mgme.1998.2714; Weisberg IS, 2001, ATHEROSCLEROSIS, V156, P409, DOI 10.1016/S0021-9150(00)00671-7; Wells GA., 2003, NEWCASTLE OTTAWA SCA; Xu XR, 2007, CARCINOGENESIS, V28, P1504, DOI 10.1093/carcin/bgm061; Yu CP, 2007, ANTICANCER RES, V27, P1727	72	74	77	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e71290	10.1371/journal.pone.0071290	http://dx.doi.org/10.1371/journal.pone.0071290			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945727	Green Submitted, Green Published, gold			2022-12-27	WOS:000340721500001
J	Wong, MM; Byun, JS; Sacta, M; Jin, QH; Baek, S; Gardner, K				Wong, Madeline M.; Byun, Jung S.; Sacta, Maria; Jin, Qihuang; Baek, SongJoon; Gardner, Kevin			Promoter-Bound p300 Complexes Facilitate Post-Mitotic Transmission of Transcriptional Memory	PLOS ONE			English	Article							RNA-POLYMERASE-II; BROMODOMAIN PROTEIN BRD4; LONG-TERM-MEMORY; MITOTIC BOOKMARKING; GENE-EXPRESSION; HISTONE ACETYLTRANSFERASES; DEPENDENT TRANSCRIPTION; EPIGENETIC CONTROL; COACTIVATOR P300; BINDING PROTEIN	A central hallmark of epigenetic inheritance is the parental transmission of changes in patterns of gene expression to progeny without modification of DNA sequence. Although, the trans-generational conveyance of this molecular memory has been traditionally linked to covalent modification of histone and/or DNA, recent studies suggest a role for proteins that persist or remain bound within chromatin to "bookmark" specific loci for enhanced or potentiated responses in daughter cells immediately following cell division. In this report we describe a role for p300 in enabling gene bookmarking by pre-initiation complexes (PICs) containing RNA polymerase II (pol II), Mediator and TBP. Once formed these complexes require p300 to facilitate reacquisition of protein complex assemblies, chromatin modifications and long range chromatin interactions that enable post-mitotic transmission of transcriptional memory of prior environmental stimuli.	[Wong, Madeline M.; Byun, Jung S.; Sacta, Maria; Gardner, Kevin] NCI, Genet Branch, Bethesda, MD 20892 USA; [Jin, Qihuang] Natl Inst Diabet & Digest & Kidney Dis, Lab Endocrinol & Receptor Biol, Bethesda, MD USA; [Baek, SongJoon] NCI, Lab Receptor Biol & Gene Express, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Gardner, K (corresponding author), NCI, Genet Branch, Bethesda, MD 20892 USA.	gardnerk@mail.nih.gov		Byun, Jung Shin/0000-0001-9049-9594	Intramural Research Program of the US National Institutes of Health; US National Cancer Institute; US National Institute on Minority Health and Health Disparities; NATIONAL CANCER INSTITUTE [ZIABC010846] Funding Source: NIH RePORTER	Intramural Research Program of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US National Institute on Minority Health and Health Disparities; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the US National Institutes of Health, the US National Cancer Institute, and the US National Institute on Minority Health and Health Disparities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM SE, 1993, ONCOGENE, V8, P1639; Acevedo ML, 2003, MOL CELL BIOL, V23, P335, DOI 10.1128/MCB.23.1.335-348.2003; Ali SA, 2008, P NATL ACAD SCI USA, V105, P6632, DOI 10.1073/pnas.0800970105; Azvolinsky A, 2009, MOL CELL, V34, P722, DOI 10.1016/j.molcel.2009.05.022; Barrett RM, 2011, NEUROPSYCHOPHARMACOL, V36, P1545, DOI 10.1038/npp.2011.61; Bedford DC, 2010, EPIGENETICS-US, V5, P9, DOI 10.4161/epi.5.1.10449; Blobel GA, 2009, MOL CELL, V36, P970, DOI 10.1016/j.molcel.2009.12.001; Butscher WG, 1998, J BIOL CHEM, V273, P552, DOI 10.1074/jbc.273.1.552; Byun JS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1652; Byun JS, 2009, P NATL ACAD SCI USA, V106, P19292, DOI 10.1073/pnas.0905469106; Caravaca JM, 2013, GENE DEV, V27, P251, DOI 10.1101/gad.206458.112; Chen DY, 2005, J CELL BIOL, V168, P41, DOI 10.1083/jcb.200407182; Chopra VS, 2009, GENE DEV, V23, P1505, DOI 10.1101/gad.1807309; Christova R, 2002, NAT CELL BIOL, V4, P79, DOI 10.1038/ncb733; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; COSENZA SC, 1994, J CELL BIOCHEM, V55, P503, DOI 10.1002/jcb.240550410; Crump NT, 2011, P NATL ACAD SCI USA, V108, P7814, DOI 10.1073/pnas.1100099108; Cuylen S, 2010, CELL STEM CELL, V7, P424, DOI 10.1016/j.stem.2010.09.006; Dallas PB, 1997, J VIROL, V71, P1726, DOI 10.1128/JVI.71.2.1726-1731.1997; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; Delcuve GP, 2009, J CELL PHYSIOL, V219, P243, DOI 10.1002/jcp.21678; Dey A, 2009, MOL BIOL CELL; Di LJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2438; FERRERI K, 1994, P NATL ACAD SCI USA, V91, P1210, DOI 10.1073/pnas.91.4.1210; Ganusov VV, 2005, J IMMUNOL METHODS, V298, P183, DOI 10.1016/j.jim.2005.01.011; Ge Y, 2006, BLOOD, V108, P4126, DOI 10.1182/blood-2006-04-017046; Giralt A, 2012, HUM MOL GENET, V21, P1203, DOI 10.1093/hmg/ddr552; Goodman RH, 2000, GENE DEV, V14, P1553; Gotea V, 2010, GENOME RES, V20, P565, DOI 10.1101/gr.104471.109; GROUDINE M, 1982, CELL, V30, P131, DOI 10.1016/0092-8674(82)90019-8; Hakim O, 2009, J BIOL CHEM, V284, P6048, DOI 10.1074/jbc.C800212200; Hasan S, 2001, NATURE, V410, P387, DOI 10.1038/35066610; Huang ZQ, 2003, EMBO J, V22, P2146, DOI 10.1093/emboj/cdg219; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Jin QH, 2011, EMBO J, V30, P249, DOI 10.1038/emboj.2010.318; John S, 1998, BIOESSAYS, V20, P275, DOI 10.1002/(SICI)1521-1878(199804)20:4<275::AID-BIES1>3.3.CO;2-6; Kadauke S, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-6; Kadauke S, 2012, CELL, V150, P725, DOI 10.1016/j.cell.2012.06.038; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kininis M, 2009, MOL CELL BIOL, V29, P1123, DOI 10.1128/MCB.00841-08; Kouskouti A, 2005, EMBO J, V24, P347, DOI 10.1038/sj.emboj.7600516; Krubasik D, 2006, BRIT J CANCER, V94, P1326, DOI 10.1038/sj.bjc.6603101; Kruhlak MJ, 2001, J BIOL CHEM, V276, P38307; Lanzuolo C, 2012, ANNU REV GENET, V46, P561, DOI 10.1146/annurev-genet-110711-155603; Li QJ, 2003, EMBO J, V22, P281, DOI 10.1093/emboj/cdg028; Liu X, 2013, BBA-GENE REGUL MECH, V1829, P2, DOI 10.1016/j.bbagrm.2012.09.003; Maddox SA, 2013, LEARN MEMORY, V20, P109, DOI 10.1101/lm.029157.112; MARTINEZBALBAS MA, 1995, CELL, V83, P29, DOI 10.1016/0092-8674(95)90231-7; Moriniere J, 2009, NATURE, V461, P664, DOI 10.1038/nature08397; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Nakajima T, 1997, CELL, V90, P1107, DOI 10.1016/S0092-8674(00)80376-1; Ng RK, 2008, NAT CELL BIOL, V10, P102, DOI 10.1038/ncb1674; O'Donnell A, 2012, BIOCHEM SOC T, V40, P58, DOI 10.1042/BST20110636; Parker D, 1996, MOL CELL BIOL, V16, P694; Parsons GG, 1997, MOL CELL BIOL, V17, P5791, DOI 10.1128/MCB.17.10.5791; Prasanth KV, 2003, MOL BIOL CELL, V14, P1043, DOI 10.1091/mbc.E02-10-0669; PRESCOTT DM, 1962, EXP CELL RES, V26, P260, DOI 10.1016/0014-4827(62)90176-3; Remeseiro S, 2013, CURR OPIN CELL BIOL, V25, P63, DOI 10.1016/j.ceb.2012.10.013; Sarge KD, 2009, CELL CYCLE, V8, P818, DOI 10.4161/cc.8.6.7849; Schaaf CA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003382; Schiltz RL, 1999, J BIOL CHEM, V274, P1189, DOI 10.1074/jbc.274.3.1189; Sekinger EA, 2001, CELL, V105, P403, DOI 10.1016/S0092-8674(01)00329-4; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; Simon JA, 2013, MOL CELL, V49, P808, DOI 10.1016/j.molcel.2013.02.013; Smallwood A, 2013, CURR OPIN CELL BIOL, V25, P387, DOI 10.1016/j.ceb.2013.02.005; Sunagawa Y, 2010, J BIOL CHEM, V285, P9556, DOI 10.1074/jbc.M109.070458; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; von MA, 2000, J CELL BIOL, V150, P265; Wang F, 2013, CELL MOL LIFE SCI, V70, P3989, DOI 10.1007/s00018-012-1254-4; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Xing HY, 2008, NAT CELL BIOL, V10, P1318, DOI 10.1038/ncb1790; Xing HY, 2005, SCIENCE, V307, P421, DOI 10.1126/science.1106478; Yang ML, 2012, DIABETES, V61, P1959, DOI 10.2337/db11-1755; Yang SH, 2003, MOL CELL, V12, P63, DOI 10.1016/S1097-2765(03)00265-X; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Young DW, 2007, P NATL ACAD SCI USA, V104, P3189, DOI 10.1073/pnas.0611419104; Young DW, 2007, NATURE, V445, P442, DOI 10.1038/nature05473; Zaidi SK, 2011, J BIOL CHEM, V286, P18355, DOI 10.1074/jbc.R110.197061; Zaidi SK, 2010, NAT REV GENET, V11, P583, DOI 10.1038/nrg2827; Zaidi SK, 2003, P NATL ACAD SCI USA, V100, P14852, DOI 10.1073/pnas.2533076100; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zhao R, 2011, NAT CELL BIOL, V13, P1295, DOI 10.1038/ncb2341	83	19	20	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e99989	10.1371/journal.pone.0099989	http://dx.doi.org/10.1371/journal.pone.0099989			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945803	gold, Green Published, Green Submitted			2022-12-27	WOS:000340721500038
J	Halpern, BS; Longo, C; Scarborough, C; Hardy, D; Best, BD; Doney, SC; Katona, SK; McLeod, KL; Rosenberg, AA; Samhouri, JF				Halpern, Benjamin S.; Longo, Catherine; Scarborough, Courtney; Hardy, Darren; Best, Benjamin D.; Doney, Scott C.; Katona, Steven K.; McLeod, Karen L.; Rosenberg, Andrew A.; Samhouri, Jameal F.			Assessing the Health of the US West Coast with a Regional-Scale Application of the Ocean Health Index	PLOS ONE			English	Article							POLICY	Management of marine ecosystems increasingly demands comprehensive and quantitative assessments of ocean health, but lacks a tool to do so. We applied the recently developed Ocean Health Index to assess ocean health in the relatively data-rich US west coast region. The overall region scored 71 out of 100, with sub-regions scoring from 65 (Washington) to 74 (Oregon). Highest scoring goals included tourism and recreation (99) and clean waters (87), while the lowest scoring goals were sense of place (48) and artisanal fishing opportunities (57). Surprisingly, even in this well-studied area data limitations precluded robust assessments of past trends in overall ocean health. Nonetheless, retrospective calculation of current status showed that many goals have declined, by up to 20%. In contrast, near-term future scores were on average 6% greater than current status across all goals and sub-regions. Application of hypothetical but realistic management scenarios illustrate how the Index can be used to predict and understand the tradeoffs among goals and consequences for overall ocean health. We illustrate and discuss how this index can be used to vet underlying assumptions and decisions with local stakeholders and decision-makers so that scores reflect regional knowledge, priorities and values. We also highlight the importance of ongoing and future monitoring that will provide robust data relevant to ocean health assessment.	[Halpern, Benjamin S.; Longo, Catherine; Scarborough, Courtney; Hardy, Darren; Best, Benjamin D.] Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93106 USA; [Halpern, Benjamin S.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Halpern, Benjamin S.] Univ London Imperial Coll Sci Technol & Med, Ascot, Berks, England; [Doney, Scott C.] Woods Hole Oceanog Inst, Marine Chem & Geochem Dept, Woods Hole, MA 02543 USA; [Katona, Steven K.] Conservat Int, Arlington, VA USA; [McLeod, Karen L.] Oregon State Univ, COMPASS, Dept Zool, Corvallis, OR 97331 USA; [Rosenberg, Andrew A.] Union Concerned Scientists, Cambridge, MA USA; [Samhouri, Jameal F.] NOAA, Natl Marine Fisheries Serv, NW Fisheries Sci Ctr, Conservat Biol Div, Seattle, WA 98112 USA; [Hardy, Darren] Stanford Univ, Digital Lib Syst & Serv, Stanford, CA 94305 USA	National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara; Imperial College London; Woods Hole Oceanographic Institution; Conservation International; Oregon State University; National Oceanic Atmospheric Admin (NOAA) - USA; Stanford University	Halpern, BS (corresponding author), Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93106 USA.	halpern@bren.ucsb.edu	Doney, Scott C/F-9247-2010	Doney, Scott C/0000-0002-3683-2437; Scarborough, Courtney/0000-0001-7270-9228	Pacific Life Foundation; Thomas W. Haas Fund of the New Hampshire Charitable Foundation; Oak Foundation; Akiko Shiraki Dynner Fund for Ocean Exploration and Conservation; Darden Restaurants Inc. Foundation; Conservation International; New England Aquarium; National Geographic; University of California Santa Barbara's National Center for Ecological Analysis and Synthesis; Ecosystem Health Working Group as part of the Science of Ecosystem-Based Management project - David and Lucile Packard Foundation; U.S. National Science Foundation	Pacific Life Foundation; Thomas W. Haas Fund of the New Hampshire Charitable Foundation; Oak Foundation; Akiko Shiraki Dynner Fund for Ocean Exploration and Conservation; Darden Restaurants Inc. Foundation; Conservation International; New England Aquarium; National Geographic(National Geographic Society); University of California Santa Barbara's National Center for Ecological Analysis and Synthesis; Ecosystem Health Working Group as part of the Science of Ecosystem-Based Management project - David and Lucile Packard Foundation; U.S. National Science Foundation(National Science Foundation (NSF))	Beau and Heather Wrigley generously provided the founding grant. Additional financial and in-kind support was provided by the Pacific Life Foundation, Thomas W. Haas Fund of the New Hampshire Charitable Foundation, the Oak Foundation, Akiko Shiraki Dynner Fund for Ocean Exploration and Conservation, Darden Restaurants Inc. Foundation, Conservation International, New England Aquarium, National Geographic, and the University of California Santa Barbara's National Center for Ecological Analysis and Synthesis, which supported the Ecosystem Health Working Group as part of the Science of Ecosystem-Based Management project funded by the David and Lucile Packard Foundation. Individual authors also acknowledge support from the U.S. National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aquarone MC, 2008, UNEP REGIONAL SEAS R, P593; Branch TA, 2013, NATURE, V495, pE5, DOI 10.1038/nature11974; Cash DW, 2000, GLOBAL ENVIRON CHANG, V10, P109, DOI 10.1016/S0959-3780(00)00017-0; CCC, 1997, CAL COAST COMM STRAT; CDFG, 1999, MAR LIFE PROT ACT FI; COA, 1998, AUSTR OC POL; *DFO, 2002, CAN OC STRAT; Folke C, 2011, AMBIO, V40, P719, DOI 10.1007/s13280-011-0184-y; Francis TB, 2011, MAR POLICY, V35, P675, DOI 10.1016/j.marpol.2011.02.008; Halpern BS, 2013, MAR POLICY, V42, P68, DOI 10.1016/j.marpol.2013.01.019; Halpern BS, 2013, NATURE, V495, pE7, DOI 10.1038/nature11975; Halpern BS, 2012, NATURE, V488, P615, DOI 10.1038/nature11397; Halpern BS, 2012, MAR POLICY, V36, P198, DOI 10.1016/j.marpol.2011.05.004; Halpern BS, PLOS ONE IN PRESS; Kareiva P, 2012, BIOSCIENCE, V62, P962, DOI 10.1525/bio.2012.62.11.5; Karieva P, 2011, BREAKTHROUGH J, V2; Kleisner KM, 2013, AMBIO, V42, P910, DOI 10.1007/s13280-013-0447-x; Liu JG, 2007, SCIENCE, V317, P1513, DOI 10.1126/science.1144004; McLeod K., 2009, ECOSYSTEM BASED MANA; MEA, 2005, EC HUM WELL BEING SY, DOI DOI 10.1119/1.2344558; Nash CE, 2004, FOOD POLICY, V29, P621, DOI 10.1016/j.foodpol.2004.10.001; NMS, 2004, MON FRAM NAT MAR SAN; Obama B, 2010, EXECUTIVE ORDER 1354; Pauly D, 2013, NATURE, V494, P303, DOI 10.1038/494303a; Pereira HM, 2006, TRENDS ECOL EVOL, V21, P123, DOI 10.1016/j.tree.2005.10.015; PFMC, 2013, PAC COAST FISH EC PL; PSP, 2008, PUG SOUND ACT AGEND; Rands MRW, 2010, SCIENCE, V329, P1298, DOI 10.1126/science.1189138; Samhouri JF, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-00366.1; Samhouri JF, 2014, MARINE ECOSYSTEM BAS, V16, P325; Soule M, 2013, CONSERV BIOL, V27, P895, DOI 10.1111/cobi.12147; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Tallis H, 2010, MAR POLICY, V34, P340, DOI 10.1016/j.marpol.2009.08.003; Walker B., 2006, RESILIENCE THINKING; WCEBM, 2010, COMM BAS MAN COAS EC; WCGA, 2006, AGR OC HLTH ACT PLAN	36	40	46	3	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e98995	10.1371/journal.pone.0098995	http://dx.doi.org/10.1371/journal.pone.0098995			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK6AC	24941007	Green Submitted, Green Published, gold			2022-12-27	WOS:000338508200012
J	Jiang, ZQ; Li, WH; Recio, G; Liu, Y; Luo, WB; Zhang, DF; Sun, D				Jiang, Zhongqing; Li, Wenhui; Recio, Guillermo; Liu, Ying; Luo, Wenbo; Zhang, Doufei; Sun, Dan			Time Pressure Inhibits Dynamic Advantage in the Classification of Facial Expressions of Emotion	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; GROUP-PERFORMANCE; SELECTIVE ATTENTION; DECISION-MAKING; ERP; FACE; SPECIFICITY; PERCEPTION; INTENSITY; STIMULI	Recent studies suggest an advantage in the recognition of dynamic over static facial expressions of emotion. Here, we explored the differences in the processing of static and dynamic faces under condition of time pressure. A group of 18 participants classified static and dynamic facial expressions (angry, happy, and neutral). In order to increase the goal-directed attention, instructions emphasized speed and announced time pressure in the interval for the response (maximal 600 ms). Participants responded faster and more accurately in the static than in the dynamic condition. Event-related potentials (ERPs) showed larger amplitude of the P1 (90-130 ms) and LPC (300-600 ms) components for dynamic relative to static stimuli, indicating enhanced early visual processing and emotional attention. On the other hand, the N170 was more negative in static relative to dynamic faces, suggesting better structural encoding for static faces under time pressure. The present study shows some advantages in the processing of static over dynamic facial expressions of emotion when the top-down (goal-driven) attention is strengthened.	[Jiang, Zhongqing; Li, Wenhui; Liu, Ying; Luo, Wenbo; Zhang, Doufei; Sun, Dan] Liaoning Normal Univ, Sch Psychol, Dalian, Peoples R China; [Recio, Guillermo] Humboldt Univ, D-10099 Berlin, Germany	Liaoning Normal University; Humboldt University of Berlin	Jiang, ZQ (corresponding author), Liaoning Normal Univ, Sch Psychol, Dalian, Peoples R China.	jzqcjj@hotmail.com		jiang, zhongqing/0000-0002-3484-2287	National Natural Science Foundation of China [31271107, 31371033]; Humanities and social science project of the China educational ministry [11YJC190010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Humanities and social science project of the China educational ministry	This research was supported by the National Natural Science Foundation of China (No. 31271107, 31371033), Humanities and social science project of the China educational ministry (11YJC190010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs Ralph, 2002, Behav Cogn Neurosci Rev, V1, P21, DOI 10.1177/1534582302001001003; Ambadar Z, 2005, PSYCHOL SCI, V16, P403, DOI 10.1111/j.0956-7976.2005.01548.x; [Anonymous], 2006, SINGULAR INVERSIONS; Ashley V, 2004, NEUROREPORT, V15, P211, DOI 10.1097/00001756-200401190-00041; Batty M, 2003, COGNITIVE BRAIN RES, V17, P613, DOI 10.1016/S0926-6410(03)00174-5; Bentin S, 2000, COGN NEUROPSYCHOL, V17, P35, DOI 10.1080/026432900380472; Blau Vera C, 2007, Behav Brain Funct, V3, P7; Eger E, 2003, NEUROPSYCHOLOGIA, V41, P808, DOI 10.1016/S0028-3932(02)00287-7; Eimer M, 2002, NEUROREPORT, V13, P427, DOI 10.1097/00001756-200203250-00013; Ferree TC, 2001, CLIN NEUROPHYSIOL, V112, P536, DOI 10.1016/S1388-2457(00)00533-2; Fichtenholtz HM, 2009, SOC NEUROSCI-UK, V4, P317, DOI 10.1080/17470910902809487; Fiorentini C, 2011, J VISION, V11, DOI 10.1167/11.3.17; Forstmann BU, 2008, P NATL ACAD SCI USA, V105, P17538, DOI 10.1073/pnas.0805903105; Franconeri SL, 2003, PERCEPT PSYCHOPHYS, V65, P999, DOI 10.3758/BF03194829; HEINZE HJ, 1994, NATURE, V372, P543, DOI 10.1038/372543a0; Hillyard SA, 1998, P NATL ACAD SCI USA, V95, P781, DOI 10.1073/pnas.95.3.781; Itier RJ, 2002, NEUROIMAGE, V15, P353, DOI 10.1006/nimg.2001.0982; Junghofer M, 2001, PSYCHOPHYSIOLOGY, V38, P175, DOI 10.1017/S0048577201000762; KARAU SJ, 1992, J EXP SOC PSYCHOL, V28, P542, DOI 10.1016/0022-1031(92)90045-L; Kelly JR, 2004, J EXP SOC PSYCHOL, V40, P185, DOI 10.1016/S0022-1031(03)00094-5; Kelly JR, 1999, PERS SOC PSYCHOL B, V25, P1342, DOI 10.1177/0146167299259002; Kerr NL, 2004, ANNU REV PSYCHOL, V55, P623, DOI 10.1146/annurev.psych.55.090902.142009; Krumhuber EG, 2013, EMOT REV, V5, P41, DOI 10.1177/1754073912451349; Luo WB, 2010, NEUROIMAGE, V49, P1857, DOI 10.1016/j.neuroimage.2009.09.018; Mangun GR, 1997, HUM BRAIN MAPP, V5, P273, DOI 10.1002/(SICI)1097-0193(1997)5:4<273::AID-HBM12>3.0.CO;2-F; Olofsson JK, 2008, BIOL PSYCHOL, V77, P247, DOI 10.1016/j.biopsycho.2007.11.006; Pourtois G, 2013, BIOL PSYCHOL, V92, P492, DOI 10.1016/j.biopsycho.2012.02.007; Recio G, 2014, BIOL PSYCHOL, V96, P111, DOI 10.1016/j.biopsycho.2013.12.003; Recio G, 2011, BRAIN RES, V1376, P66, DOI 10.1016/j.brainres.2010.12.041; Sato W, 2007, J NONVERBAL BEHAV, V31, P119, DOI 10.1007/s10919-007-0025-7; Schupp HT, 2003, NEUROREPORT, V14, P1107, DOI 10.1097/00001756-200306110-00002; Schupp HT, 2003, PSYCHOL SCI, V14, P7, DOI 10.1111/1467-9280.01411; SHIMA K, 1991, J NEUROPHYSIOL, V65, P188, DOI 10.1152/jn.1991.65.2.188; Sprengelmeyer R, 2006, NEUROPSYCHOLOGIA, V44, P2899, DOI 10.1016/j.neuropsychologia.2006.06.020; Trautmann SA, 2009, BRAIN RES, V1284, P100, DOI 10.1016/j.brainres.2009.05.075; WEISS F, 1987, MOTIV EMOTION, V11, P67, DOI 10.1007/BF00992214; Weissman DH, 2005, CEREB CORTEX, V15, P229, DOI 10.1093/cercor/bhh125	37	9	9	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100162	10.1371/journal.pone.0100162	http://dx.doi.org/10.1371/journal.pone.0100162			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK6AC	24941259	Green Submitted, Green Published, gold			2022-12-27	WOS:000338508200078
J	van der Meer, L; Swart, M; van der Velde, J; Pijnenborg, G; Wiersma, D; Bruggeman, R; Aleman, A				van der Meer, Lisette; Swart, Marte; van der Velde, Jorien; Pijnenborg, Gerdina; Wiersma, Durk; Bruggeman, Richard; Aleman, Andre			Neural Correlates of Emotion Regulation in Patients with Schizophrenia and Non-Affected Siblings	PLOS ONE			English	Article							VENTROLATERAL PREFRONTAL CORTEX; NEGATIVE SYNDROME SCALE; INDIVIDUAL-DIFFERENCES; COGNITIVE CONTROL; SOCIAL COGNITION; GENETIC RISK; PSYCHOSIS; FEELINGS; BRAIN; METAANALYSIS	Background: Patients with schizophrenia often experience problems regulating their emotions. Non-affected relatives show similar difficulties, although to a lesser extent, and the neural basis of such difficulties remains to be elucidated. In the current paper we investigated whether schizophrenia patients, non-affected siblings and healthy controls (HC) exhibit differences in brain activation during emotion regulation. Methods: All subjects (n = 20 per group) performed an emotion regulation task while they were in an fMRI scanner. The task contained two experimental conditions for the down-regulation of emotions (reappraise and suppress), in which IAPS pictures were used to generate a negative affect. We also assessed whether the groups differed in emotion regulation strategies used in daily life by means of the emotion regulation questionnaire (ERQ). Results: Though the overall negative affect was higher for patients as well as for siblings compared to HC for all conditions, all groups reported decreased negative affect after both regulation conditions. Nonetheless, neuroimaging results showed hypoactivation relative to HC in VLPFC, insula, middle temporal gyrus, caudate and thalamus for patients when reappraising negative pictures. In siblings, the same pattern was evident as in patients, but only in cortical areas. Conclusions: Given that all groups performed similarly on the emotion regulation task, but differed in overall negative affect ratings and brain activation, our findings suggest reduced levels of emotion regulation processing in neural circuits in patients with schizophrenia. Notably, this also holds for siblings, albeit to a lesser extent, indicating that it may be part and parcel of a vulnerability for psychosis.	[van der Meer, Lisette; van der Velde, Jorien; Aleman, Andre] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, NL-9713 AV Groningen, Netherlands; [van der Meer, Lisette; Swart, Marte] Lentis Psychiat Inst, Dept Rehabil, Zuidlaren, Netherlands; [Swart, Marte] Lentis Psychiat Inst, Res Dept, Groningen, Netherlands; [Pijnenborg, Gerdina; Aleman, Andre] Univ Groningen, Dept Clin Psychol & Expt Psychopathol, Groningen, Netherlands; [Pijnenborg, Gerdina] GGZ Drenthe, Dept Psychot Disorders, Assen, Netherlands; [Bruggeman, Richard] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, NL-9713 AV Groningen, Netherlands; [van der Meer, Lisette; van der Velde, Jorien; Wiersma, Durk; Bruggeman, Richard] Univ Groningen, Univ Med Ctr Groningen, Rob Giel Res Ctr, NL-9713 AV Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen	van der Meer, L (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, NL-9713 AV Groningen, Netherlands.	l.van.der.meer@umcg.nl		Bruggeman, Richard/0000-0002-3238-8471	European Science Foundation EURYI grant (NWO) [044035001]	European Science Foundation EURYI grant (NWO)	This work was supported by a European Science Foundation EURYI grant (NWO no. 044035001) awarded to A. A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman A, 2005, PROG NEUROBIOL, V77, P283, DOI 10.1016/j.pneurobio.2005.11.005; Barbalat G, 2009, ARCH GEN PSYCHIAT, V66, P377, DOI 10.1001/archgenpsychiatry.2009.10; Boos HBM, 2007, ARCH GEN PSYCHIAT, V64, P297, DOI 10.1001/archpsyc.64.3.297; Carrington SJ, 2009, HUM BRAIN MAPP, V30, P2313, DOI 10.1002/hbm.20671; Cohen AS, 2010, SCHIZOPHRENIA BULL, V36, P143, DOI 10.1093/schbul/sbn061; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; de Achaval D, 2012, SCHIZOPHR RES, V134, P171, DOI 10.1016/j.schres.2011.11.010; Diekhof EK, 2011, NEUROIMAGE, V58, P275, DOI 10.1016/j.neuroimage.2011.05.073; Fusar-Poli P, 2007, NEUROSCI BIOBEHAV R, V31, P465, DOI 10.1016/j.neubiorev.2006.11.006; Gee DG, 2012, SCHIZOPHR RES, V134, P1, DOI 10.1016/j.schres.2011.10.005; Gibson CM, 2010, SCHIZOPHR RES, V122, P179, DOI 10.1016/j.schres.2010.04.018; Giel R., 1996, SCAN 2 1 SCHEDULES C; Goldin PR, 2008, BIOL PSYCHIAT, V63, P577, DOI 10.1016/j.biopsych.2007.05.031; Gottesman II, 2001, AM PSYCHOL, V56, P867, DOI 10.1037/0003-066X.56.11.867; GROSS JJ, 1995, CLIN PSYCHOL-SCI PR, V2, P151, DOI 10.1111/j.1468-2850.1995.tb00036.x; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Gross JJ, 1998, J PERS SOC PSYCHOL, V74, P224, DOI 10.1037/0022-3514.74.1.224; Habel U, 2004, AM J PSYCHIAT, V161, P1806, DOI 10.1176/appi.ajp.161.10.1806; Hayes JP, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00230; Henry JD, 2008, J ABNORM PSYCHOL, V117, P473, DOI 10.1037/0021-843X.117.2.473; John OP, 2004, J PERS, V72, P1301, DOI 10.1111/j.1467-6494.2004.00298.x; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; KAY SR, 1988, PSYCHIAT RES, V23, P99, DOI 10.1016/0165-1781(88)90038-8; Keshavan MS, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/neuro.09.062.2009; Korver N, 2012, INT J METH PSYCH RES, V21, P205, DOI 10.1002/mpr.1352; Kring AM, 1996, J ABNORM PSYCHOL, V105, P249, DOI 10.1037/0021-843X.105.2.249; Kring AM, 2010, CURR DIR PSYCHOL SCI, V19, P255, DOI 10.1177/0963721410377599; Leitman DI, 2011, SOC COGN AFFECT NEUR, V6, P66, DOI 10.1093/scan/nsq018; Livingstone K, 2009, CLIN PSYCHOL PSYCHOT, V16, P418, DOI 10.1002/cpp.635; Minzenberg MJ, 2009, ARCH GEN PSYCHIAT, V66, P811, DOI 10.1001/archgenpsychiatry.2009.91; Modinos G, 2010, SCHIZOPHR RES, V118, P88, DOI 10.1016/j.schres.2010.01.030; Morris RW, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.16; Myin-Germeys I, 2000, SCHIZOPHRENIA BULL, V26, P847, DOI 10.1093/oxfordjournals.schbul.a033499; Myin-Germeys I, 2001, ARCH GEN PSYCHIAT, V58, P1137, DOI 10.1001/archpsyc.58.12.1137; Myin-Germeys I, 2007, CLIN PSYCHOL REV, V27, P409, DOI 10.1016/j.cpr.2006.09.005; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Petrides M, 2002, EUR J NEUROSCI, V16, P291, DOI 10.1046/j.1460-9568.2001.02090.x; Phillips LK, 2008, SCHIZOPHRENIA BULL, V34, P888, DOI 10.1093/schbul/sbn085; Phillips ML, 2003, BIOL PSYCHIAT, V54, P515, DOI 10.1016/S0006-3223(03)00171-9; Ritsner MS, 2007, PSYCHIAT RES, V153, P217, DOI 10.1016/j.psychres.2006.07.003; Sergi MJ, 2007, AM J PSYCHIAT, V164, P1585, DOI 10.1176/appi.ajp.2007.06091515; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Sitskoom MM, 2004, SCHIZOPHR RES, V71, P285, DOI 10.1016/j.schres.2004.03.007; Smith MJ, 2008, SCHIZOPHR RES, V104, P198, DOI 10.1016/j.schres.2008.06.025; Stip E, 2005, CAN J PSYCHIAT, V50, P909, DOI 10.1177/070674370505001405; Urry HL, 2009, NEUROIMAGE, V47, P852, DOI 10.1016/j.neuroimage.2009.05.069; van Buuren M, 2011, BIOL PSYCHIAT, V70, P81, DOI 10.1016/j.biopsych.2011.03.011; van der Meer L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067774; van der Meer L, 2011, NEUROIMAGE, V56, P2364, DOI 10.1016/j.neuroimage.2011.03.053; van der Meer L, 2009, PSYCHIAT RES, V170, P108, DOI 10.1016/j.psychres.2009.07.010; van Os J, 2009, PSYCHOL MED, V39, P179, DOI 10.1017/S0033291708003814; van 't Wout M, 2007, COMPR PSYCHIAT, V48, P27, DOI 10.1016/j.comppsych.2006.07.003; Vanderhasselt MA, 2012, SOC COGN AFFECT NEUR; Verhage F, 1983, REVISED SCORING METH; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wylie KP, 2010, SCHIZOPHR RES, V123, P93, DOI 10.1016/j.schres.2010.08.027	57	55	55	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99667	10.1371/journal.pone.0099667	http://dx.doi.org/10.1371/journal.pone.0099667			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK6AC	24941136	Green Published, gold, Green Submitted			2022-12-27	WOS:000338508200035
J	Han, J; Lei, YX; Liu, L; Liu, P; Xia, JK; Zhang, YL; Zeng, H; Wang, L; Wang, L; Zhuang, H				Han, Jian; Lei, Yaxin; Liu, Lin; Liu, Peng; Xia, Junke; Zhang, Yulin; Zeng, Hang; Wang, Lin; Wang, Ling; Zhuang, Hui			SPF Rabbits Infected with Rabbit Hepatitis E Virus Isolate Experimentally Showing the Chronicity of Hepatitis	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; FULL-GENOME; IDENTIFICATION; PATIENT; TRANSMISSION; PREVALENCE; GENOTYPES; DISTINCT; FECES	This study focused on investigating the pathogenesis seen in specific-pathogen-free (SPF) rabbits following infection with a homologous rabbit HEV isolate (CHN-BJ-rb14) and comparing it to that seen following infection with a heterologous swine genotype 4 HEV isolate (CHN-XJ-SW13). Three of the four animals inoculated with the homologous rabbit HEV became infected, exhibiting an intermittent viremia, obvious fluctuations of liver function biomarkers alanine aminotransferase (ALT) and aspartate aminotransferase (AST), and persistent fecal virus shedding throughout the nine month study. In addition, liver histopathology showed both chronic inflammation and some degree of fibrosis. Both positive and negative-stranded HEV RNA and HEV antigen expression were detected in liver, brain, stomach, duodenum and kidney from the necropsied rabbits. Inflammation of extrahepatic tissue (duodenum and kidney) was also observed. Three of the four rabbits inoculated with the heterologous genotype 4 swine HEV also became infected, showing similar levels of anti-HEV antibody to that generated following infection with the homologous virus isolate. The duration of both viremia and fecal shedding of virus was however shorter following infection with the heterologous virus and there was no significant elevation of liver function biomarkers. These results suggest that rabbit HEV infection may cause more severe hepatitis and prolong the course of the disease, with a possible chronic trend of hepatitis in SPF rabbits.	[Han, Jian; Lei, Yaxin; Liu, Lin; Liu, Peng; Xia, Junke; Zhang, Yulin; Zeng, Hang; Wang, Lin; Wang, Ling; Zhuang, Hui] Peking Univ, Hlth Sci Ctr, Dept Microbiol, Sch Basic Med Sci, Beijing 100871, Peoples R China	Peking University	Wang, L (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Microbiol, Sch Basic Med Sci, Beijing 100871, Peoples R China.	lingwang@bjmu.edu.cn	Liu, Peng/AGH-0228-2022		National Science Foundation of China [81271827]; Specialized Research Fund for the Doctoral Program of Higher Education [20120001110098]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was partially supported by the National Science Foundation of China (Grant No. 81271827, http://www.nsfc.gov.cn/Portal0/default152.htm) and Specialized Research Fund for the Doctoral Program of Higher Education (Grant No. 20120001110098, http://www.cutech.edu.cn/cn/kyjj/gdxxbsdkyjj/A010301index_1.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal R, 2010, CLIN INFECT DIS, V51, P477, DOI 10.1086/655157; Batts W, 2011, VIRUS RES, V158, P116, DOI 10.1016/j.virusres.2011.03.019; Bodewes R, 2013, J VIROL, V87, P7758, DOI 10.1128/JVI.00568-13; Cheng XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051616; Cossaboom CM, 2012, J GEN VIROL, V93, P1687, DOI 10.1099/vir.0.041509-0; Cossaboom CM, 2011, EMERG INFECT DIS, V17, P2047, DOI 10.3201/eid1711.110428; Dalton HR, 2009, NEW ENGL J MED, V361, P1025, DOI 10.1056/NEJMc0903778; Drexler JF, 2012, J VIROL, V86, P9134, DOI 10.1128/JVI.00800-12; Emerson S. U, 2004, VIRUS TAXONOMY, V1st, P851; Feng ZD, 2014, TRENDS MICROBIOL, V22, P59, DOI 10.1016/j.tim.2013.10.005; Fu HW, 2011, INFECT GENET EVOL, V11, P618, DOI 10.1016/j.meegid.2011.01.018; Geng J, 2011, J VIRAL HEPATITIS, V18, P661, DOI 10.1111/j.1365-2893.2010.01341.x; Geng JB, 2011, INFECT GENET EVOL, V11, P2020, DOI 10.1016/j.meegid.2011.09.006; Tallon AIG, 2011, GASTROENT HEPAT-BARC, V34, P398, DOI 10.1016/j.gastrohep.2011.02.011; Grewal P, 2014, HEPATOLOGY, V59, P347, DOI 10.1002/hep.26636; Haqshenas G, 2001, J GEN VIROL, V82, P2449, DOI 10.1099/0022-1317-82-10-2449; Hoofnagle JH, 2012, NEW ENGL J MED, V367, P1237, DOI 10.1056/NEJMra1204512; Johne R, 2010, J GEN VIROL, V91, P750, DOI 10.1099/vir.0.016584-0; Kaba M, 2011, J MED VIROL, V83, P1704, DOI 10.1002/jmv.22177; Kamar N, 2010, AM J TRANSPLANT, V10, P1321, DOI 10.1111/j.1600-6143.2010.03068.x; Kamar N, 2008, NEW ENGL J MED, V358, P811, DOI 10.1056/NEJMoa0706992; Kamar N, 2012, LANCET, V379, P2477, DOI 10.1016/S0140-6736(11)61849-7; Kamar N, 2011, EMERG INFECT DIS, V17, P173, DOI 10.3201/eid1702.100856; KHUROO MS, 1980, AM J MED, V68, P818, DOI 10.1016/0002-9343(80)90200-4; Liu P, 2013, EMERG INFECT DIS, V19, P559, DOI 10.3201/eid1904.120827; Ma HX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009160; Meng XJ, 1997, P NATL ACAD SCI USA, V94, P9860, DOI 10.1073/pnas.94.18.9860; Nakamura M, 2006, HEPATOL RES, V34, P137, DOI 10.1016/j.hepres.2005.10.010; Pujhari SK, 2010, ARCH VIROL, V155, P1483, DOI 10.1007/s00705-010-0726-9; Purcell RH, 2008, J HEPATOL, V48, P494, DOI 10.1016/j.jhep.2007.12.008; Purdy MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014376; Raj VS, 2012, EMERG INFECT DIS, V18, P1369, DOI 10.3201/eid1808.111659; Shrestha MP, 2007, NEW ENGL J MED, V356, P895, DOI 10.1056/NEJMoa061847; Takahashi M, 2002, J GEN VIROL, V83, P1931, DOI 10.1099/0022-1317-83-8-1931; Takahashi M, 2011, J GEN VIROL, V92, P902, DOI 10.1099/vir.0.029470-0; Tavitian S, 2010, J CLIN VIROL, V49, P141, DOI 10.1016/j.jcv.2010.06.016; Tomiyama D, 2009, J VIRAL HEPATITIS, V16, P524, DOI 10.1111/j.1365-2893.2009.01107.x; Wang YC, 2002, J MED VIROL, V67, P516, DOI 10.1002/jmv.10131; Zhang J, 2003, J MED VIROL, V71, P518, DOI 10.1002/jmv.10523; Zhao CY, 2009, J MED VIROL, V81, P1371, DOI 10.1002/jmv.21536	40	54	57	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99861	10.1371/journal.pone.0099861	http://dx.doi.org/10.1371/journal.pone.0099861			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937350	gold, Green Submitted, Green Published			2022-12-27	WOS:000338503400046
J	Nusinovici, S; Monestiez, P; Seegers, H; Beaudeau, F; Fourichon, C				Nusinovici, Simon; Monestiez, Pascal; Seegers, Henri; Beaudeau, Francois; Fourichon, Christine			Using Animal Performance Data to Evidence the Under-Reporting of Case Herds during an Epizootic: Application to an Outbreak of Bluetongue in Cattle	PLOS ONE			English	Article							VIRUS SEROTYPE 8; DAIRY HERDS; INFECTION; FERTILITY; FRANCE; COWS; SERVICE; RISK	Following the emergence of the Bluetongue virus serotype 8 (BTV-8) in France in 2006, a surveillance system (both passive and active) was implemented to detect and follow precociously the progression of the epizootic wave. This system did not allow a precise estimation of the extent of the epizootic. Infection by BTV-8 is associated with a decrease of fertility. The objective of this study was to evaluate whether a decrease in fertility can be used to evidence the under-reporting of cases during an epizootic and to quantify to what extent non-reported cases contribute to the total burden of the epizootic. The cow fertility in herds in the outbreak area (reported or not) was monitored around the date of clinical signs. A geostatistical interpolation method was used to estimate a date of clinical signs for non-reported herds. This interpolation was based on the spatiotemporal dynamic of confirmed case herds reported in 2007. Decreases in fertility were evidenced for both types of herds around the date of clinical signs. In non-reported herds, the decrease fertility was large (60% of the effect in reported herds), suggesting that some of these herds have been infected by the virus during 2007. Production losses in non-reported infected herds could thus contribute to an important part of the total burden of the epizootic. Overall, results indicate that performance data can be used to evidence the under-reporting during an epizootic. This approach could be generalized to pathogens that affect cattle's performance, including zoonotic agents such as Coxiella burnetii or Rift Valley fever virus.	[Nusinovici, Simon; Seegers, Henri; Beaudeau, Francois; Fourichon, Christine] INRA, Biol Epidemiol & Risk Anal Anim Hlth UMR1300, F-44026 Nantes, France; [Nusinovici, Simon; Seegers, Henri; Beaudeau, Francois; Fourichon, Christine] LUNAM Univ, Oniris, Ecole Natl Vet Agroalimentaire & Alimentat Nantes, Nantes, France; [Monestiez, Pascal] INRA, UR 546, Avignon, France	INRAE; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; INRAE	Nusinovici, S (corresponding author), INRA, Biol Epidemiol & Risk Anal Anim Hlth UMR1300, F-44026 Nantes, France.	simon.nusinovici@oniris-nantes.fr	Fourichon, Christine/B-1265-2010	Fourichon, Christine/0000-0002-7079-0955; Monestiez, Pascal/0000-0001-5851-2699	INRA; Cemagref; Basse-Normandie Council; Bretagne Council; Pays de le Loire Council; Poitou-Charentes Regional Council under SANCRE project	INRA; Cemagref; Basse-Normandie Council; Bretagne Council; Pays de le Loire Council; Poitou-Charentes Regional Council under SANCRE project(Region Nouvelle-Aquitaine)	Financial support for this research was provided by INRA, Cemagref and Basse-Normandie, Bretagne, Pays de le Loire and Poitou-Charentes Regional Councils under SANCRE project, in the framework of "For and About Regional Development'' programs. The authors gratefully acknowledge the Centre de Traitement de l'Information Genetique (INRA, Jouy-en-Josas, France) for providing the performance data and the Ministry of Agriculture (Direction Generale de l'Alimentation) for the BTV case herds data. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerholm JS, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-13; COETZER JAW, 1982, ONDERSTEPOORT J VET, V49, P11; Durand B, 2010, EMERG INFECT DIS, V16, P1861, DOI 10.3201/eid1612.100412; Elbers ARW, 2008, PREV VET MED, V87, P21, DOI 10.1016/j.prevetmed.2008.06.004; HILLERS JK, 1984, J DAIRY SCI, V67, P861, DOI 10.3168/jds.S0022-0302(84)81378-8; Malher X, 2006, THERIOGENOLOGY, V65, P1215, DOI 10.1016/j.theriogenology.2005.08.003; Marce C, 2009, THERIOGENOLOGY, V71, P807, DOI 10.1016/j.theriogenology.2008.10.017; Nusinovici S, 2012, J DAIRY SCI, V95, P3008, DOI 10.3168/jds.2011-4799; R Core Team, R LANG ENV STAT COMP; Robert A, 2004, THERIOGENOLOGY, V61, P117, DOI 10.1016/S0093-691X(03)00182-1; Saegerman C, 2015, TRANSBOUND EMERG DIS, V62, P46, DOI 10.1111/tbed.12070; Saegerman C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009405; Santman-Berends IMGA, 2011, VET MICROBIOL, V148, P183, DOI 10.1016/j.vetmic.2010.09.010; Santman-Berends IMGA, 2010, THERIOGENOLOGY, V74, P1377, DOI 10.1016/j.theriogenology.2010.06.008; Seegers H, 1998, J NATL GTV, P57	15	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100137	10.1371/journal.pone.0100137	http://dx.doi.org/10.1371/journal.pone.0100137			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937630	Green Published, gold			2022-12-27	WOS:000338503400081
J	Shi, ML; Shtraizent, N; Polotskaia, A; Bargonetti, J; Matsui, H				Shi, Menglu; Shtraizent, Nataly; Polotskaia, Alla; Bargonetti, Jill; Matsui, Hiroshi			Impedimetric Detection of Mutant p53 Biomarker-Driven Metastatic Breast Cancers under Hyposmotic Pressure	PLOS ONE			English	Article							LI-FRAUMENI-SYNDROME; GENETIC INSTABILITY; GAIN	In cancer cells, the oncogenic mutant p53 (mtp53) protein is present at high levels and gain-of-function (GOF) activities with more expression of mtp53 proteins contribute to tumor growth and metastasis. Robust analytical approaches that probe the degree of metastasis of cancer cells in connection with the mtp53 activity will be extremely useful not only for establishing a better cancer prognosis but also understanding the fundamental mechanism of mtp53 oncogenic action. Here we assessed the influence of mtp53 in breast cancers to the mechanical property of breast cancer cells. Recently, ovarian and kidney cancer cell lines have been shown to have higher cellular elasticity as compared to normal cells assessed by monitoring the degree of deformation under hyposmotic pressure. To make fast detection in large scale, the impedance measurement was applied to monitor the swelling ratio of cells with time. The results showed that knockdown of mtp53 leads to decrease in cell swelling. In addition, by means of two types of impedimetric detection systems we consistently detected enhancement of impedance signal in mtp53-expressing breast cancer cells. Based on this observation we hypothesize that highly expressed mtp53 in metastatic mutant breast cancers can promote tumor progression by making cells more deformable and easier to spread out through extracellular matrix. The identification via the electric measurement can be accomplished within 10 minutes. All results in this report suggest that electric probing for the extent of the mtp53 expression of breast cancer cells may serve as a meaningful fingerprint for the cancer diagnostics, and this outcome will also have an important clinical implication for the development of mtp53-based targeting for tumor detection and treatment.	[Shi, Menglu; Matsui, Hiroshi] CUNY, Hunter Coll, Dept Chem, New York, NY 10021 USA; [Shi, Menglu; Shtraizent, Nataly; Polotskaia, Alla; Bargonetti, Jill; Matsui, Hiroshi] CUNY, Grad Ctr, New York, NY USA; [Shtraizent, Nataly; Polotskaia, Alla; Bargonetti, Jill] CUNY, Hunter Coll, Dept Biol Sci, New York, NY 10021 USA	City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System; City University of New York (CUNY) System; Hunter College (CUNY)	Bargonetti, J (corresponding author), CUNY, Hunter Coll, Dept Biol Sci, New York, NY 10021 USA.	Bargonetti@GENECTR.HUNTER.CUNY.edu; hmatsui@hunter.cuny.edu		Bargonetti, Jill/0000-0003-2692-0991	National Institute on Minority Health and Health Disparities (NIMHD) of the National Institutes of Health (NIH) [MD007599]; sub-project pilot award; National Institute on Minority Health and Health Disparities [G12MD007599] Funding Source: NIH RePORTER	National Institute on Minority Health and Health Disparities (NIMHD) of the National Institutes of Health (NIH); sub-project pilot award; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	In this project electric detection of cells with polysilicon transducers and data analysis was supported by Grant Number MD007599 from the National Institute on Minority Health and Health Disparities (NIMHD) of the National Institutes of Health (NIH) (HM) and its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIMHD or the NIH. A portion of this project was supported by a sub-project pilot award to JB for collaboration with HM. The generation of the p53 knockdown cell lines was supported by the Breast Cancer Research Foundation (JB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Cheung K, 2005, CYTOM PART A, V65A, P124, DOI 10.1002/cyto.a.20141; de la Rica R, 2006, ELECTROCHEM COMMUN, V8, P1239, DOI 10.1016/j.elecom.2006.05.028; de la Rica R, 2009, ANAL CHEM, V81, P10167, DOI 10.1021/ac9021049; Freed-Pastor WA, 2012, CELL, V148, P244, DOI 10.1016/j.cell.2011.12.017; Gualberto A, 1998, P NATL ACAD SCI USA, V95, P5166, DOI 10.1073/pnas.95.9.5166; Guck J, 2005, BIOPHYS J, V88, P3689, DOI 10.1529/biophysj.104.045476; Ke N, 2010, ANAL CHEM, V82, P6495, DOI 10.1021/ac1007877; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Liu DP, 2010, ONCOGENE, V29, P949, DOI 10.1038/onc.2009.376; Markx GH, 1999, ENZYME MICROB TECH, V25, P161, DOI 10.1016/S0141-0229(99)00008-3; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Song H, 2007, NAT CELL BIOL, V9, P573, DOI 10.1038/ncb1571; Strano S, 2007, ONCOGENE, V26, P2212, DOI 10.1038/sj.onc.1210296; Tong X, 1997, J MEMBRANE BIOL, V156, P131, DOI 10.1007/s002329900195; Walerych D, 2012, CARCINOGENESIS, V33, P2007, DOI 10.1093/carcin/bgs232	17	5	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99351	10.1371/journal.pone.0099351	http://dx.doi.org/10.1371/journal.pone.0099351			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937470	Green Published, gold			2022-12-27	WOS:000338503400016
J	Ahmad, S; Al-Shaikh, AA; Khan, Z				Ahmad, Suhail; Al-Shaikh, Ali A.; Khan, Ziauddin			Development of a Novel Inhalational Model of Invasive Pulmonary Aspergillosis in Rats and Comparative Evaluation of Three Biomarkers for Its Diagnosis	PLOS ONE			English	Article							REAL-TIME PCR; GALACTOMANNAN ENZYME-IMMUNOASSAY; BRONCHOALVEOLAR LAVAGE FLUID; LINKED-IMMUNOSORBENT-ASSAY; CHAIN-REACTION ASSAY; FUNGAL-INFECTIONS; ANTIFUNGAL TREATMENT; FUMIGATUS; DISEASES; DNA	Aspergillus fumigatus, a thermotolerant fungus, is the main causative agent of invasive pulmonary aspergillosis (IPA) in immunocompromised patients that is associated with high mortality rates. Early diagnosis of IPA is crucial for mortality reduction and improved prognosis. An experimental inhalational model of IPA was developed in rats and the efficacy of three biomarkers, namely beta-D-glucan (BDG), a panfungal marker, galactomannan (GM), a genus-specific marker, and A. fumigatus DNA, a species-specific marker was evaluated in serum and bronchoalveolar lavage (BAL) specimens at different time points postinfection for early diagnosis of IPA. BDG and GM were detected by using commercial Fungitell and Platelia Aspergillus EIA kits, respectively. A. fumigatus DNA was detected by developing a sensitive, single-step PCR assay. IPA was successfully developed in immunosuppressed rats and all animals until 5 days post-infection were positive for A. fumigatus by culture and KOH-calcofluor microscopy also showed A. fumigatus in 19 of 24 (79%) lung tissue samples. Fourteen of 30 (47%) and 27 of 30 (90%) serum and BAL specimens, respectively, were positive for all three biomarkers with 100% specificity (none of sera or BAL specimens of 12 control rats was positive for biomarkers). Our data show that BAL is a superior specimen than serum and combined detection of BDG, GM and A. fumigatus DNA provide a sensitive diagnosis of IPA in an experimental animal model. Moreover, combined detection of GM and DNA in BAL and detection of either GM or DNA in serum was also positive in 27 of 30 (90%) animals. For economic reasons and considering that the positive predictive value of BDG is low, the detection of GM and/or DNA in serum and BAL samples has the potential to serve as an integral component of the diagnostic-driven strategy in high-risk patients suspected for IPA.	[Ahmad, Suhail; Al-Shaikh, Ali A.; Khan, Ziauddin] Kuwait Univ, Dept Microbiol, Fac Med, Safat, Kuwait	Kuwait University	Khan, Z (corresponding author), Kuwait Univ, Dept Microbiol, Fac Med, Safat, Kuwait.	zkhan@hsc.edu.kw	Ahmad, Suhail/AAJ-5456-2021		Research Sector Grant [YM07/07]; College of Graduate Studies, Kuwait University	Research Sector Grant; College of Graduate Studies, Kuwait University	The study was supported by Research Sector Grant No. YM07/07 and College of Graduate Studies, Kuwait University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2002, J CLIN MICROBIOL, V40, P2483, DOI 10.1128/JCM.40.7.2483-2489.2002; Ahmad S, 2004, INT J MED MICROBIOL, V294, P45, DOI 10.1016/j.ijmm.2004.01.002; Ahmad S, 2007, DIAGN MICR INFEC DIS, V59, P165, DOI 10.1016/j.diagmicrobio.2007.04.009; Ahmad S, 2010, MYCOSES, V53, P40, DOI 10.1111/j.1439-0507.2008.01657.x; Arendrup MC, 2012, BONE MARROW TRANSPL, V47, P1030, DOI 10.1038/bmt.2011.246; Avni T, 2011, J CLIN MICROBIOL, V49, P4150; Becker MJ, 2000, J CLIN MICROBIOL, V38, P1434, DOI 10.1128/JCM.38.4.1434-1438.2000; Buchheidt D, 2004, BRIT J HAEMATOL, V125, P196, DOI 10.1111/j.1365-2141.2004.04904.x; Caillot D, 2001, J CLIN ONCOL, V19, P253, DOI 10.1200/JCO.2001.19.1.253; Chandenier J, 2009, MYCOSES, V52, P239, DOI 10.1111/j.1439-0507.2009.01695.x; Cicogna CE, 1997, ANTIMICROB AGENTS CH, V41, P259, DOI 10.1128/AAC.41.2.259; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Dimopoulos G, 2012, ANN NY ACAD SCI, V1272, P31, DOI 10.1111/j.1749-6632.2012.06805.x; Francesconi A, 2006, J CLIN MICROBIOL, V44, P2475, DOI 10.1128/JCM.02693-05; Girmenia C, 2012, CLIN MICROBIOL INFEC, V18, P990, DOI 10.1111/j.1469-0691.2011.03685.x; Guo YL, 2010, CHEST, V138, P817, DOI 10.1378/chest.10-0488; Halliday C, 2005, J CLIN MICROBIOL, V43, P5366, DOI 10.1128/JCM.43.10.5366-5368.2005; Hashimoto A, 1998, J CLIN LAB ANAL, V12, P257, DOI 10.1002/(SICI)1098-2825(1998)12:5&lt;257::AID-JCLA1&gt;3.0.CO;2-3; Heng SC, 2015, CRIT REV MICROBIOL, V41, P124, DOI 10.3109/1040841X.2013.804033; Hope WW, 2010, ANTIMICROB AGENTS CH, V54, P4879, DOI 10.1128/AAC.00673-10; Husain S, 2008, CLIN VACCINE IMMUNOL, V15, P1760, DOI 10.1128/CVI.00226-08; Karageorgopoulos DE, 2011, CLIN INFECT DIS, V52, P750, DOI 10.1093/cid/ciq206; Karthaus M, 2011, EUR J MED RES, V16, P145, DOI 10.1186/2047-783X-16-4-145; Karthaus M, 2013, CURR PHARM DESIGN, V19, P3569, DOI 10.2174/13816128113199990330; Khan ZU, 2008, MYCOSES, V51, P129, DOI 10.1111/j.1439-0507.2007.01461.x; Khan ZU, 2007, J MED MICROBIOL, V56, P129, DOI 10.1099/jmm.0.46549-0; Kontoyiannis DP, 2010, CLIN INFECT DIS, V50, P1091, DOI 10.1086/651263; Leeflang MM, 2008, COCHRANE DB SYST REV, V8; LEVY H, 1992, RESP MED, V86, P243, DOI 10.1016/S0954-6111(06)80062-4; Lin SJ, 2001, CLIN INFECT DIS, V32, P358, DOI 10.1086/318483; Lo Giudice P, 2010, ANTIMICROB AGENTS CH, V54, P4513, DOI 10.1128/AAC.00674-10; Luong ML, 2011, CLIN INFECT DIS, V52, P1218, DOI 10.1093/cid/cir185; Meersseman W, 2008, AM J RESP CRIT CARE, V177, P27, DOI 10.1164/rccm.200704-606OC; Mengoli C, 2009, LANCET INFECT DIS, V9, P89, DOI 10.1016/S1473-3099(09)70019-2; Mikolajewska A, 2012, MYCOSES, V55, P2, DOI 10.1111/j.1439-0507.2010.01961.x; Mokaddas E, 2010, J MED MICROBIOL, V59, P1519, DOI 10.1099/jmm.0.023630-0; Morrissey CO, 2013, LANCET INFECT DIS, V13, P519, DOI 10.1016/S1473-3099(13)70076-8; Pazos C, 2005, J CLIN MICROBIOL, V43, P299, DOI 10.1128/JCM.43.1.299-305.2005; Reichenberger F, 1999, BONE MARROW TRANSPL, V24, P1195, DOI 10.1038/sj.bmt.1702045; Rogers TR, 2013, BRIT J HAEMATOL, V161, P517, DOI 10.1111/bjh.12285; Schuetz AN, 2013, CLIN LAB MED, V33, P505, DOI 10.1016/j.cll.2013.03.009; Sheppard DC, 2006, ANTIMICROB AGENTS CH, V50, P3501, DOI 10.1128/AAC.00787-06; Vallor AC, 2008, ANTIMICROB AGENTS CH, V52, P2593, DOI 10.1128/AAC.00276-08; Walsh TJ, 2011, J CLIN MICROBIOL, V49, P4150, DOI 10.1128/JCM.00570-11; White PL, 2013, J CLIN MICROBIOL, V51, P1510, DOI 10.1128/JCM.03189-12; Zhao YA, 2010, J CLIN MICROBIOL, V48, P1378, DOI 10.1128/JCM.02214-09	46	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100524	10.1371/journal.pone.0100524	http://dx.doi.org/10.1371/journal.pone.0100524			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955575	Green Published, Green Submitted, gold			2022-12-27	WOS:000338917900064
J	Gopalan, TK; Gururaj, P; Gupta, R; Gopal, DR; Rajesh, P; Chidambaram, B; Kalyanasundaram, A; Angamuthu, R				Gopalan, Tirumurugaan Krishnaswamy; Gururaj, Pradheepa; Gupta, Ravi; Gopal, Dhinakar Raj; Rajesh, Preeti; Chidambaram, Balachandran; Kalyanasundaram, Aravindan; Angamuthu, Raja			Transcriptome Profiling Reveals Higher Vertebrate Orthologous of Intra-Cytoplasmic Pattern Recognition Receptors in Grey Bamboo Shark	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-3; SEQUENCING TECHNOLOGIES; RNA; ULTRAFAST; EVOLUTION; GENOME	From an immunologist perspective, sharks are an important group of jawed cartilaginous fishes and survey of the public database revealed a great gap in availability of large-scale sequence data for the group of Chondrichthyans the elasmobranchs. In an attempt to bridge this deficit we generated the transcriptome from the spleen and kidney tissues (a total of 1,606,172 transcripts) of the shark, Chiloscyllium griseum using the Illumina HiSeq2000 platform. With a cut off of > = 300 bp and an expression value of >1RPKM we used 43,385 transcripts for BLASTX analysis which revealed 17,548 transcripts matching to the NCBI nr database with an E-value of <=10(-5) and similarity score of 40%. The longest transcript was 16,974 bases with matched to HECT domain containing E3 ubiqutin protein ligase. MEGAN4 annotation pipeline revealed immune and signalling pathways including cell adhesion molecules, cytokine-cytokine receptor interaction, T-cell receptor signalling pathway and chemokine signaling pathway to be highly expressed in spleen, while different metabolism pathways such as amino acid metabolism, carbohydrate metabolism, lipid metabolism and xenobiotic biodegradation were highly expressed in kidney. Few of the candidate genes were selected to analyze their expression levels in various tissues by real-time PCR and also localization of a receptor by in-situ PCR to validate the prediction. We also predicted the domains structures of some of the identified pattern recognition receptors, their phylogenetic relationship with lower and higher vertebrates and the complete downstream signaling mediators of classical dsRNA signaling pathway. The generated transcriptome will be a valuable resource to further genetic and genomic research in elasmobranchs.	[Gopalan, Tirumurugaan Krishnaswamy; Gururaj, Pradheepa; Gopal, Dhinakar Raj; Kalyanasundaram, Aravindan; Angamuthu, Raja] Tamil Nadu Vet & Anim Sci Univ, Dept Anim Biotechnol, Madras, Tamil Nadu, India; [Gopalan, Tirumurugaan Krishnaswamy; Gopal, Dhinakar Raj] Tamil Nadu Vet & Anim Sci Univ, Madras, Tamil Nadu, India; [Gupta, Ravi; Rajesh, Preeti] SciGenom Labs Pvt Ltd, Cochin, Kerala, India; [Chidambaram, Balachandran] Tamil Nadu Vet & Anim Sci Univ, Dept Vet Pathol, Madras, Tamil Nadu, India	Tamil Nadu Veterinary & Animal Sciences University; Tamil Nadu Veterinary & Animal Sciences University; Tamil Nadu Veterinary & Animal Sciences University	Gopal, DR (corresponding author), Tamil Nadu Vet & Anim Sci Univ, Dept Anim Biotechnol, Madras, Tamil Nadu, India.	dhinakarrajg@tanvuas.org.in	Angamuthu, Raja/AAG-6357-2020; Gopal, DHinakar Raj/AAE-4411-2020; Kalyanasundaram, Aravindan/AAC-3500-2021	Gopal, Dhinakar Raj/0000-0003-0254-926X; Kalyanasundaram, Aravindan/0000-0001-6301-4328	ICAR-NAIP [C30018]	ICAR-NAIP(Indian Council of Agricultural Research (ICAR))	The authors thank ICAR-NAIP for funding this study (C30018) and TANUVAS for all facilities to carry out his work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anandhakumar C, 2012, FISH SHELLFISH IMMUN, V33, P1174, DOI 10.1016/j.fsi.2012.09.007; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Baoprasertkul P, 2006, IMMUNOGENETICS, V58, P817, DOI 10.1007/s00251-006-0144-z; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Carroll RL, 1988, VERTEBRATE PALEONTOL; Chen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036256; Collins LJ, 2008, GENOME INFORM SER, V21, P3; Feldmeyer B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-317; Flajnik MF, 2000, CURR TOP MICROBIOL, V248, P249; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; Hao DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021220; Hazon N, 2003, COMP BIOCHEM PHYS B, V136, P685, DOI 10.1016/S1096-4959(03)00280-X; Hertzano R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002309; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Inoue J, 2010, SYST BIOL, V59, P74, DOI 10.1093/sysbio/syp078; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Litman GW, 2010, NAT REV IMMUNOL, V10, P543, DOI 10.1038/nri2807; Litman GF, 1999, ANNU REV IMMUNOL, V17, P109, DOI 10.1146/annurev.immunol.17.1.109; Mattingly C, 2004, ZEBRAFISH, V1, P111, DOI 10.1089/zeb.2004.1.111; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nykjaer A, 1999, CELL, V96, P507, DOI 10.1016/S0092-8674(00)80655-8; Phelan PE, 2005, MOL IMMUNOL, V42, P1057, DOI 10.1016/j.molimm.2004.11.005; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Rodriguez MF, 2005, IMMUNOGENETICS, V57, P510, DOI 10.1007/s00251-005-0013-1; Surget-Groba Y, 2010, GENOME RES, V20, P1432, DOI 10.1101/gr.103846.109; Swathi A, 2013, J MOL MODEL, V19, P3863, DOI 10.1007/s00894-013-1871-3; Takechi M, 2011, J EXP ZOOL PART B, V316B, P526, DOI 10.1002/jez.b.21427; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tirumurugaan KG, 2010, VET IMMUNOL IMMUNOP, V133, P296, DOI 10.1016/j.vetimm.2009.08.015; Tsuboi N, 2002, J IMMUNOL, V169, P2026, DOI 10.4049/jimmunol.169.4.2026; Venkatesh B, 2014, NATURE, V505, P174, DOI 10.1038/nature12826; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wang W, 2013, J ZHEJIANG UNIV-SC B, V14, P58, DOI 10.1631/jzus.B1200219; Wheat CW, 2011, METHODS MOL BIOL, V772, P129, DOI 10.1007/978-1-61779-228-1_7; Zhang J., 2012, FUNCTIONAL GENOMICS	41	14	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100018	10.1371/journal.pone.0100018	http://dx.doi.org/10.1371/journal.pone.0100018			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956167	gold, Green Published, Green Submitted			2022-12-27	WOS:000338917900024
J	Sanford, JL; Barski, SA; Seen, CM; Dickens, JC; Shields, VDC				Sanford, Jillian L.; Barski, Sharon A.; Seen, Christina M.; Dickens, Joseph C.; Shields, Vonnie D. C.			Neurophysiological and Behavioral Responses of Gypsy Moth Larvae to Insect Repellents: DEET, IR3535, and Picaridin	PLOS ONE			English	Article							LYMANTRIA-DISPAR L.; AEDES-AEGYPTI; MOSQUITO REPELLENTS; LEPIDOPTERA LYMANTRIIDAE; SPECIALIST HERBIVORES; CELLULAR BASIS; BITTER TASTE; DETERRENT; RECEPTOR; GENERALIST	The interactions between insect repellents and the olfactory system have been widely studied, however relatively little is known about the effects of repellents on the gustatory system of insects. In this study, we show that the gustatory receptor neuron (GRN) located in the medial styloconic sensilla on the maxillary palps of gypsy moth larvae, and known to be sensitive to feeding deterrents, also responds to the insect repellents DEET, IR3535, and picaridin. These repellents did not elicit responses in the lateral styloconic sensilla. Moreover, behavioral studies demonstrated that each repellent deterred feeding. This is the first study to show perception of insect repellents by the gustatory system of a lepidopteran larva and suggests that detection of a range of bitter or aversive compounds may be a broadly conserved feature among insects.	[Sanford, Jillian L.; Barski, Sharon A.; Seen, Christina M.; Shields, Vonnie D. C.] Towson Univ, Dept Biol Sci, Insect Morphol & Physiol Lab, Towson, MD 21252 USA; [Dickens, Joseph C.] ARS, USDA, Henry A Wallace Beltsville Agr Res Ctr, Invas Insect Biocontrol & Behav Lab, Beltsville, MD USA	University System of Maryland; Towson University; United States Department of Agriculture (USDA)	Shields, VDC (corresponding author), Towson Univ, Dept Biol Sci, Insect Morphol & Physiol Lab, Towson, MD 21252 USA.	vshields@towson.edu	Dickens, Dick/AGY-7295-2022		Towson University Graduate Student Association; NIH [1R15DC007609-01, 2R25GM058264-05A1]; Deployed War Fighter Protection (DWFP) Program - Department of Defense through the Armed Forces Pest Management Board (AFPMB); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R15DC007609] Funding Source: NIH RePORTER	Towson University Graduate Student Association; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deployed War Fighter Protection (DWFP) Program - Department of Defense through the Armed Forces Pest Management Board (AFPMB); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants to J.L.S. (Towson University Graduate Student Association), and V. D. C. S. (NIH 1R15DC007609-01). S. B. and C. S. were supported by NIH grant 2R25GM058264-05A1. J.C.D. was supported partly by a grant from the Deployed War Fighter Protection (DWFP) Program funded by the Department of Defense through the Armed Forces Pest Management Board (AFPMB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnard DR, 2004, J MED ENTOMOL, V41, P726, DOI 10.1603/0022-2585-41.4.726; BARZEEV M, 1959, J ECON ENTOMOL, V52, P268, DOI 10.1093/jee/52.2.268; Bernays EA, 2000, J COMP PHYSIOL A, V186, P13, DOI 10.1007/s003590050002; Bohbot JD, 2011, MED VET ENTOMOL, V25, P436, DOI 10.1111/j.1365-2915.2011.00949.x; Brown M, 1997, J AM ACAD DERMATOL, V36, P243, DOI 10.1016/S0190-9622(97)70289-5; Descoins C, 1999, J INSECT PHYSIOL, V45, P871, DOI 10.1016/S0022-1910(99)00057-8; Dickens JC, 2013, PESTIC BIOCHEM PHYS, V106, P149, DOI 10.1016/j.pestbp.2013.02.006; Dyer LA, 2003, J CHEM ECOL, V29, P2499, DOI 10.1023/A:1026310001958; Glendinning JI, 1997, J NEUROPHYSIOL, V78, P734, DOI 10.1152/jn.1997.78.2.734; Glendinning JI, 2006, J NEUROSCI, V26, P8900, DOI 10.1523/JNEUROSCI.2351-06.2006; HODGSON ES, 1955, SCIENCE, V122, P417, DOI 10.1126/science.122.3166.417-a; Katz TM, 2008, J AM ACAD DERMATOL, V58, P865, DOI 10.1016/j.jaad.2007.10.005; Klun JA, 2006, J MED ENTOMOL, V43, P34, DOI 10.1603/0022-2585(2006)043[0034:RADEOS]2.0.CO;2; Lee Y, 2010, NEURON, V67, P555, DOI 10.1016/j.neuron.2010.07.006; Licciardi S, 2006, MED VET ENTOMOL, V20, P288, DOI 10.1111/j.1365-2915.2006.00630.x; LIEBHOLD AM, 1995, FOREST SCI, V41, P1; Martin TL, 2012, ARTHROPOD-PLANT INTE, V6, P519, DOI 10.1007/s11829-012-9209-0; Martin TL, 2012, ARTHROPOD-PLANT INTE, V6, P259, DOI 10.1007/s11829-012-9183-6; Natarajan R, 2005, PEST MANAG SCI, V61, P1193, DOI 10.1002/ps.1116; Park BS, 2002, CROP PROT, V21, P249, DOI 10.1016/S0261-2194(01)00079-5; Rharrabe K, 2011, ENTOMOL EXP APPL, V138, P33, DOI 10.1111/j.1570-7458.2010.01068.x; Richards LA, 2010, J CHEM ECOL, V36, P1105, DOI 10.1007/s10886-010-9852-9; Sanford JL, 2013, NATURWISSENSCHAFTEN, V100, P269, DOI 10.1007/s00114-013-1021-x; SCHOONHOVEN L. M., 1966, ARCH NEER ZOOL, V16, P497; SCHOONHOVEN LM, 1994, J COMP PHYSIOL A, V175, P519; Shields VDC, 2006, NATURWISSENSCHAFTEN, V93, P127, DOI 10.1007/s00114-005-0070-1; SHIELDS VDC, 1995, PHILOS T R SOC B, V347, P447, DOI 10.1098/rstb.1995.0036; Shields VDC, 2003, ANN ENTOMOL SOC AM, V96, P920, DOI 10.1603/0013-8746(2003)096[0920:HSAAOS]2.0.CO;2; Shields VDC, 2008, ARTHROPOD-PLANT INTE, V2, P101, DOI 10.1007/s11829-008-9035-6; Shields VDC, 2009, ANN ENTOMOL SOC AM, V102, P1116, DOI 10.1603/008.102.0621; Sokal R.R., 2012, BIOMETRY PRINCIPLES; Sparks JT, 2013, INSECT BIOCHEM MOLEC, V43, P1161, DOI 10.1016/j.ibmb.2013.10.005; Tavares WS, 2011, J MED PLANTS RES, V5, P5301; van Loon JJA, 1999, ENTOMOL EXP APPL, V91, P29, DOI 10.1046/j.1570-7458.1999.00463.x; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Weiss LA, 2011, NEURON, V69, P258, DOI 10.1016/j.neuron.2011.01.001; Xia YF, 2008, P NATL ACAD SCI USA, V105, P6433, DOI 10.1073/pnas.0801007105; Zhou DS, 2010, J COMP PHYSIOL A, V196, P791, DOI 10.1007/s00359-010-0558-9	38	5	5	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e99924	10.1371/journal.pone.0099924	http://dx.doi.org/10.1371/journal.pone.0099924			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955823	Green Submitted, Green Published, gold			2022-12-27	WOS:000338917900021
J	Yoo, JY; Shin, H; Kim, TH; Choi, WS; Ferguson, SD; Fazleabas, AT; Young, SL; Lessey, BA; Ha, UH; Jeong, JW				Yoo, Jung-Yoon; Shin, Heesung; Kim, Tae Hoon; Choi, Won-Seok; Ferguson, Susan D.; Fazleabas, Asgerally T.; Young, Steven L.; Lessey, Bruce A.; Ha, Un-Hwan; Jeong, Jae-Wook			CRISPLD2 Is a Target of Progesterone Receptor and Its Expression Is Decreased in Women with Endometriosis	PLOS ONE			English	Article							MOUSE UTERUS; GENE-EXPRESSION; BRANCHING MORPHOGENESIS; REPRODUCTIVE FUNCTIONS; SIGNAL TRANSDUCER; PERITONEAL-FLUID; EPITHELIAL-CELLS; PAPIO-ANUBIS; IMPLANTATION; INFLAMMATION	Endometriosis, defined as the presence of endometrial cells outside of the uterine cavity, is a major cause of infertility and pelvic pain, afflicting more than 10% of reproductive age women. Endometriosis is a chronic inflammatory disease and lipopolysaccharide promotes the proliferation and invasion of endometriotic stromal cells. Cysteine-rich secretory protein LCCL domain-containing 2 (CRISPLD2) has high affinity for lipopolysaccharide and plays a critical role in defense against endotoxin shock. However, the function of CRISPLD2 has not been studied in endometriosis and uterine biology. Herein, we examined the expression of CRISPLD2 in endometrium from patients with and without endometriosis using immunohistochemistry. The expression of CRISPLD2 was higher in the secretory phase in human menstrual cycle compared to proliferative phase. The expression of CRISPLD2 was significantly decreased in the endometrium of women with endometriosis in the early secretory phase compared to women without endometriosis. The increase of CRISPLD2 expression at the early secretory and dysregulation of its expression in endometriosis suggest progesterone (P4) regulation of CRISPLD2. To investigate whether CRISPLD2 is regulated by P4, we examined the expression of the CRISPLD2 in the uteri of wild-type and progesterone receptor knock out (PRKO) mice. The expression of CRISPLD2 was significantly increased after P4 treatment in the wild-type mice. However, CRISPLD2 expression was significantly decreased in the (PRKO) mice treated with P4. During early pregnancy, the expression of CRISPLD2 was increased in decidua of implantation and postimplantation stages. CRISPLD2 levels were also increased in cultured human endometrial stromal cells during in vitro decidualization. These results suggest that the CRISPLD2 is a target of the progesterone receptor and may play an important role in pathogenesis of endometriosis.	[Yoo, Jung-Yoon; Shin, Heesung; Kim, Tae Hoon; Ferguson, Susan D.; Fazleabas, Asgerally T.; Jeong, Jae-Wook] Michigan State Univ, Dept Obstet Gynecol & Reprod Biol, Coll Human Med, Grand Rapids, MI USA; [Shin, Heesung; Ha, Un-Hwan] Korea Univ, Dept Biotechnol & Bioinformat, Sejong, South Korea; [Choi, Won-Seok] Korea Natl Univ Transportat, Dept Food Sci & Technol, Chungbuk, South Korea; [Young, Steven L.] Univ N Carolina, Dept Obstet & Gynecol, Chapel Hill, NC USA; [Lessey, Bruce A.] Greenville Hosp Syst, Univ Med Grp, Dept Obstet & Gynecol, Greenville, SC USA	Michigan State University; Michigan State University College of Human Medicine; Korea University; Korea National University of Transportation; University of North Carolina; University of North Carolina Chapel Hill; Greenville Health System	Ha, UH (corresponding author), Korea Univ, Dept Biotechnol & Bioinformat, Sejong, South Korea.	haunhwan@korea.ac.kr; JaeWook.Jeong@hc.msu.edu	Ha, Un-Hwan/ABH-8017-2020; Young, Steven L/G-2304-2014	Young, Steven L/0000-0002-5205-4495; Ha, Un-Hwan/0000-0001-9182-7000; Yoo, Jung-Yoon/0000-0001-9366-3863	NIH [R01 HD067721, R01 HD057873]; American Cancer Society [RSG-12-084-01-TBG]; Converging Research Center Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [2013K000249]; BK21 plus program of the Ministry of Education, Korea; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD067721] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Converging Research Center Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning; BK21 plus program of the Ministry of Education, Korea; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by NIH R01 HD067721 (to SLY and BAL), NIH R01 HD057873 and American Cancer Society Research Grant RSG-12-084-01-TBG (to JWJ), and the Converging Research Center Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (No. 2013K000249), and the BK21 plus program of the Ministry of Education, Korea (to UHH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshar Y, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.104497; Aisemberg J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056161; Al-Sabbagh M, 2012, MOL CELL ENDOCRINOL, V358, P208, DOI 10.1016/j.mce.2011.10.035; Attia GR, 2000, J CLIN ENDOCR METAB, V85, P2897, DOI 10.1210/jc.85.8.2897; BOUTTEN A, 1992, CLIN CHIM ACTA, V210, P187, DOI 10.1016/0009-8981(92)90204-4; Bruner-Tran K L, 2013, Minerva Ginecol, V65, P199; Bulun SE, 2006, MOL CELL ENDOCRINOL, V248, P94, DOI 10.1016/j.mce.2005.11.041; Bulun SE, 2009, NEW ENGL J MED, V360, P268, DOI 10.1056/NEJMra0804690; Burney RO, 2007, ENDOCRINOLOGY, V148, P3814, DOI 10.1210/en.2006-1692; Burney RO, 2007, ENDOCRINOLOGY; BUYALOS RP, 1992, FERTIL STERIL, V58, P302; Chiquet BT, 2007, HUM MOL GENET, V16, P2241, DOI 10.1093/hmg/ddm176; CLARKE CL, 1990, ENDOCR REV, V11, P266, DOI 10.1210/edrv-11-2-266; Conneely OM, 2002, RECENT PROG HORM RES, V57, P339, DOI 10.1210/rp.57.1.339; Conneely OM, 2001, MOL CELL ENDOCRINOL, V179, P97, DOI 10.1016/S0303-7207(01)00465-8; Conneely Orla M, 2002, Rev Endocr Metab Disord, V3, P201, DOI 10.1023/A:1020020308980; Daftary GS, 2004, J CLIN ENDOCR METAB, V89, P2390, DOI 10.1210/jc.2003-031389; Dekel N, 2010, AM J REPROD IMMUNOL, V63, P17, DOI 10.1111/j.1600-0897.2009.00792.x; Dimitriadis E, 2006, J REPROD IMMUNOL, V69, P53, DOI 10.1016/j.jri.2005.07.004; Eskenazi B, 1997, OBSTET GYN CLIN N AM, V24, P235, DOI 10.1016/S0889-8545(05)70302-8; Evans J, 2013, BIOL REPROD; Evans J, 2012, REV ENDOCR METAB DIS, V13, P277, DOI 10.1007/s11154-012-9223-7; Filant J, 2014, FASEB J, V28, P230, DOI 10.1096/fj.13-237446; Gibbs GM, 2008, ENDOCR REV, V29, P865, DOI 10.1210/er.2008-0032; Greer S, 2013, J PHARMACOL EXP THER, V346, P473, DOI 10.1124/jpet.113.206284; GROSSKINSKY CM, 1993, BAILLIERE CLIN OB GY, V7, P701, DOI 10.1016/S0950-3552(05)80459-6; HALME J, 1984, OBSTET GYNECOL, V64, P151; Hardy DB, 2006, MOL ENDOCRINOL, V20, P2724, DOI 10.1210/me.2006-0112; Hirano T, 2000, ONCOGENE, V19, P2548, DOI 10.1038/sj.onc.1203551; HUETHUDSON YM, 1989, ENDOCRINOLOGY, V125, P1683, DOI 10.1210/endo-125-3-1683; Kao LC, 2003, ENDOCRINOLOGY, V144, P2870, DOI 10.1210/en.2003-0043; Kaplan F, 1999, AM J PHYSIOL-LUNG C, V276, pL1027, DOI 10.1152/ajplung.1999.276.6.L1027; Kaunitz AM, 1998, INT J FERTIL WOMEN M, V43, P73; Kim JJ, 2007, MOL HUM REPROD, V13, P323, DOI 10.1093/molehr/gam005; Kim JJ, 1998, BIOL REPROD, V59, P160, DOI 10.1095/biolreprod59.1.160; Kim TH, 2010, BIOL REPROD, V82, P706, DOI 10.1095/biolreprod.109.081307; KISTNER RW, 1958, AM J OBSTET GYNECOL, V75, P264, DOI 10.1016/0002-9378(58)90384-3; Kobayashi H, 2014, MOL MED REP, V9, P9, DOI 10.3892/mmr.2013.1755; Kundu JK, 2008, MUTAT RES-REV MUTAT, V659, P15, DOI 10.1016/j.mrrev.2008.03.002; Kurihara I, 2007, PLOS GENET, V3, P1053, DOI 10.1371/journal.pgen.0030102; Lan J, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-83; Lee CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075282; Lee JH, 2013, FASEB J, V27, P2553, DOI 10.1096/fj.12-225664; Lee K, 2006, NAT GENET, V38, P1204, DOI 10.1038/ng1874; Lee KY, 2004, REPRODUCTION, V128, P679, DOI 10.1530/rep.1.00340; Liu TY, 2002, BIOL REPROD, V67, P114, DOI 10.1095/biolreprod67.1.114; Lydon JP, 1996, J STEROID BIOCHEM, V56, P67, DOI 10.1016/0960-0760(95)00254-5; LYDON JP, 1995, GENE DEV, V9, P2266, DOI 10.1101/gad.9.18.2266; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; MARTIN L, 1973, J ENDOCRINOL, V56, P133, DOI 10.1677/joe.0.0560133; MARTIN L, 1973, J ENDOCRINOL, V57, P549, DOI 10.1677/joe.0.0570549; Minici F, 2008, HUM REPROD, V23, P530, DOI 10.1093/humrep/dem399; Noyes R W, 1975, Am J Obstet Gynecol, V122, P262; OLIVE DL, 1993, NEW ENGL J MED, V328, P1759, DOI 10.1056/NEJM199306173282407; Olive DL, 2004, BEST PRACT RES CL OB, V18, P319, DOI 10.1016/j.bpobgyn.2004.03.005; Oyewumi L, 2003, BIOCHEM J, V376, P61, DOI 10.1042/BJ20030591; Oyewumi L, 2003, AM J RESP CELL MOL, V28, P232, DOI 10.1165/rcmb.4877; PARIA BC, 1993, P NATL ACAD SCI USA, V90, P10159, DOI 10.1073/pnas.90.21.10159; Pellicer A, 1998, FERTIL STERIL, V70, P425, DOI 10.1016/S0015-0282(98)00204-0; Rubel CA, 2012, MOL ENDOCRINOL, V26, P1428, DOI 10.1210/me.2011-1355; Rubel CA, 2010, SEMIN REPROD MED, V28, P27, DOI 10.1055/s-0029-1242990; Sinaii N, 2002, HUM REPROD, V17, P2715, DOI 10.1093/humrep/17.10.2715; Soyal SM, 2005, GENESIS, V41, P58, DOI 10.1002/gene.20098; Tabibzadeh S, 2000, J CLIN ENDOCR METAB, V85, P2526, DOI 10.1210/jc.85.7.2526; Vasarhelyi V, 2013, BIOCHIMIE; von Wolff M, 2000, MOL HUM REPROD, V6, P627; Wang T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065743; Wang YX, 2013, P NATL ACAD SCI USA, V110, P16975, DOI 10.1073/pnas.1315862110; Wang ZQ, 2009, J IMMUNOL, V183, P6646, DOI 10.4049/jimmunol.0802348; Wetendorf M, 2012, MOL CELL ENDOCRINOL, V357, P108, DOI 10.1016/j.mce.2011.10.028; Yang SJ, 2002, J CLIN ENDOCR METAB, V87, P2336, DOI 10.1210/jc.87.5.2336; Yuan QP, 2012, GENESIS, V50, P871, DOI 10.1002/dvg.22051	72	24	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100481	10.1371/journal.pone.0100481	http://dx.doi.org/10.1371/journal.pone.0100481			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955763	gold, Green Published, Green Submitted			2022-12-27	WOS:000338917900056
J	Cianci, F; Sweeney, S; Konate, I; Nagot, N; Low, A; Mayaud, P; Vickerman, P				Cianci, Fiona; Sweeney, Sedona; Konate, Issouf; Nagot, Nicolas; Low, Andrea; Mayaud, Philippe; Vickerman, Peter			The Cost of Providing Combined Prevention and Treatment Services, Including ART, to Female Sex Workers in Burkina Faso	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HIV PREVENTION; COMMERCIAL SEX; HIGH-RISK; CARE; HEALTH; INTERVENTIONS; TRANSMISSION; EQUIVALENCE; POPULATIONS	Background: Female Sex workers (FSW) are important in driving HIV transmission in West Africa. The Yerelon clinic in Burkina Faso has provided combined preventative and therapeutic services, including anti-retroviral therapy (ART), for FSWs since 1998, with evidence suggesting it has decreased HIV prevalence and incidence in this group. No data exists on the costs of such a combined prevention and treatment intervention for FSW. This study aims to determine the mean cost of service provision per patient year for FSWs attending the Yerelon clinic, and identifies differences in costs between patient groups. Methods: Field-based retrospective cost analyses were undertaken using top-down and bottom-up costing approaches for 2010. Expenditure and service utilisation data was collated from primary sources. Patients were divided into groups according to full-time or occasional sex-work, HIV status and ART duration. Patient specific service use data was extracted. Costs were converted to 2012 US$. Sensitivity analyses considered removal of all research costs, different discount rates and use of different ART treatment regimens and follow-up schedules. Results: Using the top-down costing approach, the mean annual cost of service provision for FSWs on or off ART was US$1098 and US$882, respectively. The cost for FSWs on ART reduced by 29%, to US$781, if all research-related costs were removed and national ART monitoring guidelines were followed. The bottom-up patient-level costing showed the cost of the service varied greatly across patient groups (US$505-US$1117), primarily due to large differences in the costs of different ART regimens. HIV-negative women had the lowest annual cost at US$505. Conclusion: Whilst FSWs may require specialised services to optimise their care and hence, the public health benefits, our study shows that the cost of ART provision within a combined prevention and treatment intervention setting is comparable to providing ART to other population groups in Africa.	[Cianci, Fiona; Sweeney, Sedona; Vickerman, Peter] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, Social & Math Epidemiol Grp, London WC1, England; [Konate, Issouf] UR VIH MA, Ctr Muraz, Bobo Dioulasso, Burkina Faso; [Nagot, Nicolas; Low, Andrea] INSERM, U1058, Montpellier, France; [Nagot, Nicolas; Low, Andrea] Univ Montpellier I, Montpellier, France; [Mayaud, Philippe] London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England; [Vickerman, Peter] Univ Bristol, Dept Social & Community Med, Bristol, Avon, England	University of London; London School of Hygiene & Tropical Medicine; Centre Muraz; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; University of London; London School of Hygiene & Tropical Medicine; University of Bristol	Cianci, F (corresponding author), London Sch Hyg & Trop Med, Dept Global Hlth & Dev, Social & Math Epidemiol Grp, London WC1, England.	fionacianci@yahoo.com	Nagot, Nicolas/I-9467-2014	Vickerman, Peter/0000-0002-8291-5890; Low, Andrea/0000-0002-7088-4556; MAYAUD, Philippe/0000-0001-5730-947X; Nagot, Nicolas/0000-0002-3493-2821				Alary M, 2004, AIDS, V18, P945, DOI 10.1097/00002030-200404090-00013; Alary M, 2002, AIDS, V16, P463, DOI 10.1097/00002030-200202150-00019; [Anonymous], UNAIDS COUNTR REP; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; BCEAO, 2012, TAUX INT BCEAO; Bikilla Asfaw Demissie, 2009, Cost Eff Resour Alloc, V7, P6, DOI 10.1186/1478-7547-7-6; Burgos Jose L, 2010, PLoS One, V5, pe11413, DOI 10.1371/journal.pone.0011413; Chakrapani V, 2009, AIDS PATIENT CARE ST, V23, P973, DOI 10.1089/apc.2009.0035; Chandrashekar S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S6-S7; Chapko MK, 2009, HEALTH ECON, V18, P1188, DOI 10.1002/hec.1422; CNLS, 2011, ENQ SURV COMP AUPR G; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cote AM, 2004, AIDS, V18, P917, DOI [10.1097/01.aids.0000111475.61782.98, 10.1097/00002030-200404090-00009]; Creese A, 1994, COST ANAL PRIMARY HL; Deghaye N, 2006, SAMJ S AFR MED J, V96, P140; Drummond MF, 2015, METHODS EC EVALUATIO; Fung ICH, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-195; Goldie SJ, 2006, NEW ENGL J MED, V355, P1141, DOI 10.1056/NEJMsa060247; Granich R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030216; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Halbwachs H, 2000, Health Estate, V54, P26; Harling G, 2007, SAMJ S AFR MED J, V97, P593; HOGAN DR, 2005, BRIT MED J, V331, P1431, DOI DOI 10.1136/BMJ.38643.368692.68; Hounton SH, 2008, AIDS CARE, V20, P582, DOI 10.1080/09540120701868303; Huet Charlotte, 2011, BMC Public Health, V11, P700, DOI 10.1186/1471-2458-11-700; Jaffar S, 2009, LANCET, V374, P2080, DOI 10.1016/S0140-6736(09)61674-3; Jia ZW, 2013, LANCET, V382, P1195, DOI 10.1016/S0140-6736(12)61898-4; Jouquet G, 2011, JAIDS-J ACQ IMM DEF, V58, pE68, DOI 10.1097/QAI.0b013e31822a9f8d; Konate I, 2011, JAIDS-J ACQ IMM DEF, V57, pS50, DOI 10.1097/QAI.0b013e3182207a3f; Loubiere S, 2010, CURR OPIN HIV AIDS, V5, P225, DOI 10.1097/COH.0b013e3283384a9d; Low AJ, 2014, JAIDS-J ACQ IMM DEF, V65, P237, DOI 10.1097/QAI.0000000000000049; Lowndes CM, 2000, AIDS, V14, P2523, DOI 10.1097/00002030-200011100-00015; Martinson N, 2009, JAIDS-J ACQ IMM DEF, V50, P327, DOI 10.1097/QAI.0b013e3181958546; Menzies NA, 2011, AIDS, V25, P1753, DOI 10.1097/QAD.0b013e3283463eec; Modjarrad K, 2008, AIDS, V22, P2179, DOI 10.1097/QAD.0b013e328312c756; Montague BT, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-701; National Institute of Drug Abuse, 2012, 2012 MTF SURV; Prinja S, 2011, SEX TRANSM INFECT, V87, P354, DOI 10.1136/sti.2010.047829; Rosen S, 2008, TROP MED INT HEALTH, V13, P1005, DOI 10.1111/j.1365-3156.2008.02114.x; Rosen S, 2008, JAIDS-J ACQ IMM DEF, V48, P334, DOI 10.1097/QAI.0b013e31817ae5ef; Tagar E SM, 2012, MULTICOUNTRY ANAL TR; Terris-Prestholt F, 2011, GUIDELINES COST EFFE; UNAIDS, 2011, WORLD AIDS DAY REP 2; UNICEF, 2011, BURK FAS STAT; Vickerman P, 2010, AIDS, V24, P2554, DOI 10.1097/QAD.0b013e32833e8663; WHO, 2010, ANT THER HIV INF AD; WHO UNICEF & UNAIDS., 2011, UN ACC, P1; Yaya Bocum F KS, 2009, CARACTERISTIQUES REV	48	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100107	10.1371/journal.pone.0100107	http://dx.doi.org/10.1371/journal.pone.0100107			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK2UZ	24950185	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000338276300037
J	Gul, T; Islam, S; Shah, RA; Khan, I; Shafie, S				Gul, Taza; Islam, Saed; Shah, Rehan Ali; Khan, Ilyas; Shafie, Sharidan			Thin Film Flow in MHD Third Grade Fluid on a Vertical Belt with Temperature Dependent Viscosity	PLOS ONE			English	Article							HOMOTOPY ASYMPTOTIC METHOD; ADOMIAN DECOMPOSITION METHOD; PERTURBATION METHOD; RELIABLE TREATMENT; STARTING SOLUTIONS; CONVECTION FLOW; 2ND-GRADE FLUID; 3RD-GRADE FLUID; HEAT-TRANSFER; POROUS-MEDIUM	In this work, we have carried out the influence of temperature dependent viscosity on thin film flow of a magnetohydrodynamic (MHD) third grade fluid past a vertical belt. The governing coupled non-linear differential equations with appropriate boundary conditions are solved analytically by using Adomian Decomposition Method (ADM). In order to make comparison, the governing problem has also been solved by using Optimal Homotopy Asymptotic Method (OHAM). The physical characteristics of the problem have been well discussed in graphs for several parameter of interest.	[Gul, Taza; Islam, Saed] Abdul Wali Khan Univ Mardan, Dept Math, Mardan, Kpk, Pakistan; [Shah, Rehan Ali] UET Peshawar, Dept Math, Peshawar, Kpk, Pakistan; [Shafie, Sharidan] Majmaah Univ, Coll Engn, Majmaah, Saudi Arabia; [Khan, Ilyas] Univ Teknol Malaysia, Fac Sci, Dept Math Sci, Utm Johor Bahru, Johor, Malaysia	Majmaah University; Universiti Teknologi Malaysia	Shafie, S (corresponding author), Majmaah Univ, Coll Engn, Majmaah, Saudi Arabia.	sharidan@utm.my	SHAFIE, SHARIDAN/A-2210-2013; Gul, Taza/R-7774-2019; Khan, Ilyas/C-8770-2019; Saeed, Islam/AAD-6067-2020	SHAFIE, SHARIDAN/0000-0001-7795-2278; Gul, Taza/0000-0003-1376-8345; Khan, Ilyas/0000-0002-2056-9371; Saeed, Islam/0000-0001-5263-4871	research Management center - UTM; MOE (Ministry of Education) [4F109, 04H27]; UTM	research Management center - UTM; MOE (Ministry of Education); UTM(University of Toronto)	The authors would like to acknowledge the research Management center - UTM and MOE (Ministry of Education) for the financial support through vote 4F109 & 04H27 for this research. Prof. S. Islam gratefully acknowledges the financial support of his visit provided by UTM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adomian G., 1994, COATINGS; Adomian G, 1992, MATH COMPUT MODEL, V13, P287; Ali F, 2012, INT J NONLIN MECH, V47, P521, DOI 10.1016/j.ijnonlinmec.2011.09.027; Costa A, 2003, NONLINEAR PROC GEOPH, V10, P545, DOI 10.5194/npg-10-545-2003; Ellahi R, 2010, MATH COMPUT MODEL, V52, P1783, DOI 10.1016/j.mcm.2010.07.005; Fakhar K, 2008, APPL MATH COMPUT, V202, P376, DOI 10.1016/j.amc.2008.02.029; Fetecau C, 2006, INT J ENG SCI, V44, P788, DOI 10.1016/j.ijengsci.2006.04.010; Fetecau C, 2005, INT J ENG SCI, V43, P781, DOI 10.1016/j.ijengsci.2004.12.009; Fetecau C, 2013, Z NATURFORSCH A, V68, P659, DOI 10.5560/ZNA.2013-0041; Fetecau C, 2011, Z NATURFORSCH A, V66, P753, DOI 10.5560/ZNA.2011-0044; Gul T, 2013, J APPL MATH, DOI 10.1155/2013/707286; Hayat T, 2014, J THERMOPHYS HEAT TR, V28, P155, DOI 10.2514/1.T4113; Joneidi AA, 2009, INT COMMUN HEAT MASS, V36, P1082, DOI 10.1016/j.icheatmasstransfer.2009.06.021; Khaled ARA, 2004, INT J ENG SCI, V42, P509, DOI 10.1016/j.ijengsci.2003.08.005; Khan A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090280; Liao S., 2003, PERTURBATION INTRO H, DOI 10.1201/9780203491164; Marinca V, 2008, CENT EUR J PHYS, V6, P648, DOI [10.2478/s11534-008-0061-x, 10.2478/S11534-008-0061-x]; Marinca V, 2008, INT COMMUN HEAT MASS, V35, P710, DOI 10.1016/j.icheatmasstransfer.2008.02.010; Marinca V, 2009, APPL MATH LETT, V22, P245, DOI 10.1016/j.aml.2008.03.019; Miladinova S, 2004, J NON-NEWTON FLUID, V122, P69, DOI 10.1016/j.jnnfm.2004.01.021; Nadeem S, 2008, PHYS LETT A, V372, P4965, DOI 10.1016/j.physleta.2008.05.048; Nazar M, 2010, NONLINEAR ANAL-REAL, V11, P584, DOI 10.1016/j.nonrwa.2008.10.055; Qasim M, 2013, ALEX ENG J, V52, P571, DOI 10.1016/j.aej.2013.08.004; Qasim M, 2014, EUR PHYS J PLUS, V129, DOI 10.1140/epjp/i2014-14007-5; Qasim M, 2012, Z NATURFORSCH A, V67, P195, DOI 10.5560/ZNA.2012-0006; Rubbab Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078352; Siddiqui AM, 2008, CHAOS SOLITON FRACT, V35, P140, DOI 10.1016/j.chaos.2006.05.026; Siddiqui AM, 2007, CHAOS SOLITON FRACT, V33, P1006, DOI 10.1016/j.chaos.2006.01.101; Siddiqui AM, 2006, PHYS LETT A, V352, P404, DOI 10.1016/j.physleta.2005.12.033; Tan WC, 2007, PHYS LETT A, V360, P454, DOI 10.1016/j.physleta.2006.08.054; Turkyilmazoglu M, 2011, INT J THERM SCI, V50, P831, DOI 10.1016/j.ijthermalsci.2010.12.014; Turkyilmazoglu M, 2010, INT J MECH SCI, V52, P1735, DOI 10.1016/j.ijmecsci.2010.09.007; Turkyilmazoglu M, 2010, APPL MATH LETT, V23, P1226, DOI 10.1016/j.aml.2010.06.003; Turkyilmazoglu M, 2010, COMPUT FLUIDS, V39, P793, DOI 10.1016/j.compfluid.2009.12.007; Wazwaz AM, 2005, APPL MATH COMPUT, V166, P652, DOI 10.1016/j.amc.2004.06.059; Wazwaz AM, 2005, APPL MATH COMPUT, V161, P543, DOI 10.1016/j.amc.2003.12.048; Yao YD, 2010, NONLINEAR ANAL-REAL, V11, P4442, DOI 10.1016/j.nonrwa.2010.05.027	37	17	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e97552	10.1371/journal.pone.0097552	http://dx.doi.org/10.1371/journal.pone.0097552			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949988	Green Published, gold			2022-12-27	WOS:000338276300003
J	Han, YS; Zhang, FF; Tian, YH; Hu, PP; Li, B; Wang, K				Han, Yongsheng; Zhang, Fangfang; Tian, Yanghua; Hu, Panpan; Li, Bo; Wang, Kai			Selective Impairment of Attentional Networks of Alerting in Wilson's Disease	PLOS ONE			English	Article							PARKINSONS-DISEASE; EXECUTIVE CONTROL; VERBAL FLUENCY; RATING-SCALE; DEFICITS; RELIABILITY; INVOLVEMENT; DYSFUNCTION	Wilson's disease (WD) is typically affected by attention, which is one of the cognitive domains. The Attention Network Test (ANT) was developed to measure the functioning of the following three individual attentional networks: orienting, alerting, and executive control. The ANT has been used in a variety of neuropsychiatric conditions; however, it has not been used in WD. The aim of this study was to investigate the attentional function of WD patients, and 35 patients with early and moderate neurological WD, as well as 35 gender-, age-, and education-matched healthy controls performed the ANT. Remarkable differences between the patients and healthy controls were observed in the alerting network (p = 0.007) in contrast the differences in the orienting (p = 0.729) and executive control (p = 0.888) networks of visual attention. The mean reaction time in the ANT was significantly longer in the WD patients than in the controls (p<0.001, 0.001). In the WD patients, there was an effect specifically on the alerting domain of the attention network, whereas the orienting and executive control domains were not affected.	[Han, Yongsheng; Zhang, Fangfang; Tian, Yanghua; Hu, Panpan; Wang, Kai] Anhui Med Univ, Affiliated Hosp 1, Dept Neurol, Hefei, Anhui, Peoples R China; [Han, Yongsheng; Li, Bo] Anhui Univ Chinese Med, Inst Neurol, Hefei, Anhui, Peoples R China	Anhui Medical University; Anhui University of Chinese Medicine	Wang, K (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Dept Neurol, Hefei, Anhui, Peoples R China.	wangkai1964@126.com	Zhang, Fang/HHN-2153-2022; hu, panpan/ABD-5695-2021	Tian, Yanghua/0000-0001-5038-0599				Ala A, 2007, LANCET, V369, P397, DOI 10.1016/S0140-6736(07)60196-2; Allcock LM, 2009, PARKINSONISM RELAT D, V15, P110, DOI 10.1016/j.parkreldis.2008.03.010; Audet T, 2000, BRAIN COGNITION, V43, P17; Beane M, 2004, PROG NEUROBIOL, V74, P167, DOI 10.1016/j.pneurobio.2004.09.001; BLACKBURN HL, 1957, J CONSULT PSYCHOL, V21, P139, DOI 10.1037/h0047235; Booth JE, 2007, ARCH CLIN NEUROPSYCH, V22, P423, DOI 10.1016/j.acn.2007.01.017; Couette M, 2008, NEUROPSYCHOLOGIA, V46, P1391, DOI 10.1016/j.neuropsychologia.2007.12.017; Cristinzio C, 2013, BEHAV NEUROL, V27, P495, DOI [10.1155/2013/312426, 10.3233/BEN-129020]; Crivelli L, 2012, J INT NEUROPSYCH SOC, V18, P757, DOI 10.1017/S1355617712000410; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Fan J, 2007, J NEUROSCI, V27, P6197, DOI 10.1523/JNEUROSCI.1833-07.2007; Farrin L, 2003, J NEUROPSYCH CLIN N, V15, P98, DOI 10.1176/appi.neuropsych.15.1.98; Frota Norberto Anizio Ferreira, 2009, Dement. neuropsychol., V3, P16, DOI 10.1590/S1980-57642009DN30100004; Fuentes LJ, 2010, DEMENT GERIATR COGN, V29, P139, DOI 10.1159/000275672; Funahashi S, 2001, NEUROSCI RES, V39, P147, DOI 10.1016/S0168-0102(00)00224-8; Gajda J, 1994, J NEUROL S, V1, P161; GJERRIS A, 1983, J AFFECT DISORDERS, V5, P163, DOI 10.1016/0165-0327(83)90009-5; Gong, 1992, WECHSLER ADULT INTEL; Green AE, 2008, NAT REV NEUROSCI, V9, P710, DOI 10.1038/nrn2461; HANLEY JR, 1990, NEUROPSYCHOLOGIA, V28, P737, DOI 10.1016/0028-3932(90)90129-C; HAWKINS RA, 1987, NEUROLOGY, V37, P1707, DOI 10.1212/WNL.37.11.1707; Hegde S, 2010, NEUROL INDIA, V58, P708, DOI 10.4103/0028-3886.72172; Henry JD, 2004, J INT NEUROPSYCH SOC, V10, P608, DOI 10.1017/S1355617704104141; Kubler A, 2003, NEUROIMAGE, V20, P1298, DOI 10.1016/S1053-8119(03)00400-2; LANG C, 1989, J CLIN EXP NEUROPSYC, V11, P569, DOI 10.1080/01688638908400914; Leinweber B, 2008, MOVEMENT DISORD, V23, P54, DOI 10.1002/mds.21761; Leskin LP, 2007, NEUROPSYCHOLOGY, V21, P275, DOI 10.1037/0894-4105.21.3.275; Lin JJ, 2006, PEDIATR NEUROL, V35, P284, DOI 10.1016/j.pediatrneurol.2006.04.004; Litwin T, 2013, J NEUROL SCI, V329, P55, DOI 10.1016/j.jns.2013.03.021; Lundervold AJ, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-27; Middleton F. A., 1995, Society for Neuroscience Abstracts, V21, P676; MIDDLETON FA, 1994, SCIENCE, V266, P458, DOI 10.1126/science.7939688; MILLER IW, 1985, PSYCHIAT RES, V14, P131, DOI 10.1016/0165-1781(85)90057-5; Pacheco-Unguetti AP, 2011, J ANXIETY DISORD, V25, P888, DOI 10.1016/j.janxdis.2011.04.010; Portala K, 2000, ACTA PSYCHIAT SCAND, V101, P104, DOI 10.1034/j.1600-0447.2000.90085.x; Portala K, 2001, EUR ARCH PSY CLIN N, V251, P262, DOI 10.1007/PL00007543; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Rathbun JK, 1996, INT J NEUROSCI, V85, P221, DOI 10.3109/00207459608986684; Roberts EA, 2008, HEPATOLOGY, V47, P2089, DOI 10.1002/hep.22261; Schiff ND, 2008, ANN NY ACAD SCI, V1129, P105, DOI 10.1196/annals.1417.029; Seniow J, 2002, MOVEMENT DISORD, V17, P1077, DOI 10.1002/mds.10195; SNOW BJ, 1991, J NEUROL NEUROSUR PS, V54, P12, DOI 10.1136/jnnp.54.1.12; STAROSTARUBINSTEIN S, 1987, ARCH NEUROL-CHICAGO, V44, P365, DOI 10.1001/archneur.1987.00520160007005; Strum W, 1997, NEUROLOGICAL REHABIL, V7, P81; Svetel M, 2009, PARKINSONISM RELAT D, V15, P772, DOI 10.1016/j.parkreldis.2009.01.010; Swainson R, 2000, NEUROPSYCHOLOGIA, V38, P596, DOI 10.1016/S0028-3932(99)00103-7; Urbanek C, 2010, MULT SCLER J, V16, P93, DOI 10.1177/1352458509350308; Wang K, 2005, SCHIZOPHR RES, V78, P235, DOI 10.1016/j.schres.2005.01.019; Zhou SS, 2012, NEUROSCI LETT, V509, P50, DOI 10.1016/j.neulet.2011.12.049	50	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100454	10.1371/journal.pone.0100454	http://dx.doi.org/10.1371/journal.pone.0100454			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK2UZ	24949936	Green Published, Green Submitted, gold			2022-12-27	WOS:000338276300075
J	Hancock, DG; Shklovskaya, E; Guy, TV; Falsafi, R; Fjell, CD; Ritchie, W; Hancock, REW; Fazekas de St Groth, B				Hancock, David G.; Shklovskaya, Elena; Guy, Thomas V.; Falsafi, Reza; Fjell, Chris D.; Ritchie, William; Hancock, Robert E. W.; Fazekas de St Groth, Barbara			A Systems Biology Approach to the Analysis of Subset-Specific Responses to Lipopolysaccharide in Dendritic Cells	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; IN-VIVO; T-CELLS; TRANSCRIPTIONAL NETWORK; NEGATIVE REGULATION; INNATE IMMUNITY; MARGINAL ZONE; CUTTING EDGE; STEADY-STATE; INTEGRATION	Dendritic cells (DCs) are critical for regulating CD4 and CD8 T cell immunity, controlling Th1, Th2, and Th17 commitment, generating inducible Tregs, and mediating tolerance. It is believed that distinct DC subsets have evolved to control these different immune outcomes. However, how DC subsets mount different responses to inflammatory and/or tolerogenic signals in order to accomplish their divergent functions remains unclear. Lipopolysaccharide (LPS) provides an excellent model for investigating responses in closely related splenic DC subsets, as all subsets express the LPS receptor TLR4 and respond to LPS in vitro. However, previous studies of the LPS-induced DC transcriptome have been performed only on mixed DC populations. Moreover, comparisons of the in vivo response of two closely related DC subsets to LPS stimulation have not been reported in the literature to date. We compared the transcriptomes of murine splenic CD8 and CD11b DC subsets after in vivo LPS stimulation, using RNA-Seq and systems biology approaches. We identified subset-specific gene signatures, which included multiple functional immune mediators unique to each subset. To explain the observed subset-specific differences, we used a network analysis approach. While both DC subsets used a conserved set of transcription factors and major signalling pathways, the subsets showed differential regulation of sets of genes that 'fine-tune' the network Hubs expressed in common. We propose a model in which signalling through common pathway components is 'fine-tuned' by transcriptional control of subset-specific modulators, thus allowing for distinct functional outcomes in closely related DC subsets. We extend this analysis to comparable datasets from the literature and confirm that our model can account for cell subset-specific responses to LPS stimulation in multiple subpopulations in mouse and man.	[Hancock, David G.; Shklovskaya, Elena; Guy, Thomas V.; Ritchie, William; Fazekas de St Groth, Barbara] Centenary Inst Canc Med & Cell Biol, Sydney, NSW, Australia; [Hancock, David G.; Shklovskaya, Elena; Guy, Thomas V.; Fazekas de St Groth, Barbara] Univ Sydney, Discipline Dermatol, Sydney, NSW 2006, Australia; [Falsafi, Reza; Fjell, Chris D.; Hancock, Robert E. W.] Univ British Columbia, Ctr Microbial Dis & Immun Res, Vancouver, BC V5Z 1M9, Canada; [Fjell, Chris D.] Univ British Columbia, James Hogg Res Ctr, St Pauls Hosp, Vancouver, BC V5Z 1M9, Canada	University of Sydney; Centenary Institute; University of Sydney; University of British Columbia; St. Paul's Hospital; University of British Columbia; University of Saskatchewan	Fazekas de St Groth, B (corresponding author), Centenary Inst Canc Med & Cell Biol, Sydney, NSW, Australia.	b.fazekas@centenary.org.au	Hancock, Robert E. W./E-1145-2013; Hancock, David/CAF-2615-2022; de St Groth, Barbara Fazekas/O-3017-2017	Hancock, Robert E. W./0000-0001-5989-8503; Hancock, David/0000-0003-4782-2661; de St Groth, Barbara Fazekas/0000-0001-6817-9690; Fjell, Christopher/0000-0001-6304-2628; Shklovskaya, Elena/0000-0002-6155-1020	Australian National Health and Medical Research Council (NHMRC) [1012930, 571156]; Canadian Institutes of Health Research (CIHR) [MOP-74493]; CIHR; Cancer Institute NSW Research Scholar Awards; NHMRC	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); Cancer Institute NSW Research Scholar Awards; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Australian National Health and Medical Research Council (NHMRC; http://www.nhmrc.gov.au/; ES and BFdSG: #1012930, WR: #571156). Funding to REWH from the Canadian Institutes of Health Research (CIHR; http://www.cihr-irsc.gc.ca/e/193.html; MOP-74493) is gratefully acknowledged. REWH holds a Canada Research Chair. CF was supported by a fellowship from CIHR. DGH and TVG were supported by Cancer Institute NSW Research Scholar Awards (http://www.cancerinstitute.org.au/). BFdSG is supported by an NHMRC Principal Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliberti J, 2003, BLOOD, V101, P305, DOI 10.1182/blood-2002-04-1088; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Anandasabapathy N, 2011, J EXP MED, V208, P1695, DOI 10.1084/jem.20102657; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Azuma M, 2012, ONCOIMMUNOLOGY, V1, P581, DOI 10.4161/onci.19893; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Baranzini SE, 2010, NATURE, V464, P1351, DOI 10.1038/nature08990; Barsky A, 2007, BIOINFORMATICS, V23, P1040, DOI 10.1093/bioinformatics/btm057; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Brown J, 2011, J DENT RES, V90, P417, DOI 10.1177/0022034510381264; Chaussabel D, 2003, BLOOD, V102, P672, DOI 10.1182/blood-2002-10-3232; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Coquerelle C, 2010, IMMUNOL REV, V234, P317, DOI 10.1111/j.0105-2896.2009.00887.x; Creagh EM, 2006, TRENDS IMMUNOL, V27, P352, DOI 10.1016/j.it.2006.06.003; Crozat K, 2011, J IMMUNOL, V187, P4411, DOI 10.4049/jimmunol.1101717; Davidson D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053641; Delgado-Martin C, 2011, J BIOL CHEM, V286, P37222, DOI 10.1074/jbc.M111.294116; DeSmedt T, 1996, J EXP MED, V184, P1413, DOI 10.1084/jem.184.4.1413; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Edwards AD, 2003, J IMMUNOL, V171, P47, DOI 10.4049/jimmunol.171.1.47; Eisenbarth SC, 2012, NATURE, V484, P510, DOI 10.1038/nature11012; Elpek KG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023921; Ermolaeva MA, 2008, NAT IMMUNOL, V9, P1037, DOI 10.1038/ni.1638; Gantier MP, 2012, NUCLEIC ACIDS RES, V40, P8048, DOI 10.1093/nar/gks521; Gardy JL, 2009, TRENDS IMMUNOL, V30, P249, DOI 10.1016/j.it.2009.03.009; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Guimond M, 2009, NAT IMMUNOL, V10, P149, DOI 10.1038/ni.1695; Hamasaki T, 2010, CLIN VACCINE IMMUNOL, V17, P748, DOI 10.1128/CVI.00505-09; Hancock DG, 2013, CLIN EXP IMMUNOL, V171, P147, DOI 10.1111/cei.12027; Haniffa M, 2012, IMMUNITY, V37, P60, DOI 10.1016/j.immuni.2012.04.012; Hsing M, 2009, BIOINFORMATION, V4, P164, DOI 10.6026/97320630004164; Ideker Trey, 2002, Bioinformatics, V18 Suppl 1, pS233; Idoyaga J, 2009, P NATL ACAD SCI USA, V106, P1524, DOI 10.1073/pnas.0812247106; Kabashima K, 2007, BIOCHEM BIOPH RES CO, V361, P1012, DOI 10.1016/j.bbrc.2007.07.128; Kasahara S, 2012, J LEUKOCYTE BIOL, V91, P437, DOI 10.1189/jlb.0711384; Kress E, 2006, MOL IMMUNOL, V43, P2002, DOI 10.1016/j.molimm.2005.11.011; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Lewis KL, 2011, IMMUNITY, V35, P780, DOI 10.1016/j.immuni.2011.08.013; Li LQ, 2000, SCAND J IMMUNOL, V51, P361; Lin CY, 2008, NUCLEIC ACIDS RES, V36, pW438, DOI 10.1093/nar/gkn257; Lind EF, 2008, J IMMUNOL, V181, P354, DOI 10.4049/jimmunol.181.1.354; Luscombe NM, 2004, NATURE, V431, P308, DOI 10.1038/nature02782; Lynn DJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.55; Mayer ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016246; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Naik SH, 2005, J IMMUNOL, V174, P6592, DOI 10.4049/jimmunol.174.11.6592; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Ostuni R, 2010, CELL MOL LIFE SCI, V67, P4109, DOI 10.1007/s00018-010-0464-x; Pandey G, 2013, J IMMUNOL METHODS, V387, P71, DOI 10.1016/j.jim.2012.09.012; Patenaude J, 2010, CELL MOL LIFE SCI, V67, P1315, DOI 10.1007/s00018-009-0251-8; Patil S, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-137; Pena OM, 2011, J IMMUNOL, V186, P7243, DOI 10.4049/jimmunol.1001952; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; Pulendran B, 2001, J IMMUNOL, V167, P5067, DOI 10.4049/jimmunol.167.9.5067; Qiu CH, 2009, J IMMUNOL, V182, P4127, DOI 10.4049/jimmunol.0803364; Robbins SH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r17; Scatizzi JC, 2009, EUR J IMMUNOL, V39, P820, DOI 10.1002/eji.200838683; Sean D, 2007, BIOINFORMATICS, V23, P1846, DOI 10.1093/bioinformatics/btm254; Seok J, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-78; Sheng KC, 2008, J IMMUNOL, V181, P2455, DOI 10.4049/jimmunol.181.4.2455; Shklovskaya E, 2011, P NATL ACAD SCI USA, V108, P18049, DOI 10.1073/pnas.1110076108; Smith JR, 2007, INVEST OPHTH VIS SCI, V48, P2676, DOI 10.1167/iovs.06-0598; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Steinman RM, 2010, IMMUNOL REV, V234, P5, DOI 10.1111/j.0105-2896.2009.00888.x; Steinman RM, 1997, IMMUNOL REV, V156, P25, DOI 10.1111/j.1600-065X.1997.tb00956.x; Sun YP, 2011, BLOOD, V117, P6172, DOI 10.1182/blood-2010-12-325647; Tegner J, 2006, CELL IMMUNOL, V244, P105, DOI 10.1016/j.cellimm.2007.01.010; Torri A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009404; Trakala M, 2009, EUR J IMMUNOL, V39, P810, DOI 10.1002/eji.200838676; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Whitmore MM, 2007, J IMMUNOL, V179, P3622, DOI 10.4049/jimmunol.179.6.3622; Xu YK, 2007, J IMMUNOL, V179, P7577, DOI 10.4049/jimmunol.179.11.7577; Yamazaki S, 2008, J IMMUNOL, V181, P6923, DOI 10.4049/jimmunol.181.10.6923; Zhu N, 2009, MOL BIOL REP, V36, P2075, DOI 10.1007/s11033-008-9419-9; Zhu YN, 2012, MOL CELL, V46, P408, DOI 10.1016/j.molcel.2012.05.011; Zietara N, 2009, J IMMUNOL, V183, P1099, DOI 10.4049/jimmunol.0803214	80	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100613	10.1371/journal.pone.0100613	http://dx.doi.org/10.1371/journal.pone.0100613			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949855	Green Published, Green Submitted, gold			2022-12-27	WOS:000338276300098
J	Mall, R; Langone, R; Suykens, JAK				Mall, Raghvendra; Langone, Rocco; Suykens, Johan A. K.			Multilevel Hierarchical Kernel Spectral Clustering for Real-Life Large Scale Complex Networks	PLOS ONE			English	Article							COMMUNITY; CUTS	Kernel spectral clustering corresponds to a weighted kernel principal component analysis problem in a constrained optimization framework. The primal formulation leads to an eigen-decomposition of a centered Laplacian matrix at the dual level. The dual formulation allows to build a model on a representative subgraph of the large scale network in the training phase and the model parameters are estimated in the validation stage. The KSC model has a powerful out-of-sample extension property which allows cluster affiliation for the unseen nodes of the big data network. In this paper we exploit the structure of the projections in the eigenspace during the validation stage to automatically determine a set of increasing distance thresholds. We use these distance thresholds in the test phase to obtain multiple levels of hierarchy for the large scale network. The hierarchical structure in the network is determined in a bottom-up fashion. We empirically showcase that real-world networks have multilevel hierarchical organization which cannot be detected efficiently by several state-of-the-art large scale hierarchical community detection techniques like the Louvain, OSLOM and Infomap methods. We show that a major advantage of our proposed approach is the ability to locate good quality clusters at both the finer and coarser levels of hierarchy using internal cluster quality metrics on 7 real-life networks.	[Mall, Raghvendra; Langone, Rocco; Suykens, Johan A. K.] Katholieke Univ Leuven, ESAT STADIUS, Leuven, Belgium	KU Leuven	Mall, R (corresponding author), Katholieke Univ Leuven, ESAT STADIUS, Leuven, Belgium.	raghvendra.mall@esat.kuleuven.be	Suykens, Johan A.K./C-9781-2014; Mall, Raghvendra/I-9470-2019	Suykens, Johan A.K./0000-0002-8846-6352; Mall, Raghvendra/0000-0003-1779-3150; Langone, Rocco/0000-0002-7583-7003	Research Council KUL: ERC AdG A-DATADRIVE-B [GOA/11/05 Ambiorics, GOA/10/09MaNet, CoE EF/05/006, IOF-SCORES4CHEM]; Flemish Government: FWO [G0226-.06, G0321.06, G.0302.07, G.0320.08, G.0558.08, G.0557.08, G.0588.09, G.0377.12, G.0377.09]; IWT: PhD Grants; Eureka-Flite+; SBO LeCoPro; SBO Climaqs; SBO POM; OO-Dsquare; Belgian Federal Science Policy Office [IUAP P6/04]; EU: ERNSI; FP7-HD-MPC [INFSO-ICT-223854]; COST intelliCIS; FP7-EMBOCON [ICT-248940]; Contract Research: AMINAL; Helmholtz: viCERP; ACCM; Bauknecht; Hoerbiger	Research Council KUL: ERC AdG A-DATADRIVE-B; Flemish Government: FWO(FWO); IWT: PhD Grants; Eureka-Flite+; SBO LeCoPro; SBO Climaqs; SBO POM; OO-Dsquare; Belgian Federal Science Policy Office(Belgian Federal Science Policy Office); EU: ERNSI; FP7-HD-MPC; COST intelliCIS(European Cooperation in Science and Technology (COST)); FP7-EMBOCON; Contract Research: AMINAL; Helmholtz: viCERP; ACCM; Bauknecht; Hoerbiger	This work was supported by Research Council KUL: ERC AdG A-DATADRIVE-B, GOA/11/05 Ambiorics, GOA/10/09MaNet, CoE EF/05/006 Optimization in Engineering(OPTEC), IOF-SCORES4CHEM, several PhD/postdoc and fellow grants; Flemish Government: FWO: PhD/postdoc grants, projects: G0226-.06 (cooperative systems & optimization), G0321.06 (Tensors), G.0302.07 (SVM/Kernel), G.0320.08 (convex MPC), G.0558.08 (Robust MHE), G.0557.08 (Glycemia2), G.0588.09 (Brain-machine) G.0377.12 (structured models) research communities (WOG:ICCoS, ANMMM, MLDM); G.0377.09 (Mechatronics MPC) IWT: PhD Grants, Eureka-Flite+, SBO LeCoPro, SBO Climaqs, SBO POM, O & O-Dsquare; Belgian Federal Science Policy Office: IUAP P6/04 (DYSCO, Dynamical systems, control and optimization, 2007-2011); EU: ERNSI; FP7-HD-MPC (INFSO-ICT-223854), COST intelliCIS, FP7-EMBOCON (ICT-248940); Contract Research: AMINAL; Other: Helmholtz: viCERP, ACCM, Bauknecht, Hoerbiger. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzate C, 2012, NEURAL NETWORKS, V35, P21, DOI 10.1016/j.neunet.2012.06.007; Alzate C, 2010, IEEE T PATTERN ANAL, V32, P335, DOI 10.1109/TPAMI.2008.292; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Chung, 1997, SPECTRAL GRAPH THEOR, DOI DOI 10.1090/CBMS/092; Clauset A, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.026132; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Danon L, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/09/P09008; Dhillon IS, 2007, IEEE T PATTERN ANAL, V29, P1944, DOI 10.1109/TP'AMI.2007.1115; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Good BH, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.046106; Karypis G, 1998, SIAM J SCI COMPUT, V20, P359, DOI 10.1137/S1064827595287997; Kumpula M, 2007, FLUCTUATION NOISE LE, V7; Kushnir D, 2006, PATTERN RECOGN, V39, P1876, DOI 10.1016/j.patcog.2006.04.007; LANCICHINETTI A, 2009, PHYS REV E 2, V80, DOI DOI 10.1103/PHYSREVE.80.056117; Lancichinetti A, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.066122; Lancichinetti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018961; Langone R, 2012, IEEE IJCNN; Leskovec J, 2006, KDD 06, P631, DOI DOI 10.1145/1150402.1150479; Mall Raghvendra, 2013, 2013 IEEE International Conference on Big Data, P385, DOI 10.1109/BigData.2013.6691599; Mall R, 2013, SOC NETW ANAL MIN, V3, P1075, DOI 10.1007/s13278-013-0144-6; Mall R, 2013, ENTROPY-SWITZ, V15, P1567, DOI 10.3390/e15051567; Newman M.E.J., 2004, PHYS REV E, V70; Ng AY, 2002, ADV NEUR IN, V14, P849; Rabbany R, 2012, 2012 IEEE/ACM INTERNATIONAL CONFERENCE ON ADVANCES IN SOCIAL NETWORKS ANALYSIS AND MINING (ASONAM), P258, DOI 10.1109/ASONAM.2012.52; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Schaeffer S, 2006, THESIS HELSINKI U TE; Shi JB, 2000, IEEE T PATTERN ANAL, V22, P888, DOI 10.1109/34.868688; Suykens J, 2002, LEAST SQUARES SUPPOR; von Luxburg U, 2007, STAT COMPUT, V17, P395, DOI 10.1007/s11222-007-9033-z; Zelnik-Manor L., 2005, ADV NEURAL INFORM PR, V17, P1601	33	18	18	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e99966	10.1371/journal.pone.0099966	http://dx.doi.org/10.1371/journal.pone.0099966			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949877	Green Submitted, Green Published, gold			2022-12-27	WOS:000338276300026
J	Xi, L; Wang, T; Zhao, F; Zheng, QJ; Li, XN; Luo, J; Liu, J; Quan, DP; Ge, J				Xi, Lei; Wang, Tao; Zhao, Feng; Zheng, Qiongjuan; Li, Xiaoning; Luo, Jing; Liu, Ji; Quan, Daping; Ge, Jian			Evaluation of an Injectable Thermosensitive Hydrogel As Drug Delivery Implant for Ocular Glaucoma Surgery	PLOS ONE			English	Article							BLOCK-COPOLYMER HYDROGELS; POLOXAMER 407 GELS; FILTRATION SURGERY; MITOMYCIN-C; IN-VITRO; PLURONIC(R) F127; THERMOREVERSIBLE HYDROGELS; INTRAPERITONEAL INJECTION; SUSTAINED DELIVERY; CONTROLLED-RELEASE	In this study, a biodegradable thermo-sensitive hydrogel from poly(trimethylene carbonate)(15)-F127-poly(trimethylene carbonate)(15)(PTMC15-F127-PTMC15) was designed and evaluated as an injectable implant during ocular glaucoma filtration surgery in vivo and in vitro. Mitomycin C (MMC) was loaded into this hydrogel for controlled released to prolong the efficacy and to reduce the long-term toxicity. The properties of the hydrogel were confirmed using H-1 NMR and gel permeation chromatography (GPC). Compared to the Pluronic F127 hydrogel, the PTMC15-F127-PTMC15 hydrogel showed a good solution-gel transition temperature at 37 degrees C, a lower work concentration of 5% w/v and a longer mass loss time of more than 2 weeks. The in vitro study showed that the drug could be released from PTMC15-F127-PTMC15 (5% w/v) hydrogel for up to 16 days with only 57% of drug released in the first day. Moreover, the cell toxicity, which was tested via LDH and ANNEXIN V/PI, decreased within 72 h in human tenon's fibroblast cells (HTFs). The in vivo behavior in a rabbit glaucoma filtration surgery model indicated that this hydrogel loaded with 0.1 mg/ml MMC led to a better functional bleb with a prolonged mean bleb survival time (25.5 +/- 2.9 days). The scar tissue formation, new collagen deposition and myofibroblast generation appeared to be reduced upon histological and immunohistochemistry examinations, with no obvious side effects and inflammatory reactions. The in vitro and in vivo results demonstrated that this novel hydrogel is a safe and effective drug delivery candidate in ocular glaucoma surgery.	[Xi, Lei; Zhao, Feng; Li, Xiaoning; Ge, Jian] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Tao; Zheng, Qiongjuan; Quan, Daping] Sun Yat Sen Univ, Sch Chem & Chem Engn, DSAPM & PCFM Lab, Guangzhou 510275, Guangdong, Peoples R China; [Li, Xiaoning] Aier Eye Hosp Grp, Changsha, Hunan, Peoples R China; [Luo, Jing] Cent S Univ, Dept Ophthalmol, Xiang Ya Hosp 2, Changsha, Hunan, Peoples R China; [Liu, Ji] Yale Univ, Yale Eye Ctr, New Haven, CT USA	Sun Yat Sen University; Sun Yat Sen University; Central South University; Yale University	Quan, DP (corresponding author), Sun Yat Sen Univ, Sch Chem & Chem Engn, DSAPM & PCFM Lab, Guangzhou 510275, Guangdong, Peoples R China.	cesqdp@mail.sysu.edu.cn; gejian@mail.sysu.edu.cn		Luo, Jing/0000-0002-8905-9388	China National Natural Science Foundation [81170846, U1134007]; Fundamental Research Funds of State Key Laboratory of Ophthalmology of China [2012PI02]	China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds of State Key Laboratory of Ophthalmology of China	This work was supported by the China National Natural Science Foundation (NO. 81170846 and U1134007), the Fundamental Research Funds of State Key Laboratory of Ophthalmology of China (N0. 2012PI02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blake DA, 2006, J GLAUCOMA, V15, P291, DOI 10.1097/01.ijg.0000212236.96039.9c; Branco MC, 2009, BIOMATERIALS, V30, P1339, DOI 10.1016/j.biomaterials.2008.11.019; Buwalda SJ, 2010, BIOMACROMOLECULES, V11, P224, DOI 10.1021/bm901080d; Chen HSL, 2006, INVEST OPHTH VIS SCI, V47, P5310, DOI 10.1167/iovs.06-0378; Chetoni P, 2007, J DRUG DELIV SCI TEC, V17, P43, DOI 10.1016/S1773-2247(07)50006-7; Congdon NG, 2012, OPHTHAL EPIDEMIOL, V19, P149, DOI 10.3109/09286586.2012.667493; Cordeiro MF, 1997, INVEST OPHTH VIS SCI, V38, P1639; DeBry PW, 2002, ARCH OPHTHALMOL-CHIC, V120, P297; Derakhshandeh K, 2010, DRUG DES DEV THER, V4, P255; Duan LH, 2012, EUR J PHARM SCI, V46, P357, DOI 10.1016/j.ejps.2012.02.023; Dumortier G, 2006, PHARM RES-DORDR, V23, P2709, DOI 10.1007/s11095-006-9104-4; Fairbanks BD, 2009, BIOMATERIALS, V30, P6702, DOI 10.1016/j.biomaterials.2009.08.055; Gao YA, 2010, DRUG DEV IND PHARM, V36, P1131, DOI 10.3109/03639041003680826; Grover DS, 2012, CURR OPIN OPHTHALMOL, V23, P127, DOI 10.1097/ICU.0b013e32834ff2b7; Gupta R, 2011, VET OPHTHALMOL, V14, P304, DOI 10.1111/j.1463-5224.2011.00877.x; He CL, 2008, J CONTROL RELEASE, V127, P189, DOI 10.1016/j.jconrel.2008.01.005; He Y, 2008, INVEST OPHTH VIS SCI, V49, P1447, DOI 10.1167/iovs.07-1361; Hiemstra C, 2007, J AM CHEM SOC, V129, P9918, DOI 10.1021/ja072113p; Hsu WC, 2000, INVEST OPHTH VIS SCI, V41, P2404; JOHNSTON T P, 1985, Journal of Parenteral Science and Technology, V39, P83; JOHNSTON TP, 1992, PHARM RES-DORDR, V9, P425, DOI 10.1023/A:1015815624334; Joo MK, 2009, J MATER CHEM, V19, P5891, DOI 10.1039/b902208b; Joshi AB, 2005, J GLAUCOMA, V14, P172, DOI 10.1097/01.ijg.0000151684.12033.4d; Kang HZ, 2011, LANGMUIR, V27, P399, DOI 10.1021/la1037553; Karlgard CCS, 2003, INT J PHARM, V257, P141, DOI 10.1016/S0378-5173(03)00124-8; KATAKAM M, 1995, J PHARM SCI-US, V84, P713, DOI 10.1002/jps.2600840609; KHAW PT, 1993, OPHTHALMOLOGY, V100, P367; Kirkland SE, 2008, BIOMACROMOLECULES, V9, P481, DOI 10.1021/bm700968t; Kirwan JF, 2013, OPHTHALMOLOGY, V120, P2532, DOI 10.1016/j.ophtha.2013.07.049; Koz OG, 2007, J GLAUCOMA, V16, P610, DOI 10.1097/IJG.0b013e31815c89b9; Kozobolis VP, 2002, J GLAUCOMA, V11, P287, DOI 10.1097/00061198-200208000-00003; Lama PJ, 2003, SURV OPHTHALMOL, V48, P314, DOI 10.1016/S0039-6257(03)00038-9; Lattanzio FA, 2005, J GLAUCOMA, V14, P441, DOI 10.1097/01.ijg.0000185432.63408.1e; Lee DS, 2010, BIOMEDICAL APPLICATIONS OF HYDROGELS HANDBOOK, P123, DOI 10.1007/978-1-4419-5919-5_7; Li EY, 2013, INVEST OPHTH VIS SCI, V54, P3394, DOI 10.1167/iovs.12-11549; Li MY, 2011, J MATER SCI-MATER M, V22, P2745, DOI 10.1007/s10856-011-4455-8; Li Z, 2009, BIOMACROMOLECULES, V10, P3306, DOI 10.1021/bm900900e; Li ZQ, 2009, INVEST OPHTH VIS SCI, V50, P5217, DOI 10.1167/iovs.08-2662; Liu WG, 2008, J MATER SCI-MATER M, V19, P3365, DOI 10.1007/s10856-008-3486-2; Liu Y, 2007, J CONTROL RELEASE, V117, P387, DOI 10.1016/j.jconrel.2006.11.024; Mead AL, 2003, INVEST OPHTH VIS SCI, V44, P3394, DOI 10.1167/iovs.02-0978; Memarzadeh F, 2009, INVEST OPHTH VIS SCI, V50, P3233, DOI 10.1167/iovs.08-2441; Meyer-Ter-Vehn T, 2008, INVEST OPHTH VIS SCI, V49, P3955, DOI 10.1167/iovs.07-1610; Nagarwal RC, 2011, COLLOID SURFACE B, V86, P28, DOI 10.1016/j.colsurfb.2011.03.023; Ness PJ, 2010, AM J OPHTHALMOL, V150, P498, DOI 10.1016/j.ajo.2010.05.006; Paavola A, 1998, J CONTROL RELEASE, V52, P169, DOI 10.1016/S0168-3659(97)00206-X; Palma SD, 2009, J CONTROL RELEASE, V138, P24, DOI 10.1016/j.jconrel.2009.04.035; Pandit NK, 1998, INT J PHARM, V167, P183, DOI 10.1016/S0378-5173(98)00074-X; Park H, 2013, BIOMATERIALS, V34, P6992, DOI 10.1016/j.biomaterials.2013.05.070; PEC EA, 1992, J PHARM SCI-US, V81, P626, DOI 10.1002/jps.2600810707; Pego AP, 2003, J BIOMED MATER RES A, V67A, P1044, DOI 10.1002/jbm.a.10121; Peng D, 1999, Yan Ke Xue Bao, V15, P51; Rhodes NP, 2007, BIOMATERIALS, V28, P5131, DOI 10.1016/j.biomaterials.2007.08.004; Sahiner N, 2009, ARCH OPHTHALMOL-CHIC, V127, P448, DOI 10.1001/archophthalmol.2009.19; SCHMOLKA IR, 1972, J BIOMED MATER RES, V6, P571, DOI 10.1002/jbm.820060609; Sen E, 2010, J OCUL PHARMACOL TH, V26, P399, DOI 10.1089/jop.2010.0064; Sharma PK, 2004, INT J PHARMACEUT, V278, P361, DOI 10.1016/j.ijpharm.2004.03.029; Sidoti PA, 2000, OPHTHALMOLOGY, V107, P422, DOI 10.1016/S0161-6420(99)00130-X; Stratton LP, 1997, J PHARM SCI, V86, P1006, DOI 10.1021/js970034d; Tang S, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/1/015008; Veyries ML, 1999, INT J PHARMACEUT, V192, P183, DOI 10.1016/S0378-5173(99)00307-5; Wang Wenhua, 2011, Eye Sci, V26, P197, DOI 10.3969/j.issn.1000-4432.2011.04.003; Wenzel JGW, 2002, J CONTROL RELEASE, V85, P51, DOI 10.1016/S0168-3659(02)00271-7; Wimmer I, 2002, OPHTHALMOLOGE, V99, P678, DOI 10.1007/s00347-002-0698-6; Wong TT, 2009, OPHTHALMOLOGY, V116, P175, DOI 10.1016/j.ophtha.2008.09.049; Xiao YQ, 2009, INVEST OPHTH VIS SCI, V50, P1698, DOI 10.1167/iovs.08-1675; Xiong XY, 2007, J CONTROL RELEASE, V120, P11, DOI 10.1016/j.jconrel.2007.04.004; Yan MF, 2012, POLYM INT, V61, P1525, DOI 10.1002/pi.4240; Yan ZC, 2011, MOL VIS, V17, P2495; Ye HH, 2010, MOL VIS, V16, P2502; Yu L, 2008, CHEM SOC REV, V37, P1473, DOI 10.1039/b713009k; Yu L, 2010, BIOMACROMOLECULES, V11, P2169, DOI 10.1021/bm100549q; Yueling Z, 2005, J HEBEI MED COLL CON, V22, P6; Zhang L, 2002, J CONTROL RELEASE, V85, P73, DOI 10.1016/S0168-3659(02)00273-0; Zhong H, 2011, INVEST OPHTH VIS SCI, V52, P3136, DOI 10.1167/iovs.10-6240; Zhou Q, 2011, COLLOID SURFACE B, V86, P45, DOI 10.1016/j.colsurfb.2011.03.013	76	42	42	6	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100632	10.1371/journal.pone.0100632	http://dx.doi.org/10.1371/journal.pone.0100632			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950176	Green Submitted, gold, Green Published			2022-12-27	WOS:000338276300101
J	Yoshida, Y; Hayashi, Y; Suda, M; Tateno, K; Okada, S; Moriya, J; Yokoyama, M; Nojima, A; Yamashita, M; Kobayashi, Y; Shimizu, I; Minamino, T				Yoshida, Yohko; Hayashi, Yuka; Suda, Masayoshi; Tateno, Kaoru; Okada, Sho; Moriya, Junji; Yokoyama, Masataka; Nojima, Aika; Yamashita, Masakatsu; Kobayashi, Yoshio; Shimizu, Ippei; Minamino, Tohru			Notch Signaling Regulates the Lifespan of Vascular Endothelial Cells via a p16-Dependent Pathway	PLOS ONE			English	Article							SENESCENCE; TELOMERE; ANGIOGENESIS; EXPRESSION; STRESS; DLL4	Evolutionarily conserved Notch signaling controls cell fate determination and differentiation during development, and is also essential for neovascularization in adults. Although recent studies suggest that the Notch pathway is associated with age-related conditions, it remains unclear whether Notch signaling is involved in vascular aging. Here we show that Notch signaling has a crucial role in endothelial cell senescence. Inhibition of Notch signaling in human endothelial cells induced premature senescence via a p16-dependent pathway. Conversely, over-expression of Notch1 or Jagged1 prolonged the replicative lifespan of endothelial cells. Notch1 positively regulated the expression of inhibitor of DNA binding 1 (Id1) and MAP kinase phosphatase 1 (MKP1), while MKP1 further up-regulated Id1 expression by inhibiting p38MAPK-induced protein degradation. Over-expression of Id1 down-regulated p16 expression, thereby inhibiting premature senescence of Notch1-deleted endothelial cells. These findings indicate that Notch1 signaling has a role in the regulation of endothelial cell senescence via a p16-dependent pathway and suggest that activation of Notch1 could be a new therapeutic target for treating age-associated vascular diseases.	[Yoshida, Yohko; Hayashi, Yuka; Suda, Masayoshi; Shimizu, Ippei; Minamino, Tohru] Niigata Univ, Grad Sch Med & Dent Sci, Dept Cardiovasc Biol & Med, Niigata, Japan; [Tateno, Kaoru; Okada, Sho; Moriya, Junji; Yokoyama, Masataka; Nojima, Aika; Kobayashi, Yoshio] Chiba Univ, Grad Sch Med, Dept Cardiovasc Med, Chiba, Japan; [Yamashita, Masakatsu] Kazusa DNA Res Inst, Chiba, Japan; [Minamino, Tohru] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan	Niigata University; Chiba University; Kazusa DNA Research Institute; Japan Science & Technology Agency (JST)	Minamino, T (corresponding author), Niigata Univ, Grad Sch Med & Dent Sci, Dept Cardiovasc Biol & Med, Niigata, Japan.	t_minamino@yahoo.co.jp	Minamino, Tohru/P-8145-2018	Minamino, Tohru/0000-0003-1627-6151; Shimizu, Ippei/0000-0003-3333-8131	Ministry of Education, Culture, Sports, Science and Technology of Japan [2430195, 25126706, 25670382]; Ono Medical Research Foundation; Uehara Memorial Foundation; NOVARTIS Foundation for the Promotion Science; Japan Diabetes Foundation; SENSHIN Medical Research Foundation; Takeda Science Foundation; Mitsubishi Pharma Research Foundation; Takeda Medical Research Foundation; SUZUKEN Memorial Foundation; Japan Heart Foundation & Astellas/Pfizer Grant for Research on Atherosclerosis Update; Japan Heart Foundation Dr. Hiroshi Irisawa & Dr. Aya Irisawa Memorial Research Grant; Grants-in-Aid for Scientific Research [24390195] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ono Medical Research Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); NOVARTIS Foundation for the Promotion Science; Japan Diabetes Foundation; SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Mitsubishi Pharma Research Foundation; Takeda Medical Research Foundation; SUZUKEN Memorial Foundation; Japan Heart Foundation & Astellas/Pfizer Grant for Research on Atherosclerosis Update; Japan Heart Foundation Dr. Hiroshi Irisawa & Dr. Aya Irisawa Memorial Research Grant; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (grant numbers 2430195, 25126706, 25670382), and the grants from the Ono Medical Research Foundation, the Uehara Memorial Foundation, the NOVARTIS Foundation for the Promotion Science, the Japan Diabetes Foundation, the SENSHIN Medical Research Foundation, the Takeda Science Foundation, and the Mitsubishi Pharma Research Foundation, the Takeda Medical Research Foundation, the SUZUKEN Memorial Foundation (to TM), and the Japan Heart Foundation & Astellas/Pfizer Grant for Research on Atherosclerosis Update and the Japan Heart Foundation Dr. Hiroshi Irisawa & Dr. Aya Irisawa Memorial Research Grant (to YY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ables JL, 2011, NAT REV NEUROSCI, V12, P269, DOI 10.1038/nrn3024; Alani RM, 2001, P NATL ACAD SCI USA, V98, P7812, DOI 10.1073/pnas.141235398; Andersson ER, 2011, DEVELOPMENT, V138, P3593, DOI 10.1242/dev.063610; Baker M, 2012, NAT PROTOC, V7, P89, DOI 10.1038/nprot.2011.435; Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Carey KA, 2007, J GERONTOL A-BIOL, V62, P9, DOI 10.1093/gerona/62.1.9; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Eilken HM, 2010, NAT MED, V16, P853, DOI 10.1038/nm0810-853; Ethell DW, 2010, NEUROSCIENTIST, V16, P614, DOI 10.1177/1073858410366162; Faragher RGA, 1998, BIOESSAYS, V20, P985, DOI 10.1002/(SICI)1521-1878(199812)20:12<985::AID-BIES4>3.3.CO;2-1; Garcia A, 2012, HISTOL HISTOPATHOL, V27, P151, DOI 10.14670/HH-27.151; Gil ME, 2004, MOL BIOTECHNOL, V27, P169, DOI 10.1385/MB:27:2:169; Gridley T, 2007, DEVELOPMENT, V134, P2709, DOI 10.1242/dev.004184; Guo SC, 2011, BBA-REV CANCER, V1815, P197, DOI 10.1016/j.bbcan.2010.12.002; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; High FA, 2008, NAT REV GENET, V9, P49, DOI 10.1038/nrg2279; Hirsch DD, 1997, J BIOL CHEM, V272, P4568, DOI 10.1074/jbc.272.7.4568; Kikuchi R, 2011, LAB INVEST, V91, P691, DOI 10.1038/labinvest.2011.5; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Limbourg FP, 2005, CIRCULATION, V111, P1826, DOI 10.1161/01.CIR.0000160870.93058.DD; Liu ZJ, 2012, ATHEROSCLEROSIS, V225, P296, DOI 10.1016/j.atherosclerosis.2012.04.010; Lobry C, 2011, J EXP MED, V208, P1931, DOI 10.1084/jem.20111855; Mancini SJC, 2005, BLOOD, V105, P2340, DOI 10.1182/blood-2004-08-3207; Minamino T, 2002, CIRCULATION, V105, P1541, DOI 10.1161/01.CIR.0000013836.85741.17; Minamino T, 2007, CIRC RES, V100, P15, DOI 10.1161/01.RES.0000256837.40544.4a; Miyauchi H, 2004, EMBO J, V23, P212, DOI 10.1038/sj.emboj.7600045; Niessen K, 2007, AM J PHYSIOL-CELL PH, V293, pC1, DOI 10.1152/ajpcell.00415.2006; Nobta M, 2005, J BIOL CHEM, V280, P15842, DOI 10.1074/jbc.M412891200; Noseda M, 2004, MOL CELL BIOL, V24, P8813, DOI 10.1128/MCB.24.20.8813-8822.2004; Ohtani N, 2001, NATURE, V409, P1067, DOI 10.1038/35059131; Ranganathan P, 2011, NAT REV CANCER, V11, P338, DOI 10.1038/nrc3035; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Serrano M, 2001, CURR OPIN CELL BIOL, V13, P748, DOI 10.1016/S0955-0674(00)00278-7; South AP, 2012, SEMIN CELL DEV BIOL, V23, P458, DOI 10.1016/j.semcdb.2012.01.017; Takeshita K, 2007, CIRC RES, V100, P70, DOI 10.1161/01.RES.0000254788.47304.6e; Thomas JL, 2013, CELL MOL LIFE SCI, V70, P1779, DOI 10.1007/s00018-013-1312-6; Vandevyver S, 2012, J CLIN INVEST, V122, P2130, DOI 10.1172/JCI60006; Venkatesh D, 2011, ARTERIOSCL THROM VAS, V31, P876, DOI 10.1161/ATVBAHA.110.221945	41	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100359	10.1371/journal.pone.0100359	http://dx.doi.org/10.1371/journal.pone.0100359			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950189	Green Published, gold, Green Submitted			2022-12-27	WOS:000338276300069
J	Chen, LW; Yu, N; Lu, Y; Wu, LJ; Chen, DS; Guo, WW; Zhao, LD; Liu, MB; Yang, SM; Sun, XJ; Zhai, SQ				Chen, Liwei; Yu, Ning; Lu, Yan; Wu, Longjun; Chen, Daishi; Guo, Weiwei; Zhao, Lidong; Liu, Mingbo; Yang, Shiming; Sun, Xuejun; Zhai, Suoqiang			Hydrogen-Saturated Saline Protects Intensive Narrow Band Noise-Induced Hearing Loss in Guinea Pigs through an Antioxidant Effect	PLOS ONE			English	Article							FREE-RADICALS; OXIDATIVE STRESS; OXYGEN RADICALS; EXPOSURE; COCHLEA; MECHANISMS; PREVENTION; APOPTOSIS; TRAUMA; GENE	The purpose of the current study was to evaluate hydrogen-saturated saline protecting intensive narrow band noise-induced hearing loss. Guinea pigs were divided into three groups: hydrogen-saturated saline; normal saline; and control. For saline administration, the guinea pigs were given daily abdominal injections (1 ml/100 g) 3 days before and 1 h before narrow band noise exposure (2.5-3.5 kHz 130 dB SPL, 1 h). The guinea pigs in the control group received no treatment. The hearing function was assessed by the auditory brainstem response (ABR) and distortion product otoacoustic emission (DPOAE) recording. The changes of free radicals in the cochlea before noise exposure, and immediately and 7 days after noise exposure were also examined. By Scanning electron microscopy and succinate dehydrogenase staining, we found that pre-treatment with hydrogen-saturated saline significantly reduced noise-induced hair cell damage and hearing loss. We also found that the malondialdehyde, lipid peroxidation, and hydroxyl levels were significantly lower in the hydrogen-saturated saline group after noise trauma, indicating that hydrogen-saturated saline can decrease the amount of harmful free radicals caused by noise trauma. Our findings suggest that hydrogen-saturated saline is effective in preventing intensive narrow band noise-induced hearing loss through the antioxidant effect.	[Chen, Liwei; Yu, Ning; Lu, Yan; Chen, Daishi; Guo, Weiwei; Zhao, Lidong; Liu, Mingbo; Yang, Shiming; Zhai, Suoqiang] Chinese Peoples Liberat Army Gen Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China; [Wu, Longjun] Wenzhou Med Coll, Dept Otolaryngol Head & Neck Surg, Wenzhou, Zhejiang, Peoples R China; [Sun, Xuejun] Second Mil Med Univ, Fac Naval Med, Dept Diving Med, Shanghai, Peoples R China	Chinese People's Liberation Army General Hospital; Wenzhou Medical University; Naval Medical University	Yu, N (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China.	yuning12@sina.com; zhaisq@plagh.com.cn	sun, xuejun/A-5561-2010	sun, xuejun/0000-0003-2387-5531; Liu, Mingbo/0000-0002-0540-2573; Zhao, Lidong/0000-0002-0810-0941	National Natural Science Fundation of China [81241034, 81271081, 30971199]	National Natural Science Fundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by the National Natural Science Fundation of China (No. 81241034, No. 81271081, No. 30971199, http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Fetoni AR, 2011, EXP GERONTOL, V46, P413, DOI 10.1016/j.exger.2010.12.003; Henderson D, 2006, EAR HEARING, V27, P1, DOI 10.1097/01.aud.0000191942.36672.f3; Hight NG, 2003, HEARING RES, V179, P21, DOI 10.1016/S0378-5955(03)00067-4; Hu BH, 1997, HEARING RES, V113, P198, DOI 10.1016/S0378-5955(97)00143-3; Hu BH, 2002, HEARING RES, V166, P62, DOI 10.1016/S0378-5955(02)00286-1; Kaygusuz I, 2001, HEARING RES, V162, P43, DOI 10.1016/S0378-5955(01)00365-3; Kikkawa YS, 2009, NEUROREPORT, V20, P689, DOI 10.1097/WNR.0b013e32832a5c68; Kopke R, 2005, ACTA OTO-LARYNGOL, V125, P235, DOI 10.1080/00016480410023038; Le Prell CG, 2007, HEARING RES, V226, P22, DOI 10.1016/j.heares.2006.10.006; Le Prell CG, 2007, FREE RADICAL BIO MED, V42, P1454, DOI 10.1016/j.freeradbiomed.2007.02.008; LIM DJ, 1971, ARCHIV OTOLARYNGOL, V94, P294; Lin Y, 2011, NEUROSCI LETT, V487, P12, DOI 10.1016/j.neulet.2010.09.064; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; Ohinata Y, 2000, BRAIN RES, V878, P163, DOI 10.1016/S0006-8993(00)02733-5; Ohlemiller KK, 1999, AUDIOL NEURO-OTOL, V4, P237, DOI 10.1159/000013847; Ohlemiller KK, 1999, AUDIOL NEURO-OTOL, V4, P229, DOI 10.1159/000013846; Ohlemiller KK, 2000, JARO-J ASSOC RES OTO, V1, P243, DOI 10.1007/s101620010043; Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577; Poirrier AL, 2010, CURR MED CHEM, V17, P3591; Sun QA, 2011, J SURG RES, V165, pE43, DOI 10.1016/j.jss.2010.09.024; Warchol ME, 2010, CURR OPIN OTOLARYNGO, V18, P454, DOI 10.1097/MOO.0b013e32833e05ec; Yamane H, 1995, EUR ARCH OTO-RHINO-L, V252, P504, DOI 10.1007/BF02114761; Yamashita D, 2005, NEUROSCIENCE, V134, P633, DOI 10.1016/j.neuroscience.2005.04.015; Yamashita D, 2004, BRAIN RES, V1019, P201, DOI 10.1016/j.brainres.2004.05.104; Zhang JY, 2012, HEPATO-GASTROENTEROL, V59, P1026, DOI 10.5754/hge11883; Zhou Y, 2012, NEUROSCIENCE, V209, P47, DOI 10.1016/j.neuroscience.2012.02.028	26	12	17	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100774	10.1371/journal.pone.0100774	http://dx.doi.org/10.1371/journal.pone.0100774			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945316	Green Published, gold			2022-12-27	WOS:000340721500104
J	Cros, A; Fatan, NA; White, A; Teoh, SJ; Tan, S; Handayani, C; Huang, C; Peterson, N; Li, RV; Siry, HY; Fitriana, R; Gove, J; Acoba, T; Knight, M; Acosta, R; Andrew, N; Beare, D				Cros, Annick; Fatan, Nurulhuda Ahamad; White, Alan; Teoh, Shwu Jiau; Tan, Stanley; Handayani, Christian; Huang, Charles; Peterson, Nate; Li, Ruben Venegas; Siry, Hendra Yusran; Fitriana, Ria; Gove, Jamison; Acoba, Tomoko; Knight, Maurice; Acosta, Renerio; Andrew, Neil; Beare, Doug			The Coral Triangle Atlas: An Integrated Online Spatial Database System for Improving Coral Reef Management	PLOS ONE			English	Article							CLIMATE-CHANGE; IMPACTS	In this paper we describe the construction of an online GIS database system, hosted by WorldFish, which stores bio-physical, ecological and socio-economic data for the 'Coral Triangle Area' in South-east Asia and the Pacific. The database has been built in partnership with all six (Timor-Leste, Malaysia, Indonesia, The Philippines, Solomon Islands and Papua New Guinea) of the Coral Triangle countries, and represents a valuable source of information for natural resource managers at the regional scale. Its utility is demonstrated using biophysical data, data summarising marine habitats, and data describing the extent of marine protected areas in the region.	[Cros, Annick; White, Alan] Nature Conservancy, Indo Pacific Div, Honolulu, HI USA; [Fatan, Nurulhuda Ahamad; Teoh, Shwu Jiau; Tan, Stanley; Li, Ruben Venegas; Andrew, Neil; Beare, Doug] Nat Resources Management, Bayan Lepas, Penang, Malaysia; [Handayani, Christian] Coral Triangle Program, WWF Indonesia, South Jakarta, Indonesia; [Huang, Charles] Coral Triangle Program, WWF United States, Washington, DC USA; [Peterson, Nate] Nature Conservancy, Indo Pacific Div, Townsville, Qld, Australia; [Siry, Hendra Yusran] Coral Triangle Initiat Coral Reefs & Food Secur, Jakarta, Indonesia; [Fitriana, Ria] Coral Triangle Ctr, Bali, Indonesia; [Gove, Jamison; Acoba, Tomoko] Natl Ocean & Atmospher Adm, Joint Inst Marine & Atmospher Res, Honolulu, HI USA; [Knight, Maurice] Coral Triangle Support Partnership, WWF Indonesia, Jakarta, Indonesia; [Acosta, Renerio] United States Agcy Int Dev Reg Dev Mission Asia, Reg Environm Off, Bangkok, Thailand	Nature Conservancy; World Wildlife Fund; National Oceanic Atmospheric Admin (NOAA) - USA; World Wildlife Fund; United States Agency for International Development (USAID)	Beare, D (corresponding author), Nat Resources Management, Bayan Lepas, Penang, Malaysia.	dbeare@cgiar.org	andrew, neil/AAG-6360-2020; Venegas Li, Rubén/G-6560-2016	andrew, neil/0000-0002-2337-8722; Venegas Li, Rubén/0000-0003-2085-8269; , Ngobrolgame.com/0000-0001-6815-9112	U.S. Government; CGIAR	U.S. Government; CGIAR(CGIAR)	The CT Atlas (http://ctatlas.reefbase.org) was developed as a partnership between WorldFish, The Nature Conservancy (TNC), World Wildlife Fund (WWF), Wildlife Conservation Society (WCS) and the International Union for Conservation of Nature (IUCN). The design and development of the CT Atlas was supported primarily by the U.S. Government through the 5-year (2009-2013) Coral Triangle Support Partnership (CTSP) in cooperation with other implementing partners of the US Coral Triangle Support Program (USCTI). The production of the current manuscript was also supported by the CGIAR Research Programs on: Climate Change, Agriculture and Food Security (CCAFS); and Aquatic Agricultural Systems (AAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen GR, 2008, AQUAT CONSERV, V18, P541, DOI 10.1002/aqc.880; Anselin L, 2010, ADV SPAT SCI, P35, DOI 10.1007/978-3-642-01976-0_3; Anthony KRN, 2008, P NATL ACAD SCI USA, V105, P17442, DOI 10.1073/pnas.0804478105; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Bruce T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036687; Burke L, 2009, REEFS RISK REVISITED; Carpenter KE, 2010, J MAR BIOL 2011; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Cinner JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074321; Cros A, 2014, COAST MANAGE, V42, P128, DOI 10.1080/08920753.2014.877760; Foale S, 2013, MAR POLICY, V38, P174, DOI 10.1016/j.marpol.2012.05.033; Francini RB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054260; Green AL, 2003, REP EXP WORKSH HELD; Heath MR, 2008, MAR ECOL PROG SER, V363, P183, DOI 10.3354/meps07460; Hoegh-Guldberg O., 2009, CORAL TRIANGLE CLIMA; HOWARTH RW, 1988, ANNU REV ECOL SYST, V19, P89, DOI 10.1146/annurev.es.19.110188.000513; Kasper-Fuehrer EC, 2001, J MANAGE, V27, P235, DOI 10.1016/S0149-2063(01)00090-3; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; Mcleod E, 2010, SUSTAIN SCI, V5, P207, DOI 10.1007/s11625-010-0105-1; Penaflor EL, 2009, CORAL REEFS, V28, P841, DOI 10.1007/s00338-009-0522-8; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Stein L, 2002, NATURE, V417, P119, DOI 10.1038/417119a; Veron J.E.N., 2009, Galaxea - Tokyo, V11, P91; Veron JEN, 2009, MAR POLLUT BULL, V58, P1428, DOI 10.1016/j.marpolbul.2009.09.009	24	14	15	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e96332	10.1371/journal.pone.0096332	http://dx.doi.org/10.1371/journal.pone.0096332			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941442	Green Published, gold, Green Submitted			2022-12-27	WOS:000338508200001
J	La Scaleia, B; Lacquaniti, F; Zago, M				La Scaleia, Barbara; Lacquaniti, Francesco; Zago, Myrka			Neural Extrapolation of Motion for a Ball Rolling Down an Inclined Plane	PLOS ONE			English	Article							VISUAL GRAVITATIONAL MOTION; MOVING TARGETS; REPRESENTATIONAL MOMENTUM; MANUAL INTERCEPTIONS; INTERNAL-MODELS; FALLING BALL; PERCEPTION; MOVEMENTS; HAND; DYNAMICS	It is known that humans tend to misjudge the kinematics of a target rolling down an inclined plane. Because visuomotor responses are often more accurate and less prone to perceptual illusions than cognitive judgments, we asked the question of how rolling motion is extrapolated for manual interception or drawing tasks. In three experiments a ball rolled down an incline with kinematics that differed as a function of the starting position (4 different positions) and slope (30 degrees, 45 degrees or 60 degrees). In Experiment 1, participants had to punch the ball as it fell off the incline. In Experiment 2, the ball rolled down the incline but was stopped at the end; participants were asked to imagine that the ball kept moving and to punch it. In Experiment 3, the ball rolled down the incline and was stopped at the end; participants were asked to draw with the hand in air the trajectory that would be described by the ball if it kept moving. We found that performance was most accurate when motion of the ball was visible until interception and haptic feedback of hand-ball contact was available (Experiment 1). However, even when participants punched an imaginary moving ball (Experiment 2) or drew in air the imaginary trajectory (Experiment 3), they were able to extrapolate to some extent global aspects of the target motion, including its path, speed and arrival time. We argue that the path and kinematics of a ball rolling down an incline can be extrapolated surprisingly well by the brain using both visual information and internal models of target motion.	[La Scaleia, Barbara; Lacquaniti, Francesco; Zago, Myrka] IRCCS Santa Lucia Fdn, Lab Neuromotor Physiol, Rome, Italy; [Lacquaniti, Francesco] Univ Roma Tor Vergata, Dept Syst Med, Rome, Italy; [Lacquaniti, Francesco] Univ Roma Tor Vergata, Ctr Space Biomed, Rome, Italy	IRCCS Santa Lucia; University of Rome Tor Vergata; University of Rome Tor Vergata	Zago, M (corresponding author), IRCCS Santa Lucia Fdn, Lab Neuromotor Physiol, Rome, Italy.	m.zago@hsantalucia.it	Zago, Myrka/B-3669-2012; La Scaleia, Barbara/A-5981-2015; Lacquaniti, Francesco/J-9842-2016; La Scaleia, Barbara/AAB-2190-2019	Zago, Myrka/0000-0001-7100-7582; La Scaleia, Barbara/0000-0003-2050-2641; Lacquaniti, Francesco/0000-0003-0896-7315; 	Italian Health Ministry; Italian University Ministry (PRIN project); Italian Space Agency (CRUSOE grant); Italian Space Agency (COREA grant); Italian Space Agency (ARIANNA grant)	Italian Health Ministry(Ministry of Health, Italy); Italian University Ministry (PRIN project); Italian Space Agency (CRUSOE grant); Italian Space Agency (COREA grant); Italian Space Agency (ARIANNA grant)	The work was supported by the Italian Health Ministry, Italian University Ministry (PRIN project), and Italian Space Agency (CRUSOE, COREA and ARIANNA grants). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGLIOTI S, 1995, CURR BIOL, V5, P679, DOI 10.1016/S0960-9822(95)00133-3; Arce F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004214; Baures R, 2011, PERCEPTION, V40, P674, DOI 10.1068/p6945; Bennett SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063382; BERTAMINI M, 1993, MEM COGNITION, V21, P449, DOI 10.3758/BF03197176; Bertamini M., 2004, MULTIDISCIPLINARY AP, P32; Bosco G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049381; Bozzi P., 1961, AUT AUT, V64, P1; Bozzi P., 1959, RIV PSICOL, VLIII, P337; Brenner E, 1998, EXP BRAIN RES, V122, P467, DOI 10.1007/s002210050535; Brenner E, 2012, ACTA PSYCHOL, V141, P104, DOI 10.1016/j.actpsy.2012.07.002; Cesqui B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031770; de Rugy A, 2012, J NEUROPHYSIOL, V107, P766, DOI 10.1152/jn.00854.2011; De Sa Teixeira N, 2014, ATTEN PERCEPT PSYCHO; Teixeira NAD, 2013, J EXP PSYCHOL HUMAN, V39, P1690, DOI 10.1037/a0031777; Dessing JC, 2004, ECOL PSYCHOL, V16, P1, DOI 10.1207/s15326969eco1601_1; Dessing JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013161; Dessing JC, 2009, EXP BRAIN RES, V192, P669, DOI 10.1007/s00221-008-1588-1; DIEM K., 1962, Documenta Geigy. Scientific tables.; Ebersbach M, 2011, INT J SCI MATH EDUC, V9, P25, DOI 10.1007/s10763-010-9208-5; FREYD JJ, 1987, PSYCHOL REV, V94, P427, DOI 10.1037/0033-295X.94.4.427; Gomez J, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00046; HECHT H, 1993, PERCEPTION, V22, P917, DOI 10.1068/p220917; Hibbard PB, 2003, EXP BRAIN RES, V148, P196, DOI 10.1007/s00221-002-1295-2; Howe CQ, 2005, P NATL ACAD SCI USA, V102, P1228, DOI 10.1073/pnas.0409311102; Hubbard TL, 2005, PSYCHON B REV, V12, P822, DOI 10.3758/BF03196775; HUBBARD TL, 1995, PSYCHON B REV, V2, P322, DOI 10.3758/BF03210971; Indovina I, 2005, SCIENCE, V308, P416, DOI 10.1126/science.1107961; KAISER MK, 1992, J EXP PSYCHOL HUMAN, V18, P669, DOI 10.1037/0096-1523.18.3.669; Katsumata H, 2012, EXP BRAIN RES, V216, P499, DOI 10.1007/s00221-011-2954-y; Khan MA, 2003, MOTOR CONTROL, V7, P290, DOI 10.1123/mcj.7.3.290; LACQUANITI F, 1987, BRAIN RES, V406, P373, DOI 10.1016/0006-8993(87)90810-9; LACQUANITI F, 1993, J NEUROPHYSIOL, V69, P1443, DOI 10.1152/jn.1993.69.5.1443; LACQUANITI F, 1989, J NEUROSCI, V9, P149; Lee D, 1997, EXP BRAIN RES, V116, P421, DOI 10.1007/PL00005770; LEE DN, 1983, Q J EXP PSYCHOL-A, V35, P333, DOI 10.1080/14640748308402138; Magdalon EC, 2011, ACTA PSYCHOL, V138, P126, DOI 10.1016/j.actpsy.2011.05.015; Marinovic W, 2009, EXP PSYCHOL, V56, P265, DOI 10.1027/1618-3169.56.4.265; MCCLOSKEY M, 1980, SCIENCE, V210, P1139, DOI 10.1126/science.210.4474.1139; McIntyre J, 2001, NAT NEUROSCI, V4, P693, DOI 10.1038/89477; McIntyre J, 1997, J NEUROPHYSIOL, V78, P1601, DOI 10.1152/jn.1997.78.3.1601; MCLEOD P, 1987, PERCEPTION, V16, P49, DOI 10.1068/p160049; Michaels CF, 2001, Q J EXP PSYCHOL-A, V54, P69, DOI 10.1080/02724980042000039; MORASSO P, 1981, EXP BRAIN RES, V42, P223; Morrison D. F., 1990, MULTIVARIATE STAT ME; Mrotek LA, 2007, J NEUROSCI, V27, P7297, DOI 10.1523/JNEUROSCI.2046-07.2007; Mrotek LA, 2007, EXP BRAIN RES, V178, P99, DOI 10.1007/s00221-006-0717-y; Oh S, 2008, PERCEPTION, V37, P317, DOI 10.1068/p5887; Port NL, 1997, EXP BRAIN RES, V116, P406, DOI 10.1007/PL00005769; PROFFITT DR, 1989, J EXP PSYCHOL HUMAN, V15, P384, DOI 10.1037/0096-1523.15.2.384; Proffitt DR, 1995, PSYCHON B REV, V2, P409, DOI 10.3758/BF03210980; PROFFITT DR, 1990, COGNITIVE PSYCHOL, V22, P342, DOI 10.1016/0010-0285(90)90007-Q; Rohrer D, 2002, J EXP PSYCHOL HUMAN, V28, P963, DOI 10.1037//0096-1523.28.4.963; SHEPARD RN, 1984, PSYCHOL REV, V91, P417, DOI 10.1037/0033-295X.91.4.417; Souto D, 2013, J VISION, V13, DOI 10.1167/13.2.9; TEASDALE N, 1993, J MOTOR BEHAV, V25, P97, DOI 10.1080/00222895.1993.9941644; Tijtgat P, 2010, EXP BRAIN RES, V201, P875, DOI 10.1007/s00221-009-2102-0; Tresilian JR, 1997, BRAIN, V120, P2093, DOI 10.1093/brain/120.11.2093; Tresilian JR, 1999, TRENDS COGN SCI, V3, P301, DOI 10.1016/S1364-6613(99)01352-2; Tresilian JR, 2002, EXP BRAIN RES, V142, P193, DOI 10.1007/s00221-001-0920-9; VICARIO GB, 1990, PERCEPTION, V19, P57, DOI 10.1068/p190057; Vishton PM, 2010, EXP BRAIN RES, V202, P661, DOI 10.1007/s00221-010-2172-z; Watamaniuk SNJ, 2003, J VISION, V3, P698, DOI 10.1167/3.11.5; WERKHOVEN P, 1992, VISION RES, V32, P2313, DOI 10.1016/0042-6989(92)90095-Z; Witt JK, 2007, PERCEPTION, V36, P1752, DOI 10.1068/p5617; Witt JK, 2007, PERCEPTION, V36, P249, DOI 10.1068/p5449; Zago M, 2005, J NEUROPHYSIOL, V94, P1346, DOI 10.1152/jn.00215.2005; Zago M, 2005, NEUROPSYCHOLOGIA, V43, P178, DOI 10.1016/j.neuropsychologia.2004.11.005; Zago M, 2005, J NEUROPHYSIOL, V93, P1055, DOI 10.1152/jn.00833.2004; Zago M, 2004, J NEUROPHYSIOL, V91, P1620, DOI 10.1152/jn.00862.2003; Zago M, 2008, VISION RES, V48, P1532, DOI 10.1016/j.visres.2008.04.005; Zago M, 2010, EXP BRAIN RES, V201, P365, DOI 10.1007/s00221-009-2041-9	72	20	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99837	10.1371/journal.pone.0099837	http://dx.doi.org/10.1371/journal.pone.0099837			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940874	Green Published, gold			2022-12-27	WOS:000338508200046
J	Rodrigues, AM; Bergamaschi, CT; Fernandes, MJS; Paredes-Gamero, EJ; Curi, MV; Ferreira, AT; Araujo, SRR; Punaro, GR; Maciel, FR; Nogueira, GB; Higa, EMS				Rodrigues, Adelson M.; Bergamaschi, Cassia T.; Fernandes, Maria Jose S.; Paredes-Gamero, Edgar J.; Curi, Marcus V.; Ferreira, Alice T.; Araujo, Sergio R. R.; Punaro, Giovana R.; Maciel, Fabiane R.; Nogueira, Guilherme B.; Higa, Elisa M. S.			P2X(7) Receptor in the Kidneys of Diabetic Rats Submitted to Aerobic Training or to N-Acetylcysteine Supplementation	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; REACTIVE OXYGEN; OXIDATIVE STRESS; ENDOTHELIAL-CELLS; EXERCISE; DYSFUNCTION; MUSCLE; TETRAHYDROBIOPTERIN; PROGRESSION; RESTRICTION	Previous studies in our laboratory showed that N-acetylcysteine supplementation or aerobic training reduced oxidative stress and the progression of diabetic nephropathy in rats. The P2X(7) receptor is up-regulated in pathological conditions, such as diabetes mellitus. This up-regulation is related to oxidative stress and induces tissue apoptosis or necrosis. The aim of the present study is to assess the role of P2X(7) receptor in the kidneys of diabetic rats submitted to aerobic training or N-acetylcysteine supplementation. Diabetes was induced in male Wistar rats by streptozotocin (60 mg/kg, i.v.) and the training was done on a treadmill; N-acetylcysteine was given in the drinking water (600 mg/L). By confocal microscopy, as compared to control, the kidneys of diabetic rats showed increased P2X7 receptor expression and a higher activation in response to 2'(3')-O-(4-benzoylbenzoyl) adenosine5'-triphosphate (specific agonist) and adenosine triphosphate (nonspecific agonist) (all p<0.05). All these alterations were reduced in diabetic rats treated with N-acetylcysteine, exercise or both. We also observed measured proteinuria and albuminuria (early marker of diabetic nephropathy) in DM groups. Lipoperoxidation was strongly correlated with P2X(7) receptor expression, which was also correlated to NO center dot, thus associating this receptor to oxidative stress and kidney lesion. We suggest that P2X(7) receptor inhibition associated with the maintenance of redox homeostasis could be useful as coadjuvant treatment to delay the progression of diabetic nephropathy.	[Rodrigues, Adelson M.; Punaro, Giovana R.; Maciel, Fabiane R.; Nogueira, Guilherme B.; Higa, Elisa M. S.] Univ Fed Sao Paulo, Div Nephrol, Dept Med, Sao Paulo, Brazil; [Bergamaschi, Cassia T.] Univ Fed Sao Paulo, Cardiovasc Div, Dept Physiol, Sao Paulo, Brazil; [Fernandes, Maria Jose S.] Univ Fed Sao Paulo, Dept Neurol Neurosurg, Sao Paulo, Brazil; [Paredes-Gamero, Edgar J.; Curi, Marcus V.] Univ Fed Sao Paulo, Dept Biochem, Sao Paulo, Brazil; [Ferreira, Alice T.] Univ Fed Sao Paulo, Div Mol Biol, Dept Biophys, Sao Paulo, Brazil; [Araujo, Sergio R. R.] Univ Fed Sao Paulo, Investigat Pathol Div, Dept Pathol, Sao Paulo, Brazil; [Higa, Elisa M. S.] Univ Fed Sao Paulo, Emergency Div, Dept Med, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Higa, EMS (corresponding author), Univ Fed Sao Paulo, Div Nephrol, Dept Med, Sao Paulo, Brazil.	emshiga@unifesp.br	Paredes-Gamero, Edgar J/C-4791-2012; da Silva Fernandes, Maria Jose/M-5095-2017; Bergamaschi, Cassia/AAZ-9441-2020; Higa, Elisa/I-3672-2013; Rodrigues, Adelson Marcal/D-8745-2014; Buri, Marcus Vinicius/L-4333-2017	Paredes-Gamero, Edgar J/0000-0003-3686-8402; da Silva Fernandes, Maria Jose/0000-0001-6559-3052; Rodrigues, Adelson Marcal/0000-0003-1220-1806; Punaro, Giovana/0000-0002-0833-1344; Buri, Marcus Vinicius/0000-0002-8925-1206; Bergamaschi, Cassia/0000-0002-5741-6993	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Apoio a Universidade Federal de Sao Paulo (FAP)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Apoio a Universidade Federal de Sao Paulo (FAP)	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and Fundacao de Apoio a Universidade Federal de Sao Paulo (FAP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afolayan AJ, 2013, AFR J TRADIT COMPLEM, V10, P15, DOI 10.4314/ajtcam.v10i1.3; Annunziato L, 2002, NEUROBIOL AGING, V23, P819, DOI 10.1016/S0197-4580(02)00069-6; BERNHEIM F, 1948, J BIOL CHEM, V174, P257; Bourzac JF, 2013, J CELL PHYSIOL, V228, P120, DOI 10.1002/jcp.24111; Coddou C, 2009, J NEUROSCI, V29, P12284, DOI 10.1523/JNEUROSCI.2096-09.2009; Conti V, 2013, MED SCI SPORT EXER, V45, P644, DOI 10.1249/MSS.0b013e318279fb59; Cosenzi A, 2002, ACTA DIABETOL, V39, P91, DOI 10.1007/s005920200019; da Cunha MJ, 2013, LIFE SCI, V92, P218, DOI 10.1016/j.lfs.2012.12.005; De Vriese AS, 2000, BRIT J PHARMACOL, V130, P963, DOI 10.1038/sj.bjp.0703393; Debevec T, 2013, MED SCI SPORTS EXERC; Dona F, 2009, EPILEPSY RES, V83, P157, DOI 10.1016/j.eplepsyres.2008.10.008; Faria AM, 2012, DIABETES, V61, P1838, DOI 10.2337/db11-1241; Forbes SC, 2012, ENDOCRINE, V42, P29, DOI 10.1007/s12020-012-9676-1; Grutzmacher C, 2013, AM J PHYSIOL-RENAL, V304, pF19, DOI 10.1152/ajprenal.00036.2012; HAMPL V, 1996, METHODS NITRIC OXIDE, P310; Hewinson J, 2007, BIOCHEM SOC T, V35, P1168, DOI 10.1042/BST0351168; Hoang HH, 2013, CURR OPIN CLIN NUTR, V16, P76, DOI 10.1097/MCO.0b013e32835ad1ef; JI LL, 1993, J APPL PHYSIOL, V74, P788, DOI 10.1152/jappl.1993.74.2.788; Kukner A, 2009, CLIN REV OPINIONS, V1, P029; Kurdak H, 2010, J SPORT SCI MED, V9, P294; Leandro SM, 2008, PHYSIOL BEHAV, V95, P145, DOI 10.1016/j.physbeh.2008.05.011; Madden KM, 2013, DIABETES METAB SYNDR, V6, P233, DOI 10.2147/DMSO.S32951; Mancini G, 1965, Immunochemistry, V2, P235, DOI 10.1016/0019-2791(65)90004-2; Manna Prasenjit, 2006, BMC Complement Altern Med, V6, P33, DOI 10.1186/1472-6882-6-33; Shimizu MHM, 2008, NEPHROL DIAL TRANSPL, V23, P3067, DOI 10.1093/ndt/gfn237; Molitch ME, 2004, DIABETES CARE, V27, P1240, DOI 10.2337/diacare.27.5.1240-a; Nogueira GB, 2011, PHIL ASN KIDN WEEK 2, P1; Ochodnicky P, 2006, J AM SOC NEPHROL, V17, pS49, DOI 10.1681/ASN.2005121322; Paredes-Gamero EJ, 2008, J BIOL CHEM, V283, P31909, DOI 10.1074/jbc.M801990200; Punaro GR, 2014, NITRIC OXIDE; Ralevic V, 1998, PHARMACOL REV, V50, P413; Rodrigues AM, 2011, EXP BIOL MED, V236, P1180, DOI 10.1258/ebm.2011.011005; ROMANELLI G, 1991, J HUM HYPERTENS, V5, P167; Roughan JV, 2004, BEHAV PHARMACOL, V15, P461, DOI 10.1097/00008877-200411000-00002; Rocha RER, 2013, ARQ BRAS ENDOCRINOL, V57, P594, DOI 10.1590/S0004-27302013000800003; Santhanam AVR, 2012, J NEUROCHEM, V122, P1211, DOI 10.1111/j.1471-4159.2012.07872.x; Santin K, 2011, BRAIN RES, V1421, P1, DOI 10.1016/j.brainres.2011.08.003; Schulze-Lohoff E, 1998, AM J PHYSIOL-RENAL, V275, pF962, DOI 10.1152/ajprenal.1998.275.6.F962; Sen CK, 2001, MED SCI SPORT EXER, V33, P368, DOI 10.1097/00005768-200103000-00005; Shimamoto K, 2011, J TOXICOL SCI, V36, P775, DOI 10.2131/jts.36.775; Shimizu MHM, 2005, KIDNEY INT, V68, P2208, DOI 10.1111/j.1523-1755.2005.00677.x; Smith JM, 1997, CARDIOVASC RES, V34, P137, DOI 10.1016/S0008-6363(96)00238-6; Song W, 2009, J GERONTOL A-BIOL, V64, P540, DOI 10.1093/gerona/glp021; Souza CO, 2012, BBA-GEN SUBJECTS, V1820, P1867, DOI 10.1016/j.bbagen.2012.08.013; Summers BA, 1999, J NEUROPHYSIOL, V81, P1449, DOI 10.1152/jn.1999.81.4.1449; Thaning P, 2010, DIABETES, V59, P182, DOI 10.2337/db09-1068; Tirkey Naveen, 2005, BMC Pharmacology, V5, P15, DOI 10.1186/1471-2210-5-15; Torres LL, 2011, J ALZHEIMERS DIS, V26, P59, DOI 10.3233/JAD-2011-110284; Trueblood KE, 2011, AM J PHYSIOL-CELL PH, V301, pC1213, DOI 10.1152/ajpcell.00265.2011; Volonte C, 2012, CNS NEUROL DISORD-DR, V11, P705, DOI 10.2174/187152712803581137; Vonend O, 2004, KIDNEY INT, V66, P157, DOI 10.1111/j.1523-1755.2004.00717.x; Winnick JJ, 2008, J CLIN ENDOCR METAB, V93, P771, DOI 10.1210/jc.2007-1524; Xu H, 2013, BRAIN RES B	53	34	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e97452	10.1371/journal.pone.0097452	http://dx.doi.org/10.1371/journal.pone.0097452			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940871	gold, Green Submitted, Green Published			2022-12-27	WOS:000338508200004
J	Briney, BS; Willis, JR; Finn, JA; McKinney, BA; Crowe, JE				Briney, Bryan S.; Willis, Jordan R.; Finn, Jessica A.; McKinney, Brett A.; Crowe, James E., Jr.			Tissue-Specific Expressed Antibody Variable Gene Repertoires	PLOS ONE			English	Article							MEMORY B-CELLS; MONOCLONAL-ANTIBODIES; IMMUNOGLOBULIN HEAVY; SOMATIC MUTATION; IMMUNE-RESPONSE; HIV-1; INSERTIONS; DELETIONS; SEGMENT; REGION	Recent developments in genetic technologies allow deep analysis of the sequence diversity of immune repertoires, but little work has been reported on the architecture of immune repertoires in mucosal tissues. Antibodies are the key to prevention of infections at the mucosal surface, but it is currently unclear whether the B cell repertoire at mucosal surfaces reflects the dominant antibodies found in the systemic compartment or whether mucosal tissues harbor unique repertoires. We examined the expressed antibody variable gene repertoires from 10 different human tissues using RNA samples derived from a large number of individuals. The results revealed that mucosal tissues such as stomach, intestine and lung possess unique antibody gene repertoires that differed substantially from those found in lymphoid tissues or peripheral blood. Mutation frequency analysis of mucosal tissue repertoires revealed that they were highly mutated, with little evidence for the presence of naive B cells, in contrast to blood. Mucosal tissue repertoires possessed longer heavy chain complementarity determining region 3 loops than lymphoid tissue repertoires. We also noted a large increase in frequency of both insertions and deletions in the small intestine antibody repertoire. These data suggest that mucosal immune repertoires are distinct in many ways from the systemic compartment.	[Briney, Bryan S.; Finn, Jessica A.; Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37235 USA; [Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA; [Willis, Jordan R.] Vanderbilt Univ, Chem & Phys Biol Program, Nashville, TN 37235 USA; [Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Vanderbilt Vaccine Ctr, Nashville, TN USA; [McKinney, Brett A.] Univ Tulsa, Tandy Sch Comp Sci, Tulsa, OK 74104 USA; [McKinney, Brett A.] Univ Tulsa, Dept Math, Tulsa, OK 74104 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Tulsa; University of Tulsa	Crowe, JE (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37235 USA.	james.crowe@vanderbilt.edu	Crowe, James/B-5549-2009	Crowe, James/0000-0002-0049-1079	NIH Contract [HHSN272200900047C]; NIH grant [R01 AI106002]; DoD grant [HDTRA1-10-1-0067]; NIH [T32 HL069765]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL069765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI106002] Funding Source: NIH RePORTER	NIH Contract(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DoD grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by NIH Contract HHSN272200900047C, NIH grant R01 AI106002, and DoD grant HDTRA1-10-1-0067. BSB was supported by NIH T32 HL069765. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDERSON EE, 1991, J IMMUNOL, V147, P1667; Aguilera I, 2001, IMMUNOLOGY, V102, P273, DOI 10.1046/j.1365-2567.2001.01159.x; Alamyar E., 2012, IMMUNOME RES, V8, P1, DOI [10.4172/1745-7580.1000056, DOI 10.4172/1745-7580.1000056]; ALT FW, 1992, IMMUNOL TODAY, V13, P306, DOI 10.1016/0167-5699(92)90043-7; Arnaout R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022365; Benckert J, 2011, J CLIN INVEST, V121, P1946, DOI 10.1172/JCI44447; Boyd SD, 2010, J IMMUNOL, V184, P6986, DOI 10.4049/jimmunol.1000445; Boyd SD, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000540; Briney BS, 2012, GENES IMMUN, V13, P523, DOI 10.1038/gene.2012.28; Briney BS, 2012, GENES IMMUN, V13, P469, DOI 10.1038/gene.2012.20; Briney BS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036750; Cerutti A, 2011, ANNU REV IMMUNOL, V29, P273, DOI 10.1146/annurev-immunol-031210-101317; CROUZIER R, 1995, J IMMUNOL, V154, P4526; DeKosky BJ, 2013, NAT BIOTECHNOL, V31, P166, DOI 10.1038/nbt.2492; Fagarasan S, 2003, NAT REV IMMUNOL, V3, P63, DOI 10.1038/nri982; Gorny MK, 2009, MOL IMMUNOL, V46, P917, DOI 10.1016/j.molimm.2008.09.005; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Holtmeier W, 2000, GASTROENTEROLOGY, V119, P1253, DOI 10.1053/gast.2000.20219; Krause JC, 2011, MBIO, V2, DOI 10.1128/mBio.00345-10; Lefranc MP, 2009, NUCLEIC ACIDS RES, V37, pD1006, DOI 10.1093/nar/gkn838; Milstein C, 1996, ADV PROTEIN CHEM, V49, P451, DOI 10.1016/S0065-3233(08)60494-5; Neuberger MS, 2008, IMMUNOL CELL BIOL, V86, P124, DOI 10.1038/sj.icb.7100160; Neuberger MS, 1995, CURR OPIN IMMUNOL; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schatz DG, 2004, IMMUNOL REV, V200, P5, DOI 10.1111/j.0105-2896.2004.00173.x; Suzuki K, 2010, IMMUNITY, V33, P71, DOI 10.1016/j.immuni.2010.07.003; Tian CX, 2008, J IMMUNOL, V180, P3279, DOI 10.4049/jimmunol.180.5.3279; Tian CX, 2007, MOL IMMUNOL, V44, P2173, DOI 10.1016/j.molimm.2006.11.020; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Weitkamp JH, 2005, J IMMUNOL, V174, P3454, DOI 10.4049/jimmunol.174.6.3454; Wilson P, 1998, IMMUNOL REV, V162, P143, DOI 10.1111/j.1600-065X.1998.tb01437.x; Wilson PC, 1998, J EXP MED, V187, P59, DOI 10.1084/jem.187.1.59; Wine Y, 2013, P NATL ACAD SCI USA, V110, P2993, DOI 10.1073/pnas.1213737110; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Wu YC, 2010, BLOOD, V116, P1070, DOI 10.1182/blood-2010-03-275859; Zemlin M, 2008, J IMMUNOL, V181, P8416, DOI 10.4049/jimmunol.181.12.8416; Zouali M, 1996, APPL BIOCHEM BIOTECH, V61, P149, DOI 10.1007/BF02785697	41	29	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100839	10.1371/journal.pone.0100839	http://dx.doi.org/10.1371/journal.pone.0100839			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956460	Green Published, gold, Green Submitted			2022-12-27	WOS:000338917900099
J	Mokhtar, SS; Marshall, CR; Phipps, ME; Thiruvahindrapuram, B; Lionel, AC; Scherer, SW; Peng, HB				Mokhtar, Siti Shuhada; Marshall, Christian R.; Phipps, Maude E.; Thiruvahindrapuram, Bhooma; Lionel, Anath C.; Scherer, Stephen W.; Peng, Hoh Boon			Novel Population Specific Autosomal Copy Number Variation and Its Functional Analysis amongst Negritos from Peninsular Malaysia	PLOS ONE			English	Article							SOUTHEAST-ASIA; GENE CHRNA7; VARIANTS; DUPLICATIONS; SELECTION; SPECTRUM; IMPACT	Copy number variation (CNV) has been recognized as a major contributor to human genome diversity. It plays an important role in determining phenotypes and has been associated with a number of common and complex diseases. However CNV data from diverse populations is still limited. Here we report the first investigation of CNV in the indigenous populations from Peninsular Malaysia. We genotyped 34 Negrito genomes from Peninsular Malaysia using the Affymetrix SNP 6.0 microarray and identified 48 putative novel CNVs, consisting of 24 gains and 24 losses, of which 5 were identified in at least 2 unrelated samples. These CNVs appear unique to the Negrito population and were absent in the DGV, HapMap3 and Singapore Genome Variation Project (SGVP) datasets. Analysis of gene ontology revealed that genes within these CNVs were enriched in the immune system (GO:0002376), response to stimulus mechanisms (GO:0050896), the metabolic pathways (GO:0001852), as well as regulation of transcription (GO:0006355). Copy number gains in CNV regions (CNVRs) enriched with genes were significantly higher than the losses (P value <0.001). In view of the small population size, relative isolation and semi-nomadic lifestyles of this community, we speculate that these CNVs may be attributed to recent local adaptation of Negritos from Peninsular Malaysia.	[Mokhtar, Siti Shuhada; Peng, Hoh Boon] Univ Teknol MARA, Fac Med, Inst Med Mol Biotechnol, Selangor, Malaysia; [Marshall, Christian R.; Thiruvahindrapuram, Bhooma; Lionel, Anath C.; Scherer, Stephen W.] Hosp Sick Children, Ctr Appl Genom, Toronto, ON M5G 1X8, Canada; [Phipps, Maude E.] Monash Univ Sunway Campus, Jeffrey Cheah Sch Med & Hlth Sci, Selangor, Malaysia; [Marshall, Christian R.; Scherer, Stephen W.] Univ Toronto, McLaughlin Ctr, Toronto, ON, Canada; [Marshall, Christian R.; Scherer, Stephen W.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada	Universiti Teknologi MARA; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Monash University; Monash University Sunway; University of Toronto; University of Toronto	Peng, HB (corresponding author), Univ Teknol MARA, Fac Med, Inst Med Mol Biotechnol, Sungai Buloh Campus, Selangor, Malaysia.	hbpeng@salam.uitm.edu.my	Scherer, Stephen W./B-3785-2013; Phipps, Maude/F-7590-2012; Hoh, Boon-Peng/H-8682-2016	Scherer, Stephen W./0000-0002-8326-1999; Phipps, Maude/0000-0001-8314-068X; Hoh, Boon-Peng/0000-0001-9249-4965	Ministry of Science, Technology and Innovation (MOSTI) [100-RM/BIOTEK 16/6/2 B, 100-RMI/GOV 16/6/2]; Dr. Ranjeet Bhagwan Singh International Fellowship (Academy of Science Malaysia); University of Toronto McLaughlin Centre; Hospital for Sick Children Foundation; NeuroDevNet doctoral fellowship	Ministry of Science, Technology and Innovation (MOSTI)(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia); Dr. Ranjeet Bhagwan Singh International Fellowship (Academy of Science Malaysia); University of Toronto McLaughlin Centre; Hospital for Sick Children Foundation; NeuroDevNet doctoral fellowship	This study is supported by Ministry of Science, Technology and Innovation (MOSTI) grant erBiotek Grant # 100-RM/BIOTEK 16/6/2 B (1/2011) and [100-RMI/GOV 16/6/2 (19/2011] awarded to HB Peng & ME Phipps, Dr. Ranjeet Bhagwan Singh International Fellowship (Academy of Science Malaysia) awarded to HB Peng and support from the University of Toronto McLaughlin Centre and The Hospital for Sick Children Foundation. ACL holds a NeuroDevNet doctoral fellowship. SWS holds the GlaxoSmithKline-CIHR Chair in Genome Sciences at the University of Toronto and The Hospital for Sick Children. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla MA, 2009, SCIENCE, V326, P1541, DOI 10.1126/science.1177074; Ali O, 1995, Asia Pac J Clin Nutr, V4, P319; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Baer A., 1999, HLTH DIS SURVIVAL BI; Barker G, 2007, J HUM EVOL, V52, P243, DOI 10.1016/j.jhevol.2006.08.011; Bellwood P, 1993, ASIAN PERSPECT, V32, P37; Bustamante CD, 2011, NATURE, V475, P163, DOI 10.1038/475163a; Chen WT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023087; Cooper GM, 2007, NAT GENET, V39, pS22, DOI 10.1038/ng2054; Estivill X, 2007, PLOS GENET, V3, P1787, DOI 10.1371/journal.pgen.0030190; Gautam P, 2012, HUM GENET, V131, P131, DOI 10.1007/s00439-011-1050-5; Girirajan S, 2011, ANNU REV GENET, V45, P203, DOI 10.1146/annurev-genet-102209-163544; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Henrichsen CN, 2009, HUM MOL GENET, V18, pR1, DOI 10.1093/hmg/ddp011; Hill C, 2006, MOL BIOL EVOL, V23, P2480, DOI 10.1093/molbev/msl124; Hoh B. P., 2011, Malaysian Applied Biology, V40, P61; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Itsara A, 2010, GENOME RES, V20, P1469, DOI 10.1101/gr.107680.110; Jinam TA, 2008, ETHNIC HEALTH, V13, P277, DOI 10.1080/13557850801930478; Korbel JO, 2008, CURR OPIN STRUC BIOL, V18, P366, DOI 10.1016/j.sbi.2008.02.005; Kristiansson K, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-109; Ku CS, 2010, HUM MUTAT, V31, P851, DOI 10.1002/humu.21287; Lahr Marta Mirazon, 1994, Evolutionary Anthropology, V3, P48, DOI 10.1002/evan.1360030206; Li J, 2001, GENETIC LINGUISTIC A; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Lionel AC, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002464; Lou HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027341; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; McElroy JP, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-15; Nguyen DQ, 2006, PLOS GENET, V2, P198, DOI 10.1371/journal.pgen.0020020; Nozawa M, 2007, P NATL ACAD SCI USA, V104, P20421, DOI 10.1073/pnas.0709956104; Otto SP, 2002, ADV GENET, V46, P451; Peng MS, 2010, MOL BIOL EVOL, V27, P2417, DOI 10.1093/molbev/msq131; Pinto D, 2011, NAT BIOTECHNOL, V29, P512, DOI 10.1038/nbt.1852; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Stephens SH, 2009, SCHIZOPHR RES, V109, P102, DOI 10.1016/j.schres.2008.12.017; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; STRINGER CB, 1988, SCIENCE, V239, P1263, DOI 10.1126/science.3125610; Taske NL, 2002, EPILEPSY RES, V49, P157, DOI 10.1016/S0920-1211(02)00027-X; Yim SH, 2010, HUM MOL GENET, V19, P1001, DOI 10.1093/hmg/ddp564; Zhang YB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041768	42	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100371	10.1371/journal.pone.0100371	http://dx.doi.org/10.1371/journal.pone.0100371			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956385	Green Published, Green Submitted, gold			2022-12-27	WOS:000338917900044
J	Pacurar, DI; Pacurar, ML; Pacurar, AM; Gutierrez, L; Bellini, C				Pacurar, Daniel I.; Pacurar, Monica L.; Pacurar, Andrea M.; Gutierrez, Laurent; Bellini, Catherine			Novel Viable Allele of Arabidopsis CULLIN1 Identified in a Screen for Superroot2 Suppressors by Next Generation Sequencing-Assisted Mapping	PLOS ONE			English	Article							MAP-BASED CLONING; UBIQUITIN-PROTEIN LIGASES; AUXIN RESPONSE; MUTATION IDENTIFICATION; JASMONATE RESPONSE; THALIANA DEFINE; GENOME; COMPLEX; MUTANT; HOMEOSTASIS	Map-based cloning (MBC) is the conventional approach for linking phenotypes to genotypes, and has been successfully used to identify causal mutations in diverse organisms. Next-generation sequencing (NGS) technologies offer unprecedented possibilities to sequence the entire genomes of organisms, thereby in principle enabling direct identification of causal mutations without mapping. However, although mapping-by-sequencing has proven to be a cost effective alternative to classical MBC in particular situations, methods based solely on NGS still have limitations and need to be refined. Aiming to identify the causal mutations in suppressors of Arabidopsis thaliana superroot2 phenotype, generated by ethyl methane sulfonate (EMS) treatment, we combined NGS and classical mapping, to rapidly identify the point mutations and restrict the number of testable candidates by defining the chromosomal intervals containing the causal mutations, respectively. The NGS-assisted mapping approach we describe here facilitates unbiased identification of virtually any causal EMS-generated mutation by overlapping the identification (deep sequencing) and validation (mapping) steps. To exemplify the useful marriage of the two approaches we discuss the strategy used to identify a new viable recessive allele of the Arabidopsis CULLIN1 gene in the non-reference Wassilewskija (Ws-4) accession.	[Pacurar, Daniel I.; Pacurar, Monica L.; Bellini, Catherine] Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, S-90187 Umea, Sweden; [Pacurar, Monica L.; Pacurar, Andrea M.] Univ Agr Sci & Vet Med, Fac Hort, Cluj Napoca, Romania; [Gutierrez, Laurent] Univ Picardie Jules Verne, Mol Biol Platform CRRBM, Amiens, France; [Bellini, Catherine] INRA, AgroParisTech, UMR1318, Inst Jean Pierre Bourgin, Versailles, France	Umea University; University of Agricultural Sciences & Veterinary Medicine Cluj Napoca; Picardie Universites; Universite de Picardie Jules Verne (UPJV); AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Pacurar, DI (corresponding author), Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, S-90187 Umea, Sweden.	Daniel.Pacurar@umu.se	Pacurar, Andrea/R-4603-2017; Bellini, Catherine/E-7189-2013	Pacurar, Andrea/0000-0001-8818-2889; Bellini, Catherine/0000-0003-2985-6649; PACURAR, DANIEL IOAN/0000-0002-1888-5228; gutierrez, laurent/0000-0003-4829-8531	Swedish Foundation for Strategic Research (SSF); Swedish Research Council for Research and Innovation for Sustainable Growth (VINNOVA); Swedish Research Council (VR) [VR 621-2010-4359]; K. AMP; A. WallenbergFoundation; Carl Trygger Foundation [CTS08: 298]; Erasmus Programme	Swedish Foundation for Strategic Research (SSF)(Swedish Foundation for Strategic Research); Swedish Research Council for Research and Innovation for Sustainable Growth (VINNOVA); Swedish Research Council (VR)(Swedish Research Council); K. AMP; A. WallenbergFoundation; Carl Trygger Foundation; Erasmus Programme	This work was supported by the Swedish Foundation for Strategic Research (SSF), the Swedish Research Council for Research and Innovation for Sustainable Growth (VINNOVA), the Swedish Research Council (VR) [VR 621-2010-4359], the K. & A. WallenbergFoundation, the Carl Trygger Foundation [CTS08: 298] to CB, and the Erasmus Programme to AMP. The specific roles of the authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe A, 2012, NAT BIOTECHNOL, V30, P174, DOI 10.1038/nbt.2095; Ashelford K, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r28; Austin RS, 2011, PLANT J, V67, P715, DOI 10.1111/j.1365-313X.2011.04619.x; Barlier I, 2000, P NATL ACAD SCI USA, V97, P14819, DOI 10.1073/pnas.260502697; Bellini C, 2014, ANNU REV PLANT BIOL, V65, P639, DOI 10.1146/annurev-arplant-050213-035645; BOERJAN W, 1995, PLANT CELL, V7, P1405, DOI 10.1105/tpc.7.9.1405; Cuperus JT, 2010, P NATL ACAD SCI USA, V107, P466, DOI 10.1073/pnas.0913203107; da Costa CT, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00133; Delarue M, 1998, PLANT J, V14, P603, DOI 10.1046/j.1365-313X.1998.00163.x; Esteve-Bruna D, 2013, PLANT PHYSIOL, V161, P1303, DOI 10.1104/pp.112.207779; Geiss G, 2009, ROOT DEV ANN PLANT R, P127; Gilkerson J, 2009, GENETICS, V181, P945, DOI 10.1534/genetics.108.097675; Gingerich DJ, 2005, J BIOL CHEM, V280, P18810, DOI 10.1074/jbc.M413247200; Gray WM, 1999, GENE DEV, V13, P1678, DOI 10.1101/gad.13.13.1678; Gutierrez L, 2012, PLANT CELL, V24, P2515, DOI 10.1105/tpc.112.099119; Gutierrez L, 2009, PLANT CELL, V21, P3119, DOI 10.1105/tpc.108.064758; Hanania U, 2004, PLANT MOL BIOL REP, V22, P173, DOI 10.1007/BF02772724; Hartwig B, 2012, PLANT PHYSIOL, V160, P591, DOI 10.1104/pp.112.200311; Hobbie L, 2000, DEVELOPMENT, V127, P23; Hua ZH, 2011, ANNU REV PLANT BIOL, V62, P299, DOI 10.1146/annurev-arplant-042809-112256; James GV, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r61; Jander G, 2002, PLANT PHYSIOL, V129, P440, DOI 10.1104/pp.003533; Laitinen RAE, 2010, PLANT PHYSIOL, V153, P652, DOI 10.1104/pp.110.156448; Lindner H, 2012, GENETICS, V191, P1381, DOI 10.1534/genetics.112.141341; Lister R, 2009, CURR OPIN PLANT BIOL, V12, P107, DOI 10.1016/j.pbi.2008.11.004; Liu KH, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-12; Lukowitz W, 2000, PLANT PHYSIOL, V123, P795, DOI 10.1104/pp.123.3.795; Mokry M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-256; Moon J, 2007, PLANT PHYSIOL, V143, P684, DOI 10.1104/pp.106.091439; Nagpal P, 2005, DEVELOPMENT, V132, P4107, DOI 10.1242/dev.01955; Neff MM, 2002, TRENDS GENET, V18, P613, DOI 10.1016/S0168-9525(02)02820-2; Nordstrom KJV, 2013, NAT BIOTECHNOL, V31, P325, DOI 10.1038/nbt.2515; Pacurar DI, 2014, PHYSIOL PLANTARUM, V151, P83, DOI 10.1111/ppl.12171; Pacurar DI, 2014, J EXP BOT, V65, P1605, DOI 10.1093/jxb/eru026; Pacurar DI, 2012, J EXP BOT, V63, P2491, DOI 10.1093/jxb/err422; Peters JL, 2003, TRENDS PLANT SCI, V8, P484, DOI 10.1016/j.tplants.2003.09.002; Pollock DD, 2004, GENETICS, V168, P489, DOI 10.1534/genetics.103.024430; Quint M, 2005, PLANT J, V43, P371, DOI 10.1111/j.1365-313X.2005.02449.x; Reeves PH, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002506; Ren CM, 2005, PLANT J, V42, P514, DOI 10.1111/j.1365-313X.2005.02394.x; Schneeberger K, 2011, TRENDS PLANT SCI, V16, P282, DOI 10.1016/j.tplants.2011.02.006; Schneeberger K, 2009, NAT METHODS, V6, P550, DOI 10.1038/nmeth0809-550; Shen WH, 2002, MOL BIOL CELL, V13, P1916, DOI 10.1091/mbc.E02-02-0077; Smolen G, 2002, GENETICS, V160, P323; Sorin C, 2005, PLANT CELL, V17, P1343, DOI 10.1105/tpc.105.031625; Sukumar P, 2013, PLANT PHYSIOL, V162, P1392, DOI 10.1104/pp.113.217174; Wasternack C, 2013, ANN BOT-LONDON, V111, P1021, DOI 10.1093/aob/mct067; Xu LH, 2002, PLANT CELL, V14, P1919, DOI 10.1105/tpc.003368; Zhu Y, 2012, GENETICS, V192, P139, DOI 10.1534/genetics.112.141986	50	5	5	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100846	10.1371/journal.pone.0100846	http://dx.doi.org/10.1371/journal.pone.0100846			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955772	gold, Green Published, Green Submitted			2022-12-27	WOS:000338917900101
J	Sugiyama, A; Ueda, Y; Zushi, T; Takase, H; Yazaki, K				Sugiyama, Akifumi; Ueda, Yoshikatsu; Zushi, Takahiro; Takase, Hisabumi; Yazaki, Kazufumi			Changes in the Bacterial Community of Soybean Rhizospheres during Growth in the Field	PLOS ONE			English	Article							SOIL MICROBIAL COMMUNITY; PROMOTING RHIZOBACTERIA; PYROSEQUENCING REVEALS; BIOCONTROL; PLANTS; DIVERSITY; PATHOGEN; PGPR	Highly diverse communities of bacteria inhabiting soybean rhizospheres play pivotal roles in plant growth and crop production; however, little is known about the changes that occur in these communities during growth. We used both culture-dependent physiological profiling and culture independent DNA-based approaches to characterize the bacterial communities of the soybean rhizosphere during growth in the field. The physiological properties of the bacterial communities were analyzed by a community-level substrate utilization assay with BioLog Eco plates, and the composition of the communities was assessed by gene pyrosequencing. Higher metabolic capabilities were found in rhizosphere soil than in bulk soil during all stages of the BioLog assay. Pyrosequencing analysis revealed that differences between the bacterial communities of rhizosphere and bulk soils at the phylum level; i.e., Proteobacteria were increased, while Acidobacteria and Firmicutes were decreased in rhizosphere soil during growth. Analysis of operational taxonomic units showed that the bacterial communities of the rhizosphere changed significantly during growth, with a higher abundance of potential plant growth promoting rhizobacteria, including Bacillus, Bradyrhizobium, and Rhizobium, in a stage-specific manner. These findings demonstrated that rhizosphere bacterial communities were changed during soybean growth in the field.	[Sugiyama, Akifumi; Ueda, Yoshikatsu; Zushi, Takahiro; Yazaki, Kazufumi] Kyoto Univ, Res Inst Sustainable Humanosphere, Uji, Kyoto, Japan; [Takase, Hisabumi] Kyoto Gakuen Univ, Fac Bioenvironm Sci, Kameoka, Kyoto, Japan	Kyoto University	Sugiyama, A (corresponding author), Kyoto Univ, Res Inst Sustainable Humanosphere, Uji, Kyoto, Japan.	akifumi_sugiyama@rish.kyoto-u.ac.jp	Ueda, Yoshikatsu/AAY-6944-2020	Ueda, Yoshikatsu/0000-0001-5896-9859; Sugiyama, Akifumi/0000-0002-9643-6639	Kyoto University Step-Up Grant for Young Scientists; Ministry of Agriculture, Forestry, and Fisheries of Japan (Genomics-based Technology for Agricultural Improvement) [SFC2001]	Kyoto University Step-Up Grant for Young Scientists; Ministry of Agriculture, Forestry, and Fisheries of Japan (Genomics-based Technology for Agricultural Improvement)	This study was partly supported by a Kyoto University Step-Up Grant for Young Scientists (AS) and a grant from the Ministry of Agriculture, Forestry, and Fisheries of Japan (Genomics-based Technology for Agricultural Improvement, SFC2001) (AS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badri DV, 2009, PLANT PHYSIOL, V151, P2006, DOI 10.1104/pp.109.147462; Badri DV, 2009, PLANT CELL ENVIRON, V32, P666, DOI [10.1111/j.1365-3040.2009.01926.x, 10.1111/j.1365-3040.2008.01926.x]; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Bakker MG, 2012, PLANT SOIL, V360, P1, DOI 10.1007/s11104-012-1361-x; BARBOUR WM, 1991, APPL ENVIRON MICROB, V57, P2635, DOI 10.1128/AEM.57.9.2635-2639.1991; Batten KM, 2006, BIOL INVASIONS, V8, P217, DOI 10.1007/s10530-004-3856-8; Beneduzi A, 2012, GENET MOL BIOL, V35, P1044, DOI 10.1590/S1415-47572012000600020; Berendsen RL, 2012, TRENDS PLANT SCI, V17, P478, DOI 10.1016/j.tplants.2012.04.001; Bloemberg GV, 2001, CURR OPIN PLANT BIOL, V4, P343, DOI 10.1016/S1369-5266(00)00183-7; Bodenhausen N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056329; Bulgarelli D, 2012, NATURE, V488, P91, DOI 10.1038/nature11336; Buonaurio R, 2002, INT J SYST EVOL MICR, V52, P2081, DOI [10.1099/ijs.0.02063-0, 10.1099/00207713-52-6-2081]; Chaparro JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055731; Chaparro JM, 2013, ISME J IN PRESS; DARRAH PR, 1993, PLANT SOIL, V155, P1, DOI 10.1007/BF00024980; de Souza R, 2013, PLANT SOIL, V366, P585, DOI 10.1007/s11104-012-1430-1; DeAngelis KM, 2009, ISME J, V3, P168, DOI 10.1038/ismej.2008.103; Denison RF, 2011, CURR BIOL, V21, pR775, DOI 10.1016/j.cub.2011.06.018; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; de Vasconcellos RLF, 2009, BIOCONTROL, V54, P807, DOI 10.1007/s10526-009-9226-9; Frac M, 2012, SENSORS-BASEL, V12, P3253, DOI 10.3390/s120303253; Garbeva P, 2008, PLANT SOIL, V302, P19, DOI 10.1007/s11104-007-9432-0; GARLAND JL, 1991, APPL ENVIRON MICROB, V57, P2351, DOI 10.1128/AEM.57.8.2351-2359.1991; Girvan MS, 2003, APPL ENVIRON MICROB, V69, P1800, DOI 10.1128/AEM.69.3.1800-1809.2003; Govindasamy V, 2010, MICROBIOL MONOGR, V18, P333, DOI 10.1007/978-3-642-13612-2_15; Haichar FE, 2008, ISME J, V2, P1221, DOI 10.1038/ismej.2008.80; Hartmann A, 2008, PLANT SOIL, V312, P7, DOI 10.1007/s11104-007-9514-z; Houlden A, 2008, FEMS MICROBIOL ECOL, V65, P193, DOI 10.1111/j.1574-6941.2008.00535.x; Ikeda S, 2010, ISME J, V4, P315, DOI 10.1038/ismej.2009.119; Inceoglu O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023321; Inceoglu O, 2010, APPL ENVIRON MICROB, V76, P3675, DOI 10.1128/AEM.00040-10; Innes L, 2004, BIOL FERT SOILS, V40, P7, DOI 10.1007/s00374-004-0748-0; Insunza V, 2002, PLANT SOIL, V241, P271, DOI 10.1023/A:1016159902759; Jie WG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072898; Johnson EG, 2008, CHEM BIOL, V15, P43, DOI 10.1016/j.chembiol.2007.11.014; Kodama Y, 2012, NUCLEIC ACIDS RES, V40, pD54, DOI 10.1093/nar/gkr854; Kumar A, 2011, BACTERIA IN AGROBIOLOGY: CROP ECOSYSTEMS, P37, DOI 10.1007/978-3-642-18357-7_2; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Lugtenberg B, 2009, ANNU REV MICROBIOL, V63, P541, DOI 10.1146/annurev.micro.62.081307.162918; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; Manter DK, 2010, MICROB ECOL, V60, P157, DOI 10.1007/s00248-010-9658-x; Marchesi JR, 1998, APPL ENVIRON MICROB, V64, P795; McKenzie VJ, 2012, ISME J, V6, P588, DOI 10.1038/ismej.2011.129; Mendes R, 2013, FEMS MICROBIOL REV, V37, P634, DOI 10.1111/1574-6976.12028; Micallef SA, 2009, J EXP BOT, V60, P1729, DOI 10.1093/jxb/erp053; Mougel C, 2006, NEW PHYTOL, V170, P165, DOI 10.1111/j.1469-8137.2006.01650.x; Ofek M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040117; Oger PM, 2004, MICROB ECOL, V47, P96, DOI 10.1007/s00248-003-2012-9; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Richardson AE, 2009, PLANT SOIL, V321, P305, DOI 10.1007/s11104-009-9895-2; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Seipke RF, 2011, MICROBIOL-SGM, V157, P2681, DOI 10.1099/mic.0.047977-0; Shentu JL, 2008, J ZHEJIANG UNIV-SC B, V9, P250, DOI 10.1631/jzus.B0710630; Sugiyama A, 2012, SECRETIONS EXUDATES, P27, DOI DOI 10.1007/978-3-642-23047-9_; Sugiyama A, 2013, BOTANY, V91, P123, DOI 10.1139/cjb-2012-0217; Sugiyama A, 2010, PLANT DIS, V94, P1329, DOI 10.1094/PDIS-02-10-0090; Tsavkelova EA, 2007, ARCH MICROBIOL, V188, P655, DOI 10.1007/s00203-007-0286-x; Uroz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055929; Uroz S, 2010, ENV MICROBIOL REP, V2, P281, DOI 10.1111/j.1758-2229.2009.00117.x; Xu YX, 2009, SOIL BIOL BIOCHEM, V41, P919, DOI 10.1016/j.soilbio.2008.10.027; Yokota K, 2011, CELL MOL LIFE SCI, V68, P1341, DOI 10.1007/s00018-011-0651-4	61	107	111	6	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100709	10.1371/journal.pone.0100709	http://dx.doi.org/10.1371/journal.pone.0100709			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955843	Green Published, gold, Green Submitted			2022-12-27	WOS:000338917900084
J	Xu, JS; Wu, YQ; Su, H; Hu, WT; Li, JX; Wang, WY; Liu, X; Cheng, XS				Xu, Jinsong; Wu, Yanqing; Su, Hai; Hu, Weitong; Li, Juxiang; Wang, Wenying; Liu, Xin; Cheng, Xiaoshu			The Value of a BP Determination Method Using a Novel Non-Invasive BP Device against the Invasive Catheter Measurement	PLOS ONE			English	Article							BLOOD-PRESSURE-MEASUREMENT; MEAN ARTERIAL-PRESSURE	Objective: The aim of this study was to evaluate the accuracy of a new blood pressure (BP) measurement method (Pulse method). Methods: This study enrolled 45 patients for selective percutaneous coronary intervention (PCI) via right radial artery. A BP device using either oscillometric (Microlife 3AC1-1) or Pulse method(RG-BP11) was used. At the beginning of each PCI, intra-radial BP was measured before Microlife BP or Pulse BP measurement as its own reference, respectively. At the end of PCI, BP was measured again with the measurement order of Microlife BP and Pulse BP reversed. The differences between intra-radial and Microlife (BPi-M) or Pulse BP (BPi-P) on SBP, DBP and mean artery pressure (MAP) were calculated. Meanwhile, in 48 patients the intra-brachial BP and intra-radial artery BP were measured to calculate the brachial -radial BP difference (BPr-b). Results: The intra-radial SBP references used prior to both the Microlife and Pulse SBP that were similar (145.1+/-27.7 vs 145.8+/-24.2 mmHg), but the Microlife SBP was significantly lower than the Pulse SBP (127.7+/-20.5 vs 130.3+/-22.7 mmHg, P, 0.05), thus the SBPi-M was higher than SBPi-P (18.1+/-11.8 vs 14.8+/-12.8 mmHg, P, 0.05). As the mean SBPr-b was 12.4 mmHg, the Pulse SBP was closer to expected intra-brachial SBP by about 3.3 mmHg than was Microlife SBP to expected intra-brachial SBP. Meanwhile, Bland-Altman plots showed that the 95% limits of agreement for intra-radial SBP by Pulse SBP were narrower than those by Microlife SBP (12.0 similar to 17.5 vs 15.5 similar to 20.6 mmHg). However, the 95% limits of agreement for Pulse DBP and MAP were similar to those for Microlife DBP and MAP. Conclusion: Against the invasive BP measurement, the pulse method may provide more accurate SBP and comparable DBP and MAP as compared with the oscillometric method.	[Xu, Jinsong; Wu, Yanqing; Su, Hai; Hu, Weitong; Li, Juxiang; Wang, Wenying; Cheng, Xiaoshu] Nanchang Univ, Affiliated Hosp 2, Res Inst Cardiovas Dis, Nanchang, Jiangxi, Peoples R China; [Xu, Jinsong; Wu, Yanqing; Su, Hai; Hu, Weitong; Li, Juxiang; Wang, Wenying; Cheng, Xiaoshu] Nanchang Univ, Affiliated Hosp 2, Dept Cardiol, Nanchang, Jiangxi, Peoples R China; [Liu, Xin] Nanchang Univ, Fuzhou Med Coll, Fuzhou, Jiangxi, Peoples R China	Nanchang University; Nanchang University; Nanchang University	Su, H (corresponding author), Nanchang Univ, Affiliated Hosp 2, Res Inst Cardiovas Dis, Nanchang, Jiangxi, Peoples R China.	suyihappy@sohu.com			National High Technology Research and Development Program of China (863 Program) [2012AA02A516]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This work was supported by a grant from the National High Technology Research and Development Program of China (863 Program, No. 2012AA02A516). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoore JN, 2012, BLOOD PRESS MONIT, V17, P80, DOI 10.1097/MBP.0b013e32835026b0; Babbs CF, 2012, BIOMED ENG ONLINE, V11, DOI 10.1186/1475-925X-11-56; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Ding FH, 2013, J HYPERTENS, V31, P86, DOI 10.1097/HJH.0b013e32835a8eca; Farsky S, 2011, BLOOD PRESS MONIT, V16, P252, DOI 10.1097/MBP.0b013e328349a4da; Raamat R, 2013, BLOOD PRESS MONIT, V18, P50, DOI 10.1097/MBP.0b013e32835d12f6; Segers P, 2009, HYPERTENSION, V54, P414, DOI 10.1161/HYPERTENSIONAHA.109.133009; Stergiou GS, 2012, J HYPERTENS, V30, P2074, DOI 10.1097/HJH.0b013e32835850d7; Vos J, 2013, AM J HYPERTENS, V26, P624, DOI 10.1093/ajh/hps072; WU XG, 2012, Patent No. 2011000866; WU XG, 2013, Patent No. 20130138001	11	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100287	10.1371/journal.pone.0100287	http://dx.doi.org/10.1371/journal.pone.0100287			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955577	gold, Green Submitted, Green Published			2022-12-27	WOS:000338917900037
J	bin Yusof, MT; Kershaw, MJ; Soanes, DM; Talbot, NJ				bin Yusof, Mohammad Termizi; Kershaw, Michael J.; Soanes, Darren M.; Talbot, Nicholas J.			FAR1 and FAR2 Regulate the Expression of Genes Associated with Lipid Metabolism in the Rice Blast Fungus Magnaporthe oryzae	PLOS ONE			English	Article							MITOCHONDRIAL BETA-OXIDATION; COENZYME-A SYNTHETASE; PLANT INFECTION; TRANSCRIPTION FACTORS; FUNCTIONAL-ANALYSIS; GLYOXYLATE CYCLE; IN-VIVO; REQUIRES; FACB; MOBILIZATION	The rice blast fungus Magnaporthe oryzae causes plant disease via specialised infection structures called appressoria. These dome-shaped cells are able to generate enormous internal pressure, which enables penetration of rice tissue by invasive hyphae. Previous studies have shown that mobilisation of lipid bodies and subsequent lipid metabolism are essential prerequisites for successful appressorium-mediated plant infection, which requires autophagic recycling of the contents of germinated spores and germ tubes to the developing appressorium. Here, we set out to identify putative regulators of lipid metabolism in the rice blast fungus. We report the identification of FAR1 and FAR2, which encode highly conserved members of the Zn2-Cys6 family of transcriptional regulators. We generated Delta far1, Delta far2 and Delta far1 Delta far2 double mutants in M. oryzae and show that these deletion mutants are deficient in growth on long chain fatty acids. In addition, Dfar2 mutants are also unable to grow on acetate and short chain fatty acids. FAR1 and FAR2 are necessary for differential expression of genes involved in fatty acid beta-oxidation, acetyl-CoA translocation, peroxisomal biogenesis, and the glyoxylate cycle in response to the presence of lipids. Furthermore, FAR2 is necessary for expression of genes associated with acetyl-CoA synthesis. Interestingly, Delta far1, Delta far2 and Delta far1Dfar2 mutants show no observable delay or reduction in lipid body mobilisation during plant infection, suggesting that these transcriptional regulators control lipid substrate utilization by the fungus but not the mobilisation of intracellular lipid reserves during infection-related morphogenesis.	[bin Yusof, Mohammad Termizi; Kershaw, Michael J.; Soanes, Darren M.; Talbot, Nicholas J.] Univ Exeter, Sch Biosci, Exeter, Devon, England; [bin Yusof, Mohammad Termizi] Univ Putra Malaysia, Fac Biotechnol & Biomol Sci, Dept Microbiol, Serdang 43400, Selangor, Malaysia	University of Exeter; Universiti Putra Malaysia	Talbot, NJ (corresponding author), Univ Exeter, Sch Biosci, Exeter, Devon, England.	n.j.talbot@exeter.ac.uk	Talbot, Nicholas J/I-5618-2019; Talbot, Nicholas J/I-9584-2014	Talbot, Nicholas J/0000-0001-6434-7757; Talbot, Nicholas J/0000-0001-6434-7757; Yusof, Mohd Termizi/0000-0002-5241-3443	Malaysia Ministry of Higher Education; Universiti Putra Malaysia; European Research Council Advanced Investigator Award [294702 GENBLAST]; BBSRC [BB/G013896/1, BB/H018727/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H018727/1, BB/G013896/1] Funding Source: researchfish	Malaysia Ministry of Higher Education(Ministry of Education, Malaysia); Universiti Putra Malaysia; European Research Council Advanced Investigator Award(European Research Council (ERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from the Malaysia Ministry of Higher Education and Universiti Putra Malaysia and a European Research Council Advanced Investigator Award 294702 GENBLAST to NJT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrianopoulos A, 2006, MOLECULAR PRINCIPLES OF FUNGAL PATHOGENESIS, P441; Badaruddin M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003604; Bhadauria V, 2012, PLANT SIGNAL BEHAV, V7, P1206, DOI 10.4161/psb.21368; Bhambra GK, 2006, MOL MICROBIOL, V61, P46, DOI 10.1111/j.1365-2958.2006.05209.x; BOURETT TM, 1990, CAN J BOT, V68, P329, DOI 10.1139/b90-044; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Catlett N.L., 2003, FUNGAL GENET NEWSL, V50, P9, DOI DOI 10.4148/1941-4765.1150; deJong JC, 1997, NATURE, V389, P244, DOI 10.1038/38418; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Foster AJ, 2003, EMBO J, V22, P225, DOI 10.1093/emboj/cdg018; Gancedo JM, 1998, MICROBIOL MOL BIOL R, V62, P334, DOI 10.1128/MMBR.62.2.334-361.1998; Gilbert MJ, 2006, NATURE, V440, P535, DOI 10.1038/nature04567; Gomez D, 2002, MOL MICROBIOL, V44, P585, DOI 10.1046/j.1365-2958.2002.02939.x; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hynes MJ, 2006, EUKARYOT CELL, V5, P794, DOI 10.1128/EC.5.5.794-805.2006; KATZ ME, 1989, MOL CELL BIOL, V9, P5696, DOI 10.1128/MCB.9.12.5696; Kershaw MJ, 2009, P NATL ACAD SCI USA, V106, P15967, DOI 10.1073/pnas.0901477106; KRATZER S, 1995, GENE, V161, P75, DOI 10.1016/0378-1119(95)00289-I; Li DX, 2002, J BIOL CHEM, V277, P7905, DOI 10.1074/jbc.M108799200; Lorenz MC, 2001, NATURE, V412, P83, DOI 10.1038/35083594; Lu JP, 2009, CURR GENET, V55, P461, DOI 10.1007/s00294-009-0259-5; Maggio-Hall LA, 2004, MOL MICROBIOL, V54, P1173, DOI 10.1111/j.1365-2958.2004.04340.x; Martinez-Rocha AL, 2008, CELL MICROBIOL, V10, P1339, DOI 10.1111/j.1462-5822.2008.01130.x; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Oldenburg KR, 1997, NUCLEIC ACIDS RES, V25, P451, DOI 10.1093/nar/25.2.451; Patkar RN, 2012, MOL MICROBIOL, V86, P1345, DOI 10.1111/mmi.12060; Ramirez MA, 2009, EUKARYOT CELL, V8, P1604, DOI 10.1128/EC.00206-09; Ramos-Pamplona M, 2006, MOL MICROBIOL, V61, P61, DOI 10.1111/j.1365-2958.2006.05194.x; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SANDEMAN RA, 1989, MOL GEN GENET, V218, P87, DOI 10.1007/BF00330569; Soanes DM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002514; Sweigard JA, 1997, FUNGAL GENET NEWSL, V44, P52, DOI DOI 10.4148/1941-4765.1287; TALBOT NJ, 1993, PLANT CELL, V5, P1575, DOI 10.1105/tpc.5.11.1575; Thines E, 2000, PLANT CELL, V12, P1703, DOI 10.1105/tpc.12.9.1703; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Todd RB, 1998, EMBO J, V17, P2042, DOI 10.1093/emboj/17.7.2042; Todd RB, 1997, FUNGAL GENET BIOL, V21, P388, DOI 10.1006/fgbi.1997.0993; Todd RB, 1997, FUNGAL GENET BIOL, V22, P92, DOI 10.1006/fgbi.1997.1007; Veneault-Fourrey C, 2006, SCIENCE, V312, P580, DOI 10.1126/science.1124550; Wang ZY, 2007, MOL PLANT MICROBE IN, V20, P475, DOI 10.1094/MPMI-20-5-0475; Wang ZY, 2003, MOL MICROBIOL, V47, P1601, DOI 10.1046/j.1365-2958.2003.03412.x; Weber RWS, 2001, PROTOPLASMA, V216, P101, DOI 10.1007/BF02680137; Wilson RA, 2010, P NATL ACAD SCI USA, V107, P21902, DOI 10.1073/pnas.1006839107; Wilson RA, 2009, NAT REV MICROBIOL, V7, P185, DOI 10.1038/nrmicro2032; Young ET, 2003, J BIOL CHEM, V278, P26146, DOI 10.1074/jbc.M301981200	45	15	15	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e99760	10.1371/journal.pone.0099760	http://dx.doi.org/10.1371/journal.pone.0099760			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949933	Green Submitted, gold, Green Published			2022-12-27	WOS:000338276300019
J	Castro, EF; Campos, RH; Cavallaro, LV				Castro, Eliana F.; Campos, Rodolfo H.; Cavallaro, Lucia V.			Stability of the Resistance to the Thiosemicarbazone Derived from 5,6-Dimethoxy-1-Indanone, a Non-Nucleoside Polymerase Inhibitor of Bovine Viral Diarrhea Virus	PLOS ONE			English	Article							DEPENDENT RNA-POLYMERASE; INTERFERON REGULATORY FACTOR-3; NONSTRUCTURAL PROTEIN; PROTEASOMAL DEGRADATION; SERINE-PROTEASE; CLEAVAGE SITES; NS5A PROTEIN; MDBK CELLS; PESTIVIRUS; APOPTOSIS	Bovine viral diarrhea virus (BVDV) is the prototype Pestivirus. BVDV infection is distributed worldwide and causes serious problems for the livestock industry. The thiosemicarbazone of 5,6-dimethoxy-1-indanone (TSC) is a non-nucleoside polymerase inhibitor (NNI) of BVDV. All TSC-resistant BVDV variants (BVDV-TSCr T1-5) present an N264D mutation in the NS5B gene (RdRp) whereas the variant BVDV-TSCr T-1 also presents an NS5B A392E mutation. In the present study, we carried out twenty passages of BVDV-TSCr T1-5 in MDBK cells in the absence of TSC to evaluate the stability of the resistance. The viral populations obtained (BVDV R1-5) remained resistant to the antiviral compound and conserved the mutations in NS5B associated with this phenotype. Along the passages, BVDV R-2, R-3 and R-5 presented a delay in the production of cytopathic effect that correlated with a decrease in cell apoptosis and intracellular accumulation of viral RNA. The complete genome sequences that encode for NS2 to NS5B, Npro and Erns were analyzed. Additional mutations were detected in the NS5B of BVDV R-1, R-3 and R-4. In both BVDV R2 and R3, most of the mutations found were localized in NS5A, whereas in BVDV R-5, the only mutation fixed was NS5A V177A. These results suggest that mutations in NS5A could alter BVDV cytopathogenicity. In conclusion, the stability of the resistance to TSC may be due to the fixation of different compensatory mutations in each BVDV-TSCr. During their replication in a TSC-free medium, some virus populations presented a kind of interaction with the host cell that resembled a persistent infection: decreased cytopathogenicity and viral genome synthesis. This is the first report on the stability of antiviral resistance and on the evolution of NNI-resistant BVDV variants. The results obtained for BVDV-TSCr could also be applied for other NNIs.	[Castro, Eliana F.; Campos, Rodolfo H.; Cavallaro, Lucia V.] Univ Buenos Aires, Fac Farm & Bioquim, Catedra Virol, RA-1113 Buenos Aires, DF, Argentina	University of Buenos Aires	Cavallaro, LV (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, Catedra Virol, RA-1113 Buenos Aires, DF, Argentina.	lcavalla@ffyb.uba.ar		Castro, Eliana F./0000-0003-1153-1176	Agencia Nacional para la Promocion Cientifica y Tecnologica [PICT 2012-2867]; Universidad de Buenos Aires (UBACYT) from Argentina [20020100100612]	Agencia Nacional para la Promocion Cientifica y Tecnologica(ANPCyT); Universidad de Buenos Aires (UBACYT) from Argentina	This research was supported by grants from Agencia Nacional para la Promocion Cientifica y Tecnologica (PICT 2012-2867) (http://www.agencia.mincyt.gob.ar/) and Universidad de Buenos Aires (UBACYT 2011-2014, No 20020100100612) (http://www.uba.ar/secyt/) from Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Applied Biosystems, 2004, 7900HT FAST REAL TIM; BAKER JC, 1995, VET CLIN N AM-FOOD A, V11, P425, DOI 10.1016/S0749-0720(15)30460-6; Baroth M, 2000, VIROLOGY, V278, P456, DOI 10.1006/viro.2000.0644; Becher P, 2001, J VIROL, V75, P6256, DOI 10.1128/JVI.75.14.6256-6264.2001; Castro EF, 2011, J VIROL, V85, P5436, DOI 10.1128/JVI.00859-10; Chen ZH, 2007, VIROLOGY, V366, P277, DOI 10.1016/j.virol.2007.04.023; Choi KH, 2004, P NATL ACAD SCI USA, V101, P4425, DOI 10.1073/pnas.0400660101; COLLETT MS, 1988, J GEN VIROL, V69, P2637, DOI 10.1099/0022-1317-69-10-2637; Di Rienzo J.A., 2011, INFOSTAT VERSION 201; Finkielsztein LM, 2010, CURR MED CHEM, V17, P2933, DOI 10.2174/092986710792065036; Finkielsztein LM, 2008, EUR J MED CHEM, V43, P1767, DOI 10.1016/j.ejmech.2007.10.023; Gallei A, 2005, J VIROL, V79, P14261, DOI 10.1128/JVI.79.22.14261-14270.2005; Gil LHVG, 2006, J VIROL, V80, P900, DOI 10.1128/JVI.80.2.900-911.2006; Giliberti G, 2010, BIOORGAN MED CHEM, V18, P6055, DOI 10.1016/j.bmc.2010.06.065; Govorkova EA, 2010, J VIROL, V84, P8042, DOI 10.1128/JVI.00689-10; Grummer B, 2002, VIRUS RES, V90, P143, DOI 10.1016/S0168-1702(02)00150-8; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hatada EN, 2000, CURR OPIN IMMUNOL, V12, P52, DOI 10.1016/S0952-7915(99)00050-3; Hilton L, 2006, J VIROL, V80, P11723, DOI 10.1128/JVI.01145-06; Hoff HS, 1997, VIRUS RES, V49, P101, DOI 10.1016/S0168-1702(97)01460-3; Hu ZX, 2010, JAIDS-J ACQ IMM DEF, V55, P148, DOI 10.1097/QAI.0b013e3181e9a87a; Isken O, 2014, J VIROL, V88, P82, DOI 10.1128/JVI.01957-13; Johnson CM, 2001, J GEN VIROL, V82, P2935, DOI 10.1099/0022-1317-82-12-2935; Jordan R, 2002, J VIROL, V76, P9588, DOI 10.1128/JVI.76.19.9588-9599.2002; Kummerer BM, 2000, J VIROL, V74, P390, DOI 10.1128/JVI.74.1.390-400.2000; Lackner T, 2004, J VIROL, V78, P10765, DOI 10.1128/JVI.78.19.10765-10775.2004; Lai VCH, 1999, J VIROL, V73, P10129, DOI 10.1128/JVI.73.12.10129-10136.1999; Lindenbach BD, 2007, FIELDS VIROLOGY, V1, P1126; Maeda K, 2009, J VET MED SCI, V71, P801, DOI 10.1292/jvms.71.801; Magkouras I, 2008, J GEN VIROL, V89, P2501, DOI 10.1099/vir.0.2008/003749-0; Matzener P, 2009, VIRUS RES, V140, P15, DOI 10.1016/j.virusres.2008.10.015; Mendez E, 1998, J VIROL, V72, P4737, DOI 10.1128/JVI.72.6.4737-4745.1998; Meyers G, 2007, J VIROL, V81, P3327, DOI 10.1128/JVI.02372-06; MOENNIG V, 1992, ADV VIRUS RES, V41, P53, DOI 10.1016/S0065-3527(08)60035-4; Newcomer BW, 2013, VIRUS RES, V174, P95, DOI 10.1016/j.virusres.2013.03.007; Pacheco J. M., 2003, Revista Argentina de Microbiologia, V35, P19; Pankraz A, 2009, J VIROL, V83, P12415, DOI 10.1128/JVI.01487-09; Peterhans E, 2010, VET RES, V41, DOI 10.1051/vetres/2010016; Qu L, 2001, J VIROL, V75, P10651, DOI 10.1128/JVI.75.22.10651-10662.2001; RUMENAPF T, 1993, J VIROL, V67, P3288; Rweyemamu M M, 1990, Rev Sci Tech, V9, P207; Sapay N, 2006, BIOCHEMISTRY-US, V45, P2221, DOI 10.1021/bi0517685; Schweizer M, 1999, J GEN VIROL, V80, P1147, DOI 10.1099/0022-1317-80-5-1147; Steffens S, 1999, J GEN VIROL, V80, P2583, DOI 10.1099/0022-1317-80-10-2583; Tautz N, 1999, J VIROL, V73, P9422, DOI 10.1128/JVI.73.11.9422-9432.1999; Tautz N, 1997, J VIROL, V71, P5415, DOI 10.1128/JVI.71.7.5415-5422.1997; Tautz N, 2000, VIROLOGY, V273, P351, DOI 10.1006/viro.2000.0425; Tellinghuisen TL, 2006, J VIROL, V80, P7450, DOI 10.1128/JVI.00358-06; Thompson JD, 1997, NUCELIC ACIDS RES, V25, P7876; Tonelli M, 2010, BIOORGAN MED CHEM, V18, P2304, DOI 10.1016/j.bmc.2010.01.058; Trotter J, 2011, WINMDI 2 9 WINDOWS M; Vassilev VB, 2000, VIRUS RES, V69, P95, DOI 10.1016/S0168-1702(00)00176-3; WARRENER P, 1995, J VIROL, V69, P1720, DOI 10.1128/JVI.69.3.1720-1726.1995; Weiskircher E, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-185; Wu WW, 2011, J VIROL, V85, P10421, DOI 10.1128/JVI.05349-11; Xu JA, 1997, J VIROL, V71, P5312, DOI 10.1128/JVI.71.7.5312-5322.1997; Yamane D, 2006, J GEN VIROL, V87, P2961, DOI 10.1099/vir.0.81820-0; Zahoor MA, 2010, J GEN VIROL, V91, P1939, DOI 10.1099/vir.0.020990-0; Zahoor MA, 2009, ARCH VIROL, V154, P1745, DOI 10.1007/s00705-009-0505-7; Zhang G, 1996, J GEN VIROL, V77, P1677, DOI 10.1099/0022-1317-77-8-1677; Zhong WD, 1998, J VIROL, V72, P9365, DOI 10.1128/JVI.72.11.9365-9369.1998; Zoth SC, 2006, J VIROL METHODS, V138, P99, DOI 10.1016/j.jviromet.2006.07.025	63	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100528	10.1371/journal.pone.0100528	http://dx.doi.org/10.1371/journal.pone.0100528			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950191	Green Published, gold, Green Submitted			2022-12-27	WOS:000338276300085
J	Molenda, N; Urbanova, K; Weiser, N; Kusche-Vihrog, K; Gunzel, D; Schillers, H				Molenda, Natalia; Urbanova, Katarina; Weiser, Nelly; Kusche-Vihrog, Kristina; Guenzel, Dorothee; Schillers, Hermann			Paracellular Transport through Healthy and Cystic Fibrosis Bronchial Epithelial Cell Lines - Do We Have a Proper Model?	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; IN-VITRO MODEL; BARRIER FUNCTION; AIRWAY EPITHELIUM; FLUID TRANSPORT; TIGHT JUNCTIONS; CFTR; PERMEABILITY; EXPRESSION; FLUORESCEIN	It has been reported recently that the cystic fibrosis transmembrane conductance regulator (CFTR) besides transcellular chloride transport, also controls the paracellular permeability of bronchial epithelium. The aim of this study was to test whether overexpressing wtCFTR solely regulates paracellular permeability of cell monolayers. To answer this question we used a CFBE41o(-) cell line transfected with wtCFTR or mutant F508del-CFTR and compered them with parental line and healthy 16HBE14o(-) cells. Transepithelial electrical resistance (TER) and paracellular fluorescein flux were measured under control and CFTR-stimulating conditions. CFTR stimulation significant decreased TER in 16HBE14o(-) and also in CFBE41o(-) cells transfected with wtCFTR. In contrast, TER increased upon stimulation in CFBE41o(-) cells and CFBE41o(-) cells transfected with F508del-CFTR. Under non-stimulated conditions, all four cell lines had similar paracellular fluorescein flux. Stimulation increased only the paracellular permeability of the 16HBE14o(-) cell monolayers. We observed that 16HBE14o(-) cells were significantly smaller and showed a different structure of cell-cell contacts than CFBE41o(-) and its overexpressing clones. Consequently, 16HBE14o(-) cells have about 80% more cell-cell contacts through which electrical current and solutes can leak. Also tight junction protein composition is different in 'healthy' 16HBE14o(-) cells compared to 'cystic fibrosis' CFBE41o(-) cells. We found that claudin-3 expression was considerably stronger in 16HBE14o- cells than in the three CFBE41o(-) cell clones and thus independent of the presence of functional CFTR. Together, CFBE41o(-) cell line transfection with wtCFTR modifies transcellular conductance, but not the paracellular permeability. We conclude that CFTR overexpression is not sufficient to fully reconstitute transport in CF bronchial epithelium. Hence, it is not recommended to use those cell lines to study CFTR-dependent epithelial transport.	[Molenda, Natalia; Urbanova, Katarina; Weiser, Nelly; Kusche-Vihrog, Kristina; Schillers, Hermann] Univ Munster, Inst Physiol 2, D-48149 Munster, Germany; [Guenzel, Dorothee] Charite Campus Benjamin Franklin, Inst Clin Physiol, Berlin, Germany	University of Munster; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Schillers, H (corresponding author), Univ Munster, Inst Physiol 2, D-48149 Munster, Germany.	Hermann.Schillers@uni-muenster.de		Gunzel, Dorothee/0000-0002-7998-7164; Schillers, Hermann/0000-0001-6090-4771	Deutsche Forschungsgemeinschaft [SFB 629 (A6)]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Work was supported by the Deutsche Forschungsgemeinschaft SFB 629 (A6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002584; Barnes LM, 2003, BIOTECHNOL BIOENG, V81, P631, DOI 10.1002/bit.10517; Bobadilla JL, 2002, HUM MUTAT, V19, P575, DOI 10.1002/humu.10041; Coyne CB, 2003, AM J PHYSIOL-LUNG C, V285, pL1166, DOI 10.1152/ajplung.00182.2003; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; Ehrhardt C, 2006, CELL TISSUE RES, V323, P405, DOI 10.1007/s00441-005-0062-7; Ehrhardt C, 2002, CELL TISSUE RES, V308, P391, DOI 10.1007/s00441-002-0548-5; Flynn AN, 2009, P NATL ACAD SCI USA, V106, P3591, DOI 10.1073/pnas.0813393106; GONZALEZMARISCAL L, 1989, J MEMBRANE BIOL, V107, P43, DOI 10.1007/BF01871082; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; Illek B, 2008, CELL PHYSIOL BIOCHEM, V22, P57, DOI 10.1159/000149783; Jiang C, 1997, J PHYSIOL-LONDON, V501, P637, DOI 10.1111/j.1469-7793.1997.637bm.x; JIANG CW, 1993, SCIENCE, V262, P424, DOI 10.1126/science.8211164; Jou TS, 1998, J CELL BIOL, V142, P101, DOI 10.1083/jcb.142.1.101; Kapus A, 2006, BIOCHEM CELL BIOL, V84, P870, DOI 10.1139/O06-202; Koljonen M, 2006, EUR J PHARM BIOPHARM, V64, P379, DOI 10.1016/j.ejpb.2006.06.006; Konishi Y, 2002, BIOSCI BIOTECH BIOCH, V66, P2449, DOI 10.1271/bbb.66.2449; Kunzelmann K, 1997, FEBS LETT, V400, P341, DOI 10.1016/S0014-5793(96)01414-7; Kuwayama K, 2002, BIOCHEM PHARMACOL, V63, P81, DOI 10.1016/S0006-2952(01)00853-X; LeSimple P, 2010, J PHYSIOL-LONDON, V588, P1195, DOI 10.1113/jphysiol.2009.182246; LEWIS SA, 1995, PHYSIOL REV, V75, P561, DOI 10.1152/physrev.1995.75.3.561; Lin XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067496; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Milatz S, 2010, BBA-BIOMEMBRANES, V1798, P2048, DOI 10.1016/j.bbamem.2010.07.014; Nilsson HE, 2010, EXP MOL PATHOL, V88, P118, DOI 10.1016/j.yexmp.2009.09.018; Overgaard CE, 2012, ANN NY ACAD SCI, V1257, P167, DOI 10.1111/j.1749-6632.2012.06545.x; Pilewski Joseph M., 1999, Physiological Reviews, V79, pS215; POWELL DW, 1981, AM J PHYSIOL, V241, pG275, DOI 10.1152/ajpgi.1981.241.4.G275; Schwiebert Erik M., 1999, Physiological Reviews, V79, pS145; Shen L, 2011, ANNU REV PHYSIOL, V73, P283, DOI 10.1146/annurev-physiol-012110-142150; Sheppard David N., 1999, Physiological Reviews, V79, pS23; Soini Y, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-70; Treharne KJ, 2009, CELL PHYSIOL BIOCHEM, V24, P347, DOI 10.1159/000257427; Turner JR, 2006, AM J PATHOL, V169, P1901, DOI 10.2353/ajpath.2006.060681; Wan H, 2000, EUR RESPIR J, V15, P1058, DOI 10.1034/j.1399-3003.2000.01514.x; Weiser N, 2011, CELL PHYSIOL BIOCHEM, V28, P289, DOI 10.1159/000331742; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R	37	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100621	10.1371/journal.pone.0100621	http://dx.doi.org/10.1371/journal.pone.0100621			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945658	Green Submitted, gold, Green Published			2022-12-27	WOS:000340721500097
J	Dvorakova-Hortova, K; Sidlova, A; Ded, L; Hladovcova, D; Vieweg, M; Weidner, W; Steger, K; Stopka, P; Paradowska-Dogan, A				Dvorakova-Hortova, Katerina; Sidlova, Adela; Ded, Lukas; Hladovcova, Denisa; Vieweg, Markus; Weidner, Wolfgang; Steger, Klaus; Stopka, Pavel; Paradowska-Dogan, Agnieszka			Toxoplasma gondii Decreases the Reproductive Fitness in Mice	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN; TRANSCRIPTION FACTORS; DNA METHYLATION; SERTOLI-CELLS; MALE RATS; SPERMATOGENESIS; PROLIFERATION; INFECTION; HOST; EPIGENETICS	Toxoplasma gondii is a common protozoan parasite that infects warm-blooded animals throughout the world, including mice and humans. During infection, both, the parasite and the host, utilize various mechanisms to maximize their own reproductive success. Mice and humans are both the intermediate hosts for Toxoplasma gondii, which forms specialized vacuoles containing reproductive cysts in the formers' tissue. As half of the human population is infected, developing a disease called toxoplasmosis, along with an ever-growing number of couples suffering with idiopathic infertility, it is therefore surprising that there is a lack of research on how Toxoplasma gondii can alter reproductive parameters. In this study, a detailed histometric screening of the testicular function along with the levels of the pituitary luteinizing hormone (LH) were analysed in infected mice. Data on relative testis and epididymis weight, and sperm count were also collected. Based on the results obtained, the level of LH in the urine of Toxoplasma gondii infected mice was lower compared to the control. In direct correlation with the hormone level, testicular function and sperm production was also significantly lower in Toxoplasma gondii positive group using sperm count and histometric analysis as a marker. Not only were the number of leptotene primary spermatocytes and spermatids lowered, but the number of Sertoli cells and the tubule diameter were elevated. In parallel, a pilot epigenetic study on global testicular methylation, and specific methylation of Crem, Creb1 and Hspa1genes essential for successfully ongoing spermatogenesis was performed. Global methylation was elevated in Toxoplasma infected mice, and differences in the DNA methylation of selected genes were detected between the Toxoplasma positive and control group. These findings demonstrate a direct relation between Toxoplasma gondii infection and the decrease of male reproductive fitness in mice, which may contribute to an increase of idiopathic infertility in humans.	[Dvorakova-Hortova, Katerina; Sidlova, Adela; Hladovcova, Denisa; Stopka, Pavel] Charles Univ Prague, Fac Sci, Dept Zool, Biocev Grp, Prague, Czech Republic; [Ded, Lukas] Acad Sci, Inst Biotechnol, Reprod Biol Lab, Prague, Czech Republic; [Vieweg, Markus; Weidner, Wolfgang; Steger, Klaus; Paradowska-Dogan, Agnieszka] Univ Giessen, Dept Urol Pediat Urol & Androl, D-35390 Giessen, Germany	Charles University Prague; Czech Academy of Sciences; Institute of Biotechnology of the Czech Academy of Sciences; Justus Liebig University Giessen	Paradowska-Dogan, A (corresponding author), Univ Giessen, Dept Urol Pediat Urol & Androl, D-35390 Giessen, Germany.	Agnieszka.Paradowska@chiru.med.uni-giessen.de	Ded, Lukas/G-9543-2014; Komrsková, Kateřina/P-7920-2019; Dvorakova-Hortova, Katerina/A-8705-2010; Stopka, Pavel/A-6193-2008	Ded, Lukas/0000-0003-1053-4025; Komrsková, Kateřina/0000-0002-6837-2148; Dvorakova-Hortova, Katerina/0000-0002-6837-2148; Stopka, Pavel/0000-0002-1104-1655	Institutional Research Support [SVV 260 087/2014]; Grant Agency of the Czech Republic GACR [P506/12/1046]; "BIOCEV - Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University" from the European Regional Development Fund [CZ.1.05/1.1.00/02.0109]	Institutional Research Support; Grant Agency of the Czech Republic GACR(Grant Agency of the Czech Republic); "BIOCEV - Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University" from the European Regional Development Fund	The work was supported by the Institutional Research Support grant No. SVV 260 087/2014, by the Grant Agency of the Czech Republic GACR No. P506/12/1046 and by the project "BIOCEV - Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University" (CZ.1.05/1.1.00/02.0109), from the European Regional Development Fund. Founding for methylation analysis was provided from LOEWE focus group MIBIE ("Male Infertility during Infection and Inflammation" projects state government of Hessen, Germany). The funders had no influence on study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdoli A, 2012, ANDROLOGIA, V44, P679, DOI 10.1111/j.1439-0272.2011.01249.x; Adham IM, 2005, MOL CELL BIOL, V25, P7657, DOI 10.1128/MCB.25.17.7657-7664.2005; Ahmed EA, 2009, BIOL REPROD, V80, P1084, DOI 10.1095/biolreprod.108.071662; Angrisano T, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-172; Behr R, 2001, INT J ANDROL, V24, P126, DOI 10.1046/j.1365-2605.2001.00277.x; Brunet J, 2008, CELL MICROBIOL, V10, P908, DOI 10.1111/j.1462-5822.2007.01093.x; Dalimi A, 2013, JUNDISHAPUR J MICROB, V6, DOI 10.5812/jjm.7184; Denkers EY, 1998, CLIN MICROBIOL REV, V11, P569, DOI 10.1128/CMR.11.4.569; Don J, 2002, MOL CELL ENDOCRINOL, V187, P115, DOI 10.1016/S0303-7207(01)00696-7; Dong Q, 2004, J ANDROL, V25, P973; Dubey J.P., 1988, TOXOPLASMOSIS ANIMAL; Eddy EM, 2002, RECENT PROG HORM RES, V57, P103, DOI 10.1210/rp.57.1.103; FAYER R, 1981, CAN VET J, V22, P344; Fu Y, 2012, J PARASITOL, V98, P310, DOI 10.1645/GE-2825.1; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; HESS RA, 1993, ENDOCRINOLOGY, V132, P2607, DOI 10.1210/en.132.6.2607; HIKIM APS, 1989, ENDOCRINOLOGY, V125, P1829, DOI 10.1210/endo-125-4-1829; Hill D, 2002, CLIN MICROBIOL INFEC, V8, P634, DOI 10.1046/j.1469-0691.2002.00485.x; Holscher C, 2000, INFECT IMMUN, V68, P4075, DOI 10.1128/IAI.68.7.4075-4083.2000; Houshdaran S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001289; HOWE DK, 1995, J INFECT DIS, V172, P1561, DOI 10.1093/infdis/172.6.1561; Kankova S, 2011, EXP PARASITOL, V128, P181, DOI 10.1016/j.exppara.2011.03.014; Kim JS, 2009, HISTOCHEM CELL BIOL, V131, P501, DOI 10.1007/s00418-009-0554-8; Kodym P, 2002, ACTA PARASITOL, V47, P239; Lambert H, 2010, CELL MICROBIOL, V12, P292, DOI 10.1111/j.1462-5822.2009.01417.x; Lee YH, 1999, EXP PARASITOL, V91, P212, DOI 10.1006/expr.1998.4359; Leng J, 2010, NIH PUBLIC ACCESS, V182, P489; Lim A, 2013, MOL ECOL, V22, P102, DOI 10.1111/mec.12042; Linkenhoker JR, 2013, J AM ASSOC LAB ANIM, V52, P531; MARATHE GK, 1995, ENDOCRINE, V3, P705, DOI 10.1007/BF03000201; Minarovits J, 2009, ACTA MICROBIOL IMM H, V56, P1, DOI 10.1556/AMicr.56.2009.1.1; Nanassy L, 2011, FERTIL STERIL, V95, P2310, DOI 10.1016/j.fertnstert.2011.03.096; O' Shaughnessy, 2001, CIRCULATING DIVALENT, V11203, P237; Paschos K, 2010, TRENDS MICROBIOL, V18, P439, DOI 10.1016/j.tim.2010.07.003; Persengiev SP, 2003, APOPTOSIS, V8, P225, DOI 10.1023/A:1023633704132; Rajender S, 2011, MUTAT RES-REV MUTAT, V727, P62, DOI 10.1016/j.mrrev.2011.04.002; Remington JS., 1995, INFECT DIS FETUS NEW, V4, P140; RIVIER C, 1991, BIOL REPROD, V45, P523, DOI 10.1095/biolreprod45.4.523; Ruwanpura SM, 2010, J ENDOCRINOL, V205, P117, DOI 10.1677/JOE-10-0025; SABIN AB, 1949, PEDIATRICS, V4, P443; Saeij JPJ, 2005, TRENDS PARASITOL, V21, P476, DOI 10.1016/j.pt.2005.08.001; Scobey MJ, 2001, ENDOCRINOLOGY, V142, P948, DOI 10.1210/en.142.2.948; Serafim TD, 2010, MEM I OSWALDO CRUZ, V105, P811, DOI 10.1590/S0074-02762010000600014; Shaha C, 2008, ADV EXP MED BIOL, V636, P42, DOI 10.1007/978-0-387-09597-4_3; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Sharpe RM, 2003, REPRODUCTION, V125, P769, DOI 10.1530/rep.0.1250769; Skallova A, 2006, PARASITOLOGY, V133, P525, DOI 10.1017/S0031182006000886; Sun Li-Hua, 2008, Zhonghua Nan Ke Xue, V14, P55; Tarulli GA, 2006, BIOL REPROD, V74, P798, DOI 10.1095/biolreprod.105.050450; Tarulli GA, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.111.095091; Terpsidis KI, 2009, EXP PARASITOL, V121, P238, DOI 10.1016/j.exppara.2008.11.006; Trasler JM, 2009, MOL CELL ENDOCRINOL, V306, P33, DOI 10.1016/j.mce.2008.12.018; Unoki M, 2009, BIOCHEM PHARMACOL, V78, P1279, DOI 10.1016/j.bcp.2009.05.035; Vyas A, 2013, J EXP BIOL, V216, P120, DOI 10.1242/jeb.072983; Walker WH, 1996, TRENDS ENDOCRIN MET, V7, P133, DOI 10.1016/1043-2760(96)00035-5; Walker WH, 2003, ENDOCRINOLOGY, V144, P3719, DOI 10.1210/en.2003-0765; Wistuba J, 2007, J ENDOCRINOL, V192, P99, DOI 10.1677/JOE-06-0054; Wu W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013884; Yang R, 2006, CHINESE J ZOONOSES, P2006; Zhou Y, 2003, CHINESE J ZOONOSES, P2003; Zhu HY, 2011, J APPL TOXICOL, V31, P484, DOI 10.1002/jat.1673	61	26	30	0	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e96770	10.1371/journal.pone.0096770	http://dx.doi.org/10.1371/journal.pone.0096770			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940596	Green Published, Green Submitted, gold			2022-12-27	WOS:000338508200002
J	Ebeling, G; Blasche, R; Hofmann, F; Augstein, A; Kasper, M; Barth, K				Ebeling, Georg; Blaesche, Robert; Hofmann, Falk; Augstein, Antje; Kasper, Michael; Barth, Kathrin			Effect of P2X7 Receptor Knockout on AQP-5 Expression of Type I Alveolar Epithelial Cells	PLOS ONE			English	Article							WATER PERMEABILITY; LUNG FIBROSIS; LIPID RAFTS; DECREASED EXPRESSION; P2X(7) RECEPTOR; RAT; PROTEIN; CALMODULIN; CHANNEL; ACTIVATION	P2X7 receptors, ATP-gated cation channels, are specifically expressed in alveolar epithelial cells. The pathophysiological function of this lung cell type, except a recently reported putative involvement in surfactant secretion, is unknown. In addition, P2X7 receptor-deficient mice show reduced inflammation and lung fibrosis after exposure with bleomycin. To elucidate the role of the P2X7 receptor in alveolar epithelial type I cells we characterized the pulmonary phenotype of P2X7 receptor knockout mice by using immunohistochemistry, western blot analysis and real-time RT PCR. No pathomorphological signs of fibrosis were found. Results revealed, however, a remarkable loss of aquaporin-5 protein and mRNA in young knockout animals. Additional in vitro experiments with bleomycin treated precision cut lung slices showed a greater sensitivity of the P2X7 receptor knockout mice in terms of aquaporin-5 reduction as wild type animals. Finally, P2X7 receptor function was examined by using the alveolar epithelial cell lines E10 and MLE-12 for stimulation experiments with bleomycin. The in vitro activation of P2X7 receptor was connected with an increase of aquaporin-5, whereas the inhibition of the receptor with oxidized ATP resulted in down regulation of aquaporin-5. The early loss of aquaporin-5 which can be found in different pulmonary fibrosis models does not implicate a specific pathogenetic role during fibrogenesis.	[Ebeling, Georg; Blaesche, Robert; Hofmann, Falk; Kasper, Michael; Barth, Kathrin] Tech Univ Dresden, Med Fac Carl Custav Carus, Inst Anat, D-01062 Dresden, Germany; [Augstein, Antje] Tech Univ Dresden, Dept Internal Med & Cardiol, D-01062 Dresden, Germany	Technische Universitat Dresden; Technische Universitat Dresden	Barth, K (corresponding author), Tech Univ Dresden, Med Fac Carl Custav Carus, Inst Anat, D-01062 Dresden, Germany.	kathrin.barth@tu-dresden.de	Barth, Kathrin/AGX-6107-2022					ADAMSON IYR, 1976, ENVIRON HEALTH PERSP, V16, P119, DOI 10.2307/3428592; Almeida C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053628; Barth K, 2007, FEBS J, V274, P3021, DOI 10.1111/j.1742-4658.2007.05830.x; Barth K, 2009, FEBS J, V276, P317, DOI 10.1111/j.1742-4658.2008.06792.x; Blasche R, 2012, INT J BIOCHEM CELL B, V44, P514, DOI 10.1016/j.biocel.2011.12.003; Borok Z, 2002, J APPL PHYSIOL, V93, P2199, DOI 10.1152/japplphysiol.01171.2001; Burnstock Geoffrey, 2013, Keio Journal of Medicine, V62, P63, DOI 10.2302/kjm.2013-0003-RE; Cao XW, 2012, CELL RES, V22, P793, DOI 10.1038/cr.2012.64; CARNEY DN, 1981, P NATL ACAD SCI-BIOL, V78, P3185, DOI 10.1073/pnas.78.5.3185; Chen ZM, 2004, BIOCHEM BIOPH RES CO, V319, P774, DOI 10.1016/j.bbrc.2004.05.048; Dart C, 2010, J PHYSIOL-LONDON, V588, P3169, DOI 10.1113/jphysiol.2010.191585; Derler I, 2006, J PHYSIOL-LONDON, V577, P31, DOI 10.1113/jphysiol.2006.118661; DieckmannSchuppert A, 1997, CELL TISSUE RES, V288, P119, DOI 10.1007/s004410050799; Dobbs LG, 1998, P NATL ACAD SCI USA, V95, P2991, DOI 10.1073/pnas.95.6.2991; Fenton RA, 2013, CURR OPIN NEPHROL HY, V22, P551, DOI 10.1097/MNH.0b013e328364000d; Gabazza EC, 2004, PATHOL INT, V54, P774, DOI 10.1111/j.1440-1827.2004.01754.x; GREEN SJ, 1988, J CELL SCI, V90, P145; Held HD, 1999, BRIT J PHARMACOL, V126, P1191, DOI 10.1038/sj.bjp.0702394; Herzog CR, 1996, ONCOGENE, V13, P1885; Iglesias R, 2008, AM J PHYSIOL-CELL PH, V295, pC752, DOI 10.1152/ajpcell.00228.2008; Ishikawa Y, 2005, AM J PHYSIOL-CELL PH, V289, pC1303, DOI 10.1152/ajpcell.00211.2005; Jacob F, 2013, PURINERG SIGNAL, V9, P285, DOI 10.1007/s11302-013-9357-4; Jang AS, 2004, INTENS CARE MED, V30, P489, DOI 10.1007/s00134-003-2129-9; Johnson MD, 2007, MOL BIOSYST, V3, P178, DOI 10.1039/b614348b; Kasper M, 2000, INT J RADIAT BIOL, V76, P493; Kasper M, 1996, HISTOCHEM CELL BIOL, V106, P419; KASPER M, 1995, AM J RESP CELL MOL, V13, P648, DOI 10.1165/ajrcmb.13.6.7576702; Kasper M, 2004, HISTOCHEM CELL BIOL, V121, P131, DOI 10.1007/s00418-003-0612-6; Kasper M, 1998, HISTOCHEM CELL BIOL, V109, P41; Kasper M, 2003, ANN ANAT, V185; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; Koslowski R, 1998, EUR RESPIR J, V12, P1397, DOI 10.1183/09031936.98.12061397; Krane CM, 2009, CYTOKINE, V46, P111, DOI 10.1016/j.cyto.2008.12.018; Kuwano K, 2008, INTERNAL MED, V47, P345, DOI 10.2169/internalmedicine.47.0713; Lee M, 2008, BRAIN RES, V1195, P1, DOI 10.1016/j.brainres.2007.12.023; Linge A, 2007, ANTICANCER RES, V27, P1343; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Ma TH, 1998, AM J RESP CELL MOL, V19, P143, DOI 10.1165/ajrcmb.19.1.2953; Maylie J, 2004, J PHYSIOL-LONDON, V554, P255, DOI 10.1113/jphysiol.2003.049072; Menzel EJ, 1998, CANCER LETT, V131, P3, DOI 10.1016/S0304-3835(98)00195-5; Nemeth-Cahalan KL, 2000, J BIOL CHEM, V275, P6777, DOI 10.1074/jbc.275.10.6777; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Panenka W, 2001, J NEUROSCI, V21, P7135, DOI 10.1523/JNEUROSCI.21-18-07135.2001; Peracchia C, 2000, J BIOL CHEM, V275, P26220, DOI 10.1074/jbc.M004007200; RAINA S, 1995, J BIOL CHEM, V270, P1908, DOI 10.1074/jbc.270.4.1908; Ramirez MI, 2003, DEV BIOL, V256, P61, DOI 10.1016/S0012-1606(02)00098-2; Riteau N, 2010, AM J RESP CRIT CARE, V182, P774, DOI 10.1164/rccm.201003-0359OC; SAIMI Y, 1990, SCIENCE, V249, P1441, DOI 10.1126/science.2169650; Saimi Y, 2002, ANNU REV PHYSIOL, V64, P289, DOI 10.1146/annurev.physiol.64.100301.111649; Sakai N, 2013, BBA-MOL BASIS DIS, V1832, P911, DOI 10.1016/j.bbadis.2013.03.001; Shivshankar P, 2012, AM J RESP CELL MOL, V47, P28, DOI 10.1165/rcmb.2011-0349OC; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Sotkis A, 2001, CELL COMMUN ADHES, V8, P277, DOI 10.3109/15419060109080737; Staubach S, 2011, EXPERT REV PROTEOMIC, V8, P263, DOI [10.1586/EPR.11.2, 10.1586/epr.11.2]; Tan HL, 2002, NATURE, V415, P442, DOI 10.1038/415442a; Varadaraj K, 2005, INVEST OPHTH VIS SCI, V46, P1393, DOI 10.1167/iovs.04-1217; Volonte C, 2012, CNS NEUROL DISORD-DR, V11, P705, DOI 10.2174/187152712803581137; Wang CM, 2003, CELL SIGNAL, V15, P1129, DOI 10.1016/S0898-6568(03)00112-8; Wang XM, 2006, J EXP MED, V203, P2895, DOI 10.1084/jem.20061536; WIKENHEISER KA, 1993, P NATL ACAD SCI USA, V90, P11029, DOI 10.1073/pnas.90.23.11029; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Yamamoto N, 2001, MOL BRAIN RES, V95, P110, DOI 10.1016/S0169-328X(01)00254-6; Zelenina M, 2002, AM J PHYSIOL-RENAL, V283, pF309, DOI 10.1152/ajprenal.00260.2001; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	64	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100282	10.1371/journal.pone.0100282	http://dx.doi.org/10.1371/journal.pone.0100282			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941004	Green Submitted, Green Published, gold			2022-12-27	WOS:000338508200089
J	Schricker, T; Sato, H; Beaudry, T; Codere, T; Hatzakorzian, R; Pruessner, JC				Schricker, Thomas; Sato, Hiroaki; Beaudry, Thomas; Codere, Takumi; Hatzakorzian, Roupen; Pruessner, Jens C.			Intraoperative Maintenance of Normoglycemia with Insulin and Glucose Preserves Verbal Learning after Cardiac Surgery	PLOS ONE			English	Article							COGNITIVE FUNCTION; ALZHEIMER-DISEASE; HYPERGLYCEMIA; MORTALITY; STRESS; MEMORY	Objective: The hyperglycemic response to surgery may be a risk factor for cognitive dysfunction. We hypothesize that strict maintenance of normoglycemia during cardiac surgery preserves postoperative cognitive function. Methods: As part of a larger randomized, single-blind, interventional efficacy study on the effects of hyperinsulinemic glucose control in cardiac surgery (NCT00524472), consenting patients were randomly assigned to receive combined administration of insulin and glucose, titrated to preserve normoglycemia (3.5-6.1 mmol L-1; experimental group), or standard metabolic care (blood glucose 3.5-10 mmol L-1; control group), during open heart surgery. The patients' cognitive function was assessed during three home visits, approximately two weeks before the operation, and two months and seven months after surgery. The following tests were performed: Rey Auditory Verbal Learning Task (RAVLT for verbal learning and memory), Digit Span Task (working memory), Trail Making A & B (visuomotor tracking and attention), and the Word Pair Task (implicit memory). Questionnaires measuring specific traits known to affect cognitive performance, such as self-esteem, depression, chronic stress and social support, were also administered. The primary outcome was to assess the effect of hyperinsulinemic-normoglycemic clamp therapy versus standard therapy on specific cognitive parameters in patients receiving normoglycemic clamp, or standard metabolic care. Results: Twenty-six patients completed the study with 14 patients in the normoglycemia and 12 patients in the control group. Multiple analysis of covariance (MANCOVA) for the RAVLT showed a significant effect for the interaction of group by visit (F = 4.07, p = 0.035), and group by visit by recall (F = 2.21, p = 0.04). The differences occurred at the second and third visit. MANCOVA for the digit span task, trail making and word pair association test showed no significant effect. Conclusions: Preserving intraoperative normoglycemia by intravenous insulin and glucose may prevent the impairment of memory function, both short and long-term, after cardiac surgery.	[Schricker, Thomas; Codere, Takumi; Hatzakorzian, Roupen] McGill Univ, Fac Med, Dept Anesthesia, Montreal, PQ H3A 2T5, Canada; [Sato, Hiroaki] Yamanashi Univ, Dept Anesthesiol, Yamanashi, Japan; [Beaudry, Thomas; Pruessner, Jens C.] McGill Univ, Fac Med, Dept Psychiat, Montreal, PQ H3A 2T5, Canada	McGill University; University of Yamanashi; McGill University	Pruessner, JC (corresponding author), McGill Univ, Fac Med, Dept Psychiat, Montreal, PQ H3A 2T5, Canada.	jens.pruessner@mcgill.ca		Pruessner, Jens/0000-0002-8582-2980	Canadian Institutes of Health research	Canadian Institutes of Health research(Canadian Institutes of Health Research (CIHR))	The work was supported by Canadian Institutes of Health research grants to TS and JCP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accardi G, 2012, REJUV RES, V15, P217, DOI 10.1089/rej.2011.1289; Anderson RE, 1999, STROKE, V30, P160, DOI 10.1161/01.STR.30.1.160; Atri A, 2004, BEHAV NEUROSCI, V118, P223, DOI 10.1037/0735-7044.118.1.223; BLACKBURN HL, 1957, J CONSULT PSYCHOL, V21, P139, DOI 10.1037/h0047235; Carvalho G, 2004, ANESTH ANALG, V99, P319, DOI 10.1213/01.ANE.0000121769.62638.EB; Carvalho G, 2011, J CLIN ENDOCR METAB, V96, P1469, DOI 10.1210/jc.2010-1934; Chaney MA, 1999, ANESTH ANALG, V89, P1091, DOI 10.1213/00000539-199911000-00004; Cohen J.E., 1988, STAT POWER ANAL BEHA; Craft S, 1999, ARCH GEN PSYCHIAT, V56, P1135, DOI 10.1001/archpsyc.56.12.1135; Crooks VC, 2008, AM J PUBLIC HEALTH, V98, P1221, DOI 10.2105/AJPH.2007.115923; Ferrannini E, 1999, EUR J CLIN INVEST, V29, P842; Finney SJ, 2003, JAMA-J AM MED ASSOC, V290, P2041, DOI 10.1001/jama.290.15.2041; Haga KK, 2011, J CARDIOTHORAC SURG, V6, DOI 10.1186/1749-8090-6-3; KILPATRICK DG, 1975, PSYCHOSOM MED, V37, P62, DOI 10.1097/00006842-197501000-00007; Kuboki K, 2000, CIRCULATION, V101, P676, DOI 10.1161/01.CIR.101.6.676; Li PA, 1996, STROKE, V27, P1592, DOI 10.1161/01.STR.27.9.1592; Messier C, 2000, J Nutr Health Aging, V4, P208; Murkin JM, 1999, J CARDIOTHOR VASC AN, V13, P12; MURKIN JM, 1995, ANN THORAC SURG, V59, P1289, DOI 10.1016/0003-4975(95)00106-U; Pedersen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051132; Petrowski K, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-42; Puskas F, 2007, ANN THORAC SURG, V84, P1467, DOI 10.1016/j.athoracsur.2007.06.023; Rosenberg M., 1979, CONCEIVING SELF; Sanz CM, 2013, DIABETES CARE, V36, P1512, DOI 10.2337/dc12-1017; Schmidt M., 1996, W PSYCHOL SERVICES; Shemesh E, 2012, J CLIN ENDOCR METAB, V97, P366, DOI 10.1210/jc.2011-1802; Stentz FB, 2004, DIABETES, V53, P2079, DOI 10.2337/diabetes.53.8.2079	27	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99661	10.1371/journal.pone.0099661	http://dx.doi.org/10.1371/journal.pone.0099661			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941010	gold, Green Submitted, Green Published			2022-12-27	WOS:000338508200033
J	Zhang, L; Ding, ZX; Li, HY; Shen, Y; Lu, JW				Zhang, Lin; Ding, Zhixuan; Li, Hongyu; Shen, Ying; Lu, Jianwei			3D Face Recognition Based on Multiple Keypoint Descriptors and Sparse Representation	PLOS ONE			English	Article							EXPRESSIONS	Recent years have witnessed a growing interest in developing methods for 3D face recognition. However, 3D scans often suffer from the problems of missing parts, large facial expressions, and occlusions. To be useful in real-world applications, a 3D face recognition approach should be able to handle these challenges. In this paper, we propose a novel general approach to deal with the 3D face recognition problem by making use of multiple keypoint descriptors (MKD) and the sparse representation-based classification (SRC). We call the proposed method 3DMKDSRC for short. Specifically, with 3DMKDSRC, each 3D face scan is represented as a set of descriptor vectors extracted from keypoints by meshSIFT. Descriptor vectors of gallery samples form the gallery dictionary. Given a probe 3D face scan, its descriptors are extracted at first and then its identity can be determined by using a multitask SRC. The proposed 3DMKDSRC approach does not require the pre-alignment between two face scans and is quite robust to the problems of missing data, occlusions and expressions. Its superiority over the other leading 3D face recognition schemes has been corroborated by extensive experiments conducted on three benchmark databases, Bosphorus, GavabDB, and FRGC2.0. The Matlab source code for 3DMKDSRC and the related evaluation results are publicly available at http://sse.tongji.edu.cn/linzhang/3dmkdsrcface/3dmkdsrc.htm.	[Zhang, Lin; Ding, Zhixuan; Li, Hongyu; Shen, Ying; Lu, Jianwei] Tongji Univ, Sch Software Engn, Shanghai 200092, Peoples R China; [Lu, Jianwei] Tongji Univ, Adv Inst Translat Med, Shanghai 200092, Peoples R China	Tongji University; Tongji University	Shen, Y (corresponding author), Tongji Univ, Sch Software Engn, Shanghai 200092, Peoples R China.	yingshen@tongji.edu.cn		Zhang, Lin/0000-0002-4360-5523	Natural Science Foundation of China [61201394, 61303112]; Shanghai Pujiang Program [13PJ1408700, 13PJ1433200]; Innovation Program of Shanghai Municipal Education Commission [12ZZ029]; National Basic Research Program of China [2013CB967101]; Jiangsu Key Laboratory of Image and Video Understanding for Social Safety (Nanjing University of Science and Technology) [30920140122007]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program(Shanghai Pujiang Program); Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); National Basic Research Program of China(National Basic Research Program of China); Jiangsu Key Laboratory of Image and Video Understanding for Social Safety (Nanjing University of Science and Technology)	This work is supported by the Natural Science Foundation of China under grant nos. 61201394 and 61303112, the Shanghai Pujiang Program under grant nos. 13PJ1408700 and 13PJ1433200, the Innovation Program of Shanghai Municipal Education Commission under grant no. 12ZZ029, the National Basic Research Program of China under grant no. 2013CB967101, and the Jiangsu Key Laboratory of Image and Video Understanding for Social Safety (Nanjing University of Science and Technology) under grant No. 30920140122007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alyuz N, 2008, P BIOID, P1; Alyuz N., 2008, 2 IEEE INT C BIOM TH, P1; Beck A, 2009, SIAM J IMAGING SCI, V2, P183, DOI 10.1137/080716542; Benabdelkader C, 2005, IMAGE VISION COMPUT, V23, P339, DOI 10.1016/j.imavis.2004.09.004; Berretti S, 2010, IEEE T PATTERN ANAL, V32, P2162, DOI 10.1109/TPAMI.2010.43; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; Bowyer KW, 2006, COMPUT VIS IMAGE UND, V101, P1, DOI 10.1016/j.cviu.2005.05.005; Bronstein AM, 2007, IEEE T IMAGE PROCESS, V16, P188, DOI 10.1109/TIP.2006.884940; Bronstein AM, 2005, INT J COMPUT VISION, V64, P5, DOI 10.1007/s11263-005-1085-y; Dibeklioglu H, 2009, LECT NOTES COMPUT SC, V5558, P309, DOI 10.1007/978-3-642-01793-3_32; Donoho DL, 2008, IEEE T INFORM THEORY, V54, P4789, DOI 10.1109/TIT.2008.929958; Donoho DL, 2006, COMMUN PUR APPL MATH, V59, P797, DOI 10.1002/cpa.20132; Elaiwat S, 2014, IEEE SIGNAL PROC LET, V21, P172, DOI 10.1109/LSP.2013.2295119; Faltemier TC, 2008, IEEE T INF FOREN SEC, V3, P62, DOI 10.1109/TIFS.2007.916287; Gupta S, 2010, INT J COMPUT VISION, V90, P331, DOI 10.1007/s11263-010-0360-8; Hajati F, 2012, PATTERN RECOGN, V45, P969, DOI 10.1016/j.patcog.2011.08.025; Heseltine T, 2004, LECT NOTES COMPUT SC, V3212, P684; Hesher C, 2003, SEVENTH INTERNATIONAL SYMPOSIUM ON SIGNAL PROCESSING AND ITS APPLICATIONS, VOL 2, PROCEEDINGS, P201, DOI 10.1109/ISSPA.2003.1224850; Jain Anil K., 2007, HDB BIOMETRICS; Kakadiaris IA, 2007, IEEE T PATTERN ANAL, V29, P640, DOI 10.1109/TPAMI.2007.1017; Kim SJ, 2007, IEEE J-STSP, V1, P606, DOI 10.1109/JSTSP.2007.910971; Kimmel R, 1998, P NATL ACAD SCI USA, V95, P8431, DOI 10.1073/pnas.95.15.8431; Koudelka ML, 2005, P CVPR WORKSH; Lee Y, 2005, LECT NOTES COMPUT SC, V3546, P909; Liao SC, 2013, IEEE T PATTERN ANAL, V35, P1193, DOI 10.1109/TPAMI.2012.191; Liu PJ, 2013, IEEE T IMAGE PROCESS, V22, P914, DOI 10.1109/TIP.2012.2222897; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Lu XG, 2006, IEEE T PATTERN ANAL, V28, P31, DOI 10.1109/TPAMI.2006.15; Lu XG, 2008, IEEE T PATTERN ANAL, V30, P1346, DOI 10.1109/TPAMI.2007.70784; Mahoor MH, 2009, PATTERN RECOGN, V42, P445, DOI 10.1016/j.patcog.2008.08.012; Mian AS, 2007, IEEE T PATTERN ANAL, V29, P1927, DOI 10.1109/TPAMI.2007.1105; Moreno AB, 2005, ISPA 2005: PROCEEDINGS OF THE 4TH INTERNATIONAL SYMPOSIUM ON IMAGE AND SIGNAL PROCESSING AND ANALYSIS, P185, DOI 10.1109/ISPA.2005.195407; Moreno AB, 2004, GAVABDB 3D FACE DATA; Moreno AB, 2003, P IMVIP; Mousavi MH, 2008, 7TH IEEE/ACIS INTERNATIONAL CONFERENCE ON COMPUTER AND INFORMATION SCIENCE IN CONJUNCTION WITH 2ND IEEE/ACIS INTERNATIONAL WORKSHOP ON E-ACTIVITY, PROCEEDINGS, P208, DOI 10.1109/ICIS.2008.77; Phillips P. J., 2005, P CVPR, P20; Russ T., 2006, P IEEE COMP SOC C CO, P1391, DOI [10.1109/CVPR.2006.13, DOI 10.1109/CVPR.2006.13]; Russ T. D., 2005, P IEEE COMP SOC C CO, V3, P169; Savran A, 2008, LECT NOTES COMPUT SC, V5372, P47, DOI 10.1007/978-3-540-89991-4_6; Smeets D, 2012, PATTERN RECOGN, V45, P2817, DOI 10.1016/j.patcog.2012.01.020; Spreeuwers L, 2011, INT J COMPUT VISION, V93, P389, DOI 10.1007/s11263-011-0426-2; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Wright J, 2009, IEEE T PATTERN ANAL, V31, P210, DOI 10.1109/TPAMI.2008.79; Wright SJ, 2009, IEEE T SIGNAL PROCES, V57, P2479, DOI 10.1109/TSP.2009.2016892; Xiaoxing Li, 2009, 2009 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), P2575, DOI 10.1109/CVPRW.2009.5206613; Yang JF, 2011, SIAM J SCI COMPUT, V33, P250, DOI 10.1137/090777761	52	14	16	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100120	10.1371/journal.pone.0100120	http://dx.doi.org/10.1371/journal.pone.0100120			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940876	Green Published, Green Submitted, gold			2022-12-27	WOS:000338508200074
J	Riper, H; Blankers, M; Hadiwijaya, H; Cunningham, J; Clarke, S; Wiers, R; Ebert, D; Cuijpers, P				Riper, Heleen; Blankers, Matthijs; Hadiwijaya, Hana; Cunningham, John; Clarke, Stella; Wiers, Reinout; Ebert, David; Cuijpers, Pim			Effectiveness of Guided and Unguided Low-Intensity Internet Interventions for Adult Alcohol Misuse: A Meta-Analysis	PLOS ONE			English	Article							COMPUTER-DELIVERED INTERVENTIONS; RANDOMIZED CONTROLLED-TRIAL; PROBLEM DRINKERS; SELF-HELP; PROBLEM DRINKING; PRIMARY-CARE; USE DISORDERS; HEALTH-CARE; COST-EFFECTIVENESS; GLOBAL BURDEN	Background: Alcohol misuse ranks within the top ten health conditions with the highest global burden of disease. Low-intensity, Internet interventions for curbing adult alcohol misuse have been shown effective. Few meta-analyses have been carried out, however, and they have involved small numbers of studies, lacked indicators of drinking within low risk guidelines, and examined the effectiveness of unguided self-help only. We therefore conducted a more thorough meta-analysis that included both guided and unguided interventions. Methods: Systematic literature searches were performed up to September 2013. Primary outcome was the mean level of alcohol consumption and drinking within low risk guidelines for alcohol consumption at post-treatment. Findings: We selected 16 randomised controlled trials (with 23 comparisons and 5,612 participants) for inclusion. Results, showed a small but significant overall effect size in favour of Internet interventions (g = 0.20, 95% CI: 0.13-0.27, p<.001). Participants in Internet interventions drunk on average 22 grams of ethanol less than controls and were significantly more likely to be adhering to low-risk drinking guidelines at post-treatment (RD 0.13, 95% CI: 0.09-0.17, p<.001). Subgroup analyses revealed no significant differences in potential moderators for the outcome of alcohol consumption, although there was a near-significant difference between comparisons with waitlist control and those with assessment-only or alcohol information control conditions (p = .056). Conclusions: Internet interventions are effective in reducing adult alcohol consumption and inducing alcohol users to adhere to guidelines for low-risk drinking. This effect is small but from a public health point of view this may warrant large scale implementation at low cost of Internet interventions for adult alcohol misuse. Moderator analyses with sufficient power are, however, needed in order to assess the robustness of these overall results and to assess whether these interventions may impact on subgroups with different levels of success.	[Riper, Heleen; Hadiwijaya, Hana; Cuijpers, Pim] Vrije Univ Amsterdam, Dept Clin Psychol, Amsterdam, Netherlands; [Riper, Heleen; Hadiwijaya, Hana; Cuijpers, Pim] Vrije Univ Amsterdam, EMGO Inst, Amsterdam, Netherlands; [Riper, Heleen; Ebert, David; Cuijpers, Pim] Leuphana Univ, EU Innovat Incubator, Div Hlth Trainings Online, Luneburg, Germany; [Blankers, Matthijs] Arkin Mental Hlth Care, Amsterdam, Netherlands; [Blankers, Matthijs] Netherlands Inst Mental Hlth & Addict, Trimbos Inst, Utrecht, Netherlands; [Blankers, Matthijs] Univ Amsterdam, Acad Med Ctr, Dept Psychiat, Amsterdam Inst Addict Res, NL-1012 WX Amsterdam, Netherlands; [Cunningham, John] Australian Natl Univ, Mental Hlth Res Ctr, Canberra, ACT, Australia; [Cunningham, John] Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Clarke, Stella] NHS Fife, Edinburgh, Midlothian, Scotland; [Wiers, Reinout] Univ Amsterdam, Dept Psychol, Addict Dev & Psychopathol ADAPT Lab, Amsterdam, Netherlands; [Ebert, David] Univ Marburg, Dept Psychol, Div Clin Psychol & Psychotherapy, D-35032 Marburg, Germany; [Hadiwijaya, Hana] Tilburg Univ, Dept Dev Psychol, TS Social & Behav Sci, NL-5000 LE Tilburg, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Leuphana University Luneburg; Trimbos Institute; University of Amsterdam; Academic Medical Center Amsterdam; Australian National University; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Amsterdam; Philipps University Marburg; Tilburg University	Riper, H (corresponding author), Vrije Univ Amsterdam, Dept Clin Psychol, Amsterdam, Netherlands.	h.riper@vu.nl	Wiers, Reinout/AAB-4008-2021; Cuijpers, Pim/G-1703-2013	Wiers, Reinout/0000-0002-4312-9766; Cuijpers, Pim/0000-0001-5497-2743; Ebert, David Daniel/0000-0001-6820-0146; Cunningham, John/0000-0002-0668-5982				Apodaca TR, 2003, J CLIN PSYCHOL, V59, P289, DOI 10.1002/jclp.10130; Bischof G, 2008, DRUG ALCOHOL DEPEN, V93, P244, DOI 10.1016/j.drugalcdep.2007.10.003; Blankers M, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.2052; Blankers M, 2011, J CONSULT CLIN PSYCH, V79, P330, DOI 10.1037/a0023498; Boon B, 2006, GEZOND VERSTAND EVID; Boon B, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1695; Borenstein M., 2009, INTRO METAANALYSIS; Burke BL, 2003, J CONSULT CLIN PSYCH, V71, P843, DOI 10.1037/0022-006X.71.5.843; Chan KK, 2007, ADDICT BEHAV, V32, P967, DOI 10.1016/j.addbeh.2006.07.003; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cuijpers P, 2004, ADDICTION, V99, P839, DOI 10.1111/j.1360-0443.2004.00778.x; Cuijpers P, 2010, PSYCHOL MED, P1; Cuijpers Pim, 2009, Cognitive Behaviour Therapy, V38, P66, DOI 10.1080/16506070802694776; Cunningham JA, 2004, ADDICT BEHAV, V29, P221, DOI 10.1016/S0306-4603(03)00077-7; Cunningham JA, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-150; Cunningham JA, 2010, DRUG ALCOHOL REV, V29, P617, DOI 10.1111/j.1465-3362.2010.00201.x; Cunningham JA, 2009, ADDICTION, V104, P2023, DOI 10.1111/j.1360-0443.2009.02726.x; Degenhardt L, 2013, LANCET, V382, P1564, DOI 10.1016/S0140-6736(13)61530-5; Donker T, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-59; Doumas DM, 2008, J SUBST ABUSE TREAT, V34, P263, DOI 10.1016/j.jsat.2007.04.006; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eysenbach G, 2005, J MED INTERNET RES, V7, DOI 10.2196/jmir.7.1.e11; Grucza RA, 2008, ALCOHOL CLIN EXP RES, V32, P763, DOI 10.1111/j.1530-0277.2008.00635.x; Hansen ABG, 2012, J MED INTERNET RES, V14, P3, DOI 10.2196/jmir.1883; Hester RK, 2013, J MED INTERNET RES, V15, P45, DOI 10.2196/jmir.2565; Hester RK, 1995, HDB ALCOHOLISM TREAT, P148; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hodgson R, 2002, ALCOHOL ALCOHOLISM, V37, P61, DOI 10.1093/alcalc/37.1.61; Ioannidis JPA, 2007, BRIT MED J, V335, P914, DOI 10.1136/bmj.39343.408449.80; Jonas DE, 2012, ANN INTERN MED, V157, P645, DOI 10.7326/0003-4819-157-9-201211060-00544; Jonas DE, 2012, COMP EFFECTIVENESS R; Kalden R, 1992, NIAAA PROJECT MATCH; Kaner EFS, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004148.pub4; Kaner E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e8501; Koski-Jannes A, 2001, ADDICT BEHAV, V26, P91, DOI 10.1016/S0306-4603(00)00092-7; Kraemer HC, 2006, BIOL PSYCHIAT, V59, P990, DOI 10.1016/j.biopsych.2005.09.014; Latimer N, 2009, PREVENTION EARLY IDE; McCambridge J, 2013, DRUG ALCOHOL DEPEND; McCambridge J, 2014, DRUG ALCOHOL DEPEN, V135, P156, DOI 10.1016/j.drugalcdep.2013.11.017; Mdege ND, 2013, DRUG ALCOHOL DEPEN, V131, P1, DOI 10.1016/j.drugalcdep.2013.01.023; Miller W, 2002, MOTIVATIONAL INTERVI, V2<feminine; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Moyer A, 2002, ADDICTION, V97, P279, DOI 10.1046/j.1360-0443.2002.00018.x; Moyer VA, 2013, ANN INTERN MED, V159, P210, DOI 10.7326/0003-4819-159-3-201308060-00652; Nilsen P, 2011, ADDICTION, V106, P1748, DOI 10.1111/j.1360-0443.2011.03476.x; O'Donnell A, 2014, ALCOHOL ALCOHOLISM, V49, P66, DOI 10.1093/alcalc/agt170; Orsini N., 2006, HETEROGI STATA MODUL; Osilla Karen Chan, 2012, Am J Manag Care, V18, pe68; Parry CD, 2011, ADDICTION, V106, P1718, DOI 10.1111/j.1360-0443.2011.03605.x; Pedersen B, 2011, BMC SURG, V11, DOI 10.1186/1471-2482-11-26; Pemberton MR, 2011, J STUD ALCOHOL DRUGS, V72, P480, DOI 10.15288/jsad.2011.72.480; Portnoy DB, 2008, PREV MED, V47, P3, DOI 10.1016/j.ypmed.2008.02.014; Postel MG, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1811; Postel MG, 2010, J MED INTERNET RES, V12, P11, DOI 10.2196/jmir.1642; Prochaska JO, 1997, AM J HEALTH PROMOT, V12, P38, DOI 10.4278/0890-1171-12.1.38; Purshouse RC, 2013, ALCOHOL ALCOHOLISM, V48, P180, DOI 10.1093/alcalc/ags103; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; Richards D, 2012, CLIN PSYCHOL REV, V32, P329, DOI 10.1016/j.cpr.2012.02.004; Riper H, 2008, ADDICTION, V103, P218, DOI 10.1111/j.1360-0443.2007.02063.x; Riper H, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1691; Riper H, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.1102; Riper H, 2009, ALCOHOL CLIN EXP RES, V33, P1401, DOI 10.1111/j.1530-0277.2009.00970.x; Riper H, 2009, AM J PREV MED, V36, P247, DOI 10.1016/j.amepre.2008.10.016; Robinson SM, 2014, ADDICT BEHAV, V39, P39, DOI 10.1016/j.addbeh.2013.09.029; Roerecke M, 2013, J CLIN PSYCHIAT, V74, pE1181, DOI 10.4088/JCP.13r08379; Rooke S, 2010, ADDICTION, V105, P1381, DOI 10.1111/j.1360-0443.2010.02975.x; Saitz R, 2010, DRUG ALCOHOL REV, V29, P631, DOI 10.1111/j.1465-3362.2010.00217.x; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Saunders JB, 2000, COMPR PSYCHIAT, V41, P95, DOI 10.1016/S0010-440X(00)80015-2; Schulz DN, 2013, J MED INTERNET RES, V15, P53, DOI 10.2196/jmir.2568; Smit F, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1694; Suffoletto B, 2012, ALCOHOL CLIN EXP RES, V36, P552, DOI 10.1111/j.1530-0277.2011.01646.x; Tang YL, 2013, B WORLD HEALTH ORGAN, V91, P270, DOI 10.2471/BLT.12.107318; Tariq L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005696; Vasilaki EI, 2006, ALCOHOL ALCOHOLISM, V41, P328, DOI 10.1093/alcalc/agl016; Vernon ML, 2010, J SUBST ABUSE TREAT, V38, P203, DOI 10.1016/j.jsat.2009.11.001; Wallace P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014740; Watson HE, 1999, J ADV NURS, V30, P513, DOI 10.1046/j.1365-2648.1999.01107.x; Watson JM, 2013, DRUG ALCOHOL REV, V32, P356, DOI 10.1111/dar.12037; White A, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1479; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6; Wilson GB, 2011, CURR PSYCHIAT REP, V13, P422, DOI 10.1007/s11920-011-0219-x; World Health Organization, 2000, INT GUID MON ALC CON	85	162	162	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99912	10.1371/journal.pone.0099912	http://dx.doi.org/10.1371/journal.pone.0099912			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK5YM	24937483	Green Published, gold, Green Submitted			2022-12-27	WOS:000338503400056
J	Mechelke, M; Habeck, M				Mechelke, Martin; Habeck, Michael			Bayesian Weighting of Statistical Potentials in NMR Structure Calculation	PLOS ONE			English	Article							PROTEIN STRUCTURES; QUALITY; REFINEMENT; DATABASE; ERRORS; ACIDS	The use of statistical potentials in NMR structure calculation improves the accuracy of the final structure but also raises issues of double counting and possible bias. Because statistical potentials are averaged over a large set of structures, they may not reflect the preferences of a particular structure or data set. We propose a Bayesian method to incorporate a knowledge-based backbone dihedral angle potential into an NMR structure calculation. To avoid bias exerted through the backbone potential, we adjust its weight by inferring it from the experimental data. We demonstrate that an optimally weighted potential leads to an improvement in the accuracy and quality of the final structure, especially with sparse and noisy data. Our findings suggest that no universally optimal weight exists, and that the weight should be determined based on the experimental data. Other knowledge-based potentials can be incorporated using the same approach.	[Mechelke, Martin; Habeck, Michael] Univ Gottingen, Inst Math Stochast, D-37073 Gottingen, Germany; [Mechelke, Martin] Max Planck Inst Dev Biol, Dept Prot Evolut, Tubingen, Germany	University of Gottingen; Max Planck Society	Habeck, M (corresponding author), Univ Gottingen, Inst Math Stochast, D-37073 Gottingen, Germany.	mhabeck@gwdg.de		Habeck, Michael/0000-0002-2188-5667	Deutsche Forschungsgemeinschaft (DFG) [HA 5918/1-1]; University of Gottingen; Max Planck Society	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); University of Gottingen; Max Planck Society(Max Planck SocietyFoundation CELLEX)	This work has been supported by Deutsche Forschungsgemeinschaft (DFG) grant HA 5918/1-1, the University of Gottingen and the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boomsma W, 2008, P NATL ACAD SCI USA, V105, P8932, DOI 10.1073/pnas.0801715105; BRUNGER AT, 1993, Q REV BIOPHYS, V26, P49, DOI 10.1017/S0033583500003966; Castellani F, 2002, NATURE, V420, P98, DOI 10.1038/nature01070; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Doreleijers JF, 1998, J MOL BIOL, V281, P149, DOI 10.1006/jmbi.1998.1808; FERRENBERG AM, 1989, PHYS REV LETT, V63, P1195, DOI 10.1103/PhysRevLett.63.1195; Gong HP, 2007, PROTEIN SCI, V16, P1515, DOI 10.1110/ps.072988407; Grishaev A, 2005, J AM CHEM SOC, V127, P16621, DOI 10.1021/ja054342m; Habeck M, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.031912; Habeck M, 2006, P NATL ACAD SCI USA, V103, P1756, DOI 10.1073/pnas.0506412103; Habeck M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018105; Habeck M, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.100601; Habeck M, 2011, J STRUCT BIOL, V173, P541, DOI 10.1016/j.jsb.2010.09.016; HOBOHM U, 1992, PROTEIN SCI, V1, P409; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Hovmoller S, 2002, ACTA CRYSTALLOGR D, V58, P768, DOI 10.1107/S0907444902003359; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Kuszewski J, 2000, J MAGN RESON, V146, P249, DOI 10.1006/jmre.2000.2142; Kuszewski J, 1997, J MAGN RESON, V125, P171, DOI 10.1006/jmre.1997.1116; Kuszewski J, 1996, PROTEIN SCI, V5, P1067; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Linge JP, 1999, J BIOMOL NMR, V13, P51, DOI 10.1023/A:1008365802830; Mal TK, 1998, J BIOMOL NMR, V12, P259, DOI 10.1023/A:1008238009056; Mardia KV, 2007, BIOMETRICS, V63, P505, DOI 10.1111/j.1541-0420.2006.00682.x; Markley JL, 1998, J MOL BIOL, V280, P933, DOI 10.1006/jmbi.1998.1852; Mechelke M, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.066705; Nederveen AJ, 2005, PROTEINS, V59, P662, DOI 10.1002/prot.20408; Pertsemlidis A, 2005, STAT APPL GENET MOL, V4; Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; Porter LL, 2011, P NATL ACAD SCI USA, V108, P109, DOI 10.1073/pnas.1014674107; Press W, 1989, NUMERICAL RECIPES AR; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Rieping W, 2005, J AM CHEM SOC, V127, P16026, DOI 10.1021/ja055092c; Rieping W, 2005, SCIENCE, V309, P303, DOI 10.1126/science.1110428; Rieping W, 2008, BIOINFORMATICS, V24, P1104, DOI 10.1093/bioinformatics/btn062; SIPPL MJ, 1995, CURR OPIN STRUC BIOL, V5, P229, DOI 10.1016/0959-440X(95)80081-6; Skolnick J, 2006, CURR OPIN STRUC BIOL, V16, P166, DOI 10.1016/j.sbi.2006.02.004; SWENDSEN RH, 1986, PHYS REV LETT, V57, P2607, DOI 10.1103/PhysRevLett.57.2607; Ting D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000763	39	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100197	10.1371/journal.pone.0100197	http://dx.doi.org/10.1371/journal.pone.0100197			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956116	Green Submitted, Green Published, gold			2022-12-27	WOS:000338917900032
J	Narahara, M; Higasa, K; Nakamura, S; Tabara, Y; Kawaguchi, T; Ishii, M; Matsubara, K; Matsuda, F; Yamada, R				Narahara, Maiko; Higasa, Koichiro; Nakamura, Seiji; Tabara, Yasuharu; Kawaguchi, Takahisa; Ishii, Miho; Matsubara, Kenichi; Matsuda, Fumihiko; Yamada, Ryo			Large-Scale East-Asian eQTL Mapping Reveals Novel Candidate Genes for LD Mapping and the Genomic Landscape of Transcriptional Effects of Sequence Variants	PLOS ONE			English	Article							CROHNS-DISEASE SUSCEPTIBILITY; LONG NONCODING RNAS; WIDE ASSOCIATION; EXPRESSION; LOCI; IMPACT; IDENTIFICATION; POLYMORPHISMS; POPULATIONS; ANNOTATION	Profiles of sequence variants that influence gene transcription are very important for understanding mechanisms that affect phenotypic variation and disease susceptibility. Using genotypes at 1.4 million SNPs and a comprehensive transcriptional profile of 15,454 coding genes and 6,113 lincRNA genes obtained from peripheral blood cells of 298 Japanese individuals, we mapped expression quantitative trait loci (eQTLs). We identified 3,804 cis-eQTLs (within 500 kb from target genes) and 165 trans-eQTLs (>500 kb away or on different chromosomes). Cis-eQTLs were often located in transcribed or adjacent regions of genes; among these regions, 59 untranslated regions and 59 flanking regions had the largest effects. Epigenetic evidence for regulatory potential accumulated in public databases explained the magnitude of the effects of our eQTLs. Cis-eQTLs were often located near the respective target genes, if not within genes. Large effect sizes were observed with eQTLs near target genes, and effect sizes were obviously attenuated as the eQTL distance from the gene increased. Using a very stringent significance threshold, we identified 165 large-effect trans-eQTLs. We used our eQTL map to assess 8,069 disease-associated SNPs identified in 1,436 genome-wide association studies (GWAS). We identified genes that might be truly causative, but GWAS might have failed to identify for 148 out of the GWAS-identified SNPs; for example, TUFM (P = 3.3E-48) was identified for inflammatory bowel disease (early onset); ZFP90 (P = 4.4E-34) for ulcerative colitis; and IDUA (P = 2.2E-11) for Parkinson's disease. We identified four genes (P<2.0E-14) that might be related to three diseases and two hematological traits; each expression is regulated by trans-eQTLs on a different chromosome than the gene.	[Narahara, Maiko; Higasa, Koichiro; Tabara, Yasuharu; Kawaguchi, Takahisa; Matsuda, Fumihiko; Yamada, Ryo] Kyoto Univ, Grad Sch Med, Ctr Genom Med, Kyoto, Japan; [Nakamura, Seiji; Ishii, Miho; Matsubara, Kenichi] DNA Chip Res Inc, Yokohama, Kanagawa, Japan	Kyoto University; DNA Chip Research Inc.	Yamada, R (corresponding author), Kyoto Univ, Grad Sch Med, Ctr Genom Med, Kyoto, Japan.	ryamada@genome.med.kyoto-u.ac.jp		Yamada, Ryo/0000-0002-1587-630X	Ministry of Health, Labour and Welfare, Japan; Kyoto University; Ministry of Health, Labour and Welfare of Japan [201238002A]; DNA Chip Research Inc.	Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Kyoto University; Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); DNA Chip Research Inc.	This work was supported by Ministry of Health, Labour and Welfare, Japan (2009-2013), Kyoto University (2006), and the Research Grant for Intractable Diseases from the Ministry of Health, Labour and Welfare of Japan (201238002A). Co-authors Seiji Nakamura, Miho Ishii and Kenichi Matsubara are employed by DNA Chip Research Inc. DNA Chip Research Inc. provided support in the form of salaries for authors Seiji Nakamura, Miho Ishii and Kenichi Matsubara, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Alberts R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000622; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Benovoy D, 2008, NUCLEIC ACIDS RES, V36, P4417, DOI 10.1093/nar/gkn409; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Brown CD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003649; Bushel PR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034286; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Cheung VG, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000480; Cookson W, 2009, NAT REV GENET, V10, P184, DOI 10.1038/nrg2537; David M, 2011, BIOINFORMATICS, V27, P1011, DOI 10.1093/bioinformatics/btr046; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Duan S, 2008, AM J HUM GENET, V82, P1101, DOI 10.1016/j.ajhg.2008.03.006; Fairfax BP, 2012, NAT GENET, V44, P502, DOI 10.1038/ng.2205; Fehrmann RSN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002197; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gieger C, 2011, NATURE, V480, P201, DOI 10.1038/nature10659; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Li J, 2013, HUM MOL GENET, V22, P1457, DOI 10.1093/hmg/dds534; Ma HQ, 2009, WORLD J GASTROENTERO, V15, P4844, DOI 10.3748/wjg.15.4844; Mehta D, 2013, EUR J HUM GENET, V21, P48, DOI 10.1038/ejhg.2012.106; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Plagnol V, 2009, BIOSTATISTICS, V10, P327, DOI 10.1093/biostatistics/kxn039; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Sasayama D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054967; Sliwerska E, 2007, BIOL PSYCHIAT, V61, P13, DOI 10.1016/j.biopsych.2006.01.023; Small KS, 2011, NAT GENET, V43, P561, DOI 10.1038/ng.833; Spielman RS, 2007, NAT GENET, V39, P226, DOI 10.1038/ng1955; Spizzo R, 2012, ONCOGENE, V31, P4577, DOI 10.1038/onc.2011.621; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Tse KP, 2009, AM J HUM GENET, V85, P194, DOI 10.1016/j.ajhg.2009.07.007; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Walter NAR, 2007, NAT METHODS, V4, P679, DOI 10.1038/nmeth0907-679; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Yang SK, 2014, GUT, V63, P80, DOI 10.1136/gutjnl-2013-305193; Zhang W, 2008, AM J HUM GENET, V82, P631, DOI 10.1016/j.ajhg.2007.12.015	46	100	100	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100924	10.1371/journal.pone.0100924	http://dx.doi.org/10.1371/journal.pone.0100924			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956270	Green Published, Green Submitted, gold			2022-12-27	WOS:000338917900106
J	Wang, CS; Wang, SG; Li, K; Ju, YP; Li, JP; Zhang, YX; Li, JH; Liu, XY; Shi, XY; Zhao, QH				Wang, Chuanshun; Wang, Shige; Li, Kai; Ju, Yaping; Li, Jipeng; Zhang, Yongxing; Li, Jinhua; Liu, Xuanyong; Shi, Xiangyang; Zhao, Qinghua			Preparation of Laponite Bioceramics for Potential Bone Tissue Engineering Applications	PLOS ONE			English	Article							POLY(LACTIC-CO-GLYCOLIC ACID) NANOFIBERS; IN-VITRO; CANCER-CELLS; HYDROXYAPATITE; REGENERATION; COMPOSITE; DIFFERENTIATION; FABRICATION; DOXORUBICIN; SCAFFOLDS	We report a facile approach to preparing laponite (LAP) bioceramics via sintering LAP powder compacts for bone tissue engineering applications. The sintering behavior and mechanical properties of LAP compacts under different temperatures, heating rates, and soaking times were investigated. We show that LAP bioceramic with a smooth and porous surface can be formed at 800 degrees C with a heating rate of 5 degrees C/h for 6 h under air. The formed LAP bioceramic was systematically characterized via different methods. Our results reveal that the LAP bioceramic possesses an excellent surface hydrophilicity and serum absorption capacity, and good cytocompatibility and hemocompatibility as demonstrated by resazurin reduction assay of rat mesenchymal stem cells (rMSCs) and hemolytic assay of pig red blood cells, respectively. The potential bone tissue engineering applicability of LAP bioceramic was explored by studying the surface mineralization behavior via soaking in simulated body fluid (SBF), as well as the surface cellular response of rMSCs. Our results suggest that LAP bioceramic is able to induce hydroxyapatite deposition on its surface when soaked in SBF and rMSCs can proliferate well on the LAP bioceramic surface. Most strikingly, alkaline phosphatase activity together with alizarin red staining results reveal that the produced LAP bioceramic is able to induce osteoblast differentiation of rMSCs in growth medium without any inducing factors. Finally, in vivo animal implantation, acute systemic toxicity test and hematoxylin and eosin (H&E)-staining data demonstrate that the prepared LAP bioceramic displays an excellent biosafety and is able to heal the bone defect. Findings from this study suggest that the developed LAP bioceramic holds a great promise for treating bone defects in bone tissue engineering.	[Wang, Chuanshun; Li, Kai; Ju, Yaping; Li, Jipeng; Zhang, Yongxing; Zhao, Qinghua] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Dept Orthopaed, Shanghai 200030, Peoples R China; [Wang, Shige; Shi, Xiangyang] Donghua Univ, Coll Mat Sci & Engn, State Key Lab Modificat Chem Fibers & Polymer Mat, Shanghai, Peoples R China; [Li, Jinhua; Liu, Xuanyong] Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China; [Shi, Xiangyang] Donghua Univ, Coll Chem Chem Engn & Biotechnol, Shanghai, Peoples R China	Shanghai Jiao Tong University; Donghua University; Chinese Academy of Sciences; Shanghai Institute of Ceramics, CAS; Donghua University	Shi, XY (corresponding author), Donghua Univ, Coll Mat Sci & Engn, State Key Lab Modificat Chem Fibers & Polymer Mat, Shanghai, Peoples R China.	xshi@dhu.edu.cn; sawboneszhao@163.com	LI, Jinhua/AAI-3716-2021; Shi, Xiangyang/A-1289-2007; Liu, Xuanyong/J-2609-2018; Wang, Shige/H-7436-2012	LI, Jinhua/0000-0003-1110-7471; Shi, Xiangyang/0000-0001-6785-6645; Wang, Shige/0000-0002-7639-6035	Medicine and Engineering Joint Foundation of Shanghai Jiao Tong University [YG2011MS28]; High-Tech Research and Development Program of China [2012AA030309]; program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning	Medicine and Engineering Joint Foundation of Shanghai Jiao Tong University; High-Tech Research and Development Program of China; program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning	This work was financially supported by the Medicine and Engineering Joint Foundation of Shanghai Jiao Tong University (No. YG2011MS28), the High-Tech Research and Development Program of China (2012AA030309), and the program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbieri D, 2013, ACTA BIOMATER, V9, P9401, DOI 10.1016/j.actbio.2013.07.026; Cao ZB, 2013, MAT SCI ENG C-MATER, V33, P3522, DOI 10.1016/j.msec.2013.04.045; Chung CJ, 2011, ACTA BIOMATER, V7, P4081, DOI 10.1016/j.actbio.2011.07.004; Dorozhkin SV, 2010, BIOMATERIALS, V31, P1465, DOI 10.1016/j.biomaterials.2009.11.050; Fernandes LF, 2009, CONNECT TISSUE RES, V50, P336, DOI 10.3109/03008200902855909; Gentleman E, 2010, BIOMATERIALS, V31, P3949, DOI 10.1016/j.biomaterials.2010.01.121; Hench L. L., 1971, J BIOMED MATER RES, V5, P117, DOI DOI 10.1002/JBM.820050611; Hoppe A, 2011, BIOMATERIALS, V32, P2757, DOI 10.1016/j.biomaterials.2011.01.004; Huang J, 2010, ACTA BIOMATER, V6, P241, DOI 10.1016/j.actbio.2009.06.032; Huang Y, 2009, BIOMATERIALS, V30, P5041, DOI 10.1016/j.biomaterials.2009.05.077; Jabbari-Farouji S, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.061405; Jung H, 2008, APPL CLAY SCI, V40, P99, DOI 10.1016/j.clay.2007.09.002; Kumar A, 2013, J BIOMED MATER RES A, V101, P2925, DOI 10.1002/jbm.a.34603; Liao HH, 2011, COLLOID SURFACE B, V84, P528, DOI 10.1016/j.colsurfb.2011.02.010; Loty C, 2001, J BONE MINER RES, V16, P231, DOI 10.1359/jbmr.2001.16.2.231; Magallanes-Perdomo M, 2013, ACTA BIOMATER, V6, P2254; Marcacci M, 1999, CALCIFIED TISSUE INT, V64, P83, DOI 10.1007/s002239900583; da Silva HM, 2010, COLLOID SURFACE B, V80, P138, DOI 10.1016/j.colsurfb.2010.05.040; Meng ZX, 2010, MAT SCI ENG C-MATER, V30, P1014, DOI 10.1016/j.msec.2010.05.003; Murugan R, 2004, BIOMATERIALS, V25, P3829, DOI 10.1016/j.biomaterials.2003.10.016; Qi RL, 2012, J BIOMAT SCI-POLYM E, V23, P299, DOI 10.1163/092050610X550340; Qi RL, 2010, J MATER CHEM, V20, P10622, DOI 10.1039/c0jm01328e; Rossi AL, 2012, BONE, V50, P301, DOI 10.1016/j.bone.2011.10.022; SCHMITZ JP, 1986, CLIN ORTHOP RELAT R, P299, DOI 10.1097/00003086-198604000-00036; Sowmya S, 2013, PROG POLYM SCI, V38, P1748, DOI 10.1016/j.progpolymsci.2013.05.005; Swetha M, 2010, INT J BIOL MACROMOL, V47, P1, DOI 10.1016/j.ijbiomac.2010.03.015; Tas AC, 2004, J MATER RES, V19, P2742, DOI 10.1557/JMR.2004.0349; Vallet-Regi M, 2001, J CHEM SOC DALTON, P97, DOI 10.1039/b007852m; Viseras C, 2010, APPL CLAY SCI, V48, P291, DOI 10.1016/j.clay.2010.01.007; Wang QZ, 2008, J MATER SCI-MATER M, V19, P1371, DOI 10.1007/s10856-007-3243-y; Wang SG, 2013, LANGMUIR, V29, P5030, DOI 10.1021/la4001363; Wang SG, 2012, J MATER CHEM, V22, P23357, DOI 10.1039/c2jm34249a; Wang SG, 2012, ACS APPL MATER INTER, V4, P6393, DOI 10.1021/am302130b; Wu CT, 2013, J INORG MATER, V28, P29, DOI 10.3724/SP.J.1077.2013.12241; Wu CT, 2006, J BIOMATER APPL, V21, P119, DOI 10.1177/0885328206057953; Wu CT, 2013, J MATER CHEM B, V1, P2710, DOI 10.1039/c3tb20275e; Wu CT, 2013, J MATER CHEM B, V1, P876, DOI 10.1039/c2tb00391k; Wu CT, 2005, BIOMATERIALS, V26, P2925, DOI 10.1016/j.biomaterials.2004.09.019; Xynos ID, 2000, CALCIFIED TISSUE INT, V67, P321, DOI 10.1007/s002230001134; Yoon E, 2007, TISSUE ENG, V13, P619, DOI 10.1089/ten.2006.0102; Zaidman N., 2012, RECENT PATENTS REGEN, V2, P65	41	47	51	3	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e99585	10.1371/journal.pone.0099585	http://dx.doi.org/10.1371/journal.pone.0099585			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955961	Green Published, gold, Green Submitted			2022-12-27	WOS:000338917900013
J	Yang, F; Zhou, XC; Du, SK; Zhao, YJ; Ren, W; Deng, Q; Wang, FL; Yuan, JL				Yang, Fan; Zhou, Xingchun; Du, Shuangkuan; Zhao, Yongjun; Ren, Wei; Deng, Qian; Wang, Fuli; Yuan, Jianlin			LIM and SH3 Domain Protein 1 (LASP-1) Overexpression Was Associated with Aggressive Phenotype and Poor Prognosis in Clear Cell Renal Cell Cancer	PLOS ONE			English	Article							INFLUENCES ZYXIN LOCALIZATION; BREAST-CANCER; ACTIN-BINDING; MIGRATION; PHOSPHORYLATION; PROLIFERATION; CARCINOMA; SURVIVAL; KINASE	Background: LIM and SH3 protein 1 (LASP-1) is a specific focal adhesion protein that is known to be involved in numerous biological and pathological processes. LASP-1 overexpression has been described in several types of cancers, but its expression and role in clear cell renal cell cancer (ccRCC) remains unknown. Methods: Using immunohistochemistry, we analyzed LASP-1 protein expression in 216 clinicopathologically characterized ccRCC cases. We also examined LASP-1 expression in 20 paired ccRCC tissues and in 2 cell lines by real-time PCR and Western blot. Using RNA interference, we investigated the effects of LASP-1 depletion on tumor cell behavior in vitro. Statistical analyses were used to determine the associations between LASP-1 levels, tumor features and patient outcomes. Results: LASP-1 overexpression was observed in ccRCC tissues (P<0.0001) compared to adjuvant nontumorous tissues, and its expression levels were closely correlated with overall survival and recurrence-free survival (P = 0.044 and 0.006, respectively) in patients with ccRCC. RNA interference-mediated silencing of the LASP-1 gene in 786-0 ccRCC cells significantly inhibited cell migration. Conclusions: The results of the present study indicate that LASP-1 may serve as a prognostic biomarker for ccRCC patients and may be a promising target for the treatment of ccRCC.	[Yang, Fan; Wang, Fuli; Yuan, Jianlin] Fourth Mil Med Univ, Xijing Hosp, Dept Urol Surg, Xian 710032, Shaanxi, Peoples R China; [Zhou, Xingchun] Fourth Mil Med Univ, State Key Lab Canc Biol, Xian 710032, Shaanxi, Peoples R China; [Zhou, Xingchun] Fourth Mil Med Univ, Expt Teaching Ctr Basic Med, Xian 710032, Shaanxi, Peoples R China; [Du, Shuangkuan; Zhao, Yongjun; Ren, Wei; Deng, Qian] Peoples Hosp Shaanxi Prov, Dept Urol Surg, Xian, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Xi'an Medical University	Wang, FL (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Urol Surg, Xian 710032, Shaanxi, Peoples R China.	fuli_wang@yeah.net; Yuanjianlin1122@163.com						Bex A, 2012, BJU INT, V110, P1289, DOI 10.1111/j.1464-410X.2012.11100.x; Butt E, 2003, J BIOL CHEM, V278, P15601, DOI 10.1074/jbc.M209009200; Chew CS, 2000, J CELL SCI, V113, P2035; Chew CS, 2002, J CELL SCI, V115, P4787, DOI 10.1242/jcs.00174; Chiyomaru T, 2012, UROL ONCOL-SEMIN ORI, V30, P434, DOI 10.1016/j.urolonc.2010.05.008; Frietsch JJ, 2010, BRIT J CANCER, V102, P1645, DOI 10.1038/sj.bjc.6605685; Grunewald TGP, 2007, BRIT J CANCER, V96, P296, DOI 10.1038/sj.bjc.6603545; Grunewald TGP, 2006, EXP CELL RES, V312, P974, DOI 10.1016/j.yexcr.2005.12.016; Keicher C, 2004, BIOCHEM BIOPH RES CO, V324, P308, DOI 10.1016/j.bbrc.2004.08.235; Leibovich BC, 2010, J UROLOGY, V183, P1309, DOI 10.1016/j.juro.2009.12.035; Li B, 2004, J BIOL CHEM, V279, P20401, DOI 10.1074/jbc.M310304200; Lin YH, 2004, J CELL BIOL, V165, P421, DOI 10.1083/jcb.200311045; Mihlan S, 2013, ONCOGENE, V32, P2107, DOI 10.1038/onc.2012.216; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Rachlin AS, 2006, J CELL SCI, V119, P995, DOI 10.1242/jcs.02825; Schreiber VR, 1998, MOL MED, V4, P675, DOI 10.1007/BF03401929; TOMASETTO C, 1995, FEBS LETT, V373, P245, DOI 10.1016/0014-5793(95)01040-L; Traenka C, 2010, CANCER RES, V70, P8003, DOI 10.1158/0008-5472.CAN-10-0592; Vicente-Manzanares M, 2009, J CELL SCI, V122, P199, DOI 10.1242/jcs.018564; Wang B, 2009, J HEPATOL, V50, P528, DOI 10.1016/j.jhep.2008.10.025; Wang H, 2013, EUR J CANCER, V49, P974, DOI 10.1016/j.ejca.2012.09.032; Zhao LA, 2010, GUT, V59, P1226, DOI 10.1136/gut.2009.202739	22	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100557	10.1371/journal.pone.0100557	http://dx.doi.org/10.1371/journal.pone.0100557			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955835	Green Submitted, gold, Green Published			2022-12-27	WOS:000338917900066
J	Zitnik, S; Subelj, L; Bajec, M				Zitnik, Slavko; Subelj, Lovro; Bajec, Marko			SkipCor: Skip-Mention Coreference Resolution Using Linear-Chain Conditional Random Fields	PLOS ONE			English	Article								Coreference resolution tries to identify all expressions (called mentions) in observed text that refer to the same entity. Beside entity extraction and relation extraction, it represents one of the three complementary tasks in Information Extraction. In this paper we describe a novel coreference resolution system SkipCor that reformulates the problem as a sequence labeling task. None of the existing supervised, unsupervised, pairwise or sequence-based models are similar to our approach, which only uses linear-chain conditional random fields and supports high scalability with fast model training and inference, and a straightforward parallelization. We evaluate the proposed system against the ACE 2004, CoNLL 2012 and SemEval 2010 benchmark datasets. SkipCor clearly outperforms two baseline systems that detect coreferentiality using the same features as SkipCor. The obtained results are at least comparable to the current state-of-the-art in coreference resolution.	[Zitnik, Slavko; Subelj, Lovro; Bajec, Marko] Univ Ljubljana, Lab Data Technol, Ljubljana, Slovenia; [Zitnik, Slavko] Optilab Doo, Ljubljana, Slovenia	University of Ljubljana	Zitnik, S (corresponding author), Univ Ljubljana, Lab Data Technol, Ljubljana, Slovenia.	slavko.zitnik@fri.uni-lj.si	Šubelj, Lovro/V-9106-2018	Šubelj, Lovro/0000-0002-4161-2260	Slovene Research Agency ARRS [P2-0359]; European Union, European Social Fund	Slovene Research Agency ARRS(Slovenian Research Agency - Slovenia); European Union, European Social Fund(European Social Fund (ESF))	The work has been supported by the Slovene Research Agency ARRS within the research program P2-0359 and partly financed by the European Union, European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN PM, 1992, THIRD CONFERENCE ON APPLIED NATURAL LANGUAGE PROCESSING, P170; Attardi Giuseppe, 2010, P 5 INT WORKSH SEM E, P108; Bagga Amit, 1998, INT C LANG RES EV W, P563, DOI DOI 10.3115/980845.980859; Bansal M, 2012, P 50 ANN M ASS COMP, V1; Bejan CA, 2010, ACL 2010: 48TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, P1412; Bejan Cosmin Adrian, 2009, ADV NEURAL INFORM PR, V22, P73; Bergsma S, 2006, COLING/ACL 2006, VOLS 1 AND 2, PROCEEDINGS OF THE CONFERENCE, P33; Bernardi R, 2010, P INT C LANG RES EV, P1; Bjorkelund Anders, 2012, JOINT C EMNLP CONLL, P49; Broscheit S., 2010, P 5 INT WORKSH SEM E, P104; Cai J., 2010, P 23 INT C COMP LING, P143; Charniak Eugene, 2001, P 2 M N AM CHAPT ASS, P1; Chen C., 2012, JOINT C EMNLP CONLL, P56; Chinchor N, 1993, P 5 C MESS UND, P6978; Chincor Nancy, 1991, P 3 C MESSAGE UNDERS, P17; Clark JH, 2008, LANGUAGE STAT 2 LIT, P1; Cohn T, 2006, LECT NOTES COMPUT SC, V4212, P606; Culotta Aron, 2007, HUM LANG TECHN C N A, P81; Doddington G. R., 2004, P LREC, V2, P1; Fernandes Eraldo, 2012, JOINT C EMNLP CONLL, P41; Finkel Jenny Rose, 2008, P 46 ANN M ASS COMP, P45; Finkel Jenny Rose, 2005, P 43 ANN M ASS COMP, P363; Fosler-Lussier E, 2013, P IEEE, V101, P1054, DOI 10.1109/JPROC.2013.2248112; Gilbert N, 2013, DOMAIN SPECIFIC CORE, P1; Haghighi Aria, 2009, P 2009 C EMP METH NA, P1152; Hirschman Lynette, 1997, P 7 MESSAGE UNDERSTA, P1; Huang S., 2009, ADV COMPUTATIONAL LI, P157; Kobdani Hamidreza, 2010, P 5 INT WORKSH SEM E, P92; Lafferty J, 2001, P 18 INT C MACH LEAR, P282, DOI DOI 10.1038/NPROT.2006.61; Lee H., 2011, P 15 C COMPUTATIONAL, P28; Li X, 2012, P JOINT C EMNLP CONL, P83; Luo X, 2004, P 42 ANN M ASS COMP, P136; Luo Xiaoqiang, 2007, HLT NAACL, P73; Luo Xiaoqiang, 2005, P C HUM LANG TECHN E, P25, DOI [DOI 10.3115/1220575.1220579, 10.3115/1220575.1220579]; McCallum A, 2004, NEURAL INFORM PROCES, P1; MILLER GA, 1995, COMMUN ACM, V38, P39, DOI 10.1145/219717.219748; Ng V, 2002, 40TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE CONFERENCE, P104; Ng Vincent, 2008, P C EMP METH NAT LAN, P640; Nguyen N, 2012, BMC BIOINFORMATICS, V13, P1; Okazaki Naoaki, 2007, CRFSUITE FAST IMPLEM; Orasan C, 2007, J ARTIF INTELL RES, V29, P79, DOI 10.1613/jair.2179; Pradhan Sameer, 2012, P 16 C COMP NAT LANG, P1; Pradipta S, 2011, P 15 C COMP NAT LANG, P1; Raghunathan Karthik, 2010, P 2010 C EMP METH NA, P492; Rahman A, 2009, P 2009 C EMP METH NA, P968, DOI DOI 10.3115/1699571.1699639; Ram RVS, 2012, P C INT TEXT PROC CO, P285; Recasens M., 2009, P 5 INT WORKSH SEM E, P1; Sapena E., 2010, P ACL WORKSH SEM EV, P88; Sarawagi S, 2007, FOUND TRENDS DATABAS, V1, P261, DOI 10.1561/1500000003; Soon WM, 2001, COMPUT LINGUIST, V27, P521, DOI 10.1162/089120101753342653; Stamborg M., 2012, JOINT C EMNLP CONLL, P64; Stoyanov V., 2010, P 48 ANN M ASS COMP, P156; Vilain Marc, 1995, 6 MESS UND C MUC 6 P, DOI [10.3115/1072399.1072405, DOI 10.3115/1072399.1072405]; Wellner B., 2004, P 20 C UNC ART INT, P593; Wimalasuriya DC, 2010, J INF SCI, V36, P306, DOI 10.1177/0165551509360123; Winkler W.E, 1990, P SECT SURV RES ISS; Zhekova D, 2010, P 5 INT WORKSH SEM E, P96; Zhekova D, 2012, JOINT C EMNLP CONLL, P88	58	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100101	10.1371/journal.pone.0100101	http://dx.doi.org/10.1371/journal.pone.0100101			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956272	gold, Green Published, Green Submitted			2022-12-27	WOS:000338917900025
J	Lee, AMD; Kirby, M; Ohtani, K; Candido, T; Shalansky, R; MacAulay, C; English, J; Finley, R; Lam, S; Coxson, HO; Lane, P				Lee, Anthony M. D.; Kirby, Miranda; Ohtani, Keishi; Candido, Tara; Shalansky, Rebecca; MacAulay, Calum; English, John; Finley, Richard; Lam, Stephen; Coxson, Harvey O.; Lane, Pierre			Validation of Airway Wall Measurements by Optical Coherence Tomography in Porcine Airways	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; COMPUTED-TOMOGRAPHY; BRONCHIAL LESIONS; DISTORTION; THICKNESS; LUNG; BIOPSY; WAX; CT	Examining and quantifying changes in airway morphology is critical for studying longitudinal pathogenesis and interventions in diseases such as chronic obstructive pulmonary disease and asthma. Here we present fiber-optic optical coherence tomography (OCT) as a nondestructive technique to precisely and accurately measure the 2-dimensional cross-sectional areas of airway wall substructure divided into the mucosa (WA(muc)), submucosa (WA(sub)), cartilage (WA(cart)), and the airway total wall area (WAt). Porcine lung airway specimens were dissected from freshly resected lung lobes (N = 10). Three-dimensional OCT imaging using a fiber-optic rotary-pullback probe was performed immediately on airways greater than 0.9 mm in diameter on the fresh airway specimens and subsequently on the same specimens post-formalin-fixation. The fixed specimens were serially sectioned and stained with H&E. OCT images carefully matched to selected sections stained with Movat's pentachrome demonstrated that OCT effectively identifies airway epithelium, lamina propria, and cartilage. Selected H&E sections were digitally scanned and airway total wall areas were measured. Traced measurements of WA(muc), WA(sub), WA(cart), and WA(t) from OCT images of fresh specimens by two independent observers found there were no significant differences (p>0.05) between the observer's measurements. The same wall area measurements from OCT images of formalin-fixed specimens found no significant differences for WA(sub), WA(cart) and WA(t), and a small but significant difference for WA(muc). Bland-Altman analysis indicated there were negligible biases between the observers for OCT wall area measurements in both fresh and formalin-fixed specimens. Bland-Altman analysis also indicated there was negligible bias between histology and OCT wall area measurements for both fresh and formalin-fixed specimens. We believe this study sets the groundwork for quantitatively monitoring pathogenesis and interventions in the airways using OCT.	[Lee, Anthony M. D.; Ohtani, Keishi; MacAulay, Calum; Lam, Stephen; Lane, Pierre] British Columbia Canc Agcy, Res Ctr, Dept Integrat Oncol, Imaging Unit, Vancouver, BC V5Z 4E6, Canada; [Kirby, Miranda; Candido, Tara; Shalansky, Rebecca; Coxson, Harvey O.] Vancouver Gen Hosp, Dept Radiol, Vancouver, BC V5Z 1M9, Canada; [English, John] Vancouver Gen Hosp, Dept Pathol, Vancouver, BC V5Z 1M9, Canada; [Finley, Richard] Vancouver Gen Hosp, Dept Surg, Vancouver, BC, Canada	British Columbia Cancer Agency; University of British Columbia; University of British Columbia; University of British Columbia	Lee, AMD (corresponding author), British Columbia Canc Agcy, Res Ctr, Dept Integrat Oncol, Imaging Unit, Vancouver, BC V5Z 4E6, Canada.	alee@bccrc.ca	MacAulay, Calum/K-1795-2016; Kirby, Miranda/P-4690-2017; Coxson, Harvey O/A-9861-2017	Coxson, Harvey O/0000-0001-5750-9711; Lane, Pierre/0000-0002-6370-4182; MacAulay, Calum/0000-0003-4440-2792; Lee, Anthony/0000-0001-6327-2351	CIHR Team Grant CIF [97687]	CIHR Team Grant CIF	This study was funded by a CIHR Team Grant CIF# 97687, http://www.cihr-irsc.gc.ca/e/193.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira M, 2009, AM J ROENTGENOL, V192, P267, DOI 10.2214/AJR.07.3953; BAI A, 1994, J APPL PHYSIOL, V77, P1011, DOI 10.1152/jappl.1994.77.2.1011; Bolin FP, 1989, APPL OPTICS, V28, P2297; BOONSTRA H, 1983, VIRCHOWS ARCH A, V402, P195, DOI 10.1007/BF00695061; Coxson HO, 2008, AM J RESP CRIT CARE, V177, P1201, DOI 10.1164/rccm.200712-1776OC; DEVERELL MH, 1989, PATHOL RES PRACT, V185, P598, DOI 10.1016/S0344-0338(89)80201-8; FUJIMOTO JG, 1995, NAT MED, V1, P970, DOI 10.1038/nm0995-970; Hanna N, 2005, J THORAC CARDIOV SUR, V129, P615, DOI 10.1016/j.jtcvs.2004.10.022; Hariri LP, 2013, CHEST, V143, P64, DOI 10.1378/chest.11-2797; Hogg J, 2004, NEW ENGL J MED, V350, P2645; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; JONES AS, 1994, CYTOMETRY, V15, P95, DOI 10.1002/cyto.990150203; Kauczor HU, 1997, JMRI-J MAGN RESON IM, V7, P538, DOI 10.1002/jmri.1880070314; Lam S, 2008, CLIN CANCER RES, V14, P2006, DOI 10.1158/1078-0432.CCR-07-4418; Lowder ML, 2007, J BIOMECH, V40, P445, DOI 10.1016/j.jbiomech.2005.12.019; McDonough JE, 2011, NEW ENGL J MED, V365, P1567, DOI 10.1056/NEJMoa1106955; Nadkarni SK, 2007, J AM COLL CARDIOL, V49, P1474, DOI 10.1016/j.jacc.2006.11.040; Niimi A, 2000, AM J RESP CRIT CARE, V162, P1518, DOI 10.1164/ajrccm.162.4.9909044; Noble PB, 2010, J APPL PHYSIOL, V108, P401, DOI 10.1152/japplphysiol.00511.2009; Orlandi I, 2005, RADIOLOGY, V234, P604, DOI 10.1148/radiol.2342040013; Tearney GJ, 1997, SCIENCE, V276, P2037, DOI 10.1126/science.276.5321.2037; Tsuboi M, 2005, LUNG CANCER, V49, P387, DOI 10.1016/j.lungcan.2005.04.007; Whiteman SC, 2006, CLIN CANCER RES, V12, P813, DOI 10.1158/1078-0432.CCR-05-0245; Williamson JP, 2011, AM J RESP CRIT CARE, V183, P612, DOI 10.1164/rccm.201002-0178OC	24	21	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100145	10.1371/journal.pone.0100145	http://dx.doi.org/10.1371/journal.pone.0100145			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949633	Green Published, gold, Green Submitted			2022-12-27	WOS:000338276300040
J	Winterbach, HEK; Winterbach, CW; Somers, MJ				Winterbach, Hanlie E. K.; Winterbach, Christiaan W.; Somers, Michael J.			Landscape Suitability in Botswana for the Conservation of Its Six Large African Carnivores	PLOS ONE			English	Article							LIONS PANTHERA-LEO; HUMAN-WILDLIFE CONFLICT; LIVESTOCK PREDATION; PREY PREFERENCES; MIGRATION; ECOSYSTEM; LEOPARDS; SAVANNA; COUNTS; AREA	Wide-ranging large carnivores often range beyond the boundaries of protected areas into human-dominated areas. Mapping out potentially suitable habitats on a country-wide scale and identifying areas with potentially high levels of threats to large carnivore survival is necessary to develop national conservation action plans. We used a novel approach to map and identify these areas in Botswana for its large carnivore guild consisting of lion (Panthera leo), leopard (Panthera pardus), spotted hyaena (Crocuta crocuta), brown hyaena (Hyaena brunnea), cheetah (Acinonyx jubatus) and African wild dog (Lycaon pictus). The habitat suitability for large carnivores depends primarily on prey availability, interspecific competition, and conflict with humans. Prey availability is most likely the strongest natural determinant. We used the distribution of biomass of typical wild ungulate species occurring in Botswana which is preyed upon by the six large carnivores to evaluate the potential suitability of the different management zones in the country to sustain large carnivore populations. In areas where a high biomass of large prey species occurred, we assumed interspecific competition between dominant and subordinated competitors to be high. This reduced the suitability of these areas for conservation of subordinate competitors, and vice versa. We used the percentage of prey biomass of the total prey and livestock biomass to identify areas with potentially high levels of conflict in agricultural areas. High to medium biomass of large prey was mostly confined to conservation zones, while small prey biomass was more evenly spread across large parts of the country. This necessitates different conservation strategies for carnivores with a preference for large prey, and those that can persist in the agricultural areas. To ensure connectivity between populations inside Botswana and also with its neighbours, a number of critical areas for priority management actions exist in the agricultural zones.	[Winterbach, Hanlie E. K.; Winterbach, Christiaan W.] Tau Consultants Pty Ltd, Maun, Botswana; [Winterbach, Hanlie E. K.; Winterbach, Christiaan W.; Somers, Michael J.] Univ Pretoria, Ctr Wildlife Management, ZA-0002 Pretoria, South Africa; [Somers, Michael J.] Univ Pretoria, Ctr Invas Biol, ZA-0002 Pretoria, South Africa	University of Pretoria; University of Pretoria	Winterbach, HEK (corresponding author), Tau Consultants Pty Ltd, Maun, Botswana.	tauconsultants@gmail.com	/A-1523-2008	/0000-0002-5836-8823	Botswana Wildlife Management Association; Tau Consultants; Tau Consultants (Pty) Ltd	Botswana Wildlife Management Association; Tau Consultants; Tau Consultants (Pty) Ltd	This work was supported by Botswana Wildlife Management Association and Tau Consultants. Co-authors H.E.K. Winterbach and C.W. Winterbach are employed by Tau Consultants (Pty) Ltd. Tau Consultants (Pty) Ltd provided support in the form of salaries for authors H.E.K. Winterbach and C.W. Winterbach, but did not have any additional role in the study design, data collection and analysis. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2011, 2011 POPULATION HOUS; [Anonymous], 2010, CONSULTANCY IDENTIFY; [Anonymous], 2000, BOTSWANA AERIAL SURV; [Anonymous], 2011, STATS BRIEF 2007 200; [Anonymous], 2009, BOTSWANA WATER STAT; [Anonymous], 2001, BOTSWANA NATL ATLAS; [Anonymous], 2012, STATS BRIEF BOTSWANA; Bartlam-Brooks HLA, 2011, ORYX, V45, P210, DOI 10.1017/S0030605310000414; Bauer D, 2014, CAN J ZOOL, V92, P97, DOI 10.1139/cjz-2013-0176; Bauer H, 2004, ORYX, V38, P26, DOI 10.1017/S0030605304000055; BEDIA, 2012, BEEF SECT; Bergstrom R, 1999, AFR J ECOL, V37, P12, DOI 10.1046/j.1365-2028.1999.00165.x; Boast LK, 2008, LARGE PREDATOR UNPUB; BROOKS CJ, 2005, THESIS U BRISTOL UK; Campbell A., 1981, Botswana Notes and Records, V13, P111; Chanda R, 2003, J ARID ENVIRON, V54, P425, DOI 10.1006/jare.2002.1100; Creel S, 2004, BIOLOGY AND CONSERVATION OF WILD CANIDS, P337; Darkoh M.B.K, 1999, CASE STUDIES RANGELA, P61; Frank LG, 2006, JOH E SO AFR LION CO; Fuller TK, 2001, CONSERV BIOL SER, V5, P163; Funston PJ, 2001, GT87; Gusset M, 2009, ORYX, V43, P67, DOI 10.1017/S0030605308990475; Hayward MW, 2007, BIOL CONSERV, V139, P219, DOI 10.1016/j.biocon.2007.06.018; Hayward MW, 2008, S AFR J WILDL RES, V38, P93, DOI 10.3957/0379-4369-38.2.93; Hemson G, 2003, THESIS U OXFORD UK; Hibert F, 2010, BIODIVERS CONSERV, V19, P2003, DOI 10.1007/s10531-010-9822-0; Houser A, 2009, S AFR J WILDL RES, V39, P11, DOI 10.3957/056.039.0102; IUCN Species Survival Commission, 2007, REG CONS ST IN PRESS; Jachmann H, 2002, J APPL ECOL, V39, P841, DOI 10.1046/j.1365-2664.2002.00752.x; Jefferis K, 2005, TRADE LIBERALIZATION, P32; Kent VT, 2010, THESIS DURHAM U UK; Kerth G, 2013, CONSERV GENET RESOUR, V5, P1101, DOI 10.1007/s12686-013-9979-4; Kissui BM, 2008, ANIM CONSERV, V11, P422, DOI 10.1111/j.1469-1795.2008.00199.x; Klein Rebecca, 2007, Cat News, P14; Lindsey PA, 2004, S AFR J WILDL RES, V34, P77; Marker LL, 2005, RANGELAND ECOL MANAG, V58, P329, DOI 10.2111/1551-5028(2005)058[0329:PEOLDP]2.0.CO;2; Marker LL, 2003, CONSERV BIOL, V17, P1290, DOI 10.1046/j.1523-1739.2003.02077.x; Marker LL, 2003, S AFR J WILDL RES, V33, P43; Mbaiwa J.E., 2006, INT J WILDERNESS, V12, P41; MBAIWA JE, 2006, INT J WILDERNESS, V12, P41; Mbaiwa JE, 2010, J SUSTAIN TOUR, V18, P635, DOI 10.1080/09669581003653500; McNutt JW, 2012, BIOL J LINN SOC, V105, P8, DOI 10.1111/j.1095-8312.2011.01785.x; Moleele NM, 2003, J ARID ENVIRON, V54, P405, DOI 10.1006/jare.2002.1099; Moleele NM, 2002, J ENVIRON MANAGE, V64, P3, DOI 10.1006/jema.2001.0486; Ogada MO, 2003, CONSERV BIOL, V17, P1521, DOI 10.1111/j.1523-1739.2003.00061.x; Ogara W. O., 2010, African Journal of Environmental Science and Technology, V4, P540; Ogutu JO, 2005, J ZOOL, V265, P281, DOI 10.1017/S0952836904006302; Patterson BD, 2004, BIOL CONSERV, V119, P507, DOI 10.1016/j.biocon.2004.01.013; Purchase G, 2007, CAT NEWS SI, VSI3, P44; Quinn GP, 2003, EXPT DESIGN DATA ANA; Riggio J, 2013, BIODIVERS CONSERV, V22, P17, DOI 10.1007/s10531-012-0381-4; Riginos C, 2012, PASTORALISM, V2, DOI 10.1186/2041-7136-2-10; Schiess-Meier M, 2007, J WILDLIFE MANAGE, V71, P1267, DOI 10.2193/2006-177; Valeix M, 2012, J APPL ECOL, V49, P73, DOI 10.1111/j.1365-2664.2011.02099.x; Van Bommel L, 2007, AFR J ECOL, V45, P490, DOI 10.1111/j.1365-2028.2007.00759.x; Verlinden A, 1998, AFR J ECOL, V36, P117; Wallgren M, 2009, AFR J ECOL, V47, P20, DOI 10.1111/j.1365-2028.2007.00904.x; Weilenmann M, 2010, WILDLIFE RES, V37, P702, DOI 10.1071/WR10013; WILLIAMSON D, 1988, AFR J ECOL, V26, P269, DOI 10.1111/j.1365-2028.1988.tb00979.x; WINT W, 2000, BOTSWANA AERIAL SURV; Winterbach CW, 2003, PREDATOR MA IN PRESS; Winterbach HEK, 2013, MAMMAL REV, V43, P89, DOI 10.1111/j.1365-2907.2011.00209.x; Woodroffe R, 2005, CONSERV BIOL SER, V9, P1; Woodroffe R, 2001, CONSERV BIOL SER, V5, P61; Woodroffe Rosie, 2005, P154	65	18	18	1	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100202	10.1371/journal.pone.0100202	http://dx.doi.org/10.1371/journal.pone.0100202			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949735	Green Published, gold, Green Submitted			2022-12-27	WOS:000338276300049
J	Bartlett, L; Weissman, E; Gubin, R; Patton-Molitors, R; Friberg, IK				Bartlett, Linda; Weissman, Eva; Gubin, Rehana; Patton-Molitors, Rachel; Friberg, Ingrid K.			The Impact and Cost of Scaling up Midwifery and Obstetrics in 58 Low- and Middle-Income Countries	PLOS ONE			English	Article							HEALTH; MORTALITY; BIRTH; CARE	Background and Methods: To guide achievement of the Millennium Development Goals, we used the Lives Saved Tool to provide a novel simulation of potential maternal, fetal, and newborn lives and costs saved by scaling up midwifery and obstetrics services, including family planning, in 58 low-and middle-income countries. Typical midwifery and obstetrics interventions were scaled to either 60% of the national population (modest coverage) or 99% (universal coverage). Findings: Under even a modest scale-up, midwifery services including family planning reduce maternal, fetal, and neonatal deaths by 34%. Increasing midwifery alone or integrated with obstetrics is more cost-effective than scaling up obstetrics alone; when family planning was included, the midwifery model was almost twice as cost-effective as the obstetrics model, at $2,200 versus $4,200 per death averted. The most effective strategy was the most comprehensive: increasing midwives, obstetricians, and family planning could prevent 69% of total deaths under universal scale-up, yielding a cost per death prevented of just $2,100. Within this analysis, the interventions which midwifery and obstetrics are poised to deliver most effectively are different, with midwifery benefits delivered across the continuum of pre-pregnancy, prenatal, labor and delivery, and postpartum-postnatal care, and obstetrics benefits focused mostly on delivery. Including family planning within each scope of practice reduced the number of likely births, and thus deaths, and increased the cost-effectiveness of the entire package (e. g., a 52% reduction in deaths with midwifery and obstetrics increased to 69% when family planning was added; cost decreased from $4,000 to $2,100 per death averted). Conclusions: This analysis suggests that scaling up midwifery and obstetrics could bring many countries closer to achieving mortality reductions. Midwives alone can achieve remarkable mortality reductions, particularly when they also perform family planning services - the greatest return on investment occurs with the scale-up of midwives and obstetricians together.	[Bartlett, Linda; Patton-Molitors, Rachel; Friberg, Ingrid K.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA; [Weissman, Eva] Futures Inst, New York, NY USA; [Gubin, Rehana] Jhpiego, Washington, DC USA; [Bartlett, Linda] MCHIP, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Jhpiego	Bartlett, L (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA.	lbartle4@jhu.edu			USAID [GHSA00080000200]	USAID(United States Agency for International Development (USAID))	Funding for this work came from USAID grant to JHPIEGO directed MCHIP program: Grant number GHSA00080000200; http://www.mchip.net/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	2013 WHOaU, 2013, ACC MAT NEWB CHILD S; Acharya A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S25; Amouzou A, 2010, INT J EPIDEMIOL, V39, P186, DOI 10.1093/ije/dyq034; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Friedman H, 2011, COSTS PRESERVICE MID; Frye J., 2012, INT DRUG PRIC IND GU; Fund UNP, 2011, STAT WORLDS MIDW 201; Graham W.J., 2001, SAFE MOTHERHOOD STRA, P97; Initiative UHP, 2011, LIV SAV TOOL COMP PR; Koblinsky M, 2006, LANCET, V368, P1377, DOI 10.1016/S0140-6736(06)69382-3; Lee ACC, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S10; Noakes TD, 2008, EPIDEMIOL INFECT, V136, P1, DOI 10.1017/S0950268807008746; Pasha O, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-82; Pattinson R, 2011, LANCET, V377, P1610, DOI 10.1016/S0140-6736(10)62306-9; Stover J, 2010, INT J EPIDEMIOL, V39, P7, DOI 10.1093/ije/dyq016; Taskforce on Innovative International Financing for Health Systems, 2009, MOR MON HLTH MOR HLT; ten Hoope-Bender P, 2011, INT J GYNECOL OBSTET, V114, P211, DOI 10.1016/j.ijgo.2011.06.002; The World Health Organisation (WHO), 2011, WHO CHOICE UN COST E; UNICEF, 2012, COUNTD 2015 MAT NEWB; UNICEF, UNICEF SUPPL CAT UNICEF SUPPL CAT; UNICEF W UNFPA, 1997, GUID MON AV US OBST; United Nations, 2012, MILLENNIUM DEV GOALS; Victora CG, 2010, INT J EPIDEMIOL, V39, P650, DOI 10.1093/ije/dyq097; Walker N, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S1; Walker N, 2010, INT J EPIDEMIOL, V39, P21, DOI 10.1093/ije/dyq036; Winfrey W, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S32; World Health Organization UNICEF, 2013, WHO UNICEF SET NAT I; World Health Organization (WHO), 2012, TRENDS MAT MORT 1990; World Health Organization (WHO), 2006, WORLD HLTH REP 2006	29	13	13	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e98550	10.1371/journal.pone.0098550	http://dx.doi.org/10.1371/journal.pone.0098550			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941336	Green Published, gold, Green Submitted			2022-12-27	WOS:000338508200008
J	Monecke, S; Muller, E; Buchler, J; Stieber, B; Ehricht, R				Monecke, Stefan; Mueller, Elke; Buechler, Joseph; Stieber, Bettina; Ehricht, Ralf			Staphylococcus aureus In Vitro Secretion of Alpha Toxin (hla) Correlates with the Affiliation to Clonal Complexes	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; METHICILLIN-RESISTANT; STRAINS; PNEUMONIA; VIRULENCE; MRSA; EXPRESSION; HEMOLYSIN	The alpha toxin of Staphylococcus aureus is a pore forming toxin that penetrates host cell membranes causing osmotic swelling, rupture, lysis and subsequently cell death. Haemolysin alpha is toxic to a wide range of different mammalian cells; i.e., neurotoxic, dermonecrotic, haemolytic, and it can cause lethality in a wide variety of animals. In this study, the in vitro alpha toxin production of 648 previously genotyped isolates of S. aureus was measured quantitatively using antibody microarrays. Isolates originated from medical and veterinary settings and were selected in order to represent diverse clonal complexes and defined clinical conditions. Generally, the production of alpha toxin in vitro is related to the clonal complex affiliation. For clonal complexes CC22, CC30, CC45, CC479, CC705 and others, invariably no alpha toxin production was noted under the given in vitro conditions, while others, such as CC1, CC5, CC8, CC15 or CC96 secreted variable or high levels of alpha toxin. There was no correlation between alpha toxin yield and clinical course of the disease, or between alpha toxin yield and host species.	[Monecke, Stefan; Mueller, Elke; Stieber, Bettina; Ehricht, Ralf] Alere Technol GmbH, Jena, Germany; [Monecke, Stefan; Stieber, Bettina] Tech Univ Dresden, Inst Med Microbiol & Hyg, D-01062 Dresden, Germany; [Buechler, Joseph] Alere San Diego Inc, San Diego, CA USA	Alere; Technische Universitat Dresden; Alere	Monecke, S (corresponding author), Alere Technol GmbH, Jena, Germany.	monecke@rocketmail.com						Albrecht N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028189; Anjum MF, 2006, CLIN VACCINE IMMUNOL, V13, P561, DOI 10.1128/CVI.13.5.561-567.2006; Mestre MB, 2010, AUTOPHAGY, V6, P110, DOI 10.4161/auto.6.1.10698; Chen L, 2013, J CLIN MICROBIOL, V51, P914, DOI 10.1128/JCM.03015-12; DeLeo FR, 2011, P NATL ACAD SCI USA, V108, P18091, DOI 10.1073/pnas.1111084108; Ehricht Ralf, 2009, V509, P85, DOI 10.1007/978-1-59745-372-1_6; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Holt DC, 2011, GENOME BIOL EVOL, V3, P881, DOI 10.1093/gbe/evr078; Huelseweh B, 2006, PROTEOMICS, V6, P2972, DOI 10.1002/pmic.200500721; Inoshima I, 2011, NAT MED, V17, P1310, DOI 10.1038/nm.2451; Lee MH, 2010, J INFECT DIS, V201, P508, DOI 10.1086/650204; Li M, 2010, J INFECT DIS, V202, P1866, DOI 10.1086/657419; McCormick CC, 2009, INVEST OPHTH VIS SCI, V50, P2848, DOI 10.1167/iovs.08-3157; Monecke S, 2012, EUR J CLIN MICROBIOL, V31, P1497, DOI 10.1007/s10096-011-1469-6; Monecke S, 2009, EUR J CLIN MICROBIOL, V28, P1159, DOI 10.1007/s10096-009-0752-2; Monecke S, 2013, SCREENING STAPHYLOCO; Monecke S, PLOS ONE; Monecke S, 2008, FEMS IMMUNOL MED MIC, V53, P237, DOI 10.1111/j.1574-695X.2008.00426.x; Monecke S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066166; Monecke S, 2013, J CLIN MICROBIOL, V51, P487, DOI 10.1128/JCM.02285-12; Monecke S, 2013, VET MICROBIOL, V162, P806, DOI 10.1016/j.vetmic.2012.10.018; Monecke S, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-146; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; Monecke S, 2011, VET MICROBIOL, V150, P309, DOI 10.1016/j.vetmic.2011.02.001; Monecke S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014025; Montgomery CP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015177; Nygaard TK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036532; OREILLY M, 1990, MOL MICROBIOL, V4, P1947, DOI 10.1111/j.1365-2958.1990.tb02044.x; Robinson DA, 2004, J BACTERIOL, V186, P1060, DOI 10.1128/JB.186.4.1060-1064.2004; Scicluna EA, 2010, EUR J CLIN MICROBIOL, V29, P163, DOI 10.1007/s10096-009-0834-1; Sibelius U, 2000, CIRCULATION, V101, P78, DOI 10.1161/01.CIR.101.1.78; Stieber B, 2013, MOL CELL PROBES; Tamber S, 2009, INFECT IMMUN, V77, P419, DOI 10.1128/IAI.00859-08; Wardenburg JB, 2007, NAT MED, V13, P1405, DOI 10.1038/nm1207-1405; Wardenburg JB, 2007, INFECT IMMUN, V75, P1040, DOI 10.1128/IAI.01313-06	35	23	24	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100427	10.1371/journal.pone.0100427	http://dx.doi.org/10.1371/journal.pone.0100427			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940872	Green Submitted, Green Published, gold			2022-12-27	WOS:000338508200102
J	Nyberg, C; Karlsson, T; Hillered, L; Engstrom, ER				Nyberg, Christoffer; Karlsson, Torbjorn; Hillered, Lars; Engstrom, Elisabeth Ronne			Metabolic Pattern of the Acute Phase of Subarachnoid Hemorrhage in a Novel Porcine Model: Studies with Cerebral Microdialysis with High Temporal Resolution	PLOS ONE			English	Article							EARLY BRAIN-INJURY; BLOOD-FLOW; INTRACEREBRAL MICRODIALYSIS; RAT; VASOSPASM; ARTERIES; TOMOGRAPHY; EXPRESSION; GLUTAMATE; BASAL	Background: Aneurysmal subarachnoid hemorrhage (SAH) may produce cerebral ischemia and systemic responses including stress. To study immediate cerebral and systemic changes in response to aneurysm rupture, animal models are needed. Objective: To study early cerebral energy changes in an animal model. Methods: Experimental SAH was induced in 11 pigs by autologous blood injection to the anterior skull base, with simultaneous control of intracranial and cerebral perfusion pressures. Intracerebral microdialysis was used to monitor concentrations of glucose, pyruvate and lactate. Results: In nine of the pigs, a pattern of transient ischemia was produced, with a dramatic reduction of cerebral perfusion pressure soon after blood injection, associated with a quick glucose and pyruvate decrease. This was followed by a lactate increase and a delayed pyruvate increase, producing a marked but short elevation of the lactate/pyruvate ratio. Glucose, pyruvate, lactate and lactate/pyruvate ratio thereafter returned toward baseline. The two remaining pigs had a more severe metabolic reaction with glucose and pyruvate rapidly decreasing to undetectable levels while lactate increased and remained elevated, suggesting persisting ischemia. Conclusion: The animal model simulates the conditions of SAH not only by deposition of blood in the basal cisterns, but also creating the transient global ischemic impact of aneurysmal SAH. The metabolic cerebral changes suggest immediate transient substrate failure followed by hypermetabolism of glucose upon reperfusion. The model has features that resemble spontaneous bleeding, and is suitable for future research of the early cerebral and systemic responses to SAH that are difficult to study in humans.	[Nyberg, Christoffer; Hillered, Lars; Engstrom, Elisabeth Ronne] Uppsala Univ, Neurosurg Sect, Dept Neurosci, Uppsala, Sweden; [Karlsson, Torbjorn] Uppsala Univ, Sect Anesthesiol & Intens Care, Dept Surg Sci, Uppsala, Sweden	Uppsala University; Uppsala University	Nyberg, C (corresponding author), Uppsala Univ, Neurosurg Sect, Dept Neurosci, Uppsala, Sweden.	christoffer.nyberg@neuro.uu.se		Hillered, Lars/0000-0002-2808-9292	Uppsala University Hospital	Uppsala University Hospital	The study was supported financially by Uppsala University Hospital grants for clinical research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruder N, 2011, NEUROCRIT CARE, V15, P257, DOI 10.1007/s12028-011-9598-4; Cesarini KG, 2002, ACTA NEUROCHIR, V144, P1121, DOI 10.1007/s00701-002-1011-9; Dai M, 2010, PHYSIOL MEAS, V31, P1229, DOI 10.1088/0967-3334/31/9/012; EDWARDS DH, 1992, J NEUROSURG, V76, P830, DOI 10.3171/jns.1992.76.5.0830; Enblad P, 2001, STROKE, V32, P1574, DOI 10.1161/01.STR.32.7.1574; Espiner EA, 2002, CLIN ENDOCRINOL, V56, P629, DOI 10.1046/j.1365-2265.2002.01285.x; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Hall C, 2004, EUR J HEART FAIL, V6, P257, DOI 10.1016/j.ejheart.2003.12.015; Hansen-Schwartz J, 2004, NEUROCRIT CARE, V1, P235, DOI 10.1385/NCC:1:2:235; Hansen-Schwartz J, 2003, NEUROSURGERY, V52, P1188, DOI 10.1227/01.NEU.0000058467.82442.64; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hutchinson PJ, 2000, J NEUROSURG, V93, P37, DOI 10.3171/jns.2000.93.1.0037; Lee JY, 2009, NEUROSURGERY, V65, P331, DOI 10.1227/01.NEU.0000345649.78556.26; Marbacher S, 2012, J NEUROSCI METH, V208, P138, DOI 10.1016/j.jneumeth.2012.05.010; Marbacher S, 2010, J NEUROSCI METH, V191, P227, DOI 10.1016/j.jneumeth.2010.07.004; Marbacher S, 2010, BRIT J NEUROSURG, V24, P415, DOI 10.3109/02688691003746274; Mollmann H, 2010, INT J CARDIOL, V143, P289, DOI 10.1016/j.ijcard.2009.03.012; Morgan CJ, 2004, J NEUROSURG, V101, P1026, DOI 10.3171/jns.2004.101.6.1026; Nordgren A, 2006, ACTA ANAESTH SCAND, V50, P840, DOI 10.1111/j.1399-6576.2006.01071.x; Prunell GF, 2004, NEUROSURGERY, V54, P426, DOI 10.1227/01.NEU.0000103670.09687.7A; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; Ronne-Engstrom E, 2001, J NEUROSURG, V94, P397, DOI 10.3171/jns.2001.94.3.0397; RONNEENGSTROM E, 1995, J NEUROCHEM, V65, P257; SALAR G, 1992, ACTA NEUROCHIR, V119, P115, DOI 10.1007/BF01541794; Schubert GA, 2008, J NEUROTRAUM, V25, P539, DOI 10.1089/neu.2007.0500; Westermaier T, 2011, NEUROSURGERY, V68, P223, DOI 10.1227/NEU.0b013e3181fe23c1; Wu CT, 2011, ANESTH ANALG, V112, P666, DOI 10.1213/ANE.0b013e318207c51f; Zetterling M, 2011, BRIT J NEUROSURG, V25, P684, DOI 10.3109/02688697.2011.584638; Zetterling M, 2010, NEUROSURGERY, V66, P1102, DOI 10.1227/01.NEU.0000370893.04586.73; Zhou YL, 2011, ACTA NEUROCHIR SUPPL, V110, P15, DOI 10.1007/978-3-7091-0353-1_3	30	5	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99904	10.1371/journal.pone.0099904	http://dx.doi.org/10.1371/journal.pone.0099904			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940881	Green Published, Green Submitted, gold			2022-12-27	WOS:000338508200053
J	Chen, J; Pan, HN; Chen, C; Wu, W; Iskandar, K; He, J; Piermartiri, T; Jacobowitz, DM; Yu, QS; McDonough, JH; Greig, NH; Marini, AM				Chen, Jun; Pan, Hongna; Chen, Cynthia; Wu, Wei; Iskandar, Kevin; He, Jeffrey; Piermartiri, Tetsade; Jacobowitz, David M.; Yu, Qian-Sheng; McDonough, John H.; Greig, Nigel H.; Marini, Ann M.			(-)-Phenserine Attenuates Soman-Induced Neuropathology	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; SUBWAY SARIN ATTACK; POSTTRAUMATIC-STRESS-DISORDER; ORGANOPHOSPHORUS NERVE AGENTS; ALZHEIMERS-DISEASE; INDUCED SEIZURES; ACETYLCHOLINESTERASE INHIBITION; CHOLINESTERASE-INHIBITORS; TRANSCRIPTION FACTOR; NEURONAL SURVIVAL	Organophosphorus (OP) nerve agents are deadly chemical weapons that pose an alarming threat to military and civilian populations. The irreversible inhibition of the critical cholinergic degradative enzyme acetylcholinesterase (AChE) by OP nerve agents leads to cholinergic crisis. Resulting excessive synaptic acetylcholine levels leads to status epilepticus that, in turn, results in brain damage. Current countermeasures are only modestly effective in protecting against OP-induced brain damage, supporting interest for evaluation of new ones. (-)-Phenserine is a reversible AChE inhibitor possessing neuroprotective and amyloid precursor protein lowering actions that reached Phase III clinical trials for Alzheimer's Disease where it exhibited a wide safety margin. This compound preferentially enters the CNS and has potential to impede soman binding to the active site of AChE to, thereby, serve in a protective capacity. Herein, we demonstrate that (-)-phenserine protects neurons against soman-induced neuronal cell death in rats when administered either as a pretreatment or post-treatment paradigm, improves motoric movement in soman-exposed animals and reduces mortality when given as a pretreatment. Gene expression analysis, undertaken to elucidate mechanism, showed that (-)-phenserine pretreatment increased select neuroprotective genes and reversed a Homer1expression elevation induced by soman exposure. These studies suggest that (-)-phenserine warrants further evaluation as an OP nerve agent protective strategy.	[Chen, Jun; Pan, Hongna; Chen, Cynthia; Wu, Wei; Iskandar, Kevin; He, Jeffrey; Piermartiri, Tetsade; Marini, Ann M.] Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA; [Jacobowitz, David M.] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA; [Yu, Qian-Sheng; Greig, Nigel H.] NIA, Drug Design & Dev Sect, Translat Gerontol Branch, Intramural Res Program,NIH, Baltimore, MD 21224 USA; [McDonough, John H.] US Army Med Res Inst Chem Def, Pharmacol Branch, Div Res, Aberdeen Proving Ground, MD USA	Uniformed Services University of the Health Sciences - USA; Uniformed Services University of the Health Sciences - USA; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); United States Department of Defense; United States Army	Marini, AM (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA.	ann.marini@usuhs.edu	McDonough, John/AAJ-9213-2021	Piermartiri, Tetsade/0000-0002-9773-6983	Defense Threat Reduction Agency-Joint Science and Technology Office, Medical ST Division [CBM.NEURO.01.10.US.012, CBM.NEURO.01.10.US.019]; Intramural Research Program, National Institute on Aging, National Institutes of Health; NATIONAL INSTITUTE ON AGING [ZIAAG000311] Funding Source: NIH RePORTER	Defense Threat Reduction Agency-Joint Science and Technology Office, Medical ST Division(United States Department of DefenseDefense Threat Reduction Agency); Intramural Research Program, National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by Defense Threat Reduction Agency-Joint Science and Technology Office, Medical S&T Division [Grant Numbers CBM.NEURO.01.10.US.012 and CBM.NEURO.01.10.US.019] (AMM); Intramural Research Program, National Institute on Aging, National Institutes of Health (NHG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Jafari AA, 1998, BIOCHEM BIOPH RES CO, V248, P180, DOI 10.1006/bbrc.1998.8931; Albuquerquet EX, 2006, P NATL ACAD SCI USA, V103, P13220, DOI 10.1073/pnas.0605370103; Alkondon M, 2009, J PHARMACOL EXP THER, V328, P69, DOI 10.1124/jpet.108.146068; ASTHANA S, 1995, CLIN PHARMACOL THER, V58, P299, DOI 10.1016/0009-9236(95)90246-5; Bajgar J, 1991, Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove, V34, P5; Bajgar J, 2004, INHAL TOXICOL, V16, P497, DOI 10.1080/08958370490442430; Bajgar J, 2004, ADV CLIN CHEM, V38, P151, DOI 10.1016/S0065-2423(04)38006-6; Bajgar Jiri, 2005, Acta Medica (Hradec Kralove), V48, P3; Bamforth SD, 2001, NAT GENET, V29, P469, DOI 10.1038/ng768; Becker RE, 2013, ALZHEIMERS DEMENT, V9, P50, DOI 10.1016/j.jalz.2012.01.007; Brown MA, 1998, J APPL TOXICOL, V18, P393, DOI 10.1002/(SICI)1099-1263(199811/12)18:6<393::AID-JAT528>3.0.CO;2-0; Buckley NA, 2004, J TOXICOL-CLIN TOXIC, V42, P113, DOI 10.1081/CLT-120028756; Carpentier P, 2008, TOXICOLOGY, V253, P97, DOI 10.1016/j.tox.2008.08.016; Chen J, 2011, DOSE-RESPONSE, V9, P416, DOI 10.2203/dose-response.10-041.Marini; Chen Y, 2012, NEUROTOXICOLOGY, V33, P391, DOI 10.1016/j.neuro.2012.03.011; Cho Y, 2012, ENVIRON TOXICOL PHAR, V33, P1, DOI 10.1016/j.etap.2011.10.002; Darreh-Shori T, 2014, J ALZHEIMERS DIS, V39, P423, DOI 10.3233/JAD-130845; Darvesh S, 2003, NAT REV NEUROSCI, V4, P131, DOI 10.1038/nrn1035; de la Monte SM, 2003, LAB INVEST, V83, P287, DOI 10.1097/01.LAB.0000056995.07053.C0; Dijkmans TF, 2009, BRAIN RES, V1249, P19, DOI 10.1016/j.brainres.2008.10.050; Dillman JF, 2009, CHEM RES TOXICOL, V22, P633, DOI 10.1021/tx800466v; Dolgin E, 2013, NAT MED, V19, P1194, DOI 10.1038/nm1013-1194; Eljaschewitsch E, 2006, NEURON, V49, P67, DOI 10.1016/j.neuron.2005.11.027; Fritsch B, 2009, NEUROSCIENCE, V163, P415, DOI 10.1016/j.neuroscience.2009.06.034; Geerts H, 2005, BRAIN RES, V1033, P186, DOI 10.1016/j.brainres.2004.11.042; Grahn H., 2004, SE90182 UMEA SWED DE; Greig NH, 2005, P NATL ACAD SCI USA, V102, P17213, DOI 10.1073/pnas.0508575102; Greig NH, 2000, ACTA NEUROL SCAND, V102, P74, DOI 10.1034/j.1600-0404.2000.00311.x; GREIG NH, 1995, MED RES REV, V15, P3, DOI 10.1002/med.2610150103; Greig Nigel H., 2005, Current Alzheimer Research, V2, P483, DOI 10.2174/156720505774330564; Greig Nigel H., 2005, Current Alzheimer Research, V2, P281, DOI 10.2174/1567205054367829; GRUNWALD J, 1994, LIFE SCI, V54, P991, DOI 10.1016/0024-3205(94)00501-X; Ikushima S, 1997, P NATL ACAD SCI USA, V94, P2609, DOI 10.1073/pnas.94.6.2609; ISAACS KR, 1994, EXP BRAIN RES, V99, P34; Israelsson C, 2008, J NEUROTRAUM, V25, P959, DOI 10.1089/neu.2008.0562; Johnson EA, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-41; Joosen MJA, 2011, ARCH TOXICOL, V85, P227, DOI 10.1007/s00204-010-0571-3; Joosen MJA, 2009, NEUROTOXICOLOGY, V30, P72, DOI 10.1016/j.neuro.2008.11.010; Junghans D, 2004, DEVELOPMENT, V131, P4425, DOI 10.1242/dev.01313; Kadir A, 2008, ANN NEUROL, V63, P621, DOI 10.1002/ana.21345; Kassa J, 2001, Acta Medica (Hradec Kralove), V44, P21; Khan S, 2004, BRAIN RES, V1016, P48, DOI 10.1016/j.brainres.2004.04.062; Kuijpers M, 2010, J NEUROIMMUNOL, V229, P73, DOI 10.1016/j.jneuroim.2010.07.004; Lahiri DK, 2007, J PHARMACOL EXP THER, V320, P386, DOI 10.1124/jpet.106.112102; LALLEMENT G, 1991, BRAIN RES, V563, P234, DOI 10.1016/0006-8993(91)91539-D; Lallement G, 1997, FUNDAM CLIN PHARM, V11, P387, DOI 10.1111/j.1472-8206.1997.tb00200.x; Lilja AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058752; Lilja AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054887; Maccecchini ML, 2012, J NEUROL NEUROSUR PS, V83, P894, DOI 10.1136/jnnp-2012-302589; Marutle A, 2007, P NATL ACAD SCI USA, V104, P12506, DOI 10.1073/pnas.0705346104; MCDONOUGH JH, 1986, NEUROBEH TOXICOL TER, V8, P179; McDonough JH, 1997, NEUROSCI BIOBEHAV R, V21, P559, DOI 10.1016/S0149-7634(96)00050-4; MCDONOUGH JH, 1993, NEUROSCI BIOBEHAV R, V17, P203, DOI 10.1016/S0149-7634(05)80151-4; Midorikawa R, 2006, CELL, V125, P371, DOI 10.1016/j.cell.2006.02.039; Mikkilineni S, 2012, PARKINSONS DIS-US, V2012, DOI 10.1155/2012/142372; Miyaki K, 2005, J OCCUP HEALTH, V47, P299, DOI 10.1539/joh.47.299; MORITA H, 1995, LANCET, V346, P290; Morris MA, 2004, CURR MOL MED, V4, P431, DOI 10.2174/1566524043360609; Myers TM, 2011, NEUROTOXICOLOGY, V32, P342, DOI 10.1016/j.neuro.2011.03.001; Myhrer T, 2005, NEUROTOXICOLOGY, V26, P39, DOI 10.1016/j.neuro.2004.07.011; Ness JM, 2008, J NEUROSCI RES, V86, P1115, DOI 10.1002/jnr.21573; Newmark J, 2007, NEUROLOGIST, V13, P20, DOI 10.1097/01.nrl.0000252923.04894.53; Nishiwaki Y, 2001, ENVIRON HEALTH PERSP, V109, P1169, DOI 10.2307/3454865; Okumura T, 1996, ANN EMERG MED, V28, P129, DOI 10.1016/S0196-0644(96)70052-5; Pan HN, 2012, NEUROTOXICOLOGY, V33, P1219, DOI 10.1016/j.neuro.2012.07.001; Romano J A Jr, 2001, Mil Med, V166, P21; Schultz MK, 2012, TOXICOL APPL PHARM, V259, P376, DOI 10.1016/j.taap.2012.01.017; Shaw KTY, 2001, P NATL ACAD SCI USA, V98, P7605, DOI 10.1073/pnas.131152998; Shih TM, 1999, PHARMACOL BIOCHEM BE, V64, P147, DOI 10.1016/S0091-3057(99)00114-8; Shih TM, 2003, TOXICOL APPL PHARM, V188, P69, DOI 10.1016/S0041-008X(03)00019-X; Shih TM, 2010, CHEM-BIOL INTERACT, V187, P207, DOI 10.1016/j.cbi.2010.03.006; Shin JN, 2009, EXP CELL RES, V315, P2249, DOI 10.1016/j.yexcr.2009.04.004; Speer RE, 2013, FREE RADICAL BIO MED, V62, P26, DOI 10.1016/j.freeradbiomed.2013.01.026; Tan YW, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-48; Taylor DM, 2013, J NEUROSCI, V33, P2313, DOI 10.1523/JNEUROSCI.4965-11.2013; Tonduli LS, 2001, NEUROTOXICOLOGY, V22, P29, DOI 10.1016/S0161-813X(00)00015-2; U.S. Department of Health and Human Services Food and Drug Administration. Center for Drug Evaluation and Research (CDER), GUID IND EST MAX STA; Wang Y, 2013, CHEM-BIOL INTERACT, V203, P120, DOI 10.1016/j.cbi.2012.10.016; Winblad B, 2010, J ALZHEIMERS DIS, V22, P1201, DOI 10.3233/JAD-2010-101311; WONG ML, 1995, NEUROREPORT, V6, P1785, DOI 10.1097/00001756-199509000-00019; Wu XM, 2012, J MOL NEUROSCI, V47, P357, DOI 10.1007/s12031-012-9761-1; Yamasue H, 2003, P NATL ACAD SCI USA, V100, P9039, DOI 10.1073/pnas.1530467100; Yamasue H, 2007, ANN NEUROL, V61, P37, DOI 10.1002/ana.21024; Yokoyama K, 1998, ARCH ENVIRON HEALTH, V53, P249, DOI 10.1080/00039899809605705; Yu Qian-sheng, 2013, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, V12, P117; Yu QS, 1997, J MED CHEM, V40, P2895, DOI 10.1021/jm970210v; Zhang SJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000604; Zhao Y, 2007, ACTA PHARMACOL SIN, V28, P273, DOI 10.1111/j.1745-7254.2007.00486.x	88	11	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e99818	10.1371/journal.pone.0099818	http://dx.doi.org/10.1371/journal.pone.0099818			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955574	gold, Green Submitted, Green Published			2022-12-27	WOS:000338917900019
J	Siemons, L; ten Klooster, PM; Vonkeman, HE; van de Laar, MAFJ; Glas, CAW				Siemons, Liseth; ten Klooster, Peter M.; Vonkeman, Harald E.; van de laar, Mart A. F. J.; Glas, Cees A. W.			Further Optimization of the Reliability of the 28-Joint Disease Activity Score in Patients with Early Rheumatoid Arthritis	PLOS ONE			English	Article							ITEM RESPONSE THEORY; 28 JOINTS DAS28; AMERICAN-COLLEGE; CLINICAL-TRIALS; REMISSION; FIBROMYALGIA; ASSOCIATION; DEFINITION; PHYSICIANS; HEALTH	Background: The 28-joint Disease Activity Score (DAS28) combines scores on a 28-tender and swollen joint count (TJC28 and SJC28), a patient-reported measure for general health (GH), and an inflammatory marker (either the erythrocyte sedimentation rate [ESR] or the C-reactive protein [CRP]) into a composite measure of disease activity in rheumatoid arthritis (RA). This study examined the reliability of the DAS28 in patients with early RA using principles from generalizability theory and evaluated whether it could be increased by adjusting individual DAS28 component weights. Methods: Patients were drawn from the DREAM registry and classified into a "fast response'' group (N = 466) and "slow response'' group (N = 80), depending on their pace of reaching remission. Composite reliabilities of the DAS28-ESR and DAS28-CRP were determined with the individual components' reliability, weights, variances, error variances, correlations and covariances. Weight optimization was performed by minimizing the error variance of the index. Results: Composite reliabilities of 0.85 and 0.86 were found for the DAS28-ESR and DAS28-CRP, respectively, and were approximately equal across patients groups. Component reliabilities, however, varied widely both within and between subgroups, ranging from 0.614 for GH ("slow response'' group) to 0.912 for ESR ("fast response'' group). Weight optimization increased composite reliability even further. In the total and "fast response'' groups, this was achieved mostly by decreasing the weight of the TJC28 and GH. In the "slow response'' group, though, the weights of the TJC28 and SJC28 were increased, while those of the inflammatory markers and GH were substantially decreased. Conclusions: The DAS28-ESR and the DAS28-CRP are reliable instruments for assessing disease activity in early RA and reliability can be increased even further by adjusting component weights. Given the low reliability and weightings of the general health component across subgroups it is recommended to explore alternative patient-reported outcome measures for inclusion in the DAS28.	[Siemons, Liseth; ten Klooster, Peter M.; Vonkeman, Harald E.; van de laar, Mart A. F. J.] Univ Twente, Dept Psychol Hlth & Technol, Arthrit Ctr Twente, NL-7500 AE Enschede, Netherlands; [Vonkeman, Harald E.; van de laar, Mart A. F. J.] Med Spectrum Twente, Dept Rheumatol, Arthrit Ctr Twente, Enschede, Netherlands; [Glas, Cees A. W.] Univ Twente, Dept Res Methodol Measurement & Data Anal, NL-7500 AE Enschede, Netherlands	University of Twente; Medical Spectrum Twente; University of Twente	Siemons, L (corresponding author), Univ Twente, Dept Psychol Hlth & Technol, Arthrit Ctr Twente, POB 217, NL-7500 AE Enschede, Netherlands.	L.siemons@utwente.nl	Klooster, Peter M. ten/D-2905-2009	Klooster, Peter M. ten/0000-0002-2565-5439				Albers CJ, 2011, J MULTIVARIATE ANAL, V102, P698, DOI 10.1016/j.jmva.2009.12.018; Albers CJ, 2011, J MULTIVARIATE ANAL, V102; Brennan RL, 1992, INSTRUCTIONAL TOPICS, V11, P225; Cheung PP, SEMIN ARTHR IN PRESS; Coury F, 2009, J RHEUMATOL, V36, P58, DOI 10.3899/jrheum.080366; Crosby RA., 2006, RES METHODS HLTH PRO; Felson DT, 2011, ARTHRITIS RHEUM-US, V63, P573, DOI 10.1002/art.30129; FELSON DT, 1993, ARTHRITIS RHEUM-US, V36, P729, DOI 10.1002/art.1780360601; Firestein GS, 2009, KELLYS TXB RHEUMATOL; FRIES JF, 1980, ARTHRITIS RHEUM, V23, P137, DOI 10.1002/art.1780230202; Fries JF, 2005, CLIN EXP RHEUMATOL, V23, pS53; He Q., 2009, ESTIMATING RELIABILI; Khan NA, 2012, ARTHRIT CARE RES, V64, P206, DOI 10.1002/acr.20685; Kievit W, 2006, ARTHRIT RHEUM-ARTHR, V55, P745, DOI 10.1002/art.22225; Kirwan JR, 2007, J RHEUMATOL, V34, P1174; KUSHNER I, 1991, ARTHRITIS RHEUM, V34, P1065, DOI 10.1002/art.1780340819; Lassere MND, 2001, J RHEUMATOL, V28, P892; Leeb BF, 2005, ARTHRIT RHEUM-ARTHR, V53, P56, DOI 10.1002/art.20923; Leeb BF, 2004, RHEUMATOLOGY, V43, P1504, DOI 10.1093/rheumatology/keh322; Leeb BF, 2009, JOINT BONE SPINE, V76, P658, DOI 10.1016/j.jbspin.2009.04.001; Lord F. M., 1968, STAT THEORIES MENTAL; Marhadour T, 2010, J RHEUMATOL, V37, P932, DOI 10.3899/jrheum.090879; Markenson JA, 2013, JCR-J CLIN RHEUMATOL, V19, P317, DOI 10.1097/RHU.0b013e3182a2164f; Mosier CI, 1943, PSYCHOMETRIKA, V8, P161, DOI 10.1007/BF02288700; Pincus T, 2008, BULL HOSP JT DIS, V66, P216; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Salaffi F, 2009, CLIN EXP RHEUMATOL, V27, P552; Siemons L, ARTHRITIS C IN PRESS; Siemons L, 2013, ARTHRIT CARE RES, V65, P212, DOI 10.1002/acr.21795; Siemons L, 2011, J RHEUMATOL, V38, P2557, DOI 10.3899/jrheum.110436; Soubrier M, 2006, J RHEUMATOL, V33, P1243; Studenic P, 2012, ARTHRITIS RHEUM-US, V64, P2814, DOI 10.1002/art.34543; Tennant A, 2007, ARTHRIT RHEUM-ARTHR, V57, P1358, DOI 10.1002/art.23108; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; van Riel PLCM, 2004, EULAR HDB CLIN ASSES; Vermeer M, 2012, RHEUMATOLOGY, V51, P1076, DOI 10.1093/rheumatology/ker425; Vermeer M, 2011, ARTHRITIS RHEUM-US, V63, P2865, DOI 10.1002/art.30494; Ware Jr JE, 2001, SCORE VERSION 2 SF 3; Wolfe F, 1997, AM J MED, V103, P12	39	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100544	10.1371/journal.pone.0100544	http://dx.doi.org/10.1371/journal.pone.0100544			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955759	Green Published, Green Submitted, gold			2022-12-27	WOS:000338917900065
J	Ng, LC; Kanyanganzi, F; Munyanah, M; Mushashi, C; Betancourt, TS				Ng, Lauren C.; Kanyanganzi, Frederick; Munyanah, Morris; Mushashi, Christine; Betancourt, Theresa S.			Developing and Validating the Youth Conduct Problems Scale-Rwanda: A Mixed Methods Approach	PLOS ONE			English	Article							STUDIES DEPRESSION SCALE; MENTAL-HEALTH PROBLEMS; INCOME COUNTRIES; DISORDER; ADOLESCENTS; CHILDREN; PREVALENCE; CHILDHOOD; GENDER; ONSET	This study developed and validated the Youth Conduct Problems Scale-Rwanda (YCPS-R). Qualitative free listing (n = 74) and key informant interviews (n = 47) identified local conduct problems, which were compared to existing standardized conduct problem scales and used to develop the YCPS-R. The YCPS-R was cognitive tested by 12 youth and caregiver participants, and assessed for test-retest and inter-rater reliability in a sample of 64 youth. Finally, a purposive sample of 389 youth and their caregivers were enrolled in a validity study. Validity was assessed by comparing YCPS-R scores to conduct disorder, which was diagnosed with the Mini International Neuropsychiatric Interview for Children, and functional impairment scores on the World Health Organization Disability Assessment Schedule Child Version. ROC analyses assessed the YCPS-R's ability to discriminate between youth with and without conduct disorder. Qualitative data identified a local presentation of youth conduct problems that did not match previously standardized measures. Therefore, the YCPS-R was developed solely from local conduct problems. Cognitive testing indicated that the YCPS-R was understandable and required little modification. The YCPS-R demonstrated good reliability, construct, criterion, and discriminant validity, and fair classification accuracy. The YCPS-R is a locally-derived measure of Rwandan youth conduct problems that demonstrated good psychometric properties and could be used for further research.	[Ng, Lauren C.] Harvard Univ, Sch Publ Hlth, FXB Ctr Hlth & Human Rights, Boston, MA 02115 USA; [Kanyanganzi, Frederick; Munyanah, Morris; Mushashi, Christine] Partners Hlth Inshuti Mu Buzima, Rwinkwavu, Rwanda; [Betancourt, Theresa S.] Harvard Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Betancourt, TS (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Global Hlth, 665 Huntington Ave, Boston, MA 02115 USA.	Theresa_Betancourt@harvard.edu			National Institute of Mental Health [1K01MH07724601 A2, 1R34MH084679-01 A1, R34MH084679-03S1]; Harvard Center for the Developing Child; Julie Henry Development Fund; FXB Center for Health and Human Rights; Peter C. Alderman Foundation; Julie Henry Faculty Development Fund; NATIONAL INSTITUTE OF MENTAL HEALTH [R34MH084679] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Harvard Center for the Developing Child; Julie Henry Development Fund; FXB Center for Health and Human Rights; Peter C. Alderman Foundation; Julie Henry Faculty Development Fund; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by the Peter C. Alderman Foundation, the Harvard Center for the Developing Child, and the Julie Henry Faculty Development Fund. This publication was supported by grants 1K01MH07724601 A2, 1R34MH084679-01 A1 and R34MH084679-03S1 from the National Institute of Mental Health, the Harvard Center for the Developing Child, the Julie Henry Development Fund, and the FXB Center for Health and Human Rights. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Angold A, 1999, J AM ACAD CHILD PSY, V38, P129, DOI 10.1097/00004583-199902000-00011; Benjet C, 2010, CURR OPIN PSYCHIATR, V23, P356, DOI 10.1097/YCO.0b013e32833ad79b; Betancourt T, 2012, J AM ACAD CHILD PSY, V51, P1284, DOI 10.1016/j.jaac.2012.09.003; Betancourt TS, 2011, AIDS CARE, V23, P401, DOI 10.1080/09540121.2010.516333; Bolton P, 2001, J NERV MENT DIS, V189, P238, DOI 10.1097/00005053-200104000-00005; Boyle MH, 1991, CANADIAN J PSYCHIAT; Brislin RW, 1970, J CROSS CULT PSYCHOL, V1, P158; Brown LK, 2010, J CONSULT CLIN PSYCH, V78, P590, DOI 10.1037/a0019632; Canino G, 2010, SOC PSYCH PSYCH EPID, V45, P695, DOI 10.1007/s00127-010-0242-y; Chen XJ, 2007, J INTERPERS VIOLENCE, V22, P1156, DOI 10.1177/0886260507303731; Cortina MA, 2012, ARCH PEDIAT ADOL MED, V166, P276, DOI 10.1001/archpediatrics.2011.592; Courtois CA, 2008, PSYCHOL TRAUMA S, VS, P86; Daud A, 2005, INT J SOC WELF, V14, P23, DOI 10.1111/j.1468-2397.2005.00336.x; Doku Paul Narh, 2009, Int J Ment Health Syst, V3, P26, DOI 10.1186/1752-4458-3-26; FENDRICH M, 1990, AM J EPIDEMIOL, V131, P538, DOI 10.1093/oxfordjournals.aje.a115529; GIACONIA RM, 1995, J AM ACAD CHILD PSY, V34, P1369, DOI 10.1097/00004583-199510000-00023; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HINSHAW SP, 1992, J CONSULT CLIN PSYCH, V60, P893, DOI 10.1037/0022-006X.60.6.893; Jayawickreme N, 2012, PSYCHOL ASSESSMENT, V24, P791, DOI 10.1037/a0027564; Kessler RC, 2007, WORLD PSYCHIATRY, V6, P168; Kleinman A., 1988, RETHINKING PSYCHIAT; KOVACS M, 1994, J AM ACAD CHILD PSY, V33, P106, DOI 10.1097/00004583-199401000-00014; KOVACS M, 1988, J AFFECT DISORDERS, V15, P205, DOI 10.1016/0165-0327(88)90018-3; Lee J, 2012, CONDUCTING COGNITIVE; Lester P, 2006, VULNERABLE CHILD YOU, V1, P81, DOI 10.1080/17450120600659028; Makame V, 2002, ACTA PAEDIATR, V91, P459, DOI 10.1080/080352502317371724; Maughan B, 2004, J CHILD PSYCHOL PSYC, V45, P609, DOI 10.1111/j.1469-7610.2004.00250.x; Ministry of Gender Family Promotion, 2008, SIT AN ORPH OTH VULN; Murphy DA, 2006, J DEV BEHAV PEDIATR, V27, P386, DOI 10.1097/00004703-200610000-00004; Murray CJL, 1996, GLOBAL BURDEN DIS IN, V1; Patel V, 2008, J CHILD PSYCHOL PSYC, V49, P313, DOI 10.1111/j.1469-7610.2007.01824.x; Scorza P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057725; Seedat S, 2009, ARCH GEN PSYCHIAT, V66, P785, DOI 10.1001/archgenpsychiatry.2009.36; Sheehan D., 2009, MINI INT NEUROPSYCHI; SPSS I., 2009, PASW STAT WIND; Tramontina S, 2001, CAN J PSYCHIAT, V46, P941, DOI 10.1177/070674370104601006; UNAIDS, 2012, COUNTR PROGR REP RWA; Whitmore EA, 1997, DRUG ALCOHOL DEPEN, V47, P87, DOI 10.1016/S0376-8716(97)00074-4; WINDLE M, 1990, J ABNORM PSYCHOL, V99, P86, DOI 10.1037/0021-843X.99.1.86; Wolff JC, 2006, CLIN CHILD FAM PSYCH, V9, P201, DOI 10.1007/s10567-006-0011-3; ZOCCOLILLO M, 1991, J AM ACAD CHILD PSY, V30, P973, DOI 10.1097/00004583-199111000-00016	42	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100549	10.1371/journal.pone.0100549	http://dx.doi.org/10.1371/journal.pone.0100549			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK2UZ	24949628	Green Submitted, Green Published, gold			2022-12-27	WOS:000338276300088
J	Hager, HA; Sinasac, SE; Gedalof, Z; Newman, JA				Hager, Heather A.; Sinasac, Sarah E.; Gedalof, Ze'ev; Newman, Jonathan A.			Predicting Potential Global Distributions of Two Miscanthus Grasses: Implications for Horticulture, Biofuel Production, and Biological Invasions	PLOS ONE			English	Article							WILL CLIMATE-CHANGE; X GIGANTEUS; SPECIES DISTRIBUTION; C-4 PHOTOSYNTHESIS; COLD TOLERANCE; SINENSIS; RISK; GENOTYPES; SUCCESS; NICHE	In many regions, large proportions of the naturalized and invasive non-native floras were originally introduced deliberately by humans. Pest risk assessments are now used in many jurisdictions to regulate the importation of species and usually include an estimation of the potential distribution in the import area. Two species of Asian grass (Miscanthus sacchariflorus and M. sinensis) that were originally introduced to North America as ornamental plants have since escaped cultivation. These species and their hybrid offspring are now receiving attention for large-scale production as biofuel crops in North America and elsewhere. We evaluated their potential global climate suitability for cultivation and potential invasion using the niche model CLIMEX and evaluated the models' sensitivity to the parameter values. We then compared the sensitivity of projections of future climatically suitable area under two climate models and two emissions scenarios. The models indicate that the species have been introduced to most of the potential global climatically suitable areas in the northern but not the southern hemisphere. The more narrowly distributed species (M. sacchariflorus) is more sensitive to changes in model parameters, which could have implications for modelling species of conservation concern. Climate projections indicate likely contractions in potential range in the south, but expansions in the north, particularly in introduced areas where biomass production trials are under way. Climate sensitivity analysis shows that projections differ more between the selected climate change models than between the selected emissions scenarios. Local-scale assessments are required to overlay suitable habitat with climate projections to estimate areas of cultivation potential and invasion risk.	[Hager, Heather A.; Sinasac, Sarah E.; Newman, Jonathan A.] Univ Guelph, Sch Environm Sci, Guelph, ON N1G 2W1, Canada; [Gedalof, Ze'ev] Univ Guelph, Dept Geog, Guelph, ON N1G 2W1, Canada	University of Guelph; University of Guelph	Hager, HA (corresponding author), Univ Guelph, Sch Environm Sci, Guelph, ON N1G 2W1, Canada.	hhager@uoguelph.ca	Hager, Heather/A-2984-2014; Newman, Jonathan/A-5932-2008	Hager, Heather/0000-0002-0066-6844; Newman, Jonathan/0000-0003-3155-4084	Ontario Ministry of Agriculture and Food and Ministry of Rural Affairs [027167]; Mitacs Elevate post-doctoral fellowship; Natural Sciences and Engineering Research Council of Canada	Ontario Ministry of Agriculture and Food and Ministry of Rural Affairs; Mitacs Elevate post-doctoral fellowship; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This research was funded by the Ontario Ministry of Agriculture and Food and Ministry of Rural Affairs (project 027167, www.omafra.gov.on.ca), a Mitacs Elevate post-doctoral fellowship (www.mitacs.ca), and the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MB, 2012, ECOLOGY, V93, P1527, DOI 10.1890/11-1930.1; Atkinson CJ, 2009, BIOMASS BIOENERG, V33, P752, DOI 10.1016/j.biombioe.2009.01.005; Baker R. H. A., 2012, Bulletin OEPP, V42, P65, DOI [10.1111/j.1365-2338.2012.02545.x, 10.1111/epp.2545]; Barney JN, 2008, BIOSCIENCE, V58, P64, DOI 10.1641/B580111; Barney JN, 2010, BIOMASS BIOENERG, V34, P124, DOI 10.1016/j.biombioe.2009.10.009; BEERLING DJ, 1995, J VEG SCI, V6, P269, DOI 10.2307/3236222; Bellard C, 2013, GLOBAL CHANGE BIOL, V19, P3740, DOI 10.1111/gcb.12344; Bourdot GW, 2012, BIOL INVASIONS, V14, P1545, DOI 10.1007/s10530-010-9905-6; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; Chapman SC, 2012, CROP PASTURE SCI, V63, P251, DOI 10.1071/CP11303; Clifton-Brown JC, 2000, NEW PHYTOL, V148, P287, DOI 10.1046/j.1469-8137.2000.00764.x; Clifton-Brown JC, 2002, NEW PHYTOL, V154, P335, DOI 10.1046/j.1469-8137.2002.00381.x; Clifton-Brown JC, 2001, AGRON J, V93, P1013, DOI 10.2134/agronj2001.9351013x; Commonwealth Scientific and Industrial Research Organisation, 2004, DYM SIM APPL 2 0; Daubenmire RF, 1974, PLANTS ENV TXB PLANT; Dore WG, 1980, AGR CANADA MONOGRAPH, V26; Dougherty RF, 2014, INVASIVE PL IN PRESS, V7; Dukes JS, 1999, TRENDS ECOL EVOL, V14, P135, DOI 10.1016/S0169-5347(98)01554-7; Ewel JJ, 1999, BIOSCIENCE, V49, P619, DOI 10.2307/1313438; Farage PK, 2006, PLANT CELL ENVIRON, V29, P720, DOI 10.1111/j.1365-3040.2005.01460.x; Farrell AD, 2006, ANN APPL BIOL, V149, P337, DOI 10.1111/j.1744-7348.2006.00099.x; Flory SL, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/4/045904; Gallagher RV, 2010, J ECOL, V98, P790, DOI 10.1111/j.1365-2745.2010.01677.x; Gordon DR, 2008, CONSERV LETT, V1, P227, DOI 10.1111/j.1755-263X.2008.00032.x; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Guo QF, 2012, BIOL INVASIONS, V14, P547, DOI 10.1007/s10530-011-0094-8; Hastings A, 2009, GCB BIOENERGY, V1, P154, DOI 10.1111/j.1757-1707.2009.01007.x; Heaton EA, 2010, ADV BOT RES, V56, P75, DOI 10.1016/S0065-2296(10)56003-8; Heikkinen RK, 2006, PROG PHYS GEOG, V30, P751, DOI 10.1177/0309133306071957; Hodkinson TR, 2002, J PLANT RES, V115, P381, DOI 10.1007/s10265-002-0049-3; HOLDRIDGE LR, 1947, SCIENCE, V105, P367, DOI 10.1126/science.105.2727.367; Horton JL, 2010, CASTANEA, V75, P52, DOI 10.2179/08-040.1; Huang QQ, 2010, BIODIVERS CONSERV, V19, P1251, DOI 10.1007/s10531-009-9751-y; IPCC, 2000, SPECIAL REPORT EMISS; IPPC, 2007, INT STAND PHYT MEAS; Jorgensen U, 2003, ACTA AGR SCAND B-S P, V53, P190, DOI 10.1080/09064710310017605; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; Kearney MR, 2010, CONSERV LETT, V3, P203, DOI 10.1111/j.1755-263X.2010.00097.x; Koop AL, 2012, BIOL INVASIONS, V14, P273, DOI 10.1007/s10530-011-0061-4; Kriticos DJ, 2003, BIOL INVASIONS, V5, P147, DOI 10.1023/A:1026193424587; Kriticos DJ, 2011, WEED RES, V51, P85, DOI 10.1111/j.1365-3180.2010.00827.x; Lavergne S, 2007, P NATL ACAD SCI USA, V104, P3883, DOI 10.1073/pnas.0607324104; Li F, 2013, LIMNOLOGY, V14, P71, DOI 10.1007/s10201-012-0386-4; Mack RN, 2002, ANN MO BOT GARD, V89, P176, DOI 10.2307/3298562; Mika AM, 2008, GLOBAL CHANGE BIOL, V14, P1721, DOI 10.1111/j.1365-2486.2008.01620.x; Mika AM, 2010, AGR FOREST ENTOMOL, V12, P213, DOI 10.1111/j.1461-9563.2009.00464.x; Naidu SL, 2004, PLANTA, V220, P145, DOI 10.1007/s00425-004-1322-6; Naidu SL, 2003, PLANT PHYSIOL, V132, P1688, DOI 10.1104/pp.103.021790; New M, 1999, J CLIMATE, V12, P829, DOI 10.1175/1520-0442(1999)012<0829:RTCSTC>2.0.CO;2; Nishiwaki A, 2011, AM J BOT, V98, P154, DOI 10.3732/ajb.1000258; Parker Matthew A., 2001, Diversity and Distributions, V7, P125, DOI 10.1046/j.1472-4642.2001.00103.x; Petitpierre B, 2012, SCIENCE, V335, P1344, DOI 10.1126/science.1215933; Pheloung PC, 1999, J ENVIRON MANAGE, V57, P239, DOI 10.1006/jema.1999.0297; POHL RICHARD W., 1963, RHODORA, V65, P146; Pysek P, 2003, OECOLOGIA, V135, P122, DOI 10.1007/s00442-002-1170-7; Pysek P, 2009, DIVERS DISTRIB, V15, P891, DOI 10.1111/j.1472-4642.2009.00602.x; Pyter R, 2009, METHODS MOL BIOL, V581, P41, DOI 10.1007/978-1-60761-214-8_3; Quinn LD, 2012, BIOENERG RES, V5, P139, DOI 10.1007/s12155-011-9163-1; Quinn LD, 2011, INVAS PLANT SCI MANA, V4, P142, DOI 10.1614/IPSM-D-10-00067.1; Quinn LD, 2010, GCB BIOENERGY, V2, P310, DOI 10.1111/j.1757-1707.2010.01062.x; Raghu S, 2006, SCIENCE, V313, P1742, DOI 10.1126/science.1129313; Rahmstorf S, 2007, SCIENCE, V316, P709, DOI 10.1126/science.1136843; Randall DA., 2007, CLIMATE CHANGE 2007; Ross JL, 2010, BIOL INVASIONS, V12, P603, DOI 10.1007/s10530-009-9467-7; Schaffner U, 2011, ECOLOGY, V92, P829, DOI 10.1890/10-1230.1; SCOTT JK, 1993, J BIOGEOGR, V20, P87, DOI 10.2307/2845742; Sultan SE, 2013, EVOL APPL, V6, P266, DOI 10.1111/j.1752-4571.2012.00287.x; Sutherst RW, 2007, GLOBAL CHANGE BIOL, V13, P1843, DOI 10.1111/j.1365-2486.2007.01396.x; Sutherst R. W., 2007, TERRESTRIAL ECOSYSTE, P211, DOI DOI 10.1007/978-3-540-32730-1_17; Sutherst RW, 2005, ENVIRON ENTOMOL, V34, P317, DOI 10.1603/0046-225X-34.2.317; Sutherst RW, 2003, J BIOGEOGR, V30, P805, DOI 10.1046/j.1365-2699.2003.00861.x; SUTHERST RW, 1985, AGR ECOSYST ENVIRON, V13, P281, DOI 10.1016/0167-8809(85)90016-7; Sutherst RW, 2006, CLIMEX VERSION 3 USE; Taylor SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036748; Venette RC, 2006, FOREST ECOL MANAG, V231, P18, DOI 10.1016/j.foreco.2006.04.036; Venette RC, 2010, BIOSCIENCE, V60, P349, DOI 10.1525/bio.2010.60.5.5; Walther GR, 2009, TRENDS ECOL EVOL, V24, P686, DOI 10.1016/j.tree.2009.06.008; Whitney KD, 2008, DIVERS DISTRIB, V14, P569, DOI 10.1111/j.1472-4642.2008.00473.x; Williamson M, 1996, ECOLOGY, V77, P1661, DOI 10.2307/2265769; Woodward F.I., 1987, CLIMATE PLANT DISTRI; Xu CY, 2010, ECOL LETT, V13, P32, DOI 10.1111/j.1461-0248.2009.01395.x; YAMASAKI S, 1990, AQUAT BOT, V36, P367, DOI 10.1016/0304-3770(90)90053-N; Yan J, 2012, GCB BIOENERGY, V4, P49, DOI 10.1111/j.1757-1707.2011.01108.x	84	17	17	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100032	10.1371/journal.pone.0100032	http://dx.doi.org/10.1371/journal.pone.0100032			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945154	Green Submitted, Green Published, gold			2022-12-27	WOS:000340721500041
J	Houghton, C				Houghton, Conor			Supervised Learning with Complex Spikes and Spike-Timing-Dependent Plasticity	PLOS ONE			English	Article							CEREBELLAR PURKINJE-CELLS; LONG-TERM DEPRESSION; PARALLEL FIBER SYNAPSES; SYNAPTIC PLASTICITY; CLIMBING FIBERS; MOTOR CONTROL; MOSSY FIBER; OLIVOCEREBELLAR SYSTEM; HIPPOCAMPAL-NEURONS; ACTION-POTENTIALS	One distinctive feature of Purkinje cells is that they have two types of discharge: in addition to simple spikes they fire complex spikes in response to input from the climbing fibers. These complex spikes have an initial rapid burst of spikes and spikelets followed by a sustained depolarization; in some models of cerebellar function this climbing fiber input supervises learning in Purkinje cells. On the other hand, synaptic plasticity is often thought to rely on the timing of pre-synaptic and post-synaptic spikes. It is suggested here that the period of depolarization following a complex spike, combined with a simple spike-timing-dependent plasticity rule, gives a mechanism for the climbing fiber to supervise learning in the Purkinje cell. This proposal is illustrated using a simple simulation in which it is seen that the climbing fiber succeeds in supervising the learning.	Univ Bristol, Dept Comp Sci, Bristol, Avon, England	University of Bristol	Houghton, C (corresponding author), Univ Bristol, Dept Comp Sci, Bristol, Avon, England.	conor.houghton@bristol.ac.uk	Houghton, Conor/H-3793-2014	Houghton, Conor/0000-0001-5017-9473	James S. McDonnell Foundation	James S. McDonnell Foundation	The author is grateful to the James S. McDonnell Foundation for financial support through a Scholar Award in Human Cognition. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; ARMSTRONG DM, 1979, J PHYSIOL-LONDON, V289, P425, DOI 10.1113/jphysiol.1979.sp012745; Bell C, 1997, BRAIN BEHAV EVOLUT, V50, P17, DOI 10.1159/000113352; Bell CC, 1997, NATURE, V387, P278, DOI 10.1038/387278a0; BELL CC, 1969, J NEUROPHYSIOL, V32, P1044, DOI 10.1152/jn.1969.32.6.1044; BENEDETTI F, 1984, EXP BRAIN RES, V55, P368; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Blakemore SJ, 2001, NEUROREPORT, V12, P3741, DOI 10.1097/00001756-200112040-00027; Brown IE, 2001, J COMP NEUROL, V429, P59, DOI 10.1002/1096-9861(20000101)429:1<59::AID-CNE5>3.0.CO;2-3; Brown S., 1892, BRAIN, V15, P250; Brunel N, 2004, NEURON, V43, P745, DOI 10.1016/j.neuron.2004.08.023; Caporale N, 2008, ANNU REV NEUROSCI, V31, P25, DOI 10.1146/annurev.neuro.31.060407.125639; Cerminara NL, 2004, J NEUROSCI, V24, P4510, DOI 10.1523/JNEUROSCI.4530-03.2004; Chadderton P, 2004, NATURE, V428, P856, DOI 10.1038/nature02442; Clopath Claudia, 2010, Front Synaptic Neurosci, V2, P25, DOI 10.3389/fnsyn.2010.00025; COLIN F, 1980, BRAIN RES, V187, P3, DOI 10.1016/0006-8993(80)90491-6; D'Angelo E, 2009, TRENDS NEUROSCI, V32, P30, DOI 10.1016/j.tins.2008.09.007; Davie JT, 2008, J NEUROSCI, V28, P7599, DOI 10.1523/JNEUROSCI.0559-08.2008; Dean P, 2010, NAT REV NEUROSCI, V11, P30, DOI 10.1038/nrn2756; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; DIENER HC, 1992, MOVEMENT DISORD, V7, P95, DOI 10.1002/mds.870070202; Dow RS, 1942, J NEUROPHYSIOL, V5, P363, DOI 10.1152/jn.1942.5.5.363; Dow RS, 1991, CLIN NEUROLOGY, V3, P34; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; ECCLES JC, 1966, J PHYSIOL-LONDON, V182, P268, DOI 10.1113/jphysiol.1966.sp007824; EKEROT CF, 1989, NEUROSCI RES, V6, P264, DOI 10.1016/0168-0102(89)90065-5; EKEROT CF, 1985, BRAIN RES, V342, P357, DOI 10.1016/0006-8993(85)91136-9; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; Flourens P, 1825, RECHERCHES EXPT PROP; FRITH C. D., 1992, COGNITIVE NEUROPSYCH; Frith CD, 2000, PHILOS T R SOC B, V355, P1771, DOI 10.1098/rstb.2000.0734; Froemke RC, 2005, NATURE, V434, P221, DOI 10.1038/nature03366; FUJITA M, 1982, BIOL CYBERN, V45, P195, DOI 10.1007/BF00336192; FUJITA Y, 1968, J NEUROPHYSIOL, V31, P131, DOI 10.1152/jn.1968.31.2.131; Gao JH, 1996, SCIENCE, V272, P545, DOI 10.1126/science.272.5261.545; Gerstner W, 1996, NATURE, V383, P76, DOI 10.1038/383076a0; GILBERT PFC, 1977, BRAIN RES, V128, P309, DOI 10.1016/0006-8993(77)90997-0; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Holmes G, 1917, BRAIN, V40, P461, DOI 10.1093/brain/40.4.461; HOUNSGAARD J, 1979, EXP BRAIN RES, V37, P387; ITO M, 1982, J PHYSIOL-LONDON, V324, P113, DOI 10.1113/jphysiol.1982.sp014103; ITO M, 1971, BRAIN RES, V31, P215, DOI 10.1016/0006-8993(71)90648-2; Ito M, 1984, CEREBELLUM NEURAL CO; Jacob V, 2007, J NEUROSCI, V27, P1271, DOI 10.1523/JNEUROSCI.4264-06.2007; Kampa BM, 2007, TRENDS NEUROSCI, V30, P456, DOI 10.1016/j.tins.2007.06.010; KAWATO M, 1987, BIOL CYBERN, V57, P169, DOI 10.1007/BF00364149; Kempter R, 1999, PHYS REV E, V59, P4498, DOI 10.1103/PhysRevE.59.4498; Kitazawa S, 1998, NATURE, V392, P494, DOI 10.1038/33141; LLINAS R, 1968, SCIENCE, V160, P1132, DOI 10.1126/science.160.3832.1132; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P171, DOI 10.1113/jphysiol.1980.sp013357; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Markram H, 1995, SOC NEUR, V21; Markram Henry, 2011, Front Synaptic Neurosci, V3, P4, DOI 10.3389/fnsyn.2011.00004; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Mauk MD, 1998, NEURON, V20, P359, DOI 10.1016/S0896-6273(00)80978-2; MCCORMICK DA, 1984, SCIENCE, V223, P296, DOI 10.1126/science.6701513; Meliza CD, 2006, NEURON, V49, P183, DOI 10.1016/j.neuron.2005.12.009; MONTAROLO PG, 1982, J PHYSIOL-LONDON, V332, P187, DOI 10.1113/jphysiol.1982.sp014409; Palay S.L., 1974, CEREBELLAR CORTEX; Rancz EA, 2007, NATURE, V450, P1245, DOI 10.1038/nature05995; REKATE HL, 1985, ARCH NEUROL-CHICAGO, V42, P697, DOI 10.1001/archneur.1985.04060070091023; Russell J.S.R., 1894, PHILOS T R SOC LON B, V185, P819; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; Schuett S, 2001, NEURON, V32, P325, DOI 10.1016/S0896-6273(01)00472-X; SHIDARA M, 1993, NATURE, V365, P50, DOI 10.1038/365050a0; Sjostrom PJ, 2008, PHYSIOL REV, V88, P769, DOI 10.1152/physrev.00016.2007; Sjostrom J., 2010, SCHOLARPEDIA, V5, P1362, DOI [10.4249/scholarpedia.1362, DOI 10.4249/SCHOLARPEDIA.1362]; Sjostrom PJ, 2006, NEURON, V51, P227, DOI 10.1016/j.neuron.2006.06.017; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/S0896-6273(01)00542-6; Song S, 2001, NEURON, V32, P339, DOI 10.1016/S0896-6273(01)00451-2; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Stefan K, 2000, BRAIN, V123, P572, DOI 10.1093/brain/123.3.572; STUART G, 1994, NEURON, V13, P703, DOI 10.1016/0896-6273(94)90037-X; Voogd J, 1998, TRENDS NEUROSCI, V21, P370, DOI 10.1016/S0166-2236(98)01318-6; Wang SSH, 2000, NAT NEUROSCI, V3, P1266, DOI 10.1038/81792; WELSH JP, 1995, NATURE, V374, P453, DOI 10.1038/374453a0; Wolpert DM, 1997, TRENDS COGN SCI, V1, P209, DOI 10.1016/S1364-6613(97)01070-X; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665	79	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e99635	10.1371/journal.pone.0099635	http://dx.doi.org/10.1371/journal.pone.0099635			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945786	Green Submitted, Green Published, gold			2022-12-27	WOS:000340721500025
J	Luo, BH; Xiong, F; Wang, JP; Li, JH; Zhong, M; Liu, QL; Luo, GQ; Yang, XJ; Xiao, N; Xie, B; Xiao, H; Liu, RJ; Dong, CS; Wang, KS; Wen, JF				Luo, Bai-Hua; Xiong, Feng; Wang, Jun-Pu; Li, Jing-He; Zhong, Ming; Liu, Qin-Lai; Luo, Geng-Qiu; Yang, Xiao-Jing; Xiao, Ni; Xie, Bin; Xiao, Heng; Liu, Rui-Jie; Dong, Chang-Sheng; Wang, Kuan-Song; Wen, Ji-Fang			Epidermal Growth Factor-Like Domain-Containing Protein 7 (EGFL7) Enhances EGF Receptor-AKT Signaling, Epithelial-Mesenchymal Transition, and Metastasis of Gastric Cancer Cells	PLOS ONE			English	Article							E-CADHERIN EXPRESSION; ANOIKIS RESISTANCE; POOR-PROGNOSIS; UP-REGULATION; NOTCH; SNAIL; MIGRATION; EMT; ENDOCYTOSIS; ACTIVATION	Epidermal growth factor-like domain-containing protein 7 (EGFL7) is upregulated in human epithelial tumors and so is a potential biomarker for malignancy. Indeed, previous studies have shown that high EGFL7 expression promotes infiltration and metastasis of gastric carcinoma. The epithelial-mesenchymal transition (EMT) initiates the metastatic cascade and endows cancer cells with invasive and migratory capacity; however, it is not known if EGFL7 promotes metastasis by triggering EMT. We found that EGFL7 was overexpressed in multiple human gastric cancer (GC) cell lines and that overexpression promoted cell invasion and migration as revealed by scratch wound and transwell migration assays. Conversely, shRNA-mediated EGFL7 knockdown reduced invasion and migration. Furthermore, EGFL7-overexpressing cells grew into larger tumors and were more likely to metastasize to the liver compared to underexpressing CG cells following subcutaneous injection in mice. EGFL7 overexpression protected GC cell lines against anoikis, providing a plausible mechanism for this enhanced metastatic capacity. In excised human gastric tumors, expression of EGFL7 was positively correlated with expression levels of the mesenchymal marker vimentin and the EMT-associated transcription repressor Snail, and negatively correlated with expression of the epithelial cell marker E-cadherin. In GC cell lines, EGFL7 knockdown reversed morphological signs of EMT and decreased both vimentin and Snail expression. In addition, EGFL7 overexpression promoted EGF receptor (EGFR) and protein kinase B (AKT) phospho-activation, effects markedly suppressed by the EGFR tyrosine kinase inhibitor AG1478. Moreover, AG1478 also reduced the elevated invasive and migratory capacity of GC cell lines overexpressing EGFL7. Collectively, these results strongly suggest that EGFL7 promotes metastasis by activating EMT through an EGFR-AKT-Snail signaling pathway. Disruption of EGFL7-EGFR-AKT-Snail signaling may a promising therapeutic strategy for gastric cancer.	[Luo, Bai-Hua; Wang, Jun-Pu; Li, Jing-He; Zhong, Ming; Luo, Geng-Qiu; Yang, Xiao-Jing; Xiao, Ni; Xie, Bin; Xiao, Heng; Liu, Rui-Jie; Wang, Kuan-Song; Wen, Ji-Fang] Cent South Univ, Xiangya Hosp, Dept Pathol, Changsha, Hunan, Peoples R China; [Luo, Bai-Hua; Wang, Jun-Pu; Li, Jing-He; Zhong, Ming; Luo, Geng-Qiu; Yang, Xiao-Jing; Xiao, Ni; Xie, Bin; Xiao, Heng; Liu, Rui-Jie; Wang, Kuan-Song; Wen, Ji-Fang] Cent South Univ, Sch Basic Med Sci, Dept Pathol, Changsha, Hunan, Peoples R China; [Xiong, Feng] Second Peoples Hosp, Ctr Furong Judicial Authenticat, Changsha, Hunan, Peoples R China; [Liu, Qin-Lai] Taishan Med Coll, Dept Pathol, Tai An, Shandong, Peoples R China; [Dong, Chang-Sheng] Cent South Univ, Affiliated Tumor Hosp, Xiangya Med Coll, Dept Anesthesiol, Changsha, Hunan, Peoples R China	Central South University; Central South University; Shandong First Medical University & Shandong Academy of Medical Sciences; Central South University	Wang, KS (corresponding author), Cent South Univ, Xiangya Hosp, Dept Pathol, Changsha, Hunan, Peoples R China.	13787146109@126.com; jifangw@yahoo.com	Xiao, Heng/GVU-6125-2022		National Natural Science Foundation of China [81001080]; Open-End Fund for the Valuable and Precision Instruments of Central South University [JJ3121]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open-End Fund for the Valuable and Precision Instruments of Central South University	This work was supported by National Natural Science Foundation of China (No. 81001080) and the Open-End Fund for the Valuable and Precision Instruments of Central South University (No. JJ3121). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre A, 2010, NATURE, V467, P323, DOI 10.1038/nature09347; [Anonymous], 2013, CANCER DISCOV, V3, P1092, DOI 10.1158/2159-8290.CD-RW2013-189; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Boisvert-Adamo K, 2009, MOL CANCER RES, V7, P549, DOI 10.1158/1541-7786.MCR-08-0358; Caja L, 2007, CELL SIGNAL, V19, P683, DOI 10.1016/j.cellsig.2006.09.002; Cheng JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034071; Cheng JC, 2010, MOL ENDOCRINOL, V24, P1569, DOI 10.1210/me.2010-0034; Chiarugi P, 2008, BIOCHEM PHARMACOL, V76, P1352, DOI 10.1016/j.bcp.2008.07.023; Chitnis A, 2006, DEV DYNAM, V235, P886, DOI 10.1002/dvdy.20683; Christofori G, 2006, NATURE, V441, P444, DOI 10.1038/nature04872; Danaei G, 2005, LANCET, V366, P1784, DOI 10.1016/S0140-6736(05)67725-2; Espinoza I, 2013, PHARMACOL THERAPEUT, V139, P95, DOI 10.1016/j.pharmthera.2013.02.003; Farges O, 2011, CANCER-AM CANCER SOC, V117, P2170, DOI 10.1002/cncr.25712; Fitch MJ, 2004, DEV DYNAM, V230, P316, DOI 10.1002/dvdy.20063; Geiger TR, 2007, CANCER RES, V67, P6221, DOI 10.1158/0008-5472.CAN-07-0121; Geiger TR, 2005, CANCER RES, V65, P7033, DOI 10.1158/0008-5472.CAN-05-0709; Gibbons DL, 2009, GENE DEV, V23, P2140, DOI 10.1101/gad.1820209; Gill S, 2003, J CLIN ONCOL, V21, P2070, DOI 10.1200/JCO.2003.11.054; Grille SJ, 2003, CANCER RES, V63, P2172; Guadamillas MC, 2011, J CELL SCI, V124, P3189, DOI 10.1242/jcs.072165; Guarino M, 2007, INT J BIOCHEM CELL B, V39, P2153, DOI 10.1016/j.biocel.2007.07.011; Guo Y, 2013, WSPOLCZESNA ONKOL, V17, P150, DOI 10.5114/wo.2013.34618; Halmaciu I, 2013, ACTA MED MARISIENSIS, V59, P165; Huang CH, 2010, J CANCER RES CLIN, V136, P1737, DOI 10.1007/s00432-010-0832-9; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jing JJ, 2012, WORLD J GASTROENTERO, V18, P1262, DOI 10.3748/wjg.v18.i11.1262; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kanat O, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0464-4; Kang M, 2012, BIOCHEM J, V443, P691, DOI 10.1042/BJ20111584; Kim MA, 2009, HISTOPATHOLOGY, V54, P442, DOI 10.1111/j.1365-2559.2009.03247.x; Ko H, 2012, MOL CANCER RES, V10, P1032, DOI 10.1158/1541-7786.MCR-12-0261; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lavy R, 2013, GASTRIC CANCER, P1; Le Borgne R, 2005, DEVELOPMENT, V132, P1751, DOI 10.1242/dev.01789; Li XH, 2011, MOL CANCER RES, V9, P824, DOI 10.1158/1541-7786.MCR-10-0529; [李景和 LIJinghe], 2011, [世界科技研究与发展, World Sci-Tech R and D], V33, P650; Miele L, 2006, CURR CANCER DRUG TAR, V6, P313, DOI 10.2174/156800906777441771; Miele L, 2006, CLIN CANCER RES, V12, P1074, DOI 10.1158/1078-0432.CCR-05-2570; Miele L, 2006, CURR MOL MED, V6, P905, DOI 10.2174/156652406779010830; Minard ME, 2006, CLIN EXP METASTAS, V23, P301, DOI 10.1007/s10585-006-9040-z; Nichol D, 2012, BLOOD, V119, P1345, DOI 10.1182/blood-2011-10-322446; Niessen K, 2008, J CELL BIOL, V182, P315, DOI 10.1083/jcb.200710067; Noseda M, 2004, CIRC RES, V94, P910, DOI 10.1161/01.RES.0000124300.76171.C9; Parker LH, 2004, NATURE, V428, P754, DOI 10.1038/nature02416; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; REMMELE W, 1986, VIRCHOWS ARCH A, V409, P127, DOI 10.1007/BF00708323; Sahlgren C, 2008, P NATL ACAD SCI USA, V105, P6392, DOI 10.1073/pnas.0802047105; Schmidt M, 2007, DEVELOPMENT, V134, P2913, DOI 10.1242/dev.002576; Schmidt MHH, 2009, NAT CELL BIOL, V11, P873, DOI 10.1038/ncb1896; Shin NR, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-521; Soncin F, 2003, EMBO J, V22, P5700, DOI 10.1093/emboj/cdg549; Suman S, 2013, MOL CARCINOG; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tiwari N, 2012, SEMIN CANCER BIOL, V22, P194, DOI 10.1016/j.semcancer.2012.02.013; Vergara D, 2011, CANCER LETT, V310, P1, DOI 10.1016/j.canlet.2011.04.009; Wang L, 2013, INT J CANCER, V133, P1419, DOI 10.1002/ijc.28140; Wang ZW, 2008, ANTICANCER RES, V28, P3621; Wu F, 2009, HEPATOLOGY, V50, P1839, DOI 10.1002/hep.23197; Wu Y, 2008, ACTA BIOCH BIOPH SIN, V40, P643, DOI 10.1111/j.1745-7270.2008.00443.x; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0	61	39	42	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e99922	10.1371/journal.pone.0099922	http://dx.doi.org/10.1371/journal.pone.0099922			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945379	Green Submitted, Green Published, gold			2022-12-27	WOS:000340721500033
J	Yan, M; Zhao, K; Du, J; Li, LZ; Wu, DL; Xu, SM; Zeng, XC; Wang, GJ; Yu, XF				Yan, Ming; Zhao, Ke; Du, Juan; Li, Linzhang; Wu, Donglin; Xu, Shengming; Zeng, Xiangchao; Wang, Guanjun; Yu, Xiao-Fang			HIV-1 Diversity and Drug-Resistant Mutations in Infected Individuals in Changchun, China	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MOLECULAR EPIDEMIOLOGY; GENETIC DIVERSITY; LIAONING PROVINCE; SUBTYPE; TRANSMISSION; STRAINS; USERS; RECOMBINANT; SEQUENCES	Objectives: Human immunodeficiency virus type 1 (HIV-1) infection has been detected in all provinces of China. Although epidemiological and phylogenetic studies have been conducted in many regions, such analyses are lacking from Jilin province in northeastern China. Method: Epidemiological and phylogenetic analyses, as well as detection of drug-resistant mutations, were conducted on 57 HIV-1 infected patients from Changchun city identified and confirmed through annual surveillance by local Centers for Disease Control in Jilin province of northeastern China in 2012. Results: Sexual contact was determined to be the major pathway for HIV-1 transmission in Jilin, where hetero- and homosexual activities contributed almost equally. Phylogenetic analyses detected multiple subtypes of HIV-1 including subtype G circulating in Jilin, with multiple origins for each of them. Both subtype B and CRF01_AE were dominant, and evidence of subtype B transmitting between different high-risk groups was observed. Mutations in the viral protease at position 71 indicated the presence of a selective pressure. Several drug-resistant mutations were detected, although they were predicted with low-level resistance to antiviral treatments. Conclusions: Information from this study fills the gap in knowledge of HIV-1 transmission in Changchun city, Jilin province, China. By revealing the origin and evolutionary status of local HIV-1 strains, this work contributes to ongoing efforts in the control and prevention of AIDS.	[Yan, Ming; Zhao, Ke; Du, Juan; Li, Linzhang; Xu, Shengming; Zeng, Xiangchao; Wang, Guanjun; Yu, Xiao-Fang] Jilin Univ, Hosp 1, Changchun 130023, Jilin, Peoples R China; [Wu, Donglin] Jilin Prov Ctr Dis Control & Prevent, Changchun, Jilin, Peoples R China; [Yu, Xiao-Fang] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	Jilin University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Wang, GJ (corresponding author), Jilin Univ, Hosp 1, Changchun 130023, Jilin, Peoples R China.	gjwang.fhjlu@gmail.com; xfyu@jhsph.edu			Chinese Ministry of Science and Technology [2012CB911100, 2013ZX0001-005]; Chinese Ministry of Education [IRT1016]; Key Laboratory of Molecular Virology, Jilin Province, China [20102209]; National Institute of Allergy and Infectious Diseases [2R56AI62644-6]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Chinese Ministry of Education(Ministry of Education, China); Key Laboratory of Molecular Virology, Jilin Province, China; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by funding from the Chinese Ministry of Science and Technology (2012CB911100 and No. 2013ZX0001-005) and Chinese Ministry of Education (IRT1016), the Key Laboratory of Molecular Virology, Jilin Province (20102209), China, and a grant (2R56AI62644-6) from the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao LL, 2008, AIDS RES HUM RETROV, V24, P733, DOI 10.1089/aid.2007.0269; Chen M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060101; Chu TX, 2005, CELL RES, V15, P865, DOI 10.1038/sj.cr.7290360; Fourati S, 2012, AIDS, V26, P1619, DOI 10.1097/QAD.0b013e3283560703; Han XX, 2007, AIDS RES HUM RETROV, V23, P357, DOI 10.1089/aid.2006.0094; Han XX, 2010, JAIDS-J ACQ IMM DEF, V53, pS27, DOI 10.1097/QAI.0b013e3181c7d5bf; Imade GE, 2014, AIDS RES HUM RETROV, V30, P127, DOI [10.1089/aid.2013.0074, 10.1089/AID.2013.0074]; Laeyendecker O, 2005, JAIDS-J ACQ IMM DEF, V38, P356; Lai S, 2001, J ACQ IMMUN DEF SYND, V26, P365, DOI 10.1097/00126334-200104010-00014; Li L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075777; Li XX, 2013, J APPL MATH, DOI 10.1155/2013/245963; Li XJ, 2005, AIDS RES HUM RETROV, V21, P977, DOI 10.1089/aid.2005.21.977; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Pircher M, 2012, AIDS RES HUM RETROV, V28, P1798, DOI [10.1089/aid.2012.0083, 10.1089/AID.2012.0083]; Piyasirisilp S, 2000, J VIROL, V74, P11286, DOI 10.1128/JVI.74.23.11286-11295.2000; Qi HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068656; Rodenburg CM, 2001, AIDS RES HUM RETROV, V17, P161, DOI 10.1089/08892220150217247; Shang H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010631; Skar H, 2011, ANN NY ACAD SCI, V1230, P108, DOI 10.1111/j.1749-6632.2011.06128.x; Song YH, 2007, ARCH VIROL, V152, P1553, DOI 10.1007/s00705-007-0973-6; Su QJ, 2012, AIDS RES HUM RETROV, V28, P725, DOI [10.1089/AID.2011.0246, 10.1089/aid.2011.0246]; Su R, 2003, AIDS, V17, P2515, DOI 10.1097/00002030-200311210-00015; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teng T, 2011, Adv Dent Res, V23, P10, DOI 10.1177/0022034511398871; Wang FX, 2007, CHINESE MED J-PEKING, V120, P2006, DOI 10.1097/00029330-200711020-00013; Xu SH, 2010, MOL DIAGN THER, V14, P31, DOI 10.2165/11530900-000000000-00000; Yu ESH, 1996, AM J PUBLIC HEALTH, V86, P1116, DOI 10.2105/AJPH.86.8_Pt_1.1116; Yu XF, 1998, J VIROL, V72, P3412, DOI 10.1128/JVI.72.4.3412-3417.1998; Yu XF, 2002, AIDS RES HUM RETROV, V18, P167, DOI 10.1089/08892220252779719; Zhang LQ, 2004, J VIROL, V78, P13591, DOI 10.1128/JVI.78.24.13591-13599.2004; Zhong P, 2007, AIDS RES HUM RETROV, V23, P847, DOI 10.1089/aid.2006.0196	31	4	7	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100540	10.1371/journal.pone.0100540	http://dx.doi.org/10.1371/journal.pone.0100540			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945273	Green Published, Green Submitted, gold			2022-12-27	WOS:000340721500091
J	Berkunsky, I; Daniele, G; Kacoliris, FP; Diaz-Luque, JA; Frias, CPS; Aramburu, RM; Gilardi, JD				Berkunsky, Igor; Daniele, Gonzalo; Kacoliris, Federico P.; Diaz-Luque, Jose A.; Frias, Carmen P. Silva; Aramburu, Rosana M.; Gilardi, James D.			Reproductive Parameters in the Critically Endangered Blue-Throated Macaw: Limits to the Recovery of a Parrot under Intensive Management	PLOS ONE			English	Article							BREEDING SUCCESS; GROWTH; FOREST	Rediscovered in the wild twenty years ago, the breeding biology of wild Blue-throated Macaws remains largely unexplored, yet is essential to its effective conservation and recovery. Here, we analyse reproductive parameters in an intensively managed wild population of Blue-throated Macaws, providing the first data on the breeding biology of this critically endangered species. During the six-year study period, 2007-2012, the number of active breeding pairs either remained constant or decreased, depending on the site, and no new breeding pairs were discovered despite extensive searching. We documented nesting attempts in natural cavities in dead palms or live hardwoods, and artificial nest boxes. Egg-laying was concentrated during the end of dry season and the beginning of the wet season, August through December. Hatching failure was the greatest cause of egg losses. Half of the breeding attempts of Blue-throated Macaws produced at least one fledging, on average two, after a 85 days nestling period. An average of 4.3 nestlings per year fledged from all known wild nests combined. Each pair lost roughly 65% of its initial reproductive investment at each nesting attempt. In most successful nesting attempts of individualized pairs, a new nesting attempt was not detected the following year. All monitored breeding pairs showed high nest site fidelity, reusing hardwood-tree cavities and nest boxes. Our findings will aid conservation efforts by refining current actions and prompting new approaches towards the conservation and recovery of the Blue-throated Macaw.	[Berkunsky, Igor; Diaz-Luque, Jose A.] Univ Nacl Ctr Provincia Buenos Aires, Inst Multidisciplinario Ecosistemas & Desarrollo, Buenos Aires, DF, Argentina; [Berkunsky, Igor; Daniele, Gonzalo; Kacoliris, Federico P.; Diaz-Luque, Jose A.; Frias, Carmen P. Silva] World Parrot Trust, Proyecto Conservac Paraba Barba Azul, Beni, Bolivia; [Kacoliris, Federico P.; Aramburu, Rosana M.] Univ Nacl La Plata, Div Zool Vertebrados, Museo La Plata, Buenos Aires, DF, Argentina; [Frias, Carmen P. Silva] Univ Austral Chile, Fac Ciencias, Inst Ciencias Ambient & Evolutivas, Valdivia, Chile; [Gilardi, James D.] World Parrot Trust, Lake Alfred, FL USA	National University of La Plata; Museo La Plata; Universidad Austral de Chile	Berkunsky, I (corresponding author), Univ Nacl Ctr Provincia Buenos Aires, Inst Multidisciplinario Ecosistemas & Desarrollo, Buenos Aires, DF, Argentina.	iberkunsky@parrot.org	Kacoliris, Federico/AAA-2535-2021; Berkunsky, Igor/AAS-4517-2020	Berkunsky, Igor/0000-0001-9219-4241	World Parrot Trust; Rufford Small Grants Foundation; Idea Wild; PICT (FONCyT) [2011-0173]; Birder's Exchange; CREOI	World Parrot Trust; Rufford Small Grants Foundation; Idea Wild; PICT (FONCyT); Birder's Exchange; CREOI	This work was supported by the World Parrot Trust, Rufford Small Grants Foundation, Idea Wild, Birder's Exchange, CREOI and PICT 2011-0173 (FONCyT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beissinger SR, 2008, ECOL MONOGR, V78, P185, DOI 10.1890/07-0018.1; Berkunsky I, 2009, IBIS, V151, P145, DOI 10.1111/j.1474-919X.2008.00896.x; BirdLife International, SPEC FACTSH AR GLAUC; Brightsmith DJ, 2005, WILSON BULL, V117, P296, DOI 10.1676/03-087A.1; Collar N. J., 2000, International Zoo Yearbook, V37, P21, DOI 10.1111/j.1748-1090.2000.tb00704.x; Collar NJ, 1996, WORK, V5, P26; Forshaw J, 1989, PARROTS WORLD; Guedes NMR, 1995, ETOL, V13, P274; Hanagarth W, 1996, GEOGR RUNDSCH, V48, P662; Hangarth W, 1990, ECOLOGIA BOLIVIA, V16, P47; Herrera M, 2007, KEMPFFIANA, V3, P18; Hesse AJ, 2000, BIRD CONSERV INT, V10, P255, DOI 10.1017/S0959270900000216; IUCN, 2011, IUCN 2011 IUCN RED L; JORDAN OC, 1993, WILSON BULL, V105, P694; Kuniy A. A., 2006, Braz. J. Biol., V66, P381, DOI 10.1590/S1519-69842006000200021; Langstroth R. P., 1996, FOREST ISLANDS AMAZO; Low R, 1990, COMPLETE BOOK MACAWS; Masello JF, 2002, CONDOR, V104, P574, DOI 10.1650/0010-5422(2002)104[0574:CGABSO]2.0.CO;2; Mayle FE, 2007, PHILOS T R SOC B, V362, P291, DOI 10.1098/rstb.2006.1987; Nice M. M., 1954, Condor, V56, P173, DOI 10.2307/1365113; Nycander E., 1995, LARGE MACAWS THEIR C, P423; Olah G, 2014, J NAT CONSERV, V22, P176, DOI 10.1016/j.jnc.2013.11.003; Renton K, 2009, J FIELD ORNITHOL, V80, P1, DOI 10.1111/j.1557-9263.2009.00198.x; Snyder Noel, 2000, PARROTS STATUS SURVE; Sweeney RG, 2002, MACAWS; Yamashita Carlos, 1997, Ararajuba, V5, P141	26	18	19	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99941	10.1371/journal.pone.0099941	http://dx.doi.org/10.1371/journal.pone.0099941			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941317	Green Published, gold, Green Submitted			2022-12-27	WOS:000338508200057
J	Rupprecht, CDD; Byrne, JA				Rupprecht, Christoph D. D.; Byrne, Jason A.			Informal Urban Green-Space: Comparison of Quantity and Characteristics in Brisbane, Australia and Sapporo, Japan	PLOS ONE			English	Article							BIODIVERSITY; ENVIRONMENTS; CHALLENGE; PLANTS; LIFE	Informal urban green-space (IGS) such as vacant lots, brownfields and street or railway verges is receiving growing attention from urban scholars. Research has shown IGS can provide recreational space for residents and habitat for flora and fauna, yet we know little about the quantity, spatial distribution, vegetation structure or accessibility of IGS. We also lack a commonly accepted definition of IGS and a method that can be used for its rapid quantitative assessment. This paper advances a definition and typology of IGS that has potential for global application. Based on this definition, IGS land use percentage in central Brisbane, Australia and Sapporo, Japan was systematically surveyed in a 10610 km grid containing 121 sampling sites of 2,500 m 2 per city, drawing on data recorded in the field and aerial photography. Spatial distribution, vegetation structure and accessibility of IGS were also analyzed. We found approximately 6.3% of the surveyed urban area in Brisbane and 4.8% in Sapporo consisted of IGS, a non-significant difference. The street verge IGS type (80.4% of all IGS) dominated in Brisbane, while lots (42.2%) and gaps (19.2%) were the two largest IGS types in Sapporo. IGS was widely distributed throughout both survey areas. Vegetation structure showed higher tree cover in Brisbane, but higher herb cover in Sapporo. In both cities over 80% of IGS was accessible or partly accessible. The amount of IGS we found suggests it could play a more important role than previously assumed for residents' recreation and nature experience as well as for fauna and flora, because it substantially increased the amount of potentially available greenspace in addition to parks and conservation greenspace. We argue that IGS has potential for recreation and conservation, but poses some challenges to urban planning. To address these challenges, we propose some directions for future research.	[Rupprecht, Christoph D. D.; Byrne, Jason A.] Griffith Univ, Environm Futures Res Inst, Nathan, Qld 4111, Australia; [Rupprecht, Christoph D. D.; Byrne, Jason A.] Griffith Univ, Griffith Sch Environm, Nathan, Qld 4111, Australia	Griffith University; Griffith University	Rupprecht, CDD (corresponding author), Griffith Univ, Environm Futures Res Inst, Nathan, Qld 4111, Australia.	christoph.rupprecht@griffithuni.edu.au	Byrne, Jason/AAC-6344-2019; Byrne, Jason A/L-7140-2013	Byrne, Jason A/0000-0001-8733-0333; Rupprecht, Christoph/0000-0003-1809-2129	Griffith University	Griffith University(Griffith University)	This work was supported by scholarships and research funding from Griffith University (http://www.griffith.edu.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Australian Bureau of Statistics, 2013, NAT REG PROF BRISB C; Brisbane City Council, 2010, CIT PLAN 2000; Brisbane City Council, 2007, CITYSHAPE IMPL STRAT; Brisbane City Council, 2010, BRISB COUNC LAND US; Byrne J., 2010, GREEN; Byrne J, 2010, AUST PLAN, V47, P162, DOI 10.1080/07293682.2010.508204; Campo D, 2013, ACCIDENTAL PLAYGROUND: BROOKLYN WATERFRONT NARRATIVES OF THE UNDESIGNED AND UNPLANNED, P1; Corbin C.I., 2003, LANDSC J, V22, P12, DOI [DOI 10.3368/LJ.22.1.12, 10.3368/lj.22.1.12]; Davison A, 2008, GEOFORUM, V39, P1284, DOI 10.1016/j.geoforum.2007.06.011; De Sousa CA, 2006, LOCAL ENVIRON, V11, P577, DOI 10.1080/13549830600853510; Del Tredici P., 2010, WILD URBAN PLANTS NE; Del Tredici P, 2010, NAT CULT, V5, P299, DOI 10.3167/nc.2010.050305; Dunn RR, 2006, CONSERV BIOL, V20, P1814, DOI 10.1111/j.1523-1739.2006.00533.x; Fanck Karen A., 2007, LOOSE SPACE POSSIBIL; Foster J, 2014, CITIES, V40, P124, DOI 10.1016/j.cities.2013.09.002; Francis RA, 2012, RIVER RES APPL, V28, P1200, DOI 10.1002/rra.1497; GLICKMAN NJ, 1978, J URBAN ECON, V5, P505, DOI 10.1016/0094-1190(78)90006-2; Haase D, 2008, NAT CULT, V3, P1, DOI 10.3167/nc.2008.030101; HABY MM, 1995, EUR RESPIR J, V8, P729; Hayashi Masayuki, 1999, LANDSCAPE RES JAPAN, V63, P667, DOI [10.5632/jila.63.667, DOI 10.5632/JILA.63.667]; Head L, 2006, T I BRIT GEOGR, V31, P505, DOI 10.1111/j.1475-5661.2006.00228.x; Helden AJ, 2004, BASIC APPL ECOL, V5, P367, DOI 10.1016/j.baae.2004.06.004; Hirzel A, 2002, ECOL MODEL, V157, P331, DOI 10.1016/S0304-3800(02)00203-X; Howitt R., 2001, AUST GEOGR STUD, V39, P233, DOI [10.1111/1467-8470.00142, DOI 10.1111/1467-8470.00142]; Jonas M., 2007, J LANDSC ARCHIT, V2, P18; Jorgensen A, 2012, URBAN WILDSCAPES, P1; Jorgensen A, 2007, LANDSCAPE RES, V32, P443, DOI 10.1080/01426390701449802; Kowarik I, 2011, ENVIRON POLLUT, V159, P1974, DOI 10.1016/j.envpol.2011.02.022; Lisci M, 2003, INT BIODETER BIODEGR, V51, P1, DOI 10.1016/S0964-8305(02)00071-9; Lososova Z, 2011, J BIOGEOGR, V38, P1152, DOI 10.1111/j.1365-2699.2011.02475.x; McLain RJ, 2014, LOCAL ENVIRON, V19, P220, DOI 10.1080/13549839.2013.841659; Meffert PJ, 2012, BIOL CONSERV, V153, P87, DOI 10.1016/j.biocon.2012.04.018; Melander B, 2009, WEED RES, V49, P516, DOI 10.1111/j.1365-3180.2009.00713.x; Moran D, 2013, GEOJOURNAL, V78, P339, DOI 10.1007/s10708-011-9442-6; Mugford K, 2012, URBAN WILDSCAPES, P80; Nohl W, 1990, LANDSCHAFT STADT, V22, P57; Penone C, 2012, BIOL CONSERV, V148, P126, DOI 10.1016/j.biocon.2012.01.041; Phinn S, 2002, INT J REMOTE SENS, V23, P4131, DOI 10.1080/01431160110114998; Pysek P, 2005, ECOSCIENCE, V12, P302, DOI 10.2980/i1195-6860-12-3-302.1; Rink D, 2012, APPLIED URBAN ECOLOGY : A GLOBAL FRAMEWORK, P82; Robinson SL, 2012, URBAN ECOSYST, V15, P545, DOI 10.1007/s11252-012-0225-8; Sapporo Kankyekyoku Midori No Suishinbu, 2012, SAPP KOCN RYOK; Sapporo Kankyekyoku Midori No Suishinbu, 2011, SAPP MID KIH KEIK; Sapporo Shiche Seisakujitsu Seisaku Kikakubu, 2012, SAPP MACH SENR BISH; Schulz, 2012, URBAN SPACES JAPAN C, P74; Tobita T, 2012, OBSERVED DAMAGE WAST, P1, DOI [10.1061/41050(357)75, DOI 10.1061/41050(357)75]; Trigger DS, 2010, NAT CULT, V5, P231, DOI 10.3167/nc.2010.050302; Unt AL, 2014, LANDSCAPE RES, V39, P267, DOI 10.1080/01426397.2012.742046; Wittig R, 2010, FLORA, V205, P704, DOI 10.1016/j.flora.2009.09.001	49	68	69	9	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99784	10.1371/journal.pone.0099784	http://dx.doi.org/10.1371/journal.pone.0099784			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK6AC	24941046	Green Published, gold			2022-12-27	WOS:000338508200041
J	Zhu, KL; Li, WZ; Fu, XM; Nagler, J				Zhu, Konglin; Li, Wenzhong; Fu, Xiaoming; Nagler, Jan			How Do Online Social Networks Grow?	PLOS ONE			English	Article							CITIES; POPULATION; DYNAMICS; LAWS	Online social networks such as Facebook, Twitter and Gowalla allow people to communicate and interact across borders. In past years online social networks have become increasingly important for studying the behavior of individuals, group formation, and the emergence of online societies. Here we focus on the characterization of the average growth of online social networks and try to understand which are possible processes behind seemingly long-range temporal correlated collective behavior. In agreement with recent findings, but in contrast to Gibrat's law of proportionate growth, we find scaling in the average growth rate and its standard deviation. In contrast, Renren and Twitter deviate, however, in certain important aspects significantly from those found in many social and economic systems. Whereas independent methods suggest no significance for temporally long-range correlated behavior for Renren and Twitter, a scaling analysis of the standard deviation does suggest long-range temporal correlated growth in Gowalla. However, we demonstrate that seemingly long-range temporal correlations in the growth of online social networks, such as in Gowalla, can be explained by a decomposition into temporally and spatially independent growth processes with a large variety of entry rates. Our analysis thus suggests that temporally or spatially correlated behavior does not play a major role in the growth of online social networks.	[Zhu, Konglin; Li, Wenzhong; Fu, Xiaoming] Univ Gottingen, Inst Comp Sci, D-37073 Gottingen, Germany; [Li, Wenzhong] Nanjing Univ, State Key Lab Novel Software & Technol, Nanjing 210008, Jiangsu, Peoples R China; [Nagler, Jan] Swiss Fed Inst Technol, IfB, Zurich, Switzerland; [Nagler, Jan] Max Planck Inst Dynam & Self Org MPI DS, Gottingen, Germany	University of Gottingen; Nanjing University; Swiss Federal Institutes of Technology Domain; ETH Zurich; Max Planck Society	Nagler, J (corresponding author), Swiss Fed Inst Technol, IfB, Zurich, Switzerland.	jnagler@ethz.ch	Fu, Xiaoming/B-7208-2016; Fu, Xiaoming/AAD-2828-2022	Fu, Xiaoming/0000-0002-8012-4753; 	Alexander von Humboldt Foundation; German Academic Exchange Service; Lindemann Foundation	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); Lindemann Foundation	The authors acknowledge the funding from Alexander von Humboldt Foundation, German Academic Exchange Service and also the support of Lindemann Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERAN J, 1995, IEEE T COMMUN, V43, P1566, DOI 10.1109/26.380206; Buldyrev SV, 2010, NATURE, V464, P1025, DOI 10.1038/nature08932; Canning D, 1998, ECON LETT, V60, P335, DOI 10.1016/S0165-1765(98)00121-9; Cho Eunjoon, 2011, KDD, P1082, DOI [10.1145/2020408.2020579, DOI 10.1145/2020408.2020579]; Dunn P. F., 2010, MEASUREMENT DATA ANA; Easley D, 2010, NETWORKS CROWDS MARK; Gabaix X., 2004, HDB REGIONAL URBAN E, P2341, DOI DOI 10.1016/S1574-0080(04)80010-5; Gallos LK, 2012, PHYS REV X, V2, DOI 10.1103/PhysRevX.2.031014; Gibrat R, 1931, INGALITS CONOMIQUES; Hennig H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026457; Ioannides YM, 2003, REG SCI URBAN ECON, V33, P127, DOI 10.1016/S0166-0462(02)00006-6; Kossinets G, 2006, SCIENCE, V311, P88, DOI 10.1126/science.1116869; Kurant M, 2011, IEEE J SELECTED AREA, V29; Levy M, 2009, AM ECON REV, V99, P1672, DOI 10.1257/aer.99.4.1672; Malmgren RD, 2008, P NATL ACAD SCI USA, V105, P18153, DOI 10.1073/pnas.0800332105; MANTEGNA RN, 2000, INTRO ECONOPHYSICS C; Matia K, 2005, J AM SOC INF SCI TEC, V56, P893, DOI 10.1002/asi.20183; Nikolic D, 2012, EUR J NEUROSCI, V35, P742, DOI 10.1111/j.1460-9568.2011.07987.x; Palla G, 2007, NATURE, V446, P664, DOI 10.1038/nature05670; Plerou V, 1999, NATURE, V400, P433, DOI 10.1038/22719; RODGERS JL, 1988, AM STAT, V42, P59, DOI 10.2307/2685263; Rozenfeld HD, 2011, AM ECON REV, V101, P2205, DOI 10.1257/aer.101.5.2205; Rozenfeld HD, 2008, P NATL ACAD SCI USA, V105, P18702, DOI 10.1073/pnas.0807435105; Rybski D, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.042114; Rybski D, 2009, P NATL ACAD SCI USA, V106, P12640, DOI 10.1073/pnas.0902667106; Samorodnitsky G., 2006, FOUND TRENDS STOCH S, V1, P163, DOI [DOI 10.1561/0900000004, 10.1561/0900000004]; Santarelli E, 2006, INT STUD ENTREP, V12, P41; Stanley MHR, 1996, NATURE, V379, P804, DOI 10.1038/379804a0; VANDERZIEL A, 1988, P IEEE, V76, P233, DOI 10.1109/5.4401	29	3	4	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100023	10.1371/journal.pone.0100023	http://dx.doi.org/10.1371/journal.pone.0100023			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK6AC	24940744	Green Published, gold			2022-12-27	WOS:000338508200066
J	Li, J; Greenwood, PL; Cockett, NE; Hadfield, TS; Vuocolo, T; Byrne, K; White, JD; Tellam, RL; Schirra, HJ				Li, Juan; Greenwood, Paul L.; Cockett, Noelle E.; Hadfield, Tracy S.; Vuocolo, Tony; Byrne, Keren; White, Jason D.; Tellam, Ross L.; Schirra, Horst Joachim			Impacts of the Callipyge Mutation on Ovine Plasma Metabolites and Muscle Fibre Type	PLOS ONE			English	Article							MYOSIN HEAVY-CHAIN; RETROTRANSPOSON-LIKE GENE; MEAT QUALITY TRAITS; SKELETAL-MUSCLE; PHENOTYPIC CHARACTERIZATION; MYOFIBER CHARACTERISTICS; POLAR OVERDOMINANCE; IMPRINTED GENES; GROWTH-HORMONE; SHEEP RUMEN	The ovine Callipyge mutation causes postnatal muscle hypertrophy localized to the pelvic limbs and torso, as well as body leanness. The mechanism underpinning enhanced muscle mass is unclear, as is the systemic impact of the mutation. Using muscle fibre typing immunohistochemistry, we confirmed muscle specific effects and demonstrated that affected muscles had greater prevalence and hypertrophy of type 2X fast twitch glycolytic fibres and decreased representation of types 1, 2C, 2A and/or 2AX fibres. To investigate potential systemic effects of the mutation, proton NMR spectra of plasma taken from lambs at 8 and 12 weeks of age were measured. Multivariate statistical analysis of plasma metabolite profiles demonstrated effects of development and genotype but not gender. Plasma from Callipyge lambs at 12 weeks of age, but not 8 weeks, was characterized by a metabolic profile consistent with contributions from the affected hypertrophic fast twitch glycolytic muscle fibres. Microarray analysis of the perirenal adipose tissue depot did not reveal a transcriptional effect of the mutation in this tissue. We conclude that there is an indirect systemic effect of the Callipyge mutation in skeletal muscle in the form of changes of blood metabolites, which may contribute to secondary phenotypes such as body leanness.	[Li, Juan; Vuocolo, Tony; Byrne, Keren; Tellam, Ross L.] CSIRO Anim Food & Hlth Sci, Brisbane, Qld, Australia; [Greenwood, Paul L.] CSIRO Anim Food & Hlth Sci, FD McMaster Lab, Armidale, NSW, Australia; [Greenwood, Paul L.] Univ New England, Beef Ind Ctr Excellence, New South Wales Dept Primary Ind, Armidale, NSW, Australia; [Cockett, Noelle E.; Hadfield, Tracy S.] Utah State Univ, Dept Anim Dairy & Vet Sci, Logan, UT 84322 USA; [White, Jason D.] Univ Melbourne, Sch Vet Sci, Parkville, Vic 3052, Australia; [Schirra, Horst Joachim] Univ Queensland, Ctr Adv Imaging, Brisbane, Qld, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); NSW Department of Primary Industries; University of New England; Utah System of Higher Education; Utah State University; University of Melbourne; University of Queensland	Tellam, RL (corresponding author), CSIRO Anim Food & Hlth Sci, Brisbane, Qld, Australia.	ross.tellam@csiro.au; h.schirra@uq.edu.au	Schirra, Horst Joachim/B-4210-2009; Tellam, Ross/T-2423-2019; Greenwood, Paul L/G-9747-2013; White, Jason/AAF-8712-2020; Byrne, Keren A/H-7552-2013; Tellam, Ross/H-2798-2013	Schirra, Horst Joachim/0000-0002-7541-246X; Greenwood, Paul L/0000-0002-7719-8233; White, Jason/0000-0002-0557-392X; Byrne, Keren A/0000-0003-4759-0645; Tellam, Ross/0000-0003-2353-1640	Queensland State Government; CSIRO Office of the Chief Scientist	Queensland State Government; CSIRO Office of the Chief Scientist	The authors acknowledge financial support provided by the Queensland State Government to the Queensland NMR Network facilities, as well as project and fellowship support (to Juan Li) from the CSIRO Office of the Chief Scientist. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd Rahman S, 2013, GROWTH HORM IGF RES, V23, P29, DOI 10.1016/j.ghir.2012.12.001; ALWAIZ M, 1992, METABOLISM, V41, P135, DOI 10.1016/0026-0495(92)90140-6; Arguello A, 2001, ANAT RECORD, V264, P284, DOI 10.1002/ar.1165; ASATOOR AM, 1965, BIOCHIM BIOPHYS ACTA, V111, P384, DOI 10.1016/0304-4165(65)90048-6; BAKER JR, 1962, J BIOL CHEM, V237, P1309; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; Belanche A, 2010, J ANIM PHYSIOL AN N, V94, P648, DOI 10.1111/j.1439-0396.2009.00952.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bidwell CA, 2001, ANIM GENET, V32, P248, DOI 10.1046/j.1365-2052.2001.00776.x; Bidwell CA, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-17; Bidwell CA, 2012, LIVESTOCK EPIGENETICS, P73; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Byrne K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008638; Caiment F, 2010, GENOME RES, V20, P1651, DOI 10.1101/gr.108787.110; Chadeau-Hyam M, 2013, ENVIRON MOL MUTAGEN, V54, P542, DOI 10.1002/em.21797; Charlier C, 2001, NAT GENET, V27, P367, DOI 10.1038/86856; Charlier C, 2004, Bull Mem Acad R Med Belg, V159, P490; Charlier C, 2001, GENOME RES, V11, P850, DOI 10.1101/gr.172701; Cloarec O, 2005, ANAL CHEM, V77, P517, DOI 10.1021/ac048803i; Cockett NE, 2005, GENET SEL EVOL, V37, pS65, DOI 10.1051/gse:2004032; Cockett NE, 1996, SCIENCE, V273, P236, DOI 10.1126/science.273.5272.236; Ellis JL, 2008, J AGR SCI-CAMBRIDGE, V146, P213, DOI 10.1017/S0021859608007752; Eriksson L., 2006, MULTI MEGAVARIATE DA, V2nd, DOI DOI 10.1016/j.arabjc.2013.10.006; ETHERTON TD, 1977, J ANIM SCI, V44, P1100, DOI 10.2527/jas1977.4461100x; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Fleming-Waddell JN, 2007, ANIM GENET, V38, P28, DOI 10.1111/j.1365-2052.2006.01562.x; Fleming-Waddell JN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007399; Freking BA, 1998, J ANIM SCI, V76, P2062; Freking BA, 1998, J ANIM SCI, V76, P2549; Freking BA, 1999, J ANIM SCI, V77, P2336; Freking BA, 2002, GENOME RES, V12, P1496, DOI 10.1101/gr.571002; Goodpaster AM, 2010, ANAL BIOCHEM, V401, P134, DOI 10.1016/j.ab.2010.02.005; Greenwood PL, 2007, AUST J EXP AGR, V47, P1137, DOI 10.1071/EA06324; Greenwood PL, 2006, AUST J AGR RES, V57, P627, DOI 10.1071/AR04318; Greenwood PL, 2006, AUST J AGR RES, V57, P1, DOI 10.1071/AR04316; Haug K, 2013, NUCLEIC ACIDS RES, V41, pD781, DOI 10.1093/nar/gks1004; HEYMSFIELD SB, 1983, AM J CLIN NUTR, V37, P478, DOI 10.1093/ajcn/37.3.478; Jackson SP, 1997, J ANIM SCI, V75, P14; Jackson SP, 1997, J ANIM SCI, V75, P125; Jackson SP, 1997, J ANIM SCI, V75, P133; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kerth CR, 2003, J ANIM SCI, V81, P2213; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Koohmaraie M, 1995, J ANIM SCI, V73, P3596; Lane MA, 2000, J ANIM SCI, V78, P1990; Li JA, 2011, J PROTEOME RES, V10, P1073, DOI 10.1021/pr100862t; LOBLEY GE, 1992, J ANIM SCI, V70, P3264; Maccatrozzo L, 2004, EUR J HISTOCHEM, V48, P357; MITCHELL AD, 1979, J ANIM SCI, V49, P764, DOI 10.2527/jas1979.493764x; Murphy SK, 2005, MAMM GENOME, V16, P171, DOI 10.1007/s00335-004-2421-1; NEILL AR, 1978, BIOCHEM J, V170, P529, DOI 10.1042/bj1700529; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; NICHOLSON JK, 1989, PROG NUCL MAG RES SP, V21, P449, DOI 10.1016/0079-6565(89)80008-1; Picard B, 1998, HISTOCHEM J, V30, P473, DOI 10.1023/A:1003207922944; Picard B, 2009, MEAT SCI, V82, P30, DOI 10.1016/j.meatsci.2008.11.022; POL A, 1988, APPL ENVIRON MICROB, V54, P832, DOI 10.1128/AEM.54.3.832-834.1988; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; QUIGLEY JD, 1991, J DAIRY SCI, V74, P250, DOI 10.3168/jds.S0022-0302(91)78167-8; Reggiani C, 2004, MUSCLE DEV LIVESTOCK; Salek R, 2011, METHOD ENZYMOL, V500, P337, DOI 10.1016/B978-0-12-385118-5.00017-7; Sauer U, 2004, METAB ENG, V6, P220, DOI 10.1016/j.ymben.2003.11.004; Schirra HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002764; Schmidt JV, 2000, GENE DEV, V14, P1997; Schulze A, 2003, MOL CELL BIOCHEM, V244, P143, DOI 10.1023/A:1022443503883; Seal C. J., 1993, Nutrition Research Reviews, V6, P185, DOI 10.1079/NRR19930012; Seitz H, 2003, NAT GENET, V34, P261, DOI 10.1038/ng1171; Slupsky CM, 2007, ANAL CHEM, V79, P6995, DOI 10.1021/ac0708588; Smit M, 2003, GENETICS, V163, P453; Takeda H, 2006, P NATL ACAD SCI USA, V103, P8119, DOI 10.1073/pnas.0602844103; Tanabe R, 1998, MAMM GENOME, V9, P1056, DOI 10.1007/s003359900924; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; VARNAM GCE, 1978, BRIT J NUTR, V40, P359, DOI 10.1079/BJN19780132; Vuocolo T, 2005, AUST J EXP AGR, V45, P879, DOI 10.1071/EA05049; Vuocolo T, 2007, PHYSIOL GENOMICS, V28, P253, DOI 10.1152/physiolgenomics.00121.2006; WALLIMANN T, 1992, BIOCHEM J, V281, P21, DOI 10.1042/bj2810021; Whisnant CS, 1998, J ANIM SCI, V76, P1443; White JD, 2008, DIFFERENTIATION, V76, P283, DOI 10.1111/j.1432-0436.2007.00208.x; WILSON MARION K., 1955, JOUR APPL BACT, V18, P294, DOI 10.1111/j.1365-2672.1955.tb02086.x; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Wyss M, 2002, NEUROSCIENCE, V112, P243, DOI 10.1016/S0306-4522(02)00088-X; Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Yeung CK, 2007, ARCH BIOCHEM BIOPHYS, V464, P251, DOI 10.1016/j.abb.2007.04.014; ZEISEL SH, 1983, J PHARMACOL EXP THER, V225, P320; ZHANG AQ, 1993, BIOCHEM PHARMACOL, V45, P2185, DOI 10.1016/0006-2952(93)90187-2	85	2	2	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99726	10.1371/journal.pone.0099726	http://dx.doi.org/10.1371/journal.pone.0099726			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937646	Green Published, gold			2022-12-27	WOS:000338503400033
J	Fonteh, AN; Cipolla, M; Chiang, JR; Arakaki, XH; Harrington, MG				Fonteh, Alfred N.; Cipolla, Matthew; Chiang, Jiarong; Arakaki, Xianghong; Harrington, Michael G.			Human Cerebrospinal Fluid Fatty Acid Levels Differ between Supernatant Fluid and Brain-Derived Nanoparticle Fractions, and Are Altered in Alzheimer's Disease	PLOS ONE			English	Article							MEDITERRANEAN DIET; BINDING PROTEINS; COGNITIVE DECLINE; LIPID MEDIATORS; AMYLOID-BETA; DEMENTIA; INFLAMMATION; METABOLISM; DIAGNOSIS; VOLUMES	Background: Although saturated (SAFA), monounsaturated (MUFA), and polyunsaturated (PUFA) fatty acids are important structural components of neuronal membranes and precursors of signaling molecules, knowledge of their metabolism in Alzheimer's disease (AD) is limited. Based on recent discovery that lipids in cerebrospinal fluid (CSF) are distributed in both brain-derived nanoparticles (NP) and supernatant fluid (SF), we hypothesized that fatty acid (FA) abundance and distribution into these compartments is altered in early AD pathology. Methodology and Findings: We assayed the FA composition and abundance in CSF fractions from cognitively healthy (CH), mild cognitive impairment (MCI), and AD study participants using gas chromatography -mass spectrometry. In the SF fraction, concentration of docosahexaenoic acid [DHA, (C22:6n-3)] was less in AD compared with CH, while alpha linolenic acid [alpha-LNA, (C18:3n-3)] was lower in MCI compared with CH. In the NP fraction, levels of SAFAs (C15:0, C16:0) and a MUFA (C15:1) differentiated CH from MCI, while two MUFAs (C15:1, C19:1) and four PUFAs (C20:2n-6, C20:3n-3, C22:4n-6, C22:5n-3) were higher in AD compared with CH. Levels of even-chain free SAFA and total free FA levels were higher in AD, levels of odd-chain free SAFAs, MUFAs, n-3 PUFAs, and total PUFA, were lower in AD compared with CH. Free n-6 PUFA levels were similar in all three groups. Conclusions and Significance: FA metabolism is compartmentalized differently in NP versus SF fractions of CSF, and altered FA levels reflect the importance of abnormal metabolism and oxidative pathways in AD. Depleted DHA in CSF fractions in AD is consistent with the importance of n-3 PUFAs in cognitive function, and suggests that disturbed PUFA metabolism contributes to AD pathology. This study of FA levels in CSF fractions from different cognitive stages shows potential AD biomarkers, and provides further insight into cell membrane dysfunctions, including mechanisms leading to amyloid production.	[Fonteh, Alfred N.; Cipolla, Matthew; Chiang, Jiarong; Arakaki, Xianghong; Harrington, Michael G.] Huntington Med Res Inst, Mol Neurol Program, Pasadena, CA 91105 USA	Huntington Medical Research Institutes	Fonteh, AN (corresponding author), Huntington Med Res Inst, Mol Neurol Program, Pasadena, CA 91105 USA.	afonteh@hmri.org; mghworks@hmri.org		Harrington, Michael/0000-0002-7923-8032	L. K. Whittier Foundation; Jerry Dunlevy Family Foundation; Helen Posthuma Foundation	L. K. Whittier Foundation; Jerry Dunlevy Family Foundation; Helen Posthuma Foundation	L. K. Whittier Foundation, the Jerry Dunlevy Family, and Helen Posthuma Foundations. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal R, 2013, BIOCHIM BIOPHYS ACTA, V1842, P535; Akers JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078115; Amtul Z, 2011, BRAIN PATHOL, V21, P321, DOI 10.1111/j.1750-3639.2010.00449.x; Anstey KJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086141; AVELDANO MI, 1983, J LIPID RES, V24, P1101; Bauer I, 2014, HUM PSYCHOPHARM CLIN, V29, P133, DOI 10.1002/hup.2379; Bazan NG, 2013, PROSTAG LEUKOTR ESS, V88, P127, DOI 10.1016/j.plefa.2012.08.008; Bazan NG, 2009, J LIPID RES, V50, pS400, DOI 10.1194/jlr.R800068-JLR200; Bhattacharyya R, 2013, J NEUROSCI, V33, P11169, DOI 10.1523/JNEUROSCI.4704-12.2013; Boneva NB, 2011, J PHARMACOL SCI, V116, P163, DOI 10.1254/jphs.10R34FM; Bowman GL, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00092; Bruce-Keller AJ, 2010, FREE RADICAL BIO MED, V49, P22, DOI 10.1016/j.freeradbiomed.2010.03.006; Cederholm T, 2013, ADV NUTR, V4, P672, DOI 10.3945/an.113.004556; Chang Chia-Yu, 2009, Acta Neurol Taiwan, V18, P231; Cudaback E, 2014, BIOCHEM PHARMACOL, V88, P565, DOI 10.1016/j.bcp.2013.12.014; Dacks PA, 2013, J NUTR HEALTH AGING, V17, P240, DOI 10.1007/s12603-012-0431-3; Desikan RS, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-39; Farias SE, 2011, J TRAUMA, V71, P1211, DOI 10.1097/TA.0b013e3182092c62; Fonteh AN, 2006, DIS MARKERS, V22, P39, DOI 10.1155/2006/202938; Fonteh AN, 2013, J LIPID RES, V54, P2884, DOI 10.1194/jlr.M037622; Galasko D, 2010, BIOMARK MED, V4, P27, DOI 10.2217/BMM.09.89; Gupta S, 2012, J NEUROCHEM, V120, P1060, DOI 10.1111/j.1471-4159.2012.07660.x; Harrington MG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079378; Harrington MG, 2009, FLUIDS BARRIERS CNS, V6, DOI 10.1186/1743-8454-6-10; Hulbert AJ, 2010, INTEGR COMP BIOL, V50, P808, DOI 10.1093/icb/icq007; Innis SM, 2007, EARLY HUM DEV, V83, P761, DOI 10.1016/j.earlhumdev.2007.09.004; Ishimura S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081318; Liu RZ, 2010, INT J DEV BIOL, V54, P1229, DOI 10.1387/ijdb.092976rl; Long EK, 2010, FREE RADICAL BIO MED, V49, P1, DOI 10.1016/j.freeradbiomed.2010.03.015; Lourida I, 2013, EPIDEMIOLOGY, V24, P479, DOI 10.1097/EDE.0b013e3182944410; Marin R, 2013, NEUROSCIENCE, V245, P26, DOI 10.1016/j.neuroscience.2013.04.025; Martin V, 2010, J ALZHEIMERS DIS, V19, P489, DOI 10.3233/JAD-2010-1242; Martinez M, 1998, J NEUROCHEM, V71, P2528; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Milligan G, 2014, BRIT J NUTR, V111, pS3, DOI 10.1017/S0007114513002249; Montine KS, 2004, CHEM PHYS LIPIDS, V128, P117, DOI 10.1016/j.chemphyslip.2003.10.010; Moulle VS, 2014, DIABETES METAB, V40, P29, DOI 10.1016/j.diabet.2013.10.001; Moulle VSF, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00385; Musiek ES, 2012, CURR OPIN NEUROL, V25, P715, DOI 10.1097/WCO.0b013e32835a30f4; OBRIEN JS, 1965, J LIPID RES, V6, P537; Otaegui-Arrazola A, 2014, EUR J NUTR, V53, P1, DOI 10.1007/s00394-013-0561-3; Pelsers MMAL, 2004, CLIN CHEM, V50, P1568, DOI 10.1373/clinchem.2003.030361; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Piomelli D, 2007, NAT REV NEUROSCI, V8, P743, DOI 10.1038/nrn2233; Poojari C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078399; Pottala JV, 2014, NEUROLOGY, V82, P435, DOI 10.1212/WNL.0000000000000080; Quehenberger O, 2008, PROSTAG LEUKOTR ESS, V79, P123, DOI 10.1016/j.plefa.2008.09.021; Rabiei Z, 2013, CURR NEUROVASC RES, V10, P231, DOI 10.2174/15672026113109990007; Roe CM, 2008, ARCH NEUROL-CHICAGO, V65, P1467, DOI 10.1001/archneur.65.11.1467; SASTRY PS, 1985, PROG LIPID RES, V24, P69, DOI 10.1016/0163-7827(85)90011-6; Selkoe DJ, 2000, ANN NY ACAD SCI, V924, P17; Serhan CN, 2013, CURR OPIN PHARMACOL, V13, P632, DOI 10.1016/j.coph.2013.05.012; Solfrizzi V, 2011, CURR ALZHEIMER RES, V8, P520, DOI 10.2174/156720511796391809; Sonnino S, 2014, MOL NEUROBIOL, V50, P130, DOI 10.1007/s12035-013-8614-4; Tanzi RE, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006296; Than ME, 2014, BIOL CHEM, DOI [10.1515/hsz-2013-0280, DOI 10.1515/HSZ-2013-0280]; Titova OE, 2013, EXP GERONTOL, V48, P1443, DOI 10.1016/j.exger.2013.10.002; Yamada D, 2014, NEUROPSYCHOPHARMACOL, V39, P1852, DOI 10.1038/npp.2014.32; Yang XG, 2011, NEUROCHEM INT, V58, P321, DOI 10.1016/j.neuint.2010.12.004; Zhao YH, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0015816, 10.1371/journal.pone.0016470]	60	73	75	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100519	10.1371/journal.pone.0100519	http://dx.doi.org/10.1371/journal.pone.0100519			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956173	Green Published, Green Submitted, gold			2022-12-27	WOS:000338917900060
J	Jiang, NH; Zhang, GH; Zhang, JJ; Shu, LP; Zhang, W; Long, GQ; Liu, T; Meng, ZG; Chen, JW; Yang, SC				Jiang, Ni-Hao; Zhang, Guang-Hui; Zhang, Jia-Jin; Shu, Li-Ping; Zhang, Wei; Long, Guang-Qiang; Liu, Tao; Meng, Zheng-Gui; Chen, Jun-Wen; Yang, Sheng-Chao			Analysis of the Transcriptome of Erigeron breviscapus Uncovers Putative Scutellarin and Chlorogenic Acids Biosynthetic Genes and Genetic Markers	PLOS ONE			English	Article							FUNCTIONAL-CHARACTERIZATION; FLAVONOID BIOSYNTHESIS; IDENTIFICATION; PURIFICATION; GENERATION; DATABASE; PROTEIN; HYDROXYCINNAMOYLTRANSFERASE; REGULATOR; ARTICHOKE	Background: Erigeron breviscapus (Vant.) Hand-Mazz. is a famous medicinal plant. Scutellarin and chlorogenic acids are the primary active components in this herb. However, the mechanisms of biosynthesis and regulation for scutellarin and chlorogenic acids in E. breviscapus are considerably unknown. In addition, genomic information of this herb is also unavailable. Principal Findings: Using Illumina sequencing on GAIIx platform, a total of 64,605,972 raw sequencing reads were generated and assembled into 73,092 non-redundant unigenes. Among them, 44,855 unigenes (61.37%) were annotated in the public databases Nr, Swiss-Prot, KEGG, and COG. The transcripts encoding the known enzymes involved in flavonoids and in chlorogenic acids biosynthesis were discovered in the Illumina dataset. Three candidate cytochrome P450 genes were discovered which might encode flavone 6-hydroase converting apigenin to scutellarein. Furthermore, 4 unigenes encoding the homologues of maize P1 (R2R3-MYB transcription factors) were defined, which might regulate the biosynthesis of scutellarin. Additionally, a total of 11,077 simple sequence repeat (SSR) were identified from 9,255 unigenes. Of SSRs, tri-nucleotide motifs were the most abundant motif. Thirty-six primer pairs for SSRs were randomly selected for validation of the amplification and polymorphism. The result revealed that 34 (94.40%) primer pairs were successfully amplified and 19 (52.78%) primer pairs exhibited polymorphisms. Conclusion: Using next generation sequencing (NGS) technology, this study firstly provides abundant genomic data for E. breviscapus. The candidate genes involved in the biosynthesis and transcriptional regulation of scutellarin and chlorogenic acids were obtained in this study. Additionally, a plenty of genetic makers were generated by identification of SSRs, which is a powerful tool for molecular breeding and genetics applications in this herb.	[Jiang, Ni-Hao; Zhang, Guang-Hui; Zhang, Jia-Jin; Zhang, Wei; Long, Guang-Qiang; Liu, Tao; Meng, Zheng-Gui; Chen, Jun-Wen; Yang, Sheng-Chao] Yunnan Agr Univ, Yunnan Res Ctr Good Agr Practice Dominant Chinese, Kunming, Yunnan, Peoples R China; [Shu, Li-Ping] Kunming Univ Sci & Technol, Kunming, Yunnan, Peoples R China	Yunnan Agricultural University; Kunming University of Science & Technology	Chen, JW (corresponding author), Yunnan Agr Univ, Yunnan Res Ctr Good Agr Practice Dominant Chinese, Kunming, Yunnan, Peoples R China.	cjw31412@hotmail.com; shengchaoyang@163.com			National Natural Science Foundation of China [81160499, 81260614]; Yunan Base Construction Project of Technical Industry Actions for TCM Modernization	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunan Base Construction Project of Technical Industry Actions for TCM Modernization	This work was supported by National Natural Science Foundation of China (no. 81160499 and no. 81260614), and Yunan Base Construction Project of Technical Industry Actions for TCM Modernization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal RK, 2007, THEOR APPL GENET, V114, P359, DOI 10.1007/s00122-006-0440-x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anzellotti D, 2000, ARCH BIOCHEM BIOPHYS, V382, P161, DOI 10.1006/abbi.2000.2002; Berim A, 2013, J BIOL CHEM, V288, P1795, DOI 10.1074/jbc.M112.420448; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Borevitz JO, 2000, PLANT CELL, V12, P2383, DOI 10.1105/tpc.12.12.2383; Cardle L, 2000, GENETICS, V156, P847; Comino C, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-30; Comino C, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-14; Czemmel S, 2009, PLANT PHYSIOL, V151, P1513, DOI 10.1104/pp.109.142059; [董媛 Dong Yuan], 2010, [中国医药工业杂志, Chinese Journal of Pharmaceuticals], V41, P447; Flora of China Editorial Committee, 1985, FLORA CHINA; Fu N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057686; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo JX, 1987, TRADITIONAL PATENT M, V9, P31; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Halbwirth H, 2010, INT J MOL SCI, V11, P595, DOI 10.3390/ijms11020595; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hoffmann L, 2003, J BIOL CHEM, V278, P95, DOI 10.1074/jbc.M209362200; Hong H, 2004, LIFE SCI, V74, P2959, DOI 10.1016/j.lfs.2003.09.074; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kantartzi SK, 2009, GENETICA, V136, P141, DOI 10.1007/s10709-008-9327-x; Latunde-Dada AO, 2001, J BIOL CHEM, V276, P1688, DOI 10.1074/jbc.M006277200; Lee D, 1996, PLANT PHYSIOL, V112, P193, DOI 10.1104/pp.112.1.193; Li Xiao-Bo, 2013, Zhongguo Zhong Yao Za Zhi, V38, P2237; Liu Chun-Xia, 2010, Wuhan Zhiwuxue Yanjiu, V28, P682, DOI 10.3724/SP.J.1142,2010.60682; [刘鹏 LIU Peng], 2006, [第四军医大学学报, Journal of the Fourth Military Medical University], V27, P781; Liu Tao, 2013, Zhongguo Zhong Yao Za Zhi, V38, P2241; Mahesh V, 2007, PLANT MOL BIOL, V64, P145, DOI 10.1007/s11103-007-9141-3; Martens S, 2005, PHYTOCHEMISTRY, V66, P2399, DOI 10.1016/j.phytochem.2005.07.013; Mehrtens F, 2005, PLANT PHYSIOL, V138, P1083, DOI 10.1104/pp.104.058032; Menin B, 2010, PLANT SCI, V179, P338, DOI 10.1016/j.plantsci.2010.06.010; Mulder NJ, 2003, NUCLEIC ACIDS RES, V31, P315, DOI 10.1093/nar/gkg046; Nagashima S, 2000, PHYTOCHEMISTRY, V53, P533, DOI 10.1016/S0031-9422(99)00593-2; Nakatsuka T, 2012, J EXP BOT, V63, P6505, DOI 10.1093/jxb/ers306; Niggeweg R, 2004, NAT BIOTECHNOL, V22, P746, DOI 10.1038/nbt966; Noguchi A, 2009, PLANT CELL, V21, P1556, DOI 10.1105/tpc.108.063826; Qu J, 2001, J CHROMATOGR A, V928, P155, DOI 10.1016/S0021-9673(01)01111-6; Rohlf FJ, 2000, NTSYS PC NUMERICAL T; Sonnante G, 2010, PLANT PHYSIOL, V153, P1224, DOI 10.1104/pp.109.150144; Spelt C, 2000, PLANT CELL, V12, P1619, DOI 10.1105/tpc.12.9.1619; Stracke R, 2007, PLANT J, V50, P660, DOI 10.1111/j.1365-313X.2007.03078.x; Strickler SR, 2012, AM J BOT, V99, P257, DOI 10.3732/ajb.1100292; Sun HD, 2009, PROG CHEM, V21, P77; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Wang S, 2011, NEUROSCIENCE, V185, P150, DOI 10.1016/j.neuroscience.2011.04.005; Wang YF, 2010, CHROMATOGRAPHIA, V71, P845, DOI 10.1365/s10337-010-1540-y; Weir B.S., 1990, GENETIC DATA ANAL ME; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Yang Shengchao, 2010, Zhongguo Zhong Yao Za Zhi, V35, P554; Yang XF, 2003, ACTA PHARMACOL SIN, V24, P1118; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yeh Francis C., 1997, Belgian Journal of Botany, V129, P157; Yu Hong-Yuan, 2002, Acta Botanica Yunnanica, V24, P115; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang Guang-Hui, 2013, Zhongguo Zhong Yao Za Zhi, V38, P2231; Zhang RW, 1981, ACTA PHARM SIN, V16, P68; Zhang ZF, 2008, J PHARMACEUT BIOMED, V48, P980, DOI 10.1016/j.jpba.2008.06.010	60	18	25	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100357	10.1371/journal.pone.0100357	http://dx.doi.org/10.1371/journal.pone.0100357			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956277	Green Published, Green Submitted, gold			2022-12-27	WOS:000338917900043
J	Liu, J; Nian, QG; Zhang, Y; Xu, LJ; Hu, Y; Li, J; Deng, YQ; Zhu, SY; Wu, XY; Qin, ED; Jiang, T; Qin, CF				Liu, Juan; Nian, Qing-Gong; Zhang, Yu; Xu, Li-Juan; Hu, Yi; Li, Jing; Deng, Yong-Qiang; Zhu, Shun-Ya; Wu, Xiao-Yan; Qin, E-De; Jiang, Tao; Qin, Cheng-Feng			In Vitro Characterization of Human Adenovirus Type 55 in Comparison with Its Parental Adenoviruses, Types 11 and 14	PLOS ONE			English	Article							ACUTE RESPIRATORY-DISEASE; B ADENOVIRUSES; OUTBREAK; RECEPTOR; ILLNESS; CHINA; TRANSMISSION; INFECTIONS; CAMP	Human adenovirus type 55 (HAdV-B55) represents a re-emerging human pathogen, and this adenovirus has been reported to cause outbreaks of acute respiratory diseases among military trainees and in school populations around the world. HAdV-B55 has been revealed to have evolved from homologous recombination between human adenovirus type 14 (HAdV-B14) and type 11 (HAdV-B11), but it presents different clinical manifestations from parental virus HAdV-B11. In the present paper, we report the distinct biological features of HAdV-B55 in comparison with the parental viruses HAdV-B11 and HAdV-B14 in cell cultures. The results showed that HAdV-B55 replicated well in various cells, similar to HAdV-B11 and HAdV-B14, but that its processing had a slower and milder cytopathic effect in the early stages of infection. Viral fitness analysis showed that HAdV-B55 exhibited higher levels of replication in respiratory cells than did either of its parents. Cytotoxicity and apoptosis analyses in A549 cells indicated that HAdV-B55 was less cytotoxic than HAdV-B11 and HAdV-B14 were and induced milder apoptosis. Finally, thermal sensitivity analysis revealed that HAdV-B55 exhibited lower thermostability than did either HAdV-B11 or HAdV-B14, which may limit the transmission of HAdV-B55 in humans. Together, the findings described here expand current knowledge about this re-emerging recombinant HAdV, shedding light on the pathogenesis of HAdV-B55.	[Liu, Juan; Nian, Qing-Gong; Zhang, Yu; Xu, Li-Juan; Hu, Yi; Li, Jing; Deng, Yong-Qiang; Zhu, Shun-Ya; Wu, Xiao-Yan; Qin, E-De; Jiang, Tao; Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Dept Virol, Beijing, Peoples R China; [Liu, Juan] Gen Hosp PLA Air Force, Dept Transfus Med, Beijing, Peoples R China	Beijing Institute of Microbiology & Epidemiology	Jiang, T (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Dept Virol, Beijing, Peoples R China.	jiang_tao@126.com; qincf@bmi.ac.cn	Tao, Jiang/AAE-6623-2019; Li, Jing/AAE-6038-2019; Qin, Cheng-Feng/I-6839-2019	Tao, Jiang/0000-0003-1908-2926; Qin, Cheng-Feng/0000-0002-0632-2807; Li, Jing/0000-0002-6860-6135	National Basic Research Project of China [2012CB518904]; Beijing Nova Program of Science and Technology [2010B041]	National Basic Research Project of China(National Basic Research Program of China); Beijing Nova Program of Science and Technology	This work was supported by the National Basic Research Project of China (Grant 2012CB518904). Cheng-Feng Qin was supported by the Beijing Nova Program of Science and Technology (Grant 2010B041). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson BD, 2012, J CLIN VIROL, V54, P265, DOI 10.1016/j.jcv.2012.03.006; Anonymous, 2007, Morbidity and Mortality Weekly Report, V56, P1181; Arnberg N, 2012, TRENDS PHARMACOL SCI, V33, P442, DOI 10.1016/j.tips.2012.04.005; Carr MJ, 2011, EMERG INFECT DIS, V17, P1402, DOI [10.3201/eid1708.101760, 10.3201/1708.101760]; Chmielewicz B, 2005, J MED VIROL, V77, P232, DOI 10.1002/jmv.20441; Gaggar A, 2003, NAT MED, V9, P1408, DOI 10.1038/nm952; Hayashi S, 2007, CURR OPIN PHARMACOL, V7, P237, DOI 10.1016/j.coph.2006.11.014; HIERHOLZER JC, 1974, AM J EPIDEMIOL, V99, P434, DOI 10.1093/oxfordjournals.aje.a121632; Huang GH, 2013, INFLUENZA OTHER RESP, V7, P1048, DOI 10.1111/irv.12118; Kajon AE, 2010, J INFECT DIS, V202, P93, DOI 10.1086/653083; Kajon AE, 2010, J CLIN MICROBIOL, V48, P1438, DOI 10.1128/JCM.01928-09; Kalyuzhniy O, 2008, P NATL ACAD SCI USA, V105, P5483, DOI 10.1073/pnas.0711757105; Killingley B, 2013, INFLUENZA OTHER RESP, V7, P42, DOI 10.1111/irv.12080; Louie JK, 2008, CLIN INFECT DIS, V46, P421, DOI 10.1086/525261; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; Lu QB, 2014, INFLUENZA OTHER RESP, V8, P302, DOI 10.1111/irv.12232; Mei YF, 2002, VIROLOGY, V295, P30, DOI 10.1006/viro.2002.1359; Metzgar D, 2007, J INFECT DIS, V196, P1465, DOI 10.1086/522970; Robinson CM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01812; Walsh MP, 2010, J CLIN MICROBIOL, V48, P991, DOI 10.1128/JCM.01694-09; Wang HJ, 2011, NAT MED, V17, P96, DOI 10.1038/nm.2270; Wang HJ, 2009, VIROLOGY, V387, P436, DOI 10.1016/j.virol.2009.02.034; Yang ZH, 2009, J CLIN MICROBIOL, V47, P3082, DOI 10.1128/JCM.00282-09; Zhu Z, 2009, J CLIN MICROBIOL, V47, P697, DOI 10.1128/JCM.01769-08	24	11	16	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100665	10.1371/journal.pone.0100665	http://dx.doi.org/10.1371/journal.pone.0100665			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956280	Green Submitted, Green Published, gold			2022-12-27	WOS:000338917900079
J	Natoli, L; Maher, L; Shephard, M; Hengel, B; Tangey, A; Badman, SG; Ward, J; Guy, RJ				Natoli, Lisa; Maher, Lisa; Shephard, Mark; Hengel, Belinda; Tangey, Annie; Badman, Steven G.; Ward, James; Guy, Rebecca J.		TTANGO Investigators	Point-of-Care Testing for Chlamydia and Gonorrhoea: Implications for Clinical Practice	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; REMOTE ABORIGINAL COMMUNITIES; NEISSERIA-GONORRHOEAE; TRACHOMATIS INFECTION; AUSTRALIA; PERFORMANCE; PREVALENCE; MANAGEMENT; PROGRAMS; OUTCOMES	Objectives: Point-of-care (POC) testing for chlamydia (CT) and gonorrhoea (NG) offers a new approach to the diagnosis and management of these sexually transmitted infections (STIs) in remote Australian communities and other similar settings. Diagnosis of STIs in remote communities is typically symptom driven, and for those who are asymptomatic, treatment is generally delayed until specimens can be transported to the reference laboratory, results returned and the patient recalled. The objective of this study was to explore the clinical implications of using CT/NG POC tests in routine clinical care in remote settings. Methods: In-depth qualitative interviews were conducted with a purposively selected group of 18 key informants with a range of sexual health and laboratory expertise. Results: Participants highlighted the potential impact POC testing would have on different stages of the current STI management pathway in remote Aboriginal communities and how the pathway would change. They identified implications for offering a POC test, specimen collection, conducting the POC test, syndromic management of STIs, pelvic inflammatory disease diagnosis and management, interpretation and delivery of POC results, provision of treatment, contact tracing, management of client flow and wait time, and re-testing at 3 months after infection. Conclusions: The introduction of POC testing to improve STI service delivery requires careful consideration of both its advantages and limitations. The findings of this study will inform protocols for the implementation of CT/NG POC testing, and also STI testing and management guidelines.	[Natoli, Lisa; Maher, Lisa; Badman, Steven G.; Guy, Rebecca J.] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia; [Natoli, Lisa] Burnet Inst, Melbourne, Vic, Australia; [Hengel, Belinda] Apunipima Cape York Hlth Council, Cairns, Qld, Australia; [Tangey, Annie] Ngaanyatjarra Hlth Serv, Alice Springs, NT, Australia; [Shephard, Mark] Flinders Univ S Australia, Int Ctr Point Of Care Testing, Adelaide, SA 5001, Australia; [Ward, James] Baker IDI, Alice Springs, NT, Australia	University of New South Wales Sydney; Kirby Institute; Burnet Institute; Flinders University South Australia; Baker Heart and Diabetes Institute	Natoli, L (corresponding author), Univ New S Wales, Kirby Inst, Sydney, NSW, Australia.	lisan@burnet.edu.au	Ward, James/ABD-1439-2020; Whiley, David M/E-8955-2011	Ward, James/0000-0002-2892-4542; Whiley, David M/0000-0001-5969-3161; Maher, Lisa/0000-0001-6020-6519; Badman, Steven G/0000-0003-4222-3176; Hengel, Belinda/0000-0002-3013-7716; Shephard, Mark DS/0000-0002-9181-1874; Anderson, David/0000-0002-9969-3905; Regan, David/0000-0002-2893-0969; Guy, Rebecca/0000-0002-2929-4634; Tangey, Annie/0000-0003-0798-0542	National Health and Medical Research Council (NHMRC) [109902]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	TTANGO is funded by a National Health and Medical Research Council (NHMRC) Project Grant # 109902. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alary M, 2006, SEX TRANSM INFECT, V82, pV29, DOI 10.1136/sti.2006.021865; Allaire A D, 1998, Infect Dis Obstet Gynecol, V6, P116, DOI 10.1002/(SICI)1098-0997(1998)6:3<116::AID-IDOG4>3.0.CO;2-V; [Anonymous], 2011, RAP SYPH TEST TOOLK; Bowden FJ, 2002, MED J AUSTRALIA, V176, P551, DOI 10.5694/j.1326-5377.2002.tb04554.x; Bradshaw N, 2004, FERTIL STERIL, V82, pS15, DOI 10.1016/j.fertnstert.2004.07.043; Cecil JA, 2001, J INFECT DIS, V184, P1216, DOI 10.1086/323662; Centre for Disease Control, 2008, NT GUID MAN SEX TRAN; Communicable Disease Control Directorate, 2006, GUID MAN SEX TRANSM; Dallabetta GA, 1998, SEX TRANSM INFECT, V74, pS1; Fagan P, 2001, VENEREOLOGY, V14, P55; Farley TA, 2003, PREV MED, V36, P502, DOI 10.1016/S0091-7435(02)00058-0; Foundation for Innovative New Diagnostics, 2013, MAL REP DIAGN TESTS; Gaydos CA, 2013, J CLIN MICROBIOL, V51, P1666, DOI 10.1128/JCM.03461-12; Geisler WM, 2008, SEX TRANSM DIS, V35, P119, DOI 10.1097/OLQ.0b013e318151497d; Gibbs L, 2007, AUST NZ J PUBL HEAL, V31, P540, DOI 10.1111/j.1753-6405.2007.00140.x; Goldenberg SM, 2008, CAN J PUBLIC HEALTH, V99, P350, DOI 10.1007/BF03403770; Guy R, 2011, AUSTR SEX HLTH C CAN; Guy R, 2012, SEX HEALTH, V9, P205, DOI 10.1071/SH11074; Guy RJ, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-485; HOOK EW, 1994, JAMA-J AM MED ASSOC, V272, P867, DOI 10.1001/jama.272.11.867; KATZ BP, 1994, ADOLESCENT PEDIAT G, V7, P147, DOI 10.1016/S0932-8610(19)80118-4; Korenromp EL, 2002, INT J STD AIDS, V13, P91, DOI 10.1258/0956462021924712; Lewis D, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-113; Low N, 2006, SEX TRANSM INFECT, V82, P212, DOI 10.1136/sti.2005.017186; Mayaud P, 2004, SEX TRANSM INFECT, V80, P174, DOI 10.1136/sti.2002.004101; McDonagh P, 2009, SEX HEALTH, V6, P241, DOI 10.1071/SH09025; NACCHO/RACGP, 2012, NAT GUID PREV HLTH A; Oakeshott P, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1642; Peeling RW, 2006, SEX TRANSM INFECT, V82, pV1, DOI 10.1136/sti.2006.024265; Peeling RW, 2013, SEX TRANSM INFECT, V89, P115, DOI 10.1136/sextrans-2012-050617; Peeling RW, 2011, SEX TRANSM INFECT, V87, pII28, DOI 10.1136/sti.2010.047647; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Regan DG, 2008, J INFECT DIS, V198, P349, DOI 10.1086/589883; Shephard M, 2013, POINT CARE, V12, P41, DOI 10.1097/POC.0b013e318265f79e; Skov S, 2003, CARPA REFERENCE MANU; SMITH L, 2013, SEX TRANSM INFECT, P89; STI in Gay Men Action Group, 2010, SEX TRANSM INF GUID; STIGMA, 2019, GUID MAN SEX TRANSM; Tabrizi SN, 2013, J CLIN MICROBIOL, V51, P1945, DOI 10.1128/JCM.00806-13; The Royal Australian College of General Practitioners, 2012, GUID PREV ACT GEN PR; van Dommelen L, 2010, SEX TRANSM INFECT, V86, P355, DOI 10.1136/sti.2010.042598; Weinstein SA, 2011, SEX HEALTH, V8, P143, DOI 10.1071/SH10065; Whiley DM, 2012, J ANTIMICROB CHEMOTH, V67, P2059, DOI 10.1093/jac/dks188	43	23	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100518	10.1371/journal.pone.0100518	http://dx.doi.org/10.1371/journal.pone.0100518			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956111	gold, Green Submitted, Green Published			2022-12-27	WOS:000338917900059
J	Walk, EL; McLaughlin, S; Coad, J; Weed, SA				Walk, Elyse L.; McLaughlin, Sarah; Coad, James; Weed, Scott A.			Use of High Frequency Ultrasound to Monitor Cervical Lymph Node Alterations in Mice	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMAS; FINE-NEEDLE-ASPIRATION; ORAL-CAVITY TUMORS; NECK-CANCER; BREAST-CANCER; HEAD; CARCINOGENESIS; MODEL; MOUSE; ULTRASONOGRAPHY	Cervical lymph node evaluation by clinical ultrasound is a non-invasive procedure used in diagnosing nodal status, and when combined with fine-needle aspiration cytology (FNAC), provides an effective method to assess nodal pathologies. Development of high-frequency ultrasound (HF US) allows real-time monitoring of lymph node alterations in animal models. While HF US is frequently used in animal models of tumor biology, use of HF US for studying cervical lymph nodes alterations associated with murine models of head and neck cancer, or any other model of lymphadenopathy, is lacking. Here we utilize HF US to monitor cervical lymph nodes changes in mice following exposure to the oral cancer-inducing carcinogen 4-nitroquinoline-1-oxide (4-NQO) and in mice with systemic autoimmunity. 4-NQO induces tumors within the mouse oral cavity as early as 19 wks that recapitulate HNSCC. Monitoring of cervical (mandibular) lymph nodes by gray scale and power Doppler sonography revealed changes in lymph node size eight weeks after 4-NQO treatment, prior to tumor formation. 4-NQO causes changes in cervical node blood flow resulting from oral tumor progression. Histological evaluation indicated that the early 4-NQO induced changes in lymph node volume were due to specific hyperproliferation of T-cell enriched zones in the paracortex. We also show that HF US can be used to perform image-guided fine needle aspirate (FNA) biopsies on mice with enlarged mandibular lymph nodes due to genetic mutation of Fas ligand (Fasl). Collectively these studies indicate that HF US is an effective technique for the non-invasive study of cervical lymph node alterations in live mouse models of oral cancer and other mouse models containing cervical lymphadenopathy.	[Walk, Elyse L.; Weed, Scott A.] W Virginia Univ, Dept Neurobiol & Anat, Morgantown, WV 26506 USA; [Coad, James] W Virginia Univ, Dept Pathol, Morgantown, WV 26506 USA; [Walk, Elyse L.; Weed, Scott A.] W Virginia Univ, Program Canc Cell Biol, Morgantown, WV 26506 USA; [McLaughlin, Sarah] W Virginia Univ, Anim Models & Imaging Facil, Morgantown, WV 26506 USA; [Walk, Elyse L.; McLaughlin, Sarah; Weed, Scott A.] W Virginia Univ, Mary Babb Randolph Canc Ctr, Morgantown, WV 26506 USA	West Virginia University; West Virginia University; West Virginia University; West Virginia University; West Virginia University	Weed, SA (corresponding author), W Virginia Univ, Dept Neurobiol & Anat, Morgantown, WV 26506 USA.	scweed@hsc.wvu.edu		McLaughlin, Sarah/0000-0002-8413-3585; Weed, Scott/0000-0001-7033-9999	West Virginia University, Mary Babb Randolph Cancer Center, Dorothy D. Radford Endowment; Mary Babb Randolph Cancer Center; National Institute of Health [P20 RR016440, P30 RR032138/GM103488, S10 RR026378]; NATIONAL CENTER FOR RESEARCH RESOURCES [P30RR032138, S10RR026378, P20RR016440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103488] Funding Source: NIH RePORTER	West Virginia University, Mary Babb Randolph Cancer Center, Dorothy D. Radford Endowment; Mary Babb Randolph Cancer Center; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funds from the West Virginia University, Mary Babb Randolph Cancer Center, Dorothy D. Radford Endowment. The West Virginia University Animal Models & Imaging Facility is supported by the Mary Babb Randolph Cancer Center and National Institute of Health grants P20 RR016440, P30 RR032138/GM103488 and S10 RR026378. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja AT, 2008, CANCER IMAGING, V8, P48, DOI 10.1102/1470-7330.2008.0006; Alyas F, 2005, BRIT J RADIOL, V78, P362, DOI 10.1259/bjr/93120352; Argiris A, 2008, LANCET, V371, P1695, DOI 10.1016/S0140-6736(08)60728-X; Bosisio MR, 2009, ULTRASOUND MED BIOL, V35, P1209, DOI 10.1016/j.ultrasmedbio.2009.02.005; CHANG DB, 1994, AM J ROENTGENOL, V162, P965, DOI 10.2214/ajr.162.4.8141027; Charles RP, 2011, CANCER RES, V71, P3863, DOI 10.1158/0008-5472.CAN-10-4463; Chung MK, 2012, ANN SURG ONCOL, V19, P1595, DOI 10.1245/s10434-011-2154-9; Czeminski R, 2009, CANCER PREV RES, V2, P27, DOI 10.1158/1940-6207.CAPR-08-0147; de Bondt RBJ, 2007, EUR J RADIOL, V64, P266, DOI 10.1016/j.ejrad.2007.02.037; Diallo-Krou E, 2009, ENDOCRINOLOGY, V150, P5181, DOI 10.1210/en.2009-0701; Ehlers S, 2003, J IMMUNOL, V170, P5210, DOI 10.4049/jimmunol.170.10.5210; Greco A, 2011, J BIOMEDICINE BIOTEC, V2012; Hasina R, 2009, CANCER PREV RES, V2, P385, DOI 10.1158/1940-6207.CAPR-08-0211; Jugold M, 2008, EUR RADIOL, V18, P753, DOI 10.1007/s00330-007-0825-5; Kanojia D, 2006, ORAL ONCOL, V42, P655, DOI 10.1016/j.oraloncology.2005.10.013; Kim S, 2009, CLIN EXP OTORHINOLAR, V2, P55, DOI 10.3342/ceo.2009.2.2.55; Kodama T, 2011, CANCER RES, V71, P6957, DOI 10.1158/0008-5472.CAN-11-2389; Lee SY, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-206; Leeman-Neill RJ, 2011, CANCER PREV RES, V4, P230, DOI 10.1158/1940-6207.CAPR-10-0249; LEEMANS CR, 1993, CANCER, V71, P452, DOI 10.1002/1097-0142(19930115)71:2<452::AID-CNCR2820710228>3.0.CO;2-B; Li J, 2012, ORAL ONCOL; Li L, 2013, CANC RES; Li L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055797; Liao LJ, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-236; Loveless ME, 2008, J ULTRAS MED, V27, P1699, DOI 10.7863/jum.2008.27.12.1699; Lu SL, 2006, HEAD NECK-J SCI SPEC, V28, P945, DOI 10.1002/hed.20397; Mancini M, 2009, ENDOCRINOLOGY, V150, P4810, DOI 10.1210/en.2009-0417; Ng Shu-Hang, 2006, Chang Gung Med J, V29, P119; Noguti J, 2012, CANCER GENOM PROTEOM, V9, P329; Pezold JC, 2006, ORL-J OTO-RHIN-LARYN, V68, P159, DOI 10.1159/000091324; Qian CN, 2006, CANCER RES, V66, P10365, DOI 10.1158/0008-5472.CAN-06-2977; ROTHS JB, 1984, J EXP MED, V159, P1, DOI 10.1084/jem.159.1.1; Rubaltelli L, 2004, J ULTRAS MED, V23, P829, DOI 10.7863/jum.2004.23.6.829; Sano D, 2009, HEAD NECK ONCOL, V1, DOI 10.1186/1758-3284-1-32; Sapino A, 2003, BRIT J CANCER, V88, P702, DOI 10.1038/sj.bjc.6600744; Snyder CS, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-106; Stoeckli SJ, 2012, HEAD NECK-J SCI SPEC, V34, P469, DOI 10.1002/hed.21764; TAKAHASHI T, 1994, CELL, V76, P969, DOI 10.1016/0092-8674(94)90375-1; Tang XH, 2004, CLIN CANCER RES, V10, P301, DOI 10.1158/1078-0432.CCR-0999-3; Van den Broeck W, 2006, J IMMUNOL METHODS, V312, P12, DOI 10.1016/j.jim.2006.01.022; van Herpen CML, 2005, CLIN CANCER RES, V11, P1899, DOI 10.1158/1078-0432.CCR-04-1524; VANDENBREKEL MWM, 1994, RADIOLOGY, V192, P617, DOI 10.1148/radiology.192.3.8058923; Vered M, 2007, ORAL ONCOL, V43, P999, DOI 10.1016/j.oraloncology.2006.11.007; Vitale-Cross L, 2012, CANCER PREV RES, V5, P562, DOI 10.1158/1940-6207.CAPR-11-0502; Vitale-Cross L, 2009, CANCER PREV RES, V2, P419, DOI 10.1158/1940-6207.CAPR-09-0058; Wilkey JF, 2009, MOL CARCINOGEN, V48, P853, DOI 10.1002/mc.20531; Woolgar JA, 2012, EUROPEAN ARCH OTORHI, P1; Ying M, 2006, RADIOGRAPHY, V12, P105, DOI 10.1016/j.radi.2005.04.004; Yuan B, 1997, ONCOGENE, V15, P1161, DOI 10.1038/sj.onc.1201269; Zagorianakou P, 2005, EUR J GYNAECOL ONCOL, V26, P143; Zenk J, 2005, ANN OTO RHINOL LARYN, V114, P43, DOI 10.1177/000348940511400108; Zhou GL, 2010, CANCER PREV RES, V3, P1493, DOI 10.1158/1940-6207.CAPR-10-0135	52	4	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100185	10.1371/journal.pone.0100185	http://dx.doi.org/10.1371/journal.pone.0100185			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955984	Green Submitted, gold, Green Published			2022-12-27	WOS:000338917900031
J	Crane, MM; Clark, IBN; Bakker, E; Smith, S; Swain, PS				Crane, Matthew M.; Clark, Ivan B. N.; Bakker, Elco; Smith, Stewart; Swain, Peter S.			A Microfluidic System for Studying Ageing and Dynamic Single-Cell Responses in Budding Yeast	PLOS ONE			English	Article							NUCLEAR-LOCALIZATION; GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTOR; KINASE PATHWAY; DEVICE; NOISE; STRESS; SIGNAL; POLY(DIMETHYLSILOXANE)	Recognition of the importance of cell-to-cell variability in cellular decision-making and a growing interest in stochastic modeling of cellular processes has led to an increased demand for high density, reproducible, single-cell measurements in time-varying surroundings. We present ALCATRAS (A Long-term Culturing And TRApping System), a microfluidic device that can quantitatively monitor up to 1000 cells of budding yeast in a well-defined and controlled environment. Daughter cells are removed by fluid flow to avoid crowding allowing experiments to run for over 60 hours, and the extracellular media may be changed repeatedly and in seconds. We illustrate use of the device by measuring ageing through replicative life span curves, following the dynamics of the cell cycle, and examining history-dependent behaviour in the general stress response.	[Crane, Matthew M.; Clark, Ivan B. N.; Bakker, Elco; Swain, Peter S.] Univ Edinburgh, SynthSys Ctr Synthet & Syst Biol, Edinburgh, Midlothian, Scotland; [Crane, Matthew M.; Clark, Ivan B. N.; Bakker, Elco; Swain, Peter S.] Univ Edinburgh, Sch Biol Sci, Edinburgh, Midlothian, Scotland; [Smith, Stewart] Univ Edinburgh, Scottish Microelect Ctr, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; University of Edinburgh	Swain, PS (corresponding author), Univ Edinburgh, SynthSys Ctr Synthet & Syst Biol, Edinburgh, Midlothian, Scotland.	peter.swain@ed.ac.uk	Swain, Peter S/AAW-3265-2020; Smith, Stewart/C-1178-2008	Smith, Stewart/0000-0002-7004-9219; Swain, Peter/0000-0001-7489-8587	Biotechnology and Biological Sciences Research Council of the United Kingdom; Scottish University Life Sciences Alliance; Biotechnology and Biological Sciences Research Council [BB/I00906X/1, 1064638] Funding Source: researchfish; BBSRC [BB/I00906X/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Scottish University Life Sciences Alliance; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council of the United Kingdom and the Scottish University Life Sciences Alliance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Bennett MR, 2008, NATURE, V454, P1119, DOI 10.1038/nature07211; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; CHANT J, 1995, J CELL BIOL, V129, P751, DOI 10.1083/jcb.129.3.751; Charvin G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001468; Costanzo M, 2004, CELL, V117, P899, DOI 10.1016/j.cell.2004.05.024; Denervaud N, 2013, P NATL ACAD SCI USA, V110, P15842, DOI 10.1073/pnas.1308265110; Di Carlo D, 2006, LAB CHIP, V6, P1445, DOI 10.1039/b605937f; Di Talia S, 2007, NATURE, V448, P947, DOI 10.1038/nature06072; Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z; Edelstein A, 2010, CURR PROTOC MOL BIOL, V92; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Enfors SO, 2001, J BIOTECHNOL, V85, P175, DOI 10.1016/S0168-1656(00)00365-5; Falconnet D, 2011, LAB CHIP, V11, P466, DOI [10.1039/c0lc00228c, 10.1039/c01c00228c]; Fehrmann S, CELL REPORTS, V5, P1589; Gorner W, 2002, EMBO J, V21, P135, DOI 10.1093/emboj/21.1.135; Gorner W, 1998, GENE DEV, V12, P586, DOI 10.1101/gad.12.4.586; Hao N, 2013, SCIENCE, V339, P460, DOI 10.1126/science.1227299; Hao N, 2012, NAT STRUCT MOL BIOL, V19, P31, DOI 10.1038/nsmb.2192; Hersen P, 2008, P NATL ACAD SCI USA, V105, P7165, DOI 10.1073/pnas.0710770105; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jacquet M, 2003, J CELL BIOL, V161, P497, DOI 10.1083/jcb.200303030; Lee PJ, 2008, BIOTECHNIQUES, V44, P91, DOI 10.2144/000112673; Lee SS, 2012, P NATL ACAD SCI USA, V109, P4916, DOI 10.1073/pnas.1113505109; McClean MN, 2011, METHODS MOL BIOL, V734, P101, DOI 10.1007/978-1-61779-086-7_6; McDonald JC, 2000, ELECTROPHORESIS, V21, P27, DOI 10.1002/(SICI)1522-2683(20000101)21:1<27::AID-ELPS27>3.0.CO;2-C; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Ricicova M, 2013, P NATL ACAD SCI USA, V110, P11403, DOI 10.1073/pnas.1215850110; Ryley J, 2006, YEAST, V23, P1065, DOI 10.1002/yea.1412; Shahrezaei V, 2008, CURR OPIN BIOTECH, V19, P369, DOI 10.1016/j.copbio.2008.06.011; Skelley AM, 2009, NAT METHODS, V6, P147, DOI [10.1038/NMETH.1290, 10.1038/nmeth.1290]; Steinkraus KA, 2008, ANNU REV CELL DEV BI, V24, P29, DOI 10.1146/annurev.cellbio.23.090506.123509; Tan WH, 2007, P NATL ACAD SCI USA, V104, P1146, DOI 10.1073/pnas.0606625104; Taylor RJ, 2009, P NATL ACAD SCI USA, V106, P3758, DOI 10.1073/pnas.0813416106; Wheeler AR, 2003, ANAL CHEM, V75, P3581, DOI 10.1021/ac0340758; Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153; Xie ZW, 2012, AGING CELL, V11, P599, DOI 10.1111/j.1474-9726.2012.00821.x; Zechner C, 2014, NAT METHODS, V11, P197, DOI [10.1038/NMETH.2794, 10.1038/nmeth.2794]; Zhang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048275; Zhou CK, 2011, CELL, V147, P1186, DOI 10.1016/j.cell.2011.11.002	42	39	41	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100042	10.1371/journal.pone.0100042	http://dx.doi.org/10.1371/journal.pone.0100042			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950344	Green Submitted, Green Published, gold			2022-12-27	WOS:000338276300031
J	Dong, WW; Liu, YX; Zhu, WJ; Mou, Q; Wang, JL; Hu, Y				Dong, Weiwei; Liu, Yixuan; Zhu, Weijie; Mou, Quan; Wang, Jinliang; Hu, Yi			Simulation of Swanson's Literature-Based Discovery: Anandamide Treatment Inhibits Growth of Gastric Cancer Cells In Vitro and In Silico	PLOS ONE			English	Article							ENDOCANNABINOID SYSTEM; HYPOTHESES; TARGET	Swanson's literature-based discovery focus on resurrecting previously published but neglected knowledge. In this study, we propose a two-step model of the discovery process and generate a hypothesis between anandamide and gastric cancer. Further, the potential relationship was confirmed by follow-up experimentation. The anandamide treatment resulted in cell cycle redistribution of gastric cancer cells. Most importantly, the variation of cell cycle was mediated by some genes from the B-terms of the closed discovery, indicating the potential role of the B-terms. Swanson's literature-based discovery not only collates data for possible interactions, but also provides the potential to observe the larger background behind these direct links and is an invaluable discovery tool for investigators.	[Dong, Weiwei; Wang, Jinliang; Hu, Yi] Gen Hosp PLA, Dept Oncol, Beijing, Peoples R China; [Liu, Yixuan] Peking Univ, Dept Gastroenterol, Hosp 3, Hlth Sci Ctr, Beijing 100871, Peoples R China; [Zhu, Weijie] Beijing Ctr Dis Control & Prevent CDC, Beijing, Peoples R China; [Zhu, Weijie] Ctr Prevent Med Res, Beijing, Peoples R China; [Mou, Quan] PLA 252 Hosp, Dept Surg, Baoding, Peoples R China	Chinese People's Liberation Army General Hospital; Peking University	Hu, Y (corresponding author), Gen Hosp PLA, Dept Oncol, Beijing, Peoples R China.	13810869059@163.com			Chinese Geriatric Oncology Society [CGOS-03-2013-1-1-00600]	Chinese Geriatric Oncology Society	This study was funded by the Chinese Geriatric Oncology Society (oncology program, grants CGOS-03-2013-1-1-00600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamic LA, 2002, CSB2002: IEEE COMPUTER SOCIETY BIOINFORMATICS CONFERENCE, P109, DOI 10.1109/CSB.2002.1039334; Allum WH, 2011, GUT, V60, P1449, DOI 10.1136/gut.2010.228254; Bari M, 2006, MINI-REV MED CHEM, V6, P257, DOI 10.2174/138955706776073466; Borrelli F, 2009, BEST PRACT RES CL EN, V23, P33, DOI 10.1016/j.beem.2008.10.003; Gaetani S, 2009, INT REV NEUROBIOL, V85, P57, DOI 10.1016/S0074-7742(09)85005-8; Gu Chen-yi, 2004, Zhongguo Zhong Xi Yi Jie He Za Zhi, V24, P973; Hamtiaux L, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-92; Hamtiaux L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026823; Hur J, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-49; Karam SM, 2008, ANN NY ACAD SCI, V1138, P162, DOI 10.1196/annals.1414.023; Maccarrone M, 2003, CELL DEATH DIFFER, V10, P946, DOI 10.1038/sj.cdd.4401284; Miyato H, 2009, J SURG RES, V155, P40, DOI 10.1016/j.jss.2008.06.045; Nithipatikom K, 2012, ENDOCRINOLOGY, V153, P29, DOI 10.1210/en.2011-1144; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Smalheiser NR, 2009, COMPUT METH PROG BIO, V94, P190, DOI 10.1016/j.cmpb.2008.12.006; Smalheiser NR, 1998, COMPUT METH PROG BIO, V57, P149, DOI 10.1016/S0169-2607(98)00033-9; Srinivasan P, 2004, J AM SOC INF SCI TEC, V55, P396, DOI 10.1002/asi.10389; Swanson DR, 2006, J AM SOC INF SCI TEC, V57, P1427, DOI 10.1002/asi.20438; Swanson DR, 2011, J BIOMED DISCOV COLL, V6, DOI 10.5210/disco.v6i0.3515; SWANSON DR, 1990, B MED LIBR ASSOC, V78, P29; Weeber M, 2001, J AM SOC INF SCI TEC, V52, P548, DOI 10.1002/asi.1104	21	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100436	10.1371/journal.pone.0100436	http://dx.doi.org/10.1371/journal.pone.0100436			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949851	gold, Green Published, Green Submitted			2022-12-27	WOS:000338276300074
J	Hays, T; Ma'ayan, A; Clark, NR; Tan, CM; Teixeira, A; Teixeira, A; Choi, JW; Burdis, N; Jung, SY; Bajaj, AO; O'Malley, BW; He, JC; Hyink, DP; Klotman, PE				Hays, Thomas; Ma'ayan, Avi; Clark, Neil R.; Tan, Christopher M.; Teixeira, Avelino; Teixeira, Angela; Choi, Jae W.; Burdis, Nora; Jung, Sung Yun; Bajaj, Amol O.; O'Malley, Bert W.; He, John C.; Hyink, Deborah P.; Klotman, Paul E.			Proteomics Analysis of the Non-Muscle Myosin Heavy Chain IIa-Enriched Actin-Myosin Complex Reveals Multiple Functions within the Podocyte	PLOS ONE			English	Article							INTERACTION NETWORK; MYH9; DISEASE; RESOURCE; DATABASE; NEF; EXPRESSION; GENES; PATHOGENICITY; ASSOCIATION	MYH9 encodes non-muscle myosin heavy chain IIA (NMMHCIIA), the predominant force-generating ATPase in non-muscle cells. Several lines of evidence implicate a role for MYH9 in podocytopathies. However, NMMHCIIA` s function in podocytes remains unknown. To better understand this function, we performed immuno-precipitation followed by mass-spectrometry proteomics to identify proteins interacting with the NMMHCIIA-enriched actin-myosin complexes. Computational analyses revealed that these proteins belong to functional networks including regulators of cytoskeletal organization, metabolism and networks regulated by the HIV-1 gene nef. We further characterized the subcellular localization of NMMHCIIA within podocytes in vivo, and found it to be present within the podocyte major foot processes. Finally, we tested the effect of loss of MYH9 expression in podocytes in vitro, and found that it was necessary for cytoskeletal organization. Our results provide the first survey of NMMHCIIA-enriched actin-myosin-interacting proteins within the podocyte, demonstrating the important role of NMMHCIIA in organizing the elaborate cytoskeleton structure of podocytes. Our characterization of NMMHCIIA's functions goes beyond the podocyte, providing important insights into its general molecular role.	[Hays, Thomas; Teixeira, Avelino; Teixeira, Angela; He, John C.] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA; [Ma'ayan, Avi; Clark, Neil R.; Tan, Christopher M.] Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Choi, Jae W.; Burdis, Nora; Jung, Sung Yun; Hyink, Deborah P.; Klotman, Paul E.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Bajaj, Amol O.; O'Malley, Bert W.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Baylor College of Medicine; Baylor College of Medicine	Hays, T (corresponding author), Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA.	thomas.hays@mssm.edu	Bajaj, Amol/AHA-0698-2022; Hyink, Deborah/AAT-6821-2021; Hays, Thomas/ABA-6640-2020; Ma'ayan, Avi/AAG-3131-2019	Hyink, Deborah/0000-0001-5820-4995; Ma'ayan, Avi/0000-0002-6904-1017; Bajaj, Amol/0000-0001-5099-1365; Jung, Sung Yun/0000-0003-1521-7977	 [P01 DK056492];  [1RC4DK090860];  [3T32GM007280-33S1];  [R01GM098316-01A1];  [P50GM071558-05];  [R01DK088541-01A1];  [U54HG006097-02S1]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006097] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071558, T32GM007280, R01GM098316] Funding Source: NIH RePORTER	; ; ; ; ; ; ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the following grants: P01 DK056492 and 1RC4DK090860 to PK; 3T32GM007280-33S1 to TH; R01GM098316-01A1, P50GM071558-05, R01DK088541-01A1, and U54HG006097-02S1 to AM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P37, DOI 10.1093/nar/29.1.37; Asanuma K, 2005, J CLIN INVEST, V115, P1188, DOI 10.1172/JCI200523371; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ashley-Koch AE, 2011, BRIT J HAEMATOL, V155, P386, DOI 10.1111/j.1365-2141.2011.08832.x; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Barisoni L, 2003, CURR OPIN NEPHROL HY, V12, P251, DOI 10.1097/00041552-200305000-00005; Beuming T, 2005, BIOINFORMATICS, V21, P827, DOI 10.1093/bioinformatics/bti098; Chatr-Aryamontri A, 2007, NUCLEIC ACIDS RES, V35, pD572, DOI 10.1093/nar/gkl950; Chatr-aryamontri A, 2009, NUCLEIC ACIDS RES, V37, pD669, DOI 10.1093/nar/gkn739; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chuang PY, 2009, NEPHRON PHYSIOL, V111, P9, DOI 10.1159/000191075; Clauset A, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.026132; Cooke JN, 2012, NEPHROL DIAL TRANSPL, V27, P1505, DOI 10.1093/ndt/gfr522; Dannenfelser R, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-156; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Faul C, 2007, TRENDS CELL BIOL, V17, P428, DOI 10.1016/j.tcb.2007.06.006; Garg P, 2007, NEPHRON EXP NEPHROL, V106, pE67, DOI 10.1159/000101795; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hamosh A, 2002, NUCLEIC ACIDS RES, V30, P52, DOI 10.1093/nar/30.1.52; Hanna Z, 2001, J VIROL, V75, P9378, DOI 10.1128/JVI.75.19.9378-9392.2001; Hanna Z, 1998, CELL, V95, P163, DOI 10.1016/S0092-8674(00)81748-1; Hays T, 2012, AIDS, V26, P797, DOI 10.1097/QAD.0b013e328351f6cf; He JCJ, 2004, J CLIN INVEST, V114, P643, DOI 10.1172/JCI200421004; Hermjakob H, 2004, NUCLEIC ACIDS RES, V32, pD452, DOI 10.1093/nar/gkh052; Johnstone DB, 2011, MOL CELL BIOL, V31, P2162, DOI 10.1128/MCB.05234-11; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kao WHL, 2008, NAT GENET, V40, P1185, DOI 10.1038/ng.232; Kelder T, 2012, NUCLEIC ACIDS RES, V40, pD1301, DOI 10.1093/nar/gkr1074; Kopp JB, 2008, NAT GENET, V40, P1175, DOI 10.1038/ng.226; Lachmann A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-87; Lachmann A, 2009, BIOINFORMATICS, V25, P684, DOI 10.1093/bioinformatics/btp026; Li Y, 2008, CELL MOTIL CYTOSKEL, V65, P393, DOI 10.1002/cm.20268; Lu TC, 2008, J BIOL CHEM, V283, P8173, DOI 10.1074/jbc.M708920200; Lynn DJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.55; Ma'ayan A, 2005, SCIENCE, V309, P1078, DOI 10.1126/science.1108876; Mewes HW, 2004, NUCLEIC ACIDS RES, V32, pD41, DOI 10.1093/nar/gkh092; Mundel P, 1997, J AM SOC NEPHROL, V8, P697; Peri S, 2004, NUCLEIC ACIDS RES, V32, pD497, DOI 10.1093/nar/gkh070; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Sekine T, 2010, KIDNEY INT, V78, P207, DOI 10.1038/ki.2010.21; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; Seri M, 2003, MEDICINE, V82, P203, DOI 10.1097/00005792-200305000-00006; Shankland SJ, 2007, KIDNEY INT, V72, P26, DOI 10.1038/sj.ki.5002291; Singh N, 2009, AM J KIDNEY DIS, V54, P732, DOI 10.1053/j.ajkd.2009.06.023; Sonnhammer ELL, 1998, NUCLEIC ACIDS RES, V26, P320, DOI 10.1093/nar/26.1.320; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Tan CM, 2013, BIOINFORMATICS, V29, P1872, DOI 10.1093/bioinformatics/btt319; Vastrik I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r39; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Wei CC, 2010, OTOLARYNG HEAD NECK, V142, P699, DOI 10.1016/j.otohns.2009.12.030; Xenarios I, 2000, NUCLEIC ACIDS RES, V28, P289, DOI 10.1093/nar/28.1.289; Yu HY, 2011, NAT METHODS, V8, P478, DOI [10.1038/NMETH.1597, 10.1038/nmeth.1597]; Zhu L, 2011, J AM SOC NEPHROL, V22, P1621, DOI 10.1681/ASN.2010111146	57	11	11	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100660	10.1371/journal.pone.0100660	http://dx.doi.org/10.1371/journal.pone.0100660			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949636	Green Submitted, gold, Green Published			2022-12-27	WOS:000338276300104
J	van der Ploeg, T; Datema, F; de Jong, RB; Steyerberg, EW				van der Ploeg, Tjeerd; Datema, Frank; de Jong, Robert Baatenburg; Steyerberg, Ewout W.			Prediction of Survival with Alternative Modeling Techniques Using Pseudo Values	PLOS ONE			English	Article							REGRESSION-ANALYSIS; NEURAL-NETWORKS; HEAD; COMORBIDITY; MORTALITY; IMPACT	Background: The use of alternative modeling techniques for predicting patient survival is complicated by the fact that some alternative techniques cannot readily deal with censoring, which is essential for analyzing survival data. In the current study, we aimed to demonstrate that pseudo values enable statistically appropriate analyses of survival outcomes when used in seven alternative modeling techniques. Methods: In this case study, we analyzed survival of 1282 Dutch patients with newly diagnosed Head and Neck Squamous Cell Carcinoma (HNSCC) with conventional Kaplan-Meier and Cox regression analysis. We subsequently calculated pseudo values to reflect the individual survival patterns. We used these pseudo values to compare recursive partitioning (RPART), neural nets (NNET), logistic regression (LR) general linear models (GLM) and three variants of support vector machines (SVM) with respect to dichotomous 60-month survival, and continuous pseudo values at 60 months or estimated survival time. We used the area under the ROC curve (AUC) and the root of the mean squared error (RMSE) to compare the performance of these models using bootstrap validation. Results: Of a total of 1282 patients, 986 patients died during a median follow-up of 66 months (60-month survival: 52% [ 95% CI: 50%-255%]). The LR model had the highest optimism corrected AUC (0.791) to predict 60-month survival, followed by the SVM model with a linear kernel (AUC 0.787). The GLM model had the smallest optimism corrected RMSE when continuous pseudo values were considered for 60-month survival or the estimated survival time followed by SVM models with a linear kernel. The estimated importance of predictors varied substantially by the specific aspect of survival studied and modeling technique used. Conclusions: The use of pseudo values makes it readily possible to apply alternative modeling techniques to survival problems, to compare their performance and to search further for promising alternative modeling techniques to analyze survival time.	[van der Ploeg, Tjeerd] Alkmaar Inholland Univ, Med Ctr, Dept Sci, Alkmaar, Netherlands; [Datema, Frank; de Jong, Robert Baatenburg] Erasmus MC, Dept Otorhinolaryngol & Head & Neck Surg, Rotterdam, Netherlands; [Steyerberg, Ewout W.] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	van der Ploeg, T (corresponding author), Alkmaar Inholland Univ, Med Ctr, Dept Sci, Alkmaar, Netherlands.	tvdploeg@quicknet.nl		van der Ploeg, Tjeerd/0000-0003-0429-6753; Baatenburg de Jong, Robert/0000-0001-7236-264X				Andersen PK, 2004, LIFETIME DATA ANAL, V10, P335, DOI 10.1007/s10985-004-4771-0; Biganzoli E, 1998, STAT MED, V17, P1169, DOI 10.1002/(SICI)1097-0258(19980530)17:10<1169::AID-SIM796>3.0.CO;2-D; Breiman L., 1984, CLASSIFICATION REGRE; Chen S., 2006, ESTIMATION DEFAULT P; Datema FR, 2012, HEAD NECK-J SCI SPEC, V34, P50, DOI 10.1002/hed.21698; Datema FR, 2010, HEAD NECK-J SCI SPEC, V32, P728, DOI 10.1002/hed.21245; de Jong RJB, 2001, HEAD NECK-J SCI SPEC, V23, P718; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Ennis M, 1998, STAT MED, V17, P2501; Harrell FE, 2001, REGRESSION MODELING; Intrator O, 1995, Stat Methods Med Res, V4, P237, DOI 10.1177/096228029500400305; Ishwaran H, 2008, ANN APPL STAT, V2, P841, DOI 10.1214/08-AOAS169; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Klein JP, 2008, COMPUT METH PROG BIO, V89, P289, DOI 10.1016/j.cmpb.2007.11.017; LEE YJ, 2000, DIMACS SERIES DISCRE, V55, P1; Piccirillo JF, 2000, LARYNGOSCOPE, V110, P593, DOI 10.1097/00005537-200004000-00011; R Core Team, 2016, R FDN STAT COMP; Schwarzer G, 2000, STAT MED, V19, P541, DOI 10.1002/(SICI)1097-0258(20000229)19:4<541::AID-SIM355>3.0.CO;2-V; Steyerberg E., 2009, CLIN PREDICTION MODE; Steyerberg EW, 2000, STAT MED, V19, P1059, DOI 10.1002/(SICI)1097-0258(20000430)19:8<1059::AID-SIM412>3.0.CO;2-0; Tuffery S., 2011, DATA MINING STAT DEC; Ture M, 2009, EXPERT SYST APPL, V36, P8247, DOI 10.1016/j.eswa.2008.10.014; van der Schroeff MP, 2007, EUR ARCH OTO-RHINO-L, V264, P415, DOI 10.1007/s00405-006-0203-y; van der Schroeff MP, 2010, HEAD NECK-J SCI SPEC, V32, P1613, DOI 10.1002/hed.21369; Yung KC, 2008, ARCH OTOLARYNGOL, V134, P1045, DOI 10.1001/archotol.134.10.1045; ZANI S, 2006, DAT AN CLASS FORW SE	27	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100234	10.1371/journal.pone.0100234	http://dx.doi.org/10.1371/journal.pone.0100234			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950066	Green Published, gold, Green Submitted			2022-12-27	WOS:000338276300052
J	Wendt, D; Brand, T; Kollmeier, B				Wendt, Dorothea; Brand, Thomas; Kollmeier, Birger			An Eye-Tracking Paradigm for Analyzing the Processing Time of Sentences with Different Linguistic Complexities	PLOS ONE			English	Article							SPEECH-INTELLIGIBILITY; SPOKEN LANGUAGE; CUE-INTEGRATION; NOISE-REDUCTION; WORLD KNOWLEDGE; COMPREHENSION; INFORMATION; MOVEMENTS; HEARING; CONTEXT	An eye-tracking paradigm was developed for use in audiology in order to enable online analysis of the speech comprehension process. This paradigm should be useful in assessing impediments in speech processing. In this paradigm, two scenes, a target picture and a competitor picture, were presented simultaneously with an aurally presented sentence that corresponded to the target picture. At the same time, eye fixations were recorded using an eye-tracking device. The effect of linguistic complexity on language processing time was assessed from eye fixation information by systematically varying linguistic complexity. This was achieved with a sentence corpus containing seven German sentence structures. A novel data analysis method computed the average tendency to fixate the target picture as a function of time during sentence processing. This allowed identification of the point in time at which the participant understood the sentence, referred to as the decision moment. Systematic differences in processing time were observed as a function of linguistic complexity. These differences in processing time may be used to assess the efficiency of cognitive processes involved in resolving linguistic complexity. Thus, the proposed method enables a temporal analysis of the speech comprehension process and has potential applications in speech audiology and psychoacoustics.	[Wendt, Dorothea] Carl von Ossietzky Univ Oldenburg, D-26111 Oldenburg, Germany; Carl von Ossietzky Univ Oldenburg, Cluster Excellence Hearing4all, D-26111 Oldenburg, Germany	Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg	Wendt, D (corresponding author), Carl von Ossietzky Univ Oldenburg, D-26111 Oldenburg, Germany.	wendt@elektro.dtu.dk		Wendt, Dorothea/0000-0002-3340-1180	Deutsche Forschungsgemeinschaft (DFG) within the AULIN Project [KO 942/20-1, BR 3668/1-2]	Deutsche Forschungsgemeinschaft (DFG) within the AULIN Project(German Research Foundation (DFG))	This study was supported by the Deutsche Forschungsgemeinschaft (DFG) within the AULIN Project (grant numbers KO 942/20-1 and BR 3668/1-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allopenna PD, 1998, J MEM LANG, V38, P419, DOI 10.1006/jmla.1997.2558; Altmann GTM, 2007, J MEM LANG, V57, P502, DOI 10.1016/j.jml.2006.12.004; Altmann GTM, 1998, TRENDS COGN SCI, V2, P146, DOI 10.1016/S1364-6613(98)01153-X; Altmann GTM, 1999, COGNITION, V73, P247, DOI 10.1016/S0010-0277(99)00059-1; Arnold JE, 2003, J PSYCHOLINGUIST RES, V32, P25, DOI 10.1023/A:1021980931292; Bader M, 1999, J PSYCHOLINGUIST RES, V28, P121, DOI 10.1023/A:1023206208142; Bader M, 2006, STUD THEOR PSYCHOLIN, V34, P1, DOI 10.1007/1-4020-4344-9; Barr DJ, 2011, ACTA PSYCHOL, V137, P201, DOI 10.1016/j.actpsy.2010.09.011; Ben-David BM, 2011, J SPEECH LANG HEAR R, V54, P243, DOI 10.1044/1092-4388(2010/09-0233); Bentler Ruth A, 2005, J Am Acad Audiol, V16, P473, DOI 10.3766/jaaa.16.7.7; BOOTHROYD A, 1988, J ACOUST SOC AM, V84, P101, DOI 10.1121/1.396976; Brons I, 2013, EAR HEARING, V34, P29, DOI 10.1097/AUD.0b013e31825f299f; Carroll R, 2013, J PSYCHOLINGUIST RES, V42, P139, DOI 10.1007/s10936-012-9213-7; CERELLA J, 1994, ACTA PSYCHOL, V86, P109, DOI 10.1016/0001-6918(94)90002-7; Chambers CG, 2002, J MEM LANG, V47, P30, DOI 10.1006/jmla.2001.2832; COOPER RM, 1974, COGNITIVE PSYCHOL, V6, P84, DOI 10.1016/0010-0285(74)90005-X; EBERHARD KM, 1995, J PSYCHOLINGUIST RES, V24, P409, DOI 10.1007/BF02143160; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Fanselow G, 2008, LANGUAGE CONTEXT COG, P413; Fredelake S, 2012, INT J AUDIOL, V51, P299, DOI 10.3109/14992027.2011.645075; Gibson E, 2000, IMAGE, LANGUAGE, BRAIN, P95; Gordon PC, 2002, PSYCHOL SCI, V13, P425, DOI 10.1111/1467-9280.00475; Gorrell Paul, 2000, GERMAN SENTENCE PROC, P25; HAGERMAN B, 1982, SCAND AUDIOL, V11, P79, DOI 10.3109/01050398209076203; Haumann S, 2012, AUDIOL RES, V2, P55, DOI 10.4081/audiores.2012.e12; Huettig F, 2007, J MEM LANG, V57, P460, DOI 10.1016/j.jml.2007.02.001; Huettig F, 2011, ACTA PSYCHOL, V137, P151, DOI 10.1016/j.actpsy.2010.11.003; Kaiser E, 2008, LANG COGNITIVE PROC, V23, P709, DOI 10.1080/01690960701771220; KALIKOW DN, 1977, J ACOUST SOC AM, V61, P1337, DOI 10.1121/1.381436; Kamide Y, 2003, J MEM LANG, V49, P133, DOI 10.1016/S0749-596X(03)00023-8; Knoeferle P, 2005, COGNITION, V95, P95, DOI 10.1016/j.cognition.2004.03.002; Knoeferle P, 2007, J MEM LANG, V57, P519, DOI 10.1016/j.jml.2007.01.003; Knoeferle P, 2006, COGNITIVE SCI, V30, P481, DOI 10.1207/s15516709cog0000_65; Knoeferle Pia, 2007, P517, DOI 10.1016/B978-008044980-7/50026-4; Kollmeier B, 1997, J ACOUST SOC AM, V102, P2412, DOI 10.1121/1.419624; Laroche C, 2003, Noise Health, V6, P17; Marzinzik M, 2000, THESIS C VONOSSIETZK; McMurray B, 2008, PSYCHON B REV, V15, P1064, DOI 10.3758/PBR.15.6.1064; NILSSON M, 1994, J ACOUST SOC AM, V95, P1085, DOI 10.1121/1.408469; Ozimek E, 2010, INT J AUDIOL, V49, P444, DOI 10.3109/14992021003681030; Piquado T, 2010, PSYCHOPHYSIOLOGY, V47, P560, DOI 10.1111/j.1469-8986.2009.00947.x; PLOMP R, 1979, AUDIOLOGY, V18, P43; Pratt J, 2006, J MOTOR BEHAV, V38, P373, DOI 10.3200/JMBR.38.5.373-382; Sarampalis A, 2009, J SPEECH LANG HEAR R, V52, P1230, DOI 10.1044/1092-4388(2009/08-0111); Schlueter A, 2014, J ACOUST SOC AM, V135, P1541, DOI 10.1121/1.4863654; Sherbecoe RL, 2004, INT J AUDIOL, V43, P442, DOI 10.1080/14992020400050056; Snedeker J, 2004, COGNITIVE PSYCHOL, V49, P238, DOI 10.1016/j.cogpsych.2004.03.001; TANENHAUS MK, 1995, SCIENCE, V268, P1632, DOI 10.1126/science.7777863; Toscano JC, 2012, ATTEN PERCEPT PSYCHO, V74, P1284, DOI 10.3758/s13414-012-0306-z; Tun PA, 2010, PSYCHOL AGING, V25, P730, DOI 10.1037/a0019300; Uslar V, 2011, INT J AUDIOL, V50, P621, DOI 10.3109/14992027.2011.582166; Uslar VN, 2013, J ACOUST SOC AM, V134, P3039, DOI 10.1121/1.4818760; Van Zandt T, 2002, STEVENSHANDBOOK EXPT, V4, P461, DOI DOI 10.1002/0471214426.PAS0412; Weskott Thomas., 2011, LINGUISTISCHE BERICH, V225, P3; Wingfield A, 2007, J AM ACAD AUDIOL, V18, P548, DOI 10.3766/jaaa.18.7.3; Wingfield A, 2006, J AM ACAD AUDIOL, V17, P487, DOI 10.3766/jaaa.17.7.4; Zokoll MA, 2013, AM J AUDIOL, V22, P175, DOI 10.1044/1059-0889(2013/12-0061)	57	25	25	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100186	10.1371/journal.pone.0100186	http://dx.doi.org/10.1371/journal.pone.0100186			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK2UZ	24950184	gold, Green Published, Green Submitted			2022-12-27	WOS:000338276300045
J	Narayanan, S; Mohan, A; Gill, KS; Prasad, PVV				Narayanan, Sruthi; Mohan, Amita; Gill, Kulvinder S.; Prasad, P. V. Vara			Variability of Root Traits in Spring Wheat Germplasm	PLOS ONE			English	Article							CICER-ARIETINUM L.; COLEOPTILE LENGTH; GRAIN-YIELD; ARCHITECTURAL TRAITS; STAND ESTABLISHMENT; GENETIC-VARIABILITY; DROUGHT-AVOIDANCE; ISOGENIC LINES; WINTER-WHEAT; SEED YIELD	Root traits influence the amount of water and nutrient absorption, and are important for maintaining crop yield under drought conditions. The objectives of this research were to characterize variability of root traits among spring wheat genotypes and determine whether root traits are related to shoot traits (plant height, tiller number per plant, shoot dry weight, and coleoptile length), regions of origin, and market classes. Plants were grown in 150-cm columns for 61 days in a greenhouse under optimal growth conditions. Rooting depth, root dry weight, root: shoot ratio, and shoot traits were determined for 297 genotypes of the germplasm, Cultivated Wheat Collection (CWC). The remaining root traits such as total root length and surface area were measured for a subset of 30 genotypes selected based on rooting depth. Significant genetic variability was observed for root traits among spring wheat genotypes in CWC germplasm or its subset. Genotypes Sonora and Currawa were ranked high, and genotype Vandal was ranked low for most root traits. A positive relationship (R-2 >= 0.35) was found between root and shoot dry weights within the CWC germplasm and between total root surface area and tiller number; total root surface area and shoot dry weight; and total root length and coleoptile length within the subset. No correlations were found between plant height and most root traits within the CWC germplasm or its subset. Region of origin had significant impact on rooting depth in the CWC germplasm. Wheat genotypes collected from Australia, Mediterranean, and west Asia had greater rooting depth than those from south Asia, Latin America, Mexico, and Canada. Soft wheat had greater rooting depth than hard wheat in the CWC germplasm. The genetic variability identified in this research for root traits can be exploited to improve drought tolerance and/or resource capture in wheat.	[Narayanan, Sruthi; Prasad, P. V. Vara] Kansas State Univ, Dept Agron, Manhattan, KS 66506 USA; [Mohan, Amita; Gill, Kulvinder S.] Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA	Kansas State University; Washington State University	Prasad, PVV (corresponding author), Kansas State Univ, Dept Agron, Manhattan, KS 66506 USA.	vara@ksu.edu	Prasad, P.V. Vara/B-3835-2012	Prasad, P.V. Vara/0000-0001-6632-3361	Kansas Wheat Alliance, Coordinated Agricultural Project from the USDA National Institute of Food and Agriculture [2011-68002-30029]; USAID Feed the Future Innovation Lab on Climate-Resilient Wheat	Kansas Wheat Alliance, Coordinated Agricultural Project from the USDA National Institute of Food and Agriculture; USAID Feed the Future Innovation Lab on Climate-Resilient Wheat(United States Agency for International Development (USAID))	This research was funded by Kansas Wheat Alliance, Coordinated Agricultural Project Grant no. 2011-68002-30029 (Triticeae- CAP) from the USDA National Institute of Food and Agriculture, and USAID Feed the Future Innovation Lab on Climate-Resilient Wheat. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blum A, 2005, AUST J AGR RES, V56, P1159, DOI 10.1071/AR05069; Botwright TL, 2001, EUPHYTICA, V119, P349, DOI 10.1023/A:1017527911084; Boyer JS, 1996, ADV AGRON, V56, P187, DOI 10.1016/S0065-2113(08)60182-0; BUSH MG, 1988, FIELD CROP RES, V18, P243, DOI 10.1016/0378-4290(88)90018-4; CAASSEN N, 1976, AGRON J, V68, P961, DOI 10.2134/agronj1976.00021962006800060030x; CHAMPOUX MC, 1995, THEOR APPL GENET, V90, P969, DOI 10.1007/BF00222910; CHASTAIN TG, 1995, CROP SCI, V35, P213, DOI 10.2135/cropsci1995.0011183X003500010040x; Clark LJ, 2008, FUNCT PLANT BIOL, V35, P1163, DOI 10.1071/FP08132; CORNISH PS, 1988, AUST J EXP AGR, V28, P521, DOI 10.1071/EA9880521; EISSENSTAT DM, 1992, J PLANT NUTR, V15, P763, DOI 10.1080/01904169209364361; FAO, 2011, FAOSTAT; Fitter A., 2002, PLANT ROOTS HIDDEN H, P15; FUKAI S, 1995, FIELD CROP RES, V40, P67, DOI 10.1016/0378-4290(94)00096-U; Gupta P. K., 2012, Plant Breeding Reviews, V36, P85; Hodge A, 1999, PLANT CELL ENVIRON, V22, P811, DOI 10.1046/j.1365-3040.1999.00454.x; Huang BR, 1998, CROP SCI, V38, P1017, DOI [10.2135/cropsci1998.0011183X003800040022x, 10.2135/cropsci1998.0011183X003800050018x]; Jones H, 2008, MOL BIOL EVOL, V25, P2211, DOI 10.1093/molbev/msn167; Kashiwagi J, 2005, EUPHYTICA, V146, P213, DOI 10.1007/s10681-005-9007-1; Kashiwagi J, 2006, FIELD CROP RES, V95, P171, DOI 10.1016/j.fcr.2005.02.012; KAUFMANN ML, 1968, CAN J PLANT SCI, V48, P357, DOI 10.4141/cjps68-068; Krishnamurthy L, 1999, J AGRON CROP SCI, V183, P9, DOI 10.1046/j.1439-037x.1999.00306.x; Krishnamurthy L, 1996, ROOT NITROGEN CROPPI, P234; Ludlow M. M., 1990, ADV AGRONOMY, V43, P107; Manschadi AM, 2008, PLANT SOIL, V303, P115, DOI 10.1007/s11104-007-9492-1; Manschadi AM, 2006, FUNCT PLANT BIOL, V33, P823, DOI 10.1071/FP06055; Manske G. G. B., 2002, Plant roots: the hidden half, P249; Manske GGB, 2000, PLANT SOIL, V221, P189, DOI 10.1023/A:1004727201568; McPhee K, 2005, CROP SCI, V45, P1758, DOI 10.2135/cropsci2004.0544; MIAN AR, 1992, J PROD AGRIC, V5, P265, DOI 10.2134/jpa1992.0265; Mohan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073314; Nik M. M., 2011, Scientific Research and Essays, V6, P2019; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Pierret A, 2005, NEW PHYTOL, V166, P967, DOI 10.1111/j.1469-8137.2005.01389.x; Poorter H, 2000, AUST J PLANT PHYSIOL, V27, P1191, DOI 10.1071/PP99173; Rebetzke GJ, 2007, THEOR APPL GENET, V114, P1173, DOI 10.1007/s00122-007-0509-1; Rebetzke GJ, 2007, FIELD CROP RES, V100, P10, DOI 10.1016/j.fcr.2006.05.001; RICHARDS RA, 1989, AUST J AGR RES, V40, P943, DOI 10.1071/AR9890943; Sanguineti MC, 2007, ANN APPL BIOL, V151, P291, DOI 10.1111/j.1744-7348.2007.00198.x; Schillinger WF, 1998, AGRON J, V90, P582, DOI 10.2134/agronj1998.00021962009000050002x; Serraj R, 2004, FIELD CROP RES, V88, P115, DOI 10.1016/j.fcr.2003.12.001; SINCLAIR TR, 1994, PHYSIOLOGY AND DETERMINATION OF CROP YIELD, P509; Singh V, 2011, CROP SCI, V51, P2011, DOI 10.2135/cropsci2011.01.0038; Smucker A. J. M., 1984, Roots, nutrient and water influx, and plant growth . ASA Special PublicationNo. 49., P27; Wojciechowski T, 2009, J EXP BOT, V60, P2565, DOI 10.1093/jxb/erp107; Yoshida S., 1982, Drought resistance in crops with emphasis on rice, P97	45	78	86	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100317	10.1371/journal.pone.0100317	http://dx.doi.org/10.1371/journal.pone.0100317			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945438	Green Published, Green Submitted, gold			2022-12-27	WOS:000340721500059
J	Rakhmanov, M; Sic, H; Kienzler, AK; Fischer, B; Rizzi, M; Seidl, M; Melkaoui, K; Unger, S; Moehle, L; Schmit, NE; Deshmukh, SD; Ayata, CK; Schuh, W; Zhang, ZB; Cosset, FL; Verhoeyen, E; Peter, HH; Voll, RE; Salzer, U; Eibel, H; Warnatz, K				Rakhmanov, Mirzokhid; Sic, Heiko; Kienzler, Anne-Kathrin; Fischer, Beate; Rizzi, Marta; Seidl, Maximilian; Melkaoui, Kerstina; Unger, Susanne; Moehle, Luisa; Schmit, Nadine E.; Deshmukh, Sachin D.; Ayata, Cemil Korcan; Schuh, Wolfgang; Zhang, Zhibing; Cosset, Francois-Loic; Verhoeyen, Els; Peter, Hans-Hartmut; Voll, Reinhard E.; Salzer, Ulrich; Eibel, Hermann; Warnatz, Klaus			High Levels of SOX5 Decrease Proliferative Capacity of Human B Cells, but Permit Plasmablast Differentiation	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; LENTIVIRAL VECTORS; GENE-EXPRESSION; DNA-BINDING; LONG FORM; L-SOX5; CARTILAGE; PROTEINS; MOUSE; GENERATION	Currently very little is known about the differential expression and function of the transcription factor SOX5 during B cell maturation. We identified two new splice variants of SOX5 in human B cells, encoding the known L-SOX5B isoform and a new shorter isoform L-SOX5F. The SOX5 transcripts are highly expressed during late stages of B-cell differentiation, including atypical memory B cells, activated CD21(low) B cells and germinal center B cells of tonsils. In tonsillar sections SOX5 expression was predominantly polarized to centrocytes within the light zone. After in vitro stimulation, SOX5 expression was down-regulated during proliferation while high expression levels were permissible for plasmablast differentiation. Overexpression of L-SOX5F in human primary B lymphocytes resulted in reduced proliferation, less survival of CD138(neg) B cells, but comparable numbers of CD138(+)CD38(hi) plasmablasts compared to control cells. Thus, our findings describe for the first time a functional role of SOX5 during late B cell development reducing the proliferative capacity and thus potentially affecting the differentiation of B cells during the germinal center response.	[Rakhmanov, Mirzokhid; Sic, Heiko; Kienzler, Anne-Kathrin; Fischer, Beate; Rizzi, Marta; Seidl, Maximilian; Melkaoui, Kerstina; Unger, Susanne; Moehle, Luisa; Schmit, Nadine E.; Deshmukh, Sachin D.; Peter, Hans-Hartmut; Voll, Reinhard E.; Salzer, Ulrich; Eibel, Hermann; Warnatz, Klaus] Univ Med Ctr, Ctr Chron Immunodeficiency, Freiburg, Germany; [Rakhmanov, Mirzokhid; Sic, Heiko; Kienzler, Anne-Kathrin; Fischer, Beate; Rizzi, Marta; Seidl, Maximilian; Melkaoui, Kerstina; Unger, Susanne; Moehle, Luisa; Schmit, Nadine E.; Deshmukh, Sachin D.; Ayata, Cemil Korcan; Peter, Hans-Hartmut; Voll, Reinhard E.; Salzer, Ulrich; Eibel, Hermann; Warnatz, Klaus] Univ Freiburg, D-79106 Freiburg, Germany; [Ayata, Cemil Korcan] Univ Med Ctr, Dept Pneumol, Freiburg, Germany; [Schuh, Wolfgang] Univ Erlangen Nurnberg, Div Mol Immunol, Nikolaus Fiebiger Ctr, Dept Internal Med 3, D-91054 Erlangen, Germany; [Zhang, Zhibing] Virginia Commonwealth Univ, Dept Obstet & Gynecol, Richmond, VA USA; [Cosset, Francois-Loic; Verhoeyen, Els] Univ Lyon, Ecole Normale Super Lyon, CIRI, INSERM U1111,EVIR, Lyon, France; [Verhoeyen, Els] C3M, INSERM U1065, Nice, France; [Peter, Hans-Hartmut; Voll, Reinhard E.; Salzer, Ulrich; Eibel, Hermann; Warnatz, Klaus] Univ Med Ctr Freiburg, Div Rheumatol & Clin Immunol, Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg; University of Erlangen Nuremberg; Virginia Commonwealth University; Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); University of Freiburg	Rakhmanov, M (corresponding author), Univ Med Ctr, Ctr Chron Immunodeficiency, Freiburg, Germany.	mirzokhid.rakhmanov@uniklinik-freiburg.de	Verhoeyen, Els/AAW-4853-2021; Warnatz, Klaus/AAD-3464-2022; Verhoeyen, Els/H-6360-2016; Rakhmanov, Mirzokhid/P-8351-2019; Seidl, Maxmilian/ABF-3322-2021; Rizzi, Marta/ABE-7264-2020; Cosset, François-Loïc/M-5862-2019; Rakhmanov, Mirzokhid/GMW-5383-2022; Ayata, Korcan/G-8626-2013	Verhoeyen, Els/0000-0001-9224-5491; Seidl, Maxmilian/0000-0002-5559-4980; Cosset, François-Loïc/0000-0001-8842-3726; Ayata, Korcan/0000-0001-7043-6692; Mohle, Luisa/0000-0002-4535-9952; Kienzler, Anne-Kathrin/0000-0002-3082-9210; Rizzi, Marta/0000-0002-5153-6089; Unger, Susanne/0000-0001-6916-7544; Salzer, Ulrich/0000-0002-1769-1157	German Federal Ministry of Education and Research [BMBF 01 EO 0803]; German Research Foundation (DFG) [SFB620]; 7th Framework Program (FP7) of the European Union [HEALTH-F2-2008-201549]; FP7-E-Rare "GENTHALTHER''; Virginia Commonwealth University (VCU) Presidential Research Incentive Program (PRIP); VCU Massey Cancer Center/American Cancer Society Institutional Research Awards; NIH [HD076257]; University Freiburg (UF) Medical Faculty Research Committee; UF Scientific Society Freiburg Research Grants; PERSIST [FP7-HEALTH-2007-B/222878]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD076257] Funding Source: NIH RePORTER	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG)); 7th Framework Program (FP7) of the European Union; FP7-E-Rare "GENTHALTHER''; Virginia Commonwealth University (VCU) Presidential Research Incentive Program (PRIP); VCU Massey Cancer Center/American Cancer Society Institutional Research Awards; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University Freiburg (UF) Medical Faculty Research Committee; UF Scientific Society Freiburg Research Grants; PERSIST; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was funded by the German Federal Ministry of Education and Research (BMBF 01 EO 0803) (to K.W., H.E., U.S. and R.V.), the German Research Foundation (DFG) Grant SFB620, Projects C1 (to K.W. and H.H.P.) and C7 (to US), the 7th Framework Program (FP7) of the European Union Grant Nr. HEALTH-F2-2008-201549 (to K. W., H. E. and U.S.); FP7-HEALTH-2007-B/222878 "PERSIST" and FP7-E-Rare "GENTHALTHER'' Grants (to EV and FLC); Virginia Commonwealth University (VCU) Presidential Research Incentive Program (PRIP), VCU Massey Cancer Center/American Cancer Society Institutional Research Awards and NIH Award HD076257 (to Z.Z.); University Freiburg (UF) Medical Faculty Research Committee and UF Scientific Society Freiburg Research Grants (to M.Ra.). The authors are responsible for the contents of this publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Charles ED, 2011, BLOOD, V117, P5425, DOI 10.1182/blood-2010-10-312942; Chew LJ, 2009, J NEUROSCI RES, V87, P3277, DOI 10.1002/jnr.22128; CONNER F, 1994, NUCLEIC ACIDS RES, V22, P3339, DOI 10.1093/nar/22.16.3339; CONNOR F, 1995, NUCLEIC ACIDS RES, V23, P3365, DOI 10.1093/nar/23.17.3365; da Silva GN, 2012, MOL BIOL REP, V39, P10373, DOI 10.1007/s11033-012-1916-1; DENNY P, 1992, EMBO J, V11, P3705, DOI 10.1002/j.1460-2075.1992.tb05455.x; Edwards SKE, 2014, LEUKEMIA RES, V38, P393, DOI 10.1016/j.leukres.2013.12.016; Ehrhardt GRA, 2008, J EXP MED, V205, P1807, DOI 10.1084/jem.20072682; Frecha C, 2009, BLOOD, V114, P3173, DOI 10.1182/blood-2009-05-220798; Funke S, 2008, MOL THER, V16, P1427, DOI 10.1038/mt.2008.128; Han Y, 2008, MOL CELL BIOL, V28, P4999, DOI 10.1128/MCB.00695-08; Ikeda T, 2004, ARTHRITIS RHEUM-US, V50, P3561, DOI 10.1002/art.20611; Ikeda T, 2002, GENE, V298, P59, DOI 10.1016/S0378-1119(02)00927-7; Isnardi I, 2010, BLOOD, V115, P5026, DOI 10.1182/blood-2009-09-243071; Kiselak EA, 2010, J BIOL CHEM, V285, P30496, DOI 10.1074/jbc.M110.121590; Kwan KY, 2008, P NATL ACAD SCI USA, V105, P16021, DOI 10.1073/pnas.0806791105; Lai T, 2008, NEURON, V57, P232, DOI 10.1016/j.neuron.2007.12.023; Lefebvre V, 1998, EMBO J, V17, P5718, DOI 10.1093/emboj/17.19.5718; Lefebvre V, 2007, INT J BIOCHEM CELL B, V39, P2195, DOI 10.1016/j.biocel.2007.05.019; Lefebvre V, 2010, INT J BIOCHEM CELL B, V42, P429, DOI 10.1016/j.biocel.2009.07.016; Lefebvre W, 2002, J BONE MINER METAB, V20, P121, DOI 10.1007/s007740200017; Lioubinski O, 2003, DEV DYNAM, V227, P402, DOI 10.1002/dvdy.10311; Martinez-Morales PL, 2010, EMBO REP, V11, P466, DOI 10.1038/embor.2010.61; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Perez-Alcala S, 2004, DEVELOPMENT, V131, P4455, DOI 10.1242/dev.01329; Rakhmanov M, 2009, P NATL ACAD SCI USA, V106, P13451, DOI 10.1073/pnas.0901984106; Reiser J, 2000, J VIROL, V74, P10589, DOI 10.1128/JVI.74.22.10589-10599.2000; Reiser J, 1996, P NATL ACAD SCI USA, V93, P15266, DOI 10.1073/pnas.93.26.15266; Reiser J, 2000, GENE THER, V7, P910, DOI 10.1038/sj.gt.3301188; Saito T, 2007, EMBO REP, V8, P504, DOI 10.1038/sj.embor.7400934; Smits P, 2001, DEV CELL, V1, P277, DOI 10.1016/S1534-5807(01)00003-X; Stolt CC, 2008, NUCLEIC ACIDS RES, V36, P5427, DOI 10.1093/nar/gkn527; Stolt CC, 2006, DEV CELL, V11, P697, DOI 10.1016/j.devcel.2006.08.011; Tchougounova E, 2009, ONCOGENE, V28, P1537, DOI 10.1038/onc.2009.9; Warnatz K, 2009, P NATL ACAD SCI USA, V106, P13945, DOI 10.1073/pnas.0903543106; Wegner M, 2010, INT J BIOCHEM CELL B, V42, P381, DOI 10.1016/j.biocel.2009.07.006; Wunderle VM, 1996, GENOMICS, V36, P354, DOI 10.1006/geno.1996.0474; Zhang XY, 2002, MOL THER, V5, P555, DOI 10.1006/mthe.2002.0585	38	11	12	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100328	10.1371/journal.pone.0100328	http://dx.doi.org/10.1371/journal.pone.0100328			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945754	gold, Green Published, Green Submitted			2022-12-27	WOS:000340721500062
J	Shestopaloff, YK				Shestopaloff, Yuri K.			Method for Finding Metabolic Properties Based on the General Growth Law. Liver Examples. A General Framework for Biological Modeling	PLOS ONE			English	Article							IN-VITRO; REGENERATION; DYNAMICS; DONORS	We propose a method for finding metabolic parameters of cells, organs and whole organisms, which is based on the earlier discovered general growth law. Based on the obtained results and analysis of available biological models, we propose a general framework for modeling biological phenomena and discuss how it can be used in Virtual Liver Network project. The foundational idea of the study is that growth of cells, organs, systems and whole organisms, besides biomolecular machinery, is influenced by biophysical mechanisms acting at different scale levels. In particular, the general growth law uniquely defines distribution of nutritional resources between maintenance needs and biomass synthesis at each phase of growth and at each scale level. We exemplify the approach considering metabolic properties of growing human and dog livers and liver transplants. A procedure for verification of obtained results has been introduced too. We found that two examined dogs have high metabolic rates consuming about 0.62 and 1 gram of nutrients per cubic centimeter of liver per day, and verified this using the proposed verification procedure. We also evaluated consumption rate of nutrients in human livers, determining it to be about 0.088 gram of nutrients per cubic centimeter of liver per day for males, and about 0.098 for females. This noticeable difference can be explained by evolutionary development, which required females to have greater liver processing capacity to support pregnancy. We also found how much nutrients go to biomass synthesis and maintenance at each phase of liver and liver transplant growth. Obtained results demonstrate that the proposed approach can be used for finding metabolic characteristics of cells, organs, and whole organisms, which can further serve as important inputs and constraints for many applications in biology (such as protein expression), biotechnology (synthesis of substances), and medicine.	Segmentsoft Inc, Toronto, ON, Canada		Shestopaloff, YK (corresponding author), Segmentsoft Inc, Toronto, ON, Canada.	shes169@yahoo.ca						Arias I M, 2008, LIVER BIOL PATHOBIOL; Berg JM, 2006, BIOCHEMISTRY; Bogorodskii V. V., 1985, Soviet Physics - Technical Physics, V30, P1236; Byrne H, 2009, J MATH BIOL, V58, P657, DOI 10.1007/s00285-008-0212-0; Calvetti D, 2008, J PHYS C SERIES, V241; Drasdo D, 2005, PHYS BIOL, V2, P133, DOI 10.1088/1478-3975/2/3/001; Drasdo D, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/5/055025; Furchtgott LA, 2009, BIOPHYS J, V96, P3926, DOI 10.1016/j.bpj.2009.01.061; Goncalves E, 2013, MOL BIOSYST, V9, P1576, DOI 10.1039/c3mb25489e; Grabin VG, 1989, ORUZHIE POBEDY WEAPO; Guillouzo A, 2007, CHEM-BIOL INTERACT, V168, P66, DOI 10.1016/j.cbi.2006.12.003; Haga J, 2008, LIVER TRANSPLANT, V14, P1718, DOI 10.1002/lt.21622; Hohme S, 2007, CHEM-BIOL INTERACT, V168, P74, DOI 10.1016/j.cbi.2007.01.010; Hoehme S, 2010, P NATL ACAD SCI USA, V107, P10371, DOI 10.1073/pnas.0909374107; Holzhutter HG, 2012, WIRES SYST BIOL MED, V4, P221, DOI 10.1002/wsbm.1158; Huthmacher C, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-120; Jones GW, 2012, SIAM REV, V54, P52, DOI 10.1137/080731785; KAM I, 1987, HEPATOLOGY, V7, P362, DOI 10.1002/hep.1840070225; Krauss M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002750; MaalOe O, 1966, CONTROL MACROMOLECUL; Mahadevan R, 2002, BIOPHYS J, V83, P1331, DOI 10.1016/S0006-3495(02)73903-9; Malmivuo P., 1995, BIOELECTROMAGNETISM, DOI [DOI 10.1093/ACPROF:OSO/9780195058239.001.0001, 10.1093/acprof:oso/9780195058239.001.0001]; Matthias K, 2012, J BIOL CHEM, V287, P36978; Mente C, 2012, ACTA PHYS POL B PR S, V5, P99, DOI 10.5506/APhysPolBSupp.5.99; Mitchell S, 2013, 13085826QBIOMN ARXIV; Ochoa JGD, 2013, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00204; Pollitzer E, 2013, NATURE, V500, P23, DOI 10.1038/500023a; Pomfret EA, 2003, TRANSPLANTATION, V76, P5, DOI 10.1097/01.TP.0000079064.08263.8E; Schwen LO, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/357687; Shestopaloff AY, 2013, MCMC NONLINEAR STATE; Shestopaloff Y. K., 2012, Biophysical Reviews and Letters, V7, P177, DOI 10.1142/S1793048012500075; Shestopaloff Y. K., 2010, PROPERTIES INTERRELA; Shestopaloff YK, 2011, DESIGN IMPLEMENTATIO; Shestopaloff YK, 2011, HYPOTHESIS VALIDATIO; Shestopaloff YK, 2010, PHYS GROWTH REPLICAT; Shestopaloff YK, 2012, LAW REPLICATION GROW; Shestopaloff YK, 2014, GROWTH UNION FORM BI; Shestopaloff YK, 2012, J PERFORMANCE MEASUR, V17, P48; Shestopaloff YK, 2011, COMP MATH MATH PHYS+, V51, P699, DOI 10.1134/S0965542511050162; Shestopaloff YK, 2013, ACTA BIOTHEOR, V61, P499, DOI 10.1007/s10441-013-9202-8; Shestopaloff Yuri K., 2012, Biophysical Reviews and Letters, V7, P71, DOI 10.1142/S1793048012500051; Shestopaloff YK, 2011, APPL OPTICS, V50, P6606, DOI 10.1364/AO.50.006606; Shestopaloff YK, 2011, INT J ELECTRON, V98, P1433, DOI 10.1080/00207217.2011.601441; Shestopaloff YK, 2011, INT J BIOMATH, V4, P35, DOI 10.1142/S1793524511001180; Shestopaloff Yuri K., 2010, Biophysical Reviews and Letters, V5, P43, DOI 10.1142/S1793048010001111; SHESTOPALOV YK, 1993, IEEE T GEOSCI REMOTE, V31, P1060, DOI 10.1109/36.263777; Stephanopoulos G., 1998, METAB ENG; Thiele I, 2013, NAT BIOTECHNOL, V31, P419, DOI 10.1038/nbt.2488; Tyson JJ, 2002, BIOESSAYS, V24, P1095, DOI 10.1002/bies.10191	49	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99836	10.1371/journal.pone.0099836	http://dx.doi.org/10.1371/journal.pone.0099836			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940740	Green Published, gold, Green Submitted			2022-12-27	WOS:000338508200045
J	Zaniboni, M; Cacciani, F; Lux, RL				Zaniboni, Massimiliano; Cacciani, Francesca; Lux, Robert L.			Beat-to-Beat Cycle Length Variability of Spontaneously Beating Guinea Pig Sinoatrial Cells: Relative Contributions of the Membrane and Calcium Clocks	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; RYANODINE RECEPTOR; CURRENT IF; MODULATION; RELEASE; MECHANISMS; MYOCYTES; CURRENTS; MODEL	The heartbeat arises rhythmically in the sino-atrial node (SAN) and then spreads regularly throughout the heart. The molecular mechanism underlying SAN rhythm has been attributed by recent studies to the interplay between two clocks, one involving the hyperpolarization activated cation current I-f (the membrane clock), and the second attributable to activation of the electrogenic NaCa exchanger by spontaneous sarcoplasmic releases of calcium (the calcium clock). Both mechanisms contain, in principle, sources of beat-to-beat cycle length variability, which can determine the intrinsic variability of SAN firing and, in turn, contribute to the heart rate variability. In this work we have recorded long sequences of action potentials from patch clamped guinea pig SAN cells (SANCs) perfused, in turn, with normal Tyrode solution, with the I-f inhibitor ivabradine (3 mu M), then back to normal Tyrode, and again with the ryanodine channels inhibitor ryanodine (3 mM). We have found that, together with the expected increase in beating cycle length (+25%), the application of ivabradine brought about a significant and dramatic increase in beat-to-beat cycle length variability (+50%). Despite the similar effect on firing rate, ryanodine did not modify significantly beat-to-beat cycle length variability. Acetylcholine was also applied and led to a 131% increase of beating cycle length, with only a 70% increase in beat-to-beat cycle length variability. We conclude that the main source of inter-beat variability of SANCs firing rate is related to the mechanism of the calcium clock, whereas the membrane clock seems to act in stabilizing rate. Accordingly, when the membrane clock is silenced by application of ivabradine, stochastic variations of the calcium clock are free to make SANCs beating rhythm more variable.	[Zaniboni, Massimiliano; Cacciani, Francesca] Univ Parma, Dept Life Sci, I-43100 Parma, Italy; [Zaniboni, Massimiliano] Univ Parma, Ctr Excellence Toxicol Res, I-43100 Parma, Italy; [Lux, Robert L.] Univ Utah, Cardiovasc Res & Training Inst, Salt Lake City, UT USA	University of Parma; University of Parma; Utah System of Higher Education; University of Utah	Zaniboni, M (corresponding author), Univ Parma, Dept Life Sci, I-43100 Parma, Italy.	massimiliano.zaniboni@unipr.it	Zaniboni, Massimiliano/M-8144-2015	Zaniboni, Massimiliano/0000-0001-8808-2239	Chiesi Farmaceutici S.p.A. within the project "Pharmacological modulation of electrophysiological properties of guinea pig SA nodal cells"	Chiesi Farmaceutici S.p.A. within the project "Pharmacological modulation of electrophysiological properties of guinea pig SA nodal cells"	This work has been funded to the corresponding author by Chiesi Farmaceutici S.p.A. within the project "Pharmacological modulation of electrophysiological properties of guinea pig SA nodal cells" 2012-2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPEL ML, 1989, J AM COLL CARDIOL, V14, P1139, DOI 10.1016/0735-1097(89)90408-7; Bogdanov KY, 2001, CIRC RES, V88, P1254, DOI 10.1161/hh1201.092095; BROWN HF, 1979, NATURE, V280, P235, DOI 10.1038/280235a0; Bucchi A, 2003, J MOL CELL CARDIOL, V35, P905, DOI 10.1016/S0022-2828(03)00150-0; Bucchi A, 2007, J MOL CELL CARDIOL, V43, P39, DOI 10.1016/j.yjmcc.2007.04.017; Clark RB, 2004, AM J PHYSIOL-HEART C, V286, pH1757, DOI 10.1152/ajpheart.00753.2003; CLAY JR, 1979, BIOPHYS J, V28, P377, DOI 10.1016/S0006-3495(79)85187-5; Costa M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.198102; DIFRANCESCO D, 1986, J PHYSIOL-LONDON, V377, P61, DOI 10.1113/jphysiol.1986.sp016177; DIFRANCESCO D, 1985, PROG BIOPHYS MOL BIO, V46, P163, DOI 10.1016/0079-6107(85)90008-2; DIFRANCESCO D, 1993, ANNU REV PHYSIOL, V55, P455, DOI 10.1146/annurev.physiol.55.1.455; DIFRANCESCO D, 1991, J PHYSIOL-LONDON, V434, P23, DOI 10.1113/jphysiol.1991.sp018457; Frey B, 1996, PACE, V19, P1882, DOI 10.1111/j.1540-8159.1996.tb03245.x; Gao Z, 2010, J MOL CELL CARDIOL, V49, P33, DOI 10.1016/j.yjmcc.2010.03.019; GOLDBERGER AL, 1991, NEWS PHYSIOL SCI, V6, P87, DOI 10.1152/physiologyonline.1991.6.2.87; Huser J, 2000, J PHYSIOL-LONDON, V524, P415, DOI 10.1111/j.1469-7793.2000.00415.x; Johnson DM, 2010, J MOL CELL CARDIOL, V48, P122, DOI 10.1016/j.yjmcc.2009.08.033; JONGSMA HJ, 1983, J MOL CELL CARDIOL, V15, P123, DOI 10.1016/0022-2828(83)90288-2; JOYNER RW, 1986, BIOPHYS J, V50, P1157, DOI 10.1016/S0006-3495(86)83559-7; Koorpelainen JT, 1999, STROKE, V30, P1008, DOI 10.1161/01.STR.30.5.1008; Kucera JP, 2000, CIRC RES, V86, P1140, DOI 10.1161/01.RES.86.11.1140; MALIK M, 1994, BRIT HEART J, V71, P3; Maltsev VA, 2009, AM J PHYSIOL-HEART C, V296, pH594, DOI 10.1152/ajpheart.01118.2008; Manzo A, 2009, LAB ANIM-UK, V43, P41, DOI 10.1258/la.2007.007085; MEISSNER G, 1994, ANNU REV PHYSIOL, V56, P485, DOI 10.1146/annurev.ph.56.030194.002413; Monfredi O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067247; NOBLE D, 1992, P ROY SOC B-BIOL SCI, V250, P199, DOI 10.1098/rspb.1992.0150; Papaioannou VE, 2013, CURR CARDIOL REV, V9, P82, DOI 10.2174/1573403X11309010010; Posokhova E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076973; Rigg L, 1996, EXP PHYSIOL, V81, P877, DOI 10.1113/expphysiol.1996.sp003983; Rocchetti M, 2000, J CARDIOVASC ELECTR, V11, P522, DOI 10.1111/j.1540-8167.2000.tb00005.x; Sarkar AX, 2010, PLOS COMPUT BIOL, V2, P6, DOI DOI 10.1371/J0URNAL.PCBI.1000914; SCHECHTMAN VL, 1992, PEDIATR RES, V31, P606, DOI 10.1203/00006450-199206000-00014; Severi S, 2012, J PHYSIOL-LONDON, V590, P4483, DOI 10.1113/jphysiol.2012.229435; Song DK, 1999, PFLUG ARCH EUR J PHY, V438, P147, DOI 10.1007/s004240050892; Spitzer Kenneth W, 2006, J Cardiovasc Electrophysiol, V17 Suppl 1, pS8, DOI 10.1111/j.1540-8167.2006.00379.x; WILDERS R, 1993, BIOPHYS J, V65, P2601, DOI 10.1016/S0006-3495(93)81289-X; Zaniboni M, 2000, AM J PHYSIOL-HEART C, V278, pH677, DOI 10.1152/ajpheart.2000.278.3.H677; Zaniboni M, 2012, IEEE T BIO-MED ENG, V59, P2372, DOI 10.1109/TBME.2012.2204880; Zaniboni M, 2010, MATH BIOSCI, V228, P56, DOI 10.1016/j.mbs.2010.08.007; Zaza A, 2001, CARDIOVASC RES, V50, P434, DOI 10.1016/S0008-6363(01)00240-1	41	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100242	10.1371/journal.pone.0100242	http://dx.doi.org/10.1371/journal.pone.0100242			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940609	Green Published, Green Submitted, gold			2022-12-27	WOS:000338508200086
J	Claidiere, N; Bowler, M; Brookes, S; Brown, R; Whiten, A				Claidiere, Nicolas; Bowler, Mark; Brookes, Sarah; Brown, Rebecca; Whiten, Andrew			Frequency of Behavior Witnessed and Conformity in an Everyday Social Context	PLOS ONE			English	Article							CULTURAL TRANSMISSION; EVOLUTION; ENVIRONMENT; MAJORITY	Conformity is thought to be an important force in human evolution because it has the potential to stabilize cultural homogeneity within groups and cultural diversity between groups. However, the effects of such conformity on cultural and biological evolution will depend much on the particular way in which individuals are influenced by the frequency of alternative behavioral options they witness. In a previous study we found that in a natural situation people displayed a tendency to be 'linear-conformist'. When visitors to a Zoo exhibit were invited to write or draw answers to questions on cards to win a small prize and we manipulated the proportion of text versus drawings on display, we found a strong and significant effect of the proportion of text displayed on the proportion of text in the answers, a conformist effect that was largely linear with a small non-linear component. However, although this overall effect is important to understand cultural evolution, it might mask a greater diversity of behavioral responses shaped by variables such as age, sex, social environment and attention of the participants. Accordingly we performed a further study explicitly to analyze the effects of these variables, together with the quality of the information participants' responses made available to further visitors. Results again showed a largely linear conformity effect that varied little with the variables analyzed.	[Claidiere, Nicolas; Bowler, Mark; Brookes, Sarah; Brown, Rebecca; Whiten, Andrew] Univ St Andrews, Sch Psychol & Neurosci, Ctr Social Learning & Cognit Evolut, St Andrews, Fife, Scotland; [Claidiere, Nicolas] Aix Marseille Univ, CNRS, Lab Psychol Cognit, UMR 7290, Marseille, France; [Bowler, Mark] San Diego Zoo Global, Inst Conservat Res, Iquitos, Peru	University of St Andrews; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite	Claidiere, N (corresponding author), Univ St Andrews, Sch Psychol & Neurosci, Ctr Social Learning & Cognit Evolut, St Andrews, Fife, Scotland.	nicolas.claidiere@normalesup.org	Bowler, Mark/I-1967-2019; Claidiere, Nicolas/HGE-8036-2022	Bowler, Mark/0000-0001-5236-3477; Claidiere, Nicolas/0000-0002-4472-6597; Whiten, Andrew/0000-0003-2426-5890	Wellcome Trust [WT094440MA]; Fyssen Foundation; John Templeton Foundation	Wellcome Trust(Wellcome TrustEuropean Commission); Fyssen Foundation; John Templeton Foundation	MB was supported by grant WT094440MA from the Wellcome Trust to AW. The study was begun while NC was supported by a Research Fellowship from the Fyssen Foundation and later by a John Templeton Foundation grant to AW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acerbi A, 2014, EVOL HUM BEHAV, V35, P228, DOI 10.1016/j.evolhumbehav.2014.02.003; ASCH SE, 1955, SCI AM, V193, P31, DOI 10.1038/scientificamerican1155-31; ASCH SE, 1956, PSYCHOL MONOGR, V70, P1, DOI 10.1037/h0093718; Bentley RA, 2004, P ROY SOC B-BIOL SCI, V271, P1443, DOI 10.1098/rspb.2004.2746; Bowler MT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034505; Boyd R., 1985, CULTURE EVOLUTIONARY; Cialdini RB, 2004, ANNU REV PSYCHOL, V55, P591, DOI 10.1146/annurev.psych.55.090902.142015; Claidiere N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030970; Claidiere N, 2012, PSYCHOL BULL, V138, P126, DOI 10.1037/a0025868; Corriveau KH, 2010, DEV PSYCHOL, V46, P437, DOI 10.1037/a0017553; Corriveau KH, 2009, PSYCHOL SCI, V20, P372, DOI 10.1111/j.1467-9280.2009.02291.x; Coultas JC, 2004, GROUP PROCESS INTERG, V7, P317, DOI 10.1177/1368430204046141; Efferson C, 2008, EVOL HUM BEHAV, V29, P56, DOI 10.1016/j.evolhumbehav.2007.08.003; Efferson C, 2007, EVOL HUM BEHAV, V28, P11, DOI 10.1016/j.evolhumbehav.2006.05.005; Eriksson K., 2009, J EVOL PSYCHOL, V7, P5, DOI [10.1556/JEP.7.2009.1.3, DOI 10.1556/JEP.7.2009.1.3]; Eriksson K., 2007, J EVOL PSYCHOL, V5, P67, DOI [10.1556/JEP.2007.1009, DOI 10.1556/JEP.2007.1009]; Henrich J, 1998, EVOL HUM BEHAV, V19, P215, DOI 10.1016/S1090-5138(98)00018-X; Henrich J, 2001, J THEOR BIOL, V208, P79, DOI 10.1006/jtbi.2000.2202; Kameda T, 2002, EVOL HUM BEHAV, V23, P373, DOI 10.1016/S1090-5138(02)00101-0; Kendal J, 2009, J THEOR BIOL, V260, P210, DOI 10.1016/j.jtbi.2009.05.029; Macdonald C., 2011, International Zoo Yearbook, V45, P7, DOI 10.1111/j.1748-1090.2010.00120.x; McElreath R, 2005, EVOL HUM BEHAV, V26, P483, DOI 10.1016/j.evolhumbehav.2005.04.003; McElreath R, 2008, PHILOS T R SOC B, V363, P3515, DOI 10.1098/rstb.2008.0131; Mesoudi A, 2009, EVOL HUM BEHAV, V30, P41, DOI 10.1016/j.evolhumbehav.2008.07.005; Morgan TJH, 2012, P ROY SOC B-BIOL SCI, V279, P653, DOI 10.1098/rspb.2011.1172; Nakahashi W, 2007, THEOR POPUL BIOL, V72, P52, DOI 10.1016/j.tpb.2007.03.003; Richerson PJ., 2005, NOT GENES ALONE CULT; Wakano JY, 2007, THEOR POPUL BIOL, V72, P504, DOI 10.1016/j.tpb.2007.04.003; Walker MB, 1996, J SOC PSYCHOL, V136, P367, DOI 10.1080/00224545.1996.9714014	29	10	10	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e99874	10.1371/journal.pone.0099874	http://dx.doi.org/10.1371/journal.pone.0099874			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK2UZ	24950212	Green Submitted, Green Published, gold			2022-12-27	WOS:000338276300022
J	Fatti, G; Mothibi, E; Meintjes, G; Grimwood, A				Fatti, Geoffrey; Mothibi, Eula; Meintjes, Graeme; Grimwood, Ashraf			Antiretroviral Treatment Outcomes amongst Older Adults in a Large Multicentre Cohort in South Africa	PLOS ONE			English	Article							HIV-INFECTION; THERAPY; AGE; SELECTION; SURVIVAL; MODEL; AIDS	Introduction: Increasing numbers of patients are starting antiretroviral treatment (ART) at advanced age or reaching advanced age while on ART. We compared baseline characteristics and ART outcomes of older adults (aged >55 years) vs. younger adults (aged 25-54 years) in routine care settings in South Africa. Methods: A multicentre cohort study of ART-naive adults starting ART at 89 public sector facilities was conducted. Mortality, loss to follow-up (LTFU), immunological and virological outcomes until five years of ART were compared using competing-risks regression, generalised estimating equations and mixed-effects models. Results: 4065 older adults and 86,006 younger adults were included. There were more men amongst older adults; 44.7% vs. 33.4%; RR = 1.34 (95% CI: 1.29-1.39). Mortality after starting ART was substantially higher amongst older adults, adjusted sub-hazard ratio (asHR) = 1.44 over 5 years (95% CI: 1.26-1.64), particularly for the period 7-60 months of treatment, asHR = 1.73 (95% CI: 1.44-2.10). LTFU was lower in older adults, asHR = 0.87 (95% CI: 0.78-0.97). Achievement of virological suppression was greater in older adults, adjusted odds ratio = 1.42 (95% CI: 1.23-1.64). The probabilities of viral rebound and confirmed virological failure were both lower in older adults, adjusted hazard ratios = 0.69 (95% CI: 0.56-0.85) and 0.64 (95% CI: 0.47-0.89), respectively. The rate of CD4 cell recovery (amongst patients with continuous viral suppression) was 25 cells/6 months of ART (95% CI: 17.3-33.2) lower in older adults. Conclusions: Although older adults had better virological outcomes and reduced LTFU, their higher mortality and slower immunological recovery warrant consideration of age-specific ART initiation criteria and management strategies.	[Fatti, Geoffrey; Mothibi, Eula; Grimwood, Ashraf] KhethImpilo, Cape Town, South Africa; [Meintjes, Graeme] Univ Cape Town, Dept Med, Div Infect Dis & HIV Med, ZA-7925 Cape Town, South Africa; [Meintjes, Graeme] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Meintjes, Graeme] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England	University of Cape Town; University of Cape Town; Imperial College London	Fatti, G (corresponding author), KhethImpilo, Cape Town, South Africa.	geoffrey.fatti@khethimpilo.org	Fatti, Geoffrey/AAA-9217-2019	Fatti, Geoffrey/0000-0002-6467-662X; Meintjes, Graeme/0000-0003-1196-4414	Presidents Emergency Plan for AIDS Relief; Wellcome Trust fellowship [098316]	Presidents Emergency Plan for AIDS Relief(United States Agency for International Development (USAID)); Wellcome Trust fellowship(Wellcome Trust)	Presidents Emergency Plan for AIDS Relief partly funded the program on which the study was based. Graeme Meintjes is supported by a Wellcome Trust fellowship (098316). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg Judith A, 2012, Top Antivir Med, V20, P101; Actuarial Society of South Africa, 2011, ASSA2008 AIDS DEM MO; [Anonymous], 2014, WORLD AIDS DAY 2014; [Anonymous], DEF OLD ELD PERS; Boscardin W J, 1998, Stat Methods Med Res, V7, P13; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Case A, 2005, HLTH SEEKING BEHAV N; Chi BH, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001111; Collinson MA, 2007, SCAND J PUBLIC HEALT, V35, P77, DOI 10.1080/14034950701356401; Cornell M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001304; Cornell M, 2010, AIDS, V24, P2263, DOI 10.1097/QAD.0b013e32833d45c5; Effros RB, 2008, CLIN INFECT DIS, V47, P542, DOI 10.1086/590150; Fatti G, 2012, J INT AIDS SOC, V15, P265, DOI 10.7448/IAS.15.2.17381; Fatti G, 2012, JAIDS-J ACQ IMM DEF, V61, pE50, DOI 10.1097/QAI.0b013e31826a6aee; Fatti G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012888; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Forster M, 2008, B WORLD HEALTH ORGAN, V86, P939, DOI 10.2471/BLT.07.049908; Gleason LJ, 2013, CLIN INTERV AGING, V8, P749, DOI 10.2147/CIA.S37738; Grabar S, 2004, AIDS, V18, P2029, DOI 10.1097/00002030-200410210-00007; Grabar S, 2006, J ANTIMICROB CHEMOTH, V57, P4, DOI 10.1093/jac/dki411; Greenbaum AH, 2008, AIDS, V22, P2331, DOI 10.1097/QAD.0b013e32831883f9; Greene M, 2013, JAMA-J AM MED ASSOC, V309, P1397, DOI 10.1001/jama.2013.2963; Greig Jane, 2012, AIDS, V26 Suppl 1, pS31; Hasse B, 2011, CLIN INFECT DIS, V53, P1130, DOI 10.1093/cid/cir626; High KP, 2012, JAIDS-J ACQ IMM DEF, V60, pS1, DOI 10.1097/QAI.0b013e31825a3668; Hinkin CH, 2004, AIDS, V18, pS19, DOI 10.1097/00002030-200418001-00004; Hontelez Jan A C, 2012, AIDS, V26 Suppl 1, pS19; Johnson LF, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001418; Johnson LF, 2012, S AFR J HIV MED, P22; Keiser O, 2008, TROP MED INT HEALTH, V13, P870, DOI 10.1111/j.1365-3156.2008.02078.x; Keiser O, 2008, PLOS MED, V5, P1409, DOI 10.1371/journal.pmed.0050195; Kuk D, 2013, STAT MED, V32, P3077, DOI 10.1002/sim.5762; Leclerc-Madlala S, 2008, AIDS, V22, pS17, DOI 10.1097/01.aids.0000341774.86500.53; Loveday M, 2011, SAMJ S AFR MED J, V101, P887; Mair C, 2008, CLIN EXP IMMUNOL, V151, P432, DOI 10.1111/j.1365-2249.2007.03573.x; Malaza A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070126; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; Maskew Mhairi, 2012, J Int Assoc Physicians AIDS Care (Chic), V11, P57, DOI 10.1177/1545109711421641; Mtei L N, 2001, East Afr Med J, V78, P144; Mutevedzi PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021795; Nachega Jean B, 2012, AIDS, V26 Suppl 1, pS39; National Department of Health of South Africa, 2012, 2011 NAT ANT SENT HI; National Department of Health South Africa, 2010, CLIN GUID MAN HIV AI; Negin J, 2012, AIDS BEHAV, V16, P63, DOI 10.1007/s10461-011-9994-y; Negin J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026546; Pantazis N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032369; Parrott FR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027917; Pathai S, 2013, AIDS, V27, P2375, DOI 10.1097/QAD.0b013e328363bf7f; Perez JL, 2003, CLIN INFECT DIS, V36, P212, DOI 10.1086/345669; Schneider MF, 2005, AIDS, V19, P2009, DOI 10.1097/01.aids.0000189864.90053.22; Schoni-Affolter F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027919; Schomaker M, 2013, JAIDS-J ACQ IMM DEF, V63, P142, DOI 10.1097/QAI.0b013e318288b39d; Silverberg MJ, 2007, ARCH INTERN MED, V167, P684, DOI 10.1001/archinte.167.7.684; South Africa National Department of Health, 2010, CLIN GUID MAN HIV AI; South African National Department of Health, 2004, NAT ANT TREATM GUID; Statistics South Africa, 2014, MORT CAUS DEATH S AF	56	24	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100273	10.1371/journal.pone.0100273	http://dx.doi.org/10.1371/journal.pone.0100273			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949879	gold, Green Published, Green Submitted			2022-12-27	WOS:000338276300058
J	Fulham, WR; Michie, PT; Ward, PB; Rasser, PE; Todd, J; Johnston, PJ; Thompson, PM; Schall, U				Fulham, W. Ross; Michie, Patricia T.; Ward, Philip B.; Rasser, Paul E.; Todd, Juanita; Johnston, Patrick J.; Thompson, Paul M.; Schall, Ulrich			Mismatch Negativity in Recent-Onset and Chronic Schizophrenia: A Current Source Density Analysis	PLOS ONE			English	Article							AUDITORY CHANGE-DETECTION; INFORMATION-PROCESSING DEFICITS; ULTRA-HIGH-RISK; PREFRONTAL CORTEX; FREQUENCY CHANGES; ELECTROPHYSIOLOGICAL EVIDENCE; 1ST-EPISODE PSYCHOSIS; SPECTRUM DISORDERS; NEURAL CIRCUITRY; PARIETAL LOBULE	Mismatch negativity (MMN) is a component of the event-related potential elicited by deviant auditory stimuli. It is presumed to index pre-attentive monitoring of changes in the auditory environment. MMN amplitude is smaller in groups of individuals with schizophrenia compared to healthy controls. We compared duration-deviant MMN in 16 recent-onset and 19 chronic schizophrenia patients versus age-and sex-matched controls. Reduced frontal MMN was found in both patient groups, involved reduced hemispheric asymmetry, and was correlated with Global Assessment of Functioning (GAF) and negative symptom ratings. A cortically-constrained LORETA analysis, incorporating anatomical data from each individual's MRI, was performed to generate a current source density model of the MMN response over time. This model suggested MMN generation within a temporal, parietal and frontal network, which was right hemisphere dominant only in controls. An exploratory analysis revealed reduced CSD in patients in superior and middle temporal cortex, inferior and superior parietal cortex, precuneus, anterior cingulate, and superior and middle frontal cortex. A region of interest (ROI) analysis was performed. For the early phase of the MMN, patients had reduced bilateral temporal and parietal response and no lateralisation in frontal ROIs. For late MMN, patients had reduced bilateral parietal response and no lateralisation in temporal ROIs. In patients, correlations revealed a link between GAF and the MMN response in parietal cortex. In controls, the frontal response onset was 17 ms later than the temporal and parietal response. In patients, onset latency of the MMN response was delayed in secondary, but not primary, auditory cortex. However amplitude reductions were observed in both primary and secondary auditory cortex. These latency delays may indicate relatively intact information processing upstream of the primary auditory cortex, but impaired primary auditory cortex or cortico-cortical or thalamo-cortical communication with higher auditory cortices as a core deficit in schizophrenia.	[Fulham, W. Ross; Michie, Patricia T.; Rasser, Paul E.; Todd, Juanita; Schall, Ulrich] Univ Newcastle, Ctr Translat Neurosci & Mental Hlth, Newcastle, NSW 2300, Australia; [Fulham, W. Ross; Michie, Patricia T.; Rasser, Paul E.; Todd, Juanita; Thompson, Paul M.; Schall, Ulrich] Schizophrenia Res Inst, Darlinghurst, NSW, Australia; [Fulham, W. Ross; Rasser, Paul E.; Schall, Ulrich] Hunter Med Res Inst, Newcastle, NSW, Australia; [Michie, Patricia T.; Todd, Juanita] Univ Newcastle, Sch Psychol, Newcastle, NSW 2300, Australia; [Ward, Philip B.] Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia; [Ward, Philip B.] South Western Sydney Local Hlth Dist, Schizophrenia Res Unit, Sydney, NSW, Australia; [Johnston, Patrick J.] Univ York, Dept Psychol, Heslington, Yorks, England; [Johnston, Patrick J.] Univ York, York Neuroimaging Ctr, Heslington, Yorks, England; [Thompson, Paul M.] Univ So Calif, Keck Sch Med, Imaging Genet Ctr, Inst Neuroimaging & Informat, Los Angeles, CA 90033 USA; [Thompson, Paul M.] Univ So Calif, Dept Neurol, Los Angeles, CA USA; [Thompson, Paul M.] Univ So Calif, Dept Psychiat, Los Angeles, CA USA; [Thompson, Paul M.] Univ So Calif, Dept Radiol, Los Angeles, CA USA; [Thompson, Paul M.] Univ So Calif, Dept Engn, Los Angeles, CA USA; [Thompson, Paul M.] Univ So Calif, Dept Pediat, Los Angeles, CA 90089 USA; [Thompson, Paul M.] Univ So Calif, Dept Ophthalmol, Los Angeles, CA 90089 USA	University of Newcastle; Hunter Medical Research Institute; University of Newcastle; University of Newcastle; University of New South Wales Sydney; University of York - UK; University of York - UK; University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California	Fulham, WR (corresponding author), Univ Newcastle, Ctr Translat Neurosci & Mental Hlth, Newcastle, NSW 2300, Australia.	ross.fulham@newcastle.edu.au	Ward, Philip/E-3959-2010; Thompson, Paul M/C-4194-2018; Johnston, Patrick/P-3158-2014; SCHALL, ULRICH ANDREAS/G-7452-2013; , Juanita/B-6191-2013	Ward, Philip/0000-0002-5779-7722; Thompson, Paul M/0000-0002-4720-8867; Johnston, Patrick/0000-0001-7703-1073; SCHALL, ULRICH ANDREAS/0000-0001-9041-4562; , Juanita/0000-0002-0443-600X	National Health and Medical Research Council of Australia [252480]; NSW Health; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015922] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NSW Health; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This project was funded by a National Health and Medical Research Council of Australia Project Grant, ID 252480. The contents of this article are solely the responsibility of the authors and do not reflect the views of NHMRC (http://www.nhmrc.gov.au/). Infrastructure support was received from the Hunter Medical Research Institute (http://www.hmri.com.au/) and the Schizophrenia Research Institute (http://www.schizophreniaresearch.org.au/), which are supported by infrastructure funding from NSW Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alho K, 1998, PSYCHOPHYSIOLOGY, V35, P211, DOI 10.1111/1469-8986.3520211; Andreasen N. C., 1984, SCALE ASSESSMENT POS; Andreasen NC, 1983, SCALE ASSESSMENT NEG; Atkinson RJ, 2012, BIOL PSYCHIAT, V71, P98, DOI 10.1016/j.biopsych.2011.08.023; Ayala Y, 2013, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00089; Baldeweg T, 2004, SCHIZOPHR RES, V69, P203, DOI 10.1016/j.schres.2003.09.009; Bodatsch M, 2011, BIOL PSYCHIAT, V69, P959, DOI 10.1016/j.biopsych.2010.09.057; Brockhaus-Dumke A, 2005, SCHIZOPHR RES, V73, P297, DOI 10.1016/j.schres.2004.05.016; CATTS SV, 1995, AM J PSYCHIAT, V152, P213; Cheng CH, 2013, INT J PSYCHOPHYSIOL, V90, P165, DOI 10.1016/j.ijpsycho.2013.06.026; CSEPE V, 1991, INT J PSYCHOPHYSIOL, V11, P19, DOI 10.1016/0167-8760(91)90093-D; Devrim-Ucok M, 2007, EUR ARCH PSY CLIN N, V258, P179; Dickey CC, 2008, SCHIZOPHR RES, V103, P26, DOI 10.1016/j.schres.2008.04.041; Dima D, 2012, SCHIZOPHR RES, V135, P23, DOI 10.1016/j.schres.2011.12.024; Dittmann-Balcar A, 2001, NEUROSCI LETT, V308, P119, DOI 10.1016/S0304-3940(01)01995-4; Doeller CF, 2003, NEUROIMAGE, V20, P1270, DOI 10.1016/S1053-8119(03)00389-6; Edwards E, 2005, J NEUROPHYSIOL, V94, P4269, DOI 10.1152/jn.00324.2005; Escera C, 2013, BRAIN TOPOG IN PRESS, DOI [10.1007/s10548-10013-10328-10544, DOI 10.1007/S10548-10013-10328-10544]; First M. B., 1997, STRUCTURED CLIN INTE; Fisher DJ, 2011, INT J PSYCHOPHYSIOL, V81, P245, DOI 10.1016/j.ijpsycho.2011.06.018; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Garrido MI, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002999; Garrido MI, 2009, J NEUROPHYSIOL, V101, P2620, DOI 10.1152/jn.90291.2008; GIARD MH, 1990, PSYCHOPHYSIOLOGY, V27, P627, DOI 10.1111/j.1469-8986.1990.tb03184.x; Grimm S, 2012, INT J PSYCHOPHYSIOL, V85, P88, DOI 10.1016/j.ijpsycho.2011.05.012; Grimm S, 2011, PSYCHOPHYSIOLOGY, V48, P377, DOI 10.1111/j.1469-8986.2010.01073.x; Grzella I, 2001, J PSYCHIATR NEUROSCI, V26, P235; HALGREN E, 1995, ELECTROEN CLIN NEURO, V94, P191, DOI 10.1016/0013-4694(94)00259-N; Hermens DF, 2010, PROG NEURO-PSYCHOPH, V34, P822, DOI 10.1016/j.pnpbp.2010.03.019; Hirayasu Y, 1998, AM J PSYCHIAT, V155, P1281, DOI 10.1176/ajp.155.9.1281; Holmes CJ, 1998, J COMPUT ASSIST TOMO, V22, P324, DOI 10.1097/00004728-199803000-00032; Hsiao FJ, 2010, BIOL PSYCHOL, V84, P336, DOI 10.1016/j.biopsycho.2010.03.019; Hu B, 2003, EXP BRAIN RES, V153, P543, DOI 10.1007/s00221-003-1611-5; Hughes HC, 2001, NEUROIMAGE, V13, P1073, DOI 10.1006/nimg.2001.0766; Jaaskelainen IP, 1996, BIOL PSYCHOL, V43, P13, DOI 10.1016/0301-0511(95)05174-0; Jablensky A, 2000, AUST NZ J PSYCHIAT, V34, P221, DOI 10.1046/j.1440-1614.2000.00728.x; Jacobsen T, 2003, CLIN NEUROPHYSIOL, V114, P1133, DOI 10.1016/S1388-2457(03)00043-9; Jahshan C, 2012, PSYCHOL MED, V42, P85, DOI 10.1017/S0033291711001061; Javitt DC, 2000, CLIN NEUROPHYSIOL, V111, P1733, DOI 10.1016/S1388-2457(00)00377-1; Jemel B, 2002, BRAIN TOPOGR, V15, P13, DOI 10.1023/A:1019944805499; Kasai K, 1999, NEUROREPORT, V10, P2267, DOI 10.1097/00001756-199908020-00008; Kasai K, 2002, AM J PSYCHIAT, V159, P546, DOI 10.1176/appi.ajp.159.4.546; Kaur M, 2013, PROG NEURO-PSYCHOPH, V46, P161, DOI 10.1016/j.pnpbp.2013.07.002; Kaur M, 2011, SCHIZOPHR RES, V130, P203, DOI 10.1016/j.schres.2011.03.025; Kawakubo Y, 2006, PROG NEURO-PSYCHOPH, V30, P1367, DOI 10.1016/j.pnpbp.2006.03.003; Kiang M, 2007, J INT NEUROPSYCH SOC, V13, P653, DOI 10.1017/S1355617707070816; Kiang M, 2009, CLIN NEUROPHYSIOL, V120, P1949, DOI 10.1016/j.clinph.2009.08.019; Kircher TTJ, 2004, AM J PSYCHIAT, V161, P294, DOI 10.1176/appi.ajp.161.2.294; Kujala T, 2007, BIOL PSYCHOL, V74, P1, DOI 10.1016/j.biopsycho.2006.06.001; Lappe C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061296; LAVIKAINEN J, 1995, EVOKED POTENTIAL, V96, P93, DOI 10.1016/0013-4694(94)00283-Q; Leung S, 2013, CLIN NEUROPHYSIOL, V124, P2397, DOI 10.1016/j.clinph.2013.06.001; Levanen S, 1996, CEREB CORTEX, V6, P288, DOI 10.1093/cercor/6.2.288; Lewis DA, 2009, J CLIN INVEST, V119, P706, DOI 10.1172/JCI37335; Lieder F, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002911; Light GA, 2005, AM J PSYCHIAT, V162, P1741, DOI 10.1176/appi.ajp.162.9.1741; Light GA, 2005, ARCH GEN PSYCHIAT, V62, P127, DOI 10.1001/archpsyc.62.2.127; Light GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039434; LUBORSKY L, 1962, ARCH GEN PSYCHIAT, V7, P407; Magno E, 2008, BIOL PSYCHIAT, V64, P385, DOI 10.1016/j.biopsych.2008.03.019; Marco-Pallares J, 2005, NEUROIMAGE, V25, P471, DOI 10.1016/j.neuroimage.2004.11.028; Michel CM, 2004, CLIN NEUROPHYSIOL, V115, P2195, DOI 10.1016/j.clinph.2004.06.001; Michie PT, 2000, CLIN NEUROPHYSIOL, V111, P1054, DOI 10.1016/S1388-2457(00)00275-3; Michie PT, 2002, BIOL PSYCHIAT, V52, P749, DOI 10.1016/S0006-3223(02)01379-3; Michie PT, 2001, INT J PSYCHOPHYSIOL, V42, P177, DOI 10.1016/S0167-8760(01)00166-0; Miller J, 1998, PSYCHOPHYSIOLOGY, V35, P99, DOI 10.1111/1469-8986.3510099; Miyanishi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061152; Molholm S, 2005, CEREB CORTEX, V15, P545, DOI 10.1093/cercor/bhh155; Molholm S, 2006, J NEUROPHYSIOL, V96, P721, DOI 10.1152/jn.00285.2006; Mordkoff JT, 2000, PSYCHOPHYSIOLOGY, V37, P347; Morey RA, 2008, J NEUROPSYCH CLIN N, V20, P419, DOI 10.1176/appi.neuropsych.20.4.419; Muller BW, 2002, NEUROIMAGE, V17, P231, DOI 10.1006/nimg.2002.1176; NAATANEN R, 1979, BIOL PSYCHOL, V8, P81, DOI 10.1016/0301-0511(79)90053-X; Naatanen R, 2012, CLIN NEUROPHYSIOL, V123, P424, DOI 10.1016/j.clinph.2011.09.020; Naatanen R, 2009, INT J NEUROPSYCHOPH, V12, P125, DOI 10.1017/S1461145708009322; Nagai T, 2013, SCHIZOPHR RES, V150, P547, DOI 10.1016/j.schres.2013.08.005; Novitski N, 2006, J NEUROSCI METH, V155, P149, DOI 10.1016/j.jneumeth.2006.01.030; Oades RD, 2006, BMC PSYCHIATRY, V6, DOI 10.1186/1471-244X-6-7; Oertel-Knochell V, 2011, NEUROSCIENTIST, V17, P456, DOI 10.1177/1073858410386493; Oknina LB, 2005, SCHIZOPHR RES, V76, P25, DOI 10.1016/j.schres.2004.10.003; Opitz B, 2002, NEUROIMAGE, V15, P167, DOI 10.1006/nimg.2001.0970; Paavilainen P, 2003, NEUROSCI LETT, V349, P79, DOI 10.1016/S0304-3940(03)00787-0; Park HJ, 2002, HUM BRAIN MAPP, V17, P168, DOI 10.1002/hbm.10059; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P91; Pekkonen E, 2002, SCHIZOPHRENIA BULL, V28, P467, DOI 10.1093/oxfordjournals.schbul.a006954; Perez VB, 2013, BIOL PSYCHIAT, DOI [10.1016/j.biopsych.2013.1007.1038, DOI 10.1016/J.BIOPSYCH.2013.1007.1038]; Rasser PE, 2011, SCHIZOPHRENIA BULL, V37, P131, DOI 10.1093/schbul/sbp060; Rauschecker JP, 2011, HEARING RES, V271, P16, DOI 10.1016/j.heares.2010.09.001; Restuccia D, 2005, COGNITIVE BRAIN RES, V25, P891, DOI 10.1016/j.cogbrainres.2005.09.023; Rinne T, 2005, NEUROIMAGE, V26, P66, DOI 10.1016/j.neuroimage.2005.01.017; Rinne T, 2000, NEUROIMAGE, V12, P14, DOI 10.1006/nimg.2000.0591; Rinne T, 2007, NEUROSCI LETT, V416, P247, DOI 10.1016/j.neulet.2007.01.077; Rissling AJ, 2012, CLIN NEUROPHYSIOL, V123, P1942, DOI 10.1016/j.clinph.2012.02.079; Rosburg T, 2004, HUM BRAIN MAPP, V21, P44, DOI 10.1002/hbm.10146; Salisbury DF, 2007, ARCH GEN PSYCHIAT, V64, P521, DOI 10.1001/archpsyc.64.5.521; Salisbury DF, 2002, ARCH GEN PSYCHIAT, V59, P686, DOI 10.1001/archpsyc.59.8.686; Salmi J, 2009, BRAIN RES, V1286, P155, DOI 10.1016/j.brainres.2009.06.083; Sato Y, 2000, NEUROREPORT, V11, P3703, DOI 10.1097/00001756-200011270-00023; Sato Y, 2003, BIOL PSYCHOL, V62, P49, DOI 10.1016/S0301-0511(02)00113-8; Schall U, 1999, INT J NEUROPSYCHOPH, V2, P83, DOI 10.1017/S1461145799001418; Schall U, 2003, NEUROIMAGE, V20, P729, DOI 10.1016/S1053-8119(03)00398-7; Schmidt A, 2013, CEREB CORTEX, V23, P2394, DOI 10.1093/cercor/bhs238; Schonwiesner M, 2007, J NEUROPHYSIOL, V97, P2075, DOI 10.1152/jn.01083.2006; Schwarzenau P, 1998, BEHAV RES METH INS C, V30, P110, DOI 10.3758/BF03209421; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; SHELLEY AM, 1991, BIOL PSYCHIAT, V30, P1059, DOI 10.1016/0006-3223(91)90126-7; Shin KS, 2012, SCHIZOPHRENIA BULL, V38, P1258, DOI 10.1093/schbul/sbr138; Shin KS, 2009, BIOL PSYCHIAT, V65, P1071, DOI 10.1016/j.biopsych.2008.12.024; Shinozaki N, 2002, BIOL PSYCHOL, V59, P105, DOI 10.1016/S0301-0511(01)00129-6; Swadlow HA, 2012, SCHOLARPEDIA, V7, P1451, DOI DOI 10.4249/SCHOLARPEDIA.1451; Sweet RA, 2007, BIOL PSYCHIAT, V61, P854, DOI 10.1016/j.biopsych.2006.07.033; Sweet RA, 2009, NEUROPSYCHOPHARMACOL, V34, P374, DOI 10.1038/npp.2008.67; Takahashi H, 2013, NEUROIMAGE, V66, P594, DOI 10.1016/j.neuroimage.2012.09.074; Tervaniemi M, 2005, CLIN NEUROPHYSIOL, V116, P1897, DOI 10.1016/j.clinph.2005.03.025; Thonnessen H, 2008, BIOL PSYCHOL, V77, P205, DOI 10.1016/j.biopsycho.2007.10.009; Thompson PM, 2001, P NATL ACAD SCI USA, V98, P11650, DOI 10.1073/pnas.201243998; Todd J, 2008, BIOL PSYCHIAT, V63, P58, DOI 10.1016/j.biopsych.2007.02.016; Torrey EF, 2007, SCHIZOPHR RES, V97, P215, DOI 10.1016/j.schres.2007.08.023; Tse CY, 2008, NEUROIMAGE, V41, P1462, DOI 10.1016/j.neuroimage.2008.03.043; Tse CY, 2013, NEUROIMAGE, V83, P870, DOI 10.1016/j.neuroimage.2013.07.037; Tse CY, 2007, IEEE ENG MED BIOL, V26, P52, DOI 10.1109/MEMB.2007.384096; Turetsky BI, 2009, PSYCHIAT RES, V165, P27, DOI 10.1016/j.psychres.2008.04.013; Umbricht D, 2005, SCHIZOPHR RES, V76, P1, DOI 10.1016/j.schres.2004.12.002; Umbricht D, 2003, BIOL PSYCHIAT, V53, P1120, DOI 10.1016/S0006-3223(02)01642-6; Umbricht DSG, 2006, BIOL PSYCHIAT, V59, P762, DOI 10.1016/j.biopsych.2005.08.030; Wagner M., 1996, NEUROIMAGE, V3, pS168; Watkins S, 2007, CEREB CORTEX, V17, P1694, DOI 10.1093/cercor/bhl080; Wible CG, 2001, AM J PSYCHIAT, V158, P938; Winkler I, 2007, J PSYCHOPHYSIOL, V21, P147, DOI 10.1027/0269-8803.21.34.147; Wynn JK, 2010, BIOL PSYCHIAT, V67, P940, DOI 10.1016/j.biopsych.2009.11.024; Yago E, 2001, NEUROREPORT, V12, P2583, DOI 10.1097/00001756-200108080-00058; Yildiz M, 2011, SCHIZOPHRENIA RES TR, V2011, P1; Youn T, 2004, HUM BRAIN MAPP, V21, P46, DOI 10.1002/hbm.10147; Youn T, 2003, SCHIZOPHR RES, V59, P253, DOI 10.1016/S0920-9964(02)00154-8	135	39	39	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100221	10.1371/journal.pone.0100221	http://dx.doi.org/10.1371/journal.pone.0100221			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949859	gold, Green Published			2022-12-27	WOS:000338276300050
J	Jones-Smith, JC; Dieckmann, MG; Gottlieb, L; Chow, J; Fernald, LCH				Jones-Smith, Jessica C.; Dieckmann, Marlowe Gates; Gottlieb, Laura; Chow, Jessica; Fernald, Lia C. H.			Socioeconomic Status and Trajectory of Overweight from Birth to Mid-Childhood: The Early Childhood Longitudinal Study-Birth Cohort	PLOS ONE			English	Article							OBESITY; PREVALENCE; CHILDREN; HEALTH; DISPARITIES; ADOLESCENTS; POVERTY; TRENDS; RISK; ASSOCIATIONS	Objective: Our objective was to use longitudinal data from a US birth cohort to test whether the probability of overweight or obesity during the first 6 years of life varied according to socioeconomic status. Design and Methods: Using six waves of longitudinal data from full-term children in the Early Childhood Longitudinal Study-Birth Cohort (2001-2007; n approximate to 4,950), we examined the prevalence of overweight or obesity (Body Mass Index (BMI)>2 standard deviations above age- and sex- specific WHO Childhood Growth Standard reference mean; henceforth, "overweight/obesity") according to age, socioeconomic status, and race/ethnicity using generalized estimating equation models. Results: The association between socioeconomic status and overweight/obesity varied significantly by race/ethnicity, but not by sex. Overweight/obesity was significantly associated with socioeconomic status among whites, Hispanics and Asians; the adjusted odds of overweight/obesity began to diverge according to SES after the first 9 months of life. By approximately 4 years, children with the highest SES had a significantly lower odds of overweight/obesity. SES was not significantly related to overweight/obesity among African Americans and American Indians during early childhood. Conclusions: Few studies have assessed the associations between SES and overweight/obesity within racial/ethnic groups in the US. We find that in contemporary, US-born children, SES was inversely associated with overweight/obesity among more racial/ethnic groups (whites, Hispanics, and Asians) than previously reported.	[Jones-Smith, Jessica C.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth Human Nutr, Baltimore, MD 21205 USA; [Jones-Smith, Jessica C.; Dieckmann, Marlowe Gates; Fernald, Lia C. H.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Dieckmann, Marlowe Gates] Univ Louisville, Sch Med, Louisville, KY 40292 USA; [Gottlieb, Laura] Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA; [Gottlieb, Laura] Univ Calif San Francisco, Ctr Hlth & Commun, San Francisco, CA 94143 USA; [Chow, Jessica] Univ Calif San Francisco, Univ Calif Berkeley, JMP, Berkeley, CA USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of California System; University of California Berkeley; University of Louisville; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California San Francisco	Jones-Smith, JC (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth Human Nutr, Baltimore, MD 21205 USA.	jonessmith@jhu.edu		Jones-Smith, Jessica/0000-0001-8962-1695; Fernald, Lia C.H./0000-0003-1555-4607	National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health and Human Development [1K99HD073327, R21 HD056581]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R00HD073327, K99HD073327, R24HD042854] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD056581] Funding Source: NIH RePORTER	National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	JCJS was funded in part by the National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health and Human Development (Grant numbers: 1K99HD073327 and R21 HD056581). No additional funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SE, 2009, ARCH PEDIAT ADOL MED, V163, P344, DOI 10.1001/archpediatrics.2009.18; Bocca-Tjeertes IFA, 2012, J PEDIATR-US, V161, P460, DOI 10.1016/j.jpeds.2012.03.016; Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879; CDC, 2021, FLUV WEEKL INFL SURV; Chang VW, 2006, SOC SCI MED, V63, P1289, DOI 10.1016/j.socscimed.2006.03.049; Chang VW, 2003, AM J PREV MED, V24, P332, DOI 10.1016/S0749-3797(03)00020-5; Coogan PF, 2012, ETHNIC DIS, V22, P198; Cunningham SA, 2014, NEW ENGL J MED, V370, P403, DOI [10.1056/NEJMoa1309753, 10.1056/NEJMc1402397]; de Onis M, 2010, INT J PEDIATR OBES, V5, P458, DOI 10.3109/17477161003615583; Drewnowski A, 2004, AM J CLIN NUTR, V79, P6; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Freedman DS, 2009, PEDIATRICS, V124, pS23, DOI 10.1542/peds.2008-3586E; Fujioka Y, 2009, COMMUN RES, V36, P451, DOI 10.1177/0093650209333031; Gordon-Larsen P, 2006, PEDIATRICS, V117, P417, DOI 10.1542/peds.2005-0058; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; Hajat A, 2011, AM J EPIDEMIOL, V173, P192, DOI 10.1093/aje/kwq348; Heeringa SG, 2017, APPL SURVEY DATA ANA, VSecond, DOI DOI 10.1201/9781315153278; JEWELL N. P., 2004, STAT EPIDEMIOLOGY; KLEINBAUM DG, 2007, APPL REGRESSION ANAL; LaVeist TA, 2005, J URBAN HEALTH, V82, pIII26, DOI 10.1093/jurban/jti061; LaVeist T, 2011, HEALTH AFFAIR, V30, P1880, DOI 10.1377/hlthaff.2011.0640; Lee H, 2014, AM J PUBLIC HEALTH, V104, pE70, DOI 10.2105/AJPH.2013.301806; Lovasi GS, 2009, EPIDEMIOL REV, V31, P7, DOI 10.1093/epirev/mxp005; Madsen KA, 2010, PEDIATRICS, V126, P434, DOI 10.1542/peds.2009-3411; Miech RA, 2006, JAMA-J AM MED ASSOC, V295, P2385, DOI 10.1001/jama.295.20.2385; Mujahid MS, 2005, OBES RES, V13, P1412, DOI 10.1038/oby.2005.171; Nader PR, 2006, PEDIATRICS, V118, pE594, DOI 10.1542/peds.2005-2801; National Center for Education Statisitics, US MAN ECLS B LONG 9; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Wang YF, 2006, AM J CLIN NUTR, V84, P707, DOI 10.1093/ajcn/84.4.707; Wei Yang KS, 2012, J OBES, V2012, P9; Williams DR, 1999, ANN NY ACAD SCI, V896, P173, DOI 10.1111/j.1749-6632.1999.tb08114.x; Wolfe B, 2012, DEMOGRAPHY, V49, P499, DOI 10.1007/s13524-012-0098-8	34	34	35	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100181	10.1371/journal.pone.0100181	http://dx.doi.org/10.1371/journal.pone.0100181			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK2UZ	24950056	gold, Green Published			2022-12-27	WOS:000338276300044
J	Zhang, YY; Huang, Y; He, QZ; Liu, JY; Luo, J; Zhu, L; Lu, SS; Huang, PF; Chen, XY; Zeng, XZ; Liang, SP				Zhang, Yiya; Huang, Yong; He, Quanze; Liu, Jinyan; Luo, Ji; Zhu, Li; Lu, Shanshan; Huang, Pengfei; Chen, Xinyi; Zeng, Xiongzhi; Liang, Songping			Toxin Diversity Revealed by a Transcriptomic Study of Ornithoctonus huwena	PLOS ONE			English	Article							SPIDER SELENOCOSMIA-HUWENA; CHINESE BIRD SPIDER; GATED SODIUM-CHANNELS; VENOM-GLAND TRANSCRIPTOME; HUWENTOXIN-I; TARANTULA TOXINS; VOLTAGE SENSORS; DUCT TRANSCRIPTOME; CALCIUM-CHANNELS; CONUS-CONSORS	Spider venom comprises a mixture of compounds with diverse biological activities, which are used to capture prey and defend against predators. The peptide components bind a broad range of cellular targets with high affinity and selectivity, and appear to have remarkable structural diversity. Although spider venoms have been intensively investigated over the past few decades, venomic strategies to date have generally focused on high-abundance peptides. In addition, the lack of complete spider genomes or representative cDNA libraries has presented significant limitations for researchers interested in molecular diversity and understanding the genetic mechanisms of toxin evolution. In the present study, second-generation sequencing technologies, combined with proteomic analysis, were applied to determine the diverse peptide toxins in venom of the Chinese bird spider Ornithoctonus huwena. In total, 626 toxin precursor sequences were retrieved from transcriptomic data. All toxin precursors clustered into 16 gene superfamilies, which included six novel superfamilies and six novel cysteine patterns. A surprisingly high number of hypermutations and fragment insertions/deletions were detected, which accounted for the majority of toxin gene sequences with low-level expression. These mutations contribute to the formation of diverse cysteine patterns and highly variable isoforms. Furthermore, intraspecific venom variability, in combination with variable transcripts and peptide processing, contributes to the hypervariability of toxins in venoms, and associated rapid and adaptive evolution of toxins for prey capture and defense.	[Zhang, Yiya; Liu, Jinyan; Luo, Ji; Zhu, Li; Lu, Shanshan; Huang, Pengfei; Chen, Xinyi; Zeng, Xiongzhi; Liang, Songping] Hunan Normal Univ, Coll Life Sci, Minist Educ, Key Lab Prot Chem & Dev Biol, Changsha, Hunan, Peoples R China; [Huang, Yong] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [He, Quanze] Fudan Univ, State Key Lab Genet Engn, Inst Biomed Sci, Shanghai 200433, Peoples R China	Hunan Normal University; Beijing Institute of Microbiology & Epidemiology; Fudan University	Zeng, XZ (corresponding author), Hunan Normal Univ, Coll Life Sci, Minist Educ, Key Lab Prot Chem & Dev Biol, Changsha, Hunan, Peoples R China.	xiongzhizeng@yahoo.com.cn; liangsp@hunnu.edu.cn		Zhang, Yiya/0000-0003-3644-3500	National Basic Research Program of China (973) [2010CB529800, 2012CB22305]; Cooperative Innovation Center of Engineering and New Products for Developmental Biology of Hunan Province [20134486]	National Basic Research Program of China (973)(National Basic Research Program of China); Cooperative Innovation Center of Engineering and New Products for Developmental Biology of Hunan Province	Funding came from: 1. The National Basic Research Program of China (973), 2010CB529800 and 2012CB22305 and 2. The Cooperative Innovation Center of Engineering and New Products for Developmental Biology of Hunan Province (20134486). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bohlen CJ, 2010, CELL, V141, P834, DOI 10.1016/j.cell.2010.03.052; Buczek O, 2007, BIOCHEMISTRY-US, V46, P9929, DOI 10.1021/bi700797f; Chen JJ, 2008, TOXICON, V52, P794, DOI 10.1016/j.toxicon.2008.08.003; Chuang RSI, 1998, NAT NEUROSCI, V1, P668, DOI 10.1038/3669; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Davis J, 2009, PEPTIDES, V30, P1222, DOI 10.1016/j.peptides.2009.03.019; Deng MC, 2008, EUR J PHARMACOL, V582, P12, DOI 10.1016/j.ejphar.2007.12.014; Diego-Garcia E, 2010, CELL MOL LIFE SCI, V67, P2799, DOI 10.1007/s00018-010-0359-x; Duan Z, 2012, J PROTEOMICS; Duda TF, 2000, MOL BIOL EVOL, V17, P1286, DOI 10.1093/oxfordjournals.molbev.a026412; Durban J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-259; Dutertre S, 2010, TOXICON, V55, P1453, DOI 10.1016/j.toxicon.2010.02.025; Dutertre S, 2010, J BIOL CHEM, V285, P13315, DOI 10.1074/jbc.R109.076596; Escoubas P, 2008, J MASS SPECTROM, V43, P279, DOI 10.1002/jms.1389; Fernandes-Pedrosa MD, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-279; Gao B, 2012, COMP BIOCHEM PHYS B, V163, P238, DOI 10.1016/j.cbpb.2012.06.002; Gong JP, 1997, J BIOL CHEM, V272, P8320, DOI 10.1074/jbc.272.13.8320; Gunning SJ, 2003, FEBS LETT, V554, P211, DOI 10.1016/S0014-5793(03)01175-X; Huang RH, 2003, ACTA BIOCH BIOPH SIN, V35, P976; Isbister GK, 2011, LANCET, V378, P2039, DOI 10.1016/S0140-6736(10)62230-1; Jakubowski JA, 2005, J EXP BIOL, V208, P2873, DOI 10.1242/jeb.01713; Jiang LP, 2008, TOXICON, V51, P1479, DOI 10.1016/j.toxicon.2008.03.024; Jiang LP, 2010, COMP BIOCHEM PHYS D, V5, P81, DOI 10.1016/j.cbd.2010.01.001; Jimenez EC, 2003, J NEUROCHEM, V85, P610, DOI 10.1046/j.1471-4159.2003.01685.x; Jin AH, 2013, MOL CELL PROTEOMICS, V12, P3824, DOI 10.1074/mcp.M113.030353; Klint JK, 2012, TOXICON, V60, P478, DOI 10.1016/j.toxicon.2012.04.337; Kozlov S, 2005, PROTEINS, V59, P131, DOI 10.1002/prot.20390; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lavergne V, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-708; Lee SY, 2004, NATURE, V430, P232, DOI 10.1038/nature02632; Li ZH, 2006, J BIOL CHEM, V281, P8628, DOI 10.1074/jbc.M513542200; Liang S, 2008, EXPERT REV PROTEOMIC, V5, P731, DOI 10.1586/14789450.5.5.731; Liang SP, 2000, J PROTEIN CHEM, V19, P225, DOI 10.1023/A:1007011904904; Liang SP, 2004, TOXICON, V43, P575, DOI 10.1016/j.toxicon.2004.02.005; Liao Z, 2007, PROTEOMICS, V7, P1892, DOI 10.1002/pmic.200600785; Liu L, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/251364; Lluisma AO, 2012, MAR GENOM, V5, P43, DOI 10.1016/j.margen.2011.09.002; Lu SY, 1999, J PROTEIN CHEM, V18, P609, DOI 10.1023/A:1020663619657; Margres MJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-531; Milescu M, 2007, J GEN PHYSIOL, V130, P497, DOI 10.1085/jgp.200709869; Milescu M, 2009, NAT STRUCT MOL BIOL, V16, P1080, DOI 10.1038/nsmb.1679; Morgenstern D, 2011, TOXICON, V57, P695, DOI 10.1016/j.toxicon.2011.02.001; Nisani Z, 2007, COMP BIOCHEM PHYS A, V147, P509, DOI 10.1016/j.cbpa.2007.01.027; Pan ZS, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-32; Peng K, 2001, TOXICON, V39, P491, DOI 10.1016/S0041-0101(00)00150-1; Peng K, 2002, J BIOL CHEM, V277, P47564, DOI 10.1074/jbc.M204063200; Peng K, 2006, ACTA BIOCH BIOPH SIN, V38, P457, DOI 10.1111/j.1745-7270.2006.00191.x; Phillips LR, 2005, NATURE, V436, P857, DOI 10.1038/nature03873; Rash LD, 2002, TOXICON, V40, P225, DOI 10.1016/S0041-0101(01)00199-4; Rong MQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065984; Sanz L, 2006, BIOCHEM J, V395, P385, DOI 10.1042/BJ20051678; Sharma M, 2006, J STRUCT BIOL, V155, P52, DOI 10.1016/j.jsb.2005.12.005; Sidach SS, 2002, J NEUROSCI, V22, P2023, DOI 10.1523/JNEUROSCI.22-06-02023.2002; Swartz KJ, 2007, TOXICON, V49, P213, DOI 10.1016/j.toxicon.2006.09.024; Tang X, 2010, J PROTEOME RES, V9, P2550, DOI 10.1021/pr1000016; Tawfik DS, 2010, NAT CHEM BIOL, V6, P692, DOI 10.1038/nchembio.441; Terrat Y, 2012, TOXICON, V59, P34, DOI 10.1016/j.toxicon.2011.10.001; Vassilevski AA, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1505, DOI 10.1134/S0006297909130069; Vetter I, 2011, AMINO ACIDS, V40, P15, DOI 10.1007/s00726-010-0516-4; Violette A, 2012, J PROTEOMICS; Wang MC, 2012, PEPTIDES, V34, P19, DOI 10.1016/j.peptides.2011.10.029; Wang RL, 2010, J ZHEJIANG UNIV-SC B, V11, P451, DOI 10.1631/jzus.B0900393; Xiao YC, 2011, J BIOL CHEM, V286, P27301, DOI 10.1074/jbc.M111.246876; Yuan CH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003414; Yuan CH, 2007, J PROTEOME RES, V6, P2792, DOI 10.1021/pr0700192; Zakharova E, 2008, J MOL BIOL, V382, P998, DOI 10.1016/j.jmb.2008.07.063; Zelanis A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001554; ZHANG DG, 1993, J PROTEIN CHEM, V12, P735, DOI 10.1007/BF01024931; Zhang J, 2011, J GENET GENOMICS, V38, P95, DOI 10.1016/j.jgg.2011.02.003; Zhang YQ, 2010, ZOOLOGY, V113, P10, DOI 10.1016/j.zool.2009.04.001; Zhou PA, 1997, TOXICON, V35, P39, DOI 10.1016/S0041-0101(96)00072-4; ZHOU XH, 1989, BIOCHEM J, V257, P509, DOI 10.1042/bj2570509	74	13	14	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100682	10.1371/journal.pone.0100682	http://dx.doi.org/10.1371/journal.pone.0100682			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949878	Green Published, Green Submitted, gold			2022-12-27	WOS:000338276300106
J	Bastiaansen, AJNM; Karper, JC; Wezel, A; de Boer, HC; Welten, SMJ; de Jong, RCM; Peters, EAB; de Vries, MR; van Oeveren-Rietdijk, AM; van Zonneveld, AJ; Hamming, JF; Nossent, AY; Quax, PHA				Bastiaansen, Antonius J. N. M.; Karper, Jacco C.; Wezel, Anouk; de Boer, Hetty C.; Welten, Sabine M. J.; de Jong, Rob C. M.; Peters, Erna A. B.; de Vries, Margreet R.; van Oeveren-Rietdijk, Annemarie M.; van Zonneveld, Anton Jan; Hamming, Jaap F.; Nossent, A. Yael; Quax, Paul H. A.			TLR4 Accessory Molecule RP105 (CD180) Regulates Monocyte-Driven Arteriogenesis in a Murine Hind Limb Ischemia Model	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-4; COLLATERAL ARTERY GROWTH; BONE-MARROW; INTERLEUKIN-1 RECEPTOR; CIRCULATING MONOCYTES; HOMOLOG RP105; CELLS; EXPRESSION; MICE; ANGIOGENESIS	Aims: We investigated the role of the TLR4-accessory molecule RP105 (CD180) in post-ischemic neovascularization, i.e. arteriogenesis and angiogenesis. TLR4-mediated activation of pro-inflammatory Ly6C(hi) monocytes is crucial for effective neovascularization. Immunohistochemical analyses revealed that RP105(+) monocytes are present in the perivascular space of remodeling collateral arterioles. As RP105 inhibits TLR4 signaling, we hypothesized that RP105 deficiency would lead to an unrestrained TLR4-mediated inflammatory response and hence to enhanced blood flow recovery after ischemia. Methods and Results: RP105(-/-) and wild type (WT) mice were subjected to hind limb ischemia and blood flow recovery was followed by Laser Doppler Perfusion Imaging. Surprisingly, we found that blood flow recovery was severely impaired in RP105(-/-) mice. Immunohistochemistry showed that arteriogenesis was reduced in these mice compared to the WT. However, both in vivo and ex vivo analyses showed that circulatory pro-arteriogenic Ly6C(hi) monocytes were more readily activated in RP105(-/-) mice. FACS analyses showed that Ly6C(hi) monocytes became activated and migrated to the affected muscle tissues in WT mice following induction of hind limb ischemia. Although Ly6C(hi) monocytes were readily activated in RP105(-/-) mice, migration into the ischemic tissues was hampered and instead, Ly6C(hi) monocytes accumulated in their storage compartments, bone marrow and spleen, in RP105(-/-) mice. Conclusions: RP105 deficiency results in an unrestrained inflammatory response and monocyte over-activation, most likely due to the lack of TLR4 regulation. Inappropriate, premature systemic activation of pro-inflammatory Ly6C(hi) monocytes results in reduced infiltration of Ly6C(hi) monocytes in ischemic tissues and in impaired blood flow recovery.	[Bastiaansen, Antonius J. N. M.; Karper, Jacco C.; Wezel, Anouk; Welten, Sabine M. J.; de Jong, Rob C. M.; Peters, Erna A. B.; de Vries, Margreet R.; Hamming, Jaap F.; Nossent, A. Yael; Quax, Paul H. A.] Leiden Univ, Med Ctr, Dept Surg, Leiden, Netherlands; [Bastiaansen, Antonius J. N. M.; Karper, Jacco C.; Wezel, Anouk; de Boer, Hetty C.; Welten, Sabine M. J.; de Jong, Rob C. M.; Peters, Erna A. B.; de Vries, Margreet R.; van Oeveren-Rietdijk, Annemarie M.; van Zonneveld, Anton Jan; Nossent, A. Yael; Quax, Paul H. A.] Leiden Univ, Med Ctr, Einthoven Lab Expt Vasc Med, Leiden, Netherlands; [Wezel, Anouk] Leiden Univ, Leiden Acad Ctr Drug Res, Dept Biopharmaceut, Leiden, Netherlands; [de Boer, Hetty C.; van Oeveren-Rietdijk, Annemarie M.; van Zonneveld, Anton Jan] Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Nossent, AY (corresponding author), Leiden Univ, Med Ctr, Dept Surg, Leiden, Netherlands.	a.y.nossent@lumc.nl; p.h.a.quax@lumc.nl	Quax, Paul/W-8520-2019; Quax, Paul/ABD-5294-2020; van Zonneveld, Anton Jan/D-8060-2018; de Vries, Margreet/Z-5653-2019	Quax, Paul/0000-0002-6853-5760; van Zonneveld, Anton Jan/0000-0002-1676-7738; Nossent, Anne Yael/0000-0002-2155-4286	Netherlands Organization for Scientific Research (NWO) [Veni 916.12.041]; BioMedical Materials, Dutch Ministry of Economic Affairs, Agriculture and Innovation (BMM-PENT) [P1.03]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); BioMedical Materials, Dutch Ministry of Economic Affairs, Agriculture and Innovation (BMM-PENT)	This work was supported by BioMedical Materials, Dutch Ministry of Economic Affairs, Agriculture and Innovation (BMM-PENT; P1.03) and the Netherlands Organization for Scientific Research (NWO) (Veni 916.12.041). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Arras M, 1998, J CLIN INVEST, V101, P40, DOI 10.1172/JCI119877; Ashida K, 2005, J ATHEROSCLER THROMB, V12, P53, DOI 10.5551/jat.12.53; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Bastiaansen AJ, 2013, ARTERIOSCLER THROMB; Bergmann CE, 2006, J LEUKOCYTE BIOL, V80, P59, DOI 10.1189/jlb.0206087; Biscetti F, 2010, DIABETES, V59, P1496, DOI 10.2337/db09-1507; Brint EK, 2004, NAT IMMUNOL, V5, P373, DOI 10.1038/ni1050; Capoccia BJ, 2008, J LEUKOCYTE BIOL, V84, P760, DOI 10.1189/jlb.1107756; Chalothorn D, 2007, PHYSIOL GENOMICS, V30, P179, DOI 10.1152/physiolgenomics.00047.2007; Chalothorn D, 2010, PHYSIOL GENOMICS, V42, P469, DOI 10.1152/physiolgenomics.00070.2010; Chuang TH, 2004, NAT IMMUNOL, V5, P495, DOI 10.1038/ni1066; Cochain C, 2010, CARDIOVASC RES, V88, P186, DOI 10.1093/cvr/cvq153; de Groot D, 2011, J MOL CELL CARDIOL, V50, P25, DOI 10.1016/j.yjmcc.2010.08.006; Divanovic S, 2005, NAT IMMUNOL, V6, P571, DOI 10.1038/ni1198; Divanovic S, 2007, J LEUKOCYTE BIOL, V82, P265, DOI 10.1189/jlb.0107021; Francke A, 2011, J HISTOCHEM CYTOCHEM, V59, P813, DOI 10.1369/0022155411416007; Freudenberg J, 2010, HUM MOL GENET, V19, P3863, DOI 10.1093/hmg/ddq304; Hansson GK, 2005, ARTERIOSCL THROM VAS, V25, P1085, DOI 10.1161/01.ATV.0000168894.43759.47; Heil M, 2004, CIRC RES, V95, P449, DOI 10.1161/01.RES.0000141145.78900.44; Heil M, 2002, AM J PHYSIOL-HEART C, V283, pH2411, DOI 10.1152/ajpheart.01098.2001; Hellingman A, 2011, J CELL MOL MED; Hellingman AA, 2010, EUR J VASC ENDOVASC, V40, P796, DOI 10.1016/j.ejvs.2010.07.009; Hoefer IE, 2002, CIRCULATION, V105, P1639, DOI 10.1161/01.CIR.0000014987.32865.8E; Hollestelle SCG, 2004, CIRCULATION, V109, P393, DOI 10.1161/01.CIR.0000109140.51366.72; Karper JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067923; Karper JC, 2011, ARTERIOSCL THROM VAS, V31, P1033, DOI 10.1161/ATVBAHA.111.223271; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kiechl S, 2002, NEW ENGL J MED, V347, P185, DOI 10.1056/NEJMoa012673; Koarada S, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/259186; Matijevic N, 2011, ANGIOLOGY, V62, P237, DOI 10.1177/0003319710385336; Meisner JK, 2010, MICROCIRCULATION, V17, P583, DOI 10.1111/j.1549-8719.2010.00051.x; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; SCHAPER J, 1976, VIRCHOWS ARCH A, V370, P193, DOI 10.1007/BF00427580; Shi C, 2011, IMMUNITY, V34, P590, DOI 10.1016/j.immuni.2011.02.016; Stabile E, 2006, CIRCULATION, V113, P118, DOI 10.1161/CIRCULATIONAHA.105.576702; Stabile E, 2003, CIRCULATION, V108, P205, DOI 10.1161/01.CIR.0000079225.50817.71; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Tada Y, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2529; van Weel V, 2007, ARTERIOSCL THROM VAS, V27, P2310, DOI 10.1161/ATVBAHA.107.151407; Vink A, 2002, CIRCULATION, V106, P1985, DOI 10.1161/01.CIR.0000032146.75113.EE; Voskuil M, 2004, VASC MED, V9, P287, DOI 10.1191/1358863x04vm571oa; Wald D, 2003, NAT IMMUNOL, V4, P920, DOI 10.1038/ni968; Wang SL, 2010, CIRC RES, V107, P558, DOI 10.1161/CIRCRESAHA.110.224634; Willems S, 2012, MINERVA MED, V103, P513; Xu XH, 2001, CIRCULATION, V104, P3103, DOI 10.1161/hc5001.100631; Yoon SI, 2011, NAT STRUCT MOL BIOL, V18, P1028, DOI 10.1038/nsmb.2106; Zhang H, 2010, J CEREBR BLOOD F MET, V30, P923, DOI 10.1038/jcbfm.2010.10; Zouggari Y, 2009, CIRCULATION, V120, P1415, DOI 10.1161/CIRCULATIONAHA.109.875583	51	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e99882	10.1371/journal.pone.0099882	http://dx.doi.org/10.1371/journal.pone.0099882			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945347	Green Published, gold, Green Submitted			2022-12-27	WOS:000340721500032
J	Ganz, J; Arie, I; Buch, S; Ben Zur, T; Barhum, Y; Pour, S; Araidy, S; Pitaru, S; Offen, D				Ganz, Javier; Arie, Ina; Buch, Sigal; Ben Zur, Tali; Barhum, Yael; Pour, Sammy; Araidy, Shareef; Pitaru, Sandu; Offen, Daniel			Dopaminergic-Like Neurons Derived from Oral Mucosa Stem Cells by Developmental Cues Improve Symptoms in the Hemi-Parkinsonian Rat Model	PLOS ONE			English	Article							MESENCHYMAL STROMAL CELLS; NUCLEAR RECEPTOR NURR1; NEURAL CREST; BONE-MARROW; LAMINA PROPRIA; IN-VIVO; DISEASE; MIDBRAIN; DIFFERENTIATION; TRANSPLANTATION	Achieving safe and readily accessible sources for cell replacement therapy in Parkinson's disease (PD) is still a challenging unresolved issue. Recently, a primitive neural crest stem cell population (hOMSC) was isolated from the adult human oral mucosa and characterized in vitro and in vivo. In this study we assessed hOMSC ability to differentiate into dopamine-secreting cells with a neuronal-dopaminergic phenotype in vitro in response to dopaminergic developmental cues and tested their therapeutic potential in the hemi-Parkinsonian rat model. We found that hOMSC express constitutively a repertoire of neuronal and dopaminergic markers and pivotal transcription factors. Soluble developmental factors induced a reproducible neuronal-like morphology in the majority of hOMSC, downregulated stem cells markers, upregulated the expression of the neuronal and dopaminergic markers that resulted in dopamine release capabilities. Transplantation of these dopaminergic-induced hOMSC into the striatum of hemi-Parkinsonian rats improved their behavioral deficits as determined by amphetamine-induced rotational behavior, motor asymmetry and motor coordination tests. Human TH expressing cells and increased levels of dopamine in the transplanted hemispheres were observed 10 weeks after transplantation. These results demonstrate for the first time that soluble factors involved in the development of DA neurons, induced a DA phenotype in hOMSC in vitro that significantly improved the motor function of hemiparkinsonian rats. Based on their neural-related origin, their niche accessibility by minimal-invasive procedures and their propensity for DA differentiation, hOMSC emerge as an attractive tool for autologous cell replacement therapy in PD.	[Ganz, Javier; Ben Zur, Tali; Barhum, Yael; Offen, Daniel] Tel Aviv Univ, Neurosci Lab, Felsenstein Med Res Ctr, Rabin Med Ctr, IL-69978 Tel Aviv, Israel; [Arie, Ina; Buch, Sigal; Pitaru, Sandu] Tel Aviv Univ, Dept Oral Biol, Sch Dent Med, Fac Med, IL-69978 Tel Aviv, Israel; [Pour, Sammy; Araidy, Shareef] Baruch Padeh Med Ctr, Oral & Maxillofacial Dept, Poria, Lower Galilee, Israel	Rabin Medical Center; Tel Aviv University; Tel Aviv University	Offen, D (corresponding author), Tel Aviv Univ, Neurosci Lab, Felsenstein Med Res Ctr, Rabin Med Ctr, IL-69978 Tel Aviv, Israel.	danioffen@gmail.com		Ganz, Javier/0000-0002-2370-9819	Binational United States - Israel Science Foundation [9007002, 2011017]; Israel Science Foundation of the Israeli Academy of Science [646/09, 384/13]; MOIA fellowship; SAIA	Binational United States - Israel Science Foundation; Israel Science Foundation of the Israeli Academy of Science; MOIA fellowship; SAIA	This work was supported, in part, by the Binational United States - Israel Science Foundation [Grants number 9007002 and 2011017] to Sandu Pitaru [SP]; the Israel Science Foundation of the Israeli Academy of Science [Grants number 646/09 and 384/13] to S. P.; SAIA and MOIA fellowship to J.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenas E, 2008, CELL STEM CELL, V2, P110, DOI 10.1016/j.stem.2008.01.012; BACKLUND EO, 1985, J NEUROSURG, V62, P169, DOI 10.3171/jns.1985.62.2.0169; Bartold PM, 2000, PERIODONTOL 2000, V24, P253, DOI 10.1034/j.1600-0757.2000.2240113.x; Barzilay R, 2009, STEM CELLS DEV, V18, P591, DOI 10.1089/scd.2008.0138; Blondheim NR, 2006, STEM CELLS DEV, V15, P141, DOI 10.1089/scd.2006.15.141; Bronner ME, 2012, DEV BIOL, V366, P2, DOI 10.1016/j.ydbio.2011.12.042; Cai JL, 2009, STEM CELLS, V27, P220, DOI 10.1634/stemcells.2008-0734; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Chang YS, 2011, CELL TRANSPLANT; Chung S, 2011, P NATL ACAD SCI USA, V108, P9703, DOI 10.1073/pnas.1016443108; Chung S, 2009, CELL STEM CELL, V5, P646, DOI 10.1016/j.stem.2009.09.015; Datta I, 2011, CYTOTHERAPY, V13, P918, DOI 10.3109/14653249.2011.579957; Davies LC, 2010, STEM CELLS DEV, V19, P819, DOI 10.1089/scd.2009.0089; Debernard KAB, 2012, NEUROCHEM INT, V61, P79, DOI 10.1016/j.neuint.2012.04.002; Fasano Caroline, 2008, Curr Protoc Neurosci, VChapter 3, DOI 10.1002/0471142301.ns0321s44; FREED CR, 1992, NEW ENGL J MED, V327, P1549, DOI 10.1056/NEJM199211263272202; FREED WJ, 1981, NATURE, V292, P351, DOI 10.1038/292351a0; Ganz J, 2011, EXPERT REV NEUROTHER, V11, P1325, DOI [10.1586/ERN.11.74, 10.1586/ern.11.74]; Hargus G, 2010, P NATL ACAD SCI USA, V107, P15921, DOI 10.1073/pnas.1010209107; Iancu R, 2005, BEHAV BRAIN RES, V162, P1, DOI 10.1016/j.bbr.2005.02.023; Inamoto T, 2010, CANCER-AM CANCER SOC, V116, P340, DOI 10.1002/cncr.24737; Kim DS, 2007, CELL TRANSPLANT, V16, P117; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; Kim TE, 2003, BIOCHEM BIOPH RES CO, V305, P1040, DOI 10.1016/S0006-291X(03)00879-9; Kirik D, 1998, EXP NEUROL, V152, P259, DOI 10.1006/exnr.1998.6848; Kittappa R, 2007, PLOS BIOL, V5, P2875, DOI 10.1371/journal.pbio.0050325; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; Levy YS, 2008, CYTOTHERAPY, V10, P340, DOI 10.1080/14653240802021330; MADRAZO I, 1987, NEW ENGL J MED, V316, P831, DOI 10.1056/NEJM198704023161402; Maijenburg MW, 2012, STEM CELLS DEV, V21, P228, DOI 10.1089/scd.2011.0076; Marynka-Kalmani K, 2010, STEM CELLS, V28, P984, DOI 10.1002/stem.425; MASSAS R, 1993, J DENT RES, V72, P1005, DOI 10.1177/00220345930720060201; Montzka K, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-16; Nagoshi N, 2008, CELL STEM CELL, V2, P392, DOI 10.1016/j.stem.2008.03.005; Nakatani T, 2010, DEV BIOL, V339, P101, DOI 10.1016/j.ydbio.2009.12.017; Nishimura K, 2013, BIOL PHARM BULL, V36, P171, DOI 10.1248/bpb.b12-00929; O'Kane M, 2008, J INVEST DERMATOL, V128, P300, DOI 10.1038/sj.jid.5701023; Papanikolaou T, 2009, EUR J NEUROSCI, V29, P2264, DOI 10.1111/j.1460-9568.2009.06784.x; Prakash N, 2006, DEVELOPMENT, V133, P89, DOI 10.1242/dev.02181; Prakash N, 2006, J PHYSIOL-LONDON, V575, P403, DOI 10.1113/jphysiol.2006.113464; RITCHIE AK, 1979, J PHYSIOL-LONDON, V286, P541, DOI 10.1113/jphysiol.1979.sp012636; Rozas G, 1997, BRAIN RES, V749, P188, DOI 10.1016/S0006-8993(96)01162-6; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Schwarting RKW, 1996, PROG NEUROBIOL, V50, P275, DOI 10.1016/S0301-0082(96)00040-8; Smidt MP, 2009, ADV EXP MED BIOL, V651, P47; Smits SM, 2006, J NEURAL TRANSM-SUPP, P57; SNAPE BM, 1985, J NEUROSCI METH, V14, P53, DOI 10.1016/0165-0270(85)90114-1; Studer L, 1998, NAT NEUROSCI, V1, P290, DOI 10.1038/1105; Svendsen CN, 1997, EXP NEUROL, V148, P135, DOI 10.1006/exnr.1997.6634; Tondreau T, 2004, DIFFERENTIATION, V72, P319, DOI 10.1111/j.1432-0436.2004.07207003.x; Torres EM, 2008, NEUROSCIENCE, V154, P631, DOI 10.1016/j.neuroscience.2008.03.048; Treves-Manusevitz S, 2013, J CLIN PERIODONTOL, V40, P73, DOI 10.1111/jcpe.12016; Trzaska KA, 2007, STEM CELLS, V25, P2797, DOI 10.1634/stemcells.2007-0212; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wallen A, 2003, ANN NY ACAD SCI, V991, P48; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105; Whishaw IQ, 1997, BEHAV BRAIN RES, V89, P167, DOI 10.1016/S0166-4328(97)00057-0; Widera D, 2011, STEM CELLS DEV, V20, P2053, DOI 10.1089/scd.2010.0525; Widera D, 2009, STEM CELLS, V27, P1899, DOI 10.1002/stem.104; Wong CE, 2006, J CELL BIOL, V175, P1005, DOI 10.1083/jcb.200606062; Yan CH, 2011, J NEUROSCI, V31, P12413, DOI 10.1523/JNEUROSCI.1077-11.2011	62	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100445	10.1371/journal.pone.0100445	http://dx.doi.org/10.1371/journal.pone.0100445			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945922	Green Published, Green Submitted, gold			2022-12-27	WOS:000340721500076
J	Sitkiewicz, E; Oledzki, J; Poznanski, J; Dadlez, M				Sitkiewicz, Ewa; Oledzki, Jacek; Poznanski, Jaroslaw; Dadlez, Michal			Di-Tyrosine Cross-Link Decreases the Collisional Cross-Section of A beta Peptide Dimers and Trimers in the Gas Phase: An Ion Mobility Study	PLOS ONE			English	Article							AMYLOID-BETA; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; SYNAPTIC PLASTICITY; SECRETED OLIGOMERS; LIPID-PEROXIDATION; ACTIN RODS; AMINO-ACID; PROTEIN; DITYROSINE	Oligomeric forms of A beta peptide are most likely the main synaptotoxic and neurotoxic agent in Alzheimer's disease. Toxicity of various A beta oligomeric forms has been confirmed in vivo and also in vitro. However, in vitro preparations were found to be orders of magnitude less toxic than oligomers obtained from in vivo sources. This difference can be explained by the presence of a covalent cross-link, which would stabilize the oligomer. In the present work, we have characterized the structural properties of A beta dimers and trimers stabilized by di- and tri-tyrosine cross-links. Using ion mobility mass spectrometry we have compared the collisional cross-section of non-cross-linked and cross-linked species. We have found that the presence of cross-links does not generate new unique forms but rather shifts the equilibrium towards more compact oligomer types that can also be detected for non-cross-linked peptide. In consequence, more extended forms, probable precursors of off-pathway oligomeric species, become relatively destabilized in cross-linked oligomers and the pathway of oligomer evolution becomes redirected towards fibrillar structures.	[Sitkiewicz, Ewa; Oledzki, Jacek; Poznanski, Jaroslaw; Dadlez, Michal] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland; [Dadlez, Michal] Warsaw Univ, Dept Biol, Inst Genet & Biotechnol, Warsaw, Poland	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; University of Warsaw	Dadlez, M (corresponding author), Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland.	michald@ibb.waw.pl	Poznanski, Jaroslaw/F-7705-2014	Poznanski, Jaroslaw/0000-0003-2684-1775; Dadlez, Michal/0000-0001-8811-5176; Sitkiewicz, Ewa/0000-0002-9511-8575; Oledzki, Jacek/0000-0002-8622-3218	NanoFun [POIGT.02.02.00-00-025/09-00]; Foundation for Polish Science TEAM program [TEAM/2011-7/1]; CEPT [POIG.02.02.00-14-024/08-00]	NanoFun; Foundation for Polish Science TEAM program; CEPT	Financial support was received from NanoFun (POIGT.02.02.00-00-025/09-00), the Foundation for Polish Science TEAM program (TEAM/2011-7/1), and CEPT (POIG.02.02.00-14-024/08-00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hilaly YK, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-83; Ali FE, 2006, FREE RADICAL RES, V40, P1, DOI 10.1080/10715760500329721; Ando Y, 1998, J NEUROL SCI, V156, P172, DOI 10.1016/S0022-510X(98)00042-2; Ashcroft AE, 2010, J AM SOC MASS SPECTR, V21, P1087, DOI 10.1016/j.jasms.2010.02.026; Atwood CS, 2004, BIOCHEMISTRY-US, V43, P560, DOI 10.1021/bi0358824; Bamburg JR, 2010, CURR ALZHEIMER RES, V7, P241, DOI 10.2174/156720510791050902; Barnham KJ, 2004, FASEB J, V18, P1427, DOI 10.1096/fj.04-1890fje; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Bernstein SL, 2005, J AM CHEM SOC, V127, P2075, DOI 10.1021/ja044531p; Bernstein SL, 2009, NAT CHEM, V1, P326, DOI [10.1038/NCHEM.247, 10.1038/nchem.247]; Bitan G, 2005, AMYLOID, V12, P88, DOI 10.1080/13506120500106958; Bleiholder C, 2011, NAT CHEM, V3, P172, DOI 10.1038/NCHEM.945; Butterfield DA, 2004, BRAIN PATHOL, V14, P426; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Davis RC, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-10; DUDEK SM, 1994, BRAIN RES, V651, P129, DOI 10.1016/0006-8993(94)90688-2; Frimpong AK, 2010, PROTEINS, V78, P714, DOI 10.1002/prot.22604; Galeazzi L, 1999, AMYLOID, V6, P7, DOI 10.3109/13506129908993282; Gessel MM, 2012, ACS CHEM NEUROSCI, V3, P909, DOI 10.1021/cn300050d; Gessel MM, 2012, BIOCHEMISTRY-US, V51, P108, DOI 10.1021/bi201520b; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Grabenauer M, 2010, J AM CHEM SOC, V132, P532, DOI 10.1021/ja905595k; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hartley DM, 2008, J BIOL CHEM, V283, P16790, DOI 10.1074/jbc.M802215200; Hensley K, 1998, J NEUROSCI, V18, P8126; Huang XD, 1999, BIOCHEMISTRY-US, V38, P7609, DOI 10.1021/bi990438f; Jin M, 2011, P NATL ACAD SCI USA, V108, P5819, DOI 10.1073/pnas.1017033108; Kalback W, 2002, BIOCHEMISTRY-US, V41, P922, DOI 10.1021/bi015685+; Kaltashov IA, 2002, MASS SPECTROM REV, V21, P37, DOI 10.1002/mas.10017; Kato Y, 2000, BIOCHEM BIOPH RES CO, V275, P11, DOI 10.1006/bbrc.2000.3265; Kloniecki M, 2011, J MOL BIOL, V407, P110, DOI 10.1016/j.jmb.2011.01.012; Klyubin I, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-25; Kok WM, 2013, CHEM SCI, V4, P4449, DOI 10.1039/c3sc22295k; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Larson M, 2012, J NEUROSCI, V32, P16857, DOI 10.1523/JNEUROSCI.1858-12.2012; Larson ME, 2012, J NEUROCHEM, V120, P125, DOI 10.1111/j.1471-4159.2011.07478.x; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; Markesbery WR, 1998, NEUROBIOL AGING, V19, P33, DOI 10.1016/S0197-4580(98)00009-8; McGrath LT, 2001, QJM-MON J ASSOC PHYS, V94, P485, DOI 10.1093/qjmed/94.9.485; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Mennucci B, 1999, INT J QUANTUM CHEM, V75, P767, DOI 10.1002/(SICI)1097-461X(1999)75:4/5<767::AID-QUA43>3.0.CO;2-L; Moore BD, 2009, BIOCHEMISTRY-US, V48, P11796, DOI 10.1021/bi901571t; Mucke L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006338; Murray IVJ, 2007, J BIOL CHEM, V282, P9335, DOI 10.1074/jbc.M608589200; Noguchi A, 2009, J BIOL CHEM, V284, P32895, DOI 10.1074/jbc.M109.000208; NOMURA K, 1990, BIOCHEMISTRY-US, V29, P4525, DOI 10.1021/bi00471a004; O'Nuallain B, 2010, J NEUROSCI, V30, P14411, DOI 10.1523/JNEUROSCI.3537-10.2010; Reed MN, 2011, NEUROBIOL AGING, V32, P1784, DOI 10.1016/j.neurobiolaging.2009.11.007; Rozga M, 2007, BIOCHEM BIOPH RES CO, V364, P714, DOI 10.1016/j.bbrc.2007.10.080; Sayre LM, 1997, J NEUROCHEM, V68, P2092; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Siegel SJ, 2007, BIOCHEMISTRY-US, V46, P1503, DOI 10.1021/bi061853s; Smith DP, 2007, BIOCHEMISTRY-US, V46, P2881, DOI 10.1021/bi0620961; Terry RD, 1996, J NEUROPATH EXP NEUR, V55, P1023, DOI 10.1097/00005072-199655100-00001; Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754; Wakshlag JJ, 2006, PROTEIN J, V25, P83, DOI 10.1007/s10930-006-0009-1; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Watt AD, 2013, ACTA NEUROPATHOL, V125, P549, DOI 10.1007/s00401-013-1083-z; Wilhelmus MMM, 2009, BRAIN PATHOL, V19, P612, DOI 10.1111/j.1750-3639.2008.00197.x; Woods LA, 2013, BBA-PROTEINS PROTEOM, V1834, P1257, DOI 10.1016/j.bbapap.2012.10.002; Yamaguchi T, 2010, BIOCHEMISTRY-US, V49, P7100, DOI 10.1021/bi100583x; Yoburn JC, 2003, CHEM RES TOXICOL, V16, P531, DOI 10.1021/tx025666g	64	19	19	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100200	10.1371/journal.pone.0100200	http://dx.doi.org/10.1371/journal.pone.0100200			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945725	Green Published, gold, Green Submitted			2022-12-27	WOS:000340721500049
J	Wei, SC; Tan, YY; Weng, MT; Lai, LC; Hsiao, JH; Chuang, EY; Shun, CT; Wu, DC; Kao, AW; Chuang, CS; Ni, YH; Shieh, MJ; Tung, CC; Chen, Y; Wang, CY; Xavier, RJ; Podolsky, DK; Wong, JM				Wei, Shu-Chen; Tan, Yan-Yin; Weng, Meng-Tzu; Lai, Liang-Chuan; Hsiao, Jen-Hao; Chuang, Eric Y.; Shun, Chia-Tung; Wu, Deng-Cheng; Kao, Ai-Wen; Chuang, Chiao-Shung; Ni, Yen-Hsuan; Shieh, Ming-Jium; Tung, Chien-Chih; Chen, Yun; Wang, Cheng-Yi; Xavier, Ramnik J.; Podolsky, Daniel K.; Wong, Jau-Min			SLCO3A1, a Novel Crohn's Disease-Associated Gene, Regulates NF-kappa B Activity and Associates with Intestinal Perforation	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; NICOTINE DEPENDENCE; POLYMORPHISMS; ACTIVATION; EXPRESSION; VARIANTS; MUTATION; ELEMENTS; TNFSF15	Background & Aims: To date, only one gene (TNFSF15) has been identified and validated as a Crohn's disease (CD)-associated gene in non-Caucasian populations. This study was designed to identify novel CD-associated single nucleotide polymorphisms (SNPs)/genes and to validate candidate genes using a functional assay. Methods: SNPs from 16 CD patients and 16 age-and sex-matched control patients were analyzed using Illumina platform analysis. Subsequently, we expanded the study and followed 53 CD patients and 41 control patients by Sequenom MassArray analysis. Quantitative PCR and immunohistochemical staining were performed to assess mRNA and protein expression of the candidate gene on tissue isolated from CD patients. Genotype was correlated with CD phenotypes. Finally, the candidate gene was cloned and its effect on NF-kappa B activity assessed using a reporter luciferase assay. Results: SLCO3A1 (rs207959) reached statistical significance in the first-stage analysis (P = 2.3E-02) and was further validated in the second-stage analysis (P = 1.0E-03). Genotype and phenotype analysis showed that the rs207959 (T) allele is a risk allele that alters SLCO3A1 mRNA expression and is associated with intestinal perforation in CD patients. Higher levels of mRNA and protein expression of SLCO3A1 were seen in CD patients compared with the control group. Overexpression of SLCO3A1 induced increased NF-kappa B activity and increased phosphorylation of P65, ERK, and JNK. Nicotine augmented the activation of NF-kappa B in the presence of SLCO3A1. Conclusions: SLCO3A1, a novel CD-associated gene, mediates inflammatory processes in intestinal epithelial cells through NF-kB transcription activation, resulting in a higher incidence of bowel perforation in CD patients.	[Wei, Shu-Chen; Weng, Meng-Tzu; Wang, Cheng-Yi; Wong, Jau-Min] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Tan, Yan-Yin; Wong, Jau-Min] Natl Taiwan Univ, Grad Inst Med Engn, Taipei 10764, Taiwan; [Weng, Meng-Tzu] Far Eastern Mem Hosp, Dept Internal Med, New Taipei, Taiwan; [Lai, Liang-Chuan] Natl Taiwan Univ, Coll Med, Grad Inst Physiol, Taipei, Taiwan; [Lai, Liang-Chuan; Hsiao, Jen-Hao; Chuang, Eric Y.] Natl Taiwan Univ, Bioinformat & Biostat Core, Ctr Genom Med, Taipei 10764, Taiwan; [Chuang, Eric Y.] Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan; [Shun, Chia-Tung] Natl Taiwan Univ Hosp, Dept Pathol & Forens Med, Taipei, Taiwan; [Wu, Deng-Cheng] Kaohsiung Med Univ, Dept Internal Med, Kaohsiung, Taiwan; [Kao, Ai-Wen; Chuang, Chiao-Shung] Natl Cheng Kung Univ, Dept Internal Med, Tainan 70101, Taiwan; [Ni, Yen-Hsuan] Natl Taiwan Univ Hosp, Dept Pediat, Taipei 10016, Taiwan; [Shieh, Ming-Jium] Natl Taiwan Univ Hosp, Deparment Oncol, Taipei, Taiwan; [Tung, Chien-Chih] Natl Taiwan Univ Hosp, Dept Integrated Diagnost & Therapeut, Taipei, Taiwan; [Chen, Yun] Far Eastern Mem Hosp, New Taipei, Taiwan; [Xavier, Ramnik J.] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; [Xavier, Ramnik J.] Massachusetts Gen Hosp, Ctr Study Inflammatory Bowel Dis, Boston, MA 02114 USA; [Podolsky, Daniel K.] UT Southwestern Med Ctr, Dallas, TX USA	National Taiwan University; National Taiwan University Hospital; National Taiwan University; Far Eastern Memorial Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; Kaohsiung Medical University; National Cheng Kung University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Far Eastern Memorial Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of Texas System; University of Texas Southwestern Medical Center Dallas	Wong, JM (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.	jmwong@ntu.edu.tw	Lai, Liang-Chuan/B-4768-2009; Shun, Chia-Tung/M-1400-2019	Lai, Liang-Chuan/0000-0002-3913-5338; Ni, Yen-Hsuan/0000-0002-1158-5249; Chuang, Chiao-Hsiung/0000-0003-3283-9145; SHUN, CHIA-TUNG/0000-0002-0468-4468	National Science Council of Taiwan [NSC-98-2314-B-002-139-, 99-2314-B-002-124-MY3]; Liver Disease Prevention & Treatment Research Foundation, Taiwan	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Liver Disease Prevention & Treatment Research Foundation, Taiwan	This work was supported by National Science Council of Taiwan (NSC-98-2314-B-002-139-) (99-2314-B-002-124-MY3); Liver Disease Prevention & Treatment Research Foundation, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi H, 2003, AM J PHYSIOL-RENAL, V285, pF1188, DOI 10.1152/ajprenal.00402.2002; Asakura K, 2009, J GASTROENTEROL, V44, P659, DOI 10.1007/s00535-009-0057-3; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Beohar N, 1998, J BIOL CHEM, V273, P9168, DOI 10.1074/jbc.273.15.9168; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Carbonnel F, 2009, GASTROEN CLIN BIOL, V33, pS145, DOI 10.1016/S0399-8320(09)73150-1; Cosnes J, 2001, GASTROENTEROLOGY, V120, P1093, DOI 10.1053/gast.2001.23231; Crowley-Weber CL, 2003, CHEM-BIOL INTERACT, V145, P53, DOI 10.1016/S0009-2797(02)00162-X; Hsiao CH, 2007, J PEDIATR GASTR NUTR, V44, P342, DOI 10.1097/MPG.0b013e31802c6997; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Hui JY, 2005, EMBO J, V24, P1988, DOI 10.1038/sj.emboj.7600677; Jian ZH, 2013, J CANCER, V4, P691, DOI 10.7150/jca.7269; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Kindla J, 2011, CANCER BIOL THER, V11, P584, DOI 10.4161/cbt.11.6.14533; Lee Gin Hyug, 2005, Korean J Gastroenterol, V45, P162; Li M, 2008, WORLD J GASTROENTERO, V14, P4923, DOI 10.3748/wjg.14.4923; Monaco C, 2004, P NATL ACAD SCI USA, V101, P5634, DOI 10.1073/pnas.0401060101; Obaidat A, 2012, ANNU REV PHARMACOL, V52, P135, DOI 10.1146/annurev-pharmtox-010510-100556; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Schreiber S, 1998, GUT, V42, P477, DOI 10.1136/gut.42.4.477; Stamm S, 2005, GENE, V344, P1, DOI 10.1016/j.gene.2004.10.022; Volpi S, 2009, MOL PSYCHIATR, V14, P1024, DOI 10.1038/mp.2008.52; Wang KS, 2012, DRUG ALCOHOL DEPEN, V124, P325, DOI 10.1016/j.drugalcdep.2012.02.003; Wei SC, 2011, J FORMOS MED ASSOC, V110, P600, DOI 10.1016/j.jfma.2011.07.009; Xavier RJ, 2008, NAT REV IMMUNOL, V8, P631, DOI 10.1038/nri2361; Yamazaki K, 2005, HUM MOL GENET, V14, P3499, DOI 10.1093/hmg/ddi379; Yamazaki K, 2002, J HUM GENET, V47, P469, DOI 10.1007/s100380200067; Yang SK, 2008, AM J GASTROENTEROL, V103, P1437, DOI 10.1111/j.1572-0241.2007.01752.x; Zhang XY, 2010, PSYCHOPHARMACOLOGY, V212, P301, DOI 10.1007/s00213-010-1956-y	32	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100515	10.1371/journal.pone.0100515	http://dx.doi.org/10.1371/journal.pone.0100515			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945726	Green Published, Green Submitted, gold			2022-12-27	WOS:000340721500084
J	Gao, XY; Guo, MX; Li, Q; Peng, L; Liu, HY; Zhang, L; Bai, X; Wang, YX; Li, J; Cai, CK				Gao, Xiaoyan; Guo, Mingxing; Li, Qiang; Peng, Long; Liu, Haiyu; Zhang, Li; Bai, Xu; Wang, Yingxin; Li, Jian; Cai, Chengke			Plasma Metabolomic Profiling to Reveal Antipyretic Mechanism of Shuang-Huang-Lian Injection on Yeast-Induced Pyrexia Rats	PLOS ONE			English	Article							BETA-HYDROXYBUTYRIC ACID; DISEASE DIAGNOSIS; MASS-SPECTROMETRY; BAKERS-YEAST; METABONOMICS; FEVER; FAD; FMN; IDENTIFICATION; EXPRESSION	Shuang-huang-lian injection (SHLI) is a famous Chinese patent medicine, which has been wildly used in clinic for the treatment of acute respiratory tract infection, pneumonia, influenza, etc. The existing randomized controlled trial (RCT) studies suggested that SHLI could afford a certain anti-febrile action. However, seldom does research concern the pharmacological mechanisms of SHLI. In the current study, we explored plasma metabolomic profiling technique and selected potential metabolic markers to reveal the antipyretic mechanism of SHLI on yeast-induced pyrexia rat model using UPLC-Q-TOF/MS coupled with multivariate statistical analysis and pattern recognition techniques. We discovered a significant perturbance of metabolic profile in the plasma of fever rats and obvious reversion in SHLI-administered rats. Eight potential biomarkers, i.e. 1) 3-hydeoxybutyric acid, 2) leucine, 3) 16:0 LPC, 4) allocholic acid, 5) vitamin B2, 6) Cys-Lys-His, 7) 18:2 LPC, and 8) 3-hydroxychola-7, 22-dien-24-oic acid, were screened out by OPLS-DA approach. Five potential perturbed metabolic pathways, i.e. 1) valine, leucine, and isoleucine biosynthesis, 2) glycerophospholipid metabolism, 3) ketone bodies synthesis and degradation, 4) bile acid biosynthesis, and 5) riboflavin metabolism, were revealed to relate to the antipyretic mechanisms of SHLI. Overall, we investigated antipyretic mechanisms of SHLI at metabolomic level for the first time, and the obtained results highlights the necessity of adopting metabolomics as a reliable tool for understanding the holism and synergism of Chinese patent drug.	[Gao, Xiaoyan; Guo, Mingxing; Peng, Long; Liu, Haiyu; Zhang, Li] Beijing Univ Chinese Med, Sci Expt Ctr TCM, Beijing, Peoples R China; [Li, Qiang; Cai, Chengke] Beijing Univ Chinese Med, Sch Chinese Mat Med, Beijing, Peoples R China; [Bai, Xu] Waters Technol Shanghai Ltd, Shanghai, Peoples R China; [Wang, Yingxin] 2nd Tradit Chinese Med Factory Harbin Pharm Grp C, Harbin, Peoples R China; [Li, Jian] Beijing Univ Chinese Med, Sch Basic Med Sci, Beijing, Peoples R China	Beijing University of Chinese Medicine; Beijing University of Chinese Medicine; Beijing University of Chinese Medicine	Li, J (corresponding author), Beijing Univ Chinese Med, Sch Basic Med Sci, Beijing, Peoples R China.	lijiancn922@126.com; cck98@126.com			National Science and Technology Major Projects for "Major new drugs innovation and development" [2011ZX09201-201-15]; National Science Foundation of China [81173562]	National Science and Technology Major Projects for "Major new drugs innovation and development"; National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by National Science and Technology Major Projects for "Major new drugs innovation and development" (Grant No. 2011ZX09201-201-15), and National Science Foundation of China (Grant No. 81173562). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1987, PFLUGERS ARCH, V410, P567; Bai Yun-ping WZ-w, 2011, CJTCMP, V26, P5; Biermann M, 2013, AMINO ACIDS, V44, P1225, DOI 10.1007/s00726-013-1459-3; Bjerrum JT, 2010, J PROTEOME RES, V9, P954, DOI 10.1021/pr9008223; Blough ER, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00072; Brkic L, 2012, ATHEROSCLEROSIS, V224, P348, DOI 10.1016/j.atherosclerosis.2012.07.038; Cabezas A, 2005, BIOCHEM BIOPH RES CO, V338, P1682, DOI 10.1016/j.bbrc.2005.10.142; Chen X, 2002, LIFE SCI, V70, P2897, DOI 10.1016/S0024-3205(02)01541-2; Duncker DJ, 1996, AM J PHYSIOL-HEART C, V270, pH1189, DOI 10.1152/ajpheart.1996.270.4.H1189; Fan Y P, 2001, Zhongguo Zhong Xi Yi Jie He Za Zhi, V21, P406; Fraunberger P, 2002, CLIN CHEM LAB MED, V40, P304, DOI 10.1515/CCLM.2002.048; Gao XY, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/864747; Gao XY, 2013, CHEM-BIOL INTERACT, V204, P39, DOI 10.1016/j.cbi.2013.04.001; Han R, 2011, J ETHNOPHARMACOL, V135, P522, DOI 10.1016/j.jep.2011.03.060; Haque MM, 2012, J BIOL CHEM, V287, P30105, DOI 10.1074/jbc.M112.339697; Hasegawa S, 1968, Nihon Jibiinkoka Gakkai Kaiho, V71, P1726; Jiang Hong-li, 2009, Zhong Xi Yi Jie He Xue Bao, V7, P9, DOI 10.3736/jcim20090102; Kaufmann TB, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-47; KONG XT, 1993, ARCH DIS CHILD, V68, P468, DOI 10.1136/adc.68.4.468; Laeger T, 2012, J ENDOCRINOL, V213, P193, DOI 10.1530/JOE-11-0457; Laeger T, 2010, APPETITE, V54, P450, DOI 10.1016/j.appet.2010.04.005; Launey Y, 2011, CRIT CARE, V15, DOI 10.1186/cc10097; Li Dong, 2005, Zhong Yao Cai, V28, P796; Lindon JC, 2004, BIOMARKERS, V9, P1, DOI 10.1080/13547500410001668379; Lindon JC, 2007, FEBS J, V274, P1140, DOI 10.1111/j.1742-4658.2007.05673.x; Liu F, 2012, MOL CELL BIOCHEM, V363, P147, DOI 10.1007/s11010-011-1167-9; Lu AP, 2012, CHIN J INTEGR MED, V18, P883, DOI 10.1007/s11655-012-1290-6; LYCHIK GZ, 1987, UKR BIOKHIM ZH+, V59, P55; Pasin JSM, 2010, INFLAMM RES, V59, P189, DOI 10.1007/s00011-009-0085-8; Meng JR, 2012, ANAL CHIM ACTA, V710, P125, DOI 10.1016/j.aca.2011.09.033; MoHot P.R.C, 2009, DIAGNOSIS TREATMENT; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; Panousis N, 2012, RES VET SCI, V93, P435, DOI 10.1016/j.rvsc.2011.06.019; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; Rao SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065155; Rawat A, 2013, J BIOSCIENCES, V38, P63, DOI 10.1007/s12038-012-9288-1; Rice P, 2005, J IMMUNOL, V174, P3676, DOI 10.4049/jimmunol.174.6.3676; Schober C, 2009, BIOORG CHEM, V37, P202, DOI 10.1016/j.bioorg.2009.09.002; Shevaga V N, 1976, Vrach Delo, P124; SOBRADO J, 1983, INFECT IMMUN, V42, P997, DOI 10.1128/IAI.42.3.997-1005.1983; Song Z. J., 2000, Chinese Medical Sciences Journal, V15, P83; Tsuge H, 2006, SEIKAGAKU, V78, P41; Wang Y, 2011, J ETHNOPHARMACOL, V134, P165, DOI 10.1016/j.jep.2010.11.066; Xia JG, 2010, BIOINFORMATICS, V26, P2342, DOI 10.1093/bioinformatics/btq418; Yan GY, 2010, EXP BIOL MED, V235, P1356, DOI 10.1258/ebm.2010.009390; Ye J, 2012, J CHROMATOGR B, V898, P130, DOI 10.1016/j.jchromb.2012.04.036; Zhang FS, 2013, J PHARMACEUT BIOMED, V81-82, P168, DOI 10.1016/j.jpba.2013.04.005; Zhang Hai-ying RX-l, 2010, CHINA PHARM, V21, P4; Zhao YY, 2012, BIOMARKERS, V17, P721, DOI 10.3109/1354750X.2012.724450	49	24	27	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100017	10.1371/journal.pone.0100017	http://dx.doi.org/10.1371/journal.pone.0100017			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940599	Green Submitted, Green Published, gold			2022-12-27	WOS:000338508200065
J	Liu, M; Wu, QS; Chen, P; Buechele, B; Bian, MH; Dong, SJ; Huang, DK; Ren, CP; Zhang, YX; Hou, X; Simmet, T; Shen, JJ				Liu, Miao; Wu, Qingsi; Chen, Peng; Buechele, Berthold; Bian, Maohong; Dong, Shengjian; Huang, Dake; Ren, Cuiping; Zhang, Yuxia; Hou, Xin; Simmet, Thomas; Shen, Jijia			A Boswellic Acid-Containing Extract Ameliorates Schistosomiasis Liver Granuloma and Fibrosis through Regulating NF-kappa B Signaling in Mice	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; ACETYL-11-KETO-BETA-BOSWELLIC ACID; GROWTH-FACTOR; IN-VITRO; INHIBITION; INFECTION; SERRATA; ACTIVATION; PREVENTION; MORTALITY	Boswellic acid (BA)-containing extracts such as BSE have anti-inflammatory and immunomodulatory activity. In chronic schistosomiasis, the hepatic granuloma and fibrosis induced by egg deposition in the liver is the most serious pathological manifestations. However, little is known regarding the role of BAs in Schistosoma japonicum (S. japonicum) egg-induced liver granuloma and fibrosis. In order to investigate the effect of a water-soluble complex preparation of BSE, BSE-CD, on S. japonicum egg-induced liver pathology, liver granuloma and fibrosis were induced by infecting C57BL/6 mice with 18-22 cercariae of S. japonicum. S. japonicum cercariae infected mice were injected with BSE-CD at the onset of egg granuloma formation (early phase BSE-CD treatment after 4 weeks infection) or after the formation of liver fibrosis (late phase BSE-CD treatment after 7 weeks infection). Our data show that treatment of infected mice with BSE-CD significantly reduced both the extent of hepatic granuloma and fibrosis. Consistent with an inhibition of NF-kappa B signaling as evidenced by reduced I kappa B kinase (IKK) activation, the mRNA expression of VEGF (vascular endothelial growth factor, VEGF), TNF-alpha (tumor necrosis factor-alpha TNF-alpha) and MCP-1 (monocyte chemotactic protein 1, MCP-1) was decreased. Moreover, immunohistochemical analysis (IHC) revealed that the content of alpha-SMA in liver tissue of BSE-CD treated mice was dramatically decreased. Our findings suggest that BSE-CD treatment attenuates S. japonicum egg-induced hepatic granulomas and fibrosis, at least partly due to reduced NF-kappa B signaling and the subsequently decreased expression of VEGF, TNF-alpha, and MCP-1. Suppression of the activation of hepatic stellate cells (HSC) may also be involved in the therapeutic efficacy of BSE-CD.	[Liu, Miao; Wu, Qingsi; Huang, Dake; Ren, Cuiping; Zhang, Yuxia; Hou, Xin; Shen, Jijia] Anhui Med Univ, Dept Microbiol & Parasitol, Hefei, Anhui, Peoples R China; [Liu, Miao; Wu, Qingsi; Huang, Dake; Ren, Cuiping; Hou, Xin; Shen, Jijia] Anhui Med Univ, Anhui Prov Lab Microbiol & Parasitol, Hefei, Anhui, Peoples R China; [Chen, Peng] Anhui Med Univ, Coll Clin Med Sci, Hefei, Anhui, Peoples R China; [Buechele, Berthold; Simmet, Thomas] Univ Ulm, Inst Pharmacol Nat Prod & Clin Pharmacol, D-89069 Ulm, Germany; [Bian, Maohong] Anhui Med Univ, Affiliated Hosp 1, Dept Blood Transfus, Hefei, Anhui, Peoples R China; [Dong, Shengjian] Hefei Second Peoples Hosp, Dept Clin Lab, Hefei, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University; Anhui Medical University; Ulm University	Simmet, T (corresponding author), Univ Ulm, Inst Pharmacol Nat Prod & Clin Pharmacol, D-89069 Ulm, Germany.	thomas.simmet@uni-ulm.de; shenjijia@hotmail.com		Syrovets, Tatiana/0000-0002-6751-2233	Natural Science Foundation of China [30901251, 30972569]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Natural Science Foundation of China (http://www.nsfc.gov.cn) (grant numbers 30901251 and 30972569). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Tawab M, 2011, CLIN PHARMACOKINET, V50, P349, DOI 10.2165/11586800-000000000-00000; Ali EN, 2011, CHIN MED-UK, V6, DOI 10.1186/1749-8546-6-36; Ammon HPT, 2010, PHYTOMEDICINE, V17, P862, DOI 10.1016/j.phymed.2010.03.003; Anan A, 2006, HEPATOLOGY, V43, P335, DOI 10.1002/hep.21036; Andrade ZA, 2008, ACTA TROP, V108, P79, DOI 10.1016/j.actatropica.2008.04.003; Bartley PB, 2006, INT J PARASITOL, V36, P993, DOI 10.1016/j.ijpara.2006.04.015; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Caldas IR, 2008, ACTA TROP, V108, P109, DOI 10.1016/j.actatropica.2008.05.027; Cuaz-Perolin C, 2008, ARTERIOSCL THROM VAS, V28, P272, DOI 10.1161/ATVBAHA.107.155606; Fallon PG, 1999, J IMMUNOL, V162, P4122; Fattah NSA, 2012, EXP PARASITOL, V130, P58, DOI 10.1016/j.exppara.2011.09.014; Ferrara N, 1999, J MOL MED, V77, P527, DOI 10.1007/s001099900019; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Friedman SL, 2007, HEPATOLOGY, V45, P242, DOI 10.1002/hep.21459; Friedman SL, 2004, NAT CLIN PRACT GASTR, V1, P98, DOI 10.1038/ncpgasthep0055; Giatromanolaki A, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/67187; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Herbert DR, 2008, J IMMUNOL, V181, P7214, DOI 10.4049/jimmunol.181.10.7214; Hou X, 2009, HEPATOLOGY, V49, P940, DOI 10.1002/hep.22725; Kiela PR, 2005, AM J PHYSIOL-GASTR L, V288, pG798, DOI 10.1152/ajpgi.00433.2004; Kumar A, 2012, BIOORG MED CHEM LETT, V22, P431, DOI 10.1016/j.bmcl.2011.10.112; Latella G, 2008, EUR J CLIN INVEST, V38, P410, DOI 10.1111/j.1365-2362.2008.01955.x; Li Shi-Zhu, 2013, Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi, V25, P557; Liu M, 2013, PARASITOL RES, V112, P1105, DOI 10.1007/s00436-012-3237-7; Luedde T, 2011, NAT REV GASTRO HEPAT, V8, P108, DOI 10.1038/nrgastro.2010.213; Makhlouf Madiha M., 2002, Journal of the Egyptian Society of Parasitology, V32, P907; Mann DA, 2002, GUT, V50, P891, DOI 10.1136/gut.50.6.891; Mohamed-Ali Q, 1999, J INFECT DIS, V180, P1298, DOI 10.1086/314999; Molyneux DH, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-234; Park B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026943; SAFAYHI H, 1995, MOL PHARMACOL, V47, P1212; Sailer ER, 1996, BRIT J PHARMACOL, V117, P615, DOI 10.1111/j.1476-5381.1996.tb15235.x; Saraswati S, 2011, MICROVASC RES, V82, P263, DOI 10.1016/j.mvr.2011.08.002; Shariati F, 2011, EXP PARASITOL, V128, P44, DOI 10.1016/j.exppara.2011.01.016; Shehata AM, 2011, PHYTOMEDICINE, V18, P1037, DOI 10.1016/j.phymed.2011.06.035; Siemoneit U, 2011, BRIT J PHARMACOL, V162, P147, DOI 10.1111/j.1476-5381.2010.01020.x; Silveira-Lemos D, 2008, ACTA TROP, V108, P150, DOI 10.1016/j.actatropica.2008.04.006; Souza PRS, 2008, ACTA TROP, V108, P135, DOI 10.1016/j.actatropica.2008.04.016; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; Syrovets T, 2005, J BIOL CHEM, V280, P6170, DOI 10.1074/jbc.M409477200; Syrovets T, 2005, J IMMUNOL, V174, P498, DOI 10.4049/jimmunol.174.1.498; Wang H, 2006, J IMMUNOL, V183, P4755; Wang XH, 2008, ZHONGGUO XUE XI CHON, V28, P314; Weng HL, 2009, HEPATOLOGY, V50, P230, DOI 10.1002/hep.22934; Yu Xin-Ling, 2013, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V31, P307	45	13	16	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100129	10.1371/journal.pone.0100129	http://dx.doi.org/10.1371/journal.pone.0100129			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941000	Green Published, gold, Green Submitted			2022-12-27	WOS:000338508200075
J	Prator, CA; Murayama, KM; Schulz, JR				Prator, Cecilia A.; Murayama, Kellee M.; Schulz, Joseph R.			Venom Variation during Prey Capture by the Cone Snail, Conus textile	PLOS ONE			English	Article							MARINE GASTROPODS; MECHANISM; DIET; SUPERFAMILY; CONOTOXINS; KINEMATICS; DIVERSITY; EVOLUTION; PEPTIDES; DUCTS	Observations of the mollusc-hunting cone snail Conus textile during feeding reveal that prey are often stung multiple times in succession. While studies on the venom peptides injected by fish-hunting cone snails have become common, these approaches have not been widely applied to the analysis of the injected venoms from mollusc-hunters. We have successfully obtained multiple injected venom samples from C. textile individuals, allowing us to investigate venom compositional variation during prey capture. Our studies indicate that C. textile individuals alter the composition of prey-injected venom peptides during single feeding events. The qualitative results obtained by MALDI-ToF mass spectrometry are mirrored by quantitative changes in venom composition observed by reverse-phase high performance liquid chromatography. While it is unclear why mollusc-hunting cone snails inject prey multiple times prior to engulfment, our study establishes for the first time a link between this behavior and compositional changes of the venom during prey capture. Changes in venom composition during hunting may represent a multi-step strategy utilized by these venomous animals to slow and incapacitate prey prior to engulfment.	[Prator, Cecilia A.; Murayama, Kellee M.; Schulz, Joseph R.] Occidental Coll, Dept Biol, Los Angeles, CA 90041 USA	Occidental College	Schulz, JR (corresponding author), Occidental Coll, Dept Biol, Los Angeles, CA 90041 USA.	jschulz@oxy.edu		Prator, Cecilia/0000-0002-9638-7398	NIH [1R15NS059024]; Howard Hughes Medical Institute Award for Undergraduate Research to Occidental College; Science Scholars Program at Occidental College; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R15NS059024] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute Award for Undergraduate Research to Occidental College; Science Scholars Program at Occidental College; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the following sources: NIH 1R15NS059024 awarded to J.R. Schulz; Howard Hughes Medical Institute Award for Undergraduate Research to Occidental College; Science Scholars Program at Occidental College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow A, 2009, P ROY SOC B-BIOL SCI, V276, P2443, DOI 10.1098/rspb.2009.0048; Bingham JP, 2012, TOXICON, V60, P1166, DOI 10.1016/j.toxicon.2012.07.014; Bingham JP, 2010, CHEM-BIOL INTERACT, V183, P1, DOI 10.1016/j.cbi.2009.09.021; Corpuz GP, 2005, BIOCHEMISTRY-US, V44, P8176, DOI 10.1021/bi047541b; Daltry JC, 1996, NATURE, V379, P537, DOI 10.1038/379537a0; Dobson R, 2012, TOXICON, V60, P1370, DOI 10.1016/j.toxicon.2012.09.013; Domenici P, 1997, J EXP BIOL, V200, P1165; Duda TF, 2001, BIOL J LINN SOC, V73, P391, DOI 10.1006/bijl.2001.0544; Duda TF, 2008, J MOL EVOL, V67, P315, DOI 10.1007/s00239-008-9155-8; Dutertre S, 2013, MOL CELL PROTEOMICS, V12, P312, DOI 10.1074/mcp.M112.021469; Dutertre S, 2010, TOXICON, V55, P1453, DOI 10.1016/j.toxicon.2010.02.025; Garrett JE, 2005, BIOCHEM BIOPH RES CO, V328, P362, DOI 10.1016/j.bbrc.2004.12.178; GREENE JL, 1989, J ZOOL, V219, P487, DOI 10.1111/j.1469-7998.1989.tb02595.x; Inceoglu B, 2003, P NATL ACAD SCI USA, V100, P922, DOI 10.1073/pnas.242735499; Jakubowski JA, 2005, J EXP BIOL, V208, P2873, DOI 10.1242/jeb.01713; KOHN AJ, 1972, SCIENCE, V176, P49, DOI 10.1126/science.176.4030.49; Kohn Alan J., 2003, P101; Li M, 2005, J MOL EVOL, V60, P81, DOI 10.1007/s00239-004-0138-0; Liu JL, 2007, PEPTIDES, V28, P2313, DOI 10.1016/j.peptides.2007.09.006; Maguire D., 1992, P11; Moller C, 2011, BIOPOLYMERS, V96, P158, DOI 10.1002/bip.21406; Olivera BM, 1999, ANN NY ACAD SCI, V870, P223, DOI 10.1111/j.1749-6632.1999.tb08883.x; Reed JB, 2010, CELL MOL LIFE SCI, V67, P17, DOI [10.1007/s00018-009-0125-0, DOI 10.1007/S00018-009-0125-0]; Rivera-Ortiz JA, 2011, PEPTIDES, V32, P306, DOI 10.1016/j.peptides.2010.11.014; Salisbury SM, 2010, J EXP BIOL, V213, P673, DOI 10.1242/jeb.035550; Schulz JR, 2004, BIOL BULL-US, V207, P77, DOI 10.2307/1543581; Tayo LL, 2010, J PROTEOME RES, V9, P2292, DOI 10.1021/pr901032r; Ueberheide BM, 2009, P NATL ACAD SCI USA, V106, P6910, DOI 10.1073/pnas.0900745106	28	18	18	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e98991	10.1371/journal.pone.0098991	http://dx.doi.org/10.1371/journal.pone.0098991			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940882	Green Submitted, gold, Green Published			2022-12-27	WOS:000338508200011
J	Sun, Y; Lee, HJ; Yang, SC; Chen, TF; Lin, KN; Lin, CC; Wang, PN; Tang, LY; Chiu, MJ				Sun, Yu; Lee, Huey-Jane; Yang, Shu-Chien; Chen, Ta-Fu; Lin, Ker-Neng; Lin, Chung-Chih; Wang, Pei-Ning; Tang, Li-Yu; Chiu, Ming-Jang			A Nationwide Survey of Mild Cognitive Impairment and Dementia, Including Very Mild Dementia, in Taiwan	PLOS ONE			English	Article							ALZHEIMERS ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; PREVALENCE; POPULATION; DISEASE; SUBTYPES; EPIDEMIOLOGY; COMMUNITY; CHINA; RECOMMENDATIONS	An increasing population of dementia patients produces substantial societal impacts. We assessed the prevalence of mild cognitive impairment (MCI) and all-cause dementia, including very mild dementia (VMD), in Taiwan. In a nationwide population-based cross-sectional survey, participants were selected by computerized random sampling from all 19 Taiwan counties and were enrolled between December 2011 and March 2013. Cases were identified through in-person interviews based on the National Institute on Aging-Alzheimer's Association clinical criteria. Demographic data and histories involving mental status and function in daily living were collected. The principal objective assessments were the Taiwanese Mental Status Examination and Clinical Dementia Rating. In all, 10,432 people aged 65 years or older (mean age 76.2 +/- 6.7, 52.3% women) were interviewed. The age-adjusted prevalence of all-cause dementia was 8.04% (95% CI 7.47-8.61), including a 3.25% (95% CI 2.89-3.61) prevalence of VMD; that of MCI was 18.76% (95% CI 17.91-19.61). Women had a higher prevalence than men of both all-cause dementia (9.71% vs. 6.36%) and MCI (21.63% vs. 15.57%). MCI affects a considerable portion of the population aged 65 and above in Taiwan. The inclusion of VMD yields dementia prevalence rates higher than those previously reported from Taiwan. Old age, female gender, and a low educational level are significant associated factors.	[Sun, Yu] En Chu Kong Hosp, Dept Neurol, New Taipei City, Taiwan; [Sun, Yu] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Neurol, Taipei 10764, Taiwan; [Lee, Huey-Jane; Yang, Shu-Chien; Tang, Li-Yu] Taiwan Alzheimers Dis Assoc, Taipei, Taiwan; [Chen, Ta-Fu] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Neurol, Taipei 10764, Taiwan; [Lin, Ker-Neng] Taipei Vet Gen Hosp, Neurol Inst, Dept Neurol, Taipei, Taiwan; [Lin, Ker-Neng] Soochow Univ, Dept Psychol, Taipei, Taiwan; [Lin, Chung-Chih] Chang Gung Univ, Dept Comp Sci & Informat Engn, Taoyuan, Taiwan; [Wang, Pei-Ning] Taipei Vet Gen Hosp, Neurol Inst, Dept Neurol, Taipei, Taiwan; [Wang, Pei-Ning] Natl Yang Ming Univ, Sch Med, Dept Neurol, Taipei 112, Taiwan; [Chiu, Ming-Jang] Natl Taiwan Univ Hosp, Coll Med, Dept Neurol, Taipei, Taiwan; [Chiu, Ming-Jang] Natl Taiwan Univ, Grad Inst Brain & Mind Sci, Taipei, Taiwan; [Chiu, Ming-Jang] Natl Taiwan Univ, Grad Inst Psychol, Taipei, Taiwan; [Chiu, Ming-Jang] Natl Taiwan Univ, Grad Inst Biomed Engn & Bioinformat, Taipei, Taiwan	En Chu Kong Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Taipei Veterans General Hospital; Soochow University; Chang Gung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University	Chiu, MJ (corresponding author), Natl Taiwan Univ Hosp, Coll Med, Dept Neurol, Taipei, Taiwan.	mjchiu@ntu.edu.tw	Chiu, Ming-Jang/AAR-3940-2020	Chiu, Ming-Jang/0000-0002-4158-4423; Chen, Ta-Fu/0000-0003-1988-6924	Ministry of Health and Welfare, Taiwan	Ministry of Health and Welfare, Taiwan	This work was supported by the Ministry of Health and Welfare, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal Neelum T, 2012, Int J Alzheimers Dis, V2012, P171327, DOI 10.1155/2012/171327; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Alzheimer's Disease International, 2008, PREV DEM WORLDW; Andersen K, 1999, NEUROLOGY, V52, P85, DOI 10.1212/WNL.52.1.85; Andersen K, 1997, ACTA NEUROL SCAND, V96, P82; [Anonymous], 2013, STAT YB INTERIOR; [Anonymous], 2013, DEMENTIA STAT; Brayne C, 2010, BRAIN, V133, P2210, DOI 10.1093/brain/awq185; Busse A, 2006, NEUROLOGY, V67, P2176, DOI 10.1212/01.wnl.0000249117.23318.e1; Catindig JAS, 2012, J NEUROL SCI, V321, P11, DOI 10.1016/j.jns.2012.07.023; Chan KY, 2013, LANCET, V381, P2016, DOI 10.1016/S0140-6736(13)60221-4; Das SK, 2007, NEUROLOGY, V68, P2019, DOI 10.1212/01.wnl.0000264424.76759.e6; Dodge Hiroko H, 2012, Int J Alzheimers Dis, V2012, P956354, DOI 10.1155/2012/956354; Fuh Jong-Ling, 2008, Acta Neurol Taiwan, V17, P153; Gauthier S, 2006, LANCET, V367, P1262, DOI 10.1016/S0140-6736(06)68542-5; Hebert LE, 2013, NEUROLOGY, V80, P1778, DOI 10.1212/WNL.0b013e31828726f5; Ikeda M, 2004, J NEUROL NEUROSUR PS, V75, P146; Jhoo JH, 2008, DEMENT GERIATR COGN, V26, P270, DOI 10.1159/000160960; Kukull WA, 2002, MED CLIN N AM, V86, P573, DOI 10.1016/S0025-7125(02)00010-X; Lam LCW, 2008, INT PSYCHOGERIATR, V20, P135, DOI 10.1017/S1041610207006199; Larrieu S, 2002, NEUROLOGY, V59, P1594, DOI 10.1212/01.WNL.0000034176.07159.F8; Liu CK, 1996, J FORMOS MED ASSOC, V95, P762; Liu CK TC, 2007, RES APPL PSYCHOL, V7, P157; LIU HC, 1994, PSYCHOL MED, V24, P763, DOI 10.1017/S0033291700027914; LIU HC, 1995, J AM GERIATR SOC, V43, P144, DOI 10.1111/j.1532-5415.1995.tb06379.x; Liu HC, 1998, ALZ DIS ASSOC DIS, V12, P127, DOI 10.1097/00002093-199809000-00002; Luck T, 2007, DEMENT GERIATR COGN, V24, P307, DOI 10.1159/000108099; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Nie HW, 2011, INT J GERIATR PSYCH, V26, P558, DOI 10.1002/gps.2579; Nowrangi MA, 2011, PSYCHIAT CLIN N AM, V34, P275, DOI 10.1016/j.psc.2011.02.004; Petersen RC, 2010, NEUROLOGY, V75, P889, DOI 10.1212/WNL.0b013e3181f11d85; Plassman BL, 2008, ANN INTERN MED, V148, P427, DOI 10.7326/0003-4819-148-6-200803180-00005; Ritchie Karen, 2004, Dialogues Clin Neurosci, V6, P401; Rodriguez JJL, 2008, LANCET, V372, P464, DOI 10.1016/S0140-6736(08)61002-8; Shyu YIL, 2001, J FORMOS MED ASSOC, V100, P676; Tognoni G, 2005, ACTA NEUROL SCAND, V112, P65, DOI 10.1111/j.1600-0404.2005.00444.x; World Health Organization and Alzheimer's Disease International, 2012, DEM PUBL HLTH PRIOR; Wu YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066252; Zhang YD, 2012, J CLIN NEUROSCI, V19, P1333, DOI 10.1016/j.jocn.2012.01.029	39	154	156	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100303	10.1371/journal.pone.0100303	http://dx.doi.org/10.1371/journal.pone.0100303			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK6AC	24940604	Green Published, gold, Green Submitted			2022-12-27	WOS:000338508200093
J	Nolan, KE; Song, YH; Liao, SY; Saeed, NA; Zhang, XY; Rose, RJ				Nolan, Kim E.; Song, Youhong; Liao, Siyang; Saeed, Nasir A.; Zhang, Xiyi; Rose, Ray J.			An Unusual Abscisic Acid and Gibberellic Acid Synergism Increases Somatic Embryogenesis, Facilitates Its Genetic Analysis and Improves Transformation in Medicago truncatula	PLOS ONE			English	Article							ETHYLENE BIOSYNTHESIS; TRANSCRIPTION FACTOR; TISSUE-CULTURE; EXPRESSION; ARABIDOPSIS; PLANT; AGROBACTERIUM; REGENERATION; CELLS; TRIMETHYLATION	Somatic embryogenesis (SE) can be readily induced in leaf explants of the Jemalong 2HA genotype of the model legume Medicago truncatula by auxin and cytokinin, but rarely in wild-type Jemalong. Gibberellic acid (GA), a hormone not included in the medium, appears to act in Arabidopsis as a repressor of the embryonic state such that low ABA (abscisic acid): GA ratios will inhibit SE. It was important to evaluate the GA effect in M. truncatula in order to formulate generic SE mechanisms, given the Arabidopsis information. It was surprising to find that low ABA:GA ratios in M. truncatula acted synergistically to stimulate SE. The unusual synergism between GA and ABA in inducing SE has utility in improving SE for regeneration and transformation in M. truncatula. Expression of genes previously shown to be important in M. truncatula SE was not increased. In investigating genes previously studied in GA investigations of Arabidopsis SE, there was increased expression of GA2ox and decreased expression of PICKLE, a negative regulator of SE in Arabidopsis. We suggest that in M. truncatula there are different ABA:GA ratios required for down-regulating the PICKLE gene, a repressor of the embryonic state. In M. truncatula it is a low ABA:GA ratio while in Arabidopsis it is a high ABA:GA ratio. In different species the expression of key genes is probably related to differences in how the hormone networks optimise their expression.	[Nolan, Kim E.; Song, Youhong; Liao, Siyang; Saeed, Nasir A.; Zhang, Xiyi; Rose, Ray J.] Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW 2308, Australia	University of Newcastle	Rose, RJ (corresponding author), Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW 2308, Australia.	Ray.Rose@newcastle.edu.au	Nolan, Kim E/B-8794-2008; Song, Youhong/AAD-3654-2020		Australian Research Council [CEO348212]; University of Newcastle	Australian Research Council(Australian Research Council); University of Newcastle	This study was supported by Grant CEO348212 (Australian Research Council www.arc.gov.au); The University of Newcastle. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bozhkov PV, 2004, CELL DEATH DIFFER, V11, P175, DOI 10.1038/sj.cdd.4401330; Braybrook SA, 2006, P NATL ACAD SCI USA, V103, P3468, DOI 10.1073/pnas.0511331103; Braybrook SA, 2008, TRENDS PLANT SCI, V13, P624, DOI 10.1016/j.tplants.2008.09.008; Chabaud M, 1996, PLANT CELL REP, V15, P305, DOI 10.1007/BF00232361; Chen SK, 2009, PLANTA, V230, P827, DOI 10.1007/s00425-009-0988-1; Curaba J, 2004, PLANT PHYSIOL, V136, P3660, DOI 10.1104/pp.104.047266; DUDITS D, 1991, J CELL SCI, V99, P473; Elhiti M, 2010, J EXP BOT, V61, P4069, DOI 10.1093/jxb/erq222; Feher A, 2003, PLANT CELL TISS ORG, V74, P201, DOI 10.1023/A:1024033216561; Gaj MD, 2006, PLANT GROWTH REGUL, V49, P183, DOI 10.1007/s10725-006-9104-8; Gliwicka M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069261; HALPERIN W, 1964, SCIENCE, V146, P408, DOI 10.1126/science.146.3642.408; Hecht V, 2001, PLANT PHYSIOL, V127, P803, DOI 10.1104/pp.010324; Hedden P, 2000, TRENDS PLANT SCI, V5, P523, DOI 10.1016/S1360-1385(00)01790-8; Henderson JT, 2004, PLANT PHYSIOL, V134, P995, DOI 10.1104/pp.103.030148; Ikeda M, 2009, PLANT CELL, V21, P3493, DOI 10.1105/tpc.109.069997; Ikeda-Iwai M, 2003, PLANT J, V34, P107, DOI 10.1046/j.1365-313X.2003.01702.x; Kamada H, 1993, PLANT TISSUE CULTURE, V10, P38, DOI [DOI 10.5511/PLANTBI0TECHN0L0GY1984.10.38, DOI 10.5511/PLANTBIOTECHNOLOGY1984.10.38]; Lotan T, 1998, CELL, V93, P1195, DOI 10.1016/S0092-8674(00)81463-4; Mantiri FR, 2008, PLANT PHYSIOL, V146, P1622, DOI 10.1104/pp.107.110379; Mantiri FR, 2008, PLANT SIGNAL BEHAV, V3, P498, DOI 10.4161/psb.3.7.6049; Marino D, 2011, NEW PHYTOL, V189, P580, DOI 10.1111/j.1469-8137.2010.03509.x; Neill S, 2002, CURR OPIN PLANT BIOL, V5, P388, DOI 10.1016/S1369-5266(02)00282-0; Nishiwaki M, 2000, PLANTA, V211, P756, DOI 10.1007/s004250000387; Nolan K. E., 2010, Plant cell culture: essential methods, P39, DOI 10.1002/9780470686522.ch3; Nolan KE, 2003, PLANT PHYSIOL, V133, P218, DOI 10.1104/pp.103.020917; Nolan KE, 1998, AUST J BOT, V46, P151, DOI 10.1071/BT96138; NOLAN KE, 1989, PLANT CELL REP, V8, P278, DOI 10.1007/BF00274129; Nolan KE, 2006, PLANT CELL REP, V25, P711, DOI 10.1007/s00299-006-0135-4; Nolan KE, 2009, J EXP BOT, V60, P1759, DOI 10.1093/jxb/erp046; Ogas J, 1997, SCIENCE, V277, P91, DOI 10.1126/science.277.5322.91; Pasternak TP, 2007, PLANT GROWTH REGUL, V51, P109, DOI 10.1007/s10725-006-9152-0; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piyatrakul P, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-244; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Rieu I, 2008, PLANT CELL, V20, P2420, DOI 10.1105/tpc.108.058818; Rose RJ, 2010, PLANT DEVELOPMENTAL BIOLOGY: BIOTECHNOLOGICAL PERSPECTIVES VOL 2, P3, DOI 10.1007/978-3-642-04670-4_1; Rose R. J., 2013, SOMATIC EMBRYOGENESI, P146; Rose RJ, 2006, J EXP BOT, V57, P2227, DOI 10.1093/jxb/erj187; Rose RJ, 1999, J PLANT PHYSIOL, V155, P788, DOI 10.1016/S0176-1617(99)80097-2; Santner A, 2009, NATURE, V459, P1071, DOI 10.1038/nature08122; Sharma SK, 2008, PLANT MOL BIOL, V68, P185, DOI 10.1007/s11103-008-9360-2; Song Y, 2013, THESIS U NEWCASTLE C; Song YH, 2013, METHODS MOL BIOL, V1069, P203, DOI 10.1007/978-1-62703-613-9_14; Su YH, 2009, PLANT J, V59, P448, DOI 10.1111/j.1365-313X.2009.03880.x; THOMAS MR, 1992, PLANT CELL REP, V11, P113, DOI 10.1007/BF00232161; Tokuji Y, 2003, J PLANT PHYSIOL, V160, P133, DOI 10.1078/0176-1617-00892; Verdier J, 2008, PLANT MOL BIOL, V67, P567, DOI 10.1007/s11103-008-9320-x; Wang H, 2004, PLANT CELL, V16, P1206, DOI 10.1105/tpc.021261; Wang JH, 1996, AUST J PLANT PHYSIOL, V23, P265, DOI 10.1071/PP9960265; Weiss D, 2007, PLANT PHYSIOL, V144, P1240, DOI 10.1104/pp.107.100370; Yamada T, 2011, BREEDING SCI, V61, P480, DOI 10.1270/jsbbs.61.480; Zhang H, 2008, J BIOL CHEM, V283, P22637, DOI 10.1074/jbc.M802129200; Zhang H, 2012, PLANT PHYSIOL, V159, P418, DOI 10.1104/pp.112.194878; Zheng QL, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.25422; Zheng QL, 2013, PLANT PHYSIOL, V161, P2113, DOI 10.1104/pp.113.216275	56	16	19	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99908	10.1371/journal.pone.0099908	http://dx.doi.org/10.1371/journal.pone.0099908			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937316	Green Submitted, Green Published, gold			2022-12-27	WOS:000338503400055
J	Anadon-Rosell, A; Rixen, C; Cherubini, P; Wipf, S; Hagedorn, F; Dawes, MA				Anadon-Rosell, Alba; Rixen, Christian; Cherubini, Paolo; Wipf, Sonja; Hagedorn, Frank; Dawes, Melissa A.			Growth and Phenology of Three Dwarf Shrub Species in a Six-Year Soil Warming Experiment at the Alpine Treeline	PLOS ONE			English	Article							SIMULATED ENVIRONMENTAL-CHANGE; SHORT-TERM RESPONSES; FLOWERING PHENOLOGY; CLIMATE-CHANGE; NITROGEN MINERALIZATION; VACCINIUM-MYRTILLUS; PLANT PERFORMANCE; HEATH COMMUNITY; CO2 ENRICHMENT; CARBON-DIOXIDE	Global warming can have substantial impacts on the phenological and growth patterns of alpine and Arctic species, resulting in shifts in plant community composition and ecosystem dynamics. We evaluated the effects of a six-year experimental soil warming treatment (+4 degrees C, 2007-2012) on the phenology and growth of three co-dominant dwarf shrub species growing in the understory of Larix decidua and Pinus uncinata at treeline in the Swiss Alps. We monitored vegetative and reproductive phenology of Vaccinium myrtillus, Vaccinium gaultherioides and Empetrum hermaphroditum throughout the early growing season of 2012 and, following a major harvest at peak season, we measured the biomass of above-ground ramet fractions. For all six years of soil warming we measured annual shoot growth of the three species and analyzed ramet age and xylem ring width of V. myrtillus. Our results show that phenology of the three species was more influenced by snowmelt timing, and also by plot tree species (Larix or Pinus) in the case of V. myrtillus, than by soil warming. However, the warming treatment led to increased V. myrtillus total above-ground ramet biomass (+36% in 2012), especially new shoot biomass (+63% in 2012), as well as increased new shoot increment length and xylem ring width (+22% and +41%, respectively; average for 2007-2012). These results indicate enhanced overall growth of V. myrtillus under soil warming that was sustained over six years and was not caused by an extended growing period in early summer. In contrast, E. hermaphroditum only showed a positive shoot growth response to warming in 2011 (+21%), and V. gaultherioides showed no significant growth response. Our results indicate that V. myrtillus might have a competitive advantage over the less responsive co-occurring dwarf shrub species under future global warming.	[Anadon-Rosell, Alba] Univ Barcelona, Dept Plant Biol, Barcelona, Catalonia, Spain; [Anadon-Rosell, Alba; Rixen, Christian; Wipf, Sonja; Dawes, Melissa A.] WSL Inst Snow & Avalanche Res SLF, Davos, Switzerland; [Anadon-Rosell, Alba; Cherubini, Paolo; Hagedorn, Frank] Swiss Fed Inst Forest Snow & Landscape Res WSL, Birmensdorf, Switzerland	University of Barcelona; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research	Anadon-Rosell, A (corresponding author), Univ Barcelona, Dept Plant Biol, Barcelona, Catalonia, Spain.	a.anadon@ub.edu	Anadon-Rosell, Alba/AAA-5464-2020; Anadon-Rosell, Alba/GLR-2455-2022; Cherubini, Paolo/N-9702-2013; Wipf, Sonja/A-5075-2010; Cherubini, Paolo/AAC-3121-2021	Anadon-Rosell, Alba/0000-0002-9447-7795; Anadon-Rosell, Alba/0000-0002-9447-7795; Cherubini, Paolo/0000-0002-9809-250X; Wipf, Sonja/0000-0002-3492-1399; Cherubini, Paolo/0000-0002-9809-250X; Dawes, Melissa A./0000-0003-4919-0151; Rixen, Christian/0000-0002-2486-9988; Hagedorn, Frank/0000-0001-5218-7776	University of Barcelona; Spanish Ministry of Education (FPU); WSL; Swiss National Science Foundation [315200-116861]; Velux Foundation	University of Barcelona; Spanish Ministry of Education (FPU)(Spanish Government); WSL; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Velux Foundation(Velux Fonden)	Funding came from University of Barcelona (collaborative grant to AAR); Spanish Ministry of Education (FPU grant to AAR); WSL (funding for MAD and AAR); Swiss National Science Foundation from 2007 to 2009 (grant 315200-116861 to CR); Velux Foundation (funding for SW and FH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 2006, PLANT ECOL, V182, P65, DOI 10.1007/s11258-005-9031-1; Aerts R, 2004, GLOBAL CHANGE BIOL, V10, P1599, DOI 10.1111/j.1365-2486.2004.00815.x; Arft AM, 1999, ECOL MONOGR, V69, P491, DOI 10.1890/0012-9615(1999)069[0491:ROTPTE]2.0.CO;2; Atkin OK, 2006, J EXP BOT, V57, P267, DOI 10.1093/jxb/erj029; Barbeito I, 2012, ECOLOGY, V93, P389, DOI 10.1890/11-0384.1; Bret-Harte MS, 2002, J ECOL, V90, P251, DOI 10.1046/j.1365-2745.2001.00657.x; Campioli M, 2012, PLOS ONE, V7, DOI [10.1371/journal.-pone.0034842, DOI 10.1371/JOURNAL.-PONE.0034842]; Campioli M, 2013, PLANT ECOL, V214, P1049, DOI 10.1007/s11258-013-0230-x; CHAPIN FS, 1995, ECOLOGY, V76, P694, DOI 10.2307/1939337; Chapin FS, 2000, GLOBAL CHANGE BIOL, V6, P211, DOI 10.1046/j.1365-2486.2000.06022.x; Cook BI, 2012, P NATL ACAD SCI USA, V109, P9000, DOI 10.1073/pnas.1118364109; Cornelissen JHC, 2001, J ECOL, V89, P984, DOI 10.1111/j.1365-2745.2001.00625.x; Dawes MA, 2014, NEW PHYTOL, V202, P1237, DOI 10.1111/nph.12742; Dawes MA, 2013, OECOLOGIA, V171, P623, DOI 10.1007/s00442-012-2576-5; Dawes MA, 2011, NEW PHYTOL, V191, P806, DOI 10.1111/j.1469-8137.2011.03722.x; Dawes MA, 2011, J ECOL, V99, P383, DOI 10.1111/j.1365-2745.2010.01764.x; Dunne JA, 2003, ECOL MONOGR, V73, P69, DOI 10.1890/0012-9615(2003)073[0069:SMFPRT]2.0.CO;2; Elmendorf SC, 2012, NAT CLIM CHANGE, V2, P453, DOI 10.1038/NCLIMATE1465; Elmendorf SC, 2012, ECOL LETT, V15, P164, DOI 10.1111/j.1461-0248.2011.01716.x; Esau K., 1977, Anatomy of seed plants.; Gomez-Aparicio L, 2008, J VEG SCI, V19, P161, DOI 10.3170/2008-8-18347; Goulden ML, 1996, SCIENCE, V271, P1576, DOI 10.1126/science.271.5255.1576; Graglia E, 1997, ECOSCIENCE, V4, P191, DOI 10.1080/11956860.1997.11682395; Grau O, 2012, OIKOS, V121, P1680, DOI 10.1111/j.1600-0706.2011.20032.x; Hagedorn F, 2010, BIOGEOCHEMISTRY, V97, P1, DOI 10.1007/s10533-009-9386-9; Hartley AE, 1999, OIKOS, V86, P331, DOI 10.2307/3546450; Hattenschwiler S, 2002, NEW PHYTOL, V156, P363, DOI 10.1046/j.1469-8137.2002.00537.x; Hill GB, 2011, GLOBAL CHANGE BIOL, V17, P276, DOI 10.1111/j.1365-2486.2010.02244.x; Hoffmann AA, 2010, J ECOL, V98, P927, DOI 10.1111/j.1365-2745.2010.01667.x; Hudson JMG, 2009, ECOLOGY, V90, P2657, DOI 10.1890/09-0102.1; Klanderud K, 2008, J VEG SCI, V19, P363, DOI 10.3170/2008-8-18376; Korner C, 2010, SCIENCE, V327, P1461, DOI 10.1126/science.1186473; Korner C., 2003, ALPINE PLANT LIFE FU, V2nd ed.; Lauber K., 2018, FLORA HELVETICA; Marion GM, 1997, GLOB CHANGE BIOL, V3, P20, DOI 10.1111/j.1365-2486.1997.gcb136.x; Martin M, 2010, GLOBAL CHANGE BIOL, V16, P1057, DOI 10.1111/j.1365-2486.2009.01987.x; McEwan RW, 2011, PLANT ECOL, V212, P55, DOI 10.1007/s11258-010-9801-2; Myers-Smith IH, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/045509; Myneni RB, 1997, NATURE, V386, P698, DOI 10.1038/386698a0; Natali SM, 2012, J ECOL, V100, P488, DOI 10.1111/j.1365-2745.2011.01925.x; Oberbauer SF, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0481; PARSONS AN, 1994, J ECOL, V82, P307, DOI 10.2307/2261298; Pato J, 2012, ECOSCIENCE, V19, P59, DOI 10.2980/19-1-3407; Pau S, 2011, GLOBAL CHANGE BIOL, V17, P3633, DOI 10.1111/j.1365-2486.2011.02515.x; Pinheiro J, 2008, R PACKAGE VERSION, V57, P1; Press MC, 1998, J ECOL, V86, P315, DOI 10.1046/j.1365-2745.1998.00261.x; R Core Team, 2021, R LANGUAGE ENV STAT; Regent Instruments Inc, 2001, WINCELL PRO 2001 IM; Rixen C, 2012, OIKOS, V121, P1532, DOI 10.1111/j.1600-0706.2011.20031.x; Rixen C, 2010, POLAR RES, V29, P85, DOI 10.1111/j.1751-8369.2010.00155.x; Ropars P, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/1/015501; Rundqvist S, 2011, AMBIO, V40, P683, DOI 10.1007/s13280-011-0174-0; Rustad LE, 2001, OECOLOGIA, V126, P543, DOI 10.1007/s004420000544; Schwartz MD, 2014, INT J BIOMETEOROL, V58, P1699, DOI 10.1007/s00484-013-0723-2; Schweingruber F. H., 1978, Microscopic wood anatomy : structural variability of stems and twigs in recent and subfossil woods from Central Europe.; Smith JG, 2012, ARCT ANTARCT ALP RES, V44, P135, DOI 10.1657/1938-4246-44.1.135; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Streit K, 2014, GLOBAL CHANGE BIOL, V20, P1327, DOI 10.1111/gcb.12396; Suzuki S, 2000, ECOGRAPHY, V23, P553, DOI 10.1034/j.1600-0587.2000.230506.x; Suzuki S, 1997, GLOB CHANGE BIOL, V3, P108, DOI 10.1111/j.1365-2486.1997.gcb146.x; Tape K, 2006, GLOBAL CHANGE BIOL, V12, P686, DOI 10.1111/j.1365-2486.2006.01128.x; Totland O, 2002, OECOLOGIA, V133, P168, DOI 10.1007/s00442-002-1028-z; van Wijk MT, 2004, GLOBAL CHANGE BIOL, V10, P105, DOI 10.1111/j.1365-2486.2003.00719.x; Walther GR, 2004, PERSPECT PLANT ECOL, V6, P169, DOI 10.1078/1433-8319-00076; Wipf S, 2010, PLANT ECOL, V207, P53, DOI 10.1007/s11258-009-9653-9; Wolkovich EM, 2012, NATURE, V485, P494, DOI 10.1038/nature11014; Wookey PA, 2009, GLOBAL CHANGE BIOL, V15, P1153, DOI 10.1111/j.1365-2486.2008.01801.x; Xu ZF, 2009, PLANT SPEC BIOL, V24, P27, DOI 10.1111/j.1442-1984.2009.00229.x; Zumbrunn T, 2004, THESIS U BASEL BASEL	69	23	26	3	108	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100577	10.1371/journal.pone.0100577	http://dx.doi.org/10.1371/journal.pone.0100577			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956273	gold, Green Published, Green Submitted			2022-12-27	WOS:000338917900070
J	Guo, HW; Yun, CX; Hou, GH; Du, J; Huang, X; Lu, Y; Keller, ET; Zhang, J; Deng, JG				Guo, Hong-Wei; Yun, Chen-Xia; Hou, Guang-Han; Du, Jun; Huang, Xin; Lu, Yi; Keller, Evan T.; Zhang, Jian; Deng, Jia-Gang			Mangiferin Attenuates Th1/Th2 Cytokine Imbalance in an Ovalbumin-Induced Asthmatic Mouse Model	PLOS ONE			English	Article							ALLERGIC AIRWAY INFLAMMATION; INDICA L. EXTRACT; INDUCED MYOCARDIAL-INFARCTION; T-BET; INTERFERON-GAMMA; TH2 DEVELOPMENT; DIABETIC-RATS; MURINE MODEL; MICE; CELLS	Mangiferin is a major bioactive ingredient in Mangifera indica Linn. (Anacardiaceae) leaves. Aqueous extract of such leaves have been used as an indigenous remedy for respiratory diseases like asthma and coughing in traditional Chinese medicine. However, underlying molecular mechanisms of mangiferin on anti-asthma remain unclear. In our present study, we investigated the anti-asthmatic effect of mangiferin on Th1/Th2 cytokine profiles and explored its underlying immunoregulatory mechanism in mouse model of allergic asthma. Mangiferin significantly reduced the total inflammatory cell counts and eosinophil infiltration, decreased the production of ovalbumin-specific IgE in serum and PGD(2) in BALF. The antibody array analysis showed that mangiferin down-regulated the levels of one group of cytokines/chemokines including Th2-related IL-4, IL-5, IL-13, and others IL-3, IL-9, IL-17, RANTES, TNF-alpha, but simultaneously up-regulated Th1-related IFN-gamma, IL2 and IL-10 and IL-12 expression in serum. Thus it attenuates the imbalance of Th1/Th2 cells ratio by diminishing the abnormal mRNA levels of Th1 cytokines (IFN-gamma and IL-12) and Th2 cytokines (IL-4, IL-5 and IL-13). Finally, mangiferin substantially inhibited the activation and expression of STAT-6 and GATA-3 in excised lung tissues. Our results suggest that mangiferin can exert anti-asthmatic effect. The underlying mechanism may attribute to the modulation of Th1/Th2 cytokine imbalance via inhibiting the STAT6 signaling pathway.	[Guo, Hong-Wei; Huang, Xin; Lu, Yi; Zhang, Jian] Guangxi Med Univ, Ctr Translat Med, Nanning, Guangxi, Peoples R China; [Guo, Hong-Wei; Huang, Xin; Lu, Yi; Zhang, Jian] Chinese Minist Educ, Key Lab Longev & Aging Related Dis, Nanning, Guangxi, Peoples R China; [Guo, Hong-Wei; Hou, Guang-Han; Du, Jun; Deng, Jia-Gang] Guangxi Key Lab Pharmacodynam Studies Tradit Chin, Nanning, Guangxi, Peoples R China; [Yun, Chen-Xia] Guangxi Univ Tradit Chinese Med, Sch Basic Med Sci, Nanning, Guangxi, Peoples R China; [Keller, Evan T.] Univ Michigan, Sch Med, Dept Urol & Pathol, Ann Arbor, MI USA	Guangxi Medical University; Guangxi University of Chinese Medicine; University of Michigan System; University of Michigan	Zhang, J (corresponding author), Guangxi Med Univ, Ctr Translat Med, Nanning, Guangxi, Peoples R China.	jzhangqi@gmail.com; dengjg53@hotmail.com	Keller, Evan T/M-1446-2016; ZHANG, JIAN/Q-6334-2018; guo, hongwei/GVS-9412-2022; Lu, Yi/J-6746-2018	Keller, Evan T/0000-0002-7592-7535; guo, hongwei/0000-0002-4046-2643; Lu, Yi/0000-0002-1060-6925	National Natural Science Foundation of China [30973916, 81260666]; Guangxi Projects of China [2013GXNSFBA019177, GZPT13-35, 1355004-5, 09-007-06-14, 11-031-05-K2]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangxi Projects of China	This work was supported by the National Natural Science Foundation of China (30973916, 81260666) and the Guangxi Projects of China (2013GXNSFBA019177, GZPT13-35, 1355004-5, 09-007-06-14, 11-031-05-K2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afkarian M, 2002, NAT; Akdis M, 2011, J ALLERGY CLIN IMMUN, V127, P701, DOI 10.1016/j.jaci.2010.11.050; Barnes PJ, 2008, J CLIN INVEST, V118, P3546, DOI 10.1172/JCI36130; BRUSSELLE GG, 1994, CLIN EXP ALLERGY, V24, P73, DOI 10.1111/j.1365-2222.1994.tb00920.x; Busse WW, 2001, NEW ENGL J MED, V344, P350, DOI 10.1056/NEJM200102013440507; Carneiro ER, 2010, CYTOKINE, V50, P335, DOI 10.1016/j.cyto.2010.01.005; Chang HC, 2009, BLOOD, V113, P5887, DOI 10.1182/blood-2008-09-179820; Chen WG, 2007, J ALLERGY CLIN IMMUN, V119, P529, DOI 10.1016/j.jaci.2007.01.004; Coffey M, 2003, CURR OPIN ALLERGY CL, V3, P57, DOI 10.1097/01.all.0000053269.39029.50; Das J, 2012, TOXICOL APPL PHARM, V260, P35, DOI 10.1016/j.taap.2012.01.015; Fujitani Y, 2002, J IMMUNOL, V168, P443, DOI 10.4049/jimmunol.168.1.443; Garcia D, 2003, PHYTOTHER RES, V17, P1203, DOI 10.1002/ptr.1343; Rivera DG, 2011, J PHARM PHARMACOL, V63, P1336, DOI 10.1111/j.2042-7158.2011.01328.x; Garcia-Rivera D, 2011, CANCER LETT, V305, P21, DOI 10.1016/j.canlet.2011.02.011; Garrido G, 2001, PHYTOTHER RES, V15, P18, DOI 10.1002/1099-1573(200102)15:1&lt;18::AID-PTR676&gt;3.0.CO;2-R; Guha S, 1996, CHEMOTHERAPY, V42, P443, DOI 10.1159/000239478; Hammad H, 2011, ALLERGY, V66, P579, DOI 10.1111/j.1398-9995.2010.02528.x; Hirahara K, 2008, J ALLERGY CLIN IMMUN, V122, P512, DOI 10.1016/j.jaci.2008.06.004; Ho IC, 2002, CELL, V109, pS109, DOI 10.1016/S0092-8674(02)00705-5; Jagetia GC, 2005, PHYTOMEDICINE, V12, P209, DOI 10.1016/j.phymed.2003.08.003; Kanda Akira, 2009, P95, DOI 10.1007/978-4-431-88315-9_7; Kaplan MH, 2005, IMMUNOL RES, V31, P231, DOI 10.1385/IR:31:3:231; Kiwamoto T, 2006, AM J RESP CRIT CARE, V174, P142, DOI 10.1164/rccm.200601-079OC; Lee CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034554; Lee CC, 2008, MOL THER, V16, P60, DOI 10.1038/sj.mt.6300309; Lee SY, 2001, CLIN IMMUNOL, V101, P220, DOI 10.1006/clim.2001.5122; Leiro J, 2004, INT IMMUNOPHARMACOL, V4, P991, DOI 10.1016/j.intimp.2004.02.003; Li Chang-Chong, 2007, Zhonghua Er Ke Za Zhi, V45, P727; Li Chang-Chong, 2006, Zhongguo Ying Yong Sheng Li Xue Za Zhi, V22, P210; Li XM, 2009, J ALLERGY CLIN IMMUN, V123, P297, DOI 10.1016/j.jaci.2008.12.026; Li XA, 2010, PHYTOTHER RES, V24, P893, DOI 10.1002/ptr.3045; Li Y, 2013, ARCH MED SCI, V9, P906, DOI 10.5114/aoms.2013.33180; Lighvani AA, 2001, P NATL ACAD SCI USA, V98, P15137, DOI 10.1073/pnas.261570598; Makare N, 2001, J ETHNOPHARMACOL, V78, P133, DOI 10.1016/S0378-8741(01)00326-9; Molfino NA, 2012, CLIN EXP ALLERGY, V42, P712, DOI 10.1111/j.1365-2222.2011.03854.x; Mowen KA, 2004, IMMUNOL REV, V202, P203, DOI 10.1111/j.0105-2896.2004.00209.x; Mukherjee AB, 2011, J BIOL CHEM, V286, P32883, DOI 10.1074/jbc.R110.197046; Muruganandan S, 2005, J ETHNOPHARMACOL, V97, P497, DOI 10.1016/j.jep.2004.12.010; Muruganandan S, 2002, TOXICOLOGY, V176, P165, DOI 10.1016/S0300-483X(02)00069-0; Oh CK, 2010, EUR RESPIR REV, V19, P46, DOI 10.1183/09059180.00007609; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; Pernis AB, 2002, J CLIN INVEST, V109, P1279, DOI 10.1172/JCI200215786; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; Prabhu S, 2006, J ETHNOPHARMACOL, V107, P126, DOI 10.1016/j.jep.2006.02.014; Prabhu S., 2006, Indian Journal of Experimental Biology, V44, P209; Prabhu S, 2006, VASC PHARMACOL, V44, P519, DOI 10.1016/j.vph.2006.03.012; RACKE MK, 1994, J EXP MED, V180, P1961, DOI 10.1084/jem.180.5.1961; Ram A, 2004, INT IMMUNOPHARMACOL, V4, P1697, DOI 10.1016/j.intimp.2004.08.001; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; Sanchez GM, 2000, PHARMACOL RES, V42, P565, DOI 10.1006/phrs.2000.0727; Shi YH, 2011, CHINESE MED J-PEKING, V124, P1951, DOI 10.3760/cma.j.issn.0366-6999.2011.13.006; Singh SK, 2009, INDIAN J PHARM SCI, V71, P328, DOI 10.4103/0250-474X.56023; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Telang M, 2013, EXPERT OPIN THER PAT, V23, P1561, DOI 10.1517/13543776.2013.836182; Underwood S, 1995, EUR RESPIR J, V8, P2104, DOI 10.1183/109031936.95.08122104; Wang Qin, 2011, Zhongguo Zhong Yao Za Zhi, V36, P1348; Wei Zhiquan, 2011, Zhongguo Zhong Yao Za Zhi, V36, P1798; Yuan Y, 2013, J ETHNOPHARMACOL, V149, P701, DOI 10.1016/j.jep.2013.07.032	58	71	82	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100394	10.1371/journal.pone.0100394	http://dx.doi.org/10.1371/journal.pone.0100394			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955743	Green Published, Green Submitted, gold			2022-12-27	WOS:000338917900047
J	Xie, SS; Shen, B; Zhang, CB; Huang, XX; Zhang, YL				Xie, Shengsong; Shen, Bin; Zhang, Chaobao; Huang, Xingxu; Zhang, Yonglian			sgRNAcas9: A Software Package for Designing CRISPR sgRNA and Evaluating Potential Off-Target Cleavage Sites	PLOS ONE			English	Article							SEQUENCE-SPECIFIC CONTROL; ONE-STEP GENERATION; CONDITIONAL ALLELES; GENE-EXPRESSION; CAS9 NUCLEASE; HUMAN-CELLS; GENOME; SPECIFICITY; ZEBRAFISH; SYSTEM	Although the CRISPR/Cas9/sgRNA system efficiently cleaves intracellular DNA at desired target sites, major concerns remain on potential "off-target'' cleavage that may occur throughout the whole genome. In order to improve CRISPR-Cas9 specificity for targeted genome editing and transcriptional control, we describe a bioinformatics tool "sgRNAcas9'', which is a software package developed for fast design of CRISPR sgRNA with minimized off-target effects. This package consists of programs to perform a search for CRISPR target sites (protospacers) with user-defined parameters, predict genome-wide Cas9 potential off-target cleavage sites (POT), classify the POT into three categories, batch-design oligonucleotides for constructing 20-nt (nucleotides) or truncated sgRNA expression vectors, extract desired length nucleotide sequences flanking the on-or off-target cleavage sites for designing PCR primer pairs to validate the mutations by T7E1 cleavage assay. Importantly, by identifying potential off-target sites in silico, the sgRNAcas9 allows the selection of more specific target sites and aids the identification of bona fide off-target sites, significantly facilitating the design of sgRNA for genome editing applications. sgRNAcas9 software package is publicly available at BiooTools website (www.biootools.com) under the terms of the GNU General Public License.	[Xie, Shengsong; Zhang, Chaobao; Zhang, Yonglian] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Shanghai, Peoples R China; [Shen, Bin; Huang, Xingxu] Nanjing Univ, Model Anim Res Ctr, MOE Key Lab Model Anim Dis Study, Nanjing 210008, Jiangsu, Peoples R China; [Zhang, Yonglian] Shanghai Inst Planned Parenthood Res, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Nanjing University	Huang, XX (corresponding author), Nanjing Univ, Model Anim Res Ctr, MOE Key Lab Model Anim Dis Study, Nanjing 210008, Jiangsu, Peoples R China.	xingxuhuang@mail.nju.edu.cn; ylzhang@sibs.ac.cn	Shen, Bin/ABD-5084-2021	Shen, Bin/0000-0002-8946-8448; huang, xingxu/0000-0001-8934-1247	National Natural Science Foundation of China [31301226]; Chinese Academy of Sciences (CAS) [KSXC2-EW-R-07]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences (CAS)(Chinese Academy of Sciences)	The Project was supported by the National Natural Science Foundation of China (Grant No. 31301226) and the Chinese Academy of Sciences (CAS) Knowledge Innovation Program (KSXC2-EW-R-07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auer TO, 2014, GENOME RES, V24, P142, DOI 10.1101/gr.161638.113; Bae S., 2014, BIOINFORMATICS; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bassett AR, 2014, J GENET GENOMICS, V41, P7, DOI 10.1016/j.jgg.2013.12.004; Bikard David, 2013, F1000Prime Rep, V5, P47, DOI 10.12703/P5-47; Carroll D, 2013, NAT BIOTECHNOL, V31, P807, DOI 10.1038/nbt.2684; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Cheng AW, 2013, CELL RES, V23, P1163, DOI 10.1038/cr.2013.122; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dickinson DJ, 2013, NAT METHODS, V10, P1028, DOI 10.1038/NMETH.2641; Fu Y, 2014, NAT BIOTECHNOL; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Fujii W, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt772; Guilinger J.P., 2014, NAT BIOTECHNOL; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Hisano Y, 2014, DEV GROWTH DIFFER, V56, P26, DOI 10.1111/dgd.12094; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Jiang H, 2008, BIOINFORMATICS, V24, P2395, DOI 10.1093/bioinformatics/btn429; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jiang WZ, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt780; Larson MH, 2013, NAT PROTOC, V8, P2180, DOI 10.1038/nprot.2013.132; Ma M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/270805; Ma YW, 2014, CELL RES, V24, P122, DOI 10.1038/cr.2013.157; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Matsunaga T, 2014, BIOCHEM BIOPH RES CO, V444, P158, DOI 10.1016/j.bbrc.2014.01.037; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Ren XJ, 2013, P NATL ACAD SCI USA, V110, P19012, DOI 10.1073/pnas.1318481110; Sung YH, 2014, GENOME RES, V24, P125, DOI 10.1101/gr.163394.113; Tsai S. Q., 2014, NAT BIOTECHNOL; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wu YX, 2013, CELL STEM CELL, V13, P659, DOI 10.1016/j.stem.2013.10.016; Xiao A, 2014, BIOINFORMATICS; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Zhou JK, 2014, INT J BIOCHEM CELL B, V46, P49, DOI 10.1016/j.biocel.2013.10.010	40	179	200	4	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100448	10.1371/journal.pone.0100448	http://dx.doi.org/10.1371/journal.pone.0100448			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956386	Green Submitted, gold, Green Published			2022-12-27	WOS:000338917900053
J	Asaoka, R				Asaoka, Ryo			Mapping Glaucoma Patients' 30-2 and 10-2 Visual Fields Reveals Clusters of Test Points Damaged in the 10-2 Grid That Are Not Sampled in the Sparse 30-2 Grid	PLOS ONE			English	Article							NERVE-FIBER LAYER; PERIMETRY; SECTORIZATION; PROGRESSION; PARAFOVEAL; LOCATIONS; STIMULUS; DEFECTS; RATES	Purpose: To cluster test points in glaucoma patients' 30-2 and 10-2 visual field (VF) (Humphrey Field Analyzer: HFA, Carl Zeiss Meditec, Dublin, CA) in order to map the different regions damaged by the disease. Method: This retrospective study included 128 eyes from 128 patients. 142 total deviation (TD) values (74 from the 30-2 VF and 68 from the 10-2 VF) were clustered using the 'Hierarchical Ordered Partitioning And Collapsing Hybrid -Partitioning Around Medoids' algorithm. The stability of the identified clusters was evaluated using bootstrapping. Results: 65 sectors were identified in total: 38 sectors were located outside the 10-2 VF whereas 29 sectors were located inside the 10-2 VF (two sectors overlap in both grids). The mapping of many sectors appeared to follow the distribution of retinal nerve fiber bundles. The results of bootstrapping suggested clusters were stable whether they were outside or inside the 10-2 VF. Conclusion: A considerable number of sectors were identified in the 10-2 VF area, despite the fact that clustering was carried out on all points in both the 30-2 VF and 10-2 VF simultaneously. These findings suggest that glaucomatous central VF deterioration cannot be picked up by the 30-2 test grid alone, because of poor spatial sampling; denser estimation of the central ten degrees, than offered by the 30-2 test grid alone, is needed. It may be beneficial to develop a new VF test grid that combines test points from 30-2 and 10-2 VFs - the results of this study could help to devise this test grid.	Univ Tokyo, Dept Ophthalmol, Grad Sch Med, Tokyo 113, Japan	University of Tokyo	Asaoka, R (corresponding author), Univ Tokyo, Dept Ophthalmol, Grad Sch Med, Tokyo 113, Japan.	rasaoka-tky@umin.ac.jp						ANCTIL JL, 1984, ARCH OPHTHALMOL-CHIC, V102, P363; AULHORN E., 1967, P151; Aulhorn E., 1977, DOC OPHTHALMOL PROC, V14, P75; Bengtsson B, 2000, INVEST OPHTH VIS SCI, V41, P2201; Chauhan BC, 2008, BRIT J OPHTHALMOL, V92, P569, DOI 10.1136/bjo.2007.135012; CHAUHAN BC, 1989, GRAEF ARCH CLIN EXP, V227, P216, DOI 10.1007/BF02172752; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; COWEY A, 1974, EXP BRAIN RES, V21, P447; CURCIO CA, 1990, J COMP NEUROL, V300, P5, DOI 10.1002/cne.903000103; DANIEL PM, 1961, J PHYSIOL-LONDON, V159, P203, DOI 10.1113/jphysiol.1961.sp006803; DRANCE SM, 1969, INVEST OPHTH VISUAL, V8, P84; Garway-Heath DF, 2000, OPHTHALMOLOGY, V107, P1809, DOI 10.1016/S0161-6420(00)00284-0; Glinca S, 2013, J CHEM INF MODEL, V53, P2082, DOI 10.1021/ci300550a; HEIJL A, 1984, ACTA OPHTHALMOL, V62, P658; Hennig C, 2007, COMPUT STAT DATA AN, V52, P258, DOI 10.1016/j.csda.2006.11.025; Hood DC, 2013, PROG RETIN EYE RES, V32, P1, DOI 10.1016/j.preteyeres.2012.08.003; KATZ J, 1991, ARCH OPHTHALMOL-CHIC, V109, P1684, DOI 10.1001/archopht.1991.01080120068028; KOSEKI N, 1995, GRAEF ARCH CLIN EXP, V233, P621, DOI 10.1007/BF00185282; Lamparter J, 2013, INVEST OPHTH VIS SCI, V54, P6074, DOI 10.1167/iovs.13-11902; Langerhorst C., 1997, MEASUREMENTS DESCRIP, P67; Malik R, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002067; MANDAVA S, 1993, AM J OPHTHALMOL, V116, P684, DOI 10.1016/S0002-9394(14)73466-X; Nouri-Mahdavi K, 2012, INVEST OPHTH VIS SCI, V53, P2390, DOI 10.1167/iovs.11-9021; Park SC, 2013, OPHTHALMOLOGY, V120, P1546, DOI 10.1016/j.ophtha.2013.01.045; Park SC, 2011, OPHTHALMOLOGY, V118, P1782, DOI 10.1016/j.ophtha.2011.02.013; Pollard KS, 2002, 6TH WORLD MULTICONFERENCE ON SYSTEMICS, CYBERNETICS AND INFORMATICS, VOL II, PROCEEDINGS, P318; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; Schiefer U, 2010, INVEST OPHTH VIS SCI, V51, P5685, DOI 10.1167/iovs.09-5067; Sumi I, 2003, OPHTHALMOLOGY, V110, P332, DOI 10.1016/S0161-6420(02)01742-6; SUZUKI Y, 1993, OPHTHALMOLOGY, V100, P69; Tan O, 2009, OPHTHALMOLOGY, V116, P2305, DOI 10.1016/j.ophtha.2009.05.025; Traynis I, 2014, JAMA OPHTHALMOL; van der Laan MJ, 2003, J STAT PLAN INFER, V117, P275, DOI 10.1016/S0378-3758(02)00388-9; WEBER J, 1989, INT OPHTHALMOL, V13, P47, DOI 10.1007/BF02028637; ZALTA AH, 1991, BRIT J OPHTHALMOL, V75, P151, DOI 10.1136/bjo.75.3.151; ZEYEN TG, 1993, OPHTHALMOLOGY, V100, P518	36	28	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e98525	10.1371/journal.pone.0098525	http://dx.doi.org/10.1371/journal.pone.0098525			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950300	Green Submitted, Green Published, gold			2022-12-27	WOS:000338276300007
J	Chen, XY; Zhao, Y; Mo, B; Mi, HX				Chen, Xiao-Yan; Zhao, Yu; Mo, Bin; Mi, Hong-Xing			An Improved Experimental Method for Simulating Erosion Processes by Concentrated Channel Flow	PLOS ONE			English	Article							SOIL-EROSION; SEDIMENT TRANSPORT; RILL EROSION; SHEAR-STRESS; SLOPE; DETACHMENT; HYDRAULICS; MODEL; RATES; CATCHMENT	Rill erosion is an important process that occurs on hill slopes, including sloped farmland. Laboratory simulations have been vital to understanding rill erosion. Previous experiments obtained sediment yields using rills of various lengths to get the sedimentation process, which disrupted the continuity of the rill erosion process and was time-consuming. In this study, an improved experimental method was used to measure the rill erosion processes by concentrated channel flow. By using this method, a laboratory platform, 12 m long and 3 m wide, was used to construct rills of 0.1 m wide and 12 m long for experiments under five slope gradients (5, 10, 15, 20, and 25 degrees) and three flow rates (2, 4, and 8 L min(-1)). Sediment laden water was simultaneously sampled along the rill at locations 0.5 m, 1 m, 2 m, 3 m, 4 m, 5 m, 6 m, 7 m, 8 m, 10 m, and 12 m from the water inlet to determine the sediment concentration distribution. The rill erosion process measured by the method used in this study and that by previous experimental methods are approximately the same. The experimental data indicated that sediment concentrations increase with slope gradient and flow rate, which highlights the hydraulic impact on rill erosion. Sediment concentration increased rapidly at the initial section of the rill, and the rate of increase in sediment concentration reduced with the rill length. Overall, both experimental methods are feasible and applicable. However, the method proposed in this study is more efficient and easier to operate. This improved method will be useful in related research.	[Chen, Xiao-Yan; Zhao, Yu; Mo, Bin; Mi, Hong-Xing] Southwest Univ, Minist Educ, Key Lab Ecoenvironm Three Gorges Reg, Coll Resources & Environm, Chongqing, Peoples R China; [Chen, Xiao-Yan] Chinese Acad Sci, Inst Soil & Water Conservat, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Peoples R China; [Chen, Xiao-Yan] MWR, Yangling, Peoples R China	Southwest University - China; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Chinese Academy of Sciences	Chen, XY (corresponding author), Southwest Univ, Minist Educ, Key Lab Ecoenvironm Three Gorges Reg, Coll Resources & Environm, Chongqing, Peoples R China.	guangguang14@163.com			Foundation of State Key Laboratory of Soil Erosion and Dryland Farming on the Loess Plateau [K318009902-1312]	Foundation of State Key Laboratory of Soil Erosion and Dryland Farming on the Loess Plateau	The funding which supported this work is Foundation of State Key Laboratory of Soil Erosion and Dryland Farming on the Loess Plateau under project No. K318009902-1312 (http://english.iswc.cas.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksoy H, 2005, CATENA, V64, P247, DOI 10.1016/j.catena.2005.08.008; Aksoy H, 2013, HYDROLOG SCI J, V58, P1505, DOI 10.1080/02626667.2013.824085; Aksoy H, 2012, CATENA, V98, P63, DOI 10.1016/j.catena.2012.06.009; Bhattarai R, 2007, WATER RESOUR MANAG, V21, P1635, DOI 10.1007/s11269-006-9118-z; Ellison WD, 1949, SCI MON, V68, P241; FOSTER GR, 1984, T ASAE, V27, P797; FOSTER GR, 1984, T ASAE, V27, P790; FOSTER GR, 1981, T ASAE, V24, P1253, DOI 10.13031/2013.34429; Fox DM, 2000, CATENA, V38, P211, DOI 10.1016/S0341-8162(99)00072-7; GILLEY JE, 1993, J HYDROL, V142, P251, DOI 10.1016/0022-1694(93)90013-Y; Gimenez R, 2002, SOIL SCI SOC AM J, V66, P1475, DOI 10.2136/sssaj2002.1475; GOVERS G, 1986, EARTH SURF PROCESSES, V11, P515, DOI 10.1002/esp.3290110506; Huang C, 1998, SOIL SCI SOC AM J, V62, P423, DOI 10.2136/sssaj1998.03615995006200020019x; Kavvas ML, 2006, J HYDROL ENG, V11, P261, DOI 10.1061/(ASCE)1084-0699(2006)11:3(261); Kinnell PIA, 2000, SOIL SCI SOC AM J, V64, P1004, DOI 10.2136/sssaj2000.6431004x; Lei TW, 2006, EUR J SOIL SCI, V57, P287, DOI 10.1111/j.1365-2389.2005.00737.x; Lei T.W., 2000, J HYDRAUL ENG, V11, P49, DOI [10.13243/j.cnki.slxb.2000.11.008, DOI 10.13243/J.CNKI.SLXB.2000.11.008]; Lei TW, 1998, WATER RESOUR RES, V34, P3157, DOI 10.1029/98WR02162; Lei TW, 2002, T ASAE, V45, P1897; Lei TW, 2001, T ASAE, V44, P1537; Lei TW, 2009, PHYS BASED RILL EROS; Li M, 2006, APPL RADIAT ISOTOPES, V64, P402, DOI 10.1016/j.apradiso.2005.08.006; Li M, 2005, APPL RADIAT ISOTOPES, V62, P109, DOI 10.1016/j.apradiso.2004.06.005; Miao CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044659; Miao CY, 2011, GLOBAL PLANET CHANGE, V76, P196, DOI 10.1016/j.gloplacha.2011.01.008; Miao CY, 2010, PROG PHYS GEOG, V34, P541, DOI 10.1177/0309133310369434; Nearing MA, 1997, WATER RESOUR RES, V33, P865, DOI 10.1029/97WR00013; NEARING MA, 1989, T ASAE, V32, P1587; Polyakov VO, 2003, CATENA, V51, P33, DOI 10.1016/S0341-8162(02)00090-5; Porto P, 2013, HYDROL PROCESS, V27, P795, DOI 10.1002/hyp.9471; Schuller P, 2004, APPL RADIAT ISOTOPES, V60, P759, DOI 10.1016/j.apradiso.2003.11.087; Shi ZH, 2012, J HYDROL, V454, P123, DOI 10.1016/j.jhydrol.2012.06.004; Sirjani E, 2014, ARAB J GEOSCI, V7, P203, DOI 10.1007/s12517-012-0728-x; Sun LY, 2013, CHINESE GEOGR SCI, V23, P389, DOI 10.1007/s11769-013-0612-y; TISCARENOLOPEZ M, 1993, T ASAE, V36, P1659; Wirtz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064861; Yang DW, 2003, HYDROL PROCESS, V17, P2913, DOI 10.1002/hyp.1441; Zhang GH, 2009, SOIL SCI SOC AM J, V73, P1298, DOI 10.2136/sssaj2009.0074; Zhang XC, 2001, SOIL SCI SOC AM J, V65, P1508, DOI 10.2136/sssaj2001.6551508x; Zhu MY, 2011, J ENVIRON RADIOACTIV, V102, P1078, DOI 10.1016/j.jenvrad.2011.07.007	40	3	4	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e99660	10.1371/journal.pone.0099660	http://dx.doi.org/10.1371/journal.pone.0099660			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949621	Green Submitted, gold, Green Published			2022-12-27	WOS:000338276300016
J	Mayhoub, F; Berton, T; Bach, V; Tack, K; Deguines, C; Floch-Barneaud, A; Desmots, S; Stephan-Blanchard, E; Chardon, K				Mayhoub, Flora; Berton, Thierry; Bach, Veronique; Tack, Karine; Deguines, Caroline; Floch-Barneaud, Adeline; Desmots, Sophie; Stephan-Blanchard, Erwan; Chardon, Karen			Self-Reported Parental Exposure to Pesticide during Pregnancy and Birth Outcomes: The MecoExpo Cohort Study	PLOS ONE			English	Article							INTRAUTERINE GROWTH-RETARDATION; FETAL-GROWTH; WEIGHT; MORTALITY; ASSOCIATION; POPULATION; MORBIDITY; NEWBORNS; INFANTS; MOTHERS	The MecoExpo study was performed in the Picardy region of northern France, in order to investigate the putative relationship between parental exposures to pesticides (as reported by the mother) on one hand and neonatal parameters on the other. The cohort comprised 993 mother-newborn pairs. Each mother completed a questionnaire that probed occupational, domestic, environmental and dietary sources of parental exposure to pesticides during her pregnancy. Multivariate regression analyses were then used to test for associations between the characteristics of parental pesticide exposure during pregnancy and the corresponding birth outcomes. Maternal occupational exposure was associated with an elevated risk of low birth weight (odds ratio (OR) [95% confidence interval]: 4.2 [1.2, 15.4]). Paternal occupational exposure to pesticides was associated with a lower than average gestational age at birth (-0.7 weeks; p = 0.0002) and an elevated risk of prematurity (OR: 3.7 [1.4, 9.7]). Levels of domestic exposure to veterinary antiparasitics and to pesticides for indoor plants were both associated with a low birth weight (-70 g; p = 0.02 and -160 g; p = 0.005, respectively). Babies born to women living in urban areas had a lower birth length and a higher risk of low birth length (-0.4 cm, p = 0.006 and OR: 2.9 [1.5, 5.5], respectively). The present study results mainly demonstrate a negative correlation between fetal development on one hand and parental occupational and domestic exposure to pesticides on the other. Our study highlights the need to perform a global and detailed screening of all potential physiological effects when assessing in utero exposure to pesticides.	[Mayhoub, Flora; Berton, Thierry; Bach, Veronique; Deguines, Caroline; Floch-Barneaud, Adeline; Desmots, Sophie; Stephan-Blanchard, Erwan; Chardon, Karen] Univ Picardie Jules Verne, Unite Mixte Univ INERIS EA 4285 UMI 01, Lab PeriTox, Amiens, France; [Berton, Thierry; Tack, Karine] Inst Natl Environm Ind & Risques, Unite NOVA, Verneuil En Halatte, France; [Deguines, Caroline] Ctr Hosp Univ Amiens, Amiens, France; [Floch-Barneaud, Adeline] Inst Natl Environm Ind & Risques, Unite ISAE, Verneuil En Halatte, France; [Desmots, Sophie] Inst Natl Environm Ind & Risques, Unite TOXI, Verneuil En Halatte, France; [Mayhoub, Flora] Tishreen Univ, Fac Med, Latakia, Syria	Picardie Universites; Universite de Picardie Jules Verne (UPJV); Institut National de l'Environnement Industriel et des Risques (INERIS); Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Institut National de l'Environnement Industriel et des Risques (INERIS); Institut National de l'Environnement Industriel et des Risques (INERIS)	Chardon, K (corresponding author), Univ Picardie Jules Verne, Unite Mixte Univ INERIS EA 4285 UMI 01, Lab PeriTox, Amiens, France.	karen.chardon@u-picardie.fr	chardon, Karen/AAD-5837-2022; Bach, Veronique/AAD-5958-2022	Bach, Veronique/0000-0002-0684-0305; Stephan-Blanchard, Erwan/0000-0002-9427-4699	Picardy Regional Council; Tishreen University (Latakia, Syria); European Regional Development Fund	Picardy Regional Council(Region Hauts-de-France); Tishreen University (Latakia, Syria); European Regional Development Fund(European Commission)	This work was funded by the Picardy Regional Council. F. Mayhoub was funded by Tishreen University (Latakia, Syria) and T. Berton was funded by the European Regional Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Association des Utilisateurs de Dossiers Informatises en Pediatrie Obstetrique et Gynecologie, ET CROISS FOET INF; Bedos C, 2002, AGRONOMIE, V22, P21, DOI 10.1051/agro:2001003; Berkowitz GS, 2004, ENVIRON HEALTH PERSP, V112, P388, DOI 10.1289/ehp.6414; Brucker-Davis F, 2010, CHEMOSPHERE, V81, P169, DOI 10.1016/j.chemosphere.2010.06.068; Eskenazi B, 2004, ENVIRON HEALTH PERSP, V112, P1116, DOI 10.1289/ehp.6789; KRAMER MS, 1990, PEDIATRICS, V86, P707; Kristensen P, 1997, AM J EPIDEMIOL, V146, P329, DOI 10.1093/oxfordjournals.aje.a009274; Mamelle N, 2006, EUR J PEDIATR, V165, P717, DOI 10.1007/s00431-005-0045-4; MCCORMICK MC, 1985, NEW ENGL J MED, V312, P82, DOI 10.1056/NEJM198501103120204; McIntire DD, 1999, NEW ENGL J MED, V340, P1234, DOI 10.1056/NEJM199904223401603; Petit C, 2012, AM J EPIDEMIOL, V175, P1182, DOI 10.1093/aje/kwr422; Petit C, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-71; RESTREPO M, 1990, SCAND J WORK ENV HEA, V16, P232, DOI 10.5271/sjweh.1790; Sathyanarayana S, 2010, J AGROMEDICINE, V15, P127, DOI 10.1080/10599241003622699; SAVITZ DA, 1989, PUBLIC HEALTH REP, V104, P473; Strauss RS, 1997, J PEDIATR-US, V130, P95, DOI 10.1016/S0022-3476(97)70316-0; Whyatt RM, 2005, TOXICOL APPL PHARM, V206, P246, DOI 10.1016/j.taap.2004.11.027; Whyatt RM, 2003, ENVIRON HEALTH PERSP, V111, P749, DOI 10.1289/ehp.5768; Wohlfahrt-Veje C, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-79; Xiang HY, 2000, ENVIRON RES, V82, P160, DOI 10.1006/enrs.1999.4009; Yanney Michael, 2004, Semin Fetal Neonatal Med, V9, P411, DOI 10.1016/j.siny.2004.03.005	21	13	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e99090	10.1371/journal.pone.0099090	http://dx.doi.org/10.1371/journal.pone.0099090			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949871	gold, Green Published, Green Submitted			2022-12-27	WOS:000338276300010
J	Torres, MJ; Argandona, M; Vargas, C; Bedmar, EJ; Fischer, HM; Mesa, S; Delgado, MJ				Torres, Maria J.; Argandona, Montserrat; Vargas, Carmen; Bedmar, Eulogio J.; Fischer, Hans-Martin; Mesa, Socorro; Delgado, Maria J.			The Global Response Regulator RegR Controls Expression of Denitrification Genes in Bradyrhizobium japonicum	PLOS ONE			English	Article							2-COMPONENT SYSTEM; RNA-POLYMERASE; OXIDE REDUCTASE; NAPEDABC GENES; RESPIRATION; NIFA; IDENTIFICATION; CASCADE; NITRATE; SENSOR	Bradyrhizobium japonicum RegSR regulatory proteins belong to the family of two-component regulatory systems, and orthologs are present in many Proteobacteria where they globally control gene expression mostly in a redox-responsive manner. In this work, we have performed a transcriptional profiling of wild-type and regR mutant cells grown under anoxic denitrifying conditions. The comparative analyses of wild-type and regR strains revealed that almost 620 genes induced in the wild type under denitrifying conditions were regulated (directly or indirectly) by RegR, pointing out the important role of this protein as a global regulator of denitrification. Genes controlled by RegR included nor and nos structural genes encoding nitric oxide and nitrous oxide reductase, respectively, genes encoding electron transport proteins such as cycA (blr7544) or cy(2) (bll2388), and genes involved in nitric oxide detoxification (blr2806-09) and copper homeostasis (copCAB), as well as two regulatory genes (bll3466, bll4130). Purified RegR interacted with the promoters of norC (blr3214), nosR (blr0314), a fixK-like gene (bll3466), and bll4130, which encodes a LysR-type regulator. By using fluorescently labeled oligonucleotide extension (FLOE), we were able to identify two transcriptional start sites located at about 35 (P1) and 22 (P2) bp upstream of the putative translational start codon of norC. P1 matched with the previously mapped 5' end of norC mRNA which we demonstrate in this work to be under FixK2 control. P2 is a start site modulated by RegR and specific for anoxic conditions. Moreover, qRT-PCR experiments, expression studies with a norC-lacZ fusion, and heme c-staining analyses revealed that anoxia and nitrate are required for RegR-dependent induction of nor genes, and that this control is independent of the sensor protein RegS.	[Torres, Maria J.; Bedmar, Eulogio J.; Mesa, Socorro; Delgado, Maria J.] CSIC, Estn Expt Zaidin, Granada, Spain; [Argandona, Montserrat; Vargas, Carmen] Univ Seville, Dept Microbiol & Parasitol, Seville, Spain; [Fischer, Hans-Martin] ETH, Inst Microbiol, CH-8092 Zurich, Switzerland	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ); University of Sevilla; Swiss Federal Institutes of Technology Domain; ETH Zurich	Delgado, MJ (corresponding author), CSIC, Estn Expt Zaidin, Granada, Spain.	mdelgado@eez.csic.es	Vargas, Carmen/A-6283-2018; Torres, María J./X-7746-2018; Argandoña, Montserrat/H-5531-2015; Mesa, Socorro/G-7775-2015; Delgado, Maria J/F-2683-2017; Rojas, Cristian/X-1027-2018	Vargas, Carmen/0000-0002-4094-4319; Torres, María J./0000-0003-0706-7833; Mesa, Socorro/0000-0001-7285-3940; Delgado, Maria J/0000-0003-2410-9484; Vandepoele, Klaas/0000-0003-4790-2725; Rojas, Cristian/0000-0002-9085-6261; Argandona, Montserrat/0000-0002-2635-1023; Van Bel, Michiel/0000-0002-1873-2563	Fondo Europeo de Desarrollo Regional (FEDER), Ministerio de Economia y Competitividad (Spain) [AGL2010-18607, AGL2011-23383, BIO2011-22833]; Spanish National Network on Extremophilic Microorganisms [BIO2011-12879-E]; Junta de Andalucia [BIO-275, CVI-7293]; Consejo Superior de Investigaciones Cientificas I3P Programme; ETH Zurich; Functional Genomics Centre of ETH Zurich; University of Zurich (FGCZ)	Fondo Europeo de Desarrollo Regional (FEDER), Ministerio de Economia y Competitividad (Spain); Spanish National Network on Extremophilic Microorganisms; Junta de Andalucia(Junta de Andalucia); Consejo Superior de Investigaciones Cientificas I3P Programme; ETH Zurich(ETH Zurich); Functional Genomics Centre of ETH Zurich; University of Zurich (FGCZ)	Support was provided by Fondo Europeo de Desarrollo Regional (FEDER)-cofinanced grants AGL2010-18607, AGL2011-23383 and BIO2011-22833 from Ministerio de Economia y Competitividad (Spain) (to MJD CV SM); Spanish National Network on Extremophilic Microorganisms (BIO2011-12879-E) (to CV); Junta de Andalucia to Group BIO-275 and CVI-7293 (to EJB CV); Consejo Superior de Investigaciones Cientificas I3P Programme (to MJT); Grants from ETH Zurich and Functional Genomics Centre of ETH Zurich and University of Zurich (FGCZ) (to H-MF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdou E, 2013, INFECT IMMUN, V81, P2053, DOI 10.1128/IAI.00063-13; Babst M, 1996, MOL MICROBIOL, V19, P827, DOI 10.1046/j.1365-2958.1996.438968.x; Baek SH, 2008, J BACTERIOL, V190, P78, DOI 10.1128/JB.00792-07; BARRIOS H, 1995, J BACTERIOL, V177, P1760, DOI 10.1128/jb.177.7.1760-1765.1995; Barrios H, 1998, P NATL ACAD SCI USA, V95, P1014, DOI 10.1073/pnas.95.3.1014; Bauer E, 1998, J BACTERIOL, V180, P3853, DOI 10.1128/JB.180.15.3853-3863.1998; Bedmar EJ, 2005, BIOCHEM SOC T, V33, P141, DOI 10.1042/BST0330141; Bergersen F.J., 1977, BIOLOGY, P519; Blanco AG, 2012, BIOL CHEM, V393, P1165, DOI 10.1515/hsz-2012-0230; Bothe H, 2007, BIOLOGY OF THE NITROGEN CYCLE, P1; Bueno Emilio, 2008, FEMS Microbiol Lett, V279, P188, DOI 10.1111/j.1574-6968.2007.01034.x; Bueno E, 2012, ANTIOXID REDOX SIGN, V16, P819, DOI 10.1089/ars.2011.4051; Bueno E, 2010, ENVIRON MICROBIOL, V12, P393, DOI 10.1111/j.1462-2920.2009.02076.x; Cabrera JJ, 2011, BIOCHEM SOC T, V39, P1880, DOI 10.1042/BST20110732; Comolli JC, 2002, MOL MICROBIOL, V45, P755, DOI 10.1046/j.1365-2958.2002.03046.x; DANIEL RM, 1972, BIOCHIM BIOPHYS ACTA, V275, P347, DOI 10.1016/0005-2728(72)90215-0; Carrica MD, 2013, MOL MICROBIOL, V88, P222, DOI 10.1111/mmi.12181; Carrica MD, 2012, MOL MICROBIOL, V85, P39, DOI 10.1111/j.1365-2958.2012.08095.x; Delgado MJ, 2007, BIOLOGY OF THE NITROGEN CYCLE, P83, DOI 10.1016/B978-044452857-5.50007-2; Delgado MJ, 1998, ADV MICROB PHYSIOL, V40, P191, DOI 10.1016/S0065-2911(08)60132-0; Delgado MJ, 2003, MICROBIOL-SGM, V149, P3395, DOI 10.1099/mic.0.26620-0; Dixon R, 2004, NAT REV MICROBIOL, V2, P621, DOI 10.1038/nrmicro954; Emmerich R, 1999, EUR J BIOCHEM, V263, P455, DOI 10.1046/j.1432-1327.1999.00517.x; Fekete RA, 2003, BIOTECHNIQUES, V35, P90, DOI 10.2144/03351rr01; FISCHER HM, 1994, MICROBIOL REV, V58, P352, DOI 10.1128/MMBR.58.3.352-386.1994; Gourion B, 2009, MOL MICROBIOL, V73, P291, DOI 10.1111/j.1365-2958.2009.06769.x; Hauser F, 2006, MOL GENET GENOMICS, V275, P55, DOI 10.1007/s00438-005-0059-7; Hauser F, 2007, MOL GENET GENOMICS, V278, P255, DOI 10.1007/s00438-007-0246-9; Hernandez-Montes G, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-249; Kaneko T, 2002, DNA RES, V9, P189, DOI 10.1093/dnares/9.6.189; Kommineni S, 2010, MOL MICROBIOL, V78, P1280, DOI 10.1111/j.1365-2958.2010.07407.x; Kraft B, 2011, J BIOTECHNOL, V155, P104, DOI 10.1016/j.jbiotec.2010.12.025; KULLIK I, 1991, J BACTERIOL, V173, P1125, DOI 10.1128/jb.173.3.1125-1138.1991; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Laratta WP, 2002, J BACTERIOL, V184, P3521, DOI 10.1128/JB.184.13.3521-3529.2002; Lindemann A, 2007, J BACTERIOL, V189, P8928, DOI 10.1128/JB.01088-07; Lindemann A, 2010, FEMS MICROBIOL LETT, V312, P184, DOI 10.1111/j.1574-6968.2010.02115.x; Mesa S, 2005, J BACTERIOL, V187, P3329, DOI 10.1128/JB.187.10.3329-3338.2005; Mesa S, 2003, J BACTERIOL, V185, P3978, DOI 10.1128/JB.185.13.3978-3982.2003; Mesa S, 2002, MICROBIOL-SGM, V148, P3553, DOI 10.1099/00221287-148-11-3553; Mesa S, 2008, J BACTERIOL, V190, P6568, DOI 10.1128/JB.00748-08; MOSLEY CS, 1994, J BACTERIOL, V176, P7566, DOI 10.1128/JB.176.24.7566-7573.1994; Nellen-Anthamatten D, 1998, J BACTERIOL, V180, P5251, DOI 10.1128/JB.180.19.5251-5255.1998; Nienaber A, 2000, J BACTERIOL, V182, P1472, DOI 10.1128/JB.182.6.1472-1480.2000; Pessi G, 2007, MOL PLANT MICROBE IN, V20, P1353, DOI 10.1094/MPMI-20-11-1353; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; REGENSBURGER B, 1983, ARCH MICROBIOL, V135, P103, DOI 10.1007/BF00408017; Reutimann L, 2010, MOL GENET GENOMICS, V284, P25, DOI 10.1007/s00438-010-0547-2; Richardson D, 2011, NITROGEN CYCLING IN BACTERIA: MOLECULAR ANALYSIS, P23; Robles EF, 2006, BIOCHEM SOC T, V34, P108, DOI 10.1042/BST0340108; Rodionov DA, 2005, PLOS COMPUT BIOL, V1, P415, DOI 10.1371/journal.pcbi.0010055; Roop RM, 2012, MOL MICROBIOL, V85, P5, DOI 10.1111/j.1365-2958.2012.08096.x; Sanchez C, 2011, NITROGEN CYCLING IN BACTERIA: MOLECULAR ANALYSIS, P197; Sciotti MA, 2003, J BACTERIOL, V185, P5639, DOI 10.1128/JB.185.18.5639-5642.2003; Simon J, 2008, BBA-BIOENERGETICS, V1777, P1480, DOI 10.1016/j.bbabio.2008.09.008; Simon R., 1983, MOL GENETICS BACTERI, V1st ed., P98; Swem LR, 2006, J BIOL CHEM, V281, P6768, DOI 10.1074/jbc.M509687200; Swem LR, 2003, EMBO J, V22, P4699, DOI 10.1093/emboj/cdg461; Torres MJ, 2011, BIOCHEM SOC T, V39, P284, DOI 10.1042/BST0390284; VARGAS C, 1993, ANAL BIOCHEM, V209, P323, DOI 10.1006/abio.1993.1127; Velasco L, 2004, ANTON LEEUW INT J G, V85, P229, DOI 10.1023/B:ANTO.0000020156.42470.db; Velasco L, 2001, BBA-GENE STRUCT EXPR, V1521, P130, DOI 10.1016/S0167-4781(01)00279-2; Wu J, 2008, ADV EXP MED BIOL, V631, P131, DOI 10.1007/978-0-387-78885-2_9; Wu J, 2013, J BIOL CHEM, V288, P4755, DOI 10.1074/jbc.M112.413492; Wu JA, 2010, MBIO, V1, DOI 10.1128/mBio.00272-10; Zhang X, 2000, MOD ASP IMMUNOBIOL, V1, P160; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	67	65	66	5	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e99011	10.1371/journal.pone.0099011	http://dx.doi.org/10.1371/journal.pone.0099011			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949739	Green Published, gold			2022-12-27	WOS:000338276300009
J	Warrier, I; Hicks, LD; Battisti, JM; Raghavan, R; Minnick, MF				Warrier, Indu; Hicks, Linda D.; Battisti, James M.; Raghavan, Rahul; Minnick, Michael F.			Identification of Novel Small RNAs and Characterization of the 65 RNA of Coxiella burnetii	PLOS ONE			English	Article							SMALL NONCODING RNAS; 6S RNA; ESCHERICHIA-COLI; LISTERIA-MONOCYTOGENES; REGULATORY RNAS; VIBRIO-CHOLERAE; CHAPERONE HFQ; HOST-CELL; PHASE-II; Q-FEVER	Coxiella bumetii, an obligate intracellular bacterial pathogen that causes Q fever, undergoes a biphasic developmental cycle that alternates between a metabolically-active large cell variant (L(V) and a dormant small cell variant (S(V). As such, the bacterium undoubtedly employs complex modes of regulating its lifecycle, metabolism and pathogenesis. Small RNAs (sRNAs) have been shown to play important regulatory roles in controlling metabolism and virulence in several pathogenic bacteria. We hypothesize that sRNAs are involved in regulating growth and development of C. bumetii and its infection of host cells. To address the hypothesis and identify potential sRNAs, we subjected total RNA isolated from Coxiella cultured axenically and in Vero host cells to deep-sequencing. Using this approach, we identified fifteen novel C. bumetii sRNAs (CbSRs). Fourteen CbSRs were validated by Northern blotting. Most CbSRs showed differential expression, with increased levels in LCVs. Eight CbSRs were upregulated (>= 2-fold) during intracellular growth as compared to growth in axenic medium. Along with the fifteen sRNAs, we also identified three sRNAs that have been previously described from other bacteria, including RNase P RNA, tmRNA and 6S RNA. The 6S regulatory sRNA of C. bumetii was found to accumulate over log phase-growth with a maximum level attained in the SCV stage. The 6S RNA-encoding gene (ssrS) was mapped to the 5' UTR of ygfA; a highly conserved linkage in eubacteria. The predicted secondary structure of the 6S RNA possesses three highly conserved domains found in 6S RNAs of other eubacteria. We also demonstrate that Coxiella's 6S RNA interacts with RNA polymerase (RNAP) in a specific manner. Finally, transcript levels of 65 RNA were found to be at much higher levels when Coxiella was grown in host cells relative to axenic culture, indicating a potential role in regulating the bacterium's intracellular stress response by interacting with RNAP during transcription.	[Warrier, Indu; Hicks, Linda D.; Battisti, James M.; Minnick, Michael F.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Raghavan, Rahul] Portland State Univ, Dept Biol, Portland, OR 97207 USA	University of Montana System; University of Montana; Portland State University	Minnick, MF (corresponding author), Univ Montana, Div Biol Sci, Missoula, MT 59812 USA.	mike.minnick@mso.umt.edu		Minnick, Michael/0000-0002-1131-7930	National Institutes of Health [R15 AI103511]; Portland State University; Collins Medical Trust; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Portland State University; Collins Medical Trust; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by grants from the National Institutes of Health (R15 AI103511) to J.M.B, from Portland State University and Collins Medical Trust to R.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argaman L, 2001, CURR BIOL, V11, P941, DOI 10.1016/S0960-9822(01)00270-6; Barrick JE, 2005, RNA, V11, P774, DOI 10.1261/rna.7286705; Cavanagh AT, 2010, MICROBIOL-SGM, V156, P3791, DOI 10.1099/mic.0.043992-0; Christiansen JK, 2004, J BACTERIOL, V186, P3355, DOI 10.1128/JB.186.11.3355-3362.2004; Cockrell DC, 2008, J MICROBIOL METH, V72, P321, DOI 10.1016/j.mimet.2007.12.015; Coleman SA, 2004, J BACTERIOL, V186, P7344, DOI 10.1128/JB.186.21.7344-7352.2004; Faucher SP, 2010, P NATL ACAD SCI USA, V107, P7533, DOI 10.1073/pnas.0911764107; Gildehaus N, 2007, NUCLEIC ACIDS RES, V35, P1885, DOI 10.1093/nar/gkm085; Gong H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002120; HINDLEY J, 1967, J MOL BIOL, V30, P125, DOI 10.1016/0022-2836(67)90248-3; Kazantsev AV, 2006, NAT REV MICROBIOL, V4, P729, DOI 10.1038/nrmicro1491; Kingsford CL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r22; Klocko AD, 2009, MOL MICROBIOL, V73, P152, DOI 10.1111/j.1365-2958.2009.06758.x; Koo JT, 2011, P NATL ACAD SCI USA, V108, pE709, DOI 10.1073/pnas.1101655108; Lenz DH, 2004, CELL, V118, P69, DOI 10.1016/j.cell.2004.06.009; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Liu JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp080; Lybecker MC, 2010, MOL MICROBIOL, V78, P622, DOI 10.1111/j.1365-2958.2010.07374.x; Mandin P, 2007, NUCLEIC ACIDS RES, V35, P962, DOI 10.1093/nar/gkl1096; Mandin P, 2010, EMBO J, V29, P3094, DOI 10.1038/emboj.2010.179; Mann B, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002788; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; MCCAUL TF, 1981, J BACTERIOL, V147, P1063, DOI 10.1128/JB.147.3.1063-1076.1981; Moore SD, 2007, ANNU REV BIOCHEM, V76, P101, DOI 10.1146/annurev.biochem.75.103004.142733; Mraheil MA, 2011, NUCLEIC ACIDS RES, V39, P4235, DOI 10.1093/nar/gkr033; Omsland A, 2009, P NATL ACAD SCI USA, V106, P4430, DOI 10.1073/pnas.0812074106; Padalon-Brauch G, 2008, NUCLEIC ACIDS RES, V36, P1913, DOI 10.1093/nar/gkn050; Pall GS, 2008, NAT PROTOC, V3, P1077, DOI 10.1038/nprot.2008.67; Papenfort K, 2010, CELL HOST MICROBE, V8, P116, DOI 10.1016/j.chom.2010.06.008; Raghavan R, 2008, J BACTERIOL, V190, P5934, DOI 10.1128/JB.00602-08; Raghavan R, 2011, GENOME RES, V21, P1487, DOI 10.1101/gr.119370.110; Romano PS, 2007, CELL MICROBIOL, V9, P891, DOI 10.1111/j.1462-5822.2006.00838.x; Romby P, 2006, CURR OPIN MICROBIOL, V9, P229, DOI 10.1016/j.mib.2006.02.005; Romby P, 2010, CELL MOL LIFE SCI, V67, P217, DOI 10.1007/s00018-009-0162-8; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sahr T, 2012, RNA BIOL, V9, P503, DOI 10.4161/rna.20270; Sandoz KM, 2014, J MICROBIOL METH, V96, P104, DOI 10.1016/j.mimet.2013.11.010; Sato K, 2009, NUCLEIC ACIDS RES, V37, pW277, DOI 10.1093/nar/gkp367; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seshadri R, 2001, INFECT IMMUN, V69, P4874, DOI 10.1128/IAI.69.8.4874-4883.2001; Solovyev V., 2011, AUTOMATIC ANNOTATION; Sonnleitner E, 2003, MICROB PATHOGENESIS, V35, P217, DOI 10.1016/S0882-4010(03)00149-9; Tesorero RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064021; Tjaden B, 2008, NUCLEIC ACIDS RES, V36, pW109, DOI 10.1093/nar/gkn264; Toledo-Arana A, 2007, CURR OPIN MICROBIOL, V10, P182, DOI 10.1016/j.mib.2007.03.004; Trotochaud AE, 2005, NAT STRUCT MOL BIOL, V12, P313, DOI 10.1038/nsmb917; Trotochaud AE, 2004, J BACTERIOL, V186, P4978, DOI 10.1128/JB.186.15.4978-4985.2004; Verstraeten N, 2011, MICROBIOL MOL BIOL R, V75, P507, DOI 10.1128/MMBR.00009-11; Vogel J, 2003, NUCLEIC ACIDS RES, V31, P6435, DOI 10.1093/nar/gkg867; Vogel J, 2007, CURR OPIN MICROBIOL, V10, P262, DOI 10.1016/j.mib.2007.06.001; Wassarman KM, 2007, MOL MICROBIOL, V65, P1425, DOI 10.1111/j.1365-2958.2007.05894.x; Wassarman KM, 2000, CELL, V101, P613, DOI 10.1016/S0092-8674(00)80873-9; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Weissenmayer BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017570; WILLIAMS JC, 1981, INFECT IMMUN, V32, P840, DOI 10.1128/IAI.32.2.840-851.1981; Yan YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074495	56	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100147	10.1371/journal.pone.0100147	http://dx.doi.org/10.1371/journal.pone.0100147			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949863	Green Published, gold, Green Submitted			2022-12-27	WOS:000338276300042
J	Zyryanova, T; Schneider, R; Adams, V; Sittig, D; Kerner, C; Gebhardt, C; Ruffert, H; Glasmacher, S; Hepp, P; Punkt, K; Neuhaus, J; Hamann, J; Aust, G				Zyryanova, Tatiana; Schneider, Rick; Adams, Volker; Sittig, Doreen; Kerner, Christiane; Gebhardt, Claudia; Ruffert, Henrik; Glasmacher, Stefan; Hepp, Pierre; Punkt, Karla; Neuhaus, Jochen; Hamann, Jorg; Aust, Gabriela			Skeletal Muscle Expression of the Adhesion-GPCR CD97: CD97 Deletion Induces an Abnormal Structure of the Sarcoplasmatic Reticulum but Does Not Impair Skeletal Muscle Function	PLOS ONE			English	Article							RECEPTOR CD97; CHONDROITIN SULFATE; LIGAND CD55; CELLS; GENE; RHABDOMYOSARCOMAS; LEUKOCYTES; INHIBITION; DOMAINS; ANTIGEN	CD97 is a widely expressed adhesion class G-protein-coupled receptor (aGPCR). Here, we investigated the presence of CD97 in normal and malignant human skeletal muscle as well as the ultrastructural and functional consequences of CD97 deficiency in mice. In normal human skeletal muscle, CD97 was expressed at the peripheral sarcolemma of all myofibers, as revealed by immunostaining of tissue sections and surface labeling of single myocytes using flow cytometry. In muscle cross-sections, an intracellular polygonal, honeycomb-like CD97-staining pattern, typical for molecules located in the T-tubule or sarcoplasmatic reticulum (SR), was additionally found. CD97 co-localized with SR Ca2+-ATPase (SERCA), a constituent of the longitudinal SR, but not with the receptors for dihydropyridine (DHPR) or ryanodine (RYR), located in the T-tubule and terminal SR, respectively. Intracellular expression of CD97 was higher in slow-twitch compared to most fast-twitch myofibers. In rhabdomyosarcomas, CD97 was strongly upregulated and in part more N-glycosylated compared to normal skeletal muscle. All tumors were strongly CD97-positive, independent of the underlying histological subtype, suggesting high sensitivity of CD97 for this tumor. Ultrastructural analysis of murine skeletal myofibers confirmed the location of CD97 in the SR. CD97 knock-out mice had a dilated SR, resulting in a partial increase in triad diameter yet not affecting the T-tubule, sarcomeric, and mitochondrial structure. Despite these obvious ultrastructural changes, intracellular Ca2+ release from single myofibers, force generation and fatigability of isolated soleus muscles, and wheel-running capacity of mice were not affected by the lack of CD97. We conclude that CD97 is located in the SR and at the peripheral sarcolemma of human and murine skeletal muscle, where its absence affects the structure of the SR without impairing skeletal muscle function.	[Zyryanova, Tatiana; Schneider, Rick; Sittig, Doreen; Kerner, Christiane; Gebhardt, Claudia; Aust, Gabriela] Univ Leipzig, Res Labs, Dept Surg, D-04109 Leipzig, Germany; [Adams, Volker] Univ Leipzig, Heart Ctr Leipzig, D-04109 Leipzig, Germany; [Ruffert, Henrik] Univ Leipzig, Dept Anaesthesiol & Intens Care Med, D-04109 Leipzig, Germany; [Glasmacher, Stefan; Hepp, Pierre] Univ Leipzig, Clin Trauma & Reconstruct Surg, D-04109 Leipzig, Germany; [Punkt, Karla] Univ Leipzig, Inst Anat, D-04109 Leipzig, Germany; [Neuhaus, Jochen] Univ Leipzig, Urol Clin, Res Labs, D-04109 Leipzig, Germany; [Hamann, Jorg] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, NL-1105 AZ Amsterdam, Netherlands	Leipzig University; Heart Center Leipzig GMBH; Leipzig University; Leipzig University; Leipzig University; Leipzig University; Leipzig University; University of Amsterdam; Academic Medical Center Amsterdam	Aust, G (corresponding author), Univ Leipzig, Res Labs, Dept Surg, D-04109 Leipzig, Germany.	gabriela.aust@medizin.uni-leipzig.de		Hamann, Jorg/0000-0002-9448-1727	German Academic Exchange Service (DAAD) [A /10/76169]	German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	T.Z. received a 6-months research scholarship from the German Academic Exchange Service (DAAD, grant A /10/76169). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arac D, 2012, EMBO J, V31, P1364, DOI 10.1038/emboj.2012.26; Aust G, 2006, CELL TISSUE RES, V324, P139, DOI 10.1007/s00441-005-0103-2; Aust G, 1997, CANCER RES, V57, P1798; Becker S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008507; Bottinelli R, 2000, PROG BIOPHYS MOL BIO, V73, P195, DOI 10.1016/S0079-6107(00)00006-7; Calderon JC, 2009, J MUSCLE RES CELL M, V30, P125, DOI 10.1007/s10974-009-9181-1; Cerletti M, 2006, J CELL SCI, V119, P3117, DOI 10.1242/jcs.03056; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; EICHLER W, 1994, SCAND J IMMUNOL, V39, P111, DOI 10.1111/j.1365-3083.1994.tb03348.x; Galle J, 2006, AM J PATHOL, V169, P1802, DOI 10.2353/ajpath.2006.060006; Grange RW, 2002, AM J PHYSIOL-CELL PH, V283, pC1090, DOI 10.1152/ajpcell.00450.2001; Gray JX, 1996, J IMMUNOL, V157, P5438; Hamann J, 1999, ARTHRITIS RHEUM-US, V42, P650, DOI 10.1002/1529-0131(199904)42:4<650::AID-ANR7>3.0.CO;2-S; Hamann J, 1996, J EXP MED, V184, P1185, DOI 10.1084/jem.184.3.1185; Hamann J, 2000, INT IMMUNOL, V12, P439, DOI 10.1093/intimm/12.4.439; Hamann J, 1997, LEUCOCYTE TYPING, P527; Hochreiter-Hufford AE, 2013, NATURE, V497, P263, DOI 10.1038/nature12135; Hsiao CC, 2009, FEBS LETT, V583, P3285, DOI 10.1016/j.febslet.2009.09.001; Jaspars LH, 2001, TISSUE ANTIGENS, V57, P325, DOI 10.1034/j.1399-0039.2001.057004325.x; Juretic N, 2007, J CELL PHYSIOL, V210, P819, DOI 10.1002/jcp.20902; Karpus ON, 2013, J IMMUNOL, V190, P3740, DOI 10.4049/jimmunol.1202192; Keire Paul, 2013, Methods Mol Biol, V946, P431, DOI 10.1007/978-1-62703-128-8_28; Kwakkenbos MJ, 2005, J LEUKOCYTE BIOL, V77, P112, DOI 10.1189/jlb.0704402; Kwakkenbos MJ, 2001, LEUCOCYTE TYPING, P381; Langenhan T, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003825; Leemans JC, 2004, J IMMUNOL, V172, P1125, DOI 10.4049/jimmunol.172.2.1125; Lin HH, 2004, J BIOL CHEM, V279, P31823, DOI 10.1074/jbc.M402974200; PARHAM DM, 1991, CANCER-AM CANCER SOC, V67, P3072, DOI 10.1002/1097-0142(19910615)67:12<3072::AID-CNCR2820671223>3.0.CO;2-Z; Pickl W.F., 1995, LEUCOCYTE TYPING, P1151; Poelkens F, 2013, EXP PHYSIOL, V98, P1485, DOI 10.1113/expphysiol.2013.072710; Punkt K, 2006, HISTOCHEM CELL BIOL, V125, P567, DOI 10.1007/s00418-005-0108-7; Punkt Karla, 2002, Adv Anat Embryol Cell Biol, V162, pIII; Rossi AE, 2006, MUSCLE NERVE, V33, P715, DOI 10.1002/mus.20512; SCHMIDT RA, 1988, AM J PATHOL, V131, P19; Shaw MA, 2003, BIOCHEMISTRY-US, V42, P6128, DOI 10.1021/bi026964f; Sjaland C, 2011, J PHYSIOL-LONDON, V589, P6139, DOI 10.1113/jphysiol.2011.211987; Stacey M, 2003, BLOOD, V102, P2916, DOI 10.1182/blood-2002-11-3540; Steinert M, 2002, AM J PATHOL, V161, P1657, DOI 10.1016/S0002-9440(10)64443-4; Veninga H, 2008, J IMMUNOL, V181, P6574, DOI 10.4049/jimmunol.181.9.6574; Wandel E, 2012, J IMMUNOL, V188, P1442, DOI 10.4049/jimmunol.1003944; Wang T, 2005, BLOOD, V105, P2836, DOI 10.1182/blood-2004-07-2878; Wehner M, 2002, CLIN GENET, V62, P135, DOI 10.1034/j.1399-0004.2002.620206.x; Weibel E R, 1969, Int Rev Cytol, V26, P235, DOI 10.1016/S0074-7696(08)61637-X; Wetzel P, 1998, ARCH BIOCHEM BIOPHYS, V356, P151, DOI 10.1006/abbi.1998.0762; Wobus M, 2004, INT J CANCER, V112, P815, DOI 10.1002/ijc.20483; Wu MP, 2013, FEBS J, V280, P6097, DOI 10.1111/febs.12529; Yona S, 2008, TRENDS BIOCHEM SCI, V33, P491, DOI 10.1016/j.tibs.2008.07.005; Yoshida M, 2005, J BIOL CHEM, V280, P3500, DOI 10.1074/jbc.M406618200	48	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100513	10.1371/journal.pone.0100513	http://dx.doi.org/10.1371/journal.pone.0100513			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949957	Green Published, Green Submitted, gold			2022-12-27	WOS:000338276300083
J	Natarajan, R; Singal, V; Benes, R; Gao, JL; Chan, H; Chen, HJ; Yu, YJ; Zhou, J; Wu, P				Natarajan, Rajalaxmi; Singal, Vinamrata; Benes, Richard; Gao, Junling; Chan, Hoi; Chen, Haijun; Yu, Yongjia; Zhou, Jia; Wu, Ping			STAT3 Modulation to Enhance Motor Neuron Differentiation in Human Neural Stem Cells	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FIBROBLAST-GROWTH-FACTOR; SMALL-MOLECULE INHIBITOR; SPINAL-CORD-INJURY; ASTROCYTE DIFFERENTIATION; PROMOTES NEUROGENESIS; REACTIVE ASTROCYTES; SIGNALING PATHWAY; FETAL BRAIN; ACTIVATION	Spinal cord injury or amyotrophic lateral sclerosis damages spinal motor neurons and forms a glial scar, which prevents neural regeneration. Signal transducer and activator of transcription 3 (STAT3) plays a critical role in astrogliogenesis and scar formation, and thus a fine modulation of STAT3 signaling may help to control the excessive gliogenic environment and enhance neural repair. The objective of this study was to determine the effect of STAT3 inhibition on human neural stem cells (hNSCs). In vitro hNSCs primed with fibroblast growth factor 2 (FGF2) exhibited a lower level of phosphorylated STAT3 than cells primed by epidermal growth factor (EGF), which correlated with a higher number of motor neurons differentiated from FGF2-primed hNSCs. Treatment with STAT3 inhibitors, Stattic and Niclosamide, enhanced motor neuron differentiation only in FGF2-primed hNSCs, as shown by increased homeobox gene Hb9 mRNA levels as well as HB9(+) and microtubule-associated protein 2 (MAP2)(+) co-labeled cells. The increased motor neuron differentiation was accompanied by a decrease in the number of glial fibrillary acidic protein (GFAP)-positive astrocytes. Interestingly, Stattic and Niclosamide did not affect the level of STAT3 phosphorylation; rather, they perturbed the nuclear translocation of phosphorylated STAT3. In summary, we demonstrate that FGF2 is required for motor neuron differentiation from hNSCs and that inhibition of STAT3 further increases motor neuron differentiation at the expense of astrogliogenesis. Our study thus suggests a potential benefit of targeting the STAT3 pathway for neurotrauma or neurodegenerative diseases.	[Natarajan, Rajalaxmi; Singal, Vinamrata; Benes, Richard; Gao, Junling; Chan, Hoi; Wu, Ping] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA; [Chen, Haijun; Zhou, Jia] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA; [Yu, Yongjia] Univ Texas Med Branch, Dept Radiat Oncol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Wu, P (corresponding author), Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA.	piwu@utmb.edu			John S. Dunn Research Foundation; TIRR Foundation Mission Connect; Gillson Longenbaugh Foundation; Moody Foundation	John S. Dunn Research Foundation; TIRR Foundation Mission Connect; Gillson Longenbaugh Foundation; Moody Foundation	This study is supported by John S. Dunn Research Foundation, TIRR Foundation Mission Connect, Gillson Longenbaugh Foundation, and Moody Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Cao F, 2010, BIOCHEM BIOPH RES CO, V394, P843, DOI 10.1016/j.bbrc.2010.03.092; Chen HJ, 2013, EUR J MED CHEM, V62, P498, DOI 10.1016/j.ejmech.2013.01.023; Chen HJ, 2013, ACS MED CHEM LETT, V4, P180, DOI 10.1021/ml3003082; Cheng PY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022018; Diaz-Amarilla P, 2011, P NATL ACAD SCI USA, V108, P18126, DOI 10.1073/pnas.1110689108; Dominguez E, 2008, J NEUROCHEM, V107, P50, DOI 10.1111/j.1471-4159.2008.05566.x; Fukuda S, 2007, MOL CELL BIOL, V27, P4931, DOI 10.1128/MCB.02435-06; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; Gritti A, 1996, J NEUROSCI, V16, P1091; Gu F, 2005, J NEUROSCI RES, V81, P163, DOI 10.1002/jnr.20561; Haidet-Phillips AM, 2011, NAT BIOTECHNOL, V29, P824, DOI 10.1038/nbt.1957; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; Jordan PM, 2009, J NEUROSCI RES, V87, P318, DOI 10.1002/jnr.21856; Kamakura S, 2004, NAT CELL BIOL, V6, P547, DOI 10.1038/ncb1138; Lee S, 2013, P NATL ACAD SCI USA, V110, P11445, DOI 10.1073/pnas.1302676110; Liu L, 2005, P NATL ACAD SCI USA, V102, P8150, DOI 10.1073/pnas.0501643102; Ojeda L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023414; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Qiu J, 2005, J NEUROSCI, V25, P1645, DOI 10.1523/JNEUROSCI.3269-04.2005; Rai KS, 2007, EUR J NEUROSCI, V26, P1765, DOI 10.1111/j.1460-9568.2007.05820.x; Rajan P, 2003, J CELL BIOL, V161, P911, DOI 10.1083/jcb.200211021; Rajan P, 1998, J NEUROSCI, V18, P3620; Ren XM, 2010, ACS MED CHEM LETT, V1, P454, DOI 10.1021/ml100146z; Schubert KO, 2005, EXP BRAIN RES, V165, P520, DOI 10.1007/s00221-005-2330-x; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Shibata N, 2010, NEUROPATHOLOGY, V30, P353, DOI 10.1111/j.1440-1789.2009.01078.x; Shibata N, 2009, NEURODEGENER DIS, V6, P118, DOI 10.1159/000213762; Song MR, 2004, NAT NEUROSCI, V7, P229, DOI 10.1038/nn1192; Takizawa T, 2001, DEV CELL, V1, P749, DOI 10.1016/S1534-5807(01)00101-0; Tao Y, 1996, J COMP NEUROL, V376, P653, DOI 10.1002/(SICI)1096-9861(19961223)376:4<653::AID-CNE11>3.0.CO;2-N; Tsuda M, 2011, BRAIN, V134, P1127, DOI 10.1093/brain/awr025; Walker Sarah R, 2012, JAKSTAT, V1, P292, DOI 10.4161/jkst.22662; Werner S, 2011, J NEUROSCI RES, V89, P1605, DOI 10.1002/jnr.22680; Wu P, 2002, NAT NEUROSCI, V5, P1271, DOI 10.1038/nn974; Yamauchi K, 2006, J NEUROCHEM, V96, P1060, DOI 10.1111/j.1471-4159.2005.03559.x	37	21	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100405	10.1371/journal.pone.0100405	http://dx.doi.org/10.1371/journal.pone.0100405			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945434	Green Published, gold, Green Submitted			2022-12-27	WOS:000340721500070
J	Shen, SJ; Sun, Q; Liang, ZY; Cui, XJ; Ren, XY; Chen, H; Zhang, X; Zhou, YD				Shen, Songjie; Sun, Qiang; Liang, Zhiyong; Cui, Xiaojiang; Ren, Xinyu; Chen, Huan; Zhang, Xiao; Zhou, Yidong			A Prognostic Model of Triple-Negative Breast Cancer Based on miR-27b-3p and Node Status	PLOS ONE			English	Article							MICRORNA EXPRESSION; METASTASIS; PROGRESSION; MICROARRAY; SIGNATURE; MIRNAS; FROZEN; GROWTH; STAGE; RNA	Objective: Triple-negative breast cancer (TNBC) is an aggressive but heterogeneous subtype of breast cancer. This study aimed to identify and validate a prognostic signature for TNBC patients to improve prognostic capability and to guide individualized treatment. Methods: We retrospectively analyzed the prognostic performance of clinicopathological characteristics and miRNAs in a training set of 58 patients with invasive ductal TNBC diagnosed between 2002 and 2012. A prediction model was developed based on independent clinicopathological and miRNA covariates. The prognostic value of the model was further validated in a separate set of 41 TNBC patients diagnosed between 2007 and 2008. Results: Only lymph node status was marginally significantly associated with poor prognosis of TNBC (P = 0.054), whereas other clinicopathological factors, including age, tumor size, histological grade, lymphovascular invasion, P53 status, Ki-67 index, and type of surgery, were not. The expression levels of miR-27b-3p, miR-107, and miR-103a-3p were significantly elevated in the metastatic group compared with the disease-free group (P value: 0.008, 0.005, and 0.050, respectively). The Cox proportional hazards regression analysis revealed that lymph node status and miR-27b-3p were independent predictors of poor prognosis (P value: 0.012 and 0.027, respectively). A logistic regression model was developed based on these two independent covariates, and the prognostic value of the model was subsequently confirmed in a separate validation set. The two different risk groups, which were stratified according to the model, showed significant differences in the rates of distant metastasis and breast cancer-related death not only in the training set (P value: 0.001 and 0.040, respectively) but also in the validation set (P value: 0.013 and 0.012, respectively). Conclusion: This model based on miRNA and node status covariates may be used to stratify TNBC patients into different prognostic subgroups for potentially individualized therapy.	[Shen, Songjie; Sun, Qiang; Zhou, Yidong] Chinese Acad Med Sci, Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Breast Surg, Beijing 100730, Peoples R China; [Liang, Zhiyong; Ren, Xinyu] Chinese Acad Med Sci, Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Pathol, Beijing 100730, Peoples R China; [Cui, Xiaojiang] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Womens Canc Program, Dept Surg,Dept Obstet & Gynecol, Los Angeles, CA 90048 USA; [Chen, Huan] Zhejiang Inst Microbiol, Dept Microbiol, Hangzhou, Zhejiang, Peoples R China; [Zhang, Xiao] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Biostat & Bioinformat Core, Los Angeles, CA 90048 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Cedars Sinai Medical Center; Cedars Sinai Medical Center	Zhou, YD (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Breast Surg, Beijing 100730, Peoples R China.	zhouyidongpumc@163.com	Chen, Huan/CAH-8180-2022; Sun, Qiangming/GYE-2002-2022		Twelfth Five-year Key Programs for Science and Technology Development of China [2014BAI08B03]; Beijing Municipal Science and Technology Key Development Program [D090507043409009]; Beijing Natural Science Foundation [7132192]; Peking Union Medical College Hospital Youth Science Foundation (PUMCH) [2013-095]; National Institutes of Health [CA151610]; Avon Foundation [02-2010-068]; David Salomon Translational Breast Cancer Research Fund; NATIONAL CANCER INSTITUTE [R01CA151610] Funding Source: NIH RePORTER	Twelfth Five-year Key Programs for Science and Technology Development of China; Beijing Municipal Science and Technology Key Development Program; Beijing Natural Science Foundation(Beijing Natural Science Foundation); Peking Union Medical College Hospital Youth Science Foundation (PUMCH); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Avon Foundation; David Salomon Translational Breast Cancer Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Twelfth Five-year Key Programs for Science and Technology Development of China (2014BAI08B03), Beijing Municipal Science and Technology Key Development Program (D090507043409009), Beijing Natural Science Foundation (7132192), Peking Union Medical College Hospital Youth Science Foundation (PUMCH 2013-095), National Institutes of Health (CA151610), the Avon Foundation (02-2010-068), and David Salomon Translational Breast Cancer Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blows FM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000279; Buffa FM, 2011, CANCER RES, V71, P5635, DOI 10.1158/0008-5472.CAN-11-0489; Cascione L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055910; Cheang MCU, 2008, CLIN CANCER RES, V14, P1368, DOI 10.1158/1078-0432.CCR-07-1658; Cleator S, 2007, LANCET ONCOL, V8, P235, DOI 10.1016/S1470-2045(07)70074-8; Constantinidou A, 2010, EXPERT REV ANTICANC, V10, P1197, DOI [10.1586/era.10.50, 10.1586/ERA.10.50]; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Desmedt C, 2008, CLIN CANCER RES, V14, P5158, DOI 10.1158/1078-0432.CCR-07-4756; Dowsett M, 2013, J CLIN ONCOL, V31, P2783, DOI 10.1200/JCO.2012.46.1558; Ferracin M, 2010, EXPERT REV MOL DIAGN, V10, P297, DOI 10.1586/ERM.10.11; Foekens JA, 2008, P NATL ACAD SCI USA, V105, P13021, DOI 10.1073/pnas.0803304105; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Hallett RM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00227; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; Hernandez-Aya LF, 2011, J CLIN ONCOL, V29, P2628, DOI 10.1200/JCO.2010.32.1877; Hudis CA, 2011, ONCOLOGIST, V16, P1, DOI 10.1634/theoncologist.2011-S1-01; Jin LJ, 2013, CANCER RES, V73, P2884, DOI 10.1158/0008-5472.CAN-12-2162; Kuo WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045831; Le XF, 2010, CANCER MICROENVIRON, V3, P137, DOI 10.1007/s12307-010-0037-4; Lee JJ, 2012, ONCOGENE, V31, P3818, DOI 10.1038/onc.2011.543; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; Metzger O, 2012, J CLIN ONCOL, V30, P1879, DOI 10.1200/JCO.2011.38.2010; Mulligan AM, 2008, CLIN CANCER RES, V14, P4168, DOI 10.1158/1078-0432.CCR-07-4543; Negrini M, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1867; Rakha EA, 2007, CANCER-AM CANCER SOC, V109, P25, DOI 10.1002/cncr.22381; Rothe F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020980; Shen Song-jie, 2013, Zhonghua Wai Ke Za Zhi, V51, P1000; Straver ME, 2010, BREAST CANCER RES TR, V119, P551, DOI 10.1007/s10549-009-0333-1; Svoboda M, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-31; Thomson JM, 2004, NAT METHODS, V1, P47, DOI 10.1038/NMETH704; Toyama T, 2012, JPN J CLIN ONCOL, V42, P256, DOI 10.1093/jjco/hys001; Wirapati P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2124; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Xi YG, 2007, RNA, V13, P1668, DOI 10.1261/rna.642907; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808; Yau C, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2753; Yu SL, 2007, DNA CELL BIOL, V26, P283, DOI 10.1089/dna.2006.0555; Zhang X, 2008, J MOL DIAGN, V10, P513, DOI 10.2353/jmoldx.2008.080077	40	32	34	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100664	10.1371/journal.pone.0100664	http://dx.doi.org/10.1371/journal.pone.0100664			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945253	Green Published, gold, Green Submitted			2022-12-27	WOS:000340721500102
J	Trapp-Fragnet, L; Bencherit, D; Chabanne-Vautherot, D; Le Vern, Y; Remy, S; Boutet-Robinet, E; Mirey, G; Vautherot, JF; Denesvre, C				Trapp-Fragnet, Laetitia; Bencherit, Djihad; Chabanne-Vautherot, Daniele; Le Vern, Yves; Remy, Sylvie; Boutet-Robinet, Elisa; Mirey, Gladys; Vautherot, Jean-Francois; Denesvre, Caroline			Cell Cycle Modulation by Marek's Disease Virus: The Tegument Protein VP22 Triggers S-Phase Arrest and DNA Damage in Proliferating Cells	PLOS ONE			English	Article							LYTIC REPLICATION; H2AX PHOSPHORYLATION; PSEUDORABIES VIRUS; SEROTYPE-1 MDV-1; GENE UL49; TYPE-1; HERPESVIRUS; EXPRESSION; INFECTION; KINASE	Marek's disease is one of the most common viral diseases of poultry affecting chicken flocks worldwide. The disease is caused by an alphaherpesvirus, the Marek's disease virus (MDV), and is characterized by the rapid onset of multifocal aggressive T-cell lymphoma in the chicken host. Although several viral oncogenes have been identified, the detailed mechanisms underlying MDV-induced lymphomagenesis are still poorly understood. Many viruses modulate cell cycle progression to enhance their replication and persistence in the host cell, in the case of some oncogenic viruses ultimately leading to cellular transformation and oncogenesis. In the present study, we found that MDV, like other viruses, is able to subvert the cell cycle progression by triggering the proliferation of low proliferating chicken cells and a subsequent delay of the cell cycle progression into S-phase. We further identified the tegument protein VP22 (pUL49) as a major MDV-encoded cell cycle regulator, as its vector-driven overexpression in cells lead to a dramatic cell cycle arrest in S-phase. This striking functional feature of VP22 appears to depend on its ability to associate with histones in the nucleus. Finally, we established that VP22 expression triggers the induction of massive and severe DNA damages in cells, which might cause the observed intra S-phase arrest. Taken together, our results provide the first evidence for a hitherto unknown function of the VP22 tegument protein in herpesviral reprogramming of the cell cycle of the host cell and its potential implication in the generation of DNA damages.	[Trapp-Fragnet, Laetitia; Bencherit, Djihad; Chabanne-Vautherot, Daniele; Remy, Sylvie; Vautherot, Jean-Francois; Denesvre, Caroline] INRA, Infectiol & Sante Publ UMR1282, Equipe Biol Virus Aviaires, F-37380 Nouzilly, France; [Le Vern, Yves] INRA, Infectiol & Sante Publ UMR1282, Lab Cytometrie, F-37380 Nouzilly, France; [Boutet-Robinet, Elisa; Mirey, Gladys] INRA, UMR 1331, Toxalim, Res Ctr Food Toxicol, F-31931 Toulouse, France; [Boutet-Robinet, Elisa; Mirey, Gladys] Univ Toulouse, UPS, UMR1331, Toxalim, Toulouse, France	INRAE; INRAE; INRAE; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Trapp-Fragnet, L (corresponding author), INRA, Infectiol & Sante Publ UMR1282, Equipe Biol Virus Aviaires, F-37380 Nouzilly, France.	fragnet@tours.inra.fr	Boutet-Robinet, Elisa/Q-1342-2015; Mirey, Gladys/H-5676-2019; Boutet-Robinet, Elisa/AGU-6469-2022	Boutet-Robinet, Elisa/0000-0002-5223-4568; Mirey, Gladys/0000-0002-0095-1864; Boutet-Robinet, Elisa/0000-0002-5223-4568	Ligue contre le Cancer du Grand-Ouest; Indre et Loire; Vendee	Ligue contre le Cancer du Grand-Ouest; Indre et Loire; Vendee	This study was supported by the "Ligue contre le Cancer du Grand-Ouest'', comities of "Indre et Loire'' and "Vendee'' (http://www.ligue-cancer.net). The "Cluster en Infectiologie de la Region Centre'' (http://www.infectiologie-regioncentre.fr) supported the technical collaboration between the "Biologie des Virus Aviaires'' laboratory and the Research Center in Food Toxicology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; Berthet C, 2005, P NATL ACAD SCI USA, V102, P13634, DOI 10.1073/pnas.0504583102; Blondeau C, 2008, J VIROL, V82, P9278, DOI 10.1128/JVI.00598-08; Bontems S, 2002, J BIOL CHEM, V277, P21050, DOI 10.1074/jbc.M111872200; CALNEK BW, 1970, AVIAN DIS, V14, P219, DOI 10.2307/1588466; CARROZZA JH, 1973, AVIAN DIS, V17, P767, DOI 10.2307/1589045; Che XB, 2008, J VIROL, V82, P5825, DOI 10.1128/JVI.00303-08; COULTER LJ, 1993, J GEN VIROL, V74, P387, DOI 10.1099/0022-1317-74-3-387; del Rio T, 2002, J VIROL, V76, P774, DOI 10.1128/JVI.76.2.774-782.2002; Denesvre C, 2007, J VIROL, V81, P12348, DOI 10.1128/JVI.01177-07; Dheekollu J, 2011, J VIROL; DICKMANNS A, 1994, J VIROL, V68, P5496, DOI 10.1128/JVI.68.9.5496-5508.1994; Dorange F, 2002, J VIROL, V76, P1959, DOI 10.1128/JVI.76.4.1959-1970.2002; Dorange F, 2000, J GEN VIROL, V81, P2219, DOI 10.1099/0022-1317-81-9-2219; Duffy C, 2006, J VIROL, V80, P8664, DOI 10.1128/JVI.00498-06; Elliott G, 2005, J VIROL, V79, P9735, DOI 10.1128/JVI.79.15.9735-9745.2005; Elliott G, 2000, J VIROL, V74, P2131, DOI 10.1128/JVI.74.5.2131-2141.2000; Elliott G, 1998, J VIROL, V72, P6448, DOI 10.1128/JVI.72.8.6448-6455.1998; ELLIOTT GD, 1992, J GEN VIROL, V73, P723, DOI 10.1099/0022-1317-73-3-723; Flemington EK, 2001, J VIROL, V75, P4475, DOI 10.1128/JVI.75.10.4475-4481.2001; Fuchs W, 2002, J VIROL, V76, P6729, DOI 10.1128/JVI.76.13.6729-6742.2002; Fujimuro M, 2003, NAT MED, V9, P300, DOI 10.1038/nm829; Geiss BJ, 2001, J VIROL, V75, P10721, DOI 10.1128/JVI.75.22.10721-10729.2001; GILBERT DM, 1987, CELL, V50, P59, DOI 10.1016/0092-8674(87)90662-3; Grallert B, 2008, CELL CYCLE, V7, P2315, DOI 10.4161/cc.6389; Gruhne B, 2009, ONCOGENE, V28, P3997, DOI 10.1038/onc.2009.258; Guo KK, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-236; Helt AM, 2005, J VIROL, V79, P13218, DOI 10.1128/JVI.79.21.13218-13230.2005; Ingvarsdottir K, 2010, BBA-GENE REGUL MECH, V1799, P200, DOI 10.1016/j.bbagrm.2009.08.002; Jarosinski KW, 2011, J VIROL; Jha HC, 2013, J VIROL, V87, P5255, DOI 10.1128/JVI.03575-12; Kudoh A, 2005, J BIOL CHEM, V280, P8156, DOI 10.1074/jbc.M411405200; Kudoh A, 2004, J VIROL, V78, P104, DOI 10.1128/JVI.78.1.104-115.2004; Labiuk SL, 2010, J GEN VIROL, V91, P1117, DOI 10.1099/vir.0.016600-0; Lebailly P, 2003, OCCUP ENVIRON MED, V60, P910, DOI 10.1136/oem.60.12.910; Liang MH, 2002, J VIROL, V76, P4022, DOI 10.1128/JVI.76.8.4022-4033.2002; LIANG XP, 1995, J VIROL, V69, P3863, DOI 10.1128/JVI.69.6.3863-3867.1995; Lilley CE, 2007, TRENDS MICROBIOL, V15, P119, DOI 10.1016/j.tim.2007.01.003; Lilley CE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002084; Lomonte P, 1999, J VIROL, V73, P9456, DOI 10.1128/JVI.73.11.9456-9467.1999; Luo MH, 2007, J VIROL, V81, P1934, DOI 10.1128/JVI.01670-06; Ma W, 2011, BIOLOGICALS; Maringer K, 2012, J VIROL, V86, P12971, DOI 10.1128/JVI.01913-12; Moffat JF, 2004, BBA-PROTEINS PROTEOM, V1697, P225, DOI 10.1016/j.bbapap.2003.11.026; Mohni KN, 2013, J VIROL, V87, P531, DOI 10.1128/JVI.02504-12; Nascimento R, 2012, PROTOPLASMA, V249, P519, DOI 10.1007/s00709-011-0327-9; NAZERIAN K, 1968, CANCER RES, V28, P2454; Nikitin PA, 2012, BRIT J CANCER, V106, P429, DOI 10.1038/bjc.2011.612; Nikitin PA, 2011, FUTURE VIROL, V6, P813, DOI 10.2217/FVL.11.55; O'Donnell LA, 2002, VIROLOGY, V292, P235, DOI 10.1006/viro.2001.1223; Remy S, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-125; Ren XD, 2001, J VIROL, V75, P8251, DOI 10.1128/JVI.75.17.8251-8258.2001; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sandri-Goldin RM, 2011, FUTURE MICROBIOL, V6, P1261, DOI [10.2217/FMB.11.119, 10.2217/fmb.11.119]; Schonn I, 2010, APOPTOSIS, V15, P162, DOI 10.1007/s10495-009-0440-9; Schumacher D, 2000, J VIROL, V74, P11088, DOI 10.1128/JVI.74.23.11088-11098.2000; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Song BW, 2001, VIROLOGY, V290, P320, DOI 10.1006/viro.2001.1175; Tarakanova VL, 2010, VIROLOGY, V405, P50, DOI 10.1016/j.virol.2010.05.027; Teissier S, 2010, ONCOGENE, V29, P5061, DOI 10.1038/onc.2010.246; Turnell AS, 2012, J GEN VIROL, V93, P2076, DOI 10.1099/vir.0.044412-0; van Leeuwen H, 2003, J GEN VIROL, V84, P2501, DOI 10.1099/vir.0.19326-0; Weitzman MD, 2010, ANNU REV MICROBIOL, V64, P61, DOI 10.1146/annurev.micro.112408.134016; Xiao Y, 2013, J GEN VIROL, V94, P1870, DOI 10.1099/vir.0.053033-0; ZhuO J, 2005, J BIOL CHEM, V280, P16038, DOI 10.1074/jbc.M500054200	65	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100004	10.1371/journal.pone.0100004	http://dx.doi.org/10.1371/journal.pone.0100004			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945933	Green Published, Green Submitted, gold			2022-12-27	WOS:000340721500040
J	Toselli, C; Hyslop, CM; Hughes, M; Natale, DR; Santamaria, P; Huang, CTL				Toselli, Chiara; Hyslop, Colin M.; Hughes, Martha; Natale, David R.; Santamaria, Pere; Huang, Carol T. L.			Contribution of a Non-beta-Cell Source to beta-Cell Mass during Pregnancy	PLOS ONE			English	Article							ADULT-MOUSE PANCREAS; PROGENITOR CELLS; IN-VITRO; ENDOCRINE; DIFFERENTIATION; NEOGENESIS; MICE; PROLIFERATION; REGENERATION; EXPRESSION	beta-cell mass in the pancreas increases significantly during pregnancy as an adaptation to maternal insulin resistance. Lineage tracing studies in rodents have presented conflicting evidence on the role of cell duplication in the formation of new beta-cells during gestation, while recent human data suggest that new islets are a major contributor to increased beta-cell mass in pregnancy. Here, we aim to: 1) determine whether a non-beta-cell source contributes to the appearance of new beta-cells during pregnancy and 2) investigate whether recapitulation of the embryonic developmental pathway involving high expression of neurogenin 3 (Ngn3) plays a role in the up-regulation of beta-cell mass during pregnancy. Using a mouse beta-cell lineage-tracing model, which labels insulin-producing beta-cells with red fluorescent protein (RFP), we found that the percentage of labeled beta-cells dropped from 97% prior to pregnancy to 87% at mid-pregnancy. This suggests contribution of a non-beta-cell source to the increase in total beta-cell numbers during pregnancy. In addition, we observed a population of hormone-negative, Ngn3-positive cells in islets of both non-pregnant and pregnant mice, and this population dropped from 12% of all islets cells in the non-pregnant mice to 5% by day 8 of pregnancy. Concomitantly, a decrease in expression of Ngn3 and changes in its upstream regulatory network (Sox9 and Hes-1) as well as downstream targets (NeuroD, Nkx2.2, Rfx6 and IA1) were also observed during pregnancy. Our results show that duplication of pre-existing beta-cells is not the sole source of new beta-cells during pregnancy and that Ngn3 may be involved in this process.	[Toselli, Chiara; Hyslop, Colin M.; Hughes, Martha; Huang, Carol T. L.] Univ Calgary, Dept Pediat, Alberta Childrens Hosp, Res Inst,Fac Med, Calgary, AB T2N 1N4, Canada; [Natale, David R.] Univ Calif San Diego, Dept Reprod Med, San Diego, CA 92103 USA; [Santamaria, Pere] Univ Calgary, JMDRC, Calgary, AB, Canada; [Santamaria, Pere] Univ Calgary, Fac Med, Snyder Inst Chron Dis, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada; [Santamaria, Pere] Inst Invest Biomed August Pi i Sunyer, Barcelona, Spain	Alberta Childrens Hospital; University of Calgary; University of California System; University of California San Diego; University of Calgary; University of Calgary; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Huang, CTL (corresponding author), Univ Calgary, Dept Pediat, Alberta Childrens Hosp, Res Inst,Fac Med, Calgary, AB T2N 1N4, Canada.	Carol.Huang@albertahealthservices.ca	Santamaria, Pere/ABF-6823-2021	Natale, David/0000-0001-8365-455X	Canadian Diabetes Association [OG-3-12-3670, OG-3-13-4055-PS]; Alberta Children's Hospital Foundation [2010-014]; summer studentship from Alberta Innovates Health Solutions; Canadian Institutes for Health Research [MOP-43881]; Diabetes Association (Foothills); Canadian Diabetes Association	Canadian Diabetes Association; Alberta Children's Hospital Foundation; summer studentship from Alberta Innovates Health Solutions; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Diabetes Association (Foothills); Canadian Diabetes Association	This work was supported by grants from Canadian Diabetes Association (Grant OG-3-12-3670) and Alberta Children's Hospital Foundation (Grant 2010-014) to CTLH. CT was supported by a summer studentship from Alberta Innovates Health Solutions. P. Santamaria's contribution was supported by the Canadian Institutes for Health Research (Grant; MOP-43881) and the Canadian Diabetes Association (Grant OG-3-13-4055-PS). P. Santamaria is a Scientist of the AIHS and a scholar of the Instituto de Investigaciones Sanitarias Carlos III. The JMDRC was supported by the Diabetes Association (Foothills) and the Canadian Diabetes Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouna S, 2010, ORGANOGENESIS, V6, P125, DOI 10.4161/org.6.2.10374; Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; Bar Y, 2008, DIABETES, V57, P2413, DOI 10.2337/db07-1323; Bonner-Weir S, 2008, BIOCHEM SOC T, V36, P353, DOI 10.1042/BST0360353; Bonner-Weir S, 2010, DIABETES, V59, P2340, DOI 10.2337/db10-0084; Butler AE, 2010, DIABETOLOGIA, V53, P2167, DOI 10.1007/s00125-010-1809-6; Collombat P, 2009, CELL, V138, P449, DOI 10.1016/j.cell.2009.05.035; Darville MI, 2006, BIOCHEM BIOPH RES CO, V339, P1063, DOI 10.1016/j.bbrc.2005.11.111; De Haro-Hernandez R, 2004, ARCH MED RES, V35, P114, DOI 10.1016/j.arcmed.2003.10.001; Demeterco C, 2009, DIABETES OBES METAB, V11, P46, DOI 10.1111/j.1463-1326.2009.01105.x; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Dubois CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023131; Gasa R, 2004, P NATL ACAD SCI USA, V101, P13245, DOI 10.1073/pnas.0405301101; Georgia S, 2006, DEV BIOL, V298, P22, DOI 10.1016/j.ydbio.2006.05.036; Gierl MS, 2006, GENE DEV, V20, P2465, DOI 10.1101/gad.381806; Gu CY, 2010, CELL METAB, V11, P298, DOI 10.1016/j.cmet.2010.03.006; Huang C, 2009, ENDOCRINOLOGY, V150, P1618, DOI 10.1210/en.2008-1003; Inada A, 2008, P NATL ACAD SCI USA, V105, P19915, DOI 10.1073/pnas.0805803105; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Lee CS, 2006, DIABETES, V55, P269; Lee CS, 2002, GENE DEV, V16, P1488, DOI 10.1101/gad.985002; Luche H, 2007, EUR J IMMUNOL, V37, P43, DOI 10.1002/eji.200636745; Lynn FC, 2007, P NATL ACAD SCI USA, V104, P10500, DOI 10.1073/pnas.0704054104; MCBURNEY MW, 1993, INT J DEV BIOL, V37, P135; Metzger DE, 2012, DEVELOPMENT, V139, P1447, DOI 10.1242/dev.072892; Miyamoto Y, 2003, CANCER CELL, V3, P565, DOI 10.1016/S1535-6108(03)00140-5; Miyatsuka T, 2011, P NATL ACAD SCI USA, V108, P185, DOI 10.1073/pnas.1004842108; OHLSSON H, 1993, EMBO J, V12, P4251, DOI 10.1002/j.1460-2075.1993.tb06109.x; Oliver-Krasinski JM, 2008, GENE DEV, V22, P1998, DOI 10.1101/gad.1670808; Rooman I, 2006, AM J PATHOL, V169, P1206, DOI 10.2353/ajpath.2006.050926; Smith SB, 2010, NATURE, V463, P775, DOI 10.1038/nature08748; Sorenson RL, 2009, ENDOCRINOLOGY, V150, P1566, DOI 10.1210/en.2008-1710; Swales N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037055; Szabat M, 2009, ENDOCRINOLOGY, V150, P1627, DOI 10.1210/en.2008-1224; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Teta M, 2007, DEV CELL, V12, P817, DOI 10.1016/j.devcel.2007.04.011; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Van de Casteele M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.52; Wang S, 2010, DEV BIOL, V339, P26, DOI 10.1016/j.ydbio.2009.12.009; Wang S, 2009, P NATL ACAD SCI USA, V106, P9715, DOI 10.1073/pnas.0904247106; Wilson ME, 2003, MECH DEVELOP, V120, P65, DOI 10.1016/S0925-4773(02)00333-7; Xiao XW, 2013, J CLIN INVEST, V123, P2207, DOI 10.1172/JCI66323; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Yamamoto K, 2000, DIABETES, V49, P2021, DOI 10.2337/diabetes.49.12.2021	44	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100398	10.1371/journal.pone.0100398	http://dx.doi.org/10.1371/journal.pone.0100398			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940737	Green Published, gold, Green Submitted			2022-12-27	WOS:000338508200101
J	Chang, S; Thurber, CS; Brown, PJ; Hartman, GL; Lambert, KN; Domier, LL				Chang, Sungyul; Thurber, Carrie S.; Brown, Patrick J.; Hartman, Glen L.; Lambert, Kris N.; Domier, Leslie L.			Comparative Mapping of the Wild Perennial Glycine latifolia and Soybean (G. max) Reveals Extensive Chromosome Rearrangements in the Genus Glycine	PLOS ONE			English	Article							GENETIC-LINKAGE MAP; GENOMIC RELATIONSHIPS; ARABIDOPSIS-THALIANA; TOMENTELLA HAYATA; RESISTANCE; EVOLUTION; ALIGNMENT; RUST; DIVERSIFICATION; IDENTIFICATION	Soybean (Glycine max L. Mer.), like many cultivated crops, has a relatively narrow genetic base and lacks diversity for some economically important traits. Glycine latifolia (Benth.) Newell & Hymowitz, one of the 26 perennial wild Glycine species related to soybean in the subgenus Glycine Willd., shows high levels of resistance to multiple soybean pathogens and pests including Alfalfa mosaic virus, Heterodera glycines Ichinohe and Sclerotinia sclerotiorum (Lib.) de Bary. However, limited information is available on the genomes of these perennial Glycine species. To generate molecular resources for gene mapping and identification, high-density linkage maps were constructed for G. latifolia using single nucleotide polymorphism (SNP) markers generated by genotyping by sequencing and evaluated in an F-2 population and confirmed in an F-5 population. In each population, greater than 2,300 SNP markers were selected for analysis and segregated to form 20 large linkage groups. Marker orders were similar in the F-2 and F-5 populations. The relationships between G. latifolia linkage groups and G. max and common bean (Phaseolus vulgaris L.) chromosomes were examined by aligning SNP-containing sequences from G. latifolia to the genome sequences of G. max and P. vulgaris. Twelve of the 20 G. latifolia linkage groups were nearly collinear with G. max chromosomes. The remaining eight G. latifolia linkage groups appeared to be products of multiple interchromosomal translocations relative to G. max. Large syntenic blocks also were observed between G. latifolia and P. vulgaris. These experiments are the first to compare genome organizations among annual and perennial Glycine species and common bean. The development of molecular resources for species closely related to G. max provides information into the evolution of genomes within the genus Glycine and tools to identify genes within perennial wild relatives of cultivated soybean that could be beneficial to soybean production.	[Chang, Sungyul; Thurber, Carrie S.; Brown, Patrick J.; Hartman, Glen L.; Lambert, Kris N.; Domier, Leslie L.] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA; [Hartman, Glen L.; Domier, Leslie L.] ARS, USDA, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; United States Department of Agriculture (USDA)	Domier, LL (corresponding author), Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA.	leslie.domier@ars.usda.gov			National Sclerotinia Initiative; United States Department of Agriculture-Agricultural Research Service; ARS [ARS-0422909] Funding Source: Federal RePORTER	National Sclerotinia Initiative; United States Department of Agriculture-Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This study was supported by funding from the National Sclerotinia Initiative and the United States Department of Agriculture-Agricultural Research Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BOUTIN SR, 1995, GENOME, V38, P928, DOI 10.1139/g95-122; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Brown Lester, 2012, FULL PLANET EMPTY PL; BURDON JJ, 1981, PLANT DIS, V65, P44, DOI 10.1094/PD-65-44; Chang S, 2013, THEOR APPL GENET, V126, P1627, DOI 10.1007/s00122-013-2079-8; Choi IY, 2007, GENETICS, V176, P685, DOI 10.1534/genetics.107.070821; CHUNG GH, 1991, KOREAN J PLANT TISSU, V18, P39; Cook DE, 2012, SCIENCE, V338, P1206, DOI 10.1126/science.1228746; Cregan PB, 1999, CROP SCI, V39, P1464, DOI 10.2135/cropsci1999.3951464x; Dinkins RD, 2008, HDB NEW TECHNOLOGIES, P89; Doyle JJ, 2010, NEW PHYTOL, V186, P73, DOI 10.1111/j.1469-8137.2009.03118.x; DOYLE JJ, 1990, SYST BOT, V15, P173, DOI 10.2307/2419171; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Findley SD, 2010, GENETICS, V185, P727, DOI 10.1534/genetics.109.113753; Gill N, 2009, PLANT PHYSIOL, V151, P1167, DOI 10.1104/pp.109.137935; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Graham-Rowe D, 2011, NATURE, V474, pS6, DOI 10.1038/474S06a; HARTMAN GL, 1992, PLANT DIS, V76, P396, DOI 10.1094/PD-76-0396; Hartman GL, 2000, CROP SCI, V40, P545, DOI 10.2135/cropsci2000.402545x; Hartman GL, 2011, FOOD SECUR, V3, P5, DOI 10.1007/s12571-010-0108-x; Horlock CM, 1997, AUSTRALAS PLANT PATH, V26, P115, DOI 10.1071/AP97017; Hymowitz T., 1998, Plant Breeding Reviews, V16, P289; Hymowitz T., 2004, SOYBEANS IMPROVEMENT, P97; Hyten DL, 2010, CROP SCI, V50, P960, DOI 10.2135/cropsci2009.06.0360; Innes RW, 2008, PLANT PHYSIOL, V148, P1740, DOI 10.1104/pp.108.127902; Jones JDG, 2014, PHILOS T R SOC B, V369, DOI [10.1098/rstb.2013.0087, 10.1098/rstb.2013.008]; Jones RM, 1996, GENETIC RESOURCES CO; Kellogg EA, 2004, AM J BOT, V91, P1709, DOI 10.3732/ajb.91.10.1709; Kim J, 2013, P NATL ACAD SCI USA, V110, P1785, DOI 10.1073/pnas.1220349110; Kim MY, 2010, P NATL ACAD SCI USA, V107, P22032, DOI 10.1073/pnas.1009526107; Koch MA, 2005, AM J BOT, V92, P761, DOI 10.3732/ajb.92.4.761; Lagercrantz U, 1998, GENETICS, V150, P1217; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lavin M, 2005, SYST BIOL, V54, P575, DOI 10.1080/10635150590947131; Lee JM, 2001, THEOR APPL GENET, V103, P765, DOI 10.1007/s001220100658; LIM SM, 1987, PLANT DIS, V71, P891, DOI 10.1094/PD-71-0891; Liu Ren-Hu, 2003, Yichuan, V25, P317; Liu SM, 2012, NATURE, V492, P256, DOI 10.1038/nature11651; Ma XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033821; Mahama AA, 1999, J HERED, V90, P648, DOI 10.1093/jhered/90.6.648; McClean PE, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-184; Meyer JDF, 2009, PLANT PHYSIOL, V150, P295, DOI 10.1104/pp.108.134551; Meyer M, 2009, IEEE T VIS COMPUT GR, V15, P897, DOI 10.1109/TVCG.2009.167; Muchero W, 2009, P NATL ACAD SCI USA, V106, P18159, DOI 10.1073/pnas.0905886106; MULLER J, 1981, BOT REV, V47, P1, DOI 10.1007/BF02860537; NEWELL CA, 1980, BRITTONIA, V32, P63, DOI 10.2307/2806223; Poland JA, 2011, P NATL ACAD SCI USA, V108, P6893, DOI 10.1073/pnas.1010894108; Ragsdale DW, 2004, ANN ENTOMOL SOC AM, V97, P204, DOI 10.1603/0013-8746(2004)097[0204:SABINA]2.0.CO;2; Rech EL, 2008, NAT PROTOC, V3, P410, DOI 10.1038/nprot.2008.9; Riggs R. D., 1998, Journal of Nematology, V30, P547; Russell J, 2013, MOL BREEDING, DOI [10.1007/s11032-11013-19996-11038, DOI 10.1007/S11032-11013-19996-11038]; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schneeberger K, 2011, P NATL ACAD SCI USA, V108, P10249, DOI 10.1073/pnas.1107739108; Schneider RW, 2005, PLANT DIS, V89, P774, DOI 10.1094/PD-89-0774A; Simelton E, 2011, FOOD SECUR, V3, P35, DOI 10.1007/s12571-011-0114-7; SINGH RJ, 1993, CROP SCI, V33, P1002, DOI 10.2135/cropsci1993.0011183X003300050026x; SINGH RJ, 1985, THEOR APPL GENET, V71, P221, DOI 10.1007/BF00252059; SINGH RJ, 1985, EUPHYTICA, V34, P187, DOI 10.1007/BF00022878; SINGH RJ, 1988, GENOME, V30, P166, DOI 10.1139/g88-029; Singh RJ, 1998, CROP SCI, V38, P1483, DOI 10.2135/cropsci1998.0011183X003800060013x; SINGH RJ, 1985, Z PFLANZENZUCHT, V95, P289; Singh RJ, 2010, METHODS PRODUCING FE; Sonah H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054603; Song QJ, 2004, THEOR APPL GENET, V109, P122, DOI 10.1007/s00122-004-1602-3; Stefanovic S, 2009, SYST BOT, V34, P115, DOI 10.1600/036364409787602221; Thurber CS, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r68; Ward JA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-2; Wawrzynski A, 2008, PLANT PHYSIOL, V148, P1760, DOI 10.1104/pp.108.127910; Weinthal DM, 2013, PLANT PHYSIOL, V162, P390, DOI 10.1104/pp.112.212910; Wu Yonghui, 2008, Comput Syst Bioinformatics Conf, V7, P285, DOI 10.1142/9781848162648_0025; Wu YH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000212; Xia ZJ, 2012, P NATL ACAD SCI USA, V109, pE2155, DOI 10.1073/pnas.1117982109; Young ND, 2011, NATURE, V480, P520, DOI 10.1038/nature10625; Zhou J, 2011, VIRUS GENES, V43, P289, DOI 10.1007/s11262-011-0621-9	76	6	6	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99427	10.1371/journal.pone.0099427	http://dx.doi.org/10.1371/journal.pone.0099427			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937645	Green Submitted, Green Published, gold			2022-12-27	WOS:000338503400017
J	Babcock, GJ; Iyer, S; Smith, HL; Wang, Y; Rowley, K; Ambrosino, DM; Zamore, PD; Pierce, BG; Molrine, DC; Weng, ZP				Babcock, Gregory J.; Iyer, Sowmya; Smith, Heidi L.; Wang, Yang; Rowley, Kirk; Ambrosino, Donna M.; Zamore, Phillip D.; Pierce, Brian G.; Molrine, Deborah C.; Weng, Zhiping			High-Throughput Sequencing Analysis of Post-Liver Transplantation HCV E2 Glycoprotein Evolution in the Presence and Absence of Neutralizing Monoclonal Antibody	PLOS ONE			English	Article							HEPATITIS-C; KINETICS	Chronic hepatitis C virus (HCV) infection is the most common cause of end-stage liver disease, often leading to liver transplantation, in which case circulating virions typically infect the transplanted liver within hours and viral concentrations can quickly exceed pre-transplant levels. MBL-HCV1 is a fully human monoclonal antibody recognizing a linear epitope of the HCV E2 envelope glycoprotein (amino acids 412-423). The ability of MBL-HCV1 to prevent HCV recurrence after liver transplantation was investigated in a phase 2 randomized clinical trial evaluating six MBL-HCV1-treated subjects and five placebo-treated subjects. MBL-HCV1 treatment significantly delayed time to viral rebound compared with placebo treatment. Here we report results from high-throughput sequencing on the serum of each of the eleven enrolled subjects prior to liver transplantation and after viral rebound. We further sequenced the sera of the MBL-HCV1-treated subjects at various interim time points to study the evolution of antibody-resistant viral variants. We detected mutations at one of two positions within the antibody epitope-mutations of N at position 415 to D, K or S, or mutation of N at position 417 to S. It has been previously reported that N415 is not glycosylated in the wild-type E2 protein, but N417S can lead to glycosylation at position 415. Thus N415 is a key position for antibody recognition and the only routes we identified for viral escape, within the constraints of HCV fitness in vivo, involve mutating or glycosylating this position. Evaluation of mutations along the entire E1 and E2 proteins revealed additional positions that changed moderately before and after MBL-HCV1 treatment for subsets of the six subjects, yet underscored the relative importance of position 415 in MBL-HCV1 resistance.	[Babcock, Gregory J.; Smith, Heidi L.; Wang, Yang; Rowley, Kirk; Ambrosino, Donna M.; Molrine, Deborah C.] Univ Massachusetts, Sch Med, Boston, MA 02125 USA; [Iyer, Sowmya; Pierce, Brian G.; Weng, Zhiping] Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01605 USA; [Zamore, Phillip D.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA USA; [Iyer, Sowmya] Boston Univ, Bioinformat Program, Boston, MA 02215 USA	University of Massachusetts System; University of Massachusetts Boston; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Boston University	Weng, ZP (corresponding author), Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01605 USA.	zhiping.weng@umassmed.edu	Pierce, Brian/AAB-8965-2022	Pierce, Brian/0000-0003-4821-0368; Zamore, Phillip/0000-0002-4505-9618; Smith, Heidi/0000-0002-6670-5324; Rowley, Kirk/0000-0002-8548-001X	MassBiologics, University of Massachusetts, Boston, MA	MassBiologics, University of Massachusetts, Boston, MA	This study was funded by MassBiologics, University of Massachusetts, Boston, MA. GJB, HLS, YW, KR, DMA, and DCM are current or former employees of MassBiologics.	Bartels DJ, 2013, J VIROL, V87, P1544, DOI 10.1128/JVI.02294-12; Broering TJ, 2009, J VIROL, V83, P12473, DOI 10.1128/JVI.01138-09; Chung RT, 2013, AM J TRANSPLANT, V13, P1047, DOI 10.1111/ajt.12083; Crespo G, 2012, GASTROENTEROLOGY, V142, P1373, DOI 10.1053/j.gastro.2012.02.011; Gallegos-Orozco JF, 2009, LIVER TRANSPLANT, V15, P1872, DOI 10.1002/lt.21954; Garcia-Retortillo M, 2002, HEPATOLOGY, V35, P680, DOI 10.1053/jhep.2002.31773; Kim WR, 2013, AM J TRANSPLANT, V13, P73, DOI 10.1111/ajt.12021; Kong L, 2013, SCIENCE, V342, P1090, DOI 10.1126/science.1243876; Kong L, 2012, P NATL ACAD SCI USA, V109, P9499, DOI 10.1073/pnas.1202924109; Kwong Ann D, 2011, Gastroenterology, V140, P755, DOI 10.1053/j.gastro.2011.01.029; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Morin TJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002895; Pantua H, 2013, J MOL BIOL, V425, P1899, DOI 10.1016/j.jmb.2013.02.025; Powers KA, 2006, LIVER TRANSPLANT, V12, P207, DOI 10.1002/lt.20572; Svarovskaia ES, 2012, J CLIN MICROBIOL, V50, P3267, DOI 10.1128/JCM.00838-12	15	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100325	10.1371/journal.pone.0100325	http://dx.doi.org/10.1371/journal.pone.0100325			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956119	Green Published, Green Submitted, gold			2022-12-27	WOS:000338917900041
J	Menalled, LB; Kudwa, AE; Oakeshott, S; Farrar, A; Paterson, N; Filippov, I; Miller, S; Kwan, M; Olsen, M; Beltran, J; Torello, J; Fitzpatrick, J; Mushlin, R; Cox, K; McConnell, K; Mazzella, M; He, DS; Osborne, GF; Al-Nackkash, R; Bates, GP; Tuunanen, P; Lehtimaki, K; Brunner, D; Ghavami, A; Ramboz, S; Park, L; Macdonald, D; Munoz-Sanjuan, I; Howland, D				Menalled, Liliana B.; Kudwa, Andrea E.; Oakeshott, Steve; Farrar, Andrew; Paterson, Neil; Filippov, Igor; Miller, Sam; Kwan, Mei; Olsen, Michael; Beltran, Jose; Torello, Justin; Fitzpatrick, Jon; Mushlin, Richard; Cox, Kimberly; McConnell, Kristi; Mazzella, Matthew; He, Dansha; Osborne, Georgina F.; Al-Nackkash, Rand; Bates, Gill P.; Tuunanen, Pasi; Lehtimaki, Kimmo; Brunner, Dani; Ghavami, Afshin; Ramboz, Sylvie; Park, Larry; Macdonald, Douglas; Munoz-Sanjuan, Ignacio; Howland, David			Genetic Deletion of Transglutaminase 2 Does Not Rescue the Phenotypic Deficits Observed in R6/2 and zQ175 Mouse Models of Huntington's Disease	PLOS ONE			English	Article							TISSUE TRANSGLUTAMINASE; TRANSGENIC MOUSE; NEURODEGENERATIVE DISEASES; CAG REPEAT; MICE; INHIBITORS; CYSTAMINE; SURVIVAL; STIMULATION; CONTRIBUTES	Huntington's disease (HD) is an autosomal dominant, progressive neurodegenerative disorder caused by expansion of CAG repeats in the huntingtin gene. Tissue transglutaminase 2 (TG2), a multi-functional enzyme, was found to be increased both in HD patients and in mouse models of the disease. Furthermore, beneficial effects have been reported from the genetic ablation of TG2 in R6/2 and R6/1 mouse lines. To further evaluate the validity of this target for the treatment of HD, we examined the effects of TG2 deletion in two genetic mouse models of HD: R6/2 CAG 240 and zQ175 knock in (KI). Contrary to previous reports, under rigorous experimental conditions we found that TG2 ablation had no effect on either motor or cognitive deficits, or on the weight loss. In addition, under optimal husbandry conditions, TG2 ablation did not extend R6/2 lifespan. Moreover, TG2 deletion did not change the huntingtin aggregate load in cortex or striatum and did not decrease the brain atrophy observed in either mouse line. Finally, no amelioration of the dysregulation of striatal and cortical gene markers was detected. We conclude that TG2 is not a valid therapeutic target for the treatment of HD.	[Menalled, Liliana B.; Kudwa, Andrea E.; Oakeshott, Steve; Farrar, Andrew; Paterson, Neil; Filippov, Igor; Miller, Sam; Kwan, Mei; Olsen, Michael; Beltran, Jose; Torello, Justin; Fitzpatrick, Jon; Mushlin, Richard; Cox, Kimberly; McConnell, Kristi; Mazzella, Matthew; He, Dansha; Brunner, Dani; Ghavami, Afshin; Ramboz, Sylvie] PsychoGenics Inc, Tarrytown, NY USA; [Osborne, Georgina F.; Al-Nackkash, Rand; Bates, Gill P.] Kings Coll London, Dept Med & Mol Genet, London WC2R 2LS, England; [Tuunanen, Pasi; Lehtimaki, Kimmo] Charles River Discovery Res Serv, Kuopio, Finland; [Park, Larry; Macdonald, Douglas; Munoz-Sanjuan, Ignacio; Howland, David] CHDI Fdn, CHDI Management, Princeton, NJ 08540 USA	University of London; King's College London	Howland, D (corresponding author), CHDI Fdn, CHDI Management, Princeton, NJ 08540 USA.	David.Howland@CHDIFoundation.org	Lehtimäki, Kimmo K/A-6018-2009; Bates, Gillian/E-1146-2012	Lehtimäki, Kimmo K/0000-0003-2750-8229; Mazzella, Matthew/0000-0003-3584-1670; Bates, Gillian/0000-0002-4041-6305; Osborne, Georgina/0000-0001-8308-3179	CHDI Foundation; PsychoGenics, Inc.; Charles River Discovery Research Services; Kings College London	CHDI Foundation; PsychoGenics, Inc.; Charles River Discovery Research Services; Kings College London(General Electric)	CHDI Foundation is a privately-funded not-for-profit biomedical research organization exclusively dedicated to discovering and developing therapeutics that slow the progression of Huntington's disease. CHDI Foundation conducts research in a number of different ways; for the purposes of this manuscript, research was conducted at the contract research organizations PsychoGenics, Inc. and Charles River Discovery Research Services under a fee-for-service agreement, and at Kings College London under a sponsored research agreement. The authors listed all contributed to the conception, planning, and direction of the research; the specific roles of each author is outlined in the 'author contributions' section.	Bailey CDC, 2005, J NEUROCHEM, V92, P83, DOI 10.1111/j.1471-4159.2004.02839.x; Bailey CDC, 2006, NEUROBIOL AGING, V27, P871, DOI 10.1016/j.neurobiolaging.2005.04.001; Balci F., 2013, PLOS CURR, V5; BATES G, 2002, HUNTINGTONS DIS; Carter RJ, 2000, MOVEMENT DISORD, V15, P925, DOI 10.1002/1531-8257(200009)15:5<925::AID-MDS1025>3.0.CO;2-Z; Cha JHJ, 2007, PROG NEUROBIOL, V83, P228, DOI 10.1016/j.pneurobio.2007.03.004; Chun WJ, 2001, J CELL BIOL, V153, P25, DOI 10.1083/jcb.153.1.25; Cowin RM, 2012, BEHAV BRAIN RES, V229, P308, DOI 10.1016/j.bbr.2011.12.045; D'Eletto M, 2012, CELL DEATH DIFFER, V19, P1228, DOI 10.1038/cdd.2012.2; Dedeoglu A, 2002, J NEUROSCI, V22, P8942; Dragatsis I, 2009, NEUROBIOL DIS, V33, P315, DOI 10.1016/j.nbd.2008.10.009; GREENBERG CS, 1991, FASEB J, V5, P3071, DOI 10.1096/fasebj.5.15.1683845; Hasegawa G, 2003, BIOCHEM J, V373, P793, DOI 10.1042/BJ20021084; Heikkinen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050717; IM MJ, 1990, J BIOL CHEM, V265, P18952; Jacobs GH, 1999, J NEUROSCI, V19, P3258; Jeitner TM, 2008, J NEUROCHEM, V106, P37, DOI 10.1111/j.1471-4159.2008.05350.x; Karpuj MV, 2002, NAT MED, V8, P143, DOI 10.1038/nm0202-143; Kumar A, 2012, EXP NEUROL, V237, P78, DOI 10.1016/j.expneurol.2012.05.015; Lai TS, 1998, J BIOL CHEM, V273, P1776, DOI 10.1074/jbc.273.3.1776; Lesort M, 1999, J NEUROCHEM, V73, P2018; Mangala LS, 2005, PROG EXP TUMOR RES, V38, P125; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Mastroberardino P, 2002, CELL DEATH DIFFER, V9, P873, DOI 10.1038/sj.cdd.4401093; Mastroberardino PG, 2006, BBA-BIOENERGETICS, V1757, P1357, DOI 10.1016/j.bbabio.2006.07.007; McConoughey SJ, 2010, EMBO MOL MED, V2, P349, DOI 10.1002/emmm.201000084; Menalled L, 2009, NEUROBIOL DIS, V35, P319, DOI 10.1016/j.nbd.2009.05.007; Menalled LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049838; Molberg O, 2000, J PEDIATR GASTR NUTR, V30, P232, DOI 10.1097/00005176-200003000-00005; Morton AJ, 2009, NEUROBIOL DIS, V33, P331, DOI 10.1016/j.nbd.2008.11.015; Munsie L, 2011, HUM MOL GENET, V20, P1937, DOI 10.1093/hmg/ddr075; Nanda N, 2001, J BIOL CHEM, V276, P20673, DOI 10.1074/jbc.M010846200; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; Prime ME, 2012, J MED CHEM, V55, P1021, DOI 10.1021/jm201310y; Sathasivam K, 2001, HUM MOL GENET, V10, P2425, DOI 10.1093/hmg/10.21.2425; Sathasivam K, 2010, HUM MOL GENET, V19, P65, DOI 10.1093/hmg/ddp467; Schaertl S, 2010, J BIOMOL SCREEN, V15, P478, DOI 10.1177/1087057110366035; Siegel M, 2007, PHARMACOL THERAPEUT, V115, P232, DOI 10.1016/j.pharmthera.2007.05.003; Singer JD, 1998, J EDUC BEHAV STAT, V23, P323; TAHRIJOUTEI A, 1989, ENDOCRINOLOGY, V125, P605, DOI 10.1210/endo-125-2-605; Wood NI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009077; Zuccato C, 2009, NAT REV NEUROL, V5, P311, DOI 10.1038/nrneurol.2009.54	42	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e99520	10.1371/journal.pone.0099520	http://dx.doi.org/10.1371/journal.pone.0099520			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955833	Green Published, gold, Green Submitted			2022-12-27	WOS:000338917900012
J	Ocampo, G; Michelangeli, FA; Almeda, F				Ocampo, Gilberto; Michelangeli, Fabian A.; Almeda, Frank			Seed Diversity in the Tribe Miconieae (Melastomataceae): Taxonomic, Systematic, and Evolutionary Implications	PLOS ONE			English	Article							BAYESIAN PHYLOGENETIC INFERENCE; CLADISTIC-ANALYSIS; DNA-SEQUENCES; MORPHOLOGY; CHARACTERS; MODEL; SIGNAL; TREES; FIRE; SIZE	Miconieae is the largest tribe in the Melastomataceae with over 1,850 species. The members of Miconieae display a wide range of morphological diversity, and seed morphology is no exception. Previous studies have found that seed morphological diversity is not congruent with traditional classifications, and suggest that it may reflect evolutionary relationships within Miconieae. Here we characterize seed morphology of 364 species of Miconieae. The morphological data set and a DNA sequence data matrix were analyzed under a parsimony and Bayesian framework. Seed characters were used to test taxonomic and clade hypotheses, to estimate morphological ancestral character states, and to assess phylogenetic signal. The phylogenetic analyses of morphological data retrieved a poorly-resolved, low-supported phylogeny; in contrast, a relatively strongly supported phylogeny was estimated using the molecular data. Hypothesis testing procedures could only reject the monophyly of Clidemia, Leandra, and Miconia. The results indicated that the seed morphological characters were homoplasious, but contained phylogenetic signal. The morphological seed types that were described in previous studies did not support any of the clades retrieved by the molecular phylogeny. In contrast with previous investigations, our study shows that although seed morphology is very variable, it does not provide information for supporting some genera or clades within Miconieae. However, it is suggested that seed characters in combination with other vegetative and reproductive traits may aid in the characterization of smaller clades. The presence of phylogenetic signal retrieved by homoplasious characters may indicate that diversification of seed characters could have an adaptive component. Further studies that increase taxon sampling, refine seed trait characterization, and evaluate the alleged relationships between environmental variables and seed diversification will contribute to a better understanding of seed morphology and evolution in this species-rich tribe.	[Ocampo, Gilberto; Almeda, Frank] Calif Acad Sci, Inst Biodivers Sci & Sustainabil, Dept Bot, San Francisco, CA 94118 USA; [Michelangeli, Fabian A.] New York Bot Garden, Bronx, NY 10458 USA	California Academy of Sciences; New York Botanical Garden	Ocampo, G (corresponding author), Calif Acad Sci, Inst Biodivers Sci & Sustainabil, Dept Bot, San Francisco, CA 94118 USA.	gocampo@calacademy.org	Michelangeli, Fabian A/A-7945-2011	Michelangeli, Fabian A/0000-0001-7348-143X	U.S. National Science Foundation [DEB 0818399]; California Academy of Sciences; Division Of Environmental Biology [0818399] Funding Source: National Science Foundation	U.S. National Science Foundation(National Science Foundation (NSF)); California Academy of Sciences; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the U.S. National Science Foundation (DEB 0818399-Planetary Biodiversity Inventory: Miconieae) and the California Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Almeda F, 2003, NATURAL HIST MADAGAS, P375; Almeda F., 2011, SYST BOT MONOGR, V93, P1; Barker FK, 2002, SYST BIOL, V51, P625, DOI 10.1080/10635150290102302; Barthlott W., 1981, Nordic Journal of Botany, V1, P345, DOI 10.1111/j.1756-1051.1981.tb00704.x; Barthlott W., 1984, CURRENT CONCEPTPLA, P95; Barthlott W, 2000, SEED DIVERSITY CACTA, VV; Baumgratz J.F.A., 1985, ARQ JARD BOT RIO J, V27, P113; Becquer ER, 2014, PHYTOTAXA, V166, P241, DOI 10.11646/phytotaxa.166.4.1; Becquer-Granados ER, 2008, BOT REV, V74, P37, DOI 10.1007/s12229-008-9010-z; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Blomberg SP, 2002, J EVOLUTION BIOL, V15, P899, DOI 10.1046/j.1420-9101.2002.00472.x; Celep F, 2012, SYST BOT, V37, P893, DOI 10.1600/036364412X656563; Clausing G, 2001, AM J BOT, V88, P486, DOI 10.2307/2657114; Cogniaux A.C., 1891, MONOGRAPHIAE PHANERO, P1, DOI DOI 10.5962/BHL.TITLE.45961; Davitashvili N, 2010, BOT J LINN SOC, V162, P101, DOI 10.1111/j.1095-8339.2009.01020.x; De Candolle A.P., 1828, PRODROMUS SYSTEMATIS, V3, P99; Don D., 1823, MEMOIRS WERNERIAN NA, V4, P276, DOI DOI 10.1086/703517; Donoghue MJ, 2000, AM ZOOL, V40, P759, DOI 10.1668/0003-1569(2000)040[0759:HADCAM]2.0.CO;2; Dressler RL, 1993, PHYLOGENY CLASSIFICA; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EHLER N, 1978, Botanische Jahrbuecher fuer Systematik Pflanzengeschichte und Pflanzengeographie, V99, P329; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; FARRIS JS, 1966, EVOLUTION, V20, P587, DOI 10.1111/j.1558-5646.1966.tb03389.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gamarra R, 2012, PLANT SYST EVOL, V298, P597, DOI 10.1007/s00606-011-0569-1; Gamba D, 2014, PHYTOTAXA IN PRESS; Goldenberg R, 2008, INT J PLANT SCI, V169, P963, DOI 10.1086/589697; Goldenberg R, 2012, TAXON, V61, P1040, DOI 10.1002/tax.615010; Gomez-Gonzalez S, 2011, P NATL ACAD SCI USA, V108, P18743, DOI 10.1073/pnas.1108863108; Groenendijk JP, 1996, ACTA BOT NEERL, V45, P323; HSIAO YC, 1981, AM J BOT, V68, P1155, DOI 10.2307/2443037; Hu ZB, 2013, GENETICA, V141, P247, DOI 10.1007/s10709-013-9723-8; Johnson LA, 2004, INT J PLANT SCI, V165, P153, DOI 10.1086/380748; JUDD W S, 1991, Bulletin of the Florida Museum of Natural History Biological Sciences, V36, P25; JUDD WS, 1989, ANN MO BOT GARD, V76, P476, DOI 10.2307/2399496; Keeley JE, 2011, TRENDS PLANT SCI, V16, P406, DOI 10.1016/j.tplants.2011.04.002; KLUGE AG, 1969, SYST ZOOL, V18, P1, DOI 10.2307/2412407; Laurin M, 2004, SYST BIOL, V53, P594, DOI 10.1080/10635150490445706; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Li SY, 2000, J AM STAT ASSOC, V95, P493, DOI 10.2307/2669394; Maddison D. R., 2005, MACCLADE 4 08A ANAL, DOI [DOI 10.1046/J.1420-9101.1996.9020153.X, DOI 10.1007/s13592-012-0141-1]; Maddison WP, 2011, MESQUITE MODULAR SYS; Martin CV, 2008, CLADISTICS, V24, P315, DOI 10.1111/j.1096-0031.2007.00185.x; Martin CV, 2009, BRITTONIA, V61, P175, DOI 10.1007/s12228-008-9060-x; Mendes-Rodrigues C, 2012, PLANT BIOLOGY, V14, P845, DOI 10.1111/j.1438-8677.2011.00551.x; Mendoza H, 2006, GUIA ILUSTRADA GENER; Michelanceli FA, 2000, SYST BOT, V25, P211, DOI 10.2307/2666640; Michelangeli FA, 2004, TAXON, V53, P279, DOI 10.2307/4135608; Michelangeli FA, 2008, BOT REV, V74, P53, DOI 10.1007/s12229-008-9004-x; Moazzeni H, 2007, FLORA, V202, P447, DOI 10.1016/j.flora.2006.10.004; Muller KF, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-58; Naudin CV, 1849, ANN SCI NAT, V12-18; Neinhuis C, 1997, ANN BOT-LONDON, V79, P667, DOI 10.1006/anbo.1997.0400; Nylander JAA., 2004, MRMODELTEST 2 2; Ocampo G, 2014, PHYTOTAXA, V163, P166, DOI 10.11646/phytotaxa.163.3.3; Ocampo G, 2013, PHYTOTAXA, V80, P1; Ossi K, 2006, BEHAV ECOL SOCIOBIOL, V61, P53, DOI 10.1007/s00265-006-0236-7; Parisca L., 1972, B SOC VENEZOLANA CIE, V29, P633; Rannala B, 1996, J MOL EVOL, V43, P304, DOI 10.1007/PL00006090; REEVES JH, 1992, J MOL EVOL, V35, P17, DOI 10.1007/BF00160257; Reginato M, 2013, BRITTONIA, V65, P16, DOI 10.1007/s12228-012-9258-9; RENNER SS, 1993, NORD J BOT, V13, P519, DOI 10.1111/j.1756-1051.1993.tb00096.x; Revell LJ, 2008, SYST BIOL, V57, P591, DOI 10.1080/10635150802302427; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Simmons MP, 2002, CLADISTICS, V18, P354, DOI 10.1006/clad.2002.0201; Swenson NG, 2007, AM J BOT, V94, P451, DOI 10.3732/ajb.94.3.451; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; TEMPLETON AR, 1983, EVOLUTION, V37, P221, DOI 10.1111/j.1558-5646.1983.tb05533.x; Thompson K, 2003, SEED SCI RES, V13, P97, DOI 10.1079/SSR2003128; WHIFFIN T, 1972, AM J BOT, V59, P411, DOI 10.2307/2441552; Wiens JJ, 1999, ANNU REV ECOL SYST, V30, P327, DOI 10.1146/annurev.ecolsys.30.1.327; Wiens JJ, 1995, SYST BIOL, V44, P482, DOI 10.2307/2413656; Wilkinson M, 1995, CLADISTICS, V11, P297, DOI 10.1016/0748-3007(95)90017-9; Wurdack J. J., 1980, FLORA ECUADOR NO 13, P1; Wurdack J. J., 1993, FLORA GUIANAS, P1; Wurdack JJ, 1973, FLORA VENEZUELA, P1; Yang ZH, 1997, MOL BIOL EVOL, V14, P717, DOI 10.1093/oxfordjournals.molbev.a025811; YANG ZH, 1993, MOL BIOL EVOL, V10, P1396; Zaia J. E., 1998, Acta Botanica Brasilica, V12, P221, DOI 10.1590/S0102-33061998000300004; Zanne AE, 2005, AM J BOT, V92, P972, DOI 10.3732/ajb.92.6.972	82	9	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100561	10.1371/journal.pone.0100561	http://dx.doi.org/10.1371/journal.pone.0100561			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955964	Green Submitted, Green Published, gold			2022-12-27	WOS:000338917900067
J	Umemura, T; Katsuyama, Y; Yoshizawa, K; Kimura, T; Joshita, S; Komatsu, M; Matsumoto, A; Tanaka, E; Ota, M				Umemura, Takeji; Katsuyama, Yoshihiko; Yoshizawa, Kaname; Kimura, Takefumi; Joshita, Satoru; Komatsu, Michiharu; Matsumoto, Akihiro; Tanaka, Eiji; Ota, Masao			Human Leukocyte Antigen Class II Haplotypes Affect Clinical Characteristics and Progression of Type 1 Autoimmune Hepatitis in Japan	PLOS ONE			English	Article							PRIMARY BILIARY-CIRRHOSIS; MAJOR HISTOCOMPATIBILITY COMPLEX; HEPATOCELLULAR-CARCINOMA; BERYLLIUM DISEASE; PEPTIDE BINDING; AMINO-ACIDS; HLA-C; HLA-DPB1; SUSCEPTIBILITY; ALLELES	Although we earlier demonstrated that the human leukocyte antigen (HLA) DRB1*04:05 allele was associated with susceptibility to autoimmune hepatitis (AIH) in Japan, the precise relationship of HLA haplotype and the role of amino acid alignment with disease susceptibility and progression has not been fully clarified. We reinvestigated HLA class I A, B, and C and HLA class II DRB1, DQB1, and DPB1 alleles and haplotypes in a larger new cohort of 156 Japanese patients with type 1 AIH and compared them with the published data of 210 healthy subjects. The DRB1*04: 05-DQB1*04:01 haplotype was significantly associated with AIH susceptibility (30% vs. 11%, P = 1.2x10(-10); odds ratio [OR] = 3.51) and correlated with elevated serum IgG (3042 vs. 2606 mg/dL, P = 0.041) and anti-smooth muscle antigen positivity (77% vs. 34%, P = 0.000006). No associations with HLA-DPB1 alleles were found. The HLA A*24:02 and C*01:02 alleles were associated with disease susceptibility (corrected P = 0.0053 and 0.036, respectively), but this likely constituents of a long ranged haplotype including DRB1*04:05-DQB1*04:01 haplotype. Conversely, the DRB1*15:01-DQB1*06:02 haplotype was associated with protection from both disease onset (5% vs. 13%, P = 0.00057; OR = 0.38) and the development of hepatocellular carcinoma (25% vs. 5%, P = 0.017; OR = 6.81). The frequency of the DRB1*08:03-DQB1*06:01 haplotype was significantly higher in patients who developed hepatic failure (22% vs. 6%, P = 0.034; OR = 4.38). In conclusion, this study established the role of HLA haplotypes in determining AIH susceptibility and progression in the Japanese population. Additional sequencing of the entire HLA region is required to more precisely identify the genetic components of AIH.	[Umemura, Takeji; Yoshizawa, Kaname; Kimura, Takefumi; Joshita, Satoru; Komatsu, Michiharu; Matsumoto, Akihiro; Tanaka, Eiji] Shinshu Univ, Sch Med, Dept Med, Div Gastroenterol & Hepatol, Matsumoto, Nagano 390, Japan; [Katsuyama, Yoshihiko] Shinshu Univ Hosp, Dept Pharm, Matsumoto, Nagano, Japan; [Ota, Masao] Shinshu Univ, Sch Med, Dept Legal Med, Matsumoto, Nagano 390, Japan; [Yoshizawa, Kaname] NHO Ueda Med Ctr, Dept Gastroenterol, Ueda, Nagano, Japan	Shinshu University; Shinshu University; Shinshu University	Umemura, T (corresponding author), Shinshu Univ, Sch Med, Dept Med, Div Gastroenterol & Hepatol, Matsumoto, Nagano 390, Japan.	tumemura@shinshu-u.ac.jp; otamasao@shinshu-u.ac.jp	Joshita, Satoru/K-5679-2019	Joshita, Satoru/0000-0002-6364-9654; Ota, Masao/0000-0002-6400-5658	Ministry of Health, Labor and Welfare of Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan [23590969]; Grants-in-Aid for Scientific Research [26460996] Funding Source: KAKEN	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported in part by a research grant from the Ministry of Health, Labor and Welfare of Japan and the Ministry of Education, Culture, Sports, Science, and Technology of Japan (23590969). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez E, 1999, J HEPATOL, V31, P929, DOI 10.1016/S0168-8278(99)80297-9; Barber LD, 1996, J EXP MED, V184, P735, DOI 10.1084/jem.184.2.735; Czaja AJ, 1997, HEPATOLOGY, V25, P317; Czaja AJ, 2010, GASTROENTEROLOGY, V139, P58, DOI 10.1053/j.gastro.2010.04.053; DOHERTY DG, 1994, HEPATOLOGY, V19, P609, DOI 10.1002/hep.1840190311; Donaldson PT, 2006, HEPATOLOGY, V44, P667, DOI 10.1002/hep.21316; Donaldson PT, 2002, SEMIN LIVER DIS, V22, P353, DOI 10.1055/s-2002-35705; Fernando MMA, 2012, ANN RHEUM DIS, V71, P777, DOI 10.1136/annrheumdis-2011-200808; Furukawa H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053910; Gronbaek L, 2013, J HEPATOL; Heneghan MA, 2013, LANCET; Hino-Arinaga T, 2012, J GASTROENTEROL, V47, P569, DOI 10.1007/s00535-011-0519-2; Hoeroldt B, 2011, GASTROENTEROLOGY, V140, P1980, DOI 10.1053/j.gastro.2011.02.065; Invernizzi P, 2008, HEPATOLOGY, V48, P1906, DOI 10.1002/hep.22567; Krawitt EL, 2006, NEW ENGL J MED, V354, P54, DOI 10.1056/NEJMra050408; Lyons PA, 2012, NEW ENGL J MED, V367, P214, DOI 10.1056/NEJMoa1108735; Mandelboim O, 1996, J EXP MED, V184, P913, DOI 10.1084/jem.184.3.913; Migita K, 2012, LIVER INT, V32, P837, DOI 10.1111/j.1478-3231.2011.02734.x; Montano-Loza AJ, 2008, AM J GASTROENTEROL, V103, P1944, DOI 10.1111/j.1572-0241.2008.01922.x; Ngu JH, 2012, HEPATOLOGY, V55, P522, DOI 10.1002/hep.24743; NOMURA N, 1991, HUM IMMUNOL, V32, P261, DOI 10.1016/0198-8859(91)90089-R; Ohira H, 2013, J GASTROENTEROL, V48, P109, DOI 10.1007/s00535-012-0616-x; OTA M, 1991, TISSUE ANTIGENS, V38, P60, DOI 10.1111/j.1399-0039.1991.tb01882.x; OTA M, 1992, IMMUNOGENETICS, V36, P49, DOI 10.1007/BF00209292; RICHELDI L, 1993, SCIENCE, V262, P242, DOI 10.1126/science.8105536; Saito S, 2000, TISSUE ANTIGENS, V56, P522, DOI 10.1034/j.1399-0039.2000.560606.x; SEKI T, 1992, GASTROENTEROLOGY, V103, P1041, DOI 10.1016/0016-5085(92)90041-V; Shiina T, 2012, TISSUE ANTIGENS, V80, P305, DOI 10.1111/j.1399-0039.2012.01941.x; Silveira LJ, 2012, J IMMUNOL, V189, P4014, DOI 10.4049/jimmunol.1200798; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; Strettell MDJ, 1997, GASTROENTEROLOGY, V112, P2028, DOI 10.1053/gast.1997.v112.pm9178696; Strettell MDJ, 1997, HEPATOLOGY, V26, P1023, DOI 10.1002/hep.510260434; Umemura T, 2006, HEPATOLOGY, V43, P91, DOI 10.1002/hep.20917; Umemura T, 2003, J INFECT DIS, V188, P1545, DOI 10.1086/379216; Umemura T, 2007, HEPATOLOGY, V46, P463, DOI 10.1002/hep.21700; Umemura T, 2012, HEPATOLOGY, V55, P506, DOI 10.1002/hep.24705; Varney MD, 2010, DIABETES, V59, P2055, DOI 10.2337/db09-0680; Xie G, 2013, ARTHRITIS RHEUM-US, V65, P2457, DOI 10.1002/art.38036; Yoshizawa K, 2005, J HEPATOL, V42, P578, DOI 10.1016/j.jhep.2004.12.019; Yoshizawa K, 2012, HEPATOLOGY, V56, P668, DOI 10.1002/hep.25658	40	42	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100565	10.1371/journal.pone.0100565	http://dx.doi.org/10.1371/journal.pone.0100565			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956105	Green Published, gold, Green Submitted			2022-12-27	WOS:000338917900068
J	Wurdeman, SR; Myers, SA; Jacobsen, AL; Stergiou, N				Wurdeman, Shane R.; Myers, Sara A.; Jacobsen, Adam L.; Stergiou, Nicholas			Adaptation and Prosthesis Effects on Stride-to-Stride Fluctuations in Amputee Gait	PLOS ONE			English	Article							NONLINEAR-ANALYSIS; ENERGY-STORAGE; FOOT STIFFNESS; VARIABILITY; WALKING; LIMB; PATTERNS; FREEDOM; MOTION	Twenty-four individuals with transtibial amputation were recruited to a randomized, crossover design study to examine stride-to-stride fluctuations of lower limb joint flexion/extension time series using the largest Lyapunov exponent (lambda). Each individual wore a "more appropriate" and a "less appropriate" prosthesis design based on the subject's previous functional classification for a three week adaptation period. Results showed decreased lambda for the sound ankle compared to the prosthetic ankle (F-1,F-23 = 13.897, p = 0.001) and a decreased lambda for the "more appropriate" prosthesis (F-1,F-23 = 4.849, p = 0.038). There was also a significant effect for the time point in the adaptation period (F-2,F-46 = 3.164, p = 0.050). Through the adaptation period, a freezing and subsequent freeing of dynamic degrees of freedom was seen as the lambda at the ankle decreased at the midpoint of the adaptation period compared to the initial prosthesis fitting (p = 0.032), but then increased at the end compared to the midpoint (p = 0.042). No differences were seen between the initial fitting and the end of the adaptation for lambda (p = 0.577). It is concluded that the lambda may be a feasible clinical tool for measuring prosthesis functionality and adaptation to a new prosthesis is a process through which the motor control develops mastery of redundant degrees of freedom present in the system.	[Wurdeman, Shane R.; Myers, Sara A.; Stergiou, Nicholas] Univ Nebraska, Omaha, NE 68182 USA; [Wurdeman, Shane R.] Adv Prosthet Ctr, Omaha, NE USA; [Jacobsen, Adam L.] Vet Affairs Med Ctr, Omaha, NE USA	University of Nebraska System; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Wurdeman, SR (corresponding author), Univ Nebraska, Biomech Res Bldg, Omaha, NE 68182 USA.	shanewurdeman@gmail.com	Myers, Sara/E-1460-2015	Myers, Sara/0000-0002-2934-2624	Orthotics & Prothetics Education & Research Foundation [OPERF-2012-FA-2]; American Society of Biomechanics; American Alliance for Health, Physical Education, Recreation & Dance Research Consortium; University of Nebraska Medical Center Widaman Graduate Fellowship	Orthotics & Prothetics Education & Research Foundation; American Society of Biomechanics; American Alliance for Health, Physical Education, Recreation & Dance Research Consortium; University of Nebraska Medical Center Widaman Graduate Fellowship	This study was supported by Orthotics & Prothetics Education & Research Foundation (OPERF-2012-FA-2), www.operf.org, SRW; American Society of Biomechanics Grant-in-Aid, www.asbweb.org, SRW; American Alliance for Health, Physical Education, Recreation & Dance Research Consortium Doctoral Grant, www.aahperd.org, SRW; University of Nebraska Medical Center Widaman Graduate Fellowship, www.unmc.edu, SRW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarbanel H.D.I., 1996, ANAL OBSERVED CHAOTI; Bernstein N, 1967, COORDINATION REGULAT; Bernstein N., 1984, HUMAN MOTOR ACTIONS; Bogaert C, 2001, AUTON NEUROSCI-BASIC, V90, P142, DOI 10.1016/S1566-0702(01)00280-6; ENGLISH RD, 1995, J REHABIL RES DEV, V32, P32; Fey NP, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4007824; Fey NP, 2013, J BIOMECH, V46, P637, DOI 10.1016/j.jbiomech.2012.11.051; Fey NP, 2011, CLIN BIOMECH, V26, P1025, DOI 10.1016/j.clinbiomech.2011.06.007; Fowler CA., 1978, INFORM PROCESSING MO, P1; Gailey RS, 2002, ARCH PHYS MED REHAB, V83, P613, DOI 10.1053/ampr.2002.32309; Glazier P.S., 2003, SPORTSCIENCE, V7; Harbourne RT, 2003, DEV PSYCHOBIOL, V42, P368, DOI 10.1002/dev.10110; Huang S, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-55; Izrailtyan I, 2000, J THORAC CARDIOV SUR, V120, P737, DOI 10.1067/mtc.2000.108930; Myers SA, 2011, CLIN BIOMECH, V26, P729, DOI 10.1016/j.clinbiomech.2011.03.005; Myers SA, 2010, J SURG RES, V164, P6, DOI 10.1016/j.jss.2010.04.030; Myers SA, 2009, J VASC SURG, V49, P924, DOI 10.1016/j.jvs.2008.11.020; Newell KM, 2003, J EXP PSYCHOL HUMAN, V29, P379, DOI 10.1037/0096-1523.29.2.379; Noridian website, 2013, LOC COV DET LOW LIMB; Perry J, 2004, ARCH PHYS MED REHAB, V85, P1711, DOI 10.1016/j.apmr.2004.02.028; PERRY J, 1993, J REHABIL RES DEV, V30, P137; Perry J, 1997, IEEE Trans Rehabil Eng, V5, P283, DOI 10.1109/86.650279; Rusaw D, 2011, PROSTHET ORTHOT INT, V35, P8, DOI 10.1177/0309364610393060; Sawers A, 2011, J BIOMECH, V44, P1673, DOI 10.1016/j.jbiomech.2011.03.028; Snyder RD, 1995, J REHABIL RES DEV, V32, P309; Stergiou N, 2011, HUM MOVEMENT SCI, V30, P869, DOI 10.1016/j.humov.2011.06.002; Tuller B., 1982, HUMAN MOTOR BEHAV IN; TURVEY MT, 1990, AM PSYCHOL, V45, P938, DOI 10.1037/0003-066X.45.8.938; van Emmerik REA, 1990, THESIS U ILLINOIS UR; Vaughan C.L., 1992, DYNAMICS HUMAN GAIT; VEREIJKEN B, 1992, J MOTOR BEHAV, V24, P133, DOI 10.1080/00222895.1992.9941608; WOLF A, 1985, PHYSICA D, V16, P285, DOI 10.1016/0167-2789(85)90011-9; Wurdeman SR, 2013, J REHABIL RES DEV, V50, P671, DOI 10.1682/JRRD.2012.06.0104; Wurdeman SR, 2013, GAIT POSTURE, V38, P73, DOI 10.1016/j.gaitpost.2012.10.017; Wurdeman SR, 2013, ANN BIOMED ENG, V41, P806, DOI 10.1007/s10439-012-0705-2	35	22	22	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100125	10.1371/journal.pone.0100125	http://dx.doi.org/10.1371/journal.pone.0100125			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL1WV	24956384	Green Published, Green Submitted, gold			2022-12-27	WOS:000338917900026
J	Chrcanovic, BR; Albrektsson, T; Wennerberg, A				Chrcanovic, Bruno Ramos; Albrektsson, Tomas; Wennerberg, Ann			Flapless versus Conventional Flapped Dental Implant Surgery: A Meta-Analysis	PLOS ONE			English	Article							PARTIALLY EDENTULOUS PATIENTS; BELO-HORIZONTE; FOLLOW-UP; IMMEDIATE; OUTCOMES; BONE; REHABILITATION; PLACEMENT; FRACTURES; SURFACES	The aim of this study was to test the null hypothesis of no difference in the implant failure rates, postoperative infection, and marginal bone loss for patients being rehabilitated by dental implants being inserted by a flapless surgical procedure versus the open flap technique, against the alternative hypothesis of a difference. An electronic search without time or language restrictions was undertaken in March 2014. Eligibility criteria included clinical human studies, either randomized or not. The search strategy resulted in 23 publications. The I-2 statistic was used to express the percentage of the total variation across studies due to heterogeneity. The inverse variance method was used for random-effects model or fixed-effects model, when indicated. The estimates of relative effect were expressed in risk ratio (RR) and mean difference (MD) in millimeters. Sixteen studies were judged to be at high risk of bias, whereas two studies were considered of moderate risk of bias, and five studies of low risk of bias. The funnel plots indicated absence of publication bias for the three outcomes analyzed. The test for overall effect showed that the difference between the procedures (flapless vs. open flap surgery) significantly affect the implant failure rates (P = 0.03), with a RR of 1.75 (95% CI 1.07-2.86). However, a sensitivity analysis revealed differences when studies of high and low risk of bias were pooled separately. Thus, the results must be interpreted carefully. No apparent significant effects of flapless technique on the occurrence of postoperative infection (P = 0.96; RR 0.96, 95% CI 0.23-4.03) or on the marginal bone loss (P = 0.16; MD 20.07 mm, 95% CI 20.16-0.03) were observed.	[Chrcanovic, Bruno Ramos; Albrektsson, Tomas; Wennerberg, Ann] Malmo Univ, Fac Odontol, Dept Prosthodont, Malmo, Sweden; [Albrektsson, Tomas] Gothenburg Univ, Dept Biomat, Gothenburg, Sweden	Malmo University; University of Gothenburg	Chrcanovic, BR (corresponding author), Malmo Univ, Fac Odontol, Dept Prosthodont, Malmo, Sweden.	bruno.chrcanovic@mah.se	Chrcanovic, Bruno/A-1278-2014	Chrcanovic, Bruno/0000-0002-3460-3374	CNPq, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - Brazil	CNPq, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by CNPq, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - Brazil. The supportive institution had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Juboori Mohammed Jasim, 2012, Dent Implantol Update, V23, P9; Annibali S, 2009, INT J PERIODONT REST, V29, P325; Arisan V, 2010, CLIN ORAL IMPLAN RES, V21, P980, DOI 10.1111/j.1600-0501.2010.01957.x; Berdougo M, 2010, CLIN IMPLANT DENT R, V12, P142, DOI 10.1111/j.1708-8208.2008.00146.x; Campelo LD, 2002, INT J ORAL MAX IMPL, V17, P271; Cannizzaro G, 2008, INT J ORAL MAX IMPL, V23, P867; Cannizzaro G, 2011, EUR J ORAL IMPLANTOL, V4, P177; Chiapasco M, 2009, CLIN ORAL IMPLAN RES, V20, P113, DOI 10.1111/j.1600-0501.2009.01781.x; Chrcanovic BR, 2014, J ORAL REHABIL, V41, P443, DOI 10.1111/joor.12157; Chrcanovic BR, 2010, J ORAL IMPLANTOL, V36, P345, DOI 10.1563/AAID-JOI-D-09-00074; Chrcanovic BR, 2014, MATER RES-IBERO-AM J, V17, P373, DOI [10.1590/S1516-14392014005000042, 10.1590/S1516-14392014000200013]; Chrcanovic BR, 2013, MATER RES-IBERO-AM J, V16, P1006, DOI [10.1590/S1516-14392013005000067, 10.1590/S1516-14392013000500008]; Chrcanovic BR, 2012, MATER RES-IBERO-AM J, V15, P372, DOI [10.1590/S1516-14392012000300007, 10.1590/S1516-14392012005000035]; Chrcanovic BR, 2012, J CRANIO MAXILL SURG, V40, P116, DOI 10.1016/j.jcms.2011.03.012; Chrcanovic BR, 2010, DENT TRAUMATOL, V26, P262, DOI 10.1111/j.1600-9657.2010.00887.x; Covani U, 2008, INT J ORAL MAX IMPL, V23, P841; Danza M, 2009, J CRANIOFAC SURG, V20, P1086, DOI 10.1097/SCS.0b013e3181abb322; De Bruyn H, 2011, CLIN IMPLANT DENT R, V13, P175, DOI 10.1111/j.1708-8208.2009.00200.x; de Velde TV, 2008, CLIN ORAL IMPLAN RES, V19, P66, DOI 10.1111/j.1600-0501.2007.01423.x; Egger M, 2003, SYSTEMATIC REV HLTH, P23; Froum SJ, 2011, INT J PERIODONT REST, V31, P591; Katsoulis J, 2012, CLIN IMPLANT DENT R, V14, P915, DOI 10.1111/j.1708-8208.2010.00326.x; Kinsel RP, 2007, INT J ORAL MAX IMPL, V22, P823; Lindeboom JA, 2010, CLIN ORAL IMPLAN RES, V21, P366, DOI 10.1111/j.1600-0501.2009.01866.x; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Malo P, 2008, EUR J ORAL IMPLANTOL, V1, P293; Marcelis K, 2012, CLIN ORAL IMPLAN RES, V23, P999, DOI 10.1111/j.1600-0501.2011.02242.x; Meizi E, 2014, INT J ORAL MAX IMPL, V29, pE14, DOI 10.11607/jomi.te37; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Nkenke E, 2007, CLIN ORAL IMPLAN RES, V18, P197, DOI 10.1111/j.1600-0501.2006.01335.x; Ozan O, 2007, J ORAL REHABIL, V34, P835, DOI 10.1111/j.1365-2842.2007.01772.x; Rocci Antonio, 2003, Clin Implant Dent Relat Res, V5 Suppl 1, P29, DOI 10.1111/j.1708-8208.2003.tb00013.x; Rousseau P, 2010, J ORAL MAXIL SURG, V68, P2299, DOI 10.1016/j.joms.2010.05.031; Sennerby L, 2008, CLIN ORAL IMPLAN RES, V19, P219, DOI 10.1111/j.1600-0501.2007.01410.x; Sharaf B, 2011, J ORAL MAXIL SURG, V69, P2345, DOI 10.1016/j.joms.2011.02.095; Shrier I, 2007, AM J EPIDEMIOL, V166, P1203, DOI 10.1093/aje/kwm189; Sunitha RV, 2013, OR SURG OR MED OR PA, V116, pE237, DOI 10.1016/j.oooo.2011.12.027; ten Bruggenkate C M, 1990, Int J Oral Implantol, V7, P45; Tsoukaki M, 2013, CLIN ORAL IMPLAN RES, V24, P969, DOI 10.1111/j.1600-0501.2012.02503.x; Van de Velde T, 2010, CLIN ORAL IMPLAN RES, V21, P1223, DOI 10.1111/j.1600-0501.2010.01924.x; Villa R, 2007, J PROSTHET DENT, V97, pS96, DOI 10.1016/S0022-3913(07)60013-4; Wennerberg A, 2010, INT J ORAL MAX IMPL, V25, P63; WOOD DL, 1972, J PERIODONTOL, V43, P141, DOI 10.1902/jop.1972.43.3.141	43	40	40	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100624	10.1371/journal.pone.0100624	http://dx.doi.org/10.1371/journal.pone.0100624			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950053	Green Published, gold, Green Submitted			2022-12-27	WOS:000338276300100
J	Hakimi, M; Grassmann, JP; Betsch, M; Schneppendahl, J; Gehrmann, S; Hakimi, AR; Kropil, P; Sager, M; Herten, M; Wild, M; Windolf, J; Jungbluth, P				Hakimi, Mohssen; Grassmann, Jan-Peter; Betsch, Marcel; Schneppendahl, Johannes; Gehrmann, Sebastian; Hakimi, Ahmad-Reza; Kroepil, Patric; Sager, Martin; Herten, Monika; Wild, Michael; Windolf, Joachim; Jungbluth, Pascal			The Composite of Bone Marrow Concentrate and PRP as an Alternative to Autologous Bone Grafting	PLOS ONE			English	Article							PLATELET-RICH PLASMA; MESENCHYMAL STEM-CELLS; CRITICAL-SIZE DEFECTS; CONE-BEAM CT; OSTEOGENIC DIFFERENTIATION; DISTRACTION OSTEOGENESIS; AUTOGENOUS BONE; PHOSPHATE; PROLIFERATION; TRANSPLANTATION	One possible alternative to the application of autologous bone grafts represents the use of autologous bone marrow concentrate (BMC). The purpose of our study was to evaluate the potency of autologous platelet-rich plasma (PRP) in combination with BMC. In 32 mini-pigs a metaphyseal critical-size defect was surgically created at the proximal tibia. The animals were allocated to four treatment groups of eight animals each (1. BMC+CPG group, 2. BMC+CPG+PRP group, 3. autograft group, 4. CPG group). In the BMC+CPG group the defect was filled with autologous BMC in combination with calcium phosphate granules (CPG), whereas in the BMC+CPG+PRP group the defect was filled with the composite of autologous BMC, CPG and autologous PRP. In the autograft group the defect was filled with autologous cancellous graft, whereas in the CPG group the defect was filled with CPG solely. After 6 weeks radiological and histomorphometrical analysis showed significantly more new bone formation in the BMC+CPG+PRP group compared to the BMC+CPG group and the CPG group. There were no significant differences between the BMC+CPG+PRP group and the autograft group. In the PRP platelets were enriched significantly about 4.7-fold compared to native blood. In BMC the count of mononuclear cells increased significantly (3.5-fold) compared to the bone marrow aspirate. This study demonstrates that the composite of BMC+CPG+PRP leads to a significantly higher bone regeneration of critical-size defects at the proximal tibia in mini-pigs than the use of BMC+CPG without PRP. Furthermore, within the limits of the present study the composite BMC+CPG+PRP represents a comparable alternative to autologous bone grafting.	[Hakimi, Mohssen; Grassmann, Jan-Peter; Betsch, Marcel; Schneppendahl, Johannes; Gehrmann, Sebastian; Wild, Michael; Windolf, Joachim; Jungbluth, Pascal] Heinrich Heine Univ Hosp Duesseldorf, Dept Trauma & Handsurg, Dusseldorf, Germany; [Sager, Martin] Heinrich Heine Univ Hosp Duesseldorf, Anim Res Inst, Dusseldorf, Germany; [Hakimi, Ahmad-Reza] Heinrich Heine Univ Hosp Duesseldorf, Dept Oral Surg, Dusseldorf, Germany; [Herten, Monika] Heinrich Heine Univ Hosp Duesseldorf, Dept Orthopaed, Dusseldorf, Germany; [Kroepil, Patric] Heinrich Heine Univ Hosp Duesseldorf, Dept Diagnost & Intervent Radiol, Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital	Grassmann, JP (corresponding author), Heinrich Heine Univ Hosp Duesseldorf, Dept Trauma & Handsurg, Dusseldorf, Germany.	Jan.Grassmann@med.uni-duesseldorf.de	Jungbluth, Pascal/L-6703-2017; Herten, Monika/J-1547-2015	Herten, Monika/0000-0001-9697-0287; Hakimi, Ahmad-Reza/0000-0001-5393-7735; Wild, Michael/0000-0002-6306-4867	medical faculty of the Heinrich Heine University Duesseldorf, Germany [9772443]	medical faculty of the Heinrich Heine University Duesseldorf, Germany	This study was supported by a research grant (9772443) from the medical faculty of the Heinrich Heine University Duesseldorf, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrington ED, 1996, CLIN ORTHOP RELAT R, P300, DOI 10.1097/00003086-199608000-00037; Bohner M, 2004, BIOMATERIALS, V25, P3569, DOI 10.1016/j.biomaterials.2003.10.032; CASTROMALASPINA H, 1980, BLOOD, V56, P289; Chen TL, 2014, J CRANIOFAC SURG, V25, P215, DOI 10.1097/SCS.0000000000000420; Dallari D, 2007, J BONE JOINT SURG AM, V89A, P2413, DOI 10.2106/JBJS.F.01026; Dallari D, 2006, J ORTHOP RES, V24, P877, DOI 10.1002/jor.20112; Delorme Bruno, 2007, V140, P67; Duan JM, 2011, MOL BIOL REP, V38, P2485, DOI 10.1007/s11033-010-0385-7; Faour O, 2011, INJURY, V42, pS87, DOI 10.1016/j.injury.2011.06.020; Fellah BH, 2008, BIOMATERIALS, V29, P1177, DOI 10.1016/j.biomaterials.2007.11.034; Gan YK, 2008, BIOMATERIALS, V29, P3973, DOI 10.1016/j.biomaterials.2008.06.026; Hakimi M, 2010, INJURY, V41, P717, DOI 10.1016/j.injury.2009.12.005; Hatzokos I, 2011, J BONE JOINT SURG AM, V93A, P671, DOI 10.2106/JBJS.J.00514; Hermann PC, 2007, CELL TRANSPLANT, V16, P1059, DOI 10.3727/000000007783472363; Hernigou P, 2005, J BONE JOINT SURG AM, V87A, P1430, DOI 10.2106/JBJS.D.02215; Hernigou P, 2006, J BONE JOINT SURG AM, V88A, P2565, DOI 10.2106/JBJS.E.01455; Herten M, 2013, VET COMP ORTHOPAED, V26, P34, DOI 10.3415/VCOT-11-11-0165; Huang SY, 2010, ORAL SURG ORAL MED O, V110, P453, DOI 10.1016/j.tripleo.2010.02.009; Jager M, 2010, ORTHOPADE, V39, P449, DOI [10.1007/s00132-009-1583-7, 10.4081/or.2010.e20]; Jager M, 2011, J ORTHOP RES, V29, P173, DOI 10.1002/jor.21230; Jager M, 2010, J ORTHOP RES; Jager M, ORTHOPADE, V39, P463; Kasten P, 2012, CELLS TISSUES ORGANS, V196, P523, DOI 10.1159/000337490; Kasten P, 2008, J BIOMATER APPL, V23, P169, DOI 10.1177/0885328207088269; Kasten P, 2008, BIOMATERIALS, V29, P3983, DOI 10.1016/j.biomaterials.2008.06.014; Kasten P, 2006, CELLS TISSUES ORGANS, V183, P68, DOI 10.1159/000095511; Kitoh H, 2004, BONE, V35, P892, DOI 10.1016/j.bone.2004.06.013; Kitoh H, 2007, BONE, V40, P522, DOI 10.1016/j.bone.2006.09.019; Kropil P, 2012, ACAD RADIOL, V19, P320, DOI 10.1016/j.acra.2011.10.022; Kurkalli BGS, 2010, CURR STEM CELL RES T, V5, P49, DOI 10.2174/157488810790442831; Lucarelli E, 2003, BIOMATERIALS, V24, P3095, DOI 10.1016/S0142-9612(03)00114-5; Mahendra A, 2007, INJURY, V38, pS7, DOI 10.1016/S0020-1383(08)70004-4; Marx R E, 2001, Implant Dent, V10, P225; Marx RE, 2004, J ORAL MAXIL SURG, V62, P489, DOI 10.1016/j.joms.2003.12.003; Marx RE, 1998, ORAL SURG ORAL MED O, V85, P638, DOI 10.1016/S1079-2104(98)90029-4; Murphy MB, 2012, BIOMATERIALS, V33, P5308, DOI 10.1016/j.biomaterials.2012.04.007; Muschler GF, 2001, J ORTHOP RES, V19, P117, DOI 10.1016/S0736-0266(00)00010-3; Nagata M, 2009, BONE, V45, P339, DOI 10.1016/j.bone.2009.04.246; Riegger C, 2012, SKELETAL RADIOL, V41, P531, DOI 10.1007/s00256-011-1203-6; Rosset P, 2014, ORTHOP TRAUMATOL-SUR, V100, pS107, DOI 10.1016/j.otsr.2013.11.010; Sarkar MR, 2006, BIOMATERIALS, V27, P1817, DOI 10.1016/j.biomaterials.2005.10.039; Schlegel K A, 2003, Mund Kiefer Gesichtschir, V7, P112; Schwarz F, 2014, J CLIN PERIODONTOLOG; Tas AC, 2008, J MATER SCI-MATER M, V19, P2231, DOI 10.1007/s10856-007-3326-9; Thoesen MS, 2006, AM J VET RES, V67, P1655, DOI 10.2460/ajvr.67.10.1655; Thor A, 2007, INT J ORAL MAX SURG, V36, P1164, DOI 10.1016/j.ijom.2007.05.023; Vogl M, 2013, J ORTHOP RES, V31, P1786, DOI 10.1002/jor.22433; Weibrich G, 2004, BONE, V34, P665, DOI 10.1016/j.bone.2003.12.010; Weibrich G, 2003, CLIN ORAL IMPLAN RES, V14, P357, DOI 10.1034/j.1600-0501.2003.00810.x; Weiss P, 2003, BIOMATERIALS, V24, P4591, DOI 10.1016/S0142-9612(03)00335-1; Wiltfang J, 2004, CLIN ORAL IMPLAN RES, V15, P187, DOI 10.1111/j.1600-0501.2004.00980.x; Yamashina A, 2008, DENTOMAXILLOFAC RAD, V37, P245, DOI 10.1259/dmfr/45926904; Yoshimi R, 2009, J CRANIOFAC SURG, V20, P1523, DOI 10.1097/SCS.0b013e3181b09b7e	53	21	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100143	10.1371/journal.pone.0100143	http://dx.doi.org/10.1371/journal.pone.0100143			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950251	Green Submitted, Green Published, gold			2022-12-27	WOS:000338276300039
J	Masvekar, RR; El-Hage, N; Hauser, KF; Knapp, PE				Masvekar, Ruturaj R.; El-Hage, Nazira; Hauser, Kurt F.; Knapp, Pamela E.			Morphine Enhances HIV-1 (SF162)-Mediated Neuron Death and Delays Recovery of Injured Neurites	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; 3-(4,5-DIMETHYLTHIAZOL-2-YL)-2,5-DIPHENYLTETRAZOLIUM BROMIDE MTT; IMMUNODEFICIENCY VIRUS-1 TAT; CEREBROSPINAL-FLUID; STRIATAL NEURONS; DIFFERENTIAL INVOLVEMENT; ANTIRETROVIRAL THERAPY; NERVOUS-SYSTEM; G-PROTEIN; ACTIVATION	HIV-1 enters the CNS soon after initial systemic infection; within the CNS parenchyma infected and/or activated perivascular macrophages, microglia and astrocytes release viral and cellular toxins that drive secondary toxicity in neurons and other cell types. Our previous work has largely modeled HIV-neuropathology using the individual viral proteins Tat or gp120, with murine striatal neurons as targets. To model disease processes more closely, the current study uses supernatant from HIV-1-infected cells. Supernatant from HIV-1(SF162)-infected differentiated-U937 cells (HIVsup+) was collected and p24 level was measured by ELISA to assess the infection. Injection drug abuse is a significant risk factor for HIV-infection, and opiate drug abusers show increased HIV-neuropathology, even with anti-retroviral treatments. We therefore assessed HIVsup+ effects on neuronal survival and neurite growth/pruning with or without concurrent exposure to morphine, an opiate that preferentially acts through mu-opioid receptors. Effects of HIVsup+ +/- morphine were assessed on neuronal populations, and also by time-lapse imaging of individual cells. HIVsup+ caused dose-dependent toxicity over a range of p24 levels (10-500 pg/ml). Significant interactions occurred with morphine at lower p24 levels (10 and 25 pg/ml), and GSK3 beta was implicated as a point of convergence. In the presence of glia, selective neurotoxic measures were significantly enhanced and interactions with morphine were also augmented, perhaps related to a decreased level of BDNF. Importantly, the arrest of neurite growth that occurred with exposure to HIVsup+ was reversible unless neurons were continuously exposed to morphine. Thus, while reducing HIV-infection levels may be protective, ongoing exposure to opiates may limit recovery. Opiate interactions observed in this HIV-infective environment were similar, though not entirely concordant, with Tat/gp120 interactions reported previously, suggesting unique interactions with virions or other viral or cellular proteins released by infected and/or activated cells.	[Masvekar, Ruturaj R.; Knapp, Pamela E.] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA 23284 USA; [El-Hage, Nazira; Hauser, Kurt F.; Knapp, Pamela E.] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA USA; [Hauser, Kurt F.; Knapp, Pamela E.] Virginia Commonwealth Univ, Inst Drug & Alcohol Studies, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Knapp, PE (corresponding author), Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA 23284 USA.	peknapp@vcu.edu	Hauser, Kurt/AAX-8361-2020; Masvekar, Ruturaj/ABD-8417-2020; Masvekar, Ruturaj/AAN-4044-2021	Hauser, Kurt/0000-0001-7886-0332	NIH \ National Institute on Drug Abuse (NIDA) [DA034231, DA027374, DA033200]; NATIONAL INSTITUTE ON DRUG ABUSE [K02DA027374, R01DA033200, R01DA034231, R01DA036154] Funding Source: NIH RePORTER	NIH \ National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	NIH vertical bar National Institute on Drug Abuse (NIDA) - DA034231 [Knapp]; NIH vertical bar National Institute on Drug Abuse (NIDA) - DA034231 [Hauser]; NIH vertical bar National Institute on Drug Abuse (NIDA) - DA027374 [Hauser]; NIH vertical bar National Institute on Drug Abuse (NIDA) - DA033200 [Hauser]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony IC, 2010, BRAIN, V133, P3685, DOI 10.1093/brain/awq263; ARVIDSSON U, 1995, J NEUROSCI, V15, P3328; Bell JE, 2002, JAIDS-J ACQ IMM DEF, V31, pS35, DOI 10.1097/00126334-200210012-00003; Bellizzi MJ, 2006, J NEUROIMMUNE PHARM, V1, P20, DOI 10.1007/s11481-005-9006-y; Berger JR, 1997, INTERVIROLOGY, V40, P122, DOI 10.1159/000150539; BERRIDGE MV, 1993, ARCH BIOCHEM BIOPHYS, V303, P474, DOI 10.1006/abbi.1993.1311; Bokhari SM, 2011, J NEUROIMMUNE PHARM, V6, P626, DOI 10.1007/s11481-011-9272-9; Bokhari SM, 2009, J NEUROVIROL, V15, P219, DOI 10.1080/13550280902913628; Bruce-Keller AJ, 2008, GLIA, V56, P1414, DOI 10.1002/glia.20708; Byrd DA, 2011, JAIDS-J ACQ IMM DEF, V58, P154, DOI 10.1097/QAI.0b013e318229ba41; Chao CC, 1997, J PHARMACOL EXP THER, V281, P998; CHENGMAYER C, 1988, ANN NEUROL, V23, pS58, DOI 10.1002/ana.410230716; Chung WS, 2013, NATURE; Crews L, 2009, INT J MOL SCI, V10, P1045, DOI 10.3390/ijms10031045; Cysique LA, 2004, J NEUROVIROL, V10, P350, DOI 10.1080/13550280490521078; Cysique LA, 2009, NEUROPSYCHOL REV, V19, P169, DOI 10.1007/s11065-009-9092-3; DAVIS LE, 1992, NEUROLOGY, V42, P1736, DOI 10.1212/WNL.42.9.1736; Dore GJ, 2003, AIDS, V17, P1539, DOI 10.1097/00002030-200307040-00015; Dou HY, 2005, J NEUROSCI, V25, P8375, DOI 10.1523/JNEUROSCI.2164-05.2005; Dou HY, 2003, J NEUROSCI, V23, P9162; El-Hage N, 2005, GLIA, V50, P91, DOI 10.1002/glia.20148; El-Hage N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004093; Ellis R, 2007, NAT REV NEUROSCI, V8, P33, DOI 10.1038/nrn2040; EPSTEIN LG, 1993, ANN NEUROL, V33, P429, DOI 10.1002/ana.410330502; Everall IP, 1999, BRAIN PATHOL, V9, P209; Everall IP, 2002, MOL CELL NEUROSCI, V21, P493, DOI 10.1006/mcne.2002.1196; Fitting S, 2010, AM J PATHOL, V177, P1397, DOI 10.2353/ajpath.2010.090945; Fitting S, 2010, J PROTEOME RES, V9, P1795, DOI 10.1021/pr900926n; Frame S, 2001, MOL CELL, V7, P1321, DOI 10.1016/S1097-2765(01)00253-2; Garden GA, 2002, GLIA, V40, P240, DOI 10.1002/glia.10155; Gilman CP, 2002, NEUROMOL MED, V2, P197, DOI 10.1385/NMM:2:2:197; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Gurwell JA, 2001, NEUROSCIENCE, V102, P555, DOI 10.1016/S0306-4522(00)00461-9; HATTEN ME, 1988, DEV BIOL, V125, P280, DOI 10.1016/0012-1606(88)90211-4; Hauser KF, 2007, J NEUROCHEM, V100, P567, DOI 10.1111/j.1471-4159.2006.04227.x; Hauser KF, 2009, GLIA, V57, P194, DOI 10.1002/glia.20746; Hu SX, 2005, J INFECT DIS, V191, P886, DOI 10.1086/427830; Ikeda H, 2010, J BIOL CHEM, V285, P38415, DOI 10.1074/jbc.M110.109827; ISHIGURO K, 1993, FEBS LETT, V325, P167, DOI 10.1016/0014-5793(93)81066-9; Jacobs Keith M, 2012, Int J Cell Biol, V2012, P930710, DOI 10.1155/2012/930710; Johnson TP, 2013, P NATL ACAD SCI USA, V110, P13588, DOI 10.1073/pnas.1308673110; Jones G, 2005, VIROLOGY, V334, P178, DOI 10.1016/j.virol.2005.01.027; Kaytor MD, 2002, CURR OPIN NEUROBIOL, V12, P275, DOI 10.1016/S0959-4388(02)00320-3; Kim HJ, 2008, J NEUROSCI, V28, P12604, DOI 10.1523/JNEUROSCI.2958-08.2008; Kramer-Hammerle S, 2005, VIRUS RES, V111, P194, DOI 10.1016/j.virusres.2005.04.009; Kumar R, 2006, VIROLOGY, V354, P192, DOI 10.1016/j.virol.2006.06.020; Le Roux PD, 2002, NEUROL RES, V24, P81, DOI 10.1179/016164102101199459; Liu SJ, 2003, J NEUROCHEM, V87, P1333, DOI 10.1046/j.1471-4159.2003.02070.x; Liu YB, 1997, J NEUROCHEM, V69, P581, DOI 10.1046/j.1471-4159.1997.69020581.x; Liu YL, 2000, J NEUROVIROL, V6, pS70; Maggirwar SB, 1999, J NEUROCHEM, V73, P578, DOI 10.1046/j.1471-4159.1999.0730578.x; MANDELKOW EM, 1992, FEBS LETT, V314, P315, DOI 10.1016/0014-5793(92)81496-9; MARTINEZ AJ, 1995, PATHOL RES PRACT, V191, P427, DOI 10.1016/S0344-0338(11)80730-2; Masliah E, 1997, ANN NEUROL, V42, P963, DOI 10.1002/ana.410420618; MCMILLIAN MK, 1995, CRIT REV NEUROBIOL, V9, P91; Miyatake M, 2009, J NEUROCHEM, V110, P662, DOI 10.1111/j.1471-4159.2009.06156.x; O'Brien SJ, 2000, IMMUNOL REV, V177, P99, DOI 10.1034/j.1600-065X.2000.17710.x; Pang XS, 2013, J NEUROIMMUNE PHARM, V8, P691, DOI 10.1007/s11481-013-9454-8; Peterson PK, 2004, J NEUROIMMUNOL, V147, P123, DOI 10.1016/j.jneuroim.2003.10.026; Petito CK, 1999, J NEUROVIROL, V5, P327, DOI 10.3109/13550289909029474; PLYTE SE, 1992, BIOCHIM BIOPHYS ACTA, V1114, P147, DOI 10.1016/0304-419X(92)90012-N; Podhaizer EM, 2012, J NEUROIMMUNE PHARM, V7, P877, DOI 10.1007/s11481-011-9326-z; Proudnikov D, 2012, J INFECT DIS, V205, P1745, DOI 10.1093/infdis/jis264; Ramage SN, 2005, NEUROPATH APPL NEURO, V31, P439, DOI 10.1111/j.1365-2990.2005.00670.x; Reid W, 2001, P NATL ACAD SCI USA, V98, P9271, DOI 10.1073/pnas.161290298; ROBERTSON JR, 1994, BRIT MED J, V309, P369, DOI 10.1136/bmj.309.6951.369; Robertson K, 2012, J NEUROVIROL, V18, P388, DOI 10.1007/s13365-012-0120-3; Robertson KR, 2007, AIDS, V21, P1915, DOI 10.1097/QAD.0b013e32828e4e27; Rogers TJ, 2003, TRENDS IMMUNOL, V24, P116, DOI 10.1016/S1471-4906(03)00003-6; ROUSSELET A, 1988, DEV BIOL, V129, P495, DOI 10.1016/0012-1606(88)90395-8; ROYAL W, 1994, ANN NEUROL, V36, P32, DOI 10.1002/ana.410360109; Sacktor N, 2002, J NEUROVIROL, V8, P115, DOI 10.1080/13550280290101094; Sargeant TJ, 2008, J NEUROCHEM, V107, P883, DOI 10.1111/j.1471-4159.2008.05671.x; SAWYNOK J, 1986, CAN J PHYSIOL PHARM, V64, P1, DOI 10.1139/y86-001; Shacklett BL, 2008, PLOS MED, V5, P16, DOI 10.1371/journal.pmed.0050013; Sheng Wen S., 1997, Archivum Immunologiae et Therapiae Experimentalis, V45, P359; SHOLL DA, 1953, J ANAT, V87, P387; Singh IN, 2005, NEUROSCIENCE, V135, P781, DOI 10.1016/j.neuroscience.2005.05.028; Singh IN, 2004, J NEUROVIROL, V10, P141, DOI 10.1080/13550280490441103; Soulie C, 2009, JAIDS-J ACQ IMM DEF, V51, P60, DOI 10.1097/QAI.0b013e31819fb903; Spudich SS, 2005, J INFECT DIS, V191, P890, DOI 10.1086/428095; Sui ZY, 2006, EUR J NEUROSCI, V23, P2623, DOI 10.1111/j.1460-9568.2006.04813.x; Suzuki M, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-78; Takayama N, 2005, J NEUROSCI, V25, P430, DOI 10.1523/JNEUROSCI.3170-04.2005; van Meerloo J, 2011, METHODS MOL BIOL, V731, P237, DOI 10.1007/978-1-61779-080-5_20; Xiong HG, 2000, J NEUROVIROL, V6, pS14; Zimmerman PA, 1997, MOL MED, V3, P23, DOI 10.1007/BF03401665; Zou SP, 2011, BRAIN, V134, P3613, DOI 10.1093/brain/awr281	88	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100196	10.1371/journal.pone.0100196	http://dx.doi.org/10.1371/journal.pone.0100196			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949623	gold, Green Published, Green Submitted			2022-12-27	WOS:000338276300048
J	Nijboer, TCW; Kollen, BJ; Kwakkel, G				Nijboer, Tanja C. W.; Kollen, Boudewijn J.; Kwakkel, Gert			The Impact of Recovery of Visuo-Spatial Neglect on Motor Recovery of the Upper Paretic Limb after Stroke	PLOS ONE			English	Article							IMPROVEMENT; IMPAIRMENT; POSTSTROKE	The aim of the current study was to investigate the longitudinal relationship between improvements of synergism and strength of the upper paretic limb and severity of visuo-spatial neglect during the first 52 weeks post-stroke. The longitudinal association between severity of VSN and motor impairment using Fugl Meyer motor score and Motricity Index of the arm was measured in an intensive repeated measurement design including 18 measurement sessions for each subject. Neglect was assessed using the letter cancellation test applied in a prospective cohort of 101 ischemic, first-ever, hemispheric stroke patients. All time-dependent measures were taken weekly, starting within 14 days post-stroke. From week 10 to 20 biweekly measurements are obtained. The longitudinal relationship of (bi)weekly time on improvement of motor functions and severity of neglect was investigated using random coefficient analysis and trend analyses. Fifty-one of the 101 stroke patients showed neglect at stroke onset. Less improvement of synergism and strength of the upper paretic limb was associated with more severe neglect. This association was most pronounced in the first 10 weeks post-stroke. The seemingly suppressive effect of neglect on upper-limb motor recovery appears to take place mainly during spontaneous neurological recovery of first 10 weeks post-stroke. This finding suggests that damage to large-scale white matter tracts of especially the perceptual-attention networks suppress recovery of other networks at distance in the brain suggesting a common underlying mechanism.	[Nijboer, Tanja C. W.] Univ Utrecht, Utrecht, Netherlands; [Nijboer, Tanja C. W.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands; [Nijboer, Tanja C. W.] Univ Med Ctr Utrecht, Ctr Excellence Rehabil Med, Utrecht, Netherlands; [Nijboer, Tanja C. W.] Hoogstr Rehabil Ctr, Utrecht, Netherlands; [Kollen, Boudewijn J.] Univ Groningen, Univ Med Ctr Groningen, Dept Gen Practice, Groningen, Netherlands; [Kwakkel, Gert] Vrije Univ Amsterdam, Med Ctr, Dept Rehabil Med, Res Inst MOVE, Amsterdam, Netherlands; [Kwakkel, Gert] Ctr Rehabil & & Rheumatol READE, Dept Neurorehabil, Amsterdam, Netherlands	Utrecht University; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Groningen; Vrije Universiteit Amsterdam	Nijboer, TCW (corresponding author), Univ Utrecht, Utrecht, Netherlands.	t.c.w.nijboer@uu.nl		Kwakkel, Gert/0000-0002-4041-4043; Nijboer, Tanja/0000-0001-6683-0267	NWO (Netherlands Organization for Scientific Research) [451-10-013]; EXPLICIT-stroke grant of ZonMw [89000001]; 4D-EEG (ERC) [291339-4D-EEG]	NWO (Netherlands Organization for Scientific Research)(Netherlands Organization for Scientific Research (NWO)); EXPLICIT-stroke grant of ZonMw; 4D-EEG (ERC)	Supported by a grant from NWO (Netherlands Organization for Scientific Research; grant 451-10-013 to TCWN, and by the EXPLICIT-stroke grant of ZonMw (grant 89000001) and 4D-EEG (ERC advanced grant 291339-4D-EEG) to GK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appelros P, 2002, J REHABIL MED, V34, P215, DOI 10.1080/165019702760279206; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; Buma F, 2013, RESTOR NEUROL NEUROS, V31, P707, DOI 10.3233/RNN-130332; Buxbaum LJ, 2004, NEUROLOGY, V62, P749, DOI 10.1212/01.WNL.0000113730.73031.F4; Carey LM, 2013, FUTUR NEUROL, V8, P507, DOI 10.2217/FNL.13.39; Carmichael ST, 2004, STROKE, V35, P758, DOI 10.1161/01.STR.0000117235.11156.55; Collin C, 1988, Int Disabil Stud, V10, P61; COLLIN C, 1990, J NEUROL NEUROSUR PS, V53, P576, DOI 10.1136/jnnp.53.7.576; Corbetta M, 2005, NAT NEUROSCI, V8, P1603, DOI 10.1038/nn1574; Corbetta M, 2011, ANNU REV NEUROSCI, V34, P569, DOI 10.1146/annurev-neuro-061010-113731; Deelman BG, 1981, STICHTING AFASIE NED; DUNCAN PW, 1994, STROKE, V25, P1181, DOI 10.1161/01.STR.25.6.1181; DUNCAN PW, 1992, STROKE, V23, P1084, DOI 10.1161/01.STR.23.8.1084; FEENEY DM, 1986, STROKE, V17, P817, DOI 10.1161/01.STR.17.5.817; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; KALRA L, 1993, J AM GERIATR SOC, V41, P396, DOI 10.1111/j.1532-5415.1993.tb06947.x; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; Kinsbourne M., 1978, ATTENTION PERFORM, VVII, P345; Kollen B, 2005, STROKE, V36, P2676, DOI 10.1161/01.STR.0000190839.29234.50; Krakauer JW, 2012, NEUROREHAB NEURAL RE, V26, P923, DOI 10.1177/1545968312440745; Krakauer JW, 2005, SEMIN NEUROL, V25, P384, DOI 10.1055/s-2005-923533; Kwakkel G, 2004, RESTOR NEUROL NEUROS, V22, P281; Kwakkel G, 1999, LANCET, V354, P191, DOI 10.1016/S0140-6736(98)09477-X; Kwakkel G, 2006, STROKE, V37, P2348, DOI 10.1161/01.STR.0000238594.91938.1e; Kwakkel G, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-49; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Murase N, 2004, ANN NEUROL, V55, P400, DOI 10.1002/ana.10848; Nijboer TCW, 2013, CORTEX, V49, P2021, DOI 10.1016/j.cortex.2012.11.006; Pedersen PM, 1997, ARCH PHYS MED REHAB, V78, P161, DOI 10.1016/S0003-9993(97)90258-6; PRESCOTT RJ, 1982, STROKE, V13, P641, DOI 10.1161/01.STR.13.5.641; Rasbash J, 2009, USERS GUIDE MLWIN V2, V2, P10; Rasbash J, 2009, MLWIN VERSION 21; Rasbash J, 2009, MANUAL SUPPLEMENT ML; Rengachary J, 2011, FRONT HUM NEUROSCI, V5, DOI [10.3389/fnhum.2011.00029, 10.3389/fnhum.2011.00069]; Rieck M, 2005, DISABIL REHABIL, V27, P1425, DOI 10.1080/09638280500330435; TWITCHELL TE, 1951, BRAIN, V74, P443, DOI 10.1093/brain/74.4.443; van Kordelaar J, 2013, NEUROREHAB NEURAL RE, V27, P854, DOI 10.1177/1545968313496327; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Zarahn E, 2011, CEREB CORTEX, V21, P2712, DOI 10.1093/cercor/bhr047	40	79	82	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100584	10.1371/journal.pone.0100584	http://dx.doi.org/10.1371/journal.pone.0100584			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK2UZ	24950224	Green Published, gold, Green Submitted			2022-12-27	WOS:000338276300094
J	Pestka, JJ; Vines, LL; Bates, MA; He, KY; Langohr, I				Pestka, James J.; Vines, Laura L.; Bates, Melissa A.; He, Kaiyu; Langohr, Ingeborg			Comparative Effects of n-3, n-6 and n-9 Unsaturated Fatty Acid-Rich Diet Consumption on Lupus Nephritis, Autoantibody Production and CD4(+) T Cell-Related Gene Responses in the Autoimmune NZBWF1 Mouse	PLOS ONE			English	Article							ATTENUATES KIDNEY-DISEASE; GROWTH-FACTOR-BETA; FISH-OIL; DOCOSAHEXAENOIC ACID; EICOSAPENTAENOIC ACID; PLASMA-CELLS; MONOCLONAL-ANTIBODY; INSULIN-RESISTANCE; FOOD RESTRICTION; INFLAMED KIDNEYS	Mortality from systemic lupus erythematosus (SLE), a prototypical autoimmune disease, correlates with the onset and severity of kidney glomerulonephritis. There are both preclinical and clinical evidence that SLE patients may benefit from consumption of n-3 polyunsaturated fatty acids (PUFA) found in fish oil, but the mechanisms remain unclear. Here we employed the NZBWF1 SLE mouse model to compare the effects of dietary lipids on the onset and severity of autoimmune glomerulonephritis after consuming: 1) n-3 PUFA-rich diet containing docosahexaenoic acid-enriched fish oil (DFO), 2) n-6 PUFA-rich Western-type diet containing corn oil (CRN) or 3) n-9 monounsaturated fatty acid (MUFA)-rich Mediterranean-type diet containing high oleic safflower oil (HOS). Elevated plasma autoantibodies, proteinuria and glomerulonephritis were evident in mice fed either the n-6 PUFA or n-9 MUFA diets, however, all three endpoints were markedly attenuated in mice that consumed the n-3 PUFA diet until 34 wk of age. A focused PCR array was used to relate these findings to the expression of 84 genes associated with CD4(+) T cell function in the spleen and kidney both prior to and after the onset of the autoimmune nephritis. n-3 PUFA suppression of autoimmunity in NZBWF1 mice was found to co-occur with a generalized downregulation of CD4(+) T cell-related genes in kidney and/or spleen at wk 34. These genes were associated with the inflammatory response, antigen presentation, T cell activation, B cell activation/differentiation and leukocyte recruitment. Quantitative RT-PCR of representative affected genes confirmed that n-3 PUFA consumption was associated with reduced expression of CD80, CTLA-4, IL-10, IL-18, CCL-5, CXCR3, IL-6, TNF-alpha and osteopontin mRNAs in kidney and/or spleens as compared to mice fed n-6 PUFA or n-9 MUFA diets. Remarkably, many of the genes identified in this study are currently under consideration as biomarkers and/or biotherapeutic targets for SLE and other autoimmune diseases.	[Pestka, James J.; Vines, Laura L.; Bates, Melissa A.] Michigan State Univ, Diagnost Ctr Populat & Anim Hlth, Dept Food Sci & Human Nutr, E Lansing, MI 48824 USA; [Pestka, James J.; Vines, Laura L.; Bates, Melissa A.; He, Kaiyu] Michigan State Univ, Diagnost Ctr Populat & Anim Hlth, Ctr Integrat Toxicol, E Lansing, MI 48824 USA; [Pestka, James J.; He, Kaiyu] Michigan State Univ, Diagnost Ctr Populat & Anim Hlth, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Langohr, Ingeborg] Michigan State Univ, Diagnost Ctr Populat & Anim Hlth, Div Anat Pathol, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University; Michigan State University	Pestka, JJ (corresponding author), Michigan State Univ, Diagnost Ctr Populat & Anim Hlth, Dept Food Sci & Human Nutr, E Lansing, MI 48824 USA.	pestka@msu.edu	Langohr, Ingeborg M/H-5570-2019	Langohr, Ingeborg M/0000-0001-7366-4391	National Institute of Environmental Health Sciences [ES021265]; National Institute of Diabetes, Digestive, and Kidney Disorders [DK058833]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES021265] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of Diabetes, Digestive, and Kidney Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institute of Environmental Health Sciences (ES021265) to JJP, and National Institute of Diabetes, Digestive, and Kidney Disorders (DK058833) to JJP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoura Z, 2003, ARTHRITIS RHEUM-US, V48, P3487, DOI 10.1002/art.11350; Barnes Patricia M, 2008, Natl Health Stat Report, P1; Beli E, 2008, J NUTR, V138, P813, DOI 10.1093/jn/138.4.813; Bhattacharya A, 2003, J AM COLL NUTR, V22, P388, DOI 10.1080/07315724.2003.10719322; Blenman KRM, 2006, LAB INVEST, V86, P1136, DOI 10.1038/labinvest.3700468; Borchers AT, 2012, AUTOIMMUN REV, V12, P174, DOI 10.1016/j.autrev.2012.08.018; BRENNAN DC, 1989, J IMMUNOL, V143, P3470; Brugos B, 2012, PHARMAZIE, V67, P411, DOI 10.1691/ph.2012.1694; Calder PC, 2010, CLIN NUTR, V29, P5, DOI 10.1016/j.clnu.2009.11.003; Calvani N, 2004, CLIN EXP IMMUNOL, V138, P171, DOI 10.1111/j.1365-2249.2004.02588.x; Cash H, 2010, J RHEUMATOL, V37, P60, DOI 10.3899/jrheum.090194; CHANDRASEKAR B, 1994, BIOCHEM BIOPH RES CO, V200, P893, DOI 10.1006/bbrc.1994.1534; Chandrasekar B, 1996, NUTR RES, V16, P489, DOI 10.1016/0271-5317(96)00030-9; CHANDRASEKAR B, 1995, J AUTOIMMUN, V8, P381, DOI 10.1006/jaut.1995.0030; Clark DN, 2013, CLIN IMMUNOL, V148, P335, DOI 10.1016/j.clim.2012.11.001; CLARK WF, 1993, CLIN NEPHROL, V39, P295; Cockwell P, 2002, NEPHROL DIAL TRANSPL, V17, P734, DOI 10.1093/ndt/17.5.734; D'Agati VDAGB, 2007, LUPUS NEPHRITIS PATH, P1094; Davidson A, 2005, LUPUS, V14, P197, DOI 10.1191/0961203305lu2136oa; De La Torre M, 2009, LUPUS, V18, P216, DOI 10.1177/0961203308096068; Duffy EM, 2004, J RHEUMATOL, V31, P1551; Enghard P, 2009, ARTHRITIS RHEUM, V60, P199, DOI 10.1002/art.24136; Enghard P, 2014, ANN RHEUM DIS, V73, P277, DOI 10.1136/annrheumdis-2012-202784; Favilli F, 2009, ANN NY ACAD SCI, V1173, P301, DOI 10.1111/j.1749-6632.2009.04742.x; Fenton JI, 2013, PROSTAG LEUKOTR ESS, V89, P379, DOI 10.1016/j.plefa.2013.09.011; Fu SM, 2011, J AUTOIMMUN, V37, P104, DOI 10.1016/j.jaut.2011.05.004; Furst DE, 2013, LUPUS, V22, P99, DOI 10.1177/0961203312463110; Gabriel CL, 2012, AM J PHYSIOL-ENDOC M, V303, pE1313, DOI 10.1152/ajpendo.00665.2011; Greco CM, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-013-0378-3; Haija AJ, 2011, RHEUM DIS CLIN N AM, V37, P47, DOI 10.1016/j.rdc.2010.11.005; Halade GV, 2013, EXP BIOL MED, V238, P610, DOI 10.1177/1535370213489485; Halade GV, 2010, J NUTR BIOCHEM, V21, P1162, DOI 10.1016/j.jnutbio.2009.10.002; Halade GV, 2010, J IMMUNOL, V184, P5280, DOI 10.4049/jimmunol.0903282; Hauser AE, 2002, J IMMUNOL, V169, P1277, DOI 10.4049/jimmunol.169.3.1277; Hem A, 1998, LAB ANIM-UK, V32, P364, DOI 10.1258/002367798780599866; Hiepe F, 2011, NAT REV RHEUMATOL, V7, P170, DOI 10.1038/nrrheum.2011.1; Iizuka J, 1998, LAB INVEST, V78, P1523; Illei GG, 2010, ARTHRITIS RHEUM-US, V62, P542, DOI 10.1002/art.27221; Jia QS, 2004, J NUTR, V134, P1353, DOI 10.1093/jn/134.6.1353; Jia QS, 2006, J NUTR, V136, P366, DOI 10.1093/jn/136.2.366; Jia QS, 2005, FOOD CHEM TOXICOL, V43, P721, DOI 10.1016/j.fct.2005.01.010; Jump DB, 2004, CRIT REV CL LAB SCI, V41, P41, DOI 10.1080/10408360490278341; Kalupahana NS, 2011, ADV NUTR, V2, P304, DOI 10.3945/an.111.000505; KELLEY VE, 1985, J IMMUNOL, V134, P1914; Kim HFS, 2001, MOL PSYCHIATR, V6, P246, DOI 10.1038/sj.mp.4000837; Kim YJ, 2006, LIFE SCI, V78, P2523, DOI 10.1016/j.lfs.2005.10.034; Koenig KF, 2012, CYTOKINE, V60, P410, DOI 10.1016/j.cyto.2012.07.004; Kontoyiannis D, 2000, EUR J IMMUNOL, V30, P2038, DOI 10.1002/1521-4141(200007)30:7<2038::AID-IMMU2038>3.0.CO;2-K; Kurien BT, 1999, LAB ANIM, V33, P83, DOI 10.1258/002367799780578525; Lacotte S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058140; LAMPE MA, 1991, J IMMUNOL, V147, P2902; Lee JY, 2003, J LIPID RES, V44, P479, DOI 10.1194/jlr.M200361-JLR200; Lima G, 2007, HUM IMMUNOL, V68, P980, DOI 10.1016/j.humimm.2007.10.007; LINKERISRAELI M, 1991, J IMMUNOL, V147, P117; Lit LCW, 2006, ANN RHEUM DIS, V65, P209, DOI 10.1136/ard.2005.038315; Llorente L, 2000, ARTHRITIS RHEUM, V43, P1790, DOI 10.1002/1529-0131(200008)43:8<1790::AID-ANR15>3.0.CO;2-2; Loetscher M, 1996, J EXP MED, V184, P963, DOI 10.1084/jem.184.3.963; Bargut TCL, 2014, LIPIDS, V49, P431, DOI 10.1007/s11745-014-3892-9; Lu MM, 2012, RHEUMATOL INT, V32, P1231, DOI 10.1007/s00296-010-1761-2; Menke J, 2008, J AM SOC NEPHROL, V19, P1177, DOI 10.1681/ASN.2007111179; Mihara M, 2000, J CLIN INVEST, V106, P91, DOI 10.1172/JCI9244; Mirnikjoo B, 2001, J BIOL CHEM, V276, P10888, DOI 10.1074/jbc.M008150200; MOORE KW, 1993, ANNU REV IMMUNOL, V11, P165, DOI 10.1146/annurev.iy.11.040193.001121; Munoz LE, 2010, AUTOIMMUN REV, V10, P38, DOI 10.1016/j.autrev.2010.08.015; Muthukumar A, 2004, J CLIN IMMUNOL, V24, P471, DOI 10.1023/B:JOCI.0000040918.92219.d1; Nicholas MIW, 2008, CLIN IMMUNOL, V126, P189, DOI 10.1016/j.clim.2007.10.004; Nystrom T, 2007, EXP CELL RES, V313, P1149, DOI 10.1016/j.yexcr.2006.12.026; Ogawa D, 2005, CIRC RES, V96, P59, DOI 10.1161/01.RES.0000163630.86796.17; Okamoto A, 2012, KIDNEY INT, V82, P969, DOI 10.1038/ki.2012.242; Panzer U, 2007, J AM SOC NEPHROL, V18, P2071, DOI 10.1681/ASN.2006111237; PATARCA R, 1989, J EXP MED, V170, P145, DOI 10.1084/jem.170.1.145; Pestka JJ, 2010, PROSTAG LEUKOTR ESS, V82, P251, DOI 10.1016/j.plefa.2010.02.013; Pollard KM, 2004, J IMMUNOL, V173, P5880, DOI 10.4049/jimmunol.173.9.5880; PRICKETT JD, 1983, ARTHRITIS RHEUM, V26, P133, DOI 10.1002/art.1780260203; Ravirajan CT, 2004, RHEUMATOLOGY, V43, P442, DOI 10.1093/rheumatology/keh083; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; ROBINSON DR, 1986, ARTHRITIS RHEUM, V29, P539, DOI 10.1002/art.1780290412; ROBINSON DR, 1985, PROSTAGLANDINS, V30, P51, DOI 10.1016/S0090-6980(85)80010-1; Rothstein TL, 2009, J INTERN MED, V265, P632, DOI 10.1111/j.1365-2796.2009.02103.x; ROUSSET F, 1995, INT IMMUNOL, V7, P1243, DOI 10.1093/intimm/7.8.1243; Rudd CE, 2009, IMMUNOL REV, V229, P12, DOI 10.1111/j.1600-065X.2009.00770.x; Rullo OJ, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4150; Ryan MJ, 2006, HYPERTENSION, V48, P988, DOI 10.1161/01.HYP.0000243612.02929.df; Sales-Campos H, 2013, MINI-REV MED CHEM, V13, P201; Sang A, 2012, PROG MOL BIOL TRANSL, V105, P321, DOI 10.1016/B978-0-12-394596-9.00010-X; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Segerer S, 2004, AM J PATHOL, V164, P635, DOI 10.1016/S0002-9440(10)63152-5; Shaikh SR, 2012, MOL ASPECTS MED, V33, P46, DOI 10.1016/j.mam.2011.10.002; Shi Q, 2011, INT J IMMUNOPATH PH, V24, P583, DOI 10.1177/039463201102400304; Shi YH, 2009, J NUTR BIOCHEM, V20, P358, DOI 10.1016/j.jnutbio.2008.04.006; Shimizu C, 2012, MOD RHEUMATOL, V22, P73, DOI 10.1007/s10165-011-0471-2; Shinohara ML, 2005, P NATL ACAD SCI USA, V102, P17101, DOI 10.1073/pnas.0508666102; SPURNEY RF, 1994, PROSTAGLANDINS, V48, P331, DOI 10.1016/0090-6980(94)90032-9; Starke C, 2011, EUR J IMMUNOL, V41, P2107, DOI 10.1002/eji.201041315; Steinmetz OM, 2009, J IMMUNOL, V183, P4693, DOI 10.4049/jimmunol.0802626; Tackey E, 2004, LUPUS, V13, P339, DOI 10.1191/0961203304lu1023oa; THEOFILOPOULOS AN, 1985, ADV IMMUNOL, V37, P269, DOI 10.1016/S0065-2776(08)60342-9; Triantafyllopoulou A, 2010, P NATL ACAD SCI USA, V107, P3012, DOI 10.1073/pnas.0914902107; Turk HF, 2013, PROSTAG LEUKOTR ESS, V88, P43, DOI 10.1016/j.plefa.2012.03.008; Venkatraman JT, 1999, J AM COLL NUTR, V18, P602, DOI 10.1080/07315724.1999.10718895; Villalta D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071458; Walton AJE, 1991, DIETARY FISH OIL SEV; Weber GF, 2001, CLIN EXP IMMUNOL, V126, P578, DOI 10.1046/j.1365-2249.2001.01702.x; Weening JJ, 2004, KIDNEY INT, V65, P521, DOI 10.1111/j.1523-1755.2004.00443.x; WESTBERG G, 1989, INT ARCH ALLER A IMM, V88, P454, DOI 10.1159/000234732; WESTBERG G, 1990, SCAND J RHEUMATOL, V19, P137, DOI 10.3109/03009749009102117; Wong CK, 2005, RHEUMATOLOGY, V44, P602, DOI 10.1093/rheumatology/keh558; Wright SA, 2008, ANN RHEUM DIS, V67, P841, DOI 10.1136/ard.2007.077156; Yang Rong, 2011, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1426s95; Yap DYH, 2013, NEPHROLOGY, V18, P243, DOI 10.1111/nep.12047; Ye DQ, 2005, ARCH DERMATOL RES, V297, P108, DOI 10.1007/s00403-005-0581-9; Yumoto K, 2002, P NATL ACAD SCI USA, V99, P4556, DOI 10.1073/pnas.052523599	113	40	41	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100255	10.1371/journal.pone.0100255	http://dx.doi.org/10.1371/journal.pone.0100255			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945254	gold, Green Published, Green Submitted			2022-12-27	WOS:000340721500054
J	Steiner, JL; Pruznak, A; Deiter, G; Navaratnarajah, M; Kutzler, L; Kimball, SR; Lang, CH				Steiner, Jennifer L.; Pruznak, Annem.; Deiter, Gina; Navaratnarajah, Maithili; Kutzler, Lydia; Kimball, Scot R.; Lang, Charles H.			Disruption of Genes Encoding eIF4E Binding Proteins-1 And-2 Does Not Alter Basal or Sepsis-Induced Changes in Skeletal Muscle Protein Synthesis in Male or Female Mice	PLOS ONE			English	Article							INSULIN-RESISTANCE; SIGNALING PATHWAY; MESSENGER-RNA; GROWTH-FACTOR; PHOSPHORYLATION; TRANSLATION; MTOR; ACTIVATION; CYTOKINE; LEUCINE	Sepsis decreases skeletal muscle protein synthesis in part by impairing mTOR activity and the subsequent phosphorylation of 4E-BP1 and S6K1 thereby controlling translation initiation; however, the relative importance of changes in these two downstream substrates is unknown. The role of 4E-BP1 (and -BP2) in regulating muscle protein synthesis was assessed in wild-type (WT) and 4E-BP1/BP2 double knockout (DKO) male mice under basal conditions and in response to sepsis. At 12 months of age, body weight, lean body mass and energy expenditure did not differ between WT and DKO mice. Moreover, in vivo rates of protein synthesis in gastrocnemius, heart and liver did not differ between DKO and WT mice. Sepsis decreased skeletal muscle protein synthesis and S6K1 phosphorylation in WT and DKO male mice to a similar extent. Sepsis only decreased 4E-BP1 phosphorylation in WT mice as no 4E-BP1/BP2 protein was detected in muscle from DKO mice. Sepsis decreased the binding of eIF4G to eIF4E in WT mice; however, eIF4E center dot eIF4G binding was not altered in DKO mice under either basal or septic conditions. A comparable sepsis-induced increase in eIF4B phosphorylation was seen in both WT and DKO mice. eEF2 phosphorylation was similarly increased in muscle from WT septic mice and both control and septic DKO mice, compared to WT control values. The sepsis-induced increase in muscle MuRF1 and atrogin-1 (markers of proteolysis) as well as TNF alpha and IL-6 (inflammatory cytokines) mRNA was greater in DKO than WT mice. The sepsis-induced decrease in myocardial and hepatic protein synthesis did not differ between WT and DKO mice. These data suggest overall basal protein balance and synthesis is maintained in muscle of mice lacking both 4E-BP1/BP2 and that sepsis-induced changes in mTOR signaling may be mediated by a down-stream mechanism independent of 4E-BP1 phosphorylation and eIF4E center dot eIF4G binding.	[Steiner, Jennifer L.; Pruznak, Annem.; Deiter, Gina; Navaratnarajah, Maithili; Kutzler, Lydia; Kimball, Scot R.; Lang, Charles H.] Penn State Coll Med, Dept Cellular & Mol Physiol & Surg, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Lang, CH (corresponding author), Penn State Coll Med, Dept Cellular & Mol Physiol & Surg, Hershey, PA 17033 USA.	clang@psu.edu			National Institutes of Health [GM38032, DK13499, DK15658]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK013499, R01DK015658, R37DK013499] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM038032, R01GM038032] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Support for this study was provided by National Institutes of Health grants GM38032, DK13499 and DK15658. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albaugh VL, 2011, MOL PSYCHIATR, V16, P569, DOI 10.1038/mp.2010.33; BLACKBURN GL, 1976, SURG CLIN N AM, V56, P1195; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Browne GJ, 2004, MOL CELL BIOL, V24, P2986, DOI 10.1128/MCB.24.7.2986-2997.2004; Callahan Leigh Ann, 2009, Crit Care Med, V37, pS354, DOI 10.1097/CCM.0b013e3181b6e439; Constantin D, 2011, J PHYSIOL-LONDON, V589, P3883, DOI 10.1113/jphysiol.2011.206193; Demers G, 2006, SCIENCE, V312, P700, DOI 10.1126/science.1124036; Dennis MD, 2012, J BIOL CHEM, V287, P42890, DOI 10.1074/jbc.M112.404822; Fortin CF, 2011, EUR J IMMUNOL, V41, P1709, DOI 10.1002/eji.201040945; Frost RA, 2007, J APPL PHYSIOL, V103, P378, DOI 10.1152/japplphysiol.00089.2007; Frost RA, 2007, AM J PHYSIOL-ENDOC M, V292, pE501, DOI 10.1152/ajpendo.00359.2006; Frost RA, 2011, PHYSIOLOGY, V26, P83, DOI 10.1152/physiol.00044.2010; Frost RA, 2011, ENDOCRINOLOGY, V152, P151, DOI 10.1210/en.2010-0248; Frost RA, 2009, SHOCK, V32, P416, DOI 10.1097/SHK.0b013e3181a034d2; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; HAGHIGHAT A, 1995, EMBO J, V14, P5701, DOI 10.1002/j.1460-2075.1995.tb00257.x; Hill GL, 1998, NUTRITION, V14, P557, DOI 10.1016/S0899-9007(98)00045-8; Hong-Brown LQ, 2003, AM J PHYSIOL-ENDOC M, V285, pE63, DOI 10.1152/ajpendo.00555.2002; Huang BPH, 2009, AM J PHYSIOL-HEART C, V296, pH505, DOI 10.1152/ajpheart.01105.2008; Jeschke MG, 2008, ANN SURG, V248, P387, DOI 10.1097/SLA.0b013e3181856241; Jewell JL, 2013, TRENDS BIOCHEM SCI, V38, P233, DOI 10.1016/j.tibs.2013.01.004; Kazi AA, 2011, SHOCK, V35, P117, DOI 10.1097/SHK.0b013e3181ecb57c; Kumar NB, 2010, CURR TREAT OPTION ON, V11, P107, DOI 10.1007/s11864-010-0127-z; Lang CH, 2005, J CELL BIOCHEM, V94, P419, DOI 10.1002/jcb.20311; Lang CH, 1996, AM J PHYSIOL-ENDOC M, V270, pE430, DOI 10.1152/ajpendo.1996.270.3.E430; Lang CH, 2006, MOL MED, V12, P291, DOI 10.2119/2006-00071.Lang; Lang CH, 2007, METABOLISM, V56, P49, DOI 10.1016/j.metabol.2006.08.025; Lang CH, 2010, AM J PHYSIOL-REG I, V299, pR935, DOI 10.1152/ajpregu.00297.2010; Lang CH, 2010, AM J PHYSIOL-ENDOC M, V298, pE1283, DOI 10.1152/ajpendo.00676.2009; Lang SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038910; Le Bacquer O, 2007, J CLIN INVEST, V117, P387, DOI 10.1172/JCI29528; Nielsen KH, 2011, NUCLEIC ACIDS RES, V39, P2678, DOI 10.1093/nar/gkq1206; Nystrom G, 2009, METABOLISM, V58, P787, DOI 10.1016/j.metabol.2009.01.015; Nystrom GJ, 2008, INT J CLIN EXP MED, V1, P50; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Phillips SM, 2009, J APPL PHYSIOL, V107, P645, DOI 10.1152/japplphysiol.00452.2009; Poulin F, 1998, J BIOL CHEM, V273, P14002, DOI 10.1074/jbc.273.22.14002; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; Smith IJ, 2008, AM J PHYSIOL-ENDOC M, V295, pE762, DOI 10.1152/ajpendo.90226.2008; Thibault R, 2011, CURR OPIN CLIN NUTR, V14, P261, DOI 10.1097/MCO.0b013e3283455d60; Tsukiyama-Kohara K, 2001, NAT MED, V7, P1128, DOI 10.1038/nm1001-1128; Vary Thomas C., 2008, V447, P343, DOI 10.1007/978-1-59745-242-7_22; vonManteuffel SR, 1997, MOL CELL BIOL, V17, P5426, DOI 10.1128/MCB.17.9.5426; Yang HS, 2004, MOL CELL BIOL, V24, P3894, DOI 10.1128/MCB.24.9.3894-3906.2004; Zhai LD, 2009, J ENDOCRINOL, V203, P365, DOI 10.1677/JOE-09-0269	45	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e99582	10.1371/journal.pone.0099582	http://dx.doi.org/10.1371/journal.pone.0099582			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945486	Green Published, gold, Green Submitted			2022-12-27	WOS:000340721500022
J	Vereshchaka, AL; Anokhina, LL				Vereshchaka, Alexander L.; Anokhina, Ludmila L.			Composition and Dynamics of the Black Sea Benthopelagic Plankton and Its Contribution to the Near-Shore Plankton Communities	PLOS ONE			English	Article							ENVIRONMENT CONCEPTION BAY; HYPERBENTHIC CRUSTACEANS; POPULATION BIOLOGY; NEARSHORE HABITATS; BOUNDARY-LAYER; ZOOPLANKTON; BEHAVIOR; FAUNA; SUPRABENTHOS; MYSIDS	At a shallow (7 m) near-shore sampling site in the Black Sea we analyzed composition, abundance, and biomass of benthopelagic organisms and the contribution these animals make to the total plankton. The site was monitored across several years (1996-2001; 2006-2007) whilst for 1999-2000 the seasonal variations were analysed. A total of 321 samples from Golubaja Bay near Novorossiysk (44 degrees 34'31.04 '' N, 37 degrees 58'45.11 '' E) in 1996-2007 were taken with a Judey net. The benthopelagic fauna was represented by 69 taxa, a diversity comparable to similar shelf areas. The benthopelagic component played an important role in near-shore plankton communities in the Black Sea accounting for 50% of the total zooplankton biomass at night during all seasons. Abundance and biomass of the benthopelagic animals showed seasonal fluctuations, the highest biomass being recorded during winter (>75% of the total zooplankton biomass) and early spring due to large amphipods, whilst the highest abundances occur during late summer because of numerous young stages of various taxa. Amphipods, mysids, and decapods are the main contributors to the plankton biomass and abundances. Both night and daytime samples are strongly recommended for the adequate description of the near-shore plankton communities.	[Vereshchaka, Alexander L.; Anokhina, Ludmila L.] Russian Acad Sci, PP Shirshov Oceanol Inst, Lab Struct & Dynam Plankton Communities, Moscow, Russia; [Vereshchaka, Alexander L.] Moscow State Univ Geodesy & Cartog, Dept Appl Ecol, Moscow, Russia	Russian Academy of Sciences; Shirshov Institute of Oceanology	Vereshchaka, AL (corresponding author), Russian Acad Sci, PP Shirshov Oceanol Inst, Lab Struct & Dynam Plankton Communities, Moscow, Russia.	alv@ocean.ru	Vereshchaka, Alexander L/E-6205-2014; Anokhina, Ludmila/K-6740-2014	Vereshchaka, Alexander L/0000-0002-6756-2468; Anokhina, Ludmila/0000-0001-6178-154X	Ministry of Education and Science of the Russian Federation; Program for a Basic Research of the Presidium of the Russian Academy of Sciences	Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation); Program for a Basic Research of the Presidium of the Russian Academy of Sciences(Russian Academy of Sciences)	The studies were supported by the Ministry of Education and Science of the Russian Federation and by the Program for a Basic Research of the Presidium of the Russian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMI L, 1976, J GEOPHYS RES-OC ATM, V81, P4983, DOI 10.1029/JC081i027p04983; Beyst B, 2001, ESTUAR COAST SHELF S, V53, P877, DOI 10.1006/ecss.2001.0808; BOYSEN HO, 1977, MEERESFORSCHUNG, V25, P54; BUHLJENSEN L, 1991, MAR BIOL, V109, P245, DOI 10.1007/BF01319393; Carleton JH, 2007, MAR ECOL PROG SER, V336, P77, DOI 10.3354/meps336077; Cartes JE, 2001, DEEP-SEA RES PT I, V48, P2209, DOI 10.1016/S0967-0637(01)00012-7; Cartes JE, 2007, ESTUAR COAST SHELF S, V75, P501, DOI 10.1016/j.ecss.2007.05.047; Chukhchin VD, 1960, P SEVASTOPOL BIOL ST, V13, P89; Dauvin JC, 1996, J MAR BIOL ASSOC UK, V76, P909, DOI 10.1017/S0025315400040881; Dauvin JC, 2008, MAR POLLUT BULL, V56, P77, DOI 10.1016/j.marpolbul.2007.09.041; Demidov AB, 2008, OCEANOLOGY+, V48, P664, DOI 10.1134/S0001437008050068; Dewicke A, 2002, J SEA RES, V47, P121, DOI 10.1016/S1385-1101(02)00106-5; Dolgopolskaia M. A., 1940, Travaux de la Station Biologique de Karadagh, VNo. 6, P57; Dyakonov V.Y., 2002, OCEANOLOGICAL STUDIE, P111; Fanelli E, 2009, J SEA RES, V61, P174, DOI 10.1016/j.seares.2008.10.005; FOSSA JH, 1985, SARSIA, V70, P297, DOI 10.1080/00364827.1985.10419684; GRANT J, 1980, MAR BIOL, V56, P79, DOI 10.1007/BF00390597; Greenwood Jack G., 2002, Plankton Biology and Ecology, V49, P17; Greze V.N., 1971, BIOL MORYA-VLAD+, V24, P12; GRICE G D, 1972, Crustaceana (Leiden), V23, P219, DOI 10.1163/156854072X00138; GRICE G D, 1970, Bulletin of the Museum of Comparative Zoology, V139, P185; HAGERMAN L, 1986, MAR ECOL PROG SER, V34, P125, DOI 10.3354/meps034125; HAMMER R M, 1979, Bulletin Southern California Academy of Sciences, V78, P199; Hesthagen IH, 1978, KIELER MEERESFORSCH, V27, P19; HUBERDEAU L, 1982, MAR BIOL, V69, P331, DOI 10.1007/BF00397498; KAARTVEDT S, 1989, MAR ECOL PROG SER, V57, P119, DOI 10.3354/meps057119; KISELEVA M I, 1967, Zoologicheskii Zhurnal, V46, P764; Klyucharev KV, 1952, P KARADAG BIOL STATI, V12, P78; Kouassi E, 2006, ESTUAR COAST SHELF S, V67, P355, DOI 10.1016/j.ecss.2005.10.019; Kringel K, 2003, LIMNOL OCEANOGR, V48, P1223, DOI 10.4319/lo.2003.48.3.1223; Kusmorskaya AP, 1955, P SOVIET HYDROBIOL S, V6, P158; Lebedeva LP, 2003, OCEANOLOGY+, V43, P670; MACQUART-MOULIN C, 1984, Tethys, V11, P171; MACQUARTMOULIN C, 1995, J PLANKTON RES, V17, P531, DOI 10.1093/plankt/17.3.531; Makarov A. C., 1938, Zool J Moscow, V17, P1055; Marshall N.B., 1977, VOVAGE DISCOVERY, P483; Mees J, 1993, NETHERLAND J AQUATIC, V27, P2; Melo PAMC, 2010, MAR BIOL RES, V6, P530, DOI 10.1080/17451000903426557; Mordukhai-Boltovskoi F.D., 1968, KEY FAUNA BLACK SEA, V1; Mordukhai-Boltovskoi F.D., 1969, KEY FAUNA BLACK SEA, V2; Mordukhai-Boltovskoi FD, 1972, KEY FAUNA BLACK SEA, V2; Nikitin VN, 1939, PLANKTON BATUMI BAY; Pasternak A.F., 1983, P139; Pitt KA, 2008, ESTUAR COAST SHELF S, V76, P827, DOI 10.1016/j.ecss.2007.08.011; Richoux NB, 2004, MAR BIOL, V144, P881, DOI 10.1007/s00227-003-1249-7; Richoux NB, 2004, MAR BIOL, V144, P895, DOI 10.1007/s00227-003-1250-1; Roast SD, 2002, MAR ECOL PROG SER, V237, P185, DOI 10.3354/meps237185; ROBERTSON AI, 1987, MAR BIOL, V96, P193, DOI 10.1007/BF00427019; ROBERTSON AI, 1988, MAR ECOL PROG SER, V43, P139, DOI 10.3354/meps043139; SanVicente C, 1995, SCI MAR, V59, P71; SORBE J-C, 1989, Scientia Marina, V53, P335; TULLY O, 1986, J MAR BIOL ASSOC UK, V66, P931, DOI 10.1017/S0025315400048530; TULLY O, 1987, Irish Naturalists' Journal, V22, P190; TULLY O, 1987, P ROY IRISH ACAD B, V87, P43; Vallet C, 1998, J MAR BIOL ASSOC UK, V78, P387, DOI 10.1017/S0025315400041527; Vereshchaka A. L., 2000, THE DEEP SEA BENTHOP; Vereshchaka AL, 2002, CAH BIOL MAR, V43, P303; VERESHCHAKA AL, 1995, DEEP-SEA RES PT I, V42, P1639, DOI 10.1016/0967-0637(95)00065-E; Vereshchaka AL, 2000, GALATHEA REP, V19, P1; Vereshchaka AL, 2009, GALATHEA REP, V22, P1; Vinogradov KA, 1931, P KARADAG BIOL STA, V4, P5; Vinogradov KA, 1949, P KARADAG BIOL STA, V8, P1; Vinogradov M. E., 1970, VERTICAL DISTRIBUTIO; Vinogradov ME, 2005, OCEANOLOGY+, V45, P356; Vinogradov ME, 1980, PELAGIC ECOSYSTEMS B, P179; Williams AB, 1972, CHESAPEAKE SCI, V44, P171; WISHNER KF, 1980, DEEP-SEA RES, V27, P203, DOI 10.1016/0198-0149(80)90012-6; Yahel R, 2005, LIMNOL OCEANOGR, V50, P930, DOI 10.4319/lo.2005.50.3.0930; Yoshida T., 2012, P 2012 15 INT C ELEC, P1; Zaitsev YP, 1962, ENV STUDIES, V104, P107; ZAITSEV YU. P., 1961, ZOOL ZHUR, V40, P818; Zakhvatkina KA, 1959, P SEVASTOPOL BIOL ST, V11, P108; Zakutsky V.P., 1965, J HYDROBIOL, V1, P63; Zakutsky V. P., 1965, 1 C VGBO PROBL HYDR, P163; Zakutsky VP, 1965, OCEANOLOGY, V5, P495	75	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e99595	10.1371/journal.pone.0099595	http://dx.doi.org/10.1371/journal.pone.0099595			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945680	Green Published, Green Submitted, gold			2022-12-27	WOS:000340721500024
J	Algars, A; Avoranta, T; Osterlund, P; Lintunen, M; Sundstrom, J; Jokilehto, T; Ristimaki, A; Ristamaki, R; Carpen, O				Algars, Annika; Avoranta, Tuulia; Osterlund, Pia; Lintunen, Minnamaija; Sundstrom, Jari; Jokilehto, Terhi; Ristimaki, Ari; Ristamaki, Raija; Carpen, Olli			Heterogeneous EGFR Gene Copy Number Increase Is Common in Colorectal Cancer and Defines Response to Anti-EGFR Therapy	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; CETUXIMAB; KRAS; AMPLIFICATION; EXPRESSION; MARKER	Anti-EGFR therapy is commonly used to treat colorectal cancer (CRC), although only a subset of patients benefit from the treatment. While KRAS mutation predicts non-responsiveness, positive predictive markers are not in clinical practice. We previously showed that immunohistochemistry (IHC)-guided EGFR gene copy number (GCN) analysis may identify CRC patients benefiting from anti-EGFR treatment. Here we tested the predictive value of such analysis in chemorefractory metastatic CRC, elucidated EGFR GCN heterogeneity within the tumors, and evaluated the association between EGFR GCN, KRAS status, and anti-EGFR antibody response in CRC cell lines. The chemorefractory patient cohort consisted of 54 KRAS wild-type (WT) metastatic CRC patients. EGFR GCN status was analyzed by silver in situ hybridization using a cut-off value of 4.0 EGFR gene copies/cell. KRAS-WT and KRAS mutant CRC cell lines with different EGFR GCN were used in in vitro studies. The chemorefractory CRC tumors with EGFR GCN increase (>= 4.0) responded better to anti-EGFR therapy than EGFR GCN (, 4.0) tumors (clinical benefit, P = 0.0004; PFS, HR = 0.23, 95% CI 0.12-0.46). EGFR GCN counted using EGFR IHC guidance was significantly higher than the value from randomly selected areas verifying intratumoral EGFR GCN heterogeneity. In CRC cell lines, EGFR GCN correlated with EGFR expression. Best anti-EGFR response was seen with KRAS-WT, EGFR GCN = 4 cells and poorest response with KRAS-WT, EGFR GCN = 2 cells. Anti-EGFR response was associated with AKT and ERK1/2 phosphorylation, which was effectively inhibited only in cells with KRAS-WT and increased EGFR GCN. In conclusion, IHC-guided EGFR GCN is a promising predictor of anti-EGFR treatment efficacy in chemorefractory CRC.	[Algars, Annika; Avoranta, Tuulia; Ristamaki, Raija] Turku Univ Hosp, Dept Radiotherapy & Oncol, FIN-20520 Turku, Finland; [Osterlund, Pia] Univ Helsinki, Cent Hosp, Dept Oncol, Helsinki, Finland; [Osterlund, Pia] Univ Helsinki, Dept Oncol, Helsinki, Finland; [Lintunen, Minnamaija; Sundstrom, Jari; Jokilehto, Terhi; Carpen, Olli] Univ Turku, Dept Pathol, Turku, Finland; [Lintunen, Minnamaija; Sundstrom, Jari; Jokilehto, Terhi; Carpen, Olli] Turku Univ Hosp Tyks Sapa, Dept Pathol, Turku, Finland; [Ristimaki, Ari] Univ Helsinki, HUSLAB, Cent Hosp, Div Pathol & Genet, Helsinki, Finland; [Ristimaki, Ari] Univ Helsinki, Haartman Inst & Genome Scale Biol, Dept Pathol, Res Programs Unit, Helsinki, Finland	University of Turku; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Turku; University of Helsinki; Helsinki University Central Hospital; University of Helsinki	Carpen, O (corresponding author), Univ Turku, Dept Pathol, Turku, Finland.	ocarpen@utu.fi			The Finnish Medical Foundation; The Finnish Cancer Foundation; The National Graduate School of Clinical Investigations; Turku University Hospital EVO grant; The Academy of Finland; The Cancer Society of South-Western Finland	The Finnish Medical Foundation; The Finnish Cancer Foundation; The National Graduate School of Clinical Investigations; Turku University Hospital EVO grant; The Academy of Finland(Academy of Finland); The Cancer Society of South-Western Finland	This study was supported by The Finnish Medical Foundation, The Finnish Cancer Foundation, The National Graduate School of Clinical Investigations, Turku University Hospital EVO grant, The Academy of Finland, and The Cancer Society of South-Western Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algars A, 2011, BRIT J CANCER, V105, P255, DOI 10.1038/bjc.2011.223; Botta C, 2012, J IMMUNOTHER, V35, P440, DOI 10.1097/CJI.0b013e31825943aa; Bouche O, 2010, CANCER TREAT REV, V36, pS1, DOI 10.1016/S0305-7372(10)00036-8; Chang DZ, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-18; Correale P, 2014, J IMMUNOTHER, V37, P26, DOI 10.1097/CJI.0000000000000004; Correale P, 2010, EUR J CANCER, V46, P1703, DOI 10.1016/j.ejca.2010.03.005; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Feng Y, 2012, CELL PROLIFERAT, V45, P413, DOI 10.1111/j.1365-2184.2012.00837.x; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Kasper S, 2013, ONCOGENE, V32, P2873, DOI 10.1038/onc.2012.302; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Misale S, 2012, NATURE, V486, P532, DOI 10.1038/nature11156; Moroni M, 2005, LANCET ONCOL, V6, P279, DOI 10.1016/S1470-2045(05)70102-9; Personeni N, 2008, CLIN CANCER RES, V14, P5869, DOI 10.1158/1078-0432.CCR-08-0449; Ruschoff J, 2012, MODERN PATHOL, V25, P637, DOI 10.1038/modpathol.2011.198; Sartore-Bianchi A, 2007, J CLIN ONCOL, V25, P3238, DOI 10.1200/JCO.2007.11.5956; Sartore-Bianchi A, 2012, J CLIN PATHOL, V65, P218, DOI 10.1136/jclinpath-2011-200353; Snuderl M, 2011, CANCER CELL, V20, P810, DOI 10.1016/j.ccr.2011.11.005; Tanner M, 2005, ANN ONCOL, V16, P273, DOI 10.1093/annonc/mdi064; Vaiopoulos AG, 2012, STEM CELLS, V30, P363, DOI 10.1002/stem.1031; Yang ZY, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-52; Yoshida T, 2008, INT J CANCER, V122, P1530, DOI 10.1002/ijc.23253	22	15	15	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99590	10.1371/journal.pone.0099590	http://dx.doi.org/10.1371/journal.pone.0099590			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940619	Green Published, Green Submitted, gold			2022-12-27	WOS:000338508200030
J	Downey, CM; Aghaei, M; Schwendener, RA; Jirik, FR				Downey, Charlene M.; Aghaei, Mehrnoosh; Schwendener, Reto A.; Jirik, Frank R.			DMXAA Causes Tumor Site-Specific Vascular Disruption in Murine Non-Small Cell Lung Cancer, and like the Endogenous Non-Canonical Cyclic Dinucleotide STING Agonist, 2 ' 3 '-cGAMP, Induces M2 Macrophage Repolarization	PLOS ONE			English	Article							5,6-DIMETHYLXANTHENONE-4-ACETIC ACID DMXAA; ASA404 VADIMEZAN; ANTIVASCULAR AGENT; ANTITUMOR-ACTIVITY; BLOOD-VESSELS; MOUSE MODELS; PHASE-II; DI-GMP; MICE; ACTIVATION	The vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA), a murine agonist of the stimulator of interferon genes (STING), appears to target the tumor vasculature primarily as a result of stimulating pro-inflammatory cytokine production from tumor-associated macrophages (TAMs). Since there were relatively few reports of DMXAA effects in genetically-engineered mutant mice (GEMM), and models of non-small cell lung cancer (NSCLC) in particular, we examined both the effectiveness and macrophage dependence of DMXAA in various NSCLC models. The DMXAA responses of primary adenocarcinomas in K-ras(LA1/+) transgenic mice, as well as syngeneic subcutaneous and metastatic tumors, generated by a p53(R172HDg/+); K-ras(LA1/+) NSCLC line (344SQ-ELuc), were assessed both by in vivo bioluminescence imaging as well as by histopathology. Macrophage-dependence of DMXAA effects was explored by clodronate liposome-mediated TAM depletion. Furthermore, a comparison of the vascular structure between subcutaneous tumors and metastases was carried out using micro-computed tomography (micro-CT). Interestingly, in contrast to the characteristic hemorrhagic necrosis produced by DMXAA in 344SQ-ELuc subcutaneous tumors, this agent failed to cause hemorrhagic necrosis of either 344SQ-ELuc-derived metastases or autochthonous K-ras(LA1/+) NSCLCs. In addition, we found that clodronate liposome-mediated depletion of TAMs in 344SQ-ELuc subcutaneous tumors led to non-hemorrhagic necrosis due to tumor feeding-vessel occlusion. Since NSCLC were comprised exclusively of TAMs with anti-inflammatory M2-like phenotype, the ability of DMXAA to re-educate M2-polarized macrophages was examined. Using various macrophage phenotypic markers, we found that the STING agonists, DMXAA and the non-canonical endogenous cyclic dinucleotide, 2'3'-cGAMP, were both capable of re-educating M2 cells towards an M1 phenotype. Our findings demonstrate that the choice of preclinical model and the anatomical site of a tumor can determine the vascular disrupting effectiveness of DMXAA, and they also support the idea of STING agonists having therapeutic utility as TAM repolarizing agents.	[Downey, Charlene M.; Aghaei, Mehrnoosh; Jirik, Frank R.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada; [Downey, Charlene M.; Aghaei, Mehrnoosh; Jirik, Frank R.] Univ Calgary, McCaig Inst Bone & Joint Hlth, Calgary, AB, Canada; [Schwendener, Reto A.] Univ Zurich, Inst Mol Canc Res, Lab Liposome Res, Zurich, Switzerland	University of Calgary; University of Calgary; University of Zurich	Jirik, FR (corresponding author), Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada.	jirik@ucalgary.ca	Schwendener, Reto A/F-6373-2011		Canadian Cancer Society Research Institute (CCSRI) [2011-700953, 2012-701470]; Canadian Cancer Society (CCS)	Canadian Cancer Society Research Institute (CCSRI)(Canadian Cancer Society (CCS)); Canadian Cancer Society (CCS)(Canadian Cancer Society (CCS))	Support for different aspects of this study came from an Operating Grant (#2011-700953) from the Canadian Cancer Society Research Institute (CCSRI) (http://www.cancer.ca/Research.aspx) with funds raised by the Canadian Cancer Society (CCS). Additional support came from a CCSRI Innovation Grant (#2012-701470) enabled by funds raised on behalf of the CCS by the Women in Insurance Cancer Crusade (WICC) of Alberta. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allavena P, 2012, CLIN EXP IMMUNOL, V167, P195, DOI 10.1111/j.1365-2249.2011.04515.x; Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; Baguley BC, 2010, EXPERT OPIN INV DRUG, V19, P1413, DOI 10.1517/13543784.2010.529128; Barber GN, 2014, TRENDS IMMUNOL, V35, P88, DOI 10.1016/j.it.2013.10.010; BIBBY MC, 1989, CANCER CHEMOTH PHARM, V24, P87; Bondareva A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005620; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Chen Z, 2012, NATURE, V483, P613, DOI 10.1038/nature10937; Ching LM, 2002, BRIT J CANCER, V86, P1937, DOI 10.1038/sj.bjc.6600368; Conlon J, 2013, J IMMUNOL, V190, P5216, DOI 10.4049/jimmunol.1300097; Downey CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041685; Dubensky Thomas W Jr, 2013, Ther Adv Vaccines, V1, P131, DOI 10.1177/2051013613501988; Francia G, 2011, NAT REV CANCER, V11, P135, DOI 10.1038/nrc3001; Fridlender ZG, 2013, BRIT J CANCER, V108, P1288, DOI 10.1038/bjc.2013.93; Fridlender ZG, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.26620; Fruh M, 2012, CLIN LUNG CANC; Gibbons DL, 2009, GENE DEV, V23, P2140, DOI 10.1101/gad.1820209; Gobert AP, 2002, J IMMUNOL, V168, P4692, DOI 10.4049/jimmunol.168.9.4692; Guiducci C, 2005, CANCER RES, V65, P3437, DOI 10.1158/0008-5472.CAN-04-4262; Hagemann T, 2008, J EXP MED, V205, P1261, DOI 10.1084/jem.20080108; Head M, 2010, EXPERT OPIN INV DRUG, V19, P295, DOI 10.1517/13543780903540214; Jameson MB, 2003, BRIT J CANCER, V88, P1844, DOI 10.1038/sj.bjc.6600992; Jamniczky HA, 2011, EVOL DEV, V13, P28, DOI 10.1111/j.1525-142X.2010.00453.x; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Kim S., 2013, ACS CHEM BIOL; Lara PN, 2011, J CLIN ONCOL, V29, P2965, DOI 10.1200/JCO.2011.35.0660; Liu G, 2000, P NATL ACAD SCI USA, V97, P4174, DOI 10.1073/pnas.97.8.4174; Liu JJ, 2007, CANCER CHEMOTH PHARM, V59, P661, DOI 10.1007/s00280-006-0321-7; LoRusso PM, 2011, J CLIN ONCOL, V29, P2952, DOI 10.1200/JCO.2011.36.1311; McKeage MJ, 2008, BRIT J CANCER, V99, P2006, DOI 10.1038/sj.bjc.6604808; McKeage MJ, 2010, CANCER-AM CANCER SOC, V116, P1859, DOI 10.1002/cncr.24975; McWhirter SM, 2009, J EXP MED, V206, P1899, DOI 10.1084/jem.20082874; Moilanen E, 1998, BRIT J CANCER, V77, P426, DOI 10.1038/bjc.1998.68; Overbergh L, 1999, CYTOKINE, V11, P305, DOI 10.1006/cyto.1998.0426; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; Pili R, 2010, CLIN CANCER RES, V16, P2906, DOI 10.1158/1078-0432.CCR-09-3026; Politi K, 2011, J CLIN ONCOL, V29, P2273, DOI 10.1200/JCO.2010.30.8304; Prantner D, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.382986; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Ribatti D, 2007, LEUKEMIA, V21, P44, DOI 10.1038/sj.leu.2404402; Rolny C, 2011, CANCER CELL, V19, P31, DOI 10.1016/j.ccr.2010.11.009; Schmieder A, 2012, SEMIN CANCER BIOL, V22, P289, DOI 10.1016/j.semcancer.2012.02.002; Seshadri M, 2009, TRANSL ONCOL, V2, P121, DOI 10.1593/tlo.09103; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Siemann DW, 2002, INT J CANCER, V99, P1, DOI 10.1002/ijc.10316; Singh M, 2012, CANCER RES, V72, P2695, DOI 10.1158/0008-5472.CAN-11-2786; Standiford TJ, 2011, ONCOGENE, V30, P2475, DOI 10.1038/onc.2010.619; Sun J, 2011, BIOCHEM PHARMACOL, V82, P1175, DOI 10.1016/j.bcp.2011.07.086; Tijono SM, 2013, BRIT J CANCER, V108, P1306, DOI 10.1038/bjc.2013.101; Tozer GM, 2005, NAT REV CANCER, V5, P423, DOI 10.1038/nrc1628; Wang LCS, 2009, NEOPLASIA, V11, P793, DOI 10.1593/neo.09506; Wu Q, 2012, J PHARMACOL EXP THER, V341, P709, DOI 10.1124/jpet.112.191635; Zeisberger SM, 2006, BRIT J CANCER, V95, P272, DOI 10.1038/sj.bjc.6603240; Zhao L, 2002, BRIT J CANCER, V87, P465, DOI 10.1038/sj.bjc.6600479; Zheng S, 2007, ONCOGENE, V26, P6896, DOI 10.1038/sj.onc.1210493	55	92	105	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99988	10.1371/journal.pone.0099988	http://dx.doi.org/10.1371/journal.pone.0099988			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940883	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000338508200060
J	Jefferies, JM; Yusof, MYM; Sekaran, SD; Clarke, SC				Jefferies, Johanna M.; Yusof, Mohd Yasim Mohd; Sekaran, Shamala Devi; Clarke, Stuart C.			Novel Clones of Streptococcus pneumoniae Causing Invasive Disease in Malaysia	PLOS ONE			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; GENOTYPIC CHARACTERIZATION; HAEMOPHILUS-INFLUENZAE; ASIAN COUNTRIES; IDENTIFICATION; SEROTYPES; CARRIAGE; EPIDEMIOLOGY; SURVEILLANCE; PREVALENCE	Although Streptococcus pneumoniae is a leading cause of childhood disease in South East Asia, little has previously been reported regarding the epidemiology of invasive pneumococcal disease in Malaysia and very few studies have explored pneumococcal epidemiology using multilocus sequence typing (MLST). Here we describe serotype, multilocus sequence type (ST), and penicillin susceptibility of thirty pneumococcal invasive disease isolates received by the University of Malaya Medical Centre between February 2000 and January 2007 and relate this to the serotypes included in current pneumococcal conjugate vaccines. A high level of diversity was observed; fourteen serotypes and 26 sequence types (ST), (11 of which were not previously described) were detected from 30 isolates. Penicillin non-susceptible pneumococci accounted for 33% of isolates. The extent of molecular heterogeneity within carried and disease-causing Malaysian pneumococci remains unknown. Larger surveillance and epidemiological studies are now required in this region to provide robust evidence on which to base future vaccine policy.	[Jefferies, Johanna M.; Clarke, Stuart C.] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England; [Jefferies, Johanna M.; Clarke, Stuart C.] Univ Southampton, Inst Life Sci, Southampton SO9 5NH, Hants, England; [Jefferies, Johanna M.; Clarke, Stuart C.] NIHR Southampton Resp Biomed Res Unit, Southampton, Hants, England; [Jefferies, Johanna M.; Yusof, Mohd Yasim Mohd; Sekaran, Shamala Devi; Clarke, Stuart C.] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia; [Clarke, Stuart C.] Publ Hlth England, Southampton, Hants, England; [Clarke, Stuart C.] Univ Southampton, Nusajaya, Malaysia	University of Southampton; University of Southampton; Universiti Malaya; Public Health England	Clarke, SC (corresponding author), Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England.	S.C.Clarke@Southampton.ac.uk	Devi, Shamala Devi/B-9735-2010; Sekaran, Shamala Devi/B-8482-2008	Devi, Shamala Devi/0000-0002-0478-0425; Sekaran, Shamala Devi/0000-0002-0478-0425; Clarke, Stuart/0000-0002-7009-1548	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	We acknowledge Elita Jauneikaite for helpful discussions. This publication made use of the Multi Locus Sequence Typing website (http://www.mlst.net) at Imperial College London developed by David Aanensen and funded by the Wellcome Trust.	[Anonymous], 2000, MMWR Recomm Rep, V49, P1; Black SB, 2002, PEDIATR INFECT DIS J, V21, P810, DOI 10.1097/00006454-200209000-00005; Bravo LC, 2009, VACCINE, V27, P7282, DOI 10.1016/j.vaccine.2009.04.046; British Society for Antimicrobial Chemotherapy, 2009, BSAC METH ANT SUSC T; Calix JJ, 2012, CLIN INFECT DIS, V54, P794, DOI 10.1093/cid/cir953; Calix JJ, 2010, J INFECT DIS, V202, P29, DOI 10.1086/653123; Desa Mohd Nasir Mohd, 2003, International Journal of Infectious Diseases, V7, P190, DOI 10.1016/S1201-9712(03)90051-8; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Hanage WP, 2005, INFECT IMMUN, V73, P431, DOI 10.1128/IAI.73.1.431-435.2005; Hausdorff WP, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-4; Hausdorff WP, 2005, LANCET INFECT DIS, V5, P83, DOI 10.1016/S1473-3099(05)01280-6; Hausdorff WP, 2000, CLIN INFECT DIS, V30, P100, DOI 10.1086/313608; Hausdorff WP, 2001, LANCET, V357, P950, DOI 10.1016/S0140-6736(00)04222-7; Isaacman DJ, 2010, INT J INFECT DIS, V14, pE197, DOI 10.1016/j.ijid.2009.05.010; JAMAL F, 1987, Southeast Asian Journal of Tropical Medicine and Public Health, V18, P79; Jauneikaite E, 2012, INT J INFECT DIS, V16, pE223, DOI 10.1016/j.ijid.2012.05.825; Jauneikaite E, 2012, VACCINE, V30, P3503, DOI 10.1016/j.vaccine.2012.03.066; Jefferies JMC, 2011, J MED MICROBIOL, V60, P750, DOI 10.1099/jmm.0.030007-0; Jin P, 2009, J INFECT DIS, V200, P1375, DOI 10.1086/606118; JORGENSEN JH, 1991, J CLIN MICROBIOL, V29, P109, DOI 10.1128/JCM.29.1.109-114.1991; Kirkham LAS, 2006, J CLIN MICROBIOL, V44, P151, DOI 10.1128/JCM.44.1.151-159.2006; Le CF, 2012, EXPERT REV ANTI-INFE, V10, P707, DOI [10.1586/eri.12.54, 10.1586/ERI.12.54]; Le CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019547; Lim LH, 2007, J PAEDIATR CHILD H, V43, P366, DOI 10.1111/j.1440-1754.2007.01081.x; Lucero MG, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004977.pub2; Nathan JJ, 2014, INFECT GENET EVOL, V21, P391, DOI 10.1016/j.meegid.2013.11.026; Pai R, 2006, J CLIN MICROBIOL, V44, P124, DOI 10.1128/JCM.44.1.124-131.2006; Palmu AAI, 2004, PEDIATR INFECT DIS J, V23, P732, DOI 10.1097/01.inf.0000133049.30299.5d; Park IH, 2007, J CLIN MICROBIOL, V45, P1225, DOI 10.1128/JCM.02199-06; Prymula R, 2006, LANCET, V367, P740, DOI 10.1016/S0140-6736(06)68304-9; Rohani MY, 1999, EPIDEMIOL INFECT, V122, P77, DOI 10.1017/S0950268898001605; Rohani MY, 1999, J ANTIMICROB CHEMOTH, V44, P852, DOI 10.1093/jac/44.6.852; Schultsz C, 2007, T ROY SOC TROP MED H, V101, P484, DOI 10.1016/j.trstmh.2006.08.010; Shi ZY, 1998, J CLIN MICROBIOL, V36, P3514, DOI 10.1128/JCM.36.12.3514-3519.1998; Sjostrom K, 2006, CLIN INFECT DIS, V42, P451, DOI 10.1086/499242; Song JH, 1999, CLIN INFECT DIS, V28, P1206, DOI 10.1086/514783; Song JH, 2004, ANTIMICROB AGENTS CH, V48, P2101, DOI 10.1128/AAC.48.6.2101-2107.2004; Song JH, 2004, J ANTIMICROB CHEMOTH, V53, P457, DOI 10.1093/jac/dkh118; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; Yasin RM, 2011, VACCINE, V29, P5688, DOI 10.1016/j.vaccine.2011.06.004	41	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e97912	10.1371/journal.pone.0097912	http://dx.doi.org/10.1371/journal.pone.0097912			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941079	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000338508200006
J	McCarthy, MJ; Liang, S; Spadoni, AD; Kelsoe, JR; Simmons, AN				McCarthy, Michael J.; Liang, Sherri; Spadoni, Andrea D.; Kelsoe, John R.; Simmons, Alan N.			Whole Brain Expression of Bipolar Disorder Associated Genes: Structural and Genetic Analyses	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; END RULE PATHWAY; GRAY-MATTER VOLUME; GENOME-WIDE ASSOCIATION; FALSE DISCOVERY RATE; CORTICAL THICKNESS; UBIQUITIN LIGASES; MICE LACKING; SCHIZOPHRENIA; ABNORMALITIES	Studies of bipolar disorder (BD) suggest a genetic basis of the illness that alters brain function and morphology. In recent years, a number of genetic variants associated with BD have been identified. However, little is known about the associated genes, or brain circuits that rely upon their function. Using an anatomically comprehensive survey of the human transcriptome (The Allen Brain Atlas), we mapped the expression of 58 genes with suspected involvement in BD based upon their relationship to SNPs identified in genome wide association studies (GWAS). We then conducted a meta-analysis of structural MRI studies to identify brain regions that are abnormal in BD. Of 58 BD associated genes, 22 had anatomically distinct expression patterns that could be categorized into one of three clusters (C1-C3). Brain regions with the highest and lowest expression of these genes did not overlap strongly with anatomical sites identified as abnormal by structural MRI except in the parahippocampal gyrus, the inferior/superior temporal gyrus and the cerebellar vermis, regions where overlap was significant. Using the 22 genes in C1-C3 as reference points, additional genes with correlated expression patterns were identified and organized into sets based on similarity. Further analysis revealed that five of these gene sets were significantly associated with BD, suggesting that anatomical expression profile is correlated with genetic susceptibility to BD, particularly for genes in C2. Our data suggest that expression profiles of BD-associated genes do not explain the majority of structural abnormalities observed in BD, but may be useful in identifying new candidate genes. Our results highlight the complex neuroanatomical basis of BD, and reinforce illness models that emphasize impaired brain connectivity.	[McCarthy, Michael J.; Spadoni, Andrea D.; Kelsoe, John R.; Simmons, Alan N.] Vet Affairs San Diego Healthcare Syst, Res Serv, San Diego, CA 92161 USA; [McCarthy, Michael J.; Liang, Sherri; Spadoni, Andrea D.; Kelsoe, John R.; Simmons, Alan N.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego	McCarthy, MJ (corresponding author), Vet Affairs San Diego Healthcare Syst, Res Serv, San Diego, CA 92161 USA.	mmccarthy@ucsd.edu	McCarthy, Michael/K-9302-2017; Simmons, Alan N/A-9815-2008	McCarthy, Michael/0000-0001-6219-4945; Simmons, Alan N/0000-0003-3963-2112; Liang, Sherri/0000-0002-0031-1154; Spadoni, Andrea/0000-0002-8367-6406	Department of Veterans Affairs Office of research and Development [1IK2BX001275, IK2CX000864, I01CX000363, 1I01CX000715]; VA Center of Excellence for Stress and Mental Health; NIMH; Pharmacogenetic Research Network [MH094483, MH092758]; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH092758] Funding Source: NIH RePORTER	Department of Veterans Affairs Office of research and Development(US Department of Veterans Affairs); VA Center of Excellence for Stress and Mental Health; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Pharmacogenetic Research Network; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was support by grants from the Department of Veterans Affairs Office of research and Development providing support to M.J.M. (1IK2BX001275), A. D. S. (IK2CX000864), J.R.K. (I01CX000363), and A.N.S. (1I01CX000715), as well funds from the VA Center of Excellence for Stress and Mental Health. J.R.K. has additional support from NIMH and the Pharmacogenetic Research Network (MH094483 and MH092758). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler CM, 2007, BIOL PSYCHIAT, V61, P776, DOI 10.1016/j.biopsych.2006.05.042; Adler CM, 2005, BIOL PSYCHIAT, V58, P151, DOI 10.1016/j.biopsych.2005.03.022; Almeida JRC, 2009, PSYCHIAT RES-NEUROIM, V171, P54, DOI 10.1016/j.pscychresns.2008.02.001; An JY, 2006, P NATL ACAD SCI USA, V103, P6212, DOI 10.1073/pnas.0601700103; Balogh SA, 2002, GENES BRAIN BEHAV, V1, P223, DOI 10.1034/j.1601-183X.2002.10404.x; Beuckmann CT, 2003, J NEUROSCI, V23, P6793; Brett M, 2001, NEUROIMAGE, V13, pS85; Chen XH, 2007, AUST NZ J PSYCHIAT, V41, P327, DOI 10.1080/00048670701213229; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dickstein DP, 2005, ARCH GEN PSYCHIAT, V62, P734, DOI 10.1001/archpsyc.62.7.734; Doris A, 2004, PSYCHIAT RES-NEUROIM, V130, P153, DOI 10.1016/j.pscychresns.2003.09.002; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Ha TH, 2009, NEUROSCI LETT, V456, P44, DOI 10.1016/j.neulet.2009.03.077; Hallahan B, 2011, BIOL PSYCHIAT, V69, P326, DOI 10.1016/j.biopsych.2010.08.029; Hanoune J, 2001, ANNU REV PHARMACOL, V41, P145, DOI 10.1146/annurev.pharmtox.41.1.145; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Hawrylycz M, 2011, NEURAL NETWORKS, V24, P933, DOI 10.1016/j.neunet.2011.06.012; Holmans P, 2009, AM J HUM GENET, V85, P13, DOI 10.1016/j.ajhg.2009.05.011; Hwang CS, 2010, NAT CELL BIOL, V12, P1177, DOI 10.1038/ncb2121; Inkster B, 2010, NEUROIMAGE, V53, P908, DOI 10.1016/j.neuroimage.2010.02.065; Janssen J, 2008, J AM ACAD CHILD PSY, V47, P1311, DOI 10.1097/CHI.0b013e318184ff48; Kempton MJ, 2009, AM J PSYCHIAT, V166, P1413, DOI 10.1176/appi.ajp.2009.09050680; Kochunov P, 2002, NEUROIMAGE, V17, P922, DOI 10.1006/nimg.2002.1084; Laird AR, 2005, HUM BRAIN MAPP, V25, P155, DOI 10.1002/hbm.20136; Lee MJ, 2005, P NATL ACAD SCI USA, V102, P15030, DOI 10.1073/pnas.0507533102; Li ML, 2011, PSYCHIAT RES-NEUROIM, V191, P92, DOI 10.1016/j.pscychresns.2010.09.006; Linke J, 2012, NEUROIMAGE, V59, P3288, DOI 10.1016/j.neuroimage.2011.10.083; Lochhead RA, 2004, BIOL PSYCHIAT, V55, P1154, DOI 10.1016/j.biopsych.2004.02.026; Lyoo IK, 2004, BIOL PSYCHIAT, V55, P648, DOI 10.1016/j.biopsych.2003.10.017; Mann L, 2008, INT J NEUROPSYCHOPH, V11, P533, DOI 10.1017/S1461145707008395; McGuffin P, 2003, ARCH GEN PSYCHIAT, V60, P497, DOI 10.1001/archpsyc.60.5.497; McIntosh AM, 2004, BIOL PSYCHIAT, V56, P544, DOI 10.1016/j.biopsych.2004.07.020; Murakami Manabu, 2008, J Biol Chem, V283, P24554, DOI 10.1074/jbc.M802319200; Nugent AC, 2006, NEUROIMAGE, V30, P485, DOI 10.1016/j.neuroimage.2005.09.029; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; Panizzon MS, 2009, CEREB CORTEX, V19, P2728, DOI 10.1093/cercor/bhp026; Piatkov KI, 2012, P NATL ACAD SCI USA, V109, pE1839, DOI 10.1073/pnas.1207786109; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Rimol LM, 2010, BIOL PSYCHIAT, V68, P41, DOI 10.1016/j.biopsych.2010.03.036; Rimol LM, 2010, BIOL PSYCHIAT, V67, P493, DOI 10.1016/j.biopsych.2009.09.032; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Sarrazin S, 2014, JAMA PSYCHIAT, V2014; Schork AJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003449; Seifuddin F, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-213; Selvaraj S, 2012, BIPOLAR DISORD, V14, P135, DOI 10.1111/j.1399-5618.2012.01000.x; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; Smith EN, 2009, MOL PSYCHIATR, V14, P755, DOI 10.1038/mp.2009.43; Smith EN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002134; Sprooten E, 2013, PSYCHIAT RES, V206, P223, DOI 10.1016/j.psychres.2012.11.002; Sprooten E, 2012, MAGN RESON IMAGING, V30, P1373, DOI 10.1016/j.mri.2012.05.013; Stanfield AC, 2009, BIPOLAR DISORD, V11, P135, DOI 10.1111/j.1399-5618.2009.00666.x; Tost H, 2010, J AFFECT DISORDERS, V120, P54, DOI 10.1016/j.jad.2009.04.009; Turkeltaub PE, 2002, NEUROIMAGE, V16, P765, DOI 10.1006/nimg.2002.1131; Yatham LN, 2007, BIPOLAR DISORD, V9, P693, DOI 10.1111/j.1399-5618.2007.00414.x	54	14	15	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100204	10.1371/journal.pone.0100204	http://dx.doi.org/10.1371/journal.pone.0100204			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941232	Green Published, gold, Green Submitted			2022-12-27	WOS:000338508200084
J	Peiro-Velert, C; Valencia-Peris, A; Gonzalez, LM; Garcia-Masso, X; Serra-Ano, P; Devis-Devis, J				Peiro-Velert, Carmen; Valencia-Peris, Alexandra; Gonzalez, Luis M.; Garcia-Masso, Xavier; Serra-Ano, Pilar; Devis-Devis, Jose			Screen Media Usage, Sleep Time and Academic Performance in Adolescents: Clustering a Self-Organizing Maps Analysis	PLOS ONE			English	Article							SCHOOL-AGED CHILDREN; PHYSICAL-ACTIVITY; SEDENTARY BEHAVIOR; EUROPEAN ADOLESCENTS; SOCIOECONOMIC-STATUS; COMPUTER USE; ACHIEVEMENT; HEALTH; TELEVISION; CHILDHOOD	Screen media usage, sleep time and socio-demographic features are related to adolescents' academic performance, but interrelations are little explored. This paper describes these interrelations and behavioral profiles clustered in low and high academic performance. A nationally representative sample of 3,095 Spanish adolescents, aged 12 to 18, was surveyed on 15 variables linked to the purpose of the study. A Self-Organizing Maps analysis established non-linear interrelationships among these variables and identified behavior patterns in subsequent cluster analyses. Topological interrelationships established from the 15 emerging maps indicated that boys used more passive videogames and computers for playing than girls, who tended to use mobile phones to communicate with others. Adolescents with the highest academic performance were the youngest. They slept more and spent less time using sedentary screen media when compared to those with the lowest performance, and they also showed topological relationships with higher socioeconomic status adolescents. Cluster 1 grouped boys who spent more than 5.5 hours daily using sedentary screen media. Their academic performance was low and they slept an average of 8 hours daily. Cluster 2 gathered girls with an excellent academic performance, who slept nearly 9 hours per day, and devoted less time daily to sedentary screen media. Academic performance was directly related to sleep time and socioeconomic status, but inversely related to overall sedentary screen media usage. Profiles from the two clusters were strongly differentiated by gender, age, sedentary screen media usage, sleep time and academic achievement. Girls with the highest academic results had a medium socioeconomic status in Cluster 2. Findings may contribute to establishing recommendations about the timing and duration of screen media usage in adolescents and appropriate sleep time needed to successfully meet the demands of school academics and to improve interventions targeting to affect behavioral change.	[Peiro-Velert, Carmen; Valencia-Peris, Alexandra; Garcia-Masso, Xavier] Univ Valencia, Dept Didact Expressio Musical Plast & Corporal, Valencia, Spain; [Gonzalez, Luis M.; Devis-Devis, Jose] Univ Valencia, Dept Educ Fis & Esport, Valencia, Spain; [Serra-Ano, Pilar] Univ Valencia, Dept Fisioterapia, Valencia, Spain	University of Valencia; University of Valencia; University of Valencia	Devis-Devis, J (corresponding author), Univ Valencia, Dept Educ Fis & Esport, Valencia, Spain.	jose.devis@uv.es	Serra-Añó, Pilar/L-6085-2014; Valencia-Peris, Alexandra/L-2260-2014; Devis-Devis, Jose/G-8758-2015; García-Massó, Xavier/L-8222-2014; González, Luis-Millán/L-4779-2014; Peiró-Velert, Carmen/N-6056-2015; Valencia-Peris, Alexandra/ABE-5860-2020	Serra-Añó, Pilar/0000-0002-0743-3445; Devis-Devis, Jose/0000-0003-4599-3782; González, Luis-Millán/0000-0002-6478-4014; Peiró-Velert, Carmen/0000-0003-4794-6541; Valencia-Peris, Alexandra/0000-0002-2031-9743; Garcia-Masso, Xavier/0000-0002-5925-4537	Ministry of Science and Innovation (Spain) [EDU2009-13664]	Ministry of Science and Innovation (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	Funding for this research (EDU2009-13664) was provided by the Ministry of Science and Innovation (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-on ME, 2001, PEDIATRICS, V107, P423, DOI 10.1542/peds.107.2.423; Biddle SJH, 2009, INT J BEHAV MED, V16, P278, DOI 10.1007/s12529-008-9028-y; Blair PS, 2012, SLEEP, V35, P353, DOI 10.5665/sleep.1694; Borraccino A, 2009, MED SCI SPORT EXER, V41, P749, DOI 10.1249/MSS.0b013e3181917722; Bowers AJ, 2013, ETR&D-EDUC TECH RES, V61, P51, DOI 10.1007/s11423-012-9274-1; Bradley CB, 2000, MED SCI SPORT EXER, V32, P2071, DOI 10.1097/00005768-200012000-00017; Cain N, 2010, SLEEP MED, V11, P735, DOI 10.1016/j.sleep.2010.02.006; Chen MY, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-59; Ferrera JMC, 2013, REV EDUC-MADRID, P273, DOI 10.4438/1988-592X-RE-2011-362-161; Costigan SA, 2013, J ADOLESCENT HEALTH, V52, P382, DOI 10.1016/j.jadohealth.2012.07.018; Crespo CJ, 2001, ARCH PEDIAT ADOL MED, V155, P360, DOI 10.1001/archpedi.155.3.360; Currie C, 2008, SOC SCI MED, V66, P1429, DOI 10.1016/j.socscimed.2007.11.024; Devis-Devis J, 2012, J ADOLESCENCE, V35, P213, DOI 10.1016/j.adolescence.2010.11.009; Devis-Devis J, 2009, J ADOLESCENCE, V32, P213, DOI 10.1016/j.adolescence.2008.04.004; Dewald JF, 2010, SLEEP MED REV, V14, P179, DOI 10.1016/j.smrv.2009.10.004; Dworak M, 2007, PEDIATRICS, V120, P978, DOI 10.1542/peds.2007-0476; Foti KE, 2011, AM J PREV MED, V41, P596, DOI 10.1016/j.amepre.2011.08.009; Garcia-Continente X, 2014, EUR J PUBLIC HEALTH, V24, P5, DOI 10.1093/eurpub/ckt013; Gonzalez LM, 2011, HAEMOPHILIA, V17, P676, DOI 10.1111/j.1365-2516.2010.02469.x; Hancox RJ, 2005, ARCH PEDIAT ADOL MED, V159, P614, DOI 10.1001/archpedi.159.7.614; Hardy LL, 2007, PREV MED, V45, P71, DOI 10.1016/j.ypmed.2007.03.014; Hardy LL, 2006, AUST NZ J PUBL HEAL, V30, P534, DOI 10.1111/j.1467-842X.2006.tb00782.x; Hardy LL, 2007, J ADOLESCENT HEALTH, V40, P158, DOI 10.1016/j.jadohealth.2006.09.009; Hardy LL, 2010, ARCH PEDIAT ADOL MED, V164, P643, DOI 10.1001/archpediatrics.2010.88; Hardy LL, 2009, AM J PREV MED, V36, P120, DOI 10.1016/j.amepre.2008.09.034; Haykin S., 1994, NEURAL NETWORKS, DOI 10.5555/521706; Hofferth SL, 2012, J RES ADOLESCENCE, V22, P215, DOI 10.1111/j.1532-7795.2011.00770.x; Jackson LA, 2011, COMPUT HUM BEHAV, V27, P228, DOI 10.1016/j.chb.2010.08.001; Kiang MY, 2001, COMPUT STAT DATA AN, V38, P161, DOI 10.1016/S0167-9473(01)00040-8; KOHONEN T, 1982, BIOL CYBERN, V43, P59, DOI 10.1007/BF00337288; Li SH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0083037, 10.1371/journal.pone.0067928, 10.1371/journal.pone.0057604]; Lubans DR, 2011, OBES REV, V12, P781, DOI 10.1111/j.1467-789X.2011.00896.x; Majem LS, 2003, MED CLIN-BARCELONA, V121, P725, DOI 10.1016/S0025-7753(03)74077-9; Marshall SJ, 2004, INT J OBESITY, V28, P1238, DOI 10.1038/sj.ijo.0802706; Guerrero JDM, 2012, EXPERT SYST APPL, V39, P8793, DOI 10.1016/j.eswa.2012.02.001; Martinez-Gomez D, 2011, ARCH DIS CHILD, V96, P240, DOI 10.1136/adc.2010.187161; Mossle T, 2010, BRIT J DEV PSYCHOL, V28, P699, DOI 10.1348/026151009X475307; Morley BC, 2012, MED J AUSTRALIA, V196, P189, DOI 10.5694/mja11.11184; National Sleep Foundation, 2006, SLEEP AM POLL 2006; O'Loughlin EK, 2012, PEDIATRICS, V130, P806, DOI 10.1542/peds.2012-0391; Ohayon MM, 2004, SLEEP, V27, P1255, DOI 10.1093/sleep/27.7.1255; Oja M., 2003, NEURAL COMPUTING SUR, V3, P1; Rey-Lopez JP, 2010, PREV MED, V51, P50, DOI 10.1016/j.ypmed.2010.03.013; Sanz AB, 2005, AN PEDIATR, V63, P516, DOI 10.1016/S1695-4033(05)70252-6; Serrano-Sanchez JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024453; Sharif I, 2010, J ADOLESCENT HEALTH, V46, P52, DOI 10.1016/j.jadohealth.2009.05.012; Sirin SR, 2005, REV EDUC RES, V75, P417, DOI 10.3102/00346543075003417; Subrahmanyam K, 2001, J APPL DEV PSYCHOL, V22, P7, DOI 10.1016/S0193-3973(00)00063-0; Tandon PS, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-88; Vesanto J, 2000, IEEE T NEURAL NETWOR, V11, P586, DOI 10.1109/72.846731; Vesanto J., 2000, SOM TOOLBOX MATLAB 5, V57, P60; von Rueden U, 2006, J EPIDEMIOL COMMUN H, V60, P130, DOI 10.1136/jech.2005.039792; Yang CK, 2005, PEDIATRICS, V115, P250, DOI 10.1542/peds.2004-0815G	53	52	54	6	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99478	10.1371/journal.pone.0099478	http://dx.doi.org/10.1371/journal.pone.0099478			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK6AC	24941009	Green Published, Green Submitted, gold			2022-12-27	WOS:000338508200026
J	Qiu, X; Hu, R; Wu, ZX				Qiu, Xing; Hu, Rui; Wu, Zhixin			Evaluation of Bias-Variance Trade-Off for Commonly Used Post-Summarizing Normalization Procedures in Large-Scale Gene Expression Studies	PLOS ONE			English	Article							MICROARRAY DATA; DIFFERENTIAL EXPRESSION; STATISTICAL-METHODS; DISCOVERY; SELECTION	Normalization procedures are widely used in high-throughput genomic data analyses to remove various technological noise and variations. They are known to have profound impact to the subsequent gene differential expression analysis. Although there has been some research in evaluating different normalization procedures, few attempts have been made to systematically evaluate the gene detection performances of normalization procedures from the bias-variance trade-off point of view, especially with strong gene differentiation effects and large sample size. In this paper, we conduct a thorough study to evaluate the effects of normalization procedures combined with several commonly used statistical tests and MTPs under different configurations of effect size and sample size. We conduct theoretical evaluation based on a random effect model, as well as simulation and biological data analyses to verify the results. Based on our findings, we provide some practical guidance for selecting a suitable normalization procedure under different scenarios.	[Qiu, Xing; Hu, Rui] Univ Rochester, Dept Biostat & Computat Biol, Rochester, NY 14627 USA; [Wu, Zhixin] Depauw Univ, Dept Math, Greencastle, IN 46135 USA	University of Rochester; DePauw University	Qiu, X (corresponding author), Univ Rochester, Dept Biostat & Computat Biol, Rochester, NY 14627 USA.	xqiu@bst.rochester.edu			University of Rochester CTSI pilot award from the National Center For Research Resources [UL1RR024160]; National Center for Advancing Translational Sciences of the National Institutes of Health (NIH) [UL1TR000042]; NIH [HHSN272201000055C/N01-AI-50020, 5 R01 AI087135-02]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000042] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087135] Funding Source: NIH RePORTER	University of Rochester CTSI pilot award from the National Center For Research Resources; National Center for Advancing Translational Sciences of the National Institutes of Health (NIH); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research is supported by the University of Rochester CTSI pilot award(UL1RR024160) from the National Center For Research Resources, Award Number UL1TR000042 from the National Center for Advancing Translational Sciences of the National Institutes of Health (NIH), and HHSN272201000055C/N01-AI-50020 and 5 R01 AI087135-02 from NIH. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources or the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bilban Martin, 2002, Current Issues in Molecular Biology, V4, P57; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bremer M, 2010, METHODS MOL BIOL, V620, P287, DOI 10.1007/978-1-60761-580-4_9; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Dudoit S, 2002, STAT SINICA, V12, P111; Dunning MJ, 2007, BIOINFORMATICS, V23, P2183, DOI 10.1093/bioinformatics/btm311; Gagnon-Bartsch JA, 2012, BIOSTATISTICS, V13, P539, DOI 10.1093/biostatistics/kxr034; Hartemink A., 2001, SPIE BIOS; Hoen PA, 2008, NUCL ACIDS RES; HOLM S, 1979, SCAND J STAT, V6, P65; Hu R, 2010, BIOINFORMATICS, V26, P348, DOI 10.1093/bioinformatics/btp672; Hu R, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-20; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; KLEBANOV L, 2005, COMPUTATIONAL STAT D; Klebanov L, 2007, ANN APPL STAT, V1, P538, DOI 10.1214/07-AOAS120; Klebanov Lev, 2008, Journal of Bioinformatics and Computational Biology, V6, P301, DOI 10.1142/S0219720008003436; Lee M-LT, 2004, ANAL MICROARRAY GENE; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; McMurray HR, 2008, NATURE, V453, P1112, DOI 10.1038/nature06973; Ni TT, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-505; Ogunnaike BA, 2010, J THEOR BIOL, V264, P211, DOI 10.1016/j.jtbi.2010.02.021; Okoniewski MJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040006; Park T, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-33; Pradervand S, 2009, RNA, V15, P493, DOI 10.1261/rna.1295509; Qin LX, 2009, STAT APPL GENET MOL, V8, DOI 10.2202/1544-6115.1339; Qiu X, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-120; Qiu X, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-124; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Rao YL, 2008, STAT APPL GENET MOL, V7, DOI 10.2202/1544-6115.1287; Robinson MD, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-449; SCHERER A., 2009, BATCH EFFECTS NOISE; Schmid R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-349; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Staaf J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-409; Szabo A, 2003, BIOSTATISTICS, V4, P555, DOI 10.1093/biostatistics/4.4.555; Szabo A, 2002, MATH BIOSCI, V176, P71, DOI 10.1016/S0025-5564(01)00103-1; Tsodikov A, 2002, BIOINFORMATICS, V18, P251, DOI 10.1093/bioinformatics/18.2.251; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Westfall P.H., 1993, RESAMPLING BASED MUL, V279; Xiao YH, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-164; Yakovlev AY, 2010, STAT METHODS MICROAR; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6	50	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99380	10.1371/journal.pone.0099380	http://dx.doi.org/10.1371/journal.pone.0099380			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941114	Green Submitted, gold, Green Published			2022-12-27	WOS:000338508200021
J	de Araujo, GS; Pereira, SM; dos Santos, DN; Marinho, JM; Rodrigues, LC; Barreto, ML				de Araujo, Gleide Santos; Pereira, Susan Martins; dos Santos, Darci Neves; Marinho, Jamocyr Moura; Rodrigues, Laura Cunha; Barreto, Mauricio Lima			Common Mental Disorders Associated with Tuberculosis: A Matched Case-Control Study	PLOS ONE			English	Article							HEALTH; POPULATION; CARE	Introduction: Despite the availability of treatment and a vaccine, tuberculosis continues to be a public health problem worldwide. Mental disorders might contribute to the burden of the disease. Objective: The objective of this study was to investigate the association between common mental disorders and tuberculosis. Methods: A matched case-control study was conducted. The study population included symptomatic respiratory patients who attended three referral hospitals and six community clinics in the city of Salvador, Brazil. A doctor's diagnosis defined potential cases and controls. Cases were newly diagnosed tuberculosis cases, and controls were symptomatic respiratory patients for whom tuberculosis was excluded as a diagnosis by the attending physician. Cases and controls were ascertained in the same clinic. Data collection occurred between August 2008 and April 2010. The study instruments included a structured interview, a self-reporting questionnaire for the identification of common mental disorders, and a questionnaire for alcoholism. An univariate analysis included descriptive procedures (with chi-square statistics), and a multivariate analysis used conditional logistic regression. Results: The mean age of the cases was 38 years, and 61% of the cases were males. After adjusting for potential confounders, the odds of tuberculosis were significantly higher in patients dignosed with a common mental disorder (OR: 1.34; 95% CI 1.05-1.70). Conclusion: There appears to be a positive and independent association between common mental disorders and tuberculosis; further epidemiological studies are required to increase our understanding of the possible biological and social mechanisms responsible for this association. Independent of the direction of the association, this finding has implications for the provision of care for mental disorders and for tuberculosis.	[de Araujo, Gleide Santos; Pereira, Susan Martins; dos Santos, Darci Neves; Barreto, Mauricio Lima] Univ Fed Bahia, Inst Collect Hlth, Dept Saude Colet, BR-41170290 Salvador, BA, Brazil; [Rodrigues, Laura Cunha] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England	Universidade Federal da Bahia; University of London; London School of Hygiene & Tropical Medicine	de Araujo, GS (corresponding author), Univ Fed Bahia, Inst Collect Hlth, Dept Saude Colet, BR-41170290 Salvador, BA, Brazil.	gleide23@yahoo.com.br	Barreto, Mauricio L/B-1752-2008; RODRIGUES, LAURA CUNHA/AAO-4130-2021	Barreto, Mauricio L/0000-0002-0215-4930; Marinho, Jamocyr/0000-0003-1032-3260; Rodrigues, Laura Cunha/0000-0001-9008-660X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq - National Council for Scientific and Technological Development) [410 498/2006-8]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq - National Council for Scientific and Technological Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Authors would like to thank the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq - National Council for Scientific and Technological Development) for funding this research project [grant number 410 498/2006-8] (http://www.cnpq.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahola K, 2011, J AFFECT DISORDERS, V134, P365, DOI 10.1016/j.jad.2011.05.028; Araújo Tânia Maria de, 2005, Rev. Bras. Saude Mater. Infant., V5, P337, DOI 10.1590/S1519-38292005000300010; Balaji AL, 2013, ASIAN J PSYCHIATR, V6, P251, DOI 10.1016/j.ajp.2012.12.017; Baxter AJ, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-134; Bender A, 2012, CAN J NURS RES, V44, P56; Botti NCL, 2010, BARBAROI, V33, P178, DOI DOI 10.17058/BARBAROI.V0I0.1583; Brazilian Institute of Geography and Statistics, 2010, DEM CENS; Deribew A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-408; Deribew A, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-201; Doherty AM, 2013, GEN HOSP PSYCHIAT, V35, P398, DOI 10.1016/j.genhosppsych.2013.03.018; Dourado I, 2007, CAD SAUDE PUBLICA, V23, P25, DOI 10.1590/S0102-311X2007000100004; Fonseca Maria Liana Gesteira, 2008, REV APS, V11, P285; Harling G, 2014, HEALTH PLACE, V25, P56, DOI 10.1016/j.healthplace.2013.10.008; Maher D, 2006, INT J TUBERC LUNG D, V10, P240; MARI JD, 1986, BRIT J PSYCHIAT, V148, P23, DOI 10.1192/bjp.148.1.23; MASUR J, 1983, BRAZ J MED BIOL RES, V16, P215; Pachi Argiro, 2013, Tuberc Res Treat, V2013, P489865, DOI 10.1155/2013/489865; Patel V, 2003, B WORLD HEALTH ORGAN, V81, P609; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Rocha Saulo Vasconcelos, 2010, Rev. bras. epidemiol., V13, P630, DOI 10.1590/S1415-790X2010000400008; Schaaf HS, 2009, TUBERCULOSIS COMPREH; Schneiderman N, 2005, ANNU REV CLIN PSYCHO, V1, P607, DOI 10.1146/annurev.clinpsy.1.102803.144141; STEIN M, 1976, SCIENCE, V191, P435; da Costa JCT, 2011, J BRAS PNEUMOL, V37, P636, DOI 10.1590/S1806-37132011000500011; Udedi M, 2013, INT J SOC PSYCHIAT; Veggi Alessandra Bento, 2004, Rev. Bras. Psiquiatr., V26, P242, DOI 10.1590/S1516-44462004000400007; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1	27	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99551	10.1371/journal.pone.0099551	http://dx.doi.org/10.1371/journal.pone.0099551			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK5YM	24937319	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000338503400023
J	Amigo-Jimenez, I; Bailon, E; Ugarte-Berzal, E; Aguilera-Montilla, N; Garcia-Marco, JA; Garcia-Pardo, A				Amigo-Jimenez, Irene; Bailon, Elvira; Ugarte-Berzal, Estefania; Aguilera-Montilla, Noemi; Garcia-Marco, Jose A.; Garcia-Pardo, Angeles			Matrix Metalloproteinase-9 Is Involved in Chronic Lymphocytic Leukemia Cell Response to Fludarabine and Arsenic Trioxide	PLOS ONE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; ALPHA-4-BETA-1 INTEGRIN; B-CELLS; MATRIX METALLOPROTEINASES; SIGNALING PATHWAYS; MOLECULAR-BIOLOGY; INDUCED APOPTOSIS; GELATINASE-B; CLL; MICROENVIRONMENT	Background: Matrix metalloproteinase-9 (MMP-9) contributes to chronic lymphocytic leukemia (CLL) pathology by regulating cell migration and preventing spontaneous apoptosis. It is not known if MMP-9 is involved in CLL cell response to chemotherapy and we address this in the present study, using arsenic trioxide (ATO) and fludarabine as examples of cytotoxic drugs. Methods: We used primary cells from the peripheral blood of CLL patients and MEC-1 cells stably transfected with an empty vector or a vector containing MMP-9. The effect of ATO and fludarabine was determined by flow cytometry and by the MTT assay. Expression of mRNA was measured by RT-PCR and qPCR. Secreted and cell-bound MMP-9 was analyzed by gelatin zymography and flow cytometry, respectively. Protein expression was analyzed by Western blotting and immunoprecipitation. Statistical analyses were performed using the two-tailed Student's t-test. Results: In response to ATO or fludarabine, CLL cells transcriptionally upregulated MMP-9, preceding the onset of apoptosis. Upregulated MMP-9 primarily localized to the membrane of early apoptotic cells and blocking apoptosis with Z-VAD prevented MMP-9 upregulation, thus linking MMP-9 to the apoptotic process. Culturing CLL cells on MMP-9 or stromal cells induced drug resistance, which was overcome by anti-MMP-9 antibodies. Accordingly, MMP-9-MEC-1 transfectants showed higher viability upon drug treatment than Mock-MEC-1 cells, and this effect was blocked by silencing MMP-9 with specific siRNAs. Following drug exposure, expression of anti-apoptotic proteins (Mcl-1, Bcl-xL, Bcl-2) and the Mcl-1/Bim, Mcl-1/Noxa, Bcl-2/Bax ratios were higher in MMP-9-cells than in Mock-cells. Similar results were obtained upon culturing primary CLL cells on MMP-9. Conclusions: Our study describes for the first time that MMP-9 induces drug resistance by modulating proteins of the Bcl-2 family and upregulating the corresponding anti-apoptotic/pro-apoptotic ratios. This is a novel role for MMP-9 contributing to CLL progression. Targeting MMP-9 in combined therapies may thus improve CLL response to treatment.	[Amigo-Jimenez, Irene; Bailon, Elvira; Ugarte-Berzal, Estefania; Aguilera-Montilla, Noemi; Garcia-Pardo, Angeles] CSIC, Ctr Invest Biol, Cellular & Mol Med Dept, Madrid, Spain; [Garcia-Marco, Jose A.] Hosp Univ Puerta Hierro, Hematol Unit, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Hospital Puerta de Hierro-Majadahonda	Garcia-Pardo, A (corresponding author), CSIC, Ctr Invest Biol, Cellular & Mol Med Dept, Madrid, Spain.	agarciapardo@cib.csic.es	Garcia Marco, Jose/H-2554-2015; Garcia Pardo, Angeles/G-5987-2015; Bailón, Elvira/G-5057-2015; Aguilera-Montilla, Noemi/G-4277-2015	Garcia Marco, Jose/0000-0002-8993-5982; Garcia Pardo, Angeles/0000-0001-5577-2954; Aguilera-Montilla, Noemi/0000-0002-6925-6069	Ministry of Economy and Competitiveness (MINECO), Spain [SAF2012-31613, RD12/0036/0061]; Comunidad de Madrid/European Union [S2010/BMD-2314-Neoplasbim]; Fundacioen Puerta de Hierro, Madrid; Junta de Ampliacion de Estudios program, CSIC/EU, Spain	Ministry of Economy and Competitiveness (MINECO), Spain; Comunidad de Madrid/European Union; Fundacioen Puerta de Hierro, Madrid; Junta de Ampliacion de Estudios program, CSIC/EU, Spain	This work was supported by grants SAF2012-31613 (AGP) and RTICC (Red Tematica de Investigacion Cooperativa en Cancer) RD12/0036/0061 (AGP), from the Ministry of Economy and Competitiveness (MINECO), Spain; S2010/BMD-2314-Neoplasbim (AGP) from the Comunidad de Madrid/European Union; and by a grant from the Fundacioen Puerta de Hierro, Madrid (JAGM). IAJ and EB were were supported by the Junta de Ampliacion de Estudios program, CSIC/EU, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailon E, 2014, J LEUK BIOL IN PRESS; Balakrishnan K, 2009, BLOOD, V113, P149, DOI 10.1182/blood-2008-02-138560; Bauvois B, 2002, LEUKEMIA, V16, P791, DOI 10.1038/sj.leu.2402472; Baysan A, 2007, INT J ONCOL, V30, P313; Buchner M, 2010, BLOOD, V115, P4497, DOI 10.1182/blood-2009-07-233692; Burger JA, 2014, SEMIN CANCER BIOL, V24, P71, DOI 10.1016/j.semcancer.2013.08.011; Burger JA, 2012, CURR OPIN ONCOL, V24, P643, DOI 10.1097/CCO.0b013e3283589950; Chetty C, 2010, MOL CANCER THER, V9, P2605, DOI 10.1158/1535-7163.MCT-10-0245; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; de la Fuente MT, 2002, J LEUKOCYTE BIOL, V71, P495; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Gaidano G, 2012, J CLIN INVEST, V122, P3432, DOI 10.1172/JCI64101; Gandhi V, 2008, BLOOD, V112, P3538, DOI 10.1182/blood-2008-07-170241; Gingis-Velitski S, 2011, CANCER RES, V71, P6986, DOI 10.1158/0008-5472.CAN-11-0629; Hallek M, 2013, AM J HEMATOL, V88, P803, DOI 10.1002/ajh.23491; Jayo A, 2010, HAEMATOL-HEMATOL J, V95, P1158, DOI 10.3324/haematol.2009.018572; Lunghi P, 2008, BLOOD, V112, P2450, DOI 10.1182/blood-2007-10-114348; Mannello F, 2005, APOPTOSIS, V10, P19, DOI 10.1007/s10495-005-6058-7; Merkel O, 2008, J MOL MED-JMM, V86, P541, DOI 10.1007/s00109-008-0314-6; Meyer E, 2005, CANCER RES, V65, P4261, DOI 10.1158/0008-5472.CAN-04-2908; Mi JQ, 2012, LEUKEMIA, V26, P1743, DOI 10.1038/leu.2012.57; Morales AA, 2008, BLOOD, V111, P5152, DOI 10.1182/blood-2007-10-116889; MORODOMI T, 1992, BIOCHEM J, V285, P603, DOI 10.1042/bj2850603; Nyormoi O, 2003, CELL DEATH DIFFER, V10, P558, DOI 10.1038/sj.cdd.4401209; Pleyer L, 2009, NAT REV CLIN ONCOL, V6, P405, DOI 10.1038/nrclinonc.2009.72; Ramsay AD, 2013, BRIT J HAEMATOL, V162, P15, DOI 10.1111/bjh.12344; Redondo-Munoz J, 2008, BLOOD, V112, P169, DOI 10.1182/blood-2007-08-109249; Redondo-Munoz J, 2008, BLOOD, V111, P383, DOI 10.1182/blood-2007-08-107300; Redondo-Munoz J, 2006, BLOOD, V108, P3143, DOI 10.1182/blood-2006-03-007294; Redondo-Munoz J, 2010, CLIN CANCER RES, V16, P4382, DOI 10.1158/1078-0432.CCR-10-0072; Redondo-Munoz J, 2010, CANCER CELL, V17, P160, DOI 10.1016/j.ccr.2009.12.044; Sharma A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.155; Shooshtari P, 2010, CYTOM PART A, V77A, P873, DOI 10.1002/cyto.a.20943; Stacchini A, 1999, LEUKEMIA RES, V23, P127, DOI 10.1016/S0145-2126(98)00154-4; Stephens DM, 2013, HEMATOL ONCOL CLIN N, V27, P303, DOI 10.1016/j.hoc.2012.12.003; Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375, DOI 10.1080/10409230290771546; Vandooren J, 2013, CRIT REV BIOCHEM MOL, V48, P222, DOI 10.3109/10409238.2013.770819; Wang R, 2013, LEUKEMIA, V27, P315, DOI 10.1038/leu.2012.180; Wang ZY, 2008, BLOOD, V111, P2505, DOI 10.1182/blood-2007-07-102798; Zeng Z, 2006, MOL CANCER THER, V5, P3113, DOI 10.1158/1535-7163.MCT-06-0228; Zenz T, 2010, NAT REV CANCER, V10, P37, DOI 10.1038/nrc2764	41	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e99993	10.1371/journal.pone.0099993	http://dx.doi.org/10.1371/journal.pone.0099993			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956101	Green Published, gold			2022-12-27	WOS:000338917900023
J	Luksiene, D; Tamosiunas, A; Baceviciene, M; Radisauskas, R; Malinauskiene, V; Peasey, A; Bobak, M				Luksiene, Dalia; Tamosiunas, Abdonas; Baceviciene, Migle; Radisauskas, Ricardas; Malinauskiene, Vilija; Peasey, Anne; Bobak, Martin			Trends in Prevalence of Dyslipidaemias and the Risk of Mortality in Lithuanian Urban Population Aged 45-64 in Relation to the Presence of the Dyslipidaemias and the Other Cardiovascular Risk Factors	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CORONARY-HEART-DISEASE; DENSITY-LIPOPROTEIN CHOLESTEROL; BODY-MASS INDEX; ALL-CAUSE; INFLAMMATORY MARKERS; APICAL PERIODONTITIS; CIGARETTE-SMOKING; HDL CHOLESTEROL; ARTERY-DISEASE	The aim of this study was to provide reliable information on dyslipidaemias, to estimate the trend of the prevalence of dyslipidaemias and other selected cardiovascular disease (CVD) risk factors at population level, and to evaluate the risk of all-cause and CVD mortality in relation to presence of mixed dyslipidaemias and other CVD risk factors. Methods: Data from the five surveys (1983-2008) are presented. A random sample of 9,209 subjects aged 45-64 was selected for statistical analysis. During follow-up there were 1653 death cases from any cause, 864 deaths from CVD. Estimates of hazard ratios (HR) and 95% confidence intervals (CI) were based on the multivariate Cox proportional hazards regression for all-cause mortality and CVD mortality. Results: During 25 year period the prevalence of normal total cholesterol level (<5.2 mmol/L) significantly increased only in women; triglycerides and high density lipoprotein (HDL) cholesterol did not change in men and women. Findings in our longitudinal study showed that in men and women mixed dyslipidaemias (HDL cholesterol,1.03 mmol/L plus triglycerides >= 1.70 mmol/L) significantly increased the risk for all-cause and CVD mortality (respectively in men HR = 1.30; HR = 1.15, in women HR = 1.83; HR = 2.13). These mixed dyslipidaemia combinations combination with the other risk factors such as arterial hypertension, high fasting glucose level increased all-cause and CVD mortality risk in men and women; while, these mixed dyslipidaemias plus smoking increased all-cause and CVD mortality risk only in men compared to never smokers without these dyslipidaemias (respectively HR = 1.89; HR = 1.92); and these dyslipidaemias plus obesity increased all-cause and CVD mortality risk in women (respectively HR = 2.25; HR = 2.39) and CVD mortality risk in men (HR = 1.72), as compared to responders without obesity and these dyslipidaemias. Conclusion: Mixed dyslipidaemias (reduced HDL cholesterol plus elevated triglycerides) significantly increased the risk for all-cause and CVD mortality in this Lithuanian population aged 45-64 years.	[Luksiene, Dalia; Tamosiunas, Abdonas; Baceviciene, Migle; Radisauskas, Ricardas; Malinauskiene, Vilija] Lithuanian Univ Hlth Sci, Med Acad, Inst Cardiol, Kaunas, Lithuania; [Peasey, Anne; Bobak, Martin] UCL, Dept Epidemiol & Publ Hlth, London, England	Lithuanian University of Health Sciences; University of London; University College London	Luksiene, D (corresponding author), Lithuanian Univ Hlth Sci, Med Acad, Inst Cardiol, Kaunas, Lithuania.	dalia.luksiene@lsmuni.lt	Baceviciene, Migle/AAG-1246-2020; Tamosiunas, Abdonas/AAD-4274-2021; Radišauskas, Ričardas/AAT-8920-2021	Baceviciene, Migle/0000-0002-9819-2316; Radišauskas, Ričardas/0000-0002-1227-2674; Peasey, Anne/0000-0001-7434-2079; Bobak, Martin/0000-0002-2633-6851	Wellcome Trust [081081/Z/06/Z]; US National Institute on Aging [1R0I AG23522]; MacArthur Foundation (Health and Social Upheaval network); NATIONAL INSTITUTE ON AGING [R01AG023522] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome Trust); US National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MacArthur Foundation (Health and Social Upheaval network); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The HAPIEE study was funded by grants from the Wellcome Trust (grant no. 081081/Z/06/Z), the US National Institute on Aging (grant no. 1R0I AG23522), and by the MacArthur Foundation (Health and Social Upheaval network). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, GLOBAL HEALTH RISKS: MORTALITY AND BURDEN OF DISEASE ATTRIBUTABLE TO SELECTED MAJOR RISKS, P1; [Anonymous], 2013, HLTH BALT COUNTR 201; [Anonymous], 2012, ATHEROSCLEROSIS, V22; ASSMANN G, 1992, AM J CARDIOL, V70, P733, DOI 10.1016/0002-9149(92)90550-I; Barinas-Mitchell E, 2001, AM J EPIDEMIOL, V153, P1094, DOI 10.1093/aje/153.11.1094; Barr ELM, 2007, CIRCULATION, V116, P151, DOI 10.1161/CIRCULATIONAHA.106.685628; Barter P, 2007, NEW ENGL J MED, V357, P1301, DOI 10.1056/NEJMoa064278; Barter P, 2011, ATHEROSCLEROSIS SUPP, V12, P267, DOI 10.1016/S1567-5688(11)70885-6; Bazzano LA, 2003, ANN INTERN MED, V138, P891, DOI 10.7326/0003-4819-138-11-200306030-00010; Carroll MD, 2012, JAMA-J AM MED ASSOC, V308, P1545, DOI 10.1001/jama.2012.13260; Choi J, 2013, OBES REV, V14, P232, DOI 10.1111/obr.12003; Clarke R, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3513; Cullen P, 1998, EUR HEART J, V19, P1632, DOI 10.1053/euhj.1998.1086; Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619; Erem C, 2008, ENDOCRINE, V34, P36, DOI 10.1007/s12020-008-9100-z; Farzadfar F, 2011, LANCET, V377, P578, DOI 10.1016/S0140-6736(10)62038-7; Fuentes Ricardo, 2003, Eur J Cardiovasc Prev Rehabil, V10, P411, DOI 10.1097/01.hjr.0000085247.65733.4f; GARRISON RJ, 1978, ATHEROSCLEROSIS, V30, P17, DOI 10.1016/0021-9150(78)90149-1; Gomes MS, 2013, J ENDODONT, V39, P1205, DOI 10.1016/j.joen.2013.06.014; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Hamer M, 2010, CLIN CHEM, V56, P132, DOI 10.1373/clinchem.2009.130740; Herder C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019852; Johansson I, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-40; Kawamoto R, 2013, ANN CLIN BIOCHEM, V50, P457, DOI 10.1177/0004563212473445; Klop B, 2013, NUTRIENTS, V5, P1218, DOI 10.3390/nu5041218; Koenig W, 2008, CLIN CHEM, V54, P335, DOI 10.1373/clinchem.2007.100271; Kriaucioniene V, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-218; Laforest L, 2012, VASC HEALTH RISK MAN, V8, P247, DOI 10.2147/VHRM.S27668; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Liu J, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-159; Lowe G, 2014, DIABETES, V63, P1115, DOI 10.2337/db12-1625; Luksiene D, 2012, PREV MED, V55, P299, DOI 10.1016/j.ypmed.2012.08.002; Morrison A, 2009, VASC HEALTH RISK MAN, V5, P89; Nakamura K, 2012, CEREBROVASC DIS, V33, P480, DOI 10.1159/000336764; Norkus A., 2000, LITH ENDOCRINOL, V3, P234; Paolillo Stefania, 2013, Monaldi Arch Chest Dis, V80, P27; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Peasey A, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-255; Padilha DMP, 2008, J GERONTOL A-BIOL, V63, P739, DOI 10.1093/gerona/63.7.739; Qiao Q, 2006, DIABETOLOGIA, V49, P2837, DOI 10.1007/s00125-006-0438-6; Rao CS, 2013, J CLIN DIAGN RES, V7, P31, DOI 10.7860/JCDR/2012/5086.2663; Rohde LEP, 1999, AM J CARDIOL, V84, P1018, DOI 10.1016/S0002-9149(99)00491-9; Sidaravicius B, 1999, ENDOD DENT TRAUMATOL, V15, P210; Silbernagel G, 2013, EUR HEART J, V34, P3563, DOI 10.1093/eurheartj/eht343; Smalinskiene A, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-120; The World Health Organization, WHO MULT MON TRENDS; Toth PP, 2012, J CLIN LIPIDOL, V6, P325, DOI 10.1016/j.jacl.2012.05.002; Tsai HJ, 2008, ASIA PAC J CLIN NUTR, V17, P651; Veeranna V, 2013, INT J CARDIOL, V168, P5156, DOI 10.1016/j.ijcard.2013.07.109; WEST KM, 1983, DIABETES CARE, V6, P361, DOI 10.2337/diacare.6.4.361; Wietlisbach V, 2013, NUTR METAB CARDIOVAS, V23, P432, DOI 10.1016/j.numecd.2011.09.002; Yanbaeva DG, 2007, CHEST, V131, P1557, DOI 10.1378/chest.06-2179; Yang QH, 2012, JAMA-J AM MED ASSOC, V307, P1273, DOI 10.1001/jama.2012.339; Zhang L, 2009, ATHEROSCLEROSIS, V206, P298, DOI 10.1016/j.atherosclerosis.2008.12.043	55	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100158	10.1371/journal.pone.0100158	http://dx.doi.org/10.1371/journal.pone.0100158			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955583	Green Published, gold, Green Submitted			2022-12-27	WOS:000338917900028
J	Omori, H; Onoue, A; Katoh, T; Ogata, Y; Kawashima, H; Miyao, N; Tsuji, T; Aoshiba, K; Nagai, A; Yamaguchi, K				Omori, Hisamitsu; Onoue, Ayumi; Katoh, Takahiko; Ogata, Yasuhiro; Kawashima, Hidetoshi; Miyao, Naoki; Tsuji, Takao; Aoshiba, Kazutetsu; Nagai, Atsushi; Yamaguchi, Kazuhiro			A Large Cohort Study Concerning Age-Dependent Impacts of Anthropometric Variables on Spirometric Parameters in Nonsmoking Healthy Adults	PLOS ONE			English	Article							FAT-FREE MASS; LUNG-FUNCTION; REFERENCE EQUATIONS; PULMONARY-FUNCTION; REFERENCE VALUES; REFERENCE RANGES; BODY-WEIGHT; POPULATION; CAPACITY; WOMEN	Backgrounds: Although height (H) has been considered the principal anthropometric variable governing lung function, the age-dependent differences in its influences on determining spirometric parameters (SPs) have not been conclusively investigated. Moreover, there has been no study centered on age-dependent effects of other anthropometric variables, including body weight (BW) and body fat mass (BFM) on SPs. In addition, the age-dependent influences of these anthropometric variables are anticipated to differ quantitatively between male and female participants. Methods: A total of 16,919 nonsmoking healthy Japanese adults (men: 6,116, women: 10,803) were partitioned into six groups stratified by gender and age at intervals of 20-years: young-, middle-, and advanced-age groups of either gender. Using a model in which a SP was described by a logarithmic additive function of age, H, BW, and BFM, we determined the partial regression coefficients of the respective anthropometric variables to predict the reference means of SPs, including FVC, FEV1, FEV1/FVC, PEF, FEF50, and FEF75, in the six groups. Results/Discussion: Although the impact of H on FVC and FEV1 was relatively homogeneous irrespective of gender and age, its homogeneity faded for flow parameters, particularly in the female middle-and advanced-age groups, indicating that the age-dependent contribution of H to SPs was enhanced more in women. The impact of BW on SPs differed depending on age, and this effect was also more conspicuous for female participants. H and BW generally exerted positive effects on SPs, whereas BFM had negative effects. Opposite effects of BW and BFM were observed in the female middle-age group in particular. Conclusions: The effects of anthropometric variables on spirometric parameters are highly age-dependent, particularly in women, leading to the conclusion that the assumption of age-independent, constant partial regression coefficients of anthropometric variables while predicting the reference mean of a certain spirometric parameter may result in substantial errors.	[Omori, Hisamitsu] Kumamoto Univ, Dept Biomed Lab Sci, Kumamoto, Japan; [Onoue, Ayumi; Katoh, Takahiko] Kumamoto Univ, Fac Life Sci, Dept Publ Hlth, Kumamoto, Japan; [Ogata, Yasuhiro; Kawashima, Hidetoshi] Japanese Red Cross Kumamoto, Hlth Care Ctr, Kumamoto, Japan; [Miyao, Naoki] Nihon Koukan Hosp, Kawasaki, Kanagawa, Japan; [Tsuji, Takao; Aoshiba, Kazutetsu] Tokyo Med Univ, Ibaraki Med Ctr, Dept Resp Med, Ibaraki, Japan; [Nagai, Atsushi] Tokyo Womens Med Univ, Dept Med 1, Tokyo, Japan; [Yamaguchi, Kazuhiro] Tokyo Womens Med Univ, Med Ctr East, Tokyo, Japan	Kumamoto University; Kumamoto University; Tokyo Medical University; Tokyo Women's Medical University; Tokyo Women's Medical University	Yamaguchi, K (corresponding author), Tokyo Womens Med Univ, Med Ctr East, Tokyo, Japan.	yamaguc@sirius.ocn.ne.jp			Teijin Home Healthcare Limited Japan [873]	Teijin Home Healthcare Limited Japan	The present study was undertaken using the research funds (Consent No. 873) donated from Teijin Home Healthcare Limited Japan (http://www.teijin.co.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHEN Y, 1993, THORAX, V48, P375, DOI 10.1136/thx.48.4.375; Chinn DJ, 1996, THORAX, V51, P699, DOI 10.1136/thx.51.7.699; Cole TJ, 2009, STAT MED, V28, P880, DOI 10.1002/sim.3504; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; Cotes JE, 2001, THORAX, V56, P839, DOI 10.1136/thorax.56.11.839; COTES JE, 1979, ANN HUM BIOL, V6, P307, DOI 10.1080/03014467900003691; Cotes JE, 1993, LUNG FUNCTION; Garcia-Rio F, 2004, EUR RESPIR J, V24, P397, DOI 10.1183/09031936.04.00088403; Garcia-Rio F, 2009, AM J RESP CRIT CARE, V180, P1083, DOI 10.1164/rccm.200901-0127OC; GORE CJ, 1995, EUR RESPIR J, V8, P773; HALL AM, 1979, THORAX, V34, P359, DOI 10.1136/thx.34.3.359; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; JENKINS SC, 1991, RESP MED, V85, P309, DOI 10.1016/S0954-6111(06)80102-2; Lung Function in Growth and Aging, 2012, PUBL REF VAL; MENGESHA YA, 1985, THORAX, V40, P465, DOI 10.1136/thx.40.6.465; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Mohamed EI, 2002, LUNG, V180, P149, DOI 10.1007/s004080000089; Pistelli F, 2000, AM J RESP CRIT CARE, V161, P899, DOI 10.1164/ajrccm.161.3.9906006; Quanjer P, 2012, GAMLSS ACTION ANNOTA; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; SCHOENBERG JB, 1978, RESP PHYSIOL, V33, P367, DOI 10.1016/0034-5687(78)90063-4; Stanojevic S, 2008, AM J RESP CRIT CARE, V177, P253, DOI 10.1164/rccm.200708-1248OC; Stocks J, 2012, TF 2009 03 ESTABLISH; Wu YH, 2009, J OCCUP HEALTH, V51, P471, DOI 10.1539/joh.L9006; [No title captured]	25	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100733	10.1371/journal.pone.0100733	http://dx.doi.org/10.1371/journal.pone.0100733			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955585	Green Published, gold, Green Submitted			2022-12-27	WOS:000338917900091
J	Toutounchian, JJ; Steinle, JJ; Makena, PS; Waters, CM; Wilson, MW; Haik, BG; Miller, DD; Yates, CR				Toutounchian, Jordan J.; Steinle, Jena J.; Makena, Patrudu S.; Waters, Christopher M.; Wilson, Matthew W.; Haik, Barrett G.; Miller, Duane D.; Yates, Charles R.			Modulation of Radiation Injury Response in Retinal Endothelial Cells by Quinic Acid Derivative KZ-41 Involves p38 MAPK	PLOS ONE			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; OXYGEN-INDUCED RETINOPATHY; PROTEIN-KINASE INHIBITORS; COMS RANDOMIZED TRIAL; CHOROIDAL MELANOMA; GROWTH-FACTOR; IODINE-125 BRACHYTHERAPY; SIGNAL-TRANSDUCTION; ICAM-1 EXPRESSION; PLAQUE RADIOTHERAPY	Radiation-induced damage to the retina triggers leukostasis, retinal endothelial cell (REC) death, and subsequent hypoxia. Resultant ischemia leads to visual loss and compensatory retinal neovascularization (RNV). Using human RECs, we demonstrated that radiation induced leukocyte adhesion through mechanisms involving p38MAPK, p53, and ICAM-1 activation. Additional phenotypic changes included p38MAPK-dependent tyrosine phosphorylation of the focal adhesion scaffolding protein, paxillin (Tyr118). The quinic acid derivative KZ-41 lessened leukocyte adhesion and paxillin-dependent proliferation via inhibition of p38MAPK-p53-ICAM-1 signaling. Using the murine oxygen-induced retinopathy (OIR) model, we examined the effect of KZ-41 on pathologic RNV. Daily ocular application of a KZ-41-loaded nanoemulsion significantly reduced both the avascular and neovascular areas in harvested retinal flat mounts when compared to the contralateral eye receiving vehicle alone. Our data highlight the potential benefit of KZ-41 in reducing both the retinal ischemia and neovascularization provoked by genotoxic insults. Further research into how quinic acid derivatives target and mitigate inflammation is needed to fully appreciate their therapeutic potential for the treatment of inflammatory retinal vasculopathies.	[Toutounchian, Jordan J.; Steinle, Jena J.; Miller, Duane D.; Yates, Charles R.] Univ Tennessee, Ctr Hlth Sci, Dept Pharmaceut Sci, Memphis, TN 38163 USA; [Steinle, Jena J.; Wilson, Matthew W.; Haik, Barrett G.; Yates, Charles R.] Univ Tennessee, Ctr Hlth Sci, Dept Ophthalmol, Memphis, TN 38163 USA; [Steinle, Jena J.] Univ Tennessee, Ctr Hlth Sci, Dept Anat & Neurobiol, Memphis, TN 38163 USA; [Makena, Patrudu S.; Waters, Christopher M.] Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Yates, CR (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Pharmaceut Sci, Memphis, TN 38163 USA.	cyates4@uthsc.edu		Steinle, Jena/0000-0002-7539-2892	College of Pharmacy (Pharmaceutical Sciences), National Heart, Lung, and Blood Institute (NHLBI) [HL094366]; College of Medicine (Ophthalmology), National Heart, Lung, and Blood Institute (NHLBI) [HL094366]; National Institute of Allergy and Infectious Diseases (NIAID) [R33 AI080534-01]; Dept. of Ophthalmology from Research to Prevent Blindness, NY, NY; National Eye Institute (NEI) Vision Core Grant [PHS 3P30, EY013080]; St. Giles Foundation; NATIONAL EYE INSTITUTE [P30EY013080, P30EY021721] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R33AI080534] Funding Source: NIH RePORTER	College of Pharmacy (Pharmaceutical Sciences), National Heart, Lung, and Blood Institute (NHLBI); College of Medicine (Ophthalmology), National Heart, Lung, and Blood Institute (NHLBI); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Dept. of Ophthalmology from Research to Prevent Blindness, NY, NY; National Eye Institute (NEI) Vision Core Grant; St. Giles Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Colleges of Pharmacy (Pharmaceutical Sciences) and Medicine (Ophthalmology), National Heart, Lung, and Blood Institute (NHLBI) grant HL094366, and National Institute of Allergy and Infectious Diseases (NIAID) R33 AI080534-01 (Duane D. Miller). This work was supported by an unrestricted grant to the Dept. of Ophthalmology from Research to Prevent Blindness, NY, NY; a National Eye Institute (NEI) Vision Core Grant: PHS 3P30, EY013080; and an unrestricted grant from the St. Giles Foundation. This technology has a US patent number (8,115,031) and is owned by the University of Tennessee Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelsaid MA, 2010, J PHARMACOL EXP THER, V332, P125, DOI 10.1124/jpet.109.157941; Alon R, 1996, J CELL BIOL, V135, P849, DOI 10.1083/jcb.135.3.849; Ammar HO, 2009, AAPS PHARMSCITECH, V10, P808, DOI 10.1208/s12249-009-9268-4; ARCHER D B, 1991, Eye (London), V5, P239; Archer D B, 1994, Curr Opin Ophthalmol, V5, P59, DOI 10.1097/00055735-199406000-00011; Arnold TD, 2012, J NEUROSCI, V32, P1197, DOI 10.1523/JNEUROSCI.5648-11.2012; Avery RB, 2008, ARCH OPHTHALMOL-CHIC, V126, P207, DOI 10.1001/archophthalmol.2007.50; Bai YY, 2011, EXP MOL PATHOL, V91, P471, DOI 10.1016/j.yexmp.2011.04.016; Beinke C, 2003, INT J RADIAT BIOL, V79, P721, DOI 10.1080/09553000310001610231; Berginski ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022025; Bianciotto C, 2010, OPHTHALMOLOGY, V117, P1005, DOI 10.1016/j.ophtha.2009.10.015; BROWN GC, 1982, OPHTHALMOLOGY, V89, P1494; Bulavin DV, 1999, EMBO J, V18, P6845, DOI 10.1093/emboj/18.23.6845; Burns AR, 1999, J LEUKOCYTE BIOL, V65, P299, DOI 10.1002/jlb.65.3.299; Chang WC, 2010, EUR J NUTR, V49, P267, DOI 10.1007/s00394-009-0083-1; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; Diener-West M, 2001, ARCH OPHTHALMOL-CHIC, V119, P969; Figueroa Marta S, 2011, Retin Cases Brief Rep, V5, P171, DOI 10.1097/ICB.0b013e3181d427ed; Finger PT, 2009, OPHTHALMOLOGY, V116, P790, DOI 10.1016/j.ophtha.2008.12.027; FRANGOS JA, 1988, BIOTECHNOL BIOENG, V32, P1053, DOI 10.1002/bit.260320812; Funatsu H, 2005, OPHTHALMOLOGY, V112, P806, DOI 10.1016/j.ophtha.2004.11.045; Gaber MW, 2003, INT J RADIAT BIOL, V79, P359, DOI 10.1080/0955300031000114738; Giuliari GP, 2011, ACTA ONCOL, V50, P6, DOI 10.3109/0284186X.2010.500299; Gorgoulis VG, 2003, EMBO J, V22, P1567, DOI 10.1093/emboj/cdg157; GRAGOUDAS ES, 1987, OPHTHALMOLOGY, V94, P349; Gunduz K, 1999, AM J OPHTHALMOL, V127, P579, DOI 10.1016/S0002-9394(98)00445-0; Haas A, 2002, OPHTHALMOLOGY, V109, P909, DOI 10.1016/S0161-6420(02)01011-4; Hiroshiba N, 1999, INVEST OPHTH VIS SCI, V40, P1217; Huang CS, 1999, J BIOL CHEM, V274, P12229, DOI 10.1074/jbc.274.18.12229; Ishida S, 2003, NAT MED, V9, P781, DOI 10.1038/nm877; Jampol LM, 2002, OPHTHALMOLOGY, V109, P2197, DOI 10.1016/S0161-6420(02)01277-0; Joussen AM, 2001, AM J PATHOL, V158, P147, DOI 10.1016/S0002-9440(10)63952-1; Jung JW, 2007, EUR J CANCER, V43, P1214, DOI 10.1016/j.ejca.2007.01.034; Kanno S, 2000, ONCOGENE, V19, P2138, DOI 10.1038/sj.onc.1203533; Kinashi T, 2005, NAT REV IMMUNOL, V5, P546, DOI 10.1038/nri1646; Kornberg LJ, 2004, INVEST OPHTH VIS SCI, V45, P4463, DOI 10.1167/iovs.03-1201; Langston W, 2007, FREE RADICAL BIO MED, V42, P720, DOI 10.1016/j.freeradbiomed.2006.12.010; LAWRENCE MB, 1987, BLOOD, V70, P1284; McCarty OJT, 2000, BLOOD, V96, P1789, DOI 10.1182/blood.V96.5.1789.h8001789_1789_1797; Meineke V, 2002, INT J RADIAT BIOL, V78, P577, DOI 10.1080/09553000110113056; Miyamoto K, 1999, P NATL ACAD SCI USA, V96, P10836, DOI 10.1073/pnas.96.19.10836; PANES J, 1995, GASTROENTEROLOGY, V108, P1761, DOI 10.1016/0016-5085(95)90138-8; Radisavljevic Z, 2000, J BIOL CHEM, V275, P20770, DOI 10.1074/jbc.M002448200; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Rousseau S, 1997, ONCOGENE, V15, P2169, DOI 10.1038/sj.onc.1201380; Sanchez-Prieto R, 2000, CANCER RES, V60, P2464; Shafiq-Un-Nabi S, 2007, AAPS PHARMSCITECH, V8, DOI 10.1208/pt0802028; She QB, 2000, J BIOL CHEM, V275, P20444, DOI 10.1074/jbc.M001020200; Shields CL, 2002, OPHTHALMOLOGY, V109, P1838, DOI 10.1016/S0161-6420(02)01181-8; Siliciano JD, 1997, GENE DEV, V11, P3471, DOI 10.1101/gad.11.24.3471; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Stahl A, 2009, ANGIOGENESIS, V12, P297, DOI 10.1007/s10456-009-9155-3; Steinle JJ, 2012, INVEST OPHTH VIS SCI, V53, P2439, DOI 10.1167/iovs.12-9466; Steinle JJ, 2012, INVEST OPHTHALMOL VI; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; Thompson KE, 2014, DRUG DISCOV IN PRESS; Wagers AJ, 1998, J EXP MED, V188, P2225, DOI 10.1084/jem.188.12.2225; Wang XJ, 1997, J RADIAT RES, V38, P179, DOI 10.1269/jrr.38.179; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Yan WS, 2002, SHOCK, V17, P433, DOI 10.1097/00024382-200205000-00016; Yates CR, 2013, Provisional US Patent Application, Patent No. [14/074,457, 14074457]; Yates CR, 2012, US Patent, Patent No. [2012/0283331 A1, 20120283331]; Yu YM, 2007, BRIT J NUTR, V97, P692, DOI 10.1017/S0007114507666409; Yusuf-Makagiansar H, 2002, MED RES REV, V22, P146, DOI 10.1002/med.10001; ZAMBER RW, 1992, WESTERN J MED, V157, P530; Zeng K, 2009, BIOORG MED CHEM LETT, V19, P5458, DOI 10.1016/j.bmcl.2009.07.096; Zhang QH, 2013, INVEST OPHTH VIS SCI, V54, P5937, DOI 10.1167/iovs.13-12326; Zhang QH, 2011, J BIOL CHEM, V286, P22489, DOI 10.1074/jbc.M110.217786	70	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100210	10.1371/journal.pone.0100210	http://dx.doi.org/10.1371/journal.pone.0100210			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956278	Green Submitted, gold, Green Published			2022-12-27	WOS:000338917900034
J	Verdecchia, P; Angeli, F; Lip, GYH; Reboldi, G				Verdecchia, Paolo; Angeli, Fabio; Lip, Gregory Y. H.; Reboldi, Gianpaolo			Edoxaban in the Evolving Scenario of Non Vitamin K Antagonist Oral Anticoagulants Imputed Placebo Analysis and Multiple Treatment Comparisons	PLOS ONE			English	Article							ISPOR TASK-FORCE; ATRIAL-FIBRILLATION; STROKE PREVENTION; NON-INFERIORITY; MYOCARDIAL-INFARCTION; SECONDARY PREVENTION; DOSE WARFARIN; METAANALYSIS; EFFICACY; ASPIRIN	Background: Edoxaban recently proved non-inferior to warfarin for prevention of thromboembolism in patients with non-valvular atrial fibrillation (AF). We conducted an imputed-placebo analysis with estimates of the proportion of warfarin effect preserved by each non vitamin K antagonist oral anticoagulant (NOAC) and indirect comparisons between edoxaban and different NOACs. Methods and Findings: We performed a literature search (up to January 2014), clinical trials registers, conference proceedings, and websites of regulatory agencies. We selected non-inferiority randomised controlled phase III trials of dabigatran, rivaroxaban, apixaban and edoxaban compared with adjusted-dose warfarin in non-valvular AF. Compared to imputed placebo, all NOACs reduced the risk of stroke (ORs between 0.24 and 0.42, all p<0.001) and all-cause mortality (ORs between 0.55 and 0.59, all p<0.05). Edoxaban 30 mg and 60 mg preserved 87% and 112%, respectively, of the protective effect of warfarin on stroke, and 133% and 121%, respectively, of the protective effect of warfarin on all-cause mortality. The risk of primary outcome (stroke/systemic embolism), all strokes and ischemic strokes was significantly higher with edoxaban 30 mg than dabigatran 150 mg and apixaban. There were no significant differences between edoxaban 60 mg and other NOACs for all efficacy outcomes except stroke, which was higher with edoxaban 60 mg than dabigatran 150 mg. The risk of major bleedings was lower with edoxaban 30 mg than any other NOAC, odds ratios (ORs) ranging between 0.45 and 0.67 (all p<0.001). Conclusions: This study suggests that all NOACs preserve a substantial or even larger proportion of the protective warfarin effect on stroke and all-cause mortality. Edoxaban 30 mg is associated with a definitely lower risk of major bleedings than other NOACs. This is counterbalanced by a lower efficacy in the prevention of thromboembolism, although with a final benefit on all-cause mortality.	[Verdecchia, Paolo] Hosp Assisi, Dept Med, Assisi, Italy; [Angeli, Fabio] Univ Hosp Perugia, Perugia, Italy; [Lip, Gregory Y. H.] Univ Birmingham, City Hosp, Ctr Cardiovasc Sci, Birmingham, W Midlands, England; [Reboldi, Gianpaolo] Univ Perugia, Dept Med, I-06100 Perugia, Italy	University of Birmingham; University of Perugia	Verdecchia, P (corresponding author), Hosp Assisi, Dept Med, Assisi, Italy.	verdec@tin.it	Angeli, Fabio/K-8775-2019; Reboldi, Gianpaolo/A-3444-2009	Angeli, Fabio/0000-0003-4925-7985; Reboldi, Gianpaolo/0000-0002-9877-0702				Antman EM, 1999, CIRCULATION, V100, P1593, DOI 10.1161/01.CIR.100.15.1593; Baker WL, 2012, CIRC-CARDIOVASC QUAL, V5, P711, DOI 10.1161/CIRCOUTCOMES.112.966572; Beasley BN, 2011, NEW ENGL J MED, V364, P1788, DOI 10.1056/NEJMp1103050; Bucher HC, 1997, J CLIN EPIDEMIOL, V50, P683, DOI 10.1016/S0895-4356(97)00049-8; Camm AJ, 2012, EUR HEART J, V33; Cannon CP, 2012, J AM COLL CARDIOL, V60, P747, DOI 10.1016/j.jacc.2012.05.012; CONNOLLY SJ, 1991, J AM COLL CARDIOL, V18, P349, DOI 10.1016/0735-1097(91)90585-W; Connolly SJ, 2007, CIRCULATION, V116, P449, DOI 10.1161/CIRCULATIONAHA.107.695163; Connolly SJ, 2010, NEW ENGL J MED, V363, P1875, DOI 10.1056/NEJMc1007378; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; D'Agostino RB, 2003, STAT MED, V22, P169, DOI 10.1002/sim.1425; Durrleman S, 2003, STAT MED, V22, P941, DOI 10.1002/sim.1454; Edwards SJ, 2009, INT J CLIN PRACT, V63, P841, DOI 10.1111/j.1742-1241.2009.02072.x; EZEKOWITZ MD, 1992, NEW ENGL J MED, V327, P1406, DOI 10.1056/NEJM199211123272002; Food and Drug Administration, 2010, GUID IND NON CLIN TR; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Harenberg J, 2012, INT ANGIOL, V31, P330; Harenberg J, 2012, THROMB HAEMOSTASIS, V108, P407, DOI 10.1160/TH12-07-0463; Hart RG, 2007, ANN INTERN MED, V147, P590, DOI 10.7326/0003-4819-147-8-200710160-00018; Hasselblad V, 2001, DRUG INF J, V35, P435, DOI 10.1177/009286150103500212; Hoaglin DC, 2011, VALUE HEALTH, V14, P429, DOI 10.1016/j.jval.2011.01.011; Hung HMJ, 2003, STAT MED, V22, P213, DOI 10.1002/sim.1315; Husted S, 2014, THROMB HAEMOSTASIS, V111, P781, DOI 10.1160/TH14-03-0228; Jansen JP, 2011, VALUE HEALTH, V14, P417, DOI 10.1016/j.jval.2011.04.002; Kaul S, 2005, J AM COLL CARDIOL, V46, P1986, DOI 10.1016/j.jacc.2005.07.062; KISTLER JP, 1990, NEW ENGL J MED, V323, P1505; KOUDSTAAL PJ, 1993, LANCET, V342, P1255; Lee S, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000269; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lip GYH, 2006, THROMB RES, V118, P321, DOI 10.1016/j.thromres.2005.08.007; Lip GYH, 2012, J AM COLL CARDIOL, V60, P738, DOI 10.1016/j.jacc.2012.03.019; Mantha S, 2012, THROMB HAEMOSTASIS, V108, P476, DOI 10.1160/TH12-02-0093; MCBRIDE R, 1991, CIRCULATION, V84, P527, DOI 10.1161/01.CIR.84.2.527; Oler A, 1996, JAMA-J AM MED ASSOC, V276, P811, DOI 10.1001/jama.276.10.811; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; PETERSEN P, 1989, LANCET, V1, P175; Rasmussen LH, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7097; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Sardar P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077694; Skjoth F, 2014, THROMB HAEMOST, V111; Skjoth F, 2012, THROMB HAEMOSTASIS, V108, P405, DOI 10.1160/TH12-06-0438; Snapinn S, 2008, STAT MED, V27, P382, DOI 10.1002/sim.3073; Snapinn S, 2011, PHARM STAT, V10, P420, DOI 10.1002/pst.509; Snapinn Steven M, 2004, J Biopharm Stat, V14, P263, DOI 10.1081/BIP-120037178; Song FJ, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1147; You JJ, 2012, CHEST, V141, pE531S, DOI 10.1378/chest.11-2304	48	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100478	10.1371/journal.pone.0100478	http://dx.doi.org/10.1371/journal.pone.0100478			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955573	gold, Green Submitted, Green Published			2022-12-27	WOS:000338917900055
J	Littlejohns, B; Pasdois, P; Duggan, S; Bond, AR; Heesom, K; Jackson, CL; Angelini, GD; Halestrap, AP; Suleiman, MS				Littlejohns, Ben; Pasdois, Philippe; Duggan, Simon; Bond, Andrew R.; Heesom, Kate; Jackson, Christopher L.; Angelini, Gianni D.; Halestrap, Andrew P.; Suleiman, M. -Saadeh			Hearts from Mice Fed a Non-Obesogenic High-Fat Diet Exhibit Changes in Their Oxidative State, Calcium and Mitochondria in Parallel with Increased Susceptibility to Reperfusion Injury	PLOS ONE			English	Article							METABOLIC INHIBITION; CARDIAC DYSFUNCTION; INTRACELLULAR CA2+; ACID-METABOLISM; INDUCED OBESITY; ISOLATED RAT; GUINEA-PIG; INSULIN; CARDIOMYOCYTES; RETICULUM	Rationale: High-fat diet with obesity-associated co-morbidities triggers cardiac remodeling and renders the heart more vulnerable to ischemia/reperfusion injury. However, the effect of high-fat diet without obesity and associated co-morbidities is presently unknown. Objectives: To characterize a non-obese mouse model of high-fat diet, assess the vulnerability of hearts to reperfusion injury and to investigate cardiac cellular remodeling in relation to the mechanism(s) underlying reperfusion injury. Methods and Results: Feeding C57BL/6J male mice high-fat diet for 20 weeks did not induce obesity, diabetes, cardiac hypertrophy, cardiac dysfunction, atherosclerosis or cardiac apoptosis. However, isolated perfused hearts from mice fed high-fat diet were more vulnerable to reperfusion injury than those from mice fed normal diet. In isolated cardiomyocytes, high-fat diet was associated with higher diastolic intracellular Ca2+ concentration and greater damage to isolated cardiomyocytes following simulated ischemia/reperfusion. High-fat diet was also associated with changes in mitochondrial morphology and expression of some related proteins but not mitochondrial respiration or reactive oxygen species turnover rates. Proteomics, western blot and high-performance liquid chromatography techniques revealed that high-fat diet led to less cardiac oxidative stress, higher catalase expression and significant changes in expression of putative components of the mitochondrial permeability transition pore (mPTP). Inhibition of the mPTP conferred relatively more cardio-protection in the high-fat fed mice compared to normal diet. Conclusions: This study shows for the first time that high-fat diet, independent of obesity-induced co-morbidities, triggers changes in cardiac oxidative state, calcium handling and mitochondria which are likely to be responsible for increased vulnerability to cardiac insults.	[Littlejohns, Ben; Bond, Andrew R.; Jackson, Christopher L.; Angelini, Gianni D.; Suleiman, M. -Saadeh] Univ Bristol, Sch Clin Sci, Fac Med & Dent, Bristol Heart Inst, Bristol, Avon, England; [Pasdois, Philippe] Univ Bordeaux, Inst Rythmol & Modelisat Cardiaque, Pessac, France; [Duggan, Simon] John Radcliffe Hosp, Oxford Heart Ctr, Oxford OX3 9DU, England; [Heesom, Kate] Univ Bristol, Fac Med & Vet Sci, Prote Facil, Bristol, Avon, England; [Halestrap, Andrew P.] Univ Bristol, Sch Biochem, Fac Med & Vet Sci, Bristol, Avon, England	University of Bristol; UDICE-French Research Universities; Universite de Bordeaux; University of Oxford; University of Bristol; University of Bristol	Suleiman, MS (corresponding author), Univ Bristol, Sch Clin Sci, Fac Med & Dent, Bristol Heart Inst, Bristol, Avon, England.	M.S.Suleiman@bristol.ac.uk	Bond, Andrew/AAC-5941-2020; Pasdois, Philippe/AAH-9365-2020; Duggan, Simon/AAG-4404-2020; Suleiman, M.-Saadeh/AAF-2946-2019	Bond, Andrew/0000-0002-4255-4488; Pasdois, Philippe/0000-0002-2385-4469; angelini, gianni/0000-0002-1753-3730; Suleiman, M.-Saadeh/0000-0001-6080-480X; Halestrap, Andrew/0000-0001-5374-2778	British Heart Foundation [FS/11/57/28936]; National Institute for Health Research Bristol Biomedical Research Unit in Cardiovascular Disease; British Heart Foundation [RG/08/001/24717] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10022] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); National Institute for Health Research Bristol Biomedical Research Unit in Cardiovascular Disease; British Heart Foundation(British Heart Foundation); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded by the British Heart Foundation (www.bhf.org.uk) grant number FS/11/57/28936. The authors also acknowledge the support of the National Institute for Health Research Bristol Biomedical Research Unit in Cardiovascular Disease. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adameova A, 2006, PHARMAZIE, V61, P807; Alpert MA, 2001, AM J MED SCI, V321, P225, DOI 10.1097/00000441-200104000-00003; Anflous-Pharayra K, 2007, BBA-BIOENERGETICS, V1767, P136, DOI 10.1016/j.bbabio.2006.11.013; Ballal K, 2010, MOL CELL BIOCHEM, V344, P221, DOI 10.1007/s11010-010-0546-y; Belke DD, 2004, DIABETES, V53, P3201, DOI 10.2337/diabetes.53.12.3201; Bonnard C, 2008, DIABETES METAB, V34, P52, DOI 10.1016/j.diabet.2007.09.006; Boudina S, 2012, DIABETES, V61, P3260, DOI 10.2337/db12-0063; BOVERIS A, 1972, BIOCHEM J, V128, P617, DOI 10.1042/bj1280617; Calligaris SD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060931; Chase A, 2007, CRIT CARE MED, V35, P2344, DOI 10.1097/01.CCM.0000282085.63409.FB; Chen Q, 2007, AM J PHYSIOL-CELL PH, V292, pC137, DOI 10.1152/ajpcell.00270.2006; Chess DJ, 2008, CARDIOVASC RES, V79, P269, DOI 10.1093/cvr/cvn074; Cole MA, 2011, BASIC RES CARDIOL, V106, P447, DOI 10.1007/s00395-011-0156-1; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; Dabkowski ER, 2009, AM J PHYSIOL-HEART C, V296, pH359, DOI 10.1152/ajpheart.00467.2008; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Dhalla NS, 2000, J HYPERTENS, V18, P655, DOI 10.1097/00004872-200018060-00002; Diano S, 2011, NAT MED, V17, P1121, DOI 10.1038/nm.2421; Gallou-Kabani C, 2007, OBESITY, V15, P1996, DOI 10.1038/oby.2007.238; Griffiths EJ, 1998, BIOCHEM PHARMACOL, V56, P173, DOI 10.1016/S0006-2952(98)00016-1; Halestrap AP, 2009, BBA-BIOENERGETICS, V1787, P1402, DOI 10.1016/j.bbabio.2008.12.017; Halestrap AP, 2009, J BIOENERG BIOMEMBR, V41, P113, DOI 10.1007/s10863-009-9206-x; HALLFRISCH J, 1981, J NUTR, V111, P531, DOI 10.1093/jn/111.3.531; Harmancey R, 2008, HYPERTENSION, V52, P181, DOI 10.1161/HYPERTENSIONAHA.108.110031; Harper CR, 2001, ARCH INTERN MED, V161, P2185, DOI 10.1001/archinte.161.18.2185; Hom J, 2010, BBA-BIOENERGETICS, V1797, P913, DOI 10.1016/j.bbabio.2010.03.018; Howarth FC, 2005, MOL CELL BIOCHEM, V273, P87, DOI 10.1007/s11010-005-7758-6; Hwang H, 2009, CIRCULATION, V120, pS16, DOI 10.1161/CIRCULATIONAHA.108.844167; John S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017674; Johnson JL, 2006, CARDIOVASC RES, V71, P586, DOI 10.1016/j.cardiores.2006.05.009; Johnson JL, 2001, ATHEROSCLEROSIS, V154, P399, DOI 10.1016/S0021-9150(00)00515-3; Khaliulin I, 2011, EXP BIOL MED, V236, P736, DOI 10.1258/ebm.2011.010357; Lee J, 2013, J MOL MED, V91, P965, DOI 10.1007/s00109-013-1013-5; Liu J, 2013, NUTR RES, V33, P311, DOI 10.1016/j.nutres.2013.02.005; Lopaschuk GD, 2007, CIRC RES, V101, P335, DOI 10.1161/CIRCRESAHA.107.150417; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; Ma KL, 2013, INT J MED SCI, V10, P420, DOI 10.7150/ijms.5723; Mateos R, 2004, J CHROMATOGR B, V805, P33, DOI 10.1016/j.jchromb.2004.02.004; MILLS E, 1993, AM J PHYSIOL, V264, pR73, DOI 10.1152/ajpregu.1993.264.1.R73; Noyan-Ashraf MH, 2013, CIRCULATION, V127, P74, DOI 10.1161/CIRCULATIONAHA.112.091215; Olofsson CS, 2004, J PHYSIOL-LONDON, V557, P935, DOI 10.1113/jphysiol.2004.066258; Ong SB, 2010, CARDIOVASC RES, V88, P16, DOI 10.1093/cvr/cvq237; Ong SB, 2010, CIRCULATION, V121, P2012, DOI 10.1161/CIRCULATIONAHA.109.906610; Ouwens DM, 2005, DIABETOLOGIA, V48, P1229, DOI 10.1007/s00125-005-1755-x; PAIGEN B, 1987, ATHEROSCLEROSIS, V68, P231, DOI 10.1016/0021-9150(87)90202-4; Panagia M, 2005, AM J PHYSIOL-HEART C, V288, pH2677, DOI 10.1152/ajpheart.00200.2004; Papanicolaou KN, 2012, AM J PHYSIOL-HEART C, V302, pH167, DOI 10.1152/ajpheart.00833.2011; Papanicolaou KN, 2011, MOL CELL BIOL, V31, P1309, DOI 10.1128/MCB.00911-10; Pasdois P, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.005645; Pasdois P, 2011, BIOCHEM J, V436, P493, DOI 10.1042/BJ20101957; Pereira L, 2006, DIABETES, V55, P608, DOI 10.2337/diabetes.55.03.06.db05-1284; Piquereau J, 2012, CARDIOVASC RES, V94, P408, DOI 10.1093/cvr/cvs117; REISER S, 1977, J NUTR, V107, P147, DOI 10.1093/jn/107.1.147; REISER S, 1979, AM J CLIN NUTR, V32, P2206, DOI 10.1093/ajcn/32.11.2206; Relling DP, 2006, J HYPERTENS, V24, P549, DOI 10.1097/01.hjh.0000203846.34314.94; Rennison JH, 2009, J MOL CELL CARDIOL, V46, P883, DOI 10.1016/j.yjmcc.2009.02.019; Rindler PM, 2013, J BIOL CHEM, V288, P1979, DOI 10.1074/jbc.M112.412890; Saini HK, 2005, AM J PHYSIOL-HEART C, V288, pH2260, DOI 10.1152/ajpheart.01153.2004; Saini-Chohan HK, 2009, CAN J PHYSIOL PHARM, V87, P1110, DOI 10.1139/Y09-103; Schreyer SA, 1998, ATHEROSCLEROSIS, V136, P17, DOI 10.1016/S0021-9150(97)00165-2; Seifert EL, 2010, J BIOL CHEM, V285, P5748, DOI 10.1074/jbc.M109.026203; Sharma S, 2004, FASEB J, V18, P1692, DOI 10.1096/fj.04-2263com; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; Temsah RM, 1999, AM J PHYSIOL-HEART C, V277, pH584, DOI 10.1152/ajpheart.1999.277.2.H584; Thakker GD, 2006, AM J PHYSIOL-HEART C, V291, pH2504, DOI 10.1152/ajpheart.00322.2006; Thakker GD, 2008, OBESITY, V16, P2593, DOI 10.1038/oby.2008.414; Toida S, 1996, OBES RES, V4, P561, DOI 10.1002/j.1550-8528.1996.tb00270.x; Unger RH, 2003, TRENDS ENDOCRIN MET, V14, P398, DOI 10.1016/j.tem.2003.09.008; Varanyuwatana P, 2012, MITOCHONDRION, V12, P120, DOI 10.1016/j.mito.2011.04.006; Wang PP, 2008, LIFE SCI, V83, P836, DOI 10.1016/j.lfs.2008.09.024; Williams H, 2000, EXP PHYSIOL, V85, P505, DOI 10.1017/S095806700002025X; Williams H, 2001, J MOL CELL CARDIOL, V33, P2109, DOI 10.1006/jmcc.2000.1474; Williams TD, 2003, CLIN EXP PHARMACOL P, V30, P769, DOI 10.1046/j.1440-1681.2003.t01-1-03808.x; Williamson CL, 2010, AM J PHYSIOL-HEART C, V298, pH633, DOI 10.1152/ajpheart.00668.2009; Wilson CR, 2007, BIOCHEM J, V406, P457, DOI 10.1042/BJ20070392; Woodfield K, 1998, BIOCHEM J, V336, P287, DOI 10.1042/bj3360287; Wright JJ, 2009, CARDIOVASC RES, V82, P351, DOI 10.1093/cvr/cvp017; Xu KY, 1997, CIRC RES, V80, P76, DOI 10.1161/01.RES.80.1.76; Yu TZ, 2008, CARDIOVASC RES, V79, P341, DOI 10.1093/cvr/cvn104; Zhou YT, 2000, P NATL ACAD SCI USA, V97, P1784, DOI 10.1073/pnas.97.4.1784	80	46	47	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100579	10.1371/journal.pone.0100579	http://dx.doi.org/10.1371/journal.pone.0100579			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950187	Green Published, gold, Green Submitted			2022-12-27	WOS:000338276300093
J	Shi, R; Yang, X; Chen, L; Chang, HT; Liu, HY; Zhao, J; Wang, XW; Wang, CQ				Shi, Run; Yang, Xia; Chen, Lu; Chang, Hong-tao; Liu, Hong-ying; Zhao, Jun; Wang, Xin-wei; Wang, Chuan-qing			Pathogenicity of Shigella in Chickens	PLOS ONE			English	Article							ANIMAL-MODEL; GUINEA-PIG; FLEXNERI; INFECTION	Shigellosis in chickens was first reported in 2004. This study aimed to determine the pathogenicity of Shigella in chickens and the possibility of cross-infection between humans and chickens. The pathogenicity of Shigella in chickens was examined via infection of three-day-old SPF chickens with Shigella strain ZD02 isolated from a human patient. The virulence and invasiveness were examined by infection of the chicken intestines and primary chicken intestinal epithelial cells. The results showed Shigella can cause death via intraperitoneal injection in SPF chickens, but only induce depression via crop injection. Immunohistochemistry and transmission electron microscopy revealed the Shigella can invade the intestinal epithelia. Immunohistochemistry of the primary chicken intestinal epithelial cells infected with Shigella showed the bacteria were internalized into the epithelial cells. Electron microscopy also confirmed that Shigella invaded primary chicken intestinal epithelia and was encapsulated by phagosome-like membranes. Our data demonstrate that Shigella can invade primary chicken intestinal epithelial cells in vitro and chicken intestinal mucosa in vivo, resulting in pathogenicity and even death. The findings suggest Shigella isolated from human or chicken share similar pathogenicity as well as the possibility of human-poultry cross-infection, which is of public health significance.	[Shi, Run; Yang, Xia; Chen, Lu; Chang, Hong-tao; Liu, Hong-ying; Zhao, Jun; Wang, Xin-wei; Wang, Chuan-qing] Henan Agr Univ, Collage Anim Sci & Vet Med, Zhengzhou, Peoples R China	Henan Agricultural University	Chen, L (corresponding author), Henan Agr Univ, Collage Anim Sci & Vet Med, Zhengzhou, Peoples R China.	chenluhau@hotmail.com	Zhao, Jun/GVS-6159-2022		National Natural Science Foundation of China [30972187]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20114105110031/4boolean AND]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	The project was supported by National Natural Science Foundation of China grant 30972187 (http://www.nsfc.gov.cn) and Specialized Research Fund for the Doctoral Program of Higher Education of China grants 20114105110031/4 boolean AND http://www.cutech.edu.cn/cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashida H, 2011, CURR OPIN IMMUNOL, V23, P448, DOI 10.1016/j.coi.2011.06.001; Athman R, 2005, CELL MICROBIOL, V7, P1109, DOI 10.1111/j.1462-5822.2005.00535.x; Bardhan P, 2010, EMERG INFECT DIS, V16, P1718, DOI 10.3201/eid1611.090934; Barman S, 2011, FEMS IMMUNOL MED MIC, V62, P304, DOI 10.1111/j.1574-695X.2011.00810.x; Delaney NF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002511; Eppinger M, 2006, PLOS GENET, V2, P1097, DOI 10.1371/journal.pgen.0020120; Fernandez MI, 2003, CELL MICROBIOL, V5, P481, DOI 10.1046/j.1462-5822.2003.00295.x; Franco NH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002399; Ingersoll MA, 2003, CELL MICROBIOL, V5, P797, DOI 10.1046/j.1462-5822.2003.00320.x; Jeong KI, 2010, J INFECT DIS, V201, P903, DOI 10.1086/650995; [蒋建军 Jiang Jianjun], 2005, [安徽农业科学, Journal of anhui agricultural sciences], V33, P1666; Kisiela DI, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002733; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; Lafont F, 2002, EMBO J, V21, P4449, DOI 10.1093/emboj/cdf457; Lowder BV, 2009, P NATL ACAD SCI USA, V106, P19545, DOI 10.1073/pnas.0909285106; Lv WQ, 2013, CLIN J VET SCI, V33, P53; Martino MC, 2005, J INFECT DIS, V192, P136, DOI 10.1086/430740; Maurelli AT, 1998, MICROB PATHOGENESIS, V25, P189, DOI 10.1006/mpat.1998.0230; MOUNIER J, 1992, INFECT IMMUN, V60, P237, DOI 10.1128/IAI.60.1.237-248.1992; MURAYAMA SY, 1986, INFECT IMMUN, V51, P696, DOI 10.1128/IAI.51.2.696-698.1986; Nhieu GTV, 2000, CELL MICROBIOL, V2, P187; NIESEL DW, 1985, J CLIN MICROBIOL, V22, P897, DOI 10.1128/JCM.22.6.897-902.1985; Ogawa M, 2008, NAT REV MICROBIOL, V6, P11, DOI 10.1038/nrmicro1814; Pan BJ, 2006, GUANGXI AGR SCI, V37, P331; Prakash R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027046; Priamukhina N S, 1984, Zh Mikrobiol Epidemiol Immunobiol, P20; RABBANI GH, 1995, INFECT IMMUN, V63, P4350, DOI 10.1128/IAI.63.11.4350-4357.1995; Rudel T, 2012, CELL HOST MICROBE, V11, P219, DOI 10.1016/j.chom.2012.02.004; [师润 Shi Run], 2013, [畜牧兽医学报, Acta Veterinaria et Zootechnica Sinica], V44, P95; Shim DH, 2007, J IMMUNOL, V178, P2476, DOI 10.4049/jimmunol.178.4.2476; Streicker DG, 2012, P NATL ACAD SCI USA, V109, P19715, DOI 10.1073/pnas.1203456109; Toft C, 2010, NAT REV GENET, V11, P465, DOI 10.1038/nrg2798; Watarai M, 1996, J EXP MED, V183, P991, DOI 10.1084/jem.183.3.991; [许兰菊 Xu Lanju], 2004, [中国预防兽医学报, Chinase Journal of Preventive Veterinary Medicine], V26, P281; Xu LanJu, 2005, Chinese Journal of Veterinary Science, V25, P594; Xu LJ, 2004, ACTA VET ZOOTECHNICA, V35, P362; Yang JY, 2014, J INFECT DIS, V209, P203, DOI 10.1093/infdis/jit399; [杨霞 YANG Xia], 2009, [畜牧兽医学报, Acta Veterinaria et Zootechnica Sinica], V40, P402	38	21	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100264	10.1371/journal.pone.0100264	http://dx.doi.org/10.1371/journal.pone.0100264			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949637	gold, Green Published, Green Submitted			2022-12-27	WOS:000338276300056
J	Chen, K; Zhang, XL; Deng, HR; Zhu, LL; Su, FX; Jia, WJ; Deng, XG				Chen, Kai; Zhang, Xiaolan; Deng, Heran; Zhu, Liling; Su, Fengxi; Jia, Weijuan; Deng, Xiaogeng			Clinical Predictive Models for Chemotherapy-Induced Febrile Neutropenia in Breast Cancer Patients: A Validation Study	PLOS ONE			English	Article							EARLY LYMPHOPENIA; RISK-FACTOR; GROWTH-FACTORS; MANAGEMENT; RECOMMENDATIONS; GUIDELINES; UPDATE	Background: Predictive models for febrile neutropenia (FN) would be informative for physicians in clinical decision making. This study aims to validate a predictive model (Jenkin's model) that comprises pretreatment hematological parameters in early-stage breast cancer patients. Patients and Methods: A total of 428 breast cancer patients who received neoadjuvant/adjuvant chemotherapy without any prophylactic use of colony-stimulating factor were included. Pretreatment absolute neutrophil counts (ANC) and absolute lymphocyte counts (ALC) were used by the Jenkin's model to assess the risk of FN. In addition, we modified the threshold of Jenkin's model and generated Model-A and B. We also developed Model-C by incorporating the absolute monocyte count (AMC) as a predictor into Model-A. The rates of FN in the 1st chemotherapy cycle were calculated. A valid model should be able to significantly identify high-risk subgroup of patients with FN rate >20%. Results: Jenkin's model (Predicted as high-risk when ANC <= 3.1*10<^>9/L; ALC <= 1.5*10<^>9/L) did not identify any subgroups with significantly high risk (>20%) of FN in our population, even if we used different thresholds in Model-A(ANC <= 4.4*10<^>9/L; ALC <= 2.1*10<^>9/L) or B(ANC <= 3.8*10<^>9/L; ALC <= 1.8*10<^>9/L). However, with AMC added as an additional predictor, Model-C( ANC <= 4.4*10<^>9/L; ALC <= 2.1*10<^>9/L; AMC <= 0.28*10<^>9/L) identified a subgroup of patients with a significantly high risk of FN (23.1%). Conclusions: In our population, Jenkin's model, cannot accurately identify patients with a significant risk of FN. The threshold should be changed and the AMC should be incorporated as a predictor, to have excellent predictive ability.	[Chen, Kai; Zhang, Xiaolan; Deng, Heran; Zhu, Liling; Su, Fengxi; Jia, Weijuan] Sun Yat Sen Univ, Breast Tumor Ctr, Sun Yat Sen Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China; [Deng, Xiaogeng] Sun Yat Sen Univ, Dept Pediat Surg, Sun Yat Sen Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Jia, WJ (corresponding author), Sun Yat Sen Univ, Breast Tumor Ctr, Sun Yat Sen Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China.	jiaweijuan@aliyun.com; dengxiaogeng@aliyun.com			National Natural Science Foundation of China [81172524/H1622, 81372817/H1622]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant No. 81172524/H1622 and 81372817/H1622). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aapro MS, 2011, EUR J CANCER, V47, P8, DOI 10.1016/j.ejca.2010.10.013; Chia VM, 2013, BREAST CANCER RES TR, V138, P621, DOI 10.1007/s10549-013-2454-9; Choi CW, 2003, AM J HEMATOL, V73, P263, DOI 10.1002/ajh.10363; Crawford J, 2010, ANN ONCOL, V21, pv248, DOI 10.1093/annonc/mdq195; Dale DC, 2002, DRUGS, V62, P1, DOI 10.2165/00003495-200262001-00001; Dittrich C, 2003, EUR J CANCER, V39, P1129, DOI 10.1016/S0959-8049(03)00152-7; ELIAS A, 1989, J CLIN ONCOL, V7, P1208, DOI 10.1200/JCO.1989.7.9.1208; Flowers CR, 2013, J CLIN ONCOL, V31, P794, DOI 10.1200/JCO.2012.45.8661; Hosmer W, 2011, SUPPORT CARE CANCER, V19, P333, DOI 10.1007/s00520-010-0821-1; Jenkins P, 2012, ANN ONCOL, V23, P1766, DOI 10.1093/annonc/mdr493; Jenkins P, 2009, ANN ONCOL, V20, P34, DOI 10.1093/annonc/mdn560; Kondo M, 1999, AM J CLIN ONCOL-CANC, V22, P103, DOI 10.1097/00000421-199902000-00025; Kouroukis CT, 2008, CURR ONCOL, V15, P9, DOI 10.3747/co.2008.198; Lyman GH, 2011, CANCER-AM CANCER SOC, V117, P1917, DOI 10.1002/cncr.25691; Lyman GH, 2005, ONCOLOGIST, V10, P427, DOI 10.1634/theoncologist.10-6-427; Moreau M, 2009, ANN ONCOL, V20, P513, DOI 10.1093/annonc/mdn655; NCCN, 2013, MYEL GROWTH FACT NCC; Oguz A, 2006, PEDIATR HEMAT ONCOL, V23, P143, DOI 10.1080/08880010500457673; Ray-Coquard I, 2003, BRIT J CANCER, V88, P181, DOI 10.1038/sj.bjc.6600724; Renner P, 2012, COCHRANE DB SYST REV, V10, DOI DOI 10.1002/14651858.CD007913.PUB2; Sato I, 2012, ONCOLOGY LETT; Schwenkglenks M, 2011, SUPPORT CARE CANCER, V19, P483, DOI 10.1007/s00520-010-0840-y; Smith TJ, 2006, J CLIN ONCOL, V24, P3187, DOI 10.1200/JCO.2006.06.4451	23	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e96413	10.1371/journal.pone.0096413	http://dx.doi.org/10.1371/journal.pone.0096413			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945817	Green Submitted, Green Published, gold			2022-12-27	WOS:000340721500002
J	Chou, ML; Burnouf, T; Wang, TJ				Chou, Ming-Li; Burnouf, Thierry; Wang, Tsung-Jen			Ex vivo Expansion of Bovine Corneal Endothelial Cells in Xeno-Free Medium Supplemented with Platelet Releasate	PLOS ONE			English	Article							MESENCHYMAL STROMAL CELLS; HEPATOCYTE GROWTH-FACTOR; NEUROTROPHIC FACTOR; STEM-CELLS; SERUM; BRAIN; CULTURE; PROLIFERATION; TRANSPARENCY; KERATOPLASTY	Clinical-grade ex vivo expansion of corneal endothelial cells can increase the availability of corneal tissues for transplantation and treatment of corneal blindness. However, these cells have very limited proliferative capacity. Successful propagation has required so far to use very complex growth media supplemented with fetal bovine serum and other xenocomponents. We hypothesized that human platelet releasates rich in multiple growth factors, and in particular neurotrophins, could potentially be a useful supplement for ex vivo expansion of corneal endothelium cells due to their neural crest origin. Platelet releasates were prepared by calcium salt activation of apheresis platelet concentrates, subjected or not to complement inactivation by heat treatment at 56 degrees C for 30 minutes. Platelet releasates were characterized for their content in proteins and were found to contain high amount of growth factors including platelet-derived growth factor-AB (30.56 to 39.08 ng/ml) and brain-derived neurotrophic factor (30.57 to 37.11 ng/ml) neurotrophins. We compared the growth and viability of corneal endothelium cells in DMEM-F12 medium supplemented with different combinations of components, including 2.5%similar to 10% of the platelet releasates. Corneal endothelium cells expanded in platelet releasates exhibited good adhesion and a typical hexagonal morphology. Their growth and viability were enhanced when using the complement-inactivated platelet releasate at a concentration of 10%. Immunostaining and Western blots showed that CECs maintained the expressions of four important membrane markers: Na-K ATPase alpha 1, zona occludens-1, phospho-connexin 43 and N-cadherin. In conclusion, our study provides the first proof-of-concept that human platelet releasates can be used for ex vivo expansion of corneal endothelium cells. These findings open a new paradigm for ex vivo propagation protocols of corneal endothelium cells in compliance with good tissue culture practices and regulatory recommendations to limit the use of xenogenic materials.	[Chou, Ming-Li] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan; [Burnouf, Thierry] Taipei Med Univ, Grad Inst Biomed Mat & Tissue Engn, Taipei, Taiwan; [Wang, Tsung-Jen] Taipei Med Univ Hosp, Dept Ophthalmol, Taipei, Taiwan; [Wang, Tsung-Jen] Taipei Med Univ, Coll Med, Sch Med, Dept Ophthalmol, Taipei, Taiwan; [Wang, Tsung-Jen] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Wang, Tsung-Jen] Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Wang, TJ (corresponding author), Taipei Med Univ Hosp, Dept Ophthalmol, Taipei, Taiwan.	tjw@tmu.edu.tw	Burnouf, Thierry/H-4784-2019	Burnouf, Thierry/0000-0002-0507-9243	National Science Council, Taipei, Taiwan [NCS102-2320-B-038-012]; Taipei Medical University, Taipei, Taiwan [TMU101-AE1-B65]	National Science Council, Taipei, Taiwan(Ministry of Science and Technology, Taiwan); Taipei Medical University, Taipei, Taiwan	This work was funded by the National Science Council, Taipei, Taiwan (grant no. NCS102-2320-B-038-012), and Taipei Medical University, Taipei, Taiwan (grant no. TMU101-AE1-B65). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anitua E, 2014, EXP EYE RES, V119, P27, DOI 10.1016/j.exer.2013.12.005; Anitua E, 2007, BIOMATERIALS, V28, P4551, DOI 10.1016/j.biomaterials.2007.06.037; [Anonymous], 2009, EYE BANKING STAT 200; Bahar I, 2008, OPHTHALMOLOGY, V115, P1525, DOI 10.1016/j.ophtha.2008.02.010; BARFORT P, 1974, EXP EYE RES, V19, P11, DOI 10.1016/0014-4835(74)90067-0; Bieback K, 2009, STEM CELLS, V27, P2331, DOI 10.1002/stem.139; Burnouf T, 2011, VOX SANG, V101, P215, DOI 10.1111/j.1423-0410.2011.01486.x; Burnouf T, 2008, TRANSFUSION, V48, P1090, DOI 10.1111/j.1537-2995.2008.01691.x; Burnouf T, 2013, BLOOD REV, V27, P77, DOI 10.1016/j.blre.2013.02.001; Burnouf T, 2012, TRANSFUSION, V52, P1721, DOI 10.1111/j.1537-2995.2011.03494.x; Burnouf T, 2012, BIOLOGICALS, V40, P21, DOI 10.1016/j.biologicals.2011.09.017; Chen KH, 2002, EXP EYE RES, V75, P61, DOI 10.1006/exer.2002.1180; CHMP, 2003, CPMPBWP179302 CHMP E; Choi JS, 2010, BIOMATERIALS, V31, P6738, DOI 10.1016/j.biomaterials.2010.05.020; ENGELMANN K, 1989, IN VITRO CELL DEV B, V25, P1065; ENGELMANN K, 1988, INVEST OPHTH VIS SCI, V29, P1656; Fujimura H, 2002, THROMB HAEMOSTASIS, V87, P728; Hassell JR, 2010, EXP EYE RES, V91, P326, DOI 10.1016/j.exer.2010.06.021; Heiskanen A, 2007, STEM CELLS, V25, P197, DOI 10.1634/stemcells.2006-0444; Hemeda H, 2013, CYTOTHERAPY, V15, P1174, DOI 10.1016/j.jcyt.2013.05.006; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Horn P, 2010, CYTOTHERAPY, V12, P888, DOI 10.3109/14653249.2010.501788; Imanishi J, 2000, PROG RETIN EYE RES, V19, P113, DOI 10.1016/S1350-9462(99)00007-5; Iserovich P, 2003, ARVO ANN M, V2003, P4734; Ishino Y, 2004, INVEST OPHTH VIS SCI, V45, P800, DOI 10.1167/iovs.03-0016; Joyce NC, 2003, PROG RETIN EYE RES, V22, P359, DOI 10.1016/S1350-9462(02)00065-4; Kimoto M, 2012, INVEST OPHTH VIS SCI, V53, P7583, DOI 10.1167/iovs.12-10146; KONONEN J, 1994, MOL BRAIN RES, V27, P347, DOI 10.1016/0169-328X(94)90022-1; Li W, 2007, INVEST OPHTH VIS SCI, V48, P614, DOI 10.1167/iovs.06-1126; Luo WJ, 2012, INT J OPHTHALMOL-CHI, V5, P419, DOI 10.3980/j.issn.2222-3959.2012.04.03; Miyamoto Takeshi, 2010, Cornea, V29 Suppl 1, pS52; Miyata K, 2001, CORNEA, V20, P59, DOI 10.1097/00003226-200101000-00012; Mojica-Henshaw MP, 2013, CYTOTHERAPY, V15, P1458, DOI 10.1016/j.jcyt.2013.06.014; MURPHY RA, 1993, J NEUROSCI, V13, P2853; Peh GSL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028310; Peh GSL, 2011, TRANSPLANTATION, V91, P811, DOI 10.1097/TP.0b013e3182111f01; Price MO, 2010, CLIN EXP OPHTHALMOL, V38, P128, DOI 10.1111/j.1442-9071.2010.02213.x; Radka SF, 1996, BRAIN RES, V709, P122, DOI 10.1016/0006-8993(95)01321-0; RILEY MV, 1977, EXP EYE RES, V25, P483, DOI 10.1016/0014-4835(77)90177-4; RINDERKNECHT E, 1978, J BIOL CHEM, V253, P2769; Robertson JS, 2006, DEV BIOLOGICALS, V123, P269; Shao Yingfeng, 2008, Yan Ke Xue Bao, V24, P9; Spees JL, 2004, MOL THER, V9, P747, DOI 10.1016/j.ymthe.2004.02.012; STIEMKE MM, 1991, INVEST OPHTH VIS SCI, V32, P2757; Su CY, 2009, VOX SANG, V97, P119, DOI 10.1111/j.1423-0410.2009.01180.x; Su CY, 2008, TRANSFUSION, V48, P2414, DOI 10.1111/j.1537-2995.2008.01862.x; Wang TJ, 2012, COLLOID SURFACE B, V90, P236, DOI 10.1016/j.colsurfb.2011.10.043; Wang TJ, 2012, J BIOMED MATER RES A, V100A, P252, DOI 10.1002/jbm.a.33274; WARING GO, 1982, OPHTHALMOLOGY, V89, P531; WHO, 2006, WHO GUID TISS INF DI; WILSON SE, 1994, EXP EYE RES, V59, P63, DOI 10.1006/exer.1994.1081; WILSON SE, 1993, INVEST OPHTH VIS SCI, V34, P2544; YAMAMOTO H, 1990, J NEUROSCI, V10, P3469; Yanez-Soto B, 2013, BIOMATERIALS, V34, P9244, DOI 10.1016/j.biomaterials.2013.08.042; You LT, 2000, INVEST OPHTH VIS SCI, V41, P692; Zavala J, 2013, EYE, V27, P579, DOI 10.1038/eye.2013.15; Zhu C, 2004, INVEST OPHTH VIS SCI, V45, P1743, DOI 10.1167/iovs.03-0814; Zhu YT, 2008, INVEST OPHTH VIS SCI, V49, P3879, DOI 10.1167/iovs.08-1693	58	19	20	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e99145	10.1371/journal.pone.0099145	http://dx.doi.org/10.1371/journal.pone.0099145			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945500	Green Published, Green Submitted, gold			2022-12-27	WOS:000340721500011
J	Ha, SY; Yeo, SY; Xuan, YH; Kim, SH				Ha, Sang Yun; Yeo, So-Young; Xuan, Yan-hiua; Kim, Seok-Hyung			The Prognostic Significance of Cancer-Associated Fibroblasts in Esophageal Squamous Cell Carcinoma	PLOS ONE			English	Article							STROMAL MYOFIBROBLASTS; ACTIVATION PROTEIN; EXPRESSION; INFILTRATION; ANGIOGENESIS	Background: Cancer-associated fibroblasts (CAF) are activated fibroblasts in the cancer stroma and play an important role in cancer progression. Some reports have indicated the correlation between the expression of CAF markers and adverse prognosis in several cancers. However, no reports have studied CAF phenotype and its clinical relevance in esophageal squamous cell carcinoma (ESCC). Methods: We investigated CAF phenotype of ESCC based on histology and immunohistochemical expressions of five CAF markers such as fibroblast activation protein (FAP), smooth muscle actin (SMA), fibroblast-specific protein-1 (FSP1), platelet-derived growth factor receptor (PDGFR alpha), and PDGFR beta in 116 ESCC tissue samples. Besides, we also examined the correlation of the CAF phenotype with clinical relevance as well as other cancer-microenvironment related factors. Results: Histologically immature CAF phenotype was correlated with poor prognosis (p<0.001) and associated with increased microvessel density, increased tumor associated macrophages, and epithelial to mesenchymal transition. CAF markers were characteristically expressed in stromal fibroblast close to tumor cells and the expression pattern of 5 CAF markers was highly heterogeneous in every individual cases. Of five CAF markers, SMA, FSP1, and PDGFR alpha were unfavorable prognostic indicators of ESCC. The number of positive CAF markers was greater in ESCC with immature CAFs than in those with mature ones. Conclusions: Our results demonstrate that histologic classification of CAF phenotype is a reliable and significant prognostic predictor in ESCC. CAF markers have the potential to be diagnostic and therapeutic targets in ESCC.	[Ha, Sang Yun; Kim, Seok-Hyung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul, South Korea; [Yeo, So-Young; Kim, Seok-Hyung] Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol, Dept Hlth Sci & Technol, Seoul, South Korea; [Xuan, Yan-hiua] Yanbian Univ, Minist Educ, Key Lab Nat Resources Changbai Mt & Funct Mol, Yanji, Peoples R China; [Xuan, Yan-hiua] Yanbian Univ, Sch Med, Dept Pathol, Yanji, Peoples R China	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Yanbian University; Yanbian University	Xuan, YH (corresponding author), Yanbian Univ, Minist Educ, Key Lab Nat Resources Changbai Mt & Funct Mol, Yanji, Peoples R China.	xuanyh1@ybu.edu.cn; platoshkim@daum.net			Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI11C17620000]; Samsung Biomedical Research Institute [SS1B30131]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea; Samsung Biomedical Research Institute(Samsung)	This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI11C17620000), and Samsung Biomedical Research Institute grant SS1B30131. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bello IO, 2011, ORAL ONCOL, V47, P33, DOI 10.1016/j.oraloncology.2010.10.013; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Cardone A, 1997, PANMINERVA MED, V39, P174; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Cirri P, 2011, AM J CANCER RES, V1, P482; Dirkx AEM, 2006, J LEUKOCYTE BIOL, V80, P1183, DOI 10.1189/jlb.0905495; Fred T., 2009, WHO CLASSIFICATION T; Hagglof C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010747; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kitadai Y, 2009, CANC MICROENVIRON; Kubota Y, 2009, FRONT BIOSCI-LANDMRK, V14, P3872, DOI [10.2735/3495, 10.2741/3495]; Leek RD, 1996, CANCER RES, V56, P4625; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Liu JZ, 2012, TUMOR BIOL, V33, P495, DOI 10.1007/s13277-011-0281-3; Liu M, 2011, INT J CANCER, V129, P1795, DOI 10.1002/ijc.26116; Maeshima AM, 2002, CANCER, V95, P2546, DOI 10.1002/cncr.11006; Mao Y, 2013, CANCER METAST REV, V32, P303, DOI 10.1007/s10555-012-9415-3; Marsh D, 2011, J PATHOL, V223, P470, DOI 10.1002/path.2830; Marsh T., 2012, BIOCHIM BIOPHYS ACTA, V1832, P1070; Mukherjee S, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-91; Noma K, 2008, GASTROENTEROLOGY, V134, P1981, DOI 10.1053/j.gastro.2008.02.061; Shi M, 2012, WORLD J GASTROENTERO, V18, P840, DOI 10.3748/wjg.v18.i8.840; Sung CO, 2011, AM J PATHOL, V179, P1827, DOI 10.1016/j.ajpath.2011.06.032; Sung CO, 2011, MODERN PATHOL, V24, P1060, DOI 10.1038/modpathol.2011.59; Takenaga K, 1997, CLIN CANCER RES, V3, P2309; Tejada ML, 2006, CLIN CANCER RES, V12, P2676, DOI 10.1158/1078-0432.CCR-05-1770; Tsujino T, 2007, CLIN CANCER RES, V13, P2082, DOI 10.1158/1078-0432.CCR-06-2191; Ueno H, 2004, GUT, V53, P581, DOI 10.1136/gut.2003.028365; Wang K, 2012, J THORAC ONCOL, V7, P1457, DOI 10.1097/JTO.0b013e318260dfe8; WEIDNER N, 1995, BREAST CANCER RES TR, V36, P169, DOI 10.1007/BF00666038; Wikberg ML, 2013, TUMOR BIOL, V34, P1013, DOI 10.1007/s13277-012-0638-2; Yamashita M, 2012, BREAST CANCER-TOKYO, V19, P170, DOI 10.1007/s12282-010-0234-5; Yuzawa S, 2012, MED ONCOL, V29, P2824, DOI 10.1007/s12032-012-0193-0; Zhang CY, 2009, CLIN CANCER RES, V15, P4017, DOI 10.1158/1078-0432.CCR-08-2824; Zhang QW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050946	35	78	86	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e99955	10.1371/journal.pone.0099955	http://dx.doi.org/10.1371/journal.pone.0099955			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945657	Green Published, Green Submitted, gold			2022-12-27	WOS:000340721500036
J	Waligorska-Stachura, J; Andrusiewicz, M; Sawicka-Gutaj, N; Biczysko, M; Jankowska, A; Kubiczak, M; Czarnywojtek, A; Wrotkowska, E; Ruchala, M				Waligorska-Stachura, Joanna; Andrusiewicz, Miroslaw; Sawicka-Gutaj, Nadia; Biczysko, Maciej; Jankowska, Anna; Kubiczak, Marta; Czarnywojtek, Agata; Wrotkowska, Elzbieta; Ruchala, Marek			Survivin Delta Ex3 Overexpression in Thyroid Malignancies	PLOS ONE			English	Article							ANTI-APOPTOSIS GENE; CELL LUNG CANCERS; PROGNOSTIC VALUE; EXPRESSION; CARCINOMA; TUMORS; ASSOCIATION; RISK	Context: Thyroid cancer incidence has increased significantly during the past decades and is the most common type of endocrine malignancy. Many factors in thyroid cancers were studied as independent predictors of a poor prognosis. Objective: The objective of the study was to evaluate survivin expression - BIRC5 and its splice variants: survivin delta Ex3 and survivin 2B in benign and malignant thyroid nodules. Design: Thyroid tissues samples from a group of 50 patients consisting of: 29 patients with thyroid cancers (including medullary, papillary, follicular and undifferentiated types), as well as from 21 patients with non-cancerous thyroid tissues (including: 11 benign thyroid lesions and 10 healthy thyroid samples). Main Outcome Measures: The analysis of the survivin gene expression and evaluation of the level of splice variants were performed using quantitative RT-PCR. Results: A statistically significant higher level of expression of survivin gene - BIRC5 was detected in thyroid malignant nodules, when compared with benign lesions and healthy thyroid samples. Moreover, the comparison of survivin relative expression in different staged tumors (pT1, pT3, and pT4) revealed a much higher amount of BIRC5 transcripts in tumor tissues of pT3/pT4. The comparison of survivin expression between benign thyroid nodules and healthy thyroid did not reveal significant differences. Importantly, high expression rate of the survivin delta Ex3 splice variant characterized thyroid carcinomas. Conclusion: The results suggest that survivin, especially survivin delta Ex3 splice variant being overexpress, is a characteristic feature of thyroid malignancy.	[Waligorska-Stachura, Joanna; Sawicka-Gutaj, Nadia; Czarnywojtek, Agata; Wrotkowska, Elzbieta; Ruchala, Marek] Poznan Univ Med Sci, Dept Endocrinol Metab & Internal Med, Poznan, Poland; [Andrusiewicz, Miroslaw; Jankowska, Anna; Kubiczak, Marta] Poznan Univ Med Sci, Dept Cell Biol, Poznan, Poland; [Biczysko, Maciej] Poznan Univ Med Sci, Dept Gen Gastroenterol & Endocrine Surg, Poznan, Poland	Poznan University of Medical Sciences; Poznan University of Medical Sciences; Poznan University of Medical Sciences	Ruchala, M (corresponding author), Poznan Univ Med Sci, Dept Endocrinol Metab & Internal Med, Poznan, Poland.	mruchala@ump.edu.pl	Andrusiewicz, Mirosław/ABG-4949-2021; Andrusiewicz, Mirosław/N-3449-2017	Andrusiewicz, Mirosław/0000-0002-8781-3447; Andrusiewicz, Mirosław/0000-0002-8781-3447; Wrotkowska, Elzbieta/0000-0003-0965-7300; Czarnywojtek, Agata/0000-0003-3595-8449	Polish Committee for Scientific Research Award [N N402 523640]	Polish Committee for Scientific Research Award	This paper was supported by The Polish Committee for Scientific Research Award nr N N402 523640. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altieri DC, 2003, ONCOGENE, V22, P8581, DOI 10.1038/sj.onc.1207113; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Azuhata T, 2001, J PEDIATR SURG, V36, P1785, DOI 10.1053/jpsu.2001.28839; Chen ZX, 2012, INT J MOL MED, V30, P465, DOI 10.3892/ijmm.2012.1046; Cohen C, 2003, MODERN PATHOL, V16, P574, DOI 10.1097/01.MP.0000073868.31297.B0; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Grabowski P, 2003, BRIT J CANCER, V88, P115, DOI 10.1038/sj.bjc.6600696; Grabowski P, 2005, NEUROENDOCRINOL, V81; Hart CD, 2013, ONCOTARGETS THER, V6, P1, DOI 10.2147/OTT.S27671; Hassounah M, 2005, J NEURO-ONCOL, V72, P203, DOI 10.1007/s11060-004-2397-4; Ito Y, 2009, ENDOCR J, V56, P177, DOI 10.1507/endocrj.K08E-166; Jankowska A, 2008, NEUROENDOCRINOL LETT, V29, P1033; Kappler M, 2001, INT J CANCER, V95, P360, DOI 10.1002/1097-0215(20011120)95:6<360::AID-IJC1063>3.0.CO;2-1; Kato J, 2001, INT J CANCER, V95, P92; LaCasse EC, 1998, ONCOGENE, V17, P3247, DOI 10.1038/sj.onc.1202569; Li FZ, 1998, NATURE, V396, P580, DOI 10.1038/25141; Monzo M, 1999, J CLIN ONCOL, V17, P2100, DOI 10.1200/JCO.1999.17.7.2100; Naduparambil KJ, 2012, ONCO TARGETS THER, V5, P7; Nakano J, 2008, BRIT J CANCER, V98, P1109, DOI 10.1038/sj.bjc.6604253; Pannone G, 2013, THYROID         1213; Riesco-Eizaguirre G, 2007, ENDOCR-RELAT CANCER, V14, P957, DOI 10.1677/ERC-07-0085; Ryan BM, 2009, CANCER TREAT REV, V35, P553, DOI 10.1016/j.ctrv.2009.05.003; Selernetjev S, 2014, PATHOL RES PRACT, V210, P30, DOI 10.1016/j.prp.2013.09.014; Ueda M, 2002, J CLIN ENDOCR METAB, V87, P3452, DOI 10.1210/jc.87.7.3452; Vikman S, 2005, ACTA ONCOL, V44, P32, DOI 10.1080/02841860510007404; Waligorska-Stachura J, 2012, GINEKOL POL, V83, P537; Wang YX, 2013, PATHOL RES PRACT, V209, P151, DOI 10.1016/j.prp.2013.01.004; Xing M, 2005, ENDOCR-RELAT CANCER, V12, P245, DOI 10.1677/erc.1.0978; Yazdani N, 2012, PATHOL RES PRACT, V208, P100, DOI 10.1016/j.prp.2011.12.009; Zhang HY, 2009, CLIN EXP MED, V9, P207, DOI 10.1007/s10238-009-0031-7	30	14	14	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100534	10.1371/journal.pone.0100534	http://dx.doi.org/10.1371/journal.pone.0100534			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945990	gold, Green Published, Green Submitted			2022-12-27	WOS:000340721500088
J	Zheng, SQ; Liao, ST; Zou, YX; Qu, Z; Liu, F				Zheng, Shanqing; Liao, Sentai; Zou, Yuxiao; Qu, Zhi; Liu, Fan			ins-7 Gene Expression Is Partially Regulated by the DAF-16/IIS Signaling Pathway in Caenorhabditis elegans under Celecoxib Intervention	PLOS ONE			English	Article							LONG-LIVED MUTANTS; C-ELEGANS; LIFE-SPAN; INSULIN; LONGEVITY; RESTRICTION; INHIBITION; PEPTIDE; AKT/PKB; MEMBER	DAF-16 target genes are employed as reporters of the insulin/IGF-1 like signal pathway (IIS), and this is notably true when Caenorhabditis elegans (C. elegans) is used to study the action of anti-aging compounds on IIS activity. However, some of these genes may not be specific to DAF-16, even if their expression levels are altered when DAF-16 is activated. Celecoxib was reported to extend the lifespan of C. elegans through activation of DAF-16. Our results confirmed the function of celecoxib on aging; however, we found that the expression of ins-7, a DAF-16 target gene, was abnormally regulated by celecoxib. ins-7 plays an important role in regulating aging, and its expression is suppressed in C. elegans when DAF-16 is activated. However, we found that celecoxib upregulated the expression of ins-7 in contrast to its role in DAF-16 activation. Our subsequent analysis indicated that the expression level of ins-7 in C. elegans was negatively regulated by DAF-16 activity. Additionally, its expression was also positively regulated by DAF-16-independent mechanisms, at least following external pharmacological intervention. Our study suggests that ins-7 is not a specific target gene of DAF-16, and should not be chosen as a reporter for IIS activity. This conclusion is important in the study of INSs on aging in C. elegans, especially under the circumstance of drug intervention.	[Zheng, Shanqing; Liao, Sentai; Zou, Yuxiao; Qu, Zhi; Liu, Fan] Guangdong Acad Agr Sci, Sericulture & Agri Food Res Inst, Guangzhou, Guangdong, Peoples R China	Guangdong Academy of Agricultural Sciences	Zheng, SQ (corresponding author), Guangdong Acad Agr Sci, Sericulture & Agri Food Res Inst, Guangzhou, Guangdong, Peoples R China.	zhengshanqing@mail.kib.ac.cn; liaost@163.com		Zheng, Shanqing/0000-0002-5039-0196	Zhujiang Science and Technology New Star of Guangzhou [2013J2200085]	Zhujiang Science and Technology New Star of Guangzhou	This work was supported by the project for Zhujiang Science and Technology New Star of Guangzhou (No. 2013J2200085). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavez S, 2011, NATURE, V472, P226, DOI 10.1038/nature09873; Apfeld Jak C, 1999, REGULATION LIFE SPAN; Barbieri M, 2003, AM J PHYSIOL-ENDOC M, V285, pE1064, DOI 10.1152/ajpendo.00296.2003; Brenner S., 1974, GENETICS CAENORHABDI; Chan TO, 1999, ANNU REV BIOCHEM, V68, P965, DOI 10.1146/annurev.biochem.68.1.965; Chavez V, 2007, GENETICS, V176, P1567, DOI 10.1534/genetics.107.072587; Chen ZN, 2013, NEURON, V77, P572, DOI 10.1016/j.neuron.2012.11.025; Ching TT, 2011, AGING CELL, V10, P506, DOI 10.1111/j.1474-9726.2011.00688.x; Clancy D, 2013, AGEING RES REV, V12, P404, DOI 10.1016/j.arr.2012.03.011; Collins JJ, 2006, EXP GERONTOL, V41, P1032, DOI 10.1016/j.exger.2006.06.038; Glauser DA, 2011, P NATL ACAD SCI USA, V108, P20790, DOI 10.1073/pnas.1116712108; Greer EL, 2007, CURR BIOL, V17, P1646, DOI 10.1016/j.cub.2007.08.047; Hertweck M, 2004, DEV CELL, V6, P577, DOI 10.1016/S1534-5807(04)00095-4; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; Honda Y, 2012, SCI REP-UK, V2, DOI 10.1038/srep00487; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Kawano T, 2000, BIOCHEM BIOPH RES CO, V273, P431, DOI 10.1006/bbrc.2000.2971; Kawano T, 2006, BIOSCI BIOTECH BIOCH, V70, P3084, DOI 10.1271/bbb.60472; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Kenyon C, 2011, PHILOS T R SOC B, V366, P9, DOI 10.1098/rstb.2010.0276; Lee SJ, 2010, CURR BIOL, V20, P2131, DOI 10.1016/j.cub.2010.10.057; Li WQ, 2003, GENE DEV, V17, P844, DOI 10.1101/gad.1066503; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Longo VD, 2003, SCIENCE, V299, P1342, DOI 10.1126/science.1077991; Matsunaga Y, 2012, BIOSCI BIOTECH BIOCH, V76, P2168, DOI 10.1271/bbb.120540; Murphy CT, 2007, P NATL ACAD SCI USA, V104, P19046, DOI 10.1073/pnas.0709613104; Murphy CT, 2006, EXP GERONTOL, V41, P910, DOI 10.1016/j.exger.2006.06.040; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Narasimhan SD, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001377; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; Paradis S, 1999, GENE DEV, V13, P1438, DOI 10.1101/gad.13.11.1438; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Ritter AD, 2013, GENOME RES; Shaw WM, 2007, CURR BIOL, V17, P1635, DOI 10.1016/j.cub.2007.08.058; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Tepper RG, 2013, CELL, V154, P676, DOI 10.1016/j.cell.2013.07.006	36	2	2	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100320	10.1371/journal.pone.0100320	http://dx.doi.org/10.1371/journal.pone.0100320			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945567	Green Published, Green Submitted, gold			2022-12-27	WOS:000340721500060
J	Gumulec, J; Masarik, M; Adam, V; Eckschlager, T; Provaznik, I; Kizek, R				Gumulec, Jaromir; Masarik, Michal; Adam, Vojtech; Eckschlager, Tomas; Provaznik, Ivo; Kizek, Rene			Serum and Tissue Zinc in Epithelial Malignancies: A Meta-Analysis	PLOS ONE			English	Article							TRACE-ELEMENT CONCENTRATIONS; X-RAY-FLUORESCENCE; CU-ZN RATIO; BREAST-CANCER; COPPER/ZINC RATIO; VITAMIN-A; SUPEROXIDE-DISMUTASE; SYNCHROTRON-RADIATION; METAL CONCENTRATIONS; NUTRITIONAL-STATUS	Background and Objectives: Current studies give us inconsistent results regarding the association of neoplasms and zinc(II) serum and tissues concentrations. The results of to-date studies using meta-analysis are summarized in this paper. Methods: Web of Science (Science citation index expanded), PubMed (Medline), Embase and CENTRAL were searched. Articles were reviewed by two evaluators; quality was assessed by Newcastle-Ottawa scale; meta-analysis was performed including meta-regression and publication bias analysis. Results: Analysis was performed on 114 case control, cohort and cross-sectional studies of 22737 participants. Decreased serum zinc level was found in patients with lung (effect size = -1.04), head and neck (effect size = -1.43), breast (effect size = -0.93), liver (effect size = -2.29), stomach (effect size = -1.59), and prostate (effect size = -1.36) cancers; elevation was not proven in any tumor. More specific zinc patterns are evident at tissue level, showing increase in breast cancer tissue (effect size = 1.80) and decrease in prostatic (effect size = -3.90), liver (effect size = -8.26), lung (effect size = -3.12), and thyroid cancer (effect size = -2.84). The rest of the included tumors brought ambiguous results, both in serum and tissue zinc levels across the studies. The association between zinc level and stage or grade of tumor has not been revealed by meta-regression. Conclusion: This study provides evidence on cancer-specific tissue zinc level alteration. Although serum zinc decrease was associated with most tumors mentioned herein, further - prospective - studies are needed.	[Gumulec, Jaromir; Masarik, Michal] Masaryk Univ, Fac Med, Dept Pathol Physiol, Brno, Czech Republic; [Gumulec, Jaromir; Masarik, Michal; Adam, Vojtech; Kizek, Rene] Brno Univ Technol, Cent European Inst Technol, CS-61090 Brno, Czech Republic; [Adam, Vojtech; Kizek, Rene] Mendel Univ Brno, Dept Chem & Biochem, Brno, Czech Republic; [Eckschlager, Tomas] Charles Univ Prague, Fac Med 2, Dept Paediat Haematol & Oncol, Prague, Czech Republic; [Eckschlager, Tomas] Charles Univ Prague, Univ Hosp Motol, Prague, Czech Republic; [Provaznik, Ivo] Brno Univ Technol, Fac Elect Engn & Commun, Dept Biomed Engn, CS-61090 Brno, Czech Republic	Masaryk University Brno; Brno University of Technology; Mendel University in Brno; Charles University Prague; Charles University Prague; Motol University Hospital; Brno University of Technology	Masarik, M (corresponding author), Masaryk Univ, Fac Med, Dept Pathol Physiol, Brno, Czech Republic.	masarik@med.muni.cz	Masarik, Michal/D-9920-2012; Gumulec, Jaromir/D-7638-2012; Provaznik, Ivo/F-4121-2012; Adam, Vojtech/D-7686-2012	Masarik, Michal/0000-0003-1172-7195; Gumulec, Jaromir/0000-0002-9658-3444; Provaznik, Ivo/0000-0002-3422-7938; Adam, Vojtech/0000-0002-8527-286X; Kizek, Rene/0000-0002-0467-6169	Central European Institute of Technology [CZ.1.05/1.1.00/02.0068]; Internal Grant Agency of Ministry of Health of the Czech Republic [IGA MH NT14337-3/2013]	Central European Institute of Technology; Internal Grant Agency of Ministry of Health of the Czech Republic	Financial support from Central European Institute of Technology CZ.1.05/1.1.00/02.0068 and Internal Grant Agency of Ministry of Health of the Czech Republic (IGA MH NT14337-3/2013) is highly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnet CC, 2005, JNCI-J NATL CANCER I, V97, P301, DOI 10.1093/jnci/dji042; ADACHI S, 1991, INT ARCH OCC ENV HEA, V63, P193, DOI 10.1007/BF00381568; Akcil E, 2004, BIOL TRACE ELEM RES, V101, P193, DOI 10.1385/BTER:101:3:193; Al-Sayer H, 2004, MOL CELL BIOCHEM, V260, P1, DOI 10.1023/B:MCBI.0000026027.20680.c7; Arinola OG, 2008, AFR J BIOTECHNOL, V7, P1620; ATUKORALA S, 1979, BRIT J CANCER, V40, P927, DOI 10.1038/bjc.1979.287; BEELEY JM, 1974, THORAX, V29, P21, DOI 10.1136/thx.29.1.21; Boz Alper, 2005, Turk J Gastroenterol, V16, P81; Brys M, 1997, BIOL TRACE ELEM RES, V59, P145, DOI 10.1007/BF02783239; Carvalho ML, 2007, SPECTROCHIM ACTA B, V62, P1004, DOI 10.1016/j.sab.2007.03.030; Catalani Simona, 2008, Acta Biomed, V79 Suppl 1, P52; CAVALLO F, 1991, CANCER, V67, P738, DOI 10.1002/1097-0142(19910201)67:3<738::AID-CNCR2820670335>3.0.CO;2-#; Chen H, 2011, BIOL TRACE ELEM RES, V143, P143, DOI 10.1007/s12011-010-8864-1; Cildag O, 2004, TRACE ELEM ELECTROLY, V21, P23; Costello LC, 2011, J BIOL INORG CHEM, V16, P3, DOI 10.1007/s00775-010-0736-9; Cousins RJ, 2006, J BIOL CHEM, V281, P24085, DOI 10.1074/jbc.R600011200; Cui Y, 2007, CANCER EPIDEM BIOMAR, V16, P1682, DOI 10.1158/1055-9965.EPI-07-0187; Darago A, 2011, CLIN CHEM LAB MED, V49, P1699, DOI 10.1515/CCLM.2011.651; DIEZ M, 1989, ONCOLOGY, V46, P230; Dobrowolski Z, 2002, EUR UROL, V42, P475, DOI 10.1016/S0302-2838(02)00400-1; DROZDZ M, 1989, NEOPLASMA, V36, P357; Dunchik VN, 1980, DISCOVERIES INVENTIO, V35, P1; DURAK I, 1994, BIOMETALS, V7, P45, DOI 10.1007/BF00205193; Ebara M, 2003, ONCOLOGY-BASEL, V65, P323, DOI 10.1159/000074645; Ebrahim AM, 2007, SCI TOTAL ENVIRON, V383, P52, DOI 10.1016/j.scitotenv.2007.04.047; Eckschlager T, 2009, CURR PROTEIN PEPT SC, V10, P360, DOI 10.2174/138920309788922243; Farquharson MJ, 2009, PHYS MED BIOL, V54, P4213, DOI 10.1088/0031-9155/54/13/016; Federico A, 2001, EUR J CLIN NUTR, V55, P293, DOI 10.1038/sj.ejcn.1601157; FEUSTEL A, 1982, UROL RES, V10, P301; GAROFALO JA, 1980, J SURG ONCOL, V15, P381, DOI 10.1002/jso.2930150413; GAROFALO JA, 1980, CANCER, V46, P2682, DOI 10.1002/1097-0142(19801215)46:12<2682::AID-CNCR2820461224>3.0.CO;2-T; Gecit I, 2011, ASIAN PAC J CANCER P, V12, P3409; Geraki K, 2002, PHYS MED BIOL, V47, P2327, DOI 10.1088/0031-9155/47/13/310; Goel T, 2006, SCAND J UROL NEPHROL, V40, P108, DOI 10.1080/00365590500368922; Goyal MM, 2006, INDIAN J CLIN BIOCHE, V21, P208, DOI 10.1007/BF02913100; Gumulec J, 2011, CURR MED CHEM, V18, P5041, DOI 10.2174/092986711797636126; Guntupalli JNR, 2007, EUR J CANCER PREV, V16, P108, DOI 10.1097/01.cej.0000228409.75976.b6; GUPTA SK, 1991, J SURG ONCOL, V46, P178, DOI 10.1002/jso.2930460311; Gupta SK, 2005, J SURG ONCOL, V91, P204, DOI 10.1002/jso.20306; GUPTA SK, 1993, J SURG ONCOL, V52, P172, DOI 10.1002/jso.2930520311; Gurusamy K, 2007, BIOL TRACE ELEM RES, V118, P191, DOI 10.1007/s12011-007-0008-x; HABIB FK, 1976, J ENDOCRINOL, V71, P133, DOI 10.1677/joe.0.0710133; Han CZ, 2003, BIOL TRACE ELEM RES, V94, P113, DOI 10.1385/BTER:94:2:113; Hess SY, 2007, FOOD NUTR BULL, V28, pS403, DOI 10.1177/15648265070283S303; Hienzsch E, 1970, Z Urol Nephrol, V63, P543; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; HOARE R, 1956, CANCER, V9, P721, DOI 10.1002/1097-0142(195607/08)9:4<721::AID-CNCR2820090415>3.0.CO;2-Y; Hogstrand C, 2009, TRENDS MOL MED, V15, P101, DOI 10.1016/j.molmed.2009.01.004; HOMMA S, 1993, J TRACE ELEM EXP MED, V6, P163; Hornik P, 2006, CHEM PAP, V60, P297, DOI 10.2478/s11696-006-0052-6; Hossain MK., 2008, J APPL RES CLIN EXP, V8, P24; Huang YL, 1999, CLIN BIOCHEM, V32, P131, DOI 10.1016/S0009-9120(98)00096-4; Ionescu JG, 2006, NEUROENDOCRINOL LETT, V27, P36; ISBIR T, 1995, TRACE ELEM ELECTROLY, V12, P113; Jayadeep A, 1997, J EXP CLIN CANC RES, V16, P295; Jin YT, 2011, CANCER EPIDEMIOL, V35, P182, DOI 10.1016/j.canep.2010.06.004; KABUTO M, 1994, CANCER EPIDEM BIOMAR, V3, P465; KEW MC, 1974, BRIT J CANCER, V29, P80, DOI 10.1038/bjc.1974.11; Kim ES, 2012, J CLIN PATHOL, V65, P882, DOI 10.1136/jclinpath-2012-200666; Kiziler AR, 2010, TRACE ELEM ELECTROLY, V27, P65; Klarod K, 2011, NUTRITION, V27, P1156, DOI 10.1016/j.nut.2010.12.019; KOK FJ, 1988, AM J EPIDEMIOL, V128, P352, DOI 10.1093/oxfordjournals.aje.a114975; Kolachi NF, 2012, CLIN NUTR, V31, P967, DOI 10.1016/j.clnu.2012.04.015; Kubala-Kukus A, 2007, SPECTROCHIM ACTA B, V62, P695, DOI 10.1016/j.sab.2007.03.004; Kubala-Kukus A, 1999, NUCL INSTRUM METH B, V150, P193, DOI 10.1016/S0168-583X(98)01057-X; Kucharzewski M, 2003, BIOL TRACE ELEM RES, V93, P9, DOI 10.1385/BTER:93:1-3:9; Kucharzewski M, 2003, BIOL TRACE ELEM RES, V92, P1, DOI 10.1385/BTER:92:1:1; KUNE GA, 1989, NUTR CANCER, V12, P169, DOI 10.1080/01635588909514015; Kuo HW, 2002, BIOL TRACE ELEM RES, V89, P1, DOI 10.1385/BTER:89:1:1; Kwiatek WM, 1996, NUCL INSTRUM METH B, V109, P284, DOI 10.1016/0168-583X(95)00923-X; Leone N, 2006, EPIDEMIOLOGY, V17, P308, DOI 10.1097/01.ede.0000209454.41466.b7; Leung PL, 1996, BIOL TRACE ELEM RES, V51, P259, DOI 10.1007/BF02784080; Li XM, 2005, ASIAN J ANDROL, V7, P323, DOI 10.1111/j.1745-7262.2005.00044.x; Liaw KY, 1997, AM J GASTROENTEROL, V92, P2260; LIN HJ, 1977, NUTR REP INT, V15, P635; Littell JH, 2008, SYSTEMATIC REV METAA, P351; Maeda T, 2005, HEPATO-GASTROENTEROL, V52, P187; Magalova T, 1999, NEOPLASMA, V46, P100; Majewska U, 2007, PHYS MED BIOL, V52, P3895, DOI 10.1088/0031-9155/52/13/016; MARCZYNSKA A, 1983, International Urology and Nephrology, V15, P257, DOI 10.1007/BF02083012; Maret W, 2009, CHEM REV, V109, P4682, DOI 10.1021/cr800556u; MARGALIOTH EJ, 1983, CANCER, V52, P868, DOI 10.1002/1097-0142(19830901)52:5<868::AID-CNCR2820520521>3.0.CO;2-K; MAWSON CA, 1952, CAN J MED SCI, V30, P336, DOI 10.1139/cjms52-043; Mazdak H, 2010, INT UROL NEPHROL, V42, P89, DOI 10.1007/s11255-009-9583-4; MELLOW MH, 1983, CANCER, V51, P1615, DOI 10.1002/1097-0142(19830501)51:9<1615::AID-CNCR2820510911>3.0.CO;2-O; Meyer F, 2005, INT J CANCER, V116, P182, DOI 10.1002/ijc.21058; Milde D, 2007, CHEM PAP, V61, P348, DOI 10.2478/s11696-007-0046-z; NAGASUE N, 1989, ONCOLOGY, V46, P293; NARANG APS, 1991, TRACE ELEM MED, V8, P15; Nasiadek M, 2005, HUM EXP TOXICOL, V24, P623, DOI 10.1191/0960327105ht575oa; Ng KH, 1997, BRIT J RADIOL, V70, P375, DOI 10.1259/bjr.70.832.9166074; OKUNO T, 1988, TRACE ELEM MED, V5, P130; OYAMA T, 1994, BIOL TRACE ELEM RES, V42, P115, DOI 10.1007/BF02785383; Park SY, 2009, EPIDEMIOLOGY, V20, pS131, DOI 10.1097/01.ede.0000362451.17655.4a; Piccinini L, 1996, BIOL TRACE ELEM RES, V51, P23, DOI 10.1007/BF02790144; Plum LM, 2010, INT J ENV RES PUB HE, V7, P1342, DOI 10.3390/ijerph7041342; Poo JL, 2003, J GASTROENTEROL, V38, P45, DOI 10.1007/s005350300005; Przybylik-Mazurek E, 2011, BIOL TRACE ELEM RES, V141, P65, DOI 10.1007/s12011-010-8719-9; Raju GJN, 2006, NUCL INSTRUM METH B, V247, P361, DOI 10.1016/j.nimb.2006.02.007; Rautray TR, 2009, NUCL INSTRUM METH B, V267, P2878, DOI 10.1016/j.nimb.2009.06.084; Salehifar E, 2008, TRACE ELEM ELECTROLY, V25, P165; Sapota A, 2009, BIOMETALS, V22, P1041, DOI 10.1007/s10534-009-9255-y; Sattar N, 1997, NUTR CANCER, V28, P308, DOI 10.1080/01635589709514592; SCHRODT GR, 1964, CANCER, V17, P1555, DOI 10.1002/1097-0142(196412)17:12<1555::AID-CNCR2820171207>3.0.CO;2-U; Shobeiri MJ, 2011, PAK J MED SCI, V27, P561; Shukla VK, 2003, J SURG ONCOL, V84, P31, DOI 10.1002/jso.10283; Silva MP, 2009, X-RAY SPECTROM, V38, P103, DOI 10.1002/xrs.1126; Silvera SAN, 2007, CANCER CAUSE CONTROL, V18, P7, DOI 10.1007/s10552-006-0057-z; Singh V, 1998, BIOL TRACE ELEM RES, V64, P237, DOI 10.1007/BF02783340; Stawarz R, 2009, FRESEN ENVIRON BULL, V18, P182; Sun ZG, 2011, TRACE ELEM ELECTROLY, V28, P116, DOI 10.5414/TEP28116; Tashiro H, 2003, BIOL TRACE ELEM RES, V95, P49, DOI 10.1385/BTER:95:1:49; Taysi S, 2003, BIOL TRACE ELEM RES, V91, P11, DOI 10.1385/BTER:91:1:11; Tinoco-Veras CM, 2011, NUTR HOSP, V26, P293, DOI [10.3305/nh.2011.26.2.4804, 10.1590/S0212-16112011000200008]; Wells G, 2008, NEWCASTLE OTTAWA SCA; WHELAN P, 1983, BRIT J UROL, V55, P525, DOI 10.1111/j.1464-410X.1983.tb03362.x; Yaman M, 2007, WORLD J GASTROENTERO, V13, P612, DOI 10.3748/wjg.v13.i4.612; Yigitbasi OG, 1998, TRACE ELEM ELECTROLY, V15, P90; YUCEL I, 1994, BIOL TRACE ELEM RES, V40, P31, DOI 10.1007/BF02916818; Zaichick S, 2012, APPL RADIAT ISOTOPES, V70, P81, DOI 10.1016/j.apradiso.2011.08.021; Zaichick VY, 1997, J RADIOANAL NUCL CH, V217, P157, DOI 10.1007/BF02034434; ZAICHICK VY, 1995, ANALYST, V120, P817, DOI 10.1039/an9952000817; Zhang LL, 2012, BIOL TRACE ELEM RES, V148, P7, DOI 10.1007/s12011-012-9336-6; Zhong HH, 1999, BIOL TRACE ELEM RES, V71-2, P569, DOI 10.1007/BF02784245; Zowczak M, 2001, BIOL TRACE ELEM RES, V82, P1, DOI 10.1385/BTER:82:1-3:001; Zowczak-Drabarczyk M, 2004, TRACE ELEM ELECTROLY, V21, P236	127	64	66	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99790	10.1371/journal.pone.0099790	http://dx.doi.org/10.1371/journal.pone.0099790			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941118	Green Published, Green Submitted, gold			2022-12-27	WOS:000338508200042
J	Prasath, D; Karthika, R; Habeeba, NT; Suraby, EJ; Rosana, OB; Shaji, A; Eapen, SJ; Deshpande, U; Anandaraj, M				Prasath, Duraisamy; Karthika, Raveendran; Habeeba, Naduva Thadath; Suraby, Erinjery Jose; Rosana, Ottakandathil Babu; Shaji, Avaroth; Eapen, Santhosh Joseph; Deshpande, Uday; Anandaraj, Muthuswamy			Comparison of the Transcriptomes of Ginger (Zingiber officinale Rosc.) and Mango Ginger (Curcuma amada Roxb.) in Response to the Bacterial Wilt Infection	PLOS ONE			English	Article							1-DEOXY-D-XYLULOSE 5-PHOSPHATE SYNTHASE; ISOPRENOID BIOSYNTHESIS; RALSTONIA-SOLANACEARUM; PLANT; GENE; RESISTANCE; EXPRESSION; MICRORNAS; TOMATO; MEVALONATE	Bacterial wilt in ginger (Zingiber officinale Rosc.) caused by Ralstonia solanacearum is one of the most important production constraints in tropical, sub-tropical and warm temperature regions of the world. Lack of resistant genotype adds constraints to the crop management. However, mango ginger (Curcuma amada Roxb.), which is resistant to R. solanacearum, is a potential donor, if the exact mechanism of resistance is understood. To identify genes involved in resistance to R. solanacearum, we have sequenced the transcriptome from wilt-sensitive ginger and wilt-resistant mango ginger using Illumina sequencing technology. A total of 26387032 and 22268804 paired-end reads were obtained after quality filtering for C. amada and Z. officinale, respectively. A total of 36359 and 32312 assembled transcript sequences were obtained from both the species. The functions of the unigenes cover a diverse set of molecular functions and biological processes, among which we identified a large number of genes associated with resistance to stresses and response to biotic stimuli. Large scale expression profiling showed that many of the disease resistance related genes were expressed more in C. amada. Comparative analysis also identified genes belonging to different pathways of plant defense against biotic stresses that are differentially expressed in either ginger or mango ginger. The identification of many defense related genes differentially expressed provides many insights to the resistance mechanism to R. solanacearum and for studying potential pathways involved in responses to pathogen. Also, several candidate genes that may underline the difference in resistance to R. solanacearum between ginger and mango ginger were identified. Finally, we have developed a web resource, ginger transcriptome database, which provides public access to the data. Our study is among the first to demonstrate the use of Illumina short read sequencing for de novo transcriptome assembly and comparison in non-model species of Zingiberaceae.	[Prasath, Duraisamy; Karthika, Raveendran; Habeeba, Naduva Thadath; Suraby, Erinjery Jose; Rosana, Ottakandathil Babu; Shaji, Avaroth; Eapen, Santhosh Joseph; Anandaraj, Muthuswamy] Indian Inst Spices Res, Calicut, Kerala, India; [Deshpande, Uday] Labindia, GPOD Res & Training Div, Thana, Maharashtra, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Spices Research	Prasath, D (corresponding author), Indian Inst Spices Res, Calicut, Kerala, India.	dprasath@gmail.com	Eapen, Santhosh/F-7914-2010	Eapen, Santhosh/0000-0001-9668-5988; Ottakandathil Babu, Rosana/0000-0002-7661-6878; Raveendran, Karthika/0000-0002-3277-1921	Indian Council of Agricultural Research (ICAR) as ORP (PhytoFuRa)	Indian Council of Agricultural Research (ICAR) as ORP (PhytoFuRa)	This work received funding from Indian Council of Agricultural Research (ICAR) as ORP (PhytoFuRa), http://220.227.138.213/ phytofura/index.php. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annadurai RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056217; Annadurai RS, 2012, BMC GENOMICS, V13, P1, DOI 10.1186/1471-2164-13-663; [Anonymous], 2004, INDIAN PHYTOPATHOL; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bittel P, 2007, CURR OPIN PLANT BIOL, V10, P335, DOI 10.1016/j.pbi.2007.04.021; Boller T, 2009, SCIENCE, V324, P742, DOI 10.1126/science.1171647; Brader G, 2007, MOL PLANT MICROBE IN, V20, P589, DOI 10.1094/MPMI-20-5-0589; Cardoso-Silva CB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088462; Chen TW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S7-S9; Chen YY, 2009, PHYSIOL PLANTARUM, V136, P324, DOI 10.1111/j.1399-3054.2009.01226.x; Colaiacovo M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-595; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cordoba E, 2009, J EXP BOT, V60, P2933, DOI 10.1093/jxb/erp190; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Enfissi EMA, 2005, PLANT BIOTECHNOL J, V3, P17, DOI 10.1111/j.1467-7652.2004.00091.x; Estevez JM, 2000, PLANT PHYSIOL, V124, P95, DOI 10.1104/pp.124.1.95; Fu N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057686; Gahlan P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-126; Garg R, 2011, PLANT PHYSIOL, V156, P1661, DOI 10.1104/pp.111.178616; Gong YF, 2006, PLANTA MED, V72, P329, DOI 10.1055/s-2005-916234; Gordo SMC, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-168; Guo YH, 2005, SCI HORTIC-AMSTERDAM, V107, P90, DOI 10.1016/j.scienta.2005.07.003; Gupta OP, 2012, MOL BIOL REP, V39, P817, DOI 10.1007/s11033-011-0803-5; Iorizzo M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-389; Ishihara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046763; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Journot-Catalino N, 2006, PLANT CELL, V18, P3289, DOI 10.1105/tpc.106.044149; Joy N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056694; Kavitha PG, 2008, EUPHYTICA, V160, P89, DOI 10.1007/s10681-007-9557-5; Kawasaki T, 2006, P NATL ACAD SCI USA, V103, P230, DOI 10.1073/pnas.0509875103; KELMAN A, 1954, PHYTOPATHOLOGY, V44, P693; Koo HJ, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-27; Kumar A, 2005, MED AROM PLANTS, V41, P341; Kumar A, 2006, 4 INT BACT WILT S 17; Lange BM, 1999, ARCH BIOCHEM BIOPHYS, V365, P170, DOI 10.1006/abbi.1999.1168; Lange BM, 1998, P NATL ACAD SCI USA, V95, P2100, DOI 10.1073/pnas.95.5.2100; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Lincy AK, 2009, ACTA BOT CROAT, V68, P93; Lois LM, 2000, PLANT J, V22, P503, DOI 10.1046/j.1365-313x.2000.00764.x; LULIN H, 2012, PLOS ONE, V0007; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Miallau L, 2003, P NATL ACAD SCI USA, V100, P9173, DOI 10.1073/pnas.1533425100; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Morris WL, 2006, J EXP BOT, V57, P3007, DOI 10.1093/jxb/erl061; Ness RW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-298; Nirmalbabu K, 1996, J SPICES AROMATIC CR, V5, P134; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Policegoudra RS, 2011, J BIOSCIENCES, V36, P739, DOI 10.1007/s12038-011-9106-1; Prasath D, 2013, ACTA PHYSIOL PLANT, V35, P3293, DOI 10.1007/s11738-013-1362-2; Prasath D, 2011, PLANT CELL REP, V30, P1799, DOI 10.1007/s00299-011-1087-x; Qi X, 2006, P NATL ACAD SCI USA, V103, P18848, DOI 10.1073/pnas.0607849103; Ravindran P. N., 1994, Plant Genetic Resources Newsletter, P1; Ravindran PN, 2005, MED AROM PLANTS, V41, P15; Rodriguez-Concepcion M, 2001, PLANT J, V27, P213, DOI 10.1046/j.1365-313x.2001.01089.x; Sattar S, 2012, MOL PLANT MICROBE IN, V25, P839, DOI 10.1094/MPMI-09-11-0252; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Schwender J, 1999, FEBS LETT, V455, P140, DOI 10.1016/S0014-5793(99)00849-2; Suma B., 2008, Journal of Tropical Agriculture, V46, P38; Sun XD, 2012, PLANT CELL REP, V31, P1823, DOI 10.1007/s00299-012-1295-z; Takahashi S, 1998, PSYCHIAT CLIN NEUROS, V52, P1; Vailleau F, 2002, P NATL ACAD SCI USA, V99, P10179, DOI 10.1073/pnas.152047199; Vanitha SC, 2009, J PHYTOPATHOL, V157, P552, DOI 10.1111/j.1439-0434.2008.01526.x; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066539; Xia ZH, 2011, PLANT MOL BIOL, V77, P299, DOI 10.1007/s11103-011-9811-z; Xin MM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-123; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang HB, 2004, PLANT MOL BIOL, V55, P825, DOI 10.1007/s11103-005-2140-3; Zhang JA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-90; Zhang X, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-11-r165	71	32	32	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99731	10.1371/journal.pone.0099731	http://dx.doi.org/10.1371/journal.pone.0099731			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940878	Green Published, gold, Green Submitted			2022-12-27	WOS:000338508200039
J	Uno, Y; Mizukami, H; Ando, M; Yukihiro, R; Iwasaki, Y; Ozaki, N				Uno, Yota; Mizukami, Hitomi; Ando, Masahiko; Yukihiro, Ryoji; Iwasaki, Yoko; Ozaki, Norio			Reliability and Validity of the New Tanaka B Intelligence Scale Scores: A Group Intelligence Test	PLOS ONE			English	Article							INTELLECTUAL DISABILITY; MENTAL-HEALTH; OFFENDERS; PERFORMANCE; PREVALENCE; DISORDERS; BEHAVIOR; JAPAN; IQ	Objective: The present study evaluated the reliability and concurrent validity of the new Tanaka B Intelligence Scale, which is an intelligence test that can be administered on groups within a short period of time. Methods: The new Tanaka B Intelligence Scale and Wechsler Intelligence Scale for Children-Third Edition were administered to 81 subjects (mean age +/- SD 15.2 +/- 0.7 years) residing in a juvenile detention home; reliability was assessed using Cronbach's alpha coefficient, and concurrent validity was assessed using the one-way analysis of variance intraclass correlation coefficient. Moreover, receiver operating characteristic analysis for screening for individuals who have a deficit in intellectual function (an FIQ<70) was performed. In addition, stratum-specific likelihood ratios for detection of intellectual disability were calculated. Results: The Cronbach's alpha for the new Tanaka B Intelligence Scale IQ (BIQ) was 0.86, and the intraclass correlation coefficient with FIQ was 0.83. Receiver operating characteristic analysis demonstrated an area under the curve of 0.89 (95% CI: 0.85-0.96). In addition, the stratum-specific likelihood ratio for the BIQ <= 65 stratum was 13.8 (95% CI: 3.9-48.9), and the stratum-specific likelihood ratio for the BIQ >= 76 stratum was 0.1 (95% CI: 0.03-0.4). Thus, intellectual disability could be ruled out or determined. Conclusion: The present results demonstrated that the new Tanaka B Intelligence Scale score had high reliability and concurrent validity with the Wechsler Intelligence Scale for Children-Third Edition score. Moreover, the post-test probability for the BIQ could be calculated when screening for individuals who have a deficit in intellectual function. The new Tanaka B Intelligence Test is convenient and can be administered within a variety of settings. This enables evaluation of intellectual development even in settings where performing intelligence tests have previously been difficult.	[Uno, Yota; Ozaki, Norio] Nagoya Univ, Grad Sch Med, Dept Child & Adolescent Psychiat, Nagoya, Aichi 4648601, Japan; [Mizukami, Hitomi] Chiba Juvenile Detent Home, Dept Psychol, Chiba, Japan; [Ando, Masahiko] Nagoya Univ Hosp, Ctr Adv Med & Clin Res, Nagoya, Aichi, Japan; [Yukihiro, Ryoji] Kyoto Gakuen Univ, Dept Psychol, Kyoto, Japan; [Iwasaki, Yoko] Saitama Juvenile Detent Home, Dept Psychol, Saitama, Japan	Nagoya University; Nagoya University	Uno, Y (corresponding author), Nagoya Univ, Grad Sch Med, Dept Child & Adolescent Psychiat, Nagoya, Aichi 4648601, Japan.	yota.uno@med.nagoya-u.ac.jp	Ozaki, Norio/M-8908-2014; UNO, Yota/M-8928-2014; ANDO, Masahiko/F-7035-2015	Ozaki, Norio/0000-0002-7360-4898; 				AHMANN JS, 1985, MEAS EVAL COUNS DEV, V17, P226, DOI 10.1080/07481756.1985.12022780; Anckarsater Henrik, 2007, Dev Neurorehabil, V10, P57, DOI 10.1080/13638490600864157; Benson S, 1997, J AM ACAD CHILD ADOL, V36, p122S; Borum R., 2003, J CONTEMP CRIM JUST, V19, P114, DOI [10.1177/1043986202239745, DOI 10.1177/1043986202239745]; Breckon SE, 2013, RES DEV DISABIL, V34, P1408, DOI 10.1016/j.ridd.2013.02.009; Burke MM, 2012, J INTELL DISABIL RES, V56, P305, DOI 10.1111/j.1365-2788.2011.01422.x; Court J., 1998, MANUAL RAVENS PROGRE; Donders J, 1997, PSYCHOL ASSESSMENT, V9, P15; Douma JCH, 2007, AM J MENT RETARD, V112, P207, DOI 10.1352/0895-8017(2007)112[207:AADBIY]2.0.CO;2; FRICK PJ, 1991, J CONSULT CLIN PSYCH, V59, P289, DOI 10.1037/0022-006X.59.2.289; Furukawa TA, 1997, J AFFECT DISORDERS, V46, P1, DOI 10.1016/S0165-0327(97)00079-7; GOODMAN R, 1995, J CHILD PSYCHOL PSYC, V36, P409, DOI 10.1111/j.1469-7610.1995.tb01299.x; Harris KR, 2003, J PAEDIATR CHILD H, V39, P528, DOI 10.1046/j.1440-1754.2003.00208.x; Herrington V, 2009, J INTELL DISABIL RES, V53, P397, DOI 10.1111/j.1365-2788.2008.01150.x; Kaslow FW, 1990, AM J FAM THER, V18, P197, DOI DOI 10.1080/01926189008250804; Kroll L, 2002, LANCET, V359, P1975, DOI 10.1016/S0140-6736(02)08829-3; Kuhlmann F, 1953, J CONSULT PSYCHOL, V17, P320; Lindsay WR, 2013, J INTELL DISABIL RES, V57, P172, DOI 10.1111/j.1365-2788.2012.01600.x; Lindsay WR, 2002, J APPL RES INTELLECT, V15, P111, DOI 10.1046/j.1468-3148.2002.00112.x; Liu JH, 2011, PERS INDIV DIFFER, V50, P1222, DOI 10.1016/j.paid.2011.02.013; Lohman D. F., 2002, COGAT FORM 6 RES HDB; LYNAM D, 1993, J ABNORM PSYCHOL, V102, P187, DOI 10.1037/0021-843X.102.2.187; Mannynsalo L, 2009, J INTELL DISABIL RES, V53, P279, DOI 10.1111/j.1365-2788.2008.01125.x; Matsuura N, 2009, CHILD YOUTH SERV REV, V31, P577, DOI 10.1016/j.childyouth.2008.10.016; MOFFITT TE, 1993, DEV PSYCHOPATHOL, V5, P135, DOI 10.1017/S0954579400004302; Raven J, 2000, COGNITIVE PSYCHOL, V41, P1, DOI 10.1006/cogp.1999.0735; Rayner J, 2005, J FORENSIC PSYCHI PS, V16, P248, DOI 10.1080/14789940512331309821; SHEINER LB, 1981, J PHARMACOKINET BIOP, V9, P503, DOI 10.1007/BF01060893; Shipley W.C., 2009, SHIPLEY 2 MANUAL; STATTIN H, 1993, J ABNORM PSYCHOL, V102, P369, DOI 10.1037/0021-843X.102.3.369; Tanaka K, 2003, NEW TANAKA B INTELLI; Vanny KA, 2009, J INTELL DISABIL RES, V53, P289, DOI 10.1111/j.1365-2788.2008.01148.x; Weschler D., 1991, WECHSLER INTELLIGENC; Yang HJ, 2004, J AFFECT DISORDERS, V82, P419, DOI 10.1016/j.jad.2004.04.008	34	7	7	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100262	10.1371/journal.pone.0100262	http://dx.doi.org/10.1371/journal.pone.0100262			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK6AC	24940880	Green Published, Green Submitted, gold			2022-12-27	WOS:000338508200088
J	Zhang, BS; Zhou, M; Li, CB; Zhou, JX; Li, HQ; Zhu, D; Wang, Z; Chen, AQ; Zhao, Q				Zhang, Busheng; Zhou, Mi; Li, Canbo; Zhou, Jingxin; Li, Haiqing; Zhu, Dan; Wang, Zhe; Chen, Anqing; Zhao, Qiang			MicroRNA-92a Inhibition Attenuates Hypoxia/Reoxygenation-Induced Myocardiocyte Apoptosis by Targeting Smad7	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; ISCHEMIA/REPERFUSION INJURY; CARDIAC DYSFUNCTION; EXPRESSION; ANGIOGENESIS; PROMOTES; GENE; ACTIVATION; INFARCTION; REPAIR	Background: MicroRNAs (miRNAs) regulate a lot of physiological and pathological processes, including myocardial ischemia/reperfusion. Recent studies reported that knockdown of miR-92a could attenuate ischemia/reperfusion-induced myocardial injury. In the present study, we examined the potential anti-apoptotic effects of miR-92a in a rat myocardiocyte cell line, and the possible role of Smad7 in such actions. Methodology and Results: In a preliminary bioinformatic analysis, we identified SMAD family member 7 (Smad7) as a potential target for miR-92a. A luciferase reporter assay indeed demonstrated that miR-92a could inhibit Smad7 expression. Myocardial ischemia/reperfusion was simulated in rat H9c2 cells with 24-h hypoxia followed by 12-h reoxygenation. Prior to hypoxia/reoxygenation, cells were transfected by miR-92a inhibitor. In some experiments, cells were co-transfected with siRNA-Smad7. The miR-92a inhibitor dramatically reduced the release of lactate dehydrogenase and malonaldehyde, and attenuated cardiomyocyte apoptosis. The miR-92a inhibitor increased SMAD7 protein level and decreased nuclear NF-kappa B p65 protein. Effects of the miR-92a inhibitor were attenuated by co-transfection with siRNA-Smad7. Conclusion: Inhibiting miR-92a can attenuate myocardiocyte apoptosis induced by hypoxia/reoxygenation by targeting Smad7.	[Zhang, Busheng; Zhou, Mi; Li, Canbo; Zhou, Jingxin; Li, Haiqing; Zhu, Dan; Wang, Zhe; Chen, Anqing; Zhao, Qiang] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Cardiac Surg, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Zhao, Q (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Cardiac Surg, Shanghai 200030, Peoples R China.	zq11607@rjh.com.cn		Zhou, Jingxin/0000-0003-0471-1961	Science and Technology Commission of Shanghai Municipality of China [11JC1408000]; National Natural Science Foundation of China [81200093]	Science and Technology Commission of Shanghai Municipality of China(Science & Technology Commission of Shanghai Municipality (STCSM)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by Science and Technology Commission of Shanghai Municipality of China (11JC1408000) and the National Natural Science Foundation of China (Grant No. 81200093). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; Danielson LS, 2013, FASEB J, V27, P1460, DOI 10.1096/fj.12-221994; Ding HS, 2013, GENE, V527, P389, DOI 10.1016/j.gene.2013.05.041; Fang J, 2012, APOPTOSIS, V17, P410, DOI 10.1007/s10495-011-0683-0; Goren Y, 2014, AM J CARDIOL, V113, P976, DOI 10.1016/j.amjcard.2013.11.060; Guo J, 2013, ATHEROSCLEROSIS, V231, P384, DOI 10.1016/j.atherosclerosis.2013.10.003; Haahr-Pedersen S, 2009, J INVASIVE CARDIOL, V21, P13; Hausenloy DJ, 2013, J CLIN INVEST, V123, P92, DOI 10.1172/JCI62874; Heymans S, 2013, CIRCULATION, V128, P1420, DOI 10.1161/CIRCULATIONAHA.112.001357; Hinkel R, 2013, CIRCULATION, V128, P1066, DOI 10.1161/CIRCULATIONAHA.113.001904; Hong S, 2007, CANCER RES, V67, P9577, DOI 10.1158/0008-5472.CAN-07-1179; Ka SM, 2012, DIABETOLOGIA, V55, P509, DOI 10.1007/s00125-011-2364-5; Kortekaas KA, 2012, EUR J CARDIO-THORAC, V41, pe117, DOI 10.1093/ejcts/ezs088; Li ML, 2014, EXP CELL RES, V323, P1, DOI 10.1016/j.yexcr.2013.12.025; Li Q, 2013, CANCER LETT, V335, P168, DOI 10.1016/j.canlet.2013.02.029; Li Y, 2014, ACTA BIOCH BIOPH SIN, V46, P48, DOI 10.1093/abbs/gmt124; Liu LF, 2014, APOPTOSIS, V19, P19, DOI 10.1007/s10495-013-0899-2; Lorenzen JM, 2013, FREE RADICAL BIO MED, V64, P78, DOI 10.1016/j.freeradbiomed.2013.06.044; Meloni M, 2013, MOL THER, V21, P1390, DOI 10.1038/mt.2013.89; Pan ZW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050515; Qin H, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-154; Sharifi M, 2014, MOL BIOL REP; Tian L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075885; Tu YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075872; Wang NP, 2012, BRIT J PHARMACOL, V167, P1550, DOI 10.1111/j.1476-5381.2012.02109.x; Wang ZF, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-012-0318-9; Ye YM, 2011, PHYSIOL GENOMICS, V43, P534, DOI 10.1152/physiolgenomics.00130.2010; Zeiger AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037904; Zhang L, 2014, BIOCHEM BIOPH RES CO, V446, P952, DOI 10.1016/j.bbrc.2014.03.035; Zhang L, 2014, APOPTOSIS, V19, P975, DOI 10.1007/s10495-014-0987-y; Zhou LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079805; Zhou M, 2013, MED HYPOTHESES, V81, P108, DOI 10.1016/j.mehy.2013.03.043; Zhu HY, 2012, CARDIOVASC RES, V94, P284, DOI 10.1093/cvr/cvr291	34	56	59	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100298	10.1371/journal.pone.0100298	http://dx.doi.org/10.1371/journal.pone.0100298			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941323	Green Submitted, Green Published, gold			2022-12-27	WOS:000338508200092
J	Laurin, GV; Chan, JCW; Chen, Q; Lindsell, JA; Coomes, DA; Guerriero, L; Del Frate, F; Miglietta, F; Valentini, R				Laurin, Gaia Vaglio; Chan, Jonathan Cheung-Wai; Chen, Qi; Lindsell, Jeremy A.; Coomes, David A.; Guerriero, Leila; Del Frate, Fabio; Miglietta, Franco; Valentini, Riccardo			Biodiversity Mapping in a Tropical West African Forest with Airborne Hyperspectral Data	PLOS ONE			English	Article							SPECTRAL BAND SELECTION; PLANT-SPECIES RICHNESS; LEAF PIGMENT CONTENT; IMAGING SPECTROSCOPY; FLORISTIC COMPOSITION; SATELLITE IMAGERY; RAIN-FORESTS; VEGETATION; DIVERSITY; CLASSIFICATION	Tropical forests are major repositories of biodiversity, but are fast disappearing as land is converted to agriculture. Decision-makers need to know which of the remaining forests to prioritize for conservation, but the only spatial information on forest biodiversity has, until recently, come from a sparse network of ground-based plots. Here we explore whether airborne hyperspectral imagery can be used to predict the alpha diversity of upper canopy trees in a West African forest. The abundance of tree species were collected from 64 plots (each 1250 m(2) in size) within a Sierra Leonean national park, and Shannon-Wiener biodiversity indices were calculated. An airborne spectrometer measured reflectances of 186 bands in the visible and near-infrared spectral range at 1 m(2) resolution. The standard deviations of these reflectance values and their first-order derivatives were calculated for each plot from the c. 1250 pixels of hyperspectral information within them. Shannon-Wiener indices were then predicted from these plot-based reflectance statistics using a machine-learning algorithm (Random Forest). The regression model fitted the data well (pseudo-R-2 = 84.9%), and we show that standard deviations of green-band reflectances and infra-red region derivatives had the strongest explanatory powers. Our work shows that airborne hyperspectral sensing can be very effective at mapping canopy tree diversity, because its high spatial resolution allows within-plot heterogeneity in reflectance to be characterized, making it an effective tool for monitoring forest biodiversity over large geographic scales.	[Laurin, Gaia Vaglio; Valentini, Riccardo] Euromediterranean Ctr Climate Change, Impacts Agr Forest & Nat Ecosyst Div, Viterbo, Italy; [Chan, Jonathan Cheung-Wai; Miglietta, Franco] Fdn Edmund Mach, Foxlab, San Michele All Adige, Italy; [Chen, Qi] Univ Hawaii Manoa, Dept Geog, Honolulu, HI 96822 USA; [Lindsell, Jeremy A.] Royal Soc Protect Birds, Sandy SG19 2DL, Beds, England; [Coomes, David A.] Univ Cambridge, Dept Plant Sci, Cambridge, England; [Laurin, Gaia Vaglio; Guerriero, Leila; Del Frate, Fabio] Univ Roma Tor Vergata, Dept Civil Engn & Comp Sci Engn, Rome, Italy; [Valentini, Riccardo] Univ Tuscia, Dept Forest Resources & Environm, Viterbo, Italy; [Lindsell, Jeremy A.] Rocha Int, Cambridge, England; [Miglietta, Franco] CNR, Inst Biometeorol, Florence, Italy; [Miglietta, Franco] Ecole Polytech Fed Lausanne, Lab Ecohydrol Civil & Environm Engn, Lausanne, Switzerland; [Chan, Jonathan Cheung-Wai] Vrije Univ Brussel, Dept Elect & Informat, Brussels, Belgium; [Miglietta, Franco] Fdn EMach, MountFor Project Ctr European Forest Inst, San Michele All Adige, Italy	Centro Euro-Mediterraneo sui Cambiamenti Climatici (CMCC); Fondazione Edmund Mach; University of Hawaii System; University of Hawaii Manoa; Royal Society for Protection of Birds; University of Cambridge; University of Rome Tor Vergata; Tuscia University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biometeorologia (IBIMET-CNR); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Vrije Universiteit Brussel	Laurin, GV (corresponding author), Euromediterranean Ctr Climate Change, Impacts Agr Forest & Nat Ecosyst Div, Viterbo, Italy.	gaia.vagliolaurin@cmcc.it	Miglietta, Franco/B-6137-2008; Valentini, Riccardo/D-1226-2010; Cumming, Graeme S./B-6551-2008	Miglietta, Franco/0000-0003-1474-8143; Valentini, Riccardo/0000-0002-6756-5634; Cumming, Graeme S./0000-0002-3678-1326; Lindsell, Jeremy/0000-0003-2088-8927; Coomes, David/0000-0002-8261-2582; VAGLIO LAURIN, Gaia/0000-0002-6728-3557; Chan, Jonathan/0000-0002-3741-1124	ERC grant Africa GHG [247349]; Cambridge Conservation Initiative; Industry-Academia Partnerships and Pathways programme of the European Commission, Project AIRFORS [286079]	ERC grant Africa GHG; Cambridge Conservation Initiative; Industry-Academia Partnerships and Pathways programme of the European Commission, Project AIRFORS	The authors acknowledge the ERC grant Africa GHG #247349 and the Cambridge Conservation Initiative for providing support to the investigation. This work is also supported by the Industry-Academia Partnerships and Pathways programme of the European Commission, Project AIRFORS, contract no: 286079. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Rahman EM, 2013, INT J REMOTE SENS, V34, P712, DOI 10.1080/01431161.2012.713142; Asner GP, 2008, REMOTE SENS ENVIRON, V112, P1912, DOI 10.1016/j.rse.2007.02.043; Asner GP, 2008, REMOTE SENS ENVIRON, V112, P1942, DOI 10.1016/j.rse.2007.11.016; Balmford A, 2003, ORYX, V37, P238, DOI 10.1017/S0030605303000413; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Carlson KM, 2007, ECOSYSTEMS, V10, P536, DOI 10.1007/s10021-007-9041-z; Chambers JQ, 2007, TRENDS ECOL EVOL, V22, P414, DOI 10.1016/j.tree.2007.05.001; Chan JCW, 2008, REMOTE SENS ENVIRON, V112, P2999, DOI 10.1016/j.rse.2008.02.011; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Clark ML, 2012, REMOTE SENS-BASEL, V4, P1820, DOI 10.3390/rs4061820; Clark ML, 2005, REMOTE SENS ENVIRON, V96, P375, DOI 10.1016/j.rse.2005.03.009; Cole NHA, 1993, J PURE APPL SCI, V2, P35; CONNOR EF, 1979, AM NAT, V113, P791, DOI 10.1086/283438; Dalponte M, 2008, IEEE T GEOSCI REMOTE, V46, P1416, DOI 10.1109/TGRS.2008.916480; DEMETRIADESSHAH TH, 1990, REMOTE SENS ENVIRON, V33, P55, DOI 10.1016/0034-4257(90)90055-Q; Diaz S, 2009, CURR OPIN ENV SUST, V1, P55, DOI 10.1016/j.cosust.2009.08.001; Feilhauer H, 2009, APPL VEG SCI, V12, P429, DOI 10.1111/j.1654-109X.2009.01037.x; Felde GW, 2003, INT GEOSCI REMOTE SE, P90; Feret JB, 2014, ECOLOGICAL IN PRESS; Feret JB, 2012, REMOTE SENS-BASEL, V4, P2457, DOI 10.3390/rs4082457; Feret JB, 2011, REMOTE SENS ENVIRON, V115, P2415, DOI 10.1016/j.rse.2011.05.004; Foody GM, 2006, ECOL MODEL, V195, P37, DOI 10.1016/j.ecolmodel.2005.11.007; Foody GM, 2003, INT J REMOTE SENS, V24, P4035, DOI 10.1080/0143116031000103853; Foody GM, 2003, J BIOGEOGR, V30, P1053, DOI 10.1046/j.1365-2699.2003.00887.x; Gamon JA, 1999, NEW PHYTOL, V143, P105, DOI 10.1046/j.1469-8137.1999.00424.x; GAMON JA, 1992, REMOTE SENS ENVIRON, V41, P35, DOI 10.1016/0034-4257(92)90059-S; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; GENTRY AH, 1988, ANN MO BOT GARD, V75, P1, DOI 10.2307/2399464; Genuer R., 2010, PATTERN RECOGN LETT, V31, P2225, DOI [10.1038/nature08649, DOI 10.1038/nature08649, DOI 10.1016/j.patrec.2010.03.014]; Gitelson AA, 2001, PHOTOCHEM PHOTOBIOL, V74, P38, DOI 10.1562/0031-8655(2001)074&lt;0038:OPANEO&gt;2.0.CO;2; Gong P, 1997, REMOTE SENS ENVIRON, V62, P189, DOI 10.1016/S0034-4257(97)00094-1; Gould W, 2000, ECOL APPL, V10, P1861, DOI 10.1890/1051-0761(2000)010[1861:RSOVPS]2.0.CO;2; GREEN AA, 1988, IEEE T GEOSCI REMOTE, V26, P65, DOI 10.1109/36.3001; Grime JP, 1998, J ECOL, V86, P902, DOI 10.1046/j.1365-2745.1998.00306.x; Han J, 1997, REMOTE SENS ENVIRON, V62, P253; He KS, 2011, DIVERS DISTRIB, V17, P381, DOI 10.1111/j.1472-4642.2011.00761.x; Jones TG, 2010, REMOTE SENS ENVIRON, V114, P2841, DOI 10.1016/j.rse.2010.07.002; Jurgens N, 2012, ENVIRON MONIT ASSESS, V184, P655, DOI 10.1007/s10661-011-1993-y; Kalacska M, 2007, REMOTE SENS ENVIRON, V108, P82, DOI 10.1016/j.rse.2006.11.007; Kaufman YJ, 1996, REMOTE SENS ENVIRON, V55, P65, DOI 10.1016/0034-4257(95)00193-X; Kerr JT, 2003, TRENDS ECOL EVOL, V18, P299, DOI 10.1016/S0169-5347(03)00071-5; Kumar L, 2001, RE S D I PR, V4, P111; Laurin GV, 2013, INT J APPL EARTH OBS, V21, P7, DOI 10.1016/j.jag.2012.08.002; Leutner BF, 2012, REMOTE SENS-BASEL, V4, P2818, DOI 10.3390/rs4092818; Levin N, 2007, DIVERS DISTRIB, V13, P692, DOI 10.1111/j.1472-4642.2007.00372.x; Leyequien E, 2007, INT J APPL EARTH OBS, V9, P1, DOI 10.1016/j.jag.2006.08.002; Lindsell JA, 2013, FOREST ECOL MANAG, V289, P10, DOI 10.1016/j.foreco.2012.09.045; Lucas Richard, 2008, P47, DOI 10.1201/9781420053432.ch3; Magurran A.E, 2004, MEASURING BIOL DIVER; Martin ME, 1997, ECOL APPL, V7, P431, DOI 10.1890/1051-0761(1997)007[0431:HSRRSO]2.0.CO;2; Nagendra H, 2001, INT J REMOTE SENS, V22, P2377, DOI 10.1080/01431160117096; Nagendra H, 2008, BIODIVERS CONSERV, V17, P3431, DOI 10.1007/s10531-008-9479-0; Oldeland J, 2010, ECOL INDIC, V10, P390, DOI 10.1016/j.ecolind.2009.07.012; Palmer MW, 2002, ENVIRONMETRICS, V13, P121, DOI 10.1002/env.516; Paoli GD, 2010, CARBON BAL MANAGE, V23, P5; Rocchini D, 2007, APPL VEG SCI, V10, P325, DOI 10.1111/j.1654-109X.2007.tb00431.x; Rocchini D, 2004, ACTA OECOL, V26, P117, DOI 10.1016/j.actao.2004.03.008; Rocchini D, 2010, INT J REMOTE SENS, V31, P2745, DOI 10.1080/01431160903085651; SELLERS PJ, 1985, INT J REMOTE SENS, V6, P1335, DOI 10.1080/01431168508948283; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Simonson WD, 2012, CONSERV BIOL, V26, P840, DOI 10.1111/j.1523-1739.2012.01869.x; Sims DA, 2002, REMOTE SENS ENVIRON, V81, P337, DOI 10.1016/S0034-4257(02)00010-X; Somers B, 2013, REMOTE SENS ENVIRON, V136, P14, DOI 10.1016/j.rse.2013.04.006; Somers B, 2012, REMOTE SENS-BASEL, V4, P2510, DOI 10.3390/rs4092510; Thenkabail PS, 2004, REMOTE SENS ENVIRON, V91, P354, DOI 10.1016/j.rse.2004.03.013; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Townsend AR, 2008, TRENDS ECOL EVOL, V23, P424, DOI 10.1016/j.tree.2008.04.009; Tsai F, 1998, REMOTE SENS ENVIRON, V66, P41, DOI 10.1016/S0034-4257(98)00032-7; Turner W, 2003, TRENDS ECOL EVOL, V18, P306, DOI 10.1016/S0169-5347(03)00070-3; Ustin SL, 2004, BIOSCIENCE, V54, P523, DOI 10.1641/0006-3568(2004)054[0523:UISTSE]2.0.CO;2; VOGELMANN JE, 1993, INT J REMOTE SENS, V14, P1563, DOI 10.1080/01431169308953986; Walton JT, 2008, PHOTOGRAMM ENG REM S, V74, P1213, DOI 10.14358/PERS.74.10.1213; Zhang JK, 2006, REMOTE SENS ENVIRON, V105, P129, DOI 10.1016/j.rse.2006.06.010	73	54	55	4	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e97910	10.1371/journal.pone.0097910	http://dx.doi.org/10.1371/journal.pone.0097910			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937407	Green Published, Green Submitted, gold			2022-12-27	WOS:000338503400007
J	Shaw, C; Nitsch, D; Steenkamp, R; Junghans, C; Shah, S; O'Donoghue, D; Fogarty, D; Weston, C; Sharpe, CC				Shaw, Catriona; Nitsch, Dorothea; Steenkamp, Retha; Junghans, Cornelia; Shah, Sapna; O'Donoghue, Donal; Fogarty, Damian; Weston, Clive; Sharpe, Claire C.			Inpatient Coronary Angiography and Revascularisation following Non-ST-Elevation Acute Coronary Syndrome in Patients with Renal Impairment: A Cohort Study Using the Myocardial Ischaemia National Audit Project	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CONSERVATIVE MANAGEMENT; HEART-DISEASE; INFARCTION; OUTCOMES; RISK; INTERVENTION; GUIDELINE; THERAPIES; PATTERNS	Background: International guidelines support an early invasive management strategy (including early coronary angiography and revascularisation) for non-ST-elevation acute coronary syndrome (NSTE-ACS) in patients with renal impairment. However, evidence from outside the UK suggests that this approach is underutilised. We aimed to describe practice within the NHS, and to determine whether the severity of renal dysfunction influenced the provision of angiography and modified the association between early revascularisation and survival. Methods: We performed a cohort study, using multivariable logistic regression and propensity score analyses, of data from the Myocardial Ischaemia National Audit Project for patients presenting with NSTE-ACS to English or Welsh hospitals between 2008 and 2010. Findings: Of 35 881 patients diagnosed with NSTE-ACS, eGFR of <60 ml/minute/1.73 m(2) was present in 15 680 (43.7%). There was a stepwise decline in the odds of undergoing inpatient angiography with worsening renal dysfunction. Compared with an eGFR. 90 ml/minute/1.73 m(2), patients with an eGFR between 45-59 ml/minute/1.73 m(2) were 33% less likely to undergo angiography (adjusted OR 0.67, 95% CI 0.55-0.81); those with an eGFR, 30/minute/1.73 m(2) had a 64% reduction in odds of undergoing angiography (adjusted OR 0.36, 95% CI 0.29-0.43). Of 16 646 patients who had inpatient coronary angiography, 58.5% underwent inpatient revascularisation. After adjusting for co-variables, inpatient revascularisation was associated with approximately a 30% reduction in death within 1 year compared with those managed medically after coronary angiography (adjusted OR 0.66, 95% CI 0.57-0.77), with no evidence of modification by renal function (p interaction = 0.744). Interpretation: Early revascularisation may offer a similar survival benefit in patients with and without renal dysfunction, yet renal impairment is an important determinant of the provision of coronary angiography following NSTE-ACS. A randomised controlled trial is needed to evaluate the efficacy of an early invasive approach in patients with severe renal dysfunction to ensure that all patients who may benefit are offered this treatment option.	[Shaw, Catriona; Steenkamp, Retha] Southmead Hosp, UK Renal Registry, Bristol, Avon, England; [Shaw, Catriona; Sharpe, Claire C.] Kings Coll London, Div Transplantat Immunol & Mucosal Biol, Dept Renal Sci, London WC2R 2LS, England; [Nitsch, Dorothea] London Sch Hyg & Trop Med, London WC1, England; [Junghans, Cornelia] UCL, Dept Epidemiol & Publ Hlth, London, England; [Shah, Sapna] Kings Coll Hosp London, Dept Renal Med, London, England; [O'Donoghue, Donal] Salford Royal NHS Fdn Trust, Dept Renal Med, Salford, Lancs, England; [Fogarty, Damian] Belfast Hlth & Social CareTrust, Dept Renal Med, Belfast, Antrim, North Ireland; [Weston, Clive] Swansea Univ, Coll Med, Myocardial Ischaemia Natl Audit Project, Swansea, W Glam, Wales	Southmead Hospital; University of London; King's College London; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; King's College Hospital NHS Foundation Trust; King's College Hospital; Salford Royal NHS Foundation Trust; Swansea University	Shaw, C (corresponding author), Southmead Hosp, UK Renal Registry, Bristol, Avon, England.	catriona.shaw@nbt.nhs.uk	Sharpe, Claire/B-5619-2015; Junghans, Cornelia/ABG-4494-2020	Sharpe, Claire/0000-0003-1704-8492; Junghans, Cornelia/0000-0002-0663-3090; Nitsch, Dorothea/0000-0001-5767-248X; shah, Sapna/0000-0002-8748-6191; Weston, Clive/0000-0002-8995-8199	FOGARTY INTERNATIONAL CENTER [R25TW009337] Funding Source: NIH RePORTER; FIC NIH HHS [R25 TW009337] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Birkhead JS, 2000, HEART, V84, P116, DOI 10.1136/heart.84.2.116; Birkhead JS, 2002, J CLIN EXCELLENCE, V4, P379; Blicher TM, 2013, EUR HEART J, V34, P2916, DOI 10.1093/eurheartj/eht220; Boden WE, 1998, NEW ENGL J MED, V338, P1785, DOI 10.1056/NEJM199806183382501; Cannon CP, 2001, NEW ENGL J MED, V344, P1879, DOI 10.1056/NEJM200106213442501; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Charytan DM, 2009, CLIN J AM SOC NEPHRO, V4, P1032, DOI 10.2215/CJN.05551008; Chertow GM, 2004, J AM SOC NEPHROL, V15, P2462, DOI 10.1097/01.ASN.0000135969.33773.0B; Coca SG, 2006, JAMA-J AM MED ASSOC, V296, P1377, DOI 10.1001/jama.296.11.1377; Damman P, 2010, J AM COLL CARDIOL, V55, P858, DOI 10.1016/j.jacc.2009.11.026; Department for Communities and Local Government, 2010, ENGL IND DEPR; Eagle KA, 2004, JAMA-J AM MED ASSOC, V291, P2727, DOI 10.1001/jama.291.22.2727; Flather MD, 2000, LANCET, V355, P1575, DOI 10.1016/S0140-6736(00)02212-1; Fox CS, 2010, CIRCULATION, V121, P357, DOI 10.1161/CIRCULATIONAHA.109.865352; Fox KAA, 2007, HEART, V93, P177, DOI 10.1136/hrt.2005.084830; Fox KAA, 2010, J AM COLL CARDIOL, V55, P2435, DOI 10.1016/j.jacc.2010.03.007; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Herrett E, 2010, HEART, V96, P1264, DOI 10.1136/hrt.2009.192328; Herzog CA, 2003, J AM SOC NEPHROL, V14, P2556, DOI 10.1097/01.ASN.0000087640.94746.47; Hoenig MR, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004815.pub3; James MT, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4151; Jneid H, 2012, CIRCULATION, V126, P875, DOI 10.1161/CIR.0b013e318256f1e0; Kanderian AS, 2006, KIDNEY INT, V69, P1112, DOI 10.1038/sj.ki.5000174; Kerr M, 2012, NEPHROLOGY DIALYS S3, V27, P373; Kumar N, 2009, CLIN J AM SOC NEPHRO, V4, P1907, DOI 10.2215/CJN.01480209; Lee CH, 2008, ARCH INTERN MED, V168, P291, DOI 10.1001/archinternmed.2007.78; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 2013, KIDNEY INT, V83, P1001, DOI 10.1038/ki.2013.91; Lopez-Sendon J, 2004, EUR HEART J, V25, P1341, DOI 10.1016/j.ehj.2004.06.002; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Rubin DB, 2004, MULTIPLE IMPUTATION; Szummer K, 2009, CIRCULATION, V120, P851, DOI 10.1161/CIRCULATIONAHA.108.838169; Wickenbrock I, 2009, CLIN RES CARDIOL, V98, P765, DOI 10.1007/s00392-009-0058-5; Wong JA, 2009, EUR HEART J, V30, P549, DOI 10.1093/eurheartj/ehp014; Yan AT, 2007, ARCH INTERN MED, V167, P1009, DOI 10.1001/archinte.167.10.1009	37	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99925	10.1371/journal.pone.0099925	http://dx.doi.org/10.1371/journal.pone.0099925			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937680	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000338503400057
J	Beinder, L; Faehrmann, N; Wachtveitl, R; Winterfeld, I; Hartner, A; Menendez-Castro, C; Rauh, M; Ruebner, M; Huebner, H; Noegel, SC; Doerr, HG; Rascher, W; Fahlbusch, FB				Beinder, Lea; Faehrmann, Nina; Wachtveitl, Rainer; Winterfeld, Ilona; Hartner, Andrea; Menendez-Castro, Carlos; Rauh, Manfred; Ruebner, Matthias; Huebner, Hanna; Noegel, Stephanie C.; Doerr, Helmuth G.; Rascher, Wolfgang; Fahlbusch, Fabian B.			Detection of Expressional Changes Induced by Intrauterine Growth Restriction in the Developing Rat Mammary Gland via Exploratory Pathways Analysis	PLOS ONE			English	Article							SUPPRESSOR GENE WT1; BREAST-CANCER CELLS; FACTOR-I ACTION; BIRTH-WEIGHT; DIABETES-MELLITUS; FETAL NUTRITION; PROTEIN; RISK; AGE; MORPHOGENESIS	Background: Intrauterine growth restriction (IUGR) is thought to lead to fetal programming that in turn contributes to developmental changes of many organs postnatally. There is evidence that IUGR is a risk factor for the development of metabolic and cardiovascular disease later in life. A higher incidence of breast cancer was also observed after IUGR. This could be due to changes in mammary gland developmental pathways. We sought to characterise IUGR-induced alterations of the complex pathways of mammary development at the level of the transcriptome in a rat model of IUGR, using pathways analysis bioinformatics. Methodology/Principal Findings: We analysed the mammary glands of Wistar rats with IUGR induced by maternal low protein (LP) diet at the beginning (d21) and the end (d28) of pubertal ductal morphogenesis. Mammary glands of the LP group were smaller in size at d28, however did not show morphologic changes. We identified multiple differentially expressed genes in the mammary gland using Agilent SurePrint arrays at d21 and d28. In silico analysis was carried out using Ingenuity Pathways Analysis. In mammary gland tissue of LP rats at d21 of life a prominent upregulation of WT1 and CDKN1A (p21) expression was observed. Differentially regulated genes were associated with the extracellular regulated kinase (ERK)-1/-2 pathway. Western Blot analysis showed reduced levels of phosphorylated ERK-1/-2 in the mammary glands of the LP group at d21. To identify possible changes in circulating steroid levels, serum LC-Tandem mass-spectrometry was performed. LP rats showed higher serum progesterone levels and an increased corticosterone/dehydrocorticosterone-ratio at d28. Conclusions/Significance: Our data obtained from gene array analysis support the hypothesis that IUGR influences pubertal development of the rat mammary gland. We identified prominent differential regulation of genes and pathways for factors regulating cell cycle and growth. Moreover, we detected new pathways which appear to be programmed by IUGR.	[Beinder, Lea; Faehrmann, Nina; Wachtveitl, Rainer; Winterfeld, Ilona; Hartner, Andrea; Menendez-Castro, Carlos; Rauh, Manfred; Noegel, Stephanie C.; Doerr, Helmuth G.; Rascher, Wolfgang; Fahlbusch, Fabian B.] Univ Erlangen Nurnberg, Dept Pediat & Adolescent Med, D-91054 Erlangen, Germany; [Ruebner, Matthias; Huebner, Hanna] Univ Erlangen Nurnberg, Dept Gynecol & Obstet, D-91054 Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg	Fahlbusch, FB (corresponding author), Univ Erlangen Nurnberg, Dept Pediat & Adolescent Med, D-91054 Erlangen, Germany.	fabian.fahlbusch@uk-erlangen.de	Huebner, Hanna/U-1003-2019	Huebner, Hanna/0000-0001-6889-1493; Fahlbusch, Fabian/0000-0001-5480-0204	ELAN-Fonds of the University of Erlangen-Nurnberg, Germany [KI - 10.01.20.1]	ELAN-Fonds of the University of Erlangen-Nurnberg, Germany	This research project was supported by the ELAN-Fonds (KI - 10.01.20.1) of the University of Erlangen-Nurnberg, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts L, 2003, PLACENTA, V24, P905, DOI 10.1016/S0143-4004(03)00115-2; Alcazar MAA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026371; Aldridge GM, 2008, J NEUROSCI METH, V172, P250, DOI 10.1016/j.jneumeth.2008.05.003; Anthony FW, 2003, J SOC GYNECOL INVEST, V10, P509, DOI 10.1016/S1071-5576(03)00147-3; Barcellos-Hoff MH, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2224; Burwell EA, 2007, ONCOGENE, V26, P3423, DOI 10.1038/sj.onc.1210127; Caldon C, 2008, ONCOGENE, V27, P126, DOI 10.1038/sj.onc.1210622; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Carvajal A, 2005, BREAST CANCER RES TR, V94, P171, DOI 10.1007/s10549-005-7726-6; Cayrol C, 1998, ONCOGENE, V16, P311, DOI 10.1038/sj.onc.1201543; Cooper C, 1996, BRIT J OBSTET GYNAEC, V103, P814, DOI 10.1111/j.1471-0528.1996.tb09879.x; Daniel AR, 2007, STEROIDS, V72, P188, DOI 10.1016/j.steroids.2006.11.009; de Assis S, 2006, INT J CANCER, V119, P1537, DOI 10.1002/ijc.21936; Desai M, 1996, BRIT J NUTR, V76, P591, DOI 10.1079/BJN19960065; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Englert C, 1997, CANCER RES, V57, P1429; Fernandez-Twinn DS, 2007, CARCINOGENESIS, V28, P545, DOI 10.1093/carcin/bgl166; Fernandez-Twinn DS, 2010, CARCINOGENESIS, V31, P1873, DOI 10.1093/carcin/bgq095; Godfrey KM, 2000, AM J CLIN NUTR, V71, p1344S, DOI 10.1093/ajcn/71.5.1344s; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Han YQ, 2008, MOL CANCER RES, V6, P1347, DOI 10.1158/1541-7786.MCR-07-2179; Harms C, 2007, J NEUROSCI, V27, P4562, DOI 10.1523/JNEUROSCI.5110-06.2007; Hartner A, 2008, AM J NEPHROL, V28, P168, DOI 10.1159/000110022; Haugaard CT, 2001, SCAND J LAB ANIM SCI, V28, P10; Hinck L, 2005, BREAST CANCER RES, V7, P245, DOI 10.1186/bcr1331; Huff V, 2011, NAT REV CANCER, V11, P111, DOI 10.1038/nrc3002; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Innes K, 2000, AM J EPIDEMIOL, V152, P1121, DOI 10.1093/aje/152.12.1121; Kariagina A, 2007, ENDOCRINOLOGY, V148, P2723, DOI 10.1210/en.2006-1493; KENNEDY GC, 1963, J PHYSIOL-LONDON, V166, P408, DOI 10.1113/jphysiol.1963.sp007112; Lagoa CE, 2006, SHOCK, V26, P592, DOI 10.1097/01.shk.0000232272.03602.0a; Larsson SC, 2007, INT J CANCER, V121, P856, DOI 10.1002/ijc.22717; Leong NM, 2003, INT J CANCER, V103, P789, DOI 10.1002/ijc.10886; Leung YF, 2003, TRENDS GENET, V19, P649, DOI 10.1016/j.tig.2003.09.015; Li CJ, 2007, FUNCT INTEGR GENOMIC, V7, P193, DOI 10.1007/s10142-006-0043-2; Mazurek N, 2013, EXP TOXICOL PATHOL, V65, P949, DOI 10.1016/j.etp.2013.01.009; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; Mellemkjaer L, 2003, CANCER CAUSE CONTROL, V14, P61, DOI 10.1023/A:1022570305704; Menendez-Castro C, 2013, NEPHROL DIAL TRANSPL, V28, P1407, DOI 10.1093/ndt/gfs517; Minamino T, 2009, NAT MED, V15, P1082, DOI 10.1038/nm.2014; Nusken KD, 2011, ENDOCRINOLOGY, V152, P1327, DOI 10.1210/en.2010-1116; Owen GI, 1998, J BIOL CHEM, V273, P10696, DOI 10.1074/jbc.273.17.10696; Ozanne SE, 1999, P NUTR SOC, V58, P615, DOI 10.1017/S0029665199000804; Ozanne SE, 2001, BRIT MED BULL, V60, P143, DOI 10.1093/bmb/60.1.143; Ozanne Susan E, 2002, Expert Rev Mol Med, V4, P1, DOI 10.1017/S1462399402005240; Painter RC, 2006, AM J HUM BIOL, V18, P853, DOI 10.1002/ajhb.20564; Passos JF, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.5; Plank C, 2006, KIDNEY INT, V70, P1974, DOI 10.1038/sj.ki.5001966; Plank C, 2007, CLIN ENDOCRINOL, V67, P304, DOI 10.1111/j.1365-2265.2007.02884.x; Rauh M, 2006, STEROIDS, V71, P450, DOI 10.1016/j.steroids.2006.01.015; Rauh M, 2009, MOL CELL ENDOCRINOL, V301, P272, DOI 10.1016/j.mce.2008.10.007; Ruan WF, 2006, MOL ENDOCRINOL, V20, P426, DOI 10.1210/me.2005-0283; Ruan WF, 2005, ENDOCRINOLOGY, V146, P1170, DOI 10.1210/en.2004-1360; Russo IH, 1998, J MAMMARY GLAND BIOL, V3, P49, DOI 10.1023/A:1018770218022; Russo J, 1996, BREAST CANCER RES TR, V39, P7, DOI 10.1007/BF01806074; Sanderson M, 1996, EPIDEMIOLOGY, V7, P34, DOI 10.1097/00001648-199601000-00007; Santen RJ, 2002, J STEROID BIOCHEM, V80, P239, DOI 10.1016/S0960-0760(01)00189-3; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Silberstein GB, 2001, MICROSC RES TECHNIQ, V52, P155, DOI 10.1002/1097-0029(20010115)52:2<155::AID-JEMT1001>3.0.CO;2-P; Simmons RA, 2005, J BIOL CHEM, V280, P28785, DOI 10.1074/jbc.M505695200; SINHA YN, 1966, AM J PHYSIOL, V210, P601, DOI 10.1152/ajplegacy.1966.210.3.601; Sloboda DM, 2007, J CLIN ENDOCR METAB, V92, P46, DOI 10.1210/jc.2006-1378; Sloboda DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006744; Sternlicht MD, 2006, DIFFERENTIATION, V74, P365, DOI 10.1111/j.1432-0436.2006.00105.x; Stoll BA, 1998, BREAST CANCER RES TR, V49, P187, DOI 10.1023/A:1006003110909; TEMPEL DL, 1994, J NEUROENDOCRINOL, V6, P479, DOI 10.1111/j.1365-2826.1994.tb00611.x; van Weissenbruch MM, 2005, ENDOCRIN DEV, V8, P15, DOI 10.1159/000084084; Warfel NA, 2013, CURR OPIN ONCOL, V25, P52, DOI 10.1097/CCO.0b013e32835b639e; Weng L, 2006, BIOINFORMATICS, V22, P1111, DOI 10.1093/bioinformatics/btl045; Whyte J, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2361; Wognum S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005852; Wolf I, 2005, LANCET ONCOL, V6, P103, DOI 10.1016/S1470-2045(05)01736-5; Zheng SS, 2012, BRIT J NUTR, V108, P998, DOI 10.1017/S0007114511006222	73	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100504	10.1371/journal.pone.0100504	http://dx.doi.org/10.1371/journal.pone.0100504			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955840	Green Submitted, Green Published, gold			2022-12-27	WOS:000338917900057
J	MacCoon, DG; MacLean, KA; Davidson, RJ; Saron, CD; Lutz, A				MacCoon, Donal G.; MacLean, Katherine A.; Davidson, Richard J.; Saron, Clifford D.; Lutz, Antoine			No Sustained Attention Differences in a Longitudinal Randomized Trial Comparing Mindfulness Based Stress Reduction versus Active Control	PLOS ONE			English	Article							MEDITATION; MEDICINE; PROGRAM; BALANCE; ADULTS	Background: Mindfulness Based Stress Reduction (MBSR) is a secular form of meditation training. The vast majority of the extant literature investigating the health effects of mindfulness interventions relies on wait-list control comparisons. Previous studies have found that meditation training over several months is associated with improvements in cognitive control and attention. Methodology/Principal Findings: We used a visual continuous performance task (CPT) to test the effects of eight weeks of mindfulness training on sustained attention by comparing MBSR to the Health Enhancement Program (HEP), a structurally equivalent, active control condition in a randomized, longitudinal design (ClinicalTrials.gov, NCT01301105) focusing on a non-clinical population typical of MBSR participants. Researchers were blind to group assignment. 63 community participants were randomized to either MBSR (n = 31) or HEP (n = 32). CPT analyses were conducted on 29 MBSR participants and 25 HEP participants. We predicted that MBSR would improve visual discrimination ability and sustained attention over time on the CPT compared to HEP, with more home practice associated with greater improvements. Our hypotheses were not confirmed but we did find some evidence for improved visual discrimination similar to effects in partial replication of other research. Our study had sufficient power to demonstrate that intervention groups do not differ in their improvement over time in sustained attention performance. One of our primary predictions concerning the effects of intervention on attentional fatigue was significant but not interpretable. Conclusions: Attentional sensitivity is not affected by mindfulness practice as taught in MBSR, but it is unclear whether mindfulness might positively affect another aspect of attention, vigilance. These results also highlight the relevant procedural modifications required by future research to correctly investigate the role of sustained attention in similar samples.	[MacCoon, Donal G.; Davidson, Richard J.; Lutz, Antoine] Univ Wisconsin, Waisman Ctr Brain Imaging & Behav, Madison, WI 53706 USA; [MacCoon, Donal G.; Davidson, Richard J.; Lutz, Antoine] Univ Wisconsin, Waisman Ctr, Ctr Invest Hlth Minds, Madison, WI 53705 USA; [Davidson, Richard J.] Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA; [MacLean, Katherine A.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [MacLean, Katherine A.; Saron, Clifford D.] Univ Calif Davis, Ctr Mind & Brain, Davis, CA 95616 USA; [Saron, Clifford D.] Univ Calif Davis, Med Invest Neurodev Disorders Inst, Davis, CA 95616 USA; [Lutz, Antoine] Lyon Neurosci Res Ctr, INSERM, U1028, Brain Dynam & Cognit Team,CNRS,UMR5292, Lyon, France; [Lutz, Antoine] Univ Lyon 1, F-69365 Lyon, France	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Johns Hopkins University; University of California System; University of California Davis; University of California System; University of California Davis; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	MacCoon, DG (corresponding author), Univ Wisconsin, Waisman Ctr Brain Imaging & Behav, Madison, WI 53706 USA.	dgmaccoon@wisc.edu	LUTZ, Antoine/AAE-5114-2020	LUTZ, Antoine/0000-0002-0258-3233; Davidson, Richard/0000-0002-8506-4964	National Center for Complementary and Alternative Medicine [U01AT002114-01A1]; National Institute of Mental Health [P50-MH069315-03]; Fetzer Institute; International Re-integration Grants (IRG); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [U01AT002114] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [P01AT004952] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH069315] Funding Source: NIH RePORTER	National Center for Complementary and Alternative Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Fetzer Institute; International Re-integration Grants (IRG); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported primarily by a grant from the National Center for Complementary and Alternative Medicine (U01AT002114-01A1 to Antoine Lutz), in addition to grants from the National Institute of Mental Health (P50-MH069315-03 to Richard Davidson), the Fetzer Institute, International Re-integration Grants (IRG), FP7-PEOPLE-2009-RG (to Antoine Lutz), and gifts from Bryant Wangard, Ralph Robinson, Keith and Arlene Bronstein, John W. Kluge Foundation and the Impact Foundation (to Richard Davidson). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ND, 2007, CLIN PSYCHOL PSYCHOT, V14, P449, DOI 10.1002/cpp.544; BROWN D, 1984, PERCEPT MOTOR SKILL, V58, P775, DOI 10.2466/pms.1984.58.3.775; Chiesa A, 2011, CLIN PSYCHOL REV, V31, P449, DOI 10.1016/j.cpr.2010.11.003; Derogatis LR., 1983, SCL 90 R ADM SCORING; Farb NAS, 2013, SOC COGN AFFECT NEUR, V8, P15, DOI 10.1093/scan/nss066; Hargus E, 2010, EMOTION, V10, P34, DOI 10.1037/a0016825; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; HU MH, 1994, J GERONTOL, V49, pM62, DOI 10.1093/geronj/49.2.M62; Jensen CG, 2012, J EXP PSYCHOL GEN, V141, P106, DOI 10.1037/a0024931; Jha AP, 2007, COGN AFFECT BEHAV NE, V7, P109, DOI 10.3758/CABN.7.2.109; Kabat-Zinn J, 1984, REVISION, V7, P71; Kabat-Zinn J., 1990, FULL CATASTROPHE LIV; Kabat-Zinn J., 1994, WHEREVER YOU GO THER; KABATZINN J, 1982, GEN HOSP PSYCHIAT, V4, P33, DOI 10.1016/0163-8343(82)90026-3; Lutz A, 2008, TRENDS COGN SCI, V12, P163, DOI 10.1016/j.tics.2008.01.005; Lutz A, 2009, J NEUROSCI, V29, P13418, DOI 10.1523/JNEUROSCI.1614-09.2009; MacCoon DG, 2012, BEHAV RES THER, V50, P3, DOI 10.1016/j.brat.2011.10.011; MacLean KA, 2010, PSYCHOL SCI, V21, P829, DOI 10.1177/0956797610371339; McGuine TA, 2006, AM J SPORT MED, V34, P1103, DOI 10.1177/0363546505284191; Moore A, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00018; Semple Randye J., 2010, MINDFULNESS, V1, P121, DOI DOI 10.1007/S12671-010-0017-2; Shapiro SL, 2006, J CLIN PSYCHOL, V62, P373, DOI 10.1002/jclp.20237; Slagter HA, 2007, PLOS BIOL, V5, P1228, DOI 10.1371/journal.pbio.0050138; Stanislaw H, 1999, BEHAV RES METH INS C, V31, P137, DOI 10.3758/BF03207704; TAYLOR MM, 1967, J ACOUST SOC AM, V41, P782, DOI 10.1121/1.1910407; Thompson C., 1989, INSTRUMENTS PSYCHIAT, P127; Travis J.W, 1977, WELLNESS WORKBOOK GU; Williams JMG, 2011, CONTEMP BUDDHISM, V12, P1, DOI 10.1080/14639947.2011.564811; Williams JMG, 2000, J ABNORM PSYCHOL, V109, P150, DOI 10.1037/0021-843X.109.1.150	29	60	60	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e97551	10.1371/journal.pone.0097551	http://dx.doi.org/10.1371/journal.pone.0097551			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL1WV	24955584	gold, Green Published			2022-12-27	WOS:000338917900001
J	Shutler, D; Head, K; Burgher-MacLellan, KL; Colwell, MJ; Levitt, AL; Ostiguy, N; Williams, GR				Shutler, Dave; Head, Krista; Burgher-MacLellan, Karen L.; Colwell, Megan J.; Levitt, Abby L.; Ostiguy, Nancy; Williams, Geoffrey R.			Honey Bee Apis mellifera Parasites in the Absence of Nosema ceranae Fungi and Varroa destructor Mites	PLOS ONE			English	Article							DEFORMED-WING VIRUS; MICROSPORIDIAN PARASITE; PATHOGENS; DISEASES; INFECTION; SPREAD; HOST	Few areas of the world have western honey bee (Apis mellifera) colonies that are free of invasive parasites Nosema ceranae (fungi) and Varroa destructor (mites). Particularly detrimental is V. destructor; in addition to feeding on host haemolymph, these mites are important vectors of several viruses that are further implicated as contributors to honey bee mortality around the world. Thus, the biogeography and attendant consequences of viral communities in the absence of V. destructor are of significant interest. The island of Newfoundland, Province of Newfoundland and Labrador, Canada, is free of V. destructor; the absence of N. ceranae has not been confirmed. Of 55 Newfoundland colonies inspected visually for their strength and six signs of disease, only K-wing had prevalence above 5% (40/55 colonies = 72.7%). Similar to an earlier study, screenings again confirmed the absence of V. destructor, small hive beetles Aethina tumida (Murray), tracheal mites Acarapis woodi (Rennie), and Tropilaelaps spp. ectoparasitic mites. Of a subset of 23 colonies screened molecularly for viruses, none had Israeli acute paralysis virus, Kashmir bee virus, or sacbrood virus. Sixteen of 23 colonies (70.0%) were positive for black queen cell virus, and 21 (91.3%) had some evidence for deformed wing virus. No N. ceranae was detected in molecular screens of 55 colonies, although it is possible extremely low intensity infections exist; the more familiar N. apis was found in 53 colonies (96.4%). Under these conditions, K-wing was associated (positively) with colony strength; however, viruses and N. apis were not. Furthermore, black queen cell virus was positively and negatively associated with K-wing and deformed wing virus, respectively. Newfoundland honey bee colonies are thus free of several invasive parasites that plague operations in other parts of the world, and they provide a unique research arena to study independent pathology of the parasites that are present.	[Shutler, Dave; Colwell, Megan J.; Williams, Geoffrey R.] Acadia Univ, Dept Biol, Wolfville, NS B0P 1X0, Canada; [Head, Krista] Govt Newfoundland & Labrador, Dept Nat Resources, Agri Foods Branch, Forestry & Agri Foods Agcy, Corner Brook, NF, Canada; [Burgher-MacLellan, Karen L.] Agr & Agri Food Canada, Atlantic Food & Hort Res Ctr, Kentville, NS, Canada; [Levitt, Abby L.; Ostiguy, Nancy] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; [Williams, Geoffrey R.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada; [Williams, Geoffrey R.] Univ Bern, Inst Bee Hlth, Vetsuisse Fac, Bern, Switzerland; [Williams, Geoffrey R.] Swiss Bee Res Ctr, Agroscope, Bern, Switzerland	Acadia University; Natural Resources Canada; Agriculture & Agri Food Canada; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Dalhousie University; University of Bern; Swiss Federal Research Station Agroscope	Williams, GR (corresponding author), Acadia Univ, Dept Biol, Wolfville, NS B0P 1X0, Canada.	geoffrey.r.williams@gmail.com	Williams, Geoffrey/C-9637-2015	Williams, Geoffrey/0000-0002-0093-1126; Colwell, Megan/0000-0001-8956-5179	Agriculture and Agrifoods Research and Development Program, Forestry and Agrifoods Agency, Production and Market Development Division, Province of Newfoundland and Labrador; Natural Sciences and Engineering Research Council of Canada; USDA NIFA AFRI [2009-85118-05718]	Agriculture and Agrifoods Research and Development Program, Forestry and Agrifoods Agency, Production and Market Development Division, Province of Newfoundland and Labrador; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); USDA NIFA AFRI(United States Department of Agriculture (USDA))	The research was supported by the Agriculture and Agrifoods Research and Development Program, Forestry and Agrifoods Agency, Production and Market Development Division, Province of Newfoundland and Labrador, an Industrial Postgraduate Scholarship from the Natural Sciences and Engineering Research Council of Canada to G. R. W. and by a USDA NIFA AFRI grant "Managed Pollinator Coordinated Agricultural Project'' 2009-85118-05718. Partial funding was provided by the affiliation of KH. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript. KH collected data.	American Bee Journal, 1987, American Bee Journal, V127, P745; ANDERSON RM, 1979, NATURE, V280, P361, DOI 10.1038/280361a0; BAILEY L, 1983, ANN APPL BIOL, V103, P13, DOI 10.1111/j.1744-7348.1983.tb02735.x; BAILEY L, 1981, ANN APPL BIOL, V97, P109, DOI 10.1111/j.1744-7348.1981.tb02999.x; Botias C, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-25; Britton JR, 2013, TRENDS ECOL EVOL, V28, P93, DOI 10.1016/j.tree.2012.08.020; Bromenshenk JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013181; Calderone NW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037235; CANTWELL G E, 1970, American Bee Journal, V110, P222; Chen Y, 2008, J INVERTEBR PATHOL, V97, P186, DOI 10.1016/j.jip.2007.07.010; Costa C, 2011, J INVERTEBR PATHOL, V108, P224, DOI 10.1016/j.jip.2011.08.012; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Crawley MJ, 2005, STATISTICS AN INTROD; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Delaplane KS, 2013, J APICULT RES, V52, DOI [10.3896/IBRA.1.52.1.03, 10.3896/IBRA.1.52.4.12]; Elton C S., 1958, THE ECOLOGY OF INVAS; Fayer R, 2000, J PARASITOL, V86, P1174, DOI 10.2307/3284998; Flottum K., 1997, HONEY BEE PESTS PRED, P11; Forsgren E, 2012, J APICULT RES, V51, P136, DOI 10.3896/IBRA.1.51.1.17; Forsgren E, 2010, J INVERTEBR PATHOL, V103, pS5, DOI 10.1016/j.jip.2009.06.016; Garibaldi LA, 2013, SCIENCE, V339, P1608, DOI 10.1126/science.1230200; Genersch E, 2010, APIDOLOGIE, V41, P332, DOI 10.1051/apido/2010014; Genersch E, 2010, J INVERTEBR PATHOL, V103, pS10, DOI 10.1016/j.jip.2009.06.015; Goblirsch M, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058165, 10.1371/journal.pone.0069831]; Guzman-Novoa E, 2010, APIDOLOGIE, V41, P443, DOI 10.1051/apido/2009076; Hedtke K, 2011, J INVERTEBR PATHOL, V108, P167, DOI 10.1016/j.jip.2011.08.006; Higes M, 2006, J INVERTEBR PATHOL, V92, P93, DOI 10.1016/j.jip.2006.02.005; Higes M, 2013, ENV MICROBIOL REP, V5, P17, DOI 10.1111/1758-2229.12024; Innes EA, 1999, PARASITOL TODAY, V15, P427, DOI 10.1016/S0169-4758(99)01529-X; JACKSON DA, 1993, ECOLOGY, V74, P2204, DOI 10.2307/1939574; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kevan PG, 2006, AM BEE J, V146, P694; Klee J, 2007, J INVERTEBR PATHOL, V96, P1, DOI 10.1016/j.jip.2007.02.014; Martin SJ, 2013, ENVIRON MICROBIOL RE; Martin SJ, 2012, SCIENCE, V336, P1304, DOI 10.1126/science.1220941; Martin-Hernandez R, 2007, APPL ENVIRON MICROB, V73, P6331, DOI 10.1128/AEM.00270-07; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Mutinelli F, 2011, REV SCI TECH OIE, V30, P257; Palacios G, 2008, J VIROL, V82, P6209, DOI 10.1128/JVI.00251-08; Ravoet J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072443; Rozen S, 2000, Methods Mol Biol, V132, P365; Sammataro D, 2000, ANNU REV ENTOMOL, V45, P519, DOI 10.1146/annurev.ento.45.1.519; Shen MQ, 2005, VIROLOGY, V342, P141, DOI 10.1016/j.virol.2005.07.012; Shen MQ, 2005, J GEN VIROL, V86, P2281, DOI 10.1099/vir.0.80824-0; Shimanuki H, 2000, AGRICULTURE HANDBOOK; Singh R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014357; Sumpter DJT, 2004, J ANIM ECOL, V73, P51, DOI 10.1111/j.1365-2656.2004.00776.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; Vanengelsdorp D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004071; Whitney H, 2005, IMPORT REGULATIONS F; Williams GR, 2008, J INVERTEBR PATHOL, V97, P189, DOI 10.1016/j.jip.2007.08.005; Williams GR, 2011, APIDOLOGIE, V42, P15, DOI 10.1051/apido/2010030; Williams GR, 2010, CAN ENTOMOL, V142, P584, DOI 10.4039/n10-029; Williams GR, 2010, BIOESSAYS, V32, P845, DOI 10.1002/bies.201000075; Williams GR, 2009, J INVERTEBR PATHOL, V101, P77, DOI 10.1016/j.jip.2009.01.004; Yang XL, 2005, P NATL ACAD SCI USA, V102, P7470, DOI 10.1073/pnas.0501860102; Yue C, 2005, J GEN VIROL, V86, P3419, DOI 10.1099/vir.0.81401-0	58	18	23	1	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e98599	10.1371/journal.pone.0098599	http://dx.doi.org/10.1371/journal.pone.0098599			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955834	Green Published, gold			2022-12-27	WOS:000338917900003
J	Lenhard, F; Vigerland, S; Andersson, E; Ruck, C; Mataix-Cols, D; Thulin, U; Ljotsson, B; Serlachius, E				Lenhard, Fabian; Vigerland, Sarah; Andersson, Erik; Rueck, Christian; Mataix-Cols, David; Thulin, Ulrika; Ljotsson, Brjann; Serlachius, Eva			Internet-Delivered Cognitive Behavior Therapy for Adolescents with Obsessive-Compulsive Disorder: An Open Trial	PLOS ONE			English	Article							SELF-HELP; FUNCTIONAL IMPAIRMENT; CHILDHOOD OCD; FOLLOW-UP; CHILDREN; ANXIETY; PSYCHOTHERAPY; DEPRESSION; CLINICIAN; EFFICACY	Background: International guidelines recommend Cognitive Behavior Therapy (CBT) as the first line treatment for pediatric obsessive-compulsive disorder (OCD). However, a substantial proportion of patients do not have access to such treatment. We developed and tested the feasibility, efficacy and acceptability of a novel therapist-guided, Internet-delivered CBT (ICBT) platform for adolescents with OCD. Methods: An interactive, age-appropriate ICBT platform ("BiP OCD") was developed. Twenty-one adolescents (12-17 years) with a DSM-IV diagnosis of OCD and their parents were enrolled in the study. All participants received 12 weeks of ICBT with therapist support. The primary outcome measure was the Children's Yale-Brown Obsessive-Compulsive Scale (CY-BOCS). Acceptability was assessed at post-treatment. Results: Participants completed on average 8.29 (SD = 3.0) of the 12 treatment chapters. Treatment yielded significant improvements on all clinician-, parent-and most self-administered outcome measures, with a large effect size of d = 2.29 (95% CI 1.5-3.07) on the CY-BOCS. Patients continued to improve at follow-up. At 6-month follow-up, 71% were classified as responders (>= 35% decrease on the CY-BOCS) and 76% as being in remission (CY-BOCS score <= 12). Average clinician support time was less than 20 minutes per patient per week. The majority of participants felt that BiP OCD was age-appropriate and rated the treatment as good or very good. Conclusions: ICBT could be efficacious, acceptable, and cost-effective for adolescents with OCD. More rigorously controlled studies are needed to further evaluate the treatment.	[Lenhard, Fabian; Vigerland, Sarah; Andersson, Erik; Rueck, Christian; Mataix-Cols, David; Thulin, Ulrika; Ljotsson, Brjann; Serlachius, Eva] Karolinska Inst, Dept Clin Neurosci, Ctr Psychiat Res & Educ, Stockholm, Sweden	Karolinska Institutet	Lenhard, F (corresponding author), Karolinska Inst, Dept Clin Neurosci, Ctr Psychiat Res & Educ, Stockholm, Sweden.	fabian.lenhard@ki.se	Mataix-Cols, David/AAF-3347-2021; Mataix-Cols, David/G-3843-2010; Serlachius, Eva/E-8956-2013	Mataix-Cols, David/0000-0002-4545-0924; Mataix-Cols, David/0000-0002-4545-0924; Serlachius, Eva/0000-0001-7115-6422; Lenhard, Fabian/0000-0003-0930-6412; Ljotsson, Brjann/0000-0001-8086-1668; Ruck, Christian/0000-0002-8742-0168; Andersson, Erik/0000-0003-0088-8719	Stockholm County Council; Karolinska Institutet [PPG 20120167]	Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet)	Financial support was provided by Stockholm County Council and through the regional agreement on medical training and clinical research between Stockholm County Council and Karolinska Institutet (PPG 20120167). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitz JS, 2005, BEHAV THER, V36, P55, DOI 10.1016/S0005-7894(05)80054-1; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; American Psychiatric Association, 2007, PRACT GUID TREATM PA; Andersson E, 2012, PSYCHOL MED, V42, P2193, DOI 10.1017/S0033291712000244; Andersson E, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-125; Andersson G, 2005, BRIT J PSYCHIAT, V187, P456, DOI 10.1192/bjp.187.5.456; Barrett P, 2004, J AM ACAD CHILD PSY, V43, P46, DOI 10.1097/00004583-200401000-00014; Bergstrom J, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-54; Bolton D, 2008, J BEHAV THER EXP PSY, V39, P11, DOI 10.1016/j.jbtep.2006.11.002; Comer JS, 2013, J CLIN CHILD ADOLESC, P1; Donker T, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2791; Farris SG, 2013, J CLIN PSYCHIAT, V74, P685, DOI 10.4088/JCP.12m07789; Findahl O., 2012, SWEDES INTERNET 2012; FLAMENT MF, 1988, J AM ACAD CHILD PSY, V27, P764, DOI 10.1097/00004583-198811000-00018; Flessner CA, 2011, J PSYCHOPATHOL BEHAV, V33, P38, DOI 10.1007/s10862-010-9196-3; Fullana MA, 2009, AM J PSYCHIAT, V166, P329, DOI 10.1176/appi.ajp.2008.08071006; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Goodwin R, 2002, ACTA PSYCHIAT SCAND, V106, P143, DOI 10.1034/j.1600-0447.2002.01221.x; Guy W., 1976, CDEU ASSESSMENT MANU; Hedman E, 2012, EXPERT REV PHARM OUT, V12, P745, DOI [10.1586/erp.12.67, 10.1586/ERP.12.67]; Hedman E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018001; Hedman E, 2010, COMPUT HUM BEHAV, V26, P736, DOI 10.1016/j.chb.2010.01.010; Ivarsson T, 2010, CHILD YOUTH CARE FOR, V39, P91, DOI 10.1007/s10566-010-9097-3; Kenwright M, 2005, J CLIN PSYCHOL, V61, P1499, DOI 10.1002/jclp.20204; Kohn R, 2004, B WORLD HEALTH ORGAN, V82, P858; KOVACS M, 1985, PSYCHOPHARMACOL BULL, V21, P995; Lewin AB, 2012, J CONSULT CLIN PSYCH, V80, P1103, DOI 10.1037/a0029991; March JS, 2004, JAMA-J AM MED ASSOC, V292, P1969; MARCH JS, 1994, J AM ACAD CHILD PSY, V33, P333, DOI 10.1097/00004583-199403000-00006; March S, 2009, J PEDIATR PSYCHOL, V34, P474, DOI 10.1093/jpepsy/jsn099; Mataix-Cols D, 2006, EUR PSYCHIAT, V21, P75, DOI 10.1016/j.eurpsy.2005.07.003; Mataix-Cols D, 2006, CLIN NEUROPSYCHIATR, V3, P404; Micali N, 2011, PSYCHOL MED, V41, P2507, DOI 10.1017/S003329171100078X; Micali N, 2010, BRIT J PSYCHIAT, V197, P128, DOI 10.1192/bjp.bp.109.075317; Moritz S, 2011, CURR OPIN PSYCHIATR, V24, P541, DOI 10.1097/YCO.0b013e32834abb7f; National Institute of Clinical Excellence (NICE), 2006, OBS COMP DIS COR INT; National Institute of Mental Health, 1985, PSYCHOPHARMACOL BULL, V21, P839; Piacentini J, 2003, J CHILD ADOL PSYCHOP, V13, pS61, DOI 10.1089/104454603322126359; Piacentini J, 2007, J CLIN CHILD ADOLESC, V36, P645, DOI 10.1080/15374410701662790; Piacentini J, 2011, J AM ACAD CHILD PSY, V50, P1149, DOI 10.1016/j.jaac.2011.08.003; Reynolds S, 2012, CLIN PSYCHOL REV, V32, P251, DOI 10.1016/j.cpr.2012.01.005; Richardson T, 2010, CLIN CHILD FAM PSYCH, V13, P275, DOI 10.1007/s10567-010-0069-9; Rubin DB, 2004, MULTIPLE IMPUTATION; Salloum A, 2010, PROF PSYCHOL-RES PR, V41, P41, DOI 10.1037/a0018330; Scahill L, 1997, J AM ACAD CHILD PSY, V36, P844, DOI 10.1097/00004583-199706000-00023; Schwartz C, 2013, J OBSESSIVE COMPULS; SHAFFER D, 1983, ARCH GEN PSYCHIAT, V40, P1228; Shafran R, 2003, J ADOLESCENCE, V26, P137, DOI 10.1016/S0140-1971(02)00083-0; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Simpson HB, 2011, J CONSULT CLIN PSYCH, V79, P247, DOI 10.1037/a0022659; Skoog G, 1999, ARCH GEN PSYCHIAT, V56, P121, DOI 10.1001/archpsyc.56.2.121; Spence SH, 1998, BEHAV RES THER, V36, P545, DOI 10.1016/S0005-7967(98)00034-5; Spence SH, 2011, J CONSULT CLIN PSYCH, V79, P629, DOI 10.1037/a0024512; Storch EA, 2011, PSYCHIAT RES, V189, P407, DOI 10.1016/j.psychres.2011.05.047; Valderhaug R, 2004, NORD J PSYCHIAT, V58, P125, DOI 10.1080/08039480410005503; VALLENIBASILE LA, 1994, J AM ACAD CHILD PSY, V33, P782, DOI 10.1097/00004583-199407000-00002; Vigerland S, 2013, COGN BEHAV THERAPY, V42, P303, DOI 10.1080/16506073.2013.844201; Visser HA, 2013, J AFFECT DISORD; Watson HJ, 2008, J CHILD PSYCHOL PSYC, V49, P489, DOI 10.1111/j.1469-7610.2007.01875.x; Wewetzer C, 2001, EUR CHILD ADOLES PSY, V10, P37, DOI 10.1007/s007870170045; Williams TI, 2010, EUR CHILD ADOLES PSY, V19, P449, DOI 10.1007/s00787-009-0077-9; Wootton BM, 2013, J OBSESS-COMPULS REL, V2, P375, DOI 10.1016/j.jocrd.2013.07.002; Wootton BM, 2011, J ANXIETY DISORD, V25, P1102, DOI 10.1016/j.janxdis.2011.07.009	64	61	63	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100773	10.1371/journal.pone.0100773	http://dx.doi.org/10.1371/journal.pone.0100773			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK2UZ	24949622	Green Published, gold, Green Submitted			2022-12-27	WOS:000338276300112
J	Rahman, MM				Rahman, Mohammed M.			Reusable and Mediator-Free Cholesterol Biosensor Based on Cholesterol Oxidase Immobilized onto TGA-SAM Modified Smart Bio-Chips	PLOS ONE			English	Article							CARBON-FIBER MICROELECTRODES; CHARGE-TRANSFER TECHNIQUE; ELECTROCHEMICAL DETECTION; HYDROGEN-PEROXIDE; COMPOSITE FILM; POLYMER-FILM; SENSOR; NANOPARTICLES; STABILIZATION; ACETYLCHOLINE	A reusable and mediator-free cholesterol biosensor based on cholesterol oxidase (ChOx) was fabricated based on self-assembled monolayer (SAM) of thioglycolic acid (TGA) (covalent enzyme immobilization by dropping method) using bio-chips. Cholesterol was detected with modified bio-chip (Gold/Thioglycolic-acid/Cholesterol-oxidase i.e., Au/TGA/ChOx) by reliable cyclic voltammetric (CV) technique at room conditions. The Au/TGA/ChOx modified bio-chip sensor demonstrates good linearity (1.0 nM to 1.0 mM; R = 0.9935), low-detection limit (similar to 0.42 nM, SNR similar to 3), and higher sensitivity (similar to 74.3 mu A mu M-1 cm(-2)), lowest-small sample volume (50.0 mu L), good stability, and reproducibility. To the best of our knowledge, this is the first statement with a very high sensitivity, low-detection limit, and low-sample volumes are required for cholesterol biosensor using Au/TGA/ChOx-chips assembly. The result of this facile approach was investigated for the biomedical applications for real samples at room conditions with significant assembly (Au/TGA/ChOx) towards the development of selected cholesterol biosensors, which can offer analytical access to a large group of enzymes for wide range of biomedical applications in health-care fields.	[Rahman, Mohammed M.] King Abdulaziz Univ, Fac Sci, Dept Chem, Jeddah, Saudi Arabia; [Rahman, Mohammed M.] King Abdulaziz Univ, Fac Sci, CEAMR, Jeddah, Saudi Arabia	King Abdulaziz University; King Abdulaziz University	Rahman, MM (corresponding author), King Abdulaziz Univ, Fac Sci, Dept Chem, Jeddah, Saudi Arabia.	mmrahman@kau.edu.sa	Rahman, Mohammed M./H-5823-2012	Rahman, Mohammed M./0000-0003-2773-1244				Ansari AA, 2008, ELECTROCHEM COMMUN, V10, P1246, DOI 10.1016/j.elecom.2008.06.003; Arya SK, 2007, BIOSENS BIOELECTRON, V22, P2516, DOI 10.1016/j.bios.2006.10.011; Betancor L, 2008, TRENDS BIOTECHNOL, V26, P566, DOI 10.1016/j.tibtech.2008.06.009; Brady D, 2009, BIOTECHNOL LETT, V31, P1639, DOI 10.1007/s10529-009-0076-4; Brahim S, 2001, ANAL CHIM ACTA, V448, P27, DOI 10.1016/S0003-2670(01)01321-6; CARAS S, 1980, ANAL CHEM, V52, P1935, DOI 10.1021/ac50062a035; Chauhan N, 2012, AM J ANAL CHEM, V2, P41; Dhand C, 2007, ANAL CHIM ACTA, V602, P244, DOI 10.1016/j.aca.2007.09.028; Fernandez-Lafuente R, 2009, ENZYME MICROB TECH, V45, P405, DOI 10.1016/j.enzmictec.2009.08.009; Garcia-Galan C, 2011, ADV SYNTH CATAL, V353, P2885, DOI 10.1002/adsc.201100534; HAFEMAN DG, 1988, SCIENCE, V240, P1182, DOI 10.1126/science.3375810; HAUBRICH DR, 1981, BIOCHEM PHARMACOL, V30, P2993, DOI 10.1016/0006-2952(81)90265-3; Hernandez K, 2012, CURR ORG CHEM, V16, P2652, DOI 10.2174/138527212804004526; Hernandez K, 2011, ENZYME MICROB TECH, V48, P107, DOI 10.1016/j.enzmictec.2010.10.003; Holtz JH, 1997, NATURE, V389, P829, DOI 10.1038/39834; Hwang ET, 2013, ENG LIFE SCI, V13, P49, DOI 10.1002/elsc.201100225; Iyer PV, 2008, PROCESS BIOCHEM, V43, P1019, DOI 10.1016/j.procbio.2008.06.004; Izaki Y, 1998, NEUROSCI LETT, V258, P33, DOI 10.1016/S0304-3940(98)00841-6; Khan R, 2008, ANAL CHIM ACTA, V616, P207, DOI 10.1016/j.aca.2008.04.010; Kim Gwangseong, 2013, Methods Mol Biol, V1028, P101, DOI 10.1007/978-1-62703-475-3_6; Kon Y, 2012, J JPN PETROL INST, V55, P277, DOI 10.1627/jpi.55.277; KULLICK T, 1995, ANAL CHIM ACTA, V300, P25, DOI 10.1016/0003-2670(94)00376-W; Kumar A, 2000, ANAL CHIM ACTA, V414, P43, DOI 10.1016/S0003-2670(00)00792-3; Lee SR, 2008, BIOSENS BIOELECTRON, V24, P410, DOI 10.1016/j.bios.2008.04.017; Lee SR, 2009, BIOSENS BIOELECTRON, V24, P1877, DOI 10.1016/j.bios.2008.09.008; Lee SR, 2009, TRAC-TREND ANAL CHEM, V28, P196, DOI 10.1016/j.trac.2008.11.009; Levy RI, 1972, METABOLIC BASIS INHE, V3, P545; Marharu Z, 2012, ANALYST, V137, P747; Martin KF, 1947, LIFE SCI, V41, P865; Mateo C, 2007, ENZYME MICROB TECH, V40, P1451, DOI 10.1016/j.enzmictec.2007.01.018; McNally M, 2001, ANAL CHEM, V73, P4793, DOI 10.1021/ac0104532; Nauck M, 2000, CLIN CHEM, V46, P436; Nauck M, 1997, CLIN CHEM, V43, P1622; Netchiporouk LI, 1996, ANAL CHEM, V68, P4358, DOI 10.1021/ac960190p; Nyamsi Hendji A. M., 1993, Analytica Chimica Acta, V281, P3; Pearson A, 2003, P NATL ACAD SCI USA, V100, P15352, DOI 10.1073/pnas.2536559100; Pijanowska DG, 1997, SENSOR ACTUAT B-CHEM, V44, P370, DOI 10.1016/S0925-4005(97)00194-9; Poghossian AS, 1997, SENSOR ACTUAT B-CHEM, V44, P361, DOI 10.1016/S0925-4005(97)00202-5; POTTER PE, 1983, J NEUROCHEM, V41, P188, DOI 10.1111/j.1471-4159.1983.tb13668.x; QIAOCUI S, 2005, ELECTROANAL, V17, P857, DOI DOI 10.1002/ELAN.200403162; Rahman MM, 2009, ADV SCI LETT, V2, P28, DOI 10.1166/asl.2009.1013; Rakow NA, 2000, NATURE, V406, P710, DOI 10.1038/35021028; Rodrigues RC, 2013, CHEM SOC REV, V42, P6290, DOI 10.1039/c2cs35231a; Rodrigues RC, 2011, ADV SYNTH CATAL, V353, P2216, DOI 10.1002/adsc.201100163; ROISIN MP, 1991, J NEUROSCI METH, V37, P183, DOI 10.1016/0165-0270(91)90129-N; Sawada K, 2004, SENSOR ACTUAT B-CHEM, V98, P69, DOI 10.1016/j.snb.2003.09.027; Singh S, 2006, SENSOR ACTUAT B-CHEM, V115, P534, DOI 10.1016/j.snb.2005.10.025; Singh S, 2004, ANAL CHIM ACTA, V502, P229, DOI 10.1016/j.aca.2003.09.064; Singh SP, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2768302; Soldatkin AP, 1997, MAT SCI ENG C-BIOMIM, V5, P35, DOI 10.1016/S0928-4931(97)00020-9; STANTON TB, 1987, INFECT IMMUN, V55, P309, DOI 10.1128/IAI.55.2.309-313.1987; Stepankova V, 2013, ACS CATAL, V3, P2823, DOI 10.1021/cs400684x; Tan XC, 2005, ANAL BIOCHEM, V337, P111, DOI 10.1016/j.ab.2004.10.040; Tian CY, 1998, SENSOR ACTUAT B-CHEM, V52, P119, DOI 10.1016/S0925-4005(98)00265-2; Umar A, 2008, CHEM COMMUN, P166, DOI 10.1039/b711215g; Umar A, 2009, ELECTROCHEM COMMUN, V11, P118, DOI 10.1016/j.elecom.2008.10.046; Umar A, 2009, TALANTA, V78, P284, DOI 10.1016/j.talanta.2008.11.018; VANDERSCHOOT BH, 1987, BIOSENSORS, V3, P161; Venton BJ, 2002, ANAL CHEM, V74, P539, DOI 10.1021/ac010819a; Yang MH, 2006, ANAL CHIM ACTA, V571, P211, DOI 10.1016/j.aca.2006.04.061; Yao T, 2003, ANAL SCI, V19, P767, DOI 10.2116/analsci.19.767; Zhang S, 2001, ANAL CHIM ACTA, V427, P45, DOI 10.1016/S0003-2670(00)01124-7; Zhou N, 2006, ANAL CHEM, V78, P5227, DOI 10.1021/ac0605492; ZURN A, 1994, FRESEN J ANAL CHEM, V349, P666, DOI 10.1007/BF00323477	64	20	21	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100327	10.1371/journal.pone.0100327	http://dx.doi.org/10.1371/journal.pone.0100327			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949733	Green Submitted, Green Published, gold			2022-12-27	WOS:000338276300065
J	Si, Y; Wang, ZY; Yu, T; Lin, GZ; Zhang, J; Zhang, K; Zhang, H; Li, YC				Si, Yu; Wang, Zhenyu; Yu, Tao; Lin, Guo Zhong; Zhang, Jia; Zhang, Kuo; Zhang, Hua; Li, Yuan Chao			Results of Cervical Recapping Laminoplasty: Gross Anatomical Changes, Biomechanical Evaluation at Different Time Points and Degrees of Level Involvement	PLOS ONE			English	Article							OPEN-DOOR LAMINOPLASTY; SPINAL-CORD TUMORS; BILATERAL LAMINOTOMY; LUMBAR SPINE; IN-VITRO; LAMINECTOMY; MYELOPATHY; DEFORMITY; MODEL; FLEXIBILITY	Background: Recapping laminoplasty has become the frequently-used approach to the spinal canal when bone decompression of the vertebral canal is not the goal. However, what changes will occur after surgery, and whether recapping laminoplasty can actually reduce the risk of delayed deformities remains unknown. Methodology: We designed an animal experiment using a caprine model, and partitioned the animals into in vitro and in vivo surgical groups. We performed recapping laminoplasty on one group and laminectomy on another group. These animals were sacrificed six months after operating, cervical spines removed, biomechanically tested, and these data were compared to determine whether the recapping laminoplasty technique leads to subsequent differences in range of motion. Image data were also obtained before the surgery and when the animals were killed. Besides, we investigated the initial differences in kinetics between recapping laminoplasty and laminectomy. We did this by comparing data obtained from biomechanical testing of in vitro-performed recapping laminoplasty and laminectomy. Finally, we investigated the effect that longitudinal distance has on cervical mechanics. This was determined by performing a two-level recapping laminoplasty, and then extending the laminoplasty to the next level and repeating the mechanical testing at each step. Principal Findings: There were three mainly morphological changes at the six months after laminoplasty: volume reduction and bone nonunion of the recapping laminae, irregular fibrosis formation around the facet joints and re-implanted lamina-ligamentous complex. In the biomechanical test, comparing with laminectomy, recapping laminoplasty didn't show significant differences in the immediate postoperative comparison, while recapping laminoplasty demonstrated significantly decreased motion in flexion/extension six months later. Inclusion of additional levels in the laminotomy procedure didn't lead to changes in immediate biomechanics. Conclusions: Recapping laminoplasty can't fully restore the posterior structure, but still reduced the risk of delayed cervical instability in a caprine model.	[Si, Yu; Wang, Zhenyu; Yu, Tao; Lin, Guo Zhong; Zhang, Jia] Peking Univ, Hosp 3, Dept Neurosurg, Beijing 100871, Peoples R China; [Zhang, Kuo] Dept Lab Anim Sci, Beijing, Peoples R China; [Zhang, Hua] Peking Univ, Hosp 3, Clin Epidemiol Res Ctr, Beijing 100871, Peoples R China; [Li, Yuan Chao] Shanghai Jiao Tong Univ, Sch Mech Engn, Shanghai 200030, Peoples R China	Peking University; Peking University; Shanghai Jiao Tong University	Wang, ZY (corresponding author), Peking Univ, Hosp 3, Dept Neurosurg, Beijing 100871, Peoples R China.	wzyu502@yahoo.com	Li, Yuan/GXV-1310-2022		National Natural Science Foundation of China [5443002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported financially by the National Natural Science Foundation of China (grant 5443002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agazzi S, 2007, J NEUROSURG-SPINE, V7, P549, DOI 10.3171/SPI-07/11/549; Baisden J, 1999, SPINE, V24, P1283, DOI 10.1097/00007632-199907010-00003; Cunningham BW, 2010, J NEUROSURG-SPINE, V13, P216, DOI 10.3171/2010.3.SPINE09512; Detwiler PW, 2003, J NEUROSURG, V99, P214, DOI 10.3171/spi.2003.99.2.0214; Hara M, 2001, NEUROSURGERY, V48, P235; Kandziora F, 2001, SPINE, V26, P1028, DOI 10.1097/00007632-200105010-00008; Kawahara N, 1999, SPINE, V24, P1363, DOI 10.1097/00007632-199907010-00015; Kikkawa J, 2010, SPINE, V35, pE1465, DOI 10.1097/BRS.0b013e3181f06ca8; Kode S, 2012, SPINE, V37, pE1165, DOI 10.1097/BRS.0b013e31825e6251; Kubo S, 2003, SPINE, V28, P227, DOI 10.1097/00007632-200302010-00005; Lee MJ, 2010, SPINE, V35, P1789, DOI 10.1097/BRS.0b013e3181c9b8d6; Liu Xin-yu, 2009, Orthop Surg, V1, P275, DOI 10.1111/j.1757-7861.2009.00050.x; McGirt MJ, 2008, J NEUROS-PEDIATR, V1, P57, DOI 10.3171/PED-08/01/057; McGirt MJ, 2010, NEUROSURGERY, V66, P1005, DOI 10.1227/01.NEU.0000367721.73220.C9; NOWINSKI GP, 1993, SPINE, V18, P1995, DOI 10.1097/00007632-199310001-00012; Otani K, 2009, SPINE, V34, P268, DOI 10.1097/BRS.0b013e318195b27a; Paul CPL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033147; Puttlitz CM, 2004, EUR SPINE J, V13, P213, DOI 10.1007/s00586-004-0684-6; Raab P, 2008, INT ORTHOP, V32, P355, DOI 10.1007/s00264-007-0325-x; Rao Raj D, 2002, Spine J, V2, P320, DOI 10.1016/S1529-9430(02)00402-3; Ruggeri A, 2012, EUR SPINE J, V21, P364, DOI 10.1007/s00586-011-1826-2; Ryken TC, 2009, J NEUROSURG-SPINE, V11, P142, DOI 10.3171/2009.1.SPINE08725; Subramaniam V, 2009, SPINE, V34, pE573, DOI 10.1097/BRS.0b013e3181aa0214; Tai CL, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-84; Valentin S, 2012, J BIOMECH, V45, P2506, DOI 10.1016/j.jbiomech.2012.07.022; Wilke HJ, 1997, ANAT RECORD, V247, P542, DOI 10.1002/(SICI)1097-0185(199704)247:4<542::AID-AR13>3.0.CO;2-P; Yang LL, 2013, ORTHOPEDICS, V36, pE79, DOI 10.3928/01477447-20121217-23	27	1	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100689	10.1371/journal.pone.0100689	http://dx.doi.org/10.1371/journal.pone.0100689			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950103	gold, Green Published, Green Submitted			2022-12-27	WOS:000338276300108
J	Zhang, JA; Yin, Z; Ma, LW; Yin, ZQ; Hu, YY; Xu, Y; Wu, D; Permatasari, F; Luo, D; Zhou, BR				Zhang, Jia-an; Yin, Zhi; Ma, Li-wen; Yin, Zhi-qiang; Hu, Yan-yan; Xu, Yang; Wu, Di; Permatasari, Felicia; Luo, Dan; Zhou, Bing-rong			The Protective Effect of Baicalin against UVB Irradiation Induced Photoaging: An In Vitro and In Vivo Study	PLOS ONE			English	Article							INDUCED PREMATURE SENESCENCE; INDUCED OXIDATIVE DAMAGE; HUMAN SKIN FIBROBLASTS; MOUSE SKIN; MOLECULAR-MECHANISMS; CONNECTIVE-TISSUE; DNA-DAMAGE; ULTRAVIOLET; LIGHT; APOPTOSIS	Objective: This study was aimed to evaluate the anti-photoaging effects of baicalin on Ultraviolet B (UVB)-induced photoaging in the dorsal skin of hairless mice and premature senescence in human dermal fibroblasts. Methods: We established in vivo and in vitro photoaging models by repeated exposures to UVB irradiation. By HE staining, masson staining, immunohistostaing and real-time RT-PCR, we analyzed epidermal thickness, collagen expression and the mRNA and protein levels of type I collagen, type III collagen, interstitial collagenase (MMP-1 and MMP-3) in UVB exposed dorsal mice skin. The aging condition in human dermal fibroblasts was determined by senescence-associated beta-galactosidase (SA-beta-gal) staining. Cell viability was determined using the Cell Counting Kit-8 (CCK-8). The G1 phase cell growth arrest was analyzed by flow cytometry. The senescence-related protein levels of p16(INK-4a), p21(WAF-1), and p53 and protein levels of phosphorylated histone H2AX were estimated by Western blotting. Results: Topically application of baicalin treatment reduced UVB-induced epidermal thickening of mouse skin and also result in an increase in the production of collagen I and III, and a decrease in the expression of MMP-1 and MMP-3. Compared with the UVB-irradiated group, we found that the irradiated fibroblasts additionally treated with baicalin demonstrated a decrease in the expression of SA-beta-gal, a increase in the cell viability, a decrease in the G1 phase cell proportion, a downregulation in the level of senescence-associated and gamma-H2AX proteins. However, Baicalin had no difference in the normal fibroblasts without UVB irradiation and long-term Baicalin incubation of UVB-SIPS fibroblasts gave no effects on the cell proliferation. Conclusions: Taken together, these results suggest that baicalin significantly antagonizes photoaging induced by UVB in vivo and in vitro, indicating the potential of baicalin application for anti-photoaging treatment.	[Zhang, Jia-an; Yin, Zhi; Ma, Li-wen; Yin, Zhi-qiang; Hu, Yan-yan; Xu, Yang; Wu, Di; Permatasari, Felicia; Luo, Dan; Zhou, Bing-rong] Nanjing Med Univ, Affiliated Hosp 1, Dept Dermatol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Luo, D (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Dermatol, Nanjing, Jiangsu, Peoples R China.	daniluo2013@njmu.edu.cn; bingrong.2002@163.com	Permatasari, Felicia/I-2601-2016	Permatasari, Felicia/0000-0002-6432-2637	China National Natural Science Foundation [81000700, 81171518]; science project from traditional Chinese medicine Bureau of Jiangsu Province [LZ11084]; Jiangsu National Natural Science Foundation [BK2012877]	China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); science project from traditional Chinese medicine Bureau of Jiangsu Province; Jiangsu National Natural Science Foundation	This work was supported by grants from the China National Natural Science Foundation (81000700 and 81171518), science project from traditional Chinese medicine Bureau of Jiangsu Province (LZ11084) and Jiangsu National Natural Science Foundation (BK2012877). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes L, 2010, PHOTOCHEM PHOTOBIOL, V86, P933, DOI 10.1111/j.1751-1097.2010.00744.x; BLACK HS, 1987, PHOTOCHEM PHOTOBIOL, V46, P213, DOI 10.1111/j.1751-1097.1987.tb04759.x; Campisi J, 2001, TRENDS CELL BIOL, V11, pS27, DOI 10.1016/S0962-8924(01)02151-1; Chainiaux F, 2002, INT J BIOCHEM CELL B, V34, P1331, DOI 10.1016/S1357-2725(02)00022-5; Chen WQ, 2008, INT J MOL MED, V21, P645; Cho HS, 2007, PHOTODERMATOL PHOTO, V23, P155, DOI 10.1111/j.1600-0781.2007.00298.x; Chung JH, 2001, J INVEST DERMATOL, V117, P1218, DOI 10.1046/j.0022-202x.2001.01544.x; Debacq-Chainiaux F, 2006, J PHARM PHARMACOL, V58, P1577, DOI 10.1211/jpp.58.12.0003; Fisher GJ, 2002, ARCH DERMATOL, V138, P1462, DOI 10.1001/archderm.138.11.1462; Gilchrest BA, 1996, BRIT J DERMATOL, V135, P867, DOI 10.1046/j.1365-2133.1996.d01-1088.x; Kang J, 2008, INT J MOL MED, V21, P777; Kielbassa C, 1997, CARCINOGENESIS, V18, P811, DOI 10.1093/carcin/18.4.811; Kino K, 2005, MUTAT RES-FUND MOL M, V571, P33, DOI 10.1016/j.mrfmmm.2004.10.010; Kosmadaki MG, 2004, MICRON, V35, P155, DOI 10.1016/j.micron.2003.11.002; Lee JH, 2010, J FOOD SCI, V75, pH212, DOI 10.1111/j.1750-3841.2010.01755.x; Liou SF, 2012, J NAT MED-TOKYO, V66, P311, DOI 10.1007/s11418-011-0592-0; Scharffetter-Kochanek K, 2000, EXP GERONTOL, V35, P307, DOI 10.1016/S0531-5565(00)00098-X; Severino J, 2000, EXP CELL RES, V257, P162, DOI 10.1006/excr.2000.4875; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; SMITH JG, 1962, J INVEST DERMATOL, V39, P347, DOI 10.1038/jid.1962.122; Tierney EP, 2010, DERMATOL SURG, V36, P829, DOI 10.1111/j.1524-4725.2010.01557.x; Toussaint O, 2000, EXP GERONTOL, V35, P927, DOI 10.1016/S0531-5565(00)00180-7; UITTO J, 1989, J AM ACAD DERMATOL, V21, P614, DOI 10.1016/S0190-9622(89)70228-0; Vayalil PK, 2004, J INVEST DERMATOL, V122, P1480, DOI 10.1111/j.0022-202X.2004.22622.x; Wen YF, 2011, EXP TOXICOL PATHOL; Yaar M, 2007, BRIT J DERMATOL, V157, P874, DOI 10.1111/j.1365-2133.2007.08108.x; Zhang Y, 2011, NAT PROD RES, V25, P1150, DOI 10.1080/14786419.2010.495070; Zhou BR, 2008, ARCH DERMATOL RES, V300, P331, DOI 10.1007/s00403-008-0851-4; Zhou BR, 2008, PHOTODERMATOL PHOTO, V24, P175, DOI 10.1111/j.1600-0781.2008.00356.x; Zhou BR, 2012, FREE RADICAL RES, V46, P1458, DOI 10.3109/10715762.2012.726355; Zhou BR, 2011, ARCH PHARM RES, V34, P261, DOI 10.1007/s12272-011-0212-2; Zhou BR, 2009, PHOTODERMATOL PHOTO, V25, P250, DOI 10.1111/j.1600-0781.2009.00454.x	32	43	46	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e99703	10.1371/journal.pone.0099703	http://dx.doi.org/10.1371/journal.pone.0099703			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949843	Green Published, gold, Green Submitted			2022-12-27	WOS:000338276300018
J	Boone, AN; Senatore, A; Chemin, J; Monteil, A; Spafford, JD				Boone, Adrienne N.; Senatore, Adriano; Chemin, Jean; Monteil, Arnaud; Spafford, J. David			Gd3+ and Calcium Sensitive, Sodium Leak Currents Are Features of Weak Membrane-Glass Seals in Patch Clamp Recordings	PLOS ONE			English	Article							KIDNEY HEK293 CELLS; HEK-293 CELLS; NEURONAL EXCITABILITY; CHANNELS; MICROSCOPY; GIGASEAL; ACTIVATION; MECHANISMS; PROTEINS; PIPETTES	The properties of leaky patch currents in whole cell recording of HEK-293T cells were examined as a means to separate these control currents from expressed sodium and calcium leak channel currents from snail NALCN leak channels possessing both sodium (EKEE) and calcium (EEEE) selectivity filters. Leak currents were generated by the weakening of gigaohm patch seals by artificial membrane rupture using the ZAP function on the patch clamp amplifier. Surprisingly, we found that leak currents generated from the weakened membrane/glass seal can be surprisingly stable and exhibit behavior that is consistent with a sodium leak current derived from an expressible channel. Leaky patch currents differing by 10 fold in size were similarly reduced in size when external sodium ions were replaced with the large monovalent ion NMDG(+). Leaky patch currents increased when external Ca2+ (1.2 mM) was lowered to 0.1 mM and were inhibited (>40% to >90%) with 10 mM Gd3+, 100 mu M La3+, 1 mM Co2+ or 1 mM Cd2+. Leaky patch currents were relatively insensitive (<30%) to 1 mM Ni2+ and exhibited a variable amount of block with 1 mM verapamil and were insensitive to 100 mu M mibefradil or 100 mu M nifedipine. We hypothesize that the rapid changes in leak current size in response to changing external cations or drugs relates to their influences on the membrane seal adherence and the electro-osmotic flow of mobile cations channeling in crevices of a particular pore size in the interface between the negatively charged patch electrode and the lipid membrane. Observed sodium leak conductance currents in weak patch seals are reproducible between the electrode glass interface with cell membranes, artificial lipid or Sylgard rubber.	[Boone, Adrienne N.; Senatore, Adriano; Spafford, J. David] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada; [Chemin, Jean; Monteil, Arnaud] Univ Montpellier I, INSERM, CNRS, UMR 5203,Inst Genom Fonctionnelle,U661, Montpellier, France	University of Waterloo; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Universite de Montpellier	Spafford, JD (corresponding author), Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada.	spafford@uwaterloo.ca	Monteil, Arnaud/G-3113-2012	Monteil, Arnaud/0000-0003-1632-7318; chemin, jean/0000-0002-6089-5964	Heart and Stroke Foundation; NSERC	Heart and Stroke Foundation(Heart & Stroke Foundation of Canada); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	The authors would like to thank the Heart and Stroke Foundation and NSERC Discovery Operating for operating grant funding to JDS. The authors thank an NSERC-MSFSS award for providing Adriano Senatore an opportunity to examine the functions of NALCN with the CNRS group including Dr. Monteil in Montpellier, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE N, 1994, JPN J PHYSIOL, V44, P433, DOI 10.2170/jjphysiol.44.433; Akinlaja J, 1998, BIOPHYS J, V75, P247, DOI 10.1016/S0006-3495(98)77511-3; [Anonymous], 1994, MICR TECHN PLYM WORK; [Anonymous], 2007, AX GUID EL BIOPH LAB; Bae C, 2011, BIOPHYS J, V101, P2645, DOI 10.1016/j.bpj.2011.11.002; Berjukow S, 1996, BRIT J PHARMACOL, V118, P748, DOI 10.1111/j.1476-5381.1996.tb15463.x; Cremer PS, 1999, J PHYS CHEM B, V103, P2554, DOI 10.1021/jp983996x; Gil Z, 1999, P NATL ACAD SCI USA, V96, P14594, DOI 10.1073/pnas.96.25.14594; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Gunthorpe NJ, 2001, PFLUG ARCH EUR J PHY, V442, P668; He BJ, 2010, NEUROSCI LETT, V469, P268, DOI 10.1016/j.neulet.2009.12.012; Huang X, 2010, J EXP BIOL, V213, P2094, DOI 10.1242/jeb.042242; Jiang B, 2002, MOL CELL BIOCHEM, V238, P69, DOI 10.1023/A:1019907104763; Lu BX, 2007, CELL, V129, P371, DOI 10.1016/j.cell.2007.02.041; Lu BX, 2010, NEURON, V68, P488, DOI 10.1016/j.neuron.2010.09.014; Lu BX, 2009, NATURE, V457, P741, DOI 10.1038/nature07579; Molleman A, 2002, PATCH CLAMPING INTRO; NEHER E, 1978, PFLUG ARCH EUR J PHY, V375, P219, DOI 10.1007/BF00584247; NINHAM BW, 1970, BIOPHYS J, V10, P646, DOI 10.1016/S0006-3495(70)86326-3; OPSAHL LR, 1994, BIOPHYS J, V66, P75, DOI 10.1016/S0006-3495(94)80752-0; Priel A, 2007, BIOPHYS J, V92, P3893, DOI 10.1529/biophysj.106.099119; Rasmussen M, 2008, AM J PHYSIOL-CELL PH, V294, pC197, DOI 10.1152/ajpcell.00268.2007; Ren DJ, 2011, NEURON, V72, P899, DOI 10.1016/j.neuron.2011.12.007; RUKNUDIN A, 1991, J CELL BIOL, V112, P125, DOI 10.1083/jcb.112.1.125; SACHS F, 1993, BIOPHYS J, V65, P1101, DOI 10.1016/S0006-3495(93)81149-4; Senatore A, 2011, JOVE-J VIS EXP, DOI 10.3791/2314; Senatore A, 2013, CHANNELS, V7, P60, DOI 10.4161/chan.23981; Senatore A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055088; Senatore A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037409; Senatore A, 2011, CHANNELS, V5, P173, DOI 10.4161/chan.5.2.15141; Senatore A, 2010, J BIOL CHEM, V285, P7447, DOI 10.1074/jbc.M109.090753; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; SOEJIMA M, 1984, PFLUG ARCH EUR J PHY, V400, P424, DOI 10.1007/BF00587544; SOKABE M, 1990, J CELL BIOL, V111, P599, DOI 10.1083/jcb.111.2.599; SOKABE M, 1991, BIOPHYS J, V59, P722, DOI 10.1016/S0006-3495(91)82285-8; Suchyna TM, 2009, BIOPHYS J, V97, P738, DOI 10.1016/j.bpj.2009.05.018; Thomas Philip, 2005, Journal of Pharmacological and Toxicological Methods, V51, P187, DOI 10.1016/j.vascn.2004.08.014; Varghese A, 2006, PROG BIOPHYS MOL BIO, V90, P26, DOI 10.1016/j.pbiomolbio.2005.05.002; Yu SP, 1998, J NEUROSCI RES, V52, P612, DOI 10.1002/(SICI)1097-4547(19980601)52:5<612::AID-JNR13>3.0.CO;2-3; Zagranichnaya TK, 2005, J BIOL CHEM, V280, P29559, DOI 10.1074/jbc.M505842200	40	11	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e98808	10.1371/journal.pone.0098808	http://dx.doi.org/10.1371/journal.pone.0098808			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945283	gold, Green Published, Green Submitted			2022-12-27	WOS:000340721500007
J	Dolega, ME; Wagh, J; Gerbaud, S; Kermarrec, F; Alcaraz, JP; Martin, DK; Gidrol, X; Picollet-D'hahan, N				Dolega, Monika E.; Wagh, Jayesh; Gerbaud, Sophie; Kermarrec, Frederique; Alcaraz, Jean-Pierre; Martin, Donald K.; Gidrol, Xavier; Picollet-D'hahan, Nathalie			Facile Bench-Top Fabrication of Enclosed Circular Microchannels Provides 3D Confined Structure for Growth of Prostate Epithelial Cells	PLOS ONE			English	Article							IN-VITRO; MORPHOGENESIS; POLYELECTROLYTE; MORPHOLOGY; SECRETION; FORCES; PDMS	We present a simple bench-top method to fabricate enclosed circular channels for biological experiments. Fabricating the channels takes less than 2 hours by using glass capillaries of various diameters (from 100 mm up to 400 mm) as a mould in PDMS. The inner surface of microchannels prepared in this way was coated with a thin membrane of either Matrigel or a layer-by-layer polyelectrolyte to control cellular adhesion. The microchannels were then used as scaffolds for 3D-confined epithelial cell culture. To show that our device can be used with several epithelial cell types from exocrine glandular tissues, we performed our biological studies on adherent epithelial prostate cells (non-malignant RWPE-1 and invasive PC3) and also on breast (non-malignant MCF10A) cells We observed that in static conditions cells adhere and proliferate to form a confluent layer in channels of 150 mu m in diameter and larger, whereas cellular viability decreases with decreasing diameter of the channel. Matrigel and PSS (poly (sodium 4-styrenesulphonate)) promote cell adhesion, whereas the cell proliferation rate was reduced on the PAH (poly (allylamine hydrochloride))-terminated surface. Moreover infusing channels with a continuous flow did not induce any cellular detachment. Our system is designed to simply grow cells in a microchannel structure and could be easily fabricated in any biological laboratory. It offers opportunities to grow epithelial cells that support the formation of a light. This system could be eventually used, for example, to collect cellular secretions, or study cell responses to graduated hypoxia conditions, to chemicals (drugs, siRNA, ...) and/or physiological shear stress.	[Dolega, Monika E.; Wagh, Jayesh; Gerbaud, Sophie; Kermarrec, Frederique; Gidrol, Xavier; Picollet-D'hahan, Nathalie] Univ Grenoble Alpes, iRTSV BGE, Grenoble, France; [Dolega, Monika E.; Wagh, Jayesh; Gerbaud, Sophie; Kermarrec, Frederique; Gidrol, Xavier; Picollet-D'hahan, Nathalie] CEA, iRTSV BGE, Grenoble, France; [Dolega, Monika E.; Wagh, Jayesh; Gerbaud, Sophie; Kermarrec, Frederique; Gidrol, Xavier; Picollet-D'hahan, Nathalie] INSERM, BGE, Grenoble, France; [Alcaraz, Jean-Pierre; Martin, Donald K.] UJF Grenoble 1, CNRS, TIMC IMAG UMR SyNaBi 5525, Grenoble, France	Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Picollet-D'hahan, N (corresponding author), Univ Grenoble Alpes, iRTSV BGE, Grenoble, France.	nathalie.picollet-dhahan@cea.fr	ALCARAZ, jean-pierre/M-6821-2014	ALCARAZ, jean-pierre/0000-0002-5924-9519; Gidrol, Xavier/0000-0002-4233-3749; Dolega, Monika/0000-0003-2081-4709; Picollet-D'hahan, Nathalie/0000-0001-6307-9180; Martin, Donald/0000-0001-5913-2372	French Agence Nationale pour la Recherche [ANR-11-BSV5-009]; CEA IRTELIS international PhD program	French Agence Nationale pour la Recherche(French National Research Agency (ANR)); CEA IRTELIS international PhD program	This research was funded by a grant from the French Agence Nationale pour la Recherche (ANR-11-BSV5-009) and supported by the CEA IRTELIS international PhD program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelgawad M, 2011, LAB CHIP, V11, P545, DOI [10.1039/c0lc00093k, 10.1039/c01c00093k]; Bledi Y, 2000, BRAIN RES PROTOC, V5, P282, DOI 10.1016/S1385-299X(00)00024-6; Brown L, 2006, LAB CHIP, V6, P66, DOI 10.1039/b512179e; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Decher G, 1992, THIN SOLID FILMS; Deshiere A, 2013, ONCOGENE, V32, P1373, DOI 10.1038/onc.2012.165; Dhir V, 2009, BIOTECHNOL PROGR, V25, P594, DOI 10.1002/btpr.150; Dolega ME, 2013, BIOSENS BIOELECTRON, V49, P176, DOI 10.1016/j.bios.2013.05.001; Dolega ME, 2012, LAB CHIP, V12, P4022, DOI 10.1039/c2lc40174f; Fiddes LK, 2010, BIOMATERIALS, V31, P3459, DOI 10.1016/j.biomaterials.2010.01.082; Glass NR, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3625605; Godugu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053708; Golden AP, 2007, LAB CHIP, V7, P720, DOI 10.1039/b618409j; Hebner C, 2008, ANNU REV PATHOL-MECH, V3, P313, DOI 10.1146/annurev.pathmechdis.3.121806.151526; Huang NT, 2012, LAB CHIP, V12, P4093, DOI 10.1039/c2lc40619e; Jia YF, 2008, CHINESE SCI BULL, V53, P3928, DOI 10.1007/s11434-008-0528-6; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; Mailleux AA, 2008, CELL CYCLE, V7, P57, DOI 10.4161/cc.7.1.5150; Martin PM, 1998, P MICR ENG SANT CLAR, V41/42, P493; McDonald JC, 2002, ACCOUNTS CHEM RES, V35, P491, DOI 10.1021/ar010110q; Nicotera TM, 2009, PROSTATE, V69, P1270, DOI 10.1002/pros.20968; Park JY, 2012, SENSOR ACTUAT B-CHEM, V173, P765, DOI 10.1016/j.snb.2012.06.096; Perry H, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2719626; Picollet-D'hahan N, 2013, BIOMATERIALS, V34, P10099, DOI 10.1016/j.biomaterials.2013.08.093; Price GM, 2011, METHODS MOL BIOL, V671, P281, DOI 10.1007/978-1-59745-551-0_17; Rao N, 2013, BIOMED MICRODEVICES, V15, P161, DOI 10.1007/s10544-012-9709-9; Riha GM, 2005, ANN BIOMED ENG, V33, P772, DOI 10.1007/s10439-005-3310-9; Shevkoplyas SS, 2003, MICROVASC RES, V65, P132, DOI 10.1016/S0026-2862(02)00034-1; Song JW, 2011, P NATL ACAD SCI USA, V108, P15342, DOI 10.1073/pnas.1105316108; Su YX, 2013, CARBOHYD POLYM, V92, P2245, DOI 10.1016/j.carbpol.2012.12.003; Ting JHY, 2010, IET NANOBIOTECHNOL, V4, P77, DOI 10.1049/iet-nbt.2009.0016; Ting JHY, 2008, THESIS U TECHNOLOGY; Verma MKS, 2006, LANGMUIR, V22, P10291, DOI 10.1021/la062516n; Vidi Pierre-Alexandre, 2013, Methods Mol Biol, V945, P193, DOI 10.1007/978-1-62703-125-7_13; Webber MM, 1997, CARCINOGENESIS, V18, P1225, DOI 10.1093/carcin/18.6.1225; Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058; Wilson ME, 2011, LAB CHIP, V11, P1550, DOI 10.1039/c0lc00561d; Wong KHK, 2012, ANNU REV BIOMED ENG, V14, P205, DOI [10.1146/annurev-bioeng-071811-150052, 10.1146/annurev.bioeng-071811-150052]	38	20	20	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e99416	10.1371/journal.pone.0099416	http://dx.doi.org/10.1371/journal.pone.0099416			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945245	gold, Green Published, Green Submitted			2022-12-27	WOS:000340721500018
J	Cybulski, JS; Clements, J; Prakash, M				Cybulski, James S.; Clements, James; Prakash, Manu			Foldscope: Origami-Based Paper Microscope	PLOS ONE			English	Article							DIAGNOSIS; LENS	Here we describe an ultra-low-cost origami-based approach for large-scale manufacturing of microscopes, specifically demonstrating brightfield, darkfield, and fluorescence microscopes. Merging principles of optical design with origami enables high-volume fabrication of microscopes from 2D media. Flexure mechanisms created via folding enable a flat compact design. Structural loops in folded paper provide kinematic constraints as a means for passive self-alignment. This light, rugged instrument can survive harsh field conditions while providing a diversity of imaging capabilities, thus serving wide-ranging applications for cost-effective, portable microscopes in science and education.	[Cybulski, James S.] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA; [Clements, James; Prakash, Manu] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	Stanford University; Stanford University	Prakash, M (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	manup@stanford.edu		Prakash, Manu/0000-0002-8046-8388	Terman Fellowship; Baxter Foundation; Coulter Foundation; Spectrum Foundation [NIH CTSA UL1 TR000093]; C-Idea (National Institutes of Health) [RC4 TW008781-01]; Bill and Melinda Gates Foundation; Pew Foundation; Gordon and Betty Moore foundation; NIH Fogarty Institute Global Health Equity Scholars (GHES) Fellowship; NSF; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000093, UL1TR001085] Funding Source: NIH RePORTER	Terman Fellowship; Baxter Foundation; Coulter Foundation; Spectrum Foundation; C-Idea (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Pew Foundation; Gordon and Betty Moore foundation(Gordon and Betty Moore Foundation); NIH Fogarty Institute Global Health Equity Scholars (GHES) Fellowship; NSF(National Science Foundation (NSF)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Manu Prakash acknowledges support from Terman Fellowship, The Baxter Foundation, Coulter Foundation, Spectrum Foundation (NIH CTSA UL1 TR000093), C-Idea (National Institutes of Health grant RC4 TW008781-01), Bill and Melinda Gates Foundation, Pew Foundation, and Gordon and Betty Moore foundation for financial support. Jim Cybulski is supported by NIH Fogarty Institute Global Health Equity Scholars (GHES) Fellowship. James Clements was supported by NSF Graduate fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron EJ, 2013, CLIN INFECT DIS, V57, pE22, DOI 10.1093/cid/cit278; Bogoch II, 2013, AM J TROP MED HYG, V88, P626, DOI 10.4269/ajtmh.12-0742; Bower JM, 1996, SCI SCI ED REFORM MY; Brady S, 1998, MICROSCOPIC EPLORATI, P20; BREDDERMAN T, 1983, REV EDUC RES, V53, P499, DOI 10.3102/00346543053004499; Breslauer DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006320; Cerda E, 2005, P ROY SOC A-MATH PHY, V461, P671, DOI 10.1098/rspa.2004.1371; Cox CA, 1989, J ELEMENTARY SCI ED, V1, P14, DOI DOI 10.1007/BF03173020; Demaine Erik., 2007, GEOMETRIC FOLDING AL; Doushkina V, 2009, ADV OPTOMECHANICS, P7424; Garcia L., 2007, DIAGNOSTIC MED PARAS, V5th, P142; GOLDBERG O, 1980, MICROSCOPE, V28, P15; Hoover AM, 2008, IEEE INT CONF ROBOT, P886, DOI 10.1109/ROBOT.2008.4543317; Hyde RA, 1999, APPL OPTICS, V38, P4198, DOI 10.1364/AO.38.004198; Jeong KH, 2004, OPT EXPRESS, V12, P2494, DOI 10.1364/OPEX.12.002494; Keller E, 2006, LIGHT MICROSCOPY, P8; KIKUCHI K, 1981, APPL OPTICS, V20, P388, DOI 10.1364/AO.20.000388; KOIKE Y, 1994, APPL OPTICS, V33, P3394, DOI 10.1364/AO.33.003394; Kremer M, 2013, SCIENCE, V340, P297, DOI 10.1126/science.1235350; Lee CC, 2009, PROC IEEE MICR ELECT, P172, DOI 10.1109/MEMSYS.2009.4805346; Martinez AW, 2010, ANAL CHEM, V82, P3, DOI 10.1021/ac9013989; McArthur Meher, 2012, FOLDING PAPER INFINI; MYER JH, 1969, APPL OPTICS, V8, P260, DOI 10.1364/AO.8.000260; O'Neill I, 2011, DISCOVERY NEWS; PORTER JR, 1976, BACTERIOL REV, V40, P260, DOI 10.1128/MMBR.40.2.260-269.1976; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Slocum A.H., 1992, PRECISION MACHINE DE; Smith ZJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017150; Sreetharan PS, 2012, J MICROMECH MICROENG, V22, DOI 10.1088/0960-1317/22/5/055027; Whitesides GM, 2011, FRUGAL WAY; Whitney JP, 2011, J MICROMECH MICROENG, V21, DOI 10.1088/0960-1317/21/11/115021; Zhu HY, 2013, LAB CHIP, V13, P51, DOI [10.1039/c2lc40864c, 10.1039/c21c40864c]	32	192	199	2	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e98781	10.1371/journal.pone.0098781	http://dx.doi.org/10.1371/journal.pone.0098781			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940755	Green Published, gold, Green Submitted			2022-12-27	WOS:000338508200010
J	Read, TC; Wantiez, L; Werry, JM; Farman, R; Petro, G; Limpus, CJ				Read, Tyffen C.; Wantiez, Laurent; Werry, Jonathan M.; Farman, Richard; Petro, George; Limpus, Colin J.			Migrations of Green Turtles (Chelonia mydas) between Nesting and Foraging Grounds across the Coral Sea	PLOS ONE			English	Article							LONG-DISTANCE MIGRATION; POPULATION-MODEL; CARETTA-CARETTA; SATELLITE; MITOCHONDRIAL; ISLAND; POLYMORPHISMS; HYPOTHESIS; PATTERNS; BEHAVIOR	Marine megafauna tend to migrate vast distances, often crossing national borders and pose a significant challenge to managers. This challenge is particularly acute in the Pacific, which contains numerous small island nations and thousands of kilometers of continental margins. The green sea turtle, Chelonia mydas, is one such megafauna that is endangered in Pacific waters due to the overexploitation of eggs and adults for human consumption. Data from long-term tagging programs in Queensland (Australia) and New Caledonia were analysed to investigate the migrations by C. mydas across the Coral Sea between their nesting site and their feeding grounds. A review of data collected over the last 50 years by different projects identified multiple migrations of C. mydas to and from New Caledonia (n = 97) and indicate that turtles foraging in New Caledonia nest in the Great Barrier Reef (Australia) and vice versa. Several explanations exist for turtles exhibiting this energetically costly movement pattern from breeding to distant foraging grounds (1200-2680 km away) despite viable foraging habitat being available in the local vicinity. These include hatchling drift, oceanic movements and food abundance predictability. Most of the tag recoveries in New Caledonia belonged to females from the south Great Barrier Reef genetic stock. Some females (n = 2) even showed fidelity to foraging sites located 1200 km away from the nesting site located in New Caledonia. This study also reveals previously unknown migrations pathways of turtles within the Coral Sea.	[Read, Tyffen C.; Farman, Richard] Aquarium des Lagons, Lab Marine Biol & Ecol, Noumea, New Caledonia; [Wantiez, Laurent] Univ Nouvelle Caledonie, LIVE EA4243, Noumea, New Caledonia; [Read, Tyffen C.; Werry, Jonathan M.] Griffith Univ, Griffith Ctr Coastal Management, Nathan, Qld 4111, Australia; [Werry, Jonathan M.] Ocean & Coast Res, Main Beach, Qld, Australia; [Petro, George] Wan Smolbag Theatre, Port Vila, Vanuatu; [Limpus, Colin J.] Queensland Govt, Dept Environm & Heritage Protect, Threatened Species Unit, Brisbane, Qld, Australia	Universite Nouvelle Caledonie; Griffith University	Read, TC (corresponding author), Aquarium des Lagons, Lab Marine Biol & Ecol, Noumea, New Caledonia.	tyffen.read@aquarium.nc	Wantiez, Laurent/L-3343-2013	Wantiez, Laurent/0000-0001-5024-2057; Read, Tyffen/0000-0002-4385-0043	Environmental Advisory Customary Committee (CCCE); Vale Inco through the Biodiversity Convention signed with the Southern Province of New Caledonia; Southern Province of NC	Environmental Advisory Customary Committee (CCCE); Vale Inco through the Biodiversity Convention signed with the Southern Province of New Caledonia; Southern Province of NC	This research is funded by the Environmental Advisory Customary Committee (CCCE) and Vale Inco through the Biodiversity Convention signed with the Southern Province of New Caledonia. It takes place in the framework of a PhD from Griffith University jointly supervised by the University of New Caledonia and the Aquarium of the Lagoons. The Southern Province of NC granted a scholarship for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akesson S, 2007, BIOSCIENCE, V57, P123, DOI 10.1641/B570207; [Anonymous], 1980, TAGGING REARING GREE; Balazs G, 1994, SATELLITE TELEMETRY, P184; BALAZS G H, 1976, Biological Conservation, V9, P125, DOI 10.1016/0006-3207(76)90045-8; Balazs G.H., 1992, P 12 ANN WORKSHOP SE; Bass AL, 2006, J HERED, V97, P346, DOI 10.1093/jhered/esl004; Benson SR, 2007, CHELONIAN CONSERV BI, V6, P7, DOI 10.2744/1071-8443(2007)6[7:BUIMAM]2.0.CO;2; Bowen BW, 2007, MOL ECOL, V16, P4886, DOI 10.1111/j.1365-294X.2007.03542.x; BOWEN BW, 1992, EVOLUTION, V46, P865, DOI 10.1111/j.1558-5646.1992.tb00605.x; Boyle MC, 2009, P R SOC B, V276, P1993, DOI 10.1098/rspb.2008.1931; Broderick AC, 2007, P ROY SOC B-BIOL SCI, V274, P1533, DOI 10.1098/rspb.2007.0211; CARR A, 1986, BIOSCIENCE, V36, P92, DOI 10.2307/1310109; CARR A, 1975, COPEIA, P547; CARR AF, 1967, SO EXCELLENT FISHE N; Chaloupka M, 2004, CORAL REEFS, V23, P325, DOI 10.1007/s00338-004-0387-9; Cheng IJ, 2000, MAR BIOL, V137, P747, DOI 10.1007/s002270000375; Cincotta RP, 2000, NATURE, V404, P990, DOI 10.1038/35010105; Craig P, 2004, BIOL CONSERV, V116, P433, DOI 10.1016/S0006-3207(03)00217-9; Craig Peter, 1994, Marine Turtle Newsletter, V66, P7; CROUSE DT, 1987, ECOLOGY, V68, P1412, DOI 10.2307/1939225; Dethmers KEM, 2006, MOL ECOL, V15, P3931, DOI 10.1111/j.1365-294X.2006.03070.x; Dethmers KEM, 2010, MAR FRESHWATER RES, V61, P1376, DOI 10.1071/MF10084; Dutton P, 2002, P W PAC SEA TURTL CO, P93; FitzSimmons NN, 1997, P NATL ACAD SCI USA, V94, P8912, DOI 10.1073/pnas.94.16.8912; FitzSimmons NN, 1997, GENETICS, V147, P1843; Freake MJ, 2006, Q REV BIOL, V81, P327, DOI 10.1086/511528; Girard C, 2006, MAR ECOL PROG SER, V322, P281, DOI 10.3354/meps322281; Godley B. J., 2008, Endangered Species Research, V4, P3, DOI 10.3354/esr00060; Hamann M, 2002, J COMP PHYSIOL B, V172, P485, DOI [10.1002/s00360-002-0271-2, 10.1007/s00360-002-0271-2]; Hays GC, 2002, ANIM BEHAV, V64, P895, DOI 10.1006/anbe.2002.1975; Hays GC, 2013, FUNCT ECOL, V27, P748, DOI 10.1111/1365-2435.12073; Hays GC, 2010, CONSERV BIOL, V24, P1636, DOI 10.1111/j.1523-1739.2010.01531.x; Hays GC, 2010, J R SOC INTERFACE, V7, P1319, DOI 10.1098/rsif.2010.0009; Heppell SS, 1996, WILDLIFE RES, V23, P143, DOI 10.1071/WR9960143; Hirth HF., 1997, US FISH WILDLIFE SER; IUCN, 2010, IUCN 2010 IUCN RED L; KOCH AL, 1969, J THEOR BIOL, V22, P163, DOI 10.1016/0022-5193(69)90085-X; Lahanas PN, 1998, MAR BIOL, V130, P345, DOI 10.1007/s002270050254; Limpus C., 2009, BIOL REV AUSTR MARIN; Limpus C.J., 1985, P343; LIMPUS CJ, 1992, WILDLIFE RES, V19, P347, DOI 10.1071/WR9920347; LIMPUS CJ, 1992, WILDLIFE RES, V19, P457, DOI 10.1071/WR9920457; Limpus CJ, 1984, CAPRICORNIA SECTION, P61; Limpus CJ, 2002, P 20 ANN S SEA TURTL, P132; Limpus CJ, 1994, MEMOIRS QUEENSLAND M, P139; LIMPUS CJ, 2005, MONITORING GREEN TUR, P1; Limpus CJ, 1989, FORAGE AREA FIDELITY, P97; Limpus Colin J., 2003, Memoirs of the Queensland Museum, V49, P349; Limpus Colin J., 2009, Marine Turtle Newsletter, P3; Lohmann KJ, 2006, INTEGR COMP BIOL, V46, pE86; Lohmann KJ, 2008, P NATL ACAD SCI USA, V105, P19096, DOI 10.1073/pnas.0801859105; Luschi P, 1998, P ROY SOC B-BIOL SCI, V265, P2279, DOI 10.1098/rspb.1998.0571; Luschi P, 1996, J COMP PHYSIOL A, V178, P447; Luschi P, 2007, CURR BIOL, V17, P126, DOI 10.1016/j.cub.2006.11.062; MEYLAN AB, 1990, SCIENCE, V248, P724, DOI 10.1126/science.2333522; Meylan AB., 1982, BIOL CONSERVATION SE, P91; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Moritz C, 2002, POPULATION GENETICS, P1; MORTIMER JA, 1989, COPEIA, P962; MORTIMER JA, 1987, COPEIA, P103, DOI 10.2307/1446043; NORDENG H, 1977, OIKOS, V28, P155, DOI 10.2307/3543965; NORMAN JA, 1994, MOL ECOL, V3, P363, DOI 10.1111/j.1365-294X.1994.tb00076.x; PAPI F, 1995, MAR BIOL, V122, P171, DOI 10.1007/BF00348929; Pendoley KL, 2014, MAR BIOL, V161, P1455, DOI 10.1007/s00227-014-2433-7; Read TC, 2012, RECIFS DENTRECASTEAU, P1; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Schofield G., 2007, ENDANGER SPECIES RES, V3, P71, DOI DOI 10.1111/J.1467-2979.2000.00019.X; Schofield G, 2007, MAR ECOL PROG SER, V336, P267, DOI 10.3354/meps336267; Seminoff Jeffrey A., 2008, Endangered Species Research, V4, P57, DOI 10.3354/esr00066; Shillinger GL, 2008, PLOS BIOL, V6, P1408, DOI 10.1371/journal.pbio.0060171; Southwood A, 2010, J COMP PHYSIOL B, V180, P1, DOI 10.1007/s00360-009-0415-8; Troeng S, 2005, BIOL CONSERV, V121, P111, DOI 10.1016/j.biocon.2004.04.014; Ward HB, 1921, ECOLOGY, V2, P235, DOI 10.2307/1928977; Werry JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083249; WHITTOW GC, 1982, PAC SCI, V36, P129	75	25	28	2	118	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100083	10.1371/journal.pone.0100083	http://dx.doi.org/10.1371/journal.pone.0100083			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940598	Green Published, gold, Green Submitted			2022-12-27	WOS:000338508200072
J	Dwivedi, P; Khanna, M				Dwivedi, Puneet; Khanna, Madhu			Abatement Cost of GHG Emissions for Wood-Based Electricity and Ethanol at Production and Consumption Levels	PLOS ONE			English	Article							LIFE-CYCLE ASSESSMENT; WILLOW BIOMASS; UNITED-STATES; DILUTE-ACID; CARBON; GASIFICATION; PROFITABILITY; PLANTATIONS; BIOETHANOL; ECONOMICS	Woody feedstocks will play a critical role in meeting the demand for biomass-based energy products in the US. We developed an integrated model using comparable system boundaries and common set of assumptions to ascertain unit cost and greenhouse gas (GHG) intensity of electricity and ethanol derived from slash pine (Pinus elliottii) at the production and consumption levels by considering existing automobile technologies. We also calculated abatement cost of greenhouse gas (GHG) emissions with respect to comparable energy products derived from fossil fuels. The production cost of electricity derived using wood chips was at least cheaper by 1 (sic)MJ(-1) over electricity derived from wood pellets. The production cost of ethanol without any income from cogenerated electricity was costlier by about 0.7 (sic)MJ(-1) than ethanol with income from cogenerated electricity. The production cost of electricity derived from wood chips was cheaper by at least 0.7 (sic)MJ(-1) than the energy equivalent cost of ethanol produced in presence of cogenerated electricity. The cost of using ethanol as a fuel in a flex-fuel vehicle was at least higher by 6 (sic)km(-1) than a comparable electric vehicle. The GHG intensity of per km distance traveled in a flex-fuel vehicle was greater or lower than an electric vehicle running on electricity derived from wood chips depending on presence and absence of GHG credits related with co-generated electricity. A carbon tax of at least $7 Mg CO(2)e(-1) and $30 Mg CO(2)e(-1) is needed to promote wood-based electricity and ethanol production in the US, respectively. The range of abatement cost of GHG emissions is significantly dependent on the harvest age and selected baseline especially for electricity generation.	[Dwivedi, Puneet] Univ Georgia, Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA; [Khanna, Madhu] Univ Illinois, Energy Biosci Inst, Urbana, IL USA	University System of Georgia; University of Georgia; University of Illinois System; University of Illinois Urbana-Champaign	Dwivedi, P (corresponding author), Univ Georgia, Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA.	puneetdwivedi@gmail.com		Dwivedi, Puneet/0000-0001-6272-7473	Energy Biosciences Institute at the University of Illinois at Urbana-Champaign/University of California, Berkeley	Energy Biosciences Institute at the University of Illinois at Urbana-Champaign/University of California, Berkeley	The authors are thankful to the funding support provided by the Energy Biosciences Institute at the University of Illinois at Urbana-Champaign/University of California, Berkeley. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abt KL, 2012, FOREST SCI, V58, P523, DOI 10.5849/forsci.11-055; [Anonymous], 2013, AM REN; Bridgwater AV, 2002, RENEW SUST ENERG REV, V6, P181, DOI 10.1016/S1364-0321(01)00010-7; Budsberg E, 2012, FOREST PROD J, V62, P305; Campbell JE, 2009, SCIENCE, V324, P1055, DOI 10.1126/science.1168885; Daigneault A, 2012, ENVIRON SCI TECHNOL, V46, P5664, DOI 10.1021/es2030142; Davis SC, 2012, FORESTS, V3, P370, DOI 10.3390/f3020370; Daystar J, 2012, FOREST PROD J, V62, P314; DSIRE, 2013, DAT STAT INC REN EFF; Dwivedi P, 2012, BIOENERG RES, V5, P470, DOI 10.1007/s12155-012-9179-1; Dwivedi P, 2011, BIOENERG RES, V4, P180, DOI 10.1007/s12155-010-9111-5; Dwivedi P, 2009, CAN J FOREST RES, V39, P990, DOI 10.1139/X09-023; EERE, 2013, ALT FUELS DAT CTR VE; Gonzalez R, 2011, BIOMASS BIOENERG, V35, P767, DOI 10.1016/j.biombioe.2010.10.025; Heller MC, 2004, RENEW ENERG, V29, P1023, DOI 10.1016/j.renene.2003.11.018; Humbird D, 2011, PROCESS DESIGN EC BI; Jenkins JC, 2003, FOREST SCI, V49, P12; Kadam KL, 2000, BIOTECHNOL PROGR, V16, P947, DOI 10.1021/bp000127s; Lemoine DM, 2008, ENVIRON RES LETT, V3, DOI 10.1088/1748-9326/3/1/014003; Lemoine DM, 2010, ENVIRON SCI TECHNOL, V44, P7347, DOI 10.1021/es100418p; Lundgren K, 2012, BIGGEST ENGLISH POLL; Mann M, 2001, CLEAN PROD PROCESS, V3, P81, DOI DOI 10.1007/S100980100109; Nesbit TS, 2011, SOUTH J APPL FOR, V35, P61, DOI 10.1093/sjaf/35.2.61; Nuss P, 2013, ENVIRON SCI TECHNOL, V47, P3463, DOI 10.1021/es304312f; ORNL, 2011, US BILL TON UPD BIOM; Peterson SB, 2010, J POWER SOURCES, V195, P2377, DOI 10.1016/j.jpowsour.2009.09.070; Pirraglia A, 2013, BIOENERG RES, V6, P263, DOI 10.1007/s12155-012-9255-6; Pre Consultants, 2013, US LCI DATABASE SIMA; Robinson AL, 2003, ENVIRON SCI TECHNOL, V37, P5081, DOI 10.1021/es034367q; Smith WB., 2009, GEN TECHNICAL REPORT; Spelter H., 2009, N AM WOOD PELLET SEC; Tharakan PJ, 2005, ENERG POLICY, V33, P337, DOI 10.1016/j.enpol.2003.08.004; United States Environmental Protection Agency (USEPA), 2013, INV US GREENH GAS EM; USEIA, 2012, ANN EN OUTL 2012 PRO; USEIA, 2012, MUCH EL IS LOST TRAN; USEIA, 2012, LEV COST NEW GEN RES; USEIA, 2013, REF GAS PRIC GRAD SA; Valatin G, 2012, MARGINAL ABATEMENT C; Wang M, 2013, TREATISE SUSTAINABIL, P231; Wang MQ., 2001, DEV USE GREET 1 6 FU; Wang ZJ, 2012, FUEL, V95, P606, DOI 10.1016/j.fuel.2011.12.032; WDNR, 2010, FOR BIOM AIR EM; Yin RS, 1998, J FOREST, V96, P13	43	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100030	10.1371/journal.pone.0100030	http://dx.doi.org/10.1371/journal.pone.0100030			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937461	gold, Green Submitted, Green Published			2022-12-27	WOS:000338503400064
J	Stoter, M; Kruger, M; Banting, G; Henne-Bruns, D; Knippschild, U				Stoeter, Martin; Krueger, Marc; Banting, George; Henne-Bruns, Doris; Knippschild, Uwe			Microtubules Depolymerization Caused by the CK1 Inhibitor IC261 May Be Not Mediated by CK1 Blockage	PLOS ONE			English	Article							CASEIN-KINASE-I; MITOTIC SPINDLE FORMATION; TRANS-GOLGI-NETWORK; MEMBRANE-PROTEIN; NEGATIVE REGULATION; INDUCED APOPTOSIS; FACTOR RECEPTOR; BETA-CATENIN; BREFELDIN-A; MEIOSIS-I	The ubiquitously expressed serine/threonine specific casein kinase 1 (CK1) family plays important roles in the regulation of various physiological processes. Small-molecule inhibitors, such as the CK1 delta/epsilon selectively inhibitor IC261, have been used to antagonize CK1 phosphorylation events in cells in many studies. Here we present data to show that, similarly to the microtubule destabilizing agent nocodazole, IC261 depolymerizes microtubules in interphase cells. IC261 treatment of interphase cells affects the morphology of the TGN and Golgi apparatus as well as the localization of CK1 delta, which co-localizes with COPI positive membranes. IC261-induced depolymerization of microtubules is rapid, reversible and can be antagonized by pre-treatment of cells with taxol. At lower concentrations of IC261, mitotic spindle microtubule dynamics are affected; this leads to cell cycle arrest and, depending on the cellular background, to apoptosis in a dose-dependent manner. In addition, FACS analysis revealed that IC261 could induce apoptosis independent of cell cycle arrest. In summary this study provides additional and valuable information about various IC261-induced effects that could be caused by microtubule depolymerization rather than by inhibition of CK1. Data from studies that have used IC261 as an inhibitor of CK1 should be interpreted in light of these observations.	[Stoeter, Martin; Krueger, Marc; Henne-Bruns, Doris; Knippschild, Uwe] Ulm Univ Hosp, Dept Gen & Visceral Surg, Ulm, Germany; [Banting, George] Univ Bristol, Sch Biochem, Bristol, Avon, England	Ulm University; University of Bristol	Knippschild, U (corresponding author), Ulm Univ Hosp, Dept Gen & Visceral Surg, Ulm, Germany.	uwe.knippschild@uniklinik-ulm.de		Banting, George/0000-0001-8249-1621	Deutsche Krebshilfe, Dr. Mildred Scheel Stiftung fur Krebsforschung [10-1683-KN2, 10-2237-KN3]; International Graduate School in Molecular Medicine at the Ulm University; DAAD within the ARC program	Deutsche Krebshilfe, Dr. Mildred Scheel Stiftung fur Krebsforschung(Deutsche Krebshilfe); International Graduate School in Molecular Medicine at the Ulm University; DAAD within the ARC program	Deutsche Krebshilfe, Dr. Mildred Scheel Stiftung fur Krebsforschung (http://www.krebshilfe.de/nc/startseite.html), to UK (10-1683-KN2 and 10-2237-KN3). And by funding of the International Graduate School in Molecular Medicine at the Ulm University as well as by a grant from the DAAD to GB and UK within the ARC program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit S, 2002, GENE DEV, V16, P1066, DOI 10.1101/gad.230302; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Behrend L, 2000, ONCOGENE, V19, P5303, DOI 10.1038/sj.onc.1203939; Behrend L, 2000, EUR J CELL BIOL, V79, P240, DOI 10.1078/S0171-9335(04)70027-8; Ben-Nissan G, 2008, PLANT PHYSIOL, V148, P1897, DOI 10.1104/pp.108.129346; BEYAERT R, 1995, J BIOL CHEM, V270, P23293, DOI 10.1074/jbc.270.40.23293; Bischof J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068803; Brandizzi F, 2013, NAT REV MOL CELL BIO, V14, P382, DOI 10.1038/nrm3588; BROCKMAN JL, 1992, P NATL ACAD SCI USA, V89, P9454, DOI 10.1073/pnas.89.20.9454; Brockschmidt C, 2008, GUT, V57, P799, DOI 10.1136/gut.2007.123695; BURKE B, 1982, EMBO J, V1, P1621, DOI 10.1002/j.1460-2075.1982.tb01364.x; Camacho F, 2001, FEBS LETT, V489, P159, DOI 10.1016/S0014-5793(00)02434-0; Cegielska A, 1998, J BIOL CHEM, V273, P1357, DOI 10.1074/jbc.273.3.1357; Cheong JK, 2011, ONCOGENE, V30, P2558, DOI 10.1038/onc.2010.627; Cheong JK, 2011, INT J BIOCHEM CELL B, V43, P465, DOI 10.1016/j.biocel.2010.12.004; Cruciat CM, 2013, SCIENCE; CUKIERMAN E, 1995, SCIENCE, V270, P1999, DOI 10.1126/science.270.5244.1999; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Desagher S, 2001, MOL CELL, V8, P601, DOI 10.1016/S1097-2765(01)00335-5; DHILLON N, 1994, EMBO J, V13, P2777, DOI 10.1002/j.1460-2075.1994.tb06571.x; DONALDSON JG, 1990, J CELL BIOL, V111, P2295, DOI 10.1083/jcb.111.6.2295; Eide EJ, 2002, J BIOL CHEM, V277, P17248, DOI 10.1074/jbc.M111466200; FISH KJ, 1995, J BIOL CHEM, V270, P14875, DOI 10.1074/jbc.270.25.14875; Flajolet M, 2007, P NATL ACAD SCI USA, V104, P4159, DOI 10.1073/pnas.0611236104; Frank HG, 2000, CANCER GENET CYTOGEN, V116, P16, DOI 10.1016/S0165-4608(99)00107-7; FREEMAN AE, 1975, IN VITRO CELL DEV B, V11, P107; Funayama H., 1997, PLACENTA, V18, P191; Gault WJ, 2012, J CELL BIOL, V196, P605, DOI 10.1083/jcb.201107137; Giamas G, 2007, BIOCHEM J, V406, P389, DOI 10.1042/BJ20070091; Girotti M, 1996, J CELL SCI, V109, P2915; GONATAS JO, 1995, J CELL SCI, V108, P457; GRAVES PR, 1995, J BIOL CHEM, V270, P21689, DOI 10.1074/jbc.270.37.21689; Greer YE, 2014, MOL BIOL CELL; Greer YE, 2011, J CELL BIOL, V192, P993, DOI 10.1083/jcb.201011111; Grietzen KF, 1999, J BIOL CHEM, V274, P32063, DOI 10.1074/jbc.274.45.32063; Gross SD, 1998, CELL SIGNAL, V10, P699, DOI 10.1016/S0898-6568(98)00042-4; HAMILTON BT, 1982, EUR J CELL BIOL, V28, P190; Hottecke N, 2010, BIOORG MED CHEM LETT, V20, P2958, DOI 10.1016/j.bmcl.2010.02.110; HORN M, 1994, BIOCHEM J, V301, P69, DOI 10.1042/bj3010069; HRONOVSKY V, 1978, ACTA VIROL, V22, P123; Hutchinson JA, 2011, J BIOL CHEM, V286, P8688, DOI 10.1074/jbc.M110.141754; Ikeda K, 2011, MOL BIOL CELL, V22, P1321, DOI 10.1091/mbc.E10-09-0741; Izeradjene K, 2004, CANCER RES, V64, P8036, DOI 10.1158/0008-5472.CAN-04-0762; Kattapuram T, 2005, J BIOL CHEM, V280, P15340, DOI 10.1074/jbc.M500214200; Li GB, 2004, J BIOL CHEM, V279, P15938, DOI 10.1074/jbc.M314116200; LIN CM, 1981, J BIOL CHEM, V256, P9242; LIPPINCOTT S, 1989, BONE, V10, P265, DOI 10.1016/8756-3282(89)90063-X; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Mashhoon N, 2000, J BIOL CHEM, V275, P20052, DOI 10.1074/jbc.M001713200; Milne DM, 2001, EXP CELL RES, V263, P43, DOI 10.1006/excr.2000.5100; Murakami A, 1999, J BIOL CHEM, V274, P3804, DOI 10.1074/jbc.274.6.3804; ORCI L, 1991, CELL, V64, P1183; Peters JM, 1999, NATURE, V401, P345, DOI 10.1038/43830; Petronczki M, 2006, CELL, V126, P1049, DOI 10.1016/j.cell.2006.07.029; Popoff V, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005231; REAVES B, 1992, BIOCHEM J, V283, P313, DOI 10.1042/bj2830313; RISNIK VV, 1988, CELL MOL NEUROBIOL, V8, P315, DOI 10.1007/BF00711173; Rivers A, 1998, J BIOL CHEM, V273, P15980, DOI 10.1074/jbc.273.26.15980; Rumpf C, 2010, CELL CYCLE, V9, P2657, DOI 10.4161/cc.9.13.12146; SAMSON F, 1979, J PHARMACOL EXP THER, V208, P411; Sillibourne JE, 2002, J MOL BIOL, V322, P785, DOI 10.1016/S0022-2836(02)00857-4; SOMERS KD, 1968, J NATL CANCER I, V40, P1053; Stoter M, 2005, ONCOGENE, V24, P7964, DOI 10.1038/sj.onc.1208941; Swiatek W, 2006, J BIOL CHEM, V281, P12233, DOI 10.1074/jbc.M510580200; Swiatek W, 2004, J BIOL CHEM, V279, P13011, DOI 10.1074/jbc.M304682200; Takenaka Y, 2004, MOL CELL BIOL, V24, P4395, DOI 10.1128/MCB.24.10.4395-4406.2004; Toyoshima M, 2012, P NATL ACAD SCI USA, V109, P9545, DOI 10.1073/pnas.1121119109; VANCURA A, 1994, J BIOL CHEM, V269, P19271; Vielhaber E, 2000, MOL CELL BIOL, V20, P4888, DOI 10.1128/MCB.20.13.4888-4899.2000; Wang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063173; WANG PC, 1992, MOL BIOL CELL, V3, P275, DOI 10.1091/mbc.3.3.275; Wang XM, 1996, MOL CELL BIOL, V16, P5375; Wolff S, 2005, BBA-MOL CELL RES, V1745, P196, DOI 10.1016/j.bbamcr.2005.05.004; Yu S, 2002, MOL BIOL CELL, V13, P2559, DOI 10.1091/mbc.E02-04-0189; Zhao Y, 2004, J BIOL CHEM, V279, P30844, DOI 10.1074/jbc.M404651200; ZIEVE GW, 1980, EXP CELL RES, V126, P397, DOI 10.1016/0014-4827(80)90279-7; Zyss D, 2011, J CELL BIOL, V195, P781, DOI 10.1083/jcb.201106025	77	31	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100090	10.1371/journal.pone.0100090	http://dx.doi.org/10.1371/journal.pone.0100090			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937750	gold, Green Published, Green Submitted			2022-12-27	WOS:000338503400073
J	Su, HW; McKelvey, J; Rollins, D; Zhang, M; Brightsmith, DJ; Derr, J; Zhang, SP				Su, Hongwen; McKelvey, Jessica; Rollins, Dale; Zhang, Michael; Brightsmith, Donald J.; Derr, James; Zhang, Shuping			Cultivable Bacterial Microbiota of Northern Bobwhite (Colinus virginianus): A New Reservoir of Antimicrobial Resistance?	PLOS ONE			English	Article							ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; CLOACAL MICROBIOTA; INTESTINAL FLORA; GUT MICROBIOTA; WILD; QUAIL; PAENIBACILLUS; PREVALENCE	The northern bobwhite (Colinus virginianus) is an ecologically and economically important avian species. At the present time, little is known about the microbial communities associated with these birds. As the first step to create a quail microbiology knowledge base, the current study conducted an inventory of cultivable quail tracheal, crop, cecal, and cloacal microbiota and associated antimicrobial resistance using a combined bacteriology and DNA sequencing approach. A total of 414 morphologically unique bacterial colonies were selected from nonselective aerobic and anaerobic cultures, as well as selective and enrichment cultures. Analysis of the first 500-bp 16S rRNA gene sequences in conjunction with biochemical identifications revealed 190 non-redundant species-level taxonomic units, representing 160 known bacterial species and 30 novel species. The bacterial species were classified into 4 phyla, 14 orders, 37 families, and 59 or more genera. Firmicutes was the most commonly encountered phylum (57%) followed by Actinobacteria (24%), Proteobacteria (17%) and Bacteroidetes (0.02%). Extensive diversity in the species composition of quail microbiota was observed among individual birds and anatomical locations. Quail microbiota harbored several opportunistic pathogens, such as E. coli and Ps. aeruginosa, as well as human commensal organisms, including Neisseria species. Phenotypic characterization of selected bacterial species demonstrated a high prevalence of resistance to the following classes of antimicrobials: phenicol, macrolide, lincosamide, quinolone, and sulphate. Data from the current investigation warrant further investigation on the source, transmission, pathology, and control of antimicrobial resistance in wild quail populations.	[Su, Hongwen; McKelvey, Jessica; Zhang, Michael; Brightsmith, Donald J.; Derr, James; Zhang, Shuping] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Pathobiol, College Stn, TX USA; [Rollins, Dale] Texas AgriLife Res, Rolling Plains Quail Res Fdn, San Angelo, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M AgriLife Research	Zhang, SP (corresponding author), Univ Missouri, Coll Vet Med, Dept Vet Pathobiol, Columbia, MO 65211 USA.	zhangshup@missouri.edu		Brightsmith, Donald/0000-0002-3306-6490	Rolling Plains Quail Research Ranch Foundation	Rolling Plains Quail Research Ranch Foundation	This work was financially supported by the Rolling Plains Quail Research Ranch Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Clinical and Laboratory Standards Institute, 2007, PERF STAND ANT SUSC; Cole D, 2005, EMERG INFECT DIS, V11, P935; Collado MC, 2007, J FOOD PROTECT, V70, P2799, DOI 10.4315/0362-028X-70.12.2799; DeMaso SJ, 2002, NATL QUAIL S, P206; Diaz-Sanchez S, 2012, EUR J WILDLIFE RES, V58, P99, DOI 10.1007/s10344-011-0547-5; El-Hadad ME, 2011, BRAZ J MICROBIOL, V42, P105, DOI 10.1590/S1517-83822011000100014; Ferro PJ, 2012, AVIAN DIS, V56, P858, DOI 10.1637/10197-041012-ResNote.1; Girardin H, 2002, J FOOD PROTECT, V65, P806, DOI 10.4315/0362-028X-65.5.806; Glunder G, 2002, DEUT TIERARZTL WOCH, V109, P266; Gollwitzer ES, 2013, PHARM THER; Guenther S, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00246; Helm JD, 1999, AVIAN DIS, V43, P788, DOI 10.2307/1592750; Hidasi HW, 2013, J ZOO WILDLIFE MED, V44, P1, DOI 10.1638/1042-7260-44.1.1; Janda JM, 2007, J CLIN MICROBIOL, V45, P2761, DOI 10.1128/JCM.01228-07; Kamada N, 2013, NAT REV IMMUNOL, V13, P321, DOI 10.1038/nri3430; Kohl KD, 2012, J COMP PHYSIOL B, V182, P591, DOI 10.1007/s00360-012-0645-z; Kozak GK, 2009, APPL ENVIRON MICROB, V75, P559, DOI 10.1128/AEM.01821-08; Lan PTN, 2002, MICROBIOL IMMUNOL, V46, P371, DOI 10.1111/j.1348-0421.2002.tb02709.x; Lutz JK, 2011, INT J ENV RES PUB HE, V8, P554, DOI 10.3390/ijerph8020554; Mackie RI, 1999, AM J CLIN NUTR, V69, p1035S, DOI 10.1093/ajcn/69.5.1035s; MARKARYAN M, 1975, Veterinarno Meditsinski Nauki, V12, P33; Musso G, 2011, ANNU REV MED, V62, P361, DOI 10.1146/annurev-med-012510-175505; Nikkari S, 2002, EMERG INFECT DIS, V8, P188, DOI 10.3201/eid0802.010150; Pragman AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047305; Singh IM, 2004, VET REC, V155, P29, DOI 10.1136/vr.155.1.29; Stedt Johan, 2014, Infection Ecology & Epidemiology, V4, P21565, DOI 10.3402/iee.v4.21565; Stern NJ, 2005, J FOOD PROTECT, V68, P1450, DOI 10.4315/0362-028X-68.7.1450; Terhune TM, 2010, ECOL APPL, V20, P1040, DOI 10.1890/09-1106.1; Texas Quail Study Group, 2009, P 2009 TEX QUAIL STU; U.S. Department of the Interior U.S. Fish and Wildlife Service & U.S. Department of Commerce U.S. Census Bureau, 2013, 2011 NAT SURV FISH H; Urban KN, 2013, J WILDLIFE DIS, V49, P427, DOI 10.7589/2011-05-133; van Dongen WFD, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-11; Waite DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035803; Wang LY, 2013, ANTON LEEUW INT J G, V104, P675, DOI 10.1007/s10482-013-9974-5; Williams HD, 2012, THORAX, V67, P465, DOI 10.1136/thoraxjnl-2011-201498; Xenoulis PG, 2010, VET MICROBIOL, V146, P320, DOI 10.1016/j.vetmic.2010.05.024; Zoetendal EG, 2004, J NUTR, V134, P465, DOI 10.1093/jn/134.2.465	37	18	20	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99826	10.1371/journal.pone.0099826	http://dx.doi.org/10.1371/journal.pone.0099826			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937705	Green Published, gold, Green Submitted			2022-12-27	WOS:000338503400041
J	Yuen, CM; Weyenga, HO; Kim, AA; Malika, T; Muttai, H; Katana, A; Nganga, L; Cain, KP; De Cock, KM				Yuen, Courtney M.; Weyenga, Herman O.; Kim, Andrea A.; Malika, Timothy; Muttai, Hellen; Katana, Abraham; Nganga, Lucy; Cain, Kevin P.; De Cock, Kevin M.			Comparison of Trends in Tuberculosis Incidence among Adults Living with HIV and Adults without HIV - Kenya, 1998-2012	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; SOUTH-AFRICA; RISK-FACTORS; OPPORTUNITIES; TRANSMISSION; EPIDEMIC; OUTCOMES; NAIROBI; CARE	Background: In Kenya, the comparative incidences of tuberculosis among persons with and without HIV have not been described, and the differential impact of public health interventions on tuberculosis incidence in the two groups is unknown. Methods: We estimated annual tuberculosis incidence stratified by HIV status during 2006-2012 based on the numbers of reported tuberculosis patients with and without HIV infection, the prevalence of HIV infection in the general population, and the total population. We also made crude estimates of annual tuberculosis incidence stratified by HIV status during 1998-2012 by assuming a constant ratio of HIV prevalence among tuberculosis patients compared to the general population. Results: Tuberculosis incidence among both adults with HIV and adults without HIV increased during 1998-2004 then remained relatively stable until 2007. During 2007-2012, tuberculosis incidence declined by 28-44% among adults with HIV and by 11-26% among adults without HIV, concurrent with an increase in antiretroviral therapy uptake. In 2012, tuberculosis incidence among adults with HIV (1,839-1,936 cases/100,000 population) was still eight times as high as among adults without HIV (231-238 cases/100,000 population), and approximately one third of tuberculosis cases were attributable to HIV. Conclusions: Although tuberculosis incidence has declined among adults with and without HIV, the persistent high incidence of tuberculosis among those with HIV and the disparity between the two groups are concerning. Early diagnosis of HIV, early initiation of antiretroviral therapy, regular screening for tuberculosis, and isoniazid preventive therapy among persons with HIV, as well as tuberculosis control in the general population, are required to address these issues.	[Yuen, Courtney M.] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Div TB Eliminat, Atlanta, GA USA; [Weyenga, Herman O.] Minist Hlth, Div Leprosy TB & Lung Dis, Nairobi, Kenya; [Kim, Andrea A.; Malika, Timothy; Muttai, Hellen; Katana, Abraham; Nganga, Lucy; Cain, Kevin P.; De Cock, Kevin M.] Ctr Dis Control & Prevent Kenya, Nairobi, Kenya	Centers for Disease Control & Prevention - USA	Cain, KP (corresponding author), Ctr Dis Control & Prevent Kenya, Nairobi, Kenya.	kcain@cdc.gov	Muttai, Hellen/ABH-7164-2020	Yuen, Courtney/0000-0002-5219-2599				Akolo C, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000171.pub3; [Anonymous], 2011, GUID INT TUB CAS FIN; Chakaya J, 2008, INT J TUBERC LUNG D, V12, P1274; Chakaya JM, 2008, INT J TUBERC LUNG D, V12, P424; Corbett EL, 2006, LANCET, V367, P926, DOI 10.1016/S0140-6736(06)68383-9; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Division of Leprosy,, 2013, ANN REP 2012; Division of Leprosy Tuberculosis and Lung Disease Ministry of Health Kenya, 2012, ANN REP 2011; Dye C, 2013, ANNU REV PUBL HEALTH, V34, P271, DOI 10.1146/annurev-publhealth-031912-114431; Getahun Haileyesus, 2012, Morbidity and Mortality Weekly Report, V61, P484; Gupta A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034156; Harries AD, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17396; Kwan CK, 2011, CLIN MICROBIOL REV, V24, P351, DOI 10.1128/CMR.00042-10; Lawn SD, 2009, AIDS, V23, P1717, DOI 10.1097/QAD.0b013e32832d3b6d; Middelkoop K, 2011, JAIDS-J ACQ IMM DEF, V56, P263, DOI 10.1097/QAI.0b013e31820413b3; Muture BN, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-696; Nardell E, 2010, INT J TUBERC LUNG D, V14, P1233; National AIDS and STI Control Programme Ministry of Health Kenya, 2009, KEN AIDS IND SURV FI; National AIDS and STI Control Programme Ministry of Health Kenya, 2012, KEN AIDS EP UPD 2011; Obermeyer CM, 2013, BMC INT HEALTH HUM R, V13, DOI 10.1186/1472-698X-13-6; Pretorius C, 2014, AIDS, V28, pS25, DOI 10.1097/QAD.0000000000000085; Programme NAaSC, 2013, KEN AIDS IND SURV 20; RICHARDS SB, 1995, TUBERCLE LUNG DIS, V76, P11, DOI 10.1016/0962-8479(95)90572-3; Samandari T, 2011, LANCET, V377, P1588, DOI 10.1016/S0140-6736(11)60204-3; Suthar AB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001270; Van Rie A, 2011, JAIDS-J ACQ IMM DEF, V56, P349, DOI 10.1097/QAI.0b013e3181f9fb39; van't Hoog AH, 2012, INT J TUBERC LUNG D, V16, P1649, DOI 10.5588/ijtld.12.0135; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Williams BG, 2010, P NATL ACAD SCI USA, V107, P19485, DOI 10.1073/pnas.1005660107	29	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99880	10.1371/journal.pone.0099880	http://dx.doi.org/10.1371/journal.pone.0099880			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937804	gold, Green Submitted, Green Published			2022-12-27	WOS:000338503400049
J	Dimitrijevic, A; Qin, ZX; Aswad, DW				Dimitrijevic, Aleksandra; Qin, Zhenxia; Aswad, Dana W.			Isoaspartyl Formation in Creatine Kinase B Is Associated with Loss of Enzymatic Activity; Implications for the Linkage of Isoaspartate Accumulation and Neurological Dysfunction in the PIMT Knockout Mouse	PLOS ONE			English	Article							PROTEIN CARBOXYL METHYLTRANSFERASE; AGE-DAMAGED PROTEINS; O-METHYLTRANSFERASE; BRAIN-TYPE; REPAIR METHYLTRANSFERASE; OXIDATIVE MODIFICATION; ALZHEIMERS-DISEASE; PROTEOMIC ANALYSIS; ASPARTYL RESIDUES; MASS-SPECTROMETRY	Isoaspartate (isoAsp) formation is a common type of spontaneous protein damage that is normally kept in check by the repair enzyme protein-L-isoaspartyl methyltransferase (PIMT). PIMT-KO (knockout) mice exhibit a pronounced neuropathology highlighted by death from an epileptic seizure at 30 to 60 days after birth. The mechanisms by which isoaspartyl damage disrupts normal brain function are incompletely understood. Proteomic analysis of the PIMT-KO mouse brain has shown that a number of key neuronal proteins accumulate high levels of isoAsp, but the extent to which their cellular functions is altered has yet to be determined. One of the major neuronal targets of PIMT is creatine kinase B (CKB), a well-characterized enzyme whose activity is relatively easy to assay. We show here that (1) the specific activity of CKB is significantly reduced in the brains of PIMT-deficient mice, (2) that in vitro aging of recombinant CKB results in significant accumulation of isoAsp sites with concomitant loss of enzymatic activity, and (3) that incubation of in vitro aged CKB with PIMT and its methyl donor S-adenosyl-L-methionine substantially repairs the aged CKB with regard to both its isoAsp content and its enzymatic activity. These results, combined with similarity in phenotypes of PIMT-KO and CKB-KO mice, suggests that loss of normal CKB structure and function contributes to the mechanisms by which isoAsp accumulation leads to CNS dysfunction in the PIMT-KO mouse.	[Dimitrijevic, Aleksandra; Qin, Zhenxia; Aswad, Dana W.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA	University of California System; University of California Irvine	Aswad, DW (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA.	dwaswad@uci.edu			National Institutes of Health, USA [NS-17269]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017269] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding provided by National Institutes of Health, USA, grant # NS-17269 to DWA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksenov M, 2000, J NEUROCHEM, V74, P2520, DOI 10.1046/j.1471-4159.2000.0742520.x; Andres RH, 2008, BRAIN RES BULL, V76, P329, DOI 10.1016/j.brainresbull.2008.02.035; Aswad DW, 2000, J PHARMACEUT BIOMED, V21, P1129, DOI 10.1016/S0731-7085(99)00230-7; ASWAD DW, 1984, J BIOL CHEM, V259, P714; Barbariga M, 2014, J BIOL CHEM, V289, P3736, DOI 10.1074/jbc.M113.520981; BESSMAN SP, 1985, ANNU REV BIOCHEM, V54, P831, DOI 10.1146/annurev.bi.54.070185.004151; BOIVIN D, 1995, BIOCHEM J, V309, P993, DOI 10.1042/bj3090993; BRENNAN TV, 1994, J BIOL CHEM, V269, P24586; Burklen TS, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/35936; Cantor JR, 2009, BIOCHEMISTRY-US, V48, P11026, DOI 10.1021/bi901397h; Carter WG, 2008, BIOCHEMISTRY-US, V47, P10757, DOI 10.1021/bi8013467; Chavous DA, 2001, P NATL ACAD SCI USA, V98, P14814, DOI 10.1073/pnas.251446498; Cimmino A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003258; Clarke S, 2003, AGEING RES REV, V2, P263, DOI 10.1016/S1568-1637(03)00011-4; Curnis F, 2006, J BIOL CHEM, V281, P36466, DOI 10.1074/jbc.M604812200; D'Angelo S, 2005, FREE RADICAL BIO MED, V38, P908, DOI 10.1016/j.freeradbiomed.2004.12.015; Dai SJ, 2013, ANAL CHEM, V85, P2423, DOI 10.1021/ac303428h; Desrosiers Richard R, 2011, Curr Aging Sci, V4, P8; DeVry CG, 1999, J HUM GENET, V44, P275, DOI 10.1007/s100380050161; DILIBERTO EJ, 1976, J NEUROCHEM, V26, P1159, DOI 10.1111/j.1471-4159.1976.tb07001.x; Eder M, 1999, PROTEIN SCI, V8, P2258; Eliuk SM, 2007, CHEM RES TOXICOL, V20, P1260, DOI 10.1021/tx7000948; Ikegaya Y, 2001, HIPPOCAMPUS, V11, P287, DOI 10.1002/hipo.1043; Ingrosso D, 2000, EUR J BIOCHEM, V267, P4397, DOI 10.1046/j.1432-1327.2000.01485.x; Jazin E, 2010, NAT REV NEUROSCI, V11, P9, DOI 10.1038/nrn2754; JOHNSON BA, 1987, J BIOL CHEM, V262, P12283; JOHNSON BA, 1993, J BIOL CHEM, V268, P6174; JOHNSON BA, 1991, NEUROBIOL AGING, V12, P19, DOI 10.1016/0197-4580(91)90034-H; JOHNSON BA, 1987, J BIOL CHEM, V262, P5622; JOHNSON BA, 1991, ANAL BIOCHEM, V192, P384, DOI 10.1016/0003-2697(91)90553-6; JOHNSON BA, 1989, J BIOL CHEM, V264, P14262; Jost CR, 2002, EUR J NEUROSCI, V15, P1692, DOI 10.1046/j.1460-9568.2002.02001.x; Khare S, 2009, MECH AGEING DEV, V130, P670, DOI 10.1016/j.mad.2009.08.002; Khoury MK, 2010, ANAL BIOCHEM, V397, P129, DOI 10.1016/j.ab.2009.09.041; Kim E, 1997, P NATL ACAD SCI USA, V94, P6132, DOI 10.1073/pnas.94.12.6132; Kosugi S, 2008, BIOCHEM BIOPH RES CO, V371, P22, DOI 10.1016/j.bbrc.2008.03.109; Liu M, 2012, ANAL CHEM, V84, P1056, DOI 10.1021/ac202652z; MACFARLANE DE, 1984, J BIOL CHEM, V259, P1357; Mamula MJ, 1999, J BIOL CHEM, V274, P22321, DOI 10.1074/jbc.274.32.22321; MCFADDEN PN, 1987, P NATL ACAD SCI USA, V84, P2595, DOI 10.1073/pnas.84.9.2595; McLeish MJ, 2005, CRIT REV BIOCHEM MOL, V40, P1, DOI 10.1080/10409230590918577; MIZOBUCHI M, 1994, J NEUROCHEM, V62, P322; MURRAY ED, 1984, J BIOL CHEM, V259, P722; Nuss JE, 2009, AGING-US, V1, P557, DOI 10.18632/aging.100055; OCONNOR CM, 1988, J BIOL CHEM, V263, P1386; Okunuki Y, 2008, MOL VIS, V14, P1094; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; PARANANDI MV, 1994, J BIOL CHEM, V269, P243; Patananan AN, 2014, J BIOL CHEM; Qin Z, 2014, INVEST OPHTHALMOL VI; Qin ZX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080758; Reissner KJ, 2006, J BIOL CHEM, V281, P8389, DOI 10.1074/jbc.M510716200; Shimizu T, 2005, BIOL PHARM BULL, V28, P1590, DOI 10.1248/bpb.28.1590; Steen C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010811; Tetsuka S, 2013, J NEUROL SCI, V335, P48, DOI 10.1016/j.jns.2013.08.022; Vitali R, 2004, BEHAV BRAIN RES, V153, P129, DOI 10.1016/j.bbr.2003.11.007; WALLIMANN T, 1992, BIOCHEM J, V281, P21, DOI 10.1042/bj2810021; Yamamoto A, 1998, J NEUROSCI, V18, P2063; Young GW, 2005, J BIOL CHEM, V280, P26094, DOI 10.1074/jbc.M503624200; Zhu JX, 2006, J BIOL CHEM, V281, P33802, DOI 10.1074/jbc.M606958200; Zhu L, 2013, INVEST OPHTH VIS SCI, V54, P5675, DOI 10.1167/iovs.13-12050	61	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100622	10.1371/journal.pone.0100622	http://dx.doi.org/10.1371/journal.pone.0100622			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955845	Green Published, gold			2022-12-27	WOS:000338917900075
J	Tram, KH; Bertrand, JT				Khai Hoan Tram; Bertrand, Jane T.			Correlates of Male Circumcision in Eastern and Southern African Countries: Establishing a Baseline Prior to VMMC Scale-Up	PLOS ONE			English	Article							MEDICAL MALE CIRCUMCISION; HIV PREVENTION; INFECTION; ACCEPTABILITY; COMMUNITIES	Background: Despite the importance of male circumcision (MC) prevalence to HIV prevention efforts in Eastern and Southern Africa, there has been no systematic analysis on the correlates of male circumcision. This analysis identifies correlates of MC in 12 countries in the region with available data. Methods: Data from the male questionnaire of DHS surveys collected between 2006-2011 in Ethiopia, Kenya, Lesotho, Malawi, Mozambique, Namibia, Rwanda, Swaziland, Tanzania, Uganda, Zambia, and Zimbabwe were analyzed. The dependent variable was self-reported male circumcision status. Independent variables included age, education, wealth quintile, place of residence, ethnicity, religion and region. Bivariate and multivariate analyses were conducted separately for each country. Results: MC prevalence ranged from 8.2 percent in Swaziland to 92.2 percent in Ethiopia. Bivariate analyses showed a consistent positive association between age (being older) and male circumcision. Education, wealth quintile, and place of residence were either not significantly related or differed in the direction of the relationship by country. Multivariate logistic regression showed three variables consistently associated with MC status: age (being older), religion (being Muslim) and ethnicity. Discussion: These data were collected prior to the scale-up of voluntary medical male circumcision (VMMC) programs in 11 of the 12 countries. As the VMMC scale-up intensifies in countries across Eastern and Southern Africa, the correlates of VMMC are likely to change, with (younger) age and education emerging as key correlates of VMMC performed in medical settings. The centuries-long tradition among Muslims to circumcise should continue to favor MC among this group. Non-circumcising ethnicities may become more open to MC if promoted as a health practice for decreasing HIV risk.	[Khai Hoan Tram] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Bertrand, Jane T.] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Global Hlth Syst & Dev, New Orleans, LA USA	Stanford University; Tulane University	Tram, KH (corresponding author), Stanford Univ, Sch Med, Stanford, CA 94305 USA.	ktram@stanford.edu		Tram, Khai Hoan/0000-0003-1129-7674				Adetunji J, 2001, J BIOSOC SCI, V33, P121, DOI 10.1017/S0021932001001213; Auvert B, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001509; Avac National Empowerment Network of People Living with HIV/AIDS in Kenya Sonke Gender Justice Network and Uganda Network of AIDS Service Organizations, 2012, CALL ACT VOL MED MAL; Ben Chaim J, 2005, ISR MED ASSOC J, V7, P368; BONGAARTS J, 1989, AIDS, V3, P373, DOI 10.1097/00002030-198906000-00006; Dowsett GW, 2007, REPROD HEALTH MATTER, V15, P33, DOI 10.1016/S0968-8080(07)29302-4; FINK AJ, 1986, NEW ENGL J MED, V315, P1167; Glasier A, 2006, LANCET, V368, P1595, DOI 10.1016/S0140-6736(06)69478-6; Halperin DT, 1999, LANCET, V354, P1813, DOI 10.1016/S0140-6736(99)03421-2; Jennings L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0079524; Khumalo-Sakutukwa G, 2013, CULT HEALTH SEX, V15, P1085, DOI 10.1080/13691058.2013.807519; Lissouba P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000309; Macintyre K., 2013, EXPLORING ASPECTS DE; Mahler HR, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001131; Mattson CL, 2005, AIDS CARE, V17, P182, DOI 10.1080/09540120512331325671; MOSES S, 1990, INT J EPIDEMIOL, V19, P693, DOI 10.1093/ije/19.3.693; Mwandi Z, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001130; STEIN MT, 1982, J FAM PRACTICE, V15, P47; Wambura M, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-373; Weiss HA, 2008, AIDS, V22, P567, DOI 10.1097/QAD.0b013e3282f3f406; World Health Organization, 2007, NEW DAT MAL CIRC HIV	21	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100775	10.1371/journal.pone.0100775	http://dx.doi.org/10.1371/journal.pone.0100775			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955963	gold, Green Published, Green Submitted			2022-12-27	WOS:000338917900094
J	Kunz, S; Pesquet, E; Kleczkowski, LA				Kunz, Sabine; Pesquet, Edouard; Kleczkowski, Leszek A.			Functional Dissection of Sugar Signals Affecting Gene Expression in Arabidopsis thaliana	PLOS ONE			English	Article							PLANT-GROWTH; SUCROSE; GLUCOSE; CARBON; CELLS; BIOSYNTHESIS; DEGRADATION; RESPONSES; 3-O-METHYLGLUCOSE; TRANSCRIPTOME	Background: Sugars modulate expression of hundreds of genes in plants. Previous studies on sugar signaling, using intact plants or plant tissues, were hampered by tissue heterogeneity, uneven sugar transport and/or inter-conversions of the applied sugars. This, in turn, could obscure the identity of a specific sugar that acts as a signal affecting expression of given gene in a given tissue or cell-type. Methodology/Principal Findings: To bypass those biases, we have developed a novel biological system, based on stem-cell-like Arabidopsis suspension culture. The cells were grown in a hormone-free medium and were sustained on xylose as the only carbon source. Using functional genomics we have identified 290 sugar responsive genes, responding rapidly (within 1 h) and specifically to low concentration (1 mM) of glucose, fructose and/or sucrose. For selected genes, the true nature of the signaling sugar molecules and sites of sugar perception were further clarified using non-metabolizable sugar analogues. Using both transgenic and wild-type A. thaliana seedlings, it was shown that the expression of selected sugar-responsive genes was not restricted to a specific tissue or cell type and responded to photoperiod-related changes in sugar availability. This suggested that sugar-responsiveness of genes identified in the cell culture system was not biased toward heterotrophic background and resembled that in whole plants. Conclusions: Altogether, our research strategy, using a combination of cell culture and whole plants, has provided an unequivocal evidence for the identity of sugar-responsive genes and the identity of the sugar signaling molecules, independently from their inter-conversions or use for energy metabolism.	[Kunz, Sabine; Pesquet, Edouard; Kleczkowski, Leszek A.] Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, S-90187 Umea, Sweden	Umea University	Pesquet, E (corresponding author), Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, S-90187 Umea, Sweden.	edouard.pesquet@umu.se; leszek.kleczkowski@umu.se	; Pesquet, Edouard/K-5627-2017	Kleczkowski, Leszek A./0000-0001-8685-9665; Pesquet, Edouard/0000-0002-6959-3284	Swedish Research Council; Bio4Energy; Kempe foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Bio4Energy; Kempe foundation	This research was supported, in part, by the Swedish Research Council (LAK, EP) and by Bio4Energy and the Kempe foundation (EP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blasing OE, 2005, PLANT CELL, V17, P3257, DOI 10.1105/tpc.105.035261; CARPITA NC, 1982, PLANT PHYSIOL, V69, P1173, DOI 10.1104/pp.69.5.1173; Caspar Timothy, 1994, V27, P913; Chandran D, 2003, J BIOL CHEM, V278, P44320, DOI 10.1074/jbc.M308490200; Chaudhuri B, 2008, PLANT J, V56, P948, DOI 10.1111/j.1365-313X.2008.03652.x; Cho YH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001263; Ciereszko I, 2005, J PLANT PHYSIOL, V162, P343, DOI 10.1016/j.jplph.2004.08.003; Contento AL, 2004, PLANT PHYSIOL, V135, P2330, DOI 10.1104/pp.104.044362; Cortes S, 2003, PLANT PHYSIOL, V131, P824, DOI 10.1104/pp.010538; Fernie AR, 2001, PLANT PHYSIOL, V125, P1967, DOI 10.1104/pp.125.4.1967; Gibon Y, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r76; Hannah MA, 2005, PLOS GENET, V1, P179, DOI 10.1371/journal.pgen.0010026; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Ito Y, 2006, SCIENCE, V313, P842, DOI 10.1126/science.1128436; JANG JC, 1994, PLANT CELL, V6, P1665, DOI 10.1105/tpc.6.11.1665; Jung B, 2009, PLANT CELL, V21, P876, DOI 10.1105/tpc.108.062612; Kato A, 2007, J PLANT RES, V120, P713, DOI 10.1007/s10265-007-0117-9; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Koch KE, 1996, ANNU REV PLANT PHYS, V47, P509, DOI 10.1146/annurev.arplant.47.1.509; Li P, 2011, P NATL ACAD SCI USA, V108, P3436, DOI 10.1073/pnas.1018665108; Lloyd JC, 2004, J EXP BOT, V55, P1221, DOI 10.1093/jxb/erh143; Mandadi KK, 2009, PLANT PHYSIOL, V150, P1930, DOI 10.1104/pp.109.139220; Matiolli CC, 2011, PLANT PHYSIOL, V157, P692, DOI 10.1104/pp.111.181743; Menand B, 2002, P NATL ACAD SCI USA, V99, P6422, DOI 10.1073/pnas.092141899; Osuna D, 2007, PLANT J, V49, P463, DOI 10.1111/j.1365-313X.2006.02979.x; Paparelli E, 2013, PLANT CELL, V25, P3760, DOI 10.1105/tpc.113.115519; Pesquet E, 2010, CURR BIOL, V20, P744, DOI 10.1016/j.cub.2010.02.057; Robaglia C, 2012, CURR OPIN PLANT BIOL, V15, P301, DOI 10.1016/j.pbi.2012.01.012; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Sairanen I, 2012, PLANT CELL, V24, P4907, DOI 10.1105/tpc.112.104794; Sinha AK, 2002, PLANT PHYSIOL, V128, P1480, DOI 10.1104/pp.010771; Smith AM, 2007, PLANT CELL ENVIRON, V30, P1126, DOI 10.1111/j.1365-3040.2007.01708.x; Stevenson CC, 2009, PLANT GROWTH REGUL, V59, P255, DOI 10.1007/s10725-009-9412-x; Stitt M, 2007, FUNCT PLANT BIOL, V34, P526, DOI 10.1071/FP06249; Sugimoto K, 2011, TRENDS CELL BIOL, V21, P212, DOI 10.1016/j.tcb.2010.12.004; Usadel B, 2008, PLANT PHYSIOL, V146, P1834, DOI 10.1104/pp.107.115592; Vaughn MW, 2002, P NATL ACAD SCI USA, V99, P10876, DOI 10.1073/pnas.172198599; Villadsen D, 2004, PLANT MOL BIOL, V55, P467, DOI 10.1007/s11103-004-1050-0; Weltmeier F, 2009, PLANT MOL BIOL, V69, P107, DOI 10.1007/s11103-008-9410-9; Xiong Y, 2013, NATURE, V496, P181, DOI 10.1038/nature12030; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568	41	38	44	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100312	10.1371/journal.pone.0100312	http://dx.doi.org/10.1371/journal.pone.0100312			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950222	gold, Green Published, Green Submitted			2022-12-27	WOS:000338276300062
J	Latire, T; Legendre, F; Bigot, N; Carduner, L; Kellouche, S; Bouyoucef, M; Carreiras, F; Marin, F; Lebel, JM; Galera, P; Serpentini, A				Latire, Thomas; Legendre, Florence; Bigot, Nicolas; Carduner, Ludovic; Kellouche, Sabrina; Bouyoucef, Mouloud; Carreiras, Franck; Marin, Frederic; Lebel, Jean-Marc; Galera, Philippe; Serpentini, Antoine			Shell Extracts from the Marine Bivalve Pecten maximus Regulate the Synthesis of Extracellular Matrix in Primary Cultured Human Skin Fibroblasts	PLOS ONE			English	Article							I COLLAGEN EXPRESSION; PINCTADA-MAXIMA; SCLERODERMA FIBROBLASTS; HALIOTIS-TUBERCULATA; CARBONIC-ANHYDRASE; PROTEOMIC ANALYSIS; NACRE FORMATION; ORGANIC MATRIX; WOUND REPAIR; C-KROX	Mollusc shells are composed of more than 95% calcium carbonate and less than 5% of an organic matrix consisting mostly of proteins, glycoproteins and polysaccharides. Previous studies have elucidated the biological activities of the shell matrices from bivalve molluscs on skin, especially on the expression of the extracellular matrix components of fibroblasts. In this work, we have investigated the potential biological activities of shell matrix components extracted from the shell of the scallop Pecten maximus on human fibroblasts in primary culture. Firstly, we demonstrated that shell matrix components had different effects on general cellular activities. Secondly, we have shown that the shell matrix components stimulate the synthesis of type I and III collagens, as well as that of sulphated GAGs. The increased expression of type I collagen is likely mediated by the recruitment of transactivating factors (Sp1, Sp3 and human c-Krox) in the -112/-61 bp COL1A1 promoter region. Finally, contrarily to what was obtained in previous works, we demonstrated that the scallop shell extracts have only a small effect on cell migration during in vitro wound tests and have no effect on cell proliferation. Thus, our research emphasizes the potential use of shell matrix of Pecten maximus for dermo-cosmetic applications.	[Latire, Thomas; Lebel, Jean-Marc; Serpentini, Antoine] Univ Caen Basse Normandie, IBFA, UMR BOREA Biol ORganismes & Ecosyst Aquat, MNHN,UPMC,UCBN,CNRS 7208,IRD 207, Caen 5, France; [Latire, Thomas; Legendre, Florence; Bigot, Nicolas; Bouyoucef, Mouloud; Galera, Philippe] Univ Caen Basse Normandie, Fac Med, Lab Microenvironm Cellulaire & Pathol MILPAT, EA 4652,SFR ICORE 146,CHU Niveau 3, Caen 5, France; [Carduner, Ludovic; Kellouche, Sabrina; Carreiras, Franck] Univ Cergy Pontoise, Inst Mat, EA 1391, Equipe Rech Relat Matrice Extracellulaire Cellule, Cergy Pontoise, France; [Marin, Frederic] Univ Bourgogne, UMR CNRS Biogeosci 6282, Dijon, France	Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Universite de Caen Normandie; Universite de Caen Normandie; CY Cergy Paris Universite; Universite de Bourgogne	Serpentini, A (corresponding author), Univ Caen Basse Normandie, IBFA, UMR BOREA Biol ORganismes & Ecosyst Aquat, MNHN,UPMC,UCBN,CNRS 7208,IRD 207, Campus 1,Sci C, Caen 5, France.	antoine.serpentini@unicaen.fr		Bigot, Nicolas/0000-0002-4247-0217; legendre, florence/0000-0002-9951-1585	"Fonds Unique Interministeriel" (FUI, French Government)	"Fonds Unique Interministeriel" (FUI, French Government)	This work was financially supported by the "Fonds Unique Interministeriel" (FUI, French Government). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Atlan G, 1997, CR ACAD SCI III-VIE, V320, P253, DOI 10.1016/S0764-4469(97)86933-8; Beauchef G, 2012, J BIOL CHEM, V287, P3462, DOI 10.1074/jbc.M111.286443; Bedouet L, 2001, COMP BIOCHEM PHYS B, V128, P389, DOI 10.1016/S1096-4959(00)00337-7; Bedouet L, 2006, COMP BIOCHEM PHYS B, V144, P532, DOI 10.1016/j.cbpb.2006.05.012; Bedouet L, 2012, MAR BIOTECHNOL, V14, P446, DOI 10.1007/s10126-011-9425-0; Bigot N, 2012, J INVEST DERMATOL, V132, P2360, DOI 10.1038/jid.2012.164; Dai JP, 2010, PHARM BIOL, V48, P122, DOI 10.3109/13880200903046211; David-Raoudi M, 2008, WOUND REPAIR REGEN, V16, P274, DOI 10.1111/j.1524-475X.2007.00342.x; Ghayor C, 2000, J BIOL CHEM, V275, P27421; Howling GI, 2001, BIOMATERIALS, V22, P2959, DOI 10.1016/S0142-9612(01)00042-4; Hunt T K, 2000, Adv Skin Wound Care, V13, P6; Jiao Y, 2012, BIOCHEM BIOPH RES CO, V425, P679, DOI 10.1016/j.bbrc.2012.07.099; Jorgensen Peter Holmberg, 1997, APMIS, V105, P1; Kypriotou M, 2007, J BIOL CHEM, V282, P32000, DOI 10.1074/jbc.M705197200; Le Faou A, 1995, CALCIFIED TISSUE INT, V56, pA156; Lebonvallet N, 2010, EUR J DERMATOL, V20, P671, DOI 10.1684/ejd.2010.1054; Lee M, 2011, MOL BIOL REP, V38, P5211, DOI 10.1007/s11033-010-0672-3; Legendre F, 2003, J BIOL CHEM, V278, P2903, DOI 10.1074/jbc.M110773200; Liu YC, 2002, FISHERIES SCI, V68, P1330, DOI 10.1046/j.1444-2906.2002.00572.x; Liu YC, 2008, FISHERIES SCI, V74, P217, DOI 10.1111/j.1444-2906.2007.01515.x; Liu YC, 2006, FISHERIES SCI, V72, P388, DOI 10.1111/j.1444-2906.2006.01161.x; Lopez E, 2000, TISSUE CELL, V32, P95, DOI 10.1054/tice.1999.0091; LOPEZ E, 1992, TISSUE CELL, V24, P667, DOI 10.1016/0040-8166(92)90037-8; Lowenstam HA, 1989, BIOMINERALIZATION; Malladi P, 2006, AM J PHYSIOL-CELL PH, V290, pC1139, DOI 10.1152/ajpcell.00415.2005; Mann K, 2000, EUR J BIOCHEM, V267, P5257, DOI 10.1046/j.1432-1327.2000.01602.x; Mann K, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-28; Marie B, 2007, FEBS J, V274, P2933, DOI 10.1111/j.1742-4658.2007.05825.x; Marie B, 2012, AMINO ACIDS, V42, P2009, DOI 10.1007/s00726-011-0932-0; Marie B, 2011, J MOL EVOL, V72, P531, DOI 10.1007/s00239-011-9451-6; Marie B, 2011, FEBS J, V278, P2117, DOI 10.1111/j.1742-4658.2011.08129.x; Marie B, 2011, MAR BIOTECHNOL, V13, P955, DOI 10.1007/s10126-010-9357-0; Marie B, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-54; Marie B, 2010, CHEMBIOCHEM, V11, P2138, DOI 10.1002/cbic.201000276; Marin F, 2005, J BIOL CHEM, V280, P33895, DOI 10.1074/jbc.M506526200; Marin F, 2008, CURR TOP DEV BIOL, V80, P209, DOI 10.1016/S0070-2153(07)80006-8; Marin Frederic, 2012, Front Biosci (Schol Ed), V4, P1099; Miyamoto H, 1996, P NATL ACAD SCI USA, V93, P9657, DOI 10.1073/pnas.93.18.9657; Pereira-Mouries L, 2002, EUR J BIOCHEM, V269, P4994, DOI 10.1046/j.1432-1033.2002.03203.x; Rousseau M, 2003, COMP BIOCHEM PHYS B, V135, P1, DOI 10.1016/S1096-4959(03)00032-0; Sarashina I, 2006, J MOL EVOL, V62, P307, DOI 10.1007/s00239-005-0095-2; Shen XY, 1997, J BIOL CHEM, V272, P32472, DOI 10.1074/jbc.272.51.32472; Shen YT, 2006, BIOMATERIALS, V27, P281, DOI 10.1016/j.biomaterials.2005.05.088; SILVE C, 1992, CALCIFIED TISSUE INT, V51, P363, DOI 10.1007/BF00316881; Sorrell JM, 2009, INT REV CEL MOL BIO, V276, P161, DOI 10.1016/S1937-6448(09)76004-6; Sorrell JM, 2004, J CELL SCI, V117, P667, DOI 10.1242/jcs.01005; Strodtbeck F, 2001, NEWBORN INFANT NURS, V1, P43, DOI [10.1053/nbin.2001.23176, DOI 10.1053/NBIN.2001.23176]; Suzuki M, 2009, SCIENCE, V325, P1388, DOI 10.1126/science.1173793; Torita A, 2004, FISHERIES SCI, V70, P910, DOI 10.1111/j.1444-2906.2004.00886.x; Torita A, 2007, FISHERIES SCI, V73, P1388, DOI 10.1111/j.1444-2906.2007.01482.x; Treccani L, 2006, BIOPHYS J, V91, P2601, DOI 10.1529/biophysj.106.086108; Valacchi G, 2012, ANN NY ACAD SCI, V1259, P136, DOI 10.1111/j.1749-6632.2012.06636.x; VUORIO E, 1990, ANNU REV BIOCHEM, V59, P837, DOI 10.1146/annurev.bi.59.070190.004201; Weiss IM, 2000, BIOCHEM BIOPH RES CO, V267, P17, DOI 10.1006/bbrc.1999.1907; Westbroek P, 1998, NATURE, V392, P861, DOI 10.1038/31798; Wight TN, 2002, CURR OPIN CELL BIOL, V14, P617, DOI 10.1016/S0955-0674(02)00375-7; Zhang C, 2006, MAR BIOTECHNOL, V8, P572, DOI 10.1007/s10126-005-6029-6	58	18	19	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e99931	10.1371/journal.pone.0099931	http://dx.doi.org/10.1371/journal.pone.0099931			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949635	Green Published, gold, Green Submitted			2022-12-27	WOS:000338276300024
J	Shan, T; Lu, HW; Ji, H; Li, YM; Guo, J; Chen, X; Wu, T				Shan, Tao; Lu, Hongwei; Ji, Hong; Li, Yiming; Guo, Jian; Chen, Xi; Wu, Tao			Loss of Stromal Caveolin-1 Expression: A Novel Tumor Microenvironment Biomarker That Can Predict Poor Clinical Outcomes for Pancreatic Cancer	PLOS ONE			English	Article							LASER CAPTURE MICRODISSECTION; BREAST-CANCER; AEROBIC GLYCOLYSIS; CELL; GROWTH; FIBROBLASTS; METASTASIS; HER-2/NEU; RECEPTOR; WARBURG	Aims: Cancer development and progression is not only associated with the tumor cell proliferation but also depends on the interaction between tumor cells and the stromal microenvironment. A new understanding of the role of the tumor microenvironment suggests that the loss of stromal caveolin-1 (Cav-1) as a key regulator may become a potential therapy target. This study aims to elucidate whether stromal Cav-1 expression in pancreatic cancer can be a strong prognosis biomarker. Methods: Tissue samples from 45 pancreatic cancer patients were studied. Parenchyma and stroma were separated and purified using laser capture microdissection. Stromal Cav-1 expression was measured from pancreatic cancer, paraneoplastic, and normal tissue using immunohistochemistry. We analyzed the correlation of stromal Cav-1 expression with clinicopathologic features and prognostic indicators, such as tumor marker HER-2/neu gene. Results: Specimens from six patients (13.3%) showed high levels of stromal Cav-1 staining, those from eight patients (17.8%) showed a lower, intermediate level of staining, whereas those from 31 patients (68.9%) showed an absence of staining. Cav-1 expression in cancer-associated fibroblasts was lower than that in paracancer-associated and in normal fibroblasts. Stromal Cav-1 loss was associated with TNM stage (P=0.018), lymph node metastasis (P = 0.014), distant metastasis (P = 0.027), and HER-2/neu amplification (P = 0.007). The relationships of age, sex, histological grade, and tumor size with stromal Cav-1 expression were not significant (P > 0.05). A negative correlation was found between circulating tumor cells and stromal Cav-1 expression (P < 0.05). Conclusion: The loss of stromal Cav-1 in pancreatic cancer was an independent prognostic indicator, thus suggesting that stromal Cav-1 may be an effective therapeutic target for patients with pancreatic cancer.	[Shan, Tao; Lu, Hongwei; Ji, Hong; Li, Yiming; Chen, Xi; Wu, Tao] Xi An Jiao Tong Univ, Affiliated Hosp 2, Coll Med, Dept Gen Surg, Xian 710049, Shaanxi, Peoples R China; [Guo, Jian] Xi An Jiao Tong Univ, Affiliated Hosp 1, Coll Med, Dept Hepatobiliary Surg, Xian 710049, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University	Shan, T (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 2, Coll Med, Dept Gen Surg, Xian 710049, Shaanxi, Peoples R China.	shantao820304@163.com			Scientific Grand of Shaanxi [2012SXKG-21]	Scientific Grand of Shaanxi	This study was funded by Scientific Grand of Shaanxi (2012SXKG-21). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleric Ivan, 2012, Med Pregl, V65, P210; Ayala G, 2013, J PATHOL, V231, P77, DOI 10.1002/path.4217; Balkwill FR, 2012, J CELL SCI, V125, P5591, DOI 10.1242/jcs.116392; Bonuccelli G, 2010, CELL CYCLE, V9, P1960, DOI 10.4161/cc.9.10.11601; Braakman RBH, 2011, METHODS MOL BIOL, V755, P143, DOI 10.1007/978-1-61779-163-5_11; Cirri P, 2012, CANCER METAST REV, V31, P195, DOI 10.1007/s10555-011-9340-x; Coumans FAW, 2012, CLIN CANCER RES, V18, P5711, DOI 10.1158/1078-0432.CCR-12-1585; Deng W, 2011, AFR J BIOTECHNOL, V10, P16732, DOI 10.5897/AJB11.2397; Du XL, 2012, CANCER RES, V72, P4405, DOI 10.1158/0008-5472.CAN-12-0777; Engelstaedter V, 2012, DIAGN MOL PATHOL, V21, P77, DOI 10.1097/PDM.0b013e31823b6e43; Gobbi PG, 2013, CANCER EPIDEMIOL, V37, P186, DOI 10.1016/j.canep.2012.12.002; Gumulec J, 2012, ONCOL REP, V27, P831, DOI 10.3892/or.2011.1587; Ha TK, 2012, CANCER RES, V72, P4097, DOI 10.1158/0008-5472.CAN-12-0448; Heublein S, 2013, J OVARIAN RES, V6, DOI 10.1186/1757-2215-6-6; Koontongkaew S, 2013, J CANCER, V4, P66, DOI 10.7150/jca.5112; Kuboki Y, 2013, ANTICANCER RES, V33, P3905; Kurt M, 2012, INT J RADIAT ONCOL, V84, pS419, DOI 10.1016/j.ijrobp.2012.07.1110; Liu XJ, 2010, HUM GENE THER, V21, P157, DOI 10.1089/hum.2009.083; Lustberg Maryam, 2012, Recent Results Cancer Res, V195, P97, DOI 10.1007/978-3-642-28160-0_9; Lyu MA, 2008, BIOCHEM PHARMACOL, V75, P836, DOI 10.1016/j.bcp.2007.10.013; Mao Y, 2012, CANCER METAST REV, V32, P305; Neri E, 2013, EUR J RADIOL, V82, P1166, DOI 10.1016/j.ejrad.2012.03.035; Pancotti F, 2012, CELL SIGNAL, V24, P1390, DOI 10.1016/j.cellsig.2012.02.015; Patani N, 2012, BREAST CANCER RES TR, V131, P1, DOI 10.1007/s10549-011-1751-4; Pavlides S, 2012, ANTIOXID REDOX SIGN, V16, P1264, DOI 10.1089/ars.2011.4243; Pavlides S, 2009, CELL CYCLE, V8, P3984, DOI 10.4161/cc.8.23.10238; Salani B, 2012, FASEB J, V26, P788, DOI 10.1096/fj.11-192088; Sharon Y, 2013, JOVE-J VIS EXP, DOI 10.3791/4425; Simpkins SA, 2012, J PATHOL, V227, P490, DOI 10.1002/path.4034; Song Y, 2012, BIOMED PHARMACOTHER, V66, P439, DOI 10.1016/j.biopha.2012.03.001; Sotgia F, 2012, ANNU REV PATHOL-MECH, V7, P423, DOI 10.1146/annurev-pathol-011811-120856; Sun MZ, 2012, BIOMED PHARMACOTHER, V66, P242, DOI 10.1016/j.biopha.2011.11.003; Tahir AA, 2009, CANCER BIOL THER, V8, P2286; Tang Y, 2012, MED ONCOL, V29, P977, DOI 10.1007/s12032-011-9900-5; Trimmer C, 2011, CANCER BIOL THER, V11, P383, DOI 10.4161/cbt.11.4.14101; Winterhoff B, 2012, GYNECOL ONCOL, V125, pS166, DOI 10.1016/j.ygyno.2011.12.407; Witkiewicz AK, 2008, CELL CYCLE, V7, P3021, DOI 10.4161/cc.7.19.6719; Witkiewicz AK, 2010, CANCER BIOL THER, V10, P135, DOI 10.4161/cbt.10.2.11983; Wu KN, 2011, CELL CYCLE, V10, P4250, DOI 10.4161/cc.10.24.18551; Yang XH, 2012, CANCER INVEST, V30, P453, DOI 10.3109/07357907.2012.675384; Zanni KL, 2011, BIOL RES NURS, V13, P297, DOI 10.1177/1099800411402054; Zhao XD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059102; Zheng J, 2012, ONCOL LETT, V4, P1151, DOI 10.3892/ol.2012.928; Zhou F, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-274	44	33	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e97239	10.1371/journal.pone.0097239	http://dx.doi.org/10.1371/journal.pone.0097239			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949874	gold, Green Submitted, Green Published			2022-12-27	WOS:000338276300002
J	Borgman, KJE; van Zanten, TS; Manzo, C; Cabezon, R; Cambi, A; Benitez-Ribas, D; Garcia-Parajo, MF				Borgman, Kyra J. E.; van Zanten, Thomas S.; Manzo, Carlo; Cabezon, Raquel; Cambi, Alessandra; Benitez-Ribas, Daniel; Garcia-Parajo, Maria F.			Priming by Chemokines Restricts Lateral Mobility of the Adhesion Receptor LFA-1 and Restores Adhesion to ICAM-1 Nano-Aggregates on Human Mature Dendritic Cells	PLOS ONE			English	Article							INTEGRIN ACTIVATION; IMMUNOLOGICAL SYNAPSE; CONFORMATIONAL-CHANGES; LYMPHOCYTE ARREST; STRUCTURAL BASIS; LIGAND; TALIN; NANOCLUSTERS; AFFINITY; ORGANIZATION	LFA-1 is a leukocyte specific beta(2) integrin that plays a major role in regulating adhesion and migration of different immune cells. Recent data suggest that LFA-1 on mature dendritic cells (mDCs) may function as a chemokine-inducible anchor during homing of DCs through the afferent lymphatics into the lymph nodes, by transiently switching its molecular conformational state. However, the role of LFA-1 mobility in this process is not yet known, despite that the importance of lateral organization and dynamics for LFA-1-mediated adhesion regulation is broadly recognized. Using single particle tracking approaches we here show that LFA-1 exhibits higher mobility on resting mDCs compared to monocytes. Lymphoid chemokine CCL21 stimulation of the LFA-1 high affinity state on mDCs, led to a significant reduction of mobility and an increase on the fraction of stationary receptors, consistent with re-activation of the receptor. Addition of soluble monomeric ICAM-1 in the presence of CCL21 did not alter the diffusion profile of LFA-1 while soluble ICAM-1 nano-aggregates in the presence of CCL21 further reduced LFA-1 mobility and readily bound to the receptor. Overall, our results emphasize the importance of LFA-1 lateral mobility across the membrane on the regulation of integrin activation and its function as adhesion receptor. Importantly, our data show that chemokines alone are not sufficient to trigger the high affinity state of the integrin based on the strict definition that affinity refers to the adhesion capacity of a single receptor to its ligand in solution. Instead our data indicate that nanoclustering of the receptor, induced by multi-ligand binding, is required to maintain stable cell adhesion once LFA-1 high affinity state is transiently triggered by inside-out signals.	[Borgman, Kyra J. E.; van Zanten, Thomas S.; Manzo, Carlo; Garcia-Parajo, Maria F.] ICFO Inst Ciencies Foton, Barcelona, Spain; [Cabezon, Raquel] Hosp Clin Barcelona, IDIBAPS, Dept Gastroenterol, Barcelona, Spain; [Cambi, Alessandra] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Tumor Immunol, NL-6525 ED Nijmegen, Netherlands; [Benitez-Ribas, Daniel] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain; [Benitez-Ribas, Daniel] Ctr Esther Koplowitz, Barcelona, Spain; [Garcia-Parajo, Maria F.] ICREA Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain	Barcelona Institute of Science & Technology; Universitat Politecnica de Catalunya; Institut de Ciencies Fotoniques (ICFO); University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Radboud University Nijmegen; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; ICREA	Garcia-Parajo, MF (corresponding author), ICFO Inst Ciencies Foton, Barcelona, Spain.	maria.garcia-parajo@icfo.es	Cabezón, Raquel/F-4208-2016; Manzo, Carlo/B-9745-2012; van Zanten, Thomas S/H-5765-2012; Borgman, Kyra/F-7826-2013; Garcia-Parajo, Maria F./I-4610-2015; Cambi, Alessandra/L-4242-2015	Manzo, Carlo/0000-0002-8625-0996; van Zanten, Thomas S/0000-0002-8810-7149; Garcia-Parajo, Maria F./0000-0001-6618-3944; Cambi, Alessandra/0000-0003-1597-1582	Plan Nacional Immunanoforce [MAT2011-22887]; Human Frontier Science Program [RGP0027/2012]; European Commission (FP7-ICT-2011-7) [288263]; Netherlands Organisation for Scientific Research (NWO) [836.09.002]; ICREA Funding Source: Custom	Plan Nacional Immunanoforce; Human Frontier Science Program(Human Frontier Science Program); European Commission (FP7-ICT-2011-7); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); ICREA(ICREA)	This work was supported by grant MAT2011-22887 from the Plan Nacional Immunanoforce (http://www.idi.mineco.gob.es) (MFG-P) (http://www.idi.mineco.gob.es/%29%28MFG-P%29), grant RGP0027/2012 from the Human Frontier Science Program (http://www.hfsp.org/) (MFG-P and AC) and by the European Commission (FP7-ICT-2011-7, under grant agreement No. 288263) to MFG-P and AC (http://www.nanovista.eu). AC is the recipient of a Meervoud grant (836.09.002) from The Netherlands Organisation for Scientific Research (NWO) (http://www.nwo.nl/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon R, 2011, EXP CELL RES, V317, P632, DOI 10.1016/j.yexcr.2010.12.007; Astrof NS, 2006, BIOCHEMISTRY-US, V45, P15020, DOI 10.1021/bi061566o; Bakker G-J, 2011, LFA 1 DYNAMICS MEMBR; Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; CABANAS C, 1993, P NATL ACAD SCI USA, V90, P5838, DOI 10.1073/pnas.90.12.5838; Cairo CW, 2006, IMMUNITY, V25, P297, DOI 10.1016/j.immuni.2006.06.012; Cambi A, 2006, MOL BIOL CELL, V17, P4270, DOI 10.1091/mbc.E05-12-1098; Chen W, 2012, J CELL BIOL, V199, P497, DOI 10.1083/jcb.201201091; Constantin G, 2000, IMMUNITY, V13, P759, DOI 10.1016/S1074-7613(00)00074-1; de Vries IJM, 2002, J IMMUNOTHER, V25, P429, DOI 10.1097/00002371-200209000-00007; Diez-Ahedo R, 2009, SMALL, V5, P1258, DOI 10.1002/smll.200801699; Eich C, 2011, IMMUNOL CELL BIOL, V89, P458, DOI 10.1038/icb.2010.103; Feigelson SW, 2010, J IMMUNOL, V185, P7394, DOI 10.4049/jimmunol.1002246; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Ginsberg MH, 2005, CURR OPIN CELL BIOL, V17, P509, DOI 10.1016/j.ceb.2005.08.010; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; Hemmings L, 1996, J CELL SCI, V109, P2715; Imhof BA, 2004, NAT REV IMMUNOL, V4, P432, DOI 10.1038/nri1375; Bakker GJ, 2012, P NATL ACAD SCI USA, V109, P4869, DOI 10.1073/pnas.1116425109; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; KURZINGER K, 1981, J IMMUNOL, V127, P596; Laudanna C, 2002, IMMUNOL REV, V186, P37, DOI 10.1034/j.1600-065X.2002.18604.x; LUB M, 1995, IMMUNOL TODAY, V16, P479, DOI 10.1016/0167-5699(95)80031-X; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; MAKGOBA MW, 1988, NATURE, V331, P86, DOI 10.1038/331086a0; MARLIN SD, 1987, CELL, V51, P813, DOI 10.1016/0092-8674(87)90104-8; Rossier O, 2012, NAT CELL BIOL, V14, P1057, DOI 10.1038/ncb2588; Sampath R, 1998, J BIOL CHEM, V273, P33588, DOI 10.1074/jbc.273.50.33588; Schurpf T, 2011, EMBO J, V30, P4712, DOI 10.1038/emboj.2011.333; Schumann K, 2010, IMMUNITY, V32, P703, DOI 10.1016/j.immuni.2010.04.017; Schutz GJ, 1997, BIOPHYS J, V73, P1073, DOI 10.1016/S0006-3495(97)78139-6; Shamri R, 2005, NAT IMMUNOL, V6, P497, DOI 10.1038/ni1194; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Shulman Z, 2009, IMMUNITY, V30, P384, DOI 10.1016/j.immuni.2008.12.020; Springer TA, 2012, CURR OPIN CELL BIOL, V24, P107, DOI 10.1016/j.ceb.2011.10.004; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; van den Dries K, 2013, MOL BIOL CELL, V24, P2112, DOI 10.1091/mbc.E12-12-0856; van den Dries K, 2012, CELL MOL LIFE SCI, V69, P1889, DOI 10.1007/s00018-011-0908-y; van Kooyk Y, 1999, J BIOL CHEM, V274, P26869, DOI 10.1074/jbc.274.38.26869; van Zanten TS, 2009, P NATL ACAD SCI USA, V106, P18557, DOI 10.1073/pnas.0905217106; VANKOOYK Y, 1989, NATURE, V342, P811, DOI 10.1038/342811a0; Weber M, 2013, SCIENCE, V339, P328, DOI 10.1126/science.1228456; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Xie C, 2004, P NATL ACAD SCI USA, V101, P15422, DOI 10.1073/pnas.0406680101; Ye F, 2014, CELL, V156, DOI 10.1016/j.cell.2014.02.048; Yoshida R, 1998, J BIOL CHEM, V273, P7118, DOI 10.1074/jbc.273.12.7118	48	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e99589	10.1371/journal.pone.0099589	http://dx.doi.org/10.1371/journal.pone.0099589			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945611	Green Published, gold, Green Submitted			2022-12-27	WOS:000340721500023
J	Caverzasi, E; Papinutto, N; Amirbekian, B; Berger, MS; Henry, RG				Caverzasi, Eduardo; Papinutto, Nico; Amirbekian, Bagrat; Berger, Mitchel S.; Henry, Roland G.			Q-Ball of Inferior Fronto-Occipital Fasciculus and Beyond	PLOS ONE			English	Article							DIFFUSION-WEIGHTED MRI; SURFACE-BASED ANALYSIS; HUMAN BRAIN; FUNCTIONAL CONNECTIVITY; IN-VIVO; SPHERICAL DECONVOLUTION; FIBER DISSECTION; TENSOR MRI; RECONSTRUCTION; TRACTOGRAPHY	The inferior fronto-occipital fasciculus (IFOF) is historically described as the longest associative bundle in the human brain and it connects various parts of the occipital cortex, temporo-basal area and the superior parietal lobule to the frontal lobe through the external/extreme capsule complex. The exact functional role and the detailed anatomical definition of the IFOF are still under debate within the scientific community. In this study we present a fiber tracking dissection of the right and left IFOF by using a q-ball residual-bootstrap reconstruction of High-Angular Resolution Diffusion Imaging (HARDI) data sets in 20 healthy subjects. By defining a single seed region of interest on the coronal fractional anisotropy (FA) color map of each subject, we investigated all the pathways connecting the parietal, occipital and posterior temporal cortices to the frontal lobe through the external/extreme capsule. In line with recent post-mortem dissection studies we found more extended anterior-posterior association connections than the "classical" fronto-occipital representation of the IFOF. In particular the pathways we evidenced showed: a) diffuse projections in the frontal lobe, b) fronto-parietal lobes connections trough the external capsule in almost all the subjects and c) widespread connections in the posterior regions. Our study represents the first consistent in vivo demonstration across a large group of individuals of these novel anterior and posterior terminations of the IFOF detailed described only by post-mortem anatomical dissection. Furthermore our work establishes the feasibility of consistent in vivo mapping of this architecture with independent in vivo methodologies. In conclusion q-ball tractography dissection supports a more complex definition of IFOF, which includes several subcomponents likely underlying specific function.	[Caverzasi, Eduardo; Papinutto, Nico; Amirbekian, Bagrat; Henry, Roland G.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Amirbekian, Bagrat; Henry, Roland G.] Univ Calif San Francisco, Joint Grad Grp Bioengn, San Francisco, CA USA; [Amirbekian, Bagrat; Henry, Roland G.] Univ Calif Berkeley, San Francisco, CA USA; [Berger, Mitchel S.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California San Francisco	Caverzasi, E (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.	ecaverzasi@memory.ucsf.edu	Caverzasi, Eduardo/P-1707-2019	Caverzasi, Eduardo/0000-0002-0350-0460	National Institutes of Health (NIH) [R01 NS066654]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066654] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) R01 NS066654. PI: R.G. Henry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aganj I, 2009, LECT NOTES COMPUT SC, V5762, P423, DOI 10.1007/978-3-642-04271-3_52; Alexander AL, 2001, MAGN RESON MED, V45, P770, DOI 10.1002/mrm.1105; Amirbekian B, 2014, JOINT ANN M ISMRM ES; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Bastiani M, 2012, NEUROIMAGE, V62, P1732, DOI 10.1016/j.neuroimage.2012.06.002; Bermnan JI, 2008, NEUROIMAGE, V39, P215, DOI 10.1016/j.neuroimage.2007.08.021; Bookheimer S, 2002, ANNU REV NEUROSCI, V25, P151, DOI 10.1146/annurev.neuro.25.112701.142946; Bucci M, 2013, NEUROIMAGE-CLIN, V3, P361, DOI 10.1016/j.nicl.2013.08.008; Burgel U, 2006, NEUROIMAGE, V29, P1092, DOI 10.1016/j.neuroimage.2005.08.040; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Catani M, 2005, ANN NEUROL, V57, P8, DOI 10.1002/ana.20319; Catani M, 2002, NEUROIMAGE, V17, P77, DOI 10.1006/nimg.2002.1136; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Cohen L, 2004, NEUROIMAGE, V22, P466, DOI 10.1016/j.neuroimage.2003.12.049; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; De Benedictis A, 2012, J NEUROSURG, V117, P1053, DOI 10.3171/2012.7.JNS12628; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dick AS, 2012, BRAIN, V135, P3529, DOI 10.1093/brain/aws222; Duffau H, 2008, J NEUROL NEUROSUR PS, V79, P492, DOI 10.1136/jnnp.2007.121004; Duffau H, 2005, BRAIN, V128, P797, DOI 10.1093/brain/awh423; Duffau H, 2013, CORTEX; Duffau H, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00044; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Forkel S. J., 2012, CORTEX; Gaudio M, 2009, EUR J PEDIATR, V168, P245, DOI 10.1007/s00431-008-0814-y; Hofer S, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00015; Jeurissen B, 2011, HUM BRAIN MAPP, V32, P461, DOI 10.1002/hbm.21032; Jones DK, 2010, NMR BIOMED, V23, P803, DOI 10.1002/nbm.1543; Lawes INC, 2008, NEUROIMAGE, V39, P62, DOI 10.1016/j.neuroimage.2007.06.041; Leemans A, 2009, MAGN RESON MED, V61, P1336, DOI 10.1002/mrm.21890; Makris N, 2005, CEREB CORTEX, V15, P854, DOI 10.1093/cercor/bhh186; Martino J, 2010, CORTEX, V46, P691, DOI 10.1016/j.cortex.2009.07.015; Martino J, 2010, NEUROSURGERY, V66, P4, DOI 10.1227/01.NEU.0000348564.28415.FA; MESULAM MM, 1981, ANN NEUROL, V10, P309, DOI 10.1002/ana.410100402; Petrides M, 2012, CORTEX, V48, P46, DOI 10.1016/j.cortex.2011.07.002; Peuskens D, 2004, NEUROSURGERY, V55, P1174, DOI 10.1227/01.NEU.0000140843.62311.24; POSNER MI, 1984, J NEUROSCI, V4, P1863; Sarubbo S, 2013, BRAIN STRUCT FUNCT, V218, P21, DOI 10.1007/s00429-011-0372-3; Sarubbo S, 2012, NEUROSURG REV, V35, P287, DOI 10.1007/s10143-011-0351-4; Schmahmann JD, 2007, J HIST NEUROSCI, V16, P362, DOI 10.1080/09647040600620468; Seghier ML, 2013, NEUROSCIENTIST, V19, P43, DOI 10.1177/1073858412440596; Tarapore PE, 2012, NEUROSURGERY, V71, P1012, DOI 10.1227/NEU.0b013e31826d2b78; Tournier JD, 2007, NEUROIMAGE, V35, P1459, DOI 10.1016/j.neuroimage.2007.02.016; Tournier JD, 2002, MAGN RESON MED, V47, P701, DOI 10.1002/mrm.10116; Tournier JD, 2004, NEUROIMAGE, V23, P1176, DOI 10.1016/j.neuroimage.2004.07.037; Tristan-Vega A, 2010, NEUROIMAGE, V49, P1301, DOI 10.1016/j.neuroimage.2009.09.070; Tristan-Vega A, 2009, NEUROIMAGE, V47, P638, DOI 10.1016/j.neuroimage.2009.04.049; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Ture U, 2000, NEUROSURGERY, V47, P417, DOI 10.1097/00006123-200008000-00028; Turken AU, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00001	50	55	57	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100274	10.1371/journal.pone.0100274	http://dx.doi.org/10.1371/journal.pone.0100274			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945305	gold, Green Published			2022-12-27	WOS:000340721500056
J	Joseph, SB; Peck, KM; Burch, CL				Joseph, Sarah B.; Peck, Kayla M.; Burch, Christina L.			Dominance Effects of Deleterious and Beneficial Mutations in a Single Gene of the RNA Virus phi 6	PLOS ONE			English	Article							MOLECULAR-BASIS; BACTERIOPHAGE PHI-6; FITNESS; EVOLUTION; CORE	Most of our knowledge of dominance stems from studies of deleterious mutations. From these studies we know that most deleterious mutations are recessive, and that this recessivity arises from a hyperbolic relationship between protein function (i.e., protein concentration or activity) and fitness. Here we investigate whether this knowledge can be used to make predictions about the dominance of beneficial and deleterious mutations in a single gene. We employed a model system the bacteriophage phi 6 - that allowed us to generate a collection of mutations in haploid conditions so that it was not biased toward either dominant beneficial or recessive deleterious mutations. Screening for the ability to infect a bacterial host that does not permit infection by the wildtype w6, we generated a collection of mutations in P3, a gene involved in attachment to the host and in phage particle assembly. The resulting collection contained mutations with both deleterious and beneficial effects on fitness. The deleterious mutations in our collection had additive effects on fitness and the beneficial mutations were recessive. Neither of these observations were predicted from previous studies of dominance. This pattern is not consistent with the hyperbolic (diminishing returns) relationship between protein function and fitness that is characteristic of enzymatic genes, but could have resulted from a curve of increasing returns.	[Joseph, Sarah B.; Peck, Kayla M.; Burch, Christina L.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill	Joseph, SB (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA.	sbjoseph@email.unc.edu		Burch, Christina/0000-0001-7830-0124; Peck, Kayla/0000-0001-7745-6995	National Institutes of Health [F32-GM080086-01A1, R01-GM067940]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067940] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Institutes of Health grants F32-GM080086-01A1 to S.B.J. and R01-GM067940 to C.L.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartonova V, 2008, J BIOL CHEM, V283, P32024, DOI 10.1074/jbc.M804230200; Bourguet D, 1998, J EVOLUTION BIOL, V11, P103, DOI 10.1046/j.1420-9101.1998.11010103.x; Burch CL, 2007, GENETICS, V176, P467, DOI 10.1534/genetics.106.067199; Burch CL, 2004, GENETICS, V167, P559, DOI 10.1534/genetics.103.021196; Burch CL, 1999, GENETICS, V151, P921; Condit RC, 2007, FIELDS VIROLOGY, P50; Duffy S, 2006, GENETICS, V172, P751, DOI 10.1534/genetics.105.051136; DYKHUIZEN DE, 1990, TRENDS ECOL EVOL, V5, P257, DOI 10.1016/0169-5347(90)90067-N; Ferris MT, 2007, GENETICS, V176, P1013, DOI 10.1534/genetics.106.064634; Forshey BM, 2002, J VIROL, V76, P5667, DOI 10.1128/JVI.76.11.5667-5677.2002; Ganser-Pornillos BK, 2008, CURR OPIN STRUC BIOL, V18, P203, DOI 10.1016/j.sbi.2008.02.001; Garcia-Dorado A, 2000, GENETICS, V155, P1991; Gilchrist MA, 2001, GENETICS, V159, P423; GOTTLIEB P, 1988, VIROLOGY, V163, P183, DOI 10.1016/0042-6822(88)90245-0; Haldane J. B. S., 1924, Trans Phil Soc Cambridge U K, V23, P19; Haldane JBS, 1927, P CAMB PHILOS SOC, V23, P838, DOI 10.1017/S0305004100015644; KACSER H, 1981, GENETICS, V97, P639; KENNEY JM, 1992, VIROLOGY, V190, P635, DOI 10.1016/0042-6822(92)90901-Z; Linger BR, 2004, RNA, V10, P128, DOI 10.1261/rna.5127104; Lopez-Bigas N, 2006, BIOINFORMATICS, V22, P269, DOI 10.1093/bioinformatics/bti781; Manocheewa S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066065; Mendel G., 1865, VERHANDLUNGEN NATURF, V4, P3; Mindich L, 1999, J BACTERIOL, V181, P4505, DOI 10.1128/JB.181.15.4505-4508.1999; Mindich L, 1999, MICROBIOL MOL BIOL R, V63, P149, DOI 10.1128/MMBR.63.1.149-160.1999; MINDICH L, 1976, VIROLOGY, V75, P224, DOI 10.1016/0042-6822(76)90021-0; MINDICH L, 1985, J BACTERIOL, V162, P992, DOI 10.1128/JB.162.3.992-999.1985; Mukherjee S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000765; Nijhout H. Frederik, 2006, P61; OLKKONEN VM, 1989, VIROLOGY, V171, P229, DOI 10.1016/0042-6822(89)90530-8; Omholt SW, 2000, GENETICS, V155, P969; Perutz MF, 1998, ANNU REV BIOPH BIOM, V27, P1, DOI 10.1146/annurev.biophys.27.1.1; Phadnis N, 2005, GENETICS, V171, P385, DOI 10.1534/genetics.104.039016; SIMMONS MJ, 1977, ANNU REV GENET, V11, P49, DOI 10.1146/annurev.ge.11.120177.000405; Szafraniec K, 2003, GENET RES, V82, P19, DOI 10.1017/S001667230300630X; Tang SX, 2001, J VIROL, V75, P9357, DOI 10.1128/JVI.75.19.9357-9366.2001; Tuma R, 1999, BIOCHEMISTRY-US, V38, P15025, DOI 10.1021/bi991473p; Turner PE, 1999, J VIROL, V73, P2420, DOI 10.1128/JVI.73.3.2420-2424.1999; Veitia RA, 2003, J THEOR BIOL, V220, P19, DOI 10.1006/jtbi.2003.3105; VIDAVER AK, 1973, J VIROL, V11, P799, DOI 10.1128/JVI.11.5.799-805.1973; von Schwedler UK, 2003, J VIROL, V77, P5439, DOI 10.1128/JVI.77.9.5439-5450.2003; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; WILKIE AOM, 1994, J MED GENET, V31, P89, DOI 10.1136/jmg.31.2.89; Wright S, 1934, AM NAT, V68, P24, DOI 10.1086/280521	43	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e97717	10.1371/journal.pone.0097717	http://dx.doi.org/10.1371/journal.pone.0097717			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945910	Green Published, Green Submitted, gold			2022-12-27	WOS:000340721500003
J	Kobrsi, I				Kobrsi, Issam			Pendant Ancillary Ligand Switches Off Auto-Oxidation of Group 13 Metal Alkyl Compounds Bearing Non-Bulky Alkyl Groups	PLOS ONE			English	Article								The reaction of 3,5-di-2-pyridyl-1,2,4-triazole with excess Al(CH3)(3) and Ga(CH3)(3) afforded (3,5-di-2-pyridyl-1,2,4-triazolate) Al(CH3)(2)center dot 3Al(CH3)(3) (1) and (3,5-di-2-pyridyl-1,2,4-triazolate) Ga(CH3)(2)center dot 3Ga(CH3)(3) (2) respectively. 1 and 2 reacted with oxygen gas to produce (CH3)(2)M(mu-3,5-di-2-pyridyl-1,2,4-triazolate)(mu-OCH3)M(CH3)(2) (M = Al, 3; M = Ga, 4). 3 and 4 contain the non-bulky dimethylalumino moiety, yet they are indefinitely stable in the presence of oxygen gas. This increased stability towards oxygen is due to ancillary 2-pyridyl groups bonding to the metal centers producing a pseudotrigonal pyramidal Al and Ga environments. This environment blocks oxygen from further inserting into the M-C bond. The Al-N(pyridine) and Ga-N(pyridine) bonds reported herein are extremely elongated yet inactive towards dissociation due to the chelate effect.	Petr Inst, Dept Chem, Abu Dhabi, U Arab Emirates	Khalifa University of Science & Technology	Kobrsi, I (corresponding author), Petr Inst, Dept Chem, Abu Dhabi, U Arab Emirates.	ikobrsi@pi.ac.ae		Kobrsi, Issam/0000-0002-2017-9015	United Arab Emirates(RIFP) [13329]; Petroleum Institute Abu Dhabi	United Arab Emirates(RIFP); Petroleum Institute Abu Dhabi	The author is grateful for funding from the Petroleum Institute Abu Dhabi, United Arab Emirates(RIFP Grant No. 13329). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ault BS, 1999, J ORGANOMET CHEM, V572, P169, DOI 10.1016/S0022-328X(98)00915-2; BARRON AR, 1993, CHEM SOC REV, V22, P93, DOI 10.1039/cs9932200093; Cameron PA, 1999, CHEM COMMUN, P1883, DOI 10.1039/a905120a; CLEAVER WM, 1989, J AM CHEM SOC, V111, P8966, DOI 10.1021/ja00206a056; Kobrsi I, 2006, SYNTHESIS CHARACTERI; Lewinski J, 1999, INORG CHEM COMMUN, V2, P131, DOI 10.1016/S1387-7003(99)00029-5; Lobl J, 2007, INORG CHEM, V46, P5678, DOI 10.1021/ic700488p; McPhail AT, 1976, JCHEMSOC DA; Mukherjee D, 2012, J AM CHEM SOC, V134, P13018, DOI 10.1021/ja303440n; POWER MB, 1992, POLYHEDRON, V11, P477, DOI 10.1016/S0277-5387(00)83205-2; Qiao S, 2011, J ORGANOMET CHEM, V696, P2746, DOI 10.1016/j.jorganchem.2011.04.028; Thomas F, 2003, ORGANOMETALLICS, V22, P3471, DOI 10.1021/om0303451; Uhl W, 2009, Z NATURFORSCH B, V64, P1369, DOI 10.1515/znb-2009-11-1217; Yu ZK, 2001, ORGANOMETALLICS, V20, P4301, DOI 10.1021/om010531b	14	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100626	10.1371/journal.pone.0100626	http://dx.doi.org/10.1371/journal.pone.0100626			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945752	Green Published, gold, Green Submitted			2022-12-27	WOS:000340721500098
J	Zhang, YJ; Yang, JH; Shi, QS; Zheng, LL; Liu, J; Zhou, H; Zhang, H; Qu, LH				Zhang, Yi-Jun; Yang, Jian-Hua; Shi, Qiao-Su; Zheng, Ling-Ling; Liu, Jun; Zhou, Hui; Zhang, Hui; Qu, Liang-Hu			Rapid Birth-and-Death Evolution of Imprinted snoRNAs in the Prader-Willi Syndrome Locus: Implications for Neural Development in Euarchontoglires	PLOS ONE			English	Article							SMALL NUCLEOLAR RNA; NONCODING RNAS; MOLECULAR EVOLUTION; RIBOSE METHYLATION; GENETICS ANALYSIS; ANTISENSE RNA; SNURF-SNRPN; GENES; CLUSTER; SOFTWARE	Imprinted small nucleolar RNAs (snoRNAs) are only found in eutherian genomes and closely related to brain functions. A complex human neurological disease, Prader-Willi syndrome (PWS), is primarily attributed to the deletion of imprinted snoRNAs in chromosome 15q11-q13. Here we investigated the snoRNA repertoires in the PWS locus of 12 mammalian genomes and their evolution processes. A total of 613 imprinted snoRNAs were identified in the PWS homologous loci and the gene number was highly variable across lineages, with a peak in Euarchontoglires. Lineage-specific gene gain and loss events account for most extant genes of the HBII-52 (SNORD115) and the HBII-85 (SNORD116) gene family, and remarkable high gene-birth rates were observed in the primates and the rodents. Meanwhile, rapid sequence substitution occurred only in imprinted snoRNA genes, rather than their flanking sequences or the protein-coding genes located in the same imprinted locus. Strong selective constraints on the functional elements of these imprinted snoRNAs further suggest that they are subjected to birth-and-death evolution. Our data suggest that the regulatory role of HBII-52 on 5-HT2CR pre-mRNA might originate in the Euarchontoglires through adaptive process. We propose that the rapid evolution of PWS-related imprinted snoRNAs has contributed to the neural development of Euarchontoglires.	[Zhang, Yi-Jun; Yang, Jian-Hua; Zheng, Ling-Ling; Zhou, Hui; Qu, Liang-Hu] Sun Yat Sen Univ, Key Lab Gene Engn, Minist Educ, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Yi-Jun; Yang, Jian-Hua; Zheng, Ling-Ling; Zhou, Hui; Qu, Liang-Hu] Sun Yat Sen Univ, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [Shi, Qiao-Su] Sun Yat Sen Univ, Affiliated Hosp 3, Lab Liver Dis Hosp, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Jun; Zhang, Hui] Sun Yat Sen Univ, Zhongshan Sch Med, Inst Human Virol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Qu, LH (corresponding author), Sun Yat Sen Univ, Key Lab Gene Engn, Minist Educ, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China.	lssqlh@mail.sysu.edu.cn	zheng, lingling/Q-7227-2016; Zhang, Yijun/J-5485-2017	Zhang, Yijun/0000-0001-7971-2200; Qu, Liang-Hu/0000-0003-3657-2863; Zhou, Hui/0000-0001-9157-3792	National Natural Science Foundation of China [30830066, 81301431, 31370791]; China Postdoctoral Science Foundation [2012M511866, 2013T60824]; Guangdong Province [S2012010010510, S2013010012457]; project of Science and Technology New Star in ZhuJiang Guangzhou city [2012J2200025]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Guangdong Province; project of Science and Technology New Star in ZhuJiang Guangzhou city	This research was supported by the National Natural Science Foundation of China (No. 30830066) to Liang-Hu Qu. National Natural Science Foundation of China (No. 81301431), China Postdoctoral Science Foundation (No. 2012M511866 and No. 2013T60824) to Yi-Jun Zhang. The National Natural Science Foundation of China (No. 31370791); the funds from Guangdong Province (No. S2012010010510, S2013010012457); the project of Science and Technology New Star in ZhuJiang Guangzhou city (No. 2012J2200025) to Jian-Hua Yang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachellerie JP, 2002, BIOCHIMIE, V84, P775, DOI 10.1016/S0300-9084(02)01402-5; Belmonte MK, 2004, MOL PSYCHIATR, V9, P646, DOI 10.1038/sj.mp.4001499; Bolton PF, 2004, PSYCHIAT GENET, V14, P131, DOI 10.1097/00041444-200409000-00002; Bortolin-Cavaille ML, 2012, NUCLEIC ACIDS RES, V40, P6800, DOI 10.1093/nar/gks321; Brown JWS, 2003, TRENDS PLANT SCI, V8, P42, DOI 10.1016/S1360-1385(02)00007-9; Cassidy SB, 1997, J MED GENET, V34, P917, DOI 10.1136/jmg.34.11.917; Castle JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011779; Cavaille J, 2002, HUM MOL GENET, V11, P1527, DOI 10.1093/hmg/11.13.1527; Cavaille J, 1996, NATURE, V383, P732, DOI 10.1038/383732a0; Cavaille J, 1998, NUCLEIC ACIDS RES, V26, P1576, DOI 10.1093/nar/26.7.1576; Cavaille J, 2001, J BIOL CHEM, V276, P26374, DOI 10.1074/jbc.M103544200; Cavaille J, 2000, P NATL ACAD SCI USA, V97, P14311, DOI 10.1073/pnas.250426397; Cook EH, 2008, NATURE, V455, P919, DOI 10.1038/nature07458; Curley JP, 2004, P ROY SOC B-BIOL SCI, V271, P1303, DOI 10.1098/rspb.2004.2725; de los Santos T, 2000, AM J HUM GENET, V67, P1067, DOI 10.1086/303106; de Smith AJ, 2009, HUM MOL GENET, V18, P3257, DOI 10.1093/hmg/ddp263; Ding F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001709; Doe CM, 2009, HUM MOL GENET, V18, P2140, DOI 10.1093/hmg/ddp137; Duker AL, 2010, EUR J HUM GENET, V18, P1196, DOI 10.1038/ejhg.2010.102; Edwards CA, 2008, PLOS BIOL, V6, P1292, DOI 10.1371/journal.pbio.0060135; Glazov EA, 2008, MOL BIOL EVOL, V25, P939, DOI 10.1093/molbev/msn045; GOODMAN M, 1979, SYST ZOOL, V28, P132, DOI 10.2307/2412519; Gurevich I, 2002, J NEUROSCI, V22, P10529; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Heisler LK, 2007, GENES BRAIN BEHAV, V6, P491, DOI 10.1111/j.1601-183X.2007.00316.x; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Keverne EB, 1996, P ROY SOC B-BIOL SCI, V263, P689, DOI 10.1098/rspb.1996.0103; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kishore S, 2006, SCIENCE, V311, P230, DOI 10.1126/science.1118265; Kishore S, 2010, HUM MOL GENET, V19, P1153, DOI 10.1093/hmg/ddp585; Kiss T, 2002, CELL, V109, P145, DOI 10.1016/S0092-8674(02)00718-3; Koonin EV, 2010, NAT REV GENET, V11, P487, DOI 10.1038/nrg2810; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Leister D, 2004, TRENDS GENET, V20, P116, DOI 10.1016/j.tig.2004.01.007; Lestrade L, 2006, NUCLEIC ACIDS RES, V34, pD158, DOI 10.1093/nar/gkj002; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Li JJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002578; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lu J, 2008, MOL BIOL EVOL, V25, P929, DOI 10.1093/molbev/msn040; Lu J, 2008, NAT GENET, V40, P351, DOI 10.1038/ng.73; Meunier J, 2013, GENOME RES, V23, P34, DOI 10.1101/gr.140269.112; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1105/tpc.009308; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; Nahkuri S, 2008, J MOL BIOL, V381, P810, DOI 10.1016/j.jmb.2008.06.057; Nam J, 2005, MOL BIOL EVOL, V22, P2386, DOI 10.1093/molbev/msi229; Nei M, 2005, ANNU REV GENET, V39, P121, DOI 10.1146/annurev.genet.39.073003.112240; Niimura Y, 2003, P NATL ACAD SCI USA, V100, P12235, DOI 10.1073/pnas.1635157100; Niimura Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000708; Ogorelkova M, 2009, MOL BIOL EVOL, V26, P2563, DOI 10.1093/molbev/msp173; Page RDM, 1997, MOL PHYLOGENET EVOL, V7, P231, DOI 10.1006/mpev.1996.0390; Peters J, 2008, NAT GENET, V40, P688, DOI 10.1038/ng0608-688; Piekna-Przybylska D, 2007, RNA, V13, P305, DOI 10.1261/rna.373107; Plagge A, 2004, NAT GENET, V36, P818, DOI 10.1038/ng1397; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rapkins RW, 2006, PLOS GENET, V2, P1666, DOI 10.1371/journal.pgen.0020182; Richly E, 2002, MOL BIOL EVOL, V19, P76, DOI 10.1093/oxfordjournals.molbev.a003984; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Royo H, 2008, BIOL CELL, V100, P149, DOI 10.1042/BC20070126; Royo H, 2007, MOL BIOL CELL, V18, P2817, DOI 10.1091/mbc.E06-10-0920; Runte M, 2005, HUM GENET, V116, P228, DOI 10.1007/s00439-004-1219-2; Runte M, 2004, HUM GENET, V114, P553, DOI 10.1007/s00439-004-1104-z; Runte M, 2001, HUM MOL GENET, V10, P2687, DOI 10.1093/hmg/10.23.2687; Sahoo T, 2008, NAT GENET, V40, P719, DOI 10.1038/ng.158; Sandovici I, 2006, PLOS GENET, V2, P944, DOI 10.1371/journal.pgen.0020101; Schmitz J, 2008, GENOME RES, V18, P1005, DOI 10.1101/gr.7177908; Skryabin BV, 2007, PLOS GENET, V3, P2529, DOI 10.1371/journal.pgen.0030235; Soni S, 2007, J INTELL DISABIL RES, V51, P32, DOI 10.1111/j.1365-2788.2006.00895.x; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vitali P, 2005, J CELL BIOL, V169, P745, DOI 10.1083/jcb.200411129; Wang Yu, 2010, BMC Evol Biol, V10, P119, DOI 10.1186/1471-2148-10-119; Wilkinson LS, 2007, NAT REV NEUROSCI, V8, P832, DOI 10.1038/nrn2235; Yang JH, 2006, NUCLEIC ACIDS RES, V34, P5112, DOI 10.1093/nar/gkl672; Zhang R, 2008, MOL BIOL EVOL, V25, P1493, DOI 10.1093/molbev/msn094; Zhang YJ, 2009, SCI CHINA SER C, V52, P195, DOI 10.1007/s11427-009-0035-2; Zheng GXY, 2011, P NATL ACAD SCI USA, V108, P15804, DOI 10.1073/pnas.1112772108	77	15	15	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100329	10.1371/journal.pone.0100329	http://dx.doi.org/10.1371/journal.pone.0100329			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945811	Green Published, gold			2022-12-27	WOS:000340721500063
J	Casanova, R; Saldana, S; Chew, EY; Danis, RP; Greven, CM; Ambrosius, WT				Casanova, Ramon; Saldana, Santiago; Chew, Emily Y.; Danis, Ronald P.; Greven, Craig M.; Ambrosius, Walter T.			Application of Random Forests Methods to Diabetic Retinopathy Classification Analyses	PLOS ONE			English	Article							AUTOMATED DETECTION; FRAMEWORK; RISK; HEALTH; EYE	Background: Diabetic retinopathy (DR) is one of the leading causes of blindness in the United States and world-wide. DR is a silent disease that may go unnoticed until it is too late for effective treatment. Therefore, early detection could improve the chances of therapeutic interventions that would alleviate its effects. Methodology: Graded fundus photography and systemic data from 3443 ACCORD-Eye Study participants were used to estimate Random Forest (RF) and logistic regression classifiers. We studied the impact of sample size on classifier performance and the possibility of using RF generated class conditional probabilities as metrics describing DR risk. RF measures of variable importance are used to detect factors that affect classification performance. Principal Findings: Both types of data were informative when discriminating participants with or without DR. RF based models produced much higher classification accuracy than those based on logistic regression. Combining both types of data did not increase accuracy but did increase statistical discrimination of healthy participants who subsequently did or did not have DR events during four years of follow-up. RF variable importance criteria revealed that microaneurysms counts in both eyes seemed to play the most important role in discrimination among the graded fundus variables, while the number of medicines and diabetes duration were the most relevant among the systemic variables. Conclusions and Significance: We have introduced RF methods to DR classification analyses based on fundus photography data. In addition, we propose an approach to DR risk assessment based on metrics derived from graded fundus photography and systemic data. Our results suggest that RF methods could be a valuable tool to diagnose DR diagnosis and evaluate its progression.	[Casanova, Ramon; Saldana, Santiago; Ambrosius, Walter T.] Wake Forest Sch Med, Dept Biostat Sci, Winston Salem, NC 27157 USA; [Chew, Emily Y.] NEI, NIH, Bethesda, MD 20892 USA; [Danis, Ronald P.] Univ Wisconsin, Fundus Photograph Reading Ctr, Madison, WI USA; [Greven, Craig M.] Wake Forest Sch Med, Winston Salem, NC USA	Wake Forest University; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); University of Wisconsin System; University of Wisconsin Madison; Wake Forest University	Casanova, R (corresponding author), Wake Forest Sch Med, Dept Biostat Sci, Winston Salem, NC 27157 USA.	Casanova@wakehealth.edu			National Heart, Lung, and Blood Institute [N01-HC-95178, N01-HC-95179, N01-HC-95180, N01-HC-95181, N01-HC-95182, N01-HC-95183, N01-HC-95184, IAA-Y1-HC-9035, IAA-Y1-HC-1010]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095180, N01HC095178, N01HC095179, N01HC095183, N01HC095181, N01HC095182, N01HC095184] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [ZIAEY000485, ZIAEY000410] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by contracts (N01-HC-95178, N01-HC-95179, N01-HC-95180, N01-HC-95181, N01-HC-95182, N01-HC-95183, N01-HC-95184, IAA-Y1-HC-9035, and IAA-Y1-HC-1010) from the National Heart, Lung, and Blood Institute; by other components of the National Institutes of Health, including the National Institute of Diabetes and Digestive and Kidney Diseases, the National Institute on Aging, and the National Eye Institute; by the Centers for Disease Control and Prevention; and by General Clinical Research Centers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2010, EXPERT REV MED DEVIC, V7, P287, DOI 10.1586/ERD.09.76; Abramoff MD, 2008, DIABETES CARE, V31, P193, DOI 10.2337/dc07-1312; Acharya UR, 2012, J MED SYST, V36, P2011, DOI 10.1007/s10916-011-9663-8; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; Bureau A, 2005, GENET EPIDEMIOL, V28, P171, DOI 10.1002/gepi.20041; Casanova R, 2012, Open Neuroimag J, V6, P1, DOI 10.2174/1874440001206010001; Casanova R, 2013, ALZHEIMERS DIS RISK; Casanova R, 2013, ASSESSMENT ALZHEIMER; Casanova R., 2011, INT J BIOMEDICAL DAT, V1, P11; Casanova R, 2013, PLOS ONE IN PRESS; Casanova R, 2012, USING ALZHEIMERS DIS; Casanova R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077949; Casanova Ramon, 2011, Front Neuroinform, V5, P22, DOI 10.3389/fninf.2011.00022; Casanova R, 2011, MAGN RESON IMAGING, V29, P546, DOI 10.1016/j.mri.2010.12.001; Chew EY, 2007, AM J CARDIOL, V99, p103I, DOI 10.1016/j.amjcard.2007.03.028; Chew EY, 2010, NEW ENGL J MED, V363, P233, DOI 10.1056/NEJMoa1001288; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; Diabet Control Complications Trial Res Grp, 1995, OPHTHALMOLOGY, V102, P647; Esteves J, 2008, ARQ BRAS ENDOCRINOL, V52, P431, DOI 10.1590/S0004-27302008000300003; Faust O, 2012, J MED SYST, V36, P145, DOI 10.1007/s10916-010-9454-7; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282; Gottesman RF, 2012, NEUROLOGY, V78, P936, DOI 10.1212/WNL.0b013e31824de2bc; Haan M, 2012, Neurology, V78, P942, DOI 10.1212/WNL.0b013e31824d9655; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Lanckriet GRG, 2003, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2004, P300; Lanckriet GRG, 2004, BIOINFORMATICS, V20, P2626, DOI 10.1093/bioinformatics/bth294; Lunetta KL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-32; Ng DPK, 2010, J OPHTHALMOL, V2010, DOI 10.1155/2010/172593; Pantanowitz A, 2009, ADV INTEL SOFT COMPU, V61, P53; Priya R., 2011, International Journal of Applied Engineering Research, V1, P844; Quellec G, 2012, MED IMAGE ANAL, V16, P1228, DOI 10.1016/j.media.2012.06.003; Quellec G, 2011, INVEST OPHTH VIS SCI, V52, P8342, DOI 10.1167/iovs.11-7418; Quellec G, 2011, IEEE T MED IMAGING, V30, P523, DOI 10.1109/TMI.2010.2089383; Rakotomamonjy A, 2008, J MACH LEARN RES, V9, P2491; Siroky DS, 2008, STAT SURVEYS; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; van Leiden HA, 2002, DIABETES CARE, V25, P1320, DOI 10.2337/diacare.25.8.1320; Witten I.H., 2005, DATA MINING PRACTICA; Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909	42	80	81	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e98587	10.1371/journal.pone.0098587	http://dx.doi.org/10.1371/journal.pone.0098587			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940623	Green Published, gold, Green Submitted			2022-12-27	WOS:000338508200009
J	Coppola, N; Zampino, R; Sagnelli, C; Bellini, G; Marrone, A; Stanzione, M; Capoluongo, N; Boemio, A; Minichini, C; Adinolfi, LE; Maione, S; Del Giudice, EM; Sagnelli, E; Rossi, F				Coppola, Nicola; Zampino, Rosa; Sagnelli, Caterina; Bellini, Giulia; Marrone, Aldo; Stanzione, Maria; Capoluongo, Nicolina; Boemio, Adriana; Minichini, Carmine; Adinolfi, Luigi Elio; Maione, Sabatino; Del Giudice, Emanuele Miraglia; Sagnelli, Evangelista; Rossi, Francesca			Cannabinoid Receptor 2-63 QQ Variant Is Associated with Persistently Normal Aminotransferase Serum Levels in Chronic Hepatitis C	PLOS ONE			English	Article							VIRUS CARRIERS; T-CELLS; ENDOCANNABINOID SYSTEM; GENETIC-VARIATION; KUPFFER CELLS; LIVER-DISEASE; HCV; POLYMORPHISM; THERAPY; SUPERINFECTION	Background and Aim: To evaluate in anti-HCV-positive patients the clinical impact of the rs35761398 variant of the CNR2 gene leading to the substitution of Gln (Q) of codon 63 of the cannabinoid receptor 2 (CB2) with Arg (R). Patients and Methods: 253 consecutive anti-HCV-/HCV-RNA-positive patients were enrolled, of whom 53 were HCV carriers with persistently normal ALT (PNALT group) and 200 had a history of steadily abnormal serum ALT values (abnormal ALT group). All patients were naive for antiviral therapy and were screened for the CNR2 rs35761398 polymorphism by a TaqMan assay. Results: Subjects in the PNALT group, compared with those in the abnormal ALT group were older (58.5 +/- 12 vs. 50.7 +/- 12.4 years, p = 0.001), more frequently female (66% vs. 42%, p = 0.003), with lower body massindex (BMI) (24.5 +/- 3.1 vs. 26.6 +/- 4.6, p = 0.003), and more frequently with HCV genotype 2 (43.1% vs 17.7%, p = 0.0002) and CB2-63 QQ variant (34% vs. 11%, p = 0.0001). Considering all 253 patients, no difference in the demographic, biochemical, or virological data was observed between patients in the different CB2-63 variants. The logistic regression analysis identified CB2-63 QQ, HCV genotype 2, older age and lower BMI as independent predictors of PNALT (p<0.00001). Discussion: The CB2-63 QQ variant in HCV patients was independently associated with the PNALT status.	[Coppola, Nicola; Capoluongo, Nicolina; Minichini, Carmine; Sagnelli, Evangelista] Univ Naples 2, Dept Mental Hlth & Publ Med, Naples, Italy; [Zampino, Rosa; Marrone, Aldo; Boemio, Adriana; Adinolfi, Luigi Elio] Univ Naples 2, Naples, Italy; [Sagnelli, Caterina; Stanzione, Maria] Univ Naples 2, Dept Clin & Expt Med & Surg, Naples, Italy; [Bellini, Giulia; Maione, Sabatino] Univ Naples 2, Dept Expt Med, Naples, Italy; [Del Giudice, Emanuele Miraglia] Univ Naples 2, Dept Pediat, Naples, Italy	Universita della Campania Vanvitelli; Universita della Campania Vanvitelli; Universita della Campania Vanvitelli; Universita della Campania Vanvitelli; Universita della Campania Vanvitelli	Coppola, N (corresponding author), Univ Naples 2, Dept Mental Hlth & Publ Med, Naples, Italy.	nicola.coppola@unina2.it	del Giudice, Emanuele Muraglia/AAC-2824-2019; Sagnelli, caterina/K-9338-2016; Marrone, Aldo/AAH-3614-2020; Sagnelli, Caterina/AAD-4950-2022	Sagnelli, caterina/0000-0002-6413-7810; Sagnelli, Caterina/0000-0002-6413-7810; Sagnelli, Evangelista/0000-0003-2817-8436; MARRONE, Aldo/0000-0001-7329-4159; ZAMPINO, Rosa/0000-0003-2804-186X; Stanzione, Maria/0000-0002-8706-1310; Rossi, Francesca/0000-0003-2879-6277; Maione, Sabatino/0000-0003-3850-6704; Coppola, Nicola/0000-0001-5897-4949	PRIN, M.I.U.R., Rome, Italy "OTTIMIZZAZIONE DELLA DIAGNOSI EZIOLOGICA DELL'EPATITE ACUTA C E STUDIO DEI FATTORI VIRO-IMMUNOLOGICI DI GUARIGIONE, DI CRONICIZZAZIONE E DI RISPOSTA ALLA TERAPIA CON INTERFERONE"; Regione Campania "Progetti per il miglioramento della qualita dell'assistenza, diagnosi e terapia del paziente affetto da AIDS nei settori: immunologia, coinfezioni, informazione e prevenzione"	PRIN, M.I.U.R., Rome, Italy "OTTIMIZZAZIONE DELLA DIAGNOSI EZIOLOGICA DELL'EPATITE ACUTA C E STUDIO DEI FATTORI VIRO-IMMUNOLOGICI DI GUARIGIONE, DI CRONICIZZAZIONE E DI RISPOSTA ALLA TERAPIA CON INTERFERONE"; Regione Campania "Progetti per il miglioramento della qualita dell'assistenza, diagnosi e terapia del paziente affetto da AIDS nei settori: immunologia, coinfezioni, informazione e prevenzione"	This study was supported by a grant from PRIN 2008, M.I.U.R., Rome, Italy "OTTIMIZZAZIONE DELLA DIAGNOSI EZIOLOGICA DELL'EPATITE ACUTA C E STUDIO DEI FATTORI VIRO-IMMUNOLOGICI DI GUARIGIONE, DI CRONICIZZAZIONE E DI RISPOSTA ALLA TERAPIA CON INTERFERONE" and in part by a grant from Regione Campania "Progetti per il miglioramento della qualita dell'assistenza, diagnosi e terapia del paziente affetto da AIDS nei settori: immunologia, coinfezioni, informazione e prevenzione", 2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accapezzato D, 2004, J CLIN INVEST, V113, P963, DOI [10.1172/JCI200420415, 10.1172/JCI200420515]; Adinolfi LE, 2001, HEPATOLOGY, V33, P1358, DOI 10.1053/jhep.2001.24432; Basu PP, 2014, ALIMENT PHARM THER, V39, P790, DOI 10.1111/apt.12673; Benhamou Y, 2001, HEPATOLOGY, V34, P283, DOI 10.1053/jhep.2001.26517; Blackburn SD, 2007, TRENDS MICROBIOL, V15, P143, DOI 10.1016/j.tim.2007.02.006; Blackburn SD, 2010, J VIROL, V84, P2078, DOI 10.1128/JVI.01579-09; Cable JC, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-129; Cabral G. A., 2008, Endocrine Metabolic & Immune Disorders-Drug Targets, V8, P159, DOI 10.2174/187153008785700118; Carrasquer A, 2010, PHARMACOGENET GENOM, V20, P157, DOI 10.1097/FPC.0b013e3283367c6b; Coppola N, 2014, EUR J CLIN MICROBIOL, V33, P559, DOI 10.1007/s10096-013-1985-7; Coppola N, 2014, CLIN GASTROENTEROL H, V12, P334, DOI 10.1016/j.cgh.2013.05.008; Correa F, 2010, GLIA, V58, P135, DOI 10.1002/glia.20907; Dixon LJ, 2013, COMPR PHYSIOL, V3, P785, DOI 10.1002/cphy.c120026; Garcia F, 1996, EUR J CLIN MICROBIOL, V15, P884, DOI 10.1007/BF01691224; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Gentile I, 2013, HEPAT MON, V13, DOI 10.5812/hepatmon.8352; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Ishida JH, 2008, CLIN GASTROENTEROL H, V6, P69, DOI 10.1016/j.cgh.2007.10.021; Itose I, 2009, J VIRAL HEPATITIS, V16, P844, DOI 10.1111/j.1365-2893.2009.01131.x; Jinushi M, 2003, J IMMUNOL, V170, P1249, DOI 10.4049/jimmunol.170.3.1249; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kondo Y, 2007, VIROLOGY, V361, P161, DOI 10.1016/j.virol.2006.11.009; Kozela E, 2013, J NEUROIMMUNE PHARM, V8, P1265, DOI 10.1007/s11481-013-9493-1; Louvet A, 2011, HEPATOLOGY, V54, P1217, DOI 10.1002/hep.24524; Luongo L, 2013, CNS NEUROL DISORD-DR, V12, P45, DOI 10.2174/1871527311312010009; Machida K, 2008, J VIROL, V82, P6711, DOI 10.1128/JVI.02582-07; McGuinness PH, 1996, HEPATOLOGY, V23, P676, DOI 10.1002/hep.510230404; Nelson DR, 2003, HEPATOLOGY, V38, P859, DOI 10.1053/jhep.2003.50427; Nelson DR, 1997, J IMMUNOL, V158, P1473; Nelson DR, 1998, HEPATOLOGY, V28, P225, DOI 10.1002/hep.510280129; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Pasquale G, 2003, EUR J GASTROEN HEPAT, V15, P831, DOI 10.1097/01.meg.0000059137.68845.e2; Persico M, 2000, GASTROENTEROLOGY, V118, P760, DOI 10.1016/S0016-5085(00)70145-4; Prati D, 2010, DIGEST LIVER DIS, V42, P81, DOI 10.1016/j.dld.2009.08.001; Puoti C, 2002, J HEPATOL, V37, P117, DOI 10.1016/S0168-8278(02)00101-0; Romeo R, 1996, J VIRAL HEPATITIS, V3, P183, DOI 10.1111/j.1365-2893.1996.tb00093.x; Rossi F, 2012, PHARMACOL RES, V66, P88, DOI 10.1016/j.phrs.2012.03.011; Rossi F, 2011, HAEMATOL-HEMATOL J, V96, P1883, DOI 10.3324/haematol.2011.045732; Rossi F, 2011, HEPATOLOGY, V54, P1102, DOI 10.1002/hep.24440; Sagnelli E, 2006, J CLIN VIROL, V35, P317, DOI 10.1016/j.jcv.2005.10.006; Sagnelli E, 2013, CLIN GASTROENTEROL H, V11, P1174, DOI 10.1016/j.cgh.2013.03.025; Sagnelli E, 2009, HEPATOLOGY, V49, P1090, DOI 10.1002/hep.22794; Schirren CA, 2000, HEPATOLOGY, V32, P597, DOI 10.1053/jhep.2000.9635; SHINDO M, 1995, HEPATOLOGY, V22, P418, DOI 10.1002/hep.1840220208; Shrivastava S, 2013, J VIROL, V87, P12284, DOI 10.1128/JVI.01962-13; Singh UP, 2012, TOXICOL APPL PHARM, V258, P256, DOI 10.1016/j.taap.2011.11.005; Sipe JC, 2005, J LEUKOCYTE BIOL, V78, P231, DOI 10.1189/jlb.0205111; Tam J, 2011, HEPATOLOGY, V53, P346, DOI 10.1002/hep.24077; Teixeira-Clerc F, 2010, HEPATOLOGY, V52, P1046, DOI 10.1002/hep.23779; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Uto H, 2012, HEPAT MON, V12, P77, DOI [10.5812/hepatmon.4851, 10.5812/hepatmon.829]; Wan JH, 2014, HEPATOLOGY, V59, P130, DOI 10.1002/hep.26607; Wong JB, 2000, AM J PUBLIC HEALTH, V90, P1562, DOI 10.2105/AJPH.90.10.1562; Zampino R, 2013, J VIRAL HEPATITIS, V20, P517, DOI 10.1111/jvh.12053	54	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99450	10.1371/journal.pone.0099450	http://dx.doi.org/10.1371/journal.pone.0099450			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940753	Green Submitted, gold, Green Published			2022-12-27	WOS:000338508200024
J	Guo, X; Yin, HQ; Liang, YL; Hu, Q; Zhou, XS; Xiao, YH; Ma, LY; Zhang, X; Qiu, GZ; Liu, XD				Guo, Xue; Yin, Huaqun; Liang, Yili; Hu, Qi; Zhou, Xishu; Xiao, Yunhua; Ma, Liyuan; Zhang, Xian; Qiu, Guanzhou; Liu, Xueduan			Comparative Genome Analysis Reveals Metabolic Versatility and Environmental Adaptations of Sulfobacillus thermosulfidooxidans Strain ST	PLOS ONE			English	Article							TRANSPORTER CLASSIFICATION DATABASE; RIBULOSE MONOPHOSPHATE PATHWAY; INORGANIC SULFUR-COMPOUNDS; PENTOSE-PHOSPHATE PATHWAY; ACIDITHIOBACILLUS-FERROOXIDANS; SUBSP-ASPOROGENES; MOLECULAR-BIOLOGY; IMMUNE-SYSTEM; SP-NOV.; BACTERIA	The genus Sulfobacillus is a cohort of mildly thermophilic or thermotolerant acidophiles within the phylum Firmicutes and requires extremely acidic environments and hypersalinity for optimal growth. However, our understanding of them is still preliminary partly because few genome sequences are available. Here, the draft genome of Sulfobacillus thermosulfidooxidans strain ST was deciphered to obtain a comprehensive insight into the genetic content and to understand the cellular mechanisms necessary for its survival. Furthermore, the expressions of key genes related with iron and sulfur oxidation were verified by semi-quantitative RT-PCR analysis. The draft genome sequence of Sulfobacillus thermosulfidooxidans strain ST, which encodes 3225 predicted coding genes on a total length of 3,333,554 bp and a 48.35% G+C, revealed the high degree of heterogeneity with other Sulfobacillus species. The presence of numerous transposases, genomic islands and complete CRISPR/Cas defence systems testifies to its dynamic evolution consistent with the genome heterogeneity. As expected, S. thermosulfidooxidans encodes a suit of conserved enzymes required for the oxidation of inorganic sulfur compounds (ISCs). The model of sulfur oxidation in S. thermosulfidooxidans was proposed, which showed some different characteristics from the sulfur oxidation of Gram-negative A. ferrooxidans. Sulfur oxygenase reductase and heterodisulfide reductase were suggested to play important roles in the sulfur oxidation. Although the iron oxidation ability was observed, some key proteins cannot be identified in S. thermosulfidooxidans. Unexpectedly, a predicted sulfocyanin is proposed to transfer electrons in the iron oxidation. Furthermore, its carbon metabolism is rather flexible, can perform the transformation of pentose through the oxidative and non-oxidative pentose phosphate pathways and has the ability to take up small organic compounds. It encodes a multitude of heavy metal resistance systems to adapt the heavy metal-containing environments.	[Guo, Xue; Yin, Huaqun; Liang, Yili; Hu, Qi; Zhou, Xishu; Xiao, Yunhua; Ma, Liyuan; Zhang, Xian; Qiu, Guanzhou; Liu, Xueduan] Cent South Univ, Sch Minerals Proc & Bioengn, Changsha, Hunan, Peoples R China; [Guo, Xue; Yin, Huaqun; Liang, Yili; Hu, Qi; Zhou, Xishu; Qiu, Guanzhou; Liu, Xueduan] Cent South Univ, Minist Educ, Key Lab Biomet, Changsha, Hunan, Peoples R China	Central South University; Central South University	Liu, XD (corresponding author), Cent South Univ, Sch Minerals Proc & Bioengn, Changsha, Hunan, Peoples R China.	xueduanliu@yahoo.com	Guo, Xue/GLR-8229-2022	Guo, Xue/0000-0002-4309-6140; Zhang, Xian/0000-0003-4079-9470; Ma, Liyuan/0000-0001-7351-836X	National Basic Research Program [2010CB630901]; National Natural Science Foundation of China [30770051]	National Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program (No. 2010CB630901), and the National Natural Science Foundation of China (No. 30770051). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Auch AF, 2010, STAND GENOMIC SCI, V2, P142, DOI 10.4056/sigs.541628; Barkay T, 2010, ENVIRON MICROBIOL, V12, P2904, DOI 10.1111/j.1462-2920.2010.02260.x; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bonnefoy V, 2012, ENV MICROBIOLOGY; Brasseur G, 2004, BBA-BIOENERGETICS, V1656, P114, DOI 10.1016/j.bbabio.2004.02.008; Bugaytsova Z, 2004, EUR J BIOCHEM, V271, P272, DOI 10.1046/j.1432-1033.2003.03926.x; Busch W, 2002, CRIT REV BIOCHEM MOL, V37, P287, DOI 10.1080/10409230290771528; Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35; Chen LX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039470; Delcher AL, 2003, CURRENT PROTOCOLS BI, DOI DOI 10.13.11-10.13.18; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Deveau H, 2010, ANNU REV MICROBIOL, V64, P475, DOI 10.1146/annurev.micro.112408.134123; Dopson M, 2005, MICROBIOL-SGM, V151, P4127, DOI 10.1099/mic.0.28362-0; Egorova MA, 2004, APPL BIOCHEM MICRO+, V40, P381, DOI 10.1023/B:ABIM.0000033915.97286.0e; Euzeby JP, 1997, INT J SYST BACTERIOL, V47, P590, DOI 10.1099/00207713-47-2-590; FOX B, 1982, J BIOL CHEM, V257, P2498; Friedrich CG, 2005, CURR OPIN MICROBIOL, V8, P253, DOI 10.1016/j.mib.2005.04.005; Friedrich CG, 2001, APPL ENVIRON MICROB, V67, P2873, DOI 10.1128/AEM.67.7.2873-2882.2001; Frigaard NU, 2009, ADV MICROB PHYSIOL, V54, P103, DOI 10.1016/S0065-2911(08)00002-7; Ghosh W, 2009, FEMS MICROBIOL REV, V33, P999, DOI 10.1111/j.1574-6976.2009.00187.x; Gokce E, 2012, J PROTEOME RES, V11, P5827, DOI 10.1021/pr300604s; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Hallberg KB, 1996, FEMS MICROBIOL LETT, V145, P409; Hallet B, 1999, MOL CELL, V4, P949, DOI 10.1016/S1097-2765(00)80224-5; Hamann N, 2007, BIOCHEMISTRY-US, V46, P12875, DOI 10.1021/bi700679u; Han C, 2010, STAND GENOMIC SCI, V3, P337, DOI 10.4056/sigs.1373474; Hanke T, 2013, APPL ENVIRON MICROB, V79, P2336, DOI 10.1128/AEM.03414-12; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Johnson DB, 2008, EXTREMOPHILES, V12, P789, DOI 10.1007/s00792-008-0184-4; Johnson DB, 2003, RES MICROBIOL, V154, P466, DOI 10.1016/S0923-2508(03)00114-1; JOHNSON LN, 1992, FASEB J, V6, P2274, DOI 10.1096/fasebj.6.6.1544539; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kappler U, 2001, FEMS MICROBIOL LETT, V203, P1, DOI 10.1016/S0378-1097(01)00304-4; Katayama Y, 2000, ANTIMICROB AGENTS CH, V44, P1549, DOI 10.1128/AAC.44.6.1549-1555.2000; Kato N, 2006, BIOSCI BIOTECH BIOCH, V70, P10, DOI 10.1271/bbb.70.10; KLETZIN A, 1992, J BACTERIOL, V174, P5854, DOI 10.1128/jb.174.18.5854-5859.1992; Krasil'nikova EN, 2004, APPL BIOCHEM MICRO+, V40, P53, DOI 10.1023/B:ABIM.0000010352.40671.af; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Laska S, 2003, MICROBIOL-SGM, V149, P2357, DOI 10.1099/mic.0.26455-0; Li B, 2011, J BACTERIOL, V193, P5555, DOI 10.1128/JB.05684-11; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Mahillon J, 1998, MICROBIOL MOL BIOL R, V62, P725, DOI 10.1128/MMBR.62.3.725-774.1998; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Mangold S, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00017; Melamud VS, 2003, MICROBIOLOGY+, V72, P605, DOI 10.1023/A:1026007620113; Mukhopadhyay R, 2002, ENVIRON HEALTH PERSP, V110, P745, DOI 10.1289/ehp.02110s5745; Norris PR, 1996, MICROBIOL-UK, V142, P775, DOI 10.1099/00221287-142-4-775; Orita I, 2006, J BACTERIOL, V188, P4698, DOI 10.1128/JB.00492-06; Cardenas JP, 2010, APPL MICROBIOL BIOT, V88, P605, DOI 10.1007/s00253-010-2795-9; Paez-Espino D, 2009, BIOMETALS, V22, P117, DOI 10.1007/s10534-008-9195-y; Quatrini R, 2006, HYDROMETALLURGY, V83, P263, DOI 10.1016/j.hydromet.2006.03.030; Quatrini R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-394; Rohwerder T, 2003, MICROBIOL-SGM, V149, P1699, DOI 10.1099/mic.0.26212-0; Romano AH, 1996, RES MICROBIOL, V147, P448, DOI 10.1016/0923-2508(96)83998-2; Saier MH, 2006, NUCLEIC ACIDS RES, V34, pD181, DOI 10.1093/nar/gkj001; Saier MH, 2009, NUCLEIC ACIDS RES, V37, pD274, DOI 10.1093/nar/gkn862; Sakurai H, 2010, PHOTOSYNTH RES, V104, P163, DOI 10.1007/s11120-010-9531-2; Sayers EW, 2011, NUCLEIC ACIDS RES, V39, pD38, DOI 10.1093/nar/gkq1172; Shiers DW, 2010, HYDROMETALLURGY, V104, P363, DOI 10.1016/j.hydromet.2010.03.023; SILVERMAN MP, 1959, J BACTERIOL, V77, P642, DOI 10.1128/JB.77.5.642-647.1959; Soderberg Tim, 2005, Archaea, V1, P347, DOI 10.1155/2005/314760; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; THOMPSON JD, 2002, CURR PROTOC BIOINFOR, DOI DOI 10.1002/0471250953.BIO203S00; Tsaplina IA, 2000, MICROBIOLOGY+, V69, P271, DOI 10.1007/BF02756732; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Urich T, 2006, SCIENCE, V311, P996, DOI 10.1126/science.1120306; Valdes J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-597; van der Merwe JA, 2010, HYDROMETALLURGY, V104, P477, DOI 10.1016/j.hydromet.2010.01.017; van der Merwe JA, 2009, ADV MATER RES-SWITZ, V71-73, P171, DOI 10.4028/www.scientific.net/AMR.71-73.171; Vos P., 2009, BERGEYS MANUAL SYSTE, V3; Xia JL, 2010, INT J MINER PROCESS, V94, P52, DOI 10.1016/j.minpro.2009.11.005; Yoshizawa Y, 2004, J BACTERIOL, V186, P5685, DOI 10.1128/JB.186.17.5685-5691.2004	76	35	39	4	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99417	10.1371/journal.pone.0099417	http://dx.doi.org/10.1371/journal.pone.0099417			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940621	Green Submitted, Green Published, gold			2022-12-27	WOS:000338508200023
J	Hersh, MH; Ostfeld, RS; McHenry, DJ; Tibbetts, M; Brunner, JL; Killilea, ME; LoGiudice, K; Schmidt, KA; Keesing, F				Hersh, Michelle H.; Ostfeld, Richard S.; McHenry, Diana J.; Tibbetts, Michael; Brunner, Jesse L.; Killilea, Mary E.; LoGiudice, Kathleen; Schmidt, Kenneth A.; Keesing, Felicia			Co-Infection of Blacklegged Ticks with Babesia microti and Borrelia burgdorferi Is Higher than Expected and Acquired from Small Mammal Hosts	PLOS ONE			English	Article							HUMAN GRANULOCYTIC EHRLICHIOSIS; IXODES-SCAPULARIS ACARI; ANAPLASMA-PHAGOCYTOPHILUM; LYME-DISEASE; RESERVOIR COMPETENCE; NEW-YORK; TRANSMISSION; INFECTION; EMERGENCE; PARASITE	Humans in the northeastern and midwestern United States are at increasing risk of acquiring tickborne diseases - not only Lyme disease, but also two emerging diseases, human granulocytic anaplasmosis and human babesiosis. Co-infection with two or more of these pathogens can increase the severity of health impacts. The risk of co-infection is intensified by the ecology of these three diseases because all three pathogens (Borrelia burgdorferi, Anaplasma phagocytophilum, and Babesia microti) are transmitted by the same vector, blacklegged ticks (Ixodes scapularis), and are carried by many of the same reservoir hosts. The risk of exposure to multiple pathogens from a single tick bite and the sources of co-infected ticks are not well understood. In this study, we quantify the risk of co-infection by measuring infection prevalence in 4,368 questing nymphs throughout an endemic region for all three diseases (Dutchess County, NY) to determine if co-infections occur at frequencies other than predicted by independent assortment of pathogens. Further, we identify sources of co-infection by quantifying rates of co-infection on 3,275 larval ticks fed on known hosts. We find significant deviations of levels of co-infection in questing nymphs, most notably 83% more co-infection with Babesia microti and Borrelia burgdorferi than predicted by chance alone. Further, this pattern of increased co-infection was observed in larval ticks that fed on small mammal hosts, but not on meso-mammal, sciurid, or avian hosts. Co-infections involving A. phagocytophilum were less common, and fewer co-infections of A. phagocytophilum and B. microti than predicted by chance were observed in both questing nymphs and larvae fed on small mammals. Medical practitioners should be aware of the elevated risk of B. microti/B. burgdorferi co-infection.	[Hersh, Michelle H.; McHenry, Diana J.; Tibbetts, Michael; Keesing, Felicia] Bard Coll, Program Biol, Annandale On Hudson, NY USA; [Hersh, Michelle H.; Ostfeld, Richard S.] Cary Inst Ecosyst Studies, Millbrook, NY USA; [Brunner, Jesse L.] Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA; [Killilea, Mary E.] NYU, Dept Environm Studies, New York, NY USA; [LoGiudice, Kathleen] Union Coll, Dept Biol, Schenectady, NY 12308 USA; [Schmidt, Kenneth A.] Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA	Cary Institute of Ecosystem Studies; Washington State University; New York University; Union College; Texas Tech University System; Texas Tech University	Hersh, MH (corresponding author), Sarah Lawrence Coll, Dept Biol, Bronxville, NY 10708 USA.	mhersh@sarahlawrence.edu	Brunner, Jesse L./B-1692-2013	Brunner, Jesse L./0000-0003-4894-8274; Ostfeld, Richard/0000-0002-3707-9301; Hersh, Michelle/0000-0003-1174-7575	National Science Foundation [0813041, 0940830]; United States Environmental Protection Agency; Dutchess County, NY; Division Of Environmental Biology [0813035] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); United States Environmental Protection Agency(United States Environmental Protection Agency); Dutchess County, NY; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was funded by National Science Foundation grants 0813041 and 0940830, and from grants from the United States Environmental Protection Agency (to RSO, FK, and CD Canham) and Dutchess County, NY (to RSO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams Y, 2008, J AM BOARD FAM MED, V21, P75, DOI 10.3122/jabfm.2008.01.060182; Belongia EA, 2002, VECTOR-BORNE ZOONOT, V2, P265, DOI 10.1089/153036602321653851; Brunner JL, 2008, ECOLOGY, V89, P2259, DOI 10.1890/07-0665.1; Civitello DJ, 2010, ISR J ECOL EVOL, V56, P417, DOI 10.1560/IJEE.56.3-4.417; Coleman JL, 2005, J INFECT DIS, V192, P1634, DOI 10.1086/496891; Courtney JW, 2004, J CLIN MICROBIOL, V42, P3164, DOI 10.1128/JCM.42.7.3164-3168.2004; Dahlgren FS, 2011, AM J TROP MED HYG, V85, P124, DOI 10.4269/ajtmh.2011.10-0613; Diuk-Wasser MA, 2014, EMERG INFECT DIS, V20, P225, DOI 10.3201/eid2002.130644; Ginsberg HS, 2008, EXP APPL ACAROL, V46, P29, DOI 10.1007/s10493-008-9175-5; Hersh MH, 2012, EMERG INFECT DIS, V18, P1951, DOI 10.3201/eid1812.111392; Hesterberg T., 2011, MATH STAT RESAMPLING; Joseph JT, 2011, EMERG INFECT DIS, V17, P843, DOI 10.3201/eid1705.101334; Keesing F, 2009, P ROY SOC B-BIOL SCI, V276, P3911, DOI 10.1098/rspb.2009.1159; Keesing F, 2012, EMERG INFECT DIS, V18, P2013, DOI 10.3201/eid1812.120919; Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575; Krause PJ, 2003, AM J TROP MED HYG, V68, P431, DOI 10.4269/ajtmh.2003.68.431; Krause PJ, 1996, JAMA-J AM MED ASSOC, V275, P1657, DOI 10.1001/jama.275.21.1657; Krause PJ, 2002, CLIN INFECT DIS, V34, P1184, DOI 10.1086/339813; Levi T, 2012, P NATL ACAD SCI USA, V109, P10942, DOI 10.1073/pnas.1204536109; Levin ML, 2001, VECTOR-BORNE ZOONOT, V1, P139, DOI 10.1089/153036601316977741; Levin ML, 2002, VECTOR-BORNE ZOONOT, V2, P125, DOI 10.1089/15303660260613693; Levin ML, 2000, INFECT IMMUN, V68, P2183, DOI 10.1128/IAI.68.4.2183-2186.2000; LoGiudice K, 2003, P NATL ACAD SCI USA, V100, P567, DOI 10.1073/pnas.0233733100; Magnarelli LA, 2013, J WILDLIFE DIS, V49, P294, DOI 10.7589/2012-06-172; Martinez-Balzano C, 2015, QJM-INT J MED, V108, P141, DOI 10.1093/qjmed/hcs100; National Research Council, 2011, GUIDE CARE USE LAB A; Nieto NC, 2009, VECTOR-BORNE ZOONOT, V9, P93, DOI 10.1089/vbz.2008.0072; Oleson CV, 2003, J SPINAL CORD MED, V26, P168, DOI 10.1080/10790268.2003.11754578; Ostfeld RS, 2012, ANNU REV ECOL EVOL S, V43, P157, DOI 10.1146/annurev-ecolsys-102710-145022; Ostfeld RS, 2003, ECOLOGY, V84, P1421, DOI 10.1890/02-3125; Ostfeld RS, 2010, LYME DIS ECOLOGY COM; Pedersen AB, 2007, TRENDS ECOL EVOL, V22, P133, DOI 10.1016/j.tree.2006.11.005; PIESMAN J, 1986, J CLIN MICROBIOL, V24, P446, DOI 10.1128/JCM.24.3.446-447.1986; Rigaud T, 2010, P ROY SOC B-BIOL SCI, V277, P3693, DOI 10.1098/rspb.2010.1163; Schauber EM, 1998, J MED ENTOMOL, V35, P901, DOI 10.1093/jmedent/35.5.901; Schulze TL, 2013, J MED ENTOMOL, V50, P379, DOI 10.1603/ME12088; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Steiner FE, 2008, J MED ENTOMOL, V45, P289, DOI 10.1603/0022-2585(2008)45[289:IACROA]2.0.CO;2; Swanson KI, 2007, J VECTOR ECOL, V32, P243, DOI 10.3376/1081-1710(2007)32[243:CMIQIS]2.0.CO;2; Swanson SJ, 2006, CLIN MICROBIOL REV, V19, P708, DOI 10.1128/CMR.00011-06; Sweeney CJ, 1998, MAYO CLIN PROC, V73, P338; Telfer S, 2010, SCIENCE, V330, P243, DOI 10.1126/science.1190333; Tokarz R, 2010, VECTOR-BORNE ZOONOT, V10, P217, DOI 10.1089/vbz.2009.0036; Varde S, 1998, EMERG INFECT DIS, V4, P97, DOI 10.3201/eid0401.980113; Walk ST, 2009, EMERG INFECT DIS, V15, P585, DOI 10.3201/eid1504.080940; Wang TJ, 2000, CLIN INFECT DIS, V31, P1149, DOI 10.1086/317465	46	89	91	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99348	10.1371/journal.pone.0099348	http://dx.doi.org/10.1371/journal.pone.0099348			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940999	Green Published, gold			2022-12-27	WOS:000338508200019
J	Lei, J; Li, WH; Yang, Y; Lu, Q; Zhang, N; Bai, GZ; Zhong, DX; Su, K; Liu, BY; Li, XF; Wang, YJ; Wang, XP				Lei, Jie; Li, Wenhai; Yang, Ye; Lu, Qiang; Zhang, Na; Bai, Guangzhen; Zhong, Daixing; Su, Kai; Liu, Boya; Li, Xiaofei; Wang, Yunjie; Wang, Xiaoping			TC-1 Overexpression Promotes Cell Proliferation in Human Non-Small Cell Lung Cancer that Can Be Inhibited by PD173074	PLOS ONE			English	Article							HUMAN BREAST-CANCER; TC1 C8ORF4; GASTRIC-CANCER; THYROID-CANCER; KINASE DOMAIN; TRANSITION; EXPRESSION; AMPLICON; PATHWAY; CHIBBY	Thyroid cancer-1 (TC-1), a natively disordered protein, is widely expressed in vertebrates and overexpressed in many kinds of tumors. However, its exact role and regulation mechanism in human non-small cell lung cancer (NSCLC) are still unclear. In the present study, we found that TC-1 is highly expressed in NSCLC and that its aberrant expression is strongly associated with NSCLC cell proliferation. Exogenous TC-1 overexpression promotes cell proliferation, accelerates the cell G1-to-S-phase transition, and reduces apoptosis in NSCLC. The knockdown of TC-1, however, inhibits NSCLC cell proliferation, cycle transition, and apoptosis resistance. Furthermore, we also demonstrated that PD173074, which functions as an inhibitor of the TC-1 in NSCLC, decreases the expression of TC-1 and inhibits TC-1 overexpression mediated cell proliferation in vitro and in vivo. Nevertheless, the inhibition function of PD173074 on NSCLC cell proliferation was eliminated in cells with TC-1 knockdown. These results suggest that PD173074 plays a significant role in TC-1 overexpression mediated NSCLC cell proliferation and may be a potential intervention target for the prevention of cell proliferation in NSCLC.	[Lei, Jie; Li, Wenhai; Lu, Qiang; Zhang, Na; Bai, Guangzhen; Zhong, Daixing; Su, Kai; Liu, Boya; Li, Xiaofei; Wang, Yunjie; Wang, Xiaoping] Fourth Mil Med Univ, Tangdu Hosp, Dept Thorac Surg, Xian 710032, Shaanxi, Peoples R China; [Yang, Ye] Shaanxi Prov Peoples Hosp, Dept Thorac Surg, Xian, Shaanxi, Peoples R China	Air Force Military Medical University; Xi'an Medical University	Wang, YJ (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Thorac Surg, Xian 710032, Shaanxi, Peoples R China.	wangyunjiemd@163.com; wxpchest@fmmu.edu.cn	Li, xiaofei/GXF-7187-2022					Byron SA, 2008, CANCER RES, V68, P6902, DOI 10.1158/0008-5472.CAN-08-0770; Chua EL, 2000, GENOMICS, V69, P342, DOI 10.1006/geno.2000.6348; Gall C, 2007, PROTEIN SCI, V16, P2510, DOI 10.1110/ps.073062707; Jung YS, 2006, CANCER RES, V66, P723, DOI 10.1158/0008-5472.CAN-05-3124; Kim B, 2003, CANCER RES, V63, P8248; Kim B, 2006, CLIN CANCER RES, V12, P3541, DOI 10.1158/1078-0432.CCR-05-2440; Kim Y, 2006, FEBS LETT, V580, P3519, DOI 10.1016/j.febslet.2006.05.036; Lamont FR, 2011, BRIT J CANCER, V104, P75, DOI 10.1038/sj.bjc.6606016; Miyake M, 2010, J PHARMACOL EXP THER, V332, P795, DOI 10.1124/jpet.109.162768; Mohammadi M, 1998, EMBO J, V17, P5896, DOI 10.1093/emboj/17.20.5896; Nallasamy S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002500; Nguyen PT, 2013, BRIT J CANCER, V109, P2248, DOI 10.1038/bjc.2013.550; Pardo OE, 2009, CANCER RES, V69, P8645, DOI 10.1158/0008-5472.CAN-09-1576; Ray ME, 2004, CANCER RES, V64, P40, DOI 10.1158/0008-5472.CAN-03-1022; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sunde M, 2004, CANCER RES, V64, P2766, DOI 10.1158/0008-5472.CAN-03-2093; Traer E, 2014, BLOOD, V123, P1516, DOI 10.1182/blood-2013-07-518381; Wang YD, 2008, BMB REP, V41, P733, DOI 10.5483/BMBRep.2008.41.10.733; Yang ZQ, 2006, CANCER RES, V66, P11632, DOI 10.1158/0008-5472.CAN-06-2946; Yang ZQ, 2007, INT J CANCER, V121, P1265, DOI 10.1002/ijc.22831; Ye TH, 2014, BREAST CANCER RES TR, V143, P435, DOI 10.1007/s10549-013-2829-y; Ye YW, 2013, ONCOL REP, V30, P2777, DOI 10.3892/or.2013.2796; Zhao JB, 2010, CANCER LETT, V290, P238, DOI 10.1016/j.canlet.2009.09.013	23	11	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100075	10.1371/journal.pone.0100075	http://dx.doi.org/10.1371/journal.pone.0100075			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941347	Green Published, Green Submitted, gold			2022-12-27	WOS:000338508200071
J	Ostyn, B; Hasker, E; Dorlo, TPC; Rijal, S; Sundar, S; Dujardin, JC; Boelaert, M				Ostyn, Bart; Hasker, Epco; Dorlo, Thomas P. C.; Rijal, Suman; Sundar, Shyam; Dujardin, Jean-Claude; Boelaert, Marleen			Failure of Miltefosine Treatment for Visceral Leishmaniasis in Children and Men in South-East Asia	PLOS ONE			English	Article							KALA-AZAR; DRUG-RESISTANCE; SODIUM STIBOGLUCONATE; PALESTINE REFUGEES; ORAL MILTEFOSINE; SEX-DIFFERENCES; INFECTION; PREVALENCE; EFFICACY; INDIA	Background: High frequency of relapse in miltefosine-treated visceral leishmaniasis (VL) patients in India and Nepal followed up for twelve months. Objective: To identify epidemiological and clinical risk factors for relapse of VL in patients recently treated with standard dosing of miltefosine in India and Nepal. Design: Prospective observational study in three Primary Health Centers and one reference center in Muzaffarpur district, Bihar, India; and two zonal hospitals and a university hospital in South-east Nepal; records of all consenting patients diagnosed with VL and treated with miltefosine according to the current treatment guidelines of the Kala azar elimination program between 2009 and 2011. Results: We compared the clinical records of 78 cases of relapse with those of 775 patients who had no record of subsequent relapse. Relapse was 2 times more common amongst male patients (IRR 2.14, 95% CI 1.27-3.61), and 2 to 3 times more frequent in the age groups below 15 compared to the over 25 year olds (age 10 to 14: IRR 2.53; 95% CI 1.37-4.65 and Age 2 to 9: IRR 3.19; 95% CI 1.77-5.77). History of earlier VL episodes, or specific clinical features at time of diagnosis such as duration of symptoms or spleen size were no predictors of relapse. Conclusions: Young age and male gender were associated with increased risk of VL relapse after miltefosine, suggesting that the mechanism of relapse is mainly host-related i.e. immunological factors and/or drug exposure (pharmacokinetics). The observed decrease in efficacy of miltefosine may be explained by the inclusion of younger patients compared to the earlier clinical trials, rather than by a decreased susceptibility of the parasite to miltefosine. Our findings highlight the importance of proper clinical trials in children, including pharmacokinetics, to determine the safety, efficacy, drug exposure and therapeutic response of new drugs in this age group.	[Ostyn, Bart; Hasker, Epco; Boelaert, Marleen] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium; [Dorlo, Thomas P. C.] Univ Utrecht, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands; [Rijal, Suman] BP Koirala Inst Hlth Sci, Dept Internal Med, Dharan, Nepal; [Sundar, Shyam] Banaras Hindu Univ, Inst Med Sci, Dept Med, Varanasi 221005, Uttar Pradesh, India; [Dujardin, Jean-Claude] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium	Institute of Tropical Medicine (ITM); Utrecht University; B.P. Koirala Institute of Health Sciences; Banaras Hindu University (BHU); Institute of Tropical Medicine (ITM)	Ostyn, B (corresponding author), Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium.	bostyn@itg.be	Dorlo, Thomas/F-1339-2011; Dujardin, Jean-Claude/AAO-1783-2021; Boelaert, Marleen/E-2698-2012	Dorlo, Thomas/0000-0003-3076-8435; Boelaert, Marleen/0000-0001-8051-6776	European Union under its 7th Framework Program (INCODEV) [222895]	European Union under its 7th Framework Program (INCODEV)	This research was done in the frame of a research project in India and Nepal on new tools for monitoring drug resistance and treatment response in Visceral Leishmaniasis in the Indian subcontinent (Kaladrug-R, see also http://www.leishrisk.net/kaladrug/) funded by the European Union under its 7th Framework Program (INCODEV/Project 222895) and no commercial company was involved in the sponsoring of the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banjara MR, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/126093; Bhandari V, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001657; Bhattacharya SK, 2004, CLIN INFECT DIS, V38, P217, DOI 10.1086/380638; Bhattacharya SK, 2007, J INFECT DIS, V196, P591, DOI 10.1086/519690; BRYCESON ADM, 1985, T ROY SOC TROP MED H, V79, P700, DOI 10.1016/0035-9203(85)90197-X; Croft SL, 2006, CLIN MICROBIOL REV, V19, P111, DOI 10.1128/CMR.19.1.111-126.2006; Cruz A, 2007, J INFECT DIS, V195, P602, DOI 10.1086/510860; Das VNR, 2005, NATL MED J INDIA, V18, P131; Dorlo TPC, 2014, J INFECT DIS, V210, P146, DOI 10.1093/infdis/jiu039; Dorlo TPC, 2012, J ANTIMICROB CHEMOTH, V67, P2576, DOI 10.1093/jac/dks275; Dorlo TPC, 2012, ANTIMICROB AGENTS CH, V56, P3864, DOI 10.1128/AAC.00292-12; Gorski S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000705; Guerin PJ, 2002, LANCET INFECT DIS, V2, P494, DOI 10.1016/S1473-3099(02)00347-X; Guerra-Silveira F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062390; Jeronimo SMB, 2004, SCAND J INFECT DIS, V36, P443, DOI 10.1080/00365540410020451; Jha TK, 1999, NEW ENGL J MED, V341, P1795, DOI 10.1056/NEJM199912093412403; Khader A, 2012, TROP MED INT HEALTH, V17, P1569, DOI 10.1111/j.1365-3156.2012.03097.x; Khader A, 2012, TROP MED INT HEALTH, V17, P1163, DOI 10.1111/j.1365-3156.2012.03048.x; Klein SL, 2004, PARASITE IMMUNOL, V26, P247, DOI 10.1111/j.0141-9838.2004.00710.x; Malaviya P, 2011, TROP MED INT HEALTH, V16, P1159, DOI 10.1111/j.1365-3156.2011.02803.x; Murray HW, 2005, J IMMUNOL, V174, P4916, DOI 10.4049/jimmunol.174.8.4916; Ostyn B, 2013, TROP MED INT HEALTH, V18, P725, DOI 10.1111/tmi.12092; Prajapati VK, 2013, AM J TROP MED HYG, V89, P750, DOI 10.4269/ajtmh.13-0096; Rahman M, 2011, AM J TROP MED HYG, V85, P66, DOI 10.4269/ajtmh.2011.10-0661; Rai K, 2013, MBIO, V4, DOI 10.1128/mBio.00611-13; Ribeiro V, 2006, CURR DRUG TARGETS, V7, P1709, DOI 10.2174/138945006779025347; Rijal S, 2013, CLIN INFECT DIS, V56, P1530, DOI 10.1093/cid/cit102; Ritmeijer K, 2006, CLIN INFECT DIS, V43, P357, DOI 10.1086/505217; Shaddy RE, 2010, PEDIATRICS, V125, P850, DOI 10.1542/peds.2010-0082; SHARMA M C, 1990, Journal of Communicable Diseases, V22, P277; SHIDDO SA, 1995, T ROY SOC TROP MED H, V89, P361, DOI 10.1016/0035-9203(95)90008-X; Singh UK, 2006, INDIAN PEDIATR, V43, P1076; Snider H, 2009, NEUROIMMUNOMODULAT, V16, P106, DOI 10.1159/000180265; Sundar S, 2003, PEDIATR INFECT DIS J, V22, P434; Sundar S, 2002, NEW ENGL J MED, V347, P1739, DOI 10.1056/NEJMoa021556; SUNDAR S, 1994, BRIT MED J, V308, P307, DOI 10.1136/bmj.308.6924.307; Sundar S, 2000, CLIN INFECT DIS, V31, P1104, DOI 10.1086/318121; Sundar S, 2012, CLIN INFECT DIS, V55, P543, DOI 10.1093/cid/cis474; Uranw S, 2013, TROP MED INT HEALTH, V18, P179, DOI 10.1111/tmi.12025; WEIGLE KA, 1993, J INFECT DIS, V168, P699, DOI 10.1093/infdis/168.3.699; WIJERS DJB, 1969, TROP GEOGR MED, V21, P436; Zuk M, 1996, INT J PARASITOL, V26, P1009, DOI [10.1016/S0020-7519(96)00086-0, 10.1016/S0020-7519(96)80001-4]	42	47	48	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100220	10.1371/journal.pone.0100220	http://dx.doi.org/10.1371/journal.pone.0100220			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941345	Green Published, Green Submitted, gold			2022-12-27	WOS:000338508200085
J	Springate, DA; Kontopantelis, E; Ashcroft, DM; Olier, I; Parisi, R; Chamapiwa, E; Reeves, D				Springate, David A.; Kontopantelis, Evangelos; Ashcroft, Darren M.; Olier, Ivan; Parisi, Rosa; Chamapiwa, Edmore; Reeves, David			ClinicalCodes: An Online Clinical Codes Repository to Improve the Validity and Reproducibility of Research Using Electronic Medical Records	PLOS ONE			English	Article							PRACTICE RESEARCH DATABASE; GENERAL-PRACTICE; RHEUMATOID-ARTHRITIS; CARE; UK; VALIDATION; MORBIDITY; MORTALITY	Lists of clinical codes are the foundation for research undertaken using electronic medical records (EMRs). If clinical code lists are not available, reviewers are unable to determine the validity of research, full study replication is impossible, researchers are unable to make effective comparisons between studies, and the construction of new code lists is subject to much duplication of effort. Despite this, the publication of clinical codes is rarely if ever a requirement for obtaining grants, validating protocols, or publishing research. In a representative sample of 450 EMR primary research articles indexed on PubMed, we found that only 19 (5.1%) were accompanied by a full set of published clinical codes and 32 (8.6%) stated that code lists were available on request. To help address these problems, we have built an online repository where researchers using EMRs can upload and download lists of clinical codes. The repository will enable clinical researchers to better validate EMR studies, build on previous code lists and compare disease definitions across studies. It will also assist health informaticians in replicating database studies, tracking changes in disease definitions or clinical coding practice through time and sharing clinical code information across platforms and data sources as research objects.	[Springate, David A.; Kontopantelis, Evangelos; Chamapiwa, Edmore; Reeves, David] Univ Manchester, Ctr Primary Care, Inst Populat Hlth, Manchester, Lancs, England; [Springate, David A.; Reeves, David] Univ Manchester, Inst Populat Hlth, Ctr Biostat, Manchester, Lancs, England; [Kontopantelis, Evangelos] Univ Manchester, Ctr Hlth Informat, Inst Populat Hlth, Manchester, Lancs, England; [Ashcroft, Darren M.; Parisi, Rosa] Univ Manchester, Manchester Pharm Sch, Ctr Pharmacoepidemiol & Drug Safety Res, Manchester, Lancs, England; [Olier, Ivan] Univ Manchester, Manchester Inst Biotechnol, Manchester, Lancs, England	University of Manchester; University of Manchester; University of Manchester; University of Manchester; University of Manchester	Springate, DA (corresponding author), Univ Manchester, Ctr Primary Care, Inst Populat Hlth, Manchester, Lancs, England.	david.springate@manchester.ac.uk	Kontopantelis, Evangelos/H-2966-2019; Ashcroft, Darren M/G-3244-2015; Reeves, David/H-6203-2014	Kontopantelis, Evangelos/0000-0001-6450-5815; Ashcroft, Darren M/0000-0002-2958-915X; Parisi, Rosa/0000-0002-0968-9153; Reeves, David/0000-0001-6377-6859; Olier, Ivan/0000-0002-5679-7501	National Institute for Health Research (NIHR) School for Primary Care Research (SPCR); MRC [MR/K006665/1] Funding Source: UKRI; Medical Research Council [MR/K006665/1, MC_PC_13042] Funding Source: researchfish	National Institute for Health Research (NIHR) School for Primary Care Research (SPCR)(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The project "How valid are evaluations of effectiveness based on Primary Care Databases'' was funded by the National Institute for Health Research (NIHR) School for Primary Care Research (SPCR, http://www.nihr.ac.uk/research/Pages/programmes_primary_care_research.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bechhofer S, 2013, FUTURE GENER COMP SY, V29, P599, DOI 10.1016/j.future.2011.08.004; Bechhofer Sean, 2010, NATURE P; Bhattarai N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029776; Dave S, 2009, PHARMACOEPIDEM DR S, V18, P704, DOI 10.1002/pds.1770; Doran T, 2011, BMJ-BRIT MED J, P342; European Commission, 2017, COMM REC ACC PRES SC; Rodriguez LAG, 2009, SCAND J RHEUMATOL, V38, P173, DOI 10.1080/03009740802448825; Gulliford MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007168; Herrett E, 2010, BRIT J CLIN PHARMACO, V69, P4, DOI 10.1111/j.1365-2125.2009.03537.x; Hippisley-Cox J, 2008, HEART, V94, P34, DOI 10.1136/hrt.2007.134890; Hippisley-Cox J, 2006, BMJ-BRIT MED J; Jha AK, 2009, NEW ENGL J MED, V360, P1628, DOI 10.1056/NEJMsa0900592; Jordan K, 2004, FAM PRACT, V21, P396, DOI 10.1093/fampra/cmh409; Kontopantelis E, 2012, BMJ QUALITY SAFETY; KONTOPANTELIS E, 2014, BMJ-BRIT MED J, V348, DOI DOI 10.1136/BMJ.G330; Kotz D, 2011, J ALLERGY CLIN IMMUN, V127, P623, DOI 10.1016/j.jaci.2010.11.021; Langan Sinead M, 2013, Clin Epidemiol, V5, P29, DOI 10.2147/CLEP.S36885; Manuel DG, 2010, BMJ-BRIT MED J, P341; Morin A, 2012, SCIENCE, V336, P159, DOI 10.1126/science.1218263; Mulnier HE, 2006, DIABETIC MED, V23, P516, DOI 10.1111/j.1464-5491.2006.01838.x; Murdoch TB, 2013, JAMA-J AM MED ASSOC, V309, P1351, DOI 10.1001/jama.2013.393; Nicholson A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054878; Nicholson A, 2011, PHARMACOEPIDEM DR S, V20, P321, DOI 10.1002/pds.2086; Office of Science and Technology Policy, 2013, INCR ACC RES FED FUN; Pampel H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078080; Purves IN, 1996, BRIT MED J, V312, P1112; R Core Team, 2012, R LANG ENV STAT COMP; Reeves D, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004952; Springate DA, 2014, RCLINICALCODES R INT; Stodden V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067111; The Royal Society, 2012, 2012 ROY SOC SCI POL; Vinogradova Y, 2013, BMJ-BRIT MED J, V346; von Elm E, 2007, PREV MED, V45, P247, DOI 10.1016/j.ypmed.2007.08.012; Wang SD, 2013, J THORACIC DIS, V5; Watson DJ, 2003, J RHEUMATOL, V30, P1196	35	119	118	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99825	10.1371/journal.pone.0099825	http://dx.doi.org/10.1371/journal.pone.0099825			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941260	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000338508200043
J	Dahl, U; Rise, MB; Kulseng, B; Steinsbekk, A				Dahl, Unni; Rise, Marit By; Kulseng, Bard; Steinsbekk, Aslak			Personnel and Participant Experiences of a Residential Weight-Loss Program. A Qualitative Study	PLOS ONE			English	Article							LOSS MAINTENANCE; OBESE ADULTS; BARIATRIC SURGERY; SELF-EFFICACY; IMPACT; STIGMA; METAANALYSIS; OVERWEIGHT; EXERCISE; MORTALITY	Background: Residential weight-loss programs aim to help persons with obesity lose weight and maintain a long-term healthy lifestyle. Knowledge is needed on the different actors' perceptions and experiences from such programs. The aim of this study was to describe how personnel argued for and perceived a residential weight-loss program, to investigate how the participants experienced the program, and to contrast these perspectives. Methods: This qualitative study took place in an 18-week residential weight-loss program. Exercise, diet, and personal development were the main components in the program. Data was collected through participant observation and individual and focus group interviews with participants and personnel. Results: Program personnel characterized persons with obesity in specific terms, and these formed the basis of the educational aims, teaching principles, and content of the program. According to personnel, persons with obesity typically had problems acknowledging their own resources, lived unstructured lives, had a distorted relationship to food, experienced a range of social problems and featured a lack of personal insight. Program participants reported enthusiasm about their experiences of exercise and appreciated measures of success with the exercise program. They had, however, very different experiences regarding the usefulness and appropriateness of the parts of the program focused on social and personal development. Some felt that weight loss required an engagement with personal development while others viewed it as unnecessary and inappropriate. Conclusion: The reliance in personnel accounts on particular characteristics of persons with obesity as a rationale for the program might lead to stigmatizing and stereotyping. Program activities focused on social and personal development need to be better understood by participants if they are to be viewed as helpful. To achieve this personnel must carefully consider how these parts of the program are communicated and conducted.	[Dahl, Unni] Cent Norway Hlth Author, Stjordal, Norway; [Dahl, Unni; Rise, Marit By; Steinsbekk, Aslak] Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, N-7034 Trondheim, Norway; [Kulseng, Bard] St Olavs Univ Hosp, Reg Ctr Obes Treatment, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Rise, MB (corresponding author), Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, N-7034 Trondheim, Norway.	marit.b.rise@ntnu.no	Steinsbekk, Aslak/E-9223-2012	Steinsbekk, Aslak/0000-0001-9090-0739				Anderson RM, 2008, DIABETES EDUCATOR, V34, P109, DOI 10.1177/0145721707312398; Avenell A., 2004, HLTH TECHNOL ASSESS, P8; Bandura A, 2004, HEALTH EDUC BEHAV, V31, P143, DOI 10.1177/1090198104263660; Beach MC, 2007, J GEN INTERN MED, V22, P692, DOI 10.1007/s11606-006-0054-7; Bleich SN, 2010, PATIENT EDUC COUNS, V79, P344, DOI 10.1016/j.pec.2010.01.020; Byrne S, 2012, APPETITE, V58, P695, DOI 10.1016/j.appet.2012.01.005; Byrne SM, 2002, J PSYCHOSOM RES, V53, P1029, DOI 10.1016/S0022-3999(02)00487-7; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Chan RSM, 2009, INT J ENV RES PUB HE, V6, P2608, DOI 10.3390/ijerph6102608; Chang SH, 2014, JAMA SURG, V149, P275, DOI 10.1001/jamasurg.2013.3654; Christiansen B, 2012, INT J QUAL STUD HEAL, V7, DOI 10.3402/qhw.v7i0.17255; Christiansen T, 2007, OBESITY, V15, P413, DOI 10.1038/oby.2007.530; Cochrane G, 2008, CAN FAM PHYSICIAN, V54, P543; Douketis JD, 2005, INT J OBESITY, V29, P1153, DOI 10.1038/sj.ijo.0802982; Elfhag K, 2005, OBES REV, V6, P67, DOI 10.1111/j.1467-789X.2005.00170.x; Fabricatore A. N., 2003, Diabetes Spectrum, V16, P245, DOI 10.2337/diaspect.16.4.245; Ferrante JM, 2010, OBESITY, V18, P1153, DOI 10.1038/oby.2009.481; Foster GD, 2005, AM J CLIN NUTR, V82, p230S, DOI 10.1093/ajcn/82.1.230S; Foster GD, 2003, OBES RES, V11, P1168, DOI 10.1038/oby.2003.161; Foster-Schubert KE, 2012, OBESITY, V20, P1628, DOI 10.1038/oby.2011.76; Grol R, 2004, MED J AUSTRALIA, V180, pS57, DOI 10.5694/j.1326-5377.2004.tb05948.x; Jeffery RW, 2007, DIABETES, V56, P2673, DOI 10.2337/db07-1029; Jones N, 2007, J HUM NUTR DIET, V20, P486, DOI 10.1111/j.1365-277X.2007.00810.x; Kwok CS, 2014, INT J CARDIOL, V173, P20, DOI 10.1016/j.ijcard.2014.02.026; Maldonato A, 2010, PATIENT EDUC COUNS, V79, P287, DOI 10.1016/j.pec.2010.02.010; Martins C, 2011, OBES SURG, V21, P841, DOI 10.1007/s11695-010-0131-1; May CR, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-29; Middleton KMR, 2012, OBES REV, V13, P509, DOI 10.1111/j.1467-789X.2011.00972.x; Mobbs O, 2010, PATIENT EDUC COUNS, V79, P372, DOI 10.1016/j.pec.2010.03.003; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Myers A, 1999, INT J OBESITY, V23, P221, DOI 10.1038/sj.ijo.0800765; Nicholson F, 2010, INT J WOMENS HEALTH, V2, P393, DOI 10.2147/IJWH.S13456; Penn L, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-235; Powell LH, 2007, AM PSYCHOL, V62, P234, DOI 10.1037/0003-066X.62.3.234; Puhl RM, 2006, OBESITY, V14, P1802, DOI 10.1038/oby.2006.208; Puhl RM, 2009, OBESITY, V17, P941, DOI 10.1038/oby.2008.636; Reach G, 2009, PATIENT EDUC COUNS, V77, P192, DOI 10.1016/j.pec.2009.05.005; Romanova M, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120325; Rossner S, 2008, OBES REV, V9, P624, DOI 10.1111/j.1467-789X.2008.00516.x; Schvey NA, 2011, OBESITY, V19, P1957, DOI 10.1038/oby.2011.204; Shay LE, 2008, NURS FORUM, V43, P42, DOI 10.1111/j.1744-6198.2008.00095.x; Sikorski C, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-661; Soderlund A, 2009, PERSPECT PUBLIC HEAL, V129, P132, DOI 10.1177/1757913908094805; Vartanian LR, 2011, OBESITY, V19, P757, DOI 10.1038/oby.2010.234; Wing RR, 2001, ANNU REV NUTR, V21, P323, DOI 10.1146/annurev.nutr.21.1.323	45	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100226	10.1371/journal.pone.0100226	http://dx.doi.org/10.1371/journal.pone.0100226			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK5YM	24937479	Green Published, Green Submitted, gold			2022-12-27	WOS:000338503400096
J	Klomp, A; Hamelink, R; Feenstra, M; Denys, D; Reneman, L				Klomp, Anne; Hamelink, Ralph; Feenstra, Matthijs; Denys, Damiaan; Reneman, Liesbeth			Increased Response to a 5-HT Challenge After Discontinuation of Chronic Serotonin Uptake Inhibition in the Adult and Adolescent Rat Brain	PLOS ONE			English	Article							CHRONIC FLUOXETINE TREATMENT; SELECTIVE SEROTONIN; EXTRACELLULAR SEROTONIN; PREFRONTAL CORTEX; REUPTAKE INHIBITORS; SUICIDAL IDEATION; MONOAMINE LEVELS; FRONTAL-CORTEX; DOPAMINE; RELEASE	Little is known about the effects of chronic fluoxetine on 5-HT transmission in the adolescent brain, even though it is acknowledged that the neuroplasticity of the brain during childhood and adolescence might influence the neurobiological mechanisms underlying treatment response. Also, possible ongoing effects on monoamine function following drug discontinuation are unidentified. We therefore examined the chronic effects of fluoxetine on extracellular 5-HT and dopamine concentrations in the medial prefrontal cortex and studied their responsiveness to an acute 5-HT challenge after a one-week washout period, both in adolescent and adult rats. Noradrenaline was measured in adult animals only. Fluoxetine increased 5-HT to 200-300% of control and DA and NA to 150% of control. Although there were no lasting effects of chronic fluoxetine on basal monoamine levels, we observed a clear potentiating effect of previous treatment on the fluoxetine-induced increase in extracellular 5-HT and, to a lesser extent, extracellular DA. No differential effect was found for noradrenaline. Age-at-treatment did not influence these results. So, after cessation of chronic fluoxetine treatment 5-HT responsiveness remains heightened. This may be indicative of the continuing presence of 5-HT receptor desensitization, at least until one week after drug discontinuation in rats. No apparent age-at-treatment effects on extracellular monoamine concentrations in the medial prefrontal cortex were detected, but age-related differences in 5-HT transmission further down-stream or in the recovery processes cannot be ruled out.	[Klomp, Anne; Reneman, Liesbeth] Univ Amsterdam, Acad Med Ctr, Dept Radiol, NL-1105 AZ Amsterdam, Netherlands; [Hamelink, Ralph; Feenstra, Matthijs; Denys, Damiaan] Royal Netherlands Acad Arts & Sci, Netherlands Inst Neurosci, Amsterdam, Netherlands; [Hamelink, Ralph; Feenstra, Matthijs; Denys, Damiaan] Univ Amsterdam, Acad Med Ctr, Dept Psychiat, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); University of Amsterdam; Academic Medical Center Amsterdam	Reneman, L (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Radiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	l.reneman@amc.uva.nl		Reneman, Liesbeth/0000-0002-5912-9971	Netherlands Organisation for Scientific Research (NWO - division ZonMW) [916.86.125]	Netherlands Organisation for Scientific Research (NWO - division ZonMW)	This work is funded by the Netherlands Organisation for Scientific Research (NWO - division ZonMW; www.zonmw.nl) (Veni grant; no. 916.86.125), awarded to LR. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alex KD, 2007, PHARMACOL THERAPEUT, V113, P296, DOI 10.1016/j.pharmthera.2006.08.004; Amargos-Bosch M, 2005, EUR J PHARMACOL, V516, P235, DOI 10.1016/j.ejphar.2005.05.004; Andersen SL, 2004, INT J DEV NEUROSCI, V22, P423, DOI 10.1016/j.ijdevneu.2004.06.002; Best J, 2010, THEOR BIOL MED MODEL, V7, DOI 10.1186/1742-4682-7-34; Beyer CE, 2008, EUR J PHARMACOL, V580, P350, DOI 10.1016/j.ejphar.2007.11.028; Boileau I, 2006, ARCH GEN PSYCHIAT, V63, P1386, DOI 10.1001/archpsyc.63.12.1386; Bouet V, 2012, PSYCHOPHARMACOLOGY, V221, P329, DOI 10.1007/s00213-011-2580-1; Bridge JA, 2007, JAMA-J AM MED ASSOC, V297, P1683, DOI 10.1001/jama.297.15.1683; Bymaster FP, 2002, PSYCHOPHARMACOLOGY, V160, P353, DOI 10.1007/s00213-001-0986-x; Caballero J, 2005, AM J HEALTH-SYST PH, V62, P864, DOI 10.1093/ajhp/62.8.864; CACCIA S, 1990, PSYCHOPHARMACOLOGY, V100, P509, DOI 10.1007/BF02244004; Cheung AH, 2005, J CHILD PSYCHOL PSYC, V46, P735, DOI 10.1111/j.1469-7610.2005.01467.x; CIZEK LJ, 1965, AM J PHYSIOL, V208, P615, DOI 10.1152/ajplegacy.1965.208.4.615; Dawson LA, 2000, NEUROPHARMACOLOGY, V39, P1044, DOI 10.1016/S0028-3908(99)00192-6; de Groote L, 2002, PSYCHOPHARMACOLOGY, V162, P419, DOI 10.1007/s00213-002-1117-z; Descarries L, 2012, PHILOS TRANS R SOC L, P367; DeVane CL, 1999, CELL MOL NEUROBIOL, V19, P443, DOI 10.1023/A:1006934807375; Engelbregt MJT, 2000, PEDIATR RES, V48, P803, DOI 10.1203/00006450-200012000-00017; GARDIER AM, 1994, LIFE SCI, V54, pPL51, DOI 10.1016/0024-3205(94)00821-3; Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256; Hammad TA, 2006, ARCH GEN PSYCHIAT, V63, P332, DOI 10.1001/archpsyc.63.3.332; Hazell P, 2000, COCHRANE DB SYST REV; Hervas I, 1998, EUR J PHARMACOL, V358, P9, DOI 10.1016/S0014-2999(98)00579-2; Hetrick S, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004851.pub2; Invernizzi R, 1996, PHARMACOL BIOCHEM BE, V54, P143, DOI 10.1016/0091-3057(95)02159-0; Jureidini JN, 2004, BMJ-BRIT MED J, V328, P879, DOI 10.1136/bmj.328.7444.879; Karanges E, 2011, INT J NEUROPSYCHOPH, V14, P491, DOI 10.1017/S146114571100006X; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Klomp A, 2012, NEUROIMAGE, V59, P218, DOI 10.1016/j.neuroimage.2011.07.082; Li XM, 1999, CHINESE J PHYSIOL, V42, P53; Lubbers LS, 2010, J STEROID BIOCHEM, V122, P310, DOI 10.1016/j.jsbmb.2010.08.005; March JS, 2009, AM J PSYCHIAT, V166, P1118, DOI 10.1176/appi.ajp.2009.08101606; Merikangas KR, 2010, J AM ACAD CHILD PSY, V49, P980, DOI 10.1016/j.jaac.2010.05.017; Newman ME, 2004, EUR J PHARMACOL, V486, P25, DOI 10.1016/j.ejphar.2003.12.008; Norrholm SD, 2000, BRAIN RES, V883, P205, DOI 10.1016/S0006-8993(00)02909-7; Olivier JDA, 2011, PROG NEURO-PSYCHOPH, V35, P1400, DOI 10.1016/j.pnpbp.2010.09.013; PERRY KW, 1992, LIFE SCI, V50, P1683, DOI 10.1016/0024-3205(92)90423-M; Preece MA, 2009, NEUROSCIENCE, V159, P751, DOI 10.1016/j.neuroscience.2008.12.032; Raap DK, 1999, J PHARMACOL EXP THER, V288, P561; Rogoz Z, 2010, PHARMACOL REP, V62, P1015, DOI 10.1016/S1734-1140(10)70363-7; RUTTER JJ, 1994, NEUROSCI LETT, V171, P183, DOI 10.1016/0304-3940(94)90635-1; Sakaue M, 2000, BRIT J PHARMACOL, V129, P1028, DOI 10.1038/sj.bjp.0703139; Sharp T, 2010, HBK BEHAV NEUROSCI, V21, P233, DOI 10.1016/B978-0-12-374634-4.00013-7; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Staiti AM, 2011, NEUROPHARMACOLOGY, V61, P544, DOI 10.1016/j.neuropharm.2011.04.005; STROMINGER JL, 1947, YALE J BIOL MED, V19, P279; Tanda G, 1996, PSYCHOPHARMACOLOGY, V127, P83, DOI 10.1007/BF02805978; Wegerer V, 1999, J CHILD ADOL PSYCHOP, V9, P13, DOI 10.1089/cap.1999.9.13; Weintrob N, 2002, ARCH PEDIAT ADOL MED, V156, P696, DOI 10.1001/archpedi.156.7.696; WhitakerAzmitia PM, 1996, BEHAV BRAIN RES, V73, P19; Wijlaars LPMM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033181; Wilens TE, 2003, J CHILD ADOL PSYCHOP, V13, P143, DOI 10.1089/104454603322163862; Wohlfarth TD, 2006, EUR NEUROPSYCHOPHARM, V16, P79, DOI 10.1016/j.euroneuro.2005.10.004; WONG DT, 1983, BIOCHEM PHARMACOL, V32, P1287, DOI 10.1016/0006-2952(83)90284-8; YEN TT, 1992, AM J CLIN NUTR, V55, P177, DOI 10.1093/ajcn/55.1.177s	55	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99873	10.1371/journal.pone.0099873	http://dx.doi.org/10.1371/journal.pone.0099873			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937739	Green Published, gold, Green Submitted			2022-12-27	WOS:000338503400048
J	Brown, HM; Knowlton, AE; Snavely, E; Nguyen, BD; Richards, TS; Grieshaber, SS				Brown, Heather M.; Knowlton, Andrea E.; Snavely, Emily; Nguyen, Bidong D.; Richards, Theresa S.; Grieshaber, Scott S.			Multinucleation during C. trachomatis Infections Is Caused by the Contribution of Two Effector Pathways	PLOS ONE			English	Article							INVASIVE CERVICAL-CANCER; CHLAMYDIAL INCLUSION MEMBRANE; INTRAEPITHELIAL NEOPLASIA; RISK-FACTORS; HOST-CELLS; INHIBITION; DEFECTS; WOMEN; ABNORMALITIES; GRISEOFULVIN	Chlamydia trachomatis is an obligate intracellular bacterial pathogen and the second leading cause of sexually transmitted infections in the US. Infections cause significant morbidity and can lead to serious reproductive sequelae, including an epidemiological link to increased rates of reproductive cancers. One of the overt changes that infected cells exhibit is the development of genomic instability leading to multinucleation. Here we demonstrate that the induction of multinucleation is not conserved equally across chlamydial species; C. trachomatis L2 caused high levels of multinucleation, C. muridarum intermediate levels, and C. caviae had very modest effects on multinucleation. Our data show that at least two effector pathways together cause genomic instability during infection leading to multinucleation. We find that the highly conserved chlamydial protease CPAF is a key effector for one of these pathways. CPAF secretion is required for the loss of centrosome duplication regulation as well as inducing early mitotic exit. The second effector pathway involves the induction of centrosome position errors. This function is not conserved in three chlamydial species tested. Together these two pathways contribute to the induction of high levels of genomic instability and multinucleation seen in C. trachomatis infections.	[Brown, Heather M.; Knowlton, Andrea E.; Richards, Theresa S.; Grieshaber, Scott S.] Univ Florida, Dept Oral Biol, Gainesville, FL 32610 USA; [Snavely, Emily; Nguyen, Bidong D.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Ctr Microbial Pathogenesis, Durham, NC USA	State University System of Florida; University of Florida; Duke University	Grieshaber, SS (corresponding author), Univ Florida, Dept Oral Biol, Gainesville, FL 32610 USA.	sgriesha@ufl.edu	Brown-Harding, Heather/GRF-0385-2022	Brown-Harding, Heather/0000-0001-9636-2345	NIAID, NIH [R01 AI077583]; NIDCR, NIH [T32 DE007200, T90 DE021990]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077583] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T90DE021990] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007200] Funding Source: NIH RePORTER	NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDCR, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The authors would like to acknowledge the NIAID, NIH for funding this work from the grant R01 AI077583 Grieshaber (PI). HB and AK were supported by fellowships from the NIDCR, NIH, T32 DE007200 and T90 DE021990. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibek K, 2012, INFECT AGENTS CANCER, V7, DOI 10.1186/1750-9378-7-35; Anttila T, 2001, JAMA-J AM MED ASSOC, V285, P47, DOI 10.1001/jama.285.1.47; Bannantine JP, 2000, CELL MICROBIOL, V2, P35; Brown HM, 2012, CELL MICROBIOL, V14, P1554, DOI 10.1111/j.1462-5822.2012.01820.x; CALDWELL HD, 1981, INFECT IMMUN, V31, P1161, DOI 10.1128/IAI.31.3.1161-1176.1981; CATES W, 1991, AM J OBSTET GYNECOL, V164, P1771, DOI 10.1016/0002-9378(91)90559-A; Chen D, 2010, MICROBIOL-SGM, V156, P3031, DOI 10.1099/mic.0.040527-0; Barros NKD, 2012, J MED VIROL, V84, P1143, DOI 10.1002/jmv.23312; Deluca GD, 2011, BRAZ J INFECT DIS, V15, P567, DOI 10.1016/S1413-8670(11)70252-5; Greene W, 2003, J INFECTION, V47, P45, DOI 10.1016/S0163-4453(03)00039-2; Grieshaber SS, 2006, TRAFFIC, V7, P940, DOI 10.1111/j.1600-0854.2006.00439.x; GUPTA PK, 1979, ACTA CYTOL, V23, P315; Hinkula M, 2004, BRIT J CANCER, V90, P1025, DOI 10.1038/sj.bjc.6601650; Huang ZW, 2008, CELL HOST MICROBE, V4, P529, DOI 10.1016/j.chom.2008.10.005; Knowlton AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054022; Knowlton AE, 2011, TRAFFIC, V12, P854, DOI 10.1111/j.1600-0854.2011.01204.x; Koskela P, 2000, INT J CANCER, V85, P35, DOI 10.1002/(SICI)1097-0215(20000101)85:1&lt;35::AID-IJC6&gt;3.0.CO;2-A; Kramer A, 2008, CELL ONCOL, V30, P505, DOI 10.3233/CLO-2008-0450; Lehtinen M, 2011, SEX TRANSM INFECT, V87, P372, DOI 10.1136/sti.2010.044354; Luostarinen T, 2013, INT J CANCER, V133, P1756, DOI 10.1002/ijc.28173; Madeleine MM, 2007, INT J CANCER, V120, P650, DOI 10.1002/ijc.22325; Matsumoto K, 2003, BRIT J CANCER, V89, P831, DOI 10.1038/sj.bjc.6601220; Mital J, 2010, CELL MICROBIOL, V12, P1235, DOI 10.1111/j.1462-5822.2010.01465.x; MOULDER JW, 1991, MICROBIOL REV, V55, P143, DOI 10.1128/MMBR.55.1.143-190.1991; Nguyen BD, 2012, P NATL ACAD SCI USA, V109, P1263, DOI 10.1073/pnas.1117884109; Peitsidis P, 2012, BRATISL MED J, V113, P357, DOI 10.4149/BLL_2012_081; Pihan G, 2003, CANCER CELL, V4, P89, DOI 10.1016/S1535-6108(03)00195-8; Pihan GA, 1998, CANCER RES, V58, P3974; Read TD, 2003, NUCLEIC ACIDS RES, V31, P2134, DOI 10.1093/nar/gkg321; Read TD, 2000, NUCLEIC ACIDS RES, V28, P1397, DOI 10.1093/nar/28.6.1397; Read TD, 2013, MBIO, V4, DOI 10.1128/mBio.00604-12; Rebacz B, 2007, CANCER RES, V67, P6342, DOI 10.1158/0008-5472.CAN-07-0663; Ronnest MH, 2009, J MED CHEM, V52, P3342, DOI 10.1021/jm801517j; Samaras V, 2010, J INFECT DEV COUNTR, V4, P267, DOI 10.3855/jidc.819; Seda J, 2011, P R HEALTH SCI J, V30, P14; Smith JS, 2004, INT J CANCER, V111, P431, DOI 10.1002/ijc.20257; Smith JS, 2002, J INFECT DIS, V185, P324, DOI 10.1086/338569; Sun HS, 2011, MOL CELL BIOL, V31, P5011, DOI 10.1128/MCB.05734-11; Wallin KL, 2002, INT J CANCER, V101, P371, DOI 10.1002/ijc.10639; World Health Organization, OV EST, P1; Zhang WH, 2011, CANCER-AM CANCER SOC, V117, P4092, DOI 10.1002/cncr.26021	41	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100763	10.1371/journal.pone.0100763	http://dx.doi.org/10.1371/journal.pone.0100763			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955832	gold, Green Published, Green Submitted			2022-12-27	WOS:000338917900093
J	Demaegd, D; Colinet, AS; Deschamps, A; Morsomme, P				Demaegd, Didier; Colinet, Anne-Sophie; Deschamps, Antoine; Morsomme, Pierre			Molecular Evolution of a Novel Family of Putative Calcium Transporters	PLOS ONE			English	Article							X-RAY-STRUCTURE; MEMBRANE-PROTEINS; NA+/H+ ANTIPORTER; SEQUENCE; YEAST; GENE; HOMEOSTASIS; POLYPLOIDY; PREDICTION; EXCHANGER	The UPF0016 family is a group of uncharacterized membrane proteins, well conserved through evolution and defined by the presence of one or two copies of an E-Phi-G-D-(KR)-(ST) consensus motif. Our previous results have shown that two members of this family, the human TMEM165 and the budding yeast Gdt1p, are functionally related and might form a new group of cationCa(2+) exchangers. Most members of the family are made of two homologous clusters of three transmembrane spans, separated by a central loop and assembled with an opposite orientation in the membrane. However, some bacterial members of the family have only one cluster of transmembrane domains. Among these 'single-domain membrane proteins' some cyanobacterial members were found as pairs of adjacent genes within the genome, but each gene was slightly different. We performed a bioinformatic analysis to propose the molecular evolution of the UPF0016 family and the emergence of the antiparallel topology. Our hypotheses were confirmed experimentally using functional complementation in yeast. This suggests an important and conserved function for UPF0016 proteins in a fundamental cellular process. We also show that members of the UPF0016 family share striking similarities, but no primary sequence homology, with members of the cation/Ca2+ exchangers (CaCA) superfamily. Such similarities could be an example of convergent evolution, supporting the previous hypothesis that members of the UPF0016 family are cation/Ca2+ exchangers.	[Demaegd, Didier; Colinet, Anne-Sophie; Deschamps, Antoine; Morsomme, Pierre] Catholic Univ Louvain, Inst Sci Vie, Louvain La Neuve, Belgium	Universite Catholique Louvain	Morsomme, P (corresponding author), Catholic Univ Louvain, Inst Sci Vie, Louvain La Neuve, Belgium.	pierre.morsomme@uclouvain.be	Morsomme, Pierre/AAD-9600-2019	Morsomme, Pierre/0000-0001-7780-7230	Belgian National Fund for Scientific Research (FNRS); Communaute francaise de Belgique-Actions de Recherches Concertees	Belgian National Fund for Scientific Research (FNRS)(Fonds de la Recherche Scientifique - FNRS); Communaute francaise de Belgique-Actions de Recherches Concertees	The work was supported by grants from the Belgian National Fund for Scientific Research (FNRS) and the "Communaute francaise de Belgique-Actions de Recherches Concertees". DD and ASC are research fellows at the "Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEIJON C, 1989, P NATL ACAD SCI USA, V86, P6935, DOI 10.1073/pnas.86.18.6935; Ast T, 2013, CELL, V152, P1134, DOI 10.1016/j.cell.2013.02.003; Blanc G, 2004, PLANT CELL, V16, P1679, DOI 10.1105/tpc.021410; Blanc G, 2003, GENOME RES, V13, P137, DOI 10.1101/gr.751803; Cai XJ, 2004, MOL BIOL EVOL, V21, P1692, DOI 10.1093/molbev/msh177; Chen YJ, 2007, P NATL ACAD SCI USA, V104, P18999, DOI 10.1073/pnas.0709387104; Cui JJ, 2009, FEMS YEAST RES, V9, P1137, DOI 10.1111/j.1567-1364.2009.00552.x; Demaegd D, 2013, P NATL ACAD SCI USA, V110, P6859, DOI 10.1073/pnas.1219871110; Dudley AM, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100004; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Foulquier F, 2012, AM J HUM GENET, V91, P15, DOI 10.1016/j.ajhg.2012.05.002; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Hilge M, 2006, MOL CELL, V22, P15, DOI 10.1016/j.molcel.2006.03.008; Hodgkin J, 2000, NATURE, V404, P442, DOI 10.1038/35006526; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; IVEY DM, 1993, J BIOL CHEM, V268, P11296; Kapp K., 2009, PROTEIN TRANSPORT EN, P1; Lolkema JS, 2008, J MOL BIOL, V378, P596, DOI 10.1016/j.jmb.2008.03.005; Moller S, 2001, BIOINFORMATICS, V17, P646, DOI 10.1093/bioinformatics/17.7.646; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Nugent T, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-169; PERSSON B, 1994, J MOL BIOL, V237, P182, DOI 10.1006/jmbi.1994.1220; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pittman JK, 2011, CELL CALCIUM, V50, P139, DOI 10.1016/j.ceca.2011.01.004; Poolman B, 2007, SCIENCE, V315, P1229, DOI 10.1126/science.1140073; Rapp M, 2006, NAT STRUCT MOL BIOL, V13, P112, DOI 10.1038/nsmb1057; Rapp M, 2007, SCIENCE, V315, P1282, DOI 10.1126/science.1135406; Reinhardt TA, 2014, BIOCH BIOPHYS RES CO; Rosnoblet C, 2013, HUM MOL GENET, V22, P2914, DOI 10.1093/hmg/ddt146; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Veitia RA, 2005, PLANT CELL, V17, P4, DOI 10.1105/tpc.104.170130; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; Waight AB, 2013, NATURE, V499, P107, DOI 10.1038/nature12233; Wong S, 2002, P NATL ACAD SCI USA, V99, P9272, DOI 10.1073/pnas.142101099; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037	37	40	41	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100851	10.1371/journal.pone.0100851	http://dx.doi.org/10.1371/journal.pone.0100851			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955841	Green Published, Green Submitted, gold			2022-12-27	WOS:000338917900102
J	Sim, M; Lim, B; Sim, SH; Kim, D; Jung, E; Lee, Y; Lee, K				Sim, Minji; Lim, Boram; Sim, Se-Hoon; Kim, Daeyoung; Jung, Euihan; Lee, Younghoon; Lee, Kangseok			Two Tandem RNase III Cleavage Sites Determine betT mRNA Stability in Response to Osmotic Stress in Escherichia coli	PLOS ONE			English	Article							GLYCINE BETAINE PATHWAY; SALMONELLA-TYPHIMURIUM; RIBONUCLEASE-III; TRANSPORT-SYSTEM; RIBOSOMAL-RNA; CHOLINE; DEGRADATION; EXPRESSION; GENES; PRODUCTS	While identifying genes regulated by ribonuclease III (RNase III) in Escherichia coli, we observed that steady-state levels of betT mRNA, which encodes a transporter mediating the influx of choline, are dependent on cellular concentrations of RNase III. In the present study, we also observed that steady-state levels of betT mRNA are dependent on RNase III activity upon exposure to osmotic stress, indicating the presence of cis-acting elements controlled by RNase III in betT mRNA. Primer extension analyses of betT mRNA revealed two tandem RNase III cleavage sites in its stem-loop region, which were biochemically confirmed via in vitro cleavage assays. Analyses of cleavage sites suggested the stochastic selection of cleavage sites by RNase III, and mutational analyses indicated that RNase III cleavage at either site individually is insufficient for efficient betT mRNA degradation. In addition, both the half-life and abundance of betT mRNA were significantly increased in association with decreased RNase III activity under hyper-osmotic stress conditions. Our findings demonstrate that betT mRNA stability is controlled by RNase III at the post-transcriptional level under conditions of osmotic stress.	[Sim, Minji; Lim, Boram; Sim, Se-Hoon; Kim, Daeyoung; Lee, Kangseok] Chung Ang Univ, Dept Life Sci, Seoul 156756, South Korea; [Jung, Euihan; Lee, Younghoon] Korea Adv Inst Sci & Technol, Dept Chem, Taejon 305701, South Korea	Chung Ang University; Korea Advanced Institute of Science & Technology (KAIST)	Lee, K (corresponding author), Chung Ang Univ, Dept Life Sci, Seoul 156756, South Korea.	kangseok@cau.ac.kr	Lee, Younghoon/C-1991-2011	Lee, Younghoon/0000-0002-3841-719X	National Research Foundation of Korea [2010-0029167, 2011-0028553]; Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea (SSAC) [PJ009025]	National Research Foundation of Korea(National Research Foundation of Korea); Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea (SSAC)	This work was supported by the National Research Foundation of Korea (2010-0029167 to Y Lee and 2011-0028553 to K Lee) and the Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea (SSAC, PJ009025 to K Lee). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarasinghe AK, 2001, METHOD ENZYMOL, V342, P143, DOI 10.1016/S0076-6879(01)42542-0; ANDRESEN PA, 1988, J GEN MICROBIOL, V134, P1737; CAIRNEY J, 1985, J BACTERIOL, V164, P1218, DOI 10.1128/JB.164.3.1218-1223.1985; CAIRNEY J, 1985, J BACTERIOL, V164, P1224, DOI 10.1128/JB.164.3.1224-1232.1985; Court DL, 2013, ANNU REV GENET, V47, P405, DOI 10.1146/annurev-genet-110711-155618; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DUNN JJ, 1976, J BIOL CHEM, V251, P3807; Gravenbeek ML, 2008, MICROBIOL-SGM, V154, P3547, DOI 10.1099/mic.0.2008/022095-0; Kavalchuk K, 2012, RNA BIOL, V9, P98, DOI 10.4161/rna.9.1.18228; Kim KS, 2005, J BIOL CHEM, V280, P34667, DOI 10.1074/jbc.M505005200; Kim KS, 2008, GENE DEV, V22, P3497, DOI 10.1101/gad.1729508; LAMARK T, 1991, MOL MICROBIOL, V5, P1049, DOI 10.1111/j.1365-2958.1991.tb01877.x; LAMARK T, 1992, FEMS MICROBIOL LETT, V96, P149; Lamark T, 1996, J BACTERIOL, V178, P1655, DOI 10.1128/jb.178.6.1655-1662.1996; LANDFALD B, 1986, J BACTERIOL, V165, P849, DOI 10.1128/jb.165.3.849-855.1986; Lee K, 2001, J NUTR, V131, p2994S, DOI 10.1093/jn/131.11.2994S; Lee KS, 1997, J MOL BIOL, V269, P732, DOI 10.1006/jmbi.1997.1092; Lim B, 2014, CURR MICROBIOL, V68, P518, DOI 10.1007/s00284-013-0504-5; Lim B, 2012, J BACTERIOL, V194, P2214, DOI 10.1128/JB.00099-12; Matsunaga J, 1997, MOL MICROBIOL, V26, P1125, DOI 10.1046/j.1365-2958.1997.6652007.x; Matsunaga J, 1996, MOL MICROBIOL, V22, P977, DOI 10.1046/j.1365-2958.1996.01529.x; MAYER JE, 1983, J BIOL CHEM, V258, P5340; Miller JH., 1972, EXPT MOL GENETICS; Sim SH, 2010, MOL MICROBIOL, V75, P413, DOI 10.1111/j.1365-2958.2009.06986.x; Song W, 2014, NUCLEIC ACIDS RES, V42, P4669, DOI 10.1093/nar/gku093; STYRVOLD OB, 1986, J BACTERIOL, V165, P856, DOI 10.1128/jb.165.3.856-863.1986; Tondervik A, 2007, MICROBIOL-SGM, V153, P803, DOI 10.1099/mic.0.2006/003608-0; Wood Janet M, 2006, Sci STKE, V2006, ppe43; Wood JM, 1999, MICROBIOL MOL BIOL R, V63, P230, DOI 10.1128/MMBR.63.1.230-262.1999; Xiao JP, 2009, RNA, V15, P984, DOI 10.1261/rna.1196509; Yeom JH, 2008, FEMS MICROBIOL LETT, V285, P10, DOI 10.1111/j.1574-6968.2008.01205.x; Yeom JH, 2006, BIOCHEM BIOPH RES CO, V345, P1372, DOI 10.1016/j.bbrc.2006.05.018; Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	34	15	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100520	10.1371/journal.pone.0100520	http://dx.doi.org/10.1371/journal.pone.0100520			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956275	Green Published, Green Submitted, gold			2022-12-27	WOS:000338917900061
J	Sollai, G; Barbarossa, IT; Masala, C; Solari, P; Crnjar, R				Sollai, Giorgia; Barbarossa, Iole Tomassini; Masala, Carla; Solari, Paolo; Crnjar, Roberto			Gustatory Sensitivity and Food Acceptance in Two Phylogenetically Closely Related Papilionid Species: Papilio hospiton and Papilio machaon	PLOS ONE			English	Article							BITTER TASTE STIMULI; HOST RECOGNITION CUE; HELICOVERPA-ARMIGERA; RECEPTOR NEURONS; MANDUCA-SEXTA; POLYPHAGOUS CATERPILLAR; PYRROLIZIDINE ALKALOIDS; CONTACT CHEMORECEPTION; LEPIDOPTEROUS LARVAE; PLANT-CHEMICALS	In herbivorous insects, food selection depends on sensitivity to specific chemical stimuli from host-plants as well as to secondary metabolites (bitter) and to sugars (phagostimulatory). Bitter compounds are noxious, unpalatable or both and evoke an aversive feeding response. Instead, sugars and sugar alcohols play a critical role in determining and enhancing the palatability of foods. We assumed that peripheral taste sensitivity may be related to the width of the host selection. Our model consists of two closely phylogenetically related Papilionid species exhibiting a difference in host plant choice: Papilio hospiton and Papilio machaon. The spike activity of the lateral and medial maxillary styloconic taste sensilla was recorded following stimulation with several carbohydrates, nicotine and NaCl, with the aim of characterizing their gustatory receptor neurons and of comparing their response patterns in the light of their different acceptability in feeding behaviour. The results show that: a) each sensillum houses phagostimulant and phagodeterrent cells; b) the spike activity of the gustatory neurons in response to different taste stimuli is higher in P. hospiton than in P. machaon; c) sugar solutions inhibit the spike activity of the deterrent and salt cells, and the suppression is higher in P. machaon than in P. hospiton. In conclusion, we propose that the different balance between the phagostimulant and phagodeterrent inputs from GRNs of maxillary sensilla may contribute in determining the difference in food choice and host range.	[Sollai, Giorgia; Barbarossa, Iole Tomassini; Masala, Carla; Solari, Paolo; Crnjar, Roberto] Univ Cagliari, Dept Biomed Sci, Physiol Sect, Cagliari, Italy	University of Cagliari	Crnjar, R (corresponding author), Univ Cagliari, Dept Biomed Sci, Physiol Sect, Cagliari, Italy.	crnjar@unica.it	SOLLAI, GIORGIA/AAR-1130-2021; Masala, Carla/L-1373-2015	SOLLAI, GIORGIA/0000-0001-7341-582X; Masala, Carla/0000-0001-5272-8421; TOMASSINI BARBAROSSA, IOLE/0000-0002-2849-4052; /0000-0001-8785-1438	Regione Autonoma della Sardegna [CRP-59859]; Fondazione Banco di Sardegna [2012/0245]	Regione Autonoma della Sardegna(Regione Sardegna); Fondazione Banco di Sardegna(Fondazione Banco di Sardegna)	This work was supported by the Regione Autonoma della Sardegna [grant number CRP-59859], and the Fondazione Banco di Sardegna [grant number 2012/0245]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernays EA, 2004, J INSECT PHYSIOL, V50, P1113, DOI 10.1016/j.jinsphys.2004.09.006; Bernays EA, 2000, J CHEM ECOL, V26, P547, DOI 10.1023/A:1005430010314; Bernays EA, 2003, J EXP BIOL, V206, P4487, DOI 10.1242/jeb.00705; Bernays EA, 2000, J COMP PHYSIOL A, V186, P13, DOI 10.1007/s003590050002; Bernays EA, 2001, J INSECT PHYSIOL, V47, P1029, DOI 10.1016/S0022-1910(01)00079-8; Caicedo A, 2002, J PHYSIOL-LONDON, V544, P501, DOI 10.1113/jphysiol.2002.027862; Chapman RF, 2003, J COMP PHYSIOL A, V189, P833, DOI 10.1007/s00359-003-0461-8; Chapman RF, 2003, ANNU REV ENTOMOL, V48, P455, DOI 10.1146/annurev.ento.48.091801.112629; Cocco N, 2012, J EXP BIOL, V215, P1412, DOI 10.1242/jeb.059832; del Campo ML, 2003, J EXP BIOL, V206, P3979, DOI 10.1242/jeb.00626; DETHIER VG, 1973, J COMP PHYSIOL, V82, P103, DOI 10.1007/BF00696148; DETHIER VG, 1982, J GEN PHYSIOL, V79, P549, DOI 10.1085/jgp.79.4.549; DETHIER VG, 1971, Z VERGL PHYSIOL, V72, P343, DOI 10.1007/BF00300708; DETHIER VG, 1977, AM SCI, V65, P744; Dethier VG, 1976, HUNGRY FLY; Dolzer J, 2003, J EXP BIOL, V206, P1575, DOI 10.1242/jeb.00302; Dolzer J, 2001, J EXP BIOL, V204, P2781; Dulcis D, 2005, J NEUROSCI, V25, P271, DOI 10.1523/JNEUROSCI.2906-04.2005; EVANS DR, 1962, J GEN PHYSIOL, V45, P487, DOI 10.1085/jgp.45.3.487; Flecke C, 2006, J EXP BIOL, V209, P3898, DOI 10.1242/jeb.02432; Glendinning JI, 1999, J EXP BIOL, V202, P2091; Glendinning JI, 2000, J EXP BIOL, V203, P1299; Glendinning JI, 1996, J EXP BIOL, V199, P1523; Glendinning JI, 1997, J NEUROPHYSIOL, V78, P734, DOI 10.1152/jn.1997.78.2.734; Glendinning JI, 2001, J NEUROSCI, V21, P3688, DOI 10.1523/JNEUROSCI.21-10-03688.2001; Glendinning JI, 2001, J EXP BIOL, V204, P3355; Glendinning JI, 2007, J EXP BIOL, V210, P3054, DOI 10.1242/jeb.004671; Glendinning JI, 2006, J NEUROSCI, V26, P8900, DOI 10.1523/JNEUROSCI.2351-06.2006; Glendinning JI, 2009, J COMP PHYSIOL A, V195, P591, DOI 10.1007/s00359-009-0434-7; GRISS C, 1991, J INSECT PHYSIOL, V37, P477, DOI 10.1016/0022-1910(91)90023-S; Hiroi M, 2004, J NEUROBIOL, V61, P333, DOI 10.1002/neu.20063; Hiroi M, 2002, ZOOL SCI, V19, P1009, DOI 10.2108/zsj.19.1009; HODGSON ES, 1955, SCIENCE, V122, P417, DOI 10.1126/science.122.3166.417-a; Inoue T, 2009, NATURWISSENSCHAFTEN, V96, P355, DOI 10.1007/s00114-008-0483-8; ISHIKAWA S, 1963, J CELL COMPAR PHYSL, V61, P99, DOI 10.1002/jcp.1030610111; Ishimaru Y, 2009, ODONTOLOGY, V97, P1, DOI 10.1007/s10266-008-0095-y; Jorgensen K, 2006, J COMP NEUROL, V496, P121, DOI 10.1002/cne.20908; Miles CI, 2005, J COMP PHYSIOL A, V191, P147, DOI 10.1007/s00359-004-0580-x; Mitchell BK, 1999, MICROSC RES TECHNIQ, V47, P401, DOI 10.1002/(SICI)1097-0029(19991215)47:6<401::AID-JEMT4>3.0.CO;2-7; Munch D, 2013, CHEM SENSES, V38, P293, DOI 10.1093/chemse/bjs138; Murphy SM, 2006, ECOL MONOGR, V76, P399, DOI 10.1890/0012-9615(2006)076[0399:CFOANO]2.0.CO;2; Oka Y, 2013, NATURE, V494, P472, DOI 10.1038/nature11905; Pezier A, 2007, CHEM SENSES, V32, P305, DOI 10.1093/chemse/bjl059; ROWELL CHF, 1992, J INSECT PHYSIOL, V38, P475, DOI 10.1016/0022-1910(92)90072-L; Ryuda M, 2013, J NEUROSCI, V33, P914, DOI 10.1523/JNEUROSCI.1405-12.2013; Schoonhoven LM, 2002, ACTA ZOOL ACAD SCI H, V48, P215; SIMMONDS MSJ, 1991, ENTOMOL EXP APPL, V61, P73, DOI 10.1007/BF00367170; SIMMONDS MSJ, 1991, SYMP BIOL HUNG, V39, P17; SMITH JJB, 1990, CHEM SENSES, V15, P253, DOI 10.1093/chemse/15.3.253; Sollai G, 2012, J INSECT PHYSIOL, V58, P1686, DOI 10.1016/j.jinsphys.2012.10.010; Su CY, 2012, NATURE, V492, P66, DOI 10.1038/nature11712; Tang DL, 2000, SCI CHINA SER C, V43, P606, DOI 10.1007/BF02882281; Tepper BJ, 2008, ANNU REV NUTR, V28, P367, DOI 10.1146/annurev.nutr.28.061807.155458; van Loon JJA, 1999, ENTOMOL EXP APPL, V91, P29, DOI 10.1046/j.1570-7458.1999.00463.x; WIKLUND C, 1975, OECOLOGIA, V18, P185, DOI 10.1007/BF00345421; Wilkie L, 2013, CHEMOSENS PERCEPT, V6, P127, DOI 10.1007/s12078-013-9151-2; Yarmolinsky DA, 2009, CELL, V139, P234, DOI 10.1016/j.cell.2009.10.001; Zakharov EV, 2004, SYST BIOL, V53, P193, DOI 10.1080/10635150490423403; Zhang HJ, 2013, J CHEM ECOL, V39, P1070, DOI 10.1007/s10886-013-0303-2; Zhang YF, 2010, J EXP BIOL, V213, P2889, DOI 10.1242/jeb.042705; Zhou DS, 2009, J INSECT PHYSIOL, V55, P788, DOI 10.1016/j.jinsphys.2009.04.011; Zhou DS, 2010, J COMP PHYSIOL A, V196, P791, DOI 10.1007/s00359-010-0558-9	62	22	24	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100675	10.1371/journal.pone.0100675	http://dx.doi.org/10.1371/journal.pone.0100675			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956387	Green Submitted, Green Published, gold			2022-12-27	WOS:000338917900080
J	Aoude, LG; Xu, M; Zhao, ZZ; Kovacs, M; Palmer, JM; Johansson, P; Symmons, J; Trent, JM; Martin, NG; Montgomery, GW; Brown, KM; Hayward, NK				Aoude, Lauren G.; Xu, Mai; Zhao, Zhen Zhen; Kovacs, Michael; Palmer, Jane M.; Johansson, Peter; Symmons, Judith; Trent, Jeffrey M.; Martin, Nicholas G.; Montgomery, Grant W.; Brown, Kevin M.; Hayward, Nicholas K.			Assessment of PALB2 as a Candidate Melanoma Susceptibility Gene	PLOS ONE			English	Article							ONSET BREAST-CANCER; BRCA2-INTERACTING PROTEIN PALB2; PANCREATIC-CANCER; FANCONI-ANEMIA; GERMLINE MUTATIONS; PREVALENCE; PARTNER	Partner and localizer of BRCA2 (PALB2) interacts with BRCA2 to enable double strand break repair through homologous recombination. Similar to BRCA2, germline mutations in PALB2 have been shown to predispose to Fanconi anaemia as well as pancreatic and breast cancer. The PALB2/BRCA2 protein interaction, as well as the increased melanoma risk observed in families harbouring BRCA2 mutations, makes PALB2 a candidate for melanoma susceptibility. In order to assess PALB2 as a melanoma predisposition gene, we sequenced the entire protein-coding sequence of PALB2 in probands from 182 melanoma families lacking pathogenic mutations in known high penetrance melanoma susceptibility genes: CDKN2A, CDK4, and BAP1. In addition, we interrogated whole-genome and exome data from another 19 kindreds with a strong family history of melanoma for deleterious mutations in PALB2. Here we report a rare known deleterious PALB2 mutation (rs118203998) causing a premature truncation of the protein (p. Y1183X) in an individual who had developed four different cancer types, including melanoma. Three other family members affected with melanoma did not carry the variant. Overall our data do not support a case for PALB2 being associated with melanoma predisposition.	[Aoude, Lauren G.; Zhao, Zhen Zhen; Palmer, Jane M.; Johansson, Peter; Symmons, Judith; Martin, Nicholas G.; Montgomery, Grant W.; Hayward, Nicholas K.] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia; [Aoude, Lauren G.] Univ Queensland, Brisbane, Qld, Australia; [Xu, Mai; Kovacs, Michael; Brown, Kevin M.] NCI, Bethesda, MD 20892 USA; [Trent, Jeffrey M.; Brown, Kevin M.] Translat Genom Res Inst, Phoenix, AZ USA	QIMR Berghofer Medical Research Institute; University of Queensland; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Translational Genomics Research Institute	Aoude, LG (corresponding author), QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia.	Lauren.Aoude@qimrberghofer.edu.au	hayward, nicholas k/C-1367-2015; Johansson, Peter A/K-1053-2014; Montgomery, Grant W/B-7148-2008; hayward, nick/AAV-8802-2020; Aoude, Lauren/C-7484-2014; Martin, Nicholas/R-9235-2019	hayward, nicholas k/0000-0003-4760-1033; Johansson, Peter A/0000-0001-7015-5452; Montgomery, Grant W/0000-0002-4140-8139; Aoude, Lauren/0000-0003-1448-3923; Martin, Nicholas/0000-0003-4069-8020	Melanoma Research Alliance; National Health and Medical Research Council (NHMRC) of Australia; NHMRC; Australia and New Zealand Banking Group Limited Trustees PhD scholarship; Division of Cancer Epidemiology and Genetics, National Cancer Institute, USA; NATIONAL CANCER INSTITUTE [ZIACP010201] Funding Source: NIH RePORTER	Melanoma Research Alliance; National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australia and New Zealand Banking Group Limited Trustees PhD scholarship; Division of Cancer Epidemiology and Genetics, National Cancer Institute, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Melanoma Research Alliance and the National Health and Medical Research Council (NHMRC) of Australia. NKH and GWM receive salary support through a NHMRC Senior Principal Research Fellowship. LGA receives salary support by the Australia and New Zealand Banking Group Limited Trustees PhD scholarship. KMB is supported by the Division of Cancer Epidemiology and Genetics, National Cancer Institute, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken JF, 1996, MELANOMA RES, V6, P155, DOI 10.1097/00008390-199604000-00011; Blanco A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067538; Breast Canc Linkage Consortium, 1999, JNCI-J NATL CANCER I, V91, P1310; Cao AY, 2009, BREAST CANCER RES TR, V114, P457, DOI 10.1007/s10549-008-0036-z; Casadei S, 2011, CANCER RES, V71, P2222, DOI 10.1158/0008-5472.CAN-10-3958; Catucci I, 2012, FAM CANCER, V11, P483, DOI 10.1007/s10689-012-9540-8; Dansonka-Mieszkowska A, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-20; Erkko H, 2007, NATURE, V446, P316, DOI 10.1038/nature05609; Foulkes WD, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1828; Garcia MJ, 2009, BREAST CANCER RES TR, V113, P545, DOI 10.1007/s10549-008-9945-0; Ghadirian P, 2009, CLIN GENET, V76, P421, DOI 10.1111/j.1399-0004.2009.01277.x; Goldstein AM, 2006, CANCER RES, V66, P9818, DOI 10.1158/0008-5472.CAN-06-0494; Hellebrand H, 2011, HUM MUTAT, V32, pE2176, DOI 10.1002/humu.21478; Hofstatter EW, 2011, FAM CANCER, V10, P225, DOI 10.1007/s10689-011-9426-1; Jones S, 2009, SCIENCE, V324, P217, DOI 10.1126/science.1171202; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McGregor B, 1999, GENET EPIDEMIOL, V16, P40, DOI 10.1002/(SICI)1098-2272(1999)16:1<40::AID-GEPI4>3.3.CO;2-T; Moran A, 2012, FAM CANCER, V11, P235, DOI 10.1007/s10689-011-9506-2; Papi L, 2010, FAM CANCER, V9, P181, DOI 10.1007/s10689-009-9295-z; Peterlongo P, 2011, BREAST CANCER RES TR, V126, P825, DOI 10.1007/s10549-010-1305-1; Phuah SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073638; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959; Reid S, 2007, NAT GENET, V39, P162, DOI 10.1038/ng1947; Sabbaghian N, 2011, FAM CANCER, V10, P315, DOI 10.1007/s10689-010-9405-y; Slater EP, 2010, CLIN GENET, V78, P490, DOI 10.1111/j.1399-0004.2010.01425.x; Sluiter M, 2009, FAM CANCER, V8, P347, DOI 10.1007/s10689-009-9241-0; Stadler ZK, 2011, J MED GENET, V48, P523, DOI 10.1136/jmg.2010.087379; Teo ZL, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3392; Tischkowitz M, 2012, HUM MUTAT; Tischkowitz M, 2008, PROSTATE, V68, P675, DOI 10.1002/pros.20729; Tischkowitz MD, 2009, GASTROENTEROLOGY, V137, P1183, DOI 10.1053/j.gastro.2009.06.055; Wiesner T, 2012, J CLIN ONCOL, V30, pE337, DOI 10.1200/JCO.2011.41.2965; Xia B, 2007, NAT GENET, V39, P159, DOI 10.1038/ng1942; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022; Yang XHR, 2011, FAM CANCER, V10, P545, DOI 10.1007/s10689-011-9447-9; Zheng YL, 2012, CANCER-AM CANCER SOC, V118, P1362, DOI 10.1002/cncr.26388	36	11	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100683	10.1371/journal.pone.0100683	http://dx.doi.org/10.1371/journal.pone.0100683			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949998	gold, Green Submitted, Green Published			2022-12-27	WOS:000338276300107
J	Gaikwad, KB; Singh, N; Bhatia, D; Kaur, R; Bains, NS; Bharaj, TS; Singh, K				Gaikwad, Kiran B.; Singh, Naveen; Bhatia, Dharminder; Kaur, Rupinder; Bains, Navtej S.; Bharaj, Tajinder S.; Singh, Kuldeep			Yield-Enhancing Heterotic QTL Transferred from Wild Species to Cultivated Rice Oryza sativa L.	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; ADVANCED BACKCROSS POPULATION; INTROGRESSION LINES; RUFIPOGON GRIFF.; MORPHOLOGICAL TRAITS; GENETIC-STRUCTURE; AGRONOMIC TRAITS; O-RUFIPOGON; IDENTIFICATION; COMPONENTS	Utilization of "hidden genes" from wild species has emerged as a novel option for enrichment of genetic diversity for productivity traits. In rice we have generated more than 2000 lines having introgression from 'A' genome-donor wild species of rice in the genetic background of popular varieties PR114 and Pusa44 were developed. Out of these, based on agronomic acceptability, 318 lines were used for developing rice hybrids to assess the effect of introgressions in heterozygous state. These introgression lines and their recurrent parents, possessing fertility restoration ability for wild abortive (WA) cytoplasm, were crossed with cytoplasmic male sterile (CMS) line PMS17A to develop hybrids. Hybrids developed from recurrent parents were used as checks to compare the performance of 318 hybrids developed by hybridizing alien introgression lines with PMS17A. Seventeen hybrids expressed a significant increase in yield and its component traits over check hybrids. These 17 hybrids were re-evaluated in large-size replicated plots. Of these, four hybrids, viz., ILH299, ILH326, ILH867 and ILH901, having introgressions from O. rufipogon and two hybrids (ILH921 and ILH951) having introgressions from O. nivara showed significant heterosis over parental introgression line, recurrent parents and check hybrids for grain yield-related traits. Alien introgressions were detected in the lines taken as male parents for developing six superior hybrids, using a set of 100 polymorphic simple sequence repeat (SSR) markers. Percent introgression showed a range of 2.24 from in O. nivara to 7.66 from O. rufipogon. The introgressed regions and their putative association with yield components in hybrids is reported and discussed.	[Gaikwad, Kiran B.; Singh, Naveen; Bhatia, Dharminder; Kaur, Rupinder; Bains, Navtej S.; Bharaj, Tajinder S.] Punjab Agr Univ, Dept Plant Breeding & Genet, Ludhiana 141004, Punjab, India; [Singh, Kuldeep] Punjab Agr Univ, Sch Agr Biotechnol, Ludhiana 141004, Punjab, India	Punjab Agricultural University; Punjab Agricultural University	Singh, K (corresponding author), Punjab Agr Univ, Sch Agr Biotechnol, Ludhiana 141004, Punjab, India.	kuldeep35@pau.edu		Bhatia, Dharminder/0000-0001-6088-3886; Gaikwad, Kiran/0000-0002-9076-8640; Singh, Kuldeep/0000-0001-5239-6586	Dept. Biotechnology, Ministry of Science and Technology, Govt. of India [BT PR2159/AGR/07/107/2000]	Dept. Biotechnology, Ministry of Science and Technology, Govt. of India	This project was supported by Dept. Biotechnology, Ministry of Science and Technology, Govt. of India vide its grant no. BT PR2159/AGR/07/107/2000. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aluko G, 2004, THEOR APPL GENET, V109, P630, DOI 10.1007/s00122-004-1668-y; [Anonymous], SPAR 2 0 STAT PACK A; Bhasin H, 2012, MOL BREEDING, V30, P607, DOI 10.1007/s11032-011-9646-y; Brondani C, 2002, THEOR APPL GENET, V104, P1192, DOI 10.1007/s00122-002-0869-5; Cheema KK, 2008, EUPHYTICA, V160, P401, DOI 10.1007/s10681-007-9560-x; Chen ZW, 2009, BREEDING SCI, V59, P441, DOI 10.1270/jsbbs.59.441; [邓启云 Deng Qiyun], 2004, [杂交水稻, Hybrid Rice], V19, P6; ESHED Y, 1995, GENETICS, V141, P1147; Frey K. J., 1984, Genetics: new frontiers. XV International Congress of Genetics. Volume IV. Applied genetics, P51; Gur A, 2004, PLOS BIOL, V2, P1610, DOI 10.1371/journal.pbio.0020245; He GM, 2006, GENOME RES, V16, P618, DOI 10.1101/gr.4814006; Hua JP, 2003, P NATL ACAD SCI USA, V100, P2574, DOI 10.1073/pnas.0437907100; Ikeda R., 1990, JPN J BREED S1, V40, P280; International Rice Research Institute, 2002, STAND EV SYST RIC; Jin Feng-Xue, 2009, Journal of Crop Science and Biotechnology, V12, P9; Khush G. S., 1977, 3rd International Congress of the Society for the Advancement of Breeding Researches in Asia and Oceania (SABRAO). Plant Breeding Papers: 1. 4. Breeding for resistance to pests and diseases. (b) Resistance to other pests and diseases., P3; Khush GS, 1997, PLANT MOL BIOL, V35, P25, DOI 10.1023/A:1005810616885; Khush GS, 1991, RICE GENET NEWSL, Vl7, P121; Khush GS, 2013, PLANT BREEDING, V132, P433, DOI 10.1111/pbr.1991; Kuroda Y, 2007, CONSERV GENET, V8, P149, DOI 10.1007/s10592-006-9156-3; Lee SJ, 2005, PLANT BREEDING, V124, P209, DOI 10.1111/j.1439-0523.2005.01092.x; Li Z, 1988, RICE MALE STERILE CY, P85; Linh LH, 2008, PLANT BREEDING, V127, P262, DOI 10.1111/j.1439-0523.2007.01462.x; Luo LJ, 2001, GENETICS, V158, P1755; Luo XJ, 2011, PLANT SCI, V181, P14, DOI 10.1016/j.plantsci.2010.12.009; Marri PR, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-33; McCouch SR, 2002, DNA RES, V9, P199, DOI 10.1093/dnares/9.6.199; Moncada P, 2001, THEOR APPL GENET, V102, P41, DOI 10.1007/s001220051616; Monforte AJ, 2000, THEOR APPL GENET, V100, P471, DOI 10.1007/s001220050061; Oka H. I., 1988, Origin of cultivated rice.; Rangel PN, 2008, GENET MOL RES, V7, P184, DOI 10.4238/vol7-1gmr406; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Sang T, 2007, CURR OPIN GENET DEV, V17, P533, DOI 10.1016/j.gde.2007.09.005; Semel Y, 2006, P NATL ACAD SCI USA, V103, P12981, DOI 10.1073/pnas.0604635103; Septiningsih EM, 2003, THEOR APPL GENET, V107, P1419, DOI 10.1007/s00122-003-1373-2; Song ZP, 2006, EVOL ECOL, V20, P501, DOI 10.1007/s10682-006-9113-0; Sun CQ, 2001, THEOR APPL GENET, V102, P157, DOI 10.1007/s001220051631; Tan LB, 2007, J INTEGR PLANT BIOL, V49, P871, DOI 10.1111/j.1744-7909.2007.00497.x; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Tanksley SD, 1996, THEOR APPL GENET, V92, P191, DOI 10.1007/BF00223376; Temnykh S, 2000, THEOR APPL GENET, V100, P697, DOI 10.1007/s001220051342; Thomson MJ, 2003, THEOR APPL GENET, V107, P479, DOI 10.1007/s00122-003-1270-8; Tian F, 2006, THEOR APPL GENET, V112, P570, DOI 10.1007/s00122-005-0165-2; van Berloo R, 2008, J HERED, V99, P232, DOI 10.1093/jhered/esm109; Vaughan DA, 2003, CURR OPIN PLANT BIOL, V6, P139, DOI 10.1016/S1369-5266(03)00009-8; Xiao JH, 1996, NATURE, V384, P223, DOI 10.1038/384223a0; Xiao JH, 1998, GENETICS, V150, P899; Xie XB, 2008, THEOR APPL GENET, V116, P613, DOI 10.1007/s00122-007-0695-x; Yoon DB, 2006, THEOR APPL GENET, V112, P1052, DOI 10.1007/s00122-006-0207-4; ZHANG Q, 2000, ACTA AGRONOMICA SINI, V26, P536; Zhang QF, 2007, P NATL ACAD SCI USA, V104, P16402, DOI 10.1073/pnas.0708013104; Zhou HF, 2008, THEOR APPL GENET, V117, P1181, DOI 10.1007/s00122-008-0855-7	52	30	30	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e96939	10.1371/journal.pone.0096939	http://dx.doi.org/10.1371/journal.pone.0096939			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949743	Green Submitted, Green Published, gold			2022-12-27	WOS:000338276300001
J	Hsieh, SC; Tsai, WY; Nerurkar, VR; Wang, WK				Hsieh, Szu-Chia; Tsai, Wen-Yang; Nerurkar, Vivek R.; Wang, Wei-Kung			Characterization of the Ectodomain of the Envelope Protein of Dengue Virus Type 4: Expression, Membrane Association, Secretion and Particle Formation in the Absence of Precursor Membrane Protein	PLOS ONE			English	Article							TICK-BORNE ENCEPHALITIS; HEPATITIS-C VIRUS; RECOMBINANT SUBVIRAL PARTICLES; PROTECTIVE IMMUNE-RESPONSE; STEM-ANCHOR REGION; ENDOPLASMIC-RETICULUM; GLYCOPROTEIN; MATURATION; PRM; GLYCOSYLATION	Background: The envelope (E) of dengue virus (DENV) is the major target of neutralizing antibodies and vaccine development. After biosynthesis E protein forms a heterodimer with precursor membrane (prM) protein. Recent reports of infection enhancement by anti-prM monoclonal antibodies (mAbs) suggest anti-prM responses could be potentially harmful. Previously, we studied a series of C-terminal truncation constructs expressing DENV type 4 prM/E or E proteins and found the ectodomain of E protein alone could be recognized by all 12 mAbs tested, suggesting E protein ectodomain as a potential subunit immunogen without inducing anti-prM response. The characteristics of DENV E protein ectodomain in the absence of prM protein remains largely unknown. Methodology/Principal Findings: In this study, we investigated the expression, membrane association, glycosylation pattern, secretion and particle formation of E protein ectodomain of DENV4 in the presence or absence of prM protein. E protein ectodomain associated with membrane in or beyond trans-Golgi and contained primarily complex glycans, whereas full-length E protein associated with ER membrane and contained high mannose glycans. In the absence of prM protein, E protein ectodomain can secrete as well as form particles of approximately 49 nm in diameter, as revealed by sucrose gradient ultracentrifugation with or without detergent and electron microscopy. Mutational analysis revealed that the secretion of E protein ectodomain was affected by N-linked glycosylation and could be restored by treatment with ammonia chloride. Conclusions/Significance: Considering the enhancement of DENV infectivity by anti-prM antibodies, our findings provide new insights into the expression and secretion of E protein ectodomain in the absence of prM protein and contribute to future subunit vaccine design.	[Hsieh, Szu-Chia; Tsai, Wen-Yang; Nerurkar, Vivek R.; Wang, Wei-Kung] Univ Hawaii Manoa, Dept Trop Med Med Microbiol & Pharmacol, John A Burns Sch Med, Honolulu, HI 96822 USA; [Nerurkar, Vivek R.; Wang, Wei-Kung] Univ Hawaii Manoa, Pacific Ctr Emerging Infect Dis Res, John A Burns Sch Med, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa	Wang, WK (corresponding author), Univ Hawaii Manoa, Dept Trop Med Med Microbiol & Pharmacol, John A Burns Sch Med, Honolulu, HI 96822 USA.	wangwk@hawaii.edu	Nerurkar, Vivek R/F-5533-2011		International Vaccine Institute/Pediatric Dengue Vaccine Initiative; JABSOM; National Institute of General Medical Sciences, National Institutes of Health [P20GM103516]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103516] Funding Source: NIH RePORTER	International Vaccine Institute/Pediatric Dengue Vaccine Initiative; JABSOM; National Institute of General Medical Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by Cooperative Research Agreement by International Vaccine Institute/Pediatric Dengue Vaccine Initiative, start-up fund from JABSOM and Award Number P20GM103516 from the National Institute of General Medical Sciences, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizaki H, 2004, VIROLOGY, V324, P450, DOI 10.1016/j.virol.2004.03.034; Allison SL, 2003, J VIROL, V77, P11357, DOI 10.1128/JVI.77.21.11357-11366.2003; Allison SL, 1999, J VIROL, V73, P5605, DOI 10.1128/JVI.73.7.5605-5612.1999; Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; Ansarah-Sobrinho C, 2008, VIROLOGY, V381, P67, DOI 10.1016/j.virol.2008.08.021; Beasley DWC, 2005, J VIROL, V79, P8339, DOI 10.1128/JVI.79.13.8339-8347.2005; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; BRAY M, 1991, VIROLOGY, V185, P505, DOI 10.1016/0042-6822(91)90809-P; Bryant JE, 2007, VIROLOGY, V366, P415, DOI 10.1016/j.virol.2007.05.007; Coller BAG, 2011, VACCINE, V29, P7267, DOI 10.1016/j.vaccine.2011.07.021; Crill WD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004991; De Beeck AO, 2003, J VIROL, V77, P813, DOI 10.1128/JVI.77.2.813-820.2003; Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181; Ferlenghi I, 2001, MOL CELL, V7, P593, DOI 10.1016/S1097-2765(01)00206-4; Gladnikoff M, 2009, BIOPHYS J, V97, P2419, DOI 10.1016/j.bpj.2009.08.016; Goto A, 2005, VACCINE, V23, P3043, DOI 10.1016/j.vaccine.2004.11.068; GUIRAKHOO F, 1993, VIROLOGY, V194, P219, DOI 10.1006/viro.1993.1252; GUIRAKHOO F, 1992, VIROLOGY, V191, P921, DOI 10.1016/0042-6822(92)90267-S; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268; Han ZY, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-92; Hanna SL, 2005, J VIROL, V79, P13262, DOI 10.1128/JVI.79.21.13262-13274.2005; Hsieh SC, 2008, VIROLOGY, V374, P338, DOI 10.1016/j.virol.2007.12.041; Hsieh SC, 2011, VIROLOGY, V410, P170, DOI 10.1016/j.virol.2010.11.006; Hu HP, 2007, VIROLOGY, V368, P376, DOI 10.1016/j.virol.2007.06.026; Huang KJ, 2006, J IMMUNOL, V176, P2825, DOI 10.4049/jimmunol.176.5.2825; Keelapang P, 2004, J VIROL, V78, P2367, DOI 10.1128/JVI.78.5.2367-2381.2004; KONISHI E, 1993, J VIROL, V67, P1672, DOI 10.1128/JVI.67.3.1672-1675.1993; Kostyuchenko VA, 2013, J VIROL, V87, P7700, DOI 10.1128/JVI.00197-13; Lee E, 1997, VIROLOGY, V232, P281, DOI 10.1006/viro.1997.8570; Lee E, 2010, J VIROL, V84, P5171, DOI 10.1128/JVI.01900-09; Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263; Lin HE, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001447; Lindenbach BD, 2007, FIELDS VIROLOGY, P1101; Lorenz IC, 2003, J VIROL, V77, P4370, DOI 10.1128/JVI.77.7.4370-4382.2003; Lorenz IC, 2002, J VIROL, V76, P5480, DOI 10.1128/JVI.76.11.5480-5491.2002; MacKenzie JM, 2001, J VIROL, V75, P10787, DOI 10.1128/JVI.75.22.10787-10799.2001; Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009; Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100; Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165; Mondotte JA, 2007, J VIROL, V81, P7136, DOI 10.1128/JVI.00116-07; Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067; Murphy BR, 2011, ANNU REV IMMUNOL, V29, P587, DOI 10.1146/annurev-immunol-031210-101315; MURRAY JM, 1993, J GEN VIROL, V74, P175, DOI 10.1099/0022-1317-74-2-175; Ohtaki N, 2010, VACCINE, V28, P6588, DOI 10.1016/j.vaccine.2010.07.055; Orlinger KK, 2006, J VIROL, V80, P12197, DOI 10.1128/JVI.01540-06; RANDOLPH VB, 1990, J GEN VIROL, V71, P1845, DOI 10.1099/0022-1317-71-8-1845; Rodenhuis-Zybert IA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000718; Shi ST, 2003, J VIROL, V77, P4160, DOI 10.1128/JVI.77.7.4160-4168.2003; Stadler K, 1997, J VIROL, V71, P8475, DOI 10.1128/JVI.71.11.8475-8481.1997; Stiasny K, 1996, J VIROL, V70, P8142, DOI 10.1128/JVI.70.11.8142-8147.1996; Tsai WY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052600; Vieyres G, 2010, J VIROL, V84, P10159, DOI 10.1128/JVI.01180-10; Wang JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004908; Wang SL, 1999, J VIROL, V73, P2547, DOI 10.1128/JVI.73.3.2547-2551.1999; Wang WK, 2006, CLIN INFECT DIS, V43, P1023, DOI 10.1086/507635; Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007; White LJ, 2013, J VIROL, V87, P3409, DOI 10.1128/JVI.02298-12; WHO, 2009, DENG HEM FEV DIAGN T; Yu IM, 2009, J VIROL, V83, P12101, DOI 10.1128/JVI.01637-09; Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264; Zhang W, 2003, NAT STRUCT BIOL, V10, P907, DOI 10.1038/nsb990; Zhang XM, 2012, ADV ENG FORUM, V5, P20, DOI 10.4028/www.scientific.net/AEF.5.20	65	11	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100641	10.1371/journal.pone.0100641	http://dx.doi.org/10.1371/journal.pone.0100641			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950216	Green Published, Green Submitted, gold			2022-12-27	WOS:000338276300102
J	Chen, JM; Chiazza, F; Collino, M; Patel, NSA; Coldewey, SM; Thiemermann, C				Chen, Jianmin; Chiazza, Fausto; Collino, Massimo; Patel, Nimesh S. A.; Coldewey, Sina M.; Thiemermann, Christoph			Gender Dimorphism of the Cardiac Dysfunction in Murine Sepsis: Signalling Mechanisms and Age-Dependency	PLOS ONE			English	Article							FACTOR-ALPHA EXPRESSION; NITRIC-OXIDE SYNTHASE; NF-KAPPA-B; ESTROGEN-RECEPTOR; INFLAMMATORY RESPONSE; CONTRACTILE FUNCTION; ORGAN DYSFUNCTION; TRAUMA-HEMORRHAGE; IMMUNE FUNCTIONS; SEPTIC SHOCK	Development of cardiac dysfunction is associated with increased morbidity and mortality in patients with sepsis. Increasing evidence shows that gender determines the degree of inflammatory response of the host and that females tolerate sepsis better than males. It is unknown whether gender affects the cardiac dysfunction in animals or patients with sepsis. To investigate this, male or female C57BL/6 mice were subjected to either lipopolysaccharide (LPS)/peptidoglycan (PepG) co-administration or cecal ligation and puncture (CLP). At 18 hours after LPS/PepG injection or 24 hours after CLP, cardiac function was evaluated by echocardiography. The septic insult caused a significant cardiac dysfunction in both genders. However, the cardiac dysfunction was significantly less pronounced in females in comparison with males subjected to LPS (3 mg/kg)/PepG (0.1 mg/kg) or CLP. Compared with males injected with LPS (3 mg/kg)/PepG (0.1 mg/kg), western blotting analysis of the myocardium from females injected with LPS/PepG revealed i) profound increases in phosphorylation of Akt and eNOS; ii) significant decreases in phosphorylation of I kappa B alpha, nuclear translocation of the NF-kappa B subunit p65, decreased expression of iNOS and decreased synthesis of TNF-alpha and IL-6 in the heart. However, the gender dimorphism of the cardiac dysfunction secondary to LPS/PepG was not observed when higher doses of LPS (9 mg/kg)/PepG (1 mg/kg) were used. In conclusion, the cardiac dysfunction caused by sepsis was less pronounced in female than in male mice. The protection of female hearts against the dysfunction associated with sepsis is (at least in part) attributable to cardiac activation of the Akt/eNOS survival pathway, decreased activation of NF-kappa B, and decreased expression of iNOS, TNF-alpha and IL-6. It should be noted that the observed gender dimorphism of the cardiac dysfunction in sepsis was not seen when a very severe stimulus (high dose of LPS/PepG co-administration) was used to cause cardiac dysfunction.	[Chen, Jianmin; Patel, Nimesh S. A.; Thiemermann, Christoph] Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, London, England; [Chiazza, Fausto; Collino, Massimo] Univ Turin, Dept Drug Sci & Technol, Turin, Italy; [Coldewey, Sina M.] Jena Univ Hosp, Dept Anesthesiol & Intens Care Med, Jena, Germany	University of London; Queen Mary University London; University of Turin; Friedrich Schiller University of Jena	Thiemermann, C (corresponding author), Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, London, England.	c.thiemermann@qmul.ac.uk	Chiazza, Fausto/I-5559-2015; Collino, Massimo/AAK-8532-2020	Collino, Massimo/0000-0001-8782-3496; Chiazza, Fausto/0000-0001-7273-0051; Thiemermann, Christoph/0000-0003-4228-9722	PhD-studentship of the China Scholarship Council [201206240146]; Queen Mary University of London (QMUL); Research Fellowship of the German Research Foundation (Deutsche Forschungsgemeinschaft); DFG [CO 912/1-1]; Bart's and The London Charity [753/1722]; William Harvey Research Foundation; University of Turin (Ricerca Locale); National Institute of Health Research; Barts and The London Charity [753/1722]	PhD-studentship of the China Scholarship Council(China Scholarship Council); Queen Mary University of London (QMUL); Research Fellowship of the German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Bart's and The London Charity; William Harvey Research Foundation; University of Turin (Ricerca Locale); National Institute of Health Research(National Institute for Health Research (NIHR)); Barts and The London Charity	JC is supported by a jointly funded PhD-studentship of the China Scholarship Council (grant number 201206240146) and Queen Mary University of London (QMUL). SMC is supported by a Research Fellowship of the German Research Foundation (Deutsche Forschungsgemeinschaft; DFG CO 912/1-1). NSAP is, in part, supported by the Bart's and The London Charity (753/1722). This work is supported, in part, by the William Harvey Research Foundation and by a grant from the University of Turin (Ricerca Locale ex-60% 2013). This work forms part of the research themes contributing to the translational research portfolio of Barts and the London Cardiovascular Biomedical Research Unit, which is supported and funded by the National Institute of Health Research. This work also contributes to the Organ Protection research theme of the Barts Centre for Trauma Sciences, supported by the Barts and The London Charity (Award 753/1722). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angele MK, 1997, ARCH SURG-CHICAGO, V132, P1207; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Bae SC, 2005, J PHARMACOL EXP THER, V315, P1125, DOI 10.1124/jpet.105.090803; Barth E, 2006, CRIT CARE MED, V34, P307, DOI 10.1097/01.CCM.0000199070.46812.21; Blanco J, 2008, CRIT CARE, V12, DOI 10.1186/cc7157; BONE RC, 1992, JAMA-J AM MED ASSOC, V268, P3452, DOI 10.1001/jama.268.24.3452; Brown MA, 2004, FRONT BIOSCI-LANDMRK, V9, P1201, DOI 10.2741/1304; Camper-Kirby D, 2001, CIRC RES, V88, P1020, DOI 10.1161/hh1001.090858; Coldewey SM, 2013, DIS MODEL MECH, V6, P1031, DOI 10.1242/dmm.012435; Collino M, 2013, DIS MODEL MECH, V6, P1012, DOI 10.1242/dmm.011528; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Drechsler S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051457; Fernandes CJ, 1999, INTENS CARE MED, V25, P1165, DOI 10.1007/s001340051030; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Ghuman AK, 2013, J PEDIATR-US, V163, P835, DOI 10.1016/j.jpeds.2013.04.018; Horton JW, 2004, AM J PHYSIOL-HEART C, V286, pH202, DOI 10.1152/ajpheart.00706.2003; Hotchkiss RS, 2013, LANCET INFECT DIS, V13, P260, DOI 10.1016/S1473-3099(13)70001-X; Hsieh YC, 2007, AM J PHYSIOL-LUNG C, V292, pL1227, DOI 10.1152/ajplung.00479.2006; Hsu JT, 2009, CRIT CARE MED, V37, P2338, DOI 10.1097/CCM.0b013e3181a030ce; Jacobs MD, 1998, CELL, V95, P749, DOI 10.1016/S0092-8674(00)81698-0; Kapoor A, 2010, AM J RESP CRIT CARE, V182, P1506, DOI 10.1164/rccm.201002-0240OC; Khan AI, 2013, DIS MODEL MECH, V6, P1021, DOI 10.1242/dmm.011908; Khan R, 2010, SHOCK, V33, P242, DOI 10.1097/SHK.0b013e3181b0f96f; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kim YD, 1996, CIRCULATION, V94, P2901, DOI 10.1161/01.CIR.94.11.2901; Kleinert H, 1998, HYPERTENSION, V31, P582, DOI 10.1161/01.HYP.31.2.582; Kolodgie FD, 1997, J MOL CELL CARDIOL, V29, P2403, DOI 10.1006/jmcc.1997.0476; Liu CJ, 2009, J CELL MOL MED, V13, P3655, DOI 10.1111/j.1582-4934.2009.00669.x; Mahmood K, 2012, CRIT CARE, V16, DOI [10.1186/cc11355, 10.1186/CC11355]; Mannella P, 2006, J NEUROSCI, V26, P9439, DOI 10.1523/JNEUROSCI.1443-06.2006; McGrath JC, 2010, BRIT J PHARMACOL, V160, P1573, DOI 10.1111/j.1476-5381.2010.00873.x; Melamed A, 2009, CRIT CARE, V13, DOI 10.1186/cc7733; MIYAMOTO S, 1995, ADV CANCER RES, V66, P255, DOI 10.1016/S0065-230X(08)60257-2; NATANSON C, 1989, J EXP MED, V169, P823, DOI 10.1084/jem.169.3.823; NELSON JF, 1982, BIOL REPROD, V27, P327, DOI 10.1095/biolreprod27.2.327; Oberholzer A, 2000, J TRAUMA, V48, P932, DOI 10.1097/00005373-200005000-00019; Padkin A, 2003, CRIT CARE MED, V31, P2332, DOI 10.1097/01.CCM.0000085141.75513.2B; PARRILLO JE, 1985, J CLIN INVEST, V76, P1539, DOI 10.1172/JCI112135; Rajesh KG, 2005, J MOL CELL CARDIOL, V39, P766, DOI 10.1016/j.yjmcc.2005.07.014; Ren J, 2003, AM J PHYSIOL-HEART C, V284, pH1800, DOI 10.1152/ajpheart.00866.2002; Schroder J, 1998, ARCH SURG-CHICAGO, V133, P1200, DOI 10.1001/archsurg.133.11.1200; Sener G, 2005, J SURG RES, V128, P70, DOI 10.1016/j.jss.2005.02.019; Senftleben U, 2002, CRIT CARE MED, V30, pS18, DOI 10.1097/00003246-200201001-00003; Simoncini T, 2000, NATURE, V407, P538, DOI 10.1038/35035131; STEIN B, 1995, MOL CELL BIOL, V15, P4971; Szalay L, 2006, AM J PHYSIOL-REG I, V290, pR812, DOI 10.1152/ajpregu.00658.2005; THIEMERMANN C, 1990, EUR J PHARMACOL, V182, P591, DOI 10.1016/0014-2999(90)90062-B; Von Aulock S, 2006, J INTERF CYTOK RES, V26, P887, DOI 10.1089/jir.2006.26.887; Wang MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE321, DOI 10.1152/ajpendo.00278.2004; WEINER CP, 1994, P NATL ACAD SCI USA, V91, P5212, DOI 10.1073/pnas.91.11.5212; Weixelbaumer KM, 2014, SHOCK, V41, P145, DOI 10.1097/SHK.0000000000000070; Wichmann MW, 2000, INTENS CARE MED, V26, P167, DOI 10.1007/s001340050041; WICHTERMAN KA, 1980, J SURG RES, V29, P189, DOI 10.1016/0022-4804(80)90037-2; Yu HP, 2007, ANN SURG, V245, P971, DOI 10.1097/01.sla.0000254417.15591.88; Zellweger R, 1997, CRIT CARE MED, V25, P106, DOI 10.1097/00003246-199701000-00021; Zhu HQ, 2009, J MOL CELL CARDIOL, V47, P264, DOI 10.1016/j.yjmcc.2009.05.002	56	29	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100631	10.1371/journal.pone.0100631	http://dx.doi.org/10.1371/journal.pone.0100631			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945834	gold, Green Submitted, Green Published			2022-12-27	WOS:000340721500100
J	Law, SHW; Sargent, TD				Law, Sheran H. W.; Sargent, Thomas D.			The Serine-Threonine Protein Kinase PAK4 Is Dispensable in Zebrafish: Identification of a Morpholino-Generated Pseudophenotype	PLOS ONE			English	Article							ENDODERM FORMATION; RECEPTOR; ACTIVATION; PATHWAYS; SURVIVAL; CASANOVA; EMBRYOS; GENES; PLAYS; ALPHA	TALEN-based inactivation of the zebrafish pak4 gene resulted in embryos and adult fish that appear normal and fertile. This is in contrast to our previously published studies which were based on the use of antisense morpholino oligonucleotides (MOs). We have excluded potential explanations such as gene duplication, alternate splicing, cryptic initiation of translation, and translation-independent RNA function. Our conclusion is that pak4 is dispensable in zebrafish, and that even when corroborated by robust controls, such as RNA rescue, MOs may elicit misleading pseudophenotypes that do not correspond to results obtained by genetic mutations, and should thus be used with caution.	[Law, Sheran H. W.; Sargent, Thomas D.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Vertebrate Dev, Program Genom Differentiat, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Sargent, TD (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Vertebrate Dev, Program Genom Differentiat, NIH, Bethesda, MD 20892 USA.	tsargent@nih.gov			Intramural Research Program, National Institute of Child Health and Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001006] Funding Source: NIH RePORTER	Intramural Research Program, National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funding provided by Intramural Research Program, National Institute of Child Health and Human Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abo A, 1998, EMBO J, V17, P6527, DOI 10.1093/emboj/17.22.6527; Alexander J, 1999, DEV BIOL, V215, P343, DOI 10.1006/dbio.1999.9441; Cvejic A, 2008, J CELL SCI, V121, P3196, DOI 10.1242/jcs.032235; den Broeder MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007910; Dickmeis T, 2001, GENE DEV, V15, P1487, DOI 10.1101/gad.196901; Driever W, 1996, DEVELOPMENT, V123, P37; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; Ekker SC, 2001, GENESIS, V30, P89, DOI 10.1002/gene.1038; Eswaran J, 2008, TRENDS BIOCHEM SCI, V33, P394, DOI 10.1016/j.tibs.2008.06.002; Gerety SS, 2011, DEV BIOL, V350, P279, DOI 10.1016/j.ydbio.2010.11.030; Gnesutta N, 2003, MOL CELL BIOL, V23, P7838, DOI 10.1128/MCB.23.21.7838-7848.2003; Gnesutta N, 2001, J BIOL CHEM, V276, P14414, DOI 10.1074/jbc.M011046200; Goodale BC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029346; Haffter P, 1996, DEVELOPMENT, V123, P1; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Krone PH, 1997, BIOCHEM CELL BIOL, V75, P487, DOI 10.1139/bcb-75-5-487; Law SHW, 2013, MECH DEVELOP, V130, P181, DOI 10.1016/j.mod.2012.09.005; Li XF, 2005, J BIOL CHEM, V280, P41192, DOI 10.1074/jbc.M506884200; Lim S, 2012, DEVELOPMENT, V139, P2903, DOI 10.1242/dev.077081; Liu YY, 2008, MOL CANCER RES, V6, P1215, DOI 10.1158/1541-7786.MCR-08-0087; Luo T, 2007, DEVELOPMENT, V134, P1279, DOI 10.1242/dev.02813; Luo YJ, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001402; Matthews J, 2005, MOL CELL BIOL, V25, P5317, DOI 10.1128/MCB.25.13.5317-5328.2005; Nichols JT, 2013, DEVELOPMENT, V140, P2765, DOI 10.1242/dev.090639; Prasch AL, 2003, TOXICOL SCI, V76, P138, DOI 10.1093/toxsci/kfg202; Qu J, 2003, MOL CELL BIOL, V23, P7122, DOI 10.1128/MCB.23.20.7122-7133.2003; Reid BS, 2010, DEV DYNAM, V239, P1188, DOI 10.1002/dvdy.22248; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Romano LA, 2006, DEV GROWTH DIFFER, V48, P487, DOI 10.1111/j.1440-169x.2006.00884.x; SARGENT TD, 1986, DEV BIOL, V114, P238, DOI 10.1016/0012-1606(86)90399-4; Sperber SM, 2008, DEV BIOL, V321, P101, DOI 10.1016/j.ydbio.2008.06.004; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Tian YM, 2009, MECH DEVELOP, V126, P710, DOI 10.1016/j.mod.2009.05.002; Tucker B, 2006, HUM MOL GENET, V15, P3446, DOI 10.1093/hmg/ddl422; Wells CM, 2010, BIOCHEM J, V425, P465, DOI 10.1042/BJ20091173; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE	36	38	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100268	10.1371/journal.pone.0100268	http://dx.doi.org/10.1371/journal.pone.0100268			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945275	Green Published, gold, Green Submitted			2022-12-27	WOS:000340721500055
J	Okumura, T; Harada, K; Oue, K; Zhang, J; Asano, S; Hayashiuchi, M; Mizokami, A; Tanaka, H; Irifune, M; Kamata, N; Hirata, M; Kanematsu, T				Okumura, Toshiya; Harada, Kae; Oue, Kana; Zhang, Jun; Asano, Satoshi; Hayashiuchi, Masaki; Mizokami, Akiko; Tanaka, Hiroto; Irifune, Masahiro; Kamata, Nobuyuki; Hirata, Masato; Kanematsu, Takashi			Phospholipase C-Related Catalytically Inactive Protein (PRIP) Regulates Lipolysis in Adipose Tissue by Modulating the Phosphorylation of Hormone-Sensitive Lipase	PLOS ONE			English	Article							PERILIPIN-A; STIMULATED LIPOLYSIS; ADIPOCYTE LIPOLYSIS; MUTATIONAL ANALYSIS; SURFACE EXPRESSION; BINDING-PROTEIN; PHOSPHATASE 2A; RAT ADIPOCYTES; CELL-SURFACE; DEPHOSPHORYLATION	Phosphorylation of hormone-sensitive lipase (HSL) and perilipin by protein kinase A (PKA) promotes the hydrolysis of lipids in adipocytes. Although activation of lipolysis by PKA has been well studied, inactivation via protein phosphatases is poorly understood. Here, we investigated whether phospholipase C-related catalytically inactive protein (PRIP), a binding partner for protein phosphatase 1 and protein phosphatase 2A (PP2A), is involved in lipolysis by regulating phosphatase activity. PRIP knockout (PRIP-KO) mice displayed reduced body-fat mass as compared with wild-type mice fed with standard chow ad libitum. Most other organs appeared normal, suggesting that mutant mice had aberrant fat metabolism in adipocytes. HSL in PRIP-KO adipose tissue was highly phosphorylated compared to that in wild-type mice. Starvation of wild-type mice or stimulation of adipose tissue explants with the catabolic hormone, adrenaline, translocated both PRIP and PP2A from the cytosol to lipid droplets, but the translocation of PP2A was significantly reduced in PRIP-KO adipocytes. Consistently, the phosphatase activity associated with lipid droplet fraction in PRIP-KO adipocytes was significantly reduced and was independent of adrenaline stimulation. Lipolysis activity, as assessed by measurement of non-esterified fatty acids and glycerol, was higher in PRIP-KO adipocytes. When wild-type adipocytes were treated with a phosphatase inhibitor, they showed a high lipolysis activity at the similar level to PRIP-KO adipocytes. Collectively, these results suggest that PRIP promotes the translocation of phosphatases to lipid droplets to trigger the dephosphorylation of HSL and perilipin A, thus reducing PKA-mediated lipolysis.	[Okumura, Toshiya; Harada, Kae; Oue, Kana; Zhang, Jun; Asano, Satoshi; Hayashiuchi, Masaki; Tanaka, Hiroto; Kanematsu, Takashi] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Cellular & Mol Pharmacol, Hiroshima, Japan; [Okumura, Toshiya; Kamata, Nobuyuki] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Oral Surg, Hiroshima, Japan; [Oue, Kana; Irifune, Masahiro] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Dent Anesthesiol, Hiroshima, Japan; [Mizokami, Akiko; Tanaka, Hiroto; Hirata, Masato] Kyushu Univ, Fac Dent Sci, Lab Mol & Cellular Biochem, Fukuoka 812, Japan	Hiroshima University; Hiroshima University; Hiroshima University; Kyushu University	Kanematsu, T (corresponding author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Cellular & Mol Pharmacol, Hiroshima, Japan.	tkanema2@hiroshima-u.ac.jp	Mizokami, Akiko/AAY-2193-2020; Mizokami, Akiko/ABC-5448-2021; Asano, Satoshi/AAQ-3817-2020; Harada, Kae/AAT-1162-2020	Mizokami, Akiko/0000-0002-7490-5190; Harada, Kae/0000-0001-7620-9212; Asano, Satoshi/0000-0003-1537-4307	Funding Program for Next Generation World-Leading Researchers [LS087]; JSPS KAKENHI [25861757, 25861756, 24229009]; Grants-in-Aid for Scientific Research [26670809, 25861757] Funding Source: KAKEN	Funding Program for Next Generation World-Leading Researchers(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by funding from the Funding Program for Next Generation World-Leading Researchers (LS087) to T.K., and by JSPS KAKENHI (Grant No. 25861757 to K.H., Grant No. 25861756 to S.A., Grant No. 24229009 to M.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthonsen MW, 1998, J BIOL CHEM, V273, P215, DOI 10.1074/jbc.273.1.215; Asano S, 2014, BIOL OPEN IN PRESS; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Brasaemle DL, 2009, MOL CELL BIOCHEM, V326, P15, DOI 10.1007/s11010-008-9998-8; Brasaemle DL, 2000, BBA-MOL CELL BIOL L, V1483, P251, DOI 10.1016/S1388-1981(99)00179-1; Clifford GM, 1998, FEBS LETT, V435, P125, DOI 10.1016/S0014-5793(98)01052-7; Doira N, 2001, BIOMED RES-TOKYO, V22, P157, DOI 10.2220/biomedres.22.157; EGAN JJ, 1992, P NATL ACAD SCI USA, V89, P8537, DOI 10.1073/pnas.89.18.8537; Fujii M, 2010, J BIOL CHEM, V285, P4837, DOI 10.1074/jbc.M109.070045; Gao J, 2012, J BIOL CHEM, V287, P10565, DOI 10.1074/jbc.M111.294645; Granneman JG, 2009, J BIOL CHEM, V284, P34538, DOI 10.1074/jbc.M109.068478; Guo CY, 2002, J BIOL CHEM, V277, P41756, DOI 10.1074/jbc.M207519200; Kanematsu T, 2005, MOL CELLS, V20, P305; Kanematsu T, 1996, BIOCHEM J, V313, P319, DOI 10.1042/bj3130319; KANEMATSU T, 1992, J BIOL CHEM, V267, P6518; Kanematsu T, 2000, EUR J BIOCHEM, V267, P2731, DOI 10.1046/j.1432-1327.2000.01291.x; Kanematsu T, 2002, EMBO J, V21, P1004, DOI 10.1093/emboj/21.5.1004; Kanematsu T, 2007, J PHARMACOL SCI, V104, P285, DOI 10.1254/jphs.CP0070063; Kanematsu T, 2006, J BIOL CHEM, V281, P22180, DOI 10.1074/jbc.M603118200; King TD, 2006, EXP CELL RES, V312, P3693, DOI 10.1016/j.yexcr.2006.08.010; Kinney BP, 2010, ENDOCRINOLOGY, V151, P3624, DOI 10.1210/en.2010-0245; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Lampidonis AD, 2011, GENE, V477, P1, DOI 10.1016/j.gene.2011.01.007; Marcinkiewicz A, 2006, J BIOL CHEM, V281, P11901, DOI 10.1074/jbc.M600171200; Martin S, 2009, J BIOL CHEM, V284, P32097, DOI 10.1074/jbc.M109.002675; Martinez-Botas J, 2000, NAT GENET, V26, P474, DOI 10.1038/82630; Michelle AS, 2011, STEM CELLS DEV, V20, P1793; Miyoshi H, 2007, J BIOL CHEM, V282, P996, DOI 10.1074/jbc.M605770200; Mizokami A, 2007, J NEUROSCI, V27, P1692, DOI 10.1523/JNEUROSCI.3155-06.2007; Mizokami A, 2010, J NEUROCHEM, V114, P302, DOI 10.1111/j.1471-4159.2010.06754.x; Omori K, 2007, CIRC RES, V100, P309, DOI 10.1161/01.RES.0000256354.95791.f1; Peckett AJ, 2011, METABOLISM, V60, P1500, DOI 10.1016/j.metabol.2011.06.012; Radeau T, 1995, J LIPID RES, V36, P2552; Shen WJ, 1998, BIOCHEMISTRY-US, V37, P8973, DOI 10.1021/bi980545u; Snyder PB, 2005, J LIPID RES, V46, P494, DOI 10.1194/jlr.M400362-JLR200; Su CL, 2003, J BIOL CHEM, V278, P43615, DOI 10.1074/jbc.M301809200; Sugiyama G, 2012, BIOCHEMISTRY-US, V51, P3394, DOI 10.1021/bi2018128; Sutherland LN, 2009, J PHYSIOL-LONDON, V587, P1607, DOI 10.1113/jphysiol.2008.165464; Sztalryd C, 2003, J CELL BIOL, V161, P1093, DOI 10.1083/jcb.200210169; Takenaka K, 2003, MOL CELL BIOL, V23, P7329, DOI 10.1128/MCB.23.20.7329-7338.2003; Takeuchi H, 1996, BIOCHEM J, V318, P561, DOI 10.1042/bj3180561; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; Terunuma M, 2004, J NEUROSCI, V24, P7074, DOI 10.1523/JNEUROSCI.1323-04.2004; WOOD SL, 1993, BIOCHEM J, V295, P531, DOI 10.1042/bj2950531; YOSHIDA M, 1994, J BIOCHEM, V115, P973, DOI 10.1093/oxfordjournals.jbchem.a124447; Yoshimura K, 2001, J BIOL CHEM, V276, P17908, DOI 10.1074/jbc.M009677200; Zhang Z, 2013, J BIOL CHEM, V288, P7769, DOI 10.1074/jbc.M112.419317	47	16	18	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100559	10.1371/journal.pone.0100559	http://dx.doi.org/10.1371/journal.pone.0100559			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945349	Green Published, gold, Green Submitted			2022-12-27	WOS:000340721500093
J	Sarraf, NS; Shi, R; McDonald, L; Baardsnes, J; Zhang, LH; Cygler, M; Ekiel, I				Sarraf, Naghmeh S.; Shi, Rong; McDonald, Laura; Baardsnes, Jason; Zhang, Linhua; Cygler, Miroslaw; Ekiel, Irena			Structure of CbpA J-Domain Bound to the Regulatory Protein CbpM Explains Its Specificity and Suggests Evolutionary Link between CbpM and Transcriptional Regulators	PLOS ONE			English	Article							ESCHERICHIA-COLI; DNAJ HOMOLOG; STREPTOMYCES-COELICOLOR; CHAPERONE; HSP70; BINDING; FAMILY; MODULATOR	CbpA is one of the six E. coli DnaJ/Hsp40 homologues of DnaK co-chaperones and the only one that is additionally regulated by a small protein CbpM, conserved in gamma-proteobacteria. CbpM inhibits the co-chaperone and DNA binding activities of CbpA. This regulatory function of CbpM is accomplished through reversible interaction with the N-terminal J-domain of CbpA, which is essential for the interaction with DnaK. CbpM is highly specific for CbpA and does not bind DnaJ despite the high degree of structural and functional similarity between the J-domains of CbpA and DnaJ. Here we report the crystal structure of the complex of CbpM with the J-domain of CbpA. CbpM forms dimers and the J-domain of CbpA interacts with both CbpM subunits. The CbpM-binding surface of CbpA is highly overlapping with the CbpA interface for DnaK, providing a competitive model for regulation through forming mutually exclusive complexes. The structure also provides the explanation for the strict specificity of CbpM for CbpA, which we confirmed by making mutants of DnaJ that became regulated by CbpM. Interestingly, the structure of CbpM reveals a striking similarity to members of the MerR family of transcriptional regulators, suggesting an evolutionary connection between the functionally distinct bacterial cochaperone regulator CbpM and the transcription regulator HspR.	[Sarraf, Naghmeh S.; McDonald, Laura; Ekiel, Irena] Concordia Univ, Dept Chem & Biochem, Montreal, PQ H3G 1M8, Canada; [Sarraf, Naghmeh S.; McDonald, Laura; Baardsnes, Jason; Ekiel, Irena] Natl Res Council Canada, Montreal, PQ, Canada; [Shi, Rong] Univ Laval, Dept Biochim Microbiol & Bioinformat, Quebec City, PQ, Canada; [Shi, Rong] Univ Laval, Inst Biol Integrat & Syst, Quebec City, PQ, Canada; [Shi, Rong] Univ Laval, PROTEO, Quebec City, PQ, Canada; [Zhang, Linhua; Cygler, Miroslaw] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Cygler, Miroslaw] Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 0W0, Canada	Concordia University - Canada; National Research Council Canada; Laval University; Laval University; Laval University; McGill University; University of Saskatchewan	Cygler, M (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ, Canada.	miroslaw.cygler@usask.ca; irena.ekiel@bri.nrc.ca			Canadian Institutes of Health Research (CIHR) [MOP-48370]; Canadian Foundation for Innovation; Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This research was supported by a Canadian Institutes of Health Research (CIHR) Grant MOP-48370 (to I.E. and M.C.). The Canadian Macromolecular Crystallography Facility is supported by the Canadian Foundation for Innovation, the Natural Sciences and Engineering Research Council of Canada, and Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azam TA, 1999, J BACTERIOL, V181, P6361, DOI 10.1128/JB.181.20.6361-6370.1999; Barends TRM, 2013, ACTA CRYSTALLOGR D, V69, P1540, DOI 10.1107/S0907444913010640; Bird JG, 2006, J BIOL CHEM, V281, P34349, DOI 10.1074/jbc.M603365200; Brown NL, 2003, FEMS MICROBIOL REV, V27, P145, DOI 10.1016/S0168-6445(03)00051-2; Bucca G, 1997, J BACTERIOL, V179, P5999, DOI 10.1128/jb.179.19.5999-6004.1997; Bucca G, 2000, MOL MICROBIOL, V38, P1093, DOI 10.1046/j.1365-2958.2000.02194.x; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Caguiat JJ, 1999, J BACTERIOL, V181, P3462, DOI 10.1128/JB.181.11.3462-3471.1999; Chae C, 2004, J BIOL CHEM, V279, P33147, DOI 10.1074/jbc.M404862200; Chenoweth MR, 2008, J BACTERIOL, V190, P5153, DOI 10.1128/JB.00437-08; Chenoweth MR, 2007, J BACTERIOL, V189, P3635, DOI 10.1128/JB.01757-06; Chintakayala K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003152; Chintakayala K, 2011, J MOL BIOL, V411, P313, DOI 10.1016/j.jmb.2011.05.043; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gamer J, 1996, EMBO J, V15, P607, DOI 10.1002/j.1460-2075.1996.tb00393.x; Genevaux P, 2002, GENETICS, V162, P1045; Genevaux P, 2007, MOL MICROBIOL, V66, P840, DOI 10.1111/j.1365-2958.2007.05961.x; Hinault MP, 2010, J BIOL CHEM, V285, P38173, DOI 10.1074/jbc.M110.127753; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huang K, 1999, PROTEIN SCI, V8, P203; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Karzai AW, 1996, J BIOL CHEM, V271, P11236, DOI 10.1074/jbc.271.19.11236; Kelley WL, 1998, TRENDS BIOCHEM SCI, V23, P222, DOI 10.1016/S0968-0004(98)01215-8; Klaiman TN, 2009, COMPUT BIOL CHEM, V33, P275, DOI 10.1016/j.compbiolchem.2009.06.007; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Narberhaus F, 1999, MOL MICROBIOL, V31, P1, DOI 10.1046/j.1365-2958.1999.01166.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pellecchia M, 1996, J MOL BIOL, V260, P236, DOI 10.1006/jmbi.1996.0395; Ramos JL, 2001, CURR OPIN MICROBIOL, V4, P166, DOI 10.1016/S1369-5274(00)00183-1; Roncarati D, 2011, J BACTERIOL, V193, P5629, DOI 10.1128/JB.05295-11; Sarraf NS, 2010, J MOL BIOL, V398, P111, DOI 10.1016/j.jmb.2010.03.006; Scarlato V, 2001, INT J MED MICROBIOL, V291, P107, DOI 10.1078/1438-4221-00107; Spohn G, 1999, MOL MICROBIOL, V34, P663, DOI 10.1046/j.1365-2958.1999.01625.x; Terwilliger TC, 2002, ACTA CRYSTALLOGR D, V58, P1937, DOI 10.1107/S0907444902016438; UEGUCHI C, 1994, P NATL ACAD SCI USA, V91, P1054, DOI 10.1073/pnas.91.3.1054; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; WALL D, 1994, J BIOL CHEM, V269, P5446; Walsh P, 2004, EMBO REP, V5, P567, DOI 10.1038/sj.embor.7400172; Woolfson DN, 2005, ADV PROTEIN CHEM, V70, P79, DOI 10.1016/S0065-3233(04)70004-2; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492	42	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100441	10.1371/journal.pone.0100441	http://dx.doi.org/10.1371/journal.pone.0100441			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945826	Green Published, Green Submitted, gold			2022-12-27	WOS:000340721500075
J	Esterhammer, R; Klug, G; Wolf, C; Mayr, A; Reinstadler, S; Feistritzer, HJ; Metzler, B; Schocke, MFH				Esterhammer, Regina; Klug, Gert; Wolf, Christian; Mayr, Agnes; Reinstadler, Sebastian; Feistritzer, Hans-Josef; Metzler, Bernhard; Schocke, Michael F. H.			Cardiac High-Energy Phosphate Metabolism Alters with Age as Studied in 196 Healthy Males with the Help of 31-Phosphorus 2-Dimensional Chemical Shift Imaging	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; P-31 MR SPECTROSCOPY; LEFT-VENTRICULAR HYPERTROPHY; CREATINE-KINASE; MYOCARDIAL-INFARCTION; HUMAN HEART; EXERCISE; ENERGETICS; DISEASE; ADP	Recently published studies have elucidated alterations of mitochondrial oxidative metabolism during ageing. The intention of the present study was to evaluate the impact of ageing on cardiac high-energy phosphate metabolism and cardiac function in healthy humans. 31-phosphorus 2-dimensional chemical shift imaging (31P 2D CSI) and echocardiography were performed in 196 healthy male volunteers divided into groups of 20 to 40 years (I, n = 43), 40 to 60 years (II, n = 123) and > 60 years (III, n = 27) of age. Left ventricular PCr/beta-ATP ratio, myocardial mass (MM), ejection fraction and E/A ratio were assessed. Mean PCr/beta-ATP ratios were significantly different among the three groups of volunteers (I, 2.10 +/- 0.37; II, 1.77 +/- 0.37; III, 1.45 +/- 0.28; all p < 0.001). PCr/beta-ATP ratios were inversely related to age (r(2) = -0.25; p < 0.001) with a decrease from 2.65 by 0.02 per year of ageing. PCr/beta-ATP ratios further correlated with MM (r = -0.371; p < 0.001) and E/A ratios (r = 0.213; p < 0.02). Moreover, E/A ratios (r = 20.502, p < 0.001), MM (r = 0.304, p < 0.001), glucose-levels (r = 0.157, p < 0.05) and systolic blood pressure (r = 0.224, p < 0.005) showed significant correlations with age. The ejection fraction did not significantly differ between the groups. This study shows that cardiac PCr/beta-ATP ratios decrease moderately with age indicating an impairment of mitochondrial oxidative metabolism due to age. Furthermore, MM increases, and E/A ratio decreases with age. Both correlate with left-ventricular PCr/beta-ATP ratios. The findings of the present study confirm numerous experimental studies showing an impairment of cardiac mitochondrial function with age.	[Esterhammer, Regina; Wolf, Christian; Mayr, Agnes; Schocke, Michael F. H.] Med Univ Innsbruck, Dept Radiol, A-6020 Innsbruck, Austria; [Klug, Gert; Reinstadler, Sebastian; Feistritzer, Hans-Josef; Metzler, Bernhard] Med Univ Innsbruck, Div Cardiol, Dept Internal Med 2, A-6020 Innsbruck, Austria; [Wolf, Christian] Dist Hosp Reutte, Dept Radiol, Ehenbichl, Austria	Medical University of Innsbruck; Medical University of Innsbruck	Schocke, MFH (corresponding author), Med Univ Innsbruck, Dept Radiol, A-6020 Innsbruck, Austria.	michael.schocke@i-med.ac.at	Schocke, Michael/AAC-3666-2020	Klug, Gert/0000-0002-4737-0979; Metzler, Bernhard/0000-0002-5240-2453; , Agnes Mayr/0000-0001-9363-873X; Reinstadler, Sebastian/0000-0002-7700-1357				Bak MI, 1998, J MOL CELL CARDIOL, V30, P661, DOI 10.1006/jmcc.1997.0633; Beer M, 2007, EUR RADIOL, V17, P1275, DOI 10.1007/s00330-006-0492-y; BOTTOMLEY PA, 1994, RADIOLOGY, V191, P593, DOI 10.1148/radiology.191.3.8184033; BOTTOMLEY PA, 1987, RADIOLOGY, V165, P703, DOI 10.1148/radiology.165.3.2961004; Burtscher M, 2013, GERONTOLOGY, V59, P289, DOI 10.1159/000343990; Crilley JG, 2000, J AM COLL CARDIOL, V36, P1953, DOI 10.1016/S0735-1097(00)00960-8; Dahlof Bjorn, 2010, Am J Cardiol, V105, p3A, DOI 10.1016/j.amjcard.2009.10.007; de Souza RR, 2002, BIOGERONTOLOGY, V3, P325, DOI 10.1023/A:1021312027486; Dutta D, 2012, CIRC RES, V110, P1125, DOI 10.1161/CIRCRESAHA.111.246108; Dzeja PP, 2011, J PHYSIOL-LONDON, V589, P5193, DOI 10.1113/jphysiol.2011.212829; Edwards LM, 2011, MOL BIOSYST, V7, P3335, DOI 10.1039/c1mb05310h; Farrall AT, 1997, MAGNET RESON MED, V38, P577, DOI 10.1002/mrm.1910380412; Ferket BS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088312; FLAHERTY JT, 1982, CIRCULATION, V65, P561, DOI 10.1161/01.CIR.65.3.561; Fleg JL, 2012, HEART FAIL REV, V17, P545, DOI 10.1007/s10741-011-9270-2; Freeman DM, 1997, NMR BIOMED, V10, P381, DOI 10.1002/(SICI)1099-1492(199712)10:8<381::AID-NBM495>3.0.CO;2-7; Frick M, 2011, INT J CARDIOL, V148, P112, DOI 10.1016/j.ijcard.2011.01.042; Gabr RE, 2006, J MAGN RESON, V179, P152, DOI 10.1016/j.jmr.2005.11.004; Hacker TA, 2006, AM J PHYSIOL-HEART C, V290, pH304, DOI 10.1152/ajpheart.00290.2005; Harman D, 2006, ANN NY ACAD SCI, V1067, P10, DOI 10.1196/annals.1354.003; Hees PS, 2004, AM J PHYSIOL-HEART C, V286, pH782, DOI 10.1152/ajpheart.01092.2002; Hollingsworth KG, 2012, AM J PHYSIOL-HEART C, V302, pH885, DOI 10.1152/ajpheart.00985.2011; Hudsmith LE, 2009, JACC-CARDIOVASC IMAG, V2, P87, DOI 10.1016/j.jcmg.2008.08.005; Ingwall JS, 2004, J MOL CELL CARDIOL, V37, P613, DOI 10.1016/j.yjmcc.2004.05.020; JACOBUS WE, 1982, J BIOL CHEM, V257, P2397; Judge S, 2005, AM J PHYSIOL-REG I, V289, pR1564, DOI 10.1152/ajpregu.00396.2005; Judge S, 2007, AM J PHYSIOL-CELL PH, V292, pC1983, DOI 10.1152/ajpcell.00285.2006; Jung WI, 1998, CIRCULATION, V97, P2536, DOI 10.1161/01.CIR.97.25.2536; KITZMAN DW, 1991, J AM COLL CARDIOL, V18, P1243, DOI 10.1016/0735-1097(91)90542-H; Klug G, 2007, INT J SPORTS MED, V28, P667, DOI 10.1055/s-2007-964862; Klug G, 2011, INT J CARDIOL, V150, P208, DOI 10.1016/j.ijcard.2011.05.006; Kostler H, 2006, MAGN RESON MED, V56, P907, DOI 10.1002/mrm.21027; Lakatta EG, 2002, COMP BIOCHEM PHYS A, V132, P699, DOI 10.1016/S1095-6433(02)00124-1; Lodi R, 2004, BBA-BIOENERGETICS, V1657, P146, DOI 10.1016/j.bbabio.2004.05.003; Lodi R, 2003, ANN NEUROL, V54, P552, DOI 10.1002/ana.10744; Metzler B, 2002, J CARDIOVASC MAGN R, V4, P493, DOI 10.1081/JCMR-120016387; Nahrendorf M, 2005, CARDIOVASC RES, V65, P419, DOI 10.1016/j.cardiores.2004.10.006; Neubauer S, 1997, CIRCULATION, V96, P2190; Nikitin NP, 2006, INT J CARDIOL, V108, P76, DOI 10.1016/j.ijcard.2005.04.009; Okada M, 1998, MAGNET RESON MED, V39, P772, DOI 10.1002/mrm.1910390515; PETERSEN A, 1990, BIOCHIM BIOPHYS ACTA, V1035, P169, DOI 10.1016/0304-4165(90)90112-A; R Core Team, 2018, R LANG ENV STAT COMP; RAO BDN, 1981, J BIOL CHEM, V256, P1716; Robergs RA, 2004, AM J PHYSIOL-REG I, V287, pR502, DOI 10.1152/ajpregu.00114.2004; Saks V, 2006, J PHYSIOL-LONDON, V571, P253, DOI 10.1113/jphysiol.2005.101444; Saks VA, 2004, MOL CELL BIOCHEM, V256, P185, DOI 10.1023/B:MCBI.0000009868.92189.fb; Saupe KW, 2000, J BIOL CHEM, V275, P19742, DOI 10.1074/jbc.M001932200; Scheuermann-Freestone M, 2003, CIRCULATION, V107, P3040, DOI 10.1161/01.CIR.0000072789.89096.10; Schneider-Gold C, 2004, MUSCLE NERVE, V30, P636, DOI 10.1002/mus.20156; Schocke MFH, 2004, MAGN RESON IMAGING, V22, P515, DOI 10.1016/j.mri.2004.01.023; Schocke MFH, 2003, J CARDIOVASC MAGN R, V5, P595, DOI 10.1081/JCMR-120025234; Schocke MFH, 2003, MAGN RESON IMAGING, V21, P553, DOI 10.1016/S0730-725X(03)00079-1; Stubbs M, 1996, BBA-GEN SUBJECTS, V1291, P143, DOI 10.1016/0304-4165(96)00058-X; Suzuki Y, 1998, EUR J BIOCHEM, V257, P466, DOI 10.1046/j.1432-1327.1998.2570466.x; TANOKURA M, 1993, J BIOCHEM-TOKYO, V113, P19, DOI 10.1093/oxfordjournals.jbchem.a123996; Terman A, 2005, CARDIOVASC RES, V68, P355, DOI 10.1016/j.cardiores.2005.08.014; VANDOBBENBURGH JO, 1994, NMR BIOMED, V7, P218, DOI 10.1002/nbm.1940070504; Wallis J, 2005, CIRCULATION, V112, P3131, DOI 10.1161/CIRCULATIONAHA.105.572990; WEISS RG, 1990, NEW ENGL J MED, V323, P1593, DOI 10.1056/NEJM199012063232304; Wolf C, 2008, MOL IMAGING BIOL, V10, P24, DOI 10.1007/s11307-007-0119-y	60	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e97368	10.1371/journal.pone.0097368	http://dx.doi.org/10.1371/journal.pone.0097368			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940736	Green Published, gold, Green Submitted			2022-12-27	WOS:000338508200003
J	Li, XQ				Li, Xiu-Qing			Comparative Analysis of the Base Compositions of the Pre-mRNA 3 ' Cleaved-Off Region and the mRNA 3 ' Untranslated Region Relative to the Genomic Base Composition in Animals and Plants	PLOS ONE			English	Article							CYTOPLASMIC POLYADENYLATION; STATISTICAL-ANALYSIS; SEQUENCES; MATURATION; PATTERNS; INTRONS; SIGNALS; USAGE	The precursor messenger RNA (pre-mRNA) three-prime cleaved-off region (3'COR) and the mRNA three-prime untranslated region (3'UTR) play critical roles in regulating gene expression. The differences in base composition between these regions and the corresponding genomes are still largely uncharacterized in animals and plants. In this study, the base compositions of non-redundant 3'CORs and 3'UTRs were compared with the corresponding whole genomes of eleven animals, four dicotyledonous plants, and three monocotyledonous (cereal) plants. Among the four bases (A, C, G, and U for adenine, cytosine, guanine, and uracil, respectively), U (which corresponds to T, for thymine, in DNA) was the most frequent, A the second most frequent, G the third most frequent, and C the least frequent in most of the species in both the 3'COR and 3'UTR regions. In comparison with the whole genomes, in both regions the U content was usually the most overrepresented (particularly in the monocotyledonous plants), and the C content was the most underrepresented. The order obtained for the species groups, when ranked from high to low according to the U contents in the 3'COR and 3'UTR was as follows: dicotyledonous plants, monocotyledonous plants, non-mammal animals, and mammals. In contrast, the genomic T content was highest in dicotyledonous plants, lowest in monocotyledonous plants, and intermediate in animals. These results suggest the following: 1) there is a mechanism operating in both animals and plants which is biased toward U and against C in the 3'COR and 3'UTR; 2) the 3'UTR and 3'COR, as functional units, minimized the difference between dicotyledonous and monocotyledonous plants, while the dicotyledonous and monocotyledonous genomes evolved into two extreme groups in terms of base composition.	Agr & Agri Food Canada, Potato Res Ctr, Fredericton, NB, Canada	Agriculture & Agri Food Canada; CGIAR; International Potato Center (CIP)	Li, XQ (corresponding author), Agr & Agri Food Canada, Potato Res Ctr, Fredericton, NB, Canada.	Xiu-Qing.Li@agr.gc.ca		Li, Xiu-Qing/0000-0002-7308-0596	Agriculture and Agri-Food Canada	Agriculture and Agri-Food Canada(Agriculture & Agri Food Canada)	This research was supported by XQL's funding from Agriculture and Agri-Food Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi H, 2001, CURR OPIN GENET DEV, V11, P660, DOI 10.1016/S0959-437X(00)00250-1; Barkoff A, 1998, EMBO J, V17, P3168, DOI 10.1093/emboj/17.11.3168; Beaudoing E, 2000, GENOME RES, V10, P1001, DOI 10.1101/gr.10.7.1001; Birse CE, 1998, SCIENCE, V280, P298, DOI 10.1126/science.280.5361.298; Borodulina OR, 2008, RNA, V14, P1865, DOI 10.1261/rna.1006608; BULMER M, 1987, MOL BIOL EVOL, V4, P395; CHAMBERS A, 1988, DEV BIOL, V125, P237, DOI 10.1016/0012-1606(88)90207-2; Costantini M, 2007, GENOMICS, V90, P364, DOI 10.1016/j.ygeno.2007.05.006; Derti A, 2012, GENOME RES, V22, P1173, DOI 10.1101/gr.132563.111; Du DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044872; DURET L, 1995, J MOL EVOL, V40, P308, DOI 10.1007/BF00163235; Gonzalez Fortes G, 2007, GENETICA, V129, P281, DOI 10.1007/s10709-006-0009-2; Graber JH, 1999, P NATL ACAD SCI USA, V96, P14055, DOI 10.1073/pnas.96.24.14055; Hu J, 2005, RNA, V11, P1485, DOI 10.1261/rna.2107305; Jabbari K, 2004, GENE, V333, P183, DOI 10.1016/j.gene.2004.02.038; Juge F, 2002, EMBO J, V21, P6603, DOI 10.1093/emboj/cdf633; Kochetov AV, 2002, MOL BIOL+, V36, P510, DOI 10.1023/A:1019852427093; Li XQ, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0162-7; Li XQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088339; Li XQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079511; Li XQ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00982; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; Mukhopadhyay P, 2007, GENE, V400, P71, DOI 10.1016/j.gene.2007.05.027; Rayko E, 2006, GENE, V365, P41, DOI 10.1016/j.gene.2005.09.038; Schisa JA, 1998, DEVELOPMENT, V125, P2995; Tian B, 2012, WIRES RNA, V3, P385, DOI 10.1002/wrna.116; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Yamanaka S, 2010, EMBO J, V29, P2173, DOI 10.1038/emboj.2010.108	28	2	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99928	10.1371/journal.pone.0099928	http://dx.doi.org/10.1371/journal.pone.0099928			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941005	Green Submitted, Green Published, gold			2022-12-27	WOS:000338508200054
J	Castro-Diez, P; Valle, G; Gonzalez-Munoz, N; Alonso, A				Castro-Diez, Pilar; Valle, Guillermo; Gonzalez-Munoz, Noelia; Alonso, Alvaro			Can the Life-History Strategy Explain the Success of the Exotic Trees Ailanthus altissima and Robinia pseudoacacia in Iberian Floodplain Forests?	PLOS ONE			English	Article							ALIEN PLANTS; BLACK LOCUST; FLOWERING PHENOLOGY; INVASION SUCCESS; RIPARIAN ZONES; LOESS PLATEAU; IMPACTS; NICHE; REPRODUCTION; COMMUNITIES	Ailanthus altissima and Robina pseudoacacia are two successful invasive species of floodplains in central Spain. We aim to explain their success as invaders in this habitat by exploring their phenological pattern, vegetative and sexual reproductive growth, and allometric relations, comparing them with those of the dominant native tree Populus alba. During a full annual cycle we follow the timing of vegetative growth, flowering, fruit set, leaf abscission and fruit dispersal. Growth was assessed by harvesting two-year old branches at the peaks of vegetative, flower and fruit production and expressing the mass of current-year leaves, stems, inflorescences and infrutescences per unit of previous-year stem mass. Secondary growth was assessed as the increment of trunk basal area per previous-year basal area. A. altissima and R. pseudoacacia showed reproductive traits (late flowering phenology, insect pollination, late and long fruit set period, larger seeds) different from P. alba and other native trees, which may help them to occupy an empty reproductive niche and benefit from a reduced competition for the resources required by reproductive growth. The larger seeds of the invaders may make them less dependent on gaps for seedling establishment. If so, these invaders may benefit from the reduced gap formation rate of flood-regulated rivers of the study region. The two invasive species showed higher gross production than the native, due to the higher size of pre-existing stems rather than to a faster relative growth rate. The latter was only higher in A. altissima for stems, and in R. pseudoacacia for reproductive organs. A. altissima and R. pseudoacacia showed the lowest and highest reproductive/vegetative mass ratio, respectively. Therefore, A. altissima may outcompete native P. alba trees thanks to a high potential to overtop coexisting plants whereas R. pseudoacacia may do so by means of a higher investment in sexual reproduction.	[Castro-Diez, Pilar; Valle, Guillermo; Gonzalez-Munoz, Noelia; Alonso, Alvaro] Univ Alcala, Dept Life Sci UD Ecol, Madrid, Spain; [Gonzalez-Munoz, Noelia] Univ Paris Sud, Lab Systemat Ecol & Evolut, Paris, France	Universidad de Alcala; UDICE-French Research Universities; Universite Paris Saclay	Castro-Diez, P (corresponding author), Univ Alcala, Dept Life Sci UD Ecol, Madrid, Spain.	mpilar.castro@uah.es	González Muñoz, Noelia/A-3368-2017; Alonso, Álvaro/B-4286-2018; Castro-Diez, Pilar/L-4716-2014	González Muñoz, Noelia/0000-0001-7449-1621; Alonso, Álvaro/0000-0002-7797-8045; Castro-Diez, Pilar/0000-0002-4841-5198	Spanish Ministry of Science and Innovation [CGL2010-16388/BOS]; Junta de Comunidades de Castilla-La Mancha [POII10-0179-4700]; REMEDINAL network of Comunidad de Madrid [S2009/AMB-1783]; CONICYT (Ministry of Education, Chile Government); University of Alcala	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Comunidades de Castilla-La Mancha(Junta de Comunidades de Castilla-La Mancha); REMEDINAL network of Comunidad de Madrid; CONICYT (Ministry of Education, Chile Government); University of Alcala	This study was supported by the grants CGL2010-16388/BOS of the Spanish Ministry of Science and Innovation, POII10-0179-4700 of Junta de Comunidades de Castilla-La Mancha and the REMEDINAL network S2009/AMB-1783 of Comunidad de Madrid. PCD acknowledges CONICYT (Ministry of Education, Chile Government) for funding her stay at Concepcion University ("Concurso de atraccion de Capital Humano Extranjero-MEC" grant). NGM acknowledges the post-doctoral financial support provided by the University of Alcala. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PB, 2007, ECOL LETT, V10, P95, DOI 10.1111/j.1461-0248.2006.00996.x; Alonso A, 2010, ECOL RES, V25, P647, DOI 10.1007/s11284-010-0698-y; Alpert Peter, 2000, Perspectives in Plant Ecology Evolution and Systematics, V3, P52, DOI 10.1078/1433-8319-00004; Andreu J, 2009, ENVIRON MANAGE, V43, P1244, DOI 10.1007/s00267-009-9280-1; Arianoutsou M, 2010, BIOL INVASIONS, V12, P3525, DOI 10.1007/s10530-010-9749-0; Arizpe D., 2008, RIPARIAN TREE SHRUB; Basnou C, 2009, HDB ALIEN SPECIES EU, V3, P357; Bolmgren K, 2003, EVOLUTION, V57, P2001, DOI 10.1111/j.0014-3820.2003.tb00380.x; BORING LR, 1984, J ECOL, V72, P749, DOI 10.2307/2259529; Brown BJ, 2002, ECOLOGY, V83, P2328, DOI 10.1890/0012-9658(2002)083[2328:CFPBAI]2.0.CO;2; Burke MJW, 1996, ECOLOGY, V77, P776, DOI 10.2307/2265501; Cadotte MW, 2001, ECOSCIENCE, V8, P230, DOI 10.1080/11956860.2001.11682649; Castro-Diez P, 2014, ECOL LETT, V17, P1, DOI 10.1111/ele.12197; Castro-Diez P, 2003, PLANT ECOL, V166, P117, DOI 10.1023/A:1023209230303; Castro-Diez P, 2009, BIOL INVASIONS, V11, P1973, DOI 10.1007/s10530-008-9374-3; Castro-Diez P, 1998, PLANT ECOL, V139, P103, DOI DOI 10.1023/A:1009759318927; Castro-Diez P, 2012, PLANT SOIL, V350, P179, DOI 10.1007/s11104-011-0893-9; Castroviejo S., 1993, FLORA IBERICA, V3; Catalan Bachiller G, 1991, SEMILLAS ARBOLES ARB; Catford JA, 2011, J APPL ECOL, V48, P432, DOI 10.1111/j.1365-2664.2010.01945.x; Catford JA, 2009, DIVERS DISTRIB, V15, P22, DOI 10.1111/j.1472-4642.2008.00521.x; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Chytry M, 2008, J APPL ECOL, V45, P448, DOI 10.1111/j.1365-2664.2007.01398.x; Cierjacks A, 2013, J ECOL, V101, P1623, DOI 10.1111/1365-2745.12162; Colautti RI, 2006, BIOL INVASIONS, V8, P1023, DOI 10.1007/s10530-005-3735-y; Constan-Nava S, 2012, BIOL INVASIONS, V14, P2379, DOI 10.1007/s10530-012-0236-7; Crawley MJ, 1996, PHILOS T R SOC B, V351, P1251, DOI 10.1098/rstb.1996.0108; Crawley MJ, 1987, COLONIZATION SUCCESS, P429; D'Antonio CM, 2003, MODELS IN ECOSYSTEM SCIENCE, P363; Daehler CC, 2003, ANNU REV ECOL EVOL S, V34, P183, DOI 10.1146/annurev.ecolsys.34.011802.132403; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; Dawson W, 2009, J ECOL, V97, P657, DOI 10.1111/j.1365-2745.2009.01519.x; Dietz H, 1997, J VEG SCI, V8, P839, DOI 10.2307/3237028; Drake JA, 2009, HDB ALIEN SPECIES EU; DUNN OJ, 1961, J AM STAT ASSOC, V56, P52, DOI 10.2307/2282330; Fargione J, 2003, P NATL ACAD SCI USA, V100, P8916, DOI 10.1073/pnas.1033107100; FOX GA, 1990, EVOLUTION, V44, P1404, DOI 10.1111/j.1558-5646.1990.tb03835.x; Fridley JD, 2012, NATURE, V485, P359, DOI 10.1038/nature11056; Gerlach JD, 2003, ECOL APPL, V13, P167, DOI 10.1890/1051-0761(2003)013[0167:TLHCOI]2.0.CO;2; Glenn EP, 2005, J ARID ENVIRON, V61, P419, DOI 10.1016/j.jaridenv.2004.09.025; Godoy O, 2009, PLANT BIOLOGY, V11, P803, DOI 10.1111/j.1438-8677.2008.00185.x; Godoy O, 2014, J ECOLOGY IN PRESS; Godoy O, 2009, ANN BOT-LONDON, V103, P485, DOI 10.1093/aob/mcn232; Gomez-Aparicio L, 2008, J ECOL, V96, P447, DOI 10.1111/j.1365-2745.2007.01352.x; Gomez-Aparicio L, 2008, ECOL MONOGR, V78, P69, DOI 10.1890/06-2036.1; Gonzalez-Munoz N, 2014, BIOL INVASIONS, V16, P269, DOI 10.1007/s10530-013-0516-x; Gonzalez-Munoz N, 2013, PLANT SOIL, V363, P319, DOI 10.1007/s11104-012-1329-x; GRIME JP, 1977, AM NAT, V111, P1169, DOI 10.1086/283244; Grotkopp E, 2007, AM J BOT, V94, P526, DOI 10.3732/ajb.94.4.526; Hamerlynck EP, 2001, PHOTOSYNTHETICA, V39, P79, DOI 10.1023/A:1012448019931; Heisey RM, 2003, PLANT SOIL, V256, P85, DOI 10.1023/A:1026209614161; Herbarium W.A., 1998, FLORABASE W AUSTR FL; Hollister RD, 2005, ECOLOGY, V86, P1562, DOI 10.1890/04-0520; Hood WG, 2000, PLANT ECOL, V148, P105, DOI 10.1023/A:1009800327334; Hooper DU, 2010, J ECOL, V98, P764, DOI 10.1111/j.1365-2745.2010.01673.x; HU SY, 1979, ARNOLDIA, V39, P29; Iler AM, 2013, GLOBAL CHANGE BIOL, V19, P2348, DOI 10.1111/gcb.12246; Jung SC, 2009, J FOREST RES-JPN, V14, P101, DOI 10.1007/s10310-008-0109-1; Knapp LB, 2000, J TORREY BOT SOC, V127, P307, DOI 10.2307/3088649; Koretsune S, 2009, J FOREST RES-JPN, V14, P88, DOI 10.1007/s10310-009-0111-2; Kota NL, 2007, BIOL INVASIONS, V9, P197, DOI 10.1007/s10530-006-9026-4; Kowarik I, 2007, PERSPECT PLANT ECOL, V8, P207, DOI 10.1016/j.ppees.2007.03.002; Kozlowski TT., 1971, GROWTH DEV TREES; Kudo G, 2013, ECOLOGY, V94, P2311, DOI 10.1890/12-2003.1; Lara F., 1996, ESTUDIO VEGETACION R; Lloret F, 2005, J ECOL, V93, P512, DOI 10.1111/j.1365-2745.2005.00979.x; MacArthur R.H., 1967, THEORY ISLAND BIOGEO; MacDougall AS, 2009, J ECOL, V97, P609, DOI 10.1111/j.1365-2745.2009.01514.x; Mack RN, 2003, INT J PLANT SCI, V164, pS185, DOI 10.1086/368399; Masaka K, 2010, FOREST ECOL MANAG, V260, P780, DOI 10.1016/j.foreco.2010.05.036; Masaka K, 2009, J FOREST RES-JPN, V14, P167, DOI 10.1007/s10310-009-0117-9; Melbourne BA, 2007, ECOL LETT, V10, P77, DOI 10.1111/j.1461-0248.2006.00987.x; Milla R, 2006, PLANT BIOLOGY, V8, P103, DOI 10.1055/s-2005-872890; Nel JL, 2004, S AFR J SCI, V100, P53; Obeso JR, 2002, NEW PHYTOL, V155, P321, DOI 10.1046/j.1469-8137.2002.00477.x; Ooi MKJ, 2012, SEED SCI RES, V22, pS53, DOI 10.1017/S0960258511000407; Orshan G, 1989, PLANT PHENO MORPHOLO; Pan E., 1986, J ENV HORTICULTURE, V4, P1, DOI [10.24266/0738-2898-4.1.1, DOI 10.24266/0738-2898-4.1.1]; Parker IM, 1997, ECOLOGY, V78, P1457, DOI 10.1890/0012-9658(1997)078[1457:PLOCSS]2.0.CO;2; Perez Latorre AV, 2007, PHYTOCOENOLOGIA, V37, P239, DOI 10.1127/0340-269x/2007/0037-0239; PIANKA ER, 1970, AM NAT, V104, P592, DOI 10.1086/282697; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Piotto B, 2003, SEED PROPAGATION MED; Putterill J, 2004, BIOESSAYS, V26, P363, DOI 10.1002/bies.20021; Pysek Petr, 2007, V193, P97; Pysek P, 2012, GLOBAL CHANGE BIOL, V18, P1725, DOI 10.1111/j.1365-2486.2011.02636.x; RATHCKE B, 1985, ANNU REV ECOL SYST, V16, P179, DOI 10.1146/annurev.es.16.110185.001143; Rice SK, 2004, PLANT ECOL, V174, P97, DOI 10.1023/B:VEGE.0000046049.21900.5a; Richardson DM, 2006, PRESLIA, V78, P375; Rinn F., 1996, TSAP TIME SERIES ANA; Saumel I, 2013, PLANT ECOL, V214, P1257, DOI 10.1007/s11258-013-0249-z; Sanz Elorza M., 2004, ATLAS PLANTAS ALOCTO; Sargent RD, 2008, TRENDS ECOL EVOL, V23, P123, DOI 10.1016/j.tree.2007.11.003; Seabloom EW, 2003, P NATL ACAD SCI USA, V100, P13384, DOI 10.1073/pnas.1835728100; Seiwa K, 1996, VEGETATIO, V123, P51, DOI 10.1007/BF00044887; Tabacchi E, 2005, RIVER RES APPL, V21, P299, DOI 10.1002/rra.848; Tateno R, 2007, FOREST ECOL MANAG, V241, P84, DOI 10.1016/j.foreco.2006.12.026; Thompson K, 1992, SEEDS ECOLOGY REGENE, P231; Tickner DP, 2001, PROG PHYS GEOG, V25, P22, DOI 10.1191/030913301673178792; Toole E. H., 1946, JOUR AGRIC RES, V72, P201; van Kleunen M, 2010, ECOL LETT, V13, P947, DOI 10.1111/j.1461-0248.2010.01503.x; van Kleunen M, 2010, ECOL LETT, V13, P235, DOI 10.1111/j.1461-0248.2009.01418.x; Vila M, 2006, J BIOGEOGR, V33, P853, DOI 10.1111/j.1365-2699.2005.01430.x; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; Willis CG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008878; Wolkovich EM, 2011, FRONT ECOL ENVIRON, V9, P287, DOI 10.1890/100033; Wright SJ, 1995, J ECOL, V83, P937, DOI 10.2307/2261176; Zar J.H., 1996, BIOSTAT ANAL	109	26	26	3	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100254	10.1371/journal.pone.0100254	http://dx.doi.org/10.1371/journal.pone.0100254			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937651	gold, Green Published, Green Submitted			2022-12-27	WOS:000338503400097
J	Avriel, A; Wiessman, MP; Almog, Y; Perl, Y; Novack, V; Galante, O; Klein, M; Pencina, MJ; Douvdevani, A				Avriel, Avital; Wiessman, Maya Paryente; Almog, Yaniv; Perl, Yael; Novack, Victor; Galante, Ori; Klein, Moti; Pencina, Michael J.; Douvdevani, Amos			Admission Cell Free DNA Levels Predict 28-Day Mortality in Patients with Severe Sepsis in Intensive Care	PLOS ONE			English	Article							FREE PLASMA DNA; PROGNOSTIC MARKER; PROCALCITONIN; THERAPY; PROTEIN	Aim: The aim of the current study is to assess the mortality prediction accuracy of circulating cell-free DNA (CFD) level at admission measured by a new simplified method. Materials and Methods: CFD levels were measured by a direct fluorescence assay in severe sepsis patients on intensive care unit (ICU) admission. In-hospital and/or twenty eight day all-cause mortality was the primary outcome. Results: Out of 108 patients with median APACHE II of 20, 32.4% have died in hospital/or at 28-day. CFD levels were higher in decedents: median 3469.0 vs. 1659 ng/ml, p<0.001. In multivariable model APACHE II score and CFD (quartiles) were significantly associated with the mortality: odds ratio of 1.05, p = 0.049 and 2.57, p<0.001 per quartile respectively. C-statistics for the models was 0.79 for CFD and 0.68 for APACHE II. Integrated discrimination improvement (IDI) analyses showed that CFD and CFD+APACHE II score models had better discriminatory ability than APACHE II score alone. Conclusions: CFD level assessed by a new, simple fluorometric-assay is an accurate predictor of acute mortality among ICU patients with severe sepsis. Comparison of CFD to APACHE II score and Procalcitonin (PCT), suggests that CFD has the potential to improve clinical decision making.	[Avriel, Avital] Soroka Univ, Med Ctr, Dept Internal Med, Pulmonol Inst, Beer Sheva, Israel; [Avriel, Avital; Wiessman, Maya Paryente; Almog, Yaniv; Perl, Yael; Novack, Victor; Galante, Ori; Klein, Moti; Douvdevani, Amos] Ben Gurion Univ Negev, Fac Hlth Sci, Beer Sheva, Israel; [Wiessman, Maya Paryente; Perl, Yael; Novack, Victor] Soroka Univ, Med Ctr, Clin Res Ctr, Beer Sheva, Israel; [Almog, Yaniv] Soroka Univ, Med Ctr, Med Intens Care Unit, Beer Sheva, Israel; [Galante, Ori; Klein, Moti] Soroka Univ, Med Ctr, Gen Intens Care Unit, Beer Sheva, Israel; [Pencina, Michael J.] Duke Clin Res Inst, Durham, NC USA; [Douvdevani, Amos] Soroka Univ, Med Ctr, Beer Sheva, Israel	Ben Gurion University; Soroka Medical Center; Ben Gurion University; Ben Gurion University; Soroka Medical Center; Ben Gurion University; Soroka Medical Center; Ben Gurion University; Soroka Medical Center; Duke University; Ben Gurion University; Soroka Medical Center	Douvdevani, A (corresponding author), Soroka Univ, Med Ctr, Beer Sheva, Israel.	amosd@bgu.ac.il	Douvdevani, Amos/E-3803-2010; klein, moti/AAR-6552-2021	Douvdevani, Amos/0000-0002-0197-6481	Dr. Montague Robin Fleisher Kidney Transplant Unit Fund; Israeli Ministry of Health [3-00000-6087]	Dr. Montague Robin Fleisher Kidney Transplant Unit Fund; Israeli Ministry of Health	This work was supported by the "Dr. Montague Robin Fleisher Kidney Transplant Unit Fund" and by grant number 3-00000-6087 from the Chief Scientist, Israeli Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Calfee CS, 2012, AM J RESP CRIT CARE, V186, P2, DOI 10.1164/rccm.201205-0854ED; Chang CPY, 2003, CLIN CHIM ACTA, V327, P95, DOI 10.1016/S0009-8981(02)00337-6; Coimbra S, 2014, BRIT J DERMATOL, V170, P939, DOI 10.1111/bjd.12738; Czeiger D, 2011, AM J CLIN PATHOL, V135, P264, DOI 10.1309/AJCP4RK2IHVKTTZV; Dwivedi DJ, 2012, CRIT CARE, V16, DOI 10.1186/cc11466; Moreira VG, 2010, ANN CLIN BIOCHEM, V47, P253, DOI 10.1258/acb.2010.009173; Goldshtein H, 2009, ANN CLIN BIOCHEM, V46, P488, DOI 10.1258/acb.2009.009002; Huttunen R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021700; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kohlova M, 2013, HEMODIAL INT, V17, P664, DOI 10.1111/hdi.12055; Kumar G, 2011, CHEST, V140, P1223, DOI 10.1378/chest.11-0352; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Lichtenstern C, 2012, CURR OPIN INFECT DIS, V25, P328, DOI 10.1097/QCO.0b013e3283522038; Lo YMD, 2000, CLIN CHEM, V46, P319; McDonald B, 2012, CELL HOST MICROBE, V12, P324, DOI 10.1016/j.chom.2012.06.011; Ohayon S, 2012, J NEUROTRAUM, V29, P261, DOI 10.1089/neu.2011.1938; Okkonen M, 2011, CRIT CARE, V15, DOI 10.1186/cc10357; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Rhodes A, 2006, CRIT CARE, V10, DOI 10.1186/cc4894; Rhodes A, 2012, CRIT CARE, V16, DOI 10.1186/cc11508; Riedel S, 2012, DIAGN MICR INFEC DIS, V73, P221, DOI 10.1016/j.diagmicrobio.2012.05.002; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Saukkonen K, 2008, CLIN CHEM, V54, P1000, DOI 10.1373/clinchem.2007.101030; Shimony Avi, 2010, Acute Card Care, V12, P109, DOI 10.3109/17482941.2010.513732; Tovbin D, 2012, NEPHROL DIAL TRANSPL, V27, P3929, DOI 10.1093/ndt/gfs255; Tschaikowsky K, 2011, J CRIT CARE, V26, P54, DOI 10.1016/j.jcrc.2010.04.011; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Wijeratne S, 2004, ANN NY ACAD SCI, V1022, P232, DOI 10.1196/annals.1318.036	32	44	45	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100514	10.1371/journal.pone.0100514	http://dx.doi.org/10.1371/journal.pone.0100514			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955978	Green Submitted, Green Published, gold			2022-12-27	WOS:000338917900058
J	Ouyang, SH; Zhang, D; Han, J; Zhao, XJ; Cui, Y; Song, W; Huo, NX; Liang, Y; Xie, JZ; Wang, ZZ; Wu, QH; Chen, YX; Lu, P; Zhang, DY; Wang, LL; Sun, H; Yang, TM; Keeble-Gagnere, G; Appels, R; Dolezel, J; Ling, HQ; Luo, MC; Gu, YQ; Sun, QX; Liu, ZY				Ouyang, Shuhong; Zhang, Dong; Han, Jun; Zhao, Xiaojie; Cui, Yu; Song, Wei; Huo, Naxin; Liang, Yong; Xie, Jingzhong; Wang, Zhenzhong; Wu, Qiuhong; Chen, Yong-Xing; Lu, Ping; Zhang, De-Yun; Wang, Lili; Sun, Hua; Yang, Tsomin; Keeble-Gagnere, Gabriel; Appels, Rudi; Dolezel, Jaroslav; Ling, Hong-Qing; Luo, Mingcheng; Gu, Yongqiang; Sun, Qixin; Liu, Zhiyong			Fine Physical and Genetic Mapping of Powdery Mildew Resistance Gene MlIW172 Originating from Wild Emmer (Triticum dicoccoides)	PLOS ONE			English	Article							CHROMOSOME BIN MAP; SEQUENCE TAG LOCI; LEAF RUST; AESTIVUM L.; AEGILOPS-TAUSCHII; WHOLE-GENOME; DRAFT GENOME; WHEAT; IDENTIFICATION; RICE	Powdery mildew, caused by Blumeria graminis f. sp. tritici, is one of the most important wheat diseases in the world. In this study, a single dominant powdery mildew resistance gene MlIW172 was identified in the IW172 wild emmer accession and mapped to the distal region of chromosome arm 7AL (bin7AL-16-0.86-0.90) via molecular marker analysis. MlIW172 was closely linked with the RFLP probe Xpsr680-derived STS marker Xmag2185 and the EST markers BE405531 and BE637476. This suggested that MlIW172 might be allelic to the Pm1 locus or a new locus closely linked to Pm1. By screening genomic BAC library of durum wheat cv. Langdon and 7AL-specific BAC library of hexaploid wheat cv. Chinese Spring, and after analyzing genome scaffolds of Triticum urartu containing the marker sequences, additional markers were developed to construct a fine genetic linkage map on the MlIW172 locus region and to delineate the resistance gene within a 0.48 cM interval. Comparative genetics analyses using ESTs and RFLP probe sequences flanking the MlIW172 region against other grass species revealed a general co-linearity in this region with the orthologous genomic regions of rice chromosome 6, Brachypodium chromosome 1, and sorghum chromosome 10. However, orthologous resistance gene-like RGA sequences were only present in wheat and Brachypodium. The BAC contigs and sequence scaffolds that we have developed provide a framework for the physical mapping and map-based cloning of MlIW172.	[Ouyang, Shuhong; Zhang, Dong; Han, Jun; Zhao, Xiaojie; Cui, Yu; Song, Wei; Liang, Yong; Xie, Jingzhong; Wang, Zhenzhong; Wu, Qiuhong; Chen, Yong-Xing; Lu, Ping; Zhang, De-Yun; Wang, Lili; Yang, Tsomin; Sun, Qixin; Liu, Zhiyong] China Agr Univ, Key Lab Crop Heterosis Res & Utilizat, Beijing Key Lab Crop Genet Improvement, State Key Lab Agrobiotechnol,Minist Educ, Beijing 100094, Peoples R China; [Han, Jun] Beijing Agr Univ, Beijing 100094, Peoples R China; [Song, Wei] Beijing Acad Agr & Forestry Sci, Maize Res Ctr, Beijing, Peoples R China; [Huo, Naxin; Gu, Yongqiang] USDA ARS, Western Reg Res Ctr, Albany, CA 94710 USA; [Sun, Hua; Ling, Hong-Qing] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Cell & Chromosome Engn, Beijing, Peoples R China; [Keeble-Gagnere, Gabriel; Appels, Rudi] Murdoch Univ, Perth, WA, Australia; [Dolezel, Jaroslav] Ctr Plant Struct & Funct Genom, Inst Expt Bot, Olomouc, Czech Republic; [Luo, Mingcheng] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA	China Agricultural University; Beijing University of Agriculture; Beijing Academy of Agriculture & Forestry; United States Department of Agriculture (USDA); Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Murdoch University; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; University of California System; University of California Davis	Han, J (corresponding author), China Agr Univ, Key Lab Crop Heterosis Res & Utilizat, Beijing Key Lab Crop Genet Improvement, State Key Lab Agrobiotechnol,Minist Educ, Beijing 100094, Peoples R China.	hanjun4226@163.com; zhiyongliu@cau.edu.cn	Sun, Hua/O-6729-2018; Ling, Hong-Qing/ABC-9451-2020; Dolezel, Jaroslav/B-7716-2008; Xie, Jingzhong/AAF-5899-2020	Sun, Hua/0000-0003-2169-0808; Dolezel, Jaroslav/0000-0002-6263-0492; Liu liu, Zhiyong zhi yong/0000-0002-6958-5233; Luo, Ming-Cheng/0000-0002-9744-5887	Ministry of Agriculture [2014ZX08009-006B]; Ministry of Science & Technology of China [2011AA100104]; National Science Foundation of China [31030056]; Ministry of Education of China [111-2-03]; Chinese Scholarship Council	Ministry of Agriculture(Gida Tarim Ve Hayvancilik Bakanligi); Ministry of Science & Technology of China(Ministry of Science and Technology, China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); Chinese Scholarship Council(China Scholarship Council)	This work was financially supported by Ministry of Agriculture (2014ZX08009-006B), Ministry of Science & Technology of China (2011AA100104), the National Science Foundation of China (31030056), Ministry of Education of China (111-2-03), and Chinese Scholarship Council Fellowship (to Shuhong Ouyang). The funders had no role in study design, data collection and analysis,	Abrouk M, 2010, TRENDS PLANT SCI, V15, P479, DOI 10.1016/j.tplants.2010.06.001; Akhunov ED, 2013, PLANT PHYSIOL, V161, P252, DOI 10.1104/pp.112.205161; Allen GC, 2006, NAT PROTOC, V1, P2320, DOI 10.1038/nprot.2006.384; [Anonymous], 2014, ANN WHEAT NEWSL; Ben-David R, 2010, THEOR APPL GENET, V121, P499, DOI 10.1007/s00122-010-1326-5; Bossolini E, 2007, PLANT J, V49, P704, DOI 10.1111/j.1365-313X.2006.02991.x; Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; Cenci A, 2003, THEOR APPL GENET, V107, P931, DOI 10.1007/s00122-003-1331-z; Chantret N, 2008, J MOL EVOL, V66, P138, DOI 10.1007/s00239-008-9066-8; Chhuneja P, 2012, THEOR APPL GENET, V124, P1051, DOI 10.1007/s00122-011-1768-4; Cloutier S, 2007, PLANT MOL BIOL, V65, P93, DOI 10.1007/s11103-007-9201-8; Dong LL, 2012, MOL GENET GENOMICS, V287, P855, DOI 10.1007/s00438-012-0721-9; Erayman M, 2004, NUCLEIC ACIDS RES, V32, P3546, DOI 10.1093/nar/gkh639; Everts KL, 2001, PLANT DIS, V85, P423, DOI 10.1094/PDIS.2001.85.4.423; Feuillet C, 2003, P NATL ACAD SCI USA, V100, P15253, DOI 10.1073/pnas.2435133100; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Goyal Aakash, 2005, Functional & Integrative Genomics, V5, P260, DOI 10.1007/s10142-005-0146-1; Gupta P K, 2008, Int J Plant Genomics, V2008, P896451, DOI 10.1155/2008/896451; Guyot Romain, 2004, Functional & Integrative Genomics, V4, P47, DOI 10.1007/s10142-004-0103-4; Hossain KG, 2004, GENETICS, V168, P687, DOI 10.1534/genetics.104.034850; Huang L, 2003, GENETICS, V164, P655; Huo NX, 2009, PLANT MOL BIOL, V70, P47, DOI 10.1007/s11103-009-9456-3; Ji XL, 2008, EUPHYTICA, V159, P385, DOI 10.1007/s10681-007-9540-1; Jia JZ, 2013, NATURE, V496, P91, DOI 10.1038/nature12028; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Lazo GR, 2004, GENETICS, V168, P585, DOI 10.1534/genetics.104.034777; Li N, 2014, MOL BREEDING, V33, P669, DOI 10.1007/s11032-013-9983-0; Ling HQ, 2013, NATURE, V496, P87, DOI 10.1038/nature11997; Liu Q, 2000, NUCLEIC ACIDS RES, V28, P940, DOI 10.1093/nar/28.4.940; Liu Ren-Hu, 2003, Yichuan, V25, P317; Liu ZJ, 2012, THEOR APPL GENET, V124, P1041, DOI 10.1007/s00122-011-1767-5; Luo MC, 2013, P NATL ACAD SCI USA, V110, P7940, DOI 10.1073/pnas.1219082110; MA ZQ, 1994, GENOME, V37, P871, DOI 10.1139/g94-123; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Maxwell JJ, 2009, THEOR APPL GENET, V119, P1489, DOI 10.1007/s00122-009-1150-y; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; Miranda LM, 2007, CROP SCI, V47, P2323, DOI 10.2135/cropsci2007.01.0053; Mohler V, 2013, J APPL GENET, V54, P259, DOI 10.1007/s13353-013-0158-9; Neu C, 2002, GENOME, V45, P737, DOI [10.1139/g02-040, 10.1139/G02-040]; Nevo E., 2002, EVOLUTION WILD EMMER; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Peng J. H., 2005, Functional & Integrative Genomics, V5, P80, DOI 10.1007/s10142-004-0128-8; Periyannan S, 2013, SCIENCE, V341, P786, DOI 10.1126/science.1239028; Perugini LD, 2008, THEOR APPL GENET, V116, P417, DOI 10.1007/s00122-007-0679-x; Philippe R, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-47; Pont C, 2013, PLANT J, V76, P1030, DOI 10.1111/tpj.12366; Qi LL, 2004, GENETICS, V168, P701, DOI 10.1534/genetics.104.034868; Qiu JW, 2007, THEOR APPL GENET, V115, P159, DOI 10.1007/s00122-007-0551-z; Qiu YC, 2005, THEOR APPL GENET, V111, P1524, DOI 10.1007/s00122-005-0081-5; Quraishi UM, 2011, FUNCT INTEGR GENOMIC, V11, P71, DOI 10.1007/s10142-010-0183-2; Roder MS, 1998, GENETICS, V149, P2007; Salse J, 2008, PLANT CELL, V20, P11, DOI 10.1105/tpc.107.056309; SCHNEIDER DM, 1991, PLANT BREEDING, V107, P161, DOI 10.1111/j.1439-0523.1991.tb00545.x; SEARS ER, 1969, CROP SCI, V9, P96, DOI 10.2135/cropsci1969.0011183X000900010033x; Singrun C, 2003, THEOR APPL GENET, V106, P1420, DOI 10.1007/s00122-002-1187-7; Singrun C, 2004, THEOR APPL GENET, V109, P210, DOI 10.1007/s00122-004-1619-7; Srnic G, 2005, CROP SCI, V45, P1578, DOI 10.2135/cropsci2004.0530; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wang JR, 2013, NEW PHYTOL, V198, P925, DOI 10.1111/nph.12164; Wu HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084691; Xiao MG, 2013, THEOR APPL GENET, V126, P1397, DOI 10.1007/s00122-013-2060-6; Xie ChaoJie, 2003, Journal of Triticeae Crops, V23, P39; Xie WL, 2012, THEOR APPL GENET, V124, P911, DOI 10.1007/s00122-011-1756-8; Xue F, 2012, THEOR APPL GENET, V124, P1549, DOI 10.1007/s00122-012-1809-7; Yahiaoui N, 2004, PLANT J, V37, P528, DOI 10.1046/j.1365-313X.2003.01977.x; Yao G, 2007, THEOR APPL GENET, V114, P351, DOI 10.1007/s00122-006-0438-4; You FM, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-331; You FM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-253; Zhang XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057885	70	26	26	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100160	10.1371/journal.pone.0100160	http://dx.doi.org/10.1371/journal.pone.0100160			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955773	gold, Green Published, Green Submitted			2022-12-27	WOS:000338917900029
J	Feng, XJ; Scott, A; Wang, Y; Wang, L; Zhao, YQ; Doerner, S; Satake, M; Croniger, CM; Wang, ZH				Feng, Xiujing; Scott, Anthony; Wang, Yong; Wang, Lan; Zhao, Yiqing; Doerner, Stephanie; Satake, Masanobu; Croniger, Colleen M.; Wang, Zhenghe			PTPRT Regulates High-Fat Diet-Induced Obesity and Insulin Resistance	PLOS ONE			English	Article							RETINOL-BINDING-PROTEIN; NEUROPEPTIDE-Y; GLUCOSE-PRODUCTION; ABDOMINAL OBESITY; LEPTIN RESISTANCE; ENERGY-BALANCE; MOUSE STRAINS; RECEPTOR; MICE; IDENTIFICATION	Obesity is a risk factor for many human diseases. However, the underlying molecular causes of obesity are not well understood. Here, we report that protein tyrosine phosphatase receptor T (PTPRT) knockout mice are resistant to high-fat diet-induced obesity. Those mice avoid many deleterious side effects of high-fat diet-induced obesity, displaying improved peripheral insulin sensitivity, lower blood glucose and insulin levels. Compared to wild type littermates, PTPRT knockout mice show reduced food intake. Consistently, STAT3 phosphorylation is up-regulated in the hypothalamus of PTPRT knockout mice. These studies implicate PTPRT-modulated STAT3 signaling in the regulation of high-fat diet-induced obesity.	[Feng, Xiujing; Scott, Anthony; Wang, Yong; Zhao, Yiqing; Doerner, Stephanie; Wang, Zhenghe] Case Western Reserve Univ, Dept Genet & Genome Sci, Cleveland, OH 44106 USA; [Feng, Xiujing; Scott, Anthony; Wang, Yong; Zhao, Yiqing; Wang, Zhenghe] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Wang, Lan; Croniger, Colleen M.] Case Western Reserve Univ, Dept Nutr, Cleveland, OH 44106 USA; [Satake, Masanobu] Tohoku Univ, Dept Mol Immunol, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Wang, Zhenghe] Cleveland Clin Fdn, Genom Med Inst, Cleveland, OH 44195 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Tohoku University; Cleveland Clinic Foundation	Wang, ZH (corresponding author), Case Western Reserve Univ, Dept Genet & Genome Sci, Cleveland, OH 44106 USA.	zxw22@case.edu		Scott, Anthony/0000-0003-0644-1790; Wang, Zhenghe/0000-0003-1546-1080	National Institutes of Health [R01CA127590, P50CA150964, U24 DK059630, U24-DK76174]; NATIONAL CANCER INSTITUTE [P50CA150964, R01CA127590, P30CA043703] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK076174, U24DK059630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding came from the National Institutes of Health R01CA127590, P50CA150964, U24 DK059630 and U24-DK76174. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2011, J CLIN INVEST, V121, P2076, DOI 10.1172/JCI58719; Bagherian Ali, 2010, J Oral Sci, V52, P397; Bates SH, 2003, NATURE, V421, P856, DOI 10.1038/nature01388; Beck B, 2006, PHILOS T R SOC B, V361, P1159, DOI 10.1098/rstb.2006.1855; Bence KK, 2006, NAT MED, V12, P917, DOI 10.1038/nm1435; Berry DC, 2013, J BIOL CHEM, V288, P24528, DOI 10.1074/jbc.M113.484014; Bi S, 2012, NEUROPEPTIDES, V46, P309, DOI 10.1016/j.npep.2012.09.002; Borecki I B, 1994, Obes Res, V2, P213; Bray GA, 2010, CURR OPIN LIPIDOL, V21, P51, DOI 10.1097/MOL.0b013e3283346ca2; Brothers SP, 2010, EMBO MOL MED, V2, P429, DOI 10.1002/emmm.201000100; Buchner DA, 2012, MAMM GENOME, V23, P431, DOI 10.1007/s00335-012-9400-8; Carey M, 2013, J BIOL CHEM, V288, P34981, DOI 10.1074/jbc.R113.506782; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Elbein SC, 2011, DIABETES, V60, P1019, DOI 10.2337/db10-1270; Elmquist JK, 1998, NAT NEUROSCI, V1, P445, DOI 10.1038/2164; Flegal KM, 2007, JAMA-J AM MED ASSOC, V298, P2028, DOI 10.1001/jama.298.17.2028; Gerozissis K, 2008, EUR J PHARMACOL, V585, P38, DOI 10.1016/j.ejphar.2008.01.050; Han RJ, 2012, FASEB J, V26, P3528, DOI 10.1096/fj.12-203943; Hariri N, 2010, NUTR RES REV, V23, P270, DOI 10.1017/S0954422410000168; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Hussain AH, 2010, J DIABETOLOGY, V2; Jandacek RJ, 2004, GASTROENTEROLOGY, V127, P139, DOI 10.1053/j.gastro.2004.04.007; Jequier E, 2002, INT J OBESITY, V26, pS12, DOI 10.1038/sj.ijo.0802123; Koch L, 2008, J CLIN INVEST, V118, P2132, DOI 10.1172/JCI31073; Kuo LE, 2007, NAT MED, V13, P803, DOI 10.1038/nm1611; Lam CKL, 2011, DIABETES, V60, P107, DOI 10.2337/db10-0994; Lee JH, 1999, AM J HUM GENET, V64, P196, DOI 10.1086/302195; Lembertas AV, 1997, J CLIN INVEST, V100, P1240, DOI 10.1172/JCI119637; Loh K, 2011, CELL METAB, V14, P684, DOI 10.1016/j.cmet.2011.09.011; Marwarha G, 2013, FASEB J; Marwarha G, 2014, FASEB J, V28, P26, DOI 10.1096/fj.13-234310; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Millward CA, 2010, J LIPID RES, V51, P1452, DOI 10.1194/jlr.M005363; Munzberg H, 2005, CELL MOL LIFE SCI, V62, P642, DOI 10.1007/s00018-004-4432-1; Obici S, 2002, NAT MED, V8, P1376, DOI 10.1038/nm798; Pagotto U, 2009, DIABETES CARE, V32, pS174, DOI 10.2337/dc09-S305; Prince A, 2013, ADV EXP MED BIOL, V789, P323, DOI 10.1007/978-1-4614-7411-1_43; Rossmeisl M, 2003, DIABETES, V52, P1958, DOI 10.2337/diabetes.52.8.1958; Ruohonen ST, 2008, DIABETES, V57, P1517, DOI 10.2337/db07-0722; Ruohonen Suvi T, 2012, Int J Pept, V2012, P452524, DOI 10.1155/2012/452524; Schreyer SA, 1998, ATHEROSCLEROSIS, V136, P17, DOI 10.1016/S0021-9150(97)00165-2; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; SURWIT RS, 1991, DIABETES, V40, P82, DOI 10.2337/diabetes.40.1.82; Tinsley FC, 2004, OBES RES, V12, P150, DOI 10.1038/oby.2004.20; Vaisse C, 1996, NAT GENET, V14, P95, DOI 10.1038/ng0996-95; Visel A, 2007, PLOS GENET, V3, P1867, DOI 10.1371/journal.pgen.0030178; Warne JP, 2007, NAT MED, V13, P781, DOI 10.1038/nm0707-781; WEST DB, 1992, AM J PHYSIOL, V262, pR1025, DOI 10.1152/ajpregu.1992.262.6.R1025; Williams KW, 2012, NAT NEUROSCI, V15, P1350, DOI 10.1038/nn.3217; Xu E, 2013, REV ENDOCR METAB DIS; Zhang XD, 2007, P NATL ACAD SCI USA, V104, P4060, DOI 10.1073/pnas.0611665104; Zhao YQ, 2010, P NATL ACAD SCI USA, V107, P2592, DOI 10.1073/pnas.0914884107	52	10	10	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100783	10.1371/journal.pone.0100783	http://dx.doi.org/10.1371/journal.pone.0100783			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949727	Green Submitted, Green Published, gold			2022-12-27	WOS:000338276300113
J	Sheridan, GK; Moeendarbary, E; Pickering, M; O'Connor, JJ; Murphy, KJ				Sheridan, Graham K.; Moeendarbary, Emad; Pickering, Mark; O'Connor, John J.; Murphy, Keith J.			Theta-Burst Stimulation of Hippocampal Slices Induces Network-Level Calcium Oscillations and Activates Analogous Gene Transcription to Spatial Learning	PLOS ONE			English	Article							LONG-TERM POTENTIATION; NF-KAPPA-B; METABOTROPIC GLUTAMATE-RECEPTOR; ASTROCYTES IN-SITU; OPTICAL QUANTAL ANALYSIS; CAM KINASE-II; SYNAPTIC PLASTICITY; CA2+ OSCILLATIONS; NMDA RECEPTORS; DENTATE GYRUS	Over four decades ago, it was discovered that high-frequency stimulation of the dentate gyrus induces long-term potentiation (LTP) of synaptic transmission. LTP is believed to underlie how we process and code external stimuli before converting it to salient information that we store as 'memories'. It has been shown that rats performing spatial learning tasks display theta-frequency (3-12 Hz) hippocampal neural activity. Moreover, administering theta-burst stimulation (TBS) to hippocampal slices can induce LTP. TBS triggers a sustained rise in intracellular calcium [Ca2+](i) in neurons leading to new protein synthesis important for LTP maintenance. In this study, we measured TBS-induced [Ca2+](i) oscillations in thousands of cells at increasing distances from the source of stimulation. Following TBS, a calcium wave propagates radially with an average speed of 5.2 mu m/s and triggers multiple and regular [Ca2+](i) oscillations in the hippocampus. Interestingly, the number and frequency of [Ca2+](i) fluctuations post-TBS increased with respect to distance from the electrode. During the post-tetanic phase, 18% of cells exhibited 3 peaks in [Ca2+](i) with a frequency of 17 mHz, whereas 2.3% of cells distributed further from the electrode displayed 8 [Ca2+](i) oscillations at 33 mHz. We suggest that these observed [Ca2+](i) oscillations could lead to activation of transcription factors involved in synaptic plasticity. In particular, the transcription factor, NF-kappa B, has been implicated in memory formation and is up-regulated after LTP induction. We measured increased activation of NF-kappa B 30 min post-TBS in CA1 pyramidal cells and also observed similar temporal up-regulation of NF-kappa B levels in CA1 neurons following water maze training in rats. Therefore, TBS of hippocampal slice cultures in vitro can mimic the cell type-specific up-regulations in activated NF-kappa B following spatial learning in vivo. This indicates that TBS may induce similar transcriptional changes to spatial learning and that TBS-triggered [Ca2+](i) oscillations could activate memory-associated gene expression.	[Sheridan, Graham K.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Moeendarbary, Emad] Univ Cambridge, Cambridge, England; [Pickering, Mark] Univ Coll Dublin, Hlth Sci Ctr, Sch Med & Med Sci, Dublin 2, Ireland; [O'Connor, John J.] Univ Coll Dublin, UCD Sch Biomol & Biomed Sci, Conway Inst, Dublin 2, Ireland; [Murphy, Keith J.] Univ Coll Dublin, Conway Inst, Neurotherapeut Res Grp, UCD Sch Biomol & Biomed Sci, Dublin 2, Ireland	University of Cambridge; University of Cambridge; University College Dublin; University College Dublin; University College Dublin	Sheridan, GK (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England.	gks28@cam.ac.uk		O'Connor, John/0000-0001-8229-8602; , Graham/0000-0002-8493-2651; Moeendarbary, Emad/0000-0002-7019-3907; Pickering, Mark/0000-0002-2454-2897	Science Foundation Ireland [03/IN3/B403C, 07/IN.1/B1322]; University of Cambridge Herchel Smith Postdoctoral Fellowship	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); University of Cambridge Herchel Smith Postdoctoral Fellowship	This work was supported by a research cluster award from Science Foundation Ireland (03/IN3/B403C and 07/IN.1/B1322). E. Moeendarbary is supported by University of Cambridge Herchel Smith Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguado F, 2002, J NEUROSCI, V22, P9430; Albensi BC, 2007, EXP NEUROL, V204, P1, DOI 10.1016/j.expneurol.2006.12.009; Ashpole NM, 2012, J BIOL CHEM, V287, P8495, DOI 10.1074/jbc.M111.323915; Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; Bernardinelli Y, 2011, J NEUROSCI, V31, P8905, DOI 10.1523/JNEUROSCI.6341-10.2011; Bezzi P, 2004, NAT NEUROSCI, V7, P613, DOI 10.1038/nn1246; Bikbaev A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002155; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Borroni AM, 2000, J NEUROSCI, V20, P9272; CAESER M, 1991, J COMP NEUROL, V307, P87, DOI 10.1002/cne.903070109; Cali C, 2008, J NEUROIMMUNOL, V198, P82, DOI 10.1016/j.jneuroim.2008.04.015; Cali C, 2010, J NEUROIMMUNOL, V224, P13, DOI 10.1016/j.jneuroim.2010.05.004; Carter AG, 2002, J NEUROSCI, V22, P21, DOI 10.1523/JNEUROSCI.22-01-00021.2002; Cavallaro S, 2002, P NATL ACAD SCI USA, V99, P16279, DOI 10.1073/pnas.242597199; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Domercq M, 2006, J BIOL CHEM, V281, P30684, DOI 10.1074/jbc.M606429200; DUPONT G, 1994, BIOPHYS J, V67, P2191, DOI 10.1016/S0006-3495(94)80705-2; DUPONT G, 1993, CELL CALCIUM, V14, P311, DOI 10.1016/0143-4160(93)90052-8; Dupont G, 2003, CELL CALCIUM, V34, P485, DOI 10.1016/S0143-4160(03)00152-0; Dupont G, 1998, BIOESSAYS, V20, P607, DOI 10.1002/(SICI)1521-1878(199808)20:8<607::AID-BIES2>3.3.CO;2-2; Emptage NJ, 2003, NEURON, V38, P797, DOI 10.1016/S0896-6273(03)00325-8; FREEMAN FM, 1995, NEUROBIOL LEARN MEM, V63, P291, DOI 10.1006/nlme.1995.1034; Freudenthal R, 2005, EUR J NEUROSCI, V21, P2845, DOI 10.1111/j.1460-9568.2005.04126.x; Freudenthal R, 2004, HIPPOCAMPUS, V14, P677, DOI 10.1002/hipo.20020; FREY U, 1988, BRAIN RES, V452, P57, DOI 10.1016/0006-8993(88)90008-X; Giaume C, 1998, GLIA, V24, P50, DOI 10.1002/(SICI)1098-1136(199809)24:1<50::AID-GLIA6>3.0.CO;2-4; Gillespie JM, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00027; Gogolla N, 2006, NAT PROTOC, V1, P2452, DOI 10.1038/nprot.2006.180; Graupner M, 2012, P NATL ACAD SCI USA, V109, P3991, DOI 10.1073/pnas.1109359109; GROVER LM, 1994, SYNAPSE, V16, P66, DOI 10.1002/syn.890160108; GROVER LM, 1990, NATURE, V347, P477, DOI 10.1038/347477a0; Guthrie PB, 1999, J NEUROSCI, V19, P520, DOI 10.1523/jneurosci.19-02-00520.1999; GUTHRIE PB, 1991, NATURE, V354, P76, DOI 10.1038/354076a0; Hamilton TJ, 2010, P NATL ACAD SCI USA, V107, P18185, DOI 10.1073/pnas.1011558107; Hasselmo ME, 2005, HIPPOCAMPUS, V15, P936, DOI 10.1002/hipo.20116; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; HILL AJ, 1978, EXP NEUROL, V62, P282, DOI 10.1016/0014-4886(78)90058-4; Honsek SD, 2012, HIPPOCAMPUS, V22, P29, DOI 10.1002/hipo.20843; Hu QDeshpandeS, 1999, J BIOL CHEM, V274; Huang YHH, 2004, J NEUROSCI, V24, P4551, DOI 10.1523/JNEUROSCI.5217-03.2004; Igaz LM, 2002, J NEUROSCI, V22, P6781; Ismailov I, 2004, J NEUROSCI, V24, P9847, DOI 10.1523/JNEUROSCI.0738-04.2004; Jourdain P, 2007, NAT NEUROSCI, V10, P331, DOI 10.1038/nn1849; Kaltschmidt B, 2006, MOL CELL BIOL, V26, P2936, DOI 10.1128/MCB.26.8.2936-2946.2006; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; KANDEL ER, 1961, J NEUROPHYSIOL, V24, P243, DOI 10.1152/jn.1961.24.3.243; Kato HK, 2012, J PHYSIOL-LONDON, V590, P3019, DOI 10.1113/jphysiol.2012.232942; Kratzer S, 2012, ANESTHESIOLOGY, V116, P673, DOI 10.1097/ALN.0b013e3182475d66; LARSON J, 1986, BRAIN RES, V368, P347, DOI 10.1016/0006-8993(86)90579-2; Levenson JM, 2004, J NEUROSCI, V24, P3933, DOI 10.1523/JNEUROSCI.5646-03.2004; Leybaert L, 2012, PHYSIOL REV, V92, P1359, DOI 10.1152/physrev.00029.2011; Li L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043810; Li WH, 1998, NATURE, V392, P936, DOI 10.1038/31965; Lisman J, 2012, NAT REV NEUROSCI, V13, P169, DOI 10.1038/nrn3192; MacDonald John F., 2006, Critical Reviews in Neurobiology, V18, P71; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Martin SJ, 2002, HIPPOCAMPUS, V12, P609, DOI 10.1002/hipo.10107; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Meberg PJ, 1996, MOL BRAIN RES, V38, P179, DOI 10.1016/0169-328X(95)00229-L; Meffert MK, 2003, NAT NEUROSCI, V6, P1072, DOI 10.1038/nn1110; Meiri N, 1998, BRAIN RES, V789, P48, DOI 10.1016/S0006-8993(97)01528-X; MULLER W, 1991, NATURE, V354, P73, DOI 10.1038/354073a0; Nett WJ, 2002, J NEUROPHYSIOL, V87, P528, DOI 10.1152/jn.00268.2001; O'Leary DM, 1999, PROG NEURO-PSYCHOPH, V23, P133, DOI 10.1016/S0278-5846(98)00095-5; O'Mahony A, 2006, MOL CELL BIOL, V26, P7283, DOI 10.1128/MCB.00510-06; O'Riordan KJ, 2006, J NEUROSCI, V26, P4870, DOI 10.1523/JNEUROSCI.4527-05.2006; O'Sullivan NC, 2007, J NEUROCHEM, V101, P1085, DOI 10.1111/j.1471-4159.2006.04418.x; O'Sullivan NC, 2012, TRANSCRIPTION FACTORS CREB AND NF-KB: INVOLVEMENT IN SYNAPTIC PLASTICITY AND MEMORY FORMATION, P43; OCONNOR JJ, 1994, NATURE, V367, P557, DOI 10.1038/367557a0; Otto T, 1991, Hippocampus, V1, P181, DOI 10.1002/hipo.450010206; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Pascual O, 2012, P NATL ACAD SCI USA, V109, pE197, DOI 10.1073/pnas.1111098109; PASTI L, 1995, J BIOL CHEM, V270, P15203, DOI 10.1074/jbc.270.25.15203; Pasti L, 1997, J NEUROSCI, V17, P7817; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Piochon Claire, 2010, J Neurosci, V30, P15330, DOI 10.1523/JNEUROSCI.4344-10.2010; Pizzo P, 2001, J NEUROCHEM, V79, P98, DOI 10.1046/j.1471-4159.2001.00539.x; Poser S, 2001, INT J DEV NEUROSCI, V19, P387, DOI 10.1016/S0736-5748(00)00094-0; RANCK JB, 1973, EXP NEUROL, V41, P462, DOI 10.1016/0014-4886(73)90290-2; Raymond CR, 2006, J PHYSIOL-LONDON, V570, P97, DOI 10.1113/jphysiol.2005.098947; Romano A, 2006, EUR J NEUROSCI, V24, P1507, DOI 10.1111/j.1460-9568.2006.05022.x; Rusakov DA, 2011, NEUROSCIENTIST, V17, P513, DOI DOI 10.1177/1073858410387304; Ryan MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040538; Santello M, 2011, NEURON, V69, P988, DOI 10.1016/j.neuron.2011.02.003; Schipke CG, 2001, FASEB J, V15, P255, DOI 10.1096/fj.01-0514fje; Sergeeva M, 2003, CELL CALCIUM, V33, P283, DOI 10.1016/S0143-4160(03)00011-3; Sheridan GK, 2007, LEARN MEMORY, V14, P525, DOI 10.1101/lm.590007; Song SS, 2012, J BIOL CHEM, V287, P40246, DOI 10.1074/jbc.M112.417154; STAUBLI U, 1987, BRAIN RES, V435, P227, DOI 10.1016/0006-8993(87)91605-2; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Baez MV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055244; Ward B, 2006, NEURON, V52, P649, DOI 10.1016/j.neuron.2006.10.007; Wellmann H, 2001, J BIOL CHEM, V276, P11821, DOI 10.1074/jbc.M009253200; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Woodside BL, 2004, NEUROBIOL LEARN MEM, V81, P105, DOI 10.1016/j.nlm.2003.10.003; Yuan Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020486	98	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100546	10.1371/journal.pone.0100546	http://dx.doi.org/10.1371/journal.pone.0100546			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950243	Green Published, Green Submitted, gold			2022-12-27	WOS:000338276300087
J	Weber, M; Bujak, E; Putelli, A; Villa, A; Matasci, M; Gualandi, L; Hemmerle, T; Wulhfard, S; Neri, D				Weber, Marcel; Bujak, Emil; Putelli, Alessia; Villa, Alessandra; Matasci, Mattia; Gualandi, Laura; Hemmerle, Teresa; Wulhfard, Sarah; Neri, Dario			A Highly Functional Synthetic Phage Display Library Containing over 40 Billion Human Antibody Clones	PLOS ONE			English	Article							AFFINITY HUMAN-ANTIBODIES; SINGLE-CHAIN FV; TENASCIN-C; MONOCLONAL-ANTIBODIES; STRUCTURAL REPERTOIRE; CANONICAL STRUCTURES; CANCER-THERAPY; DOMAIN; DESIGN; IMMUNOCYTOKINE	Several synthetic antibody phage display libraries have been created and used for the isolation of human monoclonal antibodies. The performance of antibody libraries, which is usually measured in terms of their ability to yield high-affinity binding specificities against target proteins of interest, depends both on technical aspects (such as library size and quality of cloning) and on design features (which influence the percentage of functional clones in the library and their ability to be used for practical applications). Here, we describe the design, construction and characterization of a combinatorial phage display library, comprising over 40 billion human antibody clones in single-chain fragment variable (scFv) format. The library was designed with the aim to obtain highly stable antibody clones, which can be affinity-purified on protein A supports, even when used in scFv format. The library was found to be highly functional, as >90% of randomly selected clones expressed the corresponding antibody. When selected against more than 15 antigens from various sources, the library always yielded specific and potent binders, at a higher frequency compared to previous antibody libraries. To demonstrate library performance in practical biomedical research projects, we isolated the human antibody G5, which reacts both against human and murine forms of the alternatively spliced BCD segment of tenascin-C, an extracellular matrix component frequently over-expressed in cancer and in chronic inflammation. The new library represents a useful source of binding specificities, both for academic research and for the development of antibody-based therapeutics.	[Weber, Marcel; Bujak, Emil; Putelli, Alessia; Neri, Dario] Swiss Fed Inst Technol, Inst Pharmaceut Sci, Dept Chem & Appl Biosci, Zurich, Switzerland; [Weber, Marcel; Bujak, Emil; Putelli, Alessia; Villa, Alessandra; Matasci, Mattia; Gualandi, Laura; Hemmerle, Teresa; Wulhfard, Sarah] Philochem AG, Otelfingen, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Neri, D (corresponding author), Swiss Fed Inst Technol, Inst Pharmaceut Sci, Dept Chem & Appl Biosci, Zurich, Switzerland.	neri@pharma.ethz.ch	Neri, Dario/P-4368-2016	Neri, Dario/0000-0001-5234-7370; Weber, Marcel/0000-0002-8532-3321	ETH Zurich; ETH Zurich, KTI, Philochem AG	ETH Zurich(ETH Zurich); ETH Zurich, KTI, Philochem AG	ETH Zurich, KTI, Philochem AG. The funder provided support in the form of salaries for authors (MW, EB, AP, AV, TH, MM, LG, SW, DN), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the Author Contributions section.	AlLazikani B, 1997, J MOL BIOL, V273, P927, DOI 10.1006/jmbi.1997.1354; Aloj L, 2014, EUR J NUCL MED MOL I, V41, P867, DOI 10.1007/s00259-013-2658-6; BALZA E, 1993, FEBS LETT, V332, P39, DOI 10.1016/0014-5793(93)80479-E; Bernardes GJL, 2012, ANGEW CHEM INT EDIT, V51, P941, DOI 10.1002/anie.201106527; Borsi L, 2002, INT J CANCER, V102, P75, DOI 10.1002/ijc.10662; Brack SS, 2006, CLIN CANCER RES, V12, P3200, DOI 10.1158/1078-0432.CCR-05-2804; Buss NAPS, 2012, CURR OPIN PHARMACOL, V12, P615, DOI 10.1016/j.coph.2012.08.001; Carnemolla B, 1999, AM J PATHOL, V154, P1345, DOI 10.1016/S0002-9440(10)65388-6; Casi G, 2012, J CONTROL RELEASE, V161, P422, DOI 10.1016/j.jconrel.2012.01.026; Chari RVJ, 2008, ACCOUNTS CHEM RES, V41, P98, DOI 10.1021/ar700108g; CHOTHIA C, 1987, J MOL BIOL, V196, P901, DOI 10.1016/0022-2836(87)90412-8; CHOTHIA C, 1992, J MOL BIOL, V227, P799, DOI 10.1016/0022-2836(92)90224-8; CLACKSON T, 1991, NATURE, V352, P624, DOI 10.1038/352624a0; GRIFFITHS AD, 1994, EMBO J, V13, P3245, DOI 10.1002/j.1460-2075.1994.tb06626.x; Gutbrodt KL, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006221; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; HOOGENBOOM HR, 1991, NUCLEIC ACIDS RES, V19, P4133, DOI 10.1093/nar/19.15.4133; HOOGENBOOM HR, 1992, J MOL BIOL, V227, P381, DOI 10.1016/0022-2836(92)90894-P; HOOGENBOOM HR, 1992, IMMUNOL REV, V130, P41, DOI 10.1111/j.1600-065X.1992.tb01520.x; HUSTON JS, 1988, P NATL ACAD SCI USA, V85, P5879, DOI 10.1073/pnas.85.16.5879; LERNER RA, 1992, SCIENCE, V258, P1313, DOI 10.1126/science.1455226; List T, 2012, MABS-AUSTIN, V4, P775, DOI 10.4161/mabs.22271; Ma XL, 2013, J MOL BIOL, V425, P2247, DOI 10.1016/j.jmb.2013.03.020; Marks James D, 2004, Methods Mol Biol, V248, P161; MARKS JD, 1992, BIO-TECHNOL, V10, P779, DOI 10.1038/nbt0792-779; Marlind J, 2008, CLIN CANCER RES, V14, P6515, DOI 10.1158/1078-0432.CCR-07-5041; Merz DC, 1995, J NEUROSCI METH, V62, P213, DOI 10.1016/0165-0270(95)00079-8; Midwood KS, 2011, CELL MOL LIFE SCI, V68, P3175, DOI 10.1007/s00018-011-0783-6; Morea V, 1997, BIOPHYS CHEM, V68, P9, DOI 10.1016/S0301-4622(96)02266-1; Pasche N, 2012, DRUG DISCOV TODAY, V17, P583, DOI 10.1016/j.drudis.2012.01.007; Pedretti M, 2010, BRIT J CANCER, V103, P827, DOI 10.1038/sj.bjc.6605832; Pedretti M, 2010, ATHEROSCLEROSIS, V208, P382, DOI 10.1016/j.atherosclerosis.2009.07.043; Pedretti M, 2009, LUNG CANCER, V64, P28, DOI 10.1016/j.lungcan.2008.07.013; Pini A, 1998, J BIOL CHEM, V273, P21769, DOI 10.1074/jbc.273.34.21769; Ponsel D, 2011, MOLECULES, V16, P3675, DOI 10.3390/molecules16053675; Ravenni N, 2013, MABS, V6; Rothe C, 2008, J MOL BIOL, V376, P1182, DOI 10.1016/j.jmb.2007.12.018; Rothlisberger D, 2005, J MOL BIOL, V347, P773, DOI 10.1016/j.jmb.2005.01.053; Schliemann C, 2007, BBA-REV CANCER, V1776, P175, DOI 10.1016/j.bbcan.2007.08.002; Schliemann C, 2010, RECENT RESULTS CANC, V180, P201, DOI 10.1007/978-3-540-78281-0_12; Schliemann C, 2009, LEUKEMIA RES, V33, P1718, DOI 10.1016/j.leukres.2009.06.025; Schwager K, 2011, HUM REPROD, V26, P2344, DOI 10.1093/humrep/der195; Schwager K, 2011, HEAD NECK ONCOL, V3, DOI 10.1186/1758-3284-3-25; Schwager K, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2814; Senter PD, 2009, CURR OPIN CHEM BIOL, V13, P235, DOI 10.1016/j.cbpa.2009.03.023; Silacci M, 2005, PROTEOMICS, V5, P2340, DOI 10.1002/pmic.200401273; Silacci M, 2006, PROTEIN ENG DES SEL, V19, P471, DOI 10.1093/protein/gzl033; Sliwkowski MX, 2013, SCIENCE, V341, P1192, DOI 10.1126/science.1241145; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Steiner M, 2011, CLIN CANCER RES, V17, P6406, DOI 10.1158/1078-0432.CCR-11-0483; TOMLINSON IM, 1995, EMBO J, V14, P4628, DOI 10.1002/j.1460-2075.1995.tb00142.x; Tomlinson IM, 1996, J MOL BIOL, V256, P813, DOI 10.1006/jmbi.1996.0127; TOMLINSON IM, 1992, J MOL BIOL, V227, P776, DOI 10.1016/0022-2836(92)90223-7; Villa A, 2008, INT J CANCER, V122, P2405, DOI 10.1002/ijc.23408; Villa A, 2011, MABS-AUSTIN, V3, P264, DOI 10.4161/mabs.3.3.15616; WINTER G, 1994, ANNU REV IMMUNOL, V12, P433, DOI 10.1146/annurev.iy.12.040194.002245; Zuberbuhler K, 2009, PROTEIN ENG DES SEL, V22, P169, DOI 10.1093/protein/gzn068	57	29	33	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100000	10.1371/journal.pone.0100000	http://dx.doi.org/10.1371/journal.pone.0100000			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950200	Green Submitted, Green Published, gold			2022-12-27	WOS:000338276300029
J	Ma, QH; Xu, WX; Zhou, XH; Cui, CX; Pan, CW				Ma, Qinghua; Xu, Wenxin; Zhou, Xiaohua; Cui, Chunxue; Pan, Chen-Wei			The Relationship of Season of Birth with Refractive Error in Very Young Children in Eastern China	PLOS ONE			English	Article							TIME SPENT OUTDOORS; MYOPIA PROGRESSION; LIGHT EXPOSURE; SINGAPORE; NEARWORK; NIGHT; METAANALYSIS; ASSOCIATION; WORK	Purpose: To determine the association of season of birth and refractive error in very young Chinese children in China. Methods: We conducted a population-based study of Chinese children aged 0 to 3 years residing in eastern China. Refraction was determined by non-cyclopegic autorefraction using a hand-held autorefractor. Date of birth was retrieved from birth certificate of the individual subjects. A generalized linear regression model was fitted to estimate the regression coefficient and 95% confidence interval (CI) of refractive error for season of birth, adjusting for confounders. Results: Of the 1385 children eligible to participate, 1222 (88.2%) were examined. Refractive error data were available for 1219 children. The mean spherical equivalent were 1.21 diopters (D) in children born Spring, 1.24 D in those born in Summer, 1.23 D in those born in Autumn, 1.15 D in Winter. After adjusting for age, sex, father's educational level, birth weight and the number of summers between birth and examination date the children have been exposed to, children born in winter had a 0.12 D more myopic refraction compared with those born in summer (regression coefficient: -0.12; 95% CI, -0.27,-0.06; P = 0.006). The association between season of birth and cylinder power was not statistically significant. Conclusions: In China, children born in winter had a more myopic refraction compared with those born in other seasons. The observed association between season of birth and refractive error was independent of parental educational level and birth weight, suggesting that light level may have a small impact on refractive development in early life.	[Ma, Qinghua; Cui, Chunxue; Pan, Chen-Wei] Soochow Univ, Coll Med, Sch Publ Hlth, Suzhou, Peoples R China; [Ma, Qinghua; Xu, Wenxin; Zhou, Xiaohua] 3rd Peoples Hosp Xiangcheng Dist, Suzhou, Peoples R China	Soochow University - China	Pan, CW (corresponding author), Soochow Univ, Coll Med, Sch Publ Hlth, Suzhou, Peoples R China.	pcwonly@gmail.com	Pan, Chen-Wei/E-6205-2015; Pan, Chen-Wei/L-7174-2019	Pan, Chen-Wei/0000-0003-3362-4613	Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This study was funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backhouse S, 2013, OPHTHAL PHYSL OPT, V33, P563, DOI 10.1111/opo.12069; Chapell M, 2001, PERCEPT MOTOR SKILL, V92, P640, DOI 10.2466/PMS.92.3.640-642; Cui DM, 2013, OPHTHALMOLOGY, V120, P1074, DOI 10.1016/j.ophtha.2012.10.022; Czepita D, 2004, MED SCI MONITOR, V10, pCR168; Deng L, 2011, OPTOMETRY VISION SCI, V88, P383, DOI 10.1097/OPX.0b013e31820b0517; Dirani M, 2009, BRIT J OPHTHALMOL, V93, P997, DOI 10.1136/bjo.2008.150979; Guggenheim JA, 2012, INVEST OPHTH VIS SCI, V53, P2856, DOI 10.1167/iovs.11-9091; Jones-Jordan LA, 2012, INVEST OPHTH VIS SCI, V53, P7169, DOI 10.1167/iovs.11-8336; Lim LS, 2010, OPHTHALMOLOGY, V117, P993, DOI 10.1016/j.ophtha.2009.10.003; Lim LS, 2010, OPHTHALMOLOGY, V117, P524, DOI 10.1016/j.ophtha.2009.07.044; Low W, 2010, BRIT J OPHTHALMOL, V94, P1012, DOI 10.1136/bjo.2009.173187; Mandel Y, 2008, OPHTHALMOLOGY, V115, P686, DOI 10.1016/j.ophtha.2007.05.040; Marcus MW, 2011, OPHTHALMOLOGY, V118, P1989, DOI 10.1016/j.ophtha.2011.03.012; McMahon G, 2009, OPHTHALMOLOGY, V116, P468, DOI 10.1016/j.ophtha.2008.10.004; Midelfart A, 2002, ARCH OPHTHALMOL-CHIC, V120, P406; Morgan I, 2005, PROG RETIN EYE RES, V24, P1, DOI 10.1016/j.preteyeres.2004.06.004; Morgan IG, 2012, LANCET, V379, P1739, DOI 10.1016/S0140-6736(12)60272-4; Pan CW, 2013, AM J OPHTHALMOL, V156, P1021, DOI 10.1016/j.ajo.2013.06.005; Pan CW, 2013, OPHTHALMOLOGY, V120, P2058, DOI 10.1016/j.ophtha.2013.03.028; Quinn GE, 1999, NATURE, V399, P113, DOI 10.1038/20094; RICHLER A, 1980, ACTA OPHTHALMOL, V58, P468; Rose KA, 2008, OPHTHALMOLOGY, V115, P1279, DOI 10.1016/j.ophtha.2007.12.019; Saw SM, 2002, ARCH OPHTHALMOL-CHIC, V120, P620, DOI 10.1001/archopht.120.5.620; Saw SM, 2002, INVEST OPHTH VIS SCI, V43, P332; Saw SM, 2001, BRIT J OPHTHALMOL, V85, P527, DOI 10.1136/bjo.85.5.527; Saw SM, 2001, LANCET, V357, P390, DOI 10.1016/S0140-6736(05)71520-8; Sherwin JC, 2012, OPHTHALMOLOGY, V119, P2141, DOI 10.1016/j.ophtha.2012.04.020; Sherwin JC, 2012, INVEST OPHTH VIS SCI, V53, P4363, DOI 10.1167/iovs.11-8677; Vera-Diaz FA, 2002, CURR EYE RES, V24, P289, DOI 10.1076/ceyr.24.4.289.8418; Zadnik K, 2000, NATURE, V404, P143, DOI 10.1038/35004661; Zhou XT, 2010, PHOTOCHEM PHOTOBIOL, V86, P131, DOI 10.1111/j.1751-1097.2009.00637.x	31	9	11	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100472	10.1371/journal.pone.0100472	http://dx.doi.org/10.1371/journal.pone.0100472			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945317	Green Submitted, gold, Green Published			2022-12-27	WOS:000340721500079
J	van Tongeren, SP; Roest, HIJ; Degener, JE; Harmsen, HJM				van Tongeren, Sandra P.; Roest, Hendrik I. J.; Degener, John E.; Harmsen, Hermie J. M.			Bacillus anthracis-Like Bacteria and Other B. cereus Group Members in a Microbial Community Within the International Space Station: A Challenge for Rapid and Easy Molecular Detection of Virulent B. anthracis	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; IDENTIFICATION; SEQUENCE; STRAINS; GYRB	For some microbial species, such as Bacillus anthracis, the etiologic agent of the disease anthrax, correct detection and identification by molecular methods can be problematic. The detection of virulent B. anthracis is challenging due to multiple virulence markers that need to be present in order for B. anthracis to be virulent and its close relationship to Bacillus cereus and other members of the B. cereus group. This is especially the case in environments where build-up of Bacillus spores can occur and several representatives of the B. cereus group may be present, which increases the chance for false-positives. In this study we show the presence of B. anthracis-like bacteria and other members of the B. cereus group in a microbial community within the human environment of the International Space Station and their preliminary identification by using conventional culturing as well as molecular techniques including 16S rDNA sequencing, PCR and real-time PCR. Our study shows that when monitoring the microbial hygiene in a given human environment, health risk assessment is troublesome in the case of virulent B. anthracis, especially if this should be done with rapid, easy to apply and on-site molecular methods.	[van Tongeren, Sandra P.; Degener, John E.; Harmsen, Hermie J. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands; [Roest, Hendrik I. J.] Wageningen UR, Cent Vet Inst, Dept Bacteriol, Lelystad, Netherlands; [Roest, Hendrik I. J.] Wageningen UR, Cent Vet Inst, TSEs, Lelystad, Netherlands	University of Groningen; Wageningen University & Research; Wageningen University & Research	van Tongeren, SP (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands.	s.p.van.tongeren@umcg.nl	van Tongeren, Sandra P./H-3080-2011	van Tongeren, Sandra P./0000-0001-7727-1165	European Space Agency [AO-LS-99-MAP-LSS-018]; SRON [MG-064/MG-068]	European Space Agency(European Space AgencyEuropean Commission); SRON	The project has been supported by the European Space Agency (MAP Project Number AO-LS-99-MAP-LSS-018 'Biofilms'; http://www.esa.int/ESA). The SAMPLE experiments were supported by SRON (MG-064/MG-068; http://www.sron.nl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antwerpen MH, 2008, MOL CELL PROBE, V22, P313, DOI 10.1016/j.mcp.2008.06.001; Apetroaie C, 2005, ARCH MICROBIOL, V184, P141, DOI 10.1007/s00203-005-0032-1; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Edwards KA, 2006, ANAL BIOANAL CHEM, V384, P73, DOI 10.1007/s00216-005-0090-x; Fasanella A, 2001, VACCINE, V19, P4214, DOI 10.1016/S0264-410X(01)00159-1; Garcia L.S., 2007, CLIN MICROBIOLOGY PR, V2nd; Hadjinicolaou AV, 2009, J MICROBIOL METH, V78, P45, DOI 10.1016/j.mimet.2009.04.005; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HIRAISHI A, 1992, LETT APPL MICROBIOL, V15, P210, DOI 10.1111/j.1472-765X.1992.tb00765.x; Hoffmaster AR, 2006, J CLIN MICROBIOL, V44, P3352, DOI 10.1128/JCM.00561-06; Hoffmaster AR, 2004, P NATL ACAD SCI USA, V101, P8449, DOI 10.1073/pnas.0402414101; Hoffmaster AR, 2002, EMERG INFECT DIS, V8, P1178, DOI 10.3201/eid0810.020393; Horneck G, 2010, MICROBIOL MOL BIOL R, V74, P121, DOI 10.1128/MMBR.00016-09; Hu XM, 2009, FEMS MICROBIOL ECOL, V70, P344, DOI 10.1111/j.1574-6941.2009.00771.x; Irenge LM, 2012, APPL MICROBIOL BIOT, V93, P1411, DOI 10.1007/s00253-011-3845-7; Klee SR, 2006, J BACTERIOL, V188, P5333, DOI 10.1128/JB.00303-06; Kuske CR, 2006, J FORENSIC SCI, V51, P548, DOI 10.1111/j.1556-4029.2006.00131.x; La Duc MT, 2004, J MICROBIOL METH, V56, P383, DOI 10.1016/j.mimet.2003.11.004; Leendertz FH, 2006, PLOS PATHOG, V2, P632, DOI 10.1371/journal.ppat.0020008; Logan NA., 2009, BERGEYS MANUAL SYSTE, P21; Logan NA, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P455; Merrill L, 2006, J FORENSIC SCI, V51, P559, DOI 10.1111/j.1556-4029.2006.00132.x; Novikova N, 2006, RES MICROBIOL, V157, P5, DOI 10.1016/j.resmic.2005.07.010; Okinaka R, 2006, PLOS PATHOG, V2, P1025, DOI 10.1371/journal.ppat.0020122; Okinaka RT, 1999, J BACTERIOL, V181, P6509, DOI 10.1128/JB.181.20.6509-6515.1999; Pierson D L, 2001, Gravit Space Biol Bull, V14, P1; Pilo P, 2011, INFECT GENET EVOL, V11, P1218, DOI 10.1016/j.meegid.2011.05.013; Rao SS, 2010, J MICROBIOL METH, V82, P1, DOI 10.1016/j.mimet.2010.04.005; Reva ON, 2001, INT J SYST EVOL MICR, V51, P1361, DOI 10.1099/00207713-51-4-1361; Sacchi CT, 2002, EMERG INFECT DIS, V8, P1117, DOI 10.3201/eid0810.020391; TURNBULL PCB, 1992, J APPL BACTERIOL, V72, P21; van Tongeren SP, 2007, MICROGRAVITY SCI TEC, V19, P45, DOI 10.1007/BF02911866; Yamada S, 1999, APPL ENVIRON MICROB, V65, P1483; Zengler K, 2008, ACCESSING UNCULTIVATED MICROORGANISMS: FROM THE ENVIRONMENT TO ORGANISMS AND GENOMES AND BACK, P1; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	36	10	10	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e98871	10.1371/journal.pone.0098871	http://dx.doi.org/10.1371/journal.pone.0098871			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945323	Green Published, gold, Green Submitted			2022-12-27	WOS:000340721500008
J	Barbour, A; Philip, K				Barbour, Abdelahhad; Philip, Koshy			Variable Characteristics of Bacteriocin-Producing Streptococcus salivarius Strains Isolated from Malaysian Subjects	PLOS ONE			English	Article							ZYMOMONAS-MOBILIS; ANTIMICROBIAL MECHANISM; GENOME SEQUENCE; MUTACIN 1140; LANTIBIOTICS; LEVAN; PLANTARICIN; NISIN; K12; POLYSACCHARIDE	Background: Salivaricins are bacteriocins produced by Streptococcus salivarius, some strains of which can have significant probiotic effects. S. salivarius strains were isolated from Malaysian subjects showing variable antimicrobial activity, metabolic profile, antibiotic susceptibility and lantibiotic production. Methodology/Principal Findings: In this study we report new S. salivarius strains isolated from Malaysian subjects with potential as probiotics. Safety assessment of these strains included their antibiotic susceptibility and metabolic profiles. Genome sequencing using Illumina's MiSeq system was performed for both strains NU10 and YU10 and demonstrating the absence of any known streptococcal virulence determinants indicating that these strains are safe for subsequent use as probiotics. Strain NU10 was found to harbour genes encoding salivaricins A and 9 while strain YU10 was shown to harbour genes encoding salivaricins A3, G32, streptin and slnA1 lantibiotic-like protein. Strain GT2 was shown to harbour genes encoding a large non-lantibiotic bacteriocin (salivaricin-MPS). A new medium for maximum biomass production buffered with 2-(N-morpholino) ethanesulfonic acid (MES) was developed and showed better biomass accumulation compared with other commercial media. Furthermore, we extracted and purified salivaricin 9 (by strain NU10) and salivaricin G32 (by strain YU10) from S. salivarius cells grown aerobically in this medium. In addition to bacteriocin production, S. salivarius strains produced levan-sucrase which was detected by a specific ESI-LC-MS/MS method which indicates additional health benefits from the developed strains. Conclusion: The current study established the bacteriocin, levan-sucrase production and basic safety features of S. salivarius strains isolated from healthy Malaysian subjects demonstrating their potential for use as probiotics. A new bacteriocin-production medium was developed with potential scale up application for pharmaceuticals and probiotics from S. salivarius generating different	[Barbour, Abdelahhad; Philip, Koshy] Univ Malaya, Fac Sci, Div Microbiol, Inst Biol Sci, Kuala Lumpur, Malaysia	Universiti Malaya	Philip, K (corresponding author), Univ Malaya, Fac Sci, Div Microbiol, Inst Biol Sci, Kuala Lumpur, Malaysia.	kphil@um.edu.my	Barbour, Abdelahhad/AAG-1953-2021; PHILIP, Koshy/B-8803-2010; Barbour, Abdelahhad/C-5168-2015	Barbour, Abdelahhad/0000-0003-0184-8890	High Impact Research - Malaysian Ministry of Higher Education grant [UM.C/625/1/HIR/MOHE/SC/08, F000008-21001]	High Impact Research - Malaysian Ministry of Higher Education grant	The authors wish to acknowledge the support by way of facilities from University of Malaya and the High Impact Research - Malaysian Ministry of Higher Education grant designated as UM.C/625/1/HIR/MOHE/SC/08 with account F000008-21001 under the Principal Investigator Koshy Philip for the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abee T, 1995, INT J FOOD MICROBIOL, V28, P169, DOI 10.1016/0168-1605(95)00055-0; Al-Mahrous MM, 2011, EXPERT OPIN DRUG DIS, V6, P155, DOI 10.1517/17460441.2011.545387; Anderssen EL, 1998, APPL ENVIRON MICROB, V64, P2269; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Barbour A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077751; Barretto C, 2012, J BACTERIOL, V194, P5959, DOI 10.1128/JB.01268-12; Belghith H, 1996, BIOTECHNOL LETT, V18, P467, DOI 10.1007/BF00143472; Birri DJ, 2012, APPL ENVIRON MICROB, V78, P402, DOI 10.1128/AEM.06588-11; Burton JP, 2006, APPL ENVIRON MICROB, V72, P3050, DOI 10.1128/AEM.72.4.3050-3053.2006; Calazans GMT, 1997, BIOTECHNOL LETT, V19, P19, DOI 10.1023/A:1018350617120; Chaney N, 2009, CAN J MICROBIOL, V55, P1261, DOI [10.1139/w09-091, 10.1139/W09-091]; Chattoraj P, 2010, J BACTERIOL, V192, P1312, DOI 10.1128/JB.01350-09; Chen SR, 2013, APPL ENVIRON MICROB, V79, P4015, DOI 10.1128/AEM.00704-13; Cotter PD, 2005, NAT REV MICROBIOL, V3, P777, DOI 10.1038/nrmicro1273; Dahech I, 2011, INT J BIOL MACROMOL, V49, P742, DOI 10.1016/j.ijbiomac.2011.07.007; de Paula VC, 2008, BIORESOURCE TECHNOL, V99, P2466, DOI 10.1016/j.biortech.2007.04.062; HAN YW, 1990, J AGR FOOD CHEM, V38, P393, DOI 10.1021/jf00092a011; Heng NCK, 2011, J BACTERIOL, V193, P6402, DOI 10.1128/JB.06001-11; Holo H, 2001, MICROBIOL-SGM, V147, P643, DOI 10.1099/00221287-147-3-643; Hyink O, 2007, APPL ENVIRON MICROB, V73, P1107, DOI 10.1128/AEM.02265-06; Islam MR, 2012, BIOCHEM SOC T, V40, P1528, DOI 10.1042/BST20120190; JACK RW, 1995, MICROBIOL REV, V59, P171, DOI 10.1128/MMBR.59.2.171-200.1995; Jang KH, 2001, BIOTECHNOL LETT, V23, P339, DOI 10.1023/A:1005641220946; Joo NE, 2012, CANCER MED-US, V1, P295, DOI 10.1002/cam4.35; Karam L, 2013, J PEPT SCI, V19, P377, DOI 10.1002/psc.2512; Kleerebezem M, 2004, PEPTIDES, V25, P1405, DOI 10.1016/j.peptides.2003.10.021; Kristiansen PE, 2005, J BIOL CHEM, V280, P22945, DOI 10.1074/jbc.M501620200; LEIBOVICI J, 1985, CELL MOL BIOL, V31, P337; Lv WH, 2004, BIOTECHNOL LETT, V26, P235, DOI 10.1023/B:BILE.0000013721.78288.1d; Mantovani HC, 2002, MICROBIOL-SGM, V148, P3347, DOI 10.1099/00221287-148-11-3347; Nguyen T, 2009, MICROBIOL-SGM, V155, P551, DOI 10.1099/mic.0.021303-0; RATHSAM C, 1993, J BACTERIOL, V175, P4520, DOI 10.1128/JB.175.14.4520-4527.1993; ROSS KF, 1993, APPL ENVIRON MICROB, V59, P2014, DOI 10.1128/AEM.59.7.2014-2021.1993; Smith L, 2008, BIOCHEMISTRY-US, V47, P3308, DOI 10.1021/bi701262z; Smith L, 2008, CURR OPIN MICROBIOL, V11, P401, DOI 10.1016/j.mib.2008.09.008; Somkuti GA, 2007, CURR MICROBIOL, V55, P173, DOI 10.1007/s00284-007-0179-x; Tabor AB, 2011, ORG BIOMOL CHEM, V9, P7606, DOI 10.1039/c1ob05946g; TAGG JR, 1979, J MED MICROBIOL, V12, P397, DOI 10.1099/00222615-12-4-397; TAGG JR, 1984, J HYG-CAMBRIDGE, V93, P339, DOI 10.1017/S0022172400064883; Tahara T, 1997, FEMS MICROBIOL LETT, V147, P287, DOI 10.1016/S0378-1097(97)00002-5; TRAMER J, 1966, CHEM IND-LONDON, P446; vanDeVen FJM, 1996, ANTON LEEUW INT J G, V69, P99, DOI 10.1007/BF00399415; Wang Y, 2010, THESIS U OTAGO DUNED; Wescombe PA, 2011, MICROBIOL-SGM, V157, P1290, DOI 10.1099/mic.0.044719-0; Wescombe PA, 2006, APPL ENVIRON MICROB, V72, P1459, DOI 10.1128/AEM.72.2.1459-1466.2006; Wescombe PA, 2006, ANTON LEEUW INT J G, V90, P269, DOI 10.1007/s10482-006-9081-y; Wescombe Philip A, 2012, Int J Microbiol, V2012, P738503, DOI 10.1155/2012/738503; Wilson-Stanford Shawanda, 2011, Recent Pat Antiinfect Drug Discov, V6, P175	48	26	26	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100541	10.1371/journal.pone.0100541	http://dx.doi.org/10.1371/journal.pone.0100541			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941127	Green Published, gold			2022-12-27	WOS:000338508200105
J	Liang, Y; Tang, WZ; Huang, TQ; Gao, Y; Tan, AH; Yang, XB; Zhang, HY; Hu, YL; Qin, X; Li, S; Zhang, SJ; Mo, LJ; Liang, ZJ; Shi, DY; Huang, Z; Guan, YY; Zhou, JC; Winkler, C; O'Brien, SJ; Xu, JF; Mo, ZN; Peng, T				Liang, Yu; Tang, Weizhong; Huang, Tiqiang; Gao, Yong; Tan, Aihua; Yang, Xiaobo; Zhang, Haiying; Hu, Yanling; Qin, Xue; Li, Shan; Zhang, Shijun; Mo, Linjian; Liang, Zhenjia; Shi, Deyi; Huang, Zhang; Guan, Yingyong; Zhou, Jicheng; Winkler, Cheryl; O'Brien, Stephen J.; Xu, Jianfeng; Mo, Zengnan; Peng, Tao			Genetic Variations Affecting Serum Carcinoembryonic Antigen Levels and Status of Regional Lymph Nodes in Patients with Sporadic Colorectal Cancer from Southern China	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; III COLON-CANCER; BODY-MASS INDEX; BLOOD-GROUP; ADJUVANT CHEMOTHERAPY; PANCREATIC-CANCER; TUMOR-MARKERS; CEA LEVELS; CIGARETTE-SMOKING; FREE SURVIVAL	Background: Serum carcinoembryonic antigen (sCEA) level might be an indicator of disease. Indeed, an elevated sCEA level is a prognostic factor in colorectal cancer (CRC) patients. However, the genetic determinants of sCEA level in healthy and CRC population remains unclear. Thus we investigated the genetic markers associated with elevated serum sCEA level in these two populations and its clinical implications. Methods and Findings: Genome-wide association study (GWAS) was conducted in a cohort study with 4,346 healthy male adults using the Illumina Omni 1 M chip. Candidate SNPs associated with elevated sCEA levels were validated in 194 CRC patients on ABI Taqman platform. Eight candidate SNPs were validated in CRC patients. The rs1047781 (chr19-FUT2) (A/T) was associated with elevated sCEA levels, and rs8176746 (chr9-ABO) was associated with the regional lymph metastasis in the CRC patients. The preoperative sCEA level was a risk factor for tumor recurrence in 5 years after operation (OR = 1.427, 95% CI: 1.005& 1.843, P = 0.006). It was also one of the risk factors for regional lymph node metastasis (OR = 2.266, 95% CI: 1.196& 4.293, P = 0.012). The sCEA level in rs1047781-T carriers was higher than that in the A carriers in CRC patients without lymph node metastasis (P = 0.006). The regional lymph node metastasis in patients with homozygote AA of rs8176746 was more common than that in the heterozygote AG carriers (P = 0.022). In addition, rs1047781-AT and TT CRC patients exhibited a worse disease-free survival than AA genotype carriers (P = 0.023). Conclusions: We found candidate SNPs associated with elevated sCEA levels in both healthy males and CRC population. Rs1047781 (chr19-FUT2) may be the susceptible locus for recurrence of CRC in a population from Southern China.	[Liang, Yu; Peng, Tao] Guangxi Med Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Nanning, Guangxi, Peoples R China; [Tang, Weizhong; Huang, Tiqiang] Guangxi Med Univ, Affiliated Hosp 1, Dept Anal & Colorectal Surg, Nanning, Guangxi, Peoples R China; [Huang, Tiqiang; Gao, Yong; Zhang, Shijun; Mo, Linjian; Xu, Jianfeng; Mo, Zengnan] Guangxi Med Univ, Ctr Genom & Personalized Med, Nanning, Guangxi, Peoples R China; [Yang, Xiaobo; Zhang, Haiying] Guangxi Med Univ, Sch Publ Hlth, Dept Occupat Hlth & Environm Hlth, Nanning, Guangxi, Peoples R China; [Hu, Yanling] Guangxi Med Univ, Med Sci Res Ctr, Nanning, Guangxi, Peoples R China; [Qin, Xue; Li, Shan] Guangxi Med Univ, Affiliated Hosp 1, Dept Clin Lab, Nanning, Guangxi, Peoples R China; [Mo, Linjian; Mo, Zengnan] Guangxi Med Univ, Affiliated Hosp 1, Inst Urol & Nephrol, Nanning, Guangxi, Peoples R China; [Liang, Zhenjia; Shi, Deyi] Fangchenggang First Peoples Hosp, Med Examinat Ctr, Fangchenggang, Guangxi, Peoples R China; [Huang, Zhang] Guigang First Peoples Hosp, Med Examinat Ctr, Guigang, Guangxi, Peoples R China; [Guan, Yingyong] Yulin First Peoples Hosp, Med Examinat Ctr, Yulin, Guangxi, Peoples R China; [Zhou, Jicheng] Guangxi Med Univ, Affiliated Hosp 1, Dept Hematol, Nanning, Guangxi, Peoples R China; [Winkler, Cheryl] NCI, Mol Genet Epidemiol Sec, Frederick Nat Lab Canc Res, NIH, Frederick, MD USA; [O'Brien, Stephen J.; Peng, Tao] NCI, Lab Genom Divers, NIH, Frederick, MD USA; [O'Brien, Stephen J.] St Petersburg State Univ, Theodosius Dobzhansky Ctr Genome Bioinformat, St Petersburg 199034, Russia; [O'Brien, Stephen J.] Nova SE Univ, Oceanog Ctr, Ft Lauderdale, FL 33314 USA; [Xu, Jianfeng] Wake Forest Univ, Bowman Gray Sch Med, Ctr Canc Genom, Winston Salem, NC USA	Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Saint Petersburg State University; Nova Southeastern University; Wake Forest University; Wake Forest Baptist Medical Center	Mo, ZN (corresponding author), Guangxi Med Univ, Ctr Genom & Personalized Med, Nanning, Guangxi, Peoples R China.	zengnanmo@hotmail.com; pengtaocn@hotmail.com	Yang, Xiaobo/G-3854-2016; OBRIEN, STEPHEN/ABD-1346-2020	mo, zengnan/0000-0002-3047-3138; O'Brien, Stephen J./0000-0001-7353-8301; OBRIEN, STEPHEN/0000-0001-7857-0757	General Program of National Natural Science Foundation of China [30945204, 81072321, 81272853, 81360378, 81360099, 81370857, 30760243, 30460143, 30560133]; Ministry of Education, China; Key Program and University Talents Highland Innovation Team of Guangxi [2012012D003, GJR201147-09]; Chairman Science and Technology Fund and Tackle Program of Guangxi [1116-03, GKG1298003-07-01]; Guangxi Natural Science Foundation [2011 GXNSFB018100, 2012GXNSFAA053152, 2013GXNSFFA 019002]; Guangxi Nature Sciences Grant [GuiKeGong 1104003A-7]; Guangxi Provincial Department of Finance and Education [2009GJCJ150]; Guangxi Health Ministry Medicine Grant [Z201018]; Russian Ministry of Science Mega-grant [11.G34.31.0068]; NATIONAL CANCER INSTITUTE [ZIABC010297] Funding Source: NIH RePORTER	General Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education, China(Ministry of Education, China); Key Program and University Talents Highland Innovation Team of Guangxi; Chairman Science and Technology Fund and Tackle Program of Guangxi; Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province); Guangxi Nature Sciences Grant; Guangxi Provincial Department of Finance and Education; Guangxi Health Ministry Medicine Grant; Russian Ministry of Science Mega-grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the General Program of National Natural Science Foundation of China (30945204, 81072321, 81272853, 81360378, 81360099, 81370857, 30760243, 30460143 and 30560133), Ministry of Education, China (Program for New Century Excellent Talents in University, NCET2009), Key Program and University Talents Highland Innovation Team of Guangxi (2012012D003, GJR201147-09), Chairman Science and Technology Fund and Tackle Program of Guangxi (1116-03, GKG1298003-07-01), Guangxi Natural Science Foundation (2011 GXNSFB018100, 2012GXNSFAA053152, 2013GXNSFFA 019002), Guangxi Nature Sciences Grant (GuiKeGong 1104003A-7), the Guangxi Provincial Department of Finance and Education (2009GJCJ150) and Guangxi Health Ministry Medicine Grant (Z201018). This research was supported in part by Russian Ministry of Science Mega-grant no. 11.G34.31.0068; SJ O'Brien Principal Investigator, No funding body had any influence or input into the study design, data collection, analysis, data interpretation, or writing of the report.	ALEXANDER JC, 1976, JAMA-J AM MED ASSOC, V235, P1975; Amemori Sadahiro, 2007, Am J Physiol Gastrointest Liver Physiol, V292, pG923; BEASLEY RP, 1981, LANCET, V2, P1129; BEAUDONNET A, 1981, CLIN CHEM, V27, P771; BENTZEN SM, 1990, EUR J CANCER, V26, P457, DOI 10.1016/0277-5379(90)90016-M; Biagi JJ, 2011, JAMA-J AM MED ASSOC, V305, P2335, DOI 10.1001/jama.2011.749; BOOTH SN, 1973, GUT, V14, P794, DOI 10.1136/gut.14.10.794; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Chao A, 2000, JNCI-J NATL CANCER I, V92, P1888, DOI 10.1093/jnci/92.23.1888; Dai JY, 2012, CARCINOGENESIS, V33, P1327, DOI 10.1093/carcin/bgs147; Demetriades H, 2004, Tech Coloproctol, V8 Suppl 1, ps144, DOI 10.1007/s10151-004-0138-5; Edgren G, 2010, AM J EPIDEMIOL, V172, P1280, DOI 10.1093/aje/kwq299; Fietkau R, 2004, STRAHLENTHER ONKOL, V180, P478, DOI 10.1007/s00066-004-1260-z; FLETCHER RH, 1986, ANN INTERN MED, V104, P66, DOI 10.7326/0003-4819-104-1-66; Gangopadhyay A, 1996, CANCER RES, V56, P4805; Garrote LF, 2001, BRIT J CANCER, V85, P46, DOI 10.1054/bjoc.2000.1825; Gobbi PG, 2008, BRIT J CANCER, V98, P328, DOI 10.1038/sj.bjc.6604114; Gray R, 2007, LANCET, V370, P2020, DOI 10.1016/s0140-6736(07)61866-2; Gutierrez DA, 2009, CURR DIABETES REP, V9, P26, DOI 10.1007/s11892-009-0006-9; HAINES AP, 1979, LANCET, V2, P969; He MA, 2014, GUT, V63, P143, DOI 10.1136/gutjnl-2012-303434; HERBETH B, 1980, ONCODEV BIOL MED, V1, P191; Hoffmann D, 1997, J TOXICOL ENV HEALTH, V50, P307, DOI 10.1080/009841097160393; HOLBURN AM, 1974, IMMUNOLOGY, V26, P831; Hong Seung Goun, 2010, Korean J Hepatol, V16, P49, DOI 10.3350/kjhep.2010.16.1.49; Huang Fang, 2008, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V24, P370; Ilantzis C, 1997, LAB INVEST, V76, P703; Ilantzis C, 2002, NEOPLASIA, V4, P151, DOI 10.1038/sj.neo.7900201; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Kim CJ, 2007, PATHOL INT, V57, P178, DOI 10.1111/j.1440-1827.2007.02078.x; KIM J, 1992, INT J CANCER, V52, P718, DOI 10.1002/ijc.2910520509; Kim YJ, 2012, CLIN CHIM ACTA, V413, P511, DOI 10.1016/j.cca.2011.11.019; Kudo T, 1996, J BIOL CHEM, V271, P9830, DOI 10.1074/jbc.271.16.9830; Kuebler JP, 2007, J CLIN ONCOL, V25, P2198, DOI 10.1200/JCO.2006.08.2974; Kurokawa H, 1997, J ORAL MAXIL SURG, V55, P964, DOI 10.1016/S0278-2391(97)90071-9; Lee SY, 2011, J KOREAN SURG SOC, V81, P387, DOI 10.4174/jkss.2011.81.6.387; Li Y, 2010, CANCER RES, V70, P8159, DOI 10.1158/0008-5472.CAN-10-1073; Lin XL, 2012, HUM MOL GENET, V21, P2610, DOI 10.1093/hmg/dds062; LOEWENSTEIN MS, 1978, CANCER, V42, P1412, DOI 10.1002/1097-0142(197809)42:3+<1412::AID-CNCR2820420805>3.0.CO;2-8; Maestranzi S, 1998, ANN CLIN BIOCHEM, V35, P99, DOI 10.1177/000456329803500113; MAGOUS R, 1980, MOL IMMUNOL, V17, P1039, DOI 10.1016/0161-5890(80)90098-X; Ni XG, 2005, EJSO-EUR J SURG ONC, V31, P164, DOI 10.1016/j.ejso.2004.09.007; OLSEN GW, 1989, AM J PUBLIC HEALTH, V79, P1016, DOI 10.2105/AJPH.79.8.1016; Coelho MSPH, 2009, ARQ BRAS ENDOCRINOL, V53, P1146, DOI 10.1590/S0004-27302009000900012; Pare G, 2008, PLOS GENET, V4; Park JS, 2010, CANCER EPIDEM BIOMAR, V19, P2461, DOI 10.1158/1055-9965.EPI-10-0569; PFOHLLESZKOWICZ A, 1995, CANCER RES, V55, P5611; Plotnikov AN, 1999, CELL, V98, P641, DOI 10.1016/S0092-8674(00)80051-3; PRADO IB, 1995, INT J CANCER, V61, P854, DOI 10.1002/ijc.2910610618; Qin X, 2011, INT J BIOL MARKER, V26, P65, DOI 10.5301/JBM.2011.6364; Risch HA, 2012, MOL CARCINOGEN, V51, P109, DOI 10.1002/mc.20826; Sakuma K, 2012, P NATL ACAD SCI USA, V109, P7776, DOI 10.1073/pnas.1111135109; Salgia R, 2001, ANTICANCER RES, V21, P1241; Saltz LB, 2007, J CLIN ONCOL, V25, P3456, DOI 10.1200/JCO.2007.11.2144; Salvini R, 2001, J BIOL CHEM, V276, P3564, DOI 10.1074/jbc.M006662200; Sargent DJ, 2005, J CLIN ONCOL, V23, P8664, DOI 10.1200/JCO.2005.01.6071; Soreide K, 2011, WORLD J SURG, V35, P888, DOI 10.1007/s00268-011-0979-9; Staib L, 2002, WORLD J SURG, V26, P59; TOUITOU Y, 1984, EUR J CANCER CLIN ON, V20, P369, DOI 10.1016/0277-5379(84)90083-X; Vrieling A, 2010, AM J CLIN NUTR, V92, P471, DOI [10.3945/ajcn.2010.29005, 10.3945/ajcn.2009.29005]; Wichmann MW, 2001, BRIT J SURG, V88, P1092, DOI 10.1046/j.0007-1323.2001.01819.x; Yang L, 2004, BRIT J CANCER, V90, P2157, DOI 10.1038/sj.bjc.6601813; Yang XQ, 2011, ASIAN PAC J CANCER P, V12, P1251; ZENG ZS, 1993, DIS COLON RECTUM, V36, P1063, DOI 10.1007/BF02047301; Zimmer R, 2001, CANCER RES, V61, P2822	66	24	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e97923	10.1371/journal.pone.0097923	http://dx.doi.org/10.1371/journal.pone.0097923			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941225	Green Published, Green Submitted, gold			2022-12-27	WOS:000338508200007
J	Maixner, F; Thomma, A; Cipollini, G; Widder, S; Rattei, T; Zink, A				Maixner, Frank; Thomma, Anton; Cipollini, Giovanna; Widder, Stefanie; Rattei, Thomas; Zink, Albert			Metagenomic Analysis Reveals Presence of Treponema denticola in a Tissue Biopsy of the Iceman	PLOS ONE			English	Article							DNA-POLYMERASES; BACTERIAL-DNA; GENOME; SEQUENCE; ANCIENT; PERIODONTITIS; INSIGHTS; HISTORY; MUMMIES; HEALTH	Ancient hominoid genome studies can be regarded by definition as metagenomic analyses since they represent a mixture of both hominoid and microbial sequences in an environment. Here, we report the molecular detection of the oral spirochete Treponema denticola in ancient human tissue biopsies of the Iceman, a 5,300-year-old Copper Age natural ice mummy. Initially, the metagenomic data of the Iceman's genomic survey was screened for bacterial ribosomal RNA ( rRNA) specific reads. Through ranking the reads by abundance a relatively high number of rRNA reads most similar to T. denticola was detected. Mapping of the metagenome sequences against the T. denticola genome revealed additional reads most similar to this opportunistic pathogen. The DNA damage pattern of specifically mapped reads suggests an ancient origin of these sequences. The haematogenous spread of bacteria of the oral microbiome often reported in the recent literature could already explain the presence of metagenomic reads specific for T. denticola in the Iceman's bone biopsy. We extended, however, our survey to an Iceman gingival tissue sample and a mouth swab sample and could thereby detect T. denticola and Porphyrimonas gingivalis, another important member of the human commensal oral microflora. Taken together, this study clearly underlines the opportunity to detect disease-associated microorganisms when applying metagenomics-enabled approaches on datasets of ancient human remains.	[Maixner, Frank; Cipollini, Giovanna] EURAC Res, Inst Mummies & Iceman, Bolzano, Italy; [Thomma, Anton; Widder, Stefanie; Rattei, Thomas; Zink, Albert] Univ Vienna, Dept Microbiol & Ecosyst Sci, CUBE Div Computat Syst Biol, Vienna, Austria	European Academy of Bozen-Bolzano; University of Vienna	Maixner, F (corresponding author), EURAC Res, Inst Mummies & Iceman, Bolzano, Italy.	frank.maixner@eurac.edu	Zink, Albert/P-4024-2015; Maixner, Frank/AAY-7033-2020; Rattei, Thomas/F-1366-2011; Widder, Stefanie/B-9584-2014	Zink, Albert/0000-0002-1461-747X; Rattei, Thomas/0000-0002-0592-7791; Widder, Stefanie/0000-0003-0733-5666; Maixner, Frank/0000-0003-2846-8994	Sudtiroler Sparkasse; South Tyrolean [legge 14]	Sudtiroler Sparkasse; South Tyrolean	The work was supported in part by the Sudtiroler Sparkasse and the South Tyrolean grant legge 14. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler CJ, 2013, NAT GENET, V45, P450, DOI 10.1038/ng.2536; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ames SK, 2013, BIOINFORMATICS, V29, P2253, DOI 10.1093/bioinformatics/btt389; [Anonymous], 2006, PROKARYOTES, DOI DOI 10.1007/0-387-30747-8_8; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bos KI, 2011, NATURE, V478, P506, DOI 10.1038/nature10549; Cano RJ, 2000, AM J PHYS ANTHROPOL, V112, P297; Carver T, 2009, BIOINFORMATICS, V25, P119, DOI 10.1093/bioinformatics/btn578; Cavrini F, 2005, J MED MICROBIOL, V54, P93, DOI 10.1099/jmm.0.45845-0; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; DALDRUP T, 1984, Z RECHTSMED, V92, P121, DOI 10.1007/BF02116221; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; David M, 2011, BIOINFORMATICS, V27, P1011, DOI 10.1093/bioinformatics/btr046; Fogg MJ, 2002, NAT STRUCT BIOL, V9, P922, DOI 10.1038/nsb867; Ginolhac A, 2011, BIOINFORMATICS, V27, P2153, DOI 10.1093/bioinformatics/btr347; Grad YH, 2012, P NATL ACAD SCI USA, V109, P3065, DOI 10.1073/pnas.1121491109; Greagg MA, 1999, P NATL ACAD SCI USA, V96, P9045, DOI 10.1073/pnas.96.16.9045; Green RE, 2006, NATURE, V444, P330, DOI 10.1038/nature05336; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Green RE, 2009, EMBO J, V28, P2494, DOI 10.1038/emboj.2009.222; Griffen AL, 2012, ISME J, V6, P1176, DOI 10.1038/ismej.2011.191; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hormozdiari F, 2011, BIOINFORMATICS, V27, P1915, DOI 10.1093/bioinformatics/btr303; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Inaba H, 2010, J PHARMACOL SCI, V113, P103, DOI 10.1254/jphs.09R23FM; International Barley Genome Sequencing Consortium, 2012, Nature, V491, P711, DOI 10.1038/nature11543; Jaenisch Stefanie, 2010, Archiv fuer Kriminologie, V225, P99; Keller A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1701; Khairat R, 2013, J APPL GENET, V54, P309, DOI 10.1007/s13353-013-0145-1; Kirsanow K, 2012, ANN ANAT, V194, P121, DOI 10.1016/j.aanat.2011.11.002; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Martinez-Pabon MC, 2008, CLIN ORAL INVEST, V12, P73, DOI 10.1007/s00784-007-0147-7; Metzker Michael L, 2010, Nat Rev Genet, V11, P31, DOI 10.1038/nrg2626; Meyerson M, 2010, NAT REV GENET, V11, P685, DOI 10.1038/nrg2841; Murphy WA, 2003, RADIOLOGY, V226, P614, DOI 10.1148/radiol.2263020338; Ohki T, 2012, AM HEART J, V163, P164, DOI 10.1016/j.ahj.2011.10.012; Okuda K, 2001, J CLIN MICROBIOL, V39, P1114, DOI 10.1128/JCM.39.3.1114-1117.2001; Pedersen JS, 2014, GENOME RES, V24, P454, DOI 10.1101/gr.163592.113; Pinar G, 2013, FEMS MICROBIOL ECOL, V86, P341, DOI 10.1111/1574-6941.12165; Prufer K, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r47; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Rollo F, 2000, AM J PHYS ANTHROPOL, V111, P211, DOI 10.1002/(SICI)1096-8644(200002)111:2<211::AID-AJPA7>3.0.CO;2-M; Rumble SM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000386; Santamaria M, 2012, BRIEF BIOINFORM, V13, P682, DOI 10.1093/bib/bbs036; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD23, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Schatz MC, 2010, GENOME RES, V20, P1165, DOI 10.1101/gr.101360.109; Schuenemann VJ, 2013, SCIENCE, V341, P179, DOI 10.1126/science.1238286; Seiler R, 2013, EUR J ORAL SCI, V121, P137, DOI 10.1111/eos.12037; Stoneking M, 2011, NAT REV GENET, V12, P603, DOI 10.1038/nrg3029; Tang JN, 2008, J MICROBIOL METH, V75, P432, DOI 10.1016/j.mimet.2008.07.014; Wang Y, 2004, NUCLEIC ACIDS RES, V32, P1197, DOI 10.1093/nar/gkh271; Warinner C, 2014, NAT GENET, V46, P336, DOI 10.1038/ng.2906; Wheeler DL, 2000, NUCLEIC ACIDS RES, V28, P10, DOI 10.1093/nar/28.1.10; Yu K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038183; Zaremba-Niedzwiedzka K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062799	61	18	19	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99994	10.1371/journal.pone.0099994	http://dx.doi.org/10.1371/journal.pone.0099994			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941044	Green Published, Green Submitted, gold			2022-12-27	WOS:000338508200062
J	Perez-Lachaud, G; Lachaud, JP				Perez-Lachaud, Gabriela; Lachaud, Jean-Paul			Arboreal Ant Colonies as 'Hot-Points' of Cryptic Diversity for Myrmecophiles: The Weaver Ant Camponotus sp aff. textor and Its Interaction Network with Its Associates	PLOS ONE			English	Article							HYMENOPTERA CHALCIDOIDEA; ECTATOMMA-TUBERCULATUM; BIODIVERSITY LOSS; 1ST RECORD; FORMICIDAE; INSECT; CONSERVATION; PARASITISM; STREPSIPTERA; EUCHARITIDAE	Introduction: Systematic surveys of macrofaunal diversity within ant colonies are lacking, particularly for ants nesting in microhabitats that are difficult to sample. Species associated with ants are generally small and rarely collected organisms, which makes them more likely to be unnoticed. We assumed that this tendency is greater for arthropod communities in microhabitats with low accessibility, such as those found in the nests of arboreal ants that may constitute a source of cryptic biodiversity. Materials and Methods: We investigated the invertebrate diversity associated with an undescribed, but already threatened, Neotropical Camponotus weaver ant. As most of the common sampling methods used in studies of ant diversity are not suited for evaluating myrmecophile diversity within ant nests, we evaluated the macrofauna within ant nests through exhaustive colony sampling of three nests and examination of more than 80,000 individuals. Results: We identified invertebrates from three classes belonging to 18 taxa, some of which were new to science, and recorded the first instance of the co-occurrence of two brood parasitoid wasp families attacking the same ant host colony. This diversity of ant associates corresponded to a highly complex interaction network. Agonistic interactions prevailed, but the prevalence of myrmecophiles was remarkably low. Conclusions: Our data support the hypothesis of the evolution of low virulence in a variety of symbionts associated with large insect societies. Because most myrmecophiles found in this work are rare, strictly specific, and exhibit highly specialized biology, the risk of extinction for these hitherto unknown invertebrates and their natural enemies is high. The cryptic, far unappreciated diversity within arboreal ant nests in areas at high risk of habitat loss qualifies these nests as 'hotpoints' of biodiversity that urgently require special attention as a component of conservation and management programs.	[Perez-Lachaud, Gabriela; Lachaud, Jean-Paul] El Colegio Frontera Sur, Dept Conservac Biodiversidad, Chetmal, Quintana Roo, Mexico; [Lachaud, Jean-Paul] Univ Toulouse UPS, Ctr Rech Cognit Anim, CNRS UMR 5169, Toulouse, France	El Colegio de la Frontera Sur (ECOSUR); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE)	Lachaud, JP (corresponding author), El Colegio Frontera Sur, Dept Conservac Biodiversidad, Chetmal, Quintana Roo, Mexico.	jean-paul.lachaud@univ-tlse3.fr	Lachaud, Jean-Paul/H-4266-2019; LACHAUD, Jean-Paul/ABG-3831-2021	LACHAUD, Jean-Paul/0000-0002-5082-8987; Perez-Lachaud, Gabriela/0000-0002-8924-1606	El Colegio de la Frontera Sur; Centre de Recherches sur la Cognition Animale UMR5169 (Centre National de la Recherche Scientique - Universite de Toulouse)	El Colegio de la Frontera Sur; Centre de Recherches sur la Cognition Animale UMR5169 (Centre National de la Recherche Scientique - Universite de Toulouse)	This study was supported financially by El Colegio de la Frontera Sur and by Centre de Recherches sur la Cognition Animale UMR5169 (Centre National de la Recherche Scientique - Universite de Toulouse). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosti D., 2000, BIOL DIVERSITY HDB S; Allan RA, 2001, AUST J ZOOL, V49, P129, DOI 10.1071/ZO00088; [Anonymous], 2013, PSYCHE-CAMBRIDGE, DOI DOI 10.1155/2013/538316; Chase JM, 2013, ECOL LETT, V16, P17, DOI 10.1111/ele.12112; Crozier RH, 2010, MYRMECOL NEWS, V13, P57; Darling DC, 2009, ZOOKEYS, P155, DOI 10.3897/zookeys.20.195; DAVIS LR, 1990, FLA ENTOMOL, V73, P335, DOI 10.2307/3494820; DOROW WHO, 1990, INSECT SOC, V37, P73, DOI 10.1007/BF02223815; DUMPERT K, 1988, Zoologische Beitraege, V32, P217; GASTON KJ, 1991, CONSERV BIOL, V5, P283, DOI 10.1111/j.1523-1739.1991.tb00140.x; Gates MW, 2012, P ENTOMOL SOC WASH, V114, P111, DOI 10.4289/0013-8797.114.1.111; Guenard B, 2012, P NATL ACAD SCI USA, V109, P7368, DOI 10.1073/pnas.1113867109; Hansson C, 2011, ZOOKEYS, P65, DOI 10.3897/zookeys.134.1653; Holldobler B., 1990, pi; Hughes DP, 2008, TRENDS ECOL EVOL, V23, P672, DOI 10.1016/j.tree.2008.07.011; Hughes DP, 2003, INSECT SOC, V50, P148, DOI 10.1007/s00040-003-0637-9; Hughes DP, 2003, INSECT SOC, V50, P62, DOI 10.1007/s000400300010; IUCN, 2013, ICUN RED LIST THREAT; Jenkins CN, 2013, DIVERS DISTRIB, V19, P1084, DOI 10.1111/ddi.12090; Karp DS, 2012, ECOL LETT, V15, P963, DOI 10.1111/j.1461-0248.2012.01815.x; Kathirithamby J, 2002, ANN ENTOMOL SOC AM, V95, P558, DOI 10.1603/0013-8746(2002)095[0558:CFSMPI]2.0.CO;2; Kathirithamby J, 2009, ANNU REV ENTOMOL, V54, P227, DOI 10.1146/annurev.ento.54.110807.090525; Kistner D. H., 1982, Social insects. Vol. III, P1; Kondo T, 2004, NEOTROP ENTOMOL, V33, P717, DOI 10.1590/S1519-566X2004000600009; Krauss J, 2010, ECOL LETT, V13, P597, DOI 10.1111/j.1461-0248.2010.01457.x; Lachaud J. P., 2012, Psyche: A Journal of Entomology, V2012, P342157; Lachaud J-P, 2013, PSYCHE; Lachaud Jean-Paul, 2012, Psyche (Cambridge), V2012; Liefke C, 1998, INSECT SOC, V45, P411, DOI 10.1007/s000400050098; Maeyama T, 1999, AUST J ENTOMOL, V38, P305, DOI 10.1046/j.1440-6055.1999.00130.x; MATHEW A. P., 1954, JOUR BOMBAY NAT HIST SOC, V52, P249; MAY RM, 1988, SCIENCE, V241, P1441, DOI 10.1126/science.241.4872.1441; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001127; Morrison H., 1922, Psyche Boston Mass, V29, P132, DOI 10.1155/1922/21654; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; MYNHARDT G, 2013, PSYCHE-J ENTOMOL, V2013, pNIL1, DOI DOI 10.1155/2013/696401; Offenberg J, 2006, BIOTROPICA, V38, P782, DOI 10.1111/j.1744-7429.2006.00206.x; Perez-Lachaud G., 2013, Psyche: A Journal of Entomology, V2013, P230601, DOI 10.1155/2013/230601; Perez-Lachaud G, 2006, BIOTROPICA, V38, P574, DOI 10.1111/j.1744-7429.2006.00169.x; Perez-Lachaud G, 2014, BIOL J LINN SOC, V111, P462, DOI 10.1111/bij.12220; Perez-Lachaud G, 2012, FLA ENTOMOL, V95, P1066, DOI 10.1653/024.095.0436; Perez-Lachaud G, 2011, FLA ENTOMOL, V94, P677, DOI 10.1653/024.094.0333; Perfecto I, 2002, CONSERV BIOL, V16, P174, DOI 10.1046/j.1523-1739.2002.99536.x; Philpott SM, 2005, AGROFOREST SYST, V64, P219, DOI 10.1007/s10457-004-2372-2; Philpott SM, 2008, CONSERV BIOL, V22, P1093, DOI 10.1111/j.1523-1739.2008.01029.x; Poinar G, 2006, J INVERTEBR PATHOL, V91, P19, DOI 10.1016/j.jip.2005.10.003; Poinar George Jr, 2012, Psyche (Cambridge), V2012, P1, DOI 10.1155/2012/192017; Purvis A, 2000, SCIENCE, V288, P328, DOI 10.1126/science.288.5464.328; Rettenmeyer CW, 2011, INSECT SOC, V58, P281, DOI 10.1007/s00040-010-0128-8; Rougerie R, 2011, MOL ECOL, V20, P179, DOI 10.1111/j.1365-294X.2010.04918.x; Settele J, 2009, SCIENCE, V325, P41, DOI 10.1126/science.1176892; Stork NE, 2008, INSECT CONSERV DIVER, V1, P114, DOI 10.1111/j.1752-4598.2008.00016.x; Thomas JA, 2009, SCIENCE, V325, P80, DOI 10.1126/science.1175726; Wanless F.R., 1978, Bulletin of the British Museum (Natural History) Zoology, V33, P1; WAY MJ, 1954, B ENTOMOL RES, V45, P113, DOI 10.1017/S0007485300026833; Wheeler G. C., 1924, Psyche Boston, V31, P49, DOI 10.1155/1924/93136; WHEELER WILLIAM MORTON, 1929, PSYCHE, V36, P102, DOI 10.1155/1929/64398; WHEELER WILLIAM MORTON, 1933, PSYCHE, V40, P20, DOI 10.1155/1933/36308	58	16	18	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100155	10.1371/journal.pone.0100155	http://dx.doi.org/10.1371/journal.pone.0100155			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941047	gold, Green Published, Green Submitted			2022-12-27	WOS:000338508200076
J	Brancucci, NMB; Witmer, K; Schmid, C; Voss, TS				Brancucci, Nicolas M. B.; Witmer, Kathrin; Schmid, Christoph; Voss, Till S.			A var Gene Upstream Element Controls Protein Synthesis at the Level of Translation Initiation in Plasmodium falciparum	PLOS ONE			English	Article							REDUCTASE MESSENGER-RNA; ERYTHROCYTE-MEMBRANE PROTEIN-1; MUTUALLY EXCLUSIVE EXPRESSION; PREGNANCY-ASSOCIATED MALARIA; 5' UNTRANSLATED REGION; ANTIGENIC VARIATION; VIRULENCE GENES; DIHYDROFOLATE-REDUCTASE; INFECTED ERYTHROCYTES; CHONDROITIN SULFATE	Clonally variant protein expression in the malaria parasite Plasmodium falciparum generates phenotypic variability and allows isogenic populations to adapt to environmental changes encountered during blood stage infection. The underlying regulatory mechanisms are best studied for the major virulence factor P. falciparum erythrocyte membrane protein 1 (PfEMP1). PfEMP1 is encoded by the multicopy var gene family and only a single variant is expressed in individual parasites, a concept known as mutual exclusion or singular gene choice. var gene activation occurs in situ and is achieved through the escape of one locus from epigenetic silencing. Singular gene choice is controlled at the level of transcription initiation and var 5' upstream (ups) sequences harbour regulatory information essential for mutually exclusive transcription as well as for the trans-generational inheritance of the var activity profile. An additional level of control has recently been identified for the var2csa gene, where an mRNA element in the 5' untranslated region (5' UTR) is involved in the reversible inhibition of translation of var2csa transcripts. Here, we extend the knowledge on post-transcriptional var gene regulation to the common upsC type. We identified a 5' UTR sequence that inhibits translation of upsC-derived mRNAs. Importantly, this 5' UTR element efficiently inhibits translation even in the context of a heterologous upstream region. Further, we found var 5' UTRs to be significantly enriched in uAUGs which are known to impair the efficiency of protein translation in other eukaryotes. Our findings suggest that regulation at the post-transcriptional level is a common feature in the control of PfEMP1 expression in P. falciparum.	[Brancucci, Nicolas M. B.; Witmer, Kathrin; Schmid, Christoph; Voss, Till S.] Swiss Trop & Publ Hlth Inst, Dept Med Parasitol & Infect Biol, Basel, Switzerland; [Brancucci, Nicolas M. B.; Witmer, Kathrin; Schmid, Christoph; Voss, Till S.] Univ Basel, Basel, Switzerland	University of Basel; Swiss Tropical & Public Health Institute; University of Basel	Voss, TS (corresponding author), Swiss Trop & Publ Hlth Inst, Dept Med Parasitol & Infect Biol, Basel, Switzerland.	till.voss@unibas.ch		Brancucci, Nicolas/0000-0003-0655-3266; Witmer, Kathrin/0000-0002-3159-7386	Swiss National Science Foundation [PP00P3_130203]; Boehringer Ingelheim Fonds	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Boehringer Ingelheim Fonds(Boehringer Ingelheim)	This work was supported by the Swiss National Science Foundation (PP00P3_130203; www.snf.ch). N.M.B.B. received a PhD scholarshio from the Boehringer Ingelheim Fonds (www.bifonds.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amulic B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000256; Andrulis ED, 1998, NATURE, V394, P592, DOI 10.1038/29100; Bancells C, 2013, MOL MICROBIOL, V90, P472, DOI 10.1111/mmi.12379; Baruch DI, 1996, P NATL ACAD SCI USA, V93, P3497, DOI 10.1073/pnas.93.8.3497; BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Braks JAM, 2008, NUCLEIC ACIDS RES, V36, P1176, DOI 10.1093/nar/gkm1142; Brancucci NMB, 2012, CELL MICROBIOL, V14, P1836, DOI 10.1111/cmi.12004; Bunnik EM, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-11-r128; Calderwood MS, 2003, J BIOL CHEM, V278, P34125, DOI 10.1074/jbc.M213065200; Chookajorn T, 2007, P NATL ACAD SCI USA, V104, P899, DOI 10.1073/pnas.0609084103; CHU E, 1993, BIOCHEMISTRY-US, V32, P4756, DOI 10.1021/bi00069a009; Cortes A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002943; Cvijovic M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-295; Daubenberger CA, 2003, BIOL CHEM, V384, P1227, DOI 10.1515/BC.2003.135; Deitsch KW, 2001, NATURE, V412, P875, DOI 10.1038/35091146; Duffy MF, 2002, MOL MICROBIOL, V43, P1285, DOI 10.1046/j.1365-2958.2002.02822.x; Duraisingh MT, 2005, CELL, V121, P13, DOI 10.1016/j.cell.2005.01.036; Dzikowski R, 2007, EMBO REP, V8, P959, DOI 10.1038/sj.embor.7401063; Dzikowski R, 2009, CURR GENET, V55, P103, DOI 10.1007/s00294-009-0233-2; Epp C, 2009, RNA, V15, P116, DOI 10.1261/rna.1080109; Ercikan E, 1993, Adv Exp Med Biol, V338, P537; ErcikanAbali EA, 1997, BIOCHEMISTRY-US, V36, P12317, DOI 10.1021/bi971026e; Flueck C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000569; Foth BJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r177; Foth BJ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006411; Freitas-Junior LH, 2000, NATURE, V407, P1018, DOI 10.1038/35039531; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Guizetti J, 2013, CELL MICROBIOL, V15, P718, DOI 10.1111/cmi.12115; Hall N, 2005, SCIENCE, V307, P82, DOI 10.1126/science.1103717; Hasenkamp S, 2013, ACTA TROP, V127, P69, DOI 10.1016/j.actatropica.2013.03.007; Hayden CA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-61; Jiang LB, 2013, NATURE, V499, P223, DOI 10.1038/nature12361; Kozak M, 2005, GENE, V361, P13, DOI 10.1016/j.gene.2005.06.037; Kozak M, 2002, GENE, V299, P1, DOI 10.1016/S0378-1119(02)01056-9; Kyes S, 2001, ANNU REV MICROBIOL, V55, P673, DOI 10.1146/annurev.micro.55.1.673; Kyes S, 2007, MOL MICROBIOL, V63, P1237, DOI 10.1111/j.1365-2958.2007.05587.x; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; LANZER M, 1992, NUCLEIC ACIDS RES, V20, P3051, DOI 10.1093/nar/20.12.3051; Lavstsen T, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-27; Le Roch KG, 2004, GENOME RES, V14, P2308, DOI 10.1101/gr.2523904; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; LEECH JH, 1984, J EXP MED, V159, P1567, DOI 10.1084/jem.159.6.1567; Lemieux JE, 2013, MOL MICROBIOL, V90, P519, DOI 10.1111/mmi.12381; Llinas M, 2006, NUCLEIC ACIDS RES, V34, P1166, DOI 10.1093/nar/gkj517; Lomberk G, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-228; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Lopez-Rubio JJ, 2007, MOL MICROBIOL, V66, P1296, DOI 10.1111/j.1365-2958.2007.06009.x; Lopez-Rubio JJ, 2009, CELL HOST MICROBE, V5, P179, DOI 10.1016/j.chom.2008.12.012; Mair GR, 2006, SCIENCE, V313, P667, DOI 10.1126/science.1125129; Mair GR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000767; Marty AJ, 2006, MOL MICROBIOL, V62, P72, DOI 10.1111/j.1365-2958.2006.05364.x; Mok BW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001982; Noviyanti R, 2001, MOL BIOCHEM PARASIT, V114, P227, DOI 10.1016/S0166-6851(01)00266-3; O'Donnell RA, 2001, NUCLEIC ACIDS RES, V29, P716, DOI 10.1093/nar/29.3.716; Otto TD, 2010, MOL MICROBIOL, V76, P12, DOI 10.1111/j.1365-2958.2009.07026.x; Perez-Toledo K, 2009, NUCLEIC ACIDS RES, V37, P2596, DOI 10.1093/nar/gkp115; Pestova TV, 2001, P NATL ACAD SCI USA, V98, P7029, DOI 10.1073/pnas.111145798; Petter M, 2013, MOL MICROBIOL, V87, P1167, DOI 10.1111/mmi.12154; Ralph SA, 2005, P NATL ACAD SCI USA, V102, P5414, DOI 10.1073/pnas.0408883102; Reeder JC, 1999, P NATL ACAD SCI USA, V96, P5198, DOI 10.1073/pnas.96.9.5198; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; Salcedo-Amaya AM, 2009, P NATL ACAD SCI USA, V106, P9655, DOI 10.1073/pnas.0902515106; Scherf A, 1998, EMBO J, V17, P5418, DOI 10.1093/emboj/17.18.5418; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Spriggs KA, 2010, MOL CELL, V40, P228, DOI 10.1016/j.molcel.2010.09.028; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Tai NW, 2004, BIOCHEM J, V378, P999, DOI 10.1042/BJ20031396; Taylor HM, 2000, MOL BIOCHEM PARASIT, V110, P391, DOI 10.1016/S0166-6851(00)00286-3; Tonkin CJ, 2009, PLOS BIOL, V7, P771, DOI 10.1371/journal.pbio.1000084; TRAGER W, 1978, NATURE, V273, P621, DOI 10.1038/273621a0; van der Velden AW, 1999, INT J BIOCHEM CELL B, V31, P87, DOI 10.1016/S1357-2725(98)00134-4; Voss TS, 2007, MOL MICROBIOL, V66, P139, DOI 10.1111/j.1365-2958.2007.05899.x; Voss TS, 2006, NATURE, V439, P1004, DOI 10.1038/nature04407; Ward CP, 1999, MOL BIOCHEM PARASIT, V102, P167, DOI 10.1016/S0166-6851(99)00106-1; Witmer K, 2012, MOL MICROBIOL, V84, P243, DOI 10.1111/j.1365-2958.2012.08019.x; Zhang K, 2002, SCIENCE, V296, P545, DOI 10.1126/science.1068274; Zhang M, 2010, J EXP MED, V207, P1, DOI 10.1084/jem.20091975	81	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100183	10.1371/journal.pone.0100183	http://dx.doi.org/10.1371/journal.pone.0100183			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937593	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000338503400088
J	Kim, HK; Park, WC; Lee, KM; Hwang, HL; Park, SY; Sorn, S; Chandra, V; Kim, KG; Yoon, WB; Bae, JS; Shin, HD; Shin, JY; Seoh, JY; Kim, JI; Hong, KM				Kim, Hyun-Kyoung; Park, Won Cheol; Lee, Kwang Man; Hwang, Hai-Li; Park, Seong-Yeol; Sorn, Sungbin; Chandra, Vishal; Kim, Kwang Gi; Yoon, Woong-Bae; Bae, Joon Seol; Shin, Hyoung Doo; Shin, Jong-Yeon; Seoh, Ju-Young; Kim, Jong-Il; Hong, Kyeong-Man			Targeted Next-Generation Sequencing at Copy-Number Breakpoints for Personalized Analysis of Rearranged Ends in Solid Tumors	PLOS ONE			English	Article							MINIMAL RESIDUAL DISEASE; BALANCED CHROMOSOME REARRANGEMENTS; COMPETITIVE PCR; BREAST-CANCER; GENE; TRANSLOCATIONS; LEUKEMIA; AMPLIFICATION; ABERRATIONS; VALIDATION	Background: The concept of the utilization of rearranged ends for development of personalized biomarkers has attracted much attention owing to its clinical applicability. Although targeted next-generation sequencing (NGS) for recurrent rearrangements has been successful in hematologic malignancies, its application to solid tumors is problematic due to the paucity of recurrent translocations. However, copy-number breakpoints (CNBs), which are abundant in solid tumors, can be utilized for identification of rearranged ends. Method: As a proof of concept, we performed targeted next-generation sequencing at copy-number breakpoints (TNGS-CNB) in nine colon cancer cases including seven primary cancers and two cell lines, COLO205 and SW620. For deduction of CNBs, we developed a novel competitive single-nucleotide polymorphism (cSNP) microarray method entailing CNB-region refinement by competitor DNA. Result: Using TNGS-CNB, 19 specific rearrangements out of 91 CNBs (20.9%) were identified, and two polymerase chain reaction (PCR)-amplifiable rearrangements were obtained in six cases (66.7%). And significantly, TNGS-CNB, with its high positive identification rate (82.6%) of PCR-amplifiable rearrangements at candidate sites (19/23), just from filtering of aligned sequences, requires little effort for validation. Conclusion: Our results indicate that TNGS-CNB, with its utility for identification of rearrangements in solid tumors, can be successfully applied in the clinical laboratory for cancer-relapse and therapy-response monitoring.	[Kim, Hyun-Kyoung; Hwang, Hai-Li; Park, Seong-Yeol; Sorn, Sungbin; Chandra, Vishal; Kim, Kwang Gi; Yoon, Woong-Bae; Hong, Kyeong-Man] Natl Canc Ctr, Res Inst, Goyang, Gyeonggi Do, South Korea; [Kim, Hyun-Kyoung; Seoh, Ju-Young] Ewha Womans Univ, Sch Med, Dept Microbiol, Seoul, South Korea; [Park, Won Cheol; Lee, Kwang Man] Wonkwang Univ, Sch Med, Dept Surg, Iksan, South Korea; [Bae, Joon Seol] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Lab Translat Genom,Samsung Genome Inst, Seoul, South Korea; [Shin, Hyoung Doo] Sogang Univ, Dept Life Sci, Seoul, South Korea; [Shin, Hyoung Doo] SNP Genet Inc, Dept Genet Epidemiol, Seoul, South Korea; [Shin, Jong-Yeon; Kim, Jong-Il] Seoul Natl Univ, Med Res Ctr, Genom Med Inst, Seoul, South Korea; [Kim, Jong-Il] Seoul Natl Univ, Grad Sch, Dept Biomed Sci, Seoul, South Korea; [Kim, Jong-Il] Seoul Natl Univ, Coll Med, Dept Biochem & Mol Biol, Seoul, South Korea	National Cancer Center - Korea (NCC); Ewha Womans University; Wonkwang University; Samsung; Sungkyunkwan University (SKKU); Samsung Medical Center; Sogang University; SNP Genetics; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Hong, KM (corresponding author), Natl Canc Ctr, Res Inst, Goyang, Gyeonggi Do, South Korea.	kmhong@ncc.re.kr	KIM, JONG-IL/D-1019-2011; Yoon, Woong/A-2606-2016; Chandra, Vishal/AAN-8756-2020	KIM, JONG-IL/0000-0002-7240-3744; Yoon, Woong/0000-0002-8598-3127; SEOH, JU-YOUNG/0000-0002-1168-5354	Basic Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [1031020]; National Cancer Center through the Korean Ministry of Health and Welfare [1110130]	Basic Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology; National Cancer Center through the Korean Ministry of Health and Welfare	This work was supported by a grant to K.-M. H. from the Basic Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science and Technology (1031020), and by a grant to K.-M. H. from the National Cancer Center through the Korean Ministry of Health and Welfare (1110130). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeysinghe SS, 2003, HUM MUTAT, V22, P229, DOI 10.1002/humu.10254; Andersson A, 2001, LEUKEMIA, V15, P1293, DOI 10.1038/sj.leu.2402189; Buccisano F, 2012, BLOOD, V119, P332, DOI 10.1182/blood-2011-08-363291; Bzymek M, 2001, P NATL ACAD SCI USA, V98, P8319, DOI 10.1073/pnas.111008398; Chendamarai E, 2012, BLOOD, V119, P3413, DOI 10.1182/blood-2011-11-393264; Chiang C, 2012, NAT GENET, V44, P390, DOI 10.1038/ng.2202; Corbacioglu A, 2010, J CLIN ONCOL, V28, P3724, DOI 10.1200/JCO.2010.28.6468; Croce CM, 1999, J CLIN ONCOL, V17, P1618, DOI 10.1200/JCO.1999.17.5.1618; CROSS NCP, 1994, LEUKEMIA, V8, P186; Ding CM, 2003, P NATL ACAD SCI USA, V100, P3059, DOI 10.1073/pnas.0630494100; Duncavage EJ, 2012, MODERN PATHOL, V25, P795, DOI 10.1038/modpathol.2012.29; Duncavage EJ, 2011, J MOL DIAGN, V13, P325, DOI 10.1016/j.jmoldx.2011.01.006; Fan JB, 2002, GENOMICS, V79, P58, DOI 10.1006/geno.2001.6676; Guffanti A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-163; Ju YS, 2012, GENOME RES, V22, P436, DOI 10.1101/gr.133645.111; Ju YS, 2011, NAT GENET, V43, P745, DOI 10.1038/ng.872; Kim HK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069414; Kolomietz E, 2002, GENE CHROMOSOME CANC, V35, P97, DOI 10.1002/gcc.10111; LaFramboise T, 2009, NUCLEIC ACIDS RES, V37, P4181, DOI 10.1093/nar/gkp552; Leary RJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000702; Li YD, 2012, HUM MOL GENET, V21, P4957, DOI 10.1093/hmg/dds340; Luthra R, 2009, CLIN CHEM, V55, P2077, DOI 10.1373/clinchem.2009.136143; Lyon E, 2001, CLIN CHEM, V47, P844; Marotta M, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3362; McBride DJ, 2010, GENE CHROMOSOME CANC, V49, P1062, DOI 10.1002/gcc.20815; Meyerson M, 2010, NAT REV GENET, V11, P685, DOI 10.1038/nrg2841; Oosting J, 2007, GENOME RES, V17, P368, DOI 10.1101/gr.5686107; Paietta E, 2012, HEMATOL-AM SOC HEMAT, P35, DOI 10.1182/asheducation-2012.1.35; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Salto-Tellez M, 2003, J MOL DIAGN, V5, P231, DOI 10.1016/S1525-1578(10)60479-5; Sato M, 1998, HUM GENET, V103, P96, DOI 10.1007/s004390050790; Schluth-Bolard C, 2013, J MED GENET, V50, P144, DOI 10.1136/jmedgenet-2012-101351; Sengupta N, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-1; Siraj AK, 2002, CLIN CANCER RES, V8, P3832; Talkowski ME, 2011, AM J HUM GENET, V88, P469, DOI 10.1016/j.ajhg.2011.03.013; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Watanabe A, 2011, P NATL ACAD SCI USA, V108, P12384, DOI 10.1073/pnas.0906930108; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Xiao Z, 2001, LEUKEMIA, V15, P1906, DOI 10.1038/sj.leu.2402318	39	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100089	10.1371/journal.pone.0100089	http://dx.doi.org/10.1371/journal.pone.0100089			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937453	Green Published, gold, Green Submitted			2022-12-27	WOS:000338503400072
J	Robb, CK				Robb, Carolyn K.			Assessing the Impact of Human Activities on British Columbia's Estuaries	PLOS ONE			English	Article							BIODIVERSITY CONSERVATION; CLIMATE-CHANGE; COASTAL; MANAGEMENT; CHALLENGES; RECOVERY; LAND	The world's marine and coastal ecosystems are under threat and single-sector management efforts have failed to address those threats. Scientific consensus suggests that management should evolve to focus on ecosystems and their human, ecological, and physical components. Estuaries are recognized globally as one of the world's most productive and most threatened ecosystems and many estuarine areas in British Columbia (BC) have been lost or degraded. To help prioritize activities and areas for regional management efforts, spatial information on human activities that adversely affect BC's estuaries was compiled. Using statistical analyses, estuaries were assigned to groups facing related threats that could benefit from similar management. The results show that estuaries in the most populated marine ecosections have the highest biological importance but also the highest impacts and the lowest levels of protection. This research is timely, as it will inform ongoing marine planning, land acquisition, and stewardship efforts in BC.	Royal Roads Univ, Sch Environm & Management, Victoria, BC, Canada		Robb, CK (corresponding author), Royal Roads Univ, Sch Environm & Management, Victoria, BC, Canada.	ckrobb18@hotmail.com			Living Oceans Society	Living Oceans Society	Living Oceans Society (www.livingoceans.org), an environmental non-profit organization and the author's employer, provided the computer and GIS software used in the completion of this research. No other funding assistance was received. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agardy T, 2011, MAR POLICY, V35, P226, DOI 10.1016/j.marpol.2010.10.006; Austin M.A., 2008, TAKING NATURES PULSE; Balmford A, 2003, P NATL ACAD SCI USA, V100, P1046, DOI 10.1073/pnas.0236945100; Ban NC, 2013, MAR POLICY, V39, P11, DOI 10.1016/j.marpol.2012.10.017; Ban NC, 2010, MAR POLICY, V34, P876, DOI 10.1016/j.marpol.2010.01.010; Barbier EB, 2012, REV ENV ECON POLICY, V6, P1, DOI 10.1093/reep/rer017; Baustian JJ, 2012, GLOBAL CHANGE BIOL, V18, P3377, DOI 10.1111/j.1365-2486.2012.02792.x; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Callaway GC, 2009, WETLAND HABITAT N AM, P285; Campbell CR, 2010, BLUE CARBON BRIT COL; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Crowder L, 2008, MAR POLICY, V32, P772, DOI 10.1016/j.marpol.2008.03.012; DFO, 2008, ROL PROV TERR GOV OC; DFO, 2005, CAN OC ACT PLAN PRES; dfo (Department of Fisheries and Ocean), 2002, POL OP FRAM INT MAN; Douvere F, 2008, MAR POLICY, V32, P762, DOI 10.1016/j.marpol.2008.03.021; Edgar GJ, 2000, BIOL CONSERV, V92, P383, DOI 10.1016/S0006-3207(99)00111-1; Emmett R, 2000, ESTUARIES, V23, P765, DOI 10.2307/1352998; Environment Canada, 1999, DRAFT CAN NAT PROGR; Feely RA, 2010, ESTUAR COAST SHELF S, V88, P442, DOI 10.1016/j.ecss.2010.05.004; Galbraith H, 2002, WATERBIRDS, V25, P173, DOI 10.1675/1524-4695(2002)025[0173:GCCASL]2.0.CO;2; Gleason MG, 2006, FRONT ECOL ENVIRON, V4, P249, DOI 10.1890/1540-9295(2006)004[0249:AGIMCI]2.0.CO;2; Google, 2012, GOOGL EARTH V 6 1; Government of Canada, 2011, NAT FRAM CAN NETW MA; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Herr D., 2012, BLUE CARBON POLICY F; Hutchings JA, 2012, SUSTAINING CANADIAN; Imperial MT, 1996, COAST MANAGE, V24, P115, DOI 10.1080/08920759609362286; Jessen S, 2011, SCI BASED GUIDELINES; Joppa LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008273; Kelsey E, 1995, PACIFIC ESTUARY CONS; Kennish MJ, 2002, ENVIRON CONSERV, V29, P78, DOI 10.1017/S0376892902000061; Klein CJ, 2008, CONSERV BIOL, V22, P691, DOI 10.1111/j.1523-1739.2008.00896.x; Leschine TM, 2003, ESTUARIES, V26, P1189, DOI 10.1007/BF02803373; Lindeboom H., 2005, GLO CH IGBP, P1, DOI 10.1007/3-540-27851-6_1; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Luck GW, 2009, CONSERV LETT, V2, P179, DOI 10.1111/j.1755-263X.2009.00064.x; McLeod K.L., 2005, SCI CONSENSUS STATEM; Merrifield MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017407; Millennium Ecosystem Assessment, 2005, EC HUM WELLB FRAM AS; Nelleman C, 2009, BLUE CARBON RAPID RE; Nicolas D, 2011, REG ENVIRON CHANGE, V11, P639, DOI 10.1007/s10113-010-0196-3; Okey T., 2012, CLIMATE CHANGE IMPAC; Quigley MP, 1999, AQUAT CONSERV, V9, P63, DOI 10.1002/(SICI)1099-0755(199901/02)9:1<63::AID-AQC327>3.3.CO;2-R; Robb CK, 2011, MAR POLICY, V35, P309, DOI 10.1016/j.marpol.2010.10.010; Ryder JL, 2006, ALIVE INSEPARABLE BR, V35-41; Ryder JL, 2007, INTEGRATED BIOPHYSIC; Scavia D, 2002, ESTUARIES, V25, P149, DOI 10.1007/BF02691304; Sloan NA, 2007, CONSERV BIOL, V21, P897, DOI 10.1111/j.1523-1739.2007.00731.x; Smith H, 2011, J COAST CONSERV, V15, P291, DOI 10.1007/s11852-010-0098-z; Systat Software, 2010, SYST V 13; Teck SJ, 2010, ECOL APPL, V20, P1402, DOI 10.1890/09-1173.1; Wang TL, 2012, J APPL METEOROL CLIM, V51, P16, DOI 10.1175/JAMC-D-11-043.1; Williams G. L., 2002, REV ESTUARY MANAGEME	55	14	15	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99578	10.1371/journal.pone.0099578	http://dx.doi.org/10.1371/journal.pone.0099578			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK5YM	24937486	gold, Green Published, Green Submitted			2022-12-27	WOS:000338503400024
J	Blom, SM; Rottlander, M; Kehler, J; Bundgaard, C; Schmitt, N; Jensen, HS				Blom, Sigrid Marie; Rottlander, Mario; Kehler, Jan; Bundgaard, Christoffer; Schmitt, Nicole; Jensen, Henrik Sindal			From Pan-Reactive K(V)7 Channel Opener to Subtype Selective Opener/Inhibitor by Addition of a Methyl Group	PLOS ONE			English	Article							KCNQ POTASSIUM CHANNELS; ANTICONVULSANT RETIGABINE; KV7 CHANNELS; GENE; MUTATION; ACETYLCHOLINE; ACTIVATION; ICA-27243; EPILEPSY; RELEASE	The voltage-gated potassium channels of the K(V)7 family (K(V)7.1-5) play important roles in controlling neuronal excitability and are therefore attractive targets for treatment of CNS disorders linked to hyperexcitability. One of the main challenges in developing K(V)7 channel active drugs has been to identify compounds capable of discriminating between the neuronally expressed subtypes (K(V)7.2-5), aiding the identification of the subunit composition of K(V)7 currents in various tissues, and possessing better therapeutic potential for particular indications. By taking advantage of the structure-activity relationship of acrylamide K(V)7 channel openers and the effects of these compounds on mutant K(V)7 channels, we have designed and synthesized a novel K(V)7 channel modulator with a unique profile. The compound, named SMB-1, is an inhibitor of K(V)7.2 and an activator of K(V)7.4. SMB-1 inhibits K(V)7.2 by reducing the current amplitude and increasing the time constant for the slow component of the activation kinetics. The activation of K(V)7.4 is seen as an increase in the current amplitude and a slowing of the deactivation kinetics. Experiments studying mutant channels with a compromised binding site for the K(V)7.2-5 opener retigabine indicate that SMB-1 binds within the same pocket as retigabine for both inhibition of K(V)7.2 and activation of K(V)7.4. SMB-1 may serve as a valuable tool for K(V)7 channel research and may be used as a template for further design of better subtype selective K(V)7 channel modulators. A compound with this profile could hold novel therapeutic potential such as the treatment of both positive and cognitive symptoms in schizophrenia.	[Blom, Sigrid Marie; Jensen, Henrik Sindal] H Lundbeck & Co AS, Div Neurosci Drug Discovery, Copenhagen, Denmark; [Rottlander, Mario; Kehler, Jan; Bundgaard, Christoffer] H Lundbeck & Co AS, Div Discovery Chem, Copenhagen, Denmark; [Rottlander, Mario; Kehler, Jan; Bundgaard, Christoffer] H Lundbeck & Co AS, DMPK, Copenhagen, Denmark; [Blom, Sigrid Marie; Schmitt, Nicole] Univ Copenhagen, Fac Hlth & Med Sci, Dept Biomed Sci, Copenhagen, Denmark; [Blom, Sigrid Marie; Schmitt, Nicole] Univ Copenhagen, Fac Hlth & Med Sci, Danish Natl Res Fdn Ctr Cardiac Arrhythmia, Copenhagen, Denmark	Lundbeck Corporation; Lundbeck Corporation; Lundbeck Corporation; University of Copenhagen; Danmarks Grundforskningsfond; University of Copenhagen	Jensen, HS (corresponding author), H Lundbeck & Co AS, Div Neurosci Drug Discovery, Copenhagen, Denmark.	HSIN@Lundbeck.com	Schmitt, Nicole/B-8725-2012	Schmitt, Nicole/0000-0001-9482-9749	Danish National Research Foundation Centre for Cardiac Arrhythmia	Danish National Research Foundation Centre for Cardiac Arrhythmia(Danmarks Grundforskningsfond)	Funding was provided by the Danish National Research Foundation Centre for Cardiac Arrhythmia (www.DARC.ku.dk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIKEN SP, 1995, BRIT J PHARMACOL, V115, P1163, DOI 10.1111/j.1476-5381.1995.tb15019.x; Bentzen BH, 2006, NEUROPHARMACOLOGY, V51, P1068, DOI 10.1016/j.neuropharm.2006.07.001; Biervert C, 1998, SCIENCE, V279, P403, DOI 10.1126/science.279.5349.403; Blackburn-Munro G, 2003, EUR J PHARMACOL, V460, P109, DOI 10.1016/S0014-2999(02)02924-2; Blom SM, 2010, PHARMACOLOGY, V86, P174, DOI 10.1159/000317525; Blom SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008251; BROWN DA, 1980, NATURE, V283, P673, DOI 10.1038/283673a0; Chadha PS, 2014, ARTERIOSCL THROM VAS, V34, P887, DOI 10.1161/ATVBAHA.114.303405; Chadha PS, 2012, HYPERTENSION, V59, P877, DOI 10.1161/HYPERTENSIONAHA.111.187427; Charlier C, 1998, NAT GENET, V18, P53, DOI 10.1038/ng0198-53; COOK L, 1990, DRUG DEVELOP RES, V19, P301, DOI 10.1002/ddr.430190308; Duncan GE, 1999, BRAIN RES REV, V29, P250, DOI 10.1016/S0165-0173(99)00002-8; Greenwood IA, 2009, BRIT J PHARMACOL, V156, P1196, DOI 10.1111/j.1476-5381.2009.00131.x; Gribkoff VK, 2008, EXPERT OPIN THER TAR, V12, P565, DOI 10.1517/14728222.12.5.565 ; Hansen HH, 2008, J PHYSIOL-LONDON, V586, P1823, DOI 10.1113/jphysiol.2007.149450; Hansen HH, 2007, EUR J PHARMACOL, V570, P77, DOI 10.1016/j.ejphar.2007.05.029; Hansen HH, 2006, J PHARMACOL EXP THER, V318, P1006, DOI 10.1124/jpet.106.106757; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; Khanamiri S, 2013, HYPERTENSION, V62, P1090, DOI 10.1161/HYPERTENSIONAHA.113.01244; Korsgaard MPG, 2005, J PHARMACOL EXP THER, V314, P282, DOI 10.1124/jpet.105.083923; Lange W, 2009, MOL PHARMACOL, V75, P272, DOI 10.1124/mol.108.052282; LIEBERMAN JA, 1987, PSYCHOPHARMACOLOGY, V91, P415, DOI 10.1007/BF00216006; Mackie AR, 2008, MOL PHARMACOL, V74, P1171, DOI 10.1124/mol.108.049825; Miceli F, 2008, CURR OPIN PHARMACOL, V8, P65, DOI 10.1016/j.coph.2007.10.003; Mueser KT, 2004, LANCET, V363, P2063, DOI 10.1016/S0140-6736(04)16458-1; NICKOLSON VJ, 1990, DRUG DEVELOP RES, V19, P285, DOI 10.1002/ddr.430190307; Padilla K, 2009, NEUROSCI LETT, V465, P138, DOI 10.1016/j.neulet.2009.08.071; Redrobe JP, 2012, PSYCHOPHARMACOLOGY, V221, P451, DOI 10.1007/s00213-011-2593-9; Risgaard R, 2013, NUCL MED BIOL, V40, P135, DOI 10.1016/j.nucmedbio.2012.09.010; Schenzer A, 2005, J NEUROSCI, V25, P5051, DOI 10.1523/JNEUROSCI.0128-05.2005; SEEMAN P, 1987, SYNAPSE, V1, P133, DOI 10.1002/syn.890010203; Singh NA, 1998, NAT GENET, V18, P25, DOI 10.1038/ng0198-25; Sogaard R, 2001, AM J PHYSIOL-CELL PH, V280, pC859; Stott JB, 2013, DRUG DISCOV TODAY; Talebizadeh Z, 1999, HUM MUTAT, V14, P493, DOI 10.1002/(SICI)1098-1004(199912)14:6<493::AID-HUMU8>3.0.CO;2-P; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Wu YJ, 2004, J MED CHEM, V47, P2887, DOI 10.1021/jm0305826; Wu YJ, 2004, BIOORG MED CHEM LETT, V14, P1991, DOI 10.1016/j.bmcl.2004.01.069; Wu YJ, 2003, J MED CHEM, V46, P3197, DOI 10.1021/jm034073f; Wuttke TV, 2005, MOL PHARMACOL, V67, P1009, DOI 10.1124/mol.104.010793; Xiong QJ, 2008, P NATL ACAD SCI USA, V105, P3128, DOI 10.1073/pnas.0712256105	42	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100209	10.1371/journal.pone.0100209	http://dx.doi.org/10.1371/journal.pone.0100209			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956197	gold, Green Published, Green Submitted			2022-12-27	WOS:000338917900033
J	Green, BJ; Wiriyachaiporn, S; Grainge, C; Rogers, GB; Kehagia, V; Lau, L; Carroll, MP; Bruce, KD; Howarth, PH				Green, Benjamin J.; Wiriyachaiporn, Surasa; Grainge, Christopher; Rogers, Geraint B.; Kehagia, Valia; Lau, Laurie; Carroll, Mary P.; Bruce, Kenneth D.; Howarth, Peter H.			Potentially Pathogenic Airway Bacteria and Neutrophilic Inflammation in Treatment Resistant Severe Asthma	PLOS ONE			English	Article							INDUCED SPUTUM; DIVERSITY; COLONIZATION; COMMUNITIES; HETEROGENEITY; MICROBIOME; DISEASE; SAMPLES	Background: Molecular microbiological analysis of airway samples in asthma has demonstrated an altered microbiome in comparison to healthy controls. Such changes may have relevance to treatment-resistant severe asthma, particularly those with neutrophilic airway inflammation, as bacteria might be anticipated to activate the innate immune response, a process that is poorly steroid responsive. An understanding of the relationship between airway bacterial presence and dominance in severe asthma may help direct alternative treatment approaches. Objective: We aimed to use a culture independent analysis strategy to describe the presence, dominance and abundance of bacterial taxa in induced sputum from treatment resistant severe asthmatics and correlate findings with clinical characteristics and airway inflammatory markers. Methods: Induced sputum was obtained from 28 stable treatment-resistant severe asthmatics. The samples were divided for supernatant IL-8 measurement, cytospin preparation for differential cell count and Terminal Restriction Fragment Length Polymorphism (T-RFLP) profiling for bacterial community analysis. Results: In 17/28 patients, the dominant species within the airway bacterial community was Moraxella catarrhalis or a member of the Haemophilus or Streptococcus genera. Colonisation with these species was associated with longer asthma disease duration (mean (SD) 31.8 years (16.7) vs 15.6 years (8.0), p = 0.008), worse post-bronchodilator percent predicted FEV1 (68.0% (24.0) vs 85.5% (19.7), p = 0.025) and higher sputum neutrophil differential cell counts (median (IQR) 80% (67-83) vs 43% (29-67), p = 0.001). Total abundance of these organisms significantly and positively correlated with sputum IL-8 concentration and neutrophil count. Conclusions: Airway colonisation with potentially pathogenic micro-organisms in asthma is associated with more severe airways obstruction and neutrophilic airway inflammation. This altered colonisation may have a role in the development of an asthma phenotype that responds less well to current asthma therapies.	[Green, Benjamin J.; Grainge, Christopher; Kehagia, Valia; Lau, Laurie; Carroll, Mary P.; Howarth, Peter H.] Univ Southampton, Fac Med, Acad Unit Clin & Expt Sci, Southampton SO9 5NH, Hants, England; [Green, Benjamin J.; Grainge, Christopher; Kehagia, Valia; Lau, Laurie; Carroll, Mary P.; Howarth, Peter H.] Univ Southampton, Fac Med, NIHR Resp Biomed Res Unit, Southampton SO9 5NH, Hants, England; [Wiriyachaiporn, Surasa; Rogers, Geraint B.; Bruce, Kenneth D.] Kings Coll London, Div Pharmaceut Sci, Mol Microbiol Res Lab, London WC2R 2LS, England; [Grainge, Christopher] John Hunter Hosp, Hunter Med Res, Dept Resp & Sleep Med, Newcastle, NSW, Australia; [Rogers, Geraint B.] Flinders Univ S Australia, Sch Med, SAHMRI Infect & Immun Theme, Adelaide, SA 5001, Australia	University of Southampton; University of Southampton; University of London; King's College London; Hunter Medical Research Institute; John Hunter Hospital; Flinders University South Australia; South Australian Health & Medical Research Institute (SAHMRI)	Howarth, PH (corresponding author), Univ Southampton, Fac Med, Acad Unit Clin & Expt Sci, Southampton SO9 5NH, Hants, England.	p.h.howarth@southampton.ac.uk	Rogers, Geraint/AAD-1011-2020; Rogers, Geraint B/N-1957-2013	Rogers, Geraint B/0000-0003-4054-1947; Howarth, Peter/0000-0003-0619-7927; Grainge, Christopher/0000-0002-6565-9928	Medical Research Council [G0900453]; MRC [G0800649, G0900453] Funding Source: UKRI; Medical Research Council [G0800649] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was funded by the Medical Research Council (G0900453). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacci E, 2006, CHEST, V129, P565, DOI 10.1378/chest.129.3.565; Banerjee D, 2004, EUR RESPIR J, V23, P685, DOI 10.1183/09031936.04.00056804; British Thoracic Society Scottish Intercollegiate Guidelines Network, 2008, Thorax, V63 Suppl 4, piv1, DOI 10.1136/thx.2008.097741; Bisgaard H, 2007, NEW ENGL J MED, V357, P1487, DOI 10.1056/NEJMoa052632; Breekveldt-Postma NS, 2008, CURR MED RES OPIN, V24, P975, DOI [10.1185/030079908X280518, 10.1185/030079908X280518 ]; Brusselle GG, 2013, THORAX, V68, P322, DOI 10.1136/thoraxjnl-2012-202698; Cabrera-Rubio R, 2012, J CLIN MICROBIOL, V50, P3562, DOI 10.1128/JCM.00767-12; Gibson PG, 2001, CHEST, V119, P1329, DOI 10.1378/chest.119.5.1329; Goleva E, 2013, AM J RESP CRIT CARE, V188, P1193, DOI 10.1164/rccm.201304-0775OC; Green RH, 2002, THORAX, V57, P875, DOI 10.1136/thorax.57.10.875; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Huang YJ, 2011, J ALLERGY CLIN IMMUN, V127, P372, DOI 10.1016/j.jaci.2010.10.048; Jatakanon A, 1999, AM J RESP CRIT CARE, V160, P1532, DOI 10.1164/ajrccm.160.5.9806170; Marri PR, 2013, J ALLERGY CLIN IMMUN, V131, P346, DOI 10.1016/j.jaci.2012.11.013; Paggiaro PL, 2002, EUR RESPIR J, V20, p3S, DOI 10.1183/09031936.02.00000302; Patel IS, 2002, THORAX, V57, P759, DOI 10.1136/thorax.57.9.759; Pavord ID, 1999, LANCET, V353, P2213, DOI 10.1016/S0140-6736(99)01813-9; Pizzichini E, 1996, AM J RESP CRIT CARE, V154, P308, DOI 10.1164/ajrccm.154.2.8756799; Proceedings of the ATS workshop on refractory asthma: current understanding recommendations and unanswered questions. American Thoracic Society, 2000, P ATS WORKSH REFR AS, V162, P2341; Richeldi L, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002997.pub3; Rogers GB, 2006, J CLIN MICROBIOL, V44, P2601, DOI 10.1128/JCM.02282-05; Rogers GB, 2004, J CLIN MICROBIOL, V42, P5176, DOI 10.1128/JCM.42.11.5176-5183.2004; Rogers GB, 2003, J CLIN MICROBIOL, V41, P3548, DOI 10.1128/JCM.41.8.3548-3558.2003; Rogers Geraint B, 2014, Ann Am Thorac Soc, V11, P496, DOI 10.1513/AnnalsATS.201310-335OC; Rogers GB, 2013, THORAX, V68, P731, DOI 10.1136/thoraxjnl-2012-203105; Rogers GB, 2010, J CLIN MICROBIOL, V48, P78, DOI 10.1128/JCM.01324-09; Sethi S, 2006, AM J RESP CRIT CARE, V173, P991, DOI 10.1164/rccm.200509-1525OC; Simpson JL, 2008, AM J RESP CRIT CARE, V177, P148, DOI 10.1164/rccm.200707-1134OC; Simpson JL, 2007, THORAX, V62, P211, DOI 10.1136/thx.2006.061358; Stressmann FA, 2012, THORAX, V67, P867, DOI 10.1136/thoraxjnl-2011-200932; Szefler SJ, 2011, ANN ALLERG ASTHMA IM, V107, P110, DOI 10.1016/j.anai.2011.04.008; Wilkinson TMA, 2003, AM J RESP CRIT CARE, V167, P1090, DOI 10.1164/rccm.200210-1179OC; Yang IA, 2006, CURR OPIN ALLERGY CL, V6, P23, DOI 10.1097/01.all.0000200503.77295.bb	33	180	186	4	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100645	10.1371/journal.pone.0100645	http://dx.doi.org/10.1371/journal.pone.0100645			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955983	Green Published, gold			2022-12-27	WOS:000338917900076
J	Huang, WQ; Yao, YF; Long, Q; Yang, X; Sun, WJ; Liu, CB; Jin, XM; Li, Y; Chu, XJ; Chen, B; Ma, YB				Huang, Weiwei; Yao, Yufeng; Long, Qiong; Yang, Xu; Sun, Wenjia; Liu, Cunbao; Jin, Xiaomei; Li, Yang; Chu, Xiaojie; Chen, Bin; Ma, Yanbing			Immunization against Multidrug-Resistant Acinetobacter baumannii Effectively Protects Mice in both Pneumonia and Sepsis Models	PLOS ONE			English	Article							OUTER-MEMBRANE VESICLES; VACCINE; MECHANISMS; IL-33; ST2	Objective: Acinetobacter baumannii is considered the prototypical example of a multi-or pan-drug-resistant bacterium. It has been increasingly implicated as a major cause of nosocomial and community-associated infections. This study proposed to evaluate the efficacy of immunological approaches to prevent and treat A. baumannii infections. Methods: Mice were immunized with outer membrane vesicles (OMVs) prepared from a clinically isolated multidrug-resistant strain of A. baumannii. Pneumonia and sepsis models were used to evaluate the efficacy of active and passive immunization with OMVs. The probable effective mechanisms and the protective potential of clonally distinct clinical isolates were investigated in vitro using an opsonophagocytic assay. Results: Intramuscular immunization with OMVs rapidly produced high levels of OMV-specific IgG antibodies, and subsequent intranasal challenge with A. baumannii elicited mucosal IgA and IgG responses. Both active and passive immunization protected the mice from challenges with homologue bacteria in a sepsis model. Bacterial burden in bronchoalveolar lavage fluids (BALF), lung, and spleen, inflammatory cell infiltration in BALF and lung, and inflammatory cytokine accumulation in BALF was significantly suppressed in the pneumonia model by both active and passive immunization strategies. The antisera from immunized mice presented with significant opsonophagocytic activities in a dose-dependent manner against not only homologous strains but also five of the other six clonally distinct clinical isolates. Conclusions: Utilizing immunological characteristics of outer membrane proteins to elevate protective immunity and circumvent complex multidrug-resistance mechanisms might be a viable approach to effectively control A. baumannii infections.	[Huang, Weiwei; Yao, Yufeng; Long, Qiong; Yang, Xu; Sun, Wenjia; Liu, Cunbao; Jin, Xiaomei; Li, Yang; Chu, Xiaojie; Ma, Yanbing] Chinese Acad Med Sci, Inst Med Biol, Lab Mol Immunol, Kunming, Peoples R China; [Huang, Weiwei; Yao, Yufeng; Long, Qiong; Yang, Xu; Sun, Wenjia; Liu, Cunbao; Jin, Xiaomei; Li, Yang; Chu, Xiaojie; Ma, Yanbing] Peking Union Med Coll, Kunming, Peoples R China; [Huang, Weiwei; Yao, Yufeng; Long, Qiong; Yang, Xu; Sun, Wenjia; Liu, Cunbao; Jin, Xiaomei; Li, Yang; Chu, Xiaojie; Ma, Yanbing] Yunnan Key Lab Vaccine Res & Dev Severe Infect Di, Kunming, Peoples R China; [Huang, Weiwei; Yao, Yufeng; Long, Qiong; Yang, Xu; Sun, Wenjia; Liu, Cunbao; Jin, Xiaomei; Li, Yang; Chu, Xiaojie; Ma, Yanbing] Yunnan Engn Res Ctr Vaccine Res & Dev Severe Infe, Kunming, Peoples R China; [Chen, Bin] Kunming Med Univ, Affiliated Hosp 2, Kunming, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; Yunnan Key Laboratory of Vaccine Research & Development on Severe Infectious Diseases; Kunming Medical University	Ma, YB (corresponding author), Chinese Acad Med Sci, Inst Med Biol, Lab Mol Immunol, Kunming, Peoples R China.	yanbingma@126.com	Chen, Bin/I-6677-2013; Chen, Bin/AAG-3449-2019	Chu, Xiaojie/0000-0002-2745-004X; Li, Yang/0000-0001-6743-4004	Science and Technology Project of Yunnan Province [2013FZ139]; National Natural Science Foundation of China [81301467]; Peking Union Medical College (PUMC) Youth Fund; Fundamental Research Funds for the Central Universities, China [333203084]	Science and Technology Project of Yunnan Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Peking Union Medical College (PUMC) Youth Fund; Fundamental Research Funds for the Central Universities, China(Fundamental Research Funds for the Central Universities)	This research was financially supported by Science and Technology Project of Yunnan Province (2013FZ139); National Natural Science Foundation of China (81301467). The Peking Union Medical College (PUMC) Youth Fund and the Fundamental Research Funds for the Central Universities, China (333203084). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekshun MN, 2007, CELL, V128, P1037, DOI 10.1016/j.cell.2007.03.004; Alves JC, 2010, NAT MED, V16, P708, DOI 10.1038/nm.2156; Bentancor LV, 2012, INFECT IMMUN, V80, P3381, DOI 10.1128/IAI.06096-11; Bentancor LV, 2012, INFECT IMMUN, V80, P651, DOI 10.1128/IAI.05653-11; Cespedes N, 2013, VACCINE, V31, P4923, DOI 10.1016/j.vaccine.2013.05.082; Chackerian AA, 2007, J IMMUNOL, V179, P2551, DOI 10.4049/jimmunol.179.4.2551; Chang HC, 2005, J CLIN MICROBIOL, V43, P1632, DOI 10.1128/JCM.43.4.1632-1639.2005; Chiang SR, 2009, CRIT CARE MED, V37, P2590, DOI 10.1097/CCM.0b013e3181a0f8e1; de Breij A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030673; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Eveillard M, 2010, J INFECTION, V60, P154, DOI 10.1016/j.jinf.2009.09.004; Fattahian Y, 2011, MICROB PATHOGENESIS, V51, P402, DOI 10.1016/j.micpath.2011.09.004; Findlow J, 2007, CLIN VACCINE IMMUNOL, V14, P1451, DOI 10.1128/CVI.00195-07; Findlow J, 2006, INFECT IMMUN, V74, P4557, DOI 10.1128/IAI.00466-06; Gordon NC, 2010, INT J ANTIMICROB AG, V35, P219, DOI 10.1016/j.ijantimicag.2009.10.024; JolyGuillou MC, 1997, ANTIMICROB AGENTS CH, V41, P345, DOI 10.1128/AAC.41.2.345; Kimura A, 2011, CLIN VACCINE IMMUNOL, V18, P483, DOI 10.1128/CVI.00304-10; Koning RI, 2013, RES MICROBIOL, V164, P397, DOI 10.1016/j.resmic.2013.02.007; Kueakhai P, 2013, VACCINE, V31, P5518, DOI 10.1016/j.vaccine.2013.09.027; Kwon SO, 2009, FEMS MICROBIOL LETT, V297, P150, DOI 10.1111/j.1574-6968.2009.01669.x; Lin L, 2013, VACCINE, V31, P313, DOI 10.1016/j.vaccine.2012.11.008; Luo GPS, 2012, PLOS ONE, V7, P46, DOI 10.1371/journal.pone.0029446; Mao QY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046043; McConnell MJ, 2011, VACCINE, V29, P5705, DOI 10.1016/j.vaccine.2011.06.001; McConnell MJ, 2011, INFECT IMMUN, V79, P518, DOI 10.1128/IAI.00741-10; McConnell MJ, 2010, VACCINE, V29, P1, DOI 10.1016/j.vaccine.2010.10.052; Mussi MA, 2005, ANTIMICROB AGENTS CH, V49, P1432, DOI 10.1128/AAC.49.4.1432-1440.2005; Nakatsuji T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014797; Qiu HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022004; Russo TA, 2013, INFECT IMMUN, V81, P915, DOI 10.1128/IAI.01184-12; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Valentine SC, 2008, J CLIN MICROBIOL, V46, P2499, DOI 10.1128/JCM.00367-08; Zarrilli R, 2007, CLIN MICROBIOL INFEC, V13, P481, DOI 10.1111/j.1469-0691.2006.01675.x; Zavascki AP, 2010, EXPERT REV ANTI-INFE, V8, P71, DOI 10.1586/ERI.09.108	34	61	64	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100727	10.1371/journal.pone.0100727	http://dx.doi.org/10.1371/journal.pone.0100727			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956279	Green Submitted, Green Published, gold			2022-12-27	WOS:000338917900088
J	Katz, MA; Muthoka, P; Emukule, GO; Kalani, R; Njuguna, H; Waiboci, LW; Ahmed, JA; Bigogo, G; Feikin, DR; Njenga, MK; Breiman, RF; Mott, JA				Katz, Mark A.; Muthoka, Philip; Emukule, Gideon O.; Kalani, Rosalia; Njuguna, Henry; Waiboci, Lilian W.; Ahmed, Jamal A.; Bigogo, Godfrey; Feikin, Daniel R.; Njenga, Moses K.; Breiman, Robert F.; Mott, Joshua A.			Results From the First Six Years of National Sentinel Surveillance for Influenza in Kenya, July 2007-June 2013	PLOS ONE			English	Article							WESTERN KENYA; SEASONAL INFLUENZA; YOUNG-CHILDREN; RURAL KENYA; AFRICA; PNEUMONIA; ILLNESS; BURDEN; HOSPITALIZATION; EPIDEMIOLOGY	Background: Recent studies have shown that influenza is associated with significant disease burden in many countries in the tropics, but until recently national surveillance for influenza was not conducted in most countries in Africa. Methods: In 2007, the Kenyan Ministry of Health with technical support from the CDC-Kenya established a national sentinel surveillance system for influenza. At 11 hospitals, for every hospitalized patient with severe acute respiratory illness (SARI), and for the first three outpatients with influenza-like illness (ILI) per day, we collected both nasopharyngeal and oropharyngeal swabs. Beginning in 2008, we conducted in-hospital follow-up for SARI patients to determine outcome. Specimens were tested by real time RT-PCR for influenza A and B. Influenza A-positive specimens were subtyped for H1, H3, H5, and (beginning in May 2009) A(H1N1) pdm09. Results: From July 1, 2007 through June 30, 2013, we collected specimens from 24,762 SARI and 14,013 ILI patients. For SARI and ILI case-patients, the median ages were 12 months and 16 months, respectively, and 44% and 47% were female. In all, 2,378 (9.6%) SARI cases and 2,041 (14.6%) ILI cases were positive for influenza viruses. Most influenza-associated SARI cases (58.6%) were in children <2 years old. Of all influenza-positive specimens, 78% were influenza A, 21% were influenza B, and 1% were influenza A/B coinfections. Influenza circulated in every month. In four of the six years influenza activity peaked during July-November. Of 9,419 SARI patients, 2.7% died; the median length of hospitalization was 4 days. Conclusions: During six years of surveillance in Kenya, influenza was associated with nearly 10 percent of hospitalized SARI cases and one-sixth of outpatient ILI cases. Most influenza-associated SARI and ILI cases were in children <2 years old; interventions to reduce the burden of influenza, such as vaccine, could consider young children as a priority group.	[Katz, Mark A.; Emukule, Gideon O.; Njuguna, Henry; Waiboci, Lilian W.; Ahmed, Jamal A.; Bigogo, Godfrey; Feikin, Daniel R.; Njenga, Moses K.; Breiman, Robert F.; Mott, Joshua A.] Kenya Govt Med Res Ctr, Ctr Dis Control & Prevent Kenya, Nairobi, Kenya; [Muthoka, Philip; Kalani, Rosalia] Kenya Minist Hlth, Nairobi, Kenya	Kenya Medical Research Institute	Katz, MA (corresponding author), Kenya Govt Med Res Ctr, Ctr Dis Control & Prevent Kenya, Nairobi, Kenya.	markakatz@gmail.com	Bigogo, Godfrey/W-3591-2019		US Centers for Disease Control; Kenya Ministry of Health	US Centers for Disease Control; Kenya Ministry of Health	The surveillance described in this manuscript was funded by a cooperative agreement between the US Centers for Disease Control and the Kenya Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, WKLY EPIDEMIOL REC, V87, P461; [Anonymous], 2013, WORLD WEATHER ONLINE; Azziz-Baumgartner E, 2012, B WORLD HEALTH ORGAN, V90, P12, DOI 10.2471/BLT.11.090209; Berkley JA, 2010, JAMA-J AM MED ASSOC, V303, P2051, DOI 10.1001/jama.2010.675; Breiman RF, 2007, EMERG INFECT DIS, V13, P1453, DOI 10.3201/eid1310.070400; Breiman RF, 2011, J HEALTH POPUL NUTR, V29, P123; Burton DC, 2011, J HEALTH POPUL NUTR, V29, P61, DOI 10.3329/jhpn.v29i1.7567; Chudasama RK, 2013, ANN MED HEALTH SCI R, V3, P334, DOI 10.4103/2141-9248.117929; Feikin DR, 2012, B WORLD HEALTH ORGAN, V90, P256, DOI 10.2471/BLT.11.094326; Freitas FT, 2012, EPIDEMIOL INFECT, P1; Gessner BD, 2011, LANCET INFECT DIS, V11, P223, DOI 10.1016/S1473-3099(11)70008-1; Hayward AC, 2014, LANCET RESP MED; Katz MA, 2012, J INFECT DIS, V206, pS53, DOI 10.1093/infdis/jis530; Kim C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021610; Lutwama JJ, 2012, J INFECT DIS, V206, pS87, DOI 10.1093/infdis/jis578; Murray EL, 2013, EPIDEMIOL INFECT, V141, P212, DOI 10.1017/S095026881200043X; Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9; Onyango CO, 2012, J INFECT DIS, V206, pS61, DOI 10.1093/infdis/jis536; Organization WH, 2011, INTEGRATED MANAGEMEN; Organization WH, 2013, FLUNET; Ortu G, 2008, HEALTH POLICY PLANN, V23, P161, DOI 10.1093/heapol/czn004; Radin JM, 2012, J INFECT DIS, V206, pS14, DOI 10.1093/infdis/jis606; Schoub Barry D, 2010, Expert Rev Respir Med, V4, P167, DOI 10.1586/ers.10.10; Schoub BD, 2002, VACCINE, V20, pS45, DOI 10.1016/S0264-410X(02)00129-9; Sentilhes AC, 2013, INFLUENZA OTHER RESP; Simmerman JM, 2009, PLOS ONE, V4, pA107, DOI 10.1371/journal.pone.0007776; Thompson MG, 2012, J INFECT DIS, V206, P1674, DOI 10.1093/infdis/jis591; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Viboud C, 2006, PLOS MED, V3, P468, DOI 10.1371/journal.pmed.0030089; WHO (World Health Organization), 2006, GUID FIELD OP; Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630; Zerr DM, 2008, PEDIATRICS, V121, P345, DOI 10.1542/peds.2007-2812	32	35	35	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e98615	10.1371/journal.pone.0098615	http://dx.doi.org/10.1371/journal.pone.0098615			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955962	Green Published, Green Submitted, gold			2022-12-27	WOS:000338917900004
J	Adel, A; Boughoufalah, A; Saegerman, C; De Deken, R; Bouchene, Z; Soukehal, A; Berkvens, D; Boelaert, M				Adel, Amel; Boughoufalah, Amel; Saegerman, Claude; De Deken, Redgi; Bouchene, Zahida; Soukehal, Abdelkrim; Berkvens, Dirk; Boelaert, Marleen			Epidemiology of Visceral Leishmaniasis in Algeria: An Update	PLOS ONE			English	Article							RETROSPECTIVE ANALYSIS; CANINE LEISHMANIASIS; INFANTUM; INFECTION; SPREAD; PCR	Visceral leishmaniasis (VL), a zoonotic disease caused by Leishmania infantum, is endemic in Algeria. This report describes a retrospective epidemiological study conducted on human VL to document the epidemiological profile at national level. All human VL cases notified by the National Institute of Public Health between 1998 and 2008 were investigated. In parallel all VL cases admitted to the university hospitals of Algiers were surveyed to estimate the underreporting ratio. Fifteen hundred and sixty-two human VL cases were reported in Algeria between 1998-2008 with an average annual reported incidence rate of 0.45 cases per 100,000 inhabitants, of which 81.42% were in the age range of 0-4 years. Cases were detected year-round, with a peak notification in May and June. One hundred and seventy patients were admitted to the university hospitals in Algiers in the same period, of which less than one in ten had been officially notified. Splenomegaly, fever, pallor and pancytopenia were the main clinical and laboratory features. Meglumine antimoniate was the first-line therapy for paediatric VL whereas the conventional amphotericin B was used for adult patients. Visceral leishmaniasis in Algeria shows the epidemiological profile of a paediatric disease with a decrease of the annual reported incidence rate. However, vigilance is required because of huge underreporting and an apparent propagation towards the south.	[Adel, Amel] Univ Saad Dahlab, Inst Vet Sci, Blida, Algeria; [Adel, Amel; Saegerman, Claude] Univ Liege, Fac Vet Med, Dept Infect & Parasit Dis Epidemiol & Risk Anal A, Liege, Belgium; [Adel, Amel; De Deken, Redgi; Berkvens, Dirk] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Boughoufalah, Amel] Natl Inst Publ Hlth, Dept Hlth Informat, Algiers, Algeria; [Bouchene, Zahida; Soukehal, Abdelkrim] Univ Hosp Beni Messous, Algiers, Algeria; [Boelaert, Marleen] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium	Universite Saad Dahlab de Blida; University of Liege; Institute of Tropical Medicine (ITM); Institute of Tropical Medicine (ITM)	Berkvens, D (corresponding author), Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium.	dberkvens@itg.be	Boelaert, Marleen/E-2698-2012	Boelaert, Marleen/0000-0001-8051-6776; Saegerman, Claude/0000-0001-9087-7436	Belgian Directorate-General for Development Co-operation (DGDC)	Belgian Directorate-General for Development Co-operation (DGDC)	The study was funded by the Belgian Directorate-General for Development Co-operation (DGDC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRANCHES P, 1991, J PARASITOL, V77, P557, DOI 10.2307/3283159; Addadi K., 1976, Bulletin de la Societe de Pathologie Exotique, V69, P68; Alvar J, 2008, CLIN MICROBIOL REV, V21, P334, DOI 10.1128/CMR.00061-07; Alvar J, 2006, TRENDS PARASITOL, V22, P552, DOI 10.1016/j.pt.2006.09.004; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Aoun K, 2009, MED MALADIES INFECT, V39, P775, DOI 10.1016/j.medmal.2009.08.010; BADARO R, 1986, LANCET, V1, P647; Baneth G, 1998, AM J TROP MED HYG, V59, P722, DOI 10.4269/ajtmh.1998.59.722; BELAZZOUG S, 1985, ANN SOC BELG MED TR, V65, P329; Bern C, 2006, CLIN INFECT DIS, V43, P917, DOI 10.1086/507530; Bessad A., 2012, Bulletin de la Societe de Pathologie Exotique, V105, P5, DOI 10.1007/s13149-011-0182-4; Bouratbine A, 1998, B SOC PATHOL EXOT, V91, P183; Carranza-Tamayo CO, 2010, REV SOC BRAS MED TRO, V43, P396, DOI 10.1590/S0037-86822010000400012; DEDET JP, 1977, B SOC PATHOL EXOT, V70, P250; Dujardin JC, 2006, TRENDS PARASITOL, V22, P4, DOI 10.1016/j.pt.2005.11.004; Dujardin JC, 2008, EMERG INFECT DIS, V14, P1013, DOI 10.3201/eid1407.071589; FAO, 2002, EV WORLD FOR RES 200, P109; Gkolfinopoulou K, 2013, Euro Surveill, V18, P20532, DOI 10.2807/1560-7917.ES2013.18.29.20532; GRADONI L, 1995, B WORLD HEALTH ORGAN, V73, P191; Gradoni L, 2008, TROP MED INT HEALTH, V13, P1272, DOI 10.1111/j.1365-3156.2008.02144.x; Gramiccia M, 2013, EUROSURVEILLANCE, V18, P29, DOI 10.2807/1560-7917.ES2013.18.29.20535; HARRAT Z, 1992, B SOC PATHOL EXOT, V85, P296; Harrat Z, 1996, T ROY SOC TROP MED H, V90, P625, DOI 10.1016/S0035-9203(96)90410-1; IZRI MA, 1990, ANN PARASIT HUM COMP, V65, P151; KILLICKKENDRICK R, 1990, MED VET ENTOMOL, V4, P1, DOI 10.1111/j.1365-2915.1990.tb00255.x; Kowalski K., 1991, MAMMALS ALGERIA; Lachaud L, 2013, Euro Surveill, V18, P20534, DOI 10.2807/1560-7917.ES2013.18.29.20534; Lemaire X, 1911, B SOC PATHOL EXOT, V4, P554; Marty P, 2009, ARCH PEDIATRIE, V16, pS96, DOI 10.1016/S0929-693X(09)75310-2; Pagliano P, 2003, J ANTIMICROB CHEMOTH, V52, P264, DOI 10.1093/jac/dkg340; Petrela R, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000814; Seridi N, 2008, T ROY SOC TROP MED H, V102, P556, DOI 10.1016/j.trstmh.2008.03.004; Solano-Gallego L, 2001, J CLIN MICROBIOL, V39, P560, DOI 10.1128/JCM.39.2.560-563.2001; StataCorp, 2011, STAT REL 12 STAT SOF; W. H. Organization, 2005, REP WHO INF CONS LIP; WHO, 2009, LEISHM BURD DIS; Zait H, 2012, MED MALADIES INFECT, V42, P119, DOI 10.1016/j.medmal.2012.01.001; Zougaghi L, 2009, ARCH PEDIATRIE, V16, P1513, DOI 10.1016/j.arcped.2009.05.003	38	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e99207	10.1371/journal.pone.0099207	http://dx.doi.org/10.1371/journal.pone.0099207			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949958	Green Submitted, Green Published, gold			2022-12-27	WOS:000338276300011
J	Azarenko, O; Jordan, MA; Wilson, L				Azarenko, Olga; Jordan, Mary Ann; Wilson, Leslie			Erucin, the Major Isothiocyanate in Arugula (Eruca sativa), Inhibits Proliferation of MCF7 Tumor Cells by Suppressing Microtubule Dynamics	PLOS ONE			English	Article							CONSUMING BROCCOLI SPROUTS; CYCLE ARREST; IN-VITRO; PHENETHYL ISOTHIOCYANATE; KINETIC STABILIZATION; MEDIATED APOPTOSIS; ENZYME-SYSTEMS; MITOTIC BLOCK; CANCER CELLS; SULFORAPHANE	Consumption of cruciferous vegetables is associated with reduced risk of various types of cancer. Isothiocyanates including sulforaphane and erucin are believed to be responsible for this activity. Erucin [1-isothiocyanato-4-(methylthio) butane], which is metabolically and structurally related to sulforaphane, is present in large quantities in arugula (Eruca sativa, Mill.), kohlrabi and Chinese cabbage. However, its cancer preventive mechanisms remain poorly understood. We found that erucin inhibits proliferation of MCF7 breast cancer cells (IC50=28 mu M) in parallel with cell cycle arrest at mitosis (IC50=13 mu M) and apoptosis, by a mechanism consistent with impairment of microtubule dynamics. Concentrations of 5-15 mu M erucin suppressed the dynamic instability of microtubules during interphase in the cells. Most dynamic instability parameters were inhibited, including the rates and extents of growing and shortening, the switching frequencies between growing and shortening, and the overall dynamicity. Much higher erucin concentrations were required to reduce the microtubule polymer mass. In addition, erucin suppressed dynamic instability of microtubules reassembled from purified tubulin in similar fashion. The effects of erucin on microtubule dynamics, like those of sulforaphane, are similar qualitatively to those of much more powerful clinically-used microtubule-targeting anticancer drugs, including taxanes and the vinca alkaloids. The results suggest that suppression of microtubule dynamics by erucin and the resulting impairment of critically important microtubule-dependent cell functions such as mitosis, cell migration and microtubule- based transport may be important in its cancer preventive activities.	[Wilson, Leslie] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Wilson, L (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA.	leslie.wilson@lifesci.ucsb.edu						Azarenko O, 2008, CARCINOGENESIS, V29, P2360, DOI 10.1093/carcin/bgn241; Barcelo S, 1996, CARCINOGENESIS, V17, P277, DOI 10.1093/carcin/17.2.277; Barillari J, 2005, J AGR FOOD CHEM, V53, P2475, DOI 10.1021/jf047945a; Basten GP, 2002, CARCINOGENESIS, V23, P1399, DOI 10.1093/carcin/23.8.1399; Bheemreddy RM, 2007, J AGR FOOD CHEM, V55, P2861, DOI 10.1021/jf0633544; BLOCK G, 1992, NUTR CANCER, V18, P1, DOI 10.1080/01635589209514201; Bunker JM, 2004, MOL BIOL CELL, V15, P2720, DOI 10.1091/mbc.E04-01-0062; Cang SD, 2014, EXP HEMATOL ONCOL, V3, DOI 10.1186/2162-3619-3-5; Chen JG, 2002, CANCER RES, V62, P1935; Clarke JD, 2011, J AGR FOOD CHEM, V59, P10955, DOI 10.1021/jf202887c; Clarke JD, 2011, PHARMACOL RES, V64, P456, DOI 10.1016/j.phrs.2011.07.005; Fahey JW, 2001, PHYTOCHEMISTRY, V56, P5, DOI 10.1016/S0031-9422(00)00316-2; Fimognari C, 2004, INVEST NEW DRUG, V22, P119, DOI 10.1023/B:DRUG.0000011788.19754.54; Fimognari C, 2007, IN VIVO, V21, P377; Fimognari C, 2012, MUTAT RES-REV MUTAT, V750, P107, DOI 10.1016/j.mrrev.2011.12.001; Gamet-Payrastre L, 2000, CANCER RES, V60, P1426; Grishchuk EL, 2005, NATURE, V438, P384, DOI 10.1038/nature04132; Hanlon N, 2009, CHEM-BIOL INTERACT, V177, P115, DOI 10.1016/j.cbi.2008.08.015; Hanlon N, 2008, BRIT J NUTR, V99, P559, DOI 10.1017/S0007114507824093; Harris KE, 2008, J NUTR BIOCHEM, V19, P246, DOI 10.1016/j.jnutbio.2007.02.014; Jakubikova J, 2005, ANTICANCER RES, V25, P3375; Jordan M. A., 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P1, DOI 10.2174/1568011023354290; Jordan MA, 1996, CANCER RES, V56, P816; Jordan MA, 2005, MOL CANCER THER, V4, P1086, DOI 10.1158/1535-7163.MCT-04-0345; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; JORDAN MA, 1991, CANCER RES, V51, P2212; JORDAN MA, 1993, P NATL ACAD SCI USA, V90, P9552, DOI 10.1073/pnas.90.20.9552; Jordan MA, 2007, CURR CANCER DRUG TAR, V7, P730, DOI 10.2174/156800907783220417; Jordan Mary Ann, 2008, P47, DOI 10.1007/978-1-59745-336-3_3; Kamath K, 2014, CYTOSKELETON, V71, P46, DOI 10.1002/cm.21153; Kassahun K, 1997, CHEM RES TOXICOL, V10, P1228, DOI 10.1021/tx970080t; KOLM RH, 1995, BIOCHEM J, V311, P453, DOI 10.1042/bj3110453; Langouet S, 2000, CHEM RES TOXICOL, V13, P245, DOI 10.1021/tx990189w; Leoni O, 1997, BIOORGAN MED CHEM, V5, P1799, DOI 10.1016/S0968-0896(97)00112-0; Liu K, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-10; LUDUENA RF, 1991, PHARMACOL THERAPEUT, V49, P133, DOI 10.1016/0163-7258(91)90027-J; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; Melchini A, 2010, TOXINS, V2, P593, DOI 10.3390/toxins2040593; Mi LX, 2008, J BIOL CHEM, V283, P22136, DOI 10.1074/jbc.M802330200; Miller HP, 2010, METHOD CELL BIOL, V95, P3, DOI 10.1016/S0091-679X(10)95001-2; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Mohan R, 2008, CANCER RES, V68, P6181, DOI 10.1158/0008-5472.CAN-08-0584; Munday R, 2004, J AGR FOOD CHEM, V52, P1867, DOI 10.1021/jf030549s; Nastruzzi C, 2000, J AGR FOOD CHEM, V48, P3572, DOI 10.1021/jf000191p; Nestle M, 1997, P NATL ACAD SCI USA, V94, P11149, DOI 10.1073/pnas.94.21.11149; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Nogales E, 2001, ANNU REV BIOPH BIOM, V30, P397, DOI 10.1146/annurev.biophys.30.1.397; Oroudjev E, 2010, MOL CANCER THER, V9, P2700, DOI 10.1158/1535-7163.MCT-10-0645; Panda D, 1996, J BIOL CHEM, V271, P29807, DOI 10.1074/jbc.271.47.29807; PANDA D, 1995, BIOCHEMISTRY-US, V34, P9921, DOI 10.1021/bi00031a014; Parnaud G, 2004, NUTR CANCER, V48, P198, DOI 10.1207/s15327914nc4802_10; Rudner AD, 1996, CURR OPIN CELL BIOL, V8, P773, DOI 10.1016/S0955-0674(96)80077-9; Saha S, 2012, MOL NUTR FOOD RES, V56, P1906, DOI 10.1002/mnfr.201200225; Singh AV, 2004, CARCINOGENESIS, V25, P83, DOI 10.1093/carcin/bgg178; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Verhoeven DTH, 1996, CANCER EPIDEM BIOMAR, V5, P733; Vermeulen M, 2008, J AGR FOOD CHEM, V56, P10505, DOI 10.1021/jf801989e; WEBSTER DR, 1989, J CELL SCI, V92, P57; Westermann S, 2003, NAT REV MOL CELL BIO, V4, P938, DOI 10.1038/nrm1260; Zhang YS, 2001, CARCINOGENESIS, V22, P425, DOI 10.1093/carcin/22.3.425; Zhang YS, 2004, MUTAT RES-FUND MOL M, V555, P173, DOI 10.1016/j.mrfmmm.2004.04.017; ZHANG YS, 1992, P NATL ACAD SCI USA, V89, P2399, DOI 10.1073/pnas.89.6.2399; Zhang Y, 2007, ACTA PHARMACOL SIN, V28, P1343, DOI 10.1111/j.1745-7254.2007.00679.x	63	27	27	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100599	10.1371/journal.pone.0100599	http://dx.doi.org/10.1371/journal.pone.0100599			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950293	Green Published, Green Submitted, gold			2022-12-27	WOS:000338276300095
J	Hu, HL; Tian, DW; Chen, T; Han, RF; Sun, Y; Wu, CL				Hu, Hailong; Tian, Dawei; Chen, Tao; Han, Ruifa; Sun, Yan; Wu, Changli			Metastasis-Associated in Colon Cancer 1 Is a Novel Survival- Related Biomarker for Human Patients with Renal Pelvis Carcinoma	PLOS ONE			English	Article							UPPER URINARY-TRACT; COMPARATIVE GENOMIC HYBRIDIZATION; IN-SITU HYBRIDIZATION; HEPATOCELLULAR-CARCINOMA; UROTHELIAL CARCINOMA; CHROMOSOMAL-ABERRATIONS; ANATOMICAL LOCATION; GENETIC ALTERATIONS; PANCREATIC-CANCER; POOR-PROGNOSIS	Metastasis-associated in colon cancer 1 (MACC1) has recently been identified as a novel independent prognostic indicator for metastasis occurrence, overall survival and cancer-free survival for patients with colon cancer and other solid tumors. In this study, we investigated the role of MACC1 in the development and progression of renal pelvis carcinoma, a form of upper tract urothelial carcinomas. MACC1 protein has been found in the cytoplasm as well as in the nucleus of the transitional epithelial cells of the normal renal pelvis in immunohistochemical (IHC) assays. Quantitative IHC examinations revealed that MACC1 abnormal abundance in cancerous tissues might represent a biological indicator clinically suggestive of tumor malignancy in the renal pelvis. Furthermore, investigation of the association of MACC1 protein levels with clinicopathological parameters in this study has suggested a correlation of MACC1 expression with tumor-node-metastasis stage and histopathological grade of patients with renal pelvis carcinoma, with elevated MACC1 protein levels frequently associated with higher aggressiveness of the disease. Moreover, both disease-free survival and overall survival for the patients in the high MACC1 expression group were significantly lower than those in the low expression group. Multivariate analysis with a Cox proportional-hazards model suggested that MACC1 is indeed an independent prognostic indicator of overall survival and cancer-free survival for patients with renal pelvis carcinoma. Thus, MACC1 may represent a promising prognostic biomarker candidate, as well as a potential therapeutic target for this disease.	[Hu, Hailong; Tian, Dawei; Chen, Tao; Han, Ruifa; Sun, Yan; Wu, Changli] Tianjin Med Univ, Hosp 2, Tianjin Inst Urol, Dept Urol, Tianjin, Peoples R China	Tianjin Medical University	Hu, HL (corresponding author), Tianjin Med Univ, Hosp 2, Tianjin Inst Urol, Dept Urol, Tianjin, Peoples R China.	forwardgen@126.com; wucl2003@163.com			National Natural Science Foundation of China [30700834]; Natural Science Foundation of Tianjin [12ZCDZSY16600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Tianjin(Natural Science Foundation of Tianjin)	This work was supported by a grant from National Natural Science Foundation of China (Grant Number: 30700834), and another grant from Natural Science Foundation of Tianjin (Grant Number: 12ZCDZSY16600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragane H, 2001, INT J CANCER, V94, P623, DOI 10.1002/ijc.1522; Arlt F, 2009, INT J BIOCHEM CELL B, V41, P2356, DOI 10.1016/j.biocel.2009.08.001; Arslantas A, 2007, PATHOL ONCOL RES, V13, P39, DOI 10.1007/BF02893439; Catto JWF, 2007, J UROLOGY, V177, P1715, DOI 10.1016/j.juro.2007.01.030; Colin P, 2009, BJU INT, V104, P1436, DOI 10.1111/j.1464-410X.2009.08838.x; Galimi F, 2011, CLIN CANCER RES, V17, P3146, DOI 10.1158/1078-0432.CCR-10-3377; Gao J, 2013, MOL CELL BIOCHEM, V376, P21, DOI 10.1007/s11010-012-1545-y; Gu CD, 2011, ANTICANCER RES, V31, P1141; Hagemann C, 2013, NEURO-ONCOLOGY, V15, P1696, DOI 10.1093/neuonc/not136; Harada T, 2007, BRIT J CANCER, V96, P373, DOI 10.1038/sj.bjc.6603563; Herbergs J, 1996, J PATHOL, V179, P243, DOI 10.1002/(SICI)1096-9896(199607)179:3<243::AID-PATH588>3.0.CO;2-Q; Huang YB, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-16; Jemal A, 2004, CA-CANCER J CLIN, V54, P8, DOI 10.3322/canjclin.54.1.8; Lehmann J, 2007, EUR UROL, V51, P1281, DOI 10.1016/j.eururo.2006.11.021; Loeper S, 2001, CYTOGENET CELL GENET, V94, P1, DOI 10.1159/000048773; Lughezzani G, 2012, EUR UROL, V62, P100, DOI 10.1016/j.eururo.2012.02.030; Morohara K, 2006, J CANCER RES CLIN, V132, P363, DOI 10.1007/s00432-005-0062-8; Qu JH, 2012, WORLD J GASTROENTERO, V18, P2995, DOI 10.3748/wjg.v18.i23.2995; Raman JD, 2011, BJU INT, V107, P1059, DOI 10.1111/j.1464-410X.2010.09675.x; Rossi MR, 2005, GENE CHROMOSOME CANC, V44, P392, DOI 10.1002/gcc.20256; Roupret M, 2011, EUR UROL, V59, P584, DOI 10.1016/j.eururo.2010.12.042; Saito K, 2007, BJU INT, V100, P269, DOI 10.1111/j.1464-410X.2007.06934.x; Shapiro JR, 2002, AM J MED GENET, V115, P194, DOI 10.1002/ajmg.10690; Shariat SF, 2006, CLIN CANCER RES, V12, P6663, DOI 10.1158/1078-0432.CCR-06-0372; Shimokawa H, 2011, J THORAC CARDIOV SUR, V141, P895, DOI 10.1016/j.jtcvs.2010.09.044; Shirahata A, 2010, ANTICANCER RES, V30, P2689; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Stein U, 2013, EXPERT OPIN THER TAR, V17, P1039, DOI 10.1517/14728222.2013.815727; Stein U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049249; Stein U, 2010, J MOL MED, V88, P11, DOI 10.1007/s00109-009-0537-1; Stein U, 2009, NAT MED, V15, P59, DOI 10.1038/nm.1889; Suyama T, 2011, INT J UROL, V18, P43, DOI 10.1111/j.1442-2042.2010.02671.x; Tsiambas E, 2009, PATHOL ONCOL RES, V15, P511, DOI 10.1007/s12253-008-9146-5; Tyler Allison, 2012, Semin Oncol Nurs, V28, P154, DOI 10.1016/j.soncn.2012.05.004; Ubagai T, 2001, ONCOL REP, V8, P83; Wang G, 2012, ONCOL LETT, V4, P783, DOI 10.3892/ol.2012.784; Wang L, 2013, INT J CANCER, V133, P1419, DOI 10.1002/ijc.28140; Yang T, 2014, TUMOR BIOL, V35, P815, DOI 10.1007/s13277-013-1112-5; Yang YP, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-41; Yates DR, 2013, WORLD J UROL, V31, P21, DOI 10.1007/s00345-012-0946-6; Zhang K, 2013, TUMOUR BIOL; Zhang RT, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-83; Zhu MC, 2013, PATHOL ONCOL RES, V19, P749, DOI 10.1007/s12253-013-9638-9; Zimmermann U, 1997, HEPATOLOGY, V26, P1492; Zojer N, 2000, LUNG CANCER, V28, P225, DOI 10.1016/S0169-5002(00)00097-0	45	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100161	10.1371/journal.pone.0100161	http://dx.doi.org/10.1371/journal.pone.0100161			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949951	Green Published, Green Submitted, gold			2022-12-27	WOS:000338276300043
J	Antanaviciute, I; Rysevaite, K; Liutkevicius, V; Marandykina, A; Rimkute, L; Sveikatiene, R; Uloza, V; Skeberdis, VA				Antanaviciute, Ieva; Rysevaite, Kristina; Liutkevicius, Vykintas; Marandykina, Alina; Rimkute, Lina; Sveikatiene, Renata; Uloza, Virgilijus; Skeberdis, Vytenis Arvydas			Long-Distance Communication between Laryngeal Carcinoma Cells	PLOS ONE			English	Article							GAP-JUNCTION CHANNELS; PH-DEPENDENT MODULATION; TUNNELING NANOTUBES; MEMBRANE NANOTUBES; CANCER-CELLS; VOLTAGE; CONNEXIN; CONDUCTANCE; CYTONEMES; PERMEABILITY	Tunneling nanotubes and epithelial bridges are recently discovered new forms of intercellular communication between remote cells allowing their electrical synchronization, transfer of second messengers and even membrane vesicles and organelles. In the present study, we demonstrate for the first time in primary cell cultures prepared from human laryngeal squamous cell carcinoma (LSCC) samples that these cells communicate with each other over long distances (up to 1 mm) through membranous tunneling tubes (TTs), which can be open-ended or contain functional gap junctions formed of connexin 43. We found two types of TTs, containing F-actin alone or F-actin and a-tubulin. In the LSCC cell culture, we identified 5 modes of TT formation and performed quantitative assessment of their electrical properties and permeability to fluorescent dyes of different molecular weight and charge. We show that TTs, containing F-actin and a-tubulin, transport mitochondria and accommodate small DAPI-positive vesicles suggesting possible transfer of genetic material through TTs. We confirmed this possibility by demonstrating that even TTs, containing gap junctions, were capable of transmitting double-stranded small interfering RNA. To support the idea that the phenomenon of TTs is not only typical of cell cultures, we have examined microsections of samples obtained from human LSCC tissues and identified intercellular structures similar to those found in the primary LSCC cell culture.	[Antanaviciute, Ieva; Rysevaite, Kristina; Liutkevicius, Vykintas; Marandykina, Alina; Rimkute, Lina; Sveikatiene, Renata; Skeberdis, Vytenis Arvydas] Lithuanian Univ Hlth Sci, Inst Cardiol, Kaunas, Lithuania; [Rysevaite, Kristina] Lithuanian Univ Hlth Sci, Inst Anat, Kaunas, Lithuania; [Liutkevicius, Vykintas; Uloza, Virgilijus] Lithuanian Univ Hlth Sci, Dept Otorhinolaryngol, Kaunas, Lithuania	Lithuanian University of Health Sciences; Lithuanian University of Health Sciences; Lithuanian University of Health Sciences	Skeberdis, VA (corresponding author), Lithuanian Univ Hlth Sci, Inst Cardiol, Kaunas, Lithuania.	arvydas.skeberdis@lsmuni.lt		Antanaviciute, Ieva/0000-0002-7406-0298; Skeberdis, Vytenis Arvydas/0000-0001-7137-3187	Research Council of Lithuania [LIG-13/2012]	Research Council of Lithuania(Research Council of Lithuania (LMTLT))	This research was funded by a grant (No. LIG-13/2012) from the Research Council of Lithuania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abounit S, 2012, J CELL SCI, V125, P1089, DOI 10.1242/jcs.083279; BINGGELI R, 1980, CANCER RES, V40, P1830; Bobrie A, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.22565; Brink PR, 2012, BBA-BIOMEMBRANES, V1818, P2076, DOI 10.1016/j.bbamem.2011.09.025; Bukauskas FF, 2004, BBA-BIOMEMBRANES, V1662, P42, DOI 10.1016/j.bbamem.2004.01.008; Bukoreshtliev NV, 2009, FEBS LETT, V583, P1481, DOI 10.1016/j.febslet.2009.03.065; Chauveau A, 2010, P NATL ACAD SCI USA, V107, P5545, DOI 10.1073/pnas.0910074107; Chernet BT, 2013, DIS MODEL MECH, V6, P595, DOI 10.1242/dmm.010835; Chinnery HR, 2008, J IMMUNOL, V180, P5779, DOI 10.4049/jimmunol.180.9.5779; Cirri P, 2012, CANCER METAST REV, V31, P195, DOI 10.1007/s10555-011-9340-x; Cirri P, 2011, AM J CANCER RES, V1, P482; Galkina SI, 2011, FEMS IMMUNOL MED MIC, V61, P114, DOI 10.1111/j.1574-695X.2010.00754.x; Gerdes HH, 2008, CURR OPIN CELL BIOL, V20, P470, DOI 10.1016/j.ceb.2008.03.005; Gerdes HH, 2007, FEBS LETT, V581, P2194, DOI 10.1016/j.febslet.2007.03.071; Gonzalez D, 2007, PROG BIOPHYS MOL BIO, V94, P66, DOI 10.1016/j.pbiomolbio.2007.03.007; Gurke S, 2008, HISTOCHEM CELL BIOL, V129, P539, DOI 10.1007/s00418-008-0412-0; Hille B, 2001, ION CHANNELS EXCITAB, P1; Hurtig J, 2010, WIRES NANOMED NANOBI, V2, P260, DOI 10.1002/wnan.80; Kimura S, 2012, EXP CELL RES, V318, P1699, DOI 10.1016/j.yexcr.2012.05.013; Koyanagi M, 2005, CIRC RES, V96, P1039, DOI 10.1161/01.RES.0000168650.23479.0c; Kukat C, 2011, P NATL ACAD SCI USA, V108, P13534, DOI 10.1073/pnas.1109263108; Lim PK, 2011, CANCER RES, V71, P1550, DOI 10.1158/0008-5472.CAN-10-2372; Lokar M, 2010, PROTOPLASMA, V246, P81, DOI 10.1007/s00709-010-0143-7; Lou E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033093; Lucas WJ, 2009, TRENDS CELL BIOL, V19, P495, DOI 10.1016/j.tcb.2009.07.003; Margineantu DH, 2002, MITOCHONDRION, V1, P425, DOI 10.1016/S1567-7249(02)00006-5; Minuth WW, 2012, NEPHRON EXP NEPHROL, V122, P131, DOI 10.1159/000351129; Monici M, 2005, BIOTECHNOL ANN REV, V11, P227, DOI 10.1016/S1387-2656(05)11007-2; Oh S, 1999, J GEN PHYSIOL, V114, P339, DOI 10.1085/jgp.114.3.339; Ohno Hiroshi, 2010, Commun Integr Biol, V3, P231; Onfelt B, 2006, J IMMUNOL, V177, P8476, DOI 10.4049/jimmunol.177.12.8476; Palacios-Prado N, 2012, BBA-BIOMEMBRANES, V1818, P1884, DOI 10.1016/j.bbamem.2011.09.001; Palacios-Prado N, 2010, P NATL ACAD SCI USA, V107, P9897, DOI 10.1073/pnas.1004552107; Palacios-Prado N, 2009, J PHYSIOL-LONDON, V587, P3251, DOI 10.1113/jphysiol.2009.171496; Pasquier J, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-94; Paullauskas N, 2009, BIOPHYS J, V96, P3936, DOI 10.1016/j.bpj.2009.01.059; Rackauskas M, 2007, AM J PHYSIOL-HEART C, V293, pH1729, DOI 10.1152/ajpheart.00234.2007; Rackauskas M, 2010, MEDICINA-LITHUANIA, V46, P1, DOI 10.3390/medicina46010001; Ramirez-Weber FA, 1999, CELL, V97, P599, DOI 10.1016/S0092-8674(00)80771-0; Roy S, 2011, SCIENCE, V332, P354, DOI 10.1126/science.1198949; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; Sanchez-Alvarez R, 2013, CELL CYCLE, V12, P172, DOI 10.4161/cc.23058; Schiel JA, 2013, TRENDS CELL BIOL, V23, P319, DOI 10.1016/j.tcb.2013.02.003; Schiller C, 2013, J CELL SCI, V126, P767, DOI 10.1242/jcs.114033; Schneider B, 2002, ORL-J OTO-RHIN-LARYN, V64, P324, DOI 10.1159/000066086; Sherer NM, 2008, TRENDS CELL BIOL, V18, P414, DOI 10.1016/j.tcb.2008.07.003; Sherer NM, 2007, NAT CELL BIOL, V9, P310, DOI 10.1038/ncb1544; SIMPSON I, 1977, SCIENCE, V195, P294, DOI 10.1126/science.831276; Valiunas V, 2005, J PHYSIOL-LONDON, V568, P459, DOI 10.1113/jphysiol.2005.090985; VERSELIS V, 1986, SCIENCE, V234, P461, DOI 10.1126/science.3489990; WILDERS R, 1992, BIOPHYS J, V63, P942, DOI 10.1016/S0006-3495(92)81664-8; Wolvetang EJ, 2007, BIOCHEM BIOPH RES CO, V363, P610, DOI 10.1016/j.bbrc.2007.09.035; Zani Brett G, 2010, Commun Integr Biol, V3, P215; Zani BG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008930	54	71	71	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e99196	10.1371/journal.pone.0099196	http://dx.doi.org/10.1371/journal.pone.0099196			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945745	Green Submitted, Green Published, gold			2022-12-27	WOS:000340721500013
J	Duarte, CW; Stohn, JP; Wang, QZ; Emery, IF; Prueser, A; Lindner, V				Duarte, Christine W.; Stohn, J. Patrizia; Wang, Qiaozeng; Emery, Ivette F.; Prueser, Andrew; Lindner, Volkhard			Elevated Plasma Levels of the Pituitary Hormone Cthrc1 in Individuals with Red Hair but Not in Patients with Solid Tumors	PLOS ONE			English	Article							TRIPLE-HELIX REPEAT; MELANOCORTIN 1 RECEPTOR; CELL-MIGRATION; CANCER; CONTAINING-1; EXPRESSION; PROTEIN; MC1R; SKIN; METASTASIS	Background: An increasing number of studies report that Cthrc1 is expressed in various cancer cells. The present study sought to identify which cells in tumors and remodeling tissues express Cthrc1 and investigate the range of circulating human Cthrc1 levels in health and disease. Methodology/Principle Findings: Highly specific monoclonal antibodies were generated to detect Cthrc1 by ELISA in plasma and in tissues by immunohistochemistry. In human colon, gastric, breast, endometrial, pancreatic, kidney, lung and skin cancer, Cthrc1 was expressed by activated stromal cells and not the cancer cells themselves. Similarly, conditions evoking tissue remodeling, such as wound repair or angiotensin II-mediated hypertension, induced Cthrc1 expression in interstitial and adventitial fibroblasts and perivascular stromal cells. Levels of Cthrc1 in plasma from healthy subjects were near the lower detection limit except for individuals with red hair, who had up to several hundred fold higher levels. Elevated Cthrc1 was also found in patients with diabetes, inflammatory conditions, and infections, but not solid tumors. Transgenic mouse studies suggested that Cthrc1 expression by stromal cells does not contribute to circulating levels. In human pituitaries, Cthrc1 was expressed in the anterior and intermediate lobes with unencapsulated Cthrc1 accumulations typically surrounded by chromophobe cells. Conclusions: We identify Cthrc1 as a marker for activated stromal cells. Cthrc1 is a pituitary hormone with significantly elevated levels in subjects carrying variant alleles of the melanocortin-1 receptor as wells as in patients with inflammatory conditions.	[Duarte, Christine W.; Stohn, J. Patrizia; Wang, Qiaozeng; Emery, Ivette F.; Prueser, Andrew; Lindner, Volkhard] Maine Med Ctr, Res Inst, Ctr Mol Med, Scarborough, ME 04102 USA	Maine Medical Center	Lindner, V (corresponding author), Maine Med Ctr, Res Inst, Ctr Mol Med, Scarborough, ME 04102 USA.	lindnv@mmc.org			National Institutes of Health [HL69182]; National Center for Research Resources [P20 RR-15555];  [P20RR018789/P20GM103465];  [P30RR030927/P30GM103392]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103392, P30GM106391] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); ; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported in part by National Institutes of Health grants HL69182 (V. L.) and P20 RR-15555 from the National Center for Research Resources. The Histopathology Core Facility is supported by P20RR018789/P20GM103465 (D. Wojchowski,PI) and P30RR030927/ P30GM103392 (R. Friesel, PI). The Mouse Transgenic and Imaging Core is supported by P30RR030927/P30GM103392 (R. Friesel, PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohm M, 2006, J INVEST DERMATOL, V126, P1966, DOI 10.1038/sj.jid.5700421; Bohm M, 2012, ENDOCR REV, V33, P623, DOI 10.1210/er.2011-1016; Catania A, 1999, ANN NY ACAD SCI, V885, P183; Chen YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070324; Cuttler AS, 2011, GENESIS; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Glant TT, 2008, J IMMUNOL, V181, P1307, DOI 10.4049/jimmunol.181.2.1307; Harding RM, 2000, AM J HUM GENET, V66, P1351, DOI 10.1086/302863; Healy E, 2001, HUM MOL GENET, V10, P2397, DOI 10.1093/hmg/10.21.2397; Healy E, 1999, J INVEST DERMATOL, V112, P512, DOI 10.1046/j.1523-1747.1999.00554.x; Kharaishvili G, 2011, J CLIN PATHOL, V64, P977, DOI 10.1136/jclinpath-2011-200106; Kim JH, 2013, PATHOL ONCOL RES, V19, P731, DOI 10.1007/s12253-013-9636-y; Kimura H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003174; Lee M, 2007, FRONT BIOSCI-LANDMRK, V12, P3994, DOI 10.2741/2366; Lipton JM, 1999, ANN NY ACAD SCI, V885, P173; Liu GL, 2013, J BIOL CHEM, V288, P20217, DOI 10.1074/jbc.M113.473785; Palma M, 2012, BMC CLIN PATHOL, V12, DOI 10.1186/1472-6890-12-2; Park EH, 2013, CARCINOGENESIS, V34, P694, DOI 10.1093/carcin/bgs378; Pyagay P, 2005, CIRC RES, V96, P261, DOI 10.1161/01.RES.0000154262.07264.12; Rees JL, 2000, PIGM CELL RES, V13, P135, DOI 10.1034/j.1600-0749.2000.130303.x; Spector I, 2013, AM J PATHOL, V182, P905, DOI 10.1016/j.ajpath.2012.11.004; Steller EJA, 2013, NEOPLASIA, V15, P204, DOI 10.1593/neo.121726; Stohn JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047142; Tan F, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0473-3; Tang L, 2006, CLIN CANCER RES, V12, P3716, DOI 10.1158/1078-0432.CCR-06-0030; VALVERDE P, 1995, NAT GENET, V11, P328, DOI 10.1038/ng1195-328; Wang L, 2011, BRIT J DERMATOL, V164, P135, DOI 10.1111/j.1365-2133.2010.10050.x; Wang P, 2012, CANCER SCI, V103, P1327, DOI 10.1111/j.1349-7006.2012.02292.x; Williams PF, 2011, INT J CANCER, V129, P1730, DOI 10.1002/ijc.25804; Zhang GH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045037	30	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100449	10.1371/journal.pone.0100449	http://dx.doi.org/10.1371/journal.pone.0100449			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945147	Green Published, gold, Green Submitted			2022-12-27	WOS:000340721500077
J	Levin, E; Leibinger, M; Andreadaki, A; Fischer, D				Levin, Evgeny; Leibinger, Marco; Andreadaki, Anastasia; Fischer, Dietmar			Neuronal Expression of Muscle LIM Protein in Postnatal Retinae of Rodents	PLOS ONE			English	Article							STARBURST AMACRINE CELLS; RABBIT RETINA; RAT RETINA; CHOLINE-ACETYLTRANSFERASE; HEART-FAILURE; MOUSE RETINA; MLP; DIFFERENTIATION; CARDIOMYOPATHY; IDENTIFICATION	Muscle LIM protein (MLP) is a member of the cysteine rich protein family and has so far been regarded as a muscle-specific protein that is mainly involved in myogenesis and the organization of cytoskeletal structure in myocytes, respectively. The current study demonstrates for the first time that MLP expression is not restricted to muscle tissue, but is also found in the rat naive central nervous system. Using quantitative PCR, Western blot and immunohistochemical analyses we detected MLP in the postnatal rat retina, specifically in the somas and dendritic arbors of cholinergic amacrine cells (AC) of the inner nuclear layer and the ganglion cell layer (displaced AC). Induction of MLP expression started at embryonic day 20 and peaked between postnatal days 7 and 14. It subsequently decreased again to non-detectable protein levels after postnatal day 28. MLP was identified in the cytoplasm and dendrites but not in the nucleus of AC. Thus, retinal MLP expression correlates with the morphologic and functional development of cholinergic AC, suggesting a potential role of this protein in postnatal maturation and making MLP a suitable marker for these neurons.	[Levin, Evgeny; Leibinger, Marco; Andreadaki, Anastasia; Fischer, Dietmar] Univ Dusseldorf, Dept Neurol, Div Expt Neurol, Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Fischer, D (corresponding author), Univ Dusseldorf, Dept Neurol, Div Expt Neurol, Dusseldorf, Germany.	dietmar.fischer@uni-duesseldorf.de		Fischer, Dietmar/0000-0002-1816-3014	German Research Foundation (DFG)	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the German Research Foundation (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arber S, 1996, GENE DEV, V10, P289, DOI 10.1101/gad.10.3.289; ARBER S, 1994, CELL, V79, P221, DOI 10.1016/0092-8674(94)90192-9; Arber S, 1997, CELL, V88, P393, DOI 10.1016/S0092-8674(00)81878-4; Bansal A, 2000, J NEUROSCI, V20, P7672; Boateng SY, 2007, AM J PHYSIOL-HEART C, V292, pH259, DOI 10.1152/ajpheart.00766.2006; Buyandelger B, 2011, PFLUG ARCH EUR J PHY, V462, P135, DOI 10.1007/s00424-011-0961-2; ECKENSTEIN F, 1982, EMBO J, V1, P363, DOI 10.1002/j.1460-2075.1982.tb01175.x; Elshatory Y, 2007, J NEUROSCI, V27, P12707, DOI 10.1523/JNEUROSCI.3951-07.2007; Emanuela P, 2009, J COMP NEUROL, V517, P737, DOI 10.1002/cne.22200; FAMIGLIETTI EV, 1987, BRAIN RES, V413, P404, DOI 10.1016/0006-8993(87)91038-9; FAMIGLIETTI EV, 1983, BRAIN RES, V261, P138, DOI 10.1016/0006-8993(83)91293-3; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; FISHER LJ, 1979, J COMP NEUROL, V187, P359, DOI 10.1002/cne.901870207; Flick MJ, 2000, J CELL SCI, V113, P1553; Flick MJ, 2002, BIOCHEM BIOPH RES CO, V295, P910, DOI 10.1016/S0006-291X(02)00768-4; Ford KJ, 2012, VISUAL NEUROSCI, V29, P61, DOI 10.1017/S0952523811000216; Gehmlich K, 2008, J MUSCLE RES CELL M, V29, P155, DOI 10.1007/s10974-008-9159-4; Geier C, 2008, HUM MOL GENET, V17, P2753, DOI 10.1093/hmg/ddn160; Haverkamp S, 2000, J COMP NEUROL, V424, P1; HAYDEN SA, 1980, SCIENCE, V210, P435, DOI 10.1126/science.7433984; Inoue T, 2002, DEVELOPMENT, V129, P831; Kim IB, 2000, J COMP NEUROL, V427, P604, DOI 10.1002/1096-9861(20001127)427:4<604::AID-CNE8>3.0.CO;2-C; Kong YF, 1997, MOL CELL BIOL, V17, P4750, DOI 10.1128/MCB.17.8.4750; Louis HA, 1997, J BIOL CHEM, V272, P27484, DOI 10.1074/jbc.272.43.27484; Macneil MA, 1999, J COMP NEUROL, V413, P305; MacNeil MA, 1998, NEURON, V20, P971, DOI 10.1016/S0896-6273(00)80478-X; Matsuoka RL, 2011, NATURE, V470, P259, DOI 10.1038/nature09675; Papalouka V, 2009, MOL CELL BIOL, V29, P6046, DOI 10.1128/MCB.00654-09; Rapaport DH, 2004, J COMP NEUROL, V474, P304, DOI 10.1002/cne.20134; Taylor WR, 2012, VISUAL NEUROSCI, V29, P73, DOI 10.1017/S0952523811000393; VANEY DI, 1981, J COMP NEUROL, V199, P373, DOI 10.1002/cne.901990305; VOIGT T, 1986, J COMP NEUROL, V248, P19, DOI 10.1002/cne.902480103; Wang XH, 2006, J MOL CELL CARDIOL, V40, P503, DOI 10.1016/j.yjmcc.2006.01.005; Wei W, 2011, NATURE, V469, P402, DOI 10.1038/nature09600; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8; Zhang M, 2005, J COMP NEUROL, V484, P331, DOI 10.1002/cne.20470	36	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100756	10.1371/journal.pone.0100756	http://dx.doi.org/10.1371/journal.pone.0100756			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945278	gold, Green Published, Green Submitted			2022-12-27	WOS:000340721500103
J	Kanzaki, N; Tanaka, R; Giblin-Davis, RM; Davies, KA				Kanzaki, Natsumi; Tanaka, Ryusei; Giblin-Davis, Robin M.; Davies, Kerrie A.			New Plant-Parasitic Nematode from the Mostly Mycophagous Genus Bursaphelenchus Discovered inside Figs in Japan	PLOS ONE			English	Article							N. SP NEMATODA; SP TYLENCHINA APHELENCHOIDIDAE; PHYLOGENETIC-RELATIONSHIPS; PINE WOOD; PARASITAPHELENCHIDAE; FUCHS; DNA; WASPS; XYLOPHILUS; ALGORITHMS	A new nematode species, Bursaphelenchus sycophilus n. sp. is described. The species was found in syconia of a fig species, Ficus variegata during a field survey of fig-associated nematodes in Japan. Because it has a well-developed stylet and pharyngeal glands, the species is considered an obligate plant parasite, and is easily distinguished from all other fungal-feeding species in the genus based upon these characters. Although B. sycophilus n. sp. shares an important typological character, male spicule possessing a strongly recurved condylus, with the "B. eremus group" and the "B. leoni group" of the genus, it was inferred to be monophyletic with the "B. fungivorus group". The uniquely shaped stylet and well-developed pharyngeal glands is reminiscent of the fig-floret parasitic but paraphyletic assemblage of "Schistonchus". Thus, these morphological characters appear to be an extreme example of convergent evolution in the nematode family, Aphelenchoididae, inside figs. Other characters shared by the new species and its close relatives, i.e., lack of ventral P1 male genital papilla, female vulval flap, and papilla-shaped P4 genital papillae in males, corroborate the molecular phylogenetic inference. The unique biological character of obligate plant parasitism and highly derived appearance of the ingestive organs of Bursaphelenchus sycophilus n. sp. expands our knowledge of the potential morphological, physiological and developmental plasticity of the genus Bursaphelenchus.	[Kanzaki, Natsumi] Forestry & Forest Prod Res Inst, Dept Forest Microbiol, Tsukuba, Ibaraki 305, Japan; [Tanaka, Ryusei] Miyazaki Univ, Fac Med, Div Parasitol, Miyazaki, Japan; [Giblin-Davis, Robin M.] Univ Florida IFAS, Ft Lauderdale Res & Educ Ctr, Davie, FL USA; [Davies, Kerrie A.] Univ Adelaide, Ctr Evolutionary Biol & Biodivers, Sch Agr Food & Wine, Glen Osmond, SA, Australia	Forestry & Forest Products Research Institute - Japan; University of Miyazaki; State University System of Florida; University of Florida; University of Adelaide	Kanzaki, N (corresponding author), Forestry & Forest Prod Res Inst, Dept Forest Microbiol, Tsukuba, Ibaraki 305, Japan.	nkanzaki@affrc.go.jp		Giblin-Davis, Robin/0000-0002-8861-8678	Ministry of Education, Culture, Sports, Science and Technology, Japan [22310145, 24658147, 26292178, 259930]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was partly supported by Grants-in-Aid for Scientific Research, Nos 22310145, 24658147 and 26292178, Grant-in-Aid for JSPS Fellows, No 259930 from The Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen HF, 2012, ECOL EVOL, V2, P247, DOI 10.1002/ece3.58; BAUJARD P, 1989, Revue de Nematologie, V12, P323; Baujard P., 1980, Revue de Nematologie, V3, P167; Braasch H, 2002, NEMATOLOGY, V4, P853, DOI 10.1163/156854102760402621; Braasch H., 2001, Bulletin OEPP, V31, P127, DOI 10.1111/j.1365-2338.2001.tb00982.x; Braasch H., 2009, Journal of Nematode Morphology and Systematics, V12, P65; Center BJ, 1999, J NEMATOL, V31, P393; Cruaud A, 2012, SYST BIOL, V61, P1029, DOI 10.1093/sysbio/sys068; Davies K, 2010, NEMATOLOGY, V12, P935, DOI 10.1163/138855410X498932; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Futai K, 2013, ANNU REV PHYTOPATHOL, V51, P61, DOI 10.1146/annurev-phyto-081211-172910; GIBLIN R M, 1984, Revue de Nematologie, V7, P13; GIBLIN-DAVIS R M, 1989, Revue de Nematologie, V12, P285; Giblin-Davis RM, 2006, ZOOTAXA, P39; Giblin-Davis RM, 2013, CABI INVASIVE SER, P1, DOI 10.1079/9781845938291.0001; Giblin-Davis Robin M., 1993, P302; GIBLINDAVIS RM, 1989, NEMATROPICA, V19, P135; GIBLINDAVIS RM, 1995, J NEMATOL, V27, P1; GRIFFITH R, 1987, PLANT DIS, V71, P193; Gu J, 2006, RUSS J NEMATOL, V14, P91; Gu JF, 2012, RUSS J NEMATOL, V20, P53; Gu JF, 2010, RUSS J NEMATOL, V18, P59; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hembry DH, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0361; HERRE EA, 1993, SCIENCE, V259, P1442, DOI 10.1126/science.259.5100.1442; Hooper D. J., 1986, LAB METHODS WORK PLA, P59; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jauharlina J, 2012, AFR ENTOMOL, V20, P101, DOI 10.4001/003.020.0113; Jordal BH, 1998, J TROP ECOL, V14, P153, DOI 10.1017/S0266467498000133; Kanzaki N, 2002, NEMATOLOGY, V4, P35, DOI 10.1163/156854102760082186; Kanzaki N, 2001, NEMATOLOGY, V3, P473, DOI 10.1163/156854101753250809; Kanzaki N, 2013, NEMATOL RES, V43, P43; Kanzaki N., 2008, PINE WILT DISEASE, P44; Kanzaki N., 2012, PRACTICAL PLANT NEMA, P161; Kanzaki N, 2013, NEMATOLOGY, V15, P975, DOI 10.1163/15685411-00002736; Kanzaki N, 2013, NEMATOLOGY, V15, P895, DOI 10.1163/15685411-00002728; Kanzaki N, 2013, J PARASITOL, V99, P639, DOI 10.1645/12-118.1; Kanzaki N, 2012, NEMATOLOGY, V14, P223, DOI 10.1163/138855411X587121; Kanzaki N, 2011, NEMATOLOGY, V13, P787, DOI 10.1163/138855410X552652; Kanzaki N, 2009, NEMATOLOGY, V11, P129, DOI 10.1163/156854108X398480; Kanzaki NK, 2007, NEMATOLOGY, V9, P759, DOI 10.1163/156854107782331216; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kikuchi T, 2009, PHYTOPATHOLOGY, V99, P1365, DOI 10.1094/PHYTO-99-12-1365; KORENTCHENKO EA, 1980, ZOOL ZH, V59, P1768; Lange C., 2007, Journal of Nematode Morphology and Systematics, V9, P95; Larget B, 1999, MOL BIOL EVOL, V16, P750, DOI 10.1093/oxfordjournals.molbev.a026160; LIEUTIER F, 1978, NEMATOLOGICA, V24, P187, DOI 10.1163/187529278X00399; Machado CA, 2005, P NATL ACAD SCI USA, V102, P6558, DOI 10.1073/pnas.0501840102; Maehara Noritoshi, 2013, Nematological Research, V43, P9, DOI 10.3725/jjn.43.9; MAMIYA Y, 1972, NEMATOLOGICA, V18, P120, DOI 10.1163/187529272X00296; Massey C. L., 1974, BIOL TAXONOMY NEMATO; MASSEY CL, 1971, J NEMATOL, V3, P289; Minagawa Nozomu, 1994, Japanese Journal of Nematology, V24, P75; Molbo D, 2003, P NATL ACAD SCI USA, V100, P5867, DOI 10.1073/pnas.0930903100; Murray EA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0495; POINAR GO, 1979, P K NED AKAD C BIOL, V82, P375; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ronsted N, 2005, P ROY SOC B-BIOL SCI, V272, P2593, DOI 10.1098/rspb.2005.3249; Ruhm W., 1956, Parasitologische Schriftenreihe, VNo. 6, P1; Ryss A, 2005, NEMATOLOGY, V7, P393, DOI 10.1163/156854105774355581; Schonfeld U, 2006, RUSS J NEMATOL, V14, P119; Siddiqi M. R., 2000, TYLENCHIDA PARASITES; Skarmoutsos G, 2000, FOREST PATHOL, V30, P149, DOI 10.1046/j.1439-0329.2000.00198.x; Tanaka R, 2012, APPL ENTOMOL ZOOL, V47, P291, DOI 10.1007/s13355-012-0115-9; VOVLAS N, 1992, NEMATOLOGICA, V38, P215, DOI 10.1163/187529292X00180; Walter DE, 2000, AUST J ENTOMOL, V39, P229, DOI 10.1046/j.1440-6055.2000.00184.x; Weiblen GD, 2002, ANNU REV ENTOMOL, V47, P299, DOI 10.1146/annurev.ento.47.091201.145213; WIEBES JT, 1979, ANNU REV ECOL SYST, V10, P1, DOI 10.1146/annurev.es.10.110179.000245; Ye WM, 2007, MOL PHYLOGENET EVOL, V43, P1185, DOI 10.1016/j.ympev.2007.02.006; Yoder M, 2006, NEMATOLOGY, V8, P367, DOI 10.1163/156854106778493448; Zeng YS, 2013, NEMATOLOGY, V15, P771, DOI 10.1163/15685411-00002717; Zeng YS, 2013, ZOOTAXA, V3717, P598, DOI 10.11646/zootaxa.3717.4.9; Zhao ZQ, 2008, NEMATOLOGY, V10, P663, DOI 10.1163/156854108785787299; Zhuo K, 2007, NEMATOLOGY, V9, P237, DOI 10.1163/156854107780739090	74	36	37	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99241	10.1371/journal.pone.0099241	http://dx.doi.org/10.1371/journal.pone.0099241			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940595	Green Published, gold, Green Submitted			2022-12-27	WOS:000338508200016
J	Rampino, A; Walker, RM; Torrance, HS; Anderson, SM; Fazio, L; Di Giorgio, A; Taurisano, P; Gelao, B; Romano, R; Masellis, R; Ursini, G; Caforio, G; Blasi, G; Millar, JK; Porteous, DJ; Thomson, PA; Bertolino, A; Evans, KL				Rampino, Antonio; Walker, Rosie May; Torrance, Helen Scott; Anderson, Susan Maguire; Fazio, Leonardo; Di Giorgio, Annabella; Taurisano, Paolo; Gelao, Barbara; Romano, Raffaella; Masellis, Rita; Ursini, Gianluca; Caforio, Grazia; Blasi, Giuseppe; Millar, J. Kirsty; Porteous, David John; Thomson, Pippa Ann; Bertolino, Alessandro; Evans, Kathryn Louise			Expression of DISC1-Interactome Members Correlates with Cognitive Phenotypes Related to Schizophrenia	PLOS ONE			English	Article							WORKING-MEMORY; PREFRONTAL CORTEX; POSTMORTEM BRAIN; BRODMANN AREA-6; DISC1 PATHWAY; GENES; DEFICITS; ASSOCIATION	Cognitive dysfunction is central to the schizophrenia phenotype. Genetic and functional studies have implicated Disrupted-in-Schizophrenia 1 (DISC1), a leading candidate gene for schizophrenia and related psychiatric conditions, in cognitive function. Altered expression of DISC1 and DISC1-interactors has been identified in schizophrenia. Dysregulated expression of DISC1-interactome genes might, therefore, contribute to schizophrenia susceptibility via disruption of molecular systems required for normal cognitive function. Here, the blood RNA expression levels of DISC1 and DISC1-interacting proteins were measured in 63 control subjects. Cognitive function was assessed using neuropsychiatric tests and functional magnetic resonance imaging was used to assess the activity of prefrontal cortical regions during the N-back working memory task, which is abnormal in schizophrenia. Pairwise correlations between gene expression levels and the relationship between gene expression levels and cognitive function and N-back-elicited brain activity were assessed. Finally, the expression levels of DISC1, AKAP9, FEZ1, NDEL1 and PCM1 were compared between 63 controls and 69 schizophrenic subjects. We found that DISC1-interactome genes showed correlated expression in the blood of healthy individuals. The expression levels of several interactome members were correlated with cognitive performance and N-back-elicited activity in the prefrontal cortex. In addition, DISC1 and NDEL1 showed decreased expression in schizophrenic subjects compared to healthy controls. Our findings highlight the importance of the coordinated expression of DISC1-interactome genes for normal cognitive function and suggest that dysregulated DISC1 and NDEL1 expression might, in part, contribute to susceptibility for schizophrenia via disruption of prefrontal cortex-dependent cognitive functions.	[Rampino, Antonio; Walker, Rosie May; Torrance, Helen Scott; Anderson, Susan Maguire; Millar, J. Kirsty; Porteous, David John; Thomson, Pippa Ann; Evans, Kathryn Louise] Univ Edinburgh, MRC, Inst Genet & Mol Med, Ctr Genom & Expt Med,Med Genet Sect, Edinburgh, Midlothian, Scotland; [Rampino, Antonio; Fazio, Leonardo; Di Giorgio, Annabella; Taurisano, Paolo; Gelao, Barbara; Romano, Raffaella; Masellis, Rita; Ursini, Gianluca; Caforio, Grazia; Blasi, Giuseppe; Bertolino, Alessandro] Univ Bari, Dept Neurosci & Sense Organs, Bari, Italy; [Di Giorgio, Annabella] Ist Ricovero & Cura Carattere Sci Casa Sollievo S, Sect Liaison Psychiat, San Giovanni Rotondo, FG, Italy; [Porteous, David John; Thomson, Pippa Ann; Evans, Kathryn Louise] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Ctr Genom & Expt Med, MRC,Inst Genet & Mol Med,Med Genet Sect, Edinburgh, Midlothian, Scotland; [Bertolino, Alessandro] Hoffmann La Roche Ag, Neurosci Discovery & Translat Area, CH-4002 Basel, Switzerland	University of Edinburgh; Universita degli Studi di Bari Aldo Moro; University of Edinburgh; Roche Holding	Bertolino, A (corresponding author), Univ Bari, Dept Neurosci & Sense Organs, Bari, Italy.	a.bertolino@psichiat.uniba.it; kathy.evans@ed.ac.uk	Di Giorgio, Annabella/AAI-5367-2020; Ursini, Gianluca/AAA-8242-2019; Rampino, Antonio/Q-4465-2016; Taurisano, Paolo/U-1828-2017; Di Giorgio, Annabella/AAS-1137-2020; Blasi, Giuseppe/HHS-5404-2022; Di Giorgio, Annabella/D-7353-2017; Porteous, David/AAA-3446-2021; Taurisano, Paolo/AID-5342-2022	Di Giorgio, Annabella/0000-0001-7876-3495; Rampino, Antonio/0000-0002-9654-3266; Taurisano, Paolo/0000-0001-6140-9326; Di Giorgio, Annabella/0000-0001-7876-3495; Porteous, David/0000-0003-1249-6106; Taurisano, Paolo/0000-0001-6140-9326; Ursini, Gianluca/0000-0002-4733-5196; Evans, Kathryn/0000-0002-7884-5877; Walker, Rosie/0000-0002-1060-4479; Blasi, Giuseppe/0000-0003-0878-1131	Chief Scientist Office [CZB/4/782]; Scottish Funding Council; Research Council UK [G0700704/84698]; Biotechnology and Biosciences Research Council; Engineering and Physical Sciences Research Council; Economic and Social Research Council; Medical Research Council; MRC [G0902166, G0100266] Funding Source: UKRI; Medical Research Council [G0100266, MR/K026992/1, G0902166] Funding Source: researchfish	Chief Scientist Office; Scottish Funding Council; Research Council UK(UK Research & Innovation (UKRI)); Biotechnology and Biosciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Chief Scientist Office (http://www.cso.scot.nhs.uk/) [grant number CZB/4/782]; the Scottish Funding Council (http://www.sfc.ac.uk/) Strategic Research Development Grant "Biomarkers for Battling Chronic Disease"; and Research Council UK (http://www.rcuk.ac.uk/Pages/Home.aspx) fellowships to PAT and JKM. KLE, PAT and DJP are members of The University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology (CCACE), part of the cross-council Lifelong Health and Wellbeing Initiative [grant number G0700704/84698]. CCACE is funded by the Biotechnology and Biosciences Research Council (http://www.bbsrc.ac.uk/home/home.aspx); Engineering and Physical Sciences Research Council (http://www.epsrc.ac.uk/Pages/default.aspx); Economic and Social Research Council (http://www.esrc.ac.uk/); and Medical Research Council (http://www.mrc.ac.uk/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barch DM, 2012, TRENDS COGN SCI, V16, P27, DOI 10.1016/j.tics.2011.11.015; Barch DM, 2002, J ABNORM PSYCHOL, V111, P478, DOI 10.1037//0021-843X.111.3.478; Bertolino A, 2004, AM J PSYCHIAT, V161, P1798, DOI 10.1176/appi.ajp.161.10.1798; Blokland GAM, 2011, J NEUROSCI, V31, P10882, DOI 10.1523/JNEUROSCI.5334-10.2011; Bradshaw NJ, 2012, NEUROPHARMACOLOGY, V62, P1230, DOI 10.1016/j.neuropharm.2010.12.027; Bressler SL, 2010, TRENDS COGN SCI, V14, P277, DOI 10.1016/j.tics.2010.04.004; Burns MJ, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-31; Callicott JH, 2000, CEREB CORTEX, V10, P1078, DOI 10.1093/cercor/10.11.1078; Camargo LM, 2007, MOL PSYCHIATR, V12, P74, DOI 10.1038/sj.mp.4001880; Chubb JE, 2008, MOL PSYCHIATR, V13, P36, DOI 10.1038/sj.mp.4002106; Condon B, 1997, APPL NEUROPSYCHOL, V4, P201, DOI 10.1207/s15324826an0404_1; Dickinson D, 2010, SCHIZOPHR B, V37, P1157; Ferrer I, 2008, CELL TISSUE BANK, V9, P181, DOI 10.1007/s10561-008-9077-0; Gadelha A, 2013, J PSYCHIATR RES, V47, P657, DOI 10.1016/j.jpsychires.2013.01.009; Genderson MR, 2007, SCHIZOPHR RES, V94, P231, DOI 10.1016/j.schres.2006.12.031; Green MF, 2000, SCHIZOPHRENIA BULL, V26, P119, DOI 10.1093/oxfordjournals.schbul.a033430; Hanakawa T, 2002, CEREB CORTEX, V12, P1157, DOI 10.1093/cercor/12.11.1157; Hennah W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004906; Kumarasinghe N, 2013, INT J NEUROPSYCHOPH, V16, P1483, DOI 10.1017/S1461145713000035; Lai CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021635; Libby LA, 2011, CURR TOP BEHAV NEURO; Lipska BK, 2006, HUM MOL GENET, V15, P1245, DOI 10.1093/hmg/ddl040; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Maxwell M., 1992, FAMILY INTERVIEW GEN; Millar JK, 2005, SCIENCE, V310, P1187, DOI 10.1126/science.1112915; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Money TT, 2010, CNS NEUROL DISORD-DR, V9, P241, DOI 10.2174/187152710791012062; Mottaghy FM, 2002, CEREB CORTEX, V12, P369, DOI 10.1093/cercor/12.4.369; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Rastogi A, 2009, SCHIZOPHR RES, V114, P39, DOI 10.1016/j.schres.2009.06.019; Ratta-apha W, 2013, NEUROSCI RES, V77, P222, DOI 10.1016/j.neures.2013.08.010; Richards AL, 2012, MOL PSYCHIATR, V17, P193, DOI 10.1038/mp.2011.11; Snitz BE, 2006, SCHIZOPHRENIA BULL, V32, P179, DOI 10.1093/schbul/sbi048; Takahashi M, 2010, SCHIZOPHR RES, V119, P210, DOI 10.1016/j.schres.2009.12.024; Tanaka S, 2005, J NEUROSCI, V25, P496, DOI 10.1523/JNEUROSCI.4324-04.2005; Thomson Pippa A, 2013, Front Biol (Beijing), V8, P1; Tomita H, 2004, BIOL PSYCHIAT, V55, P346, DOI 10.1016/j.biopsych.2003.10.013; Tomppo L, 2009, BIOL PSYCHIAT, V65, P1055, DOI 10.1016/j.biopsych.2009.01.014; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034	39	19	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99892	10.1371/journal.pone.0099892	http://dx.doi.org/10.1371/journal.pone.0099892			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940743	Green Submitted, Green Published, gold			2022-12-27	WOS:000338508200052
J	Shahana, S; Childers, DS; Ballou, ER; Bohovych, I; Odds, FC; Gow, NAR; Brown, AJP				Shahana, Shahida; Childers, Delma S.; Ballou, Elizabeth R.; Bohovych, Iryna; Odds, Frank C.; Gow, Neil A. R.; Brown, Alistair J. P.			New Clox Systems for Rapid and Disruption in Candida albicans	PLOS ONE			English	Article							SITE-SPECIFIC RECOMBINATION; HUMAN FUNGAL PATHOGEN; SELECTABLE MARKER URA3; BETA-TUBULIN GENE; LARGE-SCALE; OROTIDINE-5'-PHOSPHATE DECARBOXYLASE; SACCHAROMYCES-CEREVISIAE; FUNCTIONAL EXPRESSION; MOLECULAR-GENETICS; MYCOPHENOLIC-ACID	Precise genome modification is essential for the molecular dissection of Candida albicans, and is yielding invaluable information about the roles of specific gene functions in this major fungal pathogen of humans. C. albicans is naturally diploid, unable to undergo meiosis, and utilizes a non-canonical genetic code. Hence, specialized tools have had to be developed for gene disruption in C. albicans that permit the deletion of both target alleles, and in some cases, the recycling of the Candida-specific selectable markers. Previously, we developed a tool based on the Cre recombinase, which recycles markers in C. albicans with 90-100% efficiency via site-specific recombination between loxP sites. Ironically, the utility of this system was hampered by the extreme efficiency of Cre, which prevented the construction in Escherichia coli of stable disruption cassettes carrying a methionine-regulatable CaMET3(p)-cre gene flanked by loxP sites. Therefore, we have significantly enhanced this system by engineering new Clox cassettes that carry a synthetic, intron-containing cre gene. The Clox kit facilitates efficient transformation and marker recycling, thereby simplifying and accelerating the process of gene disruption in C. albicans. Indeed, homozygous mutants can be generated and their markers resolved within two weeks. The Clox kit facilitates strategies involving single marker recycling or multi-marker gene disruption. Furthermore, it includes the dominant NAT1 marker, as well as URA3, HIS1 and ARG4 cassettes, thereby permitting the manipulation of clinical isolates as well as genetically marked strains of C. albicans. The accelerated gene disruption strategies afforded by this new Clox system are likely to have a profound impact on the speed with which C. albicans pathobiology can be dissected.	[Shahana, Shahida; Childers, Delma S.; Ballou, Elizabeth R.; Bohovych, Iryna; Odds, Frank C.; Gow, Neil A. R.; Brown, Alistair J. P.] Univ Aberdeen, Sch Med Sci, Aberdeen, Scotland	University of Aberdeen	Brown, AJP (corresponding author), Univ Aberdeen, Sch Med Sci, Aberdeen, Scotland.	al.brown@abdn.ac.uk	GOW, Neil/AAS-5323-2021	GOW, Neil/0000-0002-2776-5850; Brown, Alistair JP/0000-0003-1406-4251; Ballou, Elizabeth/0000-0001-8051-2302	Wellcome Trust [080088, 097377]; European Research Council (STRIFE Advanced Grant) [C-2009-AdG-249793]; European Commission (FINSysB MC-ITN) [PITN-GA-2008-214004]; UK Biotechnology and Biological Research Council [BB/F00513X/1]; BBSRC [BB/K017365/1, BB/F00513X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F00513X/1, BB/K017365/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council (STRIFE Advanced Grant); European Commission (FINSysB MC-ITN)(European CommissionEuropean Commission Joint Research Centre); UK Biotechnology and Biological Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Wellcome Trust (www.wellcome.ac.uk): S. S., F.C.O., N.A.R.G., A.J.P.B. (080088); N.A.R.G., A.J.P.B. (097377). The authors also received support from the European Research Council [http://erc.europa.eu/]: DSC. ERB, AJPB (STRIFE Advanced Grant; C-2009-AdG-249793). The European Commission also provided funding [http://ec.europa.eu/research/fp7]: I. B., A.J.P.B. (FINSysB MC-ITN; PITN-GA-2008-214004). Also the UK Biotechnology and Biological Research Council provided support [www.bbsrc.ac.uk]: N.A.R.G., A.J.P.B. (Research Grant; BB/F00513X/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alby K, 2009, NATURE, V460, P890, DOI 10.1038/nature08252; AUSTIN S, 1981, CELL, V25, P729, DOI 10.1016/0092-8674(81)90180-X; Bain JM, 2001, FEMS MICROBIOL LETT, V204, P323, DOI 10.1111/j.1574-6968.2001.tb10905.x; Barelle CJ, 2004, YEAST, V21, P333, DOI 10.1002/yea.1099; Basso LR, 2010, YEAST, V27, P1039, DOI 10.1002/yea.1813; Beckerman J, 2001, INFECT IMMUN, V69, P108, DOI 10.1128/IAI.69.1.108-114.2001; Bennett RJ, 2005, ANNU REV MICROBIOL, V59, P233, DOI 10.1146/annurev.micro.59.030804.121310; Blackwell C, 2003, YEAST, V20, P1235, DOI 10.1002/yea.1036; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; Brand A, 2004, EUKARYOT CELL, V3, P900, DOI 10.1128/EC.3.4.900-909.2004; BROWN AJP, 1991, NUCLEIC ACIDS RES, V19, P4298, DOI 10.1093/nar/19.15.4298; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Butler G, 2009, NATURE, V459, P657, DOI 10.1038/nature08064; Calderone RA., 2002, CANDIDA CANDIDIASIS; Care RS, 1999, MOL MICROBIOL, V34, P792, DOI 10.1046/j.1365-2958.1999.01641.x; Cheng SJ, 2003, INFECT IMMUN, V71, P6101, DOI 10.1128/IAI.71.10.6101-6103.2003; De Backer MD, 2000, ANNU REV MICROBIOL, V54, P463, DOI 10.1146/annurev.micro.54.1.463; Dennison PMJ, 2005, FUNGAL GENET BIOL, V42, P737, DOI 10.1016/j.fgb.2005.05.006; Enloe B, 2000, J BACTERIOL, V182, P5730, DOI 10.1128/JB.182.20.5730-5736.2000; FONZI WA, 1993, GENETICS, V134, P717; Gerami-Nejad M, 2001, YEAST, V18, P859, DOI 10.1002/yea.738; Gerami-Nejad M, 2013, MICROBIOL-SGM, V159, P565, DOI 10.1099/mic.0.064097-0; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Hickman MA, 2013, NATURE, V494, P55, DOI 10.1038/nature11865; Inglis DO, 2012, NUCLEIC ACIDS RES, V40, pD667, DOI 10.1093/nar/gkr945; Kohler GA, 1997, J BACTERIOL, V179, P2331; Lay J, 1998, INFECT IMMUN, V66, P5301, DOI 10.1128/IAI.66.11.5301-5306.1998; Legrand M., 2012, Candida and candidiasis, P505; Morschhauser J, 1999, MOL MICROBIOL, V32, P547, DOI 10.1046/j.1365-2958.1999.01393.x; Murad AMA, 2000, YEAST, V16, P325, DOI 10.1002/1097-0061(20000315)16:4&lt;325::AID-YEA538&gt;3.0.CO;2-#; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; Nakayama H, 2000, INFECT IMMUN, V68, P6712, DOI 10.1128/IAI.68.12.6712-6719.2000; Nobile CJ, 2003, MICROBIOL-SGM, V149, P3629, DOI 10.1099/mic.0.26640-0; Noble SM, 2005, EUKARYOT CELL, V4, P298, DOI 10.1128/EC.4.2.298-309.2005; Noble SM, 2007, ANNU REV GENET, V41, P193, DOI 10.1146/annurev.genet.41.042007.170146; Noble SM, 2010, NAT GENET, V42, P590, DOI 10.1038/ng.605; ODDS FC, 1988, J MED VET MYCOL, V26, P277; OSBORNE BI, 1989, P NATL ACAD SCI USA, V86, P4097, DOI 10.1073/pnas.86.11.4097; Park YN, 2005, EUKARYOT CELL, V4, P1328, DOI 10.1128/EC.4.8.1328-1342.2005; Reuss O, 2004, GENE, V341, P119, DOI 10.1016/j.gene.2004.06.021; Roemer T, 2003, MOL MICROBIOL, V50, P167, DOI 10.1046/j.1365-2958.2003.03697.x; Samaranayake DP, 2011, FUNGAL GENET BIOL, V48, P858, DOI 10.1016/j.fgb.2011.04.003; Sanglard D, 1996, ANTIMICROB AGENTS CH, V40, P2300, DOI 10.1128/AAC.40.10.2300; SANTOS MAS, 1993, EMBO J, V12, P607, DOI 10.1002/j.1460-2075.1993.tb05693.x; SANTOS MAS, 1995, NUCLEIC ACIDS RES, V23, P1481, DOI 10.1093/nar/23.9.1481; Sasse C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025623; SAUER B, 1987, MOL CELL BIOL, V7, P2087, DOI 10.1128/MCB.7.6.2087; SAUER B, 1988, P NATL ACAD SCI USA, V85, P5166, DOI 10.1073/pnas.85.14.5166; Shen JQ, 2005, INFECT IMMUN, V73, P1239, DOI 10.1128/IAI.73.2.1239-1242.2005; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SMITH HA, 1990, GENE, V90, P115, DOI 10.1016/0378-1119(90)90446-X; SMITH HA, 1988, GENE, V63, P53, DOI 10.1016/0378-1119(88)90545-8; Staib P, 1999, MOL MICROBIOL, V32, P533, DOI 10.1046/j.1365-2958.1999.01367.x; Staib P, 2000, P NATL ACAD SCI USA, V97, P6102, DOI 10.1073/pnas.110031497; STERNBERG N, 1981, J MOL BIOL, V150, P467, DOI 10.1016/0022-2836(81)90375-2; Sundstrom P, 2002, INFECT IMMUN, V70, P3281, DOI 10.1128/IAI.70.6.3281-3283.2002; Uhl MA, 2003, EMBO J, V22, P2668, DOI 10.1093/emboj/cdg256; WEINBURG RA, 1995, MOL MICROBIOL, V16, P241, DOI 10.1111/j.1365-2958.1995.tb02296.x; Wellington M, 2005, YEAST, V22, P57, DOI 10.1002/yea.1191; Wilson RB, 2000, YEAST, V16, P65, DOI 10.1002/(SICI)1097-0061(20000115)16:1&lt;65::AID-YEA508&gt;3.0.CO;2-M; Wilson RB, 1999, J BACTERIOL, V181, P1868, DOI 10.1128/JB.181.6.1868-1874.1999; Wirsching S, 2000, MOL MICROBIOL, V36, P856, DOI 10.1046/j.1365-2958.2000.01899.x; Wirsching S, 2000, J BACTERIOL, V182, P400, DOI 10.1128/JB.182.2.400-404.2000; Xu DM, 2007, PLOS PATHOG, V3, P835, DOI 10.1371/journal.ppat.0030092; Zeng GS, 2014, NAT PROTOC, V9, P464, DOI 10.1038/nprot.2014.029	65	24	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100390	10.1371/journal.pone.0100390	http://dx.doi.org/10.1371/journal.pone.0100390			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940603	Green Published, Green Submitted, gold			2022-12-27	WOS:000338508200100
J	Zhou, ZZ; Deng, H; Yan, W; Luo, M; Tu, W; Xia, YJ; He, JY; Han, P; Fu, Y; Tian, DA				Zhou, Zhenzhen; Deng, Huan; Yan, Wei; Luo, Min; Tu, Wei; Xia, Yujia; He, Jiayi; Han, Ping; Fu, Yu; Tian, De'an			AEG-1 Promotes Anoikis Resistance and Orientation Chemotaxis in Hepatocellular Carcinoma Cells	PLOS ONE			English	Article							ASTROCYTE-ELEVATED GENE-1; CHEMOKINE RECEPTOR CXCR4; BREAST-CANCER; TUMOR-CELLS; METASTASIS; ACTIVATION; EXPRESSION; GROWTH; BONE; PATHWAY	Metastasis contributes to the poor prognosis of hepatocellular carcinoma (HCC). Anoikis resistance and orientation chemotaxis are two important and sequential events in tumor cell metastasis. The process of tumor metastasis is known to be regulated by AEG-1, an important oncogene that plays a critical role in tumor metastasis, though the effects of this oncogene on anoikis resistance and orientation chemotaxis in HCC cells are currently unknown. To directly assess the role of AEG-1 in these processes, we up-regulated AEG-1 expression via exogenous transfection in SMMC-7721 cells, which express low endogenous levels of AEG-1; and down-regulated AEG-1 expression via siRNA-mediated knockdown in MHCC-97H and HCC-LM3 cells, which express high endogenous levels of AEG-1. Our data directly demonstrate that AEG-1 promotes cell growth as assessed by cell proliferation/viability and cell cycle analysis. Furthermore, the prevention of anoikis by AEG-1 correlates with decreased activation of caspase-3. AEG-1-dependent anoikis resistance is activated via the PI3K/Akt pathway and is characterized by the regulation of Bcl-2 and Bad. The PI3K inhibitor LY294002 reverses the AEG-1 dependent effects on Akt phosphorylation, Bcl-2 expression and anoikis resistance. AEG-1 also promotes orientation chemotaxis of suspension-cultured cells towards supernatant from Human Pulmonary Microvascular Endothelial Cells (HPMECs). Our results show that AEG-1 activates the expression of the metastasis-associated chemokine receptor CXCR4, and that its ligand, CXCL12, is secreted by HPMECs. Furthermore, the CXCR4 antoagonist AMD3100 decreases AEG-1-induced orientation chemotaxis. These results define a pathway by which AEG-1 regulates anoikis resistance and orientation chemotaxis during HCC cell metastasis.	[Zhou, Zhenzhen; Deng, Huan; Yan, Wei; Luo, Min; Tu, Wei; Xia, Yujia; He, Jiayi; Han, Ping; Tian, De'an] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Gastroenterol, Wuhan 430074, Peoples R China; [Fu, Yu] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Gastroenterol, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Tian, DA (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Gastroenterol, Wuhan 430074, Peoples R China.	tjtiandean@126.com			National Natural Science Foundation of China [81270507, 81372663, 81000159]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China No. 81270507, No. 81372663 and No. 81000159). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alix-Panabieres C, 2008, CLIN CANCER RES, V14, P5013, DOI 10.1158/1078-0432.CCR-07-5125; Aplin AE, 1999, CURR OPIN CELL BIOL, V11, P737, DOI 10.1016/S0955-0674(99)00045-9; Azab AK, 2009, BLOOD, V113, P4341, DOI 10.1182/blood-2008-10-186668; Boisvert-Adamo K, 2006, ONCOGENE, V25, P4848, DOI 10.1038/sj.onc.1209493; Boyce BF, 1999, ENDOCR-RELAT CANCER, V6, P333, DOI 10.1677/erc.0.0060333; Britt DE, 2004, EXP CELL RES, V300, P134, DOI 10.1016/j.yexcr.2004.06.026; Brown DM, 2004, CANCER CELL, V5, P365, DOI 10.1016/S1535-6108(04)00079-0; Cabioglu N, 2005, CANCER RES, V65, P6493, DOI 10.1158/0008-5472.CAN-04-1303; Cabioglu N, 2005, CLIN EXP METASTAS, V22, P39, DOI 10.1007/s10585-005-3222-y; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chen J, 2011, J CANCER RES CLIN, V137, P1799, DOI 10.1007/s00432-011-1057-2; Chiarugi P, 2008, BIOCHEM PHARMACOL, V76, P1352, DOI 10.1016/j.bcp.2008.07.023; Coll MAL, 2005, ONCOGENE, V24, P1727, DOI 10.1038/sj.onc.1208379; Dedhar S, 2000, CURR OPIN CELL BIOL, V12, P250, DOI 10.1016/S0955-0674(99)00083-6; Derksen PWB, 2011, DIS MODEL MECH, V4, P347, DOI 10.1242/dmm.006395; Douma S, 2004, NATURE, V430, P1034, DOI 10.1038/nature02765; Emdad L, 2006, CANCER RES, V66, P1509, DOI 10.1158/0008-5472.CAN-05-3029; Fidler IJ, 2002, SEMIN CANCER BIOL, V12, P89, DOI 10.1006/scbi.2001.0416; Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X; Frisch SM, 1999, CURR BIOL, V9, P1047, DOI 10.1016/S0960-9822(99)80455-2; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Fung C, 2008, MOL BIOL CELL, V19, P797, DOI 10.1091/mbc.E07-10-1092; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hu GH, 2009, CLIN CANCER RES, V15, P5615, DOI 10.1158/1078-0432.CCR-09-0049; Hu GH, 2009, CANCER CELL, V15, P9, DOI 10.1016/j.ccr.2008.11.013; Isakoff SJ, 2005, CANCER RES, V65, P10992, DOI 10.1158/0008-5472.CAN-05-2612; Jiang K, 2004, MOL CELL BIOL, V24, P5565, DOI 10.1128/MCB.24.12.5565-5576.2004; Jost M, 2001, MOL BIOL CELL, V12, P1519, DOI 10.1091/mbc.12.5.1519; Kang DC, 2005, GENE, V353, P8, DOI [10.1016/j.gene.2005.04.006, 10.1016/j.gene.2005.04.005]; Kang H, 2005, BREAST, V14, P360, DOI 10.1016/j.breast.2004.12.007; Kang HG, 2007, CANCER RES, V67, P3094, DOI 10.1158/0008-5472.CAN-06-3259; Katyal S, 2000, RADIOLOGY, V216, P698, DOI 10.1148/radiology.216.3.r00se24698; Kikuno N, 2007, ONCOGENE, V26, P7647, DOI 10.1038/sj.onc.1210572; Kim YN, 2012, INT J CELL BIOL, V2012, DOI DOI 10.1155/2012/306879; Kochetkova M, 2009, CELL DEATH DIFFER, V16, P664, DOI 10.1038/cdd.2008.190; Lee BC, 2004, MOL CANCER RES, V2, P327; Lee SG, 2008, ONCOGENE, V27, P1114, DOI 10.1038/sj.onc.1210713; Lee SG, 2006, P NATL ACAD SCI USA, V103, P17390, DOI 10.1073/pnas.0608386103; Li JK, 2008, WORLD J GASTROENTERO, V14, P2308, DOI 10.3748/wjg.14.2308; Liu LP, 2010, CANCER RES, V70, P3750, DOI 10.1158/0008-5472.CAN-09-3838; Lu YL, 1999, ONCOGENE, V18, P7034, DOI 10.1038/sj.onc.1203183; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mawji IA, 2007, J NATL CANCER I, V99, P811, DOI 10.1093/jnci/djk182; McFall A, 2001, MOL CELL BIOL, V21, P5488, DOI 10.1128/MCB.21.16.5488-5499.2001; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Mundy GR, 1997, CANCER-AM CANCER SOC, V80, P1546, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1546::AID-CNCR4>3.3.CO;2-R; Pattarozzi A, 2008, MOL PHARMACOL, V73, P191, DOI 10.1124/mol.107.039974; Pawlak G, 2001, CURR OPIN GENET DEV, V11, P41, DOI 10.1016/S0959-437X(00)00154-4; Sarkar D, 2008, CANCER RES, V68, P1478, DOI 10.1158/0008-5472.CAN-07-6164; Simpson CD, 2008, CANCER LETT, V272, P177, DOI 10.1016/j.canlet.2008.05.029; Su ZZ, 2002, ONCOGENE, V21, P3592, DOI 10.1038/sj.onc.1205445; Taichman RS, 2002, CANCER RES, V62, P1832; Uchida D, 2003, EXP CELL RES, V290, P289, DOI 10.1016/S0014-4827(03)00344-6; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Wendt MK, 2008, GASTROENTEROLOGY, V135, P508, DOI 10.1053/j.gastro.2008.05.033; Woodhouse EC, 1997, CANCER-AM CANCER SOC, V80, P1529, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1529::AID-CNCR2>3.0.CO;2-F; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Yang JD, 2010, NAT REV GASTRO HEPAT, V7, P448, DOI 10.1038/nrgastro.2010.100; Yoo BK, 2009, J CLIN INVEST, V119, P465, DOI 10.1172/JCI36460; Yu CP, 2009, CARCINOGENESIS, V30, P894, DOI 10.1093/carcin/bgp064; Zhou ZZ, 2012, J HUAZHONG U SCI-MED, V32, P353, DOI 10.1007/s11596-012-0061-3; Zlotnik A, 2004, SEMIN CANCER BIOL, V14, P181, DOI 10.1016/j.semcancer.2003.10.004	64	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100372	10.1371/journal.pone.0100372	http://dx.doi.org/10.1371/journal.pone.0100372			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941119	gold, Green Published, Green Submitted			2022-12-27	WOS:000338508200098
J	Kumar, J; Dhar, P; Tayade, AB; Gupta, D; Chaurasia, OP; Upreti, DK; Arora, R; Srivastava, RB				Kumar, Jatinder; Dhar, Priyanka; Tayade, Amol B.; Gupta, Damodar; Chaurasia, Om P.; Upreti, Dalip K.; Arora, Rajesh; Srivastava, Ravi B.			Antioxidant Capacities, Phenolic Profile and Cytotoxic Effects of Saxicolous Lichens from Trans-Himalayan Cold Desert of Ladakh	PLOS ONE			English	Article							RADICAL-SCAVENGING ACTIVITY; ANTIMICROBIAL ACTIVITY; CHEMICAL-COMPOSITION; ANALGESIC ACTIVITIES; XANTHORIA-ELEGANS; METHANOL EXTRACTS; ETHANOL EXTRACTS; CLADONIA-FURCATA; PLANT-EXTRACTS; DIVERSE PANEL	Fourteen saxicolous lichens from trans-Himalayan Ladakh region were identified by morpho-anatomical and chemical characteristics. The n-hexane, methanol and water extracts of the lichens were evaluated for their antioxidant capacities. The lichen extracts showing high antioxidant capacities and rich phenolic content were further investigated to determine their cytotoxic activity on human HepG2 and RKO carcinoma cell lines. The ferric reducing antioxidant power (FRAP), 2,2'-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS), 1,1-diphenyl-2-picrylhydrazyl (DPPH) and nitric oxide (NO) radical scavenging capacities and beta-carotene-linoleic acid bleaching property exhibited analogous results where the lichen extracts showed high antioxidant action. The lichen extracts were also found to possess good amount of total proanthocyanidin, flavonoid and polyphenol. The methanolic extract of Lobothallia alphoplaca exhibited highest FRAP value. Methanolic extract of Xanthoparmelia stenophylla showed the highest ABTS radical scavenging capacity. The n-hexane extract of Rhizoplaca chrysoleuca exhibited highest DPPH radical scavenging capacity. Highest antioxidant capacity in terms of beta-carotene linoleic acid bleaching property was observed in the water extract of Xanthoria elegans. Similarly, Melanelia disjuncta water extract showed highest NO scavenging capacity. Among n-hexane, methanol and water extracts of all lichens, the methanolic extract of Xanthoparmelia mexicana showed highest total proanthocyanidin, flavonoid and polyphenol content. From cytotoxic assay, it was observed that the methanolic extracts of L. alphoplaca and M. disjuncta were exhibiting high cytotoxic effects against cancer cell growth. Similarly, the water extract of Dermatocarpon vellereum, Umbilicaria vellea, X. elegans and M. disjuncta and the methanolic extract of M. disjuncta and X. stenophylla were found to possess high antioxidant capacities and were non-toxic and may be used as natural antioxidants for stress related problems. Our studies go on to prove that the unique trans-Himalayan lichens are a hitherto untapped bioresource with immense potential for discovery of new chemical entities, and this biodiversity needs to be tapped sustainably.	[Kumar, Jatinder; Dhar, Priyanka; Tayade, Amol B.; Chaurasia, Om P.; Srivastava, Ravi B.] Def Res & Dev Org, Def Inst High Altitude Res, Leh Ladakh, Jammu & Kashmir, India; [Gupta, Damodar; Arora, Rajesh] Def Res & Dev Org, Inst Nucl Med & Allied Sci, Radiat Biotechnol Grp, Med & Aromat Plants Lab, Delhi, India; [Arora, Rajesh] DRDO Bhawan, Off Director Gen Life Sci, New Delhi, India; [Upreti, Dalip K.] Natl Bot Res Inst, CSIR, Plant Biodivers & Conservat Biol Div, Lichenol Lab, Lucknow 226001, Uttar Pradesh, India	Defence Research & Development Organisation (DRDO); Defence Institute of High Altitude Research (DIHAR); Defence Research & Development Organisation (DRDO); Institute of Nuclear Medicine & Allied Sciences (INMAS); Defence Research & Development Organisation (DRDO); Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Botanical Research Institute (NBRI)	Chaurasia, OP (corresponding author), Def Res & Dev Org, Def Inst High Altitude Res, Leh Ladakh, Jammu & Kashmir, India.	dropchaurasiadihardrdo@gmail.com	CHAURASIA, OM/AAW-6347-2021; CHAURASIA, OM PRAKASH/AAP-3358-2021; Arora, Rajesh/AAE-4596-2021	CHAURASIA, OM PRAKASH/0000-0003-2921-2755; Arora, Rajesh/0000-0001-7307-9221; Srivastava, Rakesh/0000-0002-0065-4069; Srivastava, Rakesh/0000-0003-3112-4252	Defence Research & Development Organisation (DRDO), Ministry of Defence, Government of India	Defence Research & Development Organisation (DRDO), Ministry of Defence, Government of India	The study was entirely supported by Defence Research & Development Organisation (DRDO), Ministry of Defence, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acikgoz B, 2013, Z NATURFORSCH C, V68, P191; AHMADJIAN V, 1995, BIOSCIENCE, V45, P124, DOI 10.1093/bioscience/45.3.124; Anagnostopoulou MA, 2006, FOOD CHEM, V94, P19, DOI 10.1016/j.foodchem.2004.09.047; Ari F, 2014, ENVIRON TOXICOL, V29, P804, DOI 10.1002/tox.21809; Aruoma OI, 1998, J AM OIL CHEM SOC, V75, P199, DOI 10.1007/s11746-998-0032-9; Ashraf MF, 2013, SCI WORLD J, DOI 10.1155/2013/216894; Aslan A, 2012, TOXICOL IND HEALTH, V28, P505, DOI 10.1177/0748233711416944; Aubert S, 2007, PLANTA, V226, P1287, DOI 10.1007/s00425-007-0563-6; Awasthi DD, 2007, COMPENDIUM MACROLICH, P580; Ballabh B, 2007, CURR SCI INDIA, V92, P1664; Bartak M, 2007, POLAR BIOL, V31, P47, DOI 10.1007/s00300-007-0331-x; Behera BC, 2006, LWT-FOOD SCI TECHNOL, V39, P80, DOI 10.1016/j.lwt.2004.11.007; Bezivin C, 2004, PLANTA MED, V70, P874, DOI 10.1055/s-2004-827240; Bezivin C, 2003, PHYTOMEDICINE, V10, P499, DOI 10.1078/094471103322331458; Bhattarai HD, 2008, J NAT MED-TOKYO, V62, P481, DOI 10.1007/s11418-008-0257-9; Boyd MR, 1992, ANTITUMOR DRUG DISCO, P11; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; Bucar F, 2004, PHYTOMEDICINE, V11, P602, DOI 10.1016/j.phymed.2004.03.004; Burlando B, 2009, PLANTA MED, V75, P607, DOI 10.1055/s-0029-1185329; Buyukokuroglu ME, 2001, PHARM RES, V44, P1199; Cao GH, 1996, J AGR FOOD CHEM, V44, P3426, DOI 10.1021/jf9602535; Cao GH, 1997, FREE RADICAL BIO MED, V22, P749, DOI 10.1016/S0891-5849(96)00351-6; Cesquini M, 2003, BIOMED PHARMACOTHER, V57, P124, DOI 10.1016/S0753-3322(03)00018-0; Chandrasekar MJN, 2006, PHARM BIOL, V44, P100, DOI 10.1080/13880200600592046; Chen Q, 2008, P NATL ACAD SCI USA, V105, P11105, DOI 10.1073/pnas.0804226105; Chopra RN, 1958, INDIGENOUS DRUGS IND, P643; Dapkevicius A, 1998, J SCI FOOD AGR, V77, P140, DOI 10.1002/(SICI)1097-0010(199805)77:1&lt;140::AID-JSFA18&gt;3.0.CO;2-K; de Vera JP, 2010, ASTROBIOLOGY, V10, P215, DOI 10.1089/ast.2009.0362; Dhar P, 2012, J FOOD SCI, V77, pC156, DOI 10.1111/j.1750-3841.2011.02523.x; Dhar P, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-259; Divakar PK., 2005, PARMELIOID LICHENS I, P488; Melo MGD, 2011, TOXICOL IN VITRO, V25, P462, DOI 10.1016/j.tiv.2010.11.014; ELIX JA, 1993, CATALOGUE STANDARDIS; Esimone CO, 2007, J INFECT DEV COUNTR, V1, P315, DOI 10.3855/jidc.370; Esimone CO, 2005, J APPL MICROBIOL, V99, P1346, DOI 10.1111/j.1365-2672.2005.02732.x; Gao XQ, 2000, J SCI FOOD AGR, V80, P2021, DOI 10.1002/1097-0010(200011)80:14&lt;2021::AID-JSFA745&gt;3.0.CO;2-2; GONZALEZTEJERO MR, 1995, ECON BOT, V49, P96, DOI 10.1007/BF02862281; Grujicic D, 2014, CYTOTECHNOL IN PRESS; Gulcin I, 2004, J ETHNOPHARMACOL, V90, P205, DOI 10.1016/j.jep.2003.09.028; Gulcin I, 2003, J ETHNOPHARMACOL, V86, P51, DOI 10.1016/S0378-8741(03)00036-9; Gulluce M, 2006, PHYTOMEDICINE, V13, P515, DOI 10.1016/j.phymed.2005.09.008; Gulluce M, 2011, TOXICOL IND HEALTH, V27, P675, DOI 10.1177/0748233710395343; Halama P, 2004, BIOCONTROL, V49, P95, DOI 10.1023/B:BICO.0000009378.31023.ba; HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001; Halliwell B, 2000, LANCET, V355, P1179, DOI 10.1016/S0140-6736(00)02075-4; HALLIWELL B, 1990, METHOD ENZYMOL, V186, P1; Halliwell B, 1995, BIOCHEM SOC SYMP, P73, DOI 10.1042/bss0610073; Hawksworth DL, 1994, PLANT GALLS, V49; Heinonen IM, 1998, J AGR FOOD CHEM, V46, P25, DOI 10.1021/jf970489o; HIDALGO ME, 1994, PHYTOCHEMISTRY, V37, P1585, DOI 10.1016/S0031-9422(00)89571-0; Hong YP, 2008, PLANT FOOD HUM NUTR, V63, P200, DOI 10.1007/s11130-008-0088-6; Hou WC, 2003, PHYTOMEDICINE, V10, P170, DOI 10.1078/094471103321659898; Hu SY, 1980, ENUMERATION CHINESE, P101; Ikram EHK, 2009, J FOOD COMPOS ANAL, V22, P388, DOI 10.1016/j.jfca.2009.04.001; Ingolfsdottir K, 2000, PHARM BIOL, V38, P313, DOI 10.1076/1388-0209(200009)3841-AFT313; Jeong WY, 2011, J SEP SCI, V34, P2967, DOI 10.1002/jssc.201100524; Kappen L, 2000, ANTARCT SCI, V12, P314, DOI 10.1017/S0954102000000377; Karagoz A, 2005, BIOLOGIA, V60, P281; Kinoshita K, 2010, J NAT MED-TOKYO, V64, P85, DOI 10.1007/s11418-009-0364-2; Korekar G, 2011, ACTA ALIMENT HUNG, V40, P449, DOI 10.1556/AAlim.40.2011.4.4; Korekar G, 2011, PLANT FOOD HUM NUTR, V66, P376, DOI 10.1007/s11130-011-0246-0; Kosanic M, 2013, FOOD CHEM TOXICOL, V53, P112, DOI 10.1016/j.fct.2012.11.034; Kosanic M, 2012, J FOOD SCI, V77, pT20, DOI 10.1111/j.1750-3841.2011.02459.x; Kumar J, 2012, NATURE SCI, V10, P1; Luo H, 2009, POLAR BIOL, V32, P1033, DOI 10.1007/s00300-009-0602-9; Manojlovic N, 2012, PHYTOMEDICINE, V19, P1166, DOI 10.1016/j.phymed.2012.07.012; Meessen J, 2013, ORIGINS LIFE EVOL B, V43, P501, DOI 10.1007/s11084-013-9348-z; Meessen J, 2013, ORIGINS LIFE EVOL B, V43, P283, DOI 10.1007/s11084-013-9337-2; Mensor LL, 2001, PHYTOTHER RES, V15, P127, DOI 10.1002/ptr.687; Mitrovic T., 2011, BIOL NYSSANA, V2, P1; Mitrovic T, 2011, INT J MOL SCI, V12, P5428, DOI 10.3390/ijms12085428; Molnar K, 2010, Z NATURFORSCH C, V65, P157; MONKS A, 1991, J NATL CANCER I, V83, P757, DOI 10.1093/jnci/83.11.757; Nash III T.H., 1988, BIBLIOTHECA LICHENOL, V30, P11; Naveena BM, 2008, INT J FOOD SCI TECH, V43, P1807, DOI 10.1111/j.1365-2621.2007.01708.x; Neamati N, 1997, J MED CHEM, V40, P942, DOI 10.1021/jm960759e; Negi HR, 2000, CURR SCI INDIA, V78, P1105; Negi HR, 2000, J BIOSCIENCES, V25, P367, DOI 10.1007/BF02703790; Nickavar B, 2007, PAK J PHARM SCI, V20, P291; Nybakken L, 2004, OECOLOGIA, V140, P211, DOI 10.1007/s00442-004-1583-6; Odabasoglu F, 2005, FITOTERAPIA, V76, P216, DOI 10.1016/j.fitote.2004.05.012; Oksanen I, 2006, APPL MICROBIOL BIOT, V73, P723, DOI 10.1007/s00253-006-0611-3; ORANGE A, 2001, MICROCHEMICAL METHOD; Ordonez AAL, 2006, FOOD CHEM, V97, P452, DOI 10.1016/j.foodchem.2005.05.024; Pasciu V, 2010, TOXICOL SCI, V114, P101, DOI 10.1093/toxsci/kfp301; Paudel B, 2008, POLAR BIOL, V31, P605, DOI 10.1007/s00300-007-0394-8; Paudel B, 2012, BIOL RES, V45, P387, DOI 10.4067/S0716-97602012000400010; Pellegrini N, 1999, METHOD ENZYMOL, V299, P379; Rankovic B, 2007, BRIT J BIOMED SCI, V64, P143, DOI 10.1080/09674845.2007.11732776; Rankovic B, 2010, CENT EUR J BIOL, V5, P649, DOI 10.2478/s11535-010-0043-z; Rankovic BR, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-97; Richardson D. H. S., 1988, CRC HDB LICHENOLOGY, P93; RICHARDSON DHS, 1991, FRONTIERS IN MYCOLOGY, P187; Robinson EE, 1997, FREE RADICAL RES, V26, P291, DOI 10.3109/10715769709097807; Robinson SA, 2003, GLOBAL CHANGE BIOL, V9, P1681, DOI 10.1046/j.1365-2486.2003.00693.x; RUBINSTEIN LV, 1990, J NATL CANCER I, V82, P1113, DOI 10.1093/jnci/82.13.1113; Shukla V, 2010, PHYTOCHEM REV, V9, P303, DOI 10.1007/s11101-010-9189-6; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Souri E, 2008, IRAN J PHARM RES, V7, P149; Stocker-Worgotter E, 2008, NAT PROD REP, V25, P188, DOI 10.1039/b606983p; Sumangala Rao, 2013, British Biotechnology Journal, V3, P377; Sun JS, 1998, BURNS, V24, P225, DOI 10.1016/S0305-4179(97)00115-0; Tanas S, 2010, J NAT MED-TOKYO, V64, P42, DOI 10.1007/s11418-009-0367-z; Tayade AB, 2013, J FOOD SCI, V78, pC402, DOI 10.1111/1750-3841.12054; Teke GN, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-57; Turkez H, 2012, CYTOTECHNOLOGY, V64, P679, DOI 10.1007/s10616-012-9447-0; Ullah MF, 2013, CELL BIOCHEM BIOPHYS, V67, P431, DOI 10.1007/s12013-011-9303-4; Velioglu YS, 1998, J AGR FOOD CHEM, V46, P4113, DOI 10.1021/jf9801973; Wang ZH, 2009, FOOD CHEM, V112, P914, DOI 10.1016/j.foodchem.2008.06.078; Weisburg JH, 2010, ANTI-CANCER AGENT ME, V10, P634; Wong CC, 2006, FOOD CHEM, V97, P705, DOI 10.1016/j.foodchem.2005.05.049; Zambare VP, 2012, PHARM BIOL, V50, P778, DOI 10.3109/13880209.2011.633089; Zeytinoglu H, 2008, PHYTOTHER RES, V22, P118, DOI 10.1002/ptr.2279; Zhang DL, 2004, FOOD CHEM, V88, P503, DOI 10.1016/j.foodchem.2004.01.065; Zhang HH, 2010, FREE RADICAL BIO MED, V49, P2010, DOI 10.1016/j.freeradbiomed.2010.09.031; Zhang WM, 2009, AFR J BIOTECHNOL, V8, P3887; Zheng W, 2001, J AGR FOOD CHEM, V49, P5165, DOI 10.1021/jf010697n	117	23	24	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e98696	10.1371/journal.pone.0098696	http://dx.doi.org/10.1371/journal.pone.0098696			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937759	Green Published, Green Submitted, gold			2022-12-27	WOS:000338503400009
J	Meyer, JL; Paul, VJ; Teplitski, M				Meyer, Julie L.; Paul, Valerie J.; Teplitski, Max			Community Shifts in the Surface Microbiomes of the Coral Porites astreoides with Unusual Lesions	PLOS ONE			English	Article							WHITE PLAGUE DISEASE; REEF-BUILDING CORAL; BACTERIAL COMMUNITIES; CLIMATE-CHANGE; SP NOV.; MONTASTRAEA-FAVEOLATA; INFECTIOUS-DISEASES; PHAGE THERAPY; RED-SEA; HEALTHY	Apical lesions on Porites astreoides were characterized by the appearance of a thin yellow band, which was preceded by bleaching of the coral tissues and followed by a completely denuded coral skeleton, which often harbored secondary macroalgal colonizers. These characteristics have not been previously described in Porites and do not match common Caribbean coral diseases. The lesions were observed only in warmer months and at shallow depths on the fore reef in Belize. Analysis of the microbial community composition based on the V4 hypervariable region of 16S ribosomal RNA genes revealed that the surface microbiomes associated with nonsymptomatic corals were dominated by the members of the genus Endozoicomonas, consistent with other studies. Comparison of the microbiomes of nonsymptomatic and lesioned coral colonies sampled in July and September revealed two distinct groups, inconsistently related to the disease state of the coral, but showing some temporal signal. The loss of Endozoicomonas was characteristic of lesioned corals, which also harbored potential opportunistic pathogens such as Alternaria, Stenotrophomonas, and Achromobacter. The presence of lesions in P. astreoides coincided with a decrease in the relative abundance of Endozoicomonas, rather than the appearance of specific pathogenic taxa.	[Meyer, Julie L.; Teplitski, Max] Univ Florida, Inst Food & Agr Sci, Dept Soil & Water Sci, Gainesville, FL 32611 USA; [Paul, Valerie J.; Teplitski, Max] Smithsonian Marine Stn, Ft Pierce, FL USA	State University System of Florida; University of Florida; Smithsonian Institution; Smithsonian National Museum of Natural History	Teplitski, M (corresponding author), Univ Florida, Inst Food & Agr Sci, Dept Soil & Water Sci, Gainesville, FL 32611 USA.	maxtep@ufl.edu	Meyer, Julie L./D-1021-2010	Meyer, Julie L./0000-0003-3382-3321	George E. Burch Fellowship in Theoretical Medicine and Affiliated Sciences at the Smithsonian Institution; National Geographic Society Committee for Research Exploration grant [9184-12]	George E. Burch Fellowship in Theoretical Medicine and Affiliated Sciences at the Smithsonian Institution; National Geographic Society Committee for Research Exploration grant(National Geographic Society)	Support for this research was provided by the George E. Burch Fellowship in Theoretical Medicine and Affiliated Sciences at the Smithsonian Institution; M.T. was a 2012 recipient of this fellowship. Funding for sample collection was provided by the National Geographic Society Committee for Research Exploration grant # 9184-12. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeby GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020370; Aitchison J, 2003, COMP DAT AN WORKSH G; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Apprill A, 2013, ENVIRON MICROBIOL, V15, P2063, DOI 10.1111/1462-2920.12107; Arboleda MDM, 2010, DIS AQUAT ORGAN, V90, P93, DOI 10.3354/dao02222; Atad I, 2012, CORAL REEFS, V31, P665, DOI 10.1007/s00338-012-0900-5; Bayer T, 2013, APPL ENVIRON MICROB, V79, P4759, DOI 10.1128/AEM.00695-13; Bourne D, 2008, ISME J, V2, P350, DOI 10.1038/ismej.2007.112; Bourne DG, 2009, TRENDS MICROBIOL, V17, P554, DOI 10.1016/j.tim.2009.09.004; Brooke JS, 2012, CLIN MICROBIOL REV, V25, P2, DOI 10.1128/CMR.00019-11; Bruckner AW, 2009, DIS AQUAT ORGAN, V87, P19, DOI 10.3354/dao02120; Burge CA, 2014, ANNU REV MAR SCI, V6, P249, DOI 10.1146/annurev-marine-010213-135029; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cardenas A, 2012, ISME J, V6, P502, DOI 10.1038/ismej.2011.123; Cohen Y, 2013, MICROBIOLOGYOPEN, V2, P64, DOI 10.1002/mbo3.52; Croquer A, 2013, ENV MICROBIOL REP, V5, P90, DOI 10.1111/j.1758-2229.2012.00397.x; Croquer A, 2009, DIS AQUAT ORGAN, V83, P209, DOI 10.3354/dao02012; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1111/j.1654-1103.2003.tb02228.x; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Edmunds PJ, 2010, MAR ECOL PROG SER, V418, P87, DOI 10.3354/meps08823; Efrony R, 2007, CORAL REEFS, V26, P7, DOI 10.1007/s00338-006-0170-1; Efrony R, 2009, CURR MICROBIOL, V58, P139, DOI 10.1007/s00284-008-9290-x; Faust K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002606; Garrity G., 2005, BERGEYS MANUAL SYSTE; Green DH, 2008, MAR ECOL PROG SER, V359, P1, DOI 10.3354/meps07454; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; HORN HS, 1966, AM NAT, V100, P419, DOI 10.1086/282436; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Jessen C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062091; Kellogg CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079801; Kellogg CA, 2012, J MICROBIOL METH, V88, P103, DOI 10.1016/j.mimet.2011.10.019; Kim MY, 2009, J NAT PROD, V72, P2065, DOI 10.1021/np900464p; Kimes NE, 2013, ENVIRON MICROBIOL, V15, P2082, DOI 10.1111/1462-2920.12130; Kimes NE, 2010, ENVIRON MICROBIOL, V12, P541, DOI 10.1111/j.1462-2920.2009.02113.x; Krediet CJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2328; Kurahashi M, 2007, SYST APPL MICROBIOL, V30, P202, DOI 10.1016/j.syapm.2006.07.003; LECAMPIONALSUMARD T, 1995, MAR ECOL PROG SER, V117, P137, DOI 10.3354/meps117137; Lee OO, 2012, APPL ENVIRON MICROB, V78, P7173, DOI 10.1128/AEM.01111-12; Lesser MP, 2007, J EXP MAR BIOL ECOL, V346, P36, DOI 10.1016/j.jembe.2007.02.015; Levas SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063267; Li XY, 2013, APPL MICROBIOL BIOT, V97, P6413, DOI 10.1007/s00253-013-5018-3; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Miller J, 2009, CORAL REEFS, V28, P925, DOI 10.1007/s00338-009-0531-7; Mizrachi I, 2002, NCBI HDB INTERNET; Morrison-Gardiner S, 2002, FUNGAL DIVERS, V9, P105; Morrow KM, 2012, APPL ENVIRON MICROB, V78, P6438, DOI 10.1128/AEM.01162-12; Mouchka ME, 2010, INTEGR COMP BIOL, V50, P662, DOI 10.1093/icb/icq061; Muller EM, 2012, GLOBAL CHANGE BIOL, V18, P3529, DOI 10.1111/gcb.12019; Pike RE, 2013, INT J SYST EVOL MICR, V63, P4294, DOI 10.1099/ijs.0.051490-0; Pollock FJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002183; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; Richardson LL, 1998, REV BIOL TROP, V46, P187; Riegl B, 2009, ANN NY ACAD SCI, V1162, P136, DOI 10.1111/j.1749-6632.2009.04493.x; Roder C, 2014, MOL ECOL, V23, P965, DOI 10.1111/mec.12638; Roder C, 2014, ISME J, V8, P31, DOI 10.1038/ismej.2013.127; Rodriguez-Lanetty M, 2013, MOL ECOL, V22, P4349, DOI 10.1111/mec.12392; Rohwer F, 2002, MAR ECOL PROG SER, V243, P1, DOI 10.3354/meps243001; Rosenberg E, 2007, NAT REV MICROBIOL, V5, P355, DOI 10.1038/nrmicro1635; Ruiz-Morenol D, 2012, DIS AQUAT ORGAN, V100, P249, DOI 10.3354/dao02488; Sere MG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083746; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sharp KH, 2012, ISME J, V6, P790, DOI 10.1038/ismej.2011.144; Sunagawa S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009554; Sunagawa S, 2009, ISME J, V3, P512, DOI 10.1038/ismej.2008.131; Sweet MJ, 2011, CORAL REEFS, V30, P39, DOI 10.1007/s00338-010-0695-1; Thomma BPHJ, 2003, MOL PLANT PATHOL, V4, P225, DOI 10.1046/J.1364-3703.2003.00173.X; Thurber RV, 2009, ENVIRON MICROBIOL, V11, P2148, DOI 10.1111/j.1462-2920.2009.01935.x; van Woesik R, 2011, MAR ECOL PROG SER, V434, P67, DOI 10.3354/meps09203; Vezzulli L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067745; Wegley L, 2007, ENVIRON MICROBIOL, V9, P2707, DOI 10.1111/j.1462-2920.2007.01383.x; Weil E, 2012, DIS AQUAT ORGAN, V98, P163, DOI 10.3354/dao02433; Work TM, 2006, DIS AQUAT ORGAN, V70, P155, DOI 10.3354/dao070155; Yang CS, 2010, INT J SYST EVOL MICR, V60, P1158, DOI 10.1099/ijs.0.014357-0; Yu ZS, 2013, FUNGAL DIVERS, V58, P127, DOI 10.1007/s13225-012-0192-7; Zhang Y, 2009, MAR DRUGS, V7, P97, DOI 10.3390/md7020097; Zheng CJ, 2012, J NAT PROD, V75, P189, DOI 10.1021/np200766d	76	71	71	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100316	10.1371/journal.pone.0100316	http://dx.doi.org/10.1371/journal.pone.0100316			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937478	gold, Green Submitted, Green Published			2022-12-27	WOS:000338503400104
J	Chu, MJJ; Hickey, AJR; Tagaloa, S; Zhang, LD; Dare, AJ; MacDonald, JR; Yeong, ML; Bartlett, ASJR; Phillips, ARJ				Chu, Michael J. J.; Hickey, Anthony J. R.; Tagaloa, Sherry; Zhang, Linda; Dare, Anna J.; MacDonald, Julia R.; Yeong, Mee-Ling; Bartlett, Adam S. J. R.; Phillips, Anthony R. J.			Ob/ob Mouse Livers Show Decreased Oxidative Phosphorylation Efficiencies and Anaerobic Capacities after Cold Ischemia	PLOS ONE			English	Article							MITOCHONDRIAL RESPIRATION; LACTATE-DEHYDROGENASE; VERTEBRATE MUSCLE; ORGAN VIABILITY; TRANSPLANTATION; RISK; MACROSTEATOSIS; MICROSTEATOSIS; PRESERVATION; DYSFUNCTION	Background: Hepatic steatosis is a major risk factor for graft failure in liver transplantation. Hepatic steatosis shows a greater negative influence on graft function following prolonged cold ischaemia. As the impact of steatosis on hepatocyte metabolism during extended cold ischaemia is not well-described, we compared markers of metabolic capacity and mitochondrial function in steatotic and lean livers following clinically relevant durations of cold preservation. Methods: Livers from 10-week old leptin-deficient obese (ob/ob, n = 9) and lean C57 mice (n = 9) were preserved in ice-cold University of Wisconsin solution. Liver mitochondrial function was then assessed using high resolution respirometry after 1.5, 3, 5, 8, 12, 16 and 24 hours of storage. Metabolic marker enzymes for anaerobiosis and mitochondrial mass were also measured in conjunction with non-bicarbonate tissue pH buffering capacity. Results: Ob/ob and lean mice livers showed severe (>60%) macrovesicular and mild (<30%) microvesicular steatosis on Oil Red O staining, respectively. Ob/ob livers had lower baseline enzymatic complex I activity but similar adenosine triphosphate (ATP) levels compared to lean livers. During cold storage, the respiratory control ratio and complex I-fueled phosphorylation deteriorated approximately twice as fast in ob/ob livers compared to lean livers. Ob/ob livers also demonstrated decreased ATP production capacities at all time-points analyzed compared to lean livers. Ob/ob liver baseline lactate dehydrogenase activities and intrinsic non-bicarbonate buffering capacities were depressed by 60% and 40%, respectively compared to lean livers. Conclusions: Steatotic livers have impaired baseline aerobic and anaerobic capacities compared to lean livers, and mitochondrial function indices decrease particularly from after 5 hours of cold preservation. These data provide a mechanistic basis for the clinical recommendation of shorter cold storage durations in steatotic donor livers.	[Chu, Michael J. J.; Tagaloa, Sherry; Dare, Anna J.; Bartlett, Adam S. J. R.; Phillips, Anthony R. J.] Univ Auckland, Dept Surg, Auckland 1, New Zealand; [Hickey, Anthony J. R.; Zhang, Linda; MacDonald, Julia R.; Phillips, Anthony R. J.] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Hickey, Anthony J. R.; Bartlett, Adam S. J. R.; Phillips, Anthony R. J.] Univ Auckland, Maurice Wilkins Ctr Biodiscovery, Auckland 1, New Zealand; [Yeong, Mee-Ling] Auckland City Hosp, Dept Anat Pathol, Auckland, New Zealand; [Bartlett, Adam S. J. R.; Phillips, Anthony R. J.] Auckland City Hosp, New Zealand Liver Transplant Unit, Auckland, New Zealand	University of Auckland; University of Auckland; University of Auckland; Auckland City Hospital; Auckland City Hospital	Chu, MJJ (corresponding author), Univ Auckland, Dept Surg, Auckland 1, New Zealand.	michaeljjc@gmail.com		Chu, Michael Jen Jie/0000-0002-9892-7394	University of Auckland Faculty Research Development Fund; Maurice Wilkins Centre for Biodiscovery; Maurice & Phyllis Paykel Trust	University of Auckland Faculty Research Development Fund; Maurice Wilkins Centre for Biodiscovery; Maurice & Phyllis Paykel Trust	This work was directly supported by the University of Auckland Faculty Research Development Fund, Maurice Wilkins Centre for Biodiscovery and the Maurice & Phyllis Paykel Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2000, BIOCHEMISTRY-MOSCOW+, V65, P757; ADAM R, 1991, TRANSPLANT P, V23, P1538; Caraceni P, 2004, J HEPATOL, V41, P82, DOI 10.1016/j.jhep.2004.03.022; CASTELLINI MA, 1981, J COMP PHYSIOL, V143, P191; Chavin KD, 1999, J BIOL CHEM, V274, P5692, DOI 10.1074/jbc.274.9.5692; Colell A, 2003, J BIOL CHEM, V278, P33928, DOI 10.1074/jbc.M210943200; DECKER T, 1988, J IMMUNOL METHODS, V115, P61, DOI 10.1016/0022-1759(88)90310-9; Fishbein TM, 1997, TRANSPLANTATION, V64, P248, DOI 10.1097/00007890-199707270-00012; Fukumori T, 1997, TRANSPL P, V29, P412, DOI 10.1016/S0041-1345(96)00158-3; Ge FX, 2010, EXP BIOL MED, V235, P1282, DOI 10.1258/ebm.2010.010095; Gnaiger E, 2007, TXB MITOCHONDRIAL PH, P1; Gnaiger E, 2009, INT J BIOCHEM CELL B, V41, P1837, DOI 10.1016/j.biocel.2009.03.013; Hand SC, 2008, J EXP BIOL, V211, P1829, DOI 10.1242/jeb.000299; Hickey AJR, 2012, AGEING RES REV, V11, P242, DOI 10.1016/j.arr.2011.12.002; Hickey AJR, 2009, AM J PHYSIOL-CELL PH, V297, pC766, DOI 10.1152/ajpcell.00111.2009; KAMIIKE W, 1988, TRANSPLANTATION, V45, P138, DOI 10.1097/00007890-198801000-00030; Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X; Kuznetsov AV, 2002, ANAL BIOCHEM, V305, P186, DOI 10.1006/abio.2002.5658; Larter CZ, 2008, J GASTROEN HEPATOL, V23, P1635, DOI 10.1111/j.1440-1746.2008.05543.x; Lemieux H, 2006, BBA-BIOENERGETICS, P201; Llacuna L, 2011, J HEPATOL, V54, P1002, DOI 10.1016/j.jhep.2010.08.031; MacDonald JR, 2011, AM J PHYSIOL-CELL PH, V300, pC246, DOI 10.1152/ajpcell.00294.2010; MARKERT CL, 1984, CELL BIOCHEM FUNCT, V2, P131, DOI 10.1002/cbf.290020302; MARKIN RS, 1993, TRANSPLANTATION, V56, P1403, DOI 10.1097/00007890-199312000-00025; McCormack L, 2011, J HEPATOL, V54, P1055, DOI 10.1016/j.jhep.2010.11.004; Melia HP, 1999, FEBS LETT, V458, P261, DOI 10.1016/S0014-5793(99)01127-8; MJJ Chu, 2013, OPEN J TRANSPLANTATI, V6, P10; Nishimura A, 2004, TRANSPL P, V36, P2246, DOI 10.1016/j.transproceed.2004.08.051; Oyedotun KS, 2004, J BIOL CHEM, V279, P9424, DOI 10.1074/jbc.M311876200; Paradies G, 2002, GENE, V286, P135, DOI 10.1016/S0378-1119(01)00814-9; PEREZ JA, 1982, ELECTROPHORESIS, V3, P102, DOI 10.1002/elps.1150030208; Pessayre D, 2007, J GASTROEN HEPATOL, V22, pS20, DOI 10.1111/j.1440-1746.2006.04640.x; Picard M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018317; PLOEG RJ, 1993, TRANSPLANTATION, V55, P807, DOI 10.1097/00007890-199304000-00024; Selzner N, 2006, J HEPATOL, V44, P694, DOI 10.1016/j.jhep.2005.07.032; Spitzer AL, 2010, LIVER TRANSPLANT, V16, P874, DOI 10.1002/lt.22085; Tonkonogi M, 1999, AM J PHYSIOL-CELL PH, V277, pC288, DOI 10.1152/ajpcell.1999.277.2.C288; Urena MAG, 1998, TRANSPLANT P, V30, P3288, DOI 10.1016/S0041-1345(98)01033-1; Vajdova K, 2002, HEPATOLOGY, V36, P1543, DOI 10.1053/jhep.2002.37189; WILLIAMS RS, 1986, J BIOL CHEM, V261, P376	40	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100609	10.1371/journal.pone.0100609	http://dx.doi.org/10.1371/journal.pone.0100609			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956382	Green Published, gold, Green Submitted			2022-12-27	WOS:000338917900071
J	He, M; Wang, W; Ragoonundun, D; Huang, WY				He, Miao; Wang, Wei; Ragoonundun, Dina; Huang, Wenyong			Meta-Analysis of the Association between Lumican Gene Polymorphisms and Susceptibility to High Myopia	PLOS ONE			English	Article							FIBROMODULIN; POPULATION; PREVALENCE; CHINESE; SNPS; BIAS	Backgrounds: Many studies have evaluated the association between lumican (LUM) gene polymorphisms and high myopia. However, the results remain controversial. This meta-analysis aims to comprehensively evaluate the relationship between two common LUM polymorphisms (rs3759223 and rs3759222) and the risk of high myopia. Methods: A comprehensive literature search for studies published up until September of 2013 was performed. Data were extracted independently by two investigators, and the weighted Odds Ratios (ORs) and 95% Confidence Intervals (CIs) for the associations were obtained by using a random-effects model. Results: Eight studies (1425cases and 1271 controls) were identified for the analysis of the association between rs3759223 polymorphism and high myopia. The results indicated that rs3759223 polymorphism was associated with high myopia under a recessive model (OR = 1.71, 95% CI 1.04-2.81). Further subgroup analysis indicated that this polymorphism was associated with high myopia among Chinese people in the additive model (OR = 1.17, 95%CI 1.06-1.29) and a recessive model (OR = 1.75, 95%CI 1.00-3.06) with control group coming from hospital based population. Four studies (1024 cases and 1163 controls) were identified for the analysis of the association between rs3759222 polymorphism and high myopia. The results indicated that rs3759222 polymorphism was not associated with high myopia in all genetic models, even the subgroup analysis couldn't provide relative proof to assure the outcome. Conclusion: This meta-analysis suggests that LUM polymorphisms are associated with the risk of high myopia. However, well-designed studies with larger sample sizes and more ethnic groups are required to further validate this association.	[He, Miao; Wang, Wei; Ragoonundun, Dina; Huang, Wenyong] Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Huang, WY (corresponding author), Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China.	andyhwyz@aliyun.com		Huang, Wenyong/0000-0003-3167-0851	Scientific and Technology Foundation of Guangdong Province [2011B061300049, 2008B030301126]	Scientific and Technology Foundation of Guangdong Province	This research was supported by the Scientific and Technology Foundation of Guangdong Province (2011B061300049, 2008B030301126). No additional external funding was received. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Chakravarti S, 2003, INVEST OPHTH VIS SCI, V44, P2422, DOI 10.1167/iovs.02-0783; Chen YP, 2011, INVEST OPHTH VIS SCI, V52, P4003, DOI 10.1167/iovs.10-7044; Chen ZTY, 2009, OPHTHALMOLOGY, V116, P1920, DOI 10.1016/j.ophtha.2009.03.023; Dai LL, 2012, OPHTHALMIC GENET, V33, P171, DOI 10.3109/13816810.2012.675397; Deng ZJ, 2014, OPHTHALMOLOGICA; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Feng YF, 2013, OPTOMETRY VISION SCI, V90, P1321, DOI 10.1097/OPX.0000000000000032; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hornbeak DM, 2009, CURR OPIN OPHTHALMOL, V20, P356, DOI 10.1097/ICU.0b013e32832f8040; Hrynchak PK, 2013, OPTOM VIS SCI; Jones D, 2012, EYE CONTACT LENS, V38, P188, DOI 10.1097/ICL.0b013e31824ccbc3; Kim MH, 2013, INVEST OPHTH VIS SCI, V54, P3644, DOI 10.1167/iovs.12-11254; Liao X, 2013, INT J OPHTHALMOL-CHI, V6, P696, DOI 10.3980/j.issn.2222-3959.2013.05.28; Lin HJ, 2010, EYE, V24, P1093, DOI 10.1038/eye.2009.254; Lin HJ, 2010, INVEST OPHTH VIS SCI, V51, P96, DOI 10.1167/iovs.09-3612; Majava M, 2007, HUM MUTAT, V28, P336, DOI 10.1002/humu.20444; Meng WH, 2011, OPHTHALMOLOGICA, V225, P127, DOI 10.1159/000317072; Neelam K, 2012, PROG RETIN EYE RES, V31, P495, DOI 10.1016/j.preteyeres.2012.04.001; Paluru PC, 2004, MOL VIS, V10, P917; Park SH, 2013, OPHTHALMIC GENET, V34, P43, DOI 10.3109/13816810.2012.736591; Rahi JS, 2011, OPHTHALMOLOGY, V118, P797, DOI 10.1016/j.ophtha.2010.09.025; Siegwart JT, 2007, MOL VIS, V13, P1878; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sun J, 2012, INVEST OPHTH VIS SCI, V53, P7504, DOI 10.1167/iovs.11-8343; Tang WC, 2008, CLIN EXP OPTOM, V91, P4, DOI 10.1111/j.1444-0938.2007.00181.x; Verhoeven VJM, 2012, HUM GENET, V131, P1467, DOI 10.1007/s00439-012-1176-0; Wang IJ, 2006, MOL VIS, V12, P852; Wang PF, 2009, INVEST OPHTH VIS SCI, V50, P1546, DOI 10.1167/iovs.08-2537; Wells G.A., NEWCASTLE OTTAWA SCA; Wong TY, 2013, AM J OPHTHALMOL; Yeh LK, 2010, J BIOL CHEM, V285, P28141, DOI 10.1074/jbc.M109.043679; Yip SP, 2011, INVEST OPHTH VIS SCI, V52, P6396, DOI 10.1167/iovs.11-7639; Zhang FJ, 2009, J OPHTHALMOL, V2009, DOI 10.1155/2009/514306	34	34	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e98748	10.1371/journal.pone.0098748	http://dx.doi.org/10.1371/journal.pone.0098748			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956166	Green Published, gold, Green Submitted			2022-12-27	WOS:000338917900006
J	Khanna, N; Ge, YJ; Chen, J				Khanna, Nidhi; Ge, Yejing; Chen, Jie			MicroRNA-146b Promotes Myogenic Differentiation and Modulates Multiple Gene Targets in Muscle Cells	PLOS ONE			English	Article							SKELETAL-MUSCLE; SATELLITE CELLS; STEM-CELLS; NOTCH; EXPRESSION; PROLIFERATION; REGENERATION; PROTEIN; TRANSCRIPTION; MAINTENANCE	MicroRNAs are established as crucial modulators of skeletal myogenesis, but our knowledge about their identity and targets remains limited. In this study, we have identified microRNA-146b (miR-146b) as a novel regulator of skeletal myoblast differentiation. Following up on a previous microRNA profiling study, we establish that the expression of miR-146b is up-regulated during myoblast differentiation in vitro and muscle regeneration in vivo. Inhibition of miR-146b led to reduced myoblast differentiation, whereas overexpression of miR-146b enhanced differentiation. Computational prediction combined with gene expression information has revealed candidates for miR-146b targets in muscles. Among them, the expression of Smad4, Notch1, and Hmga2 are significantly suppressed by miR-146b overexpression in myocytes. In addition, expression levels of Smad4, Notch1 and Hmga2 are decreased during myoblast differentiation and muscle regeneration, inversely correlating to the levels of miR-146b. Importantly, inhibition of endogenous miR-146b prevents the down-regulation of Smad4, Notch1 and Hmga2 during differentiation. Furthermore, miR-146b directly targets the microRNA response elements (MREs) in the 3'UTR of those genes as assessed by reporter assays. Reporters with the seed regions of MREs mutated are insensitive to miR-146b, further confirming the specificity of targeting. In conclusion, miR-146b is a positive regulator of myogenic differentiation, possibly acting through multiple targets.	[Khanna, Nidhi; Ge, Yejing; Chen, Jie] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Chen, J (corresponding author), Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA.	jiechen@illinois.edu		Chen, Jie/0000-0002-7887-3747	National Institutes of Health (NIH) [AR048914, GM089771]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048914] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089771] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (NIH) (AR048914, GM089771). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bhaumik D, 2009, AGING-US, V1, P402, DOI 10.18632/aging.100042; Bjornson CRR, 2012, STEM CELLS, V30, P232, DOI 10.1002/stem.773; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen JF, 2010, J CELL BIOL, V190, P867, DOI 10.1083/jcb.200911036; Cheung TH, 2012, NATURE, V482, P524, DOI 10.1038/nature10834; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Dey BK, 2012, GENE DEV, V26, P2180, DOI 10.1101/gad.198085.112; Dmitriev P, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-265; Felekkis K, 2010, HIPPOKRATIA, V14, P236; Gagan J, 2012, J BIOL CHEM, V287, P40360, DOI 10.1074/jbc.M112.378414; Ge YJ, 2011, CELL CYCLE, V10, P441, DOI 10.4161/cc.10.3.14710; Ge YJ, 2011, J CELL BIOL, V192, P69, DOI 10.1083/jcb.201007165; Ge YJ, 2009, AM J PHYSIOL-CELL PH, V297, pC1434, DOI 10.1152/ajpcell.00248.2009; Geraldo MV, 2012, ONCOGENE, V31, P1910, DOI 10.1038/onc.2011.381; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hebert C, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-5; Hurst DR, 2009, CANCER RES, V69, P1279, DOI 10.1158/0008-5472.CAN-08-3559; Juan AH, 2009, MOL CELL, V36, P61, DOI 10.1016/j.molcel.2009.08.008; Kallen AN, 2013, MOL CELL, V52, P101, DOI 10.1016/j.molcel.2013.08.027; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; KOPAN R, 1994, DEVELOPMENT, V120, P2385; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Li ZZ, 2012, DEV CELL, V23, P1176, DOI 10.1016/j.devcel.2012.10.019; Liu N, 2007, P NATL ACAD SCI USA, V104, P20844, DOI 10.1073/pnas.0710558105; MARTIN JF, 1992, J BIOL CHEM, V267, P10956; Mineno J, 2006, NUCLEIC ACIDS RES, V34, P1765, DOI 10.1093/nar/gkl096; Mourikis P, 2012, STEM CELLS, V30, P243, DOI 10.1002/stem.775; Nakasa T, 2008, ARTHRITIS RHEUM-US, V58, P1284, DOI 10.1002/art.23429; Nakasa T, 2010, J CELL MOL MED, V14, P2495, DOI 10.1111/j.1582-4934.2009.00898.x; Novak J, 2013, PEDIATR BLOOD CANCER, V60, P1739, DOI 10.1002/pbc.24664; O'Rourke JR, 2007, DEV BIOL, V311, P359, DOI 10.1016/j.ydbio.2007.08.032; Perry MM, 2009, FEBS LETT, V583, P3349, DOI 10.1016/j.febslet.2009.09.038; Rao PK, 2006, P NATL ACAD SCI USA, V103, P8721, DOI 10.1073/pnas.0602831103; Rosenberg MI, 2006, J CELL BIOL, V175, P77, DOI 10.1083/jcb.200603039; Sabourin LA, 2000, CLIN GENET, V57, P16, DOI 10.1034/j.1399-0004.2000.570103.x; Shawber C, 1996, DEVELOPMENT, V122, P3765; Shin C, 2010, MOL CELL, V38, P789, DOI 10.1016/j.molcel.2010.06.005; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Sun YT, 2010, J CELL BIOL, V189, P1157, DOI 10.1083/jcb.200912093; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tsang JS, 2010, MOL CELL, V38, P140, DOI 10.1016/j.molcel.2010.03.007; Wagers AJ, 2005, CELL, V122, P659, DOI 10.1016/j.cell.2005.08.021; Wang H, 2010, DEV CELL, V18, P643, DOI 10.1016/j.devcel.2010.02.008; Wen YF, 2012, MOL CELL BIOL, V32, P2300, DOI 10.1128/MCB.06753-11; Wilson-Rawls J, 1999, MOL CELL BIOL, V19, P2853; Xia HP, 2009, BRAIN RES, V1269, P158, DOI 10.1016/j.brainres.2009.02.037; Yan D, 2009, J BIOL CHEM, V284, P29596, DOI 10.1074/jbc.M109.020511; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	51	42	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100657	10.1371/journal.pone.0100657	http://dx.doi.org/10.1371/journal.pone.0100657			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956113	Green Published, Green Submitted, gold			2022-12-27	WOS:000338917900077
J	Trenchevska, O; Phillips, DA; Nelson, RW; Nedelkov, D				Trenchevska, Olgica; Phillips, David A.; Nelson, Randall W.; Nedelkov, Dobrin			Delineation of Concentration Ranges and Longitudinal Changes of Human Plasma Protein Variants	PLOS ONE			English	Article							MASS-SPECTROMETRIC IMMUNOASSAY; SERUM CYSTATIN C; RETINOL-BINDING-PROTEIN; RENAL-FUNCTION; QUANTITATIVE-DETERMINATION; COMPREHENSIVE ANALYSIS; RHEUMATOID-ARTHRITIS; TRANSTHYRETIN; BETA-2-MICROGLOBULIN; PROTEOMICS	Human protein diversity arises as a result of alternative splicing, single nucleotide polymorphisms (SNPs) and posttranslational modifications. Because of these processes, each protein can exists as multiple variants in vivo. Tailored strategies are needed to study these protein variants and understand their role in health and disease. In this work we utilized quantitative mass spectrometric immunoassays to determine the protein variants concentration of beta-2-microglobulin, cystatin C, retinol binding protein, and transthyretin, in a population of 500 healthy individuals. Additionally, we determined the longitudinal concentration changes for the protein variants from four individuals over a 6 month period. Along with the native forms of the four proteins, 13 posttranslationally modified variants and 7 SNP-derived variants were detected and their concentration determined. Correlations of the variants concentration with geographical origin, gender, and age of the individuals were also examined. This work represents an important step toward building a catalog of protein variants concentrations and examining their longitudinal changes.	[Trenchevska, Olgica; Nelson, Randall W.; Nedelkov, Dobrin] Arizona State Univ, Biodesign Inst, Mol Biomarkers Lab, Tempe, AZ 85287 USA; [Trenchevska, Olgica; Phillips, David A.; Nedelkov, Dobrin] Intrins Bioprobes, Tempe, AZ USA; [Nedelkov, Dobrin] Inst Populat Prote, Tempe, AZ USA	Arizona State University; Arizona State University-Tempe	Nedelkov, D (corresponding author), Arizona State Univ, Biodesign Inst, Mol Biomarkers Lab, Tempe, AZ 85287 USA.	Dobrin.Nedelkov@asu.edu	Nedelkov, Dobrin/I-3603-2013					Anderson NL, 2004, J PROTEOME RES, V3, P235, DOI 10.1021/pr034086h; BASSET P, 1978, BLOOD, V51, P971; BEETHAM R, 1985, CLIN CHEM, V31, P1364; Connors LH, 2003, AMYLOID, V10, P160, DOI 10.3109/13506120308998998; Erlandsen EJ, 1998, CLIN CHEM LAB MED, V36, P393, DOI 10.1515/CCLM.1998.067; Farley AR, 2009, METHOD ENZYMOL, V463, P725, DOI 10.1016/S0076-6879(09)63040-8; GRUBB A, 1982, P NATL ACAD SCI-BIOL, V79, P3024, DOI 10.1073/pnas.79.9.3024; He K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063724; Hou X, 2007, FEBS J, V274, P1637, DOI 10.1111/j.1742-4658.2007.05712.x; Ignjatovic V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017213; Jackson D, 2009, PROTEOM CLIN APPL, V3, P394, DOI 10.1002/prca.200800066; JACONI S, 1995, J LIPID RES, V36, P1247; Johnson AM, 2007, CLIN CHEM LAB MED, V45, P419, DOI 10.1515/CCLM.2007.051; Kiernan UA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017282; Kim Helen, 2007, Methods Mol Biol, V371, P349; KUEPPERS F, 1978, AM J HUM GENET, V30, P359; MANICOURT D, 1978, ANN RHEUM DIS, V37, P328, DOI 10.1136/ard.37.4.328; MIFFLIN TE, 1986, CLIN LAB MED, V6, P583, DOI 10.1016/S0272-2712(18)30802-3; Nedelkov D, 2004, ANAL CHEM, V76, P1733, DOI 10.1021/ac035105+; Nedelkov D, 2005, P NATL ACAD SCI USA, V102, P10852, DOI 10.1073/pnas.0500426102; Nedelkov D, 2007, MOL CELL PROTEOMICS, V6, P1183, DOI 10.1074/mcp.M700023-MCP200; NELSON RW, 1995, ANAL CHEM, V67, P1153, DOI 10.1021/ac00103a003; NISSEN MH, 1990, EUR J BIOCHEM, V189, P423, DOI 10.1111/j.1432-1033.1990.tb15505.x; NISSEN MH, 1984, CLIN CHIM ACTA, V141, P41, DOI 10.1016/0009-8981(84)90165-7; PETTERSSON T, 1987, BIOCHEMISTRY-US, V26, P4572, DOI 10.1021/bi00388a061; PLESNER T, 1979, SCAND J IMMUNOL, V9, P247, DOI 10.1111/j.1365-3083.1979.tb02728.x; Prakash A, 2012, J PROTEOME RES, V11, P3986, DOI 10.1021/pr300014s; Randers E, 1998, SCAND J CLIN LAB INV, V58, P585, DOI 10.1080/00365519850186210; Randers E, 1999, CLIN CHEM LAB MED, V37, P389, DOI 10.1515/CCLM.1999.064; Roy B, 2013, CURR GENOMICS, V14, P182, DOI 10.2174/1389202911314030004; Saraiva MJM, 2001, FEBS LETT, V498, P201, DOI 10.1016/S0014-5793(01)02480-2; Schaefer C, 2012, BIOINFORMATICS, V28, P601, DOI 10.1093/bioinformatics/btr705; SCHARDIJN GHC, 1987, KIDNEY INT, V32, P635, DOI 10.1038/ki.1987.255; Siuti N, 2007, NAT METHODS, V4, P817, DOI 10.1038/NMETH1097; Stastna M, 2012, PROTEOMICS, V12, P2937, DOI 10.1002/pmic.201200161; Su ZD, 2011, J MOL CELL BIOL, V3, P309, DOI 10.1093/jmcb/mjr024; Tipton JD, 2011, J BIOL CHEM, V286, P25451, DOI 10.1074/jbc.R111.239442; Trenchevska O, 2011, PROTEOMICS, V11, P3633, DOI 10.1002/pmic.201100023; Trenchevska O, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-19; Trenchevska O, 2010, J PROTEOME RES, V9, P5969, DOI 10.1021/pr1007587; Vegvari A, 2013, MOL CELL PROTEOMICS, V12, P2761, DOI 10.1074/mcp.M113.028365; Wu JR, 2012, FEBS LETT, V586, P2841, DOI 10.1016/j.febslet.2012.07.036; Wu J, 2012, BIOMARKERS, V17, P125, DOI 10.3109/1354750X.2011.643485; Yates JR, 2009, ANNU REV BIOMED ENG, V11, P49, DOI 10.1146/annurev-bioeng-061008-124934; Zhang H, 2011, CIRC-CARDIOVASC GENE, V4, P711, DOI 10.1161/CIRCGENETICS.110.957829	45	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100713	10.1371/journal.pone.0100713	http://dx.doi.org/10.1371/journal.pone.0100713			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955979	Green Published, gold, Green Submitted			2022-12-27	WOS:000338917900085
J	Jung, HK; Wang, K; Jung, MK; Kim, IS; Lee, BH				Jung, Hyun-Kyung; Wang, Kai; Jung, Min Kyu; Kim, In-San; Lee, Byung-Heon			In Vivo Near-Infrared Fluorescence Imaging of Apoptosis Using Histone H1-Targeting Peptide Probe after Anti-Cancer Treatment with Cisplatin and Cetuximab for Early Decision on Tumor Response	PLOS ONE			English	Article							ADVANCED GASTRIC-CANCER; CHEMOTHERAPY	Early decision on tumor response after anti-cancer treatment is still an unmet medical need. Here we investigated whether in vivo imaging of apoptosis using linear and cyclic (disulfide-bonded) form of ApoPep-1, a peptide that recognizes histone H1 exposed on apoptotic cells, at an early stage after treatment could predict tumor response to the treatment later. Treatment of stomach tumor cells with cistplatin or cetuximab alone induced apoptosis, while combination of cisplatin plus cetuximab more efficiently induced apoptosis, as detected by binding with linear and cyclic form of ApoPep-1. However, the differences between the single agent and combination treatment were more remarkable as detected with the cyclic form compared to the linear form. In tumor-bearing mice, apoptosis imaging was performed 1 week and 2 weeks after the initiation of treatment, while tumor volumes and weights were measured 3 weeks after the treatment. In vivo fluorescence imaging signals obtained by the uptake of ApoPep-1 to tumor was most remarkable in the group injected with cyclic form of ApoPep-1 at 1 week after combined treatment with cisplatin plus cetuximab. Correlation analysis revealed that imaging signals by cyclic ApoPep-1 at 1 week after treatment with cisplatin plus cetuximab in combination were most closely related with tumor volume changes (r(2) = 0.934). These results demonstrate that in vivo apoptosis imaging using Apopep-1, especially cyclic ApoPep-1, is a sensitive and predictive tool for early decision on stomach tumor response after anti-cancer treatment.	[Jung, Hyun-Kyung; Kim, In-San; Lee, Byung-Heon] Kyungpook Natl Univ, Dept Biochem & Cell Biol, Taegu, South Korea; [Jung, Hyun-Kyung; Kim, In-San; Lee, Byung-Heon] Kyungpook Natl Univ, Sch Med, Taegu, South Korea; [Jung, Hyun-Kyung; Kim, In-San; Lee, Byung-Heon] Kyungpook Natl Univ, Grad Sch, Dept Biomed Sci, Plus KNU Biomed Convergence Program BK21, Taegu, South Korea; [Wang, Kai] Henan Prov Peoples Hosp, Dept Plast Surg, Zhengzhou, Henan, Peoples R China; [Jung, Min Kyu] Kyungpook Natl Univ, Sch Med, Dept Internal Med, Taegu, South Korea	Kyungpook National University; Kyungpook National University; Kyungpook National University; Zhengzhou University; Kyungpook National University	Lee, BH (corresponding author), Kyungpook Natl Univ, Dept Biochem & Cell Biol, Taegu, South Korea.	leebh@knu.ac.kr	김, 인산/I-8988-2014; Kim, In-San/D-3956-2017	Jung, Min Kyu/0000-0001-8749-408X	national R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea [0720550-2]; National Research Foundation of Korea [NRF-2012M2A2A7035589]	national R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea)	This study was supported by a grant from the national R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea (0720550-2 to Byung-Heon Lee) and a grant NRF-2012M2A2A7035589 (to Byung-Heon Lee) through the National Research Foundation of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya B, 2013, J CONTROL RELEASE, V172, P367, DOI 10.1016/j.jconrel.2013.08.294; Alakus H, 2010, NUCL MED COMMUN, V31, P532, DOI 10.1097/MNM.0b013e32833823ac; Amezcua CA, 2000, GYNECOL ONCOL, V79, P169, DOI 10.1006/gyno.2000.5955; [Anonymous], 2011, MOL PHARM; Bang YJ, 2010, LANCET, V376, P1302; BARRY MA, 1990, BIOCHEM PHARMACOL, V40, P2353, DOI 10.1016/0006-2952(90)90733-2; Belhocine T, 2002, CLIN CANCER RES, V8, P2766; Blankenberg FG, 2012, J NUCL MED, V53, P1659, DOI 10.2967/jnumed.112.108944; Blankenberg FG, 2011, AM J ROENTGENOL, V197, P308, DOI 10.2214/AJR.11.6953; Bogdanowich-Knipp SJ, 1999, J PEPT RES, V53, P530, DOI 10.1034/j.1399-3011.1999.00052.x; Casadei R, 2009, TUMORI J, V95, P811, DOI 10.1177/030089160909500627; Choi CH, 2004, CANCER CELL INT, V4, DOI 10.1186/1475-2867-4-6; DIVE C, 1991, BRIT J CANCER, V64, P192, DOI 10.1038/bjc.1991.269; Edgington LE, 2009, NAT MED, V15, P967, DOI 10.1038/nm.1938; Grimberg H, 2009, APOPTOSIS, V14, P257, DOI 10.1007/s10495-008-0293-7; He X, 2012, J CONTROL RELEASE, V162, P521, DOI 10.1016/j.jconrel.2012.07.023; Keren S, 2008, IEEE T MED IMAGING, V27, P58, DOI 10.1109/TMI.2007.902800; Konig K, 2000, J MICROSC-OXFORD, V200, P83, DOI 10.1046/j.1365-2818.2000.00738.x; Lordick F, 2013, LANCET ONCOL, V14, P490, DOI 10.1016/S1470-2045(13)70102-5; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Manning HC, 2008, CLIN CANCER RES, V14, P7413, DOI 10.1158/1078-0432.CCR-08-0239; Padhani AR, 2001, BRIT J RADIOL, V74, P983, DOI 10.1259/bjr.74.887.740983; Roxin A, 2012, FUTURE MED CHEM, V4, P1601, DOI [10.4155/FMC.12.75, 10.4155/fmc.12.75]; Sastre J, 2006, WORLD J GASTROENTERO, V12, P204, DOI 10.3748/wjg.v12.i2.204; Smith BA, 2012, BIOCONJUGATE CHEM, V23, P1989, DOI 10.1021/bc3003309; Stafford JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084864; Steiner P, 2007, CLIN CANCER RES, V13, P1540, DOI 10.1158/1078-0432.CCR-06-1887; Tu DG, 2009, CLIN IMAG, V33, P468, DOI 10.1016/j.clinimag.2009.02.001; Wang K, 2011, J CONTROL RELEASE; Wang K, 2010, J CONTROL RELEASE, V148, P283, DOI 10.1016/j.jconrel.2010.09.010; Yoo SA, 2005, J IMMUNOL, V174, P5846, DOI 10.4049/jimmunol.174.9.5846; Yoshioka T, 2003, J NUCL MED, V44, P690; Yun J, 2012, LAB INVEST, V92, P1033, DOI 10.1038/labinvest.2012.61	33	18	19	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100341	10.1371/journal.pone.0100341	http://dx.doi.org/10.1371/journal.pone.0100341			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949860	gold, Green Published, Green Submitted			2022-12-27	WOS:000338276300066
J	Ram, ST; Neuberger, A; Thapa, LJ; Singh, RPV; Shofty, B; Schwartz, E				Ram, Sundar Twayana; Neuberger, Ami; Thapa, Lekh Jung; Singh, Rana Pramendra Vir; Shofty, Ben; Schwartz, Eli			Japanese Encephalitis among Patients with Acute Encephalitic Syndrome Admitted to a Tertiary Hospital in Chitwan, Nepal - A Prospective Observational Study	PLOS ONE			English	Article							SURVEILLANCE	Introduction: The reported incidence of JE among patients with acute encephalitic syndrome (RES) in Nepal ranges between 20% to 62%. In light of the lack of up-to-date data, we sought to describe the epidemiology of JE in Chitwan, Nepal. Methods: A prospective observational study was conducted during 2010-2012 in the College of Medical Science in the Chitwan District. Patients with suspected JE were tested for anti-JE IgM in serum and cerebrospinal fluid (CSF). Results: Of 227 all patients tested, 18 (7.9%) were found positive for JE. 17/202 (8.4%) patients with AES had JE. All, with the exception of two patients, were diagnosed on the basis of positive a serologic test, both in serum and CSF samples. Patients with JE were significantly older (42.1 +/- 27.6 years) than patients without JE (25.6 +/- 25.2 years, p = 0.02). Half of JE cases occurred in adults older than 50. More of the JE cases (11/18, 61.1%) occurred during the rainy season when compared to the JE negative patients [71/209, (34%), p = 0.01]. None of the JE patients had a relevant travel history, and one recalled having been immunized against JE. There was a variation in the geographic distribution of cases across the districts of the central Terai. Conclusions: In this cohort, the proportion of patients with AES who had JE was lower than in previous studies. In addition, most patients were adults, and cases were not distributed uniformly across the central Terai region. The risk of acquiring JE by short-term travelers in the area is likely to be low. Vector-control programs and the promotion of mosquito avoidance behavior in the Terai region should continue. The high proportions of adults among patients with JE may suggest recent changes in the epidemiology of JE in the central Terai region, and routine immunization of all adults should be considered.	[Ram, Sundar Twayana] Kathmandu Univ Hosp, Fac Internal Med, Dhulikhel, Nepal; [Neuberger, Ami] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Unit Infect Dis & Internal Med B, Rambam Med Ctr, IL-31096 Haifa, Israel; [Thapa, Lekh Jung; Singh, Rana Pramendra Vir] Coll Med Sci, Dept Neurol, Bharatpur, Nepal; [Singh, Rana Pramendra Vir] Coll Med Sci, Dept Med, Bhartapur, Nepal; [Shofty, Ben] Tel Aviv Med Ctr & Sch Med, Gilbert Israeli Neurofibromatosis Ctr, Tel Aviv, Israel; [Schwartz, Eli] Tel Aviv Univ, Ctr Geog Med & Trop Dis, Sheba Med Ctr, IL-69978 Tel Aviv, Israel; [Schwartz, Eli] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel	Kathmandu University; Rambam Health Care Campus; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine	Neuberger, A (corresponding author), Technion Israel Inst Technol, Bruce Rappaport Fac Med, Unit Infect Dis & Internal Med B, Rambam Med Ctr, POB 9649, IL-31096 Haifa, Israel.	a_neuberger@rambam.health.gov.il						Bhattachan A, 2009, EMERG INFECT DIS, V15, P1691, DOI 10.3201/eid1510.081641; Bista M B, 2005, JNMA J Nepal Med Assoc, V44, P51; Dumre SP, 2013, AM J TROP MED HYG, V88, P677, DOI 10.4269/ajtmh.12-0436; Ghosh D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000437; Griffiths MJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002383; Hills SL, 2014, CDC HLTH INF INT TRA, V3, P78; Hills SL, 2010, AM J TROP MED HYG, V82, P930, DOI 10.4269/ajtmh.2010.09-0676; Kakoti G, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/152656; Kari K, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-8; Pant GR, 2006, COMP IMMUNOL MICROB, V29, P166, DOI 10.1016/j.cimid.2006.03.003; Partridge J, 2007, AM J TROP MED HYG, V77, P1146, DOI 10.4269/ajtmh.2007.77.1146; Rayamajhi A, 2007, PEDIATR INT, V49, P978, DOI 10.1111/j.1442-200X.2007.02495.x; Robertson C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066168; Tandan JB, 2007, VACCINE, V25, P5041, DOI 10.1016/j.vaccine.2007.04.052; Wierzba TF, 2008, AM J TROP MED HYG, V78, P1002, DOI 10.4269/ajtmh.2008.78.1002; World Health Organization, 2006, JAP ENC SURV STAND W, V46; World Health Organization, 2007, MAN LAB DIAGN JAP EN, V3, P10; World Health Organization, 2006, WEEKLY EPIDEMIOLOGIC, V81, P332	18	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e99999	10.1371/journal.pone.0099999	http://dx.doi.org/10.1371/journal.pone.0099999			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950104	Green Submitted, Green Published, gold			2022-12-27	WOS:000338276300028
J	Haralambieva, IH; Lambert, ND; Ovsyannikova, IG; Kennedy, RB; Larrabee, BR; Pankratz, VS; Poland, GA				Haralambieva, Iana H.; Lambert, Nathaniel D.; Ovsyannikova, Inna G.; Kennedy, Richard B.; Larrabee, Beth R.; Pankratz, V. Shane; Poland, Gregory A.			Associations between Single Nucleotide Polymorphisms in Cellular Viral Receptors and Attachment Factor-Related Genes and Humoral Immunity to Rubella Vaccination	PLOS ONE			English	Article							MEASLES-VACCINE; VITAMIN-A; DC-SIGN; CLINICAL-OUTCOMES; SMALLPOX VACCINE; PROMOTER REGION; CD209 GENE; PVR CD155; TOLL-LIKE; RESPONSES	Background: Viral attachment and cell entry host factors are important for viral replication, pathogenesis, and the generation and sustenance of immune responses after infection and/or vaccination, and are plausible genetic regulators of vaccine-induced immunity. Methods: Using a tag-SNP approach in candidate gene study, we assessed the role of selected cell surface receptor genes, attachment factor-related genes, along with other immune genes in the genetic control of immune response variations after live rubella vaccination in two independent study cohorts. Results: Our analysis revealed evidence for multiple associations between genetic variants in the PVR, PVRL2, CD209/DC-SIGN, RARB, MOG, IL6 and other immune function-related genes and rubella-specific neutralizing antibodies after vaccination (meta p-value <0.05). Conclusion: Our results indicate that multiple SNPs from genes involved in cell adhesion, viral attachment, and viral entry, as well as others in genes involved in signaling and/or immune response regulation, play a role in modulating humoral immune responses following live rubella vaccination.	[Haralambieva, Iana H.; Lambert, Nathaniel D.; Ovsyannikova, Inna G.; Kennedy, Richard B.; Pankratz, V. Shane; Poland, Gregory A.] Mayo Clin, Mayo Vaccine Res Grp, Rochester, MN 55905 USA; [Larrabee, Beth R.; Pankratz, V. Shane] Mayo Clin, Div Biostat, Rochester, MN USA; [Poland, Gregory A.] Mayo Clin, Dept Pediat & Adolescent Med, Rochester, MN USA; [Haralambieva, Iana H.; Lambert, Nathaniel D.; Ovsyannikova, Inna G.; Kennedy, Richard B.; Poland, Gregory A.] Mayo Clin, Program Translat Immunovirol & Biodef, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Poland, GA (corresponding author), Mayo Clin, Mayo Vaccine Res Grp, Rochester, MN 55905 USA.	poland.gregory@mayo.edu		Kennedy, Rick/0000-0001-6164-4967; Larrabee, Beth/0000-0001-9100-563X	National Institute of Allergy and Infectious Diseases of the National Institutes of Health [R37 AI048793-11]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048793, R37AI048793] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Number R37 AI048793-11 (which recently received a MERIT award). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeler-Dorner L, 2012, TRENDS IMMUNOL, V33, P34, DOI 10.1016/j.it.2011.09.007; Alagarasu K, 2013, INFECT GENET EVOL, V17, P239, DOI 10.1016/j.meegid.2013.04.024; Backovic M, 2012, CURR OPIN VIROL, V2, P4, DOI 10.1016/j.coviro.2011.12.005; Barkhash AV, 2012, ANTIVIR RES, V93, P64, DOI 10.1016/j.antiviral.2011.10.017; Bottino C, 2003, J EXP MED, V198, P557, DOI 10.1084/jem.20030788; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Cleveland WS, 1992, STAT MODELS WADSWORT; Clifford HD, 2012, CLIN VACCINE IMMUNOL, V19, P704, DOI 10.1128/CVI.05652-11; Clifford HD, 2011, VACCINE, V29, P5407, DOI 10.1016/j.vaccine.2011.05.068; Cong HL, 2011, J VIROL, V85, P11038, DOI 10.1128/JVI.05398-11; Dhiman N, 2007, J ALLERGY CLIN IMMUN, V120, P666, DOI 10.1016/j.jaci.2007.04.036; Dhiman N, 2010, IMMUNOGENETICS, V62, P197, DOI 10.1007/s00251-010-0423-6; Fuchs A, 2004, J IMMUNOL, V172, P3994, DOI 10.4049/jimmunol.172.7.3994; Greenland S, 2008, MODERN EPIDEMIOLOGY, P652; Haralambieva IH, 2013, HUM IMMUNOL, V74, P1263, DOI 10.1016/j.humimm.2013.06.031; Haralambieva IH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062149; Haralambieva IH, 2013, EXPERT REV VACCINES, V12, P57, DOI [10.1586/erv.12.134, 10.1586/ERV.12.134]; Haralambieva IH, 2011, VACCINE, V29, P8988, DOI 10.1016/j.vaccine.2011.09.043; Haralambieva IH, 2011, VACCINE, V29, P7883, DOI 10.1016/j.vaccine.2011.08.083; Haralambieva IH, 2011, J INFECT DIS, V204, P433, DOI 10.1093/infdis/jir268; Haralambieva IH, 2011, VACCINE, V29, P4485, DOI 10.1016/j.vaccine.2011.04.037; Haralambieva IH, 2010, HUM IMMUNOL, V71, P383, DOI 10.1016/j.humimm.2010.01.004; Haralambieva LH, 2014, VACCINE, V32, P1946, DOI 10.1016/j.vaccine.2014.01.090; He YN, 2000, P NATL ACAD SCI USA, V97, P79, DOI 10.1073/pnas.97.1.79; Kamran N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054406; Kennedy RB, 2012, HUM GENET, V131, P1433, DOI 10.1007/s00439-012-1179-x; Kennedy RB, 2012, VACCINE, V30, P2159, DOI 10.1016/j.vaccine.2012.01.025; Kindberg E, 2009, J MED VIROL, V81, P933, DOI 10.1002/jmv.21444; Lambert ND, 2014, CLIN VACCINE IMMUNOL, V21, P340, DOI 10.1128/CVI.00681-13; Lambert ND, 2014, IMMUNOL RES, V58, P1, DOI 10.1007/s12026-013-8475-y; Lozach PY, 2011, CELL HOST MICROBE, V10, P75, DOI 10.1016/j.chom.2011.06.007; Maier MK, 2007, EUR J IMMUNOL, V37, P2214, DOI 10.1002/eji.200737072; Malcherek G, 2007, J IMMUNOL, V179, P3804, DOI 10.4049/jimmunol.179.6.3804; Mezger M, 2008, CLIN MICROBIOL INFEC, V14, P228, DOI 10.1111/j.1469-0691.2007.01902.x; Mora JR, 2008, NAT REV IMMUNOL, V8, P685, DOI 10.1038/nri2378; Muhlebach MD, 2011, NATURE, V480, P530, DOI 10.1038/nature10639; Noyce RS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002240; Ovsyannikova IG, 2013, HUM IMMUNOL, V74, P768, DOI 10.1016/j.humimm.2013.01.031; Ovsyannikova IG, 2012, PHARMACOGENET GENOM, V22, P20, DOI 10.1097/FPC.0b013e32834df186; Ovsyannikova IG, 2011, HUM HERED, V72, P206, DOI 10.1159/000331585; Ovsyannikova I, 2011, HUM GENET, V130, P547, DOI 10.1007/s00439-011-0977-x; Ovsyannikova IG, 2010, HUM GENET, V127, P207, DOI 10.1007/s00439-009-0763-1; Ovsyannikova IG, 2010, J INFECT DIS, V201, P207, DOI 10.1086/649588; Ovsyannikova IG, 2009, VACCINE, V27, P6926, DOI 10.1016/j.vaccine.2009.08.109; Pankratz VS, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-48; Poland GA, 2011, OMICS, V15, P625, DOI 10.1089/omi.2011.0032; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Shibuya A, 1996, IMMUNITY, V4, P573, DOI 10.1016/S1074-7613(00)70060-4; Struyf F, 2002, J VIROL, V76, P12940, DOI 10.1128/JVI.76.24.12940-12950.2002; Tahara-Hanaoka S, 2004, INT IMMUNOL, V16, P533, DOI 10.1093/intimm/dxh059; Tan PL, 2001, VACCINE, V19, P2434, DOI 10.1016/S0264-410X(00)00468-0; Villamor E, 2005, CLIN MICROBIOL REV, V18, P446, DOI 10.1128/CMR.18.3.446-464.2005; Warner MS, 1998, VIROLOGY, V246, P179, DOI 10.1006/viro.1998.9218	53	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e99997	10.1371/journal.pone.0099997	http://dx.doi.org/10.1371/journal.pone.0099997			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945853	Green Published, Green Submitted, gold			2022-12-27	WOS:000340721500039
J	Ishikane, M; Watanabe, K; Tsukada, K; Nozaki, Y; Yanase, M; Igari, T; Masaki, N; Kikuchi, Y; Oka, S; Gatanaga, H				Ishikane, Masahiro; Watanabe, Koji; Tsukada, Kunihisa; Nozaki, Yuichi; Yanase, Mikio; Igari, Toru; Masaki, Naohiko; Kikuchi, Yoshimi; Oka, Shinichi; Gatanaga, Hiroyuki			Acute Hepatitis C in HIV-1 Infected Japanese Cohort: Single Center Retrospective Cohort Study	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HIV-INFECTED MEN; COMBINATION THERAPY; PLUS RIBAVIRIN; LIVER FIBROSIS; INTERFERON-ALPHA-2B; CLEARANCE; GENOTYPE; EFFICACY; IL28B	Objectives: HCV co-infection is a poor prognostic factor in HIV-1-infected patients. Although the number of newly reported patients who show seroconversion is increasing, the clinical features are still unclear, especially in Asian countries. Design: A single-center retrospective cohort study of patients diagnosed between 2001-2012. Methods: Acute hepatitis C (AHC) was diagnosed upon detection of high serum ALT (>100 IU) followed by anti-HCV seroconversion. Clinical characteristics, HIV-1-related immunological status and IL-28B genotypes (rs12979860, rs8099917) were collected. We compared these variables between patients with and without spontaneous clearance of HCV and between responders and non-responders to treatment with pegylated interferon (PEG-IFN) plus ribavirin. Results: Thirty-five patients were diagnosed with AHC during the study period. The majority (96.9%) were MSM. Three were lost to follow-up. Seventy-five percent of patients with AHC (24/32) were asymptomatic and found incidentally to have high serum ALT. Compared to those who did not show spontaneous clearance, patients with spontaneous HCV viral clearance showed more symptoms and more severe abnormalities related to acute hepatitis. Spontaneous clearance was seen in 4 out of 28 patients with CC+TT genotype, but not in 6 patients with IL-28B CT+TG genotype. PEG-IFN plus ribavirin treatment was initiated in 12 out of 28 cases without spontaneous clearance. The sustained virological response rate was high (81.8%, 9/11), even in cases with CT+TG genotype infected with HCV genotype 1b (SVR 2/2). Conclusions: Careful attention to AHC is needed in HIV-1-infected MSM. Early diagnosis and PEG-IFN plus ribavirin treatment should be considered for AHC cases.	[Ishikane, Masahiro; Watanabe, Koji; Tsukada, Kunihisa; Kikuchi, Yoshimi; Oka, Shinichi; Gatanaga, Hiroyuki] Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan; [Yanase, Mikio; Igari, Toru; Masaki, Naohiko] Natl Ctr Global Hlth & Med, Dept Gastroenterol, Tokyo, Japan; [Igari, Toru] Natl Ctr Global Hlth & Med, Pathol Div Clin Lab, Tokyo, Japan; [Masaki, Naohiko] Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, Tokyo, Japan; [Ishikane, Masahiro] Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Field Epidemiol Training Program Japan, Tokyo, Japan; [Ishikane, Masahiro] Tohoku Univ, Grad Sch Med, Med Sci Doctoral Program, Global Infect Dis Infect & Epidemiol, Sendai, Miyagi 980, Japan; [Watanabe, Koji; Oka, Shinichi; Gatanaga, Hiroyuki] Kumamoto Univ, Ctr AIDS Res, Kumamoto, Japan	National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; National Institute of Infectious Diseases (NIID); Tohoku University; Kumamoto University	Gatanaga, H (corresponding author), Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan.	higatana@acc.ncgm.go.jp	Ishikane, Masahiro/ABA-9878-2020	Ishikane, Masahirio/0000-0002-4719-651X; Oka, Shinichi/0000-0002-9283-2167	Ministry of Health, Labor, and Welfare [H23-AIDS-001]; Global COE Program (Global Education and Research Center Aiming at the Control of AIDS), MEXT, Japan	Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Global COE Program (Global Education and Research Center Aiming at the Control of AIDS), MEXT, Japan	This work was supported in part by Grants-in Aid for AIDS research from the Ministry of Health, Labor, and Welfare (H23-AIDS-001) and the Global COE Program (Global Education and Research Center Aiming at the Control of AIDS), MEXT, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert M, 2011, AIDS, V25, P399, DOI 10.1097/QAD.0b013e328343443b; Alter MJ, 2007, WORLD J GASTROENTERO, V13, P2436, DOI 10.3748/wjg.v13.i17.2436; Benhamou Y, 1999, HEPATOLOGY, V30, P1054, DOI 10.1002/hep.510300409; Boesecke C, 2014, C RETR OPP INF BOST; Boesecke C, 2011, CURR OPIN HIV AIDS, V6, P459, DOI 10.1097/COH.0b013e32834b87de; Boesecke C, 2011, CURR OPIN HIV AIDS, V6, P278, DOI 10.1097/COH.0b013e32834732cd; CDC, GUID PREV TREATM OPP; Chen TY, 2009, CLIN INFECT DIS, V49, P1605, DOI 10.1086/644771; Deterding K, 2013, LANCET INFECT DIS, V13, P497, DOI 10.1016/S1473-3099(13)70059-8; Dore GJ, 2010, GASTROENTEROLOGY, V138, P123, DOI 10.1053/j.gastro.2009.09.019; Fierer DS, 2008, J INFECT DIS, V198, P683, DOI 10.1086/590430; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Germer JJ, 1999, J CLIN MICROBIOL, V37, P2625, DOI 10.1128/JCM.37.8.2625-2630.1999; Grebely J, 2014, HEPATOLOGY, V59, P109, DOI 10.1002/hep.26639; Grebely J, 2012, AIDS, V26, P1653, DOI 10.1097/QAD.0b013e3283553719; Grebely J, 2010, HEPATOLOGY, V52, P1216, DOI 10.1002/hep.23850; Hadziyannis SJ, 2002, J HEPATOL, V36, P3, DOI 10.1016/S0168-8278(02)80001-0; Jimenez-Sousa MA, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-6; Kamal SM, 2004, HEPATOLOGY, V39, P1721, DOI 10.1002/hep.20266; Lambers FAE, 2011, AIDS, V25, pF21, DOI 10.1097/QAD.0b013e32834bac44; Lambers FAE, 2011, AIDS, V25, P1333, DOI 10.1097/QAD.0b013e3283480144; Landau A, 2001, AIDS, V15, P2149, DOI 10.1097/00002030-200111090-00010; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Nasti G, 2001, AIDS, V15, P1783, DOI 10.1097/00002030-200109280-00006; Nattermann J, 2011, J INFECT DIS, V203, P595, DOI 10.1093/infdis/jiq098; Piroth L, 2010, HEPATOLOGY, V52, P1915, DOI 10.1002/hep.23959; Ragonnet R, 2014, C RETR OPP INF BOST; Rivero-Juarez A, 2013, AIDS, V27, P1941, DOI 10.1097/QAD.0b013e328360ea1e; Sauleda S, 2001, HEPATOLOGY, V34, P1035, DOI 10.1053/jhep.2001.29130; Terrault NA, 2013, HEPATOLOGY, V57, P881, DOI 10.1002/hep.26164; Thomson EC, 2011, GUT, V60, P837, DOI 10.1136/gut.2010.217166; van de Laar TJW, 2007, J INFECT DIS, V196, P230, DOI 10.1086/518796; van de Laar TJW, 2010, AIDS, V24, P1799, DOI 10.1097/QAD.0b013e32833c11a5; van den Berg CHBS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027555	34	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100517	10.1371/journal.pone.0100517	http://dx.doi.org/10.1371/journal.pone.0100517			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945812	Green Submitted, Green Published, gold			2022-12-27	WOS:000340721500085
J	Bao, Y; Guo, YC; Li, ZX; Fang, WF; Yang, YQ; Li, XH; Li, ZZ; Xiong, BW; Chen, ZG; Wang, JG; Kang, K; Gou, DM; Yang, WC				Bao, Yonghua; Guo, Yongchen; Li, Zexin; Fang, Wenfeng; Yang, Yiqiong; Li, Xuhan; Li, Zhuangzhuang; Xiong, Bowen; Chen, Zhiguo; Wang, Jianguo; Kang, Kang; Gou, Deming; Yang, Wancai			MicroRNA Profiling in Muc2 Knockout Mice of Colitis-Associated Cancer Model Reveals Epigenetic Alterations during Chronic Colitis Malignant Transformation	PLOS ONE			English	Article							INTESTINAL TUMOR-FORMATION; COLORECTAL-CANCER; ULCERATIVE-COLITIS; COLON-CANCER; CELL MATURATION; DOWN-REGULATION; BETA-CATENIN; INFLAMMATION; METASTASIS; METAANALYSIS	Our previous studies have demonstrated that genetic deletion of the Muc2 gene causes colorectal cancers in mice. The current study further showed that at the early stage (<3 months) the Muc2 knockout mice spontaneously developed chronic inflammation in colon and rectum, similar pathological features as human colitis; and at the late stage (>3 months) the mice exhibited colorectal cancer, including a unique phenotype of rectal prolapsed (rectal severe inflammation and adenocarcinoma). Thus, the age of 3 months might be the key point of the transition from chronic inflammation to cancer. To determine the mechanisms of the malignant transformation, we conducted miRNA array on the colonic epithelial cells from the 3-month Muc2(-/-) and (+/+) mice. MicroRNA profiling showed differential expression of miRNAs (i.e. lower or higher expression enrichments) in Muc2(-/-) mice. 15 of them were validated by quantitative PCR. Based on relevance to cytokine and cancer, 4 miRNAs (miR-138, miR-145, miR-146a, and miR-150) were validate and were found significantly downregulated in human colitis and colorectal cancer tissues. The network of the targets of these miRNAs was characterized, and interestedly, miRNA-associated cytokines were significantly increased in Muc2(-/-) mice. This is the first to reveal the importance of aberrant expression of miRNAs in dynamically transformation from chronic colitis to colitis-associated cancer. These findings shed light on revealing the mechanisms of chronic colitis malignant transformation.	[Bao, Yonghua] Xinxiang Med Univ, Dept Immunol, Xinxiang, Peoples R China; [Guo, Yongchen] Xinxiang Med Univ, Dept Lab Med, Xinxiang, Peoples R China; [Li, Zexin; Wang, Jianguo] Xinxiang Med Univ, Affiliated Hosp 1, Dept Surg, Weihui, Peoples R China; [Fang, Wenfeng] Sun Yat Sen Univ, Ctr Canc, Dept Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Yang, Yiqiong; Li, Xuhan; Li, Zhuangzhuang; Xiong, Bowen; Chen, Zhiguo; Yang, Wancai] Xinxiang Med Univ, Sch Basic Med Sci, Xinxiang, Peoples R China; [Kang, Kang; Gou, Deming] Shenzhen Univ, Sch Life Sci, Shenzhen, Peoples R China; [Yang, Wancai] Univ Illinois, Dept Pathol, Chicago, IL USA	Xinxiang Medical University; Xinxiang Medical University; Xinxiang Medical University; Sun Yat Sen University; Xinxiang Medical University; Shenzhen University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Yang, WC (corresponding author), Xinxiang Med Univ, Sch Basic Med Sci, Xinxiang, Peoples R China.	wyang06@uic.edu	Yang, Wancai/O-7655-2019	Yang, Wancai/0000-0001-7437-9197	National Natural Science Foundation of China [91229115, 81272251]; Innovative Team of Science and Technology from the Department of Education, Henan Province, China; Doctor Research Fund from Xinxiang Medical University, China [100820, 505011]; Startup Fund from Xinxiang Medical University, China; National College Student Innovative Projects of China [201310472005, 201310472012, 201310472016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovative Team of Science and Technology from the Department of Education, Henan Province, China; Doctor Research Fund from Xinxiang Medical University, China; Startup Fund from Xinxiang Medical University, China; National College Student Innovative Projects of China	This work was supported in part by the grant from the National Natural Science Foundation of China (grant #91229115 and 81272251), a grant for the Innovative Team of Science and Technology from the Department of Education, Henan Province, China, and Doctor Research Fund (#100820 and 505011) and Startup Fund from Xinxiang Medical University, China. The work was also supported in part by the National College Student Innovative Projects of China (#201310472005 to XL, 201310472012 to BX, and 201310472016 to ZL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrianifahanana M, 2006, BBA-REV CANCER, V1765, P189, DOI 10.1016/j.bbcan.2006.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bi XL, 2008, CARCINOGENESIS, V29, P1435, DOI 10.1093/carcin/bgn141; Bi XL, 2012, CARCINOGENESIS, V33, P326, DOI 10.1093/carcin/bgr293; Boudiaf-Benmammar C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060895; Bousquet M, 2013, MOL CANCER RES, V11, P912, DOI 10.1158/1541-7786.MCR-13-0002-T; Canavan C, 2006, ALIMENT PHARM THER, V23, P1097, DOI 10.1111/j.1365-2036.2006.02854.x; Danese S, 2010, ONCOGENE, V29, P3313, DOI 10.1038/onc.2010.109; Di Leva G, 2014, ANNU REV PATHOL-MECH, V9, P287, DOI 10.1146/annurev-pathol-012513-104715; Eaden JA, 2001, GUT, V48, P526, DOI 10.1136/gut.48.4.526; Fang WF, 2010, CARCINOGENESIS, V31, P1360, DOI 10.1093/carcin/bgq114; Fang WF, 2010, INT J CANCER, V127, P32, DOI 10.1002/ijc.25029; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Gong H, 2013, CLIN CANCER RES, V19, P1083, DOI 10.1158/1078-0432.CCR-12-3169; Grivennikov SI, 2013, SEMIN IMMUNOPATHOL, V35, P229, DOI 10.1007/s00281-012-0352-6; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Jess T, 2012, CLIN GASTROENTEROL H, V10, P639, DOI 10.1016/j.cgh.2012.01.010; Kang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048536; Kanneganti M, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/342637; Kawata H, 2003, BIOCHEM J, V373, P747, DOI 10.1042/BJ20030171; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kumar A, 2005, J BIOL CHEM, V280, P37782, DOI 10.1074/jbc.M505278200; Lages E, 2012, FRONT BIOSCI-LANDMRK, V17, P2508, DOI 10.2741/4068; Liu X, 2012, CELL CYCLE, V11, P2495, DOI 10.4161/cc.20898; Long LM, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-275; Mariadason JM, 2005, GASTROENTEROLOGY, V128, P1081, DOI 10.1053/j.gastro.2005.01.054; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Morris VA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075815; Neufert C, 2007, NAT PROTOC, V2, P1998, DOI 10.1038/nprot.2007.279; Noguchi S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.11; Okayasu I, 1996, GUT, V39, P87, DOI 10.1136/gut.39.1.87; Pizzini S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-589; Rustgi AK, 2007, GENE DEV, V21, P2525, DOI 10.1101/gad.1593107; Saleh M, 2011, NAT REV IMMUNOL, V11, P9, DOI 10.1038/nri2891; Sen A, 2014, FEBS LETT, V588, P906, DOI 10.1016/j.febslet.2014.01.033; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sung JJY, 2005, LANCET ONCOL, V6, P871, DOI 10.1016/S1470-2045(05)70422-8; Terzic J, 2010, GASTROENTEROLOGY, V138, P2101, DOI 10.1053/j.gastro.2010.01.058; Tong C, 2007, AM J PATHOL, V171, P297, DOI 10.2353/ajpath.2007.061036; Trifari S, 2013, P NATL ACAD SCI USA, V110, P18608, DOI 10.1073/pnas.1317191110; Trinchieri G, 2012, ANNU REV IMMUNOL, V30, P677, DOI 10.1146/annurev-immunol-020711-075008; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang DS, 2013, FEBS J, V280, P3340, DOI 10.1111/febs.12323; White NMA, 2011, NAT REV CLIN ONCOL, V8, P75, DOI 10.1038/nrclinonc.2010.173; Yang K, 2008, CANCER RES, V68, P7313, DOI 10.1158/0008-5472.CAN-08-0598; Yang WC, 2005, AM J PATHOL, V166, P1239, DOI 10.1016/S0002-9440(10)62342-5; Ye XW, 2014, CLIN RESP J; Yeh YM, 2013, INT J CANCER, V133, P867, DOI 10.1002/ijc.28086; Yu CC, 2013, CANCER RES, V73, P3425, DOI 10.1158/0008-5472.CAN-12-3840; Zheng QH, 2012, J IMMUNOL, V188, P2118, DOI 10.4049/jimmunol.1103342; Zhou L, 2013, FASEB J, V27, P4929, DOI 10.1096/fj.13-233387; Zhu XS, 2014, MOL CELL BIOCHEM, V390, P75, DOI 10.1007/s11010-013-1958-2	55	19	22	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99132	10.1371/journal.pone.0099132	http://dx.doi.org/10.1371/journal.pone.0099132			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941171	Green Published, gold, Green Submitted			2022-12-27	WOS:000338508200014
J	Edmonds, JM; Sabol, JP; Rastogi, VK				Edmonds, Jason M.; Sabol, Jonathan P.; Rastogi, Vipin K.			Decontamination Efficacy of Three Commercial-Off-The-Shelf (COTS) Sporicidal Disinfectants on Medium-Sized Panels Contaminated with Surrogate Spores of Bacillus anthracis	PLOS ONE			English	Article							CHLORINE DIOXIDE GAS; SURFACES; THURINGIENSIS	In the event of a wide area release and contamination of a biological agent in an outdoor environment and to building exteriors, decontamination is likely to consume the Nation's remediation capacity, requiring years to cleanup, and leading to incalculable economic losses. This is in part due to scant body of efficacy data on surface areas larger than those studied in a typical laboratory (5x10-cm), resulting in low confidence for operational considerations in sampling and quantitative measurements of prospective technologies recruited in effective cleanup and restoration response. In addition to well-documented fumigation-based cleanup efforts, agencies responsible for mitigation of contaminated sites are exploring alternative methods for decontamination including combinations of disposal of contaminated items, source reduction by vacuuming, mechanical scrubbing, and low-technology alternatives such as pH-adjusted bleach pressure wash. If proven effective, a pressure wash-based removal of Bacillus anthracis spores from building surfaces with readily available equipment will significantly increase the readiness of Federal agencies to meet the daunting challenge of restoration and cleanup effort following a wide-area biological release. In this inter-agency study, the efficacy of commercial-of-the-shelf sporicidal disinfectants applied using backpack sprayers was evaluated in decontamination of spores on the surfaces of medium-sized (similar to 1.2 m(2)) panels of steel, pressure-treated (PT) lumber, and brick veneer. Of the three disinfectants, pH-amended bleach, Peridox, and CASCAD evaluated; CASCAD was found to be the most effective in decontamination of spores from all three panel surface types.	[Edmonds, Jason M.; Rastogi, Vipin K.] US Army, Edgewood Chem Biol Ctr, Res Dev & Engn Command, Aberdeen Proving Ground, MD 21005 USA; [Sabol, Jonathan P.] EXCET Inc, Springfield, VA USA	United States Department of Defense; US Army Research, Development & Engineering Command (RDECOM)	Rastogi, VK (corresponding author), US Army, Edgewood Chem Biol Ctr, Res Dev & Engn Command, Aberdeen Proving Ground, MD 21005 USA.	vipin.k.rastogi.civ@mail.mil			Joint Science and Technology Office of the Defense Threat Reduction Agency	Joint Science and Technology Office of the Defense Threat Reduction Agency	Funding for this program was provided by the Joint Science and Technology Office of the Defense Threat Reduction Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, CHEM ENG NEWS, V79, P18; Beuchat LR, 2005, J IND MICROBIOL BIOT, V32, P301, DOI 10.1007/s10295-005-0212-7; Brown GS, 2007, J ENVIRON MONITOR, V9, P666, DOI 10.1039/b700163k; Calfee MW, 2010, BIOL AGENT DECONTAMI; Canter DA, 2005, BIOSECUR BIOTERROR, V3, P119, DOI 10.1089/bsp.2005.3.119; Davies A, 2011, J HOSP INFECT, V77, P199, DOI 10.1016/j.jhin.2010.08.012; de Boer HEL, 2006, INFECT CONT HOSP EP, V27, P1120, DOI 10.1086/507966; Edmonds JM, 2009, APPL MICROBIOL BIOT, V84, P811, DOI 10.1007/s00253-009-2136-z; Edmonds JM, 2009, APPL ENVIRON MICROB, V75, P39, DOI 10.1128/AEM.01563-08; Han Y, 2003, J ENVIRON HEALTH, V66, P16; Justice TUSDo, 2010, AM INV SUMM; Otter JA, 2009, INFECT CONT HOSP EP, V30, P574, DOI 10.1086/597544; Rastogi VK, 2009, APPL ENVIRON MICROB, V75, P3688, DOI 10.1128/AEM.02592-08; Ritter S, 2001, CHEM ENG NEWS, V79, P13, DOI 10.1021/cen-v079n050.p013a; Tomasino SF, 2010, J AOAC INT, V93, P259; Wilson SC, 2005, APPL ENVIRON MICROB, V71, P5399, DOI 10.1128/AEM.71.9.5399-5403.2005	16	3	3	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99827	10.1371/journal.pone.0099827	http://dx.doi.org/10.1371/journal.pone.0099827			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940605	gold, Green Published, Green Submitted			2022-12-27	WOS:000338508200044
J	Heimesaat, MM; Fischer, A; Plickert, R; Wiedemann, T; Loddenkemper, C; Gobel, UB; Bereswill, S; Rieder, G				Heimesaat, Markus M.; Fischer, Andre; Plickert, Rita; Wiedemann, Tobias; Loddenkemper, Christoph; Goebel, Ulf B.; Bereswill, Stefan; Rieder, Gabriele			Helicobacter pylori Induced Gastric Immunopathology Is Associated with Distinct Microbiota Changes in the Large Intestines of Long-Term Infected Mongolian Gerbils	PLOS ONE			English	Article							ACID-SECRETION; COLONIZATION; CARCINOGENESIS; IDENTIFICATION; MICROFLORA; INDUCTION; COLITIS; STOMACH; ILEITIS; TRACT	Background: Gastrointestinal (GI) inflammation in mice and men are frequently accompanied by distinct changes of the GI microbiota composition at sites of inflammation. Helicobacter (H.) pylori infection results in gastric immunopathology accompanied by colonization of stomachs with bacterial species, which are usually restricted to the lower intestine. Potential microbiota shifts distal to the inflammatory process following long-term H. pylori infection, however, have not been studied so far. Methodology/Principal Findings: For the first time, we investigated microbiota changes along the entire GI tract of Mongolian gerbils after 14 months of infection with H. pylori B8 wildtype (WT) or its isogenic Delta cagY mutant (MUT) strain which is defective in the type IV secretion system and thus unable to modulate specific host pathways. Comprehensive cultural analyses revealed that severe gastric diseases such as atrophic pangastritis and precancerous transformations were accompanied by elevated luminal loads of E. coli and enterococci in the caecum and together with Bacteroides/Prevotella spp. in the colon of H. pylori WT, but not MUT infected gerbils as compared to naive animals. Strikingly, molecular analyses revealed that Akkermansia, an uncultivable species involved in mucus degradation, was exclusively abundant in large intestines of H. pylori WT, but not MUT infected nor naive gerbils. Conclusion/Significance: Taken together, long-term infection of Mongolian gerbils with a H. pylori WT strain displaying an intact type IV secretion system leads to distinct shifts of the microbiota composition in the distal uninflamed, but not proximal inflamed GI tract. Hence, H. pylori induced immunopathogenesis of the stomach, including hypochlorhydria and hypergastrinemia, might trigger large intestinal microbiota changes whereas the exact underlying mechanisms need to be further unraveled.	[Heimesaat, Markus M.; Fischer, Andre; Plickert, Rita; Goebel, Ulf B.; Bereswill, Stefan] Charite, Dept Microbiol & Hyg, D-13353 Berlin, Germany; [Wiedemann, Tobias] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Munich, Germany; [Loddenkemper, Christoph] Charite, Res Ctr ImmunoSci RCIS, Dept Pathol, D-13353 Berlin, Germany; [Rieder, Gabriele] Salzburg Univ, Dept Microbiol, Div Mol Biol, A-5020 Salzburg, Austria	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Salzburg University	Heimesaat, MM (corresponding author), Charite, Dept Microbiol & Hyg, D-13353 Berlin, Germany.	markus.heimesaat@charite.de		Heimesaat, Markus/0000-0001-6399-651X	German Research Foun-dation (DFG) [GO363/12-1, CampyGerm, SFB633, TP A7, TP Z1, TP B6, RI972/3-1]; German Federal Ministry of Education and Research (BMBF) [TP 1.1, TP 8.2]	German Research Foun-dation (DFG)(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by grants from the German Research Foun-dation (DFG) to UBG (GO363/12-1, CampyGerm; SFB633, TP A7), SB and AF (SFB633, TP A7), CL (SFB633, TP Z1), MMH (SFB633, TP B6), GR (RI972/3-1), and from the German Federal Ministry of Education and Research (BMBF) to SB ("Lab in a hanky" projects TP 1.1 and TP 8.2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebischer T, 2006, FEMS IMMUNOL MED MIC, V46, P221, DOI 10.1111/rp10.1016-j.femsim.2004.05.008; Chu SJ, 2013, CURR OPIN GASTROEN, V29, P636, DOI 10.1097/MOG.0b013e328365efc7; Derrien M, 2004, INT J SYST EVOL MICR, V54, P1469, DOI 10.1099/ijs.0.02873-0; DOOLEY CP, 1989, NEW ENGL J MED, V321, P1562, DOI 10.1056/NEJM198912073212302; Erridge C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009125; Farnbacher M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-335; Gaddy JA, 2013, INFECT IMMUN, V81, P2258, DOI 10.1128/IAI.01271-12; Haag LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035988; Hatakeyama M, 2006, INT J HEMATOL, V84, P301, DOI 10.1532/IJH97.06166; Heimesaat MM, 2007, GUT, V56, P941, DOI 10.1136/gut.2006.104497; Heimesaat MM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000662; Heimesaat MM, 2006, J IMMUNOL, V177, P8785, DOI 10.4049/jimmunol.177.12.8785; Heimesaat MM, 2010, GUT, V59, P1079, DOI 10.1136/gut.2009.197434; Hirayama F, 1996, J GASTROENTEROL, V31, P24; Hirayama F, 1996, J GASTROENTEROL, V31, P755, DOI 10.1007/BF02347631; Huseby ES, 2005, CELL, V122, P247, DOI 10.1016/j.cell.2005.05.013; International Agency for Research on Cancer, 1994, IARC MONOGR EVAL CAR, V61, P1; Jiang W, 2012, CURR HIV RES, V10, P504, DOI 10.2174/157016212802429848; Kavermann H, 2003, J EXP MED, V197, P813, DOI 10.1084/jem.20021531; KUIPERS EJ, 1995, LANCET, V345, P1525, DOI 10.1016/S0140-6736(95)91084-0; Muyzer G, 1998, ANTON LEEUW INT J G, V73, P127, DOI 10.1023/A:1000669317571; Osaki T, 2012, MICROB PATHOGENESIS, V53, P12, DOI 10.1016/j.micpath.2012.03.008; Poppe M, 2007, ONCOGENE, V26, P3462, DOI 10.1038/sj.onc.1210139; Rieder G, 2005, GASTROENTEROLOGY, V128, P1229, DOI 10.1053/j.gastro.2005.02.064; Saha A, 2010, GASTROENTEROLOGY, V139, P239, DOI 10.1053/j.gastro.2010.03.036; Saha A, 2010, GUT, V59, P874, DOI 10.1136/gut.2009.194795; Selgrad M, 2012, HELICOBACTER, V17, P30, DOI 10.1111/j.1523-5378.2012.00980.x; Sewald X, 2008, CELL HOST MICROBE, V3, P20, DOI 10.1016/j.chom.2007.11.003; Smolka AJ, 2012, J GASTROENTEROL, V47, P609, DOI 10.1007/s00535-012-0592-1; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Sun YQ, 2003, HELICOBACTER, V8, P149, DOI 10.1046/j.1523-5378.2003.00136.x; Tsukamoto T, 2013, SEMIN IMMUNOPATHOL, V35, P177, DOI 10.1007/s00281-012-0357-1; Valeur N, 2004, APPL ENVIRON MICROB, V70, P1176, DOI 10.1128/AEM.70.2.1176-1181.2004; Wessler S, 2008, TRENDS MICROBIOL, V16, P397, DOI 10.1016/j.tim.2008.05.005; Wiedemann T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004754; Yakoob J, 2012, BRIT J BIOMED SCI, V69, P6, DOI 10.1080/09674845.2012.11669914; Yin YN, 2011, HELICOBACTER, V16, P389, DOI 10.1111/j.1523-5378.2011.00862.x; Zaman C, 2010, J GASTROEN HEPATOL, V25, pS11, DOI 10.1111/j.1440-1746.2009.06215.x; Zhang Songhua, 2012, Methods Mol Biol, V921, P89	39	53	59	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100362	10.1371/journal.pone.0100362	http://dx.doi.org/10.1371/journal.pone.0100362			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941045	Green Submitted, Green Published, gold			2022-12-27	WOS:000338508200097
J	Nothnick, WB; Graham, A; Holbert, J; Weiss, MJ				Nothnick, Warren B.; Graham, Amanda; Holbert, Joshua; Weiss, Mitchell J.			miR-451 Deficiency Is Associated with Altered Endometrial Fibrinogen Alpha Chain Expression and Reduced Endometriotic Implant Establishment in an Experimental Mouse Model	PLOS ONE			English	Article							ERYTHROID-DIFFERENTIATION; RETROGRADE MENSTRUATION; MICRORNA-451; MICE; PROLIFERATION; PROGRESSION; INHIBITION; BIOGENESIS; ACTIVATION; PEPTIDES	Endometriosis is defined as the growth of endometrial glandular and stromal components in ectopic locations and affects as many as 10% of all women of reproductive age. Despite its high prevalence, the pathogenesis of endometriosis remains poorly understood. MicroRNAs, small non-coding RNAs that post-transcriptionally regulate gene expression, are mis-expressed in endometriosis but a functional role in the disease pathogenesis remains uncertain. To examine the role of microRNA-451 (miR-451) in the initial development of endometriosis, we utilized a novel mouse model in which eutopic endometrial fragments used to induce endometriosis were deficient for miR-451. After induction of the disease, we evaluated the impact of this deficiency on implant development and survival. Loss of miR-451 expression resulted in a lower number of ectopic lesions established in vivo. Analysis of differential protein profiles between miR-451 deficient and wildtype endometrial fragments revealed that fibrinogen alpha polypeptide isoform 2 precursor was approximately 2-fold higher in the miR-451 null donor endometrial tissue and this elevated expression of the protein was associated with altered expression of the parent fibrinogen alpha chain mRNA and protein. As this polypeptide contains RGD amino acid "cell adhesion" motifs which could impact early establishment of lesion development, we examined and confirmed using a cyclic RGD peptide antagonist, that endometrial cell adhesion and endometriosis establishment could be respectively inhibited both in vitro and in vivo. Collectively, these results suggest that the reduced miR-451 eutopic endometrial expression does not enhance initial establishment of these fragments when displaced into the peritoneal cavity, that loss of eutopic endometrial miR-451 expression is associated with altered expression of fibrinogen alpha chain mRNA and protein, and that RGD cyclic peptide antagonists inhibit establishment of endometriosis development in an experimental mouse model suggesting that this approach may prove useful in the prevention of endometriosis establishment and survival.	[Nothnick, Warren B.; Graham, Amanda; Holbert, Joshua] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66103 USA; [Weiss, Mitchell J.] Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA 19104 USA	University of Kansas; University of Kansas Medical Center; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Nothnick, WB (corresponding author), Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66103 USA.	wnothnic@kumc.edu	Weiss, Mitchell J/W-9814-2018	Weiss, Mitchell J/0000-0003-2460-3036	Eunice Kennedy Shriver National Institute Of Child Health & Human Development of the National Institutes of Health [R01HD069043]; National Institute of Diabetes and Kidney Disease [R01 DK092318, P30 DK090969]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069043, P30HD002528] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute Of Child Health & Human Development of the National Institutes of Health; National Institute of Diabetes and Kidney Disease; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Research reported in this publication was supported by the Eunice Kennedy Shriver National Institute Of Child Health & Human Development of the National Institutes of Health under Award Number R01HD069043 (WBN) and from the National Institute of Diabetes and Kidney Disease under award numbers R01 DK092318 and P30 DK090969 (MJW). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apparao KBC, 2001, J CLIN ENDOCR METAB, V86, P4991, DOI 10.1210/jc.86.10.4991; Bandres E, 2009, CLIN CANCER RES, V15, P2281, DOI 10.1158/1078-0432.CCR-08-1818; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bruchova-Votavova H, 2010, LEUKEMIA LYMPHOMA, V51, P686, DOI 10.3109/10428191003629362; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Chen XM, 1997, BIOCHEM BIOPH RES CO, V234, P594, DOI 10.1006/bbrc.1997.6593; Child TJ, 2001, DRUGS, V61, P1735, DOI 10.2165/00003495-200161120-00005; Cho S, 2012, DNA CELL BIOL, V31, P316, DOI 10.1089/dna.2011.1279; Cifuentes D, 2010, SCIENCE, V328, P1694, DOI 10.1126/science.1190809; Ding X, 2010, J INT MED RES, V38, P987, DOI 10.1177/147323001003800325; Ding XY, 2010, FERTIL STERIL, V94, P2528, DOI 10.1016/j.fertnstert.2010.04.054; DSOUZA SE, 1991, TRENDS BIOCHEM SCI, V16, P246, DOI 10.1016/0968-0004(91)90096-E; Erson AE, 2008, CLIN GENET, V74, P296, DOI 10.1111/j.1399-0004.2008.01076.x; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Filigheddu N, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/369549; Fu YF, 2009, BLOOD, V113, P1340, DOI 10.1182/blood-2008-08-174854; Godlewski J, 2010, CELL CYCLE, V9, P2742, DOI 10.4161/cc.9.14.12248; Govatati S, 2013, MITOCHONDRION, V13, P782, DOI 10.1016/j.mito.2013.05.003; Govatati S, 2013, FERTIL STERIL, V99, P1980, DOI 10.1016/j.fertnstert.2013.02.021; Govatati S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040668; Haier J, 2002, CLIN EXP METASTAS, V19, P665, DOI 10.1023/A:1021316531912; HALME J, 1984, OBSTET GYNECOL, V64, P151; Hawkins SM, 2011, MOL ENDOCRINOL, V25, P821, DOI 10.1210/me.2010-0371; Healy DL, 1998, HUM REPROD UPDATE, V4, P736, DOI 10.1093/humupd/4.5.736; Iwaya T, 2012, CARCINOGENESIS, V33, P2391, DOI 10.1093/carcin/bgs288; Jin HL, 2012, MOL CELLS, V34, P177, DOI 10.1007/s10059-012-0090-6; Kao SH, 2005, ANN NY ACAD SCI, V1042, P186, DOI 10.1196/annals.1338.021; Kim Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028293; Krikun G, 2004, ENDOCRINOLOGY, V145, P2291, DOI 10.1210/en.2003-1606; LIU CY, 1986, THROMB HAEMOSTASIS, V56, P100; LIU DTY, 1986, BRIT J OBSTET GYNAEC, V93, P859, DOI 10.1111/j.1471-0528.1986.tb07995.x; Nothnick WB, 2011, J ENDOMETR PELVIC PA, V3, P135, DOI 10.5301/JE.2011.8910; Nothnick WB, 2010, REPROD SCI, V17, P987, DOI 10.1177/1933719110377472; Pan Q, 2007, MOL HUM REPROD, V13, P797, DOI 10.1093/molehr/gam063; Patrick DM, 2010, GENE DEV, V24, P1614, DOI 10.1101/gad.1942810; Rasmussen KD, 2010, J EXP MED, V207, P1351, DOI 10.1084/jem.20100458; Teague EMCO, 2009, MOL ENDOCRINOL, V23, P265, DOI 10.1210/me.2008-0387; VANDERLINDEN PJQ, 1995, FERTIL STERIL, V63, P1210, DOI 10.1016/S0015-0282(16)57599-2; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Vigano P, 2004, BEST PRACT RES CL OB, V18, P177, DOI 10.1016/j.bpobgyn.2004.01.007; Wang T, 2013, DIGEST DIS SCI, V58, P706, DOI 10.1007/s10620-012-2395-x; Wang WZ, 2011, INT J CANCER, V129, P1624, DOI 10.1002/ijc.25818; Yu DN, 2010, GENE DEV, V24, P1620, DOI 10.1101/gad.1942110; Zhang X, 2009, MOL REPROD DEV, V76, P160, DOI 10.1002/mrd.20938; Zhang Z, 2012, FEBS LETT, V586, P20, DOI 10.1016/j.febslet.2011.07.042; Zhao J, 1995, DI YI JUN DA XUE XUE, V25, P709	46	31	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100336	10.1371/journal.pone.0100336	http://dx.doi.org/10.1371/journal.pone.0100336			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937656	Green Published, Green Submitted, gold			2022-12-27	WOS:000338503400105
J	Fontaine, M; Planel, S; Peronnet, E; Turrel-Davin, F; Piriou, V; Pachot, A; Monneret, G; Lepape, A; Venet, F				Fontaine, Mathieu; Planel, Severine; Peronnet, Estelle; Turrel-Davin, Fanny; Piriou, Vincent; Pachot, Alexandre; Monneret, Guillaume; Lepape, Alain; Venet, Fabienne			S100A8/A9 mRNA Induction in an Ex Vivo Model of Endotoxin Tolerance: Roles of IL-10 and IFN gamma	PLOS ONE			English	Article							CALCIUM-BINDING PROTEINS; SEPTIC SHOCK; MACROPHAGE EXPRESSION; WHOLE-BLOOD; S100; SEPSIS; IMMUNOSUPPRESSION; CALPROTECTIN; MONOCYTES; INFECTION	Objectives: Septic syndromes are the leading cause of death in intensive care units. They are characterized by the development of immune dysfunctions such as endotoxin tolerance (ET), whose intensity and duration are associated with increased risk of nosocomial infections and mortality. Alarmins S100A8 and S100A9 have been shown to be increased after septic shock. Importantly, a delayed S100A9 mRNA increase predicts hospital-acquired infection in patients. The aim of this study was to investigate the regulation of S100A8 and S100A9 mRNA expression in an ex vivo model of ET. Subjects and Measurements: ET was reproduced ex vivo by priming healthy peripheral blood mononuclear cells (number of donors = 9 to 10) with low-dose endotoxin (2 ng/ml) before stimulation with high dose endotoxin (100 ng/ml). S100A8 and S100A9 mRNA levels were measured by quantitative real-time polymerase chain reactions. Main Results: ET was established by observing decreased TNF alpha and increased IL-10 transcriptomic responses to two subsequent endotoxin challenges. Interestingly, ET was associated with increased S100A8 and S100A9 mRNA expression ex vivo. We showed that IL-10 played a role in this process, since S100A8 and S100A9 mRNA increases were significantly abrogated by IL-10 blockade in the model. Conversely, treatment with rIFN-c, a pro-inflammatory and immunostimulating molecule known to block ET induction, was able to restore normal S100A8 and S100A9 mRNA in this model. Conclusions: In this ex vivo model, we observed that S100A8 and S100A9 mRNA expression was significantly increased during ET. This reproduced ex vivo the observations we had previously made in septic shock patients. Interestingly, IL-10 blockade and rIFN-c treatment partially abrogated S100A8/A9 mRNA increases in this model. Pending confirmation in larger, independent clinical studies, these preliminary results suggest that S100A8 and S100A9 mRNA levels might be used as surrogate markers of ET and as stratification tools for personalized immunotherapy in septic shock patients.	[Fontaine, Mathieu; Piriou, Vincent; Lepape, Alain] Ctr Hosp Lyon Sud, Hosp Civils Lyon, Intens Care Unit, F-69310 Pierre Benite, France; [Fontaine, Mathieu; Planel, Severine; Peronnet, Estelle; Turrel-Davin, Fanny; Pachot, Alexandre; Monneret, Guillaume; Lepape, Alain; Venet, Fabienne] Hop Edouard Herriot, Joint Unit Hosp Civils Lyon BioMerieux, Lyon, France; [Fontaine, Mathieu; Piriou, Vincent; Monneret, Guillaume; Lepape, Alain; Venet, Fabienne] Univ Lyon 1, Hosp Civils Lyon, EAM Hemostasis Inflammat & Sepsis 4174, F-69365 Lyon, France; [Monneret, Guillaume; Venet, Fabienne] Hop Edouard Herriot, Hosp Civils Lyon, Immunol Lab, Lyon, France	CHU Lyon; bioMerieux; CHU Lyon; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon	Venet, F (corresponding author), Hop Edouard Herriot, Joint Unit Hosp Civils Lyon BioMerieux, Lyon, France.	fabienne.venet@chu-lyon.fr	Piriou, Vincent/AFV-4922-2022	Venet, Fabienne/0000-0003-0462-4235; LEPAPE, Alain/0000-0001-5950-7533; piriou, vincent/0000-0001-6900-1480	Hospices Civils de Lyon; bioMerieux	Hospices Civils de Lyon; bioMerieux	MF, VP, GM, AL and FV were supported by the Hospices Civils de Lyon. SP, EP, FTD and AP were supported by bioMerieux. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achouiti A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002987; Allantaz-Frager F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068218; Anceriz N, 2007, BIOCHEM BIOPH RES CO, V354, P84, DOI 10.1016/j.bbrc.2006.12.203; Bealer JF, 2010, ACAD EMERG MED, V17, P333, DOI 10.1111/j.1553-2712.2010.00663.x; Carroccio A, 2006, DIGEST DIS SCI, V51, P1749, DOI 10.1007/s10620-006-9078-4; Cavaillon JM, 2006, CRIT CARE, V10, DOI 10.1186/cc5055; Cavaillon JM, 2003, J ENDOTOXIN RES, V9, P101, DOI 10.1179/096805103125001487; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; De Lorenzo BHP, 2010, IMMUNOBIOLOGY, V215, P341, DOI 10.1016/j.imbio.2009.05.013; del Fresno C, 2009, J IMMUNOL, V182, P6494, DOI 10.4049/jimmunol.0803350; Diercks BP, 2013, SCAND J IMMUNOL, V77, P169, DOI 10.1111/sji.12015; Docke WD, 1997, NAT MED, V3, P678, DOI 10.1038/nm0697-678; Eggers K, 2011, EXP CLIN ENDOCR DIAB, V119, P353, DOI 10.1055/s-0030-1268426; Endoh Y, 2009, J IMMUNOL, V182, P2258, DOI 10.4049/jimmunol.0802683; FAGERHOL MK, 1980, SCAND J HAEMATOL, V24, P393; Fontaine M, 2011, CRIT CARE MED, V39, P2684, DOI 10.1097/CCM.0b013e3182282a40; Fuellen G, 2004, OMICS, V8, P334, DOI 10.1089/omi.2004.8.334; Goyette J, 2011, AMINO ACIDS, V41, P821, DOI 10.1007/s00726-010-0528-0; Hotchkiss RS, 2013, LANCET INFECT DIS, V13, P260, DOI 10.1016/S1473-3099(13)70001-X; Hotchkiss RS, 2009, NAT MED, V15, P496, DOI 10.1038/nm0509-496; Hsu K, 2005, J IMMUNOL, V174, P2318, DOI 10.4049/jimmunol.174.4.2318; Hsu Kenneth, 2009, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, V8, P290; Ikemoto M, 2003, CLIN CHEM, V49, P594, DOI 10.1373/49.4.594; Katashima T, 2010, CIRC J, V74, P741, DOI 10.1253/circj.CJ-09-0564; Landelle C, 2010, INTENS CARE MED, V36, P1859, DOI 10.1007/s00134-010-1962-x; Meisel C, 2009, AM J RESP CRIT CARE, V180, P640, DOI 10.1164/rccm.200903-0363OC; Monneret G, 2011, PATHOL BIOL, V59, P329, DOI 10.1016/j.patbio.2011.02.001; Monneret G, 2008, MOL MED, V14, P64, DOI 10.2119/2007-00102.Monneret; Monneret G, 2006, INTENS CARE MED, V32, P1175, DOI 10.1007/s00134-006-0204-8; ODINK K, 1987, NATURE, V330, P80, DOI 10.1038/330080a0; Pachot A, 2005, CRIT CARE MED, V33, P31, DOI 10.1097/01.CCM.0000150958.20209.A3; Pachot A, 2004, J BIOTECHNOL, V114, P121, DOI 10.1016/j.jbiotec.2004.07.001; Payen D, 2008, INTENS CARE MED, V34, P1371, DOI 10.1007/s00134-008-1048-1; Rammes A, 1997, J BIOL CHEM, V272, P9496; Ravasi T, 2004, GENOMICS, V84, P10, DOI 10.1016/j.ygeno.2004.02.002; Riva M, 2012, IMMUNOLOGY, V137, P172, DOI 10.1111/j.1365-2567.2012.03619.x; ROSETH AG, 1992, SCAND J GASTROENTERO, V27, P793, DOI 10.3109/00365529209011186; Ryckman C, 2003, J IMMUNOL, V170, P3233, DOI 10.4049/jimmunol.170.6.3233; Skirecki T, 2013, AM J RESP CRIT CARE, V187, P217, DOI 10.1164/ajrccm.187.2.217; Skrupky LP, 2011, ANESTHESIOLOGY, V115, P1349, DOI 10.1097/ALN.0b013e31823422e8; Sohnle PG, 2000, J INFECT DIS, V182, P1272, DOI 10.1086/315810; Sroussi HY, 2007, J LEUKOCYTE BIOL, V81, P818, DOI 10.1189/jlb.0706433; Turrel-Davin F, 2011, CRIT CARE, V15, DOI 10.1186/cc10513; van Zoelen MAD, 2009, AM J RESP CRIT CARE, V180, P1098, DOI 10.1164/rccm.200810-1552OC; Viemann D, 2005, BLOOD, V105, P2955, DOI 10.1182/blood-2004-07-2520; Viemann D, 2007, BLOOD, V109, P2453, DOI 10.1182/blood-2006-08-040444; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Xu K, 2000, J IMMUNOL, V164, P4916, DOI 10.4049/jimmunol.164.9.4916; Xu K, 2001, J IMMUNOL, V166, P6358, DOI 10.4049/jimmunol.166.10.6358; YOUNG HA, 1995, J LEUKOCYTE BIOL, V58, P373, DOI 10.1002/jlb.58.4.373; Zhao F, 2012, IMMUNOLOGY, V136, P176, DOI 10.1111/j.1365-2567.2012.03566.x; ZWADLO G, 1988, CLIN EXP IMMUNOL, V72, P510	52	23	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100909	10.1371/journal.pone.0100909	http://dx.doi.org/10.1371/journal.pone.0100909			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956170	Green Published, Green Submitted, gold			2022-12-27	WOS:000338917900105
J	Mao-Ying, QL; Kavelaars, A; Krukowski, K; Huo, XJ; Zhou, WJ; Price, TJ; Cleeland, C; Heijnen, CJ				Mao-Ying, Qi-Liang; Kavelaars, Annemieke; Krukowski, Karen; Huo, Xiao-Jiao; Zhou, Wenjun; Price, Theodore J.; Cleeland, Charles; Heijnen, Cobi J.			The Anti-Diabetic Drug Metformin Protects against Chemotherapy-Induced Peripheral Neuropathy in a Mouse Model	PLOS ONE			English	Article							APOLIPOPROTEIN-E; OVARIAN-CANCER; BREAST-CANCER; CORTICAL-NEURONS; NERVE-FIBERS; PAIN; INJURY; CELLS; REGENERATION; ACTIVATION	Chemotherapy-induced peripheral neuropathy (CIPN) characterized by loss of sensory sensitivity and pain in hands and feet is the major dose-limiting toxicity of many chemotherapeutics. At present, there are no FDA-approved treatments for CIPN. The anti-diabetic drug metformin is the most widely used prescription drug in the world and improves glycemic control in diabetes patients. There is some evidence that metformin enhances the efficacy of cancer treatment. The aim of this study was to test the hypothesis that metformin protects against chemotherapy-induced neuropathic pain and sensory deficits. Mice were treated with cisplatin together with metformin or saline. Cisplatin induced increased sensitivity to mechanical stimulation (mechanical allodynia) as measured using the von Frey test. Co-administration of metformin almost completely prevented the cisplatin-induced mechanical allodynia. Co-administration of metformin also prevented paclitaxel-induced mechanical allodynia. The capacity of the mice to detect an adhesive patch on their hind paw was used as a novel indicator of chemotherapy-induced sensory deficits. Co-administration of metformin prevented the cisplatin-induced increase in latency to detect the adhesive patch indicating that metformin prevents sensory deficits as well. Moreover, metformin prevented the reduction in density of intra-epidermal nerve fibers (IENFs) in the paw that develops as a result of cisplatin treatment. We conclude that metformin protects against pain and loss of tactile function in a mouse model of CIPN. The finding that metformin reduces loss of peripheral nerve endings indicates that mechanism underlying the beneficial effects of metformin includes a neuroprotective activity. Because metformin is widely used for treatment of type II diabetes, has a broad safety profile, and is currently being tested as an adjuvant drug in cancer treatment, clinical translation of these findings could be rapidly achieved.	[Mao-Ying, Qi-Liang; Kavelaars, Annemieke; Krukowski, Karen; Huo, Xiao-Jiao; Zhou, Wenjun; Heijnen, Cobi J.] Univ Texas MD Anderson Canc Ctr, Dept Symptom Res, Neuroimmunol Lab, Houston, TX 77030 USA; [Mao-Ying, Qi-Liang] Fudan Univ, Dept Integrat Med & Neurobiol, State Key Lab Med Neurobiol, Sch Basic Med Sci, Shanghai 200433, Peoples R China; [Price, Theodore J.] Univ Texas Dallas, Sch Behav & Brain Sci, Richardson, TX 75083 USA; [Cleeland, Charles] Univ Texas MD Anderson Canc Ctr, Dept Symptom Res, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Fudan University; University of Texas System; University of Texas Dallas; University of Texas System; UTMD Anderson Cancer Center	Heijnen, CJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Symptom Res, Neuroimmunol Lab, Houston, TX 77030 USA.	cjheijnen@mdanderson.org	Zhou, Wenjun/H-2824-2016; Price, Theodore/M-3810-2018	Zhou, Wenjun/0000-0003-4042-4329; Price, Theodore/0000-0002-6971-6221; Zhou, wenjun/0000-0002-8268-0251	National Cancer Institute of the National Institute of Health [PO1 CA124787]; National Institute of Neurological Diseases and Stroke of the National Institute of Health [RO1 NS073939, RO1 NS74999, RO1 NS065926]; National Institute of General Medical Sciences of the National Institute of Health [RO1 GM102575]; United States Pain Relief Committee; STARS award Universtiy of Texas System; NATIONAL CANCER INSTITUTE [P01CA124787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102575] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065926, R01NS074999, R01NS073939] Funding Source: NIH RePORTER	National Cancer Institute of the National Institute of Health; National Institute of Neurological Diseases and Stroke of the National Institute of Health; National Institute of General Medical Sciences of the National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); United States Pain Relief Committee; STARS award Universtiy of Texas System; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Cancer Institute of the National Institute of Health PO1 CA124787 (CC); National Institute of Neurological Diseases and Stroke of the National Institute of Health RO1 NS073939 (AK), RO1 NS74999 (AK), and RO1 NS065926 (TJP); National Institute of General Medical Sciences of the National Institute of Health RO1 GM102575 (TJP); United States Pain Relief Committee (CJH, CC); and STARS award Universtiy of Texas System (AK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouet V, 2009, NAT PROTOC, V4, P1560, DOI 10.1038/nprot.2009.125; Boyette-Davis J, 2011, EXP NEUROL, V229, P353, DOI 10.1016/j.expneurol.2011.02.019; Boyette-Davis J, 2011, PAIN, V152, P308, DOI 10.1016/j.pain.2010.10.030; Buac D, 2013, NEOPLASIA, V15, P1379, DOI 10.1593/neo.131434; Cata JP, 2006, MINERVA ANESTESIOL, V72, P151; Cata JP, 2008, BRAIN RES, V1230, P91, DOI 10.1016/j.brainres.2008.07.022; Cata JP, 2007, J PAIN, V8, P296, DOI 10.1016/j.jpain.2006.09.014; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen GF, 2012, J CLIN ENDOCR METAB, V97, pE510, DOI 10.1210/jc.2011-1754; Cheong JH, 2011, MOL CANCER THER, V10, P2350, DOI 10.1158/1535-7163.MCT-11-0497; Correia S, 2008, MED CHEM, V4, P358, DOI 10.2174/157340608784872299; Cufi S, 2012, ONCOTARGET, V3, P395, DOI 10.18632/oncotarget.488; Dilokthornsakul P, 2013, INT J GYNECOL CANCER, V23, P1544, DOI 10.1097/IGC.0b013e3182a80a21; El-Mir MY, 2008, J MOL NEUROSCI, V34, P77, DOI 10.1007/s12031-007-9002-1; Flatters SJL, 2006, PAIN, V122, P245, DOI 10.1016/j.pain.2006.01.037; Garofalo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083832; HANDELMANN GE, 1992, J LIPID RES, V33, P1677; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hirsch HA, 2013, P NATL ACAD SCI USA, V110, P972, DOI 10.1073/pnas.1221055110; IGNATIUS MJ, 1986, P NATL ACAD SCI USA, V83, P1125, DOI 10.1073/pnas.83.4.1125; IIfH Informatics, 2013, DECLINING MED USE CO; Jiralerspong S, 2009, J CLIN ONCOL, V27, P3297, DOI 10.1200/JCO.2009.19.6410; Kimura Naoko, 2005, Drug Metab Pharmacokinet, V20, P379, DOI 10.2133/dmpk.20.379; Kumar S, 2013, CANCER-AM CANCER SOC, V119, P555, DOI 10.1002/cncr.27706; Lauria G, 2005, J PERIPHER NERV SYST, V10, P202, DOI 10.1111/j.1085-9489.2005.0010210.x; Li FQ, 2010, J PHARMACOL EXP THER, V334, P106, DOI 10.1124/jpet.110.167882; Li J, 2010, STROKE, V41, P2645, DOI 10.1161/STROKEAHA.110.589697; Melemedjian OK, 2013, PAIN, V154, P1080, DOI 10.1016/j.pain.2013.03.021; Melemedjian OK, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-14; Melemedjian OK, 2012, EXP NEUROL, V233, P740, DOI 10.1016/j.expneurol.2011.11.016; Melemedjian OK, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-70; Melemedjian OK, 2013, NEUROSCIENCE LETT; Nolano M, 1999, PAIN, V81, P135, DOI 10.1016/S0304-3959(99)00007-X; Pachman DR, 2011, CLIN PHARMACOL THER, V90, P377, DOI 10.1038/clpt.2011.115; Romero IL, 2012, OBSTET GYNECOL, V119, P61, DOI 10.1097/AOG.0b013e3182393ab3; SCHEEN AJ, 1993, DIABETES METAB, V19, P547; Schuning J, 2009, CLIN J PAIN, V25, P683, DOI 10.1097/AJP.0b013e3181a1260e; Siau C, 2006, EXP NEUROL, V201, P507, DOI 10.1016/j.expneurol.2006.05.007; Sprowl JA, 2013, P NATL ACAD SCI USA, V110, P11199, DOI 10.1073/pnas.1305321110; Ta LE, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-15; Ullah I, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-11; Wang HJ, 2011, PAIN, V152, P1649, DOI 10.1016/j.pain.2011.03.010; Wu JZ, 2004, MED ENG PHYS, V26, P165, DOI 10.1016/j.medengphy.2003.09.004	43	108	112	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100701	10.1371/journal.pone.0100701	http://dx.doi.org/10.1371/journal.pone.0100701			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955774	gold, Green Published, Green Submitted			2022-12-27	WOS:000338917900083
J	Senn, H; Banfield, L; Wacher, T; Newby, J; Rabeil, T; Kaden, J; Kitchener, AC; Abaigar, T; Silva, TL; Maunder, M; Ogden, R				Senn, Helen; Banfield, Lisa; Wacher, Tim; Newby, John; Rabeil, Thomas; Kaden, Jennifer; Kitchener, Andrew C.; Abaigar, Teresa; Silva, Teresa Luisa; Maunder, Mike; Ogden, Rob			Splitting or Lumping? A Conservation Dilemma Exemplified by the Critically Endangered Dama Gazelle (Nanger dama)	PLOS ONE			English	Article							INBREEDING DEPRESSION; GENETIC ADAPTATION; PATTERN; POPULATIONS; SUCCESS; COLOR; REINTRODUCTION; ENVIRONMENTS; BIODIVERSITY; POLYMORPHISM	Managers of threatened species often face the dilemma of whether to keep populations separate to conserve local adaptations and minimize the risk of outbreeding, or whether to manage populations jointly to reduce loss of genetic diversity and minimise inbreeding. In this study we examine genetic relatedness and diversity in three of the five last remaining wild populations of dama gazelle and a number of captive populations, using mtDNA control region and cytochrome b data. Despite the sampled populations belonging to the three putative subspecies, which are delineated according to phenotypes and geographical location, we find limited evidence for phylogeographical structure within the data and no genetic support for the putative subspecies. In the light of these data we discuss the relevance of inbreeding depression, outbreeding depression, adaptive variation, genetic drift, and phenotypic variation to the conservation of the dama gazelle and make some recommendations for its future conservation management. The genetic data suggest that the best conservation approach is to view the dama gazelle as a single species without subspecific divisions.	[Senn, Helen; Kaden, Jennifer; Ogden, Rob] Royal Zool Soc Scotland, WildGenes Lab, Edinburgh, Midlothian, Scotland; [Banfield, Lisa] Al Ain Zoo, Conservat Dept, Al Ain, U Arab Emirates; [Wacher, Tim] Zool Soc London, Conservat Programmes, London, England; [Newby, John] Sahara Conservat Fund, Lisle, Switzerland; [Rabeil, Thomas] Sahara Conservat Fund, Niamey, Niger; [Kitchener, Andrew C.] Natl Museums Scotland, Dept Nat Sci, Edinburgh, Midlothian, Scotland; [Kitchener, Andrew C.] Univ Edinburgh, Sch Geosci, Inst Geog, Edinburgh, Midlothian, Scotland; [Silva, Teresa Luisa] Univ Porto, CIBIO InBIO, Ctr Invest Biodiversidade & Recursos Genet, Vairao, Portugal; [Abaigar, Teresa; Silva, Teresa Luisa] CSIC, Estn Expt Zonas Aridas, Almeria, Spain; [Silva, Teresa Luisa] Univ Porto, Fac Ciencias, Dept Biol, P-4100 Oporto, Portugal; [Maunder, Mike] Florida Int Univ, Coll Arts & Sci, Miami, FL 33199 USA	Zoological Society of London; University of Edinburgh; Universidade do Porto; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental de Zonas Aridas (EEZA); Universidade do Porto; State University System of Florida; Florida International University	Senn, H (corresponding author), Royal Zool Soc Scotland, WildGenes Lab, Edinburgh, Midlothian, Scotland.	hsenn@rzss.org.uk	Silva, Teresa Luísa/AAF-4772-2021; Abaigar, Teresa/R-3582-2019; Silva, Teresa Luísa/L-7902-2013	Silva, Teresa Luísa/0000-0002-6868-7035; Abaigar, Teresa/0000-0001-5177-4143; Silva, Teresa Luísa/0000-0002-6868-7035; Kitchener, Andrew/0000-0003-2594-0827	Al Ain Zoo; Royal Zoological Society of Scotland; Sahara Conservation Fund; Zoological Society of London; Saint Louis Zoo; Addax; Oryx Foundation; FCT-Fundacao para a Ciencia e a Tecnologia [SFRH/BD/73680/2010]	Al Ain Zoo; Royal Zoological Society of Scotland; Sahara Conservation Fund; Zoological Society of London; Saint Louis Zoo; Addax; Oryx Foundation; FCT-Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and Technology)	Funding for genetic analysis was provided by Al Ain Zoo and the Royal Zoological Society of Scotland. The Sahara Conservation Fund, the Zoological Society of London, Saint Louis Zoo, Al Ain Zoo, the Addax and Oryx Foundation, and HH Sheikh Mohammed bin Zayed funded the collection of the dama gazelle samples from the wild. The authors' time during the project was funded by their own institutions and TLS's work was additionally partially supported by FCT-Fundacao para a Ciencia e a Tecnologia (SFRH/BD/73680/2010). Some funders to the project (Al Ain Zoo, Royal Zoological Society of Scotland, Sahara Conservation Fund, Zoological Society of London) were directly involved in the study design, data collection and analysis, decision to publish, and preparation of the manuscript via the participation of their employees in the project. These individuals are authors on this manuscript. The other funders (Saint Louis Zoo, the Addax and Oryx Foundation, FCT-Fundacao para a Ciencia e a Tecnologia and HH Sheikh Mohammed bin Zayed) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaigar T., 1997, International Zoo Yearbook, V35, P311, DOI 10.1111/j.1748-1090.1997.tb01225.x; Abaigar T, 2005, GNUSLETTER, V28, P6; ALADOS CL, 1991, J ZOOL, V223, P307, DOI 10.1111/j.1469-7998.1991.tb04767.x; [Anonymous], 2010, SCF REPORTS; Araki H, 2007, SCIENCE, V318, P100, DOI 10.1126/science.1145621; Bennett E.T., 1833, P ZOOL SOC LOND, P1; Boratynski Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094342; Bradley RD, 2001, J MAMMAL, V82, P960, DOI 10.1644/1545-1542(2001)082<0960:ATOTGS>2.0.CO;2; Brito JC, 2014, BIOL REV, V89, P215, DOI 10.1111/brv.12049; Buffon G-LL, 1764, HIST NATURELLE GEN P, VXII; Cano, 1991, ANTILOPE MOHOR GAZEL; Cano M., 1993, International Zoo Yearbook, V32, P98; Cano Perez M., 1984, Zeitschrift des Koelner Zoo, V27, P103; Christie MR, 2012, P NATL ACAD SCI USA, V109, P238, DOI 10.1073/pnas.1111073109; Cieslak M, 2011, BIOL REV, V86, P885, DOI 10.1111/j.1469-185X.2011.00177.x; Crnokrak P, 1999, HEREDITY, V83, P260, DOI 10.1038/sj.hdy.6885530; Darwin CR, 1876, EFFECTS CROSS SELF F; Devillers P, 2005, CMS TECHNICAL SERIES, V11, P57; Drummond AJ, 2010, GENEIOUS V6 1 4; Durant SM, 2014, DIVERS DISTRIB, V20, P114, DOI 10.1111/ddi.12157; Edmands S, 2007, MOL ECOL, V16, P463, DOI 10.1111/j.1365-294X.2006.03148.x; EFFRON M, 1976, GENETICA, V46, P419, DOI 10.1007/BF00128089; Endler J.A., 1977, Monographs in Population Biology, pi; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fernandez MH, 2005, BIOL REV, V80, P269, DOI 10.1017/S1464793104006670; Frankham R, 2010, HEREDITY, V104, P124, DOI 10.1038/hdy.2009.155; Frankham R, 1995, ANNU REV GENET, V29, P305, DOI 10.1146/annurev.ge.29.120195.001513; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Frankham R, 2008, MOL ECOL, V17, P325, DOI 10.1111/j.1365-294X.2007.03399.x; Frankham R, 2012, BIOL CONSERV, V153, P25, DOI 10.1016/j.biocon.2012.04.034; Frankham R, 2011, CONSERV BIOL, V25, P465, DOI 10.1111/j.1523-1739.2011.01662.x; Gasse F, 2000, QUATERNARY SCI REV, V19, P189, DOI 10.1016/S0277-3791(99)00061-X; Gaubert P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042740; Godinho R, 2012, CONSERV GENET, V13, P1003, DOI 10.1007/s10592-012-0348-8; Gratten J, 2010, HEREDITY, V104, P206, DOI 10.1038/hdy.2009.105; Groves C, 2011, UNGULATE TAXONOMY; Hamilton-Smith CH, 1827, THE CLASS MAMMALIA, P33; Hassanin A, 2012, CR BIOL, V335, P32, DOI 10.1016/j.crvi.2011.11.002; Hedrick PW, 2006, ANNU REV ECOL EVOL S, V37, P67, DOI 10.1146/annurev.ecolsys.37.091305.110132; Hoekstra HE, 2004, EVOLUTION, V58, P1329; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hvilsom C, 2013, HEREDITY, V110, P586, DOI 10.1038/hdy.2013.9; Ibanez B, 2013, ANIM CONSERV, V16, P108, DOI 10.1111/j.1469-1795.2012.00580.x; Ibanez B, 2011, MAMM BIOL, V76, P748, DOI 10.1016/j.mambio.2011.04.002; Iyengar A, 2007, MOL ECOL, V16, P2436, DOI 10.1111/j.1365-294X.2007.03291.x; Jebali A, 2008, THESIS MUSEUM NATURA; Ruiz-Lopez MJ, 2012, CONSERV BIOL, V26, P1121, DOI 10.1111/j.1523-1739.2012.01916.x; Kephart SR, 2004, CONSERV GENET, V5, P49, DOI 10.1023/B:COGE.0000014056.65197.c4; Kingdon J, 2013, MAMMALS AFRICA, VIV; Latta RG, 2008, EVOL APPL, V1, P84, DOI 10.1111/j.1752-4571.2007.00008.x; Lawson DJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002453; Lerp H, 2011, ORG DIVERS EVOL, V11, P317, DOI 10.1007/s13127-011-0057-z; Malbrant R., 1952, FAUNE CTR AFRICAIN F; Mullen LM, 2008, EVOLUTION, V62, P1555, DOI 10.1111/j.1558-5646.2008.00425.x; Mungall C, 2007, EXOTIC ANIMAL FIELD; Nei M., 1987, MOL EVOLUTIONARY GEN; Newby J., 2008, IUCN 2012 IUCN RED L; Newby J. E., 1978, ECOLOGICAL RESOURCES; Newby JE, 1984, SAHARA DESERT; NOMBELA JJA, 1990, Z SAUGETIERKD, V55, P194; Nsubuga AM, 2010, CONSERV GENET, V11, P161, DOI 10.1007/s10592-009-0015-x; Petit RJ, 2009, TRENDS ECOL EVOL, V24, P386, DOI 10.1016/j.tree.2009.02.011; Petric A, 2012, AZA N AM REGIONAL ST; RALLS K, 1983, GENETICS CONSERVATIO; Rietkerk F, 2008, EAZA NEWS, V64, P12; Ronquist F, 2010, ANNU REV ENTOMOL, V55, P189, DOI 10.1146/annurev.ento.54.110807.090529; RZSS & IUCN Antelope Specialist Group, 2014, DAM GAZ NANG DAM CON; Schmutz SM, 2007, ANIM GENET, V38, P539, DOI 10.1111/j.1365-2052.2007.01664.x; Scholte P, 2013, MAMMALS AFRICA, P382; Sgro CM, 2011, EVOL APPL, V4, P326, DOI 10.1111/j.1752-4571.2010.00157.x; Simons ND, 2013, ECOL EVOL, V3, P80, DOI 10.1002/ece3.422; Spottiswoode C, 2004, P ROY SOC B-BIOL SCI, V271, P267, DOI 10.1098/rspb.2003.2605; Stanley-Price M, 1989, ARABIAN ORYX OMAN; Swindell WR, 2005, EVOLUTION, V59, P2159, DOI 10.1111/j.0014-3820.2005.tb00925.x; Valverde JA, 2004, SAHARA GUINEA MARRUE; VASSART M, 1993, ANN GENET-PARIS, V36, P117; VASSART M, 1995, J HERED, V86, P216, DOI 10.1093/oxfordjournals.jhered.a111565; Verma SK, 2003, MOL ECOL NOTES, V3, P28, DOI 10.1046/j.1471-8286.2003.00340.x; Vilas C, 2006, CONSERV BIOL, V20, P229, DOI 10.1111/j.1523-1739.2005.00275.x; Weeks AR, 2011, EVOL APPL, V4, P709, DOI 10.1111/j.1752-4571.2011.00192.x; Wiesner H, 1998, NATURWISSENSCHAFTEN, V85, P553, DOI 10.1007/s001140050549; Witzenberger KA, 2013, MAMM BIOL, V78, P379, DOI 10.1016/j.mambio.2013.03.001; Zachos FE, 2013, MAMM BIOL, V78, P1, DOI 10.1016/j.mambio.2012.07.083	84	21	23	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e98693	10.1371/journal.pone.0098693	http://dx.doi.org/10.1371/journal.pone.0098693			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956104	Green Published, gold, Green Submitted			2022-12-27	WOS:000338917900005
J	Yang, CH; Wang, HL; Lin, YS; Kumar, KPS; Lin, HC; Chang, CJ; Lu, CC; Huang, TT; Martel, J; Ojcius, DM; Chang, YS; Young, JD; Lai, HC				Yang, Chun-Hung; Wang, Hui-Ling; Lin, Yi-Sheng; Kumar, K. P. Shravan; Lin, Hung-Chi; Chang, Chih-Jung; Lu, Chia-Chen; Huang, Tsung-Teng; Martel, Jan; Ojcius, David M.; Chang, Yu-Sun; Young, John D.; Lai, Hsin-Chih			Identification of CD24 as a Cancer Stem Cell Marker in Human Nasopharyngeal Carcinoma (Publication with Expression of Concern. See vol. 14, 2019)	PLOS ONE			English	Article; Publication with Expression of Concern							WNT/BETA-CATENIN PATHWAY; SIDE POPULATION CELLS; OVARIAN-CANCER; MESENCHYMAL TRANSITION; SELF-RENEWAL; BETA-CATENIN; EXPRESSION; OCT4; NANOG; LINES	Cancer stem cells (CSCs) represent a unique sub-population of tumor cells with the ability to initiate tumor growth and sustain self-renewal. Although CSC biomarkers have been described for various tumors, only a few markers have been identified for nasopharyngeal carcinoma (NPC). In this study, we show that CD24(+) cells isolated from human NPC cell lines express stem cell genes (Sox2, Oct4, Nanog, Bmi-1, and Rex-1), and show activation of the Wnt/beta-catenin signaling pathway. CD24(+) cells possess typical CSC characteristics that include enhanced cell proliferation, increased colony and sphere formation, maintenance of cell differentiation potential in prolonged culture, and enhanced resistance to chemotherapeutic drugs. Notably, CD24(+) cells produce tumors following inoculation of as few as 500 cells in immunodeficient NOD/SCID mice. CD24(+) cells further show increased invasion ability in vitro, which correlates with enhanced expression of matrix metalloproteinase 2 and 9. In summary, our results suggest that CD24 represents a novel CSC biomarker in NPC.	[Yang, Chun-Hung; Lin, Hung-Chi] Chang Gung Univ, Coll Med, Grad Inst Biomed Sci, Taoyuan, Taiwan; [Yang, Chun-Hung; Lin, Hung-Chi] Taiwan Agr Chem & Tox Subst Res Inst, Div Appl Toxicol, Council Agr, Taichung, Taiwan; [Wang, Hui-Ling; Lin, Yi-Sheng; Kumar, K. P. Shravan; Chang, Chih-Jung; Huang, Tsung-Teng; Lai, Hsin-Chih] Chang Gung Univ, Coll Med, Dept Med Biotechnol & Lab Sci, Taoyuan, Taiwan; [Wang, Hui-Ling; Lin, Yi-Sheng; Kumar, K. P. Shravan; Chang, Chih-Jung; Huang, Tsung-Teng; Lai, Hsin-Chih] Linkou Chang Gung Mem Hosp, Dept Lab Med, Taoyuan, Taiwan; [Chang, Chih-Jung] Chang Gung Univ, Coll Med, Dept Microbiol & Immunol, Taoyuan, Taiwan; [Lu, Chia-Chen] Fu Jen Catholic Univ, Dept Resp Therapy, Taipei, Taiwan; [Huang, Tsung-Teng; Martel, Jan; Ojcius, David M.; Young, John D.; Lai, Hsin-Chih] Chang Gung Univ, Coll Med, Ctr Mol & Clin Immunol, Taoyuan, Taiwan; [Huang, Tsung-Teng; Lai, Hsin-Chih] Chang Gung Univ, Coll Med, Res Ctr Bacterial Pathogenesis, Taoyuan, Taiwan; [Ojcius, David M.] Univ Calif Merced, Dept Mol Cell Biol, Merced, CA USA; [Ojcius, David M.] Univ Calif Merced, Hlth Sci Res Inst, Merced, CA USA; [Chang, Yu-Sun] Chang Gung Univ, Coll Med, Mol Med Res Ctr, Taoyuan, Taiwan; [Young, John D.] Rockefeller Univ, Lab Cellular Physiol & Immunol, New York, NY 10021 USA; [Young, John D.] Ming Chi Univ Technol, Biochem Engn Res Ctr, Taipei, Taiwan	Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Fu Jen Catholic University; Chang Gung University; Chang Gung University; University of California System; University of California Merced; University of California System; University of California Merced; Chang Gung University; Rockefeller University; Ming Chi University of Technology	Young, JD (corresponding author), Chang Gung Univ, Coll Med, Ctr Mol & Clin Immunol, Taoyuan, Taiwan.	dingeyoung@hotmail.com; hclai@mail.cgu.edu.tw	Ojcius, David/ABE-6557-2020	LAI, HSIN-CHIH/0000-0002-0605-5040; Martel, Jan/0000-0003-0879-109X; Chang, Yu-Sun/0000-0002-6457-3890; Ojcius, David/0000-0003-1461-4495	National Science Council of Taiwan [NSC101-2325-B-182-005, NSC101-2320-B-030-011]; Chang Gung Memorial Hospital (Linkou, Taiwan) [CMRPD1B0052]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital (Linkou, Taiwan)(Chang Gung Memorial Hospital)	This study was supported by grants NSC101-2325-B-182-005 and NSC101-2320-B-030-011 from the National Science Council of Taiwan, and grant CMRPD1B0052 from Chang Gung Memorial Hospital (Linkou, Taiwan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Aigner S, 1998, FASEB J, V12, P1241, DOI 10.1096/fasebj.12.12.1241; [Anonymous], 2010, CANCER REGISTRY ANNU; Assimakopoulos D, 2002, HISTOL HISTOPATHOL, V17, P1269, DOI 10.14670/HH-17.1269; Atlasi Y, 2007, INT J CANCER, V120, P1598, DOI 10.1002/ijc.22508; Ben-Shushan E, 1998, MOL CELL BIOL, V18, P1866, DOI 10.1128/MCB.18.4.1866; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Cai C, 2012, MOL MED REP, V5, P1191, DOI 10.3892/mmr.2012.802; Campbell PA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000553; Cao Su-Mei, 2011, Chin J Cancer, V30, P114; Cavard C, 2008, FUTURE ONCOL, V4, P647, DOI 10.2217/14796694.4.5.647; Chang JTC, 2004, J FORMOS MED ASSOC, V103, P496; Chu WK, 2013, CARCINOGENESIS, V34, P1497, DOI 10.1093/carcin/bgt104; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Correa S, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-303; Damsky WE, 2011, CANCER CELL, V20, P741, DOI 10.1016/j.ccr.2011.10.030; DeNittis AS, 2002, AM J CLIN ONCOL-CANC, V25, P93, DOI 10.1097/00000421-200202000-00020; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Eduardo B, 2010, EUR ARCH OTO-RHINO-L, V267, P1607, DOI 10.1007/s00405-010-1258-3; Facchino Sabrina, 2011, Cancers (Basel), V3, P1777, DOI 10.3390/cancers3021777; Gao MQ, 2010, ONCOGENE, V29, P2672, DOI 10.1038/onc.2010.35; Greenspan EJ, 2011, CANCER PREV RES, V4, P161, DOI 10.1158/1940-6207.CAPR-10-0021; Griend DJV, 2008, CANCER RES, V68, P9703, DOI 10.1158/0008-5472.CAN-08-3084; Guo D, 2012, ONCOL REP, V28, P241, DOI 10.3892/or.2012.1781; Guo Y, 2011, HISTOPATHOLOGY, V59, P763, DOI 10.1111/j.1365-2559.2011.03993.x; Haraguchi N, 2006, STEM CELLS, V24, P506, DOI 10.1634/stemcells.2005-0282; Herzig M, 2007, ONCOGENE, V26, P2290, DOI 10.1038/sj.onc.1210029; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Hollier BG, 2009, J MAMMARY GLAND BIOL, V14, P29, DOI 10.1007/s10911-009-9110-3; Hou WJ, 2014, EUR ARCH OTO-RHINO-L, V271, P171, DOI 10.1007/s00405-013-2517-x; Kim JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007166; Kim M, 2002, CLIN CANCER RES, V8, P22; Lanzkron SM, 1999, BLOOD, V93, P1916, DOI 10.1182/blood.V93.6.1916.406k15_1916_1921; Larue L, 2006, FRONT BIOSCI-LANDMRK, V11, P733, DOI 10.2741/1831; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Liu AY, 2000, CANCER RES, V60, P3429; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Lu J, 2003, CANCER RES, V63, P256; Luo WR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056324; Mlarotta LLC, 2009, CURR OPIN GENET DEV, V19, P44, DOI 10.1016/j.gde.2008.12.003; Moriyama T, 2010, CANCER-AM CANCER SOC, V116, P3357, DOI 10.1002/cncr.25121; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Prosperi JR, 2010, CURR DRUG TARGETS, V11, P1074; Rattis FM, 2004, CURR OPIN HEMATOL, V11, P88, DOI 10.1097/01.moh.0000133649.61121.ec; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricardo S, 2011, J CLIN PATHOL, V64, P937, DOI 10.1136/jcp.2011.090456; Song LB, 2009, J CLIN INVEST, V119, P3626, DOI 10.1172/JCI39374; Su J, 2011, ARCH MED RES, V42, P15, DOI 10.1016/j.arcmed.2011.01.007; Suarez C, 2010, EUR ARCH OTO-RHINO-L, V267, P1811, DOI 10.1007/s00405-010-1385-x; Tang DG, 2012, CELL RES, V22, P457, DOI 10.1038/cr.2012.13; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Wang J, 2007, CANCER RES, V67, P3716, DOI 10.1158/0008-5472.CAN-06-4343; Wang S, 2013, FRONT BIOSCI-LANDMRK, V18, P447, DOI 10.2741/4113; Wang WJ, 2013, CANCER RES, V73, P1219, DOI 10.1158/0008-5472.CAN-12-1408; Wei XL, 2010, P NATL ACAD SCI USA, V107, P18874, DOI 10.1073/pnas.1012667107; Yang ZF, 2008, CANCER CELL, V13, P153, DOI 10.1016/j.ccr.2008.01.013; Yi F, 2011, NAT CELL BIOL, V13, P762, DOI 10.1038/ncb2283; Yong VW, 2001, NAT REV NEUROSCI, V2, P502, DOI 10.1038/35081571; Zhang Jian-Ting, 2007, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V32, P531; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364; ZHANG XG, 1994, BLOOD, V83, P3654; Zhou G, 2007, HUM MUTAT, V28, P1091, DOI 10.1002/humu.20570	65	40	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e99412	10.1371/journal.pone.0099412	http://dx.doi.org/10.1371/journal.pone.0099412			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955581	gold, Green Published, Green Submitted			2022-12-27	WOS:000338917900010
J	Zander, KK; Ainsworth, GB; Meyerhoff, J; Garnett, ST				Zander, Kerstin K.; Ainsworth, Gillian B.; Meyerhoff, Juergen; Garnett, Stephen T.			Threatened Bird Valuation in Australia	PLOS ONE			English	Article							WILLINGNESS-TO-PAY; CONTINGENT VALUATION; BIODIVERSITY CONSERVATION; ENVIRONMENTAL ATTITUDES; ECONOMIC VALUE; SERVICES; MOTIVATIONS; KNOWLEDGE; ECOSYSTEM; BENEFITS	Threatened species programs need a social license to justify public funding. A contingent valuation survey of a broadly representative sample of the Australian public found that almost two thirds (63%) supported funding of threatened bird conservation. These included 45% of a sample of 645 respondents willing to pay into a fund for threatened bird conservation, 3% who already supported bird conservation in another form, and 15% who could not afford to pay into a conservation fund but who nevertheless thought that humans have a moral obligation to protect threatened birds. Only 6% explicitly opposed such payments. Respondents were willing to pay about AUD 11 annually into a conservation fund (median value), including those who would pay nothing. Highest values were offered by young or middle aged men, and those with knowledge of birds and those with an emotional response to encountering an endangered bird. However, the prospect of a bird going extinct alarmed almost everybody, even most of those inclined to put the interests of people ahead of birds and those who resent the way threatened species sometimes hold up development. The results suggest that funding for threatened birds has widespread popular support among the Australian population. Conservatively they would be willing to pay about AUD 14 million per year, and realistically about AUD 70 million, which is substantially more than the AUD 10 million currently thought to be required to prevent Australian bird extinctions.	[Zander, Kerstin K.] Charles Darwin Univ, Northern Inst, Darwin, NT 0909, Australia; [Ainsworth, Gillian B.; Garnett, Stephen T.] Charles Darwin Univ, Res Inst Environm & Livelihoods, Darwin, NT 0909, Australia; [Meyerhoff, Juergen] Tech Univ Berlin, Inst Landscape Architecture & Environm Planning, Berlin, Germany	Charles Darwin University; Charles Darwin University; Technical University of Berlin	Zander, KK (corresponding author), Charles Darwin Univ, Northern Inst, Darwin, NT 0909, Australia.	kerstin.zander@cdu.edu.au	Meyerhoff, Juergen/M-5640-2019; Ainsworth, Gill/P-3013-2019; Zander, Kerstin/M-2888-2013	Meyerhoff, Juergen/0000-0003-4333-8514; Ainsworth, Gill/0000-0003-0460-6563; Zander, Kerstin/0000-0002-2237-1801	Australian Research Council [LP0990395, DP09875528]; BLA Stuart Leslie Bird Research Award	Australian Research Council(Australian Research Council); BLA Stuart Leslie Bird Research Award	The research was undertaken under the aegis of Australian Research Council Linkage Grant LP0990395 and also benefited from Australian Research Council Discovery Grant DP09875528. The survey was funded by the BLA Stuart Leslie Bird Research Award 2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Australian Bureau of Statistics (ABS), 2012, CENS POP HOUS 2011 C; Baker Rick, 2014, ENV POLICY ANAL GUID; Balmford A, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000144; BATEMAN I., 2002, EC VALUATION STATED; BirdLife Australia, 2013, VOL; BirdLife Australia, 2011, ANN REP 2011 BIRDLIF; Booth JE, 2011, BIOL CONSERV, V144, P2728, DOI 10.1016/j.biocon.2011.02.018; BOWKER JM, 1988, AM J AGR ECON, V70, P372, DOI 10.2307/1242078; Brouwer R, 2008, ECOL ECON, V64, P575, DOI 10.1016/j.ecolecon.2007.04.001; Bulte EH, 1999, ENVIRON RESOUR ECON, V14, P119, DOI 10.1023/A:1008309816658; CARSON RT, 1994, OXFORD ECON PAP, V46, P727, DOI 10.1093/oep/46.Supplement_1.727; Carson RT, 2005, HANDB ECON, V20, P821; Child D, 2006, ESSENTIALS FACTOR AN, V3rd; Daily GC, 2000, SCIENCE, V289, P395, DOI 10.1126/science.289.5478.395; Edwards P. E. T., 2011, Human Dimensions of Wildlife, V16, P435, DOI 10.1080/10871209.2011.608180; Fleming CM, 2009, J ENVIRON MANAGE, V90, P284, DOI 10.1016/j.jenvman.2007.09.011; Garnett S, 2003, BIOSCIENCE, V53, P658, DOI 10.1641/0006-3568(2003)053[0658:TCAEOF]2.0.CO;2; Garnett S. T., 2011, ACTION PLAN AUSTR BI; Gascoigne WR, 2011, ECOL ECON, V70, P1715, DOI 10.1016/j.ecolecon.2011.04.010; Haab T. C., 2002, VALUING ENV NATURAL; Hanemann W, 1999, VALUING ENV PREFEREN, P302; HANEMANN WM, 1984, AM J AGR ECON, V66, P332, DOI 10.2307/1240800; Heffelfinger James R., 2013, International Journal of Environmental Studies, V70, P399, DOI 10.1080/00207233.2013.800383; Hvenegaard Glen T., 2002, Human Dimensions of Wildlife, V7, P21, DOI 10.1080/108712002753574765; Hynes S, 2009, BIOL CONSERV, V142, P180, DOI 10.1016/j.biocon.2008.10.014; Jakobsson KM, 2001, ENVIRON RESOUR ECON, V19, P211, DOI 10.1023/A:1011128620388; Jeanty PW, 2007, N AM STAT US GROUP M, P8; Jin JJ, 2008, ECOL ECON, V68, P328, DOI 10.1016/j.ecolecon.2008.03.014; Johnson MD, 2010, ANIM CONSERV, V13, P140, DOI 10.1111/j.1469-1795.2009.00310.x; Kellert S.R., 1986, P50; Kotchen MJ, 2000, ECOL ECON, V32, P93, DOI 10.1016/S0921-8009(99)00069-5; KRINSKY I, 1986, REV ECON STAT, V68, P715, DOI 10.2307/1924536; Langford IH, 1998, ENVIRON RESOUR ECON, V12, P443, DOI 10.1023/A:1008286001085; Likert R., 1932, ARCH PSYCHOL, V140, P1, DOI DOI 10.1111/J.1540-5834.2010.00585.X; Lindhjem H, 2011, ECOL ECON, V70, P1628, DOI 10.1016/j.ecolecon.2011.04.002; Loehlin JC, 2004, LATENT VARIABLE MODE; Loomis J, 1998, ECOL ECON, V27, P29, DOI 10.1016/S0921-8009(97)00126-2; Loomis JB, 1996, ECOL ECON, V18, P197, DOI 10.1016/0921-8009(96)00029-8; Loureiro ML, 2008, ECOL ECON, V68, P362, DOI 10.1016/j.ecolecon.2008.04.002; Martin-Lopez B, 2008, CONSERV BIOL, V22, P624, DOI 10.1111/j.1523-1739.2008.00921.x; McCarthy DP, 2012, SCIENCE, V338, P946, DOI 10.1126/science.1229803; McCarthy MA, 2008, J APPL ECOL, V45, P1428, DOI 10.1111/j.1365-2664.2008.01521.x; MCFARLANE BL, 1994, WILDLIFE SOC B, V22, P361; Meyerhoff J, 2006, ECOL ECON, V57, P583, DOI 10.1016/j.ecolecon.2005.04.021; Meyerhoff J, 2012, ENVIRON SCI POLICY, V23, P109, DOI 10.1016/j.envsci.2012.07.020; Millennium Ecosystem Assessment (MA), 2005, EC HUM WELLB ASS SER; Mitchell Robert Cameron, 1989, USING SURVEY VALUE P; Morrison MD, 2000, ENVIRON RESOUR ECON, V16, P407, DOI 10.1023/A:1008368611972; Ojea E, ECOL EC, V63, P807; Olsen SB, 2009, ENVIRON RESOUR ECON, V44, P591, DOI 10.1007/s10640-009-9303-7; Possingham HP, 2013, SUBMISSION SENATE CO; Prescott-Allen C., 1986, 1 RESOURCE WILD SPEC; RUBIN J, 1991, J FOREST, V89, P25; Sax LJ, 2003, RES HIGH EDUC, V44, P409, DOI 10.1023/A:1024232915870; Sekercioglu CH, 2002, ENVIRON CONSERV, V29, P282, DOI 10.1017/S0376892902000206; Smith VK, 2006, HANDBOOK ON CONTINGENT VALUATION, P7; Spash CL, 2000, ENVIRON SCI TECHNOL, V34, P1433, DOI 10.1021/es990729b; Wenny DG, 2011, AUK, V128, P1, DOI 10.1525/auk.2011.10248; Wilson C, 2005, BIRD CONSERV INT, V15, P225, DOI 10.1017/S0959270905000419; Wilson C, 2007, CONTEMP ECON POLICY, V25, P226, DOI 10.1111/j.1465-7287.2006.00021.x; Wray-Lake L, 2010, ENVIRON BEHAV, V42, P61, DOI 10.1177/0013916509335163; Zander KK, 2014, CONSERV SOC, V12, P27, DOI 10.4103/0972-4923.132126; Zander KK, 2013, ECOL ECON, V93, P219, DOI 10.1016/j.ecolecon.2013.06.002	63	24	25	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100411	10.1371/journal.pone.0100411	http://dx.doi.org/10.1371/journal.pone.0100411			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL1WV	24955957	gold, Green Submitted, Green Published			2022-12-27	WOS:000338917900049
J	Delgado, AG; Kang, DW; Nelson, KG; Fajardo-Williams, D; Miceli, JF; Done, HY; Popat, SC; Krajmalnik-Brown, R				Delgado, Anca G.; Kang, Dae-Wook; Nelson, Katherine G.; Fajardo-Williams, Devyn; Miceli, Joseph F., III; Done, Hansa Y.; Popat, Sudeep C.; Krajmalnik-Brown, Rosa			Selective Enrichment Yields Robust Ethene-Producing Dechlorinating Cultures from Microcosms Stalled at cis-Dichloroethene	PLOS ONE			English	Article							REDUCTIVE DEHALOGENASE GENES; DEHALOCOCCOIDES SP STRAIN; 16S RIBOSOMAL-RNA; POLYMERASE-CHAIN-REACTION; VINYL-CHLORIDE REDUCTASE; MICROBIAL COMMUNITY; CONTAMINATED GROUNDWATER; MOLECULAR TECHNIQUES; BACTERIAL COMMUNITY; ELECTRON-ACCEPTORS	Dehalococcoides mccartyi strains are of particular importance for bioremediation due to their unique capability of transforming perchloroethene (PCE) and trichloroethene (TCE) to non-toxic ethene, through the intermediates cis-dichloroethene (cis-DCE) and vinyl chloride (VC). Despite the widespread environmental distribution of Dehalococcoides, biostimulation sometimes fails to promote dechlorination beyond cis-DCE. In our study, microcosms established with garden soil and mangrove sediment also stalled at cis-DCE, albeit Dehalococcoides mccartyi containing the reductive dehalogenase genes tceA, vcrA and bvcA were detected in the soil/sediment inocula. Reductive dechlorination was not promoted beyond cis-DCE, even after multiple biostimulation events with fermentable substrates and a lengthy incubation. However, transfers from microcosms stalled at cis-DCE yielded dechlorination to ethene with subsequent enrichment cultures containing up to 10(9) Dehalococcoides mccartyi cells mL(-1). Proteobacterial classes which dominated the soil/sediment communities became undetectable in the enrichments, and methanogenic activity drastically decreased after the transfers. We hypothesized that biostimulation of Dehalococcoides in the cis-DCE-stalled microcosms was impeded by other microbes present at higher abundances than Dehalococcoides and utilizing terminal electron acceptors from the soil/sediment, hence, outcompeting Dehalococcoides for H-2. In support of this hypothesis, we show that garden soil and mangrove sediment microcosms bioaugmented with their respective cultures containing Dehalococcoides in high abundance were able to compete for H2 for reductive dechlorination from one biostimulation event and produced ethene with no obvious stall. Overall, our results provide an alternate explanation to consolidate conflicting observations on the ubiquity of Dehalococcoides mccartyi and occasional stalling of dechlorination at cis-DCE; thus, bringing a new perspective to better assess biological potential of different environments and to understand microbial interactions governing bioremediation.	[Delgado, Anca G.; Kang, Dae-Wook; Nelson, Katherine G.; Fajardo-Williams, Devyn; Miceli, Joseph F., III; Done, Hansa Y.; Popat, Sudeep C.; Krajmalnik-Brown, Rosa] Arizona State Univ, Biodesign Inst, Swette Ctr Environm Biotechnol, Tempe, AZ 85287 USA; [Krajmalnik-Brown, Rosa] Arizona State Univ, Sch Sustainable Engn & Built Environm, Tempe, AZ USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Krajmalnik-Brown, R (corresponding author), Arizona State Univ, Biodesign Inst, Swette Ctr Environm Biotechnol, Tempe, AZ 85287 USA.	Dr.Rosy@asu.edu	Krajmalnik-Brown, Rosa/AAA-4803-2021; Kang, Dae-Wook/AAP-3589-2020; Delgado, Anca G/K-1924-2012	Kang, Dae-Wook/0000-0002-2585-1974; Magee, Hansa Y./0000-0001-5746-0823; Delgado, Anca/0000-0002-9354-0246; Krajmalnik-Brown, Rosa/0000-0001-6064-3524	National Science Foundation (NSF) CAREER Award [1053939]; Directorate For Engineering [1053939] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM099650] Funding Source: NIH RePORTER	National Science Foundation (NSF) CAREER Award(National Science Foundation (NSF)NSF - Office of the Director (OD)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Science Foundation (NSF) CAREER Award number 1053939. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian L, 2000, NATURE, V408, P580, DOI 10.1038/35046063; Adrian L, 2007, ENVIRON SCI TECHNOL, V41, P2318, DOI 10.1021/es062076m; Aulenta F, 2008, PROCESS BIOCHEM, V43, P161, DOI 10.1016/j.procbio.2007.11.006; Aulenta F, 2007, WATER RES, V41, P27, DOI 10.1016/j.watres.2006.09.019; Aziz CE, 2013, SERDP ESTCP REMEDIAT, P141, DOI 10.1007/978-1-4614-4115-1_5; Azizian MF, 2008, J CONTAM HYDROL, V100, P11, DOI 10.1016/j.jconhyd.2008.04.006; Badalamenti JP, 2013, BIOTECHNOL BIOENG, V110, P1020, DOI 10.1002/bit.24779; Berggren DRV, 2013, ENVIRON SCI TECHNOL, V47, P1879, DOI 10.1021/es304244z; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Cupples AM, 2003, APPL ENVIRON MICROB, V69, P953, DOI 10.1128/AEM.69.2.953-959.2003; Delgado AG, 2014, APPL MICROBIOL BIOT, V98, P2729, DOI 10.1007/s00253-013-5263-5; Delgado AG, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-128; DISTEFANO TD, 1991, APPL ENVIRON MICROB, V57, P2287, DOI 10.1128/AEM.57.8.2287-2292.1991; Duhamel M, 2002, WATER RES, V36, P4193, DOI 10.1016/S0043-1354(02)00151-3; Ekre R, 2014, GROUND WATER MONIT R, V34, P61, DOI 10.1111/gwmr.12049; Ellis DE, 2000, ENVIRON SCI TECHNOL, V34, P2254, DOI 10.1021/es990638e; Fennell DE, 1998, ENVIRON SCI TECHNOL, V32, P2450, DOI 10.1021/es980136l; Fennell DE, 1997, ENVIRON SCI TECHNOL, V31, P918, DOI 10.1021/es960756r; Fennell DE, 2001, ENVIRON SCI TECHNOL, V35, P1830, DOI 10.1021/es0016203; Futagami T, 2009, APPL ENVIRON MICROB, V75, P6905, DOI 10.1128/AEM.01124-09; Hansel CM, 2008, APPL ENVIRON MICROB, V74, P1620, DOI 10.1128/AEM.01787-07; Harkness MR, 1999, ENVIRON SCI TECHNOL, V33, P1100, DOI 10.1021/es9807690; He J, 2005, ENVIRON MICROBIOL, V7, P1442, DOI 10.1111/j.1462-2920.2005.00830.x; He JZ, 2003, NATURE, V424, P62, DOI 10.1038/nature01717; Holmes VF, 2006, APPL ENVIRON MICROB, V72, P5877, DOI 10.1128/AEM.00516-06; Hug LA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0322; Kang DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068322; Kittelmann S, 2008, ENVIRON MICROBIOL, V10, P31, DOI 10.1111/j.1462-2920.2007.01427.x; Kotsyurbenko OR, 2001, FEMS MICROBIOL ECOL, V38, P153, DOI 10.1111/j.1574-6941.2001.tb00893.x; Krajmalnik-Brown R, 2004, APPL ENVIRON MICROB, V70, P6347, DOI 10.1128/AEM.70.10.6347-6351.2004; Krzmarzick MJ, 2012, APPL ENVIRON MICROB, V78, P393, DOI 10.1128/AEM.06510-11; Lendvay JM, 2003, ENVIRON SCI TECHNOL, V37, P1422, DOI 10.1021/es025985u; Loffler FE, 2013, INT J SYST EVOL MICR, V63, P625, DOI 10.1099/ijs.0.034926-0; Loffler FE, 2005, METHOD ENZYMOL, V397, P77, DOI 10.1016/S0076-6879(05)97005-5; Loffler FE, 2000, APPL ENVIRON MICROB, V66, P1369, DOI 10.1128/AEM.66.4.1369-1374.2000; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Magnuson JK, 2000, APPL ENVIRON MICROB, V66, P5141, DOI 10.1128/AEM.66.12.5141-5147.2000; Major DW, 2002, ENVIRON SCI TECHNOL, V36, P5106, DOI 10.1021/es0255711; May HD, 2008, APPL ENVIRON MICROB, V74, P2089, DOI 10.1128/AEM.01450-07; MaymoGatell X, 1997, SCIENCE, V276, P1568, DOI 10.1126/science.276.5318.1568; Miceli JF, 2012, ENVIRON SCI TECHNOL, V46, P10349, DOI 10.1021/es301902h; Moe WM, 2009, INT J SYST EVOL MICR, V59, P2692, DOI 10.1099/ijs.0.011502-0; Muller JA, 2004, APPL ENVIRON MICROB, V70, P4880, DOI 10.1128/AEM.70.8.4880-4888.2004; Ontiveros-Valencia A, 2013, FEMS MICROBIOL ECOL, V85, P158, DOI 10.1111/1574-6941.12107; Parameswaran P, 2011, BIORESOURCE TECHNOL, V102, P263, DOI 10.1016/j.biortech.2010.03.133; Parameswaran P, 2010, BIOTECHNOL BIOENG, V105, P69, DOI 10.1002/bit.22508; Richardson RE, 2002, ENVIRON SCI TECHNOL, V36, P2652, DOI 10.1021/es0157797; Ritalahti KM, 2006, APPL ENVIRON MICROB, V72, P2765, DOI 10.1128/AEM.72.4.2765-2774.2006; Schaefer CE, 2009, CHEMOSPHERE, V75, P141, DOI 10.1016/j.chemosphere.2008.12.041; Shani N, 2013, ENVIRON SCI TECHNOL, V47, P6836, DOI 10.1021/es304017s; Sleep BE, 2006, ENVIRON SCI TECHNOL, V40, P3623, DOI 10.1021/es051493g; Smatlak CR, 1996, ENVIRON SCI TECHNOL, V30, P2850, DOI 10.1021/es9602455; Stroo HF, 2013, SERDP ESTCP REMEDIAT, P117, DOI 10.1007/978-1-4614-4115-1_4; Sung Y, 2006, APPL ENVIRON MICROB, V72, P2775, DOI 10.1128/AEM.72.4.2775-2782.2006; Tas N, 2010, MICROB BIOTECHNOL, V3, P389, DOI 10.1111/j.1751-7915.2009.00147.x; Vainberg S, 2009, J IND MICROBIOL BIOT, V36, P1189, DOI 10.1007/s10295-009-0600-5; van der Zaan B, 2010, APPL ENVIRON MICROB, V76, P843, DOI 10.1128/AEM.01482-09; Van Trump JI, 2011, MBIO, V2, DOI 10.1128/mBio.00044-11; Wang SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059178; Wolcott RD, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-226; Yang YR, 1998, ENVIRON SCI TECHNOL, V32, P3591, DOI 10.1021/es980363n; Yu SH, 2005, ENVIRON SCI TECHNOL, V39, P195, DOI 10.1021/es0496773; Yu Y, 2005, BIOTECHNOL BIOENG, V89, P670, DOI 10.1002/bit.20347; Ziv-El M, 2012, BIOTECHNOL BIOENG, V109, P2230, DOI 10.1002/bit.24504; Ziv-El M, 2012, BIOTECHNOL BIOENG, V109, P2200, DOI 10.1002/bit.24487; Ziv-El M, 2012, APPL MICROBIOL BIOT, V95, P273, DOI 10.1007/s00253-012-4161-6; Ziv-El M, 2011, APPL MICROBIOL BIOT, V92, P1063, DOI 10.1007/s00253-011-3388-y	68	25	28	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100654	10.1371/journal.pone.0100654	http://dx.doi.org/10.1371/journal.pone.0100654			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950250	Green Published, Green Submitted, gold			2022-12-27	WOS:000338276300103
J	Gonzalez, AD; Matta, NE; Ellis, VA; Miller, ET; Ricklefs, RE; Gutierrez, HR				Gonzalez, Angie D.; Matta, Nubia E.; Ellis, Vincenzo A.; Miller, Eliot T.; Ricklefs, Robert E.; Rafael Gutierrez, H.			Mixed Species Flock, Nest Height, and Elevation Partially Explain Avian Haemoparasite Prevalence in Colombia	PLOS ONE			English	Article							BLOOD PARASITES; COSTA-RICA; EMBRYONIC-DEVELOPMENT; NEOTROPICAL SAVANNA; PHYLOGENETIC SIGNAL; MALARIA PARASITES; GEOGRAPHIC RANGE; PASSERINE BIRDS; CLIFF SWALLOW; DISEASE RISK	The high avian biodiversity present in the Neotropical region offers a great opportunity to explore the ecology of host-parasite relationships. We present a survey of avian haemoparasites in a megadiverse country and explore how parasite prevalences are related to physical and ecological host characteristics. Using light microscopy, we documented the presence of haemoparasites in over 2000 individuals belonging to 246 species of wild birds, from nine localities and several ecosystems of Colombia. We analysed the prevalence of six avian haemoparasite taxa in relation to elevation and the following host traits: nest height, nest type, foraging strata, primary diet, sociality, migratory behaviour, and participation in mixed species flocks. Our analyses indicate significant associations between both mixed species flocks and nest height and Haemoproteus and Leucocytozoon prevalence. The prevalence of Leucocytozoon increased with elevation, whereas the prevalence of Trypanosoma and microfilariae decreased. Plasmodium and Haemoproteus prevalence did not vary significantly with elevation; in fact, both parasites were found up to 3300m above sea level. The distribution of parasite prevalence across the phylogeny of bird species included in this study showed little host phylogenetic signal indicating that infection rates in this system are evolutionarily labile. Vector distribution as well as the biology of transmission and the maintenance of populations of avian haemoparasites deserve more detailed study in this system.	[Gonzalez, Angie D.; Matta, Nubia E.; Rafael Gutierrez, H.] Univ Nacl Colombia, Dept Biol, Bogota, Colombia; [Ellis, Vincenzo A.; Miller, Eliot T.; Ricklefs, Robert E.] Univ Missouri, Dept Biol, St Louis, MO 63121 USA	Universidad Nacional de Colombia; University of Missouri System; University of Missouri Saint Louis	Gonzalez, AD (corresponding author), Univ Nacl Colombia, Dept Biol, Bogota, Colombia.	adgonzalezg@unal.edu.co	Matta, Nubia E/G-3621-2011	Matta, Nubia E/0000-0003-1775-0804	Departamento Administrativo de Ciencia, Tecnologia e Innovacion COLCIENCIAS [359]; Division de Investigacion Sede Bogota of the Universidad Nacional de Colombia [7509, 14456]; Jardin Botanico Jose Celestino Mutis Bogota; program Estimulos a la investigacion Thomas van der Hammen	Departamento Administrativo de Ciencia, Tecnologia e Innovacion COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Division de Investigacion Sede Bogota of the Universidad Nacional de Colombia; Jardin Botanico Jose Celestino Mutis Bogota; program Estimulos a la investigacion Thomas van der Hammen	This work was partially supported by Departamento Administrativo de Ciencia, Tecnologia e Innovacion COLCIENCIAS contract no. 359, Division de Investigacion Sede Bogota of the Universidad Nacional de Colombia project no. 7509 and no. 14456, and Jardin Botanico Jose Celestino Mutis Bogota with the program Estimulos a la investigacion Thomas van der Hammen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbelaez-Cortes E, 2011, REV MEX BIODIVERS, V82, P639; BASTO NATALIA, 2006, Caldasia, V28, P371; Benedikt V, 2009, ACTA PARASITOL, V54, P197, DOI 10.2478/s11686-009-0043-1; Bennett G. F., 1980, Memorias do Instituto Oswaldo Cruz, Brazil, V75, P117; BENNETT G F, 1976, Journal of Wildlife Diseases, V12, P454; BENNETT GF, 1992, CAN J ZOOL, V70, P188, DOI 10.1139/z92-028; BENNETT GF, 1991, J PARASITOL, V77, P207, DOI 10.2307/3283083; Berkunsky I, 2005, ORNITOL NEOTROP, V16, P573; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Buckland ST, 1997, BIOMETRICS, V53, P603, DOI 10.2307/2533961; Buehler DM, 2008, PHILOS T R SOC B, V363, P247, DOI 10.1098/rstb.2007.2138; Butler MA, 2004, AM NAT, V164, P683, DOI 10.1086/426002; Calcagano V, 2013, GLMULTIMODEL SELECTI; Cerny O, 2011, MED VET ENTOMOL, V25, P104, DOI 10.1111/j.1365-2915.2010.00875.x; Cooper N, 2010, J EVOLUTION BIOL, V23, P2529, DOI 10.1111/j.1420-9101.2010.02144.x; Ellis TM, 2004, AVIAN PATHOL, V33, P405, DOI 10.1080/03079450410001724012; Fecchio A, 2013, PARASITOLOGY, V140, P181, DOI 10.1017/S0031182012001412; Fecchio A, 2011, EMU, V111, P132, DOI 10.1071/MU10063; Fecchio Alan, 2007, Neotropical Biology and Conservation, V2, P127; Felsenstein J, 2008, AM NAT, V171, P713, DOI 10.1086/587525; FOSTER WA, 1968, J MED ENTOMOL, V5, P488, DOI 10.1093/jmedent/5.4.488; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; GABALDON A., 1974, Boletin de la Direccion de Malariologia y Saneamiento Ambiental, V14, P80; Gabaldon A., 1975, Boletin de la Direccion de Malariologia y Saneamiento Ambiental, V15, P73; Garvin MC, 2003, J WILDLIFE DIS, V39, P170, DOI 10.7589/0090-3558-39.1.170; GREGORY RD, 1990, FUNCT ECOL, V4, P645, DOI 10.2307/2389732; GREINER EC, 1975, CAN J ZOOL, V53, P1762, DOI 10.1139/z75-211; Hansen TF, 2012, SYST BIOL, V61, P413, DOI 10.1093/sysbio/syr122; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Harmon LJ, 2010, EVOLUTION, V64, P2385, DOI 10.1111/j.1558-5646.2010.01025.x; Hilty SL, 1986, GUIDE BIRDS COLOMBIA; Instituto Humboldt Colombia, 2013, COL WORLD DIV SPEC C; Ives AR, 2007, SYST BIOL, V56, P252, DOI 10.1080/10635150701313830; Jenkins T, 2012, EVOLUTION, V66, P740, DOI 10.1111/j.1558-5646.2011.01470.x; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Johnson PTJ, 2012, ECOL LETT, V15, P235, DOI 10.1111/j.1461-0248.2011.01730.x; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; LaPointe DA, 2010, J PARASITOL, V96, P318, DOI 10.1645/GE-2290.1; Latta SC, 2010, J AVIAN BIOL, V41, P25, DOI 10.1111/j.1600-048X.2009.04685.x; Lee KA, 2008, J ANIM ECOL, V77, P356, DOI 10.1111/j.1365-2656.2007.01347.x; Levin II, 2013, CONSERV BIOL, V27, P1366, DOI 10.1111/cobi.12127; Lindenfors P, 2007, GLOBAL ECOL BIOGEOGR, V16, P496, DOI 10.1111/j.1466-8238.2006.00301.x; Loiseau C, 2010, J PARASITOL, V96, P21, DOI 10.1645/GE-2123.1; Londono A, 2007, CARIBB J SCI, V43, P87; Martínez Omar, 2003, Ecología en Bolivia, V38, P99; Marzal A, 2005, OECOLOGIA, V142, P541, DOI 10.1007/s00442-004-1757-2; Matta NE, 2014, PARASITOL RES, V113, P457, DOI 10.1007/s00436-013-3675-x; Merino S, 2008, AUSTRAL ECOL, V33, P329, DOI 10.1111/j.1442-9993.2008.01820.x; Moller AP, 2009, BIOL REV, V84, P567, DOI 10.1111/j.1469-185X.2009.00087.x; Moller AP, 2007, ECOLOGY, V88, P871, DOI 10.1890/06-0747; MORSE DH, 1977, BIOSCIENCE, V27, P332, DOI 10.2307/1297632; MOYNIHAN M., 1962, SMITHSONIAN MIS COLLECTIONS, V143, P1; Munkemuller T, 2012, METHODS ECOL EVOL, V3, P743, DOI 10.1111/j.2041-210X.2012.00196.x; Oniki Y, 2002, MEM I OSWALDO CRUZ, V97, P597, DOI 10.1590/S0074-02762002000400027; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Pennycott TW, 2002, VET REC, V151, P563, DOI 10.1136/vr.151.19.563; POULIN R, 1991, CONDOR, V93, P418, DOI 10.2307/1368958; Powell G.V., 1985, ORNITH MONOGR, V36, P713, DOI DOI 10.2307/40168313; Raberg L, 1998, P ROY SOC B-BIOL SCI, V265, P1637, DOI 10.1098/rspb.1998.0482; Rahbek C, 2001, P NATL ACAD SCI USA, V98, P4534, DOI 10.1073/pnas.071034898; Remsen JVJ, 2012, CLASSIFICATION BIRD; Ribeiro SF, 2005, PARASITOLOGY, V130, P261, DOI 10.1017/S0031182004006596; Ricklefs RE, 2004, SYST BIOL, V53, P111, DOI 10.1080/10635150490264987; RICKLEFS RE, 1992, P NATL ACAD SCI USA, V89, P4722, DOI 10.1073/pnas.89.10.4722; Rifkin JL, 2012, AM NAT, V180, P70, DOI 10.1086/666081; Rodriguez OA, 2001, MEM I OSWALDO CRUZ, V96, P1173, DOI 10.1590/S0074-02762001000800026; RODRIGUEZ Q., 2003, ALETEO, V9, P1; Salaman P, 2009, CONSERVACION COLOMBI, V8, P1; Scheuerlein A, 2004, P ROY SOC B-BIOL SCI, V271, P1363, DOI 10.1098/rspb.2004.2726; Sebaio F, 2012, REV BRAS PARASITOL V, V21, P7, DOI 10.1590/S1984-29612012000100003; Silveira P, 2010, J WILDLIFE DIS, V46, P1305, DOI 10.7589/0090-3558-46.4.1305; SOUSA OE, 1982, J WILDLIFE DIS, V18, P205, DOI 10.7589/0090-3558-18.2.205; Swanson DA, 2012, MED VET ENTOMOL, V26, P56, DOI 10.1111/j.1365-2915.2011.00963.x; Swanson DA, 2010, MED VET ENTOMOL, V24, P182, DOI 10.1111/j.1365-2915.2010.00862.x; Tella JL, 1999, P NATL ACAD SCI USA, V96, P1785, DOI 10.1073/pnas.96.4.1785; Valkiunas G, 2004, J WILDLIFE DIS, V40, P555, DOI 10.7589/0090-3558-40.3.555; Valkiunas G, 2003, J WILDLIFE DIS, V39, P445, DOI 10.7589/0090-3558-39.2.445; Valkiunas G, 2009, J PARASITOL, V95, P1512, DOI 10.1645/GE-2105.1; van Rooyen J, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-139; VANRIPER C, 1986, ECOL MONOGR, V56, P327, DOI 10.2307/1942550; WHITE EM, 1978, REV BIOL TROP, V26, P43; WOODWORTHLYNAS CB, 1989, MEM I OSWALDO CRUZ, V84, P515, DOI 10.1590/S0074-02761989000400009; YOUNG BE, 1993, J WILDLIFE DIS, V29, P555, DOI 10.7589/0090-3558-29.4.555; Zamora-Vilchis I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039208	84	53	54	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100695	10.1371/journal.pone.0100695	http://dx.doi.org/10.1371/journal.pone.0100695			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950223	Green Published, gold			2022-12-27	WOS:000338276300110
J	Hu, XS; Yeh, FC				Hu, Xin-Sheng; Yeh, Francis C.			Assessing Postzygotic Isolation Using Zygotic Disequilibria in Natural Hybrid Zones	PLOS ONE			English	Article							COMPLEX ALLOZYME POLYMORPHISMS; LINKAGE DISEQUILIBRIUM; GENE FLOW; SPECIATION; SELECTION; ADAPTATION; EVOLUTION; DYNAMICS; PATTERNS; GENOMICS	Hybrid zones as windows on evolutionary processes provide a natural laboratory for studying the genetic basis and mechanisms of postzygotic isolation. One resultant pattern in hybrid zones is the Hardy-Weinberg disequilibrium (HWD) for a single locus or the linkage disequilibrium (LD) for multiple loci produced by natural selection against hybrids. However, HWD and the commonly used low-order gametic or composite digenic LD cannot fully reflect the pattern of the high-order genotypic interactions. Here we propose the use of zygotic LD to elucidate the selection mechanisms of postzygotic isolation, and its calculation is based on genotypic frequencies only, irrespective of the type of mating system. We numerically and analytically show that the maximum composite digenic LD is always greater than the maximum absolute zygotic LD under the linear-additive selection, but is comparable to or smaller than the maximum absolute zygotic LD under the strong epistatic selection. Selection mechanisms can be inferred by testing such differences. We analyze a previously reported mouse hybrid zone assayed with genome-wide SNPs, and confirm that the composite digenic LD cannot appropriately indicate all possible significant genotypic interactions for a given SNP pair. A large proportion of significant zygotic LDs, similar to 75% in general in the mouse hybrid zone, cannot be revealed from the composite digenic LD analysis. Statistical tests indicate that epistatic selection occurred among multiple loci in the mouse hybrid zone. The results highlight that the joint patterns of the composite digenic and zygotic LDs can help to elucidate the selection mechanism that is potentially involved in postzygotic isolation.	[Hu, Xin-Sheng] Univ Oxford, Dept Plant Sci, Oxford, England; [Yeh, Francis C.] Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada	University of Oxford; University of Alberta	Hu, XS (corresponding author), Univ Oxford, Dept Plant Sci, Oxford, England.	xin-sheng.hu@plants.ox.ac.uk						ARNOLD J, 1993, ANNU REV ECOL SYST, V24, P521, DOI 10.1146/annurev.es.24.110193.002513; Arnold M. L., 1997, NATURAL HYBRIDIZATIO; AVERY PJ, 1979, GENETICS, V91, P817; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; BARTON NH, 1989, NATURE, V341, P497, DOI 10.1038/341497a0; BARTON NH, 1979, HEREDITY, V43, P341, DOI 10.1038/hdy.1979.87; Barton NH, 2001, MOL ECOL, V10, P551, DOI 10.1046/j.1365-294x.2001.01216.x; Barton NH, 2000, GENET RES, V75, P179, DOI 10.1017/S0016672399004334; Barton NH, 1993, HYBRID ZONES EVOLUTI, P13, DOI DOI 10.1111/J.1558-5646.2009.00849.X; BENNETT J. H., 1956, HEREDITY, V10, P51, DOI 10.1038/hdy.1956.3; BULMER MG, 1971, AM NAT, V105, P201, DOI 10.1086/282718; COCKERHAM CC, 1973, THEOR POPUL BIOL, V4, P300, DOI 10.1016/0040-5809(73)90013-0; Corbett-Detig RB, 2013, NATURE, V504, P135, DOI 10.1038/nature12678; Coyne J.A., 2004, SPECIATION; Cucchi T, 2005, BIOL J LINN SOC, V84, P429, DOI 10.1111/j.1095-8312.2005.00445.x; Dobzhansky T., 1937; Ellegren H, 2012, NATURE, V491, P756, DOI 10.1038/nature11584; Endler J.A., 1977, Monographs in Population Biology, pi; ENNOS RA, 1994, HEREDITY, V72, P250, DOI 10.1038/hdy.1994.35; Ennos RA, 1999, SYST ASSOC SPEC VOL, V57, P1; Feder JL, 2012, TRENDS GENET, V28, P342, DOI 10.1016/j.tig.2012.03.009; Gavrilets S, 1997, EVOLUTION, V51, P1027, DOI 10.2307/2411031; Gavrilets S., 2004, FITNESS LANDSCAPE OR; HALDANE JBS, 1950, ANN EUGENIC, V15, P15, DOI 10.1111/j.1469-1809.1949.tb02418.x; HALDANE JBS, 1948, J GENET, V48, P277, DOI 10.1007/BF02986626; Harrison R.G., 1990, Oxford Surveys in Evolutionary Biology, V7, P69; Harrison RG, 1997, EVOLUTION, V51, P493, DOI 10.1111/j.1558-5646.1997.tb02437.x; Hu XS, 2008, EVOLUTION, V62, P2260, DOI 10.1111/j.1558-5646.2008.00439.x; Hu XS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080538; Hu XS, 2011, CURR GENOMICS, V12, P55, DOI 10.2174/138920211794520141; Hu XS, 2005, THEOR POPUL BIOL, V68, P119, DOI 10.1016/j.tpb.2005.02.003; Jameson DL, 1977, BENCHMARK PAPERS GEN; Jiang Q, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-65; Kimura M., 1953, ANNU REP NAT I GENET, V3, P62; Kruuk LEB, 1999, GENETICS, V153, P1959; Lee Y, 2013, P NATL ACAD SCI USA, V110, P19854, DOI 10.1073/pnas.1316851110; Li CC, 1976, 1 COURSE POPULATION; Mackay TFC, 2014, NAT REV GENET, V15, P22, DOI 10.1038/nrg3627; MALLET J, 1990, GENETICS, V124, P921; Martin SH, 2013, GENOME RES, V23, P1817, DOI 10.1101/gr.159426.113; Mayr E., 1979, ANIMAL SPECIES EVOLU; Muller HJ, 1942, BIOL S, V6, P71; OHTA T, 1980, GENET RES, V36, P181, DOI 10.1017/S0016672300019790; Orr HA, 2005, P NATL ACAD SCI USA, V102, P6522, DOI 10.1073/pnas.0501893102; PRESS WH, 1991, NUMERICAL RECIPES C; Rieseberg LH, 1999, GENETICS, V152, P713; Servedio MR, 2009, HEREDITY, V102, P51, DOI 10.1038/hdy.2008.98; Teeter KC, 2008, GENOME RES, V18, P67, DOI 10.1101/gr.6757907; Wang LY, 2011, MOL ECOL, V20, P2985, DOI 10.1111/j.1365-294X.2011.05148.x; Wang Z, 2010, P 9 WORLD C GEN APPL; WEIR BS, 1974, GENETICS, V78, P911; WEIR BS, 1972, GENETICS, V72, P505; WEIR BS, 1973, GENET RES, V21, P247, DOI 10.1017/S0016672300013446; Weir BS, 1996, SINAUER ASS SUNDERL; Wu S, 2010, STAT APPL GENET MOL, V9, DOI 10.2202/1544-6115.1578; Yang RC, 2003, GENETICS, V165, P447; Yang RC, 2002, GENETICS, V161, P435; Zaykin DV, 2008, GENETICS, V180, P533, DOI 10.1534/genetics.108.089409; [No title captured]	59	3	5	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100568	10.1371/journal.pone.0100568	http://dx.doi.org/10.1371/journal.pone.0100568			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950065	Green Published, Green Submitted, gold			2022-12-27	WOS:000338276300092
J	Lorenz, T; Heinitz, K				Lorenz, Timo; Heinitz, Kathrin			Aspergers - Different, Not Less: Occupational Strengths and Job Interests of Individuals with Asperger's Syndrome	PLOS ONE			English	Article							SELF-EFFICACY; AUTISM; ADULTS; EMPLOYMENT; WORK; EXPERIENCES; THINKING; PROGRAM; ABILITY; FIT	Rooted in the neurodiversity approach, this study provides an overview of the strengths and interests of individuals with Asperger's Syndrome. We interviewed136 individuals with Asperger's Syndrome and 155 neurotypical individuals via an online survey with regards to (a) demography, (b) occupational strengths, (c) general self-efficacy, (d) occupational self-efficacy, and (e) the job interest profile according to Holland. The vocational and educational fields of the individuals with Asperger's in the sample are more diverse than and surpass those classical fields stated in research and biographical literature. The comparison of both groups in cross-tables showed that the indicated strengths differ in several areas (Phi(Cramer) =.02-.47), which means that a specific strength profile can be derived, and this profile goes beyond the clinical view of the diagnostic criteria. Individuals with Asperger's indicate lower self-efficacy, both general and occupational. Furthermore, a high concentration of individuals with Asperger's can be found in the areas I (Investigative) and C (Conventional) of Holland's RIASEC model.	[Lorenz, Timo; Heinitz, Kathrin] Free Univ Berlin, Dept Psychol, Berlin, Germany	Free University of Berlin	Lorenz, T (corresponding author), Free Univ Berlin, Dept Psychol, Berlin, Germany.	timo.lorenz@fu-berlin.de	Lorenz, Timo/AAC-2249-2022	Lorenz, Timo/0000-0002-3830-489X				Alexander C, 2013, IT CONSULTANTS AUTIS; Allison C, 2012, J AM ACAD CHILD PSY, V51, P202, DOI 10.1016/j.jaac.2011.11.003; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; American Psychiatric Association, 2013, DSM 5 DIAGN CLASS DI, V5th, DOI [DOI 10.1176/APPI.BOOKS.9780890425596.X00DIAGNOSTICCLASSIFICATION, DOI 10.1176/APPI.BOOKS.9780890425596.DSM05]; Amt fur Statistik Berlin-Brandenburg, 2013, B 3 1 J 2012 STUD HO; [Anonymous], 1990, PERSONLICHE RESSOURC; [Anonymous], 2003, POSITIVE ORG SCHOLAR; [Anonymous], 2011, KLASSIFIKATION BERUF; Armstrong T., 2010, NEURODIVERSITY DISCO; Asperger H, 1944, ARCH PSYCHIAT NERVEN, V117, P76, DOI 10.1007/BF01837709; ATTWOOD T, 1998, ASPERGERS SYNDROME G; Attwood Tony, 2006, COMPLETE GUIDE ASPER; Bandura A, 1994, ENCY HUMAN BEHAV, DOI DOI 10.1002/9780470479216.CORPSY0836; Bandura A., 1997, SELF EFFICACY EXERCI; Benford P, 2009, J ASSIST TECHNOL, V3, P44, DOI 10.1108/17549450200900015; Chown N, 2011, J FURTHER HIGHER ED, P1; Eder, 2005, ALLGEMEINER INTERESS; Grandin T., 2006, THINKING PICTURES OT; Grandin T, 2009, PHILOS T R SOC B, V364, P1437, DOI 10.1098/rstb.2008.0297; Griffin E, 2009, DYSLEXIA, V15, P23, DOI 10.1002/dys.383; Griffith GM, 2012, AUTISM, V16, P532, DOI 10.1177/1362361311405223; Happe F, 2009, PHILOS T R SOC B, V364, P1369, DOI 10.1098/rstb.2008.0332; Harter J.K., 2010, OXFORD HDB POSITIVE, P121; Hendricks D, 2010, J VOCAT REHABIL, V32, P125, DOI 10.3233/JVR-2010-0502; Hillier A, 2007, CAREER DEV TRANSIT E, V30, P35, DOI 10.1177/08857288070300010501; Hofvander B, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-35; Holland J. L, 1997, MAKING VOCATIONAL CH; Howlin P, 2005, AUTISM, V9, P533, DOI 10.1177/1362361305057871; Howlin P, 2013, J AM ACAD CHILD PSY, V52, P897, DOI 10.1016/j.jaac.2013.06.010; Hurlbutt K., 2004, FOCUS AUTISM OTHER D, V19, P215, DOI [10.1177/10883576040190040301, DOI 10.1177/10883576040190040301]; Jaarsma P, 2012, HEALTH CARE ANAL, V20, P20, DOI 10.1007/s10728-011-0169-9; James I, 2010, MATH INTELL, V32, P56; Kapp SK, 2013, DEV PSYCHOL, V49, P59, DOI 10.1037/a0028353; Kristof-Brown AL, 2005, PERS PSYCHOL, V58, P281, DOI 10.1111/j.1744-6570.2005.00672.x; Kunda M, 2008, INT C DEVEL LEARN, P304, DOI 10.1109/DEVLRN.2008.4640847; Mesibov GB, 2010, J AUTISM DEV DISORD, V40, P570, DOI 10.1007/s10803-009-0901-6; Mottron L, 2006, J AUTISM DEV DISORD, V36, P27, DOI 10.1007/s10803-005-0040-7; Muller E., 2003, J VOCAT REHABIL, V18, P163; Organisation for Economic Co-operation and Development, 2007, REV FIELDS SCI TECHN; Rea L.M., 2014, DESIGNING CONDUCTING, V3rd ed.; Robison J. L., 2008, LOOK ME EYE MY LIFE; SAKS AM, 1995, J APPL PSYCHOL, V80, P211, DOI 10.1037/0021-9010.80.2.211; Schmidt FL, 1998, PSYCHOL BULL, V124, P262, DOI 10.1037/0033-2909.124.2.262; Schwarzer R, 1994, DIAGNOSTICA, V40, P92; Schwarzer R., 1995, MEASURES HLTH PSYCHO, P35, DOI DOI 10.1037/T00393-000; Schwarzer R., 1992, SELF EFFICACY THOUGH, P217; Schyns B, 2012, ZUSAMMENSTELLUNG SOZ; Simone R, 2010, ASPERGERS JOB MUST H; Stajkovic AD, 1998, PSYCHOL BULL, V124, P240, DOI 10.1037/0033-2909.124.2.240; Taylor JL, 2012, AJIDD-AM J INTELLECT, V117, P67, DOI 10.1352/1944-7558-117.1.67; WOOD R, 1989, J PERS SOC PSYCHOL, V56, P407, DOI 10.1037/0022-3514.56.3.407	51	42	42	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100358	10.1371/journal.pone.0100358	http://dx.doi.org/10.1371/journal.pone.0100358			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK2UZ	24950060	gold, Green Submitted, Green Published			2022-12-27	WOS:000338276300068
J	Martinez, RJ; Wu, CH; Beazley, MJ; Andersen, GL; Conrad, ME; Hazen, TC; Taillefert, M; Sobecky, PA				Martinez, Robert J.; Wu, Cindy H.; Beazley, Melanie J.; Andersen, Gary L.; Conrad, Mark E.; Hazen, Terry C.; Taillefert, Martial; Sobecky, Patricia A.			Microbial Community Responses to Organophosphate Substrate Additions in Contaminated Subsurface Sediments	PLOS ONE			English	Article							PLANT-GROWTH PROMOTION; IN-SITU BIOREDUCTION; PHOSPHATASE-ACTIVITY; URANIUM BIOMINERALIZATION; PHYLOGENETIC ANALYSIS; METHANOGENIC ARCHAEA; BACTERIAL DIVERSITY; REDUCED URANIUM; REDUCTION; REOXIDATION	Background: Radionuclide-and heavy metal-contaminated subsurface sediments remain a legacy of Cold War nuclear weapons research and recent nuclear power plant failures. Within such contaminated sediments, remediation activities are necessary to mitigate groundwater contamination. A promising approach makes use of extant microbial communities capable of hydrolyzing organophosphate substrates to promote mineralization of soluble contaminants within deep subsurface environments. Methodology/Principal Findings: Uranium-contaminated sediments from the U. S. Department of Energy Oak Ridge Field Research Center (ORFRC) Area 2 site were used in slurry experiments to identify microbial communities involved in hydrolysis of 10 mM organophosphate amendments [i.e., glycerol-2-phosphate (G2P) or glycerol-3-phosphate (G3P)] in synthetic groundwater at pH 5.5 and pH 6.8. Following 36 day (G2P) and 20 day (G3P) amended treatments, maximum phosphate (PO43-) concentrations of 4.8 mM and 8.9 mM were measured, respectively. Use of the PhyloChip 16S rRNA microarray identified 2,120 archaeal and bacterial taxa representing 46 phyla, 66 classes, 110 orders, and 186 families among all treatments. Measures of archaeal and bacterial richness were lowest under G2P (pH 5.5) treatments and greatest with G3P (pH 6.8) treatments. Members of the phyla Crenarchaeota, Euryarchaeota, Bacteroidetes, and Proteobacteria demonstrated the greatest enrichment in response to organophosphate amendments and the OTUs that increased in relative abundance by 2-fold or greater accounted for 9%-50% and 3%-17% of total detected Archaea and Bacteria, respectively. Conclusions/Significance: This work provided a characterization of the distinct ORFRC subsurface microbial communities that contributed to increased concentrations of extracellular phosphate via hydrolysis of organophosphate substrate amendments. Within subsurface environments that are not ideal for reductive precipitation of uranium, strategies that harness microbial phosphate metabolism to promote uranium phosphate precipitation could offer an alternative approach for in situ sequestration.	[Martinez, Robert J.; Beazley, Melanie J.; Sobecky, Patricia A.] Univ Alabama, Dept Biol Sci, Tuscaloosa, AL 35487 USA; [Wu, Cindy H.; Andersen, Gary L.; Conrad, Mark E.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Earth Sci, Berkeley, CA 94720 USA; [Hazen, Terry C.] Univ Tennessee, Dept Civil & Environm Engn, Knoxville, TN USA; [Taillefert, Martial] Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA	University of Alabama System; University of Alabama Tuscaloosa; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Tennessee System; University of Tennessee Knoxville; University System of Georgia; Georgia Institute of Technology	Martinez, RJ (corresponding author), Univ Alabama, Dept Biol Sci, Tuscaloosa, AL 35487 USA.	rmartinez@ua.edu	Andersen, Gary/G-2792-2015; Hazen, Terry C/C-1076-2012; Conrad, Mark E/G-2767-2010; Beazley, Melanie J./R-5716-2019	Andersen, Gary/0000-0002-1618-9827; Hazen, Terry C/0000-0002-2536-9993; Conrad, Mark E/0000-0001-9509-7324; Beazley, Melanie J./0000-0001-9973-7798	Office of Science (BER), U.S. Department of Energy [DE-FG02-04ER63906, SC0002530];  [DE-AC02-05CH11231]	Office of Science (BER), U.S. Department of Energy(United States Department of Energy (DOE)); 	This research was supported by the Office of Science (BER), U.S. Department of Energy Grant No. DE-FG02-04ER63906 (University of Alabama), Subcontract No. SC0002530 (Georgia Institute of Technology), and partially by No. DE-AC02-05CH11231 (Lawrence Berkeley National Laboratory). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RT, 2003, APPL ENVIRON MICROB, V69, P5884, DOI 10.1128/AEM.69.10.5884-5891.2003; Angel R, 2012, ISME J, V6, P847, DOI 10.1038/ismej.2011.141; Angel R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020453; Athenstaedt K, 1999, EUR J BIOCHEM, V266, P1, DOI 10.1046/j.1432-1327.1999.00822.x; Barkay T, 2003, FEMS MICROBIOL REV, V27, P355, DOI 10.1016/S0168-6445(03)00046-9; Beazley MJ, 2007, ENVIRON SCI TECHNOL, V41, P5701, DOI 10.1021/es070567g; Beazley MJ, 2011, GEOCHIM COSMOCHIM AC, V75, P5648, DOI 10.1016/j.gca.2011.07.006; Beazley MJ, 2009, GEOMICROBIOL J, V26, P431, DOI 10.1080/01490450903060780; Brodie EL, 2007, P NATL ACAD SCI USA, V104, P299, DOI 10.1073/pnas.0608255104; Brodie EL, 2006, APPL ENVIRON MICROB, V72, P6288, DOI 10.1128/AEM.00246-06; Brooks SC, 2003, ENVIRON SCI TECHNOL, V37, P1850, DOI 10.1021/es0210042; Buck EC, 1996, ENVIRON SCI TECHNOL, V30, P81, DOI 10.1021/es9500825; Buenemann EK, 2008, SOIL BIOL BIOCHEM, V40, P1908, DOI 10.1016/j.soilbio.2008.03.017; DeSantis TZ, 2007, MICROB ECOL, V53, P371, DOI 10.1007/s00248-006-9134-9; Dunbar J, 2002, APPL ENVIRON MICROB, V68, P3035, DOI 10.1128/AEM.68.6.3035-3045.2002; Forst S, 1997, ANNU REV MICROBIOL, V51, P47, DOI 10.1146/annurev.micro.51.1.47; Francis I, 2010, ENVIRON MICROBIOL, V12, P1, DOI 10.1111/j.1462-2920.2009.01989.x; Fujita Y, 2004, GEOCHIM COSMOCHIM AC, V68, P3261, DOI 10.1016/j.gca.2003.12.018; Geissler A, 2009, GEOBIOLOGY, V7, P282, DOI 10.1111/j.1472-4669.2009.00199.x; Gihring TM, 2011, APPL ENVIRON MICROB, V77, P5955, DOI 10.1128/AEM.00220-11; Green SJ, 2010, APPL ENVIRON MICROB, V76, P3244, DOI 10.1128/AEM.03069-09; Grenthe I., 2003, CHEM THERMODYNAMICS; Greub G, 2004, CLIN MICROBIOL REV, V17, P413, DOI 10.1128/CMR.17.2.413-433.2004; Grossart HP, 2011, P NATL ACAD SCI USA, V108, P19657, DOI 10.1073/pnas.1110716108; Grundling A, 2007, P NATL ACAD SCI USA, V104, P8478, DOI 10.1073/pnas.0701821104; Hayat R, 2010, ANN MICROBIOL, V60, P579, DOI 10.1007/s13213-010-0117-1; Istok JD, 2004, ENVIRON SCI TECHNOL, V38, P468, DOI 10.1021/es034639p; Jerden JL, 2003, APPL GEOCHEM, V18, P823, DOI 10.1016/S0883-2927(02)00179-8; Jones C, 2005, CARBOHYD RES, V340, P403, DOI 10.1016/j.carres.2004.12.009; Jroundi F, 2007, GEOMICROBIOL J, V24, P441, DOI 10.1080/01490450701437651; Langmuir D., 1997, AQUEOUS ENV GEOCHEMI; Liu WT, 2001, ENVIRON MICROBIOL, V3, P110, DOI 10.1046/j.1462-2920.2001.00164.x; Lloyd JR, 2003, FEMS MICROBIOL REV, V27, P411, DOI 10.1016/S0168-6445(03)00044-5; LOVLEY DR, 1991, NATURE, V350, P413, DOI 10.1038/350413a0; MACASKIE LE, 1992, SCIENCE, V257, P782, DOI 10.1126/science.1496397; Maes M, 2009, ENVIRON MICROBIOL, V11, P1453, DOI 10.1111/j.1462-2920.2009.01873.x; Marchant R, 2002, ENVIRON MICROBIOL, V4, P595, DOI 10.1046/j.1462-2920.2002.00344.x; Martinez RJ, 2007, ENVIRON MICROBIOL, V9, P3122, DOI 10.1111/j.1462-2920.2007.01422.x; Mielke PW, 2007, SPRINGER SER STAT, P1, DOI 10.1007/978-0-387-69813-7; Milanowski R, 2001, INT J SYST EVOL MICR, V51, P773, DOI 10.1099/00207713-51-3-773; Moon HS, 2007, ENVIRON SCI TECHNOL, V41, P4587, DOI 10.1021/es063063b; Novakova E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-143; Oberson A., 2005, Organic phosphorus in the environment, P133, DOI 10.1079/9780851998220.0133; Oh BC, 2004, APPL MICROBIOL BIOT, V63, P362, DOI 10.1007/s00253-003-1345-0; Oliveros J.C., 2007, VENNY INTERACTIVE TO; Ovreas L, 1997, APPL ENVIRON MICROB, V63, P3367; Pattanapipitpaisal P, 2002, ENVIRON TECHNOL, V23, P731, DOI 10.1080/09593332308618367; Porat I, 2010, MICROB ECOL, V60, P784, DOI 10.1007/s00248-010-9734-2; Rainey FA, 1998, INT J SYST BACTERIOL, V48, P635, DOI 10.1099/00207713-48-3-635; RASKIN L, 1994, APPL ENVIRON MICROB, V60, P1232, DOI 10.1128/AEM.60.4.1232-1240.1994; Rastogi G, 2010, MICROB ECOL, V60, P539, DOI 10.1007/s00248-010-9657-y; Richardson AE, 2009, PLANT SOIL, V321, P305, DOI 10.1007/s11104-009-9895-2; Rodriguez H, 1999, BIOTECHNOL ADV, V17, P319, DOI 10.1016/S0734-9750(99)00014-2; Roh Y, 2000, SOIL SEDIMENT CONTAM, V9, P463, DOI 10.1080/10588330091134356; Ryan PR, 2009, PLANT SOIL, V321, P363, DOI 10.1007/s11104-009-0001-6; Sani RK, 2005, GEOCHIM COSMOCHIM AC, V69, pA471; Shelobolina ES, 2009, APPL ENVIRON MICROB, V75, P5773, DOI 10.1128/AEM.00628-09; Simek K, 2001, APPL ENVIRON MICROB, V67, P2723, DOI 10.1128/AEM.67.6.2723-2733.2001; Singh G, 2014, CRIT REV ENV SCI TEC, V44, P391, DOI 10.1080/10643389.2012.728522; Sivaswamy V, 2011, BIOTECHNOL BIOENG, V108, P264, DOI 10.1002/bit.22956; Spain AM, 2011, GEOMICROBIOL J, V28, P418, DOI 10.1080/01490451.2010.507642; Stewart BD, 2010, ENVIRON SCI TECHNOL, V44, P928, DOI 10.1021/es902194x; Stubbs JE, 2009, GEOCHIM COSMOCHIM AC, V73, P1563, DOI 10.1016/j.gca.2008.12.004; Tajima K, 1999, FEMS MICROBIOL ECOL, V29, P159, DOI 10.1111/j.1574-6941.1999.tb00607.x; Thummes K, 2007, SYST APPL MICROBIOL, V30, P418, DOI 10.1016/j.syapm.2007.01.006; Tokunaga TK, 2008, ENVIRON SCI TECHNOL, V42, P8901, DOI 10.1021/es8019947; Turner BL, 2003, SOIL SCI SOC AM J, V67, P497, DOI 10.2136/sssaj2003.0497; Valinsky L, 2002, APPL ENVIRON MICROB, V68, P3243, DOI 10.1128/AEM.68.7.3243-3250.2002; Wan JM, 2005, ENVIRON SCI TECHNOL, V39, P6162, DOI 10.1021/es048236g; Wellman DM, 2006, ENVIRON CHEM, V3, P219, DOI 10.1071/EN05023; White C, 1998, NAT BIOTECHNOL, V16, P572, DOI 10.1038/nbt0698-572; Whitehouse CA, 2010, APPL ENVIRON MICROB, V76, P1996, DOI 10.1128/AEM.01919-09; WILSON KH, 1990, J CLIN MICROBIOL, V28, P1942, DOI 10.1128/JCM.28.9.1942-1946.1990; Wu WM, 2007, ENVIRON SCI TECHNOL, V41, P5716, DOI 10.1021/es062657b; Wu WM, 2006, ENVIRON SCI TECHNOL, V40, P3978, DOI 10.1021/es051954y; Wu WM, 2006, ENVIRON SCI TECHNOL, V40, P3986, DOI 10.1021/es051960u; Wu XL, 2006, ENVIRON MICROBIOL, V8, P394, DOI 10.1111/j.1462-2920.2005.00904.x; Yan TF, 2003, ENVIRON MICROBIOL, V5, P13, DOI 10.1046/j.1462-2920.2003.00393.x; Yanke LJ, 1998, MICROBIOL-SGM, V144, P1565, DOI 10.1099/00221287-144-6-1565; Zhang B, 2011, BIORESOURCE TECHNOL, V102, P2474, DOI 10.1016/j.biortech.2010.11.017; Zheng ZP, 2003, ENVIRON SCI TECHNOL, V37, P5603, DOI 10.1021/es0304897; Zinin NV, 2004, FEMS MICROBIOL LETT, V236, P283, DOI [10.1016/j.femsle.2004.05.051, 10.1111/j.1574-6968.2004.tb09659.x]	82	23	25	4	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100383	10.1371/journal.pone.0100383	http://dx.doi.org/10.1371/journal.pone.0100383			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950228	Green Submitted, Green Published, gold			2022-12-27	WOS:000338276300070
J	Jiang, PY; Sun, K; Lun, FMF; Guo, AM; Wang, HT; Chan, KCA; Chiu, RWK; Lo, YMD; Sun, H				Jiang, Peiyong; Sun, Kun; Lun, Fiona M. F.; Guo, Andy M.; Wang, Huating; Chan, K. C. Allen; Chiu, Rossa W. K.; Lo, Y. M. Dennis; Sun, Hao			Methy-Pipe: An Integrated Bioinformatics Pipeline for Whole Genome Bisulfite Sequencing Data Analysis	PLOS ONE			English	Article							DNA-METHYLATION; READ ALIGNMENT; ULTRAFAST	DNA methylation, one of the most important epigenetic modifications, plays a crucial role in various biological processes. The level of DNA methylation can be measured using whole-genome bisulfite sequencing at single base resolution. However, until now, there is a paucity of publicly available software for carrying out integrated methylation data analysis. In this study, we implemented Methy-Pipe, which not only fulfills the core data analysis requirements (e.g. sequence alignment, differential methylation analysis, etc.) but also provides useful tools for methylation data annotation and visualization. Specifically, it uses Burrow-Wheeler Transform (BWT) algorithm to directly align bisulfite sequencing reads to a reference genome and implements a novel sliding window based approach with statistical methods for the identification of differentially methylated regions (DMRs). The capability of processing data parallelly allows it to outperform a number of other bisulfite alignment software packages. To demonstrate its utility and performance, we applied it to both real and simulated bisulfite sequencing datasets. The results indicate that Methy-Pipe can accurately estimate methylation densities, identify DMRs and provide a variety of utility programs for downstream methylation data analysis. In summary, Methy-Pipe is a useful pipeline that can process whole genome bisulfite sequencing data in an efficient, accurate, and user-friendly manner.	[Jiang, Peiyong; Sun, Kun; Lun, Fiona M. F.; Guo, Andy M.; Chan, K. C. Allen; Chiu, Rossa W. K.; Lo, Y. M. Dennis; Sun, Hao] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Ctr Res Circulating Fetal Nucle Acids, Shatin, Hong Kong, Peoples R China; [Jiang, Peiyong; Sun, Kun; Lun, Fiona M. F.; Guo, Andy M.; Chan, K. C. Allen; Chiu, Rossa W. K.; Lo, Y. M. Dennis; Sun, Hao] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Chem Pathol, Shatin, Hong Kong, Peoples R China; [Wang, Huating] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Obstet & Gynaecol, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital	Sun, H (corresponding author), Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Ctr Res Circulating Fetal Nucle Acids, Shatin, Hong Kong, Peoples R China.	haosun@cuhk.edu.hk	JIANG, Peiyong/AAZ-9898-2020; Sun, Hao/T-5576-2019; Sun, Hao/J-9964-2013; sun, hao/GRS-7732-2022; Wang, Huating/C-6719-2014; Lo, Yuk Ming Dennis/D-4468-2011; Sun, Kun/Q-6479-2018	Sun, Hao/0000-0002-5547-9501; Sun, Hao/0000-0002-5547-9501; Wang, Huating/0000-0001-5474-2905; Lo, Yuk Ming Dennis/0000-0001-8746-0293; Sun, Kun/0000-0002-9883-1616; Jiang, Peiyong/0000-0003-4523-3476	University Grants Committee of the Government of the Hong Kong Special Administrative Region, China, under the Areas of Excellence Scheme [AoE/M-04/06]; Hong Kong Research Grants Council General Research Fund [CUHK473713]; Li Ka Shing Foundation	University Grants Committee of the Government of the Hong Kong Special Administrative Region, China, under the Areas of Excellence Scheme; Hong Kong Research Grants Council General Research Fund(Hong Kong Research Grants Council); Li Ka Shing Foundation	This work is supported by the University Grants Committee of the Government of the Hong Kong Special Administrative Region, China, under the Areas of Excellence Scheme (AoE/M-04/06). The Hong Kong Research Grants Council General Research Fund (CUHK473713). Y.M.D. Lo was supported by an Endowed Chair from the Li Ka Shing Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akalin A, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-r87, 10.1186/gb-2012-13-10-R87]; Attwood JT, 2002, CELL MOL LIFE SCI, V59, P241, DOI 10.1007/s00018-002-8420-z; Benoukraf T, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1281; Chan KC, 2013, P NATL ACAD SCI USA, DOI [10.1073/pnas.1317868110, DOI 10.1073/PNAS.1317868110]; Chen PY, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-203; Chim SSC, 2008, CLIN CHEM, V54, P500, DOI 10.1373/clinchem.2007.098731; Chiu RWK, 2007, AM J PATHOL, V170, P941, DOI 10.2353/ajpath.2007.060641; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Hansen KD, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-r83, 10.1186/gb-2012-13-10-R83]; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lam TW, 2009, IEEE INT C BIOINFORM, P31, DOI 10.1109/BIBM.2009.42; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lim JQ, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-r82, 10.1186/gb-2012-13-10-R82]; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Lun FMF, 2013, CLIN CHEM, V59, P1583, DOI 10.1373/clinchem.2013.212274; Meissner A, 2005, NUCLEIC ACIDS RES, V33, P5868, DOI 10.1093/nar/gki901; Ross JP, 2010, EPIGENOMICS-UK, V2, P245, DOI 10.2217/EPI.10.2; Schroeder DI, 2013, P NATL ACAD SCI USA, V110, P6037, DOI 10.1073/pnas.1215145110; Xi YP, 2009, BMC BIOINFORMATICS, V10, DOI [10.1186/1471-2105-10-S1-S58, 10.1186/1471-2105-10-232]	28	40	42	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100360	10.1371/journal.pone.0100360	http://dx.doi.org/10.1371/journal.pone.0100360			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945300	Green Published, gold, Green Submitted			2022-12-27	WOS:000340721500067
J	Kim, M; Ham, A; Kim, KYM; Brown, KM; Lee, HT				Kim, Mihwa; Ham, Ahrom; Kim, Katelyn Yu-Mi; Brown, Kevin M.; Lee, H. Thomas			The Volatile Anesthetic Isoflurane Increases Endothelial Adenosine Generation via Microparticle Ecto-5 '-Nucleotidase (CD73) Release	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; LIPOPOLYSACCHARIDE-INDUCED INFLAMMATION; PROXIMAL TUBULE CELLS; SMOOTH-MUSCLE-CELLS; RENAL ISCHEMIA; VASCULAR DYSFUNCTION; SPHINGOSINE KINASE; RHO-KINASE; PRETREATMENT; PROTECTS	Endothelial dysfunction is common in acute and chronic organ injury. Isoflurane is a widely used halogenated volatile anesthetic during the perioperative period and protects against endothelial cell death and inflammation. In this study, we tested whether isoflurane induces endothelial ecto-5'-nucleotidase (CD73) and cytoprotective adenosine generation to protect against endothelial cell injury. Clinically relevant concentrations of isoflurane induced CD73 activity and increased adenosine generation in cultured human umbilical vein or mouse glomerular endothelial cells. Surprisingly, isoflurane-mediated induction of endothelial CD73 activity occurred within 1 hr and without synthesizing new CD73. We determined that isoflurane rapidly increased CD73 containing endothelial microparticles into the cell culture media. Indeed, microparticles isolated from isoflurane-treated endothelial cells had significantly higher CD73 activity as well as increased CD73 protein. In vivo, plasma from mice anesthetized with isoflurane had significantly higher endothelial cell-derived CD144+ CD73+ microparticles and had increased microparticle CD73 activity compared to plasma from pentobarbital-anesthetized mice. Supporting a critical role of CD73 in isoflurane-mediated endothelial protection, a selective CD73 inhibitor (APCP) prevented isoflurane-induced protection against human endothelial cell inflammation and apoptosis. In addition, isoflurane activated endothelial cells Rho kinase evidenced by myosin phosphatase target subunit-1 and myosin light chain phosphorylation. Furthermore, isoflurane-induced release of CD73 containing microparticles was significantly attenuated by a selective Rho kinase inhibitor (Y27632). Taken together, we conclude that the volatile anesthetic isoflurane causes Rho kinase-mediated release of endothelial microparticles containing preformed CD73 and increase adenosine generation to protect against endothelial apoptosis and inflammation.	[Kim, Mihwa; Ham, Ahrom; Kim, Katelyn Yu-Mi; Brown, Kevin M.; Lee, H. Thomas] Columbia Univ, Coll Phys & Surg, Dept Anesthesiol, New York, NY 10027 USA	Columbia University	Lee, HT (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Anesthesiol, New York, NY 10027 USA.	tl128@columbia.edu			Department of Anesthesiology, Columbia University; National Institutes of Health [R01 GM-067081]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067081] Funding Source: NIH RePORTER	Department of Anesthesiology, Columbia University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by Department of Anesthesiology, Columbia University and by National Institutes of Health grant R01 GM-067081. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akis N, 2004, KIDNEY INT, V65, P2223, DOI 10.1111/j.1523-1755.2004.00634.x; Amabile N, 2005, J AM SOC NEPHROL, V16, P3381, DOI 10.1681/ASN.2005050535; Bakar AM, 2012, INT J MOL SCI, V13, P977, DOI 10.3390/ijms13010977; Budzyn K, 2007, CURR OPIN DRUG DISC, V10, P590; Burger D, 2013, CLIN SCI, V124, P423, DOI 10.1042/CS20120309; Burger D, 2011, ARTERIOSCL THROM VAS, V31, P1898, DOI 10.1161/ATVBAHA.110.222703; Colgan Sean P, 2006, Purinergic Signal, V2, P351, DOI 10.1007/s11302-005-5302-5; Cullen Karen A, 2009, Natl Health Stat Report, P1; de Klaver MJM, 2003, ANESTHESIOLOGY, V99, P896, DOI 10.1097/00000542-200310000-00023; de Klaver MJM, 2002, ANESTHESIOLOGY, V97, P24, DOI 10.1097/00000542-200207000-00005; Dignat-George F, 2011, ARTERIOSCL THROM VAS, V31, P27, DOI 10.1161/ATVBAHA.110.218123; Eckle T, 2007, CIRCULATION, V115, P1581, DOI 10.1161/CIRCULATIONAHA.106.669697; Flondor M, 2008, EUR SURG RES, V40, P1, DOI 10.1159/000107614; Fuentes JM, 2006, CLIN VACCINE IMMUNOL, V13, P281, DOI 10.1128/CVI.13.2.281-288.2006; Gelain DP, 2003, MOL CELL BIOCHEM, V245, P1, DOI 10.1023/A:1022857608849; Grenz A, 2007, J AM SOC NEPHROL, V18, P833, DOI 10.1681/ASN.2006101141; Hart ML, 2008, FASEB J, V22, P2784, DOI 10.1096/fj.07-103911; Hasko G, 2011, J IMMUNOL, V187, P4256, DOI 10.4049/jimmunol.1003379; Hasko G, 2008, NAT REV DRUG DISCOV, V7, P759, DOI 10.1038/nrd2638; Hayes JK, 2004, ANESTH ANALG, V98, P999, DOI 10.1213/01.ANE.0000104584.91385.1D; Higashi Y, 2012, HYPERTENS RES, V35, P1039, DOI 10.1038/hr.2012.138; Higashi Y, 2009, CIRC J, V73, P411, DOI 10.1253/circj.CJ-08-1102; Hofbauer R, 1999, CURR PHARM DESIGN, V5, P1015; Hofstetter C, 2005, INT IMMUNOPHARMACOL, V5, P1519, DOI 10.1016/j.intimp.2005.04.008; JAFFE EA, 1987, HUM PATHOL, V18, P234, DOI 10.1016/S0046-8177(87)80005-9; Kim M, 2010, AM J PHYSL RENAL PHY; Kim M, 2011, ANN SURG IN PRESS; Kim M, 2013, KIDNEY INT, V84, P90, DOI 10.1038/ki.2013.43; Kim M, 2010, AM J NEPHROL, V31, P353, DOI 10.1159/000298339; Kim M, 2007, AM J PHYSIOL-RENAL, V293, pF1827, DOI 10.1152/ajprenal.00290.2007; Kim M, 2009, KIDNEY INT, V75, P809, DOI 10.1038/ki.2008.699; Landoni G, 2009, MINERVA ANESTESIOL, V75, P269; Lee HT, 2007, AM J PHYSIOL-RENAL, V293, pF713, DOI 10.1152/ajprenal.00161.2007; Lee HT, 2007, SHOCK, V27, P373, DOI 10.1097/01.shk.0000248595.17130.24; Lee HT, 2006, AM J PHYSIOL-RENAL, V291, pF67, DOI 10.1152/ajprenal.00412.2005; Lemkuil BP, 2011, ANESTHESIOLOGY, V114, P49, DOI 10.1097/ALN.0b013e318201dcb3; Linden J, 2006, J CLIN INVEST, V116, P1835, DOI 10.1172/JCI29125; Luippold G, 1999, J CHROMATOGR B, V724, P231, DOI 10.1016/S0378-4347(98)00580-5; Mobert J, 1999, ANESTHESIOLOGY, V90, P1372, DOI 10.1097/00000542-199905000-00022; Park SW, 2012, J AM SOC NEPHROL, V23, P266, DOI 10.1681/ASN.2011050503; Plachinta RV, 2003, ANESTHESIOLOGY, V98, P89, DOI 10.1097/00000542-200301000-00017; Rautou PE, 2011, CIRC RES, V109, P593, DOI 10.1161/CIRCRESAHA.110.233163; Reutershan J, 2006, ANESTHESIOLOGY, V104, P511, DOI 10.1097/00000542-200603000-00019; Sapet C, 2006, BLOOD, V108, P1868, DOI 10.1182/blood-2006-04-014175; Seal JB, 2005, ANN VASC SURG, V19, P572, DOI 10.1007/s10016-005-4616-7; Strohmeier GR, 1997, J CLIN INVEST, V99, P2588, DOI 10.1172/JCI119447; Tas PWL, 2007, J CELL BIOCHEM, V102, P368, DOI 10.1002/jcb.21294; Tramontano AF, 2004, BIOCHEM BIOPH RES CO, V320, P34, DOI 10.1016/j.bbrc.2004.05.127; Van Hoozen BE, 1999, CRIT CARE MED, V27, P2836, DOI 10.1097/00003246-199912000-00044; Zhou Q, 2009, CURR PHARM DESIGN, V15, P3108, DOI 10.2174/138161209789057986	50	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e99950	10.1371/journal.pone.0099950	http://dx.doi.org/10.1371/journal.pone.0099950			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945528	gold, Green Published, Green Submitted			2022-12-27	WOS:000340721500035
J	Konig, MAE; Lehtila, K; Wiklund, C; Ehrlen, J				Konig, Malin A. E.; Lehtila, Kari; Wiklund, Christer; Ehrlen, Johan			Among-Population Variation in Tolerance to Larval Herbivory by Anthocharis cardamines in the Polyploid Herb Cardamine pratensis	PLOS ONE			English	Article							PLANT PLOIDY LEVEL; FLOWERING PHENOLOGY; IMPOSE SELECTION; RESISTANCE; COSTS; STRATEGIES; EVOLUTION; RESPONSES; FITNESS; COMPENSATION	Plants have two principal defense mechanisms to decrease fitness losses to herbivory: tolerance, the ability to compensate fitness after damage, and resistance, the ability to avoid damage. Variation in intensity of herbivory among populations should result in variation in plant defense levels if tolerance and resistance are associated with costs. Yet little is known about how levels of tolerance are related to resistance and attack intensity in the field, and about the costs of tolerance. In this study, we used information about tolerance and resistance against larval herbivory by the butterfly Anthocharis cardamines under controlled conditions together with information about damage in the field for a large set of populations of the perennial plant Cardamine pratensis. Plant tolerance was estimated in a common garden experiment where plants were subjected to a combination of larval herbivory and clipping. We found no evidence of that the proportion of damage that was caused by larval feeding vs. clipping influenced plant responses. Damage treatments had a negative effect on the three measured fitness components and also resulted in an earlier flowering in the year after the attack. Tolerance was related to attack intensity in the population of origin, i.e. plants from populations with higher attack intensity were more likely to flower in the year following damage. However, we found no evidence of a relationship between tolerance and resistance. These results indicate that herbivory drives the evolution for increased tolerance, and that changes in tolerance are not linked to changes in resistance. We suggest that the simultaneous study of tolerance, attack intensity in the field and resistance constitutes a powerful tool to understand how plant strategies to avoid negative effects of herbivore damage evolve.	[Konig, Malin A. E.; Ehrlen, Johan] Stockholm Univ, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden; [Lehtila, Kari] Sodertorn Univ, Sch Nat Sci Technol & Environm Studies, Huddinge, Sweden; [Wiklund, Christer] Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden	Stockholm University; Sodertorn University; Stockholm University	Konig, MAE (corresponding author), Stockholm Univ, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden.	malin.konig@gmail.com		Ehrlen, Johan/0000-0001-8539-8967; Lehtila, Kari/0000-0002-0260-3978	Swedish research council [1043720]	Swedish research council(Swedish Research CouncilEuropean Commission)	This research was funded by a grant from the Swedish research council (1043720, http://www.vr.se/) to Johan Ehrlen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 1999, EVOLUTION, V53, P1093, DOI [10.2307/2640814, 10.1111/j.1558-5646.1999.tb04524.x]; Arvanitis L, 2008, OIKOS, V117, P1020, DOI 10.1111/j.0030-1299.2008.16347.x; Arvanitis L, 2007, OECOLOGIA, V152, P275, DOI 10.1007/s00442-007-0659-5; BALDWIN IT, 1990, TRENDS ECOL EVOL, V5, P91, DOI 10.1016/0169-5347(90)90237-8; BELSKY AJ, 1993, EVOL ECOL, V7, P109, DOI 10.1007/BF01237737; Boalt E, 2010, EVOL ECOL, V24, P1101, DOI 10.1007/s10682-010-9364-7; Bustos-Segura C, 2014, J EVOL BIOL IN PRESS; Carmona D, 2013, NEW PHYTOL, V197, P576, DOI 10.1111/nph.12023; COURTNEY SP, 1982, OECOLOGIA, V52, P258, DOI 10.1007/BF00363846; Dempster JP, 1997, OECOLOGIA, V111, P549, DOI 10.1007/s004420050270; DEMPSTER JP, 1992, ECOL ENTOMOL, V17, P83, DOI 10.1111/j.1365-2311.1992.tb01043.x; Espinosa EG, 2006, NEW PHYTOL, V170, P609, DOI 10.1111/j.1469-8137.2006.01681.x; FINEBLUM WL, 1995, NATURE, V377, P517, DOI 10.1038/377517a0; Fornoni J, 2004, EVOLUTION, V58, P1696, DOI 10.1111/j.0014-3820.2004.tb00455.x; FORNONI J, 2003, COMMENTS THEORETICAL, V8, P643, DOI DOI 10.1080/713713331; Fox J., 2014, R COMPANION APPL REG; Freeman RS, 2003, OECOLOGIA, V136, P394, DOI 10.1007/s00442-003-1276-6; Garrido E, 2012, NEW PHYTOL, V193, P445, DOI 10.1111/j.1469-8137.2011.03923.x; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; Konig MAE, 2014, OECOLOGIA, V174, P1265, DOI 10.1007/s00442-013-2831-4; Koricheva J, 2002, ECOLOGY, V83, P176, DOI 10.2307/2680130; Lehtila K, 2004, ECOL STU AN, V173, P257; Leimu R, 2006, OIKOS, V112, P1, DOI 10.1111/j.0030-1299.2006.41023.x; Lennartsson T, 1997, AM NAT, V149, P1147, DOI 10.1086/286043; Loreti J, 2001, PLANT ECOL, V157, P195, DOI 10.1023/A:1013976316924; LOVKVIST B, 1956, THESIS U UPPSALA UPP; MARQUIS RJ, 1984, SCIENCE, V226, P537, DOI 10.1126/science.226.4674.537; MASCHINSKI J, 1989, AM NAT, V134, P1, DOI 10.1086/284962; Mauricio R, 1997, ECOLOGY, V78, P1301, DOI 10.1890/0012-9658(1997)078[1301:VITDSO]2.0.CO;2; McCall AC, 2006, ECOL LETT, V9, P1351, DOI 10.1111/j.1461-0248.2006.00975.x; Nunez-Farfan J, 2007, ANNU REV ECOL EVOL S, V38, P541, DOI 10.1146/annurev.ecolsys.38.091206.095822; Pilson D, 2000, OECOLOGIA, V122, P72, DOI 10.1007/PL00008838; Pilson D, 2000, EVOL ECOL, V14, P457, DOI 10.1023/A:1010953714344; Puustinen S, 2004, OECOLOGIA, V139, P76, DOI 10.1007/s00442-004-1488-4; R Core Team, 2021, R LANGUAGE ENV STAT; Rosenheim JA, 1997, ENTOMOL EXP APPL, V85, P45, DOI 10.1023/A:1003026507687; Rotundo JL, 2008, PLANT ECOL, V194, P121, DOI 10.1007/s11258-007-9279-8; Sadras VO, 1996, OECOLOGIA, V106, P432, DOI 10.1007/BF00329698; Stinchcombe JR, 2002, EVOL ECOL, V16, P595, DOI 10.1023/A:1021617418037; Stinchcombe JR, 2002, EVOLUTION, V56, P1063; Stowe KA, 2000, ANNU REV ECOL SYST, V31, P565, DOI 10.1146/annurev.ecolsys.31.1.565; Strauss SY, 1999, TRENDS ECOL EVOL, V14, P179, DOI 10.1016/S0169-5347(98)01576-6; THOMAS C D, 1984, Entomologist's Gazette, V35, P145; Tiffin P, 1999, AM NAT, V154, P700, DOI 10.1086/303271; Tiffin P, 2000, EVOL ECOL, V14, P523, DOI 10.1023/A:1010881317261; van Kleunen M, 2003, ECOLOGY, V84, P2816, DOI 10.1890/02-0494; VANDERMEIJDEN E, 1988, OIKOS, V51, P355, DOI 10.2307/3565318; Walling LL, 2000, J PLANT GROWTH REGUL, V19, P195; WIKLUND C, 1978, OIKOS, V31, P169, DOI 10.2307/3543560; WIKLUND C, 1984, OECOLOGIA, V63, P23, DOI 10.1007/BF00379780	50	13	13	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e99333	10.1371/journal.pone.0099333	http://dx.doi.org/10.1371/journal.pone.0099333			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945875	gold, Green Published, Green Submitted			2022-12-27	WOS:000340721500015
J	Liu, Z; Qian, JC; Liu, BM; Wang, Q; Ni, XY; Dong, YL; Zhong, K; Wu, YJ				Liu, Zan; Qian, Junchao; Liu, Binmei; Wang, Qi; Ni, Xiaoyu; Dong, Yaling; Zhong, Kai; Wu, Yuejin			Effects of the Magnetic Resonance Imaging Contrast Agent Gd-DTPA on Plant Growth and Root Imaging in Rice	PLOS ONE			English	Article							MRI; TRANSPORT	Although paramagnetic contrast agents have a wide range of applications in medical studies involving magnetic resonance imaging (MRI), these agents are seldom used to enhance MRI images of plant root systems. To extend the application of MRI contrast agents to plant research and to develop related techniques to study root systems, we examined the applicability of the MRI contrast agent Gd-DTPA to the imaging of rice roots. Specifically, we examined the biological effects of various concentrations of Gd-DTPA on rice growth and MRI images. Analysis of electrical conductivity and plant height demonstrated that 5 mmol Gd-DTPA had little impact on rice in the short-term. The results of signal intensity and spin-lattice relaxation time (T1) analysis suggested that 5 mmol Gd-DTPA was the appropriate concentration for enhancing MRI signals. In addition, examination of the long-term effects of Gd-DTPA on plant height showed that levels of this compound up to 5 mmol had little impact on rice growth and (to some extent) increased the biomass of rice.	[Liu, Zan; Liu, Binmei; Wang, Qi; Ni, Xiaoyu; Dong, Yaling; Wu, Yuejin] Chinese Acad Sci, Hefei Inst Phys Sci, Inst Tech Biol & Agr Engn, Key Lab Ion Beam Bioengn, Hefei, Peoples R China; [Qian, Junchao; Zhong, Kai] Chinese Acad Sci, Hefei Inst Phys Sci, High Field Magnet Lab, Hefei, Peoples R China	Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS; Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS	Zhong, K (corresponding author), Chinese Acad Sci, Hefei Inst Phys Sci, High Field Magnet Lab, Hefei, Peoples R China.	kzhong@hmfl.ac.cn; yjwu@ipp.ac.cn	Binmei, Liu/ABB-8384-2020		Strategic Priority Research Program of the Chinese Academy of Sciences [XDA08040107]; National Natural Science Foundation of China [31301297]; Knowledge Innovative Program of the Chinese Academy of Sciences [KJCX2-EW-N05, KJCX2-YW-N34]	Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovative Program of the Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences)	This work was supported by the Strategic Priority Research Program of the Chinese Academy of Sciences, Grant No. XDA08040107(http://www.cas.cn/), the National Natural Science Foundation of China (No. 31301297) (http://www.nsfc.gov.cn/), the Knowledge Innovative Program of the Chinese Academy of Sciences (No. KJCX2-EW-N05; No. KJCX2-YW-N34) (http://www.cas.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blossfeld Stephan, 2011, Commun Agric Appl Biol Sci, V76, P11; Borisjuk L, 2012, PLANT J, V70, P129, DOI 10.1111/j.1365-313X.2012.04927.x; BOTTOMLEY PA, 1986, P NATL ACAD SCI USA, V83, P87, DOI 10.1073/pnas.83.1.87; Cordova-Tellez L, 2002, CROP SCI, V42, P1989, DOI 10.2135/cropsci2002.1989; Eberhardt TL, 2009, HOLZFORSCHUNG, V63, P75, DOI 10.1515/HF.2009.024; Edzes HT, 1998, MAGN RESON IMAGING, V16, P185, DOI 10.1016/S0730-725X(97)00274-9; Hillnhutter C, 2012, J EXP BOT, V63, P319, DOI 10.1093/jxb/err273; Johnson MG, 2001, ENVIRON EXP BOT, V45, P263, DOI 10.1016/S0098-8472(01)00077-6; Kaestner A, 2006, GEODERMA, V136, P459, DOI 10.1016/j.geoderma.2006.04.009; Kaufmann I, 2009, NEW PHYTOL, V184, P245, DOI 10.1111/j.1469-8137.2009.02919.x; Melkus G, 2011, PLANT BIOTECHNOL J, V9, P1022, DOI 10.1111/j.1467-7652.2011.00618.x; Melkus G, 2009, PLANT PHYSIOL, V151, P1139, DOI 10.1104/pp.109.143974; Mooney SJ, 2012, PLANT SOIL, V352, P1, DOI 10.1007/s11104-011-1039-9; Ni JZ, 1995, USE RARE EARTH ELEME, P13; QUIQUAMPOIX H, 1990, J INORG BIOCHEM, V38, P265, DOI 10.1016/0162-0134(90)80002-F; Rathjen JR, 2009, J EXP BOT, V60, P1619, DOI 10.1093/jxb/erp037; Schneider H, 2003, NEW PHYTOL, V159, P487, DOI 10.1046/j.1469-8137.2003.00814.x; SNAAR JEM, 1992, BIOPHYS J, V63, P1654, DOI 10.1016/S0006-3495(92)81741-1; Sorensen AG, 1997, JMRI-J MAGN RESON IM, V7, P47, DOI 10.1002/jmri.1880070108; TOLLNER EW, 1991, COMMUN SOIL SCI PLAN, V22, P1941, DOI 10.1080/00103629109368548; Toth E, 2002, TOP CURR CHEM, V221, P61; Van der Weerd L, 2002, PLANT CELL ENVIRON, V25, P1539, DOI 10.1046/j.1365-3040.2002.00934.x; VANDUSSCHOTEN D, 1995, J MAGN RESON SER A, V116, P22, DOI 10.1006/jmra.1995.1185; Windt CW, 2006, PLANT CELL ENVIRON, V29, P1715, DOI 10.1111/j.1365-3040.2006.01544.x; Zhang HJ, 2009, BIOL TRACE ELEM RES, V127, P81, DOI 10.1007/s12011-008-8224-6; Zhong K, 2000, NMR BIOMED, V13, P392, DOI 10.1002/1099-1492(200011)13:7<392::AID-NBM659>3.0.CO;2-O	26	3	3	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100246	10.1371/journal.pone.0100246	http://dx.doi.org/10.1371/journal.pone.0100246			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945975	Green Published, Green Submitted, gold			2022-12-27	WOS:000340721500052
J	Oizumi, R				Oizumi, Ryo			Unification Theory of Optimal Life Histories and Linear Demographic Models in Internal Stochasticity	PLOS ONE			English	Article							PARTIAL-DIFFERENTIAL-EQUATIONS; OPTIMAL-GROWTH SCHEDULE; VISCOSITY SOLUTIONS; POPULATION-DYNAMICS; PROJECTION MODELS; MAXIMUM PRINCIPLE; NATURAL-SELECTION; SIZE; AGE; PLANT	Life history of organisms is exposed to uncertainty generated by internal and external stochasticities. Internal stochasticity is generated by the randomness in each individual life history, such as randomness in food intake, genetic character and size growth rate, whereas external stochasticity is due to the environment. For instance, it is known that the external stochasticity tends to affect population growth rate negatively. It has been shown in a recent theoretical study using path-integral formulation in structured linear demographic models that internal stochasticity can affect population growth rate positively or negatively. However, internal stochasticity has not been the main subject of researches. Taking account of effect of internal stochasticity on the population growth rate, the fittest organism has the optimal control of life history affected by the stochasticity in the habitat. The study of this control is known as the optimal life schedule problems. In order to analyze the optimal control under internal stochasticity, we need to make use of "Stochastic Control Theory" in the optimal life schedule problem. There is, however, no such kind of theory unifying optimal life history and internal stochasticity. This study focuses on an extension of optimal life schedule problems to unify control theory of internal stochasticity into linear demographic models. First, we show the relationship between the general age-states linear demographic models and the stochastic control theory via several mathematical formulations, such as path-integral, integral equation, and transition matrix. Secondly, we apply our theory to a two-resource utilization model for two different breeding systems: semelparity and iteroparity. Finally, we show that the diversity of resources is important for species in a case. Our study shows that this unification theory can address risk hedges of life history in general age-states linear demographic models.	Univ Tokyo, Grad Sch Math Sci, Tokyo, Japan	University of Tokyo	Oizumi, R (corresponding author), Univ Tokyo, Grad Sch Math Sci, Tokyo, Japan.	oizumi@ms.u-tokyo.ac.jp		Oizumi, Ryo/0000-0001-7813-1236	Japanese Society for the Promotion of Science (JSPS) for Scientic Research [B-21310152, B-23370006, C-22570011]	Japanese Society for the Promotion of Science (JSPS) for Scientic Research	This research was funded in part by Grants-in-Aid from the Japanese Society for the Promotion of Science (JSPS) for Scientic Research (nos. B-21310152, B-23370006 and C-22570011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASE KK, 1984, STOCH PROC APPL, V18, P81, DOI 10.1016/0304-4149(84)90163-7; Allen EJ, 2008, STOCH ANAL APPL, V26, P357, DOI 10.1080/07362990701857319; Allen Edward J., 2009, Journal of Biological Dynamics, V3, P73, DOI 10.1080/17513750802162754; BLACK F, 1973, J POLIT ECON, V81, P637, DOI 10.1086/260062; Boltyanskiy V., 1962, MATH THEORY OPTIMAL; Boyce MS, 2006, TRENDS ECOL EVOL, V21, P141, DOI 10.1016/j.tree.2005.11.018; Caswell H., 2006, MATRIX POPULATION MO; COHEN D, 1976, AM NAT, V110, P801, DOI 10.1086/283103; CRANDALL MG, 1992, B AM MATH SOC, V27, P1, DOI 10.1090/S0273-0979-1992-00266-5; CRANDALL MG, 1983, T AM MATH SOC, V277, P1, DOI 10.2307/1999343; Cushing J.M., 1998, SIAM; Diekmann O, 1986, DYNAMICS PHYSL STRUC, V68; Easterling MR, 2000, ECOLOGY, V81, P694, DOI 10.1890/0012-9658(2000)081[0694:SSSAAN]2.0.CO;2; Ellner SP, 2007, J MATH BIOL, V54, P227, DOI 10.1007/s00285-006-0044-8; Feller W, 1941, ANN MATH STAT, V12, P243, DOI 10.1214/aoms/1177731708; Figge F, 2004, BIODIVERS CONSERV, V13, P827, DOI 10.1023/B:BIOC.0000011729.93889.34; Goel N., 1974, STOCHASTIC MODELS BI; IWASA Y, 1984, THEOR POPUL BIOL, V25, P78, DOI 10.1016/0040-5809(84)90007-8; IWASA Y, 1989, AM NAT, V133, P480, DOI 10.1086/284931; IWASA Y, 1991, THEOR POPUL BIOL, V40, P246, DOI 10.1016/0040-5809(91)90055-K; JENSEN R, 1988, P AM MATH SOC, V102, P975, DOI 10.2307/2047344; JENSEN R, 1988, ARCH RATION MECH AN, V101, P1, DOI 10.1007/BF00281780; LANGLAIS M, 1988, J MATH BIOL, V26, P319, DOI 10.1007/BF00277394; Lauenroth WK, 2008, J ECOL, V96, P1023, DOI 10.1111/j.1365-2745.2008.01415.x; LEON JA, 1976, J THEOR BIOL, V60, P301, DOI 10.1016/0022-5193(76)90062-X; Lv QM, 2007, J THEOR BIOL, V244, P640, DOI 10.1016/j.jtbi.2006.09.009; MAC ARTHUR ROBERT H., 1967; Morimoto H, 1993, STOCHASTIC CONTROL M; Morris WF, 2008, ECOLOGY, V89, P19, DOI 10.1890/07-0774.1; Oizumi R, 2013, J THEOR BIOL, V323, P76, DOI 10.1016/j.jtbi.2013.01.020; Oksendal B, 2003, STOCHASTIC DIFFERENT; Peng S., 1992, STOCH STOCH REP, V38, P119, DOI [/10.1080/17442509208833749, DOI 10.1080/17442509208833749]; PENG SG, 1990, SIAM J CONTROL OPTIM, V28, P966, DOI 10.1137/0328054; PIANKA ER, 1976, AM ZOOL, V16, P775; Salguero-Gomez R, 2010, J ECOL, V98, P250, DOI 10.1111/j.1365-2745.2009.01635.x; Schindler DE, 2010, NATURE, V465, P609, DOI 10.1038/nature09060; Suzuki M, 2000, TREE PHYSIOL, V20, P203; TAKADA T, 1994, J MATH BIOL, V32, P789, DOI 10.1007/BF00168798; TAYLOR HM, 1974, THEOR POPUL BIOL, V5, P104, DOI 10.1016/0040-5809(74)90053-7; TULJAPURKAR SD, 1982, THEOR POPUL BIOL, V21, P141, DOI 10.1016/0040-5809(82)90010-7; Webb GF, 2008, LECT NOTES MATH, V1936, P1; Yong J., 1999, STOCHASTIC CONTROLS, V43	42	3	3	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e98746	10.1371/journal.pone.0098746	http://dx.doi.org/10.1371/journal.pone.0098746			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945258	gold, Green Submitted, Green Published			2022-12-27	WOS:000340721500006
J	Omidbakhsh, N; Ahmadpour, F; Kenny, N				Omidbakhsh, Navid; Ahmadpour, Faraz; Kenny, Nicole			How Reliable Are ATP Bioluminescence Meters in Assessing Decontamination of Environmental Surfaces in Healthcare Settings?	PLOS ONE			English	Article							HYGIENE; SANITIZERS	Background: Meters based on adenosine triphosphate (ATP) bioluminescence measurements in relative light units (RLU) are often used to rapidly assess the level of cleanliness of environmental surfaces in healthcare and other settings. Can such ATP measurements be adversely affected by factors such as soil and cleaner-disinfectant chemistry? Objective: This study tested a number of leading ATP meters for their sensitivity, linearity of the measurements, correlation of the readings to the actual microbial contamination, and the potential disinfectant chemicals' interference in their readings. Methods: First, solutions of pure ATP in various concentrations were used to construct a standard curve and determine linearity and sensitivity. Serial dilutions of a broth culture of Staphylococcus aureus, as a representative nosocomial pathogen, were then used to determine if a given meter's ATP readings correlated with the actual CFUs. Next, various types of disinfectant chemistries were tested for their potential to interfere with the standard ATP readings. Results: All four ATP meters tested herein demonstrated acceptable linearity and repeatability in their readings. However, there were significant differences in their sensitivity to detect the levels of viable microorganisms on experimentally contaminated surfaces. Further, most disinfectant chemistries tested here quenched the ATP readings variably in different ATP meters evaluated. Conclusions: Apart from their limited sensitivity in detecting low levels of microbial contamination, the ATP meters tested were also prone to interference by different disinfectant chemistries.	[Omidbakhsh, Navid; Ahmadpour, Faraz] Virox Technol Inc, Res & Dev, Oakville, ON, Canada; [Kenny, Nicole] Virox Technol Inc, Profess & Tech Serv, Oakville, ON, Canada		Omidbakhsh, N (corresponding author), Virox Technol Inc, Res & Dev, Oakville, ON, Canada.	navid.omidbakhsh@gmail.com		Ahmadpour, Faraz/0000-0002-3861-1224	Virox Technologies Inc.	Virox Technologies Inc.	The authors have the following interests: This study was funded by Virox Technologies Inc. Two of the authors (Faraz Ahmadpour and Nicole Kenny) are employed by Virox Technologies Inc. The third author, Navid Omidbakhsh, used to be an employee of Virox Technologies at the time of submitting this manuscript, but not anymore. The authors hold the following patents, which are owned by Virox Technologies: Hydrogen peroxide disinfectant with increased activity US 6,346,279, US 6,803,057 (CIP), EP 1139762 B1, CA 2344471, AU 741104, AT225128, BR9915987, DE69903347, JP3350526. Enhanced activity hydrogen peroxide disinfectant US 7,632,523, NZ0534352A, AU3245498 AA, CA2475327, EP1473998A1. Enhanced activity hydrogen peroxide disinfectant 13/410737. Hydrogen Peroxide Disinfectant Containing a Cyclic Carboxylic acid and/or an Aromatic Alcohol US 7,354,604, EP1562430B1, CA2503627AA, AU 2003302067, JP 4813059. Hydrogen Peroxide Disinfectant Containing a Cyclic Carboxylic acid and/or an Aromatic Alcohol EP 1 955 593 B1. Low foaming hydrogen peroxide solutions for organic soils US 6,686,324, CA 23661741, CA 2454437. Hydrogen peroxide-based skin disinfectant 13/022683, NZ 550744, AU2005244462, CA 2564763. Antimicrobial compositions 60/955,991, WO 2009021336, EP2182811A1. Concentrated Hydrogen Peroxide disinfecting solutions US 8,591,958 B2, CA 2,733,644, 09817139.0, EP2329002B1, NZ 591314, 2011-528154. Virox is the creator and manufacturer of cleaning and disinfecting chemicals based on our patented accelerated hydrogen peroxide technology. Virox is not directly or indirectly associated with the sale or support ATP meters. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Anderson RE, 2011, J HOSP INFECT, V78, P178, DOI 10.1016/j.jhin.2011.01.030; Bellamy E., 2012, Journal of Infection Prevention, V13, P154; Brown E, 2010, J HOSP INFECT, V74, P193, DOI 10.1016/j.jhin.2009.10.006; Carrick K, 2001, J I BREWING, V107, P31, DOI 10.1002/j.2050-0416.2001.tb00077.x; Chen FC, 2006, J FOOD PROTECT, V69, P2534, DOI 10.4315/0362-028X-69.10.2534; Dancer SJ, 2009, J HOSP INFECT, V73, P378, DOI 10.1016/j.jhin.2009.03.030; Dancer SJ, 1999, J HOSP INFECT, V43, P85, DOI 10.1053/jhin.1999.0616; Green T, 1998, J FOOD; Green TA, 1999, J FOOD PROTECT, V62, P86, DOI 10.4315/0362-028X-62.1.86; Griffith CJ, 2000, J HOSP INFECT, V45, P19, DOI 10.1053/jhin.1999.0717; Hassan Mahmud, 2010, Hosp Top, V88, P82, DOI 10.1080/00185868.2010.507124; Havill NL, 2011, AM J INFECT CONTROL, V39, P602, DOI 10.1016/j.ajic.2010.10.030; Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130; Leon M. B., 2007, Journal of Foodservice, V18, P145, DOI 10.1111/j.1745-4506.2007.00060.x; Lewis T, 2008, J HOSP INFECT, V69, P156, DOI 10.1016/j.jhin.2008.03.013; Moore G, 2012, AM J INFECT CONTROL, V37, P1; Mubiru DN, 2008, ANAL LETT, V41, P2587, DOI 10.1080/00032710802363339; Mulvey D, 2011, J HOSP INFECT, V77, P25, DOI 10.1016/j.jhin.2010.08.006; Murphy SC, 1998, J DAIRY SCI, V81, P817, DOI 10.3168/jds.S0022-0302(98)75639-5; Rampling A, 2001, J HOSP INFECT, V49, P109, DOI 10.1053/jhin.2001.1013; Sciortino CV, 2012, AM J INFECT CONTROL, V40, pE233, DOI 10.1016/j.ajic.2012.04.318; Turner D, 2010, J AM; Velazquez M, 1997, J FOOD PROTECT, V60, P799, DOI 10.4315/0362-028X-60.7.799; Velusamy V, 2010, BIOTECHNOL ADV, V28, P232, DOI 10.1016/j.biotechadv.2009.12.004	24	48	52	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99951	10.1371/journal.pone.0099951	http://dx.doi.org/10.1371/journal.pone.0099951			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940751	Green Published, gold, Green Submitted			2022-12-27	WOS:000338508200059
J	Shiner, EK; Holbrook, BC; Alexander-Miller, MA				Shiner, Erin K.; Holbrook, Beth C.; Alexander-Miller, Martha A.			CD4(+) T Cell Subset Differentiation and Avidity Setpoint Are Dictated by the Interplay of Cytokine and Antigen Mediated Signals	PLOS ONE			English	Article							PROTEIN-TYROSINE KINASES; E3 UBIQUITIN LIGASE; IN-VIVO; INTERLEUKIN-4 IL-4; ADAPTIVE TOLERANCE; TH17 RESPONSE; RECEPTOR; ACTIVATION; EXPRESSION; ANERGY	CD4(+) T cell differentiation has been shown to be regulated by the cytokine milieu present during activation as well as peptide MHC levels. However, the extent to which these two important regulatory signals work in concert to shape CD4(+) T cell function has not been investigated. Using a murine OT-II transgenic TCR model of in vitro differentiation, we demonstrate that the ability of CD4(+) T cells to commit to a distinct lineage, i.e. Th1 vs. Th2 vs. Th17, is restricted by the amount of peptide antigen present in the stimulating environment. In addition, whether cells succumb to inhibitory effects associated with high dose antigen is dependent on the array of cytokine signals encountered. Specifically, stimulation with high dose antigen in Th1 or Th17 conditions promoted efficient generation of functional cells, while Th2 polarizing conditions did not. Finally, we found that the peptide sensitivity of an effector cell was determined by the combined actions of cytokine and peptide level, with Th1 cells exhibiting the highest avidity, followed by Th17 and Th2 cells. Together, these data show that the interplay of antigen and cytokine signals shape both the differentiation fate and avidity setpoint of CD4(+) T cells.	[Holbrook, Beth C.; Alexander-Miller, Martha A.] Wake Forest Sch Med, Sect Rheumatol & Immunol, Dept Microbiol & Immunol, Winston Salem, NC 27157 USA; [Shiner, Erin K.] Wake Forest Sch Med, Sect Rheumatol & Immunol, Dept Internal Med, Winston Salem, NC USA	Wake Forest University; Wake Forest University	Alexander-Miller, MA (corresponding author), Wake Forest Sch Med, Sect Rheumatol & Immunol, Dept Microbiol & Immunol, Winston Salem, NC 27157 USA.	marthaam@wakehealth.edu		Holbrook, Beth/0000-0001-6026-695X	NIH [R01 AI043591]; Department of Internal Medicine at Wake Forest University School of Medicine; Department of Microbiology and Immunology at Wake Forest University School of Medicine; NATIONAL CANCER INSTITUTE [P30CA012197] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Internal Medicine at Wake Forest University School of Medicine; Department of Microbiology and Immunology at Wake Forest University School of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grant R01 AI043591 (M. A. A.-M.) and by funds provided by the Department of Internal Medicine and the Department of Microbiology and Immunology at Wake Forest University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander-Miller MA, 2005, IMMUNOL RES, V31, P13, DOI 10.1385/IR:31:1:13; AlexanderMiller MA, 1996, P NATL ACAD SCI USA, V93, P4102, DOI 10.1073/pnas.93.9.4102; Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Almeida JR, 2009, BLOOD, V113, P6351, DOI 10.1182/blood-2009-02-206557; Balamuth F, 2001, IMMUNITY, V15, P729, DOI 10.1016/S1074-7613(01)00223-0; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Brown DM, 2006, J IMMUNOL, V177, P2888, DOI 10.4049/jimmunol.177.5.2888; Cawthon AG, 2002, J IMMUNOL, V169, P3492, DOI 10.4049/jimmunol.169.7.3492; Cawthon AG, 2001, J IMMUNOL, V167, P2577, DOI 10.4049/jimmunol.167.5.2577; Chiodetti L, 2006, J IMMUNOL, V176, P2279, DOI 10.4049/jimmunol.176.4.2279; Choi S, 2007, SEMIN IMMUNOL, V19, P140, DOI 10.1016/j.smim.2007.02.005; CONNORS M, 1994, J VIROL, V68, P5321, DOI 10.1128/JVI.68.8.5321-5325.1994; CONSTANT S, 1995, J EXP MED, V182, P1591, DOI 10.1084/jem.182.5.1591; Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297; Cote-Sierra J, 2004, P NATL ACAD SCI USA, V101, P3880, DOI 10.1073/pnas.0400339101; Derby MA, 2001, J IMMUNOL, V166, P1690, DOI 10.4049/jimmunol.166.3.1690; Dienz O, 2009, CLIN IMMUNOL, V130, P27, DOI 10.1016/j.clim.2008.08.018; GAJEWSKI TF, 1990, J IMMUNOL, V144, P4110; Gallimore A, 1998, J EXP MED, V187, P1647; Gomez-Rodriguez J, 2009, IMMUNITY, V31, P587, DOI 10.1016/j.immuni.2009.07.009; HOSKEN NA, 1995, J EXP MED, V182, P1579, DOI 10.1084/jem.182.5.1579; Jeon MS, 2004, IMMUNITY, V21, P167, DOI 10.1016/j.immuni.2004.07.013; Jorritsma PJ, 2003, J IMMUNOL, V170, P2427, DOI 10.4049/jimmunol.170.5.2427; Kroger CJ, 2007, IMMUNOLOGY, V122, P167, DOI 10.1111/j.1365-2567.2007.02622.x; Kroger CJ, 2007, J IMMUNOL, V179, P748, DOI 10.4049/jimmunol.179.2.748; McGeachy MJ, 2012, J IMMUNOL, V189, P3285, DOI 10.4049/jimmunol.1201834; McKinstry KK, 2012, J CLIN INVEST, V122, P2847, DOI 10.1172/JCI63689; McKinstry KK, 2009, J IMMUNOL, V182, P7353, DOI 10.4049/jimmunol.0900657; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Muranski P, 2011, IMMUNITY, V35, P972, DOI 10.1016/j.immuni.2011.09.019; Nakayama T, 2010, SEMIN IMMUNOL, V22, P303, DOI 10.1016/j.smim.2010.04.010; Neveu B, 2008, HEPATOLOGY, V48, P713, DOI 10.1002/hep.22379; Oling V, 2010, AUTOIMMUNITY, V43, P573, DOI 10.3109/08916930903540424; Purvis HA, 2010, BLOOD, V116, P4829, DOI 10.1182/blood-2010-03-272153; QUILL H, 1992, J IMMUNOL, V149, P2887; Ranasinghe C, 2009, EUR J IMMUNOL, V39, P1819, DOI 10.1002/eji.200838995; Rees W, 1999, P NATL ACAD SCI USA, V96, P9781, DOI 10.1073/pnas.96.17.9781; Safford M, 2005, NAT IMMUNOL, V6, P472, DOI 10.1038/ni1193; Sedlik C, 2000, J VIROL, V74, P5769, DOI 10.1128/JVI.74.13.5769-5775.2000; Seroogy CM, 2004, J IMMUNOL, V173, P79, DOI 10.4049/jimmunol.173.1.79; SloanLancaster J, 1997, J IMMUNOL, V159, P1160; Strutt TM, 2010, NAT MED, V16, P558, DOI 10.1038/nm.2142; TAMURA T, 1995, J IMMUNOL, V155, P4692; Thauland TJ, 2008, J IMMUNOL, V181, P393, DOI 10.4049/jimmunol.181.1.393; Veldhoen M, 2009, J EXP MED, V206, P43, DOI 10.1084/jem.20081438; Vella A, 1997, J EXP MED, V186, P325, DOI 10.1084/jem.186.2.325; Waite JC, 2012, INT J INFLAMM, V2012, DOI 10.1155/2012/819467; Wurster AL, 2002, MOL CELL BIOL, V22, P117, DOI 10.1128/MCB.22.1.117-126.2002; Yamashita M, 2000, J EXP MED, V191, P1869, DOI 10.1084/jem.191.11.1869; Yee C, 1999, J IMMUNOL, V162, P2227; Yoo JK, 2002, J IMMUNOL, V169, P3637, DOI 10.4049/jimmunol.169.7.3637; Zeh HJ, 1999, J IMMUNOL, V162, P989; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	53	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100175	10.1371/journal.pone.0100175	http://dx.doi.org/10.1371/journal.pone.0100175			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940899	gold, Green Submitted, Green Published			2022-12-27	WOS:000338508200081
J	Wu, H; Qi, XW; Yan, GN; Zhang, QB; Xu, C; Bian, XW				Wu, Hong; Qi, Xiao-wei; Yan, Guang-ning; Zhang, Qing-bi; Xu, Chuan; Bian, Xiu-wu			Is CD133 Expression a Prognostic Biomarker of Non-Small-Cell Lung Cancer? A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							STEM-CELLS; SELF-RENEWAL; MARKER; IDENTIFICATION	Background: The clinical and prognostic significance of CD133 in non-small-cell lung cancer (NSCLC) remains controversial. To clarify a precise determinant of the clinical significance of CD133, we conducted a systematic review and meta-analysis to evaluate the association of CD133 with prognosis and clinicopathological features of NSCLC patients. Methods: The electronic and manual searches were performed through the database of Pubmed, Medline, Web of Science, Scopus, and Chinese CNKI (from January 1, 1982 to January 1, 2014) for titles and abstracts by using the following keywords: "CD133'', "ac133'' or "Prominin-1'', and "lung cancer'' to identify the studies eligible for our analysis. Meta-analysis was performed by using Review Manager 5.0 and the outcomes included the overall survival and various clinicopathological features. Results: A total of 23 studies were finally included, and our results showed that CD133 level was significantly correlated with the overall survival (OR = 2.25, 95% CI: 1.24-4.07, P = 0.008) of NSCLC patients but not with the disease free survival (OR = 1.33, 95% CI = 0.77-2.30, P = 0.31). With respect to clinicopathological features, CD133 level was positively correlated with lymph node metastasis (OR = 1.99, 95% CI = 1.06-3.74, P = 0.03), but not correlated with the histological classification (OR = 1.00, 95% CI = 0.81-1.23, P = 0.99(ac), OR = 0.87, 95% CI = 0.61-1.24, P = 0.45(sc)), or differentiation (OR = 0.94, 95% CI 0.53-1.68, Z = 0.20, P = 0.84 random-effect) of NSCLC patients. Conclusion: High level of CD133 expression trends to correlate with a worse prognosis and a higher rate of lymph node metastasis in NSCLC patients, revealing CD133 as a potential pathological prognostic marker for NSCLC patients.	[Wu, Hong; Yan, Guang-ning; Xu, Chuan; Bian, Xiu-wu] Third Mil Med Univ, Southwest Hosp, Inst Pathol, Chongqing, Peoples R China; [Wu, Hong; Yan, Guang-ning; Xu, Chuan; Bian, Xiu-wu] Third Mil Med Univ, Southwest Hosp, Southwest Canc Ctr, Chongqing, Peoples R China; [Wu, Hong; Yan, Guang-ning; Xu, Chuan; Bian, Xiu-wu] Minist Educ China, Key Lab Tumor Immunopathol, Chongqing, Peoples R China; [Wu, Hong; Xu, Chuan] Chengdu Mil Gen Hosp, Dept Oncol, Chengdu, Sichuan, Peoples R China; [Qi, Xiao-wei] Third Mil Med Univ, Southwest Hosp, Breast Dis Ctr, Chongqing, Peoples R China; [Wu, Hong; Zhang, Qing-bi] Luzhou Med Coll, Dept Publ Hlth, Luzhou, Sichuan, Peoples R China	Army Medical University; Army Medical University; Ministry of Education, China; Army Medical University; Southwest Medical University	Zhang, QB (corresponding author), Luzhou Med Coll, Dept Publ Hlth, Luzhou, Sichuan, Peoples R China.	qingbizhang@126.com; xuchuan100@163.com	Qi, Xiaowei/O-1338-2018; Bian, Xiu-Wu/D-4736-2017	Qi, Xiaowei/0000-0002-5876-4957; Bian, Xiu-Wu/0000-0003-4383-0197; XU, CHUAN/0000-0002-5320-2277	National Basic Research Program of China (973 Program) [2010CB529403]; National Natural Science Foundations of China [81272598]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Basic Research Program of China (973 Program, Grant No. 2010CB529403), National Natural Science Foundations of China (Grant No. 81272598). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamgeer M, 2013, THORAX, V68, P1095, DOI 10.1136/thoraxjnl-2012-203021; Bertolini G, 2009, P NATL ACAD SCI USA, V106, P16281, DOI 10.1073/pnas.0905653106; Chen SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056380; [程继荣 CHENG Ji-rong], 2010, [肿瘤, Tumor], V30, P334; Cortes-Dericks L, 2012, EUR J CARDIO-THORAC, V41, pe173, DOI 10.1093/ejcts/ezs170; Gottschling S, 2013, ANTICANCER RES, V33, P981; Herpel E, 2011, ANTICANCER RES, V31, P4491; Janikova M, 2010, BIOMED PAP, V154, P321, DOI 10.5507/bp.2010.048; Li F, 2011, MED ONCOL, V28, P1458, DOI 10.1007/s12032-010-9646-5; Li LD, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-28; Li Z, 2013, EXP HEMATOL ONCOL, V2, DOI 10.1186/2162-3619-2-17; Lin Xuyong, 2009, Zhongguo Fei Ai Za Zhi, V12, P316, DOI 10.3779/j.issn.1009-3419.2009.04.11; Ma S, 2010, CELL STEM CELL, V7, P694, DOI 10.1016/j.stem.2010.11.010; Mizugaki H, 2013, INT J CLIN ONCOL; Moreira AL, 2010, MODERN PATHOL, V23, P889, DOI 10.1038/modpathol.2010.68; Okudela K, 2012, PATHOL INT, V62, P792, DOI 10.1111/pin.12019; Pine SR, 2008, DIS MARKERS, V24, P257, DOI 10.1155/2008/396281; Pirozzi G, 2013, ONCOL REP, V29, P1763, DOI 10.3892/or.2013.2294; Qu HY, 2013, INT J CLIN EXP PATHO, V6, P2644; Roudi R, 2013, CELL MOL BIOL LETT; Salnikov AV, 2010, INT J CANCER, V126, P950, DOI 10.1002/ijc.24822; Shi CJ, 2011, WORLD J GASTROENTERO, V17, P2965, DOI 10.3748/wjg.v17.i24.2965; Shien K, 2012, LUNG CANCER, V77, P162, DOI 10.1016/j.lungcan.2012.02.006; Sterlacci W, 2014, J THORAC ONCOL, V9, P41, DOI 10.1097/JTO.0000000000000021; Sullivan JP, 2010, CANCER RES, V70, P9937, DOI 10.1158/0008-5472.CAN-10-0881; Tirino V, 2009, EUR J CARDIO-THORAC, V36, P446, DOI 10.1016/j.ejcts.2009.03.063; Wang K, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-573; [魏益平 WEI Yiping], 2008, [中山大学学报. 医学科学版, Journal of Sun Yat-sen University. Medical Sciences], V29, P312; Wen L, 2013, PLOS ONE, V8; Wen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059154; Woo T, 2011, INT J CLIN EXP PATHO, V4, P32; Wu SW, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-535; Xu C, 2013, CANCER RES, V73, P3181, DOI 10.1158/0008-5472.CAN-12-4403; Xu YH, 2010, SAUDI MED J, V31, P980; Yang K, 2011, INT J BIOL MARKER, V26, P173, DOI 10.5301/JBM.2011.8551; Zeppernick F, 2008, CLIN CANCER RES, V14, P123, DOI 10.1158/1078-0432.CCR-07-0932; Zhang H, 2014, NEOPLASMA, V61, P153, DOI 10.4149/neo_2014_021; Zhang Hui-zhong, 2007, Nan Fang Yi Ke Da Xue Xue Bao, V27, P696	38	22	25	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100168	10.1371/journal.pone.0100168	http://dx.doi.org/10.1371/journal.pone.0100168			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940615	Green Published, Green Submitted, gold			2022-12-27	WOS:000338508200079
J	McDevitt, AD; Montgomery, WI; Tosh, DG; Lusby, J; Reid, N; White, TA; McDevitt, CD; O'Halloran, J; Searle, JB; Yearsley, JM				McDevitt, Allan D.; Montgomery, W. Ian; Tosh, David G.; Lusby, John; Reid, Neil; White, Thomas A.; McDevitt, C. Damien; O'Halloran, John; Searle, Jeremy B.; Yearsley, Jon M.			Invading and Expanding: Range Dynamics and Ecological Consequences of the Greater White-Toothed Shrew (Crocidura russula) Invasion in Ireland	PLOS ONE			English	Article							SOREX-MINUTUS; CLETHRIONOMYS-GLAREOLUS; DISPERSAL; EVOLUTION; COLONIZATION; COMPETITION; EXPANSION; RATES; IMPACTS; POPULATIONS	Establishing how invasive species impact upon pre-existing species is a fundamental question in ecology and conservation biology. The greater white-toothed shrew (Crocidura russula) is an invasive species in Ireland that was first recorded in 2007 and which, according to initial data, may be limiting the abundance/distribution of the pygmy shrew (Sorex minutus), previously Ireland's only shrew species. Because of these concerns, we undertook an intensive live-trapping survey (and used other data from live-trapping, sightings and bird of prey pellets/nest inspections collected between 2006 and 2013) to model the distribution and expansion of C. russula in Ireland and its impacts on Ireland's small mammal community. The main distribution range of C. russula was found to be approximately 7,600 km 2 in 2013, with established outlier populations suggesting that the species is dispersing with human assistance within the island. The species is expanding rapidly for a small mammal, with a radial expansion rate of 5.5 km/yr overall (2008-2013), and independent estimates from live-trapping in 2012-2013 showing rates of 2.4-14.1 km/yr, 0.5-7.1 km/yr and 0-5.6 km/yr depending on the landscape features present. S. minutus is negatively associated with C. russula. S. minutus is completely absent at sites where C. russula is established and is only present at sites at the edge of and beyond the invasion range of C. russula. The speed of this invasion and the homogenous nature of the Irish landscape may mean that S. minutus has not had sufficient time to adapt to the sudden appearance of C. russula. This may mean the continued decline/disappearance of S. minutus as C. russula spreads throughout the island.	[McDevitt, Allan D.; Yearsley, Jon M.] Univ Coll Dublin, Sch Biol & Environm Sci, Dublin 2, Ireland; [Montgomery, W. Ian; Tosh, David G.; Reid, Neil] Queens Univ Belfast, Sch Biol Sci, Belfast, Antrim, North Ireland; [Lusby, John] Birdwatch Ireland, Kilcoole, Wicklow, Ireland; [White, Thomas A.; Searle, Jeremy B.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY USA; [White, Thomas A.] Univ Oulu, Dept Biol, Oulu, Finland; [McDevitt, C. Damien] Deele Coll, Raphoe, Donegal, Ireland; [O'Halloran, John] Natl Univ Ireland Univ Coll Cork, Sch Biol Earth & Environm Sci, Cork, Ireland	University College Dublin; Queens University Belfast; Cornell University; University of Oulu; University College Cork	McDevitt, AD (corresponding author), Univ Coll Dublin, Sch Biol & Environm Sci, Dublin 2, Ireland.	amcdev@gmail.com	Reid, Neil/M-8517-2019; Reid, Neil/D-1896-2010; Yearsley, Jon/H-5301-2011; McDevitt, Allan/A-9316-2011	Reid, Neil/0000-0001-8951-8292; Reid, Neil/0000-0001-8951-8292; Yearsley, Jon/0000-0003-1838-0454; Searle, Jeremy/0000-0001-7710-5204; McDevitt, Allan/0000-0002-2677-7833	Government of Ireland Postdoctoral Fellowship by the Irish Research Council (IRC); Heritage Council (HC), a Heredity Fieldwork Grant from the Genetics Society; Vincent Wildlife Trust; HC; Embark Scholarship from the IRC; National Parks and Wildlife Services of the Department of Arts, Heritage and the Gaelthacht; Department of Agriculture, Fisheries and the Marine; Kerry Co. Council; Cork Co. Council; Galway Co. Council; Northern Ireland Environment Agency; Quercus, Queen's University Belfast	Government of Ireland Postdoctoral Fellowship by the Irish Research Council (IRC); Heritage Council (HC), a Heredity Fieldwork Grant from the Genetics Society; Vincent Wildlife Trust; HC; Embark Scholarship from the IRC; National Parks and Wildlife Services of the Department of Arts, Heritage and the Gaelthacht; Department of Agriculture, Fisheries and the Marine; Kerry Co. Council; Cork Co. Council; Galway Co. Council; Northern Ireland Environment Agency; Quercus, Queen's University Belfast	ADM was funded by a Government of Ireland Postdoctoral Fellowship awarded by the Irish Research Council (IRC), and was provided with additional funding by the Heritage Council (HC), a Heredity Fieldwork Grant from the Genetics Society, and the Vincent Wildlife Trust. DGT was supported by the HC. JL was funded by an Embark Scholarship from the IRC; BirdWatch Ireland received funding through The National Parks and Wildlife Services of the Department of Arts, Heritage and the Gaelthacht; The Department of Agriculture, Fisheries and the Marine; the HC; Kerry Co. Council; Cork Co. Council and Galway Co. Council. NR was supported by the Natural Heritage Research Partnership between the Northern Ireland Environment Agency and Quercus, Queen's University Belfast. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askew NP, 2006, THESIS U YORK; Barton KA, 2012, P ROY SOC B-BIOL SCI, V279, P1194, DOI 10.1098/rspb.2011.1254; Bouteiller C, 2000, P ROY SOC B-BIOL SCI, V267, P701, DOI 10.1098/rspb.2000.1059; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Burton OJ, 2010, ECOL LETT, V13, P1210, DOI 10.1111/j.1461-0248.2010.01505.x; Butet A, 2006, AGR ECOSYST ENVIRON, V113, P364, DOI 10.1016/j.agee.2005.10.008; CANTONI D, 1989, ANIM BEHAV, V38, P205, DOI 10.1016/S0003-3472(89)80083-1; Churchfield S, 2006, J ZOOL, V269, P381, DOI 10.1111/j.1469-7998.2006.00115.x; Churchfield S, 1997, J ZOOL, V241, P55, DOI 10.1111/j.1469-7998.1997.tb05499.x; Churchfield S, 2008, MAMMALS BRIT ISLES H, P267; Cornette R, 2012, BIOL J LINN SOC, V107, P322, DOI 10.1111/j.1095-8312.2012.01934.x; Croll DA, 2005, SCIENCE, V307, P1959, DOI 10.1126/science.1108485; DeCesare NJ, 2010, ANIM CONSERV, V13, P353, DOI 10.1111/j.1469-1795.2009.00328.x; DICKMAN CR, 1988, ECOLOGY, V69, P569, DOI 10.2307/1941006; Dussex N, 2008, THESIS U LAUSANNE; ELLENBROEK FJM, 1980, J ZOOL, V192, P119; Favre L, 1997, P ROY SOC B-BIOL SCI, V264, P127, DOI 10.1098/rspb.1997.0019; Flowerdew JR, 2004, MAMMAL REV, V34, P31, DOI 10.1046/j.0305-1838.2003.00025.x; Fontanillas P, 2004, EVOLUTION, V58, P886; Forsman A, 2011, P ROY SOC B-BIOL SCI, V278, P225, DOI 10.1098/rspb.2010.1325; GRAINGER JP, 1978, J ZOOL, V186, P109, DOI 10.1111/j.1469-7998.1978.tb03360.x; Guelat J, 2008, ECOLOGY, V89, P2033, DOI 10.1890/07-0905.1; HANSKI I, 1989, ANN ZOOL FENN, V26, P339; Jaquiery J, 2008, ECOLOGY, V89, P2777, DOI 10.1890/07-1833.1; Lindstrom T, 2013, P NATL ACAD SCI USA, V110, P13452, DOI 10.1073/pnas.1303157110; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; MacDougall AS, 2005, ECOLOGY, V86, P42, DOI 10.1890/04-0669; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Maestri R, 2014, ACTA THERIOL, V59, P427, DOI 10.1007/s13364-014-0177-x; MALMQUIST M, 1986, OECOLOGIA, V68, P344, DOI 10.1007/BF01036736; McDevitt AD, 2011, HEREDITY, V107, P548, DOI 10.1038/hdy.2011.41; McDevitt AD, 2008, THESIS U COLL DUBLIN; McDevitt AD, 2009, BIOL J LINN SOC, V97, P918, DOI 10.1111/j.1095-8312.2009.01218.x; Meehan JM, 2005, THESIS U COLL DUBLIN; MEHARG MJ, 1990, J ZOOL, V222, P1, DOI 10.1111/j.1469-7998.1990.tb04025.x; MICHIELSEN NORA CROIN, 1966, ARCH NEER ZOOL, V17, P73; MitchellJones A.J., 1999, ATLAS EUROPEAN MAMMA; Montgomery WI, 2012, BIOL INVASIONS, V14, P1111, DOI 10.1007/s10530-011-0142-4; O'Meara DB, 2014, ACTA THERIOL, V59, P111, DOI 10.1007/s13364-013-0155-8; PELTONEN A, 1991, ECOLOGY, V72, P1698, DOI 10.2307/1940969; Perkins TA, 2013, ECOL LETT, V16, P1079, DOI 10.1111/ele.12136; Petren K, 1998, P NATL ACAD SCI USA, V95, P11739, DOI 10.1073/pnas.95.20.11739; Petren K, 1996, ECOLOGY, V77, P118, DOI 10.2307/2265661; Phillips BL, 2010, J EVOLUTION BIOL, V23, P2595, DOI 10.1111/j.1420-9101.2010.02118.x; Phillips BL, 2009, BIOL LETTERS, V5, P802, DOI 10.1098/rsbl.2009.0367; Phillips BL, 2007, AUSTRAL ECOL, V32, P169, DOI 10.1111/j.1442-9993.2007.01664.x; Phillips BL, 2006, NATURE, V439, P803, DOI 10.1038/439803a; PREECE RC, 1986, J BIOGEOGR, V13, P487, DOI 10.2307/2844814; Reid N, 2011, BIOL INVASIONS, V13, P559, DOI 10.1007/s10530-010-9849-x; Service Forest, 2007, NAT FOR INV IR RES; Shawyer C. R., 1998, THE BARN OWL; Shine R, 2010, Q REV BIOL, V85, P253, DOI 10.1086/655116; Shine R, 2011, P NATL ACAD SCI USA, V108, P5708, DOI 10.1073/pnas.1018989108; Simberloff Daniel, 1999, Biological Invasions, V1, P21, DOI 10.1023/A:1010086329619; Simberloff D, 2013, TRENDS ECOL EVOL, V28, P58, DOI 10.1016/j.tree.2012.07.013; SMAL CM, 1984, MAMMAL REV, V14, P71, DOI 10.1111/j.1365-2907.1984.tb00340.x; Solow A, 2008, J APPL ECOL, V45, P424, DOI 10.1111/j.1365-2664.2007.01446.x; Sutherland WJ, 2013, J ECOL, V101, P58, DOI 10.1111/1365-2745.12025; Terrink BJ, 1991, HAIR W EUROPEAN MAMM; Tosh DG, 2008, MAMMAL REV, V38, P321, DOI 10.1111/j.1365-2907.2008.00130.x; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; Village A., 1990, THE KESTREL; Vogel P, 2002, ACTA THERIOL, V47, P15, DOI 10.1007/BF03193562; WATTS CHS, 1968, J ANIM ECOL, V37, P25, DOI 10.2307/2709; White TA, 2013, MOL ECOL, V22, P2971, DOI 10.1111/mec.12343; White TA, 2012, BIOL INVASIONS, V14, P2203, DOI 10.1007/s10530-012-0225-x; WOLFE JL, 1989, ANIM BEHAV, V37, P410, DOI 10.1016/0003-3472(89)90088-2; YALDEN D W, 1973, Mammalia, V37, P257, DOI 10.1515/mamm.1973.37.2.257; YALDEN DW, 1985, BIRD STUDY, V32, P50, DOI 10.1080/00063658509476855; Yalden DW, 2003, ANAL OWL PELLETS; Yalden DW, 2008, MAMMALS BRIT ISLES H, V4th, P280	71	21	21	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100403	10.1371/journal.pone.0100403	http://dx.doi.org/10.1371/journal.pone.0100403			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955824	gold, Green Submitted, Green Published			2022-12-27	WOS:000338917900048
J	Razak, FA; Jensen, HJ				Razak, Fatimah Abdul; Jensen, Henrik Jeldtoft			Quantifying 'Causality' in Complex Systems: Understanding Transfer Entropy	PLOS ONE			English	Article							TIME-SERIES	'Causal' direction is of great importance when dealing with complex systems. Often big volumes of data in the form of time series are available and it is important to develop methods that can inform about possible causal connections between the different observables. Here we investigate the ability of the Transfer Entropy measure to identify causal relations embedded in emergent coherent correlations. We do this by firstly applying Transfer Entropy to an amended Ising model. In addition we use a simple Random Transition model to test the reliability of Transfer Entropy as a measure of 'causal' direction in the presence of stochastic fluctuations. In particular we systematically study the effect of the finite size of data sets.	[Razak, Fatimah Abdul; Jensen, Henrik Jeldtoft] Univ London Imperial Coll Sci Technol & Med, Complex & Networks Grp, London, England; [Razak, Fatimah Abdul; Jensen, Henrik Jeldtoft] Univ London Imperial Coll Sci Technol & Med, Dept Math, London, England; [Razak, Fatimah Abdul] Univ Kebangsaan Malaysia, Sch Math Sci, Fac Sci & Technol, Bangi 43600, Selangor, Malaysia	Imperial College London; Imperial College London; Universiti Kebangsaan Malaysia	Razak, FA (corresponding author), Univ London Imperial Coll Sci Technol & Med, Complex & Networks Grp, London, England.	fatima84@ukm.edu.my	Razak, Fatimah Abdul/AAT-8224-2021	Razak, Fatimah Abdul/0000-0002-3045-7963	Universiti Kebangsaan Malaysia [GGPM-2013-067, DLP-2013-007]	Universiti Kebangsaan Malaysia	The authors gratefully acknowledge the financial support received in the form of research grants from Universiti Kebangsaan Malaysia (GGPM-2013-067 and DLP-2013-007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul Razak F, 2013, THESIS IMPERIAL COLL; [Anonymous], 2008, POLITICAL I DICTATOR; Bak P., 1996, NATURE WORKS SCI SEL; Bressler SL, 2011, NEUROIMAGE, V58, P323, DOI 10.1016/j.neuroimage.2010.02.059; Christensen K., 2005, COMPLEXITY CRITICALI, V1, DOI DOI 10.1142/P365; CIPRA BA, 1987, AM MATH MON, V94, P937, DOI 10.2307/2322600; Cover TM., 1999, ELEMENTS INFORM THEO; Friston KJ, 2011, NEUROIMAGE, V58, P303, DOI 10.1016/j.neuroimage.2009.09.031; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Hausman D. M., 1999, BRIT J PHILOS SCI, V50, P151, DOI [10.1093/bjps/50.1.151, DOI 10.1093/BJPS/50.1.151]; Hlavackova-Schindler K, 2007, PHYS REP, V441, P1, DOI 10.1016/j.physrep.2006.12.004; Jensen H.J., 1998, SELF ORG CRITICALITY; Jensen HJ, 2009, ENCY COMPLEXITY SYST, P7024; Kaiser A, 2002, PHYSICA D, V166, P43, DOI 10.1016/S0167-2789(02)00432-3; Kraskov A, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066138; Krauth W., 2006, STAT MECH ALGORITHMS; Li ZH, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.021929; Lungarella M, 2007, INT J BIFURCAT CHAOS, V17, P903, DOI 10.1142/S0218127407017628; Marschinski R, 2002, EUR PHYS J B, V30, P275, DOI 10.1140/epjb/e2002-00379-2; Martini M, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.011919; Nichols JM, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.046217; Palus M, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.055201; Papana A, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.036207; Pompe B, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.051122; Pruessner G, 2012, SELF-ORGANISED CRITICALITY: THEORY, MODELS AND CHARACTERISATION, P1; Runge J, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.061121; Sauer N., 2010, T ROY SOC S AFR, V65, P65, DOI [DOI 10.1080/00359191003680091, 10.1080/00359191003680091]; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; THEILER J, 1986, PHYS REV A, V34, P2427, DOI 10.1103/PhysRevA.34.2427; Vejmelka M, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.026214; Vicente R, 2011, J COMPUT NEUROSCI, V30, P45, DOI 10.1007/s10827-010-0262-3; Wibral M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055809; Wiener Norbert, 1956, I AM MATH LATER LIFE; Witthauer L., 2007, PHASE TRANSITION 2D	35	31	31	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e99462	10.1371/journal.pone.0099462	http://dx.doi.org/10.1371/journal.pone.0099462			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955766	Green Submitted, gold, Green Published			2022-12-27	WOS:000338917900011
J	Sherwood, JL; Muller, S; Orr, MCM; Ratcliffe, MJ; Walker, J				Sherwood, James L.; Mueller, Susanne; Orr, Maria C. M.; Ratcliffe, Marianne J.; Walker, Jill			Panel Based MALDI-TOF Tumour Profiling Is a Sensitive Method for Detecting Mutations in Clinical Non Small Cell Lung Cancer Tumour	PLOS ONE			English	Article							KRAS MUTATIONS; EGFR; PATHWAY; KINASE; ACTIVATION; INHIBITORS; EPIDEMIOLOGY; ADDICTION	Background: Analysis of tumour samples for mutations is becoming increasingly important in driving personalised therapy in cancer. As more targeted therapies are developed, options to survey mutations in multiple genes in a single tumour sample will become ever more attractive and are expected to become the mainstay of molecular diagnosis in non-small cell lung cancer (NSCLC) in the future. Materials and Methods: 238 non-small cell lung cancer (NSCLC) tumour samples were analysed using a custom panel of 82 mutation assays across 14 oncogenes including KRAS and EGFR using Sequenom iPlex Matrix Assisted Laser Desorption/Ionisation Time of Flight Mass Spectrometry (MALDI-TOF). We compared the data generated for KRAS mutations to those detected by Amplification Refractory Mutation System (ARMS) based DxS TheraScreen K-RAS Mutation Kit. Results: The ARMS detected mutations in 46/238 tumour samples. For samples with mutations detected by both approaches, 99.1% overall agreement was observed. The MALDI-TOF method detected an additional 6 samples as KRAS mutation positive and also provided data on concomitant mutations including PIK3CA and TP53. Conclusions: The Sequenom MALDI-TOF method provides a sensitive panel-based approach which makes efficient use of patient diagnostic samples. This technology could provide an opportunity to deliver comprehensive screening of relevant biomarkers to the clinic earlier in disease management, without the need for repeat biopsy and allow for additional downstream analysis in NSCLC where available tissue may have been exhausted.	[Sherwood, James L.; Orr, Maria C. M.; Ratcliffe, Marianne J.; Walker, Jill] AstraZeneca, Personalised Healthcare & Biomarkers, Macclesfield, Cheshire, England; [Mueller, Susanne] Sequenom GmbH, Hamburg, Germany	AstraZeneca	Sherwood, JL (corresponding author), AstraZeneca, Personalised Healthcare & Biomarkers, Macclesfield, Cheshire, England.	James.Sherwood@AstraZeneca.com	Sherwood, James L/C-5559-2016	Sherwood, James L/0000-0002-7429-4369	AstraZeneca	AstraZeneca(AstraZeneca)	This work was funded by AstraZeneca. The funder provided support in the form ofmsalaries for authors JLS, MCMO, MJR, and JW and Sequenom GmbH for author SM, but did not have any role in the study design, data collection or analysis, decision to publish or preparation of the manuscript.	Ang HC, 2006, J BIOL CHEM, V281, P21934, DOI 10.1074/jbc.M604209200; Angulo B, 2010, J MOL DIAGN, V12, P292, DOI 10.2353/jmoldx.2010.090139; Arcila M, 2011, J MOL DIAGN, V13, P64, DOI 10.1016/j.jmoldx.2010.11.005; Avruch J, 2001, RECENT PROG HORM RES, V56, P127, DOI 10.1210/rp.56.1.127; Benesova L, 2010, ANTICANCER RES, V30, P1667; Chappell WH, 2011, ONCOTARGET, V2, P135, DOI 10.18632/oncotarget.240; Dearden S, 2013, ANN ONCOL, V24, P2371, DOI 10.1093/annonc/mdt205; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Dogan S, 2012, CLIN CANCER RES, V18, P6169, DOI 10.1158/1078-0432.CCR-11-3265; Dry JR, 2010, CANCER RES, V70, P2264, DOI 10.1158/0008-5472.CAN-09-1577; Ellison G, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-132; Fumagalli D, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-101; Gazdar AF, 2004, TRENDS MOL MED, V10, P481, DOI 10.1016/j.molmed.2004.08.008; Janne PA, 2013, LANCET ONCOL, V14, P38, DOI 10.1016/S1470-2045(12)70489-8; Kalikaki A, 2008, BRIT J CANCER, V99, P923, DOI 10.1038/sj.bjc.6604629; Lee S, 2012, VIRCHOWS ARCH, V460, P141, DOI 10.1007/s00428-011-1180-0; Liao RG, 2013, CANCER RES, V73, P5195, DOI 10.1158/0008-5472.CAN-12-3950; Lindeman NI, 2013, J THORAC ONCOL, V8, P823, DOI 10.1097/JTO.0b013e318290868f; Marks JL, 2008, CANCER RES, V68, P5524, DOI 10.1158/0008-5472.CAN-08-0099; Ohashi K, 2013, CLIN CANCER RES, V19, P2584, DOI 10.1158/1078-0432.CCR-12-3173; Robert C, 2013, LANCET ONCOL, V14, P733, DOI 10.1016/S1470-2045(13)70237-7; Shin I, 2005, J BIOL CHEM, V280, P14675, DOI 10.1074/jbc.M411625200; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Wee S, 2009, CANCER RES, V69, P4286, DOI 10.1158/0008-5472.CAN-08-4765; Yeh TC, 2007, CLIN CANCER RES, V13, P1576, DOI 10.1158/1078-0432.CCR-06-1150; Youlden DR, 2008, J THORAC ONCOL, V3, P819, DOI 10.1097/JTO.0b013e31818020eb	26	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100566	10.1371/journal.pone.0100566	http://dx.doi.org/10.1371/journal.pone.0100566			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956168	Green Published, Green Submitted, gold			2022-12-27	WOS:000338917900069
J	Li, N; Yu, J; Cao, X; Wu, QY; Li, WW; Li, TF; Zhang, C; Cui, YX; Li, XJ; Yin, ZM; Xia, XY				Li, Na; Yu, Jian; Cao, Xiang; Wu, Qiu-Yue; Li, Wei-Wei; Li, Tian-Fu; Zhang, Cui; Cui, Ying-Xia; Li, Xiao-Jun; Yin, Zhi-Min; Xia, Xin-Yi			A Novel p. Gly630Ser Mutation of COL2A1 in a Chinese Family with Presentations of Legg-Calve-Perthes Disease or Avascular Necrosis of the Femoral Head	PLOS ONE			English	Article							COLLAGEN GENE; CARTILAGE; PROPEPTIDE; SPECTRUM; BONE	Objective: Mutations in the type II collagen gene are associated with certain human disorders, collectively termed type II collagenopathies. They include Legg-Calve-Perthes disease (LCPD) and avascular necrosis of the femoral head (ANFH). These two diseases are skeletal dysplasias, inherited in an autosomal dominant fashion, characterized by groin pain, dislocation of the hip and diminished joint mobility. Coxa vara and elevation of the greater trochanter of the femur comprise the typical phenotype of LCPD, but do not occur in ANFH. Lack of synthesis of type II collagen and structural defects are responsible for the major clinical outcomes, because collagen is the essential matrix protein of all connective tissues. Type II collagen, encoded by the COL2A1 gene, contains N- and C-terminal regions that are cleaved after secretion into the extracellular matrix, and the core area is composed of a triple helical (Gly-X-Y) domain. If the Gly in this specific region is replaced by other amino acids, the structure of type II collagen will be destroyed. Method: Forty-five members of a four-generation family were recruited and investigated. Diagnosis was made by independent orthopedic surgeons and radiologists. A mutation of the COL2A1 gene was detected. Result: In our research, we identify a heterozygous mutation (c.1888 G>A, p. Gly630Ser) in exon 29 of COL2A1 in the Gly-X-Y domain, in a Chinese family affected by LCPD and ANFH. Our findings provide significant clues to the phenotype-genotype relationships in these syndromes and may be helpful in clinical diagnosis. Furthermore, these results should assist further studies of the mechanisms underlying collagen diseases. Conclusion: Our data add new variants to the repertoire of COL2A1 mutation resulting in related collagenopathies.	[Li, Na; Cao, Xiang; Wu, Qiu-Yue; Li, Wei-Wei; Li, Tian-Fu; Zhang, Cui; Cui, Ying-Xia; Li, Xiao-Jun; Yin, Zhi-Min; Xia, Xin-Yi] Nanjing Univ, Sch Med, Jinling Hosp, Inst Lab Med, Nanjing 210008, Jiangsu, Peoples R China; [Yu, Jian] Nanjing Univ, Sch Med, Jinling Hosp, Dept Orthopaed, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Nanjing University	Xia, XY (corresponding author), Nanjing Univ, Sch Med, Jinling Hosp, Inst Lab Med, Nanjing 210008, Jiangsu, Peoples R China.	xinyixia78@gmail.com			Natural Science Foundation of Jiangsu province [BK2011660]; Key Foundation of Jiangsu Science and Technology Bureau [BM2013058]	Natural Science Foundation of Jiangsu province(Natural Science Foundation of Jiangsu Province); Key Foundation of Jiangsu Science and Technology Bureau	This work was financially supported by grants from the Natural Science Foundation of Jiangsu province (BK2011660) and Key Foundation of Jiangsu Science and Technology Bureau (BM2013058). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON IJ, 1990, AM J HUM GENET, V46, P896; CHEAH KSE, 1991, DEVELOPMENT, V111, P945; Chung HJ, 2009, J MOL BIOL, V390, P306, DOI 10.1016/j.jmb.2009.05.004; Eyre D, 2002, ARTHRITIS RES, V4, P30, DOI 10.1186/ar380; Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002; GODFREY M, 1988, AM J HUM GENET, V43, P894; Jobling R, 2014, CURR RHEUMATOL REP, V16, DOI 10.1007/s11926-013-0394-3; Kannu P, 2011, AM J MED GENET A, V155A, P1759, DOI 10.1002/ajmg.a.34056; Kannu P, 2011, CLIN ORTHOP RELAT R, V469, P1785, DOI 10.1007/s11999-011-1850-x; Kerachian MA, 2006, ENDOTHELIUM-J ENDOTH, V13, P237, DOI 10.1080/10623320600904211; Kuivaniemi H, 1997, HUM MUTAT, V9, P300, DOI 10.1002/(SICI)1098-1004(1997)9:4<300::AID-HUMU2>3.0.CO;2-9; Lamande SR, 1999, SEMIN CELL DEV BIOL, V10, P455, DOI 10.1006/scdb.1999.0317; Liu YF, 2005, NEW ENGL J MED, V352, P2294, DOI 10.1056/NEJMoa042480; Meredith SP, 2007, BRIT J OPHTHALMOL, V91, P1148, DOI 10.1136/bjo.2006.112482; Miyamoto Y, 2007, HUM GENET, V121, P625, DOI 10.1007/s00439-007-0354-y; Mortier GR, 2000, J MED GENET, V37, P263, DOI 10.1136/jmg.37.4.263; Nishimura G, 2005, HUM MUTAT, V26, P36, DOI 10.1002/humu.20179; Pace JM, 2001, J MED GENET, V38, P443, DOI 10.1136/jmg.38.7.443; Seegmiller RE, 2008, J HISTOCHEM CYTOCHEM, V56, P1003, DOI 10.1369/jhc.2008.951673; Su PQ, 2008, ARTHRITIS RHEUM-US, V58, P1701, DOI 10.1002/art.23491; TAKAHASHI E, 1990, HUM GENET, V86, P14; Terhal PA, 2012, AM J MED GENET C, V160C, P205, DOI 10.1002/ajmg.c.31332; TILLER GE, 1995, AM J HUM GENET, V56, P388; Warman ML, 2011, AM J MED GENET A, V155A, P943, DOI 10.1002/ajmg.a.33909; Yang RC, 2013, J FORMOS MED ASSOC, pS0929	25	41	44	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100505	10.1371/journal.pone.0100505	http://dx.doi.org/10.1371/journal.pone.0100505			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949742	Green Submitted, Green Published, gold			2022-12-27	WOS:000338276300081
J	Pohlkamp, T; Steller, L; May, P; Gunther, T; Schule, R; Frotscher, M; Herz, J; Bock, HH				Pohlkamp, Theresa; Steller, Laura; May, Petra; Guenther, Thomas; Schuele, Roland; Frotscher, Michael; Herz, Joachim; Bock, Hans H.			Generation and Characterization of an Nse-CreER(T2) Transgenic Line Suitable for Inducible Gene Manipulation in Cerebellar Granule Cells	PLOS ONE			English	Article							CRE RECOMBINASE ACTIVITY; MOUSE CEREBELLUM; PURKINJE-CELLS; QUANTITATIVE-ANALYSIS; NEURONAL MARKER; DIFFERENTIATION; EXPRESSION; MIGRATION; CORTEX; PROLIFERATION	We created an Nse-CreER(T2) mouse line expressing the tamoxifen-inducible CreER(T2) recombinase under the control of the neuron-specific enolase (Nse) promoter. By using Cre reporter lines we could show that this Nse-CreER(T2) line has recombination activity in the granule cells of all cerebellar lobules as well as in postmitotic granule cell precursors in the external granular layer of the developing cerebellum. A few hippocampal dentate gyrus granule cells showed Cre-mediated recombination as well. Cre activity could be induced in both the developing and adult mouse brain. The established mouse line constitutes a valuable tool to study the function of genes expressed by cerebellar granule cells in the developing and adult brain. In combination with reporter lines it is a useful model to analyze the development and maintenance of the cerebellar architecture including granule cell distribution, migration, and the extension of granule cell fibers in vivo.	[Pohlkamp, Theresa; Steller, Laura; May, Petra; Herz, Joachim; Bock, Hans H.] Univ Freiburg, Ctr Neurosci, Dept Neuroanat, D-79106 Freiburg, Germany; [Pohlkamp, Theresa; Herz, Joachim] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [May, Petra; Bock, Hans H.] Univ Dusseldorf, Clin Gastroenterol Hepatol & Infectiol, Dusseldorf, Germany; [Guenther, Thomas; Schuele, Roland] Univ Hosp Freiburg, Dept Urol, Freiburg, Germany; [Frotscher, Michael] Univ Hamburg, Ctr Mol Neurobiol, Inst Struct Neurobiol, Hamburg, Germany	University of Freiburg; University of Texas System; University of Texas Southwestern Medical Center Dallas; Heinrich Heine University Dusseldorf; University of Freiburg; University of Hamburg	Pohlkamp, T (corresponding author), Univ Freiburg, Ctr Neurosci, Dept Neuroanat, Hugstetter Str 55, D-79106 Freiburg, Germany.	theresa@herzlab.org; joachim.herz@utsouthwestern.edu; hans.bock@med.uni-duesseldorf.de	Bock, Hans/AAF-2635-2021; Pohlkamp, Theresa/H-2705-2019	Pohlkamp, Theresa/0000-0003-3923-1917; Gunther, Thomas/0000-0003-3903-9490	Deutsche Forschungsgemeinschaft (DFG) [SFB 780/TP5, MA2410/1-3, -4, FR 620/12-1]; National Institutes of Health (NIH) [R37 HL63762]; Bundesministerium fur Bildung und Forschung (BMBF, e:bio ReelinSys); Humboldt Foundation; American Health Assistance Foundation; Consortium for Frontotemporal Dementia Research; Bright Focus Foundation; Lupe Murchison Foundation; Ted Nash Long Life Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063762, R37HL063762] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bundesministerium fur Bildung und Forschung (BMBF, e:bio ReelinSys); Humboldt Foundation(Alexander von Humboldt Foundation); American Health Assistance Foundation(BrightFocus Foundation); Consortium for Frontotemporal Dementia Research; Bright Focus Foundation(BrightFocus Foundation); Lupe Murchison Foundation; Ted Nash Long Life Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) (grant numbers SFB 780/TP5 to J.H., H.B. and M.F.), MA2410/1-3 and -4 (P.M.), FR 620/12-1, National Institutes of Health (NIH) grant R37 HL63762 (to J.H.), and Bundesministerium fur Bildung und Forschung (BMBF, e:bio ReelinSys, to H.B.). J.H. was the recipient of a Wolfgang Paul award of the Humboldt Foundation and is further supported by the American Health Assistance Foundation, the Consortium for Frontotemporal Dementia Research, the Bright Focus Foundation, the Lupe Murchison Foundation, and The Ted Nash Long Life Foundation. M.F. is Senior Professor for Neuroscience of the Hertie Foundation. The authors wish to thank Jonathan Goldner, Aileen Koch, Tamara Terrones and Sandy Turner for technical support with genotyping. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN ND, 1988, NATURE, V333, P852, DOI 10.1038/333852a0; BAPTISTA CA, 1994, NEURON, V12, P243, DOI 10.1016/0896-6273(94)90268-2; BAYER SA, 1980, J COMP NEUROL, V190, P87, DOI 10.1002/cne.901900107; Chizhikov V, 2003, MOL GENET METAB, V80, P54, DOI 10.1016/j.ymgme.2003.08.019; Chow LML, 2006, DEV DYNAM, V235, P2991, DOI 10.1002/dvdy.20948; Cinato E, 2001, GENESIS, V31, P118, DOI 10.1002/gene.10014; ECCLES JC, 1966, EXP BRAIN RES, V1, P1; EDWARDS MA, 1986, J COMP NEUROL, V248, P410, DOI 10.1002/cne.902480309; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; FORSSPETTER S, 1990, NEURON, V5, P187, DOI 10.1016/0896-6273(90)90308-3; FUJITA S, 1966, J COMP NEUROL, V128, P191, DOI 10.1002/cne.901280206; FUJITA S, 1967, J CELL BIOL, V32, P277, DOI 10.1083/jcb.32.2.277; HAMORI J, 1983, J COMP NEUROL, V220, P365, DOI 10.1002/cne.902200402; HANAWAY J, 1967, J COMP NEUROL, V131, P1, DOI 10.1002/cne.901310102; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; Herrup K, 1997, ANNU REV NEUROSCI, V20, P61, DOI 10.1146/annurev.neuro.20.1.61; Hirai H, 2000, J NEUROSCI, V20, P5217, DOI 10.1523/JNEUROSCI.20-14-05217.2000; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Kaneko M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020108; Kioussis D, 1997, CURR OPIN GENET DEV, V7, P614, DOI 10.1016/S0959-437X(97)80008-1; KOMURO H, 1995, J NEUROSCI, V15, P1110; KOSAKA T, 1993, EXP BRAIN RES, V93, P483; Kwon CH, 2006, GENESIS, V44, P130, DOI 10.1002/gene.20197; Machold R, 2005, NEURON, V48, P17, DOI 10.1016/j.neuron.2005.08.028; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Massey PV, 2007, TRENDS NEUROSCI, V30, P176, DOI 10.1016/j.tins.2007.02.005; MIALE IL, 1961, EXP NEUROL, V4, P277, DOI 10.1016/0014-4886(61)90055-3; Morrison ME, 1998, J NEUROSCI, V18, P3563; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; RAKIC P, 1971, J COMP NEUROL, V141, P283, DOI 10.1002/cne.901410303; Ram?n, 1995, HISTOLOGY NERVOUS SY; Reinert RB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033529; SADLER M, 1984, PROC R SOC SER B-BIO, V221, P349, DOI 10.1098/rspb.1984.0037; Schmahmann JD, 2004, J NEUROPSYCH CLIN N, V16, P367, DOI 10.1176/appi.neuropsych.16.3.367; Sgaier SK, 2005, NEURON, V45, P27, DOI 10.1016/S0896-6273(04)00802-5; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Szentagothai J, 1963, MAGY TUD AKAD BIOL, V6, P217; Tsujita M, 1999, J NEUROSCI, V19, P10318; Weimann JM, 1999, NEURON, V24, P819, DOI 10.1016/S0896-6273(00)81030-2; Weyer A, 2003, J NEUROSCI RES, V73, P400, DOI 10.1002/jnr.10655; Wolf HK, 1996, J HISTOCHEM CYTOCHEM, V44, P1167, DOI 10.1177/44.10.8813082; ZILLA P, 1985, ACTA ANAT, V124, P181	43	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100384	10.1371/journal.pone.0100384	http://dx.doi.org/10.1371/journal.pone.0100384			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950299	Green Published, Green Submitted, gold			2022-12-27	WOS:000338276300071
J	Krupna-Gaylord, MA; Liveris, D; Love, AC; Wormser, GP; Schwartz, I; Petzke, MM				Krupna-Gaylord, Michelle A.; Liveris, Dionysios; Love, Andrea C.; Wormser, Gary P.; Schwartz, Ira; Petzke, Mary M.			Induction of Type I and Type III Interferons by Borrelia burgdorferi Correlates with Pathogenesis and Requires Linear Plasmid 36	PLOS ONE			English	Article							LYME-DISEASE SPIROCHETE; FIBRONECTIN-BINDING PROTEIN; INNATE IMMUNE ACTIVATION; DENDRITIC CELLS; SENSU-STRICTO; INDOLEAMINE 2,3-DIOXYGENASE; HEMATOGENOUS DISSEMINATION; EXTRACHROMOSOMAL DNAS; PERIPHERAL-BLOOD; EXPRESSION	The capacity for Borrelia burgdorferi to cause disseminated infection in humans or mice is associated with the genotype of the infecting strain. The cytokine profiles elicited by B. burgdorferi clinical isolates of different genotype (ribosomal spacer type) groups were assessed in a human PBMC co-incubation model. RST1 isolates, which are more frequently associated with disseminated Lyme disease in humans and mice, induced significantly higher levels of IFN-alpha and IFN-lambda/IL29 relative to RST3 isolates, which are less frequently associated with disseminated infection. No differences in the protein concentrations of IFN-gamma, IL-1 beta, IL-6, IL-8, IL-10 or TNF-alpha were observed between isolates of differing genotype. The ability of B. burgdorferi to induce type I and type III IFNs was completely dependent on the presence of linear plasmid (lp) 36. An lp36-deficient B. burgdorferi mutant adhered to, and was internalized by, PBMCs and specific dendritic cell (DC) subsets less efficiently than its isogenic B31 parent strain. The association defect with mDC1s and pDCs could be restored by complementation of the mutant with the complete lp36. The RST1 clinical isolates studied were found to contain a 2.5-kB region, located in the distal one-third of lp36, which was not present in any of the RST3 isolates tested. This divergent region of lp36 may encode one or more factors required for optimal spirochetal recognition and the production of type I and type III IFNs by human DCs, thus suggesting a potential role for DCs in the pathogenesis of B. burgdorferi infection.	[Krupna-Gaylord, Michelle A.; Liveris, Dionysios; Love, Andrea C.; Schwartz, Ira; Petzke, Mary M.] New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA; [Wormser, Gary P.; Schwartz, Ira] New York Med Coll, Dept Med, Div Infect Dis, Valhalla, NY 10595 USA	New York Medical College; New York Medical College	Petzke, MM (corresponding author), New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA.	mary_petzke@nymc.edu			Center for Disease Control [U01-CI000160]; Center for Prevention [U01-CI000160]; William and Sylvia Silberstein Foundation; National Institutes of Health [3R01-AR41511]; American Heart Association; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [U01CI000160] Funding Source: NIH RePORTER	Center for Disease Control; Center for Prevention; William and Sylvia Silberstein Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by a cooperative agreement (U01-CI000160) from the Centers for Disease Control and Prevention (to IS), The William and Sylvia Silberstein Foundation (to IS), ARRA supplement (3R01-AR41511) from the National Institutes of Health (to IS), and a predoctoral fellowship to MAK-G from the American Heart Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2003, CURR OPIN IMMUNOL, V15, P5, DOI 10.1016/S0952-7915(02)00013-4; Anguita J, 2000, INFECT IMMUN, V68, P1222, DOI 10.1128/IAI.68.3.1222-1230.2000; Auerbuch V, 2004, J EXP MED, V200, P527, DOI 10.1084/jem.20040976; Baban B, 2009, J IMMUNOL, V183, P2475, DOI 10.4049/jimmunol.0900986; Babolin C, 2011, J IMMUNOL, V187, P1377, DOI 10.4049/jimmunol.1100615; BARTHOLD SW, 1988, J INFECT DIS, V157, P842, DOI 10.1093/infdis/157.4.842; Bierne H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039080; Bogdan C, 2004, IMMUNOL REV, V202, P33, DOI 10.1111/j.0105-2896.2004.00207.x; Bouchonnet F, 2002, INFECT IMMUN, V70, P3020, DOI 10.1128/IAI.70.6.3020-3025.2002; Bourreau E, 2009, INFECT IMMUN, V77, P1465, DOI 10.1128/IAI.01398-08; BUKHOLM G, 1984, INFECT IMMUN, V45, P62, DOI 10.1128/IAI.45.1.62-66.1984; Carrero JA, 2004, J EXP MED, V200, P535, DOI 10.1084/jem.20040769; Carrero JA, 2007, IMMUNOL RES, V38, P333, DOI 10.1007/s12026-007-0017-z; Casjens S, 2000, MOL MICROBIOL, V35, P490, DOI 10.1046/j.1365-2958.2000.01698.x; Casjens SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033280; Cervantes JL, 2013, J LEUKOCYTE BIOL, V94, P1231, DOI 10.1189/jlb.0413206; Cervantes JL, 2011, P NATL ACAD SCI USA, V108, P3683, DOI 10.1073/pnas.1013776108; Coccia EM, 2004, EUR J IMMUNOL, V34, P796, DOI 10.1002/eji.200324610; Coleman AS, 2011, CLIN VACCINE IMMUNOL, V18, P406, DOI 10.1128/CVI.00461-10; Coleman AS, 2009, CLIN VACCINE IMMUNOL, V16, P1569, DOI 10.1128/CVI.00301-09; Crandall H, 2006, J IMMUNOL, V177, P7930, DOI 10.4049/jimmunol.177.11.7930; Cruz AR, 2008, INFECT IMMUN, V76, P56, DOI 10.1128/IAI.01039-07; DELAMAZA LM, 1985, INFECT IMMUN, V47, P719, DOI 10.1128/IAI.47.3.719-722.1985; Eggers CH, 2002, MOL MICROBIOL, V43, P281, DOI 10.1046/j.1365-2958.2002.02758.x; Elias AF, 2002, INFECT IMMUN, V70, P2139, DOI 10.1128/IAI.70.4.2139-2150.2002; Filgueira L, 1996, J IMMUNOL, V157, P2998; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Gregorio J, 2010, J EXP MED, V207, P2921, DOI 10.1084/jem.20101102; Grimm D, 2005, J MED ENTOMOL, V42, P676, DOI 10.1603/0022-2585(2005)042[0676:DPRBBB]2.0.CO;2; Hawley KL, 2012, P NATL ACAD SCI USA, V109, P1228, DOI 10.1073/pnas.1112078109; He M, 2007, J BACTERIOL, V189, P8377, DOI 10.1128/JB.01199-07; HESS CB, 1987, J IMMUNOL, V138, P3949; HESS CB, 1989, MICROB PATHOGENESIS, V7, P111, DOI 10.1016/0882-4010(89)90030-2; Hovius JWR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040031; Iyer R, 2003, INFECT IMMUN, V71, P3699, DOI 10.1128/IAI.71.7.3699-3706.2003; Jewell NA, 2010, J VIROL, V84, P11515, DOI 10.1128/JVI.01703-09; Jewett MW, 2007, MOL MICROBIOL, V64, P1358, DOI 10.1111/j.1365-2958.2007.05746.x; KAZAR J, 1971, INFECT IMMUN, V3, P825, DOI 10.1128/IAI.3.6.825-832.1971; Kenedy MR, 2009, INFECT IMMUN, V77, P2773, DOI 10.1128/IAI.00318-09; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Krupna M, 2011, J IMMUNOL, V186; La QH, 2010, EUR J CANCER, V46, P180, DOI 10.1016/j.ejca.2009.10.002; Labandeira-Rey M, 2001, INFECT IMMUN, V69, P446, DOI 10.1128/IAI.69.1.446-455.2001; Labandeira-Rey M, 2003, INFECT IMMUN, V71, P4608, DOI 10.1128/IAI.71.8.4608-4613.2003; Le Buanec H, 2011, P NATL ACAD SCI USA, V108, P18995, DOI 10.1073/pnas.1113301108; Lebreton A, 2011, SCIENCE, V331, P1319, DOI 10.1126/science.1200120; Li W, 2008, CELL PROLIFERAT, V41, P960, DOI 10.1111/j.1365-2184.2008.00558.x; Li W, 2011, INFECT IMMUN, V79, P3338, DOI 10.1128/IAI.05021-11; Li X, 2006, INFECT IMMUN, V74, P3305, DOI 10.1128/IAI.02035-05; Lindahl G, 2005, CLIN MICROBIOL REV, V18, P102, DOI 10.1128/CMR.18.1.102-127.2005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LIVERIS D, 1995, J CLIN MICROBIOL, V33, P589, DOI 10.1128/JCM.33.3.589-595.1995; Liveris D, 1996, J CLIN MICROBIOL, V34, P1306, DOI 10.1128/JCM.34.5.1306-1309.1996; Loughman JA, 2012, J INFECT DIS; Love AC, 2014, INFECT IMMUN, V82, P2405, DOI 10.1128/IAI.01617-14; Makala LHC, 2011, J INFECT DIS, V203, P715, DOI 10.1093/infdis/jiq095; Manca C, 2001, P NATL ACAD SCI USA, V98, P5752, DOI 10.1073/pnas.091096998; Mancuso G, 2007, J IMMUNOL, V178, P3126, DOI 10.4049/jimmunol.178.5.3126; Mancuso G, 2009, NAT IMMUNOL, V10, P587, DOI 10.1038/ni.1733; Mellor A, 2005, BIOCHEM BIOPH RES CO, V338, P20, DOI 10.1016/j.bbrc.2005.08.232; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Miller JC, 2008, J IMMUNOL, V181, P8492, DOI 10.4049/jimmunol.181.12.8492; Moore MW, 2007, INFECT IMMUN, V75, P2046, DOI 10.1128/IAI.01666-06; NIESEL DW, 1986, INFECT IMMUN, V52, P828, DOI 10.1128/IAI.52.3.828-833.1986; Numasaki M, 2007, J IMMUNOL, V178, P5086, DOI 10.4049/jimmunol.178.8.5086; O'Connell RM, 2004, J EXP MED, V200, P437, DOI 10.1084/jem.20040712; Pal U, 2008, J EXP MED, V205, P133, DOI 10.1084/jem.20070962; Palmer N, 2000, J BACTERIOL, V182, P2476, DOI 10.1128/JB.182.9.2476-2480.2000; Petzke MM, 2009, J IMMUNOL, V183, P5279, DOI 10.4049/jimmunol.0901390; Pietila TE, 2010, J LEUKOCYTE BIOL, V88, P665, DOI 10.1189/jlb.1009651; Purser JE, 2000, P NATL ACAD SCI USA, V97, P13865, DOI 10.1073/pnas.97.25.13865; Qiu WG, 2004, P NATL ACAD SCI USA, V101, P14150, DOI 10.1073/pnas.0402745101; Rothfuchs AG, 2001, J IMMUNOL, V167, P6453, DOI 10.4049/jimmunol.167.11.6453; SADZIENE A, 1993, INFECT IMMUN, V61, P2192, DOI 10.1128/IAI.61.5.2192-2195.1993; Salazar JC, 2003, J IMMUNOL, V171, P2660, DOI 10.4049/jimmunol.171.5.2660; Salazar JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000444; Samuels D S, 1995, Methods Mol Biol, V47, P253; Scheler M, 2007, AM J PATHOL, V171, P1936, DOI 10.2353/ajpath.2007.070281; Schutzer SE, 2011, J BACTERIOL, V193, P1018, DOI 10.1128/JB.01158-10; SCHWAN TG, 1988, INFECT IMMUN, V56, P1831, DOI 10.1128/IAI.56.8.1831-1836.1988; SCHWARTZ I, 1992, J CLIN MICROBIOL, V30, P3082, DOI 10.1128/JCM.30.12.3082-3088.1992; Seshu J, 2006, MOL MICROBIOL, V59, P1591, DOI 10.1111/j.1365-2958.2005.05042.x; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Sjowall J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018220; STEERE AC, 1986, ZBL BAKT-INT J MED M, V263, P201; STEERE AC, 1989, NEW ENGL J MED, V321, P586, DOI 10.1056/NEJM198908313210906; Steere AC, 2001, NEW ENGL J MED, V345, P115, DOI 10.1056/NEJM200107123450207; Strle K, 2011, AM J PATHOL, V178, P2726, DOI 10.1016/j.ajpath.2011.02.018; TEETSON W, 1983, AM J CLIN PATHOL, V79, P500, DOI 10.1093/ajcp/79.4.500; Terekhova D, 2006, J BACTERIOL, V188, P6124, DOI 10.1128/JB.00459-06; von Bubnoff D, 2011, J AM ACAD DERMATOL, V65, P819, DOI 10.1016/j.jaad.2010.07.050; Wang G, 2001, INFECT IMMUN, V69, P4303, DOI 10.1128/IAI.69.7.4303-4312.2001; Wang GQ, 2004, INFECT IMMUN, V72, P6702, DOI 10.1128/IAI.72.11.6702-6706.2004; Wang GQ, 2002, J INFECT DIS, V186, P782, DOI 10.1086/343043; Wolk K, 2008, J LEUKOCYTE BIOL, V83, P1181, DOI 10.1189/jlb.0807525; Wooten RM, 2002, VECTOR-BORNE ZOONOT, V2, P275, DOI 10.1089/153036602321653860; Wormser GP, 2008, J INFECT DIS, V198, P1358, DOI 10.1086/592279; Wormser GP, 1999, J INFECT DIS, V180, P720, DOI 10.1086/314922; Xu YN, 1996, INFECT IMMUN, V64, P3870, DOI 10.1128/IAI.64.9.3870-3876.1996; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	101	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100174	10.1371/journal.pone.0100174	http://dx.doi.org/10.1371/journal.pone.0100174			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945497	gold, Green Submitted, Green Published			2022-12-27	WOS:000340721500047
J	Raich, JW; Clark, DA; Schwendenmann, L; Wood, TE				Raich, James W.; Clark, Deborah A.; Schwendenmann, Luitgard; Wood, Tana E.			Aboveground Tree Growth Varies with Belowground Carbon Allocation in a Tropical Rainforest Environment	PLOS ONE			English	Article							NET PRIMARY PRODUCTIVITY; SOIL RESPIRATION; SHOOT RATIOS; LA-SELVA; NITROGEN; ROOT; PLANTATIONS; LIMITATION; PASTURE; CO2	Young secondary forests and plantations in the moist tropics often have rapid rates of biomass accumulation and thus sequester large amounts of carbon. Here, we compare results from mature forest and nearby 15-20 year old tree plantations in lowland Costa Rica to evaluate differences in allocation of carbon to aboveground production and root systems. We found that the tree plantations, which had fully developed, closed canopies, allocated more carbon belowground - to their root systems - than did mature forest. This increase in belowground carbon allocation correlated significantly with aboveground tree growth but not with canopy production (i.e., leaf fall or fine litter production). In contrast, there were no correlations between canopy production and either tree growth or belowground carbon allocation. Enhanced allocation of carbon to root systems can enhance plant nutrient uptake, providing nutrients beyond those required for the production of short-lived tissues such as leaves and fine roots, and thus enabling biomass accumulation. Our analyses support this deduction at our site, showing that enhanced allocation of carbon to root systems can be an important mechanism promoting biomass accumulation during forest growth in the moist tropics. Identifying factors that control when, where and for how long this occurs would help us to improve models of forest growth and nutrient cycling, and to ascertain the role that young forests play in mitigating increased atmospheric carbon dioxide.	[Raich, James W.] Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50011 USA; [Clark, Deborah A.] Univ Missouri, Dept Biol, St Louis, MO 63121 USA; [Schwendenmann, Luitgard] Univ Auckland, Sch Environm, Auckland 1, New Zealand; [Wood, Tana E.] US Dept Agr Forest Serv, Int Inst Trop Forestry, Rio Piedras, PR USA; [Wood, Tana E.] Fdn Puertorriquena Conservac, San Juan, PR USA	Iowa State University; University of Missouri System; University of Missouri Saint Louis; University of Auckland; United States Department of Agriculture (USDA); United States Forest Service	Raich, JW (corresponding author), Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50011 USA.	jraich@iastate.edu		Clark, Deborah/0000-0002-4000-4925; Schwendenmann, Luitgard/0000-0002-2290-3003; Wood, Tana/0000-0001-6322-6224	U.S. National Science Foundation [DEB-9629245, BCE-0421178, EAR-0421178, DEB-0841872, DEB-0236502, DEB-0703561]; U.S. Department of Energy [DE-FG02-96ER62289]; Andrew W. Mellon Foundation; Conservation International's TEAM Initiative; University of Virginia	U.S. National Science Foundation(National Science Foundation (NSF)); U.S. Department of Energy(United States Department of Energy (DOE)); Andrew W. Mellon Foundation; Conservation International's TEAM Initiative; University of Virginia	Funding for measurements of the mature forest plots was provided by the U.S. National Science Foundation (http://www.nsf.gov) grants DEB-9629245, BCE-0421178, EAR-0421178 and DEB-0841872; the U.S. Department of Energy (http://science.energy.gov/funding-opportunities/find-funding/) grant DE-FG02-96ER62289; the Andrew W. Mellon Foundation (http://www.mellon.org/grant_programs/programs); and Conservation International's TEAM Initiative (http://www.conservation.org). Plantation studies were funded by U.S. National Science Foundation grants DEB-0236502 and DEB-0703561. Leaf fall N studies were funded by the University of Virginia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 1997, ECOLOGY, V78, P1277, DOI 10.1890/0012-9658(1997)078[1277:RTFMAO]2.0.CO;2; Aragao LEOC, 2009, BIOGEOSCIENCES, V6, P2759, DOI 10.5194/bg-6-2759-2009; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Brown S., 1997, FAO Forestry Paper; BROWN S, 1990, J TROP ECOL, V6, P1, DOI 10.1017/S0266467400003989; Chamberlin T. C., 1890, SCIENCE, V15, P92, DOI DOI 10.1126/SCIENCE.NS-15.366.92; Chazdon RL, 2008, SCIENCE, V320, P1458, DOI 10.1126/science.1155365; Clark DA, 2001, ECOL APPL, V11, P356, DOI 10.1890/1051-0761(2001)011[0356:MNPPIF]2.0.CO;2; Clark DB, 2008, ECOL LETT, V11, P163, DOI 10.1111/j.1461-0248.2007.01134.x; Clark DB, 2000, FOREST ECOL MANAG, V137, P185, DOI 10.1016/S0378-1127(99)00327-8; Clark DA, 2013, J GEOPHYS RES-BIOGEO, V118, P783, DOI 10.1002/jgrg.20067; Davidson EA, 2002, AGR FOREST METEOROL, V113, P39, DOI 10.1016/S0168-1923(02)00101-6; dePury DGG, 1997, PLANT CELL ENVIRON, V20, P537, DOI 10.1111/j.1365-3040.1997.00094.x; Dybzinski R, 2011, AM NAT, V177, P153, DOI 10.1086/657992; Espeleta JF, 2007, ECOL MONOGR, V77, P377, DOI 10.1890/06-1257.1; Evans J., 2004, PLANTATION FOREST TR, V3rd; FISHER RF, 1995, SOIL SCI SOC AM J, V59, P544, DOI 10.2136/sssaj1995.03615995005900020039x; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Fu SL, 2002, PLANT SOIL, V238, P289, DOI 10.1023/A:1014488128054; Giardina CP, 2002, ECOSYSTEMS, V5, P487, DOI 10.1007/s10021-002-0130-8; Goll DS, 2012, BIOGEOSCIENCES, V9, P3547, DOI 10.5194/bg-9-3547-2012; GONZALEZ JE, 1994, FOREST ECOL MANAG, V70, P159, DOI 10.1016/0378-1127(94)90083-3; Haggar J, 1997, FOREST ECOL MANAG, V99, P55, DOI 10.1016/S0378-1127(97)00194-1; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Herman DJ, 2006, SOIL SCI SOC AM J, V70, P1504, DOI 10.2136/sssaj2005.0113; Johnson DW, 2006, ECOLOGY, V87, P64, DOI 10.1890/04-1781; Jones DL, 2009, PLANT SOIL, V321, P5, DOI 10.1007/s11104-009-9925-0; KELLER M, 1994, GLOBAL BIOGEOCHEM CY, V8, P399, DOI 10.1029/94GB01660; KIRA TATUO, 1967, JAP J ECOL, V17, P70; Kleber M, 2007, GEODERMA, V138, P1, DOI 10.1016/j.geoderma.2006.10.004; Lamb D, 2005, SCIENCE, V310, P1628, DOI 10.1126/science.1111773; LeBauer DS, 2008, ECOLOGY, V89, P371, DOI 10.1890/06-2057.1; Levy PE, 1999, TREE PHYSIOL, V19, P53; Litton CM, 2007, GLOBAL CHANGE BIOL, V13, P2089, DOI 10.1111/j.1365-2486.2007.01420.x; Malhi Y, 2011, PHILOS T R SOC B, V366, P3225, DOI 10.1098/rstb.2011.0062; MARSCHNER H, 1994, PLANT SOIL, V159, P89, DOI 10.1007/BF00000098; Marschner H, 1996, J EXP BOT, V47, P1255, DOI 10.1093/jxb/47.Special_Issue.1255; McMurtrie RE, 2013, NEW PHYTOL, V199, P981, DOI 10.1111/nph.12344; Mokany K, 2006, GLOBAL CHANGE BIOL, V12, P84, DOI 10.1111/j.1365-2486.2005.001043.x; Monsi M, 2005, ANN BOT-LONDON, V95, P549, DOI 10.1093/aob/mci052; ODUM EP, 1969, SCIENCE, V164, P262, DOI 10.1126/science.164.3877.262; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Raich JW, 2007, FOREST ECOL MANAG, V239, P128, DOI 10.1016/j.foreco.2006.11.016; RAICH JW, 1989, ECOLOGY, V70, P1346, DOI 10.2307/1938194; Rastetter EB, 1997, ECOL APPL, V7, P444; REINERS WA, 1994, ECOL APPL, V4, P363, DOI 10.2307/1941940; Russell AE, 2007, SOIL SCI SOC AM J, V71, P1389, DOI 10.2136/sssaj2006.0069; Russell AE, 2012, P NATL ACAD SCI USA, V109, P10398, DOI 10.1073/pnas.1204157109; Russell AE, 2010, ECOL APPL, V20, P1087, DOI 10.1890/09-0635.1; Ryan MG, 1979, ADV ECOL RES, V27, P213; Schwendenmann L, 2003, BIOGEOCHEMISTRY, V64, P111, DOI 10.1023/A:1024941614919; Silver WL, 2000, RESTOR ECOL, V8, P394, DOI 10.1046/j.1526-100x.2000.80054.x; Sollins Phillip, 1994, P34; SOLTIS DE, 1995, P NATL ACAD SCI USA, V92, P2647, DOI 10.1073/pnas.92.7.2647; THORNLEY JH, 1972, ANN BOT-LONDON, V36, P431, DOI 10.1093/oxfordjournals.aob.a084602; Tinker P.B., 2000, SOLUTE MOVEMENT RHIZ, V2nd, DOI [10.1093/oso/9780195124927.001.0001, DOI 10.1093/OSO/9780195124927.001.0001]; Valverde-Barrantes OJ, 2007, CAN J FOREST RES, V37, P1954, DOI 10.1139/X07-057; Veldkamp E, 2003, GLOBAL CHANGE BIOL, V9, P1171, DOI 10.1046/j.1365-2486.2003.00656.x; Vitousek PM, 2010, ECOL APPL, V20, P5, DOI 10.1890/08-0127.1; Wardle DA, 2004, SCIENCE, V305, P509, DOI 10.1126/science.1098778; Wareing PF, 1979, CONTROL GROWTH DIFFE; Wood TE, 2006, ECOSYSTEMS, V9, P700, DOI 10.1007/s10021-005-0016-7	62	36	39	4	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100275	10.1371/journal.pone.0100275	http://dx.doi.org/10.1371/journal.pone.0100275			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945351	Green Published, gold			2022-12-27	WOS:000340721500057
J	Iop, L; Bonetti, A; Naso, F; Rizzo, S; Cagnin, S; Bianco, R; Dal Lin, C; Martini, P; Poser, H; Franci, P; Lanfranchi, G; Busetto, R; Spina, M; Basso, C; Marchini, M; Gandaglia, A; Ortolani, F; Gerosa, G				Iop, Laura; Bonetti, Antonella; Naso, Filippo; Rizzo, Stefania; Cagnin, Stefano; Bianco, Roberto; Dal Lin, Carlo; Martini, Paolo; Poser, Helen; Franci, Paolo; Lanfranchi, Gerolamo; Busetto, Roberto; Spina, Michel; Basso, Cristina; Marchini, Maurizio; Gandaglia, Alessandro; Ortolani, Fulvia; Gerosa, Gino			Decellularized Allogeneic Heart Valves Demonstrate Self-Regeneration Potential after a Long-Term Preclinical Evaluation	PLOS ONE			English	Article							AORTIC-VALVE; INTERSTITIAL-CELLS; PEDIATRIC-PATIENTS; JUVENILE SHEEP; EARLY FAILURE; STEM-CELLS; CALCIFICATION; TISSUE; BIOPROSTHESES; CONDUITS	Tissue-engineered heart valves are proposed as novel viable replacements granting longer durability and growth potential. However, they require extensive in vitro cell-conditioning in bioreactor before implantation. Here, the propensity of non-preconditioned decellularized heart valves to spontaneous in body self-regeneration was investigated in a large animal model. Decellularized porcine aortic valves were evaluated for right ventricular outflow tract (RVOT) reconstruction in Vietnamese Pigs (n = 11) with 6 (n = 5) and 15 (n = 6) follow-up months. Repositioned native valves (n = 2 for each time) were considered as control. Tissue and cell components from explanted valves were investigated by histology, immunohistochemistry, electron microscopy, and gene expression. Most substitutes constantly demonstrated in vivo adequate hemodynamic performances and ex vivo progressive repopulation during the 15 implantation months without signs of calcifications, fibrosis and/or thrombosis, as revealed by histological, immunohistochemical, ultrastructural, metabolic and transcriptomic profiles. Colonizing cells displayed native-like phenotypes and actively synthesized novel extracellular matrix elements, as collagen and elastin fibers. New mature blood vessels, i.e. capillaries and vasa vasorum, were identified in repopulated valves especially in the medial and adventitial tunicae of regenerated arterial walls. Such findings correlated to the up-regulated vascular gene transcription. Neoinnervation hallmarks were appreciated at histological and ultrastructural levels. Macrophage populations with reparative M2 phenotype were highly represented in repopulated valves. Indeed, no aspects of adverse/immune reaction were revealed in immunohistochemical and transcriptomic patterns. Among differentiated elements, several cells were identified expressing typical stem cell markers of embryonic, hematopoietic, neural and mesenchymal lineages in significantly higher number and specific topographic distribution in respect to control valves. Following the longest follow-up ever realized in preclinical models, non-preconditioned decellularized allogeneic valves offer suitable microenvironment for in vivo cell homing and tissue remodeling. Manufactured with simple, timesaving and cost-effective procedures, these promising valve replacements hold promise to become an effective alternative, especially for pediatric patients.	[Iop, Laura; Naso, Filippo; Rizzo, Stefania; Bianco, Roberto; Dal Lin, Carlo; Basso, Cristina; Gandaglia, Alessandro; Gerosa, Gino] Univ Padua, Dept Cardiac Thorac & Vasc Sci, Padua, Italy; [Bonetti, Antonella; Marchini, Maurizio; Ortolani, Fulvia] Univ Udine, Dept Expt & Clin Med, I-33100 Udine, Italy; [Cagnin, Stefano; Martini, Paolo; Lanfranchi, Gerolamo] Univ Padua, Dept Biol, Padua, Italy; [Cagnin, Stefano; Martini, Paolo; Lanfranchi, Gerolamo] Univ Padua, CRIBI Biotechnol Ctr, Padua, Italy; [Poser, Helen; Franci, Paolo; Busetto, Roberto] Univ Padua, Dept Anim Med Prod & Hlth, Legnaro, Italy; [Spina, Michel] Univ Padua, Dept Biomed Sci, Padua, Italy	University of Padua; University of Udine; University of Padua; University of Padua; University of Padua; University of Padua	Iop, L (corresponding author), Univ Padua, Dept Cardiac Thorac & Vasc Sci, Padua, Italy.	laura.iop@unipd.it	cagnin, stefano/E-9095-2011; Gerosa, Gino/M-8106-2014; Martini, Paolo/AAG-7398-2020; Iop, Laura/A-3761-2015; Bianco, Roberto/AAC-2343-2019	cagnin, stefano/0000-0001-7271-4625; Gerosa, Gino/0000-0002-6261-699X; Martini, Paolo/0000-0002-0146-1031; Iop, Laura/0000-0002-7034-9414; Bianco, Roberto/0000-0002-6485-1205; Gandaglia, Alessandro/0000-0002-0227-5257; Naso, Filippo/0000-0002-8198-8799; basso, cristina/0000-0002-0195-9753; Poser, Helen/0000-0003-2323-7708; Rizzo, Stefania/0000-0001-5969-4412	Italian grant Azione Biotech III;  [RSF 286/08]	Italian grant Azione Biotech III; 	Italian grants Azione Biotech III and RSF 286/08 (Veneto Region) supported this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa E, 2009, CIRCULATION, V119, P1785, DOI 10.1161/CIRCULATIONAHA.108.827972; Arciniegas E, 2005, ENDOTHELIUM-J ENDOTH, V12, P193, DOI 10.1080/10623320500227283; Bertipaglia B, 2003, ANN THORAC SURG, V75, P1274, DOI 10.1016/S0003-4975(02)04706-9; BINET JP, 1965, LANCET, V2, P1275; Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; Bottio T, 2010, J HEART VALVE DIS, V19, P485; Cebotari S, 2011, CIRCULATION, V124, pS115, DOI 10.1161/CIRCULATIONAHA.110.012161; Cho HJ, 2009, CURR ATHEROSCLER REP, V11, P206, DOI 10.1007/s11883-009-0032-8; Cicha I, 2011, CARDIOVASC PATHOL, V20, P222, DOI 10.1016/j.carpath.2010.04.006; Conti CA, 2010, MED ENG PHYS, V32, P212, DOI 10.1016/j.medengphy.2009.12.003; Dohmen PM, 2006, J HEART VALVE DIS, V15, P823; Dohmen PM, 2006, CIRC RES, V99, pE10, DOI 10.1161/01.RES.0000234909.24367.a9; Gallo M, 2012, ARTIF ORGANS, V36, pE138, DOI 10.1111/j.1525-1594.2012.01447.x; GENDLER E, 1984, J BIOMED MATER RES, V18, P727, DOI 10.1002/jbm.820180703; Grande KJ, 1998, ANN BIOMED ENG, V26, P534, DOI 10.1114/1.122; Han M, 2009, LIFE SCI, V84, P394, DOI 10.1016/j.lfs.2008.11.017; Heinrich EM, 2012, CIRC RES, V110, P1014, DOI 10.1161/CIRCRESAHA.111.243394; Henegar C, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r14; Hopkins RA, 2009, J THORAC CARDIOV SUR, V137, P907, DOI 10.1016/j.jtcvs.2008.12.009; IDE C, 1983, BRAIN RES, V288, P61, DOI 10.1016/0006-8993(83)90081-1; Immenschuh S, 2005, ANTIOXID REDOX SIGN, V7, P768, DOI 10.1089/ars.2005.7.768; Iop L, 2009, BIOMATERIALS, V30, P4104, DOI 10.1016/j.biomaterials.2009.04.031; Konertz W, 2011, J HEART VALVE DIS, V20, P341; Kou PM, 2011, J BIOMED MATER RES A, V96A, P239, DOI 10.1002/jbm.a.32971; Leen LLS, 2008, ARTERIOSCL THROM VAS, V28, P2131, DOI 10.1161/ATVBAHA.108.167965; Manginas A, 2009, J HEART LUNG TRANSPL, V28, P710, DOI 10.1016/j.healun.2009.04.006; Mangold A, 2009, THORAC CARDIOV SURG, V57, P191, DOI 10.1055/s-0029-1185395; Manji RA, 2006, CIRCULATION, V114, P318, DOI 10.1161/CIRCULATIONAHA.105.549311; Mayer J E Jr, 1995, Semin Thorac Cardiovasc Surg, V7, P130; Naso F, 2011, ACTA BIOMATER, V7, P1728, DOI 10.1016/j.actbio.2010.11.030; Pettenazzo E, 2001, J THORAC CARDIOV SUR, V121, P500, DOI 10.1067/mtc.2001.112464; Rattazzi M, 2008, ARTERIOSCL THROM VAS, V28, P2165, DOI 10.1161/ATVBAHA.108.174342; Ruffer A, 2010, EUR J CARDIO-THORAC, V38, P78, DOI 10.1016/j.ejcts.2010.01.044; Samouillan V, 1999, J BIOMED MATER RES, V46, P531, DOI 10.1002/(SICI)1097-4636(19990915)46:4<531::AID-JBM11>3.0.CO;2-2; Sartore S, 1999, Rev Physiol Biochem Pharmacol, V134, P235; Schoen FJ, 2012, ANNU REV PATHOL-MECH, V7, P161, DOI 10.1146/annurev-pathol-011110-130257; Shin DH, 2005, DEV DYNAM, V233, P1589, DOI 10.1002/dvdy.20479; Simon P, 2003, EUR J CARDIO-THORAC, V23, P1002, DOI 10.1016/S1010-7940(03)00094-0; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Steinhoff G, 2000, CIRCULATION, V102, P50; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; THIENE G, 1994, EUR J CARDIO-THORAC, V8, P476, DOI 10.1016/1010-7940(94)90017-5; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wu FS, 2009, BIOCHEM BIOPH RES CO, V386, P549, DOI 10.1016/j.bbrc.2009.06.075	44	56	56	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99593	10.1371/journal.pone.0099593	http://dx.doi.org/10.1371/journal.pone.0099593			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940754	Green Published, gold			2022-12-27	WOS:000338508200031
J	Abdul-Hamid, S; Denman, C; Dudas, RB				Abdul-Hamid, Sawsan; Denman, Chess; Dudas, Robert B.			Self-Relevant Disgust and Self-Harm Urges in Patients with Borderline Personality Disorder and Depression: A Pilot Study with a Newly Designed Psychological Challenge	PLOS ONE			English	Article							RISK-FACTORS; BODY-IMAGE; SUICIDAL IDEATION; INJURY; ADOLESCENTS; FEATURES; ADULTS; WOMEN; OBJECTIFICATION; PREVALENCE	Background: Borderline personality disorder (BPD) is a common psychiatric condition associated with self-harm. Self-harm is poorly understood and there is currently no treatment for acute presentations with self-harm urges. Objectives: By using a new task (Self-relevant Task; SRT), to explore emotions related to one's own person (PERSON task) and body (BODY task), to study the correlations of these emotions, specifically disgust, with self-harm urge level changes, and to test the task's potential to be developed into an experimental model of self-harming for treatment trials. Methods: 17 BPD patients, 27 major depressive disorder (MDD) patients, and 25 healthy volunteers performed the SRT. Emotion labels were extracted from task narratives and disgust and self-harm urge level changes measured by visual analogue scales. We used validated rating scales to measure symptom severity. Results: The SRT was effective at inducing negative emotions and self-harm urge changes. Self-harm urge changes correlated with borderline symptom severity. Post-task disgust levels on the visual analogue scales were higher in BPD patients than in healthy controls in the PERSON task, and higher than in both control groups in the BODY task. Changes in disgust levels during the task were significantly greater in the patient groups. Post-task disgust levels or changes in disgust were not associated with self-harm urge changes (except the latter in MDD in the PERSON task), but self-harm urge changes and disgust (but no other emotion) narrative labels were on a whole sample level. Conclusion: Although associations with the analogue scale measures were not significant, self-disgust reported in the narrative of patients may be associated with a higher probability of self-harm urges. Further research with larger sample sizes is needed to confirm this relationship and to examine whether reducing self-disgust could reduce self-harm urges. The SRT was effective and safe, and could be standardized for experimental studies.	[Abdul-Hamid, Sawsan; Dudas, Robert B.] Univ Cambridge, Dept Psychiat, Cambridge, England; [Denman, Chess; Dudas, Robert B.] Cambridgeshire & Peterborough Fdn NHS Trust, Complex Cases Serv, Cambridge, England; [Dudas, Robert B.] Univ Cambridge, Behav & Clin Neurosci Inst, Cambridge, England	University of Cambridge; University of Cambridge	Dudas, RB (corresponding author), Univ Cambridge, Dept Psychiat, Cambridge, England.	rbd21@cam.ac.uk	Dudas, Robert/Y-1497-2019	Dudas, Robert/0000-0001-6151-2630	Medical Research Council; Wellcome Trust [MRC Ref G1000183, WT Ref 093875/Z/10/Z]; Evelyn Trust; Talisman Trust; MRC [G1000183] Funding Source: UKRI; Medical Research Council [G1000183, G0001354B, G0001354] Funding Source: researchfish; National Institute for Health Research [CL-2007-14-005] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Evelyn Trust; Talisman Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was partly funded by a Core Award from the Medical Research Council and the Wellcome Trust to the Behavioural and Clinical Neuroscience Institute (MRC Ref G1000183; WT Ref 093875/Z/10/Z). Sawsan Abdul-Hamid received a grant from the Evelyn Trust to help to cover the costs of her research placement with the research group. The Talisman Trust also supported the study with a grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateman A, 2009, AM J PSYCHIAT, V166, P1355, DOI 10.1176/appi.ajp.2009.09040539; Black DW, 2004, J PERS DISORD, V18, P226, DOI 10.1521/pedi.18.3.226.35445; Brausch AM, 2007, BODY IMAGE, V4, P207, DOI 10.1016/j.bodyim.2007.02.001; Brausch AM, 2009, SUICIDE LIFE-THREAT, V39, P58, DOI 10.1521/suli.2009.39.1.58; Casillas A, 2002, J PERS DISORD, V16, P424, DOI 10.1521/pedi.16.5.424.22124; Distel MA, 2008, PSYCHOL MED, V38, P1219, DOI 10.1017/S0033291707002024; Dixon-Gordon KL, 2011, PERSONAL DISORD, V2, P243, DOI 10.1037/a0021799; First M. B., 1997, STRUCTURED CLIN INTE; Goldstein JM, 2005, J NEUROSCI, V25, P9309, DOI 10.1523/JNEUROSCI.2239-05.2005; Grant BF, 2008, J CLIN PSYCHIAT, V69, P533, DOI 10.4088/JCP.v69n0404; Gratz KL, 2003, CLIN PSYCHOL-SCI PR, V10, P192, DOI 10.1093/clipsy/bpg022; Gunnell D, 2005, J PUBLIC HEALTH-UK, V27, P67, DOI 10.1093/pubmed/fdh192; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hawton K, 2006, PSYCHOL MED, V36, P397, DOI 10.1017/S0033291705006914; Horrocks J, 2002, CLIN MED, V2, P509, DOI 10.7861/clinmedicine.2-6-509; Ille R, 2014, COMPR PSYCHIAT; Kleindienst N, 2008, J NERV MENT DIS, V196, P230, DOI 10.1097/NMD.0b013e3181663026; Klonsky ED, 2007, J CLIN PSYCHOL, V63, P1045, DOI 10.1002/jclp.20412; Kraus A, 2010, ACTA PSYCHIAT SCAND, V121, P41, DOI 10.1111/j.1600-0447.2009.01417.x; Lieb K, 2010, BRIT J PSYCHIAT, V196, P4, DOI 10.1192/bjp.bp.108.062984; LINEHAN MM, 1991, ARCH GEN PSYCHIAT, V48, P1060; Morey L.C., 1991, PERSONALITY ASSESSME; Muehlenkamp JJ, 2012, J ADOLESCENCE, V35, P1, DOI 10.1016/j.adolescence.2011.06.010; Muehlenkamp JJ, 2005, PSYCHOL WOMEN QUART, V29, P24, DOI 10.1111/j.1471-6402.2005.00164.x; Muehlenkamp JJ, 2008, J ADOLESCENCE, V35, P1; National Institute for Clinical Excellence (NICE), 2004, SELF HARM SHORT TERM; Nelson A, 2012, ARCH SUICIDE RES, V16, P1, DOI 10.1080/13811118.2012.640578; Orbach I, 2006, SUICIDE LIFE-THREAT, V36, P136, DOI 10.1521/suli.2006.36.2.136; Overton PG, 2008, EMOTION, V8, P379, DOI 10.1037/1528-3542.8.3.379; Rosenthal MZ, 2008, CLIN PSYCHOL REV, V28, P75, DOI 10.1016/j.cpr.2007.04.001; Rusch N, 2011, EUR ARCH PSY CLIN N, V261, P369, DOI 10.1007/s00406-010-0174-2; Schienle A, 2013, J NERV MENT DIS, V201, P105, DOI 10.1097/NMD.0b013e31827f64da; Sheehan DV., 2006, MINI INT NEUROPSYCHI; Silbersweig D, 2007, AM J PSYCHIAT, V164, P1832, DOI 10.1176/appi.ajp.2007.06010126; Smith NB, 2013, ROLE TRAUMA SYMPTOMS; Soloff PH, 2000, BIOL PSYCHIAT, V47, P540, DOI 10.1016/S0006-3223(99)00202-4; Surguladze SA, 2010, J PSYCHIATR RES, V44, P894, DOI 10.1016/j.jpsychires.2010.02.010; Tantam D, 2009, UNDERSTANDING REPEAT; TRULL TJ, 1995, PSYCHOL ASSESSMENT, V7, P33, DOI 10.1037/1040-3590.7.1.33; Wichstrom L, 2009, ARCH SUICIDE RES, V13, P105, DOI 10.1080/13811110902834992; Wilkinson P, 2011, EUR CHILD ADOLES PSY, V20, P103, DOI 10.1007/s00787-010-0156-y; You JN, 2012, J PERS DISORD, V26, P226, DOI 10.1521/pedi.2012.26.2.226	42	10	11	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e99696	10.1371/journal.pone.0099696	http://dx.doi.org/10.1371/journal.pone.0099696			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL1WV	24956153	Green Submitted, Green Published, gold			2022-12-27	WOS:000338917900015
J	Hatzirodos, N; Irving-Rodgers, HF; Hummitzsch, K; Rodgers, RJ				Hatzirodos, Nicholas; Irving-Rodgers, Helen F.; Hummitzsch, Katja; Rodgers, Raymond J.			Transcriptome Profiling of the Theca Interna from Bovine Ovarian Follicles during Atresia	PLOS ONE			English	Article							GRANULOSA-CELLS; ANTRAL FOLLICLES; DOMINANT FOLLICLE; BINDING-PROTEINS; GENE ONTOLOGY; BASAL LAMINA; EXPRESSION; GROWTH; CATTLE; DIFFERENTIATION	The theca interna is a specialized stromal layer that envelops each growing ovarian follicle. It contains capillaries, fibroblasts, immune cells and the steroidogenic cells that synthesize androgens for conversion to estradiol by the neighboring granulosa cells. During reproductive life only a small number of follicles will grow to a sufficient size to ovulate, whereas the majority of follicles will undergo regression/atresia and phagocytosis by macrophages. To identify genes which are differentially regulated in the theca interna during follicular atresia, we undertook transcriptome profiling of the theca interna from healthy (n = 10) and antral atretic (n = 5) bovine follicles at early antral stages (<5 mm). Principal Component Analyses and hierarchical classification of the signal intensity plots for the arrays showed primary clustering into two groups, healthy and atretic. A total of 543 probe sets were differentially expressed between the atretic and healthy theca interna. Further analyses of these genes by Ingenuity Pathway Analysis and Gene Ontology Enrichment Analysis Toolkit software found most of the genes being expressed were related to cytokines, hormones and receptors as well as the cell cycle and DNA replication. Cell cycle genes which encode components of the replicating chromosome complex and mitotic spindle were down-regulated in atretic theca interna, whereas stress response and inflammation-related genes such as TP53, IKBKB and TGFB1 were up-regulated. In addition to cell cycle regulators, upstream regulators that were predicted to be inhibited included Retinoblastoma 1, E2 transcription factor 1, and hepatocyte growth factor. Our study suggests that during antral atresia of small follicles in the theca interna, arrest of cell cycle and DNA replication occurs rather than up-regulation of apoptosis-associated genes as occurs in granulosa cells.	[Hatzirodos, Nicholas; Irving-Rodgers, Helen F.; Hummitzsch, Katja; Rodgers, Raymond J.] Univ Adelaide, Res Ctr Reprod Hlth, Discipline Obstet & Gynaecol, Sch Paediat & Reprod Hlth,Robinson Res Inst, Adelaide, SA, Australia	Robinson Research Institute; University of Adelaide	Rodgers, RJ (corresponding author), Univ Adelaide, Res Ctr Reprod Hlth, Discipline Obstet & Gynaecol, Sch Paediat & Reprod Hlth,Robinson Res Inst, Adelaide, SA, Australia.	ray.rodgers@adelaide.edu.au	Rodgers, Raymond J/C-3476-2009; Irving-Rodgers, Helen/E-3660-2010; Hummitzsch, Katja/K-6940-2013	Hummitzsch, Katja/0000-0001-5023-2668	National Health and Medical Research Council of Australia; Australian Research Council; University of Adelaide	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); University of Adelaide	This work was supported by the National Health and Medical Research Council of Australia, the Australian Research Council and the University of Adelaide. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreu-Vieyra C, 2008, MOL ENDOCRINOL, V22, P2141, DOI 10.1210/me.2008-0033; [Anonymous], 2005, IPA NETW GEN ALG; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Carvajal LA, 2013, EMBO REP, V14, P414, DOI 10.1038/embor.2013.25; Christenson LK, 2013, MOL ENDOCRINOL, V27, P1153, DOI 10.1210/me.2013-1093; Chu T, 2012, THERIOGENOLOGY, V77, P1928, DOI 10.1016/j.theriogenology.2012.01.015; Clark LJ, 2004, BIOL REPROD, V71, P1071, DOI 10.1095/biolreprod.104.029652; Cross MJ, 2001, TRENDS PHARMACOL SCI, V22, P201, DOI 10.1016/S0165-6147(00)01676-X; EISENHART C, 1947, BIOMETRICS, V3, P1, DOI 10.2307/3001534; Evans ACO, 2004, BIOL REPROD, V70, P1475, DOI 10.1095/biolreprod.103.025114; FALCK B, 1959, NATURE, V184, P1082, DOI 10.1038/1841082a0; Hatzirodos N, 2014, PLOS ONE UNPUB; Hatzirodos N, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-40; Hotelling H, 1933, J EDUC PSYCHOL, V24, P417, DOI 10.1037/h0071325; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irving-Rodgers HF, 2009, HUM REPROD, V24, P936, DOI 10.1093/humrep/den447; Irving-Rodgers HF, 2003, BIOL REPROD, V69, P2022, DOI 10.1095/biolreprod.103.017442; Irving-Rodgers HF, 2003, REPROD FERT DEVELOP, V15, P241, DOI 10.1071/RD03008; Irving-Rodgers HF, 2002, REPRODUCTION, V123, P97, DOI 10.1530/rep.0.1230097; Irving-Rodgers HF, 2001, REPRODUCTION, V122, P761, DOI 10.1530/rep.0.1220761; Irving-Rodgers HF, 2000, J REPROD FERTIL, V118, P221, DOI 10.1530/reprod/118.2.221; Ishimi Y, 1997, J BIOL CHEM, V272, P24508, DOI 10.1074/jbc.272.39.24508; Knight PG, 2006, REPRODUCTION, V132, P191, DOI 10.1530/rep.1.01074; Li B, 2010, FASEB J, V24, P4767, DOI 10.1096/fj.10-154757; Matsuda F, 2012, J REPROD DEVELOP, V58, P44, DOI 10.1262/jrd.2011-012; Mattera L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000983; Mihm M, 2008, REPRODUCTION, V135, P253, DOI 10.1530/REP-06-0193; Mourot M, 2006, MOL REPROD DEV, V73, P1367, DOI 10.1002/mrd.20585; Patel SS, 2010, REPROD SCI, V17, P978, DOI 10.1177/1933719110379055; Portela VM, 2010, BIOL REPROD, V83, P339, DOI 10.1095/biolreprod.110.084277; Prodoehl MJ, 2009, MOL CELL ENDOCRINOL, V307, P133, DOI 10.1016/j.mce.2009.03.002; Rodgers RJ, 2010, REPRODUCTION, V139, P309, DOI 10.1530/REP-09-0177; Rodgers RJ, 2010, BIOL REPROD, V82, P1021, DOI 10.1095/biolreprod.109.082941; Sharma SC, 2000, J BIOL CHEM, V275, P33718, DOI 10.1074/jbc.M003555200; Sivko GS, 2004, J CELL BIOCHEM, V93, P830, DOI 10.1002/jcb.20223; Skinner MK, 2008, MOL REPROD DEV, V75, P1457, DOI 10.1002/mrd.20883; Turner EC, 2011, REPRODUCTION, V141, P821, DOI 10.1530/REP-10-0327; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Wu RJ, 2004, HUM REPROD UPDATE, V10, P119, DOI 10.1093/humupd/dmh011; YU BP, 1994, PHYSIOL REV, V74, P139, DOI 10.1152/physrev.1994.74.1.139; Zheng Q, 2008, NUCLEIC ACIDS RES, V36, pW358, DOI 10.1093/nar/gkn276	43	29	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e99706	10.1371/journal.pone.0099706	http://dx.doi.org/10.1371/journal.pone.0099706			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956388	Green Submitted, Green Published, gold			2022-12-27	WOS:000338917900017
J	O'Donnell, DR; Parigi, A; Fish, JA; Dworkin, I; Wagner, AP				O'Donnell, Daniel R.; Parigi, Abhijna; Fish, Jordan A.; Dworkin, Ian; Wagner, Aaron P.			The Roles of Standing Genetic Variation and Evolutionary History in Determining the Evolvability of Anti-Predator Strategies	PLOS ONE			English	Article							HETEROGENEOUS ENVIRONMENT; ADAPTATION; POPULATION; RESPONSES; SELECTION; GENOMICS; SIZE	Standing genetic variation and the historical environment in which that variation arises (evolutionary history) are both potentially significant determinants of a population's capacity for evolutionary response to a changing environment. Using the open-ended digital evolution software Avida, we evaluated the relative importance of these two factors in influencing evolutionary trajectories in the face of sudden environmental change. We examined how historical exposure to predation pressures, different levels of genetic variation, and combinations of the two, affected the evolvability of anti-predator strategies and competitive abilities in the presence or absence of threats from new, invasive predator populations. We show that while standing genetic variation plays some role in determining evolutionary responses, evolutionary history has the greater influence on a population's capacity to evolve anti-predator traits, i.e. traits effective against novel predators. This adaptability likely reflects the relative ease of repurposing existing, relevant genes and traits, and the broader potential value of the generation and maintenance of adaptively flexible traits in evolving populations.	[O'Donnell, Daniel R.; Parigi, Abhijna; Dworkin, Ian] Michigan State Univ, Program Ecol Evolutionary Biol & Behav, E Lansing, MI 48824 USA; [O'Donnell, Daniel R.; Parigi, Abhijna; Fish, Jordan A.; Dworkin, Ian] Michigan State Univ, Dept Zool, E Lansing, MI 48824 USA; [Fish, Jordan A.] Michigan State Univ, Ctr Microbial Ecol, E Lansing, MI 48824 USA; [Dworkin, Ian; Wagner, Aaron P.] Michigan State Univ, BEACON Ctr Study Evolut Act, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University; Michigan State University	O'Donnell, DR (corresponding author), Michigan State Univ, Program Ecol Evolutionary Biol & Behav, E Lansing, MI 48824 USA.	odonn146@msu.edu	ODonnell, Daniel/GXG-8072-2022	Dworkin, Ian/0000-0002-2874-287X; O'Donnell, Daniel/0000-0003-0452-2888	BEACON Center for the Study of Evolution in Action (NSF) [DBI-0939454]; Michigan State University Institute for Cyber Enabled Research	BEACON Center for the Study of Evolution in Action (NSF); Michigan State University Institute for Cyber Enabled Research	Funding was provided by BEACON Center for the Study of Evolution in Action (NSF Cooperative Agreement DBI-0939454), beacon-center.org; and Michigan State University Institute for Cyber Enabled Research, icer.msu.edu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CJ, 2013, ARTIF LIFE, V13, P3; Barrett RDH, 2008, TRENDS ECOL EVOL, V23, P38, DOI 10.1016/j.tree.2007.09.008; Barton K, 2013, R PACKAGE MUMIN MULT; Bell G, 2008, EVOL APPL, V1, P3, DOI 10.1111/j.1752-4571.2007.00011.x; Blount ZD, 2008, P NATL ACAD SCI USA, V105, P7899, DOI 10.1073/pnas.0803151105; BONNELL ML, 1974, SCIENCE, V184, P908, DOI 10.1126/science.184.4139.908; Bryson DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083242; Colegrave N, 2008, HEREDITY, V100, P464, DOI 10.1038/sj.hdy.6801095; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Dettman JR, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-35; Dionne M, 2009, PHILOS T R SOC B, V364, P1555, DOI 10.1098/rstb.2009.0011; DODSON S, 1989, BIOSCIENCE, V39, P447, DOI 10.2307/1311136; Drake JW, 1998, GENETICS, V148, P1667; Elmer KR, 2011, TRENDS ECOL EVOL, V26, P298, DOI 10.1016/j.tree.2011.02.008; Fortuna MA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002928; Fox J, 2013, R PACKAGE EFFECTS EF; Frankham R, 1999, ANIM CONSERV, V2, P255, DOI 10.1111/j.1469-1795.1999.tb00071.x; Fry JD, 2001, J EVOLUTION BIOL, V14, P296, DOI 10.1046/j.1420-9101.2001.00271.x; Futuyma DJ, 1979, EVOLUTIONARY BIOL; Gillings MR, 2012, TRENDS ECOL EVOL, V27, P346, DOI 10.1016/j.tree.2012.02.006; Hayden EJ, 2011, NATURE, V474, P92, DOI 10.1038/nature10083; HEDRICK PW, 1976, GENETICS, V84, P145; Hermisson J, 2005, GENETICS, V169, P2335, DOI 10.1534/genetics.104.036947; Innan H, 2004, P NATL ACAD SCI USA, V101, P10667, DOI 10.1073/pnas.0401720101; Jerome JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016399; Kawecki TJ, 2012, TRENDS ECOL EVOL, V27, P547, DOI 10.1016/j.tree.2012.06.001; LANDE R, 1988, SCIENCE, V241, P1455, DOI 10.1126/science.3420403; Lehmann K, 2013, PLOS ONE, V9; Lenski RE, 2003, NATURE, V423, P139, DOI 10.1038/nature01568; LEVINS R, 1963, AM NAT, V97, P75, DOI 10.1086/282258; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Litchman E, 2012, MAR ECOL PROG SER, V470, P235, DOI 10.3354/meps09912; Lohbeck KT, 2012, NAT GEOSCI, V5, P346, DOI [10.1038/ngeo1441, 10.1038/NGEO1441]; McCollum SA, 1996, EVOLUTION, V50, P583, DOI 10.1111/j.1558-5646.1996.tb03870.x; McGuigan K, 2009, TRENDS ECOL EVOL, V24, P305, DOI 10.1016/j.tree.2009.02.001; Messer PW, 2013, TRENDS ECOL EVOL, V28, P659, DOI 10.1016/j.tree.2013.08.003; Mitchell-Olds T, 2007, NAT REV GENET, V8, P845, DOI 10.1038/nrg2207; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Ofria C, 2009, ARTIFICIAL LIFE MODE; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Orr HA, 2001, GENETICS, V157, P875; Pennings PS, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002527; Pinheiro J., 2014, R PACKAGE VERSION, V3, P1; Potts R, 1996, SCIENCE, V273, P922, DOI 10.1126/science.273.5277.922; Przeworski M, 2005, EVOLUTION, V59, P2312, DOI 10.1554/05-273.1; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Schmitz OJ, 2008, SCIENCE, V319, P952, DOI 10.1126/science.1152355; Sih A., 1987, P203; Wagner AP, 2013, ARXIV13101369V2; Wilke CO, 2002, TRENDS ECOL EVOL, V17, P528, DOI 10.1016/S0169-5347(02)02612-5; Yoshida T, 2003, NATURE, V424, P303, DOI 10.1038/nature01767	52	9	9	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100163	10.1371/journal.pone.0100163	http://dx.doi.org/10.1371/journal.pone.0100163			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955847	Green Published, gold, Green Submitted			2022-12-27	WOS:000338917900030
J	Soebiyanto, RP; Clara, W; Jara, J; Castillo, L; Sorto, OR; Marinero, S; de Antinori, MEB; McCracken, JP; Widdowson, MA; Azziz-Baumgartner, E; Kiang, RK				Soebiyanto, Radina P.; Clara, Wilfrido; Jara, Jorge; Castillo, Leticia; Rene Sorto, Oscar; Marinero, Sidia; Barnett de Antinori, Maria E.; McCracken, John P.; Widdowson, Marc-Alain; Azziz-Baumgartner, Eduardo; Kiang, Richard K.			The Role of Temperature and Humidity on Seasonal Influenza in Tropical Areas: Guatemala, El Salvador and Panama, 2008-2013	PLOS ONE			English	Article							RELATIVE-HUMIDITY; TRANSMISSION; SURVEILLANCE; SURVIVAL; VIRUS; PATTERNS; DRIVERS; MODEL	Background: The role of meteorological factors on influenza transmission in the tropics is less defined than in the temperate regions. We assessed the association between influenza activity and temperature, specific humidity and rainfall in 6 study areas that included 11 departments or provinces within 3 tropical Central American countries: Guatemala, El Salvador and Panama. Method/Findings: Logistic regression was used to model the weekly proportion of laboratory-confirmed influenza positive samples during 2008 to 2013 (excluding pandemic year 2009). Meteorological data was obtained from the Tropical Rainfall Measuring Mission satellite and the Global Land Data Assimilation System. We found that specific humidity was positively associated with influenza activity in El Salvador (Odds Ratio (OR) and 95% Confidence Interval of 1.18 (1.07-1.31) and 1.32 (1.08-1.63)) and Panama (OR = 1.44 (1.08-1.93) and 1.97 (1.34-2.93)), but negatively associated with influenza activity in Guatemala (OR = 0.72 (0.6-0.86) and 0.79 (0.69-0.91)). Temperature was negatively associated with influenza in El Salvador's west-central departments (OR = 0.80 (0.7-0.91)) whilst rainfall was positively associated with influenza in Guatemala's central departments (OR = 1.05 (1.01-1.09)) and Panama province (OR = 1.10 (1.05-1.14)). In 4 out of the 6 locations, specific humidity had the highest contribution to the model as compared to temperature and rainfall. The model performed best in estimating 2013 influenza activity in Panama and west-central El Salvador departments (correlation coefficients: 0.5-0.9). Conclusions/Significance: The findings highlighted the association between influenza activity and specific humidity in these 3 tropical countries. Positive association with humidity was found in El Salvador and Panama. Negative association was found in the more subtropical Guatemala, similar to temperate regions. Of all the study locations, Guatemala had annual mean temperature and specific humidity that were lower than the others.	[Soebiyanto, Radina P.] Univ Space Res Assoc, Goddard Earth Sci Technol & Res GESTAR, Columbia, MD USA; [Soebiyanto, Radina P.; Kiang, Richard K.] NASA, Global Change Data Ctr, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Clara, Wilfrido] Ctr Dis Control & Prevent CDC, Reg Off Cent Amer Reg, Influenza Program, Guatemala City, Guatemala; [Jara, Jorge; McCracken, John P.] Univ Valle Guatemala, Influenza Unit, Ctr Hlth Studies, Guatemala City, Guatemala; [Castillo, Leticia] Minist Hlth Guatemala, Natl Influenza Ctr, Guatemala City, Guatemala; [Rene Sorto, Oscar] Minist Hlth El Salvador, Hlth Surveillance Div, San Salvador, El Salvador; [Marinero, Sidia] Minist Environm & Nat Resources El Salvador, Div Meteorol, Natl Environm Observ, San Salvador, El Salvador; [Barnett de Antinori, Maria E.] Gorgas Mem Inst Hlth Studies, Natl Influenza Ctr, Panama City, Panama; [Widdowson, Marc-Alain; Azziz-Baumgartner, Eduardo] Ctr Dis Control & Prevent CDC, Influenza Div, Atlanta, GA USA	Universities Space Research Association (USRA); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Universidad del Valle de Guatemala; Instituto Conmemorativo Gorgas de Estudios de la Salud; Centers for Disease Control & Prevention - USA	Kiang, RK (corresponding author), NASA, Global Change Data Ctr, Goddard Space Flight Ctr, Code 610-2, Greenbelt, MD 20771 USA.	richard.kiang@nasa.gov			NASA Applied Science - Public Health program; CDC Influenza Division	NASA Applied Science - Public Health program; CDC Influenza Division(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study was supported by NASA Applied Science - Public Health program and CDC Influenza Division. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acker J. G., 2007, EOS T AGU, V88, P14, DOI [DOI 10.1029/2007EO020003, 10.1029/2007EO020003]; Alonso WJ, 2007, AM J EPIDEMIOL, V165, P1434, DOI 10.1093/aje/kwm012; Baumgartner EA, 2012, J INFECT DIS, V206, P838, DOI 10.1093/infdis/jis467; *CDC CAP INFL PROG, 2010, NAT INV COR CAP PAND; *CDC CAP INFL PROG, 2009, INST DES UN CENT INF; *CDC CAP INFL PROG, 2010, ANN REPORT; *CDC CAR INFL PROG, 2011, INFL SURV CENTR AM R; Chadha MS, 2012, INFLUENZA OTHER RESP, V6, P196, DOI 10.1111/j.1750-2659.2011.00293.x; Charland KML, 2009, EPIDEMIOL INFECT, V137, P1377, DOI 10.1017/S0950268809002283; Chew FT, 1998, EPIDEMIOL INFECT, V121, P121, DOI 10.1017/S0950268898008905; Crawley M.J., 2007, R BOOK; Dosseh A, 2000, AM J TROP MED HYG, V62, P639, DOI 10.4269/ajtmh.2000.62.639; Dushoff J, 2004, P NATL ACAD SCI USA, V101, P16915, DOI 10.1073/pnas.0407293101; Ek MB, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003296; Hampson AW, 1999, VACCINE, V17, pS19, DOI 10.1016/S0264-410X(99)00100-0; HARPER GJ, 1961, J HYG-CAMBRIDGE, V59, P479, DOI 10.1017/S0022172400039176; Haynes AK, 2013, J INFECT DIS, V208, pS246, DOI 10.1093/infdis/jit515; HEMMES JH, 1962, ANTON VAN LEE J M S, V28, P221, DOI 10.1007/BF02538737; Kasasa S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-63; Kazembe Lawrence N, 2006, Int J Health Geogr, V5, P41, DOI 10.1186/1476-072X-5-41; Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130; Liao CM, 2009, INT J INFECT DIS, V13, P589, DOI 10.1016/j.ijid.2008.09.019; Lofgren E, 2007, J VIROL, V81, P5429, DOI 10.1128/JVI.01680-06; Lowen AC, 2008, J VIROL, V82, P5650, DOI 10.1128/JVI.00325-08; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; Mahamat A, 2013, J INFECTION, V67, P141, DOI 10.1016/j.jinf.2013.03.018; Moura FEA, 2009, AM J TROP MED HYG, V81, P180, DOI 10.4269/ajtmh.2009.81.180; *PAHO, 2006, PAHO CDC GEN PROT IN; *PAHO CDC, 2009, PROT GEN VIG INFL; Polozov IV, 2008, NAT CHEM BIOL, V4, P248, DOI 10.1038/nchembio.77; R Core Team, 2012, R LANG ENV STAT COMP; Rodell M, 2004, B AM METEOROL SOC, V85, P381, DOI 10.1175/BAMS-85-3-381; SAHA S, WHO B IN PRESS; SCHAFFER FL, 1976, ARCH VIROL, V51, P263, DOI 10.1007/BF01317930; SERFLING RE, 1963, PUBLIC HEALTH REP, V78, P494, DOI 10.2307/4591848; Shaman J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000316; Shaman J, 2009, P NATL ACAD SCI USA, V106, P3243, DOI 10.1073/pnas.0806852106; Soebiyanto RP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009450; Tamerius J, 2011, ENVIRON HEALTH PERSP, V119, P439, DOI 10.1289/ehp.1002383; Tamerius JD, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003194; Tang JW, 2010, J MED VIROL, V82, P1958, DOI 10.1002/jmv.21892; te Beest DE, 2013, AM J EPIDEMIOL, V178, P1469, DOI 10.1093/aje/kwt132; Thompson WW, 2006, J INFECT DIS, V194, pS82, DOI 10.1086/507558; Urashima M, 2003, JPN J INFECT DIS, V56, P43; Viboud C, 2006, PLOS MED, V3, P468, DOI 10.1371/journal.pmed.0030089; Weber TP, 2008, J INFECTION, V57, P361, DOI 10.1016/j.jinf.2008.08.013; WHO, 2008, INFLUENZA; WHO, 2007, REC LAB PROC DET AV; Yang L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001399; Yu HJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001552; Zaman RU, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008452	51	55	57	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100659	10.1371/journal.pone.0100659	http://dx.doi.org/10.1371/journal.pone.0100659			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956184	Green Submitted, gold, Green Published			2022-12-27	WOS:000338917900078
J	Kim, H; Shibayama, K; Rimbara, E; Mori, S				Kim, Hyun; Shibayama, Keigo; Rimbara, Emiko; Mori, Shigetarou			Biochemical Characterization of Quinolinic Acid Phosphoribosyltransferase from Mycobacterium tuberculosis H37Rv and Inhibition of Its Activity by Pyrazinamide	PLOS ONE			English	Article							NICOTINAMIDE ADENINE-DINUCLEOTIDE; CRYSTAL-STRUCTURE; SALMONELLA-TYPHIMURIUM; NAD KINASE; RESISTANCE; ENZYME; BIOSYNTHESIS; METABOLISM; MECHANISMS; ROLES	Quinolinic acid phosphoribosyltransferase (QAPRTase EC 2.4.2.19) a key enzyme in the de novo pathway of nicotinamide adenine dinucleotide (NAD) biosynthesis and a target for h development of new anti-tuberculosis drugs. QAPRTase catalyzes the synthesis of nicotinic acid nlononucleotide from quinolinic acid (QA) and 5-phosphoribosyl-1-pyrophosphate (PRPP) through a phosphoribosyl transfer reaction followed by decarboycylation. The crystal structure of QAPRTase from Mycobacterium tuberculosis H37Rv (AAtQAPRTase) has been determined; however, a detailed functional analysis of MtQAPRTase has not been published. Here, we analyzed the enzymatic activities of MtQAPRTase and determined the effect. on catalysis of the anti-tuberculosis drug pyrazinamide (PZA). The optimum temperature and pH for MtQAPRTase activity were 60 degrees C and pH 9.2. MtQAPRTase required bivalent metal ions and its activity was highest in the presence of Mg2+. Kinetic analyses revealed that the K-m values for QA and PRPP were 0.08 and 0.39 mM, respectively, and the k(cat), values for A and PRPP were 0.12 and 0.14 [s(-1)], respectively. When the amino acid residues of MtQAPRTase, which may interact with QA, were substittuted with alanine residues, catalytic activity was undetectable. Further, PZA, which is an anti-tuberculosis drug and a structural analog of QA, markedly inhibited the catalytic activity of MtQAPRTase. The structure of PZA may provide the basis or the design of new inhibitors of MtQAPRTase. These findings provide new insights into the catalytic properties of MtQAPRTase.	[Kim, Hyun; Shibayama, Keigo; Rimbara, Emiko; Mori, Shigetarou] Natl Inst Infect Dis, Dept Bacteriol 2, Tokyo, Japan	National Institute of Infectious Diseases (NIID)	Mori, S (corresponding author), Natl Inst Infect Dis, Dept Bacteriol 2, Tokyo, Japan.	mshige@niid.go.jp	Rimbara, Emiko/F-4113-2017	Rimbara, Emiko/0000-0001-8847-1840	Ministry of Health, Labor, and Welfare of Japan [H24-Shinkou-Ippan-010]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [25860329]	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported, in part, by a grant from the Ministry of Health, Labor, and Welfare of Japan (H24-Shinkou-Ippan-010) and by a Grant-in-Aid for Young Scientists (No. 25860329) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz MA, 2006, LANCET, V368, P2142, DOI 10.1016/S0140-6736(06)69863-2; Bellinzoni M, 2002, PROTEIN EXPRES PURIF, V25, P547, DOI 10.1016/S1046-5928(02)00041-4; Bello Z, 2010, BIOCHEMISTRY-US, V49, P1377, DOI 10.1021/bi9018219; Bello Z, 2010, BIOCHEMISTRY-US, V49, P1388, DOI 10.1021/bi9018225; Boshoff HI, 2002, J BACTERIOL, V184, P2167, DOI 10.1128/JB.184.8.2167-2172.2002; Cao H, 2002, BIOCHEMISTRY-US, V41, P3520, DOI 10.1021/bi012148g; Cer RZ, 2009, NUCLEIC ACIDS RES, V37, pW441, DOI 10.1093/nar/gkp253; Champagne KS, 2006, BIOCHEMISTRY-US, V45, P14933, DOI 10.1021/bi061802v; Chappie JS, 2005, STRUCTURE, V13, P1385, DOI 10.1016/j.str.2005.05.016; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; de Figueiredo LF, 2011, BIOCHEM J, V439, P341, DOI 10.1042/BJ20110320; Di Luccio E, 2008, BIOCHEMISTRY-US, V47, P4039, DOI 10.1021/bi7020475; Eads JC, 1997, STRUCTURE, V5, P47, DOI 10.1016/S0969-2126(97)00165-2; FOSTER JW, 1980, MICROBIOL REV, V44, P83, DOI 10.1128/MMBR.44.1.83-105.1980; FOSTER JW, 1990, J BACTERIOL, V172, P4187, DOI 10.1128/jb.172.8.4187-4196.1990; Garavaglia S, 2004, J BIOL CHEM, V279, P40980, DOI 10.1074/jbc.M406586200; IWAI K, 1979, AGR BIOL CHEM TOKYO, V43, P345, DOI 10.1080/00021369.1979.10863445; KALIKIN L, 1988, BIOCHEM BIOPH RES CO, V152, P559, DOI 10.1016/S0006-291X(88)80074-3; Kim C, 2002, FEBS LETT, V523, P239, DOI 10.1016/S0014-5793(02)02905-8; Kim H, 2011, ANTIMICROB AGENTS CH, V55, P3661, DOI 10.1128/AAC.00042-11; Kim MK, 2006, PROTEINS, V63, P252, DOI 10.1002/prot.20834; Leslie NR, 2002, BMC BIOCHEM, V3, DOI 10.1186/1472-2091-3-20; Liu H, 2007, J MOL BIOL, V373, P755, DOI 10.1016/j.jmb.2007.08.043; Mori S, 2010, PROTEIN EXPRES PURIF, V69, P99, DOI 10.1016/j.pep.2009.09.010; MUSICK WDL, 1981, CRC CR REV BIOCH MOL, V11, P1, DOI 10.3109/10409238109108698; Ngo SC, 2007, ANTIMICROB AGENTS CH, V51, P2430, DOI 10.1128/AAC.01458-06; Pelicic V, 1997, P NATL ACAD SCI USA, V94, P10955, DOI 10.1073/pnas.94.20.10955; Penfound T, 1995, ESCHERICHIA COLI SAL, P721; Raffaelli N, 2004, BIOCHEMISTRY-US, V43, P7610, DOI 10.1021/bi049650w; Raynaud C, 1999, MICROBIOL-SGM, V145, P1359, DOI 10.1099/13500872-145-6-1359; Schramm VL, 2004, PROG NUCLEIC ACID RE, V78, P261, DOI 10.1016/S0079-6603(04)78007-1; Sharma V, 1998, STRUCTURE, V6, P1587, DOI 10.1016/S0969-2126(98)00156-7; Shi WL, 2011, SCIENCE, V333, P1630, DOI 10.1126/science.1208813; Shin DH, 2005, J BIOL CHEM, V280, P18326, DOI 10.1074/jbc.M501622200; Sinha SC, 2001, CURR OPIN STRUC BIOL, V11, P733, DOI 10.1016/S0959-440X(01)00274-3; Somoskovi A, 2001, RESP RES, V2, P164, DOI 10.1186/rr54; Tritz GJ, 1987, ESCHERICHIA COLI SAL, P557; Wang T, 2006, NAT STRUCT MOL BIOL, V13, P661, DOI 10.1038/nsmb1114; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; World Health Organization, 2008, WHOHTMTB2008402; Zhang Y, 1999, J BACTERIOL, V181, P2044, DOI 10.1128/JB.181.7.2044-2049.1999; Zignol M, 2006, J INFECT DIS, V194, P479, DOI 10.1086/505877; Zimhony O, 2000, NAT MED, V6, P1043, DOI 10.1038/79558	43	15	15	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100062	10.1371/journal.pone.0100062	http://dx.doi.org/10.1371/journal.pone.0100062			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949952	Green Submitted, Green Published, gold			2022-12-27	WOS:000338276300035
J	Marr, N; Hirschfeld, AF; Lam, A; Wang, S; Lavoie, PM; Turvey, SE				Marr, Nico; Hirschfeld, Aaron F.; Lam, Angie; Wang, Shirley; Lavoie, Pascal M.; Turvey, Stuart E.			Assessment of Genetic Associations between Common Single Nucleotide Polymorphisms in RIG-I-Like Receptor and IL-4 Signaling Genes and Severe Respiratory Syncytial Virus Infection in Children: A Candidate Gene Case-Control Study	PLOS ONE			English	Article							ILE50VAL VARIANT; RISK-FACTORS; SUSCEPTIBILITY; BRONCHIOLITIS; DISEASE; HOST; INTERLEUKIN-4; EPIDEMIOLOGY; REINFECTION; IL-4R-ALPHA	The majority of cases of severe pediatric respiratory syncytial virus (RSV) infection occur in otherwise healthy infants who have no identifiable risk factors, suggesting that additional subclinical factors, such as population genetic variation, influence the course of RSV infection. The objective of this study was to test if common single nucleotide polymorphisms (SNPs) in genes encoding for immune signalling components of the RIG-I-like receptor (RLR) and IL-4-signalling pathways affect the outcome of RSV infection in early life. We genotyped 8 SNPs using allele-specific probes combined with real-time PCR. Each of the SNPs tested had previously been established to have a functional impact on immune responsiveness and two of the SNPs in the IL4 and IL4R genes had previously been associated with severe RSV bronchiolitis. Association with susceptibility to severe RSV infection was tested by statistically comparing genotype and allele frequencies in infants and young children hospitalized with severe RSV bronchiolitis (n = 140) with two control groups-children who tested positive for RSV but did not require hospitalization (n = 100), and a general population control group (n = 285). Our study was designed with sufficient power (>80%) to detect clinically-relevant associations with effect sizes >= 1.5. However, we detected no statistically significant differences in allele and genotype frequencies of the investigated SNPs between the inpatient and control groups. To conclude, we could not replicate the previously reported association with SNPs in the IL4 and IL4R genes in our independent cohort, nor did we find that common SNPs in genes encoding for RLRs and the downstream adapter MAVS were associated with susceptibility to severe RSV infections. Despite the existing evidence demonstrating a functional immunological impact of these SNPs, our data suggest that the biological effect of each individual SNP is unlikely to affect clinical outcomes of RSV infection.	[Marr, Nico; Hirschfeld, Aaron F.; Lam, Angie; Wang, Shirley; Lavoie, Pascal M.; Turvey, Stuart E.] Univ British Columbia, Dept Pediat, Child & Family Res Inst, Vancouver, BC V6T 1W5, Canada	Child & Family Research Institute; University of British Columbia	Marr, N (corresponding author), Univ British Columbia, Dept Pediat, Child & Family Res Inst, Vancouver, BC V6T 1W5, Canada.	nmarr@cfri.ca; sturvey@cw.bc.ca	Marr, Nico/T-7741-2019; Turvey, Stuart/HGV-1191-2022	Marr, Nico/0000-0002-1927-7072; Turvey, Stuart/0000-0003-1599-1065; Lavoie, Pascal/0000-0002-2205-0362	British Columbia Lung Association; Canadian Institutes of Health Research; AllerGen N.C.E., Canada; Child and Family Research Institute; Michael Smith Foundation for Health Research	British Columbia Lung Association; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); AllerGen N.C.E., Canada; Child and Family Research Institute; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	This study was funded by the British Columbia Lung Association (to N.M.), and the Canadian Institutes of Health Research (to S. E. T.). A.L. and S.W. were recipients of undergraduate summer studentships from AllerGen N.C.E., Canada and the Child and Family Research Institute. P.M.L. and S.E.T. acknowledge support from the Michael Smith Foundation for Health Research. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2013, J IMMUNOL, V190, P3949, DOI 10.4049/jimmunol.1201015; Amanatidou V, 2009, PEDIATR INFECT DIS J, V28, P135, DOI 10.1097/INF.0b013e31818c8d17; Awomoyi AA, 2007, J IMMUNOL, V179, P3171, DOI 10.4049/jimmunol.179.5.3171; Bendelja K, 2000, CLIN EXP IMMUNOL, V121, P332, DOI 10.1046/j.1365-2249.2000.01297.x; Bhoj VG, 2008, P NATL ACAD SCI USA, V105, P14046, DOI 10.1073/pnas.0804717105; Boyce TG, 2000, J PEDIATR-US, V137, P865, DOI 10.1067/mpd.2000.110531; Choi EH, 2002, J INFECT DIS, V186, P1207, DOI 10.1086/344310; Clarke GM, 2011, NAT PROTOC, V6, P121, DOI 10.1038/nprot.2010.182; Clausen LN, 2014, J VIRAL HEPATITIS, V21, P578, DOI 10.1111/jvh.12188; Culley FJ, 2002, J EXP MED, V196, P1381, DOI 10.1084/jem.20020943; Demoor T, 2012, J IMMUNOL, V189, P5942, DOI 10.4049/jimmunol.1201763; Garcia CG, 2010, PEDIATRICS, V126, pE1453, DOI 10.1542/peds.2010-0507; Goetghebuer T, 2004, PEDIATR PULM, V38, P321, DOI 10.1002/ppul.20069; Hakonarson H, 2009, SEMIN IMMUNOL, V21, P355, DOI 10.1016/j.smim.2009.06.001; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Hashimoto Shu, 2008, Allergol Int, V57, P21, DOI 10.2332/allergolint.R-07-156; Hoebee B, 2003, J INFECT DIS, V187, P2, DOI 10.1086/345859; Hu JZ, 2010, J IMMUNOL, V185, P424, DOI 10.4049/jimmunol.0903291; Kwiatkowski D, 2000, BMJ-BRIT MED J, V321, P1061, DOI 10.1136/bmj.321.7268.1061; Lahti M, 2002, PEDIATR RES, V51, P696, DOI [10.1203/00006450-200206000-00006, 10.1023/01.PDR.0000015911.65104.93]; Liu XW, 2011, MOL BIOL REP, V38, P4583, DOI 10.1007/s11033-010-0590-4; Lofgren J, 2010, PEDIATR PULM, V45, P687, DOI 10.1002/ppul.21248; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Marr N, 2014, J IMMUNOL, V192, P948, DOI 10.4049/jimmunol.1302007; Marr N, 2013, TRENDS MICROBIOL, V21, P568, DOI 10.1016/j.tim.2013.08.006; Mitsuyasu H, 1998, NAT GENET, V19, P119, DOI 10.1038/472; Mitsuyasu H, 1999, J IMMUNOL, V162, P1227; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Ovsyannikova IG, 2010, J INFECT DIS, V201, P207, DOI 10.1086/649588; Paes BA, 2011, CAN RESPIR J, V18, pE10, DOI 10.1155/2011/493056; Parkes M, 2013, NAT REV GENET, V14, P661, DOI 10.1038/nrg3502; Paulus SC, 2007, CLIN IMMUNOL, V123, P252, DOI 10.1016/j.clim.2007.03.003; Petersen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010603; Pickerling LK., 2012, RED BOOK 2012 REPORT, V29th ed, P609; Pothlichet J, 2011, EMBO MOL MED, V3, P142, DOI 10.1002/emmm.201000120; Pothlichet J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007582; Puthothu B, 2006, J INFECT DIS, V193, P438, DOI 10.1086/499316; Ramet M, 2011, PEDIATR PULM, V46, P101, DOI 10.1002/ppul.21348; Ripple MJ, 2010, J IMMUNOL, V185, P4804, DOI 10.4049/jimmunol.1000484; Selvarajah S, 2010, CURR OPIN HEMATOL, V17, P550, DOI 10.1097/MOH.0b013e32833e7544; Siezen CLE, 2009, PEDIATR INFECT DIS J, V28, P333, DOI 10.1097/INF.0b013e31818e2aa9; Simoes EAF, 2003, PEDIATR INFECT DIS J, V22, pS13, DOI 10.1097/00006454-200302001-00003; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; SORENSEN TIA, 1988, NEW ENGL J MED, V318, P727, DOI 10.1056/NEJM198803243181202; Soucy-Faulkner A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000930; Tal G, 2004, J INFECT DIS, V189, P2057, DOI 10.1086/420830; Thomsen SF, 2008, PEDIATRICS, V121, P493, DOI 10.1542/peds.2007-1889; Welliver RC, 2003, J PEDIATR-US, V143, pS112, DOI 10.1067/S0022-3476(03)00508-0; Yang H, 2012, AUTOIMMUNITY, V45, P226, DOI 10.3109/08916934.2011.633134; Yoboua F, 2010, J VIROL, V84, P7267, DOI 10.1128/JVI.00142-10; You DH, 2013, J LEUKOCYTE BIOL, V93, P933, DOI 10.1189/jlb.1012498	54	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100269	10.1371/journal.pone.0100269	http://dx.doi.org/10.1371/journal.pone.0100269			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949794	Green Published, gold			2022-12-27	WOS:000338276300057
J	Shafique, S; Siddiqi, S; Schraders, M; Oostrik, J; Ayub, H; Bilal, A; Ajmal, M; Seco, CZ; Strom, TM; Mansoor, A; Mazhar, K; Shah, STA; Hussain, A; Azam, M; Kremer, H; Qamar, R				Shafique, Sobia; Siddiqi, Saima; Schraders, Margit; Oostrik, Jaap; Ayub, Humaira; Bilal, Ammad; Ajmal, Muhammad; Seco, Celia Zazo; Strom, Tim M.; Mansoor, Atika; Mazhar, Kehkashan; Shah, Syed Tahir A.; Hussain, Alamdar; Azam, Maleeha; Kremer, Hannie; Qamar, Raheel			Genetic Spectrum of Autosomal Recessive Non-Syndromic Hearing Loss in Pakistani Families	PLOS ONE			English	Article							GJB2 MUTATIONS; HIGH-FREQUENCY; DEAFNESS; BARTTIN; TMPRSS3; MECHANISMS; EXPRESSION; SUBUNIT; DISEASE; DFNB1	The frequency of inherited bilateral autosomal recessive non-syndromic hearing loss (ARNSHL) in Pakistan is 1.6/1000 individuals. More than 50% of the families carry mutations in GJB2 while mutations in MYO15A account for about 5% of recessive deafness. In the present study a cohort of 30 ARNSHL families was initially screened for mutations in GJB2 and MYO15A. Homozygosity mapping was performed by employing whole genome single nucleotide polymorphism (SNP) genotyping in the families that did not carry mutations in GJB2 or MYO15A. Mutation analysis was performed for the known ARNSHL genes present in the homozygous regions to determine the causative mutations. This allowed the identification of a causative mutation in all the 30 families including 9 novel mutations, which were identified in 9 different families (GJB2 (c.598G>A, p.Gly200Arg); MYO15A (c.9948G>A, p.Gln3316GIn; c.3866+1G>A; c.8767C>T, p.Arg2923* and c.8222T>C, p.Phe2741Ser), TMC1 (c.362+18A>G), BSND (c.97G>C, p.Val33Leu), TMPRSS3 (c.726C>G, p.Cys242Trp) and MSRB3 (c.20T>G, p.Leu7Arg)). Furthermore, 12 recurrent mutations were detected in 21 other families. The 21 identified mutations included 10 (48%) missense changes, 4 (19%) nonsense mutations, 3 (14%) intronic mutations, 2 (9%) splice site mutations and 2 (9%) frameshift mutations. GJB2 accounted for 53% of the families, while mutations in MYO15A were the second most frequent (13%) cause of ARNSHL in these 30 families. The identification of novel as well as recurrent mutations in the present study increases the spectrum of mutations in known deafness genes which could lead to the identification of novel founder mutations and population specific mutated deafness genes causative of ARNSHL. These results provide detailed genetic information that has potential diagnostic implication in the establishment of cost-efficient allele-specific analysis of frequently occurring variants in combination with other reported mutations in Pakistani populations.	[Shafique, Sobia; Ayub, Humaira; Ajmal, Muhammad; Shah, Syed Tahir A.; Hussain, Alamdar; Azam, Maleeha; Qamar, Raheel] COMSATS Inst Informat Technol, Islamabad, Pakistan; [Siddiqi, Saima; Mansoor, Atika; Mazhar, Kehkashan] IBGE, Islamabad, Pakistan; [Schraders, Margit; Oostrik, Jaap; Seco, Celia Zazo; Kremer, Hannie] Radboud Univ Nijmegen, Dept Otorhinolaryngol Hearing & Genes, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Schraders, Margit; Oostrik, Jaap; Seco, Celia Zazo; Kremer, Hannie] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands; [Schraders, Margit; Oostrik, Jaap; Seco, Celia Zazo; Kremer, Hannie] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Bilal, Ammad] Simon Fraser Univ, Vancouver, BC, Canada; [Strom, Tim M.] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Human Genet, Neuherberg, Germany; [Kremer, Hannie] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Qamar, Raheel] Isra Univ, Al Nafees Med Coll & Hosp, Islamabad, Pakistan	COMSATS University Islamabad (CUI); Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Simon Fraser University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Radboud University Nijmegen	Kremer, H (corresponding author), Radboud Univ Nijmegen, Dept Otorhinolaryngol Hearing & Genes, Med Ctr, NL-6525 ED Nijmegen, Netherlands.	Hannie.Kremer@radboudumc.nl; raheelqamar@hotmail.com	Azam, Maleeha/AAD-9924-2022; Oostrik, Jaap/A-1703-2016; Schraders, Margit/A-1607-2016; Siddiqi, Saima/AAJ-6584-2021; Shah, Syed Tahir Abbas/K-4637-2015; Seco, Celia Zazo/AAB-7636-2020; Kremer, Hannie/F-5126-2010; Ajmal, Muhammad/G-8163-2012; Azam, Maleeha/L-1721-2017	Shah, Syed Tahir Abbas/0000-0001-9151-9374; Seco, Celia Zazo/0000-0003-3506-7611; Kremer, Hannie/0000-0002-0841-8693; Ajmal, Muhammad/0000-0001-5207-2469; Azam, Maleeha/0000-0003-0170-3325	Higher Education Commission (HEC) under the National Research Program for Universities [2155]; Oticon Foundation [09-3742]; ZorgOnderzoek Nederland/Medische Wetenschappen [40-00812-98-09047]	Higher Education Commission (HEC) under the National Research Program for Universities; Oticon Foundation; ZorgOnderzoek Nederland/Medische Wetenschappen	This work was supported by Higher Education Commission (HEC) grant no 2155 to RQ under the National Research Program for Universities, by The Oticon Foundation (grant 09-3742 to HK), and by ZorgOnderzoek Nederland/Medische Wetenschappen (grant 40-00812-98-09047 to HK). The authors also acknowledge the Higher Education Commission of Pakistan for providing funds to S. Shafique and S. Siddiqi to work in The Netherlands. The funders had no role in study design, data collection and anlaysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ahmed ZM, 2011, AM J HUM GENET, V88, P19, DOI 10.1016/j.ajhg.2010.11.010; Anderson DW, 2000, HUM MOL GENET, V9, P1729, DOI 10.1093/hmg/9.12.1729; Bashir R, 2012, EUR J MED GENET, V55, P99, DOI 10.1016/j.ejmg.2011.12.003; Batissoco AC, 2009, BRAZ J MED BIOL RES, V42, P168, DOI 10.1590/S0100-879X2009000200004; Bayazit YA, 2006, ORL-J OTO-RHIN-LARYN, V68, P57, DOI 10.1159/000091090; Belyantseva IA, 2003, P NATL ACAD SCI USA, V100, P13958, DOI 10.1073/pnas.2334417100; Ben Said M, 2010, GENET TEST MOL BIOMA, V14, P307, DOI 10.1089/gtmb.2009.0174; BRUNAK S, 1991, J MOL BIOL, V220, P49, DOI 10.1016/0022-2836(91)90380-O; Bukhari I, 2013, BIOCHEM GENET, V51, P524, DOI 10.1007/s10528-013-9583-z; de Heer AMR, 2011, AUDIOL NEURO-OTOL, V16, P93, DOI 10.1159/000313282; Elahi MM, 1998, J OTOLARYNGOL, V27, P348; Elbracht M, 2007, J MED GENET, V44, DOI 10.1136/jmg.2007.049122; Estevez R, 2001, NATURE, V414, P558, DOI 10.1038/35107099; Estivill X, 1998, LANCET, V351, P394, DOI 10.1016/S0140-6736(97)11124-2; Fasquelle L, 2011, J BIOL CHEM, V286, P17383, DOI 10.1074/jbc.M110.190652; Hayama A, 2003, HISTOCHEM CELL BIOL, V119, P485, DOI 10.1007/s00418-003-0535-2; Hilgert N, 2008, CLIN GENET, V74, P223, DOI 10.1111/j.1399-0004.2008.01053.x; Hilgert N, 2009, MUTAT RES-REV MUTAT, V681, P189, DOI 10.1016/j.mrrev.2008.08.002; Hoffmann K, 2005, BIOINFORMATICS, V21, P3565, DOI 10.1093/bioinformatics/bti571; Janssen AGH, 2009, J AM SOC NEPHROL, V20, P145, DOI 10.1681/ASN.2008010102; Gamundi MJ, 2008, HUM MUTAT, V29, P869, DOI 10.1002/humu.20747; Kelley PM, 1998, AM J HUM GENET, V62, P792, DOI 10.1086/301807; Kitajiri SI, 2007, CLIN GENET, V72, P546, DOI 10.1111/j.1399-0004.2007.00895.x; Kramer BK, 2008, NAT CLIN PRACT NEPHR, V4, P38, DOI 10.1038/ncpneph0689; Mani RS, 2009, EUR J HUM GENET, V17, P502, DOI 10.1038/ejhg.2008.179; Matos TD, 2010, GENET TEST MOL BIOMA, V14, P141, DOI 10.1089/gtmb.2009.0103; Minarik G, 2003, GEN PHYSIOL BIOPHYS, V22, P549; MORTON NE, 1991, ANN NY ACAD SCI, V630, P16, DOI 10.1111/j.1749-6632.1991.tb19572.x; Mustapha M, 2001, J Med Genet, V38, pE36, DOI 10.1136/jmg.38.10.e36; Naz S, 2002, AM J HUM GENET, V71, P632, DOI 10.1086/342193; Padma G, 2009, J GENET, V88, P267, DOI 10.1007/s12041-009-0039-5; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Qamar R, 2002, AM J HUM GENET, V70, P1107, DOI 10.1086/339929; Reardon W, 2000, QJM-INT J MED, V93, P99, DOI 10.1093/qjmed/93.2.99; Rickheit G, 2008, EMBO J, V27, P2907, DOI 10.1038/emboj.2008.203; Rozen S, 2000, Methods Mol Biol, V132, P365; Sambrook J., 2006, CONDENSED PROTOCOLS; Santos Regie Lyn P, 2005, Hum Mutat, V26, P396, DOI 10.1002/humu.9374; Santos RLP, 2005, CLIN GENET, V67, P61, DOI 10.1111/j.1399-0004.2005.00379.x; Schraders M, 2010, AM J HUM GENET, V86, P138, DOI 10.1016/j.ajhg.2009.12.017; Schultz JM, 2009, AM J HUM GENET, V85, P25, DOI 10.1016/j.ajhg.2009.06.003; Searle C, 2012, GENET TEST MOL BIOMA, V16, P453, DOI 10.1089/gtmb.2011.0254; Seelow D, 2009, NUCLEIC ACIDS RES, V37, pW593, DOI 10.1093/nar/gkp369; Sim NL, 2012, NUCLEIC ACIDS RES, V40, pW452, DOI 10.1093/nar/gks539; Sirmaci A, 2009, INT J PEDIATR OTORHI, V73, P699, DOI 10.1016/j.ijporl.2009.01.005; Snoeckx RL, 2005, AM J HUM GENET, V77, P945, DOI 10.1086/497996; VanCamp G, 1997, GENOMICS, V41, P70, DOI 10.1006/geno.1997.4624; Venselaar H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-548; Waldegger S, 2002, PFLUG ARCH EUR J PHY, V444, P411, DOI 10.1007/s00424-002-0819-8; Weegerink NJD, 2011, JARO-J ASSOC RES OTO, V12, P753, DOI 10.1007/s10162-011-0282-3; WENG ZG, 1995, MOL CELL BIOL, V15, P5627; Zelante L, 1997, HUM MOL GENET, V6, P1605, DOI 10.1093/hmg/6.9.1605	53	48	54	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100146	10.1371/journal.pone.0100146	http://dx.doi.org/10.1371/journal.pone.0100146			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949729	Green Published, Green Submitted, gold			2022-12-27	WOS:000338276300041
J	Silvani, A; Berteotti, C; Bastianini, S; Cohen, G; Lo Martire, V; Mazza, R; Pagotto, U; Quarta, C; Zoccoli, G				Silvani, Alessandro; Berteotti, Chiara; Bastianini, Stefano; Cohen, Gary; Lo Martire, Viviana; Mazza, Roberta; Pagotto, Uberto; Quarta, Carmelo; Zoccoli, Giovanna			Cardiorespiratory Anomalies in Mice Lacking CB1 Cannabinoid Receptors	PLOS ONE			English	Article							AUTONOMIC NERVOUS-SYSTEM; DIET-INDUCED OBESITY; BLOOD-PRESSURE; CARDIOVASCULAR FUNCTION; ENDOCANNABINOID SYSTEM; BAROREFLEX SENSITIVITY; ANGIOTENSIN-II; SLEEP; HEART; ACTIVATION	Cannabinoid type 1 (CB1) receptors are expressed in the nervous and cardiovascular systems. In mice, CB1 receptor deficiency protects from metabolic consequences of a high-fat diet (HFD), increases sympathetic activity to brown fat, and entails sleep anomalies. We investigated whether sleep-wake and diet-dependent cardiorespiratory control is altered in mice lacking CB1 receptors. CB1 receptor knock-out (KO) and intact wild-type (WT) mice were fed standard diet or a HFD for 3 months, and implanted with a telemetric arterial pressure transducer and electrodes for sleep scoring. Sleep state was assessed together with arterial pressure and heart rate (home cage), or breathing (whole-body plethysmograph). Increases in arterial pressure and heart rate on passing from the light (rest) to the dark (activity) period in the KO were significantly enhanced compared with the WT. These increases were unaffected by cardiac (beta(1)) or vascular (alpha(1)) adrenergic blockade. The breathing rhythm of the KO during sleep was also more irregular than that of the WT. A HFD increased heart rate, impaired cardiac vagal modulation, and blunted the central autonomic cardiac control during sleep. A HFD also decreased cardiac baroreflex sensitivity in the KO but not in the WT. In conclusion, we performed the first systematic study of cardiovascular function in CB1 receptor deficient mice during spontaneous wake-sleep behavior, and demonstrated that CB1 receptor KO alters cardiorespiratory control particularly in the presence of a HFD. The CB1 receptor signaling may thus play a role in physiological cardiorespiratory regulation and protect from some adverse cardiovascular consequences of a HFD.	[Silvani, Alessandro; Berteotti, Chiara; Bastianini, Stefano; Lo Martire, Viviana; Zoccoli, Giovanna] Alma Mater Studiorum Univ Bologna, PRISM Lab, Dept Biomed & Neuromotor Sci, Bologna, Italy; [Cohen, Gary] Karolinska Inst, Dept Women & Child Hlth, Stockholm, Sweden; [Mazza, Roberta; Pagotto, Uberto; Quarta, Carmelo] Alma Mater Studiorum Univ Bologna, Endocrinol Unit, Bologna, Italy; [Mazza, Roberta; Pagotto, Uberto; Quarta, Carmelo] Alma Mater Studiorum Univ Bologna, Ctr Appl Biomed Res, Dept Med & Surg Sci, S Orsola Univ Hosp, Bologna, Italy	University of Bologna; Karolinska Institutet; University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna	Zoccoli, G (corresponding author), Alma Mater Studiorum Univ Bologna, PRISM Lab, Dept Biomed & Neuromotor Sci, Bologna, Italy.	giovanna.zoccoli@unibo.it	Silvani, Alessandro/A-1027-2015; berteotti, chiara/AAK-9065-2020; Bastianini, Stefano/AAO-7982-2020; Zoccoli, Giovanna/CAH-3382-2022; Quarta, Carmelo/AAC-1629-2020	Silvani, Alessandro/0000-0003-3992-3892; Bastianini, Stefano/0000-0003-2468-1704; Zoccoli, Giovanna/0000-0002-9670-9959; Cohen, Gary/0000-0001-9677-2870; Quarta, Carmelo/0000-0002-1352-4239; Lo Martire, Viviana/0000-0001-8696-0835; BERTEOTTI, CHIARA/0000-0002-4143-9445	Bologna University	Bologna University	This work was funded by Bologna University (RFO 2010 and 2011 http://www.unibo.it/Portale/Ricerca/Servizi+Docenti+Ricercatori/finanziamentinaz/RFO+-+Finanziamento+alla+ricerca+di+base.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARONNE LJ, 1995, AM J PHYSIOL-REG I, V269, pR222, DOI 10.1152/ajpregu.1995.269.1.R222; Bastianini S, 2012, CHRONOBIOL INT, V29, P82, DOI 10.3109/07420528.2011.635231; Batkai S, 2004, CIRCULATION, V110, P1996, DOI 10.1161/01.CIR.0000143230.23252.D2; Bellocchio L, 2013, P NATL ACAD SCI USA, V110, P4786, DOI 10.1073/pnas.1218573110; Billman GE, 2006, PHARMACOL THERAPEUT, V111, P808, DOI 10.1016/j.pharmthera.2006.01.002; Brennan M, 2001, IEEE T BIO-MED ENG, V48, P1342, DOI 10.1109/10.959330; Calik MW, 2014, RESP PHYSIOL NEUROBI, V190, P20, DOI 10.1016/j.resp.2013.10.001; Carley DW, 2002, SLEEP, V25, P391; Cohen G, 2002, J PHYSIOL-LONDON, V540, P691, DOI 10.1113/jphysiol.2001.014464; Cohen G, 2002, P NATL ACAD SCI USA, V99, P13272, DOI 10.1073/pnas.192463599; Gross V, 2005, AM J PHYSIOL-REG I, V288, pR1134, DOI 10.1152/ajpregu.00246.2004; HERKENHAM M, 1990, P NATL ACAD SCI USA, V87, P1932, DOI 10.1073/pnas.87.5.1932; JACKY JP, 1978, J APPL PHYSIOL, V45, P644, DOI 10.1152/jappl.1978.45.4.644; Johansson M, 2007, J HYPERTENS, V25, P163, DOI 10.1097/01.hjh.0000254377.18983.eb; Kario K, 2010, HYPERTENSION, V56, P765, DOI 10.1161/HYPERTENSIONAHA.110.157149; LUCE JM, 1980, CHEST, V78, P626, DOI 10.1378/chest.78.4.626; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; Massa F, 2010, J NEUROSCI, V30, P6273, DOI 10.1523/JNEUROSCI.2648-09.2010; McCully BH, 2012, AM J PHYSIOL-HEART C, V302, pH2083, DOI 10.1152/ajpheart.01200.2011; Montecucco F, 2012, TRENDS PHARMACOL SCI, V33, P331, DOI 10.1016/j.tips.2012.03.002; Morrison SF, 1999, AM J PHYSIOL-REG I, V276, pR962, DOI 10.1152/ajpregu.1999.276.4.R962; MULLER JE, 1989, CIRCULATION, V79, P733, DOI 10.1161/01.CIR.79.4.733; Nanduri J, 2012, P NATL ACAD SCI USA, V109, P2515, DOI 10.1073/pnas.1120600109; O'Donnell CP, 1999, AM J RESP CRIT CARE, V159, P1477, DOI 10.1164/ajrccm.159.5.9809025; Prasad Bharati, 2013, Front Psychiatry, V4, P1, DOI 10.3389/fpsyt.2013.00001; Quarta C, 2010, CELL METAB, V11, P273, DOI 10.1016/j.cmet.2010.02.015; Seagard JL, 2005, NEUROSCI LETT, V381, P334, DOI 10.1016/j.neulet.2005.02.044; Silvani A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089432; Silvani A, 2013, AM J PHYSIOL-HEART C, V305, pH1683, DOI 10.1152/ajpheart.00554.2013; Silvani A, 2011, AUTON NEUROSCI-BASIC, V162, P66, DOI 10.1016/j.autneu.2011.04.003; Silvani A, 2010, SLEEP, V33, P355, DOI 10.1093/sleep/33.3.355; Silvani A, 2009, HYPERTENSION, V53, P251, DOI 10.1161/HYPERTENSIONAHA.108.125542; Silvestri C, 2013, CELL METAB, V17, P475, DOI 10.1016/j.cmet.2013.03.001; Skrapari I, 2007, OBESITY, V15, P1685, DOI 10.1038/oby.2007.201; Szekeres M, 2012, J BIOL CHEM, V287, P31540, DOI 10.1074/jbc.M112.346296; Tissot AC, 2008, LANCET, V371, P821, DOI 10.1016/S0140-6736(08)60381-5; Wagner JA, 1997, NATURE, V390, P518, DOI 10.1038/37371; Williams TD, 2003, CLIN EXP PHARMACOL P, V30, P769, DOI 10.1046/j.1440-1681.2003.t01-1-03808.x	38	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100536	10.1371/journal.pone.0100536	http://dx.doi.org/10.1371/journal.pone.0100536			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950219	gold, Green Published, Green Submitted			2022-12-27	WOS:000338276300086
J	Tan, TE; Peh, GSL; George, BL; Cajucom-Uy, HY; Dong, D; Finkelstein, EA; Mehta, JS				Tan, Tien-En; Peh, Gary S. L.; George, Benjamin L.; Cajucom-Uy, Howard Y.; Dong, Di; Finkelstein, Eric A.; Mehta, Jodhbir S.			A Cost-Minimization Analysis of Tissue-Engineered Constructs for Corneal Endothelial Transplantation	PLOS ONE			English	Article							STEM-CELL THERAPY; DONOR-TISSUE; DESCEMET MEMBRANE; EYE BANK; KERATOPLASTY; CARRIER; STRATEGIES; RECIPIENTS; PRIMATE; FUTURE	Corneal endothelial transplantation or endothelial keratoplasty has become the preferred choice of transplantation for patients with corneal blindness due to endothelial dysfunction. Currently, there is a worldwide shortage of transplantable tissue, and demand is expected to increase further with aging populations. Tissue-engineered alternatives are being developed, and are likely to be available soon. However, the cost of these constructs may impair their widespread use. A cost-minimization analysis comparing tissue-engineered constructs to donor tissue procured from eye banks for endothelial keratoplasty was performed. Both initial investment costs and recurring costs were considered in the analysis to arrive at a final tissue cost per transplant. The clinical outcomes of endothelial keratoplasty with tissue-engineered constructs and with donor tissue procured from eye banks were assumed to be equivalent. One-way and probabilistic sensitivity analyses were performed to simulate various possible scenarios, and to determine the robustness of the results. A tissue engineering strategy was cheaper in both investment cost and recurring cost. Tissue-engineered constructs for endothelial keratoplasty could be produced at a cost of US$880 per transplant. In contrast, utilizing donor tissue procured from eye banks for endothelial keratoplasty required US$3,710 per transplant. Sensitivity analyses performed further support the results of this cost-minimization analysis across a wide range of possible scenarios. The use of tissue-engineered constructs for endothelial keratoplasty could potentially increase the supply of transplantable tissue and bring the costs of corneal endothelial transplantation down, making this intervention accessible to a larger group of patients. Tissue-engineering strategies for corneal epithelial constructs or other tissue types, such as pancreatic islet cells, should also be subject to similar pharmacoeconomic analyses.	[Tan, Tien-En] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117595, Singapore; [Tan, Tien-En; Mehta, Jodhbir S.] Singapore Natl Eye Ctr, Singapore, Singapore; [Peh, Gary S. L.; George, Benjamin L.; Mehta, Jodhbir S.] Singapore Eye Res Inst, Tissue Engn & Stem Cell Grp, Singapore, Singapore; [Cajucom-Uy, Howard Y.] Singapore Eye Bank, Singapore, Singapore; [Dong, Di; Finkelstein, Eric A.] Duke NUS Grad Med Sch, Singapore, Singapore; [Finkelstein, Eric A.] Lien Ctr Palliat Care, Singapore, Singapore; [Mehta, Jodhbir S.] Duke NUS Grad Med Sch, Dept Clin Sci, Singapore, Singapore	National University of Singapore; Singapore National Eye Center; National University of Singapore; Singapore National Eye Center; National University of Singapore; National University of Singapore	Tan, TE (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117595, Singapore.	jodmehta@gmail.com	Peh, Gary/A-8327-2010	Peh, Gary/0000-0002-5387-4209				Aguayo-Mazzucato C, 2010, NAT REV ENDOCRINOL, V6, P139, DOI 10.1038/nrendo.2009.274; Anshu A, 2012, SURV OPHTHALMOL, V57, P236, DOI 10.1016/j.survophthal.2011.10.005; Badenoch PR, 2009, MED J AUSTRALIA, V191, P408, DOI 10.5694/j.1326-5377.2009.tb02853.x; Bayyoud T, 2012, CURR EYE RES, V37, P179, DOI 10.3109/02713683.2011.644382; Bohringer D, 2009, DEV OPHTHALMOL, V43, P120, DOI 10.1159/000223845; Bose S, 2012, OPHTHALMOLOGY; Cheong YK, 2013, INVEST OPHTH VIS SCI, V54, P4538, DOI 10.1167/iovs.13-11754; Chng ZZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067546; COLE G, 1994, CORNEA, V13, P87, DOI 10.1097/00003226-199401000-00016; Dominguez-Bendala J, 2011, CURR OPIN ORGAN TRAN, V16, P76, DOI 10.1097/MOT.0b013e32834252b5; Ezhkova E, 2010, NATURE, V466, P567, DOI 10.1038/466567a; Heindl LM, 2013, OPHTHALMOLOGY, V120, P899, DOI 10.1016/j.ophtha.2012.11.012; Heindl LM, 2011, AM J OPHTHALMOL, V152, P523, DOI 10.1016/j.ajo.2011.03.021; Heindl LM, 2011, OPHTHALMOLOGY, V118, P294, DOI 10.1016/j.ophtha.2010.05.025; Hirata-Tominaga K, 2013, STEM CELLS, V31, P1396, DOI 10.1002/stem.1390; JOLICOEUR LM, 1992, AM J HOSP PHARM, V49, P1741, DOI 10.1093/ajhp/49.7.1741; JUMBLATT MM, 1978, INVEST OPHTH VIS SCI, V17, P1135; Keenan TDL, 2011, BRIT J OPHTHALMOL, V95, P468, DOI 10.1136/bjo.2010.182329; Khor WB, 2011, AM J OPHTHALMOL, V151, P223, DOI 10.1016/j.ajo.2010.08.027; Kitzmann AS, 2008, CORNEA, V27, P634, DOI 10.1097/QAI.0b013e31815e4011; Koizumi N, 2008, CORNEA, V27, pS48, DOI 10.1097/ICO.0b013e31817f2298; Koizumi N, 2007, INVEST OPHTH VIS SCI, V48, P4519, DOI 10.1167/iovs.07-0567; Koo TS, 2011, AM J OPHTHALMOL, V152, P40, DOI 10.1016/j.ajo.2011.01.017; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Leung PS, 2013, CURR MOL MED, V13, P109; Levis HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050993; Li Jennifer Y, 2010, Int Ophthalmol Clin, V50, P101, DOI 10.1097/IIO.0b013e3181e20ebb; Liang Y, 2011, J MATER SCI-MATER M, V22, P175, DOI 10.1007/s10856-010-4190-6; Mannis MJ, 2006, CORNEA, V25, P164; Melles GRJ, 2006, CORNEA, V25, P987, DOI 10.1097/01.ico.0000248385.16896.34; Melles GRJ, 2004, CORNEA, V23, P286, DOI 10.1097/00003226-200404000-00011; Mohamed-Noriega K, 2011, TRANSPLANTATION, V92, pE31, DOI 10.1097/TP.0b013e31822d882d; Okumura N, 2012, AM J PATHOL, V181, P268, DOI 10.1016/j.ajpath.2012.03.033; Peh Gary S L, 2013, BMC Res Notes, V6, P176, DOI 10.1186/1756-0500-6-176; Peh GSL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028310; Peh GSL, 2011, TRANSPLANTATION, V91, P811, DOI 10.1097/TP.0b013e3182111f01; Peh GS, 2013, CELL TRANSPLANT; Price FW, 2005, J REFRACT SURG, V21, P339; Price MO, 2013, OPHTHALMOLOGY, V120, P246, DOI 10.1016/j.ophtha.2012.08.007; Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955; Sabater AL, 2013, REGEN MED, V8, P183, DOI [10.2217/rme.13.11, 10.2217/RME.13.11]; Schlotzer-Schrehardt U, 2013, OPHTHALMOLOGY, V120, P1769, DOI 10.1016/j.ophtha.2013.06.038; Shapiro AMJ, 2011, CURR DIABETES REP, V11, P345, DOI 10.1007/s11892-011-0217-8; Sharma N, 2011, CORNEA, V30, P1140, DOI 10.1097/ICO.0b013e318209d23c; Shima N, 2011, INVEST OPHTH VIS SCI, V52, P8711, DOI 10.1167/iovs.11-7592; Tan DTH, 2012, LANCET, V379, P1749, DOI 10.1016/S0140-6736(12)60437-1; Tan DTH, 2009, ANN ACAD MED SINGAP, V38, P332; Vajpayee RB, 2007, ARCH OPHTHALMOL-CHIC, V125, P552, DOI 10.1001/archopht.125.4.552; Viswanathan C, 2013, CURR DIABETES REV, V9, P429, DOI 10.2174/15733998113096660082; Wang TJ, 2012, MOL VIS, V18, P255; Watanabe R, 2011, TISSUE ENG PT A, V17, P2213, DOI [10.1089/ten.tea.2010.0568, 10.1089/ten.TEA.2010.0568]; Wen YJ, 2011, EXPERT OPIN BIOL TH, V11, P41, DOI 10.1517/14712598.2011.540235; Woodward MA, 2013, CORNEA, V32, P737, DOI 10.1097/ICO.0b013e3182685cb2; Woodward MA, 2012, JOVE-J VIS EXP, DOI 10.3791/3847; Zhang WJ, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt352; Zhu C, 2004, INVEST OPHTH VIS SCI, V45, P1743, DOI 10.1167/iovs.03-0814; Zhu YT, 2012, J CELL SCI, V125, P3636, DOI 10.1242/jcs.103267; Zinger A, 2013, DIABETES METAB RES R	58	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100563	10.1371/journal.pone.0100563	http://dx.doi.org/10.1371/journal.pone.0100563			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949869	Green Submitted, Green Published, gold			2022-12-27	WOS:000338276300090
J	Wessels, B; Ciapaite, J; van den Broek, NMA; Nicolay, K; Prompers, JJ				Wessels, Bart; Ciapaite, Jolita; van den Broek, Nicole M. A.; Nicolay, Klaas; Prompers, Jeanine J.			Metformin Impairs Mitochondrial Function in Skeletal Muscle of Both Lean and Diabetic Rats in a Dose-Dependent Manner	PLOS ONE			English	Article							OXIDATIVE CAPACITY; LIVER-MITOCHONDRIA; INSULIN ACTION; GLUCOSE; EXERCISE; MECHANISM; PHARMACOKINETICS; PHOSPHORYLATION; INCREASES	Metformin is a widely prescribed drug for the treatment of type 2 diabetes. Previous studies have demonstrated in vitro that metformin specifically inhibits Complex I of the mitochondrial respiratory chain. This seems contraindicative since muscle mitochondrial dysfunction has been linked to the pathogenesis of type 2 diabetes. However, its significance for in vivo skeletal muscle mitochondrial function has yet to be elucidated. The aim of this study was to assess the effects of metformin on in vivo and ex vivo skeletal muscle mitochondrial function in a rat model of diabetes. Healthy (fa/+) and diabetic (fa/fa) Zucker diabetic fatty rats were treated by oral gavage with metformin dissolved in water (30, 100 or 300 mg/kg bodyweight/day) or water as a control for 2 weeks. After 2 weeks of treatment, muscle oxidative capacity was assessed in vivo using P-31 magnetic resonance spectroscopy and ex vivo by measuring oxygen consumption in isolated mitochondria using high-resolution respirometry. Two weeks of treatment with metformin impaired in vivo muscle oxidative capacity in a dose-dependent manner, both in healthy and diabetic rats. Whereas a dosage of 30 mg/kg/day had no significant effect, in vivo oxidative capacity was 21% and 48% lower after metformin treatment at 100 and 300 mg/kg/day, respectively, independent of genotype. High-resolution respirometry measurements demonstrated a similar dose-dependent effect of metformin on ex vivo mitochondrial function. In conclusion, metformin compromises in vivo and ex vivo muscle oxidative capacity in Zucker diabetic fatty rats in a dose-dependent manner.	[Wessels, Bart; van den Broek, Nicole M. A.; Nicolay, Klaas; Prompers, Jeanine J.] Eindhoven Univ Technol, Dept Biomed Engn, Biomed NMR, NL-5600 MB Eindhoven, Netherlands; [Ciapaite, Jolita] Univ Groningen, Univ Med Ctr Groningen, Ctr Liver Digest & Metab Dis, Dept Pediat, NL-9700 AB Groningen, Netherlands	Eindhoven University of Technology; University of Groningen	Prompers, JJ (corresponding author), Eindhoven Univ Technol, Dept Biomed Engn, Biomed NMR, POB 513, NL-5600 MB Eindhoven, Netherlands.	j.j.prompers@tue.nl		Ciapaite, Jolita/0000-0001-8761-9233; Prompers, Jeanine/0000-0002-4756-4474; Nicolay, Klaas/0000-0002-4179-616X	VIDI grant from the Netherlands Organisation for Scientific Research (NWO) [700.58.421]; NWO	VIDI grant from the Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NWO(Netherlands Organization for Scientific Research (NWO))	B.W. and J.J.P. are supported by a VIDI grant (project number 700.58.421) from the Netherlands Organisation for Scientific Research (NWO). J.C. is supported by the NWO-funded Groningen Systems Biology Center for Energy Metabolism and Aging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; ARGAUD D, 1993, EUR J BIOCHEM, V213, P1341, DOI 10.1111/j.1432-1033.1993.tb17886.x; BAILEY CJ, 1986, DIABETES METAB, V12, P212; Braun B, 2008, APPL PHYSIOL NUTR ME, V33, P61, DOI 10.1139/H07-144; Brunmair B, 2004, DIABETES, V53, P1052, DOI 10.2337/diabetes.53.4.1052; Carvalho C, 2008, MOL CELL BIOCHEM, V308, P75, DOI 10.1007/s11010-007-9614-3; Choi YH, 2006, J PHARM SCI-US, V95, P2543, DOI 10.1002/jps.20744; Ciapaite J, 2007, BBA-MOL BASIS DIS, V1772, P307, DOI 10.1016/j.bbadis.2006.10.018; De Feyter HM, 2008, FASEB J, V22, P3947, DOI 10.1096/fj.08-112318; Detaille D, 2002, BIOCHEM PHARMACOL, V63, P1259, DOI 10.1016/S0006-2952(02)00858-4; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Gnaiger E, 2009, INT J BIOCHEM CELL B, V41, P1837, DOI 10.1016/j.biocel.2009.03.013; Graham GG, 2011, CLIN PHARMACOKINET, V50, P81, DOI 10.2165/11534750-000000000-00000; Guigas B, 2004, BIOCHEM J, V382, P877, DOI 10.1042/BJ20040885; Hundal RS, 2000, DIABETES, V49, P2063, DOI 10.2337/diabetes.49.12.2063; Inzucchi SE, 1998, NEW ENGL J MED, V338, P867, DOI 10.1056/NEJM199803263381303; Kane DA, 2010, FREE RADICAL BIO MED, V49, P1082, DOI 10.1016/j.freeradbiomed.2010.06.022; KLIP A, 1990, DIABETES CARE, V13, P696, DOI 10.2337/diacare.13.6.696; Kristensen JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053533; Larsen RG, 2009, J APPL PHYSIOL, V107, P873, DOI 10.1152/japplphysiol.00260.2009; Larsen S, 2012, DIABETOLOGIA, V55, P443, DOI 10.1007/s00125-011-2340-0; Leverve XM, 2003, DIABETES METAB, V29, pS88; Morino K, 2006, DIABETES, V55, pS9, DOI 10.2337/db06-S002; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Palenickova E, 2011, PHYSIOL RES, V60, P835, DOI 10.33549/physiolres.932193; PENICAUD L, 1989, BIOCHEM J, V262, P881, DOI 10.1042/bj2620881; Picard M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018317; Praet SFE, 2007, J APPL PHYSIOL, V103, P1113, DOI 10.1152/japplphysiol.00566.2007; ROSSETTI L, 1990, METABOLISM, V39, P425, DOI 10.1016/0026-0495(90)90259-F; ROURU J, 1995, BRIT J PHARMACOL, V115, P1182, DOI 10.1111/j.1476-5381.1995.tb15022.x; SCHAFER G, 1974, EUR J BIOCHEM, V46, P613, DOI 10.1111/j.1432-1033.1974.tb03657.x; Sharoff CG, 2010, AM J PHYSIOL-ENDOC M, V298, pE815, DOI 10.1152/ajpendo.00517.2009; Smith AC, 2007, AM J PHYSIOL-ENDOC M, V293, pE172, DOI 10.1152/ajpendo.00677.2006; Suwa M, 2006, J APPL PHYSIOL, V101, P1685, DOI 10.1152/japplphysiol.00255.2006; Szendroedi J, 2012, NAT REV ENDOCRINOL, V8, P92, DOI 10.1038/nrendo.2011.138; Taylor D J, 1983, Mol Biol Med, V1, P77; van den Broek NMA, 2010, FASEB J, V24, P1354, DOI 10.1096/fj.09-143842; van den Broek NMA, 2007, AM J PHYSIOL-CELL PH, V293, pC228, DOI 10.1152/ajpcell.00023.2007; Vanhamme L, 1997, J MAGN RESON, V129, P35, DOI 10.1006/jmre.1997.1244; Vytla VS, 2013, J BIOL CHEM, V288, P20369, DOI 10.1074/jbc.M113.482646; WILCOCK C, 1990, BIOCHEM PHARMACOL, V39, P1831, DOI 10.1016/0006-2952(90)90136-9	41	75	77	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100525	10.1371/journal.pone.0100525	http://dx.doi.org/10.1371/journal.pone.0100525			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950069	Green Published, Green Submitted, gold			2022-12-27	WOS:000338276300084
J	Amarsaikhan, N; O'Dea, EM; Tsoggerel, A; Owegi, H; Gillenwater, J; Templeton, SP				Amarsaikhan, Nansalmaa; O'Dea, Evan M.; Tsoggerel, Angar; Owegi, Henry; Gillenwater, Jordan; Templeton, Steven P.			Isolate-Dependent Growth, Virulence, and Cell Wall Composition in the Human Pathogen Aspergillus fumigatus	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; MURINE MODEL; BETA-GLUCAN; CHITIN; LUNG; DECTIN-1; DEFENSE; PROTEIN; ENVIRONMENTS; RECOGNITION	The ubiquitous fungal pathogen Aspergillus fumigatus is a mediator of allergic sensitization and invasive disease in susceptible individuals. The significant genetic and phenotypic variability between and among clinical and environmental isolates are important considerations in host-pathogen studies of A. fumigatus-mediated disease. We observed decreased radial growth, rate of germination, and ability to establish colony growth in a single environmental isolate of A. fumigatus, Af5517, when compared to other clinical and environmental isolates. Af5517 also exhibited increased hyphal diameter and cell wall beta-glucan and chitin content, with chitin most significantly increased. Morbidity, mortality, lung fungal burden, and tissue pathology were decreased in neutropenic Af5517-infected mice when compared to the clinical isolate Af293. Our results support previous findings that suggest a correlation between in vitro growth rates and in vivo virulence, and we propose that changes in cell wall composition may contribute to this phenotype.	[Amarsaikhan, Nansalmaa; O'Dea, Evan M.; Tsoggerel, Angar; Owegi, Henry; Gillenwater, Jordan; Templeton, Steven P.] Indiana Univ Sch Med Terre Haute, Dept Microbiol & Immunol, Terre Haute, IN 47809 USA	Indiana University System	Templeton, SP (corresponding author), Indiana Univ Sch Med Terre Haute, Dept Microbiol & Immunol, Terre Haute, IN 47809 USA.	sptemple@iupui.edu	Templeton, Steven/I-6635-2013	Templeton, Steven/0000-0003-3430-7011	IUSM-TH start-up funds	IUSM-TH start-up funds	This research was supported by IUSM-TH start-up funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimanianda V, 2009, NATURE, V460, P1117, DOI 10.1038/nature08264; Araujo R, 2010, MED MYCOL, V48, P832, DOI 10.3109/13693780903575360; Askew DS, 2008, CURR OPIN MICROBIOL, V11, P331, DOI 10.1016/j.mib.2008.05.009; Aufauvre-Brown A, 1998, EUR J CLIN MICROBIOL, V17, P778, DOI 10.1007/s100960050184; Balajee SA, 2008, J MICROBIOL METH, V73, P252, DOI 10.1016/j.mimet.2008.02.011; Bhabhra R, 2005, MED MYCOL, V43, pS87, DOI 10.1080/13693780400029486; BORGIA PT, 1992, J BACTERIOL, V174, P377, DOI 10.1128/jb.174.2.377-383.1992; Bowman JC, 2001, ANTIMICROB AGENTS CH, V45, P3474, DOI 10.1128/AAC.45.12.3474-3481.2001; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Chai LYA, 2011, MICROBES INFECT, V13, P151, DOI 10.1016/j.micinf.2010.10.005; Chazalet V, 1998, J CLIN MICROBIOL, V36, P1494, DOI 10.1128/JCM.36.6.1494-1500.1998; COVE DJ, 1966, BIOCHIM BIOPHYS ACTA, V113, P51, DOI 10.1016/S0926-6593(66)80120-0; Cramer RA, 2008, EUKARYOT CELL, V7, P1085, DOI 10.1128/EC.00086-08; Dague E, 2008, BIOPHYS J, V94, P656, DOI 10.1529/biophysj.107.116491; de Valk HA, 2008, MYCOSES, V51, P463, DOI 10.1111/j.1439-0507.2008.01538.x; de Valk HA, 2009, J CYST FIBROS, V8, P110, DOI 10.1016/j.jcf.2008.10.003; Faro-Trindade I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035675; Fontaine T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002372; Gessner MA, 2012, INFECT IMMUN, V80, P410, DOI 10.1128/IAI.05939-11; GIRARDIN H, 1994, J CLIN MICROBIOL, V32, P684, DOI 10.1128/JCM.32.3.684-690.1994; Grahl N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002145; Greenberger PA, 2004, ALLERGY ASTHMA PROC, V25, P219; Hohl TM, 2007, EUKARYOT CELL, V6, P1953, DOI 10.1128/EC.00274-07; Hohl TM, 2005, PLOS PATHOG, V1, P232, DOI 10.1371/journal.ppat.0010030; Latge JP, 2005, MED MYCOL, V43, pS15, DOI 10.1080/13693780400029155; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Leal SM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000976; Leenders ACAP, 1999, J CLIN MICROBIOL, V37, P1752, DOI 10.1128/JCM.37.6.1752-1757.1999; Lenardon MD, 2010, CURR OPIN MICROBIOL, V13, P416, DOI 10.1016/j.mib.2010.05.002; Levdansky E, 2010, EUKARYOT CELL, V9, P1403, DOI 10.1128/EC.00126-10; Li HY, 2011, EUKARYOT CELL, V10, P174, DOI 10.1128/EC.00288-10; Li K, 2011, MICROBIOL-SGM, V157, P1968, DOI 10.1099/mic.0.047712-0; Maduzia LL, 2011, J BIOL CHEM, V286, P4371, DOI 10.1074/jbc.M110.188581; Maubon D, 2006, FUNGAL GENET BIOL, V43, P366, DOI 10.1016/j.fgb.2006.01.006; Mellado E, 1996, MOL MICROBIOL, V20, P667, DOI 10.1046/j.1365-2958.1996.5571084.x; Mondon P, 1996, J MED MICROBIOL, V45, P186, DOI 10.1099/00222615-45-3-186; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; Paisley D, 2005, MED MYCOL, V43, P397, DOI 10.1080/13693780400005866; Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746; Rizzetto L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056651; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; Sato M, 2003, J IMMUNOL, V171, P417, DOI 10.4049/jimmunol.171.1.417; Scharf DH, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003859; Shepardson KM, 2013, MICROBES INFECT, V15, P259, DOI 10.1016/j.micinf.2012.11.010; Steele C, 2005, PLOS PATHOG, V1, P323, DOI 10.1371/journal.ppat.0010042; Templeton SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018777; Templeton SP, 2010, MED MYCOL, V48, P217, DOI 10.3109/13693780903420658; THAU N, 1994, INFECT IMMUN, V62, P4380, DOI 10.1128/IAI.62.10.4380-4388.1994; Tomee JFC, 2000, CLIN EXP ALLERGY, V30, P476, DOI 10.1046/j.1365-2222.2000.00796.x; Van Dyken SJ, 2014, IMMUNITY, V40, P414, DOI 10.1016/j.immuni.2014.02.003; Van Dyken SJ, 2011, J IMMUNOL, V187, P2261, DOI 10.4049/jimmunol.1100972; Vanhee LME, 2009, CLIN MICROBIOL INFEC, V15, P643, DOI 10.1111/j.1469-0691.2009.02844.x; Verwer PEB, 2012, ANTIMICROB AGENTS CH, V56, P1595, DOI 10.1128/AAC.05323-11; Wagener J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004050; Warn PA, 2010, INT J ANTIMICROB AG, V35, P146, DOI 10.1016/j.ijantimicag.2009.09.029; WATANABE T, 1994, J BACTERIOL, V176, P4465, DOI 10.1128/JB.176.15.4465-4472.1994; Werner JL, 2009, J IMMUNOL, V182, P4938, DOI 10.4049/jimmunol.0804250	58	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100430	10.1371/journal.pone.0100430	http://dx.doi.org/10.1371/journal.pone.0100430			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945802	Green Published, Green Submitted, gold			2022-12-27	WOS:000340721500074
J	Wenzel, UA; Magnusson, MK; Rydstrom, A; Jonstrand, C; Hengst, J; Johansson, MEV; Velcich, A; Ohman, L; Strid, H; Sjovall, H; Hansson, GC; Wick, MJ				Wenzel, Ulf A.; Magnusson, Maria K.; Rydstrom, Anna; Jonstrand, Caroline; Hengst, Julia; Johansson, Malin E. V.; Velcich, Anna; Ohman, Lena; Strid, Hans; Sjovall, Henrik; Hansson, Gunnar C.; Wick, Mary Jo			Spontaneous Colitis in Muc2-Deficient Mice Reflects Clinical and Cellular Features of Active Ulcerative Colitis	PLOS ONE			English	Article							DENDRITIC CELLS; MUCUS LAYERS; GOBLET CELL; MACROPHAGES; DISEASE; MUCIN; PATHOGENESIS; PROMOTES; GUT; DEFICIENT	Background: The colonic mucus layer plays a critical role in intestinal homeostasis by limiting contact between luminal bacteria and the mucosal immune system. A defective mucus barrier in animal models allows bacterial contact with the intestinal epithelium and results in spontaneous colitis. A defective mucus barrier is also a key feature of active ulcerative colitis (UC). Alterations in the immune compartment due to intestinal bacterial breach in mice lacking the colon mucus barrier have not been characterized and correlated to active UC. Aims: To characterize alterations in the immune compartment due to intestinal bacterial breach in Muc2(-/-) mice, which lack the colon mucus barrier, and correlate the findings to active UC. Methods: Bacterial contact with colon epithelium and penetration into colon tissue was examined in Muc2(-/-) mice and colon biopsies from patients with active UC using fluorescence microscopy and qPCR. Neutrophils, lymphocytes, CD103(+) dendritic cell subsets and macrophages in colon from Muc2(-/-) mice and biopsies from UC patients were quantitated by flow cytometry. Results: Inflamed UC patients and Muc2(-/-) mice had bacteria in contact with the colon epithelium. Bacterial rRNA was present in colonic mucosa in humans and Muc2(-/-) mice and in the draining lymph nodes of mice. Inflamed Muc2(-/-) mice and UC patients had elevated colon neutrophils, T cells and macrophages while a reduced frequency of CD103(+) DCs was present in the inflamed colon of both mice and humans. Conclusions: The parallel features of the colon immune cell compartment in Muc2(-/-) mice and UC patients supports the usefulness of this model to understand the early phase of spontaneous colitis and will provide insight into novel strategies to treat UC.	[Wenzel, Ulf A.; Magnusson, Maria K.; Rydstrom, Anna; Jonstrand, Caroline; Hengst, Julia; Ohman, Lena; Wick, Mary Jo] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Microbiol & Immunol, Gothenburg, Sweden; [Wenzel, Ulf A.; Magnusson, Maria K.; Rydstrom, Anna; Jonstrand, Caroline; Hengst, Julia; Ohman, Lena; Wick, Mary Jo] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Mucosal Immunobiol & Vaccine Ctr MIVAC, Gothenburg, Sweden; [Magnusson, Maria K.; Ohman, Lena; Strid, Hans; Sjovall, Henrik] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Internal Med & Clin Nutr, Gothenburg, Sweden; [Magnusson, Maria K.; Johansson, Malin E. V.; Ohman, Lena; Strid, Hans; Sjovall, Henrik; Hansson, Gunnar C.] Univ Gothenburg, MIVAC, Gothenburg, Sweden; [Johansson, Malin E. V.; Hansson, Gunnar C.] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Med Biochem, Gothenburg, Sweden; [Velcich, Anna] Montefiore Med Ctr, Albert Einstein Canc Ctr, Dept Oncol, New York, NY USA	University of Gothenburg; University of Gothenburg; University of Gothenburg; University of Gothenburg; University of Gothenburg; Montefiore Medical Center; Yeshiva University	Wick, MJ (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Microbiol & Immunol, Gothenburg, Sweden.	mary-jo.wick@immuno.gu.se	Hansson, Gunnar C./AAF-7324-2019; Hansson, Gunnar C/A-1236-2009; Johansson, Malin E. V./HCH-7451-2022	Hansson, Gunnar C./0000-0002-1900-1869; Hansson, Gunnar C/0000-0002-1900-1869; Magnusson, Maria/0000-0002-8888-4968; Ohman, Lena/0000-0001-8142-2106; Johansson, Malin E. V./0000-0002-4237-6677; Wick, Mary Jo/0000-0003-3195-2904	Swedish Research Council; Swedish Cancer Foundation; Sahlgren's University Hospital (LUA-ALF); AFA Insurance; Knut and Alice Wallenberg Foundation; National Institute of Allergy and Infectious Diseases [U01AI095473]; Swedish Foundation for Strategic Research, Assar Gabrielssons Fond; Ruth and Richard Julin Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI095473] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; Sahlgren's University Hospital (LUA-ALF); AFA Insurance; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Swedish Foundation for Strategic Research, Assar Gabrielssons Fond; Ruth and Richard Julin Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Swedish Research Council, The Swedish Cancer Foundation, Sahlgren's University Hospital (LUA-ALF), AFA Insurance, The Knut and Alice Wallenberg Foundation, National Institute of Allergy and Infectious Diseases (U01AI095473, the content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH), the Swedish Foundation for Strategic Research, Assar Gabrielssons Fond and The Ruth and Richard Julin Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Bain CC, 2012, MUCOSAL IMMUNOL, V6, P498; Barrett JC, 2009, NAT GENET, V41, P1330, DOI 10.1038/ng.483; Beitnes ACR, 2011, SCAND J IMMUNOL, V74, P186, DOI 10.1111/j.1365-3083.2011.02549.x; Bibiloni R, 2006, J MED MICROBIOL, V55, P1141, DOI 10.1099/jmm.0.46498-0; Burger-van Paassen N, 2011, AM J PHYSIOL-GASTR L, V301, pG667, DOI 10.1152/ajpgi.00199.2010; Cerovic V, 2013, MUCOSAL IMMUNOL, V6, P104, DOI 10.1038/mi.2012.53; Denning TL, 2011, J IMMUNOL, V187, P733, DOI 10.4049/jimmunol.1002701; Dianda L, 1997, AM J PATHOL, V150, P91; Eri RD, 2011, MUCOSAL IMMUNOL, V4, P354, DOI 10.1038/mi.2010.74; Fortin G, 2009, J EXP MED, V206, P1995, DOI 10.1084/jem.20082805; Franze E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069839; Fu JX, 2011, J CLIN INVEST, V121, P1657, DOI 10.1172/JCI45538; Gisbert JP, 2009, INFLAMM BOWEL DIS, V15, P1190, DOI 10.1002/ibd.20933; Hashimoto D, 2011, IMMUNITY, V35, P323, DOI 10.1016/j.immuni.2011.09.007; Hasnain SZ, 2013, GASTROENTEROLOGY, V144, P357, DOI 10.1053/j.gastro.2012.10.043; He WM, 2003, GASTROENTEROLOGY, V125, P1388, DOI 10.1016/j.gastro.2003.07.009; Iliev ID, 2009, GUT, V58, P1481, DOI 10.1136/gut.2008.175166; Jaensson E, 2008, J EXP MED, V205, P2139, DOI 10.1084/jem.20080414; Johansson MEV, 2014, GUT, V63, P281, DOI 10.1136/gutjnl-2012-303207; Johansson MEV, 2013, GUT, V62, P188, DOI 10.1136/gutjnl-2012-302582; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Kamada N, 2008, J CLIN INVEST, V118, P2269, DOI [10.1172/JCI34610, 10.1172/JC134610]; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Kojima R, 2004, J PHARMACOL SCI, V96, P307, DOI 10.1254/jphs.FP0040214; Matteoli G, 2010, GUT, V59, P595, DOI 10.1136/gut.2009.185108; Ordas I, 2012, LANCET, V380, P1606, DOI 10.1016/S0140-6736(12)60150-0; Pfaffl MW., 2006, REAL TIME PCR, P63; Platt AM, 2010, J IMMUNOL, V184, P6843, DOI 10.4049/jimmunol.0903987; Rivollier A, 2012, J EXP MED, V209, P139, DOI 10.1084/jem.20101387; Rupp J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006020; Rydstrom A, 2007, J IMMUNOL, V178, P5789, DOI 10.4049/jimmunol.178.9.5789; Scott CL, 2011, TRENDS IMMUNOL, V32, P412, DOI 10.1016/j.it.2011.06.003; Siddiqui KRR, 2010, IMMUNITY, V32, P557, DOI 10.1016/j.immuni.2010.03.017; Strauch UG, 2010, WORLD J GASTROENTERO, V16, P21, DOI 10.3748/wjg.v16.i1.21; Tamoutounour S, 2012, EUR J IMMUNOL, V42, P3150, DOI 10.1002/eji.201242847; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Varol C, 2010, NAT REV IMMUNOL, V10, P415, DOI 10.1038/nri2778; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094; Weber B, 2011, EUR J IMMUNOL, V41, P773, DOI 10.1002/eji.201040965; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005	43	64	69	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100217	10.1371/journal.pone.0100217	http://dx.doi.org/10.1371/journal.pone.0100217			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945909	gold, Green Submitted, Green Published			2022-12-27	WOS:000340721500051
J	Ye, C; Ruan, Y; Zou, LY; Li, GH; Li, CD; Chen, Y; Jia, CX; Megson, IL; Wei, J; Zhang, WY				Ye, Chun; Ruan, Yan; Zou, Liying; Li, Guanghui; Li, Changdong; Chen, Yi; Jia, Chaoxia; Megson, Ian L.; Wei, Jun; Zhang, Weiyuan			The 2011 Survey on Hypertensive Disorders of Pregnancy (HDP) in China: Prevalence, Risk Factors, Complications, Pregnancy and Perinatal Outcomes	PLOS ONE			English	Article							BODY-MASS INDEX; PREDICTING PREECLAMPSIA; MATERNAL MORTALITY; FAMILY-HISTORY; BLOOD-PRESSURE; WOMEN; ECLAMPSIA; EDUCATION; ACCURACY; ALCOHOL	Hypertensive disorders of pregnancy (HDP) are a group of medical complications in pregnancy and also a risk factor for severe pregnancy outcomes, but it lacks a large-scale epidemiological investigation in recent years. This survey represents a multicenter cross-sectional retrospective study to estimate the prevalence and analyze the risk factors for HDP among the pregnant women who had referred for delivery between January 1st 2011 and December 31st 2011 in China Mainland. A total of 112,386 pregnant women were investigated from 38 secondary and tertiary specialized or general hospitals randomly selected across the country, of which 5,869 had HDP, accounting for 5.22% of all pregnancies. There were significant differences in the prevalence of HDP between geographical regions, in which the North China showed the highest (7.44%) and Central China showed the lowest (1.23%). Of six subtypes of HDP, severe preeclampsia accounted for 39.96%, gestational hypertension for 31.40%, mild preeclampsia for 15.13%, chronic hypertension in pregnancy for 6.00%, preeclampsia superimposed on chronic hypertension for 3.68% and eclampsia for 0.89%. A number of risk factors for HDP were identified, including twin pregnancy, age of >35 years, overweight and obesity, primipara, history of hypertension as well as family history of hypertension and diabetes. The prevalence of pre-term birth, placental abruption and postpartum hemorrhage were significantly higher in women with HDP than those without HDP. The possible risk factors confirmed in this study may be useful for the development of early diagnosis and appropriate treatment of HDP.	[Ye, Chun; Ruan, Yan; Zou, Liying; Li, Guanghui; Li, Changdong; Chen, Yi; Zhang, Weiyuan] Capital Med Univ, Beijing Obstet & Gynecol Hosp, Dept Obstet, Beijing, Peoples R China; [Jia, Chaoxia] Capital Med Univ, Beijing Obstet & Gynecol Hosp, Dept Publ Healthcare Informat Adm Sect, Beijing, Peoples R China; [Megson, Ian L.; Wei, Jun] Univ Highlands & Isl, Dept Diabet & Cardiovasc Sci, Inverness, Scotland	Capital Medical University; Capital Medical University; UHI Millennium Institute	Zhang, WY (corresponding author), Capital Med Univ, Beijing Obstet & Gynecol Hosp, Dept Obstet, Beijing, Peoples R China.	zhangwy9921@hotmail.com	; Megson, Ian/K-2195-2012	Wei, Jun/0000-0002-2916-4944; Megson, Ian/0000-0001-8287-2459	State Ministry of Health, the People's Republic of China [201002013]; Beijing Health Bureau [2009-2-11]	State Ministry of Health, the People's Republic of China; Beijing Health Bureau	Sources of Funding: This project was supported by the State Ministry of Health, the People's Republic of China (Grant number 201002013) and the Beijing Health Bureau (Grant number 2009-2-11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACOG Committee on Obstetric Practice, 2002, Int J Gynaecol Obstet, V77, P67; [Anonymous], 1991, Zhonghua Fu Chan Ke Za Zhi, V26, P67; Ascherio A, 1996, HYPERTENSION, V27, P1065, DOI 10.1161/01.HYP.27.5.1065; Athukorala C, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-56; Carr DB, 2005, AM J OBSTET GYNECOL, V193, P965, DOI 10.1016/j.ajog.2005.06.034; Cnattingius S, 1997, AM J OBSTET GYNECOL, V177, P156, DOI 10.1016/S0002-9378(97)70455-1; Cnossen JS, 2007, BJOG-INT J OBSTET GY, V114, P1477, DOI 10.1111/j.1471-0528.2007.01483.x; Cnossen JS, 2008, BMJ-BRIT MED J, V336, P1117, DOI 10.1136/bmj.39540.522049.BE; Cooperative Meta-analysis Group of China Obesity Task Force, 2002, CHIN J EPIDEMIOL, V23, P5; Cunningham FG, 2010, PREGNANCY HYPERTENS, P706; Dinatale Angela, 2010, J Prenat Med, V4, P5; DOUGLAS KA, 1994, BMJ-BRIT MED J, V309, P1395, DOI 10.1136/bmj.309.6966.1395; Duckitt K, 2005, BRIT MED J, V330, P565, DOI 10.1136/bmj.38380.674340.E0; Duley L, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002960.pub2; Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010; England L, 2007, FRONT BIOSCI-LANDMRK, V12, P2471, DOI 10.2741/2248; Esplin MS, 2001, NEW ENGL J MED, V344, P867, DOI 10.1056/NEJM200103223441201; Fuchs FD, 2001, HYPERTENSION, V37, P1242, DOI 10.1161/01.HYP.37.5.1242; Gaio DS, 2001, HYPERTENS PREGNANCY, V20, P269, DOI 10.1081/PRG-100107829; Ghulmiyyah L, 2012, SEMIN PERINATOL, V36, P56, DOI 10.1053/j.semperi.2011.09.011; Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; Jasovic-Siveska E, 2011, BRATISL MED J, V112, P188; Karlsen S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-606; Klatsky AL, 1996, CLIN CHIM ACTA, V246, P91, DOI 10.1016/0009-8981(96)06230-4; Kvetny Jan, 2003, Archives of Gynecology and Obstetrics, V267, P153, DOI 10.1007/s00404-001-0286-z; Lamminpaa R, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-47; Lee CJ, 2000, INT J GYNECOL OBSTET, V70, P327, DOI 10.1016/S0020-7292(00)00240-X; Liu YY, 2012, ARCH GYNECOL OBSTET, V286, P905, DOI 10.1007/s00404-012-2403-6; McAlister C, 2006, J OBSTET GYNAECOL CA, V28, P983, DOI 10.1016/S1701-2163(16)32294-0; Montoro MN, 2005, DIABETES CARE, V28, P1995, DOI 10.2337/diacare.28.8.1995; Morikawa M, 2012, INT J GYNECOL OBSTET, V117, P66, DOI 10.1016/j.ijgo.2011.11.009; Ness RB, 2003, OBSTET GYNECOL, V102, P1366, DOI 10.1016/j.obstetgynecol.2003.08.011; O'Brien TE, 2003, EPIDEMIOLOGY, V14, P368, DOI 10.1097/00001648-200305000-00020; Obiechina NJ, 2011, INT J WOMENS HEALTH, V3, P227, DOI 10.2147/IJWH.S22059; Odegard RA, 2000, BRIT J OBSTET GYNAEC, V107, P1410, DOI 10.1111/j.1471-0528.2000.tb11657.x; Rudra CB, 2005, J MATERN-FETAL NEO M, V18, P319, DOI 10.1080/14767050500275838; SAFTLAS AF, 1990, AM J OBSTET GYNECOL, V163, P460, DOI 10.1016/0002-9378(90)91176-D; Samadi AR, 1996, OBSTET GYNECOL, V87, P557, DOI 10.1016/0029-7844(95)00480-7; Stamilio DM, 2000, AM J OBSTET GYNECOL, V182, P589, DOI 10.1067/mob.2000.103890; Steyn W, 2012, Pregnancy Hypertens, V2, P312, DOI 10.1016/j.preghy.2012.04.247; Subramaniam Vidya, 2007, BMC Womens Health, V7, P18, DOI 10.1186/1472-6874-7-18; Walker RL, 2009, CAN J CARDIOL, V25, pE284, DOI 10.1016/S0828-282X(09)70125-4; Weiss JL, 2004, AM J OBSTET GYNECOL, V190, P1091, DOI 10.1016/j.ajog.2003.09.058; World Health Organization, 1995, OBSQUID PROJ QUAL DE; Yamada T, 2012, HYPERTENS PREGNANCY, V31, P268, DOI 10.3109/10641955.2011.638957	45	112	135	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100180	10.1371/journal.pone.0100180	http://dx.doi.org/10.1371/journal.pone.0100180			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937406	Green Submitted, gold, Green Published			2022-12-27	WOS:000338503400087
J	Dietrich, J; Andreasen, LV; Andersen, P; Agger, EM				Dietrich, Jes; Andreasen, Lars Vibe; Andersen, Peter; Agger, Else Marie			Inducing Dose Sparing with Inactivated Polio Virus Formulated in Adjuvant CAF01	PLOS ONE			English	Article							CD4(+) T-CELLS; MATERNALLY DERIVED ANTIBODIES; MUCOSAL IMMUNE-RESPONSES; INTRADERMAL DELIVERY; CATIONIC LIPOSOMES; HEPATITIS-A; FEVER VIRUS; LIVE VIRUS; VACCINE; MICE	The development of new low cost inactivated polio virus based vaccines (IPV) is a high priority, and will be required to eradicate polio. In addition, such a vaccine constitutes the only realistic polio vaccine in the post-eradication era. One way to reduce the cost of a vaccine is to increase immunogenicity by use of adjuvants. The CAF01 adjuvant has previously been shown to be a safe and potent adjuvant with several antigens, and here we show that in mice IPV formulated with CAF01 induced increased systemic protective immunity measured by binding and neutralization antibody titers in serum. CAF01 also influenced the kinetics of both the cellular and humoral response against IPV to produce a faster, as well as a stronger, response, dominated by IgG2a, IgG2b, and IgG2c isotypes as well as IPV specific T cells secreting IFN-gamma/IL-2. Finally, as intestinal immunity is also a priority of polio vaccines, we present a vaccine strategy based on simultaneous priming at an intradermal and an intramuscular site that generate intestinal immune responses against polio virus. Taken together, the IPV-CAF01 formulation constitutes a new promising vaccine against polio with the ability to generate strong humoral and cellular immunity against the polio virus.	[Dietrich, Jes; Andersen, Peter; Agger, Else Marie] Statens Serum Inst, Dept Infect Dis Immunol, DK-2300 Copenhagen, Denmark; [Andreasen, Lars Vibe] Statens Serum Inst, Dept Vaccine Dev, DK-2300 Copenhagen, Denmark	Statens Serum Institut; Statens Serum Institut	Dietrich, J (corresponding author), Statens Serum Inst, Dept Infect Dis Immunol, DK-2300 Copenhagen, Denmark.	jdi@ssi.dk		Andersen, Peter/0000-0002-5869-2551	Bill and Melinda Gates Foundation [OPP1041024, OPP1070613]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This study was supported by the Bill and Melinda Gates Foundation, Grant Number OPP1041024 and the Bill and Melinda Gates Foundation, Grant Number OPP1070613. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agger EM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003116; Baldwin SL, 2011, VACCINE, V29, P644, DOI 10.1016/j.vaccine.2010.11.043; Baras B, 2008, INFLUENZA OTHER RESP, V2, P251, DOI 10.1111/j.1750-2659.2008.00054.x; Billeskov R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039909; Brady RC, 2009, VACCINE, V27, P5091, DOI 10.1016/j.vaccine.2009.06.057; Buisman AM, 2008, J INFECT DIS, V197, P698, DOI 10.1086/527487; Chen J, 2010, J VIROL, V84, P1289, DOI 10.1128/JVI.01281-09; Dagan R, 2000, PEDIATR INFECT DIS J, V19, P1045, DOI 10.1097/00006454-200011000-00004; Davidsen J, 2005, BBA-BIOMEMBRANES, V1718, P22, DOI 10.1016/j.bbamem.2005.10.011; Enioutina EY, 2000, VACCINE, V18, P2753, DOI 10.1016/S0264-410X(00)00059-1; Estivariz CF, 2013, CURR OPIN VIROL, V3, P309, DOI 10.1016/j.coviro.2013.05.007; Estivariz CF, 2012, LANCET INFECT DIS, V12, P128, DOI 10.1016/S1473-3099(11)70190-6; Fiore AE, 2003, PEDIATR INFECT DIS J, V22, P354; Fomsgaard A, 2011, VACCINE, V29, P7067, DOI 10.1016/j.vaccine.2011.07.025; Galindo M, 2007, NEW ENGL J MED, V356, P1536, DOI 10.1056/NEJMoa054960; Hawken J, 2012, VACCINE, V30, P6971, DOI 10.1016/j.vaccine.2012.09.059; HENRY JL, 1966, J HYG-CAMB, V64, P105, DOI 10.1017/S0022172400040389; Herremans TMPT, 1999, J IMMUNOL, V162, P5011; Hickling JK, 2011, B WORLD HEALTH ORGAN, V89, P221, DOI 10.2471/BLT.10.079426; Hird TR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002599; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Holmgren J, 2012, CURR OPIN IMMUNOL, V24, P343, DOI 10.1016/j.coi.2012.03.014; Ivanov AP, 2006, J INFECT DIS, V193, P598, DOI 10.1086/499970; Ivanov AP, 2005, EXPERT REV VACCINES, V4, P167, DOI 10.1586/14760584.4.2.167; Jenkins HE, 2010, NEW ENGL J MED, V362, P2360, DOI 10.1056/NEJMoa0910074; Karlsson I, 2013, CLIN IMMUNOL, V146, P120, DOI 10.1016/j.clim.2012.12.005; KATRAK K, 1991, J GEN VIROL, V72, P1093, DOI 10.1099/0022-1317-72-5-1093; Keitel W, 2010, VACCINE, V28, P840, DOI 10.1016/j.vaccine.2009.10.019; Kew OM, 2005, ANNU REV MICROBIOL, V59, P587, DOI 10.1146/annurev.micro.58.030603.123625; Klinkenberg D, 2002, VACCINE, V20, P3005, DOI 10.1016/S0042-207X(02)00283-X; KRISHNAN R, 1983, B WORLD HEALTH ORGAN, V61, P689; Leroux-Roels I, 2010, VACCINE, V28, P849, DOI 10.1016/j.vaccine.2009.10.017; Liu T, 2001, J VIROL, V75, P2107, DOI 10.1128/JVI.75.5.2107-2118.2001; Loeffen WLA, 2003, VET IMMUNOL IMMUNOP, V92, P23, DOI 10.1016/S0165-2427(03)00019-9; MAHON BP, 1995, J EXP MED, V181, P1285, DOI 10.1084/jem.181.4.1285; MARINE WM, 1962, AM J HYG, V76, P173, DOI 10.1093/oxfordjournals.aje.a120272; Martel CJM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022891; Mateen FJ, 2013, VACCINE, V31, P2517, DOI 10.1016/j.vaccine.2012.06.020; MILICH DR, 1987, NATURE, V329, P547, DOI 10.1038/329547a0; Modlin JF, 2012, LANCET INFECT DIS, V12, P93, DOI 10.1016/S1473-3099(11)70312-7; Mohammed AJ, 2010, NEW ENGL J MED, V362, P2351, DOI 10.1056/NEJMoa0909383; MORINIERE BJ, 1993, LANCET, V341, P1545, DOI 10.1016/0140-6736(93)90693-B; Nahm MH, 2003, VACCINE, V21, P3393, DOI 10.1016/S0264-410X(03)00340-2; Okayasu H, 2011, VACCINE, V29, P8205, DOI 10.1016/j.vaccine.2011.08.059; Olsen AW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010768; Ranasinghe C, 2014, IMMUNOL LETT, V161, P204, DOI 10.1016/j.imlet.2014.01.006; Resik S, 2010, J INFECT DIS, V201, P1344, DOI 10.1086/651611; Roman VRG, 2013, AIDS RES HUM RETROV, V29, P1504, DOI 10.1089/AID.2013.0076; Rosenkrands I, 2011, VACCINE, V29, P6283, DOI 10.1016/j.vaccine.2011.06.040; SCHERLE PA, 1986, J EXP MED, V164, P1114, DOI 10.1084/jem.164.4.1114; Sette A, 2008, IMMUNITY, V28, P847, DOI 10.1016/j.immuni.2008.04.018; Siegrist CA, 1998, EUR J IMMUNOL, V28, P4138, DOI 10.1002/(SICI)1521-4141(199812)28:12<4138::AID-IMMU4138>3.0.CO;2-L; SIMHON A, 1990, INT J EPIDEMIOL, V19, P164, DOI 10.1093/ije/19.1.164; Swain SL, 2012, NAT REV IMMUNOL, V12, P136, DOI 10.1038/nri3152; Thomsen AR, 1997, INT IMMUNOL, V9, P1757, DOI 10.1093/intimm/9.11.1757; Treanor JJ, 2006, NEW ENGL J MED, V354, P1343, DOI 10.1056/NEJMoa055778; Weeratna RD, 2001, FEMS IMMUNOL MED MIC, V30, P241, DOI 10.1016/S0928-8244(01)00231-0; Westdijk J, 2013, VACCINE, V31, P1298, DOI 10.1016/j.vaccine.2012.12.076; Yang CT, 2009, VACCINE, V27, P6558, DOI 10.1016/j.vaccine.2009.08.047; Yin LS, 2013, J IMMUNOL, V190, P6023, DOI 10.4049/jimmunol.1202523; Yoshino N, 2010, SCAND J IMMUNOL, V72, P98, DOI 10.1111/j.1365-3083.2010.02416.x; Zehrung D, 2013, VACCINE, V31, P3392, DOI 10.1016/j.vaccine.2012.11.021	62	26	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100879	10.1371/journal.pone.0100879	http://dx.doi.org/10.1371/journal.pone.0100879			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956110	Green Published, gold, Green Submitted			2022-12-27	WOS:000338917900104
J	Grandchamp, N; Altemir, D; Philippe, S; Ursulet, S; Pilet, H; Serre, MC; Lenain, A; Serguera, C; Mallet, J; Sarkis, C				Grandchamp, Nicolas; Altemir, Dorothee; Philippe, Stephanie; Ursulet, Suzanna; Pilet, Heloise; Serre, Marie-Claude; Lenain, Aude; Serguera, Che; Mallet, Jacques; Sarkis, Chamsy			Hybrid Lentivirus-phiC31-int-NLS Vector Allows Site-Specific Recombination in Murine and Human Cells but Induces DNA Damage	PLOS ONE			English	Article							PHAGE PHI-C31 INTEGRASE; ZINC-FINGER NUCLEASES; XENOPUS-LAEVIS EMBRYOS; MEDIATED GENE-THERAPY; LENTIVIRAL VECTORS; PHIC31 INTEGRASE; MAMMALIAN-CELLS; GENOMIC INTEGRATION; CRE RECOMBINASE; IN-VIVO	Gene transfer allows transient or permanent genetic modifications of cells for experimental or therapeutic purposes. Gene delivery by HIV-derived lentiviral vector (LV) is highly effective but the risk of insertional mutagenesis is important and the random/uncontrollable integration of the DNA vector can deregulate the cell transcriptional activity. Non Integrative Lentiviral Vectors (NILVs) solve this issue in non-dividing cells, but they do not allow long term expression in dividing cells. In this context, obtaining stable expression while avoiding the problems inherent to unpredictable DNA vector integration requires the ability to control the integration site. One possibility is to use the integrase of phage phiC31 (phiC31-int) which catalyzes efficient site-specific recombination between the attP site in the phage genome and the chromosomal attB site of its Streptomyces host. Previous studies showed that phiC31-int is active in many eukaryotic cells, such as murine or human cells, and directs the integration of a DNA substrate into pseudo attP sites (pattP) which are homologous to the native attP site. In this study, we combined the efficiency of NILV for gene delivery and the specificity of phiC31-int for DNA substrate integration to engineer a hybrid tool for gene transfer with the aim of allowing long term expression in dividing and nondividing cells preventing genotoxicity. We demonstrated the feasibility to target NILV integration in human and murine pattP sites with a dual NILV vectors system: one which delivers phiC31-int, the other which constitute the substrate containing an attB site in its DNA sequence. These promising results are however alleviated by the occurrence of significant DNA damages. Further improvements are thus required to prevent chromosomal rearrangements for a therapeutic use of the system. However, its use as a tool for experimental applications such as transgenesis is already applicable.	[Grandchamp, Nicolas; Altemir, Dorothee; Philippe, Stephanie; Ursulet, Suzanna; Pilet, Heloise; Mallet, Jacques; Sarkis, Chamsy] Univ Paris 06, Inst Cerveau & Moelle Epiniere, INSERM, Ctr Rech,Unit Biotechnol & Biotherapy, Paris, France; [Grandchamp, Nicolas; Altemir, Dorothee; Philippe, Stephanie; Ursulet, Suzanna; Pilet, Heloise; Sarkis, Chamsy] NewVectys, Villebon Sur Yvette, France; [Grandchamp, Nicolas; Philippe, Stephanie; Ursulet, Suzanna; Pilet, Heloise] Biosource, Paris, France; [Serre, Marie-Claude] Lab Virol Mol & Struct, Gif Sur Yvette, France; [Lenain, Aude] CEA, Lab Radiobiol & Oncol, Fontenay Aux Roses, France; [Serguera, Che] Mol Imaging Res Ctr Modelisat Biotherapies, Fontenay Aux Roses, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Universite Paris Saclay	Sarkis, C (corresponding author), Univ Paris 06, Inst Cerveau & Moelle Epiniere, INSERM, Ctr Rech,Unit Biotechnol & Biotherapy, Paris, France.	chamsy.sarkis@newvectys.com		Serguera, Che/0000-0002-9210-0636; SERRE, Marie-Claude/0000-0002-7899-9833	European FP6 (INTEGRA NEST-Adventure contract) [29025]; AFM (Association Francaise contre les Myopathies); Retina France	European FP6 (INTEGRA NEST-Adventure contract); AFM (Association Francaise contre les Myopathies)(Association Francaise contre les Myopathies); Retina France	This work was supported by grants from European FP6 (INTEGRA NEST-Adventure contract #29025), AFM (Association Francaise contre les Myopathies), and Retina France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-authors NG, DA, SP, SU and HP are employed by NewVectys SAS. NewVectys SAS provided support in the form of salaries for authors NG, DA, SP, SU and HP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Allen BG, 2005, NAT METHODS, V2, P975, DOI 10.1038/NMETH814; Allen BG, 2006, NAT PROTOC, V1, P1248, DOI 10.1038/nprot.2006.183; Andreas S, 2002, NUCLEIC ACIDS RES, V30, P2299, DOI 10.1093/nar/30.11.2299; ANTON M, 1995, J VIROL, V69, P4600, DOI 10.1128/JVI.69.8.4600-4606.1995; Bauer JW, 2004, EXPERT OPIN BIOL TH, V4, P1435, DOI 10.1517/14712598.4.9.1435; Belteki G, 2003, NAT BIOTECHNOL, V21, P321, DOI 10.1038/nbt787; Bertoni C, 2006, P NATL ACAD SCI USA, V103, P419, DOI 10.1073/pnas.0504505102; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Bitinaite J, 1998, P NATL ACAD SCI USA, V95, P10570, DOI 10.1073/pnas.95.18.10570; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bolusani S, 2006, NUCLEIC ACIDS RES, V34, P5259, DOI 10.1093/nar/gkl548; Bozas A, 2009, GENETICS, V182, P641, DOI 10.1534/genetics.109.101329; BYRNES AP, 1995, NEUROSCIENCE, V66, P1015, DOI 10.1016/0306-4522(95)00068-T; Carlson DF, 2012, P NATL ACAD SCI USA, V109, P17382, DOI 10.1073/pnas.1211446109; Chalberg TW, 2005, INVEST OPHTH VIS SCI, V46, P2140, DOI 10.1167/iovs.04-1252; Chalberg TW, 2006, J MOL BIOL, V357, P28, DOI 10.1016/j.jmb.2005.11.098; Chavez CL, 2012, HUM GENE THER, V23, P390, DOI 10.1089/hum.2011.110; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cornu TI, 2007, MOL THER, V15, P2107, DOI 10.1038/sj.mt.6300345; Cornu TI, 2010, METHODS MOL BIOL, V649, P237, DOI 10.1007/978-1-60761-753-2_14; Cronin J, 2005, CURR GENE THER, V5, P387, DOI 10.2174/1566523054546224; Druskovic M, 2006, CROAT MED J, V47, P832; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Ehrhardt A, 2007, MOL THER, V15, P146, DOI 10.1038/sj.mt.6300011; Ehrhardt A, 2006, HUM GENE THER, V17, P1077, DOI 10.1089/hum.2006.17.1077; Fish MP, 2007, NAT PROTOC, V2, P2325, DOI 10.1038/nprot.2007.328; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Gaj T, 2012, NAT METHODS, V9, P805, DOI [10.1038/nmeth.2030, 10.1038/NMETH.2030]; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Grandchamp Nicolas, 2011, Genet Vaccines Ther, V9, P1, DOI 10.1186/1479-0556-9-1; Gregory MA, 2003, J BACTERIOL, V185, P5320, DOI 10.1128/JB.185.17.5320-5323.2003; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Groth AC, 2000, P NATL ACAD SCI USA, V97, P5995, DOI 10.1073/pnas.090527097; Guo J, 2010, J MOL BIOL, V400, P96, DOI 10.1016/j.jmb.2010.04.060; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Held PK, 2005, MOL THER, V11, P399, DOI 10.1016/j.ymthe.2004.11.001; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Holkers M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1446; Hollis Roger P, 2003, Reprod Biol Endocrinol, V1, P79, DOI 10.1186/1477-7827-1-79; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Ishikawa Y, 2006, J GENE MED, V8, P646, DOI 10.1002/jgm.891; Jore MM, 2011, NAT STRUCT MOL BIOL, V18, P529, DOI 10.1038/nsmb.2019; Kafri T, 1997, NAT GENET, V17, P314, DOI 10.1038/ng1197-314; Keravala A, 2011, GENE THER, V18, P842, DOI 10.1038/gt.2011.31; Keravala A, 2006, J GENE MED, V8, P1008, DOI 10.1002/jgm.928; Kolot M, 2003, BIOTECHNOL BIOENG, V84, P56, DOI 10.1002/bit.10747; Kondo S, 2009, J MOL BIOL, V390, P221, DOI 10.1016/j.jmb.2009.04.057; Lister JA, 2011, METHOD CELL BIOL, V104, P195, DOI 10.1016/B978-0-12-374814-0.00011-2; Liu J, 2006, GENE THER, V13, P1188, DOI 10.1038/sj.gt.3302789; Liu J, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-31; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; Ma QW, 2006, BIOCHEM BIOPH RES CO, V345, P984, DOI 10.1016/j.bbrc.2006.04.145; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marumoto T, 2009, NAT MED, V15, P110, DOI 10.1038/nm.1863; Meredith JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059264; Miller OJ, 2006, NAT METHODS, V3, P561, DOI 10.1038/NMETH897; Moldt B, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-60; Morton J, 2006, P NATL ACAD SCI USA, V103, P16370, DOI 10.1073/pnas.0605633103; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Nakano M, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.7.e40; Nakayama G, 2006, MOL GENET GENOMICS, V275, P1, DOI 10.1007/s00438-005-0026-3; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; OGORMAN S, 1991, SCIENCE, V251, P1351, DOI 10.1126/science.1900642; Olivares EC, 2001, GENE, V278, P167, DOI 10.1016/S0378-1119(01)00711-9; Olivares EC, 2002, NAT BIOTECHNOL, V20, P1124, DOI 10.1038/nbt753; ORBAN PC, 1992, P NATL ACAD SCI USA, V89, P6861, DOI 10.1073/pnas.89.15.6861; Ortiz-Urda S, 2003, HUM GENE THER, V14, P923, DOI 10.1089/104303403765701204; Pfeifer A, 2001, P NATL ACAD SCI USA, V98, P11450, DOI 10.1073/pnas.201415498; Philippe S, 2006, P NATL ACAD SCI USA, V103, P17684, DOI 10.1073/pnas.0606197103; Portlock JL, 2006, HUM GENE THER, V17, P871, DOI 10.1089/hum.2006.17.871; Pruett-Miller SM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000376; Ramalingam S, 2011, J MOL BIOL, V405, P630, DOI 10.1016/j.jmb.2010.10.043; Raper SE, 2003, MOL GENET METAB, V80, P148, DOI 10.1016/j.ymgme.2003.08.016; Robert MA, 2012, HUM GENE THER METHOD, V23, P393, DOI 10.1089/hgtb.2012.122; Rohlmann A, 1996, NAT BIOTECHNOL, V14, P1562, DOI 10.1038/nbt1196-1562; Sander JD, 2011, NAT BIOTECHNOL, V29, P697, DOI 10.1038/nbt.1934; Santoro SW, 2002, P NATL ACAD SCI USA, V99, P4185, DOI 10.1073/pnas.022039799; Sarkis C, 2008, CURR GENE THER, V8, P430, DOI 10.2174/156652308786848012; Schnell MA, 2001, MOL THER, V3, P708, DOI 10.1006/mthe.2001.0330; Sclimenti CR, 2001, NUCLEIC ACIDS RES, V29, P5044, DOI 10.1093/nar/29.24.5044; SMITH AJH, 1995, NAT GENET, V9, P376, DOI 10.1038/ng0495-376; Smith J, 2000, NUCLEIC ACIDS RES, V28, P3361, DOI 10.1093/nar/28.17.3361; Smith MCM, 2010, BIOCHEM SOC T, V38, P388, DOI 10.1042/BST0380388; Staunstrup NH, 2009, MOL THER, V17, P1205, DOI 10.1038/mt.2009.10; Tay Y, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1089; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Thorpe HM, 1998, P NATL ACAD SCI USA, V95, P5505, DOI 10.1073/pnas.95.10.5505; Thyagarajan B, 2001, MOL CELL BIOL, V21, P3926, DOI 10.1128/MCB.21.12.3926-3934.2001; Thyagarajan B, 2008, STEM CELLS, V26, P119, DOI 10.1634/stemcells.2007-0283; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Vink CA, 2009, MOL THER, V17, P1197, DOI 10.1038/mt.2009.94; Wah DA, 1998, P NATL ACAD SCI USA, V95, P10564, DOI 10.1073/pnas.95.18.10564; Wilson JH, 2003, NAT BIOTECHNOL, V21, P759, DOI 10.1038/nbt0703-759; Yanez-Munoz RJ, 2006, NAT MED, V12, P348, DOI 10.1038/nm1365; Zayed H, 2004, MOL THER, V9, P292, DOI 10.1016/j.ymthe.2003.11.024	97	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e99649	10.1371/journal.pone.0099649	http://dx.doi.org/10.1371/journal.pone.0099649			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956106	Green Published, gold, Green Submitted			2022-12-27	WOS:000338917900014
J	Lage, GM; Miranda, DM; Romano-Silva, MA; Campos, SB; Albuquerque, MR; Correa, H; Malloy-Diniz, LF				Lage, Guilherme M.; Miranda, Debora M.; Romano-Silva, Marco A.; Campos, Simone B.; Albuquerque, Maicon R.; Correa, Humberto; Malloy-Diniz, Leandro F.			Association between the Catechol-O-Methyltransferase (COMT) Val(158)Met Polymorphism and Manual Aiming Control in Healthy Subjects	PLOS ONE			English	Article							WORKING-MEMORY; NUCLEUS-ACCUMBENS; DECISION-MAKING; MET GENOTYPE; DOPAMINE; VAL158MET; GENE	Background: Prefrontal dopamine is catabolized by the catechol-O-methyltransferase (COMT) enzyme. Current evidence suggests that the val/met single nucleotide polymorphism in the COMT gene can predict the efficiency of executive cognition in humans. Individuals carrying the val allele perform more poorly because less synaptic dopamine is available. Methodology/Principal Findings: We investigated the influence of the COMT polymorphism on motor performance in a task that requires different executive functions. We administered a manual aiming motor task that was performed under four different conditions of execution by 111 healthy participants. Participants were grouped according to genotype (met/met, met/val, val/val), and the motor performance among groups was compared. Overall, the results indicate that met/met carriers presented lower levels of peak velocity during the movement trajectory than the val carriers, but met/met carriers displayed higher accuracy than the val carriers. Conclusions/Significance: This study found a significant association between the COMT polymorphism and manual aiming control. Few studies have investigated the genetics of motor control, and these findings indicate that individual differences in motor control require further investigation using genetic studies.	[Lage, Guilherme M.] Univ Fed Minas Gerais, Escola Educ Fis Fisioterapia & Terapia Ocupac, Dept Educ Fis, Grp Estudo Desenvolvimento Motor & Aprendizagem M, Belo Horizonte, MG, Brazil; [Lage, Guilherme M.; Miranda, Debora M.; Romano-Silva, Marco A.; Albuquerque, Maicon R.; Correa, Humberto; Malloy-Diniz, Leandro F.] Univ Fed Minas Gerais, Fac Med, LINC, Belo Horizonte, MG, Brazil; [Lage, Guilherme M.; Miranda, Debora M.; Romano-Silva, Marco A.; Campos, Simone B.; Albuquerque, Maicon R.; Correa, Humberto; Malloy-Diniz, Leandro F.] Univ Fed Minas Gerais, Fac Med, INCT Med Mol, Belo Horizonte, MG, Brazil; [Romano-Silva, Marco A.; Correa, Humberto] Univ Fed Minas Gerais, Fac Med, Dept Saude Mental, Belo Horizonte, MG, Brazil; [Miranda, Debora M.; Malloy-Diniz, Leandro F.] Univ Fed Minas Gerais, Fac Med, Dept Pediat, Belo Horizonte, MG, Brazil; [Albuquerque, Maicon R.] Univ Fed Vicosa, Dept Educ Fis, Vicosa, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Vicosa	Lage, GM (corresponding author), Univ Fed Minas Gerais, Escola Educ Fis Fisioterapia & Terapia Ocupac, Dept Educ Fis, Grp Estudo Desenvolvimento Motor & Aprendizagem M, Belo Horizonte, MG, Brazil.	menezeslage@gmail.com	Lage, Guilherme/F-4355-2011; Malloy-Diniz, Leandro/D-7829-2013; Miranda, Debora/AAQ-1952-2020; Correa, Humberto/B-6497-2009; Romano-Silva, Marco Aurelio/T-8321-2019; Romano-Silva, Marco Aurelio/A-1790-2008; Malloy-Diniz, Leandro Fernandes/AAR-4025-2021; Albuquerque, Maicon Rodrigues/I-6227-2013	Lage, Guilherme/0000-0001-8296-3676; Malloy-Diniz, Leandro/0000-0002-6606-1354; Miranda, Debora/0000-0002-7081-8401; Correa, Humberto/0000-0003-4327-6413; Romano-Silva, Marco Aurelio/0000-0002-6558-4639; Malloy-Diniz, Leandro Fernandes/0000-0002-6606-1354; Albuquerque, Maicon Rodrigues/0000-0001-6021-8480	INCT-MM [FAPEMIG: CBB-APQ-00075- 584 09/CNPq 573646/2008-2]; FAPEMIG	INCT-MM; FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	Funding was provided by grant INCT-MM (FAPEMIG: CBB-APQ-00075- 584 09/CNPq 573646/2008-2); FAPEMIG - incentive program for publication in indexed journals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera M, 2008, AM J MED GENET B, V147B, P898, DOI 10.1002/ajmg.b.30705; Amorim P., 2000, REV BRAS PSIQUIATR, V22, P106, DOI DOI 10.1590/S1516-44462000000300003; Bardgett ME, 2009, BEHAV NEUROSCI, V123, P242, DOI 10.1037/a0014625; Bender S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037814; Bilder RM, 2002, BIOL PSYCHIAT, V52, P701, DOI 10.1016/S0006-3223(02)01416-6; Blasi G, 2005, J NEUROSCI, V25, P5038, DOI 10.1523/JNEUROSCI.0476-05.2005; BOUDIKOVA B, 1990, CLIN PHARMACOL THER, V48, P381, DOI 10.1038/clpt.1990.166; Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589; Congdon E, 2008, J PERS, V76, P1447, DOI 10.1111/j.1467-6494.2008.00528.x; Cools R, 2011, BIOL PSYCHIAT, V69, pE113, DOI 10.1016/j.biopsych.2011.03.028; Diamond A, 2000, CHILD DEV, V71, P44, DOI 10.1111/1467-8624.00117; Dickinson D, 2009, NEUROSCIENCE, V164, P72, DOI 10.1016/j.neuroscience.2009.05.014; DUM RP, 1991, J NEUROSCI, V11, P667; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; Goldberg TE, 2003, ARCH GEN PSYCHIAT, V60, P889, DOI 10.1001/archpsyc.60.9.889; Karlsgodt KH, 2011, BEHAV BRAIN RES, V225, P610, DOI 10.1016/j.bbr.2011.08.016; KAROUM F, 1994, J NEUROCHEM, V63, P972, DOI 10.1046/j.1471-4159.1994.63030972.x; Kennedy Q, 2011, BEHAV GENET, V41, P700, DOI 10.1007/s10519-010-9436-z; Lage GM, 2012, PSYCHIAT RES, V30, P140; Lage GM, 2012, HUM MOVEMENT SCI, V31, P811, DOI 10.1016/j.humov.2011.08.008; LAHIRI DK, 1991, NUCLEIC ACIDS RES, V19, P5444, DOI 10.1093/nar/19.19.5444; LOTTA T, 1995, BIOCHEMISTRY-US, V34, P4202, DOI 10.1021/bi00013a008; Malhotra AK, 2002, AM J PSYCHIAT, V159, P652, DOI 10.1176/appi.ajp.159.4.652; Malloy-Diniz LF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073509; Mattay VS, 2003, P NATL ACAD SCI USA, V100, P6186, DOI 10.1073/pnas.0931309100; Muller T, 2008, CLIN NEUROPHARMACOL, V31, P134, DOI 10.1097/WNF.0b013e31811510ed; Narum SR, 2006, CONSERV GENET, V7, P783, DOI 10.1007/s10592-005-9056-y; Nolan KA, 2004, AM J PSYCHIAT, V161, P359, DOI 10.1176/appi.ajp.161.2.359; Noudoost B, 2011, TRENDS COGN SCI, V15, P585, DOI 10.1016/j.tics.2011.10.006; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pattij T, 2007, PSYCHOPHARMACOLOGY, V191, P587, DOI 10.1007/s00213-006-0533-x; Rosa EC, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-53; Serrien DJ, 2007, PROG NEUROBIOL, V82, P95, DOI 10.1016/j.pneurobio.2007.02.003; Sheldrick AJ, 2008, EUR PSYCHIAT, V23, P385, DOI 10.1016/j.eurpsy.2008.05.002; TANJI J, 1994, NEUROSCI RES, V19, P251, DOI 10.1016/0168-0102(94)90038-8; van den Bos R, 2009, NEUROPHARMACOLOGY, V56, P493, DOI 10.1016/j.neuropharm.2008.10.002; Wahlstrom D, 2007, BIOL PSYCHIAT, V61, P626, DOI 10.1016/j.biopsych.2006.05.045; Winterer G, 2006, NEUROIMAGE, V32, P1722, DOI 10.1016/j.neuroimage.2006.05.058; Woodworth RS, 1899, PSYCHOL REV-MONOGR S, V3, P1	40	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e99698	10.1371/journal.pone.0099698	http://dx.doi.org/10.1371/journal.pone.0099698			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AL1WV	24956262	Green Submitted, Green Published, gold			2022-12-27	WOS:000338917900016
J	Valdivia, N; Diaz, MJ; Holtheuer, J; Garrido, I; Huovinen, P; Gomez, I				Valdivia, Nelson; Diaz, Maria J.; Holtheuer, Jorge; Garrido, Ignacio; Huovinen, Pirjo; Gomez, Ivan			Up, Down, and All Around: Scale-Dependent Spatial Variation in Rocky-Shore Communities of Fildes Peninsula, King George Island, Antarctica	PLOS ONE			English	Article							ENVIRONMENTAL-STRESS; INTERTIDAL HABITATS; POTTER COVE; ICE SCOUR; PATTERNS; DISTURBANCE; MACROALGAE; ASSEMBLAGES; ZONATION; BIODIVERSITY	Understanding the variation of biodiversity along environmental gradients and multiple spatial scales is relevant for theoretical and management purposes. Hereby, we analysed the spatial variability in diversity and structure of intertidal and subtidal macrobenthic Antarctic communities along vertical environmental stress gradients and across multiple horizontal spatial scales. Since biotic interactions and local topographic features are likely major factors for coastal assemblages, we tested the hypothesis that fine-scale processes influence the effects of the vertical environmental stress gradients on the macrobenthic diversity and structure. We used nested sampling designs in the intertidal and subtidal habitats, including horizontal spatial scales ranging from few centimetres to 1000s of metres along the rocky shore of Fildes Peninsula, King George Island. In both intertidal and subtidal habitats, univariate and multivariate analyses showed a marked vertical zonation in taxon richness and community structure. These patterns depended on the horizontal spatial scale of observation, as all analyses showed a significant interaction between height (or depth) and the finer spatial scale analysed. Variance and pseudo-variance components supported our prediction for taxon richness, community structure, and the abundance of dominant species such as the filamentous green alga Urospora penicilliformis (intertidal), the herbivore Nacella concinna (intertidal), the large kelp-like Himantothallus grandifolius (subtidal), and the red crustose red alga Lithothamnion spp. (subtidal). We suggest that in coastal ecosystems strongly governed by physical factors, fine-scale processes (e. g. biotic interactions and refugia availability) are still relevant for the structuring and maintenance of the local communities. The spatial patterns found in this study serve as a necessary benchmark to understand the dynamics and adaptation of natural assemblages in response to observed and predicted environmental changes in Antarctica.	[Valdivia, Nelson; Diaz, Maria J.; Holtheuer, Jorge; Garrido, Ignacio; Huovinen, Pirjo; Gomez, Ivan] Univ Austral Chile, Fac Ciencias, Inst Ciencias Marinas & Limnol, Valdivia, Chile; [Holtheuer, Jorge] Univ Austral Chile, Fac Ciencias, Programa Doctorado Biol Marina, Valdivia, Chile	Universidad Austral de Chile; Universidad Austral de Chile	Valdivia, N (corresponding author), Univ Austral Chile, Fac Ciencias, Inst Ciencias Marinas & Limnol, Valdivia, Chile.	nelson.valdivia@uach.cl	Valdivia, Nelson A/C-3613-2009	Valdivia, Nelson A/0000-0002-5394-2072; Gomez, Ivan/0000-0001-8381-3792; Huovinen, Pirjo/0000-0002-7754-4933	PIA-CONICYT Anillo grant [ART1101]; Programa de Mejoramiento de la Calidad y la Equidad de la Educacioen Superior (MECESUP) through grant Fortalecimiento de las Ciencias Ecoloegicas y Evolutivas en la UACH [AUS0805]	PIA-CONICYT Anillo grant(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/ANILLOS); Programa de Mejoramiento de la Calidad y la Equidad de la Educacioen Superior (MECESUP) through grant Fortalecimiento de las Ciencias Ecoloegicas y Evolutivas en la UACH	Financial support was provided by the PIA-CONICYT Anillo grant # ART1101 to I.G., P.H., and N.V.; and by the Programa de Mejoramiento de la Calidad y la Equidad de la Educacioen Superior (MECESUP) through grant # AUS0805 Fortalecimiento de las Ciencias Ecoloegicas y Evolutivas en la UACH to N.V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PB, 2001, OECOLOGIA, V128, P465, DOI 10.1007/s004420100737; Airoldi L, 2003, OCEANOGR MAR BIOL, V41, P161; Anderson MJ, 2003, J STAT COMPUT SIM, V73, P85, DOI 10.1080/00949650215733; ARNTZ WE, 1994, OCEANOGR MAR BIOL, V32, P241; Barnes DKA, 2011, CURR BIOL, V21, pR451, DOI 10.1016/j.cub.2011.04.012; Benedetti-Cecchi L, 1999, MAR ECOL PROG SER, V181, P13, DOI 10.3354/meps181013; Benedetti-Cecchi L, 2000, NATURE, V407, P370, DOI 10.1038/35030089; BenedettiCecchi L, 1997, J EXP MAR BIOL ECOL, V209, P171, DOI 10.1016/S0022-0981(96)02686-X; Bick A, 2013, POLAR BIOL, V36, P673, DOI 10.1007/s00300-013-1293-9; Botsford LW, 2003, ECOL APPL, V13, pS25; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Coleman RA, 2006, OECOLOGIA, V147, P556, DOI 10.1007/s00442-005-0296-9; CONNELL JH, 1961, ECOLOGY, V42, P710, DOI 10.2307/1933500; Denny MW, 2011, J EXP MAR BIOL ECOL, V400, P175, DOI 10.1016/j.jembe.2011.02.006; Diaz ER, 2011, J ECOL, V99, P416, DOI 10.1111/j.1365-2745.2010.01779.x; Fraschetti S, 2005, MAR ECOL PROG SER, V296, P13, DOI 10.3354/meps296013; Gomez I, 1997, MAR ECOL PROG SER, V148, P281, DOI 10.3354/meps148281; Gomez I, 2011, MAR ECOL PROG SER, V422, P77, DOI 10.3354/meps08937; Gorley C.K., 2006, GETTING STARTED PRIM; Harley CDG, 2003, LIMNOL OCEANOGR, V48, P1498, DOI 10.4319/lo.2003.48.4.1498; Harley CDG, 2011, SCIENCE, V334, P1124, DOI 10.1126/science.1210199; Huovinen P, 2013, POLAR BIOL, V36, P1319, DOI 10.1007/s00300-013-1351-3; Johnston EL, 2007, POLAR BIOL, V30, P781, DOI 10.1007/s00300-006-0237-z; Khim BK, 2007, ESTUAR COAST SHELF S, V73, P111, DOI 10.1016/j.ecss.2006.12.015; Kiirikki M, 1996, EUR J PHYCOL, V31, P61, DOI 10.1080/09670269600651201; Kim D., 2001, SEASONALITY MARINE A; KLOSER H, 1994, POLAR BIOL, V14, P11; Kloser H, 1996, HYDROBIOLOGIA, V333, P1, DOI 10.1007/BF00020959; Konar B, 2009, MAR ECOL-EVOL PERSP, V30, P63, DOI 10.1111/j.1439-0485.2008.00259.x; Campana GL, 2009, BOT MAR, V52, P655, DOI 10.1515/BOT.2009.076; Martins GM, 2008, MAR ECOL PROG SER, V356, P15, DOI 10.3354/meps07247; MENGE BA, 1987, AM NAT, V130, P730, DOI 10.1086/284741; Menge BA, 2013, ECOL MONOGR, V83, P283, DOI 10.1890/12-1706.1; Molina-Montenegro MA, 2005, MAR ECOL PROG SER, V292, P173, DOI 10.3354/meps292173; Nybakken J., 2005, MARINE BIOL ECOLOGIC; PAINE RT, 1981, ECOL MONOGR, V51, P145, DOI 10.2307/2937261; Poore AGB, 2012, ECOL LETT, V15, P912, DOI 10.1111/j.1461-0248.2012.01804.x; Pugh PJA, 1997, J EXP MAR BIOL ECOL, V210, P1, DOI 10.1016/S0022-0981(96)02711-6; Richards ZT, 2013, DIVERS DISTRIB, V19, P884, DOI 10.1111/ddi.12032; Sarr DA, 2005, Q REV BIOL, V80, P187, DOI 10.1086/433058; Scrosati RA, 2011, ECOGRAPHY, V34, P151, DOI 10.1111/j.1600-0587.2010.06119.x; Smale DA, 2008, SCIENCE, V321, P371, DOI 10.1126/science.1158647; Smale DA, 2007, AUSTRAL ECOL, V32, P878, DOI 10.1111/j.1442-9993.2007.01776.x; Smale DA, 2010, DIVERS DISTRIB, V16, P985, DOI 10.1111/j.1472-4642.2010.00709.x; Smith SDA, 2002, ANTARCT SCI, V14, P374, DOI 10.1017/S0954102002000160; SOUSA WP, 1979, ECOLOGY, V60, P1225, DOI 10.2307/1936969; STEPHENSON TA, 1949, J ECOL, V37, P289, DOI 10.2307/2256610; Team RC, 2014, R LANG ENV STAT COMP; Terlizzi A, 2005, MAR BIOL, V148, P293, DOI 10.1007/s00227-005-0080-8; Terlizzi A, 2007, MAR ECOL PROG SER, V332, P25, DOI 10.3354/meps332025; Thompson RM, 2007, ECOLOGY, V88, P612, DOI 10.1890/05-1454; Underwood AJ, 2000, J EXP MAR BIOL ECOL, V250, P97, DOI 10.1016/S0022-0981(00)00181-7; Underwood AJ, 1996, OECOLOGIA, V107, P212, DOI 10.1007/BF00327905; Underwood AJ, 2000, J EXP MAR BIOL ECOL, V250, P51, DOI 10.1016/S0022-0981(00)00179-9; Valdivia N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024062; Waller CL, 2006, AUSTRAL ECOL, V31, P656, DOI 10.1111/j.1442-9993.2006.01618.x; Waller CL, 2013, ANTARCT SCI, V25, P62, DOI 10.1017/S0954102012000867; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; Zacher K, 2007, POLAR BIOL, V30, P1203, DOI 10.1007/s00300-007-0278-y; Zacher K, 2007, GLOBAL CHANGE BIOL, V13, P1201, DOI 10.1111/j.1365-2486.2007.01349.x; Zacher K, 2009, BOT MAR, V52, P483, DOI 10.1515/BOT.2009.082	61	25	28	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100714	10.1371/journal.pone.0100714	http://dx.doi.org/10.1371/journal.pone.0100714			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956114	Green Published, Green Submitted, gold			2022-12-27	WOS:000338917900086
J	Wang, YY; Luo, Y; Bing, T; Chen, Z; Lu, MH; Zhang, N; Shangguan, DH; Gao, X				Wang, Yuanyuan; Luo, Yun; Bing, Tao; Chen, Zheng; Lu, Minhua; Zhang, Nan; Shangguan, Dihua; Gao, Xin			DNA Aptamer Evolved by Cell-SELEX for Recognition of Prostate Cancer	PLOS ONE			English	Article							NUCLEIC-ACID APTAMERS; BREAST-CANCER; LIVE CELLS; IN-VIVO; ANTIGEN; INTERNALIZATION; THERAPEUTICS; DIAGNOSTICS; MOLECULES; MORTALITY	Morbidity and mortality of prostate cancer (PCa) have increased in recent years worldwide. Currently existing methods for diagnosis and treatment do not make the situation improve, especially for hormone refractory prostate cancer (HRPC). The lack of molecular probes for PCa hindered the early diagnosis of metastasis and accurate staging for PCa. In this work, we have developed a new aptamer probe Wy-5a against PCa cell line PC-3 by cell-SELEX technique. Wy-5a shows high specificity to the target cells with dissociation constants in the nanomolar range, and does not recognize other tested PCa cell lines and other tested tumor cell lines. The staining of clinical tissue sections with fluorescent dye labeled Wy-5a shows that sections from high risk group with metastasis exhibited stronger fluorescence and sections from Benign Prostatic Hyperplasia (BPH) did not exhibit notable fluorescence, which suggests that aptamer Wy-5a may bind to protein related to the progression of PCa. The high affinity and specificity of Wy-5a makes this aptamer hold potential for application in diagnosis and target therapy of PCa.	[Wang, Yuanyuan; Luo, Yun; Chen, Zheng; Lu, Minhua; Gao, Xin] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Urol, Guangzhou 510275, Guangdong, Peoples R China; [Bing, Tao; Zhang, Nan; Shangguan, Dihua] Chinese Acad Sci, Inst Chem, Key Lab Analyt Chem Living Biosyst, Beijing Natl Lab Mol Sci, Beijing 100080, Peoples R China	Sun Yat Sen University; Chinese Academy of Sciences; Institute of Chemistry, CAS	Shangguan, DH (corresponding author), Chinese Acad Sci, Inst Chem, Key Lab Analyt Chem Living Biosyst, Beijing Natl Lab Mol Sci, Beijing 100080, Peoples R China.	sgdh@iccas.ac.cn; xin.gao.zsu@gmail.com	Bing, Tao/AAM-6162-2020; Bing, Tao/F-3476-2017; Shangguan, Dihua/G-4530-2011; Lv, Yuanjie/AER-0767-2022	Bing, Tao/0000-0002-5121-053X; Bing, Tao/0000-0002-5121-053X; Shangguan, Dihua/0000-0002-5746-803X; 	National Natural Science Foundation of China [81172430, 81372728, 21205124, 81201694]; Grant 973 Program [2011CB935800]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20120171120059]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Grant 973 Program; Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	The authors acknowledge the financial support from National Natural Science Foundation of China (81172430, 81372728, 21205124 and 81201694) and Grant 973 Program (2011CB935800) and Specialized Research Fund for the Doctoral Program of Higher Education of China (20120171120059). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti C, 2013, EUR REV MED PHARMACO, V17, P1658; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Bing T, 2010, BIOORGAN MED CHEM, V18, P1798, DOI 10.1016/j.bmc.2010.01.054; Breaker RR, 2004, NATURE, V432, P838, DOI 10.1038/nature03195; Bubendorf L, 2000, HUM PATHOL, V31, P578, DOI 10.1053/hp.2000.6698; Chen HW, 2008, CHEMMEDCHEM, V3, P991, DOI 10.1002/cmdc.200800030; Damber JE, 2008, LANCET, V371, P1710, DOI 10.1016/S0140-6736(08)60729-1; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Etzioni R, 2003, NAT REV CANCER, V3, P243, DOI 10.1038/nrc1041; Famulok M, 2007, CHEM REV, V107, P3715, DOI 10.1021/cr0306743; Gown AM, 2008, MODERN PATHOL, V21, pS8, DOI 10.1038/modpathol.2008.34; GUESS HA, 1993, PROSTATE, V22, P31, DOI 10.1002/pros.2990220105; Jayasena SD, 1999, CLIN CHEM, V45, P1628; Jiang YX, 2003, ANAL CHEM, V75, P2112, DOI 10.1021/ac026182s; Kanwar JR, 2011, CRIT REV BIOCHEM MOL, V46, P459, DOI 10.3109/10409238.2011.614592; Kanwar JR, 2010, NANOMEDICINE-UK, V5, P1435, DOI 10.2217/NNM.10.115; Keefe AD, 2010, NAT REV DRUG DISCOV, V9, P537, DOI 10.1038/nrd3141; Kovar JL, 2006, AM J PATHOL, V169, P1415, DOI 10.2353/ajpath.2006.060324; Lin GW, 2009, ASIAN J ANDROL, V11, P443, DOI 10.1038/aja.2008.36; Min K, 2011, BIOMATERIALS, V32, P2124, DOI 10.1016/j.biomaterials.2010.11.035; Montironi R, 2005, BJU INT, V95, P1146, DOI 10.1111/j.1464-410X.2005.05540.x; Navani NK, 2006, CURR OPIN CHEM BIOL, V10, P272, DOI 10.1016/j.cbpa.2006.04.003; Osborne SE, 1997, CURR OPIN CHEM BIOL, V1, P5, DOI 10.1016/S1367-5931(97)80102-0; Patil SD, 2005, AAPS J, V7, pE61, DOI 10.1208/aapsj070109; Pulukuri SM, 2005, J BIOL CHEM, V280, P36529, DOI 10.1074/jbc.M503111200; Rimmele M, 2003, CHEMBIOCHEM, V4, P963, DOI 10.1002/cbic.200300648; Robertson D, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-13; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Sefah K, 2010, NAT PROTOC, V5, P1169, DOI 10.1038/nprot.2010.66; Shangguan DH, 2008, ANAL CHEM, V80, P721, DOI 10.1021/ac701962v; Shangguan D, 2007, CHEMBIOCHEM, V8, P603, DOI 10.1002/cbic.200600532; Shangguan D, 2006, P NATL ACAD SCI USA, V103, P11838, DOI 10.1073/pnas.0602615103; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sim HG, 2005, EUR J CANCER, V41, P834, DOI 10.1016/j.ejca.2004.12.033; Tchetgen MB, 1996, UROLOGY, V47, P511, DOI 10.1016/S0090-4295(99)80486-5; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Wessels JT, 2007, CYTOM PART A, V71A, P542, DOI 10.1002/cyto.a.20419; World Health Organization, 2008, WORLD CANC REPORT, P450; Xia SJ, 2012, ASIAN J ANDROL, V14, P458, DOI 10.1038/aja.2010.137; Xiao ZY, 2008, CHEM-EUR J, V14, P1769, DOI 10.1002/chem.200701330; Yang XJ, 2011, ANALYST, V136, P577, DOI 10.1039/c0an00550a; Zhang KJ, 2012, CHEMMEDCHEM, V7, P79, DOI 10.1002/cmdc.201100457; Zhao ZL, 2009, ANALYST, V134, P1808, DOI 10.1039/b904476k; Zhou JH, 2011, OLIGONUCLEOTIDES, V21, P1, DOI 10.1089/oli.2010.0264; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	45	25	25	5	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100243	10.1371/journal.pone.0100243	http://dx.doi.org/10.1371/journal.pone.0100243			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956390	Green Published, gold, Green Submitted			2022-12-27	WOS:000338917900035
J	Breyer, MK; Spruit, MA; Hanson, CK; Franssen, FME; Vanfleteren, LEGW; Groenen, MTJ; Bruijnzeel, PLB; Wouters, EFM; Rutten, EPA				Breyer, Marie-Kathrin; Spruit, Martijn A.; Hanson, Corrine K.; Franssen, Frits M. E.; Vanfleteren, Lowie E. G. W.; Groenen, Miriam T. J.; Bruijnzeel, Piet L. B.; Wouters, Emiel F. M.; Rutten, Erica P. A.			Prevalence of Metabolic Syndrome in COPD Patients and Its Consequences	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; QUALITY-OF-LIFE; BONE-MINERAL DENSITY; CARDIOVASCULAR-DISEASE; EXERCISE CAPACITY; OBESE INDIVIDUALS; BODY-COMPOSITION; MORTALITY; COMORBIDITIES; ASSOCIATION	Background: The prevalence of metabolic syndrome in COPD patients and its impact on patient related outcomes has been little studied. We evaluated the prevalence of metabolic syndrome and clinical and functional characteristics in patients with COPD and healthy subjects. Methods: 228 COPD patients and 156 healthy subjects were included. Metabolic syndrome was defined using criteria of the IDF. In all patients spirometry, body composition, functional exercise performance, and mood and health status were assessed. Groups were stratified for BMI and gender. Results: Metabolic syndrome was present in 57% of the COPD patients and 40% of the healthy subjects. After stratification for BMI, presence of metabolic syndrome in patients with a BMI >= 25 kg/m(2) was higher than in healthy peers. Patients with metabolic syndrome and a BMI <25 kg/m(2) had higher BMI, fat free mass index and bone mineral density, and a lower 6MWD than the BMI matched patients without metabolic syndrome. Spirometry, maximal ergometry, mood and health status, and blood gases were not different between those groups. In COPD patients with metabolic syndrome self-reported co-morbidities and medication use were higher than in those without. Conclusion: Metabolic syndrome is more prevalent in overweight or obese COPD patients than in BMI matched healthy subjects. Metabolic syndrome did not additionally impact patients' functional outcomes, but did impact the prevalence of co-morbidities.	[Breyer, Marie-Kathrin; Wouters, Emiel F. M.] MUMC, Dept Resp Med, Maastricht, Netherlands; [Breyer, Marie-Kathrin; Spruit, Martijn A.; Franssen, Frits M. E.; Vanfleteren, Lowie E. G. W.; Groenen, Miriam T. J.; Wouters, Emiel F. M.; Rutten, Erica P. A.] Ctr Expertise Chron Organ Failure, Program Dev Ctr CIRO, Horn, Netherlands; [Breyer, Marie-Kathrin] Otto Wagner Hosp, Dept Resp & Crit Care Med, Vienna, Austria; [Breyer, Marie-Kathrin] Otto Wagner Hosp, Ludwig Boltzmann Inst COPD & Pulm Epidemiol, Vienna, Austria; [Hanson, Corrine K.] Univ Nebraska Med Ctr, Sch Allied Hlth Profess, Div Med Nutr Educ, Ohmaha, NE USA; [Bruijnzeel, Piet L. B.] AstraZeneca, Inflammat Neurosci & Resp, Molndal, Sweden	Maastricht University; University of Nebraska System; University of Nebraska Medical Center; AstraZeneca	Breyer, MK (corresponding author), MUMC, Dept Resp Med, Maastricht, Netherlands.	marie.breyer@gmx.at	Wouters, Emiel/ABD-6200-2021; Franssen, Frits M.E./L-3334-2019; Franssen, Frits M.E./B-6988-2018	Franssen, Frits M.E./0000-0002-1633-6356; Franssen, Frits M.E./0000-0002-1633-6356; Hanson, Corrine/0000-0002-5118-591X	Ludwig Boltzmann Institute for COPD and Respiratory Epidemiology, Vienna, Austria; AstraZeneca	Ludwig Boltzmann Institute for COPD and Respiratory Epidemiology, Vienna, Austria; AstraZeneca(AstraZeneca)	MKB was funded by the Ludwig Boltzmann Institute for COPD and Respiratory Epidemiology, Vienna, Austria. AstraZeneca provided support in the form of a salary for author PLBB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the author contributions section.	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Barnes PJ, 2009, EUR RESPIR J, V33, P1165, DOI 10.1183/09031936.00128008; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Curkendall SM, 2006, ANN EPIDEMIOL, V16, P63, DOI 10.1016/j.annepidem.2005.04.008; Divo M, 2012, AM J RESP CRIT CARE, V186, P155, DOI 10.1164/rccm.201201-0034OC; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Ferrer M, 1997, ANN INTERN MED, V127, P1072, DOI 10.7326/0003-4819-127-12-199712150-00003; Ford Earl S, 2006, Expert Rev Cardiovasc Ther, V4, P897, DOI 10.1586/14779072.4.6.897; Hajiro T, 1998, AM J RESP CRIT CARE, V157, P785, DOI 10.1164/ajrccm.157.3.9703055; Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; JONES PW, 1992, AM REV RESPIR DIS, V145, P1321, DOI 10.1164/ajrccm/145.6.1321; Ketelaars CAJ, 1996, THORAX, V51, P39, DOI 10.1136/thx.51.1.39; Kinjo M, 2007, J CLIN ENDOCR METAB, V92, P4161, DOI 10.1210/jc.2007-0757; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Leone N, 2009, AM J RESP CRIT CARE, V179, P509, DOI 10.1164/rccm.200807-1195OC; Mannino DM, 2008, EUR RESPIR J, V32, P962, DOI 10.1183/09031936.00012408; Marquis K, 2005, J CARDIOPULM REHABIL, V25, P233; Marquis Karine, 2005, J Cardiopulm Rehabil, V25, P226, DOI 10.1097/00008483-200507000-00010; Minas M, 2011, COPD, V8, P414, DOI 10.3109/15412555.2011.619600; Pobeha P, 2011, BONE, V48, P1008, DOI 10.1016/j.bone.2011.02.017; Reid IR, 2010, ARCH BIOCHEM BIOPHYS, V503, P20, DOI 10.1016/j.abb.2010.06.027; Reid IR, 2006, ANN ENDOCRINOL-PARIS, V67, P125, DOI 10.1016/S0003-4266(06)72567-7; Ribisl PM, 2007, DIABETES CARE, V30, P2679, DOI 10.2337/dc06-2487; Roriz-Cruz M, 2007, J AM GERIATR SOC, V55, P374, DOI 10.1111/j.1532-5415.2007.01068.x; SCHOLS AMWJ, 1991, THORAX, V46, P695, DOI 10.1136/thx.46.10.695; Shoup R, 1997, EUR RESPIR J, V10, P1576, DOI 10.1183/09031936.97.10071576; Tsai AG, 2008, OBESITY, V16, P59, DOI 10.1038/oby.2007.8; van den Borst B, 2012, AM J CLIN NUTR, V96, P516, DOI 10.3945/ajcn.112.040774; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Watz H, 2009, CHEST, V136, P1039, DOI 10.1378/chest.09-0393; Wells G, 2013, EUROPEAN RESP MONOGR; Wong CY, 2005, AM J CARDIOL, V96, P1686, DOI 10.1016/j.amjcard.2005.07.091; Yamaguchi T, 2009, BONE, V45, P174, DOI 10.1016/j.bone.2009.05.003; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	34	52	54	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e98013	10.1371/journal.pone.0098013	http://dx.doi.org/10.1371/journal.pone.0098013			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950070	Green Published, Green Submitted, gold			2022-12-27	WOS:000338276300004
J	Dodd, KA; Bird, BH; Jones, MEB; Nichol, ST; Spiropoulou, CF				Dodd, Kimberly A.; Bird, Brian H.; Jones, Megan E. B.; Nichol, Stuart T.; Spiropoulou, Christina F.			Kyasanur Forest Disease Virus Infection in Mice Is Associated with Higher Morbidity and Mortality than Infection with the Closely Related Alkhurma Hemorrhagic Fever Virus	PLOS ONE			English	Article							SAUDI-ARABIA; ENCEPHALITIS; TICKS; NAJRAN; MODELS; MOUSE; INDIA	Background: Kyasanur Forest disease virus (KFDV) and Alkhurma hemorrhagic fever virus (AHFV) are closely related members of the Flavivirus genus and are important causes of human disease in India and the Arabian Peninsula, respectively. Despite high genetic similarity, the viruses have distinctly different host ranges and ecologies. Human cases of KFDV or AHFV develop a spectrum of disease syndromes ranging from liver pathology to neurologic disease. Case reports suggest KFDV is more commonly associated with hepatic and gastrointestinal manifestations whereas AHFV is more commonly associated with neurologic disease. Methodology/Principal Findings: Inoculation of three immunocompetent laboratory mouse strains revealed that KFDV was consistently more lethal than AHFV. In subsequent studies utilizing C57BL/6J mice, we demonstrated that KFDV infection was associated with higher viral loads and significantly higher mortality. KFDV-infected mice rapidly developed more severe disease than AHFV-infected mice, as evidenced by significant abnormalities on clinical chemistry panels and more severe pathology in the brain and gastrointestinal tract. Conclusions/Significance: Infections of C57BL/6J mice with KFDV or AHFV resulted in clinical disease syndromes that closely approximate the diseases seen in human cases. Despite high genetic similarity, there were clear differences in survival, viral kinetics, clinical chemistry data and histology. These results suggest that distinct mouse models for AHFV and KFDV are necessary in order to gain a better understanding of the unique pathogenesis of each virus, as well as to provide platforms for testing promising vaccines and therapeutics.	[Dodd, Kimberly A.; Bird, Brian H.; Jones, Megan E. B.; Nichol, Stuart T.; Spiropoulou, Christina F.] Ctr Dis Control & Prevent, Viral Special Pathogens Branch, Div High Consequence Pathogens & Pathol, Atlanta, GA 30333 USA; [Dodd, Kimberly A.] Univ Calif Davis, Sch Vet Med, Davis, CA 95616 USA; [Jones, Megan E. B.] Univ Georgia, Coll Vet Med, Dept Pathol, Athens, GA 30602 USA	Centers for Disease Control & Prevention - USA; University of California System; University of California Davis; University System of Georgia; University of Georgia	Spiropoulou, CF (corresponding author), Ctr Dis Control & Prevent, Viral Special Pathogens Branch, Div High Consequence Pathogens & Pathol, Atlanta, GA 30333 USA.	ccs8@cdc.gov						Adhikari Prabha M R, 1993, Indian J Med Sci, V47, P124; Alzahrani AG, 2010, EMERG INFECT DIS, V16, P1882, DOI 10.3201/eid1612.100417; Carletti F, 2010, EMERG INFECT DIS, V16, P1979, DOI 10.3201/eid1612.101092; Charrel RN, 2007, EMERG INFECT DIS, V13, P153, DOI 10.3201/eid1301.061094; Dodd KA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001352; Holbrook MR, 2005, J INFECT DIS, V191, P100, DOI 10.1086/426397; Kamphuis E, 2006, BLOOD, V108, P3253, DOI 10.1182/blood-2006-06-027599; Kasabi GS, 2013, EMERG INFECT DIS, V19, P278, DOI 10.3201/eid1902.120544; Kimura T, 2010, VET PATHOL, V47, P806, DOI 10.1177/0300985810372507; Madani TA, 2005, J INFECTION, V51, P91, DOI 10.1016/j.jinf.2004.11.012; Madani TA, 2011, J INFECTION, V62, P67, DOI 10.1016/j.jinf.2010.09.032; Mahdi M, 2011, EMERG INFECT DIS, V17, P945, DOI 10.3201/eid1705.101824; Memish ZA, 2005, BRIT J BIOMED SCI, V62, P37, DOI 10.1080/09674845.2005.11978070; Memish ZA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001604; Memish ZA, 2010, INT J ANTIMICROB AG, V36, pS53, DOI 10.1016/j.ijantimicag.2010.06.022; Munoz-Jordan JL, 2010, VIRUSES-BASEL, V2, P676, DOI 10.3390/v2020676; Pattnaik P, 2006, REV MED VIROL, V16, P151, DOI 10.1002/rmv.495; PAVRI K, 1989, REV INFECT DIS, V11, pS854; Tigabu B, 2010, VIROLOGY, V408, P57, DOI 10.1016/j.virol.2010.08.021; Zaki AM, 1997, T ROY SOC TROP MED H, V91, P179, DOI 10.1016/S0035-9203(97)90215-7; Zivcec M, 2013, PATHOGENS, V2, P402, DOI 10.3390/pathogens2020402	21	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100301	10.1371/journal.pone.0100301	http://dx.doi.org/10.1371/journal.pone.0100301			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950196	gold, Green Published, Green Submitted			2022-12-27	WOS:000338276300061
J	Regterschot, GRH; Van Heuvelen, MJG; Zeinstra, EB; Fuermaier, ABM; Tucha, L; Koerts, J; Tucha, O; Van der Zee, EA				Regterschot, G. Ruben H.; Van Heuvelen, Marieke J. G.; Zeinstra, Edzard B.; Fuermaier, Anselm B. M.; Tucha, Lara; Koerts, Janneke; Tucha, Oliver; Van der Zee, Eddy A.			Whole Body Vibration Improves Cognition in Healthy Young Adults	PLOS ONE			English	Article							EXERCISE; INTERFERENCE; ACTIVATION	This study investigated the acute effects of passive whole body vibration (WBV) on executive functions in healthy young adults. Participants (112 females, 21 males; age: 20.5 +/- 2.2 years) underwent six passive WBV sessions (frequency 30 Hz, amplitude approximately 0.5 mm) and six non-vibration control sessions of two minutes each while sitting on a chair mounted on a vibrating platform. A passive WBV session was alternated with a control session. Directly after each session, performance on the Stroop Color-Block Test (CBT), Stroop Color-Word Interference Test (CWIT), Stroop Difference Score (SDS) and Digit Span Backward task (DSBT) was measured. In half of the passive WBV and control sessions the test order was CBT-CWIT-DSBT, and DSBT-CBT-CWIT in the other half. Passive WBV improved CWIT (p = 0.009; effect size r = 0.20) and SDS (p = 0.034; r = 0.16) performance, but only when the CBT and CWIT preceded the DSBT. CBT and DSBT performance did not change. This study shows that two minutes passive WBV has positive acute effects on attention and inhibition in young adults, notwithstanding their high cognitive functioning which could have hampered improvement. This finding indicates the potential of passive WBV as a cognition-enhancing therapy worth further evaluation, especially in persons unable to perform active forms of exercise.	[Regterschot, G. Ruben H.; Van Heuvelen, Marieke J. G.; Zeinstra, Edzard B.] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands; [Fuermaier, Anselm B. M.; Tucha, Lara; Koerts, Janneke; Tucha, Oliver] Univ Groningen, Dept Clin & Dev Neuropsychol, Groningen, Netherlands; [Zeinstra, Edzard B.; Van der Zee, Eddy A.] Univ Groningen, Dept Mol Neurobiol, Ctr Behav & Neurosci, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Regterschot, GRH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands.	g.r.h.regterschot@umcg.nl	Tucha, Oliver/AAD-1403-2019; Meijer, Anna/K-5118-2016; van der Zee, Eddy/AAZ-2120-2020	Fuermaier, Anselm/0000-0002-2331-0840				Braak H, 1996, J CHILD NEUROL, V11, P265, DOI 10.1177/088307389601100402; Cardinale M, 2003, J STRENGTH COND RES, V17, P621; Cardinale M, 2003, EXERC SPORT SCI REV, V31, P3, DOI 10.1097/00003677-200301000-00002; Chan RCK, 2008, ARCH CLIN NEUROPSYCH, V23, P201, DOI 10.1016/j.acn.2007.08.010; Cochrane DI, 2008, ARCH PHYS MED REHAB, V89, P815, DOI 10.1016/j.apmr.2007.09.055; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; DYKES RW, 1983, BRAIN RES REV, V6, P47, DOI 10.1016/0165-0173(83)90004-8; Field A, 2013, DISCOVERING STAT USI; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; JOHANSSON RS, 1983, TRENDS NEUROSCI, V6, P27, DOI 10.1016/0166-2236(83)90011-5; Kang DK, 2000, MOL CELLS, V10, P546, DOI 10.1007/s100590000010; Kolb B., 2003, FUNDAMENTALS HUMAN N; Kramer AF, 2006, J APPL PHYSIOL, V101, P1237, DOI 10.1152/japplphysiol.00500.2006; Lahr MMH, 2009, 8 DUTCH END, P170; Martin JH., 2003, NEUROANATOMY TEXT AT; Rittweger J, 2001, EUR J APPL PHYSIOL, V86, P169, DOI 10.1007/s004210100511; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; TALBOT WH, 1968, J NEUROPHYSIOL, V31, P301, DOI 10.1152/jn.1968.31.2.301; Timmer M, 2006, FED EUR NEUROSCI SOC, V3; Tischmeyer W, 1999, CELL MOL LIFE SCI, V55, P564, DOI 10.1007/s000180050315; Uttl B, 1997, J CLIN EXP NEUROPSYC, V19, P405, DOI 10.1080/01688639708403869; Van der Zee EA, 2010, FED EUR NEUR SOC ABS, V5; Wechsler D, 1987, WMS R WECHSLER MEMOR; Zysset S, 2001, NEUROIMAGE, V13, P29, DOI 10.1006/nimg.2000.0665	25	38	40	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100506	10.1371/journal.pone.0100506	http://dx.doi.org/10.1371/journal.pone.0100506			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949870	gold, Green Published, Green Submitted			2022-12-27	WOS:000338276300082
J	Garcia, TI; Matos, I; Shen, YJ; Pabuwal, V; Coelho, MM; Wakamatsu, Y; Schartl, M; Walter, RB				Garcia, Tzintzuni I.; Matos, Isa; Shen, Yingjia; Pabuwal, Vagmita; Coelho, Maria Manuela; Wakamatsu, Yuko; Schartl, Manfred; Walter, Ronald B.			Novel Method for Analysis of Allele Specific Expression in Triploid Oryzias latipes Reveals Consistent Pattern of Allele Exclusion	PLOS ONE			English	Article							COPY-NUMBER ALTERATION; RNA-SEQ DATA; GENE-EXPRESSION; SQUALIUS-ALBURNOIDES; VARIANT DETECTION; MEDAKA; GENOME; TRANSPLANTATION; GENERATION; EVOLUTION	Assessing allele-specific gene expression (ASE) on a large scale continues to be a technically challenging problem. Certain biological phenomena, such as X chromosome inactivation and parental imprinting, affect ASE most drastically by completely shutting down the expression of a whole set of alleles. Other more subtle effects on ASE are likely to be much more complex and dependent on the genetic environment and are perhaps more important to understand since they may be responsible for a significant amount of biological diversity. Tools to assess ASE in a diploid biological system are becoming more reliable. Non-diploid systems are, however, not uncommon. In humans full or partial polyploid states are regularly found in both healthy (meiotic cells, polynucleated cell types) and diseased tissues (trisomies, non-disjunction events, cancerous tissues). In this work we have studied ASE in the medaka fish model system. We have developed a method for determining ASE in polyploid organisms from RNAseq data and we have implemented this method in a software tool set. As a biological model system we have used nuclear transplantation to experimentally produce artificial triploid medaka composed of three different haplomes. We measured ASE in RNA isolated from the livers of two adult, triploid medaka fish that showed a high degree of similarity. The majority of genes examined (82%) shared expression more or less evenly among the three alleles in both triploids. The rest of the genes (18%) displayed a wide range of ASE levels. Interestingly the majority of genes (78%) displayed generally consistent ASE levels in both triploid individuals. A large contingent of these genes had the same allele entirely suppressed in both triploids. When viewed in a chromosomal context, it is revealed that these genes are from large sections of 4 chromosomes and may be indicative of some broad scale suppression of gene expression.	[Garcia, Tzintzuni I.; Shen, Yingjia; Pabuwal, Vagmita; Walter, Ronald B.] Texas State Univ, Dept Chem & Biochem, Mol Biosci Res Grp, San Marcos, TX 78666 USA; [Matos, Isa; Wakamatsu, Yuko; Schartl, Manfred] Univ Wurzburg, Biozentrum, D-97070 Wurzburg, Germany; [Matos, Isa; Coelho, Maria Manuela] Univ Lisbon, Fac Ciencias, Ctr Biol Ambiental, Lisbon, Portugal; [Schartl, Manfred] Univ Clin Wurzburg, Ctr Comprehens Canc, Wurzburg, Germany	Texas State University System; Texas State University San Marcos; University of Wurzburg; Universidade de Lisboa; University of Wurzburg	Walter, RB (corresponding author), Texas State Univ, Dept Chem & Biochem, Mol Biosci Res Grp, San Marcos, TX 78666 USA.	RWalter@txstate.edu	Walter, Ronald/AAI-5522-2020; Coelho, Maria M/B-8672-2009	Coelho, Maria M/0000-0003-3288-1693; Schartl, Manfred/0000-0001-9882-5948	NIH, ORIP, Division of Comparative Medicine [R24-OD-011120, R24-OD-011199]; Graduate Training programme 1048 of the Deutsche Forschungsgemeinschaft; International Graduate School for Life Sciences of the University of Wurzburg; Fundacao para a Ciencia e Tecnologia PhD grant [SFRH/BD/61217/2009]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD011120] Funding Source: NIH RePORTER	NIH, ORIP, Division of Comparative Medicine; Graduate Training programme 1048 of the Deutsche Forschungsgemeinschaft; International Graduate School for Life Sciences of the University of Wurzburg; Fundacao para a Ciencia e Tecnologia PhD grant; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding was provided partly by the NIH, ORIP, Division of Comparative Medicine (http://dpcpsi.nih.gov/orip/CM/index) grants R24-OD-011120 and R24-OD-011199. IM was supported by the Graduate Training programme 1048 of the Deutsche Forschungsgemeinschaft (http://www.dfg.de), and by the International Graduate School for Life Sciences of the University of Wurzburg (http://www.graduateschools.uni-wuerzburg.de/life_sciences). Support was also provided by the Fundacao para a Ciencia e Tecnologia PhD grant SFRH/BD/61217/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2003, P NATL ACAD SCI USA, V100, P4649, DOI 10.1073/pnas.0630618100; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bubenshchikova E, 2005, CLONING STEM CELLS, V7, P255, DOI 10.1089/clo.2005.7.255; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Doyle JJ, 2008, ANNU REV GENET, V42, P443, DOI 10.1146/annurev.genet.42.110807.091524; Hyodo-Taguchi Y., 1996, FISH BIOL J MEDAKA, V8, P11; Inacio A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041158; IWAMATSU T, 1983, J EXP ZOOL, V228, P83, DOI 10.1002/jez.1402280109; Johnson NA, 2000, J THEOR BIOL, V205, P527, DOI 10.1006/jtbi.2000.2070; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Levine M, 2002, NATURE, V415, P848, DOI 10.1038/415848a; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Madlung A, 2012, POLYPLOIDY ITS EFFEC; Matos I, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-101; MCFADDEN DE, 1993, HUM GENET, V92, P465, DOI 10.1007/BF00216452; Meynert AM, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-195; Mochida K, 2004, MOL GENET GENOMICS, V270, P371, DOI 10.1007/s00438-003-0939-7; Nanda I, 2003, GENETICS, V163, P245; Niwa K, 1999, DEV GROWTH DIFFER, V41, P163; Pala I, 2008, CURR BIOL, V18, P1344, DOI 10.1016/j.cub.2008.07.096; Pala I, 2010, P ROY SOC B-BIOL SCI, V277, P3519, DOI 10.1098/rspb.2010.1071; Rapp RA, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-18; Sakaizumi M., 1987, Korean Journal of Limnology, V20, P13; Santini F, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-194; Skelly DA, 2011, GENOME RES, V21, P1728, DOI 10.1101/gr.119784.110; Stevenson KR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-536; Tang FC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021208; Wakamatsu Yuko, 1993, Molecular Marine Biology and Biotechnology, V2, P325; Yoo MJ, 2013, HEREDITY, V110, P171, DOI 10.1038/hdy.2012.94; Zhai RR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060668	33	7	7	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100250	10.1371/journal.pone.0100250	http://dx.doi.org/10.1371/journal.pone.0100250			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945156	Green Submitted, Green Published, gold			2022-12-27	WOS:000340721500053
J	May, SL; Zhou, Q; Lewellen, M; Carter, CM; Coffey, D; Highfill, SL; Bucher, CM; Matise, I; Morse, HC; O'Sullivan, MG; Schutten, M; Johnson, C; Bellgrau, D; Blazar, BR; Modiano, JF				May, Sarah L.; Zhou, Qing; Lewellen, Mitzi; Carter, Cristan M.; Coffey, David; Highfill, Steven L.; Bucher, Christoph M.; Matise, Ilze; Morse, Herbert C., III; O'Sullivan, M. Gerard; Schutten, Melissa; Johnson, Charles; Bellgrau, Donald; Blazar, Bruce R.; Modiano, Jaime F.			Nfatc2 and Tob1 Have Non-Overlapping Function in T Cell Negative Regulation and Tumorigenesis	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; NUCLEAR FACTOR; CYCLOSPORINE-A; MICE; ACTIVATION; FOXP3; TOLERANCE; NEOPLASMS; PARTNERS; CANCER	Nfatc2 and Tob1 are intrinsic negative regulators of T cell activation. Nfatc2-deficient and Tob1-deficient T cells show reduced thresholds of activation; however, whether these factors have independent or overlapping roles in negative regulation of T cell responses has not been previously examined. Here, we show that Nfatc2 knockout (KO) but not Tob1 KO mice have age-associated accumulation of persistently activated T cells in vivo and expansion of the CD44(+) memory cell compartment and age-associated lymphocytic infiltrates in visceral organs, without significant changes in numbers of CD4(+)CD25(+)Foxp3(+) regulatory T cells (Treg). In vitro, CD4(+)CD25(-) "conventional'' T cells (Tconvs) from both KO strains showed greater proliferation than wild type (WT) Tconvs. However, while Tregs from Nfatc2 KO mice retained normal suppressive function, Tregs from Tob1 KOs had enhanced suppressive activity. Nfatc2 KO Tconvs expanded somewhat more rapidly than WT Tconvs under conditions of homeostatic proliferation, but their accelerated growth capacity was negated, at least acutely, in a lymphoreplete environment. Finally, Nfatc2 KO mice developed a previously uncharacterized increase in B-cell malignancies, which was not accelerated by the absence of Tob1. The data thus support the prevailing hypothesis that Nfatc2 and Tob1 are non-redundant regulators of lymphocyte homeostasis.	[May, Sarah L.; Zhou, Qing; Lewellen, Mitzi; Highfill, Steven L.; Bucher, Christoph M.; Matise, Ilze; O'Sullivan, M. Gerard; Schutten, Melissa; Johnson, Charles; Blazar, Bruce R.; Modiano, Jaime F.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA; [May, Sarah L.; Lewellen, Mitzi; Modiano, Jaime F.] Univ Minnesota, Coll Vet Med, Dept Vet Clin Sci, St Paul, MN 55108 USA; [Zhou, Qing; Highfill, Steven L.; Bucher, Christoph M.; Blazar, Bruce R.] Univ Minnesota, Sch Med, Dept Pediat, Minneapolis, MN 55455 USA; [Carter, Cristan M.; Coffey, David; Bellgrau, Donald; Modiano, Jaime F.] Univ Colorado, Sch Med, Integrated Dept Immunol, Denver, CO USA; [Carter, Cristan M.; Coffey, David; Bellgrau, Donald; Modiano, Jaime F.] Univ Colorado, Ctr Canc, Aurora, CO USA; [Matise, Ilze; O'Sullivan, M. Gerard; Schutten, Melissa; Johnson, Charles] Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA; [Morse, Herbert C., III] NIAID, NIH, Rockville, MD USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Modiano, JF (corresponding author), Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA.	modiano@umn.edu	bucher, christoph/A-2520-2008; MODIANO, JAIME/K-3583-2019; Bucher, Christoph/AAQ-5650-2021	MODIANO, JAIME/0000-0001-6398-7648; Bucher, Christoph/0000-0003-0902-2874; Morse, Herbert/0000-0002-9331-3705; Coffey, David G./0000-0003-3544-8836	National Institute of Diabetes and Digestive and Kidney Diseases [R21DK63410]; National Institutes of Health National Heart Lung and Blood Institute [R01HL56067]; National Institutes of Health National Cancer Institute [R01CA72669, P01CA065493, P30CA077598]; National Institutes of Health National Institute of Allergy and Infectious Diseases [R01AI081918]; National Institutes of Health (Cancer Center Support Grant, Masonic Cancer Center, University of Minnesota, Douglas Yee) Intramural Research Program of the National Institutes of Health; National Institute of Allergy and Infectious Diseases University of Minnesota Animal Cancer Care and Research Program Alvin S. and June Perlman Chair in Animal Oncology at the University of Minnesota; NATIONAL CANCER INSTITUTE [P30CA077598, R01CA072669, P01CA142106, P01CA065493] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118979, R01HL056067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK063410] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health (Cancer Center Support Grant, Masonic Cancer Center, University of Minnesota, Douglas Yee) Intramural Research Program of the National Institutes of Health; National Institute of Allergy and Infectious Diseases University of Minnesota Animal Cancer Care and Research Program Alvin S. and June Perlman Chair in Animal Oncology at the University of Minnesota; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	R21DK63410 National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health (JFM DB) R01HL56067 National Heart Lung and Blood Institute, National Institutes of Health (BRB) R01CA72669 National Cancer Institute, National Institutes of Health (BRB) R01AI081918 National Institute of Allergy and Infectious Diseases, National Institutes of Health (BRB) P01CA065493 National Cancer Institute, National Institutes of Health (BRB) P30CA077598 National Cancer Institute, National Institutes of Health (Cancer Center Support Grant, Masonic Cancer Center, University of Minnesota, Douglas Yee) Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Diseases (HRM) University of Minnesota Animal Cancer Care and Research Program (JFM) Alvin S. and June Perlman Chair in Animal Oncology at the University of Minnesota (JFM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe BT, 2012, CANCER RES, V72, P4642, DOI 10.1158/0008-5472.CAN-11-3775; Baine I, 2009, IMMUNOL REV, V231, P225, DOI 10.1111/j.1600-065X.2009.00817.x; Baksh S, 2002, MOL CELL, V10, P1071, DOI 10.1016/S1097-2765(02)00701-3; Bocian K, 2010, NEPHROL DIAL TRANSPL, V25, P710, DOI 10.1093/ndt/gfp586; Bopp T, 2005, J EXP MED, V201, P181, DOI 10.1084/jem.20041538; Davidson WF, 1998, J EXP MED, V187, P1825, DOI 10.1084/jem.187.11.1825; Fehr T, 2010, BLOOD, V115, P1280, DOI 10.1182/blood-2009-07-230680; Fisher SG, 2006, CURR OPIN ONCOL, V18, P417, DOI 10.1097/01.cco.0000239878.31463.0b; Frazer-Abel AA, 2004, J PHARMACOL EXP THER, V311, P758, DOI 10.1124/jpet.104.070060; Gerlach K, 2012, CANCER RES, V72, P4340, DOI 10.1158/0008-5472.CAN-11-4155; Ghosh S, 2010, P NATL ACAD SCI USA, V107, P15169, DOI 10.1073/pnas.1009193107; Hu H, 2007, TRENDS IMMUNOL, V28, P329, DOI 10.1016/j.it.2007.06.006; Jia SJ, 2007, DEV DYNAM, V236, P913, DOI 10.1002/dvdy.21092; Jubala C, 2009, CANCER IMMUNOL IMMUN, V58, P171, DOI 10.1007/s00262-008-0535-0; Karwot R, 2008, J ALLERGY CLIN IMMUN, V121, P992, DOI 10.1016/j.jaci.2007.12.1172; Karwot R, 2012, IMMUNOBIOLOGY, V217, P905, DOI 10.1016/j.imbio.2012.01.004; Kiani A, 2000, IMMUNITY, V12, P359, DOI 10.1016/S1074-7613(00)80188-0; Kondo E, 2003, EUR J IMMUNOL, V33, P1, DOI 10.1002/immu.200390000; Lim DG, 2010, TRANSPLANTATION, V89, P928, DOI 10.1097/TP.0b013e3181d3c9d4; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; Meloni F, 2006, INT IMMUNOPHARMACOL, V6, P2002, DOI 10.1016/j.intimp.2006.07.019; Miroux C, 2009, TRANSPL P, V41, P3371, DOI 10.1016/j.transproceed.2009.08.043; Miroux C, 2012, TRANSPLANTATION, V94, P123, DOI 10.1097/TP.0b013e3182590d8f; Modiano JF, 2008, IMMUNOL RES, V41, P137, DOI 10.1007/s12026-008-8017-1; Morse HC, 2002, BLOOD, V100, P246, DOI 10.1182/blood.V100.1.246; Muller MR, 2010, NAT REV IMMUNOL, V10, P645, DOI 10.1038/nri2818; Qi CF, 2007, CANCER RES, V67, P2439, DOI 10.1158/0008-5472.CAN-06-1561; Ranger AM, 2000, J EXP MED, V191, P9, DOI 10.1084/jem.191.1.9; Robbs BK, 2008, MOL CELL BIOL, V28, P7168, DOI 10.1128/MCB.00256-08; Schulze-Topphoff U, 2013, J EXP MED, V210, P1301, DOI 10.1084/jem.20121611; Sundrud MS, 2007, CURR OPIN IMMUNOL, V19, P287, DOI 10.1016/j.coi.2007.04.014; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549; Tzachanis D, 2001, NAT IMMUNOL, V2, P1174, DOI 10.1038/ni730; Vaeth M, 2012, P NATL ACAD SCI USA, V109, P16258, DOI 10.1073/pnas.1203870109; Weigmann B, 2008, J EXP MED, V205, P2099, DOI 10.1084/jem.20072484; Werneck MBF, 2011, CANCER IMMUNOL IMMUN, V60, P537, DOI 10.1007/s00262-010-0964-4; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Xanthoudakis S, 1996, SCIENCE, V272, P892, DOI 10.1126/science.272.5263.892; Xiao X, 2008, J IMMUNOL, V181, P3193, DOI 10.4049/jimmunol.181.5.3193; Yamashiro H, 2002, BIOCHEM BIOPH RES CO, V299, P148, DOI 10.1016/S0006-291X(02)02586-X; Yang J, 2007, P NATL ACAD SCI USA, V104, P19954, DOI 10.1073/pnas.0704397104; Yoshida Y, 2000, CELL, V103, P1085, DOI 10.1016/S0092-8674(00)00211-7; Zeiser R, 2006, BLOOD, V108, P390, DOI 10.1182/blood-2006-01-0329; Zhang JQ, 2004, J EXP MED, V200, P1467, DOI 10.1084/jem.20041575	44	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100629	10.1371/journal.pone.0100629	http://dx.doi.org/10.1371/journal.pone.0100629			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945807	Green Published, gold, Green Submitted			2022-12-27	WOS:000340721500099
J	Xu, W; Zhu, X; Tan, TT; Li, WZ; Shan, AS				Xu, Wei; Zhu, Xin; Tan, Tingting; Li, Weizhong; Shan, Anshan			Design of Embedded-Hybrid Antimicrobial Peptides with Enhanced Cell Selectivity and Anti-Biofilm Activity	PLOS ONE			English	Article							ACINETOBACTER-BAUMANNII; ANTIBACTERIAL PEPTIDE; BIOLOGICAL-ACTIVITY; MOLECULAR-BASIS; PORE FORMATION; MEMBRANE; MECHANISMS; CECROPIN; DEFENSE; CHARGE	Antimicrobial peptides have attracted considerable attention because of their broad-spectrum antimicrobial activity and their low prognostic to induce antibiotic resistance which is the most common source of failure in bacterial infection treatment along with biofilms. The method to design hybrid peptide integrating different functional domains of peptides has many advantages. In this study, we designed an embedded-hybrid peptide R-FV-I16 by replacing a functional defective sequence RR7 with the anti-biofilm sequence FV7 embedded in the middle position of peptide RI16. The results demonstrated that the synthetic hybrid the peptide R-FV-I16 had potent antimicrobial activity over a wide range of Gram-negative and Gram-positive bacteria, as well as anti-biofilm activity. More importantly, R-FV-I16 showed lower hemolytic activity and cytotoxicity. Fluorescent assays demonstrated that R-FV-I16 depolarized the outer and the inner bacterial membranes, while scanning electron microscopy and transmission electron microscopy further indicated that this peptide killed bacterial cells by disrupting the cell membrane, thereby damaging membrane integrity. Results from SEM also provided evidence that R-FV-I16 inherited anti-biofilm activity from the functional peptide sequence FV7. Embedded-hybrid peptides could provide a new pattern for combining different functional domains and showing an effective avenue to screen for novel antimicrobial agents.	[Xu, Wei; Zhu, Xin; Tan, Tingting; Li, Weizhong; Shan, Anshan] Northeast Agr Univ, Inst Anim Nutr, Lab Mol Nutr & Immun, Harbin, Heilongjiang, Peoples R China	Northeast Agricultural University - China	Shan, AS (corresponding author), Northeast Agr Univ, Inst Anim Nutr, Lab Mol Nutr & Immun, Harbin, Heilongjiang, Peoples R China.	asshan@neau.edu.cn	Shan, Anshan/U-9119-2019	Xu, Wei/0000-0002-6370-7930	National Basic Research Program [2012CB124703]; National Natural Research Foundation of China [31272453]; Program for Innovative Research Team of Universities in Heilongjiang Province	National Basic Research Program(National Basic Research Program of China); National Natural Research Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Innovative Research Team of Universities in Heilongjiang Province	This study was supported by the National Basic Research Program (Grant No. 2012CB124703), the National Natural Research Foundation of China (Grant No. 31272453), and the Program for Innovative Research Team of Universities in Heilongjiang Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aquila M, 2013, CELL CALCIUM, V53, P180, DOI 10.1016/j.ceca.2012.11.012; Banin E, 2005, P NATL ACAD SCI USA, V102, P11076, DOI 10.1073/pnas.0504266102; Brogden KA, 2003, INT J ANTIMICROB AG, V22, P465, DOI 10.1016/S0924-8579(03)00180-8; Brown KL, 2006, CURR OPIN IMMUNOL, V18, P24, DOI 10.1016/j.coi.2005.11.004; Dashper SG, 2005, ANTIMICROB AGENTS CH, V49, P2322, DOI 10.1128/AAC.49.6.2322-2328.2005; Dathe M, 1999, BBA-BIOMEMBRANES, V1462, P71, DOI 10.1016/S0005-2736(99)00201-1; de la Fuente-Nunez C, 2012, ANTIMICROB AGENTS CH, V56, P2696, DOI 10.1128/AAC.00064-12; Epand RM, 1999, BBA-BIOMEMBRANES, V1462, P11, DOI 10.1016/S0005-2736(99)00198-4; Fox MA, 2012, PEPTIDES, V33, P197, DOI 10.1016/j.peptides.2012.01.013; Gotz F, 2004, CURR OPIN MICROBIOL, V7, P477, DOI 10.1016/j.mib.2004.08.014; Hamley IW, 2011, SOFT MATTER, V7, P4122, DOI 10.1039/c0sm01218a; Hancock RD, 2001, COORDIN CHEM REV, V212, P1, DOI 10.1016/S0010-8545(00)00418-5; Hauser CAE, 2011, P NATL ACAD SCI USA, V108, P1361, DOI 10.1073/pnas.1014796108; Hawrani A, 2008, J BIOL CHEM, V283, P18636, DOI 10.1074/jbc.M709154200; Huang JF, 2011, PEPTIDES, V32, P1488, DOI 10.1016/j.peptides.2011.05.023; HUGHES DE, 1962, J GEN MICROBIOL, V29, P39, DOI 10.1099/00221287-29-1-39; Jiang ZQ, 2008, BIOPOLYMERS, V90, P369, DOI 10.1002/bip.20911; Jiang ZQ, 2011, CHEM BIOL DRUG DES, V77, P225, DOI 10.1111/j.1747-0285.2011.01086.x; Jin XB, 2010, ACTA BIOCH BIOPH SIN, V42, P259, DOI 10.1093/abbs/gmq021; Jin Y, 2005, ANTIMICROB AGENTS CH, V49, P4957, DOI 10.1128/AAC.49.12.4957-4964.2005; KATSU T, 1989, BIOCHIM BIOPHYS ACTA, V983, P135, DOI 10.1016/0005-2736(89)90226-5; Khew ST, 2008, BIOMATERIALS, V29, P3034, DOI 10.1016/j.biomaterials.2008.03.023; Laverty G, 2011, INT J MOL SCI, V12, P6566, DOI 10.3390/ijms12106566; Lee JK, 2013, BBA-BIOMEMBRANES, V1828, P443, DOI 10.1016/j.bbamem.2012.09.005; Liu LH, 2009, NAT NANOTECHNOL, V4, P457, DOI [10.1038/NNANO.2009.153, 10.1038/nnano.2009.153]; Liu LP, 1998, J BIOL CHEM, V273, P23645, DOI 10.1074/jbc.273.37.23645; Liu YF, 2013, BIOMATERIALS, V34, P237, DOI 10.1016/j.biomaterials.2012.09.032; LOH B, 1984, ANTIMICROB AGENTS CH, V26, P546, DOI 10.1128/AAC.26.4.546; Lopez D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000398; Lv YF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0115448, 10.1371/journal.pone.0086364]; Maisetta G, 2008, PEPTIDES, V29, P1, DOI 10.1016/j.peptides.2007.10.013; Marr AK, 2006, CURR OPIN PHARMACOL, V6, P468, DOI 10.1016/j.coph.2006.04.006; MATSUZAKI K, 1995, BIOCHEMISTRY-US, V34, P3423, DOI 10.1021/bi00010a034; Matsuzaki K, 1999, BBA-BIOMEMBRANES, V1462, P1, DOI 10.1016/S0005-2736(99)00197-2; Mihajlovic M, 2012, BBA-BIOMEMBRANES, V1818, P1274, DOI 10.1016/j.bbamem.2012.01.016; Mulet X, 2011, ANTIMICROB AGENTS CH, V55, P4560, DOI 10.1128/AAC.00519-11; Overhage J, 2008, INFECT IMMUN, V76, P4176, DOI 10.1128/IAI.00318-08; Pitts B, 2003, J MICROBIOL METH, V54, P269, DOI 10.1016/S0167-7012(03)00034-4; Saising J, 2012, ANTIMICROB AGENTS CH, V56, P5804, DOI 10.1128/AAC.01296-12; Saugar JM, 2006, ANTIMICROB AGENTS CH, V50, P1251, DOI 10.1128/AAC.50.4.1251-1256.2006; Schmidtchen A, 2014, ADV COLLOID INTERFAC, V205, P265, DOI 10.1016/j.cis.2013.06.009; Scocchi M, 2005, FEBS J, V272, P4398, DOI 10.1111/j.1742-4658.2005.04852.x; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Shai Y, 2002, CURR PHARM DESIGN, V8, P715, DOI 10.2174/1381612023395367; Stark M, 2002, ANTIMICROB AGENTS CH, V46, P3585, DOI 10.1128/AAC.46.11.3585-3590.2002; Steinberg DA, 1997, ANTIMICROB AGENTS CH, V41, P1738, DOI 10.1128/AAC.41.8.1738; STORICI P, 1994, FEBS LETT, V337, P303, DOI 10.1016/0014-5793(94)80214-9; Takahashi D, 2010, BIOCHIMIE, V92, P1236, DOI 10.1016/j.biochi.2010.02.023; Teixeira V, 2012, PROG LIPID RES, V51, P149, DOI 10.1016/j.plipres.2011.12.005; Wang KR, 2008, PEPTIDES, V29, P963, DOI 10.1016/j.peptides.2008.01.015; Weiner JH, 1999, BACTERIAL CYTOPLASMI; Wiradharma N, 2008, ADV FUNCT MATER, V18, P943, DOI 10.1002/adfm.200700884; WU CSC, 1981, BIOCHEMISTRY-US, V20, P566, DOI 10.1021/bi00506a019; Wu MH, 1999, BIOCHEMISTRY-US, V38, P7235, DOI 10.1021/bi9826299; Xue R, 2008, BBA-BIOMEMBRANES, V1778, P1444, DOI 10.1016/j.bbamem.2008.02.005; Yang L, 2001, BIOPHYS J, V81, P1475, DOI 10.1016/S0006-3495(01)75802-X; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhao XB, 2010, CHEM SOC REV, V39, P3480, DOI 10.1039/b915923c; Zhu X, 2014, ACTA BIOMATER, V10, P244, DOI 10.1016/j.actbio.2013.08.043	60	62	65	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e98935	10.1371/journal.pone.0098935	http://dx.doi.org/10.1371/journal.pone.0098935			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945359	Green Published, gold, Green Submitted			2022-12-27	WOS:000340721500009
J	Enns, GM; Moore, T; Le, A; Atkuri, K; Shah, MK; Cusmano-Ozog, K; Niemi, AK; Cowan, TM				Enns, Gregory M.; Moore, Tereza; Le, Anthony; Atkuri, Kondala; Shah, Monisha K.; Cusmano-Ozog, Kristina; Niemi, Anna-Kaisa; Cowan, Tina M.			Degree of Glutathione Deficiency and Redox Imbalance Depend on Subtype of Mitochondrial Disease and Clinical Status	PLOS ONE			English	Article							OXIDATIVE STRESS; OXIDIZED GLUTATHIONE; CHAIN DISORDERS; PROGRESSION; SUPEROXIDE; METABOLISM; APOPTOSIS; BLOOD; CELL; DNA	Mitochondrial disorders are associated with decreased energy production and redox imbalance. Glutathione plays a central role in redox signaling and protecting cells from oxidative damage. In order to understand the consequences of mitochondrial dysfunction on in vivo redox status, and to determine how this varies by mitochondrial disease subtype and clinical severity, we used a sensitive tandem mass spectrometry assay to precisely quantify whole blood reduced (GSH) and oxidized (GSSG) glutathione levels in a large cohort of mitochondrial disorder patients. Glutathione redox potential was calculated using the Nernst equation. Compared to healthy controls (n = 59), mitochondrial disease patients (n = 58) as a group showed significant redox imbalance (redox potential -251 mV +/- 9.7, p<0.0001) with an increased level of oxidation by similar to 9 mV compared to controls (-260 mV +/- 6.4). Underlying this abnormality were significantly lower whole blood GSH levels (p = 0.0008) and GSH/GSSG ratio (p = 0.0002), and significantly higher GSSG levels (p<0.0001) in mitochondrial disease patients compared to controls. Redox potential was significantly more oxidized in all mitochondrial disease subgroups including Leigh syndrome (n = 15), electron transport chain abnormalities (n = 10), mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (n = 8), mtDNA deletion syndrome (n = 7), mtDNA depletion syndrome (n = 7), and miscellaneous other mitochondrial disorders (n = 11). Patients hospitalized in metabolic crisis (n = 7) showed the greatest degree of redox imbalance at -242 mV +/- 7. Peripheral whole blood GSH and GSSG levels are promising biomarkers of mitochondrial dysfunction, and may give insights into the contribution of oxidative stress to the pathophysiology of the various mitochondrial disorders. In particular, evaluation of redox potential may be useful in monitoring of clinical status or response to redox-modulating therapies in clinical trials.	[Enns, Gregory M.; Shah, Monisha K.; Cusmano-Ozog, Kristina; Niemi, Anna-Kaisa] Stanford Univ, Lucile Packard Childrens Hosp, Div Med Genet, Dept Pediat, Stanford, CA 94305 USA; [Moore, Tereza; Le, Anthony; Cowan, Tina M.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Atkuri, Kondala] Stanford Univ, Dept Genet, Stanford, CA 94305 USA	Lucile Packard Children's Hospital (LPCH); Stanford University; Stanford University; Stanford University	Enns, GM (corresponding author), Stanford Univ, Lucile Packard Childrens Hosp, Div Med Genet, Dept Pediat, Stanford, CA 94305 USA.	greg.enns@stanford.edu		cusmano, kristina/0000-0002-0346-6864	Stanford NIH/NCRR CTSA award [UL1 RR025744]; Lucile Packard Foundation for Children's Health; United Mitochondrial Disease foundation; Help Mito Kids and Edison Pharmaceuticals, Inc.; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001085] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025744] Funding Source: NIH RePORTER	Stanford NIH/NCRR CTSA award; Lucile Packard Foundation for Children's Health; United Mitochondrial Disease foundation; Help Mito Kids and Edison Pharmaceuticals, Inc.; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The project described in this publication was supported by the Stanford NIH/NCRR CTSA award number UL1 RR025744 and by the Lucile Packard Foundation for Children's Health. Michael and Ellen Michelson, Bobbie and Mike Wilsey, the United Mitochondrial Disease foundation, Help Mito Kids and Edison Pharmaceuticals, Inc. provided additional support for this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari MA, 2010, J NEUROPATH EXP NEUR, V69, P155, DOI 10.1097/NEN.0b013e3181cb5af4; Atkuri KR, 2009, P NATL ACAD SCI USA, V106, P3941, DOI 10.1073/pnas.0813409106; Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00; BUTTKE TM, 1994, IMMUNOL TODAY, V15, P7, DOI 10.1016/0167-5699(94)90018-3; Cadenas Enrique, 2004, Molecular Aspects of Medicine, V25, P17, DOI 10.1016/j.mam.2004.02.005; Cai JY, 1998, J BIOL CHEM, V273, P11401, DOI 10.1074/jbc.273.19.11401; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Circu ML, 2012, BBA-MOL CELL RES, V1823, P1767, DOI 10.1016/j.bbamcr.2012.06.019; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Ellerby LM, 1996, J NEUROCHEM, V67, P1259; Esposito LA, 1999, P NATL ACAD SCI USA, V96, P4820, DOI 10.1073/pnas.96.9.4820; Forman HJ, 2003, BIOFACTORS, V17, P1, DOI 10.1002/biof.5520170101; GILBERT HF, 1990, ADV ENZYMOL RAMB, V63, P69; Go YM, 2010, ANTIOXID REDOX SIGN, V13, P489, DOI 10.1089/ars.2009.3021; Hansen JM, 2004, TOXICOL SCI, V82, P308, DOI 10.1093/toxsci/kfh231; Hansford RG, 1997, J BIOENERG BIOMEMBR, V29, P89, DOI 10.1023/A:1022420007908; Hargreaves IP, 2005, J INHERIT METAB DIS, V28, P81, DOI 10.1007/s10545-005-4160-1; Haun Florian, 2013, J Cell Death, V6, P27; HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0; Ikawa M, 2012, EUR NEUROL, V67, P232, DOI 10.1159/000336568; Iuso A, 2006, J BIOL CHEM, V281, P10374, DOI 10.1074/jbc.M513387200; Jones DP, 2006, ANTIOXID REDOX SIGN, V8, P1865, DOI 10.1089/ars.2006.8.1865; Jones DP, 2002, METHOD ENZYMOL, V348, P93, DOI 10.1016/S0076-6879(02)48630-2; Kerr DS, 2013, NEUROTHERAPEUTICS, V10, P307, DOI 10.1007/s13311-013-0176-7; Kerr DS, 2010, MOL GENET METAB, V99, P246, DOI 10.1016/j.ymgme.2009.11.005; Kirlin WG, 1999, FREE RADICAL BIO MED, V27, P1208, DOI 10.1016/S0891-5849(99)00145-8; LENNON SV, 1991, CELL PROLIFERAT, V24, P203, DOI 10.1111/j.1365-2184.1991.tb01150.x; Makino Y, 1999, J BIOL CHEM, V274, P3182, DOI 10.1074/jbc.274.5.3182; Martinelli D, 2012, MOL GENET METAB, V107, P383, DOI 10.1016/j.ymgme.2012.09.007; Merad-Boudia M, 1998, BIOCHEM PHARMACOL, V56, P645, DOI 10.1016/S0006-2952(97)00647-3; Moore T, 2013, J CHROMATOGR B, V929, P51, DOI 10.1016/j.jchromb.2013.04.004; Pastore A, 2003, CLIN CHIM ACTA, V333, P19, DOI 10.1016/S0009-8981(03)00200-6; Pastore A, 2001, CLIN CHEM, V47, P1467; Pastore A, 2014, J INHERIT METAB DIS, V37, P125, DOI 10.1007/s10545-013-9605-3; Pastore A, 2013, MOL GENET METAB, V109, P208, DOI 10.1016/j.ymgme.2013.03.011; Phoenix C, 2006, NEUROMUSCULAR DISORD, V16, P814, DOI 10.1016/j.nmd.2006.08.006; Piemonte F, 2001, EUR J CLIN INVEST, V31, P1007, DOI 10.1046/j.1365-2362.2001.00922.x; Pitkanen S, 1996, J CLIN INVEST, V98, P345, DOI 10.1172/JCI118798; Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930; Salmi H, 2012, ACTA PAEDIATR, V101, pe505, DOI 10.1111/j.1651-2227.2012.02799.x; Sandhu JK, 2005, BIOCHEM J, V391, P191, DOI 10.1042/BJ20050272; Schaefer AM, 2004, BBA-BIOENERGETICS, V1659, P115, DOI 10.1016/j.bbabio.2004.09.005; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Schulz JB, 2000, EUR J BIOCHEM, V267, P4904, DOI 10.1046/j.1432-1327.2000.01595.x; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Stacpoole PW, 2011, MITOCHONDRION, V11, P679, DOI 10.1016/j.mito.2011.05.002; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Wright AF, 2004, NAT GENET, V36, P1153, DOI 10.1038/ng1448; Zhang Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069282; Zimmermann AK, 2007, J BIOL CHEM, V282, P29296, DOI 10.1074/jbc.M702853200	50	31	33	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100001	10.1371/journal.pone.0100001	http://dx.doi.org/10.1371/journal.pone.0100001			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941115	Green Submitted, Green Published, gold			2022-12-27	WOS:000338508200063
J	Kurtz, BE				Kurtz, Bruce E.			An Electrical Analogy Relating the Atlantic Multidecadal Oscillation to the Atlantic Meridional Overturning Circulation	PLOS ONE			English	Article							ANTARCTIC CIRCUMPOLAR CURRENT; SEA-SURFACE TEMPERATURE; THERMOHALINE CIRCULATION; CLIMATE VARIABILITY; NORTH-AMERICAN; HEAT-TRANSPORT; DYNAMICS; MODELS	The Atlantic meridional overturning circulation (AMOC) is the northward flow of surface water to subpolar latitudes where deepwater is formed, balanced by southward abyssal flow and upwelling in the vicinity of the Southern Ocean. It is generally accepted that AMOC flow oscillates with a period of 60-80 years, creating a regular variation in North Atlantic sea surface temperature known as the Atlantic multidecadal oscillation (AMO). This article attempts to answer two questions: how is the AMOC driven and why does it oscillate? Using methods commonly employed by chemical engineers for analyzing processes involving flowing liquids, apparently not previously applied to trying to understand the AMOC, an equation is developed for AMOC flow as a function of the meridional density gradient or the corresponding temperature gradient. The equation is based on the similarity between the AMOC and an industrial thermosyphon loop cooler, which circulates a heat transfer liquid without using a mechanical pump. Extending this equation with an analogy between the flow of heat and electricity explains why the AMOC flow oscillates and what determines its period. Calculated values for AMOC flow and AMO oscillation period are in good agreement with measured values.				kurtz36ti@gmail.com		Kurtz, Bruce/0000-0001-5108-3510				ALLEN PC, 1980, P NATL ACAD SCI USA, V77, P39, DOI 10.1073/pnas.77.1.39; Allen PC, 1980, P NATL ACAD SCI USA, V78, P31; Bird R. B., 2002, TRANSPORT PHENOMENA, P178; Bower AS, 2009, NATURE, V459, P243, DOI 10.1038/nature07979; Chu PC, 2010, P MTS IEEE OC 10 SEA, V10, P1001; Cunningham SA, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2001JC001147; Delworth T.L., 2007, GEOPHYS MONOGR SER, P131, DOI DOI 10.1029/173GM10; Delworth TL, 2000, CLIM DYNAM, V16, P661, DOI 10.1007/s003820000075; Edwards M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057212; Enfield DB, 2001, GEOPHYS RES LETT, V28, P2077, DOI 10.1029/2000GL012745; Fitzgerald AE, 1981, BASIC ELECT ENG, P166; Gray ST, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019932; HALL MM, 1982, DEEP-SEA RES, V29, P339, DOI 10.1016/0198-0149(82)90099-1; Hu Q, 2011, J CLIMATE, V24, P5555, DOI 10.1175/2011JCLI4060.1; Jeffreys H, 1925, Q J ROY METEOR SOC, V51, P347; JOHNSON GC, 1989, DEEP-SEA RES, V36, P39, DOI 10.1016/0198-0149(89)90017-4; Kaplan A, 1998, J GEOPHYS RES-OCEANS, V103, P18567, DOI 10.1029/97JC01734; Kerr RA, 2000, SCIENCE, V288, P1984, DOI 10.1126/science.288.5473.1984; Knight JR, 2009, J CLIMATE, V22, P1610, DOI 10.1175/2008JCLI2628.1; Knight JR, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024233; Knudsen MF, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1186; Kuhlbrodt T, 2007, REV GEOPHYS, V45, DOI 10.1029/2004RG000166; Kuhlbrodt T, 2008, TELLUS A, V60, P819, DOI 10.1111/j.1600-0870.2008.00357.x; Kumar S, 2013, J CLIMATE, V26, P3511, DOI 10.1175/JCLI-D-12-00535.1; Latif M, 2004, J CLIMATE, V17, P1605, DOI 10.1175/1520-0442(2004)017<1605:RMAPMC>2.0.CO;2; Lozier MS, 2010, SCIENCE, V328, P1507, DOI 10.1126/science.1189250; Macias D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081591; Marotzke J., 1988, Tellus, Series A (Dynamic Meteorology and Oceanography), V40A, P162, DOI 10.1111/j.1600-0870.1988.tb00414.x; Marotzke J, 1997, J PHYS OCEANOGR, V27, P1713, DOI 10.1175/1520-0485(1997)027<1713:BMATDO>2.0.CO;2; Marshall J, 2003, J PHYS OCEANOGR, V33, P2341, DOI 10.1175/1520-0485(2003)033<2341:RSFTAC>2.0.CO;2; Nilsson J, 2001, TELLUS A, V53, P629, DOI 10.1034/j.1600-0870.2001.00263.x; Polyakov IV, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023740; Polyakov IV, 2005, J CLIMATE, V18, P4562, DOI 10.1175/JCLI3548.1; Rahmstorf S, 1996, CLIM DYNAM, V12, P799, DOI 10.1007/s003820050144; Rintoul S. R., 2001, ANTARCTIC CIRCUMPOLA, P271; Schewe J, 2010, CLIM DYNAM, V34, P547, DOI 10.1007/s00382-009-0572-1; SCHLESINGER ME, 1994, NATURE, V367, P723, DOI 10.1038/367723a0; Schloesser F, 2012, PROG OCEANOGR, V101, P33, DOI 10.1016/j.pocean.2012.01.002; Srokosz M, 2012, B AM METEOROL SOC, V93, P1663, DOI 10.1175/BAMS-D-11-00151.1; STOMMEL H, 1961, TELLUS, V13, P224, DOI 10.1111/j.2153-3490.1961.tb00079.x; Stommel H, 1959, CONTRIBUTION, P140; Straneo F, 2006, J PHYS OCEANOGR, V36, P1822, DOI 10.1175/JPO2932.1; Sutton RT, 2005, SCIENCE, V309, P115, DOI 10.1126/science.1109496; Wang CZ, 2010, CLIM DYNAM, V34, P953, DOI 10.1007/s00382-009-0560-5; Wang XC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022740; Wei W, 2012, J CLIMATE, V25, P6989, DOI 10.1175/JCLI-D-11-00667.1; Wu ZH, 2011, CLIM DYNAM, V37, P759, DOI 10.1007/s00382-011-1128-8; Wunsch C, 2005, TELLUS A, V57, P84, DOI 10.1111/j.1600-0870.2005.00093.x; Wunsch C, 2002, SCIENCE, V298, P1179, DOI 10.1126/science.1079329; Wyatt MG, 2012, CLIM DYNAM, V38, P929, DOI 10.1007/s00382-011-1071-8; Zhang R, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028683	51	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100306	10.1371/journal.pone.0100306	http://dx.doi.org/10.1371/journal.pone.0100306			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940739	Green Published, Green Submitted, gold			2022-12-27	WOS:000338508200094
J	Lima, CKF; Silva, RM; Lacerda, RB; Santos, BLR; Silva, RV; Amaral, LS; Quintas, LEM; Fraga, CAM; Barreiro, EJ; Guimaraes, MZP; Miranda, ALP				Lima, Cleverton K. F.; Silva, Rafael M.; Lacerda, Renata B.; Santos, Bruna L. R.; Silva, Rafaela V.; Amaral, Luciana S.; Quintas, Luis E. M.; Fraga, Carlos A. M.; Barreiro, Eliezer J.; Guimaraes, Marilia Z. P.; Miranda, Ana L. P.			LASSBio-1135: A Dual TRPV1 Antagonist and Anti-TNF-Alpha Compound Orally Effective in Models of Inflammatory and Neuropathic Pain	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; DORSAL-ROOT GANGLIA; RECEPTOR POTENTIAL VANILLOID-1; MECHANICAL ALLODYNIA; CAPSAICIN; KINASE; ACTIVATION; ARTHRITIS; NEURONS; HYPERNOCICEPTION	LASSBio-1135 is an imidazo[1,2-a]pyridine derivative with high efficacy in screening models of nociception and inflammation, presumed as a weak COX-2 inhibitor. In order to tease out its mechanism of action, we investigated others possible target for LASSBio-1135, such as TNF-alpha and TRPV1, to better characterize it as a multitarget compound useful in the treatment of chronic pain. TRPV1 modulation was assessed in TRPV1-expressing Xenopus oocytes against capsaicin and low pH-induced current. Modulation of TNF-alpha production was evaluated in culture of macrophages stimulated with LPS. In vivo efficacy of LASSBio-1135 was investigated in carrageenan and partial sciatic ligation-induced thermal hyperalgesia and mechanical allodynia. Corroborating its previous demonstration of efficacy in a model of capsaicin-induced hyperalgesia, LASSBio-1135 blocks capsaicin-elicited currents in a non-competitive way with an IC50 of 580 nM as well as low pH-induced current at 50 mu M. As an additional action, LASSBio-1135 inhibited TNF-alpha release in these cells stimulated by LPS with an IC50 of 546 nM by reducing p38 MAPK phosphorilation. Oral administration of 100 mu mol.Kg(-1) LASSBio-1135 markedly reduced thermal hyperalgesia induced by carrageenan, however at mu mol.Kg(-1) only a partial reduction was observed at the 4th h. Neutrophil recruitment and TNF-alpha production after carrageenan stimulus was also inhibited by the treatment with LASSBio-1135. Modulating TRPV1 and TNF-alpha production, two key therapeutic targets of neuropathic pain, 100 mu mol.Kg(-1) LASSBio-1135 was orally efficacious in reversing thermal hyperalgesia and mechanical allodynia produced by partial sciatic ligation 7-11 days after surgery without provoking hyperthermia, a common side effect of TRPV1 antagonists. In conclusion LASSBio-1135, besides being a weak COX-2 inhibitor, is a noncompetitive TRPV1 antagonist and a TNF-alpha inhibitor. As a multitarget compound, LASSBio-1135 is orally efficacious in a model of neuropathic pain without presenting hyperthermia.	[Lima, Cleverton K. F.; Santos, Bruna L. R.; Silva, Rafaela V.; Miranda, Ana L. P.] Univ Fed Rio de Janeiro, Fac Farm, LEFEx, Rio De Janeiro, Brazil; [Silva, Rafael M.; Amaral, Luciana S.; Quintas, Luis E. M.; Fraga, Carlos A. M.; Guimaraes, Marilia Z. P.] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Rio De Janeiro, Brazil; [Lacerda, Renata B.; Fraga, Carlos A. M.; Barreiro, Eliezer J.] Univ Fed Rio de Janeiro, Fac Farm, LASSBio, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Miranda, ALP (corresponding author), Univ Fed Rio de Janeiro, Fac Farm, LEFEx, Rio De Janeiro, Brazil.	analu@pharma.ufrj.br	Silva, Rafaela Vieira/AGP-2596-2022; Guimaraes, Marilia ZP/C-3255-2009; Quintas, Luis Eduardo M/C-3308-2009; Barreiro, Eliezer J/B-1131-2011; lacerda, renata/V-4003-2019; Fraga, Carlos/G-3495-2012	Silva, Rafaela Vieira/0000-0002-8687-2154; Guimaraes, Marilia ZP/0000-0001-6397-8506; Quintas, Luis Eduardo M/0000-0002-0767-1240; Barreiro, Eliezer J/0000-0003-1759-0038; Fraga, Carlos/0000-0001-6733-7079	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro; Instituto Nacional de Ciencia e Tecnologia em Farmacos e Medicamentos	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Instituto Nacional de Ciencia e Tecnologia em Farmacos e Medicamentos	This work was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (BR), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (BR), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (BR), and Instituto Nacional de Ciencia e Tecnologia em Farmacos e Medicamentos (BR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin PJ, 2010, J NEUROIMMUNOL, V229, P26, DOI 10.1016/j.jneuroim.2010.08.013; Badger AM, 1996, J PHARMACOL EXP THER, V279, P1453; Blum CA, 2010, J MED CHEM, V53, P3330, DOI 10.1021/jm100051g; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Carlton SM, 2001, NEUROSCI LETT, V310, P53, DOI 10.1016/S0304-3940(01)02093-6; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chen Y, 2009, EXP NEUROL, V220, P383, DOI 10.1016/j.expneurol.2009.09.030; CUNHA FQ, 1992, BRIT J PHARMACOL, V107, P660, DOI 10.1111/j.1476-5381.1992.tb14503.x; Cunha TM, 2008, J LEUKOCYTE BIOL, V83, P824, DOI 10.1189/jlb.0907654; Cunha TM, 2005, P NATL ACAD SCI USA, V102, P1755, DOI 10.1073/pnas.0409225102; Dubovy P, 2006, CELL MOL NEUROBIOL, V26, P1205, DOI 10.1007/s10571-006-9006-3; Gaestel M, 2009, NAT REV DRUG DISCOV, V8, P480, DOI 10.1038/nrd2829; Gallily R, 1997, J PHARMACOL EXP THER, V283, P918; Garcia-Martinez C, 2002, P NATL ACAD SCI USA, V99, P2374, DOI 10.1073/pnas.022285899; George A, 2005, EXP NEUROL, V192, P163, DOI 10.1016/j.expneurol.2004.11.002; Gunthorpe MJ, 2009, DRUG DISCOV TODAY, V14, P56, DOI 10.1016/j.drudis.2008.11.005; Hambleton J, 1996, P NATL ACAD SCI USA, V93, P2774, DOI 10.1073/pnas.93.7.2774; Hudson LJ, 2001, EUR J NEUROSCI, V13, P2105, DOI 10.1046/j.0953-816x.2001.01591.x; Jin XC, 2006, J NEUROSCI, V26, P246, DOI 10.1523/JNEUROSCI.3858-05.2006; Kawasaki Y, 2008, J NEUROSCI, V28, P5189, DOI 10.1523/JNEUROSCI.3338-07.2008; Keeble J, 2005, ARTHRITIS RHEUM, V52, P3248, DOI 10.1002/art.21297; Lacerda RB, 2009, BIOORGAN MED CHEM, V17, P74, DOI 10.1016/j.bmc.2008.11.018; Lavich TR, 2005, BRAZ J MED BIOL RES, V38, P445, DOI 10.1590/S0100-879X2005000300016; Ledeboer A, 2007, EXPERT OPIN INV DRUG, V16, P935, DOI 10.1517/13543784.16.7.935; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Lehto SG, 2008, J PHARMACOL EXP THER, V326, P218, DOI 10.1124/jpet.107.132233; Leung L, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-27; Miller Richard J, 2009, Handb Exp Pharmacol, P417, DOI 10.1007/978-3-540-79090-7_12; Nicol GD, 1997, J NEUROSCI, V17, P975; Romano CL, 2009, J ORTHOP TRAUMATOL, V10, P185, DOI 10.1007/s10195-009-0077-z; Scholz J, 2007, NAT NEUROSCI, V10, P1361, DOI 10.1038/nn1992; SELTZER Z, 1990, PAIN, V43, P205, DOI 10.1016/0304-3959(90)91074-S; Sena J, 2008, GEN COMP ENDOCR, V157, P165, DOI 10.1016/j.ygcen.2008.04.012; Szabo A, 2005, J PHARMACOL EXP THER, V314, P111, DOI 10.1124/jpet.104.082487; Tributino JLM, 2010, BRIT J PHARMACOL, V159, P1716, DOI 10.1111/j.1476-5381.2010.00672.x; Tsuji F, 2010, EUR J PHARMACOL, V627, P332, DOI 10.1016/j.ejphar.2009.10.044; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; von Banchet GS, 2009, PAIN, V145, P151, DOI 10.1016/j.pain.2009.06.002; Walker KM, 2003, J PHARMACOL EXP THER, V304, P56, DOI 10.1124/jpet.102.042010; Watabiki T, 2011, BIOL PHARM BULL, V34, P1105, DOI 10.1248/bpb.34.1105; WATKINS LR, 2004, DRUG DISCOV TODAY TH, V1, P83; Wei XH, 2007, EXP NEUROL, V205, P471, DOI 10.1016/j.expneurol.2007.03.012; Wong GY, 2009, BRAIN RES REV, V60, P267, DOI 10.1016/j.brainresrev.2008.12.006; Zwerina J, 2006, ARTHRITIS RHEUM-US, V54, P463, DOI 10.1002/art.21626; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	45	11	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99510	10.1371/journal.pone.0099510	http://dx.doi.org/10.1371/journal.pone.0099510			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941071	Green Submitted, Green Published, gold			2022-12-27	WOS:000338508200027
J	Rakai, BD; Chrusch, MJ; Spanswick, SC; Dyck, RH; Antle, MC				Rakai, Brooke D.; Chrusch, Michael J.; Spanswick, Simon C.; Dyck, Richard H.; Antle, Michael C.			Survival of Adult Generated Hippocampal Neurons Is Altered in Circadian Arrhythmic Mice	PLOS ONE			English	Article							CLOCK GENE-EXPRESSION; CELL-PROLIFERATION; SLEEP-DEPRIVATION; DENTATE GYRUS; NEUROGENESIS; BRAIN; BMAL1; DISRUPTION; DEFICIENT; COMPONENT	The subgranular zone of the hippocampal formation gives rise to new neurons that populate the dentate gyrus throughout life. Cells in the hippocampus exhibit rhythmic clock gene expression and the circadian clock is known to regulate the cycle of cell division in other areas of the body. These facts suggest that the circadian clock may regulate adult neurogenesis in the hippocampus as well. In the present study, neurogenesis in the hippocampal subgranular zone was examined in arrhythmic Bmal1 knockout (-KO) mice and their rhythmic heterozygous and wildtype littermates. Proliferation and survival of newly generated subgranular zone cells were examined using bromodeoxyuridine labelling, while pyknosis (a measure of cell death) and hippocampal volume were examined in cresyl violet stained sections. There was no significant difference in cellular proliferation between any of the groups, yet survival of proliferating cells, 6 weeks after the bromodeoxyuridine injection, was significantly greater in the BMAL1-KO animals. The number of pyknotic cells was significantly decreased in Bmal1-KO animals, yet hippocampal volume remained the same across genotypes. These findings suggest that while a functional circadian clock is not necessary for normal proliferation of neuronal precursor cells, the normal pruning of newly generated neurons in the hippocampus may require a functional circadian clock.	[Rakai, Brooke D.; Chrusch, Michael J.; Spanswick, Simon C.; Dyck, Richard H.; Antle, Michael C.] Univ Calgary, Dept Psychol, Calgary, AB T2N 1N4, Canada; [Rakai, Brooke D.; Spanswick, Simon C.; Dyck, Richard H.; Antle, Michael C.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB T2N 1N4, Canada; [Chrusch, Michael J.] Univ Calgary, Dept Neurosci, Calgary, AB T2N 1N4, Canada; [Dyck, Richard H.] Univ Calgary, Dept Cell Biol & Anat, Calgary, AB T2N 1N4, Canada; [Antle, Michael C.] Univ Calgary, Calgary, AB T2N 1N4, Canada	University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary	Antle, MC (corresponding author), Univ Calgary, Dept Psychol, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	antlem@ucalgary.ca		Antle, Michael/0000-0001-5178-4683; Dyck, Richard/0000-0002-3254-8332	Natural Sciences and Engineering Research Council of Canada [311874-2010]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Funded by the Natural Sciences and Engineering Research Council of Canada (Grant #311874-2010) (http://www.nserc-crsng.gc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2004, MOL BRAIN RES, V124, P178, DOI 10.1016/j.molbrainres.2004.02.015; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Antle MC, 2005, TRENDS NEUROSCI, V28, P145, DOI 10.1016/j.tins.2005.01.003; Antle MC, 2005, DEV BRAIN RES, V157, P8, DOI 10.1016/j.devbrainres.2005.02.017; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Ben Abdallah NMB, 2010, NEUROBIOL AGING, V31, P151, DOI 10.1016/j.neurobiolaging.2008.03.002; Borgs L, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-30; Bouchard-Cannon P, 2013, CELL REP, V5, P961, DOI 10.1016/j.celrep.2013.10.037; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Bunger MK, 2005, GENESIS, V41, P122, DOI 10.1002/gene.20102; Cain SW, 2009, NEUROBIOL LEARN MEM, V91, P81, DOI 10.1016/j.nlm.2008.10.005; Cain SW, 2004, BEHAV BRAIN RES, V150, P201, DOI 10.1016/j.bbr.2003.07.001; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; GAGE FH, 1995, ANNU REV NEUROSCI, V18, P159, DOI 10.1146/annurev.neuro.18.1.159; Gilhooley MJ, 2011, NEUROSCI LETT, V489, P177, DOI 10.1016/j.neulet.2010.12.011; Golini RS, 2012, HIPPOCAMPUS, V22, P1720, DOI 10.1002/hipo.22007; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Grechez-Cassiau A, 2008, J BIOL CHEM, V283, P4535, DOI 10.1074/jbc.M705576200; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Hill MN, 2006, EUR J NEUROSCI, V24, P1845, DOI 10.1111/j.1460-9568.2006.05061.x; Holmes MM, 2004, J NEUROSCI RES, V76, P216, DOI 10.1002/jnr.20039; Jilg A, 2010, HIPPOCAMPUS, V20, P377, DOI 10.1002/hipo.20637; Kochman LJ, 2006, NEUROSCI LETT, V406, P256, DOI 10.1016/j.neulet.2006.07.058; Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lee JH, 2011, P NATL ACAD SCI USA, V108, P12036, DOI 10.1073/pnas.1108125108; Lee JH, 2011, P NATL ACAD SCI USA, V108, P10668, DOI 10.1073/pnas.1106284108; Lin FW, 2013, CELL BIOCHEM FUNCT, V31, P166, DOI 10.1002/cbf.2871; Marin-Burgin A, 2012, BEHAV BRAIN RES, V227, P391, DOI 10.1016/j.bbr.2011.07.001; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; Meerlo P, 2009, SLEEP MED REV, V13, P187, DOI 10.1016/j.smrv.2008.07.004; Mirescu C, 2006, P NATL ACAD SCI USA, V103, P19170, DOI 10.1073/pnas.0608644103; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Mueller AD, 2011, NEUROSCIENCE, V193, P170, DOI 10.1016/j.neuroscience.2011.07.019; Mueller AD, 2008, AM J PHYSIOL-REG I, V294, pR1693, DOI 10.1152/ajpregu.00858.2007; Namihira M, 1999, NEUROSCI LETT, V267, P69, DOI 10.1016/S0304-3940(99)00324-9; Fonzo LSN, 2009, HIPPOCAMPUS, V19, P869, DOI 10.1002/hipo.20571; Schmitz C, 2005, NEUROSCIENCE, V130, P813, DOI 10.1016/j.neuroscience.2004.08.050; Segall LA, 2010, J MOL NEUROSCI, V42, P168, DOI 10.1007/s12031-010-9341-1; Shieh KR, 2003, NEUROSCIENCE, V118, P831, DOI 10.1016/S0306-4522(03)00004-6; Smith JM, 2010, NEUROSCI LETT, V473, P192, DOI 10.1016/j.neulet.2010.02.039; Smith VM, 2008, NEUROSCIENCE, V157, P513, DOI 10.1016/j.neuroscience.2008.09.030; Thompson EB, 1998, ANNU REV PHYSIOL, V60, P575, DOI 10.1146/annurev.physiol.60.1.575; Valentinuzzi VS, 2004, J BIOL RHYTHM, V19, P312, DOI 10.1177/0748730404265688; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Wang LMC, 2009, ASN NEURO, V1, DOI 10.1042/AN20090020; Yamamoto S, 2001, J COMP NEUROL, V430, P518	49	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99527	10.1371/journal.pone.0099527	http://dx.doi.org/10.1371/journal.pone.0099527			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941219	Green Published, Green Submitted, gold			2022-12-27	WOS:000338508200028
J	Wu, G; Cheng, M; Huang, H; Yang, B; Jiang, H; Huang, CX				Wu, Gang; Cheng, Mian; Huang, He; Yang, Bo; Jiang, Hong; Huang, Congxin			A Variant of IL6R Is Associated with the Recurrence of Atrial Fibrillation after Catheter Ablation in a Chinese Han Population	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; C-REACTIVE PROTEIN; INFLAMMATION; PREDICTOR; MARKERS; IMPACT; HEART	Background: Recent studies have identified a variant, rs4845625, in the interleukin-6 receptor (IL6R) gene associated with Atrial Fibrillation (AF). Levels of circulating interleukin-6 and other proinflammatory molecules have consistently been associated with a risk for AF and its recurrence after catheter ablation. This study tested the hypothesis that variant rs4845625 is associated with AF recurrence after catheter ablation in a Chinese Han population. Methods: A total of 278 consecutive patients (mean age 59.4 +/- 11.5 years, 43% female) with paroxysmal (36.0%), persistent (59.7%), and permanent (4.3%) AF who underwent catheterablation from 2007-2011, were included in this study. Patients were monitored for 12 months for a recurrence of AF. The SNP rs4845625 was genotyped using high resolution melting analysis. Results: In our study cohort, an early recurrence of AF (ERAF), defined as a recurrence within the first 4 weeks, was observed in 42.8% of the patients, whereas late recurrence of AF (LRAF) (between 3 and 12 months) occurred in 25.9% of the patients. No significant differences in baseline clinical or echocardiographic characteristics were observed between patients with ERAF and LRAF. In contrast, the presence of the T allele of rs4845625 was associated with an increase in the risk for both ERAF (odds ratio [OR]: 1.84, 95% confidence interval [CI]: 1.31-2.59, p = 4.10x10(-4)) and LRAF (OR: 1.92, 95% CI: 1.30-2.81, p = 0.001). Furthermore, this association was significant after adjustments for age, sex, hypertension, diabetes and other risk factors. No significant relationship between rs4845625 and serum levels of IL6 was observed. Conclusions: In this study, a variant of the IL6R gene, rs4845625, was found confer risk to AF recurrence after catheter ablation in a Chinese Han population. Our findings indicated that the IL6R pathway or inflammation may play important rols in the recurrence of AF after catheter ablation.	[Wu, Gang; Huang, He; Yang, Bo; Jiang, Hong; Huang, Congxin] Wuhan Univ, Renmin Hosp, Dept Cardiol, Wuhan 430072, Hubei, Peoples R China; [Cheng, Mian] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Geriatr, Wuhan 430074, Hubei, Peoples R China	Wuhan University; Huazhong University of Science & Technology	Huang, CX (corresponding author), Wuhan Univ, Renmin Hosp, Dept Cardiol, Wuhan 430072, Hubei, Peoples R China.	circulationline@tom.com			National Natural Science Foundation of China [81270305]; National Science & Technology Pillar Program of China [2011BAI11B12]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science & Technology Pillar Program of China	This study was funded by National Natural Science Foundation of China (NO: 81270305) and National Science & Technology Pillar Program of China (NO: 2011BAI11B12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aviles RJ, 2003, CIRCULATION, V108, P3006, DOI 10.1161/01.CIR.0000103131.70301.4F; Frustaci A, 1997, CIRCULATION, V96, P1180, DOI 10.1161/01.CIR.96.4.1180; Fuster V, 2006, CIRCULATION, V114, pE257, DOI 10.1161/CIRCULATIONAHA.106.177292; Guo YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031489; Henningsen KMA, 2009, SCAND CARDIOVASC J, V43, P285, DOI 10.1080/14017430802653676; Hu YJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0057593, 10.1371/journal.pone.0056362, 10.1371/journal.pone.0073264, 10.1371/journal.pone.0056440]; Hu YF, 2011, HEART RHYTHM, V8, P650, DOI 10.1016/j.hrthm.2010.12.036; Issac TT, 2007, J AM COLL CARDIOL, V50, P2021, DOI 10.1016/j.jacc.2007.06.054; Kannel WB, 1998, AM J CARDIOL, V82, p2N, DOI 10.1016/S0002-9149(98)00583-9; Kornej J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044165; Liu J, 2011, PACE, V34, P398, DOI 10.1111/j.1540-8159.2010.02978.x; Marcus GM, 2008, HEART RHYTHM, V5, P215, DOI 10.1016/j.hrthm.2007.10.007; Marcus GM, 2008, AM HEART J, V155, P303, DOI 10.1016/j.ahj.2007.09.006; Marcus GM, 2010, HEART RHYTHM, V7, P149, DOI 10.1016/j.hrthm.2009.10.004; Narducci ML, 2011, EUROPACE, V13, P1133, DOI 10.1093/europace/eur068; Okumura Y, 2011, J CARDIOVASC ELECTR, V22, P987, DOI 10.1111/j.1540-8167.2011.02059.x; Schnabel RB, 2011, CIRC-CARDIOVASC GENE, V4, P557, DOI 10.1161/CIRCGENETICS.110.959197; Shoemaker MB, 2013, HEART RHYTHM, V10, P394, DOI 10.1016/j.hrthm.2012.11.012; Smit MD, 2012, EUROPACE, V14, P810, DOI 10.1093/europace/eur402; Wang F, 2011, NAT GENET, V43, P345, DOI 10.1038/ng.783; Zhang XL, 2012, EXP THER MED, V4, P741, DOI 10.3892/etm.2012.650; Zoller B, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-121	22	20	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99623	10.1371/journal.pone.0099623	http://dx.doi.org/10.1371/journal.pone.0099623			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940886	Green Published, Green Submitted, gold			2022-12-27	WOS:000338508200032
J	Jha, AK; Jackson, WM; Healy, KE				Jha, Amit K.; Jackson, Wesley M.; Healy, Kevin E.			Controlling Osteogenic Stem Cell Differentiation via Soft Bioinspired Hydrogels	PLOS ONE			English	Article							SEMIINTERPENETRATING POLYMER NETWORKS; TISSUE ENGINEERING APPLICATIONS; POLY(ACRYLIC ACID) CHAINS; OSTEOBLASTIC DIFFERENTIATION; LIGAND DENSITY; BONE-FORMATION; EXPRESSION; STIFFNESS; ADHESION; MECHANOTRANSDUCTION	Osteogenic differentiation of human mesenchymal stem cells (hMSCs) is guided by various physical and biochemical factors. Among these factors, modulus (i.e., rigidiy) of the ECM has gained significant attention as a physical osteoinductive signal that can contribute to endochondral ossification of a cartilaginous skeletal template. However, MSCs also participate in intramembranous bone formation, which occurs de novo from within or on a more compliant tissue environment. To further understand the role of the matrix interactions in this process, we evaluated osteogenic differentiation of hMSCs cultured on low moduli (102, 390 or 970 Pa) poly(N-isopropylacrylamide) (p(NIPAAm)) based semi-interpenetrating networks (sIPN) modified with the integrin engaging peptide bsp-RGD(15) (0, 105 or 210 mu M). Cell adhesion, proliferation, and osteogenic differentiation of hMSCs, as measured by alkaline phosphatase (ALP), runt-related transcription factor 2 (RUNX2), bone sialoprotein-2 (iBSP), and osteocalcien (OCN) protein expression, was highest on substrates with the highest modulus and peptide concentrations. However, within this range of substrate stiffness, many osteogenic cellular functions were enhanced by increasing either the modulus or the peptide density. These findings suggest that within a compliant and low modulus substrate, a high affinity adhesive ligand serves as a substitute for a rigid matrix to foster osteogenic differentiation.	[Jha, Amit K.; Jackson, Wesley M.; Healy, Kevin E.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Healy, Kevin E.] Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Healy, KE (corresponding author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.	kehealy@berkeley.edu			National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health [R01AR043187, R01AR047304]; National Heart, Lung and Blood Institute of the National Institutes of Health [R01HL096525]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043187, R01AR047304] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Heart, Lung and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Research reported in this publication was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under Award Numbers R01AR043187 and R01AR047304 and the National Heart, Lung and Blood Institute of the National Institutes of Health under award number R01HL096525. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsberg E, 2003, J DENT RES, V82, P903, DOI 10.1177/154405910308201111; Barber TA, 2005, BIOMATERIALS, V26, P6897, DOI 10.1016/j.biomaterials.2005.04.043; Barber TA, 2007, J BIOMED MATER RES A, V80A, P306, DOI 10.1002/jbm.a.30927; Barber TA, 2006, J ORTHOP RES, V24, P1366, DOI 10.1002/jor.20165; Bearinger JP, 1998, J BIOMAT SCI-POLYM E, V9, P629, DOI 10.1163/156856298X00064; BIANCO P, 1991, CALCIFIED TISSUE INT, V49, P421, DOI 10.1007/BF02555854; Bidarra SJ, 2010, BIOMACROMOLECULES, V11, P1956, DOI 10.1021/bm100264a; Born AK, 2009, EUR CELLS MATER, V18, P49; Chu C, 2009, TISSUE ENG PT A, V15, P255, DOI 10.1089/ten.tea.2008.0100; Chung EH, 2006, J BIOMED MATER RES A, V79A, P815, DOI 10.1002/jbm.a.30809; Collins JM, 2010, SMALL, V6, P355, DOI 10.1002/smll.200901757; Coquelin L, 2012, TISSUE ENG PT A, V18, P1921, DOI [10.1089/ten.TEA.2011.0645, 10.1089/ten.tea.2011.0645]; Docheva D, 2008, J CELL MOL MED, V12, P537, DOI 10.1111/j.1582-4934.2007.00138.x; Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Forgacs G, 1998, BIOPHYS J, V74, P2227, DOI 10.1016/S0006-3495(98)77932-9; Fu JP, 2010, NAT METHODS, V7, P733, DOI 10.1038/nmeth.1487; Gronthos S, 1999, J BONE MINER RES, V14, P47, DOI 10.1359/jbmr.1999.14.1.47; Han SJ, 2012, BIOPHYS J, V103, P640, DOI 10.1016/j.bpj.2012.07.023; Harbers GM, 2005, J BIOMED MATER RES A, V75A, P855, DOI 10.1002/jbm.a.30482; Harbers GM, 2005, LANGMUIR, V21, P8374, DOI 10.1021/la050396y; Ho JE, 2007, J BIOMED MATER RES A, V83A, P1200, DOI 10.1002/jbm.a.31355; Hsiong SX, 2008, J BIOMED MATER RES A, V85A, P145, DOI 10.1002/jbm.a.31521; Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]; Kasza KE, 2011, CURR OPIN CELL BIOL, V23, P30, DOI 10.1016/j.ceb.2010.10.014; Khanna R, 2011, J NANOTECHNOLOGY ENG, V2; Khatiwala CB, 2007, J CELL PHYSIOL, V211, P661, DOI 10.1002/jcp.20974; Khatiwala CB, 2009, J BONE MINER RES, V24, P886, DOI [10.1359/jbmr.081240, 10.1359/JBMR.081240]; Khetan S, 2013, NAT MATER, V12, P458, DOI [10.1038/NMAT3586, 10.1038/nmat3586]; Kim HJ, 2005, BIOMATERIALS, V26, P4442, DOI 10.1016/j.biomaterials.2004.11.013; Kim S, 2005, J BIOMED MATER RES A, V75A, P73, DOI 10.1002/jbm.a.30375; Kim S, 2003, BIOMACROMOLECULES, V4, P1214, DOI 10.1021/bm0340467; Kimura Y, 2010, TISSUE ENG PT A, V16, P1263, DOI [10.1089/ten.tea.2009.0322, 10.1089/ten.TEA.2009.0322]; Kisiel M, 2013, BIOMATERIALS, V34, P704, DOI 10.1016/j.biomaterials.2012.10.015; Mari-Buye N, 2013, TISSUE ENG PT A, V19, P870, DOI [10.1089/ten.tea.2012.0077, 10.1089/ten.TEA.2012.0077]; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; McMurray RJ, 2011, NAT MATER, V10, P637, DOI [10.1038/NMAT3058, 10.1038/nmat3058]; Morimoto D, 2009, RHEUMATOLOGY, V48, P643, DOI 10.1093/rheumatology/kep044; Oliveira SM, 2010, J BIOMED MATER RES A, V94A, P371, DOI 10.1002/jbm.a.32694; Petrie TA, 2008, BIOMATERIALS, V29, P2849, DOI 10.1016/j.biomaterials.2008.03.036; Rezania A, 1999, BIOTECHNOL PROGR, V15, P19, DOI 10.1021/bp980083b; Rezania A, 2000, J BIOMED MATER RES, V52, P595, DOI 10.1002/1097-4636(20001215)52:4<595::AID-JBM3>3.0.CO;2-3; Rowlands AS, 2008, AM J PHYSIOL-CELL PH, V295, pC1037, DOI 10.1152/ajpcell.67.2008; Saha K, 2007, J BIOMED MATER RES A, V81A, P240, DOI 10.1002/jbm.a.30986; Shapiro F, 2008, EUR CELLS MATER, V15, P53, DOI 10.22203/eCM.v015a05; Shih YRV, 2011, J BONE MINER RES, V26, P730, DOI 10.1002/jbmr.278; Shui CX, 2003, J BONE MINER RES, V18, P213, DOI 10.1359/jbmr.2003.18.2.213; Stile RA, 2004, J BIOMAT SCI-POLYM E, V15, P865, DOI 10.1163/1568562041271129; Stile RA, 2001, BIOMACROMOLECULES, V2, P185, DOI 10.1021/bm0000945; Stile RA, 2002, BIOMACROMOLECULES, V3, P591, DOI 10.1021/bm0101466; Sun J, 2012, SOFT MATTER, V8, P2398, DOI 10.1039/c2sm06869a; Thomas CH, 2002, P NATL ACAD SCI USA, V99, P1972, DOI 10.1073/pnas.032668799; Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/nmat3339, 10.1038/NMAT3339]; Wall ST, 2010, J BIOMED MATER RES A, V95A, P1055, DOI 10.1002/jbm.a.32904; Wang LS, 2010, BIOMATERIALS, V31, P8608, DOI 10.1016/j.biomaterials.2010.07.075; Wise JK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012987; Wozniak MA, 2009, NAT REV MOL CELL BIO, V10, P34, DOI 10.1038/nrm2592; Wu LC, 2011, BIOMATERIALS, V32, P5341, DOI 10.1016/j.biomaterials.2011.04.014	58	30	32	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e98640	10.1371/journal.pone.0098640	http://dx.doi.org/10.1371/journal.pone.0098640			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937602	Green Published, Green Submitted, gold			2022-12-27	WOS:000338503400008
J	Barord, GJ; Dooley, F; Dunstan, A; Ilano, A; Keister, KN; Neumeister, H; Preuss, T; Schoepfer, S; Ward, PD				Barord, Gregory J.; Dooley, Frederick; Dunstan, Andrew; Ilano, Anthony; Keister, Karen N.; Neumeister, Heike; Preuss, Thomas; Schoepfer, Shane; Ward, Peter D.			Comparative Population Assessments of Nautilus sp in the Philippines, Australia, Fiji, and American Samoa Using Baited Remote Underwater Video Systems	PLOS ONE			English	Article							DEMERSAL FISHES; POMPILIUS; CEPHALOPOD; GROWTH; ALLONAUTILUS; BELAUENSIS; LONGEVITY; COMMUNITY; STATIONS; SPEED	The extant species of Nautilus and Allonautilus (Cephalopoda) inhabit fore-reef slope environments across a large geographic area of the tropical western Pacific and eastern Indian Oceans. While many aspects of their biology and behavior are now well-documented, uncertainties concerning their current populations and ecological role in the deeper, fore-reef slope environments remain. Given the historical to current day presence of nautilus fisheries at various locales across the Pacific and Indian Oceans, a comparative assessment of the current state of nautilus populations is critical to determine whether conservation measures are warranted. We used baited remote underwater video systems (BRUVS) to make quantitative photographic records as a means of estimating population abundance of Nautilus sp. at sites in the Philippine Islands, American Samoa, Fiji, and along an approximately 125 km transect on the fore reef slope of the Great Barrier Reef from east of Cairns to east of Lizard Island, Australia. Each site was selected based on its geography, historical abundance, and the presence (Philippines) or absence (other sites) of Nautilus fisheries The results from these observations indicate that there are significantly fewer nautiluses observable with this method in the Philippine Islands site. While there may be multiple possibilities for this difference, the most parsimonious is that the Philippine Islands population has been reduced due to fishing. When compared to historical trap records from the same site the data suggest there have been far more nautiluses at this site in the past. The BRUVS proved to be a valuable tool to measure Nautilus abundance in the deep sea (300-400 m) while reducing our overall footprint on the environment.	[Barord, Gregory J.] CUNY, Grad Ctr, Dept Biol, New York, NY 10021 USA; [Barord, Gregory J.] CUNY Brooklyn Coll, Dept Biol, Brooklyn, NY 11210 USA; [Dooley, Frederick; Schoepfer, Shane; Ward, Peter D.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Dunstan, Andrew] Univ Queensland, Sch Biomed Sci, Brisbane St Lucia, Qld, Australia; [Ilano, Anthony] Univ San Carlos, Dept Biol, Cebu, Philippines; [Keister, Karen N.] Alaskan Observers Inc, Dept Biol, Seattle, WA USA; [Neumeister, Heike; Preuss, Thomas] CUNY Hunter Coll, Dept Psychol, New York, NY 10021 USA; [Schoepfer, Shane; Ward, Peter D.] Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA	City University of New York (CUNY) System; City University of New York (CUNY) System; Brooklyn College (CUNY); University of Washington; University of Washington Seattle; University of Queensland; University of San Carlos; City University of New York (CUNY) System; Hunter College (CUNY); University of Washington; University of Washington Seattle	Barord, GJ (corresponding author), CUNY, Grad Ctr, Dept Biol, New York, NY 10021 USA.	gjbarord@gmail.com		Barord, Gregory/0000-0002-4482-8016; ILANO, ANTHONY/0000-0002-5409-5389	United States Fish and Wildlife Service [10170-J-001]; Tiffany Foundation [11661]; National Science Foundation [NSF GDE-0638718]; Norman M. Saks Travel Award; Minnesota Zoo Ulysses S. Seal Conservation Grant; Riverbanks Zoo and Garden Conservation Award; National Oceanic and Atmospheric Administration [NA11NMF4720256, NA12NMF4690220]; Phoenix Zoo Conservation Award	United States Fish and Wildlife Service(US Fish & Wildlife Service); Tiffany Foundation; National Science Foundation(National Science Foundation (NSF)); Norman M. Saks Travel Award; Minnesota Zoo Ulysses S. Seal Conservation Grant; Riverbanks Zoo and Garden Conservation Award; National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); Phoenix Zoo Conservation Award	The Philippines research was supported by the United States Fish and Wildlife Service (#10170-J-001) the Tiffany Foundation (#11661), the National Science Foundation (NSF GDE-0638718), the Norman M. Saks Travel Award, the Minnesota Zoo Ulysses S. Seal Conservation Grant, and the Riverbanks Zoo and Garden Conservation Award. The Australian research was supported by the United States Fish and Wildlife Service (#10170-J-001) and the National Science Foundation (NSF GDE-0638718). The Fiji research was supported by the National Oceanic and Atmospheric Administration (NA11NMF4720256) National Science Foundation (NSF GDE-0638718), the Phoenix Zoo Conservation Award. The American Samoa research was supported by the National Oceanic and Atmospheric Administration (NA12NMF4690220) the National Science Foundation (NSF GDE-0638718), and the Phoenix Zoo Conservation Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcala AC, 2002, ASIAN FISH SC, V15, P177; Basil JA, 2000, J EXP BIOL, V203, P1409; Bonacum J, 2011, AM MALACOL BULL, V29, P77, DOI 10.4003/006.029.0221; Cappo M, 2007, MAR ECOL PROG SER, V350, P209, DOI 10.3354/meps07189; Carlson BA., 2010, NAUTILUS BIOL PALEOB, P563, DOI [10.1007/978-90-481-3299-7_35, DOI 10.1007/978-90-481-3299-7_35]; Crall JP, 2013, IEEE WORK APP COMP, P230, DOI 10.1109/WACV.2013.6475023; De Angelis P, 2012, GEOBIOS-LYON, V45, P5, DOI 10.1016/j.geobios.2011.11.005; Del Norte-Campos A.G.C., 2005, PHUKET MAR BIO CEN R, V66, P299; Dorman SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041538; Dunstan A, 2010, FISH RES, V106, P239, DOI 10.1016/j.fishres.2010.06.015; Dunstan A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016716; Gladstone W, 2012, J EXP MAR BIOL ECOL, V429, P28, DOI 10.1016/j.jembe.2012.06.013; Harvey ES, 2007, MAR ECOL PROG SER, V350, P245, DOI 10.3354/meps07192; Harvey ES, 2012, FISH RES, V125, P108, DOI 10.1016/j.fishres.2012.01.026; Haven D, 1977, J MAR BIO, V42, P177; Kroger B, 2011, BIOESSAYS, V33, P602, DOI 10.1002/bies.201100001; Landman N.H., 2010, NAUTILUS BIOL PALEOB, P401, DOI DOI 10.1007/978-90-481-3299-7_28; Langlois TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045973; Lowry M, 2012, J EXP MAR BIOL ECOL, V416, P243, DOI 10.1016/j.jembe.2012.01.013; ODOR RK, 1990, J EXP BIOL, V154, P383; OKUBO S, 1995, VELIGER, V38, P192; Priede IG, 1996, J FISH BIOL, V49, P207, DOI 10.1111/j.1095-8649.1996.tb06077.x; SAUNDERS WB, 1983, PALEOBIOLOGY, V9, P280, DOI 10.1017/S0094837300007697; SAUNDERS WB, 1984, SCIENCE, V224, P990, DOI 10.1126/science.224.4652.990; SAUNDERS WB, 1978, PALEOBIOLOGY, V4, P349, DOI 10.1017/S0094837300006047; Saunders WB, 2010, NAUTILUS BIOL PALEOB, V6, P137; Sinclair W, 2011, REV FISH SCI, V19, P52, DOI 10.1080/10641262.2010.533794; Uchiyama K, 1996, ADV RES LIVING FOSSI, P13; WARD P, 1977, PALEOBIOLOGY, V3, P377, DOI 10.1017/S0094837300005534; Ward P. D., 1987, NATURAL HIST NAUTILU; WARD PD, 1980, VELIGER, V22, P259; Ward PD, 1997, J PALEONTOL, V71, P1054, DOI 10.1017/S0022336000036039; Ward PD, 1980, SHELL IMPOLSION DEPT, P13; WARD PD, 1988, SEARCH NAUTILUS; Woodruff DS, 2010, NAUTILUS BIOL PALEOB, P65; WRAY CG, 1995, PALEOBIOLOGY, V21, P220, DOI 10.1017/S009483730001321X	36	20	21	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100799	10.1371/journal.pone.0100799	http://dx.doi.org/10.1371/journal.pone.0100799			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956107	Green Published, gold			2022-12-27	WOS:000338917900095
J	Di Marco, F; Di Paolo, M; Romeo, S; Colecchi, L; Fiorani, L; Spana, S; Stone, J; Bisti, S				Di Marco, Fabiana; Di Paolo, Mattia; Romeo, Stefania; Colecchi, Linda; Fiorani, Lavinia; Spana, Sharon; Stone, Jonathan; Bisti, Silvia			Combining Neuroprotectants in a Model of Retinal Degeneration: No Additive Benefit	PLOS ONE			English	Article							SAFFRON SUPPLEMENTATION; LIGHT; PHOTOBIOMODULATION; DEATH; MECHANISMS; SURVIVAL; OXYGEN	The central nervous system undergoing degeneration can be stabilized, and in some models can be restored to function, by neuroprotective treatments. Photobiomodulation (PBM) and dietary saffron are distinctive as neuroprotectants in that they upregulate protective mechanisms, without causing measurable tissue damage. This study reports a first attempt to combine the actions of PBM and saffron. Our working hypothesis was that the actions of PBM and saffron in protecting retinal photoreceptors, in a rat light damage model, would be additive. Results confirmed the neuroprotective potential of each used separately, but gave no evidence that their effects are additive. Detailed analysis suggests that there is actually a negative interaction between PBM and saffron when given simultaneously, with a consequent reduction of the neuroprotection. Specific testing will be required to understand the mechanisms involved and to establish whether there is clinical potential in combining neuroprotectants, to improve the quality of life of people affected by retinal pathology, such as age-related macular degeneration, the major cause of blindness and visual impairment in older adults.	[Di Marco, Fabiana; Di Paolo, Mattia; Romeo, Stefania; Colecchi, Linda; Fiorani, Lavinia; Bisti, Silvia] Univ Aquila, Dept Biotechnol & Appl Clin Sci, I-67100 Laquila, Italy; [Spana, Sharon; Stone, Jonathan] Univ Sydney, Discipline Physiol, Sydney, NSW 2006, Australia; [Spana, Sharon; Stone, Jonathan] Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia; [Stone, Jonathan; Bisti, Silvia] Australian Natl Univ, ARC Ctr Excellence Vis Sci, Canberra, ACT, Australia	University of L'Aquila; University of Sydney; University of Sydney; Australian National University	Di Marco, F (corresponding author), Univ Aquila, Dept Biotechnol & Appl Clin Sci, I-67100 Laquila, Italy.	dm.fabiana@hotmail.it			Australian Research Council Centre of Excellence in Vision Science; Sir Zelman Cowen Universities Fund; Lord Mayor's Charitable Foundation; Australian Travel Awards for L'Aquila Researchers (ARIA); Ministero dell'Istruzione, dell'Universita e della Ricerca dedicato ai PRIN, Progetti di Ricerca di Interesse Nazionale (MIUR-PRIN)	Australian Research Council Centre of Excellence in Vision Science(Australian Research Council); Sir Zelman Cowen Universities Fund; Lord Mayor's Charitable Foundation; Australian Travel Awards for L'Aquila Researchers (ARIA); Ministero dell'Istruzione, dell'Universita e della Ricerca dedicato ai PRIN, Progetti di Ricerca di Interesse Nazionale (MIUR-PRIN)	This work was supported by the Australian Research Council Centre of Excellence in Vision Science, by the Sir Zelman Cowen Universities Fund and the Lord Mayor's Charitable Foundation, by Australian Travel Awards for L'Aquila Researchers (ARIA) to FDM and SR and by a Ministero dell'Istruzione, dell'Universita e della Ricerca dedicato ai PRIN, Progetti di Ricerca di Interesse Nazionale (MIUR-PRIN) (2010-2011) research grant to SB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albarracin R, 2011, INVEST OPHTH VIS SCI, V52, P3582, DOI 10.1167/iovs.10-6664; Begum R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057828; Bisti S, 2014, VISUAL NEUROSCI, V12, P1; Bowers F, 2001, INVEST OPHTH VIS SCI, V42, P804; Di Marco F, 2013, AM J NEURODEGENER DI, V2, P208; Eells JT, 2008, LECT NOTES ELECTR EN, V12, P39; Falsini B, 2010, INVEST OPHTH VIS SCI, V51, P6118, DOI 10.1167/iovs.09-4995; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Giaccio M, 2004, CRIT REV FOOD SCI, V44, P155, DOI 10.1080/10408690490441433; Maccarone R, 2008, INVEST OPHTH VIS SCI, V49, P1254, DOI 10.1167/iovs.07-0438; Marangoni D, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-228; Maslim J, 1997, INVEST OPHTH VIS SCI, V38, P1667; Natoli R, 2010, MOL VIS, V16, P1801; Organisciak DT, 2010, PROG RETIN EYE RES, V29, P113, DOI 10.1016/j.preteyeres.2009.11.004; Purushothuman S, 2013, BRAIN RES, V1535, P61, DOI 10.1016/j.brainres.2013.08.047; Rutar M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-257; Stone J, 1999, PROG RETIN EYE RES, V18, P689, DOI 10.1016/S1350-9462(98)00032-9	17	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100389	10.1371/journal.pone.0100389	http://dx.doi.org/10.1371/journal.pone.0100389			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955576	Green Submitted, Green Published, gold			2022-12-27	WOS:000338917900046
J	Meng, HZ; Li, XC; Qiao, PH				Meng, Hongzhe; Li, Xiaochen; Qiao, Penghai			Population Structure, Historical Biogeography and Demographic History of the Alpine Toad Scutiger ningshanensis in the Tsinling Mountains of Central China	PLOS ONE			English	Article							HIGH GENETIC DIVERSITY; LAST GLACIAL MAXIMUM; SPECIES GROUP; PHYLOGENETIC-RELATIONSHIPS; MOLECULAR PHYLOGENETICS; LANDSCAPE GENETICS; AMPHIBIAN DECLINES; MITOCHONDRIAL-DNA; AREA CLADOGRAM; SALAMANDER	Population genetic structure, historical biogeography and historical demography of the alpine toad Scutiger ningshanensis were studied using the combined data mtDNA cytochrome b (cyt b) and the mtDNA cytochrome c oxidase subunit I (COI) as the molecular markers. This species has high genetic variation. There was a significant genetic differentiation among most populations. Three lineages were detected. The phylogenetic relationship analyses and the SAMOVA (spatial analysis of molecular variance) results showed significant phylogeographic structure. 82.15% genetic variation occurred among populations whereas differentiation within populations only contributed 17.85% to the total. Mantel test results showed a significant correlation between the pairwise calculated genetic distance and pairwise calculated geographical distance of the populations (regression coefficient = 0.001286, correlation coefficient = 0.77051, p (r(rand)>= r(obs)) = 0.0185<0.05), indicating the existence of isolation-by-distance pattern of genetic divergence for cyt b + COI sequence, which suggests that the distribution of genetic variation is due to geographical separation rather than natural selection. The population expansion or contraction and genetic differentiation between populations or lineages could be explained by topography and the repetitive uplifts of the Tsinling Mountains and the climatic cycles during the late Pliocene and Pleistocene. S. ningshanensis experienced a rapid population expansion about 40,000 years before present. The current decline in population size was probably caused by anthropogenic disturbance. Current populations of S. ningshanensis are from different refugia though the location of these refugia could not be determined in our study. Topography, climatic changes and repetitive population expansion/contraction together led to the high level of genetic variation in S. ningshanensis. A total of three management units (MUs) was determined, which must be considered when conservation policy is made in the future.	[Meng, Hongzhe; Li, Xiaochen; Qiao, Penghai] Shaanxi Normal Univ, Coll Life Sci, Coinnovat Ctr Qinba Reg Sustainable Dev, Xian, Peoples R China	Shaanxi Normal University	Li, XC (corresponding author), Shaanxi Normal Univ, Coll Life Sci, Coinnovat Ctr Qinba Reg Sustainable Dev, Xian, Peoples R China.	xiaochen@snnu.edu.cn			National Natural Science Foundation of China [31071888]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding was provided by the National Natural Science Foundation of China (No. 31071888). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; ArisBrosou S, 1996, MOL BIOL EVOL, V13, P494, DOI 10.1093/oxfordjournals.molbev.a025610; Avise J.C., 2000, PHYLOGEOGRAPHY; Axelrod D, 1998, HIST MODERN FLORA CH; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bidlack AL, 2001, ANIM CONSERV, V4, P283, DOI 10.1017/S1367943001008885; BLAUSTEIN AR, 1994, CONSERV BIOL, V8, P60, DOI 10.1046/j.1523-1739.1994.08010060.x; Bryson RW, 2011, J BIOGEOGR, V38, P2299, DOI 10.1111/j.1365-2699.2011.02565.x; Bryson RW, 2011, J BIOGEOGR, V38, P697, DOI 10.1111/j.1365-2699.2010.02431.x; Carey C, 2003, AMPHIBIAN DECLINE: AN INTEGRATED ANALYSIS OF MULTIPLE STRESSOR EFFECTS, P153; Carstens BC, 2004, MOL ECOL, V13, P2557, DOI 10.1111/j.1365-294X.2004.02250.x; Carstens BC, 2005, EVOLUTION, V59, P1639, DOI 10.1554/04-661.1; Chen Xiao-Hong, 2009, Acta Zootaxonomica Sinica, V34, P647; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Collins JP, 2003, DIVERS DISTRIB, V9, P89, DOI 10.1046/j.1472-4642.2003.00012.x; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; DeChaine EG, 2004, EVOLUTION, V58, P113, DOI 10.1111/j.0014-3820.2004.tb01578.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fang Rengsheng, 1985, Acta Herpetologica Sinica, V4, P305; Fei L., 2009, FAUNA SIN; Fouquet A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001109; Fu YX, 1997, GENETICS, V147, P915; Guillot G, 2013, METHODS ECOL EVOL, V4, P336, DOI 10.1111/2041-210x.12018; Guo XR, 2000, J NW FORESTRY U, V15, P71; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hayes John P., 1992, Systematic Biology, V41, P331, DOI 10.2307/2992570; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hickerson MJ, 2010, MOL PHYLOGENET EVOL, V54, P291, DOI 10.1016/j.ympev.2009.09.016; Hillis David M., 1996, P321; Huang YZ, 1985, ACTA BIOL PLATEAU SI, V4, P77; Jijun L., 2001, QUAT SCI, V21, P381, DOI DOI 10.3321/J.ISSN:1001-7410.2001.05.001; Ju LX, 2007, PALAEOGEOGR PALAEOCL, V248, P376, DOI 10.1016/j.palaeo.2006.12.012; Knowles LL, 2009, ANNU REV ECOL EVOL S, V40, P593, DOI 10.1146/annurev.ecolsys.38.091206.095702; Knowles LL, 2002, MOL ECOL, V11, P2623, DOI 10.1046/j.1365-294X.2002.01637.x; Kraaijeveld-Smit FJL, 2005, MOL ECOL, V14, P3307, DOI 10.1111/j.1365-294X.2005.02614.x; Kuhner MK, 2006, BIOINFORMATICS, V22, P768, DOI 10.1093/bioinformatics/btk051; Kumbar SM, 2001, J BIOSCIENCE, V26, P265, DOI 10.1007/BF02703650; Lessa EP, 2003, P NATL ACAD SCI USA, V100, P10331, DOI 10.1073/pnas.1730921100; Liang G, 1989, J SHAANXI NORMAL U N, V17, P92; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; [刘康 Liu Kang], 2004, [生态学杂志, Chinese Journal of Ecology], V23, P157; Liu YH, 1974, J SHAANXI NORM U NAT, P74; Liu YM, 1985, B TIANJIN I GEOL MIN, V14, P1; Lu Yu-Yan, 2007, Acta Zoologica Sinica, V53, P383; Ma CC, 2007, J SUZHOU U, V22, p[23, 109]; Ma Q., 1988, J GLACIOL GEOCRYOL, V10, P66; Macey JR, 2001, MOL PHYLOGENET EVOL, V19, P131, DOI 10.1006/mpev.2000.0908; Macey JR, 1999, MOL PHYLOGENET EVOL, V12, P320, DOI 10.1006/mpev.1999.0641; Macey JR, 1998, MOL PHYLOGENET EVOL, V9, P80, DOI 10.1006/mpev.1997.0440; Macey JR, 1998, MOL PHYLOGENET EVOL, V10, P118, DOI 10.1006/mpev.1997.0478; Maddison WP, 2011, MESQUITE MODULAR SYS; Martel C, 2004, J EXP MAR BIOL ECOL, V305, P155, DOI 10.1016/j.jembe.2003.11.011; Masel J, 2011, CURR BIOL, V21, pR837, DOI 10.1016/j.cub.2011.08.007; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; MORITZ C, 1987, ANNU REV ECOL SYST, V18, P269, DOI 10.1146/annurev.ecolsys.18.1.269; Murphy MA, 2010, MOL ECOL, V19, P3634, DOI 10.1111/j.1365-294X.2010.04723.x; NEI M, 2003, MOL EVOLUTION PHYLOG; [潘保田 Pan Baotian], 2004, [第四纪研究, Quaternary Sciences], V24, P50; Pinot S, 1999, CLIM DYNAM, V15, P857, DOI 10.1007/s003820050318; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rost KT, 1994, J XIAN COLL GEOL, V16, P39; Rowe G, 2000, OIKOS, V88, P641, DOI 10.1034/j.1600-0706.2000.880321.x; Schneider S, 1999, GENETICS, V152, P1079; Shepard DB, 2009, MOL ECOL, V18, P2243, DOI 10.1111/j.1365-294X.2009.04164.x; Shepard DB, 2008, MOL ECOL, V17, P5315, DOI 10.1111/j.1365-294X.2008.03998.x; SLATKIN M, 1985, ANNU REV ECOL SYST, V16, P393, DOI 10.1146/annurev.ecolsys.16.1.393; Smith CI, 2005, MOL ECOL, V14, P3049, DOI 10.1111/j.1365-294X.2005.02647.x; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Spear SF, 2005, MOL ECOL, V14, P2553, DOI 10.1111/j.1365-294X.2005.02573.x; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; TAJIMA F, 1993, MECHANISMS OF MOLECULAR EVOLUTION, P37; Tajima F, 1996, GENETICS, V143, P1457; TAJIMA F, 1989, GENETICS, V123, P585; Takahashi K, 2000, MOL BIOL EVOL, V17, P1251, DOI 10.1093/oxfordjournals.molbev.a026408; Tallmon DA, 2000, COPEIA, P27, DOI 10.1643/0045-8511(2000)2000[0027:GDALTS]2.0.CO;2; Teng ZH, 1996, GEOL SHAANXI, V14, P33; Tian ZS, 1990, GEOGR RES, V9, P15; Torres-Diaz C, 2007, ANN BOT-LONDON, V100, P75, DOI 10.1093/aob/mcm073; Walker George F., 2008, Bulletin Southern California Academy of Sciences, V107, P158, DOI 10.3160/0038-3872-107.3.158; Wang B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041579; Wang GZ., 1984, GEOLOGY SHAANXI, V2, P47; Wang HW, 2006, MOL ECOL, V15, P4109, DOI 10.1111/j.1365-294X.2006.03086.x; Weisrock DW, 2001, MOL PHYLOGENET EVOL, V18, P434, DOI 10.1006/mpev.2000.0905; Xia ZK, 1990, J GLACIOL GEOCRYOL, V12, P155; Xue DW, 2004, ACTA BOT SIN, V46, P1163; [薛祥煦 Xue Xiangxu], 2004, [第四纪研究, Quaternary Sciences], V24, P82; [薛祥煦 Xue Xiangxu], 2002, [西北大学学报. 自然科学版, Journal of Northwest University], V32, P451; Xue XX, 1996, GEOL REV, V42, P30; Yuan SL, 2006, MOL ECOL, V15, P2119, DOI 10.1111/j.1365-294X.2006.02875.x; Zhang JL, 1997, CHINESE BIODIVERSITY, V5, P155; ZHANG Y, 1978, ACTA ZOOL SINICA, V24, P196; Zhao ZZ, 1997, J GEOMECH, V3, P18	104	7	11	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100729	10.1371/journal.pone.0100729	http://dx.doi.org/10.1371/journal.pone.0100729			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956389	gold, Green Published, Green Submitted			2022-12-27	WOS:000338917900089
J	Chaiyasap, P; Kulawonganunchai, S; Srichomthong, C; Tongsima, S; Suphapeetiporn, K; Shotelersuk, V				Chaiyasap, Pongsathorn; Kulawonganunchai, Supasak; Srichomthong, Chalurmpon; Tongsima, Sissades; Suphapeetiporn, Kanya; Shotelersuk, Vorasuk			Whole Genome and Exome Sequencing of Monozygotic Twins with Trisomy 21, Discordant for a Congenital Heart Defect and Epilepsy	PLOS ONE			English	Article							DOWN-SYNDROME; CHROMOSOME-21; DISEASE	Congenital heart defects (CHD) occur in 40% of patients with trisomy 21, while the other 60% have a structurally normal heart. This suggests that the increased dosage of genes on chromosome 21 is a risk factor for abnormal heart development. Interaction of genes on chromosome 21 or their gene products with certain alleles of genes on other chromosomes could contribute to CHD. Here, we identified a pair of monozygotic twins with trisomy 21 but discordant for a ventricular septal defect and epilepsy. Twin-zygosity was confirmed by microsatellite genotyping. We hypothesized that some genetic differences from post-twinning mutations caused the discordant phenotypes. Thus, next generation sequencing (NGS) technologies were applied to sequence both whole genome and exome of their leukocytes. The post-analyses of the sequencing data revealed 21 putative discordant exonic variants between the twins from either genome or exome data. However, of the 15 variants chosen for validation with conventional Sanger sequencing, these candidate variants showed no differences in both twins. The fact that no discordant DNA variants were found suggests that sequence differences of DNA from leukocytes of monozygotic twins might be extremely rare. It also emphasizes the limitation of the current NGS technology in identifying causative genes for discordant phenotypes in monozygotic twins.	[Chaiyasap, Pongsathorn; Kulawonganunchai, Supasak] Chulalongkorn Univ, Fac Grad Sch, Interdept Biomed Sci, Bangkok, Thailand; [Kulawonganunchai, Supasak; Tongsima, Sissades] Natl Ctr Genet Engn & Biotechnol, Genome Inst, Khlong Luang, Pathum Thani, Thailand; [Srichomthong, Chalurmpon; Suphapeetiporn, Kanya; Shotelersuk, Vorasuk] Chulalongkorn Univ, Fac Med, Dept Pediat, Ctr Excellence Med Genet, Bangkok 10330, Thailand; [Srichomthong, Chalurmpon; Suphapeetiporn, Kanya; Shotelersuk, Vorasuk] King Chulalongkorn Mem Hosp, Excellence Ctr Med Genet, Bangkok, Thailand	Chulalongkorn University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Chulalongkorn University; Chulalongkorn University	Suphapeetiporn, K (corresponding author), Chulalongkorn Univ, Fac Med, Dept Pediat, Ctr Excellence Med Genet, Bangkok 10330, Thailand.	Kanya.Su@chula.ac.th	; Tongsima, Sissades/F-4891-2011	Shotelersuk, Vorasuk/0000-0002-1856-0589; Tongsima, Sissades/0000-0002-1491-1839	Ratchadapiseksomphot Endowment Fund of Chulalongkorn University [RES560530177-HR]; Thailand Research Fund [RTA5680003, RSA5480022, RSA5480026]; Royal Golden Jubilee Ph.D. Program [PHD/0071/2552]; Research Chair Grants by the National Science and Technology Development Agency (NSTDA)	Ratchadapiseksomphot Endowment Fund of Chulalongkorn University; Thailand Research Fund(Thailand Research Fund (TRF)); Royal Golden Jubilee Ph.D. Program(Thailand Research Fund (TRF)); Research Chair Grants by the National Science and Technology Development Agency (NSTDA)	This study was funded through Ratchadapiseksomphot Endowment Fund of Chulalongkorn University (RES560530177-HR) awarded to CS, VS and KS and through the Thailand Research Fund (RTA5680003, RSA5480022). PC is a recipient of Royal Golden Jubilee Ph.D. Program (Grant No. PHD/0071/2552). ST and SK were supported in part by the 2011 Research Chair Grants issued by the National Science and Technology Development Agency (NSTDA) and the Thailand Research Fund (RSA5480026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Antonarakis SE, 2004, NAT REV GENET, V5, P725, DOI 10.1038/nrg1448; Antonarakis SE, 1998, GENOMICS, V51, P1, DOI 10.1006/geno.1998.5335; Aparicio SAJR, 2010, J PATHOL, V220, P307, DOI 10.1002/path.2636; Baranzini SE, 2010, NATURE, V464, P1351, DOI 10.1038/nature08990; Biesecker LG, 2013, NAT REV GENET, V14, P307, DOI 10.1038/nrg3424; Brickell KL, 2007, J NEUROL NEUROSUR PS, V78, P1050, DOI 10.1136/jnnp.2006.113803; Chahrour MH, 2012, PLOS GENET, V8, P236, DOI 10.1371/journal.pgen.1002635; Erlich Y, 2011, TWIN RES HUM GENET, V14, P137, DOI 10.1375/twin.14.2.137; Imelfort Michael, 2009, V513, P345, DOI 10.1007/978-1-59745-427-8_18; Ketelaar ME, 2012, CLIN GENET, V81, P325, DOI 10.1111/j.1399-0004.2011.01795.x; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Kuhlenbaumer G, 2011, HUM MUTAT, V32, P144, DOI 10.1002/humu.21400; Langdon J, 1966, HEREDITY, V21, P695; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Maiti S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017125; Makrythanasis P, 2013, CLIN GENET, V84, P422, DOI 10.1111/cge.12272; Nachman MW, 2000, GENETICS, V156, P297; Nielsen R, 2011, NAT REV GENET, V12, P443, DOI 10.1038/nrg2986; Reumers J, 2012, NAT BIOTECHNOL, V30, P61, DOI 10.1038/nbt.2053; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Roizen NJ, 2003, LANCET, V361, P1281, DOI 10.1016/S0140-6736(03)12987-X; Solomon BD, 2013, MOL SYNDROMOL, V4, P27, DOI 10.1159/000345406	23	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100191	10.1371/journal.pone.0100191	http://dx.doi.org/10.1371/journal.pone.0100191			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950249	Green Published, Green Submitted, gold			2022-12-27	WOS:000338276300047
J	Li, HY; Zhang, Y; Yi, ZHZ; Huang, DH; Wei, SH				Li, Hongyang; Zhang, Yan; Yi, Zuohuizi; Huang, Dehui; Wei, Shihui			Frequency of Autoantibodies and Connective Tissue Diseases in Chinese Patients with Optic Neuritis	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; PRIMARY SJOGRENS-SYNDROME; MULTIPLE-SCLEROSIS; NEUROMYELITIS-OPTICA; CLASSIFICATION CRITERIA; OLIGODENDROCYTE GLYCOPROTEIN; DIAGNOSTIC-CRITERIA; ANTIBODIES; AUTOIMMUNITY; DISTINCTION	Background: Optic neuritis (ON) is often associated with other clinical or serological markers of connective tissue diseases (CTDs). To date, the effects of autoantibodies on ON are not clear. Purpose: To assess the prevalence, clinical patterns, and short outcomes of autoantibodies and Sjogren's syndrome (SS) involvement in Chinese ON patients and evaluate the relationship between ON, including their subtypes, and autoantibodies. Methods: A total of 190 ON patients were divided into recurrent ON (RON), bilateral ON (BON), and isolated monocular ON (ION). Demographic, clinical, and serum autoantibodies data were compared between them with and without SS involvement. Serum was drawn for antinuclear antibody (ANA), extractable nuclear antigen antibodies (SSA/SSB), rheumatoid factor (RF), anticardiolipin antibodies (ACA), and anti-double-stranded DNA antibody (A-ds DNA), anticardiolipin antibody (ACLs), anti-beta 2-glycoprotein I (beta 2-GPI) and Aquaporin-4 antibodies (AQP4-Ab). Spectral-domain optical coherence tomography (SD-OCT) was used to evaluate the atrophy of the optic nerve. Results: 68 patients (35.79%) had abnormal autoantibodies, 26(13.68%) patients met diagnostic criteria for CTDs, including 15(7.89%) patients meeting the criteria for SS. Antibodies including SSA/SSB 23 (30.26%) (p1 and p 2<0.001) and AQP4-Ab10 (13.16%) (p1 = 0.044, p2 = 0.01) were significantly different in patients in the RON group when compared with those in the BON (P1 = RON VS ION) and ION (p2 = RON VS ION) groups. SS was more common in RON patients (p1 = 0.04, p2 = 0.028). There was no significant difference between SSA/SSB positive and negative patients in disease characteristics or severity. Similar results were obtained when SS was diagnosed in SSA/SSB positive patients. Conclusion: RON and BON were more likely associated with abnormal autoantibodies; furthermore, AQP4 antibody, SSA/SSB and SS were more common in the RON patients. AQP4 antibodydetermination is crucial in RON patients who will develop NMO. However, when compared with other autoantibodies, SSA/SSB detected in patients was not significantly associated with disease characteristics or severity.	[Li, Hongyang; Wei, Shihui] Chinese Peoples Liberat Army Gen Hosp, Dept Ophthalmol, Beijing, Peoples R China; [Zhang, Yan] Gen Hosp Beijing Mil Reg, Dept Ophthalmol, Beijing, Peoples R China; [Yi, Zuohuizi] Wuhan Univ, Peoples Hosp, Dept Ophthalmol, Wuhan 430072, Peoples R China; [Huang, Dehui] Chinese Peoples Liberat Army Gen Hosp, Dept Neurol, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Seventh Medical Center of Chinese PLA General Hospital; Wuhan University; Chinese People's Liberation Army General Hospital	Wei, SH (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Ophthalmol, Beijing, Peoples R China.	weishihui1958@163.com			National the 12th Five-Year Plan Science and Technology support project "clinical epidemiological studies of optic neuritis [2012BAI08B06]; China Postdoctoral Science Foundation [2013M532109]	National the 12th Five-Year Plan Science and Technology support project "clinical epidemiological studies of optic neuritis; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work is supported by National the 12th Five-Year Plan Science and Technology support project "clinical epidemiological studies of optic neuritis (Number: 2012BAI08B06) and China Postdoctoral Science Foundation (NO:2013M532109). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; [Anonymous], 1991, ARCH OPHTHALMOL, V109, P1673; BECK RW, 1992, NEW ENGL J MED, V326, P581, DOI 10.1056/NEJM199202273260901; Bejot Y, 2008, REV NEUROL-FRANCE, V164, P1044, DOI 10.1016/j.neurol.2008.04.017; Benoilid A, 2013, MULT SCLER; Bichuetti DB, 2009, MULT SCLER, V15, P613, DOI 10.1177/1352458508101935; Burgoyne PS, 2002, CYTOGENET GENOME RES, V99, P252, DOI 10.1159/000071601; Capel B, 1999, MECH DEVELOP, V84, P127, DOI 10.1016/S0925-4773(99)00047-7; Castro J, 2008, AUTOIMMUN REV, V7, P345, DOI 10.1016/j.autrev.2008.01.001; Cojocaru Inimioara Mihaela, 2011, Rom J Intern Med, V49, P301; de Seze J, 2001, NEUROLOGY, V57, P1359, DOI 10.1212/WNL.57.8.1359; DEROSBO NK, 1993, J CLIN INVEST, V92, P2602, DOI 10.1172/JCI116875; Eckstein C, 2012, J NEUROL, V259, P801, DOI 10.1007/s00415-011-6240-5; Etemadifar M, 2012, INT J PREVENTIVE MED, V3, P612; Fox RI, 2005, LANCET, V366, P321, DOI 10.1016/S0140-6736(05)66990-5; Gan FY, 2014, CLIN RHEUMATOL, V33, P355, DOI 10.1007/s10067-013-2444-7; Garcia-Martin E, 2014, OPHTHALMOLOGY, V121, P573, DOI 10.1016/j.ophtha.2013.09.035; Gono T, 2011, CLIN RHEUMATOL, V30, P485, DOI 10.1007/s10067-010-1458-7; Heinzlef O, 2002, J NEUROL NEUROSUR PS, V72, P647, DOI 10.1136/jnnp.72.5.647; Hinson SR, 2010, NEUROSCIENCE, V168, P1009, DOI 10.1016/j.neuroscience.2009.08.032; HOFFMAN GS, 1992, ANN INTERN MED, V116, P488, DOI 10.7326/0003-4819-116-6-488; Hummers LK, 2004, NEUROLOGY, V62, P147, DOI 10.1212/01.WNL.0000101715.32569.1A; International Study Group for Behcet's Disease, 1990, LANCET, V335, P1078; Jarius S, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-14; Jarius S, 2010, J NEUROL SCI, V298, P158, DOI 10.1016/j.jns.2010.07.011; Javed A, 2008, MULT SCLER, V14, P809, DOI 10.1177/1352458508088941; Kurne A, 2008, J NEUROL, V255, P1625, DOI 10.1007/s00415-008-0882-y; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Mader S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010455; Massara A, 2010, RHEUMATOLOGY, V49, P1540, DOI 10.1093/rheumatology/keq111; Matiello M, 2008, NEUROLOGY, V70, P2197, DOI 10.1212/01.wnl.0000303817.82134.da; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x; Mochizuki A, 2000, NEUROLOGY, V54, P1391, DOI 10.1212/WNL.54.6.1391; Nielsen NM, 2011, HUM REPROD, V26, P1555, DOI 10.1093/humrep/der105; Petzold A, 2010, J NEUROL NEUROSUR PS, V81, P109, DOI 10.1136/jnnp.2008.146894; Pittock SJ, 2008, ARCH NEUROL-CHICAGO, V65, P78, DOI 10.1001/archneurol.2007.17; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Ramirez M, 2009, MED CLIN-BARCELONA, V133, P349, DOI 10.1016/j.medcli.2008.12.027; Ramos-Casals M, 2007, J RHEUMATOL, V34, P754; Rostasy K, 2012, ARCH NEUROL-CHICAGO, V69, P752, DOI 10.1001/archneurol.2011.2956; SANDBERGWOLLHEIM M, 1992, NEUROLOGY, V42, P845, DOI 10.1212/WNL.42.4.845; Sato DK, 2014, NEUROLOGY, V82, P474, DOI 10.1212/WNL.0000000000000101; Silva FR, 2013, ARQ BRAS OFTALMOL, V76, P170, DOI 10.1590/S0004-27492013000300008; Solomon A, 2013, NY TIMES BK REV, P8; Spadaro M, 1999, MULT SCLER, V5, P121, DOI 10.1191/135245899678847211; Szmyrka-Kaczmarek M, 2012, LUPUS, V21, P412, DOI 10.1177/0961203311427550; Tan Petrina, 2012, J Med Case Rep, V6, P401, DOI 10.1186/1752-1947-6-401; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Waschbisch A, 2013, J NEUROL SCI, V331, P72, DOI 10.1016/j.jns.2013.05.012; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Wingerchuk DM, 2012, MULT SCLER J, V18, P5, DOI 10.1177/1352458511431077; Yang Y, 2013, J CLIN NEUROSCI, V20, P94, DOI 10.1016/j.jocn.2012.06.006	53	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e99323	10.1371/journal.pone.0099323	http://dx.doi.org/10.1371/journal.pone.0099323			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950188	Green Published, gold, Green Submitted			2022-12-27	WOS:000338276300013
J	Mosley, JD; Van Driest, SL; Weeke, PE; Delaney, JT; Wells, QS; Bastarache, L; Roden, DM; Denny, JC				Mosley, Jonathan D.; Van Driest, Sara L.; Weeke, Peter E.; Delaney, Jessica T.; Wells, Quinn S.; Bastarache, Lisa; Roden, Dan M.; Denny, Josh C.			Integrating EMR-Linked and In Vivo Functional Genetic Data to Identify New Genotype-Phenotype Associations	PLOS ONE			English	Article							ELECTRONIC MEDICAL-RECORDS; GENOME-WIDE ASSOCIATION; DISEASE-ASSOCIATED MUTATIONS; HEPATOCYTE GROWTH-FACTOR; VLGR1 KNOCKOUT MICE; PHENOME-WIDE; EMERGE NETWORK; RARE VARIANTS; HEALTH RECORD; RISK	The coupling of electronic medical records (EMR) with genetic data has created the potential for implementing reverse genetic approaches in humans, whereby the function of a gene is inferred from the shared pattern of morbidity among homozygotes of a genetic variant. We explored the feasibility of this approach to identify phenotypes associated with low frequency variants using Vanderbilt's EMR-based BioVU resource. We analyzed 1,658 low frequency non-synonymous SNPs (nsSNPs) with a minor allele frequency (MAF) <10% collected on 8,546 subjects. For each nsSNP, we identified diagnoses shared by at least 2 minor allele homozygotes and with an association p<0.05. The diagnoses were reviewed by a clinician to ascertain whether they may share a common mechanistic basis. While a number of biologically compelling clinical patterns of association were observed, the frequency of these associations was identical to that observed using genotype-permuted data sets, indicating that the associations were likely due to chance. To refine our analysis associations, we then restricted the analysis to 711 nsSNPs in genes with phenotypes in the On-line Mendelian Inheritance in Man (OMIM) or knock-out mouse phenotype databases. An initial comparison of the EMR diagnoses to the known in vivo functions of the gene identified 25 candidate nsSNPs, 19 of which had significant genotype-phenotype associations when tested using matched controls. Twleve of the 19 nsSNPs associations were confirmed by a detailed record review. Four of 12 nsSNP-phenotype associations were successfully replicated in an independent data set: thrombosis (F5, rs6031), seizures/convulsions (GPR98, rs13157270), macular degeneration (CNGB3, rs3735972), and GI bleeding (HGFAC, rs16844401). These analyses demonstrate the feasibility and challenges of using reverse genetics approaches to identify novel gene-phenotype associations in human subjects using low frequency variants. As increasing amounts of rare variant data are generated from modern genotyping and sequence platforms, model organism data may be an important tool to enable discovery.	[Mosley, Jonathan D.; Weeke, Peter E.; Delaney, Jessica T.; Wells, Quinn S.; Roden, Dan M.; Denny, Josh C.] Vanderbilt Univ, Dept Med, Nashville, TN 37235 USA; [Van Driest, Sara L.] Vanderbilt Univ, Dept Pediat, Nashville, TN USA; [Bastarache, Lisa; Denny, Josh C.] Vanderbilt Univ, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Denny, JC (corresponding author), Vanderbilt Univ, Dept Med, Nashville, TN 37235 USA.	joshua.denny@vanderbilt.edu	Roden, Dan/ABD-5412-2021; Denny, Josh/AAL-3359-2021	Denny, Josh/0000-0002-3049-7332; Mosley, Jonathan/0000-0001-6421-2887	Vanderbilt University Medical Center Clinical Pharmacology Training grant [T32 GM07569]; Vanderbilt site of the electronic MEdical Records and GEnomics (eMERGE) Network [U01-HG006378, R01-LM-01685]; ARRA grant [RC2 GM092618]; Vanderbilt CTSA grant from National Center for Advancing Translational Sciences/National Institutes of Health [UL1 TR000445]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006378] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC2GM092618, T32GM007569] Funding Source: NIH RePORTER	Vanderbilt University Medical Center Clinical Pharmacology Training grant; Vanderbilt site of the electronic MEdical Records and GEnomics (eMERGE) Network; ARRA grant; Vanderbilt CTSA grant from National Center for Advancing Translational Sciences/National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Vanderbilt University Medical Center Clinical Pharmacology Training grant (T32 GM07569), the Vanderbilt site of the electronic MEdical Records and GEnomics (eMERGE) Network U01-HG006378, R01-LM-01685, and an ARRA grant RC2 GM092618, and the Vanderbilt CTSA grant UL1 TR000445 from National Center for Advancing Translational Sciences/National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Anholt RRH, 2004, NAT REV GENET, V5, P838, DOI 10.1038/nrg1472; Austin CP, 2004, NAT GENET, V36, P921, DOI 10.1038/ng0904-921; Bansal V, 2010, NAT REV GENET, V11, P773, DOI 10.1038/nrg2867; Bielinski SJ, 2011, MAYO CLIN PROC, V86, P606, DOI 10.4065/mcp.2011.0178; Bowton E, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008604; Bright SR, 2005, MOL VIS, V11, P1141; Bromberg Y, 2008, BIOINFORMATICS, V24, P2397, DOI 10.1093/bioinformatics/btn435; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Cooper GM, 2011, NAT REV GENET, V12, P628, DOI 10.1038/nrg3046; CUNDELL DR, 1995, NATURE, V377, P435, DOI 10.1038/377435a0; Delaney JT, 2012, CLIN PHARMACOL THER, V91, P257, DOI 10.1038/clpt.2011.221; Denny JC, 2013, NAT BIOTECHNOL, V31, P1102, DOI 10.1038/nbt.2749; Denny JC, 2011, AM J HUM GENET, V89, P529, DOI 10.1016/j.ajhg.2011.09.008; Denny JC, 2010, CIRCULATION, V122, P2016, DOI 10.1161/CIRCULATIONAHA.110.948828; Denny JC, 2010, BIOINFORMATICS, V26, P1205, DOI 10.1093/bioinformatics/btq126; Do R, 2012, HUM MOL GENET; Frankovich J, 2011, NEW ENGL J MED, V365, P1758, DOI 10.1056/NEJMp1108726; Gerhardt A, 2000, NEW ENGL J MED, V342, P374, DOI 10.1056/NEJM200002103420602; Hebbring SJ, 2013, GENES IMMUN, V14, P187, DOI 10.1038/gene.2013.2; Itoh H, 2004, GASTROENTEROLOGY, V127, P1423, DOI 10.1053/j.gastro.2004.08.027; Jenkins RB, 2012, NAT GENET, V44, P1122, DOI 10.1038/ng.2388; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Kho AN, 2012, J AM MED INFORM ASSN, V19, P212, DOI 10.1136/amiajnl-2011-000439; Kho AN, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001807; Lettre G, 2007, GENET EPIDEMIOL, V31, P358, DOI 10.1002/gepi.20217; Lingappa JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023413; Liu CM, 2013, MOL VIS, V19, P1268; Maddatu TP, 2012, NUCLEIC ACIDS RES, V40, pD887, DOI 10.1093/nar/gkr1061; Manis JP, 2007, NEW ENGL J MED, V357, P2426, DOI 10.1056/NEJMp0707712; McCarty CA, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-13; Mosley JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081503; Nakayama J, 2002, ANN NEUROL, V52, P654, DOI 10.1002/ana.10347; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pendergrass SA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003087; Pritchard JK, 2000, GENETICS, V155, P945; Pulley J, 2010, CTS-CLIN TRANSL SCI, V3, P42, DOI 10.1111/j.1752-8062.2010.00175.x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramirez AH, 2012, PHARMACOGENOMICS, V13, P407, DOI [10.2217/PGS.11.164, 10.2217/pgs.11.164]; Roden DM, 2008, CLIN PHARMACOL THER, V84, P362, DOI 10.1038/clpt.2008.89; Schaefer C, 2012, BIOINFORMATICS, V28, P601, DOI 10.1093/bioinformatics/btr705; SHIMOMURA T, 1992, CYTOTECHNOLOGY, V8, P219, DOI 10.1007/BF02522039; Simioni P, 1997, NEW ENGL J MED, V336, P399, DOI 10.1056/NEJM199702063360602; Thiadens AAHJ, 2010, OPHTHALMOLOGY, V117, P825, DOI 10.1016/j.ophtha.2009.09.008; Walsh VL, 2011, MAMM GENOME, V22, P170, DOI 10.1007/s00335-010-9310-6; White JK, 2013, CELL, V154, P452, DOI 10.1016/j.cell.2013.06.022; Yagi H, 2005, J NEUROCHEM, V92, P191, DOI 10.1111/j.1471-4159.2004.02875.x; Yagi H, 2009, NEUROSCI LETT, V461, P190, DOI 10.1016/j.neulet.2009.06.012; Zuvich RL, 2011, GENET EPIDEMIOL, V35, P887, DOI 10.1002/gepi.20639	50	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100322	10.1371/journal.pone.0100322	http://dx.doi.org/10.1371/journal.pone.0100322			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949630	Green Submitted, Green Published, gold			2022-12-27	WOS:000338276300064
J	Wong, YYE; Hyde, Z; McCaul, KA; Yeap, BB; Golledge, J; Hankey, GJ; Flicker, L				Wong, Yuen Y. E.; Hyde, Zoe; McCaul, Kieran A.; Yeap, Bu B.; Golledge, Jonathan; Hankey, Graeme J.; Flicker, Leon			In Older Men, Lower Plasma 25-Hydroxyvitamin D Is Associated with Reduced Incidence of Prostate, but Not Colorectal or Lung Cancer	PLOS ONE			English	Article							VITAMIN-D SUPPLEMENTATION; D METABOLITE LEVELS; 1,25-DIHYDROXYVITAMIN D-3; SUBSEQUENT DEVELOPMENT; RISK; HEALTH; COHORT; POLYMORPHISMS; POPULATION; PREVALENCE	Context and objective: Prostate, colorectal and lung cancers are common in men. In this study, we aimed to determine whether vitamin D status is associated with the incidence of these cancers in older men. Design: Prospective cohort study. Setting and participants: 4208 older men aged 70-88 years in Perth, Western Australia Main outcome measures: Plasma 25-hydroxyvitamin D [25(OH)D] concentration was measured by immunoassay. New diagnoses of prostate, colorectal and lung cancers were determined via electronic record linkage. Results: During a mean follow-up of 6.7 +/- 1.8 years, there were 315, 117 and 101 new diagnoses of prostate, colorectal and lung cancer. In multivariate competing risks proportional hazards models, every 10 nmol/l decrease in 25(OH)D concentration was associated with a 4% reduction in prostate cancer incidence (sub-hazard ratio [SHR] 0.96, 95% confidence interval [CI] 0.92-1.00). Every halving of 25(OH)D concentration was associated with a 21% reduction in incident prostate cancer in multivariate analysis (SHR 0.79, 95% CI 0.63-0.99). Following exclusion of prostate cancer cases diagnosed within 3 years of blood sampling, low 25(OH)D <50 nmol/l was associated with lower incident prostate cancer, and higher 25(OH)D >75 nmol/l was associated with higher incidence, when compared to the reference range 50-75 nmol/l, respectively (p = 0.027). Significant associations were also observed when 25(OH)D was modeled as a quantitative variable. No associations were observed between plasma 25(OH)D concentration with incidence of colorectal or lung cancer. Conclusion: Lower levels of vitamin D may reduce prostate cancer risk in older men. By contrast, levels of vitamin D did not predict incidence of colorectal or lung cancers. Further studies are needed to determine whether a causal relationship exists between vitamin D and prostate cancer in ageing men.	[Wong, Yuen Y. E.; Hyde, Zoe; Flicker, Leon] Western Australian Inst Med Res, Med Res Ctr, Western Australian Ctr Hlth & Ageing, Perth, WA, Australia; [Wong, Yuen Y. E.; Hyde, Zoe; McCaul, Kieran A.; Yeap, Bu B.; Hankey, Graeme J.; Flicker, Leon] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Yeap, Bu B.] Fremantle Hosp, Dept Endocrinol & Diabet, Perth, WA, Australia; [Golledge, Jonathan] James Cook Univ, Sch Med & Dent, Queensland Res Ctr Peripheral Vasc Dis, Vasc Biol Unit, Townsville, Qld 4811, Australia; [Golledge, Jonathan] Townsville Hosp, Dept Vasc & Endovasc Surg, Townsville, Qld, Australia; [Hankey, Graeme J.] Sir Charles Gairdner Hosp, Dept Neurol, Perth, WA, Australia	University of Western Australia; University of Western Australia; James Cook University; University of Western Australia	Wong, YYE (corresponding author), Western Australian Inst Med Res, Med Res Ctr, Western Australian Ctr Hlth & Ageing, Perth, WA, Australia.	elizabeth.wong@uwa.edu.au; leon.flicker@uwa.edu.au	golledge, jonathan/I-2371-2013; Hankey, Graeme J/H-4968-2014; Hyde, Zoë/B-6411-2009; Flicker, Leon/AAE-1530-2022; McCaul, Kieran A/B-8751-2008	Hankey, Graeme J/0000-0002-6044-7328; Hyde, Zoë/0000-0002-5985-1729; Flicker, Leon/0000-0002-3650-0475; golledge, jonathan/0000-0002-5779-8848	National Health and Medical Research Council (NHMRC) of Australia [279408, 379600, 404963, 634492]; Australian Postgraduate Awards Scholarship through University of Western Australia	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Awards Scholarship through University of Western Australia	This work was supported by funding from the National Health and Medical Research Council (NHMRC) of Australia (Grant numbers 279408, 379600, 404963 and 634492). YYE Wong was recipient of the Australian Postgraduate Awards Scholarship through the University of Western Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzal S, 2013, CLIN CHEM, V59, P771, DOI 10.1373/clinchem.2012.201939; Ahn J, 2008, JNCI-J NATL CANCER I, V100, P796, DOI 10.1093/jnci/djn152; Ahonen MH, 2000, CANCER CAUSE CONTROL, V11, P847, DOI 10.1023/A:1008923802001; Autier P, 2014, LANCET DIABETES ENDO, V2, P76, DOI 10.1016/S2213-8587(13)70165-7; Baeke F, 2008, MOL ASPECTS MED, V29, P376, DOI 10.1016/j.mam.2008.05.004; Barreto AM, 2000, CANCER EPIDEM BIOMAR, V9, P265; Beer TM, 2004, CANCER EPIDEM BIOMAR, V13, P2225; BRAUN MM, 1995, AM J EPIDEMIOL, V142, P608, DOI 10.1093/oxfordjournals.aje.a117682; Cancer Research UK, 2011, CANCERSTATS CANC WOR; Chapuy MC, 1997, OSTEOPOROSIS INT, V7, P439, DOI 10.1007/s001980050030; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chiang KC, 2013, ANTI-CANCER AGENT ME, V13, P126, DOI 10.2174/187152013804487443; CORDER EH, 1993, CANCER EPIDEM BIOMAR, V2, P467; Dawson-Hughes B, 2010, OSTEOPOROSIS INT, V21, P1151, DOI 10.1007/s00198-010-1285-3; Deeb KK, 2007, NAT REV CANCER, V7, P684, DOI 10.1038/nrc2196; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Gann PH, 1996, CANCER EPIDEM BIOMAR, V5, P121; Holick MF, 2006, MAYO CLIN PROC, V81, P353, DOI 10.4065/81.3.353; Hollis BW, 2013, J STEROID BIOCHEM, V136, P233, DOI 10.1016/j.jsbmb.2012.11.012; Holman CDJ, 1999, AUST NZ J PUBL HEAL, V23, P453, DOI 10.1111/j.1467-842X.1999.tb01297.x; Jenab M, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5500; Kilkkinen A, 2008, CANCER EPIDEM BIOMAR, V17, P3274, DOI 10.1158/1055-9965.EPI-08-0199; Lazzeroni M, 2013, ANTI-CANCER AGENT ME, V13, P118, DOI 10.2174/187152013804487281; Li HJ, 2007, PLOS MED, V4, P562, DOI 10.1371/journal.pmed.0040103; Ma YL, 2011, J CLIN ONCOL, V29, P3775, DOI 10.1200/JCO.2011.35.7566; Mikhak B, 2007, PROSTATE, V67, P911, DOI 10.1002/pros.20570; Nakagawa K, 2005, CARCINOGENESIS, V26, P1044, DOI 10.1093/carcin/bgi049; Nomura AMY, 1998, CANCER CAUSE CONTROL, V9, P425, DOI 10.1023/A:1008875819232; Norman PE, 2009, INT J EPIDEMIOL, V38, P48, DOI 10.1093/ije/dyn041; Norton K., 2000, ANTHROPOMETRICA, V2, P27; Ordonez-Mena JM, 2013, CANCER EPIDEM BIOMAR, V22, P905, DOI 10.1158/1055-9965.EPI-12-1332; Otani T, 2007, BRIT J CANCER, V97, P446, DOI 10.1038/sj.bjc.6603892; Pilz S, 2013, ANTI-CANCER AGENT ME, V13, P107, DOI 10.2174/187152013804487407; Ranasinghe W, 2013, BJU INT; Schwartz GG, 1998, CANCER EPIDEM BIOMAR, V7, P391; Trivedi DP, 2003, BMJ-BRIT MED J, V326, P469, DOI 10.1136/bmj.326.7387.469; Tuohimaa P, 2004, INT J CANCER, V108, P104, DOI 10.1002/ijc.11375; Wactawski-Wende J, 2006, NEW ENGL J MED, V354, P684, DOI 10.1056/NEJMoa055222; Weinstein SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020796; Whidatch LW, 2002, MOL BIOL, V81, P135; Wong YYE, 2013, EUR J VASC ENDOVASC, V45, P657, DOI 10.1016/j.ejvs.2013.03.015; Wong YY, 2013, J CLIN ENDOCRINOL ME; Woolcott CG, 2010, CANCER EPIDEM BIOMAR, V19, P130, DOI 10.1158/1055-9965.EPI-09-0475; Wu K, 2007, J NATL CANCER I, V99, P1120, DOI 10.1093/jnci/djm038	44	27	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e99954	10.1371/journal.pone.0099954	http://dx.doi.org/10.1371/journal.pone.0099954			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949795	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000338276300025
J	Alonso, BD; Tobon, SH; Suarez, PD; Flores, JG; Carrillo, BD; Perez, EB				de Celis Alonso, Benito; Hidalgo Tobon, Silvia; Dies Suarez, Pilar; Flores, Julio Garcia; de Celis Carrillo, Benito; Barragan Perez, Eduardo			A Multi-Methodological MR Resting State Network Analysis to Assess the Changes in Brain Physiology of Children with ADHD	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; LOW-FREQUENCY FLUCTUATION; FUNCTIONAL CONNECTIVITY; REGIONAL HOMOGENEITY; CINGULATE CORTEX; TEMPORAL CORTEX; DEFAULT-MODE; FMRI; ACTIVATION	The purpose of this work was to highlight the neurological differences between the MR resting state networks of a group of children with ADHD (pre-treatment) and an age-matched healthy group. Results were obtained using different image analysis techniques. A sample of n = 46 children with ages between 6 and 12 years were included in this study (23 per cohort). Resting state image analysis was performed using ReHo, ALFF and ICA techniques. ReHo and ICA represent connectivity analyses calculated with different mathematical approaches. ALFF represents an indirect measurement of brain activity. The ReHo and ICA analyses suggested differences between the two groups, while the ALFF analysis did not. The ReHo and ALFF analyses presented differences with respect to the results previously reported in the literature. ICA analysis showed that the same resting state networks that appear in healthy volunteers of adult age were obtained for both groups. In contrast, these networks were not identical when comparing the healthy and ADHD groups. These differences affected areas for all the networks except the Right Memory Function network. All techniques employed in this study were used to monitor different cerebral regions which participate in the phenomenological characterization of ADHD patients when compared to healthy controls. Results from our three analyses indicated that the cerebellum and mid-frontal lobe bilaterally for ReHo, the executive function regions in ICA, and the precuneus, cuneus and the clacarine fissure for ALFF, were the "hubs" in which the main inter-group differences were found. These results do not just help to explain the physiology underlying the disorder but open the door to future uses of these methodologies to monitor and evaluate patients with ADHD.	[de Celis Alonso, Benito] Benemerita Univ Autonoma Puebla, Fac Math & Phys, Puebla, Mexico; [Hidalgo Tobon, Silvia; Dies Suarez, Pilar] Hosp Infantil Mexico Dr Federico Gomez, Dept Imaging, Mexico City, DF, Mexico; [Flores, Julio Garcia] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [de Celis Carrillo, Benito] Univ Leon, Sch Ind Engn, E-24071 Leon, Castilla & Leon, Spain; [Barragan Perez, Eduardo] Hosp Infantil Mexico Dr Federico Gomez, Dept Neurol, Mexico City, DF, Mexico	Benemerita Universidad Autonoma de Puebla; Hospital Infantil de Mexico Federico Gomez; Northwestern University; Feinberg School of Medicine; Universidad de Leon; Hospital Infantil de Mexico Federico Gomez	Alonso, BD (corresponding author), Benemerita Univ Autonoma Puebla, Fac Math & Phys, Puebla, Mexico.	benileon@yahoo.com	, db/GRS-6835-2022; , de Celis Alonso Benito/AAP-4512-2021	, de Celis Alonso Benito/0000-0003-2124-1084; , Eduardo Javier/0000-0003-1019-8017				Anderson A., 2013, NEUROIMAGE; [Anonymous], BIOL PSYCHIAT; Arnsten AFT, 2005, BIOL PSYCHIAT, V57, P1377, DOI 10.1016/j.biopsych.2004.08.019; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Berquin PC, 1998, NEUROLOGY, V50, P1087, DOI 10.1212/WNL.50.4.1087; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Born P, 1998, PEDIATR RES, V44, P578, DOI 10.1203/00006450-199810000-00018; Calhoun VD, 2004, MAGN RESON IMAGING, V22, P1181, DOI 10.1016/j.mri.2004.09.004; Cao Qing-jiu, 2007, Beijing Da Xue Xue Bao Yi Xue Ban, V39, P261; Cao QJ, 2006, NEUROREPORT, V17, P1033, DOI 10.1097/01.wnr.0000224769.92454.5d; Castellanos FX, 2012, TRENDS COGN SCI, V16, P17, DOI 10.1016/j.tics.2011.11.007; Castellanos FX, 2009, CAN J PSYCHIAT, V54, P665, DOI 10.1177/070674370905401003; Cherkassky VL, 2006, NEUROREPORT, V17, P1687, DOI 10.1097/01.wnr.0000239956.45448.4c; Cubillo A, 2014, CEREB CORTEX, V24, P174, DOI 10.1093/cercor/bhs296; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Alonso BD, 2008, CEREB CORTEX, V18, P1314, DOI 10.1093/cercor/bhm163; Dey S, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00075; Ferreira LK, 2013, NEUROSCI BIOBEHAV R, V37, P384, DOI 10.1016/j.neubiorev.2013.01.017; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Hampson M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044067; He HJ, 2012, NEUROIMAGE, V59, P2339, DOI 10.1016/j.neuroimage.2011.09.018; Kobel M, 2010, PSYCHIAT RES-NEUROIM, V183, P230, DOI 10.1016/j.pscychresns.2010.03.010; Konrad K, 2010, HUM BRAIN MAPP, V31, P904, DOI 10.1002/hbm.21058; Lenz D, 2010, NEUROPSYCHOLOGIA, V48, P1985, DOI 10.1016/j.neuropsychologia.2010.03.019; Li L, 2013, NEUROPSYCHOLOGIA, V51, P1571, DOI 10.1016/j.neuropsychologia.2013.05.011; Li Q, 2013, CHINESE MED J-PEKING, V126, P734, DOI 10.3760/cma.j.issn.0366-6999.20120960; Li YY, 2013, CEREB CORTEX, V23, P1988, DOI 10.1093/cercor/bhs185; LOU H, 1990, BRAIN DEV-JPN, V12, P301, DOI 10.1016/S0387-7604(12)80310-X; Lv YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064115; Mueller Andreas, 2010, Nonlinear Biomed Phys, V4 Suppl 1, pS1, DOI 10.1186/1753-4631-4-S1-S1; Pievani M, 2011, LANCET NEUROL, V10, P829, DOI 10.1016/S1474-4422(11)70158-2; Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942; Power JD, 2013, NEUROIMAGE, V76, P439, DOI 10.1016/j.neuroimage.2012.03.017; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Robinson SD, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00724; Rubia K, 2011, NEUROPSYCHOPHARMACOL, V36, P1575, DOI 10.1038/npp.2011.30; SATTERFIELD JH, 1984, BIOL PSYCHIAT, V19, P973; Skidmore FM, 2013, NEUROIMAGE, V81, P484, DOI 10.1016/j.neuroimage.2011.07.012; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Spinelli S, 2011, J CHILD PSYCHOL PSYC, V52, P808, DOI 10.1111/j.1469-7610.2010.02356.x; Sripada C, 2014, HUM BRAIN MAPP; Takeuchi H., 2012, CORTEX; Tang JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071061; Teicher MH, 2000, NAT MED, V6, P470, DOI 10.1038/74737; Tian LX, 2008, BRAIN DEV-JPN, V30, P342, DOI 10.1016/j.braindev.2007.10.005; Tian LX, 2006, NEUROSCI LETT, V400, P39, DOI 10.1016/j.neulet.2006.02.022; Turner JA, 2012, PSYCHIAT RES-NEUROIM, V201, P253, DOI 10.1016/j.pscychresns.2011.09.012; Uddin LQ, 2008, J NEUROSCI METH, V169, P249, DOI 10.1016/j.jneumeth.2007.11.031; Wolf RC, 2009, HUM BRAIN MAPP, V30, P2252, DOI 10.1002/hbm.20665; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yang H, 2007, NEUROIMAGE, V36, P144, DOI 10.1016/j.neuroimage.2007.01.054; Yu DC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054516; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zeng HW, 2013, EPILEPSIA, V54, P658, DOI 10.1111/epi.12066; Zou QH, 2008, J NEUROSCI METH, V172, P137, DOI 10.1016/j.jneumeth.2008.04.012	57	20	20	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e99119	10.1371/journal.pone.0099119	http://dx.doi.org/10.1371/journal.pone.0099119			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945408	gold, Green Published			2022-12-27	WOS:000340721500010
J	Sussenbach, SP; Silva, EN; Pufal, MA; Casagrande, DS; Padoin, AV; Mottin, CC				Sussenbach, Samanta Pereira; Silva, Everton Nunes; Pufal, Milene Amarante; Casagrande, Daniela Shan; Padoin, Alexandre Vontobel; Mottin, Claudio Cora			Systematic Review of Economic Evaluation of Laparotomy versus Laparoscopy for Patients Submitted to Roux-en-Y Gastric Bypass	PLOS ONE			English	Article							PRESCRIPTION MEDICATION COSTS; QUALITY-OF-LIFE; BARIATRIC SURGERY; WEIGHT-LOSS; OUTCOMES; OBESITY	Background: Because of the high prevalence of obesity, there is a growing demand for bariatric surgery worldwide. The objective of this systematic review was to analyze the difference in relation to cost-effectiveness of access route by laparoscopy versus laparotomy of Roux en-Y gastric bypass (RYGB). Methods: A systematic review was conducted in the electronic databases MEDLINE, Embase, Scopus, Cochrane and Lilacs in order to identify economic evaluation studies that compare the cost-effectiveness of laparoscopic and laparotomic routes in RYGB. Results: In a total of 494 articles, only 6 fulfilled the eligibility criteria. All studies were published between 2001 and 2008 in the United States (USA). Three studies fulfilled less than half of the items that evaluated the results quality; two satisfied 5 of the required items, and only 1 study fulfilled 7 of 10 items. The economic evaluation of studies alternated between cost-effectiveness and cost-consequence. Five studies considered the surgery by laparoscopy the dominant strategy, because it showed greater clinical benefit (less probability of post-surgical complications, less hospitalization time) and lower total cost. Conclusion: This review indicates that laparoscopy is a safe and well-tolerated technique, despite the costs of surgery being higher when compared with laparotomy. However, the additional costs are compensated by the lower probability of complications after surgery and, consequently, avoiding their costs.	[Sussenbach, Samanta Pereira; Pufal, Milene Amarante; Casagrande, Daniela Shan; Padoin, Alexandre Vontobel; Mottin, Claudio Cora] Pontificia Univ Catolica Rio Grande do Sul, COM HSL PUCRS, Hosp Sao Lucas, Ctr Obesidade & Sindrome Metab, Porto Alegre, RS, Brazil; [Sussenbach, Samanta Pereira; Pufal, Milene Amarante; Padoin, Alexandre Vontobel; Mottin, Claudio Cora] Pontificia Univ Catolica Rio Grande do Sul, Porto Alegre, RS, Brazil; [Silva, Everton Nunes] Univ Brasilia, Fac Ceilandia, Brasilia, DF, Brazil; [Casagrande, Daniela Shan] Univ Fed Rio Grande do Sul, Hosp Clin Port Alegre, Postgrad Program Med Sci Endocrinol & Metab, Porto Alegre, RS, Brazil	Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul; Universidade de Brasilia; Universidade Federal do Rio Grande do Sul	Mottin, CC (corresponding author), Pontificia Univ Catolica Rio Grande do Sul, COM HSL PUCRS, Hosp Sao Lucas, Ctr Obesidade & Sindrome Metab, Porto Alegre, RS, Brazil.	samysuss@gmail.com	Padoin, Alexandre V/M-7660-2013	Padoin, Alexandre V/0000-0002-9754-4818; Silva, Everton/0000-0001-8747-4185	Brazilian Government (FINEP)	Brazilian Government (FINEP)	There is no financial interest by any of the authors. This study was supported by the Brazilian Government (FINEP). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbash GI, 2010, NEW ENGL J MED, V363, P701, DOI 10.1056/NEJMp1006602; Batsis JA, 2009, APPETITE, V52, P637, DOI 10.1016/j.appet.2009.02.017; Brasil. Ministerio da Saude, 2008, AR EC SAUD DES, P104; Brethauer SA, 2006, CLEV CLIN J MED, V73, P993, DOI 10.3949/ccjm.73.11.993; Buchwald H, 2004, JAMA-J AM MED ASSOC, V292, P1724, DOI 10.1001/jama.292.14.1724; DeMaria J, 2002, ANN SURG, V235, P640, DOI 10.1097/00000658-200205000-00005; Drummond MF., 2005, METHODS EC EVALUATIO, P55; El-Kadre L, 2013, SURG OBES RELAT DIS; Elder KA, 2007, GASTROENTEROLOGY, V132, P2253, DOI 10.1053/j.gastro.2007.03.057; Encinosa WE, 2005, HEALTH AFFAIR, V24, P1039, DOI 10.1377/hlthaff.24.4.1039; Faria GR, 2013, OBES SURG, V23, P460, DOI 10.1007/s11695-012-0816-8; Gould JC, 2004, J GASTROINTEST SURG, V8, P983, DOI 10.1016/j.gassur.2004.09.042; Jones KB, 2006, OBES SURG, V16, P721; Keating CL, 2009, DIABETES CARE, V32, P580, DOI 10.2337/dc08-1748; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Neto RML, 2012, OBES SURG, V22, P1580, DOI 10.1007/s11695-012-0731-z; Lynch J, 2012, OBES SURG, V22, P1507, DOI 10.1007/s11695-012-0693-1; Maggard MA, 2005, ANN INTERN MED, V142, P547, DOI 10.7326/0003-4819-142-7-200504050-00013; McEwen LN, 2010, OBES SURG, V20, P919, DOI 10.1007/s11695-010-0169-0; Neovius M, 2012, JAMA-J AM MED ASSOC, V308, P1132, DOI 10.1001/2012.jama.11792; Nguyen NT, 2006, AM SURGEON, V72, P853; Nguyen Ninh T, 2002, Semin Laparosc Surg, V9, P86, DOI 10.1053/slas.2002.126330; Nguyen NT, 2001, ANN SURG, V234, P279, DOI 10.1097/00000658-200109000-00002; Paxton JH, 2005, OBES SURG, V15, P24, DOI 10.1381/0960892052993477; Podnos YD, 2003, ARCH SURG-CHICAGO, V138, P957, DOI 10.1001/archsurg.138.9.957; Reoch J, 2011, ARCH SURG-CHICAGO, V146, P1314, DOI 10.1001/archsurg.2011.270; Salem L, 2008, SURG OBES RELAT DIS, V4, P26, DOI 10.1016/j.soard.2007.09.009; Siddiqui A, 2006, AM J SURG E, Ve-1, P192, DOI DOI 10.1016/j.amjsurg.2006.08.023; Snow LL, 2004, OBES SURG, V14, P1031, DOI 10.1381/0960892041975677; Tiwari MM, 2011, SURG ENDOSC, V25, P1127, DOI 10.1007/s00464-010-1328-z; Weller WE, 2008, ANN SURG, V248, P10, DOI 10.1097/SLA.0b013e31816d953a; WITTGROVE AC, 1994, OBES SURG, V4, P353, DOI 10.1381/096089294765558331	32	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e99976	10.1371/journal.pone.0099976	http://dx.doi.org/10.1371/journal.pone.0099976			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945704	Green Published, Green Submitted, gold			2022-12-27	WOS:000340721500037
J	Alam-Faruque, Y; Hill, DP; Dimmer, EC; Harris, MA; Foulger, RE; Tweedie, S; Attrill, H; Howe, DG; Thomas, SR; Davidson, D; Woolf, AS; Blake, JA; Mungall, CJ; O'Donovan, C; Apweiler, R; Huntley, RP				Alam-Faruque, Yasmin; Hill, David P.; Dimmer, Emily C.; Harris, Midori A.; Foulger, Rebecca E.; Tweedie, Susan; Attrill, Helen; Howe, Douglas G.; Thomas, Stephen Randall; Davidson, Duncan; Woolf, Adrian S.; Blake, Judith A.; Mungall, Christopher J.; O'Donovan, Claire; Apweiler, Rolf; Huntley, Rachael P.			Representing Kidney Development Using the Gene Ontology	PLOS ONE			English	Article							DIABETIC-NEPHROPATHY; TRANSCRIPTION FACTOR; EXPRESSION; APOPTOSIS; DATABASE; PAX2; DIFFERENTIATION; TOOL	Gene Ontology (GO) provides dynamic controlled vocabularies to aid in the description of the functional biological attributes and subcellular locations of gene products from all taxonomic groups (www.geneontology.org). Here we describe collaboration between the renal biomedical research community and the GO Consortium to improve the quality and quantity of GO terms describing renal development. In the associated annotation activity, the new and revised terms were associated with gene products involved in renal development and function. This project resulted in a total of 522 GO terms being added to the ontology and the creation of approximately 9,600 kidney-related GO term associations to 940 UniProt Knowledgebase (UniProtKB) entries, covering 66 taxonomic groups. We demonstrate the impact of these improvements on the interpretation of GO term analyses performed on genes differentially expressed in kidney glomeruli affected by diabetic nephropathy. In summary, we have produced a resource that can be utilized in the interpretation of data from small- and large-scale experiments investigating molecular mechanisms of kidney function and development and thereby help towards alleviating renal disease.	[Alam-Faruque, Yasmin; Dimmer, Emily C.; Foulger, Rebecca E.; O'Donovan, Claire; Apweiler, Rolf; Huntley, Rachael P.] European Bioinformat Inst EMBL EBI, European Mol Biol Lab, Cambridge, England; [Hill, David P.; Blake, Judith A.] Jackson Lab, Bar Harbor, ME 04609 USA; [Harris, Midori A.] Univ Cambridge, Cambridge Syst Biol Ctr, Cambridge, England; [Harris, Midori A.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Tweedie, Susan; Attrill, Helen] Univ Cambridge, Dept Genet, FlyBase, Cambridge CB2 3EH, England; [Howe, Douglas G.] Univ Oregon, Zebrafish Model Organism Database ZFIN, Eugene, OR 97403 USA; [Thomas, Stephen Randall] Univ Paris 11, CNRS, IR4M UMR8081, F-91405 Orsay, France; [Davidson, Duncan] Western Gen Hosp, Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Woolf, Adrian S.] Univ Manchester, Fac Med & Human Sci, Inst Human Dev, Manchester, Lancs, England; [Mungall, Christopher J.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Genom Div, Berkeley, CA 94720 USA	European Molecular Biology Laboratory (EMBL); Jackson Laboratory; University of Cambridge; University of Cambridge; University of Cambridge; University of Oregon; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite Paris Saclay; University of Edinburgh; University of Manchester; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Alam-Faruque, Y (corresponding author), European Bioinformat Inst EMBL EBI, European Mol Biol Lab, Cambridge, England.	yasmin.alamfaruque@gmail.com	Mungall, Chris/I-6006-2019; Woolf, Adrian S./AAZ-1075-2020; Huntley, Rachael/J-4951-2019; Huntley, Rachael/R-1036-2016; Tweedie, Susan/B-3695-2019	Mungall, Chris/0000-0002-6601-2165; Woolf, Adrian S./0000-0001-5541-1358; Huntley, Rachael/0000-0001-6718-3559; Huntley, Rachael/0000-0001-6718-3559; Tweedie, Susan/0000-0003-1818-8243; Harris, Midori/0000-0003-4148-4606; Attrill, Helen/0000-0003-3212-6364; Blake, Judith/0000-0001-8522-334X; Apweiler, Rolf/0000-0001-7078-200X; Foulger, Rebecca/0000-0001-8682-8754; O'Donovan, Claire/0000-0001-8051-7429	Kidney Research UK (KRUK) [RP26/2008]; National Institutes of Health (NIH) - National Human Genome Research Institute (NIHGR) [R01HG02273]; European Molecular Biology Laboratory (EMBL); British Heart Foundation (BHF) [RG/13/5/30112]; NIH-NHGRI grant [U41HG002273, U41HG00330, HG000739, U41HG002659]; Medical Research Council (MRC) [G1000968, MR/L2744/1]; Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy [DE-AC02-05CH11231]; VPH NoE [EU FP7] [23920]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U41HG000739, U41HG000330, P41HG002659, R01HG002273, U41HG002273, U41HG002659] Funding Source: NIH RePORTER; MRC [G1000968] Funding Source: UKRI; British Heart Foundation [RG/13/5/30112] Funding Source: researchfish; Medical Research Council [G1000968] Funding Source: researchfish	Kidney Research UK (KRUK)(Kidney Research UK (KRUK)); National Institutes of Health (NIH) - National Human Genome Research Institute (NIHGR); European Molecular Biology Laboratory (EMBL); British Heart Foundation (BHF)(British Heart Foundation); NIH-NHGRI grant; Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy(United States Department of Energy (DOE)); VPH NoE [EU FP7]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	YA-F was supported by Kidney Research UK (KRUK; http://www.kidneyresearchuk.org) grant [RP26/2008]. The UniProt-GO Annotation Project is supported by the National Institutes of Health (NIH; www.nih.gov/) - National Human Genome Research Institute (NIHGR; www.genome.gov) grant [R01HG02273], the European Molecular Biology Laboratory (EMBL; www.embl.de) core funding and the British Heart Foundation (BHF; www.bhf.org.uk) grant [RG/13/5/30112]. The GO Consortium is supported by NIH-NHGRI grant [U41HG002273]. The Mouse Genome Informatics group is supported by NIH-NHGRI grant [U41HG00330]. FlyBase is supported by NIH-NHGRI grant [HG000739]. ST is supported by Medical Research Council (MRC; http://www.mrc.ac.uk) grant [G1000968]. DGH is supported by the NIH-NHGRI grant [U41HG002659]. ASW is supported by MRC grant [MR/L2744/1]. CJM was supported by the Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231. SRT was supported by VPH NoE [EU FP7, Grant 23920]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRASS CK, 1995, WESTERN J MED, V162, P318; Acland A, 2014, NUCLEIC ACIDS RES, V42, pD7, DOI 10.1093/nar/gkt1146; Alam-Faruque Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027541; Alam-Faruque Y, 2010, ORGANOGENESIS, V6, P71, DOI 10.4161/org.6.2.11294; Alarcon P, 2008, DEVELOPMENT, V135, P3197, DOI 10.1242/dev.023697; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Baelde HJ, 2004, AM J KIDNEY DIS, V43, P636, DOI 10.1053/j.ajkd.2003.12.028; Balakrishnan R, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat054; Bauer S, 2008, BIOINFORMATICS, V24, P1650, DOI 10.1093/bioinformatics/btn250; Baylis C, 2008, AM J PHYSIOL-RENAL, V294, pF1, DOI 10.1152/ajprenal.00424.2007; Blake JA, 2014, NUCLEIC ACIDS RES, V42, pD810, DOI 10.1093/nar/gkt1225; Brunskill EW, 2008, DEV CELL, V15, P781, DOI 10.1016/j.devcel.2008.09.007; Carroll TJ, 1999, DEV BIOL, V214, P46, DOI 10.1006/dbio.1999.9414; Dessapt-Baradez C, 2014, J AM SOC NEPHROL, V25, P33, DOI 10.1681/ASN.2012121218; Dihazi H, 2005, MOL CELL PROTEOMICS, V4, P1445, DOI 10.1074/mcp.M400184-MCP200; Dimmer Emily, 2007, V406, P495; Doniger SW, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-r7; Dow JAT, 2010, AM J PHYSIOL-RENAL, V299, pF1237, DOI 10.1152/ajprenal.00521.2010; Dziarmaga A, 2006, J AM SOC NEPHROL, V17, P1568, DOI 10.1681/ASN.2005101074; Feltrin E, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-6; Fierlbeck W, 2003, J AM SOC NEPHROL, V14, P1349, DOI 10.1097/01.ASN.0000061779.70530.06; Harding SD, 2011, DEVELOPMENT, V138, P2845, DOI 10.1242/dev.063594; Hills CE, 2011, CYTOKINE GROWTH F R, V22, P131, DOI 10.1016/j.cytogfr.2011.06.002; Hirschman J, 2010, MOL GENET GENOMICS, V283, P415, DOI 10.1007/s00438-010-0525-8; Howe DG, 2013, NUCLEIC ACIDS RES, V41, pD854, DOI 10.1093/nar/gks938; James RG, 2006, DEVELOPMENT, V133, P2995, DOI 10.1242/dev.02442; Janech MG, 2007, AM J PHYSIOL-RENAL, V292, pF501, DOI 10.1152/ajprenal.00298.2006; Khodiyar VK, 2011, DEV BIOL, V354, P9, DOI 10.1016/j.ydbio.2011.03.011; KRIZ W, 1988, KIDNEY INT, V33, P1; Kumar D, 2004, MOL CELL BIOCHEM, V259, P67, DOI 10.1023/B:MCBI.0000021346.03260.7e; Lan Y, 2004, DEVELOPMENT, V131, P3207, DOI 10.1242/dev.01175; Little MH, 2007, GENE EXPR PATTERNS, V7, P680, DOI 10.1016/j.modgep.2007.03.002; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Meehan TF, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-6; Mungall CJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r5; Mungall CJ, 2011, J BIOMED INFORM, V44, P80, DOI 10.1016/j.jbi.2010.02.002; Nakagawa T, 2007, J AM SOC NEPHROL, V18, P539, DOI 10.1681/ASN.2006050459; Narlis M, 2007, J AM SOC NEPHROL, V18, P1121, DOI 10.1681/ASN.2006070739; Nowik M, 2008, PHYSIOL GENOMICS, V32, P322, DOI 10.1152/physiolgenomics.00160.2007; Raciti D, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r84; Reggiani L, 2007, GENE DEV, V21, P2358, DOI 10.1101/gad.450707; Salomon R, 2001, KIDNEY INT, V59, P457, DOI 10.1046/j.1523-1755.2001.059002457.x; Siu KWM, 2009, J PROTEOME RES, V8, P3797, DOI 10.1021/pr800389e; St Pierre SE, 2014, NUCLEIC ACIDS RES, V42, pD780, DOI 10.1093/nar/gkt1092; Tang SCW, 2006, J AM SOC NEPHROL, V17, P1633, DOI 10.1681/ASN.2005101113; Tena JJ, 2007, DEV BIOL, V301, P518, DOI 10.1016/j.ydbio.2006.08.063; Tilton RG, 2007, PROTEOMICS, V7, P1729, DOI 10.1002/pmic.200700017; Verzola D, 2007, KIDNEY INT, V72, P1262, DOI 10.1038/sj.ki.5002531; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Welsh GI, 2010, CELL METAB, V12, P329, DOI 10.1016/j.cmet.2010.08.015; Welsh GI, 2010, CURR OPIN NEPHROL HY, V19, P379, DOI 10.1097/MNH.0b013e32833ad5e4; Wu GZ, 2004, EUR J BIOCHEM, V271, P3715, DOI 10.1111/j.1432-1033.2004.04312.x; Yasuda Yoshinari, 2006, Clin Exp Nephrol, V10, P91, DOI 10.1007/s10157-006-0421-z; Zambon AC, 2012, BIOINFORMATICS, V28, P2209, DOI 10.1093/bioinformatics/bts366	55	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99864	10.1371/journal.pone.0099864	http://dx.doi.org/10.1371/journal.pone.0099864			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941002	Green Published, Green Submitted, gold			2022-12-27	WOS:000338508200047
J	Allen, CPG; Dunkley, BT; Muthukumaraswamy, SD; Edden, R; Evans, CJ; Sumner, P; Singh, KD; Chambers, CD				Allen, Christopher P. G.; Dunkley, Benjamin T.; Muthukumaraswamy, Suresh D.; Edden, Richard; Evans, C. John; Sumner, Petroc; Singh, Krish D.; Chambers, Christopher D.			Enhanced Awareness Followed Reversible Inhibition of Human Visual Cortex: A Combined TMS, MRS and MEG Study	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; THETA-BURST STIMULATION; ALPHA-BAND; PHOSPHENE THRESHOLDS; CONFIDENCE-INTERVALS; OSCILLATORY ACTIVITY; BETA OSCILLATIONS; NEURONAL-ACTIVITY; MOTOR; SYNCHRONIZATION	This series of experiments investigated the neural basis of conscious vision in humans using a form of transcranial magnetic stimulation (TMS) known as continuous theta burst stimulation (cTBS). Previous studies have shown that occipital TMS, when time-locked to the onset of visual stimuli, can induce a phenomenon analogous to blindsight in which conscious detection is impaired while the ability to discriminate 'unseen' stimuli is preserved above chance. Here we sought to reproduce this phenomenon using offline occipital cTBS, which has been shown to induce an inhibitory cortical aftereffect lasting 45-60 minutes. Contrary to expectations, our first experiment revealed the opposite effect: cTBS enhanced conscious vision relative to a sham control. We then sought to replicate this cTBS-induced potentiation of consciousness in conjunction with magnetoencephalography (MEG) and undertook additional experiments to assess its relationship to visual cortical excitability and levels of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA; via magnetic resonance spectroscopy, MRS). Occipital cTBS decreased cortical excitability and increased regional GABA concentration. No significant effects of cTBS on MEG measures were observed, although the results provided weak evidence for potentiation of event related desynchronisation in the beta band. Collectively these experiments suggest that, through the suppression of noise, cTBS can increase the signal-to-noise ratio of neural activity underlying conscious vision. We speculate that gating-byinhibition in the visual cortex may provide a key foundation of consciousness.	[Allen, Christopher P. G.; Dunkley, Benjamin T.; Muthukumaraswamy, Suresh D.; Edden, Richard; Evans, C. John; Sumner, Petroc; Singh, Krish D.; Chambers, Christopher D.] Cardiff Univ, Sch Psychol, Brain Res Imaging Ctr, Cardiff CF10 3AX, S Glam, Wales; [Dunkley, Benjamin T.] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Edden, Richard] Johns Hopkins Univ, Sch Med, Baltimore, MD USA	Cardiff University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Johns Hopkins University	Allen, CPG (corresponding author), Cardiff Univ, Sch Psychol, Brain Res Imaging Ctr, Cardiff CF10 3AX, S Glam, Wales.	allencp@cf.ac.uk	Chambers, Chris/E-7827-2010; Singh, Krish/D-1066-2009; Evans, C. John/A-8054-2010	Evans, C. John/0000-0002-6619-4245; Edden, Richard/0000-0002-0671-7374; Dunkley, Benjamin Thomas/0000-0001-6173-1171; Muthukumaraswamy, Suresh/0000-0001-7042-3920; Singh, Krishna/0000-0002-3094-2475; Chambers, Chris/0000-0001-6058-4114; Allen, Chris/0000-0001-9809-1630	BBSRC [B/K008277/1]; Welcome Trust [086453/z/08/z]; National Institutes of Health [R01EB016089, P41EB15909]; Biotechnology and Biological Sciences Research Council [BB/C515271/1, BB/C515271/2] Funding Source: researchfish; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB016089, P41EB015909] Funding Source: NIH RePORTER	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Welcome Trust(Wellcome Trust); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This research was completed with assistance from the Welsh Institute of Cognitive Neuroscience (CPGA, CDC ref: WCI018), a BBSRC David Phillips Fellowship (CDC) and grant (CPGA and CDC B/K008277/1), the Welcome Trust (PS, CPGA ref: 086453/z/08/z), the National Institutes of Health (RE, CJE ref: R01EB016089 and RE ref: P41EB15909). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamyan A, 2011, J NEUROSCI, V31, P3290, DOI 10.1523/JNEUROSCI.6256-10.2011; Allen Sumner P, J COGNITIVE IN PRESS; Babiloni C, 2006, CEREB CORTEX, V16, P37, DOI 10.1093/cercor/bhi082; Babiloni C, 2006, CEREB CORTEX, V16, P1690, DOI 10.1093/cercor/bhj104; Berger H, 1929, ARCH PSYCHIAT NERVEN, V87, P527, DOI 10.1007/BF01797193; BLOCK N, 1995, BEHAV BRAIN SCI, V18, P227, DOI 10.1017/S0140525X00038188; Boyer JL, 2005, P NATL ACAD SCI USA, V102, P16875, DOI 10.1073/pnas.0505332102; Bradley MM, 2008, PSYCHOPHYSIOLOGY, V45, P602, DOI 10.1111/j.1469-8986.2008.00654.x; BRADSHAW J, 1967, NATURE, V216, P515, DOI 10.1038/216515a0; BRESSLER SL, 1990, TRENDS NEUROSCI, V13, P161, DOI 10.1016/0166-2236(90)90039-D; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; CAMPION J, 1983, BEHAV BRAIN SCI, V6, P423, DOI 10.1017/S0140525X00016861; Cazzoli D, 2012, BRAIN, V135, P3426, DOI 10.1093/brain/aws182; Cazzoli D, 2009, EUR J NEUROSCI, V29, P1271, DOI 10.1111/j.1460-9568.2009.06665.x; Cohen J.E., 1988, STAT POWER ANAL BEHA; Corwin J, 1994, NEUROPSYCHOLOGY, V8, P110, DOI 10.1037/0894-4105.8.1.110; Crick F, 1990, SEMINARS NEUROSCIENC, V2, P12; Deblieck C, 2008, HUM BRAIN MAPP, V29, P662, DOI 10.1002/hbm.20427; Dehaene S, 2001, COGNITION, V79, P1, DOI 10.1016/S0010-0277(00)00123-2; Del Cul A, 2007, PLOS BIOL, V5, P2408, DOI 10.1371/journal.pbio.0050260; Dienes Z., 2008, UNDERSTANDING PSYCHO; Dienes Z, USING BAYES IN PRESS; Dienes Z, 2011, PERSPECT PSYCHOL SCI, V6, P274, DOI 10.1177/1745691611406920; EASON RG, 1969, PHYSIOL BEHAV, V4, P283, DOI 10.1016/0031-9384(69)90176-0; EBERT U, 1995, EXP BRAIN RES, V104, P310; Edden RAE, 2013, J MAGNETIC RESONANCE; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Ericsson KA, 2003, J CONSCIOUSNESS STUD, V10, P1; Foxe JJ, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00154; Franca M, 2006, CLIN NEUROPHYSIOL, V117, P1808, DOI 10.1016/j.clinph.2006.03.019; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Funke K, 2011, J PHYSIOL-LONDON, V589, P4423, DOI 10.1113/jphysiol.2011.206573; Galarreta M, 2001, NAT REV NEUROSCI, V2, P425, DOI 10.1038/35077566; Green D. M., 1966, SIGNAL DETECTION THE, DOI DOI 10.1086/405615; Hamidi M, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.014.2009; Hilgetag CC, 2001, NAT NEUROSCI, V4, P953, DOI 10.1038/nn0901-953; HOLM S, 1979, SCAND J STAT, V6, P65; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Jeffreys ET., 1961, THEORY PROBABILITY, V3; Jensen O, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00186; Jolij J, 2005, P NATL ACAD SCI USA, V102, P10747, DOI 10.1073/pnas.0500834102; Kaernbach C, 1999, NEUROREPORT, V10, P713, DOI 10.1097/00001756-199903170-00010; Katzner S, 2011, J NEUROSCI, V31, P5931, DOI 10.1523/JNEUROSCI.5753-10.2011; Kerr N L, 1998, Pers Soc Psychol Rev, V2, P196, DOI 10.1207/s15327957pspr0203_4; Kindler J, 2012, STROKE, V43, P2175, DOI 10.1161/STROKEAHA.111.647503; Koch G, 2008, BRAIN, V131, P3147, DOI 10.1093/brain/awn273; Koelewijn L, 2013, NEUROIMAGE, V79, P295, DOI 10.1016/j.neuroimage.2013.04.108; Koivisto M, 2003, PSYCHOPHYSIOLOGY, V40, P423, DOI 10.1111/1469-8986.00044; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Kujala J, 2007, CEREB CORTEX, V17, P1476, DOI 10.1093/cercor/bhl059; Lamme VAF, 2001, ACTA PSYCHOL, V107, P209, DOI 10.1016/S0001-6918(01)00020-8; Lamy D, 2009, J COGNITIVE NEUROSCI, V21, P1435, DOI 10.1162/jocn.2009.21064; Lau HC, 2006, P NATL ACAD SCI USA, V103, P18763, DOI 10.1073/pnas.0607716103; Liddell BJ, 2004, J COGNITIVE NEUROSCI, V16, P479, DOI 10.1162/089892904322926809; Llinas R, 2005, TRENDS NEUROSCI, V28, P325, DOI 10.1016/j.tins.2005.04.006; Lloyd DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082828; LOFTUS GR, 1994, PSYCHON B REV, V1, P476, DOI 10.3758/BF03210951; Lutz A, 2004, P NATL ACAD SCI USA, V101, P16369, DOI 10.1073/pnas.0407401101; Lutz A, 2002, P NATL ACAD SCI USA, V99, P1586, DOI 10.1073/pnas.032658199; Macmillan NA, 1990, DETECTION THEORY USE; Maizey L, 2013, CLIN NEUROPHYSIOL, V124, P8; Marzi CA, 1998, EXP BRAIN RES, V118, P435, DOI 10.1007/s002210050299; Marzi CA, 2000, J COGNITIVE NEUROSCI, V12, P869, DOI 10.1162/089892900562471; Masson MEJ, 2003, CAN J EXP PSYCHOL, V57, P203, DOI 10.1037/h0087426; McAllister CJ, 2013, J NEUROSCI, V33, P7919, DOI 10.1523/JNEUROSCI.5624-12.2013; McAllister SM, 2011, EUR J NEUROSCI, V33, P1916, DOI 10.1111/j.1460-9568.2011.07673.x; Melloni L, 2007, J NEUROSCI, V27, P2858, DOI 10.1523/JNEUROSCI.4623-06.2007; Mescher M, 1998, NMR BIOMED, V11, P266, DOI 10.1002/(SICI)1099-1492(199810)11:6<266::AID-NBM530>3.0.CO;2-J; Muthukumaraswamy SD, 2009, P NATL ACAD SCI USA, V106, P8356, DOI 10.1073/pnas.0900728106; Niehaus L, 2001, J NEUROL SCI, V182, P123, DOI 10.1016/S0022-510X(00)00462-7; NOGAWA T, 1976, ELECTROEN CLIN NEURO, V40, P78, DOI 10.1016/0013-4694(76)90181-4; Noh NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035080; Panagiotaropoulos TI, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00603; Panagiotaropoulos TI, 2012, NEURON, V74, P924, DOI 10.1016/j.neuron.2012.04.013; PFURTSCHELLER G, 1992, ELECTROEN CLIN NEURO, V83, P62, DOI 10.1016/0013-4694(92)90133-3; Pfurtscheller G, 1996, INT J PSYCHOPHYSIOL, V24, P39, DOI 10.1016/S0167-8760(96)00066-9; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; PFURTSCHELLER G, 1979, ELECTROEN CLIN NEURO, V46, P138, DOI 10.1016/0013-4694(79)90063-4; PFURTSCHELLER G, 1983, ELECTROEN CLIN NEURO, V56, P114, DOI 10.1016/0013-4694(83)90014-7; Pfurtscheller Gert, 1994, Brain Topography, V6, P269, DOI 10.1007/BF01211172; Piantoni G, 2010, J VISION, V10, DOI 10.1167/10.13.18; Polonsky A, 2000, NAT NEUROSCI, V3, P1153, DOI 10.1038/80676; Puts NAJ, 2012, PROG NUCL MAG RES SP, V60, P29, DOI 10.1016/j.pnmrs.2011.06.001; Rahnev D, 2013, J NEUROPHYSIOL, V110, P10; REUTERLORENZ PA, 1990, BRAIN COGNITION, V12, P240, DOI 10.1016/0278-2626(90)90018-J; Ro T, 2004, P NATL ACAD SCI USA, V101, P9933, DOI 10.1073/pnas.0403061101; Romei V, 2010, J NEUROSCI, V30, P8692, DOI 10.1523/JNEUROSCI.0160-10.2010; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Sanchez-Meca J, 2003, PSYCHOL METHODS, V8, P448, DOI 10.1037/1082-989X.8.4.448; Schwarzkopf DS, 2011, J NEUROSCI, V31, P3143, DOI 10.1523/JNEUROSCI.4863-10.2011; Sergent C, 2005, NAT NEUROSCI, V8, P1391, DOI 10.1038/nn1549; Shafi MM, 2014, BRAIN TOPOGR, V27, P172, DOI 10.1007/s10548-013-0277-y; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Simon M, 2011, CLIN NEUROPHYSIOL, V122, P1168, DOI 10.1016/j.clinph.2010.10.044; Stagg CJ, 2009, J NEUROPHYSIOL, V101, P2872, DOI 10.1152/jn.91060.2008; Stewart LM, 2001, NEUROPSYCHOLOGIA, V39, P415, DOI 10.1016/S0028-3932(00)00130-5; Stokes MG, 2013, J NEUROPHYSIOL, V109, P437, DOI 10.1152/jn.00510.2012; Taylor JR, 1997, INTRO ERROR ANAL STU, VSecond; Tegenthoff M, 2005, PLOS BIOL, V3, P2031, DOI 10.1371/journal.pbio.0030362; Thielscher A, 2010, CEREB CORTEX, V20, P328, DOI 10.1093/cercor/bhp102; Thompson B, 2008, CURR BIOL, V18, P1067, DOI 10.1016/j.cub.2008.06.052; Van Dijk H, 2008, J NEUROSCI, V28, P1816, DOI 10.1523/JNEUROSCI.1853-07.2008; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; VARELA FJ, 1981, NEUROPSYCHOLOGIA, V19, P675; Varnava A, 2011, J NEUROSCI METH, V201, P327, DOI 10.1016/j.jneumeth.2011.08.016; Verbruggen F, 2010, P NATL ACAD SCI USA, V107, P13966, DOI 10.1073/pnas.1001957107; Vernet M, 2013, EUR J NEUROSCI, V37, P598, DOI 10.1111/ejn.12069; VONDERMALSBURG C, 1986, BIOL CYBERN, V54, P29, DOI 10.1007/BF00337113; Vrba J, 2001, METHODS, V25, P249, DOI 10.1006/meth.2001.1238; Vuilleumier P, 2001, P NATL ACAD SCI USA, V98, P3495, DOI 10.1073/pnas.051436898; Walsh V, 2000, NAT REV NEUROSCI, V1, P73, DOI 10.1038/35036239; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8; Waterston ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010354; Weiskrantz L., 1986, BLINDSIGHT CASE STUD; Weiskrantz L, 2009, EXP BRAIN RES, V192, P413, DOI 10.1007/s00221-008-1388-7; Wilke M, 2006, P NATL ACAD SCI USA, V103, P17507, DOI 10.1073/pnas.0604673103; Yamanaka K, 2010, CEREB CORTEX, V20, P1037, DOI 10.1093/cercor/bhp163; Zeki S, 1998, BRAIN, V121, P25, DOI 10.1093/brain/121.1.25; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	123	15	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100350	10.1371/journal.pone.0100350	http://dx.doi.org/10.1371/journal.pone.0100350			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956195	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000338917900042
J	Gore, B; Izikki, M; Mercier, O; Dewachter, L; Fadel, E; Humbert, M; Dartevelle, P; Simonneau, G; Naeije, R; Lebrin, F; Eddahibi, S				Gore, Benoit; Izikki, Mohamed; Mercier, Olaf; Dewachter, Laurence; Fadel, Elie; Humbert, Marc; Dartevelle, Philippe; Simonneau, Gerald; Naeije, Robert; Lebrin, Franck; Eddahibi, Saadia			Key Role of the Endothelial TGF-beta/ALK1/Endoglin Signaling Pathway in Humans and Rodents Pulmonary Hypertension	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; BONE MORPHOGENETIC PROTEIN; SMOOTH-MUSCLE HYPERPLASIA; ARTERIAL-HYPERTENSION; INHIBITION; EXPRESSION; MUTATION; CELLS; LUNG; PROLIFERATION	Mutations affecting transforming growth factor-beta (TGF-beta) superfamily receptors, activin receptor-like kinase (ALK)-1, and endoglin (ENG) occur in patients with pulmonary arterial hypertension (PAH). To determine whether the TGF-beta/ALK1/ENG pathway was involved in PAH, we investigated pulmonary TGF-beta, ALK1, ALK5, and ENG expressions in human lung tissue and cultured pulmonary-artery smooth-muscle-cells (PA-SMCs) and pulmonary endothelial cells (PECs) from 14 patients with idiopathic PAH (iPAH) and 15 controls. Seeing that ENG was highly expressed in PEC, we assessed the effects of TGF-beta on Smad1/5/8 and Smad2/3 activation and on growth factor production by the cells. Finally, we studied the consequence of ENG deficiency on the chronic hypoxic-PH development by measuring right ventricular (RV) systolic pressure (RVSP), RV hypertrophy, and pulmonary arteriolar remodeling in ENG-deficient (Eng(+/-)) and wild-type (Eng(+/+)) mice. We also evaluated the pulmonary blood vessel density, macrophage infiltration, and cytokine expression in the lungs of the animals. Compared to controls, iPAH patients had higher serum and pulmonary TGF-beta levels and increased ALK1 and ENG expressions in lung tissue, predominantly in PECs. Incubation of the cells with TGF-beta led to Smad1/5/8 phosphorylation and to a production of FGF2, PDGFb and endothelin-inducing PA-SMC growth. Endoglin deficiency protected mice from hypoxic PH. As compared to wild-type, Eng(+/-) mice had a lower pulmonary vessel density, and no change in macrophage infiltration after exposure to chronic hypoxia despite the higher pulmonary expressions of interleukin-6 and monocyte chemoattractant protein-1. The TGF-beta/ALK1/ENG signaling pathway plays a key role in iPAH and experimental hypoxic PH via a direct effect on PECs leading to production of growth factors and inflammatory cytokines involved in the pathogenesis of PAH.	[Gore, Benoit; Izikki, Mohamed; Humbert, Marc; Simonneau, Gerald; Eddahibi, Saadia] INSERM, U999, Le Plessis Robinson, France; [Dewachter, Laurence; Naeije, Robert] Free Univ Brussels, Fac Med, Physiol Lab, Brussels, Belgium; [Mercier, Olaf; Fadel, Elie; Dartevelle, Philippe; Eddahibi, Saadia] Ctr Chirurg Marie Lannelongue, Le Plessis Robinson, France; [Lebrin, Franck] Coll France, INSERM, U833, F-75231 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Hopital Marie Lannelongue; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France	Eddahibi, S (corresponding author), INSERM, U999, Le Plessis Robinson, France.	saadia.eddahibi@inserm.fr	Humbert, Marc/AAC-8459-2019; Humbert, Marc/ABD-5112-2021; Simonneau, Gerald/ABE-6614-2020	Humbert, Marc/0000-0003-0703-2892; Mercier, Olaf/0000-0002-4760-6267; lebrin, franck/0000-0002-1650-6757	INSERM; Agence National de la Recherche [ANR-08-GENOPAT-004]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence National de la Recherche(French National Research Agency (ANR))	This study was supported by grants from the INSERM, and the Agence National de la Recherche (ANR-08-GENOPAT-004 to S. E., A. L-V and M. H.). This article reflects only the authors' views and under no circumstances is the European Community liable for any use that may be made of the information it contains. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambalavanan N, 2008, AM J PHYSIOL-LUNG C, V295, pL86, DOI 10.1152/ajplung.00534.2007; Ardelean DS, 2014, ANGIOGENESIS; BOTNEY MD, 1994, AM J PATHOL, V144, P286; Burton VJ, 2011, BLOOD, V117, P333, DOI 10.1182/blood-2010-05-285973; Castanares C, 2007, J CELL SCI, V120, P1256, DOI 10.1242/jcs.03419; Chen Q, 2010, J PATHOL, V221, P87, DOI 10.1002/path.2690; Chen YF, 2006, J APPL PHYSIOL, V100, P564, DOI 10.1152/japplphysiol.00595.2005; Eddahibi S, 2000, J CLIN INVEST, V105, P1555, DOI 10.1172/JCI8678; Eddahibi S, 2006, CIRCULATION, V113, P1857, DOI 10.1161/CIRCULATIONAHA.105.591321; Eddahibi S, 2001, J CLIN INVEST, V108, P1141, DOI 10.1172/JCI12805; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; Girerd B, 2010, AM J RESP CRIT CARE, V181, P851, DOI 10.1164/rccm.200908-1284OC; Goumans MJ, 2003, TRENDS CARDIOVAS MED, V13, P301, DOI 10.1016/S1050-1738(03)00142-7; Hassoun PM, 2009, J AM COLL CARDIOL, V54, pS10, DOI 10.1016/j.jacc.2009.04.006; Humbert M, 2004, J AM COLL CARDIOL, V43, p13S, DOI 10.1016/j.jacc.2004.02.029; Izikki M, 2009, J CLIN INVEST, V119, P512, DOI 10.1172/JCI35070; Jiang BH, 2010, J CARD FAIL, V16, P679, DOI 10.1016/j.cardfail.2010.03.003; Lebrin F, 2004, EMBO J, V23, P4018, DOI 10.1038/sj.emboj.7600386; Long L, 2009, CIRCULATION, V119, P566, DOI 10.1161/CIRCULATIONAHA.108.821504; Tu L, 2011, AM J RESP CELL MOL, V45, P311, DOI 10.1165/rcmb.2010-0317OC; Machado RD, 2009, J AM COLL CARDIOL, V54, pS32, DOI 10.1016/j.jacc.2009.04.015; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Mata-Greenwood E, 2003, AM J PHYSIOL-LUNG C, V285, pL209, DOI 10.1152/ajplung.00171.2002; Megalou AJ, 2010, INT J CLIN EXP MED, V3, P332; Perros F, 2012, AM J RESP CRIT CARE; Rajkumar R, 2010, AM J PHYSIOL-HEART C, V298, pH1235, DOI 10.1152/ajpheart.00254.2009; Ramos MF, 2008, TOXICOL PATHOL, V36, P311, DOI 10.1177/0192623307311402; Selimovic N, 2009, EUR RESPIR J, V34, P662, DOI 10.1183/09031936.00174908; Shintani M, 2009, J MED GENET, V46, P331, DOI 10.1136/jmg.2008.062703; Star GP, 2010, MICROVASC RES, V80, P349, DOI 10.1016/j.mvr.2010.05.010; Torsney E, 2003, CIRCULATION, V107, P1653, DOI 10.1161/01.CIR.0000058170.92267.00; Zakrzewicz A, 2007, EUR RESPIR J, V29, P1094, DOI 10.1183/09031936.00138206	32	68	70	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100310	10.1371/journal.pone.0100310	http://dx.doi.org/10.1371/journal.pone.0100310			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956016	Green Published, Green Submitted, gold			2022-12-27	WOS:000338917900040
J	Hoellein, T; Rojas, M; Pink, A; Gasior, J; Kelly, J				Hoellein, Timothy; Rojas, Miguel; Pink, Adam; Gasior, Joseph; Kelly, John			Anthropogenic Litter in Urban Freshwater Ecosystems: Distribution and Microbial Interactions	PLOS ONE			English	Article							MARINE DEBRIS; PLASTIC DEBRIS; NUTRIENT LIMITATION; TEMPORAL VARIATIONS; ENVIRONMENT; INGESTION; BIOFILMS; POLLUTION; BEACHES; SEA	Accumulation of anthropogenic litter (i.e. garbage; AL) and its ecosystem effects in marine environments are well documented. Rivers receive AL from terrestrial habitats and represent a major source of AL to marine environments, but AL is rarely studied within freshwater ecosystems. Our objectives were to 1) quantify AL density in urban freshwaters, 2) compare AL abundance among freshwater, terrestrial, and marine ecosystems, and 3) characterize the activity and composition of AL biofilms in freshwater habitats. We quantified AL from the Chicago River and Chicago's Lake Michigan shoreline, and found that AL abundance in Chicago freshwater ecosystems was comparable to previously reported data for marine and terrestrial ecosystems, although AL density and composition differed among habitats. To assess microbial interactions with AL, we incubated AL and natural substrates in 3 freshwater ecosystems, quantified biofilm metabolism as gross primary production (GPP) and community respiration (CR), and characterized biofilm bacterial community composition via high-throughput sequencing of 16S rRNA genes. The main driver of biofilm community composition was incubation location (e.g., river vs pond), but there were some significant differences in biofilm composition and metabolism among substrates. For example, biofilms on organic substrates (cardboard and leaves) had lower GPP than hard substrates (glass, plastic, aluminum and tiles). In addition, bacterial communities on organic substrates were distinct in composition from those on hard substrates, with higher relative abundances of bacteria associated with cellulose decomposition. Finally, we used our results to develop a conceptual diagram designed to unite the study of AL in terrestrial and freshwater environments with the well-established field of marine debris research. We suggest this broad perspective will be useful for future studies which synthesize AL sources, ecosystem effects, and fate across multiple ecosystem types, and will benefit management and reduction of global AL accumulations.	[Hoellein, Timothy; Rojas, Miguel; Pink, Adam; Gasior, Joseph; Kelly, John] Loyola Univ, Dept Biol, Chicago, IL 60626 USA	Loyola University Chicago	Hoellein, T (corresponding author), Loyola Univ, Dept Biol, Chicago, IL 60626 USA.	thoellein@luc.edu	Raju, Nethaji/J-9085-2018	Hoellein, Timothy/0000-0002-9201-3225; Kelly, John/0000-0002-0894-137X	Loyola University Chicago through Center for Urban Environment Research and Policy (CUERP); Loyola University Chicago through Department of Biology; NSF [NSF-DGE-1257295]	Loyola University Chicago through Center for Urban Environment Research and Policy (CUERP); Loyola University Chicago through Department of Biology; NSF(National Science Foundation (NSF))	Loyola University Chicago supported undergraduate researchers Adam Pink and Joseph Gasior through summer research fellowships from the Center for Urban Environment Research and Policy (CUERP) and the Department of Biology, respectively. Miguel Rojas's work on this project was supported by an NSF Graduate Research Fellowship (NSF-DGE-1257295). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Hilal A, 2009, J ENVIRON MANAGE, V90, P1043, DOI 10.1016/j.jenvman.2008.03.014; Andrady AL, 2011, MAR POLLUT BULL, V62, P1596, DOI 10.1016/j.marpolbul.2011.05.030; [Anonymous], 2001, BERGEYS MANUAL SYSTE; [Anonymous], 2005, BERGEYS MANUAL SYSTE; Araujo M. C. B., 2006, PAN AM J AQUATIC SCI, V1, P28; Armitage N, 2000, WATER SA, V26, P181; Barnes DKA, 2005, MAR BIOL, V146, P815, DOI 10.1007/s00227-004-1474-8; Battin TJ, 2003, NATURE, V426, P439, DOI 10.1038/nature02152; Besemer K, 2007, APPL ENVIRON MICROB, V73, P4966, DOI 10.1128/AEM.00588-07; Bott Thomas L., 1996, P533; Bowman D, 1998, J COASTAL RES, V14, P418; Browne MA, 2011, ENVIRON SCI TECHNOL, V45, P9175, DOI 10.1021/es201811s; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Chassard C, 2012, INT J SYST EVOL MICR, V62, P138, DOI 10.1099/ijs.0.027375-0; Choy CA, 2013, MAR ECOL PROG SER, V485, P155, DOI 10.3354/meps10342; Chung EJ, 2012, INT J SYST EVOL MICR, V62, P3030, DOI 10.1099/ijs.0.036442-0; Claereboudt MR, 2004, MAR POLLUT BULL, V49, P770, DOI 10.1016/j.marpolbul.2004.06.004; CLARKE KR, 1988, MAR ECOL PROG SER, V46, P213, DOI 10.3354/meps046213; Cole M, 2011, MAR POLLUT BULL, V62, P2588, DOI 10.1016/j.marpolbul.2011.09.025; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; Derraik JGB, 2002, MAR POLLUT BULL, V44, P842, DOI 10.1016/S0025-326X(02)00220-5; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Fitzpatrick FA, 2005, AM FISH S S, V47, P87; Gregory MR, 2009, PHILOS T R SOC B, V364, P2013, DOI 10.1098/rstb.2008.0265; Hall RO, 1998, ECOLOGY, V79, P1995, DOI 10.1890/0012-9658(1998)079[1995:TTSOBI]2.0.CO;2; Hammer J, 2012, REV ENVIRON CONTAM T, V220, P1, DOI 10.1007/978-1-4614-3414-6_1; Hoellein TJ, 2010, HYDROBIOLOGIA, V649, P331, DOI 10.1007/s10750-010-0276-x; Hoellein TJ, 2009, J N AM BENTHOL SOC, V28, P305, DOI 10.1899/08-073.1; Hoppe PD, 2012, FRESHW SCI, V31, P379, DOI 10.1899/11-089; Isanapong J, 2012, J BACTERIOL, V194, P2744, DOI 10.1128/JB.00264-12; do Sul JAI, 2007, MAR POLLUT BULL, V54, P1087, DOI 10.1016/j.marpolbul.2007.05.004; do Sul JAI, 2011, ESTUAR COAST, V34, P814, DOI 10.1007/s12237-011-9392-8; Johnson LT, 2009, CAN J FISH AQUAT SCI, V66, P1081, DOI 10.1139/F09-065; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Law KL, 2010, SCIENCE, V329, P1185, DOI 10.1126/science.1192321; Lee DI, 2006, ESTUAR COAST SHELF S, V70, P187, DOI 10.1016/j.ecss.2006.06.003; Madzena A, 1997, MAR POLLUT BULL, V34, P900, DOI 10.1016/S0025-326X(97)00052-0; McNamara CJ, 2004, J N AM BENTHOL SOC, V23, P677, DOI 10.1899/0887-3593(2004)023<0677:BCCIBO>2.0.CO;2; Mhedbi-Hajri N, 2011, ADV EXP MED BIOL, V715, P71, DOI 10.1007/978-94-007-0940-9_5; Moore CJ, 2008, ENVIRON RES, V108, P131, DOI 10.1016/j.envres.2008.07.025; NOLLKAEMPER A, 1994, MAR POLLUT BULL, V28, P649, DOI 10.1016/0025-326X(94)90299-2; Ofek M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040117; Phillips RA, 2010, BIOL CONSERV, V143, P501, DOI 10.1016/j.biocon.2009.11.020; Puls J, 2011, J POLYM ENVIRON, V19, P152, DOI 10.1007/s10924-010-0258-0; Ribic CA, 1998, MAR POLLUT BULL, V36, P887, DOI 10.1016/S0025-326X(98)00064-2; Rickard AH, 2003, FEMS MICROBIOL LETT, V220, P133, DOI 10.1016/S0378-1097(03)00094-6; Ryan PG, 2009, PHILOS T R SOC B, V364, P1999, DOI 10.1098/rstb.2008.0207; Santos IR, 2009, ENVIRON MONIT ASSESS, V148, P455, DOI 10.1007/s10661-008-0175-z; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schuyler Q, 2014, CONSERV BIOL, V28, P129, DOI 10.1111/cobi.12126; Pon JPS, 2012, WASTE MANAGE, V32, P343, DOI 10.1016/j.wasman.2011.10.012; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Sheavly SB, 2007, J POLYM ENVIRON, V15, P301, DOI 10.1007/s10924-007-0074-3; van Sebille E, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/4/044040; Vos P., 2009, BERGEYS MANUAL SYSTE; Walsh CJ, 2005, J N AM BENTHOL SOC, V24, P706, DOI 10.1899/04-020.1; Williams AT, 1999, WATER AIR SOIL POLL, V112, P197, DOI 10.1023/A:1005000724803; Yue JC, 2005, COMMUN STAT-THEOR M, V34, P2123, DOI 10.1080/STA-200066418; Zbyszewski M, 2011, WATER AIR SOIL POLL, V220, P365, DOI 10.1007/s11270-011-0760-6; Zettler ER, 2013, ENVIRON SCI TECHNOL, V47, P7137, DOI 10.1021/es401288x	60	162	166	4	189	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e98485	10.1371/journal.pone.0098485	http://dx.doi.org/10.1371/journal.pone.0098485			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955768	gold, Green Published			2022-12-27	WOS:000338917900002
J	Morrison, PK; Bing, C; Harris, PA; Maltin, CA; Grove-White, D; Argo, CM				Morrison, Philippa K.; Bing, Chen; Harris, Patricia A.; Maltin, Charlotte A.; Grove-White, Dai; Argo, Caroline McG			Post-Mortem Stability of RNA in Skeletal Muscle and Adipose Tissue and the Tissue-Specific Expression of Myostatin, Perilipin and Associated Factors in the Horse	PLOS ONE			English	Article							REAL-TIME PCR; GENE-EXPRESSION; MESSENGER-RNA; ACTIVIN-A; ADIPOCYTE LIPOLYSIS; BOVINE PREADIPOCYTE; FOLLISTATIN; MICE; DIFFERENTIATION; OBESITY	Obesity, a major concern for equine welfare, is highly prevalent in the leisure horse population. Skeletal-muscle and adipose tissues are important determinants of maintenance energy requirements. The myostatin and perilipin pathways play key roles in the regulation of muscle mass and lipolysis respectively and have both been associated with obesity predisposition in other mammalian species. High quality samples, suitable for molecular biology, are an essential prerequisite for detailed investigations of gene and protein expression. Hence, this study has evaluated a) the post-mortem stability of RNA extracted from skeletal-muscle and adipose-tissues collected under commercial conditions and b) the tissue-specific presence of myostatin, the moystatin receptor (activin receptor IIB, ActRIIB), follistatin and perilipin, genes and proteins across a range of equine tissues. Objectives were addressed using tissues from 7 Thoroughbred horses presented for slaughter at a commercial abattoir; a) samples were collected at 7 time-points from Masseter muscle and perirenal adipose from 5 minutes to 6 hours post-mortem. Extracted RN was appraised by Optical Density analysis and agarose-gel electrophoresis. b) Quantitative real time PCR and Western Blotting were used to evaluate gene and protein expression in anatomically-defined samples collected from 17 tissues (6 organs, 4 skeletal muscles and 7 discrete adipose depots). The results indicate that, under the present collection conditions, intact, good quality RNA could be extracted from skeletal-muscle for up to 2 hours post-mortem. However, RNA from adipose tissue may be more susceptible to degradation/contamination and samples should be collected no later than 30 minutes post-mortem. The data also show that myostatin and ActRIIB genes and proteins were almost exclusively expressed in skeletal muscle. The follistatin gene showed a more diverse gene expression profile, with expression evident in several organs, adipose tissue depots and skeletal muscles. Perilipin gene and protein were almost exclusively expressed by adipose tissue.	[Morrison, Philippa K.; Bing, Chen; Maltin, Charlotte A.; Grove-White, Dai; Argo, Caroline McG] Univ Liverpool, Dept Obes & Endocrinol, Fac Hlth & Life Sci, Wirral L64 7TE, Merseyside, England; [Harris, Patricia A.] WALTHAM Ctr Pet Nutr, Equine Studies Grp, Melton Mowbray, Leics, England	University of Liverpool; Mars; WALTHAM Petcare Science Institute	Argo, CM (corresponding author), Univ Liverpool, Dept Obes & Endocrinol, Fac Hlth & Life Sci, Leahurst Campus, Wirral L64 7TE, Merseyside, England.	argo@liv.ac.uk		Morrison, Philippa/0000-0003-4187-0371; Argo, Caroline/0000-0002-8279-6350	WALTHAM	WALTHAM	This research was funded by a PhD Scholarship from WALTHAM. The funders (with the exception of Patricia A. Harris, co-author and collaborator), had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn K, 2011, GENES GENOM, V33, P245, DOI 10.1007/s13258-010-0114-6; Allen DL, 2008, AM J PHYSIOL-ENDOC M, V294, pE918, DOI 10.1152/ajpendo.00798.2007; Amthor H, 2004, DEV BIOL, V270, P19, DOI 10.1016/j.ydbio.2004.01.046; Argo CM, 2012, VET J; Arvidsson E, 2004, J INTERN MED, V255, P595, DOI 10.1111/j.1365-2796.2004.01314.x; Bahar B, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-108; Bickel PE, 2009, BBA-MOL CELL BIOL L, V1791, P419, DOI 10.1016/j.bbalip.2009.04.002; Bogaert L, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-24; Brandt C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037236; Carlson CJ, 1999, AM J PHYSIOL-REG I, V277, pR601, DOI 10.1152/ajpregu.1999.277.2.R601; Cash JN, 2012, MOL ENDOCRINOL, V26, P1167, DOI 10.1210/me.2012-1061; Flanagan JN, 2009, J CLIN ENDOCR METAB, V94, P3003, DOI 10.1210/jc.2008-2005; Fleige S, 2006, BIOTECHNOL LETT, V28, P1601, DOI 10.1007/s10529-006-9127-2; Fontanesi L, 2008, MEAT SCI, V80, P1345, DOI 10.1016/j.meatsci.2008.06.014; Gill JL, 2009, ANIM GENET, V40, P97, DOI 10.1111/j.1365-2052.2008.01790.x; Gjelstad IMF, 2012, ARCH PHYSIOL BIOCHEM, V118, P22, DOI 10.3109/13813455.2011.630009; Grobet L, 1997, NAT GENET, V17, P71, DOI 10.1038/ng0997-71; Gu YR, 2011, J ANIM BREED GENET, V128, P319, DOI 10.1111/j.1439-0388.2011.00920.x; Guo W, 2008, J BIOL CHEM, V283, P9136, DOI 10.1074/jbc.M708968200; Harker I.J., 2011, J EQUINE VET SCI, V31, P253, DOI [10.1016/j.jevs.2011.03.058, DOI 10.1016/J.JEVS.2011.03.058]; HARRIS RBS, 1986, J NUTR, V116, P2536, DOI 10.1093/jn/116.12.2536; Hemmrich K, 2010, LABMEDICINE, V41, P104, DOI 10.1309/LMFSBPUOA19MH5BV; Hennebry A, 2009, AM J PHYSIOL-CELL PH, V296, pC525, DOI 10.1152/ajpcell.00259.2007; Hickford JGH, 2010, ANIM GENET, V41, P64, DOI 10.1111/j.1365-2052.2009.01965.x; Hill EW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-552; Hirai S, 2007, DOMEST ANIM ENDOCRIN, V33, P269, DOI 10.1016/j.domaniend.2006.06.001; Hirai S, 2007, DOMEST ANIM ENDOCRIN, V32, P1, DOI 10.1016/j.domaniend.2005.12.001; Hittel DS, 2009, DIABETES, V58, P30, DOI 10.2337/db08-0943; Hosoyama T, 2002, J REPROD DEVELOP, V48, P335, DOI 10.1262/jrd.48.335; Ju MJ, 2009, AM J CLIN PATHOL, V131, P498, DOI 10.1309/AJCP86PPBNGOHNNL; Kern PA, 2004, J CLIN ENDOCR METAB, V89, P1352, DOI 10.1210/jc.2003-031388; Kessler Y, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-106; Keutmann HT, 2004, MOL ENDOCRINOL, V18, P228, DOI 10.1210/me.2003-0112; Kijas JW, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-80; Koch L, 2008, J CLIN INVEST, V118, P2132, DOI 10.1172/JCI31073; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Mosher DS, 2007, PLOS GENET, V3; Mottagui-Tabar S, 2003, DIABETOLOGIA, V46, P789, DOI 10.1007/s00125-003-1112-x; Pedersen B.K., 2012, NAT REV ENDOCRINOL; Peters IR, 2007, VET IMMUNOL IMMUNOP, V117, P55, DOI 10.1016/j.vetimm.2007.01.011; Pratt S, 2013, ISOLATION TOTAL RNA, P181; Qi L, 2004, CLIN GENET, V66, P299, DOI 10.1111/j.1399-0004.2004.00309.x; Rebouissou S, 2008, J HEPATOL, V49, P61, DOI 10.1016/j.jhep.2008.03.013; Ruiz JR, 2011, BRIT J NUTR, V106, P486, DOI 10.1017/S0007114511000432; Shen WJ, 2009, J LIPID RES, V50, P2306, DOI 10.1194/jlr.M900176-JLR200; Sidis Y, 2006, ENDOCRINOLOGY, V147, P3586, DOI 10.1210/en.2006-0089; Tansey JT, 2004, IUBMB LIFE, V56, P379, DOI 10.1080/15216540400009968; Taylor S, 2010, METHODS, V50, pS1, DOI 10.1016/j.ymeth.2010.01.005; Tortoriello DV, 2001, ENDOCRINOLOGY, V142, P3426, DOI 10.1210/en.142.8.3426; Trayhurn Paul, 2011, Archives of Physiology and Biochemistry, V117, P47, DOI 10.3109/13813455.2010.535835; Tu PA, 2012, ANIM BIOTECHNOL, V23, P291, DOI 10.1080/10495398.2012.709205; UENO N, 1987, P NATL ACAD SCI USA, V84, P8282, DOI 10.1073/pnas.84.23.8282; Wang YX, 2003, OBES RES, V11, P930, DOI 10.1038/oby.2003.128; Whittemore LA, 2003, BIOCHEM BIOPH RES CO, V300, P965, DOI 10.1016/S0006-291X(02)02953-4; Zaragosi LE, 2010, DIABETES, V59, P2513, DOI 10.2337/db10-0013; Zhang C, 2012, DIABETOLOGIA, V55, P183, DOI 10.1007/s00125-011-2304-4; Zimmers TA, 2002, SCIENCE, V296, P1486, DOI 10.1126/science.1069525	57	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100810	10.1371/journal.pone.0100810	http://dx.doi.org/10.1371/journal.pone.0100810			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956155	Green Submitted, Green Published, gold			2022-12-27	WOS:000338917900096
J	Bao, ZL; Hua, J				Bao, Zhilong; Hua, Jian			Interaction of CPR5 with Cell Cycle Regulators UVI4 and OSD1 in Arabidopsis	PLOS ONE			English	Article							DEFENSE RESPONSES; PLANT DEVELOPMENT; GENE-EXPRESSION; PROTEIN; RESISTANCE; THALIANA; ENDOREPLICATION; COMPLEX; GROWTH; ENDOREDUPLICATION	The impact of cell cycle on plant immunity was indicated by the enhancement of disease resistance with overexpressing OSD1 and UVI4 genes that are negative regulators of cell cycle controller APC (anaphase promoting complex). CPR5 is another gene that is implicated in cell cycle regulation and plant immunity, but its mode of action is not known. Here we report the analysis of genetic requirement for the function of UVI4 and OSD1 in cell cycle progression control and in particular the involvement of CPR5 in this regulation. We show that the APC activator CCS52A1 partially mediates the function of OSD1 and UVI4 in female gametophyte development. We found that the cpr5 mutation suppresses the endoreduplication defect in the uvi4 single mutant and partially rescued the gametophyte development defect in the osd1 uvi4 double mutant while the uvi4 mutation enhances the cpr5 defects in trichome branching and plant disease resistance. In addition, cyclin B1 genes CYCB1;1, CYCB1;2, and CYCB1;4 are upregulated in cpr5. Therefore, CPR5 has a large role in cell cycle regulation and this role has a complex interaction with that of UVI4 and OSD1. This study further indicates an intrinsic link between plant defense responses and cell cycle progression.	[Bao, Zhilong; Hua, Jian] Cornell Univ, Dept Plant Biol, Ithaca, NY 14850 USA	Cornell University	Hua, J (corresponding author), Cornell Univ, Dept Plant Biol, Ithaca, NY 14850 USA.	jh299@cornell.edu	Bao, Zhilong/L-8048-2018	Bao, Zhilong/0000-0002-2670-8344	National Science Foundation (NSF) [IOS-0642289, IOS-0919914]; Plant Biology Department at Cornell University	National Science Foundation (NSF)(National Science Foundation (NSF)); Plant Biology Department at Cornell University	This work was supported by National Science Foundation (NSF) grants IOS-0642289 and IOS-0919914 and the Plant Biology Department at Cornell University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumuganathan K., 1991, PLANT MOL BIOL REP, V9, P229, DOI [10.1007/BF02672073, DOI 10.1007/BF02672073]; Ascencio-Ibanez JT, 2008, PLANT PHYSIOL, V148, P436, DOI 10.1104/pp.108.121038; Bao ZL, 2013, P NATL ACAD SCI USA, V110, P2407, DOI 10.1073/pnas.1217024110; Boch J, 1998, MOL PLANT MICROBE IN, V11, P1196, DOI 10.1094/MPMI.1998.11.12.1196; Borghi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026360; Bowling SA, 1997, PLANT CELL, V9, P1573, DOI 10.1105/tpc.9.9.1573; Breuer C, 2010, CURR OPIN PLANT BIOL, V13, P654, DOI 10.1016/j.pbi.2010.10.006; Brininstool G, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-58; Chandran D, 2010, P NATL ACAD SCI USA, V107, P460, DOI 10.1073/pnas.0912492107; Chevalier C, 2011, ANN BOT-LONDON, V107, P1159, DOI 10.1093/aob/mcq257; Christensen CA, 1997, SEX PLANT REPROD, V10, P49, DOI 10.1007/s004970050067; Cromer L, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002865; d'Erfurth I, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000989; d'Erfurth I, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000124; De Veylder L, 2011, TRENDS PLANT SCI, V16, P624, DOI 10.1016/j.tplants.2011.07.001; del Pozo JC, 2006, PLANT CELL, V18, P2224, DOI 10.1105/tpc.105.039651; Gao GL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019406; Hase Y, 2006, PLANT J, V46, P317, DOI 10.1111/j.1365-313X.2006.02696.x; Heyman J, 2011, PLANT CELL; Inagaki S, 2011, INT REV CEL MOL BIO, V291, P227, DOI 10.1016/B978-0-12-386035-4.00007-0; Inze D, 2006, ANNU REV GENET, V40, P77, DOI 10.1146/annurev.genet.40.110405.090431; Iwata E, 2011, PLANT CELL; Iwata E, 2012, PLANT SIGNAL BEHAV, V7, P1079, DOI 10.4161/psb.21133; Kasili R, 2010, GENETICS, V185, P257, DOI 10.1534/genetics.109.113274; Katagiri Fumiaki, 2002, Arabidopsis Book, V1, pe0039, DOI 10.1199/tab.0039; Kirik V, 2001, CURR BIOL, V11, P1891, DOI 10.1016/S0960-9822(01)00590-5; Lageix S, 2007, J VIROL, V81, P4177, DOI 10.1128/JVI.02103-06; Lammens T, 2008, P NATL ACAD SCI USA, V105, P14721, DOI 10.1073/pnas.0806510105; Larson-Rabin Z, 2009, PLANT PHYSIOL, V149, P874, DOI 10.1104/pp.108.132449; Marrocco K, 2010, CURR OPIN PLANT BIOL, V13, P631, DOI 10.1016/j.pbi.2010.07.004; Menges M, 2003, PLANT MOL BIOL, V53, P423, DOI 10.1023/B:PLAN.0000019059.56489.ca; Menges M, 2002, J BIOL CHEM, V277, P41987, DOI 10.1074/jbc.M207570200; Mukhtar MS, 2011, SCIENCE, V333, P596, DOI 10.1126/science.1203659; Perazza D, 1999, GENETICS, V152, P461; Perazza D, 2011, PLANT PHYSIOL, V157, P1232, DOI 10.1104/pp.111.179804; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Shi DQ, 2005, PLANT CELL, V17, P2340, DOI 10.1105/tpc.105.033563; Stevens C, 2004, DNA REPAIR, V3, P1071, DOI 10.1016/j.dnarep.2004.03.034; Van Leene J, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.53; Vanstraelen M, 2009, P NATL ACAD SCI USA, V106, P11806, DOI 10.1073/pnas.0901193106; Yang HJ, 2006, PLANT J, V48, P238, DOI 10.1111/j.1365-313X.2006.02869.x; Yang SH, 2004, PLANT CELL, V16, P1060, DOI 10.1105/tpc.020479; Yoshida S, 2002, PLANT J, V29, P427, DOI 10.1046/j.0960-7412.2001.01228.x; Zheng BL, 2011, PLANT CELL, V23, P1033, DOI 10.1105/tpc.111.083980; Zhu Y, 2011, PLANT J, V66, P443, DOI 10.1111/j.1365-313X.2011.04504.x; Zhu Y, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000844	46	18	18	5	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100347	10.1371/journal.pone.0100347	http://dx.doi.org/10.1371/journal.pone.0100347			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945150	Green Submitted, Green Published, gold			2022-12-27	WOS:000340721500065
J	Deitch, JS; Alexander, GM; Bensinger, A; Yang, S; Jiang, JT; Heiman-Patterson, TD				Deitch, Jeffrey S.; Alexander, Guillermo M.; Bensinger, Andrew; Yang, Steven; Jiang, Juliann T.; Heiman-Patterson, Terry D.			Phenotype of Transgenic Mice Carrying a Very Low Copy Number of the Mutant Human G93A Superoxide Dismutase-1 Gene Associated with Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							FAMILIAL ALS; MOUSE MODEL; SOD1; MUTATIONS; SURVIVAL	Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease of the motor neuron. While most cases of ALS are sporadic, 10% are familial (FALS) with 20% of FALS caused by a mutation in the gene that codes for the enzyme Cu/Zn superoxide dismutase (SOD1). There is variability in sporadic ALS as well as FALS where even within the same family some siblings with the same mutation do not manifest disease. A transgenic (Tg) mouse model of FALS containing 25 copies of the mutant human SOD1 gene demonstrates motor neuron pathology and progressive weakness similar to ALS patients, leading to death at approximately 130 days. The onset of symptoms and survival of these transgenic mice are directly related to the number of copies of the mutant gene. We report the phenotype of a very low expressing (VLE) G93A SOD1 Tg carrying only 4 copies of the mutant G93ASOD1 gene. While weakness can start at 9 months, only 74% of mice 18 months or older demonstrate disease. The VLE mice show decreased motor neurons compared to wild-type mice as well as increased cytoplasmic translocation of TDP-43. In contrast to the standard G93A SOD1 Tg mouse which always develops motor weakness leading to death, not all VLE animals manifested clinical disease or shortened life span. In fact, approximately 20% of mice older than 24 months had no motor symptoms and only 18% of VLE mice older than 22 months reached end stage. Given the variable penetrance of clinical phenotype, prolonged survival, and protracted loss of motor neurons the VLE mouse provides a new tool that closely mimics human ALS. This tool will allow the study of pathologic events over time as well as the study of genetic and environmental modifiers that may not be causative, but can exacerbate or accelerate motor neuron disease.	[Deitch, Jeffrey S.; Alexander, Guillermo M.; Jiang, Juliann T.; Heiman-Patterson, Terry D.] Drexel Univ, Coll Med, Dept Neurol, Philadelphia, PA 19104 USA; [Bensinger, Andrew; Yang, Steven] Philadelphia Coll Osteopath Med, Philadelphia, PA USA	Drexel University	Heiman-Patterson, TD (corresponding author), Drexel Univ, Coll Med, Dept Neurol, Philadelphia, PA 19104 USA.	theiman@drexelmed.edu			ALS Hope Foundation	ALS Hope Foundation	Funding for this study was made possible through the ALS Hope Foundation support of transgenic mouse colonies and exploratory research, http://www.alshopefoundation.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Chalabi A, 2013, NAT REV NEUROL, V9, P617, DOI 10.1038/nrneurol.2013.203; Alexander GM, 2004, MOL BRAIN RES, V130, P7, DOI 10.1016/j.molbrainres.2004.07.002; Camu W, 1999, J NEUROL SCI, V165, pS21, DOI 10.1016/S0022-510X(99)00022-2; Cleveland DW, 1999, NEURON, V24, P515, DOI 10.1016/S0896-6273(00)81108-3; DALCANTO MC, 1994, AM J PATHOL, V145, P1271; DalCanto MC, 1997, ACTA NEUROPATHOL, V93, P537; DALCANTO MC, 1995, BRAIN RES, V676, P25, DOI 10.1016/0006-8993(95)00063-V; Felbecker A, 2010, J NEUROL NEUROSUR PS, V81, P572, DOI 10.1136/jnnp.2009.192310; Gurney ME, 1997, J NEUROL SCI, V152, pS67, DOI 10.1016/S0022-510X(97)00247-5; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Heiman-Patterson TD, 2005, J NEUROL SCI, V236, P1, DOI 10.1016/j.jns.2005.02.006; Heiman-Patterson TD, 2011, AMYOTROPH LATERAL SC, V12, P79, DOI 10.3109/17482968.2010.550626; Henriques A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015445; RIPPS ME, 1995, P NATL ACAD SCI USA, V92, P689, DOI 10.1073/pnas.92.3.689; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; SIDDIQUE T, 1991, NEW ENGL J MED, V324, P1381, DOI 10.1056/NEJM199105163242001	16	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e99879	10.1371/journal.pone.0099879	http://dx.doi.org/10.1371/journal.pone.0099879			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945277	Green Published, Green Submitted, gold			2022-12-27	WOS:000340721500031
J	Ibahim, MJ; Crosbie, JC; Yang, YQ; Zaitseva, M; Stevenson, AW; Rogers, PAW; Paiva, P				Ibahim, Mohammad Johari; Crosbie, Jeffrey C.; Yang, Yuqing; Zaitseva, Marina; Stevenson, Andrew W.; Rogers, Peter A. W.; Paiva, Premila			An Evaluation of Dose Equivalence between Synchrotron Microbeam Radiation Therapy and Conventional Broadbeam Radiation Using Clonogenic and Cell Impedance Assays	PLOS ONE			English	Article							BREAST-CANCER METASTASIS; 9L GLIOSARCOMA; MONTE-CARLO; X-RAYS; MODEL; BEAM; BYSTANDER; MOUSE; SKIN; QUANTIFICATION	Background: High-dose synchrotron microbeam radiation therapy (MRT) has shown the potential to deliver improved outcomes over conventional broadbeam (BB) radiation therapy. To implement synchrotron MRT clinically for cancer treatment, it is necessary to undertake dose equivalence studies to identify MRT doses that give similar outcomes to BB treatments. Aim: To develop an in vitro approach to determine biological dose equivalence between MRT and BB using two different cell-based assays. Methods: The acute response of tumour and normal cell lines (EMT6.5, 4T1.2, NMuMG, EMT6.5ch, 4T1ch5, SaOS-2) to MRT (50-560 Gy) and BB (1.5-10 Gy) irradiation was investigated using clonogenic and real time cell impedance sensing (RT-CIS)/xCELLigence assays. MRT was performed using a lattice of 25 or 50 mm-wide planar, polychromatic kilovoltage X-ray microbeams with 200 mm peak separation. BB irradiations were performed using a Co-60 teletherapy unit or a synchrotron radiation source. BB doses that would generate biological responses similar to MRT were calculated by data interpolation and verified by clonogenic and RT-CIS assays. Results: For a given cell line, MRT equivalent BB doses identified by RT-CIS/xCELLigence were similar to those identified by clonogenic assays. Dose equivalence between MRT and BB were verified in vitro in two cell lines; EMT6.5ch and SaOS-2 by clonogenic assays and RT-CIS/xCELLigence. We found for example, that BB doses of 3.4 +/- 0.1 Gy and 4.40 +/- 0.04 Gy were radiobiologically equivalent to a peak, microbeam dose of 112 Gy using clonogenic and RT-CIS assays respectively on EMT6.5ch cells. Conclusion: Our data provides the first determination of biological dose equivalence between BB and MRT modalities for different cell lines and identifies RT-CIS/xCELLigence assays as a suitable substitute for clonogenic assays. These results will be useful for the safe selection of MRT doses for future veterinary and clinical trials.	[Ibahim, Mohammad Johari; Crosbie, Jeffrey C.; Yang, Yuqing; Zaitseva, Marina; Rogers, Peter A. W.; Paiva, Premila] Univ Melbourne, Royal Womens Hosp, Dept Obstet & Gynaecol, Parkville, Vic 3052, Australia; [Ibahim, Mohammad Johari] Univ Teknol MARA, Fac Med, Sungai Buloh, Selangor, Malaysia; [Crosbie, Jeffrey C.] Alfred Hosp, William Buckland Radiotherapy Ctr, Melbourne, Vic, Australia; [Stevenson, Andrew W.] Australian Synchrotron Imaging & Med Beamline, Clayton, Vic, Australia; [Stevenson, Andrew W.] CSIRO Mat Sci & Engn, Clayton, Vic, Australia	University of Melbourne; Universiti Teknologi MARA; Florey Institute of Neuroscience & Mental Health; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Rogers, PAW (corresponding author), Univ Melbourne, Royal Womens Hosp, Dept Obstet & Gynaecol, Parkville, Vic 3052, Australia.	parogers@unimelb.edu	Rogers, Peter AW/C-2651-2008; Stevenson, Andrew W/B-4948-2019; Ibahim, Mohammad Johari/A-9576-2017; Crosbie, Jeffrey/F-8465-2010	Rogers, Peter AW/0000-0002-7399-8997; Stevenson, Andrew W/0000-0002-0691-6883; Ibahim, Mohammad Johari/0000-0003-3826-7360; Crosbie, Jeffrey/0000-0002-8047-5465; Paiva, Premila/0000-0001-8532-0326	National Health and Medical Research Council (NHMRC) (Australia) Project Grant [606614]; Cancer Council Victoria [1048205]; NHMRC Postdoctoral Early Career Fellowship [1013774, 1036174]; Malaysian Government under University Staff Academic Scheme(SLAI)	National Health and Medical Research Council (NHMRC) (Australia) Project Grant; Cancer Council Victoria(Cancer Council VictoriaCanadian Institutes of Health Research (CIHR)); NHMRC Postdoctoral Early Career Fellowship; Malaysian Government under University Staff Academic Scheme(SLAI)	The work was supported by National Health and Medical Research Council (NHMRC) (Australia) Project Grant (#606614) to PAR and by Cancer Council Victoria (#1048205). PP and JCC were supported by a NHMRC Postdoctoral Early Career Fellowship (#1013774 and #1036174). MJI was sponsored by the Malaysian Government under University Staff Academic Scheme(SLAI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Asur RS, 2012, RADIAT RES, V177, P751, DOI 10.1667/RR2780.1; Brauer-Krisch E, 2003, MED PHYS, V30, P583, DOI 10.1118/1.1562169; Crosbie JC, 2008, PHYS MED BIOL, V53, P6861, DOI 10.1088/0031-9155/53/23/014; Crosbie JC, 2013, MED PHYS, V40, DOI 10.1118/1.4803675; Crosbie JC, 2010, INT J RADIAT ONCOL, V77, P886, DOI 10.1016/j.ijrobp.2010.01.035; Dilmanian F A, 2003, Cardiovasc Radiat Med, V4, P139, DOI 10.1016/S1522-1865(03)00180-X; Dilmanian FA, 2005, NUCL INSTRUM METH A, V548, P30, DOI 10.1016/j.nima.2005.03.062; Dilmanian FA, 2002, NEURO-ONCOLOGY, V4, P26, DOI 10.1093/neuonc/4.1.26; DOUGLAS BG, 1976, RADIAT RES, V66, P401, DOI 10.2307/3574407; Eckhardt BL, 2005, MOL CANCER RES, V3, P1; Fernandez-Palomo C, 2013, INT J RADIAT BIOL, V89, P445, DOI 10.3109/09553002.2013.766770; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Laissue JA, 2007, DEV MED CHILD NEUROL, V49, P577, DOI 10.1111/j.1469-8749.2007.00577.x; Laissue JA, 1998, INT J CANCER, V78, P654, DOI 10.1002/(SICI)1097-0215(19981123)78:5<654::AID-IJC21>3.0.CO;2-L; Lelekakis M, 1999, CLIN EXP METASTAS, V17, P163, DOI 10.1023/A:1006689719505; MACKILLOP WJ, 1983, J NATL CANCER I, V70, P9; Mandal P, 2012, IRRADIATION INDUCED; Mothersill C, 2006, CURR CANCER DRUG TAR, V6, P447, DOI 10.2174/156800906777723976; Nettelbeck H, 2009, MED PHYS, V36, P447, DOI 10.1118/1.3049786; O'Rourke SFC, 2009, J MATH BIOL, V58, P799, DOI 10.1007/s00285-008-0222-y; Prise KM, 2005, LANCET ONCOL, V6, P520, DOI 10.1016/S1470-2045(05)70246-1; Priyadarshika RCU, 2011, BRIT J RADIOL, V84, P833, DOI 10.1259/bjr/58503354; PUCK TT, 1956, J EXP MED, V103, P653, DOI 10.1084/jem.103.5.653; Regnard P, 2008, PHYS MED BIOL, V53, P861, DOI 10.1088/0031-9155/53/4/003; Roa W, 2011, ANAL BIOANAL CHEM, V400, P2003, DOI 10.1007/s00216-011-4934-2; ROCKWELL S, 1981, CANCER RES, V41, P527; Rothkamm K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029853; Serduc R, 2008, PHYS MED BIOL, V53, P1153, DOI 10.1088/0031-9155/53/5/001; Siegbahn EA, 2006, MED PHYS, V33, P3248, DOI 10.1118/1.2229422; Williams SA, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-250; Zhong N, 2003, RADIAT RES, V160, P133, DOI 10.1667/3033	32	39	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100547	10.1371/journal.pone.0100547	http://dx.doi.org/10.1371/journal.pone.0100547			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945301	Green Published, Green Submitted, gold			2022-12-27	WOS:000340721500092
J	McCrickerd, K; Chambers, L; Yeomans, MR				McCrickerd, Keri; Chambers, Lucy; Yeomans, Martin R.			Fluid or Fuel? The Context of Consuming a Beverage Is Important for Satiety	PLOS ONE			English	Article							ENERGY-INTAKE; FOOD-INTAKE; REPEATED CONSUMPTION; APPETITE; HUNGER; MEAL; THIRST; MOTIVATION; DRINKING; ADULTS	Energy-containing beverages have a weak effect on satiety, limited by their fluid characteristics and perhaps because they are not considered 'food'. This study investigated whether the context of consuming a beverage can influence the satiating power of its nutrients. Eighty participants consumed a lower- (LE, 75 kcal) and higher-energy (HE, 272 kcal) version of a beverage (covertly manipulated within-groups) on two test days, in one of four beverage contexts (between-groups): thin versions of the test-drinks were consumed as a thirst-quenching drink (n = 20), a filling snack (n = 20), or without additional information (n = 20). A fourth group consumed subtly thicker versions of the beverages without additional information (n = 20). Lunch intake 60 minutes later depended on the beverage context and energy content (p = 0.030): participants who consumed the thin beverages without additional information ate a similar amount of lunch after the LE and HE versions (LE = 475 kcal, HE = 464 kcal; p = 0.690) as did those participants who believed the beverages were designed to quench-thirst (LE = 442 kcal, HE = 402 kcal; p = 0.213), despite consuming an additional 197 kcal in the HE beverage. Consuming the beverage as a filling snack led participants to consume less at lunch after the HE beverage compared to the LE version (LE = 506 kcal, HE = 437 kcal; p = 0.025). This effect was also seen when the beverages were subtly thicker, with participants in this group displaying the largest response to the beverage's energy content, consuming less at lunch after the HE version (LE = 552 kcal, HE = 415 kcal; p<0.001). These data indicate that beliefs about the consequences of consuming a beverage can affect the impact of its nutrients on appetite regulation and provide further evidence that a beverage's sensory characteristics can limit its satiating power.	[McCrickerd, Keri; Chambers, Lucy; Yeomans, Martin R.] Univ Sussex, Sch Psychol, Brighton, E Sussex, England	University of Sussex	McCrickerd, K (corresponding author), Univ Sussex, Sch Psychol, Brighton, E Sussex, England.	k.mccrickerd@sussex.ac.uk	Yeomans, Martin/A-5291-2012	Yeomans, Martin/0000-0003-1436-1483; McCrickerd, Keri/0000-0003-3171-7584	UK Biotechnology and Biological Science Research Council, Diet and Research Industry club (DRINC) initiative [BB/H004645/1]; BBSRC [BB/H004645/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H004645/1, 1074568] Funding Source: researchfish	UK Biotechnology and Biological Science Research Council, Diet and Research Industry club (DRINC) initiative(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was conducted as part of a PhD studentship supported by the research grant BB/H004645/1 from the UK Biotechnology and Biological Science Research Council as part of the Diet and Research Industry club (DRINC) initiative. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almiron-Roig E, 2013, NUTR REV, V71, P458, DOI 10.1111/nure.12048; Bertenshaw EJ, 2013, BRIT J NUTR, V110, P578, DOI 10.1017/S0007114512005375; Blundell J, 2010, OBES REV, V11, P251, DOI 10.1111/j.1467-789X.2010.00714.x; Blundell J. E., 1987, In 'Food acceptance and nutrition', by Solms, J. et al. Conference. Zurich, Switzerland 7-10 April 1987. London, UK; Academic Press Ltd. ISBN 0-12-654430-1 [see FSTA (1989) 21 3A6]., P205; Brunstrom JM, 2007, APPETITE, V49, P268, DOI 10.1016/j.appet.2006.11.007; Brunstrom JM, 2011, APPETITE, V56, P310, DOI 10.1016/j.appet.2011.01.002; Capaldi ED, 2006, APPETITE, V46, P117, DOI 10.1016/j.appet.2005.10.008; Cassady BA, 2012, AM J CLIN NUTR, V95, P587, DOI 10.3945/ajcn.111.025437; Chambers L, 2013, FOOD QUAL PREFER, V28, P271, DOI 10.1016/j.foodqual.2012.08.008; Cohen DA, 2012, OBES REV, V13, P766, DOI 10.1111/j.1467-789X.2012.01001.x; Cohen J.E., 1988, STAT POWER ANAL BEHA; Davidson TL, 2004, INT J OBESITY, V28, P933, DOI 10.1038/sj.ijo.0802660; DellaValle DM, 2005, APPETITE, V44, P187, DOI 10.1016/j.appet.2004.11.003; Escobar MAC, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1072; Fletcher JM, 2010, CONTEMP ECON POLICY, V28, P23, DOI 10.1111/j.1465-7287.2009.00182.x; Heymsfield SB, 2003, INT J OBESITY, V27, P537, DOI 10.1038/sj.ijo.0802258; Hogenkamp PS, 2012, APPETITE, V59, P419, DOI 10.1016/j.appet.2012.06.008; Hogenkamp PS, 2011, APPETITE, V57, P635, DOI 10.1016/j.appet.2011.08.008; Hogenkamp PS, 2010, AM J CLIN NUTR, V91, P841, DOI 10.3945/ajcn.2009.28360; Holt E, 2011, LANCET, V378, P755, DOI 10.1016/S0140-6736(11)61359-7; Kleiman S, 2012, OBES REV, V13, P258, DOI 10.1111/j.1467-789X.2011.00949.x; Koliandris AL, 2010, FOOD HYDROCOLLOID, V24, P792, DOI 10.1016/j.foodhyd.2010.04.006; Martens MJI, 2012, OBESITY, V20, P517, DOI 10.1038/oby.2011.345; Mattes R, 2005, PHYSIOL BEHAV, V83, P739, DOI 10.1016/j.physbeh.2004.09.021; MATTES R, 1990, APPETITE, V15, P103, DOI 10.1016/0195-6663(90)90043-8; Mattes RD, 2006, INT J OBESITY, V30, pS60, DOI 10.1038/sj.ijo.0803494; Mattes RD, 2010, PHYSIOL BEHAV, V100, P22, DOI 10.1016/j.physbeh.2009.12.026; Mattes RD, 2009, J AM DIET ASSOC, V109, P430, DOI 10.1016/j.jada.2008.11.031; McCrickerd K., 2012, FLAVOUR SCI RECENT D, V1, P20, DOI [DOI 10.1186/2044-7248-1-20, 10.1186/2044-7248-1-20]; McKiernan F, 2008, PHYSIOL BEHAV, V94, P700, DOI 10.1016/j.physbeh.2008.04.007; Mourao DM, 2007, INT J OBESITY, V31, P1688, DOI 10.1038/sj.ijo.0803667; Ng SW, 2012, BRIT J NUTR, V108, P536, DOI 10.1017/S0007114511006465; Pliner P, 2007, APPETITE, V48, P278, DOI 10.1016/j.appet.2006.04.009; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; ROLLS BJ, 1990, PHYSIOL BEHAV, V48, P19, DOI 10.1016/0031-9384(90)90254-2; Stubbs RJ, 2000, BRIT J NUTR, V84, P405, DOI 10.1017/S0007114500001719; STUNKARD AJ, 1985, J PSYCHOSOM RES, V29, P71, DOI 10.1016/0022-3999(85)90010-8; TOURNIER A, 1991, APPETITE, V16, P17, DOI 10.1016/0195-6663(91)90107-4; Van Kleef E, 2012, CRIT REV FOOD SCI, V52, P611, DOI 10.1080/10408398.2010.504901; Wanders AJ, 2011, OBES REV, V12, P724, DOI 10.1111/j.1467-789X.2011.00895.x; Wansink B, 2010, APPETITE, V54, P214, DOI 10.1016/j.appet.2009.09.016; Woods SC, 2009, CELL METAB, V9, P489, DOI 10.1016/j.cmet.2009.04.007; Yeomans MR, 2014, BRIT J NUTR, V111, P1137, DOI 10.1017/S0007114513003474; Yeomans MR, 2011, AM J CLIN NUTR, V94, P1410, DOI 10.3945/ajcn.111.011650; Yeomans MR, 2000, NEUROSCI BIOBEHAV R, V24, P249, DOI 10.1016/S0149-7634(99)00078-0; Zhu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067482; Zijlstra N, 2008, INT J OBESITY, V32, P676, DOI 10.1038/sj.ijo.0803776	47	29	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100406	10.1371/journal.pone.0100406	http://dx.doi.org/10.1371/journal.pone.0100406			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945526	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000340721500071
J	Rivero-Juarez, A; Lopez-Cortes, LF; Camacho, A; Torres-Cornejo, A; Gordon, A; Ruiz-Valderas, R; Torre-Cisneros, J; Pineda, JA; Viciana, P; Rivero, A				Rivero-Juarez, Antonio; Lopez-Cortes, Luis F.; Camacho, Angela; Torres-Cornejo, Almudena; Gordon, Ana; Ruiz-Valderas, Rosa; Torre-Cisneros, Julian; Pineda, Juan A.; Viciana, Pompeyo; Rivero, Antonio			HCV Viral Decline at Week 2 of Peg-IFN-Alpha-2a/RBV Therapy as a Predictive Tool for Tailoring Treatment in HIV/HCV Genotype 1 Co-Infected Patients	PLOS ONE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; INTERFERON PLUS RIBAVIRIN; HEPATITIS-C; VIRUS; ALPHA-2A; WORLD; LOAD; HIV	Background: Optimizing HCV genotype 1 therapy in terms of response prediction and tailoring treatment is undoubtedly the cornerstone of treating HIV co-infected patients in clinical practice. Accordingly, our aim was to analyze the predictive value of HCV viral decline for sustained virological response (SVR), measured at a time point as early as week 2 of therapy with pegylated interferon alpha-2a plus ribavirin (Peg-IFN/RBV). Methods: Previously untreated HIV/HCV genotype 1 co-infected patients were included in this study. The HCV RNA titer was measured at week 2 after starting treatment with Peg-IFN/RBV. The likelihood of reaching SVR when HCV RNA viral titers declined at week 2 was evaluated relative to predictive baseline factors. Results: A total of 192 HIV/HCV genotype-1 co-infected patients were enrolled in the study and began therapy. One hundred and sixty-three patients completed a full course of Peg-IFN/RBV treatment for 2 weeks and 59 of these (36.2%) reached SVR. An HCV RNA viral load decline of >= 1.5 log IU/mL at week 2 had the maximum positive predictive value for SVR (83.3%; 95% CI: 68.5%-92.9%) and was identified as the strongest independent predictive factor for reaching SVR across all baseline predictive factors. Conclusions: HCV viral decline at week 2 had a high predictive value for identifying patients with a high and low likelihood of reaching SVR using dual therapy, regardless of strong predictive baseline factors. This finding may be useful for developing a predictive tool to help tailor HCV genotype 1 therapy in HIV co-infected patients.	[Rivero-Juarez, Antonio; Camacho, Angela; Gordon, Ana; Torre-Cisneros, Julian; Rivero, Antonio] Hosp Univ Reina Sofia Cordoba, Inst Maimonides Invest Biomed Cordoba IMIBIC, Unidad Enfermedades Infecciosas, Cordoba, Spain; [Lopez-Cortes, Luis F.; Torres-Cornejo, Almudena; Ruiz-Valderas, Rosa; Viciana, Pompeyo] Univ Seville, CSIC, Hosp Univ Virgen del Rocio,Inst Biomed Sevilla IB, Unidad Clin Enfermedades Infecciosas Microbiol &, Seville, Spain; [Pineda, Juan A.] Hosp Univ Valme, Inst Biomed Sevilla IBiS, Unidad Enfermedades Infecciosas & Microbiol Clin, Seville, Spain	Hospital Universitario Reina Sofia - Cordoba; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Hospital Valme	Rivero, A (corresponding author), Hosp Univ Reina Sofia Cordoba, Inst Maimonides Invest Biomed Cordoba IMIBIC, Unidad Enfermedades Infecciosas, Cordoba, Spain.	ariveror@gmail.com	Rivero, Antonio/ABE-5294-2020; Gordon, Ana/Q-5853-2018; IBIS, VIH/O-8856-2015; Espejo, Angela Camacho/AAM-9991-2021; Pineda, Juan A./AAO-9312-2021; Rivero-Juarez, Antonio/E-4528-2019; DE LA TORRE CISNEROS, JULIAN/AAL-5723-2021; Lopez.Cortes, Luis Fernando/W-8323-2019	Gordon, Ana/0000-0002-4911-1436; Pineda, Juan A./0000-0002-3751-0296; Rivero-Juarez, Antonio/0000-0002-5813-6889; Lopez.Cortes, Luis Fernando/0000-0002-3804-3458; Rivero Roman, Antonio/0000-0002-8643-4250; Rivero, Antonio/0000-0001-5005-8268	Fundacion Progreso y Salud, Consejeria de Salud de la Junta de Andalucia [0036-2010, 0157-2011, 0430-2012, AI-0021]	Fundacion Progreso y Salud, Consejeria de Salud de la Junta de Andalucia(Junta de Andalucia)	This work was partly supported by grants from the Fundacion Progreso y Salud, Consejeria de Salud de la Junta de Andalucia (grants for health research projects; refs. 0036-2010, 0157-2011, 0430-2012). A.R. was the recipient of a research extension grant from the Fundacion Progreso y Salud, Consejeria de Salud de la Junta de Andalucia (ref. AI-0021). A.R.-J. is the recipient of a Post-Doctoral Research Grant from the Fundacion Progreso y Salud, Consejeria de Salud de la Junta de Andalucia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed F, 2013, J VIRAL HEPATITIS, V20, P367, DOI 10.1111/j.1365-2893.2012.01613.x; Andriulli A, 2014, J HEPATOL, V60, P16, DOI 10.1016/j.jhep.2013.07.040; Dogan UB, 2013, EUR J GASTROEN HEPAT, V25, P1317, DOI 10.1097/MEG.0b013e328362797b; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Marcellin P, 2012, HEPATOLOGY, V56, P2039, DOI 10.1002/hep.25892; Marcellin P, 2012, J HEPATOL, V56, P1276, DOI 10.1016/j.jhep.2011.12.026; Neukam K, 2013, AIDS, V27, P2715, DOI 10.1097/01.aids.0000432459.36970.a9; Neukam K, 2013, J INFECTION, V67, P59, DOI 10.1016/j.jinf.2013.03.010; Pascale A, 2013, J HEPATOL, V58, P391, DOI 10.1016/j.jhep.2012.09.023; Pearlman BL, 2014, HEPATOLOGY, V59, P71, DOI 10.1002/hep.26624; Pineda JA, 2011, AIDS, V25, P1415, DOI 10.1097/QAD.0b013e328348a7ac; Pineda JA, 2010, CLIN INFECT DIS, V51, P788, DOI 10.1086/656235; Rivero-Juarez A, 2014, J INFECTION, V68, P372, DOI 10.1016/j.jinf.2013.11.009; Rivero-Juarez A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061992; Vergara S, 2007, CLIN INFECT DIS, V45, P969, DOI 10.1086/521857; WHO, 2014, GUID SCREEN CAR TREA	16	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e99468	10.1371/journal.pone.0099468	http://dx.doi.org/10.1371/journal.pone.0099468			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945348	Green Published, gold, Green Submitted			2022-12-27	WOS:000340721500020
J	Su, ZX; Zhu, HG; Zhang, MH; Wang, LL; He, HC; Jiang, SL; Hou, FF; Li, AQ				Su, Zhengxiu; Zhu, Hongguo; Zhang, Menghuan; Wang, Liangliang; He, Hanchang; Jiang, Shaoling; Hou, Fan Fan; Li, Aiqing			Salt-Induced Changes in Cardiac Phosphoproteome in a Rat Model of Chronic Renal Failure	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; LEFT-VENTRICULAR HYPERTROPHY; GLOMERULAR-FILTRATION-RATE; CARDIOVASCULAR COMPLICATIONS; OXIDATIVE STRESS; RISK-FACTORS; HEART; HYPERTENSION; PHOSPHORYLATION; PROTEINS	Heart damage is widely present in patients with chronic kidney disease. Salt diet is the most important environmental factor affecting development of chronic renal failure and cardiovascular diseases. The proteins involved in chronic kidney disease induced heart damage, especially their posttranslational modifications, remain largely unknown to date. Sprague-Dawley rats underwent 5/6 nephrectomy (chronic renal failure model) or sham operation were treated for 2 weeks with a normal(0.4% NaCl), or high-salt (4% NaCl) diet. We employed TiO2 enrichment, iTRAQ labeling and liquid-chromatography tandem mass spectrometry strategy for phosphoproteomic profiling of left ventricular free walls in these animals. A total of 1724 unique phosphopeptides representing 2551 non-redundant phosphorylation sites corresponding to 763 phosphoproteins were identified. During normal salt feeding, 89 (54%) phosphopeptides upregulated and 76 (46%) phosphopeptides downregulated in chronic renal failure rats relative to sham rats. In chronic renal failure rats, high salt intake induced upregulation of 84 (49%) phosphopeptides and downregulation of 88 (51%) phosphopeptides. Database searches revealed that most of the identified phospholproteins were important signaling molecules such as protein kinases, receptors and phosphatases. These phospholproteins were involved in energy metabolism, cell communication, cell differentiation, cell death and other biological processes. The Search Tool for the Retrieval of Interacting Genes analysis revealed functional links among 15 significantly regulated phosphoproteins in chronic renal failure rats compared to sham group, and 23 altered phosphoproteins induced by high salt intake. The altered phosphorylation levels of two proteins involved in heart damage, lamin A and phospholamban were validated. Expression of the downstream genes of these two proteins, desmin and SERCA2a, were also analyzed.	[Su, Zhengxiu; Zhu, Hongguo; Zhang, Menghuan; Wang, Liangliang; He, Hanchang; Jiang, Shaoling; Hou, Fan Fan; Li, Aiqing] Southern Med Univ, Nanfang Hosp, State Key Lab Organ Failure Res, Div Nephrol,Natl Clin Res Ctr Kidney Dis, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China	Hou, FF (corresponding author), Southern Med Univ, Nanfang Hosp, State Key Lab Organ Failure Res, Div Nephrol,Natl Clin Res Ctr Kidney Dis, Guangzhou, Guangdong, Peoples R China.	ffhouguangzhou@163.com; liaiqing@smu.edu.cn			Major State Basic Research Development Program of China (National 973 program) [2012CB517703, 2011CB504005]; National Nature and Science [81270825, 31201751]	Major State Basic Research Development Program of China (National 973 program); National Nature and Science	This study is supported by the Major State Basic Research Development Program of China (National 973 program) (Nos. 2012CB517703 & 2011CB504005) to Dr. Fan Fan Hou and National Nature and Science Grants (Nos. 81270825 & 31201751) to Dr. Ai Qing Li. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggeli IKS, 2008, CELL SIGNAL, V20, P1292, DOI 10.1016/j.cellsig.2008.02.019; Aviv A, 2001, ARCH INTERN MED, V161, P507, DOI 10.1001/archinte.161.4.507; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Bugger H, 2010, CARDIOVASC RES, V85, P376, DOI 10.1093/cvr/cvp344; Cacciapuoti F, 2011, J AM SOC HYPERTENS, V5, P449, DOI 10.1016/j.jash.2011.08.006; Cook NR, 2007, BMJ-BRIT MED J, V334, P885, DOI 10.1136/bmj.39147.604896.55; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Delom F, 2006, PROTEOME SCI, V4, DOI 10.1186/1477-5956-4-15; du Cailar G, 2004, J HYPERTENS, V22, P697, DOI 10.1097/00004872-200404000-00011; DUCAILAR G, 1992, AM J PHYSIOL, V263, pH177, DOI 10.1152/ajpheart.1992.263.1.H177; DUCAILAR G, 1995, ARCH MAL COEUR VAISS, V88, P15; El-Armouche A, 2007, J MOL CELL CARDIOL, V43, P223, DOI 10.1016/j.yjmcc.2007.05.003; Engholm-Keller K, 2013, PROTEOMICS, V13, P910, DOI 10.1002/pmic.201200484; Frisoli TM, 2012, AM J MED, V125, P433, DOI 10.1016/j.amjmed.2011.10.023; Frock RL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042918; Frock RL, 2006, GENE DEV, V20, P486, DOI 10.1101/gad.1364906; Garbino A, 2010, ACTA PHARMACOL SIN, V31, P1019, DOI 10.1038/aps.2010.116; Grussenmeyer T, 2011, J PROTEOMICS, V74, P672, DOI 10.1016/j.jprot.2011.02.015; Gupta MP, 2007, J MOL CELL CARDIOL, V43, P388, DOI 10.1016/j.yjmcc.2007.07.045; Gustavsson M, 2013, P NATL ACAD SCI USA, V110, P17338, DOI 10.1073/pnas.1303006110; Jin X, 2006, PROTEOMICS, V6, P1948, DOI 10.1002/pmic.200500337; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kotlo K, 2012, J PROTEOMICS, V77, P1, DOI 10.1016/j.jprot.2012.05.041; Landstrom AP, 2007, J MOL CELL CARDIOL, V42, P1026, DOI 10.1016/j.yjmcc.2007.04.006; Levey AS, 1998, PRIMER KIDNEY DIS, P20; Li AQ, 2010, BRAIN PATHOL, V20, P1077, DOI 10.1111/j.1750-3639.2010.00414.x; Li AQ, 2009, PROTEOMICS, V9, P2788, DOI 10.1002/pmic.200800850; Li AQ, 2009, BBA-PROTEINS PROTEOM, V1794, P663, DOI 10.1016/j.bbapap.2008.11.025; LOTT JA, 1983, CLIN CHEM, V29, P1946; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; Mataradzija A, 2010, BOSNIAN J BASIC MED, V10, pS44; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Meng C, 2009, J PROTEOME RES, V8, P2463, DOI 10.1021/pr801059u; Mensah GA, 2003, CURR PROB CARDIOLOGY, V28, P156, DOI 10.1016/S0146-2806(03)00017-3; Mensah George A., 2002, Cardiology Clinics, V20, P225, DOI 10.1016/S0733-8651(02)00004-8; Minamisawa S, 2004, BIOCHEM BIOPH RES CO, V325, P852, DOI 10.1016/j.bbrc.2004.10.107; Morimoto A, 1997, LANCET, V350, P1734, DOI 10.1016/S0140-6736(97)05189-1; Muntner P, 2005, J AM SOC NEPHROL, V16, P529, DOI 10.1681/ASN.2004080656; Rizzi E, 2013, EXP MOL PATHOL, V94, P1, DOI 10.1016/j.yexmp.2012.10.010; Ross L, 2013, INT J CLIN PRACT, V67, P4, DOI 10.1111/ijcp.12069; Shiba N, 2011, J CARDIOL, V57, P8, DOI 10.1016/j.jjcc.2010.09.004; Stenvinkel P, 2008, CLIN J AM SOC NEPHRO, V3, P505, DOI 10.2215/CJN.03670807; Sun ZY, 2012, J MOL CELL CARDIOL, V53, P354, DOI 10.1016/j.yjmcc.2012.06.001; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Thingholm TE, 2006, NAT PROTOC, V1, P1929, DOI 10.1038/nprot.2006.185; Van Biesen W, 2007, EUR HEART J, V28, P478, DOI 10.1093/eurheartj/ehl455; Weir MR, 2005, AM J KIDNEY DIS, V45, P176, DOI 10.1053/j.ajkd.2004.08.041; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Zamorano-Leon JJ, 2010, CELL PHYSIOL BIOCHEM, V25, P347, DOI 10.1159/000276567; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6	51	12	12	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100331	10.1371/journal.pone.0100331	http://dx.doi.org/10.1371/journal.pone.0100331			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945867	Green Published, Green Submitted, gold			2022-12-27	WOS:000340721500064
J	Yang, PW; Hsieh, MS; Huang, YC; Hsieh, CY; Chiang, TH; Lee, JM				Yang, Pei-Wen; Hsieh, Min-Shu; Huang, Ya-Chuan; Hsieh, Ching-Yueh; Chiang, Tzu-Hsuan; Lee, Jang-Ming			Genetic Variants of EGF and VEGF Predict Prognosis of Patients with Advanced Esophageal Squamous Cell Carcinoma	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; R497K POLYMORPHISM; COLORECTAL-CANCER; FACTOR PRECURSOR; IN-VITRO; SURVIVAL; PATHWAY; RISK; EXPRESSION; RECEPTORS	Purpose: To investigate the association between genetic polymorphisms of growth factor-related genes and prognosis in patients with advanced esophageal squamous cell carcinoma (ESCC). Patients and Methods: A total of 334 ESCC patients with advanced tumor stages (stages IIB, III and IV) were enrolled in the study. The genotypes of 14 candidate single nucleotide polymorphisms (SNPs) involved in growth factor-related functions were analyzed using iPLEX Gold technology from the genomic DNA of peripheral leukocytes, and were correlated with the clinical outcome of patients. Serum levels of growth factors were examined by enzyme-linked immunosorbent assay (ELISA). Results: The genetic polymorphisms of EGF:rs4444903, EGF:rs2237051 and VEGF:rs2010963 showed significant associations with overall survival (OS) of advanced ESCC patients (A/A+ A/G vs. GG, [HR = 0.77, 95% CI = 0.60-0.99, P = 0.039 for rs4444903; A/G+ G/G vs. A/A, [HR = 0.74, 95% CI = 0.58-0.95, P = 0.019 for rs2237051; G/G+ G/C vs. C/C, [HR] inves = 0.69, 95% CI = 0.50-0.95, P = 0.023 for rs2010963). EGFR:rs2227983 and 3 SNPs of PIK3CA also showed borderline significant correlation with OS of advanced ESCC patients (P = 0.058 for rs2227983; P = 0.069, 0.091 and 0.067 for rs6443624, rs7651265 and rs7621329 of PIK3CA respectively). According to cumulative effect analysis of multiple SNPs, patients carrying 4 unfavorable genotypes exhibited more than a 3-fold increased risk of mortality. Finally, both EGF and VEGF expression levels significantly associated with patient mortality. Conclusion: The genetic variants and expression levels of EGF and VEGF can serve as prognostic predictors in patients with advanced ESCC, and thus provide more information for optimizing personalized therapies for patients with ESCC.	[Yang, Pei-Wen; Huang, Ya-Chuan; Hsieh, Ching-Yueh; Chiang, Tzu-Hsuan; Lee, Jang-Ming] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Yang, Pei-Wen; Hsieh, Min-Shu; Huang, Ya-Chuan; Hsieh, Ching-Yueh; Chiang, Tzu-Hsuan; Lee, Jang-Ming] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Hsieh, Min-Shu] Natl Taiwan Univ Hosp, Dept Pathol, Taipei 100, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Lee, JM (corresponding author), Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan.	jmlee@ntu.edu.tw		Hsieh, Min-Shu/0000-0002-0594-3732; LEE, JANG-MING/0000-0001-9727-227X	Ministry of Science and Technology [NSC100-2314-B-002-016, NSC 101-2314-B-002-020-MY3]; National Health Research Institutes [NHRI-EX102-10032BI]; Ministry of Health and Welfare [DOH101-TD-PB-111-NSC003]; National Taiwan University Hospital [NTUH.102-S2140]; National Taiwan University College of Medicine; National Taiwan University Hospital of the Republic of China	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Health Research Institutes(National Health Research Institutes, Japan); Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan); National Taiwan University Hospital(National Taiwan University); National Taiwan University College of Medicine(National Taiwan University); National Taiwan University Hospital of the Republic of China(National Taiwan University)	This study was supported by the Ministry of Science and Technology (NSC100-2314-B-002-016, NSC 101-2314-B-002-020-MY3), National Health Research Institutes (NHRI-EX102-10032BI), Ministry of Health and Welfare (DOH101-TD-PB-111-NSC003), National Taiwan University Hospital (NTUH.102-S2140), and Excellent Translational Medicine Research Projects of National Taiwan University College of Medicine and National Taiwan University Hospital of the Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedenne L, 2007, J CLIN ONCOL, V25, P1160, DOI 10.1200/JCO.2005.04.7118; BELL GI, 1986, NUCLEIC ACIDS RES, V14, P8427, DOI 10.1093/nar/14.21.8427; Boyd D Barry, 2003, Integr Cancer Ther, V2, P315, DOI 10.1177/1534735403259152; Bradbury PA, 2009, CLIN CANCER RES, V15, P4680, DOI 10.1158/1078-0432.CCR-09-0192; Buerger H, 2000, CANCER RES, V60, P854; CARPENTER G, 1987, ANNU REV BIOCHEM, V56, P881, DOI 10.1146/annurev.biochem.56.1.881; Dong J, 2010, CARCINOGENESIS, V31, P1080, DOI 10.1093/carcin/bgq079; Edge S, 2009, AJCC CANC STAGING MA, P143; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Ferrara N, 2002, SEMIN ONCOL, V29, P10, DOI 10.1053/sonc.2002.37264; Goncalves A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-169; HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2; Hildebrandt MAT, 2009, J CLIN ONCOL, V27, P857, DOI 10.1200/JCO.2008.17.6297; Hirai T, 1998, Dis Esophagus, V11, P221; Ho GYF, 2003, BRIT J CANCER, V88, P263, DOI 10.1038/sj.bjc.6600747; Hosgood HD, 2008, CARCINOGENESIS, V29, P1938, DOI 10.1093/carcin/bgn178; Inada S, 1999, SURG TODAY, V29, P493, DOI 10.1007/BF02482343; Islami F, 2010, INT J CANC; ITAKURA Y, 1994, CANCER, V74, P795, DOI 10.1002/1097-0142(19940801)74:3<795::AID-CNCR2820740303>3.0.CO;2-I; Jain M, 2007, CANCER BIOL THER, V6, P1553, DOI 10.4161/cbt.6.10.4709; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kelsen DP, 1998, NEW ENGL J MED, V339, P1979, DOI 10.1056/NEJM199812313392704; Kitadai Y, 1998, CLIN CANCER RES, V4, P2195; Lambrechts D, 2003, NAT GENET, V34, P383, DOI 10.1038/ng1211; Lanuti M, 2008, CLIN CANCER RES, V14, P3216, DOI 10.1158/1078-0432.CCR-07-4932; Lee JM, 2011, ANN SURG ONCOL, V18, P2066, DOI 10.1245/s10434-011-1559-9; Melis M, 2011, ANN SURG ONCOL, V18, P824, DOI 10.1245/s10434-010-1336-1; MORIAI T, 1994, P NATL ACAD SCI USA, V91, P10217, DOI 10.1073/pnas.91.21.10217; MROCZKOWSKI B, 1988, P NATL ACAD SCI USA, V85, P126, DOI 10.1073/pnas.85.1.126; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; Normanno N, 2003, ENDOCR-RELAT CANCER, V10, P1, DOI 10.1677/erc.0.0100001; PARRIES G, 1995, J BIOL CHEM, V270, P27954, DOI 10.1074/jbc.270.46.27954; Pawson T, 2002, FEBS LETT, V513, P2, DOI 10.1016/S0014-5793(01)03292-6; Pechlivanis S, 2007, ENDOCR-RELAT CANCER, V14, P733, DOI 10.1677/ERC-07-0107; Perez CA, 2010, J UROLOGY, V183, P2062, DOI 10.1016/j.juro.2009.12.098; Reid TD, 2012, CLIN ONCOL R COLL RA; Sasaki H, 2009, J CANCER RES CLIN, V135, P313, DOI 10.1007/s00432-008-0464-5; Schemper M, 1996, CONTROL CLIN TRIALS, V17, P343, DOI 10.1016/0197-2456(96)00075-X; Shahbazi M, 2002, LANCET, V359, P397, DOI 10.1016/S0140-6736(02)07600-6; Shih CH, 2000, CLIN CANCER RES, V6, P1161; Tzeng CWD, 2007, ANN SURG ONCOL, V14, P2150, DOI 10.1245/s10434-007-9409-5; Upadhyay R, 2008, ONCOL RES, V17, P167, DOI 10.3727/096504008785114147; Wang LE, 2012, J CANCER RES CLIN, V138, P377, DOI 10.1007/s00432-011-1103-0; Wang WS, 2007, CLIN CANCER RES, V13, P3597, DOI 10.1158/1078-0432.CCR-06-2601; Watson CJ, 2000, CYTOKINE, V12, P1232, DOI 10.1006/cyto.2000.0692; Winder T, 2010, CLIN CANCER RES, V16, P5591, DOI 10.1158/1078-0432.CCR-10-2092; Wu MT, 2001, BRIT J CANCER, V85, P658, DOI 10.1054/bjoc.2001.1927; Zhang JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059254	48	28	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100326	10.1371/journal.pone.0100326	http://dx.doi.org/10.1371/journal.pone.0100326			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945674	Green Published, Green Submitted, gold			2022-12-27	WOS:000340721500061
J	Zhang, JJ; Huang, XW; Xiao, JJ; Yang, YJ; Zhou, YH; Wang, XF; Liu, QM; Yang, JM; Wang, MY; Qiu, LX; Zheng, YB; Zhang, P; Li, J; Wang, YN; Wei, QY; Jin, L; Wang, JC; Wang, MH				Zhang, Junjie; Huang, Xuewen; Xiao, Juanjuan; Yang, Yajun; Zhou, Yinghui; Wang, Xiaofeng; Liu, Qingmei; Yang, Jingmin; Wang, Mengyun; Qiu, Lixin; Zheng, Yabiao; Zhang, Ping; Li, Jin; Wang, Ya'nong; Wei, Qingyi; Jin, Li; Wang, Jiucun; Wang, Minghua			Pri-miR-124 rs531564 and pri-miR-34b/c rs4938723 Polymorphisms Are Associated with Decreased Risk of Esophageal Squamous Cell Carcinoma in Chinese Populations	PLOS ONE			English	Article							TUMOR-SUPPRESSIVE MICRORNAS; HEPATOCELLULAR-CARCINOMA; COLORECTAL-CANCER; RNA-INTERFERENCE; GENETIC-VARIANTS; PROMOTER REGION; CERVICAL-CANCER; GASTRIC-CANCER; C-ELEGANS; MIR-124	MicroRNAs are a new class of small non-protein-coding RNAs that sometimes function as tumor suppressors or oncogenes. Aberrant expression and structural alteration of microRNAs have been reported to be involved in tumorigenesis and cancer development. Recently, rs531564/pri-miR-124-1, rs4938723/pri-miR-34b/c, rs7372209/pri-miR-26a-1, rs895819/pre-miR-27a, and rs11134527/pri-miR-218 were reported to be associated with risks of various cancers. In order to evaluate the relationship of these SNPs and esophageal squamous cell carcinoma (ESCC) risk, we conducted a case-control study with 1109 ESCC patients and 1275 control subjects to examine the potential association of these pri/pre-miRNA polymorphisms with ESCC susceptibility. As a result, two SNPs were associated with a significant risk of ESCC. We found that the GG genotype of pri-miR-124-1 rs531564 was associated to a significantly decreased risk of ESCC comparing with the CC/CG genotypes ( p = 0.005; OR = 0.61, 95% CI = 0.43-0.86). In addition, the CC genotype of pri-miR-34b/c rs4938723 was associated with a significant decreased risk of ESCC ( CC VS. TT/TC: p = 0.007, OR = 0.82, 95% CI = 0.71-0.95) in Chinese population. The present study provides the first evidence that pri-miR-124-1 rs531564 and pri-miR-34 rs4938723 were associated with the risk of ESCC in Chinese population.	[Zhang, Junjie; Xiao, Juanjuan; Zhou, Yinghui; Zheng, Yabiao; Zhang, Ping; Wang, Minghua] Soochow Univ, Coll Med, Dept Biochem & Mol Biol, Suzhou, Jiangsu, Peoples R China; [Huang, Xuewen] Huadong Sanat, Clin Lab, Wuxi, Jiangsu, Peoples R China; [Yang, Yajun; Wang, Xiaofeng; Liu, Qingmei; Yang, Jingmin; Jin, Li; Wang, Jiucun] Fudan Univ, Sch Life Sci, MOE Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China; [Yang, Yajun; Wang, Xiaofeng; Liu, Qingmei; Yang, Jingmin; Jin, Li; Wang, Jiucun] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Wang, Mengyun; Wei, Qingyi] Fudan Univ, Shanghai Canc Ctr, Canc Res Lab, Shanghai 200433, Peoples R China; [Wang, Mengyun; Qiu, Lixin; Li, Jin; Wei, Qingyi] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China; [Qiu, Lixin; Li, Jin] Fudan Univ, Shanghai Canc Ctr, Dept Med Oncol, Shanghai 200433, Peoples R China; [Wang, Ya'nong] Fudan Univ, Shanghai Canc Ctr, Dept Gastr Canc & Soft Tissue Sarcoma Surg, Shanghai 200433, Peoples R China	Soochow University - China; Fudan University; Fudan University; Fudan University; Fudan University; Fudan University; Fudan University	Wang, JC (corresponding author), Fudan Univ, Sch Life Sci, MOE Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China.	jcwang@fudan.edu.cn; mhwang@suda.edu.cn	Wang, Jiucun/J-8744-2012; Jin, Li/C-1468-2009; Wei, Qingyi/T-8315-2019; Jin, Li/M-5063-2019	Wang, Jiucun/0000-0003-2765-0620; Jin, Li/0000-0002-4546-2415; Wei, Qingyi/0000-0002-3845-9445; 	National Natural Science Foundation fo China [81071957]; Ministry of Health [201002007]; Key Project in the National Science & Techonlogy Pillar Program [2011BAI09B00]; "China's Thousand Talents Program" at Fudan University	National Natural Science Foundation fo China(National Natural Science Foundation of China (NSFC)); Ministry of Health; Key Project in the National Science & Techonlogy Pillar Program; "China's Thousand Talents Program" at Fudan University	This work was supported by the grant from the National Natural Science Foundation fo China (grant number 81071957)(http://www.nsfc.gov.cn/), the Ministry of Health (grant number 201002007)(http://www.nhfpc.gov.cn/qjjys/index.shtml), the Key Project in the National Science & Techonlogy Pillar Program (grant number 2011BAI09B00)(http://kjzc.jhgl.org/), and the funds from "China's Thousand Talents Program'' at Fudan University (http://www.1000plan.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bracht J, 2004, RNA, V10, P1586, DOI 10.1261/rna.7122604; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Furuta M, 2010, CARCINOGENESIS, V31, P766, DOI 10.1093/carcin/bgp250; Gao LB, 2013, BIOL CHEM, V394, P415, DOI 10.1515/hsz-2012-0297; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; He X, 2007, ONCOGENE, V26, P4961, DOI 10.1038/sj.onc.1210307; Hongo M, 2009, J GASTROEN HEPATOL, V24, P729, DOI 10.1111/j.1440-1746.2009.05824.x; Hu ZB, 2009, HUM MUTAT, V30, P79, DOI 10.1002/humu.20837; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Kozaki KI, 2008, CANCER RES, V68, P2094, DOI 10.1158/0008-5472.CAN-07-5194; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li LJ, 2013, TUMOR BIOL, V34, P1919, DOI 10.1007/s13277-013-0736-9; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Mishra PJ, 2007, P NATL ACAD SCI USA, V104, P13513, DOI 10.1073/pnas.0706217104; Qi L, 2012, NEUROSCI LETT, V515, P1, DOI 10.1016/j.neulet.2012.02.061; Shi DN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046566; Shi TY, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-19; Toyota M, 2008, CANCER RES, V68, P4123, DOI 10.1158/0008-5472.CAN-08-0325; Vizcaino AP, 2002, INT J CANCER, V99, P860, DOI 10.1002/ijc.10427; Wang XF, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-223; Wilting SM, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-167; Wong KY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019027; Xia JT, 2012, J PATHOL, V227, P470, DOI 10.1002/path.4030; Xu Y, 2011, INT J CANCER, V128, P412, DOI 10.1002/ijc.25342; Yang HS, 2008, CANCER RES, V68, P2530, DOI 10.1158/0008-5472.CAN-07-5991; Ye YQ, 2008, CANCER PREV RES, V1, P460, DOI 10.1158/1940-6207.CAPR-08-0135; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444; Zhou XY, 2010, GYNECOL ONCOL, V117, P287, DOI 10.1016/j.ygyno.2010.01.020; Zhou Y, 2012, J CANCER RES CLIN, V138, P939, DOI 10.1007/s00432-012-1164-8; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24	34	54	55	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100055	10.1371/journal.pone.0100055	http://dx.doi.org/10.1371/journal.pone.0100055			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945256	Green Published, Green Submitted, gold			2022-12-27	WOS:000340721500042
J	Hattori, Y; Kitamura, A; Nagatsuka, K; Ihara, M				Hattori, Yorito; Kitamura, Akihiro; Nagatsuka, Kazuyuki; Ihara, Masafumi			A Novel Mouse Model of Ischemic Carotid Artery Disease	PLOS ONE			English	Article							CEREBRAL-ISCHEMIA; LASER SPECKLE; OCCLUSION; BRAIN; IMPAIRMENT; STENOSIS	Background: Carotid artery occlusive disease gradually develops over time, eventually leading to cerebral infarction and high mortality rate. Animal models replicating cerebral infarction resulting from carotid artery occlusive disease have thus been developed to test potential novel treatments, which could be subsequently administered clinically. Methods: Adult C57BL/6J male mice were subjected to ameroid constrictor (AC) placement to gradually narrow the bilateral common carotid arteries. Cerebral blood flow (CBF) was measured at several time points. At 7 and 28 days post-operation, post-mortem brain samples were analyzed for ischemic changes. Results: The mortality rate was 58.8% at 28 days post-operation. Surviving mice with AC showed continuous reduction of CBF by up to 70% of the baseline level at 28 days. Most of the mice (75%) showed multiple cerebral infarctions in the gray and white matter. Non-surviving mice showed critical CBF reduction below 20-30% of the baseline level before death. Conclusion: The application of the AC on the bilateral common carotid arteries in mice could offer a reliable model of severe cerebrovascular insufficiency due to carotid artery occlusive disease and may thus be useful in exploring pharmacological intervention in stroke through monitoring survival rate, infarct formation, and CBF profile.	[Hattori, Yorito; Ihara, Masafumi] Natl Cerebral & Cardiovasc Ctr, Dept Regenerat Med & Tissue Engn, Suita, Osaka, Japan; [Hattori, Yorito; Kitamura, Akihiro] Kyoto Univ, Grad Sch Med, Dept Neurol, Kyoto, Japan; [Nagatsuka, Kazuyuki; Ihara, Masafumi] Natl Cerebral & Cardiovasc Ctr, Dept Stroke & Cerebrovasc Dis, Suita, Osaka, Japan	National Cerebral & Cardiovascular Center - Japan; Kyoto University; National Cerebral & Cardiovascular Center - Japan	Ihara, M (corresponding author), Natl Cerebral & Cardiovasc Ctr, Dept Regenerat Med & Tissue Engn, Suita, Osaka, Japan.	ihara@ncvc.go.jp	Ihara, Masafumi/O-5020-2019	Ihara, Masafumi/0000-0002-7102-4048	Ministry of Health, Labor and Welfare [0605-1]; Takeda Science Foundation	Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Takeda Science Foundation(Takeda Science Foundation (TSF))	The authors have grant support from the Ministry of Health, Labor and Welfare (M. I., No. 0605-1) and the Takeda Science Foundation (M. I.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuRahma AF, 1998, CARDIOVASC SURG, V6, P579, DOI 10.1016/S0967-2109(98)00072-6; Ayata C, 2004, J CEREBR BLOOD F MET, V24, P744, DOI 10.1097/01.WCB.0000122745.72175.D5; Balestrini S, 2013, NEUROLOGY, V80, P2145, DOI 10.1212/WNL.0b013e318295d71a; Bink DI, 2013, J CEREBR BLOOD F MET, V33, P1666, DOI 10.1038/jcbfm.2013.140; Carare RO, 2013, NEUROPATH APPL NEURO, V39, P593, DOI 10.1111/nan.12042; Forrester KR, 2002, MED BIOL ENG COMPUT, V40, P687, DOI 10.1007/BF02345307; HATTORI H, 1992, ACTA NEUROPATHOL, V84, P437; Herrmann M, 2004, EXP BRAIN RES, V154, P176, DOI 10.1007/s00221-003-1655-6; Jiwa NS, 2010, J NEUROCHEM, V115, P814, DOI 10.1111/j.1471-4159.2010.06958.x; Kitagawa K, 1998, J CEREBR BLOOD F MET, V18, P570, DOI 10.1097/00004647-199805000-00012; Kitamura A, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.10.033; Lai SL, 2005, J NEUROL SCI, V238, P101, DOI 10.1016/j.jns.2005.06.012; Moustafa RR, 2010, STROKE, V41, P1410, DOI 10.1161/STROKEAHA.110.580415; Shibata M, 2004, STROKE, V35, P2598, DOI 10.1161/01.STR.0000143725.19053.60; Shibata M, 2007, STROKE, V38, P2826, DOI 10.1161/STROKEAHA.107.490151; Willie CK, 2014, J PHYSIOL-LONDON, V592, P841, DOI 10.1113/jphysiol.2013.268953; Yang GM, 1997, BRAIN RES, V752, P209, DOI 10.1016/S0006-8993(96)01453-9	17	19	19	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100257	10.1371/journal.pone.0100257	http://dx.doi.org/10.1371/journal.pone.0100257			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940742	Green Published, gold, Green Submitted			2022-12-27	WOS:000338508200087
J	Schou, JV; Rossi, S; Jensen, BV; Nielsen, DL; Pfeiffer, P; Hogdall, E; Yilmaz, M; Tejpar, S; Delorenzi, M; Kruhoffer, M; Johansen, JS				Schou, Jakob V.; Rossi, Simona; Jensen, Benny V.; Nielsen, Dorte L.; Pfeiffer, Per; Hogdall, Estrid; Yilmaz, Mette; Tejpar, Sabine; Delorenzi, Mauro; Kruhoffer, Mogens; Johansen, Julia S.			miR-345 in Metastatic Colorectal Cancer: A Non-Invasive Biomarker for Clinical Outcome in Non-KRAS Mutant Patients Treated with 3rd Line Cetuximab and Irinotecan	PLOS ONE			English	Article							1ST-LINE TREATMENT; LIVER METASTASES; EXPRESSION DATA; BREAST-CANCER; MICRORNA; PLASMA; SERUM; MIR-143; MIR-21; BLOOD	Introduction: MicroRNAs (miRNAs) have important regulatory functions in cellular processes and have shown promising potential as prognostic markers for disease outcome in patients with cancer. The aim of the present study was to find miRNA expression profiles in whole blood that were prognostic for overall survival (OS) in patients with metastatic colorectal cancer (mCRC) treated with cetuximab and irinotecan. Methods: From 138 patients with mCRC in 3rd line therapy with cetuximab and irinotecan in a prospective phase II study, 738 pretreatment miRNAs were isolated and profiled from whole blood using the TaqMan MicroRNA Array v2.0. Mutation status of KRAS, BRAF, and PI3KCA was known. Results: After Bonferroni adjustment, 6 miRNAs: (miR-345, miR-143, miR-34a*, miR-628-5p, miR-886-3p and miR-324-3p), were found associated with short OS. miR-345 was the strongest prognostic miRNA, significant in the full cohort and in the non-KRAS mutant population. miR-345, as a continuous variable in the full cohort, resulted in a hazard ratio (HR) of 2.38 per IQR (CI 95%: 1.8-3.1, P-value = 2.86e-07, Bonferroni adjusted, univariable analysis) and a HR = 1.75 per IQR (CI 95%: 1.24-2.48, P-Wald = 1.45e-03) in the multivariable analysis adjusted for gender, age, KRAS, PI3KCA and performance status. miR-345 was prognostic in progression-free survival (PFS) with a HR = 1.63 per IQR (CI 95%: 1.25-2.114, P-Wald = 2.92e-4) in the multivariable analysis. In addition, high miR-345 expression was associated with lack of response to treatment with cetuximab and irinotecan. Conclusion: We identified miR-345 in whole blood as a potential biomarker for clinical outcome. MiR-345 was a single prognostic biomarker for both OS and PFS in all patients and also in the non-KRAS mutant population.	[Schou, Jakob V.; Jensen, Benny V.; Nielsen, Dorte L.; Johansen, Julia S.] Herlev Univ Hosp, Dept Oncol, DK-2730 Herlev, Denmark; [Rossi, Simona; Delorenzi, Mauro] Swiss Inst Bioinformat, Bioinformat Core Facil, Lausanne, Switzerland; [Pfeiffer, Per] Odense Univ Hosp, Dept Oncol, DK-5000 Odense, Denmark; [Tejpar, Sabine] Univ Hosp Gasthuisberg, Digest Oncol Unit, Leuven, Belgium; [Hogdall, Estrid] Herlev Univ Hosp, Dept Pathol, DK-2730 Herlev, Denmark; [Yilmaz, Mette] Aalborg Univ Hosp, Dept Oncol, Aalborg, Denmark; [Kruhoffer, Mogens] AROS Appl Biotechnol, Aarhus, Denmark; [Delorenzi, Mauro] Univ Lausanne, Dept Oncol, Lausanne, Switzerland; [Delorenzi, Mauro] Univ Lausanne, Ludwig Ctr Canc Res, Lausanne, Switzerland	University of Copenhagen; Herlev & Gentofte Hospital; Swiss Institute of Bioinformatics; University of Southern Denmark; Odense University Hospital; KU Leuven; University Hospital Leuven; University of Copenhagen; Herlev & Gentofte Hospital; Aalborg University; Aalborg University Hospital; University of Lausanne; University of Lausanne	Schou, JV (corresponding author), Herlev Univ Hosp, Dept Oncol, DK-2730 Herlev, Denmark.	j.schou@dadlnet.dk		Hogdall, Estrid/0000-0003-4689-5658; Nielsen, Dorte Lisbet/0000-0002-8766-8729; Pfeiffer, Per/0000-0002-2925-0586	Research Council at Herlev Hospital; Danish Ministry of the Interior and Health, Merck-Serono Denmark/Sweden; European Union [222916]; Belgian National Cancer Plan; Foundation Fournier-Majoie, FFMI, Belgium; Swiss National Science Foundation (SNF) [320030_135421]; Krebsforschung Schweiz (KFS) [02697-08-2010]; Fondation Medic	Research Council at Herlev Hospital; Danish Ministry of the Interior and Health, Merck-Serono Denmark/Sweden; European Union(European Commission); Belgian National Cancer Plan; Foundation Fournier-Majoie, FFMI, Belgium; Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); Krebsforschung Schweiz (KFS); Fondation Medic	This work was supported by grants from The Research Council at Herlev Hospital, the Danish Ministry of the Interior and Health, Merck-Serono Denmark/Sweden, and the European Union Seventh Framework Programme [FP7/2007-2013] under grant agreement no 222916 (given to MK). ST is a senior clinical investigator of the Fund for Scientific Research Flanders and is supported by Belgian National Cancer Plan. ST and SR is also supported by the Foundation Fournier-Majoie, FFMI, Belgium. MD is supported in part by the Swiss National Science Foundation (SNF; http://www.snf.ch/E/; Grant No. 320030_135421); Krebsforschung Schweiz (KFS; http://www.krebsforschung.ch/; Grant No. 02697-08-2010); and by the Fondation Medic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arndt GM, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-374; Boeri M, 2011, P NATL ACAD SCI USA, V108, P3713, DOI 10.1073/pnas.1100048108; Bokemeyer C, 2009, J CLIN ONCOL, V27, P663, DOI 10.1200/JCO.2008.20.8397; Chen X, 2009, ONCOGENE, V28, P1385, DOI 10.1038/onc.2008.474; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Cheng HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017745; Cheng HH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064795; Cross J, 2008, PHARMACOGENOMICS, V9, P463, DOI 10.2217/14622416.9.4.463; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; D'haene Barbara, 2012, Methods Mol Biol, V822, P261, DOI 10.1007/978-1-61779-427-8_18; Dvinge H, 2013, NATURE, V497, P378, DOI 10.1038/nature12108; Heneghan HM, 2010, J CLIN ONCOL, V28, pE573, DOI 10.1200/JCO.2010.29.8901; Hofsli E, 2013, BRIT J CANCER, V108, P1712, DOI 10.1038/bjc.2013.121; Hu ZB, 2012, CARCINOGENESIS, V33, P828, DOI 10.1093/carcin/bgs030; Huang ZH, 2010, INT J CANCER, V127, P118, DOI 10.1002/ijc.25007; Jensen Bv, 2010, J CLIN ONCOL, V28; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Kotoula V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007746; Kruhoffer M, 2007, J MOL DIAGN, V9, P452, DOI 10.2353/jmoldx.2007.060175; Kulda V, 2010, CANCER GENET CYTOGEN, V200, P154, DOI 10.1016/j.cancergencyto.2010.04.015; Luo XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062880; Madi A, 2012, BRIT J CANCER, V107, P1037, DOI 10.1038/bjc.2012.384; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Ng EKO, 2009, GUT, V58, P1375, DOI 10.1136/gut.2008.167817; Nugent M, 2012, J SURG ONCOL, V106, P947, DOI 10.1002/jso.23174; Papadopoulos GL, 2009, BIOINFORMATICS, V25, P1991, DOI 10.1093/bioinformatics/btp299; Patnaik SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046045; Pichler M, 2012, BRIT J CANCER, V106, P1826, DOI 10.1038/bjc.2012.175; Pu XX, 2010, J GASTROEN HEPATOL, V25, P1674, DOI 10.1111/j.1440-1746.2010.06417.x; Richman SD, 2009, J CLIN ONCOL, V27, P5931, DOI 10.1200/JCO.2009.22.4295; Saltz LB, 2004, J CLIN ONCOL, V22, P1201, DOI 10.1200/JCO.2004.10.182; Schultz NA, 2014, JAMA-J AM MED ASSOC, V311, P392, DOI 10.1001/jama.2013.284664; Shen J, 2013, NATURE, V497, P383, DOI 10.1038/nature12080; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Slaby O, 2007, ONCOLOGY-BASEL, V72, P397, DOI 10.1159/000113489; Tang JT, 2011, CARCINOGENESIS, V32, P1207, DOI 10.1093/carcin/bgr114; Toiyama Y, 2013, JNCI-J NATL CANCER I, V105, P849, DOI 10.1093/jnci/djt101; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Tveit KM, 2012, J CLIN ONCOL, V30, P1755, DOI 10.1200/JCO.2011.38.0915; Van Cutsem E, 2006, EUR J CANCER, V42, P2212, DOI 10.1016/j.ejca.2006.04.012; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Willems E, 2008, ANAL BIOCHEM, V379, P127, DOI 10.1016/j.ab.2008.04.036; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103	46	57	60	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99886	10.1371/journal.pone.0099886	http://dx.doi.org/10.1371/journal.pone.0099886			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940606	gold, Green Published, Green Submitted			2022-12-27	WOS:000338508200051
J	Lanfranconi, F; Pollastri, L; Ferri, A; Fraschini, D; Masera, G; Miserocchi, G				Lanfranconi, Francesca; Pollastri, Luca; Ferri, Alessandra; Fraschini, Donatella; Masera, Giuseppe; Miserocchi, Giuseppe			Near Infrared Spectroscopy (NIRS) as a New Non-Invasive Tool to Detect Oxidative Skeletal Muscle Impairment in Children Survived to Acute Lymphoblastic Leukaemia	PLOS ONE			English	Article							BONE-MARROW-TRANSPLANTATION; CHILDHOOD-CANCER; PHYSICAL-ACTIVITY; RANDOMIZED-TRIAL; YOUNG-ADULTS; EXERCISE; DEXAMETHASONE; THERAPY; ADOLESCENTS; PERFORMANCE	Background: Separating out the effects of cancer and treatment between central and peripheral components of the O-2 delivery chain should be of interest to clinicians for longitudinal evaluation of potential functional impairment in order to set appropriate individually tailored training/rehabilitation programmes. We propose a non-invasive method (NIRS, near infrared spectroscopy) to be used in routine clinical practice to evaluate a potential impairment of skeletal muscle oxidative capacity during exercise in children previously diagnosed with acute lymphoblastic leukaemia (ALL). The purpose of this study was to evaluate the capacity of skeletal muscle to extract O-2 in 10 children diagnosed with ALL, 1 year after the end of malignancy treatment, compared to a control group matched for gender and age (mean +/- SD = 7.8 +/- 1.5 and 7.3 +/- 1.4 years, respectively). Methods and Findings: Participants underwent an incremental exercise test on a treadmill until exhaustion. Oxygen uptake ((V) over dotO(2)), heart rate (HR), and tissue oxygenation status (Delta[HHb]) of the vastus lateralis muscle evaluated by NIRS, were measured. The results showed that, in children with ALL, a significant linear regression was found by plotting (V) over dotO(2) vs Delta[HHb] both measured at peak of exercise. In children with ALL, the slope of the HR vs (V) over dotO(2) linear response (during submaximal and peak work rates) was negatively correlated with the peak value of Delta[HHb]. Conclusions: The present study proves that the NIRS technique allows us to identify large inter-individual differences in levels of impairment in muscle O-2 extraction in children with ALL. The outcome of these findings is variable and may reflect either muscle atrophy due to lack of use or, in the most severe cases, an undiagnosed myopathy.	[Lanfranconi, Francesca; Pollastri, Luca; Ferri, Alessandra; Miserocchi, Giuseppe] Univ Milano Bicocca, Dept Hlth Sci, Lab Clin Physiol & Sport Med, Monza, Italy; [Fraschini, Donatella; Masera, Giuseppe] Univ Milano Bicocca, San Gerardo Hosp, Dept Pediat, Monza, Italy	University of Milano-Bicocca; San Gerardo Hospital; University of Milano-Bicocca	Lanfranconi, F (corresponding author), Univ Milano Bicocca, Dept Hlth Sci, Lab Clin Physiol & Sport Med, Monza, Italy.	francesca.lanfranconi@unimib.it	Lanfranconi, Francesca/F-3511-2018	Lanfranconi, Francesca/0000-0001-5777-0821; FERRI, ALESSANDRA/0000-0003-0457-6931	Department of health sciences of University of Milano-Bicocca	Department of health sciences of University of Milano-Bicocca	All the sources of funding are related to the Department of health sciences of University of Milano-Bicocca. The senjor researcher, prof. G. Miserocchi, who provided this fund, was involved in study design and preparation of the manuscript.	Ahtikoski AM, 2004, PFLUG ARCH EUR J PHY, V448, P123, DOI 10.1007/s00424-003-1226-5; Amigoni M, 2010, PEDIATR BLOOD CANCER, V55, P1343, DOI 10.1002/pbc.22637; Arico M, 2008, J CLIN ONCOL, V26, P283, DOI 10.1200/JCO.2007.12.3927; Benedetti G, 2003, CILEA B, V86, P15; Conter V, 2010, BLOOD, V115, P3206, DOI 10.1182/blood-2009-10-248146; COOPER DM, 1984, J APPL PHYSIOL, V56, P628, DOI 10.1152/jappl.1984.56.3.628; Cox CL, 2009, CANCER-AM CANCER SOC, V115, P642, DOI 10.1002/cncr.24043; Dama E, 2008, EUR J CANCER, V44, P2101, DOI 10.1016/j.ejca.2008.07.023; Ferrari M, 2004, CAN J APPL PHYSIOL, V29, P463, DOI 10.1139/h04-031; Gitt AK, 2002, CIRCULATION, V106, P3079, DOI 10.1161/01.CIR.0000041428.99427.06; Grassi B, 2007, MUSCLE NERVE, V35, P510, DOI 10.1002/mus.20708; Harila-Saari AH, 1998, CANCER, V82, P200, DOI 10.1002/(SICI)1097-0142(19980101)82:1<200::AID-CNCR25>3.0.CO;2-5; Hartman A, 2009, PEDIATR BLOOD CANCER, V53, P64, DOI 10.1002/pbc.21942; Haupt R, 2007, EUR J CANCER, V43, P1778, DOI 10.1016/j.ejca.2007.04.015; Hauser M, 2001, EUR J PEDIATR, V160, P607, DOI 10.1007/s004310100830; Hogarty AN, 2000, J PEDIATR-US, V136, P311, DOI 10.1067/mpd.2000.103444; HOVI L, 1993, CANCER, V72, P276, DOI 10.1002/1097-0142(19930701)72:1<276::AID-CNCR2820720148>3.0.CO;2-2; JENNEY MEM, 1995, MED PEDIATR ONCOL, V24, P222, DOI 10.1002/mpo.2950240403; Lanfranconi F, 2006, MED SCI SPORT EXER, V38, P1374, DOI 10.1249/01.mss.0000228943.62776.69; Long W, 2001, AM J PHYSIOL-ENDOC M, V280, pE570, DOI 10.1152/ajpendo.2001.280.4.E570; Mancini D, 1997, J Biomed Opt, V2, P22, DOI 10.1117/12.263747; Marchese VG, 2004, PEDIATR BLOOD CANCER, V42, P127, DOI 10.1002/pbc.10481; Marchese VG, 2008, PHYS THER, V88, P341, DOI 10.2522/ptj.20070108; McCully K K, 2000, Exerc Sport Sci Rev, V28, P123; McNarry MA, 2011, J APPL PHYSIOL, V110, P375, DOI 10.1152/japplphysiol.00988.2010; Muratt MD, 2011, CLINICS, V66, P1277, DOI 10.1590/S1807-59322011000700026; Nysom K, 1999, J CLIN ENDOCR METAB, V84, P4591, DOI 10.1210/jc.84.12.4591; Porcelli S, 2010, J APPL PHYSIOL, V109, P101, DOI 10.1152/japplphysiol.00782.2009; Rowland TW, 2005, CHEST, V127, P1023, DOI 10.1378/chest.127.3.1023; San Juan AF, 2008, INT J SPORTS MED, V29, P439, DOI 10.1055/s-2007-965571; San Juan AF, 2008, J SPORTS MED, V29, P163; Speyer E, 2010, PEDIATR BLOOD CANCER, V55, P1160, DOI 10.1002/pbc.22698; Takken T, 2009, PSYCHO-ONCOLOGY, V18, P440, DOI 10.1002/pon.1484; Teuffel O, 2011, LEUKEMIA, V25, P1232, DOI 10.1038/leu.2011.84; van Brussel M, 2005, LEUKEMIA, V19, P13, DOI 10.1038/sj.leu.2403547; Vizinova H, 2002, Cas Lek Cesk, V141, P491; Wallace AM, 2003, CLIN ENDOCRINOL, V58, P770, DOI 10.1046/j.1365-2265.2003.01790.x; Wright Marilyn J, 2003, Pediatr Phys Ther, V15, P146, DOI 10.1097/01.PEP.0000083122.74062.1B	38	14	14	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e99282	10.1371/journal.pone.0099282	http://dx.doi.org/10.1371/journal.pone.0099282			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956391	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000338917900008
J	Seifert, M; Abou-El-Ardat, K; Friedrich, B; Klink, B; Deutsch, A				Seifert, Michael; Abou-El-Ardat, Khalil; Friedrich, Betty; Klink, Barbara; Deutsch, Andreas			Autoregressive Higher-Order Hidden Markov Models: Exploiting Local Chromosomal Dependencies in the Analysis of Tumor Expression Profiles	PLOS ONE			English	Article							COPY-NUMBER ALTERATION; ARRAY CGH; ANALYSIS REVEALS; PATTERNS; SUBTYPES; CANCER	Changes in gene expression programs play a central role in cancer. Chromosomal aberrations such as deletions, duplications and translocations of DNA segments can lead to highly significant positive correlations of gene expression levels of neighboring genes. This should be utilized to improve the analysis of tumor expression profiles. Here, we develop a novel model class of autoregressive higher-order Hidden Markov Models (HMMs) that carefully exploit local data-dependent chromosomal dependencies to improve the identification of differentially expressed genes in tumor. Autoregressive higher-order HMMs overcome generally existing limitations of standard first-order HMMs in the modeling of dependencies between genes in close chromosomal proximity by the simultaneous usage of higher-order state-transitions and autoregressive emissions as novel model features. We apply autoregressive higher-order HMMs to the analysis of breast cancer and glioma gene expression data and perform in-depth model evaluation studies. We find that autoregressive higher-order HMMs clearly improve the identification of overexpressed genes with underlying gene copy number duplications in breast cancer in comparison to mixture models, standard first-and higher-order HMMs, and other related methods. The performance benefit is attributed to the simultaneous usage of higher-order state-transitions in combination with autoregressive emissions. This benefit could not be reached by using each of these two features independently. We also find that autoregressive higher-order HMMs are better able to identify differentially expressed genes in tumors independent of the underlying gene copy number status in comparison to the majority of related methods. This is further supported by the identification of well-known and of previously unreported hotspots of differential expression in glioblastomas demonstrating the efficacy of autoregressive higher-order HMMs for the analysis of individual tumor expression profiles. Moreover, we reveal interesting novel details of systematic alterations of gene expression levels in known cancer signaling pathways distinguishing oligodendrogliomas, astrocytomas and glioblastomas. An implementation is available under www.jstacs.de/index.php/ARHMM.	[Seifert, Michael; Friedrich, Betty; Deutsch, Andreas] Tech Univ Dresden, Ctr Informat Serv & High Performance Comp, Dresden, Germany; [Abou-El-Ardat, Khalil; Klink, Barbara] Tech Univ Dresden, Fac Med Carl Gustav Carus, Inst Clin Genet, Dresden, Germany	Technische Universitat Dresden; Technische Universitat Dresden	Seifert, M (corresponding author), Tech Univ Dresden, Ctr Informat Serv & High Performance Comp, Dresden, Germany.	michael.seifert@zih.tu-dresden.de		Klink, Barbara/0000-0002-8753-8238	European Social Fund; Free State of Saxony; German Research Foundation; Open Access Publication Funds of the TU Dresden	European Social Fund(European Social Fund (ESF)); Free State of Saxony; German Research Foundation(German Research Foundation (DFG)); Open Access Publication Funds of the TU Dresden	This work was done in the frame of the GlioMath-Dresden project funded by the European Social Fund and the Free State of Saxony. We acknowledge support by the German Research Foundation and the Open Access Publication Funds of the TU Dresden.	Aycard O., 2004, International Journal of Advanced Robotic Systems, V1, P231; Baum LE, 1972, INEQUALITIES, V3, P1; Benyoussef L, 2008, DIGIT SIGNAL PROCESS, V18, P849, DOI 10.1016/j.dsp.2007.10.010; Berchtold A, 2002, STAT SCI, V17, P328; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; BILMES JA, 1998, 97021 ICSITR; Callegaro A, 2006, BIOINFORMATICS, V22, P2658, DOI 10.1093/bioinformatics/btl455; Cassidy MJ, 2002, J NEUROSCI METH, V116, P35, DOI 10.1016/S0165-0270(02)00026-2; Cavalli G, 2013, NAT STRUCT MOL BIOL, V20, P290, DOI 10.1038/nsmb.2474; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Cooper LAD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012548; Crawley JJ, 2002, GENOME BIOL, V3; de Tayrac M, 2009, GENE CHROMOSOME CANC, V48, P55, DOI 10.1002/gcc.20618; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Derrode S, 2004, 2004 IEEE INTERNATIONAL CONFERENCE ON ACOUSTICS, SPEECH, AND SIGNAL PROCESSING, VOL V, PROCEEDINGS, P769; Diaz-Uriarte R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000737; Durbin R., 1998, BIOL SEQUENCE ANAL P; Eng C, 2009, J COMPUT BIOL, V16, P1211, DOI 10.1089/cmb.2008.0122; Ephraim Y, 1988, APR P INT C AC SPEEC, P533; Fan X, 2004, CANCER RES, V64, P7787, DOI 10.1158/0008-5472.CAN-04-1446; Fridlyand J, 2004, J MULTIVARIATE ANAL, V90, P132, DOI 10.1016/j.jmva.2004.02.008; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Grau J, 2012, J MACH LEARN RES, V13, P1967; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heidenblad M, 2005, ONCOGENE, V24, P1794, DOI 10.1038/sj.onc.1208383; Hicklin J., 2012, JAMA JAVA MATRIX PAC; Holland JD, 2013, CURR OPIN CELL BIOL, V25, P254, DOI 10.1016/j.ceb.2013.01.004; Hsu L, 2005, BIOSTATISTICS, V6, P211, DOI 10.1093/biostatistics/kxi004; Hupe P, 2004, BIOINFORMATICS, V20, P3413, DOI 10.1093/bioinformatics/bth418; Hyman E, 2002, CANCER RES, V62, P6240; Jelinek F., 1998, STAT METHODS SPEECH; Junttila MR, 2009, NAT REV CANCER, V9, P821, DOI 10.1038/nrc2728; Kalliovirta L, 2012, 35217950562 HECER; Kamburov A, 2011, NUCLEIC ACIDS RES, V39, pD712, DOI 10.1093/nar/gkq1156; Khan MS, 2011, THESIS U EDINBURGH; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lai WR, 2005, BIOINFORMATICS, V21, P3763, DOI 10.1093/bioinformatics/bti611; Lee LM, 2006, STUDY HIGH ORDER HID; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Madhavan S, 2009, MOL CANCER RES, V7, P157, DOI 10.1158/1541-7786.MCR-08-0435; Marioni JC, 2006, BIOINFORMATICS, V22, P1144, DOI 10.1093/bioinformatics/btl089; Martinez-Beneito MA, 2008, STAT MED, V27, P4455, DOI 10.1002/sim.3320; Myers CL, 2004, BIOINFORMATICS, V20, P3533, DOI 10.1093/bioinformatics/bth440; Nel EM, 2005, IEEE T PATTERN ANAL, V27, P1733, DOI 10.1109/TPAMI.2005.221; Ohgaki H, 2005, J NEUROPATH EXP NEUR, V64, P479, DOI 10.1093/jnen/64.6.479; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Olteanu M, 2009, LECT NOTES COMPUT SC, V5517, P886, DOI 10.1007/978-3-642-02478-8_111; Picard F, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-27; Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Seifert M., 2010, THESIS M LUTHER U HA; Seifert M, 2012, BIOINFORMATICS, V28, P2930, DOI 10.1093/bioinformatics/bts562; Seifert M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002286; Seifert M, 2011, BIOINFORMATICS, V27, P1645, DOI 10.1093/bioinformatics/btr199; Shai R, 2003, ONCOGENE, V22, P4918, DOI 10.1038/sj.onc.1206753; Shannon M, 2010, 11TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2010 (INTERSPEECH 2010), VOLS 1-2, P829; Shi SM, 1997, PROCEEDINGS OF THE IEEE/IAFE 1997 COMPUTATIONAL INTELLIGENCE FOR FINANCIAL ENGINEERING (CIFER), P244, DOI 10.1109/CIFER.1997.618944; Stockhausen MT, 2010, NEURO-ONCOLOGY, V12, P199, DOI 10.1093/neuonc/nop022; Tak-Kuen Siu, 2005, Computational Economics, V26, P251, DOI 10.1007/s10614-005-9010-6; Toedling J, 2005, BIOINFORMATICS, V21, P2112, DOI 10.1093/bioinformatics/bti183; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Xuan T, 2004, THESIS U SASKATCHEWA; Zucchini W, 2009, MONOGR STAT APPL PRO, V110, P3	64	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100295	10.1371/journal.pone.0100295	http://dx.doi.org/10.1371/journal.pone.0100295			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24955771	gold, Green Published, Green Submitted			2022-12-27	WOS:000338917900038
J	Allman, D; Ditmore, MH; Kaplan, K				Allman, Dan; Ditmore, Melissa Hope; Kaplan, Karyn			Improving Ethical and Participatory Practice for Marginalized Populations in Biomedical HIV Prevention Trials: Lessons from Thailand	PLOS ONE			English	Article							RESEARCH-AND-DEVELOPMENT; CIVIL-SOCIETY PERSPECTIVES; FEMALE SEX WORKERS; COMMUNITY ENGAGEMENT; PREEXPOSURE PROPHYLAXIS; VULNERABLE POPULATIONS; COMBINATION PREVENTION; RESEARCH CONTEXTS; VACCINE TRIALS; PUBLIC-HEALTH	Background: This paper presents findings from a qualitative investigation of ethical and participatory issues related to the conduct of biomedical HIV prevention trials among marginalized populations in Thailand. This research was deemed important to conduct, as several large-scale biomedical HIV prevention trials among marginalized populations had closed prematurely in other countries, and a better understanding of how to prevent similar trial closures from occurring in the future was desired. Methods: In-depth key informant interviews were held in Bangkok and Chiang Mai, Thailand. Interviews were audio recorded, transcribed, translated and thematically analyzed. The Good Participatory Practice Guidelines for Biomedical HIV Prevention Trials (GPP) guided this work. Results: Fourteen interviews were conducted: 10 with policymakers, academic and community-based researchers and trial staff and four with representatives of non-governmental organizations (NGOs). Suggested ways to improve ethical and participatory practice centered on standards of HIV prevention, informed consent, communication and human rights. In particular, the need to overcome language and literacy differences was identified. Key informants felt communication was the basis of ethical understanding and trust within biomedical HIV prevention trial contexts, and thus fundamental to trial participants' ability to exercise free will. Discussion: Biomedical HIV prevention trials present opportunities for inclusive and productive ethical and participatory practice. Key informants suggested that efforts to improve practice could result in better relationships between research stakeholders and research investigative teams and by extension, better, more ethical participatory trials. This research took place in Thailand and its findings apply primarily to Thailand. However, given the universality of many ethical considerations, the results of this study can inform the improvement of ethical and participatory practice in other parts of the world where biomedical HIV prevention trials occur, and where clinical trials in marginalized populations continue.	[Allman, Dan] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Allman, Dan] Univ Toronto, Dalla Lana Sch Publ Hlth, CIHR Social Res Ctr HIV Prevent SRC, Toronto, ON, Canada; [Ditmore, Melissa Hope] Urban Justice Ctr, Sex Workers Project, New York, NY USA; [Kaplan, Karyn] Thai AIDS Treatment Act Grp TTAG, Bangkok, Thailand	University of Toronto; University of Toronto	Allman, D (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.	dan.allman@utoronto.ca	Allman, Dan/B-5086-2012	Allman, Dan/0000-0001-5198-751X	AVAC: Global Advocacy for HIV Prevention	AVAC: Global Advocacy for HIV Prevention	The funding for this research was provided by AVAC: Global Advocacy for HIV Prevention. The funder had a role in study design through participation in the development of the questions asked of key informants. The funder had no role in the data collection, data analysis, decision to publish, or preparation of the manuscript.	Ahmed SM, 2010, AM J PUBLIC HEALTH, V100, P1380, DOI 10.2105/AJPH.2009.178137; Andanda Pamela, 2011, Afr J AIDS Res, V10, P451, DOI 10.2989/16085906.2011.646660; [Anonymous], 2011, GOOD PART PRACT GUID; Barsdorf N, 2010, DEV WORLD BIOETH, V10, P78, DOI 10.1111/j.1471-8847.2009.00265.x; Bekker LG, 2014, JAIDS-J ACQ IMM DEF, V65, pS24, DOI 10.1097/QAI.0000000000000036; Benatar SR, 2010, J MED ETHICS, V36, P194, DOI 10.1136/jme.2009.032672; Bhan A, 2007, PLOS MED, V4, P1456, DOI 10.1371/journal.pmed.0040272; Borek N, 2010, JAIDS-J ACQ IMM DEF, V54, pS43, DOI 10.1097/QAI.0b013e3181e3627d; Boulanger RF, 2013, LANCET INFECT DIS, V13, P540, DOI 10.1016/S1473-3099(13)70042-2; Buchbinder SP, 2011, AIDS BEHAV, V15, pS72, DOI 10.1007/s10461-011-9894-1; Bull S, 2013, J EMPIR RES HUM RES, V8, P1, DOI 10.1525/jer.2013.8.4.1; Bull S, 2012, J EMPIR RES HUM RES, V7, P37, DOI 10.1525/jer.2012.7.1.37; Chakrapani V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051080; Chilengi Roma, 2009, Acta Trop, V112 Suppl 1, pS53, DOI 10.1016/j.actatropica.2009.08.004; Chua A, 2005, PLOS MED, V2, P1044, DOI 10.1371/journal.pmed.0020346; Cole CA, 2013, PROG COMM HLTH PARTN, V7, P323, DOI 10.1353/cpr.2013.0034; de Wit JBF, 2011, HEALTH EDUC RES, V26, P381, DOI 10.1093/her/cyr021; Delany-Moretlwe S, 2011, HEALTH RES POLICY SY, V9, DOI 10.1186/1478-4505-9-S1-S8; Ditmore MH, 2011, HEALTH EDUC RES, V26, P466, DOI 10.1093/her/cyq087; Ellen JM, 2010, JAIDS-J ACQ IMM DEF, V54, pS7, DOI 10.1097/QAI.0b013e3181e25779; Essack Z, 2012, AIDS CARE, V24, P1249, DOI 10.1080/09540121.2012.656566; Essack Z, 2010, DEV WORLD BIOETH, V10, P11, DOI 10.1111/j.1471-8847.2009.00254.x; Essack Z, 2010, SAMJ S AFR MED J, V100, P45; Fast PE, 2010, AIDS, V24, pS50, DOI 10.1097/01.aids.0000390707.58512.5e; Folayan MO, 2015, DEV WORLD BIOETH, V15, P1, DOI 10.1111/dewb.12020; Folayan MO, 2014, DEV WORLD BIOETH, V14, P1, DOI 10.1111/j.1471-8847.2012.00340.x; Folayan MO, 2011, J CULT ECON-UK, V4, P97, DOI 10.1080/17530350.2011.535376; Frew PM, 2011, VACCINE, V29, P6136, DOI 10.1016/j.vaccine.2011.06.082; Frew PM, 2010, PREV SCI, V11, P207, DOI 10.1007/s11121-009-0162-9; Fuchs JD, 2013, JAIDS-J ACQ IMM DEF, V63, P259, DOI 10.1097/QAI.0b013e318296df94; Fuchs JD, 2010, JAIDS-J ACQ IMM DEF, V55, pS128, DOI 10.1097/QAI.0b013e3181fbca02; Gafos M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014577; Gahagan J, 2008, INT J INFECT DIS, V12, P569, DOI 10.1016/j.ijid.2008.07.002; Golub Sarit A, 2010, Curr HIV/AIDS Rep, V7, P201, DOI 10.1007/s11904-010-0057-1; Gomez G B, 2013, Adv Prev Med, V2013, P190190, DOI 10.1155/2013/190190; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Haire B, 2013, DEV WORLD BIOETH, V13, P87, DOI 10.1111/dewb.12032; Haire B, 2012, AM J BIOETHICS, V12, P21, DOI 10.1080/15265161.2012.671887; Haire BG, 2011, DEV WORLD BIOETH, V11, P63, DOI 10.1111/j.1471-8847.2010.00292.x; Hankins CA, 2010, AIDS, V24, pS70, DOI 10.1097/01.aids.0000390709.04255.fd; Kaewkungwal J, 2013, AIDS RES HUM RETROV, V29, P1524, DOI [10.1089/aid.2012.0265, 10.1089/AID.2012.0265]; Kiawi E, 2012, BMC INT HEALTH HUM R, V12, DOI 10.1186/1472-698X-12-8; Koen J, 2013, DEV WORLD BIOETH, V13, P138, DOI 10.1111/j.1471-8847.2012.00338.x; Koff WC, 2013, VACCINE, V31, pB204, DOI 10.1016/j.vaccine.2012.10.115; Kokolo MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022497; Lang TA, 2012, INT HEALTH, V4, P47, DOI 10.1016/j.inhe.2011.10.003; Lau CY, 2011, VACCINE, V29, P7794, DOI 10.1016/j.vaccine.2011.07.108; Lienhardt C, 2012, TUBERCULOSIS, V92, pS33, DOI 10.1016/S1472-9792(12)70011-2; Loff B, 2005, LANCET, V365, P1618, DOI 10.1016/S0140-6736(05)66502-6; Mack N, 2013, OPEN ACCESS J CLIN T, V5, P127, DOI 10.2147/OAJCT.S45717; Mack N, 2010, J EMPIR RES HUM RES, V5, P3, DOI 10.1525/jer.2010.5.2.3; Macklin R, 2011, INT J FEM APPROACHES, V4, P124; Macklin R, 2012, AM J BIOETHICS, V12, P31, DOI 10.1080/15265161.2012.671889; Macklin R, 2010, PUBLIC HEALTH ETH-UK, V3, P199, DOI 10.1093/phe/phq019; Macklin Ruth, 2009, HIV Therapy, V3, P229, DOI 10.2217/HIV.09.7; MacQueen Kathleen M, 2011, J Int AIDS Soc, V14 Suppl 2, pS3, DOI 10.1186/1758-2652-14-S2-S3; Mamotte N, 2010, BMC MED ETHICS, V11, DOI 10.1186/1472-6939-11-3; McCormick JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004659; Meyer DZ, 2009, FIELD METHOD, V21, P91, DOI 10.1177/1525822X08323985; Michael M, 2012, THEOR CULT SOC, V29, P93, DOI 10.1177/0263276412443567; Miller L, 2010, INT J CLIN PRACT, V64, P1179, DOI 10.1111/j.1742-1241.2010.02421.x; Mills EJ, 2005, BRIT MED J, V331, P1403, DOI 10.1136/bmj.331.7529.1403; Ngongo BP, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-S2-O25; Ngongo PB, 2012, AIDS CARE, V24, P1277, DOI 10.1080/09540121.2012.656572; Okpokoro E., 2013, Journal of AIDS and Clinical Research, V4, P260; Ozdemir V, 2009, AM J BIOETHICS, V9, P65, DOI 10.1080/15265160903197671; Philpott S, 2011, J MED ETHICS, V37, P244, DOI 10.1136/jme.2010.037176; Pitisuttithum P, 2010, VACCINE, V28, pB45, DOI 10.1016/j.vaccine.2009.08.061; Poynten IM, 2010, HIV MED, V11, P282, DOI 10.1111/j.1468-1293.2009.00777.x; Presidential Commission for the Study of Bioethical Issues, 2011, MOR SCI PROT PART HU; Raju M S, 2008, Indian J Lepr, V80, P267; Reed E, 2014, J EMPIR RES HUM RES, V9, P19, DOI 10.1525/jer.2014.9.1.19; Rennie S, 2010, J MED ETHICS, V36, P810, DOI 10.1136/jme.2010.035444; Rerks-Ngarm S, 2010, CURR OPIN HIV AIDS, V5, P435, DOI 10.1097/COH.0b013e32833c95c1; Ritchie J., 2003, GUIDE SOCIAL SCI STU, P77; Rosengarten M, 2009, SCI CULT-UK, V18, P183, DOI 10.1080/09505430902885565; Rosengarten M, 2009, SOC SCI MED, V69, P1049, DOI 10.1016/j.socscimed.2009.07.039; Sahay Seema, 2011, East J Med, V16, P168; Shagi C, 2008, AIDS CARE, V20, P1039, DOI 10.1080/09540120701842803; Simon C, 2010, AM J BIOETHICS, V10, P3, DOI 10.1080/15265160903585578; Singh JA, 2005, PLOS MED, V2, P824, DOI 10.1371/journal.pmed.0020234; Stobie M, 2010, DEV WORLD BIOETH, V10, P150, DOI 10.1111/j.1471-8847.2009.00272.x; Swallow V, 2003, J CLIN NURS, V12, P610, DOI 10.1046/j.1365-2702.2003.00728.x; Tarimo EAM, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-283; UNAIDS AVAC, 2007, GOOD PART PRACT GUID; Urada LA, 2014, J EMPIR RES HUM RES, V9, P29, DOI 10.1525/jer.2014.9.1.29; Vallely A, 2012, AM J BIOETHICS, V12, P46, DOI 10.1080/15265161.2012.719268; Watermeyer Jennifer, 2011, J Pharm Pract, V24, P498, DOI 10.1177/0897190011415685; Weijer C, 2006, J LAW MED ETHICS, V34, P793, DOI 10.1111/j.1748-720X.2006.00099.x; White R, 2011, CLIN TRIALS, V8, P103, DOI 10.1177/1740774510387170	90	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100058	10.1371/journal.pone.0100058	http://dx.doi.org/10.1371/journal.pone.0100058			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK2UZ	24949864	Green Published, Green Submitted, gold			2022-12-27	WOS:000338276300034
J	Ge, S; Wang, RM; Yu, DC				Ge, Sheng; Wang, Ruimin; Yu, Dongchuan			Classification of Four-Class Motor Imagery Employing Single-Channel Electroencephalography	PLOS ONE			English	Article							BRAIN-COMPUTER INTERFACES; BCI COMPETITION 2003; EEG; MU; PATTERNS; FILTERS	With advances in brain-computer interface (BCI) research, a portable few-or single-channel BCI system has become necessary. Most recent BCI studies have demonstrated that the common spatial pattern (CSP) algorithm is a powerful tool in extracting features for multiple-class motor imagery. However, since the CSP algorithm requires multi-channel information, it is not suitable for a few-or single-channel system. In this study, we applied a short-time Fourier transform to decompose a single-channel electroencephalography signal into the time-frequency domain and construct multi-channel information. Using the reconstructed data, the CSP was combined with a support vector machine to obtain high classification accuracies from channels of both the sensorimotor and forehead areas. These results suggest that motor imagery can be detected with a single channel not only from the traditional sensorimotor area but also from the forehead area.	[Ge, Sheng; Yu, Dongchuan] Southeast Univ, Res Ctr Learning Sci, Minist Educ, Key Lab Child Dev & Learning Sci, Nanjing, Jiangsu, Peoples R China; [Wang, Ruimin] Nanjing Univ Sci & Technol, Sch Elect Engn & Optoelect Technol, Nanjing, Jiangsu, Peoples R China	Southeast University - China; Nanjing University of Science & Technology	Ge, S (corresponding author), Southeast Univ, Res Ctr Learning Sci, Minist Educ, Key Lab Child Dev & Learning Sci, Nanjing, Jiangsu, Peoples R China.	shengge@seu.edu.cn			National Natural Science Foundation of China [51007040, 61273224]; Program for New Century Excellent Talents in University of Ministry of Education, China [61074126]; Fundamental Research Funds for the Central Universities, China [3250183202, 10602026]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University of Ministry of Education, China(Program for New Century Excellent Talents in University (NCET)); Fundamental Research Funds for the Central Universities, China(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (No. 51007040, 61273224), the Program for New Century Excellent Talents in University of Ministry of Education, China (No. 61074126), and the Fundamental Research Funds for the Central Universities, China (No. 3250183202, 10602026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belousov AI, 2002, CHEMOMETR INTELL LAB, V64, P15, DOI 10.1016/S0169-7439(02)00046-1; Birbaumer N, 2006, PSYCHOPHYSIOLOGY, V43, P517, DOI 10.1111/j.1469-8986.2006.00456.x; Blankertz B, 2003, IEEE T NEUR SYS REH, V11, P127, DOI 10.1109/TNSRE.2003.814456; Blankertz B, 2004, IEEE T BIO-MED ENG, V51, P1044, DOI 10.1109/TBME.2004.826692; Blankertz B, 2008, IEEE SIGNAL PROC MAG, V25, P41, DOI 10.1109/MSP.2008.4408441; Blankertz B, 2006, IEEE T NEUR SYS REH, V14, P153, DOI 10.1109/TNSRE.2006.875642; Cabrera AF, 2008, J NEUROSCI METH, V174, P135, DOI 10.1016/j.jneumeth.2008.06.026; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; COLLURA T F, 1990, Brain Topography, V3, P65, DOI 10.1007/BF01128863; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Coyle D, 2008, IEEE IJCNN, P3696, DOI 10.1109/IJCNN.2008.4634328; Dornhege G, 2006, IEEE T BIO-MED ENG, V53, P2274, DOI 10.1109/TBME.2006.883649; Ebrahimpour Reza, 2012, 2012 16th CSI International Symposium on Artificial Intelligence and Signal Processing (AISP), P458, DOI 10.1109/AISP.2012.6313791; Nicolas-Alonso LF, 2012, SENSORS-BASEL, V12, P1211, DOI 10.3390/s120201211; Fried SJ, 2012, CLIN EEG NEUROSCI, V43, P121, DOI 10.1177/1550059411433613; Fukunaga K., 2013, INTRO STAT PATTERN R; Graimann B, 2003, IEEE T NEUR SYS REH, V11, P276, DOI 10.1109/TNSRE.2003.816863; Guger C, 2000, IEEE T REHABIL ENG, V8, P447, DOI 10.1109/86.895947; Hsu C.W., 2003, PRACTICAL GUIDE SUPP; Ince NF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014384; Jeannerod M, 2001, NEUROIMAGE, V14, pS103, DOI 10.1006/nimg.2001.0832; Jha AK, 2013, INT J ENG RES TECHNO, V2, P269; KOLES Z J, 1990, Brain Topography, V2, P275, DOI 10.1007/BF01129656; Lal TN, 2004, IEEE T BIO-MED ENG, V51, P1003, DOI 10.1109/TBME.2004.827827; Lemm S, 2004, IEEE T BIO-MED ENG, V51, P1077, DOI 10.1109/TBME.2004.827076; Li KD, 2009, EIGHTH IEEE INTERNATIONAL CONFERENCE ON DEPENDABLE, AUTONOMIC AND SECURE COMPUTING, PROCEEDINGS, P430, DOI 10.1109/DASC.2009.66; Lu Wang, 2008, 2008 2nd International Conference on Bioinformatics and Biomedical Engineering (ICBBE '08), P2153; Luck SJ., 2011, OXFORD HDB EVENT REL, DOI DOI 10.1093/OXFORDHB/9780195374148.013.0089; McFarland DJ, 2000, BRAIN TOPOGR, V12, P177, DOI 10.1023/A:1023437823106; Mingai Li, 2011, Proceedings of the 2011 IEEE International Conference on Mechatronics and Automation (ICMA 2011), P1184, DOI 10.1109/ICMA.2011.5985829; Mu ZD, 2009, INT J DIGITAL CONTEN, V3, P116; Muller-Putz GR, 2010, MED BIOL ENG COMPUT, V48, P229, DOI 10.1007/s11517-009-0572-7; Neuper C, 2009, CLIN NEUROPHYSIOL, V120, P239, DOI 10.1016/j.clinph.2008.11.015; Nunez PL, 2000, BEHAV BRAIN SCI, V23, P371, DOI 10.1017/S0140525X00003253; Pfurtscheller G, 2006, NEUROIMAGE, V31, P153, DOI 10.1016/j.neuroimage.2005.12.003; Pfurtscheller G, 2009, CLIN NEUROPHYSIOL, V120, P24, DOI 10.1016/j.clinph.2008.09.027; Rato RT, 2008, MECH SYST SIGNAL PR, V22, P1374, DOI 10.1016/j.ymssp.2007.11.028; Schlogl A, 2005, J NEURAL ENG, V2, pL14, DOI 10.1088/1741-2560/2/4/L02; Shi LC, 2011, LECT NOTES COMPUT SC, V7062, P725, DOI 10.1007/978-3-642-24955-6_86; Shih JJ, 2012, MAYO CLIN PROC, V87, P268, DOI 10.1016/j.mayocp.2011.12.008; Solis-Escalante T, 2010, BIOMED SIGNAL PROCES, V5, P15, DOI 10.1016/j.bspc.2009.09.002; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; van den Broek SP, 1998, ELECTROEN CLIN NEURO, V106, P522, DOI 10.1016/S0013-4694(97)00147-8; Vapnik V. N., 2000, NATURE STAT LEARNING, DOI DOI 10.1007/978-1-4757-3264-1_1	44	42	49	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e98019	10.1371/journal.pone.0098019	http://dx.doi.org/10.1371/journal.pone.0098019			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950192	Green Submitted, gold, Green Published			2022-12-27	WOS:000338276300005
J	Kraus, D; Horowitz-Kraus, T				Kraus, Dror; Horowitz-Kraus, Tzipi			The Effect of Learning on Feedback-Related Potentials in Adolescents with Dyslexia: An EEG-ERP Study	PLOS ONE			English	Article							CARD SORTING TEST; ERROR-DETECTION MECHANISM; EVENT-RELATED POTENTIALS; PERFORMANCE FEEDBACK; SKILLED READERS; WORKING-MEMORY; CHILDREN; TASK; NEGATIVITY; DEFICITS	Introduction: Individuals with dyslexia exhibit associated learning deficits and impaired executive functions. The Wisconsin Card Sorting Test (WCST) is a learning-based task that relies heavily on executive functioning, in particular, attention shift and working memory. Performance during early and late phases of a series within the task represents learning and implementation of a newly learned rule. Here, we aimed to examine two event-related potentials associated with learning, feedback-related negativity (FRN)-P300 complex, in individuals with dyslexia performing the WCST. Methods: Adolescents with dyslexia and age-matched typical readers performed the Madrid card sorting test (MCST), a computerized version of the WCST. Task performance, reading measures, and cognitive measures were collected. FRN and the P300 complex were acquired using the event-related potentials methodology and were compared in early vs late errors within a series. Results: While performing the MCST, both groups showed a significant reduction in average reaction times and a trend toward decreased error rates. Typical readers performed consistently better than individuals with dyslexia. FRN amplitudes in early phases were significantly smaller in dyslexic readers, but were essentially equivalent to typical readers in the late phase. P300 amplitudes were initially smaller among readers with dyslexia and tended to decrease further in late phases. Differences in FRN amplitudes for early vs late phases were positively correlated with those of P300 amplitudes in the entire sample. Conclusion: Individuals with dyslexia demonstrate a behavioral and electrophysiological change within single series of the MCST. However, learning patterns seem to differ between individuals with dyslexia and typical readers. We attribute these differences to the lower baseline performance of individuals with dyslexia. We suggest that these changes represent a fast compensatory mechanism, demonstrating the importance of learning strategies on reading among individuals with dyslexia.	[Kraus, Dror] Cincinnati Childrens Hosp Med Ctr, Dept Pediat Neurol, Cincinnati, OH 45229 USA; [Horowitz-Kraus, Tzipi] Cincinnati Childrens Hosp Med Ctr, Pediat Neuroimaging Res Consortium, Cincinnati, OH 45229 USA; [Horowitz-Kraus, Tzipi] Univ Haifa, Fac Educ, Edmond J Safra Brain Res Ctr Study Learning Disab, IL-31999 Haifa, Israel	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University of Haifa	Horowitz-Kraus, T (corresponding author), Cincinnati Childrens Hosp Med Ctr, Pediat Neuroimaging Res Consortium, Cincinnati, OH 45229 USA.	Tzipi.Horowitz-Kraus@cchmc.org			Edmond J Safra foundation	Edmond J Safra foundation	This study was supported by the Edmond J Safra foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barcelo F, 2002, NEUROPSYCHOLOGIA, V40, P349, DOI 10.1016/S0028-3932(01)00110-5; Barcelo F, 2003, BRAIN RES PROTOC, V11, P27, DOI 10.1016/S1385-299X(03)00013-8; Barcelo F, 2002, NEUROREPORT, V13, P1887, DOI 10.1097/00001756-200210280-00011; Bellebaum C, 2008, EUR J NEUROSCI, V27, P1823, DOI 10.1111/j.1460-9568.2008.06138.x; Breznitz Z, 2003, BRAIN LANG, V85, P486, DOI 10.1016/S0093-934X(03)00071-3; Breznitz Z., 2006, FLUENCY READING SYNC; Brown L, 1997, TONI 3 FORM PICTURE; Bujoreanu IS, 2008, DEV NEUROPSYCHOL, V33, P584, DOI 10.1080/87565640802254364; COURCHESNE E, 1975, ELECTROEN CLIN NEURO, V39, P131, DOI 10.1016/0013-4694(75)90003-6; Crutch SJ, 2006, NEUROCASE, V12, P91, DOI 10.1080/13554790500507172; DENCKLA MB, 1976, NEUROPSYCHOLOGIA, V14, P471, DOI 10.1016/0028-3932(76)90075-0; Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001; GRANT DA, 1948, J EXP PSYCHOL, V38, P404, DOI 10.1037/h0059831; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Greve KW, 2002, BRAIN INJURY, V16, P29, DOI 10.1080/0269905011008803; Groen Y, 2007, BIOL PSYCHOL, V76, P174, DOI 10.1016/j.biopsycho.2007.07.006; Helland T, 2000, CHILD NEUROPSYCHOL, V6, P37, DOI 10.1076/0929-7049(200003)6:1;1-B;FT037; Henson R, 2005, Q J EXP PSYCHOL-A, V58, P193, DOI 10.1080/02724980443000502; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Horowitz-Kraus T., 2012, J LEARNING DISABILIT, V10; Horowitz-Kraus T, 2012, INT DYSL ASS C BALT; Horowitz-Kraus T, 2008, CLIN NEUROPHYSIOL, V119, P2238, DOI 10.1016/j.clinph.2008.06.009; Horowitz-Kraus T, 2011, DEV NEUROPSYCHOL, V36, P914, DOI 10.1080/87565641.2011.606415; Horowitz-Kraus T, 2011, INT J DISABIL DEV ED, V58, P33, DOI 10.1080/1034912X.2011.548466; Horowitz-Kraus T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007141; Igarashi K, 2002, BRAIN DEV-JPN, V24, P174, DOI 10.1016/S0387-7604(02)00024-4; International Dyslexia Association, 2011, DEF DYSL; Jacobson LA, 2011, CHILD NEUROPSYCHOL, V17, P209, DOI 10.1080/09297049.2010.532204; Kado Y, 2012, BRAIN DEV-JPN, V34, P354, DOI 10.1016/j.braindev.2011.08.008; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Kopp B, 2006, J COGNITIVE NEUROSCI, V18, P949, DOI 10.1162/jocn.2006.18.6.949; Menghini D, 2006, NEUROIMAGE, V33, P1218, DOI 10.1016/j.neuroimage.2006.08.024; Milner B., 1963, ARCH NEUROL-CHICAGO, V9, P90, DOI DOI 10.1001/ARCHNEUR.1963.00460070100010; Nicolson RI, 1999, LANCET, V353, P1662, DOI 10.1016/S0140-6736(98)09165-X; Nieuwenhuis S, 2004, CEREB CORTEX, V14, P741, DOI 10.1093/cercor/bhh034; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Reitan RM, 1985, HALSTEAD REITAN NEUR; Ritter F.E., 2001, INT ENCY SOCIAL BEHA, P8602, DOI DOI 10.1016/B0-08-043076-7/01480-7; Romine CB, 2004, ARCH CLIN NEUROPSYCH, V19, P1027, DOI 10.1016/j.acn.2003.12.009; RUDEL RG, 1978, BRAIN LANG, V6, P52, DOI 10.1016/0093-934X(78)90043-3; Sailer U, 2010, BRAIN RES, V1342, P85, DOI 10.1016/j.brainres.2010.04.051; Segalowitz SJ, 2004, BRAIN COGNITION, V55, P116, DOI 10.1016/s0278-2626(03)00283-5; Shany M., 2006, TEL AVIV; Shatil E., 2008, ELULL LEARNING DISAB; Stoet G, 2007, NEUROSCI LETT, V427, P61, DOI 10.1016/j.neulet.2007.09.014; van Noordt SJR, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00197; Vicari S, 2005, J NEUROL NEUROSUR PS, V76, P1392, DOI 10.1136/jnnp.2004.061093; Wechsler D., 1997, WECHSLER ADULT INTEL; WITELSON SF, 1976, SCIENCE, V193, P425, DOI 10.1126/science.935879; WOLF M, 1986, CHILD DEV, V57, P988, DOI 10.2307/1130373	50	16	17	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100486	10.1371/journal.pone.0100486	http://dx.doi.org/10.1371/journal.pone.0100486			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950233	Green Published, gold, Green Submitted			2022-12-27	WOS:000338276300079
J	Zhang, PJ; Li, CH; Zhang, P; Jin, CH; Pan, DD; Bao, YB				Zhang, Pengjuan; Li, Chenghua; Zhang, Peng; Jin, Chunhua; Pan, Daodong; Bao, Yongbo			iTRAQ-Based Proteomics Reveals Novel Members Involved in Pathogen Challenge in Sea Cucumber Apostichopus japonicus	PLOS ONE			English	Article							SKIN ULCERATION SYNDROME; CAENORHABDITIS-ELEGANS; IDENTIFICATION; APOPTOSIS; VINCULIN; VITRONECTIN; MICRORNAS; RESPONSES	Skin ulceration syndrome (SUS) is considered to be a major constraint for the stable development of Apostichopus japonicus culture industries. In this study, we investigated protein changes in the coelomocytes of A. japonicus challenged by Vibrio splendidus using isobaric tags for relative and absolute quantification (iTRAQ) over a 96 h time course. Consequently, 228 differentially expressed proteins were identified in two iTRAQs. A comparison of the protein expression profiles among different time points detected 125 proteins primarily involved in response to endogenous stimuli at 24 h. At 48 h, the number of differentially expressed proteins decreased to 67, with their primary function being oxidation reduction. At the end of pathogen infection, proteins responsive to amino acid stimuli and some metabolic processes were classified as the predominant group. Fifteen proteins were differentially expressed at all time points, among which eight proteins related to pathologies in higher animals were shown to be down-regulated after V. splendidus infection: paxillin, fascin-2, aggrecan, ololfactomedin-1, nesprin-3, a disintegrin-like and metallopeptidase with thrombospondin type 1 motif (Adamts7), C-type lectin domain family 4 (Clec4g) and n-myc downstream regulated gene 1 (Ndrg1). To gain more insight into two SUS-related miRNA (miR-31 and miR-2008) targets at the protein level, all 129 down-regulated proteins were further analyzed in combination with RNA-seq. Twelve and eight proteins were identified as putative targets for miR-31 and miR-2008, respectively, in which six proteins (5 for miR-31 and 1 for miR-2008) displayed higher possibilities to be regulated at the level of translation. Overall, the present work enhances our understanding of the process of V. splendidus-challenged sea cucumber and provides a new method for screening miRNAs targets at the translation level.	[Zhang, Pengjuan; Li, Chenghua; Zhang, Peng; Jin, Chunhua; Pan, Daodong] Ningbo Univ, Dept Aquaculture, Ningbo 315211, Zhejiang, Peoples R China; [Bao, Yongbo] Zhejiang Wanli Univ, Dept Aquat Germplasm Resources, Ningbo, Zhejiang, Peoples R China	Ningbo University; Zhejiang Wanli University	Li, CH (corresponding author), Ningbo Univ, Dept Aquaculture, Ningbo 315211, Zhejiang, Peoples R China.	lichenghua@nbu.edu.cn	Li, Chenghua/L-9825-2019	Li, Chenghua/0000-0003-2978-8762	NSFC [31101919, 4127610]; Zhejiang Provincial Natural Science Foundation of China; young academic leaders in colleges and universities in Zhejiang province [pd2013099]; Natural Science foundation of Ningbo [2013C10013]; K.C. Wong Magna Fund at Ningbo University	NSFC(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); young academic leaders in colleges and universities in Zhejiang province; Natural Science foundation of Ningbo; K.C. Wong Magna Fund at Ningbo University	This work was financially supported by NSFC (31101919, 4127610), Zhejiang Provincial Natural Science Foundation of China, the young academic leaders in colleges and universities in Zhejiang province (pd2013099), the Natural Science foundation of Ningbo (2013C10013), and the K.C. Wong Magna Fund at Ningbo University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae HB, 2012, AM J RESP CELL MOL, V46, P790, DOI 10.1165/rcmb.2011-0187OC; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen CZ, 2013, IMMUNOL REV, V253, P112, DOI 10.1111/imr.12060; Chen M, 2013, PLOS ONE, V15; Di Pietro G, 2010, EXPERT OPIN DRUG MET, V6, P153, DOI 10.1517/17425250903427980; Evans C, 2012, ANAL BIOANAL CHEM, V404, P1011, DOI 10.1007/s00216-012-5918-6; Haasnoot J, 2011, METHODS MOL BIOL, V721, P23, DOI 10.1007/978-1-61779-037-9_2; HE L, 2004, NAT REV GENET, V5, P522; Herbrich SM, 2013, J PROTEOME RES, V12, P594, DOI 10.1021/pr300624g; Li CH, 2012, FISH SHELLFISH IMMUN, V33, P436, DOI 10.1016/j.fsi.2012.04.013; Li CY, 2012, EXPERT REV PROTEOMIC, V9, P549, DOI [10.1586/EPR.12.49, 10.1586/epr.12.49]; Li ZJ, 2007, MOL CELL PROTEOMICS, V6, P1609, DOI 10.1074/mcp.M600327-MCP200; Lietzen N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001340; Lopez J, 2012, CELL DEATH DIFFER, V19, P1459, DOI 10.1038/cdd.2012.21; Lu AJ, 2014, FISH SHELLFISH IMMUN, V36, P229, DOI 10.1016/j.fsi.2013.11.007; Ma Yue-xin, 2006, Dalian Shuichan Xueyuan Xuebao, V21, P13; Magro AM, 2007, NEOPLASMA, V54, P517; Morita S, 2013, PEERJ, V1, DOI 10.7717/peerj.162; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Ou ML, 2014, EUR J HUM GENET, V22, P625, DOI 10.1038/ejhg.2013.221; Peng XA, 2011, INT REV CEL MOL BIO, V287, P191, DOI 10.1016/B978-0-12-386043-9.00005-0; Rabilloud T, 2010, J PROTEOMICS, V73, P2064, DOI 10.1016/j.jprot.2010.05.016; Ren Yushan, 2014, Virologica Sinica, V29, P25, DOI 10.1007/s12250-014-3421-2; Revathy KS, 2012, COMP BIOCHEM PHYS B, V162, P10, DOI 10.1016/j.cbpb.2012.02.004; Seggerson K, 2002, DEV BIOL, V243, P215, DOI 10.1006/dbio.2001.0563; Shao YN, 2013, J AGR FOOD CHEM, V61, P10766, DOI 10.1021/jf4038776; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Subauste MC, 2004, J CELL BIOL, V165, P371, DOI 10.1083/jcb.200308011; Thakur SS, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003699; Tsuruta Y, 2007, J IMMUNOL, V179, P7079, DOI 10.4049/jimmunol.179.10.7079; Uhlmann S, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2011.100; Wang Pin-hong, 2005, Journal of Fishery Sciences of China, V12, P766; [王印庚 Wang Yingeng], 2005, [海洋科学, Marine Sciences], V29, P1; Zhang Chun-yun, 2006, Journal of Fisheries of China, V30, P118; [张春云 Zhang Chunyun], 2004, [海洋水产研究, Marine Fisheries Research], V25, P89; Zhang PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073506; Zhou ZC, 2014, MOL ECOL RESOUR, V14, P127, DOI 10.1111/1755-0998.12147; Zhu L, 2013, GENET MOL RES, V12, P3028, DOI 10.4238/2013.August.20.4	39	54	56	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100492	10.1371/journal.pone.0100492	http://dx.doi.org/10.1371/journal.pone.0100492			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949634	Green Submitted, Green Published, gold			2022-12-27	WOS:000338276300080
J	Cheng, VCC; Tai, JWM; Chau, PH; Chen, JHK; Yan, MK; So, SYC; To, KKW; Chan, JFW; Wong, SCY; Ho, PL; Yuen, KY				Cheng, Vincent Chi-Chung; Tai, Josepha Wai-Ming; Chau, Pui-Hing; Chen, Jonathan Hon-Kwan; Yan, Mei-Kum; So, Simon Yung-Chun; To, Kelvin Kai-Wang; Chan, Jasper Fuk-Woo; Wong, Sally Cheuk-Ying; Ho, Pak-Leung; Yuen, Kwok-Yung			Minimal Intervention for Controlling Nosocomial Transmission of Methicillin-Resistant Staphylococcus aureus in Resource Limited Setting with High Endemicity	PLOS ONE			English	Article							HEALTH-CARE SETTINGS; HONG-KONG; HAND HYGIENE; INFECTION; SURVEILLANCE; PRECAUTIONS; BACTEREMIA; MRSA; ENTEROBACTERIACEAE; DECOLONIZATION	Objective: To control nosocomial transmission of methicillin-resistant Staphylococcus aureus (MRSA) in resource-limited healthcare setting with high endemicity. Methods: Three phases of infection control interventions were implemented in a University-affiliated hospital between 1-January-2004 and 31-December-2012. The first phase of baseline period, defined as the first 48-months of the study period, when all MRSA patients were managed with standard precautions, followed by a second phase of 24-months, when a hospital-wide hand hygiene campaign was launched. In the third phase of 36-months, contact precautions in open cubicle, use of dedicated medical items, and 2% chlorhexidine gluconate daily bathing for MRSA-positive patients were implemented while hand hygiene campaign was continued. The changes in the incidence rates of hospital-acquired MRSA-per-1000-patient admissions, per-1000-patient-days, and per-1000-MRSA-positive-days were analyzed using segmented Poisson regression (an interrupted time series model). Usage density of broad-spectrum antibiotics was monitored. Results: During the study period, 4256 MRSA-positive patients were newly diagnosed, of which 1589 (37.3%) were hospital-acquired. The reduction of hospital-acquired MRSA per 1000-patient admissions, per 1000-patient-days, and per 1000-MRSA-positive-days from phase 1 to 2 was 36.3% (p < 0.001), 30.4% (p < 0.001), and 19.6% (p = 0.040), while the reduction of hospital-acquired MRSA per 1000-patient admissions, per 1000-patient-days, and per 1000-MRSA-positive-days from phase 2 to 3 was 27.4% (p < 0.001), 24.1% (p < 0.001), and 21.9% (p = 0.041) respectively. This reduction is sustained despite that the usage density of broad-spectrum antibiotics has increased from 132.02 (phase 1) to 168.99 per 1000 patient-days (phase 3). Conclusions: Nosocomial transmission of MRSA can be reduced with hand hygiene campaign, contact precautions in open cubicle, and 2% chlorhexidine gluconate daily bathing for MRSA-positive despite an increasing consumption of broad-spectrum antibiotics.	[Cheng, Vincent Chi-Chung; Chen, Jonathan Hon-Kwan; Yan, Mei-Kum; So, Simon Yung-Chun; To, Kelvin Kai-Wang; Chan, Jasper Fuk-Woo; Wong, Sally Cheuk-Ying; Ho, Pak-Leung; Yuen, Kwok-Yung] Queen Mary Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Cheng, Vincent Chi-Chung; Tai, Josepha Wai-Ming] Queen Mary Hosp, Infect Control Team, Hong Kong, Hong Kong, Peoples R China; [Chau, Pui-Hing] Univ Hong Kong, Sch Nursing, Hong Kong, Hong Kong, Peoples R China; [To, Kelvin Kai-Wang; Chan, Jasper Fuk-Woo; Ho, Pak-Leung; Yuen, Kwok-Yung] Univ Hong Kong, Carol Yu Ctr Infect, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong	Yuen, KY (corresponding author), Queen Mary Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China.	kyyuen@hkucc.hku.hk	何栢良, Pak-Leung HO/C-4310-2009; To, Kelvin/AAV-7007-2020; Chan, Jasper F. W./D-8007-2013	何栢良, Pak-Leung HO/0000-0002-8811-1308; To, Kelvin/0000-0002-1921-5824; Chan, Jasper F. W./0000-0001-6336-6657; Yuen, Kwok-yung/0000-0002-2083-1552; CHENG, Vincent Chi-Chung/0000-0003-1765-7706				Bosso JA, 2006, ANTIMICROB AGENTS CH, V50, P2106, DOI 10.1128/AAC.01359-05; Cepeda JA, 2005, LANCET, V365, P295, DOI 10.1016/S0140-6736(05)17783-6; Cheng VCC, 2008, J HOSP INFECT, V70, P27, DOI 10.1016/j.jhin.2008.05.019; Cheng VCC, 2011, J HOSP INFECT, V79, P206, DOI 10.1016/j.jhin.2011.03.024; Cheng VCC, 2009, EUR J CLIN MICROBIOL, V28, P1447, DOI 10.1007/s10096-009-0803-8; Cheng VCC, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-205; Cheng VCC, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-151; Cheng VCC, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-263; Cheng VCC, 2013, CHINESE MED J-PEKING, V126, P4504, DOI 10.3760/cma.j.issn.0366-6999.20130741; Cheng VCC, 2012, CHINESE MED J-PEKING, V125, P3450, DOI 10.3760/cma.j.issn.0366-6999.2012.19.017; Climo MW, 2013, NEW ENGL J MED, V368, P533, DOI 10.1056/NEJMoa1113849; Cooper BS, 2004, BMJ-BRIT MED J, V329, P533, DOI 10.1136/bmj.329.7465.533; Deeny SR, 2013, J HOSP INFECT, V85, P33, DOI 10.1016/j.jhin.2013.03.011; Ellingson K, 2011, INFECT CONT HOSP EP, V32, P1, DOI 10.1086/657665; Fisher D, 2013, J HOSP INFECT, V85, P141, DOI 10.1016/j.jhin.2013.07.005; Halcomb EJ, 2008, INT J EVID-BASED HEA, V6, P206, DOI 10.1111/j.1479-6988.2008.00089.x; Ho PL, 2012, J ANTIMICROB CHEMOTH, V67, P1553, DOI 10.1093/jac/dks095; Ho PL, 2012, J ANTIMICROB CHEMOTH, V67, P778, DOI 10.1093/jac/dkr502; Ho PL, 2010, INT J ANTIMICROB AG, V36, P469, DOI 10.1016/j.ijantimicag.2010.07.004; Huang SS, 2006, CLIN INFECT DIS, V43, P971, DOI 10.1086/507636; Huang SS, 2013, NEW ENGL J MED, V368, P2255, DOI 10.1056/NEJMoa1207290; Jain R, 2011, NEW ENGL J MED, V364, P1419, DOI 10.1056/NEJMoa1007474; Johnson AP, 2012, J ANTIMICROB CHEMOTH, V67, P802, DOI 10.1093/jac/dkr561; Kassakian SZ, 2011, INFECT CONT HOSP EP, V32, P238, DOI 10.1086/658334; Masse V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057057; Morgan DJ, 2013, INFECT CONT HOSP EP, V34, P69, DOI 10.1086/668775; Pittet D, 2000, LANCET, V356, P1307, DOI 10.1016/S0140-6736(00)02814-2; Siegel JD, 2007, AM J INFECT CONTROL, V35, pS65, DOI 10.1016/j.ajic.2007.10.007; Siegel JD, 2007, AM J INFECT CONTROL, V35, pS165, DOI 10.1016/j.ajic.2007.10.006; Tai JW, IMPACT IMPLEME UNPUB	31	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100493	10.1371/journal.pone.0100493	http://dx.doi.org/10.1371/journal.pone.0100493			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945412	Green Published, gold, Green Submitted			2022-12-27	WOS:000340721500081
J	Huang, CY; Lee, CL				Huang, Chung-Yuan; Lee, Chun-Liang			Influences of Agents with a Self-Reputation Awareness Component in an Evolutionary Spatial IPD Game	PLOS ONE			English	Article							COOPERATION; TRUST; INFORMATION; DILEMMAS; NETWORKS	Iterated prisoner's dilemma (IPD) researchers have shown that strong positive reputations plus an efficient reputation evaluation system encourages both sides to pursue long-term collaboration and to avoid falling into mutual defection cycles. In agent-based environments with reliable reputation rating systems, agents interested in maximizing their private interests must show concern for other agents as well as their own self-reputations-an important capability that standard IPD game agents lack. Here we present a novel learning agent model possessing self-reputation awareness. Agents in our proposed model are capable of evaluating self-behaviors based on a mix of public and private interest considerations, and of testing various solutions aimed at meeting social standards. Simulation results indicate multiple outcomes from the addition of a small percentage of self-reputation awareness agents: faster cooperation, faster movement toward stability in an agent society, a higher level of public interest in the agent society, the resolution of common conflicts between public and private interests, and a lower potential for rational individual behavior to transform into irrational group behavior.	[Huang, Chung-Yuan; Lee, Chun-Liang] Chang Gung Univ, Coll Engn, Sch Elect & Comp Engn, Dept Comp Sci & Informat Engn, Taoyuan, Taiwan	Chang Gung University	Lee, CL (corresponding author), Chang Gung Univ, Coll Engn, Sch Elect & Comp Engn, Dept Comp Sci & Informat Engn, Taoyuan, Taiwan.	cllee@mail.cgu.edu.tw	Huang, Chung-Yuan/AAH-2330-2019	Huang, Chung-Yuan/0000-0002-8680-6755	High Speed Intelligent Communication (HSIC) research center, Chang Gung University, Taiwan, R.O.C.; Republic of China National Science Council [NSC-102-2221-E-182-052, NSC-102-2221-E-182-034]	High Speed Intelligent Communication (HSIC) research center, Chang Gung University, Taiwan, R.O.C.; Republic of China National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported in part by the High Speed Intelligent Communication (HSIC) research center, Chang Gung University, Taiwan, R.O.C. and by grants from the Republic of China National Science Council (NSC-102-2221-E-182-052 and NSC-102-2221-E-182-034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER E, 1992, INT ORGAN, V46, P101, DOI 10.1017/S0020818300001466; [Anonymous], 1999, P 4 NORD WORKSH SEC, P496; Aronson E., 2010, SOC PSYCHOL-GERMANY, V7; Axelrod R., 1997, COMPLEXITY COOPERATI, DOI [10.1515/9781400822300, DOI 10.1515/9781400822300]; Axelrod R, 1987, REV AUSTRIAN EC, V211, P227; Baumeister R. F., 1999, SELF SOCIAL PSYCHOL; Bromley Dennis-Basil, 1993, REPUTATION IMAGE IMP; Carter J, 2002, COMPUT INTELL-US, V18, P515, DOI 10.1111/1467-8640.t01-1-00201; Carver C.S., 2012, ATTENTION SELF REGUL; Chen SH, 2001, J ECON DYN CONTROL, V25, P363, DOI 10.1016/S0165-1889(00)00030-0; Dobbyn C, 2003, MIND MACH, V13, P187, DOI 10.1023/A:1022997315561; Fu F, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.016104; Garfinkel S, 2002, WEB SECURITY PRIVACY; Gutowska A, 2010, LECT NOTES BUS INF P, V45, P212; Hendler J, 2009, COMPUTER, V42, P111, DOI 10.1109/MC.2009.30; Huang CY, 2004, LECT NOTES COMPUT SC, V3103, P774; Kawamura K, 2003, PROCEEDINGS OF THE 11TH INTERNATIONAL CONFERENCE ON ADVANCED ROBOTICS 2003, VOL 1-3, P568; KREPS DM, 1982, J ECON THEORY, V27, P253, DOI 10.1016/0022-0531(82)90030-8; Leimar O, 2001, P ROY SOC B-BIOL SCI, V268, P745, DOI 10.1098/rspb.2000.1573; Liu YK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030689; Maes P, 1999, COMMUN ACM, V42, P81, DOI 10.1145/295685.295716; MARKUS H, 1977, J PERS SOC PSYCHOL, V35, P63, DOI 10.1037/0022-3514.35.2.63; Maskin E, 2009, SPRINGER SER GAME TH, P79, DOI 10.1007/978-3-540-85436-4_4; McGillivray F, 2000, INT ORGAN, V54, P809, DOI 10.1162/002081800551370; McKnight D. H., 2002, INT J ELECTRON COMM, V62, P35, DOI DOI 10.1080/10864415.2001.11044235; Mintz Anne P, 2002, WEB DECEPTION MISINF; Mitchell Melanie, 1998, INTRO GENETIC ALGORI; Mitchell T.M, 2003, MACH LEARN; Morris RD, 2011, TECHTRENDS, V55, P42, DOI 10.1007/s11528-011-0469-9; Noe E, 2005, J NEUROL, V252, P168, DOI 10.1007/s00415-005-0625-2; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Nowak MA, 1993, INT J BIFURCAT CHAOS, V3, P35, DOI 10.1142/S0218127493000040; Peacocke Christopher, 2009, MENTAL ACTIONS; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Phillips AG, 2005, PERS SOC PSYCHOL B, V31, P703, DOI 10.1177/0146167204271559; Ramchurn SD, 2004, KNOWL ENG REV, V19, P1, DOI 10.1017/S0269888904000116; Resnick P, 2002, ADV APP M-E, V11, P127; Russell S, 2009, ARTIFICIAL INTELLIGE; Sachs JL, 2004, Q REV BIOL, V79, P135, DOI 10.1086/383541; Santos FC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098104; Slater P., 2006, WEB SERVICE SECURITY; Sutton R. S., 1998, INTRO REINFORCEMENT; Tasner M., 2010, MARKETING MOMENT PRA; Wang L, 2009, INT J DISTRIB SENS N, V5, P39, DOI 10.1080/15501320802533467; Wang W, 2006, LECT NOTES ARTIF INT, V4088, P211; Wang Y, 2008, IEEE INTERNET COMPUT, V12, P55, DOI 10.1109/MIC.2008.84; Wang Z, 2014, J THEOR BIOL, V349, P50, DOI 10.1016/j.jtbi.2014.01.037; Wang Z, 2013, SCI REP-UK, V3, DOI 10.1038/srep02470; Wang Z, 2013, SCI REP-UK, V3, DOI 10.1038/srep01183; Wang Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040218; Wang Z, 2012, SCI REP-UK, V2, DOI 10.1038/srep00369; Wang Z, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.037101; Wang Z, 2012, EPL-EUROPHYS LETT, V97, DOI 10.1209/0295-5075/97/48001; Wellman M. P., 2007, AUTONOMOUS BIDDING A	54	0	0	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e99841	10.1371/journal.pone.0099841	http://dx.doi.org/10.1371/journal.pone.0099841			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945966	Green Submitted, Green Published, gold			2022-12-27	WOS:000340721500028
J	Lightfoot, YL; Yang, T; Sahay, B; Zadeh, M; Cheng, SX; Wang, GP; Owen, JL; Mohamadzadeh, M				Lightfoot, Yaima L.; Yang, Tao; Sahay, Bikash; Zadeh, Mojgan; Cheng, Sam X.; Wang, Gary P.; Owen, Jennifer L.; Mohamadzadeh, Mansour			Colonic Immune Suppression, Barrier Dysfunction, and Dysbiosis by Gastrointestinal Bacillus anthracis Infection	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; REGULATORY T-CELLS; LETHAL TOXIN; INHALATION ANTHRAX; B7-H1 EXPRESSION; EDEMA TOXIN; PATHOGENESIS; MURINE; SUSCEPTIBILITY; INACTIVATION	Gastrointestinal (GI) anthrax results from the ingestion of Bacillus anthracis. Herein, we investigated the pathogenesis of GI anthrax in animals orally infected with toxigenic non-encapsulated B. anthracis Sterne strain (pXO1(+) pXO2(-)) spores that resulted in rapid animal death. B. anthracis Sterne induced significant breakdown of intestinal barrier function and led to gut dysbiosis, resulting in systemic dissemination of not only B. anthracis, but also of commensals. Disease progression significantly correlated with the deterioration of innate and T cell functions. Our studies provide critical immunologic and physiologic insights into the pathogenesis of GI anthrax infection, whereupon cleavage of mitogen-activated protein kinases (MAPKs) in immune cells may play a central role in promoting dysfunctional immune responses against this deadly pathogen.	[Lightfoot, Yaima L.; Yang, Tao; Sahay, Bikash; Zadeh, Mojgan; Mohamadzadeh, Mansour] Univ Florida, Dept Infect Dis & Pathol, Gainesville, FL 32611 USA; [Lightfoot, Yaima L.; Yang, Tao; Sahay, Bikash; Zadeh, Mojgan; Mohamadzadeh, Mansour] Univ Florida, Dept Med, Div Gastroenterol Hepatol & Nutr, Gainesville, FL USA; [Cheng, Sam X.] Univ Florida, Dept Pediat, Div Gastroenterol, Gainesville, FL USA; [Wang, Gary P.] Univ Florida, Dept Med, Div Infect Dis & Global Med, Gainesville, FL USA; [Owen, Jennifer L.] Univ Florida, Coll Vet Med, Dept Physiol Sci, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Mohamadzadeh, M (corresponding author), Univ Florida, Dept Infect Dis & Pathol, Gainesville, FL 32611 USA.	m.zadeh@ufl.edu	yang, tao/J-2418-2015	yang, tao/0000-0002-4182-9793; Sahay, Bikash/0000-0003-0905-733X	National Institute of Allergy and Infectious Diseases [RO1 AI093370]	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Diseases RO1 AI093370 to MM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2003, NATURE, V424, P329, DOI 10.1038/nature01794; [Anonymous], 2013, DIVERSITY-BASEL, DOI DOI 10.3390/d5030627; Antharam VC, 2013, J CLIN MICROBIOL, V51, P2884, DOI 10.1128/JCM.00845-13; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Bachmann M, 2007, MOL CANCER THER, V6, P723, DOI 10.1158/1535-7163.MCT-06-0505; Baldari CT, 2006, TRENDS IMMUNOL, V27, P434, DOI 10.1016/j.it.2006.07.002; Balhara J, 2012, MUCOSAL IMMUNOL, V5, P605, DOI 10.1038/mi.2012.74; Barman M, 2008, INFECT IMMUN, V76, P907, DOI 10.1128/IAI.01432-07; Beatty ME, 2003, ARCH INTERN MED, V163, P2527, DOI 10.1001/archinte.163.20.2527; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; Chandra RK, 1996, P NATL ACAD SCI USA, V93, P14304, DOI 10.1073/pnas.93.25.14304; Cheng SX, 2012, AM J PHYSIOL-GASTR L, V303, pG60, DOI 10.1152/ajpgi.00425.2011; Chopra AP, 2003, J BIOL CHEM, V278, P9402, DOI 10.1074/jbc.M211262200; Chou PJ, 2008, DNA CELL BIOL, V27, P637, DOI 10.1089/dna.2008.0760; Coggeshall KM, 2013, J CELL MOL MED, V17, P914, DOI 10.1111/jcmm.12075; Datta SK, 2010, P NATL ACAD SCI USA, V107, P10638, DOI 10.1073/pnas.1002348107; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; During RL, 2005, J INFECT DIS, V192, P837, DOI 10.1086/432516; Ebrahimi CM, 2011, INFECT IMMUN, V79, P2510, DOI 10.1128/IAI.00006-11; Ewaschuk JB, 2008, AM J PHYSIOL-GASTR L, V295, pG1025, DOI 10.1152/ajpgi.90227.2008; Gianchecchi E, 2013, AUTOIMMUNITY REV; Glomski IJ, 2007, PLOS PATHOG, V3, P699, DOI 10.1371/journal.ppat.0030076; Goossens PL, 2009, MOL ASPECTS MED, V30, P467, DOI 10.1016/j.mam.2009.07.005; GREEN BD, 1985, INFECT IMMUN, V49, P291, DOI 10.1128/IAI.49.2.291-297.1985; Hill JE, 2010, APPL ENVIRON MICROB, V76, P4550, DOI 10.1128/AEM.01510-09; Hu HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007946; Kao C, 2011, NAT IMMUNOL, V12, P663, DOI 10.1038/ni.2046; Karakhanova S, 2010, EUR J IMMUNOL, V40, P254, DOI 10.1002/eji.200939289; Kern J, 2010, MOL MICROBIOL, V75, P324, DOI 10.1111/j.1365-2958.2009.06958.x; Lacotte S, 2009, ANN NY ACAD SCI, V1173, P310, DOI 10.1111/j.1749-6632.2009.04813.x; Lau SKP, 2006, J CLIN PATHOL, V59, P748, DOI 10.1136/jcp.2005.031773; Loving CL, 2007, INFECT IMMUN, V75, P2689, DOI 10.1128/IAI.01875-06; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Makino S, 2002, J INFECT DIS, V186, P227, DOI 10.1086/341299; Manichanh C, 2012, NAT REV GASTRO HEPAT, V9, P599, DOI 10.1038/nrgastro.2012.152; MIKESELL P, 1983, INFECT IMMUN, V39, P371, DOI 10.1128/IAI.39.1.371-376.1983; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; Mohamadzadeh M, 2009, P NATL ACAD SCI USA, V106, P4331, DOI 10.1073/pnas.0900029106; Mohamadzadeh M, 2007, NAT REV IMMUNOL, V7, P556, DOI 10.1038/nri2098; Paccani SR, 2011, J ALLERGY CLIN IMMUN, V127, P1635, DOI 10.1016/j.jaci.2010.12.1104; Park JM, 2002, SCIENCE, V297, P2048, DOI 10.1126/science.1073163; Pepper M, 2010, NAT IMMUNOL, V11, P83, DOI 10.1038/ni.1826; Qian YG, 2008, CANCER INVEST, V26, P816, DOI 10.1080/07357900801941852; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Scorpio A, 2007, ANTIMICROB AGENTS CH, V51, P215, DOI 10.1128/AAC.00706-06; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Sun C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033583; Swartz MN, 2001, NEW ENGL J MED, V345, P1621, DOI 10.1056/NEJMra012892; Thibault R, 2010, INFLAMM BOWEL DIS, V16, P684, DOI 10.1002/ibd.21108; Tonello F, 2012, TOXINS, V4, P536, DOI 10.3390/toxins4070536; Tonry JH, 2013, MICROBES INFECT, V15, P37, DOI 10.1016/j.micinf.2012.10.004; Tournier JN, 2009, EXPERT REV ANTI-INFE, V7, P219, DOI 10.1586/14787210.7.2.219; Tsuji NM, 2008, TRENDS IMMUNOL, V29, P532, DOI 10.1016/j.it.2008.09.002; TURNBULL PCB, 1991, VACCINE, V9, P533, DOI 10.1016/0264-410X(91)90237-Z; Vitale G, 2000, BIOCHEM J, V352, P739, DOI 10.1042/0264-6021:3520739; WELKOS SL, 1986, INFECT IMMUN, V51, P795, DOI 10.1128/IAI.51.3.795-800.1986; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Xie T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066943; Xie T, 2011, TOXINS, V3, P591, DOI 10.3390/toxins3060591; Xu LX, 2007, INT J BIOCHEM CELL B, V39, P20, DOI 10.1016/j.biocel.2006.08.010	60	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100532	10.1371/journal.pone.0100532	http://dx.doi.org/10.1371/journal.pone.0100532			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945934	Green Published, gold, Green Submitted			2022-12-27	WOS:000340721500087
J	Daskin, JH; Bell, SC; Schwarzkopf, L; Alford, RA				Daskin, Joshua H.; Bell, Sara C.; Schwarzkopf, Lin; Alford, Ross A.			Cool Temperatures Reduce Antifungal Activity of Symbiotic Bacteria of Threatened Amphibians - Implications for Disease Management and Patterns of Decline	PLOS ONE			English	Article							SALAMANDER PLETHODON-CINEREUS; BATRACHOCHYTRIUM-DENDROBATIDIS; CUTANEOUS BACTERIA; PSEUDOMONAS-FLUORESCENS; ANTIBIOTIC PRODUCTION; IMMUNE DEFENSES; SKIN BACTERIA; RANA-MUSCOSA; CHYTRIDIOMYCOSIS; FROG	Chytridiomycosis, caused by the fungus Batrachochytrium dendrobatidis (Bd), is a widespread disease of amphibians responsible for population declines and extinctions. Some bacteria from amphibians' skins produce antimicrobial substances active against Bd. Supplementing populations of these cutaneous antifungal bacteria might help manage chytridiomycosis in wild amphibians. However, the activity of protective bacteria may depend upon environmental conditions. Biocontrol of Bd in nature thus requires knowledge of how environmental conditions affect their anti-Bd activity. For example, Bd-driven amphibian declines have often occurred at temperatures below Bd's optimum range. It is possible these declines occurred due to reduced anti-Bd activity of bacterial symbionts at cool temperatures. Better understanding of the effects of temperature on chytridiomycosis development could also improve risk evaluation for amphibian populations yet to encounter Bd. We characterized, at a range of temperatures approximating natural seasonal variation, the anti-Bd activity of bacterial symbionts from the skins of three species of rainforest tree frogs (Litoria nannotis, Litoria rheocola, and Litoria serrata). All three species declined during chytridiomycosis outbreaks in the late 1980s and early 1990s and have subsequently recovered to differing extents. We collected anti-Bd bacterial symbionts from frogs and cultured the bacteria at constant temperatures from 8 degrees C to 33 degrees C. Using a spectrophotometric assay, we monitored Bd growth in cell-free supernatants (CFSs) from each temperature treatment. CFSs from 11 of 24 bacteria showed reduced anti-Bd activity in vitro when they were produced at cool temperatures similar to those encountered by the host species during population declines. Reduced anti-Bd activity of metabolites produced at low temperatures may, therefore, partially explain the association between Bd-driven declines and cool temperatures. We show that to avoid inconsistent antifungal activity, bacteria evaluated for use in chytridiomycosis biocontrol should be tested over a range of environmental temperatures spanning those likely to be encountered in the field.	[Daskin, Joshua H.; Bell, Sara C.; Schwarzkopf, Lin; Alford, Ross A.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia	James Cook University	Daskin, JH (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	daskin@princeton.edu	Schwarzkopf, Lin/C-1242-2012; Alford, Ross A/H-1577-2011	Schwarzkopf, Lin/0000-0002-1009-670X; Alford, Ross A/0000-0002-3010-6768; Bell, Sara/0000-0003-1327-0360	Australian Research Council [DP0986537, DP130101635]; Australian-American Fulbright Commission	Australian Research Council(Australian Research Council); Australian-American Fulbright Commission	Research funding was provided by the Australian Research Council (http://www.arc.gov.au/) Discovery Grants "Understanding and managing resistance to the amphibian chytrid fungus Batrachochytrium dendrobatidis in Australian tropical rainforest frogs" (DP0986537) and "Understanding the tipping point between epidemic and endemic disease: amphibian chytridiomycosis as a model system" (DP130101635). JHD was supported by a U.S. Postgraduate Fulbright Scholarship from the Australian-American Fulbright Commission (http://www.fulbright.com.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker MH, 2009, APPL ENVIRON MICROB, V75, P6635, DOI 10.1128/AEM.01294-09; Bell S.C., 2012, ROLE CUTANEOUS BACTE; Bell SC, 2013, DIS AQUAT ORGAN, V103, P77, DOI 10.3354/dao02560; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Berger L, 2004, AUST VET J, V82, P434, DOI 10.1111/j.1751-0813.2004.tb11137.x; Bletz MC, 2013, ECOL LETT, V16, P807, DOI 10.1111/ele.12099; Boyles JG, 2010, FRONT ECOL ENVIRON, V8, P92, DOI 10.1890/080187; BRONSTEIN JL, 1994, TRENDS ECOL EVOL, V9, P214, DOI 10.1016/0169-5347(94)90246-1; Brucker RM, 2008, J CHEM ECOL, V34, P1422, DOI 10.1007/s10886-008-9555-7; Brucker RM, 2008, J CHEM ECOL, V34, P39, DOI 10.1007/s10886-007-9352-8; Cundliffe E, 2006, J IND MICROBIOL BIOT, V33, P500, DOI 10.1007/s10295-006-0083-6; Daskin JH, 2012, P ROY SOC B-BIOL SCI, V279, P1457, DOI 10.1098/rspb.2011.2276; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Drummond AJ., 2010, GENEIOUS V5 3 3; Duffy B, 2003, ANNU REV PHYTOPATHOL, V41, P501, DOI 10.1146/annurev.phyto.41.052002.095606; Eskew EA, 2013, EMERG INFECT DIS, V19, P1; Fisher MC, 2009, ANNU REV MICROBIOL, V63, P291, DOI 10.1146/annurev.micro.091208.073435; Haas D, 2005, NAT REV MICROBIOL, V3, P307, DOI 10.1038/nrmicro1129; Harris RN, 2006, ECOHEALTH, V3, P53, DOI 10.1007/s10393-005-0009-1; Harris RN, 2009, ISME J, V3, P818, DOI 10.1038/ismej.2009.27; Harris RN, 2009, DIS AQUAT ORGAN, V83, P11, DOI 10.3354/dao02004; Harvell D, 2007, OCEANOGRAPHY, V20, P172, DOI 10.5670/oceanog.2007.91; Humair B, 2009, ISME J, V3, P955, DOI 10.1038/ismej.2009.42; Kavitha A, 2009, RES J BIOTECHNOL, V4, P56; Kilpatrick AM, 2010, TRENDS ECOL EVOL, V25, P109, DOI 10.1016/j.tree.2009.07.011; Kriger KM, 2008, AUSTRAL ECOL, V33, P1022, DOI 10.1111/j.1442-9993.2008.01872.x; Lam BA, 2010, BIOL CONSERV, V143, P529, DOI 10.1016/j.biocon.2009.11.015; Lane D.J., 1991, NUCL ACID TECHNIQUES, DOI [10.1099/ijs.0.060731-0, DOI 10.1099/ijs.0.060731-0]; Lauer A, 2008, ISME J, V2, P145, DOI 10.1038/ismej.2007.110; Lauer A, 2007, COPEIA, P630, DOI 10.1643/0045-8511(2007)2007[630:CCBFTE]2.0.CO;2; Lips KR, 1998, CONSERV BIOL, V12, P106, DOI 10.1046/j.1523-1739.1998.96359.x; Little AEF, 2008, ECOLOGY, V89, P1216, DOI 10.1890/07-0815.1; Longo AV, 2010, DIS AQUAT ORGAN, V92, P253, DOI 10.3354/dao02054; McDonald KR, 1999, REV DECLINING FROGS, P14; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; Plowright RK, 2008, FRONT ECOL ENVIRON, V6, P420, DOI 10.1890/070086; Prado SS, 2010, APPL ENVIRON MICROB, V76, P1261, DOI 10.1128/AEM.02034-09; Puschendorf R, 2009, ENV EFFECTS HOST PAT; Puschendorf R, 2006, BIOL CONSERV, V132, P136, DOI 10.1016/j.biocon.2006.03.010; Raaijmakers JM, 2002, ANTON LEEUW INT J G, V81, P537, DOI 10.1023/A:1020501420831; Richards SJ, 2005, AUST J ZOOL, V53, P229, DOI 10.1071/ZO03036; Richards Stephen J., 1993, Pacific Conservation Biology, V1, P66; Rollins-Smith LA, 2002, BIOCHEM BIOPH RES CO, V297, P361, DOI 10.1016/S0006-291X(02)02217-9; Rollins-Smith LA, 2011, INTEGR COMP BIOL, V51, P552, DOI 10.1093/icb/icr095; Rowley JJL, 2006, WHY DOES CHYTRIDIOMY; Rowley JJL, 2013, SCI REPORTS; Salle A. J., 1961, LAB MANUAL FUNDAMENT; Savage AE, 2011, BIOL CONSERV, V144, P1910, DOI 10.1016/j.biocon.2011.03.018; Schouten A, 2004, MOL PLANT MICROBE IN, V17, P1201, DOI 10.1094/MPMI.2004.17.11.1201; Walke JB, 2011, BIOTROPICA, V43, P396, DOI 10.1111/j.1744-7429.2011.00787.x; Woodhams DC, 2005, CONSERV BIOL, V19, P1449, DOI 10.1111/j.1523-1739.2005.004403.x; Woodhams DC, 2008, ECOLOGY, V89, P1627, DOI 10.1890/06-1842.1; Woodhams DC, 2007, BIOL CONSERV, V138, P390, DOI 10.1016/j.biocon.2007.05.004; Woodhams DC, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-8	55	51	52	1	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100378	10.1371/journal.pone.0100378	http://dx.doi.org/10.1371/journal.pone.0100378			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941262	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000338508200099
J	Dressick, WJ; Soto, CM; Fontana, J; Baker, CC; Myers, JD; Frantz, JA; Kim, W				Dressick, Walter J.; Soto, Carissa M.; Fontana, Jake; Baker, Colin C.; Myers, Jason D.; Frantz, Jesse A.; Kim, Woohong			Preparation and Layer-by-Layer Solution Deposition of Cu(In,Ga)O-2 Nanoparticles with Conversion to Cu(In,Ga)S-2 Films	PLOS ONE			English	Article							FLAME SPRAY-PYROLYSIS; SOLAR-CELLS; POLYELECTROLYTE MULTILAYER; PHOTOVOLTAIC DEVICES; NANOCRYSTAL FILMS; EFFICIENCY; POLYDOPAMINE; SELENIZATION; PARTICLES; POWDERS	We present a method of Cu(In,Ga)S-2 (CIGS) thin film formation via conversion of layer-by-layer (LbL) assembled Cu-In-Ga oxide (CIGO) nanoparticles and polyelectrolytes. CIGO nanoparticles were created via a novel flame-spray pyrolysis method using metal nitrate precursors, subsequently coated with polyallylamine (PAH), and dispersed in aqueous solution. Multilayer films were assembled by alternately dipping quartz, Si, and/or Mo substrates into a solution of either polydopamine (PDA) or polystyrenesulfonate (PSS) and then in the CIGO-PAH dispersion to fabricate films as thick as 1-2 microns. PSS/CIGO-PAH films were found to be inadequate due to weak adhesion to the Si and Mo substrates, excessive particle diffusion during sulfurization, and mechanical softness ill-suited to further processing. PDA/CIGO-PAH films, in contrast, were more mechanically robust and more tolerant of high temperature processing. After LbL deposition, films were oxidized to remove polymer and sulfurized at high temperature under flowing hydrogen sulfide to convert CIGO to CIGS. Complete film conversion from the oxide to the sulfide is confirmed by X-ray diffraction characterization.	[Dressick, Walter J.; Soto, Carissa M.; Fontana, Jake] US Naval Res Lab, Ctr Bio Mol Sci & Engn, Washington, DC 20375 USA; [Baker, Colin C.; Myers, Jason D.; Frantz, Jesse A.; Kim, Woohong] US Naval Res Lab, Opt Sci Div, Washington, DC USA	United States Department of Defense; United States Navy; Naval Research Laboratory; United States Department of Defense; United States Navy; Naval Research Laboratory	Dressick, WJ (corresponding author), US Naval Res Lab, Ctr Bio Mol Sci & Engn, Washington, DC 20375 USA.	walter.dressick@nrl.navy.mil; rick.kim@nrl.navy.mil	Baker, Colin C/I-6657-2015	Baker, Colin/0000-0001-5662-1795; Dressick, Walter/0000-0001-9549-9219	Office of Naval Research under the Naval Research Laboratory Accelerated Research Initiative (ARI) 6.1 Program, ONR/ARI [ONR 61153N]	Office of Naval Research under the Naval Research Laboratory Accelerated Research Initiative (ARI) 6.1 Program, ONR/ARI	The authors thank the Office of Naval Research under the Naval Research Laboratory Accelerated Research Initiative (ARI) 6.1 Program, ONR/ARI (ONR 61153N), for financial support for this work. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed I, 2013, CHEM COMMUN, V49, P496, DOI 10.1039/c2cc37519b; Ariga K, 1999, APPL CLAY SCI, V15, P137, DOI 10.1016/S0169-1317(99)00012-5; Bandara N, 2013, J ADHES SCI TECHNOL, V27, P2139, DOI 10.1080/01694243.2012.697703; Bassim ND, 2012, J PHYS CHEM C, V116, P1694, DOI 10.1021/jp207912b; Carenco S, 2010, CHEM MATER, V22, P1340, DOI 10.1021/cm902007g; Contreras MA, 1999, PROG PHOTOVOLTAICS, V7, P311, DOI 10.1002/(SICI)1099-159X(199907/08)7:4<311::AID-PIP274>3.0.CO;2-G; Cotton F. A., 1988, ADV INORGANIC CHEM; Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232; Dilena E, 2013, CHEM MATER, V25, P3180, DOI 10.1021/cm401563u; Dressick WJ, 2012, LANGMUIR, V28, P15831, DOI 10.1021/la3033176; Dressick WJ, 1996, COLLOID SURFACE A, V108, P101, DOI 10.1016/0927-7757(95)03392-0; Dressick WJ, 1999, J VAC SCI TECHNOL A, V17, P1432, DOI 10.1116/1.581833; Fontana J, 2013, ADV OPT MATER, V1, P100, DOI 10.1002/adom.201200039; GABOR AM, 1994, APPL PHYS LETT, V65, P198, DOI 10.1063/1.112670; Ghostine RA, 2013, LANGMUIR, V29, P11742, DOI 10.1021/la401632x; Gougaud C, 2013, J ELECTROCHEM SOC, V160, pD485, DOI 10.1149/2.105310jes; Gur I, 2005, SCIENCE, V310, P462, DOI 10.1126/science.1117908; Harvey TB, 2013, ACS APPL MATER INTER, V5, P9134, DOI 10.1021/am4025142; Hemati A, 2012, J NANOMATER, V2012, DOI 10.1155/2012/512409; Hibberd CJ, 2010, PROG PHOTOVOLTAICS, V18, P434, DOI 10.1002/pip.914; Hong S, 2012, ADV FUNCT MATER, V22, P4711, DOI 10.1002/adfm.201201156; ILER RK, 1966, J COLLOID INTERF SCI, V21, P569, DOI 10.1016/0095-8522(66)90018-3; Jiang C, 2013, IND ENG CHEM RES, V52, P13393, DOI 10.1021/ie401769h; Kaelin M, 2005, THIN SOLID FILMS, V480, P486, DOI 10.1016/j.tsf.2004.11.007; Kemell M, 2005, CRIT REV SOLID STATE, V30, P1, DOI 10.1080/10408430590918341; Kim HW, 2013, ACS APPL MATER INTER, V5, P233, DOI 10.1021/am302439g; Kim YJ, 2012, LANGMUIR, V28, P10620, DOI 10.1021/la3015699; Kostelansky CN, 2006, J PHYS CHEM B, V110, P21487, DOI 10.1021/jp062663u; Laine RM, 1999, KEY ENG MAT, V159-1, P17, DOI 10.4028/www.scientific.net/KEM.159-160.17; Liebscher J, 2013, LANGMUIR, V29, P10539, DOI 10.1021/la4020288; Lundin M, 2011, LANGMUIR, V27, P7537, DOI 10.1021/la200441u; Luther JM, 2008, NANO LETT, V8, P3488, DOI 10.1021/nl802476m; Lvov YM, 2011, LANGMUIR, V27, P1212, DOI 10.1021/la1041635; Madler L, 2002, J AEROSOL SCI, V33, P369, DOI 10.1016/S0021-8502(01)00159-8; Mitzi DB, 2008, ADV MATER, V20, P3657, DOI 10.1002/adma.200800555; Mitzi DB, 2009, THIN SOLID FILMS, V517, P2158, DOI 10.1016/j.tsf.2008.10.079; Panthani MG, 2008, J AM CHEM SOC, V130, P16770, DOI 10.1021/ja805845q; Peng S, 2006, J AM CHEM SOC, V128, P10676, DOI 10.1021/ja063969h; Porcel C, 2007, LANGMUIR, V23, P1898, DOI 10.1021/la062728k; Pratsinis SE, 1998, PROG ENERG COMBUST, V24, P197, DOI 10.1016/S0360-1285(97)00028-2; Ramanathan K, 2003, PROG PHOTOVOLTAICS, V11, P225, DOI 10.1002/pip.494; Ramasamy K, 2012, CHEM COMMUN, V48, P5703, DOI 10.1039/c2cc30792h; Sasaki T, 2001, CHEM MATER, V13, P4661, DOI 10.1021/cm010478h; Schaubroeck D, 2012, J ADHES SCI TECHNOL, V26, P2301, DOI 10.1163/156856111X623104; Schmidtke J, 2010, OPT EXPRESS, V18, pA477, DOI 10.1364/OE.18.00A477; Schmitt J, 1997, ADV MATER, V9, P61, DOI 10.1002/adma.19970090114; Shi JH, 2011, PROG PHOTOVOLTAICS, V19, P160, DOI 10.1002/pip.1001; Stewart RJ, 2011, J POLYM SCI POL PHYS, V49, P757, DOI 10.1002/polb.22256; Sun YG, 2013, CHEM SOC REV, V42, P2497, DOI 10.1039/c2cs35289c; Tan HL, 2003, LANGMUIR, V19, P9311, DOI 10.1021/la035094f; Tanaka Y, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2891083; Thomson JW, 2011, J AM CHEM SOC, V133, P5036, DOI 10.1021/ja1109997; Vasekar PS, 2009, SOL ENERG MAT SOL C, V93, P69, DOI 10.1016/j.solmat.2008.04.013; Vercelli B, 2010, CHEM MATER, V22, P2001, DOI 10.1021/cm903824e; Wang XF, 2011, REACT FUNCT POLYM, V71, P254, DOI 10.1016/j.reactfunctpolym.2010.09.007; Wei SH, 1998, APPL PHYS LETT, V72, P3199, DOI 10.1063/1.121548; Wu Y, 2008, NANO LETT, V8, P2551, DOI 10.1021/nl801817d; Zhang W, 2013, BIOMACROMOLECULES, V14, P394, DOI 10.1021/bm3015768; Zhou Y, 2013, J OPTIMIZ THEORY APP, V156, P1, DOI 10.1007/s10957-013-0271-2	59	5	6	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100203	10.1371/journal.pone.0100203	http://dx.doi.org/10.1371/journal.pone.0100203			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941104	Green Submitted, Green Published, gold			2022-12-27	WOS:000338508200083
J	Endres, S; Galgani, L; Riebesell, U; Schulz, KG; Engel, A				Endres, Sonja; Galgani, Luisa; Riebesell, Ulf; Schulz, Kai-Georg; Engel, Anja			Stimulated Bacterial Growth under Elevated pCO(2): Results from an Off-Shore Mesocosm Study	PLOS ONE			English	Article							DISSOLVED ORGANIC-MATTER; TRANSPARENT EXOPOLYMER PARTICLES; EMILIANIA-HUXLEYI; HETEROTROPHIC BACTERIA; AQUATIC ENVIRONMENTS; PHYTOPLANKTON BLOOMS; OCEAN ACIDIFICATION; CO2 CONCENTRATION; ENZYME-ACTIVITIES; CLIMATE-CHANGE	Marine bacteria are the main consumers of freshly produced organic matter. Many enzymatic processes involved in the bacterial digestion of organic compounds were shown to be pH sensitive in previous studies. Due to the continuous rise in atmospheric CO2 concentration, seawater pH is presently decreasing at a rate unprecedented during the last 300 million years but the consequences for microbial physiology, organic matter cycling and marine biogeochemistry are still unresolved. We studied the effects of elevated seawater pCO(2) on a natural plankton community during a large-scale mesocosm study in a Norwegian fjord. Nine Kiel Off-Shore Mesocosms for Future Ocean Simulations (KOSMOS) were adjusted to different pCO(2) levels ranging initially from ca. 280 to 3000 mu atm and sampled every second day for 34 days. The first phytoplankton bloom developed around day 5. On day 14, inorganic nutrients were added to the enclosed, nutrient-poor waters to stimulate a second phytoplankton bloom, which occurred around day 20. Our results indicate that marine bacteria benefit directly and indirectly from decreasing seawater pH. During the first phytoplankton bloom, 5-10% more transparent exopolymer particles were formed in the high pCO(2) mesocosms. Simultaneously, the efficiency of the protein-degrading enzyme leucine aminopeptidase increased with decreasing pH resulting in up to three times higher values in the highest pCO(2)/lowest pH mesocosm compared to the controls. In general, total and cell-specific aminopeptidase activities were elevated under low pH conditions. The combination of enhanced enzymatic hydrolysis of organic matter and increased availability of gel particles as substrate supported up to 28% higher bacterial abundance in the high pCO(2) treatments. We conclude that ocean acidification has the potential to stimulate the bacterial community and facilitate the microbial recycling of freshly produced organic matter, thus strengthening the role of the microbial loop in the surface ocean.	[Endres, Sonja; Galgani, Luisa; Riebesell, Ulf; Schulz, Kai-Georg; Engel, Anja] GEOMAR Helmholtz Ctr Ocean Res Kiel, Kiel, Germany; [Endres, Sonja; Galgani, Luisa] Helmholtz Ctr Polar & Marine Res AWI, Alfred Wegener Inst, Bremerhaven, Germany; [Schulz, Kai-Georg] So Cross Univ, Ctr Coastal Biogeochem, Sch Environm Sci & Management, Lismore, NSW 2480, Australia	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Southern Cross University	Endres, S (corresponding author), GEOMAR Helmholtz Ctr Ocean Res Kiel, Kiel, Germany.	sendres@geomar.de	Galgani, Luisa/J-4026-2017; Riebesell, Ulf/AAC-9717-2020; Schulz, Kai G./Q-5608-2017; Schulz, Kai/AEZ-9073-2022	Galgani, Luisa/0000-0001-5239-6893; Schulz, Kai G./0000-0002-8481-4639; Schulz, Kai/0000-0002-8481-4639; Riebesell, Ulf/0000-0002-9442-452X; Engel, Anja/0000-0002-1042-1955	BMBF project BIOACID (Biological impacts of ocean acidification) [03F0608B]; BMBF project SOPRAN II (Surface Ocean Processes in the Anthropocene) [03F0611C-TP01]	BMBF project BIOACID (Biological impacts of ocean acidification); BMBF project SOPRAN II (Surface Ocean Processes in the Anthropocene)	This work was funded by the BMBF projects BIOACID (Biological impacts of ocean acidification, 03F0608B) and SOPRAN II (Surface Ocean Processes in the Anthropocene, 03F0611C-TP01). This is contribution to the international SOLAS programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allgaier M, 2008, BIOGEOSCIENCES, V5, P1007, DOI 10.5194/bg-5-1007-2008; Amon RMW, 1996, LIMNOL OCEANOGR, V41, P41, DOI 10.4319/lo.1996.41.1.0041; AMON RMW, 1994, NATURE, V369, P549, DOI 10.1038/369549a0; Azam F, 1998, SCIENCE, V280, P694, DOI 10.1126/science.280.5364.694; AZAM F, 1994, MICROBIAL ECOL, V28, P167, DOI 10.1007/BF00166806; Azam F, 2007, NAT REV MICROBIOL, V5, P782, DOI 10.1038/nrmicro1747; Beardall J, 2004, PHYCOLOGIA, V43, P26, DOI 10.2216/i0031-8884-43-1-26.1; Borchard C, 2012, BIOGEOSCIENCES, V9, P3405, DOI 10.5194/bg-9-3405-2012; Boyd PW, 2011, NAT GEOSCI, V4, P273, DOI 10.1038/ngeo1150; Brussaard CPD, 2013, BIOGEOSCIENCES, V10, P719, DOI 10.5194/bg-10-719-2013; Caruso G, 2000, J APPL MICROBIOL, V89, P951, DOI 10.1046/j.1365-2672.2000.01198.x; CHO BC, 1988, NATURE, V332, P441, DOI 10.1038/332441a0; CHROST RJ, 1992, HYDROBIOLOGIA, V243, P61, DOI 10.1007/BF00007020; Chrost RJ, 2002, BOOK SOIL P, P35; CHROST RJ, 1989, J PLANKTON RES, V11, P223, DOI 10.1093/plankt/11.2.223; Cunha A., 2010, CURRENT RES TECHNOLO, V1, P124; del Giorgio PA, 2002, NATURE, V420, P379, DOI 10.1038/nature01165; del Giorgio PA, 1998, ANNU REV ECOL SYST, V29, P503, DOI 10.1146/annurev.ecolsys.29.1.503; Dickson A., 2010, GUIDE BEST PRACTICES, P17, DOI DOI 10.2777/58454; Endres S, 2013, BIOGEOSCIENCES, V10, P567, DOI 10.5194/bg-10-567-2013; Engel A, 2004, AQUAT MICROB ECOL, V34, P93, DOI 10.3354/ame034093; Engel A, 2004, NATURE, V428, P929, DOI 10.1038/nature02453; Engel A, 2013, BIOGEOSCIENCES, V10, P1291, DOI 10.5194/bg-10-1291-2013; Engel A, 2002, J PLANKTON RES, V24, P49, DOI 10.1093/plankt/24.1.49; Engel A, 2014, J PLANKTON RES, V36, P641, DOI 10.1093/plankt/fbt125; Engel A, 2011, J PLANKTON RES, V33, P357, DOI 10.1093/plankt/fbq122; Fagerbakke KM, 1996, AQUAT MICROB ECOL, V10, P15, DOI 10.3354/ame010015; Gasol JM, 2000, SCI MAR, V64, P197, DOI 10.3989/scimar.2000.64n2197; Grossart HP, 2006, LIMNOL OCEANOGR, V51, P1, DOI 10.4319/lo.2006.51.1.0001; HOPPE HG, 1983, MAR ECOL PROG SER, V11, P299, DOI 10.3354/meps011299; Jiao N, 2010, NAT REV MICROBIOL, V8, P593, DOI 10.1038/nrmicro2386; Joint I, 2011, ISME J, V5, P1, DOI 10.1038/ismej.2010.79; Kattner G, 2011, MICROBIAL CARBON PUM, P60, DOI DOI 10.1126/SCIENCE.OPMS.SB0001; Kirchman DL, 2009, NAT REV MICROBIOL, V7, P451, DOI 10.1038/nrmicro2115; KIRCHMAN DL, 1994, MICROBIAL ECOL, V28, P255, DOI 10.1007/BF00166816; Long RA, 1996, AQUAT MICROB ECOL, V10, P213, DOI 10.3354/ame010213; Lovdal T, 2008, BIOGEOSCIENCES, V5, P371, DOI 10.5194/bg-5-371-2008; Lunau M, 2005, ENVIRON MICROBIOL, V7, P961, DOI 10.1111/j.1462-2920.2005.00767.x; Maas EW, 2013, AQUAT MICROB ECOL, V70, P1, DOI 10.3354/ame01633; MARTIN JH, 1987, DEEP-SEA RES, V34, P267, DOI 10.1016/0198-0149(87)90086-0; Nagata T., 2008, MICROBIAL ECOLOGY OC, P207, DOI DOI 10.1002/9780470281840.CH7; OBERNOSTERER I, 1995, MAR ECOL PROG SER, V116, P247, DOI 10.3354/meps116247; Ogawa H, 2001, SCIENCE, V292, P917, DOI 10.1126/science.1057627; Parvathi A, 2011, ENVIRON MONIT ASSESS, V177, P227, DOI 10.1007/s10661-010-1629-7; Passow U, 2002, PROG OCEANOGR, V55, P287, DOI 10.1016/S0079-6611(02)00138-6; Passow U, 1995, LIMNOL OCEANOGR, V40, P1326, DOI 10.4319/lo.1995.40.7.1326; Passow U, 2001, CONT SHELF RES, V21, P327, DOI 10.1016/S0278-4343(00)00101-1; Passow U, 2012, MAR ECOL PROG SER, V470, P249, DOI 10.3354/meps09985; Piontek J, 2013, BIOGEOSCIENCES, V10, P297, DOI 10.5194/bg-10-297-2013; Piontek J, 2010, BIOGEOSCIENCES, V7, P1615, DOI 10.5194/bg-7-1615-2010; Piontek J, 2009, AQUAT MICROB ECOL, V54, P305, DOI 10.3354/ame01273; Riebesell U, 2013, BIOGEOSCIENCES, V10, P1835, DOI 10.5194/bg-10-1835-2013; Riebesell U., 2011, OCEAN ACIDIFICATION; Riebesell U, 2009, P NATL ACAD SCI USA, V106, P20602, DOI 10.1073/pnas.0813291106; Rochelle-Newall E, 2004, MAR ECOL PROG SER, V272, P25, DOI 10.3354/meps272025; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Schippers P, 2004, ECOL LETT, V7, P446, DOI 10.1111/j.1461-0248.2004.00597.x; Schulz KG, 2013, BIOGEOSCIENCES, V10, P161, DOI 10.5194/bg-10-161-2013; SMITH DC, 1992, NATURE, V359, P139, DOI 10.1038/359139a0; SUESS E, 1980, NATURE, V288, P260, DOI 10.1038/288260a0; Tanaka T, 2008, BIOGEOSCIENCES, V5, P669, DOI 10.5194/bg-5-669-2008; Thingstad TF, 2008, NATURE, V455, P387, DOI 10.1038/nature07235; Tipton KF, 2009, CONT ENZYME KINETICS; TROUSSELLIER M, 1995, ESTUAR COAST SHELF S, V40, P621, DOI 10.1006/ecss.1995.0042; TURLEY CM, 1994, J MAR BIOL ASSOC UK, V74, P259, DOI 10.1017/S0025315400035827; Verdugo P, 2004, MAR CHEM, V92, P67, DOI 10.1016/j.marchem.2004.06.017; WELSCHMEYER NA, 1994, LIMNOL OCEANOGR, V39, P1985, DOI 10.4319/lo.1994.39.8.1985; Wohlers J, 2009, P NATL ACAD SCI USA, V106, P7067, DOI 10.1073/pnas.0812743106; Wohlers-Zollner J, 2011, LIMNOL OCEANOGR, V56, P599, DOI 10.4319/lo.2011.56.2.0599; Wolf-Gladrow DA, 1999, TELLUS B, V51, P461, DOI 10.1034/j.1600-0889.1999.00023.x; Yamada N, 2010, J OCEANOGR, V66, P233, DOI 10.1007/s10872-010-0021-0; Ziervogel K, 2007, MAR CHEM, V104, P241, DOI 10.1016/j.marchem.2006.12.001; [No title captured]	73	48	48	0	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99228	10.1371/journal.pone.0099228	http://dx.doi.org/10.1371/journal.pone.0099228			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941307	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000338508200015
J	Neselius, S; Brisby, H; Marcusson, J; Zetterberg, H; Blennow, K; Karlsson, T				Neselius, Sanna; Brisby, Helena; Marcusson, Jan; Zetterberg, Henrik; Blennow, Kaj; Karlsson, Thomas			Neurological Assessment and Its Relationship to CSF Biomarkers in Amateur Boxers	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; NEUROPSYCHOLOGICAL TEST-PERFORMANCE; DIFFUSE AXONAL INJURY; WORD-ASSOCIATION TEST; CLOSED-HEAD-INJURY; COGNITIVE IMPAIRMENT; WORKING-MEMORY; FOOTBALL PLAYERS; HIGH-SCHOOL; INDIVIDUAL-DIFFERENCES	Background: Mild traumatic brain injury (TBI) or concussion is common in many sports. Today, neuropsychological evaluation is recommended in the monitoring of a concussion and in return-to-play considerations. To investigate the sensitivity of neuropsychological assessment, we tested amateur boxers post bout and compared with controls. Further the relationship between neuropsychological test results and brain injury biomarkers in the cerebrospinal fluid (CSF) were investigated. Method: Thirty amateur boxers on high elite level with a minimum of 45 bouts and 25 non-boxing matched controls were included. Memory tests (Rey Osterrieth Complex Figure, Listening Span, Digit Span, Controlled Word Association Test, and computerized testing of episodic memory), tests of processing speed and executive functions (Trail Making, Reaction Time, and Finger Tapping) were performed and related to previously published CSF biomarker results for the axonal injury marker neurofilament light (NFL). Results: The neurological assessment showed no significant differences between boxers and controls, although elevated CSF NFL, as a sign of axonal injury, was detected in about 80% of the boxers 1-6 days post bout. The investigation of the relationship between neuropsychological evaluation and CSF NFL concentrations revealed that boxers with persisting NFL concentration elevation after at least 14 days resting time post bout, had a significantly poorer performance on Trail Making A (p = 0.041) and Simple Reaction Time (p = 0.042) compared to other boxers. Conclusion: This is the first study showing traumatic axonal brain injury can be present without measureable cognitive impairment. The repetitive, subconcussive head trauma in amateur boxing causes axonal injury that can be detected with analysis of CSF NFL, but is not sufficient to produce impairment in memory tests, tests of processing speed, or executive functions. The association of prolonged CSF NFL increase in boxers with impairment of processing speed is an interesting observation, which needs to be verified in larger studies.	[Neselius, Sanna; Brisby, Helena] Sahlgrens Univ Hosp, Dept Orthopaed, Gothenburg, Sweden; [Neselius, Sanna; Brisby, Helena] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Gothenburg, Sweden; [Marcusson, Jan] Linkoping Univ Hosp, Geriatr Sect, S-58185 Linkoping, Sweden; [Marcusson, Jan] Linkoping Univ, Inst Clin & Expt Med, Linkoping, Sweden; [Zetterberg, Henrik; Blennow, Kaj] Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden; [Zetterberg, Henrik; Blennow, Kaj] Univ Gothenburg, Sahlgrenska Acad, Dept Psychiat & Neurochem, Inst Neurosci & Physiol, Gothenburg, Sweden; [Zetterberg, Henrik] UCL Inst Neurol, London, England; [Karlsson, Thomas] Linkoping Univ, Dept Behav Sci & Learning, Linkoping, Sweden; [Karlsson, Thomas] Linkoping Univ, Linnaeus Ctr HEAD, Linkoping, Sweden	Sahlgrenska University Hospital; University of Gothenburg; Linkoping University; Linkoping University; Sahlgrenska University Hospital; University of Gothenburg; University of London; University College London; Linkoping University; Linkoping University	Neselius, S (corresponding author), Sahlgrens Univ Hosp, Dept Orthopaed, Gothenburg, Sweden.	sanna.neselius@vgregion.se			ALF Grants, County Council of Vastra Gotaland, Sweden; Gothenburg Medical Society, Sweden; ALF Grants, County Council of Ostergotland	ALF Grants, County Council of Vastra Gotaland, Sweden; Gothenburg Medical Society, Sweden; ALF Grants, County Council of Ostergotland	This work was supported by ALF Grants, County Council of Vastra Gotaland, Sweden; Gothenburg Medical Society, Sweden; and ALF Grants, County Council of Ostergotland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atchison TB, 2004, CLIN NEUROPSYCHOL, V18, P249, DOI 10.1080/13854040490501475; Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; Benton AL, 1994, MULTILINGUAL APHASIA; Bianco M, 2013, BRIT J SPORT MED, V47, P452, DOI 10.1136/bjsports-2012-091771; BIGLER ED, 1989, J CLIN PSYCHOL, V45, P277, DOI 10.1002/1097-4679(198903)45:2<277::AID-JCLP2270450216>3.0.CO;2-M; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Bleiberg J, 2000, CLIN NEUROPSYCHOL, V14, P287, DOI 10.1076/1385-4046(200008)14:3;1-P;FT287; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; BUTLER RJ, 1994, BRIT J SPORT MED, V28, P187, DOI 10.1136/bjsm.28.3.187; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Comper P, 2010, BRAIN INJURY, V24, P1257, DOI 10.3109/02699052.2010.506854; CORNELL DG, 1997, ARCH CLIN NEUROPSYCH, V12, P47; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Echemendia RJ, 2012, CLIN NEUROPSYCHOL, V26, P1077, DOI 10.1080/13854046.2012.721006; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; HAALAND KY, 1994, J CLIN EXP NEUROPSYC, V16, P448, DOI 10.1080/01688639408402655; Halstead W.C., 1947, BRAIN INTELLIGENCE Q; Hannay H. J., 1986, EXPT TECHNIQUES HUMA; Haut M W, 2000, Appl Neuropsychol, V7, P237, DOI 10.1207/S15324826AN0704_5; Heilbronner RL, 2009, ARCH CLIN NEUROPSYCH, V24, P11, DOI 10.1093/arclin/acp005; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; Hinton-Bayre AD, 2002, NEUROLOGY, V59, P1068, DOI 10.1212/WNL.59.7.1068; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Jordan BD, 1996, AM J SPORT MED, V24, P704, DOI 10.1177/036354659602400526; Kane MJ, 2002, PSYCHON B REV, V9, P637, DOI 10.3758/BF03196323; KASTE M, 1982, LANCET, V2, P1186; Kirov II, 2013, J NEUROL, V260, P242, DOI 10.1007/s00415-012-6626-z; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Lange RT, 2005, J CLIN EXP NEUROPSYC, V27, P897, DOI 10.1080/1380339049091290; Lezak MD, 1984, SCANDINAVIAN J WO S1, V10, P25; Loring DW, 1990, NEUROLOGY, V74, P685; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Malek-Ahmadi M, 2011, DEMENT GERIATR COGN, V32, P235, DOI 10.1159/000334525; Malm J, 1998, NEUROLOGY, V51, P433, DOI 10.1212/WNL.51.2.433; Maruff P, 2009, ARCH CLIN NEUROPSYCH, V24, P165, DOI 10.1093/arclin/acp010; Mayers LB, 2011, J CLIN EXP NEUROPSYC, V33, P532, DOI 10.1080/13803395.2010.535506; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Mitrushina M., 2005, HDB NORMATIVE DATA N; MURELIUS O, 1991, ACTA NEUROL SCAND, V83, P9; Neselius S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081249; Neselius S, 2013, BRAIN INJURY, V27, P425, DOI 10.3109/02699052.2012.750752; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; Perianez JA, 2007, ARCH CLIN NEUROPSYCH, V22, P433, DOI 10.1016/j.acn.2007.01.022; Porter MD, 2003, CLIN J SPORT MED, V13, P339, DOI 10.1097/00042752-200311000-00002; Prigatano GP, 2003, J INT NEUROPSYCH SOC, V9, P128, DOI 10.1017/S1355617703000134; Randolph C, 2009, J INT NEUROPSYCH SOC, V15, P512, DOI 10.1017/S135561770909064X; Reitan R., 1992, NEUROPSYCHOLOGICAL E; REITAN RM, 1994, J CLIN PSYCHOL, V50, P47, DOI 10.1002/1097-4679(199401)50:1<47::AID-JCLP2270500106>3.0.CO;2-X; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Rosen VM, 2002, NEUROPSYCHOLOGIA, V40, P2226, DOI 10.1016/S0028-3932(02)00132-X; Ross TP, 2003, ARCH CLIN NEUROPSYCH, V18, P153, DOI 10.1016/S0887-6177(01)00192-5; Spreen O, 1998, COMPENDIUM NEUROPSYC; Thomas JR, 1999, RES Q EXERCISE SPORT, V70, P11, DOI 10.1080/02701367.1999.10607726; Thomas M, 2011, PEDIATRICS, V128, pE1, DOI 10.1542/peds.2010-2743; Tulving E., 1985, CAN PSYCHOL, V1, P1; Vallat-Azouvi C, 2007, J INT NEUROPSYCH SOC, V13, P770, DOI 10.1017/S1355617707070993; Wall SE, 2006, J NEUROL NEUROSUR PS, V77, P518, DOI 10.1136/jnnp.2004.061044; Wechsler D, 2008, WAIS 3 WECHSLER ADUL, VFourth; Wright MJ, 2010, J CLIN EXP NEUROPSYC, V32, P728, DOI 10.1080/13803390903512652; Zetterberg H, 2006, ARCH NEUROL-CHICAGO, V63, P1277, DOI 10.1001/archneur.63.9.1277	65	26	26	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99870	10.1371/journal.pone.0099870	http://dx.doi.org/10.1371/journal.pone.0099870			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941067	Green Published, Green Submitted, gold			2022-12-27	WOS:000338508200048
J	Peri, E; Cusumano, A; Amodeo, V; Wajnberg, E; Colazza, S				Peri, Ezio; Cusumano, Antonino; Amodeo, Valentina; Wajnberg, Eric; Colazza, Stefano			Intraguild Interactions between Two Egg Parasitoids of a True Bug in Semi-Field and Field Conditions	PLOS ONE			English	Article							TRISSOLCUS-BASALIS HYMENOPTERA; NEZARA-VIRIDULA HETEROPTERA; INTRINSIC COMPETITION; INTERSPECIFIC COMPETITION; BIOLOGICAL-CONTROL; LARVAL PARASITOIDS; SPATIAL DYNAMICS; HOST; PENTATOMIDAE; COEXISTENCE	Research on interspecific competitive interactions among insect parasitoids has often been characterized by laboratory studies in which host insects are exposed to female parasitoids of different species in various sequences and combinations. In the last years, an increasing number of studies have investigated interspecific interactions under field and semi-field conditions although just a few number of works focused on egg parasitoids. In this work, we undertook a two-year study to investigate interspecific interactions between Trissolcus basalis (Wollaston) (Hymenoptera: Platygastridae) and Ooencyrtus telenomicida (Vassiliev) (Hymenoptera: Encyrtidae), two egg parasitoids of the pest Nezara viridula (L.) (Heteroptera: Pentatomidae) that co-occur in cultivated crops. Under semi-field (in out-door mesh cages) and field conditions, we investigated: 1) the seasonal occurrence of competing parasitoid species on sentinel egg masses; 2) the impact achieved by competing species on the shared host on naturally laid egg masses; 3) the outcome of intraguild interactions under controlled conditions. Results from sentinel egg masses showed that T. basalis occurs in May and successfully parasitizes hosts until the end of September/beginning of October, whereas O. telenomicida is mainly occurring in July-August. In both years, it was found that T. basalis is predominant. From naturally laid egg masses, results indicated that T. basalis achieves higher impact on the hosts, even in those egg masses which are parasitized by more than one female of different species (= multiparasitism). Results from manipulating intraguild interactions showed that T. basalis achieves higher impact on N. viridula when released alone, but it suffers from competition with O. telenomicida. The ecological factors that play a role in intraguild interactions in the context of biological control perspective are discussed.	[Peri, Ezio; Cusumano, Antonino; Amodeo, Valentina; Colazza, Stefano] Univ Palermo, Dipartimento Sci Agr & Forestali, Palermo, Italy; [Wajnberg, Eric] INRA, Sophia Antipolis, France	University of Palermo; INRAE	Cusumano, A (corresponding author), Univ Palermo, Dipartimento Sci Agr & Forestali, Palermo, Italy.	cusumanoantonino@unipa.it	Wajnberg, Eric/A-4862-2009; Cusumano, Antonino/L-7375-2015	Wajnberg, Eric/0000-0002-6700-7114; Cusumano, Antonino/0000-0001-9663-9164; PERI, Ezio/0000-0002-1095-7258; colazza, stefano/0000-0001-8023-7814	Marie Curie International Research Staff Exchange Scheme (IRSES); project "Better Understanding of Bugs for Improved Environment" - BUGSIE [PIRSES-GA-2012-317981]; University of Palermo -Fondo Finalizzato alla Ricerca (FFR) bando	Marie Curie International Research Staff Exchange Scheme (IRSES)(European Commission); project "Better Understanding of Bugs for Improved Environment" - BUGSIE; University of Palermo -Fondo Finalizzato alla Ricerca (FFR) bando	This project was supported by the Marie Curie International Research Staff Exchange Scheme (IRSES) with the project "Better Understanding of Bugs for Improved Environment" - BUGSIE (PIRSES-GA-2012-317981). This work was supported by the University of Palermo -Fondo Finalizzato alla Ricerca (FFR) bando 2012. No additional internal or external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agboka K, 2002, J INSECT BEHAV, V15, P1, DOI 10.1023/A:1014471826914; Amarasekare P, 2000, ECOLOGY, V81, P1286, DOI 10.1890/0012-9658(2000)081[1286:COCPOA]2.0.CO;2; Amarasekare P, 2000, J ANIM ECOL, V69, P201, DOI 10.1046/j.1365-2656.2000.00378.x; Bin F, 1990, TRICHOGRAMMA OTHER E, P175, DOI [10.1016/j.chemosphere.2011.12.082, DOI 10.1016/J.CHEMOSPHERE.2011.12.082]; Bogran CE, 2002, ECOLOGY, V83, P653, DOI 10.1890/0012-9658(2002)083[0653:ICAIPF]2.0.CO;2; Boivin G, 2006, PROG BIOL CONTROL, V3, P123; Borer ET, 2004, ECOLOGY, V85, P667, DOI 10.1890/02-0566; Bretz F., 2010, MULTIPLE COMP USING; BUSCHMAN LL, 1980, FLA ENTOMOL, V63, P154, DOI 10.2307/3494669; CALTAGIRONE LE, 1981, ANNU REV ENTOMOL, V26, P213, DOI 10.1146/annurev.en.26.010181.001241; CLARKE AR, 1990, AUST J AGR RES, V41, P1127, DOI 10.1071/AR9901127; Colazza S, 1995, ENVIRON ENTOMOL, V24, P1703, DOI 10.1093/ee/24.6.1703; Colazza S, 2004, J EXP BIOL, V207, P47, DOI 10.1242/jeb.00732; Colazza S, 1999, BIOL CONTROL, V16, P310, DOI 10.1006/bcon.1999.0763; Correa-Ferreira SB, 1986, AN SOC ENTOMOL BRAS, V5, P189; CORREAFERREIRA BS, 1995, BIOL CONTROL, V5, P196, DOI 10.1006/bcon.1995.1024; Cusumano A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064768; Cusumano A, 2012, BIOCONTROL, V57, P719, DOI 10.1007/s10526-012-9451-5; Cusumano A, 2012, ENTOMOL EXP APPL, V143, P155, DOI 10.1111/j.1570-7458.2012.01236.x; Cusumano A, 2011, BIOCONTROL, V56, P173, DOI 10.1007/s10526-010-9320-z; De Moraes CM, 2005, ECOL ENTOMOL, V30, P564, DOI 10.1111/j.0307-6946.2005.00723.x; De Moraes CM, 1999, ECOL ENTOMOL, V24, P402, DOI 10.1046/j.1365-2311.1999.00212.x; Denoth M, 2002, BIOL CONTROL, V24, P20, DOI 10.1016/S1049-9644(02)00002-6; Ehler LE, 2002, BIOCONTROL, V47, P309, DOI 10.1023/A:1014895028451; Cingolani MF, 2013, BIOCONTROL, V58, P37, DOI 10.1007/s10526-012-9484-9; Fisher R. A., 1954, STAT METHODS RES WOR, DOI DOI 10.1007/BF01603396; Follett Peter A., 2000, American Entomologist, V46, P82; Godfray H. C. J., 1994, PARASITOIDS BEHAV EV, DOI 10.1515/9780691207025; Harvey JA, 2013, ANNU REV ENTOMOL, V58, P333, DOI 10.1146/annurev-ento-120811-153622; Harvey JA, 2009, ENTOMOL EXP APPL, V130, P238, DOI 10.1111/j.1570-7458.2008.00816.x; Hawkins B. A., 1994, PATTERN PROCESS HOST; Hoffmann M. P., 1991, California Agriculture, V45, P20; Hokyo N., 1965, NANKI SEIBUTSU, V7, P1; Irvin NA, 2006, BIOCONTROL SCI TECHN, V16, P359, DOI 10.1080/09583150500532048; JALALI SK, 1988, ENTOMOL EXP APPL, V46, P221, DOI 10.1007/BF00364192; Jones WA, 1996, J AGR ENTOMOL, V13, P243; Kidd D, 2012, J ANIM ECOL, V81, P47, DOI 10.1111/j.1365-2656.2011.01881.x; KOZIOL JA, 1978, J AM STAT ASSOC, V73, P753, DOI 10.2307/2286276; Lei GC, 1998, J ANIM ECOL, V67, P422, DOI 10.1046/j.1365-2656.1998.00204.x; Mainali BP, 2012, CROP PROT, V36, P37, DOI 10.1016/j.cropro.2012.01.016; Meiners T, 2013, CHEM ECOLOGY INSECT, P191, DOI DOI 10.1002/9781118409589.CH9; Mucheru OM, 2009, ENTOMOL EXP APPL, V130, P10, DOI 10.1111/j.1570-7458.2008.00788.x; Nechols J. R., 1992, Selection criteria and ecological consequences of importing natural enemies., P41; Peri E, 2011, BIOCONTROL, V207, P47; Peri E, 2006, J EXP BIOL, V209, P3629, DOI 10.1242/jeb.02416; Peri E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079054; R Core Team, 2016, R FDN STAT COMP; ROSENHEIM JA, 1995, BIOL CONTROL, V5, P303, DOI 10.1006/bcon.1995.1038; Rosenheim JA, 2006, PROG BIOL CONTROL, V3, P1; Salerno G, 2006, EUR J ENTOMOL, V103, P311, DOI 10.14411/eje.2006.040; SHEPARD BM, 1994, J AGR ENTOMOL, V11, P375; Shi ZH, 2004, J APPL ENTOMOL, V128, P437, DOI 10.1111/j.1439-0418.2004.00869.x; Sjaarda N., 1989, THESIS U CALIFORNIA; SOLUK DA, 1988, OIKOS, V52, P94, DOI 10.2307/3565987; Stiling P, 2005, BIOL CONTROL, V34, P236, DOI 10.1016/j.biocontrol.2005.02.017; TODD JW, 1989, ANNU REV ENTOMOL, V34, P273, DOI 10.1146/annurev.en.34.010189.001421; VANALEBEEK FAN, 1993, ENTOMOL EXP APPL, V69, P21, DOI 10.1007/BF02380670; Wajnberg E, 1994, BIOL CONTROL EGG PAR; ZWOLFER H, 1971, P405	59	18	18	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99876	10.1371/journal.pone.0099876	http://dx.doi.org/10.1371/journal.pone.0099876			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941172	gold, Green Published			2022-12-27	WOS:000338508200049
J	Reisser, J; Shaw, J; Hallegraeff, G; Proietti, M; Barnes, DKA; Thums, M; Wilcox, C; Hardesty, BD; Pattiaratchi, C				Reisser, Julia; Shaw, Jeremy; Hallegraeff, Gustaaf; Proietti, Maira; Barnes, David K. A.; Thums, Michele; Wilcox, Chris; Hardesty, Britta Denise; Pattiaratchi, Charitha			Millimeter-Sized Marine Plastics: A New Pelagic Habitat for Microorganisms and Invertebrates	PLOS ONE			English	Article							DENSITY POLYETHYLENE; DEBRIS; MICROPLASTICS; OCEAN; ENVIRONMENT; INGESTION; SEA; BIODEGRADATION; ACCUMULATION; OVIPOSITION	Millimeter-sized plastics are abundant in most marine surface waters, and known to carry fouling organisms that potentially play key roles in the fate and ecological impacts of plastic pollution. In this study we used scanning electron microscopy to characterize biodiversity of organisms on the surface of 68 small floating plastics (length range = 1.7-24.3 mm, median = 3.2 mm) from Australia-wide coastal and oceanic, tropical to temperate sample collections. Diatoms were the most diverse group of plastic colonizers, represented by 14 genera. We also recorded 'epiplastic' coccolithophores (7 genera), bryozoans, barnacles (Lepas spp.), a dinoflagellate (Ceratium), an isopod (Asellota), a marine worm, marine insect eggs (Halobates sp.), as well as rounded, elongated, and spiral cells putatively identified as bacteria, cyanobacteria, and fungi. Furthermore, we observed a variety of plastic surface microtextures, including pits and grooves conforming to the shape of microorganisms, suggesting that biota may play an important role in plastic degradation. This study highlights how anthropogenic millimeter-sized polymers have created a new pelagic habitat for microorganisms and invertebrates. The ecological ramifications of this phenomenon for marine organism dispersal, ocean productivity, and biotransfer of plastic-associated pollutants, remains to be elucidated.	[Reisser, Julia; Pattiaratchi, Charitha] Univ Western Australia, Sch Environm Syst Engn, Perth, WA 6009, Australia; [Reisser, Julia; Thums, Michele; Pattiaratchi, Charitha] Univ Western Australia, Oceans Inst, Perth, WA 6009, Australia; [Reisser, Julia; Wilcox, Chris; Hardesty, Britta Denise] CSIRO, Wealth Oceans Flagship, Perth, WA, Australia; [Shaw, Jeremy] Univ Western Australia, Ctr Microscopy Characterisat & Anal, Perth, WA 6009, Australia; [Hallegraeff, Gustaaf] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Proietti, Maira] Univ Fed Rio Grande, Inst Oceanog, Rio Grande, Brazil; [Barnes, David K. A.] British Antarctic Survey, Nat Environm Res Council, Cambridge CB3 0ET, England; [Thums, Michele] UWA Oceans Inst, Australian Inst Marine Sci, Perth, WA, Australia; [Wilcox, Chris; Hardesty, Britta Denise] CSIRO, Hobart, Tas, Australia	University of Western Australia; University of Western Australia; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Western Australia; University of Tasmania; Universidade Federal do Rio Grande; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Australian Institute of Marine Science; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Reisser, J (corresponding author), Univ Western Australia, Sch Environm Syst Engn, Perth, WA 6009, Australia.	jureisser@gmail.com	Hardesty, Britta Denise/A-3189-2011; Wilcox, Chris/A-3585-2010; Shaw, Jeremy A/B-4156-2011; Thums, Michele/A-3850-2013; Pattiaratchi, Charitha/E-6916-2011; Hallegraeff, Gustaaf/C-8351-2013; Reisser, Julia/K-2065-2013	Hardesty, Britta Denise/0000-0003-1948-5098; Wilcox, Chris/0000-0002-5983-657X; Shaw, Jeremy A/0000-0002-5140-457X; Thums, Michele/0000-0002-8669-8440; Proietti, Maira/0000-0002-5504-5770; Pattiaratchi, Charitha/0000-0003-2229-6183; Hallegraeff, Gustaaf/0000-0001-8464-7343; Reisser, Julia/0000-0002-1785-1042	University of Western Australia; Commonwealth Scientific and Industrial Research; Australia's Marine National Facility; Austral Fisheries; Australian Institute of Marine Science; CSIRO's Flagship postgraduate scholarship; Shell social investment program; NERC [bas0100025] Funding Source: UKRI; Natural Environment Research Council [bas0100025] Funding Source: researchfish	University of Western Australia; Commonwealth Scientific and Industrial Research; Australia's Marine National Facility; Austral Fisheries; Australian Institute of Marine Science; CSIRO's Flagship postgraduate scholarship; Shell social investment program; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This project was funded by University of Western Australia (http://www.uwa.edu.au) and Commonwealth Scientific and Industrial Research (http://www.csiro.au). It has also been supported by Australia's Marine National Facility, Austral Fisheries, Australian Institute of Marine Science, CSIRO's Flagship postgraduate scholarship (JR), and the Shell social investment program (BDH and CW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliani S, 2003, HYDROBIOLOGIA, V503, P59, DOI 10.1023/B:HYDR.0000008480.95045.26; Andrady AL, 2011, MAR POLLUT BULL, V62, P1596, DOI 10.1016/j.marpolbul.2011.05.030; Artham T, 2009, J POLYM ENVIRON, V17, P170, DOI 10.1007/s10924-009-0135-x; Balasubramanian V, 2010, LETT APPL MICROBIOL, V51, P205, DOI 10.1111/j.1472-765X.2010.02883.x; Barnes David K. A., 2004, EFFECTS HUMAN TRANSP, P193; Barnes DKA, 2003, MAR ECOL PROG SER, V262, P289, DOI 10.3354/meps262289; Barnes DKA, 2002, NATURE, V416, P808, DOI 10.1038/416808a; Basheer C, 2004, MAR POLLUT BULL, V48, P1161, DOI 10.1016/j.marpolbul.2004.04.009; Boerger CM, 2010, MAR POLLUT BULL, V60, P2275, DOI 10.1016/j.marpolbul.2010.08.007; CARPENTE.EJ, 1972, SCIENCE, V178, P749, DOI 10.1126/science.178.4062.749; CARPENTER E J, 1970, Phycologia, V9, P269, DOI 10.2216/i0031-8884-9-3-269.1; CARPENTER EJ, 1972, SCIENCE, V175, P1240, DOI 10.1126/science.175.4027.1240; Carson HS, 2013, MAR POLLUT BULL, V75, P126, DOI 10.1016/j.marpolbul.2013.07.054; Carson HS, 2011, MAR POLLUT BULL, V62, P1708, DOI 10.1016/j.marpolbul.2011.05.032; Cheng L., 1976, MARINE INSECTS; Choy CA, 2013, MAR ECOL PROG SER, V485, P155, DOI 10.3354/meps10342; Cole M, 2013, ENVIRON SCI TECHNOL, V47, P6646, DOI 10.1021/es400663f; Congestri R, 2011, BENITHIC DIATOMS BIO, P227; Cooper DA, 2010, MAR POLLUT BULL, V60, P650, DOI 10.1016/j.marpolbul.2009.12.026; Corcoran PL, 2009, MAR POLLUT BULL, V58, P80, DOI 10.1016/j.marpolbul.2008.08.022; Eriksen M, 2013, MAR POLLUT BULL, V68, P71, DOI 10.1016/j.marpolbul.2012.12.021; Ferreira T., 2012, IMAGEJ USER GUIDE, Vp, P198; Fortuno J, 2010, RAPP COMM INT MER ME, V39, P358; Fossi MC, 2012, MAR POLLUT BULL, V64, P2374, DOI 10.1016/j.marpolbul.2012.08.013; Gassel M, 2013, MARINE POLLUTION B, V64, P2374; Goldstein MC, 2014, MAR BIOL, V161, P1441, DOI 10.1007/s00227-014-2432-8; Goldstein MC, 2012, BIOL LETTERS, V8, P817, DOI 10.1098/rsbl.2012.0298; GREGORY MR, 1978, NEW ZEAL J MAR FRESH, V12, P399, DOI 10.1080/00288330.1978.9515768; GREGORY MR, 1983, MAR ENVIRON RES, V10, P73, DOI 10.1016/0141-1136(83)90011-9; Gregory MR, 2009, PHILOS T R SOC B, V364, P2013, DOI 10.1098/rstb.2008.0265; HALLEGRAEFF GM, 2010, ALGAE AUSTR PHYTOPLA; Harrison JP, 2011, MAR TECHNOL SOC J, V45, P12, DOI 10.4031/MTSJ.45.2.2; Harshvardhan K, 2013, MAR POLLUT BULL, V77, P100, DOI 10.1016/j.marpolbul.2013.10.025; Hidalgo-Ruz V, 2012, ENVIRON SCI TECHNOL, V46, P3060, DOI 10.1021/es2031505; JOKIEL PL, 1990, ENDEAVOUR, V14, P66, DOI 10.1016/0160-9327(90)90074-2; Kawamura T, 1995, J EXP MAR BIOL ECOL, V194, P189, DOI 10.1016/0022-0981(95)00099-2; KENSLEY B, 1994, P BIOL SOC WASH, V107, P274; Kittelmann S, 2005, J EXP MAR BIOL ECOL, V327, P201, DOI 10.1016/j.jembe.2005.06.020; Law KL, 2014, ENVIRON SCI TECHNOL, V48, P4732, DOI 10.1021/es4053076; Law KL, 2010, SCIENCE, V329, P1185, DOI 10.1126/science.1192321; Lobelle D, 2011, MAR POLLUT BULL, V62, P197, DOI 10.1016/j.marpolbul.2010.10.013; Magalhaes WF, 2012, ZOOTAXA, P1; Majer AP, 2012, MAR POLLUT BULL, V64, P1143, DOI 10.1016/j.marpolbul.2012.03.029; Maso M, 2003, SCI MAR, V67, P107, DOI 10.3989/scimar.2003.67n1107; Mato Y, 2001, ENVIRON SCI TECHNOL, V35, P318, DOI 10.1021/es0010498; Moore CJ, 2001, MAR POLLUT BULL, V42, P1297, DOI 10.1016/S0025-326X(01)00114-X; Moret-Ferguson S, 2010, MAR POLLUT BULL, V60, P1873, DOI 10.1016/j.marpolbul.2010.07.020; Paulrud S, 2002, FUEL PROCESS TECHNOL, V76, P23, DOI 10.1016/S0378-3820(02)00008-5; Pham PH, 2012, J FISH DIS, V35, P73, DOI 10.1111/j.1365-2761.2011.01323.x; Polovina JJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031745; Reisser J, 2014, DATA MILLIMETER SIZE; Reisser J, 2013, DATA MARINE PLASTIC; Reisser J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080466; Reisser Julia, 2010, Marine Biodiversity Records, V3, pe75; Rios LM, 2007, MAR POLLUT BULL, V54, P1230, DOI 10.1016/j.marpolbul.2007.03.022; Rochman CM, 2013, SCI REP-UK, V3, DOI 10.1038/srep03263; Rochman CM, 2013, NATURE, V494, P169, DOI 10.1038/494169a; Romagnoli T, 2014, TURKISH J BOT, V38; Sangale M, 2012, J BIOREMED BIODEG, V3; SCHOLZ J, 1995, FACIES, V32, P109, DOI 10.1007/BF02536866; Sivan A, 2011, CURR OPIN BIOTECH, V22, P422, DOI 10.1016/j.copbio.2011.01.013; SONG Y, 1991, MAR POLLUT BULL, V22, P608; Sudhakar M, 2007, POLYM DEGRAD STABIL, V92, P1743, DOI 10.1016/j.polymdegradstab.2007.03.029; Teuten EL, 2009, PHILOS T R SOC B, V364, P2027, DOI 10.1098/rstb.2008.0284; Thiel M, 2005, OCEANOGR MAR BIOL, V43, P279; Tiffany MA, 2011, CELL ORIG LIFE EXTRE, V19, P195, DOI 10.1007/978-94-007-1327-7_8; Totti C, 2009, POLAR BIOL, V32, P1681, DOI 10.1007/s00300-009-0668-4; von Moos N, 2012, ENVIRON SCI TECHNOL, V46, P11327, DOI 10.1021/es302332w; Webb HK, 2013, POLYMERS-BASEL, V5, P1, DOI 10.3390/polym5010001; WEISE W, 1978, MICROBIAL ECOL, V4, P175, DOI 10.1007/BF02015075; WINSTON JE, 1982, MAR POLLUT BULL, V13, P348, DOI 10.1016/0025-326X(82)90038-8; Wright SL, 2013, ENVIRON POLLUT, V178, P483, DOI 10.1016/j.envpol.2013.02.031; Wuchter C, 2003, HELGOLAND MAR RES, V57, P13, DOI 10.1007/s10152-002-0117-z; Zettler ER, 2013, ENVIRON SCI TECHNOL, V47, P7137, DOI 10.1021/es401288x	74	216	231	14	350	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100289	10.1371/journal.pone.0100289	http://dx.doi.org/10.1371/journal.pone.0100289			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941218	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000338508200091
J	Mehemed, TM; Fushimi, Y; Okada, T; Yamamoto, A; Kanagaki, M; Kido, A; Fujimoto, K; Sakashita, N; Togashi, K				Mehemed, Taha M.; Fushimi, Yasutaka; Okada, Tomohisa; Yamamoto, Akira; Kanagaki, Mitsunori; Kido, Aki; Fujimoto, Koji; Sakashita, Naotaka; Togashi, Kaori			Dynamic Oxygen-Enhanced MRI of Cerebrospinal Fluid	PLOS ONE			English	Article							ATTENUATED INVERSION-RECOVERY; SUPPLEMENTAL OXYGEN; SIGNAL INTENSITY; GENERAL-ANESTHESIA; RELAXATION-TIMES; PARTIAL-PRESSURE; IMAGES; CONTRAST; INHALATION; BRAIN	Oxygen causes an increase in the longitudinal relaxation rate of tissues through its T1-shortening effect owing to its paramagnetic properties. Due to such effects, MRI has been used to study oxygen-related signal intensity changes in various body parts including cerebrospinal fluid (CSF) space. Oxygen enhancement of CSF has been mainly studied using MRI sequences with relatively longer time resolution such as FLAIR, and T1 value calculation. In this study, fifteen healthy volunteers were scanned using fast advanced spin echo MRI sequence with and without inversion recovery pulse in order to dynamically track oxygen enhancement of CSF. We also focused on the differences of oxygen enhancement at sulcal and ventricular CSF. Our results revealed that CSF signal after administration of oxygen shows rapid signal increase in both sulcal CSF and ventricular CSF on both sequences, with statistically significant predominant increase in sulcal CSF compared with ventricular CSF. CSF is traditionally thought to mainly form from the choroid plexus in the ventricles and is absorbed at the arachnoid villi, however, it is also believed that cerebral arterioles contribute to the production and absorption of CSF, and controversy remains in terms of the precise mechanism. Our results demonstrated rapid oxygen enhancement in sulcal CSF, which may suggest inhaled oxygen may diffuse into sulcal CSF space rapidly probably due to the abundance of pial arterioles on the brain sulci.	[Mehemed, Taha M.; Fushimi, Yasutaka; Okada, Tomohisa; Yamamoto, Akira; Kanagaki, Mitsunori; Kido, Aki; Fujimoto, Koji; Togashi, Kaori] Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Kyoto, Japan; [Sakashita, Naotaka] Toshiba Med Syst Corp, MRI Syst Dev Dept, Otawara, Tochigi, Japan	Kyoto University; Toshiba Corporation	Fushimi, Y (corresponding author), Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Kyoto, Japan.	yfushimi@kuhp.kyoto-u.ac.jp	Fushimi, Yasutaka/L-8922-2017; Okada, Tomohisa/C-5939-2008	Fushimi, Yasutaka/0000-0002-1982-3168; Kanagaki, Mitsunori/0000-0002-9447-018X; Okada, Tomohisa/0000-0003-2312-5677; Mehemed, Taha/0000-0003-2670-9993	JSPS KAKENHI Grant [25461815]; Toshiba Medical Systems Corporation, Japan [150100700014]; Grants-in-Aid for Scientific Research [25461815] Funding Source: KAKEN	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Toshiba Medical Systems Corporation, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 25461815 and a sponsored research program, "Researches for improvement of MR visualization (No. 150100700014)'' provided to one of the authors, Professor Kaori Togashi, by Toshiba Medical Systems Corporation, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALKSNE JF, 1972, ARCH NEUROL-CHICAGO, V27, P371, DOI 10.1001/archneur.1972.00490170003002; Anzai Y, 2004, AM J NEURORADIOL, V25, P274; Bargallo N, 2005, AM J NEURORADIOL, V26, P2514; BHADELIA RA, 1995, RADIOLOGY, V196, P195, DOI 10.1148/radiology.196.1.7784567; Braga F, 2004, AM J NEURORADIOL, V25, P295; Braga FT, 2003, AM J NEURORADIOL, V24, P1863; Bulat M, 2011, BRAIN RES REV, V65, P99, DOI 10.1016/j.brainresrev.2010.08.002; Cohen Benjamin, 2009, Cerebrospinal Fluid Res, V6, P12, DOI 10.1186/1743-8454-6-12; Daners MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037502; Deliganis AV, 2001, RADIOLOGY, V218, P152, DOI 10.1148/radiology.218.1.r01ja43152; Filippi CG, 2001, AM J NEURORADIOL, V22, P394; Frigon C, 2004, RADIOLOGY, V233, P51, DOI 10.1148/radiol.2331031375; Fushimi Y, 2003, RADIOLOGY, V229, P360, DOI 10.1148/radiol.2292021507; Greitz D, 2004, NEUROSURG REV, V27, P145, DOI 10.1007/s10143-004-0326-9; Igarashi H, 2014, NEUROREPORT, V25, P39, DOI 10.1097/WNR.0000000000000042; Jones RA, 2002, MAGN RESON MED, V47, P728, DOI 10.1002/mrm.10127; Losert C, 2002, MAGN RESON MED, V48, P271, DOI 10.1002/mrm.10215; Moody DM, 2006, SEMIN CARDIOTHORAC V, V10, P128, DOI 10.1177/1089253206288992; O'Connor JPB, 2007, MAGN RESON MED, V58, P490, DOI 10.1002/mrm.21357; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Okada T, 2005, ACAD RADIOL, V12, P142, DOI 10.1016/j.acra.2004.11.012; Oreskovic D, 2010, BRAIN RES REV, V64, P241, DOI 10.1016/j.brainresrev.2010.04.006; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Stock KW, 1999, JMRI-J MAGN RESON IM, V9, P838, DOI 10.1002/(SICI)1522-2586(199906)9:6<838::AID-JMRI11>3.0.CO;2-H; Tadamura E, 1997, J MAGN RESON IMAGING, V7, P220, DOI 10.1002/jmri.1880070134; Taoka T, 2001, AM J ROENTGENOL, V176, P519, DOI 10.2214/ajr.176.2.1760519; Yamada S, 2008, RADIOLOGY, V249, P644, DOI 10.1148/radiol.2492071985; Yang DW, 1999, MAGN RESON IMAGING, V17, P171, DOI 10.1016/S0730-725X(98)00165-9; Yoshino N, 2003, RADIOLOGY, V228, P539, DOI 10.1148/radiol.2282020439; Zaharchuk G, 2005, MAGNET RESON MED, V54, P113, DOI 10.1002/mrm.20546; Zaharchuk G, 2006, ACAD RADIOL, V13, P1016, DOI 10.1016/j.acra.2006.04.016	31	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100723	10.1371/journal.pone.0100723	http://dx.doi.org/10.1371/journal.pone.0100723			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956198	Green Published, Green Submitted, gold			2022-12-27	WOS:000338917900087
J	Carazzolle, MF; de Carvalho, LM; Slepicka, HH; Vidal, RO; Pereira, GAG; Kobarg, J; Meirelles, GV				Carazzolle, Marcelo Falsarella; de Carvalho, Lucas Miguel; Slepicka, Hugo Henrique; Vidal, Ramon Oliveira; Guimaraes Pereira, Goncalo Amarante; Kobarg, Joerg; Meirelles, Gabriela Vaz			IIS - Integrated Interactome System: A Web-Based Platform for the Annotation, Analysis and Visualization of Protein-Metabolite-Gene-Drug Interactions by Integrating a Variety of Data Sources and Tools	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; ARABIDOPSIS-THALIANA; KAPPA-B; NETWORK; IDENTIFICATION; KNOWLEDGEBASE; CYTOSCAPE; ONTOLOGY; ASSOCIATION; RESISTANCE	Background: High-throughput screening of physical, genetic and chemical-genetic interactions brings important perspectives in the Systems Biology field, as the analysis of these interactions provides new insights into protein/gene function, cellular metabolic variations and the validation of therapeutic targets and drug design. However, such analysis depends on a pipeline connecting different tools that can automatically integrate data from diverse sources and result in a more comprehensive dataset that can be properly interpreted. Results: We describe here the Integrated Interactome System (IIS), an integrative platform with a web-based interface for the annotation, analysis and visualization of the interaction profiles of proteins/genes, metabolites and drugs of interest. IIS works in four connected modules: (i) Submission module, which receives raw data derived from Sanger sequencing (e. g. two-hybrid system); (ii) Search module, which enables the user to search for the processed reads to be assembled into contigs/singlets, or for lists of proteins/genes, metabolites and drugs of interest, and add them to the project; (iii) Annotation module, which assigns annotations from several databases for the contigs/singlets or lists of proteins/genes, generating tables with automatic annotation that can be manually curated; and (iv) Interactome module, which maps the contigs/singlets or the uploaded lists to entries in our integrated database, building networks that gather novel identified interactions, protein and metabolite expression/concentration levels, subcellular localization and computed topological metrics, GO biological processes and KEGG pathways enrichment. This module generates a XGMML file that can be imported into Cytoscape or be visualized directly on the web. Conclusions: We have developed IIS by the integration of diverse databases following the need of appropriate tools for a systematic analysis of physical, genetic and chemical-genetic interactions. IIS was validated with yeast two-hybrid, proteomics and metabolomics datasets, but it is also extendable to other datasets. IIS is freely available online at: http://www.lge.ibi.unicamp.br/lnbio/IIS/.	[Carazzolle, Marcelo Falsarella; de Carvalho, Lucas Miguel; Kobarg, Joerg; Meirelles, Gabriela Vaz] Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Biociencias, Sao Paulo, Brazil; [Carazzolle, Marcelo Falsarella; Vidal, Ramon Oliveira; Guimaraes Pereira, Goncalo Amarante] Univ Estadual Campinas, Inst Biol, Dept Genet & Evolucao, Lab Genom & Expressao, Sao Paulo, Brazil; [Slepicka, Hugo Henrique] Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Luz Sincrotron, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Laboratorio Nacional de Luz Sincrotron (LNLS)	Meirelles, GV (corresponding author), Ctr Nacl Pesquisa Energia & Mat, Lab Nacl Biociencias, Sao Paulo, Brazil.	gabriela.meirelles@lnbio.cnpem.br	de Carvalho, Lucas/GRY-7167-2022; Pereira, Gonçalo A. G./B-7944-2012; Carazzolle, Marcelo Falsarella/C-6503-2012; Kobarg, Jörg/T-4736-2019; UNICAMP, CCES -/J-7787-2015; Slepicka, Hugo/F-7844-2012; Meirelles, Gabriela Vaz/H-4151-2013	Carazzolle, Marcelo Falsarella/0000-0002-5474-2830; Kobarg, Jörg/0000-0002-9419-0145; Slepicka, Hugo/0000-0002-8378-3017; Meirelles, Gabriela Vaz/0000-0003-4371-0419	Fundacao de Amparo a Pesquisa do Estado Sao Paulo (FAPESP); Conselho Nacional de Pesquisa e Desenvolvimento (CNPq); Brazilian Biosciences National Laboratory (LNBio); Center for Computational Engineering and Sciences at UNICAMP/Brazil (FAPESP/CEPID project) [2013/08293-7]	Fundacao de Amparo a Pesquisa do Estado Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Pesquisa e Desenvolvimento (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Biosciences National Laboratory (LNBio); Center for Computational Engineering and Sciences at UNICAMP/Brazil (FAPESP/CEPID project)	This work was supported by Fundacao de Amparo a Pesquisa do Estado Sao Paulo (FAPESP), Conselho Nacional de Pesquisa e Desenvolvimento (CNPq), Brazilian Biosciences National Laboratory (LNBio) and Center for Computational Engineering and Sciences at UNICAMP/Brazil (FAPESP/CEPID project #2013/08293-7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barsky A, 2007, BIOINFORMATICS, V23, P1040, DOI 10.1093/bioinformatics/btm057; Baudet C, 2006, GENET MOL RES, V5, P169; Berger SI, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-372; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Brandao MM, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-454; Breitkreutz BJ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r22; Chen Jin, 2006, Genome Inform, V17, P284; Chen J, 2006, BIOINFORMATICS, V22, P1998, DOI 10.1093/bioinformatics/btl335; Chua HN, 2006, BIOINFORMATICS, V22, P1623, DOI 10.1093/bioinformatics/btl145; De Bodt S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-288; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Fong MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019963; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Gerstein M, 2002, SCIENCE, V295, P284, DOI 10.1126/science.1068664; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Guo AC, 2013, NUCLEIC ACIDS RES, V41, pD625, DOI 10.1093/nar/gks992; Hermjakob H, 2004, NUCLEIC ACIDS RES, V32, pD452, DOI 10.1093/nar/gkh052; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Jewison T, 2012, NUCLEIC ACIDS RES, V40, pD815, DOI 10.1093/nar/gkr916; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Kanehisa M, 2002, NUCLEIC ACIDS RES, V30, P42, DOI 10.1093/nar/30.1.42; Kang HG, 2008, PLANT SIGNAL BEHAV, V3, P689, DOI 10.4161/psb.3.9.5822; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Kormish JD, 2010, DEV DYNAM, V239, P56, DOI 10.1002/dvdy.22046; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Lin MZ, 2009, PLANT PHYSIOL, V151, P34, DOI 10.1104/pp.109.141317; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Liu GM, 2009, BIOINFORMATICS, V25, P1891, DOI 10.1093/bioinformatics/btp311; Liu H, 2005, CYTOKINE, V31, P251, DOI 10.1016/j.cyto.2004.12.008; Lopes CT, 2010, BIOINFORMATICS, V26, P2347, DOI 10.1093/bioinformatics/btq430; Lupetti A, 2002, TRENDS MOL MED, V8, P76, DOI 10.1016/S1471-4914(02)02280-3; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Matsuda A, 2003, ONCOGENE, V22, P3307, DOI 10.1038/sj.onc.1206406; Meirelles Gabriela Vaz, 2014, World J Biol Chem, V5, P141, DOI 10.4331/wjbc.v5.i2.141; Meirelles GV, 2010, J PROTEOME RES, V9, P6298, DOI 10.1021/pr100562w; Mostafavi S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s4; Pellet Johann, 2009, BMC Res Notes, V2, P220, DOI 10.1186/1756-0500-2-220; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Talebnia F, 2006, J BIOTECHNOL, V125, P377, DOI 10.1016/j.jbiotec.2006.03.013; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Wang YY, 2006, NAT IMMUNOL, V7, P139, DOI 10.1038/ni1294; Westman JO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049335; Westman JO, 2012, INT J MOL SCI, V13, P11881, DOI 10.3390/ijms130911881; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; Xenarios I, 2000, NUCLEIC ACIDS RES, V28, P289, DOI 10.1093/nar/28.1.289; Zanzoni A, 2002, FEBS LETT, V513, P135, DOI 10.1016/S0014-5793(01)03293-8; Zhu F, 2012, NUCLEIC ACIDS RES, V40, pD1128, DOI 10.1093/nar/gkr797	61	35	35	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100385	10.1371/journal.pone.0100385	http://dx.doi.org/10.1371/journal.pone.0100385			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949626	gold, Green Published, Green Submitted			2022-12-27	WOS:000338276300072
J	Feilotter, HE; Michel, C; Uy, P; Bathurst, L; Davey, S				Feilotter, Harriet E.; Michel, Claire; Uy, Paolo; Bathurst, Lauren; Davey, Scott			BRCA1 Haploinsufficiency Leads to Altered Expression of Genes Involved in Cellular Proliferation and Development	PLOS ONE			English	Article							MAMMARY EPITHELIAL-CELLS; INACTIVE X-CHROMOSOME; INDUCED DNA-DAMAGE; BREAST-CANCER SUSCEPTIBILITY; POLYMERASE-II HOLOENZYME; IONIZING-RADIATION; UBIQUITIN LIGASE; TRANSCRIPTIONAL ACTIVATION; MUTATION CARRIERS; OVARIAN-TUMORS	The assessment of BRCA1 and BRCA2 coding sequences to identify pathogenic mutations associated with inherited breast/ovarian cancer syndrome has provided a method to identify high-risk individuals, allowing them to seek preventative treatments and strategies. However, the current test is expensive, and cannot differentiate between pathogenic variants and those that may be benign. Focusing only on one of the two BRCA partners, we have developed a biological assay for haploinsufficiency of BRCA1. Using a series of EBV-transformed cell lines, we explored gene expression patterns in cells that were BRCA1 wildtype compared to those that carried (heterozygous) BRCA1 pathogenic mutations. We identified a subset of 43 genes whose combined expression pattern is a sensitive predictor of BRCA1 status. The gene set was disproportionately made up of genes involved in cellular differentiation, lending credence to the hypothesis that single copy loss of BRCA1 function may impact differentiation, rendering cells more susceptible to undergoing malignant processes.	[Feilotter, Harriet E.; Michel, Claire; Uy, Paolo; Bathurst, Lauren; Davey, Scott] Queens Univ, Dept Pathol, Kingston, ON K7L 3N6, Canada; [Feilotter, Harriet E.; Michel, Claire; Uy, Paolo; Bathurst, Lauren; Davey, Scott] Queens Univ, Dept Mol Med, Kingston, ON, Canada; [Davey, Scott] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Davey, Scott] Queens Univ, Dept Oncol, Kingston, ON, Canada; [Feilotter, Harriet E.] Queens Univ, Canc Res Inst, Kingston, ON, Canada; [Michel, Claire; Uy, Paolo; Bathurst, Lauren; Davey, Scott] Queens Univ, Div Canc Biol & Genet, Kingston, ON, Canada	Queens University - Canada; Queens University - Canada; Queens University - Canada; Queens University - Canada; Queens University - Canada; Queens University - Canada	Davey, S (corresponding author), Queens Univ, Dept Pathol, Kingston, ON K7L 3N6, Canada.	sd13@queensu.ca			Canadian Breast Cancer Foundation (Ontario Chapter); Kingston General Hospital Department of Pathology Clinical Trust Fund	Canadian Breast Cancer Foundation (Ontario Chapter); Kingston General Hospital Department of Pathology Clinical Trust Fund	This work was supported by operating funds from the Canadian Breast Cancer Foundation (Ontario Chapter) and the Kingston General Hospital Department of Pathology Clinical Trust Fund to SD and HF, and by infrastructure support through the Canada Foundation for Innovation Leaders Opportunity Fund, and the Ontario Research Fund (SD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SE, 1998, NAT GENET, V19, P254, DOI 10.1038/930; Andrulis IL, 2002, HUM MUTAT, V20, P65, DOI 10.1002/humu.10097; Bellacosa A, 2010, CANCER PREV RES, V3, P48, DOI 10.1158/1940-6207.CAPR-09-0078; Bork P, 1997, FASEB J, V11, P68, DOI 10.1096/fasebj.11.1.9034168; Brody LC, 1998, MEDICINE, V77, P208, DOI 10.1097/00005792-199805000-00006; Burga LN, 2009, CANCER RES, V69, P1273, DOI 10.1158/0008-5472.CAN-08-2954; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Chang SW, 2009, J CLIN INVEST, V119, P3160, DOI 10.1172/JCI39836; Chapman MS, 1996, NATURE, V382, P678, DOI 10.1038/382678a0; Chen A, 2002, J BIOL CHEM, V277, P22085, DOI 10.1074/jbc.M201252200; CORNELIS RS, 1995, GENE CHROMOSOME CANC, V13, P203, DOI 10.1002/gcc.2870130310; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; Fabbro M, 2004, J BIOL CHEM, V279, P31251, DOI 10.1074/jbc.M405372200; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; Frank TS, 2002, J CLIN ONCOL, V20, P1480, DOI 10.1200/JCO.20.6.1480; Furuta S, 2005, P NATL ACAD SCI USA, V102, P9176, DOI 10.1073/pnas.0503793102; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; Ganesan S, 2002, CELL, V111, P393, DOI 10.1016/S0092-8674(02)01052-8; Ganesan S, 2004, PHILOS T R SOC B, V359, P123, DOI 10.1098/rstb.2003.1371; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; Huen MSY, 2010, NAT REV MOL CELL BIO, V11, P138, DOI 10.1038/nrm2831; Jen KY, 2003, GENOME RES, V13, P2092, DOI 10.1101/gr.1240103; King TA, 2007, ANN SURG ONCOL, V14, P2510, DOI 10.1245/s10434-007-9372-1; Kote-Jarai Z, 2004, CLIN CANCER RES, V10, P958, DOI 10.1158/1078-0432.CCR-1067-3; Kote-Jarai Z, 2006, CLIN CANCER RES, V12, P3896, DOI 10.1158/1078-0432.CCR-05-2805; Kubista M, 2002, ONCOGENE, V21, P4747, DOI 10.1038/sj.onc.1205580; Lee MS, 2010, CANCER RES, V70, P4880, DOI 10.1158/0008-5472.CAN-09-4563; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Liu S, 2008, P NATL ACAD SCI USA, V105, P1680, DOI 10.1073/pnas.0711613105; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Mak TW, 2000, NAT IMMUNOL, V1, P77, DOI 10.1038/76950; MERAJVER SD, 1995, NAT GENET, V9, P439, DOI 10.1038/ng0495-439; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Monteiro ANA, 1996, P NATL ACAD SCI USA, V93, P13595, DOI 10.1073/pnas.93.24.13595; Morris JR, 2006, HUM MOL GENET, V15, P599, DOI 10.1093/hmg/ddi476; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Moynahan ME, 2001, CANCER RES, V61, P4842; NEUHAUSEN SL, 1994, CANCER RES, V54, P6069; Proia TA, 2011, CELL STEM CELL, V8, P149, DOI 10.1016/j.stem.2010.12.007; Rieger KE, 2004, NUCLEIC ACIDS RES, V32, P4786, DOI 10.1093/nar/gkh783; Salmon AY, 2013, CANCER PREV RES, V6, P82, DOI 10.1158/1940-6207.CAPR-12-0105; Scully R, 1997, P NATL ACAD SCI USA, V94, P5605, DOI 10.1073/pnas.94.11.5605; Silver DP, 2007, CELL, V128, P991, DOI 10.1016/j.cell.2007.02.025; SMITH SA, 1992, NAT GENET, V2, P128, DOI 10.1038/ng1092-128; Sorlie T, 1998, BREAST CANCER RES TR, V48, P259, DOI 10.1023/A:1005953519972; Starita LM, 2004, MOL CELL BIOL, V24, P8457, DOI 10.1128/MCB.24.19.8457-8466.2004; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Turner JMA, 2004, CURR BIOL, V14, P2135, DOI 10.1016/j.cub.2004.11.032; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vallon-Christersson J, 2001, HUM MOL GENET, V10, P353, DOI 10.1093/hmg/10.4.353; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Wright MH, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1855; Xu B, 2002, CANCER RES, V62, P4588; Xu B, 2001, MOL CELL BIOL, V21, P3445, DOI 10.1128/MCB.21.10.3445-3450.2001; Xu XL, 1999, MOL CELL, V3, P389, DOI 10.1016/S1097-2765(00)80466-9; Yarden RI, 2002, NAT GENET, V30, P285, DOI 10.1038/ng837; Zhu Q, 2011, NATURE, V477, P179, DOI 10.1038/nature10371	59	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100068	10.1371/journal.pone.0100068	http://dx.doi.org/10.1371/journal.pone.0100068			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950059	Green Published, Green Submitted, gold			2022-12-27	WOS:000338276300036
J	Munir, A; Shahzad, A; Khan, M				Munir, Asif; Shahzad, Azeem; Khan, Masood			Forced Convective Heat Transfer in Boundary Layer Flow of Sisko Fluid over a Nonlinear Stretching Sheet	PLOS ONE			English	Article							POWER-LAW FLUID; SURFACE	The major focus of this article is to analyze the forced convective heat transfer in a steady boundary layer flow of Sisko fluid over a nonlinear stretching sheet. Two cases are studied, namely (i) the sheet with variable temperature (PST case) and (ii) the sheet with variable heat flux (PHF case). The heat transfer aspects are investigated for both integer and non-integer values of the power-law index. The governing partial differential equations are reduced to a system of nonlinear ordinary differential equations using appropriate similarity variables and solved numerically. The numerical results are obtained by the shooting method using adaptive Runge Kutta method with Broyden's method in the domain 0,infinity). The numerical results for the temperature field are found to be strongly dependent upon the power-law index, stretching parameter, wall temperature parameter, material parameter of the Sisko fluid and Prandtl number. In addition, the local Nusselt number versus wall temperature parameter is also graphed and tabulated for different values of pertaining parameters. Further, numerical results are validated by comparison with exact solutions as well as previously published results in the literature.	[Munir, Asif; Khan, Masood] Quaid I Azam Univ, Dept Math, Islamabad, Pakistan; [Shahzad, Azeem] UET, Dept Basic Sci, Taxila, Pakistan	Quaid I Azam University	Munir, A (corresponding author), Quaid I Azam Univ, Dept Math, Islamabad, Pakistan.	asifmunir1000@yahoo.com	KHAN, Masood/AAA-7384-2020; khan, Masood/F-7143-2015; Shahzad, Azeem/P-9740-2019	KHAN, Masood/0000-0003-4404-1456; 	Higher education Commission of Pakistan	Higher education Commission of Pakistan(Higher Education Commission of Pakistan)	Sincere thanks are due to Higher education Commission of Pakistan for granting scholarship in Indigenous Ph.D. Fellowship Program to carry out Ph.D. studies. Moreover, the authors would like to thank the reviewer for his careful assessment and fruitful suggestions.	Abel MS, 2009, INT J HEAT MASS TRAN, V52, P2902, DOI 10.1016/j.ijheatmasstransfer.2008.08.042; Alinejad J, 2012, J APPL MATH, DOI 10.1155/2012/587834; Barnes H.A., 1989, INTRO RHEOLOGY; Berk Z, 2008, FOOD PROCESSING ENG; Chen CH, 2008, INT J THERM SCI, V47, P954, DOI 10.1016/j.ijthermalsci.2007.06.003; Chhabra R. P., 2006, BUBBLES DROPS PARTIC; Chhabra RP, 2008, NON-NEWTONIAN FLOW AND APPLIED RHEOLOGY: ENGINEERING APPLICATIONS, 2ND EDITION, P1; Cortell R, 2007, APPL MATH COMPUT, V184, P864, DOI 10.1016/j.amc.2006.06.077; Cortell RB, 2008, J MATER PROCESS TECH, V203, P176; Dandapat BS, 2004, ARCH MECH, V56, P87; Deshpande AP, 2010, RHEOLOGY OF COMPLEX FLUIDS, P87, DOI 10.1007/978-1-4419-6494-6_4; Hassanien IA, 1998, MATH COMPUT MODEL, V28, P105, DOI 10.1016/S0895-7177(98)00148-4; Howell TG, 1997, INT J HEAT MASS TRAN, V40, P1853, DOI 10.1016/S0017-9310(96)00247-5; JADHAV BP, 1990, WARME STOFFUBERTRAG, V25, P377, DOI 10.1007/BF01811562; Khan M, 2010, INT J HEAT MASS TRAN, V53, P1290, DOI 10.1016/j.ijheatmasstransfer.2009.12.037; Khan M, 2013, QUAEST MATH, V36, P137, DOI 10.2989/16073606.2013.779971; Khan M, 2012, INT J NONLIN MECH, V47, P999, DOI 10.1016/j.ijnonlinmec.2012.06.003; Magyari E, 1999, J PHYS D APPL PHYS, V32, P577, DOI 10.1088/0022-3727/32/5/012; SAKIADIS BC, 1961, AICHE J, V7, P26, DOI 10.1002/aic.690070108; SCHOWALTER WR, 1960, AICHE J, V6, P24, DOI 10.1002/aic.690060105; Shahzad A, 2012, CHINESE PHYS LETT, V29, DOI 10.1088/0256-307X/29/8/084705; SISKO AW, 1958, IND ENG CHEM, V50, P1789, DOI 10.1021/ie50588a042; Tadmor Z, 2006, PRINCIPLES POLYM PRO, P184; Xu, 2005, THESIS OHIO STATE U; Young I C, 2011, ADV HEAT TRANSFER, V43	25	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100056	10.1371/journal.pone.0100056	http://dx.doi.org/10.1371/journal.pone.0100056			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949738	Green Submitted, Green Published, gold			2022-12-27	WOS:000338276300033
J	Zhang, J; Hsieh, JH; Zhu, H				Zhang, Jun; Hsieh, Jui-Hua; Zhu, Hao			Profiling Animal Toxicants by Automatically Mining Public Bioassay Data: A Big Data Approach for Computational Toxicology	PLOS ONE			English	Article							PUBCHEM; MANAGEMENT; CHEMICALS; TOXICITY; ASSAYS	In vitro bioassays have been developed and are currently being evaluated as potential alternatives to traditional animal toxicity models. Already, the progress of high throughput screening techniques has resulted in an enormous amount of publicly available bioassay data having been generated for a large collection of compounds. When a compound is tested using a collection of various bioassays, all the testing results can be considered as providing a unique bio-profile for this compound, which records the responses induced when the compound interacts with different cellular systems or biological targets. Profiling compounds of environmental or pharmaceutical interest using useful toxicity bioassay data is a promising method to study complex animal toxicity. In this study, we developed an automatic virtual profiling tool to evaluate potential animal toxicants. First, we automatically acquired all PubChem bioassay data for a set of 4,841 compounds with publicly available rat acute toxicity results. Next, we developed a scoring system to evaluate the relevance between these extracted bioassays and animal acute toxicity. Finally, the top ranked bioassays were selected to profile the compounds of interest. The resulting response profiles proved to be useful to prioritize untested compounds for their animal toxicity potentials and form a potential in vitro toxicity testing panel. The protocol developed in this study could be combined with structure-activity approaches and used to explore additional publicly available bioassay datasets for modeling a broader range of animal toxicities.	[Zhang, Jun; Zhu, Hao] Rutgers State Univ, Dept Chem, Camden, NJ 08102 USA; [Zhang, Jun; Zhu, Hao] Rutgers Ctr Computat & Integrat Biol, Camden, NJ USA; [Hsieh, Jui-Hua] Natl Inst Environm Hlth Sci, Div Natl Toxicol Program, Biomol Screening Branch, Res Triangle Pk, NC USA	Rutgers State University Camden; Rutgers State University New Brunswick; Rutgers State University Camden; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Zhu, H (corresponding author), Rutgers State Univ, Dept Chem, Camden, NJ 08102 USA.	hao.zhu99@rutgers.edu	zh, H/HIK-0903-2022	Zhu, Hao/0000-0002-3559-6129	National Institute of Environmental Health Sciences of the National Institutes of Health [R15ES023148]; Colgate-Palmolive Grant for Alternative Research; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R15ES023148] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Colgate-Palmolive Grant for Alternative Research; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in part, by the National Institute of Environmental Health Sciences of the National Institutes of Health under Award Number [R15ES023148] and the Colgate-Palmolive Grant for Alternative Research. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. https://www.niehs.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betts KS, 2013, ENVIRON HEALTH PERSP, V121, pA228, DOI 10.1289/ehp.121-a228; Butkiewicz M, 2013, MOLECULES, V18, P735, DOI 10.3390/molecules18010735; Chen B, 2010, J MOL GRAPH MODEL, V28, P420, DOI 10.1016/j.jmgm.2009.10.001; Clothier R, 2008, ATLA-ALTERN LAB ANIM, V36, P503, DOI 10.1177/026119290803600509; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Greenwood PE, 1996, GUIDE CHI SQUARE TES, V280; Han LY, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-401; Judson RS, 2010, ENVIRON HEALTH PERSP, V118, P485, DOI 10.1289/ehp.0901392; Kavlock R, 2012, CHEM RES TOXICOL, V25, P1287, DOI 10.1021/tx3000939; Kinsner-Ovaskainen A, 2009, TOXICOL IN VITRO, V23, P476, DOI 10.1016/j.tiv.2008.12.019; Liao Q, 2009, J CHEM INF MODEL, V49, P2718, DOI 10.1021/ci900337f; Martin MT, 2009, TOXICOL SCI, V110, P181, DOI 10.1093/toxsci/kfp080; Rohrer SG, 2009, J CHEM INF MODEL, V49, P169, DOI 10.1021/ci8002649; Schadt EE, 2011, NAT REV GENET, V12, DOI 10.1038/nrg2857-c2; Schadt EE, 2010, NAT REV GENET, V11, P647, DOI 10.1038/nrg2857; Schierz AC, 2009, J CHEMINFORMATICS, V1, DOI 10.1186/1758-2946-1-21; Sedykh A, 2011, ENVIRON HEALTH PERSP, V119, P364, DOI 10.1289/ehp.1002476; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Sipes NS, 2013, CHEM RES TOXICOL, V26, P878, DOI 10.1021/tx400021f; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Walum E, 1998, ENVIRON HEALTH PERSP, V106, P497, DOI 10.2307/3433801; Wang YL, 2012, NUCLEIC ACIDS RES, V40, pD400, DOI [10.1093/nar/gkr1132, 10.1093/nar/gkr1293]; Wang YL, 2009, NUCLEIC ACIDS RES, V37, pW623, DOI 10.1093/nar/gkp456; Weis DC, 2008, J MOL GRAPH MODEL, V27, P466, DOI 10.1016/j.jmgm.2008.08.004; WOOSLEY RL, 1993, JAMA-J AM MED ASSOC, V269, P1532, DOI 10.1001/jama.269.12.1532; Xia M, 2008, ENVIRON HEALTH PERSP, V116, P284, DOI 10.1289/ehp.10727; Xie XQS, 2010, EXPERT OPIN DRUG DIS, V5, P1205, DOI 10.1517/17460441.2010.524924; Zhu H, 2009, ENVIRON HEALTH PERSP, V117, P1257, DOI 10.1289/ehp.0800471	28	28	28	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e99863	10.1371/journal.pone.0099863	http://dx.doi.org/10.1371/journal.pone.0099863			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950175	Green Published, gold, Green Submitted			2022-12-27	WOS:000338276300021
J	Bhardwaj, N; Saxena, RK				Bhardwaj, Nitin; Saxena, Rajiv K.			Elimination of Young Erythrocytes from Blood Circulation and Altered Erythropoietic Patterns during Paraquat Induced Anemic Phase in Mice	PLOS ONE			English	Article							OXIDATIVE STRESS; EXPRESSION; CLEARANCE; SURVIVAL; RISK; SOD1	Paraquat a widely used herbicide causes a variety of toxic effects on humans and animals. The present study is focused on the interaction of paraquat with the mouse erythroid system. Administration of paraquat (10 mg/kg body weight i.p. on alternate days in C57Bl/6 mice) induced a significant fall in blood erythrocyte count on 7, 14, and 21 day time points but the erythrocyte count reverted back to normal by 28th day indicating the emergence of refractoriness to paraquat. A marked surge in the blood reticulocyte count was observed in paraquat treated mice that also subsided by 28th day. Young erythrocytes in circulation were randomly eliminated from blood circulation in paraquat treated mice and a significant elevation in the level of reactive oxygen species (ROS) was also observed maximally the erythrocytes of this age group. Cells representing various stages of erythroid differentiation in bone marrow and spleen were identified and enumerated flow cytometrically based on their expression of Ter119 and transferrin (CD71) receptor. Proliferative activity of erythroid cells, their relative proportion as well as their absolute numbers fell significantly in bone marrow of paraquat treated mice but all these parameters were significantly elevated in spleens of paraquat treated mice. These changes were essentially restricted to the cells belonging to the two earliest stages of erythroid differentiation. Taken together our results indicate that paraquat treatment causes a transient anemia in mice resulting from random elimination of young circulating erythrocytes as well as depressed erythropoietic activity in bone marrow. Spleen erythropoietic activity however was elevated in paraquat treated mice.	[Bhardwaj, Nitin; Saxena, Rajiv K.] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India; [Saxena, Rajiv K.] South Asian Univ, Fac Life Sci & Biotechnol, New Delhi, India	Jawaharlal Nehru University, New Delhi; South Asian University (SAU)	Saxena, RK (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India.	rajivksaxena@hotmail.com			Department of Science and technology, Government of India [SR/SO/HS-133/2007, SR/S0/HS/0261/2012]; University Grants Commission, India	Department of Science and technology, Government of India(Department of Science & Technology (India)); University Grants Commission, India(University Grants Commission, India)	Work funded by grants from Department of Science and technology, Government of India (Grants SR/SO/HS-133/2007 and SR/S0/HS/0261/2012). NB received a fellowship from University Grants Commission, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BISMUTH C, 1990, DRUG SAFETY, V5, P243, DOI 10.2165/00002018-199005040-00002; BULLIVANT CM, 1966, BMJ-BRIT MED J, V1, P1272, DOI 10.1136/bmj.1.5498.1272; Dawson AH, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000357; Eddleston M, 2000, QJM-INT J MED, V93, P715, DOI 10.1093/qjmed/93.11.715; Eisler R, 1990, 85121 PAT WILDL RES; Hattangadi SM, 2007, J CLIN INVEST, V117, P2075, DOI 10.1172/JCI32559; Hong SY, 2000, TOXICOL LETT, V118, P53, DOI 10.1016/S0378-4274(00)00264-2; Iuchi Y, 2007, BIOCHEM J, V402, P219, DOI 10.1042/BJ20061386; Iuchi Y, 2009, BIOCHEM J, V422, P313, DOI 10.1042/BJ20090176; JOENJE H, 1987, CANCER GENET CYTOGEN, V25, P37, DOI 10.1016/0165-4608(87)90157-9; Kalfa TA, 2010, HAEMATOL-HEMATOL J, V95, P27, DOI 10.3324/haematol.2009.006239; Khandelwal S, 2008, EXP GERONTOL, V43, P764, DOI 10.1016/j.exger.2008.05.002; Khandelwal S, 2007, J BIOSCIENCES, V32, P1139, DOI 10.1007/s12038-007-0115-z; Khandelwal S, 2007, TRANSFUSION, V47, P1725, DOI 10.1111/j.1537-2995.2007.01348.x; Khandelwal S, 2006, EXP GERONTOL, V41, P855, DOI 10.1016/j.exger.2006.06.045; Kono M, 2009, CLIN CHIM ACTA, V404, P105, DOI 10.1016/j.cca.2009.03.017; Lenox LE, 2005, BLOOD, V105, P2741, DOI 10.1182/blood-2004-02-0703; Liou HH, 1997, NEUROLOGY, V48, P1583, DOI 10.1212/WNL.48.6.1583; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marinkovic D, 2007, J CLIN INVEST, V117, P2133, DOI 10.1172/JCI31807; MORLEY SJ, 1990, BIOCHIMIE, V72, P259, DOI 10.1016/0300-9084(90)90081-Q; Paulson RF, 2011, CURR OPIN HEMATOL, V18, P139, DOI 10.1097/MOH.0b013e32834521c8; Prasad K, 2009, EXP NEUROL, V215, P358, DOI 10.1016/j.expneurol.2008.11.003; Prihartono N, 2011, ASIA-PAC J PUBLIC HE, V23, P369, DOI 10.1177/1010539511403605; Sachar S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022032; Saxena RK, 2012, TRANSFUS MED HEMOTH, V39, P335, DOI 10.1159/000342524; Saxena RK, 2009, CURR SCI INDIA, V97, P500; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Socolovsky M, 2007, CURR OPIN HEMATOL, V14, P215, DOI 10.1097/MOH.0b013e3280de2bf1; Tsiftsoglou AS, 2009, IUBMB LIFE, V61, P800, DOI 10.1002/iub.226; U. S. EPA, 1997, 738F96018 US EPA; VANHOVE L, 1990, CLIN LAB HAEMATOL, V12, P287; Wu DC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011303	33	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e99364	10.1371/journal.pone.0099364	http://dx.doi.org/10.1371/journal.pone.0099364			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945144	Green Published, Green Submitted, gold			2022-12-27	WOS:000340721500017
J	Puig-Barbera, J; Natividad-Sancho, A; Launay, O; Burtseva, E; Ciblak, MA; Tormos, A; Buigues-Vila, A; Martinez-Ubeda, S; Sominina, A				Puig-Barbera, Joan; Natividad-Sancho, Angels; Launay, Odile; Burtseva, Elena; Ciblak, Meral A.; Tormos, Anita; Buigues-Vila, Amparo; Martinez-Ubeda, Sergio; Sominina, Anna		GIHSN Grp	2012-2013 Seasonal Influenza Vaccine Effectiveness against Influenza Hospitalizations: Results from the Global Influenza Hospital Surveillance Network	PLOS ONE			English	Article							CIRCULATION; EFFICACY; PEOPLE; ADULTS; VIRUS	Background: The effectiveness of currently licensed vaccines against influenza has not been clearly established, especially among individuals at increased risk for complications from influenza. We used a test-negative approach to estimate influenza vaccine effectiveness (IVE) against hospitalization with laboratory-confirmed influenza based on data collected from the Global Influenza Hospital Surveillance Network (GIHSN). Methods and Findings: This was a multi-center, prospective, active surveillance, hospital-based epidemiological study during the 2012-2013 influenza season. Data were collected from hospitals participating in the GIHSN, including five in Spain, five in France, and four in the Russian Federation. Influenza was confirmed by reverse transcription-polymerase chain reaction. IVE against hospitalization for laboratory-confirmed influenza was estimated for adult patients targeted for vaccination and who were swabbed within 7 days of symptom onset. The overall adjusted IVE was 33% (95% confidence interval [CI], 11% to 49%). Point estimates of IVE were 23% (95% CI, -26% to 53%) for influenza A(H1N1)pdm09, 30% (95% CI, -37% to 64%) for influenza A(H3N2), and 43% (95% CI, 17% to 60%) for influenza B/Yamagata. IVE estimates were similar in subjects,65 and >= 65 years of age (35% [95% CI, -15% to 63%] vs. 31% [95% CI, 4% to 51%]). Heterogeneity in site-specific IVE estimates was high (I-2 = 63.4%) for A(H1N1)pdm09 in patients >= 65 years of age. IVE estimates for influenza B/Yamagata were homogenous (I-2 = 0.0%). Conclusions: These results, which were based on data collected from the GIHSN during the 2012-2013 influenza season, showed that influenza vaccines provided low to moderate protection against hospital admission with laboratory-confirmed influenza in adults targeted for influenza vaccination. In this population, IVE estimates against A(H1N1)pdm09 were sensitive to age group and study site. Influenza vaccination was moderately effective in preventing admissions with influenza B/Yamagata for all sites and age groups.	[Puig-Barbera, Joan; Natividad-Sancho, Angels; Tormos, Anita; Buigues-Vila, Amparo; Martinez-Ubeda, Sergio] Fdn Promot Hlth & Biomed Res Valencia Reg FISABIO, Valencia, Spain; [Launay, Odile] Univ Paris 05, Sorbonne Paris Cite, INSERM, CIC 1417, Paris, France; [Burtseva, Elena] DI Ivanovskii Inst Virol, Moscow 123098, Russia; [Ciblak, Meral A.] Natl Influenza Reference Lab Cappa Istanbul, Istanbul, Turkey; [Sominina, Anna] Res Inst Influenza, St Petersburg, Russia	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Russian Academy of Medical Sciences; Gamaleya National Research Center for Epidemiology & Microbiology, RAMS	Puig-Barbera, J (corresponding author), Fdn Promot Hlth & Biomed Res Valencia Reg FISABIO, Valencia, Spain.	puig_joa@gva.es	Gencer, Serap/R-2814-2019; Guillén, Vicente Francisco Gil/AAE-8201-2019; GENCER, SERAP/E-3471-2015; Puig-Barberà, Joan/F-1563-2015; Pisareva, Maria/AAV-1692-2021; Borekci, Sermin/AAC-9099-2021	Gencer, Serap/0000-0002-3217-6305; GENCER, SERAP/0000-0002-3217-6305; Puig-Barberà, Joan/0000-0001-5783-0409; Pisareva, Maria/0000-0002-1499-9957; Borekci, Sermin/0000-0002-0089-1312; Carratala-Munuera, Concepcion/0000-0002-1303-6294; Stolyarov, Kirill/0000-0002-1765-2799; Burtseva, Elena/0000-0003-2518-6801; Tormos, Anita/0000-0003-4881-7338; Gil-Guillen, Vicente F/0000-0003-3793-9786	FISABIO in Valencia, Spain; INSERM in France; French Vaccine Research Network (REIVAC) in France; D.I. Ivanovsky Institute of Virology in Moscow, Russian Federation; Research Institute of Influenza in St. Petersburg, Russian Federation; National Influenza Reference Laboratory Capa-Istanbul, Turkey; Sanofi Pasteur	FISABIO in Valencia, Spain; INSERM in France; French Vaccine Research Network (REIVAC) in France; D.I. Ivanovsky Institute of Virology in Moscow, Russian Federation; Research Institute of Influenza in St. Petersburg, Russian Federation; National Influenza Reference Laboratory Capa-Istanbul, Turkey(Istanbul University); Sanofi Pasteur	The study was funded by a collaboration between CSISP (now FISABIO) in Valencia, Spain; INSERM and the French Vaccine Research Network (REIVAC) in France; the D.I. Ivanovsky Institute of Virology in Moscow, Russian Federation; the Research Institute of Influenza in St. Petersburg, Russian Federation; the National Influenza Reference Laboratory Capa-Istanbul, Turkey; and Sanofi Pasteur. Sanofi Pasteur participated in the design of the study but did not participate in the collection, management, analysis, or interpretation of the data, writing the manuscript, or the decision to submit the manuscript for publication.	[Anonymous], 2012, Wkly Epidemiol Rec, V87, P233; [Anonymous], 2013, Wkly Epidemiol Rec, V88, P437; [Anonymous], 2013, Wkly Epidemiol Rec, V88, P101; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P461; Anton Andres, 2012, Enferm Infecc Microbiol Clin, V30 Suppl 4, P10, DOI 10.1016/S0213-005X(12)70099-X; Beyer WEP, 2013, VACCINE, V31, P6030, DOI 10.1016/j.vaccine.2013.09.063; Bragstad K, 2013, EURO SURVEILL, V18; Brammer L, 2009, INFLUENZA OTHER RESP, V3, P51, DOI 10.1111/j.1750-2659.2009.00077.x; Castilla J, 2013, EUROSURVEILLANCE, V18, P6; Cheng AC, 2013, COMMUN DIS INTELL, V37, pE246; Cheng AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068760; Daniels R, 2013, SURVEILLANCE REPORT; De Serres G, 2013, Euro Surveill, V18; Eick-Cost Angelia A, 2013, MSMR, V20, P15; Fielding JE, 2011, EMERG INFECT DIS, V17, P1181, DOI 10.3201/eid1707.101959; Foppa IM, 2013, VACCINE, V31, P3104, DOI 10.1016/j.vaccine.2013.04.026; Galobardes B, 2006, J EPIDEMIOL COMMUN H, V60, P95, DOI 10.1136/jech.2004.028092; Grijalva CG, 2007, EPIDEMIOL INFECT, V135, P951, DOI 10.1017/S095026880600762X; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Iwane MK, 2004, PEDIATRICS, V113, P1758, DOI 10.1542/peds.113.6.1758; Jackson L, 2013, MMWR-MORBID MORTAL W, V62, P119; Jackson L, 2013, MMWR-MORBID MORTAL W, V62, P32; Kelly HA, 2013, INFLUENZA OTHER RESP, V7, P729, DOI 10.1111/irv.12018; Kirkwood BR, 2003, ANAL CLUSTERED DATA, P355; MAHONEY F I, 1965, Md State Med J, V14, P61; McMenamin J, 2013, EUROSURVEILLANCE, V18, P18; Monto AS, 2009, VACCINE, V27, P5043, DOI 10.1016/j.vaccine.2009.06.032; Motulsky A, 2004, FITTING MODEL BIOL D; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Puig-Barbera J, 2013, VACCINE, V31, P3995, DOI 10.1016/j.vaccine.2013.05.070; Puig-Barbera J, 2012, VACCINE, V30, P5714, DOI 10.1016/j.vaccine.2012.07.006; Rondy M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059681; Rothman KJ, 2008, MODERN EPIDEMIOLOGY, P111; Skowronski D M, 2013, Euro Surveill, V18; Skowronski DM, 2012, CLIN INFECT DIS, V55, P332, DOI 10.1093/cid/cis431; Smith DJ, 1999, P NATL ACAD SCI USA, V96, P14001, DOI 10.1073/pnas.96.24.14001; Sterne JAC, 2009, META ANALYSIS STATA; Sullivan SG, 2013, VACCINE, V31, P4280, DOI 10.1016/j.vaccine.2013.06.103; Talbot HK, 2013, CLIN INFECT DIS, V56, P1774, DOI 10.1093/cid/cit124; Treanor JJ, 2012, CLIN INFECT DIS, V55, P951, DOI 10.1093/cid/cis574; Valenciano M, 2013, Euro Surveill, V18, P3; Valenciano M, 2012, EURO SURVEILL, V17	43	28	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100497	10.1371/journal.pone.0100497	http://dx.doi.org/10.1371/journal.pone.0100497			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945510	Green Published, gold, Green Submitted			2022-12-27	WOS:000340721500082
J	Thiagarajah, JR; Yildiz, H; Carlson, T; Thomas, AR; Steiger, C; Pieretti, A; Zukerberg, LR; Carrier, RL; Goldstein, AM				Thiagarajah, Jay R.; Yildiz, Hasan; Carlson, Taylor; Thomas, Alyssa R.; Steiger, Casey; Pieretti, Alberto; Zukerberg, Lawrence R.; Carrier, Rebecca L.; Goldstein, Allan M.			Altered Goblet Cell Differentiation and Surface Mucus Properties in Hirschsprung Disease	PLOS ONE			English	Article							ENTERIC NERVOUS-SYSTEM; PATHO-PHYSIOLOGY; MOUSE; ENTEROCOLITIS; SECRETION; TRANSPORT; MATH1; ACETYLCHOLINE; AGANGLIONOSIS; INTESTINE	Hirschsprung disease-associated enterocolitis (HAEC) leads to significant mortality and morbidity, but its pathogenesis remains unknown. Changes in the colonic epithelium related to goblet cells and the luminal mucus layer have been postulated to play a key role. Here we show that the colonic epithelium of both aganglionic and ganglionic segments are altered in patients and in mice with Hirschsprung disease (HSCR). Structurally, goblet cells were altered with increased goblet cell number and reduced intracellular mucins in the distal colon of biopsies from patients with HSCR. Endothelin receptor B (Ednrb) mutant mice showed increased goblet cell number and size and increased cell proliferation compared to wild-type mice in aganglionic segments, and reduced goblet cell size and number in ganglionic segments. Functionally, compared to littermates, Ednrb(-/-) mice showed increased transepithelial resistance, reduced stool water content and similar chloride secretion in the distal colon. Transcript levels of goblet cell differentiation factors SPDEF and Math1 were increased in the distal colon of Ednrb(-/-) mice. Both distal colon from Ednrb mice and biopsies from HSCR patients showed reduced Muc4 expression as compared to controls, but similar expression of Muc2. Particle tracking studies showed that mucus from Ednrb(-/-) mice provided a more significant barrier to diffusion of 200 nm nanoparticles as compared to wildtype mice. These results suggest that aganglionosis is associated with increased goblet cell proliferation and differentiation and subsequent altered surface mucus properties, prior to the development of inflammation in the distal colon epithelium. Restoration of normal goblet cell function and mucus layer properties in the colonic epithelium may represent a therapeutic strategy for prevention of HAEC.	[Thiagarajah, Jay R.] Boston Childrens Hosp, Dept Gastroenterol & Nutr, Boston, MA USA; [Yildiz, Hasan; Carlson, Taylor; Carrier, Rebecca L.] Northeastern Univ, Dept Chem Engn, Boston, MA 02115 USA; [Thomas, Alyssa R.; Steiger, Casey; Pieretti, Alberto; Goldstein, Allan M.] Massachusetts Gen Hosp, Dept Pediat Surg, Boston, MA 02114 USA; [Zukerberg, Lawrence R.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA	Harvard University; Boston Children's Hospital; Northeastern University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Goldstein, AM (corresponding author), Massachusetts Gen Hosp, Dept Pediat Surg, Boston, MA 02114 USA.	agoldstein@partners.org	yıldız, hasan/GSN-9276-2022; Carrier, Rebecca/AAK-2315-2020	Pieretti, Alberto/0000-0003-4268-4597	NIH [5R21EB015750]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB015750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by grant NIH 5R21EB015750 (RC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslam A, 1997, J PEDIATR SURG, V32, P1206, DOI 10.1016/S0022-3468(97)90683-7; Aslam A, 1998, J PEDIATR SURG, V33, P103, DOI 10.1016/S0022-3468(98)90372-4; Aslam A, 1999, J PEDIATR SURG, V34, P330, DOI 10.1016/S0022-3468(99)90202-6; Aslam A., 1997, Biochemical Society Transactions, V25, p8S; Austin KM, 2012, SEMIN PEDIATR SURG, V21, P319, DOI 10.1053/j.sempedsurg.2012.07.006; Chen G, 2009, J CLIN INVEST, V119, P2914, DOI 10.1172/JCI39731; Cheng Z, 2010, J PEDIATR SURG, V45, P475, DOI 10.1016/j.jpedsurg.2009.06.009; FUJIMOTO T, 1988, J PEDIATR SURG, V23, P237, DOI 10.1016/S0022-3468(88)80730-9; Gersemann M, 2009, DIFFERENTIATION, V77, P84, DOI 10.1016/j.diff.2008.09.008; Gregorieff A, 2009, GASTROENTEROLOGY, V137, P1333, DOI 10.1053/j.gastro.2009.06.044; HARDY SP, 1993, GUT, V34, P1405, DOI 10.1136/gut.34.10.1405; Heanue TA, 2007, NAT REV NEUROSCI, V8, P466, DOI 10.1038/nrn2137; HEATH AL, 1985, J PEDIATR SURG, V20, P34, DOI 10.1016/S0022-3468(85)80388-2; HOSODA K, 1994, CELL, V79, P1267, DOI 10.1016/0092-8674(94)90017-5; JODAL M, 1993, GASTROENTEROLOGY, V105, P1286, DOI 10.1016/0016-5085(93)90130-5; Johansson MEV, 2013, DIGEST DIS, V31, P305, DOI 10.1159/000354683; Johansson MEV, 2013, NAT REV GASTRO HEPAT, V10, P352, DOI 10.1038/nrgastro.2013.35; Johansson ME, 2013, GUT; Kenny SE, 2010, SEMIN PEDIATR SURG, V19, P194, DOI 10.1053/j.sempedsurg.2010.03.004; Koch S, 2011, GASTROENTEROLOGY, V141, P259, DOI 10.1053/j.gastro.2011.03.043; Lai SK, 2007, P NATL ACAD SCI USA, V104, P1482, DOI 10.1073/pnas.0608611104; Lundgren O, 2000, SCIENCE, V287, P491, DOI 10.1126/science.287.5452.491; Mattar AF, 2003, J PEDIATR SURG, V38, P417, DOI 10.1053/jpsu.2003.50071; McConnell BB, 2011, GASTROENTEROLOGY, V140, P540, DOI 10.1053/j.gastro.2010.10.061; Moore SW, 2008, J PEDIATR SURG, V43, P1439, DOI 10.1016/j.jpedsurg.2007.12.057; Moore SW, 2012, SEMIN PEDIATR SURG, V21, P302, DOI 10.1053/j.sempedsurg.2012.07.004; Neumann H, 2012, INFLAMM BOWEL DIS, V18, P2261, DOI 10.1002/ibd.22907; Noah TK, 2010, EXP CELL RES, V316, P452, DOI 10.1016/j.yexcr.2009.09.020; Oue T, 2000, PEDIATR SURG INT, V16, P267, DOI 10.1007/s003830050742; Park KS, 2007, J CLIN INVEST, V117, P978, DOI 10.1172/JCI29176; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Sbalzarini IF, 2005, J STRUCT BIOL, V151, P182, DOI 10.1016/j.jsb.2005.06.002; Schmitz-Moormann P, 1985, Pathol Annu, V20 Pt 1, P281; Shroyer NF, 2005, GENE DEV, V19, P2412, DOI 10.1101/gad.1353905; Shroyer NF, 2007, GASTROENTEROLOGY, V132, P2478, DOI 10.1053/j.gastro.2007.03.047; Soret R, 2013, NEUROGASTROENT MOTIL, V25, pE755, DOI 10.1111/nmo.12200; Suh JH, 2004, BIOTECHNOL PROGR, V20, P598, DOI 10.1021/bp034251y; TEITELBAUM DH, 1989, J PEDIATR SURG, V24, P1271, DOI 10.1016/S0022-3468(89)80566-4; Thiagarajah JR, 2007, GUT, V56, P1529, DOI 10.1136/gut.2006.104620; Ward NL, 2012, NEUROGASTROENT MOTIL, V24, P874, DOI 10.1111/j.1365-2982.2012.01937.x; Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718; Zhang YQ, 2012, LAB INVEST, V92, P437, DOI 10.1038/labinvest.2011.192	42	37	38	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e99944	10.1371/journal.pone.0099944	http://dx.doi.org/10.1371/journal.pone.0099944			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945437	Green Published, Green Submitted, gold			2022-12-27	WOS:000340721500034
J	Yin, YG; Zhang, Y; Zhao, XH				Yin, Yangguang; Zhang, Yao; Zhao, Xiaohui			Safety and Efficacy of Biodegradable Drug-Eluting vs. Bare Metal Stents: A Meta-Analysis from Randomized Trials	PLOS ONE			English	Article							BIOABSORBABLE POLYMER; FOLLOW-UP; MYOCARDIAL-INFARCTION; CLINICAL-OUTCOMES; EVEROLIMUS; PACLITAXEL; THROMBOSIS; IMPLANTATION; STENOSIS; DISEASE	Background: Biodegradable polymeric coatings have been proposed as a promising strategy to enhance biocompatibility and improve the delayed healing in the vessel. However, the efficacy and safety of biodegradable polymer drug-eluting stents (BP-DES) vs. bare metal stents (BMS) are unknown. The aim of this study was to perform a meta-analysis of randomized controlled trials (RCTs) comparing the outcomes of BP-DES vs. BMS. Methods and Results: PubMed, Embase, and Cochrane Central Register of Controlled Trials (CENTRAL) were searched for randomized clinical trials, until December 2013, that compared any of approved BP-DES and BMS. Efficacy endpoints were target-vessel revascularization (TVR), target-lesion revascularization (TLR) and in-stent late loss (ISLL). Safety endpoints were death, myocardial infarction (MI), definite stent thrombosis (DST). The meta-analysis included 7 RCTs with 2,409 patients. As compared with BMS, there was a significantly reduced TVR (OR [95% CI] = 0.37 [0.28-0.50]), ISLL (OR [95% CI] = -0.41 [-0.48-0.34]) and TLR (OR [95% CI] = 0.38 [0.27-0.52]) in BP-DES patients. However, there were no difference for safety outcomes between BP-DES and BMS. Conclusions: BP-DES is more effective in reducing ISLL, TVR and TLR, as safe as standard BMS with regard to death, ST and MI. Further large RCTs with long-term follow-up are warranted to better define the relative merits of BP-DES.	[Yin, Yangguang; Zhao, Xiaohui] Third Mil Med Univ, Xinqiao Hosp, Cardiovasc Dis Res Ctr, Chongqing, Peoples R China; [Zhang, Yao] Third Mil Med Univ, Evidence Based Med & Clin Epidemiol Ctr, Chongqing, Peoples R China	Army Medical University; Army Medical University	Zhao, XH (corresponding author), Third Mil Med Univ, Xinqiao Hosp, Cardiovasc Dis Res Ctr, Chongqing, Peoples R China.	zxhwn@tmmu.edu.cn			National Natural Science Foundation of China [81070168, 81370213]; Third Military Medical University [2010XLC28]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Third Military Medical University	This study was supported by grants from National Natural Science Foundation of China (81070168 and 81370213) and Third Military Medical University (2010XLC28). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bangalore S, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6625; Bangalore S, 2012, CIRCULATION, V125, P2873, DOI 10.1161/CIRCULATIONAHA.112.097014; Camenzind E, 2007, CIRCULATION, V115, P1440, DOI 10.1161/CIRCULATIONAHA.106.666800; Cochrane Collaboration, COCHRANE HDB SYSTEMA; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014; Finn AV, 2005, CIRCULATION, V112, P270, DOI 10.1161/CIRCULATIONAHA.104.508937; FISCHMAN DL, 1994, NEW ENGL J MED, V331, P496, DOI 10.1056/NEJM199408253310802; Garg S, 2013, NAT REV CARDIOL, V10, P248, DOI 10.1038/nrcardio.2013.13; Grube E, 2004, CIRCULATION, V109, P2168, DOI 10.1161/01.CIR.0000128850.84227.FD; Grube Eberhard, 2005, EuroIntervention, V1, P53; Lemos PA, 2012, EUROINTERVENTION, V8, P117, DOI 10.4244/EIJV8I1A18; Lemos PA, 2009, CATHETER CARDIO INTE, V74, P665, DOI 10.1002/ccd.22166; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; Natsuaki M, 2013, J AM COLL CARDIOL, V62, P181, DOI 10.1016/j.jacc.2013.04.045; Navarese EP, 2011, EUROINTERVENTION, V7, P985, DOI 10.4244/EIJV7I8A155; Omar A, 2014, CATHETER CARDIOVASC; Ormiston JA, 2012, LANCET, V379, P1368, DOI 10.1016/S0140-6736(12)60440-1; Palmerini T, 2014, J AM COLL CARDIOL, V63, P299, DOI 10.1016/j.jacc.2013.09.061; Palmerini T, 2012, LANCET, V379, P1393, DOI 10.1016/S0140-6736(12)60324-9; Raber L, 2012, JAMA-J AM MED ASSOC, V308, P777, DOI 10.1001/jama.2012.10065; Reifart N, 2010, EUROINTERVENTION, V6, P356, DOI 10.4244/EIJV6I3A59; Ricardo Costa RM, 2011, JACC SB, V58; Rodriguez AE, 2011, CATHETER CARDIO INTE, V77, P335, DOI 10.1002/ccd.22769; Rodriguez-Granillo AM MJ, 2013, EUROINTERVENTION; Sabate M, 2014, JACC-CARDIOVASC INTE, V7, P64, DOI 10.1016/j.jcin.2013.09.006; Separham A, 2011, J CARDIOVASC THORAC, V3, P113, DOI 10.5681/jcvtr.2011.025; Silber S, 2011, EUROINTERVENTION, V7, P64, DOI 10.4244/EIJV7I1A13; Smits PC, 2011, J AM COLL CARDIOL, V58, P11, DOI 10.1016/j.jacc.2011.02.023; Smits PC, 2013, LANCET, V381, P651, DOI 10.1016/S0140-6736(12)61852-2; Stefanini GG, 2012, EUR HEART J, V33, P1214, DOI 10.1093/eurheartj/ehs086; Stone GW, 2011, J AM COLL CARDIOL, V58, P19, DOI 10.1016/j.jacc.2011.02.022; Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tada T, 2014, INT J CARDIOVAS IMAG, V30, P495, DOI 10.1007/s10554-014-0376-1; Valgimigli M, 2014, JACC-CARDIOVASC INTE, V7, P20, DOI 10.1016/j.jcin.2013.09.008; Virmani R, 2004, CIRCULATION, V109, P701, DOI 10.1161/01.CIR.0000116202.41966.D4; Zhang YJ, 2014, J CARDIOL	39	5	5	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e99648	10.1371/journal.pone.0099648	http://dx.doi.org/10.1371/journal.pone.0099648			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945816	gold, Green Published, Green Submitted			2022-12-27	WOS:000340721500026
J	Gedaly, R; Galuppo, R; Daily, MF; Shah, M; Maynard, E; Chen, CG; Zhang, XP; Esser, KA; Cohen, DA; Evers, BM; Jiang, JY; Spear, BT				Gedaly, Roberto; Galuppo, Roberto; Daily, Michael F.; Shah, Malay; Maynard, Erin; Chen, Changguo; Zhang, Xiping; Esser, Karyn A.; Cohen, Donald A.; Evers, B. Mark; Jiang, Jieyun; Spear, Brett T.			Targeting the Wnt/beta-Catenin Signaling Pathway in Liver Cancer Stem Cells and Hepatocellular Carcinoma Cell Lines with FH535	PLOS ONE			English	Article							ALPHA-FETOPROTEIN ENHANCER; BETA-CATENIN; INHIBITION; ACTIVATION; SORAFENIB; CYCLE; PI3K/AKT/MTOR; TRANSCRIPTION; RAS/RAF/MAPK; APOPTOSIS	Activation of the Wnt/beta-catenin pathway has been observed in at least 1/3 of hepatocellular carcinomas (HCC), and a significant number of these have mutations in the beta-catenin gene. Therefore, effective inhibition of this pathway could provide a novel method to treat HCC. The purposed of this study was to determine whether FH535, which was previously shown to block the beta-catenin pathway, could inhibit beta-catenin activation of target genes and inhibit proliferation of Liver Cancer Stem Cells (LCSC) and HCC cell lines. Using beta-catenin responsive reporter genes, our data indicates that FH535 can inhibit target gene activation by endogenous and exogenously expressed beta-catenin, including the constitutively active form of beta-catenin that contains a Serine37Alanine mutation. Our data also indicate that proliferation of LCSC and HCC lines is inhibited by FH535 in a dose-dependent manner, and that this correlates with a decrease in the percentage of cells in S phase. Finally, we also show that expression of two well-characterized targets of beta-catenin, Cyclin D1 and Survivin, is reduced by FH535. Taken together, this data indicates that FH535 has potential therapeutic value in treatment of liver cancer. Importantly, these results suggest that this therapy may be effective at several levels by targeting both HCC and LCSC.	[Gedaly, Roberto; Galuppo, Roberto; Daily, Michael F.; Shah, Malay; Maynard, Erin; Chen, Changguo] Univ Kentucky, Dept Surg, Lexington, KY 40506 USA; [Zhang, Xiping; Esser, Karyn A.] Univ Kentucky, Dept Physiol, Lexington, KY USA; [Cohen, Donald A.; Jiang, Jieyun; Spear, Brett T.] Univ Kentucky, Dept Microbiol Immunol & Mol Genet, Lexington, KY USA; [Cohen, Donald A.; Evers, B. Mark; Jiang, Jieyun; Spear, Brett T.] Univ Kentucky, Markey Canc Ctr, Lexington, KY USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky	Gedaly, R (corresponding author), Univ Kentucky, Dept Surg, Lexington, KY 40506 USA.	rgeda2@uky.edu		Spear, Brett/0000-0002-4343-9393	National Center for Research Resources (NCRR) [UL1RR033173, TL1 RR033172, KL2 RR033171]; Office of the Director, National Institutes of Health (NIH) [DK074816]; NIH Roadmap for Medical Research; Flow Cytometry and Cell Sorting Shared Resource of the University of Kentucky Markey Cancer Center [P30CA177558]; NATIONAL CANCER INSTITUTE [P30CA177558] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000117] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR033171, TL1RR033172, UL1RR033173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR061939] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074816] Funding Source: NIH RePORTER	National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of the Director, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Flow Cytometry and Cell Sorting Shared Resource of the University of Kentucky Markey Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This publication was supported by grant number UL1RR033173 [TL1 RR033172, KL2 RR033171] from the National Center for Research Resources (NCRR), DK074816 (BTS) funded by the Office of the Director, National Institutes of Health (NIH), and supported by the NIH Roadmap for Medical Research. This research also was supported by the Flow Cytometry and Cell Sorting Shared Resource of the University of Kentucky Markey Cancer Center (P30CA177558). The content is solely the responsibility of the authors and does not necessarily represent the official views of NCRR and NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Chang JS, 2005, LIFE SCI, V76, P1883, DOI 10.1016/j.lfs.2004.11.003; Clinkenbeard EL, 2012, HEPATOLOGY, V56, P1892, DOI 10.1002/hep.25819; Fabregat I, 2009, WORLD J GASTROENTERO, V15, P513, DOI 10.3748/wjg.15.513; Fujikawa T, 2007, J GASTROEN HEPATOL, V22, P436, DOI 10.1111/j.1440-1746.2006.04541.x; Gedaly R, 2013, J SURG RES, V185, P225, DOI 10.1016/j.jss.2013.05.016; Gedaly R, 2012, J SURG RES, V176, P542, DOI 10.1016/j.jss.2011.10.045; Gedaly R, 2010, ANTICANCER RES, V30, P4951; Ghous Z, 2008, ANTICANCER RES, V28, P3757; GODBOUT R, 1988, GENE DEV, V2, P949, DOI 10.1101/gad.2.8.949; GROUPP ER, 1994, J BIOL CHEM, V269, P22178; Handeli S, 2008, MOL CANCER THER, V7, P521, DOI 10.1158/1535-7163.MCT-07-2063; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Hui AM, 1998, HEPATO-GASTROENTEROL, V45, P1635; Jennings BH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-205; Ji JF, 2012, SEMIN ONCOL, V39, P461, DOI 10.1053/j.seminoncol.2012.05.011; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Llovet JM, 2008, HEPATOLOGY, V48, P1312, DOI 10.1002/hep.22506; Lopez-Terrada D, 2009, HUM PATHOL, V40, P1512, DOI 10.1016/j.humpath.2009.07.003; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Nambotin SB, 2011, ANTI-CANCER AGENT ME, V11, P549; Olmeda D, 2003, MOL BIOL CELL, V14, P2844, DOI 10.1091/mbc.E03-01-0865; Orford K, 1997, J BIOL CHEM, V272, P24735, DOI 10.1074/jbc.272.40.24735; Palacino JJ, 2001, J BIOL CHEM, V276, P38563, DOI 10.1074/jbc.M105376200; Sameh M. A., 2011, INT J HEPATOL, V2011, P1; Shi ZD, 2012, J NEUROIMMUNE PHARM, V7, P892, DOI 10.1007/s11481-012-9354-3; Su SJ, 2003, NUTR CANCER, V45, P113, DOI 10.1207/S15327914NC4501_13; Sun YN, 2000, P NATL ACAD SCI USA, V97, P12613, DOI 10.1073/pnas.220158597; Takigawa Y, 2008, CURR DRUG TARGETS, V9, P1013, DOI 10.2174/138945008786786127; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tong CM, 2011, J GASTROEN HEPATOL, V26, P1229, DOI 10.1111/j.1440-1746.2011.06762.x; Wachter J, 2012, INT J BIOL SCI, V8, P15, DOI 10.7150/ijbs.8.15; Welzel TM, 2013, AM J GASTROENTEROL, V108, P1314, DOI 10.1038/ajg.2013.160; Whitfield JF, 2009, CANCER LETT, V275, P9, DOI 10.1016/j.canlet.2008.07.001; Yamashita T, 2007, CANCER RES, V67, P10831, DOI 10.1158/0008-5472.CAN-07-0908; Zaffaroni N, 2007, CELL ONCOL, V29, P453	39	81	85	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99272	10.1371/journal.pone.0099272	http://dx.doi.org/10.1371/journal.pone.0099272			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940873	Green Submitted, Green Published, gold			2022-12-27	WOS:000338508200018
J	Le Roux, DS; Ikin, K; Lindenmayer, DB; Manning, AD; Gibbons, P				Le Roux, Darren S.; Ikin, Karen; Lindenmayer, David B.; Manning, Adrian D.; Gibbons, Philip			The Future of Large Old Trees in Urban Landscapes	PLOS ONE			English	Article							COARSE WOODY DEBRIS; CONSERVATION IMPLICATIONS; KEYSTONE STRUCTURES; SCATTERED TREES; NEST BOXES; HOLLOWS; FORESTS; REGENERATION; DECLINE; BIODIVERSITY	Large old trees are disproportionate providers of structural elements (e. g. hollows, coarse woody debris), which are crucial habitat resources for many species. The decline of large old trees in modified landscapes is of global conservation concern. Once large old trees are removed, they are difficult to replace in the short term due to typically prolonged time periods needed for trees to mature (i.e. centuries). Few studies have investigated the decline of large old trees in urban landscapes. Using a simulation model, we predicted the future availability of native hollow-bearing trees (a surrogate for large old trees) in an expanding city in southeastern Australia. In urban greenspace, we predicted that the number of hollow-bearing trees is likely to decline by 87% over 300 years under existing management practices. Under a worst case scenario, hollow-bearing trees may be completely lost within 115 years. Conversely, we predicted that the number of hollow-bearing trees will likely remain stable in semi-natural nature reserves. Sensitivity analysis revealed that the number of hollow-bearing trees perpetuated in urban greenspace over the long term is most sensitive to the: (1) maximum standing life of trees; (2) number of regenerating seedlings ha 21; and (3) rate of hollow formation. We tested the efficacy of alternative urban management strategies and found that the only way to arrest the decline of large old trees requires a collective management strategy that ensures: (1) trees remain standing for at least 40% longer than currently tolerated lifespans; (2) the number of seedlings established is increased by at least 60%; and (3) the formation of habitat structures provided by large old trees is accelerated by at least 30% (e. g. artificial structures) to compensate for short term deficits in habitat resources. Immediate implementation of these recommendations is needed to avert long term risk to urban biodiversity.	[Le Roux, Darren S.; Ikin, Karen; Lindenmayer, David B.; Manning, Adrian D.; Gibbons, Philip] Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia	Australian National University	Le Roux, DS (corresponding author), Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia.	darren_lrx@yahoo.com	Ikin, Karen/G-2845-2012; Gibbons, Philip/I-8248-2012; Manning, Adrian/AAX-7288-2021; Lindenmayer, David B/P-7183-2017; Manning, Adrian/AAG-2949-2019	Manning, Adrian/0000-0003-0989-9203; Lindenmayer, David B/0000-0002-4766-4088; 	Australian National University; Land Development Agency (ACT Government); Environmental Decision Hub of the Australian Government's National Environmental Research Program	Australian National University(Australian National University); Land Development Agency (ACT Government); Environmental Decision Hub of the Australian Government's National Environmental Research Program	Darren Le Roux was funded by an Australian Postgraduate Award from the Australian National University and a top-up scholarship from the Land Development Agency (ACT Government). The authors also received funding from The Environmental Decision Hub of the Australian Government's National Environmental Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACT Government, 2011, POP RES DENS CANB; [ACT Government Territory and Municipal Services], 2012, CANB TREE AUD METH F; ACT Government, 2013, MAN TREES PUBL LAND; Adkins M. F., 2006, Australian Forestry, V69, P107; Andersson R, 2004, BIOL CONSERV, V118, P443, DOI 10.1016/j.biocon.2003.09.020; [Anonymous], 2004, WOODL WILDL ACT LOWL; Banks J.C.G., 1997, COMING AGE FOREST AG, P17; Banks John C. G., 2003, Urban Forestry & Urban Greening, V1, P151, DOI 10.1078/1618-8667-00015; Blewett CM, 2005, CONDOR, V107, P678, DOI 10.1650/0010-5422(2005)107[0678:EOUSOS]2.0.CO;2; BULL EL, 1986, WILDLIFE SOC B, V14, P142; CAREY A B, 1981, Wildlife Society Bulletin, V9, P14; Carpaneto GM, 2010, J INSECT CONSERV, V14, P555, DOI 10.1007/s10841-010-9283-5; Cockle KL, 2011, FRONT ECOL ENVIRON, V9, P377, DOI 10.1890/110013; Cohen JE, 2003, SCIENCE, V302, P1172, DOI 10.1126/science.1088665; Department of the Environment and Heritage, 2006, EPBC POL STAT 3 5 WH; Fischer J, 2010, P NATL ACAD SCI USA, V107, P19597, DOI 10.1073/pnas.1008476107; Fischer J, 2009, P NATL ACAD SCI USA, V106, P10386, DOI 10.1073/pnas.0900110106; Gibbons P, 2008, CONSERV BIOL, V22, P1309, DOI 10.1111/j.1523-1739.2008.00997.x; Gibbons P., 2000, Pacific Conservation Biology, V6, P218; Gibbons P, 2002, BIOL CONSERV, V103, P1, DOI 10.1016/S0006-3207(01)00109-4; Gibbons P., 2002, TREE HOLLOWS WILDLIF, DOI [10.1071/9780643090033, DOI 10.1071/9780643090033]; Gibbons P, 2008, BIOL CONSERV, V141, P2483, DOI 10.1016/j.biocon.2008.07.009; Gibbons Philip, 2002, Ecological Management & Restoration, V3, P205, DOI 10.1046/j.1442-8903.2002.00114.x; Gibbons P, 2010, FOREST ECOL MANAG, V260, P975, DOI 10.1016/j.foreco.2010.06.016; Goodburn JM, 1998, CAN J FOREST RES, V28, P427, DOI 10.1139/cjfr-28-3-427; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Hane ME, 2012, FOREST ECOL MANAG, V282, P167, DOI 10.1016/j.foreco.2012.06.037; Harper MJ, 2005, WILDLIFE RES, V32, P509, DOI 10.1071/WR04106; Harper MJ, 2005, BIOL CONSERV, V122, P181, DOI 10.1016/j.biocon.2004.07.003; Laurance WF, 1997, SCIENCE, V278, P1117, DOI 10.1126/science.278.5340.1117; Laurance WF, 2000, NATURE, V404, P836, DOI 10.1038/35009032; Lehvavirta S, 2002, J VEG SCI, V13, P57, DOI 10.1111/j.1654-1103.2002.tb02023.x; Lindenmayer D., 2013, CONSTR LETT IN PRESS, V1, P1, DOI DOI 10.1111/C0N1.12013; Lindenmayer DB, 2012, SCIENCE, V338, P1305, DOI 10.1126/science.1231070; Lindenmayer DB, 2010, CAN J FOREST RES, V40, P48, DOI 10.1139/X09-185; Lindenmayer DB, 2009, BIOL CONSERV, V142, P33, DOI 10.1016/j.biocon.2008.09.026; LINDENMAYER DB, 1990, BIOL CONSERV, V54, P133, DOI 10.1016/0006-3207(90)90138-F; Lutz JA, 2009, FOREST ECOL MANAG, V257, P2296, DOI 10.1016/j.foreco.2009.03.009; Manning AD, 2013, ANIM CONSERV, V16, P395, DOI 10.1111/acv.12006; Manning AD, 2004, BIOL CONSERV, V120, P363, DOI 10.1016/j.biocon.2004.03.008; Manning AD, 2006, BIOL CONSERV, V132, P311, DOI 10.1016/j.biocon.2006.04.023; Manning Adrian D., 2007, Ecological Management & Restoration, V8, P221, DOI 10.1111/j.1442-8903.2007.00371.x; MCCARTHY MA, 1995, BIOL CONSERV, V73, P93, DOI 10.1016/0006-3207(95)00046-7; Mcdonald RI, 2008, BIOL CONSERV, V141, P1695, DOI 10.1016/j.biocon.2008.04.025; Mooney C.Z., 1997, MONTE CARLO SIMULATI; Nagendra H, 2010, URBAN FOR URBAN GREE, V9, P129, DOI 10.1016/j.ufug.2009.12.005; NEWTON I, 1994, BIOL CONSERV, V70, P265, DOI 10.1016/0006-3207(94)90172-4; Nowak David J., 2004, Urban Forestry & Urban Greening, V2, P139, DOI 10.1078/1618-8667-00030; Pauleit S, 2005, LANDSCAPE URBAN PLAN, V71, P295, DOI [10.1016/S0169-2046(04)00083-0, 10.1016/j.landurbplan.2004.03.009]; Pauleit S, 2003, P I CIVIL ENG-MUNIC, V156, P43, DOI 10.1680/muen.2003.156.1.43; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; Pincetl S, 2010, ENVIRON MANAGE, V45, P227, DOI 10.1007/s00267-009-9412-7; Pulido FJ, 2001, FOREST ECOL MANAG, V146, P1, DOI 10.1016/S0378-1127(00)00443-6; Ranius T, 2002, BIOL CONSERV, V103, P85, DOI 10.1016/S0006-3207(01)00124-0; Ranius T, 2009, FOREST ECOL MANAG, V257, P303, DOI 10.1016/j.foreco.2008.09.007; Rayner L, 2011, AUSTRAL ECOL, V36, P252, DOI 10.1111/j.1442-9993.2010.02145.x; Rhodes M, 2006, APPL NETWORK ANAL CO; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; SCHONAU APG, 1989, FOREST ECOL MANAG, V29, P245, DOI 10.1016/0378-1127(89)90097-2; Shepherd K. R., 1957, Australian Forestry, V21, P70; Sodhi NS, 2010, BIOL CONSERV, V143, P2375, DOI 10.1016/j.biocon.2009.12.029; Stagoll K, 2012, CONSERV LETT, V5, P115, DOI 10.1111/j.1755-263X.2011.00216.x; Terho M, 2009, URBAN FOR URBAN GREE, V8, P77, DOI 10.1016/j.ufug.2009.02.004; Theobald DM, 1997, LANDSCAPE URBAN PLAN, V39, P25, DOI 10.1016/S0169-2046(97)00041-8; Thor G, 2010, BIODIVERS CONSERV, V19, P2307, DOI 10.1007/s10531-010-9843-8; Tonnesen AS, 1997, WEST N AM NATURALIST, V57, P55; Webb JK, 1997, BIOL CONSERV, V81, P21, DOI 10.1016/S0006-3207(96)00160-7; Weinberg A, 2011, BIOL CONSERV, V144, P227, DOI 10.1016/j.biocon.2010.08.020; WELLINGTON AB, 1985, J ECOL, V73, P645, DOI 10.2307/2260501; White JW, 2014, OIKOS, V123, P385, DOI 10.1111/j.1600-0706.2013.01073.x; Whitford K. R., 1995, Australian Forestry, V58, P172; Wu Chunxia, 2008, Urban Forestry & Urban Greening, V7, P65, DOI 10.1016/j.ufug.2008.01.002	72	58	64	6	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99403	10.1371/journal.pone.0099403	http://dx.doi.org/10.1371/journal.pone.0099403			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941258	Green Published, Green Submitted, gold			2022-12-27	WOS:000338508200022
J	Mitra, S; Wade, MS; Sun, XG; Moldobaeva, N; Flores, C; Ma, SF; Zhang, W; Garcia, JGN; Jacobson, JR				Mitra, Sumegha; Wade, Michael S.; Sun, Xiaoguang; Moldobaeva, Nurgul; Flores, Carlos; Ma, Shwu-Fan; Zhang, Wei; Garcia, Joe G. N.; Jacobson, Jeffrey R.			GADD45a Promoter Regulation by a Functional Genetic Variant Associated with Acute Lung Injury	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; COLONY-ENHANCING FACTOR; POLYMORPHISMS; SEPSIS; EXPRESSION; RISK; SUSCEPTIBILITY; TRANSCRIPTION; DEFINITIONS; HAPLOTYPE	Rationale: Growth arrest DNA damage inducible alpha (GADD45a) is a stress-induced gene we have shown to participate in the pathophysiology of ventilator-induced lung injury (VILI) via regulation of mechanical stress-induced Akt ubiquitination and phosphorylation. The regulation of GADD45a expression by mechanical stress and its relationship with acute lung injury (ALI) susceptibility and severity, however, remains unknown. Objectives: We examined mechanical stress-dependent regulatory elements (MSRE) in the GADD45a promoter and the contribution of promoter polymorphisms in GADD45a expression and ALI susceptibility. Methods and Results: Initial studies in GADD45a knockout and heterozygous mice confirmed the relationship of GADD45a gene dose to VILI severity. Human lung endothelial cells (EC) transfected with a luciferase vector containing the full length GADD45a promoter sequence (-771 to +223) demonstrated a >4 fold increase in GADD45a expression in response to 18% cyclic stretch (CS, 4 h) compared to static controls while specific promoter regions harboring CS-dependent MSRE were identified using vectors containing serial deletion constructs of the GADD45a promoter. In silico analyses of GADD45a promoter region (-371 to -133) revealed a potential binding site for specificity protein 1 (SP1), a finding supported by confirmed SP1 binding with the GADD45a promoter and by the significant attenuation of CS-dependent GADD45a promoter activity in response to SP1 silencing. Separately, case-control association studies revealed a significant association of a GADD45a promoter SNP at -589 (rs581000, G>C) with reduced ALI susceptibility. Subsequently, we found allelic variation of this SNP is associated with both differential GADD45a expression in mechanically stressed EC (18% CS, 4 h) and differential binding site of interferon regulatory factor 7 (IRF7) at this site. Conclusion: These results strongly support a functional role for GADD45a in ALI/VILI and identify a specific gene variant that confers risk for ALI.	[Mitra, Sumegha; Wade, Michael S.; Sun, Xiaoguang; Moldobaeva, Nurgul; Zhang, Wei; Jacobson, Jeffrey R.] Univ Illinois, Dept Med, Div Pulm Crit Care Sleep & Allergy, Chicago, IL 60607 USA; [Flores, Carlos] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Resp, Madrid, Spain; [Flores, Carlos] Hosp Univ Nuestra Senora Candelaria, Res Unit, Tenerife, Spain; [Ma, Shwu-Fan] Univ Illinois, Div Pulm Crit Care & Sleep, Chicago, IL USA; [Zhang, Wei] Univ Illinois, Dept Pediat, Chicago, IL USA; [Garcia, Joe G. N.] Univ Arizona, Arizona Hlth Sci Ctr, Tucson, AZ USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Arizona; University of Arizona Health Sciences	Jacobson, JR (corresponding author), Univ Illinois, Dept Med, Div Pulm Crit Care Sleep & Allergy, Chicago, IL 60607 USA.	jrjacob@uic.edu	Flores, Carlos/R-1159-2019	Flores, Carlos/0000-0001-5352-069X; Mitra, Sumegha/0000-0002-5567-3347	NCATS NIH HHS [UL1 TR000430] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Altemeier WA, 2005, J IMMUNOL, V175, P3369, DOI 10.4049/jimmunol.175.5.3369; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Birukov KG, 2003, AM J PHYSIOL-LUNG C, V285, pL785, DOI 10.1152/ajplung.00336.2002; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Cao YX, 2003, J CELL BIOCHEM, V89, P887, DOI 10.1002/jcb.10555; Flores C, 2008, TRANSL RES, V152, P11, DOI 10.1016/j.trsl.2008.05.006; Gao L, 2006, AM J RESP CELL MOL, V34, P487, DOI 10.1165/rcmb.2005-0404OC; Gao L, 2007, TRANSL RES, V150, P18, DOI 10.1016/j.trsl.2007.02.007; Grigoryev DN, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-r34; Han YJ, 2012, J MOL MED, V90, P299, DOI 10.1007/s00109-011-0820-9; Hollander MC, 1999, NAT GENET, V23, P176, DOI 10.1038/13802; Hong SB, 2008, AM J RESP CRIT CARE, V178, P605, DOI 10.1164/rccm.200712-1822OC; Lin Z, 2000, CLIN GENET, V58, P181, DOI 10.1034/j.1399-0004.2000.580305.x; Liu YX, 2012, CLIN CHEM LAB MED, V50, P1917, DOI 10.1515/cclm-2012-0238; Ma SF, 2011, AM J RESP CELL MOL, V45, P1203, DOI 10.1165/rcmb.2011-0179OC; Marshall RP, 2002, AM J RESP CRIT CARE, V166, P646, DOI 10.1164/rccm.2108086; Meyer NJ, 2009, FASEB J, V23, P1325, DOI 10.1096/fj.08-119073; Mitra S, 2006, MATURITAS, V55, P27, DOI 10.1016/j.maturitas.2006.01.003; Mitra S, 2011, AM J RESP CRIT CARE, V184, P1030, DOI 10.1164/rccm.201103-0447OC; Moss M, 2002, CRIT CARE MED, V30, P1679, DOI 10.1097/00003246-200208000-00001; Nemeth E, 2000, AM J OBSTET GYNECOL, V182, P50, DOI 10.1016/S0002-9378(00)70490-X; Ney L, 2000, NEW ENGL J MED, V343, P812; O'Mahony DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051104; Pino-Yanes M, 2011, AM J RESP CELL MOL, V45, P740, DOI 10.1165/rcmb.2010-0292OC; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Seefried L, 2010, EUR CELLS MATER, V20, P344; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; Song ZJ, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-168; Tejera P, 2012, J MED GENET, V49, P671, DOI 10.1136/jmedgenet-2012-100972; Weale ME, 2003, AM J HUM GENET, V73, P551, DOI 10.1086/378098; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Ye SQ, 2005, AM J RESP CRIT CARE, V171, P361, DOI 10.1164/rccm.200404-563OC	35	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100169	10.1371/journal.pone.0100169	http://dx.doi.org/10.1371/journal.pone.0100169			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940746	gold, Green Submitted, Green Published			2022-12-27	WOS:000338508200080
J	Guariglia, P; Matano, A; Piccardi, L				Guariglia, Paola; Matano, Alessandro; Piccardi, Laura			Bisecting or Not Bisecting: This Is the Neglect Question. Line Bisection Performance in the Diagnosis of Neglect in Right Brain-Damaged Patients	PLOS ONE			English	Article							HORIZONTAL SPACE MISREPRESENTATION; UNILATERAL SPATIAL NEGLECT; VISUAL NEGLECT; VISUOSPATIAL NEGLECT; HEMINEGLECT DISORDER; HEMISPATIAL NEGLECT; EYE-MOVEMENTS; HEMIANOPIA; STROKE; REHABILITATION	In the present study we analysed the bisecting behaviour of 287 chronic right brain-damaged patients by taking into account the presence and severity of extrapersonal and/or personal neglect diagnosed with the hemineglect battery. We also analysed right brain-damaged patients who had (or did not have) neglect according to their line bisection performance. Our results showed that performance of the line bisection task correlates with performance of cancellation tasks, reading and perceptual tasks, but not with the presence of personal neglect. Personal neglect seems to be unrelated to line bisection behaviour. Indeed, patients affected by extrapersonal and personal neglect do not show more severe neglect in line bisection than patients with only extrapersonal neglect. Furthermore, we observed that 20.56% of the patients were considered affected or not by neglect on the line bisection task compared with the other spatial tasks of the hemineglect battery. We conclude that using a battery with multiple tests is the only way to guarantee a reliable diagnosis and effectively plan for rehabilitative training.	[Guariglia, Paola] Univ Enna Kore, Dipartimento Sci Uomo & Soc, Enna, Italy; [Matano, Alessandro; Piccardi, Laura] IRCCS Fdn Santa Lucia, Unita Neuropsicol, Rome, Italy; [Piccardi, Laura] Univ Aquila, Dipartimento Med Clin Sanita Pubbl Sci Vita & Amb, I-67100 Laquila, Italy	Universita Kore di ENNA; IRCCS Santa Lucia; University of L'Aquila	Guariglia, P (corresponding author), Univ Enna Kore, Dipartimento Sci Uomo & Soc, Enna, Italy.	paola.guariglia@unikore.it	Piccardi, laura/AAC-7587-2022	Piccardi, Laura/0000-0002-1322-5538				ALBERT ML, 1973, NEUROLOGY, V23, P658, DOI 10.1212/WNL.23.6.658; [Anonymous], 1989, PSYCHOL ASSESSMENT; Azouvi P, 2002, J NEUROL NEUROSUR PS, V73, P160, DOI 10.1136/jnnp.73.2.160; Azouvi P, 2006, RESTOR NEUROL NEUROS, V24, P273; Baas U, 2011, NEUROPSYCHOLOGIA, V49, P898, DOI 10.1016/j.neuropsychologia.2011.01.043; BINDER J, 1992, ARCH NEUROL-CHICAGO, V49, P1187, DOI 10.1001/archneur.1992.00530350109026; BISIACH E, 1986, NEUROPSYCHOLOGIA, V24, P759, DOI 10.1016/0028-3932(86)90075-8; Bisiach E, 1978, CORTEX; Bowen A, 1999, STROKE, V30, P1196, DOI 10.1161/01.STR.30.6.1196; Buxbaum LJ, 2004, NEUROLOGY, V62, P749, DOI 10.1212/01.WNL.0000113730.73031.F4; Ciurli P, 1996, ESAME LINGUAGGIO 2; Committeri G, 2007, BRAIN, V130, P431, DOI 10.1093/brain/awl265; Diller L, 1977, Adv Neurol, V18, P63; Doricchi F, 1999, NEUROLOGY, V52, P1845, DOI 10.1212/WNL.52.9.1845; Doricchi F, 2005, BRAIN, V128, P1386, DOI 10.1093/brain/awh461; Doricchi F, 2003, J NEUROL NEUROSUR PS, V74, P116, DOI 10.1136/jnnp.74.1.116; Doricchi F, 2002, NEUROPSYCHOLOGIA, V40, P1118, DOI 10.1016/S0028-3932(02)00011-8; Doricchi F, 2002, NEUROPSYCHOLOGIA, V40, P1107, DOI 10.1016/S0028-3932(02)00010-6; GROSSI D, 1989, BRAIN COGNITION, V10, P18, DOI 10.1016/0278-2626(89)90072-9; GUARIGLIA C, 1992, NEUROPSYCHOLOGIA, V30, P1001, DOI 10.1016/0028-3932(92)90051-M; Guariglia C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067390; HALLIGAN PW, 1991, NATURE, V350, P498, DOI 10.1038/350498a0; Halligan PW, 2003, TRENDS COGN SCI, V7, P125, DOI 10.1016/S1364-6613(03)00032-9; HALLIGAN PW, 1992, CORTEX, V28, P525, DOI 10.1016/S0010-9452(13)80225-0; Jehkonen M, 1998, LANCET, V351, P727, DOI 10.1016/S0140-6736(05)78497-X; Machner B, 2009, J NEUROL, V256, P289, DOI 10.1007/s00415-009-0148-3; MASSIRONI M, 1988, NEUROPSYCHOLOGIA, V26, P161, DOI 10.1016/0028-3932(88)90039-5; Molenberghs P, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00078; Molenberghs P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023017; Ota H, 2001, NEUROLOGY, V57, P2064, DOI 10.1212/WNL.57.11.2064; Pizzamiglio L, 2004, CORTEX, V40, P441, DOI 10.1016/S0010-9452(08)70138-2; Raven J. C., 1938, STANDARD PROGRESSIVE; Rorden C, 2006, BRAIN RES, V1080, P17, DOI 10.1016/j.brainres.2004.10.071; Saj A, 2012, BRAIN, V135, DOI 10.1093/brain/awr227; Saj A, 2012, NEUROPSYCHOLOGY, V26, P37, DOI 10.1037/a0025733; Schuett S, 2009, VISION RES, V49, P1668, DOI 10.1016/j.visres.2009.04.004; Spinnler H., 1987, ITAL J NEUROL SCI, V6, P1; Vallar G, 1998, TRENDS COGN SCI, V2, P87, DOI 10.1016/S1364-6613(98)01145-0; Verdon V, 2010, BRAIN, V133, P880, DOI 10.1093/brain/awp305; WILSON B, 1987, ARCH PHYS MED REHAB, V68, P98; Zihl J, 2009, NEUROPSYCHOLOGIA, V47, P2417, DOI 10.1016/j.neuropsychologia.2009.04.009; ZOCCOLOTTI P, 1989, INT J NEUROSCI, V47, P209, DOI 10.3109/00207458908987435; Zoccolotti P., 1991, NEUROPSYCHOL REHABIL, V1, P33, DOI [10.1080/09602019108401378, DOI 10.1080/09602019108401378]	43	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99700	10.1371/journal.pone.0099700	http://dx.doi.org/10.1371/journal.pone.0099700			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937472	Green Published, gold, Green Submitted			2022-12-27	WOS:000338503400032
J	Niemuth, ND; Fleming, KK; Reynolds, RE				Niemuth, Neal D.; Fleming, Kathleen K.; Reynolds, Ronald E.			Waterfowl Conservation in the US Prairie Pothole Region: Confronting the Complexities of Climate Change	PLOS ONE			English	Article							NORTH-DAKOTA; LAND-USE; WETLANDS; TRENDS; UNCERTAINTY; HYDROLOGY; DYNAMICS; SURVIVAL; FISH; SIZE	The Prairie Pothole Region (PPR) is the most important waterfowl production area in North America. However, waterfowl populations there are predicted to decline because of climate-related drying of wetlands. Consequently, changes in the geographic focus of PPR waterfowl conservation have been recommended, which could have long-lasting and costly impacts. We used a 40-year dataset of pond counts collected in the PPR to test hypotheses about climate-related drying. We assessed May (1974-2013) and July (1974-2003) pond numbers in 20 waterfowl survey strata to determine if trends in pond numbers were consistent with predictions of drying. We also assessed trends in precipitation and temperature for the 20 strata and developed models describing May pond numbers from 1974 through 2010 as a function of precipitation, temperature, the previous year's pond numbers, and location. None of the 20 strata showed significant declines in May pond numbers, although seven strata showed increases over time. July pond numbers declined significantly in one stratum, and increased in seven strata. An index to hydroperiod showed significant increasing trends in three strata, and no strata had decreasing trends. Precipitation increased significantly in two strata and decreased in two from 1974 to 2010; no strata showed significant changes in temperature. The best linear model described pond numbers within all strata as a function of precipitation, temperature, the previous year's pond numbers, and the latitude and longitude of the stratum, and explained 62% of annual variation in pond numbers. We hypothesize that direct effects of climate change on prairie pothole wetlands and waterfowl may be overshadowed by indirect effects such as intensified land use and increased pressure to drain wetlands. We recommend that an adaptive, data-driven approach be used to resolve uncertainties regarding direct and indirect effects of climate change on prairie wetlands and waterfowl, and guide future conservation efforts.	[Niemuth, Neal D.; Reynolds, Ronald E.] US Fish & Wildlife Serv, Habitat & Populat Evaluat Team, Bismarck, ND 58501 USA; [Fleming, Kathleen K.] US Fish & Wildlife Serv, Div Migratory Bird Management, Laurel, MD USA	United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; US Fish & Wildlife Service	Niemuth, ND (corresponding author), US Fish & Wildlife Serv, Habitat & Populat Evaluat Team, Bismarck, ND 58501 USA.	Neal_Niemuth@fws.gov						Ando AW, 2012, P NATL ACAD SCI USA, V109, P6484, DOI 10.1073/pnas.1114653109; [Anonymous], 2009, CLIMATE CHANGE IMPAC, DOI DOI 10.1111/j.1365-2664.2010.01827.x; [Anonymous], 2012, KIKA; Batt B.D.J., 1989, P204; BETHKE RW, 1995, ECOL APPL, V5, P588, DOI 10.2307/1941969; Bouffard SH, 1997, WILDLIFE SOC B, V25, P146; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Conly FM, 2001, ENVIRON MONIT ASSESS, V67, P195, DOI 10.1023/A:1006486607040; Cowardin LM, 1995, 2 NAT BIOL SERV; Cox RR, 1998, J WILDLIFE MANAGE, V62, P124, DOI 10.2307/3802270; Doherty KE, 2013, WILDLIFE SOC B, V37, P546, DOI 10.1002/wsb.284; Fargione JE, 2009, BIOSCIENCE, V59, P767, DOI 10.1525/bio.2009.59.9.8; Felton A, 2009, BIODIVERS CONSERV, V18, P2243, DOI 10.1007/s10531-009-9652-0; Fry JA, 2011, PHOTOGRAMM ENG REM S, V77, P859; HARRIS SW, 1963, ECOLOGY, V44, P331, DOI 10.2307/1932180; Hintze J, 2007, NUMBER CRUNCHER STAT; Horn DJ, 2005, ECOL APPL, V15, P1367, DOI 10.1890/03-5254; Johnson RR, 2008, J SOIL WATER CONSERV, V63, p84A, DOI 10.2489/63.3.84A; Johnson WC, 2010, BIOSCIENCE, V60, P128, DOI 10.1525/bio.2010.60.2.7; Johnson WC, 2005, BIOSCIENCE, V55, P863, DOI 10.1641/0006-3568(2005)055[0863:VONPWT]2.0.CO;2; Kantrud H.A., 1989, US FISH WILDLIFE SER, V85; KLETT AT, 1988, J WILDLIFE MANAGE, V52, P431, DOI 10.2307/3801586; KRAPU GL, 1983, AUK, V100, P689, DOI 10.1093/auk/100.3.689; Krapu GL, 2004, WILDLIFE SOC B, V32, P127, DOI 10.2193/0091-7648(2004)32[127:LWCMLI]2.0.CO;2; LaBaugh J. W., 1989, Northern prairie wetlands., P56; Laingen Chris, 2012, PAPERS APPL GEOGRAPH, V35, P173; LARSON DL, 1995, CLIMATIC CHANGE, V30, P169, DOI 10.1007/BF01091840; LEITCH WG, 1985, J WILDLIFE MANAGE, V49, P212, DOI 10.2307/3801873; Liu GM, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR011539; Loesch CR, 2012, J FISH WILDL MANAG, V3, P1, DOI 10.3996/032011-JFWM-020; Matsuura K., 2012, TERRESTRIAL PRECIPIT; Meehl GA, 2007, B AM METEOROL SOC, V88, P1383, DOI 10.1175/BAMS-88-9-1383; Millett B, 2009, CLIMATIC CHANGE, V93, P243, DOI 10.1007/s10584-008-9543-5; Murkin HR, 1997, ECOL APPL, V7, P1144; Murkin HR, 1989, NO PRAIRIE WETLANDS, P317; Nichols JD, 2011, J WILDLIFE MANAGE, V75, P6, DOI 10.1002/jwmg.33; Niemuth ND, 2010, WETLANDS, V30, P1053, DOI 10.1007/s13157-010-0111-1; Pietz PJ, 2000, CONDOR, V102, P936, DOI 10.1650/0010-5422(2000)102[0936:EOWCOC]2.0.CO;2; POIANI KA, 1991, BIOSCIENCE, V41, P611, DOI 10.2307/1311698; Prairie Habitat Joint Venture, 2008, PRAIR HAB JOINT VENT; R Core Team, 2021, R LANGUAGE ENV STAT; Rashford BS, 2011, CONSERV BIOL, V25, P276, DOI 10.1111/j.1523-1739.2010.01618.x; Reynolds RE, 2001, J WILDLIFE MANAGE, V65, P765, DOI 10.2307/3803027; Reynolds RE, 2006, WILDLIFE SOC B, V34, P963, DOI 10.2193/0091-7648(2006)34[963:TFBADP]2.0.CO;2; Ringelman J., 2005, PRAIRIE POTHOLE JOIN; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Service Wildlife, 2011, WAT POP STAT 2011; SMITH GW, 1995, 5 US DEP INT NAT BIO; Sohl TL, 2004, PHOTOGRAMM ENG REM S, V70, P439, DOI 10.14358/PERS.70.4.439; Sorenson LG, 1998, CLIMATIC CHANGE, V40, P343, DOI 10.1023/A:1005441608819; Stephens SE, 2005, ECOL APPL, V15, P2137, DOI 10.1890/04-1162; U.S. Department of the Interior and Environment Canada, 1986, N AM WAT MAN PLAN; van der Valk AG, 2005, HYDROBIOLOGIA, V539, P171, DOI 10.1007/s10750-004-4866-3; VANDERVALK AG, 1978, ECOLOGY, V59, P322, DOI 10.2307/1936377; Walker J, 2013, J WILDLIFE MANAGE, V77, P392, DOI 10.1002/jwmg.466; WILEN BO, 1995, VEGETATIO, V118, P153, DOI 10.1007/BF00045197; Winter T. C., 1989, Northern prairie wetlands., P16; Woodhouse CA, 1998, B AM METEOROL SOC, V79, P2693, DOI 10.1175/1520-0477(1998)079<2693:YODVIT>2.0.CO;2; Zhang H, 2011, J HYDROL, V396, P94, DOI 10.1016/j.jhydrol.2010.10.037; Zhang XB, 2000, ATMOS OCEAN, V38, P395, DOI 10.1080/07055900.2000.9649654	60	38	38	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100034	10.1371/journal.pone.0100034	http://dx.doi.org/10.1371/journal.pone.0100034			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937641	Green Submitted, Green Published, gold			2022-12-27	WOS:000338503400065
J	Park, JM; Tougeron, D; Huang, SB; Okamoto, K; Sinicrope, FA				Park, Jae Myung; Tougeron, David; Huang, Shengbing; Okamoto, Koichi; Sinicrope, Frank A.			Beclin 1 and UVRAG Confer Protection from Radiation-Induced DNA Damage and Maintain Centrosome Stability in Colorectal Cancer Cells	PLOS ONE			English	Article							INDUCED APOPTOSIS; AUTOPHAGY; REPAIR; INHIBITION; RECOMBINATION; CYCLE; GENE; LC3; ATM	Beclin 1 interacts with UV-irradiation-resistance-associated gene (UVRAG) to form core complexes that induce autophagy. While cells with defective autophagy are prone to genomic instability that contributes to tumorigenesis, it is unknown whether Beclin1 or UVRAG can regulate the DNA damage/repair response to cancer treatment in established tumor cells. We found that siRNA knockdown of Beclin 1 or UVRAG can increase radiation-induced DNA double strand breaks (DSBs), shown by pATM and gamma H2Ax, and promote colorectal cancer cell death. Furthermore, knockdown of Beclin 1, UVRAG or ATG5 increased the percentage of irradiated cells with nuclear foci expressing 53BP1, a marker of nonhomologous end joining but not RAD51 (homologous recombination), compared to control siRNA. Beclin 1 siRNA was shown to attenuate UVRAG expression. Cells with a UVRAG deletion mutant defective in Beclin 1 binding showed increased radiation-induced DSBs and cell death compared to cells with ectopic wild-type UVRAG. Knockdown of Beclin 1 or UVRAG, but not ATG5, resulted in a significant increase in centrosome number (gamma-tubulin staining) in irradiated cells compared to control siRNA. Taken together, these data indicate that Beclin 1 and UVRAG confer protection against radiation-induced DNA DSBs and may maintain centrosome stability in established tumor cells.	[Sinicrope, Frank A.] Mayo Clin, Rochester, MN 55902 USA; Mayo Clin, Ctr Canc, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Sinicrope, FA (corresponding author), Mayo Clin, Rochester, MN 55902 USA.	sinicrope.frank@mayo.edu	tougeron, david/ABF-3217-2020	tougeron, david/0000-0002-8065-9635	National Cancer Institute [5 K05 CA142885, CA113681]; Multi-Organizational Thematic Institute for Cancer; French National Cancer Institute; NATIONAL CANCER INSTITUTE [K05CA142885, R01CA113681] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Multi-Organizational Thematic Institute for Cancer; French National Cancer Institute(Institut National du Cancer (INCA) France); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Cancer Institute (5 K05 CA142885 and CA113681, both to FAS). DT is a recipient of financial support from the Multi-Organizational Thematic Institute for Cancer and the French National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Acu ID, 2010, CANCER RES, V70, P3320, DOI 10.1158/0008-5472.CAN-09-3800; Aita VM, 1999, GENOMICS, V59, P59, DOI 10.1006/geno.1999.5851; Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Bothmer A, 2011, MOL CELL, V42, P319, DOI 10.1016/j.molcel.2011.03.019; Bourke E, 2007, EMBO REP, V8, P603, DOI 10.1038/sj.embor.7400962; D'Assoro AB, 2002, ONCOGENE, V21, P6146, DOI 10.1038/sj.onc.1205772; Flatten K, 2005, J BIOL CHEM, V280, P14349, DOI 10.1074/jbc.M411890200; Fremont S, 2013, EMBO REP, V14, P364, DOI 10.1038/embor.2013.23; Fukasawa K, 2007, NAT REV CANCER, V7, P911, DOI 10.1038/nrc2249; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Huang SB, 2013, J BIOL CHEM, V288, P33654, DOI 10.1074/jbc.M113.518134; Huang SB, 2011, J BIOL CHEM, V286, P40002, DOI 10.1074/jbc.M111.297432; Huang SB, 2010, AUTOPHAGY, V6, P256, DOI 10.4161/auto.6.2.11124; Ionov Y, 2004, ONCOGENE, V23, P639, DOI 10.1038/sj.onc.1207178; Itakura E, 2008, MOL BIOL CELL, V19, P5360, DOI 10.1091/mbc.E08-01-0080; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Karantza-Wadsworth V, 2007, GENE DEV, V21, P1621, DOI 10.1101/gad.1565707; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kuwahara Y, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.56; Li XH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1648; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Liang XH, 2001, CANCER RES, V61, P3443; Liu J, 2010, CELL, V147, P223; Mao ZY, 2008, CELL CYCLE, V7, P2902, DOI 10.4161/cc.7.18.6679; Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107; Park JM, 2013, CANCER BIOL THER, V14, P100, DOI 10.4161/cbt.22954; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Sato N, 2000, ONCOGENE, V19, P5281, DOI 10.1038/sj.onc.1203902; Sinha S, 2008, ONCOGENE, V27, pS137, DOI 10.1038/onc.2009.51; Suwaki N, 2011, SEMIN CELL DEV BIOL, V22, P898, DOI 10.1016/j.semcdb.2011.07.019; Ward IM, 2003, MOL CELL BIOL, V23, P2556, DOI 10.1128/MCB.23.7.2556-2563.2003; Yang ZNJ, 2011, MOL CANCER THER, V10, P1533, DOI 10.1158/1535-7163.MCT-11-0047; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Zhao Z, 2012, AUTOPHAGY, V8, P1392, DOI 10.4161/auto.21035; Zhao Z, 2012, DEV CELL, V22, P1001, DOI 10.1016/j.devcel.2011.12.027	39	50	53	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100819	10.1371/journal.pone.0100819	http://dx.doi.org/10.1371/journal.pone.0100819			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24956373	Green Published, gold, Green Submitted			2022-12-27	WOS:000338917900098
J	Huang, SY; Ko, CE; Chen, GS; Chung, IF; Yang, FY				Huang, Sheng-Yao; Ko, Chia-En; Chen, Gin-Shin; Chung, I-Fang; Yang, Feng-Yi			Focused Ultrasound Simultaneous Irradiation/MRI Imaging, and Two-Stage General Kinetic Model	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; CONTRAST-ENHANCED MRI; ARTERIAL INPUT FUNCTION; QUANTITATIVE-EVALUATION; IN-VIVO; DCE-MRI; PERMEABILITY; DISRUPTION; DELIVERY; TRACER	Many studies have investigated how to use focused ultrasound (FUS) to temporarily disrupt the blood-brain barrier (BBB) in order to facilitate the delivery of medication into lesion sites in the brain. In this study, through the setup of a real-time system, FUS irradiation and injections of ultrasound contrast agent (UCA) and Gadodiamide (Gd, an MRI contrast agent) can be conducted simultaneously during MRI scanning. By using this real-time system, we were able to investigate in detail how the general kinetic model (GKM) is used to estimate Gd penetration in the FUS irradiated area in a rat's brain resulting from UCA concentration changes after single FUS irradiation. Two-stage GKM was proposed to estimate the Gd penetration in the FUS irradiated area in a rat's brain under experimental conditions with repeated FUS irradiation combined with different UCA concentrations. The results showed that the focal increase in the transfer rate constant of K-trans caused by BBB disruption was dependent on the doses of UCA. Moreover, the amount of in vivo penetration of Evans blue in the FUS irradiated area in a rat's brain under various FUS irradiation experimental conditions was assessed to show the positive correlation with the transfer rate constants. Compared to the GKM method, the Two-stage GKM is more suitable for estimating the transfer rate constants of the brain treated with repeated FUS irradiations. This study demonstrated that the entire process of BBB disrupted by FUS could be quantitatively monitored by real-time dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI).	[Huang, Sheng-Yao; Chung, I-Fang] Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan; [Chung, I-Fang] Natl Yang Ming Univ, Ctr Syst & Synthet Biol, Taipei 112, Taiwan; [Yang, Feng-Yi] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan; [Yang, Feng-Yi] Natl Yang Ming Univ, Biophoton & Mol Imaging Res Ctr, Taipei 112, Taiwan; [Chen, Gin-Shin] Natl Hlth Res Inst, Div Med Engn Res, Zhunan, Miaoli County, Taiwan; [Ko, Chia-En] Mackay Mem Hosp Tan Shui, Dept Diagnost Radiol, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Health Research Institutes - Taiwan; Mackay Memorial Hospital	Chung, IF (corresponding author), Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan.	ifchung@ym.edu.tw; fyyang@ym.edu.tw	Chen, Gin-Shin/E-3988-2010	Huang, Sheng-Yao/0000-0002-3241-430X; Chen, Gin-Shin/0000-0003-3368-7470	National Science Council of Taiwan [NSC 101-2320-B-010-036-MY3, NSC 102-2221-E-010-005-MY3, NSC 102-2221-E-010-014]; Cheng Hsin General Hospital Foundation [102F218C11, 103F003C17]; Biophotonics & Molecular Imaging Research Center; Ministry of Education, Aim for the Top University Plan	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Cheng Hsin General Hospital Foundation; Biophotonics & Molecular Imaging Research Center; Ministry of Education, Aim for the Top University Plan(Ministry of Education, Taiwan)	This study was supported by grants from the National Science Council of Taiwan (no. NSC 101-2320-B-010-036-MY3, NSC 102-2221-E-010-005-MY3, and NSC 102-2221-E-010-014), Cheng Hsin General Hospital Foundation (no. 102F218C11 and 103F003C17), Biophotonics & Molecular Imaging Research Center, and the Ministry of Education, Aim for the Top University Plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Beaumont M, 2009, J CEREBR BLOOD F MET, V29, P1714, DOI 10.1038/jcbfm.2009.86; Bilgen M, 2001, MAGN RESON MED, V46, P1099, DOI 10.1002/mrm.1305; Chan AH, 2002, MED PHYS, V29, P2611, DOI 10.1118/1.1513990; Choi JJ, 2010, IEEE T BIO-MED ENG, V57, P145, DOI 10.1109/TBME.2009.2034533; Duiardin M, 2009, EUR J RADIOL, V69, P542, DOI 10.1016/j.ejrad.2007.11.033; Ferrier MC, 2007, NEOPLASIA, V9, P546, DOI 10.1593/neo.07289; Holford NHG, 2005, STAT MED, V24, P2745, DOI DOI 10.1002/SIM.2181; Hynynen K, 2001, RADIOLOGY, V220, P640, DOI 10.1148/radiol.2202001804; Kinoshita M, 2006, P NATL ACAD SCI USA, V103, P11719, DOI 10.1073/pnas.0604318103; Liu HL, 2010, P NATL ACAD SCI USA, V107, P15205, DOI 10.1073/pnas.1003388107; McDannold N, 2006, PHYS MED BIOL, V51, P793, DOI 10.1088/0031-9155/51/4/003; McGrath DM, 2009, MAGN RESON MED, V61, P1173, DOI 10.1002/mrm.21959; MILLER DL, 1987, ULTRASOUND MED BIOL, V13, P443, DOI 10.1016/0301-5629(87)90110-4; Muldoon LL, 2011, NEURO-ONCOLOGY, V13, P51, DOI 10.1093/neuonc/noq150; Nyborg WL, 2001, ULTRASOUND MED BIOL, V27, P301, DOI 10.1016/S0301-5629(00)00333-1; Park J, 2012, J CONTROL RELEASE, V162, P134, DOI 10.1016/j.jconrel.2012.06.012; Peruzzo D, 2011, COMPUT METH PROG BIO, V104, pE148, DOI 10.1016/j.cmpb.2011.02.012; Ponce AM, 2007, J NATL CANCER I, V99, P53, DOI 10.1093/jnci/djk005; Raymond SB, 2007, J CEREBR BLOOD F MET, V27, P393, DOI 10.1038/sj.jcbfm.9600336; Sheikov N, 2006, ULTRASOUND MED BIOL, V32, P1399, DOI 10.1016/j.ultrasmedbio.2006.05.015; Simpson NE, 1999, MAGN RESON MED, V42, P42, DOI 10.1002/(SICI)1522-2594(199907)42:1<42::AID-MRM8>3.0.CO;2-Z; Thomas DL, 2006, MAGN RESON MED, V55, P943, DOI 10.1002/mrm.20823; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; TOFTS PS, 1991, MAGNET RESON MED, V17, P357, DOI 10.1002/mrm.1910170208; Vlachos F, 2010, PHYS MED BIOL, V55, P5451, DOI 10.1088/0031-9155/55/18/012; Vlachos F, 2011, MAGN RESON MED, V66, P821, DOI 10.1002/mrm.22848; Yang FY, 2008, ULTRASON SONOCHEM, V15, P636, DOI 10.1016/j.ultsonch.2007.08.003; Yang FY, 2007, ULTRASOUND MED BIOL, V33, P1421, DOI 10.1016/j.ultrasmedbio.2007.04.006; Yang FY, 2011, IEEE T ULTRASON FERR, V58, P964, DOI 10.1109/TUFFC.2011.1897; Yang FY, 2011, J CONTROL RELEASE, V150, P111, DOI 10.1016/j.jconrel.2010.10.038; Yang FY, 2009, J ACOUST SOC AM, V126, P3344, DOI 10.1121/1.3242376; Yankeelov TE, 2005, MAGN RESON IMAGING, V23, P519, DOI 10.1016/j.mri.2005.02.013	33	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100280	10.1371/journal.pone.0100280	http://dx.doi.org/10.1371/journal.pone.0100280			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24949997	Green Submitted, Green Published, gold			2022-12-27	WOS:000338276300059
J	Panagopoulos, I; Gorunova, L; Bjerkehagen, B; Heim, S				Panagopoulos, Ioannis; Gorunova, Ludmila; Bjerkehagen, Bodil; Heim, Sverre			The "Grep" Command But Not FusionMap, FusionFinder or ChimeraScan Captures the CIC-DUX4 Fusion Gene from Whole Transcriptome Sequencing Data on a Small Round Cell Tumor with t(4;19)(q35;q13)	PLOS ONE			English	Article							DUX4; SARCOMAS; RHABDOMYOSARCOMA; ENCODES; LOCUS	Whole transcriptome sequencing was used to study a small round cell tumor in which a t(4;19)(q35;q13) was part of the complex karyotype but where the initial reverse transcriptase PCR (RT-PCR) examination did not detect a CIC-DUX4 fusion transcript previously described as the crucial gene-level outcome of this specific translocation. The RNA sequencing data were analysed using the FusionMap, FusionFinder, and ChimeraScan programs which are specifically designed to identify fusion genes. FusionMap, FusionFinder, and ChimeraScan identified 1017, 102, and 101 fusion transcripts, respectively, but CIC-DUX4 was not among them. Since the RNA sequencing data are in the fastq text-based format, we searched the files using the "grep" command-line utility. The "grep" command searches the text for specific expressions and displays, by default, the lines where matches occur. The "specific expression" was a sequence of 20 nucleotides from the coding part of the last exon 20 of CIC (Reference Sequence: NM_015125.3) chosen since all the so far reported CIC breakpoints have occurred here. Fifteen chimeric CIC-DUX4 cDNA sequences were captured and the fusion between the CIC and DUX4 genes was mapped precisely. New primer combinations were constructed based on these findings and were used together with a polymerase suitable for amplification of GC-rich DNA templates to amplify CIC-DUX4 cDNA fragments which had the same fusion point found with "grep". In conclusion, FusionMap, FusionFinder, and ChimeraScan generated a plethora of fusion transcripts but did not detect the biologically important CIC-DUX4 chimeric transcript; they are generally useful but evidently suffer from imperfect both sensitivity and specificity. The "grep" command is an excellent tool to capture chimeric transcripts from RNA sequencing data when the pathological and/or cytogenetic information strongly indicates the presence of a specific fusion gene.	[Panagopoulos, Ioannis; Gorunova, Ludmila; Heim, Sverre] Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Genet & Informat, Sect Canc Cytogenet, Oslo, Norway; [Panagopoulos, Ioannis; Gorunova, Ludmila; Heim, Sverre] Univ Oslo, Fac Med, Ctr Canc Biomed, Oslo, Norway; [Bjerkehagen, Bodil] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Pathol, Oslo, Norway; [Heim, Sverre] Univ Oslo, Fac Med, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo	Panagopoulos, I (corresponding author), Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Genet & Informat, Sect Canc Cytogenet, Oslo, Norway.	ioannis.panagopoulos@rr-research.no		Panagopoulos, Ioannis/0000-0003-2159-5341	Norwegian Cancer Society	Norwegian Cancer Society(Norwegian Cancer Society)	This work was supported by grants from the Norwegian Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carrara M, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S7-S2; Carrara M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/340620; Choi EYK, 2013, AM J SURG PATHOL, V37, P1379, DOI 10.1097/PAS.0b013e318297a57d; Dixit M, 2007, P NATL ACAD SCI USA, V104, P18157, DOI 10.1073/pnas.0708659104; Field D, 2006, NAT BIOTECHNOL, V24, P801, DOI 10.1038/nbt0706-801; Francis RW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039987; Gabriels J, 1999, GENE, V236, P25, DOI 10.1016/S0378-1119(99)00267-X; Ge HY, 2011, BIOINFORMATICS, V27, P1922, DOI 10.1093/bioinformatics/btr310; Graham C, 2012, HUM PATHOL, V43, P180, DOI 10.1016/j.humpath.2011.04.023; Italiano A, 2012, GENE CHROMOSOME CANC, V51, P207, DOI 10.1002/gcc.20945; Iyer MK, 2011, BIOINFORMATICS, V27, P2903, DOI 10.1093/bioinformatics/btr467; Kajtar B, 2014, CYTOPATHOLOGY, V25, P129, DOI 10.1111/cyt.12079; Kawamura-Saito M, 2006, HUM MOL GENET, V15, P2125, DOI 10.1093/hmg/ddl136; Kowaljow V, 2007, NEUROMUSCULAR DISORD, V17, P611, DOI 10.1016/j.nmd.2007.04.002; Machado I, 2013, VIRCHOWS ARCH, V463, P837, DOI 10.1007/s00428-013-1499-9; Mandahl N, 2001, HUMAN CYTOGENETICS M, P165; Nyquist KB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049705; Panagopoulos I, 2013, GENE CHROMOSOME CANC, V52, P733, DOI 10.1002/gcc.22068; Panagopoulos I, 2013, GENE CHROMOSOME CANC, V52, P610, DOI 10.1002/gcc.22057; Rakheja D, 2008, PEDIATR DEVEL PATHOL, V11, P239, DOI 10.2350/07-06-0296.1; Richkind KE, 1996, CANCER GENET CYTOGEN, V87, P71, DOI 10.1016/0165-4608(95)00240-5; ROBERTS P, 1992, CANCER GENET CYTOGEN, V60, P135, DOI 10.1016/0165-4608(92)90005-S; Schaffer LG, 2009, ISCN 2009 INT SYSTEM; Somers GR, 2004, PEDIATR DEVEL PATHOL, V7, P538, DOI 10.1007/s10024-004-2024-6; URUMOV IJ, 1992, CANCER GENET CYTOGEN, V61, P214, DOI 10.1016/0165-4608(92)90092-M; van Geel M, 2002, GENOMICS, V79, P210, DOI 10.1006/geno.2002.6690; Wang QG, 2013, BRIEF BIOINFORM, V14, P506, DOI 10.1093/bib/bbs044; Yoshimoto M, 2009, CANCER GENET CYTOGEN, V195, P1, DOI 10.1016/j.cancergencyto.2009.06.015	28	41	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e99439	10.1371/journal.pone.0099439	http://dx.doi.org/10.1371/journal.pone.0099439			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950227	Green Published, Green Submitted, gold			2022-12-27	WOS:000338276300014
J	Varela, M; Diaz-Rosales, P; Pereiro, P; Forn-Cuni, G; Costa, MM; Dios, S; Romero, A; Figueras, A; Novoa, B				Varela, Monica; Diaz-Rosales, Patricia; Pereiro, Patricia; Forn-Cuni, Gabriel; Costa, Maria M.; Dios, Sonia; Romero, Alejandro; Figueras, Antonio; Novoa, Beatriz			Interferon-Induced Genes of the Expanded IFIT Family Show Conserved Antiviral Activities in Non-Mammalian Species	PLOS ONE			English	Article							INDUCIBLE PROTEIN; STIMULATED GENES; RNA-BINDING; INDUCTION; EXPRESSION; EVOLUTION; P56; INFECTION; SELECTION; INNATE	Interferon-induced proteins with tetratricopeptide repeats (IFITs) are involved in the protective response to viral infection, although the precise mechanism of IFITs for reducing viral proliferation is currently unknown. The interaction with the translation initiation factor eIF-3 or viral proteins and the sequestering of viral RNA have been proposed as potential antiviral functions for these proteins. In humans, four members of this family have been characterized. Nevertheless, information about these proteins in fish is almost non-existent. Exploiting the conservation of synteny between human and zebrafish genomes, we have identified ten members of the IFIT family located on four different chromosomes. The induction of these genes was examined both in vitro and in vivo after interferon (IFN) administration and rhabdovirus challenge. Whereas an induction of IFIT genes was observed after interferon treatments (IFN Phi 1, IFN Phi 2 and IFN Phi 3), the viral infection did not affect these IFN-induced genes in vitro, and even reduced the IFN-induced expression of these genes. The response was largely different in vivo, with a broad up-regulation of IFIT genes after viral challenge. In addition, three selected IFITs were cloned in an expression vector and microinjected into zebrafish larvae to examine the protective effect of IFITs upon viral infection. Reduction in the mortality rate was observed confirming a conserved antiviral function in non-mammalian species.	[Varela, Monica; Diaz-Rosales, Patricia; Pereiro, Patricia; Forn-Cuni, Gabriel; Costa, Maria M.; Dios, Sonia; Romero, Alejandro; Figueras, Antonio; Novoa, Beatriz] CSIC, IIM, Vigo, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM)	Novoa, B (corresponding author), CSIC, IIM, Vigo, Spain.	virus@iim.csic.es	Forn-Cuní, Gabriel/M-8498-2016; Romero, Alejandro/R-4565-2019; Dios, Sonia/M-4201-2018; Novoa, Beatriz/K-3785-2014; Pereiro, Patricia/AAS-9514-2020; Figueras, Antonio/B-5133-2015; Diaz-Rosales, Patricia/H-9679-2013; Costa, María M/M-2485-2017; Figueras, Antonio/AAB-8921-2019	Forn-Cuní, Gabriel/0000-0001-5976-4759; Romero, Alejandro/0000-0002-9343-3352; Dios, Sonia/0000-0002-2126-991X; Pereiro, Patricia/0000-0002-8734-3334; Figueras, Antonio/0000-0002-0617-0030; Diaz-Rosales, Patricia/0000-0001-6965-3702; Costa, María M/0000-0002-5497-3102; Figueras, Antonio/0000-0002-0617-0030; Novoa, Beatriz/0000-0003-4888-8419	Spanish Ministerio de Ciencia e Innovacion [CSD2007-00002, AGL2011-28921]; "FISHFORPHARMA" (EU) [ITN 289209]; Agencia Estatal Consejo Superior de Investigaciones Cientificas (CSIC) [201230E057]; CSIC, Spain; Ministerio de Educacion [AP2010-2408]; JAE Program	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); "FISHFORPHARMA" (EU); Agencia Estatal Consejo Superior de Investigaciones Cientificas (CSIC); CSIC, Spain; Ministerio de Educacion; JAE Program	This study was funded through the project CSD2007-00002 "Aquagenomics" and AGL2011-28921 from the Spanish Ministerio de Ciencia e Innovacion. The authors' laboratory is also funded by ITN 289209 "FISHFORPHARMA" (EU) and project 201230E057 from the Agencia Estatal Consejo Superior de Investigaciones Cientificas (CSIC). P. Diaz-Rosales received a JAE-Doc contract from the CSIC, Spain, and P. Pereiro and M. Varela received predoctoral grants from the Ministerio de Educacion (F.P.U. fellowship AP2010-2408) and the JAE Program (funded though the CSIC and European Social Funds), respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas YM, 2013, NATURE, V494, P60, DOI 10.1038/nature11783; Aggad D, 2009, J IMMUNOL, V183, P3924, DOI 10.4049/jimmunol.0901495; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Belanger SE, 2010, AQUAT TOXICOL, V97, P88, DOI 10.1016/j.aquatox.2009.11.020; Berchtold S, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-75; Boudinot P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022022; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Campanella JJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-29; Chiou PP, 2000, J VIROL, V74, P7619, DOI 10.1128/JVI.74.16.7619-7627.2000; Daffis S, 2007, PLOS PATHOG, V3, P1005, DOI 10.1371/journal.ppat.0030106; Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Diamond MS, 2013, NAT REV IMMUNOL, V13, P46, DOI 10.1038/nri3344; Diaz-Rosales P, 2012, MAR BIOTECHNOL, V14, P515, DOI 10.1007/s10126-012-9465-0; DRIEVER W, 1993, IN VITRO CELL DEV-AN, V29, P749; Du Pasquier L, 2009, FRONT BIOSCI-LANDMRK, V14, P177, DOI 10.2741/3239; Faul EJ, 2009, VIRUSES-BASEL, V1, P832, DOI 10.3390/v1030832; Fensterl V, 2008, J VIROL, V82, P11045, DOI 10.1128/JVI.01593-08; Fensterl V, 2011, J INTERF CYTOK RES, V31, P71, DOI 10.1089/jir.2010.0101; Fernandes JMO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009501; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Garcia-Sastre A, 2011, VIRUS RES, V162, P12, DOI 10.1016/j.virusres.2011.10.017; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guo JJ, 2000, VIROLOGY, V267, P209, DOI 10.1006/viro.1999.0135; Guo JJ, 2000, EMBO J, V19, P6891, DOI 10.1093/emboj/19.24.6891; Haller O, 2007, BIOCHIMIE, V89, P812, DOI 10.1016/j.biochi.2007.04.015; Hui DJ, 2003, J BIOL CHEM, V278, P39477, DOI 10.1074/jbc.M305038200; Karpenahalli MR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-2; Katibah GE, 2013, MOL CELL, V49, P743, DOI 10.1016/j.molcel.2012.12.015; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; KIMURA M, 1977, NATURE, V267, P275, DOI 10.1038/267275a0; Kylaniemi MK, 2009, MICROB PATHOGENESIS, V46, P235, DOI 10.1016/j.micpath.2009.01.006; Liu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066859; Lopez-Munoz A, 2009, J IMMUNOL, V182, P3440, DOI 10.4049/jimmunol.0802528; Martens S, 2006, ANNU REV CELL DEV BI, V22, P559, DOI 10.1146/annurev.cellbio.22.010305.104619; McCurley AT, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-102; Nusslein-Volhard C., 2002, ZEBRAFISH PRACTICAL; Ovstebo R, 2008, INFECT IMMUN, V76, P2685, DOI 10.1128/IAI.01625-07; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pichlmair A, 2011, NAT IMMUNOL, V12, P624, DOI 10.1038/ni.2048; Postlethwait JH, 2000, GENOME RES, V10, P1890, DOI 10.1101/gr.164800; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Rathi AV, 2010, VIROLOGY, V406, P202, DOI 10.1016/j.virol.2010.07.018; Ravi V, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003177; Raychoudhuri A, 2011, J VIROL, V85, P12881, DOI 10.1128/JVI.05633-11; Reed L.J., 1938, SIMPLE METHOD ESTIMA, V27, P493, DOI [10.1093/oxfordjournals.aje.a118408, DOI 10.1093/OXFORDJOURNALS.AJE.A118408]; Rieder M, 2009, J INTERF CYTOK RES, V29, P499, DOI 10.1089/jir.2009.0068; Robertsen B, 2006, FISH SHELLFISH IMMUN, V20, P172, DOI 10.1016/j.fsi.2005.01.010; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Rozen S, 2000, Methods Mol Biol, V132, P365; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Saha S, 2003, J GEN VIROL, V84, P1729, DOI 10.1099/vir.0.18826-0; Samuel MA, 2006, J VIROL, V80, P9349, DOI 10.1128/JVI.01122-06; Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008; Soukup S. W, 1974, TERATOLOGY, V9, P250, DOI DOI 10.1002/TERA.1420090224; Stein C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r251; Sunyer JO, 1998, IMMUNOL REV, V166, P39, DOI 10.1111/j.1600-065X.1998.tb01251.x; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Terenzi F, 2007, J VIROL, V81, P8656, DOI 10.1128/JVI.00322-07; Terenzi F, 2008, EMBO J, V27, P3311, DOI 10.1038/emboj.2008.241; Verrier ER, 2011, DEV COMP IMMUNOL, V35, P1204, DOI 10.1016/j.dci.2011.03.012; Viertlboeck BC, 2005, J IMMUNOL, V175, P385, DOI 10.4049/jimmunol.175.1.385; Vilches C, 2002, ANNU REV IMMUNOL, V20, P217, DOI 10.1146/annurev.immunol.20.092501.134942; Wacher C, 2007, J VIROL, V81, P860, DOI 10.1128/JVI.01167-06; Wang CF, 2003, J VIROL, V77, P3898, DOI 10.1128/JVI.77.7.3898-3912.2003; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Woods IG, 2005, GENOME RES, V15, P1307, DOI 10.1101/gr.4134305; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Yang ZL, 2012, CELL RES, V22, P1328, DOI 10.1038/cr.2012.111; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yu XJ, 2006, GENOMICS, V88, P745, DOI 10.1016/j.ygeno.2006.05.008; Zhang JZ, 1998, P NATL ACAD SCI USA, V95, P3708, DOI 10.1073/pnas.95.7.3708; Zhou X, 2013, INT J BIOL SCI, V9, P200, DOI 10.7150/ijbs.5613; Zhu H, 1997, P NATL ACAD SCI USA, V94, P13985, DOI 10.1073/pnas.94.25.13985; Zou J, 2007, J IMMUNOL, V179, P3859, DOI 10.4049/jimmunol.179.6.3859; Zou J, 2011, DEV COMP IMMUNOL, V35, P1376, DOI 10.1016/j.dci.2011.07.001	79	30	33	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2014	9	6							e100015	10.1371/journal.pone.0100015	http://dx.doi.org/10.1371/journal.pone.0100015			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2UZ	24950240	Green Published, gold			2022-12-27	WOS:000338276300030
J	Kelly, JF; Stout, RL; Greene, MC; Slaymaker, V				Kelly, John F.; Stout, Robert L.; Greene, M. Claire; Slaymaker, Valerie			Young Adults, Social Networks, and Addiction Recovery: Post Treatment Changes in Social Ties and Their Role as a Mediator of 12-Step Participation	PLOS ONE			English	Article							MULTIVARIATE PROCESS MODEL; SUBSTANCE-ABUSE PATIENTS; SELF-HELP GROUPS; DRINKING OUTCOMES; BEHAVIOR-CHANGE; FRIENDSHIP NETWORKS; EMERGING ADULTHOOD; ALCOHOL; SUPPORT; MECHANISMS	Background: Social factors play a key role in addiction recovery. Research with adults indicates individuals with substance use disorder (SUD) benefit from mutual-help organizations (MHOs), such as Alcoholics Anonymous, via their ability to facilitate adaptive network changes. Given the lower prevalence of sobriety-conducive, and sobriety-supportive, social contexts in the general population during the life-stage of young adulthood, however, 12-step MHOs may play an even more crucial recovery-supportive social role for young adults, but have not been investigated. Greater knowledge could enhance understanding of recovery-related change and inform young adults' continuing care recommendations. Methods: Emerging adults (N = 302; 18-24 yrs; 26% female; 95% White) enrolled in a study of residential treatment effectiveness were assessed at intake, 1, 3, 6, and 12 months on 12-step attendance, peer network variables ("high [relapse] risk'' and "low [relapse] risk'' friends), and treatment outcomes (Percent Days Abstinent; Percent Days Heavy Drinking). Hierarchical linear models tested for change in social risk over time and lagged mediational analyses tested whether 12-step attendance conferred recovery benefits via change in social risk. Results: High-risk friends were common at treatment entry, but decreased during follow-up; low-risk friends increased. Contrary to predictions, while substantial recovery-supportive friend network changes were observed, this was unrelated to 12-step participation and, thus, not found to mediate its positive influence on outcome. Conclusions: Young adult 12-step participation confers recovery benefit; yet, while encouraging social network change, 12-step MHOs may be less able to provide social network change directly for young adults, perhaps because similar-aged peers are less common in MHOs. Findings highlight the importance of both social networks and 12-step MHOs and raise further questions as to how young adults benefit from 12-step MHOs.	[Kelly, John F.; Greene, M. Claire] Massachusetts Gen Hosp, Dept Psychiat, Ctr Addict Med, Boston, MA 02114 USA; [Kelly, John F.; Greene, M. Claire] Harvard Univ, Sch Med, Boston, MA USA; [Stout, Robert L.] Pacific Inst Res & Evaluat, Providence, RI USA; [Slaymaker, Valerie] Hazelden Fdn, Ctr City, MN USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Pacific Institute for Research & Evaluation (PIRE)	Kelly, JF (corresponding author), Massachusetts Gen Hosp, Dept Psychiat, Ctr Addict Med, Boston, MA 02114 USA.	jkelly11@mgh.harvard.edu	Kelly, John/Q-6780-2019	Kelly, John/0000-0001-6915-0750; Stout, Robert/0000-0003-2596-241X	National Institute of Alcohol Abuse and Alcoholism (NIAAA) [1R21AA018185-01A2]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA018185] Funding Source: NIH RePORTER	National Institute of Alcohol Abuse and Alcoholism (NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was was supported by the National Institute of Alcohol Abuse and Alcoholism (NIAAA) Grant Number: 1R21AA018185-01A2 and by an anonymous donation to the Hazelden Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1993, Alcohol Clin Exp Res, V17, P1130; Arnett JJ, 2000, AM PSYCHOL, V55, P469, DOI 10.1037/0003-066X.55.5.469; Beattie MC, 1999, ADDICT BEHAV, V24, P593, DOI 10.1016/S0306-4603(98)00120-8; Beattie MC, 2001, J STUD ALCOHOL, V62, P518, DOI 10.15288/jsa.2001.62.518; Bergman BG, 2013, ALCOHOL CLIN EXP RES; Blonigen DM, 2013, SUBST ABUS, V34, P4, DOI 10.1080/08897077.2012.691448; Bond J, 2003, J STUD ALCOHOL, V64, P579, DOI 10.15288/jsa.2003.64.579; BROWN SA, 1989, ADDICT BEHAV, V14, P291, DOI 10.1016/0306-4603(89)90060-9; Delucchi KL, 2008, ADDICT BEHAV, V33, P134, DOI 10.1016/j.addbeh.2007.04.027; Dennis Michael, 2007, Addict Sci Clin Pract, V4, P45; Fenster J, 2006, DRUG ALCOHOL DEPEN, V83, P238, DOI 10.1016/j.drugalcdep.2005.11.017; Hser YI, 2011, CURR CLIN PSYCHIAT, P9, DOI 10.1007/978-1-60327-960-4_2; Humphreys K, 1999, ANN BEHAV MED, V21, P54, DOI 10.1007/BF02895034; Humphreys K, 1997, PSYCHIATR SERV, V48, P1445; Humphreys K, 1997, AM J COMMUN PSYCHOL, V25, P1, DOI 10.1023/A:1024613507082; Kaskutas LA, 2002, ADDICTION, V97, P891, DOI 10.1046/j.1360-0443.2002.00118.x; Kelly J.F., 2013, ADDICTIONS COMPREHEN; Kelly JF, 2002, J STUD ALCOHOL, V63, P293, DOI 10.15288/jsa.2002.63.293; Kelly JF, 2000, PSYCHOL ADDICT BEHAV, V14, P376; Kelly JF, 2013, J SUBST ABUSE TREAT; Kelly JF, 2008, PRACT RESOUR MENT, P61, DOI 10.1016/B978-012088520-6.50005-6; Kelly JF, 2013, DRUG ALCOHOL DEPEN, V129, P151, DOI 10.1016/j.drugalcdep.2012.10.005; Kelly JF, 2012, ADDICTION, V107, P289, DOI 10.1111/j.1360-0443.2011.03593.x; Kelly JF, 2011, DRUG ALCOHOL DEPEN, V114, P119, DOI 10.1016/j.drugalcdep.2010.09.009; Kelly JF, 2010, ADDICTION, V105, P626, DOI 10.1111/j.1360-0443.2009.02820.x; Kelly JF, 2009, ADDICT RES THEORY, V17, P236, DOI 10.1080/16066350902770458; Labbe AK, 2013, DRUG ALCOHOL DEPEND; Litt MD, 2009, J CONSULT CLIN PSYCH, V77, P229, DOI 10.1037/a0015252; Little R.J.A., 2002, STAT ANAL MISSING DA; Longabaugh R, 1998, ADDICTION, V93, P1313, DOI 10.1046/j.1360-0443.1998.93913133.x; Longabaugh R, 2010, J STUD ALCOHOL DRUGS, V71, P837, DOI 10.15288/jsad.2010.71.837; MacKinnon DavidP., 2012, STAT MEDIATION ANAL; Maisto SA, 2003, PSYCHOL ADDICT BEHAV, V17, P98, DOI 10.1037/0893-164X.17.2.98; Marlatt G.A, 2005, RELAPSE PREVENTION M; McLellan AT, 2000, JAMA-J AM MED ASSOC, V284, P1689, DOI 10.1001/jama.284.13.1689; Miller WR, 1996, PSYCHOL ADDICT BEHAV, V10, P81, DOI 10.1037/0893-164X.10.2.81; MILLER WR, 1994, J STUD ALCOHOL, P112, DOI 10.15288/jsas.1994.s12.112; Moos RH, 2003, AM J COMMUN PSYCHOL, V31, P1, DOI 10.1023/A:1023041101850; Moos RH, 2007, DRUG ALCOHOL DEPEN, V88, P109, DOI 10.1016/j.drugalcdep.2006.10.010; Moos RH, 2011, CURR CLIN PSYCHIAT, P45, DOI 10.1007/978-1-60327-960-4_4; Morgenstern J, 1997, J CONSULT CLIN PSYCH, V65, P768, DOI 10.1037/0022-006X.65.5.768; Raudenbush SW, 2002, HIERARCHICAL LINEAR; Richter S S, 1991, J Subst Abuse, V3, P371; SARASON IG, 1983, J PERS SOC PSYCHOL, V44, P127, DOI 10.1037/0022-3514.44.1.127; Slesnick Natasha, 2004, Alcohol Treat Q, V22, P21; Stout RL, 2012, J STUD ALCOHOL DRUGS, V73, P489, DOI 10.15288/jsad.2012.73.489; Substance Abuse and Mental Health Services Administration, 2013, RES 2012 NAT SURV DR; Tarter R. E., 2002, ETIOLOGY SUBSTANCE U; Tonigan JS, 1997, J STUD ALCOHOL, V58, P358, DOI 10.15288/jsa.1997.58.358; Valente TW, 2010, SOCIAL NETWORKS HLTH, DOI DOI 10.1093/ACPROF:OSO/9780195301014.001.0001/ACPROF-9780195301014; Zywiak WH, 2002, J STUD ALCOHOL, V63, P114	52	54	54	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100121	10.1371/journal.pone.0100121	http://dx.doi.org/10.1371/journal.pone.0100121			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN6QP	24945357	Green Published, gold, Green Submitted			2022-12-27	WOS:000340721500045
J	Qaddoumi, MG; Ananthalakshmi, KVV; Phillips, OA; Edafiogho, IO; Kombian, SB				Qaddoumi, Mohamed G.; Ananthalakshmi, Kethireddy V. V.; Phillips, Oludotun A.; Edafiogho, Ivan O.; Kombian, Samuel B.			Evaluation of Anticonvulsant Actions of Dibromophenyl Enaminones Using In Vitro and In Vivo Seizure Models	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; SUPPRESSES EPILEPTIFORM ACTIVITY; ELECTROSHOCK-INDUCED SEIZURES; RAT HIPPOCAMPAL SLICE; ANTIEPILEPTIC DRUGS; RECEPTOR ANTAGONISTS; NEUROPEPTIDE-Y; BRAIN-SLICES; PHARMACOLOGY; PROFILE	Epilepsy and other seizure disorders are not adequately managed with currently available drugs. We recently synthesized a series of dibromophenyl enaminones and demonstrated that AK6 and E249 were equipotent to previous analogs but more efficacious in suppressing neuronal excitation. Here we examined the actions of these lead compounds on in vitro and in vivo seizure models. In vitro seizures were induced in the hippocampal slice chemically (zero Mg2+ buffer and picrotoxin) and electrically using patterned high frequency stimulation (HFS) of afferents. In vivo seizures were induced in rats using the 6 Hz and the maximal electroshock models. AK6 (10 mu M) and E249 (10 mu M) depressed the amplitude of population spikes recorded in area CA1 of the hippocampus by -50.5 +/- 4.3% and -40.1 +/- 3.1% respectively, with partial recovery after washout. In the zero Mg2+ model, AK6 (10 mu M) depressed multiple population spiking (mPS) by -59.3 +/- 6.9% and spontaneous bursts (SBs) by -65.9 +/- 7.2% and in the picrotoxin-model by -43.3 +/- 7.2% and -50.0 +/- 8.3%, respectively. Likewise, E249 (10 mu M) depressed the zero-Mg2+-induced mPS by -48.8 +/- 9.5% and SBs by -55.8 +/- 15.5%, and in the picrotoxin model by -37.1 +/- 5.5% and -56.5 +/- 11.4%, respectively. They both suppressed post-HFS induced afterdischarges and SBs. AK6 and E249 dose-dependently protected rats in maximal electroshock and 6 Hz models of in vivo seizures after 30 min pretreatment. Their level of protection in both models was similar to that obtained with phenytoin Finally, while AK6 had no effect on locomotion in rats, phenytoin significantly decreased locomotion. AK6 and E249, suppressed in vitro and in vivo seizures to a similar extent. Their in vivo activities are comparable with but not superior to phenytoin. The most efficacious, AK6 produced no locomotor suppression while phenytoin did. Thus, AK6 and E249 may be excellent candidates for further investigation as potential agents for the treatment of epilepsy syndromes with possibly less CNS side effects.	[Qaddoumi, Mohamed G.; Ananthalakshmi, Kethireddy V. V.; Kombian, Samuel B.] Kuwait Univ, Fac Pharm, Dept Pharmacol & Therapeut, Safat, Kuwait; [Phillips, Oludotun A.] Kuwait Univ, Fac Pharm, Dept Pharmaceut Chem, Safat, Kuwait; [Edafiogho, Ivan O.] Univ St Joseph, Sch Pharm, Dept Pharmaceut Sci, Hartford, CT USA	Kuwait University; Kuwait University	Kombian, SB (corresponding author), Kuwait Univ, Fac Pharm, Dept Pharmacol & Therapeut, Safat, Kuwait.	kombian@hsc.edu.kw	Qaddoumi, Mohammad/AAT-2452-2020		Kuwait University Research grant [PR01/08]	Kuwait University Research grant	This work was funded by Kuwait University Research grant award #PR01/08. Kuwait University had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananthalakshmi KVV, 2006, NEUROSCIENCE, V141, P345, DOI 10.1016/j.neuroscience.2006.03.021; Ananthalakshmi KVV, 2007, EPILEPSY RES, V76, P85, DOI 10.1016/j.eplepsyres.2007.07.001; Avoli Massimo, 2006, Epilepsy Curr, V6, P203, DOI 10.1111/j.1535-7511.2006.00146.x; Avoli M, 2013, NEUROPHARMACOLOGY, V69, P37, DOI 10.1016/j.neuropharm.2012.06.044; Barton ME, 2001, EPILEPSY RES, V47, P217, DOI 10.1016/S0920-1211(01)00302-3; Bethmann K, 2008, NEUROBIOL DIS, V31, P169, DOI 10.1016/j.nbd.2008.01.005; Borgland SL, 2004, J NEUROSCI, V24, P7482, DOI 10.1523/JNEUROSCI.1312-04.2004; Brodie MJ, 2013, EPILEPSIA, V54, P11, DOI 10.1111/j.1528-1167.2012.03671.x; BROWNING RA, 1985, LIFE SCI, V37, P2205, DOI 10.1016/0024-3205(85)90573-9; BUCKMASTER PS, 1994, HIPPOCAMPUS, V4, P393, DOI 10.1002/hipo.450040402; Curia G, 2008, J NEUROSCI METH, V172, P143, DOI 10.1016/j.jneumeth.2008.04.019; de Curtis M, 2012, NETWORK; Deeb TZ, 2012, EPILEPSIA, V53, P79, DOI 10.1111/epi.12037; Delgado-Escueta A V, 1999, Adv Neurol, V79, P3; EDAFIOGHO IO, 1992, J MED CHEM, V35, P2798, DOI 10.1021/jm00093a012; Edafiogho IO, 2007, J PHARM SCI-US, V96, P2509, DOI 10.1002/jps.20967; Edafiogho IO, 2014, EUR J MED CHEM, V76, P20, DOI 10.1016/j.ejmech.2014.02.002; El Bahh B, 2005, EUR J NEUROSCI, V22, P1417, DOI 10.1111/j.1460-9568.2005.04338.x; Faught E, 2007, LANCET NEUROL, V6, P476, DOI 10.1016/S1474-4422(07)70115-1; Feng ZY, 2003, J NEUROPHYSIOL, V90, P2253, DOI 10.1152/jn.00241.2003; Gaitatzis A, 2013, CNS DRUGS, V27, P435, DOI 10.1007/s40263-013-0063-0; GEAN PW, 1988, NEUROPHARMACOLOGY, V27, P557, DOI 10.1016/0028-3908(88)90175-X; Gulyas-Kovacs A, 2002, BRAIN RES, V945, P174, DOI 10.1016/S0006-8993(02)02751-8; Huberfeld G, 2011, NAT NEUROSCI, V14, P627, DOI 10.1038/nn.2790; KALIVAS PW, 1993, J NEUROSCI, V13, P266; Kerr MP, 2012, ACTA NEUROL SCAND, V126, P1, DOI 10.1111/ane.12014; Klapstein GJ, 1997, J NEUROPHYSIOL, V78, P1651, DOI 10.1152/jn.1997.78.3.1651; Kobow K, 2012, EPILEPSIA, V53, P1868, DOI 10.1111/j.1528-1167.2012.03716.x; Kombian SB, 2005, BRIT J PHARMACOL, V145, P945, DOI 10.1038/sj.bjp.0706250; Kwan P, 2011, NEW ENGL J MED, V365, P919, DOI 10.1056/NEJMra1004418; Lenkowski PW, 2007, NEUROPHARMACOLOGY, V52, P1044, DOI 10.1016/j.neuropharm.2006.11.001; Loscher W, 1998, PROG NEUROBIOL, V54, P721, DOI 10.1016/S0301-0082(97)00092-0; Loscher W, 2002, EPILEPSY RES, V50, P105, DOI 10.1016/S0920-1211(02)00073-6; Loscher W, 2002, EPILEPSY RES, V50, P3, DOI 10.1016/S0920-1211(02)00063-3; Mares P, 2006, MODELS OF SEIZURES AND EPILEPSY, P153, DOI 10.1016/B978-012088554-1/50014-1; Mattson RH, 1998, NEUROLOGY, V51, pS15, DOI 10.1212/WNL.51.5_Suppl_4.S15; MAYER ML, 1987, J PHYSIOL-LONDON, V394, P501, DOI 10.1113/jphysiol.1987.sp016883; McCormick DA, 2001, ANNU REV PHYSIOL, V63, P815, DOI 10.1146/annurev.physiol.63.1.815; MCNAMARA JO, 1994, EPILEPSIA, V35, pS51, DOI 10.1111/j.1528-1157.1994.tb05929.x; McNamara JO, 2006, SCI STKE, P12; Motamedia GK, 2006, EPILEPSY RES, V70, P200, DOI 10.1016/j.eplepsyres.2006.05.001; MULZAC D, 1993, EPILEPSIA, V34, P1141, DOI 10.1111/j.1528-1157.1993.tb02147.x; Pahuja M, 2012, EPILEPSY BEHAV, V25, P368, DOI 10.1016/j.yebeh.2012.08.014; Pollard JR, 2006, LANCET NEUROL; Rogawski Michael A, 2006, Epilepsy Curr, V6, P197, DOI 10.1111/j.1535-7511.2006.00144.x; Rowley NM, 2010, EPILEPSY RES, V92, P163, DOI 10.1016/j.eplepsyres.2010.09.002; Rubio Carmen, 2010, Central Nervous System Agents in Medicinal Chemistry, V10, P298; Santhouse J, 2007, EPILEPSIA; SCHARFMAN HE, 1990, NEUROSCIENCE, V35, P491, DOI 10.1016/0306-4522(90)90324-W; Schmidt D, 2012, EPILEPTIC DISORD, V14, P105, DOI 10.1684/epd.2012.0512; Sorensen AT, 2013, EPILEPSIA, V54, P1, DOI 10.1111/epi.12000; Staley Kevin J, 2006, Epilepsy Curr, V6, P199, DOI 10.1111/j.1535-7511.2006.00145.x; Staley KJ, 2011, NEUROSCI LETT, V497, P247, DOI 10.1016/j.neulet.2011.03.070; STASHEFF SF, 1985, BRAIN RES, V344, P296, DOI 10.1016/0006-8993(85)90807-8; Stohr T, 2007, EPILEPSY RES, V74, P147, DOI 10.1016/j.eplepsyres.2007.03.004; SUZDAK PD, 1995, EPILEPSIA, V36, P612, DOI 10.1111/j.1528-1157.1995.tb02576.x; SWANSON TH, 1995, J CLIN NEUROPHYSIOL, V12, P2; SWARTZWELDER HS, 1987, BRAIN RES, V410, P362; TRAYNELIS SF, 1988, J NEUROPHYSIOL, V59, P259, DOI 10.1152/jn.1988.59.1.259; Trinka E, 2012, ACTA NEUROL SCAND, V126, P10, DOI 10.1111/ane.12015; URUNO K, 1994, HIPPOCAMPUS, V4, P583, DOI 10.1002/hipo.450040508; Vincent P, 2009, NEUROSCIENCE, V158, P309, DOI 10.1016/j.neuroscience.2008.02.066; Wang ZJ, 2011, J PHARMACOL EXP THER, V336, P916, DOI 10.1124/jpet.110.173740; White HS, 2002, J PHARMACOL EXP THER, V302, P636, DOI 10.1124/jpet.102.034819; WONG BY, 1990, EPILEPSY RES, V7, P29, DOI 10.1016/0920-1211(90)90051-V	65	9	9	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e99770	10.1371/journal.pone.0099770	http://dx.doi.org/10.1371/journal.pone.0099770			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945912	gold, Green Published, Green Submitted			2022-12-27	WOS:000340721500027
J	van Straten, G; van Steenbeek, FG; Grinwis, GCM; Favier, RP; Kummeling, A; van Gils, IH; Fieten, H; Koerkamp, MJAG; Holstege, FCP; Rothuizen, J; Spee, B				van Straten, Giora; van Steenbeek, Frank G.; Grinwis, Guy C. M.; Favier, Robert P.; Kummeling, Anne; van Gils, Ingrid H.; Fieten, Hille; Koerkamp, Marian J. A. Groot; Holstege, Frank C. P.; Rothuizen, Jan; Spee, Bart			Aberrant Expression and Distribution of Enzymes of the Urea Cycle and Other Ammonia Metabolizing Pathways in Dogs with Congenital Portosystemic Shunts	PLOS ONE			English	Article							CARBAMOYL-PHOSPHATE SYNTHETASE; GENE-EXPRESSION; RAT-LIVER; GLUTAMINE-SYNTHETASE; IRISH WOLFHOUNDS; ORNITHINE CYCLE; MOUSE-LIVER; IMMUNOHISTOCHEMICAL LOCALIZATION; HEPATOCELLULAR EXPRESSION; NITROGEN-METABOLISM	The detoxification of ammonia occurs mainly through conversion of ammonia to urea in the liver via the urea cycle and glutamine synthesis. Congenital portosystemic shunts (CPSS) in dogs cause hyperammonemia eventually leading to hepatic encephalopathy. In this study, the gene expression of urea cycle enzymes (carbamoylphosphate synthetase (CPS1), ornithine carbamoyltransferase (OTC), argininosuccinate synthetase (ASS1), argininosuccinate lyase (ASL), and arginase (ARG1)), N-acetylglutamate synthase (NAGS), Glutamate dehydrogenase (GLUD1), and glutamate-ammonia ligase (GLUL) was evaluated in dogs with CPSS before and after surgical closure of the shunt. Additionally, immunohistochemistry was performed on urea cycle enzymes and GLUL on liver samples of healthy dogs and dogs with CPSS to investigate a possible zonal distribution of these enzymes within the liver lobule and to investigate possible differences in distribution in dogs with CPSS compared to healthy dogs. Furthermore, the effect of increasing ammonia concentrations on the expression of the urea cycle enzymes was investigated in primary hepatocytes in vitro. Gene-expression of CPS1, OTC, ASL, GLUD1 and NAGS was down regulated in dogs with CPSS and did not normalize after surgical closure of the shunt. In all dogs GLUL distribution was localized pericentrally. CPS1, OTC and ASS1 were localized periportally in healthy dogs, whereas in CPSS dogs, these enzymes lacked a clear zonal distribution. In primary hepatocytes higher ammonia concentrations induced mRNA levels of CPS1. We hypothesize that the reduction in expression of urea cycle enzymes, NAGS and GLUD1 as well as the alterations in zonal distribution in dogs with CPSS may be caused by a developmental arrest of these enzymes during the embryonic or early postnatal phase.	[van Straten, Giora; van Steenbeek, Frank G.; Favier, Robert P.; Kummeling, Anne; van Gils, Ingrid H.; Fieten, Hille; Rothuizen, Jan; Spee, Bart] Univ Utrecht, Fac Vet Med, Dept Clin Sci Compan Anim, Utrecht, Netherlands; [Grinwis, Guy C. M.] Univ Utrecht, Fac Vet Med, Dept Pathobiol, Utrecht, Netherlands; [Koerkamp, Marian J. A. Groot; Holstege, Frank C. P.] Univ Med Ctr Utrecht, Utrecht, Netherlands	Utrecht University; Utrecht University; Utrecht University; Utrecht University Medical Center	van Straten, G (corresponding author), Univ Utrecht, Fac Vet Med, Dept Clin Sci Compan Anim, Utrecht, Netherlands.	G.vanStraten@uu.nl	Holstege, Frank/AAM-9944-2021; Kummeling, Anne/GNW-3198-2022; van Steenbeek, F.G./AFL-0046-2022	van Steenbeek, F.G./0000-0001-5460-6540; Groot Koerkamp, Marian JA/0000-0002-0867-0821; Grinwis, Guy/0000-0002-1583-9648				ADCOCK MW, 1984, J BIOL CHEM, V259, P3471; [Anonymous], 2006, WSAVA STANDARDS CLIN; Arends B, 2009, STEM CELLS DEV, V18, P351, DOI 10.1089/scd.2008.0043; Benhamouche S, 2006, DEV CELL, V10, P759, DOI 10.1016/j.devcel.2006.03.015; Berent AC, 2009, VET CLIN N AM-SMALL, V39, P513, DOI 10.1016/j.cvsm.2009.02.004; Brinkhof B, 2006, ANAL BIOCHEM, V356, P36, DOI 10.1016/j.ab.2006.06.001; Christoffels VM, 1998, MOL CELL BIOL, V18, P6305, DOI 10.1128/MCB.18.11.6305; DEGROOT CJ, 1986, BIOCHIM BIOPHYS ACTA, V866, P61, DOI 10.1016/0167-4781(86)90101-6; Dingemanse MA, 1996, HEPATOLOGY, V24, P407; Fossum TW, 2007, SMALL ANIMAL SURG, P531; Gebhardt R, 2007, PROG HISTOCHEM CYTO, V41, P201, DOI 10.1016/j.proghi.2006.12.001; GLUECKSOHNWAELSCH S, 1975, DEV BIOL, V45, P369, DOI 10.1016/0012-1606(75)90075-5; HAUSSINGER D, 1990, BIOCHEM J, V267, P281; Haussinger D, 1990, J PARENTER ENTERAL N, V14, p56S; Heibel SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029527; IMAMURA Y, 1990, FEBS LETT, V260, P119, DOI 10.1016/0014-5793(90)80081-S; Janzen JWG, 1987, J HISTOCHEM CYTOCHEM, V35, P49, DOI 10.1177/35.1.2878950; JANZEN JWG, 1988, J HISTOCHEM CYTOCHEM, V36, P1223, DOI 10.1177/36.10.2458406; JANZEN JWG, 1984, J HISTOCHEM CYTOCHEM, V32, P557, DOI 10.1177/32.6.6373912; Jungermann K, 2000, HEPATOLOGY, V31, P255, DOI 10.1002/hep.510310201; JUNGERMANN K, 1989, PHYSIOL REV, V69, P708, DOI 10.1152/physrev.1989.69.3.708; Koga H, 2010, AM J MED GENET A, V152A, P2387, DOI 10.1002/ajmg.a.33566; Krebs H. A., 1964, METABOLIC FATE AMINO, P125; LAMERS WH, 1987, DIFFERENTIATION, V35, P228, DOI 10.1111/j.1432-0436.1987.tb00173.x; MATSUBASA T, 1994, J BIOCHEM, V116, P1044, DOI 10.1093/oxfordjournals.jbchem.a124626; MCINTYRE P, 1985, DNA-J MOLEC CELL BIO, V4, P147, DOI 10.1089/dna.1985.4.147; MEIJER AJ, 1990, PHYSIOL REV, V70, P701, DOI 10.1152/physrev.1990.70.3.701; MEYER HP, 1994, RES VET SCI, V57, P58, DOI 10.1016/0034-5288(94)90082-5; MEYER HP, 1995, VET REC, V136, P13, DOI 10.1136/vr.136.1.13; MOORMAN AFM, 1990, HISTOCHEM J, V22, P457, DOI 10.1007/BF01007229; MOORMAN AFM, 1989, HEPATOLOGY, V9, P367, DOI 10.1002/hep.1840090305; MORRIS SM, 1989, ARCH BIOCHEM BIOPHYS, V269, P175, DOI 10.1016/0003-9861(89)90097-0; MORRIS SM, 1988, BIOCHEM GENET, V26, P769, DOI 10.1007/BF02395522; Morris SM, 2002, ANNU REV NUTR, V22, P87, DOI 10.1146/annurev.nutr.22.110801.140547; MULTHAUPT H, 1987, HISTOCHEMISTRY, V87, P465, DOI 10.1007/BF00496818; Notenboom RGE, 1996, DEVELOPMENT, V122, P321; POWERSLEE SG, 1987, J BIOL CHEM, V262, P15683; RABIER D, 1983, BIOCHIMIE, V65, P1, DOI 10.1016/S0300-9084(83)80022-4; Roskams T., 2007, MACSWEENS PATHOLOGY, V1, P1; ROTHUIZEN J, 1982, RES VET SCI, V33, P22, DOI 10.1016/S0034-5288(18)32353-1; RUPPERT S, 1992, GENE DEV, V6, P1430, DOI 10.1101/gad.6.8.1430; SHIOJIRI N, 1995, LAB INVEST, V72, P740; SIGSGAARD I, 1988, LIVER, V8, P193; Stringer MD, 2008, CLIN ANAT, V21, P147, DOI 10.1002/ca.20574; Takiguchi M, 1995, BIOCHEM J, V312, P649, DOI 10.1042/bj3120649; Tobias KM, 2003, J AM VET MED ASSOC, V223, P1636, DOI 10.2460/javma.2003.223.1636; TOBIAS KM, 2003, TXB SMALL ANIMAL SUR, P727; TOMOMURA M, 1992, BIOCHIM BIOPHYS ACTA, V1138, P167, DOI 10.1016/0925-4439(92)90058-U; TOMOMURA M, 1994, BBA-MOL BASIS DIS, V1226, P307, DOI 10.1016/0925-4439(94)90042-6; TONJES RR, 1992, EMBO J, V11, P127, DOI 10.1002/j.1460-2075.1992.tb05035.x; Torre C, 2011, INT J BIOCHEM CELL B, V43, P271, DOI 10.1016/j.biocel.2009.11.004; Torre C, 2010, PROG MOL BIOL TRANSL, V97, P127, DOI 10.1016/B978-0-12-385233-5.00005-2; Ubbink GJ, 1998, AM J VET RES, V59, P1553; Ubbink GJ, 1998, VET REC, V142, P209, DOI 10.1136/vr.142.9.209; Uchino T, 1999, J PEDIATR-US, V135, P254, DOI 10.1016/S0022-3476(99)70031-4; van Steenbeek FG, 2009, J VET INTERN MED, V23, P950, DOI 10.1111/j.1939-1676.2009.0319.x; van Steenbeek FG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057662; van Steenbeek FG, 2012, MAMM GENOME, V23, P76, DOI 10.1007/s00335-011-9364-0; van Straten G, 2005, J VET INTERN MED, V19, P321, DOI 10.1892/0891-6640(2005)19[321:ICEPSI]2.0.CO;2; VANDENINGH TSGAM, 1995, VET QUART, V17, P70, DOI 10.1080/01652176.1995.9694536; Wolschrijn CF, 2000, VET QUART, V22, P94, DOI 10.1080/01652176.2000.9695032; Wu H., 2003, ANAL GENE EXPRESSION, P313, DOI DOI 10.1007/0-387-21679-0_14; YOKOTA S, 1986, HISTOCHEM J, V18, P451, DOI 10.1007/BF01675338	63	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100077	10.1371/journal.pone.0100077	http://dx.doi.org/10.1371/journal.pone.0100077			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945279	gold, Green Published, Green Submitted			2022-12-27	WOS:000340721500043
J	Yu, DD; Xu, L; Liu, XH; Fan, Y; Lu, LB; Yao, YG				Yu, Dandan; Xu, Ling; Liu, Xiao-Hong; Fan, Yu; Lu, Long-Bao; Yao, Yong-Gang			Diverse Interleukin-7 mRNA Transcripts in Chinese Tree Shrew (Tupaia belangeri chinensis)	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; PHYLOGENETIC POSITION; EXPRESSION ANALYSIS; IL-7; CELLS; CLONING; MURINE; VIRUS; IDENTIFICATION; TRANSDUCTION	Interleukin-7 (IL7) is a pleiotropic cytokine that is actively involved in the immune system. The Chinese tree shrew (Tupaia belangeri chinensis) has been proposed as an alternative experimental animal to primates in biomedical research. However, there is a lack of biological knowledge about the immune system of the tree shrew. In this study, we cloned the IL7 gene (tIL7) in the Chinese tree shrew and quantified the expression of mRNA transcripts in eight tissues (heart, liver, spleen, lung, kidney, intestine, skeletal muscle and brain) from 20 individuals. Eleven tIL7 mRNA transcripts were identified in different tissues. The canonical form (tIL7c) had a length of 1817 bp and encoded a predicted gene product with 177 amino acids. Phylogenetic analyses based on the amino acid sequences revealed a considerably large genetic difference between tree shrew and human. Quantification of mRNA expression of transcripts tIL7c, tIL7-sv1, tIL7-sv2 and tIL7-sv3 showed that these transcripts were expressed in all tissues, albeit the expression levels varied in different tissues. Transcripts tIL7c, tIL7-sv1, and tIL7-sv2 had the lowest expression in brain, and tIL7-sv3 had a dramatically high mRNA expression in skeletal muscle and heart. The mRNA expression levels of tIL7c and tIL7-sv1 were significantly increased upon ploy(I: C) stimulation in tree shrew primary renal cells. As with human full-length IL7, tIL7c, tIL7-sv1, tIL7-sv2 and tIL7-sv3 showed similar a subcellular localization pattern. Our results identified diverse tIL7 transcripts in the Chinese tree shrew, which may play a potential role in modulating IL7-regulated biological effects.	[Yu, Dandan; Xu, Ling; Liu, Xiao-Hong; Fan, Yu; Yao, Yong-Gang] Chinese Acad Sci & Yunnan Prov, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan, Peoples R China; [Xu, Ling; Fan, Yu; Yao, Yong-Gang] Univ Chinese Acad Sci, Kunming Coll Life Sci, Kunming, Yunnan, Peoples R China; [Lu, Long-Bao; Yao, Yong-Gang] Chinese Acad Sci, Kunming Inst Zool, Expt Anim Core Facil, Kunming, Peoples R China; [Lu, Long-Bao; Yao, Yong-Gang] Chinese Acad Sci, Kunming Inst Zool, Kunming Primate Res Ctr, Kunming, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; Kunming Institute of Zoology	Yao, YG (corresponding author), Chinese Acad Sci & Yunnan Prov, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan, Peoples R China.	ygyaozh@gmail.com	Yao, Yong-Gang/AAH-2303-2021; hong, liu/AAW-5380-2021	Yao, Yong-Gang/0000-0002-2955-0693; Liu, Xiaohong/0000-0002-5420-2391; Fan, Yu/0000-0002-5978-5004	National 863 Project of China [2012AA021801, 2012AA022402]; Chinese Academy of Sciences [KSCX2-EW-R-11, KSCX2-EW-J23]; Yunnan Province [2013FB071]	National 863 Project of China(National High Technology Research and Development Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); Yunnan Province	This study was supported by the National 863 Project of China (2012AA021801 and 2012AA022402) and grants from Chinese Academy of Sciences (KSCX2-EW-R-11, KSCX2-EW-J23 and One-Three-Five Strategic Planning Project) and Yunnan Province (2013FB071). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpdogan O, 2005, TRENDS IMMUNOL, V26, P56, DOI 10.1016/j.it.2004.11.002; Altekar G, 2004, BIOINFORMATICS, V20, P407, DOI 10.1093/bioinformatics/btg427; Alves NL, 2009, P NATL ACAD SCI USA, V106, P1512, DOI 10.1073/pnas.0809559106; Amako Y, 2010, J VIROL, V84, P303, DOI 10.1128/JVI.01448-09; Arrode-Bruses G, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-83; BARCHAM GJ, 1995, GENE, V154, P265, DOI 10.1016/0378-1119(94)00857-O; Brack M, 1998, J COMP PATHOL, V118, P301, DOI 10.1016/S0021-9975(07)80006-5; Cao J, 2003, J MED PRIMATOL, V32, P123, DOI 10.1034/j.1600-0684.2003.00022.x; Cella M, 2010, P NATL ACAD SCI USA, V107, P10961, DOI 10.1073/pnas.1005641107; Chen Shi-Yi, 2011, Zoological Research, V32, P17, DOI 10.3724/SP.J.1141.2011.01017; Cook RF, 2008, VET IMMUNOL IMMUNOP, V125, P126, DOI 10.1016/j.vetimm.2008.05.006; Fan Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2416; Fuchs E., 2010, The UFAW handbook on the care and management of laboratory and other research animals, P262; GOODWIN RG, 1989, P NATL ACAD SCI USA, V86, P302, DOI 10.1073/pnas.86.1.302; Hara T, 2012, J IMMUNOL, V189, P1577, DOI 10.4049/jimmunol.1200586; Haugen F, 2010, AM J PHYSIOL-CELL PH, V298, pC807, DOI 10.1152/ajpcell.00094.2009; HEUFLER C, 1993, J EXP MED, V178, P1109, DOI 10.1084/jem.178.3.1109; Jiang Q, 2005, CYTOKINE GROWTH F R, V16, P513, DOI 10.1016/j.cytogfr.2005.05.004; Jin JO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077605; Kock J, 2001, J VIROL, V75, P5084, DOI 10.1128/JVI.75.11.5084-5089.2001; Kono T, 2008, FEBS J, V275, P1213, DOI 10.1111/j.1742-4658.2008.06281.x; Kroemer RT, 1996, PROTEIN ENG, V9, P493, DOI 10.1093/protein/9.6.493; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Lum JJ, 2004, J VIROL, V78, P6033, DOI 10.1128/JVI.78.11.6033-6042.2004; Mackall CL, 2011, NAT REV IMMUNOL, V11, P330, DOI 10.1038/nri2970; Mazzucchelli RI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007637; Milne CD, 2006, SEMIN IMMUNOL, V18, P20, DOI 10.1016/j.smim.2005.10.003; Moors M, 2010, GENES IMMUN, V11, P11, DOI 10.1038/gene.2009.77; Murphy WJ, 2004, TRENDS GENET, V20, P631, DOI 10.1016/j.tig.2004.09.005; NAMEN AE, 1988, NATURE, V333, P571, DOI 10.1038/333571a0; Or R, 1998, CYTOKINES CELL MOL T, V4, P287; Pellegrini M, 2011, CELL, V144, P601, DOI 10.1016/j.cell.2011.01.011; Peng YZ, 1991, BIOL CHINESE TREE SH, P46; RABB GB, 1966, DIABETES, V15, P327, DOI 10.2337/diab.15.5.327; Repass JF, 2009, GENESIS, V47, P281, DOI 10.1002/dvg.20497; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; ROSEN A, 1985, MED MICROBIOL IMMUN, V173, P257, DOI 10.1007/BF02124943; Sawa Y, 2009, IMMUNITY, V30, P447, DOI 10.1016/j.immuni.2009.01.007; Shalapour S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031939; Siewe BT, 2010, DEV COMP IMMUNOL, V34, P828, DOI 10.1016/j.dci.2010.03.003; Singer A, 2002, CURR OPIN IMMUNOL, V14, P207, DOI 10.1016/S0952-7915(02)00323-0; Takahashi K, 1997, HUM IMMUNOL, V55, P103, DOI 10.1016/S0198-8859(97)00094-3; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Ueha S, 2001, BBA-GENE STRUCT EXPR, V1517, P468, DOI 10.1016/S0167-4781(00)00304-3; Vudattu NK, 2009, GENES IMMUN, V10, P132, DOI 10.1038/gene.2008.90; WATANABE M, 1995, J CLIN INVEST, V95, P2945, DOI 10.1172/JCI118002; Xu Lin, 2013, Zoological Research, V34, P59, DOI 10.3724/SP.J.1141.2013.02059; Xu Ling, 2013, Zoological Research, V34, P70, DOI 10.3724/SP.J.1141.2013.02070; Xu L, 2012, J GENET GENOMICS, V39, P131, DOI 10.1016/j.jgg.2012.02.003; Yan R, 1984, J GUANGXI MED U, V1, P10; Yan RQ, 1996, J CANCER RES CLIN, V122, P283, DOI 10.1007/BF01261404; Yu Q, 2006, J EXP MED, V203, P165, DOI 10.1084/jem.20051836	52	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e99859	10.1371/journal.pone.0099859	http://dx.doi.org/10.1371/journal.pone.0099859			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945249	Green Published, gold, Green Submitted			2022-12-27	WOS:000340721500030
J	Yuasa, D; Ohashi, K; Shibata, R; Takeshita, K; Kikuchi, R; Takahashi, R; Kataoka, Y; Miyabe, M; Joki, Y; Kambara, T; Uemura, Y; Matsuo, K; Hayakawa, S; Hiramatsu-Ito, M; Ito, M; Ikeda, N; Murohara, T; Ouchi, N				Yuasa, Daisuke; Ohashi, Koji; Shibata, Rei; Takeshita, Kyosuke; Kikuchi, Ryosuke; Takahashi, Ryotaro; Kataoka, Yoshiyuki; Miyabe, Megumi; Joki, Yusuke; Kambara, Takahiro; Uemura, Yusuke; Matsuo, Kazuhiro; Hayakawa, Satoko; Hiramatsu-Ito, Mizuho; Ito, Masanori; Ikeda, Nobuo; Murohara, Toyoaki; Ouchi, Noriyuki			Association of Circulating C1q/TNF-Related Protein 1 Levels with Coronary Artery Disease in Men	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; RISK-FACTORS; INFLAMMATORY DISEASE; ADIPOSE-TISSUE; OBESITY; EXPRESSION; CTRP1; ADIPOKINE	Objective: Obesity is a major risk factor for cardiovascular disease. Recent evidence demonstrates that dysregulation of fat-derived hormones, also known as adipokines, is linked with the pathogenesis of obesity-related disorders including coronary artery disease (CAD). Here, we investigated whether circulating level of an adipokine C1q/TNF-related protein (CTRP) 1 is associated with the prevalence of CAD. Methods and Results: Consecutive 76 male CAD patients were enrolled from inpatients that underwent coronary angiography. Sixty four healthy male subjects served as controls. Plasma CTRP1 concentration was determined by enzyme-linked immunosorbent assay. CTRP1 levels were correlated positively with systolic blood pressure (BP) and triglyceride levels, and negatively with HDL cholesterol levels in all subjects. Plasma levels of CTRP1 were significantly higher in CAD patients than in control subjects (CAD: 443.3 +/- 18.6 ng/ml, control: 307.8 +/- 21.5 ng/ml, p<0.001). Multiple logistic regression analysis with body mass index, systolic BP, glucose, total cholesterol, HDL cholesterol, triglyceride, adiponectin and CTRP1 revealed that CTRP1 levels, together with systolic BP and HDL cholesterol, correlated with CAD. Conclusions: Our data indicate the close association of high CTRP1 levels with CAD prevalence, suggesting that CTRP1 represents a novel biomarker for CAD.	[Yuasa, Daisuke; Shibata, Rei; Takeshita, Kyosuke; Kikuchi, Ryosuke; Kataoka, Yoshiyuki; Miyabe, Megumi; Joki, Yusuke; Kambara, Takahiro; Uemura, Yusuke; Matsuo, Kazuhiro; Hayakawa, Satoko; Hiramatsu-Ito, Mizuho; Ito, Masanori; Murohara, Toyoaki] Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4648601, Japan; [Ohashi, Koji; Ouchi, Noriyuki] Nagoya Univ, Grad Sch Med, Dept Mol Cardiol, Nagoya, Aichi 4648601, Japan; [Takahashi, Ryotaro; Ikeda, Nobuo] Chunichi Hosp, Dept Cardiol, Nagoya, Aichi, Japan	Nagoya University; Nagoya University	Ohashi, K (corresponding author), Nagoya Univ, Grad Sch Med, Dept Mol Cardiol, Nagoya, Aichi 4648601, Japan.	ohashik@med.nagoya-u.ac.jp; nouchi@med.nagoya-u.ac.jp	Kikuchi, Ryosuke/AAX-4971-2021; Takeshita, Kyosuke/B-7008-2012; OUCHI, Noriyuki/I-7306-2014; Murohara, Toyoaki/M-4958-2014; OHASHI, Koji/I-7307-2014; Takeshita, Kyosuke/AAD-9515-2020	Takeshita, Kyosuke/0000-0002-8283-3799; Takeshita, Kyosuke/0000-0002-8283-3799; Hiramatsu-Ito, Mizuho/0000-0003-1740-1794	Takeda Science Foundation; Uehara Memorial Foundation; Daiichi-Sankyo Foundation of Life Science; SENSHIN Medical Research Foundation; Suzuken Memorial Foundation	Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); Daiichi-Sankyo Foundation of Life Science; SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation); Suzuken Memorial Foundation	This work was supported by Grant-in-Aid for Scientific Research, Grant-in-Aid for Challenging Exploratory Research and grants from Takeda Science Foundation, the Uehara Memorial Foundation, Daiichi-Sankyo Foundation of Life Science, and SENSHIN Medical Research Foundation to N. Ouchi. R. Shibata was supported with the Grant-in-Aid for Young Scientists B and the Uehara Memorial Foundation. K. Ohashi was supported with the Grant-in-Aid for Scientific Research C and Suzuken Memorial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Chalupova L, 2013, CLIN BIOCHEM, V46, P73, DOI 10.1016/j.clinbiochem.2012.09.006; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Enomoto T, 2011, J BIOL CHEM, V286, P34552, DOI 10.1074/jbc.M111.277319; Friedman JM, 2003, SCIENCE, V299, P856, DOI 10.1126/science.1079856; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Jeon JH, 2008, FASEB J, V22, P1502, DOI 10.1096/fj.07-9412com; Kastorini CM, 2013, AM J CARDIOL, V112, P349, DOI 10.1016/j.amjcard.2013.03.039; Kim KY, 2006, FEBS LETT, V580, P3953, DOI 10.1016/j.febslet.2006.06.034; Lasser G, 2006, BLOOD, V107, P423, DOI 10.1182/blood-2005-04-1425; Liu LJ, 2014, AM J CARDIOL, V113, P84, DOI 10.1016/j.amjcard.2013.08.042; Long Y, 2013, AM J CARDIOL, V111, P68, DOI 10.1016/j.amjcard.2012.08.045; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Matsuzawa Y, 2006, NAT CLIN PRACT CARD, V3, P35, DOI 10.1038/ncpcardio0380; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Ouchi N, 2003, CURR OPIN LIPIDOL, V14, P561, DOI 10.1097/00041433-200312000-00003; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Ouchi N, 2010, SCIENCE, V329, P454, DOI 10.1126/science.1188280; Peterson JM, 2012, J BIOL CHEM, V287, P1576, DOI 10.1074/jbc.M111.278333; Shibata R, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-37; Shibata R, 2011, ATHEROSCLEROSIS, V219, P811, DOI 10.1016/j.atherosclerosis.2011.08.017; Wong GW, 2008, BIOCHEM J, V416, P161, DOI 10.1042/BJ20081240; Wong GW, 2004, P NATL ACAD SCI USA, V101, P10302, DOI 10.1073/pnas.0403760101	24	39	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e99846	10.1371/journal.pone.0099846	http://dx.doi.org/10.1371/journal.pone.0099846			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	24945145	gold, Green Published, Green Submitted			2022-12-27	WOS:000340721500029
J	Chang, SW; Fann, CSJ; Su, WH; Wang, YC; Weng, CC; Yu, CJ; Hsu, CL; Hsieh, AR; Chien, RN; Chu, CM; Tai, DI				Chang, Su-Wei; Fann, Cathy Shen-Jang; Su, Wen-Hui; Wang, Yu Chen; Weng, Chia Chan; Yu, Chia-Jung; Hsu, Chia-Lin; Hsieh, Ai-Ru; Chien, Rong-Nan; Chu, Chia-Ming; Tai, Dar-In			A Genome-Wide Association Study on Chronic HBV Infection and Its Clinical Progression in Male Han-Taiwanese	PLOS ONE			English	Article							CHRONIC HEPATITIS-B; PEGINTERFERON ALPHA-2A; LAMIVUDINE TREATMENT; COST-EFFECTIVENESS; ENTECAVIR THERAPY; POLYMORPHISMS; GENE; PREVALENCE; EXPRESSION; RELATIVES	It is common to observe the clustering of chronic hepatitis B surface antigen (HBsAg) carriers in families. Intra-familial transmission of hepatitis B virus (HBV) could be the reason for the familial clustering of HBsAg carriers. Additionally, genetic and gender factors have been reported to be involved. We conducted a three-stage genome-wide association study to identify genetic factors associated with chronic HBV susceptibility. A total of 1,065 male controls and 1,623 male HBsAg carriers were included. The whole-genome genotyping was done on Illumina HumanHap550 beadchips in 304 healthy controls and HumanHap610 beadchips in 321 cases. We found that rs9277535 (HLA-DPB1, P = 4.87x10(-14)), rs9276370 (HLA-DQA2, P = 1.9x10(-12)), rs7756516 and rs7453920 (HLA-DQB2, P = 1.48610(-11) and P = 6.66x10(-15) respectively) were significantly associated with persistent HBV infection. A novel SNP rs9366816 near HLA-DPA3 also showed significant association (P = 2.58x10(-10)). The "T-T-G-G-T" haplotype of the five SNPs further signified their association with the disease (P = 1.48x10(-12); OR = 1.49). The "T-T" haplotype composed of rs7756516 and rs9276370 was more prevalent in severe disease subgroups and associated with non-sustained therapeutic response (P = 0.0262). The "G-C" haplotype was associated with sustained therapeutic response (P = 0.0132; OR = 2.49). We confirmed that HLA-DPB1, HLA-DQA2 and HLA-DQB2 loci were associated with persistent HBV infection in male Taiwan Han-Chinese. In addition, the HLA-DQA2 and -DQB2 complex was associated with clinical progression and therapeutic response.	[Chang, Su-Wei] Chang Gung Univ, Coll Med, Clin Informat & Med Stat Res Ctr, Taoyuan, Taiwan; [Fann, Cathy Shen-Jang; Hsu, Chia-Lin] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan; [Su, Wen-Hui] Chang Gung Univ, Chang Gung Mol Med Res Ctr, Grad Inst Biomed Sci, Dept Biomed Sci, Taoyuan, Taiwan; [Wang, Yu Chen; Weng, Chia Chan; Chien, Rong-Nan; Chu, Chia-Ming; Tai, Dar-In] Chang Gung Mem Hosp, Dept Gastroenterol & Hepatol, Div Hepatol, Linkou, Taiwan; [Yu, Chia-Jung] Chang Gung Univ, Coll Med & Mol Med, Res Ctr, Dept Cell & Mol Biol, Taoyuan, Taiwan; [Hsieh, Ai-Ru] China Med Univ, Grad Inst Biostat, Taichung, Taiwan	Chang Gung University; Academia Sinica - Taiwan; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; China Medical University Taiwan	Tai, DI (corresponding author), Chang Gung Mem Hosp, Dept Gastroenterol & Hepatol, Div Hepatol, Linkou, Taiwan.	tai48978@adm.cgmh.org.tw	Fann, Cathy SJ/F-9410-2010	Fann, Cathy SJ/0000-0001-9025-2276; HSIEH, AIRU/0000-0003-3900-9101; HSU, CHIA-LIN/0000-0001-5785-0733; Su, Wen-Hui/0000-0003-1037-4615	Chang Gung Memorial hospital [CMRPG360771-3, CMRPG3B0221]; National Science Council, Taipei Taiwan [NSC101-2314-B-182A-025-MY3, NSC102-2314-B-001-003-MY2]	Chang Gung Memorial hospital(Chang Gung Memorial Hospital); National Science Council, Taipei Taiwan	This study was supported by grants from the Chang Gung Memorial hospital (CMRPG360771-3 and CMRPG3B0221) and the National Science Council (NSC101-2314-B-182A-025-MY3 and NSC102-2314-B-001-003-MY2), Taipei Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Qahtani AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0080445; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BEASLEY RP, 1982, J INFECT DIS, V146, P198, DOI 10.1093/infdis/146.2.198; BURK RD, 1994, J INFECT DIS, V170, P1418, DOI 10.1093/infdis/170.6.1418; Chang TT, 2010, HEPATOLOGY, V52, P886, DOI 10.1002/hep.23785; Chen CC, 2005, INT J EPIDEMIOL, V34, P1310, DOI 10.1093/ije/dyi191; Chen CH, 2004, J HEPATOL, V40, P653, DOI 10.1016/j.jhep.2003.12.002; CHUNG DC, 1988, J MED VIROL, V26, P411, DOI 10.1002/jmv.1890260408; Dai CY, 2013, J ANTIMICROB CHEMOTH, V68, P2332, DOI 10.1093/jac/dkt193; de Man RA, 2001, HEPATOLOGY, V34, P578, DOI 10.1053/jhep.2001.26815; Hu ZB, 2013, NAT GENET, V45, P1499, DOI 10.1038/ng.2809; Jeng WJ, 2013, HEPATOLOGY, V58, P1888, DOI 10.1002/hep.26549; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; Liaw YF, 2011, HEPATOLOGY, V54, P1591, DOI 10.1002/hep.24555; Liaw YF, 2004, NEW ENGL J MED, V351, P1521, DOI 10.1056/NEJMoa033364; Liaw YF, 2008, HEPATOL INT, V2, P263, DOI 10.1007/s12072-008-9080-3; LINCHU M, 1990, TRANSFUSION, V30, P471, DOI 10.1046/j.1537-2995.1990.30590296383.x; Mbarek H, 2011, HUM MOL GENET, V20, P3884, DOI 10.1093/hmg/ddr301; O'Brien TR, 2011, GENES IMMUN, V12, P428, DOI 10.1038/gene.2011.11; Pan LP, 2014, HUM MOL GENET, V23, P2210, DOI 10.1093/hmg/ddt586; Pan WH, 2006, HUM HERED, V61, P27, DOI 10.1159/000091834; Shaw CK, 1999, TISSUE ANTIGENS, V53, P51, DOI 10.1034/j.1399-0039.1999.530106.x; Singh R, 2007, WORLD J GASTROENTERO, V13, P1770, DOI 10.3748/wjg.v13.i12.1770; Stephens R, 1999, J MOL BIOL, V291, P789, DOI 10.1006/jmbi.1999.3004; Sullivan SD, 2007, J GASTROEN HEPATOL, V22, P1494, DOI 10.1111/j.1440-1746.2006.04539.x; SUNG J-L, 1977, Gastroenterologia Japonica, V12, P58; Tai DI, 2010, AM J GASTROENTEROL, V105, P1102, DOI 10.1038/ajg.2009.669; Tai DI, 2009, HEPATOLOGY, V49, P1859, DOI 10.1002/hep.22878; Tai DI, 2002, J GASTROEN HEPATOL, V17, P682, DOI 10.1046/j.1440-1746.2002.02747.x; Tai DI, 1999, AM J TROP MED HYG, V61, P716, DOI 10.4269/ajtmh.1999.61.716; Thomas R, 2012, J VIROL, V86, P6979, DOI 10.1128/JVI.00406-12; Tsay Pei-Kwei, 2009, Chang Gung Med J, V32, P155; Veenstra DL, 2008, VALUE HEALTH, V11, P131, DOI 10.1111/j.1524-4733.2007.00221.x; Wang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017608; Yu MW, 2003, J NATL CANCER I, V95, P1485, DOI 10.1093/jnci/djg051	35	46	49	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99724	10.1371/journal.pone.0099724	http://dx.doi.org/10.1371/journal.pone.0099724			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940741	Green Published, Green Submitted, gold			2022-12-27	WOS:000338508200038
J	Chetboul, V; Reynolds, BS; Trehiou-Sechi, E; Nguyen, P; Concordet, D; Sampedrano, CC; Testault, I; Elliott, J; Abadie, J; Biourge, V; Lefebvre, HP				Chetboul, Valerie; Reynolds, Brice Stephane; Trehiou-Sechi, Emilie; Nguyen, Patrick; Concordet, Didier; Sampedrano, Carolina Carlos; Testault, Isabelle; Elliott, Jonathan; Abadie, Jerome; Biourge, Vincent; Lefebvre, Herve Pierre			Cardiovascular Effects of Dietary Salt Intake in Aged Healthy Cats: A 2-Year Prospective Randomized, Blinded, and Controlled Study	PLOS ONE			English	Article							LEFT-VENTRICULAR MASS; YOUNG NORMOTENSIVE INDIVIDUALS; BLOOD-PRESSURE; SODIUM-INTAKE; SYSTEMIC HYPERTENSION; ECHOCARDIOGRAPHIC MEASUREMENTS; SENSITIVE RATS; RENAL-FUNCTION; HEART-FAILURE; DISEASE	High salt dry expanded diets are commercially available for cats to increase water intake and urine volume, as part of the prevention or treatment of naturally occurring urinary stone formation (calcium oxalates and struvites). However, chronic high salt intake may have potential cardiovascular adverse effects in both humans, especially in aging individuals, and several animal models. The objective of this prospective, randomized, blinded, and controlled study was to assess the long-term cardiovascular effects of high salt intake in healthy aged cats. Twenty healthy neutered cats (10.1 +/- 2.4 years) were randomly allocated into 2 matched groups. One group was fed a high salt diet (3.1 g/Mcal sodium, 5.5 g/Mcal chloride) and the other group a control diet of same composition except for salt content (1.0 g/Mcal sodium, 2.2 g/Mcal chloride). Clinical examination, systolic and diastolic arterial blood pressure measurements, standard transthoracic echocardiography and conventional Doppler examinations were repeatedly performed on non-sedated cats by trained observers before and over 24 months after diet implementation. Radial and longitudinal velocities of the left ventricular free wall and the interventricular septum were also assessed in systole and diastole using 2-dimensional color tissue Doppler imaging. Statistics were performed using a general linear model. No significant effect of dietary salt intake was observed on systolic and diastolic arterial blood pressure values. Out of the 33 tested imaging variables, the only one affected by dietary salt intake was the radial early on late diastolic velocity ratio assessed in the endocardium of the left ventricular free wall, statistically lower in the high salt diet group at 12 months only (P = 0.044). In conclusion, in this study involving healthy aged cats, chronic high dietary salt intake was not associated with an increased risk of systemic arterial hypertension and myocardial dysfunction, as observed in some elderly people, salt-sensitive patients and animal models.	[Chetboul, Valerie; Trehiou-Sechi, Emilie; Sampedrano, Carolina Carlos] Univ Paris Est, Ecole Natl Vet Alfort, Univ Vet Alfort, Unite Cardiol Alfort, Maisons Alfort, France; [Chetboul, Valerie] INSERM, U955, Creteil, France; [Reynolds, Brice Stephane] Univ Toulouse, Ecole Natl Vet Toulouse, Unite Rech Clin, Toulouse, France; [Nguyen, Patrick] LUNAM Univ, Natl Coll Vet Med, Endocrinol & Nutr Unit, Nantes, France; [Concordet, Didier] Univ Toulouse, INP, INRA, UMR Toxalim 1331,Ecole Natl Vet Toulouse, Toulouse, France; [Testault, Isabelle] Atlantia Vet Hosp, Nantes, France; [Elliott, Jonathan] Univ London Royal Vet Coll, Dept Comparat Biomed Sci, London, England; [Biourge, Vincent] LUNAM Univ, Dept Pathol, Natl Coll Vet Med, Nantes, France; [Biourge, Vincent] Royal Canin SAS, Ctr Rech, Aimargues, France	Ecole Nationale Veterinaire d'Alfort (ENVA); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse; University of London; University of London Royal Veterinary College	Chetboul, V (corresponding author), Univ Paris Est, Ecole Natl Vet Alfort, Univ Vet Alfort, Unite Cardiol Alfort, Maisons Alfort, France.	vchetboul@vet-alfort.fr	Concordet, Didier/AAT-1120-2020; Abadie, Jérôme/ABF-5089-2020	Concordet, Didier/0000-0003-3916-577X; Elliott, Jonathan/0000-0002-4517-6590; Chetboul, Valerie/0000-0001-7891-1814	Royal Canin SAS, a petfood company	Royal Canin SAS, a petfood company	Royal Canin SAS, a petfood company, has sponsored financially this study. Vincent Biourge is a full time employee of Royal Canin, SAS. Vincent Biourge was involved in the study design, in designing and providing the diets, in the preparation of the manuscript and in the decision to publish. He was not involved in data collection and all other investigators were blinded to the dietary treatments.	Aburto NJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1326; BEIL AH, 1994, CARDIOVASC DRUG THER, V8, P425, DOI 10.1007/BF00877918; Borke JA, 2013, J EMERG MED, V44, P36, DOI 10.1016/j.jemermed.2012.02.081; Brown S, 2007, J VET INTERN MED, V21, P542, DOI 10.1892/0891-6640(2007)21[542:GFTIEA]2.0.CO;2; Buranakarl C, 2004, AM J VET RES, V65, P620, DOI 10.2460/ajvr.2004.65.620; Carlos Sampedrano C, 2009, J VET INTERN MED, V23, P91, DOI 10.1111/j.1939-1676.2008.0218.x; Chetboul V, 2006, AM J VET RES, V67, P250, DOI 10.2460/ajvr.67.2.250; Chetboul V, 2003, J VET MED A, V50, P326, DOI 10.1046/j.1439-0442.2003.00546.x; Chetboul V, 2003, J VET INTERN MED, V17, P89, DOI 10.1111/j.1939-1676.2003.tb01328.x; Chetboul V, 2006, J VET INTERN MED, V20, P640, DOI 10.1892/0891-6640(2006)20[640:TDIFDO]2.0.CO;2; Chetboul VR, 2004, AM J VET RES, V65, P566, DOI 10.2460/ajvr.2004.65.566; delaSierra A, 1996, J HUM HYPERTENS, V10, P795; dos Santos L, 2006, LIFE SCI, V78, P2272, DOI 10.1016/j.lfs.2005.09.028; du Cailar G, 2002, AM J HYPERTENS, V15, P222, DOI 10.1016/S0895-7061(01)02287-7; Dumler F, 2009, J RENAL NUTR, V19, P57, DOI 10.1053/j.jrn.2008.10.006; ELLIOTT P, 1989, J HUM HYPERTENS, V3, P289; Ely DL, 1997, AM J CLIN NUTR, V65, P594; FERRARI AU, 1987, HYPERTENSION, V10, P55, DOI 10.1161/01.HYP.10.1.55; Gerber B, 2005, J SMALL ANIM PRACT, V46, P571, DOI 10.1111/j.1748-5827.2005.tb00288.x; Gouni Vassiliki, 2008, J Vet Cardiol, V10, P117, DOI 10.1016/j.jvc.2008.09.002; Hawthorne AJ, 2004, J NUTR, V134, p2128S, DOI 10.1093/jn/134.8.2128S; He FJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1325; He FJ, 2011, EUR HEART J, V32, P3073, DOI 10.1093/eurheartj/ehr194; He FJ, 2010, PROG CARDIOVASC DIS, V52, P363, DOI 10.1016/j.pcad.2009.12.006; Houston DM, 2004, VET THER, V5, P187; Houston DM, 2011, BRIT J NUTR, V106, pS90, DOI 10.1017/S0007114511000894; Hu G, 2002, CURR HYPERTENS REP, V4, P13, DOI 10.1007/s11906-002-0047-9; *I LAB AN RES, 1996, GUID CAR US LAB ANIM; Jepson R, 2011, J FELINE MED SURG, V13, P25, DOI 10.1016/j.jfms.2010.11.007; Kassab S, 1998, HYPERTENSION, V31, P397, DOI 10.1161/01.HYP.31.1.397; Kirk CA, 2006, VET THER, V7, P333; KUPARI M, 1994, CIRCULATION, V89, P1041, DOI 10.1161/01.CIR.89.3.1041; Lal A, 2003, AM J HYPERTENS, V16, P319, DOI 10.1016/S0895-7061(02)03268-5; Le Corvoisier P, 2010, EUR J HEART FAIL, V12, P1171, DOI 10.1093/eurjhf/hfq146; Luckschander N, 2004, J VET INTERN MED, V18, P463, DOI 10.1892/0891-6640(2004)18&lt;463:DNDNAB&gt;2.0.CO;2; Mak GS, 2013, EUR HEART J-CARD IMG, V14, P1092, DOI 10.1093/ehjci/jet036; Mohan S, 2009, CLIN SCI, V117, P1, DOI 10.1042/CS20080207; Morrison AC, 2011, ANNU REV PUBL HEALTH, V32, P71, DOI 10.1146/annurev-publhealth-031210-101209; Nishida Y, 1998, J HYPERTENS, V16, P1611, DOI 10.1097/00004872-199816110-00007; Pearson TA, 2002, CIRCULATION, V106, P388, DOI 10.1161/01.CIR.0000020190.45892.75; Penz ED, 2008, CAN J CARDIOL, V24, P497, DOI 10.1016/S0828-282X(08)70625-1; PERRY IJ, 1992, J HUM HYPERTENS, V6, P23; Reynolds BS, 2013, J VET INTERN MED, V27, P507, DOI 10.1111/jvim.12074; Rodriguez CJ, 2011, HYPERTENSION, V58, P410, DOI 10.1161/HYPERTENSIONAHA.110.168054; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; Salehi-Abargouei A, 2013, NUTRITION, V29, P611, DOI 10.1016/j.nut.2012.12.018; Sampedrano CC, 2006, J VET INTERN MED, V20, P1106; Schober Karsten, 2010, J Vet Cardiol, V12, P1, DOI 10.1016/j.jvc.2009.09.004; SIMCHON S, 1991, HYPERTENSION, V17, P1063, DOI 10.1161/01.HYP.17.6.1063; Stamler J, 1997, AM J CLIN NUTR, V65, P626, DOI 10.1093/ajcn/65.2.626S; Syme HM, 2006, J VET INTERN MED, V20, P528, DOI 10.1892/0891-6640(2006)20[528:SOCWNO]2.0.CO;2; Taylor RS, 2011, AM J HYPERTENS, V24, P843, DOI 10.1038/ajh.2011.115; THOMAS WP, 1993, J VET INTERN MED, V7, P247, DOI 10.1111/j.1939-1676.1993.tb01015.x; Tzemos N, 2008, HYPERTENSION, V51, P1525, DOI 10.1161/HYPERTENSIONAHA.108.109868; Walker Jay, 2007, Interact Cardiovasc Thorac Surg, V6, P793, DOI 10.1510/icvts.2007.165415; Williams JS, 2006, TRANSL RES, V148, P49, DOI 10.1016/j.trsl.2005.12.001; Xu H, 2009, J FELINE MED SURG, V11, P435, DOI 10.1016/j.jfms.2008.10.001; ZEMEL MB, 1988, AM J CARDIOL, V61, pH7, DOI 10.1016/0002-9149(88)91098-3	58	13	13	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e97862	10.1371/journal.pone.0097862	http://dx.doi.org/10.1371/journal.pone.0097862			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941013	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000338508200005
J	Kovac, M; Bauer, A; Stahl, G				Kovac, Marko; Bauer, Arthur; Stahl, Goran			Merging National Forest and National Forest Health Inventories to Obtain an Integrated Forest Resource Inventory - Experiences from Bavaria, Slovenia and Sweden	PLOS ONE			English	Article							STATISTICAL POWER; EUROPE	Backgrounds, Material and Methods: To meet the demands of sustainable forest management and international commitments, European nations have designed a variety of forest-monitoring systems for specific needs. While the majority of countries are committed to independent, single-purpose inventorying, a minority of countries have merged their single-purpose forest inventory systems into integrated forest resource inventories. The statistical efficiencies of the Bavarian, Slovene and Swedish integrated forest resource inventory designs are investigated with the various statistical parameters of the variables of growing stock volume, shares of damaged trees, and deadwood volume. The parameters are derived by using the estimators for the given inventory designs. The required sample sizes are derived via the general formula for non-stratified independent samples and via statistical power analyses. The cost effectiveness of the designs is compared via two simple cost effectiveness ratios. Results: In terms of precision, the most illustrative parameters of the variables are relative standard errors; their values range between 1% and 3% if the variables' variations are low (s%<80%) and are higher in the case of higher variations. A comparison of the actual and required sample sizes shows that the actual sample sizes were deliberately set high to provide precise estimates for the majority of variables and strata. In turn, the successive inventories are statistically efficient, because they allow detecting the mean changes of variables with powers higher than 90%; the highest precision is attained for the changes of growing stock volume and the lowest for the changes of the shares of damaged trees. Two indicators of cost effectiveness also show that the time input spent for measuring one variable decreases with the complexity of inventories. Conclusion: There is an increasing need for credible information on forest resources to be used for decision making and national and international policy making. Such information can be cost-efficiently provided through integrated forest resource inventories.	[Kovac, Marko] Slovenian Forestry Inst, Dept Forest & Landscape Planning & Monitoring, Ljubljana, Slovenia; [Bauer, Arthur] Bavarian State Minist Food Agr & Forestry, Div Forestry, Dept Food Agr & Forestry Cham, Waldmunchen, Germany; [Stahl, Goran] Swedish Univ Agr Sci SLU, Dept Forest Resource Management, Umea, Sweden	Slovenian Forestry Institute; Swedish University of Agricultural Sciences	Kovac, M (corresponding author), Slovenian Forestry Inst, Dept Forest & Landscape Planning & Monitoring, Vecna Pot 2, Ljubljana, Slovenia.	marko.kovac@gozdis.si			project JGS 4 (MAE); research program PS 1001 (SRA)	project JGS 4 (MAE); research program PS 1001 (SRA)	The Slovene part of research was financed by the project JGS 4 (MAE; http://www.mko.gov.si/en/areas_of_work/forestry/) and the research program PS 1001 (SRA; http://www.arrs.gov.si/en/dobrodoslica.asp). The Bavarian and Swedish parts of research were part of regular research activities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegrini MC, 2009, J ENVIRON MONITOR, V11, P782, DOI 10.1039/b818170p; [Anonymous], 2004, MEMORANDUM UNDERSTAN; Axelsson AL, 2010, NATIONAL FOREST INVENTORIES: PATHWAYS FOR COMMON REPORTING, P541, DOI 10.1007/978-90-481-3233-1_35; Barth A, 2006, SCAND J FOREST RES, V21, P94, DOI 10.1080/14004080500486922; Bechtold WA, 2005, SRS80 GTR USDAF FOR; Bernasconi A, 1996, BEIHEFT SCHWEIZ FORS, V76; Bernstein S., 1999, SCHAUMS OUTLINE SERI; Braun Von R, 1975, ALLG FORST JAGDZTG, V146, P2; Cerny M, 2010, NATIONAL FOREST INVENTORIES: PATHWAYS FOR COMMON REPORTING, P145, DOI 10.1007/978-90-481-3233-1_8; Chirici G, 2012, FOREST SCI, V58, P257, DOI 10.5849/forsci.12-003; Christensen P, 2013, ENVIRON MONIT ASSESS, V185, P7279, DOI 10.1007/s10661-013-3100-z; CLRTAP, 1979, 1979 GEN CONV LONG R; Cochran WG., 1963, SAMPLING TECHNIQUES; *COST E43, 2007, HARM NAT FOR INV EUR; De Vries P.G., 1986, SAMPLING THEORY FORE; DETSKY AS, 1990, ANN INTERN MED, V113, P147, DOI 10.7326/0003-4819-113-2-147; Eichhorn J., 2016, UNECE ICP FOR PROGR; FAO, 2010, 163 FAO; FECS, 2012, FOR FOR SYST COND SU; Ferretti M, 2010, IFOREST, V3, P1, DOI 10.3832/ifor0518-003; Forest Europe, 2013, IMPR PAN EUR IND SUS; Foster JR, 2001, FOREST ECOL MANAG, V151, P211, DOI 10.1016/S0378-1127(01)00591-6; Gillis MD, 2010, NATIONAL FOREST INVENTORIES: PATHWAYS FOR COMMON REPORTING, P97; Gillis MD, 2001, ENVIRON MONIT ASSESS, V67, P121, DOI 10.1023/A:1006405820244; Gschwantner T, 2010, NATIONAL FOREST INVENTORIES: PATHWAYS FOR COMMON REPORTING, P57; Gulder HJ, 1993, FORSTLICHE FORSCHUNG, V132; Hladnik D, 2012, RES REPORTS FORESTRY, V97, P31; Hocevar M., 2003, Obmocni gozdnogospodarski nacrti in razvojne perspektive slovenskega gozdarstva: zbornik referatov XXI. gozdarski studijski dnevi, 27-28 marec 2003, P103; Hocevar M., 2002, Zbornik Gozdarstva in Lesarstva, P119; Hocevar M, 1997, RES REPORTS FORESTRY, V52, P93; KANDLER O, 1992, ENVIRON TOXICOL CHEM, V11, P1077, DOI [10.1897/1552-8618(1992)11[1077:HDADOC]2.0.CO;2, 10.1002/etc.5620110805]; Kennel E, 1983, FORSTLICHE FORSCHUNG, V57; Kovac M, 2010, STUDIA FORESTALIA SL, V136, P7; Kovac M, 2009, OHRANITVENO GOSPODAR, P46; Kovac M, 2010, STUDIA FORESTALIA SL, V136, P23; Kruger S, 1994, BERICHTE BAYERISCHEN; Kusar G, 2010, NATIONAL FOREST INVENTORIES: PATHWAYS FOR COMMON REPORTING, P505, DOI 10.1007/978-90-481-3233-1_33; Loetsch F., 1964, FOREST INVENTORY, V1; Matern B, 1960, MEDDELANDEN FRAN STA, V49; McRoberts RE, 2010, NATIONAL FOREST INVENTORIES: PATHWAYS FOR COMMON REPORTING, P567, DOI 10.1007/978-90-481-3233-1_37; Muller-Edzards C, 1997, STUDIES TEMPORAL DEV; Phillips C, 2009, WHAT IS COST EFFECTI; Polley H, 2010, NATIONAL FOREST INVENTORIES: PATHWAYS FOR COMMON REPORTING, P223, DOI 10.1007/978-90-481-3233-1_13; Schieck J, 2002, STAT POWER ALBERTA F; Schnell A, 2005, ZWEITE BUNDESWALDINV, V49; Schreuder H.T., 1993, SAMPLING METHODS MUL; Schreuder HT, 2004, RMRSRN17 USDAF FOR S; Skogsdata, 2012, FOR STAT 2012; Solar M, 1985, POSKODBE GOZDOV ZARA; StatSoft Inc., 2011, STAT DAT AN SOFTW SY; Taylor LB, 1993, CONSERV BIOL, V7, P489; Thorell K. E., 1931, J FOREST, V4, P585; Tomppo E, 2010, NATIONAL FOREST INVENTORIES: PATHWAYS FOR COMMON REPORTING, P185, DOI 10.1007/978-90-481-3233-1_11; Tomppo E, 2010, NATIONAL FOREST INVENTORIES: PATHWAYS FOR COMMON REPORTING, P1, DOI 10.1007/978-90-481-3233-1_1; Tomppo EO, 2012, FOREST SCI, V58, P191, DOI 10.5849/forsci.10-091; Tzschupke W, 1986, ALLG FORST Z, V41, P790; Wagner F., 2003, IPCC GOOD PRACTICE G; Zohrer F, 1980, FORTSTINVENTUR LEITF	58	9	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100157	10.1371/journal.pone.0100157	http://dx.doi.org/10.1371/journal.pone.0100157			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941120	Green Published, Green Submitted, gold			2022-12-27	WOS:000338508200077
J	Nyffeler, M; Pusey, BJ				Nyffeler, Martin; Pusey, Bradley J.			Fish Predation by Semi-Aquatic Spiders: A Global Pattern	PLOS ONE			English	Article							STICKLEBACK GASTEROSTEUS-ACULEATUS; NURSERY-WEB SPIDERS; FRESH-WATER FISH; DOLOMEDES-TRITON; GAMBUSIA-HOLBROOKI; DISSOLVED-OXYGEN; FOOD WEBS; ARGYRONETA-AQUATICA; FEEDING-BEHAVIOR; CENTRAL AMAZONIA	More than 80 incidences of fish predation by semi-aquatic spiders - observed at the fringes of shallow freshwater streams, rivers, lakes, ponds, swamps, and fens - are reviewed. We provide evidence that fish predation by semi-aquatic spiders is geographically widespread, occurring on all continents except Antarctica. Fish predation by spiders appears to be more common in warmer areas between 40 degrees S and 40 degrees N. The fish captured by spiders, usually ranging from 2-6 cm in length, are among the most common fish taxa occurring in their respective geographic area (e. g., mosquitofish [Gambusia spp.] in the southeastern USA, fish of the order Characiformes in the Neotropics, killifish [Aphyosemion spp.] in Central and West Africa, as well as Australian native fish of the genera Galaxias, Melanotaenia, and Pseudomugil). Naturally occurring fish predation has been witnessed in more than a dozen spider species from the superfamily Lycosoidea (families Pisauridae, Trechaleidae, and Lycosidae), in two species of the superfamily Ctenoidea (family Ctenidae), and in one species of the superfamily Corinnoidea (family Liocranidae). The majority of reports on fish predation by spiders referred to pisaurid spiders of the genera Dolomedes and Nilus (>75% of observed incidences). There is laboratory evidence that spiders from several more families (e. g., the water spider Argyroneta aquatica [Cybaeidae], the intertidal spider Desis marina [Desidae], and the 'swimming' huntsman spider Heteropoda natans [Sparassidae]) predate fish as well. Our finding of such a large diversity of spider families being engaged in fish predation is novel. Semi-aquatic spiders captured fish whose body length exceeded the spiders' body length (the captured fish being, on average, 2.2 times as long as the spiders). Evidence suggests that fish prey might be an occasional prey item of substantial nutritional importance.	[Nyffeler, Martin] Univ Basel, Dept Environm Sci, Sect Conservat Biol, Basel, Switzerland; [Pusey, Bradley J.] Univ Western Australia, Ctr Excellence Nat Resource Management, Albany, Australia	University of Basel; University of Western Australia	Nyffeler, M (corresponding author), Univ Basel, Dept Environm Sci, Sect Conservat Biol, Basel, Switzerland.	martin.nyffeler@unibas.ch						Abraham N., 1923, Annals of the Natal Museum, V5, P89; Adams W, 1927, B ZOOL SOC NY, V30, P77; Airame S, 2000, J ARACHNOL, V28, P251, DOI 10.1636/0161-8202(2000)028[0251:HAFBOO]2.0.CO;2; Aizpurua O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080163; Akabane H, 1995, KISHIDAIA, V69, P40; Arias CR, 2012, DIS AQUAT ORGAN, V100, P77, DOI 10.3354/dao02492; Arnold H., 2013, EDIBLE INSECTS FUTUR, V171, P1; BAERG W. J., 1938, JOUR NEW YORK ENT SOC, V46, P31; Ballinger A, 2006, MAR FRESHWATER RES, V57, P15, DOI 10.1071/MF05154; Barbour T., 1921, Psyche Boston Mass, V28, P131, DOI 10.1155/1921/19421; Begon M., 2005, ECOLOGY INDIVIDUALS, V4th ed.; Bellmann H., 1997, KOSMOS ATLAS SPINNEN; Benoy GA, 2002, HYDROBIOLOGIA, V481, P47, DOI 10.1023/A:1021260920095; Berland L., 1934, Bulletin de la Societe Zoologique de France T, V59, P210; Bernarde Paulo Sergio, 1999, Biociencias, V7, P199; Bhattacharjee GC, 1931, T BOSE RES I, V7, P238; BISHOP SC, 1924, B NEW YORK STATE MUS, V252, P1; Bleckmann H., 1988, P619; BLECKMANN H, 1987, ANIM BEHAV, V35, P641, DOI 10.1016/S0003-3472(87)80100-8; Breene Jr RG, 2006, QUICK EASY TARANTULA; BRISTOWE W. S, 1941, COMITY SPIDERS, V2; Bristowe WilliamS., 1958, WORLD SPIDERS; Brooks DM, 2012, WILSON J ORNITHOL, V124, P345, DOI 10.1676/11-148.1; Brose U, 2006, ECOLOGY, V87, P2411, DOI 10.1890/0012-9658(2006)87[2411:CBRINF]2.0.CO;2; BRYAN PG, 1980, MAR FISH REV, V42, P15; Brzostowicz Frank, 2007, Acta Biologica Benrodis, V14, P39; Caldwell JP, 1998, BIOTROPICA, V30, P92, DOI 10.1111/j.1744-7429.1998.tb00372.x; Carico J.E., 1985, Bulletin of the British Arachnological Society, V6, P289; CARICO J E, 1973, Bulletin of the Museum of Comparative Zoology, V144, P435; CARICO JE, 1993, J ARACHNOL, V21, P226; Chan EKW, 2008, MAR FRESHWATER RES, V59, P653, DOI 10.1071/MF07191; Chubb EC, 1913, NATURE, V91, P136, DOI 10.1038/091136a0; Ciancio Javier, 2006, Ecol. austral, V16, P91; COMITA GW, 1963, SCIENCE, V140, P1394, DOI 10.1126/science.140.3574.1394; COREY DT, 1988, J ARACHNOL, V16, P391; CROME W, 1951, WASSERSPINNE; Cruz da Silva E. L., 2005, BIOCIENCIAS, V13, P85; Cummins KW, 1967, CALORITIC EQUIVALENT; Cupul-Magana FG, 2008, B SOC HERPETOLOGICA, V16, P41; Da Silveira R, 1999, J HERPETOL, V33, P181; Davis WT, 1891, ENTOMOL NEWS, V2, P77; DELANY MF, 1986, J WILDLIFE MANAGE, V50, P348, DOI 10.2307/3801926; Dippenaar-Schoeman AS, 1997, PRETORIA PLANT PROTE, V9; Dudgeon D., 1999, TROPICAL ASIAN STREA; Duffey E., 1995, P 15 EUR C AR, P54; Dunlop Jason A., 1996, Forum of the American Tarantula Society, V5, P79; Edrey Hernandez-Cuadrado Ever, 2009, Herpetological Review, V40, P431; EGUCHI K, 1980, RES POPUL ECOL, V22, P284, DOI 10.1007/BF02530852; Estabrook GF, 2007, EVOLUTION, V61, P1176, DOI 10.1111/j.1558-5646.2007.00089.x; Eterovick PC, 2001, J HERPETOL, V35, P442, DOI 10.2307/1565962; FIGIEL CR, 1994, J ARACHNOL, V22, P185; Foelix R. F, 2011, BIOL SPIDERS; Foelix RF, 1992, BIOL SPINNEN; Fontoura NF, 2010, NEOTROP ICHTHYOL, V8, P835, DOI 10.1590/S1679-62252010005000013; Gasnier TR, 2002, J ARACHNOL, V30, P146, DOI 10.1636/0161-8202(2002)030[0146:ASOEHS]2.0.CO;2; Gertsch W.J., 1979, AM SPIDERS; Gettmann W.W., 1978, Mitteilungen der Deutschen Gesellschaft fuer Allgemeine und Angewandte Entomologie, V1, P63; Greene H. W., 1997, SNAKES EVOLUTION MYS; Greenwood M, 2007, THESIS U CANTERBURY; Gregio AMT, 1999, TOXICON, V37, P545, DOI 10.1016/S0041-0101(98)00002-6; Griffiths D, 2006, J ANIM ECOL, V75, P734, DOI 10.1111/j.1365-2656.2006.01094.x; Gudger E. W., 1925, Natural History New York, V25, P261; GUDGER E. W., 1931, NAT HIST [NEW YORK], V31, P58; Gudger WE, 1922, J AM MUS NAT HIST, V22, P565; Helfman G., 2009, DIVERSITY FISH BIOL; Hillyard P., 2007, PRIVATE LIFE SPIDERS; Hofer H, 2000, INSECT SYST EVOL, V31, P323, DOI 10.1163/187631200X00075; HOLOPAINEN IJ, 1985, ANN ZOOL FENN, V22, P397; HOOGLAND R., 1956, BEHAVIOUR, V10, P205, DOI 10.1163/156853956X00156; Horstkotte Joachim, 2010, Bulletin of the British Arachnological Society, V15, P55; HUGHES SG, 1984, J NUTR, V114, P1660, DOI 10.1093/jn/114.9.1660; Ishijima C, 2006, APPL ENTOMOL ZOOL, V41, P195, DOI 10.1303/aez.2006.195; Ito Y., 1964, Researches on Population Ecology Kyoto, V6, P13; Jager P, 2011, ZOOTAXA, P1; Jager P, 2005, J ARACHNOL, V33, P715, DOI 10.1636/H04-9.1; James R., 2004, Indian Journal of Fisheries, V51, P75; Jiang LP, 2013, TOXICON, V73, P23, DOI 10.1016/j.toxicon.2013.07.005; JOHNSON DM, 1975, ECOLOGY, V56, P1081, DOI 10.2307/1936148; JONES R. D, 1983, COUNTRY LIFE GUIDE S; JORDAN F, 1994, WETLANDS, V14, P239, DOI 10.1007/BF03160661; Kapusta Andrzej, 2008, Archiwum Rybactwa Polskiego, V16, P49, DOI 10.2478/s10086-008-0004-6; King R.P, 1998, NAGA ICLARM Q, V21, P33; KIRITANI K, 1972, Researches on Population Ecology (Tokyo), V13, P187, DOI 10.1007/BF02521977; Knouft JH, 2004, OECOLOGIA, V139, P408, DOI 10.1007/s00442-004-1510-x; Koh J.K.H., 1989, GUIDE COMMON SINGAPO; Kosuge Takeharu, 2002, Biological Magazine Okinawa, V40, P51; KRAMER DL, 1987, ENVIRON BIOL FISH, V18, P81, DOI 10.1007/BF00002597; KREBS JR, 1984, OECOLOGIA, V64, P363, DOI 10.1007/BF00379134; Krupa JJ, 1998, OECOLOGIA, V117, P258, DOI 10.1007/s004420050656; LaFrentz BR, 2003, J FISH DIS, V26, P377, DOI 10.1046/j.1365-2761.2003.00468.x; Lapinski W, 2013, J ARACHNOL, V41, P151, DOI 10.1636/P11-88.1; Leblond C, 2006, BEHAVIOUR, V143, P1263, DOI 10.1163/156853906778691603; Leroy B, 2013, BIOL CONSERV, V161, P155, DOI 10.1016/j.biocon.2013.03.022; Leroy J, 2003, SPIDERS SO AFRICA; LEWIS WM, 1970, COPEIA, P319, DOI 10.2307/1441653; Lewis WM, 1996, PERSPECTIVES IN TROPICAL LIMNOLOGY, P43; LOONEN H, 1994, CHEMOSPHERE, V28, P1433, DOI 10.1016/0045-6535(94)90238-0; Lynch RJ, 2002, AUSTRAL ECOL, V27, P515, DOI 10.1046/j.1442-9993.2002.01208.x; MADENJIAN CP, 1995, CONDOR, V97, P141, DOI 10.2307/1368992; Maffei Fabio, 2010, Herpetology Notes, V3, P167; MANNES J C, 1980, Southwestern Naturalist, V25, P297, DOI 10.2307/3670686; Marshall SD, 2001, TARANTULAS OTHER ARA; Matthews PGD, 2011, J INSECT PHYSIOL, V57, P1698, DOI 10.1016/j.jinsphys.2011.09.006; MCCORMICK KD, 1993, TETRAHEDRON, V49, P11155, DOI 10.1016/S0040-4020(01)81803-2; MCCORMICK S, 1982, BIOL REV, V57, P29, DOI 10.1111/j.1469-185X.1982.tb00363.x; McDowall R. M., 1994, Ecology of Freshwater Fish, V3, P67, DOI 10.1111/j.1600-0633.1994.tb00108.x; McKeown Keith C., 1943, PROC ROY ZOOL SOC N S WALES, V1942-43, P17; McKinsey DM, 1998, ENVIRON BIOL FISH, V53, P211, DOI 10.1023/A:1007497503542; MCLAY CL, 1987, NEW ZEAL J ZOOL, V14, P29, DOI 10.1080/03014223.1987.10422679; MCQUEEN DJ, 1983, NEW ZEAL J ZOOL, V10, P393, DOI 10.1080/03014223.1983.10423934; Meehean O. L., 1934, Natural History New York, VVol. 34, P538; Menin Marcelo, 2005, Phyllomedusa, V4, P39; Mohrhardt D, 1963, TURTOX NEWS, V41, P197; Moore MK, 1998, OIKOS, V81, P329, DOI 10.2307/3547053; Morante T, 2012, LIMNETICA, V31, P85; Moshenko RW, 1972, THESIS U MANITOBA WI; Moura MR, 2011, BIOTA NEOTROP, V11, P349, DOI 10.1590/S1676-06032011000400028; Moyle P.B., 1987, P25; MULVEY M, 1995, ENVIRON TOXICOL CHEM, V14, P1411, DOI 10.1002/etc.5620140818; Naiman RJ, 2002, ECOSYSTEMS, V5, P399, DOI 10.1007/s10021-001-0083-3; Nakano S, 1999, ECOLOGY, V80, P2435; NEEDHAM KM, 1990, THESIS U BRIT COLUMB; Nicholas AC, 2011, J ARACHNOL, V39, P22, DOI 10.1636/Hi09-17.1; Niethammer K.R., 1983, Colonial Waterbirds, V6, P148, DOI 10.2307/1520982; Nyffeler M, 2001, J ARACHNOL, V29, P119, DOI 10.1636/0161-8202(2001)029[0119:SFOE]2.0.CO;2; Nyffeler M, 2001, ECOL ENTOMOL, V26, P617, DOI 10.1046/j.1365-2311.2001.00365.x; Nyffeler M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058120; Offill YA, 1999, J AM MOSQUITO CONTR, V15, P380; Okorie A, 2010, J VECTOR DIS, V47, P181; PANDIAN TJ, 1985, COPEIA, P653; Pazin Victor F. V., 2006, Herpetological Review, V37, P336; Perna Colton N., 2009, Ecological Management & Restoration, V10, P241; Pickard-Cambridge F, 1903, P ZOOL SOC LOND, V1903, P151; Pitt WC, 1996, J WILDLIFE MANAGE, V60, P616, DOI 10.2307/3802080; Platnick N. I., 2013, WORLD SPIDER CATALOG; Pocock RI, 1902, P ZOOL SOC LOND, V1902, P98; Poppe Sabine, 1995, Arachnologische Mitteilungen, V9, P1; Prado GM, 2003, PREDATION HERPETOL R, V34, P238; Pusey B., 2004, FRESHWATER FISHES N, DOI DOI 10.1071/9780643092082; Pusey BJ, 2003, MAR FRESHWATER RES, V54, P1, DOI 10.1071/MF02041; Queensland Museum, 2013, SPIDERS; RAVEN P, 1986, BIRD STUDY, V33, P6, DOI 10.1080/00063658609476884; Riley J, 2000, COPEIA, P582, DOI 10.1643/0045-8511(2000)000[0582:DALPOS]2.0.CO;2; Robson CH, 1877, T P NZ I, V10, P299; Rodrigues Domingos J., 2007, Herpetological Review, V38, P437; Romand R., 1980, Aquarien- und Terrarien-Zeitschrift, V33, P262; Rubbo MJ, 2003, J ZOOL, V261, P1, DOI 10.1017/S0952836903003923; RUEDA LM, 1990, J MED ENTOMOL, V27, P892, DOI 10.1093/jmedent/27.5.892; Rybczyk A, 2005, EJPAU, V8, P06; SALONEN K, 1976, LIMNOL OCEANOGR, V21, P724, DOI 10.4319/lo.1976.21.5.0724; SAMU F, 1993, EUR J ENTOMOL, V90, P471; Sanzone DM, 2003, OECOLOGIA, V134, P238, DOI 10.1007/s00442-002-1113-3; SCHAEFER JF, 1994, COPEIA, P516; Schmidt G., 1957, Zoologischer Anzeiger, V158, P83; Schmidt G., 1980, SPINNEN ALLES WISSES; Schuster-Woldan E, 1939, N-S ARCH EX PATH PH, V194, P156, DOI 10.1007/BF01860432; Schutz D, 2003, EVOL ECOL RES, V5, P105; Sebastian PA, 2009, SPIDERS INDIA; Seymour RS, 2011, J EXP BIOL, V214, P2175, DOI 10.1242/jeb.056093; SIERWALD P, 1988, Psyche (Cambridge), V95, P243, DOI 10.1155/1988/91410; Sisson RF, 1972, NATL GEOGR, V1972, P694; Smith H, 2000, BIOL CONSERV, V95, P153, DOI 10.1016/S0006-3207(00)00030-6; Soleng A, 1998, FOLIA PARASIT, V45, P270; STADDON BW, 1963, J EXP BIOL, V40, P563; Suhr JM, 1974, BIOL BULL, V21, P87; Suter RB, 2000, J ARACHNOL, V28, P300, DOI 10.1636/0161-8202(2000)028[0300:SSALOT]2.0.CO;2; Suter RB, 1997, J EXP BIOL, V200, P2523; Suter RB, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.19; Tate W.B., 2005, DISTRIBUTION ECOLOGI; Townsend CR, 1978, P 2 INT S TRICH 1977, P283; TURNBULL AL, 1973, ANNU REV ENTOMOL, V18, P305, DOI 10.1146/annurev.en.18.010173.001513; U. S. Geological Survey, 2013, NON AQ SPEC DAT; Uzenbaev SD, 2009, ENTOMOL REV, V89, P479; van Helsdingen P.J., 1993, B ACC GIOENIA SCI NA, V26, P181; VANBERKUM FH, 1982, J ARACHNOL, V10, P117; Vidal O, 2010, BIOL INVASIONS, V12, P841, DOI 10.1007/s10530-009-9505-5; VONESH JR, 2003, THESIS U FLORIDA GAI; Wallace KM, 2006, THESIS U STELLENBOSC; Wang HY, 2013, TOXICON, V65, P68, DOI 10.1016/j.toxicon.2013.01.014; WHITCOMB W. H., 1963, ANN ENTOMOL SOC AMER, V56, P653, DOI 10.1093/aesa/56.5.653; WILLIAMS DS, 1979, NEW ZEAL J ZOOL, V6, P95, DOI 10.1080/03014223.1979.10428352; Wise DH, 1993, SPIDERS ECOLOGICAL W; Yamamoto Y, 2010, ZOOL STUD, V49, P625; Zahl P, 1971, NAT GEOGRAPHIC, V140, P190; Zampatti B, 1997, ASSESSMENT ENV FLOW; Zeug SC, 2008, ECOLOGY, V89, P1733, DOI 10.1890/07-1064.1; Zhang JX, 2004, J ARACHNOL, V32, P353, DOI 10.1636/M02-58; ZIMMERMANN M, 1989, OECOLOGIA, V80, P187, DOI 10.1007/BF00380149	188	47	51	0	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99459	10.1371/journal.pone.0099459	http://dx.doi.org/10.1371/journal.pone.0099459			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940885	Green Submitted, Green Published, gold			2022-12-27	WOS:000338508200025
J	Schulze, M; Junkes, C; Mueller, P; Speck, S; Ruediger, K; Dathe, M; Mueller, K				Schulze, Martin; Junkes, Christof; Mueller, Peter; Speck, Stephanie; Ruediger, Karin; Dathe, Margitta; Mueller, Karin			Effects of Cationic Antimicrobial Peptides on Liquid-Preserved Boar Spermatozoa	PLOS ONE			English	Article							PLASMA-MEMBRANE; TRYPTOPHAN-RICH; ARGININE-RICH; IN-VITRO; SPERM; PHOSPHOLIPIDS; CAPACITATION; CHOLESTEROL; MECHANISMS; SEMEN	Antibiotics are mandatory additives in semen extenders to control bacterial contamination. The worldwide increase in resistance to conventional antibiotics requires the search for alternatives not only for animal artificial insemination industries, but also for veterinary and human medicine. Cationic antimicrobial peptides are of interest as a novel class of antimicrobial additives for boar semen preservation. The present study investigated effects of two synthetic cyclic hexapeptides (c-WFW, c-WWW) and a synthetic helical magainin II amide derivative (MK5E) on boar sperm during semen storage at 16 degrees C for 4 days. The standard extender, Beltsville Thawing Solution (BTS) containing 250 mu g/mL gentamicin (standard), was compared to combinations of BTS with each of the peptides in a split-sample procedure. Examination revealed peptide-and concentration-dependent effects on sperm integrity and motility. Negative effects were more pronounced for MK5E than in hexapeptide-supplemented samples. The cyclic hexapeptides were partly able to stimulate a linear progressive sperm movement. When using low concentrations of cyclic hexapeptides (4 mu M c-WFW, 2 mM c-WWW) sperm quality was comparable to the standard extender over the course of preservation. C-WFW-supplemented boar semen resulted in normal fertility rates after AI. In order to investigate the interaction of peptides with the membrane, electron spin resonance spectroscopic measurements were performed using spin-labeled lipids. C-WWW and c-WFW reversibly immobilized an analog of phosphatidylcholine (PC), whereas MK5E caused an irreversible increase of PC mobility. These results suggest testing the antimicrobial efficiency of non-toxic concentrations of selected cyclic hexapeptides as potential candidates to supplement/replace common antibiotics in semen preservation.	[Schulze, Martin; Ruediger, Karin] Inst Reprod Farm Anim Schonow Inc, Bernau, Brandenburg, Germany; [Junkes, Christof; Dathe, Margitta] Leibniz Inst Mol Pharmacol, Berlin, Germany; [Mueller, Peter] Humboldt Univ, Dept Biol, Berlin, Germany; [Speck, Stephanie] Univ Leipzig, Inst Anim Hyg & Vet Publ Hlth, D-04109 Leipzig, Sachsen, Germany; [Mueller, Karin] Leibniz Inst Zoo & Wildlife Res, Berlin, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Humboldt University of Berlin; Leipzig University; Leibniz Institut fur Zoo und Wildtierforschung	Schulze, M (corresponding author), Inst Reprod Farm Anim Schonow Inc, Bernau, Brandenburg, Germany.	m.schulze@ifn-schoenow.de	郑, 丽丽/HGE-2239-2022; Schulze, Martin/AAR-3244-2020		AiF Inc. [PRO INNO II: KF0140502MD6]; Association for Biotechnology Research (FBF) Germany	AiF Inc.; Association for Biotechnology Research (FBF) Germany	This research was partially supported by the AiF Inc. PRO INNO II: KF0140502MD6 and by the Association for Biotechnology Research (FBF) Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althouse GC, 2005, THERIOGENOLOGY, V63, P573, DOI 10.1016/j.theriogenology.2004.09.031; Appelt C, 2005, CHEMBIOCHEM, V6, P1654, DOI 10.1002/cbic.200500095; Bagheri M, 2011, ANTIMICROB AGENTS CH, V55, P788, DOI 10.1128/AAC.01098-10; Broekhuijse MLWJ, 2012, J ANIM SCI, V90, P779, DOI 10.2527/jas.2011-4311; Chan DI, 2006, BBA-BIOMEMBRANES, V1758, P1184, DOI 10.1016/j.bbamem.2006.04.006; Choi YH, 1998, BIOL REPROD, V59, P1328, DOI 10.1095/biolreprod59.6.1328; Clara A, 2004, FERTIL STERIL, V81, P1357, DOI 10.1016/j.fertnstert.2003.09.073; Clinical and Laboratory Standards Institute (CLSI), 2008, M31A3 CLSI, V28; Conover WJ, 1999, PRACTICAL NONPARAMET, P367; Dathe M, 2004, BIOCHEMISTRY-US, V43, P9140, DOI 10.1021/bi035948v; Dathe M, 2001, FEBS LETT, V501, P146, DOI 10.1016/S0014-5793(01)02648-5; DEWAAL A, 1991, FEBS LETT, V293, P219, DOI 10.1016/0014-5793(91)81191-A; Epand RM, 1999, BBA-BIOMEMBRANES, V1462, P11, DOI 10.1016/S0005-2736(99)00198-4; Fellmann P, 1994, Methods Mol Biol, V27, P161; Hancock R. E. W., 2002, Current Drug Targets - Infectious Disorders, V2, P79, DOI 10.2174/1568005024605855; Junkes C, 2008, J PEPT SCI, V14, P535, DOI 10.1002/psc.940; Junkes C, 2011, EUR BIOPHYS J BIOPHY, V40, P515, DOI 10.1007/s00249-011-0671-x; Kurz A, 2005, REPRODUCTION, V130, P615, DOI 10.1530/rep.1.00561; Lohner K, 2005, COMB CHEM HIGH T SCR, V8, P241, DOI 10.2174/1386207053764576; MORSE PD, 1977, BIOCHEM BIOPH RES CO, V77, P1486, DOI 10.1016/S0006-291X(77)80146-0; Mortimer ST, 1997, HUM REPROD, V12, P1006; Muller K, 2008, BIOL REPROD, V78, P390, DOI 10.1095/biolreprod.107.064253; MULLER K, 1994, BIOCHEMISTRY-US, V33, P9968; Muller K, 1997, ADV EXP MED BIOL, V424, P243; Reddy KVR, 1996, CONTRACEPTION, V53, P205, DOI 10.1016/0010-7824(96)00038-8; Rossi LM, 2008, J PHARM SCI-US, V97, P1060, DOI 10.1002/jps.21053; Schulze M, 2013, THERIOGENOLOGY, V80, P990, DOI 10.1016/j.theriogenology.2013.07.026; Schulze M, 2013, ANIM REPROD SCI, V140, P70, DOI 10.1016/j.anireprosci.2013.05.012; Shadan S, 2004, BIOL REPROD, V71, P253, DOI 10.1095/biolreprod.103.026435; Toke O, 2005, BIOPOLYMERS, V80, P717, DOI 10.1002/bip.20286; Waterhouse KE, 2006, REPRODUCTION, V131, P887, DOI 10.1530/rep.1.01049; Wieprecht T, 1997, BIOCHEMISTRY-US, V36, P6124, DOI 10.1021/bi9619987; Yanagimachi R., 1988, P135; ZACHOWSKI A, 1993, BIOCHEM J, V294, P1; Zhao XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066557	35	26	26	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100490	10.1371/journal.pone.0100490	http://dx.doi.org/10.1371/journal.pone.0100490			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940997	Green Published, Green Submitted, gold			2022-12-27	WOS:000338508200103
J	Yim, N; Ryu, SW; Han, EC; Yoon, J; Choi, K; Choi, C				Yim, Nambin; Ryu, Seung-Wook; Han, Eun Chun; Yoon, Jonghee; Choi, Kyungsun; Choi, Chulhee			Mutant Ubiquitin UBB+1 Induces Mitochondrial Fusion by Destabilizing Mitochondrial Fission-Specific Proteins and Confers Resistance to Oxidative Stress-Induced Cell Death in Astrocytic Cells	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; NEURODEGENERATIVE DISORDERS; ABERRANT UBIQUITIN; MAMMALIAN-CELLS; INHIBITION; PROTEASOME; DYSFUNCTION; BRAIN; HSP70; ACCUMULATION	Mutant ubiquitin UBB+1 is observed in a variety of aging-related neurodegenerative diseases and acts as a potent inhibitor of the ubiquitin proteasome system (UPS). In the present study, we investigated the relationship between impaired UPS (using ectopic expression of UBB+1) and mitochondrial dynamics in astrocytes, which are the most abundant glial cells in the central nervous system. Immunocytochemistry and fluorescence recovery after photobleaching revealed that ectopic expression of UBB+1 induced mitochondrial elongation. We further demonstrated that overexpression of UBB+1 destabilized mitochondrial fission-specific proteins including Drp1, Fis1, and OPA3, but not the mitochondrial fusion-specific proteins Mfn1, Mfn2, and OPA1. The reduction in mitochondrial fission-specific proteins by UBB+1 was prevented by inhibiting the 26 S proteasome using chemical inhibitors, including MG132, lactacystin and epoxomicin. We then assessed the involvement of proteases that target mitochondrial proteins by using various protease inhibitors. Finally, we confirmed that either overexpression of UBB+1 or inhibiting the proteasome can protect astrocytic cells from H2O2-induced cell death compared with control cells. Our results suggest that UBB+1 destabilizes mitochondrial fission-specific proteins, leading to mitochondrial fusion and the subsequent resistance to oxidative stress. We therefore propose a protective role of UBB+1 overexpression or the proteasome inhibition in astrocytes in degenerative brains.	[Yim, Nambin; Ryu, Seung-Wook; Yoon, Jonghee; Choi, Kyungsun; Choi, Chulhee] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Cell Signaling & BioImaging Lab, Taejon 305701, South Korea; [Han, Eun Chun; Choi, Chulhee] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Taejon 305701, South Korea; [Ryu, Seung-Wook; Choi, Chulhee] Korea Adv Inst Sci & Technol, KI BioCentury, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST)	Choi, K (corresponding author), Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Cell Signaling & BioImaging Lab, Taejon 305701, South Korea.	ccbioks@kaist.ac.kr; cchoi@kaist.ac.kr	Choi, Chulhee/C-1642-2011	Choi, Chulhee/0000-0001-5542-9136; Yoon, Jonghee/0000-0003-3886-2792	National Research Foundation of Korea (NRF) - Korean government (MEST) [2012R1A2A4A01007108]	National Research Foundation of Korea (NRF) - Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government)	This research was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST) (No. 2012R1A2A4A01007108 to C. C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Azem A, 1997, J BIOL CHEM, V272, P20901, DOI 10.1074/jbc.272.33.20901; Calabrese V, 2001, NEUROCHEM RES, V26, P739, DOI 10.1023/A:1010955807739; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Cho DH, 2009, SCIENCE, V324, P102, DOI 10.1126/science.1171091; Choi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067891; de Pril R, 2004, HUM MOL GENET, V13, P1803, DOI 10.1093/hmg/ddh188; De Vrij FMS, 2001, FASEB J, V15, P2680, DOI 10.1096/fj.01-0438com; Dennissen FJA, 2011, FEBS LETT, V585, P2568, DOI 10.1016/j.febslet.2011.06.037; Fan CY, 2003, CELL STRESS CHAPERON, V8, P309, DOI 10.1379/1466-1268(2003)008<0309:MFROHF>2.0.CO;2; Fischer DF, 2009, NEUROBIOL AGING, V30, P847, DOI 10.1016/j.neurobiolaging.2008.06.009; Fischer DF, 2003, FASEB J, V17, P2014, DOI 10.1096/fj.03-0205com; Germain M, 2005, EMBO J, V24, P1546, DOI 10.1038/sj.emboj.7600592; Hayashi M, 2006, NAT MED, V12, P128, DOI 10.1038/nm1327; Hol EM, 2005, TRENDS MOL MED, V11, P488, DOI 10.1016/j.molmed.2005.09.001; Hope AD, 2003, J NEUROCHEM, V86, P394, DOI 10.1046/j.1471-4159.2003.01844.x; Irmler M, 2012, ACTA NEUROPATHOL, V124, P187, DOI 10.1007/s00401-012-1003-7; Itoh K, 2013, TRENDS CELL BIOL, V23, P64, DOI 10.1016/j.tcb.2012.10.006; Kageyama Y, 2011, CURR OPIN CELL BIOL, V23, P427, DOI 10.1016/j.ceb.2011.04.009; Kawai A, 2001, J CELL SCI, V114, P3565; Kienlen-Campard P, 2006, J NEUROSCI RES, V84, P1311, DOI 10.1002/jnr.21025; Ko S, 2010, J BIOL CHEM, V285, P36070, DOI 10.1074/jbc.M110.145219; Lee J, 2010, BIOCHEM BIOPH RES CO, V391, P33, DOI 10.1016/j.bbrc.2009.10.155; Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294; Lindsten K, 2002, J CELL BIOL, V157, P417, DOI 10.1083/jcb.200111034; Livnat-Levanon N, 2011, BBA-GENE REGUL MECH, V1809, P80, DOI 10.1016/j.bbagrm.2010.07.005; Morano KA, 2007, ANN NY ACAD SCI, V1113, P1, DOI 10.1196/annals.1391.018; Nedergaard M, 2005, GLIA, V50, P281, DOI 10.1002/glia.20205; Otera H, 2010, J CELL BIOL, V191, P1141, DOI 10.1083/jcb.201007152; Palmer CS, 2011, EMBO REP, V12, P565, DOI 10.1038/embor.2011.54; Ryu SW, 2010, CELL MOL LIFE SCI, V67, P2839, DOI 10.1007/s00018-010-0365-z; Schon EA, 2011, NEURON, V70, P1033, DOI 10.1016/j.neuron.2011.06.003; Shutt TE, 2013, BBA-MOL CELL RES, V1833, P417, DOI 10.1016/j.bbamcr.2012.05.024; Song S, 2003, MOL CELL, V12, P553, DOI 10.1016/j.molcel.2003.08.005; Tamura Y, 2011, CELL, V145, DOI 10.1016/j.cell.2011.06.018; Tan Z, 2007, CELL DEATH DIFFER, V14, P1721, DOI 10.1038/sj.cdd.4402180; van Leeuwen FW, 2002, INT J BIOCHEM CELL B, V34, P1502, DOI 10.1016/S1357-2725(02)00043-2; van Tijn P, 2007, J CELL SCI, V120, P1615, DOI 10.1242/jcs.03438; van Tijn P, 2012, NEUROCHEM INT, V61, P739, DOI 10.1016/j.neuint.2012.07.007; van Tijn P, 2010, J NEUROSCI RES, V88, P2325, DOI 10.1002/jnr.22396; Voloboueva LA, 2007, J NEUROCHEM, V102, P1383, DOI 10.1111/j.1471-4159.2007.04634.x; Wang XL, 2009, J NEUROSCI, V29, P9090, DOI 10.1523/JNEUROSCI.1357-09.2009; Yoon Y, 2003, MOL CELL BIOL, V23, P5409, DOI 10.1128/MCB.23.15.5409-5420.2003; Zhang Y, 2010, J CEREBR BLOOD F MET, V30, P566, DOI 10.1038/jcbfm.2009.228	46	9	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99937	10.1371/journal.pone.0099937	http://dx.doi.org/10.1371/journal.pone.0099937			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941066	gold, Green Submitted, Green Published			2022-12-27	WOS:000338508200055
J	Edelstein, M; Wallensten, A; Zetterqvist, I; Hulth, A				Edelstein, Michael; Wallensten, Anders; Zetterqvist, Inga; Hulth, Anette			Detecting the Norovirus Season in Sweden Using Search Engine Data - Meeting the Needs of Hospital Infection Control Teams	PLOS ONE			English	Article							ECONOMIC VALUE; GASTROENTERITIS; EPIDEMIOLOGY; ENGLAND; COMMUNITY; OUTBREAKS; WEATHER; DISEASE	Norovirus outbreaks severely disrupt healthcare systems. We evaluated whether Websok, an internet-based surveillance system using search engine data, improved norovirus surveillance and response in Sweden. We compared Websok users' characteristics with the general population, cross-correlated weekly Websok searches with laboratory notifications between 2006 and 2013, compared the time Websok and laboratory data crossed the epidemic threshold and surveyed infection control teams about their perception and use of Websok. Users of Websok were not representative of the general population. Websok correlated with laboratory data (b = 0.88-0.89) and gave an earlier signal to the onset of the norovirus season compared with laboratory-based surveillance. 17/21 (81%) infection control teams answered the survey, of which 11 (65%) believed Websok could help with infection control plans. Websok is a low-resource, easily replicable system that detects the norovirus season as reliably as laboratory data, but earlier. Using Websok in routine surveillance can help infection control teams prepare for the yearly norovirus season.	[Edelstein, Michael; Wallensten, Anders; Zetterqvist, Inga; Hulth, Anette] Publ Hlth Agcy Sweden, Dept Epidemiol & Evaluat, Solna, Sweden; [Edelstein, Michael] European Ctr Dis Prevent & Control ECDC, EPIET, Stockholm, Sweden	Public Health Agency of Sweden; European Centre for Disease Prevention & Control	Edelstein, M (corresponding author), Publ Hlth Agcy Sweden, Dept Epidemiol & Evaluat, Solna, Sweden.	Michael.edelstein@folkhalsomyndigheten.se	Edelstein, Michael/GQY-7219-2022; Hulth, Anette/E-2162-2017	Edelstein, Michael/0000-0002-7323-0806; Hulth, Anette/0000-0002-3132-808X				Bartsch SM, 2012, VACCINE, V30, P7097, DOI 10.1016/j.vaccine.2012.09.040; Butler D, 2013, NATURE, V494, P155, DOI 10.1038/494155a; Crepey P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075226; Desai R, 2012, CLIN INFECT DIS, V55, pE75, DOI 10.1093/cid/cis579; Eysenbach Gunther, 2006, AMIA Annu Symp Proc, P244; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Hall AJ, 2013, EMERG INFECT DIS, V19, P1198, DOI 10.3201/eid1908.130465; Hall AJ, 2011, EMERG INFECT DIS, V17, P1381, DOI 10.3201/eid1708.101533; Hedlund KO, 2000, J INFECT DIS, V181, pS275, DOI 10.1086/315585; Hulth A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-252; Hulth A, 2010, EMERG INFECT DIS, V16, P1319, DOI 10.3201/eid1608.100093; Hulth A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004378; Koopmans M, 2009, J HOSP INFECT, V73, P331, DOI 10.1016/j.jhin.2009.06.028; Lazer D, 2014, SCIENCE, V343, P1203, DOI 10.1126/science.1248506; Lee BY, 2011, CLIN MICROBIOL INFEC, V17, P640, DOI 10.1111/j.1469-0691.2010.03345.x; Lee BY, 2011, INFECT CONT HOSP EP, V32, P191, DOI 10.1086/657910; Lopman BA, 2004, EMERG INFECT DIS, V10, P1827, DOI 10.3201/eid1010.030941; Lopman B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006671; Loveridge P, 2010, J HOSP INFECT, V74, P385, DOI 10.1016/j.jhin.2009.10.007; MONTO AS, 1983, J INFECT DIS, V148, P284, DOI 10.1093/infdis/148.2.284; Mounts AW, 2000, J INFECT DIS, V181, pS284, DOI 10.1086/315586; Olson DR, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003256; Patel MM, 2009, J CLIN VIROL, V44, P1, DOI 10.1016/j.jcv.2008.10.009; Pelat C, 2009, EMERG INFECT DIS, V15, P1327, DOI 10.3201/eid1508.090299; Pelat C, 2007, BMC MED INFORM DECIS, V7, DOI 10.1186/1472-6947-7-29; SERFLING RE, 1963, PUBLIC HEALTH REP, V78, P494, DOI 10.2307/4591848; Vega E, 2011, EMERG INFECT DIS, V17, P1389, DOI 10.3201/eid1708.101837; Wheeler JG, 1999, BMJ-BRIT MED J, V318, P1046, DOI 10.1136/bmj.318.7190.1046	28	23	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2014	9	6							e100309	10.1371/journal.pone.0100309	http://dx.doi.org/10.1371/journal.pone.0100309			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WV	24944844	Green Published, Green Submitted, gold			2022-12-27	WOS:000338917900039
J	Fernandez, J; Wilson, RA				Fernandez, Jessie; Wilson, Richard A.			Characterizing Roles for the Glutathione Reductase, Thioredoxin Reductase and Thioredoxin Peroxidase-Encoding Genes of Magnaporthe oryzae during Rice Blast Disease	PLOS ONE			English	Article							PLANT INFECTION; SACCHAROMYCES-CEREVISIAE; TRIGGERED IMMUNITY; ESCHERICHIA-COLI; OXIDATIVE STRESS; NADPH OXIDASES; CELL-DEATH; FUNGUS; METABOLISM; INVASION	Understanding how pathogenic fungi adapt to host plant cells is of major concern to securing global food production. The hemibiotrophic rice blast fungus Magnaporthe oryzae, cause of the most serious disease of cultivated rice, colonizes leaf cells asymptomatically as a biotroph for 4-5 days in susceptible rice cultivars before entering its destructive necrotrophic phase. During the biotrophic growth stage, M. oryzae remains undetected in the plant while acquiring nutrients and growing cell-to-cell. Which fungal processes facilitate in planta growth and development are still being elucidated. Here, we used gene functional analysis to show how components of the NADPH-requiring glutathione and thioredoxin antioxidation systems of M. oryzae contribute to disease. Loss of glutathione reductase, thioredoxin reductase and thioredoxin peroxidase-encoding genes resulted in strains severely attenuated in their ability to grow in rice cells and that failed to produce spreading necrotic lesions on the leaf surface. Glutathione reductase, but not thioredoxin reductase or thioredoxin peroxidase, was shown to be required for neutralizing plant generated reactive oxygen species (ROS). The thioredoxin proteins, but not glutathione reductase, were shown to contribute to cell-wall integrity. Furthermore, glutathione and thioredoxin gene expression, under axenic growth conditions, was dependent on both the presence of glucose and the M. oryzae sugar/NADPH sensor Tps1, thereby suggesting how glucose availability, NADPH production and antioxidation might be connected. Taken together, this work identifies components of the fungal glutathione and thioredoxin antioxidation systems as determinants of rice blast disease that act to facilitate biotrophic colonization of host cells by M. oryzae.	[Fernandez, Jessie; Wilson, Richard A.] Univ Nebraska, Dept Plant Pathol, Lincoln, NE 68583 USA	University of Nebraska System; University of Nebraska Lincoln	Wilson, RA (corresponding author), Univ Nebraska, Dept Plant Pathol, Lincoln, NE 68583 USA.	rwilson10@unl.edu	Fernandez, Jessie/AAR-3477-2021	Fernandez, Jessie/0000-0002-0897-2707	National Science Foundation [IOS-1145347]	National Science Foundation(National Science Foundation (NSF))	This work was funded by the National Science Foundation (IOS-1145347). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avery AM, 2001, J BIOL CHEM, V276, P33730, DOI 10.1074/jbc.M105672200; Carmel-Harel O, 2000, ANNU REV MICROBIOL, V54, P439, DOI 10.1146/annurev.micro.54.1.439; Chi MH, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000401; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Dagdas YF, 2012, SCIENCE, V336, P1590, DOI 10.1126/science.1222934; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Donofrio NM, 2014, NEW PHYTOL, V201, P367, DOI 10.1111/nph.12623; Egan MJ, 2007, P NATL ACAD SCI USA, V104, P11772, DOI 10.1073/pnas.0700574104; Fernandez J, 2012, MOL PLANT MICROBE IN, V25, P1286, DOI 10.1094/MPMI-12-11-0326; Fernandez J., 2011, Mycology - An International Journal on Fungal Biology, V2, P46, DOI 10.1080/21501203.2011.563431; Fernandez J, 2014, PROTOPLASMA, V251, P37, DOI 10.1007/s00709-013-0541-8; Fernandez J, 2013, SCI REP-UK, V3, DOI 10.1038/srep02398; Fernandez J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002673; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Foster AJ, 2003, EMBO J, V22, P225, DOI 10.1093/emboj/cdg018; Gassmann W, 2012, MOL PLANT MICROBE IN, V25, P862, DOI 10.1094/MPMI-01-12-0024-IA; Giraldo MC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2996; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; Huang K, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001335; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kankanala P, 2007, PLANT CELL, V19, P706, DOI 10.1105/tpc.106.046300; Koeck M, 2011, CELL MICROBIOL, V13, P1849, DOI 10.1111/j.1462-5822.2011.01665.x; KOSOWER NS, 1969, BIOCHEM BIOPH RES CO, V37, P593, DOI 10.1016/0006-291X(69)90850-X; Kumar JK, 2004, P NATL ACAD SCI USA, V101, P3759, DOI 10.1073/pnas.0308701101; Kupferschmidt K, 2012, SCIENCE, V337, P636, DOI 10.1126/science.337.6095.636; Lu J, 2014, FREE RADICAL BIO MED, V66, P75, DOI 10.1016/j.freeradbiomed.2013.07.036; Meng L, 2010, P NATL ACAD SCI USA, V107, P3900, DOI 10.1073/pnas.0913759107; Mentlak TA, 2012, PLANT CELL, V24, P322, DOI 10.1105/tpc.111.092957; Muller EGD, 1996, MOL BIOL CELL, V7, P1805, DOI 10.1091/mbc.7.11.1805; O'Connell RJ, 2012, NAT GENET, V44, P1060, DOI 10.1038/ng.2372; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; Park CH, 2012, PLANT CELL, V24, P4748, DOI 10.1105/tpc.112.105429; Pennisi E, 2010, SCIENCE, V327, P804, DOI 10.1126/science.327.5967.804; Pollak N, 2007, BIOCHEM J, V402, P205, DOI 10.1042/BJ20061638; Rodriguez-Manzaneque MT, 1999, MOL CELL BIOL, V19, P8180; Ross SJ, 2000, MOL BIOL CELL, V11, P2631, DOI 10.1091/mbc.11.8.2631; Ryder LS, 2013, P NATL ACAD SCI USA, V110, P3179, DOI 10.1073/pnas.1217470110; Schulze A, 2012, NATURE, V491, P364, DOI 10.1038/nature11706; Skamnioti P, 2007, MOL PLANT MICROBE IN, V20, P568, DOI 10.1094/MPMI-20-5-0568; Tanabe S, 2011, MOL PLANT MICROBE IN, V24, P163, DOI 10.1094/MPMI-07-10-0175; Torres MA, 2005, NAT GENET, V37, P1130, DOI 10.1038/ng1639; Valent B, 2010, CURR OPIN PLANT BIOL, V13, P434, DOI 10.1016/j.pbi.2010.04.012; van der Hoorn RAL, 2008, PLANT CELL, V20, P2009, DOI 10.1105/tpc.108.060194; Wilson RA, 2007, EMBO J, V26, P3673, DOI 10.1038/sj.emboj.7601795; Wilson RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047392; Wilson RA, 2010, P NATL ACAD SCI USA, V107, P21902, DOI 10.1073/pnas.1006839107; Wilson RA, 2009, NAT REV MICROBIOL, V7, P185, DOI 10.1038/nrmicro2032; Yi M, 2013, ANNU REV PHYTOPATHOL, V51, P587, DOI 10.1146/annurev-phyto-081211-172916; Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672; Zhou XY, 2011, METHODS MOL BIOL, V722, P199, DOI 10.1007/978-1-61779-040-9_15	51	43	43	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2014	9	1							e87300	10.1371/journal.pone.0087300	http://dx.doi.org/10.1371/journal.pone.0087300			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298QQ	24955977	Green Published, gold			2022-12-27	WOS:000330339800093
J	Yang, F; Ning, K; Chang, XZ; Yuan, X; Tu, QC; Yuan, T; Deng, Y; Hemme, CL; Van Nostrand, J; Cui, XP; He, ZL; Chen, ZG; Guo, DW; Yu, JB; Zhang, Y; Zhou, JZ; Xu, J				Yang, Fang; Ning, Kang; Chang, Xingzhi; Yuan, Xiao; Tu, Qichao; Yuan, Tong; Deng, Ye; Hemme, Christopher L.; Van Nostrand, Joy; Cui, Xinping; He, Zhili; Chen, Zhenggang; Guo, Dawei; Yu, Jiangbo; Zhang, Yue; Zhou, Jizhong; Xu, Jian			Saliva Microbiota Carry Caries-Specific Functional Gene Signatures	PLOS ONE			English	Article							WHOLE-SALIVA; STREPTOCOCCI; COMMUNITY; ASSOCIATION; EXPERIENCE; TOOL	Human saliva microbiota is phylogenetically divergent among host individuals yet their roles in health and disease are poorly appreciated. We employed a microbial functional gene microarray, HuMiChip 1.0, to reconstruct the global functional profiles of human saliva microbiota from ten healthy and ten caries-active adults. Saliva microbiota in the pilot population featured a vast diversity of functional genes. No significant distinction in gene number or diversity indices was observed between healthy and caries-active microbiota. However, co-presence network analysis of functional genes revealed that caries-active microbiota was more divergent in non-core genes than healthy microbiota, despite both groups exhibited a similar degree of conservation at their respective core genes. Furthermore, functional gene structure of saliva microbiota could potentially distinguish caries-active patients from healthy hosts. Microbial functions such as Diaminopimelate epimerase, Prephenate dehydrogenase, Pyruvate-formate lyase and N-acetylmuramoyl-L-alanine amidase were significantly linked to caries. Therefore, saliva microbiota carried disease-associated functional signatures, which could be potentially exploited for caries diagnosis.	[Yang, Fang; Yuan, Xiao; Chen, Zhenggang; Guo, Dawei; Yu, Jiangbo; Zhang, Yue] Qingdao Municipal Hosp, Oral Res Ctr, Qingdao, Shandong, Peoples R China; [Ning, Kang; Chang, Xingzhi; Xu, Jian] Chinese Acad Sci, CAS Key Lab Biofuels, Shandong Key Lab Energy Genet, Qingdao, Shandong, Peoples R China; [Ning, Kang; Chang, Xingzhi; Xu, Jian] Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, BioEnergy Genome Ctr, Qingdao, Shandong, Peoples R China; [Tu, Qichao; Yuan, Tong; Deng, Ye; Hemme, Christopher L.; Van Nostrand, Joy; He, Zhili; Zhou, Jizhong] Univ Oklahoma, Inst Environm Genom, Norman, OK 73019 USA; [Cui, Xinping] Univ Calif Riverside, Dept Stat, Riverside, CA 92521 USA	Qingdao Municipal Hospital; Chinese Academy of Sciences; Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS; University of Oklahoma System; University of Oklahoma - Norman; University of California System; University of California Riverside	Zhou, JZ (corresponding author), Univ Oklahoma, Inst Environm Genom, Norman, OK 73019 USA.	jzhou@ou.edu; xujian@qibebt.ac.cn	He, Zhili/C-2879-2012; 吴, 昊/AAB-1620-2020; Xu, Jian/G-8430-2012; Zhang, Qiang/B-6233-2012; Deng, Ye/X-4358-2019; Van Nostrand, Joy D/F-1740-2016; Ning, Kang/ABD-3446-2020	He, Zhili/0000-0001-8225-7333; Xu, Jian/0000-0002-0548-8477; Deng, Ye/0000-0002-7584-0632; Van Nostrand, Joy D/0000-0001-9548-6450; Tu, Qichao/0000-0002-3245-7545; Ning, Kang/0000-0003-3325-5387; Yang, Fulin/0000-0002-5530-0954; YANG, Fang/0000-0002-6783-972X	Ministry of Science and Technology of China [2011IM030100, 2009AA02Z310]; National Science Foundation of China [31271410, 31300424]; Qingdao [2011-WSZD029, KJZD-12-16-nsh, VII2013W002]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Qingdao	This work was supported in part by grants 2011IM030100 and 2009AA02Z310 from Ministry of Science and Technology of China, grants 31271410 and 31300424 from National Science Foundation of China, and grants 2011-WSZD029, KJZD-12-16-nsh and VII2013W002 from Qingdao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Amerongen AV, 2004, CARIES RES, V38, P247, DOI 10.1159/000077762; Baldini C, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3523; Baum B J, 2011, Adv Dent Res, V23, P360, DOI 10.1177/0022034511420433; Bergandi L, 2007, EUR J ORAL SCI, V115, P93, DOI 10.1111/j.1600-0722.2007.00437.x; Bowen WH, 2011, CARIES RES, V45, P69, DOI 10.1159/000324598; Brinkmann O, 2011, ORAL ONCOL, V47, P51, DOI 10.1016/j.oraloncology.2010.10.009; Denny P, 2008, J PROTEOME RES, V7, P1994, DOI 10.1021/pr700764j; Doel JJ, 2004, EUR J ORAL SCI, V112, P424, DOI 10.1111/j.1600-0722.2004.00153.x; Farrell JJ, 2011, GUT; Fodor AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041294; Fonteles CSR, 2009, ARCH ORAL BIOL, V54, P80, DOI 10.1016/j.archoralbio.2008.07.011; Griffen AL, 2012, ISME J, V6, P1176, DOI 10.1038/ismej.2011.191; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; He Z, 2012, CURR OPIN BIOTECHNOL; He ZL, 2012, CURR OPIN BIOTECH, V23, P49, DOI 10.1016/j.copbio.2011.11.001; He ZL, 2010, ISME J, V4, P1167, DOI 10.1038/ismej.2010.46; Holgerson PL, 2005, ACTA ODONTOL SCAND, V63, P233, DOI 10.1080/00016350510019883; Huang S, 2011, BMC ORAL HEALTH, V11, DOI 10.1186/1472-6831-11-33; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jiang Q, 2012, MOL CELL BIOCH; Kanasi E, 2010, J DENT RES, V89, P378, DOI 10.1177/0022034509360010; Keijser BJF, 2008, J DENT RES, V87, P1016, DOI 10.1177/154405910808701104; Ku HK, 2011, INT J BIOL MACROMOL, V49, P761, DOI 10.1016/j.ijbiomac.2011.07.009; Lazarevic V, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-523; Lazarevic V, 2009, J MICROBIOL METH, V79, P266, DOI 10.1016/j.mimet.2009.09.012; Ling ZX, 2010, MICROB ECOL, V60, P677, DOI 10.1007/s00248-010-9712-8; Lu ZM, 2012, ISME J, V6, P451, DOI 10.1038/ismej.2011.91; Martínez-Pabón María C, 2010, Acta odontol. latinoam., V23, P249; Mirzaii-Dizgah Iraj, 2011, J Contemp Dent Pract, V12, P114; Morgan JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010209; MORMANN JE, 1983, CARIES RES, V17, P353; Nasidze I, 2009, ANAL BIOCHEM, V391, P64, DOI 10.1016/j.ab.2009.04.034; Qi X, 2008, 3 NATL SAMPLING EPID; Quinque D, 2006, ANAL BIOCHEM, V353, P272, DOI 10.1016/j.ab.2006.03.021; Smith AMV, 2007, CARIES RES, V41, P445, DOI 10.1159/000107930; Takahashi-Abbe S, 2003, ORAL MICROBIOL IMMUN, V18, P293, DOI 10.1034/j.1399-302X.2003.00081.x; Tao RC, 2005, ANTIMICROB AGENTS CH, V49, P3883, DOI 10.1128/AAC.49.9.3883-3888.2005; Thanyasrisung P, 2009, ORAL MICROBIOL IMMUN, V24, P451, DOI 10.1111/j.1399-302X.2009.00536.x; Thomadaki K, 2011, J DENT RES, V90, P1325, DOI 10.1177/0022034511420721; VANWUYCKHUYSE BC, 1995, J DENT RES, V74, P686, DOI 10.1177/00220345950740021001; Xiao H, 2011, MOL CELL PROTEOMICS; Xie G, 2010, MOL ORAL MICROBIOL, V25, P391, DOI 10.1111/j.2041-1014.2010.00587.x; Yamamoto Y, 2000, INFECT IMMUN, V68, P4773, DOI 10.1128/IAI.68.8.4773-4777.2000; Yang F, 2012, ISME J, V6, P1, DOI 10.1038/ismej.2011.71; Zahir S, 2006, J Indian Soc Pedod Prev Dent, V24, P27; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259; Zhang Q, 2007, J DENT, V35, P177, DOI 10.1016/j.jdent.2006.07.004	47	98	102	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 12	2014	9	2							e76458	10.1371/journal.pone.0076458	http://dx.doi.org/10.1371/journal.pone.0076458			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7FJ	24941017	Green Submitted, Green Published, gold			2022-12-27	WOS:000331262600001
J	Park, S; Ang, RR; Duffy, SP; Bazov, J; Chi, KN; Black, PC; Ma, HS				Park, Sunyoung; Ang, Richard R.; Duffy, Simon P.; Bazov, Jenny; Chi, Kim N.; Black, Peter C.; Ma, Hongshen			Morphological Differences between Circulating Tumor Cells from Prostate Cancer Patients and Cultured Prostate Cancer Cells	PLOS ONE			English	Article							METASTATIC BREAST-CANCER; LABEL-FREE ISOLATION; PERIPHERAL-BLOOD; IMMUNOCYTOCHEMICAL DETECTION; BONE-MARROW; SEPARATION; SIZE; PROGRESSION; SURVIVAL; MICROCHANNEL	Circulating tumor cell (CTC) enumeration promises to be an important predictor of clinical outcome for a range of cancers. Established CTC enumeration methods primarily rely on affinity capture of cell surface antigens, and have been criticized for underestimation of CTC numbers due to antigenic bias. Emerging CTC capture strategies typically distinguish these cells based on their assumed biomechanical characteristics, which are often validated using cultured cancer cells. In this study, we developed a software tool to investigate the morphological properties of CTCs from patients with castrate resistant prostate cancer and cultured prostate cancer cells in order to establish whether the latter is an appropriate model for the former. We isolated both CTCs and cultured cancer cells from whole blood using the CellSearch (R) system and examined various cytomorphological characteristics. In contrast with cultured cancer cells, CTCs enriched by CellSearch (R) system were found to have significantly smaller size, larger nuclear-cytoplasmic ratio, and more elongated shape. These CTCs were also found to exhibit significantly more variability than cultured cancer cells in nuclear-cytoplasmic ratio and shape profile.	[Park, Sunyoung; Ang, Richard R.; Duffy, Simon P.; Ma, Hongshen] Univ British Columbia, Dept Mech Engn, Vancouver, BC V6T 1W5, Canada; [Duffy, Simon P.] Kwantlen Polytech Univ, Dept Biol, Surrey, BC, Canada; [Bazov, Jenny; Chi, Kim N.; Ma, Hongshen] Vancouver Gen Hosp, Vancouver Prostate Ctr, Vancouver, BC, Canada; [Chi, Kim N.; Black, Peter C.] BC Canc Agcy, Vancouver Canc Ctr, Vancouver, BC, Canada; [Chi, Kim N.; Black, Peter C.; Ma, Hongshen] Univ British Columbia, Dept Urol Sci, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia; British Columbia Cancer Agency; University of British Columbia	Ma, HS (corresponding author), Univ British Columbia, Dept Mech Engn, Vancouver, BC V6T 1W5, Canada.	hongma@mech.ubc.ca	Black, Peter/AAE-8424-2020	Black, Peter/0000-0002-2919-7068; Miller, Carol/0000-0002-3091-5602; Dobrowski, Solomon/0000-0003-2561-3850	Natural Science and Engineering Research Council of Canada; Canadian Institutes of Health Research; Vancouver Prostate Centre's Translational Research Initiative for Accelerated Discovery and Development; Terry Fox Research Institute; Movember Global Action Plan (GAP) Prostate Cancer Biomarker Initiative; Engineers-in-Scrubs training program at UBC; Prostate Cancer Canada	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Vancouver Prostate Centre's Translational Research Initiative for Accelerated Discovery and Development; Terry Fox Research Institute; Movember Global Action Plan (GAP) Prostate Cancer Biomarker Initiative; Engineers-in-Scrubs training program at UBC; Prostate Cancer Canada	This work was supported by grants from Natural Science and Engineering Research Council of Canada, Canadian Institutes of Health Research, Prostate Cancer Canada, Vancouver Prostate Centre's Translational Research Initiative for Accelerated Discovery and Development, Engineers-in-Scrubs training program at UBC, Terry Fox Research Institute, and an award from the Movember Global Action Plan (GAP) Prostate Cancer Biomarker Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alazzam A, 2011, ELECTROPHORESIS, V32, P1327, DOI 10.1002/elps.201000625; Alix-Panabieres C, 2012, ANNU REV MED, V63, P199, DOI 10.1146/annurev-med-062310-094219; Andreopoulou E, 2012, INT J CANCER, V130, P1590, DOI 10.1002/ijc.26111; Armstrong AJ, 2011, MOL CANCER RES, V9, P997, DOI 10.1158/1541-7786.MCR-10-0490; Bhagat AAS, 2008, LAB CHIP, V8, P1906, DOI 10.1039/b807107a; Borgen E, 1999, CYTOTHERAPY, V1, P377, DOI 10.1080/0032472031000141283; BREIER A, 1994, GEN PHYSIOL BIOPHYS, V13, P287; Chi KN, 2012, J CLIN ONCOL, V30; Cohen SJ, 2008, J CLIN ONCOL, V26, P3213, DOI 10.1200/JCO.2007.15.8923; Coumans FAW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061770; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; Danila DC, 2007, CLIN CANCER RES, V13, P7053, DOI 10.1158/1078-0432.CCR-07-1506; de Bono JS, 2008, CLIN CANCER RES, V14, P6302, DOI 10.1158/1078-0432.CCR-08-0872; Desitter I, 2011, ANTICANCER RES, V31, P427; DONG C, 1991, BIORHEOLOGY, V28, P557; Fehm T, 2005, CYTOTHERAPY, V7, P171, DOI 10.1080/14653240510027082; Gascoyne PRC, 2009, ELECTROPHORESIS, V30, P1388, DOI 10.1002/elps.200800373; Gerhardt T, 2011, LAB CHIP, V11, P2731, DOI 10.1039/c1lc20092e; Hofman V, 2011, INT J CANCER, V129, P1651, DOI 10.1002/ijc.25819; Huang SB, 2013, LAB CHIP, V13, P1371, DOI 10.1039/c3lc41256c; Hur SC, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3576780; Hyun KA, 2013, BIOSENS BIOELECTRON, V40, P206, DOI 10.1016/j.bios.2012.07.021; Jin C, 2013, LAB CHIP; Joosse SA, 2012, CLIN CANCER RES, V18, P993, DOI 10.1158/1078-0432.CCR-11-2100; Kraeft SK, 2000, CLIN CANCER RES, V6, P434; Lazar DC, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/1/016002; Ligthart ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067148; Lin HK, 2010, CLIN CANCER RES, V16, P5011, DOI 10.1158/1078-0432.CCR-10-1105; Marrinucci D, 2007, HUM PATHOL, V38, P514, DOI 10.1016/j.humpath.2006.08.027; Marrinucci D, 2010, J ONCOL, V2010, DOI 10.1155/2010/861341; Matrone MA, 2010, CANCER RES, V70, P7737, DOI 10.1158/0008-5472.CAN-10-1569; McFaul SM, 2012, LAB CHIP, V12, P2369, DOI 10.1039/c2lc21045b; Mehes G, 2001, AM J PATHOL, V159, P17, DOI 10.1016/S0002-9440(10)61667-7; Meng SD, 2004, CLIN CANCER RES, V10, P8152, DOI 10.1158/1078-0432.CCR-04-1110; Miller MC, 2010, J ONCOL, V2010, DOI 10.1155/2010/617421; Otsuka K, 2013, ANTICANCER RES, V33, P625; Pantel K, 2009, NAT REV CLIN ONCOL, V6, P339, DOI 10.1038/nrclinonc.2009.44; Pierga JY, 2004, CLIN CANCER RES, V10, P1392, DOI 10.1158/1078-0432.CCR-0102-03; Raimondi C, 2011, BREAST CANCER RES TR, V130, P449, DOI 10.1007/s10549-011-1373-x; Riethdorf S, 2007, CLIN CANCER RES, V13, P920, DOI 10.1158/1078-0432.CCR-06-1695; Rosenberg R, 2002, CYTOMETRY, V49, P150, DOI 10.1002/cyto.10161; Shaffer DR, 2007, CLIN CANCER RES, V13, P2023, DOI 10.1158/1078-0432.CCR-06-2701; SHI YA, 1993, BIOTECHNOL BIOENG, V41, P745, DOI 10.1002/bit.260410709; Shim S, 2011, INTEGR BIOL-UK, V3, P850, DOI 10.1039/c1ib00032b; Sim TS, 2011, LAB CHIP, V11, P93, DOI [10.1039/c0lc00109k, 10.1039/c01c00109k]; Song H, 2003, BIOTECHNOL PROGR, V19, P1742, DOI 10.1021/bp034061n; Sun JS, 2012, LAB CHIP, V12, P3952, DOI 10.1039/c2lc40679a; Tan SJ, 2010, BIOSENS BIOELECTRON, V26, P1701, DOI 10.1016/j.bios.2010.07.054; Vona G, 2000, AM J PATHOL, V156, P57, DOI 10.1016/S0002-9440(10)64706-2; WEISS L, 1992, CANCER METAST REV, V11, P227, DOI 10.1007/BF01307179; Willipinski-Stapelfeldt B, 2005, CLIN CANCER RES, V11, P8006, DOI 10.1158/1078-0432.CCR-05-0632; Yap TA, 2010, NAT REV CANCER, V10, P514, DOI 10.1038/nrc2870; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522; Zhe XN, 2011, AM J CANCER RES, V1, P740; Zheng SY, 2011, BIOMED MICRODEVICES, V13, P203, DOI 10.1007/s10544-010-9485-3; Zhou J, 2013, LAB CHIP, V13, P1919, DOI 10.1039/c3lc50101a	56	129	139	4	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2014	9	1							e85264	10.1371/journal.pone.0085264	http://dx.doi.org/10.1371/journal.pone.0085264			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291WL	24941290	Green Submitted, Green Published, gold			2022-12-27	WOS:000329862500231
J	Heming, N; Urien, S; Fulda, V; Meziani, F; Gacouin, A; Clavel, M; Planquette, B; Faisy, C				Heming, Nicholas; Urien, Saik; Fulda, Virginie; Meziani, Ferhat; Gacouin, Arnaud; Clavel, Marc; Planquette, Benjamin; Faisy, Christophe			Population Pharmacodynamic Modeling and Simulation of the Respiratory Effect of Acetazolamide in Decompensated COPD Patients	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; INTENSIVE-CARE-UNIT; MECHANICAL VENTILATION; METABOLIC ALKALOSIS; CRITICALLY-ILL; ACUTE EXACERBATION; SURVIVAL; FAILURE; PHARMACOKINETICS; DETERMINANTS	Background: Chronic obstructive pulmonary disease (COPD) patients may develop metabolic alkalosis during weaning from mechanical ventilation. Acetazolamide is one of the treatments used to reverse metabolic alkalosis. Methods: 619 time-respiratory (minute ventilation, tidal volume and respiratory rate) and 207 time-PaCO2 observations were obtained from 68 invasively ventilated COPD patients. We modeled respiratory responses to acetazolamide in mechanically ventilated COPD patients and then simulated the effect of increased amounts of the drug. Results: The effect of acetazolamide on minute ventilation and PaCO2 levels was analyzed using a nonlinear mixed effect model. The effect of different ventilatory modes was assessed on the model. Only slightly increased minute ventilation without decreased PaCO2 levels were observed in response to 250 to 500 mg of acetazolamide administered twice daily. Simulations indicated that higher acetazolamide dosage (>1000 mg daily) was required to significantly increase minute ventilation (P<.001 vs pre-acetazolamide administration). Based on our model, 1000 mg per day of acetazolamide would increase minute ventilation by >0.75 L min(-1) in 60% of the population. The model also predicts that 45% of patients would have a decrease of PaCO2>5 mmHg with doses of 1000 mg per day. Conclusions: Simulations suggest that COPD patients might benefit from the respiratory stimulant effect after the administration of higher doses of acetazolamide.	[Heming, Nicholas; Faisy, Christophe] Univ Paris 05, Hop Europeen Georges Pompidou, AP HP, Sorbonne Paris Cite,Serv Reanimat Med, Paris, France; [Urien, Saik] Univ Paris 05, Hop Tarnier, AP HP,Unite Rech Clin, Sorbonne Paris Cite,CIC Cochin Necker INSERM 0110, Paris, France; [Fulda, Virginie] Univ Paris 05, Hop Europeen Georges Pompidou, AP HP, Sorbonne Paris Cite,Ctr Reg Pharmacovigilance, Paris, France; [Meziani, Ferhat] Hop Civil, Serv Reanimat Med, Strasbourg, France; [Gacouin, Arnaud] Hop Pontchaillou, Serv Reanimat Med & Infect, Rennes, France; [Clavel, Marc] CHU Limoges, Serv Reanimat Polyvalente, Limoges, France; [Planquette, Benjamin] Hop Andre Mignot, Serv Reanimat Med Chirurg, Le Chesnay, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Strasbourg; CHU Rennes; CHU Limoges; Centre Hospitalier de Versailles	Heming, N (corresponding author), Univ Paris 05, Hop Europeen Georges Pompidou, AP HP, Sorbonne Paris Cite,Serv Reanimat Med, Paris, France.	nicholas.heming@orange.fr	Urien, Saïk/G-3240-2013; PLANQUETTE, Benjamin/AAL-7166-2021	Urien, Saïk/0000-0002-1065-0600; 				Arozullah AM, 2000, ANN SURG, V232, P242, DOI 10.1097/00000658-200008000-00015; BERTHELSEN P, 1985, INTENS CARE MED, V11, P26; Boles JM, 2007, EUR RESPIR J, V29, P1033, DOI 10.1183/09031936.00010206; BRIMIOULLE S, 1989, CRIT CARE MED, V17, P232, DOI 10.1097/00003246-198903000-00006; ESTEBAN A, 1995, NEW ENGL J MED, V332, P345, DOI 10.1056/NEJM199502093320601; Faisy C, 2010, INTENS CARE MED, V36, P859, DOI 10.1007/s00134-010-1795-7; Gosselink R, 1996, AM J RESP CRIT CARE, V153, P976, DOI 10.1164/ajrccm.153.3.8630582; Groenewegen KH, 2003, CHEST, V124, P459, DOI 10.1378/chest.124.2.459; Gunen H, 2005, EUR RESPIR J, V26, P234, DOI 10.1183/09031936.05.00024804; Gursel G, 2005, RESPIRATION, V72, P61, DOI 10.1159/000083402; Heming N, 2012, CRIT CARE, V16, DOI 10.1186/cc11323; Heming N, 2011, CRIT CARE, V15, DOI 10.1186/cc10448; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; Khanna A, 2001, Respir Care, V46, P354; Kiwull-Schone HF, 2001, AM J RESP CRIT CARE, V163, P478, DOI 10.1164/ajrccm.163.2.9911075; Laghi F, 2012, MINERVA ANESTESIOL, V78, P201; Levine S, 2008, NEW ENGL J MED, V358, P1327, DOI 10.1056/NEJMoa070447; Mazur JE, 1999, CRIT CARE MED, V27, P1257, DOI 10.1097/00003246-199907000-00004; MENZIES R, 1989, CHEST, V95, P398, DOI 10.1378/chest.95.2.398; Moran JL, 1998, CRIT CARE MED, V26, P71, DOI 10.1097/00003246-199801000-00019; Nevins ML, 2001, CHEST, V119, P1840, DOI 10.1378/chest.119.6.1840; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Ritschel WA, 1998, J CLIN PHARMACOL, V38, P533, DOI 10.1002/j.1552-4604.1998.tb05791.x; SENEFF MG, 1995, JAMA-J AM MED ASSOC, V274, P1852, DOI 10.1001/jama.274.23.1852; Supuran CT, 2008, NAT REV DRUG DISCOV, V7, P168, DOI 10.1038/nrd2467; Swenson ER, 1998, EUR RESPIR J, V12, P1242, DOI 10.1183/09031936.98.12061242; Teppema LJ, 1999, AM J RESP CRIT CARE, V160, P1592, DOI 10.1164/ajrccm.160.5.9903088; VOS PJE, 1994, EUR RESPIR J, V7, P850; Webster NR, 1999, CRIT REV CL LAB SCI, V36, P497, DOI 10.1080/10408369991239286; WONG DH, 1995, ANESTH ANALG, V80, P276, DOI 10.1097/00000539-199502000-00013; YANG KL, 1991, NEW ENGL J MED, V324, P1445, DOI 10.1056/NEJM199105233242101; Yano I, 1998, EUR J CLIN PHARMACOL, V54, P63, DOI 10.1007/s002280050422	32	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2014	9	1							e86313	10.1371/journal.pone.0086313	http://dx.doi.org/10.1371/journal.pone.0086313			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297EA	24956152	Green Submitted, gold, Green Published			2022-12-27	WOS:000330237000090
J	Zhang, LF; Qi, J; Zuo, GL; Jia, P; Shen, X; Shao, J; Kang, H; Yang, HL; Deng, LF				Zhang, Lian-Fang; Qi, Jin; Zuo, GuiLai; Jia, Peng; Shen, Xing; Shao, Jin; Kang, Hui; Yang, HuiLin; Deng, LianFu			Osteoblast-Secreted Factors Promote Proliferation and Osteogenic Differentiation of Bone Marrow Stromal Cells via VEGF/Heme-Oxygenase-1 Pathway	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; ENDOTHELIAL GROWTH-FACTOR; HEME OXYGENASE-1; FACTOR VEGF; IN-VITRO; MOUSE; ANGIOGENESIS; INHIBITION; EXPRESSION; SURVIVAL	The hypoxia-inducible factors (HIF alpha) are the critical factors that couple angiogenesis and osteogenesis by activating transcription of VEGF in osteoblasts. Mice lacking von Hippel-Lindau gene (Vhl), thus overexpressing HIF alpha in osteoblasts develop extremely dense and highly vascularized long bones. Here we provide evidence that osteoblasts lacking Vhl overexpress and secrete high levels of VEGF, which subsequently promotes the proliferation and osteogenic differentiation of bone marrow stromal cells (BMSC) by promoting expression of Heme oxygenase-1 (HO-1) in BMSC. Conditioned medium from osteoblasts Vhl (CM-CRE) promoted the proliferation and osteogenic differentiation of BMSC, in comparison with conditioned medium derived from normal osteoblasts (CM-GFP). Recombinant VEGF stimulated the proliferation and osteogenic differentiation of BMSC culturing in CM-GFP. By contrast, VEGF-neutralizing antibody inhibited the proliferation and osteogenic differentiation of BMSC culturing in CM-CRE. Treatment with a HO-1 inhibitor, SnPP, significantly inhibited VEGF-induced BMSC proliferation and osteogenic differentiation. On the contrary, activation of HO-1 with CoPP reversed the suppressing of VEGF-antibody on the proliferation and osteogesis of BMSC culturing in CM-CRE. These studies suggest that osteoblasts promote the proliferation and osteogenic differentiation of BMCS by VEGF/HO-1 pathway.	[Zhang, Lian-Fang; Qi, Jin; Zuo, GuiLai; Jia, Peng; Shen, Xing; Shao, Jin; Kang, Hui; Deng, LianFu] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Shanghai Inst Traumatol & Orthopaed,Shanghai Key, Shanghai 200030, Peoples R China; [Zhang, Lian-Fang; Yang, HuiLin] Soochow Univ, Affiliated Hosp 1, Dept Orthopaed, Suzhou, Peoples R China	Shanghai Jiao Tong University; Soochow University - China	Deng, LF (corresponding author), Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Shanghai Inst Traumatol & Orthopaed,Shanghai Key, Shanghai 200030, Peoples R China.	deng_lianfu@hotmail.com		Xu, Yunan/0000-0001-6484-6118	International Cooperation and Exchange of the National Natural Science Foundation of China [81061160510]; Foundation of Science and Technology Commission of Shanghai Municipality [12JC1408200, 13431900702]; Graduate Student Innovation Fund of Shanghai Jiao Tong University School of Medicine [BXJ201242]	International Cooperation and Exchange of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Graduate Student Innovation Fund of Shanghai Jiao Tong University School of Medicine	This work was supported by the funds from the International Cooperation and Exchange of the National Natural Science Foundation of China (No. 81061160510), the Foundation of Science and Technology Commission of Shanghai Municipality (No. 12JC1408200, No. 13431900702), and the Graduate Student Innovation Fund of Shanghai Jiao Tong University School of Medicine (No. BXJ201242). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM NG, 1985, EXP HEMATOL, V13, P838; ABRAHAM NG, 1991, BLOOD REV, V5, P19, DOI 10.1016/0268-960X(91)90004-V; Armour KE, 2001, ENDOCRINOLOGY, V142, P760, DOI 10.1210/en.142.2.760; Ball SG, 2007, J CELL BIOL, V177, P489, DOI 10.1083/jcb.200608093; Barbagallo I, 2010, J BONE MINER METAB, V28, P276, DOI 10.1007/s00774-009-0134-y; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Bussolati B, 2004, BLOOD, V103, P761, DOI 10.1182/blood-2003-06-1974; Carlevaro MF, 2000, J CELL SCI, V113, P59; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; Dennis JE, 1999, J BONE MINER RES, V14, P700, DOI 10.1359/jbmr.1999.14.5.700; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Garrett IR, 2001, CURR PHARM DESIGN, V7, P715, DOI 10.2174/1381612013397762; Gerber HP, 1999, NAT MED, V5, P623, DOI 10.1038/9467; Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336; Hiltunen MO, 2003, FASEB J, V17, P1147, DOI 10.1096/fj.02-0514fje; Hsiao FSH, 2010, CELL PROLIFERAT, V43, P235, DOI 10.1111/j.1365-2184.2010.00674.x; Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I; Kweider N, 2011, J BIOL CHEM, V286, P42863, DOI 10.1074/jbc.M111.286880; Lin H, 2008, J CELL PHYSIOL, V216, P458, DOI 10.1002/jcp.21414; Luttun A, 2002, NAT MED, V8, P831, DOI 10.1038/nm731; Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517; Marinissen MJ, 2006, J BIOL CHEM, V281, P11332, DOI 10.1074/jbc.M512199200; Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946; Peng HR, 2002, J CLIN INVEST, V110, P751, DOI 10.1172/JCI200215153; Penna C, 2013, J CELL MOL MED, V17, P192, DOI 10.1111/j.1582-4934.2012.01662.x; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Sass G, 2003, HEPATOLOGY, V38, P909, DOI 10.1053/jhep.2003.50386; Soleimani M, 2009, NAT PROTOC, V4, P102, DOI 10.1038/nprot.2008.221; Sun J, 2012, CELLS TISSUES ORGANS, V196, P510, DOI 10.1159/000339245; Sun SK, 2003, STEM CELLS, V21, P527, DOI 10.1634/stemcells.21-5-527; TENHUNEN R, 1968, P NATL ACAD SCI USA, V61, P748, DOI 10.1073/pnas.61.2.748; Vanella L, 2010, BONE, V46, P236, DOI 10.1016/j.bone.2009.10.012; Wagner M, 2003, KIDNEY INT, V63, P1564, DOI 10.1046/j.1523-1755.2003.00897.x; Wan C, 2008, P NATL ACAD SCI USA, V105, P686, DOI 10.1073/pnas.0708474105; Wang Y, 2007, J CLIN INVEST, V117, P1616, DOI 10.1172/JCI31581; Yeh LCC, 1999, MOL CELL ENDOCRINOL, V153, P113, DOI 10.1016/S0303-7207(99)00076-3; Zhu H, 2010, NAT PROTOC, V5, P550, DOI 10.1038/nprot.2009.238	38	84	96	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e99946	10.1371/journal.pone.0099946	http://dx.doi.org/10.1371/journal.pone.0099946			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24940620	Green Published, gold, Green Submitted			2022-12-27	WOS:000338508200058
J	Erickson, ZT; Falkenberg, EA; Metz, GAS				Erickson, Zachary T.; Falkenberg, Erin A.; Metz, Gerlinde A. S.			Lifespan Psychomotor Behaviour Profiles of Multigenerational Prenatal Stress and Artificial Food Dye Effects in Rats	PLOS ONE			English	Article							SPONTANEOUSLY HYPERTENSIVE-RAT; ADHD SYMPTOMS; DISORDER ADHD; ANIMAL-MODEL; ANXIETY; CORTICOSTERONE; HYPERACTIVITY; ADDITIVES; DOPAMINE; TOXICITY	The consumption of artificial food dye (AFD) during childhood and adolescence has been linked to behavioural changes, such as hyperactivity. It is possible that the vulnerability to AFDs is modified by prenatal stress. Common consequences of prenatal stress include hyperactivity, thus potentially leading to synergistic actions with AFDs. Here, we investigated the compounding effect of multigenerational prenatal stress (MPS) and AFD consumption on the development of hyperactivity and anxiety-related behaviours across the lifespan in male rats. MPS treatment involved a family history of four consecutive generations of prenatal stress (F4 generation). AFD treatment included a 4%-concentration of FD&C Red 40, FD&C Yellow 5, FD&C Yellow 6, and FD&C Blue 1 in the drinking water from postnatal days 22 to 50 to resemble juvenile and adolescent dietary exposure. Using several exploration tasks, animals were tested in motor activity and anxiety-like behaviours from adolescence to 13 months of age. MPS resulted in hyperactivity both early (50 days) and later in life (13 months), with normalized activity patterns at reproductive age. AFD consumption resulted in hyperactivity during consumption, which subsided following termination of treatment. Notably, both MPS and AFD promoted risk-taking behaviour in young adults (3 months). There were few synergistic effects between MPS and AFD in this study. The findings suggest that AFDs exert the most noticeable effects at the time of exposure. MPS, however, results in a characteristic lifespan profile of behavioural changes, indicating that development and aging represent particularly vulnerable periods in life during which a family history of prenatal stress may precipitate.	[Erickson, Zachary T.; Falkenberg, Erin A.; Metz, Gerlinde A. S.] Univ Lethbridge, Canadian Ctr Behav Neurosci, Lethbridge, AB T1K 3M4, Canada	University of Lethbridge	Metz, GAS (corresponding author), Univ Lethbridge, Canadian Ctr Behav Neurosci, Lethbridge, AB T1K 3M4, Canada.	gerlinde.metz@uleth.ca			Alberta Innovates-Health Solutions [200700595]; Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research [102652]	Alberta Innovates-Health Solutions; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The authors acknowledge support by the Alberta Innovates-Health Solutions Interdisciplinary Team Grant #200700595 "Preterm Birth and Healthy Outcomes" (GM), grants from Alberta Innovates-Health Solutions (GM), the Natural Sciences and Engineering Research Council of Canada (GM), and the Canadian Institutes of Health Research #102652 (GM). GM is an AHFMR Senior Scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold LE, 2012, NEUROTHERAPEUTICS, V9, P599, DOI 10.1007/s13311-012-0133-x; Bateman B, 2004, ARCH DIS CHILD, V89, P506, DOI 10.1136/adc.2003.031435; Bourin M, 2003, EUR J PHARMACOL, V463, P55, DOI 10.1016/S0014-2999(03)01274-3; Crespi EJ, 2005, AM J HUM BIOL, V17, P44, DOI 10.1002/ajhb.20098; Fernandez F, 2004, NEUROPSYCHOPHARMACOL, V29, P59, DOI 10.1038/sj.npp.1300308; Field T, 2008, INFANT BEHAV DEV, V31, P590, DOI 10.1016/j.infbeh.2008.07.007; FLORES CM, 1990, J NEUROIMMUNOL, V28, P219, DOI 10.1016/0165-5728(90)90015-F; Food and Drug Administration/Center for Food Safety and Applied Nutrition, 2011, BACKGR INF FOOD ADV; Gatzke-Kopp LM, 2011, NEUROSCI BIOBEHAV R, V35, P794, DOI 10.1016/j.neubiorev.2010.09.013; Glover V, 2011, J CHILD PSYCHOL PSYC, V52, P356, DOI 10.1111/j.1469-7610.2011.02371.x; Hao Y, 2013, NONGENETIC INHERITAN, V1, P9, DOI DOI 10.2478/NGI-2013-0001; Harris A, 2011, HORM BEHAV, V59, P279, DOI 10.1016/j.yhbeh.2010.06.007; Holmes MC, 2006, J NEUROSCI, V26, P3840, DOI 10.1523/JNEUROSCI.4464-05.2006; Jadavji NM, 2011, NEUROENDOCRINOLOGY, V94, P278, DOI 10.1159/000329988; Jankord R, 2011, ENDOCRINOLOGY, V152, P629, DOI 10.1210/en.2010-0658; Kanarek RB, 2011, NUTR REV, V69, P385, DOI 10.1111/j.1753-4887.2011.00385.x; Korosi A, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.027.2009; Laloux C, 2012, PSYCHONEUROENDOCRINO, V37, P1646, DOI 10.1016/j.psyneuen.2012.02.010; Lau K, 2006, TOXICOL SCI, V90, P178, DOI 10.1093/toxsci/kfj073; Li Q, 2007, NEUROCHEM INT, V50, P848, DOI 10.1016/j.neuint.2007.02.005; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Matthews SG, 2010, ENDOCRINOLOGY, V151, P7, DOI 10.1210/en.2009-0916; McCann D, 2007, LANCET, V370, P1560, DOI 10.1016/S0140-6736(07)61306-3; Metz GA, 2005, EUR J NEUROSCI, V22, P1190, DOI 10.1111/j.1460-9568.2005.04285.x; Metz GA, 2007, REV NEUROSCIENCE, V18, P209; Nosek K, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-23; O'Connor TG, 2003, J CHILD PSYCHOL PSYC, V44, P1025, DOI 10.1111/1469-7610.00187; Park M, 2009, J TOXICOL ENV HEAL A, V72, P1412, DOI 10.1080/15287390903212816; Prediger RDS, 2005, INT J NEUROPSYCHOPH, V8, P583, DOI 10.1017/S1461145705005341; REISEN CA, 1986, NEUROTOXICOL TERATOL, V8, P317; Sagvolden T, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-6; Sandman CA, 2013, J PSYCHOSOM RES, V75, P327, DOI 10.1016/j.jpsychores.2013.07.009; Schab DW, 2004, J DEV BEHAV PEDIATR, V25, P423, DOI 10.1097/00004703-200412000-00007; Smith LK, 2008, EUR J NEUROSCI, V27, P2133, DOI 10.1111/j.1460-9568.2008.06177.x; Stevens LJ, 2011, CLIN PEDIATR, V50, P279, DOI 10.1177/0009922810384728; Tanaka T, 2006, FOOD CHEM TOXICOL, V44, P179, DOI 10.1016/j.fct.2005.06.011; Tanaka T, 2008, REPROD TOXICOL, V26, P156, DOI 10.1016/j.reprotox.2008.07.001; Vallee M, 1999, EUR J NEUROSCI, V11, P2906, DOI 10.1046/j.1460-9568.1999.00705.x; Van den Bergh BRH, 2004, CHILD DEV, V75, P1085, DOI 10.1111/j.1467-8624.2004.00727.x; VORHEES CV, 1983, TOXICOLOGY, V28, P207, DOI 10.1016/0300-483X(83)90118-X; Ward ID, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-S1-S9; Wilson CA, 2013, BEHAV BRAIN RES, V238, P279, DOI 10.1016/j.bbr.2012.10.003; Zucchi Fabiola C. R., 2012, Frontiers in Genetics, V3, P96, DOI 10.3389/fgene.2012.00096	43	44	46	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e92132	10.1371/journal.pone.0092132	http://dx.doi.org/10.1371/journal.pone.0092132			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	25222738	Green Published, Green Submitted, gold			2022-12-27	WOS:000338503400001
J	Yang, FL; Zhang, Q; Wang, RY; Zhou, J				Yang, Fulin; Zhang, Qiang; Wang, Runyuan; Zhou, Jing			Evapotranspiration Measurement and Crop Coefficient Estimation over a Spring Wheat Farmland Ecosystem in the Loess Plateau	PLOS ONE			English	Article							WATER-VAPOR; WINTER-WHEAT; MAIZE; TRANSPIRATION; MODEL; HEAT; FLUX; GRASSLAND; EXCHANGE; REGION	Evapotranspiration (ET) is an important component of the surface energy balance and hydrological cycle. In this study, the eddy covariance technique was used to measure ET of the semi-arid farmland ecosystem in the Loess Plateau during 2010 growing season (April to September). The characteristics and environmental regulations of ET and crop coefficient (Kc) were investigated. The results showed that the diurnal variation of latent heat flux (LE) was similar to single-peak shape for each month, with the largest peak value of LE occurring in August (151.4 W m(-2)). The daily ET rate of the semi-arid farmland in the Loess Plateau also showed clear seasonal variation, with the maximum daily ET rate of 4.69 mm day(-1). Cumulative ET during 2010 growing season was 252.4 mm, and lower than precipitation. Radiation was the main driver of farmland ET in the Loess Plateau, which explained 88% of the variances in daily ET (p<0.001). The farmland Kc values showed the obvious seasonal fluctuation, with the average of 0.46. The correlation analysis between daily Kc and its major environmental factors indicated that wind speed (Ws), relative humidity (RH), soil water content (SWC), and atmospheric vapor pressure deficit (VPD) were the major environmental regulations of daily Kc. The regression analysis results showed that Kc exponentially decreased with Ws increase, an exponentially increased with RH, SWC increase, and a linearly decreased with VPD increase. An experiential Kc model for the semi-arid farmland in the Loess Plateau, driven by Ws, RH, SWC and VPD, was developed, showing a good consistency between the simulated and the measured Kc values.	[Yang, Fulin; Zhang, Qiang; Wang, Runyuan] CMA, Inst Arid Meteorol, Key Open Lab Arid Climat Change & Disaster Reduct, Key Lab Arid Climat Change & Reducing Disaster Ga, Lanzhou, Peoples R China; [Zhou, Jing] Lanzhou Univ, Coll Pastoral Agr Sci & Technol, State Key Lab Grassland Agroecosyst, Lanzhou 730000, Peoples R China	China Meteorological Administration; Lanzhou University	Zhang, Q (corresponding author), CMA, Inst Arid Meteorol, Key Open Lab Arid Climat Change & Disaster Reduct, Key Lab Arid Climat Change & Reducing Disaster Ga, Lanzhou, Peoples R China.	zhangqiang@cma.gov.cn	He, Zhili/C-2879-2012; 吴, 昊/AAB-1620-2020; Xu, Jian/G-8430-2012; Zhang, Qiang/B-6233-2012; Deng, Ye/X-4358-2019; Van Nostrand, Joy D/F-1740-2016; Ning, Kang/ABD-3446-2020	He, Zhili/0000-0001-8225-7333; Xu, Jian/0000-0002-0548-8477; Deng, Ye/0000-0002-7584-0632; Van Nostrand, Joy D/0000-0001-9548-6450; Tu, Qichao/0000-0002-3245-7545; Ning, Kang/0000-0003-3325-5387; Yang, Fulin/0000-0002-5530-0954; YANG, Fang/0000-0002-6783-972X	National Basic Research Program of China [2012CB955304, 2013CB430206]; National Natural Science Foundation of China [31300376, 40830957, 41275118, 41305134]; Natural Science Foundation of Gansu province [1208RJYA025]; China Postdoctoral Science Foundation [2012M512044]; Meteorological Research Program of Gansu Provincial Meteorological Service; Science Research Foundation for Drought Meteorology [IAM201312]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Gansu province; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Meteorological Research Program of Gansu Provincial Meteorological Service; Science Research Foundation for Drought Meteorology	This research was jointly supported by National Basic Research Program of China (2012CB955304, 2013CB430206), National Natural Science Foundation of China (31300376, 40830957, 41275118, 41305134), Natural Science Foundation of Gansu province (1208RJYA025), China Postdoctoral Science Foundation (2012M512044), Meteorological Research Program of Gansu Provincial Meteorological Service (2012-15), and Science Research Foundation for Drought Meteorology (IAM201312). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[张永强 Zhang Yongqiang], 2002, [地理学报, Acta Geographica Sinica], V57, P333; Allen R. G., 1998, FAO Irrigation and Drainage Paper; Baldocchi D, 1998, AGR FOREST METEOROL, V90, P1, DOI 10.1016/S0168-1923(97)00072-5; Burba GG, 2005, AGR FOREST METEOROL, V135, P190, DOI 10.1016/j.agrformet.2005.11.017; Ding RS, 2013, AGR FOREST METEOROL, V168, P140, DOI 10.1016/j.agrformet.2012.08.003; Falge E, 2001, AGR FOREST METEOROL, V107, P71, DOI 10.1016/S0168-1923(00)00235-5; [郭家选 GUO JiaXuan], 2006, [生态学报, Acta Ecologica Sinica], V26, P130; Jung M, 2010, NATURE, V467, P951, DOI 10.1038/nature09396; Kang SZ, 2003, AGR WATER MANAGE, V59, P239, DOI 10.1016/S0378-3774(02)00150-6; Kimura R, 2006, ACTA OECOL, V29, P45, DOI 10.1016/j.actao.2005.07.003; Kite G, 2000, J HYDROL, V229, P59, DOI 10.1016/S0022-1694(99)00199-7; Lei HM, 2010, AGR FOREST METEOROL, V150, P581, DOI 10.1016/j.agrformet.2010.01.022; Li SG, 2005, HYDROL PROCESS, V19, P517, DOI 10.1002/hyp.5673; Li Yi-Jun, 2007, Zhiwu Shengtai Xuebao, V31, P1132; Li YL, 2003, AGR WATER MANAGE, V61, P1, DOI 10.1016/S0378-3774(02)00177-4; [李志 Li Zhi], 2012, [生态学报, Acta Ecologica Sinica], V32, P4139; Li Zhi, 2012, Transactions of the Chinese Society of Agricultural Engineering, V28, P106; Liu CM, 2002, AGR FOREST METEOROL, V111, P109, DOI 10.1016/S0168-1923(02)00015-1; Lockwood JG, 1999, CLIMATIC CHANGE, V41, P193, DOI 10.1023/A:1005469416067; Papale D, 2006, BIOGEOSCIENCES, V3, P571, DOI 10.5194/bg-3-571-2006; Pauwels VRN, 2006, AGR WATER MANAGE, V82, P1, DOI 10.1016/j.agwat.2005.06.001; Qin Z, 2004, SCI CHINA SER D, V34, P183; Suyker AE, 2008, AGR FOREST METEOROL, V148, P417, DOI 10.1016/j.agrformet.2007.10.005; Trezza R, 2013, REMOTE SENS-BASEL, V5, P5397, DOI 10.3390/rs5105397; Villalobos FJ, 2013, AGR FOREST METEOROL, V171, P93, DOI 10.1016/j.agrformet.2012.11.010; Wang GY, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013372; Wang KC, 2012, REV GEOPHYS, V50, DOI 10.1029/2011RG000373; Wang YouQi, 2010, Transactions of the Chinese Society of Agricultural Engineering, V26, P6; WEBB EK, 1980, Q J ROY METEOR SOC, V106, P85, DOI 10.1002/qj.49710644707; Xuan SL, 2011, ADV ATMOS SCI, V28, P387, DOI 10.1007/s00376-010-0111-3; Yang FL, 2011, J HYDROL, V396, P139, DOI 10.1016/j.jhydrol.2010.11.001; Yang K, 2008, SCI CHINA SER D, V51, P721, DOI 10.1007/s11430-008-0036-1; [杨晓光 Yang Xiaohua], 2003, [中国生态农业学报, Chinese journal of eco-agriculture], V11, P66; Yu GR, 2006, AGR FOREST METEOROL, V137, P125, DOI 10.1016/j.agrformet.2006.02.011; Yu WY, 2008, ACTA ECOL SINICA, V28, P4894; Zhang BZ, 2013, IRRIGATION SCI, V31, P1303, DOI 10.1007/s00271-013-0405-1; Zhang Q, 2011, CHINESE J GEOPHYS-CH, V54, P1727, DOI 10.3969/j.issn.0001-5733.2011.07.005; 信忠保, 2007, [中国科学. D辑, 地球科学, Science in China. Series D, Earth Sciences], V37, P1504	38	98	102	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2014	9	6							e100031	10.1371/journal.pone.0100031	http://dx.doi.org/10.1371/journal.pone.0100031			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK6AC	24941017	Green Published, gold, Green Submitted			2022-12-27	WOS:000338508200068
J	Liu, N; Lin, ZF; Guan, LL; Gaughan, G; Lin, GZ				Liu, Nan; Lin, Zhifang; Guan, Lanlan; Gaughan, Gerald; Lin, Guizhu			Antioxidant Enzymes Regulate Reactive Oxygen Species during Pod Elongation in Pisum sativum and Brassica chinensis	PLOS ONE			English	Article							HYDROXYL RADICALS; HYDROGEN-PEROXIDE; CELL-WALL; ROOT; SUPEROXIDE; GROWTH; LEAVES; H2O2	Previous research has focused on the involvement of reactive oxygen species (ROS) in cell wall loosening and cell extension in plant vegetative growth, but few studies have investigated ROS functions specifically in plant reproductive organs. In this study, ROS levels and antioxidant enzyme activities were assessed in Pisum sativum and Brassica chinensis pods at five developmental stages. In juvenile pods, the high levels of O-2(-) and OH indicates that they had functions in cell wall loosening and cell elongation. In later developmental stages, high levels of. OH were also related to increases in cell wall thickness in lignified tissues. Throughout pod development, most of the O-2(-) was detected on plasma membranes of parenchyma cells and outer epidermis cells of the mesocarp, while most of the H2O2 was detected on plasma membranes of most cells throughout the mesocarp. This suggests that these sites are presumably the locations of ROS generation. The antioxidant enzymes superoxide dismutase (SOD), peroxidase (POD), and catalase (CAT) apparently contributed to ROS accumulation in pod wall tissues. Furthermore, specifically SOD and POD were found to be associated with pod growth through the regulation of ROS generation and transformation. Throughout pod development, O-2(-) decreases were associated with increased SOD activity, while changes in H2O2 accumulation were associated with changes in CAT and POD activities. Additionally, high POD activity may contribute to the generation of. OH in the early development of pods. It is concluded that the ROS are produced in different sites of plasma membranes with the regulation of antioxidant enzymes, and that substantial ROS generation and accumulation are evident in cell elongation and cell wall loosening in pod wall cells.	[Liu, Nan; Lin, Zhifang; Guan, Lanlan; Lin, Guizhu] Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China; [Gaughan, Gerald] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA	Chinese Academy of Sciences; South China Botanical Garden, CAS; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Lin, ZF (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China.	linzhif@scbg.ac.cn	刘, 芳延/AAO-8535-2021; Strugnell, Jan M/P-9921-2016; Moltschaniwskyj, Natalie/AAB-7236-2019; Pecl, Gretta/D-7267-2011; Bertin, Aline/T-5005-2017; van den Bosch, Frank C./ABH-3801-2020; Malausa, Thibaut/X-1614-2018; León, Rafael I/N-6510-2014; Botton, Marcos/I-1731-2016; Deary, Ian/C-6297-2009; Aidar, Marcos Pereira Marinho/B-2212-2013; Inskip, Hazel/L-5467-2018; Persinoti, Gabriela/C-5933-2016; Silva-Rocha, Rafael/H-4929-2012; Sujii, Edison Ryoiti/H-7715-2015; Benzeval, Michaela/J-3163-2015; Apparecida Desiderio, Janete/F-5848-2012; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Dodds, Richard/D-7772-2016; Sujii, Edison/H-7715-2015	刘, 芳延/0000-0002-5155-1916; Pecl, Gretta/0000-0003-0192-4339; Bertin, Aline/0000-0003-4232-4241; van den Bosch, Frank C./0000-0003-3236-2068; Malausa, Thibaut/0000-0003-1681-7958; León, Rafael I/0000-0003-3197-4185; Botton, Marcos/0000-0002-0554-3157; Deary, Ian/0000-0002-1733-263X; Favati, Anna/0000-0002-6435-011X; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Fernandes, Odair/0000-0003-3489-4754; Aihie Sayer, Avan/0000-0003-1283-6457; Der, Geoff/0000-0002-8677-073X; Choo, Robin/0000-0002-3240-3029; Dennison, Elaine/0000-0002-3048-4961; Strugnell, Jan/0000-0003-2994-637X; Germain, Jean-Francois/0000-0001-7927-6031; Inskip, Hazel/0000-0001-8897-1749; Persinoti, Gabriela/0000-0002-0975-7283; Silva-Rocha, Rafael/0000-0001-6319-631X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Sujii, Edison Ryoiti/0000-0001-7602-8999; Benzeval, Michaela/0000-0002-0372-2098; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Apparecida Desiderio, Janete/0000-0001-7723-3070; Souza, Silvia/0000-0001-6293-7665; Semmens, Jayson/0000-0003-1742-6692; Ramos, Jorge E/0000-0002-8690-761X; Wong, Joshua/0000-0001-8268-5610; timbo, renata/0000-0003-1989-7412; Gale, Catharine/0000-0002-3361-8638; Jagger, Carol/0000-0002-6377-9926; Paveley, Neil/0000-0002-1709-4563; Leimar, Olof/0000-0001-8621-6977; Wong, Jason/0000-0002-8167-540X; Cooper, Cyrus/0000-0003-3510-0709; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Pacheco da Silva, Vitor/0000-0002-8420-1779; Gan, Victor/0000-0002-6966-2729; Tilling, Kate/0000-0002-1010-8926; R. Silva, Rogerio/0000-0002-0599-2155; Lawlor, Debbie A/0000-0002-6793-2262; Vucicevic, Katarina/0000-0001-9676-5785; Robinson, Sian/0000-0003-1766-7269; Dodds, Richard/0000-0003-4968-7678; Lye, David/0000-0003-0324-0205; Sujii, Edison/0000-0002-0702-0181; N. Silva, Roberto/0000-0002-8992-7130; De Vivo, Immaculata/0000-0002-7185-7402; Cooper, Rachel/0000-0003-3370-5720	China Scholarship Council [201204910138]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	China Scholarship Council(China Scholarship Council); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The current study was supported by China Scholarship Council (No. 201204910138, http://www.csc.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alscher RG, 1997, PHYSIOL PLANTARUM, V100, P224, DOI 10.1034/j.1399-3054.1997.1000203.x; BARRETO JC, 1994, LIFE SCI, V56, pPL89, DOI 10.1016/0024-3205(94)00925-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carol RJ, 2006, J EXP BOT, V57, P1829, DOI 10.1093/jxb/erj201; Derbyshire P, 2007, J EXP BOT, V58, P2079, DOI 10.1093/jxb/erm074; Dunand C, 2007, NEW PHYTOL, V174, P332, DOI 10.1111/j.1469-8137.2007.01995.x; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Fry SC, 2001, BIOCHEM J, V357, P729, DOI 10.1042/0264-6021:3570729; Gapper C, 2006, PLANT PHYSIOL, V141, P341, DOI 10.1104/pp.106.079079; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P315, DOI 10.1104/pp.59.2.309; GILBERT DL, 1981, OXYGEN LIVING PROCES; Hernandez JA, 2001, PLANT PHYSIOL, V127, P817, DOI 10.1104/pp.010188; Ivakov A, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00439; Ivanchenko MG, 2013, ANN BOT, DOI [10.1093/aob/mct181, DOI 10.1093/A0B/MCT181]; Johnansen DA, 1940, PLANT MICROTECHNIQUE; Kranner I, 2010, J PLANT PHYSIOL, V167, P805, DOI 10.1016/j.jplph.2010.01.019; Kukavica B, 2009, PLANT CELL PHYSIOL, V50, P304, DOI 10.1093/pcp/pcn199; Li SW, 2009, ENVIRON EXP BOT, V65, P63, DOI 10.1016/j.envexpbot.2008.06.004; Liszkay A, 2004, PLANT PHYSIOL, V136, P3114, DOI 10.1104/pp.104.044784; Liu N, 2013, J PLANT GROWTH REGUL, V32, P83, DOI 10.1007/s00344-012-9278-4; Liu N, 2010, ECOTOX ENVIRON SAFE, V73, P1238, DOI 10.1016/j.ecoenv.2010.06.017; Muller K, 2009, PLANT PHYSIOL, V150, P1855, DOI 10.1104/pp.109.139204; Perl RT., 2002, OXIDATIVE STRESS PLA, P1; Romero-Puertas MC, 2004, PLANT CELL ENVIRON, V27, P1122, DOI 10.1111/j.1365-3040.2004.01217.x; Barcelo AR, 2009, SIGNAL COMMUN PLANTS, P73, DOI 10.1007/978-3-642-00390-5_5; Schopfer P, 2006, BIOFACTORS, V28, P73, DOI 10.1002/biof.5520280202; Schopfer P, 2002, PLANTA, V214, P821, DOI 10.1007/s00425-001-0699-8; Schopfer P, 2001, PLANT PHYSIOL, V125, P1591, DOI 10.1104/pp.125.4.1591; Sugimoto-Shirasu K, 2003, CURR OPIN PLANT BIOL, V6, P544, DOI 10.1016/j.pbi.2003.09.009; Yang XF, 2001, ANALYST, V126, P928, DOI 10.1039/b100085n; ZENG S-X, 1991, Acta Phytophysiologica Sinica, V17, P177; [张玲玲 ZHANG LingLing], 2006, [生态学报, Acta Ecologica Sinica], V26, P1330, DOI 10.1016/S1872-2032(06)60025-5	32	446	498	61	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87588	10.1371/journal.pone.0087588	http://dx.doi.org/10.1371/journal.pone.0087588			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VA	24671213	Green Published, gold, Green Submitted			2022-12-27	WOS:000330631800048
J	Hobbelen, PHF; Paveley, ND; van den Bosch, F				Hobbelen, Peter H. F.; Paveley, Neil D.; van den Bosch, Frank			The Emergence of Resistance to Fungicides	PLOS ONE			English	Article							STRESS-INDUCED MUTAGENESIS; MYCOSPHAERELLA-GRAMINICOLA; PESTICIDE RESISTANCE; SPRAY HETEROGENEITY; SEPTORIA-TRITICI; SELECTION; MIXTURES; PATHOGEN; MODEL; POPULATIONS	Many studies exist about the selection phase of fungicide resistance evolution, where a resistant strain is present in a pathogen population and is differentially selected for by the application of fungicides. The emergence phase of the evolution of fungicide resistance - where the resistant strain is not present in the population and has to arise through mutation and subsequently invade the population - has not been studied to date. Here, we derive a model which describes the emergence of resistance in pathogen populations of crops. There are several important examples where a single mutation, affecting binding of a fungicide with the target protein, shifts the sensitivity phenotype of the resistant strain to such an extent that it cannot be controlled effectively('qualitative' or 'single-step' resistance). The model was parameterized for this scenario for Mycosphaerella graminicola on winter wheat and used to evaluate the effect of fungicide dose rate on the time to emergence of resistance for a range of mutation probabilities, fitness costs of resistance and sensitivity levels of the resistant strain. We also evaluated the usefulness of mixing two fungicides of differing modes of action for delaying the emergence of resistance. The results suggest that it is unlikely that a resistant strain will already have emerged when a fungicide with a new mode of action is introduced. Hence, 'anti-emergence' strategies should be identified and implemented. For all simulated scenarios, the median emergence time of a resistant strain was affected little by changing the dose rate applied, within the range of doses typically used on commercial crops. Mixing a single-site acting fungicide with a multi-site acting fungicide delayed the emergence of resistance to the single-site component. Combining the findings with previous work on the selection phase will enable us to develop more efficient anti-resistance strategies.	[Hobbelen, Peter H. F.; van den Bosch, Frank] Rothamsted Res, Harpenden, Herts, England; [Paveley, Neil D.] ADAS UK Ltd, Malton, N Yorkshire, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	van den Bosch, F (corresponding author), Rothamsted Res, Harpenden, Herts, England.	frank.vandenbosch@rothamsted.ac.uk	刘, 芳延/AAO-8535-2021; Strugnell, Jan M/P-9921-2016; Moltschaniwskyj, Natalie/AAB-7236-2019; Pecl, Gretta/D-7267-2011; Bertin, Aline/T-5005-2017; van den Bosch, Frank C./ABH-3801-2020; Malausa, Thibaut/X-1614-2018; León, Rafael I/N-6510-2014; Botton, Marcos/I-1731-2016; Deary, Ian/C-6297-2009; Aidar, Marcos Pereira Marinho/B-2212-2013; Inskip, Hazel/L-5467-2018; Persinoti, Gabriela/C-5933-2016; Silva-Rocha, Rafael/H-4929-2012; Sujii, Edison Ryoiti/H-7715-2015; Benzeval, Michaela/J-3163-2015; Apparecida Desiderio, Janete/F-5848-2012; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Dodds, Richard/D-7772-2016; Sujii, Edison/H-7715-2015	刘, 芳延/0000-0002-5155-1916; Pecl, Gretta/0000-0003-0192-4339; Bertin, Aline/0000-0003-4232-4241; van den Bosch, Frank C./0000-0003-3236-2068; Malausa, Thibaut/0000-0003-1681-7958; León, Rafael I/0000-0003-3197-4185; Botton, Marcos/0000-0002-0554-3157; Deary, Ian/0000-0002-1733-263X; Favati, Anna/0000-0002-6435-011X; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Fernandes, Odair/0000-0003-3489-4754; Aihie Sayer, Avan/0000-0003-1283-6457; Der, Geoff/0000-0002-8677-073X; Choo, Robin/0000-0002-3240-3029; Dennison, Elaine/0000-0002-3048-4961; Strugnell, Jan/0000-0003-2994-637X; Germain, Jean-Francois/0000-0001-7927-6031; Inskip, Hazel/0000-0001-8897-1749; Persinoti, Gabriela/0000-0002-0975-7283; Silva-Rocha, Rafael/0000-0001-6319-631X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Sujii, Edison Ryoiti/0000-0001-7602-8999; Benzeval, Michaela/0000-0002-0372-2098; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Apparecida Desiderio, Janete/0000-0001-7723-3070; Souza, Silvia/0000-0001-6293-7665; Semmens, Jayson/0000-0003-1742-6692; Ramos, Jorge E/0000-0002-8690-761X; Wong, Joshua/0000-0001-8268-5610; timbo, renata/0000-0003-1989-7412; Gale, Catharine/0000-0002-3361-8638; Jagger, Carol/0000-0002-6377-9926; Paveley, Neil/0000-0002-1709-4563; Leimar, Olof/0000-0001-8621-6977; Wong, Jason/0000-0002-8167-540X; Cooper, Cyrus/0000-0003-3510-0709; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Pacheco da Silva, Vitor/0000-0002-8420-1779; Gan, Victor/0000-0002-6966-2729; Tilling, Kate/0000-0002-1010-8926; R. Silva, Rogerio/0000-0002-0599-2155; Lawlor, Debbie A/0000-0002-6793-2262; Vucicevic, Katarina/0000-0001-9676-5785; Robinson, Sian/0000-0003-1766-7269; Dodds, Richard/0000-0003-4968-7678; Lye, David/0000-0003-0324-0205; Sujii, Edison/0000-0002-0702-0181; N. Silva, Roberto/0000-0002-8992-7130; De Vivo, Immaculata/0000-0002-7185-7402; Cooper, Rachel/0000-0003-3370-5720	Biological and Biotechnological Research Council of the United Kingdom; Department for Environment, Food and Rural Affairs of the United Kingdom [PS2712]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	Biological and Biotechnological Research Council of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Department for Environment, Food and Rural Affairs of the United Kingdom(Department for Environment, Food & Rural Affairs (DEFRA)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Rothamsted Research receives support from the Biological and Biotechnological Research Council of the United Kingdom. Part of this research was funded by the Department for Environment, Food and Rural Affairs of the United Kingdom (project number PS2712). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birch CPD, 1997, J APPL ECOL, V34, P1032, DOI 10.2307/2405292; Bjedov I, 2003, SCIENCE, V300, P1404, DOI 10.1126/science.1082240; Cao Y, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2159468; Carnegie SF, 2008, POTATO RES, V51, P113, DOI 10.1007/s11540-008-9094-1; DOSTER MA, 1990, PHYTOPATHOLOGY, V80, P1190, DOI 10.1094/Phyto-80-1190; Eyal Z, 1999, EUR J PLANT PATHOL, V105, P629, DOI 10.1023/A:1008716812259; Fraaije BA, 2005, PHYTOPATHOLOGY, V95, P933, DOI 10.1094/PHYTO-95-0933; Fraaije BA, 2012, MOL PLANT PATHOL, V13, P263, DOI 10.1111/j.1364-3703.2011.00746.x; Galhardo RS, 2007, CRIT REV BIOCHEM MOL, V42, P399, DOI 10.1080/10409230701648502; Genet JL, 2006, PEST MANAG SCI, V62, P188, DOI 10.1002/ps.1146; Grabski C., 1985, BRIT CROP PROT C MON, V31, P315; Grimmer M, 2011, RESISTANCE 2011, P94; Gubbins S, 1999, P ROY SOC B-BIOL SCI, V266, P2539, DOI 10.1098/rspb.1999.0957; Hall RJ, 2007, B MATH BIOL, V69, P525, DOI 10.1007/s11538-006-9139-z; Hall RJ, 2004, B MATH BIOL, V66, P825, DOI 10.1016/j.bulm.2003.11.006; HOARE FA, 1986, PLANT PATHOL, V35, P506, DOI 10.1111/j.1365-3059.1986.tb02048.x; Hobbelen PHF, 2013, PHYTOPATHOLOGY, V103, P690, DOI 10.1094/PHYTO-06-12-0142-R; Hobbelen PHF, 2011, PHYTOPATHOLOGY, V101, P1224, DOI 10.1094/PHYTO-10-10-0290; Hobbelen PHF, 2011, PLANT PATHOL, V60, P304, DOI 10.1111/j.1365-3059.2010.02380.x; Horsten JAHM, 1979, THESIS WAGENINGEN U; HUNTER T, 1987, ANN APPL BIOL, V110, P515, DOI 10.1111/j.1744-7348.1987.tb04169.x; Iwasa Y, 2004, J THEOR BIOL, V226, P205, DOI 10.1016/j.jtbi.2003.08.014; JOSEPOVITS G, 1989, CROP PROT, V8, P106, DOI 10.1016/0261-2194(89)90084-7; Kang JM, 2006, FASEB J, V20, P2476, DOI 10.1096/fj.06-6209com; LaMondia J. A., 2001, Journal of Environmental Horticulture, V19, P51; Mavroeidi VI, 2006, PLANT PATHOL, V55, P715, DOI 10.1111/j.1365-3059.2006.01441.x; McCartney C, 2007, CROP PROT, V26, P1272, DOI 10.1016/j.cropro.2006.10.027; Metcalfe RJ, 2000, PLANT PATHOL, V49, P546, DOI 10.1046/j.1365-3059.2000.00486.x; MILGROOM MG, 1990, PHYTOPATHOLOGY, V80, P410, DOI 10.1094/Phyto-80-410; Parnell S, 2006, PHYTOPATHOLOGY, V96, P549, DOI 10.1094/PHYTO-96-0549; Parnell S, 2005, PHYTOPATHOLOGY, V95, P632, DOI 10.1094/PHYTO-95-0632; Paveley ND, 2011, HGCA WHEAT DIS MANAG; Robert C, 2008, FUNCT PLANT BIOL, V35, P997, DOI 10.1071/FP08066; SANDERS PL, 1985, PLANT DIS, V69, P939; SANOAMUANG N, 1995, MYCOL RES, V99, P677, DOI 10.1016/S0953-7562(09)80527-3; Serra MC, 2007, THEOR POPUL BIOL, V72, P167, DOI 10.1016/j.tpb.2007.01.005; Serra MC, 2006, J APPL PROBAB, V43, P296, DOI 10.1239/jap/1143936262; Shaw MW, 2000, PHYTOPATHOLOGY, V90, P333, DOI 10.1094/PHYTO.2000.90.4.333; SHAW MW, 1993, CROP PROT, V12, P120, DOI 10.1016/0261-2194(93)90138-9; Tenaillon O, 2004, TRENDS MICROBIOL, V12, P264, DOI 10.1016/j.tim.2004.04.002; Thornley JHM., 1990, PLANT CROP MODELLING; Thygesen K, 2009, EUR J PLANT PATHOL, V123, P435, DOI 10.1007/s10658-008-9381-3; Turechek WW, 2004, PLANT HLTH PROG; VALI RJ, 1992, PLANT DIS, V76, P919, DOI 10.1094/PD-76-0919; van den Bosch F, 2011, PLANT PATHOL, V60, P597, DOI 10.1111/j.1365-3059.2011.02439.x; van den Bosch F, 2008, ANNU REV PHYTOPATHOL, V46, P123, DOI 10.1146/annurev.phyto.011108.135838; WAGGONER PE, 1987, PHYTOPATHOLOGY, V77, P393; Zhang CQ, 2008, ANN APPL BIOL, V153, P205, DOI 10.1111/j.1744-7348.2008.00248.x	48	446	498	61	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e91910	10.1371/journal.pone.0091910	http://dx.doi.org/10.1371/journal.pone.0091910			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24671213	Green Published, Green Submitted, gold			2022-12-27	WOS:000333355300044
J	da Silva, VCP; Bertin, A; Blin, A; Germain, JF; Bernardi, D; Rignol, G; Botton, M; Malausa, T				Pacheco da Silva, Vitor C.; Bertin, Aline; Blin, Aurelie; Germain, Jean-Francois; Bernardi, Daniel; Rignol, Guylene; Botton, Marcos; Malausa, Thibaut			Molecular and Morphological Identification of Mealybug Species (Hemiptera: Pseudococcidae) in Brazilian Vineyards	PLOS ONE			English	Article							FERRISIA FULLAWAY HEMIPTERA; SCALE INSECTS HEMIPTERA; EXPORT GRAPE PRODUCTION; MULTIPLEX PCR; PEST; PHYLOGENY; MARKERS	Mealybugs (Hemiptera: Pseudococcidae) are pests constraining the international trade of Brazilian table grapes. They damage grapes by transmitting viruses and toxins, causing defoliation, chlorosis, and vigor losses and favoring the development of sooty mold. Difficulties in mealybug identification remain an obstacle to the adequate management of these pests. In this study, our primary aim was to identify the principal mealybug species infesting the major table grape-producing regions in Brazil, by morphological and molecular characterization. Our secondary aim was to develop a rapid identification kit based on species-specific Polymerase Chain Reactions, to facilitate the routine identification of the most common pest species. We surveyed 40 sites infested with mealybugs and identified 17 species: Dysmicoccus brevipes (Cockerell), Dysmicoccus sylvarum Williams and Granara de Willink, Dysmicoccus texensis (Tinsley), Ferrisia cristinae Kaydan and Gullan, Ferrisia meridionalis Williams, Ferrisia terani Williams and Granara de Willink, Phenacoccus baccharidis Williams, Phenacoccus parvus Morrison, Phenacoccus solenopsis Tinsley, Planococcus citri (Risso), Pseudococcus viburni (Signoret), Pseudococcus cryptus Hempel, four taxa closely related each of to Pseudococcus viburni, Pseudococcus sociabilis Hambleton, Pseudococcus maritimus (Ehrhorn) and Pseudococcus meridionalis Prado, and one specimen from the genus Pseudococcus Westwood. The PCR method developed effectively identified five mealybug species of economic interest on grape in Brazil: D. brevipes, Pl. citri, Ps. viburni, Ph. solenopsis and Planococcus ficus (Signoret). Nevertheless, it is not possible to assure that this procedure is reliable for taxa that have not been sampled already and might be very closely related to the target species.	[Pacheco da Silva, Vitor C.; Botton, Marcos] Embrapa Uva & Vinho, Bento Goncalves, Brazil; [Bertin, Aline; Bernardi, Daniel] Univ Sao Paulo, Escola Super Agr Luiz de Queiroz, Piracicaba, Brazil; [Blin, Aurelie; Rignol, Guylene; Malausa, Thibaut] INRA, Inst Sophia Agrobiotech, UMR INRA UNSA CNRS, F-06903 Sophia Antipolis, France; [Germain, Jean-Francois] ANSES, Lab Sante Vegetaux, Unite Entomol & Plantes Invas, Montferrier Sur Lez, France	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Sao Paulo; INRAE; UDICE-French Research Universities; Universite Cote d'Azur; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de la Sante des Vegetaux	Malausa, T (corresponding author), INRA, Inst Sophia Agrobiotech, UMR INRA UNSA CNRS, BP 167, F-06903 Sophia Antipolis, France.	tmalausa@sophia.inra.fr	刘, 芳延/AAO-8535-2021; Strugnell, Jan M/P-9921-2016; Moltschaniwskyj, Natalie/AAB-7236-2019; Pecl, Gretta/D-7267-2011; Bertin, Aline/T-5005-2017; van den Bosch, Frank C./ABH-3801-2020; Malausa, Thibaut/X-1614-2018; León, Rafael I/N-6510-2014; Botton, Marcos/I-1731-2016; Deary, Ian/C-6297-2009; Aidar, Marcos Pereira Marinho/B-2212-2013; Inskip, Hazel/L-5467-2018; Persinoti, Gabriela/C-5933-2016; Silva-Rocha, Rafael/H-4929-2012; Sujii, Edison Ryoiti/H-7715-2015; Benzeval, Michaela/J-3163-2015; Apparecida Desiderio, Janete/F-5848-2012; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Dodds, Richard/D-7772-2016; Sujii, Edison/H-7715-2015	刘, 芳延/0000-0002-5155-1916; Pecl, Gretta/0000-0003-0192-4339; Bertin, Aline/0000-0003-4232-4241; van den Bosch, Frank C./0000-0003-3236-2068; Malausa, Thibaut/0000-0003-1681-7958; León, Rafael I/0000-0003-3197-4185; Botton, Marcos/0000-0002-0554-3157; Deary, Ian/0000-0002-1733-263X; Favati, Anna/0000-0002-6435-011X; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Fernandes, Odair/0000-0003-3489-4754; Aihie Sayer, Avan/0000-0003-1283-6457; Der, Geoff/0000-0002-8677-073X; Choo, Robin/0000-0002-3240-3029; Dennison, Elaine/0000-0002-3048-4961; Strugnell, Jan/0000-0003-2994-637X; Germain, Jean-Francois/0000-0001-7927-6031; Inskip, Hazel/0000-0001-8897-1749; Persinoti, Gabriela/0000-0002-0975-7283; Silva-Rocha, Rafael/0000-0001-6319-631X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Sujii, Edison Ryoiti/0000-0001-7602-8999; Benzeval, Michaela/0000-0002-0372-2098; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Apparecida Desiderio, Janete/0000-0001-7723-3070; Souza, Silvia/0000-0001-6293-7665; Semmens, Jayson/0000-0003-1742-6692; Ramos, Jorge E/0000-0002-8690-761X; Wong, Joshua/0000-0001-8268-5610; timbo, renata/0000-0003-1989-7412; Gale, Catharine/0000-0002-3361-8638; Jagger, Carol/0000-0002-6377-9926; Paveley, Neil/0000-0002-1709-4563; Leimar, Olof/0000-0001-8621-6977; Wong, Jason/0000-0002-8167-540X; Cooper, Cyrus/0000-0003-3510-0709; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Pacheco da Silva, Vitor/0000-0002-8420-1779; Gan, Victor/0000-0002-6966-2729; Tilling, Kate/0000-0002-1010-8926; R. Silva, Rogerio/0000-0002-0599-2155; Lawlor, Debbie A/0000-0002-6793-2262; Vucicevic, Katarina/0000-0001-9676-5785; Robinson, Sian/0000-0003-1766-7269; Dodds, Richard/0000-0003-4968-7678; Lye, David/0000-0003-0324-0205; Sujii, Edison/0000-0002-0702-0181; N. Silva, Roberto/0000-0002-8992-7130; De Vivo, Immaculata/0000-0002-7185-7402; Cooper, Rachel/0000-0003-3370-5720	European Union [265865, 269196, 324475]; French grants Agropolis Fondation (RTRA - Montpellier, BIOFIS) [1001001]; Bibliotheque du Vivant; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	European Union(European Commission); French grants Agropolis Fondation (RTRA - Montpellier, BIOFIS); Bibliotheque du Vivant; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the European Union Seventh Framework Programme FP7-KBBE #265865 "PURE'', FP7-IRSES #269196 "IPRABIO'' and FP7-IAPP #324475 "COLBICS'' and by the French grants Agropolis Fondation (http://www.agropolis-fondation.fr/) (RTRA - Montpellier, BIOFIS project number 1001001) and 'Bibliotheque du Vivant'. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-Rabou S, 2012, B ENTOMOL RES, V102, P515, DOI 10.1017/S0007485312000041; Beltra A, 2012, B ENTOMOL RES, V102, P165, DOI 10.1017/S0007485311000514; Ben-Dov Y, 2012, SCALENET DATABASE SC; Bertin S, 2010, PHYTOPARASITICA, V38, P401, DOI 10.1007/s12600-010-0109-5; Beuning LL, 1999, J ECON ENTOMOL, V92, P463, DOI 10.1093/jee/92.2.463; Camargo UA, 2011, REV BRAS FRUTIC, V33, P144, DOI 10.1590/S0100-29452011000500017; Cavalieri V, 2008, ZOOTAXA, P65, DOI 10.11646/zootaxa.1816.1.6; Charles J. G., 2006, New Zealand Plant Protection, V59, P330; Charles JG, 2011, BIOCONTROL, V56, P155, DOI 10.1007/s10526-010-9322-x; Correa L. R. B., 2005, Laranja, V26, P265; Correa MCG, 2012, B ENTOMOL RES, V102, P524, DOI 10.1017/S0007485312000053; Correa M, 2011, ZOOTAXA, P46, DOI 10.11646/zootaxa.2926.1.2; Santa-Cecilia LVC, 2009, ACTA SCI-AGRON, V31, P13, DOI 10.4025/actasciagron.v31i1.6603; Culik Mark Paul, 2007, Biota Neotrop., V7, P61, DOI 10.1590/S1676-06032007000300006; Culik MP, 2005, ZOOTAXA, P1; Daane KM, 2008, CALIF AGR, V62, P167, DOI 10.3733/ca.v062n04p167; Daane Kent M., 2012, P271; Daane KM, 2011, ENVIRON ENTOMOL, V40, P1595, DOI 10.1603/EN11075; Granara De Willink María Cristina, 2007, Rev. Soc. Entomol. Argent., V66, P29; Demontis MA, 2007, J APPL ENTOMOL, V131, P59, DOI 10.1111/j.1439-0418.2006.01126.x; Foldi Imre, 2005, Nouvelle Revue d'Entomologie, V22, P305; GARAU R, 1995, VITIS, V34, P67; Gimpel William F. Jr, 1996, Contributions on Entomology International, V2, P1; Golino D. A., 2002, California Agriculture, V56, P196, DOI 10.3733/ca.v056n06p196; Gonzalez R. H., 2004, Revista Fruticola, V25, P41; Gullan PJ, 2010, SYST ENTOMOL, V35, P329, DOI 10.1111/j.1365-3113.2009.00513.x; Gullan PJ, 2003, ANN ENTOMOL SOC AM, V96, P723, DOI 10.1603/0013-8746(2003)096[0723:ANPSOT]2.0.CO;2; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Kaydan MB, 2012, ZOOTAXA, P1; Kuniyuki Hugo, 2006, Summa phytopathol., V32, P151, DOI 10.1590/S0100-54052006000200009; Malausa T, 2011, J APPL ENTOMOL, V135, P142, DOI 10.1111/j.1439-0418.2009.01495.x; Martelli G P, 2002, Arch Virol, V147, P2039, DOI 10.1007/s007050200048; Mello LMR, 2013, VITICULTURA BRASILEI; Miller DR, 2002, P ENTOMOL SOC WASH, V104, P825; Morandi Filho WJ, 2008, ARQ I BIOL-SAO PAULO, V76, P427; Morse GE, 2006, SYST ENTOMOL, V31, P338, DOI 10.1111/j.1365-3113.2005.00316.x; Park DS, 2011, B ENTOMOL RES, V101, P429, DOI 10.1017/S0007485310000714; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Saccaggi DL, 2008, B ENTOMOL RES, V98, P27, DOI 10.1017/S000748530700538X; SANTA-CECÍLIA LENIRA V.C., 2002, Neotrop. entomol., V31, P333, DOI 10.1590/S1519-566X2002000200024; Selwyn B, 2007, J AGRAR CHANGE, V7, P526, DOI 10.1111/j.1471-0366.2007.00155.x; Selwyn B, 2010, J AGRAR CHANGE, V10, P537, DOI 10.1111/j.1471-0366.2009.00245.x; Souza B., 2008, Coffee Science, V3, P104; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Villard P, 2013, MOL ECOL RESOUR, V13, P755, DOI 10.1111/1755-0998.12116; Walton V. M., 2004, South African Journal of Enology and Viticulture, V25, P54; Walton VM, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.4701; Willians DJ, 1992, MEALYBUGS CENTRAL S; Yokogawa T, 2009, GENES GENET SYST, V84, P57, DOI 10.1266/ggs.84.57	50	446	498	61	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2014	9	7							e103267	10.1371/journal.pone.0103267	http://dx.doi.org/10.1371/journal.pone.0103267			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RP	24671213	Green Submitted, Green Published, gold			2022-12-27	WOS:000339992600050
J	Ramos, JE; Pecl, GT; Moltschaniwskyj, NA; Strugnell, JM; Leon, RI; Semmens, JM				Ramos, Jorge E.; Pecl, Gretta T.; Moltschaniwskyj, Natalie A.; Strugnell, Jan M.; Leon, Rafael I.; Semmens, Jayson M.			Body Size, Growth and Life Span: Implications for the Polewards Range Shift of Octopus tetricus in South-Eastern Australia	PLOS ONE			English	Article							CLIMATE-CHANGE; COMMON OCTOPUS; REPRODUCTIVE-CYCLE; UPWELLING SYSTEM; VULGARIS; SQUID; EVOLUTIONARY; ECOLOGY; AGE; TEMPERATURE	Understanding the response of any species to climate change can be challenging. However, in short-lived species the faster turnover of generations may facilitate the examination of responses associated with longer-term environmental change. Octopus tetricus, a commercially important species, has undergone a recent polewards range shift in the coastal waters of south-eastern Australia, thought to be associated with the southerly extension of the warm East Australian Current. At the cooler temperatures of a polewards distribution limit, growth of a species could be slower, potentially leading to a bigger body size and resulting in a slower population turnover, affecting population viability at the extreme of the distribution. Growth rates, body size, and life span of O. tetricus were examined at the leading edge of a polewards range shift in Tasmanian waters (40 degrees S and 147 degrees E) throughout 2011. Octopus tetricus had a relatively small body size and short lifespan of approximately 11 months that, despite cooler temperatures, would allow a high rate of population turnover and may facilitate the population increase necessary for successful establishment in the new extended area of the range. Temperature, food availability and gender appear to influence growth rate. Individuals that hatched during cooler and more productive conditions, but grew during warming conditions, exhibited faster growth rates and reached smaller body sizes than individuals that hatched into warmer waters but grew during cooling conditions. This study suggests that fast growth, small body size and associated rapid population turnover may facilitate the range shift of O. tetricus into Tasmanian waters.	[Ramos, Jorge E.; Pecl, Gretta T.; Leon, Rafael I.; Semmens, Jayson M.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Moltschaniwskyj, Natalie A.] Univ Newcastle, Sch Environm & Life Sci, Ourimbah, NSW, Australia; [Strugnell, Jan M.] La Trobe Univ, Dept Genet, La Trobe Inst Mol Sci, Bundoora, Vic, Australia	University of Tasmania; University of Newcastle; La Trobe University	Ramos, JE (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia.	jeramos@utas.edu.au	刘, 芳延/AAO-8535-2021; Strugnell, Jan M/P-9921-2016; Moltschaniwskyj, Natalie/AAB-7236-2019; Pecl, Gretta/D-7267-2011; Bertin, Aline/T-5005-2017; van den Bosch, Frank C./ABH-3801-2020; Malausa, Thibaut/X-1614-2018; León, Rafael I/N-6510-2014; Botton, Marcos/I-1731-2016; Deary, Ian/C-6297-2009; Aidar, Marcos Pereira Marinho/B-2212-2013; Inskip, Hazel/L-5467-2018; Persinoti, Gabriela/C-5933-2016; Silva-Rocha, Rafael/H-4929-2012; Sujii, Edison Ryoiti/H-7715-2015; Benzeval, Michaela/J-3163-2015; Apparecida Desiderio, Janete/F-5848-2012; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Dodds, Richard/D-7772-2016; Sujii, Edison/H-7715-2015	刘, 芳延/0000-0002-5155-1916; Pecl, Gretta/0000-0003-0192-4339; Bertin, Aline/0000-0003-4232-4241; van den Bosch, Frank C./0000-0003-3236-2068; Malausa, Thibaut/0000-0003-1681-7958; León, Rafael I/0000-0003-3197-4185; Botton, Marcos/0000-0002-0554-3157; Deary, Ian/0000-0002-1733-263X; Favati, Anna/0000-0002-6435-011X; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Fernandes, Odair/0000-0003-3489-4754; Aihie Sayer, Avan/0000-0003-1283-6457; Der, Geoff/0000-0002-8677-073X; Choo, Robin/0000-0002-3240-3029; Dennison, Elaine/0000-0002-3048-4961; Strugnell, Jan/0000-0003-2994-637X; Germain, Jean-Francois/0000-0001-7927-6031; Inskip, Hazel/0000-0001-8897-1749; Persinoti, Gabriela/0000-0002-0975-7283; Silva-Rocha, Rafael/0000-0001-6319-631X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Sujii, Edison Ryoiti/0000-0001-7602-8999; Benzeval, Michaela/0000-0002-0372-2098; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Apparecida Desiderio, Janete/0000-0001-7723-3070; Souza, Silvia/0000-0001-6293-7665; Semmens, Jayson/0000-0003-1742-6692; Ramos, Jorge E/0000-0002-8690-761X; Wong, Joshua/0000-0001-8268-5610; timbo, renata/0000-0003-1989-7412; Gale, Catharine/0000-0002-3361-8638; Jagger, Carol/0000-0002-6377-9926; Paveley, Neil/0000-0002-1709-4563; Leimar, Olof/0000-0001-8621-6977; Wong, Jason/0000-0002-8167-540X; Cooper, Cyrus/0000-0003-3510-0709; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Pacheco da Silva, Vitor/0000-0002-8420-1779; Gan, Victor/0000-0002-6966-2729; Tilling, Kate/0000-0002-1010-8926; R. Silva, Rogerio/0000-0002-0599-2155; Lawlor, Debbie A/0000-0002-6793-2262; Vucicevic, Katarina/0000-0001-9676-5785; Robinson, Sian/0000-0003-1766-7269; Dodds, Richard/0000-0003-4968-7678; Lye, David/0000-0003-0324-0205; Sujii, Edison/0000-0002-0702-0181; N. Silva, Roberto/0000-0002-8992-7130; De Vivo, Immaculata/0000-0002-7185-7402; Cooper, Rachel/0000-0003-3370-5720	Consejo Nacional de Ciencia y Tecnologia of Mexico [308672]; University of Tasmania; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	Consejo Nacional de Ciencia y Tecnologia of Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); University of Tasmania; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	J. Ramos was awarded the scholarship 308672 by Consejo Nacional de Ciencia y Tecnologia of Mexico, a Tasmania Graduate Research scholarship from the University of Tasmania and a Bookend Lynchpin Ocean Scholarship 2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Amundsen PA, 2012, BIOL INVASIONS, V14, P1501, DOI 10.1007/s10530-012-0175-3; Anderson RC, 2008, MAR ECOL PROG SER, V371, P199, DOI 10.3354/meps07649; Arenas M, 2012, MOL BIOL EVOL, V29, P207, DOI 10.1093/molbev/msr187; Arkhipkin AI, 2005, MAR FRESHWATER RES, V56, P371, DOI 10.1071/MF04274; Barratt IM, 2010, ICES J MAR SCI, V67, P1452, DOI 10.1093/icesjms/fsq047; Berteaux D, 2004, INTEGR COMP BIOL, V44, P140, DOI 10.1093/icb/44.2.140; Blois JL, 2013, SCIENCE, V341, P499, DOI 10.1126/science.1237184; Calosi P, 2013, INTEGR COMP BIOL, V53, P660, DOI 10.1093/icb/ict041; Calosi P, 2010, J ANIM ECOL, V79, P194, DOI 10.1111/j.1365-2656.2009.01611.x; Canali E, 2011, MAR ECOL PROG SER, V441, P141, DOI 10.3354/meps09399; Carrasco JF, 2006, AQUAC RES, V37, P1601, DOI 10.1111/j.1365-2109.2006.01594.x; CHEN Y, 1992, CAN J FISH AQUAT SCI, V49, P1228, DOI 10.1139/f92-138; Clarke MR, 1996, PHILOS T ROY SOC B, V351, P1105, DOI 10.1098/rstb.1996.0096; Colautti RI, 2006, BIOL INVASIONS, V8, P1023, DOI 10.1007/s10530-005-3735-y; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Dia M.A., 1988, THESIS U W BRITTANY THESIS U W BRITTANY; Domain F, 2000, J MAR BIOL ASSOC UK, V80, P699, DOI 10.1017/S0025315400002526; Doubleday Z, 2006, J EXP MAR BIOL ECOL, V338, P35, DOI 10.1016/j.jembe.2006.06.027; Edgar G, 2000, AUSTR MARINE LIFE PL; Engel Katharina, 2011, Communicative & Integrative Biology, V4, P247, DOI 10.4161/cib.4.3.14885; Forsythe J.W., 1987, P135; FORSYTHE JW, 1988, MAR BIOL, V98, P369, DOI 10.1007/BF00391113; Forsythe JW, 2004, MAR FRESHWATER RES, V55, P331, DOI 10.1071/MF03146; Fox J., 2019, R COMPANION APPL REG, V.; Fulton EA, 2011, ICES J MAR SCI, V68, P1329, DOI 10.1093/icesjms/fsr032; Guzik MT, 2005, MOL PHYLOGENET EVOL, V37, P235, DOI 10.1016/j.ympev.2005.05.009; Hanlon RT, 1996, CEPHALOPOD BEHAV; Harrington JJ, 2006, FISH RES, V77, P10, DOI 10.1016/j.fishres.2005.09.003; Hermosilla CA, 2010, ICES J MAR SCI, V67, P1458, DOI 10.1093/icesjms/fsq054; Herwig JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043679; Hill KL, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032912; Hoffmann AA, 2008, NAT REV GENET, V9, P421, DOI 10.1038/nrg2339; Holt RD, 2003, EVOL ECOL RES, V5, P159; Hoving HJT, 2013, GLOBAL CHANGE BIOL, V19, P2089, DOI 10.1111/gcb.12198; Jackson GD, 2004, MAR FRESHWATER RES, V55, P357, DOI 10.1071/MF03152; Jackson GD, 2003, MAR BIOL, V142, P925, DOI 10.1007/s00227-002-1005-4; Jackson GD, 2001, MAR ECOL PROG SER, V218, P167, DOI 10.3354/meps218167; Johnson CR, 2011, J EXP MAR BIOL ECOL, V400, P17, DOI 10.1016/j.jembe.2011.02.032; Katsanevakis S, 2006, ICES J MAR SCI, V63, P151, DOI 10.1016/j.icesjms.2005.07.004; Last PR, 2011, GLOBAL ECOL BIOGEOGR, V20, P58, DOI 10.1111/j.1466-8238.2010.00575.x; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Leporati SC, 2008, MAR ECOL PROG SER, V367, P213, DOI 10.3354/meps07558; Leporati SC, 2008, MAR BIOL, V155, P375, DOI 10.1007/s00227-008-1033-9; Leporati SC, 2007, MAR BIOL, V151, P1375, DOI 10.1007/s00227-006-0575-y; Lourenco S, 2012, FISH RES, V127, P116, DOI 10.1016/j.fishres.2012.04.006; Mangold K., 1983, P335; Mangold K., 1987, P157; Mather JA, 2012, CURR ZOOL, V58, P597, DOI 10.1093/czoolo/58.4.597; McMahon RF, 2002, CAN J FISH AQUAT SCI, V59, P1235, DOI 10.1139/F02-105; Moreno A, 2012, J MAR BIOL ASSOC UK, V92, P1619, DOI 10.1017/S0025315411002141; Norman M.D., 2000, GUIDE SQUID CUTTLEFI; Okei N, 1999, STOCK ENHANCEMENT AND SEA RANCHING, P468; Oosthuizen A, 2003, J MAR BIOL ASSOC UK, V83, P535, DOI 10.1017/S0025315403007458h; Otero J, 2008, MAR ECOL PROG SER, V362, P181, DOI 10.3354/meps07437; Otero J, 2007, FISH RES, V85, P122, DOI 10.1016/j.fishres.2007.01.007; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pecl GT, 2008, REV FISH BIOL FISHER, V18, P373, DOI 10.1007/s11160-007-9077-3; Pecl GT, 2004, MAR FRESHWATER RES, V55, P387, DOI 10.1071/MF03153; Pinsky ML, 2013, SCIENCE, V341, P1239, DOI 10.1126/science.1239352; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Poloczanska ES, 2007, OCEANOGR MAR BIOL, V45, P407; Poloczanska ES, 2013, NAT CLIM CHANGE, V3, P919, DOI [10.1038/nclimate1958, 10.1038/NCLIMATE1958]; R Core Team, 2021, R LANGUAGE ENV STAT; Ridgway KR, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030392; Ridgway KR, 2003, PROG OCEANOGR, V56, P189, DOI 10.1016/S0079-6611(03)00004-1; Rosa R, 2008, P NATL ACAD SCI USA, V105, P20776, DOI 10.1073/pnas.0806886105; Rosas C, 2008, AQUACULTURE, V275, P291, DOI 10.1016/j.aquaculture.2008.01.015; Sandery PA, 2007, ESTUAR COAST SHELF S, V74, P684, DOI 10.1016/j.ecss.2007.05.011; Scandol J, 2008, STATUS FISHERIES RES, P193; Schwarz R, 2010, FISH RES, V106, P177, DOI 10.1016/j.fishres.2010.06.008; Semmens J, 2011, J EXP BIOL, V214, P2799, DOI 10.1242/jeb.051631; Semmens JM, 2004, MAR FRESHWATER RES, V55, P367, DOI 10.1071/MF03155; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; Spiess A, 2013, QPCR MODELLING ANAL; Sunday JM, 2012, NAT CLIM CHANGE, V2, P686, DOI 10.1038/NCLIMATE1539; Tasmania Wild Fisheries Management Branch Tasmania Department of Primary Industries and Water, 2009, SACL FISH MAN PLAN R; Travis JMJ, 2013, OIKOS, V122, P1532, DOI 10.1111/j.1600-0706.2013.00399.x; Villanueva R, 1995, CAN J FISH AQUAT SCI, V52, P2639, DOI 10.1139/f95-853; VILLANUEVA R, 1992, J EXP MAR BIOL ECOL, V159, P157, DOI 10.1016/0022-0981(92)90034-8; Villanueva R, 2008, OCEANOGR MAR BIOL, V46, P105; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; Ware DM, 2005, SCIENCE, V308, P1280, DOI 10.1126/science.1109049; Wolf BM, 1997, J SHELLFISH RES, V16, P533	85	446	498	61	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103480	10.1371/journal.pone.0103480	http://dx.doi.org/10.1371/journal.pone.0103480			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	24671213	Green Accepted, Green Published, gold			2022-12-27	WOS:000339812700029
J	Wu, KL; Zeng, SJ; Lin, DI; da Silva, JAT; Bu, ZY; Zhang, JX; Duan, J				Wu, Kunlin; Zeng, Songjun; Lin, Danni; da Silva, Jaime A. Teixeira; Bu, Zhaoyang; Zhang, Jianxia; Duan, Ju			In Vitro Propagation and Reintroduction of the Endangered Renanthera imschootiana Rolfe	PLOS ONE			English	Article							ASYMBIOTIC SEED-GERMINATION; CALCIUM HYPOCHLORITE; ESTABLISHMENT; REGENERATION; GROWTH; ORCHID	Renanthera imschootiana Rolfe is an endangered tropical epiphytic orchid that is threatened with extinction due to over-collection and the loss of suitable habitats. In vitro propagation is a useful way to mass produce plants for re-establishment in the wild and for commercial propagation. Seeds collected 150 days after pollination (DAP) were the optimum stage for in vitro culture. Seed germination reached 93.1% on quarter-strength MS (i.e., MS containing a quarter of macro-and micronutrients) medium containing 0.5 mg l(-1) a-naphthaleneacetic acid (NAA), 20% coconut water (CW), 1.0 g l(-1) peptone, 10 g l(-1) sucrose and 1.0 g l(-1) activated charcoal (AC). Quarter-strength MS medium supplemented with 1.0 mg l(-1) BA, 0.5 mg l(-1) NAA, 1.0 g l(-1) peptone, 10 g l(-1) sucrose and 20% CW was suitable for the sub-culture of protocorm-like bodies (PLBs) in which the PLB proliferation ratio was 2.88. Quarter-strength MS medium containing 1.0 mg l(-1) NAA, 1.0 g l(-1) peptone, 100 g l(-1) banana homogenate (BH), and 1.0 g l(-1) AC was suitable for plantlet formation and 95.67% of plantlets developed from PLBs within 60 days of culture. Hyponex N016 medium supplemented with 0.5 mg l(-1) NAA, 1.0 g l(-1) peptone, 20 g l(-1) sucrose, 150 g l(-1) BH, and 1.0 g l(-1) AC was suitable for the in vitro growth of plantlets about 2-cm in height. Plantlets 3-cm in height or taller were transplanted to Chilean sphagnum moss, and 95% of plantlets survived after 60 days in a greenhouse. Three hundred transplanted of seedlings 360-days old were reintroduced into three natural habitats. Highest percentage survival (79.67%) was observed in Yuanjiang Nature Reserve two years after reintroduction, followed by Huolu Mountain forest park (71.33%). This protocol is an efficient means for the large-scale propagation and in vitro and in vivo germplasm conservation of R. imschootiana.	[Wu, Kunlin; Zeng, Songjun; Lin, Danni; Zhang, Jianxia] Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China; [Duan, Ju] Chinese Acad Sci, South China Bot Garden, Key Lab S China Agr Plant Mol Anal & Gene Improve, Guangzhou, Guangdong, Peoples R China; [da Silva, Jaime A. Teixeira] Kagawa Ken, Takamatsu, Kagawa, Japan; [Bu, Zhaoyang] Guangxi Acad Agr Sci, Flower Res Inst, Nanning 150931, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; South China Botanical Garden, CAS; Guangxi Academy of Agricultural Sciences	Zeng, SJ (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China.	zengsongjun@scib.ac.cn; yangnv@126.com	刘, 芳延/AAO-8535-2021; Strugnell, Jan M/P-9921-2016; Moltschaniwskyj, Natalie/AAB-7236-2019; Pecl, Gretta/D-7267-2011; Bertin, Aline/T-5005-2017; van den Bosch, Frank C./ABH-3801-2020; Malausa, Thibaut/X-1614-2018; León, Rafael I/N-6510-2014; Botton, Marcos/I-1731-2016; Deary, Ian/C-6297-2009; Aidar, Marcos Pereira Marinho/B-2212-2013; Inskip, Hazel/L-5467-2018; Persinoti, Gabriela/C-5933-2016; Silva-Rocha, Rafael/H-4929-2012; Sujii, Edison Ryoiti/H-7715-2015; Benzeval, Michaela/J-3163-2015; Apparecida Desiderio, Janete/F-5848-2012; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Dodds, Richard/D-7772-2016; Sujii, Edison/H-7715-2015	刘, 芳延/0000-0002-5155-1916; Pecl, Gretta/0000-0003-0192-4339; Bertin, Aline/0000-0003-4232-4241; van den Bosch, Frank C./0000-0003-3236-2068; Malausa, Thibaut/0000-0003-1681-7958; León, Rafael I/0000-0003-3197-4185; Botton, Marcos/0000-0002-0554-3157; Deary, Ian/0000-0002-1733-263X; Favati, Anna/0000-0002-6435-011X; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Fernandes, Odair/0000-0003-3489-4754; Aihie Sayer, Avan/0000-0003-1283-6457; Der, Geoff/0000-0002-8677-073X; Choo, Robin/0000-0002-3240-3029; Dennison, Elaine/0000-0002-3048-4961; Strugnell, Jan/0000-0003-2994-637X; Germain, Jean-Francois/0000-0001-7927-6031; Inskip, Hazel/0000-0001-8897-1749; Persinoti, Gabriela/0000-0002-0975-7283; Silva-Rocha, Rafael/0000-0001-6319-631X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Sujii, Edison Ryoiti/0000-0001-7602-8999; Benzeval, Michaela/0000-0002-0372-2098; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Apparecida Desiderio, Janete/0000-0001-7723-3070; Souza, Silvia/0000-0001-6293-7665; Semmens, Jayson/0000-0003-1742-6692; Ramos, Jorge E/0000-0002-8690-761X; Wong, Joshua/0000-0001-8268-5610; timbo, renata/0000-0003-1989-7412; Gale, Catharine/0000-0002-3361-8638; Jagger, Carol/0000-0002-6377-9926; Paveley, Neil/0000-0002-1709-4563; Leimar, Olof/0000-0001-8621-6977; Wong, Jason/0000-0002-8167-540X; Cooper, Cyrus/0000-0003-3510-0709; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Pacheco da Silva, Vitor/0000-0002-8420-1779; Gan, Victor/0000-0002-6966-2729; Tilling, Kate/0000-0002-1010-8926; R. Silva, Rogerio/0000-0002-0599-2155; Lawlor, Debbie A/0000-0002-6793-2262; Vucicevic, Katarina/0000-0001-9676-5785; Robinson, Sian/0000-0003-1766-7269; Dodds, Richard/0000-0003-4968-7678; Lye, David/0000-0003-0324-0205; Sujii, Edison/0000-0002-0702-0181; N. Silva, Roberto/0000-0002-8992-7130; De Vivo, Immaculata/0000-0002-7185-7402; Cooper, Rachel/0000-0003-3370-5720	Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences [211026]; Guangzhou Key Technology Research and Development Program [Y233051001]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences; Guangzhou Key Technology Research and Development Program; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported by a fund of the Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences (No. 211026), and the Guangzhou Key Technology Research and Development Program (Y233051001). Songjun Zeng received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akeroyd J., 1995, HDB BOT GARDENS REIN; [Anonymous], 2014, WORLD CHECKLIST SELE; Arditti J., 1993, MICROPROPAGATION ORC; Arditti J, 1982, ORCHID BIOL REV PERS, P352; Chu Chin-Chang, 1994, Lindleyana, V9, P153; Chugh S, 2009, SCI HORTIC-AMSTERDAM, V122, P507, DOI 10.1016/j.scienta.2009.07.016; da Silva JAT, 2006, PLANT CELL TISS ORG, V84, P135, DOI 10.1007/s11240-005-9003-0; da Silva JAT, 2005, PROPAG ORNAM PLANTS, V5, P129; DASILVA JAT, 2012, ASIAN AUSTRALASIAN J, V6, P121; DeMarie E., 1991, HORTSCIENCE, V26, P272; Dix L., 1982, PLANT CELL TISSUE OR, V12, P39; Ernst R., 1975, American Orchid Society Bulletin, V44, P12; Ernst R., 1974, American Orchid Society Bulletin, V43, P35; Goh C. J., 1982, Orchid Review, V90, P295; GOH CJ, 1990, SCI HORTIC-AMSTERDAM, V44, P315, DOI 10.1016/0304-4238(90)90132-X; HARVAIS G, 1973, CAN J BOT, V51, P327, DOI 10.1139/b73-040; Hossain MM, 2013, CRIT REV PLANT SCI, V32, P69, DOI 10.1080/07352689.2012.715984; Kauth P.J., 2008, FLORICULTURE ORNAMEN, P375; Kishor R, 2009, EUPHYTICA, V165, P247, DOI 10.1007/s10681-008-9755-9; Knudson Lewis, 1946, AMER ORCHID SOC BULL, V15, P214; Lee YI, 2006, ANN BOT-LONDON, V98, P1311, DOI 10.1093/aob/mcl222; Lin DL, 2008, J FOOD DRUG ANAL, V16, P1; Lo SF, 2004, IN VITRO CELL DEV-PL, V40, P528, DOI 10.1079/IVP2004571; McNaughton S.J., 1989, P109; Miyoshi K, 1998, PHYSIOL PLANTARUM, V102, P481, DOI 10.1034/j.1399-3054.1998.1020401.x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Mweetwa AM, 2008, SCI HORTIC-AMSTERDAM, V117, P257, DOI 10.1016/j.scienta.2008.03.035; NAGASHIMA T, 1982, J JPN SOC HORTIC SCI, V51, P94, DOI 10.2503/jjshs.51.94; PIERIK RLM, 1988, SCI HORTIC-AMSTERDAM, V34, P139, DOI 10.1016/0304-4238(88)90084-2; Raghavan V., 1977, CRC HDB SERIES NUTR, P361; Ren H, 2012, ORYX, V46, P391, DOI 10.1017/S0030605311000615; Rout TM, 2009, ECOL APPL, V19, P515, DOI 10.1890/07-1989.1; SEENI S, 1992, PLANT CELL TISS ORG, V29, P167, DOI 10.1007/BF00034349; Seeni S, 2000, PLANT CELL TISS ORG, V61, P1, DOI 10.1023/A:1006444614657; Teixeira da Silva J., 2013, FLORIC ORNAM BIOTECH, V7, P1, DOI DOI 10.1016/0168-1656(90)90117-T; Thomale H., 1954, ORCHIDEEN, P62; Thomas TD, 2008, BIOTECHNOL ADV, V26, P618, DOI 10.1016/j.biotechadv.2008.08.003; Tsi Z. H., 1999, FLORA REIPUBLICAE PO, V19, P291; VACIN EF, 1949, BOT GAZ, V110, P605, DOI 10.1086/335561; van der Kinderen G., 1987, LINDLEYANA, V2, P84; VANWAES JM, 1986, PHYSIOL PLANTARUM, V66, P435, DOI 10.1111/j.1399-3054.1986.tb05947.x; Vyas S, 2009, SCI HORTIC-AMSTERDAM, V121, P32, DOI 10.1016/j.scienta.2009.01.012; Wu KL, 2012, SCI HORTIC-AMSTERDAM, V135, P194, DOI 10.1016/j.scienta.2011.11.028; Wu KunLin, 2010, Acta Horticulturae Sinica, V37, P685; Wu Z.Y., 2009, FLORA CHINA, V25; YAM T W, 1990, Lindleyana, V5, P256; Yong JWH, 2009, MOLECULES, V14, P5144, DOI 10.3390/molecules14125144; Zeng SJ, 2015, CRIT REV BIOTECHNOL, V35, P279; Zeng SJ, 2011, HORTSCIENCE, V46, P460, DOI 10.21273/HORTSCI.46.3.460; Zeng SJ, 2012, SCI HORTIC-AMSTERDAM, V138, P198, DOI 10.1016/j.scienta.2012.02.026	51	446	498	61	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110033	10.1371/journal.pone.0110033	http://dx.doi.org/10.1371/journal.pone.0110033			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	24671213	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943100017
